PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	van de Haar, J; Hoes, LR; Coles, CE; Seamon, K; Frohling, S; Jager, D; Valenza, F; de Braud, F; De Petris, L; Bergh, J; Ernberg, I; Besse, B; Barlesi, F; Garralda, E; Piris-Gimenez, A; Baumann, M; Apolone, G; Soria, JC; Tabernero, J; Caldas, C; Voest, EE				van de Haar, Joris; Hoes, Louisa R.; Coles, Charlotte E.; Seamon, Kenneth; Frohling, Stefan; Jager, Dirk; Valenza, Franco; de Braud, Filippo; De Petris, Luigi; Bergh, Jonas; Ernberg, Ingemar; Besse, Benjamin; Barlesi, Fabrice; Garralda, Elena; Piris-Gimenez, Alejandro; Baumann, Michael; Apolone, Giovanni; Soria, Jean Charles; Tabernero, Josep; Caldas, Carlos; Voest, Emile E.			Caring for patients with cancer in the COVID-19 era	NATURE MEDICINE			English	Article							CORE EUROPE	The current COVID-19 pandemic challenges oncologists to profoundly re-organize oncological care in order to dramatically reduce hospital visits and admissions and therapy-induced immune-related complications without compromising cancer outcomes. Since COVID-19 is a novel disease, guidance by scientific evidence is often unavailable, and impactful decisions are inevitably made on the basis of expert opinions. Here we report how the seven comprehensive cancer centers of Cancer Core Europe have organized their healthcare systems at an unprecedented scale and pace to make their operations 'pandemic proof'. We identify and discuss many commonalities, but also important local differences, and pinpoint critical research priorities to enable evidence-based remodeling of cancer care during the COVID-19 pandemic. Also, we discuss how the current situation offers a unique window of opportunity for assessing the effects of de-escalating anticancer regimens, which may fast-forward the development of more-refined and less-toxic treatments. By sharing our joint experiences, we offer a roadmap for proceeding and aim to mobilize the global research community to generate the data that are critically needed to offer the best possible care to patients.	[van de Haar, Joris; Hoes, Louisa R.; Voest, Emile E.] Netherlands Canc Inst, Div Mol Oncol & Immunol, Amsterdam, Netherlands; [van de Haar, Joris] Netherlands Canc Inst, Div Mol Carcinogenesis, Amsterdam, Netherlands; [van de Haar, Joris; Voest, Emile E.] Netherlands Canc Inst, Oncode Inst, Amsterdam, Netherlands; [Coles, Charlotte E.; Seamon, Kenneth; Caldas, Carlos] Canc Res UK Cambridge Canc Ctr, Cambridge, England; [Frohling, Stefan] German Canc Consortium, Heidelberg, Germany; [Frohling, Stefan] Natl Ctr Tumor Dis Heidelberg, Div Translat Med Oncol, Heidelberg, Germany; [Frohling, Stefan; Baumann, Michael] German Canc Res Ctr, Heidelberg, Germany; [Jager, Dirk] Natl Ctr Tumor Dis Heidelberg, Dept Med Oncol, Heidelberg, Germany; [Jager, Dirk] Heidelberg Univ Hosp, Heidelberg, Germany; [Valenza, Franco; de Braud, Filippo] Univ Statale Milano, Milan, Italy; [Valenza, Franco; de Braud, Filippo; Apolone, Giovanni] Fdn IRCCS Ist Nazl Tumori Milano, Milan, Italy; [De Petris, Luigi; Bergh, Jonas] Karolinska Inst, Dept Oncol & Pathol, Stockholm, Sweden; [De Petris, Luigi; Bergh, Jonas] Karolinska Univ Hosp, Theme Canc, Stockholm, Sweden; [Ernberg, Ingemar] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden; [Besse, Benjamin; Barlesi, Fabrice; Soria, Jean Charles] Gustave Roussy Canc Campus, Villejuif, France; [Barlesi, Fabrice] Aix Marseille Univ, CNRS, INSERM, CRCM, Marseille, France; [Garralda, Elena; Piris-Gimenez, Alejandro; Tabernero, Josep] Vall dHebron Univ Hosp, Vall dHebron Inst Oncol, Dept Med Oncol, Barcelona, Spain; [Caldas, Carlos] Univ Cambridge, Dept Oncol, Li Ka Shing Ctr, Cambridge, England; [Caldas, Carlos] Univ Cambridge, Canc Res UK Cambridge Inst, Li Ka Shing Ctr, Cambridge, England	Netherlands Cancer Institute; Netherlands Cancer Institute; Netherlands Cancer Institute; Cancer Research UK; CRUK Cambridge Institute; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; University of Milan; Fondazione IRCCS Istituto Nazionale Tumori Milan; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; UNICANCER; Gustave Roussy; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UNICANCER; Institut Paoli-Calmette (IPC); Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut d'Oncologia (VHIO); CRUK Cambridge Institute; University of Cambridge; Cancer Research UK; CRUK Cambridge Institute; University of Cambridge	Voest, EE (corresponding author), Netherlands Canc Inst, Div Mol Oncol & Immunol, Amsterdam, Netherlands.; Voest, EE (corresponding author), Netherlands Canc Inst, Oncode Inst, Amsterdam, Netherlands.; Caldas, C (corresponding author), Canc Res UK Cambridge Canc Ctr, Cambridge, England.; Caldas, C (corresponding author), Univ Cambridge, Dept Oncol, Li Ka Shing Ctr, Cambridge, England.; Caldas, C (corresponding author), Univ Cambridge, Canc Res UK Cambridge Inst, Li Ka Shing Ctr, Cambridge, England.	carlos.caldas@cruk.cam.ac.uk; e.voest@nki.nl	Caldas, Carlos/U-7250-2019; Soria, Jean-Charles/F-3619-2014; Apolone, Giovanni/R-9799-2016	Caldas, Carlos/0000-0003-3547-1489; Bergh, Jonas/0000-0001-5526-1847; GARRALDA, Elena/0000-0002-4412-7842; Apolone, Giovanni/0000-0001-5179-104X; Baumann, Michael/0000-0002-9340-974X	Cancer Research UK (Major Center Award) [A25117]; National Institute for Health Research Cambridge Biomedical Research Center; Mark Foundation for Cancer Research; Dutch Cancer Society; Radiumhemmets Research Foundations, Stockholm; La Caixa Foundation; FERO Foundation	Cancer Research UK (Major Center Award); National Institute for Health Research Cambridge Biomedical Research Center(National Institute for Health Research (NIHR)); Mark Foundation for Cancer Research; Dutch Cancer Society(KWF Kankerbestrijding); Radiumhemmets Research Foundations, Stockholm; La Caixa Foundation(La Caixa Foundation); FERO Foundation	We thank all members of CCE centers who contributed to the development of the guidelines presented in this perspective. A list of members of CCE centers is provided in the Supplementary Note. The Cancer Research UK Cambridge Center acknowledges funding from Cancer Research UK (Major Center Award A25117), the National Institute for Health Research Cambridge Biomedical Research Center, and The Mark Foundation for Cancer Research. Authors with the Netherlands Cancer Institute acknowledge the Dutch Cancer Society for funding. Authors with the Karolinska Institutet acknowledge Radiumhemmets Research Foundations, Stockholm, for funding. Authors with the Vall d'Hebron Institute of Oncology acknowledge the Cellex Foundation for providing research facilities and equipment and La Caixa Foundation and FERO Foundation for their funding support.	Bitterman R, 2018, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008983.pub3; Calvo F, 2018, EUR J CANCER, V103, P155, DOI 10.1016/j.ejca.2018.08.023; Coles CE, 2020, CLIN ONCOL-UK, V32, P279, DOI 10.1016/j.clon.2020.03.006; Eggermont AMM, 2019, MOL ONCOL, V13, P521, DOI 10.1002/1878-0261.12447; Eggermont AMM, 2014, EUR J CANCER, V50, P2745, DOI 10.1016/j.ejca.2014.07.025; Kunisaki KM, 2009, LANCET INFECT DIS, V9, P493, DOI 10.1016/S1473-3099(09)70175-6; Lefevre JH, 2016, J CLIN ONCOL, V34, P3773, DOI 10.1200/JCO.2016.67.6049; Liang WH, 2020, LANCET ONCOL, V21, P335, DOI 10.1016/S1470-2045(20)30096-6; NHS England, 2020, CLIN GUID MAN NONC P; Persad G, 2020, NEW ENGL J MED, V382, DOI 10.1056/NEJMc2009666; Walker P.G., 2020, REPORT 12 GLOBAL IMP, P1; Wang HP, 2020, LANCET ONCOL, V21, pE181, DOI 10.1016/S1470-2045(20)30149-2; Watanabe K, 2022, SOC SCI COMPUT REV, V40, P346, DOI 10.1177/0894439320907027; Xia Y, 2020, LANCET ONCOL, V21, pE180, DOI 10.1016/S1470-2045(20)30150-9; Yang Y, 2020, INNOVATION-AMSTERDAM, V1, DOI 10.1016/j.xinn.2020.100061; ZHANG MD, 2020, ANN ONCOL, DOI DOI 10.1016/J.ANNONC.2020.03.296	16	195	197	2	10	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	MAY	2020	26	5					665	671		10.1038/s41591-020-0874-8	http://dx.doi.org/10.1038/s41591-020-0874-8			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	ML1JP	32405058	Bronze			2022-12-27	WOS:000549231500019
J	Burd, A; Levine, RL; Ruppert, AS; Mims, AS; Borate, U; Stein, EM; Patel, P; Baer, MR; Stock, W; Deininger, M; Blum, W; Schiller, G; Olin, R; Litzow, M; Foran, J; Lin, TRL; Ball, B; Boyiadzis, M; Traer, E; Odenike, O; Arellano, M; Walker, A; Duong, VH; Kovacsovics, T; Collins, R; Shoben, AB; Heerema, NA; Foster, MC; Vergilio, JA; Brennan, T; Vietz, C; Severson, E; Miller, M; Rosenberg, L; Marcus, S; Yocum, A; Chen, T; Stefanos, M; Druker, B; Byrd, JC				Burd, Amy; Levine, Ross L.; Ruppert, Amy S.; Mims, Alice S.; Borate, Uma; Stein, Eytan M.; Patel, Prapti; Baer, Maria R.; Stock, Wendy; Deininger, Michael; Blum, William; Schiller, Gary; Olin, Rebecca; Litzow, Mark; Foran, James; Lin, Tara L.; Ball, Brian; Boyiadzis, Michael; Traer, Elie; Odenike, Olatoyosi; Arellano, Martha; Walker, Alison; Duong, Vu. H.; Kovacsovics, Tibor; Collins, Robert; Shoben, Abigail B.; Heerema, Nyla A.; Foster, Matthew C.; Vergilio, Jo-Anne; Brennan, Tim; Vietz, Christine; Severson, Eric; Miller, Molly; Rosenberg, Leonard; Marcus, Sonja; Yocum, Ashley; Chen, Timothy; Stefanos, Mona; Druker, Brian; Byrd, John C.			Precision medicine treatment in acute myeloid leukemia using prospective genomic profiling: feasibility and preliminary efficacy of the Beat AML Master Trial	NATURE MEDICINE			English	Article							ELDERLY-PATIENTS; SUPPORTIVE CARE; OLDER PATIENTS; PHASE-III; CHEMOTHERAPY; MUTATIONS; CANCER; DECITABINE; THERAPY; PROTEIN	Acute myeloid leukemia (AML) is the most common diagnosed leukemia. In older adults, AML confers an adverse outcome(1,2). AML originates from a dominant mutation, then acquires collaborative transformative mutations leading to myeloid transformation and clinical/biological heterogeneity. Currently, AML treatment is initiated rapidly, precluding the ability to consider the mutational profile of a patient's leukemia for treatment decisions. Untreated patients with AML >= 60 years were prospectively enrolled on the ongoing Beat AML trial (ClinicalTrials.gov ), which aims to provide cytogenetic and mutational data within 7 days (d) from sample receipt and before treatment selection, followed by treatment assignment to a sub-study based on the dominant clone. A total of 487 patients with suspected AML were enrolled; 395 were eligible. Median age was 72 years (range 60-92 years; 38% >= 75 years); 374 patients (94.7%) had genetic and cytogenetic analysis completed within 7 d and were centrally assigned to a Beat AML sub-study; 224 (56.7%) were enrolled on a Beat AML sub-study. The remaining 171 patients elected standard of care (SOC) (103), investigational therapy (28) or palliative care (40); 9 died before treatment assignment. Demographic, laboratory and molecular characteristics were not significantly different between patients on the Beat AML sub-studies and those receiving SOC (induction with cytarabine + daunorubicin (7 + 3 or equivalent) or hypomethylation agent). Thirty-day mortality was less frequent and overall survival was significantly longer for patients enrolled on the Beat AML sub-studies versus those who elected SOC. A precision medicine therapy strategy in AML is feasible within 7 d, allowing patients and physicians to rapidly incorporate genomic data into treatment decisions without increasing early death or adversely impacting overall survival. Preliminary results from the Beat AML umbrella trial demonstrates the feasibility and efficacy of applying prospective genomic profiling for matching newly diagnosed patients with AML with targeted therapies.	[Burd, Amy; Rosenberg, Leonard; Marcus, Sonja; Yocum, Ashley] Leukemia & Lymphoma Soc, Rye Brook, NY USA; [Levine, Ross L.; Stein, Eytan M.; Ball, Brian] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA; [Ruppert, Amy S.; Mims, Alice S.; Walker, Alison; Shoben, Abigail B.; Heerema, Nyla A.; Miller, Molly; Chen, Timothy; Stefanos, Mona; Byrd, John C.] Ohio State Univ, Columbus, OH 43210 USA; [Borate, Uma; Traer, Elie; Druker, Brian] Oregon Hlth & Sci Univ, Portland, OR 97201 USA; [Patel, Prapti; Collins, Robert] Univ Texas Southwestern Med Ctr Dallas, Dallas, TX 75390 USA; [Baer, Maria R.; Duong, Vu. H.] Univ Maryland, Med Ctr, Baltimore, MD 21201 USA; [Stock, Wendy; Odenike, Olatoyosi] Univ Chicago, Chicago, IL 60637 USA; [Deininger, Michael; Kovacsovics, Tibor] Univ Utah, Salt Lake City, UT USA; [Blum, William; Arellano, Martha] Emory Univ, Atlanta, GA 30322 USA; [Schiller, Gary] Univ Calif Los Angeles, Los Angeles, CA USA; [Olin, Rebecca] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Litzow, Mark] Mayo Clin, Rochester, MN USA; [Foran, James] Mayo Clin, Jacksonville, FL 32224 USA; [Lin, Tara L.] Univ Kansas, Med Ctr, Kansas City, KS 66103 USA; [Boyiadzis, Michael] Univ Pittsburgh, Pittsburgh, PA USA; [Foster, Matthew C.] Univ N Carolina, Chapel Hill, NC 27515 USA; [Vergilio, Jo-Anne; Brennan, Tim; Vietz, Christine; Severson, Eric] Fdn Med, Cambridge, MA USA	Memorial Sloan Kettering Cancer Center; University System of Ohio; Ohio State University; Oregon Health & Science University; University of Texas System; University of Texas Southwestern Medical Center Dallas; University System of Maryland; University of Maryland Baltimore; University of Chicago; Utah System of Higher Education; University of Utah; Emory University; University of California System; University of California Los Angeles; University of California System; University of California San Francisco; Mayo Clinic; Mayo Clinic; University of Kansas; University of Kansas Medical Center; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of North Carolina; University of North Carolina Chapel Hill; Foundation Medicine	Byrd, JC (corresponding author), Ohio State Univ, Columbus, OH 43210 USA.	John.Byrd@osumc.edu		levine, ross/0000-0002-7884-1905; Mims, Alice/0000-0002-8971-2199	LLS; Harry T. Mangurian Foundation; NCI [R35 CA198183, R35 CA197594]; NIH/NCI Cancer Center Support grant [P30 CA008748, P30CA069533, P30 CA016058]	LLS; Harry T. Mangurian Foundation; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH/NCI Cancer Center Support grant	The investigative team thanks the patients and their caregivers who participated in this trial. The study was sponsored by the LLS, which holds the investigational new drug (IND) application for this trial. Funding for the trial was made possible by the Harry T. Mangurian Foundation, many other donors and the sites that enabled resources for rapid turnaround for cytogenetics and other monitoring requirements of patients. The IND and ultimate design and implementation of this trial came forth from integral collaboration of the LLS team and members at the FDA under the leadership of R. Pazdur, D. Przepiorka, A. Deisseroth and A. Farrell, to whom we are greatly indebted. We thank the investigators and coordinators at each of the clinical sites and the patients who participated in this trial and their families who supported them. Sub-studies in this trial were supported by the pharmaceutical sponsor. We thank the pharmaceutical sponsors who paid the cost of performing the specific sub-studies with their investigational drugs. This work was supported by the NCI (grant no. R35 CA198183 to J.C.B.; grant no. R35 CA197594 to R.L.L.) and in part through the NIH/NCI Cancer Center Support grant nos. P30 CA008748, P30CA069533 and P30 CA016058. We acknowledge many references that could not be included based on the limitations of the journal.	Abelson S, 2018, NATURE, V559, P400, DOI 10.1038/s41586-018-0317-6; Becker H, 2010, J CLIN ONCOL, V28, P596, DOI 10.1200/JCO.2009.25.1496; Bertoli S, 2013, BLOOD, V121, P2618, DOI 10.1182/blood-2012-09-454553; Chen JH, 2019, NAT MED, V25, P103, DOI 10.1038/s41591-018-0267-4; Desai P, 2018, NAT MED, V24, P1015, DOI 10.1038/s41591-018-0081-z; DiNardo CD, 2018, NEW ENGL J MED, V378, P2386, DOI 10.1056/NEJMoa1716984; DiNardo C, 2019, CURR HEMATOL MALIG R, V14, P386, DOI 10.1007/s11899-019-00535-7; Eisfeld AK, 2017, LEUKEMIA, V31, P2211, DOI 10.1038/leu.2017.86; Eisfeld AK, 2018, LEUKEMIA, V32, P1338, DOI 10.1038/s41375-018-0068-2; Fenaux P, 2010, J CLIN ONCOL, V28, P562, DOI 10.1200/JCO.2009.23.8329; Fong JY, 2019, CANCER CELL, V36, P194, DOI 10.1016/j.ccell.2019.07.003; Frampton GM, 2013, NAT BIOTECHNOL, V31, P1023, DOI 10.1038/nbt.2696; Intlekofer AM, 2018, BLOOD CANCER J, V8, DOI 10.1038/s41408-018-0089-0; Kantarjian HM, 2012, J CLIN ONCOL, V30, P2670, DOI 10.1200/JCO.2011.38.9429; Karjalainen E, 2016, PROG MOL BIOL TRANSL, V144, P383, DOI 10.1016/bs.pmbts.2016.09.005; Khwaja A, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.10; Koszarska M, 2013, LEUKEMIA LYMPHOMA, V54, P1028, DOI 10.3109/10428194.2012.736981; Lubbert M, 2011, J CLIN ONCOL, V29, P1987, DOI 10.1200/JCO.2010.30.9245; Mardis ER, 2009, NEW ENGL J MED, V361, P1058, DOI 10.1056/NEJMoa0903840; Mill CP, 2019, BLOOD, V134, P59, DOI 10.1182/blood.2018893982; Nguyen HD, 2018, CANCER RES, V78, P5363, DOI 10.1158/0008-5472.CAN-17-3970; Papaemmanuil E, 2016, NEW ENGL J MED, V374, P2209, DOI 10.1056/NEJMoa1516192; Patel JP, 2012, NEW ENGL J MED, V366, P1079, DOI 10.1056/NEJMoa1112304; Stone A, 2019, LEUKEMIA RES, V82, P36, DOI 10.1016/j.leukres.2019.05.007; Stone RM, 2017, NEW ENGL J MED, V377, P454, DOI 10.1056/NEJMoa1614359; Takahashi K, 2017, LANCET ONCOL, V18, P100, DOI 10.1016/S1470-2045(16)30626-X; Uy GL, 2017, BLOOD ADV, V1, P331, DOI 10.1182/bloodadvances.2016003053; van Buuren S, 2007, STAT METHODS MED RES, V16, P219, DOI 10.1177/0962280206074463; Vasu S, 2018, BLOOD ADV, V2, P1645, DOI 10.1182/bloodadvances.2017015222; Yang H, 2018, BLOOD, V131, P328, DOI 10.1182/blood-2017-06-789669	30	51	51	2	14	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	2020	26	12								10.1038/s41591-020-1089-8	http://dx.doi.org/10.1038/s41591-020-1089-8		OCT 2020	11	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	PB8QO	33106665	Green Accepted			2022-12-27	WOS:000584042900002
J	Hadjadj, D; Deshmukh, S; Jabado, N				Hadjadj, Djihad; Deshmukh, Shriya; Jabado, Nada			Entering the era of precision medicine in pediatric oncology	NATURE MEDICINE			English	Editorial Material							MUTATIONS; CLASSIFICATION; GENES	The Zero Childhood Cancer Program's multi-platform sequencing approach identified molecular alterations in 94% of a cohort of 247 pediatric patients with high-risk cancers, which has enabled more-precise diagnoses and alternative therapeutic recommendations.	[Hadjadj, Djihad; Jabado, Nada] McGill Univ, Dept Human Genet, Montreal, PQ, Canada; [Deshmukh, Shriya; Jabado, Nada] McGill Univ, Dept Expt Med, Montreal, PQ, Canada; [Jabado, Nada] McGill Univ, Dept Pediat, Montreal, PQ, Canada; [Jabado, Nada] McGill Univ, Ctr Hlth, Res Inst, Montreal, PQ, Canada	McGill University; McGill University; McGill University; McGill University	Jabado, N (corresponding author), McGill Univ, Dept Human Genet, Montreal, PQ, Canada.; Jabado, N (corresponding author), McGill Univ, Dept Expt Med, Montreal, PQ, Canada.; Jabado, N (corresponding author), McGill Univ, Dept Pediat, Montreal, PQ, Canada.; Jabado, N (corresponding author), McGill Univ, Ctr Hlth, Res Inst, Montreal, PQ, Canada.	nada.jabado@mcgill.ca	Hadjadj, Djihad/AAD-5882-2022; Dji, Hadjadj/GQQ-2555-2022	Deshmukh, Shriya/0000-0001-9086-3261				Capper D, 2018, NATURE, V555, P469, DOI 10.1038/nature26000; Cunningham RM, 2018, NEW ENGL J MED, V379, P2468, DOI 10.1056/NEJMsr1804754; DuBois SG, 2019, SCIENCE, V363, P1175, DOI 10.1126/science.aaw4153; Grobner SN, 2018, NATURE, V555, P321, DOI 10.1038/nature25480; Schwartzentruber J, 2012, NATURE, V482, P226, DOI [10.1038/nature10833, 10.1007/s13311-012-0137-6]; Steliarova-Foucher E, 2017, LANCET ONCOL, V18, P719, DOI 10.1016/S1470-2045(17)30186-9; Sturm D, 2016, CELL, V164, P1060, DOI 10.1016/j.cell.2016.01.015; Sturm D, 2012, CANCER CELL, V22, P425, DOI 10.1016/j.ccr.2012.08.024; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Wong M, 2020, NAT MED, V26, P1742, DOI 10.1038/s41591-020-1072-4; Zhang JH, 2015, NEW ENGL J MED, V373, P2336, DOI 10.1056/NEJMoa1508054	11	8	8	1	3	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2020	26	11					1684	1685		10.1038/s41591-020-1119-6	http://dx.doi.org/10.1038/s41591-020-1119-6		OCT 2020	2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	OT0SR	33077957				2022-12-27	WOS:000579706700004
J	Fujii, M; Sugimoto, S; Sato, T				Fujii, Masayuki; Sugimoto, Shinya; Sato, Toshiro			Linking human intestinal scaffolds and organoids to combat intestinal failure	NATURE MEDICINE			English	Editorial Material								Combining organoids and decellularized intestinal scaffolds generates durable hybrid intestines that will open up new avenues for the regenerative treatment of patients with intestinal failure.	[Fujii, Masayuki; Sugimoto, Shinya; Sato, Toshiro] Keio Univ, Dept Organoid Med, Sch Med, Tokyo, Japan	Keio University	Sato, T (corresponding author), Keio Univ, Dept Organoid Med, Sch Med, Tokyo, Japan.	t.sato@keio.jp	Sugimoto, Shinya/X-6548-2018; Sato, Toshiro/J-3522-2014	Sato, Toshiro/0000-0001-8353-8137				Barker N, 2014, NAT REV MOL CELL BIO, V15, P19, DOI 10.1038/nrm3721; Clevers H, 2019, CELL STEM CELL, V24, P855, DOI 10.1016/j.stem.2019.04.018; Giobbe GG, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-13605-4; Massironi S, 2020, DIGEST LIVER DIS, V52, P253, DOI 10.1016/j.dld.2019.11.013; Meran L, 2020, NAT MED, V26, P1593, DOI 10.1038/s41591-020-1024-z; Nakamura T, 2018, CELL MOL GASTROENTER, V5, P51, DOI 10.1016/j.jcmgh.2017.10.006; Sato T, 2011, GASTROENTEROLOGY, V141, P1762, DOI 10.1053/j.gastro.2011.07.050; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Spence JR, 2011, NATURE, V470, P105, DOI 10.1038/nature09691; Watson CL, 2014, NAT MED, V20, P1310, DOI 10.1038/nm.3737	10	3	3	5	10	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	OCT	2020	26	10					1517	1518		10.1038/s41591-020-1096-9	http://dx.doi.org/10.1038/s41591-020-1096-9		SEP 2020	2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	NX8MD	32968235				2022-12-27	WOS:000572324600002
J	Morse, KE; Bagley, SC; Shah, NGH				Morse, Keith E.; Bagley, Steven C.; Shah, Nigam H.			Estimate the hidden deployment cost of predictive models to improve patient care (vol 26, pg 18, 2020)	NATURE MEDICINE			English	Correction												kmorse@stanfordchildrens.org		Morse, Keith/0000-0002-8307-1642				Morse KE, 2020, NAT MED, V26, P18, DOI 10.1038/s41591-019-0651-8	1	1	1	0	2	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	MAY	2020	26	5					803	803		10.1038/s41591-020-0862-z	http://dx.doi.org/10.1038/s41591-020-0862-z		APR 2020	1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	ML1MY	32291415	Bronze			2022-12-27	WOS:000526350100004
J	Ernst, CM; Braxton, JR; Rodriguez-Osorio, CA; Zagieboylo, AP; Li, L; Pironti, A; Manson, AL; Nair, AV; Benson, M; Cummins, K; Clatworthy, AE; Earl, AM; Cosimi, LA; Hung, DBT				Ernst, Christoph M.; Braxton, Julian R.; Rodriguez-Osorio, Carlos A.; Zagieboylo, Anna P.; Li, Li; Pironti, Alejandro; Manson, Abigail L.; Nair, Anil V.; Benson, Maura; Cummins, Kaelyn; Clatworthy, Anne E.; Earl, Ashlee M.; Cosimi, Lisa A.; Hung, Deborah T.			Adaptive evolution of virulence and persistence in carbapenem-resistant Klebsiella pneumoniae	NATURE MEDICINE			English	Article							CAPSULAR POLYSACCHARIDE SYNTHESIS; UROPATHOGENIC ESCHERICHIA-COLI; LIVER-ABSCESS; EPIDEMIOLOGY; MECHANISMS; VECTORS; CONSTRUCTION; INFECTION; ALIGNMENT; GENE	Among the most urgent public health threats is the worldwide emergence of carbapenem-resistant Enterobacteriaceae(1-4), which are resistant to the antibiotic class of 'last resort'. In the United States and Europe, carbapenem-resistant strains of the Klebsiella pneumoniae ST258 (ref. (5)) sequence type are dominant, endemic(6-8) and associated with high mortality(6,9,10). We report the global evolution of pathogenicity in carbapenem-resistant K. pneumoniae, resulting in the repeated convergence of virulence and carbapenem resistance in the United States and Europe, dating back to as early as 2009. We demonstrate that K. pneumoniae can enhance its pathogenicity by adopting two opposing infection programs through easily acquired gain- and loss-of-function mutations. Single-nucleotide polymorphisms in the capsule biosynthesis gene wzc lead to hypercapsule production, which confers phagocytosis resistance, enhanced dissemination and increased mortality in animal models. In contrast, mutations disrupting capsule biosynthesis genes impair capsule production, which enhances epithelial cell invasion, in vitro biofilm formation and persistence in urinary tract infections. These two types of capsule mutants have emerged repeatedly and independently in Europe and the United States, with hypercapsule mutants associated with bloodstream infections and capsule-deficient mutants associated with urinary tract infections. In the latter case, drug-tolerant K. pneumoniae can persist to yield potentially untreatable, persistent infection. Mutations in Klebsiella pneumoniae that lead to gain or loss of capsule production affect pathogenicity and associate with bloodstream or urinary tract infections, respectively.	[Ernst, Christoph M.; Braxton, Julian R.; Rodriguez-Osorio, Carlos A.; Zagieboylo, Anna P.; Li, Li; Pironti, Alejandro; Manson, Abigail L.; Clatworthy, Anne E.; Earl, Ashlee M.; Hung, Deborah T.] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Ernst, Christoph M.; Braxton, Julian R.; Rodriguez-Osorio, Carlos A.; Zagieboylo, Anna P.; Li, Li; Clatworthy, Anne E.; Hung, Deborah T.] Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; [Ernst, Christoph M.; Braxton, Julian R.; Rodriguez-Osorio, Carlos A.; Zagieboylo, Anna P.; Li, Li; Clatworthy, Anne E.; Hung, Deborah T.] Massachusetts Gen Hosp, Ctr Computat & Integrat Biol, Boston, MA 02114 USA; [Ernst, Christoph M.; Braxton, Julian R.; Rodriguez-Osorio, Carlos A.; Zagieboylo, Anna P.; Li, Li; Clatworthy, Anne E.; Hung, Deborah T.] Harvard Med Sch, Dept Genet, Boston, MA 02115 USA; [Nair, Anil V.] Massachusetts Gen Hosp, Ctr Syst Biol, Program Membrane Biol, Div Nephrol, Boston, MA 02114 USA; [Benson, Maura; Cummins, Kaelyn; Cosimi, Lisa A.] Brigham & Womens Hosp, Div Infect Dis, 75 Francis St, Boston, MA 02115 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital	Hung, DBT (corresponding author), Broad Inst MIT & Harvard, Cambridge, MA 02142 USA.; Hung, DBT (corresponding author), Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA.; Hung, DBT (corresponding author), Massachusetts Gen Hosp, Ctr Computat & Integrat Biol, Boston, MA 02114 USA.; Hung, DBT (corresponding author), Harvard Med Sch, Dept Genet, Boston, MA 02115 USA.	hung@molbio.mgh.harvard.edu		Rodriguez Osorio, Carlos A/0000-0002-4972-4611; Ernst, Christoph/0000-0002-5575-1325; Braxton, Julian/0000-0002-1170-5140	National Institute of Allergy and Infectious Diseases of the National Institutes of Health (NIH) [R01AI117043]; German Research Foundation (Deutsche Forschungsgemeinschaft); Fund for Medical Discovery Postdoctoral Fellowship from MGH; Mexican National Council for Science and Technology; Fundacion Mexico en Harvard; Center for the Study of Inflammatory Bowel Disease grant [DK043351]; Boston Area Diabetes and Endocrinology Research Center award [DK057521]; NIH Shared Instrumentation grant [1S10OD021577-01]	National Institute of Allergy and Infectious Diseases of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); German Research Foundation (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG)); Fund for Medical Discovery Postdoctoral Fellowship from MGH; Mexican National Council for Science and Technology(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Fundacion Mexico en Harvard; Center for the Study of Inflammatory Bowel Disease grant; Boston Area Diabetes and Endocrinology Research Center award; NIH Shared Instrumentation grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank L. Van Dijk for his help with the illustration of the phylogenetic analysis and Z. Ackermann-Bloom for advice on imaging. This work was supported by a generous gift from A. and J. Bekenstein and by the National Institute of Allergy and Infectious Diseases of the National Institutes of Health (NIH) under award no. R01AI117043 to D.T.H. C.M.E. was supported by a Research Fellowship from the German Research Foundation (Deutsche Forschungsgemeinschaft) and by a Fund for Medical Discovery Postdoctoral Fellowship from MGH. C.A.R. was supported by the Mexican National Council for Science and Technology and Fundacion Mexico en Harvard. The Microscopy Core of the Program in Membrane Biology was partially supported by a Center for the Study of Inflammatory Bowel Disease grant (no. DK043351) and a Boston Area Diabetes and Endocrinology Research Center award (no. DK057521). The Zeiss LSM 800 Airyscan confocal microscope was purchased using an NIH Shared Instrumentation grant (no. 1S10OD021577-01).	Arndt D, 2016, NUCLEIC ACIDS RES, V44, pW16, DOI 10.1093/nar/gkw387; Blango MG, 2010, ANTIMICROB AGENTS CH, V54, P1855, DOI 10.1128/AAC.00014-10; BLUMENKR.N, 1973, ANAL BIOCHEM, V54, P484, DOI 10.1016/0003-2697(73)90377-1; Bowers JR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133727; Broberg Christopher A, 2014, F1000Prime Rep, V6, P64, DOI 10.12703/P6-64; Centers for Disease Control, 2013, ANTIBIOTIC RESISTANC; Cerqueira GC, 2017, P NATL ACAD SCI USA, V114, P1135, DOI 10.1073/pnas.1616248114; CHANG ACY, 1978, J BACTERIOL, V134, P1141, DOI 10.1128/JB.134.3.1141-1156.1978; Coffey BM, 2014, METHODS MOL BIOL, V1149, P631, DOI 10.1007/978-1-4939-0473-0_48; Crepin S, 2012, APPL ENVIRON MICROB, V78, P6001, DOI 10.1128/AEM.00986-12; Dautzenberg MJD, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-009971; Davis JH, 2011, NUCLEIC ACIDS RES, V39, P1131, DOI 10.1093/nar/gkq810; Deleo FR, 2014, P NATL ACAD SCI USA, V111, P4988, DOI 10.1073/pnas.1321364111; DOMENICO P, 1989, INFECT IMMUN, V57, P3778, DOI 10.1128/IAI.57.12.3778-3782.1989; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Edwards RA, 1998, GENE, V207, P149, DOI 10.1016/S0378-1119(97)00619-7; Eto DS, 2006, CELL MICROBIOL, V8, P704, DOI 10.1111/j.1462-5822.2006.00691.x; European Centre for Disease Prevention and Control, 2018, RAP RISK ASS CARB RE; Fang CT, 2004, J EXP MED, V199, P697, DOI 10.1084/jem.20030857; Ferrieres L, 2010, J BACTERIOL, V192, P6418, DOI 10.1128/JB.00621-10; Flores-Mireles AL, 2015, NAT REV MICROBIOL, V13, P269, DOI 10.1038/nrmicro3432; Geisinger E, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004691; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Goris J, 2007, INT J SYST EVOL MICR, V57, P81, DOI 10.1099/ijs.0.64483-0; GOTTESMAN S, 1991, MOL MICROBIOL, V5, P1599, DOI 10.1111/j.1365-2958.1991.tb01906.x; Gu DX, 2018, LANCET INFECT DIS, V18, P37, DOI [10.1016/S1473-3099(17)30489-9, 10.1016/s1473-3099(17)30489-9]; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Hsu CR, 2011, MICROBIOL-SGM, V157, P3446, DOI 10.1099/mic.0.050336-0; Hung CS, 2009, NAT PROTOC, V4, P1230, DOI 10.1038/nprot.2009.116; Hunstad DA, 2010, ANNU REV MICROBIOL, V64, P203, DOI 10.1146/annurev.micro.112408.134258; Inouye M, 2014, GENOME MED, V6, DOI 10.1186/s13073-014-0090-6; Kobayashi SD, 2018, FUTURE MICROBIOL, V13, P1343, DOI 10.2217/fmb-2018-0189; Kobayashi SD, 2016, J INFECT DIS, V213, P1615, DOI 10.1093/infdis/jiw001; Lam MMC, 2018, GENOME MED, V10, DOI 10.1186/s13073-018-0587-5; Lam MMC, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05114-7; Lam MMC, 2018, MICROB GENOMICS, V4, DOI 10.1099/mgen.0.000196; Lee CR, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00895; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Mulvey MA, 2001, INFECT IMMUN, V69, P4572, DOI 10.1128/IAI.69.7.4572-4579.2001; Munoz-Price LS, 2013, LANCET INFECT DIS, V13, P785, DOI 10.1016/S1473-3099(13)70190-7; Mysorekar IU, 2006, P NATL ACAD SCI USA, V103, P14170, DOI 10.1073/pnas.0602136103; NASSIF X, 1989, INFECT IMMUN, V57, P546, DOI 10.1128/IAI.57.2.546-552.1989; Pitout JDD, 2015, ANTIMICROB AGENTS CH, V59, P5873, DOI 10.1128/AAC.01019-15; Ruppe E, 2017, CLIN MICROBIOL INFEC, V23, P470, DOI 10.1016/j.cmi.2017.01.015; Russo TA, 2019, CLIN MICROBIOL REV, V32, DOI 10.1128/CMR.00001-19; Sahly H, 2000, INFECT IMMUN, V68, P6744, DOI 10.1128/IAI.68.12.6744-6749.2000; Shaner NC, 2013, NAT METHODS, V10, P407, DOI [10.1038/NMETH.2413, 10.1038/nmeth.2413]; Siguier P, 2006, NUCLEIC ACIDS RES, V34, pD32, DOI 10.1093/nar/gkj014; Siu LK, 2012, LANCET INFECT DIS, V12, P881, DOI 10.1016/S1473-3099(12)70205-0; Skurnik D, 2016, J ANTIMICROB CHEMOTH, V71, P927, DOI 10.1093/jac/dkv448; Snitkin ES, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004129; Spencer MD, 2019, J INFECTION, V78, P187, DOI 10.1016/j.jinf.2018.11.003; Sperlea T, 2019, BORIS IDENTIFICATION, DOI [10.1101/597070, DOI 10.1101/597070]; Uhlemann AC, 2014, INFECT GENET EVOL, V21, P563, DOI 10.1016/j.meegid.2013.04.030; Valentini M, 2018, CURR OPIN MICROBIOL, V41, P15, DOI 10.1016/j.mib.2017.11.006; Walker BJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112963; Walker KA, 2019, MBIO, V10, DOI 10.1128/mBio.00089-19; Whitfield C, 2006, ANNU REV BIOCHEM, V75, P39, DOI 10.1146/annurev.biochem.75.103004.142545; Wilm A, 2012, NUCLEIC ACIDS RES, V40, P11189, DOI 10.1093/nar/gks918; World Health Organization, 2014, ANT RES GLOB REP SUR; Wozniak JE, 2019, ANTIMICROB AGENTS CH, V63, DOI [10.1128/AAC.00107-19, 10.1128/aac.00107-19]; Wyres KL, 2016, MICROB GENOMICS, V2, DOI 10.1099/mgen.0.000102; Yoshida K, 2000, J MED MICROBIOL, V49, P1003, DOI 10.1099/0022-1317-49-11-1003; Zilberberg MD, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2383-z	64	57	61	3	32	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	MAY	2020	26	5					705	711		10.1038/s41591-020-0825-4	http://dx.doi.org/10.1038/s41591-020-0825-4		APR 2020	7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	MC2NG	32284589	Green Accepted			2022-12-27	WOS:000526266600003
J	Stower, H				Stower, Hannah			Lopinavir-ritonavir in severe COVID-19	NATURE MEDICINE			English	Editorial Material																			0	44	46	0	6	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	APR	2020	26	4					465	465		10.1038/s41591-020-0849-9	http://dx.doi.org/10.1038/s41591-020-0849-9			1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	QH1UE	32273604	Bronze			2022-12-27	WOS:000618061900015
J	Tadros, AR; Romanyuk, A; Miller, IC; Santiago, A; Noel, RK; O'Farrell, L; Kwong, GA; Prausnitz, MR				Tadros, Andrew R.; Romanyuk, Andrey; Miller, Ian C.; Santiago, Andrea; Noel, Richard K.; O'Farrell, Laura; Kwong, Gabriel A.; Prausnitz, Mark R.			STAR particles for enhanced topical drug and vaccine delivery	NATURE MEDICINE			English	Article							MICRONEEDLE PATCHES; SKIN-DISEASE; METHOTREXATE; PSORIASIS; EFFICACY; DESIGN; BURDEN; IMPACT	Drug delivery to the skin is highly constrained by the stratum corneum barrier layer(1). Here, we developed star-shaped particles, termed STAR particles, to dramatically increase skin permeability. STAR particles are millimeter-scale particles made of aluminum oxide or stainless steel with micron-scale projections designed to create microscopic pores across the stratum corneum. After gentle topical application for 10 s to porcine skin ex vivo, delivery of dermatological drugs and macromolecules, including those that cannot be given topically, was increased by 1 to 2 orders of magnitude. In mice treated with topical 5-fluorouracil, use of STAR particles increased the efficacy of the drug in suppressing the growth of subcutaneous melanoma tumors and prolonging survival. Moreover, topical delivery of tetanus toxoid vaccine to mice using STAR particles generated immune responses that were at least as strong as delivery of the vaccine by intramuscular injection, albeit at a higher dose for topical than intramuscular vaccine administration. STAR particles were well tolerated and effective at creating micropores when applied to the skin of human participants. Use of STAR particles provides a simple, low-cost and well-tolerated method for increasing drug and vaccine delivery to the skin and could widen the range of compounds that can be topically administered. Star-shaped, approximately 1-mm-wide ceramic particles, termed STAR particles, create micropores in the skin and, when added to topical formulations, enhance drug and vaccine delivery through the skin in mice.	[Tadros, Andrew R.; Romanyuk, Andrey; Prausnitz, Mark R.] Georgia Inst Technol, Sch Chem & Biomol Engn, Atlanta, GA 30332 USA; [Miller, Ian C.; Santiago, Andrea; Kwong, Gabriel A.; Prausnitz, Mark R.] Georgia Tech, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30332 USA; [Miller, Ian C.; Santiago, Andrea; Kwong, Gabriel A.; Prausnitz, Mark R.] Emory Univ, Georgia Inst Technol, Atlanta, GA 30322 USA; [Noel, Richard K.; O'Farrell, Laura] Georgia Inst Technol, Physiol Res Lab, Atlanta, GA 30332 USA	University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology; Emory University; University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology	Prausnitz, MR (corresponding author), Georgia Inst Technol, Sch Chem & Biomol Engn, Atlanta, GA 30332 USA.; Prausnitz, MR (corresponding author), Georgia Tech, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30332 USA.	prausnitz@gatech.edu	Kwong, Gabriel A/M-5376-2013; Kwong, Gabriel/AAO-8266-2021	Kwong, Gabriel A/0000-0002-6255-6755; Kwong, Gabriel/0000-0002-6255-6755; Prausnitz, Mark/0000-0002-9076-8448	Georgia Research Alliance [GRA.VL17.B18]; CDC Foundation; UNICEF [969-17SC.GTRC]; National Institutes of Health Director's New Innovator Award [DP2HD091793]; Burroughs Wellcome Fund	Georgia Research Alliance; CDC Foundation(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); UNICEF; National Institutes of Health Director's New Innovator Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Fund(Burroughs Wellcome Fund)	The authors thank D. McAllister, S. Henry and W. Pewin for helpful discussions; R. Schafer for his expertise and assistance with laser micromachining; and D. Bondy for administrative support. This work was supported financially by the Georgia Research Alliance (no. GRA.VL17.B18, M.R.P.), the CDC Foundation with funding that originated from UNICEF (no. 969-17SC.GTRC, M.R.P.), the National Institutes of Health Director's New Innovator Award (no. DP2HD091793, G.A.K.) and a Career Award at the Scientific Interface from the Burroughs Wellcome Fund (G.A.K.).	Alster TS, 2018, DERMATOL SURG, V44, P397, DOI 10.1097/DSS.0000000000001248; [Anonymous], 2012, STAND SPEC HIGH PUR; Arora A, 2008, INT J PHARMACEUT, V364, P227, DOI 10.1016/j.ijpharm.2008.08.032; Becker LC, 2016, INT J TOXICOL, V35, p16S, DOI 10.1177/1091581816677948; Beyer V, 2010, ARCH DERMATOL, V146, P46, DOI 10.1001/archdermatol.2009.319; Bolognia JL, 2018, DERMATOLOGY, V4th; Cary JH, 2019, BIOMED MICRODEVICES, V21, DOI 10.1007/s10544-019-0371-3; Cazzaniga S, 2016, J EUR ACAD DERMATOL, V30, P628, DOI 10.1111/jdv.13479; Choy YB, 2011, PHARM RES-DORDR, V28, P943, DOI 10.1007/s11095-010-0292-6; Edens C, 2015, VACCINE, V33, P4683, DOI 10.1016/j.vaccine.2015.01.089; Eskicirak B, 2006, INT J DERMATOL, V45, P965, DOI 10.1111/j.1365-4632.2006.02911.x; Gill HS, 2008, CLIN J PAIN, V24, P585, DOI 10.1097/AJP.0b013e31816778f9; Gomaa YA, 2010, TOXICOL IN VITRO, V24, P1971, DOI 10.1016/j.tiv.2010.08.012; Good LM, 2011, J AM ACAD DERMATOL, V64, P413, DOI 10.1016/j.jaad.2009.12.013; Gross K, 2007, DERMATOL SURG, V33, P433, DOI 10.1111/j.1524-4725.2007.33090.x; Gupta PN, 2005, J PHARM PHARMACOL, V57, P295, DOI 10.1211/0022357055515; Hay RJ, 2014, J INVEST DERMATOL, V134, P1527, DOI 10.1038/jid.2013.446; Horn TD, 2005, ARCH DERMATOL, V141, P589, DOI 10.1001/archderm.141.5.589; Hutin YJF, 2003, BMJ-BRIT MED J, V327, P1075, DOI 10.1136/bmj.327.7423.1075; Karande P, 2005, P NATL ACAD SCI USA, V102, P4688, DOI 10.1073/pnas.0501176102; Kirby JS, 2010, J AM ACAD DERMATOL, V63, P689, DOI 10.1016/j.jaad.2009.09.048; Lee HS, 2017, PHARM RES-DORDR, V34, P101, DOI 10.1007/s11095-016-2042-x; Lim HW, 2017, J AM ACAD DERMATOL, V76, P958, DOI 10.1016/j.jaad.2016.12.043; McKay KM, 2013, BRIT J DERMATOL, V169, P549, DOI 10.1111/bjd.12402; Moustafa F, 2014, J AM ACAD DERMATOL, V71, P973, DOI 10.1016/j.jaad.2014.05.036; OECD, 2004, TEST NO 28 GUID DOC; Pastore MN, 2015, BRIT J PHARMACOL, V172, P2179, DOI 10.1111/bph.13059; Prausnitz MR, 2008, NAT BIOTECHNOL, V26, P1261, DOI 10.1038/nbt.1504; Prausnitz MR, 2017, ANNU REV CHEM BIOMOL, V8, P177, DOI 10.1146/annurev-chembioeng-060816-101514; PRAUSNITZ MR, 1993, P NATL ACAD SCI USA, V90, P10504, DOI 10.1073/pnas.90.22.10504; Rademaker M, 2010, AUSTRALAS J DERMATOL, V51, P248, DOI 10.1111/j.1440-0960.2010.00657.x; Riedel R, 2008, CERAMICS SCI TECHNOL; Ripolin A, 2017, INT J PHARMACEUT, V521, P92, DOI 10.1016/j.ijpharm.2017.02.011; Siddhapura K, 2016, NANOMED-NANOTECHNOL, V12, P213, DOI 10.1016/j.nano.2015.10.009; Taudorff EH, 2015, EXPERT OPIN DRUG DEL, V12, P1059, DOI 10.1517/17425247.2015.1031216; Nguyen TT, 2018, EXPERT OPIN DRUG DEL, V15, P235, DOI 10.1080/17425247.2018.1410138; Upadhyaya A., 2011, POWDER METALLURGY SC, Vfirst; Watkinson AC, 2016, EXPERT OPIN DRUG DEL, V13, P523, DOI 10.1517/17425247.2016.1130034; Wollina U, 2001, CLIN RHEUMATOL, V20, P406, DOI 10.1007/s100670170004; Ye YQ, 2018, ADV DRUG DELIVER REV, V127, P106, DOI 10.1016/j.addr.2018.01.015	40	20	20	6	75	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	MAR	2020	26	3					341	+		10.1038/s41591-020-0787-6	http://dx.doi.org/10.1038/s41591-020-0787-6		MAR 2020	19	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	KU0MC	32152581				2022-12-27	WOS:000518737200001
J	Rackaityte, E; Halkias, J; Fukui, EM; Mendoza, VF; Hayzelden, C; Crawford, ED; Fujimura, KE; Burt, TD; Lynch, SV				Rackaityte, E.; Halkias, J.; Fukui, E. M.; Mendoza, V. F.; Hayzelden, C.; Crawford, E. D.; Fujimura, K. E.; Burt, T. D.; Lynch, S. V.			Viable bacterial colonization is highly limited in the human intestine in utero	NATURE MEDICINE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; DENDRITIC CELLS; AMNIOTIC-FLUID; BODY SITES; FETAL; MICROBIOTA; IMMUNE; PROGESTERONE; TRANSMISSION; RESPONSES	Microscopy and 16S rRNA sequencing suggest that there is a limited bacterial presence in the human fetal intestine, with one enriched Micrococcus species exhibiting immunomodulatory activity ex vivo. Mucosal immunity develops in the human fetal intestine by 11-14 weeks of gestation, yet whether viable microbes exist in utero and interact with the intestinal immune system is unknown. Bacteria-like morphology was identified in pockets of human fetal meconium at mid-gestation by scanning electron microscopy (n = 4), and a sparse bacterial signal was detected by 16S rRNA sequencing (n = 40 of 50) compared to environmental controls (n = 87). Eighteen taxa were enriched in fetal meconium, with Micrococcaceae (n = 9) and Lactobacillus (n = 6) the most abundant. Fetal intestines dominated by Micrococcaceae exhibited distinct patterns of T cell composition and epithelial transcription. Fetal Micrococcus luteus, isolated only in the presence of monocytes, grew on placental hormones, remained viable within antigen presenting cells, limited inflammation ex vivo and possessed genomic features linked with survival in the fetus. Thus, viable bacteria are highly limited in the fetal intestine at mid-gestation, although strains with immunomodulatory capacity are detected in subsets of specimens.	[Rackaityte, E.; Fukui, E. M.; Fujimura, K. E.; Lynch, S. V.] Univ Calif San Francisco, Dept Med, Div Gastroenterol, San Francisco, CA 94143 USA; [Rackaityte, E.] Univ Calif San Francisco, Biomed Sci Grad Program, San Francisco, CA 94143 USA; [Halkias, J.; Mendoza, V. F.] Univ Calif San Francisco, Dept Pediat, Div Neonatol, San Francisco, CA USA; [Halkias, J.; Mendoza, V. F.] Univ Calif San Francisco, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, San Francisco, CA 94143 USA; [Hayzelden, C.] San Francisco State Univ, Coll Sci & Engn, San Francisco, CA 94132 USA; [Crawford, E. D.] Chan Zuckerberg Biohub, San Francisco, CA USA; [Crawford, E. D.] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA; [Burt, T. D.] Duke Univ, Sch Med, Durham, NC USA; [Fujimura, K. E.] Genentech Inc, San Francisco, CA 94080 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; California State University System; San Francisco State University; University of California System; University of California San Francisco; Duke University; Roche Holding; Genentech	Lynch, SV (corresponding author), Univ Calif San Francisco, Dept Med, Div Gastroenterol, San Francisco, CA 94143 USA.	susan.lynch@ucsf.edu		Crawford, Emily/0000-0003-4182-2337; Lynch, Susan/0000-0001-5695-7336; Halkias, Joanna/0000-0003-0721-8961; Burt, Trevor/0000-0001-7933-529X; Rackaityte, Elze/0000-0003-3889-8082	National Institutes of Health (NIH) [P30 DK063720]; NIH Shared Instrument grant [1S10OD021822-01]; National Science Foundation (NSF)MRI award [0821619]; NSF-EAR award [0949176]; UCSF Clinical and Translational Science Institute Pilot Award for Basic and Translational Investigators grant [2014908]; NSF Graduate Research Fellowship [1650113]; National Institute of Allergy and Infectious Diseases (NIAID) of the NIH [F31 AI136336]; NIH NIAID [K08 AI128007, AI114271, AI113916]	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Shared Instrument grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation (NSF)MRI award(National Science Foundation (NSF)); NSF-EAR award; UCSF Clinical and Translational Science Institute Pilot Award for Basic and Translational Investigators grant; NSF Graduate Research Fellowship(National Science Foundation (NSF)); National Institute of Allergy and Infectious Diseases (NIAID) of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank the tissue donors. We also thank M. Ng, H. Boushey and A. Molofsky for thoughtful critique of this manuscript. UCSF flow core provided instrumentation assistance, which was supported by National Institutes of Health (NIH) grant no. P30 DK063720 and NIH Shared Instrument grant no. 1S10OD021822-01. The FE-SEM and supporting facilities were obtained under National Science Foundation (NSF)MRI award no. 0821619 and NSF-EAR award no. 0949176, respectively. This study was supported in part by the UCSF Clinical and Translational Science Institute Pilot Award for Basic and Translational Investigators grant no. 2014908 to J.H. E.R. was supported by NSF Graduate Research Fellowship grant no. 1650113 and by the National Institute of Allergy and Infectious Diseases (NIAID) of the NIH F31 AI136336. J.H. was supported by NIH NIAID grant no. K08 AI128007. S.V.L. was supported by NIH NIAID grant no. AI114271 and AI113916. We thank C. Domingo for support of the electron microscopy core facility at San Francisco State University and D. Mars for assistance with FE-SEM sample preparation. We thank J. L. DeRisi at UCSF for generously sharing custom-made T7 RNA polymerase with our group. We thank E. Stapleton for illustration assistance and J. M. Rackaitis for support during these studies. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NSF or the NIH.	Aagaard K, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008599; Arrieta MC, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aab2271; Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; Benach J, 2002, BIOCHEMISTRY-US, V41, P14659, DOI 10.1021/bi0203684; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chen CR, 2017, NAT COMMUN, V8, DOI [10.1038/ncomms14561, 10.1038/ncomms15523]; Chu DM, 2017, NAT MED, V23, P314, DOI 10.1038/nm.4272; Collin MA, 2016, SCI REP-UK, V6, DOI 10.1038/srep21589; Davis NM, 2018, MICROBIOME, V6, DOI 10.1186/s40168-018-0605-2; de Goffau MC, 2019, NATURE, V572, P329, DOI 10.1038/s41586-019-1451-5; Denning TL, 2007, NAT IMMUNOL, V8, P1086, DOI 10.1038/ni1511; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dons LE, 2014, PATHOG DIS, V70, P70, DOI 10.1111/2049-632X.12081; Ducsay CA, 2018, PHYSIOL REV, V98, P1241, DOI 10.1152/physrev.00043.2017; Duerkop BA, 2009, IMMUNITY, V31, P368, DOI 10.1016/j.immuni.2009.08.009; Durack J, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03157-4; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Edgar RC, 2015, BIOINFORMATICS, V31, P3476, DOI 10.1093/bioinformatics/btv401; Egea L, 2010, EXPERT REV GASTROENT, V4, P723, DOI [10.1586/egh.10.73, 10.1586/EGH.10.73]; Eren AM, 2015, PEERJ, V3, DOI 10.7717/peerj.1319; Ferretti P, 2018, CELL HOST MICROBE, V24, P133, DOI 10.1016/j.chom.2018.06.005; Fujimura KE, 2016, NAT MED, V22, P1187, DOI 10.1038/nm.4176; Gu W, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0904-5; Gurevich A, 2013, BIOINFORMATICS, V29, P1072, DOI 10.1093/bioinformatics/btt086; Halkias J, 2019, J CLIN INVEST, V129, P3562, DOI 10.1172/JCI125957; Hillas PJ, 2000, J BIOL CHEM, V275, P18801, DOI 10.1074/jbc.M001001200; Howie D, 1998, J IMMUNOL, V161, P5862; Iwai S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095726; Johansson MEV, 2012, METHODS MOL BIOL, V842, P229, DOI 10.1007/978-1-61779-513-8_13; Krause P, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8055; Kuznetsova A, 2017, J STAT SOFTW, V82, P1, DOI 10.18637/jss.v082.i13; Lauder AP, 2016, MICROBIOME, V4, DOI 10.1186/s40168-016-0172-3; Letunic I, 2016, NUCLEIC ACIDS RES, V44, pW242, DOI 10.1093/nar/gkw290; Li N, 2019, NAT IMMUNOL, V20, P301, DOI 10.1038/s41590-018-0294-9; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Lim ES, 2018, MICROBIOME, V6, DOI 10.1186/s40168-018-0475-7; LOVE MI, 2014, GENOME BIOL, V15, DOI DOI 10.1186/S13059-014-0550-8; Magoc T, 2011, BIOINFORMATICS, V27, P2957, DOI 10.1093/bioinformatics/btr507; Martin Rebeca, 2008, Int Microbiol, V11, P261; McGovern N, 2017, NATURE, V546, P662, DOI 10.1038/nature22795; Minich JJ, 2019, MSYSTEMS, V4, DOI 10.1128/mSystems.00186-19; Mold JE, 2008, SCIENCE, V322, P1562, DOI 10.1126/science.1164511; Mold JE, 2010, SCIENCE, V330, P1695, DOI 10.1126/science.1196509; Mukamolova GV, 2002, MOL MICROBIOL, V46, P611, DOI 10.1046/j.1365-2958.2002.03183.x; Oksanen J., 2020, VEGAN COMMUNITY ECOL; Pastor-Vargas C, 2016, PEDIAT ALLERG IMM-UK, V27, P716, DOI 10.1111/pai.12608; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Pritchard L, 2016, ANAL METHODS-UK, V8, P12, DOI [10.1039/c5ay02550h, 10.1039/C5AY02550H]; Pruesse E, 2012, BIOINFORMATICS, V28, P1823, DOI 10.1093/bioinformatics/bts252; Rinke C, 2013, NATURE, V499, P431, DOI 10.1038/nature12352; Rosen DB, 2008, J IMMUNOL, V180, P6508, DOI 10.4049/jimmunol.180.10.6508; Schreurs RRCE, 2019, IMMUNITY, V50, P462, DOI 10.1016/j.immuni.2018.12.010; Sekar S, 2011, J THERM ANAL CALORIM, V104, P149, DOI 10.1007/s10973-010-1121-1; SPENCER J, 1986, CLIN EXP IMMUNOL, V64, P536; SPENCER J, 1986, CLIN EXP IMMUNOL, V65, P553; Sprouffske K, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-016-1016-7; Steel JH, 2005, PEDIATR RES, V57, P404, DOI 10.1203/01.PDR.0000153869.96337.90; SUBASHCHANDRABO.S, 2013, PLOS PATHOG, V9, P15, DOI DOI 10.1371/journal.ppat.1003788; Trotter A, 1999, PEDIATR RES, V45, P489, DOI 10.1203/00006450-199904010-00006; Vaishnava S, 2011, SCIENCE, V334, P255, DOI 10.1126/science.1209791; Varghese NJ, 2015, NUCLEIC ACIDS RES, V43, P6761, DOI 10.1093/nar/gkv657; WEISBURG WG, 1991, J BACTERIOL, V173, P697, DOI 10.1128/JB.173.2.697-703.1991; Wood DE, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-3-r46; Yassour M, 2018, CELL HOST MICROBE, V24, P146, DOI 10.1016/j.chom.2018.06.007; YOTIS W, 1966, J BACTERIOL, V92, P1285, DOI 10.1128/JB.92.5.1285-1289.1966; Yu JJ, 2018, ADV ENERGY MATER, V8, DOI 10.1002/aenm.201701313	67	95	95	1	31	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	APR	2020	26	4					599	+		10.1038/s41591-020-0761-3	http://dx.doi.org/10.1038/s41591-020-0761-3		FEB 2020	22	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	QH1UE	32094926	Green Accepted			2022-12-27	WOS:000515477500003
J	Stower, H				Stower, Hannah			AI for breast-cancer screening	NATURE MEDICINE			English	Editorial Material																			0	4	4	2	6	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	FEB	2020	26	2					163	163		10.1038/s41591-020-0776-9	http://dx.doi.org/10.1038/s41591-020-0776-9			1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	KK7DU	32047318	Bronze			2022-12-27	WOS:000512899200031
J	Chowell, D; Krishna, C; Pierini, F; Makarov, V; Rizvi, NA; Kuo, FS; Morris, LGT; Riaz, N; Lenz, TL; Chan, TA				Chowell, Diego; Krishna, Chirag; Pierini, Federica; Makarov, Vladimir; Rizvi, Naiyer A.; Kuo, Fengshen; Morris, Luc G. T.; Riaz, Nadeem; Lenz, Tobias L.; Chan, Timothy A.			Evolutionary divergence of HLA class I genotype impacts efficacy of cancer immunotherapy	NATURE MEDICINE			English	Article							SOMATIC POINT MUTATIONS; HETEROZYGOTE ADVANTAGE; CTLA-4 BLOCKADE; NEOANTIGENS; SENSITIVITY; LANDSCAPE; ALIGNMENT; HIV-1	Functional diversity of the highly polymorphic human leukocyte antigen class I (HLA-I) genes underlies successful immunologic control of both infectious disease and cancer. The divergent allele advantage hypothesis dictates that an HLA-I genotype with two alleles with sequences that are more divergent enables presentation of more diverse immunopeptidomes(1-3). However, the effect of sequence divergence between HLA-I alleles-a quantifiable measure of HLA-I evolution-on the efficacy of immune checkpoint inhibitor (ICI) treatment for cancer remains unknown. In the present study the germline HLA-I evolutionary divergence (HED) of patients with cancer treated with ICIs was determined by quantifying the physiochemical sequence divergence between HLA-I alleles of each patient's genotype. HED was a strong determinant of survival after treatment with ICIs. Even among patients fully heterozygous at HLA-I, patients with an HED in the upper quartile respond better to ICIs than patients with a low HED. Furthermore, HED strongly impacts the diversity of tumor, viral and self-immunopeptidomes and intratumoral T cell receptor clonality. Similar to tumor mutation burden, HED is a fundamental metric of diversity at the major histocompatibility complex-peptide complex, which dictates ICI efficacy. The data link divergent HLA allele advantage to immunotherapy efficacy and unveil how ICI response relies on the evolved efficiency of HLA-mediated immunity.	[Chowell, Diego; Makarov, Vladimir; Chan, Timothy A.] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, 1275 York Ave, New York, NY 10021 USA; [Chowell, Diego; Makarov, Vladimir; Kuo, Fengshen; Morris, Luc G. T.; Riaz, Nadeem; Chan, Timothy A.] Mem Sloan Kettering Canc Ctr, Immunogen & Precis Oncol Platform, 1275 York Ave, New York, NY 10021 USA; [Krishna, Chirag] Mem Sloan Kettering Canc Ctr, Computat & Syst Biol Program, 1275 York Ave, New York, NY 10021 USA; [Pierini, Federica; Lenz, Tobias L.] Max Planck Inst Evolutionary Biol, Res Grp Evolutionary Immunogenom, Plon, Germany; [Rizvi, Naiyer A.] Columbia Univ, Med Ctr, Dept Med, New York, NY USA; [Morris, Luc G. T.] Mem Sloan Kettering Canc Ctr, Dept Surg, 1275 York Ave, New York, NY 10021 USA; [Riaz, Nadeem; Chan, Timothy A.] Mem Sloan Kettering Canc Ctr, Dept Radiat Oncol, 1275 York Ave, New York, NY 10021 USA; [Chan, Timothy A.] Weill Cornell Sch Med, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Max Planck Society; Columbia University; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Cornell University	Chan, TA (corresponding author), Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, 1275 York Ave, New York, NY 10021 USA.; Chan, TA (corresponding author), Mem Sloan Kettering Canc Ctr, Immunogen & Precis Oncol Platform, 1275 York Ave, New York, NY 10021 USA.; Lenz, TL (corresponding author), Max Planck Inst Evolutionary Biol, Res Grp Evolutionary Immunogenom, Plon, Germany.; Chan, TA (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Radiat Oncol, 1275 York Ave, New York, NY 10021 USA.; Chan, TA (corresponding author), Weill Cornell Sch Med, New York, NY 10065 USA.	lenz@post.harvard.edu; chant@mskcc.org	Chan, Timothy A/ABD-5850-2021; Lenz, Tobias L/D-1387-2009	Lenz, Tobias L/0000-0002-7203-0044; Morris, Luc/0000-0002-4417-2280; Kuo, Fengshen/0000-0003-1797-2896; Pierini, Federica/0000-0002-8246-5316	National Institutes of Health (NIH) [R35 CA232097]; NIH [RO1 CA205426]; PaineWebber Chair; NIH/National Cancer Institute's Cancer Center [P30 CA008748]; Deutsche Forschungsgemeinschaft [LE 2593/3-1]; NATIONAL CANCER INSTITUTE [P30CA008748, R01CA205426] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); PaineWebber Chair; NIH/National Cancer Institute's Cancer Center; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank the Chan lab and members of the Immunogenomics and Precision Oncology Platform for advice and input. This work was supported in part by the National Institutes of Health (NIH) grant no. R35 CA232097 (to T.A.C.), NIH grant no. RO1 CA205426 (to T.A.C. and N.A.R.), the PaineWebber Chair (to T.A.C.), and the NIH/National Cancer Institute's Cancer Center support grant (no. P30 CA008748) and the Deutsche Forschungsgemeinschaft grant no. LE 2593/3-1 (to T.L.L.).	Abelin JG, 2017, IMMUNITY, V46, P315, DOI 10.1016/j.immuni.2017.02.007; Bradburn MJ, 2003, BRIT J CANCER, V89, P431, DOI 10.1038/sj.bjc.6601119; Brostrom G., 2012, EVENT HIST ANAL R; Buhler S, 2016, IMMUNOGENETICS, V68, P401, DOI 10.1007/s00251-016-0918-x; Carlson CS, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3680; Carrington M, 1999, SCIENCE, V283, P1748, DOI 10.1126/science.283.5408.1748; Chowell D, 2018, SCIENCE, V359, P582, DOI 10.1126/science.aao4572; Cibulskis K, 2013, NAT BIOTECHNOL, V31, P213, DOI 10.1038/nbt.2514; DOHERTY PC, 1975, LANCET, V1, P1406, DOI 10.1016/S0140-6736(75)92610-0; DOHERTY PC, 1975, NATURE, V256, P50, DOI 10.1038/256050a0; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Gfeller D, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01716; GRANTHAM R, 1974, SCIENCE, V185, P862, DOI 10.1126/science.185.4154.862; Grueber CE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089632; Hughes AL, 1998, ANNU REV GENET, V32, P415, DOI 10.1146/annurev.genet.32.1.415; Hugo W, 2016, CELL, V165, P35, DOI 10.1016/j.cell.2016.02.065; Jurtz V, 2017, J IMMUNOL, V199, P3360, DOI 10.4049/jimmunol.1700893; Koboldt DC, 2012, GENOME RES, V22, P568, DOI 10.1101/gr.129684.111; Larson DE, 2012, BIOINFORMATICS, V28, P311, DOI 10.1093/bioinformatics/btr665; Lenz TL, 2011, EVOLUTION, V65, P2380, DOI 10.1111/j.1558-5646.2011.01288.x; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Marty R, 2018, CELL, V175, P416, DOI 10.1016/j.cell.2018.08.048; Marty R, 2017, CELL, V171, P1272, DOI 10.1016/j.cell.2017.09.050; Mayer KFX, 2014, SCIENCE, V345, DOI 10.1126/science.1251788; McGranahan N, 2017, CELL, V170, P825, DOI 10.1016/j.cell.2017.08.012; McGranahan N, 2016, SCIENCE, V351, P1463, DOI 10.1126/science.aaf1490; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; McKenzie LM, 1999, GENES IMMUN, V1, P120, DOI 10.1038/sj.gene.6363648; Parham P, 1996, SCIENCE, V272, P67, DOI 10.1126/science.272.5258.67; Paul S, 2013, J IMMUNOL, V191, P5831, DOI 10.4049/jimmunol.1302101; Pearson H, 2016, J CLIN INVEST, V126, P4690, DOI 10.1172/JCI88590; Penn DJ, 2002, P NATL ACAD SCI USA, V99, P11260, DOI 10.1073/pnas.162006499; Pierini F, 2018, MOL BIOL EVOL, V35, P2145, DOI 10.1093/molbev/msy116; POTTS WK, 1990, TRENDS ECOL EVOL, V5, P181, DOI 10.1016/0169-5347(90)90207-T; Rentoft M, 2016, P NATL ACAD SCI USA, V113, P4723, DOI 10.1073/pnas.1519128113; Riaz N, 2017, CELL, V171, P934, DOI 10.1016/j.cell.2017.09.028; Rizvi NA, 2015, SCIENCE, V348, P124, DOI 10.1126/science.aaa1348; Robins HS, 2009, BLOOD, V114, P4099, DOI 10.1182/blood-2009-04-217604; Robinson J, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006862; Robinson J, 2015, NUCLEIC ACIDS RES, V43, pD423, DOI 10.1093/nar/gku1161; Rosenthal R, 2019, NATURE, V567, P479, DOI 10.1038/s41586-019-1032-7; Samstein RM, 2019, NAT GENET, V51, P202, DOI 10.1038/s41588-018-0312-8; Saunders CT, 2012, BIOINFORMATICS, V28, P1811, DOI 10.1093/bioinformatics/bts271; Schumacher TN, 2015, SCIENCE, V348, P69, DOI 10.1126/science.aaa4971; Shen RL, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkw520; Shukla SA, 2015, NAT BIOTECHNOL, V33, P1152, DOI 10.1038/nbt.3344; Snyder A, 2014, NEW ENGL J MED, V371, P2189, DOI 10.1056/NEJMoa1406498; Subramanian S, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-306; Sundaram L, 2018, NAT GENET, V50, P1161, DOI 10.1038/s41588-018-0167-z; Thursz MR, 1997, NAT GENET, V17, P11, DOI 10.1038/ng0997-11; Van Allen EM, 2015, SCIENCE, V350, P207, DOI 10.1126/science.aad0095; Wain LV, 2007, MOL BIOL EVOL, V24, P1853, DOI 10.1093/molbev/msm110; WAKELAND EK, 1990, IMMUNOL RES, V9, P115, DOI 10.1007/BF02918202; Wei L, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1779-7; Zehir A, 2017, NAT MED, V23, P703, DOI 10.1038/nm.4333; Zerbino DR, 2018, NUCLEIC ACIDS RES, V46, pD754, DOI 10.1093/nar/gkx1098	56	105	105	1	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2019	25	11					1715	+		10.1038/s41591-019-0639-4	http://dx.doi.org/10.1038/s41591-019-0639-4			20	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	JT2KI	31700181	Green Accepted			2022-12-27	WOS:000500824300029
J	Kim, JW; Marquez, CP; Kostyrko, K; Koehne, AL; Marini, K; Simpson, DR; Lee, AG; Leung, SG; Sayles, LC; Shrager, J; Ferrer, I; Paz-Ares, L; Gephart, MH; Vicent, S; Cochran, JR; Sweet-Cordero, EA				Kim, Jun W.; Marquez, Cesar P.; Kostyrko, Kaja; Koehne, Amanda L.; Marini, Kieren; Simpson, David R.; Lee, Alex G.; Leung, Stanley G.; Sayles, Leanne C.; Shrager, Joseph; Ferrer, Irene; Paz-Ares, Luis; Gephart, Melanie Hayden; Vicent, Silvestre; Cochran, Jennifer R.; Sweet-Cordero, E. Alejandro			Antitumor activity of an engineered decoy receptor targeting CLCF1-CNTFR signaling in lung adenocarcinoma	NATURE MEDICINE			English	Article							CILIARY NEUROTROPHIC FACTOR; CARDIOTROPHIN-LIKE CYTOKINE; ALPHA COMPONENT; BRAF MUTANTS; KRAS; FIBROBLASTS; PROTEIN; IL-6; CNTF; AFFINITY	Proinflammatory cytokines in the tumor microenvironment can promote tumor growth, yet their value as therapeutic targets remains underexploited. We validated the functional significance of the cardiotrophin-like cytokine factor 1 (CLCF1)-ciliary neurotrophic factor receptor (CNTFR) signaling axis in lung adenocarcinoma (LUAD) and generated a high-affinity soluble receptor (eCNTFR-Fc) that sequesters CLCF1, thereby inhibiting its oncogenic effects. eCNTFR-Fc inhibits tumor growth in multiple xenograft models and in an autochthonous, highly aggressive genetically engineered mouse model of LUAD, driven by activation of oncogenic Kras and loss of Trp53. Abrogation of CLCF1 through eCNTFR-Fc appears most effective in tumors driven by oncogenic KRAS. We observed a correlation between the effectiveness of eCNTFR-Fc and the presence of KRAS mutations that retain the intrinsic capacity to hydrolyze guanosine triphosphate, suggesting that the mechanism of action may be related to altered guanosine triphosphate loading. Overall, we nominate blockade of CLCF1-CNTFR signaling as a novel therapeutic opportunity for LUAD and potentially for other tumor types in which CLCF1 is present in the tumor microenvironment.	[Kim, Jun W.; Cochran, Jennifer R.] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Marquez, Cesar P.; Kostyrko, Kaja; Koehne, Amanda L.; Marini, Kieren; Simpson, David R.; Lee, Alex G.; Leung, Stanley G.; Sayles, Leanne C.; Sweet-Cordero, E. Alejandro] Univ Calif San Francisco, Dept Pediat, Div Hematol & Oncol, San Francisco, CA 94143 USA; [Marquez, Cesar P.; Koehne, Amanda L.] Stanford Univ, Sch Med, Stanford, CA 94305 USA; [Koehne, Amanda L.] Stanford Univ, Dept Comparat Med, Stanford, CA 94305 USA; [Shrager, Joseph] Stanford Univ, Dept Surg, Sch Med, Div Thorac Surg, Stanford, CA 94305 USA; [Ferrer, Irene; Paz-Ares, Luis] Spanish Natl Canc Res Ctr, I 12 Res Inst, H120 CNIO Lung Canc Clin Res Unit, Madrid, Spain; [Ferrer, Irene; Paz-Ares, Luis; Vicent, Silvestre] Ctr Invest Biomed Red Canc, Madrid, Spain; [Gephart, Melanie Hayden] Stanford Univ, Sch Med, Dept Neurosurg, Stanford, CA 94305 USA; [Vicent, Silvestre] Univ Navarra, Ctr Appl Med Res, Program Solid Tumors & Biomarkers, Pamplona, Spain; [Vicent, Silvestre] Univ Navarra, Dept Pathol Anat & Physiol, Pamplona, Spain	Stanford University; University of California System; University of California San Francisco; Stanford University; Stanford University; Stanford University; Centro Nacional de Investigaciones Oncologicas (CNIO); CIBER - Centro de Investigacion Biomedica en Red; CIBERONC; Stanford University; University of Navarra; University of Navarra	Cochran, JR (corresponding author), Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA.; Sweet-Cordero, EA (corresponding author), Univ Calif San Francisco, Dept Pediat, Div Hematol & Oncol, San Francisco, CA 94143 USA.	Jennifer.Cochran@stanford.edu; Alejandro.Sweet-Cordero@ucsf.edu	Vicent, Silvestre/K-4261-2017	Vicent, Silvestre/0000-0002-9457-6881; Marquez, Cesar/0000-0002-9758-4414; Hayden Gephart, Melanie/0000-0003-2965-9231; Kostyrko, Kaja/0000-0002-2842-4089	Howard Hughes Medical Institute; National Cancer Institute of the National Institutes of Health under the Ruth L. Kirschstein National Service Research Award (NRSA) [F31CA236324]; Stanford Medical Scientist Training Program T32 Grant; Stanford Bio-X Program; Swiss National Science Foundation [P300PB-174377]; Lungevity Foundation; Upstage Lung Cancer; Stanford Coulter Foundation; American Lung Association; National Cancer Institute [R01CA225103]; NATIONAL CANCER INSTITUTE [R01CA225103, F31CA236324] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Cancer Institute of the National Institutes of Health under the Ruth L. Kirschstein National Service Research Award (NRSA); Stanford Medical Scientist Training Program T32 Grant; Stanford Bio-X Program; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Lungevity Foundation; Upstage Lung Cancer; Stanford Coulter Foundation; American Lung Association; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank D. Gwinn especially and all of the other members of the Sweet-Cordero and Cochran labs for helpful suggestions as well as S. Hunter, T. Hunter and Y. Shi for assistance with the STAT3 immunohistochemical assay. C.P.M. was supported by a fellowship from the Howard Hughes Medical Institute, by the National Cancer Institute of the National Institutes of Health under the Ruth L. Kirschstein National Service Research Award (NRSA) F31 (F31CA236324) and by the Stanford Medical Scientist Training Program T32 Grant. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. J.W.K. was funded by a graduate fellowship from the Stanford Bio-X Program. K.K. was supported by a Postdoc Mobility grant (P300PB-174377) from the Swiss National Science Foundation. E.A.S.C. and J.R.C. were funded by a grant from the Lungevity Foundation and Upstage Lung Cancer. J.R.C. was also funded by a Stanford Coulter Foundation Translational Partnership Award. E.A.S.C. also received funding from the American Lung Association. This work was also funded by a multi-investigator grant from the National Cancer Institute (R01CA225103) to E.A.S.C. and J.R.C.	Aguinaldo Anna Marie, 2002, Methods Mol Biol, V192, P235; Albrengues J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10204; Auguste P, 1996, J BIOL CHEM, V271, P26049, DOI 10.1074/jbc.271.42.26049; Boder ET, 2000, P NATL ACAD SCI USA, V97, P10701, DOI 10.1073/pnas.170297297; Brooks GD, 2016, CANCER RES, V76, P866, DOI 10.1158/0008-5472.CAN-15-2388; Camidge DR, 2019, NAT REV CLIN ONCOL, V16, P341, DOI 10.1038/s41571-019-0173-9; Camidge DR, 2014, NAT REV CLIN ONCOL, V11, P473, DOI 10.1038/nrclinonc.2014.104; Chen WJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4472; Chiu ML, 2016, CURR OPIN STRUC BIOL, V38, P163, DOI 10.1016/j.sbi.2016.07.012; Chong CR, 2013, NAT MED, V19, P1389, DOI 10.1038/nm.3388; Ciombor KK, 2014, CURR ONCOL REP, V16, DOI 10.1007/s11912-013-0368-7; Cox AD, 2014, NAT REV DRUG DISCOV, V13, P828, DOI 10.1038/nrd4389; DAVIS S, 1993, SCIENCE, V259, P1736, DOI 10.1126/science.7681218; de Palma M, 2017, NAT REV CANCER, V17, P457, DOI 10.1038/nrc.2017.51; Economides AN, 2003, NAT MED, V9, P47, DOI 10.1038/nm811; Fan K, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07124-9; Gandhi L, 2018, NEW ENGL J MED, V378, P2078, DOI 10.1056/NEJMoa1801005; Haigis KM, 2017, TRENDS CANCER, V3, P686, DOI 10.1016/j.trecan.2017.08.006; Hellmann MD, 2018, NEW ENGL J MED, V378, P2093, DOI 10.1056/NEJMoa1801946; Herbst RS, 2018, NATURE, V553, P446, DOI 10.1038/nature25183; Hu X, 2008, HEPATOLOGY, V47, P1298, DOI 10.1002/hep.22163; Hunter JC, 2015, MOL CANCER RES, V13, P1325, DOI 10.1158/1541-7786.MCR-15-0203; Hunter SA, 2016, METHOD ENZYMOL, V580, P21, DOI 10.1016/bs.mie.2016.05.002; IP NY, 1992, CELL, V69, P1121, DOI 10.1016/0092-8674(92)90634-O; Jackson EL, 2005, CANCER RES, V65, P10280, DOI 10.1158/0008-5472.CAN-05-2193; Jackson EL, 2001, GENE DEV, V15, P3243, DOI 10.1101/gad.943001; Janes MR, 2018, CELL, V172, P578, DOI 10.1016/j.cell.2018.01.006; Johnstone CD, 2017, PHYS MED BIOL, V62, P5760, DOI 10.1088/1361-6560/aa76b4; Johnstone CD, 2018, PHYS MED BIOL, V63, DOI 10.1088/1361-6560/aac335; Jonkers J, 2001, NAT GENET, V29, P418, DOI 10.1038/ng747; Kalluri R, 2016, NAT REV CANCER, V16, P582, DOI 10.1038/nrc.2016.73; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Kempf E, 2016, EUR RESPIR REV, V25, DOI 10.1183/16000617.0071-2015; Kim JW, 2017, CURR OPIN CHEM BIOL, V38, P62, DOI 10.1016/j.cbpa.2017.03.010; Kintzing JR, 2016, TRENDS PHARMACOL SCI, V37, P993, DOI 10.1016/j.tips.2016.10.005; Kober P, 2011, MOL CARCINOGEN, V50, P846, DOI 10.1002/mc.20763; Kunita A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-27128-3; Labernadie A, 2017, NAT CELL BIOL, V19, P224, DOI 10.1038/ncb3478; Lee SJ, 2013, J BIOL CHEM, V288, P25244, DOI 10.1074/jbc.M113.489708; Leibinger M, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.310; Lelievre E, 2001, J BIOL CHEM, V276, P22476, DOI 10.1074/jbc.M101681200; Lin JJ, 2017, CANCER DISCOV, V7, P137, DOI 10.1158/2159-8290.CD-16-1123; Lito P, 2016, SCIENCE, V351, P604, DOI 10.1126/science.aad6204; Liu JF, 2018, CELL, V173, P400, DOI 10.1016/j.cell.2018.02.052; Lu J, 2012, J NEUROSURG, V117, P1022, DOI 10.3171/2012.9.JNS1212; Mainardi S, 2018, NAT MED, V24, P961, DOI 10.1038/s41591-018-0023-9; Marini KD, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aat3504; Nichols RJ, 2018, NAT CELL BIOL, V20, P1064, DOI 10.1038/s41556-018-0169-1; Ostrem JML, 2016, NAT REV DRUG DISCOV, V15, P771, DOI 10.1038/nrd.2016.139; Pento JT, 2017, ANTICANCER RES, V37, P5935, DOI 10.21873/anticanres.12040; Perret D, 2004, J BIOL CHEM, V279, P43961, DOI 10.1074/jbc.M407686200; Rousseau F, 2008, J BIOL CHEM, V283, P30341, DOI 10.1074/jbc.M803239200; Ruess DA, 2018, NAT MED, V24, P954, DOI 10.1038/s41591-018-0024-8; SAGGIO I, 1994, ANAL BIOCHEM, V221, P387, DOI 10.1006/abio.1994.1430; Sansone P, 2007, J CLIN INVEST, V117, P3988, DOI 10.1172/JCI32533; Senaldi G, 1999, P NATL ACAD SCI USA, V96, P11458, DOI 10.1073/pnas.96.20.11458; Shi Y, 2019, NATURE, V569, P131, DOI 10.1038/s41586-019-1130-6; Silver JS, 2010, J LEUKOCYTE BIOL, V88, P1145, DOI 10.1189/jlb.0410217; Su SC, 2018, CELL, V172, P841, DOI 10.1016/j.cell.2018.01.009; Tebbutt NC, 2002, NAT MED, V8, P1089, DOI 10.1038/nm763; Van Deventer JA, 2014, METHODS MOL BIOL, V1131, P151, DOI 10.1007/978-1-62703-992-5_10; Vicent S, 2012, CANCER RES, V72, P5744, DOI 10.1158/0008-5472.CAN-12-1097; Weinblatt ME, 1999, NEW ENGL J MED, V340, P253, DOI 10.1056/NEJM199901283400401; Wong GS, 2018, NAT MED, V24, P968, DOI 10.1038/s41591-018-0022-x; Wong J, 2008, INT J RADIAT ONCOL, V71, P1591, DOI 10.1016/j.ijrobp.2008.04.025; Wu XJ, 2016, MOL CANCER THER, V15, P2609, DOI 10.1158/1535-7163.MCT-15-0921; Yang X, 2018, NEW ENGL J MED, V379, DOI 10.1056/NEJMc1808251; Yao Z, 2017, NATURE, V548, P234, DOI 10.1038/nature23291; Yao Z, 2015, CANCER CELL, V28, P370, DOI 10.1016/j.ccell.2015.08.001	69	25	27	1	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2019	25	11					1783	+		10.1038/s41591-019-0612-2	http://dx.doi.org/10.1038/s41591-019-0612-2			26	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	JT2KI	31700175	Green Accepted			2022-12-27	WOS:000500824300038
J	Lev-Sagie, A; Goldman-Wohl, D; Cohen, Y; Dori-Bachash, M; Leshem, A; Mor, U; Strahilevitz, J; Moses, AE; Shapiro, H; Yagel, S; Elinav, E				Lev-Sagie, Ahinoam; Goldman-Wohl, Debra; Cohen, Yotam; Dori-Bachash, Mally; Leshem, Avner; Mor, Uria; Strahilevitz, Jacob; Moses, Allon E.; Shapiro, Hagit; Yagel, Simcha; Elinav, Eran			Vaginal microbiome transplantation in women with intractable bacterial vaginosis	NATURE MEDICINE			English	Article							METRONIDAZOLE; THERAPY; FLORA	We report the results of a first exploratory study testing the use of vaginal microbiome transplantation (VMT) from healthy donors as a therapeutic alternative for patients suffering from symptomatic, intractable and recurrent bacterial vaginosis (ClinicalTrials. gov NCT02236429). In our case series, five patients were treated, and in four of them VMT was associated with full long-term remission until the end of follow-up at 5-21 months after VMT, defined as marked improvement of symptoms, Amsel criteria, microscopic vaginal fluid appearance and reconstitution of a Lactobacillus-dominated vaginal microbiome. One patient presented with incomplete remission in clinical and laboratory features. No adverse effects were observed in any of the five women. Notably, remission in three patients necessitated repeated VMT, including a donor change in one patient, to elicit a long-standing clinical response. The therapeutic efficacy of VMT in women with intractable and recurrent bacterial vaginosis should be further determined in randomized, placebo-controlled clinical trials.	[Lev-Sagie, Ahinoam; Goldman-Wohl, Debra; Yagel, Simcha] Hadassah Hebrew Univ Med Ctr, Dept Obstet & Gynecol, Jerusalem, Israel; [Cohen, Yotam; Dori-Bachash, Mally; Leshem, Avner; Mor, Uria; Shapiro, Hagit; Elinav, Eran] Weizmann Inst Sci, Immunol Dept, Rehovot, Israel; [Leshem, Avner] Tel Aviv Sourasky Med Ctr, Dept Surg, Tel Aviv, Israel; [Strahilevitz, Jacob; Moses, Allon E.] Hadassah Hebrew Univ Med Ctr, Dept Clin Microbiol & Infect Dis, Jerusalem, Israel; [Elinav, Eran] DKFZ, Div Canc Microbiome Res, Heidelberg, Germany	Hebrew University of Jerusalem; Weizmann Institute of Science; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; Hebrew University of Jerusalem; Helmholtz Association; German Cancer Research Center (DKFZ)	Lev-Sagie, A (corresponding author), Hadassah Hebrew Univ Med Ctr, Dept Obstet & Gynecol, Jerusalem, Israel.; Elinav, E (corresponding author), Weizmann Inst Sci, Immunol Dept, Rehovot, Israel.; Elinav, E (corresponding author), DKFZ, Div Canc Microbiome Res, Heidelberg, Germany.	levsagie@netvision.net.il; eran.elinav@weizmann.ac.il	Elinav, Eran/ABE-8881-2020; Shapiro, Hagit/F-8648-2015	Elinav, Eran/0000-0002-5775-2110; Leshem, Avner/0000-0003-4082-2036; Mor, Uria/0000-0002-2918-6406	Hebrew University of Jerusalem; Leona M. and Harry B. Helmsley Charitable Trust; Adelis Foundation; Pearl Welinsky Merlo Scientific Progress Research Fund; Lawrence and Sandra Post Family Foundation; Daniel Morris Trust; Park Avenue Charitable Fund; Hanna and Dr. Ludwik Wallach Cancer Research Fund; Howard and Nancy Marks Charitable Fund; estate of Malka Moskowitz; estate of Myron H. Ackerman; estate of Bernard Bishin; European Research Council; Israel Science Foundation; Israel Ministry of Health; Helmholtz Foundation; Else Kroener Fresenius Foundation; Garvan Institute; European Crohn's and Colitis Organization; Deutsch-Israelische Projektkooperation; Wellcome Trust; Hadassah Medical Center; Israel Ministry of Science and Technology	Hebrew University of Jerusalem; Leona M. and Harry B. Helmsley Charitable Trust; Adelis Foundation; Pearl Welinsky Merlo Scientific Progress Research Fund; Lawrence and Sandra Post Family Foundation; Daniel Morris Trust; Park Avenue Charitable Fund; Hanna and Dr. Ludwik Wallach Cancer Research Fund; Howard and Nancy Marks Charitable Fund; estate of Malka Moskowitz; estate of Myron H. Ackerman; estate of Bernard Bishin; European Research Council(European Research Council (ERC)European Commission); Israel Science Foundation(Israel Science Foundation); Israel Ministry of Health; Helmholtz Foundation(Helmholtz Association); Else Kroener Fresenius Foundation; Garvan Institute; European Crohn's and Colitis Organization; Deutsch-Israelische Projektkooperation; Wellcome Trust(Wellcome TrustEuropean Commission); Hadassah Medical Center; Israel Ministry of Science and Technology(Ministry of Science, Technology and Space (MOST), Israel)	We thank the members of the Hadassah-Hebrew University Medical Center Department of Obstetrics and Gynecology, the Elinav lab at the Weizmann Institute of Science and members of the DKFZ Cancer-Microbiome division for insightful discussions. We thank S.M. Cohen for expert editing. All cartoons were created, under a license, using BioRender software. The study was supported by a grant from the Joint Research Fund of the Hebrew University of Jerusalem and Hadassah Medical Center. H.S. is the incumbent of the V.R. Schwartz Research Fellow Chair. E.E. is supported by Yael and Rami Ungar, the Leona M. and Harry B. Helmsley Charitable Trust, the Adelis Foundation, the Pearl Welinsky Merlo Scientific Progress Research Fund, the Lawrence and Sandra Post Family Foundation, the Daniel Morris Trust, the Park Avenue Charitable Fund, the Hanna and Dr. Ludwik Wallach Cancer Research Fund, the Howard and Nancy Marks Charitable Fund, Aliza Moussaieff, the estate of Malka Moskowitz, the estate of Myron H. Ackerman, the estate of Bernard Bishin for the WIS-Clalit Program, Donald and Susan Schwarz, and grants funded by the European Research Council, the Israel Science Foundation, the Israel Ministry of Science and Technology, the Israel Ministry of Health, the Helmholtz Foundation, the Else Kroener Fresenius Foundation, the Garvan Institute, the European Crohn's and Colitis Organization, the Deutsch-Israelische Projektkooperation and the Wellcome Trust. E. E. is the incumbent of the Sir Marc and Lady Tania Feldmann Professorial Chair, a senior fellow at the Canadian Institute of Advanced Research and an international scholar at the Bill & Melinda Gates Foundation and the Howard Hughes Medical Institute.	AMSEL R, 1983, AM J MED, V74, P14, DOI 10.1016/0002-9343(83)91112-9; Babu G, 2017, J CLIN DIAGN RES, V11, pDC18, DOI 10.7860/JCDR/2017/28296.10417; Beigi R. H, 2006, AM J OBSTET GYNECOL, V194, P1283; Bohbot JM, 2018, J GYNECOL OBSTET HUM, V47, P81, DOI 10.1016/j.jogoh.2017.11.005; Bolyen E, 2019, NAT BIOTECHNOL, V37, P852, DOI 10.1038/s41587-019-0209-9; Bradshaw CS, 2006, J INFECT DIS, V193, P1478, DOI 10.1086/503780; Eriksson K, 2011, APMIS, V119, P373, DOI 10.1111/j.1600-0463.2011.02742.x; Franzosa EA, 2018, NAT METHODS, V15, P962, DOI 10.1038/s41592-018-0176-y; Gajer P, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003605; Haahr T, 2016, HUM REPROD, V31, P795, DOI 10.1093/humrep/dew026; Hay P, 2009, CURR OPIN INFECT DIS, V22, P82, DOI 10.1097/QCO.0b013e32832180c6; Ison CA, 2002, SEX TRANSM INFECT, V78, P413, DOI 10.1136/sti.78.6.413; JOESOEF MR, 1995, CLIN INFECT DIS, V20, pS72, DOI 10.1093/clinids/20.Supplement_1.S72; Koedooder R, 2019, HUM REPROD, V34, P1042, DOI 10.1093/humrep/dez065; Koumans EH, 2007, SEX TRANSM DIS, V34, P864, DOI 10.1097/OLQ.0b013e318074e565; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Malikowski T, 2017, CURR OPIN GASTROEN, V33, P8, DOI 10.1097/MOG.0000000000000326; Marrazzo JM, 2010, SEX TRANSM DIS, V37, P732, DOI 10.1097/OLQ.0b013e3181fbbc95; Mastromarino P, 2013, NEW MICROBIOL, V36, P229; Nasioudis D, 2017, BJOG-INT J OBSTET GY, V124, P61, DOI 10.1111/1471-0528.14209; Oduyebo OO, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006055.pub2; Paavonen J, 2018, NEW ENGL J MED, V379, P2246, DOI [10.1056/NEJMra1808418, 10.1056/nejmra1808418]; Peipert JF, 1997, AM J OBSTET GYNECOL, V177, P1184, DOI 10.1016/S0002-9378(97)70038-3; Ravel J, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0291-2; Ravel J, 2011, P NATL ACAD SCI USA, V108, P4680, DOI 10.1073/pnas.1002611107; Sanchez S, 2004, AM J OBSTET GYNECOL, V191, P1898, DOI 10.1016/j.ajog.2004.06.089; Sobel JD, 2006, AM J OBSTET GYNECOL, V194, P1283, DOI 10.1016/j.ajog.2005.11.041; Taha TE, 1998, AIDS, V12, P1699, DOI 10.1097/00002030-199813000-00019; US Food and Drug Administration, 2019, IMP SAF AL REG US FE; Wood DE, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-3-r46; Workowski KA, 2015, MMWR RECOMM REP, V64, P1, DOI 10.15585/mmwr.rr7004a1	31	105	112	1	30	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	OCT	2019	25	10					1500	+		10.1038/s41591-019-0600-6	http://dx.doi.org/10.1038/s41591-019-0600-6			14	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	JC3GJ	31591599	Green Submitted			2022-12-27	WOS:000489166700017
J	Gupta, RK; Calderwood, CJ; Yavlinsky, A; Krutikov, M; Quartagno, M; Aichelburg, MC; Altet, N; Diel, R; Dobler, CC; Dominguez, J; Doyle, JS; Erkens, C; Geis, S; Haldar, P; Hauri, AM; Hermansen, T; Johnston, JC; Lange, C; Lange, B; van Leth, F; Munoz, L; Roder, C; Romanowski, K; Roth, D; Sester, M; Sloot, R; Sotgiu, G; Woltmann, G; Yoshiyama, T; Zellweger, JP; Zenner, D; Aldridge, RW; Copas, A; Rangaka, MX; Lipman, M; Noursadeghi, M; Abubakar, I				Gupta, Rishi K.; Calderwood, Claire J.; Yavlinsky, Alexei; Krutikov, Maria; Quartagno, Matteo; Aichelburg, Maximilian C.; Altet, Neus; Diel, Roland; Dobler, Claudia C.; Dominguez, Jose; Doyle, Joseph S.; Erkens, Connie; Geis, Steffen; Haldar, Pranabashis; Hauri, Anja M.; Hermansen, Thomas; Johnston, James C.; Lange, Christoph; Lange, Berit; van Leth, Frank; Munoz, Laura; Roder, Christine; Romanowski, Kamila; Roth, David; Sester, Martina; Sloot, Rosa; Sotgiu, Giovanni; Woltmann, Gerrit; Yoshiyama, Takashi; Zellweger, Jean-Pierre; Zenner, Dominik; Aldridge, Robert W.; Copas, Andrew; Rangaka, Molebogeng X.; Lipman, Marc; Noursadeghi, Mahdad; Abubakar, Ibrahim			Discovery and validation of a personalized risk predictor for incident tuberculosis in low transmission settings	NATURE MEDICINE			English	Article							GAMMA RELEASE ASSAYS; ACTIVE TUBERCULOSIS; SKIN-TEST; IMMUNOCOMPROMISED PATIENTS; INFECTION; CONTACTS; CHILDREN; DISEASE; MODELS; PREVENTION	The risk of tuberculosis (TB) is variable among individuals with latentMycobacterium tuberculosisinfection (LTBI), but validated estimates of personalized risk are lacking. In pooled data from 18 systematically identified cohort studies from 20 countries, including 80,468 individuals tested for LTBI, 5-year cumulative incident TB risk among people with untreated LTBI was 15.6% (95% confidence interval (CI), 8.0-29.2%) among child contacts, 4.8% (95% CI, 3.0-7.7%) among adult contacts, 5.0% (95% CI, 1.6-14.5%) among migrants and 4.8% (95% CI, 1.5-14.3%) among immunocompromised groups. We confirmed highly variable estimates within risk groups, necessitating an individualized approach to risk stratification. Therefore, we developed a personalized risk predictor for incident TB (PERISKOPE-TB) that combines a quantitative measure of T cell sensitization and clinical covariates. Internal-external cross-validation of the model demonstrated a random effects meta-analysis C-statistic of 0.88 (95% CI, 0.82-0.93) for incident TB. In decision curve analysis, the model demonstrated clinical utility for targeting preventative treatment, compared to treating all, or no, people with LTBI. We challenge the current crude approach to TB risk estimation among people with LTBI in favor of our evidence-based and patient-centered method, in settings aiming for pre-elimination worldwide. The risk of developing active tuberculosis (TB) in individuals with latent TB infection is highly variable within and among different risk groups. A personalized risk predictor was developed to better target preventative treatment to individuals at greatest risk, supporting evidence-based clinical decision-making for latent TB.	[Gupta, Rishi K.; Calderwood, Claire J.; Krutikov, Maria; Zenner, Dominik; Rangaka, Molebogeng X.; Abubakar, Ibrahim] UCL, Inst Global Hlth, London, England; [Yavlinsky, Alexei; Aldridge, Robert W.] UCL, Inst Hlth Informat, London, England; [Quartagno, Matteo; Rangaka, Molebogeng X.] UCL, Inst Clin Trials & Methodol, MRC Clin Trials Unit, London, England; [Aichelburg, Maximilian C.] Donauspital, Dept Dermatol, Sozialmed Zentrum Ost, Vienna, Austria; [Altet, Neus] Hosp Univ Vall dHebron Drassanes, Unitat TB, Barcelona, Spain; [Altet, Neus] Unitat TDO TB Serv Clin, Barcelona, Spain; [Diel, Roland] Univ Hosp Schleswig Holstein, Inst Epidemiol, Campus Kiel, Kiel, Germany; [Diel, Roland] Airway Res Ctr North ARCN, Lung Clin Grosshansdorf, Grosshansdorf, Germany; [Dobler, Claudia C.] Bond Univ, Inst Evidence Based Healthcare, Fac Hlth Sci & Med, Gold Coast, Qld, Australia; [Dobler, Claudia C.] Liverpool Hosp, Dept Resp Med, Sydney, NSW, Australia; [Dominguez, Jose] Inst Invest Germans Trias & Pujol, Barcelona, Spain; [Dominguez, Jose] CIBER Enfermedades Resp, Barcelona, Spain; [Dominguez, Jose; Copas, Andrew] Univ Autonoma Barcelona, Barcelona, Spain; [Doyle, Joseph S.; Roder, Christine] Alfred & Monash Univ, Dept Infect Dis, Melbourne, Vic, Australia; [Doyle, Joseph S.; Roder, Christine] Burnet Inst, Dis Eliminat Program, Melbourne, Vic, Australia; [Erkens, Connie] KNCV TB Fdn, The Hague, Netherlands; [Geis, Steffen] Philipps Univ Marburg, Inst Med Microbiol & Hosp Hyg, Marburg, Germany; [Haldar, Pranabashis; Woltmann, Gerrit] Univ Leicester, Inst Lung Hlth, Dept Resp Sci, Resp Biomed Res Ctr, Leicester, Leics, England; [Hauri, Anja M.] Hesse State Hlth Off, Dillenburg, Germany; [Hermansen, Thomas] Statens Serum Inst, Int Reference Lab Mycobacteriol, Copenhagen, Denmark; [Johnston, James C.; Romanowski, Kamila; Roth, David] British Columbia Ctr Dis Control, Vancouver, BC, Canada; [Lange, Christoph] Res Ctr Borstel, Div Clin Infect Dis, Borstel, Germany; [Lange, Christoph] German Ctr Infect Res DZIF, Clin TB Ctr, Borstel, Germany; [Lange, Christoph; van Leth, Frank; Sester, Martina; Sotgiu, Giovanni; Zellweger, Jean-Pierre] TB Network European Trials Grp TBnet, Borstel, Germany; [Lange, Christoph] Karolinska Inst, Dept Med, Stockholm, Sweden; [Lange, Berit] Helmholtz Ctr Infect Res, Dept Epidemiol, Braunschweig, Germany; [van Leth, Frank] Amsterdam Inst Global Hlth & Dev, Amsterdam, Netherlands; [van Leth, Frank] Univ Amsterdam, Dept Global Hlth, Med Ctr, Amsterdam, Netherlands; [Munoz, Laura] Univ Barcelona, Dept Clin Sci, Barcelona, Spain; [Sester, Martina] Saarland Univ, Dept Transplant & Infect Immunol, Homburg, Germany; [Sloot, Rosa] Stellenbosch Univ, Desmond Tutu TB Ctr, Dept Paediat & Child Hlth, Fac Med & Hlth Sci, Cape Town, South Africa; [Sotgiu, Giovanni] Uniivers Sassari, Dept Med Surg & Expt Sci, Clin Epidemiol & Med Stat Unit, Sassari, Italy; [Yoshiyama, Takashi] Res Inst TB, Tokyo, Japan; [Zellweger, Jean-Pierre] Swiss Lung Assoc, Bern, Switzerland; [Rangaka, Molebogeng X.] Univ Cape Town, Inst Infect Dis & Mol Med, Wellcome Ctr Infect Dis Res Africa, Cape Town, South Africa; [Rangaka, Molebogeng X.] Univ Cape Town, Sch Publ Hlth, Div Epidemiol & Biostat, Cape Town, South Africa; [Lipman, Marc] UCL, UCL TB & UCL Resp, London, England; [Lipman, Marc] Royal Free London NHS Fdn Trust, London, England; [Noursadeghi, Mahdad] UCL, Div Infect & Immun, London, England	University of London; University College London; University of London; University College London; Medical Research Council Clinical Trials Unit; University of London; University College London; Donauspital; University of Kiel; Schleswig Holstein University Hospital; Bond University; Liverpool Hospital; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Autonomous University of Barcelona; Monash University; Burnet Institute; KNCV Tuberculosis Foundation; Philipps University Marburg; University of Leicester; Statens Serum Institut; Forschungszentrum Borstel; German Center for Infection Research; Karolinska Institutet; Helmholtz Association; Helmholtz-Center for Infection Research; University of Amsterdam; University of Barcelona; Universitatsklinikum des Saarlandes; Stellenbosch University; University of Cape Town; University of Cape Town; University of London; University College London; University of London; University College London; Royal Free London NHS Foundation Trust; University of London; University College London	Abubakar, I (corresponding author), UCL, Inst Global Hlth, London, England.	i.abubakar@ucl.ac.uk	Sester, Martina/AAA-3383-2022; Lange, Berit/AAO-4436-2021; Roder, Christine/N-3058-2017	Lange, Berit/0000-0002-9325-9307; Abubakar, Ibrahim/0000-0002-0370-1430; Calderwood, Claire/0000-0002-1926-7464; Noursadeghi, Mahdad/0000-0002-4774-0853; Woltmann, Gerrit/0000-0002-9253-6034; RANGAKA, Molebogeng/0000-0001-9594-188X; Dobler, Claudia/0000-0002-5460-0189; Krutikov, Maria/0000-0002-3982-642X; Quartagno, Matteo/0000-0003-4446-0730; Gupta, Rishi/0000-0002-6257-1285; Lipman, Marc/0000-0001-7501-4448; Yavlinsky, Alexei/0000-0002-4100-4257; Sloot, Rosa/0000-0001-7295-3247; Aldridge, Robert/0000-0003-0542-0816; Romanowski, Kamila/0000-0002-7027-3579; van Leth, Frank/0000-0002-5490-8968; Copas, Andrew/0000-0001-8968-5963; Zenner, Dominik/0000-0002-9200-6180; Haldar, Pranabashis/0000-0002-1572-5421	National Institute for Health Research (NIHR) [DRF-2018-11-ST2-004, SRF-2011-04-001, NF-SI-0616-10037]; Wellcome Trust [207511/Z/17/Z]; NIHR; German Center for Infection Research; MRC [MC_UU_12023/21] Funding Source: UKRI	National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); Wellcome Trust(Wellcome TrustEuropean Commission); NIHR(National Institute for Health Research (NIHR)); German Center for Infection Research; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was funded by the National Institute for Health Research (NIHR) (DRF-2018-11-ST2-004 to R.K.G. and SRF-2011-04-001 and NF-SI-0616-10037 to I.A.), the Wellcome Trust (207511/Z/17/Z to M.N.) and NIHR biomedical research funding to University College London Hospitals. C.L. is funded by the German Center for Infection Research. J.S.D. receives salary support from the National Health and Medical Research Council (Australia). This paper presents independent research supported by the NIHR. The views expressed are those of the authors and not necessarily those of the National Health Service, the NIHR or the Department of Health and Social Care. The study funders had no role in the conceptualization, design, data collection, analysis, decision to publish or preparation of the manuscript. The authors would like to thank all of the research teams involved in the primary studies that contributed data for this analysis.	Abubakar I, 2018, LANCET INFECT DIS, V18, P1077, DOI 10.1016/S1473-3099(18)30355-4; Aichelburg MC, 2009, CLIN INFECT DIS, V48, P954, DOI 10.1086/597351; Alsdurf H, 2016, LANCET INFECT DIS, V16, P1269, DOI 10.1016/S1473-3099(16)30216-X; Altet N, 2015, ANN AM THORAC SOC, V12, P680, DOI 10.1513/AnnalsATS.201408-394OC; Andrews JR, 2017, LANCET RESP MED, V5, P282, DOI [10.1016/S2213-2600(17)30060-7, 10.1016/s2213-2600(17)30060-7]; Audigier V, 2019, MICEMD MULTIPLE IMPU; Audigier V, 2018, STAT SCI, V33, P160, DOI 10.1214/18-STS646; Balduzzi S, 2019, EVID-BASED MENT HEAL, V22, P153, DOI 10.1136/ebmental-2019-300117; Behr MA, 2018, BMJ-BRIT MED J, V362, DOI 10.1136/bmj.k2738; Bower H, 2021, COMMUN STAT-SIMUL C, V50, P3777, DOI 10.1080/03610918.2019.1634201; Campbell JR, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.m549; Clements M, 2019, RSTPM2 SMOOTH SURVIV; Cobelens FG, 2006, CLIN INFECT DIS, V43, P634, DOI 10.1086/506432; Collins GS, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.g7594; Debray TPA, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001886; Diel R, 2011, AM J RESP CRIT CARE, V183, P88, DOI 10.1164/rccm.201006-0974OC; Dobler CC, 2013, EUR RESPIR J, V41, P1459, DOI 10.1183/09031936.00183812; Doyle JS, 2014, JAIDS-J ACQ IMM DEF, V66, P48, DOI 10.1097/QAI.0000000000000109; Drain PK, 2018, CLIN MICROBIOL REV, V31, DOI 10.1128/CMR.00021-18; Erkens CGM, 2016, EUR RESPIR J, V48, P1420, DOI 10.1183/13993003.01157-2016; Gao J, 2015, INT J FAMILY MED, V2015; Geis S, 2013, EUR RESPIR J, V42, P1743, DOI 10.1183/09031936.00187112; Getahun H, 2015, EUR RESPIR J, V46, P1563, DOI 10.1183/13993003.01245-2015; Getahun H, 2015, NEW ENGL J MED, V372, P2127, DOI 10.1056/NEJMra1405427; Groenwold RHH, 2016, J CLIN EPIDEMIOL, V78, P90, DOI 10.1016/j.jclinepi.2016.03.017; Gupta RK, 2020, ANN AM THORAC SOC, V17, P646, DOI 10.1513/AnnalsATS.201905-407RL; Gupta RK, 2020, LANCET RESP MED, V8, P395, DOI 10.1016/S2213-2600(19)30282-6; Gupta RK, 2020, AM J RESP CRIT CARE, V201, P984, DOI 10.1164/rccm.201905-0969OC; Haldar P, 2013, THORAX, V68, P240, DOI 10.1136/thoraxjnl-2011-200956; Harrell F. E, 2004, BIOSTATISTICAL MODEL; Katelaris AL, 2020, J INFECT DIS, V221, P146, DOI 10.1093/infdis/jiz430; Lange B, 2012, INT J TUBERC LUNG D, V16, P492, DOI 10.5588/ijtld.11.0416; Li RR, 2020, CLIN INFECT DIS, V71, pE338, DOI 10.1093/cid/ciz1221; Mack U, 2009, EUR RESPIR J, V33, P956, DOI 10.1183/09031936.00120908; Martinez L, 2020, LANCET, V395, P973, DOI 10.1016/S0140-6736(20)30166-5; Menzies D, 2008, INT J TUBERC LUNG D, V12, P498; Munoz L, 2015, TRANSPLANT DIRECT, V1, DOI 10.1097/TXD.0000000000000520; Nemes E, 2018, NEW ENGL J MED, V379, P138, DOI [10.1056/NEJMoa1714021, 10.1056/nejmoa1714021]; Pai M, 2014, CLIN MICROBIOL REV, V27, P3, DOI 10.1128/CMR.00034-13; Rangaka MX, 2012, LANCET INFECT DIS, V12, P45, DOI 10.1016/S1473-3099(11)70210-9; Roe J, 2020, CLIN INFECT DIS, V70, P731, DOI 10.1093/cid/ciz252; Roth DZ, 2017, EUR RESPIR J, V49, DOI 10.1183/13993003.01546-2016; Royston P, 2002, STAT MED, V21, P2175, DOI 10.1002/sim.1203; Rubin D. B, 2004, SURVEYS; Saunders MJ, 2020, LANCET INFECT DIS, V20, P110, DOI 10.1016/S1473-3099(19)30423-2; Saunders MJ, 2017, LANCET INFECT DIS, V17, P1190, DOI 10.1016/S1473-3099(17)30447-4; Seddon JA, 2016, THORAX, V71, P932, DOI 10.1136/thoraxjnl-2015-207687; Sester M, 2014, AM J RESP CRIT CARE, V190, P1168, DOI 10.1164/rccm.201405-0967OC; Sjoberg D.D., 2020, DCA DECISION CURVE A; Sloot R, 2014, AM J RESP CRIT CARE, V190, P1044, DOI 10.1164/rccm.201406-1159OC; Snell KIE, 2018, STAT METHODS MED RES, V27, P3505, DOI 10.1177/0962280217705678; Sterling Timothy R, 2020, MMWR Recomm Rep, V69, P1, DOI 10.15585/mmwr.rr6901a1; Stewart LA, 2015, JAMA-J AM MED ASSOC, V313, P1657, DOI 10.1001/jama.2015.3656; Steyerberg EW, 2016, J CLIN EPIDEMIOL, V69, P245, DOI 10.1016/j.jclinepi.2015.04.005; Steyerberg EW, 2014, EUR HEART J, V35, P1925, DOI 10.1093/eurheartj/ehu207; Vickers Andrew J, 2019, Diagn Progn Res, V3, P18, DOI 10.1186/s41512-019-0064-7; Wells G.A., NEWCASTLE OTTAWA SCA; Westeneng HJ, 2018, LANCET NEUROL, V17, P423, DOI 10.1016/S1474-4422(18)30089-9; White IR, 2011, STAT MED, V30, P377, DOI 10.1002/sim.4067; WHO, 2019, GLOB TUB REP; WHO, 2015, WORLD HEAL ORGAN, V58, P7250; Winje BA, 2018, THORAX, V73, P652, DOI 10.1136/thoraxjnl-2017-211147; World Health Organization, 2018, LAT TB INF UPD CONS; Yoshiyama T, 2015, INFECT DIS-NOR, V47, P542, DOI 10.3109/23744235.2015.1026935; Zellweger JP, 2015, AM J RESP CRIT CARE, V191, P1176, DOI 10.1164/rccm.201502-0232OC; Zenner D, 2017, ANN INTERN MED, V167, P248, DOI 10.7326/M17-0609; Zenner D, 2017, EUR RESPIR J, V50, DOI 10.1183/13993003.02505-2016; ZHANG Z, 2018, ANN TRANSL MED, V6, P19, DOI DOI 10.1186/s12967-018-1395-9	68	24	26	1	6	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	2020	26	12								10.1038/s41591-020-1076-0	http://dx.doi.org/10.1038/s41591-020-1076-0		OCT 2020	22	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	PB8QO	33077958	Green Submitted			2022-12-27	WOS:000579706700005
J	Algazi, AP; Othus, M; Daud, AI; Lo, RS; Mehnert, JM; Truong, TG; Conry, R; Kendra, K; Doolittle, GC; Clark, JI; Messino, MJ; Moore, DF; Lao, C; Faller, BA; Govindarajan, R; Harker-Murray, A; Dreisbach, L; Moon, J; Grossmann, KF; Ribas, A				Algazi, Alain P.; Othus, Megan; Daud, Adil, I; Lo, Roger S.; Mehnert, Janice M.; Thach-Giao Truong; Conry, Robert; Kendra, Kari; Doolittle, Gary C.; Clark, Joseph, I; Messino, Michael J.; Moore, Dennis F., Jr.; Lao, Christopher; Faller, Bryan A.; Govindarajan, Rangaswamy; Harker-Murray, Amy; Dreisbach, Luke; Moon, James; Grossmann, Kenneth F.; Ribas, Antoni			Continuous versus intermittent BRAF and MEK inhibition in patients withBRAF-mutated melanoma: a randomized phase 2 trial	NATURE MEDICINE			English	Article							ADVANCED BRAF(V600)-MUTANT MELANOMA; ACQUIRED-RESISTANCE; DOUBLE-BLIND; VEMURAFENIB; COMBINATION; DABRAFENIB; TRAMETINIB; EVOLUTION; STRATEGY; EFFICACY	The randomized phase 2 trial S1320 comparing different dosing schedules of BRAF/MEK inhibitor combination inBRAF-mutated advanced melanoma shows intermittent therapy does not result in superior progression-free survival in patients. Preclinical modeling suggests that intermittent BRAF inhibitor therapy may delay acquired resistance when blocking oncogenicBRAF(V600)in melanoma(1,2). We conducted S1320, a randomized, open-label, phase 2 clinical trial (NCT02196181) evaluating whether intermittent dosing of the BRAF inhibitor dabrafenib and the MEK inhibitor trametinib improves progression-free survival in patients with metastatic and unresectableBRAF(V600)melanoma. Patients were enrolled at 68 academic and community sites nationally. All patients received continuous dabrafenib and trametinib during an 8-week lead-in period, after which patients with non-progressing tumors were randomized to either continuous or intermittent dosing of both drugs on a 3-week-off, 5-week-on schedule. The trial has completed accrual and 206 patients with similar baseline characteristics were randomized 1:1 to the two study arms (105 to continuous dosing, 101 to intermittent dosing). Continuous dosing yielded a statistically significant improvement in post-randomization progression-free survival compared with intermittent dosing (median 9.0 months versus 5.5 months,P = 0.064, pre-specified two-sided alpha = 0.2). Therefore, contrary to the initial hypothesis, intermittent dosing did not improve progression-free survival in patients. There were no differences in the secondary outcomes, including overall survival and the overall incidence of treatment-associated toxicity, between the two groups.	[Algazi, Alain P.; Daud, Adil, I] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Othus, Megan; Moon, James] Fred Hutchinson Canc Res Ctr, 1124 Columbia St, Seattle, WA 98104 USA; [Lo, Roger S.; Ribas, Antoni] Univ Calif Los Angeles, Los Angeles, CA USA; [Mehnert, Janice M.] Rutgers Canc Inst New Jersey, New Brunswick, NJ USA; [Thach-Giao Truong] Kaiser Permanente Northern Calif, Vallejo, CA USA; [Conry, Robert] Univ Alabama Birmingham, Birmingham, AL USA; [Kendra, Kari] Ohio State Univ, Columbus, OH 43210 USA; [Doolittle, Gary C.] Univ Kansas Hosp Westwood, Canc Ctr, Westwood, KS USA; [Clark, Joseph, I] Loyola Univ, Chicago, IL 60611 USA; [Messino, Michael J.] Southeast COR NCORP Asheville, Messino Canc Ctr Asheville, Asheville, NC USA; [Moore, Dennis F., Jr.] Wichita NCORP, Canc Ctr Kansas, Wichita, KS USA; [Lao, Christopher] Univ Michigan, Ann Arbor, MI 48109 USA; [Faller, Bryan A.] Heartland NCORP, Missouri Baptist Med Ctr Canc Ctr, St Louis, MO USA; [Govindarajan, Rangaswamy] Univ Arkansas, Little Rock, AR 72204 USA; [Harker-Murray, Amy] Froedtert, Milwaukee, WI USA; [Harker-Murray, Amy] Med Coll Wisconsin, Milwaukee, WI 53226 USA; [Dreisbach, Luke] Eisenhower Med Ctr, Rancho Mirage, CA USA; [Grossmann, Kenneth F.] Huntsman Canc Inst, Salt Lake City, UT USA	University of California System; University of California San Francisco; Fred Hutchinson Cancer Center; University of California System; University of California Los Angeles; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers Cancer Institute of New Jersey; Kaiser Permanente; University of Alabama System; University of Alabama Birmingham; University System of Ohio; Ohio State University; Loyola University Chicago; Cancer Center of Kansas; University of Michigan System; University of Michigan; University of Arkansas System; University of Arkansas Fayetteville; University of Arkansas Little Rock; Medical College of Wisconsin; Huntsman Cancer Institute	Algazi, AP (corresponding author), Univ Calif San Francisco, San Francisco, CA 94143 USA.	alain.algazi@ucsf.edu		Othus, Megan/0000-0001-8176-6371	National Cancer Institute's Cancer Therapeutics Evaluation Program (NCI-CTEP); NCI/NIH [CA180888, CA180819, CA180820, CA180850, CA239767, CA189808, CA46282, CA189858, CA189830, CA233230, CA189829, CA189954, CA189860, CA189822, CA189953, CA180834, CA189809, CA189957, CA189958, R35 CA197633, P01 CA244118]	National Cancer Institute's Cancer Therapeutics Evaluation Program (NCI-CTEP); NCI/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We gratefully acknowledge B. Suttle and D. Ouellet for their work on the pharmacokinetic modeling for dabrafenib and trametinib. We also acknowledge M. Voi, T. Haas and E. Gasal from Novartis for their critical reading of the manuscript and for their helpful comments. S1320 is an intergroup trial led by the SWOG Cancer Research Network with funding and supervision from the National Cancer Institute's Cancer Therapeutics Evaluation Program (NCI-CTEP). Research reported in this publication was supported by NCI/NIH awards CA180888, CA180819, CA180820, CA180850, CA239767, CA189808, CA46282, CA189858, CA189830, CA233230, CA189829, CA189954, CA189860, CA189822, CA189953, CA180834, CA189809, CA189957 and CA189958 (to SWOG), R35 CA197633 (to A.R.) and P01 CA244118 (to A.R. and R.S.L.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. Glaxo-Smith-Kline, the manufacturer of dabrafenib and trametinib at the time of study initiation, reviewed and approved the study protocol and provided the study drugs to NCI-CTEP. Novartis, the manufacturer of the study drugs at the time of study completion, reviewed and commented on the final study manuscript. All data analysis was completed by M.O. and J.M. at the SWOG statistical center. All authors had full access to all of the study data and they had sole responsibility for the decision to submit the paper for publication and for the contents of the submitted manuscript.	Ascierto PA, 2016, LANCET ONCOL, V17, P1248, DOI 10.1016/S1470-2045(16)30122-X; Das Thakur M, 2013, NATURE, V494, P251, DOI 10.1038/nature11814; de Moura CR, 2020, TRANSL ONCOL, V13, P275, DOI 10.1016/j.tranon.2019.10.003; Dreno B, 2017, LANCET ONCOL, V18, P404, DOI 10.1016/S1470-2045(17)30072-4; Dummer R, 2018, LANCET ONCOL, V19, P1315, DOI 10.1016/S1470-2045(18)30497-2; Flaherty KT, 2010, NEW ENGL J MED, V363, P809, DOI 10.1056/NEJMoa1002011; Long GV, 2015, LANCET, V386, P444, DOI 10.1016/S0140-6736(15)60898-4; Minami S, 2013, LUNG CANCER, V82, P271, DOI 10.1016/j.lungcan.2013.07.022; Moriceau G, 2015, CANCER CELL, V27, P240, DOI 10.1016/j.ccell.2014.11.018; Nazarian R, 2010, NATURE, V468, P973, DOI 10.1038/nature09626; Poulikakos PI, 2011, NATURE, V480, P387, DOI 10.1038/nature10662; Schreuer M, 2017, LANCET ONCOL, V18, P464, DOI 10.1016/S1470-2045(17)30171-7; Shi HB, 2014, CANCER DISCOV, V4, P80, DOI 10.1158/2159-8290.CD-13-0642; Somasundaram R, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00452-4; Song CY, 2017, CANCER DISCOV, V7, P1248, DOI 10.1158/2159-8290.CD-17-0401; Tate SC, 2016, BRIT J CANCER, V114, P669, DOI 10.1038/bjc.2016.40; Valpione S, 2018, EUR J CANCER, V91, P116, DOI 10.1016/j.ejca.2017.12.007; Villanueva J, 2010, CANCER CELL, V18, P683, DOI 10.1016/j.ccr.2010.11.023; Xue YH, 2017, NAT MED, V23, P929, DOI 10.1038/nm.4369; Yu HA, 2017, LUNG CANCER, V112, P195, DOI 10.1016/j.lungcan.2017.08.017	20	41	42	0	6	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	OCT	2020	26	10					1564	+		10.1038/s41591-020-1060-8	http://dx.doi.org/10.1038/s41591-020-1060-8		OCT 2020	17	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	NX8MD	33020646	Green Accepted			2022-12-27	WOS:000575801100005
J	Stower, H				Stower, Hannah			Monoclonal antibodies for yellow fever	NATURE MEDICINE			English	Editorial Material												h.stower@us.nature.com							0	0	0	1	1	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	SEP	2020	26	9					1331	1331		10.1038/s41591-020-1067-1	http://dx.doi.org/10.1038/s41591-020-1067-1			1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	PF3EM	32908279				2022-12-27	WOS:000598942000014
J	Charney, AW; Simons, NW; Mouskas, K; Lepow, L; Cheng, E; Le Berichel, J; Chang, C; Marvin, R; Del Valle, DM; Calorossi, S; Lansky, A; Walker, L; Patel, M; Xie, H; Yi, N; Yu, A; Kang, G; Liharska, LE; Moya, E; Hartnett, M; Hatem, S; Wilkins, L; Eaton, M; Jamal, H; Tuballes, K; Chen, ST; Chung, J; Harris, J; Batchelor, C; Lacunza, J; Yishak, M; Argueta, K; Karekar, N; Lee, B; Kelly, G; Geanon, D; Handler, D; Leech, J; Stefanos, H; Dawson, T; Scott, I; Francoeur, N; Johnson, JS; Vaid, A; Glicksberg, BS; Nadkarni, GN; Schadt, EE; Gelb, BD; Rahman, A; Sebra, R; Martin, G; Marron, T; Beckmann, N; Kim-Schulze, S; Gnjatic, S; Merad, M				Charney, Alexander W.; Simons, Nicole W.; Mouskas, Konstantinos; Lepow, Lauren; Cheng, Esther; Le Berichel, Jessica; Chang, Christie; Marvin, Robert; Del Valle, Diane Marie; Calorossi, Sharlene; Lansky, Alona; Walker, Laura; Patel, Manishkumar; Xie, Hui; Yi, Nancy; Yu, Alex; Kang, Gurpawan; Liharska, Lora E.; Moya, Emily; Hartnett, Matthew; Hatem, Sandra; Wilkins, Lillian; Eaton, Melody; Jamal, Hajra; Tuballes, Kevin; Chen, Steven T.; Chung, Jonathan; Harris, Jocelyn; Batchelor, Craig; Lacunza, Jose; Yishak, Mahlet; Argueta, Kimberly; Karekar, Neha; Lee, Brian; Kelly, Geoffrey; Geanon, Daniel; Handler, Diana; Leech, John; Stefanos, Hiyab; Dawson, Travis; Scott, Ieisha; Francoeur, Nancy; Johnson, Jessica S.; Vaid, Akhil; Glicksberg, Benjamin S.; Nadkarni, Girish N.; Schadt, Eric E.; Gelb, Bruce D.; Rahman, Adeeb; Sebra, Robert; Martin, Glenn; Marron, Thomas; Beckmann, Noam; Kim-Schulze, Seunghee; Gnjatic, Sacha; Merad, Miriam		Mount Sinai COVID-19 Biobank Team	Sampling the host response to SARS-CoV-2 in hospitals under siege (vol 54, pg 231, 2020)	NATURE MEDICINE			English	Correction													XIE, HUI/AAU-7178-2021; Patel, Manishkumar/AAA-7287-2022	Chang, Serena/0000-0002-5683-2469; Humblin, Etienne/0000-0002-4559-6106; Patel, Manishkumar/0000-0002-7949-5610; Gnjatic, Sacha/0000-0001-5643-9520; Glicksberg, Benjamin/0000-0003-4515-8090; Chang, Christie/0000-0002-7651-7220; Del Valle, Diane/0000-0001-6983-5362				Charney AW, 2020, NAT MED, V26, P1157, DOI 10.1038/s41591-020-1004-3	1	0	0	1	4	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	SEP	2020	26	9					1493	1493		10.1038/s41591-020-1057-3	http://dx.doi.org/10.1038/s41591-020-1057-3		AUG 2020	1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	PF3EM	32826990	Green Published, Bronze			2022-12-27	WOS:000561690500001
J	Gill, JMR				Gill, Jason M. R.			Linking volume and intensity of physical activity to mortality	NATURE MEDICINE			English	Editorial Material								In a study of 96,476 participants from the UK Biobank cohort who had their physical activity objectively measured by accelerometer, both the volume of physical activity and its intensity were associated with risk of mortality.	[Gill, Jason M. R.] Univ Glasgow, BHF Glasgow Cardiovasc Res Ctr, Inst Cardiovasc & Med Sci, Coll Med Vet & Life Sci, Glasgow, Lanark, Scotland	University of Glasgow	Gill, JMR (corresponding author), Univ Glasgow, BHF Glasgow Cardiovasc Res Ctr, Inst Cardiovasc & Med Sci, Coll Med Vet & Life Sci, Glasgow, Lanark, Scotland.	jason.gill@glasgow.ac.uk		Gill, Jason/0000-0003-3615-0986				Ainsworth BE, 2011, MED SCI SPORT EXER, V43, P1575, DOI 10.1249/MSS.0b013e31821ece12; Allen N, 2012, HEALTH POLICY TECHN, V1, P123, DOI 10.1016/j.hlpt.2012.07.003; [Anonymous], 2010, GLOB REC PHYS ACT HL; Celis-Morales CA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036345; Department of Health & Social Care, 2019, UK CHIEF MED OFF PHY; Ekelund U, 2019, BMJ-BRIT MED J, V366, DOI 10.1136/bmj.l4570; Kobayashi LC, 2017, AGE AGEING, V46, P427, DOI 10.1093/ageing/afw199; Moore SC, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001335; Piercy KL, 2018, JAMA-J AM MED ASSOC, V320, P2020, DOI 10.1001/jama.2018.14854; Samitz G, 2011, INT J EPIDEMIOL, V40, P1382, DOI 10.1093/ije/dyr112; Strain T, 2020, NAT MED, V26, DOI 10.1038/s41591-020-1012-3; Strain T, 2020, INT J EPIDEMIOL, V49, P162, DOI 10.1093/ije/dyz212	12	3	3	3	8	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	SEP	2020	26	9					1332	1334		10.1038/s41591-020-1019-9	http://dx.doi.org/10.1038/s41591-020-1019-9		AUG 2020	3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	PF3EM	32807932	Green Accepted			2022-12-27	WOS:000560288000007
J	Strain, T; Wijndaele, K; Dempsey, PC; Sharp, SJ; Pearce, M; Jeon, J; Lindsay, T; Wareham, N; Brage, S				Strain, Tessa; Wijndaele, Katrien; Dempsey, Paddy C.; Sharp, Stephen J.; Pearce, Matthew; Jeon, Justin; Lindsay, Tim; Wareham, Nick; Brage, Soren			Wearable-device-measured physical activity and future health risk	NATURE MEDICINE			English	Article							CORONARY-HEART-DISEASE; ACCELEROMETER DATA; SEDENTARY TIME; DOSE-RESPONSE; INTENSITY; PREVENTION; MORTALITY; EXERCISE	Use of wearable devices that monitor physical activity is projected to increase more than fivefold per half-decade(1). We investigated how device-based physical activity energy expenditure (PAEE) and different intensity profiles were associated with all-cause mortality. We used a network harmonization approach to map dominant-wrist acceleration to PAEE in 96,476 UK Biobank participants (mean age 62 years, 56% female). We also calculated the fraction of PAEE accumulated from moderate-to-vigorous-intensity physical activity (MVPA). Over the median 3.1-year follow-up period (302,526 person-years), 732 deaths were recorded. Higher PAEE was associated with a lower hazard of all-cause mortality for a constant fraction of MVPA (for example, 21% (95% confidence interval 4-35%) lower hazard for 20 versus 15 kJ kg(-1) d(-1)PAEE with 10% from MVPA). Similarly, a higher MVPA fraction was associated with a lower hazard when PAEE remained constant (for example, 30% (8-47%) lower hazard when 20% versus 10% of a fixed 15 kJ kg(-1) d(-1)PAEE volume was from MVPA). Our results show that higher volumes of PAEE are associated with reduced mortality rates, and achieving the same volume through higher-intensity activity is associated with greater reductions than through lower-intensity activity. The linkage of device-measured activity to energy expenditure creates a framework for using wearables for personalized prevention. Analysis of UK Biobank participants with wearable physical activity monitors demonstrates that high-volume physical activity and high-intensity activity are associated with reduced mortality.	[Strain, Tessa; Wijndaele, Katrien; Dempsey, Paddy C.; Sharp, Stephen J.; Pearce, Matthew; Jeon, Justin; Lindsay, Tim; Wareham, Nick; Brage, Soren] Univ Cambridge, Inst Metab Sci, MRC Epidemiol Unit, Cambridge, England; [Dempsey, Paddy C.] Baker Heart & Diabet Inst, Phys Act Lab, Melbourne, Vic, Australia; [Dempsey, Paddy C.] Baker Heart & Diabet Inst, Behav Epidemiol Lab, Melbourne, Vic, Australia; [Jeon, Justin] Yonsei Univ, Exercise Med Ctr Diabet & Canc Patients ICONS, Dept Sport Ind Studies, Seoul, South Korea	University of Cambridge; Yonsei University	Brage, S (corresponding author), Univ Cambridge, Inst Metab Sci, MRC Epidemiol Unit, Cambridge, England.	soren.brage@mrc-epid.cam.ac.uk	DEMPSEY, PADDY/ABG-9629-2020; Wijndaele, Katrien/H-5465-2013; Brage, Soren/C-6415-2013	DEMPSEY, PADDY/0000-0002-1714-6087; Jeon, Justin/0000-0001-7978-4271; Wijndaele, Katrien/0000-0003-2199-7981; Strain, Tessa/0000-0002-7086-1047; Brage, Soren/0000-0002-1265-7355; Lindsay, Tim/0000-0003-2857-1764	UK Medical Research Council [MC_UU_12015/1, MC_UU_12015/3]; National Health and Medical Research Council of Australia [1142685]; Cambridge Trust; St Catharine's College; MRC [MC_UU_12015/1, MC_UU_12015/3, MC_UU_00006/4] Funding Source: UKRI	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Cambridge Trust; St Catharine's College; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We are grateful to the participants of the UK Biobank study and those who collected and managed the data. This work was conducted under UK Biobank application number 20684. T.S., K.W., S.B., S.J.S., T.L., P.C.D., M.P., J.J. and N.W. are supported by the UK Medical Research Council (unit program numbers MC_UU_12015/1 and MC_UU_12015/3). P.C.D. is supported by a National Health and Medical Research Council of Australia research fellowship (no. 1142685). T.L. is supported by the Cambridge Trust and St Catharine's College.	Ainsworth BE, 2011, MED SCI SPORT EXER, V43, P1575, DOI 10.1249/MSS.0b013e31821ece12; [Anonymous], 2009, NUTR REV, V67, P114, DOI 10.1111/j.1753-4887.2008.00136.x; [Anonymous], 2019, WEAR DEV; Brage S, 2004, J APPL PHYSIOL, V96, P343, DOI 10.1152/japplphysiol.00703.2003; Brage S, 2007, J APPL PHYSIOL, V103, P682, DOI 10.1152/japplphysiol.00092.2006; Brage S, 2020, INT J EPIDEMIOL, V49, P1007, DOI 10.1093/ije/dyaa005; Brage S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137206; Chastin SFM, 2019, BRIT J SPORT MED, V53, P370, DOI 10.1136/bjsports-2017-097563; Chief Medical Officer, 2019, UK CHIEF MED OFF PHY; Department of Health, 2011, START ACT STAY ACT R; Doherty A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169649; Dormann CF, 2013, ECOGRAPHY, V36, P27, DOI 10.1111/j.1600-0587.2012.07348.x; Ekelund U, 2019, BMJ-BRIT MED J, V366, DOI 10.1136/bmj.l4570; Fry A, 2017, AM J EPIDEMIOL, V186, P1026, DOI 10.1093/aje/kwx246; Gebel K, 2014, PREV MED, V60, P131, DOI 10.1016/j.ypmed.2013.12.030; Klass M, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0224948; Lindsay T, 2019, INT J BEHAV NUTR PHY, V16, DOI 10.1186/s12966-019-0882-6; Manson JE, 1999, NEW ENGL J MED, V341, P650, DOI 10.1056/NEJM199908263410904; Matthews CE, 2016, AM J CLIN NUTR, V104, P1424, DOI 10.3945/ajcn.116.135129; PATE RR, 1995, JAMA-J AM MED ASSOC, V273, P402, DOI 10.1001/jama.273.5.402; Pearce M, 2019, J MEAS PHYS BEHAV, DOI 10.1123/jmpb.2019-0001; Saint-Maurice PF, 2018, J AM HEART ASSOC, V7, DOI 10.1161/JAHA.118.008815; Schmid D, 2016, MED SCI SPORT EXER, V48, P1312, DOI 10.1249/MSS.0000000000000913; Shephard RJ, 2001, MED SCI SPORT EXER, V33, pS400, DOI 10.1097/00005768-200106001-00008; Shiroma EJ, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.000802; Strain T, 2020, INT J EPIDEMIOL, V49, P162, DOI 10.1093/ije/dyz212; Strath SJ, 2005, MED SCI SPORT EXER, V37, pS563, DOI 10.1249/01.mss.0000185650.68232.3f; Sudlow C, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001779; Tanasescu N, 2002, JAMA-J AM MED ASSOC, V288, P1994, DOI 10.1001/jama.288.16.1994; Thompson D, 2006, J NUTR, V136, P1037, DOI 10.1093/jn/136.4.1037; Tikkanen E, 2018, CIRCULATION, V137, P2583, DOI [10.1161/circulationaha.117.032432, 10.1161/CIRCULATIONAHA.117.032432]; U.S. Department of Health and Human Services, 2008, 2008 PHYS ACT GUID A; van Hees VT, 2014, J APPL PHYSIOL, V117, P738, DOI 10.1152/japplphysiol.00421.2014; van Hees VT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061691; Welk GJ, 2019, MED SCI SPORT EXER, V51, P1767, DOI 10.1249/MSS.0000000000001966; White IR, 2009, STAT MED, V28, P1982, DOI 10.1002/sim.3618; White T, 2019, INT J OBESITY, V43, P2333, DOI 10.1038/s41366-019-0352-x; White T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167472; Wijndaele K, 2017, MED SCI SPORT EXER, V49, P1111, DOI 10.1249/MSS.0000000000001206; World Health Organization, 2010, Global recommendations on physical activity for health	40	65	67	4	31	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	SEP	2020	26	9								10.1038/s41591-020-1012-3	http://dx.doi.org/10.1038/s41591-020-1012-3		AUG 2020	18	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	PF3EM	32807930	Green Accepted, Green Submitted			2022-12-27	WOS:000560288000003
J	Fisher, AJ; Dark, JH				Fisher, Andrew J.; Dark, John H.			Ex vivo repair of human donor lungs for transplantation	NATURE MEDICINE			English	Editorial Material							PERFUSION	Injured human donor lungs deemed unsuitable for immediate transplantation may be successfully recovered by connection into the circulation of a porcine host with perfusion and ventilation ex vivo for 24 hours.	[Fisher, Andrew J.] Newcastle Univ, Translat & Clin Res Inst, Regenerat Med Stem Cells & Transplantat Theme, Newcastle Upon Tyne, Tyne & Wear, England; Newcastle Upon Tyne Hosp NHS Fdn Trust, Inst Transplantat, Newcastle Upon Tyne, Tyne & Wear, England	Newcastle University - UK; Newcastle Upon Tyne Hospitals NHS Foundation Trust	Fisher, AJ (corresponding author), Newcastle Univ, Translat & Clin Res Inst, Regenerat Med Stem Cells & Transplantat Theme, Newcastle Upon Tyne, Tyne & Wear, England.	a.j.fisher@ncl.ac.uk		Fisher, Andrew/0000-0003-4822-7223; Dark, John Henry/0000-0002-4727-6085	National Institute for Health Research Blood and Transplant Research Unit in Organ Donation and Transplantation at the University of Cambridge; Newcastle University; NHS Blood and Transplant	National Institute for Health Research Blood and Transplant Research Unit in Organ Donation and Transplantation at the University of Cambridge; Newcastle University; NHS Blood and Transplant	A.J.F. and J.H.D. are supported by the National Institute for Health Research Blood and Transplant Research Unit in Organ Donation and Transplantation at the University of Cambridge and Newcastle University and in partnership with NHS Blood and Transplant. The views expressed are those of the authors and not necessarily those of the National Institute for Health Research, the Department of Health and Social Care or NHS Blood and Transplant .	Andreasson ASI, 2014, EUR J CARDIO-THORAC, V46, P779, DOI 10.1093/ejcts/ezu228; Basil MC, 2020, CELL STEM CELL, V26, P482, DOI 10.1016/j.stem.2020.03.009; Cypel M, 2011, NEW ENGL J MED, V364, P1431, DOI 10.1056/NEJMoa1014597; Fisher AJ, 2001, AM J RESP CRIT CARE, V163, P259, DOI 10.1164/ajrccm.163.1.2005093; Fisher AJ, 1999, LANCET, V353, P1412, DOI 10.1016/S0140-6736(99)00494-8; Gilmour J, 2020, CURR OPIN ORGAN TRAN, V25, P285, DOI 10.1097/MOT.0000000000000765; Hozain AE, 2020, NAT MED, V26, DOI 10.1038/s41591-020-0971-8; Hozain AE, 2020, J THORAC CARDIOV SUR, V159, P1640, DOI 10.1016/j.jtcvs.2019.09.121; Laird C, 2016, CURR OPIN ORGAN TRAN, V21, P272, DOI 10.1097/MOT.0000000000000311; Sommer W, 2019, AM J TRANSPLANT, V19, P345, DOI 10.1111/ajt.15075; Tian D, 2020, J THORAC CARDIOV SUR, V159, P720, DOI 10.1016/j.jtcvs.2019.07.087; Whitson BA, 2007, J HEART LUNG TRANSPL, V26, P1004, DOI 10.1016/j.healun.2007.07.018	12	0	0	1	2	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	JUL	2020	26	7					1015	1016		10.1038/s41591-020-0967-4	http://dx.doi.org/10.1038/s41591-020-0967-4		JUL 2020	2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	MK3XO	32651577				2022-12-27	WOS:000547236500006
J	Hozain, AE; O'Neill, JD; Pinezich, MR; Tipograf, Y; Donocoff, R; Cunningham, KM; Tumen, A; Fung, K; Ukita, R; Simpson, MT; Reimer, JA; Ruiz, EC; Queen, D; Stokes, JW; Cardwell, NL; Talackine, J; Kim, J; Snoeck, HW; Chen, YW; Romanov, A; Marboe, CC; Griesemer, AD; Guenthart, BA; Bacchetta, M; Vunjak-Novakovic, G				Hozain, Ahmed E.; O'Neill, John D.; Pinezich, Meghan R.; Tipograf, Yuliya; Donocoff, Rachel; Cunningham, Katherine M.; Tumen, Andrew; Fung, Kenmond; Ukita, Rei; Simpson, Michael T.; Reimer, Jonathan A.; Ruiz, Edward C.; Queen, Dawn; Stokes, John W.; Cardwell, Nancy L.; Talackine, Jennifer; Kim, Jinho; Snoeck, Hans-Willem; Chen, Ya-Wen; Romanov, Alexander; Marboe, Charles C.; Griesemer, Adam D.; Guenthart, Brandon A.; Bacchetta, Matthew; Vunjak-Novakovic, Gordana			Xenogeneic cross-circulation for extracorporeal recovery of injured human lungs	NATURE MEDICINE			English	Article							ACUTE VASCULAR REJECTION; COBRA VENOM; IN-VIVO; PIG; PERFUSION; EXPRESSION; XENOTRANSPLANTATION; TRANSPLANTATION; INTERLEUKIN-8; INFLAMMATION	In a new strategy for increasing the availability of lungs for transplantation, human lungs declined for transplantation because of their poor quality can be recuperated by connecting them to the circulation of a pig. Patients awaiting lung transplantation face high wait-list mortality, as injury precludes the use of most donor lungs. Although ex vivo lung perfusion (EVLP) is able to recover marginal quality donor lungs, extension of normothermic support beyond 6 h has been challenging. Here we demonstrate that acutely injured human lungs declined for transplantation, including a lung that failed to recover on EVLP, can be recovered by cross-circulation of whole blood between explanted human lungs and a Yorkshire swine. This xenogeneic platform provided explanted human lungs a supportive, physiologic milieu and systemic regulation that resulted in functional and histological recovery after 24 h of normothermic support. Our findings suggest that cross-circulation can serve as a complementary approach to clinical EVLP to recover injured donor lungs that could not otherwise be utilized for transplantation, as well as a translational research platform for immunomodulation and advanced organ bioengineering.	[Hozain, Ahmed E.; O'Neill, John D.; Pinezich, Meghan R.; Cunningham, Katherine M.; Reimer, Jonathan A.; Ruiz, Edward C.; Kim, Jinho; Guenthart, Brandon A.; Bacchetta, Matthew; Vunjak-Novakovic, Gordana] Columbia Univ, Dept Biomed Engn, New York, NY 10027 USA; [Hozain, Ahmed E.; Tipograf, Yuliya; Simpson, Michael T.; Reimer, Jonathan A.; Griesemer, Adam D.] Columbia Univ, Med Ctr, Dept Surg, New York, NY USA; [Donocoff, Rachel; Romanov, Alexander] Columbia Univ, Med Ctr, Inst Comparat Med, New York, NY USA; [Tumen, Andrew; Ukita, Rei; Stokes, John W.; Cardwell, Nancy L.; Talackine, Jennifer; Bacchetta, Matthew] Vanderbilt Univ, Dept Thorac Surg, 221 Kirkland Hall, Nashville, TN 37235 USA; [Fung, Kenmond] Columbia Univ, Med Ctr, Dept Clin Perfus, New York, NY USA; [Queen, Dawn] Columbia Univ, Med Ctr, Vagelos Coll Phys & Surg, New York, NY USA; [Kim, Jinho] Stevens Inst Technol, Dept Biomed Engn, Hoboken, NJ 07030 USA; [Snoeck, Hans-Willem; Chen, Ya-Wen; Vunjak-Novakovic, Gordana] Columbia Univ, Dept Med, Med Ctr, New York, NY 10027 USA; [Snoeck, Hans-Willem] Columbia Univ, Med Ctr, Dept Microbiol & Immunol, New York, NY USA; [Snoeck, Hans-Willem] Columbia Univ, Med Ctr, Columbia Ctr Human Dev, New York, NY USA; [Chen, Ya-Wen] Univ Southern Calif, Dept Med, Los Angeles, CA 90007 USA; [Chen, Ya-Wen] Univ Southern Calif, Dept Stem Cell Biol & Regenerat Med, Los Angeles, CA 90007 USA; [Marboe, Charles C.] Columbia Univ, Med Ctr, Dept Pathol & Cell Biol, New York, NY USA; [Griesemer, Adam D.] Columbia Univ, Med Ctr, Ctr Translat Immunol, New York, NY USA; [Guenthart, Brandon A.] Stanford Univ, Dept Cardiothorac Surg, Stanford, CA 94305 USA; [Bacchetta, Matthew] Vanderbilt Univ, Dept Cardiac Surg, 221 Kirkland Hall, Nashville, TN 37235 USA; [Bacchetta, Matthew] Vanderbilt Univ, Dept Biomed Engn, Nashville, TN 37235 USA	Columbia University; Columbia University; Columbia University; Vanderbilt University; Columbia University; Columbia University; Stevens Institute of Technology; Columbia University; Columbia University; Columbia University; University of Southern California; University of Southern California; Columbia University; Columbia University; Stanford University; Vanderbilt University; Vanderbilt University	Bacchetta, M; Vunjak-Novakovic, G (corresponding author), Columbia Univ, Dept Biomed Engn, New York, NY 10027 USA.; Bacchetta, M (corresponding author), Vanderbilt Univ, Dept Thorac Surg, 221 Kirkland Hall, Nashville, TN 37235 USA.; Vunjak-Novakovic, G (corresponding author), Columbia Univ, Dept Med, Med Ctr, New York, NY 10027 USA.; Bacchetta, M (corresponding author), Vanderbilt Univ, Dept Cardiac Surg, 221 Kirkland Hall, Nashville, TN 37235 USA.; Bacchetta, M (corresponding author), Vanderbilt Univ, Dept Biomed Engn, Nashville, TN 37235 USA.	matthew.bacchetta@vumc.org; gv2131@columbia.edu		Ukita, Rei/0000-0002-3523-6182; Guenthart, Brandon A./0000-0002-9864-0035; Chen, Ya-Wen/0000-0003-2382-8444	National Institutes of Health [EB27062, HL007854, HL120046, HL134760]; Mikati Foundation; Blavatnik Foundation (STAR grant)	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mikati Foundation; Blavatnik Foundation (STAR grant)	The authors thank the following collaborators and supporters: Institute of Comparative Medicine veterinary staff, including A. Hubbard, S. Robertson, R. Ober, A. McLuckie, N. Herndon, D. Ordanes and A. Rivas for supporting animal studies; Weill Cornell Microscopy and Image Analysis Core Facility staff, including L. Cohen-Gould and J. P. Jimenez for transmission electron microscopy imaging services; Rockefeller University Electron Microscopy Resource Center staff, including K. Uyru and N. Soplop for scanning electron microscopy imaging services; Herbert Irving Comprehensive Cancer Center Molecular Pathology Shared Resources, including T. Wu, D. Sun and R. Chen for histology services; S. Chicotka, P. Liou, M. Foley, J. Diaz, M.S. Fultz, J. Adcock, N. Llore, E. Lopes, G. Pierre and I. Fedoriv for technical and analytical support; S. Pistilli, K. Fragoso and S. Halligan for administrative support. The authors gratefully acknowledge funding support from the National Institutes of Health (EB27062, HL007854, HL120046, HL134760), Mikati Foundation and Blavatnik Foundation (STAR grant).	Andreasson A, 2014, J HEART LUNG TRANSPL, V33, P910, DOI 10.1016/j.healun.2013.12.023; Andreasson ASI, 2017, J HEART LUNG TRANSPL, V36, P985, DOI 10.1016/j.healun.2017.05.012; Andreasson ASI, 2017, EUR J CARDIO-THORAC, V51, P577, DOI 10.1093/ejcts/ezw358; Baquerizo A, 1999, TRANSPLANTATION, V67, P5, DOI 10.1097/00007890-199901150-00003; BICKEL M, 1993, J PERIODONTOL, V64, P456; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Boneva RS, 2004, ANN MED, V36, P504, DOI 10.1080/07853890410018826; Bottino R, 2017, XENOTRANSPLANTATION, V24, DOI 10.1111/xen.12283; Breimer ME, 1996, XENOTRANSPLANTATION, V3, P328, DOI 10.1111/j.1399-3089.1996.tb00155.x; BRIGHAM KL, 1973, J CLIN INVEST, V52, P2041, DOI 10.1172/JCI107388; Campos MM, 2002, BRIT J PHARMACOL, V135, P1107, DOI 10.1038/sj.bjp.0704488; COCHRANE CG, 1970, J IMMUNOL, V105, P55; Cypel M, 2011, NEW ENGL J MED, V364, P1431, DOI 10.1056/NEJMoa1014597; de Perrot M, 2003, AM J RESP CRIT CARE, V167, P490, DOI 10.1164/rccm.200207-670SO; De Perrot M, 2002, AM J RESP CRIT CARE, V165, P211, DOI 10.1164/ajrccm.165.2.2011151; Denner J, 2017, VIROL J, V14, DOI 10.1186/s12985-017-0836-z; Dieckhoff B, 2008, XENOTRANSPLANTATION, V15, P36, DOI 10.1111/j.1399-3089.2008.00442.x; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Fujino N, 2011, LAB INVEST, V91, P363, DOI 10.1038/labinvest.2010.187; Godehardt AW, 2015, XENOTRANSPLANTATION, V22, P95, DOI 10.1111/xen.12154; Gorsuch WB, 2009, MOL IMMUNOL, V47, P506, DOI 10.1016/j.molimm.2009.08.017; Griesemer A, 2014, IMMUNOL REV, V258, P241, DOI 10.1111/imr.12152; Guenthart BA, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09908-1; Guenthart BA, 2019, J HEART LUNG TRANSPL, V38, P215, DOI 10.1016/j.healun.2018.11.007; Haihua C, 2018, SCI REP, V8, P1; Halloran PF, 2001, J IMMUNOL, V166, P7072, DOI 10.4049/jimmunol.166.12.7072; Hozain AE, 2020, J THORAC CARDIOV SUR, V159, P1640, DOI 10.1016/j.jtcvs.2019.09.121; Kawut SM, 2009, CHEST, V136, P237, DOI 10.1378/chest.08-2697; Kuwaki K, 2005, NAT MED, V11, P29, DOI 10.1038/nm1171; Lee K, 2014, P NATL ACAD SCI USA, V111, P7260, DOI 10.1073/pnas.1406376111; Levy MF, 2000, TRANSPLANTATION, V69, P272, DOI 10.1097/00007890-200001270-00013; Li Q, 2018, XENOTRANSPLANTATION, V25, DOI 10.1111/xen.12393; Lonsdale J, 2013, NAT GENET, V45, P580, DOI 10.1038/ng.2653; Loor G, 2019, LANCET RESP MED, V7, P975, DOI 10.1016/S2213-2600(19)30200-0; Loor G, 2017, TRANSPLANTATION, V101, P2303, DOI 10.1097/TP.0000000000001616; Loss M, 2000, XENOTRANSPLANTATION, V7, P186, DOI 10.1034/j.1399-3089.2000.00059.x; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; McCurry KR, 1997, HUM IMMUNOL, V58, P91, DOI 10.1016/S0198-8859(97)00229-2; Niu D, 2017, SCIENCE, V357, P1303, DOI 10.1126/science.aan4187; Noordergraaf J, 2018, XENOTRANSPLANTATION, V25, DOI 10.1111/xen.12428; Nottle MB, 2017, SCI REP, V7, P1; O'Neill JD, 2017, NAT BIOMED ENG, V1, DOI 10.1038/s41551-017-0037; Oberholzer J, 1999, IMMUNOLOGY, V97, P173; Okamoto T, 2019, TRANSPLANTATION, V103, P1799, DOI 10.1097/TP.0000000000002667; Olajuyin AM, 2019, CELL DEATH DISCOV, V5, DOI 10.1038/s41420-019-0147-9; Pan H, 2016, TRANSPL IMMUNOL, V39, P74, DOI 10.1016/j.trim.2016.08.005; Pinezich M, 2019, EXP BIOL MED, V244, P630, DOI 10.1177/1535370219834498; Rock JR, 2010, DIS MODEL MECH, V3, P545, DOI 10.1242/dmm.006031; Sadaria MR, 2011, ANN THORAC SURG, V92, P478, DOI 10.1016/j.athoracsur.2011.04.027; Sahebian A, 2018, J HEART LUNG TRANSPL, V37, P420, DOI 10.1016/j.healun.2017.11.016; Scheffert JL, 2014, J THORAC DIS, V6, P1039, DOI 10.3978/j.issn.2072-1439.2014.04.23; Scheller J, 2011, BBA-MOL CELL RES, V1813, P878, DOI 10.1016/j.bbamcr.2011.01.034; Slama A, 2017, J HEART LUNG TRANSPL, V36, P744, DOI 10.1016/j.healun.2017.02.011; Sommer W, 2019, AM J TRANSPLANT, V19, P345, DOI 10.1111/ajt.15075; Sommer W, 2013, J HEART LUNG TRANSPL, V32, P1065, DOI 10.1016/j.healun.2013.06.021; Spratt JR, 2017, TRANSPL INT, V30, P932, DOI 10.1111/tri.12981; Subhash S, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-016-1250-z; Sykes M, 2019, SCI IMMUNOL, V4, DOI 10.1126/sciimmunol.aau6298; Tata A, 2018, CELL STEM CELL, V22, P668, DOI 10.1016/j.stem.2018.03.018; Van Herck A, 2017, J THORAC DIS, V9, P5472, DOI 10.21037/jtd.2017.11.85; Warnecke G, 2018, LANCET RESP MED, V6, P357, DOI 10.1016/S2213-2600(18)30136-X; World Health Statistics, 2017, WORLD HLTH STAT 2017; Yamada K, 2005, NAT MED, V11, P32, DOI 10.1038/nm1172; Zuber J, 2017, TRENDS IMMUNOL, V38, P829, DOI 10.1016/j.it.2017.07.008	64	27	28	3	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUL	2020	26	7								10.1038/s41591-020-0971-8	http://dx.doi.org/10.1038/s41591-020-0971-8			30	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	MK3UH	32661401				2022-12-27	WOS:000548708000001
J	Hall, W; Degenhardt, L; Hickman, M				Hall, Wayne; Degenhardt, Louisa; Hickman, Matthew			Generational trends in US opioid-overdose deaths	NATURE MEDICINE			English	Editorial Material							DRUG		[Hall, Wayne] Univ Queensland, Ctr Youth Subst Abuse Res, Brisbane, Qld, Australia; [Hall, Wayne] Univ Queensland, Queensland Alliance Environm Hlth, Brisbane, Qld, Australia; [Degenhardt, Louisa] Univ New South Wales, Natl Drug & Alcohol Res Ctr, Sydney, NSW, Australia; [Hickman, Matthew] Univ Bristol Sch Med, Populat Hlth Sci, Bristol, Avon, England	University of Queensland; University of Queensland; University of New South Wales Sydney; University of Bristol	Hall, W (corresponding author), Univ Queensland, Ctr Youth Subst Abuse Res, Brisbane, Qld, Australia.; Hall, W (corresponding author), Univ Queensland, Queensland Alliance Environm Hlth, Brisbane, Qld, Australia.	w.hall@uq.edu.au	Hickman, Matthew/Y-2400-2019; Hall, Wayne D/A-3283-2008	Hickman, Matthew/0000-0001-9864-459X; Hall, Wayne D/0000-0003-1984-0096	MRC [MR/N00616X/1] Funding Source: UKRI; Medical Research Council [MR/N00616X/1] Funding Source: Medline; Department of Health [RP-DG-0610-10055, RP-PG-0616-20008] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Department of Health		Boslett AJ, 2020, ADDICTION, V115, P1308, DOI 10.1111/add.14943; Case A, 2015, P NATL ACAD SCI USA, V112, P15078, DOI 10.1073/pnas.1518393112; Degenhardt L, 2019, LANCET, V394, P1560, DOI 10.1016/S0140-6736(19)32229-9; Hall WD, 1999, MED J AUSTRALIA, V171, P34, DOI 10.5694/j.1326-5377.1999.tb123495.x; Jalal H, 2020, NAT MED, V26, P699, DOI 10.1038/s41591-020-0855-y; Kolodny A, 2015, ANNU REV PUBL HEALTH, V36, P559, DOI 10.1146/annurev-publhealth-031914-122957; Merrall ELC, 2010, ADDICTION, V105, P1545, DOI 10.1111/j.1360-0443.2010.02990.x; Saloner B, 2018, PUBLIC HEALTH REP, V133, p24S, DOI 10.1177/0033354918793627; Strang J, 2020, NAT REV DIS PRIMERS, V6, DOI 10.1038/s41572-019-0137-5; Strang J, 2019, DRUGS, V79, P1395, DOI 10.1007/s40265-019-01154-5; Wakeman SE, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2019.20622; Wilson N, 2020, MMWR-MORBID MORTAL W, V69, P290, DOI 10.15585/mmwr.mm6911a4	12	4	4	0	5	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	MAY	2020	26	5					651	652		10.1038/s41591-020-0875-7	http://dx.doi.org/10.1038/s41591-020-0875-7		MAY 2020	3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	ML1JP	32367061				2022-12-27	WOS:000530244500003
J	Lau, LS; Samari, G; Moresky, RT; Casey, SE; Kachur, SP; Roberts, LF; Zard, M				Lau, Ling San; Samari, Goleen; Moresky, Rachel T.; Casey, Sara E.; Kachur, S. Patrick; Roberts, Leslie F.; Zard, Monette			COVID-19 in humanitarian settings and lessons learned from past epidemics	NATURE MEDICINE			English	Editorial Material							INFLUENZA; IMPACT		[Lau, Ling San; Samari, Goleen; Moresky, Rachel T.; Casey, Sara E.; Kachur, S. Patrick; Roberts, Leslie F.; Zard, Monette] Columbia Univ, Mailman Sch Publ Hlth, Heilbrunn Dept Populat & Family Hlth, Program Forced Migrat & Hlth, New York, NY 10032 USA; [Moresky, Rachel T.] Columbia Univ, Dept Emergency Med, Irving Med Ctr, New York, NY USA	Columbia University; Columbia University; NewYork-Presbyterian Hospital	Zard, M (corresponding author), Columbia Univ, Mailman Sch Publ Hlth, Heilbrunn Dept Populat & Family Hlth, Program Forced Migrat & Hlth, New York, NY 10032 USA.	mz2621@cumc.columbia.edu	Kachur, Patrick/ABE-7220-2021					[Anonymous], 2014, ASS SOC IMP EB VIR G; Bamrah S, 2013, PREHOSP DISASTER MED, V28, P43, DOI 10.1017/S1049023X12001665; Barden-O'Fallon J, 2015, PLOS CURR, V7; Coutts Adam, 2015, Lancet Respir Med, V3, pe8, DOI 10.1016/S2213-2600(15)00041-7; Dahn B, 2017, LANCET, V389, P1189, DOI 10.1016/S0140-6736(17)30775-4; Fallon K., 2020, GUARDIAN; Heffelfinger JD, 2009, AM J PUBLIC HEALTH, V99, pS333, DOI 10.2105/AJPH.2008.158170; Hovring R., 2020, 10 THINGS YOU SHOULD; Hussey PS, 2014, JAMA INTERN MED, V174, P742, DOI 10.1001/jamainternmed.2014.245; IFRC. IOM UNHCR WHO, 2020, SCAL UP COV 19 OUTBR; Knobler S, 2004, LEARNING SARS PREPAR; Konwloh P K, 2017, Public Health Action, V7, pS62, DOI 10.5588/pha.16.0097; Madhav N., 2017, DIS CONTROL PRIORITI, V9, P315, DOI [10.1596/978-1-4648-0527-1_ch17, DOI 10.1596/978-1-4648-0527-1]; Mateus ALP, 2014, B WORLD HEALTH ORGAN, V92, P868, DOI 10.2471/BLT.14.135590; Parpia AS, 2016, EMERG INFECT DIS, V22, P433, DOI 10.3201/eid2203.150977; Person B, 2004, EMERG INFECT DIS, V10, P358, DOI 10.3201/eid1002.030750; Rubinson L, 2013, MED CARE, V51, P259, DOI 10.1097/MLR.0b013e31827da8ea; UNHCR, 2020, COR EM APP UNHCRS PR; Vaughan E, 2009, AM J PUBLIC HEALTH, V99, pS324, DOI 10.2105/AJPH.2009.162537	19	79	80	1	3	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	MAY	2020	26	5					647	648		10.1038/s41591-020-0851-2	http://dx.doi.org/10.1038/s41591-020-0851-2			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	ML1JP	32269357	Bronze			2022-12-27	WOS:000549231500009
J	Li, A; Zalesky, A; Yue, WH; Howes, O; Yan, H; Liu, Y; Fan, LZ; Whitaker, KJ; Xu, KB; Rao, GX; Li, J; Liu, S; Wang, M; Sun, YQ; Song, M; Li, P; Chen, J; Chen, YC; Wang, HN; Liu, WM; Li, ZG; Yang, YF; Guo, H; Wan, P; Lv, LX; Lu, L; Yan, J; Song, YQ; Wang, HL; Zhang, HX; Wu, HW; Ning, YP; Du, YH; Cheng, YQ; Xu, J; Xu, XF; Zhang, D; Wang, XQ; Jiang, TZ; Liu, B				Li, Ang; Zalesky, Andrew; Yue, Weihua; Howes, Oliver; Yan, Hao; Liu, Yong; Fan, Lingzhong; Whitaker, Kirstie J.; Xu, Kaibin; Rao, Guangxiang; Li, Jin; Liu, Shu; Wang, Meng; Sun, Yuqing; Song, Ming; Li, Peng; Chen, Jun; Chen, Yunchun; Wang, Huaning; Liu, Wenming; Li, Zhigang; Yang, Yongfeng; Guo, Hua; Wan, Ping; Lv, Luxian; Lu, Lin; Yan, Jun; Song, Yuqing; Wang, Huiling; Zhang, Hongxing; Wu, Huawang; Ning, Yuping; Du, Yuhui; Cheng, Yuqi; Xu, Jian; Xu, Xiufeng; Zhang, Dai; Wang, Xiaoqun; Jiang, Tianzi; Liu, Bing			A neuroimaging biomarker for striatal dysfunction in schizophrenia	NATURE MEDICINE			English	Article							TREATMENT-RESISTANT SCHIZOPHRENIA; RESTING-STATE FMRI; FUNCTIONAL CONNECTIVITY; DOPAMINE HYPOTHESIS; GENE-EXPRESSION; NETWORK; PSYCHOSIS; RISK; DYSCONNECTIVITY; DISORDER	Mounting evidence suggests that function and connectivity of the striatum is disrupted in schizophrenia(1-5). We have developed a new hypothesis-driven neuroimaging biomarker for schizophrenia identification, prognosis and subtyping based on functional striatal abnormalities (FSA). FSA scores provide a personalized index of striatal dysfunction, ranging from normal to highly pathological. Using inter-site cross-validation on functional magnetic resonance images acquired from seven independent scanners (n = 1,100), FSA distinguished individuals with schizophrenia from healthy controls with an accuracy exceeding 80% (sensitivity, 79.3%; specificity, 81.5%). In two longitudinal cohorts, inter-individual variation in baseline FSA scores was significantly associated with antipsychotic treatment response. FSA revealed a spectrum of severity in striatal dysfunction across neuropsychiatric disorders, where dysfunction was most severe in schizophrenia, milder in bipolar disorder, and indistinguishable from healthy individuals in depression, obsessive-compulsive disorder and attention-deficit hyperactivity disorder. Loci of striatal hyperactivity recapitulated the spatial distribution of dopaminergic function and the expression profiles of polygenic risk for schizophrenia. In conclusion, we have developed a new biomarker to index striatal dysfunction and established its utility in predicting antipsychotic treatment response, clinical stratification and elucidating striatal dysfunction in neuropsychiatric disorders. A new cross-validated neuroimaging biomarker that reflects striatal dysfunctioning can be used to distinguish patients with schizophrenia from healthy controls, and is associated with treatment response to antipsychotics.	[Li, Ang; Liu, Yong; Fan, Lingzhong; Xu, Kaibin; Rao, Guangxiang; Li, Jin; Liu, Shu; Wang, Meng; Sun, Yuqing; Song, Ming; Chen, Jun; Jiang, Tianzi; Liu, Bing] Chinese Acad Sci, Brainnetome Ctr, Beijing, Peoples R China; [Li, Ang; Liu, Yong; Fan, Lingzhong; Xu, Kaibin; Rao, Guangxiang; Li, Jin; Liu, Shu; Wang, Meng; Sun, Yuqing; Song, Ming; Chen, Jun; Jiang, Tianzi; Liu, Bing] Chinese Acad Sci, Natl Lab Pattern Recognit, Inst Automat, Beijing, Peoples R China; [Li, Ang; Liu, Yong; Fan, Lingzhong; Xu, Kaibin; Rao, Guangxiang; Li, Jin; Liu, Shu; Wang, Meng; Sun, Yuqing; Song, Ming; Chen, Jun; Wang, Xiaoqun; Jiang, Tianzi; Liu, Bing] Univ Chinese Acad Sci, Sch Artificial Intelligence, Beijing, Peoples R China; [Li, Ang; Liu, Yong; Fan, Lingzhong; Rao, Guangxiang; Liu, Shu; Wang, Meng; Sun, Yuqing; Wang, Xiaoqun; Jiang, Tianzi; Liu, Bing] Chinese Acad Sci, Ctr Excellence Brain Sci & Intelligence Technol, Shanghai, Peoples R China; [Zalesky, Andrew] Univ Melbourne, Dept Psychiat, Melbourne Neuropsychiat Ctr, Melbourne, Vic, Australia; [Zalesky, Andrew] Melbourne Hlth, Melbourne, Vic, Australia; [Zalesky, Andrew] Univ Melbourne, Dept Biomed Engn, Melbourne, Vic, Australia; [Yue, Weihua; Yan, Hao; Li, Peng; Lu, Lin; Yan, Jun; Song, Yuqing; Zhang, Dai] Peking Univ, Sixth Hosp, Inst Mental Hlth, Beijing, Peoples R China; [Yue, Weihua; Yan, Hao; Li, Peng; Lu, Lin; Yan, Jun; Song, Yuqing; Zhang, Dai] Peking Univ, Sixth Hosp, Minist Hlth, Key Lab Mental Hlth, Beijing, Peoples R China; [Yue, Weihua; Yan, Hao; Li, Peng; Lu, Lin; Yan, Jun; Song, Yuqing; Zhang, Dai] Peking Univ, Sixth Hosp, Natl Clin Res Ctr Mental Disorders, Beijing, Peoples R China; [Howes, Oliver] Imperial Coll London, MRC London Inst Med Sci, Hammersmith Hosp, Psychiat Imaging Grp, London, England; [Howes, Oliver] Kings Coll London, Inst Psychiat, London, England; [Whitaker, Kirstie J.] Univ Cambridge, Dept Psychiat, Cambridge, England; [Whitaker, Kirstie J.] British Lib, Alan Turing Inst, London, England; Wuhan Univ, Renmin Hosp, Dept Radiol, Wuhan, Peoples R China; [Chen, Yunchun; Wang, Huaning; Liu, Wenming] Fourth Mil Med Univ, Xijing Hosp, Dept Psychiat, Xian, Peoples R China; [Li, Zhigang; Guo, Hua; Wan, Ping] Zhumadian Psychiat Hosp, Zhumadian, Peoples R China; [Yang, Yongfeng; Lv, Luxian; Zhang, Hongxing] Xinxiang Med Univ, Affiliated Hosp 2, Henan Mental Hosp, Dept Psychiat, Xinxiang, Henan, Peoples R China; [Yang, Yongfeng; Lv, Luxian; Zhang, Hongxing] Xinxiang Med Univ, Int Joint Res Lab Psychiat & Neurosci Henan, Henan Key Lab Biol Psychiat, Xinxiang, Henan, Peoples R China; [Wang, Huiling] Wuhan Univ, Renmin Hosp, Dept Psychiat, Wuhan, Peoples R China; [Zhang, Hongxing] Xinxiang Med Univ, Dept Psychol, Xinxiang, Henan, Peoples R China; [Wu, Huawang; Ning, Yuping] Guangzhou Med Univ, Guangzhou Huiai Hosp, Affiliated Brain Hosp, Guangzhou, Peoples R China; [Du, Yuhui] Shanxi Univ, Sch Comp & Informat Technol, Taiyuan, Peoples R China; [Cheng, Yuqi; Xu, Jian; Xu, Xiufeng] Kunming Med Univ, Affiliated Hosp 1, Dept Psychiat, Kunming, Yunnan, Peoples R China; [Zhang, Dai] Peking Univ, McGovern Inst Brain Res, PKU IDG, Ctr Life Sci, Beijing, Peoples R China; [Wang, Xiaoqun] Chinese Acad Sci, Inst Biophys, State Key Lab Brain & Cognit Sci, Beijing, Peoples R China; [Jiang, Tianzi; Liu, Bing] Chinese Acad Sci, Innovat Acad Artificial Intelligence, Beijing, Peoples R China; [Jiang, Tianzi] Univ Elect Sci & Technol China, Sch Life Sci & Technol, Minist Educ, Key Lab Neuro Informat, Chengdu, Peoples R China; [Jiang, Tianzi] Univ Queensland, Queensland Brain Inst, Brisbane, Qld, Australia	Chinese Academy of Sciences; Chinese Academy of Sciences; Institute of Automation, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; University of Melbourne; University of Melbourne; Peking University; Peking University; Peking University; Imperial College London; University of London; King's College London; University of Cambridge; Wuhan University; Air Force Military Medical University; Xinxiang Medical University; Xinxiang Medical University; Wuhan University; Xinxiang Medical University; Guangzhou Medical University; Shanxi University; Kunming Medical University; Peking University; Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; University of Electronic Science & Technology of China; University of Queensland	Jiang, TZ; Liu, B (corresponding author), Chinese Acad Sci, Brainnetome Ctr, Beijing, Peoples R China.; Jiang, TZ; Liu, B (corresponding author), Chinese Acad Sci, Natl Lab Pattern Recognit, Inst Automat, Beijing, Peoples R China.; Jiang, TZ; Liu, B (corresponding author), Univ Chinese Acad Sci, Sch Artificial Intelligence, Beijing, Peoples R China.; Jiang, TZ; Liu, B (corresponding author), Chinese Acad Sci, Ctr Excellence Brain Sci & Intelligence Technol, Shanghai, Peoples R China.; Jiang, TZ; Liu, B (corresponding author), Chinese Acad Sci, Innovat Acad Artificial Intelligence, Beijing, Peoples R China.; Jiang, TZ (corresponding author), Univ Elect Sci & Technol China, Sch Life Sci & Technol, Minist Educ, Key Lab Neuro Informat, Chengdu, Peoples R China.; Jiang, TZ (corresponding author), Univ Queensland, Queensland Brain Inst, Brisbane, Qld, Australia.	jiangtz@nlpr.ia.ac.cn; bliu@nlpr.ia.ac.cn	liu, wen/HGE-3071-2022; Jiang, Tianzi/I-4256-2012; Liu, Yong/F-2682-2011; Fan, Lingzhong/K-6273-2014	Jiang, Tianzi/0000-0001-9531-291X; Liu, Yong/0000-0002-1862-3121; Fan, Lingzhong/0000-0002-4813-621X; ZALESKY, ANDREW/0000-0003-2298-9908; Wang, Hua-Ning/0000-0003-1981-4293; Li, Ang/0000-0002-2309-9811	National Key Basic Research and Development Program (973) [2011CB707800]; National Key Research and Development Plan [2016YFC0904300]; Strategic Priority Research Program of Chinese Academy of Science [XDB32020200]; Natural Science Foundation of China [81771451]	National Key Basic Research and Development Program (973)(National Basic Research Program of China); National Key Research and Development Plan; Strategic Priority Research Program of Chinese Academy of Science; Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	We thank C. Y. Wang, T. M. Si, G. L. Gong and M. Li for their critical discussions and comments, N. N. Tian for her assistance with figure drawing, and R. E. Perozzi and E. F. Perozzi for reviewing the English and content of this study. This work was supported by the National Key Basic Research and Development Program (973) (grant 2011CB707800 to T.J.), the National Key Research and Development Plan (grant 2016YFC0904300 to B.L.), the Strategic Priority Research Program of Chinese Academy of Science (grant XDB32020200 to B.L.) and the Natural Science Foundation of China (grant 81771451 to B.L.).	Abraham A, 2017, NEUROIMAGE, V147, P736, DOI 10.1016/j.neuroimage.2016.10.045; Abraham A, 2014, FRONT NEUROINFORM, V8, DOI 10.3389/fninf.2014.00014; Alonso-Solis A, 2015, SCHIZOPHR RES, V161, P261, DOI 10.1016/j.schres.2014.10.047; Arbabshirani MR, 2017, NEUROIMAGE, V145, P137, DOI 10.1016/j.neuroimage.2016.02.079; Chen KC, 2013, SCHIZOPHRENIA BULL, V39, P378, DOI 10.1093/schbul/sbr163; Falkai P, 2011, WORLD PSYCHIATRY, V10, P38; Fan LZ, 2016, CEREB CORTEX, V26, P3508, DOI 10.1093/cercor/bhw157; Fornito A, 2013, JAMA PSYCHIAT, V70, P1143, DOI 10.1001/jamapsychiatry.2013.1976; Frank J, 2015, MOL PSYCHIATR, V20, P150, DOI 10.1038/mp.2014.56; Friston KJ, 1996, MAGNET RESON MED, V35, P346, DOI 10.1002/mrm.1910350312; Garcia-Gomez FJ, 2013, REV ESP MED NUCL IMA, V32, P350, DOI 10.1016/j.remn.2013.02.009; Grecchi E, 2014, PHYS MED BIOL, V59, P2517, DOI 10.1088/0031-9155/59/10/2517; Hadley JA, 2014, NEUROPSYCHOPHARMACOL, V39, P1020, DOI 10.1038/npp.2013.305; Hawrylycz MJ, 2012, NATURE, V489, P391, DOI 10.1038/nature11405; Howes OD, 2017, AM J PSYCHIAT, V174, P216, DOI 10.1176/appi.ajp.2016.16050503; Howes OD, 2014, BRIT J PSYCHIAT, V205, P1, DOI 10.1192/bjp.bp.113.138578; Howes OD, 2012, ARCH GEN PSYCHIAT, V69, P776, DOI 10.1001/archgenpsychiatry.2012.169; Howes OD, 2009, SCHIZOPHRENIA BULL, V35, P549, DOI 10.1093/schbul/sbp006; Jauhar S, 2019, BIOL PSYCHIAT, V85, P79, DOI 10.1016/j.biopsych.2018.07.003; Jauhar S, 2017, JAMA PSYCHIAT, V74, P1206, DOI 10.1001/jamapsychiatry.2017.2943; Kaar SJ, 2020, NEUROPHARMACOLOGY, V172, DOI 10.1016/j.neuropharm.2019.107704; KAY SR, 1987, SCHIZOPHRENIA BULL, V13, P261, DOI 10.1093/schbul/13.2.261; Kennedy JL, 2014, INT CLIN PSYCHOPHARM, V29, P63, DOI 10.1097/YIC.0b013e32836508e6; Kusumi I, 2015, PSYCHIAT CLIN NEUROS, V69, P243, DOI 10.1111/pcn.12242; Lancaster TM, 2019, SCHIZOPHRENIA BULL, V45, P405, DOI 10.1093/schbul/sby037; Lancaster TM, 2016, JAMA PSYCHIAT, V73, P852, DOI 10.1001/jamapsychiatry.2016.1135; Lee SH, 2013, NAT GENET, V45, P984, DOI 10.1038/ng.2711; Lichtenstein P, 2009, LANCET, V373, P234, DOI 10.1016/S0140-6736(09)60072-6; LINDENMAYER JP, 1994, J NERV MENT DIS, V182, P631, DOI 10.1097/00005053-199411000-00006; Martino M, 2018, SCHIZOPHRENIA BULL, V44, P419, DOI 10.1093/schbul/sbx067; McCutcheon RA, 2020, JAMA PSYCHIAT, V77, P201, DOI 10.1001/jamapsychiatry.2019.3360; McCutcheon RA, 2019, TRENDS NEUROSCI, V42, P205, DOI 10.1016/j.tins.2018.12.004; McNabb CB, 2018, SCHIZOPHR RES, V195, P160, DOI 10.1016/j.schres.2017.10.015; Poldrack RA, 2016, SCI DATA, V3, DOI 10.1038/sdata.2016.110; Power JD, 2017, NEUROIMAGE, V146, P609, DOI 10.1016/j.neuroimage.2016.09.038; Power JD, 2011, NEURON, V72, P665, DOI 10.1016/j.neuron.2011.09.006; Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185; Richiardi J, 2015, SCIENCE, V348, P1241, DOI 10.1126/science.1255905; Ripke S, 2014, NATURE, V511, P421, DOI 10.1038/nature13595; Rizzo G, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148744; Romme IAC, 2017, BIOL PSYCHIAT, V81, P495, DOI 10.1016/j.biopsych.2016.07.012; Sarpal DK, 2016, AM J PSYCHIAT, V173, P69, DOI 10.1176/appi.ajp.2015.14121571; Scholvinck ML, 2010, P NATL ACAD SCI USA, V107, P10238, DOI 10.1073/pnas.0913110107; Shirer WR, 2012, CEREB CORTEX, V22, P158, DOI 10.1093/cercor/bhr099; Simpson EH, 2010, NEURON, V65, P585, DOI 10.1016/j.neuron.2010.02.014; Smyser CD, 2010, CEREB CORTEX, V20, P2852, DOI 10.1093/cercor/bhq035; STEIGER JH, 1980, PSYCHOL BULL, V87, P245, DOI 10.1037/0033-2909.87.2.245; Tziortzi AC, 2014, CEREB CORTEX, V24, P1165, DOI 10.1093/cercor/bhs397; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Valenti O, 2011, J NEUROSCI, V31, P12330, DOI 10.1523/JNEUROSCI.2808-11.2011; van Os J, 2009, LANCET, V374, P635, DOI [10.1016/S0140-6736(09)60995-8, 10.1016/S0140-6736(15)01121-6]; Velligan D.I., 2011, DRUG DISCOV TODAY, V8, P11, DOI DOI 10.1016/j.ddstr.2011.10.001; Watanabe K, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01261-5; White TP, 2016, NEUROPSYCHOPHARMACOL, V41, P1274, DOI 10.1038/npp.2015.277; Xu KB, 2018, FRONT NEUROINFORM, V12, DOI 10.3389/fninf.2018.00052; Yang GJ, 2014, P NATL ACAD SCI USA, V111, P7438, DOI 10.1073/pnas.1405289111; Zang YF, 2004, NEUROIMAGE, V22, P394, DOI 10.1016/j.neuroimage.2003.12.030; Zhang JP, 2019, AM J PSYCHIAT, V176, P21, DOI 10.1176/appi.ajp.2018.17121363; Zou QH, 2008, J NEUROSCI METH, V172, P137, DOI 10.1016/j.jneumeth.2008.04.012	59	71	78	10	94	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	APR	2020	26	4					558	+		10.1038/s41591-020-0793-8	http://dx.doi.org/10.1038/s41591-020-0793-8		MAR 2020	20	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	QH1UE	32251404				2022-12-27	WOS:000521529700004
J	He, FJ; Tan, MN; Song, J; MacGregor, GA				He, Feng J.; Tan, Monique; Song, Jing; MacGregor, Graham A.			Salt substitution to lower population blood pressure	NATURE MEDICINE			English	Editorial Material							SODIUM	A study in Peru of community-wide implementation of the use of salt substitution strengthens the evidence for its use as a public-health strategy to reduce blood pressure and, thus, chronic disease risk.	[He, Feng J.; Tan, Monique; Song, Jing; MacGregor, Graham A.] Queen Mary Univ London, Wolfson Inst Prevent Med, Barts & London Sch Med & Dent, London, England	University of London; Queen Mary University London	He, FJ (corresponding author), Queen Mary Univ London, Wolfson Inst Prevent Med, Barts & London Sch Med & Dent, London, England.	f.he@qmul.ac.uk	He, Feng/HHS-6457-2022	He, Feng/0000-0002-1996-0744; Tan, Monique/0000-0003-4287-5553; MacGregor, Graham/0000-0001-9206-4500; Song, Jing/0000-0002-0987-3284; He, Feng/0000-0003-2807-4119	Medical Research Council [MR/P012590/1] Funding Source: Medline; Department of Health [16/136/77] Funding Source: Medline; MRC [MR/P012590/1] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Department of Health; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Bernabe-Ortiz A, 2020, NAT MED, V26, P374, DOI 10.1038/s41591-020-0754-2; Chang HY, 2006, AM J CLIN NUTR, V83, P1289, DOI 10.1093/ajcn/83.6.1289; He FJ, 2018, NAT REV CARDIOL, V15, P371, DOI 10.1038/s41569-018-0004-1; He FJ, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1325; He FJ, 2010, PROG CARDIOVASC DIS, V52, P363, DOI 10.1016/j.pcad.2009.12.006; He FJ, 2001, BMJ-BRIT MED J, V323, P497, DOI 10.1136/bmj.323.7311.497; Huang LP, 2020, AM HEART J, V221, P136, DOI 10.1016/j.ahj.2019.12.020; Karppanen H, 2006, PROG CARDIOVASC DIS, V49, P59, DOI 10.1016/j.pcad.2006.07.001; Newberry S.J, 2018, COMP EFFECTIVENESS R, V206, DOI [10.23970/AHRQEPCCER206, DOI 10.23970/AHRQEPCCER206]; Sacks FM, 2001, NEW ENGL J MED, V344, P3, DOI 10.1056/NEJM200101043440101; Trieu K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130247	11	3	4	1	3	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	MAR	2020	26	3					313	314		10.1038/s41591-020-0784-9	http://dx.doi.org/10.1038/s41591-020-0784-9		MAR 2020	2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	KU0MC	32132716	Green Submitted			2022-12-27	WOS:000518096400002
J	Janelidze, S; Mattsson, N; Palmqvist, S; Smith, R; Beach, TG; Serrano, GE; Chai, XY; Proctor, NK; Eichenlaub, U; Zetterberg, H; Blennow, K; Reiman, EM; Stomrud, E; Dage, JL; Hansson, O				Janelidze, Shorena; Mattsson, Niklas; Palmqvist, Sebastian; Smith, Ruben; Beach, Thomas G.; Serrano, Geidy E.; Chai, Xiyun; Proctor, Nicholas K.; Eichenlaub, Udo; Zetterberg, Henrik; Blennow, Kaj; Reiman, Eric M.; Stomrud, Erik; Dage, Jeffrey L.; Hansson, Oskar			Plasma P-tau181 in Alzheimer's disease: relationship to other biomarkers, differential diagnosis, neuropathology and longitudinal progression to Alzheimer's dementia	NATURE MEDICINE			English	Article							MILD COGNITIVE IMPAIRMENT; CSF T-TAU; CEREBROSPINAL-FLUID; CLINICAL-DIAGNOSIS; NATIONAL INSTITUTE; SUPRANUCLEAR PALSY; CROSS-VALIDATION; AMYLOID-BETA; P-TAU; F-18-AV-1451	Plasma phosphorylated tau181 (P-tau181) might be increased in Alzheimer's disease (AD), but its usefulness for differential diagnosis and prognosis is unclear. We studied plasma P-tau181 in three cohorts, with a total of 589 individuals, including cognitively unimpaired participants and patients with mild cognitive impairment (MCI), AD dementia and non-AD neurodegenerative diseases. Plasma P-tau181 was increased in preclinical AD and further increased at the MCI and dementia stages. It correlated with CSF P-tau181 and predicted positive Tau positron emission tomography (PET) scans (area under the curve (AUC) = 0.87-0.91 for different brain regions). Plasma P-tau181 differentiated AD dementia from non-AD neurodegenerative diseases with an accuracy similar to that of Tau PET and CSF P-tau181 (AUC = 0.94-0.98), and detected AD neuropathology in an autopsy-confirmed cohort. High plasma P-tau181 was associated with subsequent development of AD dementia in cognitively unimpaired and MCI subjects. In conclusion, plasma P-tau181 is a noninvasive diagnostic and prognostic biomarker of AD, which may be useful in clinical practice and trials. Plasma P-tau18 level increased with progression of Alzheimer's disease (AD) and differentiated AD dementia from other neurodegenerative diseases, supporting its further development as a blood-based biomarker for AD.	[Janelidze, Shorena; Mattsson, Niklas; Palmqvist, Sebastian; Smith, Ruben; Stomrud, Erik; Hansson, Oskar] Lund Univ, Clin Memory Res Unit, Lund, Sweden; [Mattsson, Niklas; Palmqvist, Sebastian; Smith, Ruben] Skane Univ Hosp, Dept Neurol, Lund, Sweden; [Mattsson, Niklas] Lund Univ, Wallenberg Ctr Mol Med, Lund, Sweden; [Beach, Thomas G.; Serrano, Geidy E.] Banner Sun Hlth Res Inst, Sun City, AZ USA; [Chai, Xiyun; Proctor, Nicholas K.; Dage, Jeffrey L.] Eli Lilly & Co, Indianapolis, IN 46285 USA; [Eichenlaub, Udo] Roche Diagnost GmbH, Penzberg, Germany; [Zetterberg, Henrik; Blennow, Kaj] Univ Gothenburg, Sahlgrenska Acad, Dept Psychiat & Neurochem, Molndal, Sweden; [Zetterberg, Henrik; Blennow, Kaj] Sahlgrens Univ Hosp, Clin Neurochem Lab, Molndal, Sweden; [Zetterberg, Henrik] UCL Inst Neurol, Dept Neurodegenerat Dis, London, England; [Zetterberg, Henrik] UCL, UK Dementia Res Inst, London, England; [Reiman, Eric M.] Banner Alzheimers Inst, Phoenix, AZ USA; [Stomrud, Erik; Hansson, Oskar] Skane Univ Hosp, Memory Clin, Malmo, Sweden	Lund University; Lund University; Skane University Hospital; Lund University; Banner Research; Banner Health; Banner Sun Health Research Institute; Eli Lilly; Roche Holding; University of Gothenburg; Sahlgrenska University Hospital; University of London; University College London; University of London; University College London; Banner Research; Banner Health; Banner Alzheimer's Institute; Lund University; Skane University Hospital	Janelidze, S; Hansson, O (corresponding author), Lund Univ, Clin Memory Res Unit, Lund, Sweden.; Hansson, O (corresponding author), Skane Univ Hosp, Memory Clin, Malmo, Sweden.	shorena.janelidze@med.lu.se; Oskar.Hansson@med.lu.se	Palmqvist, Sebastian/AAU-1148-2021; Mattsson-Carlgren, Niklas/H-7597-2019; Palmqvist, Sebastian/AFQ-9019-2022; Hansson, Oskar/A-7134-2013	Mattsson-Carlgren, Niklas/0000-0002-8885-7724; Palmqvist, Sebastian/0000-0002-9267-1930; Hansson, Oskar/0000-0001-8467-7286	European Research Council [311292]; Swedish Research Council [2016-00906]; Knut and Alice Wallenberg foundation [2017-0383]; Marianne and Marcus Wallenberg foundation [2015.0125]; Swedish Alzheimer Foundation [AF-745911, AF-843991, AF-846521]; Swedish Brain Foundation [FO2019-0326, FO2019-0029]; Swedish Medical Association [SLS-780901]; Parkinson Foundation of Sweden [1127718]; Skane University Hospital Foundation [2019-o000032]; Swedish federal government under the ALF agreement [2018-Projekt0279]; Medical Faculty at Lund University; US National Institutes of Health [U24 NS072026, P30 AG19610]; Arizona Department of Health Services [211002]; Arizona Biomedical Research Commission [4001, 0011, 05-901, 1001]; Michael J. Fox Foundation for Parkinson's Research; GE Healthcare; Region Skane (Wallenberg Molecular Medicine Fellow grant 2019)	European Research Council(European Research Council (ERC)European Commission); Swedish Research Council(Swedish Research CouncilEuropean Commission); Knut and Alice Wallenberg foundation(Knut & Alice Wallenberg Foundation); Marianne and Marcus Wallenberg foundation; Swedish Alzheimer Foundation; Swedish Brain Foundation; Swedish Medical Association; Parkinson Foundation of Sweden; Skane University Hospital Foundation; Swedish federal government under the ALF agreement; Medical Faculty at Lund University; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Arizona Department of Health Services; Arizona Biomedical Research Commission; Michael J. Fox Foundation for Parkinson's Research; GE Healthcare(General ElectricGE Healthcare); Region Skane (Wallenberg Molecular Medicine Fellow grant 2019)	The work in the present study was supported by the European Research Council (grant no. 311292 to O.H), the Swedish Research Council (grant no. 2016-00906 to O.H), the Knut and Alice Wallenberg foundation (grant no. 2017-0383), the Marianne and Marcus Wallenberg foundation (grant no. 2015.0125 to O.H), the Swedish Alzheimer Foundation (grant nos. AF-745911 to O.H, AF-843991 to N.M. and AF-846521 to S.J.), the Swedish Brain Foundation (grant nos. FO2019-0326 to O.H. and FO2019-0029 to N.M.), the Swedish Medical Association (grant no. SLS-780901 to N.M.), the Parkinson Foundation of Sweden (grant no. 1127718 to O.H), the Skane University Hospital Foundation (grant no. 2019-o000032 to O.H) and the Swedish federal government under the ALF agreement (grant no. 2018-Projekt0279 to O.H) and The Medical Faculty at Lund University and Region Skane (Wallenberg Molecular Medicine Fellow grant 2019 to N.M.). E.M.R., T.G.B. and their research programs (the Arizona Alzheimer's Disease Center, Arizona Alzheimer's Consortium and Arizona Study of Aging and Neurodegenerative Disorders) have been supported by the US National Institutes of Health (nos. U24 NS072026 and P30 AG19610), Arizona Department of Health Services (contract no. 211002), Arizona Biomedical Research Commission (contract nos. 4001, 0011, 05-901 and 1001) and the Michael J. Fox Foundation for Parkinson's Research. Doses of [18F]flutemetamol injection were sponsored by GE Healthcare. The precursor of 18F-flortaucipir was provided by AVID radiopharmaceuticals.	Armstrong MJ, 2013, NEUROLOGY, V80, P496, DOI 10.1212/WNL.0b013e31827f0fd1; Ball M, 1997, NEUROBIOL AGING, V18, pS1, DOI 10.1016/s0197-4580(97)00057-2; Barthelemy NR., 2017, BIORXIV226977, DOI [10.1101/226977, DOI 10.1101/226977]; Beach TG, 2012, J NEUROPATH EXP NEUR, V71, P266, DOI 10.1097/NEN.0b013e31824b211b; Blennow K, 2010, NAT REV NEUROL, V6, P131, DOI 10.1038/nrneurol.2010.4; Cho H, 2016, ANN NEUROL, V80, P247, DOI 10.1002/ana.24711; Chouraki V, 2015, ALZHEIMERS DEMENT, V11, P249, DOI 10.1016/j.jalz.2014.07.001; COUCHIE D, 1992, P NATL ACAD SCI USA, V89, P4378, DOI 10.1073/pnas.89.10.4378; Gelb DJ, 1999, ARCH NEUROL-CHICAGO, V56, P33, DOI 10.1001/archneur.56.1.33; Hahn A, 2017, J NUCL MED, V58, P623, DOI 10.2967/jnumed.116.174508; Hansson O, 2006, LANCET NEUROL, V5, P228, DOI 10.1016/S1474-4422(06)70355-6; Hansson O, 2017, NEUROLOGY, V88, P930, DOI 10.1212/WNL.0000000000003680; Hoglinger GU, 2017, MOVEMENT DISORD, V32, P853, DOI 10.1002/mds.26987; Jack CR, 2018, ALZHEIMERS DEMENT, V14, P535, DOI 10.1016/j.jalz.2018.02.018; Kuhlmann J, 2017, CLIN CHIM ACTA, V467, P27, DOI 10.1016/j.cca.2016.05.014; Litvan I, 1996, NEUROLOGY, V47, P1, DOI 10.1212/WNL.47.1.1; Maass A, 2017, NEUROIMAGE, V157, P448, DOI 10.1016/j.neuroimage.2017.05.058; Mattsson N, NEUROLOGY; Mattsson N, 2019, JAMA NEUROL, V76, P791, DOI 10.1001/jamaneurol.2019.0765; Mattsson N, 2018, NEUROLOGY, V90, pE388, DOI 10.1212/WNL.0000000000004887; Mattsson N, 2017, EMBO MOL MED, V9, P1212, DOI 10.15252/emmm.201707809; Mattsson N, 2016, NEUROLOGY, V87, P1827, DOI 10.1212/WNL.0000000000003246; Mattsson N, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10918; Mielke MM, 2018, ALZHEIMERS DEMENT, V14, P989, DOI 10.1016/j.jalz.2018.02.013; Nakamura A, 2018, NATURE, V554, P249, DOI 10.1038/nature25456; Olsson B, 2016, LANCET NEUROL, V15, P673, DOI [10.1016/S1474-4422(16)00070-3, 10.1016/s1474-4422(16)00070-3]; Ossenkoppele R, 2019, NEUROLOGY, V92, pE601, DOI 10.1212/WNL.0000000000006875; Ossenkoppele R, 2018, JAMA-J AM MED ASSOC, V320, P1151, DOI 10.1001/jama.2018.12917; Palmqvist S, 2019, JAMA NEUROL, V76, P1060, DOI 10.1001/jamaneurol.2019.1632; Palmqvist S, 2019, ALZHEIMERS DEMENT, V15, P194, DOI 10.1016/j.jalz.2018.08.014; Palmqvist S, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01150-x; Palmqvist S, 2014, JAMA NEUROL, V71, P1282, DOI 10.1001/jamaneurol.2014.1358; Pase MP, 2019, JAMA NEUROL, V76, P598, DOI 10.1001/jamaneurol.2018.4666; Petersen RC, 2004, J INTERN MED, V256, P183, DOI 10.1111/j.1365-2796.2004.01388.x; Randall J, 2013, RESUSCITATION, V84, P351, DOI 10.1016/j.resuscitation.2012.07.027; Rissin DM, 2010, NAT BIOTECHNOL, V28, P595, DOI 10.1038/nbt.1641; Sato C, 2018, NEURON, V97, P1284, DOI 10.1016/j.neuron.2018.02.015; Schindler SE, 2019, NEUROLOGY, V93, pE1647, DOI 10.1212/WNL.0000000000008081; Scholl M, 2019, MOL CELL NEUROSCI, V97, P18, DOI 10.1016/j.mcn.2018.12.001; Smith R, 2019, JAMA NEUROL, V76, P310, DOI 10.1001/jamaneurol.2018.3692; Smith R, 2016, BRAIN, V139, P2372, DOI 10.1093/brain/aww163; Sperling RA, 2011, ALZHEIMERS DEMENT, V7, P280, DOI 10.1016/j.jalz.2011.03.003; Tatebe H, 2017, MOL NEURODEGENER, V12, DOI 10.1186/s13024-017-0206-8; Van Essen DC, 2005, NEUROIMAGE, V28, P635, DOI 10.1016/j.neuroimage.2005.06.058; Yang CC, 2018, J ALZHEIMERS DIS, V61, P1323, DOI 10.3233/JAD-170810; Zetterberg H, 2013, ALZHEIMERS RES THER, V5, DOI 10.1186/alzrt163	46	354	360	26	157	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	MAR	2020	26	3					379	+		10.1038/s41591-020-0755-1	http://dx.doi.org/10.1038/s41591-020-0755-1		MAR 2020	17	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	KU0MC	32123385	Green Submitted			2022-12-27	WOS:000517739000002
J	Staniszewka, S				Staniszewka, Sophie			A patient-researcher partnership for rare cancer research	NATURE MEDICINE			English	Editorial Material							PUBLIC INVOLVEMENT; IMPACT	A genetic study of angiosarcoma designed through an online patient-partnership model overcomes key barriers in rare-disease research and provides indicators of clinical approaches.	[Staniszewka, Sophie] Warwick Med Sch, Coventry, W Midlands, England	University of Warwick	Staniszewka, S (corresponding author), Warwick Med Sch, Coventry, W Midlands, England.	sophie.staniszewska@warwick.ac.uk						Brett J, 2014, PATIENT, V7, P387, DOI 10.1007/s40271-014-0065-0; Brett J, 2014, HEALTH EXPECT, V17, P637, DOI 10.1111/j.1369-7625.2012.00795.x; Hickey G, 2018, NIHR INVOLVE; INVOLVE, 2012, BRIEF NOT RES INV PU; Mockford C, 2012, INT J QUAL HEALTH C, V24, P28, DOI 10.1093/intqhc/mzr066; National Institute for Health Research, 2015, GOING EXTRA MILE IMP; Oliver SR, 2008, HEALTH EXPECT, V11, P72, DOI 10.1111/j.1369-7625.2007.00476.x; Painter CA, 2020, NAT MED, V26, P181, DOI 10.1038/s41591-019-0749-z; Patient-Centered Outcomes Research Institute, 2020, ENG US; Staniszewska S, 2017, BMJ-BRIT MED J, V358, DOI 10.1136/bmj.j3453; Wilson P, 2015, NIHR J LIB SOUTHAMPT	11	0	0	0	1	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	FEB	2020	26	2					164	165		10.1038/s41591-020-0766-y	http://dx.doi.org/10.1038/s41591-020-0766-y		FEB 2020	2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	KK7DU	32042195				2022-12-27	WOS:000512529400001
J	Marshall, AT; Betts, S; Kan, EC; McConnell, R; Lanphear, BP; Sowell, ER				Marshall, Andrew T.; Betts, Samantha; Kan, Eric C.; McConnell, Rob; Lanphear, Bruce P.; Sowell, Elizabeth R.			Association of lead-exposure risk and family income with childhood brain outcomes	NATURE MEDICINE			English	Article							BLOOD LEAD; SOCIOECONOMIC-STATUS; INTELLECTUAL FUNCTION; COGNITIVE-DEVELOPMENT; EARLY-LIFE; CHILDREN; DEFICITS; AGE; INEQUALITIES; POVERTY	Cross-sectional analysis of data from the Adolescent Brain Cognitive Development Study shows that children from families with low income are at increased risk of cognitive impairment associated with high lead-exposure risk when compared with children from families with high income. Socioeconomic factors influence brain development and structure, but most studies have overlooked neurotoxic insults that impair development, such as lead exposure. Childhood lead exposure affects cognitive development at the lowest measurable concentrations, but little is known about its impact on brain development during childhood. We examined cross-sectional associations among brain structure, cognition, geocoded measures of the risk of lead exposure and sociodemographic characteristics in 9,712 9- and 10-year-old children. Here we show stronger negative associations of living in high-lead-risk census tracts in children from lower- versus higher-income families. With increasing risk of exposure, children from lower-income families exhibited lower cognitive test scores, smaller cortical volume and smaller cortical surface area. Reducing environmental insults associated with lead-exposure risk might confer greater benefit to children experiencing more environmental adversity, and further understanding of the factors associated with high lead-exposure risk will be critical for improving such outcomes in children.	[Marshall, Andrew T.; Betts, Samantha; Kan, Eric C.; Sowell, Elizabeth R.] Childrens Hosp Los Angeles, Los Angeles, CA 90027 USA; [Marshall, Andrew T.; Betts, Samantha; Kan, Eric C.; Sowell, Elizabeth R.] Univ Southern Calif, Dept Pediat, Los Angeles, CA 90007 USA; [McConnell, Rob] Univ Southern Calif, Dept Prevent Med, Los Angeles, CA 90007 USA; [Lanphear, Bruce P.] Simon Fraser Univ, Fac Hlth Sci, Vancouver, BC, Canada	Children's Hospital Los Angeles; University of Southern California; University of Southern California; Simon Fraser University	Sowell, ER (corresponding author), Childrens Hosp Los Angeles, Los Angeles, CA 90027 USA.; Sowell, ER (corresponding author), Univ Southern Calif, Dept Pediat, Los Angeles, CA 90007 USA.	esowell@chla.usc.edu		Betts, Samantha/0000-0002-8154-7010; Marshall, Andrew/0000-0002-0068-8138; Kan, Eric/0000-0002-6593-0845; Sowell, Elizabeth/0000-0001-7558-4280	National Institutes of Health (NIH);  [U01DA041022];  [U01DA041028];  [U01DA041048];  [U01DA041089];  [U01DA041106];  [U01DA041117];  [U01DA041120];  [U01DA041134];  [U01DA041148];  [U01DA041156];  [U01DA041174];  [U24DA041123];  [U24DA041147]	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; ; ; ; ; ; ; ; ; ; ; ; 	We thank the Adolescent Brain Cognitive Development (ABCD) participants and their families for their time and dedication to this project, and G. Dowling and C. Chieh Fan for their comments and feedback during the development of this manuscript. We also thank W. Thompson for statistical support, comments and feedback during the development of this manuscript. ABCD acknowledgement: data used in the preparation of this article were obtained from the ABCD Study (https://abcdstudy.org/), and are held in the NIMH Data Archive. This is a multisite, longitudinal study designed to recruit more than 10,000 children aged 9-10 and follow them over 10 yr into early adulthood. The ABCD Study is supported by the National Institutes of Health (NIH) and additional federal partners under award numbers U01DA041022, U01DA041028, U01DA041048, U01DA041089, U01DA041106, U01DA041117, U01DA041120, U01DA041134, U01DA041148, U01DA041156, U01DA041174, U24DA041123 and U24DA041147. A full list of supporters is available at https://abcdstudy.org/federal-partners/.A listing of participating sites and a complete listing of the study investigators can be found at https://abcdstudy.org/principal-investigators/.ABCD consortium investigators designed and implemented the study and/or provided data but did not necessarily participate in analysis or writing of this report. This manuscript reflects the views of the authors and may not reflect the opinions or views of the NIH or ABCD consortium investigators. The ABCD data repository grows and changes over time. The ABCD data used in this report came from https://doi.org/10.15154/1503209.	Akkus C, 2014, INT J ENV RES PUB HE, V11, P6314, DOI 10.3390/ijerph110606314; Akshoomoff N, 2014, NEUROPSYCHOLOGY, V28, P1, DOI 10.1037/neu0000001; [Anonymous], 2018, FED ACT PLAN RED CHI; Arora M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097805; Barch DM, 2018, DEV COGN NEUROS-NETH, V32, P55, DOI 10.1016/j.dcn.2017.10.010; Bauer PJ, 2013, MONOGR SOC RES CHILD, V78, P133, DOI 10.1111/mono.12039; Bellinger DC, 2008, CURR OPIN PEDIATR, V20, P172, DOI 10.1097/MOP.0b013e3282f4f97b; Bradley RH, 2002, ANNU REV PSYCHOL, V53, P371, DOI 10.1146/annurev.psych.53.100901.135233; Braun JM, 2006, ENVIRON HEALTH PERSP, V114, P1904, DOI 10.1289/ehp.9478; Bressler J, 2019, STATE ALASKA EPIDEMI; Brubaker CJ, 2010, NEUROTOXICOLOGY, V31, P259, DOI 10.1016/j.neuro.2010.03.004; Brubaker CJ, 2009, NEUROTOXICOLOGY, V30, P867, DOI 10.1016/j.neuro.2009.07.007; Canfield RL, 2003, NEW ENGL J MED, V348, P1517, DOI 10.1056/NEJMoa022848; Casey BJ, 2018, DEV COGN NEUROS-NETH, V32, P43, DOI 10.1016/j.dcn.2018.03.001; Cecil KM, 2008, PLOS MED, V5, P741, DOI 10.1371/journal.pmed.0050112; Chen AM, 2005, ENVIRON HEALTH PERSP, V113, P597, DOI 10.1289/ehp.7625; Chetty R, 2016, AM ECON REV, V106, P855, DOI 10.1257/aer.20150572; DIETRICH KN, 1991, NEUROTOXICOL TERATOL, V13, P203, DOI 10.1016/0892-0362(91)90012-L; DIETRICH KN, 1987, PEDIATRICS, V80, P721; Dietrich KN, 2001, NEUROTOXICOL TERATOL, V23, P511, DOI 10.1016/S0892-0362(01)00184-2; Elardo R., 1981, DEV REV, V1, P113, DOI [DOI 10.1016/0273-2297(81)90012-5, 10.1016/0273-2297(81)90012-5]; Farah MJ, 2008, DEVELOPMENTAL SCI, V11, P793, DOI 10.1111/j.1467-7687.2008.00688.x; Frostenson S, 2016, RISK LEAD POISONING; Garavan H, 2018, DEV COGN NEUROS-NETH, V32, P16, DOI 10.1016/j.dcn.2018.04.004; Guilarte TR, 2012, NEUROTOXICOLOGY, V33, P560, DOI 10.1016/j.neuro.2011.11.008; Guilarte TR, 2003, ANN NEUROL, V53, P50, DOI 10.1002/ana.10399; Hagler DJ, 2019, NEUROIMAGE, V202, DOI 10.1016/j.neuroimage.2019.116091; Hair NL, 2015, JAMA PEDIATR, V169, P822, DOI 10.1001/jamapediatrics.2015.1475; Hanson JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080954; Hornung RW, 2009, ENVIRON HEALTH PERSP, V117, P1309, DOI 10.1289/ehp.0800426; Jacobs DE, 2002, ENVIRON HEALTH PERSP, V110, pA599, DOI 10.1289/ehp.021100599; Jernigan TL, 2018, J RES ADOLESCENCE, V28, P154, DOI 10.1111/jora.12374; Kind AJH, 2014, ANN INTERN MED, V161, P765, DOI 10.7326/M13-2946; Krieger N, 2003, J EPIDEMIOL COMMUN H, V57, P186, DOI 10.1136/jech.57.3.186; Lanphear BP, 1998, PEDIATRICS, V101, P264, DOI 10.1542/peds.101.2.264; Lanphear BP, 2000, PUBLIC HEALTH REP, V115, P521, DOI 10.1093/phr/115.6.521; Lanphear BP, 2005, ENVIRON HEALTH PERSP, V113, P894, DOI 10.1289/ehp.7688; Lanphear BP, 1997, ENVIRON RES, V74, P67, DOI 10.1006/enrs.1997.3726; Lucchini RG, 2012, ENVIRON RES, V118, P65, DOI 10.1016/j.envres.2012.08.003; Luciana M, 2018, DEV COGN NEUROS-NETH, V32, P67, DOI 10.1016/j.dcn.2018.02.006; Luders E, 2009, INTELLIGENCE, V37, P156, DOI 10.1016/j.intell.2008.07.002; Magzamen S, 2015, ENVIRON RES, V137, P108, DOI 10.1016/j.envres.2014.12.004; Mazumdar M., 2012, Environmental Health Perspectives, V120, P702, DOI 10.1289/ehp.1104474; Menezes JA, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15112418; Miranda ML, 2002, ENVIRON HEALTH PERSP, V110, P947, DOI 10.1289/ehp.02110947; Muller C, 2018, ANNU REV SOCIOL, V44, P263, DOI 10.1146/annurev-soc-073117-041222; National Toxicology Program (NTP), 2012, NTP MON HLTH EFF LOW; NEEDLEMAN HL, 1979, NEW ENGL J MED, V300, P689, DOI 10.1056/NEJM197903293001301; Noble KG, 2015, NAT NEUROSCI, V18, P773, DOI 10.1038/nn.3983; Noble KG, 2012, DEVELOPMENTAL SCI, V15, P516, DOI 10.1111/j.1467-7687.2012.01147.x; Pirkle JL, 1998, ENVIRON HEALTH PERSP, V106, P745, DOI 10.2307/3434264; Reuben A, 2017, JAMA-J AM MED ASSOC, V317, P1244, DOI 10.1001/jama.2017.1712; Roy Siddhartha, 2019, Current Opinion in Environmental Science & Health, V7, P34, DOI 10.1016/j.coesh.2018.10.002; Sadler R.C., 2016, ZIP CODES NEARLY MAS; Safer Chemicals Healthy Families, 2017, CHILDREN RISK GAPS S; SARGENT JD, 1995, AM J PUBLIC HEALTH, V85, P528, DOI 10.2105/AJPH.85.4.528; Schneider JS, 2001, BRAIN RES, V896, P48, DOI 10.1016/S0006-8993(00)03249-2; Singh GK, 2003, AM J PUBLIC HEALTH, V93, P1137, DOI 10.2105/AJPH.93.7.1137; The ABCD Consortium, 2019, DAT REL 2 0 FIX REL, DOI [10.15154/1503209, DOI 10.15154/1503209]; US Census Bureau, 2010, AM COMMUNITY SURVEY; Washington Tracking Network Washington State Department of Health, 2017, CHILDH LEAD RISK MAP; Wasserman GA, 2003, CHILD NEUROPSYCHOL, V9, P22, DOI 10.1076/chin.9.1.22.14497; Weintraub S, 2013, NEUROLOGY, V80, pS54, DOI 10.1212/WNL.0b013e3182872ded; Wheeler DC, 2019, SCI TOTAL ENVIRON, V650, P970, DOI 10.1016/j.scitotenv.2018.09.088; Wolf S, 2017, CHILD YOUTH SERV REV, V79, P368, DOI 10.1016/j.childyouth.2017.06.040; Wright JP, 2008, PLOS MED, V5, P732, DOI 10.1371/journal.pmed.0050101; Wu J, 2008, J NEUROSCI, V28, P3, DOI 10.1523/JNEUROSCI.4405-07.2008	67	49	50	3	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JAN	2020	26	1					91	+		10.1038/s41591-019-0713-y	http://dx.doi.org/10.1038/s41591-019-0713-y			16	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	KG3GZ	31932788	Green Accepted			2022-12-27	WOS:000509831900032
J	Reuben, A; Elliott, M; Caspi, A				Reuben, Aaron; Elliott, Maxwell; Caspi, Avshalom			Implications of legacy lead for children's brain development	NATURE MEDICINE			English	Editorial Material								Children at a higher risk of lead exposure develop smaller brain cortical surface area and volume, but only if they are from low-income families.	[Reuben, Aaron; Elliott, Maxwell; Caspi, Avshalom] Duke Univ, Dept Psychol & Neurosci, Durham, NC 27708 USA; [Caspi, Avshalom] Duke Univ, Sch Med, Dept Psychiat & Behav Sci, Durham, NC 27708 USA; [Caspi, Avshalom] Duke Univ, Ctr Genom & Computat Biol, Durham, NC 27708 USA; [Caspi, Avshalom] Kings Coll London, Social Genet & Dev Psychiat Ctr, Inst Psychiat Psychol & Neurosci, London, England	Duke University; Duke University; Duke University; University of London; King's College London	Caspi, A (corresponding author), Duke Univ, Dept Psychol & Neurosci, Durham, NC 27708 USA.; Caspi, A (corresponding author), Duke Univ, Sch Med, Dept Psychiat & Behav Sci, Durham, NC 27708 USA.; Caspi, A (corresponding author), Duke Univ, Ctr Genom & Computat Biol, Durham, NC 27708 USA.; Caspi, A (corresponding author), Kings Coll London, Social Genet & Dev Psychiat Ctr, Inst Psychiat Psychol & Neurosci, London, England.	ac115@duke.edu	Elliott, Maxwell L/I-8937-2019; caspi, avshalom/AAJ-5874-2020	Elliott, Maxwell L/0000-0003-1083-6277; caspi, avshalom/0000-0003-0082-4600; Reuben, Aaron/0000-0001-5713-4913	NIEHS NIH HHS [F31 ES029358] Funding Source: Medline	NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Bellinger DC, 2008, CURR OPIN PEDIATR, V20, P172, DOI 10.1097/MOP.0b013e3282f4f97b; Drum K., 2013, MOTHER JONES; Eid A, 2016, NEUROTOXICOLOGY, V56, P254, DOI 10.1016/j.neuro.2016.04.006; Ettinger AS, 2019, J PUBLIC HEALTH MAN, V25, pS1, DOI 10.1097/PHH.0000000000000902; LESSLER MA, 1988, OHIO J SCI, V88, P78; Lidsky TI, 2003, BRAIN, V126, P5, DOI 10.1093/brain/awg014; Marshall A.T, 2020, NAT MED, DOI [10.1038/s41591-019-0713-y, DOI 10.1038/S41591-019-0713-Y]; Nriagu J. O., 1983, LEAD LEAD POISONING; NRIAGU JO, 1990, SCI TOTAL ENVIRON, V92, P13, DOI 10.1016/0048-9697(90)90318-O; Reuben A, 2018, J ALZHEIMERS DIS, V64, P17, DOI 10.3233/JAD-180267; Rosner D, 2005, PUBLIC HEALTH REP, V120, P330, DOI 10.1177/003335490512000319; Thomas VM, 1999, ENVIRON SCI TECHNOL, V33, P3942, DOI 10.1021/es990231+; Trahan LH, 2014, PSYCHOL BULL, V140, P1332, DOI 10.1037/a0037173; Weiss B, 2006, ENVIRON HEALTH PERSP, V114, P1479, DOI 10.1289/ehp.9101	14	5	5	2	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JAN	2020	26	1					23	25		10.1038/s41591-019-0731-9	http://dx.doi.org/10.1038/s41591-019-0731-9			3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	KG3GZ	31932789				2022-12-27	WOS:000509831900020
J	Chen, CJ; Sgritta, M; Mays, J; Zhou, HY; Lucero, R; Park, J; Wang, IC; Park, JH; Kaipparettu, BA; Stoica, L; Jafar-Nejad, P; Rigo, F; Chin, J; Noebels, JL; Costa-Mattioli, M				Chen, Chien-Ju; Sgritta, Martina; Mays, Jacqunae; Zhou, Hongyi; Lucero, Rocco; Park, Jin; Wang, I-Ching; Park, Jun Hyoung; Kaipparettu, Benny Abraham; Stoica, Loredana; Jafar-Nejad, Paymaan; Rigo, Frank; Chin, Jeannie; Noebels, Jeffrey L.; Costa-Mattioli, Mauro			Therapeutic inhibition of mTORC2 rescues the behavioral and neurophysiological abnormalities associated with Pten-deficiency	NATURE MEDICINE			English	Article							MOUSE MODEL; ANTISENSE OLIGONUCLEOTIDES; SYNAPTIC PLASTICITY; SOMA SIZE; AUTISM; METABOLISM; INDIVIDUALS; EXPRESSION; REDUCTION; MUTATIONS	Dysregulation of the mammalian target of rapamycin (mTOR) signaling, which is mediated by two structurally and functionally distinct complexes, mTORC1 and mTORC2, has been implicated in several neurological disorders(1-3). Individuals carrying loss-of-function mutations in the phosphatase and tensin homolog (PTEN) gene, a negative regulator of mTOR signaling, are prone to developing macrocephaly, autism spectrum disorder (ASD), seizures and intellectual disability(2,4,5). It is generally believed that the neurological symptoms associated with loss of PTEN and other mTORopathies (for example, mutations in the tuberous sclerosis genes TSC1 or TSC2) are due to hyperactivation of mTORC1-mediated protein synthesis(1,2,4,6,7). Using molecular genetics, we unexpectedly found that genetic deletion of mTORC2 (but not mTORC1) activity prolonged lifespan, suppressed seizures, rescued ASD-like behaviors and long- term memory, and normalized metabolic changes in the brain of mice lacking Pten. In a more therapeutically oriented approach, we found that administration of an antisense oligonucleotide (ASO) targeting mTORC2's defining component Rictor specifically inhibits mTORC2 activity and reverses the behavioral and neurophysiological abnormalities in adolescent Pten-deficient mice. Collectively, our findings indicate that mTORC2 is the major driver underlying the neuropathophysiology associated with Pten-deficiency, and its therapeutic reduction could represent a promising and broadly effective translational therapy for neurological disorders where mTOR signaling is dysregulated.	[Chen, Chien-Ju; Sgritta, Martina; Mays, Jacqunae; Zhou, Hongyi; Park, Jin; Wang, I-Ching; Stoica, Loredana; Chin, Jeannie; Noebels, Jeffrey L.; Costa-Mattioli, Mauro] Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA; [Chen, Chien-Ju; Sgritta, Martina; Mays, Jacqunae; Zhou, Hongyi; Park, Jin; Wang, I-Ching; Stoica, Loredana; Chin, Jeannie; Costa-Mattioli, Mauro] Baylor Coll Med, Memory & Brain Res Ctr, Houston, TX 77030 USA; [Lucero, Rocco; Park, Jun Hyoung; Kaipparettu, Benny Abraham; Noebels, Jeffrey L.; Costa-Mattioli, Mauro] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Lucero, Rocco; Noebels, Jeffrey L.] Baylor Coll Med, Dept Neurol, Houston, TX 77030 USA; [Kaipparettu, Benny Abraham] Baylor Coll Med, Dan L Duncan Canc Ctr, Houston, TX 77030 USA; [Jafar-Nejad, Paymaan; Rigo, Frank] Ionis Pharmaceut, Carlsbad, CA USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Ionis Pharmaceuticals, Inc.	Costa-Mattioli, M (corresponding author), Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA.; Costa-Mattioli, M (corresponding author), Baylor Coll Med, Memory & Brain Res Ctr, Houston, TX 77030 USA.; Costa-Mattioli, M (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.	costamat@bcm.edu		Chin, Jeannie/0000-0001-9902-3744	NIMH [096816]; Department of Defense [AR120254]; Sammons Enterprises; NINDS [NS29709];  [NS085171]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH096816] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS076708] Funding Source: NIH RePORTER	NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Department of Defense(United States Department of Defense); Sammons Enterprises; NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); ; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank A. Placzek and members of the Costa-Mattioli laboratory for comments on the manuscript. This work was supported by funds to M.C.-M. (NIMH 096816, Department of Defense AR120254 and Sammons Enterprises), J.N. (NINDS NS29709) and J.C. (NS085171).	American Psychiatric Association. & American Psychiatric Association. DSM-5 Task Force, 2013, DIAGNOSTIC STAT MANU; Backman SA, 2001, NAT GENET, V29, P396, DOI 10.1038/ng782; Buffington SA, 2016, CELL, V165, P1762, DOI 10.1016/j.cell.2016.06.001; Buffington SA, 2014, ANNU REV NEUROSCI, V37, P17, DOI 10.1146/annurev-neuro-071013-014100; Cioffi CL, 1997, MOL PHARMACOL, V51, P383; Costa-Mattioli M, 2013, NAT NEUROSCI, V16, P1537, DOI 10.1038/nn.3546; Crino PB, 2016, NAT REV NEUROL, V12, P379, DOI 10.1038/nrneurol.2016.81; Deacon RMJ, 2006, NAT PROTOC, V1, P7, DOI 10.1038/nprot.2006.2; Ehninger D, 2011, TRENDS MOL MED, V17, P78, DOI 10.1016/j.molmed.2010.10.002; Fombonne E, 1999, PSYCHOL MED, V29, P769, DOI 10.1017/S0033291799008508; Frazier AE, 2012, METHODS MOL BIOL, V837, P49, DOI 10.1007/978-1-61779-504-6_4; Garcia-Cao I, 2012, CELL, V149, P49, DOI 10.1016/j.cell.2012.02.030; Hagiwara A, 2012, CELL METAB, V15, P725, DOI 10.1016/j.cmet.2012.03.015; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Hobert JA, 2014, EUR J HUM GENET, V22, P273, DOI 10.1038/ejhg.2013.114; Hoeffer CA, 2010, TRENDS NEUROSCI, V33, P67, DOI 10.1016/j.tins.2009.11.003; Hu WF, 2014, ANNU REV GENOM HUM G, V15, P195, DOI 10.1146/annurev-genom-090413-025600; Huang W, 2016, ELIFE, V5, DOI 10.7554/eLife.12052; Huang W, 2013, NAT NEUROSCI, V16, P441, DOI 10.1038/nn.3351; Jiang YH, 2013, NEURON, V78, P8, DOI 10.1016/j.neuron.2013.03.016; Johnson JL, 2015, SCI REP-UK, V5, DOI 10.1038/srep15193; Kazdoba TM, 2016, CURR TOP BEHAV NEURO, V28, P1, DOI 10.1007/7854_2015_5003; Kelleher RJ, 2008, CELL, V135, P401, DOI 10.1016/j.cell.2008.10.017; Knafo S, 2017, TRENDS NEUROSCI, V40, P83, DOI 10.1016/j.tins.2016.11.008; Kwon CH, 2001, NAT GENET, V29, P404, DOI 10.1038/ng781; Kwon CH, 2006, NEURON, V50, P377, DOI 10.1016/j.neuron.2006.03.023; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lipton JO, 2014, NEURON, V84, P275, DOI 10.1016/j.neuron.2014.09.034; Ljungberg MC, 2009, DIS MODEL MECH, V2, P389, DOI 10.1242/dmm.002386; Lopez BR, 2005, J AUTISM DEV DISORD, V35, P445, DOI 10.1007/s10803-005-5035-x; Ma YW, 2010, BBA-BIOENERGETICS, V1797, P29, DOI 10.1016/j.bbabio.2009.07.008; Masui K, 2013, CELL METAB, V18, P726, DOI 10.1016/j.cmet.2013.09.013; McBride KL, 2010, AUTISM RES, V3, P137, DOI 10.1002/aur.132; Mirzaa GM, 2014, AM J MED GENET C, V166, P156, DOI 10.1002/ajmg.c.31401; Nguyen LH, 2015, EPILEPSIA, V56, P636, DOI 10.1111/epi.12946; Noebels JL, 2015, CSH PERSPECT MED, V5, DOI 10.1101/cshperspect.a022756; Ostendorf AP, 2015, CNS DRUGS, V29, P91, DOI 10.1007/s40263-014-0223-x; Panasyuk G, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1667; Rinaldi C, 2018, NAT REV NEUROL, V14, P9, DOI 10.1038/nrneurol.2017.148; Robey RB, 2009, SEMIN CANCER BIOL, V19, P25, DOI 10.1016/j.semcancer.2008.11.010; Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054; Saxton RA, 2017, CELL, V168, P960, DOI [10.1016/j.cell.2017.03.035, 10.1016/j.cell.2017.02.004]; Silverman JL, 2010, NAT REV NEUROSCI, V11, P490, DOI 10.1038/nrn2851; Stoica L, 2011, P NATL ACAD SCI USA, V108, P3791, DOI 10.1073/pnas.1014715108; Swayze EE, 2007, NUCLEIC ACIDS RES, V35, P687, DOI 10.1093/nar/gkl1071; Tilot AK, 2016, MOL PSYCHIATR, V21, P118, DOI 10.1038/mp.2015.17; Venegas V, 2012, METHODS MOL BIOL, V837, P327, DOI 10.1007/978-1-61779-504-6_22; Vickers TA, 2003, J BIOL CHEM, V278, P7108, DOI 10.1074/jbc.M210326200; Winden KD, 2018, ANNU REV NEUROSCI, V41, P1, DOI 10.1146/annurev-neuro-080317-061747; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Zhang H, 2000, NAT BIOTECHNOL, V18, P862, DOI 10.1038/78475; Zhou J, 2012, CURR OPIN NEUROBIOL, V22, P873, DOI 10.1016/j.conb.2012.05.004; Zhou J, 2009, J NEUROSCI, V29, P1773, DOI 10.1523/JNEUROSCI.5685-08.2009; Zhu PJ, 2018, NAT NEUROSCI, V21, P799, DOI 10.1038/s41593-018-0156-7; Zhu PJ, 2011, CELL, V147, P1384, DOI 10.1016/j.cell.2011.11.029	55	47	49	1	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2019	25	11					1684	+		10.1038/s41591-019-0608-y	http://dx.doi.org/10.1038/s41591-019-0608-y			21	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	JT2KI	31636454	Green Accepted			2022-12-27	WOS:000500824300025
J	Ghatalia, P; Plimack, E				Ghatalia, Pooja; Plimack, Elizabeth			CANCER THERAPY Biomarkers for neoadjuvant checkpoint blockade response in urothelial cancer	NATURE MEDICINE			English	Editorial Material							PEMBROLIZUMAB	Activated CD8(+) T cells in the tumor and cytotoxic T cell signature correlate with immune response in patients receiving neoadjuvant immunotherapy for treatment of muscle invasive bladder cancer.	[Ghatalia, Pooja; Plimack, Elizabeth] Fox Chase Canc Ctr, 7701 Burholme Ave, Philadelphia, PA 19111 USA	Fox Chase Cancer Center	Plimack, E (corresponding author), Fox Chase Canc Ctr, 7701 Burholme Ave, Philadelphia, PA 19111 USA.	elizabeth.plimack@fccc.edu		Plimack, Elizabeth/0000-0002-7618-0744				Ayers M, 2017, J CLIN INVEST, V127, P2930, DOI 10.1172/JCI91190; Balar AV, 2017, LANCET ONCOL, V18, P1483, DOI 10.1016/S1470-2045(17)30616-2; Bellmunt J, 2017, NEW ENGL J MED, V376, P2304, DOI 10.1056/NEJMc1704612; Hoimes C. J, 2018, ESMO 2018 C; Huang AC, 2019, NAT MED, V25, P454, DOI 10.1038/s41591-019-0357-y; Mariathasan S, 2018, NATURE, V554, P544, DOI 10.1038/nature25501; Necchi A, 2018, J CLIN ONCOL, V36, P3353, DOI 10.1200/JCO.18.01148; Sjodahl G, 2012, CLIN CANCER RES, V18, P3377, DOI 10.1158/1078-0432.CCR-12-0077-T; Teo MY, 2018, J CLIN ONCOL	9	5	6	1	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2019	25	11					1650	1651		10.1038/s41591-019-0645-6	http://dx.doi.org/10.1038/s41591-019-0645-6			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	JT2KI	31686037				2022-12-27	WOS:000500824300017
J	Wei, XZ; Nielsen, R				Wei, Xinzhu; Nielsen, Rasmus			RETRACTION: CCR5-Delta 32 is deleterious in the homozygous state in humans (Retraction Article, vol 25, pg 909, 2019) (Retraction of Vol 25, Pg 909, 2019)	NATURE MEDICINE			English	Retraction													Nielsen, Rasmus/D-4405-2009	Nielsen, Rasmus/0000-0003-0513-6591; Wei, Xinzhu/0000-0001-8184-7016				Wei XZ, 2019, NAT MED, V25, P909, DOI 10.1038/s41591-019-0459-6	1	4	4	0	1	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2019	25	11					1796	1796		10.1038/s41591-019-0637-6	http://dx.doi.org/10.1038/s41591-019-0637-6			1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	JT2KI	31595084	Bronze, Green Submitted, Green Accepted			2022-12-27	WOS:000500824300040
J	Moroni, F; Dwyer, BJ; Graham, C; Pass, C; Bailey, L; Ritchie, L; Mitchell, D; Glover, A; Laurie, A; Doig, S; Hargreaves, E; Fraser, AR; Turner, ML; Campbell, JDM; McGowan, NWA; Barry, J; Moore, JK; Hayes, PC; Leeming, DJ; Nielsen, MJ; Musa, K; Fallowfield, JA; Forbes, SJ				Moroni, Francesca; Dwyer, Benjamin J.; Graham, Catriona; Pass, Chloe; Bailey, Laura; Ritchie, Lisa; Mitchell, Donna; Glover, Alison; Laurie, Audrey; Doig, Stuart; Hargreaves, Emily; Fraser, Alasdair R.; Turner, Marc L.; Campbell, John D. M.; McGowan, Neil W. A.; Barry, Jacqueline; Moore, Joanna K.; Hayes, Peter C.; Leeming, Diana J.; Nielsen, Mette J.; Musa, Kishwar; Fallowfield, Jonathan A.; Forbes, Stuart J.			Safety profile of autologous macrophage therapy for liver cirrhosis	NATURE MEDICINE			English	Article							FUNCTIONAL-CHARACTERIZATION; DUCTULAR REACTIONS; CELL THERAPY; DISEASE; INJURY; TRANSPLANTATION; DIAGNOSIS; MARKER	Therapies to reduce liver fibrosis and stimulate organ regeneration are urgently needed. We conducted a first-in-human, phase 1 dose-escalation trial of autologous macrophage therapy in nine adults with cirrhosis and a Model for End-Stage Liver Disease (MELD) score of 10-16 (ISRCTN 10368050). Groups of three participants received a single peripheral infusion of 10(7), 10(8) or up to 10(9) cells. Leukapheresis and macrophage infusion were well tolerated with no transfusion reactions, dose-limiting toxicities or macrophage activation syndrome. All participants were alive and transplant-free at one year, with only one clinical event recorded, the occurrence of minimal ascites. The primary outcomes of safety and feasibility were met. This study informs and provides a rationale for efficacy studies in cirrhosis and other fibrotic diseases.	[Moroni, Francesca; Dwyer, Benjamin J.; Moore, Joanna K.; Forbes, Stuart J.] Univ Edinburgh, MRC Ctr Regenerat Med, Edinburgh, Midlothian, Scotland; [Graham, Catriona] Univ Edinburgh, Edinburgh Clin Res Facil, Edinburgh, Midlothian, Scotland; [Pass, Chloe; Bailey, Laura; Ritchie, Lisa; Mitchell, Donna; Glover, Alison; Laurie, Audrey; Doig, Stuart; Hargreaves, Emily; Fraser, Alasdair R.; Turner, Marc L.; Campbell, John D. M.; McGowan, Neil W. A.] SNBTS, Tissues Cells & Adv Therapeut, Edinburgh, Midlothian, Scotland; [Barry, Jacqueline] Guys Hosp, Cell & Gene Therapy Catapult, 12th Floor Tower Wing, London, England; [Hayes, Peter C.; Fallowfield, Jonathan A.] Univ Edinburgh, Ctr Inflammat Res, Edinburgh, Midlothian, Scotland; [Leeming, Diana J.; Nielsen, Mette J.; Musa, Kishwar] Nord Biosci, Fibrosis Biol & Biomarkers, Herlev, Denmark	University of Edinburgh; University of Edinburgh; Guy's & St Thomas' NHS Foundation Trust; University of Edinburgh; Nordic Bioscience	Forbes, SJ (corresponding author), Univ Edinburgh, MRC Ctr Regenerat Med, Edinburgh, Midlothian, Scotland.	stuart.forbes@ed.ac.uk		Dwyer, Benjamin/0000-0003-2527-5417; Fallowfield, Jonathan/0000-0002-5741-1471; Fraser, Alasdair/0000-0001-7822-650X	Medical Research Council UK grant (Biomedical Catalyst Major Awards Committee) [MR/M007588/1]; MRC [MC_PC_16043, MR/R015635/1, MR/M007588/1, G84/6205] Funding Source: UKRI	Medical Research Council UK grant (Biomedical Catalyst Major Awards Committee); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by a Medical Research Council UK grant (Biomedical Catalyst Major Awards Committee; reference MR/M007588/1) to S.J. Forbes. We thank Z.M. Younossi (Center for Outcomes Research in Liver Diseases, Washington, DC, USA) for academic use of the CLDQ instrument and L.J. Fallowfield (Sussex Health Outcomes Research & Education in Cancer (SHORE-C), University of Sussex, UK) for advice about health-related quality of life assessment.	Asrani SK, 2019, J HEPATOL, V70, P151, DOI 10.1016/j.jhep.2018.09.014; Barber K, 2011, TRANSPLANTATION, V92, P469, DOI 10.1097/TP.0b013e318225db4d; Bird TG, 2013, P NATL ACAD SCI USA, V110, P6542, DOI 10.1073/pnas.1302168110; Boulter L, 2012, NAT MED, V18, P572, DOI 10.1038/nm.2667; D'Amico G, 2006, J HEPATOL, V44, P217, DOI 10.1016/j.jhep.2005.10.013; Day J, 2019, J APPL LAB MED, V3, P815, DOI 10.1373/jalm.2018.027359; Duffield JS, 2005, J CLIN INVEST, V115, P56, DOI 10.1172/JCI200522675; Fallowfield JA, 2007, J IMMUNOL, V178, P5288, DOI 10.4049/jimmunol.178.8.5288; Forbes SJ, 2015, J HEPATOL, V62, pS157, DOI 10.1016/j.jhep.2015.02.040; Foucher J, 2006, GUT, V55, P403, DOI 10.1136/gut.2005.069153; Fraser AR, 2017, CYTOTHERAPY, V19, P1113, DOI 10.1016/j.jcyt.2017.05.009; Friedrich-Rust M, 2010, BMC GASTROENTEROL, V10, DOI 10.1186/1471-230X-10-103; Gouw ASH, 2011, HEPATOLOGY, V54, P1853, DOI 10.1002/hep.24613; Henter JI, 2007, PEDIATR BLOOD CANCER, V48, P124, DOI 10.1002/pbc.21039; Huo TI, 2005, J HEPATOL, V42, P826, DOI 10.1016/j.jhep.2005.01.019; Hutchinson JA, 2011, J IMMUNOL, V187, P2072, DOI 10.4049/jimmunol.1100762; Karsdal MA, 2019, AM J PHYSIOL-GASTR L, V316, pG25, DOI 10.1152/ajpgi.00158.2018; Karsdal MA, 2013, ASSAY DRUG DEV TECHN, V11, P70, DOI 10.1089/adt.2012.474; Kullak-Ublick GA, 2017, GUT, V66, P1154, DOI 10.1136/gutjnl-2016-313369; Le Tourneau C, 2009, JNCI-J NATL CANCER I, V101, P708, DOI 10.1093/jnci/djp079; Leeming DJ, 2015, SCAND J GASTROENTERO, V50, P584, DOI 10.3109/00365521.2014.996590; Loria Anthony, 2013, Curr Gastroenterol Rep, V15, P301, DOI 10.1007/s11894-012-0301-5; Mehta RL, 2007, CRIT CARE, V11, DOI 10.1186/cc5713; Moore JK, 2015, CYTOTHERAPY, V17, P1604, DOI 10.1016/j.jcyt.2015.07.016; Newsome PN, 2018, LANCET GASTROENTEROL, V3, P25, DOI 10.1016/S2468-1253(17)30326-6; Nielsen MJ, 2013, AM J TRANSL RES, V5, P303; Ramachandran P, 2012, P NATL ACAD SCI USA, V109, pE3186, DOI 10.1073/pnas.1119964109; Schuppan D, 2013, J CLIN INVEST, V123, P1887, DOI 10.1172/JCI66028; Sharkey J, 2017, CYTOTHERAPY, V19, P555, DOI 10.1016/j.jcyt.2017.01.003; Thomas JA, 2011, HEPATOLOGY, V53, P2003, DOI 10.1002/hep.24315; Tinegate H, 2012, BRIT J HAEMATOL, V159, P143, DOI 10.1111/bjh.12017; Veidal SS, 2010, LIVER INT, V30, P1293, DOI 10.1111/j.1478-3231.2010.02309.x; Younossi ZM, 1999, GUT, V45, P295, DOI 10.1136/gut.45.2.295; Younossi ZM, 2000, LIVER TRANSPLANT, V6, P779, DOI 10.1053/jlts.2000.18499	34	66	67	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	OCT	2019	25	10					1560	+		10.1038/s41591-019-0599-8	http://dx.doi.org/10.1038/s41591-019-0599-8			16	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	JC3GJ	31591593	Green Accepted			2022-12-27	WOS:000489166700025
J	Saphire, EO				Saphire, Erica Ollmann			A glimpse into immune responses evolving against Ebola virus	NATURE MEDICINE			English	Editorial Material							MONOCLONAL-ANTIBODIES; INFECTION		[Saphire, Erica Ollmann] La Jolla Inst Immunol, La Jolla, CA 92037 USA	La Jolla Institute for Immunology	Saphire, EO (corresponding author), La Jolla Inst Immunol, La Jolla, CA 92037 USA.	erica@lji.org		Saphire, Erica Ollmann/0000-0002-1206-7451	U.S. Department of Health &amp; Human Services | National Institutes of Health (NIH) [U19 142790] Funding Source: Medline	U.S. Department of Health &amp; Human Services | National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Bornholdt ZA, 2016, SCIENCE, V351, P1078, DOI 10.1126/science.aad5788; Corti D, 2016, SCIENCE, V351, P1339, DOI 10.1126/science.aad5224; Davis CW, 2019, CELL, V177, P1566, DOI 10.1016/j.cell.2019.04.036; Ehrhardt S. A., 2019, NAT MED; Henao-Restrepo AM, 2017, LANCET, V389, P505, DOI 10.1016/S0140-6736(16)32621-6; Misasi J, 2016, SCIENCE, V351, P1343, DOI 10.1126/science.aad6117; Rijal P, 2019, CELL REP, V27, P172, DOI 10.1016/j.celrep.2019.03.020; Saphire EO, 2018, CELL, V174, P938, DOI 10.1016/j.cell.2018.07.033	8	6	6	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	OCT	2019	25	10					1470	1471		10.1038/s41591-019-0607-z	http://dx.doi.org/10.1038/s41591-019-0607-z			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	JC3GJ	31591604				2022-12-27	WOS:000489166700011
J	Song, YF; Morales, L; Malik, AS; Mead, AF; Greer, CD; Mitchell, MA; Petrov, MT; Su, LT; Choi, ME; Rosenblum, ST; Lu, XP; VanBelzen, DJ; Krishnankutty, RK; Balzer, FJ; Loro, E; French, R; Propert, KJ; Zhou, SZ; Kozyak, BW; Nghiem, PP; Khurana, TS; Kornegay, JN; Stedman, HH				Song, Yafeng; Morales, Leon; Malik, Alock S.; Mead, Andrew F.; Greer, Christopher D.; Mitchell, Marilyn A.; Petrov, Mihail T.; Su, Leonard T.; Choi, Margaret E.; Rosenblum, Shira T.; Lu, Xiangping; VanBelzen, Daniel J.; Krishnankutty, Ranjith K.; Balzer, Frederick J.; Loro, Emanuele; French, Robert; Propert, Kathleen J.; Zhou, Shangzhen; Kozyak, Benjamin W.; Nghiem, Peter P.; Khurana, Tejvir S.; Kornegay, Joe N.; Stedman, Hansell H.			Non-immunogenic utrophin gene therapy for the treatment of muscular dystrophy animal models	NATURE MEDICINE			English	Article							MUSCLE FUNCTION; SKELETAL-MUSCLE; CANINE MODEL; ZZ DOMAIN; LIFE-SPAN; VECTOR; EXPRESSION; SARCOLEMMA; MECHANISM; SEQUENCE	The essential product of the Duchenne muscular dystrophy (DMD) gene is dystrophin(1), a rod-like protein(2) that protects striated myocytes from contraction-induced injury(3,4). Dystrophin-related protein (or utrophin) retains most of the structural and protein binding elements of dystrophin(5). Importantly, normal thymic expression in DMD patients(6) should protect utrophin by central immunologic tolerance. We designed a codon-optimized, synthetic transgene encoding a miniaturized utrophin (mu Utro), deliverable by adeno-associated virus (AAV) vectors. Here, we show that mu Utro is a highly functional, non-immunogenic substitute for dystrophin, preventing the most deleterious histological and physiological aspects of muscular dystrophy in small and large animal models. Following systemic administration of an AAV-mu Utro to neonatal dystrophin-deficient mdx mice, histological and biochemical markers of myonecrosis and regeneration are completely suppressed throughout growth to adult weight. In the dystrophin-deficient golden retriever model, mu Utro non-toxically prevented myonecrosis, even in the most powerful muscles. In a stringent test of immunogenicity, focal expression of mu Utro in the deletional-null German shorthaired pointer model produced no evidence of cell-mediated immunity, in contrast to the robust T cell response against similarly constructed mu Dystrophin (mu Dystro). These findings support a model in which utrophin-derived therapies might be used to treat clinical dystrophin deficiency, with a favorable immunologic profile and preserved function in the face of extreme miniaturization.	[Song, Yafeng; Morales, Leon; Malik, Alock S.; Mead, Andrew F.; Greer, Christopher D.; Mitchell, Marilyn A.; Petrov, Mihail T.; Su, Leonard T.; Choi, Margaret E.; Rosenblum, Shira T.; Lu, Xiangping; VanBelzen, Daniel J.; Krishnankutty, Ranjith K.; Balzer, Frederick J.; French, Robert; Kozyak, Benjamin W.; Stedman, Hansell H.] Univ Penn, Dept Surg, Perelman Sch Med, Penn Muscle Inst,Penn Cardiovasc Inst, Philadelphia, PA 19104 USA; [Loro, Emanuele; Khurana, Tejvir S.] Univ Penn, Dept Physiol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Propert, Kathleen J.] Univ Penn, Perelman Sch Med, Dept Biostat Epidemiol & Informat, Philadelphia, PA 19104 USA; [Zhou, Shangzhen] Univ Penn, Dept Ophthalmol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Kozyak, Benjamin W.] Childrens Hosp Philadelphia, Dept Anesthesiol & Crit Care Med, Philadelphia, PA 19104 USA; [Nghiem, Peter P.; Kornegay, Joe N.] Texas A&M Univ, Coll Vet Med, Dept Vet Integrat Biosci, College Stn, TX 77843 USA; [Nghiem, Peter P.; Kornegay, Joe N.] Texas A&M Univ, Texas A&M Inst Neurosci, College Stn, TX USA; [Stedman, Hansell H.] Corporal Michael J Crescenz Vet Affairs Med Ctr, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station	Stedman, HH (corresponding author), Univ Penn, Dept Surg, Perelman Sch Med, Penn Muscle Inst,Penn Cardiovasc Inst, Philadelphia, PA 19104 USA.; Stedman, HH (corresponding author), Corporal Michael J Crescenz Vet Affairs Med Ctr, Philadelphia, PA 19104 USA.	hstedman@pennmedicine.upenn.edu	VanBelzen, Jake/GLQ-8227-2022; Loro, Emanuele/L-4999-2017	Kornegay, Joe/0000-0002-5594-1882; Greer, Christopher/0000-0003-2185-8500; Loro, Emanuele/0000-0002-0822-4514; Morales, Leon/0000-0003-3079-8183; Rosenblum, Shira/0000-0002-0599-7837; VanBelzen, Jake/0000-0003-0949-3641	NIH [R01NS042874, U01NS052476, S10RR028027, T32AR053461, T32HL007954, U24NS059696, P30AR050950]; Muscular Dystrophy Association; NHLBI Gene Therapy Resource Center; University of Pennsylvania; family of O. Soot; family of M. Haider;  [P30DK047757]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [T32AR053461] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Muscular Dystrophy Association(Muscular Dystrophy Association); NHLBI Gene Therapy Resource Center; University of Pennsylvania; family of O. Soot; family of M. Haider; ; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by grants from the NIH (H.S., R01NS042874, U01NS052476 and S10RR028027; L.M., T32AR053461; C.D.G., T32HL007954; J.K., U24NS059696; A.M., F.B. and M.P., T32AR053461; Y.S. and histology, P30AR050950), the Muscular Dystrophy Association (H.S. and J.K.) and the families of O. Soot and M. Haider, to whom this work is dedicated. Additional services were supported by P30DK047757 and the NHLBI Gene Therapy Resource Center as well as the University of Pennsylvania Vector and Immunology Cores. We thank L. Vandenberghe for providing helper plasmid (AAP2) for Anc80 production, A. Stout and J. Zhao as well as the UPenn CDB microscopy core for their technical assistance and resource access, and V. Arruda, J. Bennett, J. Johnston, R. Calcedo, F. Wright and J. Plotkin for support and expertise. Dedicated to the memory of Mohammed Haider and Beth Stedman.	Aarts E, 2014, NAT NEUROSCI, V17, P491, DOI 10.1038/nn.3648; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Calcedo R, 2011, CLIN VACCINE IMMUNOL, V18, P1586, DOI 10.1128/CVI.05107-11; Clemens PR, 1996, GENE THER, V3, P965; Davey MG, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171132; Duan DS, 2018, MOL THER, V26, P2337, DOI 10.1016/j.ymthe.2018.07.011; Foster H, 2008, MOL THER, V16, P1825, DOI 10.1038/mt.2008.186; Gregorevic P, 2004, NAT MED, V10, P828, DOI 10.1038/nm1085; Gregorevic P, 2006, NAT MED, V12, P787, DOI 10.1038/nm1439; Harper SQ, 2002, NAT MED, V8, P253, DOI 10.1038/nm0302-253; Hinderer C, 2018, HUM GENE THER, V29, P285, DOI 10.1089/hum.2018.015; Hnia K, 2007, BIOCHEM J, V401, P667, DOI 10.1042/BJ20061051; HOFFMAN EP, 1987, CELL, V51, P919, DOI 10.1016/0092-8674(87)90579-4; Hordeaux J, 2018, MOL THER, V26, P664, DOI 10.1016/j.ymthe.2018.01.018; IBRAGHIMOVBESKROVNAYA O, 1992, NATURE, V355, P696, DOI 10.1038/355696a0; Ishikawa-Sakurai M, 2004, HUM MOL GENET, V13, P693, DOI 10.1093/hmg/ddh087; Kennedy TL, 2018, MOL THER-METH CLIN D, V11, P92, DOI 10.1016/j.omtm.2018.10.005; Kobayashi YM, 2008, NATURE, V456, P511, DOI 10.1038/nature07414; KOENIG M, 1988, CELL, V53, P219, DOI 10.1016/0092-8674(88)90383-2; Kornegay JN, 2010, MOL THER, V18, P1501, DOI 10.1038/mt.2010.94; Le Guiner C, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms16105; Li XY, 1999, NAT BIOTECHNOL, V17, P241, DOI 10.1038/6981; Liu JMK, 2004, MUSCLE NERVE, V30, P767, DOI 10.1002/mus.20154; Lock M, 2012, HUM GENE THER METHOD, V23, P56, DOI 10.1089/hgtb.2011.217; Mendell JR, 2010, NEW ENGL J MED, V363, P1429, DOI 10.1056/NEJMoa1000228; Mesnard-Rouiller L, 2004, J NEUROIMMUNOL, V148, P97, DOI 10.1016/j.jneuroim.2003.11.013; Mingozzi F, 2009, BLOOD, V114, P2077, DOI 10.1182/blood-2008-07-167510; Mishra MK, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182676; Moore MJ, 2010, NEW ENGL J MED, V363, P1473, DOI 10.1056/NEJMe1009056; Muthu M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040066; Nichols TC, 2015, HUM GENE THER CL DEV, V26, P5, DOI 10.1089/humc.2014.153; Odom GL, 2008, MOL THER, V16, P1539, DOI 10.1038/mt.2008.149; Ortega E, 2016, J BIOL CHEM, V291, P18643, DOI 10.1074/jbc.M116.732909; PETROF BJ, 1993, P NATL ACAD SCI USA, V90, P3710, DOI 10.1073/pnas.90.8.3710; Schatzberg SJ, 1998, MUSCLE NERVE, V21, P991, DOI 10.1002/(SICI)1097-4598(199808)21:8<991::AID-MUS2>3.3.CO;2-S; Schatzberg SJ, 1999, NEUROMUSCULAR DISORD, V9, P289, DOI 10.1016/S0960-8966(99)00011-5; Shi Y, 2013, GENE THER, V20, P987, DOI 10.1038/gt.2013.22; Solovyev V, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-s1-s10; Song YF, 2017, J APPL PHYSIOL, V122, P593, DOI 10.1152/japplphysiol.00776.2016; Song YG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041274; Sonnemann KJ, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000083; Stedman HH, 2004, NATURE, V428, P415, DOI 10.1038/nature02358; STEDMAN HH, 1991, NATURE, V352, P536, DOI 10.1038/352536a0; TINSLEY JM, 1992, NATURE, V360, P591, DOI 10.1038/360591a0; Toniolo L, 2008, AM J PHYSIOL-CELL PH, V295, pC1535, DOI 10.1152/ajpcell.00093.2008; VanBelzen DJ, 2017, MOL THER-METH CLIN D, V4, P62, DOI 10.1016/j.omtm.2016.12.001; Vandenberghe LH, 2010, HUM GENE THER, V21, P1251, DOI 10.1089/hum.2010.107; Wang B, 2000, P NATL ACAD SCI USA, V97, P13714, DOI 10.1073/pnas.240335297; Yiu EM, 2015, J PAEDIATR CHILD H, V51, P759, DOI 10.1111/jpc.12868; Yue YP, 2015, HUM MOL GENET, V24, P5880, DOI 10.1093/hmg/ddv310; Zincarelli C, 2008, MOL THER, V16, P1073, DOI 10.1038/mt.2008.76; Zinn E, 2015, CELL REP, V12, P1056, DOI 10.1016/j.celrep.2015.07.019	53	39	40	3	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	OCT	2019	25	10					1505	+		10.1038/s41591-019-0594-0	http://dx.doi.org/10.1038/s41591-019-0594-0			19	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	JC3GJ	31591596	Green Accepted			2022-12-27	WOS:000489166700018
J	Schneider, JW; Oommen, S; Qureshi, MY; Goetsch, SC; Pease, DR; Sundsbak, RS; Guo, W; Sun, MM; Sun, H; Kuroyanagi, H; Webster, DA; Coutts, AW; Holst, KA; Edwards, BS; Newville, N; Hathcock, MA; Melkamu, T; Briganti, F; Wei, W; Romanelli, MG; Fahrenkrug, SC; Frantz, DE; Olson, TM; Steinmetz, LM; Carlson, DF; Nelson, TJ				Schneider, Jay W.; Oommen, Saji; Qureshi, Muhammad Y.; Goetsch, Sean C.; Pease, David R.; Sundsbak, Rhianna S.; Guo, Wei; Sun, Mingming; Sun, Han; Kuroyanagi, Hidehito; Webster, Dennis A.; Coutts, Alexander W.; Holst, Kimberly A.; Edwards, Brooks S.; Newville, Nikolas; Hathcock, Matthew A.; Melkamu, Tamene; Briganti, Francesca; Wei, Wu; Romanelli, Maria G.; Fahrenkrug, Scott C.; Frantz, Doug E.; Olson, Timothy M.; Steinmetz, Lars M.; Carlson, Daniel F.; Nelson, Timothy J.		Wanek Program Preclinical Pipeline	Dysregulated ribonucleoprotein granules promote cardiomyopathy in RBM20 gene-edited pigs	NATURE MEDICINE			English	Article							STRESS GRANULES; RNA GRANULES; TITIN; PRINCIPLES; INSIGHTS; DOMAINS; HEARTS	Dysregulation of ribonucleoprotein complex granules, previously implicated in neuromuscular disease, can drive pathogenesis in a genetic form of dilated cardiomyopathy, as shown in gene-edited pigs and patient-derived cardiomyocytes. Ribonucleoprotein (RNP) granules are biomolecular condensates-liquid-liquid phase-separated droplets that organize and manage messenger RNA metabolism, cell signaling, biopolymer assembly, biochemical reactions and stress granule responses to cellular adversity. Dysregulated RNP granules drive neuromuscular degenerative disease but have not previously been linked to heart failure. By exploring the molecular basis of congenital dilated cardiomyopathy (DCM) in genome-edited pigs homozygous for an RBM20 allele encoding the pathogenic R636S variant of human RNA-binding motif protein-20 (RBM20), we discovered that RNP granules accumulated abnormally in the sarcoplasm, and we confirmed this finding in myocardium and reprogrammed cardiomyocytes from patients with DCM carrying the R636S allele. Dysregulated sarcoplasmic RBM20 RNP granules displayed liquid-like material properties, docked at precisely spaced intervals along cytoskeletal elements, promoted phase partitioning of cardiac biomolecules and fused with stress granules. Our results link dysregulated RNP granules to myocardial cellular pathobiology and heart failure in gene-edited pigs and patients with DCM caused by RBM20 mutation.	[Schneider, Jay W.; Oommen, Saji; Qureshi, Muhammad Y.; Pease, David R.; Sundsbak, Rhianna S.; Holst, Kimberly A.; Edwards, Brooks S.; Newville, Nikolas; Hathcock, Matthew A.; Olson, Timothy M.; Nelson, Timothy J.] Mayo Clin, Discovery Engine Todd & Karen Wanek Family Progra, Rochester, MN 55905 USA; [Schneider, Jay W.; Goetsch, Sean C.] Univ Texas Southwestern Med Ctr, Hamon Ctr Regenerat Sci & Med, Dept Med Cardiol, Dallas, TX 75390 USA; [Guo, Wei; Sun, Mingming] Univ Wyoming, Dept Anim Sci, Laramie, WY 82071 USA; [Sun, Han; Briganti, Francesca; Wei, Wu; Steinmetz, Lars M.] Stanford Univ, Dept Genet, Stanford, CA 94305 USA; [Sun, Han; Briganti, Francesca; Wei, Wu; Steinmetz, Lars M.] Stanford Univ, Genome Ctr, Stanford, CA 94305 USA; [Kuroyanagi, Hidehito] Tokyo Med & Dent Univ, Med Res Inst, Lab Gene Express, Tokyo, Japan; [Webster, Dennis A.; Coutts, Alexander W.; Melkamu, Tamene; Fahrenkrug, Scott C.; Carlson, Daniel F.] Recombinetics, St Paul, MN 55104 USA; [Briganti, Francesca; Steinmetz, Lars M.] European Mol Biol Lab, Genome Biol Unit, Heidelberg, Germany; [Romanelli, Maria G.] Univ Verona, Dept Neurosci Biomed & Movement Sci, Verona, Italy; [Frantz, Doug E.] Univ Texas San Antonio, Dept Chem, San Antonio, TX USA; [Nelson, Timothy J.] Mayo Clin, Dept Gen Internal Med, Rochester, MN USA; [Nelson, Timothy J.] Mayo Clin, Dept Mol Pharmacol, Rochester, MN USA; [Guo, Wei] Univ Wisconsin, Dept Anim Sci, Madison, WI USA	Mayo Clinic; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Wyoming; Stanford University; Stanford University; Tokyo Medical & Dental University (TMDU); European Molecular Biology Laboratory (EMBL); University of Verona; University of Texas System; University of Texas at San Antonio (UTSA); Mayo Clinic; Mayo Clinic; University of Wisconsin System; University of Wisconsin Madison	Schneider, JW (corresponding author), Mayo Clin, Discovery Engine Todd & Karen Wanek Family Progra, Rochester, MN 55905 USA.; Schneider, JW (corresponding author), Univ Texas Southwestern Med Ctr, Hamon Ctr Regenerat Sci & Med, Dept Med Cardiol, Dallas, TX 75390 USA.; Carlson, DF (corresponding author), Recombinetics, St Paul, MN 55104 USA.	schneider.jay1@mayo.edu; dan@recombinetics.com	Romanelli, Maria/AAS-7946-2020; Qureshi, Muhammad Yasir/AAW-6612-2020	Qureshi, Muhammad Yasir/0000-0002-9898-2318; oommen, saji/0000-0001-6824-4894; Olson, Timothy/0000-0003-2716-9423; Briganti, Francesca/0000-0001-5738-2642; guo, wei/0000-0002-9158-8107; Steinmetz, Lars/0000-0002-3962-2865; Schneider, Jay/0000-0002-7386-9343; Sun, Mingming/0000-0002-3117-7066; Fahrenkrug, Scott/0000-0002-7176-6551	NIH/NHLBI [U01HL100404]; NIH [U54HD087351]; American Heart Association [19TPA34830072]; JSPS KAKENHI [JP20K21385]; Steinmetz Cardiomyopathy Fund	NIH/NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Steinmetz Cardiomyopathy Fund	We thank the patients who contributed cells and tissues to this study, E. Olson and J. Hill for support during the transition of J.W.S. from the University of Texas Southwestern Medical Center to Mayo Clinic, and J. Dearani and A. Terzic at Mayo Clinic. We also thank C. Riggs and N. Kedersha (Harvard Medical School) for sharing FRAP plasmids, and M. Rosen and S. McKnight (University of Texas Southwestern Medical Center) for sharing resources and helpful discussions. We also acknowledge grant support from NIH/NHLBI U01HL100404 (Progenitor Cell Biology Consortium) and NIH U54HD087351 (Wellstone Center for Muscular Dystrophy Research) to J.W.S., American Heart Association grant 19TPA34830072 to W.G., JSPS KAKENHI Grant Number JP20K21385 and Nanken-Kyoten, TMDU to H.K. and Steinmetz Cardiomyopathy Fund to L.M.S.	Alberti S, 2017, J CELL SCI, V130, P2789, DOI 10.1242/jcs.200295; Anderson P, 2008, TRENDS BIOCHEM SCI, V33, P141, DOI 10.1016/j.tibs.2007.12.003; Arrell DK, 2014, CIRC-CARDIOVASC GENE, V7, P732, DOI 10.1161/CIRCGENETICS.114.000879; Banani SF, 2017, NAT REV MOL CELL BIO, V18, P285, DOI 10.1038/nrm.2017.7; Bertero A, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09483-5; Boeynaems S, 2018, CELL DIV, V13, DOI 10.1186/s13008-018-0034-4; Brauch KM, 2009, J AM COLL CARDIOL, V54, P930, DOI 10.1016/j.jacc.2009.05.038; Buchan JR, 2009, MOL CELL, V36, P932, DOI 10.1016/j.molcel.2009.11.020; Cutler AA, 2019, J EXP NEUROSCI, V13, DOI 10.1177/1179069519842157; De Graeve F, 2018, BIOL CHEM, V399, P623, DOI 10.1515/hsz-2018-0141; Filippello A, 2013, FEBS LETT, V587, P2989, DOI 10.1016/j.febslet.2013.07.018; Thomas MG, 2011, CELL SIGNAL, V23, P324, DOI 10.1016/j.cellsig.2010.08.011; Gacita AM, 2019, CIRC-HEART FAIL, V12, DOI 10.1161/CIRCHEARTFAILURE.119.005850; Gilks N, 2004, MOL BIOL CELL, V15, P5383, DOI 10.1091/mbc.E04-08-0715; Guo W, 2012, NAT MED, V18, P766, DOI 10.1038/nm.2693; Harvey R, 2017, BIOCHEM SOC T, V45, P1007, DOI 10.1042/BST20160364; Hey TM, 2019, CIRC-HEART FAIL, V12, DOI 10.1161/CIRCHEARTFAILURE.118.005700; Ito D, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aah5436; Jain S, 2016, CELL, V164, P487, DOI 10.1016/j.cell.2015.12.038; Jourdain AA, 2016, J CELL BIOL, V212, P611, DOI 10.1083/jcb.201507125; Kato M, 2018, ANNU REV BIOCHEM, V87, P351, DOI 10.1146/annurev-biochem-061516-044700; Kato M, 2017, CSH PERSPECT BIOL, V9, DOI 10.1101/cshperspect.a023598; Kato M, 2012, CELL, V149, P753, DOI 10.1016/j.cell.2012.04.017; Khong A, 2017, MOL CELL, V68, P808, DOI 10.1016/j.molcel.2017.10.015; Kiebler MA, 2006, NEURON, V51, P685, DOI 10.1016/j.neuron.2006.08.021; Labeit S, 1997, CIRC RES, V80, P290, DOI 10.1161/01.RES.80.2.290; Lee CY, 2019, NAT CELL BIOL, V21, P116, DOI 10.1038/s41556-019-0278-5; Li SJ, 2013, NUCLEIC ACIDS RES, V41, P2659, DOI 10.1093/nar/gks1362; Li YR, 2013, J CELL BIOL, V201, P361, DOI 10.1083/jcb.201302044; Linke WA, 2012, NAT MED, V18, P660, DOI 10.1038/nm.2762; Methawasin M, 2016, CIRCULATION, V134, P1085, DOI 10.1161/CIRCULATIONAHA.116.023003; Moon SL, 2019, NAT CELL BIOL, V21, P162, DOI 10.1038/s41556-018-0263-4; Murayama R, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-26624-w; Nedelsky NB, 2019, NAT REV NEUROL, V15, P272, DOI 10.1038/s41582-019-0157-5; Parikh VN, 2019, CIRC-HEART FAIL, V12, DOI 10.1161/CIRCHEARTFAILURE.118.005371; Protter DSW, 2016, TRENDS CELL BIOL, V26, P668, DOI 10.1016/j.tcb.2016.05.004; Ramaswami M, 2013, CELL, V154, P727, DOI 10.1016/j.cell.2013.07.038; Refaat MM, 2012, HEART RHYTHM, V9, P390, DOI 10.1016/j.hrthm.2011.10.016; Rexiati M, 2018, GENES-BASEL, V9, DOI 10.3390/genes9010018; Shin Y, 2017, SCIENCE, V357, DOI 10.1126/science.aaf4382; Sutcliffe MD, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19539-z; van den Hoogenhof MMG, 2016, CIRC RES, V118, P454, DOI 10.1161/CIRCRESAHA.115.307872; Vanderweyde T, 2013, GERONTOLOGY, V59, P524, DOI 10.1159/000354170; Vogler TO, 2018, NATURE, V563, P508, DOI 10.1038/s41586-018-0665-2; Waris S, 2014, INT J MOL SCI, V15, P23377, DOI 10.3390/ijms151223377; Watanabe T, 2018, FRONT MOL BIOSCI, V5, DOI 10.3389/fmolb.2018.00105; Weeland CJ, 2015, J MOL CELL CARDIOL, V81, P107, DOI 10.1016/j.yjmcc.2015.02.008; Wolozin B, 2014, DISCOV MED, V17, P47; Zarnescu DC, 2013, TRENDS CARDIOVAS MED, V23, P275, DOI 10.1016/j.tcm.2013.03.003	49	31	32	0	6	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2020	26	11					1788	+		10.1038/s41591-020-1087-x	http://dx.doi.org/10.1038/s41591-020-1087-x		NOV 2020	28	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	OT0SR	33188278	Green Accepted			2022-12-27	WOS:000589457400001
J	Stower, H				Stower, Hannah			An miRNA linked to metabolic disease	NATURE MEDICINE			English	Editorial Material												h.stower@us.nature.com							0	1	1	0	0	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2020	26	11					1677	1677		10.1038/s41591-020-1137-4	http://dx.doi.org/10.1038/s41591-020-1137-4		NOV 2020	1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	OT0SR	33154585				2022-12-27	WOS:000587145800004
J	Depner, M; Taft, DH; Kirjavainen, PV; Kalanetra, KM; Karvonen, AM; Peschel, S; Schmausser-Hechfellner, E; Roduit, C; Frei, R; Lauener, R; Divaret-Chauveau, A; Dalphin, JC; Riedler, J; Roponen, M; Kabesch, M; Renz, H; Pekkanen, J; Farquharson, FM; Louis, P; Mills, DA; von Mutius, E; Ege, MJ				Depner, Martin; Taft, Diana Hazard; Kirjavainen, Pirkka V.; Kalanetra, Karen M.; Karvonen, Anne M.; Peschel, Stefanie; Schmausser-Hechfellner, Elisabeth; Roduit, Caroline; Frei, Remo; Lauener, Roger; Divaret-Chauveau, Amandine; Dalphin, Jean-Charles; Riedler, Josef; Roponen, Marjut; Kabesch, Michael; Renz, Harald; Pekkanen, Juha; Farquharson, Freda M.; Louis, Petra; Mills, David A.; von Mutius, Erika; Ege, Markus J.		PASTURE study grp	Maturation of the gut microbiome during the first year of life contributes to the protective farm effect on childhood asthma	NATURE MEDICINE			English	Article							ATOPY; RISK; DIVERSITY; BACTERIA; SUSCEPTIBILITY; POLYMORPHISMS; COLONIZATION; ENVIRONMENTS; ASSOCIATION; VARIANTS	Growing up on a farm is associated with an asthma-protective effect, but the mechanisms underlying this effect are largely unknown. In the Protection against Allergy: Study in Rural Environments (PASTURE) birth cohort, we modeled maturation using 16S rRNA sequence data of the human gut microbiome in infants from 2 to 12 months of age. The estimated microbiome age (EMA) in 12-month-old infants was associated with previous farm exposure (beta = 0.27 (0.12-0.43), P = 0.001, n = 618) and reduced risk of asthma at school age (odds ratio (OR) = 0.72 (0.56-0.93), P = 0.011). EMA mediated the protective farm effect by 19%. In a nested case-control sample (n = 138), we found inverse associations of asthma with the measured level of fecal butyrate (OR = 0.28 (0.09-0.91), P = 0.034), bacterial taxa that predict butyrate production (OR = 0.38 (0.17-0.84), P = 0.017) and the relative abundance of the gene encoding butyryl-coenzyme A (CoA):acetate-CoA-transferase, a major enzyme in butyrate metabolism (OR = 0.43 (0.19-0.97), P = 0.042). The gut microbiome may contribute to asthma protection through metabolites, supporting the concept of a gut-lung axis in humans. Growing up in the rich microbial environment of a farm strongly influences the maturation of the gut microbiome in the first year of life, which helps protect against the development of asthma in children.	[Depner, Martin; Peschel, Stefanie; Schmausser-Hechfellner, Elisabeth; von Mutius, Erika] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Asthma & Allergy Prevent, Neuherberg, Germany; [Taft, Diana Hazard; Kalanetra, Karen M.; Mills, David A.] Univ Calif Davis, Dept Food Sci & Technol, Davis, CA 95616 USA; [Kirjavainen, Pirkka V.; Karvonen, Anne M.; Pekkanen, Juha] Finnish Inst Hlth & Welf, Dept Hlth Secur, Kuopio, Finland; [Kirjavainen, Pirkka V.] Univ Eastern Finland, Inst Publ Hlth & Clin Nutr, Kuopio, Finland; [Roduit, Caroline; Frei, Remo; Lauener, Roger] Christine Kuhne Ctr Allergy Res & Educ CK CARE, Davos, Switzerland; [Roduit, Caroline] Univ Zurich, Childrens Hosp, Zurich, Switzerland; [Roduit, Caroline; Lauener, Roger] Childrens Hosp Eastern Switzerland, St Gallen, Switzerland; [Frei, Remo] Univ Zurich, Swiss Inst Allergy & Asthma Res SIAF, Davos, Switzerland; [Lauener, Roger] Univ Zurich, Zurich, Switzerland; [Lauener, Roger] Univ St Gallen, Sch Med, St Gallen, Switzerland; [Divaret-Chauveau, Amandine] Univ Hosp Nancy, Childrens Hosp, Pediat Allergy Dept, Vandoeuvre Les Nancy, France; [Divaret-Chauveau, Amandine] Univ Lorraine, EA 3450 DevAH, Fac Med, Vandoeuvre Les Nancy, France; [Divaret-Chauveau, Amandine; Dalphin, Jean-Charles] Univ Hosp Besancon, CNRS, UMR 6249 Chronoenvironm, Dept Resp Dis, Besancon, France; [Riedler, Josef] Childrens Hosp, Schwarzach, Austria; [Roponen, Marjut] Univ Eastern Finland, Dept Environm & Biol Sci, Kuopio, Finland; [Kabesch, Michael] KUNO Childrens Univ Hosp Regensburg, Dept Pediat Pneumol & Allergy, Regensburg, Germany; [Renz, Harald] Philipps Univ Marburg, Dept Clin Chem & Mol Diagnost, Marburg, Germany; [Renz, Harald; von Mutius, Erika; Ege, Markus J.] German Ctr Lung Research, Giessen, Germany; [Pekkanen, Juha] Univ Helsinki, Dept Publ Hlth, Helsinki, Finland; [Farquharson, Freda M.; Louis, Petra] Univ Aberdeen, Rowett Inst, Foresterhill, Aberdeen, Scotland; [von Mutius, Erika; Ege, Markus J.] Ludwig Maximilian Univ Munich, Dr von Hauner Childrens Hosp, Munich, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of California System; University of California Davis; University of Eastern Finland; University Children's Hospital Zurich; University of Zurich; Swiss Institute of Allergy & Asthma Research; University of Zurich; University of Zurich; University of St Gallen; CHU de Nancy; Universite de Lorraine; Universite de Lorraine; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite de Franche-Comte; CHU Besancon; University of Eastern Finland; Philipps University Marburg; University of Helsinki; University of Aberdeen; University of Munich	Ege, MJ (corresponding author), German Ctr Lung Research, Giessen, Germany.; Ege, MJ (corresponding author), Ludwig Maximilian Univ Munich, Dr von Hauner Childrens Hosp, Munich, Germany.	markus.ege@med.uni-muenchen.de	Genuneit, Jon/I-9323-2012; Kalanetra, Karen/AAP-3669-2021; Mills, David/GXF-1821-2022; Kabesch, Michael/GZM-1583-2022; Kirjavainen, Pirkka/AAW-6833-2021; Mills, David Andrew/G-2282-2011; Lauener, Roger/O-8612-2016	Genuneit, Jon/0000-0001-5764-1528; Kirjavainen, Pirkka/0000-0001-6119-8768; Mills, David Andrew/0000-0003-1913-9865; Peschel, Stefanie/0000-0002-7936-7627; Prof. Dr. med. Schaub, Bianca/0000-0003-1652-8873; Taft, Diana/0000-0002-9306-9968; Louis, Petra/0000-0003-2115-2399; Ege, Markus/0000-0001-6643-3923; Lauener, Roger/0000-0002-8412-606X; Divaret-Chauveau, Amandine/0000-0002-2492-9864; Roduit, Caroline/0000-0002-5988-0570	European Commission [QLK4-CT-2001-00250, FOOD-CT-2006-31708, KBBE-2007-2-2-06]; European Research Council [250268]; German Federal Ministry of Education and Research (BMBF; project German Center for Lung Research (DZL)); Scottish Government's Rural and Environment Sciences and Analytical Services Division (RESAS)	European Commission(European CommissionEuropean Commission Joint Research Centre); European Research Council(European Research Council (ERC)European Commission); German Federal Ministry of Education and Research (BMBF; project German Center for Lung Research (DZL))(Federal Ministry of Education & Research (BMBF)); Scottish Government's Rural and Environment Sciences and Analytical Services Division (RESAS)	This paper is dedicated to Jean-Charles Dalphin, one of the founders of the PASTURE study, who passed away shortly after the submission of this manuscript. We are very grateful for his constant support of this successful collaboration. We thank B. Stecher and A.-L. Boulesteix for valuable input in discussions about biological and statistical issues, respectively. We are grateful to G. Pagani for technical support with graphs. The PASTURE study was supported by the European Commission (research grants QLK4-CT-2001-00250, FOOD-CT-2006-31708 and KBBE-2007-2-2-06) and the European Research Council (grant 250268). The current analyses were supported by the German Federal Ministry of Education and Research (BMBF; project German Center for Lung Research (DZL)). P.L. and F.M.F. receive funding from the Scottish Government's Rural and Environment Sciences and Analytical Services Division (RESAS).	Abarenkov K, 2010, NEW PHYTOL, V186, P281, DOI 10.1111/j.1469-8137.2009.03160.x; Abrahamsson TR, 2014, CLIN EXP ALLERGY, V44, P842, DOI 10.1111/cea.12253; AITCHISON J, 1982, J ROY STAT SOC B MET, V44, P139; Arrieta MC, 2018, J ALLERGY CLIN IMMUN, V142, P424, DOI 10.1016/j.jaci.2017.08.041; Arrieta MC, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aab2271; Backhed F, 2015, CELL HOST MICROBE, V17, P690, DOI [10.1016/j.chom.2015.04.004, 10.1016/j.chom.2015.05.012]; BARKER DJP, 1990, BRIT MED J, V301, P1111, DOI 10.1136/bmj.301.6761.1111; Birzele LT, 2017, ALLERGY, V72, P109, DOI 10.1111/all.13002; Bokulich NA, 2018, MICROBIOME, V6, DOI 10.1186/s40168-018-0470-z; Bokulich NA, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad7121; Bokulich NA, 2014, P NATL ACAD SCI USA, V111, pE139, DOI 10.1073/pnas.1317377110; Bokulich NA, 2013, APPL ENVIRON MICROB, V79, P2519, DOI 10.1128/AEM.03870-12; Bonaz B, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00049; Borewicz K, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-38268-x; Bouzigon E, 2008, NEW ENGL J MED, V359, P1985, DOI 10.1056/NEJMoa0806604; Brandes U, 2008, IEEE T KNOWL DATA EN, V20, P172, DOI 10.1109/TKDE.2007.190689; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Cait A, 2019, J ALLERGY CLIN IMMUN, V144, P1638, DOI 10.1016/j.jaci.2019.06.029; Caliskan M, 2013, NEW ENGL J MED, V368, P1398, DOI 10.1056/NEJMoa1211592; Callahan BJ, 2016, NAT METHODS, V13, P581, DOI [10.1038/NMETH.3869, 10.1038/nmeth.3869]; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chung HC, 2012, CELL, V149, P1578, DOI 10.1016/j.cell.2012.04.037; Depner M, 2017, J ALLERGY CLIN IMMUN, V139, P826, DOI 10.1016/j.jaci.2016.05.050; Depner M, 2014, AM J RESP CRIT CARE, V189, P129, DOI 10.1164/rccm.201307-1198OC; Depner M, 2013, J ALLERGY CLIN IMMUN, V131, P781, DOI 10.1016/j.jaci.2012.11.048; Derrien M, 2019, TRENDS MICROBIOL, V27, P997, DOI 10.1016/j.tim.2019.08.001; Dostal A, 2014, BRIT J NUTR, V112, P547, DOI 10.1017/S0007114514001160; Ege MJ, 2012, ALLERGY, V67, P1565, DOI 10.1111/all.12028; Ege MJ, 2017, ANN AM THORAC SOC, V14, pS348, DOI 10.1513/AnnalsATS.201702-139AW; Ege MJ, 2011, NEW ENGL J MED, V364, P701, DOI 10.1056/NEJMoa1007302; Forbes JD, 2018, MICROBIOME, V6, DOI 10.1186/s40168-018-0603-4; Frati F, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20010123; Friedman J, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002687; Fuchs O, 2012, J ALLERGY CLIN IMMUN, V130, P382, DOI 10.1016/j.jaci.2012.04.049; Fujimura KE, 2016, NAT MED, V22, P1187, DOI 10.1038/nm.4176; Galazzo G, 2020, GASTROENTEROLOGY, V158, P1584, DOI 10.1053/j.gastro.2020.01.024; Gardiner BJ, 2015, J CLIN MICROBIOL, V53, P626, DOI 10.1128/JCM.02926-14; Gloor GB, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02224; Holmes I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030126; Hose AJ, 2017, J ALLERGY CLIN IMMUN, V139, P1935, DOI 10.1016/j.jaci.2016.08.046; Illi S, 2012, J ALLERGY CLIN IMMUN, V129, P1470, DOI 10.1016/j.jaci.2012.03.013; Kabata H, 2019, J CLIN INVEST, V129, P1475, DOI 10.1172/JCI124609; Kemter AM, 2019, J CLIN INVEST, V129, P1483, DOI 10.1172/JCI124610; Kepert I, 2017, J ALLERGY CLIN IMMUN, V139, P1525, DOI 10.1016/j.jaci.2016.09.003; Kormann MSD, 2005, AM J RESP CRIT CARE, V171, P1358, DOI 10.1164/rccm.200410-1312OC; Kumbhare SV, 2019, J BIOSCIENCES, V44, DOI 10.1007/s12038-019-9860-z; Langfelder P, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-54; Loss G, 2015, J ALLERGY CLIN IMMUN, V135, P56, DOI 10.1016/j.jaci.2014.08.044; Loss GJ, 2016, AM J RESP CRIT CARE, V193, P889, DOI 10.1164/rccm.201507-1493OC; Louis P, 2010, ENVIRON MICROBIOL, V12, P304, DOI 10.1111/j.1462-2920.2009.02066.x; Marsland BJ, 2015, ANN AM THORAC SOC, V12, pS150, DOI 10.1513/AnnalsATS.201503-133AW; McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139; Moffatt MF, 2007, NATURE, V448, P470, DOI 10.1038/nature06014; Moffatt MF, 2010, NEW ENGL J MED, V363, P1211, DOI 10.1056/NEJMoa0906312; Muthen L. K., 2017, MPLUS USERS GUIDE, DOI DOI 10.1111/J.1600-0447.2011.01711.X; Osadchiy V, 2019, CLIN GASTROENTEROL H, V17, P322, DOI 10.1016/j.cgh.2018.10.002; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Pham VT, 2016, ENVIRON MICROBIOL, V18, P2246, DOI 10.1111/1462-2920.13316; Piters WAAD, 2016, AM J RESP CRIT CARE, V194, P1104, DOI 10.1164/rccm.201602-0220OC; Ramirez-Farias C, 2009, BRIT J NUTR, V101, P541, DOI 10.1017/S0007114508019880; Reichardt N, 2018, ISME J, V12, P610, DOI 10.1038/ismej.2017.196; Reichardt N, 2014, ISME J, V8, P1323, DOI 10.1038/ismej.2014.14; Riviere A, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00979; Roduit C, 2019, ALLERGY, V74, P799, DOI 10.1111/all.13660; Roduit C, 2014, J ALLERGY CLIN IMMUN, V133, P1056, DOI 10.1016/j.jaci.2013.12.1044; Schedel M, 2015, J ALLERGY CLIN IMMUN, V136, P893, DOI 10.1016/j.jaci.2015.03.014; Singh P, 2015, MICROBIOME, V3, DOI 10.1186/s40168-015-0109-2; Sjodin KS, 2019, ALLERGY, V74, P176, DOI 10.1111/all.13485; Stein MM, 2016, NEW ENGL J MED, V375, P411, DOI 10.1056/NEJMoa1508749; Stewart CJ, 2018, NATURE, V562, P583, DOI 10.1038/s41586-018-0617-x; Stiemsma LT, 2016, CLIN SCI, V130, P2199, DOI 10.1042/CS20160349; Stokholm J, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02573-2; Tamanai-Shacoori Z, 2017, FUTURE MICROBIOL, V12, P157, DOI 10.2217/fmb-2016-0130; Tamburini S, 2016, NAT MED, V22, P713, DOI 10.1038/nm.4142; Theiler A, 2019, J ALLERGY CLIN IMMUN, V144, P764, DOI 10.1016/j.jaci.2019.05.002; Torgerson DG, 2011, NAT GENET, V43, P887, DOI 10.1038/ng.888; Trompette A, 2014, NAT MED, V20, P159, DOI 10.1038/nm.3444; von Mutius E, 2006, ALLERGY, V61, P407, DOI 10.1111/j.1398-9995.2006.01009.x; Wang Q, 2018, BMC MICROBIOL, V18, DOI 10.1186/s12866-018-1257-x; Yang B, 2019, MEDICINE, V98, DOI 10.1097/MD.0000000000016618; Yassour M, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad0917; Zhai SX, 2019, FEMS MICROBIOL LETT, V366, DOI 10.1093/femsle/fnz153	83	88	91	4	31	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2020	26	11					1766	+		10.1038/s41591-020-1095-x	http://dx.doi.org/10.1038/s41591-020-1095-x		NOV 2020	24	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	OT0SR	33139948	Green Submitted, Green Published			2022-12-27	WOS:000584339200001
J	Koido, M; Kawakami, E; Fukumura, J; Noguchi, Y; Ohori, M; Nio, Y; Nicoletti, P; Aithal, GP; Daly, AK; Watkins, PB; Anayama, H; Dragan, Y; Shinozawa, T; Takebe, T				Koido, Masaru; Kawakami, Eri; Fukumura, Junko; Noguchi, Yui; Ohori, Momoko; Nio, Yasunori; Nicoletti, Paola; Aithal, Guruprasad P.; Daly, Ann K.; Watkins, Paul B.; Anayama, Hisashi; Dragan, Yvonne; Shinozawa, Tadahiro; Takebe, Takanori			Polygenic architecture informs potential vulnerability to drug-induced liver injury	NATURE MEDICINE			English	Article							OXIDATIVE STRESS; ENDOPLASMIC-RETICULUM; GENOTYPE IMPUTATION; INDUCED CHOLESTASIS; FASIGLIFAM TAK-875; EXPRESSION; HLA	Drug-induced liver injury (DILI) is a leading cause of termination in drug development programs and removal of drugs from the market; this is partially due to the inability to identify patients who are at risk(1). In this study, we developed a polygenic risk score (PRS) for DILI by aggregating effects of numerous genome-wide loci identified from previous large-scale genome-wide association studies(2). The PRS predicted the susceptibility to DILI in patients treated with fasiglifam, amoxicillin-clavulanate or flucloxacillin and in primary hepatocytes and stem cell-derived organoids from multiple donors treated with over ten different drugs. Pathway analysis highlighted processes previously implicated in DILI, including unfolded protein responses and oxidative stress. In silico screening identified compounds that elicit transcriptomic signatures present in hepatocytes from individuals with elevated PRS, supporting mechanistic links and suggesting a novel screen for safety of new drug candidates. This genetic-, cellular-, organoid- and human-scale evidence underscored the polygenic architecture underlying DILI vulnerability at the level of hepatocytes, thus facilitating future mechanistic studies. Moreover, the proposed 'polygenicity-in-a-dish' strategy might potentially inform designs of safer, more efficient and robust clinical trials.	[Koido, Masaru; Fukumura, Junko; Noguchi, Yui; Takebe, Takanori] Yokohama City Univ, Dept Regenerat Med, Grad Sch Med, Yokohama, Kanagawa, Japan; [Koido, Masaru; Kawakami, Eri; Fukumura, Junko; Noguchi, Yui; Ohori, Momoko; Nio, Yasunori; Shinozawa, Tadahiro; Takebe, Takanori] T CiRA Joint Program, Organoid Med Project, Fujisawa, Kanagawa, Japan; [Kawakami, Eri; Ohori, Momoko; Nio, Yasunori; Shinozawa, Tadahiro; Takebe, Takanori] Takeda Pharmaceut Co, T CiRA Discovery, Fujisawa, Kanagawa, Japan; [Nicoletti, Paola] Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY 10029 USA; [Aithal, Guruprasad P.] Nottingham Univ Hosp NHS Trust, NIHR Nottingham Biomed Res Ctr, Nottingham, England; [Aithal, Guruprasad P.] Univ Nottingham, Nottingham, England; [Daly, Ann K.] Newcastle Univ, Translat & Clin Res Inst, Fac Med Sci, Newcastle Upon Tyne, Tyne & Wear, England; [Watkins, Paul B.] Univ N Carolina, Inst Drug Safety Sci, UNC Eshelman Sch Pharm, Chapel Hill, NC 27515 USA; [Anayama, Hisashi; Shinozawa, Tadahiro] Takeda Pharmaceut Co, Drug Safety Res & Evaluat, Fujisawa, Kanagawa, Japan; [Dragan, Yvonne] Takeda Pharmaceut Co, Global Discovery & Investigat Toxicol, Cambridge, MA USA; [Takebe, Takanori] Tokyo Med & Dent Univ, Inst Res, Bunkyo Ku, Tokyo, Japan; [Takebe, Takanori] Cincinnati Childrens Hosp Med Ctr, Div Gastroenterol Hepatol & Nutr, Cincinnati, OH 45229 USA; [Takebe, Takanori] Cincinnati Childrens Hosp Med Ctr, Div Dev Biol, Cincinnati, OH 45229 USA; [Takebe, Takanori] Cincinnati Childrens Hosp Med Ctr, Ctr Stem Cell & Organoid Med CuSTOM, Cincinnati, OH 45229 USA; [Takebe, Takanori] Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati, OH 45221 USA	Yokohama City University; Takeda Pharmaceutical Company Ltd; Icahn School of Medicine at Mount Sinai; Nottingham University Hospital NHS Trust; University of Nottingham; Newcastle University - UK; The Hamner Institutes for Health Sciences; University of North Carolina; University of North Carolina Chapel Hill; Takeda Pharmaceutical Company Ltd; Tokyo Medical & Dental University (TMDU); Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati	Takebe, T (corresponding author), Yokohama City Univ, Dept Regenerat Med, Grad Sch Med, Yokohama, Kanagawa, Japan.; Takebe, T (corresponding author), T CiRA Joint Program, Organoid Med Project, Fujisawa, Kanagawa, Japan.; Takebe, T (corresponding author), Takeda Pharmaceut Co, T CiRA Discovery, Fujisawa, Kanagawa, Japan.; Takebe, T (corresponding author), Tokyo Med & Dent Univ, Inst Res, Bunkyo Ku, Tokyo, Japan.; Takebe, T (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Gastroenterol Hepatol & Nutr, Cincinnati, OH 45229 USA.; Takebe, T (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Dev Biol, Cincinnati, OH 45229 USA.; Takebe, T (corresponding author), Cincinnati Childrens Hosp Med Ctr, Ctr Stem Cell & Organoid Med CuSTOM, Cincinnati, OH 45229 USA.; Takebe, T (corresponding author), Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati, OH 45221 USA.	takanori.takebe@cchmc.org	Koido, Masaru/I-2930-2019; Nio, Yasunori/AFE-2456-2022; Daly, Ann/H-3144-2011	Koido, Masaru/0000-0002-0348-0666; Daly, Ann/0000-0002-7321-0629; Aithal, Guruprasad/0000-0003-3924-4830	T-CiRA Joint Program from Takeda Pharmaceutical Company; Cincinnati Children's Research Foundation grant; National Institutes of Health grant [UG3 DK119982]; Dr. Ralph and Marian Falk Medical Research Trust Awards Program; Takeda Science Foundation award; Mitsubishi Foundation award; AMED [JP19fk0210037, JP19bm0704025, JP19fk0210060, JP19bm0404045]; JSPS [JP18H02800, 19K22416]; Medical Research Council: Confidence in Concept [MC_PC_17173]; MRC [MC_PC_17173] Funding Source: UKRI	T-CiRA Joint Program from Takeda Pharmaceutical Company; Cincinnati Children's Research Foundation grant; National Institutes of Health grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dr. Ralph and Marian Falk Medical Research Trust Awards Program; Takeda Science Foundation award; Mitsubishi Foundation award; AMED; JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Medical Research Council: Confidence in Concept(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank S. Yamanaka, S. Izumo and Y. Kajii for their critical comments. We thank T. Kono, K. Araki, K. Enya and H. Kawaguchi for technical and analytical supports and W. L. Thompson for critical reading of the manuscript. The authors thank the Drug Induced Liver Injury Network (DILIN) and the international Drug-Induced Liver Injury Consortium (iDILIC) for providing data included in this paper. The DILIN and iDILIC were not involved in data analyses, manuscript preparation or manuscript review. This study was supported by the T-CiRA Joint Program from Takeda Pharmaceutical Company to T.T. T.T. is a New York Stem Cell Foundation Robertson Investigator and also the recipient of a Cincinnati Children's Research Foundation grant, National Institutes of Health grant UG3 DK119982, the Dr. Ralph and Marian Falk Medical Research Trust Awards Program, a Takeda Science Foundation award, a Mitsubishi Foundation award and AMED JP19fk0210037, JP19bm0704025, JP19fk0210060, JP19bm0404045 and JSPS JP18H02800, 19K22416. G.P.A. was supported by Medical Research Council: Confidence in Concept, reference number MC_PC_17173.	Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Andrade RJ, 2019, J HEPATOL, V70, P1222, DOI 10.1016/j.jhep.2019.02.014; Asai A, 2017, DEVELOPMENT, V144, P1056, DOI 10.1242/dev.142794; Bulik-Sullivan BK, 2015, NAT GENET, V47, P291, DOI 10.1038/ng.3211; Burant CF, 2012, LANCET, V379, P1403, DOI 10.1016/S0140-6736(11)61879-5; Burban A, 2018, FREE RADICAL BIO MED, V115, P166, DOI 10.1016/j.freeradbiomed.2017.11.017; Chalasani N, 2015, GASTROENTEROLOGY, V148, P1340, DOI 10.1053/j.gastro.2015.03.006; Chang CC, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0047-8; Chen MJ, 2015, J HEPATOL, V63, P503, DOI 10.1016/j.jhep.2015.04.016; Cirulli ET, 2019, GASTROENTEROLOGY, V156, P1707, DOI 10.1053/j.gastro.2019.01.034; Daly AK, 2009, NAT GENET, V41, P816, DOI 10.1038/ng.379; Das S, 2016, NAT GENET, V48, P1284, DOI 10.1038/ng.3656; Delaneau O, 2019, SCIENCE, V364, P452, DOI 10.1126/science.aat8266; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Euesden J, 2015, BIOINFORMATICS, V31, P1466, DOI 10.1093/bioinformatics/btu848; Fabregat A, 2018, NUCLEIC ACIDS RES, V46, pD649, DOI [10.1093/nar/gkx1132, 10.1093/nar/gkz1031]; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Fredriksson L, 2014, TOXICOL SCI, V140, P144, DOI 10.1093/toxsci/kfu072; Hybertson BM, 2011, MOL ASPECTS MED, V32, P234, DOI 10.1016/j.mam.2011.10.006; Igarashi Y, 2015, NUCLEIC ACIDS RES, V43, pD921, DOI 10.1093/nar/gku955; Iotchkova V, 2019, NAT GENET, V51, P343, DOI 10.1038/s41588-018-0322-6; Kaliyaperumal K, 2018, J HEPATOL, V69, P948, DOI 10.1016/j.jhep.2018.05.013; Kass GEN, 2008, CLIN LIVER DIS, V12, P27, DOI 10.1016/j.cld.2007.11.005; Khera AV, 2018, NAT GENET, V50, P1219, DOI 10.1038/s41588-018-0183-z; Lamparter D, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004714; Liberzon A, 2015, CELL SYST, V1, P417, DOI 10.1016/j.cels.2015.12.004; Lo CC, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/s12859-014-0366-2; Loh PR, 2016, NAT GENET, V48, P1443, DOI 10.1038/ng.3679; Lucena MI, 2011, GASTROENTEROLOGY, V141, P338, DOI 10.1053/j.gastro.2011.04.001; Marchini J, 2010, NAT REV GENET, V11, P499, DOI 10.1038/nrg2796; Marcinak JF, 2018, DRUG SAFETY, V41, P625, DOI 10.1007/s40264-018-0642-6; McCall MN, 2010, BIOSTATISTICS, V11, P242, DOI 10.1093/biostatistics/kxp059; Nicoletti P, 2017, GASTROENTEROLOGY, V152, P1078, DOI 10.1053/j.gastro.2016.12.016; Ogimura E, 2011, BIOCHEM BIOPH RES CO, V416, P313, DOI 10.1016/j.bbrc.2011.11.032; Schadt EE, 2008, PLOS BIOL, V6, P1020, DOI 10.1371/journal.pbio.0060107; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Takebe T, 2017, CELL REP, V21, P2661, DOI 10.1016/j.celrep.2017.11.005; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Vatakuti S, 2017, ARCH TOXICOL, V91, P1401, DOI 10.1007/s00204-016-1778-8; Wolenski FS, 2017, TOXICOL SCI, V157, P50, DOI 10.1093/toxsci/kfx018	40	37	37	1	20	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	OCT	2020	26	10					1541	+		10.1038/s41591-020-1023-0	http://dx.doi.org/10.1038/s41591-020-1023-0		SEP 2020	26	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	NX8MD	32895570	Green Accepted			2022-12-27	WOS:000566880900004
J	Liu, XX; Rivera, SC; Moher, D; Calvert, MJ; Denniston, AK				Liu, Xiaoxuan; Rivera, Samantha Cruz; Moher, David; Calvert, Melanie J.; Denniston, Alastair K.		SPIRT-AI CONSORT-AI Working Grp	Reporting guidelines for clinical trial reports for interventions involving artificial intelligence: the CONSORT-AI extension	NATURE MEDICINE			English	Article							RANDOMIZED-TRIALS; SYSTEM; STATEMENT; QUALITY; PREDICTION; CANCER	The CONSORT 2010 statement provides minimum guidelines for reporting randomized trials. Its widespread use has been instrumental in ensuring transparency in the evaluation of new interventions. More recently, there has been a growing recognition that interventions involving artificial intelligence (AI) need to undergo rigorous, prospective evaluation to demonstrate impact on health outcomes. The CONSORT-AI (Consolidated Standards of Reporting Trials-Artificial Intelligence) extension is a new reporting guideline for clinical trials evaluating interventions with an AI component. It was developed in parallel with its companion statement for clinical trial protocols: SPIRIT-AI (Standard Protocol Items: Recommendations for Interventional Trials-Artificial Intelligence). Both guidelines were developed through a staged consensus process involving literature review and expert consultation to generate 29 candidate items, which were assessed by an international multi-stakeholder group in a two-stage Delphi survey (103 stakeholders), agreed upon in a two-day consensus meeting (31 stakeholders) and refined through a checklist pilot (34 participants). The CONSORT-AI extension includes 14 new items that were considered sufficiently important for AI interventions that they should be routinely reported in addition to the core CONSORT 2010 items. CONSORT-AI recommends that investigators provide clear descriptions of the AI intervention, including instructions and skills required for use, the setting in which the AI intervention is integrated, the handling of inputs and outputs of the AI intervention, the human-AI interaction and provision of an analysis of error cases. CONSORT-AI will help promote transparency and completeness in reporting clinical trials for AI interventions. It will assist editors and peer reviewers, as well as the general readership, to understand, interpret and critically appraise the quality of clinical trial design and risk of bias in the reported outcomes. The CONSORT-AI and SPIRIT-AI extensions improve the transparency of clinical trial design and trial protocol reporting for artificial intelligence interventions.	[Liu, Xiaoxuan] Moorfields Eye Hosp NHS Fdn Trust, London, England; [Liu, Xiaoxuan; Denniston, Alastair K.] Univ Birmingham, Inst Inflammat & Ageing, Acad Unit Ophthalmol, Birmingham, W Midlands, England; [Liu, Xiaoxuan; Calvert, Melanie J.; Denniston, Alastair K.] Univ Hosp Birmingham NHS Fdn Trust, Birmingham, W Midlands, England; [Liu, Xiaoxuan; Calvert, Melanie J.; Denniston, Alastair K.] Hlth Data Res UK, London, England; [Liu, Xiaoxuan; Rivera, Samantha Cruz; Calvert, Melanie J.; Denniston, Alastair K.] Univ Birmingham, Birmingham Hlth Partners Ctr Regulatory Sci & Inn, Birmingham, W Midlands, England; [Rivera, Samantha Cruz; Calvert, Melanie J.; Denniston, Alastair K.] Univ Birmingham, Inst Appl Hlth Res, Ctr Patient Reported Outcomes Res, Birmingham, W Midlands, England; [Rivera, Samantha Cruz] Univ Birmingham, Inst Appl Hlth Res, Birmingham, W Midlands, England; [Moher, David] Ottawa Hosp Res Inst, Ctr Journalol, Clin Epidemiol Program, Ottawa, ON, Canada; [Moher, David] Univ Ottawa, Sch Epidemiol & Publ Hlth, Fac Med, Ottawa, ON, Canada; [Calvert, Melanie J.] Univ Birmingham, Birmingham Biomed Res Ctr, Natl Inst Hlth Res, Birmingham, W Midlands, England; [Calvert, Melanie J.] Natl Inst Hlth Res Appl Res Collaborat West Midla, Coventry, W Midlands, England; [Calvert, Melanie J.] Univ Birmingham, Surg Reconstruct & Microbiol Ctr, Natl Inst Hlth Res, Birmingham, W Midlands, England; [Denniston, Alastair K.] Moorfields Eye Hosp NHS Fdn Trust, NIHR Biomed Res Ctr, London, England; [Denniston, Alastair K.] UCL Inst Ophthalmol, London, England	University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust; University of Birmingham; University of Birmingham; University of Birmingham; University of Birmingham; University of Birmingham; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; University of Birmingham; University of Birmingham; University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust; University of London; University College London	Denniston, AK (corresponding author), Univ Birmingham, Inst Inflammat & Ageing, Acad Unit Ophthalmol, Birmingham, W Midlands, England.; Denniston, AK (corresponding author), Univ Hosp Birmingham NHS Fdn Trust, Birmingham, W Midlands, England.; Denniston, AK (corresponding author), Hlth Data Res UK, London, England.; Denniston, AK (corresponding author), Univ Birmingham, Birmingham Hlth Partners Ctr Regulatory Sci & Inn, Birmingham, W Midlands, England.; Denniston, AK (corresponding author), Univ Birmingham, Inst Appl Hlth Res, Ctr Patient Reported Outcomes Res, Birmingham, W Midlands, England.; Denniston, AK (corresponding author), Moorfields Eye Hosp NHS Fdn Trust, NIHR Biomed Res Ctr, London, England.; Denniston, AK (corresponding author), UCL Inst Ophthalmol, London, England.	a.denniston@bham.ac.uk	Calvert, Melanie/F-7055-2011; Denniston, Alastair/ABD-1238-2020	Calvert, Melanie/0000-0002-1856-837X; Denniston, Alastair/0000-0001-7849-0087; Liu, Xiaoxuan/0000-0002-1286-0038; Keane, Pearse/0000-0002-9239-745X; Rowley, Samuel/0000-0002-2468-801X	MRC [MC_PC_19005] Funding Source: UKRI	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Abramoff MD, 2016, INVEST OPHTH VIS SCI, V57, P5200, DOI 10.1167/iovs.16-19964; Adamson AS, 2018, JAMA DERMATOL, V154, P1247, DOI 10.1001/jamadermatol.2018.2348; [Anonymous], 2010, DRUG DISCOV TODAY TE, V7, pe1; [Anonymous], 2020, LANCET EDITORIAL, V2, pE268, DOI 10.1016/S2589-7500(20)30113-8; [Anonymous], 2020, LANCET EDITORIAL, V2, pE268, DOI 10.1016/S2589-7500(20)30113-8; [Anonymous], 2010, DRUG DISCOV TODAY TE, V7, pe1; Boutron I, 2017, ANN INTERN MED, V167, P40, DOI 10.7326/M17-0046; Caballero-Ruiz E, 2017, INT J MED INFORM, V102, P35, DOI 10.1016/j.ijmedinf.2017.02.014; Calvert M, 2013, JAMA-J AM MED ASSOC, V309, P814, DOI 10.1001/jama.2013.879; Cardiovascular Disease and Risk Management, 2019, DIABETES CARE, V2, pS103, DOI 10.2337/dc19-S010; Chen IY, 2020, NAT MED, V26, P16, DOI 10.1038/s41591-019-0649-2; Cheng CW, 2017, ANN INTERN MED, V167, P112, DOI [10.7326/M16-2977, 10.7326/IsTranslatedFrom_M17-2977_2, 10.7326/IsTranslatedFrom_M17-2977_1]; Choi KJ, 2018, RADIOLOGY, V289, P688, DOI 10.1148/radiol.2018180763; Collins GS, 2019, LANCET, V393, P1577, DOI 10.1016/S0140-6736(19)30037-6; CONSORT, EXT CONSORT STAT; De Fauw J, 2018, NAT MED, V24, P1342, DOI 10.1038/s41591-018-0107-6; Esteva A, 2017, NATURE, V542, P115, DOI 10.1038/nature21056; Expert Panel on Women's I, 2018, J AM COLL RADIOL, V15, pS365; Finlayson SG, 2019, SCIENCE, V363, P1287, DOI 10.1126/science.aaw4399; Fleuren LM, 2020, INTENS CARE MED, V46, P383, DOI 10.1007/s00134-019-05872-y; Gagnier JJ, 2006, ANN INTERN MED, V144, P364, DOI 10.7326/0003-4819-144-5-200603070-00013; Glasziou P, 2014, LANCET, V383, P267, DOI 10.1016/S0140-6736(13)62228-X; Gong DX, 2020, LANCET GASTROENTEROL, V5, P352, DOI 10.1016/S2468-1253(19)30413-3; Gregory J, 2020, J MAGN RESON IMAGING, V52, P248, DOI 10.1002/jmri.27035; Habli I., 2020, B WHO; He JX, 2019, NAT MED, V25, P30, DOI 10.1038/s41591-018-0307-0; Heaven D, 2019, NATURE, V574, P163, DOI 10.1038/d41586-019-03013-5; Hopewell S, 2008, LANCET, V371, P281, DOI 10.1016/S0140-6736(07)61835-2; International Medical Device Regulators Forum, 2019, UN DEV ID SYST UDI S; Juni P, 2001, BMJ-BRIT MED J, V323, P42, DOI 10.1136/bmj.323.7303.42; Kelly CJ, 2019, BMC MED, V17, DOI 10.1186/s12916-019-1426-2; Kiani A, 2020, NPJ DIGIT MED, V3, DOI 10.1038/s41746-020-0232-8; Kim H, 2020, RADIOLOGY, V296, P216, DOI 10.1148/radiol.2020192764; Labovitz DL, 2017, STROKE, V48, P1416, DOI 10.1161/STROKEAHA.116.016281; Lin HT, 2019, ECLINICALMEDICINE, V9, P52, DOI 10.1016/j.eclinm.2019.03.001; Liu XX, 2019, NAT MED, V25, P1467, DOI 10.1038/s41591-019-0603-3; Liu XX, 2019, LANCET, V394, P1225, DOI 10.1016/S0140-6736(19)31819-7; McKinney SM, 2020, NATURE, V577, P89, DOI 10.1038/s41586-019-1799-6; Moher D, 2001, JAMA-J AM MED ASSOC, V285, P1992, DOI 10.1001/jama.285.15.1992; Moher David, 2012, Int J Surg, V10, P28, DOI 10.1016/j.ijsu.2011.10.001; Nagendran M, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.m689; Nicolae A, 2017, INT J RADIAT ONCOL, V97, P822, DOI 10.1016/j.ijrobp.2016.11.036; Oakden-Rayner L., 2019, HIDDEN STRATIFICATIO; PETO R, 1995, J CLIN EPIDEMIOL, V48, P23, DOI 10.1016/0895-4356(94)00150-O; Pooch E., 2019, CAN WE TRUST DEEP LE, DOI [10.1007/978-3-030-62469-9_7, DOI 10.1007/978-3-030-62469-9_7]; SCHULZ KF, 1995, JAMA-J AM MED ASSOC, V273, P408, DOI 10.1001/jama.273.5.408; Sibbald B, 1998, BRIT MED J, V316, P201; Sounderajah V, 2020, NAT MED, V26, P807, DOI 10.1038/s41591-020-0941-1; Su JR, 2020, GASTROINTEST ENDOSC, V91, P415, DOI 10.1016/j.gie.2019.08.026; Sutton RT, 2020, NPJ DIGIT MED, V3, DOI 10.1038/s41746-020-0221-y; Talmon J, 2009, INT J MED INFORM, V78, P1, DOI 10.1016/j.ijmedinf.2008.09.002; The Lancet HIV, 2016, LANCET HIV, V3, pe191; Tyler NS, 2020, NAT METAB, V2, P612, DOI 10.1038/s42255-020-0212-y; Voss C, 2019, JAMA PEDIATR, V173, P446, DOI 10.1001/jamapediatrics.2019.0285; Wang P, 2020, LANCET GASTROENTEROL, V5, P343, DOI [10.1016/S2468-1253(19)30411-X, 10.1016/S2468-1253(19)30411-x]; Wang P, 2019, GUT, V68, P1813, DOI 10.1136/gutjnl-2018-317500; Wiens J, 2019, NAT MED, V25, P1337, DOI 10.1038/s41591-019-0548-6; Wijnberge M, 2020, JAMA-J AM MED ASSOC, V323, P1052, DOI 10.1001/jama.2020.0592; Wu LL, 2019, GUT, V68, P2161, DOI 10.1136/gutjnl-2018-317366; Yim J, 2020, NAT MED, V26, P892, DOI 10.1038/s41591-020-0867-7; Zech J. R., 2018, CONFOUNDING VARIABLE; Zou J, 2018, NATURE, V559, P324, DOI 10.1038/d41586-018-05707-8; 2019, LANCET DIGITAL HLTH, V1, pE271	63	173	178	11	55	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	SEP	2020	26	9					1364	1374		10.1038/s41591-020-1034-x	http://dx.doi.org/10.1038/s41591-020-1034-x			11	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	PF3EM	32908283	Green Published, hybrid			2022-12-27	WOS:000598942000021
J	Stower, H				Stower, Hannah			Paying it forward in sexual health	NATURE MEDICINE			English	Editorial Material												h.stower@us.nature.com							0	0	0	0	0	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	SEP	2020	26	9					1331	1331		10.1038/s41591-020-1064-4	http://dx.doi.org/10.1038/s41591-020-1064-4			1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	PF3EM	32908277				2022-12-27	WOS:000598942000011
J	Topol, EJ				Topol, Eric J.			Welcoming new guidelines for AI clinical research	NATURE MEDICINE			English	Editorial Material							DEEP; PERFORMANCE; SYSTEM	With only a limited number of clinical trials of artificial intelligence in medicine thus far, the first guidelines for protocols and reporting arrive at an opportune time. Better protocol design, along with consistent and complete data presentation, will greatly facilitate interpretation and validation of these trials, and will help the field to move forward.	[Topol, Eric J.] Scripps Res, Scripps Res Translat Inst, La Jolla, CA 92037 USA	Scripps Research Institute	Topol, EJ (corresponding author), Scripps Res, Scripps Res Translat Inst, La Jolla, CA 92037 USA.	etopol@scripps.edu		Topol, Eric/0000-0002-1478-4729				Abramoff MD, 2018, NPJ DIGIT MED, V1, DOI 10.1038/s41746-018-0040-6; Dascalu A, 2019, EBIOMEDICINE, V43, P107, DOI 10.1016/j.ebiom.2019.04.055; Esteva A, 2017, NATURE, V542, P115, DOI 10.1038/nature21056; Gong DX, 2020, LANCET GASTROENTEROL, V5, P352, DOI 10.1016/S2468-1253(19)30413-3; Gulshan V, 2019, JAMA OPHTHALMOL, V137, P987, DOI 10.1001/jamaophthalmol.2019.2004; Hollon TC, 2020, NAT MED, V26, P52, DOI 10.1038/s41591-019-0715-9; Kanagasingam Y, 2018, JAMA NETW OPEN, V1, DOI 10.1001/jamanetworkopen.2018.2665; Keane PA, 2018, NPJ DIGIT MED, V1, DOI 10.1038/s41746-018-0048-y; Lee H, 2019, NAT BIOMED ENG, V3, P173, DOI 10.1038/s41551-018-0324-9; Li CF, 2018, CANCER COMMUN, V38, DOI 10.1186/s40880-018-0325-9; Lin HT, 2019, ECLINICALMEDICINE, V9, P52, DOI 10.1016/j.eclinm.2019.03.001; Liu XX, 2020, NAT MED, V26, P1364, DOI 10.1038/s41591-020-1034-x; Liu XX, 2019, LANCET DIGIT HEALTH, V1, pE271, DOI 10.1016/S2589-7500(19)30123-2; Long EP, 2017, NAT BIOMED ENG, V1, DOI 10.1038/s41551-016-0024; Moher David, 2012, Int J Surg, V10, P28, DOI 10.1016/j.ijsu.2011.10.001; Mori Y, 2018, ANN INTERN MED, V169, P357, DOI 10.7326/M18-0249; Nagendran M, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.m689; Perez MV, 2019, NEW ENGL J MED, V381, P1909, DOI 10.1056/NEJMoa1901183; Phillips M, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2019.13436; Rivera SC, 2020, LANCET DIGIT HEALTH, V2, pE549, DOI [10.1038/s41591-020-1037-7, 10.1016/S2589-7500(20)30219-3, 10.1136/bmj.m3210]; Steiner DF, 2018, AM J SURG PATHOL, V42, P1636, DOI 10.1097/PAS.0000000000001151; Su JR, 2020, GASTROINTEST ENDOSC, V91, P415, DOI 10.1016/j.gie.2019.08.026; Topol EJ, 2019, NAT MED, V25, P44, DOI 10.1038/s41591-018-0300-7; Wang P, 2020, LANCET GASTROENTEROL, V5, P343, DOI [10.1016/S2468-1253(19)30411-X, 10.1016/S2468-1253(19)30411-x]; Wang P, 2019, GUT, V68, P1813, DOI 10.1136/gutjnl-2018-317500; Wijnberge M, 2020, JAMA-J AM MED ASSOC, V323, P1052, DOI 10.1001/jama.2020.0592; Wu LL, 2019, GUT, V68, P2161, DOI 10.1136/gutjnl-2018-317366	27	34	35	3	10	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	SEP	2020	26	9					1318	1320		10.1038/s41591-020-1042-x	http://dx.doi.org/10.1038/s41591-020-1042-x			3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	PF3EM	32908274				2022-12-27	WOS:000598942000006
J	Stower, H				Stower, Hannah			A bacterial substitute for a kidney	NATURE MEDICINE			English	Editorial Material												h.stower@us.nature.com							0	0	0	0	0	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	AUG	2020	26	8					1170	1170		10.1038/s41591-020-1027-9	http://dx.doi.org/10.1038/s41591-020-1027-9		AUG 2020	1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	MX8ZF	32770159	Bronze			2022-12-27	WOS:000557134700012
J	Sharma, T; Bashir, M				Sharma, Tanusree; Bashir, Masooda			Use of apps in the COVID-19 response and the loss of privacy protection	NATURE MEDICINE			English	Editorial Material								Mobile apps provide a convenient source of tracking and data collection to fight against the spread of COVID-19. We report our analysis of 50 COVID-19-related apps, including their use and their access to personally identifiable information, to ensure that the right to privacy and civil liberties are protected.	[Sharma, Tanusree] Univ Illinois, Illinois Informat Inst, Champaign, IL 61820 USA; [Bashir, Masooda] Univ Illinois, Sch Informat Sci, Champaign, IL 61820 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Sharma, T (corresponding author), Univ Illinois, Illinois Informat Inst, Champaign, IL 61820 USA.; Bashir, M (corresponding author), Univ Illinois, Sch Informat Sci, Champaign, IL 61820 USA.	tsharma6@illinois.edu; mnb@illinois.edu		Sharma, Tanusree/0000-0003-1523-163X				[Anonymous], 2020, THE ECONOMIST; Hart V., 2020, OUTPACING VIRUS DIGI; Kahn FS, 2002, LAW REV, V6, P1579; Singer N., NY TIMES; Ting DSW, 2020, NAT MED, V26, P459, DOI 10.1038/s41591-020-0824-5	5	47	48	2	23	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	AUG	2020	26	8					1165	1167		10.1038/s41591-020-0928-y	http://dx.doi.org/10.1038/s41591-020-0928-y			3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	MX8ZF	32457443	Green Published, Bronze			2022-12-27	WOS:000558006900008
J	Mckee, M; Stuckler, D				Mckee, Martin; Stuckler, David			If the world fails to protect the economy, COVID-19 will damage health not just now but also in the future	NATURE MEDICINE			English	Editorial Material							LIFE; ENGLAND; EUROPE		[Mckee, Martin] London Sch Hyg & Trop Med, Ctr Global Chron Condit, London, England; [Stuckler, David] Bocconi Univ, Dondena Ctr Res Social Dynam & Publ Policy, Milan, Italy	University of London; London School of Hygiene & Tropical Medicine; Bocconi University	Mckee, M (corresponding author), London Sch Hyg & Trop Med, Ctr Global Chron Condit, London, England.; Stuckler, D (corresponding author), Bocconi Univ, Dondena Ctr Res Social Dynam & Publ Policy, Milan, Italy.	martin.mckee@lshtm.ac.uk; david.stuckler@unibocconi.it	McKee, Martin/E-6673-2018	McKee, Martin/0000-0002-0121-9683; Stuckler, David/0000-0002-1288-8401				Alesina A., 2004, FIGHTING POVERTY US; [Anonymous], 2006, AM J PUBLIC HEALTH, V96, P2102, DOI 10.2105/AJPH.2005.078436; Badger Emily, 2020, NY TIMES; Bor J, 2017, AM J PUBLIC HEALTH, V107, P1560, DOI [10.2105/ajph.2017.303945, 10.2105/AJPH.2017.303945]; Calomiris C.W., 1994, 08982937 NAT BUR EC; Case A, 2017, BROOKINGS PAP ECO AC, P397; Cassidy J, 2013, NEW YORKER; Correia S, 2020, ELECT J, DOI DOI 10.2139/SSRN.3561560; Dayen D., 2020, AM PROSPECT; Enserink M, 2020, SCIENCE, V367, P1414, DOI 10.1126/science.367.6485.1414-b; Hiam L, 2018, J EPIDEMIOL COMMUN H, V72, P404, DOI 10.1136/jech-2017-210401; Ho JY, 2018, BMJ-BRIT MED J, V362, DOI 10.1136/bmj.k2562; Hobbes Thomas, 1968, LEVIATHAN; Kaufman A.C., 2020, HUFFPOST; Keynes John Maynard, 2018, GEN THEORY EMPLOYMEN; Klein Naomi, 2007, SHOCK DOCTRINE, P21; Koltai J, 2020, AM J PUBLIC HEALTH, V110, P401, DOI 10.2105/AJPH.2019.305488; Loopstra R, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h1775; Lupovitch H.N., 2009, JEWS JUDAISM WORLD H; Mance H., 2016, FINANCIAL TIMES; Mckee M, 2017, ARCH PUBLIC HEALTH, V75, DOI 10.1186/s13690-017-0183-y; Nordstrom Carolyn, 2004, SHADOWS WAR VIOLENCE, V10; Peckham R, 2013, ECON SOC, V42, P226, DOI 10.1080/03085147.2012.718626; Phillips Tom, 2020, GUARDIAN; Piketty T., 2014, CAPITAL 21 CENTURY; Proctor K., 2020, GUARDIAN; Rawls J., 2009, THEORY JUSTICE; Rawnsley A., 2020, GUARDIAN; Reeves A, 2014, BRIT J PSYCHIAT, V205, P246, DOI 10.1192/bjp.bp.114.144766; Reeves A, 2014, HEALTH POLICY, V115, P1, DOI 10.1016/j.healthpol.2013.11.008; Reinicke C., 2020, MARKETS INSIDER; Stuckler D, 2009, LANCET, V374, P315, DOI 10.1016/S0140-6736(09)61124-7	32	271	276	3	30	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	MAY	2020	26	5					640	642		10.1038/s41591-020-0863-y	http://dx.doi.org/10.1038/s41591-020-0863-y			3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	ML1JP	32273610	Bronze			2022-12-27	WOS:000549231500006
J	Stower, H				Stower, Hannah			Virological assessment of SARS-CoV-2	NATURE MEDICINE			English	Editorial Material																			0	2	2	0	1	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	APR	2020	26	4					465	465		10.1038/s41591-020-0848-x	http://dx.doi.org/10.1038/s41591-020-0848-x			1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	QH1UE	32273607	Bronze			2022-12-27	WOS:000618061900014
J	Stower, H				Stower, Hannah			Lack of maternal-fetal SARS-CoV-2 transmission	NATURE MEDICINE			English	Editorial Material												h.stower@us.nature.com							0	5	6	0	9	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	MAR	2020	26	3					312	312		10.1038/s41591-020-0810-y	http://dx.doi.org/10.1038/s41591-020-0810-y			1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	KU0MC	32161408	Green Published, Bronze			2022-12-27	WOS:000519405000012
J	Stower, H				Stower, Hannah			IMMUNOTHERAPY A new generation of immunotherapy	NATURE MEDICINE			English	Editorial Material																			0	0	0	3	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	2019	25	12					1798	1799		10.1038/s41591-019-0684-z	http://dx.doi.org/10.1038/s41591-019-0684-z			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	JT2KO	31806898				2022-12-27	WOS:000500824900006
J	Yelin, I; Flett, KB; Merakou, C; Mehrotra, P; Stam, J; Snesrud, E; Hinkle, M; Lesho, E; McGann, P; McAdam, AJ; Sandora, TJ; Kishony, R; Priebe, GP				Yelin, Idan; Flett, Kelly B.; Merakou, Christina; Mehrotra, Preeti; Stam, Jason; Snesrud, Erik; Hinkle, Mary; Lesho, Emil; McGann, Patrick; McAdam, Alexander J.; Sandora, Thomas J.; Kishony, Roy; Priebe, Gregory P.			Genomic and epidemiological evidence of bacterial transmission from probiotic capsule to blood in ICU patients	NATURE MEDICINE			English	Article							LACTOBACILLUS-RHAMNOSUS GG; VENTILATOR-ASSOCIATED PNEUMONIA; PEDIATRIC INTENSIVE-CARE; PSEUDOMONAS-AERUGINOSA; STREAM INFECTION; CRITICALLY-ILL; RPOB MUTATIONS; BACTEREMIA; RESISTANCE; IMPACT	Probiotics are routinely administered to hospitalized patients for many potential indications(1) but have been associated with adverse effects that may outweigh their potential benefits(2-7). It is particularly alarming that probiotic strains can cause bacteremia(8,9), yet direct evidence for an ancestral link between blood isolates and administered probiotics is lacking. Here we report a markedly higher risk of Lactobacillus bacteremia for intensive care unit (ICU) patients treated with probiotics compared to those not treated, and provide genomics data that support the idea of direct clonal transmission of probiotics to the bloodstream. Whole-genome-based phylogeny showed that Lactobacilli isolated from treated patients' blood were phylogenetically inseparable from Lactobacilli isolated from the associated probiotic product. Indeed, the minute genetic diversity among the blood isolates mostly mirrored pre-existing genetic heterogeneity found in the probiotic product. Some blood isolates also contained de novo mutations, including a non-synonymous SNP conferring antibiotic resistance in one patient. Our findings support that probiotic strains can directly cause bacteremia and adaptively evolve within ICU patients.	[Yelin, Idan; Kishony, Roy] Technion Israel Inst Technol, Dept Biol, Haifa, Israel; [Flett, Kelly B.; Mehrotra, Preeti; McAdam, Alexander J.; Sandora, Thomas J.; Priebe, Gregory P.] Boston Childrens Hosp, Div Infect Dis, Dept Pediat, Boston, MA 02115 USA; [Flett, Kelly B.; Merakou, Christina; McAdam, Alexander J.; Sandora, Thomas J.; Priebe, Gregory P.] Harvard Med Sch, Boston, MA 02115 USA; [Merakou, Christina; Priebe, Gregory P.] Boston Childrens Hosp, Div Crit Care Med, Dept Anesthesiol Crit Care & Pain Med, Boston, MA 02115 USA; [Mehrotra, Preeti] Beth Israel Deaconess Med Ctr, Div Infect Dis, Boston, MA 02215 USA; [Stam, Jason; Snesrud, Erik; Hinkle, Mary; Lesho, Emil; McGann, Patrick] Walter Reed Army Inst Res, Silver Spring, MD USA; [McAdam, Alexander J.] Boston Childrens Hosp, Dept Lab Med, Boston, MA USA; [Kishony, Roy] Technion Israel Inst Technol, Dept Comp Sci, Haifa, Israel; [Flett, Kelly B.] Novant Hlth Eastover Pediat, Charlotte, NC USA	Technion Israel Institute of Technology; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard University; Beth Israel Deaconess Medical Center; United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); Harvard University; Boston Children's Hospital; Technion Israel Institute of Technology	Kishony, R (corresponding author), Technion Israel Inst Technol, Dept Biol, Haifa, Israel.; Sandora, TJ; Priebe, GP (corresponding author), Boston Childrens Hosp, Div Infect Dis, Dept Pediat, Boston, MA 02115 USA.; Sandora, TJ; Priebe, GP (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.; Priebe, GP (corresponding author), Boston Childrens Hosp, Div Crit Care Med, Dept Anesthesiol Crit Care & Pain Med, Boston, MA 02115 USA.; Kishony, R (corresponding author), Technion Israel Inst Technol, Dept Comp Sci, Haifa, Israel.	thomas.sandora@childrens.harvard.edu; rkishony@technion.ac.il; gregory.priebe@childrens.harvard.edu	Priebe, Gregory/AAG-4027-2021	Priebe, Gregory/0000-0001-9831-0354; Merakou, Christina/0000-0002-2098-599X; Yelin, Idan/0000-0003-2515-4113; Mc Gann, Patrick/0000-0003-1548-9438	Richard A. and Susan F. Smith President's Innovation Award; Department of Anesthesiology, Critical Care and Pain Medicine at Boston Children's Hospital; US National Institutes of Health [R01 GM081617]; Ernest and Bonnie Beutler Research Program of Excellence in Genomic Medicine; European Research Council FP7 ERC [281891]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081617] Funding Source: NIH RePORTER	Richard A. and Susan F. Smith President's Innovation Award; Department of Anesthesiology, Critical Care and Pain Medicine at Boston Children's Hospital; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ernest and Bonnie Beutler Research Program of Excellence in Genomic Medicine; European Research Council FP7 ERC; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank T. Moniz who provided the probiotic administration data; J. Kinlay and P. Scanlon who noted the pattern of cases; A. Mello, who provided epidemiological data, and R. Marshall and E. Derderian, who performed strain analysis and antibiotic susceptibility testing on the clinical isolates. This work was funded in part by the Richard A. and Susan F. Smith President's Innovation Award (to G.P.P.) and by funds for the Translational Research for Infection Prevention in Pediatric Anesthesia and Critical Care (TRIPPACC) Program of the Department of Anesthesiology, Critical Care and Pain Medicine at Boston Children's Hospital (to G.P.P.), US National Institutes of Health grant R01 GM081617 (to R.K.), The Ernest and Bonnie Beutler Research Program of Excellence in Genomic Medicine (to R.K.), and European Research Council FP7 ERC grant 281891 (to R.K.).	Barraud D, 2013, CHEST, V143, P646, DOI 10.1378/chest.12-1745; Barraud D, 2010, INTENS CARE MED, V36, P1540, DOI 10.1007/s00134-010-1927-0; Baym M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128036; Cai XC, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00178; Campbell EA, 2005, EMBO J, V24, P674, DOI 10.1038/sj.emboj.7600499; Chung H, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14078; CLSI, 2020, PERF STAND ANT SUSC, V40; De Groote MA, 2005, PEDIATR INFECT DIS J, V24, P278, DOI 10.1097/01.inf.0000154588.79356.e6; Enne VI, 2004, J ANTIMICROB CHEMOTH, V53, P203, DOI 10.1093/jac/dkh044; Ghouri YA, 2014, CLIN EXP GASTROENTER, V7, P473, DOI 10.2147/CEG.S27530; Gouriet F, 2012, EUR J CLIN MICROBIOL, V31, P2469, DOI 10.1007/s10096-012-1599-5; Gu WJ, 2012, CHEST, V142, P859, DOI 10.1378/chest.12-0679; Honeycutt TCB, 2007, PEDIATR CRIT CARE ME, V8, P452, DOI 10.1097/01.PCC.0000282176.41134.E6; Hua XT, 2016, JUNDISHAPUR J MICROB, V9, DOI 10.5812/jjm.37322; Kunz AN, 2004, J PEDIATR GASTR NUTR, V38, P457, DOI 10.1097/00005176-200404000-00017; Lebeer S, 2008, MICROBIOL MOL BIOL R, V72, P728, DOI 10.1128/MMBR.00017-08; Lebeer S, 2007, APPL ENVIRON MICROB, V73, P6768, DOI 10.1128/AEM.01393-07; Lebeer S, 2012, APPL ENVIRON MICROB, V78, P185, DOI 10.1128/AEM.06192-11; LeDoux D, 2006, INT J STD AIDS, V17, P280, DOI 10.1258/095646206776253507; Lieberman TD, 2016, NAT MED, V22, P1470, DOI 10.1038/nm.4205; Lieberman TD, 2011, NAT GENET, V43, P1275, DOI 10.1038/ng.997; Lolis N, 2008, CRIT CARE, V12, DOI 10.1186/cc6843; Mariam DH, 2004, ANTIMICROB AGENTS CH, V48, P1289, DOI 10.1128/AAC.48.4.1289-1294.2004; Oudhuis GJ, 2011, CURR OPIN CRIT CARE, V17, P487, DOI 10.1097/MCC.0b013e32834a4bab; Priebe GP, 2004, INFECT IMMUN, V72, P4224, DOI 10.1128/IAI.72.7.4224-4232.2004; Salminen MK, 2004, CLIN INFECT DIS, V38, P62, DOI 10.1086/380455; Salminen MK, 2002, CLIN INFECT DIS, V35, P1155, DOI 10.1086/342912; See I, 2013, INFECT CONT HOSP EP, V34, P769, DOI 10.1086/671281; Siempos II, 2010, CRIT CARE MED, V38, P954, DOI 10.1097/CCM.0b013e3181c8fe4b; Smith EE, 2006, P NATL ACAD SCI USA, V103, P8487, DOI 10.1073/pnas.0602138103; Suez J, 2018, CELL, V174, P1406, DOI 10.1016/j.cell.2018.08.047; Szajewska H, 2016, ARCH DIS CHILD, V101, P398, DOI 10.1136/archdischild-2015-308656; Theodorakopoulou M, 2013, INT J ANTIMICROB AG, V42, pS41, DOI 10.1016/j.ijantimicag.2013.04.010; Thomas DW, 2010, PEDIATRICS, V126, P1217, DOI 10.1542/peds.2010-2548; Watanabe Y, 2011, J CLIN MICROBIOL, V49, P2680, DOI 10.1128/JCM.02144-10; Wi YM, 2018, INT J ANTIMICROB AG, V51, P670, DOI 10.1016/j.ijantimicag.2017.12.019; Wylie MC, 2010, INFECT CONT HOSP EP, V31, P1049, DOI 10.1086/656246; Xu M, 2005, J BACTERIOL, V187, P2783, DOI 10.1128/JB.187.8.2783-2792.2005; Yi SH, 2016, AM J INFECT CONTROL, V44, P548, DOI 10.1016/j.ajic.2015.12.001; Zhang GQ, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000002581; Zmora N, 2018, CELL, V174, P1388, DOI 10.1016/j.cell.2018.08.041	41	104	106	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2019	25	11					1728	+		10.1038/s41591-019-0626-9	http://dx.doi.org/10.1038/s41591-019-0626-9			14	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	JT2KI	31700189	Green Accepted, Bronze			2022-12-27	WOS:000500824300031
J	Stower, H				Stower, Hannah			Immunotherapy for heart injury	NATURE MEDICINE			English	Editorial Material																			0	0	0	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	OCT	2019	25	10					1469	1469		10.1038/s41591-019-0615-z	http://dx.doi.org/10.1038/s41591-019-0615-z			1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	JC3GJ	31591584	Bronze			2022-12-27	WOS:000489166700008
J	Stower, H				Stower, Hannah			Skin test for Parkinson's disease	NATURE MEDICINE			English	Editorial Material												h.stower@us.nature.com							0	0	0	0	2	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2020	26	11					1677	1677		10.1038/s41591-020-1135-6	http://dx.doi.org/10.1038/s41591-020-1135-6		NOV 2020	1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	OT0SR	33154586				2022-12-27	WOS:000587145800001
J	Martinez, OM; Bridges, ND; Goldmuntz, E; Pascual, V				Martinez, Olivia M.; Bridges, Nancy D.; Goldmuntz, Ellen; Pascual, Virginia			The immune roadmap for understanding multi-system inflammatory syndrome in children: opportunities and challenges	NATURE MEDICINE			English	Editorial Material								In the spring of 2020, a series of reports from Europe and the USA described clusters of children and adolescents presenting with a life-threatening, hyperinflammatory syndrome - called 'multi-system inflammatory syndrome in children' (MIS-C) - that was seemingly linked to prior exposure to the coronavirus SARS-CoV-2. In June 2020, the US National Institutes of Health convened a workshop of immunologists and clinicians to discuss emerging knowledge and identify key questions surrounding MIS-C, with a focus on innate and adaptive immunity, genetics and epigenetics. This Meeting Report describes the main findings from the workshop.	[Martinez, Olivia M.] Stanford Univ, Sch Med, Dept Surg & Stanford Immunol, Stanford, CA 94305 USA; [Bridges, Nancy D.; Goldmuntz, Ellen] NIAID, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Pascual, Virginia] Weill Cornell Med, Drukier Inst Childrens Hlth, New York, NY 10065 USA; [Pascual, Virginia] Weill Cornell Med, Dept Pediat, New York, NY 10065 USA	Stanford University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Cornell University; Cornell University	Martinez, OM (corresponding author), Stanford Univ, Sch Med, Dept Surg & Stanford Immunol, Stanford, CA 94305 USA.; Pascual, V (corresponding author), Weill Cornell Med, Drukier Inst Childrens Hlth, New York, NY 10065 USA.; Pascual, V (corresponding author), Weill Cornell Med, Dept Pediat, New York, NY 10065 USA.	omm@stanford.edu; vip2021@med.cornell.edu		, Olivia/0000-0002-2798-0251				Anthony RM, 2008, SCIENCE, V320, P373, DOI 10.1126/science.1154315; Arvin AM, 2020, NATURE, V584, P353, DOI 10.1038/s41586-020-2538-8; Bournazos S, 2017, ANNU REV IMMUNOL, V35, P285, DOI 10.1146/annurev-immunol-051116-052433; Chakraborty S, 2020, SYMPTOMATIC SARS COV, P52581, DOI [10.1101/2020.05.15.20103341v1, 10.1101/2020.05.15.20103341]; Cheng Mary Hongying, 2020, bioRxiv, DOI 10.1101/2020.05.21.109272; Dufort EM, 2020, NEW ENGL J MED, V383, P347, DOI 10.1056/NEJMoa2021756; El-Behi M, 2011, NAT IMMUNOL, V12, P568, DOI 10.1038/ni.2031; Feldstein LR, 2020, NEW ENGL J MED, V383, P334, DOI 10.1056/NEJMoa2021680; Glanville J, 2017, NATURE, V547, P94, DOI 10.1038/nature22976; Grifoni A, 2020, CELL, V181, P1489, DOI 10.1016/j.cell.2020.05.015; Gruber Conor N, 2020, Cell, V183, P982, DOI [10.1101/2020.07.04.20142752, 10.1016/j.cell.2020.09.034]; Guthmiller Jenna J, 2020, bioRxiv, DOI 10.1101/2020.09.12.294066; Henderson LA, 2020, ARTHRITIS RHEUMATOL, V72, P1059, DOI 10.1002/art.41285; Huang H, 2020, NAT BIOTECHNOL, V38, P1194, DOI 10.1038/s41587-020-0505-4; Iwasaki A, 2020, NAT REV IMMUNOL, V20, P339, DOI 10.1038/s41577-020-0321-6; Jenks SA, 2018, IMMUNITY, V49, P725, DOI 10.1016/j.immuni.2018.08.015; Kaushik S, 2020, J PEDIATR-US, V224, P24, DOI 10.1016/j.jpeds.2020.06.045; Long QX, 2020, NAT MED, V26, P1200, DOI 10.1038/s41591-020-0965-6; Lucas C, 2020, NATURE, V584, P463, DOI 10.1038/s41586-020-2588-y; Mateus J, 2020, SCIENCE, V370, P89, DOI 10.1126/science.abd3871; Mathew D, 2020, SCIENCE, V369, P1209, DOI 10.1126/science.abc8511; Nielsen SCA, 2020, CELL HOST MICROBE, V28, P516, DOI 10.1016/j.chom.2020.09.002; Riphagen Shelley, 2020, Lancet, V395, P1607, DOI 10.1016/S0140-6736(20)31094-1; Stock AT, 2016, J EXP MED, V213, P1983, DOI 10.1084/jem.20151853; Teuwen LA, 2020, NAT REV IMMUNOL, V20, P389, DOI 10.1038/s41577-020-0343-0; Toubiana J, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m2094; Trapnell BC, 2002, ANNU REV PHYSIOL, V64, P775, DOI 10.1146/annurev.physiol.64.090601.113847; Ulrich H, 2020, CYTOM PART A, V97, P662, DOI 10.1002/cyto.a.24047; Verdoni L, 2020, LANCET, V395, P1771, DOI 10.1016/S0140-6736(20)31103-X; Weisberg Stuart P, 2020, medRxiv, DOI 10.1101/2020.07.12.20151068; Woodruff MC, 2020, NAT IMMUNOL, V21, P1506, DOI 10.1038/s41590-020-00814-z; Yuan M, 2020, SCIENCE, V369, P1119, DOI 10.1126/science.abd2321; Zheng M, 2020, J BIOL CHEM, V295, P14040, DOI 10.1074/jbc.RA120.015036	33	22	23	3	4	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	2020	26	12					1819	1824		10.1038/s41591-020-1140-9	http://dx.doi.org/10.1038/s41591-020-1140-9		NOV 2020	6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	PB8QO	33139949	Bronze			2022-12-27	WOS:000584339200002
J	Adigbli, G				Adigbli, George			Race, science and (im)precision medicine	NATURE MEDICINE			English	Editorial Material							VAGINAL BIRTH; PREDICTION; ETHNICITY; COHORT; HEALTH	The limitations of using race in biomedicine are important to recognize because race is often afforded more biological value than can be scientifically justified - and less social value than it commands.	[Adigbli, George] Univ Oxford, Nuffield Dept Surg Sci, Transplantat Res & Immunol Grp, Oxford, England	University of Oxford	Adigbli, G (corresponding author), Univ Oxford, Nuffield Dept Surg Sci, Transplantat Res & Immunol Grp, Oxford, England.	george.adigbli@nhs.net		Adigbli, George/0000-0003-3790-927X				Attanasio LB, 2019, J WOMENS HEALTH, V28, P1302, DOI 10.1089/jwh.2018.7270; Bentley AR, 2020, NPJ GENOM MED, V5, DOI 10.1038/s41525-019-0111-x; Collins FS, 2004, NAT GENET, V36, pS13, DOI 10.1038/ng1436; Costa DL, 2018, P NATL ACAD SCI USA, V115, P11215, DOI 10.1073/pnas.1803630115; Delanaye P, 2011, CLIN J AM SOC NEPHRO, V6, P906, DOI 10.2215/CJN.10931210; Duncan L, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11112-0; Gianfrancesco MA, 2018, JAMA INTERN MED, V178, P1544, DOI 10.1001/jamainternmed.2018.3763; Grobman WA, 2007, OBSTET GYNECOL, V109, P806, DOI 10.1097/01.AOG.0000259312.36053.02; Joyner MJ, 2019, J CLIN INVEST, V129, P946, DOI 10.1172/JCI126119; Kalewold KH, 2020, BIOL PHILOS, V35, DOI 10.1007/s10539-020-09759-x; Knight HE, 2014, BJOG-INT J OBSTET GY, V121, P183, DOI 10.1111/1471-0528.12508; Manrai AK, 2016, NEW ENGL J MED, V375, P655, DOI 10.1056/NEJMsa1507092; Marigorta UM, 2018, TRENDS GENET, V34, P504, DOI 10.1016/j.tig.2018.03.005; McDade TW, 2019, AM J PHYS ANTHROPOL, V169, P3, DOI 10.1002/ajpa.23800; Murphy SA, 2019, JAMA CARDIOL, V4, P613, DOI 10.1001/jamacardio.2019.0886; Oh SS, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001918; Rutherford A., 2020, ARGUE RACIST WHAT OU; Saini A., 2019, SUPERIOR RETURN RACE; Sehgal AR, 2020, ANN INTERN MED, V173, P1008, DOI 10.7326/M20-4951; Sheffet AJ, 2018, STROKE, V49, P84, DOI 10.1161/STROKEAHA.117.018063; Snyder-Mackler N, 2020, SCIENCE, V368, P843, DOI 10.1126/science.aax9553; Tillin T, 2014, HEART, V100, P60, DOI 10.1136/heartjnl-2013-304474; Udler MS, 2015, J AM SOC NEPHROL, V26, P1682, DOI 10.1681/ASN.2014050474; Vyas DA, 2020, NEW ENGL J MED, V383, P874, DOI 10.1056/NEJMms2004740; Wang C, 2019, BRIT J CLIN PHARMACO, V85, P114, DOI 10.1111/bcp.13767; Witherspoon DJ, 2007, GENETICS, V176, P351, DOI 10.1534/genetics.106.067355; Zuk O, 2012, P NATL ACAD SCI USA, V109, P1193, DOI 10.1073/pnas.1119675109	27	7	7	4	8	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2020	26	11					1675	1676		10.1038/s41591-020-1115-x	http://dx.doi.org/10.1038/s41591-020-1115-x		OCT 2020	2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	OT0SR	33093683				2022-12-27	WOS:000582377100001
J	Dukes, A				Dukes, Angeline			How to better support Black trainees in the biomedical sciences	NATURE MEDICINE			English	Editorial Material								The relentless violence against Black people takes an overwhelming emotional toll on Black trainees. In those we continue to lose, we see our families, our friends and our own lives being taken.	[Dukes, Angeline] Univ Calif Irvine, Interdept Neurosci Program, Irvine, CA 92697 USA	University of California System; University of California Irvine	Dukes, A (corresponding author), Univ Calif Irvine, Interdept Neurosci Program, Irvine, CA 92697 USA.	aeugene@uci.edu		Dukes, Angeline/0000-0001-7025-5947					0	3	3	0	2	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2020	26	11					1674	1674		10.1038/s41591-020-1101-3	http://dx.doi.org/10.1038/s41591-020-1101-3		OCT 2020	1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	OT0SR	33060851	Bronze			2022-12-27	WOS:000577964800002
J	Riggare, S				Riggare, Sara			Patient researchers - the missing link?	NATURE MEDICINE			English	Editorial Material									[Riggare, Sara] Uppsala Univ, Dept Womens & Childrens Hlth, Uppsala, Sweden	Uppsala University	Riggare, S (corresponding author), Uppsala Univ, Dept Womens & Childrens Hlth, Uppsala, Sweden.	sara@riggare.se		Riggare, Sara/0000-0002-2256-7310				Levitan B, 2018, THER INNOV REGUL SCI, V52, P220, DOI 10.1177/2168479017716715	1	10	10	0	0	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	OCT	2020	26	10					1507	1507		10.1038/s41591-020-1080-4	http://dx.doi.org/10.1038/s41591-020-1080-4			1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	NX8MD	33029015				2022-12-27	WOS:000575957200006
J	Stower, H				Stower, Hannah			The influence of sex on the transcriptome	NATURE MEDICINE			English	Editorial Material																			0	0	0	0	0	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	OCT	2020	26	10					1512	1512		10.1038/s41591-020-1107-x	http://dx.doi.org/10.1038/s41591-020-1107-x			1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	QH1TN	33029021				2022-12-27	WOS:000618059800002
J	Tostanoski, LH; Wegmann, F; Martinot, AJ; Loos, C; McMahan, K; Mercado, NB; Yu, JY; Chan, CN; Bondoc, S; Starke, CE; Nekorchuk, M; Busman-Sahay, K; Piedra-Mora, C; Wrijil, LM; Ducat, S; Custers, J; Atyeo, C; Fischinger, S; Burke, JS; Feldman, J; Hauser, BM; Caradonna, TM; Bondzie, EA; Dagotto, G; Gebre, MS; Jacob-Dolan, C; Lin, ZJ; Mahrokhian, SH; Nampanya, F; Nityanandam, R; Pessaint, L; Porto, M; Ali, V; Benetiene, D; Tevi, K; Andersen, H; Lewis, MG; Schmidt, AG; Lauffenburger, DA; Alter, G; Estes, JD; Schuitemaker, H; Zahn, R; Barouch, DH				Tostanoski, Lisa H.; Wegmann, Frank; Martinot, Amanda J.; Loos, Carolin; McMahan, Katherine; Mercado, Noe B.; Yu, Jingyou; Chan, Chi N.; Bondoc, Stephen; Starke, Carly E.; Nekorchuk, Michael; Busman-Sahay, Kathleen; Piedra-Mora, Cesar; Wrijil, Linda M.; Ducat, Sarah; Custers, Jerome; Atyeo, Caroline; Fischinger, Stephanie; Burke, John S.; Feldman, Jared; Hauser, Blake M.; Caradonna, Timothy M.; Bondzie, Esther A.; Dagotto, Gabriel; Gebre, Makda S.; Jacob-Dolan, Catherine; Lin, Zijin; Mahrokhian, Shant H.; Nampanya, Felix; Nityanandam, Ramya; Pessaint, Laurent; Porto, Maciel; Ali, Vaneesha; Benetiene, Dalia; Tevi, Komlan; Andersen, Hanne; Lewis, Mark G.; Schmidt, Aaron G.; Lauffenburger, Douglas A.; Alter, Galit; Estes, Jacob D.; Schuitemaker, Hanneke; Zahn, Roland; Barouch, Dan H.			Ad26 vaccine protects against SARS-CoV-2 severe clinical disease in hamsters	NATURE MEDICINE			English	Article							INFECTION; TRANSMISSION; IMMUNITY; SARS	Coronavirus disease 2019 (COVID-19) in humans is often a clinically mild illness, but some individuals develop severe pneumonia, respiratory failure and death(1-4). Studies of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in hamsters(5-7)and nonhuman primates(8-10)have generally reported mild clinical disease, and preclinical SARS-CoV-2 vaccine studies have demonstrated reduction of viral replication in the upper and lower respiratory tracts in nonhuman primates(11-13). Here we show that high-dose intranasal SARS-CoV-2 infection in hamsters results in severe clinical disease, including high levels of virus replication in tissues, extensive pneumonia, weight loss and mortality in a subset of animals. A single immunization with an adenovirus serotype 26 vector-based vaccine expressing a stabilized SARS-CoV-2 spike protein elicited binding and neutralizing antibody responses and protected against SARS-CoV-2-induced weight loss, pneumonia and mortality. These data demonstrate vaccine protection against SARS-CoV-2 clinical disease. This model should prove useful for preclinical studies of SARS-CoV-2 vaccines, therapeutics and pathogenesis. A single immunization with an adenovirus vector-based vaccine expressing a stabilized SARS-CoV-2 spike protein induces protection against SARS-CoV-2-induced weight loss, pneumonia and mortality in hamsters.	[Tostanoski, Lisa H.; Martinot, Amanda J.; McMahan, Katherine; Mercado, Noe B.; Yu, Jingyou; Piedra-Mora, Cesar; Bondzie, Esther A.; Dagotto, Gabriel; Gebre, Makda S.; Jacob-Dolan, Catherine; Lin, Zijin; Mahrokhian, Shant H.; Nampanya, Felix; Nityanandam, Ramya; Barouch, Dan H.] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Ctr Virol & Vaccine Res, Boston, MA 02115 USA; [Wegmann, Frank; Custers, Jerome; Schuitemaker, Hanneke; Zahn, Roland] Janssen Vaccines & Prevent BV, Leiden, Netherlands; [Martinot, Amanda J.; Piedra-Mora, Cesar; Wrijil, Linda M.; Ducat, Sarah] Tufts Univ, Cummings Sch Vet Med, 200 Westboro Rd, North Grafton, MA 01536 USA; [Loos, Carolin; Atyeo, Caroline; Fischinger, Stephanie; Burke, John S.; Feldman, Jared; Hauser, Blake M.; Caradonna, Timothy M.; Schmidt, Aaron G.; Alter, Galit; Barouch, Dan H.] Ragon Inst MGH MIT & Harvard, Cambridge, MA 02139 USA; [Loos, Carolin; Lauffenburger, Douglas A.] MIT, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Chan, Chi N.; Bondoc, Stephen; Starke, Carly E.; Nekorchuk, Michael; Busman-Sahay, Kathleen; Estes, Jacob D.] Oregon Hlth & Sci Univ, Beaverton, OR USA; [Atyeo, Caroline; Fischinger, Stephanie; Feldman, Jared; Hauser, Blake M.; Caradonna, Timothy M.; Dagotto, Gabriel; Gebre, Makda S.; Jacob-Dolan, Catherine; Schmidt, Aaron G.; Barouch, Dan H.] Harvard Med Sch, Boston, MA 02115 USA; [Pessaint, Laurent; Porto, Maciel; Ali, Vaneesha; Benetiene, Dalia; Tevi, Komlan; Andersen, Hanne; Lewis, Mark G.] Bioqual, Rockville, MD USA; [Schmidt, Aaron G.; Alter, Galit; Barouch, Dan H.] Massachusetts Consortium Pathogen Readiness, Boston, MA 02115 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Tufts University; Harvard University; Harvard Medical School; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute; Massachusetts Institute of Technology (MIT); Oregon Health & Science University; Harvard University; Harvard Medical School; BIOQUAL Inc.	Barouch, DH (corresponding author), Harvard Med Sch, Beth Israel Deaconess Med Ctr, Ctr Virol & Vaccine Res, Boston, MA 02115 USA.; Barouch, DH (corresponding author), Ragon Inst MGH MIT & Harvard, Cambridge, MA 02139 USA.; Barouch, DH (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.; Barouch, DH (corresponding author), Massachusetts Consortium Pathogen Readiness, Boston, MA 02115 USA.	dbarouch@bidmc.harvard.edu	Chan, Chi Ngai/GON-5574-2022; Zahn, Roland/ABE-8779-2021; Mercado, Noe/ABE-8247-2020	Chan, Chi Ngai/0000-0001-9106-9481; Hauser, Blake/0000-0002-0100-1684; Lin, Zijin/0000-0002-6706-5410; Martinot, Amanda/0000-0001-6237-6191; Tostanoski, Lisa/0000-0001-9255-5684; Starke, Carly Elizabeth/0000-0002-9548-9368; Caradonna, Timothy/0000-0001-7138-4441; Piedra-Mora, Cesar/0000-0003-1146-7717; Gebre, Makda/0000-0001-8520-2178; Elyard, Hanne/0000-0003-1103-9608; Mercado, Noe/0000-0001-7769-7326; Ducat, Sarah/0000-0002-5285-7642; Nampanya, Felix/0000-0003-4102-1265; Wegmann, Frank/0000-0002-9821-1492; Jacob-Dolan, Catherine/0000-0001-6641-0342; Mahrokhian, Shant/0000-0003-4094-8739	Bill & Melinda Gates Foundation [INV-006131]; Janssen Vaccines Prevention BV; Ragon Institute of MGH, MIT and Harvard; Mark and Lisa Schwartz Foundation; Massachusetts Consortium on Pathogen Readiness; National Institutes of Health [OD024917, AI129797, AI124377, AI128751, AI126603, AI007387, AI146779, AI135098, OD011092, OD025002]; Department of Health and Human Services Biomedical Advanced Research and Development Authority [HHS0100201700018C]; Emergent Ventures, Mercatus Center at George Mason University	Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); Janssen Vaccines Prevention BV; Ragon Institute of MGH, MIT and Harvard; Mark and Lisa Schwartz Foundation; Massachusetts Consortium on Pathogen Readiness; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Health and Human Services Biomedical Advanced Research and Development Authority; Emergent Ventures, Mercatus Center at George Mason University	We thank J. van Hoof, M. Mammon, P. Stoffels, D. van Manen, T. Kwaks, K. Bauer, N. Callaham, L. Mistretta, A. Thomas, A. Chandrashekar, L. Peter, L. Maxfield, M. Lifton, E. Borducchi, M. Silva, A. Richardson and C. Caron for generous advice, assistance and reagents. We acknowledge support from the Bill & Melinda Gates Foundation (INV-006131), Janssen Vaccines & Prevention BV, the Ragon Institute of MGH, MIT and Harvard, the Mark and Lisa Schwartz Foundation, the Massachusetts Consortium on Pathogen Readiness and the National Institutes of Health (OD024917, AI129797, AI124377, AI128751, AI126603 to D.H.B.; AI007387 to L.H.T.; AI146779 to A.G.S.; AI135098 to A.J.M.; and OD011092, OD025002 to J.D.E.). This project was funded, in part, by the Department of Health and Human Services Biomedical Advanced Research and Development Authority under contract HHS0100201700018C. We also acknowledge a Fast Grant, Emergent Ventures, Mercatus Center at George Mason University to A.J.M.	Abbink P, 2007, J VIROL, V81, P4654, DOI 10.1128/JVI.02696-06; Bao LN, 2020, NATURE, V583, P830, DOI 10.1038/s41586-020-2312-y; Blanco-Melo D, 2020, CELL, V181, P1036, DOI 10.1016/j.cell.2020.04.026; Chan JFW, 2020, CLIN INFECT DIS, V71, P2428, DOI 10.1093/cid/ciaa325; Chandrashekar A, 2020, SCIENCE, V369, P812, DOI 10.1126/science.abc4776; Chen NS, 2020, LANCET, V395, P507, DOI 10.1016/S0140-6736(20)30211-7; Chung AW, 2015, CELL, V163, P988, DOI 10.1016/j.cell.2015.10.027; Gao Q, 2020, SCIENCE, V369, P77, DOI 10.1126/science.abc1932; Guan W, 2020, NEW ENGL J MED, V382, P1708, DOI 10.1056/NEJMoa2002032; Imai M, 2020, P NATL ACAD SCI USA, V117, P16587, DOI 10.1073/pnas.2009799117; Kim YI, 2020, CELL HOST MICROBE, V27, P704, DOI 10.1016/j.chom.2020.03.023; Li Q., 2020, NEW ENGL J MED, V382, P1199; Mercado NB, 2020, NATURE, V586, P583, DOI 10.1038/s41586-020-2607-z; Munster VJ, 2020, NATURE, V585, P268, DOI [10.1038/s41586-020-2324-7, 10.1101/2020.03.21.001628]; Netland J, 2008, J VIROL, V82, P7264, DOI 10.1128/JVI.00737-08; Rockx B, 2020, SCIENCE, V368, P1012, DOI 10.1126/science.abb7314; Shi JZ, 2020, SCIENCE, V368, P1016, DOI 10.1126/science.abb7015; Sia SF, 2020, NATURE, V583, P834, DOI 10.1038/s41586-020-2342-5; Sun SH, 2020, CELL HOST MICROBE, V28, P124, DOI 10.1016/j.chom.2020.05.020; Wolfel R, 2020, NATURE, V581, P465, DOI 10.1038/s41586-020-2196-x; Wrapp D, 2020, SCIENCE, V367, P1260, DOI [10.1101/2020.02.11.944462, 10.1126/science.abb2507]; Yang ZY, 2004, NATURE, V428, P561, DOI 10.1038/nature02463; Yu JY, 2020, SCIENCE, V369, P806, DOI 10.1126/science.abc6284; Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017	26	167	174	5	25	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2020	26	11					1694	+		10.1038/s41591-020-1070-6	http://dx.doi.org/10.1038/s41591-020-1070-6		SEP 2020	20	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	OT0SR	32884153	Green Published, hybrid			2022-12-27	WOS:000566411600001
J	Stower, H				Stower, Hannah			A shift in cholesterol geography	NATURE MEDICINE			English	Editorial Material												h.stower@us.nature.com							0	1	1	0	0	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	SEP	2020	26	9					1331	1331		10.1038/s41591-020-1066-2	http://dx.doi.org/10.1038/s41591-020-1066-2			1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	PF3EM	32908278				2022-12-27	WOS:000598942000012
J	Bai, WJ; Suzuki, H; Huang, J; Francis, C; Wang, S; Tarroni, G; Guitton, F; Aung, N; Fung, K; Petersen, SE; Piechnik, SK; Neubauer, S; Evangelou, E; Dehghan, A; O'Regan, DP; Wilkins, MR; Guo, YK; Matthews, PM; Rueckert, D				Bai, Wenjia; Suzuki, Hideaki; Huang, Jian; Francis, Catherine; Wang, Shuo; Tarroni, Giacomo; Guitton, Florian; Aung, Nay; Fung, Kenneth; Petersen, Steffen E.; Piechnik, Stefan K.; Neubauer, Stefan; Evangelou, Evangelos; Dehghan, Abbas; O'Regan, Declan P.; Wilkins, Martin R.; Guo, Yike; Matthews, Paul M.; Rueckert, Daniel			A population-based phenome-wide association study of cardiac and aortic structure and function	NATURE MEDICINE			English	Article							HEALTH-CARE PROFESSIONALS; LEFT-VENTRICULAR MASS; MENDELIAN RANDOMIZATION; CARDIOVASCULAR-DISEASE; BIRTH-WEIGHT; RISK-TAKING; HEART; PATHOPHYSIOLOGY; TRACKING; OUTCOMES	Using magnetic resonance images of the heart and aorta from 26,893 individuals in the UK Biobank, a phenome-wide association study associates cardiovascular imaging phenotypes with a wide range of demographic, lifestyle and clinical features. Differences in cardiac and aortic structure and function are associated with cardiovascular diseases and a wide range of other types of disease. Here we analyzed cardiovascular magnetic resonance images from a population-based study, the UK Biobank, using an automated machine-learning-based analysis pipeline. We report a comprehensive range of structural and functional phenotypes for the heart and aorta across 26,893 participants, and explore how these phenotypes vary according to sex, age and major cardiovascular risk factors. We extended this analysis with a phenome-wide association study, in which we tested for correlations of a wide range of non-imaging phenotypes of the participants with imaging phenotypes. We further explored the associations of imaging phenotypes with early-life factors, mental health and cognitive function using both observational analysis and Mendelian randomization. Our study illustrates how population-based cardiac and aortic imaging phenotypes can be used to better define cardiovascular disease risks as well as heart-brain health interactions, highlighting new opportunities for studying disease mechanisms and developing image-based biomarkers.	[Bai, Wenjia; Wang, Shuo; Guitton, Florian; Guo, Yike] Imperial Coll London, Data Sci Inst, London, England; [Bai, Wenjia; Suzuki, Hideaki; Matthews, Paul M.] Imperial Coll London, Dept Brain Sci, London, England; [Suzuki, Hideaki] Tohoku Univ Hosp, Dept Cardiovasc Med, Sendai, Miyagi, Japan; [Suzuki, Hideaki] Tohoku Univ, Tohoku Med Megabank Org, Sendai, Miyagi, Japan; [Huang, Jian; Evangelou, Evangelos; Dehghan, Abbas] Imperial Coll London, Sch Publ Hlth, Dept Epidemiol & Biostat, MRC Ctr Environm & Hlth, London, England; [Huang, Jian; Evangelou, Evangelos; Dehghan, Abbas; Matthews, Paul M.] Imperial Coll London, UK Dementia Res Inst, London, England; [Francis, Catherine; Wilkins, Martin R.] Imperial Coll London, Natl Heart & Lung Inst, London, England; [Tarroni, Giacomo; Rueckert, Daniel] Imperial Coll London, Dept Comp, Biomed Image Anal Grp, London, England; [Tarroni, Giacomo] City Univ London, CitAI Res Ctr, Dept Comp Sci, London, England; [Aung, Nay; Fung, Kenneth; Petersen, Steffen E.] Queen Mary Univ London, NIHR Barts Biomed Res Ctr, London, England; [Petersen, Steffen E.; Piechnik, Stefan K.; Neubauer, Stefan] Univ Oxford, Radcliffe Dept Med, Div Cardiovasc Med, NIHR Oxford Biomed Res Ctr, Oxford, England; [Evangelou, Evangelos] Univ Ioannina, Med Sch, Dept Hyg & Epidemiol, Ioannina, Greece; [O'Regan, Declan P.] Imperial Coll London, MRC London Inst Med Sci, London, England	Imperial College London; Imperial College London; Tohoku University; Tohoku University; Imperial College London; Imperial College London; Imperial College London; Imperial College London; City University London; University of London; Queen Mary University London; University of Oxford; University of Ioannina; Imperial College London	Bai, WJ (corresponding author), Imperial Coll London, Data Sci Inst, London, England.; Bai, WJ (corresponding author), Imperial Coll London, Dept Brain Sci, London, England.	w.bai@imperial.ac.uk	Petersen, Steffen E/A-8389-2011; Bai, Wenjia/ABH-6023-2020; 郭, 伊可/GYD-3212-2022; Huang, Jian/AAV-1355-2021; Wilkins, Martin/ABH-1140-2021; Evangelou, Evangelos/C-3033-2013; Dehghan, Abbas/ABE-7377-2020; Wang, Shuo/AAR-3823-2020	Petersen, Steffen E/0000-0003-4622-5160; Bai, Wenjia/0000-0003-2943-7698; Huang, Jian/0000-0002-3931-5013; Wilkins, Martin/0000-0003-3926-1171; Evangelou, Evangelos/0000-0002-5488-2999; Wang, Shuo/0000-0002-2947-8783; Guitton, Florian/0000-0002-1617-6620; O'Regan, Declan/0000-0002-0691-0270; Francis, Catherine/0000-0002-4370-9461; Aung, Nay/0000-0001-5095-1611; Neubauer, Stefan/0000-0001-9017-5645	SmartHeart EPSRC Programme Grant [EP/P001009/1]; Imperial BHF Centre of Excellence Grant [RE/18/4/34215]; Japan Society for the Promotion of Science [20K07776]; NIHR Barts Biomedical Research Centre; European Union [825903]; British Heart Foundation [RE/18/4/34215, PG/14/89/31194, NH/17/1/32725, RG/19/6/34387]; Uehara Memorial Foundation; Wellcome Trust [206046/Z/17/Z]; Medical Research Council [MC-A651-53301]; Edmond J. Safra Foundation; Lily Safra; Imperial College Healthcare Trust Biomedical Research Centre; EPSRC Centre for Mathematics in Precision Healthcare; UK Dementia Research Institute; EPSRC [EP/P001009/1] Funding Source: UKRI; MRC [UKDRI-5001] Funding Source: UKRI	SmartHeart EPSRC Programme Grant(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Imperial BHF Centre of Excellence Grant; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NIHR Barts Biomedical Research Centre; European Union(European Commission); British Heart Foundation(British Heart Foundation); Uehara Memorial Foundation(Uehara Memorial Foundation); Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Edmond J. Safra Foundation; Lily Safra; Imperial College Healthcare Trust Biomedical Research Centre; EPSRC Centre for Mathematics in Precision Healthcare(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); UK Dementia Research Institute; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We would like to thank H. Gao, D. Schneider-Luftman, T. J. W. Dawes and A. Kolbeinsson for fruitful discussion. This research was conducted using the UK Biobank Resource under Application Number 18545, using methods developed under Application Number 18545 or 2964. Images were reproduced with kind permission of UK Biobank. We wish to thank all UK Biobank participants and staff. This work is supported by the SmartHeart EPSRC Programme Grant (EP/P001009/1) and the Imperial BHF Centre of Excellence Grant (RE/18/4/34215). H.S. is supported by a research fellowship from the Uehara Memorial Foundation and the Grants-in-Aid program from the Japan Society for the Promotion of Science (20K07776). S.E.P. acknowledges support from the NIHR Barts Biomedical Research Centre and S.E.P. has received funding from the European Union's Horizon 2020 research and innovation programme under grant agreement No. 825903 (euCanSHare project). S.E.P., S.N. and S.K.P. acknowledge the British Heart Foundation for funding the manual analysis to create a cardiovascular magnetic resonance imaging reference standard for the UK Biobank imaging resource in 5000 CMR scans (PG/14/89/31194). A.D. is funded by the Wellcome Trust seed award (206046/Z/17/Z). D.P.O. is supported by the Medical Research Council (MC-A651-53301) and British Heart Foundation (NH/17/1/32725, RG/19/6/34387, RE/18/4/34215). P.M.M. gratefully acknowledges support from the Edmond J. Safra Foundation and Lily Safra, the Imperial College Healthcare Trust Biomedical Research Centre, the EPSRC Centre for Mathematics in Precision Healthcare and the UK Dementia Research Institute.	Alastruey J, 2016, J R SOC INTERFACE, V13, DOI 10.1098/rsif.2016.0073; Alfaro-Almagro F, 2018, NEUROIMAGE, V166, P400, DOI 10.1016/j.neuroimage.2017.10.034; Alonso-Gonzalez R, 2013, CIRCULATION, V127, P882, DOI 10.1161/CIRCULATIONAHA.112.126755; Ambrose JA, 2004, J AM COLL CARDIOL, V43, P1731, DOI 10.1016/j.jacc.2003.12.047; Armstrong AC, 2012, JACC-CARDIOVASC IMAG, V5, P837, DOI 10.1016/j.jcmg.2012.06.003; Arnott C, 2015, OPEN HEART, V2, DOI 10.1136/openhrt-2015-000265; Bai WJ, 2018, LECT NOTES COMPUT SC, V11073, P586, DOI 10.1007/978-3-030-00937-3_67; Bai WJ, 2018, J CARDIOVASC MAGN R, V20, DOI 10.1186/s12968-018-0471-x; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Bello GA, 2019, NAT MACH INTELL, V1, P95, DOI 10.1038/s42256-019-0019-2; Bhuva AN, 2019, CIRC-CARDIOVASC IMAG, V12, DOI 10.1161/CIRCIMAGING.119.009214; Bild DE, 2002, AM J EPIDEMIOL, V156, P871, DOI 10.1093/aje/kwf113; Bowden J, 2018, INT J EPIDEMIOL, V47, P1264, DOI [10.1093/ije/dyy265, 10.1093/ije/dyy101]; Bowden J, 2016, GENET EPIDEMIOL, V40, P304, DOI 10.1002/gepi.21965; Burgess S, 2017, EUR J EPIDEMIOL, V32, P377, DOI 10.1007/s10654-017-0255-x; Burgess S, 2016, GENET EPIDEMIOL, V40, P597, DOI 10.1002/gepi.21998; Bycroft C, 2018, NATURE, V562, P203, DOI 10.1038/s41586-018-0579-z; Cerqueira MD, 2002, CIRCULATION, V105, P539, DOI 10.1161/hc0402.102975; Chaddha A, 2016, AM J MED, V129, P1145, DOI 10.1016/j.amjmed.2016.05.018; Collins R, 2012, LANCET, V379, P1173, DOI 10.1016/S0140-6736(12)60404-8; Cruickshank K, 2002, CIRCULATION, V106, P2085, DOI 10.1161/01.CIR.0000033824.02722.F7; Davies G, 2011, MOL PSYCHIATR, V16, P996, DOI 10.1038/mp.2011.85; Davies NM, 2018, BMJ-BRIT MED J, V362, DOI 10.1136/bmj.k601; de Bruijn RFAG, 2014, BMC MED, V12, DOI 10.1186/s12916-014-0130-5; de Haan L, 2015, DRUG ALCOHOL DEPEN, V155, P222, DOI 10.1016/j.drugalcdep.2015.07.013; Elliott LT, 2018, NATURE, V562, P210, DOI 10.1038/s41586-018-0571-7; Erbel Raimund, 2014, Kardiol Pol, V72, P1169, DOI 10.5603/KP.2014.0225; Evangelou E, 2019, NAT HUM BEHAV, V3, P950, DOI 10.1038/s41562-019-0653-z; Evangelou E, 2018, NAT GENET, V50, P1412, DOI 10.1038/s41588-018-0205-x; Friedrich MG, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.114.001685; Fry A, 2017, AM J EPIDEMIOL, V186, P1026, DOI 10.1093/aje/kwx246; Gansevoort RT, 2013, LANCET, V382, P339, DOI 10.1016/S0140-6736(13)60595-4; Geelhoed JJM, 2010, EUR J EPIDEMIOL, V25, P677, DOI 10.1007/s10654-010-9510-0; Gibson LM, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0218267; Gorelick PB, 2011, STROKE, V42, P2672, DOI 10.1161/STR.0b013e3182299496; Hardy R, 2016, INT J EPIDEMIOL, V45, P1091, DOI 10.1093/ije/dyw150; Heckbert SR, 2006, J AM COLL CARDIOL, V48, P2285, DOI 10.1016/j.jacc.2006.03.072; Hemani G, 2018, ELIFE, V7, DOI 10.7554/eLife.34408; Jefferson AL, 2011, AM J CARDIOL, V108, P1346, DOI 10.1016/j.amjcard.2011.06.056; Jiang BY, 2006, PEDIATRICS, V117, pE257, DOI 10.1542/peds.2005-1325; Kadish AH, 2009, J CARDIOVASC ELECTR, V20, P982, DOI 10.1111/j.1540-8167.2009.01503.x; Kamimura D, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.116.005005; Kreek MJ, 2005, NAT NEUROSCI, V8, P1450, DOI 10.1038/nn1583; LEVY D, 1990, NEW ENGL J MED, V0322; Linner RK, 2019, NAT GENET, V51, P245, DOI 10.1038/s41588-018-0309-3; Maceira AM, 2010, J CARDIOVASC MAGN R, V12, DOI 10.1186/1532-429X-12-65; Manolio TA, 2018, NAT MED, V24, P1792, DOI 10.1038/s41591-018-0276-3; Miller KL, 2016, NAT NEUROSCI, V19, P1523, DOI 10.1038/nn.4393; Morris AP, 2012, NAT GENET, V44, P981, DOI 10.1038/ng.2383; Nadruz W, 2016, CIRC-CARDIOVASC IMAG, V9, DOI 10.1161/CIRCIMAGING.116.004950; Nethononda RM, 2015, J CARDIOVASC MAGN R, V17, DOI 10.1186/s12968-015-0126-0; Petersen SE, 2016, J CARDIOVASC MAGN R, V18, DOI 10.1186/s12968-016-0227-4; Ponikowski P, 2016, EUR HEART J, V37, P2129, DOI 10.1093/eurheartj/ehw128; Puyol-Anton E, 2018, I S BIOMED IMAGING, P1139; Qiu CX, 2015, NAT REV CARDIOL, V12, P267, DOI 10.1038/nrcardio.2014.223; Redheuil A, 2010, HYPERTENSION, V55, P319, DOI 10.1161/HYPERTENSIONAHA.109.141275; Repesse X, 2015, CHEST, V147, P259, DOI 10.1378/chest.14-0877; Ronksley Paul E, 2011, BMJ, V342, pd671, DOI 10.1136/bmj.d671; Royle NA, 2013, NEUROBIOL AGING, V34, P2726, DOI 10.1016/j.neurobiolaging.2013.05.015; Rozanski A, 1999, CIRCULATION, V99, P2192, DOI 10.1161/01.CIR.99.16.2192; Rueckert D, 1999, IEEE T MED IMAGING, V18, P712, DOI 10.1109/42.796284; Sabayan B, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.114.001294; Schuster A, 2015, CLIN RADIOL, V70, P989, DOI 10.1016/j.crad.2015.05.006; Simpson HJ, 2010, HEART, V96, P148, DOI 10.1136/hrt.2009.177238; Steingrub Jay S, 2003, J Intensive Care Med, V18, P92, DOI 10.1177/0885066602250369; Strawbridge RJ, 2018, TRANSL PSYCHIAT, V8, DOI 10.1038/s41398-018-0236-1; Sudlow C, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001779; Taylor RJ, 2015, EUR HEART J-CARD IMG, V16, P871, DOI 10.1093/ehjci/jev006; Tobon-Gomez C, 2013, MED IMAGE ANAL, V17, P632, DOI 10.1016/j.media.2013.03.008; Tsang TSM, 2006, J AM COLL CARDIOL, V47, P1018, DOI 10.1016/j.jacc.2005.08.077; Upadhya B, 2019, HYPERTENSION, V74, P276, DOI 10.1161/HYPERTENSIONAHA.119.13073; van Buchem MA, 2014, J ALZHEIMERS DIS, V42, pS443, DOI 10.3233/JAD-141542; Verbanck M, 2018, NAT GENET, V50, P693, DOI 10.1038/s41588-018-0099-7; Victor RG, 2004, AM J CARDIOL, V93, P1473, DOI 10.1016/j.amjcard.2004.02.058; Warrington NM, 2019, NAT GENET, V51, P804, DOI 10.1038/s41588-019-0403-1; Watz H, 2010, CHEST, V138, P32, DOI 10.1378/chest.09-2810	77	27	28	7	18	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	OCT	2020	26	10					1654	+		10.1038/s41591-020-1009-y	http://dx.doi.org/10.1038/s41591-020-1009-y		AUG 2020	16	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	NX8MD	32839619	Green Submitted, Green Accepted			2022-12-27	WOS:000562338700005
J	Corridoni, D; Antanaviciute, A; Gupta, T; Fawkner-Corbett, D; Aulicino, A; Jagielowicz, M; Parikh, K; Repapi, E; Taylor, S; Ishikawa, D; Hatano, R; Yamada, T; Xin, W; Slawinski, H; Bowden, R; Napolitani, G; Brain, O; Morimoto, C; Koohy, H; Simmons, A				Corridoni, Daniele; Antanaviciute, Agne; Gupta, Tarun; Fawkner-Corbett, David; Aulicino, Anna; Jagielowicz, Marta; Parikh, Kaushal; Repapi, Emmanouela; Taylor, Steve; Ishikawa, Dai; Hatano, Ryo; Yamada, Taketo; Xin, Wei; Slawinski, Hubert; Bowden, Rory; Napolitani, Giorgio; Brain, Oliver; Morimoto, Chikao; Koohy, Hashem; Simmons, Alison			Single-cell atlas of colonic CD8(+)T cells in ulcerative colitis	NATURE MEDICINE			English	Article							INFLAMMATORY-BOWEL-DISEASE; GENOME-WIDE ASSOCIATION; T-CELLS; EXPRESSION; RISK; INTERLEUKIN-26; ACCURATE; BROWSER; GENES; LOCI	Colonic antigen-experienced lymphocytes such as tissue-resident memory CD8(+)T cells can respond rapidly to repeated antigen exposure. However, their cellular phenotypes and the mechanisms by which they drive immune regulation and inflammation remain unclear. Here we compiled an unbiased atlas of human colonic CD8(+)T cells in health and ulcerative colitis (UC) using single-cell transcriptomics with T-cell receptor repertoire analysis and mass cytometry. We reveal extensive heterogeneity in CD8(+)T-cell composition, including expanded effector and post-effector terminally differentiated CD8(+)T cells. While UC-associated CD8(+)effector T cells can trigger tissue destruction and produce tumor necrosis factor (TNF)-alpha, post-effector cells acquire innate signatures to adopt regulatory functions that may mitigate excessive inflammation. Thus, we identify colonic CD8(+)T-cell phenotypes in health and UC, define their clonal relationships and characterize terminally differentiated dysfunctional UC CD8(+)T cells expressing IL-26, which attenuate acute colitis in a humanized IL-26 transgenic mouse model. Multimodal single-cell profiling reveals heterogeneity of colonic CD8(+)T cells in patients with ulcerative colitis, including expansion of a chronically activated IL-26-expressing subpopulation with innate-like features.	[Corridoni, Daniele; Antanaviciute, Agne; Gupta, Tarun; Fawkner-Corbett, David; Aulicino, Anna; Jagielowicz, Marta; Parikh, Kaushal; Napolitani, Giorgio; Koohy, Hashem; Simmons, Alison] Univ Oxford, MRC Weatherall Inst Mol Med WIMM, John Radcliffe Hosp, Med Res Council MRC,Human Immunol Unit, Oxford, England; [Corridoni, Daniele; Gupta, Tarun; Fawkner-Corbett, David; Aulicino, Anna; Jagielowicz, Marta; Parikh, Kaushal; Brain, Oliver; Simmons, Alison] Univ Oxford, John Radcliffe Hosp, Translat Gastroenterol Unit, Oxford, England; [Antanaviciute, Agne; Koohy, Hashem] Univ Oxford, John Radcliffe Hosp, MRC WIMM, MRC WIMM Ctr Computat Biol, Oxford, England; [Repapi, Emmanouela; Taylor, Steve] Univ Oxford, John Radcliffe Hosp, Computat Biol Res Grp, Oxford, England; [Ishikawa, Dai] Juntendo Univ, Sch Med, Dept Gastroenterol, Tokyo, Japan; [Hatano, Ryo; Morimoto, Chikao] Juntendo Univ, Dept Therapy Dev & Innovat Immune Disorders & Can, Tokyo, Japan; [Yamada, Taketo] Saitama Med Univ, Dept Pathol, Saitama, Japan; [Xin, Wei] Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA; [Slawinski, Hubert; Bowden, Rory] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England	University of Oxford; University of Oxford; University of Oxford; University of Oxford; Juntendo University; Juntendo University; Saitama Medical University; Case Western Reserve University; University of Oxford; Wellcome Centre for Human Genetics	Koohy, H; Simmons, A (corresponding author), Univ Oxford, MRC Weatherall Inst Mol Med WIMM, John Radcliffe Hosp, Med Res Council MRC,Human Immunol Unit, Oxford, England.; Simmons, A (corresponding author), Univ Oxford, John Radcliffe Hosp, Translat Gastroenterol Unit, Oxford, England.; Koohy, H (corresponding author), Univ Oxford, John Radcliffe Hosp, MRC WIMM, MRC WIMM Ctr Computat Biol, Oxford, England.	hashem.koohy@rdm.ox.ac.uk; alison.simmons@imm.ox.ac.uk		Gupta, Tarun/0000-0002-9235-8717; Parikh, Kaushal/0000-0002-3247-3676; Corridoni, Daniele/0000-0003-0251-2248; /0000-0001-8085-0731; Aulicino, Anna/0000-0002-3407-2796; Fawkner-Corbett, David/0000-0002-5273-3682	National Institutes of Health Research (NIHR) Senior Investigator Award; Wellcome Investigator Award; UK Medical Research Council; Crohn's and Colitis UK; BMS; Oxford NIHR Biomedical Research Centre; Lee Placito Medical Fund; Wellcome Trust Clinical Research Fellowship; MRC [MC_PC_MR/S025952/1, MR/S036377/1, MC_UU_00008/7, MC_UU_12010/7, MR/M00919X/1] Funding Source: UKRI	National Institutes of Health Research (NIHR) Senior Investigator Award; Wellcome Investigator Award; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Crohn's and Colitis UK; BMS(Bristol-Myers Squibb); Oxford NIHR Biomedical Research Centre(National Institute for Health Research (NIHR)); Lee Placito Medical Fund; Wellcome Trust Clinical Research Fellowship(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank all the patients who contributed to this study, the generous support of our endoscopy teams and the clinical research nurses led by S. Fourie, who made this work possible. We acknowledge support of the MRC WIMM Flow Cytometry, Single Cell and Mass Cytometry facilities, Oxford NIHR Biomedical Research Centre, Oxford Translational Gastroenterology Unit (TGU) Investigators, Targeting Immune Pathways in IBD study investigators, NIHR CRN Thames Valley and the Oxford Single Cell Consortium. We thank O. Acuto (Dunn School, University of Oxford, UK) and T. M. Aune (Vanderbilt University, Nashville, USA) for helpful discussions and technical assistance. This work was supported by a National Institutes of Health Research (NIHR) Senior Investigator Award (to A.S.), a Wellcome Investigator Award (to A.S.), the UK Medical Research Council (to H.K. and A.S.), Crohn's and Colitis UK (to D.C.), BMS (to A. Aulicino and A. Antanaviciute), the Oxford NIHR Biomedical Research Centre (to K.P.), The Lee Placito Medical Fund (to T.G.) and a Wellcome Trust Clinical Research Fellowship (to D.F.-C.). Data from ref. 55 were obtained from the Broad Data Use Oversight System (DUOS-000110) following institutional approval. We thank and acknowledge the original authors and funders who contributed to this study. The views expressed in this article are those of the authors and not necessarily those of the NIHR or the Department of Health and Social Care.	Abraham C, 2009, INFLAMM BOWEL DIS, V15, P1090, DOI 10.1002/ibd.20894; Aibar S, 2017, NAT METHODS, V14, P1083, DOI [10.1038/NMETH.4463, 10.1038/nmeth.4463]; Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Andrews S., 2010, FASTQC QUALITY CONTR; [Anonymous], 2016, PACKAGE GGPLOT2, DOI DOI 10.1007/978-3-319-24277-4; Azizi E, 2018, CELL, V174, P1293, DOI 10.1016/j.cell.2018.05.060; Bahrami Shahram, 2016, Advances in Biological Regulation, V62, P37, DOI 10.1016/j.jbior.2016.05.001; Bamias G, 2017, CURR OPIN GASTROEN, V33, P411, DOI 10.1097/MOG.0000000000000402; Bamias G, 2012, CYTOKINE, V59, P451, DOI 10.1016/j.cyto.2012.06.014; Bartolome-Casado R, 2019, J EXP MED, V216, P2412, DOI 10.1084/jem.20190414; Buniello A, 2019, NUCLEIC ACIDS RES, V47, pD1005, DOI 10.1093/nar/gky1120; Carbon S, 2019, NUCLEIC ACIDS RES, V47, pD330, DOI 10.1093/nar/gky1055; Chen H, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1005112; Collins PL, 2012, GENES IMMUN, V13, P481, DOI 10.1038/gene.2012.22; Constantinides MG, 2014, NATURE, V508, P397, DOI 10.1038/nature13047; Correia MP, 2018, P NATL ACAD SCI USA, V115, pE5980, DOI 10.1073/pnas.1720564115; Corridoni D, 2017, MUCOSAL IMMUNOL, V10, P971, DOI 10.1038/mi.2016.98; Corridoni D, 2013, P NATL ACAD SCI USA, V110, P16999, DOI 10.1073/pnas.1311657110; de Lange KM, 2017, NAT GENET, V49, P256, DOI 10.1038/ng.3760; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Efremova M, 2020, NAT PROTOC, V15, P1484, DOI 10.1038/s41596-020-0292-x; Finak G, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0844-5; Finck R, 2013, CYTOM PART A, V83A, P483, DOI 10.1002/cyto.a.22271; Fujii M, 2017, WORLD J GASTROENTERO, V23, P5519, DOI 10.3748/wjg.v23.i30.5519; Galili T, 2015, BIOINFORMATICS, V31, P3718, DOI 10.1093/bioinformatics/btv428; Gao X, 2019, BIOINFORMATICS, V35, P3038, DOI 10.1093/bioinformatics/btz024; Glanville J, 2017, NATURE, V547, P94, DOI 10.1038/nature22976; Grenningloh K, 2005, J EXP MED, V201, P615, DOI 10.1084/jem.20041330; Griffiths JA, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05083-x; Hatano R, 2019, MABS-AUSTIN, V11, P1428, DOI 10.1080/19420862.2019.1654305; Hor S, 2004, J BIOL CHEM, V279, P33343, DOI 10.1074/jbc.M405000200; Huynh-Thu VA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012776; Itoh T, 2019, J INVEST DERMATOL, V139, P878, DOI 10.1016/j.jid.2018.09.037; Karolchik D, 2004, NUCLEIC ACIDS RES, V32, pD493, DOI 10.1093/nar/gkh103; Kinchen J, 2018, CELL, V175, P372, DOI 10.1016/j.cell.2018.08.067; Kuhn RM, 2013, BRIEF BIOINFORM, V14, P144, DOI 10.1093/bib/bbs038; Lareau CA, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-14667-5; Lee JC, 2011, J CLIN INVEST, V121, P4170, DOI 10.1172/JCI59255; Levine JH, 2015, CELL, V162, P184, DOI 10.1016/j.cell.2015.05.047; Lex A, 2014, IEEE T VIS COMPUT GR, V20, P1983, DOI 10.1109/TVCG.2014.2346248; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liao Y, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt214; Liu JZ, 2015, NAT GENET, V47, P979, DOI 10.1038/ng.3359; Lopetuso LR, 2018, P NATL ACAD SCI USA, V115, pE9362, DOI 10.1073/pnas.1803613115; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lun ATL, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1662-y; Maggi L, 2010, EUR J IMMUNOL, V40, P2174, DOI 10.1002/eji.200940257; Martin M, 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, 10.10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; Mazzurana L, 2018, SEMIN IMMUNOPATHOL, V40, P407, DOI 10.1007/s00281-018-0688-7; McGinnis CS, 2019, CELL SYST, V8, P329, DOI 10.1016/j.cels.2019.03.003; McGovern DPB, 2010, NAT GENET, V42, P332, DOI 10.1038/ng.549; McInnes L., 2018, UMAP UNIFORM MANIFOL, DOI DOI 10.21105/JOSS.00861; McKinney EF, 2015, NATURE, V523, P612, DOI 10.1038/nature14468; Meller S, 2015, NAT IMMUNOL, V16, P970, DOI 10.1038/ni.3211; Mueller SN, 2016, NAT REV IMMUNOL, V16, P79, DOI 10.1038/nri.2015.3; Parikh K, 2019, NATURE, V567, P49, DOI 10.1038/s41586-019-0992-y; Qiu X, 2017, NAT METHODS, V14, P979; Satija R, 2015, NAT BIOTECHNOL, V33, P495, DOI 10.1038/nbt.3192; Saunders PM, 2015, IMMUNOL REV, V267, P148, DOI 10.1111/imr.12319; Schoenborn JR, 2007, NAT IMMUNOL, V8, P732, DOI 10.1038/ni1474; Scialdone A, 2015, METHODS, V85, P54, DOI 10.1016/j.ymeth.2015.06.021; Shugay M, 2018, NUCLEIC ACIDS RES, V46, pD419, DOI 10.1093/nar/gkx760; Shugay M, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004503; Silverberg MS, 2009, NAT GENET, V41, P216, DOI 10.1038/ng.275; Slowikowski K, 2014, BIOINFORMATICS, V30, P2496, DOI 10.1093/bioinformatics/btu326; Smillie CS, 2019, CELL, V178, P714, DOI 10.1016/j.cell.2019.06.029; Stockenhuber K, 2018, J EXP MED, V215, P1987, DOI 10.1084/jem.20172094; Stoeckius M, 2018, GENOME BIOL, V19, DOI 10.1186/s13059-018-1603-1; Travis SPL, 2012, GUT, V61, P535, DOI 10.1136/gutjnl-2011-300486; Ueno A, 2018, J AUTOIMMUN, V87, P38, DOI 10.1016/j.jaut.2017.12.004; Vivekanand P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037151; Wang Y, 2019, ITALK R PACKAGE CHAR, DOI [10.1101/507871v1, DOI 10.1101/507871V1]; Welch JD, 2019, CELL, V177, P1873, DOI 10.1016/j.cell.2019.05.006; Wysoker A., 2013, PICARD TOOLS V 1 90; Yu GC, 2012, OMICS, V16, P284, DOI 10.1089/omi.2011.0118; Zeng BN, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-1540-2; Zhang L, 2018, NATURE, V564, P268, DOI 10.1038/s41586-018-0694-x; Zheng CH, 2017, CELL, V169, P1342, DOI 10.1016/j.cell.2017.05.035	79	54	55	3	32	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	SEP	2020	26	9								10.1038/s41591-020-1003-4	http://dx.doi.org/10.1038/s41591-020-1003-4		AUG 2020	32	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	PF3EM	32747828				2022-12-27	WOS:000555386300001
J	Chng, KR; Li, CH; Bertrand, D; Ng, AHQ; Kwah, JS; Low, HM; Tong, CX; Natrajan, M; Zhang, MH; Xu, LC; Ko, KKK; Ho, EXP; Av-Shalom, TV; Teo, JWP; Khor, CC; Chen, SL; Mason, CE; Ng, OT; Marimuthu, K; Ang, B; Nagarajan, N; Danko, D; Bezdan, D; Afshinnekoo, E; Ahsanuddin, S; Bhattacharya, C; Butler, DJ; De Filippis, F; Hecht, J; Kahles, A; Karasikov, M; Kyrpides, NC; Leung, MHY; Meleshko, D; Mustafa, H; Mutai, B; Neches, RY; Ng, A; Nieto-Caballero, M; Nikolayeva, O; Nikolayeva, T; Png, E; Sanchez, JL; Shaaban, H; Sierra, MA; Tong, XZ; Young, B; Alicea, J; Bhattacharyya, M; Blekhman, R; Castro-Nallar, E; Canas, AM; Chatziefthimiou, AD; Crawford, RW; Deng, YP; Desnues, C; Dias-Neto, E; Donnellan, D; Dybwad, M; Elhaik, E; Ercolini, D; Frolova, A; Graf, AB; Green, DC; Hajirasouliha, I; Hernandez, M; Iraola, G; Jang, S; Jones, A; Kelly, FJ; Knights, K; Labaj, PP; Lee, PKH; Shawn, L; Ljungdahl, P; Lyons, A; Mason-Buck, G; McGrath, K; Mongodin, EF; Moraes, MO; Noushmehr, H; Oliveira, M; Ossowski, S; Osuolale, OO; Ozcan, O; Paez-Espino, D; Rascovan, N; Richard, H; Ratsch, G; Schriml, LM; Semmler, T; Sezerman, OU; Shi, LM; Song, LH; Suzuki, H; Court, DS; Thomas, D; Tighe, SW; Udekwu, KI; Ugalde, JA; Valentine, B; Vassilev, DI; Vayndorf, E; Velavan, TP; Zambrano, MM; Zhu, JF; Zhu, S				Chng, Kern Rei; Li, Chenhao; Bertrand, Denis; Ng, Amanda Hui Qi; Kwah, Junmei Samantha; Low, Hwee Meng; Tong, Chengxuan; Natrajan, Maanasa; Zhang, Michael Hongjie; Xu, Licheng; Ko, Karrie Kwan Ki; Ho, Eliza Xin Pei; Av-Shalom, Tamar, V; Teo, Jeanette Woon Pei; Khor, Chiea Chuen; Chen, Swaine L.; Mason, Christopher E.; Ng, Oon Tek; Marimuthu, Kalisvar; Ang, Brenda; Nagarajan, Niranjan; Danko, David; Bezdan, Daniela; Afshinnekoo, Ebrahim; Ahsanuddin, Sofia; Bhattacharya, Chandrima; Butler, Daniel J.; De Filippis, Francesca; Hecht, Jochen; Kahles, Andre; Karasikov, Mikhail; Kyrpides, Nikos C.; Leung, Marcus H. Y.; Meleshko, Dmitry; Mustafa, Harun; Mutai, Beth; Neches, Russell Y.; Ng, Amanda; Nieto-Caballero, Marina; Nikolayeva, Olga; Nikolayeva, Tatyana; Png, Eileen; Sanchez, Jorge L.; Shaaban, Heba; Sierra, Maria A.; Tong, Xinzhao; Young, Ben; Alicea, Josue; Bhattacharyya, Malay; Blekhman, Ran; Castro-Nallar, Eduardo; Canas, Ana M.; Chatziefthimiou, Aspassia D.; Crawford, Robert W.; Deng, Youping; Desnues, Christelle; Dias-Neto, Emmanuel; Donnellan, Daisy; Dybwad, Marius; Elhaik, Eran; Ercolini, Danilo; Frolova, Alina; Graf, Alexandra B.; Green, David C.; Hajirasouliha, Iman; Hernandez, Mark; Iraola, Gregorio; Jang, Soojin; Jones, Angela; Kelly, Frank J.; Knights, Kaymisha; Labaj, Pawel P.; Lee, Patrick K. H.; Shawn, Levy; Ljungdahl, Per; Lyons, Abigail; Mason-Buck, Gabriella; McGrath, Ken; Mongodin, Emmanuel F.; Moraes, Milton Ozorio; Noushmehr, Houtan; Oliveira, Manuela; Ossowski, Stephan; Osuolale, Olayinka O.; Ozcan, Orhan; Paez-Espino, David; Rascovan, Nicolas; Richard, Hugues; Raetsch, Gunnar; Schriml, Lynn M.; Semmler, Torsten; Sezerman, Osman U.; Shi, Leming; Song, Le Huu; Suzuki, Haruo; Court, Denise Syndercombe; Thomas, Dominique; Tighe, Scott W.; Udekwu, Klas, I; Ugalde, Juan A.; Valentine, Brandon; Vassilev, Dimitar, I; Vayndorf, Elena; Velavan, Thirumalaisamy P.; Zambrano, Maria M.; Zhu, Jifeng; Zhu, Sibo		MetaSUB Consortium	Cartography of opportunistic pathogens and antibiotic resistance genes in a tertiary hospital environment	NATURE MEDICINE			English	Article							INTENSIVE-CARE-UNIT; STAPHYLOCOCCUS-AUREUS; ACQUIRED INFECTION; TRANSMISSION; PREVENTION; SURFACES; GENOMES; CLUSTER	Although disinfection is key to infection control, the colonization patterns and resistomes of hospital-environment microbes remain underexplored. We report the first extensive genomic characterization of microbiomes, pathogens and antibiotic resistance cassettes in a tertiary-care hospital, from repeated sampling (up to 1.5 years apart) of 179 sites associated with 45 beds. Deep shotgun metagenomics unveiled distinct ecological niches of microbes and antibiotic resistance genes characterized by biofilm-forming and human-microbiome-influenced environments with corresponding patterns of spatiotemporal divergence. Quasi-metagenomics with nanopore sequencing provided thousands of high-contiguity genomes, phage and plasmid sequences (>60% novel), enabling characterization of resistome and mobilome diversity and dynamic architectures in hospital environments. Phylogenetics identified multidrug-resistant strains as being widely distributed and stably colonizing across sites. Comparisons with clinical isolates indicated that such microbes can persist in hospitals for extended periods (>8 years), to opportunistically infect patients. These findings highlight the importance of characterizing antibiotic resistance reservoirs in hospitals and establish the feasibility of systematic surveys to target resources for preventing infections. Spatiotemporal characterization of microbial diversity and antibiotic resistance in a tertiary-care hospital reveals broad distribution and persistence of antibiotic-resistant organisms that could cause opportunistic infections in a healthcare setting.	[Chng, Kern Rei; Li, Chenhao; Bertrand, Denis; Ng, Amanda Hui Qi; Kwah, Junmei Samantha; Low, Hwee Meng; Tong, Chengxuan; Natrajan, Maanasa; Zhang, Michael Hongjie; Ho, Eliza Xin Pei; Av-Shalom, Tamar, V; Khor, Chiea Chuen; Chen, Swaine L.; Nagarajan, Niranjan] Genome Inst Singapore, Computat & Syst Biol, Singapore, Singapore; [Xu, Licheng] Singapore Univ Technol & Design, Informat Syst Technol & Design, Singapore, Singapore; [Ko, Karrie Kwan Ki] Singapore Gen Hosp, Dept Microbiol, Singapore, Singapore; [Ko, Karrie Kwan Ki] Singapore Gen Hosp, Dept Mol Pathol, Singapore, Singapore; [Ko, Karrie Kwan Ki] Duke NUS Grad Med Sch, Singapore, Singapore; [Teo, Jeanette Woon Pei] Natl Univ Singapore Hosp, Dept Lab Med, Singapore, Singapore; [Mason, Christopher E.] Weill Cornell Med, Dept Physiol & Biophys, New York, NY USA; [Ng, Oon Tek; Marimuthu, Kalisvar; Ang, Brenda] Natl Ctr Infect Dis, Singapore, Singapore; [Ng, Oon Tek; Marimuthu, Kalisvar; Ang, Brenda] Tan Tock Seng Hosp, Dept Infect Dis, Singapore, Singapore; [Ng, Oon Tek] Nanyang Technol Univ, Lee Kong Chian Sch Med, Singapore, Singapore; [Marimuthu, Kalisvar; Nagarajan, Niranjan] Natl Univ Singapore, Yong Loo Lin Sch Med, Singapore, Singapore; [Mason, Christopher E.; Danko, David; Bezdan, Daniela; Afshinnekoo, Ebrahim; Bhattacharya, Chandrima; Butler, Daniel J.; Meleshko, Dmitry; Sanchez, Jorge L.; Shaaban, Heba; Sierra, Maria A.; Young, Ben; Alicea, Josue; Canas, Ana M.; Donnellan, Daisy; Hajirasouliha, Iman; Knights, Kaymisha; Lyons, Abigail; Thomas, Dominique; Valentine, Brandon; Zhu, Jifeng] Weill Cornell Med, New York, NY USA; [Mason, Christopher E.; Danko, David; Bezdan, Daniela; Afshinnekoo, Ebrahim; Bhattacharya, Chandrima; Butler, Daniel J.; Meleshko, Dmitry; Shaaban, Heba; Sierra, Maria A.; Young, Ben; Alicea, Josue; Hajirasouliha, Iman] Bin Talal Bin Abdulaziz Alsaud Inst Computat Biom, New York, NY USA; [Ahsanuddin, Sofia] Icahn Sch Med Mt Sinai, New York, NY 10029 USA; [Chng, Kern Rei; Nagarajan, Niranjan; Ng, Amanda; Png, Eileen] Genome Inst Singapore, Singapore, Singapore; [De Filippis, Francesca; Ercolini, Danilo] Univ Naples Federico II, Naples, Italy; [Hecht, Jochen; Mutai, Beth] Barcelona Inst Sci & Technol, Barcelona, Spain; [Kahles, Andre; Karasikov, Mikhail; Mustafa, Harun; Nikolayeva, Olga; Nikolayeva, Tatyana; Raetsch, Gunnar] Swiss Fed Inst Technol, Zurich, Switzerland; [Kyrpides, Nikos C.; Neches, Russell Y.; Paez-Espino, David] Joint Genome Inst, Walnut Creek, CA USA; [Leung, Marcus H. Y.; Tong, Xinzhao; Lee, Patrick K. H.] City Univ Hong Kong, Hong Kong, Peoples R China; [Mutai, Beth] Kenya Govt Med Res Ctr, Med Res Directorate Africa, Kisumu, Kenya; [Nieto-Caballero, Marina; Hernandez, Mark] Univ Colorado, Boulder, CO USA; [Bhattacharyya, Malay] Indian Stat Inst, Kolkata, India; [Blekhman, Ran] Univ Minnesota, Minneapolis, MN USA; [Castro-Nallar, Eduardo] Univ Andres Bello, Santiago, Chile; [Chatziefthimiou, Aspassia D.] Weill Cornell Med Qatar, Doha, Qatar; [Crawford, Robert W.] Calif State Univ Sacramento, Sacramento, CA 95819 USA; [Deng, Youping] Univ Hawaii, Honolulu, HI 96822 USA; [Desnues, Christelle; Rascovan, Nicolas] Aix Marseille Univ, Marseille, France; [Dias-Neto, Emmanuel] AC Camargo Canc Ctr, Sao Paulo, Brazil; [Dybwad, Marius] Norwegian Def Res Estab, Kjeller, Norway; [Elhaik, Eran] Univ Sheffield, Sheffield, S Yorkshire, England; [Frolova, Alina] Natl Acad Sci Ukraine, Inst Mol Biol & Genet, Kiev, Ukraine; [Graf, Alexandra B.] Univ Appl Sci FH, Campus Wien, Vienna, Austria; [Green, David C.; Kelly, Frank J.; Mason-Buck, Gabriella; Court, Denise Syndercombe] Kings Coll London, London, England; [Iraola, Gregorio] Inst Pasteur Montevideo, Montevideo, Uruguay; [Jang, Soojin] Inst Pasteur Korea, Seongnam, South Korea; [Jones, Angela; Zambrano, Maria M.] Corporac Corpogen, Bogota, Colombia; [Labaj, Pawel P.] Jagiellonian Univ, Krakow, Poland; [Shawn, Levy] HudsonAlpha Inst Biotechnol, Huntsville, AL USA; [Ljungdahl, Per; Udekwu, Klas, I] Stockholm Univ, Stockholm, Sweden; [McGrath, Ken] Microba, Brisbane, Qld, Australia; [Mongodin, Emmanuel F.; Schriml, Lynn M.] Univ Maryland, Sch Med, Baltimore, MD 21201 USA; [Moraes, Milton Ozorio] Fundacao Oswaldo Cruz Lab Hanseniase, Rio De Janeiro, Brazil; [Noushmehr, Houtan] Univ Sao Paulo, Ribeirao Preto Med Sch, Sao Paulo, Brazil; [Oliveira, Manuela] Univ Porto, Inst Patol & Imunol Mol, Porto, Portugal; [Ossowski, Stephan] Univ Tubingen, Tubingen, Germany; [Osuolale, Olayinka O.] Elizade Univ, Ilara Mokin, Ondo State, Nigeria; [Ozcan, Orhan; Sezerman, Osman U.] Acibadem Mehmet Ali Aydinlar Univ, Istanbul, Turkey; [Richard, Hugues] Sorbonne Univ, Paris, France; [Semmler, Torsten] Robert Koch Inst, Berlin, Germany; [Shi, Leming; Zhu, Sibo] Fudan Univ, Shanghai, Peoples R China; [Song, Le Huu] Vietnamese German Ctr Excellence, Hanoi, Vietnam; [Suzuki, Haruo] Keio Univ, Fujisawa, Kanagawa, Japan; [Tighe, Scott W.] Univ Vermont, Burlington, VT USA; [Ugalde, Juan A.] Millennium Initiat Collaborat Res Bacterial Resis, Santiago, Chile; [Vassilev, Dimitar, I] Sofia Univ, Sofia, Bulgaria; [Vayndorf, Elena] Univ Alaska Fairbanks, Fairbanks, AK USA; [Velavan, Thirumalaisamy P.] Univ Klinikum Tubingen, Tubingen, Germany	Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); Singapore University of Technology & Design; Singapore General Hospital; Singapore General Hospital; National University of Singapore; National University of Singapore; Cornell University; National Centre for Infectious Diseases Singapore; Tan Tock Seng Hospital; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; National University of Singapore; Cornell University; Icahn School of Medicine at Mount Sinai; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); University of Naples Federico II; Barcelona Institute of Science & Technology; Swiss Federal Institutes of Technology Domain; ETH Zurich; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI; City University of Hong Kong; Kenya Medical Research Institute; University of Colorado System; University of Colorado Boulder; Indian Statistical Institute; Indian Statistical Institute Kolkata; University of Minnesota System; University of Minnesota Twin Cities; Universidad Andres Bello; Qatar Foundation (QF); Weill Cornell Medical College Qatar; California State University System; California State University Sacramento; University of Hawaii System; UDICE-French Research Universities; Aix-Marseille Universite; A.C.Camargo Cancer Center; Norwegian Defence Research Establishment; University of Sheffield; National Academy of Sciences Ukraine; Institute of Molecular Biology & Genetics of NASU; University of London; King's College London; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur de Montevideo; Institut Pasteur Korea; Jagiellonian University; HudsonAlpha Institute for Biotechnology; Stockholm University; University System of Maryland; University of Maryland Baltimore; Universidade de Sao Paulo; Universidade do Porto; Eberhard Karls University of Tubingen; Acibadem University; UDICE-French Research Universities; Sorbonne Universite; Robert Koch Institute; Fudan University; Keio University; University of Vermont; University of Sofia; University of Alaska System; University of Alaska Fairbanks; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Nagarajan, N (corresponding author), Genome Inst Singapore, Computat & Syst Biol, Singapore, Singapore.; Nagarajan, N (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Singapore, Singapore.; Nagarajan, N (corresponding author), Genome Inst Singapore, Singapore, Singapore.	nagarajann@gis.a-star.edu.sg	BEZDAN, DANIELA/H-2259-2015; Nieto-Caballero, Marina/ABC-8804-2021; Dias-Neto, Emmanuel/A-5869-2008; Osuolale, Olayinka/L-5391-2013; Oliveira, Maria Manuela Martins/J-6237-2013; Kahles, Andre/ABB-8343-2020; Elhaik, Eran/H-6838-2019; Li, Chenhao/U-7206-2019; Frolova, Alina O/I-3134-2016; Kyrpides, Nikos C./A-6305-2014; Nieto-Caballero, Marina/AIE-0739-2022; Kelly, Frank/ABG-3411-2021; Desnues, Christelle/ABG-2910-2021; Vassilev, Dimitar/AAN-3179-2021; Velavan, Thirumalaisamy P/C-1223-2010; Moraes, Milton Ozório/G-9753-2011; Meleshko, Dmitry A/C-7803-2018; Ugalde, Juan Antonio/GLV-2034-2022; SEZERMAN, OSMAN U/X-6441-2018; ko, karrie/S-6721-2019; Mason, Christopher/HCH-3977-2022; Schriml, Lynn/AFO-9472-2022; Moraes, Milton/AFF-1842-2022; Dias-Neto, Emmanuel/AAE-9147-2020; De Filippis, Francesca/K-3816-2016	BEZDAN, DANIELA/0000-0002-1203-8239; Dias-Neto, Emmanuel/0000-0001-5670-8559; Osuolale, Olayinka/0000-0001-6525-8502; Oliveira, Maria Manuela Martins/0000-0001-5785-7521; Kahles, Andre/0000-0002-3411-0692; Elhaik, Eran/0000-0003-4795-1084; Li, Chenhao/0000-0003-1182-6804; Frolova, Alina O/0000-0001-5469-7366; Kyrpides, Nikos C./0000-0002-6131-0462; Nieto-Caballero, Marina/0000-0002-7755-2490; Kelly, Frank/0000-0003-2558-8392; Desnues, Christelle/0000-0002-2178-0355; Vassilev, Dimitar/0000-0002-2478-7528; Velavan, Thirumalaisamy P/0000-0002-9809-9883; Moraes, Milton Ozório/0000-0003-2653-0037; Meleshko, Dmitry A/0000-0002-7398-9820; Ugalde, Juan Antonio/0000-0001-6638-0817; ko, karrie/0000-0002-5968-1870; De Filippis, Francesca/0000-0002-3474-2884; Zambrano, Maria Mercedes/0000-0002-0796-4473; Butler, Daniel J./0000-0002-3687-8419; Chng, Kern Rei/0000-0003-2746-9880; Castro-Nallar, Eduardo/0000-0003-4384-8661; Bhattacharya, Chandrima/0000-0003-2991-8491; Nagarajan, Niranjan/0000-0003-0850-5604; Labaj, Pawel/0000-0002-4994-0234; Natrajan, Maanasa/0000-0002-0492-6041; Blekhman, Ran/0000-0003-3218-613X; Teo, Jeanette/0000-0002-9321-3341; Bhattacharyya, Malay/0000-0001-7781-1264	A*STAR; NMRC [NMRC CGAug16C005]; WorldQuant Foundation; Bill and Melinda Gates Foundation [OPP1151054]; Alfred P. Sloan Foundation [G-2015-13964]; MRC [MR/S020810/1, MR/S020810/2, MR/L01341X/1] Funding Source: UKRI; NERC [NE/S006729/2, NE/S006729/1, NE/N007018/1] Funding Source: UKRI	A*STAR(Agency for Science Technology & Research (A*STAR)); NMRC(National Medical Research Council, Singapore); WorldQuant Foundation; Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	Funding for this work was provided by A*STAR (N.N.), and we are grateful for support from NMRC (NMRC CGAug16C005: O.T.N. and K.M.). C.E.M. acknowledges support from the WorldQuant Foundation, the Bill and Melinda Gates Foundation (OPP1151054) and the Alfred P. Sloan Foundation (G-2015-13964). The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript. We would like to thank J. Gilbert for insightful comments and feedback on this work.	Allegranzi B, 2011, LANCET, V377, P228, DOI 10.1016/S0140-6736(10)61458-4; Almeida A, 2019, NATURE, V568, P499, DOI 10.1038/s41586-019-0965-1; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Beggs C, 2015, INDOOR AIR, V25, P462, DOI 10.1111/ina.12170; Bertrand D, 2019, NAT BIOTECHNOL, V37, P937, DOI 10.1038/s41587-019-0191-2; Brooks B, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-02018-w; Bruen TC, 2006, GENETICS, V172, P2665, DOI 10.1534/genetics.105.048975; Buckner MMC, 2018, FEMS MICROBIOL REV, V42, P781, DOI 10.1093/femsre/fuy031; Calero-Caceres W, 2019, TRENDS MICROBIOL, V27, P570, DOI 10.1016/j.tim.2019.02.008; Che Y, 2019, MICROBIOME, V7, DOI 10.1186/s40168-019-0663-0; Conlan S, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009845; Dancer SJ, 2008, LANCET INFECT DIS, V8, P101, DOI 10.1016/S1473-3099(07)70241-4; Danko D.C, 2019, BIORXIV, DOI [10.1101/724526, DOI 10.1101/724526]; David S, 2019, NAT MICROBIOL, V4, P1919, DOI 10.1038/s41564-019-0492-8; de Goffau MC, 2018, NAT MICROBIOL, V3, P851, DOI 10.1038/s41564-018-0202-y; Fahimipour AK, 2018, MSYSTEMS, V3, DOI 10.1128/mSystems.00200-18; Falagas ME, 2009, EXPERT OPIN INV DRUG, V18, P921, DOI 10.1517/13543780902967624; Fischer M.M., 2019, HOSP USE ANTIBIOTICS, DOI [10.1101/553537, DOI 10.1101/553537]; Galata V, 2019, NUCLEIC ACIDS RES, V47, pD195, DOI 10.1093/nar/gky1050; Gao NL, 2018, NUCLEIC ACIDS RES, V46, pD700, DOI 10.1093/nar/gkx1124; Gao S, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0951-y; Goodman ER, 2008, INFECT CONT HOSP EP, V29, P593, DOI 10.1086/588566; Gordon AEK, 2017, CLIN INFECT DIS, V64, P1435, DOI 10.1093/cid/cix132; Gupta SK, 2014, ANTIMICROB AGENTS CH, V58, P212, DOI 10.1128/AAC.01310-13; Hartmann EM, 2016, ENVIRON SCI TECHNOL, V50, P9807, DOI 10.1021/acs.est.6b00262; Ho CM, 2012, ANTIMICROB AGENTS CH, V56, P5693, DOI 10.1128/AAC.00761-12; Hsieh TC, 2016, METHODS ECOL EVOL, V7, P1451, DOI 10.1111/2041-210X.12613; Htun HL, 2018, EPIDEMIOL INFECT, V146, DOI 10.1017/S0950268818001966; Inouye M, 2014, GENOME MED, V6, DOI 10.1186/s13073-014-0090-6; Izadpanah M, 2015, J RES PHARM PRACT, V4, P105, DOI 10.4103/2279-042X.162360; Janda JM, 2007, J CLIN MICROBIOL, V45, P2761, DOI 10.1128/JCM.01228-07; Johnson RC, 2018, NEW ENGL J MED, V379, P2529, DOI [10.1056/NEJMoa1803238, 10.1056/nejmoa1803238]; Kanamori H, 2016, CLIN INFECT DIS, V62, P1423, DOI 10.1093/cid/ciw122; Koren S, 2017, GENOME RES, V27, P722, DOI 10.1101/gr.215087.116; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Ladner JT, 2019, NAT MED, V25, P206, DOI 10.1038/s41591-019-0345-2; Lax S, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aah6500; Lax S, 2015, TRENDS MOL MED, V21, P427, DOI 10.1016/j.molmed.2015.03.005; Laxminarayan R, 2013, LANCET INFECT DIS, V13, P1057, DOI 10.1016/S1473-3099(13)70318-9; Lee JYH, 2018, NAT MICROBIOL, V3, P1175, DOI 10.1038/s41564-018-0230-7; Lerminiaux NA, 2019, CAN J MICROBIOL, V65, P34, DOI 10.1139/cjm-2018-0275; Longtin Yves, 2011, N Engl J Med, V364, pe24, DOI 10.1056/NEJMvcm0903599; Magill SS, 2014, NEW ENGL J MED, V370, P1198, DOI 10.1056/NEJMoa1306801; Mahnert A, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08864-0; McIntyre ABR, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1299-7; Miller RR, 2013, GENOME MED, V5, DOI 10.1186/gm485; Ministry of Health Singapore, 2013, GUID CONTR PREV MULT; Mitchell BG, 2019, LANCET INFECT DIS, V19, P410, DOI 10.1016/S1473-3099(18)30714-X; Monecke S, 2006, CLIN MICROBIOL INFEC, V12, P718, DOI 10.1111/j.1469-0691.2006.01420.x; Nasser K, 2018, GENOME ANNOUNCEMENTS, V6, DOI [10.1128/genomeA.00264-18, 10.1128/genomea.00264-18]; O'Neill J., 2016, REV ANTIMICROBIAL RE; Oberauner L, 2013, SCI REP-UK, V3, DOI 10.1038/srep01413; Ondov BD, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0997-x; Otter JA, 2013, AM J INFECT CONTROL, V41, pS6, DOI 10.1016/j.ajic.2012.12.004; Parks DH, 2018, NAT BIOTECHNOL, V36, P996, DOI 10.1038/nbt.4229; Parks DH, 2015, GENOME RES, V25, P1043, DOI 10.1101/gr.186072.114; Pasolli E, 2019, CELL, V176, P649, DOI 10.1016/j.cell.2019.01.001; Pierce N Tessa, 2019, F1000Res, V8, P1006, DOI 10.12688/f1000research.19675.1; Price JR, 2017, LANCET INFECT DIS, V17, P207, DOI [10.1016/S1473-3099(16)30413-3, 10.1016/s1473-3099(16)30413-3]; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Roux S, 2015, PEERJ, V3, DOI 10.7717/peerj.985; San Millan A, 2018, TRENDS MICROBIOL, V26, P978, DOI 10.1016/j.tim.2018.06.007; Sehulster Lynne, 2003, MMWR Recomm Rep, V52, P1; Song Gao, 2012, Algorithms in Bioinformatics. Proceedings of the12th International Workshop, WABI 2012, P314, DOI 10.1007/978-3-642-33122-0_25; Sundin GW, 1996, MOL ECOL, V5, P133, DOI 10.1111/j.1365-294X.1996.tb00299.x; Temiz M, 2014, MED SCI MONITOR, V20, P544, DOI 10.12659/MSM.890177; Teo J, 2013, LANCET, V382, P855, DOI 10.1016/S0140-6736(13)61858-9; Treangen TJ, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0524-x; Truong DT, 2015, NAT METHODS, V12, P902, DOI 10.1038/nmeth.3589; Urban C, 2010, ANTIMICROB AGENTS CH, V54, P2732, DOI 10.1128/AAC.01768-09; Walker BJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112963; Walker JT, 2007, J HOSP INFECT, V65, P43, DOI 10.1016/S0195-6701(07)60014-0; Wattam AR, 2014, NUCLEIC ACIDS RES, V42, pD581, DOI 10.1093/nar/gkt1099; Weiner LM, 2016, INFECT CONT HOSP EP, V37, P1288, DOI 10.1017/ice.2016.174; Weingarten RA, 2018, MBIO, V9, DOI 10.1128/mBio.02011-17; WEINSTEIN L, 1957, ANN NY ACAD SCI, V69, P408, DOI 10.1111/j.1749-6632.1957.tb49681.x; Werner G, 2001, ANTIMICROB AGENTS CH, V45, P3267, DOI 10.1128/AAC.45.11.3267-3269.2001; Wood DE, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-3-r46; Wright GD, 2019, CURR OPIN MICROBIOL, V51, P57, DOI 10.1016/j.mib.2019.06.005; Yu GC, 2018, MOL BIOL EVOL, V35, P3041, DOI 10.1093/molbev/msy194	80	53	56	16	56	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	JUN	2020	26	6					941	+		10.1038/s41591-020-0894-4	http://dx.doi.org/10.1038/s41591-020-0894-4		JUN 2020	14	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	LZ3ZG	32514171	Green Published, Green Submitted, hybrid			2022-12-27	WOS:000538976400005
J	Basolo, A; Hohenadel, M; Ang, QY; Piaggi, P; Heinitz, S; Walter, M; Walter, P; Parrington, S; Trinidad, DD; von Schwartzenberg, RJ; Turnbaugh, PJ; Krakoff, J				Basolo, Alessio; Hohenadel, Maximilian; Ang, Qi Yan; Piaggi, Paolo; Heinitz, Sascha; Walter, Mary; Walter, Peter; Parrington, Shannon; Trinidad, Donovan D.; von Schwartzenberg, Reiner Jumpertz; Turnbaugh, Peter J.; Krakoff, Jonathan			Effects of underfeeding and oral vancomycin on gut microbiome and nutrient absorption in humans	NATURE MEDICINE			English	Article							AKKERMANSIA-MUCINIPHILA; ENERGY-BALANCE; PERMEABILITY; METABOLISM; ACCURACY; OBESITY; DETERMINANTS; ANTIBIOTICS; BUTYRATE; LEPTIN	Direct evidence in humans for the impact of the microbiome on nutrient absorption is lacking. We conducted an extended inpatient study using two interventions that we hypothesized would alter the gut microbiome and nutrient absorption. In each, stool calorie loss, a direct proxy of nutrient absorption, was measured. The first phase was a randomized cross-over dietary intervention in which all participants underwent in random order 3 d of over- and underfeeding. The second was a randomized, double-blind, placebo-controlled pharmacologic intervention using oral vancomycin or matching placebo (). Twenty-seven volunteers (17 men and 10 women, age 35.1 +/- 7.3, BMI 32.3 +/- 8.0), who were healthy other than having impaired glucose tolerance and obesity, were enrolled and 25 completed the entire trial. The primary endpoints were the effects of dietary and pharmacological intervention on stool calorie loss. We hypothesized that stool calories expressed as percentage of caloric intake would increase with underfeeding compared with overfeeding and increase during oral vancomycin treatment. Both primary endpoints were met. Greater stool calorie loss was observed during underfeeding relative to overfeeding and during vancomycin treatment compared with placebo. Key secondary endpoints were to evaluate the changes in gut microbial community structure as evidenced by amplicon sequencing and metagenomics. We observed only a modest perturbation of gut microbial community structure with under- versus overfeeding but a more widespread change in community structure with reduced diversity with oral vancomycin. Increase in Akkermansia muciniphila was common to both interventions that resulted in greater stool calorie loss. These results indicate that nutrient absorption is sensitive to environmental perturbations and support the translational relevance of preclinical models demonstrating a possible causal role for the gut microbiome in dietary energy harvest. A proof-of-concept clinical study shows that perturbations to the gut microbiome affect nutrient absorption in humans.	[Basolo, Alessio; Hohenadel, Maximilian; Piaggi, Paolo; Heinitz, Sascha; Parrington, Shannon; Krakoff, Jonathan] NIDDK, Obes & Diabet Clin Res Sect, Phoenix Epidemiol & Clin Res Branch, NIH,US Dept HHS, Phoenix, AZ USA; [Ang, Qi Yan; Trinidad, Donovan D.; Turnbaugh, Peter J.] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA; [Heinitz, Sascha] Univ Leipzig, Div Endocrinol & Nephrol, Dept Med, Leipzig, Germany; [Heinitz, Sascha] Univ Leipzig, Helmholtz Inst Metab Obes & Vasc Res HI MAG, Helmholtz Zentrum Munchen, Leipzig, Germany; [Heinitz, Sascha] Univ Hosp Leipzig, Leipzig, Germany; [Walter, Mary] NIDDK, Clin Core Lab, NIH, Bethesda, MD 20892 USA; [Walter, Peter] NIDDK, Clin Mass Spectrometry Core, NIH, Bethesda, MD 20892 USA; [von Schwartzenberg, Reiner Jumpertz] Charite, Dept Endocrinol & Metab Dis, Berlin, Germany; [Turnbaugh, Peter J.] Chan Zuckerberg Biohub, San Francisco, CA 94158 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); University of California System; University of California San Francisco; Leipzig University; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Leipzig University; Leipzig University; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Basolo, A; Krakoff, J (corresponding author), NIDDK, Obes & Diabet Clin Res Sect, Phoenix Epidemiol & Clin Res Branch, NIH,US Dept HHS, Phoenix, AZ USA.; Turnbaugh, PJ (corresponding author), Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA.; Turnbaugh, PJ (corresponding author), Chan Zuckerberg Biohub, San Francisco, CA 94158 USA.	alessio.basolo@nih.gov; peter.turnbaugh@ucsf.edu; jkrakoff@mail.nih.gov	Basolo, Alessio/ABA-1769-2020; Piaggi, Paolo/E-2539-2011	Piaggi, Paolo/0000-0003-2774-9161; Ang, Qi Yan/0000-0002-9788-1283; Jumpertz von Schwartzenberg, Reiner/0000-0002-5544-099X; Turnbaugh, Peter/0000-0002-0888-2875; Trinidad, Donovan/0000-0002-1439-9927	Intramural Research Program of the National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; National Institutes of Health [R01HL122593, R21CA227232, P30DK098722]; Damon Runyon Cancer Research Foundation [DRR-42-16]; Searle Scholars Program [SSP-2016-1352]; A*STAR	Intramural Research Program of the National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Damon Runyon Cancer Research Foundation; Searle Scholars Program; A*STAR(Agency for Science Technology & Research (A*STAR))	We thank the volunteers who participated in the studies and the clinical staff of the Phoenix Epidemiology and Clinical Research Branch for conducting the examinations. This work was supported by the Intramural Research Program of the National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases. Additional support for the research in the Turnbaugh laboratory was provided by the National Institutes of Health (grant nos. R01HL122593, R21CA227232 and P30DK098722). The sponsors did not have any role in study design or analysis. P.J.T. holds an Investigators in the Pathogenesis of Infectious Disease Award from the Burroughs Wellcome Fund, is a Chan Zuckerberg Biohub investigator and is a Nadia's Gift Foundation Innovator supported, in part, by the Damon Runyon Cancer Research Foundation (grant no. DRR-42-16) and the Searle Scholars Program (grant no. SSP-2016-1352). Q.Y.A. was the recipient of a graduate fellowship from A*STAR.	Allegretti JR, 2020, CLIN GASTROENTEROL H, V18, P855, DOI 10.1016/j.cgh.2019.07.006; ALLISON DB, 1993, JAMA-J AM MED ASSOC, V270, P1454, DOI 10.1001/jama.270.12.1454; Basolo EA, 2019, J ENDOCRINOL INVEST, V42, P557, DOI 10.1007/s40618-018-0954-5; BEYER PL, 1978, J AM DIET ASSOC, V72, P271; Blanton LV, 2016, SCIENCE, V352, DOI 10.1126/science.aad9359; Block JP, 2018, PEDIATRICS, V142, DOI 10.1542/peds.2018-0290; Bolyen E, 2019, NAT BIOTECHNOL, V37, P852, DOI 10.1038/s41587-019-0209-9; Callahan BJ, 2016, NAT METHODS, V13, P581, DOI [10.1038/NMETH.3869, 10.1038/nmeth.3869]; Canani RB, 2011, WORLD J GASTROENTERO, V17, P1519, DOI [10.3748/wjg.v17.i12. 1519, 10.3748/wjg.v17.i12.1519]; Cani PD, 2007, DIABETES, V56, P1761, DOI 10.2337/db06-1491; Chagwedera DN, 2019, CELL METAB, V30, P364, DOI 10.1016/j.cmet.2019.05.002; Chen SF, 2018, BIOINFORMATICS, V34, P884, DOI 10.1093/bioinformatics/bty560; Depommier C, 2019, NAT MED, V25, P1096, DOI 10.1038/s41591-019-0495-2; Derrien M, 2004, INT J SYST EVOL MICR, V54, P1469, DOI 10.1099/ijs.0.02873-0; Dixon P, 2003, J VEG SCI, V14, P927, DOI 10.1111/j.1654-1103.2003.tb02228.x; Drucker DJ, 2001, J CLIN ENDOCR METAB, V86, P1759, DOI 10.1210/jc.86.4.1759; Everard A, 2013, P NATL ACAD SCI USA, V110, P9066, DOI 10.1073/pnas.1219451110; Fasano A, 2012, CLIN GASTROENTEROL H, V10, P1096, DOI 10.1016/j.cgh.2012.08.012; Feng YH, 2018, CELL PHYSIOL BIOCHEM, V49, P190, DOI 10.1159/000492853; FERRARO R, 1991, AM J CLIN NUTR, V53, P1368, DOI 10.1093/ajcn/53.6.1368; Franzosa EA, 2018, NAT METHODS, V15, P962, DOI 10.1038/s41592-018-0176-y; Gavin JR, 1999, DIABETES CARE, V22, pS5; Gohl DM, 2016, NAT BIOTECHNOL, V34, P942, DOI 10.1038/nbt.3601; Guilmeau S, 2004, CURR OPIN PHARMACOL, V4, P561, DOI 10.1016/j.coph.2004.06.008; Guo SH, 2013, AM J PATHOL, V182, P375, DOI 10.1016/j.ajpath.2012.10.014; Hall KD, 2011, LANCET, V378, P826, DOI 10.1016/S0140-6736(11)60812-X; HEYMSFIELD SB, 1981, AM J CLIN NUTR, V34, P1954, DOI 10.1093/ajcn/34.9.1954; Huang KC, 2004, OBES RES, V12, P840, DOI 10.1038/oby.2004.101; Isanaka S, 2016, NEW ENGL J MED, V374, P444, DOI 10.1056/NEJMoa1507024; Jones ML, 2014, EXPERT OPIN BIOL TH, V14, P467, DOI 10.1517/14712598.2014.880420; Jumpertz R, 2013, OBESITY, V21, P164, DOI 10.1002/oby.20185; Jumpertz R, 2011, AM J CLIN NUTR, V94, P58, DOI 10.3945/ajcn.110.010132; Kanehisa M, 2019, NUCLEIC ACIDS RES, V47, pD590, DOI 10.1093/nar/gky962; Kolaczynski JW, 1996, J CLIN ENDOCR METAB, V81, P4162, DOI 10.1210/jc.81.11.4162; Konig J, 2016, CLIN TRANSL GASTROEN, V7, DOI 10.1038/ctg.2016.54; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Liu L, 2018, FOOD FUNCT, V9, P5588, DOI [10.1039/c8fo01143e, 10.1039/C8FO01143E]; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; MATZKE GR, 1986, CLIN PHARMACOKINET, V11, P257, DOI 10.2165/00003088-198611040-00001; Modi SR, 2013, NATURE, V499, P219, DOI 10.1038/nature12212; MUNAKATA A, 1995, TOHOKU J EXP MED, V176, P227, DOI 10.1620/tjem.176.227; Murphy EF, 2013, GUT, V62, P220, DOI 10.1136/gutjnl-2011-300705; Ohlsson B, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18030582; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Petersen C, 2019, SCIENCE, V365, P340, DOI 10.1126/science.aat9351; Qin XF, 2005, AM J PHYSIOL-GASTR L, V288, pG943, DOI 10.1152/ajpgi.00303.2004; RAVUSSIN E, 1986, J CLIN INVEST, V78, P1568, DOI 10.1172/JCI112749; RAVUSSIN E, 1993, DIABETES CARE, V16, P232, DOI 10.2337/diacare.16.1.232; Reijnders D, 2016, CELL METAB, V24, P63, DOI [10.1016/j.cmet.2016.06.016, 10.1016/j.cmet.2016.07.008]; Reunanen J, 2015, APPL ENVIRON MICROB, V81, P3655, DOI 10.1128/AEM.04050-14; Ross S, 2000, AM J CLIN NUTR, V71, p1735S, DOI 10.1093/ajcn/71.6.1735S; Sapone A, 2006, DIABETES, V55, P1443, DOI 10.2337/db05-1593; Scheiman J, 2019, NAT MED, V25, P1104, DOI 10.1038/s41591-019-0485-4; Segata N, 2012, NAT METHODS, V9, P811, DOI [10.1038/NMETH.2066, 10.1038/nmeth.2066]; Sommer F, 2013, NAT REV MICROBIOL, V11, P227, DOI 10.1038/nrmicro2974; Tataranni PA, 2003, INT J OBESITY, V27, P1578, DOI 10.1038/sj.ijo.0802469; Thearle MS, 2013, J CLIN ENDOCR METAB, V98, P2791, DOI 10.1210/jc.2013-1289; Trehan I, 2013, NEW ENGL J MED, V368, P425, DOI 10.1056/NEJMoa1202851; Tuohimaa A, 2006, ARCH VIROL, V151, P947, DOI 10.1007/s00705-005-0672-0; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Urban LE, 2010, J AM DIET ASSOC, V110, P116, DOI 10.1016/j.jada.2009.10.003; Vrieze A, 2012, GASTROENTEROLOGY, V143, P913, DOI 10.1053/j.gastro.2012.06.031; Wadden D, 2013, NUTR METAB, V10, DOI 10.1186/1743-7075-10-33; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Yadav H, 2013, J BIOL CHEM, V288, P25088, DOI 10.1074/jbc.M113.452516; Yu GC, 2017, METHODS ECOL EVOL, V8, P28, DOI 10.1111/2041-210X.12628; ZARLING EJ, 1986, J LAB CLIN MED, V107, P5; Zmora N, 2019, NAT REV GASTRO HEPAT, V16, P35, DOI 10.1038/s41575-018-0061-2	68	42	42	6	30	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	APR	2020	26	4					589	+		10.1038/s41591-020-0801-z	http://dx.doi.org/10.1038/s41591-020-0801-z		MAR 2020	21	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	QH1UE	32235930				2022-12-27	WOS:000521529700003
J	Bernabe-Ortiz, A; Rosas, VGSY; Ponce-Lucero, V; Cardenas, MK; Carrillo-Larco, RM; Diez-Canseco, F; Pesantes, MA; Sacksteder, KA; Gilman, RH; Miranda, JJ				Bernabe-Ortiz, Antonio; Sal y Rosas, Victor G.; Ponce-Lucero, Vilarmina; Cardenas, Maria K.; Carrillo-Larco, Rodrigo M.; Diez-Canseco, Francisco; Pesantes, M. Amalia; Sacksteder, Katherine A.; Gilman, Robert H.; Miranda, J. Jaime			Effect of salt substitution on community-wide blood pressure and hypertension incidence	NATURE MEDICINE			English	Article							TO-POTASSIUM RATIO; CARDIOVASCULAR-DISEASE; STEPPED WEDGE; SODIUM; METAANALYSIS; REDUCTION; PREVENTION; MORTALITY; CHINESE; ADULTS	Replacement of regular salt with potassium-enriched substitutes reduces blood pressure in controlled situations, mainly among people with hypertension. We report on a population-wide implementation of this strategy in a stepped-wedge cluster randomized trial (). The regular salt in enrolled households was retrieved and replaced, free of charge, with a combination of 75% NaCl and 25% KCl. A total of 2,376 participants were enrolled in 6 villages in Tumbes, Peru. The fully adjusted intention-to-treat analysis showed an average reduction of 1.29 mm Hg (95% confidence interval (95% CI) (-2.17, -0.41)) in systolic and 0.76 mm Hg (95% CI (-1.39, -0.13)) in diastolic blood pressure. Among participants without hypertension at baseline, in the time- and cluster-adjusted model, the use of the salt substitute was associated with a 51% (95% CI (29%, 66%)) reduced risk of developing hypertension compared with the control group. In 24-h urine samples, there was no evidence of differences in sodium levels (mean difference 0.01; 95% CI (0.25, -0.23)), but potassium levels were higher at the end of the study than at baseline (mean difference 0.63; 95% CI (0.78, 0.47)). Our results support a case for implementing a pragmatic, population-wide, salt-substitution strategy for reducing blood pressure and hypertension incidence.	[Bernabe-Ortiz, Antonio; Ponce-Lucero, Vilarmina; Cardenas, Maria K.; Carrillo-Larco, Rodrigo M.; Diez-Canseco, Francisco; Pesantes, M. Amalia; Miranda, J. Jaime] Univ Peruana Cayetano Heredia, CRONICAS Ctr Excellence Chron Dis, Lima, Peru; [Sal y Rosas, Victor G.] Pontificia Univ Catolica Peru, Dept Sci, Lima, Peru; [Carrillo-Larco, Rodrigo M.] Imperial Coll London, Sch Publ Hlth, Dept Epidemiol & Biostat, London, England; [Sacksteder, Katherine A.; Gilman, Robert H.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD USA; [Miranda, J. Jaime] Univ Peruana Cayetano Heredia, Sch Med, Dept Med, Lima, Peru	Universidad Peruana Cayetano Heredia; Pontificia Universidad Catolica del Peru; Imperial College London; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Universidad Peruana Cayetano Heredia	Miranda, JJ (corresponding author), Univ Peruana Cayetano Heredia, CRONICAS Ctr Excellence Chron Dis, Lima, Peru.; Miranda, JJ (corresponding author), Univ Peruana Cayetano Heredia, Sch Med, Dept Med, Lima, Peru.	Jaime.Miranda@upch.pe	; Ponce Lucero, Vilarmina/A-9066-2017	CARDENAS, MARIA KATHIA/0000-0002-3173-9284; Ponce Lucero, Vilarmina/0000-0002-8439-3096; Diez-Canseco, Francisco/0000-0002-7611-8190; Sal y Rosas Celi, Victor Giancarlo/0000-0001-8636-7142; Miranda, J. Jaime/0000-0002-4738-5468	National Heart, Lung and Blood Institute under the Global Alliance for Chronic Diseases hypertension program [5 U01 HL114180-01]; Wellcome Trust Research Training Fellowship in Public Health and Tropical Medicine [103994/Z/14/Z]; Direccion de Gestion de la Investigacion at the Pontifica Universidad Catolica del Peru [DGI-2017-496]	National Heart, Lung and Blood Institute under the Global Alliance for Chronic Diseases hypertension program; Wellcome Trust Research Training Fellowship in Public Health and Tropical Medicine; Direccion de Gestion de la Investigacion at the Pontifica Universidad Catolica del Peru	This study was supported by the National Heart, Lung and Blood Institute (Project 5 U01 HL114180-01), under the Global Alliance for Chronic Diseases hypertension program. A.B.-O. was supported by a Wellcome Trust Research Training Fellowship in Public Health and Tropical Medicine (grant no. 103994/Z/14/Z). V.G.S.y.R. was funded by the Direccion de Gestion de la Investigacion at the Pontifica Universidad Catolica del Peru (grant no. DGI-2017-496).	Aminde LN, 2018, COST EFFECT RESOUR A, V16, DOI 10.1186/s12962-018-0108-9; [Anonymous], 2017, CENS NAC 2017 POBL 6; Attaei MW, 2017, LANCET PUBLIC HEALTH, V2, pE411, DOI 10.1016/S2468-2667(17)30141-X; Bernabe-Ortiz A, 2017, HEART, V103, P827, DOI 10.1136/heartjnl-2016-310347; Bernabe-Ortiz A, 2016, J EPIDEMIOL COMMUN H, V70, P49, DOI 10.1136/jech-2015-205988; Bernabe-Ortiz A, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-93; Binia A, 2015, J HYPERTENS, V33, P1509, DOI 10.1097/HJH.0000000000000611; Brown C, 2006, BMC HEALTH SERV RES, V6, DOI 10.1186/1472-6963-6-81; Campbell MK, 2004, BMJ-BRIT MED J, V328, P702, DOI 10.1136/bmj.328.7441.702; Chobanian AV., 2003, HYPERTENSION, V42, P1206, DOI [10.1161/01.HYP.0000107251, DOI 10.1161/01.HYP.9.2_PT_2.II36, DOI 10.1161/01.HYP.0000107251.49515.C2]; Coleman A, 2008, BLOOD PRESS MONIT, V13, P49, DOI 10.1097/MBP.0b013e3282cb57b6; Davey C, 2015, TRIALS, V16, DOI 10.1186/s13063-015-0838-3; Durovni B, 2013, LANCET INFECT DIS, V13, P852, DOI 10.1016/S1473-3099(13)70187-7; Filippini T, 2017, INT J CARDIOL, V230, P127, DOI 10.1016/j.ijcard.2016.12.048; French J., 2010, SOCIAL MARKETING PUB; Garret J.L, 2001, COMEDORES POPULARES; GELEIJNSE JM, 1994, BRIT MED J, V309, P436, DOI 10.1136/bmj.309.6952.436; He FJ, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1325; Hemming K, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h391; Hu JH, 2018, CLIN EXP HYPERTENS, V40, P664, DOI 10.1080/10641963.2018.1425415; Hughes JP, 2015, CONTEMP CLIN TRIALS, V45, P55, DOI 10.1016/j.cct.2015.07.006; Kontis V, 2019, CIRCULATION, V140, P715, DOI 10.1161/CIRCULATIONAHA.118.038160; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; Li N, 2007, J HYPERTENS, V25, P2011, DOI 10.1097/HJH.0b013e3282b9714b; Li N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166620; Melander O, 2007, J HYPERTENS, V25, P619, DOI 10.1097/HJH.0b013e328013cd50; Mente A, 2018, LANCET, V392, P496, DOI [10.1016/S0140-6736(18)31376-X, 10.1016/s0140-6736(18)31376-x]; Murray CJL, 2003, LANCET, V361, P717, DOI 10.1016/S0140-6736(03)12655-4; Peng YG, 2014, AM J CLIN NUTR, V100, P1448, DOI 10.3945/ajcn.114.089235; Perez V, 2014, ADV NUTR, V5, P712, DOI 10.3945/an.114.006783; Poorolajal J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174967; Pretell EA, 2009, IDD NEWSL, V31, P12; R Core Team, 2019, LANG ENV STAT COMP; ROSE G, 1985, INT J EPIDEMIOL, V14, P32, DOI 10.1093/ije/14.1.32; Saavedra-Garcia L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134700; Sacks FM, 2001, NEW ENGL J MED, V344, P3, DOI 10.1056/NEJM200101043440101; SCHOENFELD D, 1982, BIOMETRIKA, V69, P239, DOI 10.1093/biomet/69.1.239; Scott JM, 2017, STAT METHODS MED RES, V26, P583, DOI 10.1177/0962280214552092; Stolarz-Skrzypek K, 2011, JAMA-J AM MED ASSOC, V305, P1777, DOI 10.1001/jama.2011.574; Swanepoel B, 2016, J AM SOC HYPERTENS, V10, P829, DOI 10.1016/j.jash.2016.08.007; Trieu K, 2017, INT J BEHAV NUTR PHY, V14, DOI 10.1186/s12966-017-0467-1; Trieu K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130247; Wang GJ, 2013, CURR ATHEROSCLER REP, V15, DOI 10.1007/s11883-013-0349-1; Whelton PK, 2018, J AM COLL CARDIOL, V71, P2199, DOI 10.1016/j.jacc.2017.11.005; WHO, 2016, SALT RED FACT SHEET; Zhou B, 2013, J HUM HYPERTENS, V27, P427, DOI 10.1038/jhh.2012.63; Zhou B, 2017, LANCET, V389, P37, DOI 10.1016/S0140-6736(16)31919-5	47	59	63	0	10	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	MAR	2020	26	3					374	+		10.1038/s41591-020-0754-2	http://dx.doi.org/10.1038/s41591-020-0754-2		FEB 2020	10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	KU0MC	32066973	Green Submitted, Green Accepted, Bronze			2022-12-27	WOS:000514065500003
J	Vaduganathan, M; Butler, J				Vaduganathan, Muthiah; Butler, Javed			CARDIOVASCULAR DISEASE SGLT-2 inhibitors in heart failure: a new therapeutic avenue	NATURE MEDICINE			English	Editorial Material								Dapagliflozin, a sodium-glucose co-transporter-2 inhibitor, reduced the risk of cardiovascular death or heart failure events in 4,744 patients with chronic heart failure with reduced ejection fraction.	[Vaduganathan, Muthiah] Brigham & Womens Hosp, Heart & Vasc Ctr, 75 Francis St, Boston, MA 02115 USA; [Vaduganathan, Muthiah] Harvard Med Sch, Boston, MA 02115 USA; [Butler, Javed] Univ Mississippi, Med Ctr, Dept Med, Jackson, MS 39216 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; University of Mississippi; University of Mississippi Medical Center	Butler, J (corresponding author), Univ Mississippi, Med Ctr, Dept Med, Jackson, MS 39216 USA.	jbutler4@umc.edu			NIGMS NIH HHS [U54 GM115428] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Greene SJ, 2019, J AM COLL CARDIOL, V73, P2365, DOI 10.1016/j.jacc.2019.02.015; Greene SJ, 2018, J AM COLL CARDIOL, V71, P1379, DOI 10.1016/j.jacc.2018.01.047; Inzucchi SE, 2018, DIABETES CARE, V41, pE4, DOI 10.2337/dc17-1551; McMurray JJV, 2019, NEW ENGL J MED, V381, P1995, DOI 10.1056/NEJMoa1911303; Mentz RJ, 2018, J AM COLL CARDIOL, V72, P41, DOI 10.1016/j.jacc.2018.04.038; Neuen BL, 2019, LANCET DIABETES ENDO, V7, P845, DOI 10.1016/S2213-8587(19)30256-6; Verma S, 2019, CIRCULATION, V139, P2537, DOI 10.1161/CIRCULATIONAHA.119.040514; Vijayakumar S, 2018, CIRCULATION, V137, P1060, DOI 10.1161/CIRCULATIONAHA.117.032099; White JR., 2010, CLIN DIABETES, V28, P5, DOI DOI 10.2337/DIACLIN.28.1.5; Zelniker TA, 2019, LANCET, V393, P31, DOI 10.1016/S0140-6736(18)32590-X	10	3	3	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2019	25	11					1653	1654		10.1038/s41591-019-0647-4	http://dx.doi.org/10.1038/s41591-019-0647-4			3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	JT2KI	31700170				2022-12-27	WOS:000500824300019
J	Bai, T; Li, JQ; Sinclair, A; Imren, S; Merriam, F; Sun, F; O'Kelly, MB; Nourigat, C; Jain, P; Delrow, JJ; Basom, RS; Hung, HC; Zhang, P; Li, BW; Heimfeld, S; Jiang, SY; Delaney, C				Bai, Tao; Li, Jianqiang; Sinclair, Andrew; Imren, Suzan; Merriam, Fabiola; Sun, Fang; O'Kelly, Mary Beth; Nourigat, Cynthia; Jain, Priyesh; Delrow, Jeffrey J.; Basom, Ryan S.; Hung, Hsiang-Chieh; Zhang, Peng; Li, Bowen; Heimfeld, Shelly; Jiang, Shaoyi; Delaney, Colleen			Expansion of primitive human hematopoietic stem cells by culture in a zwitterionic hydrogel	NATURE MEDICINE			English	Article							CORD-BLOOD TRANSPLANTATION; ACTIVATED PROTEIN-KINASE; SELF-RENEWAL; WNT; MAINTENANCE; HOMEOSTASIS; DERIVATIVES; POLYMERS; GLYCOL); NICHE	The ability to expand hematopoietic stem and progenitor cells (HSPCs) ex vivo is critical to fully realize the potential of HSPC-based therapies. In particular, the application of clinically effective therapies, such as cord blood transplantation, has been impeded because of limited HSPC availability. Here, using 3D culture of human HSPCs in a degradable zwitterionic hydrogel, we achieved substantial expansion of phenotypically primitive CD34(+) cord blood and bone-marrow-derived HSPCs. This culture system led to a 73-fold increase in long-term hematopoietic stem cell (LT-HSC) frequency, as demonstrated by limiting dilution assays, and the expanded HSPCs were capable of hematopoietic reconstitution for at least 24 weeks in immunocompromised mice. Both the zwitterionic characteristics of the hydrogel and the 3D format were important for HSPC self-renewal. Mechanistically, the impact of 3D zwitterionic hydrogel culture on mitigating HSPC differentiation and promoting self-renewal might result from an inhibition of excessive reactive oxygen species (ROS) production via suppression of O-2-related metabolism. HSPC expansion using zwitterionic hydrogels has the potential to facilitate the clinical application of hematopoietic-stem-cell therapies.	[Bai, Tao; Sinclair, Andrew; Sun, Fang; O'Kelly, Mary Beth; Jain, Priyesh; Hung, Hsiang-Chieh; Zhang, Peng; Jiang, Shaoyi] Univ Washington, Dept Chem Engn, Seattle, WA 98195 USA; [Li, Jianqiang; Imren, Suzan; Merriam, Fabiola; Nourigat, Cynthia; Heimfeld, Shelly; Delaney, Colleen] Fred Hutchinson Canc Res Ctr, Div Clin Res, 1124 Columbia St, Seattle, WA 98104 USA; [Delrow, Jeffrey J.; Basom, Ryan S.] Fred Hutchinson Canc Res Ctr, Genom & Bioinformat Shared Resources, 1124 Columbia St, Seattle, WA 98104 USA; [Li, Bowen; Jiang, Shaoyi] Univ Washington, Dept Bioengn, Seattle, WA 98195 USA; [Delaney, Colleen] Univ Washington, Dept Pediat, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Jiang, SY (corresponding author), Univ Washington, Dept Chem Engn, Seattle, WA 98195 USA.; Delaney, C (corresponding author), Fred Hutchinson Canc Res Ctr, Div Clin Res, 1124 Columbia St, Seattle, WA 98104 USA.; Jiang, SY (corresponding author), Univ Washington, Dept Bioengn, Seattle, WA 98195 USA.; Delaney, C (corresponding author), Univ Washington, Dept Pediat, Seattle, WA 98195 USA.	sjiang@uw.edu; cdelaney@fredhutch.org	Li, Jin/GYQ-5363-2022; Zhang, Peng/K-9566-2014; LI, JIAN/GRY-2197-2022; Li, Jing/GYU-5036-2022; li, jian/GSE-0245-2022	Zhang, Peng/0000-0002-5409-7480; O'Kelly Boit, Mary/0000-0001-9990-6950; Delrow, Jeffrey/0000-0003-1020-3154	National Science Foundation [CBET-1264477, DMR 1307375]; Office of Naval Research [N00014-14-1-0090, N00014-15-1-2277]; University of Washington; NIDDK [DK 106829]; NIH/NCI Cancer Center Support Grant [P30 CA015704]; NATIONAL CANCER INSTITUTE [P30CA015704] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U54DK106829] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); Office of Naval Research(Office of Naval Research); University of Washington(University of Washington); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIH/NCI Cancer Center Support Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	T.B., A.S., P.Z. and S.J. were supported by National Science Foundation (DMR 1307375). F.S., B.L. and S.J. were supported by National Science Foundation (CBET-1264477). P.J., H.-C.H. and S.J. were supported by the Office of Naval Research (N00014-14-1-0090 and N00014-15-1-2277). M.B.O. and S.J. were supported by the University of Washington. S.H. was supported by NIDDK grant (DK 106829). J.J.D. and R.S.B. were supported by NIH/NCI Cancer Center Support Grant (P30 CA015704). We thank D. Raftery and H. Gu from the Northwest Metabolomics Research Center (NW-MRC) for assisting with LC-MS assessment. We also thank all the mothers who donated their cord blood for research, without whom this work would not have been possible.	Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Anderson SB, 2011, BIOMATERIALS, V32, P3564, DOI 10.1016/j.biomaterials.2011.01.064; Antonchuk J, 2002, CELL, V109, P39, DOI 10.1016/S0092-8674(02)00697-9; Ballen KK, 2013, BLOOD, V122, P491, DOI 10.1182/blood-2013-02-453175; Bigarella CL, 2014, DEVELOPMENT, V141, P4206, DOI 10.1242/dev.107086; Boitano AE, 2010, SCIENCE, V329, P1345, DOI 10.1126/science.1191536; BRETSCHER MS, 1975, NATURE, V258, P43, DOI 10.1038/258043a0; Carey AL, 2006, DIABETES, V55, P2688, DOI 10.2337/db05-1404; Csaszar E, 2012, CELL STEM CELL, V10, P218, DOI 10.1016/j.stem.2012.01.003; Cuchiara ML, 2016, BIOTECHNOL BIOENG, V113, P870, DOI 10.1002/bit.25848; Dahlberg A, 2011, BLOOD, V117, P6083, DOI 10.1182/blood-2011-01-283606; de Almeida MJ, 2017, CELL STEM CELL, V21, P725, DOI 10.1016/j.stem.2017.11.002; de Lima M, 2008, BONE MARROW TRANSPL, V41, P771, DOI 10.1038/sj.bmt.1705979; DeForest CA, 2011, NAT CHEM, V3, P925, DOI [10.1038/NCHEM.1174, 10.1038/nchem.1174]; DeForest CA, 2009, NAT MATER, V8, P659, DOI [10.1038/NMAT2473, 10.1038/nmat2473]; Delaney C, 2016, LANCET HAEMATOL, V3, pE330, DOI 10.1016/S2352-3026(16)30023-0; Delaney C, 2010, NAT MED, V16, P232, DOI 10.1038/nm.2080; Enver T, 2009, CELL STEM CELL, V4, P387, DOI 10.1016/j.stem.2009.04.011; Fares I, 2014, SCIENCE, V345, P1509, DOI 10.1126/science.1256337; Fleming HE, 2008, CELL STEM CELL, V2, P274, DOI 10.1016/j.stem.2008.01.003; Folmes CDL, 2012, CELL STEM CELL, V11, P596, DOI 10.1016/j.stem.2012.10.002; Gragert L, 2014, NEW ENGL J MED, V371, P339, DOI 10.1056/NEJMsa1311707; Hu YF, 2009, J IMMUNOL METHODS, V347, P70, DOI 10.1016/j.jim.2009.06.008; Huang J, 2012, NAT MED, V18, P1778, DOI 10.1038/nm.2984; Ito K, 2006, NAT MED, V12, P446, DOI 10.1038/nm1388; Ito K, 2004, NATURE, V431, P997, DOI 10.1038/nature02989; Ito K, 2014, NAT REV MOL CELL BIO, V15, P243, DOI 10.1038/nrm3772; Ito M, 2002, BLOOD, V100, P3175, DOI 10.1182/blood-2001-12-0207; Jang YY, 2007, BLOOD, V110, P3056, DOI 10.1182/blood-2007-05-087759; Jiang SY, 2010, ADV MATER, V22, P920, DOI 10.1002/adma.200901407; KAPLAN SS, 1992, J BIOMED MATER RES, V26, P1039, DOI 10.1002/jbm.820260806; Keefe AJ, 2012, NAT CHEM, V4, P60, DOI 10.1038/nchem.1213; Liu WE, 2011, BIOMATERIALS, V32, P1796, DOI 10.1016/j.biomaterials.2010.11.029; Long YC, 2006, J CLIN INVEST, V116, P1776, DOI 10.1172/JCI29044; Luo Y, 2014, TRANSPLANTATION, V97, P20, DOI 10.1097/TP.0b013e3182a7fcf8; Lutz JF, 2006, MACROMOLECULES, V39, P6376, DOI 10.1021/ma061557n; McGraw TE, 2010, NAT CHEM BIOL, V6, P176, DOI 10.1038/nchembio.324; Milano F, 2016, NEW ENGL J MED, V375, P944, DOI 10.1056/NEJMoa1602074; Murray LJ, 1999, EXP HEMATOL, V27, P1019, DOI 10.1016/S0301-472X(99)00031-4; Nel A, 2006, SCIENCE, V311, P622, DOI 10.1126/science.1114397; Nishida M, 2005, J BIOL CHEM, V280, P18434, DOI 10.1074/jbc.M409710200; Pineault N, 2015, EXP HEMATOL, V43, P498, DOI 10.1016/j.exphem.2015.04.011; Ratajczak MZ, 2008, CURR OPIN HEMATOL, V15, P293, DOI 10.1097/MOH.0b013e328302c7ca; Rau A, 2013, BIOINFORMATICS, V29, P2146, DOI 10.1093/bioinformatics/btt350; Ray PD, 2012, CELL SIGNAL, V24, P981, DOI 10.1016/j.cellsig.2012.01.008; Reiner A, 2003, BIOINFORMATICS, V19, P368, DOI 10.1093/bioinformatics/btf877; Reya T, 2003, NATURE, V423, P409, DOI 10.1038/nature01593; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Shen YI, 2014, BIOMATER SCI-UK, V2, P655, DOI 10.1039/c3bm60274e; Shin SY, 2004, CANCER LETT, V212, P225, DOI 10.1016/j.canlet.2004.03.003; Supek F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021800; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Wang Y, 2011, STEM CELLS DEV, V20, P1143, DOI 10.1089/scd.2010.0413; West JL, 1999, MACROMOLECULES, V32, P241, DOI 10.1021/ma981296k; Yoshida S, 2011, J BIOL CHEM, V286, P32651, DOI 10.1074/jbc.M111.238014; Young MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r14; Yu L, 2015, J BIOMED MATER RES A, V103, P2987, DOI 10.1002/jbm.a.35432; Zhang L, 2013, NAT BIOTECHNOL, V31, P553, DOI 10.1038/nbt.2580; Zhang P, 2015, P NATL ACAD SCI USA, V112, P12046, DOI 10.1073/pnas.1512465112; Zhang Z, 2006, J PHYS CHEM B, V110, P10799, DOI 10.1021/jp057266i	60	109	111	18	212	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	OCT	2019	25	10					1566	+		10.1038/s41591-019-0601-5	http://dx.doi.org/10.1038/s41591-019-0601-5			23	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	JC3GJ	31591594				2022-12-27	WOS:000489166700026
J	Ross, ME				Ross, M. Elizabeth			Unlocking the genetic complexity of congenital hydrocephalus	NATURE MEDICINE			English	Editorial Material								Genome sequencing of patients with sporadic congenital hydrocephalus reveals mutations of large effect size indicative of a developmental origin for the disease.	[Ross, M. Elizabeth] Weill Cornell Med, Feil Family Brain & Mind Res Inst, Ctr Neurogenet, New York, NY 10065 USA	Cornell University	Ross, ME (corresponding author), Weill Cornell Med, Feil Family Brain & Mind Res Inst, Ctr Neurogenet, New York, NY 10065 USA.	mer2005@med.cornell.edu		Ross, Margaret/0000-0001-6440-8089	NICHD NIH HHS [P01 HD067244] Funding Source: Medline	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Furey CG, 2018, NEURON, V99, P302, DOI 10.1016/j.neuron.2018.06.019; Harmacek L, 2014, DEV NEUROBIOL, V74, P483, DOI 10.1002/dneu.22142; Jin SC, 2020, NAT MED, V26, P1754, DOI 10.1038/s41591-020-1090-2; Polioudakis D, 2019, NEURON, V103, P785, DOI 10.1016/j.neuron.2019.06.011; Tully HM, 2014, EUR J MED GENET, V57, P359, DOI 10.1016/j.ejmg.2014.06.002; Walker RL, 2019, CELL, V179, P750, DOI 10.1016/j.cell.2019.09.021; Welte T, 2019, GENE DEV, V33, P1221, DOI 10.1101/gad.328492.119	7	5	4	0	1	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2020	26	11					1682	1683		10.1038/s41591-020-1120-0	http://dx.doi.org/10.1038/s41591-020-1120-0		OCT 2020	2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	OT0SR	33106667				2022-12-27	WOS:000584042900004
J	Stower, H				Stower, Hannah			Effective treatment of NSCLC	NATURE MEDICINE			English	Editorial Material																			0	2	2	1	6	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	OCT	2020	26	10					1512	1512		10.1038/s41591-020-1106-y	http://dx.doi.org/10.1038/s41591-020-1106-y			1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	QH1TN	33029022				2022-12-27	WOS:000618059800001
J	Stower, H				Stower, Hannah			Targeting porphyria	NATURE MEDICINE			English	Editorial Material												h.stower@us.nature.com							0	0	0	0	0	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	JUL	2020	26	7					1009	1009		10.1038/s41591-020-0987-0	http://dx.doi.org/10.1038/s41591-020-0987-0		JUL 2020	1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	MK3XO	32651574	Bronze			2022-12-27	WOS:000547236500002
J	Park, JK; Xiao, YL; Ramuta, MD; Rosas, LA; Fong, S; Matthews, AM; Freeman, AD; Gouzoulis, MA; Batchenkova, NA; Yang, XD; Scherler, K; Qi, L; Reed, S; Athota, R; Czajkowski, L; Han, AL; Morens, DM; Walters, KA; Memoli, MJ; Kash, JC; Taubenberger, JK				Park, Jae-Keun; Xiao, Yongli; Ramuta, Mitchell D.; Rosas, Luz Angela; Fong, Sharon; Matthews, Alexis M.; Freeman, Ashley D.; Gouzoulis, Monica A.; Batchenkova, Natalia A.; Yang, Xingdong; Scherler, Kelsey; Qi, Li; Reed, Susan; Athota, Rani; Czajkowski, Lindsay; Han, Alison; Morens, David M.; Walters, Kathie-Anne; Memoli, Matthew J.; Kash, John C.; Taubenberger, Jeffery K.			Pre-existing immunity to influenza virus hemagglutinin stalk might drive selection for antibody-escape mutant viruses in a human challenge model	NATURE MEDICINE			English	Article							STEM; H1	The conserved region of influenza hemagglutinin (HA) stalk (or stem) has gained attention as a potent target for universal influenza vaccines(1-5). Although the HA stalk region is relatively well conserved, the evolutionarily dynamic nature of influenza viruses(6)raises concerns about the possible emergence of viruses carrying stalk escape mutation(s) under sufficient immune pressure. Here we show that immune pressure on the HA stalk can lead to expansion of escape mutant viruses in study participants challenged with a 2009 H1N1 pandemic influenza virus inoculum containing an A388V polymorphism in the HA stalk (45% wild type and 55% mutant). High level of stalk antibody titers was associated with the selection of the mutant virus both in humans and in vitro. Although the mutant virus showed slightly decreased replication in mice, it was not observed in cell culture, ferrets or human challenge participants. The A388V mutation conferred resistance to some of the potent HA stalk broadly neutralizing monoclonal antibodies (bNAbs). Co-culture of wild-type and mutant viruses in the presence of either a bNAb or human serum resulted in rapid expansion of the mutant. These data shed light on a potential obstacle for the success of HA-stalk-targeting universal influenza vaccines-viral escape from vaccine-induced stalk immunity. High levels of antibodies specific for the stalk region of influenza hemagglutinin protein are associated with expansion of mutant viruses in human volunteers, suggesting potential challenges for influenza vaccine efforts targeting the HA stalk.	[Park, Jae-Keun; Xiao, Yongli; Ramuta, Mitchell D.; Rosas, Luz Angela; Fong, Sharon; Matthews, Alexis M.; Freeman, Ashley D.; Batchenkova, Natalia A.; Yang, Xingdong; Qi, Li; Kash, John C.; Taubenberger, Jeffery K.] NIAID, Viral Pathogenesis & Evolut Sect, Lab Infect Dis, Div Intramural Res,NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Gouzoulis, Monica A.; Reed, Susan; Athota, Rani; Czajkowski, Lindsay; Han, Alison; Memoli, Matthew J.] NIAID, LID Clin Studies Unit, Lab Infect Dis, Div Intramural Res,NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Scherler, Kelsey; Walters, Kathie-Anne] Inst Syst Biol, Seattle, WA USA; [Morens, David M.] NIAID, Off Director, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Ramuta, Mitchell D.] Univ Wisconsin, Dept Pathol & Lab Med, Madison, WI USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Institute for Systems Biology (ISB); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Wisconsin System; University of Wisconsin Madison	Taubenberger, JK (corresponding author), NIAID, Viral Pathogenesis & Evolut Sect, Lab Infect Dis, Div Intramural Res,NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	taubenbergerj@niaid.nih.gov	Taubenberger, Jeffery/AAQ-1407-2021; Kash, John/ABE-8280-2021	Park, Jaekeun/0000-0002-4506-8127; Rosas, Luz Angela/0000-0002-8743-7189; Matthews, Lex/0000-0001-8637-3614	intramural research program of the National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH)	intramural research program of the National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH)	This work was supported by the intramural research program of the National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH). We thank the Comparative Medicine Branch (NIAID, NIH) for assistance with the animal studies and S. Hunsberger (Biostatistics Research Branch, NIAID, NIH) for the helpful discussion of statistical analyses performed in this study. We also thank Janssen Pharmaceutica, R. Ahmed (Emory Vaccine Center) and A. Townsend (University of Oxford) for generously sharing monoclonal antibodies.	Altman MO, 2018, VIRAL IMMUNOL, V31, P142, DOI 10.1089/vim.2017.0129; Anderson CS, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14931-7; Andrews SF, 2018, CSH PERSPECT BIOL, V10, DOI 10.1101/cshperspect.a029413; Andrews SF, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aad0522; Bush RM, 1999, MOL BIOL EVOL, V16, P1457, DOI 10.1093/oxfordjournals.molbev.a026057; Chai N, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005702; Christensen SR, 2019, J VIROL, V93, DOI [10.1128/JVI.02134-18, 10.1128/jvi.02134-18]; Clementi N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028001; Corti D, 2011, SCIENCE, V333, P850, DOI 10.1126/science.1205669; Coughlan L, 2018, CELL HOST MICROBE, V24, P18, DOI 10.1016/j.chom.2018.06.016; Doud MB, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03665-3; Dreyfus C, 2012, SCIENCE, V337, P1343, DOI 10.1126/science.1222908; Dunand CJH, 2016, CELL HOST MICROBE, V19, P800, DOI 10.1016/j.chom.2016.05.014; Dunand CJH, 2015, J CLIN INVEST, V125, P1255, DOI 10.1172/JCI74374; Ekiert DC, 2009, SCIENCE, V324, P246, DOI 10.1126/science.1171491; Huang KYA, 2015, J CLIN INVEST, V125, P2631, DOI 10.1172/JCI81104; Impagliazzo A, 2015, SCIENCE, V349, P1301, DOI 10.1126/science.aac7263; Kirkpatrick E, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-28706-1; Krammer F, 2013, J VIROL, V87, P6542, DOI [10.1128/JVI.00641-13, 10.1128/JVI.03183-13]; Krammer F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043603; Lee J, 2016, NAT MED, V22, P1456, DOI 10.1038/nm.4224; Linderman SL, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005806; Memoli M., 2016, MBIO, V7, P1, DOI DOI 10.1128/MBI0.00417-16; Memoli MJ, 2015, CLIN INFECT DIS, V60, P693, DOI 10.1093/cid/ciu924; Morens DM, 2019, J INFECT DIS, V219, pS5, DOI 10.1093/infdis/jiy728; Neumann G, 1999, P NATL ACAD SCI USA, V96, P9345, DOI 10.1073/pnas.96.16.9345; Ng S, 2019, NAT MED, V25, P962, DOI 10.1038/s41591-019-0463-x; OKUNO Y, 1993, J VIROL, V67, P2552, DOI 10.1128/JVI.67.5.2552-2558.1993; Park JK, 2018, MBIO, V9, DOI [10.1128/mBio.02284-17, 10.1128/mbio.02284-17]; Paules CI, 2019, J INFECT DIS, V219, pS1, DOI 10.1093/infdis/jiy633; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Poritz MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026047; Rambaut A, 2008, NATURE, V453, P615, DOI 10.1038/nature06945; REED L. J., 1938, AMER JOUR HYG, V27, P493; Shu B, 2011, J CLIN MICROBIOL, V49, P2614, DOI 10.1128/JCM.02636-10; Stevens J, 2004, SCIENCE, V303, P1866, DOI 10.1126/science.1093373; Tan GS, 2012, J VIROL, V86, P6179, DOI 10.1128/JVI.00469-12; Taubenberger JK, 2010, PUBLIC HEALTH REP, V125, P16, DOI 10.1177/00333549101250S305; Throsby M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003942; Wang RX, 2008, VIROLOGY, V375, P182, DOI 10.1016/j.virol.2008.01.041; WHO Global Influenza Surveillance Network, 2011, MAN LAB DIAGN VIR SU; Wrammert J, 2011, J EXP MED, V208, P181, DOI 10.1084/jem.20101352; Wu NC, 2017, J MOL BIOL, V429, P2694, DOI 10.1016/j.jmb.2017.06.015; Wu Y, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8708; Xiao YL, 2019, VIROLOGY, V534, P96, DOI 10.1016/j.virol.2019.06.004; Xie H., 2015, SCI REP, V5; Xu R, 2010, SCIENCE, V328, P357, DOI 10.1126/science.1186430; Yassine HM, 2015, NAT MED, V21, P1065, DOI 10.1038/nm.3927	48	23	23	1	5	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	AUG	2020	26	8					1240	+		10.1038/s41591-020-0937-x	http://dx.doi.org/10.1038/s41591-020-0937-x		JUN 2020	17	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	MX8ZF	32601336	Green Accepted, Bronze			2022-12-27	WOS:000544159600002
J	Lipsitch, M; Kahn, R; Mina, MJ				Lipsitch, Marc; Kahn, Rebecca; Mina, Michael J.			Antibody testing will enhance the power and accuracy of COVID-19-prevention trials	NATURE MEDICINE			English	Editorial Material							SAFETY; INFLUENZA; EFFICACY; VACCINE	Researchers starting clinical trials of prevention measures for COVID-19 have a unique window of opportunity for collecting blood from the participants, at baseline and at the end of the trial, to be able to incorporate critical data into their analysis once serological tests for the causative coronavirus become available.	[Lipsitch, Marc; Kahn, Rebecca; Mina, Michael J.] Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Ctr Communicable Dis Dynam, Boston, MA 02115 USA; [Lipsitch, Marc; Mina, Michael J.] Harvard TH Chan Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health	Lipsitch, M (corresponding author), Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Ctr Communicable Dis Dynam, Boston, MA 02115 USA.; Lipsitch, M (corresponding author), Harvard TH Chan Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA.	mlipsitc@hsph.harvard.edu		Kahn, Rebecca/0000-0001-9511-6142; Lipsitch, Marc/0000-0003-1504-9213	NIH HHS [DP5 OD028145] Funding Source: Medline	NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Black S, 2000, PEDIATR INFECT DIS J, V19, P187, DOI 10.1097/00006454-200003000-00003; Cai FY, 2018, PLOS COMPUT BIOL, V14, DOI 10.1371/journal.pcbi.1006333; CALLOW KA, 1990, EPIDEMIOL INFECT, V105, P435, DOI 10.1017/S0950268800048019; Cowling BJ, 2009, ANN INTERN MED, V151, P437, DOI 10.7326/0003-4819-151-7-200910060-00142; Feng S, 2020, LANCET RESP MED, V8, P434, DOI 10.1016/S2213-2600(20)30134-X; Hernandez AV, 2006, ANN EPIDEMIOL, V16, P41, DOI 10.1016/j.annepidem.2005.09.007; Kahn R, 2019, AM J EPIDEMIOL, V188, P467, DOI 10.1093/aje/kwy239; Kimball A, 2020, MMWR-MORBID MORTAL W, V69, P377, DOI 10.15585/mmwr.mm6913e1; Lurie N., 2020, ENGL J MED, DOI [10.1056/NEJMp2005630, DOI 10.1056/NEJMP2005630]; Sivay MV, 2017, JAIDS-J ACQ IMM DEF, V75, P271, DOI 10.1097/QAI.0000000000001374; Sridhar S, 2018, NEW ENGL J MED, V379, P327, DOI 10.1056/NEJMoa1800820; Sukwa TY, 1999, AM J TROP MED HYG, V60, P521, DOI 10.4269/ajtmh.1999.60.521; Welliver R, 2001, JAMA-J AM MED ASSOC, V285, P748, DOI 10.1001/jama.285.6.748; Xue J, 2020, REINFECTION COULD NO, DOI [10.1101/2020.03.13.990226v2, DOI 10.1101/2020.03.13.990226V1, 10.1101/2020.03.13.990226]	14	29	29	0	15	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	JUN	2020	26	6					818	819		10.1038/s41591-020-0887-3	http://dx.doi.org/10.1038/s41591-020-0887-3		APR 2020	2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	LZ3ZG	32341581	Bronze			2022-12-27	WOS:000528983800001
J	Kinyoki, DK; Ross, JM; Lazzar-Atwood, A; Munro, SB; Schaeffer, LE; Bhattacharjee, NV; Collison, ML; Cork, MA; Cormier, N; Weaver, ND; Deshpande, A; Dharmaratne, SD; Earl, L; Henry, NJ; Hollerich, G; Johnson, KB; Kassebaum, NJ; Krohn, KJ; Letourneau, ID; Marczak, LB; Mayala, BK; Mokdad, AH; Mosser, JF; Murray, CJL; Naghavi, M; Osgood-Zimmerman, AE; Pickering, BV; Pigott, DM; Ray, SE; Sbarra, AN; Schipp, MF; VanderHeide, J; Wang, HD; Wiens, KE; Afshin, A; Hay, SI; Sartorius, B; Khalil, IA; Abbasalizad-Farhangi, M; Hasankhani, M; Abbasi, M; Farzam, H; Moradi, M; Rezaeian, S; Abbastabar, H; Abdelalim, A; El-Jaafary, SI; Shehata, HS; Abdoli, A; Abdollahi, M; Abdollahpour, I; Abdulkader, RS; Abebe, ND; Deribe, K; Abebo, TA; Abegaz, KH; Abolhassani, H; Rezaei, N; Abreu, LG; Abrigo, MRM; Abushouk, AI; Accrombessi, MMK; Acharya, D; Adabi, M; Adebiyi, AO; Ilesanmi, OS; Adedeji, IA; Adekanmbi, V; Adeoye, AM; Adetokunboh, OO; Mahasha, PW; Ndwandwe, DE; Nnaji, CA; Sambala, EZ; Adham, D; Aduroja, PE; Dipeolu, IO; Ibitoye, SE; John-Akinola, YO; Oluwasanu, MM; Advani, SM; Afarideh, M; Esteghamati, A; Ghajar, A; Heidari, B; Sayyah, M; Aghaali, M; Agrawal, A; Ahmad, T; Ahmadi, K; Ahmadi, S; Ahmed, MB; Gebrehiwot, TT; Gesesew, HA; Ahmed, R; Das Gupta, R; Ajumobi, O; Akal, CG; Demeke, FM; Melese, A; Akalu, TY; Baraki, AG; Mekonnen, FA; Sisay, MMM; Tamirat, KS; Tessema, ZT; Wolde, HF; Yeshaw, Y; Akinyemiju, T; Akombi, B; Karki, S; Al-Aly, Z; Alam, S; Alamene, GM; Alanzi, TM; Rabanal, JEA; Cahuana-Hurtado, L; Montero-Zamora, PA; Alema, NM; Araya, EM; Kassaye, HG; Ali, BA; Mohammad, KA; Ali, M; Alijanzadeh, M; Kalhor, R; Alinia, C; Yusefzadeh, H; Alipour, V; Arabloo, J; Azari, S; Rezapour, A; Sheikhtaheri, A; Moghadam, TZ; Alizade, H; Aljunid, SM; Almasi, A; Fattahi, N; Matin, BK; Karyani, AK; Pirsaheb, M; Rajati, F; Sadeghi, E; Safari, Y; Sharafi, K; Vasseghian, Y; Almasi-Hashiani, A; Moradzadeh, R; Zamanian, M; Al-Mekhlafi, HM; Al-Raddadi, RM; Altirkawi, K; Alvis-Guzman, N; Alvis-Zakzuk, NJ; Amare, AT; Gedefaw, GA; Amegah, AK; Amini, S; Rarani, MA; Amiri, F; Amit, AML; Anber, NH; Andrei, CL; Ansari, F; Ansari-Moghaddam, A; Anteneh, ZA; Asrat, AA; Bogale, KA; Zewale, TA; Antonio, CAT; Antriyandarti, E; Anvari, D; Anwer, R; Appiah, SCY; Arab-Zozani, M; Arefi, Z; Aremu, O; Arnlov, J; Fereshtehnejad, SM; Arzani, A; Jahani, MA; Mouodi, S; Asadi-Aliabadi, M; Babaee, E; Moradi-Lakeh, M; Asadi-Pooya, AA; Asgari, S; Asghari, B; Ashagre, AF; Ataeinia, B; Farzadfar, F; Mohebi, F; Atalay, HT; Gebremeskel, GG; Weldesamuel, GT; Atnafu, DD; Atout, MMW; Ausloos, M; Herteliu, C; Pana, A; Avokpaho, EFGA; Awasthi, A; Zodpey, S; Quintanilla, BPA; Ayanore, MA; Aynalem, YAA; Shiferaw, WS; Azadmehr, A; Azarian, G; Khazaei, M; Leili, M; Azene, ZN; Badawi, A; Badiye, AD; Kapoor, N; Bahrami, MA; Baig, AAA; Bakhtiari, A; Bakkannavar, SM; Nayak, V; Marami, D; Bali, AG; Banach, M; Banik, PC; Barua, L; Baradaran-Seyed, Z; Barboza, MA; Barnighausen, TW; De Neve, JW; Moazen, B; Mohammed, S; Dinsa, GD; Basaleem, H; Basu, S; Saxena, S; Bayati, M; Bayih, MT; Baynes, HW; Bedi, N; Behzadifar, M; Behzadifar, M; Bekele, YA; Nigatu, D; Bennett, DA; Karim, MA; Lacey, B; Berbada, DA; Geramo, YCD; Hayelom, DH; Meles, GG; Sorrie, MB; Berhe, K; Gebremariam, H; Gebretsadik, GGG; Kahsay, A; Berhe, AK; Berman, AE; Bernstein, RS; Narayan, KMV; Bhageerathy, R; Bhandari, D; Bharadwaj, P; Quazi Syed, Z; Bhattacharyya, K; Bijani, A; Bikbov, B; Bilano, V; Bililign, N; Bin Sayeed, MS; Lal, A; Birara, S; Kahssay, M; Mohammed, JA; Zepro, NB; Birhane, MBB; Birhanu, M; Biswas, RK; Bitew, ZW; Bohlouli, S; Bolla, SR; Boloor, A; Borzi, AM; Vacante, M; Borzouei, S; Brady, OJ; Bragazzi, NL; Braithwaite, D; Briko, NI; Britton, G; Castro, F; Budhathoki, SS; Nagaraja, SB; Busse, R; Butt, ZA; Camera, LA; Campos-Nonato, IR; Cano, J; Car, J; Cardenas, R; Carrero, JJ; Carvalho, F; Costa, VM; Castaldelli-Maia, JM; Wang, YP; Castaneda-Orjuela, CA; Cerin, E; Chansa, C; Charan, J; Chatterjee, P; Chattu, VK; Chauhan, BG; Goli, S; Kumar, P; Chavshin, AR; Chehrazi, M; Chichiabellu, TY; Chin, KL; Christopher, DJ; Chu, DT; Cicuttini, FM; Guo, YM; Li, SS; Cortesi, PA; Dadi, AFF; Dagnew, B; Dahlawi, SMA; Damiani, G; Darwish, AH; Daryani, A; Das, JK; Davila-Cervantes, C; De Leo, D; Demis, AB; Tlaye, KG; Demissie, DB; Demoz, GT; Kasahun, GG; Denova-Gutierrez, E; Desai, R; Desalegn, BB; Desalew, A; Dey, S; Dhillon, P; Dhimal, M; Dhungana, GP; Nasab, MD; Diaz, D; Forooshani, ZSD; Djalalinia, S; Do, HT; Do, HP; Hoang, CL; Doku, PN; Dorostkar, F; Doshmangir, L; Dubey, M; Adema, BD; Dunachie, SJ; Lewycka, S; Duncan, BB; Cousin, E; Schmidt, MI; Duraes, AR; Leylabadlo, HE; Eftekhari, A; El Sayed, I; Zaki, ME; El-Sherbiny, YM; El Tantawi, M; Elbarazi, I; Grivna, M; Elemineh, DA; El-Khatib, Z; Elsharkawy, A; Elyazar, IRF; Emamian, MH; Enany, S; Endalew, DA; Endalifer, ML; Eskandari, K; Eskandarieh, S; Sahraian, MA; Esmaeilnejad, S; Etemadi, A; Etisso, AE; Fanzo, J; Farahmand, M; Faraj, A; Farashi, S; Fareed, M; Farioli, A; Violante, FS; Faro, A; Fatima, SS; Fauk, NK; Fazaeli, AA; Fentahun, N; Ferede, TY; Fernandes, E; Gomes, NGM; Fernandes, JC; Feyissa, GT; Filip, I; Fischer, F; Flohr, C; Foigt, NA; Folayan, MO; Fomenkov, AA; Titova, MV; Foroutan, M; Forster, J; Francis, JM; Fukumoto, T; Gayesa, RT; Kasaye, HK; Geberemariyam, BS; Handiso, DW; Gebremariam, KT; Gebreslassie, AAA; Gebremedhin, KBB; Wondmieneh, AB; Geta, B; Getenet, AB; Yeshitila, YG; Gezae, KE; Ghaffarifar, F; Pirestani, M; Zaki, L; Ghafourifard, M; Ghajar, A; Ghajarzadeh, M; Ghashghaee, A; Ghiasvand, H; Gholamian, A; Gilani, SA; Gill, TK; Ginawi, IA; Gopalani, SV; Goudarzi, H; Goulart, AC; Govindakarnavar, A; Grada, A; Guimaraes, RA; Guled, RA; Gupta, R; Gupta, R; Hafezi-Nejad, N; Haj-Mirzaian, A; Shafaat, O; Haile, MT; Haj-Mirzaian, A; Hall, BJ; Halvaei, I; Hamadeh, RR; Hamidi, Y; Hankey, GJ; Haririan, H; Hariyani, N; Hasaballah, AI; Hasan, MM; Hasanpoor, E; Hasanzadeh, A; Hashemian, M; Hassanipour, S; Joukar, F; Mansour-Ghanaei, F; Hassen, HY; Henok, A; Havmoeller, R; Hawkes, C; Hayat, K; Heidari-Soureshjani, R; Hendrie, D; Miller, TR; Herrero, M; Heydarpour, F; Soleymani, B; de Hidru, HD; Hoek, HW; Hole, MK; Holla, R; Rad, EH; Hong, SH; Hoogar, P; Horino, M; Hossain, N; Hosseini, M; Mansournia, MA; Tohidinik, HR; Hosseinzadeh, M; Hostiuc, M; Negoi, I; Hostiuc, S; Househ, M; Hsairi, M; Hu, GQ; Huda, TM; Karim, MA; Bin Zaman, S; Humayun, A; Hwang, BF; Ilic, MD; Imani-Nasab, MH; Inbaraj, LR; Iqbal, U; Irvani, SSN; Islam, SMS; Iwu, CCD; Iwu, CJ; Izadi, N; Riahi, SM; Sabour, S; Jaafari, J; Jaca, A; Jadidi-Niaragh, F; Balalami, NJ; Jafarinia, M; Jakovljevic, M; Jalali, A; Jalilian, F; Mirzaei-Alavijeh, M; Salimi, Y; Jayatilleke, AU; Jeemon, P; Mini, GK; Jehan, F; Jenabi, E; Jha, RP; Jha, V; John, O; Ji, JS; Jia, P; Jonas, JB; Joseph, N; Mithra, P; Unnikrishnan, B; Jozwiak, JJ; Jungari, SB; Jurisson, M; Kabir, A; Kabir, Z; Kalani, H; Kalankesh, LL; Kamiab, Z; Kanchan, T; Kapil, U; Karami, M; Khazaei, S; Karch, A; Kasaeian, A; Kassa, TD; Kianipour, N; Kengne, AP; Mensah, GA; Noubiap, JJ; Ketema, DB; Wonde, TE; Khader, YS; Khafaie, MA; Khaksarian, M; Khalid, N; Khalilov, R; Khan, A; Uddin, R; Khan, EA; Khan, MN; Khan, MS; Khan, MS; Siddiqi, TJ; Usman, MS; Khatab, K; Khater, A; Khater, MM; Yousof, HASA; Khatib, MN; Khayamzadeh, M; Khazaei-Pool, M; Khodayari, MT; Khosravi, MH; Khundkar, R; Kiadaliri, A; Kiirithio, DN; Kim, YJ; Kimokoti, RW; Kisa, A; Kisa, S; Kolola, T; Komaki, H; Kondlahalli, SKM; Koolivand, A; Koul, PA; Koyanagi, A; Kraemer, MUG; Krishan, K; Kugbey, N; Zotor, FB; Asante, KO; Kumar, M; Kumar, V; Kurmi, OP; Olagunju, TO; Kuti, O; La Vecchia, C; Lacey, B; Lad, DP; Lal, DK; Lami, FH; Lamichhane, P; Lang, JJ; Lansingh, VC; Lasrado, S; Lebedev, G; Lee, PH; Lee, SWH; Lim, LL; Linn, S; Shuval, K; Liu, SW; Liu, SM; Lodha, R; Longbottom, J; Lopez, JCF; Lorkowski, S; Macarayan, ERK; Madadin, M; Abd El Razek, HM; Abd El Razek, MM; Maghavani, DP; Mahotra, NB; Maled, V; Maleki, A; Pashaei, T; Maleki, S; Naderi, M; Malta, DC; Manafi, A; Manafi, F; Manafi, N; Manohar, ND; Mansouri, B; Mapoma, CC; Arnedo, CAM; Martins-Melo, FR; Masaka, A; Massenburg, BB; Maulik, PK; Mazidi, M; Mehndiratta, MM; Mehri, F; Mehta, KM; Meitei, WB; Mekonnen, T; Meles, HG; Mendoza, W; Menezes, RG; Mengesha, MB; Meretoja, TJ; Miazgowski, T; Kostova, NM; Mills, EJ; Mir, SM; Mosapour, A; Parsian, H; Miri, M; Mirjalali, H; Yadegar, A; Mirrakhimov, EM; Mirzaei, H; Mirzaei, M; Mirzaei, R; Mohamadi, E; Mohamadi-Bolbanabad, A; Moradi, G; Moradpour, F; Piroozi, B; Mohammad, Y; Mohammad, DK; Darwesh, AM; Mezerji, NMG; Mohammadian-Hafshejani, A; Mohammadnia-Afrouzi, M; Mohammadoo-Khorasani, M; Mohammadpourhodki, R; Mohammed, S; Mohammed, AS; Mokari, A; Montanez, JC; Moodley, Y; Moossavi, M; Moradi, Y; Moradi-Joo, M; Moraga, P; Morrison, SD; Khaneghah, AM; Mozaffarian, D; Mueller, UO; Werdecker, A; Murthy, GVS; Musa, KI; Mustafa, G; Muthupandian, S; Nabavizadeh, B; Nadkarni, GN; Nagarajan, AJ; Naheed, A; Naik, G; Najafi, F; Nansseu, JR; Nascimento, BR; Nazari, J; Negoi, RI; Ngunjiri, JW; Nguyen, CT; Nguyen, HLT; Nong, VM; Nigatu, YT; Nikbakhsh, R; Ningrum, DNA; Nowak, C; Oancea, B; Ofori-Asenso, R; Oghenetega, OB; Oh, IH; Oladimeji, O; Oladnabi, M; Olagunju, AT; Olusanya, BO; Olusanya, JO; Omer, MO; Onwujekwe, OE; Asante, KO; Oren, E; Orisakwe, OE; Ortiz, A; Osarenotor, O; Owolabi, MO; Mahesh, PA; Padubidri, JR; Rastogi, P; Pakshir, K; Zomorodian, K; Panda-Jonas, S; Pasupula, DK; Patel, SK; Pathak, A; Pathak, M; Pati, S; Patle, A; Patton, GC; Paulos, K; Toroudi, HP; Pepito, VCF; Perico, N; Remuzzi, G; Petri, WA; Pokhrel, KN; Postma, MJ; Pourjafar, H; Pourmalek, F; Kalhori, RP; Pourshams, A; Poustchi, H; Roshandel, G; Salimzadeh, H; Prada, SI; Preotescu, L; Pribadi, DRA; Rabiee, M; Rabiee, N; Radfar, A; Rafiei, A; Rahim, F; Rahimi-Movaghar, V; Rahman, MA; ur Rahman, S; Rai, RK; Vollmer, S; Rajabpour-Sanati, A; Ramezanzadeh, K; Rana, SM; Ranabhat, CL; Rao, SJ; Rasella, D; Rashedi, V; Rathi, P; Rawaf, S; Rawaf, DL; Rawal, L; Renjith, V; Renzaho, AMN; Resnikoff, S; Rezaei, N; Rezai, MS; Ribeiro, AI; Rickard, J; Rodriguez, A; Roever, L; Roro, EM; Yilma, MT; Roshandel, G; Rostami, A; Rubagotti, E; Saad, AM; Saadatagah, S; Sabde, YD; Sadeghi, M; Safari, S; Safarpour, H; Sagar, R; Sahebkar, A; Sajadi, SM; Salahshoor, MR; Salam, N; Salehi, F; Zahabi, SS; Salem, H; Salem, MRR; Kafil, HS; Samy, AM; Santos, IS; Jose, BPS; Saraswathy, SYI; Sarker, AR; Sarveazad, A; Sathian, B; Satpathy, M; Schutte, AE; Schwebel, DC; Senbeta, AM; Senthilkumaran, S; Seyedmousavi, S; Shaahmadi, F; Shahabi, S; Shaikh, MA; Shalash, AS; Shams-Beyranvand, M; Shamshirian, A; Shamsizadeh, M; Shannawaz, M; Sharif, M; Sharma, R; Sheikhtaheri, A; Shibuya, K; Shigematsu, M; Shin, JI; Shiri, R; Shirkoohi, R; Shiue, I; Siabani, S; Sigfusdottir, ID; Silva, DAS; Simonetti, B; Singh, A; Singh, P; Singh, V; Singh, JA; Singh, PK; Sinha, DN; Sintayehu, Y; Soheili, A; Soltani, F; Soltani, S; Soriano, JB; Soshnikov, S; Soyiri, IN; Spotin, A; Sreeramareddy, CT; Srivastava, RKK; Starodubova, A; Sudaryanto, A; Sufiyan, MB; Suleria, HAR; Sulo, G; Sunguya, BF; Sykes, BL; Tabares-Seisdedos, R; Tabuchi, T; Tadesse, BT; Taherkhani, A; Tassew, SG; Taveira, N; Teklehaimanot, BF; Tekulu, GH; Temsah, MH; Terkawi, AS; Thomas, N; Tonelli, M; Tovani-Palone, MR; Traini, E; Tran, KB; Tripathi, M; Ullah, I; Upadhyay, E; Useh, U; Uthman, OA; Vaezghasemi, M; Valdez, PR; Varavikova, E; Varughese, S; Vasankari, TJ; Veisani, Y; Venkatesh, S; Venketasubramanian, N; Verma, M; Vidale, S; Vlassov, V; Vukovic, R; Waheed, Y; Wang, YF; Yu, CH; Wiangkham, T; Wijeratne, T; Wondafrash, DZ; Wondmieneh, AB; Wu, AM; Xu, GL; Yadollahpour, A; Jabbari, SHY; Yamada, T; Yano, Y; Yaya, S; Yazdi-Feyzabadi, V; Yeshaneh, A; Yip, P; Yonemoto, N; Yoon, SJ; Youm, Y; Younis, MZ; Yousefi, Z; Zandian, H; Zamani, M; Zarafshan, H; Zerfu, TA; Zhang, YQ; Zhang, ZJ; Zhao, XJ				Kinyoki, Damaris K.; Ross, Jennifer M.; Lazzar-Atwood, Alice; Munro, Sandra B.; Schaeffer, Lauren E.; Bhattacharjee, Natalia V.; Collison, Michael L.; Cork, Michael A.; Cormier, Natalie; Weaver, Nicole Davis; Deshpande, Aniruddha; Dharmaratne, Samath Dhamminda; Earl, Lucas; Henry, Nathaniel J.; Hollerich, Gillian; Johnson, Kimberly B.; Kassebaum, Nicholas J.; Krohn, Kris J.; Letourneau, Ian D.; Marczak, Laurie B.; Mayala, Benjamin K.; Mokdad, Ali H.; Mosser, Jonathan F.; Murray, Christopher J. L.; Naghavi, Mohsen; Osgood-Zimmerman, Aaron E.; Pickering, Brandon V.; Pigott, David M.; Ray, Sarah E.; Sbarra, Alyssa N.; Schipp, Megan F.; VanderHeide, John; Wang, Haidong; Wiens, Kirsten E.; Afshin, Ashkan; Hay, Simon I.; Sartorius, Benn; Khalil, Ibrahim A.; Abbasalizad-Farhangi, Mahdieh M.; Hasankhani, Milad; Abbasi, Masoumeh; Farzam, Hossein; Moradi, Masoud; Rezaeian, Shahab; Abbastabar, Hedayat; Abdelalim, Ahmed; El-Jaafary, Shaimaa I.; Shehata, Hatem Samir; Abdoli, Amir; Abdollahi, Mohammad; Abdollahpour, Ibrahim; Abdulkader, Rizwan Suliankatchi; Abebe, Nebiyu Dereje; Deribe, Kebede; Abebo, Teshome Abuka; Abegaz, Kedir Hussein; Abolhassani, Hassan; Rezaei, Nima; Abreu, Lucas Guimaraes; Abrigo, Michael R. M.; Abushouk, Abdelrahman I.; Accrombessi, Manfred Mario Kokou; Acharya, Dilaram; Adabi, Maryam; Adebiyi, Akindele Olupelumi; Ilesanmi, Olayinka Stephen; Adedeji, Isaac Akinkunmi; Adekanmbi, Victor; Adeoye, Abiodun Moshood; Adetokunboh, Olatunji O.; Mahasha, Phetole Walter; Ndwandwe, Duduzile Edith; Nnaji, Chukwudi A.; Sambala, Evanson Zondani; Adham, Davoud; Aduroja, Posi Emmanuel; Dipeolu, Isaac Oluwafemi; Ibitoye, Segun Emmanuel; John-Akinola, Yetunde O.; Oluwasanu, Mojisola Morenike; Advani, Shailesh M.; Afarideh, Mohsen; Esteghamati, Alireza; Ghajar, Alireza; Heidari, Behnam; Sayyah, Mehdi; Aghaali, Mohammad; Agrawal, Anurag; Ahmad, Tauseef; Ahmadi, Keivan; Ahmadi, Sepideh; Ahmed, Muktar Beshir; Gebrehiwot, Tsegaye Tewelde; Gesesew, Hailay Abrha; Ahmed, Rushdia; Das Gupta, Rajat; Ajumobi, Olufemi; Akal, Chalachew Genet; Demeke, Feleke Mekonnen; Melese, Addisu; Akalu, Temesgen Yihunie; Baraki, Adhanom Gebreegziabher; Mekonnen, Fantahun Ayenew; Sisay, Malede Mequanent M.; Tamirat, Koku Sisay; Tessema, Zemenu Tadesse; Wolde, Haileab Fekadu; Yeshaw, Yigizie; Akinyemiju, Tomi; Akombi, Blessing; Karki, Surendra; Al-Aly, Ziyad; Alam, Samiah; Alamene, Genet Melak; Alanzi, Turki M.; Alcalde Rabanal, Jacqueline Elizabeth; Cahuana-Hurtado, Lucero; Montero-Zamora, Pablo A.; Alema, Niguse Meles; Araya, Ephrem Mebrahtu; Kassaye, Hagazi Gebremedhin; Ali, Beriwan Abdulqadir; Mohammad, Karzan Abdulmuhsin; Ali, Muhammad; Alijanzadeh, Mehran; Kalhor, Rohollah; Alinia, Cyrus; Yusefzadeh, Hasan; Alipour, Vahid; Arabloo, Jalal; Azari, Samad; Rezapour, Aziz; Sheikhtaheri, Abbas; Moghadam, Telma Zahirian; Alizade, Hesam; Aljunid, Syed Mohamed; Almasi, Afshin; Fattahi, Nazir; Matin, Behzad Karami; Karyani, Ali Kazemi; Pirsaheb, Meghdad; Rajati, Fatemeh; Sadeghi, Ehsan; Safari, Yahya; Sharafi, Kiomars; Vasseghian, Yasser; Almasi-Hashiani, Amir; Moradzadeh, Rahmatollah; Zamanian, Maryam; Al-Mekhlafi, Hesham M.; Al-Raddadi, Rajaa M.; Altirkawi, Khalid; Alvis-Guzman, Nelson; Alvis-Zakzuk, Nelson J.; Amare, Azmeraw T.; Gedefaw, Getnet Azeze; Amegah, Adeladza Kofi; Amini, Saeed; Rarani, Mostafa Amini; Amiri, Fatemeh; Amit, Arianna Maever Loreche; Anber, Nahla Hamed; Andrei, Catalina Liliana; Ansari, Fereshteh; Ansari-Moghaddam, Alireza; Anteneh, Zelalem Alamrew; Asrat, Anemaw A.; Bogale, Kassawmar Angaw; Zewale, Taye Abuhay; Antonio, Carl Abelardo T.; Antriyandarti, Ernoiz; Anvari, Davood; Anwer, Razique; Appiah, Seth Christopher Yaw; Arab-Zozani, Morteza; Arefi, Zohreh; Aremu, Olatunde; Arnlov, Johan; Fereshtehnejad, Seyed-Mohammad; Arzani, Afsaneh; Jahani, Mohammad Ali; Mouodi, Simin; Asadi-Aliabadi, Mehran; Babaee, Ebrahim; Moradi-Lakeh, Maziar; Asadi-Pooya, Ali A.; Asgari, Samaneh; Asghari, Babak; Ashagre, Alebachew Fasil; Ataeinia, Bahar; Farzadfar, Farshad; Mohebi, Farnam; Atalay, Hagos Tasew; Gebremeskel, Gebreamlak Gebremedhn; Weldesamuel, Girmay Teklay; Atnafu, Desta Debalkie; Atout, Maha Moh'd Wahbi; Ausloos, Marcel; Herteliu, Claudiu; Pana, Adrian; Avokpaho, Euripide F. G. A.; Awasthi, Ashish; Zodpey, Sanjay; Quintanilla, Beatriz Paulina Ayala; Ayanore, Martin Amogre; Aynalem, Yared A. Asmare; Shiferaw, Wondimeneh Shibabaw; Azadmehr, Abbas; Azarian, Ghasem; Khazaei, Mohammad; Leili, Mostafa; Azene, Zelalem Nigussie; Badawi, Alaa; Badiye, Ashish D.; Kapoor, Neeti; Bahrami, Mohamad Amin; Baig, Atif Amin A.; Bakhtiari, Ahad; Bakkannavar, Shankar M.; Nayak, Vinod; Marami, Dadi; Bali, Ayele Geleto; Banach, Maciej; Banik, Palash Chandra; Barua, Lingkan; Baradaran-Seyed, Zahra; Barboza, Miguel A.; Baernighausen, Till Winfried; De Neve, Jan-Walter; Moazen, Babak; Mohammed, Shafiu; Dinsa, Girmaye Deye; Basaleem, Huda; Basu, Sanjay; Saxena, Sonia; Bayati, Mohsen; Bayih, Mulat Tirfie; Baynes, Habtamu Wondifraw; Bedi, Neeraj; Behzadifar, Masoud; Behzadifar, Meysam; Bekele, Yibeltal Alemu; Nigatu, Dabere; Bennett, Derrick A.; Karim, Mohd A.; Lacey, Ben; Berbada, Dessalegn Ajema; Geramo, Yilma Chisha Dea; Hayelom, Desta Haftu; Meles, Gebrekiros Gebremichael; Sorrie, Muluken Bekele; Berhe, Kidanemaryam; Gebremariam, Hadush; Gebretsadik, Gebretsadkan G. G.; Kahsay, Amaha; Berhe, Abadi Kidanemariam; Berman, Adam E.; Bernstein, Robert S.; Narayan, K. M. Venkat; Bhageerathy, Reshmi; Bhandari, Dinesh; Bharadwaj, Pankaj; Quazi Syed, Zahiruddin; Bhattacharyya, Krittika; Bijani, Ali; Bikbov, Boris; Bilano, Ver; Bililign, Nigus; Bin Sayeed, Muhammad Shahdaat; Lal, Aparna; Birara, Setognal; Kahssay, Molla; Mohammed, Jemal Abdu; Zepro, Nejimu Biza; Birhane, Minuye Biniam Biniam; Birhanu, Minyichil; Biswas, Raaj Kishore; Bitew, Zebenay Workneh; Bohlouli, Somayeh; Bolla, Srinivasa Rao; Boloor, Archith; Borzi, Antonio M.; Vacante, Marco; Borzouei, Shiva; Brady, Oliver J.; Bragazzi, Nicola Luigi; Braithwaite, Dejana; Briko, Nikolay Ivanovich; Britton, Gabrielle; Castro, Franz; Budhathoki, Shyam S.; Nagaraja, Sharath Burugina; Busse, Reinhard; Butt, Zahid A.; Alberto Camera, Luis; Campos-Nonato, Ismael R.; Cano, Jorge; Car, Josip; Cardenas, Rosario; Carrero, Juan J.; Carvalho, Felix; Costa, Vera M.; Castaldelli-Maia, Joao Mauricio; Wang, Yuan-Pang; Castaneda-Orjuela, Carlos A.; Cerin, Ester; Chansa, Collins; Charan, Jaykaran; Chatterjee, Pranab; Chattu, Vijay Kumar; Chauhan, Bal Govind; Goli, Srinivas; Kumar, Pushpendra; Chavshin, Ali Reza; Chehrazi, Mohammad; Chichiabellu, Tesfaye Yitna; Chin, Ken Lee; Christopher, Devasahayam J.; Dinh-Toi Chu; Cicuttini, Flavia M.; Guo, Yuming; Li, Shanshan; Cortesi, Paolo Angelo; Dadi, Abel Fekadu Fekadu; Dagnew, Baye; Dahlawi, Saad M. A.; Damiani, Giovanni; Darwish, Amira Hamed; Daryani, Ahmad; Das, Jai K.; Davila-Cervantes, Claudio; De Leo, Diego; Demis, Asmamaw Bizuneh; Tlaye, Kenean Getaneh; Demissie, Dereje Bayissa; Demoz, Gebre Teklemariam; Kasahun, Gebremicheal Gebreslassie; Denova-Gutierrez, Edgar; Desai, Rupak; Desalegn, Beruk Berhanu; Desalew, Assefa; Dey, Sagnik; Dhillon, Preeti; Dhimal, Meghnath; Dhungana, Govinda Prasad; Nasab, Mostafa Dianati; Diaz, Daniel; Forooshani, Zahra Sadat Dibaji; Djalalinia, Shirin; Hoa Thi Do; Huyen Phuc Do; Chi Linh Hoang; Doku, Paul Narh; Dorostkar, Fariba; Doshmangir, Leila; Dubey, Manisha; Adema, Bereket Duko; Dunachie, Susanna J.; Lewycka, Sonia; Duncan, Bruce B.; Cousin, Ewerton; Schmidt, Maria Ines; Duraes, Andre R.; Leylabadlo, Hamed Ebrahimzadeh; Eftekhari, Aziz; El Sayed, Iman; Zaki, Maysaa El Sayed; El-Sherbiny, Yasser Mohamed; El Tantawi, Maha; Elbarazi, Iffat; Grivna, Michal; Elemineh, Demelash Abewa; El-Khatib, Ziad; Elsharkawy, Aisha; Elyazar, Iqbal R. F.; Emamian, Mohammad Hassan; Enany, Shymaa; Endalew, Daniel Adane; Endalifer, Melese Linger; Eskandari, Khalil; Eskandarieh, Sharareh; Sahraian, Mohammad Ali; Esmaeilnejad, Saman; Etemadi, Arash; Etisso, Atkilt Esaiyas; Fanzo, Jessica; Farahmand, Mohammad; Faraj, Anwar; Farashi, Sajjad; Fareed, Mohammad; Farioli, Andrea; Violante, Francesco S.; Faro, Andre; Fatima, Syeda Sadia; Fauk, Nelsensius Klau; Fazaeli, Ali Akbar; Fentahun, Netsanet; Ferede, Tomas Y.; Fernandes, Eduarda; Gomes, Nelson G. M.; Fernandes, Joao C.; Feyissa, Garumma Tolu; Filip, Irina; Fischer, Florian; Flohr, Carsten; Foigt, Nataliya A.; Folayan, Morenike Oluwatoyin; Fomenkov, Artem Alekseevich; Titova, Mariya Vladimirovna; Foroutan, Masoud; Foerster, Jana; Francis, Joel Msafiri; Fukumoto, Takeshi; Gayesa, Reta Tsegaye; Kasaye, Habtamu Kebebe; Geberemariyam, Biniyam Sahiledengle; Handiso, Demelash Woldeyohannes; Gebremariam, Kidane Tadesse; Gebreslassie, Assefa Ayalew Ayalew; Gebremedhin, Ketema Bizuwork Bizuwork; Wondmieneh, Adam Belay; Geta, Birhanu; Getenet, Agegnehu Bante; Yeshitila, Yordanos Gizachew; Gezae, Kebede Embaye; Ghaffarifar, Fatemeh; Pirestani, Majid; Zaki, Leila; Ghafourifard, Mansour; Ghajar, Alireza; Ghajarzadeh, Mahsa; Ghashghaee, Ahmad; Ghiasvand, Hesam; Gholamian, Asadollah; Gilani, Syed Amir; Gill, Tiffany K.; Ginawi, Ibrahim Abdelmageed; Gopalani, Sameer Vali; Goudarzi, Houman; Goulart, Alessandra C.; Govindakarnavar, Arunkumar; Grada, Ayman; Guimaraes, Rafael Alves; Guled, Rashid Abdi; Gupta, Rahul; Gupta, Rajeev; Hafezi-Nejad, Nima; Haj-Mirzaian, Arya; Shafaat, Omid; Haile, Michael Tamene; Haj-Mirzaian, Arvin; Hall, Brian J.; Halvaei, Iman; Hamadeh, Randah R.; Hamidi, Yadollah; Hankey, Graeme J.; Haririan, Hamidreza; Hariyani, Ninuk; Hasaballah, Ahmed I.; Hasan, Md. Mehedi; Hasanpoor, Edris; Hasanzadeh, Amir; Hashemian, Maryam; Hassanipour, Soheil; Joukar, Farahnaz; Mansour-Ghanaei, Fariborz; Hassen, Hamid Yimam; Henok, Andualem; Havmoeller, Rasmus; Hawkes, Corinna; Hayat, Khezar; Heidari-Soureshjani, Reza; Hendrie, Delia; Miller, Ted R.; Herrero, Mario; Heydarpour, Fatemeh; Soleymani, Bija; de Hidru, Hagos D.; Hoek, Hans W.; Hole, Michael K.; Holla, Ramesh; Rad, Enayatollah Homaie; Hong, Sung Hwi; Hoogar, Praveen; Horino, Masako; Hossain, Naznin; Hosseini, Mostafa; Mansournia, Mohammad Ali; Tohidinik, Hamid Reza; Hosseinzadeh, Mehdi; Hostiuc, Mihaela; Negoi, Ionut; Hostiuc, Sorin; Househ, Mowafa; Hsairi, Mohamed; Hu, Guoqing; Huda, Tanvir M.; Karim, Mohd A.; Bin Zaman, Sojib; Humayun, Ayesha; Hwang, Bing-Fang; Ilic, Milena D.; Imani-Nasab, Mohammad Hasan; Inbaraj, Leeberk Raja; Iqbal, Usman; Irvani, Seyed Sina Naghibi; Islam, Sheikh Mohammed Shariful; Iwu, Chidozie C. D.; Iwu, Chinwe Juliana; Izadi, Neda; Riahi, Seyed Mohammad; Sabour, Siamak; Jaafari, Jalil; Jaca, Anelisa; Jadidi-Niaragh, Farhad; Balalami, Nader Jafari; Jafarinia, Morteza; Jakovljevic, Mihajlo; Jalali, Amir; Jalilian, Farzad; Mirzaei-Alavijeh, Mehdi; Salimi, Yahya; Jayatilleke, Achala Upendra; Jeemon, Panniyammakal; Mini, G. K.; Jehan, Fyezah; Jenabi, Ensiyeh; Jha, Ravi Prakash; Jha, Vivekanand; John, Oommen; Ji, John S.; Jia, Peng; Jonas, Jost B.; Joseph, Nitin; Mithra, Prasanna; Unnikrishnan, Bhaskaran; Jozwiak, Jacek Jerzy; Jungari, Suresh Banayya; Jurisson, Mikk; Kabir, Ali; Kabir, Zubair; Kalani, Hamed; Kalankesh, Leila L.; Kamiab, Zahra; Kanchan, Tanuj; Kapil, Umesh; Karami, Manoochehr; Khazaei, Salman; Karch, Andre; Kasaeian, Amir; Kassa, Tesfaye Dessale; Kianipour, Neda; Kengne, Andre Pascal; Mensah, George A.; Noubiap, Jean Jacques; Ketema, Daniel Bekele; Wonde, Tewodros Eshete; Khader, Yousef Saleh; Khafaie, Morteza Abdullatif; Khaksarian, Mojtaba; Khalid, Nauman; Khalilov, Rovshan; Khan, Asad; Uddin, Riaz; Khan, Ejaz Ahmad; Khan, Md Nuruzzaman; Khan, Mohammad Saud; Khan, Muhammad Shahzeb; Siddiqi, Tariq J.; Usman, Muhammad Shariq; Khatab, Khaled; Khater, Amir; Khater, Mona M.; Yousof, Hebat-Allah Salah A.; Khatib, Mahalqua Nazli; Khayamzadeh, Maryam; Khazaei-Pool, Maryam; Khodayari, Mohammad Taghi; Khosravi, Mohammad Hossein; Khundkar, Roba; Kiadaliri, Ali; Kiirithio, Daniel N.; Kim, Yun Jin; Kimokoti, Ruth W.; Kisa, Adnan; Kisa, Sezer; Kolola, Tufa; Komaki, Hamidreza; Kondlahalli, Shivakumar K. M.; Koolivand, Ali; Koul, Parvaiz A.; Koyanagi, Ai; Kraemer, Moritz U. G.; Krishan, Kewal; Kugbey, Nuworza; Zotor, Francis Bruno; Asante, Kwaku Oppong; Kumar, Manasi; Kumar, Vivek; Kurmi, Om P.; Olagunju, Tinuke O.; Kuti, Oluwatosin; La Vecchia, Carlo; Lacey, Ben; Lad, Deepesh P.; Lal, Dharmesh Kumar; Lami, Faris Hasan; Lamichhane, Prabhat; Lang, Justin J.; Lansingh, Van C.; Lasrado, Savita; Lebedev, Georgy; Lee, Paul H.; Lee, Shaun Wen Huey; Lim, Lee-Ling; Linn, Shai; Shuval, Kerem; Liu, Shiwei; Liu, Simin; Lodha, Rakesh; Longbottom, Joshua; Lopez, Jaifred Christian F.; Lorkowski, Stefan; Macarayan, Erlyn Rachelle King; Madadin, Mohammed; Abd El Razek, Hassan Magdy; Abd El Razek, Muhammed Magdy; Maghavani, Dhaval P.; Mahotra, Narayan Bahadur; Maled, Venkatesh; Maleki, Afshin; Pashaei, Tahereh; Maleki, Shokofeh; Naderi, Mehdi; Malta, Deborah Carvalho; Manafi, Ali; Manafi, Farzad; Manafi, Navid; Manohar, Narendar Dawanu; Mansouri, Borhan; Mapoma, Chabila Christopher; Marrugo Arnedo, Carlos Alberto; Rogerlandio Martins-Melo, Francisco; Masaka, Anthony; Massenburg, Benjamin Ballard; Maulik, Pallab K.; Mazidi, Mohsen; Mehndiratta, Man Mohan; Mehri, Freshteh; Mehta, Kala M.; Meitei, Wahengbam Bigyananda; Mekonnen, Teferi; Meles, Hagazi Gebre; Mendoza, Walter; Menezes, Ritesh G.; Mengesha, Meresa Berwo; Meretoja, Tuomo J.; Miazgowski, Tomasz; Kostova, Neda Milevska; Mills, Edward J.; Mir, Seyed Mostafa; Mosapour, Abbas; Parsian, Hadi; Miri, Mohammad; Mirjalali, Hamed; Yadegar, Abbas; Mirrakhimov, Erkin M.; Mirzaei, Hamed; Mirzaei, Maryam; Mirzaei, Roya; Mohamadi, Efat; Mohamadi-Bolbanabad, Amjad; Moradi, Ghobad; Moradpour, Farhad; Piroozi, Bakhtiar; Mohammad, Yousef; Mohammad, Dara K.; Darwesh, Aso Mohammad; Mezerji, Naser Mohammad Gholi; Mohammadian-Hafshejani, Abdollah; Mohammadnia-Afrouzi, Mousa; Mohammadoo-Khorasani, Milad; Mohammadpourhodki, Reza; Mohammed, Salahuddin; Mohammed, Ammas Siraj; Mokari, Amin; Cesar Montanez, Julio; Moodley, Yoshan; Moossavi, Maryam; Moradi, Yousef; Moradi-Joo, Mohammad; Moraga, Paula; Morrison, Shane Douglas; Khaneghah, Amin Mousavi; Mozaffarian, Dariush; Mueller, Ulrich Otto; Werdecker, Andrea; Murthy, G. V. S.; Musa, Kamarul Imran; Mustafa, Ghulam; Muthupandian, Saravanan; Nabavizadeh, Behnam; Nadkarni, Girish N.; Nagarajan, Ahamarshan Jayaraman; Naheed, Aliya; Naik, Gurudatta; Najafi, Farid; Nansseu, Jobert Richie; Nascimento, Bruno Ramos; Nazari, Javad; Negoi, Ruxandra Irina; Ngunjiri, Josephine W.; Cuong Tat Nguyen; Huong Lan Thi Nguyen; Vuong Minh Nong; Nigatu, Yeshambel T.; Nikbakhsh, Rajan; Ningrum, Dina Nur Anggraini; Nowak, Christoph; Oancea, Bogdan; Ofori-Asenso, Richard; Oghenetega, Onome Bright; Oh, In-Hwan; Oladimeji, Olanrewaju; Oladnabi, Morteza; Olagunju, Andrew T.; Olusanya, Bolajoko Olubukunola; Olusanya, Jacob Olusegun; Omer, Muktar Omer; Onwujekwe, Obinna E.; Asante, Kwaku Oppong; Oren, Eyal; Orisakwe, Orish Ebere; Ortiz, Alberto; Osarenotor, Osayomwanbo; Owolabi, Mayowa Ojo; Mahesh, P. A.; Padubidri, Jagadish Rao; Rastogi, Prateek; Pakshir, Keyvan; Zomorodian, Kamiar; Panda-Jonas, Songhomitra; Pasupula, Deepak Kumar; Patel, Sangram Kishor; Pathak, Ashish; Pathak, Mona; Pati, Sanghamitra; Patle, Ajay; Patton, George C.; Paulos, Kebreab; Toroudi, Hamidreza Pazoki; Pepito, Veincent Christian Filipino; Perico, Norberto; Remuzzi, Giuseppe; Petri, William A.; Pokhrel, Khem Narayan; Postma, Maarten J.; Pourjafar, Hadi; Pourmalek, Farshad; Kalhori, Reza Pourmirza; Pourshams, Akram; Poustchi, Hossein; Roshandel, Gholamreza; Salimzadeh, Hamideh; Prada, Sergio I.; Preotescu, Liliana; Pribadi, Dimas Ria Angga; Rabiee, Mohammad; Rabiee, Navid; Radfar, Amir; Rafiei, Alireza; Rahim, Fakher; Rahimi-Movaghar, Vafa; Rahman, Muhammad Aziz; ur Rahman, Sajjad; Rai, Rajesh Kumar; Vollmer, Sebastian; Rajabpour-Sanati, Ali; Ramezanzadeh, Kiana; Rana, Saleem Muhammad; Ranabhat, Chhabi Lal; Rao, Sowmya J.; Rasella, Davide; Rashedi, Vahid; Rathi, Priya; Rawaf, Salman; Rawaf, David Laith; Rawal, Lal; Renjith, Vishnu; Renzaho, Andre M. N.; Resnikoff, Serge; Rezaei, Nima; Rezai, Mohammad Sadegh; Ribeiro, Ana Isabel; Rickard, Jennifer; Rodriguez, Alina; Roever, Leonardo; Roro, Elias Merdassa; Yilma, Mekdes Tigistu; Roshandel, Gholamreza; Rostami, Ali; Rubagotti, Enrico; Saad, Anas M.; Saadatagah, Seyedmohammad; Sabde, Yogesh Damodar; Sadeghi, Masoumeh; Safari, Saeed; Safarpour, Hamid; Sagar, Rajesh; Sahebkar, Amirhossein; Sajadi, S. Mohammad; Salahshoor, Mohammad Reza; Salam, Nasir; Salehi, Farkhonde; Zahabi, Saleh Salehi; Salem, Hosni; Salem, Marwa R. Rashad; Kafil, Hossein Samadi; Samy, Abdallah M.; Santos, Itamar S.; Sao Jose, Bruno Piassi; Saraswathy, Sivan Yegnanarayana Iyer; Sarker, Abdur Razzaque; Sarveazad, Arash; Sathian, Brijesh; Satpathy, Maheswar; Schutte, Aletta Elisabeth; Schwebel, David C.; Senbeta, Anbissa Muleta; Senthilkumaran, Subramanian; Seyedmousavi, Seyedmojtaba; Shaahmadi, Faramarz; Shahabi, Saeed; Shaikh, Masood Ali; Shalash, Ali S.; Shams-Beyranvand, Mehran; Shamshirian, Amir; Shamsizadeh, Morteza; Shannawaz, Mohammed; Sharif, Mehdi; Sharma, Rajesh; Sheikhtaheri, Abbas; Shibuya, Kenji; Shigematsu, Mika; Shin, Jae Il; Shiri, Rahman; Shirkoohi, Reza; Shiue, Ivy; Siabani, Soraya; Sigfusdottir, Inga Dora; Santos Silva, Diego Augusto; Simonetti, Biagio; Singh, Ambrish; Singh, Pushpendra; Singh, Virendra; Singh, Jasvinder A.; Singh, Pankaj Kumar; Sinha, Dhirendra Narain; Sintayehu, Yitagesu; Soheili, Amin; Soltani, Farzaneh; Soltani, Shahin; Soriano, Joan B.; Soshnikov, Sergey; Soyiri, Ireneous N.; Spotin, Adel; Sreeramareddy, Chandrashekhar T.; Srivastava, Rajni Kant Kant; Starodubova, Antonina; Sudaryanto, Agus; Sufiyan, Mu'awiyyah Babale; Suleria, Hafiz Ansar Rasul; Sulo, Gerhard; Sunguya, Bruno F.; Sykes, Bryan L.; Tabares-Seisdedos, Rafael; Tabuchi, Takahiro; Tadesse, Birkneh Tilahun; Taherkhani, Amir; Tassew, Segen Gebremeskel; Taveira, Nuno; Teklehaimanot, Berhane Fseha; Tekulu, Gebretsadkan Hintsa; Temsah, Mohamad-Hani; Terkawi, Abdullah Sulieman; Thomas, Nihal; Tonelli, Marcello; Tovani-Palone, Marcos Roberto; Traini, Eugenio; Khanh Bao Tran; Tripathi, Manjari; Ullah, Irfan; Upadhyay, Era; Useh, Ushotanefe; Uthman, Olalekan A.; Vaezghasemi, Masoud; Valdez, Pascual R.; Varavikova, Elena; Varughese, Santosh; Vasankari, Tommi Juhani; Veisani, Yousef; Venkatesh, Srinivasaraghavan; Venketasubramanian, Narayanaswamy; Verma, Madhur; Vidale, Simone; Vlassov, Vasily; Vukovic, Rade; Waheed, Yasir; Wang, Yafeng; Yu, Chuanhua; Wiangkham, Taweewat; Wijeratne, Tissa; Wondafrash, Dawit Zewdu; Wondmieneh, Adam Belay; Wu, Ai-Min; Xu, Gelin; Yadollahpour, Ali; Jabbari, Seyed Hossein Yahyazadeh; Yamada, Tomohide; Yano, Yuichiro; Yaya, Sanni; Yazdi-Feyzabadi, Vahid; Yeshaneh, Alex; Yip, Paul; Yonemoto, Naohiro; Yoon, Seok-Jun; Youm, Yoosik; Younis, Mustafa Z.; Yousefi, Zabihollah; Zandian, Hamed; Zamani, Mohammad; Zarafshan, Hadi; Zerfu, Taddese Alemu; Zhang, Yunquan; Zhang, Zhi-Jiang; Zhao, Xiu-Ju		LBD Double Burden Malnutr	Mapping local patterns of childhood overweight and wasting in low- and middle-income countries between 2000 and 2017	NATURE MEDICINE			English	Article							GROWTH FAILURE; DOUBLE BURDEN; MALNUTRITION; OBESITY; MODELS; TRENDS; UNDERNUTRITION; PREVALENCE; MORTALITY; AFRICA		[Kinyoki, Damaris K.; Ross, Jennifer M.; Lazzar-Atwood, Alice; Munro, Sandra B.; Schaeffer, Lauren E.; Bhattacharjee, Natalia V.; Collison, Michael L.; Cork, Michael A.; Cormier, Natalie; Weaver, Nicole Davis; Deshpande, Aniruddha; Dharmaratne, Samath Dhamminda; Earl, Lucas; Henry, Nathaniel J.; Hollerich, Gillian; Johnson, Kimberly B.; Kassebaum, Nicholas J.; Krohn, Kris J.; Letourneau, Ian D.; Marczak, Laurie B.; Mayala, Benjamin K.; Mokdad, Ali H.; Mosser, Jonathan F.; Murray, Christopher J. L.; Naghavi, Mohsen; Osgood-Zimmerman, Aaron E.; Pickering, Brandon V.; Pigott, David M.; Ray, Sarah E.; Sbarra, Alyssa N.; Schipp, Megan F.; VanderHeide, John; Wang, Haidong; Wiens, Kirsten E.; Afshin, Ashkan; Hay, Simon I.] Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA 98195 USA; [Kinyoki, Damaris K.; Mokdad, Ali H.; Murray, Christopher J. L.; Naghavi, Mohsen; Pigott, David M.; Wang, Haidong; Afshin, Ashkan; Hay, Simon I.; Sartorius, Benn] Univ Washington, Sch Med, Dept Hlth Metr Sci, Seattle, WA USA; [Ross, Jennifer M.; Khalil, Ibrahim A.] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA; [Ross, Jennifer M.] Univ Washington, Dept Med, Seattle, WA USA; [Abbasalizad-Farhangi, Mahdieh M.; Hasankhani, Milad] Tabriz Univ Med Sci, Sch Nutr & Food Sci, Tabriz, Iran; [Abbasi, Masoumeh; Farzam, Hossein; Moradi, Masoud; Rezaeian, Shahab] Kermanshah Univ Med Sci, Kermanshah, Iran; [Abbastabar, Hedayat] Univ Tehran Med Sci, Adv Diagnost & Intervent Radiol Res Ctr, Tehran, Iran; [Abdelalim, Ahmed; El-Jaafary, Shaimaa I.; Shehata, Hatem Samir] Cairo Univ, Dept Neurol, Cairo, Egypt; [Abdoli, Amir] Jahrom Univ Med Sci, Dept Parasitol & Mycol, Jahrom, Iran; [Abdollahi, Mohammad] Univ Tehran Med Sci, TIPS, Toxicol & Dis Grp, Tehran, Iran; [Abdollahpour, Ibrahim] Isfahan Univ Med Sci, Neurosci Res Ctr, Esfahan, Iran; [Abdulkader, Rizwan Suliankatchi] Minist Hlth, Dept Publ Hlth, Riyadh, Saudi Arabia; [Abebe, Nebiyu Dereje; Deribe, Kebede] Addis Ababa Univ, Sch Publ Hlth, Addis Ababa, Ethiopia; [Abebe, Nebiyu Dereje] Wachemo Univ, Publ Hlth, Hosanna, Ethiopia; [Abebo, Teshome Abuka] Hawassa Univ, Coll Med & Hlth Sci, Hawassa, Ethiopia; [Abegaz, Kedir Hussein] Madda Walabu Univ, Biostat & Hlth Informat, Bale Robe, Ethiopia; [Abegaz, Kedir Hussein] Addis Ababa Univ, Radiotherapy Ctr, Addis Ababa, Ethiopia; [Abolhassani, Hassan] Karolinska Univ Hosp, LABMED, Huddinge, Sweden; [Abolhassani, Hassan; Rezaei, Nima] Univ Tehran Med Sci, Res Ctr Immunodeficiencies, Tehran, Iran; [Abreu, Lucas Guimaraes] Univ Fed Minas Gerais, Dept Pediat Dent, Belo Horizonte, MG, Brazil; [Abrigo, Michael R. M.] Philippine Inst Dev Studies, Res Dept, Quezon City, Philippines; [Abushouk, Abdelrahman I.] Ain Shams Univ, Cardiovasc Med, Abbasiya, Egypt; [Accrombessi, Manfred Mario Kokou] IRCB, Cotonou, Benin; [Acharya, Dilaram] Dongguk Univ, Dept Prevent Med, Gyeongju, South Korea; [Acharya, Dilaram] Kathmandu Univ, Dept Community Med, Devdaha, Nepal; [Adabi, Maryam] Hamadan Univ Med Sci, Hamadan, Iran; [Adebiyi, Akindele Olupelumi; Ilesanmi, Olayinka Stephen] Univ Ibadan, Dept Community Med, Ibadan, Nigeria; [Adebiyi, Akindele Olupelumi] Univ Coll Hosp, Dept Community Med, Ibadan, Nigeria; [Adedeji, Isaac Akinkunmi] Olabisi Onabanjo Univ, Dept Sociol, Ago Iwoye, Nigeria; [Adekanmbi, Victor] Cardiff Univ, Sch Med, Cardiff, S Glam, Wales; [Adeoye, Abiodun Moshood] Univ Ibadan, Coll Med, Ibadan, Nigeria; [Adeoye, Abiodun Moshood] Elyon Heart Rehabil Ctr, Community Cardiovasc Res Unit, Ibadan, Nigeria; [Adetokunboh, Olatunji O.] Stellenbosch Univ, Dept Global Hlth, Stellenbosch, South Africa; [Adetokunboh, Olatunji O.; Mahasha, Phetole Walter; Ndwandwe, Duduzile Edith; Nnaji, Chukwudi A.; Sambala, Evanson Zondani] South African Med Res Council, Cochrane South Africa, Cape Town, South Africa; [Adham, Davoud] Ardabil Univ Med Sci, Sch Hlth, Ardebil, Iran; [Aduroja, Posi Emmanuel; Dipeolu, Isaac Oluwafemi; Ibitoye, Segun Emmanuel; John-Akinola, Yetunde O.; Oluwasanu, Mojisola Morenike] Univ Ibadan, Dept Hlth Promot & Educ, Ibadan, Nigeria; [Advani, Shailesh M.] NIH, Social Behav Res Branch, Bldg 10, Bethesda, MD 20892 USA; [Advani, Shailesh M.] Georgetown Univ, Canc Prevent & Control, Washington, DC USA; [Afarideh, Mohsen; Esteghamati, Alireza; Ghajar, Alireza; Heidari, Behnam; Sayyah, Mehdi] Univ Tehran Med Sci, EMRC, Tehran, Iran; [Aghaali, Mohammad] Qom Univ Med Sci, Epidemiol, Qom, Iran; [Agrawal, Anurag] CSIR Inst Genom & Integrat Biol, Res Area Informat & Big Data, Delhi, India; [Agrawal, Anurag] Baylor Coll Med, Dept Internal Med, Houston, TX 77030 USA; [Ahmad, Tauseef] Southeast Univ Nanjing, Sch Publ Hlth, Dept Epidemiol & Hlth Stat, Nanjing, Jiangsu, Peoples R China; [Ahmad, Tauseef] Hazara Univ Mansehra, Dept Microbiol, Mansehra, Pakistan; [Ahmadi, Keivan] Univ Nottingham, Lincoln Med Sch, Lincoln, England; [Ahmadi, Keivan] Univ Lincoln, Lincoln Med Sch, Lincoln, England; [Ahmadi, Sepideh] Shahid Beheshti Univ Med Sci, Sch Adv Technol Med, Tehran, Iran; [Ahmed, Muktar Beshir; Gebrehiwot, Tsegaye Tewelde; Gesesew, Hailay Abrha] Jimma Univ, Dept Epidemiol, Jimma, Ethiopia; [Ahmed, Rushdia; Das Gupta, Rajat] BRAC Univ, James P Grant Sch Publ Hlth, Dhaka, Bangladesh; [Ahmed, Rushdia] Int Ctr Diarrhoeal Dis Res, Hlth Syst & Populat Studies Div, Dhaka, Bangladesh; [Ajumobi, Olufemi] Univ Nevada, Sch Community Hlth Sci, Reno, NV 89557 USA; [Ajumobi, Olufemi] Fed Minist Hlth, Natl Malaria Eliminat Program, Abuja, Nigeria; [Akal, Chalachew Genet; Demeke, Feleke Mekonnen; Melese, Addisu] Bahir Dar Univ, Dept Med Lab Sci, Bahir Dar, Ethiopia; [Akalu, Temesgen Yihunie; Baraki, Adhanom Gebreegziabher; Mekonnen, Fantahun Ayenew; Sisay, Malede Mequanent M.; Tamirat, Koku Sisay; Tessema, Zemenu Tadesse; Wolde, Haileab Fekadu; Yeshaw, Yigizie] Univ Gondar, Dept Epidemiol & Biostat, Gondar, Ethiopia; [Akinyemiju, Tomi] Duke Univ, Dept Populat Hlth Sci, Durham, NC USA; [Akinyemiju, Tomi] Duke Univ, Duke Global Hlth Inst, Durham, NC USA; [Akombi, Blessing; Karki, Surendra] Univ New South Wales, Sch Publ Hlth & Community Med, Sydney, NSW, Australia; [Al-Aly, Ziyad] Washington Univ, John T Milliken Dept Internal Med, St Louis, MO 63110 USA; [Al-Aly, Ziyad] US Dept Vet Affairs, Clin Epidemiol Ctr, VA St Louis Hlth Care Syst, St Louis, MO USA; [Alam, Samiah] Dalhousie Univ, Dept Med, Halifax, NS, Canada; [Alamene, Genet Melak] Madda Walabu Univ, Sch Hlth Sci, Bale Goba, Ethiopia; [Alanzi, Turki M.] Imam Abdulrahman Bin Faisal Univ, Dept Hlth Informat Management & Technol, Dammam, Saudi Arabia; [Alcalde Rabanal, Jacqueline Elizabeth; Cahuana-Hurtado, Lucero; Montero-Zamora, Pablo A.] Natl Inst Publ Hlth, Ctr Hlth Syst Res, Cuernavaca, Morelos, Mexico; [Alema, Niguse Meles; Araya, Ephrem Mebrahtu; Kassaye, Hagazi Gebremedhin] Adigrat Univ, Dept Pharm, Adigrat, Ethiopia; [Ali, Beriwan Abdulqadir] Erbil Polytech Univ, Med Tech Inst, Erbil, Iraq; [Ali, Beriwan Abdulqadir; Mohammad, Karzan Abdulmuhsin] Ishik Univ, Erbil, Iraq; [Ali, Muhammad] Quaid I Azam Univ Islamabad, Dept Biotechnol, Islamabad, Pakistan; [Alijanzadeh, Mehran; Kalhor, Rohollah] Qazvin Univ Med Sci, Social Determinants Hlth Res Ctr, Qazvin, Iran; [Alinia, Cyrus; Yusefzadeh, Hasan] Urmia Univ Med Sci, Dept Hlth Care Management & Econ, Orumiyeh, Iran; [Alipour, Vahid; Arabloo, Jalal; Azari, Samad; Rezapour, Aziz; Sheikhtaheri, Abbas; Moghadam, Telma Zahirian] Iran Univ Med Sci, Hlth Management & Econ Res Ctr, Tehran, Iran; [Alipour, Vahid] Iran Univ Med Sci, Hlth Econ Dept, Tehran, Iran; [Alizade, Hesam] Kerman Univ Med Sci, Dept Microbiol, Kerman, Iran; [Alizade, Hesam] Hormozgan Univ Med Sci, Dept Microbiol, Bandar Abbas, Iran; [Aljunid, Syed Mohamed] Kuwait Univ, Dept Hlth Policy & Management, Safat, Kuwait; [Aljunid, Syed Mohamed] Natl Univ Malaysia, Int Ctr Casemix & Clin Coding, Bandar Tun Razak, Malaysia; [Moradi, Masoud; Almasi, Afshin; Fattahi, Nazir; Matin, Behzad Karami; Karyani, Ali Kazemi; Pirsaheb, Meghdad; Rajati, Fatemeh; Sadeghi, Ehsan; Safari, Yahya; Sharafi, Kiomars; Vasseghian, Yasser] Kermanshah Univ Med Sci, RCEDH, Kermanshah, Iran; [Almasi-Hashiani, Amir; Moradzadeh, Rahmatollah; Zamanian, Maryam] Arak Univ Med Sci, Dept Epidemiol, Arak, Iran; [Al-Mekhlafi, Hesham M.] Jazan Univ, Med Res Ctr, Jazan, Saudi Arabia; [Al-Mekhlafi, Hesham M.] Sanaa Univ, Dept Med Parasitol, Sanaa, Yemen; [Al-Raddadi, Rajaa M.] King Abdulaziz Univ, Dept Family & Community Med, Jeddah, Saudi Arabia; [Altirkawi, Khalid] King Saud Univ, Riyadh, Saudi Arabia; [Alvis-Guzman, Nelson] Univ Cartagena, Hlth Econ Res Grp, Cartagena, Colombia; [Alvis-Guzman, Nelson] Univ Coast, Res Grp Hosp Management & Hlth Policies, Barranquilla, Colombia; [Alvis-Zakzuk, Nelson J.] Univ Costa, Dept Ciencias Econ, Barranquilla, Colombia; [Alvis-Zakzuk, Nelson J.] Natl Inst Hlth, Observ Nacl Salud, Bogota, Colombia; [Amare, Azmeraw T.] South Australian Hlth & Med Res Inst, Sansom Inst, Adelaide, SA, Australia; [Amare, Azmeraw T.; Gedefaw, Getnet Azeze] Bahir Dar Univ, Bahir Dar, Ethiopia; [Amegah, Adeladza Kofi] Univ Cape Coast, Biomed Sci, Cape Coast, Ghana; [Amini, Saeed] Arak Univ Med Sci, Hlth Serv Management Dept, Arak, Iran; [Rarani, Mostafa Amini] Isfahan Univ Med Sci, Hlth Serv Management, Esfahan, Iran; [Amiri, Fatemeh] Kermanshah Univ Med Sci, Dept Radiol, Kermanshah, Iran; [Amit, Arianna Maever Loreche] Univ Philippines Manila, Dept Epidemiol & Biostat, Manila, Philippines; [Amit, Arianna Maever Loreche] Johns Hopkins Univ, Online Programs Appl Learning, Baltimore, MD USA; [Anber, Nahla Hamed] Mansoura Univ, Mansoura, Egypt; [Andrei, Catalina Liliana] Carol Davila Univ Med & Pharm, Bucharest, Romania; [Ansari, Fereshteh] Tabriz Univ Med Sci, Res Ctr Evidence Based Med, Hlth Management & Safety Promot Res Inst, Tabriz, Iran; [Ansari, Fereshteh] AREEO, Razi Vaccine & Serum Res Inst, Tehran, Iran; [Ansari-Moghaddam, Alireza] Hlth Promot Res Ctr, Dept Epidemiol & Biostat, Zahedan, Iran; [Anteneh, Zelalem Alamrew; Asrat, Anemaw A.; Bogale, Kassawmar Angaw; Zewale, Taye Abuhay] Bahir Dar Univ, Dept Epidemiol & Biostat, Bahir Dar, Ethiopia; [Antonio, Carl Abelardo T.] Univ Philippines Manila, Dept Hlth Policy & Adm, Manila, Philippines; [Antonio, Carl Abelardo T.] Hong Kong Polytech Univ, Dept Appl Social Sci, Hong Kong, Peoples R China; [Antriyandarti, Ernoiz] Univ Sebelas Maret, Dept Agribusiness, Surakarta, Indonesia; [Anvari, Davood] Mazandaran Univ Med Sci, Dept Parasitol, Sari, Iran; [Anvari, Davood] Iranshahr Univ Med Sci, Dept Microbiol & Immunol, Iranshahr, Iran; [Anwer, Razique] Al Imam Mohammad Ibn Saud Islamic Univ, Dept Pathol, Riyadh, Saudi Arabia; [Appiah, Seth Christopher Yaw] Kwame Nkrumah Univ Sci & Technol, Dept Sociol & Social Work, Kumasi, Ghana; [Appiah, Seth Christopher Yaw] Ludwig Maximilians Univ Munchen, Ctr Int Hlth, Munich, Germany; [Arab-Zozani, Morteza] Birjand Univ Med Sci, Social Determinants Hlth Res Ctr, Birjand, Iran; [Arefi, Zohreh] Univ Tehran Med Sci, Dept Hlth Promot & Educ, Tehran, Iran; [Aremu, Olatunde] Birmingham City Univ, Sch Hlth Sci, Birmingham, W Midlands, England; [Arnlov, Johan; Fereshtehnejad, Seyed-Mohammad] Karolinska Inst, Dept Neurobiol, Stockholm, Sweden; [Arnlov, Johan] Dalarna Univ, Sch Hlth & Social Studies, Falun, Sweden; [Arzani, Afsaneh] Babol Univ Med Sci, Sch Nursing & Midwife, Babol, Iran; [Arzani, Afsaneh; Jahani, Mohammad Ali; Mouodi, Simin] Babol Univ Med Sci, Babol, Iran; [Asadi-Aliabadi, Mehran; Babaee, Ebrahim; Moradi-Lakeh, Maziar] Iran Univ Med Sci, Prevent Med & Publ Hlth Res Ctr, Tehran, Iran; [Asadi-Pooya, Ali A.] Shiraz Univ Med Sci, Neurol, Shiraz, Iran; [Asgari, Samaneh] Shahid Beheshti Univ Med Sci, Prevent Metab Disorders Res Ctr, Tehran, Iran; [Asghari, Babak] Hamedan Univ Med Sci, Dept Microbiol, Hamadan, Iran; [Ashagre, Alebachew Fasil] Univ Gondar, Dept Clin Chem, Gondar, Ethiopia; [Ataeinia, Bahar; Farzadfar, Farshad; Mohebi, Farnam] Univ Tehran Med Sci, Noncommunicable Dis Res Ctr, Tehran, Iran; [Atalay, Hagos Tasew; Gebremeskel, Gebreamlak Gebremedhn; Weldesamuel, Girmay Teklay] Aksum Univ, Dept Nursing, Aksum, Ethiopia; [Atnafu, Desta Debalkie] Bahir Dar Univ, Dept Hlth Syst & Hlth Econ, Bahir Dar City, Ethiopia; [Atout, Maha Moh'd Wahbi] Univ Nottingham, Sch Nursing, Amman, Jordan; [Ausloos, Marcel] Univ Leicester, Sch Business, Leicester, Leics, England; [Ausloos, Marcel; Herteliu, Claudiu; Pana, Adrian] Bucharest Univ Econ Studies, Dept Stat & Econometr, Bucharest, Romania; [Avokpaho, Euripide F. G. A.] IRCB, Abomey Calavi, Benin; [Avokpaho, Euripide F. G. A.] Controle Malad Infect, Lab Studies & Res Act Hlth, Porto Novo, Benin; [Awasthi, Ashish; Zodpey, Sanjay] Publ Hlth Fdn India, Indian Inst Publ Hlth, Gurugram, India; [Quintanilla, Beatriz Paulina Ayala] La Trobe Univ, Judith Lumley Ctr, Melbourne, Vic, Australia; [Quintanilla, Beatriz Paulina Ayala] Peruvian Natl Inst Hlth, Gen Off Res & Technol Transfer, Lima, Peru; [Ayanore, Martin Amogre] Univ Hlth & Allied Sci, Dept Hlth Policy Planning & Management, Ho, Ghana; [Aynalem, Yared A. Asmare; Shiferaw, Wondimeneh Shibabaw] Debre Berhan Univ, Dept Nursing, Debre Berhan, Ethiopia; [Azadmehr, Abbas] Babol Univ Med Sci, Cellular & Mol Biol Res Ctr, Babol, Iran; [Azarian, Ghasem; Khazaei, Mohammad; Leili, Mostafa] Hamadan Univ Med Sci, Dept Environm Hlth Engn, Hamadan, Iran; [Azene, Zelalem Nigussie] Univ Gondar, Dept Reprod Hlth, Gondar, Ethiopia; [Badawi, Alaa] Publ Hlth Agcy Canada, Publ Hlth Risk Sci Div, Toronto, ON, Canada; [Badawi, Alaa] Univ Toronto, Dept Nutr Sci, Toronto, ON, Canada; [Badiye, Ashish D.; Kapoor, Neeti] Govt Inst Forens Sci, Dept Forens Sci, Nagpur, Maharashtra, India; [Bahrami, Mohamad Amin] Shiraz Univ Med Sci, Healthcare Management Dept, Shiraz, Iran; [Baig, Atif Amin A.] Univ Sultan Zainal Abidin, Biochem Unit, Kuala Terengganu, Malaysia; [Baig, Atif Amin A.] Univ Sultan Zainal Abidin Gongbedak, Biomed Dept, Kuala Terengganu, Malaysia; [Bakhtiari, Ahad] Univ Tehran Med Sci, Hlth Policy & Management Dept, Tehran, Iran; [Bakkannavar, Shankar M.; Nayak, Vinod] Manipal Acad Higher Educ, Dept Forens Med & Toxicol, Manipal, Karnataka, India; [Marami, Dadi; Senthilkumaran, Subramanian] Haramaya Univ, Dept Med Lab Sci, Harar, Ethiopia; [Bali, Ayele Geleto] Haramaya Univ, Sch Publ Hlth, Harar, Ethiopia; [Banach, Maciej] Med Univ Lodz, Dept Hypertens, Lodz, Poland; [Banach, Maciej] Polish Mothers Mem Hosp Res Inst, Lodz, Poland; [Banik, Palash Chandra; Barua, Lingkan] BUHS, Dept Noncommunicable Dis, Dhaka, Bangladesh; [Baradaran-Seyed, Zahra] Razi Vaccine & Serum Res Inst, Dept Anim Pathol & Epidemiol, Karaj, Iran; [Barboza, Miguel A.] Costa Rican Dept Social Secur, Dept Neurosci, San Jose, Costa Rica; [Barboza, Miguel A.] Univ Costa Rica, Sch Med, San Pedro, Costa Rica; [Baernighausen, Till Winfried; De Neve, Jan-Walter; Moazen, Babak; Mohammed, Shafiu] Heidelberg Univ, HIGH, Heidelberg, Germany; [Baernighausen, Till Winfried; Dinsa, Girmaye Deye] Harvard Univ, TH Chan Sch Publ Hlth, Boston, MA 02115 USA; [Basaleem, Huda] Univ Aden, Aden, Yemen; [Basu, Sanjay; Saxena, Sonia] Imperial Coll London, Sch Publ Hlth, London, England; [Bayati, Mohsen] Shiraz Univ Med Sci, Hlth Human Resources Res Ctr, Shiraz, Iran; [Bayih, Mulat Tirfie] Bahir Dar Univ, Dept Appl Human Nutr, Bahir Dar, Ethiopia; [Baynes, Habtamu Wondifraw] Univ Gondar, Gondar, Ethiopia; [Bedi, Neeraj] Gandhi Med Coll Bhopal, Dept Community Med, Bhopal, India; [Bedi, Neeraj] Jazan Univ, Jazan, Saudi Arabia; [Behzadifar, Masoud] Lorestan Univ Med Sci, Social Determinants Hlth Res Ctr, Khorramabad, Iran; [Behzadifar, Meysam] Lorestan Univ Med Sci, Dept Epidemiol & Biostat, Khorramabad, Iran; [Bekele, Yibeltal Alemu; Nigatu, Dabere] Bahir Dar Univ, Dept Reprod Hlth & Populat Studies, Bahir Dar, Ethiopia; [Bennett, Derrick A.; Karim, Mohd A.; Lacey, Ben] Univ Oxford, Nuffield Dept Populat Hlth, Oxford, England; [Berbada, Dessalegn Ajema; Geramo, Yilma Chisha Dea; Hayelom, Desta Haftu; Meles, Gebrekiros Gebremichael; Sorrie, Muluken Bekele] Arba Minch Univ, Dept Publ Hlth, Arba Minch, Ethiopia; [Berhe, Kidanemaryam; Gebremariam, Hadush; Gebretsadik, Gebretsadkan G. G.; Kahsay, Amaha] Mekelle Univ, Dept Nutr & Dietet, Mekelle, Ethiopia; [Berhe, Abadi Kidanemariam] Adigrat Univ, Adigrat, Ethiopia; [Berhe, Abadi Kidanemariam] Wolaita Sodo Univ, Sch Publ Hlth, Addis Ababa, Ethiopia; [Berman, Adam E.] Augusta Univ, Dept Med, Med Coll Georgia, Augusta, GA USA; [Bernstein, Robert S.; Narayan, K. M. Venkat] Emory Univ, Hubert Dept Global Hlth, Atlanta, GA 30322 USA; [Bernstein, Robert S.] Univ S Florida, Dept Global Hlth, Tampa, FL 33620 USA; [Bhageerathy, Reshmi] Manipal Acad Higher Educ, Dept Hlth Informat Management, Manipal, India; [Bhandari, Dinesh] Univ Adelaide, Sch Publ Hlth, Adelaide, SA, Australia; [Bhandari, Dinesh] Tribhuvan Univ, Inst Med, Publ Hlth Res Lab, Kathmandu, Nepal; [Bharadwaj, Pankaj] All India Inst Med Sci, Dept Community Med & Family Med, Jodhpur, Rajasthan, India; [Bharadwaj, Pankaj; Quazi Syed, Zahiruddin] Deemed Univ, Datta Meghe Inst Med Sci, Dept Community Med, Wardha, India; [Bhattacharyya, Krittika] Natl Inst Biomed Genom, Dept Stat & Computat Genom, Kalyani, W Bengal, India; [Bhattacharyya, Krittika] Univ Calcutta, Dept Stat, Kolkata, India; [Bijani, Ali] Babol Univ Med Sci, Social Determinants Hlth Res Ctr, Babol, Iran; [Bikbov, Boris] IRCCS, Ist Ric Farmacol Mario Negri, Ranica, Italy; [Bilano, Ver] Creat Ceut Huntsworth Hlth, Hlth Econ & Outcomes Res, London, England; [Bililign, Nigus] Woldia Univ, Woldia, Ethiopia; [Bin Sayeed, Muhammad Shahdaat; Lal, Aparna] Australian Natl Univ, Natl Ctr Epidemiol & Populat Hlth, Canberra, ACT, Australia; [Bin Sayeed, Muhammad Shahdaat] Univ Dhaka, Dept Clin Pharm & Pharmacol, Dhaka, Bangladesh; [Birara, Setognal; Kahssay, Molla; Mohammed, Jemal Abdu; Zepro, Nejimu Biza] Samara Univ, Dept Publ Hlth, Samara, Ethiopia; [Birhane, Minuye Biniam Biniam] Addis Ababa Univ, Debretabor Univ, Debretabor, Ethiopia; [Birhanu, Minyichil] Bahir Dar Univ, Dept Pediat & Child Hlth Nursing, Bahir Dar, Ethiopia; [Biswas, Raaj Kishore] Univ New South Wales, Transport & Rd Safety TARS Res Ctr, Sydney, NSW, Australia; [Biswas, Raaj Kishore] Swinburne Univ Technol, Sch Hlth Sci, Melbourne, Vic, Australia; [Bitew, Zebenay Workneh] St Pauls Hosp, Dept Nutr, Millennium Med Coll, Addis Ababa, Ethiopia; [Bohlouli, Somayeh] Islamic Azad Univ, Dept Vet Med, Kermanshah, Iran; [Bolla, Srinivasa Rao] Nazarbayev Univ, Dept Biomed Sci, Nur Sultan City, Kazakhstan; [Boloor, Archith] Manipal Acad Higher Educ, Dept Internal Med, Mangalore, India; [Borzi, Antonio M.; Vacante, Marco] Univ Catania, Dept Gen Surg & Med Surg Specialties, Catania, Italy; [Borzouei, Shiva] Hamadan Univ Med Sci, Sch Med, Hamadan, Iran; [Brady, Oliver J.] London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London, England; [Bragazzi, Nicola Luigi] Univ Genoa, Genoa, Italy; [Braithwaite, Dejana] Georgetown Univ, Div Hematol & Oncol, Washington, DC USA; [Briko, Nikolay Ivanovich] IM Sechenov First Moscow State Med Univ, Epidemiol & Evidence Based Med, Moscow, Russia; [Britton, Gabrielle; Castro, Franz] Gorgas Mem Inst Hlth Studies, Panama City, Panama; [Budhathoki, Shyam S.] Golden Community, Dept Res, Golden, CO, Nepal; [Nagaraja, Sharath Burugina] Employees State Insurance Model Hosp, Dept Community Med, Bangalore, Karnataka, India; [Busse, Reinhard] Tech Univ Berlin, Dept Hlth Care Management, Berlin, Germany; [Butt, Zahid A.] Univ Waterloo, Sch Publ Hlth & Hlth Syst, Waterloo, ON, Canada; [Butt, Zahid A.] Al Shifa Trust Eye Hosp, Al Shifa Sch Publ Hlth, Rawalpindi, Pakistan; [Alberto Camera, Luis] Hosp Italiano Buenos Aires, Dept Internal Med, Buenos Aires, DF, Argentina; [Alberto Camera, Luis] Argentine Soc Med, Comis Direct, Buenos Aires, DF, Argentina; [Campos-Nonato, Ismael R.] Natl Inst Publ Hlth, Cuernavaca, Morelos, Mexico; [Cano, Jorge] London Sch Hyg & Trop Med, Dept Dis Control, London, England; [Car, Josip] Nanyang Technol Univ, Ctr Populat Hlth Sci, Singapore, Singapore; [Car, Josip] Imperial Coll London, Global eHlth Unit, London, England; [Cardenas, Rosario] Metropolitan Autonomous Univ, Dept Populat & Hlth, Mexico City, DF, Mexico; [Carrero, Juan J.] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Carvalho, Felix; Costa, Vera M.] Univ Porto, Res Unit Appl Mol Biosci UCIBIO, Porto, Portugal; [Castaldelli-Maia, Joao Mauricio; Wang, Yuan-Pang] Univ Sao Paulo, Dept Psychiat, Sao Paulo, Brazil; [Castaneda-Orjuela, Carlos A.] Colombian Natl Hlth Observ, Natl Inst Hlth, Bogota, Colombia; [Castaneda-Orjuela, Carlos A.] Univ Nacl Colombia, Epidemiol & Publ Hlth Evaluat Grp, Bogota, Colombia; [Cerin, Ester] Australian Catholic Univ, Mary MacKillop Inst Hlth Res, Melbourne, Vic, Australia; [Cerin, Ester] Univ Hong Kong, Sch Publ Hlth, Hong Kong, Peoples R China; [Chansa, Collins] World Bank, Hlth Nutr & Populat, Lusaka, Zambia; [Chansa, Collins] Heidelberg Univ, Inst Global Hlth, Heidelberg, Germany; [Charan, Jaykaran] All India Inst Med Sci, Dept Pharmacol, Jodhpur, Rajasthan, India; [Chatterjee, Pranab] Natl Inst Cholera & Enter Dis, Div Epidemiol, Kolkata, India; [Chattu, Vijay Kumar] Univ Toronto, Dept Med, Toronto, ON, Canada; [Chauhan, Bal Govind] Gokhale Inst Polit & Econ, Populat Res Ctr, Pune, Maharashtra, India; [Chauhan, Bal Govind; Goli, Srinivas; Kumar, Pushpendra] Int Inst Populat Sci, Mumbai, Maharashtra, India; [Chavshin, Ali Reza] Urmia Univ Med Sci, Dept Med Entomol & Vector Control, Orumiyeh, Iran; [Chehrazi, Mohammad] Babol Univ Med Sci, Dept Biostat & Epidemiol, Babol, Iran; [Chehrazi, Mohammad] Royan Inst, Epidemiol Res Ctr, Tehran, Iran; [Chichiabellu, Tesfaye Yitna] Wolaita Sodo Univ, Dept Nursing, Sodo, Ethiopia; [Chin, Ken Lee] Monash Univ, Dept Epidemiol & Prevent Med, Melbourne, Vic, Australia; [Christopher, Devasahayam J.] Christian Med Coll & Hosp CMC, Dept Pulm Med, Vellore, Tamil Nadu, India; [Dinh-Toi Chu] Hanoi Natl Univ Educ, Hanoi, Vietnam; [Cicuttini, Flavia M.; Guo, Yuming; Li, Shanshan] Monash Univ, Sch Publ Hlth & Prevent Med, Melbourne, Vic, Australia; [Cortesi, Paolo Angelo] Univ Milano Bicocca, Sch Med & Surg, Monza, Italy; [Dadi, Abel Fekadu Fekadu] Univ Gondar, Inst Publ Hlth, Gondar, Ethiopia; [Dadi, Abel Fekadu Fekadu] Flinders Univ S Australia, Discipline Publ Hlth, Adelaide, SA, Australia; [Dagnew, Baye] Univ Gondar, Dept Human Physiol, Gondar, Ethiopia; [Dahlawi, Saad M. A.] Imam Abdulrahman Bin Faisal Univ, Dept Environm Hlth, Dammam, Saudi Arabia; [Damiani, Giovanni] Case Western Reserve Univ, Dept Dermatol, Cleveland, OH 44106 USA; [Damiani, Giovanni] Univ Milan, Dept Dermatol, Milan, Italy; [Darwish, Amira Hamed] Tanta Univ, Dept Pediat, Tanta, Egypt; [Daryani, Ahmad] Mazandaran Univ Med Sci, Toxoplasmosis Res Ctr, Sari, Iran; [Das, Jai K.] Aga Khan Univ, Div Women & Child Hlth, Karachi, Pakistan; [Das Gupta, Rajat] Univ South Carolina, Arnold Sch Publ Hlth, Dept Epidemiol & Biostat, Columbia, SC 29208 USA; [Davila-Cervantes, Claudio] Fac Latinoamer Ciencias Sociales Mexico, Populat & Dev, Mexico City, DF, Mexico; [De Leo, Diego] Griffith Univ, Australian Inst Suicide Res & Prevent, Mt Gravatt, Qld, Australia; [Demis, Asmamaw Bizuneh; Tlaye, Kenean Getaneh] Woldia Univ, Dept Nursing, Woldia, Ethiopia; [Demis, Asmamaw Bizuneh] Jimma Univ, Dept Nursing, Jimma, Ethiopia; [Demissie, Dereje Bayissa] St Pauls Hosp, Dept Neonatal Nursing, Millennium Med Coll, Addis Ababa, Ethiopia; [Demissie, Dereje Bayissa] Ambo Univ, Ambo, Ethiopia; [Demoz, Gebre Teklemariam; Kasahun, Gebremicheal Gebreslassie] Aksum Univ, Sch Pharm, Aksum, Ethiopia; [Demoz, Gebre Teklemariam] Addis Ababa Univ, Addis Ababa, Ethiopia; [Denova-Gutierrez, Edgar] Natl Inst Publ Hlth, Ctr Nutr & Hlth Res, Cuernavaca, Morelos, Mexico; [Deribe, Kebede] Brighton & Sussex Med Sch, Dept Global Hlth & Infect, Brighton, E Sussex, England; [Desai, Rupak] Atlanta Vet Affairs Med Ctr, Div Cardiol, Decatur, GA USA; [Desalegn, Beruk Berhanu] Hawassa Univ, Sch Nutr Food Sci & Technol, Hawassa, Ethiopia; [Desalew, Assefa] Haramaya Univ, Sch Nursing & Midwifery, Harar, Ethiopia; [Dey, Sagnik] Indian Inst Technol Delhi, Ctr Atmospher Sci, New Delhi, India; [Dharmaratne, Samath Dhamminda] Univ Peradeniya, Dept Community Med, Peradeniya, Sri Lanka; [Dhillon, Preeti] Int Inst Populat Sci, Math Demog & Stat, Mumbai, Maharashtra, India; [Dhimal, Meghnath] Nepal Hlth Res Council, Hlth Res Sect, Kathmandu, Nepal; [Dhungana, Govinda Prasad] Far Western Univ, Dept Microbiol, Mahendranagar, Nepal; [Nasab, Mostafa Dianati] Shiraz Univ Med Sci, Dept Epidemiol, Shiraz, Iran; [Diaz, Daniel] Univ Nacl Autonoma Mexico, Ctr Complex Sci, Mexico City, DF, Mexico; [Diaz, Daniel] Autonomous Univ Sinaloa, Fac Med Vet & Zootecnia, Culiacan, Sinaloa, Mexico; [Forooshani, Zahra Sadat Dibaji] Bank Melli, Dept Nursing, Tehran, Iran; [Dinsa, Girmaye Deye] Harvard Univ, Fenot Project, Addis Ababa, Ethiopia; [Djalalinia, Shirin] Minist Hlth & Med Educ, Tehran, Iran; [Hoa Thi Do] Nguyen Tat Thanh Univ, Ctr Excellence Publ Hlth Nutr, Ho Chi Minh, Vietnam; [Huyen Phuc Do; Chi Linh Hoang] Nguyen Tat Thanh Univ, Ctr Excellence Behav Med, Ho Chi Minh City, Vietnam; [Doku, Paul Narh] Univ Cape Coast, Sch Nursing & Midwifery, Cape Coast, Ghana; [Dorostkar, Fariba] Iran Univ Med Sci, Tehran, Iran; [Doshmangir, Leila] Tabriz Univ Med Sci, Dept Hlth Policy & Econ, Tabriz, Iran; [Dubey, Manisha] World Food Programme, New Delhi, India; [Adema, Bereket Duko] Hawassa Univ, Dept Publ Hlth, Hawassa, Ethiopia; [Adema, Bereket Duko] Curtin Univ, Perth, Australia; [Dunachie, Susanna J.; Lewycka, Sonia] Univ Oxford, Ctr Trop Med & Global Hlth, Oxford, England; [Dunachie, Susanna J.] Mahidol Oxford Trop Med Res Unit, Bangkok, Thailand; [Duncan, Bruce B.; Cousin, Ewerton; Schmidt, Maria Ines] Univ Fed Rio Grande do Sul, Postgrad Program Epidemiol, Porto Alegre, RS, Brazil; [Duraes, Andre R.] Univ Fed Bahia, Sch Med, Salvador, BA, Brazil; [Duraes, Andre R.] Escola Bahiana Med & Saude Publ, Med Interna, Salvador, BA, Brazil; [Leylabadlo, Hamed Ebrahimzadeh] Tabriz Univ Med Sci, Dept Bacteriol & Virol, Tabriz, Iran; [Eftekhari, Aziz] Maragheh Univ Med Sci, Dept Pharmacol & Toxicol, Maragheh, Iran; [Eftekhari, Aziz] Tabriz Univ Med Sci, Dept Pharmacol & Toxicol, Tabriz, Iran; [El Sayed, Iman] Alexandria Univ, Biomed Informat & Med Stat, Alexandria, Egypt; [Zaki, Maysaa El Sayed; El-Sherbiny, Yasser Mohamed] Mansoura Univ, Dept Clin Pathol, Mansoura, Egypt; [El Tantawi, Maha] Alexandria Univ, Pediat Dent & Dent Publ Hlth, Alexandria, Egypt; [Elbarazi, Iffat; Grivna, Michal] United Arab Emirates Univ, Inst Publ Hlth, Al Ain, U Arab Emirates; [Elemineh, Demelash Abewa] Debre Markos Univ, Dept Stat, Debre Markos, Ethiopia; [El-Khatib, Ziad] Karolinska Inst, Dept Publ Hlth Sci, Stockholm, Sweden; [El-Khatib, Ziad] Univ Quebec Abitibi Temiscamingue, World Hlth Programme, Rouyn Noranda, PQ, Canada; [Elsharkawy, Aisha] Cairo Univ, Endem Med & Hepatogastroentrol Dept, Cairo, Egypt; [El-Sherbiny, Yasser Mohamed] Nottingham Trent Univ, Dept Biosci, Nottingham, England; [Elyazar, Iqbal R. F.] Eijkman Inst Mol Biol, Eijkman Oxford Clin Res Unit, Jakarta, Indonesia; [Emamian, Mohammad Hassan] Shahroud Univ Med Sci, Ophthalm Epidemiol Res Ctr, Shahroud, Iran; [Enany, Shymaa] Suez Canal Univ, Dept Microbiol & Immunol, Ismailia, Egypt; [Endalew, Daniel Adane] Wolkite Univ, Dept Midwifery, Wolkite, Ethiopia; [Endalifer, Melese Linger] Woldia Univ, Dept Midwifery, Woldia, Ethiopia; [Eskandari, Khalil] Kerman Univ Med Sci, Dept Med Chem, Kerman, Iran; [Eskandari, Khalil] Kerman Univ Med Sci, Pharmaceut Res Ctr, Kerman, Iran; [Eskandarieh, Sharareh; Sahraian, Mohammad Ali] Univ Tehran Med Sci, Multiple Sclerosis Res Ctr, Tehran, Iran; [Esmaeilnejad, Saman] Tarbiat Modares Univ, Dept Physiol, Tehran, Iran; [Etemadi, Arash] NCI, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA; [Etemadi, Arash] Univ Tehran Med Sci, Tehran, Iran; [Etisso, Atkilt Esaiyas] Hawassa Univ, Unit Med Physiol, Hawassa, Ethiopia; [Fanzo, Jessica] Johns Hopkins Univ, Berman Inst Bioeth, Baltimore, MD USA; [Fanzo, Jessica] United Nations, Nutr & Food Syst Div, Food & Agr Org, Rome, Italy; [Farahmand, Mohammad] Univ Tehran Med Sci, Sch Publ Hlth, Tehran, Iran; [Faraj, Anwar] Univ Human Dev, Dept Polit Sci, Sulaimaniyah, Iraq; [Farashi, Sajjad] Hamadan Univ Med Sci, Deputy Res & Technol, Hamadan, Iran; [Fareed, Mohammad] Imam Mohammad Ibn Saud Islamic Univ, Coll Med, Riyadh, Saudi Arabia; [Farioli, Andrea; Violante, Francesco S.] Univ Bologna, Dept Med & Surg Sci, Bologna, Italy; [Faro, Andre] Univ Fed Sergipe, Dept Psychol, Sao Cristovao, Brazil; [Fatima, Syeda Sadia] Aga Khan Univ, Dept Biol & Biomed Sci, Karachi, Pakistan; [Gesesew, Hailay Abrha; Fauk, Nelsensius Klau] Flinders Univ S Australia, Coll Med & Publ Hlth, Adelaide, SA, Australia; [Fauk, Nelsensius Klau] Inst Resource Governance & Social Change, Kupang, Indonesia; [Fazaeli, Ali Akbar] Hamadan Univ Med Sci, Social Determinants Hlth Res Ctr, Hamadan, Iran; [Fentahun, Netsanet] Bahir Dar Univ, Dept Publ Hlth Nutr, Bahir Dar, Ethiopia; [Ferede, Tomas Y.] Hawassa Univ, Sch Nursing & Midwifery, Hawassa, Ethiopia; [Fereshtehnejad, Seyed-Mohammad] Univ Ottawa, Div Neurol, Ottawa, ON, Canada; [Fernandes, Eduarda; Gomes, Nelson G. M.] Univ Porto, REQUIMTE LAQV Network Chem & Technol, Porto, Portugal; [Fernandes, Joao C.] Catholic Univ Portugal, Ctr Biotechnol & Fine Chem, Porto, Portugal; [Feyissa, Garumma Tolu] Jimma Univ, Dept Hlth Educ & Behav Sci, Jimma, Ethiopia; [Feyissa, Garumma Tolu] Jimma Univ, Jimma, Ethiopia; [Filip, Irina] Kaiser Permanente, Dept Psychiat, Fontana, CA USA; [Filip, Irina] AT Still Univ, Sch Hlth Sci, Mesa, AZ USA; [Fischer, Florian] Bielefeld Univ, Dept Populat Med & Hlth Serv Res, Bielefeld, Germany; [Flohr, Carsten] Kings Coll London, Unit Populat Based Dermatol Res, London, England; [Foigt, Nataliya A.] Natl Acad Med Sci Ukraine, Inst Gerontol, Kiev, Ukraine; [Folayan, Morenike Oluwatoyin] Obafemi Awolowo Univ, Dept Child Dent Hlth, Ife, Nigeria; [Fomenkov, Artem Alekseevich; Titova, Mariya Vladimirovna] Russian Acad Sci, Timiryazev Inst Plant Physiol IPPRAS, Moscow, Russia; [Foroutan, Masoud] Abadan Univ Med Sci, Abadan Sch Med Sci, Abadan, Iran; [Foerster, Jana] Ctr Populat & Hlth, Dept Res, Wiesbaden, Germany; [Francis, Joel Msafiri] Univ Witwatersrand, Dept Family Med & Primary Care, Johannesburg, South Africa; [Fukumoto, Takeshi] Kobe Univ, Dept Dermatol, Kobe, Hyogo, Japan; [Fukumoto, Takeshi] Wistar Inst Anat & Biol, Gene Express Regulat Program, Philadelphia, PA USA; [Gayesa, Reta Tsegaye; Kasaye, Habtamu Kebebe] Wollega Univ, Sch Nursing & Midwifery, Nekemte, Ethiopia; [Geberemariyam, Biniyam Sahiledengle; Handiso, Demelash Woldeyohannes] Madda Walabu Univ, Dept Publ Hlth, Bale Robe, Ethiopia; [Zepro, Nejimu Biza; Gebremariam, Kidane Tadesse; Gebreslassie, Assefa Ayalew Ayalew] Mekelle Univ, Sch Publ Hlth, Mekelle, Ethiopia; [Gebremedhin, Ketema Bizuwork Bizuwork; Wondmieneh, Adam Belay] Addis Ababa Univ, Dept Nursing & Midwifery, Addis Ababa, Ethiopia; [Gebremeskel, Gebreamlak Gebremedhn] Mekelle Univ, Dept Nursing, Mekelle, Ethiopia; [Gedefaw, Getnet Azeze] Haramaya Univ, Dire Dawa, Ethiopia; [Geta, Birhanu] Wollo Univ, Pharm, Dessie, Ethiopia; [Getenet, Agegnehu Bante; Yeshitila, Yordanos Gizachew] Arba Minch Univ, Dept Nursing, Arba Minch, Ethiopia; [Gezae, Kebede Embaye] Mekelle Univ, Dept Biostat, Mekelle, Ethiopia; [Ghaffarifar, Fatemeh; Pirestani, Majid; Zaki, Leila] Tarbiat Modares Univ, Dept Parasitol & Entomol, Tehran, Iran; [Ghafourifard, Mansour] Tabriz Univ Med Sci, Dept Med Surg, Tabriz, Iran; [Ghajar, Alireza] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Ghajarzadeh, Mahsa] Acad Med Sci, Neurosci Inst, Tehran, Iran; [Ghashghaee, Ahmad] Iran Univ Med Sci, Dept Hlth Serv Management, Tehran, Iran; [Ghiasvand, Hesam] Univ Social Welf & Rehabil Sci, Social Determinants Hlth Res Ctr, Tehran, Iran; [Gholamian, Asadollah] Islamic Azad Univ, Sci & Res Branch, Tehran, Iran; [Gholamian, Asadollah] Islamic Azad Univ, Young Researchers & Elite Club, Rasht, Iran; [Gilani, Syed Amir] Univ Lahore, Lahore, Pakistan; [Gilani, Syed Amir] Afro Asian Inst, Lahore, Pakistan; [Gill, Tiffany K.] Univ Adelaide, Adelaide Med Sch, Adelaide, SA, Australia; [Ginawi, Ibrahim Abdelmageed] Univ Hail, Dept Family & Community Med, Hail, Saudi Arabia; [Goli, Srinivas] Jawahar Lal Nehru Univ, Ctr Study Reg Dev, New Delhi, India; [Gomes, Nelson G. M.] Univ Porto, Dept Chem, Porto, Portugal; [Gopalani, Sameer Vali] Univ Oklahoma, Dept Biostat & Epidemiol, Oklahoma City, OK USA; [Gopalani, Sameer Vali] Govt Federated States Micronesia, Dept Hlth & Social Affairs, Palikir, Micronesia; [Goudarzi, Houman] Hokkaido Univ, Dept Resp Med, Sapporo, Hokkaido, Japan; [Goudarzi, Houman] Hokkaido Univ, Ctr Environm & Hlth Sci, Sapporo, Hokkaido, Japan; [Goulart, Alessandra C.] Univ Sao Paulo, Ctr Clin & Epidemiol Res, Sao Paulo, Brazil; [Goulart, Alessandra C.] Univ Sao Paulo, Dept Internal Med, Sao Paulo, SP, Brazil; [Govindakarnavar, Arunkumar] Manipal Acad Higher Educ, Manipal Inst Virol, Manipal, India; [Grada, Ayman] Boston Univ, Dept Dermatol, Boston, MA 02215 USA; [Guimaraes, Rafael Alves] Univ Fed Goias, Inst Patol Trop & Saude Publ, Goiania, Go, Brazil; [Guled, Rashid Abdi] Jigjiga Univ, Coll Med & Hlth Sci, Jigjiga, Ethiopia; [Guo, Yuming] Zhengzhou Univ, Dept Epidemiol & Biostat, Zhengzhou, Henan, Peoples R China; [Gupta, Rahul] March Dimes, Arlington, VA USA; [Gupta, Rahul] West Virginia Univ, Sch Publ Hlth, Morgantown, WV USA; [Gupta, Rajeev] Rajasthan Univ Hlth Sci, Acad & Res Dept, Jaipur, Rajasthan, India; [Gupta, Rajeev] Mahatma Gandhi Univ Med Sci & Technol, Dept Med, Jaipur, Rajasthan, India; [Hafezi-Nejad, Nima; Haj-Mirzaian, Arya; Shafaat, Omid] Johns Hopkins Univ, Dept Radiol & Radiol Sci, Baltimore, MD USA; [Hafezi-Nejad, Nima] Univ Tehran Med Sci, Sch Med, Tehran, Iran; [Haile, Michael Tamene] St Pauls Hosp, Dept Nursing, Millennium Med Coll, Addis Ababa, Ethiopia; [Haj-Mirzaian, Arya; Haj-Mirzaian, Arvin] Univ Tehran Med Sci, Dept Pharmacol, Tehran, Iran; [Haj-Mirzaian, Arvin] Shahid Beheshti Univ Med Sci, Obes Res Ctr, Tehran, Iran; [Hall, Brian J.] Univ Macau, Global & Community Mental Hlth Res Grp, Macau, Peoples R China; [Halvaei, Iman] Tarbiat Modares Univ, Dept Anat Sci, Tehran, Iran; [Hamadeh, Randah R.] Arabian Gulf Univ, Dept Family & Community Med, Manama, Bahrain; [Hamidi, Yadollah] Hamadan Univ Med Sci, Dept Hlth Management & Econ, Hamadan, Iran; [Hankey, Graeme J.] Univ Western Australia, Sch Med, Perth, Australia; [Hankey, Graeme J.] Sir Charles Gairdner Hosp, Dept Neurol, Perth, WA, Australia; [Haririan, Hamidreza] Tabriz Univ Med Sci, Tabriz, Iran; [Hariyani, Ninuk] Univ Airlangga Indonesia, Dept Dent Publ Hlth, Surabaya, Indonesia; [Hariyani, Ninuk] Univ Adelaide, Australian Res Ctr Populat Oral Hlth, Adelaide, SA, Australia; [Hasaballah, Ahmed I.] Al Azhar Univ, Dept Zool, Cairo, Egypt; [Hasan, Md. Mehedi] Univ Queensland, Social Sci Res Inst, Indooroopilly, Qld, Australia; [Hasanpoor, Edris] Maragheh Univ Med Sci, Dept Healthcare Management, Maragheh, Iran; [Hasanzadeh, Amir] Maragheh Univ Med Sci, Dept Microbiol, Maragheh, Iran; [Hasanzadeh, Amir] Univ Tehran Med Sci, Dept Microbiol, Tehran, Iran; [Hashemian, Maryam] Utica Coll, Dept Biol, Utica, NY USA; [Hassanipour, Soheil; Joukar, Farahnaz; Mansour-Ghanaei, Fariborz] Guilan Univ Med Sci, Gastrointestinal & Liver Dis Res Ctr, Rasht, Iran; [Hassanipour, Soheil] Guilan Univ Med Sci, Rasht, Iran; [Hassen, Hamid Yimam; Henok, Andualem] Mizan Tepi Univ, Dept Publ Hlth, Tepi, Ethiopia; [Hassen, Hamid Yimam] Univ Hosp Antwerp, Unit Epidemiol & Social Med, Antwerp, Belgium; [Havmoeller, Rasmus] Karolinska Univ Hosp, Dept Clin Sci, Stockholm, Sweden; [Hawkes, Corinna] City Univ London, Sch Hlth Sci, London, England; [Hayat, Khezar] Univ Vet & Anim Sci, Inst Pharmaceut Sci, Lahore, Pakistan; [Hayat, Khezar] Xi An Jiao Tong Univ, Dept Pharm Adm & Clin Pharm, Xian, Peoples R China; [Heidari-Soureshjani, Reza] Shahrekord Univ Med Sci, Shahrekord, Iran; [Hendrie, Delia; Miller, Ted R.] Curtin Univ, Sch Publ Hlth, Perth, WA, Australia; [Herrero, Mario] Agr & Food Commonwealth Sci & Ind Res Org, St Lucia, Qld, Australia; [Heydarpour, Fatemeh; Soleymani, Bija] Kermanshah Univ Med Sci, Med Biol Res Ctr, Kermanshah, Iran; [de Hidru, Hagos D.] Adigrat Univ, Dept Biostat & Epidemiol, Adigrat, Ethiopia; [Hoek, Hans W.] Univ Med Ctr Groningen, Dept Psychiat, Groningen, Netherlands; [Hoek, Hans W.] Columbia Univ, Dept Epidemiol, New York, NY USA; [Hole, Michael K.] Univ Texas Austin, Dell Med Sch, Dept Pediat, Austin, TX 78712 USA; [Holla, Ramesh] Manipal Acad Higher Educ, Kasturba Med Coll, Manipal, India; [Rad, Enayatollah Homaie] Guilan Univ Med Sci, Guilan Rd Trauma Res Ctr, Rasht, Iran; [Rad, Enayatollah Homaie] Guilan Univ Med Sci, Social Determinants Hlth Res Ctr, Rasht, Iran; [Hong, Sung Hwi] Yonsei Univ, Dept Pediat, Seoul, South Korea; [Hong, Sung Hwi] Elect Med Records Dev World, Res Dept, York, N Yorkshire, England; [Hoogar, Praveen] Manipal Acad Higher Educ, Transdisciplinary Ctr Qualitat Methods, Manipal, India; [Horino, Masako] Nevada Div Publ & Behav Hlth, Carson City, NV USA; [Hossain, Naznin] Dhaka Med Coll, Dept Pharmacol & Therapeut, Dhaka, Bangladesh; [Hossain, Naznin] Bangladesh Ind Gases Ltd, Dept Pharmacol, Tangail, Bangladesh; [Hosseini, Mostafa; Mansournia, Mohammad Ali; Tohidinik, Hamid Reza] Univ Tehran Med Sci, Dept Epidemiol & Biostat, Tehran, Iran; [Hosseinzadeh, Mehdi] Islamic Azad Univ, Dept Comp Engn, Tehran, Iran; [Hosseinzadeh, Mehdi] Univ Human Dev, Dept Comp Sci, Sulaymaniyah, Iraq; [Hostiuc, Mihaela; Negoi, Ionut] Carol Davila Univ Med & Pharm, Dept Gen Surg, Bucharest, Romania; [Hostiuc, Mihaela] Bucharest Emergency Hosp, Dept Internal Med, Bucharest, Romania; [Hostiuc, Sorin] Carol Davila Univ Med & Pharm, Dept Legal Med & Bioeth, Fac Dent, Bucharest, Romania; [Hostiuc, Sorin] Natl Inst Legal Med, Clin Legal Med Dept, Bucharest, Romania; [Househ, Mowafa] Hamad Bin Khalifa Univ, Coll Sci & Engn, Doha, Qatar; [Hsairi, Mohamed] Med Sch Tunis, Baab Saadoun, Tunisia; [Hu, Guoqing] Cent South Univ, Dept Epidemiol & Hlth Stat, Changsha, Peoples R China; [Huda, Tanvir M.] Univ Sydney, Sch Publ Hlth, Sydney, NSW, Australia; [Karim, Mohd A.; Huda, Tanvir M.; Bin Zaman, Sojib] Int Ctr Diarrhoeal Dis Res, Maternal & Child Hlth Div, Dhaka, Bangladesh; [Humayun, Ayesha] Shaikh Zayed Med Complex, Dept Publ Hlth & Community Med, Shaikh Khalifa Bin Zayed Al Nahyan Med Coll, Lahore, Pakistan; [Hwang, Bing-Fang] China Med Univ, Dept Occupat Safety & Hlth, Taichung, Taiwan; [Ilic, Milena D.] Univ Kragujevac, Dept Epidemiol, Kragujevac, Serbia; [Imani-Nasab, Mohammad Hasan] Lorestan Univ Med Sci, Dept Publ Hlth, Khorramabad, Iran; [Inbaraj, Leeberk Raja] Bangalore Baptist Hosp, Dept Family Med, Bangalore, Karnataka, India; [Iqbal, Usman] Taipei Med Univ, Global Hlth & Dev Dept, Taipei, Taiwan; [Irvani, Seyed Sina Naghibi] Shahid Beheshti Univ Med Sci, Res Inst Endocrine Sci, Tehran, Iran; [Islam, Sheikh Mohammed Shariful] Deakin Univ, Inst Phys Act & Nutr, Burwood, Vic, Australia; [Islam, Sheikh Mohammed Shariful] Univ Sydney, Sydney Med Sch, Sydney, NSW, Australia; [Iwu, Chidozie C. D.] Univ Pretoria, Sch Hlth Syst & Publ Hlth, Hatfield, Herts, South Africa; [Iwu, Chinwe Juliana] South African Med Res Council, Cochrane Ctr, Parow Valley, South Africa; [Iwu, Chinwe Juliana] Stellenbosch Univ, Hlth Syst & Publ Hlth, Cape Town, South Africa; [Izadi, Neda; Riahi, Seyed Mohammad; Sabour, Siamak] Shahid Beheshti Univ Med Sci, Dept Epidemiol, Tehran, Iran; [Jaafari, Jalil] Guilan Univ Med Sci, Dept Environm Hlth Engn, Rasht, Iran; [Jaca, Anelisa] Med Res Council South Africa, Cape Town, South Africa; [Jaca, Anelisa] Stellenbosch Univ, Ctr Evidence Based Hlth Care, Cape Town, South Africa; [Jadidi-Niaragh, Farhad] Tabriz Univ Med Sci, Dept Immunol, Tabriz, Iran; [Balalami, Nader Jafari] Babol Noshirvani Univ Technol, Dept Psychosis, Babol, Iran; [Jafarinia, Morteza] Isfahan Univ Med Sci, Dept Immunol, Esfahan, Iran; [Jakovljevic, Mihajlo] Sechenov First Moscow State Med Univ, Dept Hlth Care & Publ Hlth, Moscow, Russia; [Jalali, Amir] Kermanshah Univ Med Sci, Dept Psychiat, Kermanshah, Iran; [Jalilian, Farzad; Mirzaei-Alavijeh, Mehdi; Salimi, Yahya] Kermanshah Univ Med Sci, Social Dev Hlth Promot Res Ctr, Kermanshah, Iran; [Jalilian, Farzad; Mirzaei-Alavijeh, Mehdi; Salimi, Yahya] Kermanshah Univ Med Sci, Kermanshah, Iran; [Jayatilleke, Achala Upendra] Univ Colombo, Inst Med, Colombo, Sri Lanka; [Jayatilleke, Achala Upendra] Univ Colombo, Colombo, Sri Lanka; [Jeemon, Panniyammakal; Mini, G. K.] Sree Chitra Tirunal Inst Med Sci & Technol, Achutha Menon Ctr Hlth Sci Studies, Trivandrum, Kerala, India; [Jehan, Fyezah] Aga Khan Univ, Dept Pediat & Child Hlth, Karachi, Pakistan; [Jenabi, Ensiyeh] Hamadan Univ Med Sci, Autism Spectrum Disorders Res Ctr, Hamadan, Iran; [Jha, Ravi Prakash] Banaras Hindu Univ, Dept Community Med, Varanasi, Uttar Pradesh, India; [Jha, Vivekanand] Manipal Acad Higher Educ, Manipal, India; [Jha, Vivekanand; John, Oommen] Univ New South Wales, George Inst Global Hlth, New Delhi, India; [Ji, John S.] Duke Kunshan Univ, Environm Res Ctr, Kunshan, Peoples R China; [Ji, John S.] Duke Univ, Nicholas Sch Environm, Durham, NC USA; [Jia, Peng] Univ Twente, Dept Earth Observat Sci, Enschede, Netherlands; [Jonas, Jost B.] Heidelberg Univ, Dept Ophthalmol, Mannheim, Germany; [Jonas, Jost B.] Beijing Tongren Hosp, Beijing Ophthalmol & Visual Sci Key Lab, Beijing, Peoples R China; [Joseph, Nitin] Manipal Acad Higher Educ, Dept Community Med, Mangalore, India; [Jozwiak, Jacek Jerzy] Univ Opole, Dept Family Med & Publ Hlth, Opole, Poland; [Jungari, Suresh Banayya] Savitribai Phule Pune Univ, Sch Hlth Sci, Pune, Maharashtra, India; [Jurisson, Mikk] Univ Tartu, Inst Family Med & Publ Hlth, Tartu, Estonia; [Kabir, Ali] Iran Univ Med Sci, Minimally Invas Surg Res Ctr, Tehran, Iran; [Kabir, Ali] Univ Coll Cork, Sch Publ Hlth, Cork, Ireland; [Kalani, Hamed] Golestan Univ Med Sci, Infect Dis Res Ctr, Gorgan, Golestan, Iran; [Kalankesh, Leila L.] Tabriz Univ Med Sci, Dept Med Informat, Tabriz, Iran; [Kalhor, Rohollah] Qazvin Univ Med Sci Qazvin, Hlth Serv Management Dept, Sch Hlth, Qazvin, Iran; [Kamiab, Zahra] Rafsanjan Univ Med Sci, Dept Community Med, Rafsanjan, Iran; [Kanchan, Tanuj] All India Inst Med Sci, Dept Forens Med & Toxicol, Jodhpur, Rajasthan, India; [Kapil, Umesh] All India Inst Med Sci, New Delhi, India; [Karami, Manoochehr; Khazaei, Salman] Hamadan Univ Med Sci, Dept Epidemiol, Hamadan, Iran; [Karch, Andre] Univ Munster, Inst Epidemiol & Social Med, Munster, Germany; [Karki, Surendra] Australian Red Cross Blood Serv, Res & Dev, Sydney, NSW, Australia; [Kasaeian, Amir] Univ Tehran Med Sci, Hematol Oncol & Stem Cell Transplantat Res Ctr, Tehran, Iran; [Kasaeian, Amir] Iran Univ Med Sci, Pars Adv & Minimally Invas Med Manners Res Ctr, Tehran, Iran; [Kassa, Tesfaye Dessale] Mekelle Univ, Clin Pharm Unit, Mekelle, Ethiopia; [Kassebaum, Nicholas J.] Univ Washington, Dept Anesthesiol & Pain Med, Seattle, WA 98195 USA; [Karyani, Ali Kazemi; Kianipour, Neda] Kermanshah Univ Med Sci, Dept Publ Hlth, Kermanshah, Iran; [Kengne, Andre Pascal] Med Res Council South Africa, Noncommunicable Dis Res Unit, Cape Town, South Africa; [Kengne, Andre Pascal; Mensah, George A.; Noubiap, Jean Jacques] Univ Cape Town, Dept Med, Cape Town, South Africa; [Ketema, Daniel Bekele; Wonde, Tewodros Eshete] Debre Markos Univ, Dept Publ Hlth, Debre Markos, Ethiopia; [Khader, Yousef Saleh] Jordan Univ Sci & Technol, Dept Publ Hlth, Irbid, Jordan; [Khafaie, Morteza Abdullatif] Ahvaz Jundishapur Univ Med Sci, Social Determinants Hlth Res Ctr, Ahvaz, Iran; [Khaksarian, Mojtaba] Lorestan Univ Med Sci, Dept Physiol, Khorramabad, Iran; [Khalid, Nauman] Univ Management & Technol, Sch Food & Agr Sci, Lahore, Pakistan; [Khalilov, Rovshan] Baku State Univ, Dept Physiol, Baku, Azerbaijan; [Khan, Asad; Uddin, Riaz] Univ Queensland, Sch Hlth & Rehabil Sci, Brisbane, Qld, Australia; [Khan, Ejaz Ahmad] Hlth Serv Acad, Epidemiol & Biostat Dept, Islamabad, Pakistan; [Khan, Md Nuruzzaman] Jatiya Kabi Kazi Nazrul Islam Univ, Dept Populat Sci, Mymensingh, Bangladesh; [Khan, Md Nuruzzaman] Univ Newcastle, Dept Publ Hlth, Newcastle, NSW, Australia; [Khan, Mohammad Saud] Brown Univ, Miriam Hosp, Dept Hosp Med, Providence, RI USA; [Khan, Muhammad Shahzeb] John H Stroger Jr Hosp Cook Cty, Dept Internal Med, Chicago, IL USA; [Khan, Muhammad Shahzeb; Siddiqi, Tariq J.; Usman, Muhammad Shariq] Dow Univ Hlth Sci, Dept Internal Med, Karachi, Pakistan; [Khatab, Khaled] Sheffield Hallam Univ, Fac Hlth & Wellbeing, Sheffield, S Yorkshire, England; [Khatab, Khaled] Ohio Univ, Coll Arts & Sci, Zanesville, OH USA; [Khater, Amir] Natl Hepatol & Trop Res Inst, Internal Med & Gastroenterol Dept, Cairo, Egypt; [Khater, Mona M.; Yousof, Hebat-Allah Salah A.] Cairo Univ, Dept Med Parasitol, Cairo, Egypt; [Khatib, Mahalqua Nazli] Datta Meghe Inst Med Sci, Div Evidence Synth, Wardha, India; [Khayamzadeh, Maryam] Shahid Beheshti Univ Med Sci, Canc Res Ctr, Tehran, Iran; [Khayamzadeh, Maryam] Acad Med Sci, Tehran, Iran; [Khazaei-Pool, Maryam] Mazandaran Univ Med Sci, Dept Publ Hlth, Sari, Iran; [Khodayari, Mohammad Taghi] Shahid Beheshti Univ Med Sci, Dept Biostatist, Tehran, Iran; [Khosravi, Mohammad Hossein] Iran Univ Med Sci, Dept Neurosurg, Tehran, Iran; [Khundkar, Roba] Univ Oxford, Global Surg Grp, Oxford, England; [Kiadaliri, Ali] Lund Univ, Clin Epidemiol Unit, Lund, Sweden; [Kiirithio, Daniel N.] Synotech Consultant, Res & Data Solut, Nairobi, Kenya; [Kim, Yun Jin] Xiamen Univ Malaysia, Sch Med, Sepang, Malaysia; [Kimokoti, Ruth W.] Simmons Univ, Dept Nutr, Boston, MA USA; [Kisa, Adnan] Kristiania Univ Coll, Sch Hlth Sci, Oslo, Norway; [Kisa, Sezer] Oslo Metropolitan Univ, Dept Nursing & Hlth Promot, Oslo, Norway; [Kolola, Tufa] Ambo Univ, Dept Publ Hlth, Ambo, Ethiopia; [Komaki, Hamidreza] Hamadan Univ Med Sci, Neurophysiol Res Ctr, Hamadan, Iran; [Komaki, Hamidreza] Inst Res Fundamental Sci, Brain Engn Res Ctr, Tehran, Iran; [Kondlahalli, Shivakumar K. M.] Deemed Univ, Dept Publ Hlth Dent, Karad, India; [Koolivand, Ali] Arak Univ Med Sci, Dept Environm Hlth Engn, Arak, Iran; [Koul, Parvaiz A.] Sheri Kashmir Inst Med Sci, Dept Internal & Pulm Med, Srinagar, India; [Koyanagi, Ai] CIBERSAM, San Juan de Dios Sanitary Pk, St Boi De Llobregat, Spain; [Kraemer, Moritz U. G.] Univ Oxford, Dept Zool, Oxford, England; [Kraemer, Moritz U. G.] Harvard Univ, Harvard Med Sch, Boston, MA 02115 USA; [Krishan, Kewal] Panjab Univ, Dept Anthropol, Chandigarh, India; [Kugbey, Nuworza; Zotor, Francis Bruno] Univ Hlth & Allied Sci, Dept Family & Community Hlth, Ho, Ghana; [Kugbey, Nuworza; Asante, Kwaku Oppong] Univ KwaZulu Natal, Dept Psychol & Hlth Promot, Durban, South Africa; [Kumar, Manasi] Univ Nairobi, Dept Psychiat, Nairobi, Kenya; [Kumar, Manasi] UCL, Div Psychol & Language Sci, London, England; [Kumar, Vivek] Harvard Univ, Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; [Kurmi, Om P.; Olagunju, Tinuke O.] McMaster Univ, Dept Pathol & Mol Med, Hamilton, ON, Canada; [Kurmi, Om P.] Univ Birmingham, Inst Occupat & Environm Med, Birmingham, W Midlands, England; [Kuti, Oluwatosin] United Nations Childrens Fund UNICEF, Hlth & Nutr Sect, Accra, Ghana; [La Vecchia, Carlo] Univ Milan, Clin Med & Community Hlth, Milan, Italy; [Lacey, Ben] Oxford Biomed Res Ctr, NIHR, Oxford, England; [Lad, Deepesh P.] Post Grad Inst Med Educ & Res, Dept Internal Med, Chandigarh, India; [Lal, Dharmesh Kumar] Publ Hlth Fdn India, Gurugram, India; [Lami, Faris Hasan] Univ Baghdad, Dept Community & Family Med, Baghdad, Iraq; [Lamichhane, Prabhat] Deakin Univ, Sch Med, Geelong, Vic, Australia; [Lang, Justin J.] Publ Hlth Agcy Canada, Hlth Promot & Chron Dis Prevent Branch, Ottawa, ON, Canada; [Lansingh, Van C.] HelpMeSee, New York, NY USA; [Lansingh, Van C.] Mexican Inst Ophthalmol, Int Relat, Queretaro, Mexico; [Lasrado, Savita] Father Muller Med Coll, Dept Otorhinolaryngol ENT & Head & Neck Surg, Mangalore, India; [Lebedev, Georgy] IM Sechenov First Moscow State Med Univ, Dept Informat & Internet Technol, Moscow, Russia; [Lebedev, Georgy] Minist Hlth, FRIHOI, Moscow, Russia; [Lee, Paul H.] Hong Kong Polytech Univ, Sch Nursing, Hong Kong, Peoples R China; [Lee, Shaun Wen Huey] Monash Univ, Sch Pharm, Bandar Sunway, Malaysia; [Lee, Shaun Wen Huey] Taylors Univ Lakeside Campus, Sch Pharm, Subang Jaya, Malaysia; [Lewycka, Sonia] Univ Oxford, Wellcome Trust Asia Programme, Clin Res Unit, Hanoi, Vietnam; [Lim, Lee-Ling] Univ Malaya, Dept Med, Kuala Lumpur, Malaysia; [Lim, Lee-Ling] Chinese Univ Hong Kong, Dept Med & Therapeut, Hong Kong, Peoples R China; [Linn, Shai; Shuval, Kerem] Univ Haifa, Sch Publ Hlth, Haifa, Israel; [Liu, Shiwei] Ctr Chron Dis Control, Beijing, Peoples R China; [Liu, Simin] Brown Univ, Dept Epidemiol, Providence, RI 02912 USA; [Lodha, Rakesh] All India Inst Med Sci, Dept Paediat, New Delhi, India; [Longbottom, Joshua] Univ Liverpool Liverpool Sch Trop Med, Vector Biol, Liverpool, Merseyside, England; [Lopez, Jaifred Christian F.] Univ Philippines Manila, Dept Nutr, Manila, Philippines; [Lopez, Jaifred Christian F.] Alliance Improving Hlth Outcomes Inc, Quezon City, Philippines; [Lorkowski, Stefan] Friedrich Schiller Univ Jena, Inst Nutr, Jena, Germany; [Lorkowski, Stefan] Competence Cluster Nutr & Cardiovasc Hlth NutriCA, Jena, Germany; [Macarayan, Erlyn Rachelle King] Harvard Univ, Ariadne Labs, Boston, MA 02115 USA; [Macarayan, Erlyn Rachelle King] Univ Philippines Los Banos, Dev & Commun Studies, Laguna, Philippines; [Madadin, Mohammed] Imam Abdulrahman Bin Faisal Univ, Dept Pathol, Dammam, Saudi Arabia; [Abd El Razek, Hassan Magdy] Mansoura Univ Hosp, Dept Radiol, Mansoura, Egypt; [Abd El Razek, Muhammed Magdy] Aswan Fac Med, Dept Ophthalmol, Aswan, Egypt; [Maghavani, Dhaval P.] Grant Med Coll & Sir JJ Grp Hosp, Dept Internal Med, Mumbai, Maharashtra, India; [Mahotra, Narayan Bahadur] Tribhuvan Univ, Inst Med, Kathmandu, Nepal; [Maled, Venkatesh] SDM Coll Med Sci & Hosp, Hlth Educ & Res Dept, Dharwad, Karnataka, India; [Maled, Venkatesh] Rajiv Gandhi Univ Hlth Sci, Hlth Univ, Bangalore, Karnataka, India; [Maleki, Afshin; Pashaei, Tahereh] Kurdistan Univ Med Sci, Environm Hlth Res Ctr, Sanandaj, Iran; [Maleki, Shokofeh; Naderi, Mehdi] Kermanshah Univ Med Sci, Clin Res Dev Ctr, Kermanshah, Iran; [Malta, Deborah Carvalho] Univ Fed Minas Gerais, Dept Maternal & Child Nursing & Publ Hlth, Belo Horizonte, MG, Brazil; [Manafi, Ali] Iran Univ Med Sci, Dept Plast Surg, Tehran, Iran; [Manafi, Farzad] Univ Toronto, Joint Ctr Bioeth, Toronto, ON, Canada; [Manafi, Navid] Iran Univ Med Sci, Dept Ophthalmol, Tehran, Iran; [Manafi, Navid] Univ Manitoba, Dept Ophthalmol, Winnipeg, MB, Canada; [Manohar, Narendar Dawanu] Western Sydney Univ, Sch Sci & Hlth, Sydney, NSW, Australia; [Mansouri, Borhan] Kermanshah Univ Med Sci, Subst Abuse Prevent Res Ctr, Kermanshah, Iran; [Mapoma, Chabila Christopher] Univ Zambia, Dept Populat Studies, Lusaka, Zambia; [Marrugo Arnedo, Carlos Alberto] Grp Invest Fundovida Fundovida IPS, Res Dept, Cartagena, Colombia; [Marrugo Arnedo, Carlos Alberto] Univ Cartagena, Grp Invest Econ Salud, Cartagena, Colombia; [Rogerlandio Martins-Melo, Francisco] Fed Inst Educ Sci & Technol Ceara, Campus Caucaia, Caucaia, Brazil; [Masaka, Anthony] Botho Univ Botswana, Dept Publ Hlth, Gaborone, Botswana; [Massenburg, Benjamin Ballard] Univ Washington, Div Plast Surg, Seattle, WA 98195 USA; [Maulik, Pallab K.] George Inst Global Hlth, Res Dept, New Delhi, India; [Maulik, Pallab K.] Univ New South Wales, Sch Med, Sydney, NSW, Australia; [Mayala, Benjamin K.] ICF Int, DHS Program, Rockville, MD USA; [Mazidi, Mohsen] Kings Coll London, Dept Twin Res & Genet Epidemiol, London, England; [Mehndiratta, Man Mohan] Janakpuri Super Specialty Hosp Soc, Dept Neurol, New Delhi, India; [Mehndiratta, Man Mohan] Govind Ballabh Inst Med Educ & Res, Dept Neurol, New Delhi, India; [Mehri, Freshteh] Hamadan Univ Med Sci, Pharmacol & Toxicol, Hamadan, Iran; [Mehta, Kala M.] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA USA; [Meitei, Wahengbam Bigyananda] Int Inst Populat Sci, Publ Hlth & Mortal, Mumbai, Maharashtra, India; [Mekonnen, Teferi] Univ Oslo, Dept Nutr, Oslo, Norway; [Meles, Hagazi Gebre] Mekelle Univ, Mekelle, Ethiopia; [Mendoza, Walter] United Nations Populat Fund UNFPA, Peru Country Off, Lima, Peru; [Menezes, Ritesh G.] Imam Abdulrahman Bin Faisal Univ, Forens Med Div, Dammam, Saudi Arabia; [Mengesha, Meresa Berwo] Adigrat Univ, Dept Midwifery, Adigrat, Ethiopia; [Mensah, George A.] NIH, Ctr Translat Res & Implementat Sci, Bldg 10, Bethesda, MD 20892 USA; [Meretoja, Tuomo J.] Helsinki Univ Hosp, Breast Surg Unit, Helsinki, Finland; [Meretoja, Tuomo J.] Univ Helsinki, Helsinki, Finland; [Miazgowski, Tomasz] Pomeranian Med Univ, Dept Propedeut Internal Dis & Arterial Hypertens, Szczecin, Poland; [Kostova, Neda Milevska] Ctr Reg Policy Res & Cooperat Studiorum, Hlth Policy & Management, Skopje, North Macedonia; [Miller, Ted R.] Pacific Inst Res Evaluat, Calverton, MD USA; [Mills, Edward J.] McMaster Univ, Dept Hlth Res Methods Evidence & Impact, Hamilton, ON, Canada; [Mini, G. K.] Ananthapuri Hosp & Res Ctr, GIPH, Trivandrum, Kerala, India; [Mir, Seyed Mostafa; Mosapour, Abbas; Parsian, Hadi] Babol Univ Med Sci, Dept Clin Biochem, Babol, Iran; [Mir, Seyed Mostafa] Golestan Univ Med Sci, Gorgan, Golestan, Iran; [Miri, Mohammad] Sabzevar Univ Med Sci, Dept Environm Hlth, Sabzevar, Iran; [Mirjalali, Hamed; Yadegar, Abbas] Shahid Beheshti Univ Med Sci, Res Inst Gastroenterol & Liver Dis, Foodborne & Waterborne Dis Res Ctr, Tehran, Iran; [Mirrakhimov, Erkin M.] Kyrgyz State Med Acad, Bishkek, Kyrgyzstan; [Mirrakhimov, Erkin M.] Natl Ctr Cardiol & Internal Dis, Dept Atherosclerosis & Coronary Heart Dis, Bishkek, Kyrgyzstan; [Mirzaei, Hamed] Kashan Univ Med Sci, Res Ctr Biochem & Nutr Metab Dis, Kashan, Iran; [Mirzaei, Maryam] Kermanshah Univ Med Sci, Dept Rehabil & Sports Med, Kermanshah, Iran; [Mirzaei, Roya] Iran Univ Med Sci, Deputy Social Hlth, Tehran, Iran; [Mohamadi, Efat] Univ Tehran Med Sci, Hlth Equ Res Ctr, Tehran, Iran; [Mohamadi-Bolbanabad, Amjad; Moradi, Ghobad; Moradpour, Farhad; Piroozi, Bakhtiar] Kurdistan Univ Med Sci, Social Determinants Hlth Res Ctr, Sanandaj, Iran; [Mohammad, Karzan Abdulmuhsin] Salahaddin Univ, Res Ctr, Erbil, Iraq; [Mohammad, Yousef] King Saud Univ, Dept Internal Med, Riyadh, Saudi Arabia; [Mohammad, Dara K.] Salahaddin Univ, Dept Food Technol, Erbil, Iraq; [Mohammad, Dara K.] Karolinska Inst, Dept Med, Stockholm, Sweden; [Darwesh, Aso Mohammad] Univ Human Dev, Dept Informat Technol, Sulaymaniyah, Iraq; [Mezerji, Naser Mohammad Gholi] Hamadan Univ Med Sci, Dept Biostat, Hamadan, Iran; [Mohammadian-Hafshejani, Abdollah] Shahrekord Univ Med Sci, Dept Epidemiol & Biostat, Shahrekord, Iran; [Mohammadnia-Afrouzi, Mousa] Babol Univ Med Sci, Dept Immunol, Babol, Iran; [Mohammadoo-Khorasani, Milad] Tarbiat Modares Univ, Clin Biochem, Tehran, Iran; [Mohammadpourhodki, Reza] Shahroud Univ Med Sci, Dept Nursing, Shahroud, Iran; [Mohammed, Salahuddin] Univ Mississippi, Dept Biomol Sci, Oxford, MS USA; [Mohammed, Salahuddin] Mizan Tepi Univ, Dept Pharm, Mizan, Ethiopia; [Mohammed, Shafiu] Ahmadu Bello Univ, Hlth Syst & Policy Res Unit, Zaria, Nigeria; [Mohammed, Ammas Siraj] Haramaya Univ, Sch Pharm, Harar, Ethiopia; [Mohebi, Farnam] Univ Tehran Med Sci, Iran Natl Inst Hlth Res, Tehran, Iran; [Mokari, Amin] Shahid Beheshti Univ Med Sci, Community Nutr, Tehran, Iran; [Cesar Montanez, Julio] Natl Hlth Res Inst, Hlth Syst Res Ctr, Cuernavaca, Morelos, Mexico; [Montero-Zamora, Pablo A.] Univ Miami, Dept Publ Hlth Sci, Miami, FL USA; [Moodley, Yoshan] Univ KwaZulu Natal, Dept Publ Hlth Med, Durban, South Africa; [Moossavi, Maryam] Birjand Univ Med Sci, Dept Mol Med, Birjand, Iran; [Moradi, Ghobad] Kurdistan Univ Med Sci, Dept Epidemiol & Biostat, Sanandaj, Iran; [Moradi, Yousef] Iran Univ Med Sci, Dept Epidemiol, Tehran, Iran; [Moradi-Joo, Mohammad] Univ Tehran Med Sci, Dept Econ & Management Sci Hlth, Tehran, Iran; [Moraga, Paula] Univ Bath, Dept Math Sci, Bath, Avon, England; [Morrison, Shane Douglas] Univ Washington, Dept Surg, Seattle, WA 98195 USA; [Mosapour, Abbas] Tarbiat Modares Univ, Dept Clin Biochem, Tehran, Iran; [Khaneghah, Amin Mousavi] Univ Estadual Campinas, Food Sci, Campinas, SP, Brazil; [Mozaffarian, Dariush] Tufts Univ, Friedman Sch Nutr Sci & Policy, Boston, MA 02111 USA; [Mueller, Ulrich Otto] Fed Inst Populat Res, Wiesbaden, Germany; [Mueller, Ulrich Otto; Werdecker, Andrea] Ctr Populat & Hlth, Wiesbaden, Germany; [Murthy, G. V. S.] Publ Hlth Fdn India, Indian Inst Publ Hlth Hyderabad, Hyderabad, India; [Musa, Kamarul Imran] Sci Univ Malaysia, Sch Med Sci, Kubang Kerian, Malaysia; [Mustafa, Ghulam] Nishtar Med Univ, Dept Pediat Med, Multan, Pakistan; [Mustafa, Ghulam] Inst Mother & Child Care, Dept Pediat & Pediat Pulmonol, Multan, Pakistan; [Muthupandian, Saravanan] Mekelle Univ, Dept Microbiol & Immunol, Mekelle, Ethiopia; [Nabavizadeh, Behnam] Univ Tehran Med Sci, Dept Urol, Tehran, Iran; [Nadkarni, Girish N.] Icahn Sch Med Mt Sinai, Dept Med, New York, NY USA; [Nagarajan, Ahamarshan Jayaraman] Initiat Financing Hlth & Human Dev, Res & Analyt, Chennai, Tamil Nadu, India; [Nagarajan, Ahamarshan Jayaraman] Bioinsilico Technol, Res & Analyt, Chennai, Tamil Nadu, India; [Naheed, Aliya] Int Ctr Diarrhoeal Dis Res, Initiat Noncommunicable Dis, Dhaka, Bangladesh; [Naik, Gurudatta] Univ Alabama Birmingham, Ctr Comprehens Canc, Birmingham, AL 35294 USA; [Salimi, Yahya; Najafi, Farid] Kermanshah Univ Med Sci, Dept Epidemiol & Biostat, Kermanshah, Iran; [Nansseu, Jobert Richie] Minist Publ Hlth, Dept Dis Epidem & Pandem Control, Yaounde, Cameroon; [Nansseu, Jobert Richie] Univ Yaounde I, Dept Publ Heath, Yaounde, Cameroon; [Nascimento, Bruno Ramos] Univ Fed Minas Gerais, Hosp Fed Univ Minas Gerais, Belo Horizonte, MG, Brazil; [Nazari, Javad] Arak Univ Med Sci, Dept Pediat, Arak, Iran; [Nazari, Javad] Iranian Minist Hlth & Med Educ, Tehran, Iran; [Negoi, Ionut] Emergency Hosp Bucharest, Gen Surg, Bucharest, Romania; [Negoi, Ruxandra Irina] Carol Davila Univ Med & Pharm, Anat & Embryol, Bucharest, Romania; [Negoi, Ruxandra Irina] Cardioaid, Cardiol, Bucharest, Romania; [Ngunjiri, Josephine W.] Univ Embu, Dept Biol Sci, Embu, Kenya; [Cuong Tat Nguyen; Huong Lan Thi Nguyen; Vuong Minh Nong] Duy Tan Univ, Inst Global Hlth Innovat, Hanoi, Vietnam; [Nigatu, Yeshambel T.] Univ Ottawa, Mental Hlth Res Inst, Ottawa, ON, Canada; [Nigatu, Yeshambel T.] Inst Clin Evaluat Sci, Dept Clin Epidemiol, Ottawa, ON, Canada; [Nikbakhsh, Rajan] Univ Tehran Med Sci, Shahid Beheshti Univ Med Sci, Dept Pharmacol, Tehran, Iran; [Nikbakhsh, Rajan] Heidelberg Univ Hosp, Heidelberg, Germany; [Ningrum, Dina Nur Anggraini] Univ Negeri Semarang, Dept Publ Hlth, Kota Semarang, Indonesia; [Ningrum, Dina Nur Anggraini] Taipei Med Univ, Grad Inst Biomed Informat, Taipei, Taiwan; [Nnaji, Chukwudi A.] Univ Cape Town, Sch Publ Hlth & Family Med, Cape Town, South Africa; [Nowak, Christoph] Karolinska Inst, Div Family Med & Primary Care, Dept Neurobiol Care Sci & Soc NVS, H1, Huddinge, Sweden; [Oancea, Bogdan] Univ Bucharest, Adm & Econ Sci, Bucharest, Romania; [Ofori-Asenso, Richard] Monash Univ, Ctr Cardiovasc Res & Educ Therapeut, Melbourne, Vic, Australia; [Oghenetega, Onome Bright] Univ Ibadan, Dept Obstet & Gynecol, Ibadan, Nigeria; [Oh, In-Hwan] Kyung Hee Univ, Dept Prevent Med, Seoul, South Korea; [Oladimeji, Olanrewaju] Human Sci Res Council, HAST, Durban, South Africa; [Oladimeji, Olanrewaju] Univ Namibia, Sch Publ Hlth, Osakhati, Namibia; [Oladnabi, Morteza] Golestan Univ Med Sci, Sch Adv Technol Med, Dept Med Genet, Gorgan, Golestan, Iran; [Olagunju, Andrew T.] McMaster Univ, Dept Psychiat & Behav Neurosci, Hamilton, ON, Canada; [Olagunju, Andrew T.] Univ Lagos, Dept Psychiat, Lagos, Nigeria; [Olusanya, Bolajoko Olubukunola] Ctr Hlth Start Initiat, Lagos, Nigeria; [Olusanya, Jacob Olusegun] Phon Hearing Ctr, Ctr Hlth Start Initiat, Lagos, Nigeria; [Omer, Muktar Omer] Jigjiga Univ, Publ Hlth, Jig Jiga, Ethiopia; [Omer, Muktar Omer] Jigjiga Univ, Sch Grad Studies, Jig Jiga, Ethiopia; [Onwujekwe, Obinna E.] Univ Nigeria Nsukka, Dept Pharmacol & Therapeut, Enugu, Nigeria; [Asante, Kwaku Oppong] Univ Ghana, Dept Psychol, Accra, Ghana; [Oren, Eyal] San Diego State Univ, Grad Sch Publ Hlth, San Diego, CA 92182 USA; [Oren, Eyal] Univ Washington, Seattle, WA 98195 USA; [Orisakwe, Orish Ebere] Univ Port Harcourt, Port Harcourt, Nigeria; [Ortiz, Alberto] Autonomous Univ Madrid, Sch Med, Madrid, Spain; [Ortiz, Alberto] Inst Hlth Res Fdn Jimenez Diaz Univ Hosp, Dept Hypertens & Nephrol, Madrid, Spain; [Osarenotor, Osayomwanbo] Univ Benin, Dept Environm Management & Toxicol, Benin, Nigeria; [Owolabi, Mayowa Ojo] Univ Ibadan, Inst Adv Med Res & Training, Ibadan, Nigeria; [Mahesh, P. A.] Jagadguru Sri Shivarathreeshwara Acad Hlth Educ &, Dept Resp Med, Mysore, Karnataka, India; [Padubidri, Jagadish Rao; Rastogi, Prateek] Manipal Acad Higher Educ, Dept Forens Med & Toxicol, Mangalore, India; [Pakshir, Keyvan; Zomorodian, Kamiar] Shiraz Univ Med Sci, Dept Med Mycol & Parasitol, Shiraz, Iran; [Pana, Adrian] Ctr Hlth Outcomes & Evaluat, Bucharest, Romania; [Panda-Jonas, Songhomitra] Heidelberg Univ, Heidelberg, Germany; [Pasupula, Deepak Kumar] Univ Pittsburgh, Med Ctr, Internal Med, Pittsburgh, PA USA; [Patel, Sangram Kishor] Populat Council, Res & Evaluat, New Delhi, India; [Patel, Sangram Kishor] Indian Inst Hlth Management Res Univ, Jaipur, Rajasthan, India; [Pathak, Ashish] RD Gardi Med Coll, Dept Pediat, Ujjain, Madhya Pradesh, India; [Pathak, Ashish] Karolinska Inst, Publ Hlth Sci, Stockholm, Sweden; [Pathak, Mona] Kalinga Inst Med Sci, Res & Publicat Cell, Bhubaneswar, India; [Pati, Sanghamitra] Indian Council Med Res, Reg Med Res Ctr, Bhubaneswar, India; [Patle, Ajay] Int Inst Populat Sci, Dept Populat Studies, Mumbai, Maharashtra, India; [Patle, Ajay] Int Inst Hlth Management Res, New Delhi, India; [Patton, George C.] Univ Melbourne, Dept Paediat, Melbourne, Vic, Australia; [Patton, George C.] Murdoch Childrens Res Inst, Populat Hlth, Melbourne, Vic, Australia; [Paulos, Kebreab] Wolaita Sodo Univ, Sodo, Ethiopia; [Toroudi, Hamidreza Pazoki] Iran Univ Med Sci, Dept Physiol, Tehran, Iran; [Pepito, Veincent Christian Filipino] Ateneo Manila Univ, Ctr Res & Innovat, Pasig, Philippines; [Perico, Norberto; Remuzzi, Giuseppe] Ist Ric Farmacol Mario Negri IRCCS, Bergamo, Italy; [Petri, William A.] Univ Virginia, Sch Med, Charlottesville, VA 22908 USA; [Pokhrel, Khem Narayan] Integrated Dev Fdn Nepal, HIV & Mental Hlth Dept, Kathmandu, Nepal; [Postma, Maarten J.] Univ Groningen, Univ Med Ctr Groningen, Groningen, Netherlands; [Postma, Maarten J.] Univ Groningen, Fac Econ & Business, Groningen, Netherlands; [Pourjafar, Hadi] Maragheh Univ Med Sci, Dept Publ Hlth, Maragheh, Iran; [Pourjafar, Hadi] Maragheh Univ Med Sci, Dept Nutr & Food Sci, Maragheh, Iran; [Pourmalek, Farshad] Univ British Columbia, Sch Populat & Publ Hlth, Vancouver, BC, Canada; [Kalhori, Reza Pourmirza] Kermanshah Univ Med Sci, Paramed Dept, Kermanshah, Iran; [Pourshams, Akram; Poustchi, Hossein; Roshandel, Gholamreza; Salimzadeh, Hamideh] Univ Tehran Med Sci, Digest Dis Res Inst, Tehran, Iran; [Prada, Sergio I.] Fdn Valle Lili, Cali, Colombia; [Preotescu, Liliana] Natl Inst Infect Dis, Infect Dis, Bucharest, Romania; [Preotescu, Liliana] Carol Davila Univ Med & Pharm, Dept Infect Dis, Bucharest, Romania; [Pribadi, Dimas Ria Angga] Muhammadiyah Univ Surakarta, Dept Hlth Sci, Sukoharjo, Indonesia; [Rabiee, Mohammad] Amirkabir Univ Technol, Dept Biomed Engn, Tehran, Iran; [Rabiee, Navid] Sharif Univ Technol, Dept Chem, Tehran, Iran; [Radfar, Amir] Univ Cent Florida, Coll Med, Orlando, FL 32816 USA; [Radfar, Amir] AT Still Univ, Coll Grad Hlth Sci, Mesa, AZ USA; [Rafiei, Alireza] Mazandaran Univ Med Sci, Dept Immunol, Sari, Iran; [Rafiei, Alireza] Mazandaran Univ Med Sci, Mol & Cell Biol Res Ctr, Sari, Iran; [Rahim, Fakher] Ahvaz Jundishapur Univ Med Sci, Thalassemia & Hemoglobinopathy Res Ctr, Ahvaz, Iran; [Rahim, Fakher] Univ Tehran Med Sci, Metabol & Genom Res Ctr, Tehran, Iran; [Rahimi-Movaghar, Vafa] Univ Tehran Med Sci, Sina Trauma & Surg Res Ctr, Tehran, Iran; [Rahman, Muhammad Aziz] Federat Univ, Sch Nursing & Healthcare Profess, Heidelberg, Vic, Australia; [Rahman, Muhammad Aziz] Deakin Univ, Natl Ctr Farmer Hlth, Waurn Ponds, Vic, Australia; [ur Rahman, Sajjad] Sweidi Hosp, Dept Clin Pediat, Riyadh, Saudi Arabia; [ur Rahman, Sajjad] North West Univ, Dept Pediat, Peshawar, Pakistan; [Rai, Rajesh Kumar] Soc Hlth & Demog Surveillance, Suri, India; [Rai, Rajesh Kumar; Vollmer, Sebastian] Univ Gottingen, Dept Econ, Gottingen, Germany; [Rajabpour-Sanati, Ali] Birjand Univ Med Sci, Birjand, Iran; [Ramezanzadeh, Kiana] Shahid Beheshti Univ Med Sci, Dept Pharmacol, Tehran, Iran; [Rana, Saleem Muhammad] Univ Lahore, Univ Inst Publ Hlth, Lahore, Pakistan; [Rana, Saleem Muhammad] Univ Hlth Sci, Dept Publ Hlth, Lahore, Pakistan; [Ranabhat, Chhabi Lal] Policy Res Inst, Kathmandu, Nepal; [Ranabhat, Chhabi Lal] Yonsei Univ, Inst Poverty Alleviat & Int Dev, Wonju, South Korea; [Rao, Sowmya J.] Srinivas Inst Dent Sci, Dept Oral Pathol, Mangalore, India; [Rasella, Davide] Fundacao Oswaldo Cruz, Goncalo Moniz Inst, Salvador, BA, Brazil; [Rasella, Davide] Univ Fed Bahia, Inst Publ Hlth, Salvador, BA, Brazil; [Rashedi, Vahid] Tehran Inst Psychiat, Sch Behav Sci & Mental Hlth, Tehran, Iran; [Rathi, Priya] Manipal Acad Higher Educ, Kasturba Med Coll, Mangalore, India; [Rawaf, Salman] Imperial Coll London, Dept Primary Care & Publ Hlth, London, England; [Rawaf, Salman] Publ Hlth England, Acad Publ Hlth Dept, London, England; [Rawaf, David Laith] Imperial Coll London, WHO Collaborating Ctr Publ Hlth Educ & Training, London, England; [Rawaf, David Laith] Univ Coll London Hosp, London, England; [Rawal, Lal] Cent Queensland Univ, Sch Hlth Med & Appl Sci, Sydney, NSW, Australia; [Renjith, Vishnu] Sree Chitra Tirunal Inst Med Sci & Technol, Dept Neurol, Thiruvananthapuram, Kerala, India; [Renzaho, Andre M. N.] Western Sydney Univ, Sch Social Sci & Psychol, Penrith, NSW, Australia; [Renzaho, Andre M. N.] Western Sydney Univ, Translat Hlth Res Inst, Penrith, NSW, Australia; [Resnikoff, Serge] Brien Holden Vis Inst, Sydney, NSW, Australia; [Resnikoff, Serge] Org Prevent Blindness, Paris, France; [Rezaei, Nima] USERN, NIIMA, Tehran, Iran; [Rezai, Mohammad Sadegh] Mazandaran Univ Med Sci, Pediat Infect Dis Res Ctr, Sari, Iran; [Riahi, Seyed Mohammad] Birjand Univ Med Sci, Dept Epidemiol, Birjand, Iran; [Ribeiro, Ana Isabel] Univ Porto, Publ Hlth Inst Univ Porto ISPUP, EPIUnit, Porto, Portugal; [Rickard, Jennifer] Univ Minnesota, Dept Surg, Box 242 UMHC, Minneapolis, MN 55455 USA; [Rickard, Jennifer] Univ Teaching Hosp Kigali, Dept Surg, Kigali, Rwanda; [Rodriguez, Alina] Univ Lincoln, Sch Psychol, Lincoln, England; [Rodriguez, Alina] Imperial Coll London, Dept Epidemiol & Biostat, London, England; [Roever, Leonardo] Univ Fed Uberlandia, Dept Clin Res, Uberlandia, MG, Brazil; [Roro, Elias Merdassa; Yilma, Mekdes Tigistu] Wollega Univ, Dept Publ Hlth, Nekemte, Ethiopia; [Roro, Elias Merdassa] Addis Ababa Univ, Dept Publ Hlth, Addis Ababa, Ethiopia; [Roshandel, Gholamreza] Golestan Univ Med Sci, Golestan Res Ctr Gastroenterol & Hepatol, Gorgan, Golestan, Iran; [Rostami, Ali] Babol Univ Med Sci, Infect Dis & Trop Med Res Ctr, Babol, Iran; [Rubagotti, Enrico] Agrosavia, Ctr Invest Palmira, Palmira, Colombia; [Rubagotti, Enrico] Southern Univ Sci & Technol, Dept Ocean Sci & Engn, Shenzhen, Guangdong, Peoples R China; [Saad, Anas M.] Ain Shams Univ, Cairo, Egypt; [Saadatagah, Seyedmohammad] Univ Tehran Med Sci, Dept Cardiol, Tehran, Iran; [Sabde, Yogesh Damodar] Indian Council Med Res, Natl Inst Res Environm Hlth, Bhopal, India; [Sadeghi, Masoumeh] Isfahan Univ Med Sci, Cardiovasc Res Inst, Esfahan, Iran; [Safari, Saeed] Shahid Beheshti Univ Med Sci, Emergency Dept, Tehran, Iran; [Safarpour, Hamid] Shahid Beheshti Univ Med Sci, Dept Hlth Disasters & Emergencies, Tehran, Iran; [Sagar, Rajesh] All India Inst Med Sci, Dept Psychiat, New Delhi, India; [Sahebkar, Amirhossein] FDA, Halal Res Ctr IRI, Tehran, Iran; [Sahebkar, Amirhossein] Mashhad Univ Med Sci, Neurogen Inflammat Res Ctr, Mashhad, Razavi Khorasan, Iran; [Sajadi, S. Mohammad] Soran Univ, Nanobiotechnol Ctr, Soran, Iraq; [Salahshoor, Mohammad Reza] Kermanshah Univ Med Sci, Dept Anat Sci, Kermanshah, Iran; [Salam, Nasir] Imam Mohammad Ibn Saud Islam Univ, Dept Pathol, Riyadh, Saudi Arabia; [Salehi, Farkhonde] Kermanshah Univ Med Sci, Taleghani Hosp, Kermanshah, Iran; [Zahabi, Saleh Salehi] Kermanshah Univ Med Sci, Radiol & Nucl Med Dept, Kermanshah, Iran; [Zahabi, Saleh Salehi] Taleghani Hosp, Kermanshah, Iran; [Salem, Hosni] Cairo Univ, Dept Urol, Cairo, Egypt; [Salem, Marwa R. Rashad] Cairo Univ, Publ Hlth & Community Med, Giza, Egypt; [Kafil, Hossein Samadi] Tabriz Univ Med Sci, Drug Appl Res Ctr, Tabriz, Iran; [Samy, Abdallah M.] Ain Shams Univ, Dept Entomol, Cairo, Egypt; [Santos, Itamar S.] Univ Sao Paulo, Dept Internal Med, Sao Paulo, SP, Brazil; [Sao Jose, Bruno Piassi] Univ Fed Minas Gerais, Dept Infect Dis & Trop Med, Belo Horizonte, MG, Brazil; [Saraswathy, Sivan Yegnanarayana Iyer] PSG Inst Med Sci & Res, Dept Community Med, Coimbatore, Tamil Nadu, India; [Saraswathy, Sivan Yegnanarayana Iyer] PSG FAIMER, South Asia Reg Inst, Coimbatore, Tamil Nadu, India; [Sarker, Abdur Razzaque] Int Ctr Diarrhoeal Dis Res, Hlth Econ & Financing Res Grp, Dhaka, Bangladesh; [Sartorius, Benn] London Sch Hyg & Trop Med, Fac Infect & Trop Dis, London, England; [Sarveazad, Arash] Iran Univ Med Sci, Colorectal Res Ctr, Tehran, Iran; [Sathian, Brijesh] Hamad Med Corp, Hamad Gen Hosp, Dept Surg, Doha, Qatar; [Sathian, Brijesh] Bournemouth Univ, Fac Hlth Social Sci, Bournemouth, Dorset, England; [Satpathy, Maheswar] Utkal Univ, UGC Ctr Adv Study Psychol, Bhubaneswar, India; [Satpathy, Maheswar] Udyam Global Assoc Sustainable Dev, Bhubaneswar, India; [Schutte, Aletta Elisabeth] North West Univ, HART, Potchefstroom, South Africa; [Schutte, Aletta Elisabeth] South African Med Res Council, Unit Hypertens & Cardiovasc Dis, Cape Town, South Africa; [Schwebel, David C.] Univ Alabama Birmingham, Dept Psychol, Birmingham, AL 35294 USA; [Senbeta, Anbissa Muleta] Jigjiga Univ, Dept Food Sci & Nutr, Jigjiga, Ethiopia; [Senthilkumaran, Subramanian] Manian Med Ctr, Emergency Dept, Erode, India; [Seyedmousavi, Seyedmojtaba] NIH, Microbiol Serv, Bethesda, MD USA; [Shaahmadi, Faramarz] Alborz Univ Med Sci, Dept Hlth Promot & Educ, Karaj, Iran; [Shahabi, Saeed] Shiraz Univ Med Sci, Ctr Hlth Policy Res, Shiraz, Iran; [Shalash, Ali S.] Ain Shams Univ, Dept Neuropsychiat, Cairo, Egypt; [Shams-Beyranvand, Mehran] Alborz Univ Med Sci, Sch Med, Karaj, Iran; [Shamshirian, Amir] Mazandaran Univ Med Sci, Med Lab Sci, Sari, Iran; [Shamsizadeh, Morteza] Hamadan Univ Med Sci, Chron Dis Home Care Res Ctr, Hamadan, Iran; [Shannawaz, Mohammed] Int Inst Populat Sci, Dept Dev Studies, Mumbai, Maharashtra, India; [Sharif, Mehdi] Islamic Azad Univ, Dept Basic Sci, Sari, Iran; [Sharif, Mehdi] Islamic Azad Univ, Dept Lab Sci, Sari, Iran; [Sharma, Rajesh] Delhi Technol Univ, Univ Sch Management & Entrepreneurship, New Delhi, India; [Sheikhtaheri, Abbas] Iran Univ Med Sci, Dept Hlth Informat Management & Informat, Tehran, Iran; [Shibuya, Kenji] Kings Coll London, Inst Populat Hlth, London, England; [Shigematsu, Mika] Natl Inst Infect Dis, Tokyo, Japan; [Shin, Jae Il] Yonsei Univ, Coll Med, Seoul, South Korea; [Shin, Jae Il] Emory Univ, Div Cardiol, Atlanta, GA 30322 USA; [Shiri, Rahman] Finnish Inst Occupat Hlth, Helsinki, Finland; [Shirkoohi, Reza] Univ Tehran Med Sci, Canc Res Inst, Tehran, Iran; [Shirkoohi, Reza] Univ Tehran Med Sci, Canc Biol Res Ctr, Tehran, Iran; [Shiue, Ivy] Martin Luther Univ Halle Wittenberg, Inst Med Epidemiol, Halle, Germany; [Siabani, Soraya] Kermanshah Univ Med Sci, Dept Hlth Educ & Promot, Kermanshah, Iran; [Siabani, Soraya] Univ Technol Sydney, Sch Hlth, Sydney, NSW, Australia; [Sigfusdottir, Inga Dora] Reykjavik Univ, Dept Psychol, Reykjavik, Iceland; [Sigfusdottir, Inga Dora] Columbia Univ, Dept Hlth & Behav Studies, New York, NY USA; [Santos Silva, Diego Augusto] Univ Fed Santa Catarina, Dept Phys Educ, Florianopolis, SC, Brazil; [Simonetti, Biagio] Univ Sannio, Dept Law Econ Management & Quantitat Methods, Benevento, Italy; [Singh, Ambrish] Univ Tasmania, Menzies Inst Med Res, Hobart, Tas, Australia; [Singh, Ambrish] Eli Lilly & Co, Global Patient Outcome & Real World Evidence, Indianapolis, IN 46285 USA; [Singh, Pushpendra] Indian Inst Technol, Dept Humanities & Social Sci, Roorkee, Uttar Pradesh, India; [Singh, Virendra] Asthma Bhawan, Dept Pulm Med, Jaipur, Rajasthan, India; [Singh, Jasvinder A.] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA; [Singh, Jasvinder A.] US Dept Vet Affairs, Med Serv, Birmingham, AL USA; [Singh, Pankaj Kumar] Kathmandu Univ, Dept Forens Med, Dhulikhel, Nepal; [Sinha, Dhirendra Narain] Sch Prevent Oncol, Dept Epidemiol, Patna, Bihar, India; [Sinha, Dhirendra Narain] Healis Sekhsaria Inst Publ Hlth, Dept Epidemiol, Mumbai, Maharashtra, India; [Sintayehu, Yitagesu] Haramaya Univ, Dept Midwifery, Harar, Ethiopia; [Sisay, Malede Mequanent M.] Naestved Slagelse Ringsted Hosp, Dept Physiotherapy & Occupat Therapy, Slagelse, Denmark; [Soheili, Amin] Urmia Univ Med Sci, Med Surg Nursing Dept, Orumiyeh, Iran; [Soheili, Amin] Semnan Univ Med Sci, Emergency Nursing Dept, Semnan, Iran; [Soltani, Farzaneh] Hamadan Univ Med Sci, Midwifery Dept, Hamadan, Iran; [Soltani, Shahin] Acad Med Sci, Res Ctr Environm Determinants Hlth, Kermanshah, Iran; [Soriano, Joan B.] Autonomous Univ Madrid, Hosp Univ Princesa, Madrid, Spain; [Soriano, Joan B.] Ctr Invest Biomed Red Enfermedades Resp CIBERES, Madrid, Spain; [Soshnikov, Sergey] Minist Hlth, FRIHOI, Res Dev Dept, Moscow, Russia; [Soshnikov, Sergey] Moscow Inst Phys & Technol, Lab Publ Hlth Indicators Anal & Hlth Digitalizat, Moscow, Russia; [Soyiri, Ireneous N.] Univ Hull, Hull York Med Sch, Kingston Upon Hull, N Humberside, England; [Soyiri, Ireneous N.] Univ Edinburgh, Usher Inst Populat Hlth Sci & Informat, Edinburgh, Midlothian, Scotland; [Spotin, Adel] Tabriz Univ Med Sci, Dept Parasitol & Mycol, Tabriz, Iran; [Sreeramareddy, Chandrashekhar T.] Int Med Univ, Div Community Med, Kuala Lumpur, Malaysia; [Srivastava, Rajni Kant Kant] Indian Council Med Res, Res Management Policy Planning & Coordinat, New Delhi, India; [Starodubova, Antonina] Fed Res Inst Nutr Biotechnol & Food Safety, Dept Nutr & Dietet, Clin Dept, Moscow, Russia; [Starodubova, Antonina] Pirogov Russian Natl Res Med Univ, Dept Internal Dis, Moscow, Russia; [Sudaryanto, Agus] Muhammadiyah Univ Surakarta, Dept Nursing, Surakarta, Indonesia; [Sudaryanto, Agus] China Med Univ, Dept Publ Hlth, Taichung, Taiwan; [Sufiyan, Mu'awiyyah Babale] Ahmadu Bello Univ, Dept Community Med, Zaria, Nigeria; [Suleria, Hafiz Ansar Rasul] Univ Melbourne, Dept Agr & Food Syst, Melbourne, Vic, Australia; [Sulo, Gerhard] Norwegian Inst Publ Hlth, Bergen, Norway; [Sunguya, Bruno F.] Muhimbili Univ Hlth & Allied Sci, Dept Community Hlth, Dar Es Salaam, Tanzania; [Sunguya, Bruno F.] Muhimbili Univ Hlth & Allied Sci, Dar Es Salaam, Tanzania; [Sykes, Bryan L.] Univ Calif Irvine, Dept Criminol Law & Soc, Irvine, CA USA; [Tabares-Seisdedos, Rafael] Univ Valencia, Dept Med, Valencia, Spain; [Tabares-Seisdedos, Rafael] Carlos III Hlth Inst, Biomed Res Networking Ctr Mental Hlth Network Cib, Madrid, Spain; [Tabuchi, Takahiro] Osaka Int Canc Inst, Canc Control Ctr, Osaka, Japan; [Tadesse, Birkneh Tilahun] Hawassa Univ, Dept Pediat, Hawassa, Ethiopia; [Tadesse, Birkneh Tilahun] Int Vaccine Inst, Seoul, South Korea; [Taherkhani, Amir] Hamadan Univ Med Sci, Res Ctr Mol Med, Hamadan, Iran; [Tassew, Segen Gebremeskel] Mekelle Univ, Sch Pharm, Mekelle, Ethiopia; [Taveira, Nuno] Univ Inst Egas Moniz, Monte De Caparica, Portugal; [Taveira, Nuno] Univ Lisbon, Res Inst Med, Lisbon, Portugal; [Teklehaimanot, Berhane Fseha] Adigrat Univ, Dept Publ Hlth, Adigrat, Ethiopia; [Tekulu, Gebretsadkan Hintsa] Mekelle Univ, Pharmacognosy, Mekelle, Ethiopia; [Temsah, Mohamad-Hani] King Saud Univ, Dept Pediat, Riyadh, Saudi Arabia; [Temsah, Mohamad-Hani] Alfaisal Univ, Coll Med, Riyadh, Saudi Arabia; [Terkawi, Abdullah Sulieman] Stanford Univ, Dept Anesthesiol Perioperat & Pain Med, Stanford, CA USA; [Terkawi, Abdullah Sulieman] King Fahad Med City, Dept Anesthesiol, Riyadh, Saudi Arabia; [Thomas, Nihal] Christian Med Coll & Hosp CMC, Dept Endocrinol, Vellore, Tamil Nadu, India; [Titova, Mariya Vladimirovna] Moscow MV Lomonosov State Univ, Dept Biol, Moscow, Russia; [Tohidinik, Hamid Reza] Kerman Univ Med Sci, HIV STI Surveillance Res Ctr, Kerman, Iran; [Tohidinik, Hamid Reza] Kerman Univ Med Sci, WHO Collaborating Ctr HIV Surveillance, Kerman, Iran; [Tonelli, Marcello] Univ Calgary, Dept Med, Calgary, AB, Canada; [Tovani-Palone, Marcos Roberto] Univ Sao Paulo, Dept Pathol & Legal Med, Ribeirao Preto, Brazil; [Traini, Eugenio] Burlo Garofolo Inst Maternal & Child Hlth, Clin Epidemiol & Publ Hlth Res Unit, Trieste, Italy; [Khanh Bao Tran] Univ Auckland, Mol Med & Pathol, Auckland, New Zealand; [Khanh Bao Tran] Mil Med Univ, Clin Hematol & Toxicol, Hanoi, Vietnam; [Tripathi, Manjari] All India Inst Med Sci, Dept Neurol, Delhi, India; [Uddin, Riaz] Stamford Univ Bangladesh, Dept Pharm, Dhaka, Bangladesh; [Ullah, Irfan] Gomal Univ, Gomal Ctr Biochem & Biotechnol, Dera Ismail Khan, Pakistan; [Ullah, Irfan] Mufti Mehmood Mem Teaching Hosp Dera Ismail Khan, TB Culture Lab, Dera Ismail Khan, Pakistan; [Upadhyay, Era] Amity Univ Rajasthan, Amity Inst Biotechnol, Jaipur, Rajasthan, India; [Useh, Ushotanefe] North West Univ, Lifestyle Dis Res Ent, Mmabatho, South Africa; [Uthman, Olalekan A.] Univ Warwick, Div Hlth Sci, Coventry, W Midlands, England; [Vaezghasemi, Masoud] Umea Univ, Dept Epidemiol & Biostat, Umea, Sweden; [Valdez, Pascual R.] Argentine Soc Med, Buenos Aires, DF, Argentina; [Valdez, Pascual R.] Velez Sarsfield Hosp, Buenos Aires, DF, Argentina; [Varavikova, Elena] Minist Hlth, FRIHOI, Cent Res Inst Cytol & Genet, Moscow, Russia; [Varughese, Santosh] Christian Med Coll & Hosp CMC, Vellore, Tamil Nadu, India; [Vasankari, Tommi Juhani] UKK Inst, Tampere, Finland; [Veisani, Yousef] Ilam Univ Med Sci, Psychosocial Injuries Res Ctr, Ilam, Iran; [Venkatesh, Srinivasaraghavan] Minist Hlth, Natl AIDS Control Org, New Delhi, India; [Venketasubramanian, Narayanaswamy] Raffles Hosp, Raffles Neurosci Ctr, Singapore, Singapore; [Venketasubramanian, Narayanaswamy] Natl Univ Singapore, Yong Loo Lin Sch Med, Singapore, Singapore; [Verma, Madhur] All India Inst Med Sci, Community & Family Med, Bathinda, India; [Vidale, Simone] St Anna Hosp, Dept Neurol & Stroke Unit, Como, Italy; [Violante, Francesco S.] St Orsola Malpighi Hosp, Occupat Hlth Unit, Bologna, Italy; [Vlassov, Vasily] Natl Res Univ Higher Sch Econ, Dept Hlth Care Adm & Econ, Moscow, Russia; [Vollmer, Sebastian] Harvard Univ, Dept Global Hlth & Populat, Boston, MA 02115 USA; [Vukovic, Rade] Univ Belgrade, Sch Med, Belgrade, Serbia; [Vukovic, Rade] Mother & Child Healthcare Inst Serbia Dr Vukan Cu, Dept Pediat Endocrinol, Belgrade, Serbia; [Waheed, Yasir] Fdn Univ, Fdn Univ Med Coll, Islamabad, Pakistan; [Wang, Yafeng; Yu, Chuanhua] Wuhan Univ, Dept Epidemiol & Biostatist, Wuhan, Peoples R China; [Werdecker, Andrea] Fed Inst Populat Res, Demog Change & Ageing Res Area, Wiesbaden, Germany; [Wiangkham, Taweewat] Naresuan Univ, Dept Phys Therapy, Meung District, Thailand; [Wijeratne, Tissa] Univ Melbourne, Dept Psychol & Counselling, Melbourne, Vic, Australia; [Wijeratne, Tissa] Univ Melbourne, Dept Med, St Albans, Vic, Australia; [Wondafrash, Dawit Zewdu] Mekelle Univ, Dept Pharmacol & Toxicol, Mekelle, Ethiopia; [Wondafrash, Dawit Zewdu] Addis Ababa Univ, Dept Pharmacol, Addis Ababa, Ethiopia; [Wondmieneh, Adam Belay] Wollo Univ, Dept Nursing, Dessie, Ethiopia; [Wu, Ai-Min] Wenzhou Med Univ, Dept Orthopaed, Wenzhou, Peoples R China; [Xu, Gelin] Nanjing Univ, Sch Med, Nanjing, Jiangsu, Peoples R China; [Yadollahpour, Ali] Ahvaz Jundishapur Univ Med Sci, Dept Med Phys, Ahvaz, Iran; [Jabbari, Seyed Hossein Yahyazadeh] Milad Gen Hosp, Clin Canc Res Ctr, Tehran, Iran; [Yamada, Tomohide] Univ Tokyo, Dept Diabet & Metab Dis, Tokyo, Japan; [Yano, Yuichiro] Northwestern Univ, Dept Prevent Med, Chicago, IL 60611 USA; [Yaya, Sanni] Univ Ottawa, Sch Int Dev & Global Studies, Ottawa, ON, Canada; [Yazdi-Feyzabadi, Vahid] Kerman Univ Med Sci, Hlth Serv Management Res Ctr, Kerman, Iran; [Yazdi-Feyzabadi, Vahid] Kerman Univ Med Sci, Dept Hlth Management Policy & Econ, Kerman, Iran; [Yeshaneh, Alex] Wolkite Univ, Wolkite, Ethiopia; [Yip, Paul] Univ Hong Kong, Ctr Suicide Res & Prevent, Hong Kong, Peoples R China; [Yip, Paul] Univ Hong Kong, Dept Social Work & Social Adm, Hong Kong, Peoples R China; [Yonemoto, Naohiro] Natl Ctr Neurol & Psychiat, Dept Psychopharmacol, Tokyo, Japan; [Yoon, Seok-Jun] Korea Univ, Dept Prevent Med, Seoul, South Korea; [Youm, Yoosik] Yonsei Univ, Dept Sociol, Seoul, South Korea; [Younis, Mustafa Z.] Jackson State Univ, Dept Hlth Policy & Management, Jackson, MS USA; [Younis, Mustafa Z.] Tsinghua Univ, Sch Med, Beijing, Peoples R China; [Yousefi, Zabihollah] Mazandaran Univ Med Sci, Dept Environm Hlth, Sari, Iran; [Yousefi, Zabihollah] Acad Med Sci, Environm Hlth, Sari, Iran; [Yu, Chuanhua] Wuhan Univ, Global Hlth Inst, Wuhan, Hubei, Peoples R China; [Moghadam, Telma Zahirian; Zandian, Hamed] Ardabil Univ Med Sci, Social Determinants Hlth Res Ctr, Ardebil, Iran; [Bin Zaman, Sojib] Monash Univ, Dept Med, Melbourne, Vic, Australia; [Zamani, Mohammad] Babol Univ Med Sci, Student Res Comm, Babol, Iran; [Zandian, Hamed] Ardabil Univ Med Sci, Dept Community Med, Ardebil, Iran; [Zarafshan, Hadi] Univ Tehran Med Sci, Psychiat & Psychol Res Ctr, Tehran, Iran; [Zerfu, Taddese Alemu] African Populat Hlth Res Ctr, Maternal & Child Wellbeing Unit, Nairobi, Kenya; [Zerfu, Taddese Alemu] Dilla Univ, Dept Publ Hlth, Dilla, Ethiopia; [Zhang, Yunquan] Wuhan Univ Sci & Technol, Sch Publ Hlth, Wuhan, Hubei, Peoples R China; [Zhang, Yunquan] Wuhan Univ Sci & Technol, Hubei Prov Key Lab Occupat Hazard Identificat & C, Wuhan, Hubei, Peoples R China; [Zhang, Zhi-Jiang] Wuhan Univ, Dept Prevent Med, Wuhan, Hubei, Peoples R China; [Zhao, Xiu-Ju] Wuhan Polytech Univ, Sch Biol & Pharmaceut Engn, Wuhan, Hubei, Peoples R China	Institute for Health Metrics & Evaluation; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Tabriz University of Medical Science; Kermanshah University of Medical Sciences; Tehran University of Medical Sciences; Egyptian Knowledge Bank (EKB); Cairo University; Tehran University of Medical Sciences; Isfahan University Medical Science; Ministry of Health - Saudi Arabia; Addis Ababa University; Hawassa University; Addis Ababa University; Karolinska Institutet; Karolinska University Hospital; Tehran University of Medical Sciences; Universidade Federal de Minas Gerais; Egyptian Knowledge Bank (EKB); Ain Shams University; Dongguk University; University of Ibadan; University of Ibadan; University College Hospital, Ibadan; Cardiff University; University of Ibadan; Stellenbosch University; South African Medical Research Council; Ardabil University of Medical Sciences; University of Ibadan; National Institutes of Health (NIH) - USA; Georgetown University; Tehran University of Medical Sciences; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Genomics & Integrative Biology (IGIB); Baylor College of Medicine; Southeast University - China; Hazara University; University of Nottingham; University of Lincoln; Shahid Beheshti University Medical Sciences; Jimma University; Bangladesh Rural Advancement Committee BRAC; BRAC University; International Centre for Diarrhoeal Disease Research (ICDDR); Nevada System of Higher Education (NSHE); University of Nevada Reno; Bahir Dar University; University of Gondar; Duke University; Duke University; University of New South Wales Sydney; Washington University (WUSTL); US Department of Veterans Affairs; Dalhousie University; Imam Abdulrahman Bin Faisal University; Instituto Nacional de Salud Publica; Erbil Polytechnic University; Quaid I Azam University; Qazvin University of Medical Sciences (QUMS); Urmia University of Medical Sciences; Iran University of Medical Sciences; Iran University of Medical Sciences; Kerman University of Medical Sciences; Kuwait University; Kermanshah University of Medical Sciences; Jazan University; King Abdulaziz University; King Saud University; Universidad de Cartagena; Universidad de la Costa; Universidad de la Costa; South Australian Health & Medical Research Institute (SAHMRI); University of South Australia; Bahir Dar University; University of Cape Coast; Isfahan University Medical Science; Kermanshah University of Medical Sciences; University of the Philippines System; University of the Philippines Manila; Johns Hopkins University; Egyptian Knowledge Bank (EKB); Mansoura University; Carol Davila University of Medicine & Pharmacy; Tabriz University of Medical Science; Razi Vaccine & Serum Research Institute; Bahir Dar University; University of the Philippines System; University of the Philippines Manila; Hong Kong Polytechnic University; Sebelas Maret University; Mazandaran University Medical Sciences; Imam Mohammad Ibn Saud Islamic University (IMSIU); Kwame Nkrumah University Science & Technology; University of Munich; Tehran University of Medical Sciences; Birmingham City University; Karolinska Institutet; Dalarna University; Babol University of Medical Sciences; Babol University of Medical Sciences; Iran University of Medical Sciences; Shiraz University of Medical Science; Shahid Beheshti University Medical Sciences; University of Gondar; Tehran University of Medical Sciences; Bahir Dar University; University of Leicester; Bucharest University of Economic Studies; University of Abomey Calavi; Public Health Foundation of India; La Trobe University; Instituto Nacional de Salud - Peru; Babol University of Medical Sciences; University of Gondar; Public Health Agency of Canada; University of Toronto; Shiraz University of Medical Science; Universiti Sultan Zainal Abidin; Tehran University of Medical Sciences; Manipal Academy of Higher Education (MAHE); Haramaya University; Haramaya University; Medical University Lodz; Polish Mother's Memorial Hospital - Research Institute; Bangladesh University of Health Sciences (BUHS); Razi Vaccine & Serum Research Institute; Universidad Costa Rica; Ruprecht Karls University Heidelberg; Harvard University; Harvard T.H. Chan School of Public Health; Imperial College London; Shiraz University of Medical Science; Bahir Dar University; University of Gondar; Jazan University; Lorestan University of Medical Sciences; Lorestan University of Medical Sciences; Bahir Dar University; University of Oxford; Arba Minch University; Mekelle University; University System of Georgia; Augusta University; Emory University; State University System of Florida; University of South Florida; Manipal Academy of Higher Education (MAHE); University of Adelaide; Tribhuvan University; Institute of Medicine (IoM) - Nepal; All India Institute of Medical Sciences (AIIMS) Jodhpur; Datta Meghe Institute of Medical Sciences - Deemed to be University; Jawaharlal Nehru Medical College Wardha; Department of Biotechnology (DBT) India; National Institute of Biomedical Genomics (NIBMG); University of Calcutta; Babol University of Medical Sciences; Istituto di Ricerche Farmacologiche Mario Negri IRCCS; Australian National University; University of Dhaka; Samara University; Addis Ababa University; Bahir Dar University; University of New South Wales Sydney; Swinburne University of Technology; Islamic Azad University; Nazarbayev University; Manipal Academy of Higher Education (MAHE); University of Catania; University of London; London School of Hygiene & Tropical Medicine; University of Genoa; Georgetown University; Sechenov First Moscow State Medical University; Instituto Conmemorativo Gorgas de Estudios de la Salud; Technical University of Berlin; University of Waterloo; Hospital Italiano de Buenos Aires; University of Buenos Aires; Instituto Nacional de Salud Publica; University of London; London School of Hygiene & Tropical Medicine; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Imperial College London; Universidad Autonoma Metropolitana - Mexico; Karolinska Institutet; Universidade do Porto; Universidade de Sao Paulo; Universidad Nacional de Colombia; Australian Catholic University; University of Hong Kong; The World Bank; Ruprecht Karls University Heidelberg; All India Institute of Medical Sciences (AIIMS) Jodhpur; Indian Council of Medical Research (ICMR); ICMR - National Institute of Cholera & Enteric Diseases (NICED); University of Toronto; Gokhale Institute of Politics & Economics; International Institute for Population Sciences; Urmia University of Medical Sciences; Babol University of Medical Sciences; Monash University; Christian Medical College & Hospital (CMCH) Vellore; Hanoi National University of Education; Monash University; University of Milano-Bicocca; University of Gondar; Flinders University South Australia; University of Gondar; Imam Abdulrahman Bin Faisal University; Case Western Reserve University; University of Milan; Egyptian Knowledge Bank (EKB); Tanta University; Mazandaran University Medical Sciences; Aga Khan University; University of South Carolina System; University of South Carolina Columbia; FLACSO Mexico; Griffith University; Jimma University; Ambo University; Addis Ababa University; Instituto Nacional de Salud Publica; University of Brighton; University of Sussex; US Department of Veterans Affairs; Veterans Health Administration (VHA); Atlanta VA Health Care System; Hawassa University; Haramaya University; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Delhi; University of Peradeniya; International Institute for Population Sciences; Shiraz University of Medical Science; Universidad Nacional Autonoma de Mexico; Universidad Autonoma de Sinaloa; Harvard University; Ministry of Health & Medical Education (MOHME); Nguyen Tat Thanh University (NTTU); Nguyen Tat Thanh University (NTTU); University of Cape Coast; Iran University of Medical Sciences; Tabriz University of Medical Science; Hawassa University; Curtin University; University of Oxford; Mahidol Oxford Tropical Medicine Research Unit (MORU); Universidade Federal do Rio Grande do Sul; Universidade Federal da Bahia; Escola Bahiana de Medicina e Saude Publica; Tabriz University of Medical Science; Tabriz University of Medical Science; Egyptian Knowledge Bank (EKB); Alexandria University; Egyptian Knowledge Bank (EKB); Mansoura University; Egyptian Knowledge Bank (EKB); Alexandria University; United Arab Emirates University; Karolinska Institutet; University of Quebec; University Quebec Abitibi-Temiscamingue; Egyptian Knowledge Bank (EKB); Cairo University; Nottingham Trent University; Eijkman Institute; Shahroud University Medical Sciences; Egyptian Knowledge Bank (EKB); Suez Canal University; Kerman University of Medical Sciences; Kerman University of Medical Sciences; Tehran University of Medical Sciences; Tarbiat Modares University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Tehran University of Medical Sciences; Hawassa University; Johns Hopkins University; Food & Agriculture Organization of the United Nations (FAO); Tehran University of Medical Sciences; Imam Mohammad Ibn Saud Islamic University (IMSIU); University of Bologna; Universidade Federal de Sergipe; Aga Khan University; Flinders University South Australia; Bahir Dar University; Hawassa University; University of Ottawa; Universidade do Porto; Universidade Catolica Portuguesa; Jimma University; Jimma University; Kaiser Permanente; A.T. Still University of Health Sciences; University of Bielefeld; University of London; King's College London; National Academy of Medical Sciences of Ukraine; D. F. Chebotarev Institute of Gerontology of the National Academy of Medical Sciences of Ukraine; Obafemi Awolowo University; Russian Academy of Sciences; University of Witwatersrand; Kobe University; The Wistar Institute; Mekelle University; Addis Ababa University; Mekelle University; Haramaya University; Arba Minch University; Mekelle University; Tarbiat Modares University; Tabriz University of Medical Science; Harvard University; Massachusetts General Hospital; Iran University of Medical Sciences; Islamic Azad University; Islamic Azad University; University of Lahore; University of Adelaide; University Ha'il; Jawaharlal Nehru University, New Delhi; Universidade do Porto; University of Oklahoma System; University of Oklahoma Health Sciences Center; Hokkaido University; Hokkaido University; Universidade de Sao Paulo; Universidade de Sao Paulo; Manipal Academy of Higher Education (MAHE); Boston University; Universidade Federal de Goias; Zhengzhou University; West Virginia University; Johns Hopkins University; Tehran University of Medical Sciences; Tehran University of Medical Sciences; Shahid Beheshti University Medical Sciences; University of Macau; Tarbiat Modares University; Arabian Gulf University; University of Western Australia; University of Western Australia; Tabriz University of Medical Science; Airlangga University; University of Adelaide; Egyptian Knowledge Bank (EKB); Al Azhar University; University of Queensland; Tehran University of Medical Sciences; University of Antwerp; Karolinska Institutet; Karolinska University Hospital; City University London; University of Veterinary & Animal Science - Pakistan; Xi'an Jiaotong University; Shahrekord University Medical Sciences; Curtin University; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Kermanshah University of Medical Sciences; University of Groningen; Columbia University; University of Texas System; University of Texas Austin; Manipal Academy of Higher Education (MAHE); Kasturba Medical College, Manipal; Yonsei University; Manipal Academy of Higher Education (MAHE); Dhaka Medical College; Tehran University of Medical Sciences; Islamic Azad University; Carol Davila University of Medicine & Pharmacy; Carol Davila University of Medicine & Pharmacy; Qatar Foundation (QF); Hamad Bin Khalifa University-Qatar; Central South University; University of Sydney; International Centre for Diarrhoeal Disease Research (ICDDR); China Medical University Taiwan; University of Kragujevac; Lorestan University of Medical Sciences; Taipei Medical University; Shahid Beheshti University Medical Sciences; Deakin University; University of Sydney; University of Pretoria; South African Medical Research Council; Stellenbosch University; Shahid Beheshti University Medical Sciences; Stellenbosch University; Tabriz University of Medical Science; Babol Noshirvani University of Technology; Isfahan University Medical Science; Sechenov First Moscow State Medical University; Kermanshah University of Medical Sciences; Kermanshah University of Medical Sciences; Kermanshah University of Medical Sciences; University of Colombo; University of Colombo; Department of Science & Technology (India); Sree Chitra Tirunal Institute for Medical Sciences Technology (SCTIMST); Aga Khan University; Banaras Hindu University (BHU); Manipal Academy of Higher Education (MAHE); Duke Kunshan University; Duke University; University of Twente; Ruprecht Karls University Heidelberg; Manipal Academy of Higher Education (MAHE); University of Opole; Savitribai Phule Pune University; University of Tartu; Iran University of Medical Sciences; University College Cork; Golestan University of Medical Sciences; Tabriz University of Medical Science; Qazvin University of Medical Sciences (QUMS); All India Institute of Medical Sciences (AIIMS) Jodhpur; All India Institute of Medical Sciences (AIIMS) New Delhi; University of Munster; Australian Red Cross Blood Service; Tehran University of Medical Sciences; Iran University of Medical Sciences; Mekelle University; University of Washington; University of Washington Seattle; Kermanshah University of Medical Sciences; University of Cape Town; Jordan University of Science & Technology; Ahvaz Jundishapur University of Medical Sciences (AJUMS); Lorestan University of Medical Sciences; University of Management & Technology (UMT); Ministry of Education of Azerbaijan Republic; Baku State University; University of Queensland; Health Services Academy; University of Newcastle; Brown University; Lifespan Health Rhode Island; Miriam Hospital; John H Stroger Junior Hospital Cook County; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Dow University of Health Sciences; Sheffield Hallam University; University System of Ohio; Ohio University; Egyptian Knowledge Bank (EKB); Cairo University; Datta Meghe Institute of Medical Sciences - Deemed to be University; Jawaharlal Nehru Medical College Wardha; Shahid Beheshti University Medical Sciences; Mazandaran University Medical Sciences; Shahid Beheshti University Medical Sciences; Iran University of Medical Sciences; University of Oxford; Lund University; Xiamen University Malaysia Campus; Simmons University; Kristiania University College; Oslo Metropolitan University (OsloMet); Ambo University; Sher-i-Kashmir Institute of Medical Sciences; CIBER - Centro de Investigacion Biomedica en Red; CIBERSAM; University of Oxford; Harvard University; Harvard Medical School; Panjab University; University of Kwazulu Natal; University of Nairobi; University of London; University College London; Harvard University; Brigham & Women's Hospital; McMaster University; University of Birmingham; University of Milan; University of Oxford; Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh; Public Health Foundation of India; University of Baghdad; Deakin University; Public Health Agency of Canada; Father Muller Medical College; Sechenov First Moscow State Medical University; Ministry of Health of the Russian Federation; Hong Kong Polytechnic University; Monash University; Monash University Sunway; Taylor's University; University of Oxford; Universiti Malaya; Chinese University of Hong Kong; University of Haifa; Brown University; All India Institute of Medical Sciences (AIIMS) New Delhi; Liverpool School of Tropical Medicine; University of the Philippines System; University of the Philippines Manila; Friedrich Schiller University of Jena; Harvard University; University of the Philippines System; University of the Philippines Los Banos; Imam Abdulrahman Bin Faisal University; Egyptian Knowledge Bank (EKB); Mansoura University; Tribhuvan University; Institute of Medicine (IoM) - Nepal; Kurdistan University of Medical Sciences; Kermanshah University of Medical Sciences; Universidade Federal de Minas Gerais; Iran University of Medical Sciences; University of Toronto; Iran University of Medical Sciences; University of Manitoba; Western Sydney University; Kermanshah University of Medical Sciences; University of Zambia; Universidad de Cartagena; Instituto Federal do Ceara (IFCE); University of Washington; University of Washington Seattle; University of New South Wales Sydney; University of London; King's College London; University of California System; University of California San Francisco; International Institute for Population Sciences; University of Oslo; Mekelle University; Imam Abdulrahman Bin Faisal University; National Institutes of Health (NIH) - USA; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; Pomeranian Medical University; Pacific Institute for Research & Evaluation (PIRE); McMaster University; Babol University of Medical Sciences; Golestan University of Medical Sciences; Shahid Beheshti University Medical Sciences; Kyrgyz State Medical Academy; Ministry of Health - Kyrgyzstan; Kermanshah University of Medical Sciences; Iran University of Medical Sciences; Tehran University of Medical Sciences; Kurdistan University of Medical Sciences; Salahaddin University; King Saud University; Salahaddin University; Karolinska Institutet; Shahrekord University Medical Sciences; Babol University of Medical Sciences; Tarbiat Modares University; Shahroud University Medical Sciences; University of Mississippi; Ahmadu Bello University; Haramaya University; Tehran University of Medical Sciences; Shahid Beheshti University Medical Sciences; University of Miami; University of Kwazulu Natal; Kurdistan University of Medical Sciences; Iran University of Medical Sciences; Tehran University of Medical Sciences; University of Bath; University of Washington; University of Washington Seattle; Tarbiat Modares University; Universidade Estadual de Campinas; Tufts University; Public Health Foundation of India; Universiti Sains Malaysia; Mekelle University; Tehran University of Medical Sciences; Icahn School of Medicine at Mount Sinai; International Centre for Diarrhoeal Disease Research (ICDDR); University of Alabama System; University of Alabama Birmingham; Kermanshah University of Medical Sciences; University of Yaounde I; Universidade Federal de Minas Gerais; Ministry of Health & Medical Education (MOHME); Carol Davila University of Medicine & Pharmacy; Duy Tan University; University of Ottawa; Shahid Beheshti University Medical Sciences; Tehran University of Medical Sciences; Ruprecht Karls University Heidelberg; Universitas Negeri Semarang; Taipei Medical University; University of Cape Town; Karolinska Institutet; University of Bucharest; Monash University; University of Ibadan; Kyung Hee University; Human Sciences Research Council-South Africa; University of Namibia; Golestan University of Medical Sciences; McMaster University; University of Lagos; University of Nigeria; University of Ghana; California State University System; San Diego State University; University of Washington; University of Washington Seattle; University of Port Harcourt; Autonomous University of Madrid; University of Benin; University of Ibadan; JSS Academy of Higher Education & Research; Manipal Academy of Higher Education (MAHE); Shiraz University of Medical Science; Ruprecht Karls University Heidelberg; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Karolinska Institutet; Kalinga Institute of Industrial Technology (KIIT); Indian Council of Medical Research (ICMR); ICMR - Regional Medical Research Centre (RMRC), Bhubaneswar; International Institute for Population Sciences; University of Melbourne; Murdoch Children's Research Institute; Iran University of Medical Sciences; Ateneo de Manila University; Istituto di Ricerche Farmacologiche Mario Negri IRCCS; University of Virginia; University of Groningen; University of Groningen; University of British Columbia; Kermanshah University of Medical Sciences; Tehran University of Medical Sciences; Fundacion Valle del Lili; National Institute for Infectious Diseases "Matei Bals"; Victor Babes National Institute of Pathology; Carol Davila University of Medicine & Pharmacy; National Institute for Infectious Diseases "Matei Bals"; Universitas Muhammadiyah Surakarta; Amirkabir University of Technology; Sharif University of Technology; State University System of Florida; University of Central Florida; A.T. Still University of Health Sciences; Mazandaran University Medical Sciences; Mazandaran University Medical Sciences; Ahvaz Jundishapur University of Medical Sciences (AJUMS); Tehran University of Medical Sciences; Tehran University of Medical Sciences; Federation University Australia; Deakin University; University of Gottingen; Shahid Beheshti University Medical Sciences; University of Lahore; University of Health Science - Pakistan; Yonsei University; Srinivas Group of Institutions; Fundacao Oswaldo Cruz; Universidade Federal da Bahia; Manipal Academy of Higher Education (MAHE); Kasturba Medical College, Mangalore; Imperial College London; Public Health England; Imperial College London; University College London Hospitals NHS Foundation Trust; University of London; University College London; Central Queensland University; Department of Science & Technology (India); Sree Chitra Tirunal Institute for Medical Sciences Technology (SCTIMST); Western Sydney University; Western Sydney University; Brien Holden Vision Institute; Mazandaran University Medical Sciences; Universidade do Porto; University of Minnesota System; University of Minnesota Twin Cities; University of Lincoln; Imperial College London; Universidade Federal de Uberlandia; Addis Ababa University; Golestan University of Medical Sciences; Babol University of Medical Sciences; Corporacion Colombiana de Investigacion Agropecuaria, AGROSAVIA; Southern University of Science & Technology; Egyptian Knowledge Bank (EKB); Ain Shams University; Tehran University of Medical Sciences; Indian Council of Medical Research (ICMR); ICMR - National Institute for Research in Environmental Health (NIREH); Isfahan University Medical Science; Shahid Beheshti University Medical Sciences; Shahid Beheshti University Medical Sciences; All India Institute of Medical Sciences (AIIMS) New Delhi; Mashhad University Medical Science; Soran University; Kermanshah University of Medical Sciences; Imam Mohammad Ibn Saud Islamic University (IMSIU); Kermanshah University of Medical Sciences; Kermanshah University of Medical Sciences; Egyptian Knowledge Bank (EKB); Cairo University; Egyptian Knowledge Bank (EKB); Cairo University; Tabriz University of Medical Science; Egyptian Knowledge Bank (EKB); Ain Shams University; Universidade de Sao Paulo; Universidade Federal de Minas Gerais; International Centre for Diarrhoeal Disease Research (ICDDR); University of London; London School of Hygiene & Tropical Medicine; Iran University of Medical Sciences; Hamad Medical Corporation; Hamad General Hospital; Bournemouth University; Utkal University; North West University - South Africa; South African Medical Research Council; University of Alabama System; University of Alabama Birmingham; National Institutes of Health (NIH) - USA; Shiraz University of Medical Science; Egyptian Knowledge Bank (EKB); Ain Shams University; Mazandaran University Medical Sciences; International Institute for Population Sciences; Islamic Azad University; Islamic Azad University; Delhi Technological University; Iran University of Medical Sciences; University of London; King's College London; National Institute of Infectious Diseases (NIID); Yonsei University; Yonsei University Health System; Emory University; Finnish Institute of Occupational Health; Tehran University of Medical Sciences; Tehran University of Medical Sciences; Martin Luther University Halle Wittenberg; Kermanshah University of Medical Sciences; University of Technology Sydney; Reykjavik University; Columbia University; Universidade Federal de Santa Catarina (UFSC); University of Sannio; University of Tasmania; Menzies Institute for Medical Research; Eli Lilly; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Roorkee; University of Alabama System; University of Alabama Birmingham; US Department of Veterans Affairs; Haramaya University; Naestved Hospital; Urmia University of Medical Sciences; Semnan University of Medical Sciences; Autonomous University of Madrid; Hospital de La Princesa; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Ministry of Health of the Russian Federation; Moscow Institute of Physics & Technology; University of Hull; University of York - UK; University of Edinburgh; Tabriz University of Medical Science; International Medical University Malaysia; Indian Council of Medical Research (ICMR); Pirogov Russian National Research Medical University; Universitas Muhammadiyah Surakarta; China Medical University Taiwan; Ahmadu Bello University; University of Melbourne; Norwegian Institute of Public Health (NIPH); Muhimbili University of Health & Allied Sciences; Muhimbili University of Health & Allied Sciences; University of California System; University of California Irvine; University of Valencia; Hawassa University; International Vaccine Institute; Mekelle University; Universidade de Lisboa; Mekelle University; King Saud University; Alfaisal University; Stanford University; King Fahad Medical City; Christian Medical College & Hospital (CMCH) Vellore; Lomonosov Moscow State University; Kerman University of Medical Sciences; Kerman University of Medical Sciences; World Health Organization; University of Calgary; Universidade de Sao Paulo; IRCCS Burlo Garofolo; University of Auckland; All India Institute of Medical Sciences (AIIMS) New Delhi; Stamford University Bangladesh; Gomal University; North West University - South Africa; University of Warwick; Umea University; Ministry of Health of the Russian Federation; Christian Medical College & Hospital (CMCH) Vellore; UKK Institute; Raffles Hospital; National University of Singapore; University of Ferrara; Arcispedale Sant'Anna; IRCCS Azienda Ospedaliero-Universitaria di Bologna; HSE University (National Research University Higher School of Economics); Harvard University; University of Belgrade; Wuhan University; Naresuan University; University of Melbourne; University of Melbourne; Mekelle University; Addis Ababa University; Wenzhou Medical University; Nanjing University; Ahvaz Jundishapur University of Medical Sciences (AJUMS); University of Tokyo; Northwestern University; University of Ottawa; Kerman University of Medical Sciences; Kerman University of Medical Sciences; University of Hong Kong; University of Hong Kong; National Center for Neurology & Psychiatry - Japan; Korea University; Yonsei University; Jackson State University; Tsinghua University; Mazandaran University Medical Sciences; Wuhan University; Ardabil University of Medical Sciences; Monash University; Babol University of Medical Sciences; Ardabil University of Medical Sciences; Tehran University of Medical Sciences; African Population & Health Research Centre; Dilla University; Wuhan University of Science & Technology; Wuhan University of Science & Technology; Wuhan University; Wuhan Polytechnic University	Hay, SI (corresponding author), Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA 98195 USA.; Hay, SI (corresponding author), Univ Washington, Sch Med, Dept Hlth Metr Sci, Seattle, WA USA.	sihay@uw.edu	Sahebkar, Amirhossein/B-5124-2018; Shannawaz, Mohd/AAF-9702-2020; Sheikhtaheri, Abbas/M-6433-2018; Nagaraja, Sharath Burugina/ABD-7748-2021; Zakzuk, Nelson J. Alvis/AAV-3171-2021; Sarveazad, Arash/L-2064-2018; Rashedi, Vahid/H-6271-2018; Amit, Arianna Maever L/E-4482-2017; Yeshaneh, Alex/AAD-1562-2021; Tantawi, Maha El/K-4336-2014; Wang, Yuan/HHC-1520-2022; wangwangwang, yuanyaun/HHN-6432-2022; Kostova, Neda Milevska/E-9151-2017; Sajadi, Prof. Dr. S. Mohammad/D-9086-2014; Ji, John/AAT-4219-2021; Gebremeskel, GEBREAMLAK/ABB-8484-2020; Nigatu, Yeshambel/N-9628-2019; Jha, Ravi Prakash/ABC-6588-2020; Oghenetega, Onome Bright/AIC-6388-2022; Chehrazi, Mohammad/AAF-5545-2021; Banik, Palash Chandra/P-7613-2016; Jakovljevic, Mihajlo/B-3002-2014; Bizuneh, Asmamaw Demis/ABA-1868-2021; Arabloo, Jalal/K-1829-2019; Soltani, Shahin/CAE-8698-2022; Castaldelli-Maia, João M/I-6309-2013; Mokdad, Ali H./AAD-1232-2022; shiferaw, wondimeneh/ABB-2928-2020; Homaie Rad, Enayatollah/G-5567-2015; Renzaho, Andre M.N./AAH-7679-2021; H, Milad/AAA-2573-2019; Ibitoye, Segun Emmanuel/AAV-4960-2020; Henry, Nathaniel/ABD-4631-2020; Duko, Bereket/P-8904-2019; Bolla, Srinivasa Rao/A-6614-2015; Asante, Kwaku Oppong/B-1310-2014; A, Naheed/AHB-2940-2022; Saxena, Sonia/ABD-7737-2021; Samy, Abdallah/B-4375-2010; Violante, Francesco S/A-6934-2009; Altirkawi, Khalid A/D-7302-2017; Anwer, Razique/AAN-7825-2020; El-Jaafary, Shaimaa/ABI-5451-2020; Koolivand, Ali/W-6794-2019; Schmidt, Maria Inês/AGT-5691-2022; Kasaeian, Amir/C-8290-2017; Hassanipour, Soheil/Y-7903-2019; pokhrel, khem/AAT-6102-2021; Suleria, Hafiz Ansar Rasul/D-3385-2013; Hasaballah, Ahmed I./G-6829-2019; Moradi, Yousef/GPS-8360-2022; Ahmed, Muktar/AAY-6783-2020; Daryani, Ahmad/E-2186-2017; Khan, Prof Dr Ejaz/GNP-1245-2022; Basaleem, Huda/AAX-9878-2020; Rafiei, Alireza/A-2314-2009; Starodubova, Antonina V./F-7697-2017; Hasan, Mehedi/HHC-4236-2022; Chatterjee, Pranab/P-6272-2017; Guo, Yuming/I-8353-2018; Padubidri, Jagadish Rao/AIC-5229-2022; Khaksarian, Mojtaba/A-9914-2017; Ndwandwe, Duduzile/L-2296-2013; Dhimal, Meghnath/AAD-7261-2021; Dadi, Abel Fekadu/AAU-3433-2020; Abrigo, Michael R.M./GZH-2928-2022; Kisa, Adnan/Q-2081-2019; Fauk, Nelsensius/L-8024-2015; Leonardo, Roever MHS, PhD, Post-Doctorate, MBA (Data Science)/F-5315-2012; Kim, Yun Jin/AAE-8281-2019; Almasi-Hashiani, Amir/P-3356-2018; Islam, Mohammed Shariful/B-1219-2011; Jalali, Amir/V-2562-2018; Lim, Lee-Ling/D-7697-2015; Zaki, Maysaa El Sayed/H-3049-2019; Roshandel, Gholamreza/AAJ-9562-2021; Khan, Mohammad Saud/AAD-3358-2019; Koul, Parvaiz/B-1666-2017; Costa, Vera Marisa/D-6284-2013; Hay, Simon Iain/F-8967-2015; Bärnighausen, Till/Y-2388-2019; Koyanagi, Ai/D-3833-2018; Abushouk, Abdelrahman Ibrahim/I-9229-2018; Nazari, Javad/ABE-6348-2021; Borzouei, Shiva/F-6269-2017; Jungari, Suresh/AAG-9393-2019; Preotescu, Liliana/AFU-6281-2022; Kamyari, Naser/AAP-1999-2021; Mini, GK/GMX-3520-2022; Patton, George C/B-5246-2013; Siraj, Ammas/ABF-4925-2020; Maled, Venkatesh/ABH-3151-2020; Kasahun, Gebremicheal Gebreslassie/AAI-9900-2020; Renjith, Vishnu/Q-8043-2016; Atalay, Hagos Tasew/O-2286-2016; Alanzi, Truki/O-2778-2019; A, Rizwan S/F-5289-2014; Gupta, Rajat Das/E-5545-2018; Ali, Muhammad/AAE-9123-2019; Karim, Mohd Anisul/ABD-6578-2020; Rathi, Priya/AAU-6159-2020; Mohammadnia-Afrouzi, Mousa/I-6160-2015; Doku, Paul/GWC-6352-2022; Oluwasanu, Mojisola/AAH-8946-2021; Rajati, Fatemeh/S-1041-2017; Badiye, Ashish/I-9468-2019; Feyissa, Garumma/AAP-9097-2020; Foroutan, Masoud/AAD-6837-2020; Hamadeh, Randah R./AAE-9720-2020; kumar, Pushpendra/GRR-1736-2022; jaafari, jalil/U-3253-2018; Baradaran-Seyed, Zahra/H-5348-2017; Zhang, Zhi-Jiang/AAQ-3466-2020; Atout, Maha/ABG-4160-2021; Mirrakhimov, Erkin/E-6900-2017; Guled, Rashid Abdi/AAZ-7801-2021; Enany, Shymaa/F-2053-2010; Jenabi, Ensiyeh/S-6919-2017; Vasseghian, Yasser/AAN-4675-2020; Manafi, Navid/AAM-7393-2020; Gaidhane, Abhay/AAK-7144-2020; Ketema, Daniel Bekele/AAI-6801-2020; Gomes, Nelson/S-5420-2016; Chansa, Collins/H-3003-2019; Ahmadi, Keivan/AAU-5419-2020; Schmidt, Maria/V-3196-2019; Temsah, Mohamad-Hani/AAJ-9703-2020; Faro, Andre/J-1696-2014; Anteneh, Zelalem Alamrew/AAD-1052-2022; Amini-Rarani, Mostafa/O-3651-2018; Moradi-Lakeh, Maziar/ABC-9793-2021; Mouodi, Simin/S-5125-2019; Piroozi, Bakhtiar/G-1534-2017; Eftekhari, Aziz/O-5120-2017; Chavshin, Alireza/B-1944-2009; Borzì, Antonio Maria/X-8685-2018; Farashi, Sajjad/AAY-2951-2021; Rezai, Mohammad Sadegh/F-6274-2017; Yeshaw, Yigizie/L-6336-2019; Mohammadpourhodki, Reza/P-5260-2018; Hankey, Graeme J/H-4968-2014; Cerin, Ester/L-1271-2015; Esmaeilnejad, Saman/AAO-2794-2021; Mirjalali, Hamed/AAN-9937-2021; Sintayehu, Yitagesu/AAI-8506-2021; Inbaraj, Leeberk Raja/AAY-9266-2020; Shiri, Rahman/ABB-1780-2021; Tekulu, Gebretsadkan Hintsa/AAW-4305-2020; Silva, Diego/GRF-5446-2022; Nacimento, Bruno Ramos/F-8066-2013; Muthupandian, Saravanan/F-3835-2012; Yilma, Mekdes Tigistu/AAP-8344-2020; Lee, Shaun/E-9934-2014; Altirkawi, Khalid/AAW-5947-2021; Mansour-Ghanaei, Fariborz/ABC-0170-2022; Haj-Mirzaian, Arvin/W-6013-2019; Agrawal, Anurag/GZL-5821-2022; Schmidt, Maria Inês/AGP-6441-2022; Melese, Addisu/S-3175-2017; Soshnikov, Sergey/AAV-8566-2020; Mirzaei, Hamed/X-2374-2018; Titova, Mariya/P-6428-2019; Tohidinik, Hamid Reza/B-2268-2019; Fernandes, Joao C/AAF-2091-2019; Saxena, Sonia K/G-4821-2013; Waheed, Yasir/F-6390-2015; SHIN, JAE IL/ABD-9660-2021; Hariyani, Ninuk/AAI-7738-2021; Pepito, Veincent Christian/AAZ-7140-2020; Yazdi-Feyzabadi, Vahid/H-9647-2017; Khazaee-Pool, Maryam/G-7193-2016; Alizade, Hesam/D-7121-2016; Zaki, Maysaa El Sayed/C-1522-2013; Sagar, Rajesh/L-7775-2016; Prada, Sergio I./ABC-4648-2020; T., Olagunju Andrew/B-4746-2017; Tadesse, Zemenu/ABG-1690-2021; Ningrum, Dina Nur Anggraini/ABA-1698-2020; shirkoohi, reza/AAD-8261-2020; Gill, Tiffany/F-9042-2010; Anvari, Davood/AAA-2350-2021; Nabavizadeh, Behnam/R-3113-2018; Gutierrez, Edgar Denova/E-4600-2011; Mozaffarian, Dariush/ABC-2822-2020; Ullah, Irfan/L-5150-2017; Bijani, Ali/B-1718-2017; Endalifer, melese Linger/ABB-7868-2020; Sufiyan, Muawiyyah Babale/GWN-2609-2022; Martins-Melo, Francisco Rogerlandio/I-4868-2012; Mousavi Khaneghah, Amin/A-5925-2012; Kisa, Sezer/GPC-8087-2022; Rodriguez, Alina/B-3541-2015; Rahman, Muhammad Aziz/B-3380-2009; Syed, ZQ/K-2887-2018; Barua, Lingkan/AAP-2796-2021; Alvis-Guzman, Nelson/D-4913-2013; Ginawi, Ibrahim Abdelmageed Mohamed/H-3260-2012; Irvani, Seyed Sina Naghibi/O-2413-2018; John-Akinola, Yetunde/AAE-5345-2021; Khalilov, Rovshan/D-5445-2019; Narayan, K.M. Venkat/J-9819-2012; Hoogar, Praveen/C-4050-2017; Khalid, Nauman/G-8134-2015; Househ, Mowafa/GPX-8430-2022; Palone, Marcos Roberto Tovani/J-6491-2014; Demissie, Dereje Bayissa/AAN-3556-2021; Pathak, Mona/K-9950-2016; Akombi-Inyang, Blessing/AAT-6507-2020; Joukar, Farahnaz/GMW-7238-2022; Fomenkov, Artem Alekseevich/F-5640-2017; Moradi, Yousef/AAV-5696-2021; Rana, Saleem M/Y-9791-2018; Bin Sayeed, Muhammad Shahdaat Shahdaat/M-7055-2014; Khan, Asad/F-8739-2010; Alipour, Vahid/K-5099-2019; Chu, Dinh-Toi/I-7414-2019; Mohamadi, Efat/ABD-8458-2020; Doshmangir, Leila/AAM-7947-2021; Nigatu, Dabere/Q-9332-2018; Karami, Manoochehr/E-5030-2012; Kasaye, Habtamu Kebebe/U-5762-2019; Mirzaei, Maryam/ABC-7674-2020; Emamian, Mohammad Hassan/G-1077-2011; Lami, Faris/AAW-7666-2021; Desalew, Assefa +251913083613/C-5524-2019; Liu, Simin/I-3689-2014; Rasella, Davide/ABG-4182-2020; Sadeghi, Masoumeh/AAU-8493-2021; Shams, Mehran/S-2695-2017; Carvalho, Félix/D-4914-2013; Abolhassani, Hassan/B-3465-2014; Dagnew, Baye/AAL-9572-2020; Al-Mekhlafi, Hesham Mahyoub Sarhan/R-3568-2016; Uddin, Riaz/M-1477-2017; Safarpour, Hamid/W-3405-2018; Ribeiro, Ana Cristina/HHN-7466-2022; Herteliu, Claudiu/K-4643-2014; Oancea, Bogdan/C-4147-2011; Musa, Kamarul Imran/N-3198-2015; Khader, Yousef/AAE-9620-2019; Ahmad, Tauseef/HCH-7732-2022; Mohebi, Farnam/AGB-7159-2022; A, Naheed/AHB-2941-2022; Schutte, Aletta E/E-5126-2018; Diaz, Daniel/P-1916-2018; Mansouri, Borhan/F-4117-2011; Samadi Kafil, Hossein/AAX-2888-2021; Atout, Maha/AAI-2883-2021; boloor, archith/AAY-1719-2021; Rabiee, Mohammad/L-9865-2018; Jafarinia, Morteza/W-7706-2019; Lopez, Jaifred Christian Felicilda/A-3262-2017; Aghaali, Mohammad/M-2225-2015; Ärnlöv, Johan/AAF-2746-2019; soltani, farzaneh/N-5655-2017; Anber, Nahla/AAM-9830-2021; Kisa, Sezer/GPC-8200-2022; Sathian, Brijesh/G-7576-2014; Vollmer, Sebastian/U-6496-2017; Dereje, Nebiyu/AAF-7817-2019; Veisani, Yousef/I-7684-2017; Sharafi, Kiomars/CAF-0682-2022; Duraes, Andre R/N-2593-2017; Nagaraja, Sharath Burugina/ABD-7238-2021; Goulart, Alessandra C/A-1851-2013; Bedi, Neeraj/AGR-0606-2022; Anwer, Razique/GRR-3697-2022; FRACP, Tissa Wijeratne MD PhD/I-2086-2019; Dhillon, Preeti/ABC-7955-2020; Onwujekwe, Obinna/O-6232-2014; SHIN, JAE IL/J-6922-2017; Azarian, Ghasem/K-4554-2012; Silva, Diego Augusto Santos/AAB-9249-2020; Perico, Norberto/ABH-3222-2020; Rabiee, Navid/K-4407-2019; Francis, Joel/B-1271-2019; Aljunid, Syed/J-6009-2014; Pourmalek, Farshad/A-8188-2010; Herrero, Mario/A-6678-2015; Ilesanmi, Olayinka/AAF-8628-2021; Al-Raddadi, Rajaa/F-8337-2010; Eskandari, Khalil/G-1542-2017; Singh, Ambrish/W-2163-2017; Kengne, Andre Pascal/ABB-3696-2020; Bhandari, Dinesh/H-3159-2017; Khundkar, Roba/AAP-9178-2020; Abbastabar, Hedayat/AAC-2595-2019; Balakrishnan, Senthilkumar/J-6908-2014; Soshnikov, Sergey/AAG-9739-2020; Bhattacharyya, Krittika/AAA-8258-2021; Meles, Gebrekiros Gebremichael/AAX-8170-2020; Riahi, Seyed Mohammad/Y-1531-2018; Lorkowski, Stefan/B-9689-2008; Heidari-Soureshjani, Reza/E-8820-2019; Kabir, A./M-5979-2016; Wiangkham, Taweewat/I-9818-2019; Waheed, Yasir/AAC-3896-2019; Desai, Rupak/K-9846-2019; Humayun, Ayesha/ABC-8058-2020; Tonelli, Marcello/B-3028-2009; Kapoor, Neeti/J-4177-2019; Hostiuc, Sorin/I-2017-2019; Dagnew, Baye/AAS-3964-2021; APPIAH, SETH CHRISTOPHER YAW/J-3125-2015; Linn, Shai/N-3079-2019; Mohammed, Shafiu/P-2016-2014; YEHEYIS, TOMAS/C-2959-2018; Prasanna Mithra, MBBS/J-9621-2018; Moradi, Ghobad/R-1267-2016; Brady, Oliver/P-9421-2019; Salam, Nasir/C-8049-2015; Badawi, Alaa/ABC-1300-2021; Ajumobi, Olufemi/J-7389-2018; Khatib, Mahalaqua Nazli/E-7308-2010; Goulart, Alessandra C/J-2845-2014; Imani-Nasab, Mohammad Hasan/I-2283-2016; Radfar, Amir/I-8057-2019; K M, Shivakumar/AAV-4508-2020; Lebedev, Georgy/L-7607-2016; Taveira, Nuno C/A-6252-2014; Eftekhari, Aziz/HGF-1297-2022; Abegaz, Kedir Hussein/AAE-7080-2021; Massenburg, Benjamin B./AAB-9349-2019; Venketasubramanian, Narayanaswamy/GPP-5948-2022; El-Sherbiny, Yasser M/I-4055-2013; Center, Pars Advanced and Minimally Invasive Medical Manners Research/W-4583-2019; Meitei, Wahengbam Bigyananda/T-5412-2019; Chehrazi, Mohammad/AAF-5640-2021; Goli, Srinivas/J-7238-2012; Zhang, Yunquan/M-9828-2017; ORISAKWE, ORISH EBERE/X-5852-2019; Banach, Maciej/A-1271-2009; Fereshtehnejad, Seyed-Mohammad/ABF-6020-2020; Debalkie, Desta/AAA-1448-2022; Kugbey, Nuworza/H-9264-2019; Wang, Yuan-Pang/A-4863-2008; Chattu, Vijay Kumar/C-2778-2014; Shahabi, Saeed/AAD-1120-2020; Acharya, Dilaram/AAD-9825-2020; Demoz, Gebre Teklemariam/K-6986-2019; Krishan, Kewal/I-3285-2014; Salimzadeh, Hamideh/AAL-6666-2020; Miazgowski, Tomasz/H-9448-2014; Castaneda-Orjuela, Carlos/N-2601-2017; Car, Josip/H-6755-2015; Pakshir, Keyvan/U-6856-2017; Soyiri, Ireneous/H-4594-2011; Hwang, Bing-Fang/O-2709-2015; Koolivand, Ali/D-4524-2016; teklay, girmay/O-9966-2018; Budhathoki, Shyam Sundar/X-5167-2018; Karch, Andre/D-6973-2017; rostami, ali/R-3347-2017; Madadin, Mohammed/F-5174-2015; Dianatinasab, Mostafa/T-6904-2017; Zhao, Xiu-Ju/A-6529-2012; Santos, Itamar/K-7055-2012; Adetokunboh, Olatunji/O-7224-2018; Bragazzi, Nicola/G-1672-2011; Abbastabar, Hedayat/D-8779-2017; De Neve, Jan-Walter/D-7547-2017; Hall, Brian/B-7694-2016; Awasthi, Ashish/P-3966-2018; Fernandes, Eduarda/D-4943-2013; Amare, Dr Azmeraw/B-9487-2018; Rahimi-Movaghar, Vafa/T-7816-2017; Davila, Claudio/F-3722-2019; Olusanya, Bolajoko/F-4504-2012; Shamsizadeh, Morteza/C-6000-2014; Accrombessi, Manfred/W-1546-2017; El-Khatib, Ziad/B-5161-2017; Zandian, Hamed/J-9351-2017; Varavikova, Elena/F-2609-2017; Unnikrishnan, Bhaskaran/O-1025-2015; Soriano, Joan B/O-1215-2017; Gilani, Syed Amir/A-9458-2019; Jia, Peng/K-1446-2017; Ranandeh Kalankesh, Leila/L-8756-2017; kamiab, zahra/E-3077-2018; Duncan, Bruce/L-4140-2016; kumar, vivek/J-4421-2016; Grada, Ayman/N-3691-2013; Bikbov, Boris/I-4594-2013; Rezaei, Nima/B-4245-2008; Menezes, Ritesh/A-7480-2015; Ortiz Arduan, Alberto/Y-7582-2018; Mirzaei-Alavijeh, Mehdi/F-7870-2016; yadollahpour, ali/K-9098-2015	Shannawaz, Mohd/0000-0001-5114-5814; Sheikhtaheri, Abbas/0000-0002-6879-5415; Nagaraja, Sharath Burugina/0000-0002-6599-5753; Sarveazad, Arash/0000-0001-9273-1940; Rashedi, Vahid/0000-0002-3972-3789; Amit, Arianna Maever L/0000-0003-4571-400X; Yeshaneh, Alex/0000-0001-5876-7325; Tantawi, Maha El/0000-0003-4989-6584; Kostova, Neda Milevska/0000-0003-1596-9036; Sajadi, Prof. Dr. S. Mohammad/0000-0001-8284-5178; Ji, John/0000-0002-5002-118X; Jha, Ravi Prakash/0000-0001-5230-1436; Chehrazi, Mohammad/0000-0003-1770-4170; Banik, Palash Chandra/0000-0003-2395-9049; Jakovljevic, Mihajlo/0000-0002-9160-6846; Arabloo, Jalal/0000-0003-1223-4528; Castaldelli-Maia, João M/0000-0001-9621-2291; Mokdad, Ali H./0000-0002-4994-3339; shiferaw, wondimeneh/0000-0003-4348-591X; Homaie Rad, Enayatollah/0000-0002-9064-0380; Ibitoye, Segun Emmanuel/0000-0002-5074-816X; Henry, Nathaniel/0000-0001-8150-4988; Duko, Bereket/0000-0002-4419-0016; Bolla, Srinivasa Rao/0000-0002-2644-5169; Asante, Kwaku Oppong/0000-0002-0206-3326; A, Naheed/0000-0002-6016-5603; Saxena, Sonia/0000-0003-3787-2083; Samy, Abdallah/0000-0003-3978-1134; Violante, Francesco S/0000-0003-4084-2782; Altirkawi, Khalid A/0000-0002-7331-4196; Anwer, Razique/0000-0002-9223-1951; El-Jaafary, Shaimaa/0000-0003-0229-4420; Kasaeian, Amir/0000-0003-2018-9368; pokhrel, khem/0000-0001-6956-1672; Suleria, Hafiz Ansar Rasul/0000-0002-2450-0830; Hasaballah, Ahmed I./0000-0003-1596-1958; Moradi, Yousef/0000-0002-2936-5930; Ahmed, Muktar/0000-0002-9524-7027; Daryani, Ahmad/0000-0001-8571-5803; Khan, Prof Dr Ejaz/0000-0002-7072-8035; Basaleem, Huda/0000-0002-7353-5140; Rafiei, Alireza/0000-0002-1766-6605; Starodubova, Antonina V./0000-0001-9262-9233; Chatterjee, Pranab/0000-0001-6443-608X; Guo, Yuming/0000-0002-1766-6592; Ndwandwe, Duduzile/0000-0001-7129-3865; Dhimal, Meghnath/0000-0001-7176-7821; Dadi, Abel Fekadu/0000-0001-9967-7713; Kisa, Adnan/0000-0001-7825-3436; Fauk, Nelsensius/0000-0002-1325-2640; Leonardo, Roever MHS, PhD, Post-Doctorate, MBA (Data Science)/0000-0002-7517-5548; Kim, Yun Jin/0000-0001-8853-6587; Almasi-Hashiani, Amir/0000-0003-4434-561X; Islam, Mohammed Shariful/0000-0001-7926-9368; Jalali, Amir/0000-0002-0307-879X; Lim, Lee-Ling/0000-0002-6214-6924; Zaki, Maysaa El Sayed/0000-0001-5431-0248; Roshandel, Gholamreza/0000-0002-5494-0722; Khan, Mohammad Saud/0000-0001-5055-3226; Koul, Parvaiz/0000-0002-1700-9285; Costa, Vera Marisa/0000-0002-0471-2756; Hay, Simon Iain/0000-0002-0611-7272; Koyanagi, Ai/0000-0002-9565-5004; Abushouk, Abdelrahman Ibrahim/0000-0003-1399-6487; Borzouei, Shiva/0000-0001-6826-9872; Jungari, Suresh/0000-0003-4223-2603; Kamyari, Naser/0000-0001-6245-5447; Mini, GK/0000-0003-2775-629X; Patton, George C/0000-0001-5039-8326; Maled, Venkatesh/0000-0001-6558-7648; Kasahun, Gebremicheal Gebreslassie/0000-0002-8981-1832; Renjith, Vishnu/0000-0002-3718-8399; Atalay, Hagos Tasew/0000-0002-0886-815X; Alanzi, Truki/0000-0001-6598-1274; A, Rizwan S/0000-0002-3140-2614; Gupta, Rajat Das/0000-0002-7680-676X; Ali, Muhammad/0000-0002-7835-0663; Karim, Mohd Anisul/0000-0003-2960-6017; Rathi, Priya/0000-0002-1550-459X; Mohammadnia-Afrouzi, Mousa/0000-0003-2083-7425; Rajati, Fatemeh/0000-0001-6426-664X; Badiye, Ashish/0000-0001-8097-7249; Feyissa, Garumma/0000-0001-6179-0024; Foroutan, Masoud/0000-0002-8661-7217; Hamadeh, Randah R./0000-0002-4205-1354; jaafari, jalil/0000-0002-0186-7779; Baradaran-Seyed, Zahra/0000-0001-7959-4718; Zhang, Zhi-Jiang/0000-0003-0905-4534; Mirrakhimov, Erkin/0000-0003-2982-6108; Guled, Rashid Abdi/0000-0002-2003-2419; Enany, Shymaa/0000-0002-7827-6504; Jenabi, Ensiyeh/0000-0002-4536-0814; Vasseghian, Yasser/0000-0001-6225-627X; Manafi, Navid/0000-0002-4610-402X; Gaidhane, Abhay/0000-0002-4814-2695; Gomes, Nelson/0000-0002-8727-9678; Chansa, Collins/0000-0003-0982-5087; Ahmadi, Keivan/0000-0001-5674-2765; Faro, Andre/0000-0002-7348-6297; Anteneh, Zelalem Alamrew/0000-0003-4879-675X; Amini-Rarani, Mostafa/0000-0002-4809-2237; Moradi-Lakeh, Maziar/0000-0001-7381-5305; Piroozi, Bakhtiar/0000-0002-6973-5764; Eftekhari, Aziz/0000-0003-0274-4479; Chavshin, Alireza/0000-0002-2359-8610; Borzì, Antonio Maria/0000-0001-6984-308X; Rezai, Mohammad Sadegh/0000-0003-4585-9954; Mohammadpourhodki, Reza/0000-0001-5677-0133; Hankey, Graeme J/0000-0002-6044-7328; Cerin, Ester/0000-0002-7599-165X; Esmaeilnejad, Saman/0000-0003-1996-446X; Sintayehu, Yitagesu/0000-0002-4325-4241; Inbaraj, Leeberk Raja/0000-0001-8642-1348; Shiri, Rahman/0000-0002-9312-3100; Tekulu, Gebretsadkan Hintsa/0000-0002-2301-1453; Nacimento, Bruno Ramos/0000-0002-5586-774X; Muthupandian, Saravanan/0000-0002-1480-3555; Yilma, Mekdes Tigistu/0000-0002-1624-6529; Lee, Shaun/0000-0001-7361-6576; Altirkawi, Khalid/0000-0002-7331-4196; Mansour-Ghanaei, Fariborz/0000-0001-6747-0232; Haj-Mirzaian, Arvin/0000-0001-8977-6865; Schmidt, Maria Inês/0000-0002-3837-0731; Melese, Addisu/0000-0002-2362-5500; Mirzaei, Hamed/0000-0002-9399-8281; Titova, Mariya/0000-0002-4571-3712; Tohidinik, Hamid Reza/0000-0002-0432-0357; Fernandes, Joao C/0000-0003-1556-1698; Saxena, Sonia K/0000-0003-3787-2083; Waheed, Yasir/0000-0002-5789-4215; SHIN, JAE IL/0000-0003-2326-1820; Hariyani, Ninuk/0000-0003-0807-0081; Pepito, Veincent Christian/0000-0001-5391-3784; Yazdi-Feyzabadi, Vahid/0000-0002-8009-470X; Khazaee-Pool, Maryam/0000-0002-2587-3460; Alizade, Hesam/0000-0002-8050-836X; Zaki, Maysaa El Sayed/0000-0001-5431-0248; Prada, Sergio I./0000-0001-7986-0959; T., Olagunju Andrew/0000-0003-1736-9886; Ningrum, Dina Nur Anggraini/0000-0002-8557-2862; Gill, Tiffany/0000-0002-2822-2436; Anvari, Davood/0000-0003-1021-4347; Nabavizadeh, Behnam/0000-0003-4378-9243; Gutierrez, Edgar Denova/0000-0001-9671-9682; Bijani, Ali/0000-0003-2233-8726; Sufiyan, Muawiyyah Babale/0000-0003-3630-6995; Martins-Melo, Francisco Rogerlandio/0000-0003-3690-5023; Mousavi Khaneghah, Amin/0000-0001-5769-0004; Kisa, Sezer/0000-0002-3969-9803; Rodriguez, Alina/0000-0003-1209-8802; Rahman, Muhammad Aziz/0000-0003-1665-7966; Syed, ZQ/0000-0002-1435-899X; Barua, Lingkan/0000-0002-9281-3839; Alvis-Guzman, Nelson/0000-0001-9458-864X; Ginawi, Ibrahim Abdelmageed Mohamed/0000-0001-8628-1840; Irvani, Seyed Sina Naghibi/0000-0002-4566-7402; Narayan, K.M. Venkat/0000-0001-8621-5405; Hoogar, Praveen/0000-0003-2170-5643; Khalid, Nauman/0000-0002-8045-199X; Palone, Marcos Roberto Tovani/0000-0003-1149-2437; Demissie, Dereje Bayissa/0000-0003-1006-4318; Pathak, Mona/0000-0002-2103-9890; Akombi-Inyang, Blessing/0000-0002-6410-4154; Joukar, Farahnaz/0000-0003-0102-0575; Fomenkov, Artem Alekseevich/0000-0002-9213-7180; Moradi, Yousef/0000-0002-2936-5930; Rana, Saleem M/0000-0001-6479-9235; Bin Sayeed, Muhammad Shahdaat Shahdaat/0000-0003-0027-9614; Khan, Asad/0000-0003-4188-2065; Alipour, Vahid/0000-0003-1010-9571; Chu, Dinh-Toi/0000-0002-4596-2022; Nigatu, Dabere/0000-0001-7303-6723; Karami, Manoochehr/0000-0002-9026-3757; Kasaye, Habtamu Kebebe/0000-0003-3759-2604; Mirzaei, Maryam/0000-0001-7908-6035; Emamian, Mohammad Hassan/0000-0002-1994-1105; Lami, Faris/0000-0002-3673-3818; Liu, Simin/0000-0003-2098-3844; Rasella, Davide/0000-0002-7260-4386; Sadeghi, Masoumeh/0000-0001-7179-5558; Shams, Mehran/0000-0001-9474-0955; Carvalho, Félix/0000-0003-3858-3494; Abolhassani, Hassan/0000-0002-4838-0407; Dagnew, Baye/0000-0002-2397-5930; Al-Mekhlafi, Hesham Mahyoub Sarhan/0000-0003-2582-7410; Uddin, Riaz/0000-0001-8133-9732; Safarpour, Hamid/0000-0002-6442-6081; Ribeiro, Ana Cristina/0000-0002-0493-8376; Herteliu, Claudiu/0000-0001-8860-9547; Oancea, Bogdan/0000-0001-6987-5137; Musa, Kamarul Imran/0000-0002-3708-0628; Khader, Yousef/0000-0002-7830-6857; Ahmad, Tauseef/0000-0001-8793-273X; A, Naheed/0000-0002-6016-5603; Schutte, Aletta E/0000-0001-9217-4937; Diaz, Daniel/0000-0003-2302-1982; Mansouri, Borhan/0000-0001-5411-5362; Samadi Kafil, Hossein/0000-0001-6026-8795; Atout, Maha/0000-0002-6290-9100; Rabiee, Mohammad/0000-0003-1180-8729; Jafarinia, Morteza/0000-0002-3272-448X; Lopez, Jaifred Christian Felicilda/0000-0002-8273-992X; Aghaali, Mohammad/0000-0003-3417-1580; Ärnlöv, Johan/0000-0002-6933-4637; soltani, farzaneh/0000-0002-5407-6858; Anber, Nahla/0000-0001-5684-9298; Sathian, Brijesh/0000-0003-0851-4762; Vollmer, Sebastian/0000-0002-7863-0462; Duraes, Andre R/0000-0002-1506-0327; Nagaraja, Sharath Burugina/0000-0002-6599-5753; Goulart, Alessandra C/0000-0003-1076-5210; Bedi, Neeraj/0000-0003-4709-8423; Anwer, Razique/0000-0002-9223-1951; FRACP, Tissa Wijeratne MD PhD/0000-0002-1701-7111; Dhillon, Preeti/0000-0001-9757-6492; Onwujekwe, Obinna/0000-0002-1214-4285; SHIN, JAE IL/0000-0003-2326-1820; Silva, Diego Augusto Santos/0000-0002-0489-7906; Perico, Norberto/0000-0002-3147-4327; Rabiee, Navid/0000-0002-6945-8541; Francis, Joel/0000-0003-1902-2683; Aljunid, Syed/0000-0002-0380-1335; Pourmalek, Farshad/0000-0002-2134-0771; Herrero, Mario/0000-0002-7741-5090; Ilesanmi, Olayinka/0000-0003-0827-6442; Al-Raddadi, Rajaa/0000-0002-8921-9628; Eskandari, Khalil/0000-0002-2919-7324; Singh, Ambrish/0000-0002-4618-7507; Bhandari, Dinesh/0000-0002-0979-1406; Balakrishnan, Senthilkumar/0000-0003-4117-9695; Soshnikov, Sergey/0000-0002-6983-7066; Bhattacharyya, Krittika/0000-0002-9914-7031; Meles, Gebrekiros Gebremichael/0000-0001-6563-0001; Riahi, Seyed Mohammad/0000-0002-3184-2126; Lorkowski, Stefan/0000-0002-9649-840X; Heidari-Soureshjani, Reza/0000-0002-1212-1171; Kabir, A./0000-0001-9496-4705; Wiangkham, Taweewat/0000-0003-4115-704X; Waheed, Yasir/0000-0002-5789-4215; Desai, Rupak/0000-0002-5315-6426; Humayun, Ayesha/0000-0001-7992-8765; Tonelli, Marcello/0000-0002-0846-3187; Kapoor, Neeti/0000-0002-3646-5139; Hostiuc, Sorin/0000-0003-4130-9402; Dagnew, Baye/0000-0002-2397-5930; APPIAH, SETH CHRISTOPHER YAW/0000-0002-9844-1036; Linn, Shai/0000-0002-0867-2958; Mohammed, Shafiu/0000-0001-5715-966X; YEHEYIS, TOMAS/0000-0002-5482-8060; Prasanna Mithra, MBBS/0000-0002-7153-411X; Moradi, Ghobad/0000-0003-2612-6528; Brady, Oliver/0000-0002-3235-2129; Salam, Nasir/0000-0001-9133-1304; Ajumobi, Olufemi/0000-0002-2652-1205; Khatib, Mahalaqua Nazli/0000-0001-5875-8277; Goulart, Alessandra C/0000-0003-1076-5210; Imani-Nasab, Mohammad Hasan/0000-0003-4986-0880; Radfar, Amir/0000-0001-6177-3048; K M, Shivakumar/0000-0002-8062-9209; Lebedev, Georgy/0000-0002-4289-2102; Taveira, Nuno C/0000-0003-0176-5585; Eftekhari, Aziz/0000-0003-0274-4479; Abegaz, Kedir Hussein/0000-0001-8194-1643; Massenburg, Benjamin B./0000-0002-8570-5178; El-Sherbiny, Yasser M/0000-0003-4791-3475; Meitei, Wahengbam Bigyananda/0000-0003-2671-707X; Goli, Srinivas/0000-0002-8481-484X; Zhang, Yunquan/0000-0002-2618-5088; ORISAKWE, ORISH EBERE/0000-0002-5806-9858; Banach, Maciej/0000-0001-6690-6874; Fereshtehnejad, Seyed-Mohammad/0000-0001-9255-9351; Kugbey, Nuworza/0000-0002-0413-0350; Wang, Yuan-Pang/0000-0001-7076-8312; Chattu, Vijay Kumar/0000-0001-9840-8335; Shahabi, Saeed/0000-0002-8190-2190; Demoz, Gebre Teklemariam/0000-0002-2534-821X; Krishan, Kewal/0000-0001-5321-0958; Salimzadeh, Hamideh/0000-0002-0102-1722; Dunachie, Susanna/0000-0001-5665-6293; Miazgowski, Tomasz/0000-0002-4819-9376; Gebremariam, Kidane/0000-0003-1888-3318; Temsah, Mohamad-Hani/0000-0002-4389-9322; Bennett, Derrick/0000-0002-9170-8447; Castaneda-Orjuela, Carlos/0000-0002-8735-6223; Maulik, Pallab Kumar/0000-0001-6835-6175; Campos, Ismael/0000-0001-5939-3396; Padubidri, Jagadish Rao/0000-0002-8671-7664; Sabde, Yogesh/0000-0003-1787-2553; Kengne, Andre Pascal/0000-0002-5183-131X; Car, Josip/0000-0001-8969-371X; Pakshir, Keyvan/0000-0001-7809-4690; Soyiri, Ireneous/0000-0003-4697-5156; Hwang, Bing-Fang/0000-0002-5951-9662; Koolivand, Ali/0000-0002-9375-4631; Marczak, Laurie/0000-0001-5979-4261; Meretoja, Tuomo/0000-0002-2691-0710; SAGAR, RAJESH/0000-0003-4563-7841; Jha, Vivekanand/0000-0002-8015-9470; Gesesew, Hailay/0000-0002-3531-4400; Mahasha, Phetole/0000-0002-5750-3595; Kabir, Zubair/0000-0003-1529-004X; Dipeolu, Isaac Oluwafemi/0000-0002-7538-1050; teklay, girmay/0000-0002-3392-6585; Budhathoki, Shyam Sundar/0000-0002-8614-1087; Juliana Iwu, Chinwe/0000-0003-0765-7497; Karch, Andre/0000-0003-3014-8543; Yeshaw, Yigizie/0000-0003-4587-7925; Moradpour, Farhad/0000-0002-4449-1978; rostami, ali/0000-0002-1358-1321; Ribeiro, Ana Isabel/0000-0001-8880-6962; Longbottom, Joshua/0000-0002-4151-9031; mirzaei, mahdi/0000-0001-9817-9157; Endalifer, Melese Linger/0000-0003-1505-2500; Madadin, Mohammed/0000-0002-8594-5868; Asgari, Samaneh/0000-0002-7032-310X; Dianatinasab, Mostafa/0000-0002-0185-5807; Zotor, Francis/0000-0002-4411-4419; Minuye, Binyam/0000-0002-9338-0334; Agrawal, Anurag/0000-0002-0340-5252; Omer, Muktar/0000-0003-0365-3026; Ilic, Milena/0000-0003-3229-4990; Zhao, Xiu-Ju/0000-0003-4962-6285; P, Sowmya/0000-0001-8415-5816; Kiadaliri, Ali/0000-0002-4254-9099; Li, Shanshan/0000-0002-9021-8470; Farzadfar, Farshad/0000-0001-8288-4046; Pribadi, Dimas Ria Angga/0000-0001-5231-4974; Azene, Zelalem Nigussie/0000-0002-3511-7562; Mosser, Jonathan/0000-0001-9093-3186; LASRADO, SAVITA/0000-0001-9261-9238; Simonetti, Biagio/0000-0002-2540-7830; Haririan, Hamidreza/0000-0002-5714-8669; rastogi, prateek/0000-0001-6501-8314; Bekele, Muluken/0000-0002-3464-2584; Moradi, Masoud/0000-0003-2036-5333; Santos, Itamar/0000-0003-3212-8466; Kurmi, Om Prakash/0000-0002-9518-4716; Adetokunboh, Olatunji/0000-0002-4608-3951; Bragazzi, Nicola/0000-0001-8409-868X; Pourshams, Akram/0000-0002-7950-3983; Dereje, Nebiyu/0000-0002-3943-4434; Abbastabar, Hedayat/0000-0002-5713-4806; De Neve, Jan-Walter/0000-0003-0090-8249; Hall, Brian/0000-0001-9358-2377; Jozwiak, Jacek/0000-0002-2645-7274; Awasthi, Ashish/0000-0002-9308-9782; Tabares-Seisdedos, Rafael/0000-0002-1089-2204; Fernandes, Eduarda/0000-0001-6424-0976; Rawal, Lal/0000-0003-1106-0108; Usman, Muhammad/0000-0001-9747-8892; Jeemon, Panniyammakal/0000-0003-4172-4307; Ayanore, Martin/0000-0002-4095-3047; Haile, Michael Tamene/0000-0002-9992-9885; Izadi, Neda/0000-0002-6373-1113; nazari, javad/0000-0002-8277-6819; Dharmaratne, Samath/0000-0003-4144-2107; Olagunju, Tinuke/0000-0003-4019-8755; Magdy Abd El Razek, Hassan/0000-0002-8857-0408; Aychiluhm, Setognal Birara/0000-0001-7565-7515; Hasan, Md. Mehedi/0000-0001-7801-0506; Wiens, Kirsten E./0000-0003-4093-4054; Esteghamati, Alireza/0000-0001-5114-3982; Ray, Sarah/0000-0002-5775-8344; Komaki, Hamidreza/0000-0003-1830-9500; Azarian, Ghasem/0000-0001-9321-8073; Upadhyay, Era/0000-0002-8740-8329; Amare, Dr Azmeraw/0000-0002-7940-0335; Asadi-Pooya, Ali/0000-0002-2598-7601; , Jiansong/0000-0001-6975-620X; ziapour, arash/0000-0001-8687-7484; Mirzaei, Roya/0000-0003-2313-061X; Amiri, Fatemeh/0000-0002-4082-1060; Rahimi-Movaghar, Vafa/0000-0001-7347-8767; Khan, Md Nuruzzaman/0000-0002-4550-4363; Davila, Claudio/0000-0002-7656-3606; Olusanya, Bolajoko/0000-0002-3826-0583; Moazen, Babak/0000-0002-2552-0438; Tadesse, Birkneh Tilahun/0000-0003-4005-8605; Britton, Gabrielle/0000-0002-1758-2495; Shamsizadeh, Morteza/0000-0002-8153-5482; Accrombessi, Manfred/0000-0001-9550-9413; El-Khatib, Ziad/0000-0003-0756-7280; Desalew, Assefa/0000-0001-6065-0708; Rai, Rajesh Kumar/0000-0002-5249-9937; Bakhtiari, Ahad/0000-0003-3580-9259; Zandian, Hamed/0000-0002-1284-5823; Olusanya, Jacob/0000-0002-1566-9554; Varavikova, Elena/0000-0003-3408-3417; Nigatu, Yeshambel Tesfa/0000-0002-5192-4188; Dereje, Nebiyu/0000-0001-5406-4171; Mohammad, Dara K./0000-0001-9201-0991; Ross, Jennifer/0000-0001-5677-939X; Rahim, Fakher/0000-0002-2857-4562; Unnikrishnan, Bhaskaran/0000-0003-0892-8551; Soriano, Joan B/0000-0001-9740-2994; Gizachew, Yordanos/0000-0002-6002-7358; Gilani, Syed Amir/0000-0002-2996-0764; Foigt, Nataliya/0000-0002-3613-5965; Miller, Ted/0000-0002-0958-2639; Jia, Peng/0000-0003-0110-3637; ansari, parastoo/0000-0003-1536-1565; Asadi-Aliabadi, Mehran/0000-0003-1582-5489; Karki, Surendra/0000-0003-1561-4171; Ranandeh Kalankesh, Leila/0000-0002-4832-3170; Yadegar, Abbas/0000-0002-2135-7581; Shafaat, Omid/0000-0001-8793-7901; Hasanzadeh, Amir/0000-0003-2893-4369; Boloor, Archith/0000-0003-4513-0215; lal, aparna/0000-0001-7062-1468; Postma, Maarten/0000-0002-6306-3653; Gedefaw, Getnet/0000-0003-4906-2555; kamiab, zahra/0000-0001-6670-1828; Tabuchi, Takahiro/0000-0002-1050-3125; Ketema, Daniel/0000-0002-7464-7814; Duncan, Bruce/0000-0002-7491-2630; Biza, Nejimu/0000-0001-8502-7605; RENZAHO, ANDRE/0000-0002-6844-0833; Acharya, Dilaram/0000-0003-2270-7667; Shalash, Ali/0000-0001-7012-5907; Cahuana-Hurtado, Lucero/0000-0002-9438-1443; Kimokoti, Ruth/0000-0002-4980-3256; kumar, vivek/0000-0003-4379-5651; Grada, Ayman/0000-0002-5321-0584; Bikbov, Boris/0000-0002-1925-7506; Rezaei, Nima/0000-0002-3836-1827; Bohlouli, Somayeh/0000-0003-0854-1875; Haj-mirzaian, Arya/0000-0002-0724-2649; Menezes, Ritesh/0000-0002-2135-4161; Shiue, Ivy/0000-0003-1788-3009; Zaman, Sojib Bin/0000-0002-3043-7954; Ortiz Arduan, Alberto/0000-0002-9805-9523; Elemineh, Demelash/0000-0001-8821-0691; Ullah, Irfan/0000-0001-6992-6723; Mirzaei-Alavijeh, Mehdi/0000-0003-3695-6971; John, Oommen/0000-0002-9008-1726; Mohebi, Farnam/0000-0002-6181-2008; Marami, Dadi/0000-0002-4793-3575; Moradzadeh, Rahmatollah/0000-0003-4952-3454; Adekanmbi, Victor/0000-0002-7394-1640; Doku, Paul/0000-0001-8833-6091; Fazaeli, Ali Akbar/0000-0002-6667-0344; Arunkumar, Govindakarnavar/0000-0002-3114-0415; Davis Weaver, Nicole/0000-0002-7205-9621; Wonde, Tewodros/0000-0003-3323-8202; yadollahpour, ali/0000-0002-1216-2109; Sunguya, Bruno/0000-0003-3625-0725; Deribe, Kebede/0000-0002-8526-6996				Alegana VA, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2015.0073; Ananth CV, 1997, INT J EPIDEMIOL, V26, P1323, DOI 10.1093/ije/26.6.1323; [Anonymous], 2004, GLOB LAK WETL DAT LE; Auslander P, 2006, PAJ, P1; Bhatt S, 2017, J R SOC INTERFACE, V14, DOI 10.1098/rsif.2017.0520; Bixby H, 2019, NATURE, V569, P260, DOI 10.1038/s41586-019-1171-x; Black RE, 2003, LANCET, V361, P2226, DOI 10.1016/S0140-6736(03)13779-8; Black RE, 2008, LANCET, V371, P243, DOI 10.1016/S0140-6736(07)61690-0; Blangiardo M, 2015, SPATIAL AND SPATIO-TEMPORAL BAYESIAN MODELS WITH R-INLA, P235; Blangiardo M, 2013, SPAT SPATIO-TEMPORAL, V7, P39, DOI [10.1016/j.sste.2013.07.003, 10.1016/j.sste.2012.12.001]; Cameletti M, 2013, ASTA-ADV STAT ANAL, V97, P109, DOI 10.1007/s10182-012-0196-3; CDC, 2016, CAUS CONS CHILDH OB; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; de Onis M, 2019, PUBLIC HEALTH NUTR, V22, P175, DOI 10.1017/S1368980018002434; de Onis M, 2010, AM J CLIN NUTR, V92, P1257, DOI 10.3945/ajcn.2010.29786; Dicker D, 2018, LANCET, V392, P1684, DOI [10.1016/S0140-6736(18)31891-9, 10.1016/s0140-6736(18)31891-9]; Diggle PJ, 1998, J R STAT SOC C-APPL, V47, P299, DOI 10.1111/1467-9876.00113; Ezzati M, 2017, LANCET, V390, P2627, DOI 10.1016/S0140-6736(17)32129-3; Fanzo J, 2018, GLOBAL NUTR REPORT S; Fienberg SE, 2007, ANAL CROSS CLASSIFIE, P8, DOI [10.1007/978-0-387-72825-4, DOI 10.1007/978-0-387-72825-4]; Food and Agriculture Organization, 2020, The state of food security and nutrition in the world 2020: transforming food systems for affordable healthy diets, DOI 10.4060/ca9692en; GADM, GADM DATABASE GLOBAL; Gething PW, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000724; Global Administrative Areas, 2018, GADM DATABASE GLOBAL; Global Panel on Agriculture and Food Systems for Nutrition, 2016, COST MALN WHY POL AC; Golding N, 2017, LANCET, V390, P2171, DOI 10.1016/S0140-6736(17)31758-0; Hawkes C, 2020, LANCET, V395, P142, DOI 10.1016/S0140-6736(19)32506-1; Hawkes C, 2017, LANCET GLOB HEALTH, V5, pE745, DOI 10.1016/S2214-109X(17)30204-8; Humbwavali JB, 2018, SAO PAULO MED J, V136, P454, DOI 10.1590/1516-3180.2017.0267261117; Indrayan A, 2014, INDIAN PEDIATR, V51, P37, DOI 10.1007/s13312-014-0310-6; KINYOKI DK, 2020, NATURE, V577, P231, DOI DOI 10.1038/S41586-019-1878-8; Lehner B, 2004, J HYDROL, V296, P1, DOI 10.1016/j.jhydrol.2004.03.028; Lindgren F, 2011, J R STAT SOC B, V73, P423, DOI 10.1111/j.1467-9868.2011.00777.x; Lumley T., 2010, COMPLEX SURVEYS GUID, DOI [10.1002/9780470580066, DOI 10.1002/9780470580066]; Lumley T., 2004, J STAT SOFTW, V9, P1, DOI [10.18637/jss.v009.i08, DOI 10.18637/JSS.V009.I08]; Martins TG, 2013, COMPUT STAT DATA AN, V67, P68, DOI 10.1016/j.csda.2013.04.014; Monteiro CA, 2011, PUBLIC HEALTH NUTR, V14, P5, DOI 10.1017/S1368980010003241; Mosser JF, 2019, LANCET, V393, P1843, DOI 10.1016/S0140-6736(19)30226-0; Murray CJL, 2012, LANCET, V380, P2063, DOI 10.1016/S0140-6736(12)61899-6; Neufeld LM, 2013, INT NUTR, V78, P11; Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8; Nugent R, 2020, LANCET, V395, P156, DOI 10.1016/S0140-6736(19)32473-0; Ong KKL, 2000, BRIT MED J, V320, P967, DOI 10.1136/bmj.320.7240.967; Onis M. de, 2006, Acta Paediatrica, V95, P76; Osgood-Zimmerman A, 2018, NATURE, V555, P41, DOI 10.1038/nature25760; Patil AP, 2011, TRENDS PARASITOL, V27, P245, DOI 10.1016/j.pt.2011.01.003; Popkin BM, 2020, LANCET, V395, P65, DOI 10.1016/S0140-6736(19)32497-3; Rue H, 2009, J R STAT SOC B, V71, P319, DOI 10.1111/j.1467-9868.2008.00700.x; Scaling Up Nutrition Civil Society Network, 2016, SUN MOV STRAT ROADM; Scaling Up Nutrition (SUN) Movement, 2016, ANN PROGR REP 2016; Scharlemann JPW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001408; Stein M.L., 1999, INTERPOLATION SPATIA; Stevens GA, 2016, PLOS MED, V13, DOI [10.1371/journal.pmed.1002116, 10.1371/journal.pmed.1002056]; Tatem AJ, 2017, SCI DATA, V4, DOI 10.1038/sdata.2017.4; Tzioumis E, 2016, PUBLIC HEALTH NUTR, V19, P1375, DOI 10.1017/S1368980016000276; United Nations, GOAL 2 SUST DEV KNOW; United Nations Children's Fund (UNICEF), MULT IND CLUST SURV; Wang Y., 2012, HDB ANTHROPOMETRY PH, V1, P29, DOI DOI 10.1007/978-1-4419-1788-1_2; Wells JC, 2020, LANCET, V395, P75, DOI 10.1016/S0140-6736(19)32472-9; WHO(WorldHealthOrgan, 2018, DOUBL BURD MALN; WHO-WORLD HEALTH ORGANIZATION, 2014, GLOB NUTR TARG 2025; World Bank Group, LIV STAND MEAS SURV; World Bank Group, COR WELF IND QUEST S; World Health Organization, 1995, PHYS STAT US INT ANT; World Health Organization (WHO), 2008, TRAIN COURS CHILD GR	65	24	24	12	82	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	MAY	2020	26	5					750	759		10.1038/s41591-020-0807-6	http://dx.doi.org/10.1038/s41591-020-0807-6		APR 2020	10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	ML1MY	32313249	Green Published, Green Accepted, Green Submitted, hybrid			2022-12-27	WOS:000527507000001
J	Leung, NHL; Chu, DKW; Shiu, EYC; Chan, KH; McDevitt, JJ; Hau, BJP; Yen, HL; Li, YG; Ip, DKM; Peiris, JSM; Seto, WH; Leung, GM; Milton, DK; Cowling, BJ				Leung, Nancy H. L.; Chu, Daniel K. W.; Shiu, Eunice Y. C.; Chan, Kwok-Hung; McDevitt, James J.; Hau, Benien J. P.; Yen, Hui-Ling; Li, Yuguo; Ip, Dennis K. M.; Peiris, J. S. Malik; Seto, Wing-Hong; Leung, Gabriel M.; Milton, Donald K.; Cowling, Benjamin J.			Respiratory virus shedding in exhaled breath and efficacy of face masks	NATURE MEDICINE			English	Article							INFLUENZA-VIRUS; TRANSMISSION; CONTAMINATION; CORONAVIRUS; AIRBORNE	We identified seasonal human coronaviruses, influenza viruses and rhinoviruses in exhaled breath and coughs of children and adults with acute respiratory illness. Surgical face masks significantly reduced detection of influenza virus RNA in respiratory droplets and coronavirus RNA in aerosols, with a trend toward reduced detection of coronavirus RNA in respiratory droplets. Our results indicate that surgical face masks could prevent transmission of human coronaviruses and influenza viruses from symptomatic individuals. A study of 246 individuals with seasonal respiratory virus infections randomized to wear or not wear a surgical face mask showed that masks can significantly reduce detection of coronavirus and influenza virus in exhaled breath and may help interrupt virus transmission.	[Leung, Nancy H. L.; Chu, Daniel K. W.; Shiu, Eunice Y. C.; Hau, Benien J. P.; Yen, Hui-Ling; Ip, Dennis K. M.; Peiris, J. S. Malik; Seto, Wing-Hong; Leung, Gabriel M.; Cowling, Benjamin J.] Univ Hong Kong, Li Ka Shing Fac Med, Sch Publ Hlth, WHO Collaborating Ctr Infect Dis Epidemiol & Cont, Hong Kong, Peoples R China; [Chan, Kwok-Hung] Univ Hong Kong, Li Ka Shing Fac Med, Dept Microbiol, Hong Kong, Peoples R China; [McDevitt, James J.] Harvard Sch Publ Hlth, Dept Environm Hlth, Boston, MA USA; [Hau, Benien J. P.] Queen Mary Hosp, Dept Surg, Hong Kong, Peoples R China; [Li, Yuguo] Univ Hong Kong, Dept Mech Engn, Hong Kong, Peoples R China; [Seto, Wing-Hong] Hong Kong Baptist Hosp, Dept Pathol, Hong Kong, Peoples R China; [Milton, Donald K.] Univ Maryland, Sch Publ Hlth, Maryland Inst Appl Environm Hlth, College Pk, MD 20742 USA	University of Hong Kong; World Health Organization; University of Hong Kong; Harvard University; Harvard T.H. Chan School of Public Health; University of Hong Kong; University of Hong Kong; University System of Maryland; University of Maryland College Park	Cowling, BJ (corresponding author), Univ Hong Kong, Li Ka Shing Fac Med, Sch Publ Hlth, WHO Collaborating Ctr Infect Dis Epidemiol & Cont, Hong Kong, Peoples R China.	bcowling@hku.hk	Yen, Hui-Ling/C-4501-2009; Milton, Donald K/G-3286-2010; Chan, Kwok Hung/ABD-5399-2021; Yen, Hui-Ling/GNH-5083-2022; Leung, Nancy Hiu Lan/M-9080-2016	Yen, Hui-Ling/0000-0003-2493-3609; Milton, Donald K/0000-0002-0550-7834; Leung, Nancy Hiu Lan/0000-0001-7314-840X; Leung, Gabriel/0000-0002-2503-6283; Seto, Wing Hong/0000-0002-1139-9200	University Grants Committee [765811]; Health and Medical Research Fund [13120592]; Food and Health Bureau; Research Grants Council of the Hong Kong SAR Government [T11-705/14-N]	University Grants Committee; Health and Medical Research Fund; Food and Health Bureau; Research Grants Council of the Hong Kong SAR Government(Hong Kong Research Grants Council)	This work was supported by the General Research Fund of the University Grants Committee (grant no. 765811), the Health and Medical Research Fund (grant no. 13120592) and a commissioned grant of the Food and Health Bureau and the Theme-based Research Scheme (project no. T11-705/14-N) of the Research Grants Council of the Hong Kong SAR Government. We acknowledge colleagues including R. O. P. Fung, A. K. W. Li, T. W. Y. Ng, T. H. C. So, P. Wu and Y. Xie for technical support in preparing and conducting this study and enrolling participants; J. K. M. Chan, S. Y. Ho, Y. Z. Liu and A. Yu for laboratory support; S. Ferguson, W. K. Leung, J. Pantelic, J. Wei and M. Wolfson for technical support in constructing and maintaining the G-II device; V. J. Fang, L. M. Ho and T. T. K. Lui for setting up the database; and C. W. Y. Cheung, L. F. K. Cheung, P. T. Y. Ching, A. C. H. Lai, D. W. Y. Lam, S. S. Y. Lo, A. S. K. Luk and other colleagues at the Outpatient Center and Infection Control Team of Hong Kong Baptist Hospital for facilitating this study.	Booth TF, 2005, J INFECT DIS, V191, P1472, DOI 10.1086/429634; Chan KH, 2008, J CLIN VIROL, V42, P65, DOI 10.1016/j.jcv.2007.12.003; Cowling BJ, 2020, EUROSURVEILLANCE, V25, P2, DOI 10.2807/1560-7917.ES.2020.25.6.2000110; HAERI GB, 1980, CLIN ORTHOP RELAT R, P160; Han QM, 2020, INFLUENZA OTHER RESP, V14, P470, DOI 10.1111/irv.12735; Huynh KN, 2008, CLIN INFECT DIS, V46, P93, DOI 10.1086/523000; JENNINGS LC, 1987, EUR J EPIDEMIOL, V3, P327, DOI 10.1007/BF00145641; Johnson DF, 2009, CLIN INFECT DIS, V49, P275, DOI 10.1086/600041; Kim SH, 2016, CLIN INFECT DIS, V63, P363, DOI 10.1093/cid/ciw239; Kutter JS, 2018, CURR OPIN VIROL, V28, P142, DOI 10.1016/j.coviro.2018.01.001; Maclntyre CR, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h694; McDevitt JJ, 2013, AEROSOL SCI TECH, V47, P444, DOI 10.1080/02786826.2012.762973; Milton DK, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003205; Nichols WG, 2008, CLIN MICROBIOL REV, V21, P274, DOI 10.1128/CMR.00045-07; Patel RB, 2016, J OCCUP ENVIRON HYG, V13, P569, DOI 10.1080/15459624.2015.1043050; R Foundation for Statistical Computing, 2019, R LANG ENV STAT COMP; Shiu EYC, 2019, CURR OPIN INFECT DIS, V32, P372, DOI 10.1097/QCO.0000000000000563; Stelzer-Braid S, 2009, J MED VIROL, V81, P1674, DOI 10.1002/jmv.21556; Tellier R, 2019, BMC INFECT DIS, V19, DOI 10.1186/s12879-019-3707-y; Tovey ER, 2015, J ALLERGY CLIN IMMUN, V135, P663, DOI 10.1016/j.jaci.2014.10.020; Xiao JY, 2020, EMERG INFECT DIS, V26, P967, DOI 10.3201/eid2605.190994; Yan J, 2018, P NATL ACAD SCI USA, V115, P1081, DOI 10.1073/pnas.1716561115; Yee T. W, 2016, VECTOR GEN LINEAR AD	23	1161	1182	37	151	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	MAY	2020	26	5					676	680		10.1038/s41591-020-0843-2	http://dx.doi.org/10.1038/s41591-020-0843-2		APR 2020	5	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	LS2UV	32371934	Green Submitted, Green Accepted, Bronze			2022-12-27	WOS:000523115000001
J	Shah, PKS				Shah, Prakesh S.			Wireless monitoring in the ICU on the horizon	NATURE MEDICINE			English	Editorial Material								Wireless monitoring of vital signs in the neonatal intensive care unit enables the detection of vital signs, body movement, and vocalization.	[Shah, Prakesh S.] Mt Sinai Hosp, Dept Pediat, Toronto, ON, Canada; [Shah, Prakesh S.] Univ Toronto, Dept Pediat, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto	Shah, PKS (corresponding author), Mt Sinai Hosp, Dept Pediat, Toronto, ON, Canada.; Shah, PKS (corresponding author), Univ Toronto, Dept Pediat, Toronto, ON, Canada.	prakeshkumar.shah@sinaihealth.ca		Shah, Prakesh/0000-0002-9920-0488				Adjekum A, 2018, J MED INTERNET RES, V20, DOI 10.2196/11254; Chan GJ, 2016, B WORLD HEALTH ORGAN, V94, P130, DOI 10.2471/BLT.15.157818; Chung HU, 2020, NAT MED, V26, P418, DOI 10.1038/s41591-020-0792-9; Chung HU, 2019, SCIENCE, V363, P947, DOI 10.1126/science.aau0780; Klonoff David C, 2014, J Diabetes Sci Technol, V8, P658, DOI 10.1177/1932296814539589; O'Brien K, 2018, LANCET CHILD ADOLESC, V2, P245, DOI 10.1016/S2352-4642(18)30039-7; Poncette AS, 2019, JMIR MED INF, V7, P45, DOI 10.2196/13064; Schiavone G, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aaw5858	8	4	4	0	6	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	MAR	2020	26	3					316	317		10.1038/s41591-020-0798-3	http://dx.doi.org/10.1038/s41591-020-0798-3			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	KU0MC	32161410				2022-12-27	WOS:000519405000015
J	Goswami, S; Walle, T; Cornish, AE; Basu, S; Anandhan, S; Fernandez, I; Vence, L; Blando, J; Zhao, H; Yadav, SS; Ott, M; Kong, LY; Heimberger, AB; de Groot, J; Sepesi, B; Overman, M; Kopetz, S; Allison, JP; Pe'er, D; Sharma, P				Goswami, Sangeeta; Walle, Thomas; Cornish, Andrew E.; Basu, Sreyashi; Anandhan, Swetha; Fernandez, Irina; Vence, Luis; Blando, Jorge; Zhao, Hao; Yadav, Shalini Singh; Ott, Martina; Kong, Ling Y.; Heimberger, Amy B.; de Groot, John; Sepesi, Boris; Overman, Michael; Kopetz, Scott; Allison, James P.; Pe'er, Dana; Sharma, Padmanee			Immune profiling of human tumors identifies CD73 as a combinatorial target in glioblastoma	NATURE MEDICINE			English	Article							NIVOLUMAB; CANCER; CELLS; VISUALIZATION; ANTI-CTLA-4; MULTICENTER; IPILIMUMAB; DOCETAXEL; CARCINOMA; THERAPY	Immune checkpoint therapy with anti-CTLA-4 and anti-PD-1/PD-L1 has revolutionized the treatment of many solid tumors. However, the clinical efficacy of immune checkpoint therapy is limited to a subset of patients with specific tumor types(1,2). Multiple clinical trials with combinatorial immune checkpoint strategies are ongoing; however, the mechanistic rationale for tumor-specific targeting of immune checkpoints is elusive. To garner an insight into tumor-specific immunomodulatory targets, we analyzed 94 patients representing five different cancer types, including those that respond relatively well to immune checkpoint therapy and those that do not, such as glioblastoma multiforme, prostate cancer and colorectal cancer. Through mass cytometry and single-cell RNA sequencing, we identified a unique population of CD73(hi) macrophages in glioblastoma multiforme that persists after anti-PD-1 treatment. To test if targeting CD73 would be important for a successful combination strategy in glioblastoma multiforme, we performed reverse translational studies using CD73(-/-) mice. We found that the absence of CD73 improved survival in a murine model of glioblastoma multiforme treated with anti-CTLA-4 and anti-PD-1. Our data identified CD73 as a specific immunotherapeutic target to improve antitumor immune responses to immune checkpoint therapy in glioblastoma multiforme and demonstrate that comprehensive human and reverse translational studies can be used for rational design of combinatorial immune checkpoint strategies. Analysis of a mass cytometry dataset for different human solid tumors coupled with murine reverse translational experiments suggests that targeting CD73 could enhance the efficacy of checkpoint inhibitor therapy in glioblastoma.	[Goswami, Sangeeta; Anandhan, Swetha; Sharma, Padmanee] Univ Texas MD Anderson Canc Ctr, Dept Genitourinary Med Oncol, Houston, TX 77030 USA; [Walle, Thomas] Natl Ctr Tumor Dis, Dept Med Oncol, Heidelberg, Germany; [Walle, Thomas] German Canc Res Ctr, Clin Cooperat Unit Mol Radiooncol, Heidelberg, Germany; [Cornish, Andrew E.; Pe'er, Dana] Sloan Kettering Inst, Computat & Syst Biol Program, New York, NY USA; [Cornish, Andrew E.] NYU, Sch Med, Dept Med, New York, NY USA; [Basu, Sreyashi; Fernandez, Irina; Vence, Luis; Blando, Jorge; Zhao, Hao; Yadav, Shalini Singh; Allison, James P.; Sharma, Padmanee] Univ Texas MD Anderson Canc Ctr, Immunotherapy Platform, Houston, TX 77030 USA; [Ott, Martina; Kong, Ling Y.; Heimberger, Amy B.] Univ Texas MD Anderson Canc Ctr, Dept Neurosurg, Houston, TX 77030 USA; [de Groot, John] Univ Texas MD Anderson Canc Ctr, Dept Neurooncol, Houston, TX 77030 USA; [Sepesi, Boris] Univ Texas MD Anderson Canc Ctr, Dept Thorac & Cardiovasc Surg, Houston, TX 77030 USA; [Overman, Michael; Kopetz, Scott] Univ Texas MD Anderson Canc Ctr, Dept Gastrointestinal Med Oncol, Houston, TX 77030 USA; [Allison, James P.; Sharma, Padmanee] Univ Texas MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Memorial Sloan Kettering Cancer Center; New York University; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Sharma, P (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Genitourinary Med Oncol, Houston, TX 77030 USA.; Sharma, P (corresponding author), Univ Texas MD Anderson Canc Ctr, Immunotherapy Platform, Houston, TX 77030 USA.; Sharma, P (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77030 USA.	padsharma@mdanderson.org	Kopetz, Scott/AAC-1387-2019; Walle, Thomas/AHB-1054-2022	Kopetz, Scott/0000-0001-9647-3416; Walle, Thomas/0000-0003-4835-955X; Anandhan, Swetha/0000-0001-9187-7921; Goswami, Sangeeta/0000-0001-9201-4503	National Institutes of Health/National Cancer Institute [CA1208113, P30CA016672]	National Institutes of Health/National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank the entire Immunotherapy Platform team at the MD Anderson Cancer Center for assistance in obtaining patient samples and processing them for CyTOF, immunofluorescence and gene expression analysis. We thank F. Gherardini at The Parker Institute for Cancer Immunotherapy for his expert advice with normalization of CyTOF data and J. Zhang and S. Meena Natarajan for technical assistance with the murine experiments. This work was supported by philanthropic contributions to the University of Texas MD Anderson Cancer Center Glioblastoma Moon Shot and Lung Cancer Moon Shot Program and by the National Institutes of Health/National Cancer Institute (award no. CA1208113 to A.B.H. and no. P30CA016672 to B.S.) and used the Tissue Biospecimen and Pathology Resource. P.S. is a member of the Parker Institute for Cancer Immunotherapy and the codirector of the Parker Institute for Cancer Immunotherapy at the MD Anderson Cancer Center.	Amir ED, 2013, NAT BIOTECHNOL, V31, P545, DOI 10.1038/nbt.2594; Andrews LP, 2017, IMMUNOL REV, V276, P80, DOI 10.1111/imr.12519; Antonio L, 2017, DRUG DISCOV TODAY, V22, P1686, DOI 10.1016/j.drudis.2017.06.005; Antonioli L, 2013, TRENDS MOL MED, V19, P355, DOI 10.1016/j.molmed.2013.03.005; Azambuja JH, 2020, MOL NEUROBIOL, V57, P635, DOI 10.1007/s12035-019-01730-6; Azambuja JH, 2019, MOL NEUROBIOL, V56, P3260, DOI 10.1007/s12035-018-1240-4; Azizi E, 2018, CELL, V174, P1293, DOI 10.1016/j.cell.2018.05.060; Borghaei H, 2015, NEW ENGL J MED, V373, P1627, DOI 10.1056/NEJMoa1507643; Cannarile MA, 2017, J IMMUNOTHER CANCER, V5, DOI 10.1186/s40425-017-0257-y; Chang AL, 2016, CANCER RES, V76, P5671, DOI 10.1158/0008-5472.CAN-16-0144; Chen ZH, 2017, CANCER RES, V77, P2266, DOI 10.1158/0008-5472.CAN-16-2310; Chevrier S, 2017, CELL, V169, P736, DOI 10.1016/j.cell.2017.04.016; Chew V, 2017, P NATL ACAD SCI USA, V114, pE5900, DOI 10.1073/pnas.1706559114; Cloughesy TF, 2019, NAT MED, V25, P477, DOI 10.1038/s41591-018-0337-7; Finck R, 2013, CYTOM PART A, V83A, P483, DOI 10.1002/cyto.a.22271; Gao JJ, 2016, CELL, V167, P397, DOI 10.1016/j.cell.2016.08.069; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Pham K, 2012, J NEUROIMMUNOL, V246, P10, DOI 10.1016/j.jneuroim.2012.02.009; Kwon ED, 2014, LANCET ONCOL, V15, P700, DOI 10.1016/S1470-2045(14)70189-5; Lavin Y, 2017, CELL, V169, P750, DOI 10.1016/j.cell.2017.04.014; Le DT, 2017, SCIENCE, V357, P409, DOI 10.1126/science.aan6733; Levine JH, 2015, CELL, V162, P184, DOI 10.1016/j.cell.2015.05.047; Motzer RJ, 2018, NEW ENGL J MED, V378, P1277, DOI 10.1056/NEJMoa1712126; Motzer RJ, 2015, NEW ENGL J MED, V373, P1803, DOI 10.1056/NEJMoa1510665; Muller S, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1362-4; Papadopoulos KP, 2017, CLIN CANCER RES, V23, P5703, DOI 10.1158/1078-0432.CCR-16-3261; Perrot I, 2019, CELL REP, V27, P2411, DOI 10.1016/j.celrep.2019.04.091; Pfannenstiel LW, 2019, CANCER IMMUNOL RES, V7, P510, DOI 10.1158/2326-6066.CIR-18-0054; Pyonteck SM, 2013, NAT MED, V19, P1264, DOI 10.1038/nm.3337; Saito T, 2016, NAT MED, V22, P679, DOI 10.1038/nm.4086; Schalper KA, 2019, NAT MED, V25, P470, DOI 10.1038/s41591-018-0339-5; Sharma P, 2017, LANCET ONCOL, V18, P312, DOI 10.1016/S1470-2045(17)30065-7; Sharma P, 2015, CELL, V161, P205, DOI 10.1016/j.cell.2015.03.030; Sharma P, 2015, SCIENCE, V348, P56, DOI 10.1126/science.aaa8172; Stack EC, 2014, METHODS, V70, P46, DOI 10.1016/j.ymeth.2014.08.016; Stagg J, 2011, CANCER RES, V71, P2892, DOI 10.1158/0008-5472.CAN-10-4246; Takenaka MC, 2019, NAT NEUROSCI, V22, P729, DOI 10.1038/s41593-019-0370-y; Valsecchi ME, 2015, NEW ENGL J MED, V373, P1270, DOI [10.1056/NEJMoa1504030, 10.1056/NEJMc1509660]; van Dijk D, 2018, CELL, V174, P716, DOI 10.1016/j.cell.2018.05.061; Van Gassen S, 2015, CYTOM PART A, V87A, P636, DOI 10.1002/cyto.a.22625; Wang Y, 2016, ONCOL REP, V36, P3522, DOI 10.3892/or.2016.5171; Wei J, 2016, NEURO-ONCOLOGY, V18, P639, DOI 10.1093/neuonc/nov292; Wei SC, 2017, CELL, V170, P1120, DOI 10.1016/j.cell.2017.07.024; Yan A, 2019, J NEUROSCI, V39, P4387, DOI 10.1523/JNEUROSCI.1118-18.2019; Zunder ER, 2015, NAT PROTOC, V10, P316, DOI 10.1038/nprot.2015.020	45	149	151	12	81	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JAN	2020	26	1					39	+		10.1038/s41591-019-0694-x	http://dx.doi.org/10.1038/s41591-019-0694-x			22	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	KG3GZ	31873309	Green Accepted			2022-12-27	WOS:000509831900024
J	Stower, H				Stower, Hannah			Chemotherapy signatures	NATURE MEDICINE			English	Editorial Material												h.stower@us.nature.com							0	0	0	2	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JAN	2020	26	1					21	21		10.1038/s41591-019-0741-7	http://dx.doi.org/10.1038/s41591-019-0741-7			1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	KG3GZ	31932791	Bronze			2022-12-27	WOS:000509831900015
J	Stower, H				Stower, Hannah			A monthly oral contraceptive	NATURE MEDICINE			English	Editorial Material												h.stower@us.nature.com							0	0	0	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JAN	2020	26	1					21	21		10.1038/s41591-019-0745-3	http://dx.doi.org/10.1038/s41591-019-0745-3			1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	KG3GZ	31932794	Bronze			2022-12-27	WOS:000509831900014
J	Zhai, B; Ola, M; Rolling, T; Tosini, NL; Joshowitz, S; Littmann, ER; Amoretti, LA; Fontana, E; Wright, RJ; Miranda, E; Veelken, CA; Morjaria, SM; Peled, JU; van den Brink, MRM; Babady, NE; Butler, G; Taur, Y; Hohl, TM				Zhai, Bing; Ola, Mihaela; Rolling, Thierry; Tosini, Nicholas L.; Joshowitz, Sari; Littmann, Eric R.; Amoretti, Luigi A.; Fontana, Emily; Wright, Roberta J.; Miranda, Edwin; Veelken, Charlotte A.; Morjaria, Sejal M.; Peled, Jonathan U.; van den Brink, Marcel R. M.; Babady, N. Esther; Butler, Geraldine; Taur, Ying; Hohl, Tobias M.			High-resolution mycobiota analysis reveals dynamic intestinal translocation preceding invasive candidiasis	NATURE MEDICINE			English	Article							CLOSTRIDIUM-DIFFICILE; FUNGAL-INFECTIONS; COMMENSAL FUNGI; CANDIDEMIA; MICROBIOTA; TRANSPLANTATION; SUSCEPTIBILITY; PARAPSILOSIS; CASPOFUNGIN; FLUCONAZOLE	The intestinal microbiota is a complex community of bacteria, archaea, viruses, protists and fungi(1,2). Although the composition of bacterial constituents has been linked to immune homeostasis and infectious susceptibility(3-7), the role of non-bacterial constituents and cross-kingdom microbial interactions in these processes is poorly understood(2,8). Fungi represent a major cause of infectious morbidity and mortality in immunocompromised individuals, although the relationship of intestinal fungi (that is, the mycobiota) with fungal bloodstream infections remains undefined(9). We integrated an optimized bioinformatics pipeline with high-resolution mycobiota sequencing and comparative genomic analyses of fecal and blood specimens from recipients of allogeneic hematopoietic cell transplant. Patients with Candida bloodstream infection experienced a prior marked intestinal expansion of pathogenic Candida species; this expansion consisted of a complex dynamic between multiple species and subspecies with a stochastic translocation pattern into the bloodstream. The intestinal expansion of pathogenic Candida spp. was associated with a substantial loss in bacterial burden and diversity, particularly in the anaerobes. Thus, simultaneous analysis of intestinal fungi and bacteria identifies dysbiosis states across kingdoms that may promote fungal translocation and facilitate invasive disease. These findings support microbiota-driven approaches to identify patients at risk of fungal bloodstream infections for pre-emptive therapeutic intervention. Expansion of pathogenic Candida species coupled with bacterial dysbiosis in the gut precedes Candida bloodstream infections in hematopoietic cell transplant recipients.	[Zhai, Bing; Rolling, Thierry; Tosini, Nicholas L.; Joshowitz, Sari; Amoretti, Luigi A.; Fontana, Emily; Wright, Roberta J.; Miranda, Edwin; Veelken, Charlotte A.; Morjaria, Sejal M.; Babady, N. Esther; Taur, Ying; Hohl, Tobias M.] Mem Sloan Kettering Canc Ctr, Dept Med, Infect Dis Serv, New York, NY 10021 USA; [Ola, Mihaela; Butler, Geraldine] Univ Coll Dublin, Conway Inst, Sch Biomol & Biomed Sci, Dublin, Ireland; [Rolling, Thierry] Univ Med Ctr Hamburg Eppendorf, Dept Med 1, Div Infect Dis, Hamburg, Germany; [Littmann, Eric R.; van den Brink, Marcel R. M.; Hohl, Tobias M.] Mem Sloan Kettering Canc Ctr, Immunol Program, Sloan Kettering Inst, 1275 York Ave, New York, NY 10021 USA; [Miranda, Edwin; Babady, N. Esther] Mem Sloan Kettering Canc Ctr, Clin Microbiol Serv, Dept Lab Med, 1275 York Ave, New York, NY 10021 USA; [Morjaria, Sejal M.; Peled, Jonathan U.; van den Brink, Marcel R. M.; Taur, Ying; Hohl, Tobias M.] Weill Cornell Med Coll, New York, NY 10065 USA; [Peled, Jonathan U.; van den Brink, Marcel R. M.] Mem Sloan Kettering Canc Ctr, Dept Med, Adult Bone Marrow Transplant Serv, 1275 York Ave, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center; University College Dublin; University of Hamburg; University Medical Center Hamburg-Eppendorf; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Cornell University; Memorial Sloan Kettering Cancer Center	Taur, Y; Hohl, TM (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Med, Infect Dis Serv, New York, NY 10021 USA.; Hohl, TM (corresponding author), Mem Sloan Kettering Canc Ctr, Immunol Program, Sloan Kettering Inst, 1275 York Ave, New York, NY 10021 USA.; Taur, Y; Hohl, TM (corresponding author), Weill Cornell Med Coll, New York, NY 10065 USA.	taury@mskcc.org; hohlt@mskcc.org	van den Brink, Marcel R. M./HGB-9434-2022	Rolling, Thierry/0000-0002-0277-5067; Butler, Geraldine/0000-0002-1770-5301; van den Brink, Marcel/0000-0003-0696-4401; Zhai, Bing/0000-0001-6571-7465; Peled, Jonathan/0000-0002-4029-7625; Amoretti, Luigi/0000-0002-4625-5119	Geoffrey Beene Foundation Award; Burroughs Wellcome Fund Investigator in the Pathogenesis of Infectious Diseases Award; National Institutes of Health [P30 CA008748, R01 AI093808, R01 AI 139632, R01 AI137269, K08HL143189]; Deutsche Forschungsgemeinschaft (German Research Foundation) [RO5328/2-1]; Science Foundation Ireland [12/IA/1343]	Geoffrey Beene Foundation Award; Burroughs Wellcome Fund Investigator in the Pathogenesis of Infectious Diseases Award; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft (German Research Foundation)(German Research Foundation (DFG)); Science Foundation Ireland(Science Foundation IrelandEuropean Commission)	We thank E. Pamer, I. Iliev, J. Xavier, J. Heitman and R. Rao for discussions, I. Leiner, M. Gjonbalaj, R. Seok and MSKCC Integrated Genomics Operation Facility for technical assistance. The studies were supported by a Geoffrey Beene Foundation Award (to T.M.H.), a Burroughs Wellcome Fund Investigator in the Pathogenesis of Infectious Diseases Award (to T.M.H.), National Institutes of Health grants (nos. P30 CA008748 to the MSKCC, R01 AI093808 to T.M.H., R01 AI 139632 to T.M.H., R01 AI137269 to Y.T. and K08HL143189 to J.U.P.), a Deutsche Forschungsgemeinschaft (German Research Foundation) fellowship grant (no. RO5328/2-1 to T.R.) and the Science Foundation Ireland (grant no. 12/IA/1343 to G.B.).	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Blander JM, 2017, NAT IMMUNOL, V18, P851, DOI 10.1038/ni.3780; Branco J, 2017, CLIN MICROBIOL INFEC, V23, DOI 10.1016/j.cmi.2017.02.002; Butler G, 2009, NATURE, V459, P657, DOI 10.1038/nature08064; Callahan BJ, 2016, NAT METHODS, V13, P581, DOI [10.1038/NMETH.3869, 10.1038/nmeth.3869]; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Cesaro S, 2018, CLIN INFECT DIS, V67, P564, DOI 10.1093/cid/ciy150; Vercher MD, 2011, INT J MED MICROBIOL, V301, P531, DOI 10.1016/j.ijmm.2011.02.001; Dubin KA, 2019, INFECT IMMUN, V87, DOI 10.1128/IAI.00102-19; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; Fan D, 2015, NAT MED, V21, P808, DOI 10.1038/nm.3871; Forrest GN, 2008, J INFECTION, V56, P126, DOI 10.1016/j.jinf.2007.10.014; GOODMAN JL, 1992, NEW ENGL J MED, V326, P845, DOI 10.1056/NEJM199203263261301; Haak BW, 2018, BLOOD, V131, P2978, DOI 10.1182/blood-2018-01-828996; Hubley R., 2013, REPEATMASKER OPEN 40; Keith JW, 2019, J EXP MED, V216, P10, DOI 10.1084/jem.20180399; Kim SG, 2019, NATURE, V572, P665, DOI 10.1038/s41586-019-1501-z; Kohler JR, 2015, CSH PERSPECT MED, V5, DOI 10.1101/cshperspect.a019273; Koh AY, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006342; Lee YJ, 2017, J INFECT DIS, V215, P1117, DOI 10.1093/infdis/jix011; Lewis BB, 2017, ANNU REV MICROBIOL, V71, P157, DOI 10.1146/annurev-micro-090816-093549; Lischer HEL, 2014, MOL BIOL EVOL, V31, P817, DOI 10.1093/molbev/mst271; Liu CM, 2012, BMC MICROBIOL, V12, DOI [10.1186/1471-2180-12-56, 10.1186/1471-2180-12-255]; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; McMurdie PJ, 2012, BIOCOMPUT-PAC SYM, P235; Nash AK, 2017, MICROBIOME, V5, DOI 10.1186/s40168-017-0373-4; Nucci M, 2001, CLIN INFECT DIS, V33, P1959, DOI 10.1086/323759; Paterson MJ, 2017, CURR OPIN MICROBIOL, V40, P131, DOI 10.1016/j.mib.2017.11.012; Pryszcz LP, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005626; Pryszcz LP, 2013, GENOME BIOL EVOL, V5, P2382, DOI 10.1093/gbe/evt185; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Riccombeni A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035750; Richard ML, 2019, NAT REV GASTRO HEPAT, V16, P331, DOI 10.1038/s41575-019-0121-2; Rybak JM, 2017, ANTIMICROB AGENTS CH, V61, DOI 10.1128/AAC.00651-17; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schroder MS, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006404; Sipsas NV, 2009, CANCER-AM CANCER SOC, V115, P4745, DOI 10.1002/cncr.24507; SLAVIN MA, 1995, J INFECT DIS, V171, P1545, DOI 10.1093/infdis/171.6.1545; Snyder GM, 2019, CURR INFECT DIS REP, V21, DOI 10.1007/s11908-019-0675-8; Srivastava A, 2017, CELL MICROBIOL, V19, DOI 10.1111/cmi.12767; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Tamburini FB, 2018, NAT MED, V24, P1809, DOI 10.1038/s41591-018-0202-8; Tatusova T, 2015, NUCLEIC ACIDS RES, V43, pD599, DOI 10.1093/nar/gku1062; Taur Y, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aap9489; Taur Y, 2016, VIRULENCE, V7, P930, DOI 10.1080/21505594.2016.1250982; Taur Y, 2012, CLIN INFECT DIS, V55, P905, DOI 10.1093/cid/cis580; Turner SA, 2014, CSH PERSPECT MED, V4, DOI 10.1101/cshperspect.a019778; Ubeda C, 2010, J CLIN INVEST, V120, P4332, DOI 10.1172/JCI43918; Underhill DM, 2014, NAT REV IMMUNOL, V14, P405, DOI 10.1038/nri3684; Wang E, 2015, J ANTIMICROB CHEMOTH, V70, P2362, DOI 10.1093/jac/dkv087; Weiner LM, 2016, INFECT CONT HOSP EP, V37, P1288, DOI 10.1017/ice.2016.174; Whaley SG, 2016, ANTIMICROB AGENTS CH, V60, P6060, DOI 10.1128/AAC.00732-16; White PL, 2003, J MED MICROBIOL, V52, P229, DOI 10.1099/jmm.0.05049-0; Zhao JC, 2014, SCI REP-UK, V4, DOI 10.1038/srep04345	55	96	96	3	29	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	JAN	2020	26	1					59	+		10.1038/s41591-019-0709-7	http://dx.doi.org/10.1038/s41591-019-0709-7			18	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	KG3GZ	31907459	Green Accepted			2022-12-27	WOS:000509831900027
J	Haak, BW; Wiersinga, WJ				Haak, Bastiaan W.; Wiersinga, W. Joost			MICROBIOME The differing roles of lactobacilli in critical illness	NATURE MEDICINE			English	Editorial Material								New findings regarding the risks of over-the-counter probiotics in critically ill patients underscore the need for microbiota-targeted therapies that are based on efficacy in a disease- and host-specific context.	[Haak, Bastiaan W.; Wiersinga, W. Joost] Univ Amsterdam, Amsterdam Univ Med Ctr, Locat AMC, CEMM, Amsterdam, Netherlands; [Wiersinga, W. Joost] Univ Amsterdam, Amsterdam Univ Med Ctr, Locat AMC, Dept Internal Med,Div Infect Dis, Amsterdam, Netherlands	University of Amsterdam; University of Amsterdam	Wiersinga, WJ (corresponding author), Univ Amsterdam, Amsterdam Univ Med Ctr, Locat AMC, CEMM, Amsterdam, Netherlands.; Wiersinga, WJ (corresponding author), Univ Amsterdam, Amsterdam Univ Med Ctr, Locat AMC, Dept Internal Med,Div Infect Dis, Amsterdam, Netherlands.	W.J.Wiersinga@amsterdamumc.nl		Wiersinga, Willem/0000-0003-2277-1343				Buffie CG, 2015, NATURE, V517, P205, DOI 10.1038/nature13828; Depommier C, 2019, NAT MED, V25, P1096, DOI 10.1038/s41591-019-0495-2; Dermyshi E, 2017, NEONATOLOGY, V112, P9, DOI 10.1159/000454668; Didari T, 2014, EXPERT OPIN DRUG SAF, V13, P227, DOI 10.1517/14740338.2014.872627; Kim SG, 2019, NATURE, V572, P665, DOI 10.1038/s41586-019-1501-z; Manzanares W, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1434-y; Panigrahi P, 2017, NATURE, V548, P407, DOI 10.1038/nature23480; Salminen MK, 2004, CLIN INFECT DIS, V38, P62, DOI 10.1086/380455; Singer JR, 2019, NAT MED, V25, P1772, DOI 10.1038/s41591-019-0640-y; Suez J, 2019, NAT MED, V25, P716, DOI 10.1038/s41591-019-0439-x; Varankovich NV, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00685; Yelin I, 2019, NAT MED, V25, P1728, DOI 10.1038/s41591-019-0626-9	12	3	3	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2019	25	11					1651	1653		10.1038/s41591-019-0623-z	http://dx.doi.org/10.1038/s41591-019-0623-z			4	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	JT2KI	31700188	Bronze			2022-12-27	WOS:000500824300018
J	Houlahan, KE; Shiah, YJ; Gusev, A; Yuan, JP; Ahmed, M; Shetty, A; Ramanand, SG; Yao, CQ; Bell, C; O'Connor, E; Huang, V; Fraser, M; Heisler, LE; Livingstone, J; Yamaguchi, TN; Rouette, A; Foucal, A; Espiritu, SMG; Sinha, A; Sam, M; Timms, L; Johns, J; Wong, A; Murison, A; Orain, M; Picard, V; Hovington, H; Bergeron, A; Lacombe, L; Lupien, M; Fradet, Y; Tetu, B; McPherson, JD; Pasaniuc, B; Kislinger, T; Chua, MLK; Pomerantz, MM; van der Kwast, T; Freedman, ML; Mani, RS; He, HH; Bristow, RG; Boutros, PC				Houlahan, Kathleen E.; Shiah, Yu-Jia; Gusev, Alexander; Yuan, Jiapei; Ahmed, Musaddeque; Shetty, Anamay; Ramanand, Susmita G.; Yao, Cindy Q.; Bell, Connor; O'Connor, Edward; Huang, Vincent; Fraser, Michael; Heisler, Lawrence E.; Livingstone, Julie; Yamaguchi, Takafumi N.; Rouette, Alexandre; Foucal, Adrien; Espiritu, Shadrielle Melijah G.; Sinha, Ankit; Sam, Michelle; Timms, Lee; Johns, Jeremy; Wong, Ada; Murison, Alex; Orain, Michele; Picard, Valerie; Hovington, Helene; Bergeron, Alain; Lacombe, Louis; Lupien, Mathieu; Fradet, Yves; Tetu, Bernard; McPherson, John D.; Pasaniuc, Bogdan; Kislinger, Thomas; Chua, Melvin L. K.; Pomerantz, Mark M.; van der Kwast, Theodorus; Freedman, Matthew L.; Mani, Ram S.; He, Housheng H.; Bristow, Robert G.; Boutros, Paul C.			Genome-wide germline correlates of the epigenetic landscape of prostate cancer	NATURE MEDICINE			English	Article							SUSCEPTIBILITY LOCI; DNA METHYLATION; ANDROGEN RECEPTOR; TUMOR-SUPPRESSOR; GENETIC-VARIANTS; ASSOCIATION; POLYCOMB; IDENTIFICATION; TRANSCRIPTION; PROGRESSION	Oncogenesis is driven by germline, environmental and stochastic factors. It is unknown how these interact to produce the molecular phenotypes of tumors. We therefore quantified the influence of germline polymorphisms on the somatic epigenome of 589 localized prostate tumors. Predisposition risk loci influence a tumor's epigenome, uncovering a mechanism for cancer susceptibility. We identified and validated 1,178 loci associated with altered methylation in tumoral but not nonmalignant tissue. These tumor methylation quantitative trait loci influence chromatin structure, as well as RNA and protein abundance. One prominent tumor methylation quantitative trait locus is associated with AKT1 expression and is predictive of relapse after definitive local therapy in both discovery and validation cohorts. These data reveal intricate crosstalk between the germ line and the epigenome of primary tumors, which may help identify germline biomarkers of aggressive disease to aid patient triage and optimize the use of more invasive or expensive diagnostic assays.	[Houlahan, Kathleen E.; Shiah, Yu-Jia; Yao, Cindy Q.; Huang, Vincent; Fraser, Michael; Heisler, Lawrence E.; Livingstone, Julie; Yamaguchi, Takafumi N.; Rouette, Alexandre; Foucal, Adrien; Espiritu, Shadrielle Melijah G.; Sam, Michelle; Timms, Lee; Johns, Jeremy; Wong, Ada; Lupien, Mathieu; McPherson, John D.; Boutros, Paul C.] Ontario Inst Canc Res, Toronto, ON, Canada; [Houlahan, Kathleen E.; Sinha, Ankit; Lupien, Mathieu; Kislinger, Thomas; He, Housheng H.; Bristow, Robert G.; Boutros, Paul C.] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada; [Houlahan, Kathleen E.; Boutros, Paul C.] Vector Inst, Toronto, ON, Canada; [Gusev, Alexander; Shetty, Anamay] Dana Farber Canc Inst, Div Populat Sci, Boston, MA 02115 USA; [Gusev, Alexander; Shetty, Anamay] Harvard Med Sch, Boston, MA 02115 USA; [Gusev, Alexander] Harvard Med Sch, Brigham & Womens Hosp, Div Genet, Boston, MA 02115 USA; [Yuan, Jiapei; Ramanand, Susmita G.; Mani, Ram S.] Univ Texas Southwestern Med Ctr Dallas, Dept Pathol, Dallas, TX 75390 USA; [Ahmed, Musaddeque; Sinha, Ankit; Murison, Alex; Lupien, Mathieu; Kislinger, Thomas; Chua, Melvin L. K.; van der Kwast, Theodorus; He, Housheng H.; Bristow, Robert G.] Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON, Canada; [Shetty, Anamay] Univ Cambridge, Cambridge, England; [Bell, Connor; O'Connor, Edward; Pomerantz, Mark M.; Freedman, Matthew L.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Orain, Michele; Tetu, Bernard] Univ Laval, CHU Quebec, Ctr Rech, Dept Pathol, Quebec City, PQ, Canada; [Picard, Valerie; Hovington, Helene; Bergeron, Alain; Lacombe, Louis; Fradet, Yves] Univ Laval, CHU Quebec, Ctr Rech, Div Urol, Quebec City, PQ, Canada; [Pasaniuc, Bogdan] Univ Calif Los Angeles, Dept Computat Med, Los Angeles, CA USA; [Pasaniuc, Bogdan] Univ Calif Los Angeles, Dept Pathol & Lab Med, Los Angeles, CA USA; [Pasaniuc, Bogdan; Boutros, Paul C.] Univ Calif Los Angeles, Dept Human Genet, Los Angeles, CA 90095 USA; [Chua, Melvin L. K.] Natl Canc Ctr Singapore, Div Radiat Oncol, Singapore, Singapore; [van der Kwast, Theodorus] Univ Hlth Network, Lab Med Program, Toronto, ON, Canada; [Freedman, Matthew L.] Eli & Edythe L Broad Inst, Cambridge, MA USA; [Freedman, Matthew L.] Dana Farber Canc Inst, Ctr Funct Canc Epigenet, Boston, MA 02115 USA; [Bristow, Robert G.] Univ Toronto, Dept Radiat Oncol, Toronto, ON, Canada; [Bristow, Robert G.] Univ Manchester, Div Canc Sci, Fac Biol Hlth & Med, Manchester, Lancs, England; [Bristow, Robert G.] Christie NHS Fdn Trust, Manchester, Lancs, England; [Bristow, Robert G.] Canc Res UK Manchester Inst, Manchester, Lancs, England; [Bristow, Robert G.] Manchester Canc Res Ctr, Manchester, Lancs, England; [Boutros, Paul C.] Univ Toronto, Dept Pharmacol & Toxicol, Toronto, ON, Canada; [Boutros, Paul C.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Urol, Los Angeles, CA 90095 USA; [Boutros, Paul C.] Univ Calif Los Angeles, David Geffen Sch Med, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90095 USA; [Boutros, Paul C.] Univ Calif Los Angeles, Inst Precis Hlth, Los Angeles, CA 90095 USA	Ontario Institute for Cancer Research; University of Toronto; University Toronto Affiliates; University of Toronto; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Cambridge; Harvard University; Dana-Farber Cancer Institute; Laval University; Laval University; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; National Cancer Centre Singapore (NCCS); University of Toronto; University Toronto Affiliates; University Health Network Toronto; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Dana-Farber Cancer Institute; University of Toronto; University of Manchester; Christie NHS Foundation Trust; Cancer Research UK; University of Manchester; University of Toronto; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles	Boutros, PC (corresponding author), Ontario Inst Canc Res, Toronto, ON, Canada.; Bristow, RG; Boutros, PC (corresponding author), Univ Toronto, Dept Med Biophys, Toronto, ON, Canada.; Boutros, PC (corresponding author), Vector Inst, Toronto, ON, Canada.; Bristow, RG (corresponding author), Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON, Canada.; Boutros, PC (corresponding author), Univ Calif Los Angeles, Dept Human Genet, Los Angeles, CA 90095 USA.; Bristow, RG (corresponding author), Univ Toronto, Dept Radiat Oncol, Toronto, ON, Canada.; Bristow, RG (corresponding author), Univ Manchester, Div Canc Sci, Fac Biol Hlth & Med, Manchester, Lancs, England.; Bristow, RG (corresponding author), Christie NHS Fdn Trust, Manchester, Lancs, England.; Bristow, RG (corresponding author), Canc Res UK Manchester Inst, Manchester, Lancs, England.; Bristow, RG (corresponding author), Manchester Canc Res Ctr, Manchester, Lancs, England.; Boutros, PC (corresponding author), Univ Toronto, Dept Pharmacol & Toxicol, Toronto, ON, Canada.; Boutros, PC (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Urol, Los Angeles, CA 90095 USA.; Boutros, PC (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90095 USA.; Boutros, PC (corresponding author), Univ Calif Los Angeles, Inst Precis Hlth, Los Angeles, CA 90095 USA.	robert.bristow@manchester.ac.uk; pboutros@mednet.ucla.edu	Kislinger, Thomas/A-5934-2008; Chua, Melvin LK/ABG-6045-2020; McPherson, John/D-2633-2017	Chua, Melvin LK/0000-0002-1648-1473; Bristow, Robert/0000-0002-8553-9544; Bergeron, Alain/0000-0002-2875-0773; Yamaguchi, Takafumi/0000-0003-1082-3871; Yuan, Jiapei/0000-0002-9381-8623; Kislinger, Thomas/0000-0003-3525-5540; Fradet, Yves/0000-0002-7581-2500; Mani, Ram/0000-0003-3552-7905; McPherson, John/0000-0001-8049-9347; Lacombe, Louis/0000-0003-4811-0308; Shetty, Anamay/0000-0003-0564-7236; Picard, Valerie/0000-0002-8414-863X	Movember through Prostate Cancer Canada; Ontario Institute for Cancer Research - Government of Ontario; Princess Margaret Cancer Centre Foundation; Radiation Medicine Program Academic Enrichment Fund; Canadian Cancer Society Research Scientist Award; Prostate Cancer Canada; Movember Foundation [RS2014-01, RS2014-02, RS-2016-01]; Terry Fox Research Institute New Investigator Award; CIHR New Investigator Award; CIHR operating grant [142246]; CCSRI grant [703800]; Genome Canada through a Large-Scale Applied Project contract; CIHR Vanier Fellowship; Prostate Cancer Research Program Impact Award from the US Department of Defense [W81XWH-17-1-0675]; Individual Investigator Research Award from CPRIT [RP190454]; NIH [5R01CA193910]; Challenge Award from the Prostate Cancer Foundation; H.L. Snyder Medical Foundation; National Human Genome Research Institute [R01HG009120]; NIH/NCI [P30CA016042]; National Cancer Institute Early Detection Research Network [1U01CA214194-01]; NATIONAL CANCER INSTITUTE [U01CA214194] Funding Source: NIH RePORTER	Movember through Prostate Cancer Canada; Ontario Institute for Cancer Research - Government of Ontario; Princess Margaret Cancer Centre Foundation(University of Toronto); Radiation Medicine Program Academic Enrichment Fund; Canadian Cancer Society Research Scientist Award; Prostate Cancer Canada; Movember Foundation; Terry Fox Research Institute New Investigator Award; CIHR New Investigator Award(Canadian Institutes of Health Research (CIHR)); CIHR operating grant(Canadian Institutes of Health Research (CIHR)); CCSRI grant; Genome Canada through a Large-Scale Applied Project contract(Genome Canada); CIHR Vanier Fellowship(Canadian Institutes of Health Research (CIHR)); Prostate Cancer Research Program Impact Award from the US Department of Defense; Individual Investigator Research Award from CPRIT; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Challenge Award from the Prostate Cancer Foundation; H.L. Snyder Medical Foundation; National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Cancer Institute Early Detection Research Network(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors thank all members of the Boutros laboratory, as well as K. Kron and A. Meng, for helpful suggestions and support. The results described here are based in part on data generated by the TCGA Research Network (http://cancergenome.nih.gov/).This study was conducted with the support of Movember through Prostate Cancer Canada and with the additional support of the Ontario Institute for Cancer Research, funded by the Government of Ontario. We thank the Princess Margaret Cancer Centre Foundation and Radiation Medicine Program Academic Enrichment Fund for support (to R.G.B.). R. G. B. is the recipient of a Canadian Cancer Society Research Scientist Award. This work was supported by Prostate Cancer Canada and is proudly funded by the Movember Foundation (grant RS2014-01 to P.C.B.; grant RS2014-02 to M.L.; and grant RS-2016-01 to H.H.H.). P.C.B. was supported by a Terry Fox Research Institute New Investigator Award and a CIHR New Investigator Award. H.H.H. was supported by CIHR operating grant 142246 and CCSRI grant 703800. This project was supported by Genome Canada through a Large-Scale Applied Project contract to P.C.B., R. Morin and S.P. Shah. K.E.H. was supported by a CIHR Vanier Fellowship. R.S.M. acknowledges funding from the Prostate Cancer Research Program Impact Award from the US Department of Defense (W81XWH-17-1-0675), as well as the Individual Investigator Research Award from CPRIT (RP190454). M.L.F. acknowledges funding from NIH (5R01CA193910), the Challenge Award from the Prostate Cancer Foundation, and the H.L. Snyder Medical Foundation. B.P. acknowledges funding from the National Human Genome Research Institute (R01HG009120). This work was supported by the NIH/NCI under award number P30CA016042, and by an operating grant from the National Cancer Institute Early Detection Research Network (1U01CA214194-01) to P.C.B. and T.K.	Abeshouse A, 2015, CELL, V163, P1011, DOI 10.1016/j.cell.2015.10.025; Aguet F, 2017, NATURE, V550, P204, DOI 10.1038/nature24277; [Anonymous], 2016, NAT GENET, V48, P1279, DOI DOI 10.1038/ng.3643; Armenia J, 2018, NAT GENET, V50, P645, DOI 10.1038/s41588-018-0078-z; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bernstein BE, 2010, NAT BIOTECHNOL, V28, P1045, DOI 10.1038/nbt1010-1045; Bhandari V, 2019, NAT GENET, V51, P308, DOI 10.1038/s41588-018-0318-2; Boutros PC, 2015, NAT GENET, V47, P736, DOI 10.1038/ng.3315; Chang CC, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0047-8; Chen Y, 2013, NAT MED, V19, P1023, DOI 10.1038/nm.3216; Cooper CS, 2015, NAT GENET, V47, P367, DOI 10.1038/ng.3221; Cowper-Sal-lari R, 2012, NAT GENET, V44, P1191, DOI 10.1038/ng.2416; D'Amico AV, 2003, J CLIN ONCOL, V21, P2163, DOI 10.1200/JCO.2003.01.075; Delaneau O, 2012, NAT METHODS, V9, P179, DOI [10.1038/NMETH.1785, 10.1038/nmeth.1785]; Doose G, 2015, P NATL ACAD SCI USA, V112, pE5261, DOI 10.1073/pnas.1505753112; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Durbin R, 2014, BIOINFORMATICS, V30, P1266, DOI 10.1093/bioinformatics/btu014; Eeles RA, 2013, NAT GENET, V45, P385, DOI 10.1038/ng.2560; Eeles RA, 2009, NAT GENET, V41, P1116, DOI 10.1038/ng.450; Espiritu SMG, 2018, CELL, V173, P1003, DOI 10.1016/j.cell.2018.03.029; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Fisher S, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-1-r1; Fraser M, 2017, NATURE, V541, P359, DOI 10.1038/nature20788; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Garraway LA, 2013, CELL, V153, P17, DOI 10.1016/j.cell.2013.03.002; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hazelett DJ, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004102; Heyn H, 2014, CELL REP, V7, P331, DOI 10.1016/j.celrep.2014.03.016; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Jackson WC, 2018, EUR UROL, V74, P413, DOI 10.1016/j.eururo.2017.12.023; Jin HJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4972; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Karyadi DM, 2015, INT J CANCER, V136, P2166, DOI 10.1002/ijc.29241; Kim H, 2005, CANCER RES, V65, P8118, DOI 10.1158/0008-5472.CAN-04-4562; Klotz L, 2015, J CLIN ONCOL, V33, P272, DOI 10.1200/JCO.2014.55.1192; Knudson AG, 2001, NAT REV CANCER, V1, P157, DOI 10.1038/35101031; Kron KJ, 2017, NAT GENET, V49, P1336, DOI 10.1038/ng.3930; Krueger F, 2011, BIOINFORMATICS, V27, P1571, DOI 10.1093/bioinformatics/btr167; Kwon EM, 2011, CANCER EPIDEM BIOMAR, V20, P923, DOI 10.1158/1055-9965.EPI-10-0994; Lee JK, 2016, CANCER CELL, V29, P536, DOI 10.1016/j.ccell.2016.03.001; Levesque E, 2014, CLIN CANCER RES, V20, P2971, DOI 10.1158/1078-0432.CCR-13-2567; Li G., 2016, NUCLEIC ACIDS RES, V45, pe4; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liang Y, 2017, CANCER RES, V77, P5479, DOI 10.1158/0008-5472.CAN-17-0496; Lin DW, 2011, CANCER EPIDEM BIOMAR, V20, P1928, DOI 10.1158/1055-9965.EPI-11-0236; Liu JM, 2017, GENET MOL RES, V16, DOI 10.4238/gmr16019469; Matejcic M, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06863-1; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Mehrmohamadi M, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13666; Michailidou K, 2017, NATURE, V551, P92, DOI 10.1038/nature24284; Ng B, 2017, NAT NEUROSCI, V20, P1418, DOI 10.1038/nn.4632; Nik-Zainal S, 2012, CELL, V149, P979, DOI 10.1016/j.cell.2012.04.024; P'ng C, 2019, BMC BIOINFORMATICS, V20, DOI 10.1186/s12859-019-2610-2; Petersen GM, 2010, NAT GENET, V42, P224, DOI 10.1038/ng.522; Pidsley R, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-293; Reimand J, 2016, NUCLEIC ACIDS RES, V44, pW83, DOI 10.1093/nar/gkw199; Reynolds PA, 2006, J BIOL CHEM, V281, P24790, DOI 10.1074/jbc.M604175200; Rickman DS, 2012, P NATL ACAD SCI USA, V109, P9083, DOI 10.1073/pnas.1112570109; Saghafinia S, 2018, CELL REP, V25, P1066, DOI 10.1016/j.celrep.2018.09.082; Schumacher FR, 2018, NAT GENET, V50, P928, DOI 10.1038/s41588-018-0142-8; Shiah YJ, 2017, BIOINFORMATICS, V33, P3151, DOI 10.1093/bioinformatics/btx372; Sinha A, 2019, CANCER CELL, V35, P414, DOI 10.1016/j.ccell.2019.02.005; Song MQ, 2019, CANCER RES, V79, P1019, DOI 10.1158/0008-5472.CAN-18-2738; Stadler MB, 2011, NATURE, V480, P490, DOI 10.1038/nature10716; Stelloo S, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07270-2; Sutinen P, 2014, NUCLEIC ACIDS RES, V42, P8310, DOI 10.1093/nar/gku543; Suzuki H, 2004, NAT GENET, V36, P417, DOI 10.1038/ng1330; Szulkin R, 2015, CANCER EPIDEM BIOMAR, V24, P1796, DOI 10.1158/1055-9965.EPI-15-0543; Taberlay PC, 2014, GENOME RES, V24, P1421, DOI 10.1101/gr.163485.113; Tan PY, 2012, MOL CELL BIOL, V32, P399, DOI 10.1128/MCB.05958-11; Taylor RA, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms13671; Tomasetti C, 2017, SCIENCE, V355, P1330, DOI 10.1126/science.aaf9011; Tomlinson IPM, 2008, NAT GENET, V40, P623, DOI 10.1038/ng.111; van de Geijn B, 2015, NAT METHODS, V12, P1061, DOI [10.1038/NMETH.3582, 10.1038/nmeth.3582]; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Wang D, 2011, NATURE, V474, P390, DOI 10.1038/nature10006; Wang SH, 2016, CANCER LETT, V380, P122, DOI 10.1016/j.canlet.2016.06.019; Whitington T, 2016, NAT GENET, V48, P387, DOI 10.1038/ng.3523; Xu KX, 2012, SCIENCE, V338, P1465, DOI 10.1126/science.1227604; Yi JM, 2012, TUMOR BIOL, V33, P363, DOI 10.1007/s13277-011-0302-2; Yi JM, 2011, CLIN CANCER RES, V17, P1535, DOI 10.1158/1078-0432.CCR-10-2509; Yu JD, 2010, CANCER CELL, V17, P443, DOI 10.1016/j.ccr.2010.03.018; Zampieri M, 2012, BIOCHEM J, V441, P645, DOI 10.1042/BJ20111417; Zhang XY, 2012, GENOME RES, V22, P1437, DOI 10.1101/gr.135665.111; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	86	28	28	0	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	OCT	2019	25	10					1615	+		10.1038/s41591-019-0579-z	http://dx.doi.org/10.1038/s41591-019-0579-z			24	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	JC3GJ	31591588	Green Accepted			2022-12-27	WOS:000489166700031
J	van Dijk, N; Gil-Jimenez, A; Silina, K; Hendricksen, K; Smit, LA; de Feijter, JM; van Montfoort, ML; van Rooijen, C; Peters, D; Broeks, A; van der Poel, HG; Bruining, A; Lubeck, Y; Sikorska, K; Boellaard, TN; Kvistborg, P; Vis, DJ; Hooijberg, E; Schumacher, TN; van den Broek, M; Wessels, LFA; Blank, CU; van Rhijn, BW; van der Heijden, MS				van Dijk, Nick; Gil-Jimenez, Alberto; Silina, Karina; Hendricksen, Kees; Smit, Laura A.; de Feijter, Jeantine M.; van Montfoort, Maurits L.; van Rooijen, Charlotte; Peters, Dennis; Broeks, Annegien; van der Poel, Henk G.; Bruining, Annemarie; Lubeck, Yoni; Sikorska, Karolina; Boellaard, Thierry N.; Kvistborg, Pia; Vis, Daniel J.; Hooijberg, Erik; Schumacher, Ton N.; van den Broek, Maries; Wessels, Lodewyk F. A.; Blank, Christian U.; van Rhijn, Bas W.; van der Heijden, Michiel S.			Preoperative ipilimumab plus nivolumab in locoregionally advanced urothelial cancer: the NABUCCO trial	NATURE MEDICINE			English	Article							TERTIARY LYMPHOID STRUCTURES; CISPLATIN-INELIGIBLE PATIENTS; INVASIVE BLADDER-CANCER; SINGLE-ARM; NEOADJUVANT CHEMOTHERAPY; B-CELLS; MULTICENTER; BLOCKADE; CARCINOMA; IMMUNOTHERAPY	Preoperative immunotherapy with anti-PD1 plus anti-CTLA4 antibodies has shown remarkable pathological responses in melanoma(1)and colorectal cancer(2). In NABUCCO (ClinicalTrials.gov:), a single-arm feasibility trial, 24 patients with stage III urothelial cancer (UC) received two doses of ipilimumab and two doses of nivolumab, followed by resection. The primary endpoint was feasibility to resect within 12 weeks from treatment start. All patients were evaluable for the study endpoints and underwent resection, 23 (96%) within 12 weeks. Grade 3-4 immune-related adverse events occurred in 55% of patients and in 41% of patients when excluding clinically insignificant laboratory abnormalities. Eleven patients (46%) had a pathological complete response (pCR), meeting the secondary efficacy endpoint. Fourteen patients (58%) had no remaining invasive disease (pCR or pTisN0/pTaN0). In contrast to studies with anti-PD1/PD-L1 monotherapy, complete response to ipilimumab plus nivolumab was independent of baseline CD8(+) presence or T-effector signatures. Induction of tertiary lymphoid structures upon treatment was observed in responding patients. Our data indicate that combined CTLA-4 plus PD-1 blockade might provide an effective preoperative treatment strategy in locoregionally advanced UC, irrespective of pre-existing CD8(+)T cell activity.	[van Dijk, Nick; de Feijter, Jeantine M.; Blank, Christian U.; van der Heijden, Michiel S.] Netherlands Canc Inst, Dept Med Oncol, Amsterdam, Netherlands; [Gil-Jimenez, Alberto; Lubeck, Yoni; Vis, Daniel J.; Wessels, Lodewyk F. A.; van der Heijden, Michiel S.] Netherlands Canc Inst, Dept Mol Carcinogenesis, Amsterdam, Netherlands; [Gil-Jimenez, Alberto; Vis, Daniel J.; Schumacher, Ton N.; Wessels, Lodewyk F. A.] Oncode Inst, Utrecht, Netherlands; [Silina, Karina; van der Poel, Henk G.; van den Broek, Maries] Univ Zurich, Inst Expt Immunol, Zurich, Switzerland; [Hendricksen, Kees] Netherlands Canc Inst, Dept Urol, Amsterdam, Netherlands; [Smit, Laura A.; van Montfoort, Maurits L.; van Rooijen, Charlotte; Lubeck, Yoni; Hooijberg, Erik] Netherlands Canc Inst, Dept Pathol, Amsterdam, Netherlands; [Peters, Dennis; Broeks, Annegien] Netherlands Canc Inst, Core Facil Mol Pathol Biobanking, Amsterdam, Netherlands; [Bruining, Annemarie; Boellaard, Thierry N.] Netherlands Canc Inst, Dept Radiol, Amsterdam, Netherlands; [Sikorska, Karolina] Netherlands Canc Inst, Dept Biometr, Amsterdam, Netherlands; [Kvistborg, Pia; Schumacher, Ton N.; Blank, Christian U.] Netherlands Canc Inst, Div Mol Oncol & Immunol, Amsterdam, Netherlands; [van Rhijn, Bas W.] Univ Regensburg, Caritas St Josef Med Ctr, Dept Urol, Regensburg, Germany	Netherlands Cancer Institute; Netherlands Cancer Institute; University of Zurich; Netherlands Cancer Institute; Netherlands Cancer Institute; Netherlands Cancer Institute; Netherlands Cancer Institute; Netherlands Cancer Institute; Netherlands Cancer Institute; University of Regensburg	van der Heijden, MS (corresponding author), Netherlands Canc Inst, Dept Med Oncol, Amsterdam, Netherlands.; van der Heijden, MS (corresponding author), Netherlands Canc Inst, Dept Mol Carcinogenesis, Amsterdam, Netherlands.	ms.vd.heijden@nki.nl	Schumacher, Ton/Y-2432-2019; van den Broek, Maries/G-4128-2016	Schumacher, Ton/0000-0003-0517-8804; van den Broek, Maries/0000-0002-9489-3692; de Feijter, Jeantine/0000-0003-1398-9551; /0000-0003-0643-6676; Silina, Karina/0000-0003-3947-2710	Swiss National Science Foundation [CRSII5_177208, 310030_175565]; University of Zurich Research Priority Program 'Translational Cancer Research'; Cancer Research Center Zurich; Worldwide Cancer Research [18-0629]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); University of Zurich Research Priority Program 'Translational Cancer Research'; Cancer Research Center Zurich; Worldwide Cancer Research	We acknowledge the clinical trial data managers (C. Hagenaars and J. Kant), clinical trial nurses (A. Lechner, E. van der Laan and S. van der Kolk), the Genomics Core Facility and the Core Facility Molecular Pathology and Biobanking (I. Hofland, S. Cornelissen, L. Braaf and J. Sanders) for support, all at the Netherlands Cancer Institute. We thank B. Stegenga at Bristol-Myers Squibb. M.v.d.B. was financially supported by the Swiss National Science Foundation (CRSII5_177208 and 310030_175565), the University of Zurich Research Priority Program 'Translational Cancer Research', the Cancer Research Center Zurich and Worldwide Cancer Research (18-0629).	Abol-Enein H, 2005, EUR UROL, V48, P202, DOI 10.1016/j.eururo.2005.04.006; Amaria RN, 2018, NAT MED, V24, P1649, DOI 10.1038/s41591-018-0197-1; Ayers M, 2017, J CLIN INVEST, V127, P2930, DOI 10.1172/JCI91190; Balar AV, 2017, LANCET ONCOL, V18, P1483, DOI 10.1016/S1470-2045(17)30616-2; Balar AV, 2017, LANCET, V389, P67, DOI 10.1016/S0140-6736(16)32455-2; Bellmunt J, 2017, NEW ENGL J MED, V376, P1015, DOI 10.1056/NEJMoa1613683; Cabrita R, 2020, NATURE, V577, P561, DOI 10.1038/s41586-019-1914-8; Carthon BC, 2010, CLIN CANCER RES, V16, P2861, DOI 10.1158/1078-0432.CCR-10-0569; Chalabi M, 2020, NAT MED, V26, P566, DOI 10.1038/s41591-020-0805-8; Griss J, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12160-2; Helmink BA, 2020, NATURE, V577, P549, DOI 10.1038/s41586-019-1922-8; Hollern DP, 2019, CELL, V179, P1191, DOI 10.1016/j.cell.2019.10.028; Kim S, 2018, NAT METHODS, V15, P591, DOI 10.1038/s41592-018-0051-x; Largeot A, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8050449; Liakou CI, 2008, P NATL ACAD SCI USA, V105, P14987, DOI 10.1073/pnas.0806075105; Mariathasan S, 2018, NATURE, V554, P544, DOI 10.1038/nature25501; Massard C, 2016, J CLIN ONCOL, V34, P3119, DOI 10.1200/JCO.2016.67.9761; Meerveld-Eggink A, 2017, ANN ONCOL, V28, P862, DOI 10.1093/annonc/mdw692; Necchi A, 2020, EUR UROL, V77, P439, DOI 10.1016/j.eururo.2019.10.026; Necchi A, 2018, J CLIN ONCOL, V36, P3353, DOI 10.1200/JCO.18.01148; Powles T, 2019, NAT MED, V25, P1706, DOI 10.1038/s41591-019-0628-7; Powles T, 2018, LANCET, V391, P748, DOI 10.1016/S0140-6736(17)33297-X; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rosenberg JE, 2016, LANCET, V387, P1909, DOI 10.1016/S0140-6736(16)00561-4; Rozeman EA, 2019, LANCET ONCOL, V20, P948, DOI 10.1016/S1470-2045(19)30151-2; Sharma P, 2019, J CLIN ONCOL, V37, DOI 10.1200/JCO.19.00538; Sharma P, 2017, LANCET ONCOL, V18, P312, DOI 10.1016/S1470-2045(17)30065-7; Silina K, 2018, CANCER RES, V78, P1308, DOI 10.1158/0008-5472.CAN-17-1987; Stein JP, 2001, J CLIN ONCOL, V19, P666, DOI 10.1200/JCO.2001.19.3.666; Strimmer K, 2008, BIOINFORMATICS, V24, P1461, DOI 10.1093/bioinformatics/btn209; Talevich E, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004873; Teo MY, 2018, J CLIN ONCOL, V36, P1685, DOI 10.1200/JCO.2017.75.7740; Zargar H, 2015, EUR UROL, V67, P241, DOI 10.1016/j.eururo.2014.09.007	34	115	116	2	14	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	2020	26	12								10.1038/s41591-020-1085-z	http://dx.doi.org/10.1038/s41591-020-1085-z		OCT 2020	21	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	PB8QO	33046870				2022-12-27	WOS:000577080500003
J	Gerke, S; Shachar, C; Chai, PR; Cohen, IG				Gerke, Sara; Shachar, Carmel; Chai, Peter R.; Cohen, I. Glenn			Regulatory, safety, and privacy concerns of home monitoring technologies during COVID-19	NATURE MEDICINE			English	Article								There has been increasing interest in the use of home monitoring technologies during the COVID-19 pandemic to decrease interpersonal contacts and the resultant risks of exposure for people to the coronavirus SARS-CoV-2. This Perspective explores how the accelerated development of these technologies also raises major concerns pertaining to safety and privacy. We make recommendations for needed interventions to ensure safety and review best practices and US regulatory requirements for privacy and security. We discuss, among other topics, Emergency Use Authorizations for medical devices and privacy laws of the USA and Europe. Home monitoring technologies are being rushed to market during the COVID-19 pandemic; here, safety and privacy considerations are discussed.	[Gerke, Sara; Shachar, Carmel] Harvard Law Sch, Petrie Flom Ctr Hlth Law Policy Biotechnol & Bioe, Cambridge, MA 02138 USA; [Chai, Peter R.] Brigham & Womens Hosp, Dept Emergency Med, 75 Francis St, Boston, MA 02115 USA; [Chai, Peter R.] Dana Farber Canc Inst, Dept Psychosocial Oncol & Palliat Care, Boston, MA 02115 USA; [Chai, Peter R.] MIT, Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Chai, Peter R.] Fenway Inst, Boston, MA USA; [Cohen, I. Glenn] Harvard Law Sch, Cambridge, MA USA	Harvard University; Harvard University; Brigham & Women's Hospital; Harvard University; Dana-Farber Cancer Institute; Massachusetts Institute of Technology (MIT); Harvard University	Gerke, S (corresponding author), Harvard Law Sch, Petrie Flom Ctr Hlth Law Policy Biotechnol & Bioe, Cambridge, MA 02138 USA.	sgerke@law.harvard.edu	Gerke, Sara/AAN-5448-2021	Gerke, Sara/0000-0002-5718-3982; chai, peter/0000-0003-0955-4117; Shachar, Carmel/0000-0002-4517-6363	Collaborative Research Program for Biomedical Innovation Law; Novo Nordisk Foundation [NNF17SA0027784]; NIH [K23DA044874, R44DA051106]; e-ink corporation; Hans and Mavis Lopater Psychosocial Foundation	Collaborative Research Program for Biomedical Innovation Law; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); e-ink corporation; Hans and Mavis Lopater Psychosocial Foundation	S.G., C.S., and I.G.C. were supported by a grant from the Collaborative Research Program for Biomedical Innovation Law, a scientifically independent collaborative research program supported by a grant NNF17SA0027784 from Novo Nordisk Foundation. P.R.C. is supported by grant NIH K23DA044874, NIH R44DA051106, and investigator initiative research from e-ink corporation and the Hans and Mavis Lopater Psychosocial Foundation.	Apple, 2018, ECG APP IRR HEART RH; Babic B, 2019, SCIENCE, V366, P1202, DOI 10.1126/science.aay9547; Beauchamp T.L., 2012, PRINCIPLES BIOMEDICA, V7th; Becker Johannes K., 2019, Proceedings on Privacy Enhancing Technologies, V2019, P50, DOI 10.2478/popets-2019-0036; Calvo RA, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1373; Centers for Medicare & Medicaid Services, 2020, CMS FAST FACTS; Cohen IG, 2020, JAMA-J AM MED ASSOC, V323, P2371, DOI 10.1001/jama.2020.8570; EDPB (European Data Protection Board), 2020, STAT EDPB CHAIR PROC; European Commission, 2020, COR EU APPR EFF CONT; European Commission's High-Level Expert Group on Artificial Intelligence, 2020, ETH GUID TRUSTW AI; European Data Protection Board, 2019, GUID 3 2018 TERR SCO; FDA, 2017, EM US AUTH MED PROD; FDA, 2014, DES CONS DEV INT HOM; FDA, 2018, SOFTW MED DEV SAMD; FDA, 2020, FACT SHEET HEALTHC G; FDA, 2020, BEW FRAUD COR TESTS; FDA, 2020, DIG HLTH POL PUBL HL; FDA, 2020, REM WEAR PAT MON DEV; FDA, 2020, COR COVID 19 MED DEV; FDA, 2019, CHANG EX MED SOFTW P; FDA, 2020, ENF POL CLIN EL THER; (FDA) FaDA, 2020, ENF POL NON REM MON; Federal Trade Commission, 2020, CONS INF COR; Food and Drug Administration (FDA), 2019, POL DEV SOFTW FUNCT; Gerke S, 2020, NPJ DIGIT MED, V3, DOI 10.1038/s41746-020-0262-2; Gerke S, 2020, JAMA-J AM MED ASSOC, V323, P601, DOI 10.1001/jama.2019.21699; Gerke S, 2019, NAT ELECTRON, V2, P329, DOI 10.1038/s41928-019-0290-6; Google, EXP NOT US TECHN HEL; Price WN, 2019, NAT MED, V25, P37, DOI 10.1038/s41591-018-0272-7; Privacy International, 2020, BLUET TRACK COVID 19; Spanou Despina, 2013, SOFTWARE MED DEVICE; Spivack P.S, 2020, LIABILITY IMMUNITY P; US Food and Drug Administration, 2016, APPL HUM FACT US ENG; Wittbold K.A., 2020, HARVARD BUS REV	34	33	33	2	10	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	AUG	2020	26	8					1176	1182		10.1038/s41591-020-0994-1	http://dx.doi.org/10.1038/s41591-020-0994-1		AUG 2020	7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	MX8ZF	32770164	Bronze, Green Accepted			2022-12-27	WOS:000557134700001
J	Nassiri, F; Chakravarthy, A; Feng, SR; Shen, SY; Nejad, R; Zuccato, JA; Voisin, MR; Patil, V; Horbinski, C; Aldape, K; Zadeh, G; De Carvalho, DD				Nassiri, Farshad; Chakravarthy, Ankur; Feng, Shengrui; Shen, Shu Yi; Nejad, Romina; Zuccato, Jeffrey A.; Voisin, Mathew R.; Patil, Vikas; Horbinski, Craig; Aldape, Kenneth; Zadeh, Gelareh; De Carvalho, Daniel D.			Detection and discrimination of intracranial tumors using plasma cell-free DNA methylomes	NATURE MEDICINE			English	Article								A cell-free DNA-methylation sequencing assay accurately identifies different brain tumor types using plasma samples. Definitive diagnosis of intracranial tumors relies on tissue specimens obtained by invasive surgery. Noninvasive diagnostic approaches provide an opportunity to avoid surgery and mitigate unnecessary risk to patients. In the present study, we show that DNA-methylation profiles from plasma reveal highly specific signatures to detect and accurately discriminate common primary intracranial tumors that share cell-of-origin lineages and can be challenging to distinguish using standard-of-care imaging.	[Nassiri, Farshad; Nejad, Romina; Zuccato, Jeffrey A.; Voisin, Mathew R.; Patil, Vikas; Aldape, Kenneth; Zadeh, Gelareh] Univ Hlth Network, Princess Margaret Canc Ctr, MacFeeters Hamilton Neurooncol Program, Toronto, ON, Canada; [Nassiri, Farshad; Nejad, Romina; Zuccato, Jeffrey A.; Voisin, Mathew R.; Patil, Vikas; Aldape, Kenneth; Zadeh, Gelareh] Univ Toronto, Toronto, ON, Canada; [Nassiri, Farshad; Zuccato, Jeffrey A.; Voisin, Mathew R.; Zadeh, Gelareh] Univ Toronto, Dept Surg, Div Neurosurg, Toronto, ON, Canada; [Chakravarthy, Ankur; Feng, Shengrui; Shen, Shu Yi; De Carvalho, Daniel D.] Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON, Canada; [Feng, Shengrui; De Carvalho, Daniel D.] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada; [Horbinski, Craig] Northwestern Univ, Dept Pathol, Feinberg Sch Med, Chicago, IL 60611 USA; [Horbinski, Craig] Northwestern Univ, Feinberg Sch Med, Dept Neurol Surg, Chicago, IL 60611 USA; [Aldape, Kenneth] NCI, Lab Pathol, Ctr Canc Res, Bethesda, MD 20892 USA	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Zadeh, G (corresponding author), Univ Hlth Network, Princess Margaret Canc Ctr, MacFeeters Hamilton Neurooncol Program, Toronto, ON, Canada.; Zadeh, G (corresponding author), Univ Toronto, Toronto, ON, Canada.; Zadeh, G (corresponding author), Univ Toronto, Dept Surg, Div Neurosurg, Toronto, ON, Canada.; De Carvalho, DD (corresponding author), Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON, Canada.; De Carvalho, DD (corresponding author), Univ Toronto, Dept Med Biophys, Toronto, ON, Canada.	gelareh.zadeh@uhn.ca; daniel.decarvalho@uhnresearch.ca		Nejad, Romina/0000-0003-1391-1041; De Carvalho, Daniel/0000-0002-8572-5259; Shen, Shu Yi/0000-0001-7036-2291; Zuccato, Jeffrey/0000-0001-5418-8238	Canadian Institute of Health Research (CIHR) Vanier Scholarship; AANS/CNS Section on Tumors & NREF Research Fellowship Grant; Hold'em for Life Oncology Fellowship; CIHR Banting Fellowship; National Institutes of Health [R01NS102669]; CIHR [159452, PJT 165986]; Brain Tumor Charity UK Quest for Cures grant [GN-000430]; CIHR New Investigator salary award [201512MSH360794-228629]; Helen M. Cooke professorship from Princess Margaret Cancer Foundation; Gattuso-Slaight Personalized Cancer Medicine Fund from Princess Margaret Cancer Foundation; Canada Research Chair; CIHR Foundation grant [FDN 148430]; NSERC [489073]; Ontario Institute for Cancer Research; province of Ontario;  [P50CA221747]	Canadian Institute of Health Research (CIHR) Vanier Scholarship(Canadian Institutes of Health Research (CIHR)); AANS/CNS Section on Tumors & NREF Research Fellowship Grant; Hold'em for Life Oncology Fellowship; CIHR Banting Fellowship(Canadian Institutes of Health Research (CIHR)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CIHR(Canadian Institutes of Health Research (CIHR)); Brain Tumor Charity UK Quest for Cures grant; CIHR New Investigator salary award(Canadian Institutes of Health Research (CIHR)); Helen M. Cooke professorship from Princess Margaret Cancer Foundation; Gattuso-Slaight Personalized Cancer Medicine Fund from Princess Margaret Cancer Foundation; Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs); CIHR Foundation grant(Canadian Institutes of Health Research (CIHR)); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Ontario Institute for Cancer Research; province of Ontario; 	We thank N. Pirouzmand for her technical assistance with experimental protocols. F.N. is supported by the Canadian Institute of Health Research (CIHR) Vanier Scholarship, AANS/CNS Section on Tumors & NREF Research Fellowship Grant, and Hold'em for Life Oncology Fellowship. A.C. is supported by a CIHR Banting Fellowship. The Northwestern Nervous System Tumor Bank (C.H.) is supported by the P50CA221747 SPORE for Translational Approaches to Brain Cancer. C.H. is funded by the National Institutes of Health (grant no. R01NS102669). G.Z. is funded by a CIHR project grant award (grant no. 159452), and the Brain Tumor Charity UK Quest for Cures grant (grant no. GN-000430). D.D.C. is funded by the CIHR New Investigator salary award (201512MSH360794-228629), Helen M. Cooke professorship and the Gattuso-Slaight Personalized Cancer Medicine Fund from Princess Margaret Cancer Foundation, Canada Research Chair, CIHR Foundation grant (grant no. FDN 148430), CIHR Project grant (grant no. PJT 165986), NSERC (grant no. 489073) and Ontario Institute for Cancer Research with funds from the province of Ontario.	Capper D, 2018, NATURE, V555, P469, DOI 10.1038/nature26000; De Mattos-Arruda L, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9839; Heitzer E, 2019, NAT REV GENET, V20, P71, DOI 10.1038/s41576-018-0071-5; Iorio F, 2016, CELL, V166, P740, DOI 10.1016/j.cell.2016.06.017; Moss J, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07466-6; Newman AM, 2014, NAT MED, V20, P552, DOI 10.1038/nm.3519; Shen SY, 2019, NAT PROTOC, V14, P2749, DOI 10.1038/s41596-019-0202-2; Shen SY, 2018, NATURE, V563, P579, DOI 10.1038/s41586-018-0703-0	8	98	101	2	20	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	JUL	2020	26	7					1044	+		10.1038/s41591-020-0932-2	http://dx.doi.org/10.1038/s41591-020-0932-2		JUN 2020	12	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	MK3XO	32572265	Green Accepted			2022-12-27	WOS:000542094400001
J	Segal, E; Zhang, F; Lin, XH; King, G; Shalem, O; Shilo, S; Allen, WE; Alquaddoomi, F; Altae-Tran, H; Anders, S; Balicer, R; Bauman, T; Bonilla, X; Booman, G; Chan, AT; Cohen, O; Coletti, S; Davidson, N; Dor, Y; Drew, DA; Elemento, O; Evans, G; Ewels, P; Gale, J; Gavrieli, A; Geiger, B; Grad, YH; Greene, CS; Hajirasouliha, I; Jerala, R; Kahles, A; Kallioniemi, O; Keshet, A; Kocarev, L; Landua, G; Meir, T; Muller, A; Nguyen, LH; Oresic, M; Ovchinnikova, S; Peterson, H; Prodanova, J; Rajagopal, J; Ratsch, G; Rossman, H; Rung, J; Sboner, A; Sigaras, A; Spector, T; Steinherz, R; Stevens, I; Vilo, J; Wilmes, P				Segal, Eran; Zhang, Feng; Lin, Xihong; King, Gary; Shalem, Ophir; Shilo, Smadar; Allen, William E.; Alquaddoomi, Faisal; Altae-Tran, Han; Anders, Simon; Balicer, Ran; Bauman, Tal; Bonilla, Ximena; Booman, Gisel; Chan, Andrew T.; Cohen, Ori; Coletti, Silvano; Davidson, Natalie; Dor, Yuval; Drew, David A.; Elemento, Olivier; Evans, Georgina; Ewels, Phil; Gale, Joshua; Gavrieli, Amir; Geiger, Benjamin; Grad, Yonatan H.; Greene, Casey S.; Hajirasouliha, Iman; Jerala, Roman; Kahles, Andre; Kallioniemi, Olli; Keshet, Ayya; Kocarev, Ljupco; Landua, Gregory; Meir, Tomer; Muller, Aline; Nguyen, Long H.; Oresic, Matej; Ovchinnikova, Svetlana; Peterson, Hedi; Prodanova, Jana; Rajagopal, Jay; Ratsch, Gunnar; Rossman, Hagai; Rung, Johan; Sboner, Andrea; Sigaras, Alexandros; Spector, Tim; Steinherz, Ron; Stevens, Irene; Vilo, Jaak; Wilmes, Paul			Building an international consortium for tracking coronavirus health status	NATURE MEDICINE			English	Editorial Material								We call upon the research community to standardize efforts to use daily self-reported data about COVID-19 symptoms in the response to the pandemic and to form a collaborative consortium to maximize global gain while protecting participant privacy.	[Segal, Eran; Shilo, Smadar; Cohen, Ori; Gavrieli, Amir; Keshet, Ayya; Meir, Tomer; Rossman, Hagai] Weizmann Inst Sci, Dept Comp Sci & Appl Math, Rehovot, Israel; [Segal, Eran; Shilo, Smadar; Cohen, Ori; Gavrieli, Amir; Keshet, Ayya; Meir, Tomer; Rossman, Hagai] Weizmann Inst Sci, Dept Mol Cell Biol, Rehovot, Israel; [Zhang, Feng] Howard Hughes Med Inst, Chevy Chase, MD USA; [Zhang, Feng; Altae-Tran, Han] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Lin, Xihong] Harvard Univ, Harvard TH Chan Sch Publ Hlth, Dept Biostat, Cambridge, MA 02138 USA; [Lin, Xihong] Harvard Univ, Dept Stat, Harvard TH Chan Sch Publ Hlth, Cambridge, MA 02138 USA; [King, Gary; Evans, Georgina] Harvard Univ, Inst Quantitat Social Sci, Cambridge, MA 02138 USA; [Shalem, Ophir] Univ Penn, Perelman Sch Med, Dept Genet, Philadelphia, PA 19104 USA; [Shilo, Smadar] Rambam Healthcare Campus, Ruth Rappaport Childrens Hosp, Pediat Diabet Unit, Haifa, Israel; [Allen, William E.] Harvard Univ, Harvard Soc Fellows, Cambridge, MA 02138 USA; [Alquaddoomi, Faisal] Swiss Fed Inst Technol, NEXUS Personalized Hlth Technol, Zurich, Switzerland; MIT, Dept Biol Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Anders, Simon; Ovchinnikova, Svetlana] Heidelberg Univ, Ctr Mol Biol ZMBH, Heidelberg, Germany; [Balicer, Ran] Clalit Hlth Serv, Clalit Res Inst, Ramat Gan, Israel; [Bauman, Tal] Technion, Civil & Environm Engn Fac, Mapping & Geoinformat Engn, Haifa, Israel; [Bonilla, Ximena; Davidson, Natalie; Drew, David A.; Kahles, Andre; Nguyen, Long H.; Ratsch, Gunnar] Swiss Fed Inst Technol, Dept Comp Sci, Zurich, Switzerland; [Bonilla, Ximena; Davidson, Natalie; Drew, David A.; Kahles, Andre; Nguyen, Long H.; Ratsch, Gunnar] Univ Hosp Zurich, Med Informat, Zurich, Switzerland; [Bonilla, Ximena; Davidson, Natalie; Drew, David A.; Kahles, Andre; Nguyen, Long H.; Ratsch, Gunnar] SIB Swiss Inst Bioinformat, Zurich, Switzerland; [Booman, Gisel] Regen Network, Mar Del Plata, Argentina; [Chan, Andrew T.] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Coletti, Silvano] Chelonia Appl Sci, Allschwil, Switzerland; [Dor, Yuval] Hebrew Univ Jerusalem, Sch Med, IMRIC Dev Biol & Canc Res, Jerusalem, Israel; [Elemento, Olivier; Hajirasouliha, Iman; Sboner, Andrea; Sigaras, Alexandros] Weill Cornell Med, Englander Inst Precis Med, New York, NY USA; Weill Cornell Med, Dept Physiol & Biophys, New York, NY USA; [Ewels, Phil] Stockholm Univ, Dept Biochem & Biophys, Sci Life Lab SciLifeLab, Stockholm, Sweden; [Geiger, Benjamin] Weizmann Inst Sci, Dept Immunol, Rehovot, Israel; [Grad, Yonatan H.] Harvard Univ, Harvard TH Chan Sch Publ Hlth, Dept Immunol & Infect Dis, Cambridge, MA 02138 USA; [Greene, Casey S.] Univ Penn, Dept Syst Pharmacol & Translat Therapeut, Perelman Sch Med, Philadelphia, PA 19104 USA; [Jerala, Roman] Natl Inst Chem, Dept Synthet Biol & Immunol, Ljubljana, Slovenia; [Kallioniemi, Olli] Karolinska Inst, Dept Pathol & Oncol, Sci Life Lab SciLifeLab, Stockholm, Sweden; [Kocarev, Ljupco; Prodanova, Jana] Macedonian Acad Sci & Arts, Skopje, North Macedonia; [Landua, Gregory; Steinherz, Ron] Regen Network, Great Barrington, MA USA; [Muller, Aline] Luxembourg Inst Socioecon Res, Esch Sur Alzette, Luxembourg; [Muller, Aline] Univ Luxembourg, Esch Sur Alzette, Luxembourg; [Oresic, Matej] Orebro Univ, Sch Med Sci, Orebro, Sweden; [Oresic, Matej] Univ Turku, Turku Biosci Ctr, Turku, Finland; [Oresic, Matej] Abo Akad Univ, Turku, Finland; [Peterson, Hedi; Vilo, Jaak] Univ Tartu, Inst Comp Sci, Tartu, Estonia; [Rajagopal, Jay] Harvard Med Sch, Internal Med, Boston, MA 02115 USA; [Rajagopal, Jay] Massachusetts Gen Hosp, Dept Pulm Med & Crit Care, Boston, MA USA; [Ratsch, Gunnar] Swiss Fed Inst Technol, ELLIS Unit, Zurich, Switzerland; [Rung, Johan] Uppsala Univ, Dept Immunol Genet & Pathol, Sci Life Lab SciLifeLab, Uppsala, Sweden; [Sboner, Andrea] Weill Cornell Med, Dept Pathol & Lab Med, New York, NY USA; [Spector, Tim] Kings Coll London, London, England; [Stevens, Irene] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Sci Life Lab SciLifeLab, Stockholm, Sweden; [Wilmes, Paul] Univ Luxembourg, Luxembourg Ctr Syst Biomed, Esch Sur Alzette, Luxembourg	Weizmann Institute of Science; Weizmann Institute of Science; Howard Hughes Medical Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; University of Pennsylvania; Pennsylvania Medicine; Rambam Health Care Campus; Harvard University; Swiss Federal Institutes of Technology Domain; ETH Zurich; Massachusetts Institute of Technology (MIT); Ruprecht Karls University Heidelberg; Clalit Health Services; Technion Israel Institute of Technology; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich; University Zurich Hospital; Swiss Institute of Bioinformatics; Harvard University; Massachusetts General Hospital; Hebrew University of Jerusalem; Cornell University; Cornell University; SciLifeLab; Stockholm University; Weizmann Institute of Science; Harvard University; Harvard T.H. Chan School of Public Health; University of Pennsylvania; Pennsylvania Medicine; National Institute of Chemistry - Slovenia; Karolinska Institutet; SciLifeLab; University of Luxembourg; Orebro University; University of Turku; Abo Akademi University; University of Tartu; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Swiss Federal Institutes of Technology Domain; ETH Zurich; SciLifeLab; Uppsala University; Cornell University; University of London; King's College London; Karolinska Institutet; SciLifeLab; University of Luxembourg	Segal, E (corresponding author), Weizmann Inst Sci, Dept Comp Sci & Appl Math, Rehovot, Israel.; Segal, E (corresponding author), Weizmann Inst Sci, Dept Mol Cell Biol, Rehovot, Israel.	eran.segal@weizmann.ac.il	Bonilla, Ximena/AAI-7910-2021; Macrae, Rhiannon/AAX-1536-2020; Oresic, Matej/AAV-3978-2020; Anders, Simon/D-4087-2011; Vilo, Jaak/A-7183-2008; Sigaras, Alexandros/AAF-7111-2019; Greene, Casey/L-2057-2015; Peterson, Hedi/ABA-3355-2020; Prodanova, Jana/AAQ-9552-2021; Oresic, Matej/K-7673-2016; Prodanova, Jana/B-5628-2015; Kahles, Andre/ABB-8343-2020; Kocarev, Ljupco/AAS-3002-2020; Wilmes, Paul/B-1707-2017; Kallioniemi, Olli/H-4738-2012	Anders, Simon/0000-0003-4868-1805; Vilo, Jaak/0000-0001-5604-4107; Sigaras, Alexandros/0000-0002-7607-559X; Greene, Casey/0000-0001-8713-9213; Peterson, Hedi/0000-0001-9951-5116; Prodanova, Jana/0000-0001-6381-3621; Oresic, Matej/0000-0002-2856-9165; Prodanova, Jana/0000-0001-6381-3621; Kahles, Andre/0000-0002-3411-0692; Wilmes, Paul/0000-0002-6478-2924; Rung, Johan/0000-0001-5875-8429; King, Gary/0000-0002-5327-7631; Stevens, Irene/0000-0003-3823-1499; Kallioniemi, Olli/0000-0002-3231-0332; Coletti, Silvano/0000-0002-8754-0434; Davidson, Natalie/0000-0002-1745-8072; Shilo, Smadar/0000-0003-2399-1866; Segal, Eran/0000-0002-6859-1164; Lin, Xihong/0000-0001-7067-7752; Bonilla, Ximena/0000-0002-4950-6825				Adalja AA, 2020, JAMA-J AM MED ASSOC, V323, P1343, DOI 10.1001/jama.2020.3413; Dankar FK, 2013, TRANS DATA PRIV, V6, P35; Drew DA, 2020, SCIENCE, V368, P1362, DOI 10.1126/science.abc0473; Guan W, 2020, NEW ENGL J MED, V382, P1708, DOI 10.1056/NEJMoa2002032; Gudbjartsson DF, 2020, NEW ENGL J MED, V382, P2302, DOI 10.1056/NEJMoa2006100; King G, 2008, STAT SCI, V23, P78, DOI 10.1214/07-STS247; Menni C, 2020, NAT MED, V26, P1037, DOI 10.1038/s41591-020-0916-2; Mizumoto K, 2020, EUROSURVEILLANCE, V25, P2, DOI 10.2807/1560-7917.ES.2020.25.10.2000180; Rossman H, 2020, NAT MED, V26, P634, DOI 10.1038/s41591-020-0857-9; Smolinski MS, 2015, AM J PUBLIC HEALTH, V105, P2124, DOI 10.2105/AJPH.2015.302696; Sutton D, 2020, NEW ENGL J MED, V382, P2163, DOI 10.1056/NEJMc2009316; Tian HY, 2020, SCIENCE, V368, P638, DOI 10.1126/science.abb6105; Wu ZY, 2020, JAMA-J AM MED ASSOC, V323, P1239, DOI 10.1001/jama.2020.2648	13	14	14	2	4	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	AUG	2020	26	8					1161	1165		10.1038/s41591-020-0929-x	http://dx.doi.org/10.1038/s41591-020-0929-x		JUN 2020	5	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	MX8ZF	32488218	Green Submitted, Bronze			2022-12-27	WOS:000537391700001
J	Brastianos, PK; Lee, EQ; Cohen, JV; Tolaney, SM; Lin, NU; Wang, N; Chukwueke, U; White, MD; Nayyar, N; Kim, A; Alvarez-Breckenridge, C; Krop, I; Mahar, MK; Bertalan, MS; Shaw, B; Mora, JL; Goss, N; Subramanian, M; Nayak, L; Dietrich, J; Forst, DA; Nahed, BV; Batchelor, TT; Shih, HA; Gerstner, ER; Moy, B; Lawrence, D; Giobbie-Hurder, A; Carter, SL; Oh, K; Cahill, DP; Sullivan, RJ				Brastianos, Priscilla K.; Lee, Eudocia Quant; Cohen, Justine V.; Tolaney, Sara M.; Lin, Nancy U.; Wang, Nancy; Chukwueke, Ugonma; White, Michael D.; Nayyar, Naema; Kim, Albert; Alvarez-Breckenridge, Christopher; Krop, Ian; Mahar, Maura Keeley; Bertalan, Mia S.; Shaw, Brian; Mora, Joana L.; Goss, Nathaniel; Subramanian, Megha; Nayak, Lakshmi; Dietrich, Jorg; Forst, Deborah A.; Nahed, Brian V.; Batchelor, Tracy T.; Shih, Helen A.; Gerstner, Elizabeth R.; Moy, Beverly; Lawrence, Donald; Giobbie-Hurder, Anita; Carter, Scott L.; Oh, Kevin; Cahill, Daniel P.; Sullivan, Ryan J.			Single-arm, open-label phase 2 trial of pembrolizumab in patients with leptomeningeal carcinomatosis	NATURE MEDICINE			English	Article							CELL LUNG-CANCER; MENINGEAL CARCINOMATOSIS; INTRAVENTRICULAR METHOTREXATE; CYTARABINE DEPOCYT; BRAIN METASTASES; BREAST-CANCER; SOLID TUMORS; MELANOMA; MENINGITIS; IPILIMUMAB	An increasing fraction of patients with metastatic cancer develop leptomeningeal dissemination of disease (LMD), and survival is dismal(1-3). We conducted a single-arm, phase 2 study of pembrolizumab in patients with solid tumor malignancies and LMD (). Patients received 200 mg of pembrolizumab intravenously every 3 weeks until definitive progression or unacceptable toxicity. The primary endpoint was rate of overall survival at 3 months (OS3). Secondary objectives included toxicity, response rate and time to intracranial or extracranial disease progression. A Simon two-stage design was used to compare a null hypothesis OS3 of 18% against an alternative of 43%. Twenty patients-17 with breast cancer, two with lung cancer and one with ovarian cancer-were enrolled into the pre-specified evaluation group having received at least one dose of pembrolizumab. The median follow-up of surviving patients was 6.3 months (range, 2.2-12.5 months). The percentage of patients who experienced one (or more) grade 3 or higher adverse events at least possibly related to treatment was 40%, the most frequent being hyperglycemia (n = 6), nausea (n = 7) and vomiting (n = 7). The study met the primary endpoint, as 12 of 20 (OS3, 0.60; 90% confidence interval, 0.39-0.78) patients were alive at 3 months after enrollment. Pembrolizumab is safe and feasible and displays promising activity in patients with LMD. Further investigations are needed to identify which patients with LMD can benefit from pembrolizumab.	[Brastianos, Priscilla K.; Cohen, Justine V.; Wang, Nancy; White, Michael D.; Nayyar, Naema; Kim, Albert; Alvarez-Breckenridge, Christopher; Mahar, Maura Keeley; Bertalan, Mia S.; Shaw, Brian; Mora, Joana L.; Goss, Nathaniel; Subramanian, Megha; Dietrich, Jorg; Forst, Deborah A.; Nahed, Brian V.; Batchelor, Tracy T.; Shih, Helen A.; Gerstner, Elizabeth R.; Moy, Beverly; Lawrence, Donald; Oh, Kevin; Cahill, Daniel P.; Sullivan, Ryan J.] Harvard Med Sch, Massachusetts Gen Hosp, Boston, MA 02115 USA; [Lee, Eudocia Quant; Tolaney, Sara M.; Lin, Nancy U.; Chukwueke, Ugonma; Krop, Ian; Nayak, Lakshmi; Giobbie-Hurder, Anita; Carter, Scott L.] Harvard Med Sch, Dana Farber Canc Inst, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School	Brastianos, PK (corresponding author), Harvard Med Sch, Massachusetts Gen Hosp, Boston, MA 02115 USA.	pbrastianos@mgh.harvard.edu	Giobbie-Hurder, Anita/AAU-6193-2021	Brastianos, Priscilla/0000-0003-4470-8425; Forst, Deborah/0000-0002-8428-0841; Mora, Joana/0000-0002-5913-1107	Melanoma Research Alliance; Breast Cancer Research Foundation; Merck; Massachusetts General Hospital; National Cancer Institute [1R01CA227156-01, 5R21CA220253-02, 1R01CA244975-01]; Damon Runyon Cancer Research Foundation; Susan G. Komen Foundation; American Brain Tumor Association; Terri Brodeur Breast Cancer Foundation; Conquer Cancer Foundation	Melanoma Research Alliance; Breast Cancer Research Foundation; Merck(Merck & Company); Massachusetts General Hospital(General Electric); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Damon Runyon Cancer Research Foundation; Susan G. Komen Foundation(Susan G. Komen Breast Cancer Foundation); American Brain Tumor Association; Terri Brodeur Breast Cancer Foundation; Conquer Cancer Foundation	Funding was provided by the Melanoma Research Alliance, the Breast Cancer Research Foundation, Merck and the Massachusetts General Hospital. P.K.B. and S.L.C. are supported by the National Cancer Institute (1R01CA227156-01, 5R21CA220253-02 and 1R01CA244975-01). P.K.B. is also currently supported by the Damon Runyon Cancer Research Foundation and has previously received funding from the Susan G. Komen Foundation, the American Brain Tumor Association, the Terri Brodeur Breast Cancer Foundation and the Conquer Cancer Foundation. We also thank the patients and their families for contributing to research efforts.	BOYLE R, 1980, POSTGRAD MED J, V56, P149, DOI 10.1136/pgmj.56.653.149; Brastianos P.K., 2013, CENTRAL NERVOUS SYST, P187; Chamberlain MC, 2012, J NEURO-ONCOL, V109, P143, DOI 10.1007/s11060-012-0880-x; Chamberlain MC, 2010, SEMIN NEUROL, V30, P236, DOI 10.1055/s-0030-1255220; Chuang TY, 2008, J FORMOS MED ASSOC, V107, P851, DOI 10.1016/S0929-6646(08)60201-6; CLAMON G, 1987, BREAST CANCER RES TR, V9, P213, DOI 10.1007/BF01806382; DEVISSER BWO, 1983, NEUROLOGY, V33, P1565, DOI 10.1212/WNL.33.12.1565; Dirix LY, 2018, BREAST CANCER RES TR, V167, P671, DOI 10.1007/s10549-017-4537-5; Duchnowska R, 2016, BREAST CANCER RES, V18, DOI 10.1186/s13058-016-0702-8; El Shafie RA, 2019, FRONT ONCOL, V8, DOI 10.3389/fonc.2018.00641; Gani C, 2012, STRAHLENTHER ONKOL, V188, P148, DOI 10.1007/s00066-011-0025-8; Glantz MJ, 1999, CLIN CANCER RES, V5, P3394; Goldberg SB, 2016, LANCET ONCOL, V17, P976, DOI 10.1016/S1470-2045(16)30053-5; Grossman SA, 1999, CANCER TREAT REV, V25, P103, DOI 10.1053/ctrv.1999.0119; GROSSMAN SA, 1993, J CLIN ONCOL, V11, P561, DOI 10.1200/JCO.1993.11.3.561; Hendriks LEL, 2019, EUR J CANCER, V116, P182, DOI 10.1016/j.ejca.2019.05.019; Lara-Medina F, 2012, BREAST J, V18, P233, DOI 10.1111/j.1524-4741.2012.01228.x; Le Rhun E, 2017, J NEURO-ONCOL, V133, P419, DOI 10.1007/s11060-017-2452-6; LITTLE JR, 1974, ARCH NEUROL-CHICAGO, V30, P138, DOI 10.1001/archneur.1974.00490320026003; Long GV, 2018, LANCET ONCOL, V19, P672, DOI 10.1016/S1470-2045(18)30139-6; Margolin K, 2012, LANCET ONCOL, V13, P459, DOI 10.1016/S1470-2045(12)70090-6; Okada Hideho, 2015, Lancet Oncol, V16, pe534, DOI 10.1016/S1470-2045(15)00088-1; ROSEN ST, 1982, MEDICINE, V61, P45, DOI 10.1097/00005792-198201000-00005; Schmid P, 2018, NEW ENGL J MED, V379, P2108, DOI 10.1056/NEJMoa1809615; Tawbi HA, 2018, NEW ENGL J MED, V379, P722, DOI 10.1056/NEJMoa1805453; Waki F, 2009, J NEURO-ONCOL, V93, P205, DOI 10.1007/s11060-008-9758-3; Wang N, 2018, CANCER-AM CANCER SOC, V124, P21, DOI 10.1002/cncr.30911; WASSERSTROM WR, 1982, CANCER, V49, P759, DOI 10.1002/1097-0142(19820215)49:4<759::AID-CNCR2820490427>3.0.CO;2-7	28	37	39	1	9	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	AUG	2020	26	8					1280	+		10.1038/s41591-020-0918-0	http://dx.doi.org/10.1038/s41591-020-0918-0		JUN 2020	10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	MX8ZF	32483359				2022-12-27	WOS:000537041000003
J	Braun, DA; Hou, Y; Bakouny, Z; Ficial, M; Angelo, MS; Forman, J; Ross-Macdonald, P; Berger, AC; Jegede, OA; Elagina, L; Steinharter, J; Sun, M; Wind-Rotolo, M; Pignon, JC; Cherniack, AD; Lichtenstein, L; Neuberg, D; Catalano, P; Freeman, GJ; Sharpe, AH; McDermott, DF; Van Allen, EM; Signoretti, S; Wu, CJ; Shukla, SA; Choueiri, TK				Braun, David A.; Hou, Yue; Bakouny, Ziad; Ficial, Miriam; Sant' Angelo, Miriam; Forman, Juliet; Ross-Macdonald, Petra; Berger, Ashton C.; Jegede, Opeyemi A.; Elagina, Liudmilla; Steinharter, John; Sun, Maxine; Wind-Rotolo, Megan; Pignon, Jean-Christophe; Cherniack, Andrew D.; Lichtenstein, Lee; Neuberg, Donna; Catalano, Paul; Freeman, Gordon J.; Sharpe, Arlene H.; McDermott, David F.; Van Allen, Eliezer M.; Signoretti, Sabina; Wu, Catherine J.; Shukla, Sachet A.; Choueiri, Toni K.			Interplay of somatic alterations and immune infiltration modulates response to PD-1 blockade in advanced clear cell renal cell carcinoma	NATURE MEDICINE			English	Article							CTLA-4 BLOCKADE; CANCER; EXPRESSION; MUTATIONS; THERAPY; HETEROGENEITY; RESISTANCE; EVOLUTION; NIVOLUMAB; PTEN	PD-1 blockade has transformed the management of advanced clear cell renal cell carcinoma (ccRCC), but the drivers and resistors of the PD-1 response remain incompletely elucidated. Here, we analyzed 592 tumors from patients with advanced ccRCC enrolled in prospective clinical trials of treatment with PD-1 blockade by whole-exome and RNA sequencing, integrated with immunofluorescence analysis, to uncover the immunogenomic determinants of the therapeutic response. Although conventional genomic markers (such as tumor mutation burden and neoantigen load) and the degree of CD8(+)T cell infiltration were not associated with clinical response, we discovered numerous chromosomal alterations associated with response or resistance to PD-1 blockade. These advanced ccRCC tumors were highly CD8(+)T cell infiltrated, with only 27% having a non-infiltrated phenotype. Our analysis revealed that infiltrated tumors are depleted of favorablePBRM1mutations and enriched for unfavorable chromosomal losses of 9p21.3, as compared with non-infiltrated tumors, demonstrating how the potential interplay of immunophenotypes with somatic alterations impacts therapeutic efficacy. A pooled genetic, transcriptomic and immunopathologic analysis of over 500 tumors from patients with advanced renal cell cancer suggests that response to PD-1 blockade depends on both CD8(+)T cell infiltration and enrichment of tumor-intrinsic somatic alterations.	[Braun, David A.; Hou, Yue; Bakouny, Ziad; Forman, Juliet; Steinharter, John; Sun, Maxine; Cherniack, Andrew D.; Freeman, Gordon J.; Van Allen, Eliezer M.; Wu, Catherine J.; Shukla, Sachet A.; Choueiri, Toni K.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Braun, David A.; Bakouny, Ziad; Ficial, Miriam; Sant' Angelo, Miriam; Pignon, Jean-Christophe; Cherniack, Andrew D.; Catalano, Paul; Freeman, Gordon J.; McDermott, David F.; Van Allen, Eliezer M.; Signoretti, Sabina; Wu, Catherine J.; Choueiri, Toni K.] Harvard Med Sch, Boston, MA 02115 USA; [Braun, David A.; Forman, Juliet; Berger, Ashton C.; Elagina, Liudmilla; Cherniack, Andrew D.; Lichtenstein, Lee; Van Allen, Eliezer M.; Wu, Catherine J.; Shukla, Sachet A.] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Hou, Yue; Forman, Juliet; Shukla, Sachet A.] Dana Farber Canc Inst, Translat Immunogen Lab, Boston, MA 02115 USA; [Ficial, Miriam; Sant' Angelo, Miriam; Pignon, Jean-Christophe; Signoretti, Sabina] Brigham & Womens Hosp, Dept Pathol, 75 Francis St, Boston, MA 02115 USA; [Ross-Macdonald, Petra; Wind-Rotolo, Megan] Bristol Myers Squibb, Princeton, NJ USA; [Jegede, Opeyemi A.; Neuberg, Donna; Catalano, Paul] Dana Farber Canc Inst, Dept Data Sci, Boston, MA 02115 USA; [Sharpe, Arlene H.] Harvard Med Sch, Blavatnik Inst, Dept Immunol, Boston, MA 02115 USA; [McDermott, David F.] Beth Israel Deaconess Med Ctr, Med Oncol, Boston, MA 02215 USA; [Signoretti, Sabina] Dana Farber Canc Inst, Dept Oncol Pathol, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Bristol-Myers Squibb; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Dana-Farber Cancer Institute	Wu, CJ; Shukla, SA; Choueiri, TK (corresponding author), Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA.; Wu, CJ; Choueiri, TK (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.; Wu, CJ; Shukla, SA (corresponding author), Broad Inst MIT & Harvard, Cambridge, MA 02142 USA.; Shukla, SA (corresponding author), Dana Farber Canc Inst, Translat Immunogen Lab, Boston, MA 02115 USA.	cwu@partners.org; sachet_shukla@dfci.harvard.edu; toni_choueiri@dfci.harvard.edu	Berger, Ashton C./AAP-6278-2021; Cherniack, Andrew D./AAY-8132-2020; Choueiri, Toni/K-5238-2019; Bakouny, Ziad/A-1149-2018	Cherniack, Andrew D./0000-0003-0470-0111; Choueiri, Toni/0000-0002-9201-3217; Bakouny, Ziad/0000-0003-1906-5704; Braun, David/0000-0003-4543-5553	Dana-Farber/Harvard Cancer Center Kidney Cancer SPORE [P50-CA101942-12]; DOD CDMRP [W81XWH-18-1-0480]; Bristol-Myers Squibb; John. R. Svenson Fellowship; NIH/NCI [U24 CA224331]; G. Harold and Leila Y. Mathers Foundation; Parker Institute for Cancer Immunotherapy; NCI [R50RCA211482]; Dana-Farber/Harvard Cancer Center; Kohlberg Chair at Harvard Medical School; DFCI;  [NIH: NCI-1RO1CA155010]	Dana-Farber/Harvard Cancer Center Kidney Cancer SPORE; DOD CDMRP(United States Department of Defense); Bristol-Myers Squibb(Bristol-Myers Squibb); John. R. Svenson Fellowship; NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); G. Harold and Leila Y. Mathers Foundation; Parker Institute for Cancer Immunotherapy; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Dana-Farber/Harvard Cancer Center; Kohlberg Chair at Harvard Medical School; DFCI; 	We are grateful to G. Getz, I. Leshchiner, S. Moreno, R. Beroukhim, M. Sticco-Ivins, S. Gohil, P. Bachireddy, M. Atkins, K. Mahoney, R. Bhatt, G. Bouchard and M. Lee for discussions and input. We also appreciate the efforts of all study nurses and clinical staff that made this study feasible, and patients who generously provided their samples for this research. This works was supported in part by Dana-Farber/Harvard Cancer Center Kidney Cancer SPORE (P50-CA101942-12), DOD CDMRP (W81XWH-18-1-0480), and in part by Bristol-Myers Squibb. D.A.B. is supported by the John. R. Svenson Fellowship. C.J.W. acknowledges support from NIH: NCI-1RO1CA155010 and NIH/NCI U24 CA224331. This work was supported in part by The G. Harold and Leila Y. Mathers Foundation. C.J.W. is a scholar of the Leukemia and Lymphoma Society, and is supported in part by the Parker Institute for Cancer Immunotherapy. S.A.S acknowledges support by the NCI (R50RCA211482). T.K.C. is supported in part by the Dana-Farber/Harvard Cancer Center Kidney SPORE and Program, the Kohlberg Chair at Harvard Medical School and the Trust Family, Michael Brigham, and Loker Pinard Funds for Kidney Cancer Research at DFCI.	Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Binnewies M, 2018, NAT MED, V24, P541, DOI 10.1038/s41591-018-0014-x; Braun DA, 2019, JAMA ONCOL, V5, P1631, DOI 10.1001/jamaoncol.2019.3158; Carter SL, 2012, NAT BIOTECHNOL, V30, P413, DOI 10.1038/nbt.2203; Chen DS, 2017, NATURE, V541, P321, DOI 10.1038/nature21349; Chen YB, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13131; Chevrier S, 2017, CELL, V169, P736, DOI 10.1016/j.cell.2017.04.016; CHOUEIRI TK, 2019, J CLIN ONCOL S, V37; Choueiri TK, 2017, NEW ENGL J MED, V376, P354, DOI 10.1056/NEJMra1601333; Choueiri TK, 2016, CLIN CANCER RES, V22, P5461, DOI 10.1158/1078-0432.CCR-15-2839; Cibulskis K, 2013, NAT BIOTECHNOL, V31, P213, DOI 10.1038/nbt.2514; Cibulskis K, 2011, BIOINFORMATICS, V27, P2601, DOI 10.1093/bioinformatics/btr446; Costello M, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks1443; Creighton CJ, 2013, NATURE, V499, P43, DOI 10.1038/nature12222; Critescu R, 2018, SCIENCE, V362, peaar3593; Danaher P, 2018, J IMMUNOTHER CANCER, V6, DOI 10.1186/s40425-018-0367-1; DeLuca DS, 2012, BIOINFORMATICS, V28, P1530, DOI 10.1093/bioinformatics/bts196; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Fridman WH, 2017, NAT REV CLIN ONCOL, V14, P717, DOI 10.1038/nrclinonc.2017.101; Gao WH, 2017, P NATL ACAD SCI USA, V114, P1027, DOI 10.1073/pnas.1619726114; George S, 2017, IMMUNITY, V46, P197, DOI 10.1016/j.immuni.2017.02.001; Gerlinger M, 2014, NAT GENET, V46, P225, DOI 10.1038/ng.2891; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Giraldo NA, 2015, CLIN CANCER RES, V21, P3031, DOI 10.1158/1078-0432.CCR-14-2926; Granier C, 2017, CANCER RES, V77, P1075, DOI 10.1158/0008-5472.CAN-16-0274; Hanzelmann S, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-7; Hakimi AA, 2019, CANCER DISCOV, V9, P510, DOI 10.1158/2159-8290.CD-18-0957; Heng DYC, 2009, J CLIN ONCOL, V27, P5794, DOI 10.1200/JCO.2008.21.4809; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Jurtz V, 2017, J IMMUNOL, V199, P3360, DOI 10.4049/jimmunol.1700893; Lawrence MS, 2014, NATURE, V505, P495, DOI 10.1038/nature12912; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Liberzon A, 2015, CELL SYST, V1, P417, DOI 10.1016/j.cels.2015.12.004; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Malouf GG, 2016, EUR UROL, V70, P348, DOI 10.1016/j.eururo.2016.01.051; Mariathasan S, 2018, NATURE, V554, P544, DOI 10.1038/nature25501; Mashtalir N, 2018, CELL, V175, P1272, DOI 10.1016/j.cell.2018.09.032; McDermott DF, 2018, NAT MED, V24, P749, DOI 10.1038/s41591-018-0053-3; Mermel CH, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-r41; Miao D, 2018, SCIENCE, V359, P801, DOI 10.1126/science.aan5951; Mitchell TJ, 2018, CELL, V173, P611, DOI 10.1016/j.cell.2018.02.020; Motzer RJ, 2018, NEW ENGL J MED, V378, P1277, DOI 10.1056/NEJMoa1712126; Motzer RJ, 2015, NEW ENGL J MED, V373, P1803, DOI 10.1056/NEJMoa1510665; Motzer RJ, 2004, J CLIN ONCOL, V22, P454, DOI 10.1200/JCO.2004.06.132; Motzer RJ, 2019, NEW ENGL J MED, V380, P1103, DOI 10.1056/NEJMoa1816047; Motzer RJ, 2015, J CLIN ONCOL, V33, P1430, DOI 10.1200/JCO.2014.59.0703; Nargund AM, 2017, CELL REP, V18, P2893, DOI 10.1016/j.celrep.2017.02.074; Newman AM, 2019, NAT BIOTECHNOL, V37, P773, DOI 10.1038/s41587-019-0114-2; Pal SK, 2018, EUR UROL, V73, P71, DOI 10.1016/j.eururo.2017.05.033; Pal SK, 2016, EUR UROL, V70, P516, DOI 10.1016/j.eururo.2015.06.019; Palmer AC, 2017, CELL, V171, P1678, DOI 10.1016/j.cell.2017.11.009; Panda A, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.121522; Peng WY, 2016, CANCER DISCOV, V6, P202, DOI 10.1158/2159-8290.CD-15-0283; Ramos AH, 2015, HUM MUTAT, V36, pE2423, DOI 10.1002/humu.22771; Ribas A, 2018, SCIENCE, V359, P1350, DOI 10.1126/science.aar4060; Rini BI, 2019, NEW ENGL J MED, V380, P1116, DOI 10.1056/NEJMoa1816714; Rizvi NA, 2015, SCIENCE, V348, P124, DOI 10.1126/science.aaa1348; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Rooney MS, 2015, CELL, V160, P48, DOI 10.1016/j.cell.2014.12.033; Rosenthal R, 2019, NATURE, V567, P479, DOI 10.1038/s41586-019-1032-7; Sato Y, 2013, NAT GENET, V45, P860, DOI 10.1038/ng.2699; Saunders CT, 2012, BIOINFORMATICS, V28, P1811, DOI 10.1093/bioinformatics/bts271; Shukla SA, 2015, NAT BIOTECHNOL, V33, P1152, DOI 10.1038/nbt.3344; Smith CC, 2018, J CLIN INVEST, V128, P4804, DOI 10.1172/JCI121476; Snyder A, 2014, NEW ENGL J MED, V371, P2189, DOI 10.1056/NEJMoa1406498; Specht K, 2001, AM J PATHOL, V158, P419, DOI 10.1016/S0002-9440(10)63985-5; Takahashi Y, 2008, J CLIN INVEST, V118, P1099, DOI 10.1172/JCI34409; Taylor MD, 2002, NAT GENET, V31, P306, DOI 10.1038/ng916; Turajlic S, 2018, CELL, V173, P581, DOI 10.1016/j.cell.2018.03.057; Turajlic S, 2017, LANCET ONCOL, V18, P1009, DOI 10.1016/S1470-2045(17)30516-8; Van Allen EM, 2015, SCIENCE, V350, P207, DOI 10.1126/science.aad0095; vanSlegtenhorst M, 1997, SCIENCE, V277, P805, DOI 10.1126/science.277.5327.805; Vargiu L, 2016, RETROVIROLOGY, V13, DOI 10.1186/s12977-015-0232-y; Yan LB, 2019, PEERJ, V7, DOI 10.7717/peerj.6396; Yarchoan M, 2017, NEW ENGL J MED, V377, P2500, DOI 10.1056/NEJMc1713444; Zack TI, 2013, NAT GENET, V45, P1134, DOI 10.1038/ng.2760	77	235	238	15	33	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	JUN	2020	26	6					909	+		10.1038/s41591-020-0839-y	http://dx.doi.org/10.1038/s41591-020-0839-y			28	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	LZ3ZG	32472114	Green Accepted			2022-12-27	WOS:000541166000033
J	Murugan, R; Scally, SW; Coste, G; Mustafa, G; Thai, E; Decker, T; Bosch, A; Prieto, K; Levashina, EA; Julien, JP; Wardemann, H				Murugan, Rajagopal; Scally, Stephen W.; Coste, Giulia; Mustafa, Ghulam; Thai, Elaine; Decker, Tizian; Bosch, Alexandre; Prieto, Katherine; Levashina, Elena A.; Julien, Jean-Philippe; Wardemann, Hedda			Evolution of protective human antibodies against Plasmodium falciparum circumsporozoite protein repeat motifs	NATURE MEDICINE			English	Article							MONOCLONAL-ANTIBODIES; HUMAN MALARIA; SURFACE-ANTIGEN; SPOROZOITE; GENE; DIVERSITY; INFECTION; VACCINE; SITE; RTS	The circumsporozoite protein of the human malaria parasite Plasmodium falciparum (PfCSP) is the main target of antibodies that prevent the infection and disease, as shown in animal models. However, the limited efficacy of the PfCSP-based vaccine RTS,S calls for a better understanding of the mechanisms driving the development of the most potent human PfCSP antibodies and identification of their target epitopes. By characterizing 200 human monoclonal PfCSP antibodies induced by sporozoite immunization, we establish that the most potent antibodies bind around a conserved (N/D)PNANPN(V/A) core. High antibody affinity to the core correlates with protection from parasitemia in mice and evolves around the recognition of NANP motifs. The data suggest that the rational design of a next-generation PfCSP vaccine that elicits high-affinity antibody responses against the core epitope will promote the induction of protective humoral immune responses. Characterization of 200 antibodies that bind a malaria parasite protein provides insights that could enable better vaccine design.	[Murugan, Rajagopal; Mustafa, Ghulam; Decker, Tizian; Wardemann, Hedda] German Canc Res Inst DKFZ, B Cell Immunol, Heidelberg, Germany; [Scally, Stephen W.; Thai, Elaine; Bosch, Alexandre; Prieto, Katherine; Julien, Jean-Philippe] Hosp Sick Children, Program Mol Med, Res Inst, Toronto, ON, Canada; [Scally, Stephen W.; Julien, Jean-Philippe] Univ Toronto, Dept Immunol, Toronto, ON, Canada; [Coste, Giulia; Levashina, Elena A.] Max Planck Inst Infect Biol, Vector Biol Unit, Berlin, Germany; [Thai, Elaine; Julien, Jean-Philippe] Univ Toronto, Dept Biochem, Toronto, ON, Canada	Helmholtz Association; German Cancer Research Center (DKFZ); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; Max Planck Society; University of Toronto	Wardemann, H (corresponding author), German Canc Res Inst DKFZ, B Cell Immunol, Heidelberg, Germany.; Julien, JP (corresponding author), Hosp Sick Children, Program Mol Med, Res Inst, Toronto, ON, Canada.; Julien, JP (corresponding author), Univ Toronto, Dept Immunol, Toronto, ON, Canada.; Levashina, EA (corresponding author), Max Planck Inst Infect Biol, Vector Biol Unit, Berlin, Germany.; Julien, JP (corresponding author), Univ Toronto, Dept Biochem, Toronto, ON, Canada.	levashina@mpiib-berlin.mpg.de; jean-philippe.julien@sickkids.ca; h.wardemann@dkfz.de		Mustafa, Ghulam/0000-0002-1085-5163; Wardemann, Hedda/0000-0003-3921-5933; Murugan, Rajagopal/0000-0002-0336-7268; Scally, Stephen/0000-0002-4264-7772	Hospital for Sick Children Lap-Chee Tsui Postdoctoral Fellowship; Canadian Institutes of Health Research (CIHR) fellowship; CIHR Canada Graduate Scholarship - Master's Award; Canada Research Chairs program; Bill and Melinda Gates Foundation [OPP1179906]	Hospital for Sick Children Lap-Chee Tsui Postdoctoral Fellowship; Canadian Institutes of Health Research (CIHR) fellowship(Canadian Institutes of Health Research (CIHR)); CIHR Canada Graduate Scholarship - Master's Award(Canadian Institutes of Health Research (CIHR)); Canada Research Chairs program(Canada Research Chairs); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation)	The authors thank C. Canetta, J. Gaertner, A. Knauf, C. Winter and D. Foster (German Cancer Research Center, Heidelberg), C. Kreschel, L. Spohr, D. Eyermann and M. Andres (Max Planck Institute for Infection Biology, Berlin) and the DKFZ/European Molecular Biology Laboratory (EMBL)/Heidelberg University Chemical Biology Core Facility, especially P. Sehr, for technical assistance and services. The following reagents were obtained from BEI Resources, NIAID, NIH: HC-04, Hepatocyte (human), MRA-975, contributed by J. Sattabongkot Prachumsri. The work was supported by a Hospital for Sick Children Lap-Chee Tsui Postdoctoral Fellowship (S.W.S), a Canadian Institutes of Health Research (CIHR) fellowship (S.W.S), a CIHR Canada Graduate Scholarship - Master's Award (E.T.), the Canada Research Chairs program (J.-P.J.) and the Bill and Melinda Gates Foundation (OPP1179906; J.-P.J, H.W. and E.A.L.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Agnandji ST, 2011, NEW ENGL J MED, V365, P1863, DOI 10.1056/NEJMoa1102287; Aliprandini E, 2018, NAT MICROBIOL, V3, P1224, DOI 10.1038/s41564-018-0254-z; Bailey JA, 2012, J INFECT DIS, V206, P580, DOI 10.1093/infdis/jis329; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Batista FD, 1998, IMMUNITY, V8, P751, DOI 10.1016/S1074-7613(00)80580-4; Cohen J, 2010, HUM VACCINES, V6, P90, DOI 10.4161/hv.6.1.9677; Coppi A, 2011, J EXP MED, V208, P341, DOI 10.1084/jem.20101488; DAME JB, 1984, SCIENCE, V225, P593, DOI 10.1126/science.6204383; DYSON HJ, 1990, BIOCHEMISTRY-US, V29, P7828, DOI 10.1021/bi00486a008; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; ENEA V, 1984, SCIENCE, V225, P628, DOI 10.1126/science.6204384; Ereno-Orbea J, 2018, J MOL BIOL, V430, P322, DOI 10.1016/j.jmb.2017.12.010; Escalante AA, 2002, MOL BIOCHEM PARASIT, V125, P83, DOI 10.1016/S0166-6851(02)00216-5; Flores-Garcia Y, 2018, MBIO, V9, DOI [10.1128/mbio.02194-18, 10.1128/mBio.02194-18]; Foote J, 2000, P NATL ACAD SCI USA, V97, P10679, DOI 10.1073/pnas.97.20.10679; Foquet L, 2014, J CLIN INVEST, V124, P140, DOI 10.1172/JCI70349; FREVERT U, 1993, J EXP MED, V177, P1287, DOI 10.1084/jem.177.5.1287; Friesen J, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001058; Ghasparian A, 2006, CHEM COMMUN, P174, DOI 10.1039/b510812h; Gildenhard M, 2019, NAT MICROBIOL, V4, P941, DOI 10.1038/s41564-019-0414-9; Harris C, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001112; Hayley A, 2019, ANTIBODY FEEDBACK LI, DOI [10.1101/808543, DOI 10.1101/808543]; Imkeller K, 2018, SCIENCE, V360, P1358, DOI 10.1126/science.aar5304; Julien JP, 2019, NAT REV IMMUNOL, V19, P761, DOI 10.1038/s41577-019-0209-5; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kisalu NK, 2018, NAT MED, V24, P408, DOI 10.1038/nm.4512; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Menard R, 1997, NATURE, V385, P336, DOI 10.1038/385336a0; Mian-McCarthy S, 2012, NEW ENGL J MED, V367, P2284, DOI 10.1056/NEJMoa1208394; Mordmuller B, 2017, NATURE, V542, P445, DOI 10.1038/nature21060; Morin A, 2013, ELIFE, V2, DOI 10.7554/eLife.01456; Murugan R, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aap8029; NARDIN EH, 1982, J EXP MED, V156, P20, DOI 10.1084/jem.156.1.20; Olotu A, 2016, NEW ENGL J MED, V374, P2519, DOI 10.1056/NEJMoa1515257; Oyen D, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aau8529; Oyen D, 2017, P NATL ACAD SCI USA, V114, pE10438, DOI 10.1073/pnas.1715812114; Pompon J, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002255; POTOCNJAK P, 1980, J EXP MED, V151, P1504, DOI 10.1084/jem.151.6.1504; Sattabongkot J, 2006, AM J TROP MED HYG, V74, P708, DOI 10.4269/ajtmh.2006.74.708; Scally SW, 2018, J EXP MED, V215, P63, DOI 10.1084/jem.20170869; Tan J, 2018, NAT MED, V24, P401, DOI 10.1038/nm.4513; Tiller T, 2008, J IMMUNOL METHODS, V334, P142, DOI 10.1016/j.jim.2008.02.010; Tiller T, 2008, J IMMUNOL METHODS, V329, P112, DOI 10.1016/j.jim.2007.09.017; Tinto H, 2015, LANCET, V386, P31, DOI 10.1016/S0140-6736(15)60721-8; Triller G, 2017, IMMUNITY, V47, P1197, DOI 10.1016/j.immuni.2017.11.007; Victora GD, 2012, ANNU REV IMMUNOL, V30, P429, DOI 10.1146/annurev-immunol-020711-075032; Wardemann H, 2003, SCIENCE, V301, P1374, DOI 10.1126/science.1086907; YOSHIDA N, 1980, SCIENCE, V207, P71, DOI 10.1126/science.6985745; ZAVALA F, 1983, J EXP MED, V157, P1947, DOI 10.1084/jem.157.6.1947	50	31	31	0	9	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	JUL	2020	26	7					1135	+		10.1038/s41591-020-0881-9	http://dx.doi.org/10.1038/s41591-020-0881-9		MAY 2020	22	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	MK3XO	32451496	Green Submitted			2022-12-27	WOS:000535406400002
J	Ostendorf, BN; Bilanovic, J; Adaku, N; Tafreshian, KN; Tavora, B; Vaughan, RD; Tavazoie, SF				Ostendorf, Benjamin N.; Bilanovic, Jana; Adaku, Nneoma; Tafreshian, Kimia N.; Tavora, Bernardo; Vaughan, Roger D.; Tavazoie, Sohail F.			Common germline variants of the human APOE gene modulate melanoma progression and survival	NATURE MEDICINE			English	Article							APOLIPOPROTEIN-E; BINDING; ALLELE; HYPERCHOLESTEROLEMIA; ATHEROSCLEROSIS; ASSOCIATION; REPLACEMENT; SUPPRESSION; RECEPTORS; GENOTYPE	Heritable APOE variants in patients with melanoma influence anti-tumor immunity and modulate metastatic progression and response to immunotherapy. Common germline variants of the APOE gene are major risk modifiers of neurodegenerative and atherosclerotic diseases(1-3), but their effect on cancer outcome is poorly defined. Here we report that, in a reversal of their effect on Alzheimer's disease, the APOE4 and APOE2 variants confer favorable and poor outcomes in melanoma, respectively. Mice expressing the human APOE4 allele exhibited reduced melanoma progression and metastasis relative to APOE2 mice. APOE4 mice exhibited enhanced anti-tumor immune activation relative to APOE2 mice, and T cell depletion experiments showed that the effect of APOE genotype on melanoma progression was mediated by altered anti-tumor immunity. Consistently, patients with melanoma carrying the APOE4 variant experienced improved survival in comparison to carriers of APOE2. Notably, APOE4 mice also showed improved outcomes under PD1 immune checkpoint blockade relative to APOE2 mice, and patients carrying APOE4 experienced improved anti-PD1 immunotherapy survival after progression on frontline regimens. Finally, enhancing APOE expression via pharmacologic activation of liver X receptors, previously shown to boost anti-tumor immunity(4), exhibited therapeutic efficacy in APOE4 mice but not in APOE2 mice. These findings demonstrate that pre-existing hereditary genetics can impact progression and survival outcomes of a future malignancy and warrant prospective investigation of APOE genotype as a biomarker for melanoma outcome and therapeutic response.	[Ostendorf, Benjamin N.; Bilanovic, Jana; Adaku, Nneoma; Tafreshian, Kimia N.; Tavora, Bernardo; Tavazoie, Sohail F.] Rockefeller Univ, Lab Syst Canc Biol, 1230 York Ave, New York, NY 10021 USA; [Vaughan, Roger D.] Rockefeller Univ, Dept Biostat, 1230 York Ave, New York, NY 10021 USA	Rockefeller University; Rockefeller University	Tavazoie, SF (corresponding author), Rockefeller Univ, Lab Syst Canc Biol, 1230 York Ave, New York, NY 10021 USA.	stavazoie@rockefeller.edu	Ostendorf, Benjamin Nils/AAA-2109-2022	Ostendorf, Benjamin Nils/0000-0003-4492-9252; Bilanovic, Jana/0000-0002-0143-9694; Adaku, Nneoma/0000-0001-9287-6744	National Institutes of Health grant [RO1CA184804-01A2]; Deutsche Forschungsgemeinschaft postdoctoral fellowship [OS 498/1-1]; German National Academic Foundation; Medical Scientist Training Program grant from the National Institutes of Health [T32GM007739]; Lucy Lee Chiles Fellowship from the Hope Funds for Cancer Research; National Center for Advancing Translational Sciences, National Institutes of Health Clinical and Translational Science Award program [UL1 TR001866]; Faculty Scholars grant from the Howard Hughes Medical Institute; Black Family Metastasis Center at Rockefeller University; Reem-Kayden award	National Institutes of Health grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft postdoctoral fellowship(German Research Foundation (DFG)); German National Academic Foundation; Medical Scientist Training Program grant from the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Lucy Lee Chiles Fellowship from the Hope Funds for Cancer Research; National Center for Advancing Translational Sciences, National Institutes of Health Clinical and Translational Science Award program; Faculty Scholars grant from the Howard Hughes Medical Institute; Black Family Metastasis Center at Rockefeller University; Reem-Kayden award	We thank members of our laboratory and M. Tavazoie for comments on previous versions of the manuscript. We are grateful for assistance by Rockefeller University resource centers: S. Mazel and staff of the flow cytometry resource center, V. Francis and other veterinary staff of the Comparative Bioscience Center for animal husbandry and care, C. Zhao and staff at the genomics resource center for assistance with scRNA-seq and A. North and staff at the Bio-Imaging Resource Center. We express gratitude to M. Bosenberg (Yale University) for kindly providing the YUMM1.7 and YUMMER1.7 cell lines. We thank the groups of P. Sullivan and N. Maeda for generating the human APOE targeted-replacement mice and making them available through Taconic Biosciences. We are grateful to E. McMillan for early help with whole-exome sequencing analysis. We also thank M. Szarek and H. Mostafavi for statistical advice. This work was supported by National Institutes of Health grant RO1CA184804-01A2 (to S.F.T.). B.N.O. was supported by a Deutsche Forschungsgemeinschaft postdoctoral fellowship (OS 498/1-1). J.B. and K.N.T. were supported by scholarships from the German National Academic Foundation. N.A. was supported by Medical Scientist Training Program grant T32GM007739 from the National Institutes of Health. B.T. was supported by the Lucy Lee Chiles Fellowship from the Hope Funds for Cancer Research. R.D.V. was supported in part by grant UL1 TR001866 from the National Center for Advancing Translational Sciences, National Institutes of Health Clinical and Translational Science Award program. S.F.T. was supported by a Faculty Scholars grant from the Howard Hughes Medical Institute, the Black Family Metastasis Center at Rockefeller University and by the Reem-Kayden award.	Akbani R, 2015, CELL, V161, P1681, DOI 10.1016/j.cell.2015.05.044; Amos CI, 2011, HUM MOL GENET, V20, P5012, DOI 10.1093/hmg/ddr415; Anand R, 2014, J CANCER RES CLIN, V140, P1075, DOI 10.1007/s00432-014-1634-2; Blair CK, 2005, NEUROLOGY, V64, P268, DOI 10.1212/01.WNL.0000149643.91367.8A; Bonacina F, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05322-1; Chen JL, 2011, P NATL ACAD SCI USA, V108, P14813, DOI 10.1073/pnas.1106420108; CORDER EH, 1994, NAT GENET, V7, P180, DOI 10.1038/ng0694-180; Deelen J, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11558-2; Evans RM, 2014, CELL, V157, P255, DOI 10.1016/j.cell.2014.03.012; HIXSON JE, 1990, J LIPID RES, V31, P545; Hong C, 2014, NAT REV DRUG DISCOV, V13, P433, DOI 10.1038/nrd4280; Knouff C, 1999, J CLIN INVEST, V103, P1579, DOI 10.1172/JCI6172; KOWAL RC, 1990, J BIOL CHEM, V265, P10771; Krasemann S, 2017, IMMUNITY, V47, P566, DOI 10.1016/j.immuni.2017.08.008; Kulminski AM, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004141; Larkin J, 2019, NEW ENGL J MED, V381, P1535, DOI 10.1056/NEJMoa1910836; Leach DR, 1996, SCIENCE, V271, P1734, DOI 10.1126/science.271.5256.1734; Liu JF, 2018, CELL, V173, P400, DOI 10.1016/j.cell.2018.02.052; Mahley RW, 2016, J MOL MED, V94, P739, DOI 10.1007/s00109-016-1427-y; Meeth K, 2016, PIGM CELL MELANOMA R, V29, P590, DOI 10.1111/pcmr.12498; NATHAN BP, 1994, SCIENCE, V264, P850, DOI 10.1126/science.8171342; Okazaki T, 2007, INT IMMUNOL, V19, P813, DOI 10.1093/intimm/dxm057; Pencheva N, 2014, CELL, V156, P986, DOI 10.1016/j.cell.2014.01.038; Pencheva N, 2012, CELL, V151, P1068, DOI 10.1016/j.cell.2012.10.028; Ponomarev V, 2004, EUR J NUCL MED MOL I, V31, P740, DOI 10.1007/s00259-003-1441-5; Radmanesh F, 2014, EUR J HUM GENET, V22, P1239, DOI 10.1038/ejhg.2013.308; Riaz N, 2017, CELL, V171, P934, DOI 10.1016/j.cell.2017.09.028; Roh W, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aah3560; Shi Y, 2018, NAT REV IMMUNOL, V18, P759, DOI 10.1038/s41577-018-0051-1; Shi Y, 2017, NATURE, V549, P523, DOI 10.1038/nature24016; STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P1977, DOI 10.1073/pnas.90.5.1977; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sullivan PM, 1997, J BIOL CHEM, V272, P17972, DOI 10.1074/jbc.272.29.17972; Sullivan PM, 1998, J CLIN INVEST, V102, P130, DOI 10.1172/JCI2673; Tavazoie MF, 2018, CELL, V172, P825, DOI 10.1016/j.cell.2017.12.026; Toledo A, 2015, P NATL ACAD SCI USA, V112, P5491, DOI 10.1073/pnas.1502561112; Wang J, 2017, PIGM CELL MELANOMA R, V30, P428, DOI 10.1111/pcmr.12591; WEISGRABER KH, 1982, J BIOL CHEM, V257, P2518; Xian XD, 2018, ELIFE, V7, DOI 10.7554/eLife.40048; Yoshida H, 2019, CELL, V176, P897, DOI 10.1016/j.cell.2018.12.036; Young L, 2010, NAT PROTOC, V5, P929, DOI 10.1038/nprot.2010.43; Yu GC, 2012, OMICS, V16, P284, DOI 10.1089/omi.2011.0118	42	29	29	1	21	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	JUL	2020	26	7					1048	+		10.1038/s41591-020-0879-3	http://dx.doi.org/10.1038/s41591-020-0879-3		MAY 2020	22	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	MK3XO	32451497	Green Submitted, Green Accepted			2022-12-27	WOS:000535406400004
J	Moyer, TJ; Kato, Y; Abraham, W; Chang, JYH; Kulp, DW; Watson, N; Turner, HL; Menis, S; Abbott, RK; Bhiman, JN; Melo, MB; Simon, HA; Herrera-De la Mata, S; Liang, S; Seumois, G; Agarwal, Y; Li, N; Burton, DR; Ward, AB; Schief, WR; Crotty, S; Irvine, DJ				Moyer, Tyson J.; Kato, Yu; Abraham, Wuhbet; Chang, Jason Y. H.; Kulp, Daniel W.; Watson, Nicki; Turner, Hannah L.; Menis, Sergey; Abbott, Robert K.; Bhiman, Jinal N.; Melo, Mariane B.; Simon, Hayley A.; Herrera-De la Mata, Sara; Liang, Shu; Seumois, Gregory; Agarwal, Yash; Li, Na; Burton, Dennis R.; Ward, Andrew B.; Schief, William R.; Crotty, Shane; Irvine, Darrell J.			A Engineered immunogen binding to alum adjuvant enhances humoral immunity (vol 153, pg 272, 2020)	NATURE MEDICINE			English	Correction							SYSTEM						Schief, William/ABF-3645-2020; Ward, Andrew/ABD-7728-2021	Schief, William/0000-0002-1120-0150; Ward, Andrew/0000-0001-7153-3769; Chang, Jason Y.H./0000-0002-2238-8232	NIH HHS [S10 OD025052] Funding Source: Medline	NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Lander GC, 2009, J STRUCT BIOL, V166, P95, DOI 10.1016/j.jsb.2009.01.002; Moyer TJ, 2020, NAT MED, V26, P430, DOI 10.1038/s41591-020-0753-3; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Potter CS, 1999, ULTRAMICROSCOPY, V77, P153, DOI 10.1016/S0304-3991(99)00043-1; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Voss NR, 2009, J STRUCT BIOL, V166, P205, DOI 10.1016/j.jsb.2009.01.004; Zhao ZZ, 2014, J STRUCT BIOL, V186, P153, DOI 10.1016/j.jsb.2014.03.003	7	1	1	2	15	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	MAY	2020	26	5					804	804		10.1038/s41591-020-0861-0	http://dx.doi.org/10.1038/s41591-020-0861-0			1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	ML1MY	32405059	Green Published, Bronze			2022-12-27	WOS:000549240200009
J	Wakeman, SE; Green, TC; Rich, J				Wakeman, Sarah E.; Green, Traci C.; Rich, Josiah			An overdose surge will compound the COVID-19 pandemic if urgent action is not taken	NATURE MEDICINE			English	Article								In the USA and around the world, the COVID-19 pandemic arrived as the population was fighting a devastating opioid overdose epidemic. Urgent and decisive action is needed to protect particularly vulnerable populations, such as those with opioid use disorder, to prevent a compounding effect on public health.	[Wakeman, Sarah E.] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Wakeman, Sarah E.] Harvard Med Sch, Boston, MA 02115 USA; [Green, Traci C.] Brandeis Univ, Heller Sch Social Policy & Management, Waltham, MA USA; [Green, Traci C.; Rich, Josiah] Brown Univ, Warren Alpert Sch Med, Providence, RI 02912 USA; [Rich, Josiah] Miriam Hosp, Ctr Prisoner Hlth & Human Rights, Providence, RI 02906 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Brandeis University; Brown University; Lifespan Health Rhode Island; Miriam Hospital	Wakeman, SE (corresponding author), Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA.; Wakeman, SE (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.	swakeman@partners.org			US National Institutes of Health [P20GM125507]; Massachusetts General Hospital from the National Institutes of Health [1R01DA044526-01A1]; National Institute on Drug Abuse [3UG1DA01583117S2]; Substance Abuse and Mental Health Services Administration [1H79TI081442-01]; Laura and John Arnold Foundation	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Massachusetts General Hospital from the National Institutes of Health; National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Substance Abuse and Mental Health Services Administration(United States Department of Health & Human Services); Laura and John Arnold Foundation	The input of T.C.G. and J.R. to this manuscript was funded, in part, by US National Institutes of Health grant number P20GM125507. S.E.W. has received research support through Massachusetts General Hospital from the National Institutes of Health (1R01DA044526-01A1), the National Institute on Drug Abuse (3UG1DA01583117S2), the Substance Abuse and Mental Health Services Administration (1H79TI081442-01) and the Laura and John Arnold Foundation, and received salary support from OptumLabs as a co-investigator on a research project.	Akiyama M. J., 2020, J MED, DOI [10.1056/NEJMp2005687, DOI 10.1056/NEJMP2005687]; Ciccarone D, 2019, INT J DRUG POLICY, V71, P183, DOI 10.1016/j.drugpo.2019.01.010; John WS, 2019, DRUG ALCOHOL DEPEN, V194, P468, DOI 10.1016/j.drugalcdep.2018.11.011; Wakeman SE, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2019.20622; Wood EF, 2017, INT J DRUG POLICY, V41, P132, DOI 10.1016/j.drugpo.2016.12.010	5	76	76	0	4	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	JUN	2020	26	6					819	820		10.1038/s41591-020-0898-0	http://dx.doi.org/10.1038/s41591-020-0898-0		MAY 2020	2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	LZ3ZG	32555514	Bronze, Green Accepted			2022-12-27	WOS:000529767100001
J	[Anonymous]				[Anonymous]			Functionally assessing coronavirus entry	NATURE MEDICINE			English	Editorial Material																			0	0	0	0	2	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	APR	2020	26	4					465	465		10.1038/s41591-020-0847-y	http://dx.doi.org/10.1038/s41591-020-0847-y			1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	QH1UE	32273603	Bronze			2022-12-27	WOS:000618061900012
J	Sattar, N; Gill, JMR; Alazawi, W				Sattar, Naveed; Gill, Jason M. R.; Alazawi, William			Improving prevention strategies for cardiometabolic disease	NATURE MEDICINE			English	Article							CARDIOVASCULAR-DISEASE; PRIMARY-CARE; RISK-ASSESSMENT; GRIP STRENGTH; INTERVENTION; MORTALITY; GLUCOSE; PEOPLE; COHORT	There is a growing burden of cardiometabolic disease in many parts of the world. Despite some progress in its prevention, more can be done to tackle risks of its development in the community and in different specialty clinics. Currently, the identification and management of those at elevated risk of developing cardiovascular disease or diabetes or with conditions such as fatty liver disease remains fragmented and is not linked to constructive lifestyle advice. In this Perspective, we argue for a more consistent weight-management approach, alongside a holistic assessment of the risk for developing cardiometabolic diseases, offering patients a range of simple or more-intensive evidence-based lifestyle options in an empathetic manner, with encouragement for repeated attempts and a willingness to embrace failure. The authors argue for a consistent weight-management approach, alongside an assessment of the risk for developing cardiometabolic diseases as a prevention strategy.	[Sattar, Naveed; Gill, Jason M. R.] Univ Glasgow, Inst Cardiovasc & Med Sci, BHF Glasgow Cardiovasc Res Ctr, Glasgow, Lanark, Scotland; [Alazawi, William] Queen Mary Univ London, Blizard Inst, London, England	University of Glasgow; University of London; Queen Mary University London	Sattar, N (corresponding author), Univ Glasgow, Inst Cardiovasc & Med Sci, BHF Glasgow Cardiovasc Res Ctr, Glasgow, Lanark, Scotland.	naveed.sattar@glasgow.ac.uk		Alazawi, William/0000-0002-3891-5914; Sattar, Naveed/0000-0002-1604-2593	British Heart Foundation Research Excellence Award [RE/18/6/34217]; MRC [MR/N00308X/1] Funding Source: UKRI	British Heart Foundation Research Excellence Award; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	N.S. receives funding from the British Heart Foundation Research Excellence Award (RE/18/6/34217). We thank L. Coyle for technical support.	Ahern AL, 2017, LANCET, V389, P2214, DOI 10.1016/S0140-6736(17)30647-5; Astbury NM, 2018, BMJ-BRIT MED J, V362, DOI 10.1136/bmj.k3760; Aveyard P, 2016, LANCET, V388, P2492, DOI 10.1016/S0140-6736(16)31893-1; Barnard ND, 2019, JAMA INTERN MED, V179, P1021, DOI 10.1001/jamainternmed.2019.2273; Bluher M, 2019, NAT REV ENDOCRINOL, V15, P288, DOI 10.1038/s41574-019-0176-8; Celis-Morales Carlos A, 2017, BMJ, V357, pj1456, DOI 10.1136/bmj.j1456; Celis-Morales CA, 2018, BMJ-BRIT MED J, V361, DOI 10.1136/bmj.k1651; Chang KCM, 2015, PREV MED, V78, P1, DOI 10.1016/j.ypmed.2015.05.022; Chang LS, 2019, CURR DIABETES REP, V19, DOI 10.1007/s11892-019-1260-0; Dagenais GR, 2020, LANCET, V395, P785, DOI 10.1016/S0140-6736(19)32007-0; Danaei G, 2011, LANCET, V378, P31, DOI 10.1016/S0140-6736(11)60679-X; Donnelly LA, 2018, DIABETOLOGIA, V61, P607, DOI 10.1007/s00125-017-4519-5; EKELUND U, 2019, BMJ BRIT MED J, V366; Feter N, 2019, INT J PUBLIC HEALTH, V64, P679, DOI 10.1007/s00038-019-01210-7; Gong QH, 2019, LANCET DIABETES ENDO, V7, P452, DOI 10.1016/S2213-8587(19)30093-2; Gregg EW, 2016, LANCET DIABETES ENDO, V4, P537, DOI 10.1016/S2213-8587(16)30010-9; Harris T, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002210; HIPPISLEYCOX J, 2017, BMJ BRIT MED J, V357; Hussain S, 2019, DRUGS, V79, P231, DOI 10.1007/s40265-019-1061-4; Jebb SA, 2011, LANCET, V378, P1485, DOI 10.1016/S0140-6736(11)61344-5; Jensen P, 2016, AM J CLIN NUTR, V104, P259, DOI 10.3945/ajcn.115.125849; Jorgensen T, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g3617; Kamada M, 2017, J AM HEART ASSOC, V6, DOI [10.1161/jaha.117.007677, 10.1161/JAHA.117.007677]; Kliemann N, 2019, JMIR MHEALTH UHEALTH, V7, DOI 10.2196/12326; Kristensen SL, 2019, LANCET DIABETES ENDO, V7, P776, DOI 10.1016/S2213-8587(19)30249-9; Larsson SC, 2020, EUR HEART J, V41, P221, DOI 10.1093/eurheartj/ehz388; Lean MEJ, 2019, LANCET DIABETES ENDO, V7, P344, DOI 10.1016/S2213-8587(19)30068-3; Leong DP, 2015, LANCET, V386, P266, DOI 10.1016/S0140-6736(14)62000-6; Lim EL, 2011, DIABETOLOGIA, V54, P2506, DOI 10.1007/s00125-011-2204-7; Mihaylova B, 2012, LANCET, V380, P581, DOI 10.1016/S0140-6736(12)60367-5; Murphy MH, 2019, SPORTS MED, V49, P1585, DOI 10.1007/s40279-019-01145-2; Nicholson BD, 2019, BMC MED, V17, DOI 10.1186/s12916-019-1446-y; OSORIO M, 2020, JAMA INT MED; Piepoli MF, 2016, ATHEROSCLEROSIS, V252, P207, DOI [10.1177/2047487316653709, 10.1016/j.atherosclerosis.2016.05.037]; Piercy KL, 2018, JAMA-J AM MED ASSOC, V320, P2020, DOI 10.1001/jama.2018.14854; Preiss D, 2011, DIABETIC MED, V28, P19, DOI 10.1111/j.1464-5491.2010.03157.x; Sattar N, 2008, LANCET, V371, P1927, DOI 10.1016/S0140-6736(08)60602-9; Stamatakis E, 2018, AM J EPIDEMIOL, V187, P1102, DOI 10.1093/aje/kwx345; Steinarsson AO, 2018, DIABETOLOGIA, V61, P599, DOI 10.1007/s00125-017-4532-8; Sun XJ, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4242-7; Ueda P, 2017, LANCET DIABETES ENDO, V5, P196, DOI 10.1016/S2213-8587(17)30015-3; Valabhji J, 2020, DIABETES CARE, V43, P152, DOI 10.2337/dc19-1425; Welsh C, 2020, DIABETES CARE, V43, P440, DOI 10.2337/dc19-1683; Williams B, 2018, EUR HEART J, V39, P3021, DOI 10.1093/eurheartj/ehy339; Wyke S, 2019, PLOS MED, V16, DOI 10.1371/journal.pmed.1002736; Zelniker TA, 2019, LANCET, V393, P31, DOI 10.1016/S0140-6736(18)32590-X	46	32	33	1	8	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	MAR	2020	26	3					320	325		10.1038/s41591-020-0786-7	http://dx.doi.org/10.1038/s41591-020-0786-7		MAR 2020	6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	KU0MC	32152584	Green Accepted, Green Submitted			2022-12-27	WOS:000518737200005
J	Painter, CA; Jain, E; Tomson, BN; Dunphy, M; Stoddard, RE; Thomas, BS; Damon, AL; Shah, S; Kim, D; Zanudo, JGT; Hornick, JL; Chen, YL; Merriam, P; Raut, CP; Demetri, GD; Van Tine, BA; Lander, ES; Golub, TR; Wagle, N				Painter, Corrie A.; Jain, Esha; Tomson, Brett N.; Dunphy, Michael; Stoddard, Rachel E.; Thomas, Beena S.; Damon, Alyssa L.; Shah, Shahrayz; Kim, Dewey; Zanudo, Jorge Gomez Tejeda; Hornick, Jason L.; Chen, Yen-Lin; Merriam, Priscilla; Raut, Chandrajit P.; Demetri, George D.; Van Tine, Brian A.; Lander, Eric S.; Golub, Todd R.; Wagle, Nikhil			The Angiosarcoma Project: enabling genomic and clinical discoveries in a rare cancer through patient-partnered research	NATURE MEDICINE			English	Article							MUTATIONAL LANDSCAPE; CTLA-4 BLOCKADE; PIK3CA; AMPLIFICATION; ACTIVATION; FREQUENT; MYC	Despite rare cancers accounting for 25% of adult tumors(1), they are difficult to study due to the low disease incidence and geographically dispersed patient populations, which has resulted in significant unmet clinical needs for patients with rare cancers. We assessed whether a patient-partnered research approach using online engagement can overcome these challenges, focusing on angiosarcoma, a sarcoma with an annual incidence of 300 cases in the United States. Here we describe the development of the Angiosarcoma Project (ASCproject), an initiative enabling US and Canadian patients to remotely share their clinical information and biospecimens for research. The project generates and publicly releases clinically annotated genomic data on tumor and germline specimens on an ongoing basis. Over 18 months, 338 patients registered for the ASCproject, which comprises a large proportion of all patients with angiosarcoma. Whole-exome sequencing (WES) of 47 tumors revealed recurrently mutated genes that included KDR, TP53, and PIK3CA. PIK3CA-activating mutations were observed predominantly in primary breast angiosarcoma, which suggested a therapeutic rationale. Angiosarcoma of the head, neck, face and scalp (HNFS) was associated with a high tumor mutation burden (TMB) and a dominant ultraviolet damage mutational signature, which suggested that for the subset of patients with angiosarcoma of HNFS, ultraviolet damage may be a causative factor and that immune checkpoint inhibition may be beneficial. Medical record review revealed that two patients with HNFS angiosarcoma had received off-label therapeutic use of antibody to the programmed death-1 protein (anti-PD-1) and had experienced exceptional responses, which highlights immune checkpoint inhibition as a therapeutic avenue for HNFS angiosarcoma. This patient-partnered approach has catalyzed an opportunity to discover the etiology and potential therapies for patients with angiosarcoma. Collectively, this proof-of-concept study demonstrates that empowering patients to directly participate in research can overcome barriers in rare diseases and can enable discoveries. A framework of patient-partnered research allows patients with angiosarcoma to share their samples and clinical records securely to accelerate molecular characterization of tumors and identification of therapeutic approaches.	[Painter, Corrie A.; Jain, Esha; Tomson, Brett N.; Dunphy, Michael; Stoddard, Rachel E.; Thomas, Beena S.; Damon, Alyssa L.; Shah, Shahrayz; Kim, Dewey; Lander, Eric S.; Golub, Todd R.; Wagle, Nikhil] Count Me In, Cambridge, MA 02142 USA; [Painter, Corrie A.; Jain, Esha; Tomson, Brett N.; Dunphy, Michael; Stoddard, Rachel E.; Thomas, Beena S.; Damon, Alyssa L.; Shah, Shahrayz; Kim, Dewey; Zanudo, Jorge Gomez Tejeda; Lander, Eric S.; Golub, Todd R.; Wagle, Nikhil] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Jain, Esha; Kim, Dewey; Zanudo, Jorge Gomez Tejeda; Merriam, Priscilla; Demetri, George D.; Wagle, Nikhil] Harvard Med Sch, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Hornick, Jason L.] Harvard Med Sch, Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Chen, Yen-Lin] Massachusetts Gen Hosp, Dept Radiat Oncol, Boston, MA 02114 USA; [Merriam, Priscilla; Raut, Chandrajit P.; Demetri, George D.] Harvard Med Sch, Ctr Sarcoma & Bone Oncol, Dana Farber Canc Inst, Boston, MA 02115 USA; [Raut, Chandrajit P.] Harvard Med Sch, Brigham & Womens Hosp, Dept Surg, Boston, MA 02115 USA; [Demetri, George D.] Harvard Med Sch, Ludwig Ctr Harvard, Boston, MA 02115 USA; [Van Tine, Brian A.] Washington Univ, Sch Med, Div Oncol, St Louis, MO USA; [Lander, Eric S.] MIT, Dept Biol, Cambridge, MA USA; [Lander, Eric S.] Harvard Med Sch, Dept Syst Biol, Boston, MA 02115 USA; [Golub, Todd R.] Harvard Med Sch, Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; [Wagle, Nikhil] Harvard Med Sch, Ctr Canc Genom, Dana Farber Canc Inst, Boston, MA 02115 USA; [Wagle, Nikhil] Harvard Med Sch, Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; Washington University (WUSTL); Massachusetts Institute of Technology (MIT); Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Wagle, N (corresponding author), Count Me In, Cambridge, MA 02142 USA.; Wagle, N (corresponding author), Broad Inst MIT & Harvard, Cambridge, MA 02142 USA.; Wagle, N (corresponding author), Harvard Med Sch, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA.; Wagle, N (corresponding author), Harvard Med Sch, Ctr Canc Genom, Dana Farber Canc Inst, Boston, MA 02115 USA.; Wagle, N (corresponding author), Harvard Med Sch, Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA.	nikhil_wagle@dfci.harvard.edu		Gomez Tejeda Zanudo, Jorge/0000-0002-1092-0068; Jain, Esha/0000-0003-1201-2052; Painter, Corrie/0000-0001-6174-1548				Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Andre F, 2019, NEW ENGL J MED, V380, P1929, DOI 10.1056/NEJMoa1813904; Arora TK, 2014, GLAND SURG, V3, P28, DOI [10.3978/j.issn.2227-684X.2013.12.03S, 10.3978/j.issn.2227-684X.2013.12.03]; Behjati S, 2014, NAT GENET, V46, P376, DOI 10.1038/ng.2921; Campbell BB, 2017, CELL, V171, P1042, DOI 10.1016/j.cell.2017.09.048; Chang MT, 2018, CANCER DISCOV, V8, P174, DOI 10.1158/2159-8290.CD-17-0321; Ciriello G, 2015, CELL, V163, P506, DOI 10.1016/j.cell.2015.09.033; Cohen-Hallaleh RB, 2017, CLIN SARCOMA RES, V7, DOI 10.1186/s13569-017-0081-7; Conway JR, 2018, GENOME MED, V10, DOI 10.1186/s13073-018-0605-7; Dogruluk T, 2015, CANCER RES, V75, P5341, DOI 10.1158/0008-5472.CAN-15-1654; Giacomini CP, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003464; Girard N, 2010, CLIN CANCER RES, V16, P755, DOI 10.1158/1078-0432.CCR-09-2437; Griewank KG, 2014, MODERN PATHOL, V27, P502, DOI 10.1038/modpathol.2013.168; Guo TH, 2011, GENE CHROMOSOME CANC, V50, P25, DOI 10.1002/gcc.20827; Gymnopoulos M, 2007, P NATL ACAD SCI USA, V104, P5569, DOI 10.1073/pnas.0701005104; Hoang NT, 2018, CANCER MANAG RES, V10, P1089, DOI 10.2147/CMAR.S159641; Hodis E, 2012, CELL, V150, P251, DOI 10.1016/j.cell.2012.06.024; Hon WC, 2012, ONCOGENE, V31, P3655, DOI 10.1038/onc.2011.532; Ikenoue T, 2005, CANCER RES, V65, P4562, DOI 10.1158/0008-5472.CAN-04-4114; Italiano A, 2012, CANCER-AM CANCER SOC, V118, P5878, DOI 10.1002/cncr.27614; Juric D, 2019, JAMA ONCOL, V5, DOI 10.1001/jamaoncol.2018.4475; Juric D, 2018, J CLIN ONCOL, V36, P1291, DOI 10.1200/JCO.2017.72.7107; Kandoth C, 2013, NATURE, V502, P333, DOI 10.1038/nature12634; Karube R, 2012, INT J ORAL SCI, V4, P166, DOI 10.1038/ijos.2012.36; Kunze K, 2014, CANCER RES, V74, P6173, DOI 10.1158/0008-5472.CAN-14-1162; Lahat G, 2010, ANN SURG, V251, P1098, DOI 10.1097/SLA.0b013e3181dbb75a; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Lazar AJ, 2017, CELL, V171, P950, DOI 10.1016/j.cell.2017.10.014; LEE FI, 1974, LANCET, V1, P1316; Levine RL, 2005, CANCER CELL, V7, P387, DOI 10.1016/j.ccr.2005.03.023; Mullins B, 2015, INT ARCH OTORHINOLAR, V19, P191, DOI 10.1055/s-0035-1547520; Murali R, 2015, ONCOTARGET, V6, P36041, DOI 10.18632/oncotarget.5936; Rizvi NA, 2015, SCIENCE, V348, P124, DOI 10.1126/science.aaa1348; Samstein RM, 2019, NAT GENET, V51, P202, DOI 10.1038/s41588-018-0312-8; Sharifnia T, 2017, CELL CHEM BIOL, V24, P1075, DOI 10.1016/j.chembiol.2017.08.002; Shon W, 2014, MODERN PATHOL, V27, P509, DOI 10.1038/modpathol.2013.163; Snyder A, 2014, NEW ENGL J MED, V371, P2189, DOI 10.1056/NEJMoa1406498; Van Allen EM, 2015, SCIENCE, V350, P207, DOI 10.1126/science.aad0095; van Rooij N, 2013, J CLIN ONCOL, V31, pE439, DOI 10.1200/JCO.2012.47.7521; Zehir A, 2017, NAT MED, V23, P703, DOI 10.1038/nm.4333	40	85	86	0	6	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	FEB	2020	26	2					181	+		10.1038/s41591-019-0749-z	http://dx.doi.org/10.1038/s41591-019-0749-z		FEB 2020	26	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	KK7DU	32042194	Green Submitted			2022-12-27	WOS:000512529400003
J	Krystal, JH				Krystal, John H.			Imaging the glutamate synapse	NATURE MEDICINE			English	Editorial Material							HIPPOCAMPAL AMPA; RECEPTOR; BINDING	A new positron emission tomography radiotracer enables imaging of the human glutamate receptor AMPA-R, a fundamental component of neurotransmission involved in neuropsychiatric disorders.	[Krystal, John H.] Yale Univ, Dept Psychiat, New Haven, CT 06520 USA; [Krystal, John H.] Yale Univ, Dept Neurosci, New Haven, CT 06520 USA; [Krystal, John H.] Yale Univ, Dept Psychol, New Haven, CT 06520 USA	Yale University; Yale University; Yale University	Krystal, JH (corresponding author), Yale Univ, Dept Psychiat, New Haven, CT 06520 USA.; Krystal, JH (corresponding author), Yale Univ, Dept Neurosci, New Haven, CT 06520 USA.; Krystal, JH (corresponding author), Yale Univ, Dept Psychol, New Haven, CT 06520 USA.	john.krystal@yale.edu			NCATS NIH HHS [UL1 TR001863] Funding Source: Medline; U.S. Department of Health &amp; Human Services | NIH | National Institute on Alcohol Abuse and Alcoholism (NIAAA) [P50 AA021818] Funding Source: Medline	NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); U.S. Department of Health &amp; Human Services | NIH | National Institute on Alcohol Abuse and Alcoholism (NIAAA)		Ahmed AH, 2010, BIOCHEMISTRY-US, V49, P2843, DOI 10.1021/bi1000678; Bressan RA, 2005, BIOL PSYCHIAT, V58, P41, DOI 10.1016/j.biopsych.2005.03.016; DeLorenzo C, 2015, BIOL PSYCHIAT, V77, P266, DOI 10.1016/j.biopsych.2014.06.024; Finnema SJ, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf6667; Lam J, 2019, ANN NEUROL, V85, P218, DOI 10.1002/ana.25404; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; Martin-Facklam M, 2013, NEUROPSYCHOPHARMACOL, V38, P504, DOI 10.1038/npp.2012.212; Mathern GW, 1998, J NEUROPATH EXP NEUR, V57, P615, DOI 10.1097/00005072-199806000-00008; Mathern GW, 1997, BRAIN, V120, P1937, DOI 10.1093/brain/120.11.1937; Miyazaki T, 2020, NAT MED, V26, P281, DOI 10.1038/s41591-019-0723-9; Pilowsky LS, 2006, MOL PSYCHIATR, V11, P118, DOI 10.1038/sj.mp.4001751	11	1	2	1	11	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	FEB	2020	26	2					165	167		10.1038/s41591-020-0760-4	http://dx.doi.org/10.1038/s41591-020-0760-4		FEB 2020	3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	KK7DU	32015559				2022-12-27	WOS:000510822600005
J	Chivukula, RR; Montoro, DT; Leung, HM; Yang, J; Shamseldin, HE; Taylor, MS; Dougherty, GW; Zariwala, MA; Carson, J; Daniels, MLA; Sears, PR; Black, KE; Hariri, LP; Almogarri, I; Frenkel, EM; Vinarsky, V; Omran, H; Knowles, MR; Tearney, GJ; Alkuraya, FS; Sabatini, DM				Chivukula, Raghu R.; Montoro, Daniel T.; Leung, Hui Min; Yang, Jason; Shamseldin, Hanan E.; Taylor, Martin S.; Dougherty, Gerard W.; Zariwala, Maimoona A.; Carson, Johnny; Daniels, M. Leigh Anne; Sears, Patrick R.; Black, Katharine E.; Hariri, Lida P.; Almogarri, Ibrahim; Frenkel, Evgeni M.; Vinarsky, Vladimir; Omran, Heymut; Knowles, Michael R.; Tearney, Guillermo J.; Alkuraya, Fowzan S.; Sabatini, David M.			A human ciliopathy reveals essential functions for NEK10 in airway mucociliary clearance	NATURE MEDICINE			English	Article							MICROTUBULE-DEPOLYMERIZING KINESIN; NIMA-RELATED KINASE; CILIARY LENGTH; GENES; IDENTIFICATION; MUTATIONS	Mucociliary clearance, the physiological process by which mammalian conducting airways expel pathogens and unwanted surface materials from the respiratory tract, depends on the coordinated function of multiple specialized cell types, including basal stem cells, mucus-secreting goblet cells, motile ciliated cells, cystic fibrosis transmembrane conductance regulator (CFTR)-rich ionocytes, and immune cells(1,2). Bronchiectasis, a syndrome of pathological airway dilation associated with impaired mucociliary clearance, may occur sporadically or as a consequence of Mendelian inheritance, for example in cystic fibrosis, primary ciliary dyskinesia (PCD), and select immunodeficiencies(3). Previous studies have identified mutations that affect ciliary structure and nucleation in PCD4, but the regulation of mucociliary transport remains incompletely understood, and therapeutic targets for its modulation are lacking. Here we identify a bronchiectasis syndrome caused by mutations that inactivate NIMA-related kinase 10 (NEK10), a protein kinase with previously unknown in vivo functions in mammals. Genetically modified primary human airway cultures establish NEK10 as a ciliated-cell-specific kinase whose activity regulates the motile ciliary proteome to promote ciliary length and mucociliary transport but which is dispensable for normal ciliary number, radial structure, and beat frequency. Together, these data identify a novel and likely targetable signaling axis that controls motile ciliary function in humans and has potential implications for other respiratory disorders that are characterized by impaired mucociliary clearance. Inactivating mutations in a protein kinase, NEK10, cause a genetic bronchiectasis syndrome in humans that is characterized by short motile cilia and impaired mucociliary transport.	[Chivukula, Raghu R.; Black, Katharine E.; Vinarsky, Vladimir] Massachusetts Gen Hosp, Dept Med, Div Pulm & Crit Care Med, Boston, MA 02114 USA; [Chivukula, Raghu R.; Yang, Jason; Taylor, Martin S.; Frenkel, Evgeni M.; Sabatini, David M.] Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA; [Chivukula, Raghu R.; Yang, Jason; Taylor, Martin S.; Frenkel, Evgeni M.; Sabatini, David M.] MIT, Howard Hughes Med Inst, Dept Biol, Cambridge, MA 02139 USA; [Chivukula, Raghu R.; Montoro, Daniel T.; Yang, Jason; Taylor, Martin S.; Frenkel, Evgeni M.; Sabatini, David M.] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Chivukula, Raghu R.; Yang, Jason; Taylor, Martin S.; Frenkel, Evgeni M.; Sabatini, David M.] MIT, Dept Biol, Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA; [Leung, Hui Min; Tearney, Guillermo J.] Massachusetts Gen Hosp, Wellman Ctr Photomed, Boston, MA 02114 USA; [Leung, Hui Min; Tearney, Guillermo J.] Harvard Med Sch, Boston, MA 02115 USA; [Shamseldin, Hanan E.; Omran, Heymut; Alkuraya, Fowzan S.] King Faisal Specialist Hosp & Res Ctr, Dept Genet, Riyadh, Saudi Arabia; [Taylor, Martin S.; Hariri, Lida P.; Tearney, Guillermo J.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Dougherty, Gerard W.] Univ Childrens Hosp Muenster, Dept Gen Pediat, Munster, Germany; [Zariwala, Maimoona A.] Univ N Carolina, Dept Pathol & Lab Med, Chapel Hill, NC 27515 USA; [Carson, Johnny] Univ N Carolina, Dept Pediat, Chapel Hill, NC 27515 USA; [Daniels, M. Leigh Anne] Univ N Carolina, Dept Med, Div Pulm Dis & Crit Care Med, Chapel Hill, NC 27515 USA; [Sears, Patrick R.; Knowles, Michael R.] Univ N Carolina, Cyst Fibrosis Pulm Res & Treatment Ctr, Chapel Hill, NC 27515 USA; [Almogarri, Ibrahim] King Faisal Specialist Hosp & Res Ctr, Dept Pediat, Riyadh, Saudi Arabia; [Knowles, Michael R.] Univ N Carolina, Marsico Lung Inst, Chapel Hill, NC 27515 USA; [Tearney, Guillermo J.] Harvard Mit Div Hlth Sci & Technol, Cambridge, MA USA	Harvard University; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Whitehead Institute; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; King Faisal Specialist Hospital & Research Center; Harvard University; Massachusetts General Hospital; University of Munster; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; King Faisal Specialist Hospital & Research Center; University of North Carolina; University of North Carolina Chapel Hill; Harvard University	Chivukula, RR (corresponding author), Massachusetts Gen Hosp, Dept Med, Div Pulm & Crit Care Med, Boston, MA 02114 USA.; Chivukula, RR (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.; Chivukula, RR (corresponding author), MIT, Howard Hughes Med Inst, Dept Biol, Cambridge, MA 02139 USA.; Chivukula, RR (corresponding author), Broad Inst MIT & Harvard, Cambridge, MA 02142 USA.; Chivukula, RR (corresponding author), MIT, Dept Biol, Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA.; Alkuraya, FS (corresponding author), King Faisal Specialist Hosp & Res Ctr, Dept Genet, Riyadh, Saudi Arabia.	raghu@wi.mit.edu; falkuraya@kfshrc.edu.sa	Ariel, Pablo/AGJ-4118-2022	Omran, Heymut/0000-0003-0282-6765; Daniels, Leigh Anne/0000-0001-6979-2681; Leung, Hui Min/0000-0003-3259-3720; Montoro, Daniel/0000-0002-6222-2149; Taylor, Martin/0000-0001-5824-142X	National Institutes of Health [T32HL116275, T32CA009216, U54HL096458, UL1TR000083, R01HL071798, R01HL117836-01, R01CA129105, R37AI047389]; Massachusetts General Hospital Department of Medicine Pathways program; King Salman Center for Disability Research; Saudi Human Genome Program; National Institutes of Health Shared Instrumentation Grant [1S10OD012027-01A1]; Primary Ciliary Dyskinesia Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Massachusetts General Hospital Department of Medicine Pathways program; King Salman Center for Disability Research; Saudi Human Genome Program; National Institutes of Health Shared Instrumentation Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Primary Ciliary Dyskinesia Foundation	We are grateful to the patients and family members who participated in this research. We thank J. Rajagopal for advice and reagents, B. Stripp (Cedars-Sinai) and I. Cheeseman (Whitehead Institute for Biomedical Research) for antibodies, the Peterson (1957) Nanotechnology Materials Core Facility at the Koch Institute for electron microscopy services, S. Mordecai for advice and assistance with IFC, H. Zheng for assistance with statistical methods, M. Mino-Kenudson for pulmonary pathology assistance, KFSHRC genotyping and sequencing core facilities for technical help, M. Manion and the Primary Ciliary Dyskinesia Foundation for support, L. Ostrowski for assistance with ciliary motility studies, K. Sullivan and N. Capps for patient coordination and specimen collection, V. Madden, J. Stonebraker, R. Pace, and K. Burns for technical assistance, H. Dang and H. Namkoong for bioinformatics assistance, and A. Lee and members of the Sabatini laboratory for critical reading of the manuscript. This work was supported by grants from the National Institutes of Health: T32HL116275 (R.R.C.), T32CA009216 (M.S.T.), U54HL096458 and UL1TR000083 (M.R.K., M.A.Z., M.L.D., and P.R.S.), R01HL071798 (M.R.K., M.L.D., and M.A.Z.), R01HL117836-01 (M.R.K., M.L.D., and M.A.Z.), R01CA129105 and R37AI047389 (D.M.S.). Additional funding support was provided by the Massachusetts General Hospital Department of Medicine Pathways program (R.R.C.) and by the King Salman Center for Disability Research and the Saudi Human Genome Program (F.S.A.). The Amnis ImageStreamX Mk II was purchased using a National Institutes of Health Shared Instrumentation Grant 1S10OD012027-01A1 to Massachusetts General Hospital. D.M.S. is an investigator at the Howard Hughes Medical Institute and an American Cancer Society Research Professor.	[Anonymous], 2018, NATURE, V562, P367, DOI DOI 10.1038/S41586-018-0590-4; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Block H, 2009, METHOD ENZYMOL, V463, P439, DOI 10.1016/S0076-6879(09)63027-5; Boon M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5418; Bottier M, 2019, BIOPHYS J, V116, P1292, DOI 10.1016/j.bpj.2019.02.012; Bradley BA, 2005, J CELL SCI, V118, P3317, DOI 10.1242/jcs.02455; Braga FAV, 2019, NAT MED, V25, P1153, DOI 10.1038/s41591-019-0468-5; Broekhuis JR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108470; Carbon S, 2019, NUCLEIC ACIDS RES, V47, pD330, DOI 10.1093/nar/gky1055; Carr IM, 2006, HUM MUTAT, V27, P1041, DOI 10.1002/humu.20383; CARRERA AC, 1993, P NATL ACAD SCI USA, V90, P442, DOI 10.1073/pnas.90.2.442; Chen ZG, 2018, J THORAC DIS, V10, P1753, DOI 10.21037/jtd.2018.02.13; Doan M, 2018, TRENDS BIOTECHNOL, V36, P649, DOI 10.1016/j.tibtech.2017.12.008; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Fulcher M Leslie, 2005, Methods Mol Med, V107, P183; Gould CM, 2012, CLIN CHEST MED, V33, P249, DOI 10.1016/j.ccm.2012.03.002; He Y, 2016, NATURE, V530, P354, DOI 10.1038/nature16959; Hessel J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085453; Hilton LK, 2013, CURR BIOL, V23, P2208, DOI 10.1016/j.cub.2013.09.038; Hoffmann K, 2005, BIOINFORMATICS, V21, P3565, DOI 10.1093/bioinformatics/bti571; Ishikawa H, 2011, NAT REV MOL CELL BIO, V12, P222, DOI 10.1038/nrm3085; Karczewski K.J., 2019, GENOMICS, DOI [10.1101/531210, DOI 10.1101/531210]; Knowles MR, 2016, CLIN CHEST MED, V37, P449, DOI 10.1016/j.ccm.2016.04.008; Knowles MR, 2013, AM J RESP CRIT CARE, V188, P913, DOI 10.1164/rccm.201301-0059CI; Lai CK, 2011, MOL BIOL CELL, V22, P1104, DOI 10.1091/mbc.E10-07-0596; Leopold PL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008157; Lin HW, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005508; Liu L, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0052287, 10.1371/journal.pone.0061188, 10.1371/journal.pone.0083052]; Liu LB, 2011, NAT MED, V17, P1010, DOI 10.1038/nm.2409; Moniz L, 2010, THESIS; Moniz L, 2011, CELL DIV, V6, DOI 10.1186/1747-1028-6-18; Moniz LS, 2011, MOL CELL BIOL, V31, P30, DOI 10.1128/MCB.00648-10; Montoro DT, 2018, NATURE, V560, P319, DOI 10.1038/s41586-018-0393-7; Neuberger T, 2011, METHODS MOL BIOL, V741, P39, DOI 10.1007/978-1-61779-117-8_4; Niwa S, 2012, DEV CELL, V23, P1167, DOI 10.1016/j.devcel.2012.10.016; Oltean A, 2018, AM J RESP CELL MOL, V59, P511, DOI 10.1165/rcmb.2017-0436OC; Online Mendelian Inheritance in Man OMIM, 2019, ONL MEND INH MAN OMI; Osinka A, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8070730; Ostrowski L. E, 2005, CELL BIOL, V2; Ostrowski LE, 2003, MOL THER, V8, P637, DOI 10.1016/S1525-0016(03)00221-1; Ostrowski LE, 2002, MOL CELL PROTEOMICS, V1, P451, DOI 10.1074/mcp.M200037-MCP200; Perez-Riverol Y, 2019, NUCLEIC ACIDS RES, V47, pD442, DOI 10.1093/nar/gky1106; Piao T, 2009, P NATL ACAD SCI USA, V106, P4713, DOI 10.1073/pnas.0808671106; Porpora M, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03643-9; Reiter JF, 2017, NAT REV MOL CELL BIO, V18, P533, DOI 10.1038/nrm.2017.60; Richards MW, 2009, MOL CELL, V36, P560, DOI 10.1016/j.molcel.2009.09.038; Sbalzarini IF, 2005, J STRUCT BIOL, V151, P182, DOI 10.1016/j.jsb.2005.06.002; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Smith LA, 2006, J AM SOC NEPHROL, V17, P2821, DOI 10.1681/ASN.2006020136; Tammana TVS, 2013, J CELL SCI, V126, P5018, DOI 10.1242/jcs.133439; Teves ME, 2016, CYTOSKELETON, V73, P3, DOI 10.1002/cm.21271; Thiel C, 2011, AM J HUM GENET, V88, P106, DOI 10.1016/j.ajhg.2010.12.004; Tilley AE, 2015, ANNU REV PHYSIOL, V77, P379, DOI 10.1146/annurev-physiol-021014-071931; Vasudevan KK, 2015, MOL BIOL CELL, V26, P478, DOI 10.1091/mbc.E14-09-1354; Vladar EK, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.88027; Wallmeier J, 2014, NAT GENET, V46, P646, DOI 10.1038/ng.2961; Wang L, 2013, J CELL SCI, V126, P1531, DOI 10.1242/jcs.124255; Wang T, 2015, SCIENCE, V350, P1096, DOI 10.1126/science.aac7041; Wloga D, 2006, MOL BIOL CELL, V17, P2799, DOI 10.1091/mbc.E05-05-0450; Zariwala MA, 2007, ANNU REV PHYSIOL, V69, P423, DOI 10.1146/annurev.physiol.69.040705.141301; Zhao L, 2019, J CELL BIOL, V218, P2051, DOI 10.1083/jcb.201902017	61	29	30	0	12	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	FEB	2020	26	2					244	+		10.1038/s41591-019-0730-x	http://dx.doi.org/10.1038/s41591-019-0730-x		JAN 2020	22	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	KK7DU	31959991	Green Submitted, Green Accepted			2022-12-27	WOS:000510551600005
J	Liu, J; Lahousse, L; Nivard, MG; Bot, M; Chen, LM; van Klinken, JB; Thesing, CS; Beekman, M; van den Akker, EB; Slieker, RC; Waterham, E; van der Kallen, CJH; de Boer, I; Li-Gao, RF; Vojinovic, D; Amin, N; Radjabzadeh, D; Kraaij, R; Alferink, LJM; Murad, SD; Uitterlinden, AG; Willemsen, G; Pool, R; Milaneschi, Y; van Heemst, D; Suchiman, HED; Rutters, F; Elders, PJM; Beulens, JWJ; van der Heijden, AAWA; van Greevenbroek, MMJ; Arts, ICW; Onderwater, GLJ; van den Maagdenberg, AMJM; Mook-Kanamori, DO; Hankemeier, T; Terwindt, GM; Stehouwer, CDA; Geleijnse, JM; 't Hart, LM; Slagboom, PE; van Dijk, KW; Zhernakova, A; Fu, JY; Penninx, BWJH; Boomsma, DI; Demirkan, A; Stricker, BHC; van Duijn, CM				Liu, Jun; Lahousse, Lies; Nivard, Michel G.; Bot, Mariska; Chen, Lianmin; van Klinken, Jan Bert; Thesing, Carisha S.; Beekman, Marian; van den Akker, Erik Ben; Slieker, Roderick C.; Waterham, Eveline; van der Kallen, Carla J. H.; de Boer, Irene; Li-Gao, Ruifang; Vojinovic, Dina; Amin, Najaf; Radjabzadeh, Djawad; Kraaij, Robert; Alferink, Louise J. M.; Murad, Sarwa Darwish; Uitterlinden, Andre G.; Willemsen, Gonneke; Pool, Rene; Milaneschi, Yuri; van Heemst, Diana; Suchiman, H. Eka D.; Rutters, Femke; Elders, Petra J. M.; Beulens, Joline W. J.; van der Heijden, Amber A. W. A.; van Greevenbroek, Marleen M. J.; Arts, Ilja C. W.; Onderwater, Gerrit L. J.; van den Maagdenberg, Arn M. J. M.; Mook-Kanamori, Dennis O.; Hankemeier, Thomas; Terwindt, Gisela M.; Stehouwer, Coen D. A.; Geleijnse, Johanna M.; 't Hart, Leen M.; Slagboom, P. Eline; van Dijk, Ko Willems; Zhernakova, Alexandra; Fu, Jingyuan; Penninx, Brenda W. J. H.; Boomsma, Dorret I.; Demirkan, Ayse; Stricker, Bruno H. C.; van Duijn, Cornelia M.			Integration of epidemiologic, pharmacologic, genetic and gut microbiome data in a drug-metabolite atlas	NATURE MEDICINE			English	Article							MAGNETIC-RESONANCE METABOLOMICS; MENDELIAN RANDOMIZATION; CIRCULATING METABOLITES; DIABETES-MELLITUS; SERUM METABOLOME; RISK; OBESITY; POPULATION; PROFILES; DESIGN	Progress in high-throughput metabolic profiling provides unprecedented opportunities to obtain insights into the effects of drugs on human metabolism. The Biobanking BioMolecular Research Infrastructure of the Netherlands has constructed an atlas of drug-metabolite associations for 87 commonly prescribed drugs and 150 clinically relevant plasma-based metabolites assessed by proton nuclear magnetic resonance. The atlas includes a meta-analysis of ten cohorts (18,873 persons) and uncovers 1,071 drug-metabolite associations after evaluation of confounders including co-treatment. We show that the effect estimates of statins on metabolites from the cross-sectional study are comparable to those from intervention and genetic observational studies. Further data integration links proton pump inhibitors to circulating metabolites, liver function, hepatic steatosis and the gut microbiome. Our atlas provides a tool for targeted experimental pharmaceutical research and clinical trials to improve drug efficacy, safety and repurposing. We provide a web-based resource for visualization of the atlas (http://bbmri.researchlumc.nl/atlas/).	[Liu, Jun; Lahousse, Lies; Vojinovic, Dina; Amin, Najaf; Uitterlinden, Andre G.; Demirkan, Ayse; Stricker, Bruno H. C.; van Duijn, Cornelia M.] Erasmus MC, Univ Med Ctr, Dept Epidemiol, Rotterdam, Netherlands; [Liu, Jun; van Duijn, Cornelia M.] Univ Oxford, Nuffield Dept Populat Hlth, Oxford, England; [Lahousse, Lies] Univ Ghent, Fac Pharmaceut Sci, Dept Bioanal, Ghent, Belgium; [Nivard, Michel G.; Bot, Mariska; Thesing, Carisha S.; Willemsen, Gonneke; Pool, Rene; Milaneschi, Yuri; Penninx, Brenda W. J. H.; Boomsma, Dorret I.] Vrije Univ, Amsterdam Univ Med Ctr, Dept Biol Psychol, Amsterdam, Netherlands; [Nivard, Michel G.; Bot, Mariska; Thesing, Carisha S.; Slieker, Roderick C.; Willemsen, Gonneke; Pool, Rene; Milaneschi, Yuri; Rutters, Femke; Elders, Petra J. M.; Beulens, Joline W. J.; van der Heijden, Amber A. W. A.; 't Hart, Leen M.; Penninx, Brenda W. J. H.; Boomsma, Dorret I.] Amsterdam Publ Hlth Res Inst, Amsterdam, Netherlands; [Chen, Lianmin; Zhernakova, Alexandra; Fu, Jingyuan; Demirkan, Ayse] Univ Med Ctr Groningen, Dept Genet, Groningen, Netherlands; [Chen, Lianmin; Fu, Jingyuan] Univ Med Ctr Groningen, Dept Pediat, Groningen, Netherlands; [van Klinken, Jan Bert; van den Maagdenberg, Arn M. J. M.; van Dijk, Ko Willems] Leiden Univ, Med Ctr, Dept Human Genet, Leiden, Netherlands; [van Klinken, Jan Bert; van Dijk, Ko Willems] Leiden Univ, Med Ctr, Einthoven Lab Expt Vasc Med, Leiden, Netherlands; [van Klinken, Jan Bert] Amsterdam Univ Med Ctr, Dept Clin Chem, Lab Genet Metab Dis, Amsterdam, Netherlands; [Beekman, Marian; van den Akker, Erik Ben; Suchiman, H. Eka D.; 't Hart, Leen M.; Slagboom, P. Eline] Leiden Univ, Med Ctr, Sect Mol Epidemiol, Dept Biomed Data Sci, Leiden, Netherlands; [van den Akker, Erik Ben] Delft Univ Technol, Dept Pattern Recognit & Bioinformat, Delft, Netherlands; [van den Akker, Erik Ben] Leiden Univ, Med Ctr, Leiden Computat Biol Ctr, Leiden, Netherlands; [Slieker, Roderick C.; Rutters, Femke; Beulens, Joline W. J.; 't Hart, Leen M.] Vrije Univ, Amsterdam Univ Med Ctr, Dept Epidemiol & Biostat, Amsterdam, Netherlands; [Slieker, Roderick C.; 't Hart, Leen M.] Leiden Univ, Med Ctr, Dept Cell & Chem Biol, Leiden, Netherlands; [Waterham, Eveline; Geleijnse, Johanna M.] Wageningen Univ, Div Human Nutr & Hlth, Wageningen, Netherlands; [van der Kallen, Carla J. H.; van Greevenbroek, Marleen M. J.; Stehouwer, Coen D. A.] Maastricht Univ, Dept Internal Med, Maastricht, Netherlands; [van der Kallen, Carla J. H.; van Greevenbroek, Marleen M. J.; Arts, Ilja C. W.; Stehouwer, Coen D. A.] Maastricht Univ, Sch Cardiovasc Dis, Maastricht, Netherlands; [de Boer, Irene; Onderwater, Gerrit L. J.; van den Maagdenberg, Arn M. J. M.; Terwindt, Gisela M.] Leiden Univ, Med Ctr, Dept Neurol, Leiden, Netherlands; [Li-Gao, Ruifang; Mook-Kanamori, Dennis O.] Leiden Univ, Med Ctr, Dept Clin Epidemiol, Leiden, Netherlands; [Radjabzadeh, Djawad; Kraaij, Robert; Uitterlinden, Andre G.; Stricker, Bruno H. C.] Erasmus MC, Univ Med Ctr, Dept Internal Med, Rotterdam, Netherlands; [Alferink, Louise J. M.; Murad, Sarwa Darwish] Erasmus MC, Univ Med Ctr, Dept Gastroenterol & Hepatol, Rotterdam, Netherlands; [van Heemst, Diana] Leiden Univ, Med Ctr, Dept Internal Med, Sect Gerontol & Geriatr, Leiden, Netherlands; [Elders, Petra J. M.; van der Heijden, Amber A. W. A.] Vrije Univ, Amsterdam Univ Med Ctr, Dept Gen Practice & Elderly Care Med, Amsterdam, Netherlands; [Arts, Ilja C. W.] Maastricht Univ, Dept Epidemiol, Maastricht, Netherlands; [Arts, Ilja C. W.] Maastricht Univ, Maastricht Ctr Syst Biol, Maastricht, Netherlands; [Mook-Kanamori, Dennis O.] Leiden Univ, Med Ctr, Dept Publ Hlth & Primary Care, Leiden, Netherlands; [Hankemeier, Thomas; van Duijn, Cornelia M.] Leiden Univ, Leiden Acad Ctr Drug Res, Leiden, Netherlands; [Hankemeier, Thomas] Netherlands Metabol Ctr, Leiden, Netherlands; [van Dijk, Ko Willems] Leiden Univ, Med Ctr, Dept Internal Med, Div Endocrinol, Leiden, Netherlands; [Demirkan, Ayse] Univ Surrey, Dept Clin & Expt Med, Sect Stat Multiom, Guildford, Surrey, England; [Stricker, Bruno H. C.] Inspectorate Healthcare, The Hague, Netherlands	Erasmus University Rotterdam; Erasmus MC; University of Oxford; Ghent University; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; University of Groningen; University of Groningen; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Delft University of Technology; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Vrije Universiteit Amsterdam; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Wageningen University & Research; Maastricht University; Maastricht University; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Vrije Universiteit Amsterdam; Maastricht University; Maastricht University; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Surrey	Liu, J; van Duijn, CM (corresponding author), Erasmus MC, Univ Med Ctr, Dept Epidemiol, Rotterdam, Netherlands.; Liu, J; van Duijn, CM (corresponding author), Univ Oxford, Nuffield Dept Populat Hlth, Oxford, England.; van Duijn, CM (corresponding author), Leiden Univ, Leiden Acad Ctr Drug Res, Leiden, Netherlands.	jun.liu@ndph.ox.ac.uk; cornelia.vanduijn@ndph.ox.ac.uk	Fu, Jingyuan/E-8980-2012; Li-Gao, Ruifang/B-7172-2018; Geleijnse, Johanna Marianna M/B-5749-2012; Fu, Jingyuan/ABE-6868-2020; Fu, JY/GRR-6179-2022; Stehouwer, Coen/AAB-3435-2021; Pool, René/AFO-8147-2022; de Boer, Irene/AAM-3206-2021; Lahousse, Lies/O-9426-2019; 't Hart, Leen/ABG-3185-2021; Zhernakova, Alexandra/ABA-9372-2020; Hankemeier, Thomas/V-5407-2019; Murad, Sarwa Darwish/AAO-5493-2020; Chen, Lianmin/ABE-5876-2020; Boomsma, Dorret I/AAX-4470-2020; Arts, Ilja CW/C-6946-2008; Beekman, Marian/L-3004-2019; Penninx, Brenda WJH/S-7627-2017; Suchiman, H. Eka D./F-5024-2017	Li-Gao, Ruifang/0000-0003-0650-1351; Geleijnse, Johanna Marianna M/0000-0001-7638-0589; Fu, Jingyuan/0000-0001-5578-1236; Pool, René/0000-0001-5579-0933; de Boer, Irene/0000-0002-7261-762X; Lahousse, Lies/0000-0002-3494-4363; 't Hart, Leen/0000-0003-4401-2938; Hankemeier, Thomas/0000-0001-7871-2073; Murad, Sarwa Darwish/0000-0003-2804-1165; Chen, Lianmin/0000-0003-0660-3518; Arts, Ilja CW/0000-0001-6462-6692; van Greevenbroek, Marleen/0000-0002-2989-1631; Beekman, Marian/0000-0003-0585-6206; Elders, Petra/0000-0002-5907-7219; Beulens, Joline/0000-0002-4181-0937; Stehouwer, Coen/0000-0001-8752-3223; Liu, Jun/0000-0001-5288-3042; Penninx, Brenda WJH/0000-0001-7779-9672; Willemsen, Gonneke/0000-0003-3755-0236; Slieker, Roderick/0000-0003-0961-9152; van den Akker, Erik/0000-0002-7693-0728; Van Duijn, Cornelia/0000-0002-2374-9204; Suchiman, H. Eka D./0000-0002-7168-5516; Nivard, Michel/0000-0003-2015-1888; van der Kallen, Carla/0000-0003-1468-8793; Amin, Najaf/0000-0002-8944-1771	BBMRI-NL - Dutch government through the Netherlands Organisation for Scientific Research (NWO) [184.021.007, 184033111]; CardioVasculair Onderzoek Nederland [CVON 2012-03]; Common mechanisms and pathways in Stroke and Alzheimer's disease (CoSTREAM) project [667375]; Memorabel program [733050814]; Netherlands X-omics Research Infrastructure [U01-AG061359 NIA]; Personalized pREvention of Chronic DIseases consortium [H2020-MSCA-RISE-2014]; Dutch Science Organization (ZonMW-VENI) [2015]; China Scholarship Council [201708320268]; University of Groningen; Royal Netherlands Academy of Science Professor Award [PAH/6635]; ZonMW-VENI [916.14.023]; TransQST [116030-2]; Erasmus MC mRACE grant (Profiling of the human gut microbiome); Consortium for Systems Biology (NCSB) within Netherlands Genomics Initiative (NGI)/NWO); European Commission FP6 STRP [018947 (LSHG-CT-2006-01947)]; European Community's Seventh Framework Programme (FP7/2007-2013)/grant [HEALTH-F4-2007-201413]; European Commission under the program 'Quality of Life and Management of the Living Resources' of the 5th Framework Programme [QLG2-CT-2002-01254]; FP7 project EUROHEADPAIN [602633]; NWO [047.017.043, NWO-VIDI 864.13.013, NWO-VIDI 016.178.056]; Russian Foundation for Basic Research (NWO-RFBR) [047.017.043]; BBMRI-NL; Erasmus MC; Erasmus University Rotterdam; NWO; Netherlands Organisation for Health Research and Development (ZonMw); Research Institute for Diseases in the Elderly (RIDE); Netherlands Genomics Initiative (NGI); Ministry of Education, Culture and Science; Ministry of HealthWelfare and Sports, the European Commission (DG XII); Municipality of Rotterdam; AstraZeneca; Chiesi; MagW/ZonMW [904-61-090, 985-10-002, 904-61-193, 480-04-004, 400-05-717, Addiction-31160008, Middelgroot-911-09-032, Spinozapremie 56-464-14192]; BBMRI-NL [184.021.007]; VU University's Institute for Health and Care Research [EMGO1]; Neuroscience Campus Amsterdam (NCA); European Community's Seventh Framework Program [FP7/2007-2013]; ENGAGE [HEALTH-F4-2007-201413]; European Science Council (ERCAdvanced) [230374]; ZonMw grant, 'Genetics as a research tool: a natural experiment to elucidate the causal effects of social mobility on health' [pnr:531003014]; ZonMw project: 'Can sex-and gender-specific gene expression and epigenetics explain sex-differences in disease prevalence and etiology?' [pnr:849200011]; Geestkracht program of ZonMw [10-000-1002]; VU University Medical Center; GGZ inGeest; Leiden University Medical Center; Leiden University; GGZ Rivierduinen; University Medical Center Groningen; Lentis; GGZ Friesland; GGZ Drenthe; Rob Giel Onderzoekscentrum; Innovation-Oriented Research Program on Genomics (SenterNovem) within NWO by the BBMRI Metabolomics Consortium - BBMRI-NL (NWO) [184.021.007, 184033111, IGE05007]; Centre for Medical Systems Biology within NWO by the BBMRI Metabolomics Consortium - BBMRI-NL (NWO) [184.021.007, 184033111]; Netherlands Consortium for Healthy Ageing within NWO by the BBMRI Metabolomics Consortium - BBMRI-NL (NWO) [184.021.007, 184033111, 050-060-810]; Netherlands Heart Foundation (IN-CONTROL CVON) [2012-03]; European Research Council Starting Grant [715772]; Parelsnoer Initiative; Dutch Federation of University Medical Centres; Dutch Government; health insurers; ZonMw; Dutch Diabetes Foundation; European Foundation for the Study of Diabetes; International Diabetes Federation; European Innovative Medicine Initiative; European Union; Netherlands Heart Foundation [200T401]; National Institutes of Health (NIH) [R01HL076200]; Unilever for analyses of dietary and circulating fatty acids in the Alpha Omega Cohort; European Regional Development Fund via OP-Zuid; Province of Limburg; Dutch Ministry of Economic Affairs [31 O.041]; Stichting De Weijerhorst (Maastricht, the Netherlands); Pearl String Initiative Diabetes (Amsterdam, the Netherlands); CARIM School for Cardiovascular Diseases (Maastricht, the Netherlands); Stichting Annadal (Maastricht, the Netherlands); Health Foundation Limburg (Maastricht, the Netherlands); Janssen-Cilag B.V. (Tilburg, the Netherlands); Novo Nordisk Farma B.V. (Alphen aan den Rijn, the Netherlands); Sanofi-Aventis Netherlands B.V. (Gouda, the Netherlands); ZonMw [90700217]; VIDI (ZonMw) [91711319]; NCSB within Netherlands Genomics Initiative (NGI)/NWO; Centre for Medical System Biology (CMSB) within Netherlands Genomics Initiative (NGI)/NWO; FP7 EU project EUROHEADPAIN [602633]; Centre National de Genotypage (Paris, France); Leiden University, Research Profile Area Vascular and Regenerative Medicine; Netherlands Cardiovascular Research Initiative; Dutch Heart Foundation [CVON2014-02 ENERGISE];  [R01AG054628 02 S]	BBMRI-NL - Dutch government through the Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); CardioVasculair Onderzoek Nederland; Common mechanisms and pathways in Stroke and Alzheimer's disease (CoSTREAM) project; Memorabel program; Netherlands X-omics Research Infrastructure; Personalized pREvention of Chronic DIseases consortium; Dutch Science Organization (ZonMW-VENI); China Scholarship Council(China Scholarship Council); University of Groningen; Royal Netherlands Academy of Science Professor Award; ZonMW-VENI; TransQST; Erasmus MC mRACE grant (Profiling of the human gut microbiome); Consortium for Systems Biology (NCSB) within Netherlands Genomics Initiative (NGI)/NWO); European Commission FP6 STRP; European Community's Seventh Framework Programme (FP7/2007-2013)/grant; European Commission under the program 'Quality of Life and Management of the Living Resources' of the 5th Framework Programme; FP7 project EUROHEADPAIN; NWO(Netherlands Organization for Scientific Research (NWO)); Russian Foundation for Basic Research (NWO-RFBR)(Russian Foundation for Basic Research (RFBR)); BBMRI-NL; Erasmus MC; Erasmus University Rotterdam; NWO(Netherlands Organization for Scientific Research (NWO)); Netherlands Organisation for Health Research and Development (ZonMw)(Netherlands Organization for Health Research and Development); Research Institute for Diseases in the Elderly (RIDE); Netherlands Genomics Initiative (NGI); Ministry of Education, Culture and Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of HealthWelfare and Sports, the European Commission (DG XII)(European CommissionEuropean Commission Joint Research Centre); Municipality of Rotterdam; AstraZeneca(AstraZeneca); Chiesi(Chiesi Pharmaceuticals Inc); MagW/ZonMW; BBMRI-NL; VU University's Institute for Health and Care Research; Neuroscience Campus Amsterdam (NCA); European Community's Seventh Framework Program(European Commission); ENGAGE; European Science Council (ERCAdvanced)(European Research Council (ERC)); ZonMw grant, 'Genetics as a research tool: a natural experiment to elucidate the causal effects of social mobility on health'; ZonMw project: 'Can sex-and gender-specific gene expression and epigenetics explain sex-differences in disease prevalence and etiology?'; Geestkracht program of ZonMw; VU University Medical Center; GGZ inGeest; Leiden University Medical Center; Leiden University; GGZ Rivierduinen; University Medical Center Groningen; Lentis; GGZ Friesland; GGZ Drenthe; Rob Giel Onderzoekscentrum; Innovation-Oriented Research Program on Genomics (SenterNovem) within NWO by the BBMRI Metabolomics Consortium - BBMRI-NL (NWO); Centre for Medical Systems Biology within NWO by the BBMRI Metabolomics Consortium - BBMRI-NL (NWO); Netherlands Consortium for Healthy Ageing within NWO by the BBMRI Metabolomics Consortium - BBMRI-NL (NWO); Netherlands Heart Foundation (IN-CONTROL CVON); European Research Council Starting Grant(European Research Council (ERC)); Parelsnoer Initiative; Dutch Federation of University Medical Centres; Dutch Government; health insurers; ZonMw(Netherlands Organization for Health Research and Development); Dutch Diabetes Foundation; European Foundation for the Study of Diabetes; International Diabetes Federation; European Innovative Medicine Initiative; European Union(European Commission); Netherlands Heart Foundation(Netherlands Heart Foundation); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Unilever for analyses of dietary and circulating fatty acids in the Alpha Omega Cohort(Unilever); European Regional Development Fund via OP-Zuid; Province of Limburg; Dutch Ministry of Economic Affairs(Ministry of Economic Affairs, Netherlands); Stichting De Weijerhorst (Maastricht, the Netherlands)(Netherlands Government); Pearl String Initiative Diabetes (Amsterdam, the Netherlands)(Netherlands Government); CARIM School for Cardiovascular Diseases (Maastricht, the Netherlands); Stichting Annadal (Maastricht, the Netherlands); Health Foundation Limburg (Maastricht, the Netherlands); Janssen-Cilag B.V. (Tilburg, the Netherlands); Novo Nordisk Farma B.V. (Alphen aan den Rijn, the Netherlands); Sanofi-Aventis Netherlands B.V. (Gouda, the Netherlands)(Netherlands Government); ZonMw(Netherlands Organization for Health Research and Development); VIDI (ZonMw); NCSB within Netherlands Genomics Initiative (NGI)/NWO; Centre for Medical System Biology (CMSB) within Netherlands Genomics Initiative (NGI)/NWO; FP7 EU project EUROHEADPAIN; Centre National de Genotypage (Paris, France); Leiden University, Research Profile Area Vascular and Regenerative Medicine; Netherlands Cardiovascular Research Initiative; Dutch Heart Foundation(Netherlands Heart Foundation); 	We acknowledge all participants included in the cohorts. We also acknowledge the BBMRI Metabolomics Consortium (see Supplementary Information, http://www.bbmri.nl/omics-metabolomics/) funded by BBMRI-NL, a research infrastructure financed by the Dutch government through the Netherlands Organisation for Scientific Research (NWO) (grant nos. 184.021.007 and 184033111). This work is part of the CardioVasculair Onderzoek Nederland (CVON 2012-03), the Common mechanisms and pathways in Stroke and Alzheimer's disease (CoSTREAM) project (www.costream.eu, grant agreement no. 667375), the Memorabel program (project no. 733050814), Netherlands X-omics Research Infrastructure and U01-AG061359 NIA. The full list of funding information for each cohort can be found in the cohort acknowledgements below. J.L., C.M.v.D. and A.D. benefitted from exchange grants from the Personalized pREvention of Chronic DIseases consortium (no. H2020-MSCA-RISE-2014). A.D. is supported by the Dutch Science Organization (ZonMW-VENI, grant no. 2015). L.C. is supported by a joint PhD fellowship from China Scholarship Council (no. 201708320268) and University of Groningen. M.G.N. is supported by Royal Netherlands Academy of Science Professor Award (no. PAH/6635) to D.I.B. D.O.M.-K. is supported by the ZonMW-VENI (grant no. 916.14.023). B.H.C.S. received a grant from TransQST (no. 116030-2; IMI2). D.R. is funded by an Erasmus MC mRACE grant (Profiling of the human gut microbiome). Cohort acknowledgements, ERF: we are grateful to all study participants and their relatives, general practitioners and neurologists for their contributions and to P. Veraart for her help in genealogy, J. Vergeer for supervision of the laboratory work and P. Snijders for his help in data collection. ERF was supported by the Consortium for Systems Biology (NCSB), both within the framework of the Netherlands Genomics Initiative (NGI)/NWO). The ERF study as a part of European Special Populations Research Network (EUROSPAN) was supported by European Commission FP6 STRP, grant no. 018947 (LSHG-CT-2006-01947) and also received funding from the European Community's Seventh Framework Programme (FP7/2007-2013)/grant agreement no. HEALTH-F4-2007-201413 by the European Commission under the program 'Quality of Life and Management of the Living Resources' of the 5th Framework Programme (no. QLG2-CT-2002-01254), as well as the FP7 project EUROHEADPAIN (no. 602633). High-throughput analysis of ERF data was supported by a joint grant from NWO and the Russian Foundation for Basic Research (NWO-RFBR no. 047.017.043). High-throughput metabolomics measurements in the ERF study were supported by BBMRI-NL. Rotterdam Study: we thank the study subjects, the staff from Rotterdam Study and the participating pharmacists and general practitioners. The Rotterdam Study is supported by Erasmus MC and Erasmus University Rotterdam; by NWO, the Netherlands Organisation for Health Research and Development (ZonMw), the Research Institute for Diseases in the Elderly (RIDE), the Netherlands Genomics Initiative (NGI), the Ministry of Education, Culture and Science, the Ministry of HealthWelfare and Sports, the European Commission (DG XII) and the Municipality of Rotterdam. L.L. reports expert consultation from Boehringer Ingelheim and Novartis, and unrestricted grants from AstraZeneca and Chiesi. We are also grateful to nurse ultrasonographist, Mrs. van Wijngaarden for performing abdominal ultrasonography and liver stiffness measurements.; The generation and management of stool microbiome data for Rotterdam Study (Rotterdam Study III-2) were executed by the Human Genotyping Facility of the Genetic Laboratory of the Department of Internal Medicine, Erasmus MC, Rotterdam. We thank N. El Faquir and J. Verkroost-Van Heemst for their help in sample collection and registration, and P. van der Wal, K. Arabe, H. Razawy and K. Singh Asra for their help in DNA isolation and sequencing. Furthermore, we thank J. Raes and J. Wang (KU Leuven, Belgium) for their guidance in 16S rRNA profiling and dataset generation. NTR: we are grateful to all twins and their relatives for their continued participation. Funding was obtained from NWO and MagW/ZonMW (grant nos. 904-61-090, 985-10-002, 904-61-193,480-04-004, 400-05-717, Addiction-31160008, Middelgroot-911-09-032 and Spinozapremie 56-464-14192); BBMRI-NL (no. 184.021.007); VU University's Institute for Health and Care Research (no. EMGO1); Neuroscience Campus Amsterdam (NCA); the European Community's Seventh Framework Program (no. FP7/2007-2013); ENGAGE (no. HEALTH-F4-2007-201413); and the European Science Council (ERCAdvanced, no. 230374). M.G.N. is supported by the ZonMw grant, 'Genetics as a research tool: a natural experiment to elucidate the causal effects of social mobility on health' (pnr:531003014), ZonMw project: 'Can sex-and gender-specific gene expression and epigenetics explain sex-differences in disease prevalence and etiology?' (pnr:849200011) and grant no. R01AG054628 02 S. NESDA: the infrastructure for the NESDA study (www.nesda.nl) was funded through the Geestkracht program of ZonMw (grant no. 10-000-1002) and through financial contributions of participating universities and mental health care organizations (VU University Medical Center, GGZ inGeest, Leiden University Medical Center, Leiden University, GGZ Rivierduinen, University Medical Center Groningen, University of Groningen, Lentis, GGZ Friesland, GGZ Drenthe and Rob Giel Onderzoekscentrum). LLS: we thank all participants. This study was supported by a grant from the Innovation-Oriented Research Program on Genomics (SenterNovem, no. IGE05007), the Centre for Medical Systems Biology and the Netherlands Consortium for Healthy Ageing (grant no. 050-060-810), all within the framework of NWO by the BBMRI Metabolomics Consortium funded by BBMRI-NL (NWO, grant nos. 184.021.007 and 184033111). LifeLines DEEP: we thank participants and staff of the LifeLines DEEP cohort for their collaboration. We thank J. Dekens, M. Platteel, A. Maatman and J. Arends for management and technical support. This project was funded by the Netherlands Heart Foundation (IN-CONTROL CVON, grant no. 2012-03 to A.Z. and J.F.; by NWO (nos. NWO-VIDI 864.13.013 to J.F. and NWO-VIDI 016.178.056 to A.Z.; and by the European Research Council Starting Grant no. 715772 to A.Z., who also holds a Rosalind Franklin Fellowship from the University of Groningen. Hoorn DCS: we thank participants of this study and research staff of the Diabetes Care System West-Friesland. High-throughput metabolomics measurements in the DCS study were supported by BBMRI-NL and the Parelsnoer Initiative which is part of, and is funded by, the Dutch Federation of University Medical Centres and, from 2007 to 2011, received initial funding from the Dutch Government.; To perform additional research (in subsamples of the DCS cohort), funding was received from several sources including the Dutch Federation of University Medical Centres, health insurers, NWO, ZonMw, the Dutch Diabetes Foundation, the European Foundation for the Study of Diabetes, International Diabetes Federation, the European Innovative Medicine Initiative and the European Union. Alpha Omega Cohort: the Alpha Omega Cohort is registered with ClinicalTrials.gov. (identifier: NCT03192410). It was funded by the Netherlands Heart Foundation (grant no. 200T401) and the National Institutes of Health (NIH, grant no. R01HL076200). J.M.G. received funding from Unilever for analyses of dietary and circulating fatty acids in the Alpha Omega Cohort. High-throughput metabolomics measurements for the Alpha Omega Cohort were supported by BBMRI-NL. TMS: this study was supported by the European Regional Development Fund via OP-Zuid, the Province of Limburg, the Dutch Ministry of Economic Affairs (grant no. 31 O.041), Stichting De Weijerhorst (Maastricht, the Netherlands), the Pearl String Initiative Diabetes (Amsterdam, the Netherlands), CARIM School for Cardiovascular Diseases (Maastricht, the Netherlands), Stichting Annadal (Maastricht, the Netherlands), Health Foundation Limburg (Maastricht, the Netherlands) and by unrestricted grants from Janssen-Cilag B.V. (Tilburg, the Netherlands), Novo Nordisk Farma B.V. (Alphen aan den Rijn, the Netherlands) and Sanofi-Aventis Netherlands B.V. (Gouda, the Netherlands). LUMINA: the LUMINA study is funded by grants obtained from ZonMw (no. 90700217) and VIDI (ZonMw, no. 91711319) (to G.M.T.); by NCSB and the Centre for Medical System Biology (CMSB), both within the framework of the Netherlands Genomics Initiative (NGI)/NWO (to A.M.J.M.v.d.M.) and by the FP7 EU project EUROHEADPAIN (grant no. 602633) (to A.M.J.M.v.d.M. and G.M.T.). NEO: the authors of the NEO study thank all individuals who participated, all participating general practitioners for inviting eligible participants and all research nurses for collection of the data. We thank the NEO study group-P. van Beelen, P. Noordijk and I. de Jonge-for coordination, laboratory and data management of the study. Genotyping in the NEO study was supported by Centre National de Genotypage (Paris, France), headed by J.-F. Deleuze. This study was supported by the participating departments, the Division and the Board of Directors of Leiden University Medical Center and by Leiden University, Research Profile Area Vascular and Regenerative Medicine. The study was also supported by the Netherlands Cardiovascular Research Initiative: an initiative with the support of the Dutch Heart Foundation (no. CVON2014-02 ENERGISE).	Ahola-Olli AV, 2019, DIABETOLOGIA, V62, P2298, DOI 10.1007/s00125-019-05001-w; Akinkuolie AO, 2015, ARTERIOSCL THROM VAS, V35, P1544, DOI 10.1161/ATVBAHA.115.305635; Akinkuolie AO, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.001221; Altmaier E, 2014, EUR J EPIDEMIOL, V29, P325, DOI 10.1007/s10654-014-9910-7; Bajaj JS, 2018, AM J GASTROENTEROL, V113, P1177, DOI 10.1038/s41395-018-0085-9; Bajaj JS, 2014, AM J PHYSIOL-GASTR L, V307, pG951, DOI 10.1152/ajpgi.00268.2014; BATES CJ, 1966, J BIOL CHEM, V241, P1705; Beger RD, 2016, METABOLOMICS, V12, DOI 10.1007/s11306-016-1094-6; Boomsma DI, 2006, TWIN RES HUM GENET, V9, P849, DOI 10.1375/183242706779462426; Bot M., 2019, BIOL PSYCHIAT; Brahma DK, 2013, J PHARMACOL PHARMACO, V4, P91, DOI 10.4103/0976-500X.110872; de Mutsert R, 2013, EUR J EPIDEMIOL, V28, P513, DOI 10.1007/s10654-013-9801-3; Deelen J, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11311-9; Draisma HHM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8208; Elbadawi-Sidhu M, 2017, METABOLOMICS, V13, DOI 10.1007/s11306-016-1141-3; Fischer K, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001606; Geleijnse JM, 2010, AM HEART J, V159, P539, DOI 10.1016/j.ahj.2009.12.033; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Hamaguchi M, 2007, AM J GASTROENTEROL, V102, P2708, DOI 10.1111/j.1572-0241.2007.01526.x; Hemani G, 2018, ELIFE, V7, DOI 10.7554/eLife.34408; Hoyles L, 2018, NAT MED, V24, P1070, DOI 10.1038/s41591-018-0061-3; Ikram MA, 2017, EUR J EPIDEMIOL, V32, P807, DOI 10.1007/s10654-017-0321-4; Illig T, 2010, NAT GENET, V42, P137, DOI 10.1038/ng.507; Imhann F, 2016, GUT, V65, P740, DOI 10.1136/gutjnl-2015-310376; Inouye M, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.93; Jackson MA, 2016, GUT, V65, P749, DOI 10.1136/gutjnl-2015-310861; Kaddurah-Daouk R, 2010, METABOLOMICS, V6, P191, DOI 10.1007/s11306-010-0207-x; Kettunen J, 2018, CIRC-GENOM PRECIS ME, V11, DOI 10.1161/CIRCGEN.118.002234; Kettunen J, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11122; Koehler EM, 2016, HEPATOLOGY, V63, P138, DOI 10.1002/hep.27981; Kontush A, 2015, FRONT PHARMACOL, V6, DOI 10.3389/fphar.2015.00218; Lawlor DA, 2008, STAT MED, V27, P1133, DOI 10.1002/sim.3034; Li J, 2005, HEREDITY, V95, P221, DOI 10.1038/sj.hdy.6800717; Liu J, 2017, DIABETES, V66, P2915, DOI 10.2337/db17-0199; Liu RX, 2017, NAT MED, V23, P859, DOI 10.1038/nm.4358; Llorente C, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00796-x; Mabalirajan U., 2013, SCI REP, V3; Mapstone M, 2014, NAT MED, V20, P415, DOI 10.1038/nm.3466; McGarrah RW, 2018, CIRC RES, V122, P1238, DOI 10.1161/CIRCRESAHA.117.311002; Mitchell AJ, 2009, LANCET, V374, P609, DOI 10.1016/S0140-6736(09)60879-5; Moosavinasab S, 2016, DATABASE-OXFORD, DOI 10.1093/database/baw083; Onderwater GLJ, 2019, NEUROLOGY, V92, pE1899, DOI 10.1212/WNL.0000000000007313; Park JE, 2018, DIABETES RES CLIN PR, V140, P216, DOI 10.1016/j.diabres.2018.03.045; Patti GJ, 2012, NAT REV MOL CELL BIO, V13, P263, DOI 10.1038/nrm3314; Pedersen HK, 2016, NATURE, V535, P376, DOI 10.1038/nature18646; Penninx BWJH, 2008, INT J METH PSYCH RES, V17, P121, DOI 10.1002/mpr.256; Qin N, 2014, NATURE, V513, P59, DOI 10.1038/nature13568; Rappaport SM, 2014, ENVIRON HEALTH PERSP, V122, P769, DOI 10.1289/ehp.1308015; Sayed-Tabatabaei FA, 2005, STROKE, V36, P2351, DOI 10.1161/01.STR.0000185719.66735.dd; Schoenmaker M, 2006, EUR J HUM GENET, V14, P79, DOI 10.1038/sj.ejhg.5201508; Schram MT, 2014, EUR J EPIDEMIOL, V29, P439, DOI 10.1007/s10654-014-9889-0; Schutte B, 2016, SCI REP-UK, V6, DOI 10.1038/srep39664; Soininen P, 2015, CIRC-CARDIOVASC GENE, V8, P192, DOI 10.1161/CIRCGENETICS.114.000216; Struja T, 2018, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00623; Sturm R, 2002, HEALTH AFFAIR, V21, P245, DOI 10.1377/hlthaff.21.2.245; Suhre K, 2011, NATURE, V477, P54, DOI 10.1038/nature10354; 't Hart LM, 2018, J CLIN ENDOCR METAB, V103, P4569, DOI 10.1210/jc.2018-01165; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Thorburn AN, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8320; Tigchelaar EF, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-006772; US Food and Drug Administration, 2017, 22 CAS STUD PHAS 2 P; van den Akker E., 2019, 632919 BIORXIV; van der Heijden Amber Awa, 2017, BMJ Open, V7, pe015599, DOI 10.1136/bmjopen-2016-015599; van der Lee SJ, 2018, ALZHEIMERS DEMENT, V14, P707, DOI 10.1016/j.jalz.2017.11.012; Van Gaal LF, 2006, NATURE, V444, P875, DOI 10.1038/nature05487; Van Norman Gail A, 2016, JACC Basic Transl Sci, V1, P170, DOI 10.1016/j.jacbts.2016.03.002; van Oosterhout WPJ, 2011, CEPHALALGIA, V31, P1359, DOI 10.1177/0333102411418846; Viechtbauer W, 2010, J STAT SOFTW, V36, P1, DOI 10.18637/jss.v036.i03; Vojinovic D, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-13721-1; Voora D, 2016, J AM COLL CARDIOL, V67, P1211, DOI 10.1016/j.jacc.2016.01.022; Wang TJ, 2011, NAT MED, V17, P448, DOI 10.1038/nm.2307; Wishart DS, 2016, NAT REV DRUG DISCOV, V15, P473, DOI 10.1038/nrd.2016.32; Wray NR, 2018, NAT GENET, V50, P668, DOI 10.1038/s41588-018-0090-3; Wurtz P, 2016, J AM COLL CARDIOL, V67, P1200, DOI 10.1016/j.jacc.2015.12.060; Xu T, 2015, DIABETES CARE, V38, P1858, DOI 10.2337/dc15-0658	78	25	27	4	29	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JAN	2020	26	1					110	+		10.1038/s41591-019-0722-x	http://dx.doi.org/10.1038/s41591-019-0722-x			20	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	KG3GZ	31932804	Green Submitted			2022-12-27	WOS:000509831900034
J	Regensburger, AP; Fonteyne, LM; Jungert, J; Wagner, AL; Gerhalter, T; Nagel, AM; Heiss, R; Flenkenthaler, F; Qurashi, M; Neurath, MF; Klymiuk, N; Kemter, E; Frohlich, T; Uder, M; Woelfle, J; Rascher, W; Trollmann, R; Wolf, E; Waldner, MJ; Knieling, F				Regensburger, Adrian P.; Fonteyne, Lina M.; Juengert, Joerg; Wagner, Alexandra L.; Gerhalter, Teresa; Nagel, Armin M.; Heiss, Rafael; Flenkenthaler, Florian; Qurashi, Matthias; Neurath, Markus F.; Klymiuk, Nikolai; Kemter, Elisabeth; Froehlich, Thomas; Uder, Michael; Woelfle, Joachim; Rascher, Wolfgang; Trollmann, Regina; Wolf, Eckhard; Waldner, Maximilian J.; Knieling, Ferdinand			Detection of collagens by multispectral optoacoustic tomography as an imaging biomarker for Duchenne muscular dystrophy	NATURE MEDICINE			English	Article							6-MINUTE WALK TEST; DISEASE PROGRESSION; MUSCLE ULTRASOUND; OUTCOME MEASURE; BOYS; MRI; MULTICENTER; AMBULATION; HISTOLOGY; ATALUREN	Biomarkers for monitoring of disease progression and response to therapy are lacking for muscle diseases such as Duchenne muscular dystrophy. Noninvasive in vivo molecular imaging with multispectral optoacoustic tomography (MSOT) uses pulsed laser light to induce acoustic pressure waves, enabling the visualization of endogenous chromophores. Here we describe an application of MSOT, in which illumination in the near- and extended near-infrared ranges from 680-1,100 nm enables the visualization and quantification of collagen content. We first demonstrated the feasibility of this approach to noninvasive quantification of tissue fibrosis in longitudinal studies in a large-animal Duchenne muscular dystrophy model in pigs, and then applied this approach to pediatric patients. MSOT-derived collagen content measurements in skeletal muscle were highly correlated to the functional status of the patients and provided additional information on molecular features as compared to magnetic resonance imaging. This study highlights the potential of MSOT imaging as a noninvasive, age-independent biomarker for the implementation and monitoring of newly developed therapies in muscular diseases.	[Regensburger, Adrian P.; Juengert, Joerg; Wagner, Alexandra L.; Woelfle, Joachim; Rascher, Wolfgang; Trollmann, Regina; Knieling, Ferdinand] Friedrich Alexander Univ Erlangen Nurnberg, Univ Hosp Erlangen, Dept Pediat & Adolescent Med, Erlangen, Germany; [Fonteyne, Lina M.; Flenkenthaler, Florian; Klymiuk, Nikolai; Kemter, Elisabeth; Froehlich, Thomas; Wolf, Eckhard] Ludwig Maximilians Univ Munchen, Gene Ctr, Inst Mol Anim Breeding & Biotechnol, Munich, Germany; [Fonteyne, Lina M.; Flenkenthaler, Florian; Klymiuk, Nikolai; Kemter, Elisabeth; Froehlich, Thomas; Wolf, Eckhard] Ludwig Maximilians Univ Munchen, Gene Ctr, Lab Funct Genome Anal, Munich, Germany; [Gerhalter, Teresa; Nagel, Armin M.; Heiss, Rafael; Uder, Michael] Friedrich Alexander Univ Erlangen Nurnberg, Univ Hosp Erlangen, Inst Radiol, Erlangen, Germany; [Gerhalter, Teresa; Nagel, Armin M.] Friedrich Alexander Univ Erlangen Nurnberg, Inst Med Phys, Erlangen, Germany; [Gerhalter, Teresa; Nagel, Armin M.] German Canc Res Ctr, Div Med Phys Radiol, Heidelberg, Germany; [Qurashi, Matthias; Neurath, Markus F.; Waldner, Maximilian J.] Friedrich Alexander Univ Erlangen Nurnberg, Univ Hosp Erlangen, Dept Med 1, Erlangen, Germany; [Neurath, Markus F.] Friedrich Alexander Univ Erlangen Nurnberg, Ludwig Demling Ctr Excellence, Erlangen, Germany; [Waldner, Maximilian J.] Friedrich Alexander Univ Erlangen Nurnberg, Erlangen Grad Sch Adv Opt Technol, Erlangen, Germany	University of Erlangen Nuremberg; University of Munich; University of Munich; University of Erlangen Nuremberg; University of Erlangen Nuremberg; Helmholtz Association; German Cancer Research Center (DKFZ); University of Erlangen Nuremberg; University of Erlangen Nuremberg; University of Erlangen Nuremberg	Knieling, F (corresponding author), Friedrich Alexander Univ Erlangen Nurnberg, Univ Hosp Erlangen, Dept Pediat & Adolescent Med, Erlangen, Germany.	Ferdinand.Knieling@uk-erlangen.de	Wolf, Eckhard/AAT-7500-2021; Knieling, Ferdinand/Z-6052-2019; Klymiuk, Nikolai/AAB-8345-2022; Fröhlich, Thomas/C-6735-2011; Woellfe, joachim F/E-9406-2014; Nagel, Armin M/C-4671-2016	Wolf, Eckhard/0000-0002-0430-9510; Knieling, Ferdinand/0000-0002-3535-2626; Klymiuk, Nikolai/0000-0003-3532-1659; Fröhlich, Thomas/0000-0002-4709-3211; Nagel, Armin M/0000-0003-0948-1421; , Joachim/0000-0002-9132-6174; Kemter, Elisabeth/0000-0001-7785-7502; Heiss, Rafael/0000-0002-2897-5411; Gerhalter, Teresa/0000-0001-9734-4632	Else Kroner-Fresenius-Stiftung (Else Kroner-Memorial-Stipendium) [2018_EKMS.03]; ELAN Fond at the University Hospital of Friedrich-Alexander-Universitat (FAU) Erlangen-Nurnberg; Interdisciplinary Center for Clinical Research at the University Hospital of FAU Erlangen-Nurnberg; Johannes and Frieda Marohn Foundation; Graduate School in Advanced Optical Technologies of FAU Erlangen-Nurnberg; Emerging Fields Initiative of FAU Erlangen-Nurnberg; German Research Foundation [FOR2438, TRR241, TRR127]; Else Kroner-Fresenius Foundation [2015_180, 2018_T20]; Bayerische Forschungsstiftung [AZ 802/08]; European Union [830965]	Else Kroner-Fresenius-Stiftung (Else Kroner-Memorial-Stipendium); ELAN Fond at the University Hospital of Friedrich-Alexander-Universitat (FAU) Erlangen-Nurnberg; Interdisciplinary Center for Clinical Research at the University Hospital of FAU Erlangen-Nurnberg; Johannes and Frieda Marohn Foundation; Graduate School in Advanced Optical Technologies of FAU Erlangen-Nurnberg; Emerging Fields Initiative of FAU Erlangen-Nurnberg; German Research Foundation(German Research Foundation (DFG)); Else Kroner-Fresenius Foundation; Bayerische Forschungsstiftung; European Union(European Commission)	F.K. acknowledges founding from Else Kroner-Fresenius-Stiftung (Else Kroner-Memorial-Stipendium, no. 2018_EKMS.03). A.P.R. received support from the ELAN Fond at the University Hospital of Friedrich-Alexander-Universitat (FAU) Erlangen-Nurnberg. F.K. and A.P.R. acknowledge support by the Interdisciplinary Center for Clinical Research at the University Hospital of FAU Erlangen-Nurnberg. R.T. and A.M.N. acknowledge funding from the Johannes and Frieda Marohn Foundation. M.J.W. received support from the Graduate School in Advanced Optical Technologies of FAU Erlangen-Nurnberg. M.F.N. acknowledges funding from the Emerging Fields Initiative of FAU Erlangen-Nurnberg. M.J.W and M.F.N. acknowledge founding from the German Research Foundation (nos. FOR2438 and TRR241). E.W. acknowledges funding from the Else Kroner-Fresenius Foundation (nos. 2015_180 and 2018_T20), the Bayerische Forschungsstiftung (no. AZ 802/08) and the German Research Foundation (no. TRR127). M.F.N., M.J.W. and F.K. received funding from the European Union's Horizon 2020 research and innovation program (grant agreement no. 830965). We thank the Imaging Science Institute (Erlangen, Germany) for providing us with measurement facilities for the 3 T MRI system. The present work was performed in partial fulfillment of the requirements for obtaining the degree 'Dr med. vet.' (L.M.F.). We thank the patients and healthy volunteers who provided their time and effort. We gratefully acknowledge our physiotherapists J. Tolks, M. Muller-Allissat and P. Poepperl for excellent assistance and physical testing of the participants. We thank the administrative staff at the Center for Social Pediatrics and the Center for Rare Neuromuscular Diseases within the Center for Rare Disease at University Hospital Erlangen, with special thanks to S. Schuessler for help during patient recruitment; G. Boie and I. Allabauer for performing histological techniques; C. Blechinger for exceptional help during animal husbandry and histological preparations; B. Marty for fruitful discussions about MRI in muscular diseases; G. Poland for language editing; and M. Englbrecht for statistical review of the manuscript.	Arpan I, 2014, NEUROLOGY, V83, P974, DOI 10.1212/WNL.0000000000000775; Backman M, 2019, MOL METAB, V26, P30, DOI 10.1016/j.molmet.2019.05.011; Barnard AM, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194283; Becker A, 2018, EUR RADIOL, V28, P602, DOI 10.1007/s00330-017-5002-x; BELL CD, 1968, J NEUROL SCI, V7, P529, DOI 10.1016/0022-510X(68)90058-0; Bettica P, 2016, NEUROMUSCULAR DISORD, V26, P643, DOI 10.1016/j.nmd.2016.07.002; Bonati U, 2015, NEUROMUSCULAR DISORD, V25, P679, DOI 10.1016/j.nmd.2015.05.006; BROOKE MH, 1983, MUSCLE NERVE, V6, P204, DOI 10.1002/mus.880060307; BROOKE MH, 1981, MUSCLE NERVE, V4, P186, DOI 10.1002/mus.880040304; Bushby K, 2014, MUSCLE NERVE, V50, P477, DOI 10.1002/mus.24332; Cao Q, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.10.101318; Chrzanowski Stephen M, 2017, Acta Myol, V36, P151; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Desguerre I, 2009, J NEUROPATH EXP NEUR, V68, P762, DOI 10.1097/NEN.0b013e3181aa31c2; Diot G, 2017, CLIN CANCER RES, V23, P6912, DOI 10.1158/1078-0432.CCR-16-3200; EMERY AEH, 1977, NATURE, V266, P472, DOI 10.1038/266472a0; Escolar DM, 2011, NEUROLOGY, V77, P444, DOI 10.1212/WNL.0b013e318227b164; Fairclough RJ, 2013, NAT REV GENET, V14, P373, DOI 10.1038/nrg3460; Forbes SC, 2013, RADIOLOGY, V269, P198, DOI 10.1148/radiol.13121948; Ford SJ, 2016, J INVEST DERMATOL, V136, P753, DOI 10.1016/j.jid.2015.09.001; FOWLER WM, 1995, AM J PHYS MED REHAB, V74, pS62, DOI 10.1097/00002060-199509001-00002; Frantz C, 2010, J CELL SCI, V123, P4195, DOI 10.1242/jcs.023820; Frohlich T, 2016, SCI REP-UK, V6, DOI 10.1038/srep33362; Gerhalter T, 2019, J MAGN RESON IMAGING, V50, P1103, DOI 10.1002/jmri.26681; Glemser Philip A, 2017, Acta Myol, V36, P2; HECKMATT JZ, 1982, J PEDIATR-US, V101, P656, DOI 10.1016/S0022-3476(82)80286-2; Helfen A, 2019, J CLIN MED, V8, DOI 10.3390/jcm8010063; HOFFMAN EP, 1987, CELL, V51, P919, DOI 10.1016/0092-8674(87)90579-4; Hooijmans MT, 2017, NEUROMUSCULAR DISORD, V27, P458, DOI 10.1016/j.nmd.2017.02.009; Hooijmans MT, 2017, NMR BIOMED, V30, DOI 10.1002/nbm.3667; Joseph J, 2017, J NUCL MED, V58, P807, DOI 10.2967/jnumed.116.182311; Juras V, 2013, EUR J RADIOL, V82, P740, DOI 10.1016/j.ejrad.2011.09.022; Klingler Werner, 2012, Acta Myol, V31, P184; Klymiuk N, 2016, TOXICOL PATHOL, V44, P346, DOI 10.1177/0192623315609688; Klymiuk N, 2013, HUM MOL GENET, V22, P4368, DOI 10.1093/hmg/ddt287; Knieling F, 2017, NEW ENGL J MED, V376, P1292, DOI 10.1056/NEJMc1612455; Mayhew JE, 2007, MUSCLE NERVE, V35, P36, DOI 10.1002/mus.20654; McDonald CM, 2017, LANCET, V390, P1489, DOI 10.1016/S0140-6736(17)31611-2; McDonald CM, 2010, MUSCLE NERVE, V42, P966, DOI 10.1002/mus.21808; McDonald CM, 2010, MUSCLE NERVE, V41, P500, DOI 10.1002/mus.21544; Mendell JR, 2016, ANN NEUROL, V79, P257, DOI 10.1002/ana.24555; Mendell JR, 2013, MUSCLE NERVE, V48, P21, DOI 10.1002/mus.23810; Mercuri E, 2013, LANCET, V381, P845, DOI 10.1016/S0140-6736(12)61897-2; Min YL, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aav4324; Negroni E, 2014, J NEUROPATH EXP NEUR, V73, P789, DOI 10.1097/NEN.0000000000000098; Ntziachristos V, 2010, CHEM REV, V110, P2783, DOI 10.1021/cr9002566; Ozalevli S, 2007, RESP MED, V101, P286, DOI 10.1016/j.rmed.2006.05.007; Peverelli L, 2015, NEUROLOGY, V85, P1886, DOI 10.1212/WNL.0000000000002147; Pillen S, 2008, MUSCLE NERVE, V37, P679, DOI 10.1002/mus.21015; R Core Team, 2018, R LANG ENV STAT COMP; Rey-Barroso L, 2018, SENSORS-BASEL, V18, DOI 10.3390/s18051441; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Scholkmann F, 2014, NEUROIMAGE, V85, P6, DOI 10.1016/j.neuroimage.2013.05.004; Sekar SKV, 2017, J BIOMED OPT, V22, DOI 10.1117/1.JBO.22.1.015006; Serrano AL, 2010, EXP CELL RES, V316, P3050, DOI 10.1016/j.yexcr.2010.05.035; Stoffels I, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aad1278; Straub V, 2016, LANCET NEUROL, V15, P882, DOI 10.1016/S1474-4422(16)30035-7; Szigyarto CAK, 2018, DEGENER NEUROL NEURO, V8, P1, DOI 10.2147/DNND.S121099; Taroni P, 2017, SCI REP-UK, V7, DOI 10.1038/srep40683; Taruttis A, 2015, NAT PHOTONICS, V9, P219, DOI 10.1038/nphoton.2015.29; TOOP J, 1974, CLIN GENET, V5, P230; Tyanova S, 2016, NAT METHODS, V13, P731, DOI [10.1038/nmeth.3901, 10.1038/NMETH.3901]; Waldner MJ, 2016, GASTROENTEROLOGY, V151, P238, DOI 10.1053/j.gastro.2016.05.047; Wary C, 2015, NMR BIOMED, V28, P1150, DOI 10.1002/nbm.3352; Weber J, 2016, NAT METHODS, V13, P639, DOI [10.1038/NMETH.3929, 10.1038/nmeth.3929]; Weber MA, 2012, J NEUROL, V259, P2385, DOI 10.1007/s00415-012-6512-8; Weber MA, 2011, NEUROLOGY, V77, P2017, DOI 10.1212/WNL.0b013e31823b9c78; Weng WC, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04131-8; Willcocks RJ, 2016, ANN NEUROL, V79, P535, DOI 10.1002/ana.24599; Zaidman CM, 2015, MUSCLE NERVE, V52, P334, DOI 10.1002/mus.24609	70	72	72	3	27	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	2019	25	12					1905	+		10.1038/s41591-019-0669-y	http://dx.doi.org/10.1038/s41591-019-0669-y			21	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	JT2KO	31792454	Green Submitted			2022-12-27	WOS:000500824900034
J	Basson, M				Basson, Michael			CARDIOVASCULAR DISEASE Prevention with a polypill	NATURE MEDICINE			English	Editorial Material																			0	0	0	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2019	25	11					1647	1647		10.1038/s41591-019-0658-1	http://dx.doi.org/10.1038/s41591-019-0658-1			1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	JT2KI	31700180	Bronze			2022-12-27	WOS:000500824300013
J	Abramson, A; Caffarel-Salvador, E; Soares, V; Minahan, D; Tian, RY; Lu, XY; Dellal, D; Gao, Y; Kim, S; Wainer, J; Collins, J; Tamang, S; Hayward, A; Yoshitake, T; Lee, HC; Fujimoto, J; Fels, J; Frederiksen, MR; Rahbek, U; Roxhed, N; Langer, R; Traverso, G				Abramson, Alex; Caffarel-Salvador, Ester; Soares, Vance; Minahan, Daniel; Tian, Ryan Yu; Lu, Xiaoya; Dellal, David; Gao, Yuan; Kim, Soyoung; Wainer, Jacob; Collins, Joy; Tamang, Siddartha; Hayward, Alison; Yoshitake, Tadayuki; Lee, Hsiang-Chieh; Fujimoto, James; Fels, Johannes; Frederiksen, Morten Revsgaard; Rahbek, Ulrik; Roxhed, Niclas; Langer, Robert; Traverso, Giovanni			A luminal unfolding microneedle injector for oral delivery of macromolecules	NATURE MEDICINE			English	Article							GLYCEMIC CONTROL; DRUG-DELIVERY; UNITED-STATES; INSULIN; FORMULATION; METFORMIN; AGENTS; TIME	Insulin and other injectable biologic drugs have transformed the treatment of patients suffering from diabetes(1,2), yet patients and healthcare providers often prefer to use and prescribe less effective orally dosed medications(3-5). Compared with subcutaneously administered drugs, oral formulations create less patient discomfort(4), show greater chemical stability at high temperatures(6), and do not generate biohazardous needle waste(7). An oral dosage form for biologic medications is ideal; however, macromolecule drugs are not readily absorbed into the bloodstream through the gastrointestinal tract(8). We developed an ingestible capsule, termed the luminal unfolding microneedle injector, which allows for the oral delivery of biologic drugs by rapidly propelling dissolvable drug-loaded microneedles into intestinal tissue using a set of unfolding arms. During ex vivo human and in vivo swine studies, the device consistently delivered the microneedles to the tissue without causing complete thickness perforations. Using insulin as a model drug, we showed that, when actuated, the luminal unfolding microneedle injector provided a faster pharmacokinetic uptake profile and a systemic uptake > 10% of that of a subcutaneous injection over a 4-h sampling period. With the ability to load a multitude of microneedle formulations, the device can serve as a platform to orally deliver therapeutic doses of macromolecule drugs.	[Abramson, Alex; Caffarel-Salvador, Ester; Soares, Vance; Minahan, Daniel; Tian, Ryan Yu; Lu, Xiaoya; Gao, Yuan; Kim, Soyoung; Wainer, Jacob; Collins, Joy; Tamang, Siddartha; Hayward, Alison; Roxhed, Niclas; Langer, Robert; Traverso, Giovanni] MIT, Dept Chem Engn, Cambridge, MA 02139 USA; [Abramson, Alex; Caffarel-Salvador, Ester; Soares, Vance; Minahan, Daniel; Tian, Ryan Yu; Lu, Xiaoya; Dellal, David; Gao, Yuan; Kim, Soyoung; Wainer, Jacob; Collins, Joy; Tamang, Siddartha; Hayward, Alison; Roxhed, Niclas; Langer, Robert; Traverso, Giovanni] MIT, David H Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Caffarel-Salvador, Ester; Dellal, David; Langer, Robert] MIT, Inst Med Engn & Sci, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Hayward, Alison] MIT, Div Comparat Med, Cambridge, MA 02139 USA; [Yoshitake, Tadayuki; Lee, Hsiang-Chieh; Fujimoto, James] MIT, Dept Elect Engn & Comp Sci, Cambridge, MA 02139 USA; [Yoshitake, Tadayuki; Lee, Hsiang-Chieh; Fujimoto, James] MIT, Elect Res Lab, Cambridge, MA 02139 USA; [Fels, Johannes; Frederiksen, Morten Revsgaard; Rahbek, Ulrik] Global Drug Discovery, Global Res Technol, Malov, Denmark; [Fels, Johannes; Frederiksen, Morten Revsgaard; Rahbek, Ulrik] Novo Nordisk, Device R&D, Malov, Denmark; [Roxhed, Niclas] KTH Royal Inst Technol, Dept Micro & Nanosyst, Stockholm, Sweden; [Langer, Robert; Traverso, Giovanni] MIT, Dept Mech Engn, Cambridge, MA 02139 USA; [Langer, Robert] MIT, Media Lab, Cambridge, MA 02139 USA; [Traverso, Giovanni] Harvard Med Sch, Brigham & Womens Hosp, Div Gastroenterol, Boston, MA 02115 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Novo Nordisk; Royal Institute of Technology; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Brigham & Women's Hospital; Harvard Medical School	Langer, R; Traverso, G (corresponding author), MIT, Dept Chem Engn, Cambridge, MA 02139 USA.; Langer, R; Traverso, G (corresponding author), MIT, David H Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Langer, R (corresponding author), MIT, Inst Med Engn & Sci, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Langer, R; Traverso, G (corresponding author), MIT, Dept Mech Engn, Cambridge, MA 02139 USA.; Langer, R (corresponding author), MIT, Media Lab, Cambridge, MA 02139 USA.; Traverso, G (corresponding author), Harvard Med Sch, Brigham & Womens Hosp, Div Gastroenterol, Boston, MA 02115 USA.	rlanger@mit.edu; cgt20@mit.edu	Traverso, Carlo Giovanni/ABC-9065-2020	Traverso, Carlo Giovanni/0000-0001-7851-4077; Minahan, Daniel/0000-0003-3065-055X; /0000-0002-2976-6195; Dellal, David/0000-0001-9558-3517; Wainer, Jacob/0000-0002-4845-228X; Caffarel-Salvador, Ester/0000-0002-2844-7598; Tian, Ryan Yu/0000-0002-1096-5418; Soares, Vance/0000-0002-4094-3316; Roxhed, Niclas/0000-0002-7147-6730	Novo Nordisk; NIH [R01-CA075289-21, EB000244]; NSF Graduate Research Fellowship Program fellowship; Division of Gastroenterology at Brigham and Woman's Hospital; Department of Mechanical Engineering at MIT; MIT Undergraduate Research Opportunities Program; Viking Olof Bjork scholarship trust	Novo Nordisk(Novo Nordisk); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF Graduate Research Fellowship Program fellowship; Division of Gastroenterology at Brigham and Woman's Hospital; Department of Mechanical Engineering at MIT; MIT Undergraduate Research Opportunities Program; Viking Olof Bjork scholarship trust	We thank S. McDonnell, K. Ishida, J. Haupt and M. Jamiel for help with the in vivo porcine work. We thank C. Steiger and Y. L. Kong for helpful conversations on the capsule system. We thank J. Bales and the Edgerton Center at MIT for providing a highspeed camera setup. We thank A. Hupalowska for illustrations of the LUMI concept. We thank the Koch Institute for Integrative Cancer Research at MIT's Histology Core, High Throughput Facility and Imaging Core. We thank the National Disease Research Interchange for help with the procurement of human cadaveric tissue. We thank U. Stilz, M. Bielecki, T. Kjeldsen, L. F. Iversen, J. Trosborg, P. Herskind, R. K. Kirk, F. Hubalek, J. J. Water, A. V. Friderichsen, S. Buckley, A. Vegge and T.B. Pedersen for helpful discussions throughout the development of the LUMI. We are grateful to R. Yona and all of the other members of the Langer and Traverso laboratories and Novo Nordisk for their expertise and discussions around biologic drug delivery. This work was funded in part by a grant from Novo Nordisk and NIH grant number EB000244. A.A. was supported in part by the NSF Graduate Research Fellowship Program fellowship. G.T. was supported in part by the Division of Gastroenterology at Brigham and Woman's Hospital and the Department of Mechanical Engineering at MIT. D.D. was supported by the MIT Undergraduate Research Opportunities Program. N.R. was supported in part by the Viking Olof Bjork scholarship trust. H.-C.L., T.Y. and J. Fujimoto were supported in part by NIH R01-CA075289-21.	Abramson A, 2019, SCIENCE, V363, P611, DOI 10.1126/science.aau2277; Anselmo AC, 2019, NAT REV DRUG DISCOV, V18, P19, DOI 10.1038/nrd.2018.183; Banerjee A, 2018, P NATL ACAD SCI USA, V115, P7296, DOI 10.1073/pnas.1722338115; Banerjee A, 2017, J DRUG TARGET, V25, P608, DOI 10.1080/1061186X.2017.1300664; Bass DM, 2002, DRUG SAFETY, V25, P1021, DOI 10.2165/00002018-200225140-00004; Boye KS, 2011, EUR J HEALTH ECON, V12, P219, DOI 10.1007/s10198-010-0224-8; Calvert MJ, 2007, BRIT J GEN PRACT, V57, P455; Classen M., 2010, GASTROENTEROLOGICAL; CLELAND JL, 1994, ACS SYM SER, V567, P1; Coffey JW, 2016, BIOMATERIALS, V84, P130, DOI 10.1016/j.biomaterials.2016.01.015; Cole ET, 2002, INT J PHARMACEUT, V231, P83, DOI 10.1016/S0378-5173(01)00871-7; Dallel Nada, 2005, Tunis Med, V83, P390; Davies M, 2017, JAMA-J AM MED ASSOC, V318, P1460, DOI 10.1001/jama.2017.14752; Gatto NM, 2003, J NATL CANCER I, V95, P230, DOI 10.1093/jnci/95.3.230; Harrison GA, 1923, BRIT MED J, V1923, P1204, DOI 10.1136/bmj.2.3286.1204; Hellmig S, 2006, J GASTROEN HEPATOL, V21, P1832, DOI 10.1111/j.1440-1746.2006.04449.x; Iddan G, 2000, NATURE, V405, P417, DOI 10.1038/35013140; Korytkowski M, 2002, INT J OBESITY, V26, pS18, DOI 10.1038/sj.ijo.0802173; Mathiowitz E, 1997, NATURE, V386, P410, DOI 10.1038/386410a0; Mitragotri S, 2014, NAT REV DRUG DISCOV, V13, P655, DOI 10.1038/nrd4363; Podolsky DK, 1997, J GASTROENTEROL, V32, P122, DOI 10.1007/BF01213309; Pratley RE, 2010, LANCET, V375, P1447, DOI 10.1016/S0140-6736(10)60307-8; Pridgen EM, 2015, EXPERT OPIN DRUG DEL, V12, P1459, DOI 10.1517/17425247.2015.1018175; Sandler RS, 2000, DIGEST DIS SCI, V45, P1166, DOI 10.1023/A:1005554103531; Scudellari M., SHOT GUT ROBOTIC PIL; Snoeck V, 2004, J CONTROL RELEASE, V94, P143, DOI 10.1016/j.jconrel.2003.09.015; Traverso G, 2015, J PHARM SCI-US, V104, P362, DOI 10.1002/jps.24182; Turner RC, 1999, JAMA-J AM MED ASSOC, V281, P2005, DOI 10.1001/jama.281.21.2005; van Meer L, 2016, BRIT J CLIN PHARMACO, V82, P340, DOI 10.1111/bcp.12961; Velitchkov NG, 1996, WORLD J SURG, V20, P1001, DOI 10.1007/s002689900152; Vllasaliu D, 2018, EXPERT OPIN DRUG DEL, V15, P759, DOI 10.1080/17425247.2018.1504017; Wang YR, 2008, AM J GASTROENTEROL, V103, P313, DOI 10.1111/j.1572-0241.2007.01658.x; Ye YQ, 2018, ADV DRUG DELIVER REV, V127, P106, DOI 10.1016/j.addr.2018.01.015	33	86	93	25	252	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	OCT	2019	25	10					1512	+		10.1038/s41591-019-0598-9	http://dx.doi.org/10.1038/s41591-019-0598-9			19	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	JC3GJ	31591601	Green Published, Green Accepted			2022-12-27	WOS:000489166700019
J	Staaf, J; Glodzik, D; Bosch, A; Vallon-Christersson, J; Reutersward, C; Hakkinen, J; Degasperi, A; Amarante, TD; Saal, LH; Hegardt, C; Stobart, H; Ehinger, A; Larsson, C; Ryden, L; Loman, N; Malmberg, M; Kvist, A; Ehrencrona, H; Davies, HR; Borg, A; Nik-Zainal, S				Staaf, Johan; Glodzik, Dominik; Bosch, Ana; Vallon-Christersson, Johan; Reutersward, Christel; Hakkinen, Jari; Degasperi, Andrea; Amarante, Tauanne Dias; Saal, Lao H.; Hegardt, Cecilia; Stobart, Hilary; Ehinger, Anna; Larsson, Christer; Ryden, Lisa; Loman, Niklas; Malmberg, Martin; Kvist, Anders; Ehrencrona, Hans; Davies, Helen R.; Borg, Ake; Nik-Zainal, Serena			Whole-genome sequencing of triple-negative breast cancers in a population-based clinical study	NATURE MEDICINE			English	Article							ONCOGENE-INDUCED SENESCENCE; MUTATIONS; BRCA1; IDENTIFICATION; REVEALS; NETWORK	Whole-genome sequencing (WGS) brings comprehensive insights to cancer genome interpretation. To explore the clinical value of WGS, we sequenced 254 triple-negative breast cancers (TNBCs) for which associated treatment and outcome data were collected between 2010 and 2015 via the population-based Sweden Cancerome Analysis Network-Breast (SCAN-B) project (ClinicalTrials.gov ID:NCT02306096). Applying the HRDetect mutational-signature-based algorithm to classify tumors, 59% were predicted to have homologous-recombination-repair deficiency (HRDetect-high): 67% explained by germline/somatic mutations of BRCA1/BRCA2, BRCA1 promoter hypermethylation, RAD51C hypermethylation or biallelic loss of PALB2. A novel mechanism of BRCA1 abrogation was discovered via germline SINE-VNTR-Alu retrotransposition. HRDetect provided independent prognostic information, with HRDetect-high patients having better outcome on adjuvant chemotherapy for invasive disease-free survival (hazard ratio (HR) = 0.42; 95% confidence interval (CI) = 0.2-0.87) and distant relapse-free interval (HR = 0.31, CI = 0.13-0.76) compared to HRDetect-low, regardless of whether a genetic/epigenetic cause was identified. HRDetect-intermediate, some possessing potentially targetable biological abnormalities, had the poorest outcomes. HRDetect-low cancers also had inadequate outcomes: similar to 4.7% were mismatch-repair-deficient (another targetable defect, not typically sought) and they were enriched for (but not restricted to) PIK3CA/AKT1 pathway abnormalities. New treatment options need to be considered for now-discernible HRDetect-intermediate and HRDetect-low categories. This population-based study advocates for WGS of TNBC to better inform trial stratification and improve clinical decision-making.	[Staaf, Johan; Glodzik, Dominik; Bosch, Ana; Vallon-Christersson, Johan; Reutersward, Christel; Hakkinen, Jari; Saal, Lao H.; Hegardt, Cecilia; Ehinger, Anna; Loman, Niklas; Malmberg, Martin; Kvist, Anders; Borg, Ake] Lund Univ, Dept Clin Sci Lund, Div Oncol & Pathol, Lund, Sweden; [Glodzik, Dominik] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, Computat Oncol, New York, NY 10021 USA; [Glodzik, Dominik; Degasperi, Andrea; Amarante, Tauanne Dias; Davies, Helen R.] Wellcome Genome Campus, Wellcome Sanger Inst, Cambridge, England; [Bosch, Ana; Loman, Niklas; Malmberg, Martin] Skane Univ Hosp, Dept Oncol, Lund, Sweden; [Degasperi, Andrea; Amarante, Tauanne Dias; Davies, Helen R.; Nik-Zainal, Serena] Univ Cambridge, Sch Clin, Acad Dept Med Genet, Cambridge Biomed Res Campus, Cambridge, England; [Stobart, Hilary] Independent Canc Patients Voice, London, England; [Ehinger, Anna; Ehrencrona, Hans] Off Med Serv, Dept Lab Med, Dept Clin Genet & Pathol, Lund, Sweden; [Larsson, Christer] Lund Univ, Dept Lab Med, Div Translat Canc Res, Lund, Sweden; [Ryden, Lisa] Lund Univ, Dept Clin Sci, Div Surg, Lund, Sweden; [Ryden, Lisa] Skane Univ Hosp, Dept Surg, Lund, Sweden; [Ehrencrona, Hans] Lund Univ, Dept Lab Med, Div Clin Genet, Lund, Sweden; [Davies, Helen R.; Nik-Zainal, Serena] Cambridge Biomed Res Campus, Hutchison MRC Res Ctr, MRC Canc Unit, Cambridge, England	Lund University; Memorial Sloan Kettering Cancer Center; Wellcome Trust Sanger Institute; Lund University; Skane University Hospital; University of Cambridge; Lund University; Lund University; Lund University; Skane University Hospital; Lund University	Staaf, J (corresponding author), Lund Univ, Dept Clin Sci Lund, Div Oncol & Pathol, Lund, Sweden.; Nik-Zainal, S (corresponding author), Univ Cambridge, Sch Clin, Acad Dept Med Genet, Cambridge Biomed Res Campus, Cambridge, England.; Nik-Zainal, S (corresponding author), Cambridge Biomed Res Campus, Hutchison MRC Res Ctr, MRC Canc Unit, Cambridge, England.	johan.staaf@med.lu.se; snz@mrc-cu.cam.ac.uk	Ehrencrona, Hans/M-5619-2014; Ehrencrona, Hans/Q-4621-2019; Ehinger, Anna/I-8516-2014; Degasperi, Andrea/AAG-1315-2019; Häkkinen, Jari/AHH-4463-2022; Nik-Zainal, Serena/ABD-4437-2020; Saal, Lao/A-2919-2011	Ehrencrona, Hans/0000-0002-5589-3622; Ehrencrona, Hans/0000-0002-5589-3622; Ehinger, Anna/0000-0001-9225-7396; Degasperi, Andrea/0000-0001-6879-0596; Saal, Lao/0000-0002-0815-1896; Hakkinen, Jari/0000-0002-8466-9179; Dias Amarante, Tauanne/0000-0002-1999-9753; Kvist, Anders/0000-0002-1358-0695; Nik-Zainal, Serena/0000-0001-5054-1727; Vallon-Christersson, Johan/0000-0002-2195-0385	Swedish Cancer Society [CAN 2016/659, CAN 2018/685, SIA190013]; Mrs Berta Kamprad Foundation [FBKS-2018-3-166, FBKS-2018-4-146]; Crafoord Foundation [20180543]; Swedish Research Council; Lund-Lausanne L2-Bridge/Biltema Foundation [F 2016/1330]; Mats Paulsson Foundation [IACD 2017]; Gustav V's Jubilee Foundation [174271]; Governmental Funding of Clinical Research within the National Health Service (ALF) [2018/40612]; Wellcome Trust Intermediate Clinical Fellowship [WT100183MA]; CRUK Advanced Clinician Scientist Award [C60100/A23916]; CRUK Grand Challenge Award [C60100/A25274]	Swedish Cancer Society(Swedish Cancer Society); Mrs Berta Kamprad Foundation; Crafoord Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission); Lund-Lausanne L2-Bridge/Biltema Foundation; Mats Paulsson Foundation; Gustav V's Jubilee Foundation; Governmental Funding of Clinical Research within the National Health Service (ALF); Wellcome Trust Intermediate Clinical Fellowship(Wellcome Trust); CRUK Advanced Clinician Scientist Award; CRUK Grand Challenge Award	We thank patients and clinicians participating in the SCAN-B study, the staff at the central SCAN-B laboratory at the Division of Oncology and Pathology, Lund University, the Swedish national breast cancer quality registry (NKBC), RBC Syd, the South Sweden Breast Cancer Group (SSBCG), the CASM IT and Wellcome Sanger Institute sequencing team for support, R. Harris for administrative, technical and coordination support, K. Lovgren and E. Rambech for technical assistance with MMRd cases and P.-O. Bendahl for statistical comments. Financial support for this study was provided by the Swedish Cancer Society (CAN 2016/659, CAN 2018/685 and Senior Investigator Award SIA190013), the Mrs Berta Kamprad Foundation (FBKS-2018-3-166 and FBKS-2018-4-146), the Crafoord Foundation (20180543), the Swedish Research Council, the Lund-Lausanne L2-Bridge/Biltema Foundation (F 2016/1330), the Mats Paulsson Foundation (IACD 2017), the Gustav V's Jubilee Foundation (174271) and Governmental Funding of Clinical Research within the National Health Service (ALF) (2018/40612). Whole-genome sequencing and analysis was funded by a Wellcome Trust Intermediate Clinical Fellowship (WT100183MA), a CRUK Advanced Clinician Scientist Award (C60100/A23916) and a CRUK Grand Challenge Award (C60100/A25274).	Ali HR, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0431-1; Bartkova J, 2006, NATURE, V444, P633, DOI 10.1038/nature05268; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Brueffer C, 2018, JCO PRECIS ONCOL, V2, P1, DOI 10.1200/PO.17.00135; Chen X, 2012, CANCER INFORM, V11, P147, DOI 10.4137/CIN.S9983; Chen X, 2018, CLIN CANCER RES, V24, P6594, DOI 10.1158/1078-0432.CCR-18-1446; Curtis C, 2012, NATURE, V486, P346, DOI 10.1038/nature10983; Davies H, 2017, CANCER RES, V77, P4755, DOI 10.1158/0008-5472.CAN-17-1083; Davies H, 2017, NAT MED, V23, P517, DOI 10.1038/nm.4292; Di Micco R, 2006, NATURE, V444, P638, DOI 10.1038/nature05327; Evans DGR, 2018, AM J HUM GENET, V103, P213, DOI 10.1016/j.ajhg.2018.07.002; Forment JV, 2018, PHARMACOL THERAPEUT, V188, P155, DOI 10.1016/j.pharmthera.2018.03.005; Glodzik D, 2017, NAT GENET, V49, P341, DOI 10.1038/ng.3771; Guedj M, 2012, ONCOGENE, V31, P1196, DOI 10.1038/onc.2011.301; Haffty BG, 2006, J CLIN ONCOL, V24, P5652, DOI 10.1200/JCO.2006.06.5664; Halazonetis TD, 2008, SCIENCE, V319, P1352, DOI 10.1126/science.1140735; Hillman RT, 2018, JNCI-J NATL CANCER I, V110, DOI 10.1093/jnci/djx176; Hudis CA, 2007, J CLIN ONCOL, V25, P2127, DOI 10.1200/JCO.2006.10.3523; Lehmann BD, 2011, J CLIN INVEST, V121, P2750, DOI 10.1172/JCI45014; Liedtke C, 2008, J CLIN ONCOL, V26, P1275, DOI 10.1200/JCO.2007.14.4147; Mazouzi A, 2014, EXP CELL RES, V329, P85, DOI 10.1016/j.yexcr.2014.09.030; Nik-Zainal S, 2016, NATURE, V534, P47, DOI 10.1038/nature17676; Nik-Zainal S, 2012, CELL, V149, DOI 10.1016/j.cell.2012.04.023; Nik-Zainal S, 2012, CELL, V149, P979, DOI 10.1016/j.cell.2012.04.024; Nilsson MP, 2018, J COMMUN GENET, V9, P201, DOI 10.1007/s12687-017-0341-5; Paquet ER, 2014, JNCI-J NATL CANCER I, V107, P357; Park JY, 2014, ONCOGENE, V33, P4803, DOI 10.1038/onc.2013.421; Park JY, 2014, BBA-REV CANCER, V1846, P263, DOI 10.1016/j.bbcan.2014.06.003; Polak P, 2017, NAT GENET, V49, P1476, DOI 10.1038/ng.3934; Popova T, 2016, CANCER RES, V76, P1882, DOI 10.1158/0008-5472.CAN-15-2128; Qian Y, 2017, CANCER GENET-NY, V216, P159, DOI 10.1016/j.cancergen.2017.08.002; Ryden L, 2018, BRIT J SURG, V105, pE158, DOI 10.1002/bjs.10741; Saal LH, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0131-9; Sharma P, 2016, ONCOLOGIST, V21, P1050, DOI 10.1634/theoncologist.2016-0067; Telli ML, 2016, CLIN CANCER RES, V22, P3764, DOI 10.1158/1078-0432.CCR-15-2477	35	112	114	1	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	OCT	2019	25	10					1526	+		10.1038/s41591-019-0582-4	http://dx.doi.org/10.1038/s41591-019-0582-4			19	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	JC3GJ	31570822	Green Accepted, Green Submitted			2022-12-27	WOS:000489166700021
J	Shi, QL; Hu, YY; Peng, B; Tang, XJ; Wang, W; Su, K; Luo, C; Wu, B; Zhang, F; Zhang, Y; Anderson, B; Zhong, XN; Qiu, JF; Yang, CY; Huang, AL				Shi, Qiuling; Hu, Yaoyue; Peng, Bin; Tang, Xiao-Jun; Wang, Wei; Su, Kun; Luo, Chao; Wu, Bo; Zhang, Fan; Zhang, Yong; Anderson, Benjamin; Zhong, Xiao-Ni; Qiu, Jing-Fu; Yang, Cheng Yong; Huang, Ai-Long			Effective control of SARS-CoV-2 transmission in Wanzhou, China	NATURE MEDICINE			English	Article							CORONAVIRUS; COVID-19	The effectiveness of control measures to contain coronavirus disease 2019 (COVID-19) in Wanzhou, China was assessed. Epidemiological data were analyzed for 183 confirmed COVID-19 cases and their close contacts from five generations of transmission of severe acute respiratory syndrome coronavirus 2 throughout the entire COVID-19 outbreak in Wanzhou. Approximately 67.2% and 32.8% of cases were symptomatic and asymptomatic, respectively. Asymptomatic and presymptomatic transmission accounted for 75.9% of the total recorded transmission. The reproductive number was 1.64 (95% confidence interval: 1.16-2.40) for G1-to-G2 transmission, decreasing to 0.31-0.39 in later generations, concomitant with implementation of rigorous control measures. Substantially higher infection risk was associated with contact within 5 d after the infectors had been infected, frequent contact and >= 8 h of contact duration. The spread of COVID-19 was effectively controlled in Wanzhou by breaking the transmission chain through social distancing, extensive contact tracing, mass testing and strict quarantine of close contacts. Analysis of five generations of transmission of severe acute respiratory syndrome coronavirus 2 from cases to contacts identifies a high rate of symptomless transmission and risk factors associated with spread of COVID-19.	[Shi, Qiuling; Hu, Yaoyue; Peng, Bin; Tang, Xiao-Jun; Wang, Wei; Zhang, Fan; Zhang, Yong; Zhong, Xiao-Ni; Qiu, Jing-Fu] Chongqing Med Univ, Sch Publ Hlth & Management, Chongqing, Peoples R China; [Shi, Qiuling] Chongqing Med Univ, State Key Lab Ultrasound Med & Engn, Chongqing, Peoples R China; [Su, Kun] Ctr Dis Control & Prevent, Chongqing, Peoples R China; [Luo, Chao; Wu, Bo] Wanzhou Dist Ctr Dis Control & Prevent, Chongqing, Peoples R China; [Anderson, Benjamin] Duke Kunshan Univ, Global Hlth Res Ctr, Kunshan, Peoples R China; [Yang, Cheng Yong] Ausper Biopharma, Hangzhou, Peoples R China; [Huang, Ai-Long] Chongqing Med Univ, Key Lab Mol Biol Infect Dis, Designated Chinese Minist Educ, Chongqing, Peoples R China	Chongqing Medical University; Chongqing Medical University; Chinese Center for Disease Control & Prevention; Duke Kunshan University; Chongqing Medical University	Qiu, JF (corresponding author), Chongqing Med Univ, Sch Publ Hlth & Management, Chongqing, Peoples R China.; Yang, CY (corresponding author), Ausper Biopharma, Hangzhou, Peoples R China.; Huang, AL (corresponding author), Chongqing Med Univ, Key Lab Mol Biol Infect Dis, Designated Chinese Minist Educ, Chongqing, Peoples R China.	jfqiu@126.com; thechrisyang@gmail.com; ahuang@cqmu.edu.cn	Wang, Wei/A-1091-2016; Shi, Qiuling/AAK-4090-2021; Zhang, Yong/B-7089-2016	Wang, Wei/0000-0003-4088-5395; Shi, Qiuling/0000-0003-0660-3809; Zhang, Yong/0000-0003-1436-5951; Hu, Yaoyue/0000-0001-6517-1503; Huang, Ailong/0000-0003-0148-7423	National Science and Technology Major Project [2017ZX10202203]; Emergency Project from the Science and Technology Commission of Chongqing; National Natural Science Foundation of China [81871656, 81872506, 8181101099]	National Science and Technology Major Project; Emergency Project from the Science and Technology Commission of Chongqing; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	We thank Y. Lu, the former Major of Wanzhou, who passed away on his duty of combating the COVID-19 spread in Wanzhou, for his valuable contribution and great support. This study is supported by the National Science and Technology Major Project (2017ZX10202203), the Emergency Project from the Science and Technology Commission of Chongqing, and the National Natural Science Foundation of China (grant nos. 81871656, 81872506 and 8181101099).	Arons MM, 2020, NEW ENGL J MED, V382, P2081, DOI 10.1056/NEJMoa2008457; Backer JA, 2020, EUROSURVEILLANCE, V25, P10, DOI 10.2807/1560-7917.ES.2020.25.5.2000062; Bai Y, 2020, JAMA-J AM MED ASSOC, V323, P1406, DOI [10.1056/NEJMoa2001316, 10.1001/jama.2020.2565]; Chen Y., 2020, CHINESE J EPIDEMIOLO, V41, P667, DOI 10.3760/cma.j.cn112338-20200304-00251; HE X, 2020, NAT MED, V26, P672, DOI DOI 10.1038/S41591-020-0869-5; Hellewell J, 2020, LANCET GLOB HEALTH, V8, pE488, DOI 10.1016/S2214-109X(20)30074-7; Kimball A, 2020, MMWR-MORBID MORTAL W, V69, P377, DOI 10.15585/mmwr.mm6913e1; Lloyd-Smith JO, 2005, NATURE, V438, P355, DOI 10.1038/nature04153; Long QX, 2020, NAT MED, V26, P845, DOI 10.1038/s41591-020-0897-1; National Bureau of Statistics of China, 2019, CHIN STAT YB 2019; National Health Commission of China, 2020, PREV CONTR NOV COR P; Newman M.E.J., 2010, NETWORKS INTRO; Pastor-Satorras R, 2001, PHYS REV LETT, V86, P3200, DOI 10.1103/PhysRevLett.86.3200; Tariq A, 2020, BMC MED, V18, DOI [10.1186/s12916-020-01615-9, 10.1101/2020.02.21.20026435]; To KKW, 2020, LANCET INFECT DIS, V20, P565, DOI 10.1016/S1473-3099(20)30196-1; Tong ZD, 2020, EMERG INFECT DIS, V26, P1052, DOI 10.3201/eid2605.200198; Wang L, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-18836-4; Wang W, 2019, PHYS REP, V820, P1, DOI 10.1016/j.physrep.2019.07.001; Wang W, 2017, REP PROG PHYS, V80, DOI 10.1088/1361-6633/aa5398; Wei WE, 2020, MMWR-MORBID MORTAL W, V69, P411, DOI 10.15585/mmwr.mm6914e1; Wolfel R, 2020, NATURE, V588, pE35, DOI 10.1038/s41586-020-2984-3; Wu JT, 2020, LANCET, V395, P689, DOI 10.1016/S0140-6736(20)30260-9; Ye F, 2020, INT J INFECT DIS, V94, P133, DOI 10.1016/j.ijid.2020.03.042; Zhang YJ, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17103705; Zhou P, 2020, NATURE, V579, P270, DOI 10.1038/s41586-020-2012-7; Zou LR, 2020, NEW ENGL J MED, V382, P1177, DOI 10.1056/NEJMc2001737	26	34	37	3	23	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	JAN	2021	27	1					86	+		10.1038/s41591-020-01178-5	http://dx.doi.org/10.1038/s41591-020-01178-5		NOV 2020	19	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	PS4ZO	33257893	Bronze			2022-12-27	WOS:000594784300002
J	Luo, Y; Eran, A; Palmer, N; Avillach, P; Levy-Moonshine, A; Szolovits, P; Kohane, IS				Luo, Yuan; Eran, Alal; Palmer, Nathan; Avillach, Paul; Levy-Moonshine, Ami; Szolovits, Peter; Kohane, Isaac S.			A multidimensional precision medicine approach identifies an autism subtype characterized by dyslipidemia	NATURE MEDICINE			English	Article							CHOLESTEROL-METABOLISM; SPECTRUM; DISCOVERY; CHILDREN	Integration of large datasets of familial whole-exome sequencing, neurodevelopmental gene expression, electronic health records and healthcare claims led to the identification of a subtype of autism spectrum disorder that is associated with lipid dysregulation. The promise of precision medicine lies in data diversity. More than the sheer size of biomedical data, it is the layering of multiple data modalities, offering complementary perspectives, that is thought to enable the identification of patient subgroups with shared pathophysiology. In the present study, we use autism to test this notion. By combining healthcare claims, electronic health records, familial whole-exome sequences and neurodevelopmental gene expression patterns, we identified a subgroup of patients with dyslipidemia-associated autism.	[Luo, Yuan] Northwestern Univ, Feinberg Sch Med, Dept Prevent Med, Div Hlth & Biomed Informat, Chicago, IL 60611 USA; [Luo, Yuan] Northwestern Univ, Clin & Translat Sci Inst, Chicago, IL 60611 USA; [Luo, Yuan] Northwestern Univ, Inst Augmented Intelligence Med, Chicago, IL 60611 USA; [Luo, Yuan] Northwestern Univ, Ctr Hlth Informat Partnerships, Chicago, IL 60611 USA; [Eran, Alal] Boston Childrens Hosp, Computat Hlth Informat Program, Boston, MA USA; [Eran, Alal; Palmer, Nathan; Avillach, Paul; Kohane, Isaac S.] Harvard Med Sch, Dept Biomed Informat, Boston, MA 02115 USA; [Eran, Alal] Ben Gurion Univ Negev, Dept Life Sci, Beer Sheva, Israel; [Eran, Alal] Ben Gurion Univ Negev, Zlotowski Ctr Neurosci, Beer Sheva, Israel; [Levy-Moonshine, Ami] Broad Inst Harvard & Massachusetts Inst Technol, Cambridge, MA USA; [Szolovits, Peter] MIT, Comp Sci & Artificial Intelligence Lab, 77 Massachusetts Ave, Cambridge, MA 02139 USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Northwestern University; Northwestern University; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Ben Gurion University; Ben Gurion University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT)	Kohane, IS (corresponding author), Harvard Med Sch, Dept Biomed Informat, Boston, MA 02115 USA.	isaac_kohane@harvard.edu	Eran, Alal/AAA-8776-2021; Luo, Yuan/K-5563-2016	Eran, Alal/0000-0001-6784-7597; Luo, Yuan/0000-0003-0195-7456; Szolovits, Peter/0000-0001-8411-6403	National Institutes for Health (NIH) [2042, 1918, 2004]; US National Institutes of Health [1R21LM012618, 5UL1TR001422, U01HG007530, OT3OD025466, OT3HL142480, U54HG007963, 1U01TR002623-01, 1U54HD090255-01]; National Institute of Mental Health [P50MH106933]; Israeli Ministry of Science and Technology [17708]; PrecisionLink Initiative at BCH; Aetna Life Insurance Co	National Institutes for Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Israeli Ministry of Science and Technology(Ministry of Science, Technology and Space (MOST), Israel); PrecisionLink Initiative at BCH; Aetna Life Insurance Co	Data analyzed in this manuscript reside in the National Institutes for Health (NIH)-supported NIMH Data Archive's NDAR as Collection nos. 1918, 2004 and 2042. We thank all the families at the participating Simons Simplex Collection sites, as well as the principal investigators (A. Beaudet, R. Bernier, J. Constantino, E. Cook, E. Fombonne, D. Geschwind, R. Goin-Kochel, E. Hanson, D. Grice, A. Klin, D. Ledbetter, C. Lord, C. Martin, D. Martin, R. Maxim, J. Miles, O. Ousley, K. Pelphrey, B. Peterson, J. Piggot, C. Saulnier, M. State, W. Stone, J. Sutcliffe, C. Walsh, Z. Warren and E. Wijsman). We thank SFARI Base for access to their phenotypic data. Approved researchers can obtain the Simons Simplex Collection population dataset described in the present study (https://base.sfari.org/ordering/phenotype/sfari-phenotype/download?code=11) by applying at https://base.sfari.org.We thank J. Eichler, D. Margulies and members of the Kohane lab for fruitful discussions. We thank somersault18:24 (www.somersault1824.com) for illustrations. Y.L. was supported by the US National Institutes of Health (1R21LM012618 and 5UL1TR001422). A.E., P.S. and I.S.K. were supported by the National Institute of Mental Health (P50MH106933). A.E. was supported by the Israeli Ministry of Science and Technology (grant no. 17708) and by the PrecisionLink Initiative at BCH. N.P. received funding support from Aetna Life Insurance Co. P.A. was supported by the US National Institutes of Health (U01HG007530, OT3OD025466, OT3HL142480, U54HG007963, 1U01TR002623-01 and 1U54HD090255-01).	American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; [Anonymous], 1996, ICD 9 CM INT CLASS D; Bateni M, 2017, ADV NEUR IN, V30; Beffert U, 2004, J LIPID RES, V45, P403, DOI 10.1194/jlr.R300017-JLR200; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BRAMER G R, 1988, World Health Statistics Quarterly, V41, P32; Buchovecky CM, 2013, NAT GENET, V45, P1013, DOI 10.1038/ng.2714; Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; CLEVELAND WS, 1988, J AM STAT ASSOC, V83, P596, DOI 10.2307/2289282; Coleman DM, 2019, J CHILD ADOL PSYCHOP, V29, P107, DOI 10.1089/cap.2018.0121; Csardi G., 2006, INT J COMPLEX SYSTEM; David MM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157937; de la Torre-Ubieta L, 2016, NAT MED, V22, P345, DOI 10.1038/nm.4071; Denny JC, 2013, NAT BIOTECHNOL, V31, P1102, DOI 10.1038/nbt.2749; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; DUNN OJ, 1961, J AM STAT ASSOC, V56, P52, DOI 10.2307/2282330; El-Ansary A, 2012, LIPIDS HEALTH DIS, V11, DOI 10.1186/1476-511X-11-160; Everitt B. S., 2006, CAMBRIDGE DICT STAT; Fisher R. A., 1946, Statistical methods for research workers.; Fu BQ, 2017, IMMUNITY, V47, P1100, DOI [10.1016/j.immuni.2017.11.018, 10.15585/mmwr.ss6904a1]; Gong HL, 2013, J HISTOCHEM CYTOCHEM, V61, P857, DOI 10.1369/0022155413505601; Grissom NM, 2018, MOL PSYCHIATR, V23, P544, DOI 10.1038/mp.2017.184; Herbst RS, 2014, NATURE, V515, P563, DOI 10.1038/nature14011; Jung H, 2018, NAT NEUROSCI, V21, P1218, DOI 10.1038/s41593-018-0208-z; Kang HJ, 2011, NATURE, V478, P483, DOI 10.1038/nature10523; Kim EK, 2010, NUTR RES, V30, P255, DOI 10.1016/j.nutres.2010.04.002; Kohane IS, 2012, J AM MED INFORM ASSN, V19, P181, DOI 10.1136/amiajnl-2011-000492; Krumm N, 2015, NAT GENET, V47, P582, DOI 10.1038/ng.3303; Kyle SM, 2016, HUM MOL GENET, V25, P3029, DOI 10.1093/hmg/ddw156; Kysenius K, 2012, CELL MOL LIFE SCI, V69, P1903, DOI 10.1007/s00018-012-0977-6; Lawrence M, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003118; Li JJ, 2014, MOL SYST BIOL, V10, DOI 10.15252/msb.20145487; Lord C, 2020, NAT REV DIS PRIMERS, V6, DOI 10.1038/s41572-019-0138-4; National Research Council Committee on a Framework for Developing a New Taxonomy of Disease, 2011, PREC MED BUILD KNOWL; Neale Benjamin, 2012, STAT GENETICS; Noreen E. W., 1989, COMPUTER INTENSIVE M; Parikshak NN, 2013, CELL, V155, P1008, DOI 10.1016/j.cell.2013.10.031; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Rosenson R., UPTODATE; Rosvall M, 2008, P NATL ACAD SCI USA, V105, P1118, DOI 10.1073/pnas.0706851105; Shi L, 2016, SCI REP, V6; Sikora DM, 2006, AM J MED GENET A, V140A, P1511, DOI 10.1002/ajmg.a.31294; Su CH, 2018, FRONT MOL BIOSCI, V5, DOI 10.3389/fmolb.2018.00012; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tierney E, 2001, AM J MED GENET, V98, P191, DOI 10.1002/1096-8628(20010115)98:2<191::AID-AJMG1030>3.0.CO;2-M; Tierney E, 2006, AM J MED GENET B, V141B, P666, DOI 10.1002/ajmg.b.30368; Werling DM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10717; Wong CT, 2016, J NEUROSCI RES, V94, P759, DOI 10.1002/jnr.23759; Wong CT, 2015, EUR J NEUROSCI, V42, P2742, DOI 10.1111/ejn.13028; Zhang M, 2019, NEURON, V101, P690, DOI 10.1016/j.neuron.2019.01.022	51	18	18	3	11	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	SEP	2020	26	9								10.1038/s41591-020-1007-0	http://dx.doi.org/10.1038/s41591-020-1007-0		AUG 2020	17	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	PF3EM	32778826				2022-12-27	WOS:000558228200002
J	Gibson, EM; Monje, M				Gibson, Erin M.; Monje, Michelle			Treating cancer therapy-related cognitive impairment	NATURE MEDICINE			English	Editorial Material							NEUROGENESIS; IRRADIATION	Metformin can promote the regeneration of neural precursor cell populations and improve cognitive function in a preclinical model of cranial radiation and a pilot clinical study of children after cranial radiation and chemotherapy.	[Gibson, Erin M.; Monje, Michelle] Stanford Univ, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA; [Monje, Michelle] Stanford Univ, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA	Stanford University; Stanford University	Monje, M (corresponding author), Stanford Univ, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA.; Monje, M (corresponding author), Stanford Univ, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA.	mmonje@stanford.edu		Gibson, Erin/0000-0001-9749-3814; Monje, Michelle/0000-0002-3547-237X				Armstrong GT, 2009, JNCI-J NATL CANCER I, V101, P946, DOI 10.1093/jnci/djp148; Ayoub R, 2020, NAT MED, V26, P1285, DOI 10.1038/s41591-020-0985-2; Dadwal P, 2015, STEM CELL REP, V5, P166, DOI 10.1016/j.stemcr.2015.06.011; DIETRICH J, 2006, J BIOL, V5, pNIL5; Geraghty AC, 2019, NEURON, V103, P250, DOI 10.1016/j.neuron.2019.04.032; Gibson EM, 2019, CELL, V176, P43, DOI 10.1016/j.cell.2018.10.049; Monje ML, 2003, SCIENCE, V302, P1760, DOI 10.1126/science.1088417; Monje ML, 2002, NAT MED, V8, P955, DOI 10.1038/nm749; Neumann B, 2019, CELL STEM CELL, V25, P473, DOI 10.1016/j.stem.2019.08.015; Parent JM, 1999, J NEUROSCI, V19, P4508; Riggs L, 2017, NEURO-ONCOLOGY, V19, P440, DOI 10.1093/neuonc/now177; Wang J, 2012, CELL STEM CELL, V11, P23, DOI 10.1016/j.stem.2012.03.016	12	1	1	0	5	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	AUG	2020	26	8					1174	1175		10.1038/s41591-020-1014-1	http://dx.doi.org/10.1038/s41591-020-1014-1		JUL 2020	2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	MX8ZF	32733074				2022-12-27	WOS:000557201500002
J	Theron, G; Limberis, J; Venter, R; Smith, L; Pietersen, E; Esmail, A; Calligaro, G; te Riele, J; de Kock, M; van Helden, P; Gumbo, T; Clark, TG; Fennelly, K; Warren, R; Dheda, K				Theron, Grant; Limberis, Jason; Venter, Rouxjeane; Smith, Liezel; Pietersen, Elize; Esmail, Aliasgar; Calligaro, Greg; te Riele, Julian; de Kock, Marianna; van Helden, Paul; Gumbo, Tawanda; Clark, Taane G.; Fennelly, Kevin; Warren, Robin; Dheda, Keertan			Bacterial and host determinants of cough aerosol culture positivity in patients with drug-resistant versus drug-susceptible tuberculosis	NATURE MEDICINE			English	Article							MYCOTB MIC PLATE; MYCOBACTERIUM-TUBERCULOSIS; PULMONARY TUBERCULOSIS; TRANSMISSION; INFECTIOUSNESS; PREDICTION; OUTCOMES; VARIABILITY; EVOLUTION; DISEASE	CulturableMycobacterium tuberculosiscan be detected in cough aerosol from a high proportion of individuals infected with drug-resistantM. tuberculosisand correlate with a strong cough and low symptom score, indicating the need to focus on targeted interventions. A burgeoning epidemic of drug-resistant tuberculosis (TB) threatens to derail global control efforts. Although the mechanisms remain poorly clarified, drug-resistant strains are widely believed to be less infectious than drug-susceptible strains. Consequently, we hypothesized that lower proportions of patients with drug-resistant TB would have culturableMycobacterium tuberculosisfrom respirable, cough-generated aerosols compared to patients with drug-susceptible TB, and that multiple factors, including mycobacterial genomic variation, would predict culturable cough aerosol production. We enumerated the colony forming units in aerosols (<= 10 mu m) from 452 patients with TB (227 with drug resistance), compared clinical characteristics, and performed mycobacterial whole-genome sequencing, dormancy phenotyping and drug-susceptibility analyses onM. tuberculosisfrom sputum. After considering treatment duration, we found that almost half of the patients with drug-resistant TB were cough aerosol culture-positive. Surprisingly, neither mycobacterial genomic variants, lineage, nor dormancy status predicted cough aerosol culture positivity. However, mycobacterial sputum bacillary load and clinical characteristics, including a lower symptom score and stronger cough, were strongly predictive, thereby supporting targeted transmission-limiting interventions. Effective treatment largely abrogated cough aerosol culture positivity; however, this was not always rapid. These data question current paradigms, inform public health strategies and suggest the need to redirect TB transmission-associated research efforts toward host-pathogen interactions.	[Theron, Grant; Limberis, Jason; Smith, Liezel; Pietersen, Elize; Esmail, Aliasgar; Calligaro, Greg; Dheda, Keertan] Univ Cape Town, Div Pulmonol, Dept Med, Ctr Lung Infect & Immun, Cape Town, South Africa; [Theron, Grant; Limberis, Jason; Smith, Liezel; Pietersen, Elize; Esmail, Aliasgar; Calligaro, Greg; Dheda, Keertan] Univ Cape Town, UCT Lung Inst, Cape Town, South Africa; [Theron, Grant; Limberis, Jason; Smith, Liezel; Pietersen, Elize; Esmail, Aliasgar; Calligaro, Greg; Dheda, Keertan] Univ Cape Town, South African MRC UCT Ctr Study Antimicrobial Res, Cape Town, South Africa; [Theron, Grant; Venter, Rouxjeane; Smith, Liezel; de Kock, Marianna; van Helden, Paul; Warren, Robin] Stellenbosch Univ, DSI NRF Ctr Excellence Biomed TB Res, Div Mol Biol & Human Genet, Fac Med & Hlth Sci, Cape Town, South Africa; [Theron, Grant; Venter, Rouxjeane; Smith, Liezel; de Kock, Marianna; van Helden, Paul; Warren, Robin] Stellenbosch Univ, South African Med Res Ctr TB Res, Div Mol Biol & Human Genet, Fac Med & Hlth Sci, Cape Town, South Africa; [te Riele, Julian] Brooklyn Chest Hosp, Cape Town, South Africa; [Gumbo, Tawanda] Baylor Univ, Med Ctr, Ctr Infect Dis Res & Expt Therapeut, Dallas, TX USA; [Clark, Taane G.; Dheda, Keertan] London Sch Hyg & Trop Med, Fac Infect & Trop Dis, London, England; [Clark, Taane G.] London Sch Hyg & Trop Med, Fac Epidemiol & Publ Hlth, London, England; [Fennelly, Kevin] NHLBI, Pulm Branch, Div Intramural Res, NIH, Bldg 10, Bethesda, MD 20892 USA	University of Cape Town; University of Cape Town; University of Cape Town; Stellenbosch University; Stellenbosch University; Baylor University; Baylor University Medical Center; University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Dheda, K (corresponding author), Univ Cape Town, Div Pulmonol, Dept Med, Ctr Lung Infect & Immun, Cape Town, South Africa.; Dheda, K (corresponding author), Univ Cape Town, UCT Lung Inst, Cape Town, South Africa.; Dheda, K (corresponding author), Univ Cape Town, South African MRC UCT Ctr Study Antimicrobial Res, Cape Town, South Africa.; Dheda, K (corresponding author), London Sch Hyg & Trop Med, Fac Infect & Trop Dis, London, England.	keertan.dheda@uct.ac.za	Clark, Taane G./AAM-2570-2020; Theron, Grant/ABB-1167-2020; Limberis, Jason/X-9553-2018	Clark, Taane G./0000-0001-8985-9265; Theron, Grant/0000-0002-9216-2415; Limberis, Jason/0000-0002-7893-8416; Calligaro, Gregory/0000-0001-7324-0775; Warren, Robin/0000-0001-5741-7358; Venter, Rouxjeane/0000-0002-8710-8166; Dheda, Keertan/0000-0001-7709-5341; Pietersen, Elize/0000-0001-5286-4749	National Institutes of Health [1R01AI104817-01]; Wellcome Trust [099854/Z/12/Z, MR/S027777/1]; South African Medical Research Council [RFA-IFSP-01-2013, RFA-EMU-02-2017]; National Research Foundation of South Africa; EDCTP2 programme - European Union [SF1401]; Faculty of Medicine and Health Sciences, Stellenbosch University; EDCTP [TMA-2015SF-1043, TMA-1051-TESAII, TMA-CDF2015]; UK Medical Research Council [MR/S03563X/1]; Intramural Research Program of the National Institutes of Health, National Heart, Lung, and Blood Institute; National Research Foundation; MRC [MR/S03563X/1] Funding Source: UKRI	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome Trust(Wellcome TrustEuropean Commission); South African Medical Research Council(South African Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Research Foundation of South Africa(National Research Foundation - South Africa); EDCTP2 programme - European Union; Faculty of Medicine and Health Sciences, Stellenbosch University; EDCTP; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Intramural Research Program of the National Institutes of Health, National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Research Foundation; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We are indebted to the patients who participated. The study would not have been possible without the remarkable efforts of R. Wilson and G. Pretorius. We also thank for their invaluable assistance M. Pienaar and M. Pretorius, P. Spiller, M. Barnard, J. Simpson, T. Dolby, R. van Aarde, C. Clarke and B. Derendinger. The WGS computations were done using facilities provided by the University of Cape Town's ICTS High Performance Computing team. The project was funded by the National Institutes of Health (grant no. 1R01AI104817-01), Wellcome Trust (grant no. 099854/Z/12/Z), South African Medical Research Council (Career Development Award, Self-initiated Research Award) and the National Research Foundation of South Africa. The content is solely the responsibility of the authors and does not necessarily represent the official views of the South African Medical Research Council. G.T. acknowledges funding from the South African Medical Research Council (grant no. RFA-IFSP-01-2013), the EDCTP2 programme supported by the European Union (grant no. SF1401, OPTIMAL DIAGNOSIS) and the Faculty of Medicine and Health Sciences, Stellenbosch University. K.D. acknowledges funding from the South African Medical Research Council (grant no. RFA-EMU-02-2017), EDCTP (grant nos. TMA-2015SF-1043, TMA-1051-TESAII and TMA-CDF2015), UK Medical Research Council (grant no. MR/S03563X/1) and the Wellcome Trust (grant no. MR/S027777/1). K.F. was supported by the Intramural Research Program of the National Institutes of Health, National Heart, Lung, and Blood Institute. We acknowledge the financial assistance of the National Research Foundation toward this research. The opinions expressed and conclusions arrived at are those of the author(s) and should not necessarily to be attributed to the National Research Foundation.	Acuna-Villaorduna C, 2019, OPEN FORUM INFECT DI, V6, DOI 10.1093/ofid/ofz184; [Anonymous], 2021, LANG ENV STAT COMP; [Anonymous], 2009, 6 2 STAG VIABL SAMPL; [Anonymous], 2011, AUTOMATED RAL TIME N; [Anonymous], 1998, PUBLIC HLTH SERVICE; Ashley K., 2017, NIOSH MANUAL ANAL ME, V5th; Calligaro GL, 2017, LANCET INFECT DIS, V17, P441, DOI 10.1016/S1473-3099(16)30384-X; Casali N, 2014, NAT GENET, V46, P279, DOI 10.1038/ng.2878; Chengalroyen MD, 2016, AM J RESP CRIT CARE, V194, P1532, DOI 10.1164/rccm.201604-0769OC; Coll F, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0164-0; Coll F, 2012, BIOINFORMATICS, V28, P2991, DOI 10.1093/bioinformatics/bts544; Comas I, 2012, NAT GENET, V44, P106, DOI 10.1038/ng.1038; De Stavola BL, 2008, BIOMETRIKA, V95, P992, DOI 10.1093/biomet/asn039; de Vos M, 2013, ANTIMICROB AGENTS CH, V57, P827, DOI 10.1128/AAC.01541-12; Demay C, 2012, INFECT GENET EVOL, V12, P755, DOI 10.1016/j.meegid.2012.02.004; Dharmadhikari AS, 2014, INT J TUBERC LUNG D, V18, P1019, DOI 10.5588/ijtld.13.0834; Dharmadhikari AS, 2011, TUBERCULOSIS, V91, P329, DOI 10.1016/j.tube.2011.03.002; Dheda K, 2018, AM J RESP CRIT CARE, V198, P1208, DOI [10.1164/rccm.201711-2333OC, 10.1164/rccm.201711-2333oc]; Dheda K, 2017, LANCET RESP MED, V5, P291, DOI [10.1016/S2213-2600(17)30079-6, 10.1016/s2213-2600(17)30079-6]; Dheda K, 2017, LANCET RESP MED, V5, P269, DOI [10.1016/s2213-2600(16)30433-7, 10.1016/S2213-2600(16)30433-7]; Escombe AR, 2007, CLIN INFECT DIS, V44, P1349, DOI 10.1086/515397; Farhat MR, 2013, NAT GENET, V45, P1183, DOI 10.1038/ng.2747; Fennelly KP, 2012, AM J RESP CRIT CARE, V186, P450, DOI 10.1164/rccm.201203-0444OC; Fennelly KP, 2004, AM J RESP CRIT CARE, V169, P604, DOI 10.1164/rccm.200308-1101OC; Fitzwater SP, 2010, CLIN INFECT DIS, V51, P371, DOI 10.1086/655127; Gagneux S, 2006, PLOS PATHOG, V2, P603, DOI 10.1371/journal.ppat.0020061; Garton NJ, 2002, MICROBIOL-SGM, V148, P2951, DOI 10.1099/00221287-148-10-2951; Johnson R, 2010, INT J TUBERC LUNG D, V14, P119; Jones-Lopez EC, 2016, CLIN INFECT DIS, V63, P10, DOI 10.1093/cid/ciw199; Jones-Lopez EC, 2013, AM J RESP CRIT CARE, V187, P1007, DOI 10.1164/rccm.201208-1422OC; Kodama C, 2017, EUR RESPIR J, V50, DOI 10.1183/13993003.01044-2017; Koo TK, 2016, J CHIROPR MED, V15, P155, DOI 10.1016/j.jcm.2016.02.012; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lee J, 2014, ANTIMICROB AGENTS CH, V58, P11, DOI 10.1128/AAC.01209-13; Lin PL, 2006, INFECT IMMUN, V74, P3790, DOI 10.1128/IAI.00064-06; Lloyd-Smith JO, 2005, NATURE, V438, P355, DOI 10.1038/nature04153; McCreesh N, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23797-2; Melsew YA, 2019, BMC INFECT DIS, V19, DOI 10.1186/s12879-019-3870-1; NOBLE RC, 1981, AM J INFECT CONTROL, V9, P6, DOI 10.1016/S0196-6553(81)80003-X; Pietersen E, 2014, LANCET, V383, P1230, DOI 10.1016/S0140-6736(13)62675-6; RILEY RL, 1962, AM REV RESPIR DIS, V85, P511; ROUILLON A, 1976, TUBERCLE, V57, P275, DOI 10.1016/S0041-3879(76)80006-2; Sirgel FA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059414; Sloan DJ, 2015, CLIN INFECT DIS, V61, P1, DOI 10.1093/cid/civ195; Song T, 2014, MOL MICROBIOL, V91, P1106, DOI 10.1111/mmi.12520; South African Department of Health Management of Drug-Resistant Tuberculosis, 2011, S AFRICAN DEP HLTH M; Stoltz A. C, 2020, AM THOR SOC 2017 INT; SULTAN L, 1960, AM REV RESPIR DIS, V82, P358; te Riele JB, 2019, INT J INFECT DIS, V79, P65, DOI 10.1016/j.ijid.2018.10.026; Tostmann A, 2008, CLIN INFECT DIS, V47, P1135, DOI 10.1086/591974; Trauner A, 2014, DRUGS, V74, P1063, DOI 10.1007/s40265-014-0248-y; van Geuns H A, 1975, Bull Int Union Tuberc, V50, P107; Walker TM, 2015, LANCET INFECT DIS, V15, P1193, DOI 10.1016/S1473-3099(15)00062-6; Walker TM, 2013, LANCET INFECT DIS, V13, P137, DOI 10.1016/S1473-3099(12)70277-3; Warren R, 2006, J CLIN MICROBIOL, V44, P254, DOI 10.1128/JCM.44.1.254-256.2006; Wejse C, 2008, SCAND J INFECT DIS, V40, P111, DOI 10.1080/00365540701558698; Whitfield MG, 2015, J CLIN MICROBIOL, V53, P3633, DOI 10.1128/JCM.01001-15; Woolhouse MEJ, 1997, P NATL ACAD SCI USA, V94, P338, DOI 10.1073/pnas.94.1.338; World Health Organisation (WHO), 2016, GLOB TUB REP 2016; World Health Organization, 2014, MYC LAB MAN; World Health Organization, 2016, WHOHTMTB201604; World Health Organization, 2013, DEFINITIONS REPORTIN; Yates TA, 2016, LANCET INFECT DIS, V16, P227, DOI 10.1016/S1473-3099(15)00499-5; Ypma RJF, 2013, EPIDEMIOLOGY, V24, P395, DOI 10.1097/EDE.0b013e3182878e19; Yu X, 2016, INT J TUBERC LUNG D, V20, P329, DOI 10.5588/ijtld.15.0573	65	13	14	0	9	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	SEP	2020	26	9								10.1038/s41591-020-0940-2	http://dx.doi.org/10.1038/s41591-020-0940-2		JUN 2020	20	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	PF3EM	32601338	Green Accepted			2022-12-27	WOS:000544159600005
J	Jalal, H; Buchanich, JM; Sinclair, DR; Roberts, MS; Burke, DS				Jalal, Hawre; Buchanich, Jeanine M.; Sinclair, David R.; Roberts, Mark S.; Burke, Donald S.			Age and generational patterns of overdose death risk from opioids and other drugs	NATURE MEDICINE			English	Article							UNITED-STATES; MONITORING PROGRAMS; HEROIN; REDUCTIONS; FENTANYL; SIBLINGS; ABUSE	The ongoing substance misuse epidemic in the United States is complex and dynamic and should be approached as such in the development and evaluation of policy(1). Drug overdose deaths (largely attributable to opioid misuse) in the United States have grown exponentially for almost four decades, but the mechanisms of this growth are poorly understood(2). From analysis of 661,565 overdose deaths from 1999 to 2017, we show that the age-specific drug overdose mortality curve for each birth-year cohort rises and falls according to a Gaussian-shaped curve. The ascending portion of each successive birth-year cohort mortality curve is accelerated compared with that of all preceding birth-year cohorts. This acceleration can be attributed to either of two distinct processes: a stable peak age, with an increasing amplitude of mortality rate curves from one birth-year cohort to the next; or a youthward shift in the peak age of the mortality rate curves. The overdose epidemic emerged and increased in amplitude among the 1945-1964 cohort (Baby Boomers), shifted youthward among the 1965-1980 cohort (Generation X), and then resumed the pattern of increasing amplitude in the 1981-1990 Millennials. These shifting age and generational patterns are likely to be driven by socioeconomic factors and drug availability, the understanding of which is important for the development of effective overdose prevention measures. A new age-period-cohort analysis reveals distinct generational patterns in deaths from opioid overdose in the United States, suggesting increased risks for Baby Boomers and Millennials.	[Jalal, Hawre; Sinclair, David R.; Roberts, Mark S.] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Hlth Policy & Management, Pittsburgh, PA 15260 USA; [Buchanich, Jeanine M.] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Biostat, Pittsburgh, PA 15261 USA; [Sinclair, David R.] Newcastle Univ, Fac Med Sci, Populat Hlth Sci Inst, Newcastle Upon Tyne, Tyne & Wear, England; [Burke, Donald S.] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Epidemiol, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Newcastle University - UK; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Jalal, H (corresponding author), Univ Pittsburgh, Grad Sch Publ Hlth, Dept Hlth Policy & Management, Pittsburgh, PA 15260 USA.; Burke, DS (corresponding author), Univ Pittsburgh, Grad Sch Publ Hlth, Dept Epidemiol, Pittsburgh, PA 15260 USA.	hjalal@pitt.edu; donburke@pitt.edu		Sinclair, David/0000-0002-3468-7475; /0000-0002-5704-8094; Jalal, Hawre/0000-0002-8224-6834	National Institutes of Health/National Center for Advancing Translational Sciences [1KL2TR0001856]; Robert Wood Johnson Foundation [72858]	National Institutes of Health/National Center for Advancing Translational Sciences; Robert Wood Johnson Foundation(Robert Wood Johnson Foundation (RWJF))	This study was in part supported by National Institutes of Health/National Center for Advancing Translational Sciences grant no. 1KL2TR0001856 (H.J.), and Robert Wood Johnson Foundation grant no. 72858 (J.B. and D.S.B.).	Ahmad FB, 2019, PROVISIONAL DRUG OVE; Bao YH, 2016, HEALTH AFFAIR, V35, P1045, DOI 10.1377/hlthaff.2015.1673; Best AF, 2018, LANCET PUBLIC HEALTH, V3, pE374, DOI 10.1016/S2468-2667(18)30114-2; Bjork JM, 2015, DEV COGN NEUROS-NETH, V11, P56, DOI 10.1016/j.dcn.2014.07.008; Blanco C, 2019, LANCET, V393, P1760, DOI 10.1016/S0140-6736(18)33078-2; Bluthenthal R N, 1997, Med Anthropol, V18, P61, DOI 10.1080/01459740.1997.9966150; Burke DS, 2016, SCIENCE, V354, P529, DOI 10.1126/science.aal2943; Chernyavskiy P, 2019, STAT METHODS MED RES, V28, P20, DOI 10.1177/0962280217713033; Ciccarone D, 2019, INT J DRUG POLICY, V71, P183, DOI 10.1016/j.drugpo.2019.01.010; Ciccarone D, 2017, INT J DRUG POLICY, V46, P107, DOI 10.1016/j.drugpo.2017.06.010; Coffin PO, 2019, J URBAN HEALTH, V96, P1, DOI 10.1007/s11524-018-00344-y; Compton WM, 2016, NEW ENGL J MED, V374, P154, DOI 10.1056/NEJMra1508490; Des Jarlais D, 2009, ADDICTION, V104, P1452, DOI 10.1111/j.1360-0443.2009.02607.x; Duncan DF, 2010, J AGING SOC POLICY, V22, P237, DOI 10.1080/08959420.2010.485511; Jalal H.J., 2019, HEXAMAPS VISUALIZING, DOI [10.1101/19011700, DOI 10.1101/19011700]; Jalal H, 2018, SCIENCE, V361, P1218, DOI 10.1126/science.aau1184; Keyes KM., 2012, INJURY RES, P409; Lambdin BH, 2018, DRUG ALCOHOL DEPEN, V188, P370, DOI 10.1016/j.drugalcdep.2018.04.004; LUTHAR SS, 1992, COMPR PSYCHIAT, V33, P190, DOI 10.1016/0010-440X(92)90029-P; MAGURA S, 1989, AM J PUBLIC HEALTH, V79, P459, DOI 10.2105/AJPH.79.4.459; Mars SG, 2015, SOC SCI MED, V140, P44, DOI 10.1016/j.socscimed.2015.06.032; Mars SG, 2014, INT J DRUG POLICY, V25, P257, DOI 10.1016/j.drugpo.2013.10.004; McGinty EE, 2018, PREV MED, V111, P73, DOI 10.1016/j.ypmed.2018.02.026; Mossong J, 2008, PLOS MED, V5, P381, DOI 10.1371/journal.pmed.0050074; NEEDLE R, 1986, INT J ADDICT, V21, P739, DOI 10.3109/10826088609027390; O'Donnell JK, 2017, MMWR-MORBID MORTAL W, V66, P1197, DOI 10.15585/mmwr.mm6643e1; O'Donnell JK, 2017, MMWR-MORBID MORTAL W, V66, P897, DOI 10.15585/mmwr.mm6634a2; Oldfield BJ, 2019, J GEN INTERN MED, V34, P1854, DOI 10.1007/s11606-019-05016-4; Patrick SW, 2016, HEALTH AFFAIR, V35, P1324, DOI 10.1377/hlthaff.2015.1496; Pew Research Center, 2015, WHYS HOWS GEN RES; Rosenberg PS, 2019, STAT METHODS MED RES, V28, P3363, DOI 10.1177/0962280218801121; Rosenberg PS, 2014, CANCER EPIDEM BIOMAR, V23, P2296, DOI 10.1158/1055-9965.EPI-14-0300; Rudd RA, 2016, MMWR-MORBID MORTAL W, V65, P1445, DOI 10.15585/mmwr.mm655051e1; Ruhm CJ, 2019, J HEALTH ECON, V64, P25, DOI 10.1016/j.jhealeco.2019.01.001; Scholl L, 2019, MMWR-MORBID MORTAL W, V67, P1419; Seth P, 2018, MMWR-MORBID MORTAL W, V67, P349, DOI 10.15585/mmwr.mm6712a1; Smith MK, 2018, EPIDEMIOL INFECT, V146, DOI 10.1017/S0950268818002042; Viboud C, 2016, EPIDEMICS-NETH, V15, P27, DOI 10.1016/j.epidem.2016.01.002; Weatherburn D, 2003, ADDICTION, V98, P83, DOI 10.1046/j.1360-0443.2003.00248.x; Wheeler E, 2015, MMWR-MORBID MORTAL W, V64, P631; Windle M., 2000, APPL DEV SCI, V4, P98, DOI DOI 10.1207/S1532480XADS0402_5; Yim N., 2019, CONVENTIONAL INNOVAT, P1	42	19	19	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAY	2020	26	5					699	+		10.1038/s41591-020-0855-y	http://dx.doi.org/10.1038/s41591-020-0855-y		MAY 2020	11	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	ML1LF	32367060	Green Accepted			2022-12-27	WOS:000530244500001
J	Lu, Y; Xue, JX; Deng, T; Zhou, XJ; Yu, K; Deng, L; Huang, MJ; Yi, X; Liang, MZ; Wang, Y; Shen, HG; Tong, RZ; Wang, WB; Li, L; Song, J; Li, J; Su, XX; Ding, ZY; Gong, YL; Zhu, J; Wang, YS; Zou, BW; Zhang, Y; Li, YY; Zhou, L; Liu, YM; Yu, M; Wang, YQ; Zhang, XW; Yin, LM; Xia, XF; Zeng, Y; Zhou, Q; Ying, BW; Chen, C; Wei, YQ; Li, WM; Mok, T				Lu, You; Xue, Jianxin; Deng, Tao; Zhou, Xiaojuan; Yu, Kun; Deng, Lei; Huang, Meijuan; Yi, Xin; Liang, Maozhi; Wang, Yu; Shen, Haige; Tong, Ruizhan; Wang, Wenbo; Li, Li; Song, Jin; Li, Jing; Su, Xiaoxing; Ding, Zhenyu; Gong, Youling; Zhu, Jiang; Wang, Yongsheng; Zou, Bingwen; Zhang, Yan; Li, Yanying; Zhou, Lin; Liu, Yongmei; Yu, Min; Wang, Yuqi; Zhang, Xuanwei; Yin, Limei; Xia, Xuefeng; Zeng, Yong; Zhou, Qiao; Ying, Binwu; Chen, Chong; Wei, Yuquan; Li, Weimin; Mok, Tony			Safety and feasibility of CRISPR-edited T cells in patients with refractory non-small-cell lung cancer	NATURE MEDICINE			English	Article							SINGLE-MOLECULE AMPLIFICATION; RESEQUENCING TECHNOLOGY; GENOME; ALIGNMENT	Clustered regularly interspaced short palindromic repeats (CRISPR)-Cas9 editing of immune checkpoint genes could improve the efficacy of T cell therapy, but the first necessary undertaking is to understand the safety and feasibility. Here, we report results from a first-in-human phase I clinical trial of CRISPR-Cas9 PD-1-edited T cells in patients with advanced non-small-cell lung cancer (ClinicalTrials.gov ). Primary endpoints were safety and feasibility, and the secondary endpoint was efficacy. The exploratory objectives included tracking of edited T cells. All prespecified endpoints were met. PD-1-edited T cells were manufactured ex vivo by cotransfection using electroporation of Cas9 and single guide RNA plasmids. A total of 22 patients were enrolled; 17 had sufficient edited T cells for infusion, and 12 were able to receive treatment. All treatment-related adverse events were grade 1/2. Edited T cells were detectable in peripheral blood after infusion. The median progression-free survival was 7.7 weeks (95% confidence interval, 6.9 to 8.5 weeks) and median overall survival was 42.6 weeks (95% confidence interval, 10.3-74.9 weeks). The median mutation frequency of off-target events was 0.05% (range, 0-0.25%) at 18 candidate sites by next generation sequencing. We conclude that clinical application of CRISPR-Cas9 gene-edited T cells is generally safe and feasible. Future trials should use superior gene editing approaches to improve therapeutic efficacy.	[Lu, You; Xue, Jianxin; Zhou, Xiaojuan; Huang, Meijuan; Tong, Ruizhan; Li, Li; Ding, Zhenyu; Gong, Youling; Zhu, Jiang; Wang, Yongsheng; Zou, Bingwen; Zhang, Yan; Li, Yanying; Zhou, Lin; Liu, Yongmei; Yu, Min; Wang, Yuqi; Zhang, Xuanwei; Yin, Limei] Sichuan Univ, West China Hosp, Dept Thorac Oncol, Canc Ctr, Chengdu, Peoples R China; [Lu, You; Xue, Jianxin; Zhou, Xiaojuan; Huang, Meijuan; Tong, Ruizhan; Li, Li; Ding, Zhenyu; Gong, Youling; Zhu, Jiang; Wang, Yongsheng; Zou, Bingwen; Zhang, Yan; Li, Yanying; Zhou, Lin; Liu, Yongmei; Yu, Min; Wang, Yuqi; Zhang, Xuanwei; Yin, Limei] Sichuan Univ, West China Hosp, State Key Lab Biotherapy, Chengdu, Peoples R China; [Deng, Tao; Yu, Kun; Zeng, Yong] Chengdu MedGenCell Co Ltd, Chengdu, Peoples R China; [Deng, Lei] NYC Hlth Hosp, Albert Einstein Coll Med, Jacobi Med Ctr, New York, NY USA; [Yi, Xin; Song, Jin; Li, Jing; Xia, Xuefeng] Geneplus Beijing Inst, Beijing, Peoples R China; [Liang, Maozhi; Wang, Yongsheng] Sichuan Univ, West China Hosp, Ctr GCP, Chengdu, Peoples R China; [Wang, Yu; Shen, Haige] ZenRhyme Consulting Serv Ltd, Shanghai, Peoples R China; [Wang, Wenbo] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Natl Res Ctr Translat Med, Shanghai, Peoples R China; [Su, Xiaoxing] Berry Oncol Co Ltd, Fujian, Peoples R China; [Zhou, Qiao] Sichuan Univ, West China Hosp, Dept Pathol, Chengdu, Peoples R China; [Ying, Binwu] Sichuan Univ, West China Hosp, Dept Lab Med, Chengdu, Peoples R China; [Chen, Chong; Wei, Yuquan] Sichuan Univ, West China Hosp, State Key Lab Biotherapy, Chengdu, Peoples R China; [Chen, Chong; Wei, Yuquan] Sichuan Univ, West China Hosp, Collaborat Innovat Ctr Biotherapy, Chengdu, Peoples R China; [Li, Weimin] Sichuan Univ, West China Hosp, Dept Resp & Crit Care Med, Chengdu, Peoples R China; [Li, Weimin] Sichuan Univ, West China Hosp, Frontier Sci Ctr Dis Mol Network, Chengdu, Peoples R China; [Mok, Tony] Chinese Univ Hong Kong, Dept Clin Oncol, State Key Lab Translat Oncol, Hong Kong, Peoples R China	Sichuan University; Sichuan University; Jacobi Medical Center; Yeshiva University; Sichuan University; Shanghai Jiao Tong University; Sichuan University; Sichuan University; Sichuan University; Sichuan University; Sichuan University; Sichuan University; Chinese University of Hong Kong	Lu, Y (corresponding author), Sichuan Univ, West China Hosp, Dept Thorac Oncol, Canc Ctr, Chengdu, Peoples R China.; Lu, Y (corresponding author), Sichuan Univ, West China Hosp, State Key Lab Biotherapy, Chengdu, Peoples R China.	radyoulu@hotmail.com	Tong, Ruizhan/GXF-1315-2022; Ying, Binwu/AAB-5934-2022; Mok, Tony Shu Kam/B-2310-2019	Ying, Binwu/0000-0001-8077-3908; Mok, Tony Shu Kam/0000-0002-8251-0551; Lu, You/0000-0003-1671-1408; Lu, You/0000-0001-5761-3121	1.3.5 Project for Disciplines of Excellence, West China Hospital, Sichuan University [ZYJC18001]; West China Hospital Foundation of New Technology [XJS2016003, 190160012]; Sichuan Cancer Society Foundation [SCS-KT001]; National Science and Technology Major Project [2017ZX09304023]; National Natural Science Foundation of China [81672982]	1.3.5 Project for Disciplines of Excellence, West China Hospital, Sichuan University; West China Hospital Foundation of New Technology; Sichuan Cancer Society Foundation; National Science and Technology Major Project; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This clinical trial was supported by the 1.3.5 Project for Disciplines of Excellence, West China Hospital, Sichuan University (grant no. ZYJC18001); the West China Hospital Foundation of New Technology (grant nos. XJS2016003 and 190160012); the Sichuan Cancer Society Foundation (grant no. SCS-KT001); the National Science and Technology Major Project (grant no. 2017ZX09304023); and the National Natural Science Foundation of China (grant no. 81672982). We thank all of the study participants, H. Wakelee and G. P. Gao for providing insightful advice on this study, J.S. Kim for advice on the off-target effects, J.Y. Li and the nursing team for clinical care, Q. Lu for data collection, Q. Zhang for clinical ECG diagnosis, L. Wang for supporting preclinical study, J. Jiang for data and safety monitoring, M. Zhao for data management and S. Wang for statistical support.	Bae S, 2014, BIOINFORMATICS, V30, P1473, DOI 10.1093/bioinformatics/btu048; Beane JD, 2015, MOL THER, V23, P1380, DOI 10.1038/mt.2015.71; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Chen WQ, 2016, CA-CANCER J CLIN, V66, P115, DOI 10.3322/caac.21338; Cho SW, 2014, GENOME RES, V24, P132, DOI 10.1101/gr.162339.113; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Curti BD, 1998, J CLIN ONCOL, V16, P2752, DOI 10.1200/JCO.1998.16.8.2752; Dijkstra KK, 2018, CELL, V174, P1586, DOI 10.1016/j.cell.2018.07.009; Edge SB, 2010, AJCC CANC STAGING MA; Garon EB, 2019, J CLIN ONCOL, V37, P2518, DOI 10.1200/JCO.19.00934; Hendel A, 2015, NAT BIOTECHNOL, V33, P985, DOI 10.1038/nbt.3290; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Jia QZ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07767-w; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Johnson DB, 2016, NEW ENGL J MED, V375, P1749, DOI 10.1056/NEJMoa1609214; Kalos M, 2013, IMMUNITY, V39, P49, DOI 10.1016/j.immuni.2013.07.002; Kim D, 2015, NAT METHODS, V12, P237, DOI [10.1038/nmeth.3284, 10.1038/NMETH.3284]; Kim S, 2018, NAT METHODS, V15, P591, DOI 10.1038/s41592-018-0051-x; Kim S, 2014, GENOME RES, V24, P1012, DOI 10.1101/gr.171322.113; Kosicki M, 2018, NAT BIOTECHNOL, V36, P765, DOI 10.1038/nbt.4192; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lv WG, 2015, CLIN CHEM, V61, P172, DOI 10.1373/clinchem.2014.229328; Mandal PK, 2014, CELL STEM CELL, V15, P643, DOI 10.1016/j.stem.2014.10.004; Manghwar H, 2020, ADV SCI, V7, DOI 10.1002/advs.201902312; Mok TSK, 2019, LANCET, V393, P1819, DOI 10.1016/S0140-6736(18)32409-7; Pasetto A, 2016, CANCER IMMUNOL RES, V4, P734, DOI 10.1158/2326-6066.CIR-16-0001; Rapoport AP, 2015, NAT MED, V21, P914, DOI 10.1038/nm.3910; Reck M, 2016, NEW ENGL J MED, V375, P1823, DOI 10.1056/NEJMoa1606774; Ren JT, 2017, CLIN CANCER RES, V23, P2255, DOI 10.1158/1078-0432.CCR-16-1300; Robert L, 2014, CLIN CANCER RES, V20, P2424, DOI 10.1158/1078-0432.CCR-13-2648; Schumann K, 2015, P NATL ACAD SCI USA, V112, P10437, DOI 10.1073/pnas.1512503112; Shen B, 2014, NAT METHODS, V11, P399, DOI [10.1038/nmeth.2857, 10.1038/NMETH.2857]; Stadtmauer EA, 2020, SCIENCE, V367, P1001, DOI 10.1126/science.aba7365; Su S, 2016, SCI REP, V6, pP53, DOI DOI 10.1080/2162402X.2016.1249558; Su S, 2016, SCI REP-UK, V6, DOI 10.1038/srep20070; Sui TT, 2018, GENOME BIOL, V19, DOI 10.1186/s13059-018-1532-z; Tarasov A, 2015, BIOINFORMATICS, V31, P2032, DOI 10.1093/bioinformatics/btv098; Tsai SQ, 2015, NAT BIOTECHNOL, V33, P187, DOI 10.1038/nbt.3117; Wang Z, 2017, J MOL DIAGN, V19, P169, DOI 10.1016/j.jmoldx.2016.09.008; Xie SB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094496; Xu L, 2019, NEW ENGL J MED, V381, P1240, DOI 10.1056/NEJMoa1817426; Zarour HM, 2016, CLIN CANCER RES, V22, P1856, DOI 10.1158/1078-0432.CCR-15-1849; Zhou H, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-4225-1	43	175	184	20	156	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	MAY	2020	26	5					732	740		10.1038/s41591-020-0840-5	http://dx.doi.org/10.1038/s41591-020-0840-5		APR 2020	9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	LZ3YS	32341578				2022-12-27	WOS:000528983800002
J	Perez-Guijarro, E; Yang, HH; Araya, RE; El Meskini, R; Michael, HT; Vodnala, SK; Marie, KL; Smith, C; Chin, S; Lam, KC; Thorkelsson, A; Iacovelli, AJ; Kulaga, A; Fon, A; Michalowski, AM; Hugo, W; Lo, RS; Restifo, NP; Sharan, SK; Van Dyke, T; Goldszmid, RS; Ohler, ZW; Lee, MP; Day, CP; Merlino, G				Perez-Guijarro, Eva; Yang, Howard H.; Araya, Romina E.; El Meskini, Rajaa; Michael, Helen T.; Vodnala, Suman Kumar; Marie, Kerrie L.; Smith, Cari; Chin, Sung; Lam, Khiem C.; Thorkelsson, Andres; Iacovelli, Anthony J.; Kulaga, Alan; Fon, Anyen; Michalowski, Aleksandra M.; Hugo, Willy; Lo, Roger S.; Restifo, Nicholas P.; Sharan, Shyam K.; Van Dyke, Terry; Goldszmid, Romina S.; Ohler, Zoe Weaver; Lee, Maxwell P.; Day, Chi-Ping; Merlino, Glenn			Multimodel preclinical platform predicts clinical response of melanoma to immunotherapy	NATURE MEDICINE			English	Article							PD-1 BLOCKADE; CTLA-4 BLOCKADE; RESISTANCE; EXPRESSION; CELLS; THERAPY; IDENTIFICATION; METASTASIS; DETERMINES; SIGNATURES	Although immunotherapy has revolutionized cancer treatment, only a subset of patients demonstrate durable clinical benefit. Definitive predictive biomarkers and targets to overcome resistance remain unidentified, underscoring the urgency to develop reliable immunocompetent models for mechanistic assessment. Here we characterize a panel of syngeneic mouse models, representing a variety of molecular and phenotypic subtypes of human melanomas and exhibiting their diverse range of responses to immune checkpoint blockade (ICB). Comparative analysis of genomic, transcriptomic and tumor-infiltrating immune cell profiles demonstrated alignment with clinical observations and validated the correlation of T cell dysfunction and exclusion programs with resistance. Notably, genome-wide expression analysis uncovered a melanocytic plasticity signature predictive of patient outcome in response to ICB, suggesting that the multipotency and differentiation status of melanoma can determine ICB benefit. Our comparative preclinical platform recapitulates melanoma clinical behavior and can be employed to identify mechanisms and treatment strategies to improve patient care. Genetically engineered mouse models representing the spectrum of human cutaneous melanoma provide a platform for studying clinical responses to immunotherapy.	[Perez-Guijarro, Eva; Yang, Howard H.; Michael, Helen T.; Marie, Kerrie L.; Thorkelsson, Andres; Fon, Anyen; Michalowski, Aleksandra M.; Lee, Maxwell P.; Day, Chi-Ping; Merlino, Glenn] NCI, Lab Canc Biol & Genet, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Araya, Romina E.; Lam, Khiem C.; Goldszmid, Romina S.] NCI, Canc & Inflammat Program, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [El Meskini, Rajaa; Iacovelli, Anthony J.; Kulaga, Alan; Sharan, Shyam K.; Van Dyke, Terry; Ohler, Zoe Weaver] NCI, Ctr Adv Preclin Res, Ctr Canc Res, NIH, Frederick, MD 21701 USA; [Vodnala, Suman Kumar; Restifo, Nicholas P.] NCI, Surg Branch, Ctr Canc Res, NIH, Bldg 10, Bethesda, MD 20892 USA; [Smith, Cari; Chin, Sung] Leidos Biomed Res Inc, Lab Anim Sci Program, Frederick, MD USA; [Hugo, Willy; Lo, Roger S.] Univ Calif Los Angeles, Dept Med, Div Dermatol, Los Angeles, CA 90024 USA; [Sharan, Shyam K.] NCI, Mouse Canc Genet Program, Ctr Canc Res, NIH, Frederick, MD 21701 USA; [Vodnala, Suman Kumar; Restifo, Nicholas P.] Lyell Immunopharma, San Francisco, CA USA; [Van Dyke, Terry] Path Forward Solut, Frederick, MD USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of California System; University of California Los Angeles; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Lee, MP; Day, CP; Merlino, G (corresponding author), NCI, Lab Canc Biol & Genet, Ctr Canc Res, NIH, Bethesda, MD 20892 USA.	leemax@mail.nih.gov; chi-ping.day@nih.gov; gmerlino@helix.nih.gov	Michael, Helen/GVS-8802-2022	Lam, Khiem/0000-0001-5831-1264; Araya, Romina Elizabeth/0000-0001-9787-2670; Weaver Ohler, Zoe/0000-0002-6287-2504; Marie, Kerrie/0000-0002-2860-918X; Restifo, Nicholas P./0000-0003-4229-4580	NIH intramural research program; FLEX Synergy Award from the NCI Center for Cancer Research; NCI Director's Innovation Award; Ressler Family Foundation; Merck; Bristol-Myers Squibb; American Skin Association; Melanoma Research Alliance	NIH intramural research program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FLEX Synergy Award from the NCI Center for Cancer Research; NCI Director's Innovation Award; Ressler Family Foundation; Merck(Merck & Company); Bristol-Myers Squibb(Bristol-Myers Squibb); American Skin Association; Melanoma Research Alliance	We thank T.A. Chan (Memorial Sloan-Kettering Cancer Center) for suggestions and comments; T. Tuting (University of Magdeburg), M. McMahon (University of Utah) and M. Bosenberg (Yale School of Medicine) for mouse reagents; E. Van Allen (Dana-Farber Cancer Institute) for sharing clinical data; S. Burkett (Molecular Cytogenetics Core Facility, MCGP, NCI-Frederick) for SKY analysis; C. Redon (NCI) for assistance with gamma irradiation; Y. Boumber (Fox Chase Cancer Center) and C. Alewine (NCI) for manuscript revision and editing. This research was supported in part by funds from the NIH intramural research program and a FLEX Synergy Award from the NCI Center for Cancer Research. An NCI Director's Innovation Award to E.P.-G. helped support this project. R.S.L. received founding from the Ressler Family Foundation and from Merck and Bristol-Myers Squibb. W.H. received a Daneen & Charles Stiefel Investigative Scientist Award from American Skin Association and a Young Investigator Award from Melanoma Research Alliance.	Ackermann J, 2005, CANCER RES, V65, P4005, DOI 10.1158/0008-5472.CAN-04-2970; Aguirre AJ, 2003, GENE DEV, V17, P3112, DOI 10.1101/gad.1158703; Akbani R, 2015, CELL, V161, P1681, DOI 10.1016/j.cell.2015.05.044; Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Araya RE, 2020, METHOD ENZYMOL, V632, P309, DOI 10.1016/bs.mie.2019.11.012; Auslander N, 2018, NAT MED, V24, P1545, DOI 10.1038/s41591-018-0157-9; Ayers M, 2017, J CLIN INVEST, V127, P2930, DOI 10.1172/JCI91190; Azizi E, 2018, CELL, V174, P1293, DOI 10.1016/j.cell.2018.05.060; Bald T, 2014, CANCER DISCOV, V4, P674, DOI 10.1158/2159-8290.CD-13-0458; Bald T, 2014, NATURE, V507, P109, DOI 10.1038/nature13111; Barry KC, 2018, NAT MED, V24, P1178, DOI 10.1038/s41591-018-0085-8; Binnewies M, 2019, CELL, V177, P556, DOI 10.1016/j.cell.2019.02.005; Bloom MB, 1997, J EXP MED, V185, P453, DOI 10.1084/jem.185.3.453; Bottcher JP, 2018, TRENDS CANCER, V4, P784, DOI 10.1016/j.trecan.2018.09.001; Bottcher JP, 2018, CELL, V172, P1022, DOI 10.1016/j.cell.2018.01.004; Brown CC, 2019, CELL, V179, P846, DOI 10.1016/j.cell.2019.09.035; Chan TA, 2019, ANN ONCOL, V30, P44, DOI 10.1093/annonc/mdy495; Chen H, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1005112; CHEN LP, 1994, J EXP MED, V179, P523, DOI 10.1084/jem.179.2.523; Chen PL, 2016, CANCER DISCOV, V6, P827, DOI 10.1158/2159-8290.CD-15-1545; Chen ZY, 2017, SCI REP-UK, V7, DOI 10.1038/srep40508; Chin L, 1997, GENE DEV, V11, P2822, DOI 10.1101/gad.11.21.2822; Collin M, 2018, IMMUNOLOGY, V154, P3, DOI 10.1111/imm.12888; Damsky WE, 2011, CANCER CELL, V20, P741, DOI 10.1016/j.ccr.2011.10.030; Dankort D, 2009, NAT GENET, V41, P544, DOI 10.1038/ng.356; Day CP, 2017, LAB INVEST, V97, P698, DOI 10.1038/labinvest.2016.155; Day CP, 2015, CELL, V163, P39, DOI 10.1016/j.cell.2015.08.068; De Fabo EC, 2004, CANCER RES, V64, P6372, DOI 10.1158/0008-5472.CAN-04-1454; De Palma M, 2013, CANCER CELL, V23, P277, DOI 10.1016/j.ccr.2013.02.013; Dhomen N, 2009, CANCER CELL, V15, P294, DOI 10.1016/j.ccr.2009.02.022; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Gao JJ, 2016, CELL, V167, P397, DOI 10.1016/j.cell.2016.08.069; Godfrey DI, 2018, IMMUNITY, V48, P453, DOI 10.1016/j.immuni.2018.03.009; Guo XY, 2018, NAT MED, V24, P978, DOI 10.1038/s41591-018-0045-3; Hayward NK, 2017, NATURE, V545, P175, DOI 10.1038/nature22071; Hugo W, 2016, CELL, V165, P35, DOI 10.1016/j.cell.2016.02.065; Iida N, 2013, SCIENCE, V342, P967, DOI 10.1126/science.1240527; Jerby-Arnon L, 2018, CELL, V175, P984, DOI 10.1016/j.cell.2018.09.006; Jiang P, 2018, NAT MED, V24, P1550, DOI 10.1038/s41591-018-0136-1; Joshi SS, 2019, PLOS GENET, V15, DOI 10.1371/journal.pgen.1008034; Landsberg J, 2012, NATURE, V490, P412, DOI 10.1038/nature11538; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Marie KL, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-14085-2; Mehta A, 2018, CANCER DISCOV, V8, P935, DOI 10.1158/2159-8290.CD-17-1178; Nathanson T, 2017, CANCER IMMUNOL RES, V5, P84, DOI 10.1158/2326-6066.CIR-16-0019; NESBITT MN, 1973, CHROMOSOMA, V41, P145, DOI 10.1007/BF00319691; Newman AM, 2015, NAT METHODS, V12, P453, DOI [10.1038/nmeth.3337, 10.1038/NMETH.3337]; Noonan FP, 2001, NATURE, V413, P271, DOI 10.1038/35095108; Patel SJ, 2017, NATURE, V548, P537, DOI 10.1038/nature23477; Philip M, 2017, NATURE, V545, P452, DOI 10.1038/nature22367; Riaz N, 2017, CELL, V171, P934, DOI 10.1016/j.cell.2017.09.028; Rizvi NA, 2015, SCIENCE, V348, P124, DOI 10.1126/science.aaa1348; Rodig SJ, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aar3342; Schrock E, 1996, SCIENCE, V273, P494, DOI 10.1126/science.273.5274.494; Snyder A, 2014, NEW ENGL J MED, V371, P2189, DOI 10.1056/NEJMoa1406498; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tsoi J, 2018, CANCER CELL, V33, P890, DOI 10.1016/j.ccell.2018.03.017; Tumeh PC, 2014, NATURE, V515, P568, DOI 10.1038/nature13954; Van Allen EM, 2015, SCIENCE, V350, P207, DOI 10.1126/science.aad0095; Vandamme N, 2019, CELL MOL LIFE SCI, V76, P1919, DOI 10.1007/s00018-019-03049-w; Vasioukhin V, 1999, P NATL ACAD SCI USA, V96, P8551, DOI 10.1073/pnas.96.15.8551; Veierod MB, 2010, CANCER EPIDEM BIOMAR, V19, P111, DOI 10.1158/1055-9965.EPI-09-0567; Vidwans SJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018257; Virador V, 2001, PIGM CELL RES, V14, P289, DOI 10.1034/j.1600-0749.2001.140410.x; Wei SC, 2018, CANCER DISCOV, V8, P1069, DOI 10.1158/2159-8290.CD-18-0367; Wolkers MC, 2004, SCIENCE, V304, P1314, DOI 10.1126/science.1096268; Zappasodi R, 2018, CANCER CELL, V33, P581, DOI 10.1016/j.ccell.2018.03.005; Zaretsky JM, 2016, NEW ENGL J MED, V375, P819, DOI 10.1056/NEJMoa1604958	69	43	44	1	12	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	MAY	2020	26	5					781	+		10.1038/s41591-020-0818-3	http://dx.doi.org/10.1038/s41591-020-0818-3		APR 2020	25	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	ML1MY	32284588	Green Submitted, Green Accepted			2022-12-27	WOS:000526266600002
J	Colby, DJ; Sarnecki, M; Barouch, DH; Tipsuk, S; Stieh, DJ; Kroon, E; Schuetz, A; Intasan, J; Sacdalan, C; Pinyakorn, S; Grandin, P; Song, HS; Tovanabutra, S; Shubin, Z; Kim, D; Paquin-Proulx, D; Eller, MA; Thomas, R; de Souza, M; Wieczorek, L; Polonis, VR; Pagliuzza, A; Chomont, N; Peter, L; Nkolola, JP; Vingerhoets, J; Truyers, C; Pau, MG; Schuitemaker, H; Phanuphak, N; Michael, N; Robb, ML; Tomaka, FL; Ananworanich, J				Colby, Donn J.; Sarnecki, Michal; Barouch, Dan H.; Tipsuk, Somporn; Stieh, Daniel J.; Kroon, Eugene; Schuetz, Alexandra; Intasan, Jintana; Sacdalan, Carlo; Pinyakorn, Suteeraporn; Grandin, Pornsuk; Song, Hongshuo; Tovanabutra, Sodsai; Shubin, Zhanna; Kim, Dohoon; Paquin-Proulx, Dominic; Eller, Michael A.; Thomas, Rasmi; de Souza, Mark; Wieczorek, Lindsay; Polonis, Victoria R.; Pagliuzza, Amelie; Chomont, Nicolas; Peter, Lauren; Nkolola, Joseph P.; Vingerhoets, Johan; Truyers, Carla; Pau, Maria G.; Schuitemaker, Hanneke; Phanuphak, Nittaya; Michael, Nelson; Robb, Merlin L.; Tomaka, Frank L.; Ananworanich, Jintanat			Safety and immunogenicity of Ad26 and MVA vaccines in acutely treated HIV and effect on viral rebound after antiretroviral therapy interruption	NATURE MEDICINE			English	Article							CELLULAR IMMUNE-RESPONSES; AIDS; INDIVIDUALS; REPLICATION; TRIAL; ASSAY	We administered Ad26, modified vaccinia Ankara vectors containing mosaic HIV-1 antigens or placebo in 26 individuals who initiated antiretroviral therapy during acute human immunodeficiency virus infection as an exploratory study to determine the safety and duration of viremic control after treatment interruption. The vaccine was safe and generated robust immune responses, but delayed time to viral rebound compared to that in placebo recipients by only several days and did not lead to viremic control after treatment interruption (clinical trial NCT02919306). Test of therapeutic mosaic vaccines in HIV-infected individuals shows no control of virus after treatment interruption.	[Colby, Donn J.; Tipsuk, Somporn; Kroon, Eugene; Intasan, Jintana; Sacdalan, Carlo; de Souza, Mark; Phanuphak, Nittaya; Ananworanich, Jintanat] Thai Red Cross AIDS Res Ctr, SEARCH, Bangkok, Thailand; [Sarnecki, Michal] Janssen Vaccines, Bern, Switzerland; [Barouch, Dan H.; Peter, Lauren; Nkolola, Joseph P.] Beth Israel Deaconess Med Ctr, Ctr Virol & Vaccine Res, Boston, MA 02215 USA; [Stieh, Daniel J.; Pau, Maria G.; Schuitemaker, Hanneke] Janssen Vaccines & Prevent BV, Leiden, Netherlands; [Schuetz, Alexandra; Grandin, Pornsuk] Armed Forces Res Inst Med Sci, Bangkok, Thailand; [Schuetz, Alexandra; Pinyakorn, Suteeraporn; Song, Hongshuo; Tovanabutra, Sodsai; Shubin, Zhanna; Kim, Dohoon; Paquin-Proulx, Dominic; Eller, Michael A.; Thomas, Rasmi; Michael, Nelson; Robb, Merlin L.; Ananworanich, Jintanat] Henry M Jackson Fdn Adv Mil Med, Bethesda, MD USA; [Schuetz, Alexandra; Pinyakorn, Suteeraporn; Song, Hongshuo; Tovanabutra, Sodsai; Shubin, Zhanna; Kim, Dohoon; Paquin-Proulx, Dominic; Eller, Michael A.; Thomas, Rasmi; de Souza, Mark; Wieczorek, Lindsay; Polonis, Victoria R.; Michael, Nelson; Robb, Merlin L.; Ananworanich, Jintanat] Walter Reed Army Inst Res, US Mil HIV Res Program, Silver Spring, MD USA; [Song, Hongshuo] Univ Maryland, Sch Med, Inst Human Virol, Baltimore, MD 21201 USA; [Pagliuzza, Amelie; Chomont, Nicolas] CHUM, Ctr Rech, Montreal, PQ, Canada; [Pagliuzza, Amelie; Chomont, Nicolas] Dept Microbiol Infectiol & Immunol, Montreal, PQ, Canada; [Vingerhoets, Johan; Truyers, Carla] Janssen Pharmaceut NV, Beerse, Belgium; [Tomaka, Frank L.] Janssen Res & Dev, Titusville, NJ USA; [Ananworanich, Jintanat] Univ Amsterdam, Dept Global Hlth, Amsterdam, Netherlands	Thai Red Cross Society; Harvard University; Beth Israel Deaconess Medical Center; United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); Armed Forces Research Institute of Medical Science (AFRIMS); Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc; United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); University System of Maryland; University of Maryland Baltimore; Universite de Montreal; Johnson & Johnson; Janssen Pharmaceuticals; Johnson & Johnson; Janssen Pharmaceuticals; University of Amsterdam	Robb, ML (corresponding author), Henry M Jackson Fdn Adv Mil Med, Bethesda, MD USA.; Robb, ML (corresponding author), Walter Reed Army Inst Res, US Mil HIV Res Program, Silver Spring, MD USA.	mrobb@hivresearch.org	Paquin-Proulx, Dominic/AFS-1852-2022; Ananworanich, Jintanat/AAC-6348-2021; Eller, Michael A./I-2156-2019; Chomont, Nicolas/ABG-2545-2020	Paquin-Proulx, Dominic/0000-0003-1407-3414; Ananworanich, Jintanat/0000-0003-1369-3224; Eller, Michael A./0000-0003-3905-4877; Chomont, Nicolas/0000-0001-9747-5018; Sarnecki, Michal/0000-0001-7035-0020; colby, donn j./0000-0003-3931-5926	Janssen Vaccines Prevention BV; Henry M. Jackson Foundation for the Advancement of Military Medicine [W81XWH-07-2-0067]; US Department of Defense (DoD) [W81XWH-07-2-0067]; Janssen Pharmaceuticals	Janssen Vaccines Prevention BV; Henry M. Jackson Foundation for the Advancement of Military Medicine; US Department of Defense (DoD)(United States Department of Defense); Janssen Pharmaceuticals(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc)	We thank the HTX1001/RV405 Study Team. The HTX1001/RV405 Study Team consists of the following: from the Thai Armed Forces Research Institute of Medical Sciences: R. O'Connell, S. Vasan, D. Hsu, S. Akapirat, R. Trichavaroj, N. Tantibul, B. Nuntapinit, P. Rakyat, A. Phramtong, S. Booncharoenraksa, Y. Phuang-Ngern, C. Sajjaweerawan, P. Saetun; from Beth Israel Deaconess Medical Center: A. Agarwal, B. Alimonti, E. Borducchi, A. Chandrashekar, P. Gandhi, L. Howe, M. Kamath, S. Khatiwada, D. Jetton, S. Mojita and D. Quijada; from Janssen: I. Beeksma, S. P. Chai, D. D. Herdt, Z. Euler, M. Habets, A. Knaapen, V. Oriol Mathieu, C. McShane, M. Pagany, L. Scheppler, S. Sprangers, R. Roten, O. Yuan, W. Vandermeiren, I. V. Dromme, M. Weijtens; from the US Military HIV Research Program: M. Milazzo, L. A. Eller, L. Trautmann, H. Takata, D. Bolton, A. Tokarev, M. Rao, S. Krebs, B. Slike, M. Rolland, D. J. Curtis, A. Simmons, V. Polonis, L. Wieczorek, S. Shangguan, M. Bose, E. Turk, C. McCullough, O. Butterworth; from the Thai Red Cross AIDS Research Centre: P. Phanuphak, S. Chottanapund, P. Tantivitayakul, P. Chan, P. Eamyoung, C. Munkong, R. Kanaprach, T. Luekasemsuk. We thank J. Kim of the International Vaccine Institute, who is a co-inventor on a patent that has relevance to the vaccine regimen used for the target population in this manuscript (the patent applicants include Janssen Vaccines & Prevention BV, Beth Israel Deaconess Medical Center, Henry M. Jackson Foundation for the Advancement of Military Medicine, and The United States of America, as represented by the Secretary of the Army). This work was supported by Janssen Vaccines & Prevention BV and a cooperative agreement (W81XWH-07-2-0067) between the Henry M. Jackson Foundation for the Advancement of Military Medicine and the US Department of Defense (DoD). The US Army Medical Research Acquisition Activity is the awarding and administering acquisition office for the cooperative agreement. Medical writing support was provided by K. Holmes (Zoetic Science) and funded by Janssen Pharmaceuticals. Role of Sponsor: this study was funded by Janssen Pharmaceuticals, who participated in designing the study, safety monitoring, data analysis, interpretation and writing the manuscript. We are grateful to the participants who have made this research possible.	Baden LR, 2018, J INFECT DIS, V218, P633, DOI 10.1093/infdis/jiy212; Barouch DH, 2018, LANCET, V392, P232, DOI [10.1016/s0140-6736(18)31364-3, 10.1016/S0140-6736(18)31364-3]; Barouch DH, 2010, NAT MED, V16, P319, DOI 10.1038/nm.2089; Bashirova AA, 2011, ANNU REV IMMUNOL, V29, P295, DOI 10.1146/annurev-immunol-031210-101332; Borducchi EN, 2018, NATURE, V563, P360, DOI 10.1038/s41586-018-0600-6; Borducchi EN, 2016, NATURE, V540, P284, DOI 10.1038/nature20583; Chang D, 2018, J INT AIDS SOC, V21, DOI 10.1002/jia2.25204; Colby DJ, 2018, NAT MED, V24, P923, DOI 10.1038/s41591-018-0026-6; Crowell TA, 2019, LANCET HIV, V6, pE297, DOI 10.1016/S2352-3018(19)30053-0; de Souza MS, 2016, CLIN INFECT DIS, V63, P555, DOI 10.1093/cid/ciw365; De Souza MS, 2015, AIDS, V29, P793, DOI 10.1097/QAD.0000000000000616; Deeks SG, 2016, NAT MED, V22, P839, DOI 10.1038/nm.4108; Ehrenberg PK, 2018, METHODS MOL BIOL, V1802, P89, DOI 10.1007/978-1-4939-8546-3_6; Gomez-Roman VR, 2006, J IMMUNOL METHODS, V308, P53, DOI 10.1016/j.jim.2005.09.018; Horton H, 2007, J IMMUNOL METHODS, V323, P39, DOI 10.1016/j.jim.2007.03.002; Julg B, 2019, LANCET HIV, V6, pE259, DOI 10.1016/S2352-3018(19)30052-9; Keele BF, 2008, P NATL ACAD SCI USA, V105, P7552, DOI 10.1073/pnas.0802203105; Land S, 2009, J VIROL METHODS, V159, P185, DOI 10.1016/j.jviromet.2009.03.016; Li JZ, 2011, J INFECT DIS, V203, P976, DOI 10.1093/infdis/jiq143; Lin L, 2015, NAT BIOTECHNOL, V33, P610, DOI 10.1038/nbt.3187; Migueles SA, 2000, P NATL ACAD SCI USA, V97, P2709, DOI 10.1073/pnas.050567397; Mothe B, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0392-5; Nakanjako D, 2016, AIDS, V30, P1913, DOI 10.1097/QAD.0000000000001085; Ratto-Kim S, 2018, AIDS RES HUM RETROV, V34, P685, DOI [10.1089/aid.2017.0237, 10.1089/AID.2017.0237]; Saez-Cirion A, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003211; Scheid JF, 2016, NATURE, V535, P556, DOI 10.1038/nature18929; Schooley RT, 2010, J INFECT DIS, V202, P705, DOI 10.1086/655468; Stephenson KE, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0205139; Takata H, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aag1809; Vandergeeten C, 2014, J VIROL, V88, P12385, DOI 10.1128/JVI.00609-14	31	27	27	0	9	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	APR	2020	26	4					498	+		10.1038/s41591-020-0774-y	http://dx.doi.org/10.1038/s41591-020-0774-y		MAR 2020	19	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	QH1UE	32235883	Bronze			2022-12-27	WOS:000521529700001
J	Nagao-Kitamoto, H; Leslie, JL; Kitamoto, S; Jin, CS; Thomsson, KA; Gillilland, MG; Kuffa, P; Goto, Y; Jenq, RR; Ishii, C; Hirayama, A; Seekatz, AM; Martens, EC; Eaton, KA; Kao, JY; Fukuda, S; Higgins, PDR; Karlsson, NG; Young, VB; Kamada, N				Nagao-Kitamoto, Hiroko; Leslie, Jhansi L.; Kitamoto, Sho; Jin, Chunsheng; Thomsson, Kristina A.; Gillilland, Merritt G., III; Kuffa, Peter; Goto, Yoshiyuki; Jenq, Robert R.; Ishii, Chiharu; Hirayama, Akiyoshi; Seekatz, Anna M.; Martens, Eric C.; Eaton, Kathryn A.; Kao, John Y.; Fukuda, Shinji; Higgins, Peter D. R.; Karlsson, Niclas G.; Young, Vincent B.; Kamada, Nobuhiko			Interleukin-22-mediated host glycosylation prevents Clostridioides difficile infection by modulating the metabolic activity of the gut microbiota	NATURE MEDICINE			English	Article							GERM-FREE MICE; ULCERATIVE-COLITIS; IL-22; COLONIZATION; RESISTANCE; CELLS; TRANSPLANTATION; FUCOSYLATION; SUPPRESSOR; ADHESION	In germ-free mice colonized with human microbiota, mucosal IL-22 signaling promotes the growth of succinate-consuming commensal bacteria via host mucus glycosylation, and transplantation of these bacteria limits Clostridioides difficile infection. The involvement of host immunity in the gut microbiota-mediated colonization resistance to Clostridioides difficile infection (CDI) is incompletely understood. Here, we show that interleukin (IL)-22, induced by colonization of the gut microbiota, is crucial for the prevention of CDI in human microbiota-associated (HMA) mice. IL-22 signaling in HMA mice regulated host glycosylation, which enabled the growth of succinate-consuming bacteria Phascolarctobacterium spp. within the gut microbiome. Phascolarctobacterium reduced the availability of luminal succinate, a crucial metabolite for the growth of C. difficile, and therefore prevented the growth of C. difficile. IL-22-mediated host N-glycosylation is likely impaired in patients with ulcerative colitis (UC) and renders UC-HMA mice more susceptible to CDI. Transplantation of healthy human-derived microbiota or Phascolarctobacterium reduced luminal succinate levels and restored colonization resistance in UC-HMA mice. IL-22-mediated host glycosylation thus fosters the growth of commensal bacteria that compete with C. difficile for the nutritional niche.	[Nagao-Kitamoto, Hiroko; Kitamoto, Sho; Gillilland, Merritt G., III; Kuffa, Peter; Kao, John Y.; Higgins, Peter D. R.; Kamada, Nobuhiko] Univ Michigan, Sch Med, Div Gastroenterol, Ann Arbor, MI 48109 USA; [Leslie, Jhansi L.; Seekatz, Anna M.; Young, Vincent B.] Univ Michigan, Sch Med, Dept Internal Med, Div Infect Dis, Ann Arbor, MI USA; [Leslie, Jhansi L.; Martens, Eric C.; Eaton, Kathryn A.; Young, Vincent B.] Univ Michigan, Sch Med, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA; [Jin, Chunsheng; Thomsson, Kristina A.; Karlsson, Niclas G.] Univ Gothenburg, Inst Biomed, Dept Med Biochem, Gothenburg, Sweden; [Goto, Yoshiyuki] Chiba Univ, Med Mycol Res Ctr, Div Mol Immunol, Chiba, Japan; [Goto, Yoshiyuki] Univ Tokyo, Div Mucosal Symbiosis, Int Res & Dev Ctr Mucosal Vaccines, Inst Med Sci, Tokyo, Japan; [Goto, Yoshiyuki] Japan Agcy Med Res & Dev, AMED PRIME, Tokyo, Japan; [Jenq, Robert R.] Univ Texas MD Anderson Canc Ctr, Dept Genom Med, Div Canc Med, Houston, TX 77030 USA; [Ishii, Chiharu; Hirayama, Akiyoshi; Fukuda, Shinji] Keio Univ, Inst Adv Biosci, Tsuruoka, Yamagata, Japan; [Fukuda, Shinji] Kanagawa Inst Ind Sci & Technol, Intestinal Microbiota Project, Ebina, Kanagawa, Japan; [Fukuda, Shinji] Univ Tsukuba, Transborder Med Res Ctr, Tsukuba, Ibaraki, Japan; [Fukuda, Shinji] Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama, Japan; [Leslie, Jhansi L.] Univ Virginia, Washington, VA USA; [Seekatz, Anna M.] Clemson Univ, Columbia, SC USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Gothenburg; Chiba University; University of Tokyo; University of Texas System; UTMD Anderson Cancer Center; Keio University; University of Tsukuba; Japan Science & Technology Agency (JST); University of Virginia; Clemson University	Kamada, N (corresponding author), Univ Michigan, Sch Med, Div Gastroenterol, Ann Arbor, MI 48109 USA.	nkamada@umich.edu	Young, Vincent B/B-3179-2009; Kitamoto, Sho/AAE-4549-2021; Karlsson, Niclas/G-5235-2013; Kamada, Nobuhiko/AAW-3299-2020	Young, Vincent B/0000-0003-3687-2364; Kitamoto, Sho/0000-0003-3597-6647; Karlsson, Niclas/0000-0002-3045-2628; Kamada, Nobuhiko/0000-0002-1980-4178; Fukuda, Shinji/0000-0001-5161-9880; Ishii, Chiharu/0000-0003-2659-206X; Leslie, Jhansi/0000-0001-5600-210X	University of Michigan Center for Gastrointestinal Research [DK034933]; Michigan Regional Comprehensive Metabolomics Resource Core (MRC2) [DK097153]; National Institutes of Health (NIH) [DK110146, DK108901]; Crohn's and Colitis Foundation of America; Global Probiotics Council; Joint Usage/Research Program of Medical Mycology Research Center Chiba University 18-1; Japan Society for the Promotion of Science; Uehara Memorial Foundation; Clinical and Translational Science Awards Program; Prevent Cancer Foundation; Japan Society for the Promotion of Science KAKENHI grants [16H04901, 17H05654, 18H04805]; Japan Science and Technology Agency PRESTO grant [JPMJPR1537]; Japan Science and Technology Agency ERATO grant [JPMJER1902]; Advanced Research and Development Programs for Medical Innovation CREST program grant [JP19gm1010009]; Takeda Science Foundation; Food Science Institute Foundation; Swedish Research Council	University of Michigan Center for Gastrointestinal Research; Michigan Regional Comprehensive Metabolomics Resource Core (MRC2); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Crohn's and Colitis Foundation of America; Global Probiotics Council; Joint Usage/Research Program of Medical Mycology Research Center Chiba University 18-1; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Uehara Memorial Foundation(Uehara Memorial Foundation); Clinical and Translational Science Awards Program; Prevent Cancer Foundation; Japan Society for the Promotion of Science KAKENHI grants(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Japan Science and Technology Agency PRESTO grant; Japan Science and Technology Agency ERATO grant; Advanced Research and Development Programs for Medical Innovation CREST program grant; Takeda Science Foundation(Takeda Science Foundation (TSF)); Food Science Institute Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission)	The authors thank A. B. Shreiner for technical assistance, the University of Michigan Center for Gastrointestinal Research (DK034933), Host Microbiome Initiative, the GF Animal Facility and the Michigan Regional Comprehensive Metabolomics Resource Core (MRC2) (DK097153) for core services and I. L. Bergin from the In Vivo Animal Core at the University of Michigan Unit for Laboratory Animal Medicine for histological assessment. This work was supported by the National Institutes of Health (NIH) DK110146 and DK108901 (N.K.), Crohn's and Colitis Foundation of America (N.K and H.N.-K.), Young Investigator Grant from the Global Probiotics Council (N.K.), University of Michigan Center for Gastrointestinal Research (DK034933) (N.K.), Joint Usage/Research Program of Medical Mycology Research Center Chiba University 18-1 (N.K. and Y.G.), Japan Society for the Promotion of Science Postdoctoral Fellowship for Research Abroad (H.N.-K. and S.K.), the Uehara Memorial Foundation Postdoctoral Fellowship Award (S.K.), Clinical and Translational Science Awards Program (S.K.), Prevent Cancer Foundation (S.K.), Japan Society for the Promotion of Science KAKENHI grants 16H04901, 17H05654 and 18H04805 (S.F.), Japan Science and Technology Agency PRESTO grant JPMJPR1537 (S.F.), Japan Science and Technology Agency ERATO grant JPMJER1902 (S.F.), Advanced Research and Development Programs for Medical Innovation CREST program grant JP19gm1010009 (S.F.), the Takeda Science Foundation (S.F.) and the Food Science Institute Foundation (S.F.). MS analysis of glycans was performed by the Swedish Infrastructure for Biological Mass Spectrometry, supported by the Swedish Research Council.	Abt MC, 2015, CELL HOST MICROBE, V18, P27, DOI 10.1016/j.chom.2015.06.011; Akha AAS, 2015, IMMUNOLOGY, V144, P587, DOI 10.1111/imm.12414; Arijs I, 2018, GUT, V67, P43, DOI 10.1136/gutjnl-2016-312293; Arijs I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007984; Atarashi K, 2015, CELL, V163, P367, DOI 10.1016/j.cell.2015.08.058; Battaglioli EJ, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aam7019; Berg AM, 2013, INFLAMM BOWEL DIS, V19, P194, DOI 10.1002/ibd.22964; Britton RA, 2014, GASTROENTEROLOGY, V146, P1547, DOI 10.1053/j.gastro.2014.01.059; Buffie CG, 2015, NATURE, V517, P205, DOI 10.1038/nature13828; COHEN PS, 1995, METHOD ENZYMOL, V253, P309; Collins J, 2015, MICROBIOME, V3, DOI 10.1186/s40168-015-0097-2; Dias AM, 2014, HUM MOL GENET, V23, P2416, DOI 10.1093/hmg/ddt632; Ferreyra JA, 2014, CELL HOST MICROBE, V16, P770, DOI 10.1016/j.chom.2014.11.003; Goto Y, 2014, SCIENCE, V345, P1310, DOI 10.1126/science.1254009; Hasegawa M, 2014, IMMUNITY, V41, P620, DOI 10.1016/j.immuni.2014.09.010; Hecht G, 2014, LAB ANIM-UK, V48, P292, DOI 10.1177/0023677214544728; Hirayama A, 2012, ANAL BIOANAL CHEM, V404, P3101, DOI 10.1007/s00216-012-6412-x; Hourigan SK, 2015, ALIMENT PHARM THER, V42, P741, DOI 10.1111/apt.13326; Johnson JL, 2013, TRENDS IMMUNOL, V34, P290, DOI 10.1016/j.it.2013.01.006; Kamada N, 2013, J IMMUNOL, V190, P1389, DOI 10.4049/jimmunol.1203100; Kozich JJ, 2013, APPL ENVIRON MICROB, V79, P5112, DOI 10.1128/AEM.01043-13; Lamas B, 2016, NAT MED, V22, P598, DOI 10.1038/nm.4102; Leung JM, 2014, MUCOSAL IMMUNOL, V7, P124, DOI 10.1038/mi.2013.31; Levy M, 2015, CELL, V163, P1428, DOI 10.1016/j.cell.2015.10.048; Li Y, 2013, INFLAMM BOWEL DIS, V19, P132, DOI 10.1002/ibd.22992; Lopez Joanna, 2016, Gastroenterol Hepatol (N Y), V12, P374; Lorenz MA, 2011, ANAL CHEM, V83, P3406, DOI 10.1021/ac103313x; Mann ER, 2014, INFLAMM BOWEL DIS, V20, P2299, DOI 10.1097/MIB.0000000000000223; Martin JC, 2016, MUCOSAL IMMUNOL, V9, P539, DOI 10.1038/mi.2015.83; Morgan XC, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-9-r79; Nagao-Kitamoto H, 2016, CELL MOL GASTROENTER, V2, P468, DOI 10.1016/j.jcmgh.2016.02.003; Paik J, 2015, GUT MICROBES, V6, P255, DOI 10.1080/19490976.2015.1064576; Paramsothy S, 2017, LANCET, V389, P1218, DOI 10.1016/S0140-6736(17)30182-4; Pelczar P, 2016, SCIENCE, V354, P358, DOI 10.1126/science.aah5903; Pham TAN, 2014, CELL HOST MICROBE, V16, P504, DOI 10.1016/j.chom.2014.08.017; Pickard JM, 2014, NATURE, V514, P638, DOI 10.1038/nature13823; Reddy SS, 2013, J CLIN GASTROENTEROL, V47, P666, DOI 10.1097/MCG.0b013e31828b288a; Rodemann JF, 2007, CLIN GASTROENTEROL H, V5, P339, DOI 10.1016/j.cgh.2006.12.027; Sakamoto K, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aai8371; Sanos SL, 2009, NAT IMMUNOL, V10, P83, DOI 10.1038/ni.1684; Satoh-Takayama N, 2008, IMMUNITY, V29, P958, DOI 10.1016/j.immuni.2008.11.001; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schmechel S, 2008, INFLAMM BOWEL DIS, V14, P204, DOI 10.1002/ibd.20315; Schulz BL, 2002, ANAL CHEM, V74, P6088, DOI 10.1021/ac025890a; Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60; Sonnenberg GF, 2012, IMMUNITY, V37, P601, DOI 10.1016/j.immuni.2012.10.003; Sonnenberg GF, 2012, SCIENCE, V336, P1321, DOI 10.1126/science.1222551; Stanley P, 2016, J MOL BIOL, V428, P3166, DOI 10.1016/j.jmb.2016.03.025; Theriot CM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4114; Topping DL, 2001, PHYSIOL REV, V81, P1031, DOI 10.1152/physrev.2001.81.3.1031; Vancamelbeke M, 2017, INFLAMM BOWEL DIS, V23, P1718, DOI 10.1097/MIB.0000000000001246; Watanabe Y, 2012, APPL ENVIRON MICROB, V78, P511, DOI 10.1128/AEM.06035-11; Wolk K, 2007, J IMMUNOL, V178, P5973, DOI 10.4049/jimmunol.178.9.5973; Wu FF, 2017, EXP THER MED, V14, P3122, DOI 10.3892/etm.2017.4878; Xu AT, 2015, INFLAMM BOWEL DIS, V21, P241, DOI 10.1097/MIB.0000000000000267; Zhang LH, 2015, ANAEROBE, V34, P1, DOI 10.1016/j.anaerobe.2015.03.008; Zheng Y, 2008, NAT MED, V14, P282, DOI 10.1038/nm1720	57	74	77	8	52	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	APR	2020	26	4					608	+		10.1038/s41591-020-0764-0	http://dx.doi.org/10.1038/s41591-020-0764-0		FEB 2020	22	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	QH1UE	32066975	Green Accepted			2022-12-27	WOS:000514065500001
J	Wright, K; Parker, M; Bhattacharya, S; Blanchet, K; Caney, S; Chan, EYY; Thome, BD; Guerin, P; Hughes, J; Kingori, P; Larson, H; Moses, S; Sekalala, S; Sheather, J; Tindana, P				Wright, Katharine; Parker, Michael; Bhattacharya, Sanjoy; Blanchet, Karl; Caney, Simon; Chan, Emily Ying Yang; Thome, Beatriz da Costa; Guerin, Philippe; Hughes, Julian; Kingori, Patricia; Larson, Heidi; Moses, Soka; Sekalala, Sharifah; Sheather, Julian; Tindana, Paulina		Nuffield Council Bioethics Working	In emergencies, health research must go beyond public engagement toward a true partnership with those affected	NATURE MEDICINE			English	Article								An Ebola virus outbreak taking place in the complex political and social context of The Democratic Republic of the Congo has forced the research community to reflect on their approach to community engagement. Katharine Wright and Michael Parker, on behalf of the Nuffield Council on Bioethics Working Group on research in global health emergencies, say that those affected need to influence research choices from the very beginning and that the value of their knowledge must be recognized.	[Wright, Katharine; Parker, Michael; Bhattacharya, Sanjoy; Blanchet, Karl; Caney, Simon; Chan, Emily Ying Yang; Thome, Beatriz da Costa; Guerin, Philippe; Hughes, Julian; Kingori, Patricia; Larson, Heidi; Moses, Soka; Sekalala, Sharifah; Sheather, Julian; Tindana, Paulina] Univ Oxford, Wellcome Ctr Eth & Humanities, Oxford, England; [Wright, Katharine; Parker, Michael] Univ Oxford, Ethox Ctr, Oxford, England	University of Oxford; University of Oxford	Wright, K (corresponding author), Univ Oxford, Wellcome Ctr Eth & Humanities, Oxford, England.; Wright, K (corresponding author), Univ Oxford, Ethox Ctr, Oxford, England.	kwright@nuffieldbioethics.org	thome, beatriz C/B-7337-2018; Guerin, Philippe/AAH-8873-2021	thome, beatriz C/0000-0002-3941-3756; Parker, Michael/0000-0002-7054-4711; Tindana, Paulina/0000-0002-9171-2083; Guerin, Philippe/0000-0002-6008-2963				Callaway E, 2019, NATURE, V575, P425, DOI 10.1038/d41586-019-03490-8; Mulangu S, 2019, NEW ENGL J MED, V381, P2293, DOI 10.1056/NEJMoa1910993; Vinck P, 2019, LANCET INFECT DIS, V19, P529, DOI 10.1016/S1473-3099(19)30063-5; Nguyen VK, 2019, NEW ENGL J MED, V380, P1298, DOI 10.1056/NEJMp1902682	4	4	3	0	8	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	MAR	2020	26	3					308	309		10.1038/s41591-020-0758-y	http://dx.doi.org/10.1038/s41591-020-0758-y		JAN 2020	2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	KU0MC	31992876	Green Submitted			2022-12-27	WOS:000510551900001
J	Vaitla, B; Verhulst, S; Bengtsson, L; Gonzalez, MC; Furst-Nichols, R; Pryor, EC				Vaitla, Bapu; Verhulst, Stefaan; Bengtsson, Linus; Gonzalez, Marta C.; Furst-Nichols, Rebecca; Pryor, Emily Courey			The promise and perils of big gender data	NATURE MEDICINE			English	Editorial Material								Big Data may revolutionize social science-and also amplify our deepest cultural biases.	[Vaitla, Bapu; Furst-Nichols, Rebecca; Pryor, Emily Courey] Data2x, United Nations Fdn, Washington, DC 20006 USA; [Vaitla, Bapu] Harvard Univ, Dept Nutr, Harvard TH Chan Sch Publ Hlth, Boston, MA 02115 USA; [Verhulst, Stefaan] NYU, Tandon Sch Engn, GovLab, Brooklyn, NY USA; [Bengtsson, Linus; Gonzalez, Marta C.] Flowminder Fdn, Stockholm, Sweden; [Gonzalez, Marta C.] Univ Calif Berkeley, Dept City & Reg Planning, Berkeley, CA 94720 USA	Harvard University; Harvard T.H. Chan School of Public Health; New York University; New York University Tandon School of Engineering; University of California System; University of California Berkeley	Pryor, EC (corresponding author), Data2x, United Nations Fdn, Washington, DC 20006 USA.	epryor@data2x.org	Gonzalez, Marta C./E-9456-2011	Gonzalez, Marta C./0000-0002-8482-0318				Bosco C, 2017, J R SOC INTERFACE, V14, DOI 10.1098/rsif.2016.0825; Buvinic M., 2014, MAPPING GENDER DATA; D'Ignazio C, 2019, DATA FEMINISM; De Choudhury M, 2017, CSCW'17: PROCEEDINGS OF THE 2017 ACM CONFERENCE ON COMPUTER SUPPORTED COOPERATIVE WORK AND SOCIAL COMPUTING, P353, DOI 10.1145/2998181.2998220; Vaitla B, 2019, BIG DATA BIG IMPACT; Verhulst SG, 2019, LEVERAGING PRIVATE D; Wesolowski A, 2012, SCIENCE, V338, P267, DOI 10.1126/science.1223467	7	1	1	0	4	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	JAN	2020	26	1					17	18		10.1038/s41591-019-0712-z	http://dx.doi.org/10.1038/s41591-019-0712-z			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	KG3GZ	31932783				2022-12-27	WOS:000509831900011
J	Bellosillo, B; Montagut, C				Bellosillo, Beatriz; Montagut, Clara			High-accuracy liquid biopsies	NATURE MEDICINE			English	Editorial Material							CELL-FREE DNA; CLONAL HEMATOPOIESIS; PLASMA; RISK	Ultra-deep sequencing of paired plasma-circulating free DNA and white blood cells allows the identification of tumor-derived somatic mutations with high accuracy by filtering out variants consistent with clonal hematopoiesis.	[Bellosillo, Beatriz] Hosp del Mar, Res Inst, IMIM, Pathol Dept,CIBERONC, Barcelona, Spain; [Montagut, Clara] Hosp del Mar, IMIM, CIBERONC, Clin Oncol Dept, Barcelona, Spain	CIBER - Centro de Investigacion Biomedica en Red; CIBERONC; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; CIBER - Centro de Investigacion Biomedica en Red; CIBERONC; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar	Bellosillo, B (corresponding author), Hosp del Mar, Res Inst, IMIM, Pathol Dept,CIBERONC, Barcelona, Spain.	bbellosillo@parcdesalutmar.cat						Bolton KL, 2019, J CLIN ONCOL, V37, P7, DOI 10.1200/JCO.18.00331; Gillis NK, 2017, LANCET ONCOL, V18, P112, DOI 10.1016/S1470-2045(16)30627-1; Heitzer E, 2019, NAT REV GENET, V20, P71, DOI 10.1038/s41576-018-0071-5; Hu YB, 2018, CLIN CANCER RES, V24, P4437, DOI 10.1158/1078-0432.CCR-18-0143; Jaiswal S, 2017, NEW ENGL J MED, V377, P111, DOI 10.1056/NEJMoa1701719; Liu J, 2019, ANN ONCOL, V30, P464, DOI 10.1093/annonc/mdy513; Lui YNYN, 2002, CLIN CHEM, V48, P421; Moss J, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07466-6; Razavi P, 2019, NAT MED, V25, P1928, DOI 10.1038/s41591-019-0652-7; Snyder MW, 2016, CELL, V164, P57, DOI 10.1016/j.cell.2015.11.050; Steensma DP, 2015, BLOOD, V126, P9, DOI 10.1182/blood-2015-03-631747; Takahashi K, 2017, LANCET ONCOL, V18, P100, DOI 10.1016/S1470-2045(16)30626-X	12	8	9	1	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	2019	25	12					1820	1821		10.1038/s41591-019-0690-1	http://dx.doi.org/10.1038/s41591-019-0690-1			3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	JT2KO	31768068				2022-12-27	WOS:000500824900022
J	Lehallier, B; Gate, D; Schaum, N; Nanasi, T; Lee, SE; Yousef, H; Losada, PM; Berdnik, D; Keller, A; Verghese, J; Sathyan, S; Franceschi, C; Milman, S; Barzilai, N; Wyss-Coray, T				Lehallier, Benoit; Gate, David; Schaum, Nicholas; Nanasi, Tibor; Lee, Song Eun; Yousef, Hanadie; Losada, Patricia Moran; Berdnik, Daniela; Keller, Andreas; Verghese, Joe; Sathyan, Sanish; Franceschi, Claudio; Milman, Sofiya; Barzilai, Nir; Wyss-Coray, Tony			Undulating changes in human plasma proteome profiles across the lifespan	NATURE MEDICINE			English	Article							DISEASE; REJUVENATION; LONGEVITY; GENETICS; PACKAGE; UPDATE	Aging is a predominant risk factor for several chronic diseases that limit healthspan(1). Mechanisms of aging are thus increasingly recognized as potential therapeutic targets. Blood from young mice reverses aspects of aging and disease across multiple tissues(2-10), which supports a hypothesis that age-elated molecular changes in blood could provide new insights into age-related disease biology. We measured 2,925 plasma proteins from 4,263 young adults to nonagenarians (18-95 years old) and developed a new bioinformatics approach that uncovered marked non-linear alterations in the human plasma proteome with age. Waves of changes in the proteome in the fourth, seventh and eighth decades of life reflected distinct biological pathways and revealed differential associations with the genome and proteome of age-related diseases and phenotypic traits. This new approach to the study of aging led to the identification of unexpected signatures and pathways that might offer potential targets for age-related diseases.	[Lehallier, Benoit; Gate, David; Nanasi, Tibor; Lee, Song Eun; Yousef, Hanadie; Losada, Patricia Moran; Berdnik, Daniela; Wyss-Coray, Tony] Stanford Univ, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA; [Lehallier, Benoit; Gate, David; Nanasi, Tibor; Lee, Song Eun; Yousef, Hanadie; Losada, Patricia Moran; Berdnik, Daniela; Wyss-Coray, Tony] Stanford Univ, Wu Tsai Neurosci Inst, Stanford, CA 94305 USA; [Lehallier, Benoit; Gate, David; Nanasi, Tibor; Lee, Song Eun; Yousef, Hanadie; Losada, Patricia Moran; Berdnik, Daniela; Wyss-Coray, Tony] Stanford Univ, Paul F Glenn Ctr Biol Aging, Stanford, CA 94305 USA; [Gate, David; Lee, Song Eun; Yousef, Hanadie; Berdnik, Daniela; Wyss-Coray, Tony] VA Palo Alto Hlth Care Syst, Dept Vet Affairs, Palo Alto, CA 94304 USA; [Schaum, Nicholas] Stanford Univ, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA; [Nanasi, Tibor] Hungarian Acad Sci, Res Ctr Nat Sci, Inst Cognit Neurosci & Psychol, Budapest, Hungary; [Keller, Andreas] Saarland Univ, Clin Bioinformat, Saarbrucken, Germany; [Verghese, Joe; Sathyan, Sanish; Milman, Sofiya; Barzilai, Nir] Albert Einstein Coll Med, Dept Med, Inst Aging Res, Bronx, NY 10467 USA; [Verghese, Joe; Sathyan, Sanish] Albert Einstein Coll Med, Dept Neurol, Bronx, NY 10467 USA; [Franceschi, Claudio] Univ Bologna, Dept Expt Diagnost & Specialty Med, Bologna, Italy; [Franceschi, Claudio] Natl Res Lobachevsky State Univ Nizhny Novgorod, Dept Appl Math, Nizhnii Novgorod, Russia; [Milman, Sofiya; Barzilai, Nir] Albert Einstein Coll Med, Dept Genet, Bronx, NY 10467 USA	Stanford University; Stanford University; Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Stanford University; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Research Centre for Natural Sciences; Saarland University; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; University of Bologna; Lobachevsky State University of Nizhni Novgorod; Yeshiva University; Albert Einstein College of Medicine	Lehallier, B; Wyss-Coray, T (corresponding author), Stanford Univ, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA.; Lehallier, B; Wyss-Coray, T (corresponding author), Stanford Univ, Wu Tsai Neurosci Inst, Stanford, CA 94305 USA.; Lehallier, B; Wyss-Coray, T (corresponding author), Stanford Univ, Paul F Glenn Ctr Biol Aging, Stanford, CA 94305 USA.; Wyss-Coray, T (corresponding author), VA Palo Alto Hlth Care Syst, Dept Vet Affairs, Palo Alto, CA 94304 USA.	lehallib@stanford.edu; twc@stanford.edu	Gate, David/AAM-5007-2021; Keller, Andreas/ABB-6412-2021; SATHYAN, SANISH/CAF-8167-2022; SATHYAN, SANISH/AAU-8634-2021	Gate, David/0000-0003-0481-9657; Keller, Andreas/0000-0002-5361-0895; Wyss-Coray, Tony/0000-0001-5893-0831; LEE, SONG EUN/0000-0002-6839-7724; Lehallier, Benoit/0000-0001-7452-3785	European Union [FP6-2004-LIFESCIHEALTH-5]; National Institutes of Health National Institute on Aging (NIA) [F32 1F32AG055255 01A1]; Hungarian Brain Research Program [2017-1.2.1-NKP-2017-00002]; Fulbright Foreign Student Program; Cure Alzheimer's Fund; Nan Fung Life Sciences; NOMIS Foundation; Stanford Brain Rejuvenation Project (an initiative of the Stanford Wu Tsai Neurosciences Institute); Paul F. Glenn Center for Aging Research; NIA [R01 AG04503, DP1 AG053015, P50AG047366, K23AG051148, R01AG061155, R01AG057909]; American Federation for Aging Research [R01AG044829]; Nathan Shock Center of Excellence for the Basic Biology of Aging [P30AG038072]; Glenn Center for the Biology of Human Aging; NATIONAL INSTITUTE ON AGING [DP1AG053015, F32AG055255, P50AG047366, R01AG057909, R01AG045034] Funding Source: NIH RePORTER	European Union(European Commission); National Institutes of Health National Institute on Aging (NIA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Hungarian Brain Research Program; Fulbright Foreign Student Program; Cure Alzheimer's Fund; Nan Fung Life Sciences; NOMIS Foundation; Stanford Brain Rejuvenation Project (an initiative of the Stanford Wu Tsai Neurosciences Institute); Paul F. Glenn Center for Aging Research; NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); American Federation for Aging Research; Nathan Shock Center of Excellence for the Basic Biology of Aging; Glenn Center for the Biology of Human Aging; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank the members of the Wyss-Coray laboratory for feedback and support. We thank the clinical staff for human blood and plasma collection/coordination. We thank A. Butterworth for his help in getting access to the INTERVAL proteomics data. The AddNeuroMed data are from a public-private partnership supported by EFPIA companies and the European Union Sixth Framework program priority FP6-2004-LIFESCIHEALTH-5. Clinical leads responsible for data collection were I. Kloszewska (Lodz), S. Lovestone (London), P. Mecocci (Perugia), H. Soininen (Kuopio), M. Tsolaki (Thessaloniki) and B. Vellas (Toulouse); imaging leads were A. Simmons (London), L.O. Wahlund (Stockholm) and C. Spenger (Zurich); and bioinformatics leads were R. Dobson (London) and S. Newhouse (London). This work was supported by National Institutes of Health National Institute on Aging (NIA) F32 1F32AG055255 01A1 (D.G.), Hungarian Brain Research Program Grant No. 2017-1.2.1-NKP-2017-00002 (T.N.), the Fulbright Foreign Student Program (T.N.), the Cure Alzheimer's Fund (T.W.-C.), Nan Fung Life Sciences (T.W.-C.), the NOMIS Foundation (T.W.-C.), the Stanford Brain Rejuvenation Project (an initiative of the Stanford Wu Tsai Neurosciences Institute), the Paul F. Glenn Center for Aging Research (T.W.-C.), NIA R01 AG04503 and DP1 AG053015 (T.W.-C.) and the NIA-funded Stanford Alzheimer's Disease Research Center P50AG047366, NIA K23AG051148 (S.M.), R01AG061155 (S.M.), the American Federation for Aging Research (S.M.), R01AG044829 (J.V. and N.B.), NIA R01AG057909 (N.B.), the Nathan Shock Center of Excellence for the Basic Biology of Aging P30AG038072 (N.B.) and the Glenn Center for the Biology of Human Aging (N.B.).	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Austad SN, 2016, CELL METAB, V23, P1022, DOI 10.1016/j.cmet.2016.05.019; Baht GS, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8131; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Britschgi M, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.008862; Carayol J, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-02182-z; Castellano JM, 2017, NATURE, V544, P488, DOI 10.1038/nature22067; Castellano JM, 2016, SCI REP-UK, V6, DOI 10.1038/srep29015; Castellano JM, 2015, JAMA NEUROL, V72, P1191, DOI 10.1001/jamaneurol.2015.1616; Cohen AA, 2018, BBA-MOL BASIS DIS, V1864, P2680, DOI 10.1016/j.bbadis.2017.05.028; Cohen E, 2008, NAT REV NEUROSCI, V9, P759, DOI 10.1038/nrn2474; Conboy IM, 2005, NATURE, V433, P760, DOI 10.1038/nature03260; Croft D, 2014, NUCLEIC ACIDS RES, V42, pD472, DOI 10.1093/nar/gkt1102; Di Angelantonio E, 2017, LANCET, V390, P2360, DOI 10.1016/S0140-6736(17)31928-1; Dray S, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i04; Emilsson V, 2018, SCIENCE, V361, P769, DOI 10.1126/science.aaq1327; Epskamp S, 2012, J STAT SOFTW, V48, P1, DOI 10.18637/jss.v048.i04; Fox J., 2019, R COMPANION APPL REG, V.; Franceschi C, 2007, ANN NY ACAD SCI, V1100, P21, DOI 10.1196/annals.1395.003; Franceschi C, 2018, NAT REV ENDOCRINOL, V14, P576, DOI 10.1038/s41574-018-0059-4; Franceschi C, 2018, FRONT MED-LAUSANNE, V5, DOI 10.3389/fmed.2018.00061; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; Ganz P, 2016, JAMA-J AM MED ASSOC, V315, P2532, DOI 10.1001/jama.2016.5951; Go AS, 2013, CIRCULATION, V127, pE6, DOI 10.1161/CIR.0b013e31828124ad; Gold L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015004; Gubbi S, 2017, AM J CARDIOL, V120, P2170, DOI 10.1016/j.amjcard.2017.08.040; Guiraud S, 2017, SCI REP-UK, V7, DOI 10.1038/srep43697; HARMAN D, 1991, P NATL ACAD SCI USA, V88, P5360, DOI 10.1073/pnas.88.12.5360; Horvath S, 2018, NAT REV GENET, V19, P371, DOI 10.1038/s41576-018-0004-3; Huang Q, 2018, J GERONTOL A-BIOL, V73, P421, DOI 10.1093/gerona/glx183; Irizar PA, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02395-2; Kanehisa M, 2017, NUCLEIC ACIDS RES, V45, pD353, DOI 10.1093/nar/gkw1092; Katsimpardi L, 2014, SCIENCE, V344, P630, DOI 10.1126/science.1251141; Lehallier B, 2016, JAMA NEUROL, V73, P203, DOI 10.1001/jamaneurol.2015.3135; Loffredo FS, 2013, CELL, V153, P828, DOI 10.1016/j.cell.2013.04.015; Mehan MR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035157; Ostan R, 2016, CLIN SCI, V130, P1711, DOI 10.1042/CS20160004; Salpeter SJ, 2013, DIABETES, V62, P2843, DOI 10.2337/db13-0160; Sattlecker M, 2014, ALZHEIMERS DEMENT, V10, P724, DOI 10.1016/j.jalz.2013.09.016; Sha SJ, 2019, JAMA NEUROL, V76, P35, DOI 10.1001/jamaneurol.2018.3288; Sinha M, 2014, SCIENCE, V344, P649, DOI 10.1126/science.1251152; Stegeman R, 2017, J MOL BIOL, V429, P2427, DOI 10.1016/j.jmb.2017.06.019; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Suhre K, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14357; Sullivan KD, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13858-3; Sun BB, 2018, NATURE, V558, P73, DOI 10.1038/s41586-018-0175-2; Tanaka T, 2018, AGING CELL, V17, DOI 10.1111/acel.12799; Valdes AM, 2013, NAT REV GENET, V14, P601, DOI 10.1038/nrg3553; Villeda SA, 2014, NAT MED, V20, P659, DOI 10.1038/nm.3569; Villeda SA, 2011, NATURE, V477, P90, DOI 10.1038/nature10357; Wang MH, 2015, SCI REP-UK, V5, DOI 10.1038/srep16923; Wang RN, 2014, GENES DIS, V1, P87, DOI 10.1016/j.gendis.2014.07.005; Wiklund FE, 2010, AGING CELL, V9, P1057, DOI 10.1111/j.1474-9726.2010.00629.x; Yu GC, 2012, OMICS, V16, P284, DOI 10.1089/omi.2011.0118; Zhou JH, 2017, NAT REV DRUG DISCOV, V16, P440, DOI 10.1038/nrd.2017.86	55	206	209	12	85	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	2019	25	12					1843	+		10.1038/s41591-019-0673-2	http://dx.doi.org/10.1038/s41591-019-0673-2			19	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	JT2KO	31806903	Green Accepted, Green Submitted			2022-12-27	WOS:000500824900027
J	Gao, K				Gao, Kate			HUMAN GENETICS The genetic architecture of multiple sclerosis	NATURE MEDICINE			English	Editorial Material														Gao, Peng (Kate)/0000-0002-6557-8511					0	0	0	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2019	25	11					1647	1647		10.1038/s41591-019-0656-3	http://dx.doi.org/10.1038/s41591-019-0656-3			1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	JT2KI	31700177	Bronze			2022-12-27	WOS:000500824300011
J	Stower, H				Stower, Hannah			Preventing invasive cervical cancer	NATURE MEDICINE			English	Editorial Material												h.stower@us.nature.com							0	0	0	3	5	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2020	26	11					1677	1677		10.1038/s41591-020-1139-2	http://dx.doi.org/10.1038/s41591-020-1139-2		NOV 2020	1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	OT0SR	33154589				2022-12-27	WOS:000587145800003
J	Ryll, B				Ryll, Bettina			From good to great: what patients can do for your medical research	NATURE MEDICINE			English	Editorial Material									[Ryll, Bettina] Melanoma Patient Network Europe, Uppsala, Sweden		Ryll, B (corresponding author), Melanoma Patient Network Europe, Uppsala, Sweden.	bettina.ryll@mpneurope.org	Ryll, Bettina/AAC-6034-2022						0	3	3	0	0	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	OCT	2020	26	10					1508	1508		10.1038/s41591-020-1097-8	http://dx.doi.org/10.1038/s41591-020-1097-8			1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	NX8MD	33029016				2022-12-27	WOS:000575957200007
J	McCradden, MD; Stephenson, EA; Anderson, JA				McCradden, Melissa D.; Stephenson, Elizabeth A.; Anderson, James A.			Clinical research underlies ethical integration of healthcare artificial intelligence	NATURE MEDICINE			English	Editorial Material								Familiar concepts from research ethics can guide the meaningful and rigorous translation of artificial intelligence (AI) tools into clinical practice.	[McCradden, Melissa D.; Anderson, James A.] Hosp Sick Children, Dept Bioeth, Toronto, ON, Canada; [Stephenson, Elizabeth A.] Univ Toronto, Dept Paediat, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto	McCradden, MD (corresponding author), Hosp Sick Children, Dept Bioeth, Toronto, ON, Canada.	melissa.mccradden@sickkids.ca	McCradden, Melissa/ABD-2332-2021	McCradden, Melissa/0000-0002-6476-2165; Stephenson, Elizabeth/0000-0001-9314-385X				Baily MA, 2006, HASTINGS CENT REP, V36, pS1, DOI 10.1353/hcr.2006.0054; Council for International Organizations of Medical Sciences, 2016, GUID 4; FREEDMAN B, 1987, NEW ENGL J MED, V317, P141, DOI 10.1056/NEJM198707163170304; Government of Canada, 2018, TRIC POL STAT 2; Keane PA, 2018, NPJ DIGIT MED, V1, DOI 10.1038/s41746-018-0048-y; Liu XX, 2020, NAT MED, V26, P1364, DOI 10.1038/s41591-020-1034-x; McCradden MD, 2021, AM J MED GENET A, V185, P658, DOI 10.1002/ajmg.a.61985; Rivera SC, 2020, NAT MED, V26, P1351, DOI 10.1038/s41591-020-1037-7; Shah NH, 2019, JAMA-J AM MED ASSOC, V322, P1351, DOI 10.1001/jama.2019.10306; Vayena E, 2018, J LAW MED ETHICS, V46, P119, DOI 10.1177/1073110518766026; Wiens J, 2019, NAT MED, V25, P1337, DOI 10.1038/s41591-019-0548-6	11	20	20	4	17	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	SEP	2020	26	9					1325	1326		10.1038/s41591-020-1035-9	http://dx.doi.org/10.1038/s41591-020-1035-9			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	PF3EM	32908273				2022-12-27	WOS:000598942000008
J	Ferrat, LA; Vehik, K; Sharp, SA; Lernmark, A; Rewers, MJ; She, JX; Ziegler, AG; Toppari, J; Akolkar, B; Krischer, JP; Weedon, MN; Oram, RA; Hagopian, WA				Ferrat, Lauric A.; Vehik, Kendra; Sharp, Seth A.; Lernmark, Ake; Rewers, Marian J.; She, Jin-Xiong; Ziegler, Anette-G; Toppari, Jorma; Akolkar, Beena; Krischer, Jeffrey P.; Weedon, Michael N.; Oram, Richard A.; Hagopian, William A.		TEDDY Study Grp	A combined risk score enhances prediction of type 1 diabetes among susceptible children	NATURE MEDICINE			English	Article							ENVIRONMENTAL DETERMINANTS; AUTOANTIBODIES; INSULIN; TEDDY; YOUNG; KETOACIDOSIS; AUTOIMMUNITY; PREVENTION	Type 1 diabetes (T1D)-an autoimmune disease that destroys the pancreatic islets, resulting in insulin deficiency-often begins early in life when islet autoantibody appearance signals high risk(1). However, clinical diabetes can follow in weeks or only after decades, and is very difficult to predict. Ketoacidosis at onset remains common(2,3)and is most severe in the very young(4,5), in whom it can be life threatening and difficult to treat(6-9). Autoantibody surveillance programs effectively prevent most ketoacidosis(10-12)but require frequent evaluations whose expense limits public health adoption(13). Prevention therapies applied before onset, when greater islet mass remains, have rarely been feasible(14)because individuals at greatest risk of impending T1D are difficult to identify. To remedy this, we sought accurate, cost-effective estimation of future T1D risk by developing a combined risk score incorporating both fixed and variable factors (genetic, clinical and immunological) in 7,798 high-risk children followed closely from birth for 9.3 years. Compared with autoantibodies alone, the combined model dramatically improves T1D prediction at >= 2 years of age over horizons up to 8 years of age (area under the receiver operating characteristic curve >= 0.9), doubles the estimated efficiency of population-based newborn screening to prevent ketoacidosis, and enables individualized risk estimates for better prevention trial selection. In a study of children with high genetic risk aged 2 years or older, a risk score integrating pancreatic islet autoantibodies, genetic factors and family history is highly predictive of type 1 diabetes in the subsequent 8 years.	[Ferrat, Lauric A.; Sharp, Seth A.; Weedon, Michael N.; Oram, Richard A.] Univ Exeter, Inst Biomed & Clin Sci, Med Sch, Exeter, Devon, England; [Vehik, Kendra; Krischer, Jeffrey P.] Univ S Florida, Hlth Informat Inst, Morsani Coll Med, Tampa, FL 33620 USA; [Lernmark, Ake] Lund Univ, Dept Clin Sci, Malmo, Sweden; [Lernmark, Ake] Skane Univ Hosp, Malmo, Sweden; [Rewers, Marian J.] Univ Colorado, Barbara Davis Ctr Childhood Diabet, Sch Med, Aurora, CO USA; [She, Jin-Xiong] Augusta Univ, Med Coll Georgia, Ctr Biotechnol & Genom Med, Augusta, GA USA; [Ziegler, Anette-G] Helmholtz Zentrum Munchen, Inst Diabet Res, Munich, Germany; [Ziegler, Anette-G] Tech Univ Munich, Klinikum Rechts Isar, Forschergrp Diabet, Munich, Germany; [Ziegler, Anette-G] Forschergrp Diabet eV, Munich, Germany; [Toppari, Jorma] Turku Univ Hosp, Dept Pediat, Turku, Finland; [Toppari, Jorma] Univ Turku, Res Ctr Integrat Physiol & Pharmacol, Inst Biomed, Turku, Finland; [Akolkar, Beena] NIDDK, NIH, Bethesda, MD 20892 USA; [Oram, Richard A.] Royal Devon & Exeter NHS Fdn Trust, Acad Renal Unit, Exeter, Devon, England; [Hagopian, William A.] Pacific Northwest Res Inst, 720 Broadway, Seattle, WA 98122 USA	University of Exeter; State University System of Florida; University of South Florida; Lund University; Lund University; Skane University Hospital; University of Colorado System; University of Colorado Anschutz Medical Campus; University System of Georgia; Augusta University; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; University of Turku; University of Turku; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); University of Exeter	Hagopian, WA (corresponding author), Pacific Northwest Res Inst, 720 Broadway, Seattle, WA 98122 USA.	wah@uw.edu	Ferrat, Lauric/GLU-1762-2022; Lernmark, Åke/F-8140-2015; Lundgren, Markus/F-5745-2018; Kero, Jukka/G-3448-2014	Lernmark, Åke/0000-0003-1735-0499; Kurppa, Kalle/0000-0003-4757-2164; Vaha-Makila, Mari/0000-0003-2216-4607; Virtanen, Suvi/0000-0001-8928-0878; Sharma, Ashok/0000-0001-9597-4374; Lundgren, Markus/0000-0001-6394-7689; Elding Larsson, Helena/0000-0003-3306-1742; Mattila, Markus/0000-0002-7829-9474; Kero, Jukka/0000-0001-8767-7222; Rich, Stephen/0000-0003-3872-7793; doddapaneni, harshavardhan/0000-0002-2433-633X	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [U01 DK63829, U01 DK63861, U01 DK63821, U01 DK63865, U01 DK63863, U01 DK63836, U01 DK63790, UC4 DK63829, UC4 DK63861, UC4 DK63821, UC4 DK63865, UC4 DK63863, UC4 DK63836, UC4 DK95300, UC4 DK100238, UC4 DK106955, UC4 DK112243, UC4 DK117483, HHSN267200700014C]; National Institute of Allergy and Infectious Diseases (NIAID); Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); National Institute of Environmental Health Sciences (NIEHS); Centers for Disease Control and Prevention (CDC); JDRF; National Institutes of Health/National Center for Advancing Translational Sciences Clinical and Translational Science [UL1 TR000064, UL1 TR001082]; Diabetes Research Center [5P30 DK017047]; Diabetes UK Harry Keen Fellowship [16/0005529]; Diabetes UK PhD studentship [17/0005757]; Wellcome Trust Institutional Strategic Support Fund [WT097835MF]; JDRF [3-SRA-2019-827-S-B]	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institute of Environmental Health Sciences (NIEHS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Centers for Disease Control and Prevention (CDC)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); JDRF(Juvenile Diabetes Research Foundation); National Institutes of Health/National Center for Advancing Translational Sciences Clinical and Translational Science; Diabetes Research Center; Diabetes UK Harry Keen Fellowship(Diabetes UK); Diabetes UK PhD studentship(Diabetes UK); Wellcome Trust Institutional Strategic Support Fund(Wellcome Trust); JDRF(Juvenile Diabetes Research Foundation)	The TEDDY study is included in ClinicalTrials.gov under the identifier NCT00279318. The TEDDY Study Group is funded by U01 DK63829, U01 DK63861, U01 DK63821, U01 DK63865, U01 DK63863, U01 DK63836, U01 DK63790, UC4 DK63829, UC4 DK63861, UC4 DK63821, UC4 DK63865, UC4 DK63863, UC4 DK63836, UC4 DK95300, UC4 DK100238, UC4 DK106955, UC4 DK112243, UC4 DK117483 and UC4 DK100238, and by contract number HHSN267200700014C from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Institute of Allergy and Infectious Diseases (NIAID), Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), National Institute of Environmental Health Sciences (NIEHS), Centers for Disease Control and Prevention (CDC) and JDRF. This work is supported in part by the National Institutes of Health/National Center for Advancing Translational Sciences Clinical and Translational Science Awards (UL1 TR000064 (University of Florida) and UL1 TR001082 (University of Colorado)) and Diabetes Research Center (5P30 DK017047; University of Washington). R.A.O. is supported by a Diabetes UK Harry Keen Fellowship (16/0005529). S.A.S. is supported by a Diabetes UK PhD studentship (17/0005757). M.N.W. is supported by the Wellcome Trust Institutional Strategic Support Fund (WT097835MF). R.A.O., L.A.F., W.A.H. and K.V. are supported by a JDRF strategic research agreement (3-SRA-2019-827-S-B). The authors thank the following former staff members at TEDDY Study Group centers: Michael Abbondondolo, Lori Ballard, David Hadley, Hye-Seung Lee, Wendy McLeod, Steven Meulemans, Henry Erlich, Steven J. Mack and Anna Lisa Fear.	Alonso GT, 2020, DIABETES CARE, V43, P117, DOI 10.2337/dc19-0428; ANDERSON JR, 1983, J CLIN ONCOL, V1, P710, DOI 10.1200/JCO.1983.1.11.710; Barker JM, 2004, DIABETES CARE, V27, P1399, DOI 10.2337/diacare.27.6.1399; Beyerlein A, 2019, J MED GENET, V56, P602, DOI 10.1136/jmedgenet-2018-105532; Beyerlein A, 2013, JAMA PEDIATR, V167, P800, DOI 10.1001/jamapediatrics.2013.158; Blanche P, 2013, STAT MED, V32, P5381, DOI 10.1002/sim.5958; Bonifacio E, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002548; Bonifacio E, 2015, JAMA-J AM MED ASSOC, V313, P1541, DOI 10.1001/jama.2015.2928; Bonifacio E, 2010, J CLIN ENDOCR METAB, V95, P3360, DOI 10.1210/jc.2010-0293; Bowersox J, 2001, PEDIATRICS, V108, P972; Cheng Bi-Wen, 2018, Oncotarget, V9, P16275, DOI 10.18632/oncotarget.24527; Cortes A, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3204; Dabelea D, 2014, PEDIATRICS, V133, pE938, DOI 10.1542/peds.2013-2795; Dafni U, 2011, CIRC-CARDIOVASC QUAL, V4, P363, DOI 10.1161/CIRCOUTCOMES.110.957951; Desai D, 2018, DIABETES CARE, V41, P1631, DOI 10.2337/dc17-1379; Edge JA, 1999, ARCH DIS CHILD, V81, P318, DOI 10.1136/adc.81.4.318; Glaser N, 2001, NEW ENGL J MED, V344, P264, DOI 10.1056/NEJM200101253440404; Green A, 1998, DIABETOLOGIA, V41, P1151; Hagopian WA, 2006, ANN NY ACAD SCI, V1079, P320, DOI 10.1196/annals.1375.049; Hagopian WA, 2011, PEDIATR DIABETES, V12, P733, DOI 10.1111/j.1399-5448.2011.00774.x; Hippich M, 2019, DIABETES, V68, P847, DOI 10.2337/db18-0882; Hippisley-Cox J, 2017, BMJ-BRIT MED J, V357, P2099, DOI DOI 10.1136/BMJ.J2099; Hyoty H, 2018, EXPERT REV VACCINES, V17, P1071, DOI 10.1080/14760584.2018.1548281; Iovane Brunella, 2018, Acta Biomed, V89, P67, DOI 10.23750/abm.v89i1.6936; Jefferies C, 2015, SCI REP-UK, V5, DOI 10.1038/srep10358; Klein J. P., 2003, SURVIVAL ANAL TECHNI; Krischer JP, 2019, DIABETES CARE, V42, P1051, DOI 10.2337/dc18-2282; Krischer JP, 2017, DIABETES CARE, V40, P1194, DOI 10.2337/dc17-0238; Krischer JP, 2015, DIABETOLOGIA, V58, P980, DOI 10.1007/s00125-015-3514-y; LaGasse JM, 2002, DIABETES CARE, V25, P505, DOI 10.2337/diacare.25.3.505; Larsson HE, 2014, PEDIATR DIABETES, V15, P118, DOI 10.1111/pedi.12066; Lonnrot M, 2015, BMC PEDIATR, V15, DOI 10.1186/s12887-015-0333-8; Meehan C, 2015, PEDIATR DIABETES, V16, P565, DOI 10.1111/pedi.12313; Noble JA, 2011, CURR DIABETES REP, V11, P533, DOI 10.1007/s11892-011-0223-x; Oram RA, 2016, DIABETES CARE, V39, P337, DOI 10.2337/dc15-1111; Redondo MJ, 2018, DIABETES CARE, V41, P1887, DOI 10.2337/dc18-0087; Redondo MJ, 2017, CURR DIABETES REP, V17, DOI 10.1007/s11892-017-0961-5; Rewers M, 2007, PEDIATR DIABETES, V8, P408, DOI 10.1111/j.1399-5448.2007.00352.x; Rewers M, 2018, CURR DIABETES REP, V18, DOI 10.1007/s11892-018-1113-2; Rewers M, 2016, LANCET, V387, P2340, DOI 10.1016/S0140-6736(16)30507-4; Rewers M, 2008, ANN NY ACAD SCI, V1150, P1, DOI 10.1196/annals.1447.062; ROSE G, 1985, INT J EPIDEMIOL, V14, P32, DOI 10.1093/ije/14.1.32; Sharp SA, 2019, DIABETES CARE, V42, P200, DOI 10.2337/dc18-1785; Sosenko JM, 2008, DIABETES CARE, V31, P2188, DOI 10.2337/dc08-0935; Usher-Smith JA, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4092; Venables WN., 2002, MODERN APPL STAT S 4; Verge CF, 1996, DIABETES, V45, P926, DOI 10.2337/diabetes.45.7.926; Winkler C, 2014, DIABETOLOGIA, V57, P2521, DOI 10.1007/s00125-014-3362-1; Winkler C, 2012, PEDIATR DIABETES, V13, P301, DOI 10.1111/j.1399-5448.2011.00829.x; Ziegler AG, 2016, MOL METAB, V5, P255, DOI 10.1016/j.molmet.2016.02.003; Ziegler AG, 2013, JAMA-J AM MED ASSOC, V309, P2473, DOI 10.1001/jama.2013.6285	51	41	41	3	9	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	AUG	2020	26	8					1247	+		10.1038/s41591-020-0930-4	http://dx.doi.org/10.1038/s41591-020-0930-4		AUG 2020	21	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	MX8ZF	32770166	Green Accepted			2022-12-27	WOS:000557134700005
J	Firth, JA; Hellewell, J; Klepac, P; Kissler, S; Kucharski, AJ; Spurgin, LG				Firth, Josh A.; Hellewell, Joel; Klepac, Petra; Kissler, Stephen; Kucharski, Adam J.; Spurgin, Lewis G.		CMMID COVID-19 Working Grp	Using a real-world network to model localized COVID-19 control strategies	NATURE MEDICINE			English	Article								Case isolation and contact tracing can contribute to the control of COVID-19 outbreaks(1,2). However, it remains unclear how real-world social networks could influence the effectiveness and efficiency of such approaches. To address this issue, we simulated control strategies for SARS-CoV-2 transmission in a real-world social network generated from high-resolution GPS data that were gathered in the course of a citizen-science experiment(3,4). We found that tracing the contacts of contacts reduced the size of simulated outbreaks more than tracing of only contacts, but this strategy also resulted in almost half of the local population being quarantined at a single point in time. Testing and releasing non-infectious individuals from quarantine led to increases in outbreak size, suggesting that contact tracing and quarantine might be most effective as a 'local lockdown' strategy when contact rates are high. Finally, we estimated that combining physical distancing with contact tracing could enable epidemic control while reducing the number of quarantined individuals. Our findings suggest that targeted tracing and quarantine strategies would be most efficient when combined with other control measures such as physical distancing. Combining fine-scale social contact data with epidemic modeling reveals interactions among contact tracing, quarantine, testing and physical distancing for controlling COVID-19.	[Firth, Josh A.] Univ Oxford, Dept Zool, Oxford, England; [Firth, Josh A.] Univ Oxford, Merton Coll, Oxford, England; [Hellewell, Joel; Klepac, Petra; Kucharski, Adam J.; CMMID COVID-19 Working Grp] London Sch Hyg & Trop Med, Ctr Math Modelling Infect Dis, Dept Infect Dis Epidemiol, London, England; [Klepac, Petra] Univ Cambridge, Dept Appl Math & Theoret Phys, Cambridge, England; [Kissler, Stephen] Harvard TH Chan Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA USA; [Spurgin, Lewis G.] Univ East Anglia, Sch Biol Sci, Norwich, Norfolk, England	University of Oxford; University of Oxford; University of London; London School of Hygiene & Tropical Medicine; University of Cambridge; Harvard University; Harvard T.H. Chan School of Public Health; University of East Anglia	Spurgin, LG (corresponding author), Univ East Anglia, Sch Biol Sci, Norwich, Norfolk, England.	l.spurgin@uea.ac.uk	Procter, Simon/AAK-9047-2020; Jarvis, Christopher/A-2969-2016	Procter, Simon/0000-0002-0380-1503; Quilty, Billy/0000-0002-9094-3728; Kissler, Stephen/0000-0001-6000-8387; Bosse, Nikos I./0000-0002-7750-5280; Endo, Akira/0000-0001-6377-7296; Abbott, Sam/0000-0001-8057-8037; Deol, Arminder/0000-0002-7154-5505; Quaife, Matthew/0000-0001-9291-1511; Villabona Arenas, Christian Julian/0000-0001-9928-3968; Simons, David/0000-0001-9655-1656; Jarvis, Christopher/0000-0002-0812-2446; Medley, Graham/0000-0002-0030-7278; Tully, Damien/0000-0002-7620-9340; Flasche, Stefan/0000-0002-5808-2606; Firth, Josh/0000-0001-7183-4115; Liu, Yang/0000-0002-9368-0425; Gilbert, Nigel/0000-0002-5937-2410; Hellewell, Joel/0000-0003-2683-0849; Jit, Mark/0000-0001-6658-8255	BBSRC [BB/S009752/1]; NERC [NE/S010335/1]; Royal Society [RP\EA\180004, 206250/Z/17/Z]; European Commission [101003688]; Sir Henry Dale Fellowship - Wellcome Trust; Merton College; BBSRC [BB/N011759/1] Funding Source: UKRI	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Royal Society(Royal Society of London); European Commission(European CommissionEuropean Commission Joint Research Centre); Sir Henry Dale Fellowship - Wellcome Trust(Wellcome Trust); Merton College; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was instigated through the Royal Society's Rapid Assistance in Modelling the Pandemic (RAMP) scheme. We thank M. Pointer for helpful discussions throughout and C. van Oosterhout and J. Gog for comments on the manuscript. We thank all those in Haslemere who took part in the BBC Pandemic study. We thank H. Fry and 360 Production, especially D. Peck and C. Kinnear, for making possible the collection of the dataset that underlies this work and A. Conlan, M. Tang and J. Gog for their contribution to the BBC study. J.A.F. was supported by a research fellowship from Merton College and BBSRC (BB/S009752/1) and acknowledges funding from NERC (NE/S010335/1). P.K. was in part funded by the Royal Society under award RP\EA\180004 and the European Commission (101003688). A.J.K. was supported by a Sir Henry Dale Fellowship jointly funded by the Wellcome Trust and the Royal Society (grant 206250/Z/17/Z).	Aleta Alberto, 2020, medRxiv, DOI 10.1101/2020.05.06.20092841; [Anonymous], 2020, BBC NEWS; CAIRNS SJ, 1987, ANIM BEHAV, V35, P1454, DOI 10.1016/S0003-3472(87)80018-0; Chen S, 2020, S CHINA MORNING POST; Chinazzi M, 2020, SCIENCE, V368, P395, DOI 10.1126/science.aba9757; Cohen Andrew N., 2020, FALSE POSITIVES REVE, DOI [DOI 10.1101/2020.04.26.20080911, 10.1101/2020.04.26.20080911]; Cohen J, 2020, SCIENCE, V367, P1287, DOI 10.1126/science.367.6484.1287; Davies NG, 2020, LANCET PUBLIC HEALTH, V5, pE375, DOI 10.1016/S2468-2667(20)30133-X; Davies NG, 2020, NAT MED, V26, P1205, DOI 10.1038/s41591-020-0962-9; Del Valle SY, 2007, SOC NETWORKS, V29, P539, DOI 10.1016/j.socnet.2007.04.005; Eames KTD, 2003, P ROY SOC B-BIOL SCI, V270, P2565, DOI 10.1098/rspb.2003.2554; Ferguson N. M., 2020, REPORT 9 IMPACT NONP, V10, DOI [10.25561/77482, DOI 10.1007/S11538-020-00726-X]; Ferretti L, 2020, SCIENCE, V368, P619, DOI 10.1126/science.abb6936; Fraser C, 2004, P NATL ACAD SCI USA, V101, P6146, DOI 10.1073/pnas.0307506101; He X, 2020, NAT MED, V26, DOI 10.1038/s41591-020-0869-5; Hellewell J, 2020, LANCET GLOB HEALTH, V8, pE488, DOI 10.1016/S2214-109X(20)30074-7; Hinch R., 2020, EFFECTIVE CONFIGURAT; Keeling MJ, 2005, J R SOC INTERFACE, V2, P295, DOI 10.1098/rsif.2005.0051; Kiss IZ, 2005, P ROY SOC B-BIOL SCI, V272, P1407, DOI 10.1098/rspb.2005.3092; Kissler S. M., 2020, SPARKING BBC 4 PANDE, DOI [10.1101/479154, DOI 10.1101/479154]; Klepac P, 2018, EPIDEMICS-NETH, V24, P49, DOI 10.1016/j.epidem.2018.03.003; Klinkenberg D, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000012; Kucharski AJ, 2020, LANCET INFECT DIS, V20, P553, DOI 10.1016/S1473-3099(20)30144-4; Ma QX, 2020, J MED VIROL, V92, P1567, DOI 10.1002/jmv.25805; Maslov S, 2002, SCIENCE, V296, P910, DOI 10.1126/science.1065103; McCall B, 2020, LANCET DIGIT HEALTH, V2, pE293, DOI 10.1016/S2589-7500(20)30103-5; Chau NVV, 2020, CLIN INFECT DIS, V71, P2679, DOI 10.1093/cid/ciaa711; Peak CM, 2017, P NATL ACAD SCI USA, V114, P4023, DOI 10.1073/pnas.1616438114; Read JM, 2008, J R SOC INTERFACE, V5, P1001, DOI 10.1098/rsif.2008.0013; Tian HY, 2020, SCIENCE, V368, P638, DOI 10.1126/science.abb6105; West R, 2020, NAT HUM BEHAV, V4, P451, DOI 10.1038/s41562-020-0887-9; Xu ZW, 2009, GEOGR ANAL, V41, P263, DOI 10.1111/j.1538-4632.2009.00754.x; Zastrow Mark, 2020, Nature, DOI 10.1038/d41586-020-00740-y	33	103	104	5	26	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	OCT	2020	26	10					1616	+		10.1038/s41591-020-1036-8	http://dx.doi.org/10.1038/s41591-020-1036-8		AUG 2020	22	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	NX8MD	32770169	Green Submitted, Green Accepted, Bronze			2022-12-27	WOS:000557134700008
J	Schultebraucks, K; Shalev, AY; Michopoulos, V; Grudzen, CR; Shin, SM; Stevens, JS; Maples-Keller, JL; Jovanovic, T; Bonanno, GA; Rothbaum, BO; Marmar, CR; Nemeroff, CB; Ressler, KJ; Galatzer-Levy, IR				Schultebraucks, Katharina; Shalev, Arieh Y.; Michopoulos, Vasiliki; Grudzen, Corita R.; Shin, Soo-Min; Stevens, Jennifer S.; Maples-Keller, Jessica L.; Jovanovic, Tanja; Bonanno, George A.; Rothbaum, Barbara O.; Marmar, Charles R.; Nemeroff, Charles B.; Ressler, Kerry J.; Galatzer-Levy, Isaac R.			A validated predictive algorithm of post-traumatic stress course following emergency department admission after a traumatic stressor	NATURE MEDICINE			English	Article							HEART-RATE; PTSD RISK; DISORDER; DEPRESSION; GUIDELINES; CHECKLIST; SYMPTOMS; MODELS	Annually, approximately 30 million patients are discharged from the emergency department (ED) after a traumatic event(1). These patients are at substantial psychiatric risk, with approximately 10-20% developing one or more disorders, including anxiety, depression or post-traumatic stress disorder (PTSD)(2-4). At present, no accurate method exists to predict the development of PTSD symptoms upon ED admission after trauma(5). Accurate risk identification at the point of treatment by ED services is necessary to inform the targeted deployment of existing treatment(6-9)to mitigate subsequent psychopathology in high-risk populations(10,11). This work reports the development and validation of an algorithm for prediction of post-traumatic stress course over 12 months using two independently collected prospective cohorts of trauma survivors from two level 1 emergency trauma centers, which uses routinely collectible data from electronic medical records, along with brief clinical assessments of the patient's immediate stress reaction. Results demonstrate externally validated accuracy to discriminate PTSD risk with high precision. While the predictive algorithm yields useful reproducible results on two independent prospective cohorts of ED patients, future research should extend the generalizability to the broad, clinically heterogeneous ED population under conditions of routine medical care. A machine-learning algorithm using electronic medical records and self-reported measures of stress at admission to the emergency department due to trauma can predict the risk and long-term trajectories of post-traumatic stress disorder in two independent cohorts.	[Schultebraucks, Katharina; Shalev, Arieh Y.; Galatzer-Levy, Isaac R.] NYU, Dept Psychiat, Grossman Sch Med, 550 1St Ave, New York, NY 10016 USA; [Schultebraucks, Katharina] Columbia Univ, Dept Emergency Med, Irving Med Ctr, Vagelos Sch Physicians & Surg, New York, NY 10027 USA; [Schultebraucks, Katharina] Columbia Univ, Data Sci Inst, New York, NY 10027 USA; [Michopoulos, Vasiliki; Stevens, Jennifer S.; Maples-Keller, Jessica L.; Rothbaum, Barbara O.; Ressler, Kerry J.] Emory Univ, Sch Med, Dept Psychiat & Behav Sci, Atlanta, GA USA; [Michopoulos, Vasiliki] Yerkes Natl Primate Res Ctr, Atlanta, GA USA; [Grudzen, Corita R.; Shin, Soo-Min] NYU, Ronald O Perelman Dept Emergency Med, Grossman Sch Med, New York, NY USA; [Jovanovic, Tanja] Wayne State Univ, Dept Psychiat & Behav Neurosci, Detroit, MI 48207 USA; [Bonanno, George A.] Columbia Univ, Teachers Coll, Dept Counseling & Clin Psychol, New York, NY 10027 USA; [Marmar, Charles R.] NYU, Grossman Sch Med, Ctr Alcohol Use Disorder & PTSD, New York, NY USA; [Nemeroff, Charles B.] Univ Texas Austin, Dept Psychiat, Dell Med Sch, Austin, TX 78712 USA; [Nemeroff, Charles B.] Univ Texas Austin, Inst Early Life Advers Res, Austin, TX 78712 USA; [Ressler, Kerry J.] Harvard Med Sch, McLean Hosp, Boston, MA 02115 USA; [Galatzer-Levy, Isaac R.] AiCure LLC, New York, NY USA	New York University; Columbia University; NewYork-Presbyterian Hospital; Columbia University; Emory University; New York University; Wayne State University; Columbia University; Columbia University Teachers College; New York University; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; Harvard University; Harvard Medical School; McLean Hospital	Schultebraucks, K (corresponding author), NYU, Dept Psychiat, Grossman Sch Med, 550 1St Ave, New York, NY 10016 USA.; Schultebraucks, K (corresponding author), Columbia Univ, Dept Emergency Med, Irving Med Ctr, Vagelos Sch Physicians & Surg, New York, NY 10027 USA.; Schultebraucks, K (corresponding author), Columbia Univ, Data Sci Inst, New York, NY 10027 USA.	ks3796@cumc.columbia.edu	Stevens, Jennifer Strafford/T-4290-2018	Stevens, Jennifer Strafford/0000-0003-4674-0314; Nemeroff, Charles/0000-0001-7867-1160; Shalev, Arieh/0000-0001-9425-050X; Galatzer-Levy, Isaac/0000-0003-1864-064X; Schultebraucks, Katharina/0000-0001-5085-8249; Grudzen, Corita/0000-0003-3039-8497	German Research Foundation [SCHU 3259/1-1, K01MH102415, R01MH094759, R01MH094757]	German Research Foundation(German Research Foundation (DFG))	K.S. was supported by the German Research Foundation (SCHU 3259/1-1). The study was also supported by K01MH102415 (I.R.G.-L.), R01MH094759 (C.B.N.) and R01MH094757 (K.J.R.).	Altman DG, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b605; American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; [Anonymous], 2013, JAMA-J AM MED ASSOC, V310, P2191, DOI [DOI 10.1001/JAMA.2013.281053, 10.1001/jama.2013.281053]; [Anonymous], 2018, POSTTRAUMATIC STRESS, DOI DOI 10.1093/MED/9780190259440.003.0019; Blevins CA, 2015, J TRAUMA STRESS, V28, P489, DOI 10.1002/jts.22059; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Collins GS, 2015, CIRCULATION, V131, P211, DOI [10.1016/j.jclinepi.2014.11.010, 10.1161/CIRCULATIONAHA.114.014508, 10.1002/bjs.9736, 10.7326/M14-0697, 10.1016/j.eururo.2014.11.025, 10.1186/s12916-014-0241-z, 10.1136/bmj.g7594, 10.1038/bjc.2014.639, 10.7326/M14-0698]; DiMaggio CJ, 2017, ACAD EMERG MED, V24, P1244, DOI 10.1111/acem.13223; Fakhry SM, 2017, AM SURGEON, V83, P1308; Falsetti SA., 1993, BEHAV THERAPIST, V16, P161, DOI DOI 10.1037/T05175-000; Fawcett T., 2004, MACH LEARN, V31, P1, DOI DOI 10.1016/J.PATREC.2005.10.010; Fein JA, 2001, ANN EMERG MED, V38, P391, DOI 10.1067/mem.2001.118225; Ferri C, 2009, PATTERN RECOGN LETT, V30, P27, DOI 10.1016/j.patrec.2008.08.010; FOA EB, 1993, J TRAUMA STRESS, V6, P459, DOI 10.1007/BF00974317; Galatzer-Levy IR, 2017, TRANSL PSYCHIAT, V7, DOI 10.1038/tp.2017.38; Galatzer-Levy IR, 2014, J PSYCHIATR RES, V59, P68, DOI 10.1016/j.jpsychires.2014.08.017; Galatzer-Levy IR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070084; Hastie T., 2009, ELEMENTS STAT LEARNI, V2nd ed.; Hinrichs Rebecca, 2019, Chronic Stress (Thousand Oaks), V3, DOI 10.1177/2470547019844441; Horwitz LI, 2019, NEW ENGL J MED, V381, P1175, DOI 10.1056/NEJMsb1900856; Karstoft KI, 2015, BMC PSYCHIATRY, V15, DOI 10.1186/s12888-015-0399-8; Kuhn M., 2013, APPL PREDICTIVE MODE, DOI 10.1007/978-1-4614-6849-3; Love J, 2014, PSYCHIAT SERV, V65, P918, DOI 10.1176/appi.ps.201300399; Lundberg SM, 2017, ADV NEUR IN, V30; Luo W, 2016, J MED INTERNET RES, V18, DOI 10.2196/jmir.5870; Marmar CR, 2004, ASSESSING PSYCHOL TR, P144; McLean SA, 2020, MOL PSYCHIATR, V25, P283, DOI 10.1038/s41380-019-0581-3; Mellon SH, 2018, BIOL PSYCHIAT, V83, P866, DOI 10.1016/j.biopsych.2018.02.007; Michopoulos V, 2019, AM J PSYCHIAT, V2019, P19010039; Michopoulos V, 2017, NEUROPSYCHOPHARMACOL, V42, P254, DOI 10.1038/npp.2016.146; MOONS KGM, 2009, BMJ-BRIT MED J, V338, DOI DOI 10.1136/BMJ.B375; Morris MC, 2016, CLIN PSYCHOL REV, V49, P79, DOI 10.1016/j.cpr.2016.09.001; Muthen L. K., 2017, MPLUS USERS GUIDE, DOI DOI 10.1111/J.1600-0447.2011.01711.X; Nugent NR, 2006, J CHILD PSYCHOL PSYC, V47, P919, DOI 10.1111/j.1469-7610.2006.01648.x; Papini S, 2018, J ANXIETY DISORD, V60, P35, DOI 10.1016/j.janxdis.2018.10.004; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Ressler KJ, 2018, BIOL PSYCHIAT, V83, P792, DOI 10.1016/j.biopsych.2018.03.007; Roberts NP, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007944.pub2; Rothbaum BO, 2014, J CLIN PSYCHIAT, V75, P1380, DOI 10.4088/JCP.13m08715; Ruglass Lesia M, 2014, J Trauma Stress Disord Treat, V4, DOI 10.4172/2324-8947.1000139; Schultebraucks K, 2020, CURR EMERG HOSP ME R, V8, P1, DOI 10.1007/s40138-020-00206-5; Schultebraucks K, 2019, J ABNORM PSYCHOL, V128, P645, DOI 10.1037/abn0000440; Schultebraucks K, 2019, J TRAUMA STRESS, V32, P215, DOI 10.1002/jts.22384; Shalev A, 2017, NEW ENGL J MED, V376, P2459, DOI 10.1056/NEJMra1612499; Shalev AY, 2019, PSYCHIAT ANN, V49, P299, DOI 10.3928/00485713-20190605-01; Shalev AY, 2019, WORLD PSYCHIATRY, V18, P77, DOI 10.1002/wps.20608; Shalev AY, 2016, J CLIN PSYCHIAT, V77, pE580, DOI 10.4088/JCP.15m09932; Shalev AY, 2012, ARCH GEN PSYCHIAT, V69, P166, DOI 10.1001/archgenpsychiatry.2011.127; Shalev AY, 1998, ARCH GEN PSYCHIAT, V55, P553, DOI 10.1001/archpsyc.55.6.553; Strumbelj E, 2014, KNOWL INF SYST, V41, P647, DOI 10.1007/s10115-013-0679-x; Sullivan E, 2017, GEN HOSP PSYCHIAT, V46, P49, DOI 10.1016/j.genhosppsych.2017.03.004; van de Schoot R, 2017, STRUCT EQU MODELING, V24, P451, DOI 10.1080/10705511.2016.1247646; van Zuiden M, 2012, BIOL PSYCHIAT, V71, P309, DOI 10.1016/j.biopsych.2011.10.026; Vermetten E, 2014, CURR PSYCHIAT REP, V16, DOI 10.1007/s11920-014-0455-y; Weathers F.W., 2013, PTSD CHECKLIST DSM 5, DOI DOI 10.1037/T02622-000; Weathers FW, 2017, CURR OPIN PSYCHOL, V14, P122, DOI 10.1016/j.copsyc.2017.01.002; Wiseman TA, 2015, SCAND J TRAUMA RESUS, V23, DOI 10.1186/s13049-015-0109-z; Yehuda R, 1998, BIOL PSYCHIAT, V44, P1305, DOI 10.1016/S0006-3223(98)00276-5; Young G, 2018, SCREEN CLASSIC, P84; Zhou ZH, 2019, NATL SCI REV, V6, P74, DOI 10.1093/nsr/nwy108	60	42	44	0	11	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	JUL	2020	26	7					1084	+		10.1038/s41591-020-0951-z	http://dx.doi.org/10.1038/s41591-020-0951-z		JUL 2020	12	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	MK3XO	32632194				2022-12-27	WOS:000545954500005
J	Vermetten, E; McFarlane, AC				Vermetten, Eric; McFarlane, Alexander C.			Predicting future risk of PTSD	NATURE MEDICINE			English	Editorial Material								Data routinely collected in the emergency department after trauma have the potential to predict those at risk of later PTSD, which shows promise for computational psychiatry.	[Vermetten, Eric] Univ Med Ctr Leiden, Dept Psychiat, Leiden, Netherlands; [Vermetten, Eric] ARQ Natl Psychotrauma Ctr, Diemen, Netherlands; [McFarlane, Alexander C.] Univ Adelaide, Dept Psychiat, Adelaide, SA, Australia	Leiden University; Leiden University Medical Center (LUMC); University of Adelaide	Vermetten, E (corresponding author), Univ Med Ctr Leiden, Dept Psychiat, Leiden, Netherlands.; Vermetten, E (corresponding author), ARQ Natl Psychotrauma Ctr, Diemen, Netherlands.	e.vermetten@lumc.nl	Vermetten, Eric/B-1335-2008	Vermetten, Eric/0000-0003-0579-4404				Bryant RA, 2015, BRIT J PSYCHIAT, V206, P417, DOI 10.1192/bjp.bp.114.145516; Bryant RA, 2010, AM J PSYCHIAT, V167, P312, DOI 10.1176/appi.ajp.2009.09050617; Classen C, 1998, AM J PSYCHIAT, V155, P620, DOI 10.1176/ajp.155.5.620; Eekhout I, 2016, LANCET PSYCHIAT, V3, P58, DOI 10.1016/S2215-0366(15)00368-5; Iyadurai L, 2018, MOL PSYCHIATR, V23, P674, DOI 10.1038/mp.2017.23; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Manchia M, 2020, PHARMACOGEN PERS MED, V13, P127, DOI 10.2147/PGPM.S198225; McFarlane AC, 2017, CURR PSYCHIAT REP, V19, DOI 10.1007/s11920-017-0761-2; Schultebraucks K, 2020, NAT MED, V26, P1084, DOI 10.1038/s41591-020-0951-z; Searle AK, 2015, INT J METH PSYCH RES, V24, P32, DOI 10.1002/mpr.1460; Spinazze P, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2019-032255; Vermetten E, 2015, PSYCHONEUROENDOCRINO, V51, P441, DOI 10.1016/j.psyneuen.2014.11.017; Vermetten E, 2014, CURR PSYCHIAT REP, V16, DOI 10.1007/s11920-014-0455-y	13	2	2	0	0	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	JUL	2020	26	7					1012	1013		10.1038/s41591-020-0981-6	http://dx.doi.org/10.1038/s41591-020-0981-6		JUL 2020	2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	MK3XO	32632192				2022-12-27	WOS:000545954500004
J	Stower, H				Stower, Hannah			A therapy for beta-thalassemia	NATURE MEDICINE			English	Editorial Material																			0	0	0	0	0	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	MAY	2020	26	5					649	649		10.1038/s41591-020-0906-4	http://dx.doi.org/10.1038/s41591-020-0906-4			1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	ML1JP	32405069	Bronze			2022-12-27	WOS:000549231500012
J	Krystal, AD; Pizzagalli, DA; Smoski, M; Mathew, SJ; Nurnberger, J; Lisanby, SH; Iosifescu, D; Murrough, JW; Yang, HQ; Weiner, RD; Calabrese, JR; Sanacora, G; Hermes, G; Keefe, RSE; Song, AL; Goodman, W; Szabo, ST; Whitton, AE; Gao, KM; Potter, WZ				Krystal, Andrew D.; Pizzagalli, Diego A.; Smoski, Moria; Mathew, Sanjay J.; Nurnberger, John, Jr.; Lisanby, Sarah H.; Iosifescu, Dan; Murrough, James W.; Yang, Hongqiu; Weiner, Richard D.; Calabrese, Joseph R.; Sanacora, Gerard; Hermes, Gretchen; Keefe, Richard S. E.; Song, Allen; Goodman, Wayne; Szabo, Steven T.; Whitton, Alexis E.; Gao, Keming; Potter, William Z.			A randomized proof-of-mechanism trial applying the 'fast-fail' approach to evaluating kappa-opioid antagonism as a treatment for anhedonia	NATURE MEDICINE			English	Article							HAMILTON PLEASURE SCALE; NUCLEUS-ACCUMBENS; REWARD ANTICIPATION; ADULT OUTPATIENTS; MAJOR DEPRESSION; VENTRAL STRIATUM; RECEPTOR-AGONIST; DRUG DEVELOPMENT; ACTIVATION; DOPAMINE	A phase 2 proof-of-mechanism trial shows that a kappa-opioid receptor antagonist improves reward-related functioning in the brain and a clinical measure of anhedonia in patients with mood and anxiety disorders, serving as a model for implementing the 'fast-fail' approach to psychiatric treatment development. The National Institute of Mental Health (NIMH) 'fast-fail' approach seeks to improve too-often-misleading early-phase drug development methods by incorporating biomarker-based proof-of-mechanism (POM) testing in phase 2a. This first comprehensive application of the fast-fail approach evaluated the potential of kappa-opioid receptor (KOR) antagonism for treating anhedonia with a POM study determining whether robust target engagement favorably impacts the brain circuitry hypothesized to mediate clinical effects. Here we report the results from a multicenter, 8-week, double-blind, placebo-controlled, randomized trial in patients with anhedonia and a mood or anxiety disorder (selective KOR antagonist (JNJ-67953964, 10 mg; n = 45) and placebo (n = 44)). JNJ-67953964 significantly increased functional magnetic resonance imaging (fMRI) ventral striatum activation during reward anticipation (primary outcome) as compared to placebo (baseline-adjusted mean: JNJ-67953964, 0.72 (s.d. = 0.67); placebo, 0.33 (s.d. = 0.68); F(1,86) = 5.58, P < 0.01; effect size = 0.58 (95% confidence interval, 0.13-0.99)). JNJ-67953964, generally well tolerated, was not associated with any serious adverse events. This study supports proceeding with assessment of the clinical impact of target engagement and serves as a model for implementing the 'fast-fail' approach.	[Krystal, Andrew D.] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94115 USA; [Krystal, Andrew D.; Smoski, Moria; Weiner, Richard D.; Keefe, Richard S. E.; Song, Allen; Szabo, Steven T.] Duke Univ, Dept Psychiat, Durham, NC 27706 USA; [Krystal, Andrew D.; Smoski, Moria; Weiner, Richard D.; Keefe, Richard S. E.; Song, Allen; Szabo, Steven T.] Duke Univ, Dept Behav Sci, Durham, NC 27708 USA; [Krystal, Andrew D.; Smoski, Moria; Weiner, Richard D.; Keefe, Richard S. E.; Song, Allen; Szabo, Steven T.] Duke Univ, Dept Radiol, Durham, NC 27710 USA; [Pizzagalli, Diego A.; Whitton, Alexis E.] Harvard Med Sch, McLean Hosp, Belmont, MA USA; [Mathew, Sanjay J.; Goodman, Wayne] Baylor Coll Med, Dept Psychiat & Behav Sci, Houston, TX 77030 USA; [Mathew, Sanjay J.] Michael E Debakey VA Med Ctr, Houston, TX USA; [Nurnberger, John, Jr.] Indiana Univ, Sch Med, Dept Psychiat, Indianapolis, IN 46202 USA; [Nurnberger, John, Jr.] Indiana Univ, Sch Med, Dept Neurobiol, Indianapolis, IN USA; [Lisanby, Sarah H.; Potter, William Z.] NIMH, Bethesda, MD 20892 USA; [Iosifescu, Dan] NYU, Sch Med, Dept Psychiat, New York, NY USA; [Murrough, James W.] Icahn Sch Med Mt Sinai, Dept Psychiat & Neurosci, New York, NY 10029 USA; [Yang, Hongqiu] Duke Clin Res Inst, Durham, NC USA; [Calabrese, Joseph R.; Gao, Keming] Case Western Reserve Sch Med, Dept Psychiat, Cleveland, OH USA; [Sanacora, Gerard; Hermes, Gretchen] Yale Univ, Sch Med, Dept Psychiat, New Haven, CT USA; [Szabo, Steven T.] Durham VA Hlth Care Syst, Durham, NC USA; [Whitton, Alexis E.] Univ Sydney, Sydney, NSW, Australia	University of California System; University of California San Francisco; Duke University; Duke University; Duke University; Harvard University; McLean Hospital; Baylor College of Medicine; Baylor College of Medicine; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); New York University; Icahn School of Medicine at Mount Sinai; Duke University; Case Western Reserve University; Yale University; University of Sydney	Krystal, AD (corresponding author), Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94115 USA.; Krystal, AD (corresponding author), Duke Univ, Dept Psychiat, Durham, NC 27706 USA.; Krystal, AD (corresponding author), Duke Univ, Dept Behav Sci, Durham, NC 27708 USA.; Krystal, AD (corresponding author), Duke Univ, Dept Radiol, Durham, NC 27710 USA.	andrew.krystal@ucsf.edu	Mathew, Sanjay J/J-2830-2014; Iosifescu, Dan Vlad/L-3305-2019; Lisanby, Sarah Hollingsworth/ABE-9003-2020; Lisanby, Sarah Hollingsworth/T-3918-2019	Mathew, Sanjay J/0000-0002-2715-6641; Iosifescu, Dan Vlad/0000-0002-2512-2835; Lisanby, Sarah Hollingsworth/0000-0003-2037-6470; Lisanby, Sarah Hollingsworth/0000-0003-2037-6470; Pizzagalli, Diego/0000-0002-7772-1143	National Institute of Mental Health [HHS-N271-2012-000006-I];  [R37 MH068376]	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); 	This project was supported by contract HHS-N271-2012-000006-I from the National Institute of Mental Health awarded to A.D.K. D.A.P. was partially supported by R37 MH068376. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health or the US government.	American Psychiatric Association, 2009, DIAGN STAT MAN MENT; Andersson J.L.R., 2007, TR07JA2 FMRIB; Azur MJ, 2011, INT J METH PSYCH RES, V20, P40, DOI 10.1002/mpr.329; Borsook D, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2013.43; Brady LS, 2012, NEUROPSYCHOPHARMACOL, V37, P281, DOI 10.1038/npp.2011.106; Bruijnzeel AW, 2009, BRAIN RES REV, V62, P127, DOI 10.1016/j.brainresrev.2009.09.008; Carlezon WA, 2006, J PHARMACOL EXP THER, V316, P440, DOI 10.1124/jpet.105.092304; Carlezon WA, 2016, DEPRESS ANXIETY, V33, P895, DOI 10.1002/da.22500; Carlezon WA, 2009, PHARMACOL THERAPEUT, V123, P334, DOI 10.1016/j.pharmthera.2009.05.008; Carlson JM, 2011, NEUROIMAGE, V57, P1608, DOI 10.1016/j.neuroimage.2011.05.037; Carter RM, 2009, FRONT BEHAV NEUROSCI, V3, DOI 10.3389/neuro.08.021.2009; Chartoff E, 2012, NEUROPHARMACOLOGY, V62, P167, DOI 10.1016/j.neuropharm.2011.06.014; Cohen J.E., 1988, STAT POWER ANAL BEHA; Denys Damiaan, 2005, Curr Psychiatry Rep, V7, P252, DOI 10.1007/s11920-005-0078-4; Di Giannantonio M, 2012, EUR NEUROPSYCHOPHARM, V22, pS505, DOI 10.1016/j.euroneuro.2012.07.004; Dillon DG, 2008, PSYCHOPHYSIOLOGY, V45, P36, DOI 10.1111/j.1469-8986.2007.00594.x; Ebner SR, 2010, PSYCHOPHARMACOLOGY, V210, P241, DOI 10.1007/s00213-010-1836-5; Fava M, 2009, PSYCHOTHER PSYCHOSOM, V78, P91, DOI 10.1159/000201934; Fletcher K, 2015, J AFFECT DISORDERS, V184, P81, DOI 10.1016/j.jad.2015.05.028; Franken IHA, 2007, J AFFECT DISORDERS, V99, P83, DOI 10.1016/j.jad.2006.08.020; Friedman L, 2006, J MAGN RESON IMAGING, V23, P827, DOI 10.1002/jmri.20583; Gard DE, 2006, J RES PERS, V40, P1086, DOI 10.1016/j.jrp.2005.11.001; Green IW, 2019, NEUROIMAGE, V193, P115, DOI 10.1016/j.neuroimage.2019.02.063; Hamilton M., 1967, BRIT J SOC CLIN PSYC, V6, P278, DOI [10.1111/j.2044-8260.1967.tb00530.x, DOI 10.1111/J.2044-8260.1967.TB00530.X]; Helt M, 2008, NEUROPSYCHOL REV, V18, P339, DOI 10.1007/s11065-008-9075-9; Insel T, 2010, AM J PSYCHIAT, V167, P748, DOI 10.1176/appi.ajp.2010.09091379; Insel TR, 2009, PSYCHIAT SERV, V60, P1466, DOI 10.1176/appi.ps.60.11.1466; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Jensen J, 2003, NEURON, V40, P1251, DOI 10.1016/S0896-6273(03)00724-4; Kaiser RH, 2018, CEREB CORTEX, V28, P4281, DOI 10.1093/cercor/bhx281; Keedwell PA, 2005, BIOL PSYCHIAT, V58, P843, DOI 10.1016/j.biopsych.2005.05.019; Keller J, 2013, J PSYCHIATR RES, V47, P1319, DOI 10.1016/j.jpsychires.2013.05.015; Kesselheim AS, 2015, NAT REV DRUG DISCOV, V14, P815, DOI 10.1038/nrd4793; Knutson B, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-16-j0002.2001; Knutson B, 2001, NEUROREPORT, V12, P3683, DOI 10.1097/00001756-200112040-00016; Knutson B, 2000, NEUROIMAGE, V12, P20, DOI 10.1006/nimg.2000.0593; Knutson B, 2008, NEUROREPORT, V19, P509, DOI 10.1097/WNR.0b013e3282f85c01; Knutson B, 2008, BIOL PSYCHIAT, V63, P686, DOI 10.1016/j.biopsych.2007.07.023; Knutson B, 2007, PSYCHOPHARMACOLOGY, V191, P813, DOI 10.1007/s00213-006-0686-7; Kraemer HC, 2004, INT J METH PSYCH RES, V13, P141, DOI 10.1002/mpr.170; Krystal AD, 2019, NAT REV DRUG DISCOV, V18, DOI 10.1038/nrd.2018.222; Li Z, 2018, NEUROPSYCHOLOGY, V32, P764, DOI 10.1037/neu0000425; Liu WH, 2011, PROG NEURO-PSYCHOPH, V35, P1045, DOI 10.1016/j.pnpbp.2011.02.018; Lowe SL, 2014, J CLIN PHARMACOL, V54, P968, DOI 10.1002/jcph.286; MAIER W, 1988, J AFFECT DISORDERS, V14, P61, DOI 10.1016/0165-0327(88)90072-9; MAISONNEUVE IM, 1994, NEUROSCI LETT, V181, P57, DOI 10.1016/0304-3940(94)90559-2; Martinotti G, 2011, PROG NEURO-PSYCHOPH, V35, P953, DOI 10.1016/j.pnpbp.2011.01.013; Morris BH, 2015, DEPRESS ANXIETY, V32, P373, DOI 10.1002/da.22358; Muschamp JW, 2011, J NEUROSCI, V31, P3095, DOI 10.1523/JNEUROSCI.5973-10.2011; Nakonezny PA, 2015, J PSYCHIATR RES, V65, P124, DOI 10.1016/j.jpsychires.2015.03.010; Nakonezny PA, 2010, INT CLIN PSYCHOPHARM, V25, P328, DOI 10.1097/YIC.0b013e32833eb5ee; National Advisory Mental Health Council (NAMHC, 2010, DISC CUR ACC DEV NEW; Oldham S, 2018, HUM BRAIN MAPP, V39, P3398, DOI 10.1002/hbm.24184; Paul SM, 2010, NAT REV DRUG DISCOV, V9, P203, DOI 10.1038/nrd3078; Pizzagalli DA, 2005, BIOL PSYCHIAT, V57, P319, DOI 10.1016/j.biopsych.2004.11.026; Pizzagalli DA, 2008, PSYCHOPHARMACOLOGY, V196, P221, DOI 10.1007/s00213-007-0957-y; Pizzagalli DA, 2008, J PSYCHIATR RES, V43, P76, DOI 10.1016/j.jpsychires.2008.03.001; POSNER K, 2011, COLUMBIA SUICIDE SEV; Rorick-Kehn LM, 2014, NEUROPHARMACOLOGY, V77, P131, DOI 10.1016/j.neuropharm.2013.09.021; Rush AJ, 2006, AM J PSYCHIAT, V163, P1905, DOI 10.1176/appi.ajp.163.11.1905; Santesso DL, 2008, NEUROIMAGE, V42, P807, DOI 10.1016/j.neuroimage.2008.05.032; Schott BH, 2008, J NEUROSCI, V28, P14311, DOI 10.1523/JNEUROSCI.2058-08.2008; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P34, DOI 10.4088/JCP.09m05305whi; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; SNAITH RP, 1995, BRIT J PSYCHIAT, V167, P99, DOI 10.1192/bjp.167.1.99; Stoy M, 2012, J PSYCHOPHARMACOL, V26, P677, DOI 10.1177/0269881111416686; Tomasiewicz HC, 2008, BIOL PSYCHIAT, V64, P982, DOI 10.1016/j.biopsych.2008.05.029; TREADWAY M, 2009, PLOS ONE, V4; Vrieze E, 2013, BIOL PSYCHIAT, V73, P639, DOI 10.1016/j.biopsych.2012.10.014; Wacker J, 2009, NEUROIMAGE, V46, P327, DOI 10.1016/j.neuroimage.2009.01.058; Webb CA, 2016, NEUROPSYCHOPHARMACOL, V41, P454, DOI 10.1038/npp.2015.165; Wee S, 2010, PSYCHOPHARMACOLOGY, V210, P121, DOI 10.1007/s00213-010-1825-8; Whitton AE, 2015, CURR OPIN PSYCHIATR, V28, P7, DOI 10.1097/YCO.0000000000000122; Wiedemann K, 2011, Dialogues Clin Neurosci, V13, P225; Wilson RP, 2018, NEUROPSYCHOL REV, V28, P496, DOI 10.1007/s11065-018-9385-5; Woolrich Mark W, 2009, Neuroimage, V45, pS173, DOI 10.1016/j.neuroimage.2008.10.055; Woolrich MW, 2004, NEUROIMAGE, V21, P1732, DOI 10.1016/j.neuroimage.2003.12.023; Woolrich MW, 2001, NEUROIMAGE, V14, P1370, DOI 10.1006/nimg.2001.0931; Zheng MQ, 2013, J NUCL MED, V54, P455, DOI 10.2967/jnumed.112.109512	80	61	61	0	22	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	MAY	2020	26	5					760	+		10.1038/s41591-020-0806-7	http://dx.doi.org/10.1038/s41591-020-0806-7		MAR 2020	15	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	ML1MY	32231295				2022-12-27	WOS:000522380200002
J	Morse, KE; Bagely, SC; Shah, NH				Morse, Keith E.; Bagely, Steven C.; Shah, Nigam H.			Estimate the hidden deployment cost of predictive models to improve patient care	NATURE MEDICINE			English	Editorial Material							HEALTH; PERFORMANCE	Although examples of algorithms designed to improve healthcare delivery abound, for many, clinical integration will not be achieved. The deployment cost of machine learning models is an underappreciated barrier to success. Experts propose three criteria that, assessed early, could help estimate the deployment cost.	[Morse, Keith E.] Stanford Univ, Dept Pediat, Sch Med, Stanford, CA 94305 USA; [Morse, Keith E.] Lucile Packard Childrens Hosp, Dept Clin Informat, Palo Alto, CA 94304 USA; [Bagely, Steven C.; Shah, Nigam H.] Stanford Univ, Ctr Biomed Informat Res, Stanford, CA 94305 USA	Stanford University; Lucile Packard Children's Hospital (LPCH); Stanford University	Morse, KE (corresponding author), Stanford Univ, Dept Pediat, Sch Med, Stanford, CA 94305 USA.; Morse, KE (corresponding author), Lucile Packard Childrens Hosp, Dept Clin Informat, Palo Alto, CA 94304 USA.	kmorse@stanfordchildrens.org		Morse, Keith/0000-0002-8307-1642; Bagley, Steven/0000-0003-2187-7955				Amarasingham R, 2014, HEALTH AFFAIR, V33, P1148, DOI 10.1377/hlthaff.2014.0352; Cresswell K, 2013, INT J MED INFORM, V82, pE73, DOI 10.1016/j.ijmedinf.2012.10.007; Dummett BA, 2016, J HOSP MED, V11, pS25, DOI 10.1002/jhm.2661; Escobar GJ, 2016, J HOSP MED, V11, pS18, DOI 10.1002/jhm.2652; Esteva A, 2019, NAT MED, V25, P24, DOI 10.1038/s41591-018-0316-z; Halabi S. S., VALIDATION ARTIFICIA; Larson DB, 2018, RADIOLOGY, V287, P313, DOI 10.1148/radiol.2017170236; Shah NH, 2019, JAMA-J AM MED ASSOC, V322, P1351, DOI 10.1001/jama.2019.10306; Topol EJ, 2019, NAT MED, V25, P44, DOI 10.1038/s41591-018-0300-7; Wiens J, 2019, NAT MED, V25, P1337, DOI 10.1038/s41591-019-0548-6; Yu KH, 2018, NAT BIOMED ENG, V2, P719, DOI 10.1038/s41551-018-0305-z	11	12	12	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JAN	2020	26	1					18	19		10.1038/s41591-019-0651-8	http://dx.doi.org/10.1038/s41591-019-0651-8			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	KG3GZ	31932778				2022-12-27	WOS:000509831900012
J	Stower, H				Stower, Hannah			Activating cytokines in the brain	NATURE MEDICINE			English	Editorial Material																			0	0	0	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	OCT	2019	25	10					1469	1469		10.1038/s41591-019-0614-0	http://dx.doi.org/10.1038/s41591-019-0614-0			1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	JC3GJ	31591583	Bronze			2022-12-27	WOS:000489166700007
J	Lazarus, JV; Ratzan, SC; Palayew, A; Gostin, LO; Larson, HJ; Rabin, K; Kimball, S; El-Mohandes, A				Lazarus, Jeffrey V.; Ratzan, Scott C.; Palayew, Adam; Gostin, Lawrence O.; Larson, Heidi J.; Rabin, Kenneth; Kimball, Spencer; El-Mohandes, Ayman			A global survey of potential acceptance of a COVID-19 vaccine	NATURE MEDICINE			English	Article							TRUST; COMMUNICATION; HESITANCY	Survey data from across 19 countries reveal heterogeneity in attitudes toward acceptance of a COVID-19 vaccine and suggest that trust in government is associated with vaccine confidence. Several coronavirus disease 2019 (COVID-19) vaccines are currently in human trials. In June 2020, we surveyed 13,426 people in 19 countries to determine potential acceptance rates and factors influencing acceptance of a COVID-19 vaccine. Of these, 71.5% of participants reported that they would be very or somewhat likely to take a COVID-19 vaccine, and 61.4% reported that they would accept their employer's recommendation to do so. Differences in acceptance rates ranged from almost 90% (in China) to less than 55% (in Russia). Respondents reporting higher levels of trust in information from government sources were more likely to accept a vaccine and take their employer's advice to do so.	[Lazarus, Jeffrey V.; Palayew, Adam] Univ Barcelona, Barcelona Inst Global Hlth ISGlobal, Hosp Clin, Barcelona, Spain; [Ratzan, Scott C.; Rabin, Kenneth; El-Mohandes, Ayman] CUNY, Grad Sch Publ Hlth & Hlth Policy, New York, NY 10021 USA; [Gostin, Lawrence O.] Georgetown Univ, Washington, DC USA; [Larson, Heidi J.] London Sch Hyg & Trop Med, London, England; [Kimball, Spencer] Emerson Coll, Boston, MA 02116 USA	ISGlobal; University of Barcelona; Hospital Clinic de Barcelona; City University of New York (CUNY) System; Georgetown University; University of London; London School of Hygiene & Tropical Medicine	Lazarus, JV (corresponding author), Univ Barcelona, Barcelona Inst Global Hlth ISGlobal, Hosp Clin, Barcelona, Spain.	jeffrey.lazarus@isglobal.org	Lazarus, Jeffrey V./R-6248-2018; Larson, Heidi J./N-1018-2017	Lazarus, Jeffrey V./0000-0001-9618-2299; Larson, Heidi J./0000-0002-8477-7583; Palayew, Adam/0000-0002-1904-5730	City University of New York Graduate School of Public Health and Health Policy Foundation; United States Council for International Business Foundation; Spanish Ministry of Science, Innovation and Universities through the 'Centro de Excelencia Severo Ochoa 2019-2023' Programme [CEX2018-000806-S]; Government of Catalonia through the CERCA Programme; Bocconi University	City University of New York Graduate School of Public Health and Health Policy Foundation; United States Council for International Business Foundation; Spanish Ministry of Science, Innovation and Universities through the 'Centro de Excelencia Severo Ochoa 2019-2023' Programme(Spanish Government); Government of Catalonia through the CERCA Programme; Bocconi University	Funding was provided by the City University of New York Graduate School of Public Health and Health Policy Foundation, Bocconi University, J. Fielding, the United States Council for International Business Foundation and K. Rabin. Consensus Strategies was the funding recipient. J.V.L. acknowledges support to ISGlobal from the Spanish Ministry of Science, Innovation and Universities through the 'Centro de Excelencia Severo Ochoa 2019-2023' Programme (CEX2018-000806-S) and from the Government of Catalonia through the CERCA Programme.	Biasio LR, 2017, HUM VACC IMMUNOTHER, V13, P701, DOI 10.1080/21645515.2016.1243633; Burki TK, 2020, LANCET RESP MED, V8, pE85, DOI 10.1016/S2213-2600(20)30402-1; Cornwall W, 2020, SCIENCE, V369, P14, DOI 10.1126/science.369.6499.14; Enserink M, 2020, SCIENCE; European Centre for Disease Prevention and Control, 2017, CAT INT ADDR VACC HE; Fadda M, 2020, INT J PUBLIC HEALTH, V65, P711, DOI 10.1007/s00038-020-01404-4; Hovland CI, 1951, PUBLIC OPIN QUART, V15, P635, DOI 10.1086/266350; Johns Hopkins Coronavirus Resource Center CSSE, 2020, COVID 19 DASHB; Karafillakis E, 2017, VACCINE, V35, P4840, DOI 10.1016/j.vaccine.2017.07.061; Lane S, 2018, VACCINE, V36, P3861, DOI 10.1016/j.vaccine.2018.03.063; Larson HJ, 2018, HUM VACC IMMUNOTHER, V14, P1599, DOI 10.1080/21645515.2018.1459252; Larson HJ, 2014, VACCINE, V32, P2150, DOI 10.1016/j.vaccine.2014.01.081; Lazarus JV, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0240011; Lugo NR, 2007, AM J INFECT CONTROL, V35, P1, DOI 10.1016/j.ajic.2006.10.004; MacDonald NE, 2015, VACCINE, V33, P4161, DOI 10.1016/j.vaccine.2015.04.036; MAHASE E, 2020, BMJ-BRIT MED J, V370, DOI DOI 10.1136/bmj.m3525; Munoz DC, 2015, INT J PUBLIC HEALTH, V60, P767, DOI 10.1007/s00038-015-0715-6; Quinn SC, 2013, BIOSECUR BIOTERROR, V11, P96, DOI 10.1089/bsp.2012.0048; Shore DA, 2003, J HEALTH COMMUN, V8, P13, DOI 10.1080/10810730390224839; Siegrist M, 2014, EUR PSYCHOL, V19, P23, DOI 10.1027/1016-9040/a000169; Thomson A, 2018, VACCINE, V36, P6457, DOI 10.1016/j.vaccine.2018.08.031	21	1180	1199	31	166	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	FEB	2021	27	2					225	+		10.1038/s41591-020-1124-9	http://dx.doi.org/10.1038/s41591-020-1124-9		OCT 2020	9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	QH6OB	33082575	Green Published, Bronze			2022-12-27	WOS:000580473100001
J	Majumder, PP; Mhlanga, MM; Shalek, AK				Majumder, Partha P.; Mhlanga, Musa M.; Shalek, Alex K.			The Human Cell Atlas and equity: lessons learned	NATURE MEDICINE			English	Editorial Material									[Majumder, Partha P.] Indian Stat Inst, Kolkata, India; [Majumder, Partha P.] Natl Inst Biomed Genom, Kalyani, W Bengal, India; [Mhlanga, Musa M.] Radboud Univ Nijmegen, Radboud Inst Mol Life Sci, Med Ctr, Nijmegen, Netherlands; [Mhlanga, Musa M.] Radboud Univ Nijmegen, Dept Cell Biol, Epigen & Single Cell Biophys Grp, Nijmegen, Netherlands; [Mhlanga, Musa M.] Radboud Univ Nijmegen, Dept Human Genet, Med Ctr, Nijmegen, Netherlands; [Shalek, Alex K.] MIT, Dept Chem, Inst Med Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Shalek, Alex K.] MIT, Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Shalek, Alex K.] Ragon Inst MGH MIT & Harvard, Cambridge, MA 02142 USA; [Shalek, Alex K.] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA	Indian Statistical Institute; Indian Statistical Institute Kolkata; Department of Biotechnology (DBT) India; National Institute of Biomedical Genomics (NIBMG); Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Harvard Medical School; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Majumder, PP (corresponding author), Indian Stat Inst, Kolkata, India.; Majumder, PP (corresponding author), Natl Inst Biomed Genom, Kalyani, W Bengal, India.; Mhlanga, MM (corresponding author), Radboud Univ Nijmegen, Radboud Inst Mol Life Sci, Med Ctr, Nijmegen, Netherlands.; Mhlanga, MM (corresponding author), Radboud Univ Nijmegen, Dept Cell Biol, Epigen & Single Cell Biophys Grp, Nijmegen, Netherlands.; Mhlanga, MM (corresponding author), Radboud Univ Nijmegen, Dept Human Genet, Med Ctr, Nijmegen, Netherlands.; Shalek, AK (corresponding author), MIT, Dept Chem, Inst Med Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Shalek, AK (corresponding author), MIT, Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Shalek, AK (corresponding author), Ragon Inst MGH MIT & Harvard, Cambridge, MA 02142 USA.; Shalek, AK (corresponding author), Broad Inst MIT & Harvard, Cambridge, MA 02142 USA.	ppm1@nibmg.ac.in; musahca@mhlangalab.org; shalek@mit.edu	Mhlanga, Musa/D-1283-2011	Mhlanga, Musa/0000-0003-1381-3409; Shalek, Alex K./0000-0001-5670-8778	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome Trust)		Bumpus N, 2020, NATURE, V583, P661, DOI 10.1038/d41586-020-02203-w; Cell Editorial Team, 2020, CELL EDITORIAL TEAM, V181, P1443; Eisen MB, 2020, ELIFE, V9, DOI 10.7554/eLife.59636; Kendi I.X., 2019, BE ANTIRACIST; Regev A, 2017, ELIFE, V6, DOI 10.7554/eLife.27041; Wilkerson I., 2020, CASTE ORIGINS OUR DI	6	4	4	0	1	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	OCT	2020	26	10					1509	1511		10.1038/s41591-020-1100-4	http://dx.doi.org/10.1038/s41591-020-1100-4			3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	NX8MD	33029017	Green Submitted, Bronze			2022-12-27	WOS:000575957200008
J	Liu, STH; Lin, HM; Baine, I; Wajnberg, A; Gumprecht, JP; Rahman, F; Rodriguez, D; Tandon, P; Bassily-Marcus, A; Bander, J; Sanky, C; Dupper, A; Zheng, A; Nguyen, FT; Amanat, F; Stadlbauer, D; Altman, DR; Chen, BK; Krammer, F; Mendu, DR; Firpo-Betancourt, A; Levin, MA; Bagiella, E; Casadevall, A; Cordon-Cardo, C; Jhang, JS; Arinsburg, SA; Reich, DL; Aberg, JA; Bouvier, NM				Liu, Sean T. H.; Lin, Hung-Mo; Baine, Ian; Wajnberg, Ania; Gumprecht, Jeffrey P.; Rahman, Farah; Rodriguez, Denise; Tandon, Pranai; Bassily-Marcus, Adel; Bander, Jeffrey; Sanky, Charles; Dupper, Amy; Zheng, Allen; Nguyen, Freddy T.; Amanat, Fatima; Stadlbauer, Daniel; Altman, Deena R.; Chen, Benjamin K.; Krammer, Florian; Mendu, Damodara Rao; Firpo-Betancourt, Adolfo; Levin, Matthew A.; Bagiella, Emilia; Casadevall, Arturo; Cordon-Cardo, Carlos; Jhang, Jeffrey S.; Arinsburg, Suzanne A.; Reich, David L.; Aberg, Judith A.; Bouvier, Nicole M.			Convalescent plasma treatment of severe COVID-19: a propensity score-matched control study	NATURE MEDICINE			English	Article								Convalescent plasma for treatment of hospitalized patients with COVID-19 is associated with improved survival in a retrospective comparison with matched controls, supporting further study in randomized controlled trials. Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is a new human disease with few effective treatments(1). Convalescent plasma, donated by persons who have recovered from COVID-19, is the acellular component of blood that contains antibodies, including those that specifically recognize SARS-CoV-2. These antibodies, when transfused into patients infected with SARS-CoV-2, are thought to exert an antiviral effect, suppressing virus replication before patients have mounted their own humoral immune responses(2,3). Virus-specific antibodies from recovered persons are often the first available therapy for an emerging infectious disease, a stopgap treatment while new antivirals and vaccines are being developed(1,2). This retrospective, propensity score-matched case-control study assessed the effectiveness of convalescent plasma therapy in 39 patients with severe or life-threatening COVID-19 at The Mount Sinai Hospital in New York City. Oxygen requirements on day 14 after transfusion worsened in 17.9% of plasma recipients versus 28.2% of propensity score-matched controls who were hospitalized with COVID-19 (adjusted odds ratio (OR), 0.86; 95% confidence interval (CI), 0.75-0.98; chi-square testPvalue = 0.025). Survival also improved in plasma recipients (adjusted hazard ratio (HR), 0.34; 95% CI, 0.13-0.89; chi-square testP = 0.027). Convalescent plasma is potentially effective against COVID-19, but adequately powered, randomized controlled trials are needed.	[Liu, Sean T. H.; Gumprecht, Jeffrey P.; Rahman, Farah; Dupper, Amy; Altman, Deena R.; Chen, Benjamin K.; Aberg, Judith A.; Bouvier, Nicole M.] Icahn Sch Med Mt Sinai, Dept Med, Div Infect Dis, New York, NY 10029 USA; [Liu, Sean T. H.; Zheng, Allen; Amanat, Fatima; Stadlbauer, Daniel; Krammer, Florian; Bouvier, Nicole M.] Icahn Sch Med Mt Sinai, Dept Microbiol, New York, NY 10029 USA; [Lin, Hung-Mo; Bagiella, Emilia] Icahn Sch Med Mt Sinai, Dept Populat Hlth Sci & Policy, New York, NY 10029 USA; [Baine, Ian; Nguyen, Freddy T.; Mendu, Damodara Rao; Firpo-Betancourt, Adolfo; Cordon-Cardo, Carlos; Jhang, Jeffrey S.; Arinsburg, Suzanne A.] Icahn Sch Med Mt Sinai, Dept Pathol Mol & Cell Based Med, New York, NY 10029 USA; [Wajnberg, Ania] Icahn Sch Med Mt Sinai, Dept Med, Div Gen Internal Med, New York, NY 10029 USA; [Rodriguez, Denise] Icahn Sch Med Mt Sinai, Tisch Canc Inst, New York, NY 10029 USA; [Tandon, Pranai] Icahn Sch Med Mt Sinai, Dept Med, Div Pulm Crit Care & Sleep Med, New York, NY 10029 USA; [Bassily-Marcus, Adel] Icahn Sch Med Mt Sinai, Inst Crit Care Med, Dept Surg, New York, NY 10029 USA; [Bander, Jeffrey] Icahn Sch Med Mt Sinai, Dept Med, Div Cardiol, New York, NY 10029 USA; [Sanky, Charles] Icahn Sch Med Mt Sinai, Dept Med Educ, New York, NY 10029 USA; [Amanat, Fatima] Icahn Sch Med Mt Sinai, Grad Sch Biomed Sci, New York, NY 10029 USA; [Levin, Matthew A.; Reich, David L.] Icahn Sch Med Mt Sinai, Dept Anesthesiol Perioperat & Pain Med, New York, NY 10029 USA; [Casadevall, Arturo] Johns Hopkins Sch Med, Dept Mol Microbiol & Immunol, Baltimore, MD USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Johns Hopkins University; Johns Hopkins Medicine	Bouvier, NM (corresponding author), Icahn Sch Med Mt Sinai, Dept Med, Div Infect Dis, New York, NY 10029 USA.; Bouvier, NM (corresponding author), Icahn Sch Med Mt Sinai, Dept Microbiol, New York, NY 10029 USA.	nicole.bouvier@mssm.edu	Nguyen, Freddy/X-2742-2019; Zheng, Allen/ABD-8443-2020; Krammer, Florian/H-3237-2019	Nguyen, Freddy/0000-0003-0106-8114; Zheng, Allen/0000-0003-1103-839X; Krammer, Florian/0000-0003-4121-776X; Liu, Sean/0000-0002-3842-6838; Bassily-Marcus, Adel/0000-0003-1131-8885	MSH; ISMMS	MSH; ISMMS	This study was supported by internal funding from MSH and ISMMS. We thank all of the patients who participated in this study and their families. We also acknowledge the generosity of the thousands of anonymous tristate area residents who recovered from COVID-19 and then volunteered to donate convalescent plasma for the benefit of others. We thank the New York Blood Center, L.-A. Pirofski, T. Schneider, C. Seah, S. Srinivas, D. Tremblay, M. Geiger, C. Lebovits and J. Lustgarten. We acknowledge the assistance of ISMMS medical students: S. Ahsanuddin, A. Paasewe, R. Upadhyay, G. Mellgard, T. Martinson, B. Patil, C. Luo, S. Agrawal, A. Siddiqui, J. Schwarz, L. Piendel, J. Emerson, H. Kaplan, E. Klein, M. Garcia, J. Johnson, L. Maillie and E. Baldwin. We also appreciate the clinical expertise of the Mount Sinai Convalescent Plasma Squad: N. Shuman, D. Delbeau, D. Catamero, G. Sanchez, S. Aird, M. Mann, T. Broome, S. Kleiner-Arje, L. Wolf, A. Lee, L. Gaynes and K. Goodman. We dedicate this work to the New Yorkers who have lost their lives to COVID-19 with a special dedication to the health care workers who will always be remembered for their selflessness during this pandemic.	Amanat F, 2020, NAT MED, V26, P1033, DOI [10.1101/2020.03.17.20037713, 10.1038/s41591-020-0913-5]; Austin PC, 2014, STAT MED, V33, P1057, DOI 10.1002/sim.6004; Casadevall A, 2020, J CLIN INVEST, V130, P1545, DOI 10.1172/JCI138003; Cecil R L, 1932, Br Med J, V2, P657; Chen L, 2020, LANCET INFECT DIS, V20, P398, DOI 10.1016/S1473-3099(20)30141-9; Choe PG, 2020, EMERG INFECT DIS, V26, P2484, DOI 10.3201/eid2610.202211; Duan K, 2020, P NATL ACAD SCI USA, V117, P9490, DOI 10.1073/pnas.2004168117; ENRIA DA, 1984, LANCET, V2, P255, DOI 10.1016/S0140-6736(84)90299-X; Finland M, 1930, NEW ENGL J MED, V202, P1244, DOI 10.1056/NEJM193006262022605; Gharbharan A, 2020, CONVALESCENT PLASMA, DOI 10.1101/2020.07.01.20139857; Hung IEN, 2013, CHEST, V144, P464, DOI 10.1378/chest.12-2907; Joyner MJ, 2020, MAYO CLIN PROC, V95, P1888, DOI 10.1016/j.mayocp.2020.06.028; Joyner MJ, 2020, J CLIN INVEST, V130, P4791, DOI [10.1172/JCI140200, 10.1101/2020.05.12.20099879]; Klein Sabra, 2020, medRxiv, DOI [10.1172/JCI142004, 10.1101/2020.06.26.20139063]; Lee JS, 2019, BMC INFECT DIS, V19, DOI 10.1186/s12879-019-3980-9; Li L, 2020, JAMA-J AM MED ASSOC, V324, P460, DOI 10.1001/jama.2020.10044; Llitjos JF, 2020, J THROMB HAEMOST, V18, P1743, DOI 10.1111/jth.14869; Luke TC, 2006, ANN INTERN MED, V145, P599, DOI 10.7326/0003-4819-145-8-200610170-00139; Mair-Jenkins J, 2015, J INFECT DIS, V211, P80, DOI 10.1093/infdis/jiu396; Okba NMA, 2020, EMERG INFECT DIS, V26, P1478, DOI 10.3201/eid2607.200841; Perotti C, 2020, MORTALITY REDUCTION, DOI DOI 10.1101/2020.05.26.20113373; Richardson S, 2020, JAMA-J AM MED ASSOC, V323, P2052, DOI 10.1001/jama.2020.6775; Roback JD, 2020, JAMA-J AM MED ASSOC, V323, P1561, DOI 10.1001/jama.2020.4940; Rojas M, 2020, AUTOIMMUN REV, V19, DOI 10.1016/j.autrev.2020.102554; Salazar E, 2020, AM J PATHOL, V190, P1680, DOI 10.1016/j.ajpath.2020.05.014; Sharun K, 2020, EXPERT OPIN BIOL TH, V20, P1033, DOI 10.1080/14712598.2020.1796963; Stadlbauer Daniel, 2020, Curr Protoc Microbiol, V57, pe100, DOI 10.1002/cpmc.100; Wajnberg A, 2020, SARS COV 2 INFECT IN, DOI 14.20151126.; Ye MX, 2020, J MED VIROL, V92, P1890, DOI 10.1002/jmv.25882; Zhao JJ, 2020, CLIN INFECT DIS, V71, P2027, DOI 10.1093/cid/ciaa344; Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3	31	285	291	4	25	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2020	26	11					1708	+		10.1038/s41591-020-1088-9	http://dx.doi.org/10.1038/s41591-020-1088-9		SEP 2020	10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	OT0SR	32934372	Green Submitted, Bronze			2022-12-27	WOS:000569723100001
J	Carter, MJ; Fish, M; Jennings, A; Doores, KJ; Wellman, P; Seow, J; Acors, S; Graham, C; Timms, E; Kenny, J; Neil, S; Malim, MH; Tibby, SM; Shankar-Hari, M				Carter, Michael J.; Fish, Matthew; Jennings, Aislinn; Doores, Katie J.; Wellman, Paul; Seow, Jeffrey; Acors, Sam; Graham, Carl; Timms, Emma; Kenny, Julia; Neil, Stuart; Malim, Michael H.; Tibby, Shane M.; Shankar-Hari, Manu			Peripheral immunophenotypes in children with multisystem inflammatory syndrome associated with SARS-CoV-2 infection	NATURE MEDICINE			English	Article							T-CELLS; DISEASE	Recent reports highlight a new clinical syndrome in children related to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)(1)-multisystem inflammatory syndrome in children (MIS-C)-which comprises multiorgan dysfunction and systemic inflammation(2-13). We performed peripheral leukocyte phenotyping in 25 children with MIS-C, in the acute (n = 23; worst illness within 72 h of admission), resolution (n = 14; clinical improvement) and convalescent (n = 10; first outpatient visit) phases of the illness and used samples from seven age-matched healthy controls for comparisons. Among the MIS-C cohort, 17 (68%) children were SARS-CoV-2 seropositive, suggesting previous SARS-CoV-2 infections(14,15), and these children had more severe disease. In the acute phase of MIS-C, we observed high levels of interleukin-1 beta (IL-1 beta), IL-6, IL-8, IL-10, IL-17, interferon-gamma and differential T and B cell subset lymphopenia. High CD64 expression on neutrophils and monocytes, and high HLA-DR expression on gamma delta and CD4(+)CCR7(+)T cells in the acute phase, suggested that these immune cell populations were activated. Antigen-presenting cells had low HLA-DR and CD86 expression, potentially indicative of impaired antigen presentation. These features normalized over the resolution and convalescence phases. Overall, MIS-C presents as an immunopathogenic illness(1)and appears distinct from Kawasaki disease. Characterization of a cohort of children with multisystem inflammatory syndrome associated with SARS-CoV-2 infection provides insights into the immunopathogenic features of the disease.	[Carter, Michael J.; Kenny, Julia] Kings Coll London, Dept Women & Childrens Hlth, London, England; [Carter, Michael J.; Wellman, Paul; Kenny, Julia; Tibby, Shane M.] Evelina London Childrens Hosp, Paediat Intens Care Unit, London, England; [Fish, Matthew; Jennings, Aislinn; Shankar-Hari, Manu] Guys & St Thomas NHS Fdn Trust, Dept Intens Care Med, London, England; [Fish, Matthew; Jennings, Aislinn; Doores, Katie J.; Seow, Jeffrey; Acors, Sam; Graham, Carl; Neil, Stuart; Malim, Michael H.; Shankar-Hari, Manu] Kings Coll London, Sch Immunol & Microbial Sci, Dept Infect Dis, London, England; [Fish, Matthew; Timms, Emma] Kings Coll London, Sch Immunol & Microbial Sci, Peter Gorer Dept Immunobiol, London, England; [Shankar-Hari, Manu] Kings Coll London, Sch Immunol & Microbial Sci, London, England	University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; University of London; King's College London; University of London; King's College London	Tibby, SM (corresponding author), Evelina London Childrens Hosp, Paediat Intens Care Unit, London, England.; Shankar-Hari, M (corresponding author), Guys & St Thomas NHS Fdn Trust, Dept Intens Care Med, London, England.; Shankar-Hari, M (corresponding author), Kings Coll London, Sch Immunol & Microbial Sci, Dept Infect Dis, London, England.; Shankar-Hari, M (corresponding author), Kings Coll London, Sch Immunol & Microbial Sci, London, England.	shane.tibby@gstt.nhs.uk; manu.shankar-hari@kcl.ac.uk	Wellman, Paul/GSD-5108-2022; Shankar-Hari, Manu/Q-9056-2019	Wellman, Paul/0000-0001-6404-1758; CARTER, Michael/0000-0003-3403-4746; Fish, Matthew/0000-0001-6462-3889; Doores, Katie/0000-0002-5507-1725; Shankar-Hari, Manu/0000-0002-5338-2538; Acors, Sam/0000-0001-6428-7707; Jennings, Aislinn/0000-0002-6954-5717; Malim, Michael/0000-0002-7699-2064; Neil, Stuart/0000-0003-3306-5831	NIAID Centers of Excellence for Influenza Research and Surveillance (CEIRS) [HHSN272201400008C]; King's Together COVID-19 seed funds; National Institute for Health Research (NIHR) Academic Clinical Lectureship; National Institute of Academic Anesthesia BJA/RCoA fellowship [WKRO-2018-0047]; Critical Care Department at Guy's and St Thomas' Hospital; MRC-KCL Doctoral Training Partnership in Biomedical Sciences Industrial Collaborative Award in Science and Engineering (iCASE); Orchard Therapeutics [MR/R015643/1]; MRC-KCL Doctoral Training Partnership in Biomedical Sciences [MR/N013700/1]; NIHR Clinician Scientist Award [CS-2016-16-011]; NIHR Biomedical Research Centre based at Guy's and St Thomas' NHS Foundation Trust; KCL; NIHR Clinical Research Facility; MRC [MC_PC_14105, MC_PC_15068] Funding Source: UKRI	NIAID Centers of Excellence for Influenza Research and Surveillance (CEIRS); King's Together COVID-19 seed funds; National Institute for Health Research (NIHR) Academic Clinical Lectureship(National Institute for Health Research (NIHR)); National Institute of Academic Anesthesia BJA/RCoA fellowship; Critical Care Department at Guy's and St Thomas' Hospital; MRC-KCL Doctoral Training Partnership in Biomedical Sciences Industrial Collaborative Award in Science and Engineering (iCASE); Orchard Therapeutics; MRC-KCL Doctoral Training Partnership in Biomedical Sciences(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIHR Clinician Scientist Award; NIHR Biomedical Research Centre based at Guy's and St Thomas' NHS Foundation Trust; KCL; NIHR Clinical Research Facility; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank the parents and children who agreed to take part in this work. We thank J. Irons and the Evelina DIAMONDS Study team, the Evelina PIMS-TS Working Group and the Evelina Paediatric Research Team. We thank the flow cytometry core at the King's College London (KCL) NIHR Biomedical Research Centre, and for logistical support we thank M. Brown, R. Ellis, S. Cochrane and C. Trouillet. We thank F. Krammer (Icahn School of Medicine at Mount Sinai) for provision of the RBD expression plasmid, P. Brouwer, M. van Gils and R. Sanders (University of Amsterdam) for the spike protein expression plasmid, and L. James, J. Luptak and L. Kiss (LMB, Cambridge) for the provision of purified nucleocapsid protein. The development of SARS-CoV-2 reagents (RBD) was partially supported by the NIAID Centers of Excellence for Influenza Research and Surveillance (CEIRS) contract HHSN272201400008C. The study was supported by the King's Together COVID-19 seed funds (M.J.C., M.S.H., K.J.D., S.N. and M.H.M.). M.J.C. is supported by a National Institute for Health Research (NIHR) Academic Clinical Lectureship. M.F. is supported by a National Institute of Academic Anesthesia BJA/RCoA fellowship (WKRO-2018-0047). A.J. is supported by PhD funds from the Critical Care Department at Guy's and St Thomas' Hospital. S.A. was supported by an MRC-KCL Doctoral Training Partnership in Biomedical Sciences Industrial Collaborative Award in Science and Engineering (iCASE) in partnership with Orchard Therapeutics (MR/R015643/1). C.G. is supported by the MRC-KCL Doctoral Training Partnership in Biomedical Sciences (MR/N013700/1). M.S.-H. is supported by the NIHR Clinician Scientist Award (CS-2016-16-011). The views expressed in this publication are those of the authors and not necessarily those of the NHS, NIHR or Department of Health and Social Care. This research was funded/supported by the NIHR Biomedical Research Centre based at Guy's and St Thomas' NHS Foundation Trust and KCL and/or the NIHR Clinical Research Facility. The funding sources did not have any role in the design, conduct or interpretation of the study results.	Belhadjer Z, 2020, CIRCULATION, V142, P429, DOI 10.1161/CIRCULATIONAHA.120.048360; Brugger SD, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005633; Cabrero-Hernandez M, 2020, PEDIATR INFECT DIS J, V39, pE195, DOI 10.1097/INF.0000000000002777; Capone CA, 2020, J PEDIATR-US, V224, P141, DOI [10.1016/j.jpeds.2020.06.044, 10.1018/j.jpeds.2020.08.044]; Cherian T, 2005, B WORLD HEALTH ORGAN, V83, P353; Chiotos K, 2020, J PEDIAT INF DIS SOC, V9, P393, DOI 10.1093/jpids/piaa069; Costa S, 2019, IMMUNOLOGY, V156, P23, DOI 10.1111/imm.13005; Dallaire F, 2011, J AM SOC ECHOCARDIOG, V24, P60, DOI 10.1016/j.echo.2010.10.004; Davies P, 2020, LANCET CHILD ADOLESC, V4, P669, DOI 10.1016/S2352-4642(20)30215-7; Dono M, 2004, INT J BIOCHEM CELL B, V36, P2105, DOI 10.1016/j.biocel.2004.05.017; Dufort EM, 2020, NEW ENGL J MED, V383, P347, DOI 10.1056/NEJMoa2021756; Ellinghaus D, 2020, NEW ENGL J MED, V383, P1522, DOI 10.1056/NEJMoa2020283; Feldstein LR, 2020, NEW ENGL J MED, V383, P334, DOI 10.1056/NEJMoa2021680; Fernandez-Cooke E, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0215665; Freer G, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000384; Grehan K, 2015, METHODSX, V2, P379, DOI 10.1016/j.mex.2015.09.003; Kassambara A., 2017, EXTRACT VISUALIZE RE; Kaushik S, 2020, J PEDIATR-US, V224, P24, DOI 10.1016/j.jpeds.2020.06.045; Kolde Raivo, 2019, CRAN; KRUTMANN J, 1990, J IMMUNOL, V145, P1337; Lamers MM, 2020, SCIENCE, V369, P50, DOI 10.1126/science.abc1669; Liu L, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.123158; Long QX, 2020, NAT MED, V26, P1200, DOI 10.1038/s41591-020-0965-6; Maecker HT, 2012, NAT REV IMMUNOL, V12, P191, DOI 10.1038/nri3158; Marini O, 2017, BLOOD, V129, P1343, DOI 10.1182/blood-2016-04-713206; Mathew D, 2020, SCIENCE, V369, P1209, DOI 10.1126/science.abc8511; Matics TJ, 2017, JAMA PEDIATR, V171, DOI 10.1001/jamapediatrics.2017.2352; Matsuguma C, 2019, SCAND J RHEUMATOL, V48, P491, DOI 10.1080/03009742.2019.1604992; Monin L, 2020, CONSENSUS COVID 19 I, DOI [DOI 10.1101/2020.06.08.20125112, 10.1101/2020.06.08.20125112v1]; Newburger JW, 2016, J AM COLL CARDIOL, V67, P1738, DOI 10.1016/j.jacc.2015.12.073; R Core Team, 2020, R LANG ENV STAT COMP; Ramcharan T, 2020, PEDIATR CARDIOL, V41, P1391, DOI 10.1007/s00246-020-02391-2; Riphagen S, 2020, LANCET, V395, P1607, DOI [10.1016/50140-6736(20)31094-1, 10.1016/S0140-6736(20)31094-1]; Rowley AH, 2020, NAT REV IMMUNOL, V20, P453, DOI 10.1038/s41577-020-0367-5; Rowley AH, 2018, FRONT PEDIATR, V6, DOI 10.3389/fped.2018.00374; Royal College of Paediatrics and Child Health, 2020, GUID PAED MULT INFL; Rstudio T, 2020, RSTUDIO INT DEV R; Seow J., 2020, LONGITUDINAL EVALUAT, DOI [10.1101/2020.07.09.20148429, DOI 10.1038/S41564-020-00813-8, 10.1038/s41564-020-00813-8]; Sun BQ, 2020, EMERG MICROBES INFEC, V9, P940, DOI 10.1080/22221751.2020.1762515; Tacke CE, 2014, PEDIATR INFECT DIS J, V33, P793, DOI 10.1097/INF.0000000000000271; Tanaka M, 2009, J IMMUNOL, V183, P2349, DOI 10.4049/jimmunol.0801683; Toubiana J, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m2094; van den Broek T, 2018, NAT REV IMMUNOL, V18, P363, DOI 10.1038/s41577-018-0001-y; Verdoni L, 2020, LANCET, V395, P1771, DOI 10.1016/S0140-6736(20)31103-X; Vignali DAA, 2008, NAT REV IMMUNOL, V8, P523, DOI 10.1038/nri2343; Wan YS, 2020, J VIROL, V94, DOI 10.1128/JVI.02015-19; Wang Y, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01958; Whittaker E, 2020, JAMA-J AM MED ASSOC, V324, P259, DOI 10.1001/jama.2020.10369; Wickham H., 2019, J OPEN SOURCE SOFTW, V4, P1686, DOI [10.21105/joss.01686, DOI 10.21105/JOSS.01686]; Zanoni I, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00032; Zheng J, 2013, CELL MOL IMMUNOL, V10, P50, DOI 10.1038/cmi.2012.43	52	189	194	2	10	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2020	26	11					1701	+		10.1038/s41591-020-1054-6	http://dx.doi.org/10.1038/s41591-020-1054-6		AUG 2020	16	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	OT0SR	32812012	Bronze, Green Submitted			2022-12-27	WOS:000560628700002
J	Walters, FP; Anyane-Yeboa, A; Landry, AM				Polanco Walters, Frinny; Anyane-Yeboa, Adjoa; Landry, Alden M.			The not-so-silent killer missing in medical-training curricula: racism	NATURE MEDICINE			English	Editorial Material								Racism is a social determinant of health and negatively affects health outcomes. This Comment describes steps to take toward achieving equity and racial justice in medical training and addressing racism in clinical settings.	[Polanco Walters, Frinny; Anyane-Yeboa, Adjoa] Harvard Univ, Harvard Med Sch, Minor Hlth Policy, Boston, MA 02115 USA; [Landry, Alden M.] Harvard Med Sch, Off Divers Inclus & Community Partnership, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Walters, FP (corresponding author), Harvard Univ, Harvard Med Sch, Minor Hlth Policy, Boston, MA 02115 USA.	frinny_polancowalters@hms.harvard.edu	Walters, Frinny Polanco/AAV-6959-2020	Anyane-Yeboa, Adjoa/0000-0002-7919-4105				Laurencin CT, 2017, J RACIAL ETHN HEALTH, V4, P317, DOI 10.1007/s40615-017-0380-y; Project Implicit, 2020, PROJECT IMPLICIT; Saha S, 2008, JAMA-J AM MED ASSOC, V300, P1135, DOI 10.1001/jama.300.10.1135; Williams D R, 1997, J Health Psychol, V2, P335, DOI 10.1177/135910539700200305	4	2	2	0	4	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	AUG	2020	26	8					1160	1161		10.1038/s41591-020-0984-3	http://dx.doi.org/10.1038/s41591-020-0984-3		JUL 2020	2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	MX8ZF	32661392				2022-12-27	WOS:000548125100001
J	Segal, E; Zhang, F; Lin, XH; King, G; Shalem, O; Shilo, S; Allen, WE; Alquaddoomi, F; Altae-Tran, H; Anders, S; Balicer, R; Bauman, T; Bonilla, X; Booman, G; Chan, AT; Cohen, O; Coletti, S; Davidson, N; Dor, Y; Drew, DA; Elemento, O; Evans, G; Ewels, P; Gale, J; Gavrieli, A; Geiger, B; Grad, YH; Greene, CS; Hajirasouliha, I; Jerala, R; Kahles, A; Kallioniemi, O; Keshet, A; Kocarev, L; Landua, G; Meir, T; Muller, A; Nguyen, LH; Oresic, M; Ovchinnikova, S; Peterson, H; Prodanova, J; Rajagopal, J; Ratsch, G; Rossman, H; Rung, J; Sboner, A; Sigaras, A; Spector, T; Steinherz, R; Stevens, I; Vilo, J; Wilmes, P				Segal, Eran; Zhang, Feng; Lin, Xihong; King, Gary; Shalem, Ophir; Shilo, Smadar; Allen, William E.; Alquaddoomi, Faisal; Altae-Tran, Han; Anders, Simon; Balicer, Ran; Bauman, Tal; Bonilla, Ximena; Booman, Gisel; Chan, Andrew T.; Cohen, Ori; Coletti, Silvano; Davidson, Natalie; Dor, Yuval; Drew, David A.; Elemento, Olivier; Evans, Georgina; Ewels, Phil; Gale, Joshua; Gavrieli, Amir; Geiger, Benjamin; Grad, Yonatan H.; Greene, Casey S.; Hajirasouliha, Iman; Jerala, Roman; Kahles, Andre; Kallioniemi, Olli; Keshet, Ayya; Kocarev, Ljupco; Landua, Gregory; Meir, Tomer; Muller, Aline; Nguyen, Long H.; Oresic, Matej; Ovchinnikova, Svetlana; Peterson, Hedi; Prodanova, Jana; Rajagopal, Jay; Raetsch, Gunnar; Rossman, Hagai; Rung, Johan; Sboner, Andrea; Sigaras, Alexandros; Spector, Tim; Steinherz, Ron; Stevens, Irene; Vilo, Jaak; Wilmes, Paul			Building an international consortium for tracking coronavirus health status (vol 78, pg 931, 2020)	NATURE MEDICINE			English	Correction								An amendment to this paper has been published and can be accessed via a link at the top of the paper.				eran.segal@weizmann.ac.il	Oresic, Matej/AAV-3978-2020; Wilmes, Paul/B-1707-2017; Kocarev, Ljupco/AAS-3002-2020; Prodanova, Jana/B-5628-2015; Oresic, Matej/K-7673-2016; Bonilla, Ximena/AAI-7910-2021; Vilo, Jaak/A-7183-2008; Sigaras, Alexandros/AAF-7111-2019; Peterson, Hedi/ABA-3355-2020; Anders, Simon/D-4087-2011; Kallioniemi, Olli/H-4738-2012	Wilmes, Paul/0000-0002-6478-2924; Prodanova, Jana/0000-0001-6381-3621; Oresic, Matej/0000-0002-2856-9165; Vilo, Jaak/0000-0001-5604-4107; Sigaras, Alexandros/0000-0002-7607-559X; Peterson, Hedi/0000-0001-9951-5116; Lin, Xihong/0000-0001-7067-7752; King, Gary/0000-0002-5327-7631; Anders, Simon/0000-0003-4868-1805; Rung, Johan/0000-0001-5875-8429; Stevens, Irene/0000-0003-3823-1499; Segal, Eran/0000-0002-6859-1164; Kallioniemi, Olli/0000-0002-3231-0332	NIDDK NIH HHS [K01 DK120742] Funding Source: Medline; NIGMS NIH HHS [R35 GM138152] Funding Source: Medline	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		SEGAL E, 2020, BUILDING INT CONSORT, DOI DOI 10.1038/S41591-020-0929-X	1	0	0	0	7	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	AUG	2020	26	8					1309	1309		10.1038/s41591-020-0983-4	http://dx.doi.org/10.1038/s41591-020-0983-4		JUN 2020	1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	MX8ZF	32591764	Green Published, Bronze			2022-12-27	WOS:000543613000001
J	Xu, X; Sun, J; Nie, S; Li, HY; Kong, YZ; Liang, M; Hou, JL; Huang, XZ; Li, DF; Ma, T; Peng, JQ; Gao, SK; Shao, Y; Zhu, H; Lau, JYN; Wang, GY; Xie, CB; Jiang, L; Huang, AL; Yang, ZL; Zhang, K; Hou, FF				Xu, Xin; Sun, Jian; Nie, Sheng; Li, Huiyuan; Kong, Yaozhong; Liang, Min; Hou, Jinlin; Huang, Xianzhong; Li, Dongfeng; Ma, Tean; Peng, Jiaqing; Gao, Shikui; Shao, Yong; Zhu, Hong; Lau, Johnson Yiu-Nam; Wang, Guangyu; Xie, Chunbao; Jiang, Li; Huang, Ailong; Yang, Zhenglin; Zhang, Kang; Hou, Fan Fan			Seroprevalence of immunoglobulin M and G antibodies against SARS-CoV-2 in China	NATURE MEDICINE			English	Article								Detection of asymptomatic or subclinical novel human coronavirus SARS-CoV-2 infection is critical for understanding the overall prevalence and infection potential of COVID-19. To estimate the cumulative prevalence of SARS-CoV-2 infection in China, we evaluated the host serologic response, measured by the levels of immunoglobulins M and G in 17,368 individuals, in the city of Wuhan, the epicenter of the COVID-19 pandemic in China, and geographic regions in the country, during the period from 9 March 2020 to 10 April 2020. In our cohorts, the seropositivity in Wuhan varied between 3.2% and 3.8% in different subcohorts. Seroposivity progressively decreased in other cities as the distance to the epicenter increased. Patients who visited a hospital for maintenance hemodialysis and healthcare workers also had a higher seroprevalence of 3.3% (51 of 1,542, 2.5-4.3%, 95% confidence interval (CI)) and 1.8% (81 of 4,384, 1.5-2.3%, 95% CI), respectively. More studies are needed to determine whether these results are generalizable to other populations and geographic locations, as well as to determine at what rate seroprevalence is increasing with the progress of the COVID-19 pandemic. Serologic surveillance has the potential to provide a more faithful cumulative viral attack rate for the first season of this novel SARS-CoV-2 infection. Initial results of serological surveillance in China provide valuable data for estimation of the cumulative prevalence of SARS-CoV-2 infection in the general population.	[Xu, Xin; Sun, Jian; Nie, Sheng; Liang, Min; Hou, Jinlin; Hou, Fan Fan] Natl Clin Res Ctr Kidney Dis, State Key Lab Organ Failure Res, Guangzhou, Peoples R China; [Xu, Xin; Sun, Jian; Nie, Sheng; Liang, Min; Hou, Jinlin; Zhu, Hong; Hou, Fan Fan] Southern Med Univ, Nanfang Hosp, Guangzhou, Peoples R China; [Li, Huiyuan; Huang, Xianzhong] Kingmed Ctr Clin Lab, Guangzhou, Peoples R China; [Kong, Yaozhong] First Peoples Hosp Foshan, Foshan, Peoples R China; [Li, Dongfeng] Peoples Hosp Honghu, Honghu, Peoples R China; [Ma, Tean] First Peoples Hosp Jingzhou, Jingzhou, Peoples R China; [Peng, Jiaqing] Jingzhou Cent Hosp, Jingzhou, Peoples R China; [Gao, Shikui] Honghu Tradit Chinese Med Hosp, Honghu, Peoples R China; [Shao, Yong] Second Peoples Hosp Honghu, Honghu, Peoples R China; [Lau, Johnson Yiu-Nam] Hong Kong Polytech Univ, Dept Appl Biol & Chem Technol, Hung Hom, Hong Kong, Peoples R China; [Wang, Guangyu] Tsinghua Univ, Dept Comp Sci & Technol, Beijing, Peoples R China; [Xie, Chunbao; Jiang, Li; Yang, Zhenglin] Univ Elect Sci & Technol China, Sichuan Prov Peoples Hosp, Inst Lab Med, Sichuan Prov Key Lab Human Dis Study, Chengdu, Peoples R China; [Huang, Ailong] Chongqing Med Univ, Key Lab Mol Biol Infect Dis, Minist Educ, Chongqing, Peoples R China; [Zhang, Kang] Macau Univ Sci & Technol, Fac Med, Ctr Biomed & Innovat, Macau, Peoples R China; [Zhang, Kang; Hou, Fan Fan] Guangzhou Regenerat Med & Hlth Guangdong Lab, Guangzhou, Peoples R China	Southern Medical University - China; Hong Kong Polytechnic University; Tsinghua University; Sichuan Provincial People's Hospital; University of Electronic Science & Technology of China; Chongqing Medical University; Macau University of Science & Technology; Guangzhou Regenerative Medicine & Health Guangdong Laboratory (Bioisland Laboratory)	Hou, FF (corresponding author), Natl Clin Res Ctr Kidney Dis, State Key Lab Organ Failure Res, Guangzhou, Peoples R China.; Hou, FF (corresponding author), Southern Med Univ, Nanfang Hosp, Guangzhou, Peoples R China.; Yang, ZL (corresponding author), Univ Elect Sci & Technol China, Sichuan Prov Peoples Hosp, Inst Lab Med, Sichuan Prov Key Lab Human Dis Study, Chengdu, Peoples R China.; Huang, AL (corresponding author), Chongqing Med Univ, Key Lab Mol Biol Infect Dis, Minist Educ, Chongqing, Peoples R China.; Zhang, K (corresponding author), Macau Univ Sci & Technol, Fac Med, Ctr Biomed & Innovat, Macau, Peoples R China.; Zhang, K; Hou, FF (corresponding author), Guangzhou Regenerat Med & Hlth Guangdong Lab, Guangzhou, Peoples R China.	ahuang1964@163.com; zliny@yahoo.com; kang.zhang@gmail.com; ffhouguangzhou@163.com	Xie, Chunbao/AFI-0902-2022; Zhang, Kang/Y-2740-2019	Zhang, Kang/0000-0002-4549-1697	Clinical Innovation Research Program of Guangzhou Regenerative Medicine and Health Guangdong Laboratory [2018GZR0201003, 2018GZR110102004, 2020GZR110306001]; National Innovation Team Program [81521003]; Major Scientific and Technological Planning Project of Guangzhou [201607020004]; Macao FDCT [0035/2020/A]	Clinical Innovation Research Program of Guangzhou Regenerative Medicine and Health Guangdong Laboratory; National Innovation Team Program; Major Scientific and Technological Planning Project of Guangzhou; Macao FDCT	This study was funded by the Clinical Innovation Research Program of Guangzhou Regenerative Medicine and Health Guangdong Laboratory (2018GZR0201003 and 2018GZR110102004 to F.F.H. and 2020GZR110306001 to K.Z.), the National Innovation Team Program (81521003 to F.F.H.), the Major Scientific and Technological Planning Project of Guangzhou (grant no. 201607020004 to X.X.), and a Macao FDCT (0035/2020/A to K.Z.).	[Anonymous], 2020, NAT MED, DOI [10.1038/s41591-020-0897-1, DOI 10.1038/S41591-020-0897-1]; Guan W, 2020, NEW ENGL J MED, V382, P1708, DOI 10.1056/NEJMoa2002032; Hu ZL, 2020, SCI CHINA LIFE SCI, V63, P706, DOI 10.1007/s11427-020-1661-4; Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5; Lu XX, 2020, NEW ENGL J MED, V382, P1663, DOI 10.1056/NEJMc2005073; Munster VJ, 2020, NEW ENGL J MED, V382, P692, DOI 10.1056/NEJMp2000929; TURNBULL BW, 1976, J R STAT SOC B, V38, P290; Wang DW, 2020, JAMA-J AM MED ASSOC, V323, P1061, DOI 10.1001/jama.2020.1585; World Health Organization, GLOB SURV COVID 19 D; Xu Y, 2020, NAT MED, V26, P502, DOI 10.1038/s41591-020-0817-4; Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017	11	259	267	7	64	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	AUG	2020	26	8					1193	+		10.1038/s41591-020-0949-6	http://dx.doi.org/10.1038/s41591-020-0949-6		JUN 2020	6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	MX8ZF	32504052	Bronze			2022-12-27	WOS:000538211600001
J	Zviran, A; Schulman, RC; Shah, M; Hill, STK; Deochand, S; Khamnei, CC; Maloney, D; Patel, K; Liao, W; Widman, AJ; Wong, P; Callahan, MK; Ha, G; Reed, S; Rotem, D; Frederick, D; Sharova, T; Miao, BC; Kim, T; Gydush, G; Rhoades, J; Huang, KY; Omans, ND; Bolan, PO; Lipsky, AH; Ang, C; Malbari, M; Spinelli, CF; Kazancioglu, S; Runnels, AM; Fennessey, S; Stolte, C; Gaiti, F; Inghirami, GG; Adalsteinsson, V; Houck-Loomis, B; Ishii, J; Wolchok, JD; Boland, G; Robine, N; Altorki, NK; Landau, DA				Zviran, Asaf; Schulman, Rafael C.; Shah, Minita; Hill, Steven T. K.; Deochand, Sunil; Khamnei, Cole C.; Maloney, Dillon; Patel, Kristofer; Liao, Will; Widman, Adam J.; Wong, Phillip; Callahan, Margaret K.; Ha, Gavin; Reed, Sarah; Rotem, Denisse; Frederick, Dennie; Sharova, Tatyana; Miao, Benchun; Kim, Tommy; Gydush, Greg; Rhoades, Justin; Huang, Kevin Y.; Omans, Nathaniel D.; Bolan, Patrick O.; Lipsky, Andrew H.; Ang, Chelston; Malbari, Murtaza; Spinelli, Catherine F.; Kazancioglu, Selena; Runnels, Alexi M.; Fennessey, Samantha; Stolte, Christian; Gaiti, Federico; Inghirami, Giorgio G.; Adalsteinsson, Viktor; Houck-Loomis, Brian; Ishii, Jennifer; Wolchok, Jedd D.; Boland, Genevieve; Robine, Nicolas; Altorki, Nasser K.; Landau, Dan A.			Genome-wide cell-free DNA mutational integration enables ultra-sensitive cancer monitoring	NATURE MEDICINE			English	Article							LUNG-CANCER; RESISTANCE	A new approach for whole-genome sequencing of plasma circulating tumor DNA allows for dynamic monitoring of disease burden and ultra-sensitive detection of minimal residual disease. In many areas of oncology, we lack sensitive tools to track low-burden disease. Although cell-free DNA (cfDNA) shows promise in detecting cancer mutations, we found that the combination of low tumor fraction (TF) and limited number of DNA fragments restricts low-disease-burden monitoring through the prevailing deep targeted sequencing paradigm. We reasoned that breadth may supplant depth of sequencing to overcome the barrier of cfDNA abundance. Whole-genome sequencing (WGS) of cfDNA allowed ultra-sensitive detection, capitalizing on the cumulative signal of thousands of somatic mutations observed in solid malignancies, with TF detection sensitivity as low as 10(-5). The WGS approach enabled dynamic tumor burden tracking and postoperative residual disease detection, associated with adverse outcome. Thus, we present an orthogonal framework for cfDNA cancer monitoring via genome-wide mutational integration, enabling ultra-sensitive detection, overcoming the limitation of cfDNA abundance and empowering treatment optimization in low-disease-burden oncology care.	[Zviran, Asaf; Schulman, Rafael C.; Shah, Minita; Hill, Steven T. K.; Deochand, Sunil; Khamnei, Cole C.; Maloney, Dillon; Patel, Kristofer; Liao, Will; Widman, Adam J.; Huang, Kevin Y.; Omans, Nathaniel D.; Ang, Chelston; Kazancioglu, Selena; Runnels, Alexi M.; Fennessey, Samantha; Stolte, Christian; Gaiti, Federico; Houck-Loomis, Brian; Ishii, Jennifer; Robine, Nicolas; Landau, Dan A.] New York Genome Ctr, New York, NY 10013 USA; [Zviran, Asaf; Schulman, Rafael C.; Hill, Steven T. K.; Deochand, Sunil; Khamnei, Cole C.; Patel, Kristofer; Widman, Adam J.; Huang, Kevin Y.; Omans, Nathaniel D.; Bolan, Patrick O.; Lipsky, Andrew H.; Ang, Chelston; Malbari, Murtaza; Spinelli, Catherine F.; Gaiti, Federico; Inghirami, Giorgio G.; Altorki, Nasser K.; Landau, Dan A.] Weill Cornell Med, Meyer Canc Ctr, New York, NY 10065 USA; [Widman, Adam J.; Wong, Phillip; Callahan, Margaret K.; Wolchok, Jedd D.] Mem Sloan Kettering Canc Ctr, Dept Med, 1275 York Ave, New York, NY 10021 USA; [Ha, Gavin] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, 1124 Columbia St, Seattle, WA 98104 USA; [Reed, Sarah; Rotem, Denisse; Gydush, Greg; Rhoades, Justin; Adalsteinsson, Viktor] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Frederick, Dennie; Sharova, Tatyana; Miao, Benchun; Kim, Tommy; Boland, Genevieve] Massachussetts Gen Hosp, Div Surg Oncol, Boston, MA USA	Cornell University; Memorial Sloan Kettering Cancer Center; Fred Hutchinson Cancer Center; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts General Hospital	Landau, DA (corresponding author), New York Genome Ctr, New York, NY 10013 USA.; Landau, DA (corresponding author), Weill Cornell Med, Meyer Canc Ctr, New York, NY 10065 USA.	dlandau@nygenome.org	Lipsky, Andrew/AFK-0486-2022; Boland, Genevieve/AAP-2767-2021; Lipsky, Andrew/AAF-7446-2022; Ha, Gavin/N-1984-2019	Ha, Gavin/0000-0001-7578-7272; Stolte, Christian/0000-0002-8228-4195; Widman, Adam/0000-0001-7953-0677; Loomis, Brian/0000-0002-1863-1199; Liao, Willey/0000-0001-7574-4694; Reed, Sarah/0000-0003-2191-6643; Gaiti, Federico/0000-0001-5111-8816; Runnels, Alexi/0000-0002-8592-1444; Robine, Nicolas/0000-0001-5698-8183; Ang, Chelston/0000-0003-2122-8488; Khamnei, Cole/0000-0002-6621-8008	EMBO long-term fellowship [ALTF 140-2016]; Burroughs Wellcome Fund Career Award for Medical Scientists; Pershing Square Sohn Prize for Young Investigators in Cancer Research; National Institutes of Health Director's New Innovator Award [DP2-CA239065]; Mark Foundation ASPIRE Award; American Lung Association Cancer Discovery Award; Daedalus Fund for Innovation; Meyer Cancer Center	EMBO long-term fellowship(European Molecular Biology Organization (EMBO)); Burroughs Wellcome Fund Career Award for Medical Scientists(Burroughs Wellcome Fund); Pershing Square Sohn Prize for Young Investigators in Cancer Research(Pershing Square Sohn Cancer Research Alliance); National Institutes of Health Director's New Innovator Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mark Foundation ASPIRE Award; American Lung Association Cancer Discovery Award; Daedalus Fund for Innovation; Meyer Cancer Center	We thank the Landau lab and the New York Genome Center computational biology and sequencing teams for help and feedback throughout this work. A.Z. is supported by an EMBO long-term fellowship (ALTF 140-2016). D.A.L. is supported by the Burroughs Wellcome Fund Career Award for Medical Scientists, the Pershing Square Sohn Prize for Young Investigators in Cancer Research and the National Institutes of Health Director's New Innovator Award (DP2-CA239065). This work was supported by the Mark Foundation ASPIRE Award, the American Lung Association Cancer Discovery Award, the Daedalus Fund for Innovation and the Meyer Cancer Center.	Abbosh C, 2017, NATURE, V545, P446, DOI 10.1038/nature22364; Adalsteinsson VA, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00965-y; [Anonymous], 2017, TRUSEQ DNA PCR FREE; Bauml J, 2018, CLIN CANCER RES, V24, P4352, DOI 10.1158/1078-0432.CCR-18-0969; Bergmann Ewa A, 2016, Bioinformatics, V32, P3196, DOI 10.1093/bioinformatics/btw389; Bettegowda C, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007094; Campbell BB, 2017, CELL, V171, P1042, DOI 10.1016/j.cell.2017.09.048; Chida K, 2017, SURG CASE REP, V3, DOI 10.1186/s40792-017-0341-z; Cibulskis K, 2013, NAT BIOTECHNOL, V31, P213, DOI 10.1038/nbt.2514; Cohen JD, 2018, SCIENCE, V359, P926, DOI 10.1126/science.aar3247; Cristiano S, 2019, NATURE, V570, P385, DOI 10.1038/s41586-019-1272-6; Diehl F, 2008, NAT MED, V14, P985, DOI 10.1038/nm.1789; Goldstraw P, 2016, J THORAC ONCOL, V11, P39, DOI 10.1016/j.jtho.2015.09.009; Guerrera F, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0145100; Hadi K, 2019, NOVEL PATTERNS COMPL, DOI [10.1101/836296v1, DOI 10.1101/836296V1]; Hanna N, 2019, SYSTEMIC THERAPY RES; Itsara LS, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1003974; Jiang HS, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-182; Jiang P, 2018, P NATL ACAD SCI USA, V115, pE10925, DOI 10.1073/pnas.1814616115; Jiang PY, 2015, P NATL ACAD SCI USA, V112, pE1317, DOI 10.1073/pnas.1500076112; Karakuchi N, 2019, WORLD J SURG ONCOL, V17, DOI 10.1186/s12957-018-1552-x; Kennedy SR, 2014, NAT PROTOC, V9, P2586, DOI 10.1038/nprot.2014.170; Kim CG, 2016, BRIT J CANCER, V115, P25, DOI 10.1038/bjc.2016.161; Kobayashi S, 2005, NEW ENGL J MED, V352, P786, DOI 10.1056/NEJMoa044238; Kothen-Hill S. T., 2018, ICLR 2018 C; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Martincorena I, 2018, SCIENCE, V362, P911, DOI 10.1126/science.aau3879; Moss J, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07466-6; Mouliere F, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aat4921; Murtaza M, 2013, NATURE, V497, P108, DOI 10.1038/nature12065; Newman AM, 2016, NAT BIOTECHNOL, V34, P547, DOI 10.1038/nbt.3520; Newman AM, 2014, NAT MED, V20, P552, DOI 10.1038/nm.3519; Phallen J, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aan2415; Razavi P, 2019, NAT MED, V25, P1928, DOI 10.1038/s41591-019-0652-7; Reinert T, 2019, JAMA ONCOL, V5, P1124, DOI 10.1001/jamaoncol.2019.0528; Sadeh R, 2019, CHIP SEQ PLASMA CELL, DOI DOI 10.1101/638643V1; Salk JJ, 2019, CELL REP, V28, P132, DOI 10.1016/j.celrep.2019.05.109; Saunders CT, 2012, BIOINFORMATICS, V28, P1811, DOI 10.1093/bioinformatics/bts271; Shen SY, 2018, NATURE, V563, P579, DOI 10.1038/s41586-018-0703-0; Snyder MW, 2016, CELL, V164, P57, DOI 10.1016/j.cell.2015.11.050; Sozzi G, 2003, LUNG CANCER, V41, pS86; Spinella JF, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-3281-2; Taylor AM, 2018, CANCER CELL, V33, P676, DOI 10.1016/j.ccell.2018.03.007; Underhill HR, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006162; van Wezel EM, 2015, J MOL DIAGN, V17, P43, DOI 10.1016/j.jmoldx.2014.09.005; Wan JCM, 2017, NAT REV CANCER, V17, P223, DOI 10.1038/nrc.2017.7; Wang SH, 2010, CLIN CANCER RES, V16, P1324, DOI 10.1158/1078-0432.CCR-09-2672; Wang YX, 2019, JAMA ONCOL, V5, P1118, DOI 10.1001/jamaoncol.2019.0512; Wilm A, 2012, NUCLEIC ACIDS RES, V40, P11189, DOI 10.1093/nar/gks918; Xi RB, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-S1-O10; Yizhak K, 2019, SCIENCE, V364, P970, DOI 10.1126/science.aaw0726	51	88	91	4	15	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	JUL	2020	26	7					1114	+		10.1038/s41591-020-0915-3	http://dx.doi.org/10.1038/s41591-020-0915-3		JUN 2020	37	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	MK3XO	32483360	Green Accepted			2022-12-27	WOS:000537041000002
J	AbdulJabbar, K; Raza, SEA; Rosenthal, R; Jamal-Hanjani, M; Veeriah, S; Akarca, A; Lund, T; Moore, DA; Salgado, R; Al Bakir, M; Zapata, L; Hiley, CT; Officer, L; Sereno, M; Smith, CR; Loi, S; Hackshaw, A; Marafioti, T; Quezada, SA; McGranahan, N; Le Quesne, J; Swanton, C; Yuan, YY				AbdulJabbar, Khalid; Raza, Shan E. Ahmed; Rosenthal, Rachel; Jamal-Hanjani, Mariam; Veeriah, Selvaraju; Akarca, Ayse; Lund, Tom; Moore, David A.; Salgado, Roberto; Al Bakir, Maise; Zapata, Luis; Hiley, Crispin T.; Officer, Leah; Sereno, Marco; Smith, Claire Rachel; Loi, Sherene; Hackshaw, Allan; Marafioti, Teresa; Quezada, Sergio A.; McGranahan, Nicholas; Le Quesne, John; Swanton, Charles; Yuan, Yinyin		TRACERx Consortium	Geospatial immune variability illuminates differential evolution of lung adenocarcinoma	NATURE MEDICINE			English	Article							HETEROGENEITY; IMMUNOREACTIVITY; MATRIX	Remarkable progress in molecular analyses has improved our understanding of the evolution of cancer cells toward immune escape(1-5). However, the spatial configurations of immune and stromal cells, which may shed light on the evolution of immune escape across tumor geographical locations, remain unaddressed. We integrated multiregion exome and RNA-sequencing (RNA-seq) data with spatial histology mapped by deep learning in 100 patients with non-small cell lung cancer from the TRACERx cohort(6). Cancer subclones derived from immune cold regions were more closely related in mutation space, diversifying more recently than subclones from immune hot regions. In TRACERx and in an independent multisample cohort of 970 patients with lung adenocarcinoma, tumors with more than one immune cold region had a higher risk of relapse, independently of tumor size, stage and number of samples per patient. In lung adenocarcinoma, but not lung squamous cell carcinoma, geometrical irregularity and complexity of the cancer-stromal cell interface significantly increased in tumor regions without disruption of antigen presentation. Decreased lymphocyte accumulation in adjacent stroma was observed in tumors with low clonal neoantigen burden. Collectively, immune geospatial variability elucidates tumor ecological constraints that may shape the emergence of immune-evading subclones and aggressive clinical phenotypes. Multiregion spatial histology, exome and transcriptome data from patients with non-small cell lung cancer suggest that cancer subclones from immune cold regions diversify later than subclones from immune hot regions	[AbdulJabbar, Khalid; Raza, Shan E. Ahmed; Zapata, Luis; Yuan, Yinyin] Inst Canc Res, Ctr Evolut & Canc, London, England; [AbdulJabbar, Khalid; Raza, Shan E. Ahmed; Zapata, Luis; Yuan, Yinyin] Inst Canc Res, Div Mol Pathol, London, England; [Rosenthal, Rachel; Jamal-Hanjani, Mariam; Veeriah, Selvaraju; Moore, David A.; Hiley, Crispin T.; McGranahan, Nicholas; Swanton, Charles] UCL, Canc Inst, Canc Res UK Lung Canc Ctr Excellence, London, England; [Rosenthal, Rachel; Veeriah, Selvaraju; Al Bakir, Maise; Hiley, Crispin T.; Swanton, Charles] Francis Crick Inst, Canc Evolut & Genome Instabil Lab, London, England; [Jamal-Hanjani, Mariam; Swanton, Charles] Univ Coll London Hosp NHS Fdn Trust, Dept Med Oncol, London, England; [Akarca, Ayse; Moore, David A.; Marafioti, Teresa] UCL, Univ Coll Hosp, Dept Cellular Pathol, London, England; [Lund, Tom] Royal Marsden Hosp NHS Trust, Translat Immune Oncol Grp, Ctr Mol Med, London, England; [Salgado, Roberto] GZA ZNA Ziekenhuizen, Dept Pathol, Antwerp, Belgium; [Salgado, Roberto; Loi, Sherene] Univ Melbourne, Div Res, Peter MacCallum Canc Ctr, Melbourne, Vic, Australia; [Officer, Leah; Le Quesne, John] Univ Cambridge, MRC Toxicol Unit, Leicester, Leics, England; [Sereno, Marco; Smith, Claire Rachel; Le Quesne, John] Univ Leicester, Leicester Canc Res Ctr, Leicester, Leics, England; [Hackshaw, Allan] UCL, Canc Res UK, London, England; [Hackshaw, Allan] UCL, Canc Trials Ctr, London, England; [Quezada, Sergio A.] UCL, Canc Inst, Canc Immunol Unit, London, England; [McGranahan, Nicholas] UCL, Canc Inst, Canc Genome Evolut Res Grp, London, England; [Le Quesne, John] Univ Hosp Leicester NHS Trust, Glenfield Hosp, Leicester, Leics, England	Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Cancer Research UK; University of London; University College London; Francis Crick Institute; University College London Hospitals NHS Foundation Trust; University of London; University College London; University of London; University College London; Royal Marsden NHS Foundation Trust; Peter Maccallum Cancer Center; University of Melbourne; University of Cambridge; University of Leicester; Cancer Research UK; University of London; University College London; University of London; University College London; University of London; University College London; University of London; University College London; University Hospitals of Leicester NHS Trust; University of Leicester; Glenfield Hospital	Yuan, YY (corresponding author), Inst Canc Res, Ctr Evolut & Canc, London, England.; Yuan, YY (corresponding author), Inst Canc Res, Div Mol Pathol, London, England.; Swanton, C (corresponding author), UCL, Canc Inst, Canc Res UK Lung Canc Ctr Excellence, London, England.; Swanton, C (corresponding author), Francis Crick Inst, Canc Evolut & Genome Instabil Lab, London, England.; Swanton, C (corresponding author), Univ Coll London Hosp NHS Fdn Trust, Dept Med Oncol, London, England.; Le Quesne, J (corresponding author), Univ Cambridge, MRC Toxicol Unit, Leicester, Leics, England.; Le Quesne, J (corresponding author), Univ Leicester, Leicester Canc Res Ctr, Leicester, Leics, England.; Le Quesne, J (corresponding author), Univ Hosp Leicester NHS Trust, Glenfield Hosp, Leicester, Leics, England.	jlq2@leicester.ac.uk; Charles.Swanton@crick.ac.uk; Yinyin.Yuan@icr.ac.uk	McGranahan, Nicholas/ABD-6561-2021; Wilson, Claire Rachel/AAM-4556-2021; Quezada, Sergio/ABF-6466-2020; Aerts, Hugo/ABF-2821-2020; Marafioti, Teresa/AAA-4652-2019; Zapata, Luis/M-6751-2015; Ottensmeier, Christian/E-8131-2012; Blackhall, Fiona/N-2186-2015	McGranahan, Nicholas/0000-0001-9537-4045; Wilson, Claire Rachel/0000-0002-6401-2014; Quezada, Sergio/0000-0002-9763-1700; Aerts, Hugo/0000-0002-2122-2003; Marafioti, Teresa/0000-0003-1223-6275; Edwards, John/0000-0002-7935-5327; Herrero, Javier/0000-0001-7313-717X; Raza, Shan E Ahmed/0000-0002-1097-1738; Officer, Leah/0000-0002-3690-2386; Navani, Neal/0000-0002-6412-7516; Litchfield, Kevin/0000-0002-3725-0914; Le Quesne, John/0000-0003-3552-7446; Lowe, Helen/0000-0001-8630-378X; READING, JAMES/0000-0001-5381-978X; Hynds, Robert/0000-0002-2170-8791; Yuan, Yinyin/0000-0002-8556-4707; Chemi, Francesca/0000-0002-6652-5243; , Colin/0000-0001-8167-5461; Swanton, Charles/0000-0002-4299-3018; naidu, babu/0000-0003-1576-230X; Zapata, Luis/0000-0002-1386-2019; Ottensmeier, Christian/0000-0003-3619-1657; Stone, Richard/0000-0001-8059-3800; Johnson, Diana/0000-0003-0479-1228; Middleton, Gary/0000-0001-5695-3474; Priest, Lynsey/0000-0003-3780-8508; Blackhall, Fiona/0000-0001-8716-3395; De Sousa, Paulo/0000-0003-3011-4116; Escudero, Mickael/0000-0002-1336-815X	Cancer Research UK Career Establishment Award [C45982/A21808]; University College London (UCL) [UCL/12/0279]; Cancer Research UK [C11496/A17786]; Breast Cancer Now [2015NovPR638]; Children's Cancer and Leukaemia Group [CCLGA201906]; National Institutes of Health (NIH) [U54 CA217376, R01 CA185138]; CDMRP Breast Cancer Research Program Award [BC132057]; European Commission ITN (H2020-MSCA-ITN-2019); Wellcome Trust [105104/Z/14/Z, FC001169, FC001202]; Royal Marsden/ICR National Institute of Health Research Biomedical Research Centre; Francis Crick Institute from Cancer Research UK [FC001169, FC001202]; UK Medical Research Council [FC001169, FC001202]; Cancer Research UK (TRACERx); Cancer Research UK (PEACE); Cancer Research UK (Cancer Research UK Cancer Immunotherapy Catalyst Network); Cancer Research UK Lung Cancer Centre of Excellence; Rosetrees Trust; NovoNordisk Foundation [ID16584]; Breast Cancer Research Foundation; Stand Up To Cancer-LUNGevity-American Lung Association Lung Cancer Interception Dream Team Translational Research Grant [SU2C-AACR-DT23-17]; American Association for Cancer Research; Scientific Partner of SU2C; European Research Council (ERC) under the European Union [617844]; European Commission ITN [FP7-PloidyNet 607722]; ERC Advanced Grant (PROTEUS) from the European Research Council under the European Union's Horizon 2020 Research and Innovation Programme [835297]; European Union [665233]; Cancer Research UK Senior Cancer Research Fellowship [C36463/A22246]; Cancer Research UK Biotherapeutic Program Grant [C36463/A20764]; National Breast Cancer Foundation of Australia Endowed Chair; Breast Cancer Research Foundation, New York; European Union's Horizon 2020 Research and Innovation Programme under the Marie Sklodowska-Curie grant [846614]; UCL Biomedical Research Council; Cancer Research UK; NIH Research; UKI NETs; The Francis Crick Institute [10233] Funding Source: researchfish; MRC [MR/P014712/1] Funding Source: UKRI	Cancer Research UK Career Establishment Award; University College London (UCL); Cancer Research UK(Cancer Research UK); Breast Cancer Now; Children's Cancer and Leukaemia Group; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CDMRP Breast Cancer Research Program Award; European Commission ITN (H2020-MSCA-ITN-2019); Wellcome Trust(Wellcome TrustEuropean Commission); Royal Marsden/ICR National Institute of Health Research Biomedical Research Centre; Francis Crick Institute from Cancer Research UK; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK (TRACERx); Cancer Research UK (PEACE); Cancer Research UK (Cancer Research UK Cancer Immunotherapy Catalyst Network); Cancer Research UK Lung Cancer Centre of Excellence; Rosetrees Trust(Rosetrees Trust); NovoNordisk Foundation(Novo Nordisk Foundation); Breast Cancer Research Foundation; Stand Up To Cancer-LUNGevity-American Lung Association Lung Cancer Interception Dream Team Translational Research Grant; American Association for Cancer Research; Scientific Partner of SU2C; European Research Council (ERC) under the European Union(European Research Council (ERC)); European Commission ITN; ERC Advanced Grant (PROTEUS) from the European Research Council under the European Union's Horizon 2020 Research and Innovation Programme; European Union(European Commission); Cancer Research UK Senior Cancer Research Fellowship(Cancer Research UK); Cancer Research UK Biotherapeutic Program Grant; National Breast Cancer Foundation of Australia Endowed Chair; Breast Cancer Research Foundation, New York; European Union's Horizon 2020 Research and Innovation Programme under the Marie Sklodowska-Curie grant; UCL Biomedical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); NIH Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UKI NETs; The Francis Crick Institute; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study is funded by a Cancer Research UK Career Establishment Award to Y.Y. (C45982/A21808). The TRACERx study (ClinicalTrials.gov: NCT01888601) is sponsored by University College London (UCL) (UCL/12/0279) and has been approved by an independent research ethics committee (13/LO/1546). TRACERx is funded by Cancer Research UK (C11496/A17786) and coordinated through the Cancer Research UK and UCL Cancer Trials Centre. Y.Y. acknowledges additional support from Breast Cancer Now (2015NovPR638), Children's Cancer and Leukaemia Group (CCLGA201906), National Institutes of Health (NIH) U54 CA217376 and R01 CA185138, CDMRP Breast Cancer Research Program Award BC132057, European Commission ITN (H2020-MSCA-ITN-2019), Wellcome Trust (105104/Z/14/Z) and The Royal Marsden/ICR National Institute of Health Research Biomedical Research Centre. C.S. is a Royal Society Napier Research Professor. This work was supported by the Francis Crick Institute, which receives its core funding from Cancer Research UK (FC001169,FC001202), the UK Medical Research Council (FC001169, FC001202) and the Wellcome Trust (FC001169, FC001202). C.S. is funded by Cancer Research UK (TRACERx, PEACE and Cancer Research UK Cancer Immunotherapy Catalyst Network), the Cancer Research UK Lung Cancer Centre of Excellence, the Rosetrees Trust, NovoNordisk Foundation (ID16584) and the Breast Cancer Research Foundation. This research is supported by a Stand Up To Cancer-LUNGevity-American Lung Association Lung Cancer Interception Dream Team Translational Research Grant (grant number: SU2C-AACR-DT23-17). Stand Up To Cancer is a program of the Entertainment Industry Foundation. Research grants are administered by the American Association for Cancer Research, the Scientific Partner of SU2C. C.S. receives funding from the European Research Council (ERC) under the European Union's Seventh Framework Programme (FP7/2007-2013) Consolidator Grant (FP7-THESEUS-617844), European Commission ITN (FP7-PloidyNet 607722), an ERC Advanced Grant (PROTEUS) from the European Research Council under the European Union's Horizon 2020 Research and Innovation Programme (grant agreement 835297) and Chromavision from the European Union's Horizon 2020 Research and Innovation Programme (grant agreement 665233). S.A.Q. is funded by a Cancer Research UK Senior Cancer Research Fellowship (C36463/A22246) and a Cancer Research UK Biotherapeutic Program Grant (C36463/A20764). S.L. is supported by the National Breast Cancer Foundation of Australia Endowed Chair and the Breast Cancer Research Foundation, New York. L.Z. has received funding from the European Union's Horizon 2020 Research and Innovation Programme under the Marie Sklodowska-Curie grant agreement 846614. C.T.H. is funded by the UCL Biomedical Research Council. M.J.H. has received funding from Cancer Research UK, NIH Research, Rosetrees Trust and UKI NETs. We thank the members of the TRACERx and PEACE consortia for participating in this study. We thank the Tissue Image Analytics laboratory at the University of Warwick for their help in method implementation. We thank the Scientific Computing team at the Institute of Cancer Research for technical support. We also thank A. Teodosio and C. Ficken from the MRC Toxicology Unit Core Histology facility for their expert technical assistance.	Abadi M, 2016, PROCEEDINGS OF OSDI'16: 12TH USENIX SYMPOSIUM ON OPERATING SYSTEMS DESIGN AND IMPLEMENTATION, P265; Chen DS, 2017, NATURE, V541, P321, DOI 10.1038/nature21349; Collisson EA, 2014, NATURE, V511, P543, DOI 10.1038/nature13385; Costa A, 2018, CANCER CELL, V33, P463, DOI 10.1016/j.ccell.2018.01.011; Danaher P, 2017, J IMMUNOTHER CANCER, V5, DOI 10.1186/s40425-017-0215-8; DUBUC B, 1989, PHYS REV A, V39, P1500, DOI 10.1103/PhysRevA.39.1500; Francis K, 1997, P NATL ACAD SCI USA, V94, P12258, DOI 10.1073/pnas.94.23.12258; Giesen C, 2014, NAT METHODS, V11, P417, DOI [10.1038/NMETH.2869, 10.1038/nmeth.2869]; Goltsev Y, 2018, CELL, V174, P968, DOI 10.1016/j.cell.2018.07.010; Hammerman PS, 2012, NATURE, V489, P519, DOI 10.1038/nature11404; Heindl A, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06130-3; Heindl A, 2018, JNCI-J NATL CANCER I, V110, DOI 10.1093/jnci/djx137; Hendry S, 2017, ADV ANAT PATHOL, V24, P311, DOI 10.1097/PAP.0000000000000161; Holzinger A, 1996, HYBRIDOMA, V15, P49, DOI 10.1089/hyb.1996.15.49; Jamal-Hanjani M, 2017, NEW ENGL J MED, V376, P2109, DOI 10.1056/NEJMoa1616288; Jia QZ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07767-w; Joyce JA, 2015, SCIENCE, V348, P74, DOI 10.1126/science.aaa6204; Keren L, 2018, CELL, V174, P1373, DOI 10.1016/j.cell.2018.08.039; Matoso A, 2010, APPL IMMUNOHISTO M M, V18, P142, DOI 10.1097/PAI.0b013e3181bdf4e7; McGranahan N, 2017, CELL, V170, P825, DOI 10.1016/j.cell.2017.08.012; McGranahan N, 2016, SCIENCE, V351, P1463, DOI 10.1126/science.aaf1490; Milo I, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aat1435; Moisy F, 2004, J FLUID MECH, V513, P111, DOI 10.1017/S0022112004009802; Moore DA, 2019, MODERN PATHOL, V32, P1095, DOI 10.1038/s41379-019-0257-1; Morris LGT, 2019, CANCER CELL, V35, P711, DOI 10.1016/j.ccell.2019.04.009; Morris LGT, 2016, ONCOTARGET, V7, P10051, DOI 10.18632/oncotarget.7067; Nawaz S, 2015, MODERN PATHOL, V28, P766, DOI 10.1038/modpathol.2015.37; Ohlund D, 2017, J EXP MED, V214, P579, DOI 10.1084/jem.20162024; Pelosi G, 2012, J THORAC ONCOL, V7, P281, DOI 10.1097/JTO.0b013e31823815d3; Raza SEA, 2019, MED IMAGE ANAL, V52, P160, DOI 10.1016/j.media.2018.12.003; Rosenthal R, 2019, NATURE, V567, P479, DOI 10.1038/s41586-019-1032-7; Salmon H, 2012, J CLIN INVEST, V122, P899, DOI 10.1172/JCI45817; Shafer ABA, 2013, ECOL LETT, V16, P940, DOI 10.1111/ele.12120; Sirinukunwattana K, 2016, IEEE T MED IMAGING, V35, P1196, DOI 10.1109/TMI.2016.2525803; Sorokin L, 2010, NAT REV IMMUNOL, V10, P712, DOI 10.1038/nri2852; Thomas A, 2015, NAT REV CLIN ONCOL, V12, P511, DOI 10.1038/nrclinonc.2015.90; Thomas DA, 2005, CANCER CELL, V8, P369, DOI 10.1016/j.ccr.2005.10.012; Whittaker KA, 2017, P NATL ACAD SCI USA, V114, P2651, DOI 10.1073/pnas.1612346114; Yuan YY, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2014.1153	39	98	99	5	25	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	JUL	2020	26	7					1054	+		10.1038/s41591-020-0900-x	http://dx.doi.org/10.1038/s41591-020-0900-x		MAY 2020	30	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	MK3XO	32461698	Green Accepted, Green Submitted			2022-12-27	WOS:000535873800003
J	Whiffin, N; Armean, IM; Kleinman, A; Marshall, JL; Minikel, EV; Goodrich, JK; Quaife, NM; Cole, JB; Wang, QB; Karczewski, KJ; Cummings, BB; Francioli, L; Laricchia, K; Guan, AN; Alipanahi, B; Morrison, P; Baptista, MAS; Merchant, KM; Ware, JS; Havulinna, AS; Iliadou, B; Lee, JJ; Nadkarni, GN; Whiteman, C; Daly, M; Esko, T; Hultman, C; Loos, RJF; Milani, L; Palotie, A; Pato, C; Pato, M; Saleheen, D; Sullivan, PF; Alfoldi, J; Cannon, P; MacArthur, DG				Whiffin, Nicola; Armean, Irina M.; Kleinman, Aaron; Marshall, Jamie L.; Minikel, Eric V.; Goodrich, Julia K.; Quaife, Nicholas M.; Cole, Joanne B.; Wang, Qingbo; Karczewski, Konrad J.; Cummings, Beryl B.; Francioli, Laurent; Laricchia, Kristen; Guan, Anna; Alipanahi, Babak; Morrison, Peter; Baptista, Marco A. S.; Merchant, Kalpana M.; Ware, James S.; Havulinna, Aki S.; Iliadou, Bozenna; Lee, Jung-Jin; Nadkarni, Girish N.; Whiteman, Cole; Daly, Mark; Esko, Tonu; Hultman, Christina; Loos, Ruth J. F.; Milani, Lili; Palotie, Aarno; Pato, Carlos; Pato, Michele; Saleheen, Danish; Sullivan, Patrick F.; Alfoldi, Jessica; Cannon, Paul; MacArthur, Daniel G.		Genome Aggregation Database; Genome Aggregation Database; 23andMe Res Team	The effect of LRRK2 loss-of-function variants in humans	NATURE MEDICINE			English	Article							DISEASE-ASSOCIATED MUTATIONS; PARKINSONS-DISEASE; EPIDEMIOLOGY; COHORT; GENE	Analysis of large genomic datasets, including gnomAD, reveals that partial LRRK2 loss of function is not strongly associated with diseases, serving as an example of how human genetics can be leveraged for target validation in drug discovery. Human genetic variants predicted to cause loss-of-function of protein-coding genes (pLoF variants) provide natural in vivo models of human gene inactivation and can be valuable indicators of gene function and the potential toxicity of therapeutic inhibitors targeting these genes(1,2). Gain-of-kinase-function variants in LRRK2 are known to significantly increase the risk of Parkinson's disease(3,4), suggesting that inhibition of LRRK2 kinase activity is a promising therapeutic strategy. While preclinical studies in model organisms have raised some on-target toxicity concerns(5-8), the biological consequences of LRRK2 inhibition have not been well characterized in humans. Here, we systematically analyze pLoF variants in LRRK2 observed across 141,456 individuals sequenced in the Genome Aggregation Database (gnomAD)(9), 49,960 exome-sequenced individuals from the UK Biobank and over 4 million participants in the 23andMe genotyped dataset. After stringent variant curation, we identify 1,455 individuals with high-confidence pLoF variants in LRRK2. Experimental validation of three variants, combined with previous work(10), confirmed reduced protein levels in 82.5% of our cohort. We show that heterozygous pLoF variants in LRRK2 reduce LRRK2 protein levels but that these are not strongly associated with any specific phenotype or disease state. Our results demonstrate the value of large-scale genomic databases and phenotyping of human loss-of-function carriers for target validation in drug discovery.	[Whiffin, Nicola; Quaife, Nicholas M.; Ware, James S.] Imperial Coll London, Natl Heart & Lung Inst, London, England; [Whiffin, Nicola; Quaife, Nicholas M.; Ware, James S.] Imperial Coll London, MRC London Inst Med Sci, London, England; [Whiffin, Nicola; Quaife, Nicholas M.; Ware, James S.] Royal Brompton & Harefield Hosp NHS Trust, Cardiovasc Res Ctr, London, England; [Whiffin, Nicola; Armean, Irina M.; Marshall, Jamie L.; Minikel, Eric V.; Goodrich, Julia K.; Cole, Joanne B.; Wang, Qingbo; Karczewski, Konrad J.; Cummings, Beryl B.; Francioli, Laurent; Laricchia, Kristen; Ware, James S.; Daly, Mark; Esko, Tonu; Alfoldi, Jessica; MacArthur, Daniel G.] Broad Inst MIT & Harvard, Program Med & Populat Genet, Cambridge, MA 02142 USA; [Armean, Irina M.; Goodrich, Julia K.; Wang, Qingbo; Karczewski, Konrad J.; Cummings, Beryl B.; Francioli, Laurent; Laricchia, Kristen; Daly, Mark; Palotie, Aarno; Alfoldi, Jessica; MacArthur, Daniel G.] Massachusetts Gen Hosp, Analyt & Translat Genet Unit, Boston, MA 02114 USA; [Kleinman, Aaron; Guan, Anna; Alipanahi, Babak; Morrison, Peter; Cannon, Paul] 23andMe Inc, Sunnyvale, CA USA; [Cole, Joanne B.] Broad Inst MIT & Harvard, Program Metab, Cambridge, MA 02142 USA; [Cole, Joanne B.] Massachusetts Gen Hosp, Ctr Genom Med, Boston, MA 02114 USA; [Cole, Joanne B.] Boston Childrens Hosp, Div Endocrinol, Boston, MA USA; [Cole, Joanne B.] Boston Childrens Hosp, Ctr Basic & Translat Obes Res, Boston, MA USA; [Wang, Qingbo] Harvard Med Sch, Program Bioinformat & Integrat Genom, Boston, MA 02115 USA; [Cummings, Beryl B.] Harvard Med Sch, Program Biol & Biomed Sci, Boston, MA 02115 USA; [Baptista, Marco A. S.; Merchant, Kalpana M.] Michael J Fox Fdn, New York, NY USA; [Havulinna, Aki S.; Palotie, Aarno] Univ Helsinki, HiLIFE, Inst Mol Med Finland FIMM, Helsinki, Finland; [Havulinna, Aki S.; Daly, Mark] Natl Inst Hlth & Welf, Helsinki, Finland; [Iliadou, Bozenna; Hultman, Christina; Sullivan, Patrick F.] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Lee, Jung-Jin; Saleheen, Danish] Univ Penn, Dept Biostat & Epidemiol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Nadkarni, Girish N.; Loos, Ruth J. F.] Icahn Sch Med Mt Sinai, Charles Bronfman Inst Personalized Med, New York, NY 10029 USA; [Nadkarni, Girish N.; Hultman, Christina] Icahn Sch Med Mt Sinai, Dept Med, New York, NY 10029 USA; [Whiteman, Cole; Pato, Carlos; Pato, Michele] Suny Downstate Med Ctr, Dept Psychiat & Behav Sci, New York, NY USA; [Daly, Mark; Palotie, Aarno] Broad Inst MIT & Harvard, Stanley Ctr Psychiat Res, Cambridge, MA 02142 USA; [Esko, Tonu; Milani, Lili] Univ Tartu, Inst Genom, Estonian Genome Ctr, Tartu, Estonia; [Loos, Ruth J. F.] Icahn Sch Med Mt Sinai, Mindich Child Hlth & Dev Inst, New York, NY 10029 USA; [Saleheen, Danish] Univ Penn, Dept Med, Perelman Sch Med, Philadelphia, PA 19104 USA; [Saleheen, Danish] Ctr Noncommunicable Dis, Karachi, Pakistan; [Sullivan, Patrick F.] Univ N Carolina, Dept Genet, Chapel Hill, NC 27515 USA; [Sullivan, Patrick F.] Univ N Carolina, Dept Psychiat, Chapel Hill, NC 27515 USA; [Alipanahi, Babak] Google Inc, Mountain View, CA USA; [MacArthur, Daniel G.] Garvan Inst Med Res, Ctr Populat Genom, Sydney, NSW, Australia; [MacArthur, Daniel G.] UNSW Sydney, Sydney, NSW, Australia; [MacArthur, Daniel G.] Murdoch Childrens Res Inst, Ctr Populat Genom, Melbourne, Vic, Australia	Imperial College London; Imperial College London; Royal Brompton & Harefield NHS Foundation Trust; Harefield Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts General Hospital; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; University of Helsinki; Finland National Institute for Health & Welfare; Karolinska Institutet; University of Pennsylvania; Pennsylvania Medicine; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of Tartu; Icahn School of Medicine at Mount Sinai; University of Pennsylvania; Pennsylvania Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Google Incorporated; Garvan Institute of Medical Research; University of New South Wales Sydney; Murdoch Children's Research Institute	Whiffin, N (corresponding author), Imperial Coll London, Natl Heart & Lung Inst, London, England.; Whiffin, N (corresponding author), Imperial Coll London, MRC London Inst Med Sci, London, England.; Whiffin, N (corresponding author), Royal Brompton & Harefield Hosp NHS Trust, Cardiovasc Res Ctr, London, England.; Whiffin, N; MacArthur, DG (corresponding author), Broad Inst MIT & Harvard, Program Med & Populat Genet, Cambridge, MA 02142 USA.; MacArthur, DG (corresponding author), Massachusetts Gen Hosp, Analyt & Translat Genet Unit, Boston, MA 02114 USA.; MacArthur, DG (corresponding author), Garvan Inst Med Res, Ctr Populat Genom, Sydney, NSW, Australia.; MacArthur, DG (corresponding author), UNSW Sydney, Sydney, NSW, Australia.; MacArthur, DG (corresponding author), Murdoch Childrens Res Inst, Ctr Populat Genom, Melbourne, Vic, Australia.	n.whiffin@imperial.ac.uk; d.macarthur@garvan.org.au	Goodrich, Julia/ABD-8368-2021; Loos, Ruth/GON-5877-2022; Cole, Joanne B/GVU-0658-2022; Palmer, Colin NA/C-7053-2008; Havulinna, Aki/AAM-4769-2021; Ware, James S/G-5139-2012; sokol, harry/E-2290-2019; Erdmann, Jeanette/P-7513-2014; Ma, Ronald/C-2788-2009; Bown, Matthew/P-1957-2016; Loos, Ruth/Q-2862-2016; Glaser, Benjamin/F-8411-2017	Palmer, Colin NA/0000-0002-6415-6560; Ware, James S/0000-0002-6110-5880; sokol, harry/0000-0002-2914-1822; Melander, Olle/0000-0002-2581-484X; ELOSUA, ROBERTO/0000-0001-8235-0095; Erdmann, Jeanette/0000-0002-4486-6231; Tai, E Shyong/0000-0003-2929-8966; solinas, emilia/0000-0003-3532-1317; Ma, Ronald/0000-0002-1227-803X; Palotie, Aarno/0000-0002-2527-5874; Quaife, Nicholas/0000-0003-2755-2086; Bown, Matthew/0000-0002-6180-3611; Cibulskis, Kristian/0000-0003-1343-1582; Loos, Ruth/0000-0002-8532-5087; Alipanahi, Babak/0000-0001-8216-7178; Cole, Joanne/0000-0001-9520-2788; Wang, Qingbo/0000-0002-9110-5830; Armean, Irina/0000-0002-1043-4756; MacArthur, Daniel/0000-0002-5771-2290; Glaser, Benjamin/0000-0003-4711-5000; Solomonson, Matthew/0000-0002-5344-9026; Whiffin, Nicola/0000-0003-1554-6594; Marshall, Jamie/0000-0002-2364-391X	Rosetrees and Stoneygate Imperial College Research Fellowship; National Institutes of Health [F31 AI22592]; NIGMS [F32 GM115208, R01GM104371]; Michael J. Fox Foundation for Parkinson's Research [12868]; NIDDK [U54DK105566]; Wellcome Trust [107469/Z/15/Z]; Medical Research Council (UK); NIHR Royal Brompton Biomedical Research Unit; NIHR Imperial Biomedical Research Centre; Estonian Research Council [PUT1660, PRG184]; UK Biobank Resource [42890]; MRC [MC_UP_1102/20] Funding Source: UKRI	Rosetrees and Stoneygate Imperial College Research Fellowship; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Michael J. Fox Foundation for Parkinson's Research; NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIHR Royal Brompton Biomedical Research Unit; NIHR Imperial Biomedical Research Centre; Estonian Research Council(Estonian Research Council); UK Biobank Resource; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank the research participants and employees of 23andMe, Inc. and the research participants in gnomAD and the UK Biobank, for making this work possible. N. Whiffin is supported by a Rosetrees and Stoneygate Imperial College Research Fellowship. E.V. Minikel is supported by National Institutes of Health F31 AI22592. K.J.K. was supported by NIGMS F32 GM115208. This work was supported by the Michael J. Fox Foundation for Parkinson's Research grant 12868, NIDDK U54DK105566, NIGMS R01GM104371, Wellcome Trust (107469/Z/15/Z); Medical Research Council (UK); NIHR Royal Brompton Biomedical Research Unit; NIHR Imperial Biomedical Research Centre. T.E is supported by Estonian Research Council grant PUT1660. L.M. is supported by Estonian Research Council grant PRG184. This research has been conducted using the UK Biobank Resource (https://doi.org/10.1101/572347) under Application Number 42890.	Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Andersen MA, 2018, TOXICOLOGY, V395, P15, DOI 10.1016/j.tox.2018.01.003; [Anonymous], 2014, NEW ENGL J MED, V371, P2072, DOI DOI 10.1056/NEJMOA1405386; Baptista MAS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080705; Bellenguez C, 2012, BIOINFORMATICS, V28, P134, DOI 10.1093/bioinformatics/btr599; Blauwendraat C, 2018, JAMA NEUROL, V75, P1416, DOI 10.1001/jamaneurol.2018.1885; Borodulin K, 2018, INT J EPIDEMIOL, V47, P696, DOI 10.1093/ije/dyx239; Chen JH, 2018, EUR NEUROL, V79, P256, DOI 10.1159/000488938; Chen ZC, 2017, SCI SIGNAL, V10, DOI 10.1126/scisignal.aam6790; Cohen JC, 2006, NEW ENGL J MED, V354, P1264, DOI 10.1056/NEJMoa054013; Crosby J, 2014, NEW ENGL J MED, V371, P22, DOI 10.1056/NEJMoa1307095; Cummings B. B., 2019, TRANSCRIPT EXPRESSIO, DOI [10.1101/554444, DOI 10.1101/554444]; Dale RK, 2011, BIOINFORMATICS, V27, P3423, DOI 10.1093/bioinformatics/btr539; Daniel G, 2015, CURR TOP BEHAV NEURO, V22, P331, DOI 10.1007/7854_2014_311; de Lau LML, 2006, LANCET NEUROL, V5, P525, DOI 10.1016/S1474-4422(06)70471-9; Di Maio R, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aar5429; Do CB, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002141; Freidlin B, 2002, HUM HERED, V53, P146, DOI 10.1159/000064976; Fuji RN, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa3634; Genovese G, 2016, NAT NEUROSCI, V19, P1433, DOI 10.1038/nn.4402; Goldwurm S, 2007, NEUROLOGY, V68, P1141, DOI 10.1212/01.wnl.0000254483.19854.ef; Greggio E, 2006, NEUROBIOL DIS, V23, P329, DOI 10.1016/j.nbd.2006.04.001; Gupta RP, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-015381; Hinkle KM, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-25; Hout C.V.V, 2019, BIORXIV, DOI DOI 10.1101/572347; Karczewski K.J., 2019, GENOMICS, DOI [10.1101/531210, DOI 10.1101/531210]; Klein C, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a008888; Leitsalu L, 2015, INT J EPIDEMIOL, V44, P1137, DOI 10.1093/ije/dyt268; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Levey AS, 2010, AM J KIDNEY DIS, V55, P622, DOI 10.1053/j.ajkd.2010.02.337; Lian XJ, 2012, P NATL ACAD SCI USA, V109, pE1848, DOI 10.1073/pnas.1200250109; MacArthur DG, 2012, SCIENCE, V335, P823, DOI 10.1126/science.1215040; MacLeod D, 2006, NEURON, V52, P587, DOI 10.1016/j.neuron.2006.10.008; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; McLaren W, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0974-4; Minikel E. V, 2019, EVALUATING POTENTIAL, DOI [10.1101/530881, DOI 10.1101/530881]; Minikel EV, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad5169; Mir R, 2018, BIOCHEM J, V475, P1861, DOI 10.1042/BCJ20180248; Naito Y, 2015, BIOINFORMATICS, V31, P1120, DOI 10.1093/bioinformatics/btu743; Nelson MR, 2015, NAT GENET, V47, P856, DOI 10.1038/ng.3314; Pato MT, 2013, AM J MED GENET B, V162B, P306, DOI 10.1002/ajmg.b.32160; Plenge RM, 2013, NAT REV DRUG DISCOV, V12, P581, DOI 10.1038/nrd4051; Polymeropoulos MH, 1996, SCIENCE, V274, P1197, DOI 10.1126/science.274.5290.1197; Ripke S, 2013, NAT GENET, V45, P1150, DOI 10.1038/ng.2742; Roosen DA, 2016, MOL NEURODEGENER, V11, DOI 10.1186/s13024-016-0140-1; Ruderfer DM, 2018, CELL, V173, P1705, DOI 10.1016/j.cell.2018.05.046; Saleheen D, 2017, NATURE, V544, P235, DOI 10.1038/nature22034; Steger M, 2016, ELIFE, V5, DOI 10.7554/eLife.12813; Walter K, 2015, NATURE, V526, P82, DOI 10.1038/nature14962; West AB, 2005, P NATL ACAD SCI USA, V102, P16842, DOI 10.1073/pnas.0507360102; West AB, 2007, HUM MOL GENET, V16, P223, DOI 10.1093/hmg/ddl471; Zhao HT, 2017, MOL THER-NUCL ACIDS, V8, P508, DOI 10.1016/j.omtn.2017.08.002; Zimprich A, 2004, NEURON, V44, P601, DOI 10.1016/j.neuron.2004.11.005	54	54	54	4	6	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	JUN	2020	26	6					869	+		10.1038/s41591-020-0893-5	http://dx.doi.org/10.1038/s41591-020-0893-5		MAY 2020	18	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	LZ3ZG	32461697	Green Published, Green Submitted, hybrid			2022-12-27	WOS:000535873800002
J	Giordano, G; Blanchini, F; Bruno, R; Colaneri, P; Di Filippo, A; Di Matteo, A; Colaneri, M				Giordano, Giulia; Blanchini, Franco; Bruno, Raffaele; Colaneri, Patrizio; Di Filippo, Alessandro; Di Matteo, Angela; Colaneri, Marta			Modelling the COVID-19 epidemic and implementation of population-wide interventions in Italy	NATURE MEDICINE			English	Article							CORONAVIRUS; WUHAN	In Italy, 128,948 confirmed cases and 15,887 deaths of people who tested positive for SARS-CoV-2 were registered as of 5 April 2020. Ending the global SARS-CoV-2 pandemic requires implementation of multiple population-wide strategies, including social distancing, testing and contact tracing. We propose a new model that predicts the course of the epidemic to help plan an effective control strategy. The model considers eight stages of infection: susceptible (S), infected (I), diagnosed (D), ailing (A), recognized (R), threatened (T), healed (H) and extinct (E), collectively termed SIDARTHE. Our SIDARTHE model discriminates between infected individuals depending on whether they have been diagnosed and on the severity of their symptoms. The distinction between diagnosed and non-diagnosed individuals is important because the former are typically isolated and hence less likely to spread the infection. This delineation also helps to explain misperceptions of the case fatality rate and of the epidemic spread. We compare simulation results with real data on the COVID-19 epidemic in Italy, and we model possible scenarios of implementation of countermeasures. Our results demonstrate that restrictive social-distancing measures will need to be combined with widespread testing and contact tracing to end the ongoing COVID-19 pandemic. A new epidemiological model, termed SIDARTHE, distinguishes between diagnosed and undiagnosed cases of SARS-CoV-2 infection, as well as modeling effects of social distancing and widespread testing, to predict possible outcomes of the COVID-19 epidemic in Italy.	[Giordano, Giulia] Univ Trento, Dept Ind Engn, Trento, Italy; [Blanchini, Franco] Univ Udine, Dipartimento Sci Matemat Informat & Fis, Udine, Italy; [Bruno, Raffaele; Di Filippo, Alessandro; Di Matteo, Angela; Colaneri, Marta] Fdn IRCCS Policlin San Matteo, Div Infect Dis 1, Pavia, Italy; [Bruno, Raffaele] Univ Pavia, Dept Clin Surg Diagnost & Paediat Sci, Pavia, Italy; [Colaneri, Patrizio] Politecn Milan, Dipartimento Elettron Informaz & Bioingn, Milan, Italy; [Colaneri, Patrizio] CNR, IEIIT, Milan, Italy	University of Trento; University of Udine; IRCCS Fondazione San Matteo; University of Pavia; Polytechnic University of Milan; Consiglio Nazionale delle Ricerche (CNR); Istituto di Elettronica e di Ingegneria dell'Informazione e delle Telecomunicazioni (IEIIT-CNR)	Giordano, G (corresponding author), Univ Trento, Dept Ind Engn, Trento, Italy.	giulia.giordano@unitn.it	Colaneri, Marta/AAC-3198-2022; Giordano, Giulia/L-5209-2015; Bruno, Raffaele/AAB-9491-2022; Blanchini, Franco/A-6513-2008	Colaneri, Marta/0000-0002-5939-9576; Giordano, Giulia/0000-0002-8600-1738; Bruno, Raffaele/0000-0002-0235-9207; Blanchini, Franco/0000-0002-4109-5531; patrizio, colaneri/0000-0002-6465-0737	Italian grant PRIN 2017 'Monitoring and Control Underpinning the Energy-Aware Factory of the Future: Novel Methodologies and Industrial Validation' [2017YKXYXJ]	Italian grant PRIN 2017 'Monitoring and Control Underpinning the Energy-Aware Factory of the Future: Novel Methodologies and Industrial Validation'	We acknowledge the huge efforts of the whole COVID-19 IRCCS San Matteo Pavia Task Force. ID staff: R. Bruno, M.U. Mondelli, E. Brunetti, A. Di Matteo, E. Seminari, L. Maiocchi, V. Zuccaro, L. Pagnucco, B. Mariani, S. Ludovisi, R. Lissandrin, A. Parisi, P. Sacchi, S.F.A. Patruno, G. Michelone, R. Gulminetti, D. Zanaboni, S. Novati, R. Maserati, P. Orsolini, M. Vecchia. ID residents: M. Sciarra, E. Asperges, M. Colaneri, A. Di Filippo, M. Sambo, S. Biscarini, M. Lupi, S. Roda, T. Chiara Pieri, I. Gallazzi, M. Sachs, P. Valsecchi. Emergency Care Unit (ECU) staff: S. Perlini, C. Alfano, M. Bonzano, F. Briganti, G. Crescenzi, A.G. Falchi, R. Guarnone, B. Guglielmana, E. Maggi, I. Martino, P. Pettenazza, S. Pioli di Marco, F. Quaglia, A. Sabena, F. Salinaro, F. Speciale, I. Zunino. ECU residents: M. De Lorenzo, G. Secco, L. Dimitry, G. Cappa, I. Maisak, B. Chiodi, M. Sciarrini, B. Barcella, F. Resta, L. Moroni, G. Vezzoni, L. Scattaglia, E. Boscolo, C. Zattera, M. Fidel Tassi, V. Capozza, D. Vignaroli, M. Bazzini. Intensive care unit: G. Iotti, F. Mojoli, M. Belliato, L. Perotti, S. Mongodi, G. Tavazzi. Paediatric unit: G. Marseglia, A. Licari, I. Brambilla. Virology staff: D. Barbarini, A. Bruno, P. Cambieri, G. Campanini, G. Comolli, M. Corbella, R. Daturi, M. Furione, B. Mariani, R. Maserati, E. Monzillo, S. Paolucci, M. Parea, E. Percivalle, A. Piralla, F. Rovida, A. Sarasini, M. Zavattoni. Virology technical staff: G. Adzasehoun, L. Bellotti, E. Cabano, G. Casali, L. Dossena, G. Frisco, G. Garbagnoli, A. Girello, V. Landini, C. Lucchelli, V. Maliardi, S. Pezzaia, M. Premoli. Virology residents: A. Bonetti, G. Caneva, I. Cassaniti, A. Corcione, R. Di Martino, A. Di Napoli, A. Ferrari, G. Ferrari, L. Fiorina, F. Giardina, A. Mercato, F. Novazzi, G. Ratano, B. Rossi, I.M. Sciabica, M. Tallarita, E. Vecchio Nepita, P. Marone. Pharmacy unit: M. Calvi, M. Tizzoni. Hospital Leadership: C. Nicora, A. Triarico, V. Petronella, C. Marena, A. Muzzi, P. Lago, S. Cutti, V. Novelli. Data unit: F. Comandatore, G. Bissignandi, S. Gaiarsa, M. Rettani, C. Bandi, A. Ferrari. Also, we acknowledge financial support through Italian grant PRIN 2017 'Monitoring and Control Underpinning the Energy-Aware Factory of the Future: Novel Methodologies and Industrial Validation' (ID 2017YKXYXJ).	Anastassopoulou C, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0230405; ANDERSON R M, 1991; [Anonymous], 2020, COMMUNICATION   0329; Brauer F., 2012, MATH MODELS POPULATI, DOI 10.1007/978-1-4614-1686-9; Casella F, 2020, ARXIV200306967; Chang YC, POTENTIAL THERAPEUTI; Chen DB, 2020, INT J INFECT DIS, V93, P297, DOI 10.1016/j.ijid.2020.03.003; Chen WH, 2020, CURR TROP MED REP, V7, P61, DOI 10.1007/s40475-020-00201-6; Corman VM, 2020, EUROSURVEILLANCE, V25, P23, DOI 10.2807/1560-7917.ES.2020.25.3.2000045; Diao B, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.00827; Diekmann O., 2000, MATH EPIDEMIOLOGY IN; Ding LY, 2020, ADV ENG INFORM, V43, DOI 10.1016/j.aei.2019.100993; DOWD JB, 2020, DEMOGRAPHIC SCI AIDS, DOI DOI 10.1101/2020.03.15.20036293; Du ZW, 2020, EMERG INFECT DIS, V26, P1341, DOI [10.3201/eid2606.200357, 10.1101/2020.02.19.20025452]; Fineberg HV, 2020, NEW ENGL J MED, V382, DOI 10.1056/NEJMe2007263; Giuffrida A., 2020, GUARDIAN; Guan W, 2020, NEW ENGL J MED, V382, P1708, DOI 10.1056/NEJMoa2002032; Gumel AB, 2004, P ROY SOC B-BIOL SCI, V271, P2223, DOI 10.1098/rspb.2004.2800; Hellewell J, 2020, LANCET GLOB HEALTH, V8, pE488, DOI 10.1016/S2214-109X(20)30074-7; Hemida MG, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.44; Hethcote HW, 2000, SIAM REV, V42, P599, DOI 10.1137/S0036144500371907; Houser KV, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006565; Istituto Superiore di Sanita, REC PEOPL FAM IS THE; Istituto Superiore di Sanita, 2020, CHAR COVID 19 PAT DY; Italian Civil Protection, 2020, SIT IT 5 MARZ; Ji LN, 2020, WORLD J PEDIATR, V16, P267, DOI 10.1007/s12519-020-00356-2; Ji YP, 2020, LANCET GLOB HEALTH, V8, pE480, DOI 10.1016/S2214-109X(20)30068-1; Kermack WO, 1927, P R SOC LOND A-CONTA, V115, P700, DOI 10.1098/rspa.1927.0118; Kimball A, 2020, MMWR-MORBID MORTAL W, V69, P377, DOI 10.15585/mmwr.mm6913e1; King AA, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.0347; Kucharski AJ, 2020, LANCET INFECT DIS, V20, P553, DOI 10.1016/S1473-3099(20)30144-4; Lan L, 2020, JAMA-J AM MED ASSOC, V323, P1502, DOI 10.1001/jama.2020.2783; Li ZT, 2020, J MED VIROL, V92, P1518, DOI 10.1002/jmv.25727; Lin QY, 2020, INT J INFECT DIS, V93, P211, DOI 10.1016/j.ijid.2020.02.058; Majumder MS, 2014, PLOS CURR, V6, DOI [10.1371/currents.outbreaks.98d2f8f3382d84f390736cd5f5fe133c, DOI 10.1371/CURRENTS.OUTBREAKS.98D2F8F3382D84F390736CD5F5FE133C, https://doi.org/10.1371/currents.outbreaks.98d2f8f3382d84f390736cd5f5fe133c, DOI 10.1371/CURRENTS.OUTBREAKS.89C0D3783F36958D96EBBAE97348D571]; Nishiura H, 2020, INT J INFECT DIS, V93, P284, DOI 10.1016/j.ijid.2020.02.060; Peto J, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.m1163; Pung R, 2020, LANCET, V395, P1039, DOI 10.1016/S0140-6736(20)30528-6; Qian GQ, 2020, CLIN INFECT DIS, V71, P861, DOI 10.1093/cid/ciaa316; Read J. M., 2020, MEDRXIV, DOI 10.1101/2020.01.23.20018549; Remuzzi A, 2020, LANCET, V395, P1225, DOI 10.1016/S0140-6736(20)30627-9; Roosa K, 2020, J CLIN MED, V9, DOI 10.3390/jcm9020596; Rothe C, 2020, NEW ENGL J MED, V382, P970, DOI 10.1056/NEJMc2001468; Subbarao K, 2004, J VIROL, V78, P3572, DOI 10.1128/JVI.78.7.3572-3577.2004; Velavan TP, 2020, TROP MED INT HEALTH, V25, P278, DOI 10.1111/tmi.13383; Wang CY, 2020, J RISK FINANC MANAG, V13, DOI 10.3390/jrfm13020036; Wang ML, 2020, CELL RES, V30, P269, DOI 10.1038/s41422-020-0282-0; Wang YX, 2020, J MED VIROL, V92, P568, DOI 10.1002/jmv.25748; WHO, 2020, 76 WHO; Wu JM, 2022, CRIT REV FOOD SCI, V62, P783, DOI [10.1080/10408398.2020.1828813, 10.1038/s41591-020-0822-7]; Wu ZY, 2020, JAMA-J AM MED ASSOC, V323, P1239, DOI 10.1001/jama.2020.2648; Zhao S, 2020, INT J INFECT DIS, V92, P214, DOI 10.1016/j.ijid.2020.01.050; Zou LR, 2020, NEW ENGL J MED, V382, P1177, DOI 10.1056/NEJMc2001737	53	801	808	14	95	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	JUN	2020	26	6					855	+		10.1038/s41591-020-0883-7	http://dx.doi.org/10.1038/s41591-020-0883-7		APR 2020	30	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	LZ3ZG	32322102	Green Submitted, Green Published, Bronze			2022-12-27	WOS:000528109400001
J	Sovio, U; Goulding, N; McBride, N; Cook, E; Gaccioli, F; Charnock-Jones, DS; Lawlor, DA; Smith, GCS				Sovio, Ulla; Goulding, Neil; McBride, Nancy; Cook, Emma; Gaccioli, Francesca; Charnock-Jones, D. Stephen; Lawlor, Debbie A.; Smith, Gordon C. S.			A maternal serum metabolite ratio predicts fetal growth restriction at term	NATURE MEDICINE			English	Article							NULLIPAROUS WOMEN; BIRTH-WEIGHT; RISK; ULTRASONOGRAPHY; CONSEQUENCES; MANAGEMENT; COHORT; ONSET; BORN; POP	Fetal growth restriction (FGR) is the major single cause of stillbirth(1) and is also associated with neonatal morbidity and mortality(2,3), impaired health and educational achievement in childhood(4,5) and with a range of diseases in later life(6). Effective screening and intervention for FGR is an unmet clinical need. Here, we performed ultrahigh performance liquid chromatography-tandem mass spectroscopy (UPLC-MS/MS) metabolomics on maternal serum at 12, 20 and 28 weeks of gestational age (wkGA) using 175 cases of term FGR and 299 controls from the Pregnancy Outcome Prediction (POP) study, conducted in Cambridge, UK, to identify predictive metabolites. Internal validation using 36 wkGA samples demonstrated that a ratio of the products of the relative concentrations of two positively associated metabolites (1-(1-enyl-stearoyl)-2-oleoyl-GPC (P-18:0/18:1) and 1,5-anhydroglucitol) to the product of the relative concentrations of two negatively associated metabolites (5 alpha-androstan-3 alpha,17 alpha-diol disulfate and N1,N12-diacetylspermine) predicted FGR at term. The ratio had approximately double the discrimination as compared to a previously developed angiogenic biomarker(7), the soluble fms-like tyrosine kinase 1:placental growth factor (sFLT1:PlGF) ratio (AUC 0.78 versus 0.64, P = 0.0001). We validated the predictive performance of the metabolite ratio in two sub-samples of a demographically dissimilar cohort, Born in Bradford (BiB), conducted in Bradford, UK (P = 0.0002). Screening and intervention using this metabolite ratio in conjunction with ultrasonic imaging at around 36 wkGA could plausibly prevent adverse events through enhanced fetal monitoring and targeted induction of labor. The relative concentrations of four metabolites in maternal blood at 36 weeks of gestation predict fetal growth restriction in infants subsequently born at term, enabling enhanced fetal monitoring in pregnancies at risk.	[Sovio, Ulla; Cook, Emma; Gaccioli, Francesca; Charnock-Jones, D. Stephen; Smith, Gordon C. S.] Univ Cambridge, Dept Obstet & Gynaecol, Cambridge, England; [Sovio, Ulla; Cook, Emma; Gaccioli, Francesca; Charnock-Jones, D. Stephen; Smith, Gordon C. S.] NIHR Cambridge Biomed Res Ctr, Cambridge, England; [Sovio, Ulla; Gaccioli, Francesca; Charnock-Jones, D. Stephen; Smith, Gordon C. S.] Univ Cambridge, Ctr Trophoblast Res, Dept Physiol Dev & Neurosci, Cambridge, England; [Goulding, Neil; McBride, Nancy; Lawlor, Debbie A.] NIHR Bristol Biomed Res Ctr, Bristol, Avon, England; [Goulding, Neil; McBride, Nancy; Lawlor, Debbie A.] Univ Bristol, MRC Integrat Epidemiol Unit, Bristol, Avon, England; [Goulding, Neil; McBride, Nancy; Lawlor, Debbie A.] Univ Bristol Sch Med, Populat Hlth Sci, Bristol, Avon, England	University of Cambridge; University of Cambridge; University of Cambridge; University of Bristol; University of Bristol	Sovio, U (corresponding author), Univ Cambridge, Dept Obstet & Gynaecol, Cambridge, England.; Sovio, U (corresponding author), NIHR Cambridge Biomed Res Ctr, Cambridge, England.; Sovio, U (corresponding author), Univ Cambridge, Ctr Trophoblast Res, Dept Physiol Dev & Neurosci, Cambridge, England.	us253@medschl.cam.ac.uk	Charnock-Jones, D. Stephen/AAE-3391-2020; Sovio, Ulla/H-8532-2019; Smith, Gordon/A-8070-2008	Charnock-Jones, D. Stephen/0000-0002-2936-4890; Sovio, Ulla/0000-0002-0799-1105; Goulding, Neil/0000-0002-2488-4598; Gaccioli, Francesca/0000-0001-7178-8921; McBride, Nancy/0000-0003-4439-4710; Smith, Gordon/0000-0003-2124-0997; Lawlor, Debbie A/0000-0002-6793-2262	National Institute for Health Research (NIHR) Cambridge Biomedical Research Centre (Women's Health theme); Medical Research Council (MRC) [G1100221, MR/N024397/1]; Wellcome Trust [WT101597MA]; National Institutes of Health [R01 DK10324]; European Research Council [669545]; NIHR Biomedical Centre at the University Hospitals Bristol NHS Foundation Trust; University of Bristol (Reproductive and Perinatal Health theme); MRC [MC_UU_00011/6]; University of Bristol; MRC [MR/N024397/1, G1100221] Funding Source: UKRI	National Institute for Health Research (NIHR) Cambridge Biomedical Research Centre (Women's Health theme); Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Research Council(European Research Council (ERC)European Commission); NIHR Biomedical Centre at the University Hospitals Bristol NHS Foundation Trust; University of Bristol (Reproductive and Perinatal Health theme); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); University of Bristol; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The work was supported by the National Institute for Health Research (NIHR) Cambridge Biomedical Research Centre (Women's Health theme), the Medical Research Council (MRC) (G1100221 to G.C.S.S. and D.S.C.-J. and MR/N024397/1 to D.A.L.), the Wellcome Trust (WT101597MA), National Institutes of Health (R01 DK10324), the European Research Council (669545), and the NIHR Biomedical Centre at the University Hospitals Bristol NHS Foundation Trust and the University of Bristol (Reproductive and Perinatal Health theme), which funds N.M.'s PhD studentship. N.G., N.M. and D.A.L. work in a unit that receives support from the MRC (MC_UU_00011/6) and University of Bristol. The funders did not have any role in the design, analysis or preparation of the manuscript for publication. We are grateful to the participants in the POP and BiB studies and staff who recruited and assessed these participants. We thank L. Bibby, S. Ranawaka, K. Holmes, J. Gill and R. Millar for technical assistance.	Barker DJP, 2006, CLIN OBSTET GYNECOL, V49, P270, DOI 10.1097/00003081-200606000-00009; Bricker L, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001451.pub4; Brien M, 2017, PLACENTA, V51, P82, DOI 10.1016/j.placenta.2017.01.129; Brosens I, 2011, AM J OBSTET GYNECOL, V204, P193, DOI 10.1016/j.ajog.2010.08.009; Chauhan SP, 2017, OBSTET GYNECOL, V130, P511, DOI [10.1097/aog.0000000000002199, 10.1097/AOG.0000000000002199]; Delaney SS, 2015, EUR J OBSTET GYN R B, V189, P55, DOI 10.1016/j.ejogrb.2015.03.021; ERIKSSON H, 1970, European Journal of Biochemistry, V12, P520, DOI 10.1111/j.1432-1033.1970.tb00881.x; Evans AM, 2009, ANAL CHEM, V81, P6656, DOI 10.1021/ac901536h; Gaccioli F, 2018, LANCET CHILD ADOLESC, V2, P569, DOI 10.1016/S2352-4642(18)30129-9; Gaccioli F, 2017, PLACENTA, V59, pS17, DOI 10.1016/j.placenta.2016.10.011; GARDOSI J, 1995, ULTRASOUND OBST GYN, V6, P168, DOI 10.1046/j.1469-0705.1995.06030168.x; Gardosi J, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f108; Gong S, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.120723; HADLOCK FP, 1991, RADIOLOGY, V181, P129, DOI 10.1148/radiology.181.1.1887021; Kallen B, 2013, EUR RESPIR J, V41, P671, DOI 10.1183/09031936.00041912; Kunz J, 1976, J Perinat Med, V4, P85, DOI 10.1515/jpme.1976.4.2.85; MacDonald TM, 2015, AUST NZ J OBSTET GYN, V55, P3, DOI 10.1111/ajo.12264; MacKay DF, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000289; Mifsud W, 2014, FETAL DIAGN THER, V36, P117, DOI 10.1159/000359969; Monier I, 2015, BJOG-INT J OBSTET GY, V122, P518, DOI 10.1111/1471-0528.13148; Moraitis AA, 2014, OBSTET GYNECOL, V124, P274, DOI 10.1097/AOG.0000000000000388; Neveux LM, 1996, PRENATAL DIAG, V16, P1115, DOI 10.1002/(SICI)1097-0223(199612)16:12<1115::AID-PD3>3.0.CO;2-6; Pasupathy Dharmintra, 2008, BMC Pregnancy Childbirth, V8, P51, DOI 10.1186/1471-2393-8-51; Raeside JI, 2017, YALE J BIOL MED, V90, P449; Raynor P, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-327; Reddy UM, 2010, OBSTET GYNECOL, V116, P1119, DOI 10.1097/AOG.0b013e3181f903f8; Royal College of Obstetricians & Gynaecologists, 2013, ROYAL COLL OBST GYN; Sharp SJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101176; Smith GCS, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001274; Sorensen S, 2011, CLIN CHEM, V57, P1023, DOI 10.1373/clinchem.2010.161299; Sovio U, 2020, INT J EPIDEMIOL, V49, P301, DOI 10.1093/ije/dyz098; Sovio U, 2017, HYPERTENSION, V69, P731, DOI 10.1161/HYPERTENSIONAHA.116.08620; Sovio U, 2015, LANCET, V386, P2089, DOI 10.1016/S0140-6736(15)00131-2; Spong CY, 2013, JAMA-J AM MED ASSOC, V309, P2445, DOI 10.1001/jama.2013.6235; TANAKA T, 1985, STEROIDS, V46, P649, DOI 10.1016/0039-128X(85)90028-5; Wright J, 2013, INT J EPIDEMIOL, V42, P978, DOI 10.1093/ije/dys112; Zeisler H, 2016, NEW ENGL J MED, V374, P13, DOI 10.1056/NEJMoa1414838	37	49	50	3	17	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	MAR	2020	26	3					348	+		10.1038/s41591-020-0804-9	http://dx.doi.org/10.1038/s41591-020-0804-9			15	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	KU0MC	32161413	Green Submitted			2022-12-27	WOS:000519405000021
J	Hayden, HS; Eng, A; Pope, CE; Brittnacher, MJ; Vo, AT; Weiss, EJ; Hager, KR; Martin, BD; Leung, DH; Heltshe, SL; Borenstein, E; Miller, SI; Hoffman, LR				Hayden, Hillary S.; Eng, Alexander; Pope, Christopher E.; Brittnacher, Mitchell J.; Vo, Anh T.; Weiss, Eli J.; Hager, Kyle R.; Martin, Bryan D.; Leung, Daniel H.; Heltshe, Sonya L.; Borenstein, Elhanan; Miller, Samuel I.; Hoffman, Lucas R.			Fecal dysbiosis in infants with cystic fibrosis is associated with early linear growth failure	NATURE MEDICINE			English	Article							HUMAN GUT MICROBIOME; ESCHERICHIA-COLI; 1ST YEAR; CHILDREN; COMPLICATIONS; NUTRITION	Most infants with cystic fibrosis (CF) have pancreatic exocrine insufficiency that results in nutrient malabsorption and requires oral pancreatic enzyme replacement. Newborn screening for CF has enabled earlier diagnosis, nutritional intervention and enzyme replacement for these infants, allowing most infants with CF to achieve their weight goals by 12 months of age(1). Nevertheless, most infants with CF continue to have poor linear growth during their first year of life(1). Although this early linear growth failure is associated with worse long-term respiratory function and survival(2,3), the determinants of body length in infants with CF have not been defined. Several characteristics of the CF gastrointestinal (GI) tract, including inflammation, maldigestion and malabsorption, may promote intestinal dysbiosis(4,5). As GI microbiome activities are known to affect endocrine functions(6,7), the intestinal microbiome of infants with CF may also impact growth. We identified an early, progressive fecal dysbiosis that distinguished infants with CF and low length from infants with CF and normal length. This dysbiosis included altered abundances of taxa that perform functions that are important for GI health, nutrient harvest and growth hormone signaling, including decreased abundance of Bacteroidetes and increased abundance of Proteobacteria. Thus, the GI microbiota represent a potential therapeutic target for the correction of low linear growth in infants with CF. Most infants with cystic fibrosis have poor early linear growth in their first year despite nutritional supplementation and treatment. Intestinal dysbiosis in these infants is associated with low length, suggesting a path for intervention.	[Hayden, Hillary S.; Brittnacher, Mitchell J.; Vo, Anh T.; Weiss, Eli J.; Hager, Kyle R.; Miller, Samuel I.; Hoffman, Lucas R.] Univ Washington, Dept Microbiol, Seattle, WA 98195 USA; [Eng, Alexander; Borenstein, Elhanan; Miller, Samuel I.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Pope, Christopher E.; Hoffman, Lucas R.] Univ Washington, Dept Pediat, Seattle, WA 98195 USA; [Martin, Bryan D.] Univ Washington, Dept Stat, Seattle, WA 98195 USA; [Leung, Daniel H.] Baylor Coll Med, Dept Pediat, Div Gastroenterol Hepatol & Nutr, Houston, TX 77030 USA; [Heltshe, Sonya L.] Seattle Childrens Res Inst, Cyst Fibrosis Fdn, Therapeut Dev Network Coordinating Ctr, Seattle, WA USA; [Borenstein, Elhanan] Univ Washington, Dept Comp Sci & Engn, Seattle, WA 98195 USA; [Borenstein, Elhanan] Tel Aviv Univ, Blavatnik Sch Comp Sci, Tel Aviv, Israel; [Borenstein, Elhanan] Tel Aviv Univ, Dept Clin Microbiol & Immunol, Sackler Fac Med, Tel Aviv, Israel; [Borenstein, Elhanan] Santa Fe Inst, Santa Fe, NM 87501 USA; [Miller, Samuel I.] Univ Washington, Dept Med, Seattle, WA 98195 USA; [Hoffman, Lucas R.] Seattle Childrens Hosp, Pulm & Sleep Med, Seattle, WA 98105 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Baylor College of Medicine; Cystic Fibrosis Foundation; Seattle Children's Hospital; University of Washington; University of Washington Seattle; Tel Aviv University; Tel Aviv University; Sackler Faculty of Medicine; The Santa Fe Institute; University of Washington; University of Washington Seattle; Seattle Children's Hospital	Miller, SI; Hoffman, LR (corresponding author), Univ Washington, Dept Microbiol, Seattle, WA 98195 USA.; Borenstein, E; Miller, SI (corresponding author), Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA.; Hoffman, LR (corresponding author), Univ Washington, Dept Pediat, Seattle, WA 98195 USA.; Borenstein, E (corresponding author), Univ Washington, Dept Comp Sci & Engn, Seattle, WA 98195 USA.; Borenstein, E (corresponding author), Tel Aviv Univ, Blavatnik Sch Comp Sci, Tel Aviv, Israel.; Borenstein, E (corresponding author), Tel Aviv Univ, Dept Clin Microbiol & Immunol, Sackler Fac Med, Tel Aviv, Israel.; Borenstein, E (corresponding author), Santa Fe Inst, Santa Fe, NM 87501 USA.; Miller, SI (corresponding author), Univ Washington, Dept Med, Seattle, WA 98195 USA.; Hoffman, LR (corresponding author), Seattle Childrens Hosp, Pulm & Sleep Med, Seattle, WA 98105 USA.	elbo@uw.edu; millersi@uw.edu; lhoffm@uw.edu	Hoffman, Lucas/AAX-1853-2021		National Institutes of Health [R01DK095869, K24HL141669, 5P30DK089507]; Cystic Fibrosis Foundation [SINGH15R0]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation)	This project was supported by grants from the National Institutes of Health (R01DK095869, K24HL141669, 5P30DK089507) and the Cystic Fibrosis Foundation (SINGH15R0). E.B. is a Faculty Fellow of the Edmond J. Safra Center for Bioinformatics at Tel Aviv University. We gratefully acknowledge the contributions of the principal investigators (including D. Borowitz, B. Ramsey and D. Gelfond), study site coordinators and participants of the BONUS and Healthy Infants Study.	Backhed F, 2015, CELL HOST MICROBE, V17, P690, DOI [10.1016/j.chom.2015.04.004, 10.1016/j.chom.2015.05.012]; Bassis CM, 2017, BMC MICROBIOL, V17, DOI 10.1186/s12866-017-0983-9; Boets E, 2015, NUTRIENTS, V7, P8916, DOI 10.3390/nu7115440; Borowitz D, 2013, CURR OPIN PULM MED, V19, P676, DOI 10.1097/MCP.0b013e3283659ef2; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Choo JM, 2015, SCI REP-UK, V5, DOI 10.1038/srep16350; De Lisle RC, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a009753; Debyser G, 2016, J CYST FIBROS, V15, P242, DOI 10.1016/j.jcf.2015.08.003; Deng HT, 2013, PATTERN RECOGN, V46, P3483, DOI 10.1016/j.patcog.2013.05.018; Elborn JS, 2016, LANCET, V388, P2519, DOI 10.1016/S0140-6736(16)00576-6; Gelfond D, 2013, CLIN GASTROENTEROL H, V11, P333, DOI 10.1016/j.cgh.2012.11.006; Gupta RW, 2013, J PEDIATR GASTR NUTR, V56, P397, DOI 10.1097/MPG.0b013e318282a8c2; Hildebrandt MA, 2009, GASTROENTEROLOGY, V137, P1716, DOI 10.1053/j.gastro.2009.08.042; Hoffman LR, 2014, CLIN INFECT DIS, V58, P396, DOI 10.1093/cid/cit715; Huang YH, 2017, J GASTROEN HEPATOL, V32, P1949, DOI 10.1111/jgh.13806; Imhann F, 2016, GUT, V65, P740, DOI 10.1136/gutjnl-2015-310376; Konstan MW, 2003, J PEDIATR-US, V142, P624, DOI 10.1067/mpd.2003.152; Lang A. J., 2016, General Technical Report - Southern Research Station, USDA Forest Service, P8; Leung DH, 2017, JAMA PEDIATR, V171, P546, DOI 10.1001/jamapediatrics.2017.0206; Manor O, 2016, SCI REP-UK, V6, DOI 10.1038/srep22493; Matamouros S, 2018, P NATL ACAD SCI USA, V115, P1605, DOI 10.1073/pnas.1714373115; Matel JL, 2009, SEMIN RESP CRIT CARE, V30, P579, DOI 10.1055/s-0029-1238916; Morgan XC, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-9-r79; Nielsen S, 2016, SCI REP-UK, V6, DOI 10.1038/srep24857; Ooi CY, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-36364-6; Owira PMO, 2008, JPEN-PARENTER ENTER, V32, P63, DOI 10.1177/014860710803200163; Pannaraj PS, 2017, JAMA PEDIATR, V171, P647, DOI 10.1001/jamapediatrics.2017.0378; Piper HG, 2018, SEMIN PEDIATR SURG, V27, P223, DOI 10.1053/j.sempedsurg.2018.07.007; Schirmer M, 2018, CELL HOST MICROBE, V24, P600, DOI 10.1016/j.chom.2018.09.009; Segata N, 2012, NAT METHODS, V9, P811, DOI [10.1038/NMETH.2066, 10.1038/nmeth.2066]; Stalvey MS, 2017, PEDIATRICS, V139, DOI 10.1542/peds.2016-2522; Subramanian S, 2014, NATURE, V510, P417, DOI 10.1038/nature13421; Tedjo DI, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126685; TRAN M, 1994, J PEDIATR GASTR NUTR, V19, P299, DOI 10.1097/00005176-199410000-00007; TREEM WR, 1994, J PEDIATR GASTR NUTR, V18, P159, DOI 10.1097/00005176-199402000-00007; VandenNeucker A, 1997, ACTA PAEDIATR, V86, P466; Vatanen T, 2018, NATURE, V562, P589, DOI 10.1038/s41586-018-0620-2; Vernocchi P, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0208171; Vogt JA, 2003, J NUTR, V133, P3145, DOI 10.1093/jn/133.10.3145; Wang YN, 2019, GUT MICROBES, V10, P367, DOI 10.1080/19490976.2018.1534512; Wilson DC, 1998, NUTRITION, V14, P792, DOI 10.1016/S0899-9007(98)00086-0; Yan J, 2018, CALCIFIED TISSUE INT, V102, P406, DOI 10.1007/s00223-018-0395-3; Yan J, 2016, P NATL ACAD SCI USA, V113, pE7554, DOI 10.1073/pnas.1607235113; Yen EH, 2013, J PEDIATR-US, V162, P530, DOI 10.1016/j.jpeds.2012.08.040; Yu ZT, 2004, BIOTECHNIQUES, V36, P808, DOI 10.2144/04365ST04	45	26	26	0	10	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	FEB	2020	26	2					215	+		10.1038/s41591-019-0714-x	http://dx.doi.org/10.1038/s41591-019-0714-x		JAN 2020	19	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	KK7DU	31959989	Green Accepted			2022-12-27	WOS:000510551600003
J	Liu, D; Schilling, B; Liu, D; Sucker, A; Livingstone, E; Jerby-Amon, L; Zimmer, L; Gutzmer, R; Satzger, I; Loquai, C; Grabbe, S; Vokes, N; Margolis, CA; Conway, J; He, MX; Elmarakeby, H; Dietlein, F; Miao, D; Tracy, A; Gogas, H; Goldinger, SM; Utikal, J; Blank, CU; Rauschenberg, R; von Bubnoff, D; Krackhardt, A; Weide, B; Haferkamp, S; Kiecker, F; Izar, B; Garraway, L; Regev, A; Flaherty, K; Paschen, A; Van Allen, EM; Schadendorf, D				Liu, David; Schilling, Bastian; Liu, Derek; Sucker, Antje; Livingstone, Elisabeth; Jerby-Amon, Livnat; Zimmer, Lisa; Gutzmer, Ralf; Satzger, Imke; Loquai, Carmen; Grabbe, Stephan; Vokes, Natalie; Margolis, Claire A.; Conway, Jake; He, Meng Xiao; Elmarakeby, Haitham; Dietlein, Felix; Miao, Diana; Tracy, Adam; Gogas, Helen; Goldinger, Simone M.; Utikal, Jochen; Blank, Christian U.; Rauschenberg, Ricarda; von Bubnoff, Dagmar; Krackhardt, Angela; Weide, Benjamin; Haferkamp, Sebastian; Kiecker, Felix; Izar, Ben; Garraway, Levi; Regev, Aviv; Flaherty, Keith; Paschen, Annette; Van Allen, Eliezer M.; Schadendorf, Dirk			Integrative molecular and clinical modeling of clinical outcomes to PD1 blockade in patients with metastatic melanoma	NATURE MEDICINE			English	Article							PD-1 BLOCKADE; OPEN-LABEL; CTLA-4 BLOCKADE; RESISTANCE; MUTATIONS; PEMBROLIZUMAB; IPILIMUMAB; SIGNATURES; NIVOLUMAB; MULTICENTER	Immune-checkpoint blockade (ICB) has demonstrated efficacy in many tumor types, but predictors of responsiveness to anti-PD1 ICB are incompletely characterized. In this study, we analyzed a clinically annotated cohort of patients with melanoma (n = 144) treated with anti-PD1 ICB, with whole-exome and whole-transcriptome sequencing of pre-treatment tumors. We found that tumor mutational burden as a predictor of response was confounded by melanoma subtype, whereas multiple novel genomic and transcriptomic features predicted selective response, including features associated with MHC-I and MHC-II antigen presentation. Furthermore, previous anti-CTLA4 ICB exposure was associated with different predictors of response compared to tumors that were naive to ICB, suggesting selective immune effects of previous exposure to anti-CTLA4 ICB. Finally, we developed parsimonious models integrating clinical, genomic and transcriptomic features to predict intrinsic resistance to anti-PD1 ICB in individual tumors, with validation in smaller independent cohorts limited by the availability of comprehensive data. Broadly, we present a framework to discover predictive features and build models of ICB therapeutic response.	[Liu, David; Liu, Derek; Vokes, Natalie; Margolis, Claire A.; Elmarakeby, Haitham; Dietlein, Felix; Miao, Diana; Izar, Ben; Van Allen, Eliezer M.] Dana Farber Canc Inst, Boston, MA 02115 USA; [Liu, David; Liu, Derek; Jerby-Amon, Livnat; Vokes, Natalie; Margolis, Claire A.; Conway, Jake; He, Meng Xiao; Elmarakeby, Haitham; Dietlein, Felix; Miao, Diana; Tracy, Adam; Izar, Ben; Regev, Aviv; Van Allen, Eliezer M.] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Schilling, Bastian] Univ Hosp Wurzburg, Dept Dermatol, Wurzburg, Germany; [Schilling, Bastian; Sucker, Antje; Livingstone, Elisabeth; Zimmer, Lisa; Paschen, Annette; Schadendorf, Dirk] Univ Hosp, Dept Dermatol, Essen, Germany; [Schilling, Bastian; Sucker, Antje; Livingstone, Elisabeth; Zimmer, Lisa; Krackhardt, Angela; Paschen, Annette; Schadendorf, Dirk] German Canc Res Ctr, German Canc Consortium Translat Canc Res, Heidelberg, Germany; [Liu, Derek; Conway, Jake; He, Meng Xiao; Miao, Diana] Harvard Med Sch, Boston, MA 02115 USA; [Gutzmer, Ralf; Satzger, Imke] Hannover Med Sch, Dept Dermatol & Allergy, Skin Canc Ctr Hannover, Hannover, Germany; [Loquai, Carmen; Grabbe, Stephan] Univ Med Ctr, Dept Dermatol, Mainz, Germany; [He, Meng Xiao] Harvard Univ, Biophys Program, Cambridge, MA 02138 USA; [Gogas, Helen] Univ Athens, Dept Med 1, Athens, Greece; [Goldinger, Simone M.] Univ Hosp Zurich, Dept Dermatol, Zurich, Switzerland; [Utikal, Jochen] Ruprecht Karl Univ Heidelberg, Univ Med Ctr Mannheim, Dept Dermatol, Mannheim, Germany; [Utikal, Jochen] German Canc Res Ctr, Skin Canc Unit, Heidelberg, Germany; [Blank, Christian U.] Netherlands Canc Inst, Dept Med Oncol, Amsterdam, Netherlands; [Rauschenberg, Ricarda] Tech Univ Dresden, Univ Hosp Carl Gustav Carus, Fac Med, Skin Canc Ctr,Univ Canc Ctr,Dept Dermatol, Dresden, Germany; [Rauschenberg, Ricarda] Natl Ctr Tumor Dis, Dresden, Germany; [Rauschenberg, Ricarda] German Canc Res Ctr, Heidelberg, Germany; [von Bubnoff, Dagmar] Univ Freiburg, Fac Med, Med Ctr, Dept Dermatol, Freiburg, Germany; [Krackhardt, Angela] Tech Univ Munich, Klinikum Rechts Isar, Med Klin 3, Munich, Germany; [Weide, Benjamin] Univ Med Ctr Tubingen, Dept Dermatol, Tubingen, Germany; [Haferkamp, Sebastian] Univ Hosp Regensburg, Dept Dermatol, Regensburg, Germany; [Kiecker, Felix] Univ Hosp Berlin, Dept Dermatol, Berlin, Germany; [Garraway, Levi] Eli Lilly & Co, Indianapolis, IN 46285 USA; [Flaherty, Keith] Massachusetts Gen Hosp, Boston, MA 02114 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of Wurzburg; University of Duisburg Essen; Helmholtz Association; German Cancer Research Center (DKFZ); Harvard University; Harvard Medical School; Hannover Medical School; Johannes Gutenberg University of Mainz; Harvard University; National & Kapodistrian University of Athens; University of Zurich; University Zurich Hospital; Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Netherlands Cancer Institute; Technische Universitat Dresden; Carl Gustav Carus University Hospital; University of Hamburg; University Medical Center Hamburg-Eppendorf; Helmholtz Association; German Cancer Research Center (DKFZ); University of Freiburg; Technical University of Munich; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; University of Regensburg; Eli Lilly; Harvard University; Massachusetts General Hospital	Van Allen, EM (corresponding author), Dana Farber Canc Inst, Boston, MA 02115 USA.; Van Allen, EM (corresponding author), Broad Inst MIT & Harvard, Cambridge, MA 02142 USA.; Schadendorf, D (corresponding author), Univ Hosp, Dept Dermatol, Essen, Germany.; Schadendorf, D (corresponding author), German Canc Res Ctr, German Canc Consortium Translat Canc Res, Heidelberg, Germany.	eliezerm_vanallen@dfci.harvard.edu; dirk.schadendorf@uk-essen.de	Schilling, Bastian/AAY-8646-2020; Elmarakeby, Haitham/AAA-4636-2020; Livingstone, Elisabeth/AHE-9171-2022; Haferkamp, Sebastian/ABD-7390-2021; Liu, David/ABF-1275-2020; Loquai, Carmen/AAW-9241-2020; Weide, Benjamin/N-3698-2013; Zimmer, Lisa/AAP-8495-2021; Haferkamp, Sebastian/AAN-3649-2021; Grabe, Stephan/AAJ-4578-2021; ELMARAKEBY, HAITHAM/ABC-4881-2020	Schilling, Bastian/0000-0001-8859-4103; Haferkamp, Sebastian/0000-0002-3894-8345; Liu, David/0000-0003-0346-5033; Zimmer, Lisa/0000-0002-3680-3521; Grabe, Stephan/0000-0002-6863-8719; Elmarakeby, Haitham/0000-0002-4315-4347; Schadendorf, Dirk/0000-0003-3524-7858	Adelson Medical Research Foundation; Conquer Cancer Foundation; Society for Immunotherapy of Cancers; Damon Runyon Cancer Research Foundation; BroadNext10; National Institutes of Health [K08 CA234458, R01 CA227388, U01 CA233100, T32 GM008313]; Deutsche Forschungsgemeinschaft (German Research Foundation) [SCHA 422/17-1, PA 2376/1-1, HO 6389/2-1 (KFO 337)]; National Science Foundation [DGE1144152]; NATIONAL CANCER INSTITUTE [R01CA227388, K08CA234458, K08CA222663] Funding Source: NIH RePORTER	Adelson Medical Research Foundation; Conquer Cancer Foundation; Society for Immunotherapy of Cancers; Damon Runyon Cancer Research Foundation; BroadNext10; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft (German Research Foundation)(German Research Foundation (DFG)); National Science Foundation(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors thank the active investigators A. Gesierich (University Hospital Wurzburg), J.C. Hassel (NCT Heidelberg), C. Pfohler (Saarland University Medical Center), E. Dabrowski (Ludwigshafen Medical Center), L.A. Schneider (University Medical Center Ulm), C. Weishaupt (University Hospital of Munster), K.G. Griewank (University Hospital Essen), E. Hadaschik (University Hospital Essen), G. Kyriakakis (Laikon General Hospital), F. Meier (NCT Dresden), M.H. Geukes Foppen (The Netherlands Cancer Institute), R. Dummer (University Hospital Zurich), E. Braunlein (Technical University Munich) and M. Boxberg (Technical University Munich) for providing additional patient samples and clinical data. The authors also thank A. Giobbie-Hurder (Dana-Farber Cancer Institute) and J. Weirather (Dana-Farber Cancer Institute) for useful discussions regarding statistical testing. This work was supported by the Adelson Medical Research Foundation (L.G.), the Conquer Cancer Foundation (David Liu), the Society for Immunotherapy of Cancers (David Liu), the Damon Runyon Cancer Research Foundation (David Liu), the BroadNext10 (E.M.V.), the National Institutes of Health (K08 CA234458 (David Liu), R01 CA227388 (E.M.V.), U01 CA233100 (E.M.V.), T32 GM008313 (M.X.H.)), the Deutsche Forschungsgemeinschaft (German Research Foundation), SCHA 422/17-1, PA 2376/1-1 and HO 6389/2-1 (KFO 337; D.S, A.P.) and National Science Foundation Graduate Research Fellowship Program DGE1144152 (M.X.H.).	Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Amaria RN, 2018, NAT MED, V24, P1649, DOI 10.1038/s41591-018-0197-1; Auslander N, 2018, NAT MED, V24, P1545, DOI 10.1038/s41591-018-0157-9; Ayers M, 2017, J CLIN INVEST, V127, P2930, DOI 10.1172/JCI91190; Barbie DA, 2009, NATURE, V462, P108, DOI 10.1038/nature08460; Birkeland E, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05063-1; Blank CU, 2018, NAT MED, V24, P1655, DOI 10.1038/s41591-018-0198-0; Brastianos PK, 2015, CANCER DISCOV, V5, P1164, DOI 10.1158/2159-8290.CD-15-0369; Brunet JP, 2004, P NATL ACAD SCI USA, V101, P4164, DOI 10.1073/pnas.0308531101; Carter SL, 2012, NAT BIOTECHNOL, V30, P413, DOI 10.1038/nbt.2203; Cesano A, 2015, J IMMUNOTHER CANCER, V3, DOI 10.1186/s40425-015-0088-7; Cibulskis K, 2013, NAT BIOTECHNOL, V31, P213, DOI 10.1038/nbt.2514; Cibulskis K, 2011, BIOINFORMATICS, V27, P2601, DOI 10.1093/bioinformatics/btr446; Costello M, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks1443; Cristescu R, 2018, SCIENCE, V362, P197, DOI 10.1126/science.aar3593; Davoli T, 2017, SCIENCE, V355, DOI 10.1126/science.aaf8399; Dewhurst SM, 2014, CANCER DISCOV, V4, P175, DOI 10.1158/2159-8290.CD-13-0285; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Durinck S, 2005, BIOINFORMATICS, V21, P3439, DOI 10.1093/bioinformatics/bti525; Fehrenbacher L, 2016, LANCET, V387, P1837, DOI 10.1016/S0140-6736(16)00587-0; Fisher S, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-1-r1; Forbes SA, 2015, NUCLEIC ACIDS RES, V43, pD805, DOI 10.1093/nar/gku1075; Fransen MF, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.124507; Gao JJ, 2016, CELL, V167, P397, DOI 10.1016/j.cell.2016.08.069; Gaujoux R, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-367; Gehring JS, 2015, BIOINFORMATICS, V31, P3673, DOI 10.1093/bioinformatics/btv408; George S, 2017, IMMUNITY, V46, P197, DOI 10.1016/j.immuni.2017.02.001; Gnirke A, 2009, NAT BIOTECHNOL, V27, P182, DOI 10.1038/nbt.1523; Hayward NK, 2017, NATURE, V545, P175, DOI 10.1038/nature22071; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Huang AC, 2019, NAT MED, V25, P454, DOI 10.1038/s41591-019-0357-y; Hugo W, 2016, CELL, V165, P35, DOI 10.1016/j.cell.2016.02.065; Jerby-Arnon L, 2018, CELL, V175, P984, DOI 10.1016/j.cell.2018.09.006; Jiang P, 2018, NAT MED, V24, P1550, DOI 10.1038/s41591-018-0136-1; Johnson DB, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10582; Lee DD, 1999, NATURE, V401, P788, DOI 10.1038/44565; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Liberzon A, 2015, CELL SYST, V1, P417, DOI 10.1016/j.cels.2015.12.004; Liu D, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-02320-7; McGranahan N, 2017, CELL, V170, P825, DOI 10.1016/j.cell.2017.08.012; McGranahan N, 2016, SCIENCE, V351, P1463, DOI 10.1126/science.aaf1490; Messina JL, 2012, SCI REP-UK, V2, DOI 10.1038/srep00765; Miao D, 2018, NAT GENET, V50, P1271, DOI 10.1038/s41588-018-0200-2; Morris LGT, 2016, ONCOTARGET, V7, P10051, DOI 10.18632/oncotarget.7067; Motzer RJ, 2015, NEW ENGL J MED, V373, P1803, DOI 10.1056/NEJMoa1510665; Newman AM, 2015, NAT METHODS, V12, P453, DOI [10.1038/nmeth.3337, 10.1038/NMETH.3337]; Nielsen M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000796; Ock CY, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01018-0; Olshen AB, 2004, BIOSTATISTICS, V5, P557, DOI 10.1093/biostatistics/kxh008; Peng WY, 2016, CANCER DISCOV, V6, P202, DOI 10.1158/2159-8290.CD-15-0283; Ramos AH, 2015, HUM MUTAT, V36, pE2423, DOI 10.1002/humu.22771; Reck M, 2016, NEW ENGL J MED, V375, P1823, DOI 10.1056/NEJMoa1606774; Riaz N, 2017, CELL, V171, P934, DOI 10.1016/j.cell.2017.09.028; Riaz N, 2016, NAT GENET, V48, P1327, DOI 10.1038/ng.3677; Rizvi NA, 2015, SCIENCE, V348, P124, DOI 10.1126/science.aaa1348; Robert C, 2015, NEW ENGL J MED, V372, P2521, DOI 10.1056/NEJMoa1503093; Rodig SJ, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aar3342; Roh W, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aah3560; Rooney MS, 2015, CELL, V160, P48, DOI 10.1016/j.cell.2014.12.033; Rosenberg JE, 2016, LANCET, V387, P1909, DOI 10.1016/S0140-6736(16)00561-4; Sade-Feldman M, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01062-w; Saunders CT, 2012, BIOINFORMATICS, V28, P1811, DOI 10.1093/bioinformatics/bts271; Seiwert TY, 2016, LANCET ONCOL, V17, P956, DOI 10.1016/S1470-2045(16)30066-3; Shin DS, 2017, CANCER DISCOV, V7, P188, DOI 10.1158/2159-8290.CD-16-1223; Shukla SA, 2015, NAT BIOTECHNOL, V33, P1152, DOI 10.1038/nbt.3344; Snyder A, 2014, NEW ENGL J MED, V371, P2189, DOI 10.1056/NEJMoa1406498; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sucker A, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15440; Thorsson V, 2018, IMMUNITY, V48, P812, DOI [10.1016/j.immuni.2018.03.023, 10.1016/j.immuni.2019.08.004]; Tumeh PC, 2014, NATURE, V515, P568, DOI 10.1038/nature13954; Van Allen EM, 2015, SCIENCE, V350, P207, DOI 10.1126/science.aad0095; Van Allen EM, 2014, NAT MED, V20, P682, DOI 10.1038/nm.3559; Weber J, 2016, ANN ONCOL, V27, DOI 10.1093/annonc/mdw378.1; Weber JS, 2016, LANCET ONCOL, V17, P943, DOI 10.1016/S1470-2045(16)30126-7; Weide B, 2016, CLIN CANCER RES, V22, P5487, DOI 10.1158/1078-0432.CCR-16-0127; Wolchok JD, 2017, NEW ENGL J MED, V377, P1345, DOI 10.1056/NEJMoa1709684; Zaretsky JM, 2016, NEW ENGL J MED, V375, P819, DOI 10.1056/NEJMoa1604958	77	265	268	3	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	2019	25	12					1916	+		10.1038/s41591-019-0654-5	http://dx.doi.org/10.1038/s41591-019-0654-5			26	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	JT2KO	31792460	Green Published, Green Accepted, hybrid			2022-12-27	WOS:000500824900035
J	Ogier, R; Knecht, W; Schwab, ME				Ogier, Roch; Knecht, Wolfgang; Schwab, Martin E.			Academic leadership: (with)holding the keys to translational medicine?	NATURE MEDICINE			English	Editorial Material								To promote effective translational medicine, academia must take the lead in creating a conducive environment for the first steps into translation, urge Roch Ogier and colleagues.	[Ogier, Roch] Univ Zurich, Therapy Dev Accelerator, Zurich, Switzerland; [Knecht, Wolfgang] Univ Zurich, Neurosci Ctr, Zurich, Switzerland; [Knecht, Wolfgang] Swiss Fed Inst Technol, Zurich, Switzerland; [Schwab, Martin E.] Univ Zurich, Inst Regenerat Med, Zurich, Switzerland; [Schwab, Martin E.] Swiss Fed Inst Technol, Dept Hlth Sci & Technol, Zurich, Switzerland	University of Zurich; University of Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich	Ogier, R (corresponding author), Univ Zurich, Therapy Dev Accelerator, Zurich, Switzerland.	roch.ogier@uzh.ch						Butler D, 2008, NATURE, V453, P840, DOI 10.1038/453840a; Duda GN, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.aaa0599; European Federation of Pharmaceutical Industries and Associations, PHARM IND FIG KEY DA; Ogier R., 2019, SWISS ACAD MED SCI, V14, P1; Roach M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170444	5	3	3	1	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	2019	25	12					1812	1813		10.1038/s41591-019-0670-5	http://dx.doi.org/10.1038/s41591-019-0670-5			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	JT2KO	31806891				2022-12-27	WOS:000500824900017
J	Stower, H				Stower, Hannah			Supporting HPV vaccination	NATURE MEDICINE			English	Editorial Material																			0	0	0	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	OCT	2019	25	10					1469	1469		10.1038/s41591-019-0618-9	http://dx.doi.org/10.1038/s41591-019-0618-9			1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	JC3GJ	31591586	Bronze			2022-12-27	WOS:000489166700009
J	Stower, H				Stower, Hannah			Tracking hidden Zika	NATURE MEDICINE			English	Editorial Material																			0	0	0	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	OCT	2019	25	10					1469	1469		10.1038/s41591-019-0616-y	http://dx.doi.org/10.1038/s41591-019-0616-y			1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	JC3GJ	31591585	Bronze			2022-12-27	WOS:000489166700010
J	Nachbagauer, R; Feser, J; Naficy, A; Bernstein, DI; Guptill, J; Walter, EB; Berlanda-Scorza, F; Stadlbauer, D; Wilson, PC; Aydillo, T; Behzadi, MA; Bhavsar, D; Bliss, C; Capuano, C; Carreno, JM; Chromikova, V; Claeys, C; Coughlan, L; Freyn, AW; Gast, C; Javier, A; Jiang, KJ; Mariottini, C; McMahon, M; McNeal, M; Solorzano, A; Strohmeier, S; Sun, WN; Van der Wielen, M; Innis, BL; Garcia-Sastre, A; Palese, P; Krammer, F				Nachbagauer, Raffael; Feser, Jodi; Naficy, Abdollah; Bernstein, David, I; Guptill, Jeffrey; Walter, Emmanuel B.; Berlanda-Scorza, Franceso; Stadlbauer, Daniel; Wilson, Patrick C.; Aydillo, Teresa; Behzadi, Mohammad Amin; Bhavsar, Disha; Bliss, Carly; Capuano, Christina; Carreno, Juan Manuel; Chromikova, Veronika; Claeys, Carine; Coughlan, Lynda; Freyn, Alec W.; Gast, Christopher; Javier, Andres; Jiang, Kaijun; Mariottini, Chiara; McMahon, Meagan; McNeal, Monica; Solorzano, Alicia; Strohmeier, Shirin; Sun, Weina; Van der Wielen, Marie; Innis, Bruce L.; Garcia-Sastre, Adolfo; Palese, Peter; Krammer, Florian			A chimeric hemagglutinin-based universal influenza virus vaccine approach induces broad and long-lasting immunity in a randomized, placebo-controlled phase I trial	NATURE MEDICINE			English	Article							ANTIBODY RECOGNITION; CONSTRUCTS PROTECT; STALK ANTIBODIES; SAFETY; HEAD; NEUTRALIZATION; IMMUNOGENICITY; ANTIINFLUENZA; INDUCTION; RESPONSES	New influenza virus vaccines tested in humans elicit broadly cross-reactive antibodies that bind the stalk of the viral hemagglutinin protein and may serve as templates to design a universal influenza vaccine. Seasonal influenza viruses constantly change through antigenic drift and the emergence of pandemic influenza viruses through antigenic shift is unpredictable. Conventional influenza virus vaccines induce strain-specific neutralizing antibodies against the variable immunodominant globular head domain of the viral hemagglutinin protein. This necessitates frequent re-formulation of vaccines and handicaps pandemic preparedness. In this completed, observer-blind, randomized, placebo-controlled phase I trial (NCT03300050), safety and immunogenicity of chimeric hemagglutinin-based vaccines were tested in healthy, 18-39-year-old US adults. The study aimed to test the safety and ability of the vaccines to elicit broadly cross-reactive antibodies against the hemagglutinin stalk domain. Participants were enrolled into five groups to receive vaccinations with live-attenuated followed by AS03-adjuvanted inactivated vaccine (n = 20), live-attenuated followed by inactivated vaccine (n = 15), twice AS03-adjuvanted inactivated vaccine (n = 16) or placebo (n = 5, intranasal followed by intramuscular; n = 10, twice intramuscular) 3 months apart. Vaccination was found to be safe and induced a broad, strong, durable and functional immune response targeting the conserved, immunosubdominant stalk of the hemagglutinin. The results suggest that chimeric hemagglutinins have the potential to be developed as universal vaccines that protect broadly against influenza viruses.	[Nachbagauer, Raffael; Stadlbauer, Daniel; Aydillo, Teresa; Behzadi, Mohammad Amin; Bhavsar, Disha; Bliss, Carly; Capuano, Christina; Carreno, Juan Manuel; Chromikova, Veronika; Coughlan, Lynda; Freyn, Alec W.; Javier, Andres; Jiang, Kaijun; Mariottini, Chiara; McMahon, Meagan; Solorzano, Alicia; Strohmeier, Shirin; Sun, Weina; Garcia-Sastre, Adolfo; Palese, Peter; Krammer, Florian] Icahn Sch Med Mt Sinai, Dept Microbiol, New York, NY 10029 USA; [Feser, Jodi; Naficy, Abdollah; Berlanda-Scorza, Franceso; Gast, Christopher; Innis, Bruce L.] PATH, Ctr Vaccine Innovat & Access, Seattle, WA USA; [Bernstein, David, I; McNeal, Monica] Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati, OH USA; [Bernstein, David, I; McNeal, Monica] Cincinnati Childrens Hosp Med Ctr, Div Infect Dis, Cincinnati, OH 45229 USA; [Guptill, Jeffrey; Walter, Emmanuel B.] Duke Clin Res Inst, Duke Early Phase Clin Res Unit, Durham, NC USA; [Walter, Emmanuel B.] Duke Univ, Sch Med, Duke Human Vaccine Inst, Durham, NC USA; [Wilson, Patrick C.] Univ Chicago, Dept Med, Sect Rheumatol, 5841 S Maryland Ave, Chicago, IL 60637 USA; [Wilson, Patrick C.] Univ Chicago, Comm Immunol, Chicago, IL 60637 USA; [Aydillo, Teresa; Garcia-Sastre, Adolfo] Icahn Sch Med Mt Sinai, Global Hlth & Emerging Pathogens Inst, New York, NY 10029 USA; [Claeys, Carine; Van der Wielen, Marie] GSK, Wavre, Belgium; [Freyn, Alec W.] Icahn Sch Med Mt Sinai, Grad Sch Biomed Sci, New York, NY 10029 USA; [Strohmeier, Shirin] Univ Nat Resources & Life Sci, Dept Biotechnol, Vienna, Austria; [Garcia-Sastre, Adolfo; Palese, Peter] Icahn Sch Med Mt Sinai, Dept Med, New York, NY 10029 USA; [Garcia-Sastre, Adolfo; Palese, Peter] Icahn Sch Med Mt Sinai, Tisch Canc Ctr, New York, NY 10029 USA; [Nachbagauer, Raffael] Moderna, Cambridge, MA USA; [Berlanda-Scorza, Franceso] GSK, Siena, Italy; [Claeys, Carine] Spmt Arista Asbl, Brussels, Belgium; [Solorzano, Alicia] Pfizer, Pearl River, NY USA	Icahn School of Medicine at Mount Sinai; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Duke University; Duke University; University of Chicago; University of Chicago; Icahn School of Medicine at Mount Sinai; GlaxoSmithKline; Icahn School of Medicine at Mount Sinai; University of Natural Resources & Life Sciences, Vienna; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; GlaxoSmithKline; Pfizer	Krammer, F (corresponding author), Icahn Sch Med Mt Sinai, Dept Microbiol, New York, NY 10029 USA.	florian.krammer@mssm.edu	Nachbagauer, Raffael/H-7798-2019; Aydillo Gomez, Teresa Allende/W-4439-2019; Freyn, Alec/AAD-3481-2019; Krammer, Florian/H-3237-2019; Bhavsar, Disha/GOG-9149-2022; Wilson, Patrick/HGC-3157-2022	Nachbagauer, Raffael/0000-0001-5568-5420; Aydillo Gomez, Teresa Allende/0000-0003-3086-1058; Krammer, Florian/0000-0003-4121-776X; Bhavsar, Disha/0000-0003-1564-3298; Jiang, Kaijun/0000-0002-3607-2220; Carreno Quiroz, Juan Manuel/0000-0002-9039-9275; Coughlan, Lynda/0000-0001-9880-6560; Stadlbauer, Daniel/0000-0001-6792-7650; McNeal, Monica/0000-0002-3784-9062; Wilson, Patrick C./0000-0002-3537-1245	Bill and Melinda Gates Foundation [OPP1084518]; National Institute of Allergy and Infectious Diseases (NIAID) [P01 AI097092, HHSN26620070010C, HHSN272201400008C, U19 AI109946, R01 AI128821]; NIAID [75N93019C00051]; GlaxoSmithKline Biologicals SA	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); GlaxoSmithKline Biologicals SA(GlaxoSmithKline)	We thank the research team at the Department of Microbiology at the Icahn School of Medicine at Mount Sinai for supporting the development of this vaccine concept since 2011. We also thank the teams at PATH (with special acknowledgement to J.C. Victor, R. Wahid and K. Mahmood), Cincinnati Children's Hospital Medical Center, Duke University, the University of Chicago, GSK, NEOMED-LABS and the EMMES Corporation for their work on this project. We are grateful for help from V. Simon at Mount Sinai with IRB protocol development, D. Wentworth and L. M. Chen at the US CDC with the initial LAIV seed virus rescue and for help from D. Suarez from the US Department of Agriculture for pathogenicity testing of the vaccine virus strains. We thank G. Georgiou for providing monoclonal antibody D1 H1-3/H3-3 used in competition ELISAs. This study was funded in part by the Bill and Melinda Gates Foundation (grant OPP1084518). Basic research leading to this trial was supported by the National Institute of Allergy and Infectious Diseases (NIAID) (grants P01 AI097092, HHSN26620070010C, HHSN272201400008C, U19 AI109946, R01 AI128821). NIAID continues to support analysis of samples from this trial through a Collaborative Influenza Vaccine Innovation Centers contract (75N93019C00051). GSK made adjuvants and vaccine preparations available and contributed through providing expertise as well (funding for this study was provided by GlaxoSmithKline Biologicals SA). The findings and conclusions contained within are those of the authors and do not necessarily reflect positions or policies of the Gates Foundation. GlaxoSmithKline Biologicals SA was provided the opportunity to review a preliminary version of this manuscript for factual accuracy, but the authors are solely responsible for final content and interpretation.	Bangaru S, 2019, CELL, V177, P1136, DOI 10.1016/j.cell.2019.04.011; Barria MI, 2013, J INFECT DIS, V207, P115, DOI 10.1093/infdis/jis641; Bernstein DI, 2020, LANCET INFECT DIS, V20, P80, DOI 10.1016/S1473-3099(19)30393-7; Bliss CM, 2020, MOL THER-METH CLIN D, V16, P108, DOI 10.1016/j.omtm.2019.12.003; Brandenburg B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080034; Chan MCW, 2018, EMERG INFECT DIS, V24, P1825, DOI 10.3201/eid2410.180652; Choi Angela, 2019, Immunohorizons, V3, P133, DOI 10.4049/immunohorizons.1900022; Chromikova V, 2020, VACCINE, V38, P1953, DOI 10.1016/j.vaccine.2020.01.008; Chromikova V, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183315; Cohet C, 2019, VACCINE, V37, P3006, DOI 10.1016/j.vaccine.2019.04.048; Corti D, 2011, SCIENCE, V333, P850, DOI 10.1126/science.1205669; DiLillo DJ, 2014, NAT MED, V20, P143, DOI 10.1038/nm.3443; Doud MB, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8060155; Dreyfus C, 2012, SCIENCE, V337, P1343, DOI 10.1126/science.1222908; Ekiert DC, 2012, NATURE, V489, P526, DOI 10.1038/nature11414; Ekiert DC, 2009, SCIENCE, V324, P246, DOI 10.1126/science.1171491; Ellebedy AH, 2014, P NATL ACAD SCI USA, V111, P13133, DOI 10.1073/pnas.1414070111; Flannery B, 2020, J INFECT DIS, V221, P8, DOI 10.1093/infdis/jiz543; Hai R, 2012, J VIROL, V86, P5774, DOI 10.1128/JVI.00137-12; He WQ, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00928-3; Heaton NS, 2013, P NATL ACAD SCI USA, V110, P20248, DOI 10.1073/pnas.1320524110; HOBSON D, 1972, J HYG-CAMBRIDGE, V70, P767, DOI 10.1017/S0022172400022610; Hong MS, 2013, J VIROL, V87, P12471, DOI 10.1128/JVI.01388-13; Impagliazzo A, 2015, SCIENCE, V349, P1301, DOI 10.1126/science.aac7263; Isakova-Sivak I, 2018, VIROLOGY, V518, P313, DOI 10.1016/j.virol.2018.03.013; Isakova-Sivak I, 2011, VIROLOGY, V412, P297, DOI 10.1016/j.virol.2011.01.004; Jacobsen H, 2017, MBIO, V8, DOI 10.1128/mBio.01463-17; Khurana S, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002336; Kirkpatrick E, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-28706-1; Krammer F, 2019, NAT REV IMMUNOL, V19, P383, DOI 10.1038/s41577-019-0143-6; Krammer F, 2015, NAT REV DRUG DISCOV, V14, P167, DOI 10.1038/nrd4529; Krammer F, 2013, J VIROL, V87, P6542, DOI [10.1128/JVI.00641-13, 10.1128/JVI.03183-13]; Lee J, 2016, NAT MED, V22, P1456, DOI 10.1038/nm.4224; Lu Y, 2009, AM J GASTROENTEROL, V104, P444, DOI 10.1038/ajg.2008.120; Margine I, 2013, J VIROL, V87, P10435, DOI 10.1128/JVI.01715-13; Margine I, 2013, JOVE-J VIS EXP, DOI 10.3791/51112; Martinez-Sobrido Luis, 2010, J Vis Exp, DOI 10.3791/2057; McMahon M, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02005; Nachbagauer R, 2019, NPJ VACCINES, V4, DOI 10.1038/s41541-019-0147-z; Nachbagauer R, 2017, NPJ VACCINES, V2, DOI 10.1038/s41541-017-0026-4; Nachbagauer R, 2016, NPJ VACCINES, V1, DOI 10.1038/npjvaccines.2016.15; Nachbagauer R, 2016, MBIO, V7, DOI 10.1128/mBio.01996-15; Nachbagauer R, 2014, J VIROL, V88, P13260, DOI 10.1128/JVI.02133-14; Ng S, 2019, NAT MED, V25, P962, DOI 10.1038/s41591-019-0463-x; OKUNO Y, 1993, J VIROL, V67, P2552, DOI 10.1128/JVI.67.5.2552-2558.1993; Owusu D, 2020, MMWR-MORBID MORTAL W, V69, P40, DOI 10.15585/mmwr.mm6902e1; Palese P, 2004, NAT MED, V10, pS82, DOI 10.1038/nm1141; Pitisuttithum P, 2017, LANCET INFECT DIS, V17, P833, DOI [10.1016/S1473-3099(17)30240-2, 10.1016/s1473-3099(17)30240-2]; Rajendran M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194830; Rajendran M, 2017, MBIO, V8, DOI [10.1128/mBio.02281-16, 10.1128/mbio.02281-16]; Rudenko L, 2015, HUM VACC IMMUNOTHER, V11, P2839, DOI 10.1080/21645515.2015.1069931; Skowronski D. M., 2019, Eurosurveillance, V24, P1900585; Stadlbauer D, 2019, SCIENCE, V366, P499, DOI 10.1126/science.aay0678; Sui J, 2011, CLIN INFECT DIS, V52, P1003, DOI 10.1093/cid/cir121; Sui JH, 2009, NAT STRUCT MOL BIOL, V16, P265, DOI 10.1038/nsmb.1566; Sun WN, 2019, J VIROL, V93, DOI 10.1128/JVI.00333-19; Talaat KR, 2014, J INFECT DIS, V209, P1860, DOI 10.1093/infdis/jiu123; Treanor JJ, 2007, JAMA-J AM MED ASSOC, V297, P1577, DOI 10.1001/jama.297.14.1577; Virk RK, 2020, P NATL ACAD SCI USA, V117, P619, DOI 10.1073/pnas.1916585116; Wang G, 2019, EMERG MICROBES INFEC, V8, P1017, DOI 10.1080/22221751.2019.1637284; Watanabe A, 2019, CELL, V177, P1124, DOI 10.1016/j.cell.2019.03.048; Wu NC, 2018, NAT STRUCT MOL BIOL, V25, P115, DOI 10.1038/s41594-018-0025-9	62	92	93	3	11	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	JAN	2021	27	1					106	+		10.1038/s41591-020-1118-7	http://dx.doi.org/10.1038/s41591-020-1118-7		DEC 2020	20	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	PS4ZO	33288923	Bronze			2022-12-27	WOS:000598994800001
J	Davies, RW; Fiksinski, AM; Breetvelt, EJ; Williams, NM; Hooper, SR; Monfeuga, T; Bassett, AS; Owen, MJ; Gur, RE; Morrow, BE; McDonald-McGinn, DM; Swillen, A; Chow, EWC; van den Bree, M; Emanuel, BS; Vermeesch, JR; van Amelsvoort, T; Arango, C; Armando, M; Campbell, LE; Cubells, JF; Eliez, S; Garcia-Minaur, S; Gothelf, D; Kates, WR; Murphy, KC; Murphy, CM; Murphy, DG; Philip, N; Repetto, GM; Shashi, V; Simon, TJ; Suner, DH; Vicari, S; Scherer, SW; Bearden, CE; Vorstman, JAS				Davies, Robert W.; Fiksinski, Ania M.; Breetvelt, Elemi J.; Williams, Nigel M.; Hooper, Stephen R.; Monfeuga, Thomas; Bassett, Anne S.; Owen, Michael J.; Gur, Raquel E.; Morrow, Bernice E.; McDonald-McGinn, Donna M.; Swillen, Ann; Chow, Eva W. C.; van den Bree, Marianne; Emanuel, Beverly S.; Vermeesch, Joris R.; van Amelsvoort, Therese; Arango, Celso; Armando, Marco; Campbell, Linda E.; Cubells, Joseph F.; Eliez, Stephan; Garcia-Minaur, Sixto; Gothelf, Doron; Kates, Wendy R.; Murphy, Kieran C.; Murphy, Clodagh M.; Murphy, Declan G.; Philip, Nicole; Repetto, Gabriela M.; Shashi, Vandana; Simon, Tony J.; Suner, Damian Heine; Vicari, Stefano; Scherer, Stephen W.; Bearden, Carrie E.; Vorstman, Jacob A. S.		Int 22q11 2 Bran Behav Consortium	Using common genetic variation to examine phenotypic expression and risk prediction in 22q11.2 deletion syndrome	NATURE MEDICINE			English	Article							COGNITIVE-DEVELOPMENT; PREMORBID IQ; SCHIZOPHRENIA; PSYCHOSIS; INTELLIGENCE; DECLINE; ABNORMALITIES; METAANALYSIS; RELIABILITY; PERFORMANCE	The 22q11.2 deletion syndrome (22q11DS) is associated with a 20-25% risk of schizophrenia. In a cohort of 962 individuals with 22q11DS, we examined the shared genetic basis between schizophrenia and schizophrenia-related early trajectory phenotypes: sub-threshold symptoms of psychosis, low baseline intellectual functioning and cognitive decline. We studied the association of these phenotypes with two polygenic scores, derived for schizophrenia and intelligence, and evaluated their use for individual risk prediction in 22q11DS. Polygenic scores were not only associated with schizophrenia and baseline intelligence quotient (IQ), respectively, but schizophrenia polygenic score was also significantly associated with cognitive (verbal IQ) decline and nominally associated with sub-threshold psychosis. Furthermore, in comparing the tail-end deciles of the schizophrenia and IQ polygenic score distributions, 33% versus 9% of individuals with 22q11DS had schizophrenia, and 63% versus 24% of individuals had intellectual disability. Collectively, these data show a shared genetic basis for schizophrenia and schizophrenia-related phenotypes and also highlight the future potential of polygenic scores for risk stratification among individuals with highly, but incompletely, penetrant genetic variants. Polygenic risk scores are nearing a level of differentiation required for their clinical utility in risk prediction in populations with high-risk rare pathogenic genetic variants.	[Davies, Robert W.] Hosp Sick Children, Program Genet & Genome Biol, Toronto, ON, Canada; [Davies, Robert W.] Hosp Sick Children, Ctr Appl Genom, Toronto, ON, Canada; [Davies, Robert W.] Univ Oxford, Dept Stat, Oxford, England; [Fiksinski, Ania M.; Vorstman, Jacob A. S.] Univ Med Ctr Utrecht, Brain Ctr, Dept Psychiat, Utrecht, Netherlands; [Fiksinski, Ania M.; Bassett, Anne S.; Chow, Eva W. C.] Ctr Addict & Mental Hlth, Clin Genet Res Program, Toronto, ON, Canada; [Breetvelt, Elemi J.] Hosp Sick Children, Dept Psychiat, Toronto, ON, Canada; [Williams, Nigel M.; Monfeuga, Thomas; Owen, Michael J.; van den Bree, Marianne] Cardiff Univ, Sch Med, Div Psychol Med & Clin Neurosci, MRC Ctr Neuropsychiat Genet & Genom, Cardiff, S Glam, Wales; [Hooper, Stephen R.] Univ N Carolina, Sch Med, Dept Appl Hlth Sci, Chapel Hill, NC 27515 USA; [Bassett, Anne S.; Chow, Eva W. C.] Univ Toronto, Dept Psychiat, Toronto, ON, Canada; [Bassett, Anne S.] Univ Hlth Network, Toronto Gen Hosp, Dalglish Family Clin 22q, Toronto, ON, Canada; [Gur, Raquel E.] Univ Penn, Dept Psychiat, Penn Med CHOP, Philadelphia, PA USA; [Gur, Raquel E.] Univ Penn, Lifespan Brain Inst, Penn Med CHOP, Philadelphia, PA USA; [Morrow, Bernice E.] Albert Einstein Coll Med, Dept Genet, Bronx, NY USA; [McDonald-McGinn, Donna M.; Emanuel, Beverly S.] Childrens Hosp Philadelphia, Div Human Genet, Clin Genet Ctr, 22q & You Ctr, Philadelphia, PA 19104 USA; [McDonald-McGinn, Donna M.; Emanuel, Beverly S.] Childrens Hosp Philadelphia, Sect Genet Counseling, Dept Pediat, Philadelphia, PA 19104 USA; [McDonald-McGinn, Donna M.] Univ Penn, Dept Pediat, Perelman Sch Med, Philadelphia, PA 19104 USA; [Swillen, Ann; Vermeesch, Joris R.] Univ Hosp Gasthuisberg, Ctr Human Genet, Leuven, Belgium; [Swillen, Ann] Katholieke Univ Leuven, Dept Human Genet, Leuven, Belgium; [van Amelsvoort, Therese] Maastricht Univ, Dept Psychiat & Neuropsychol, Maastricht, Netherlands; [Arango, Celso] Univ Complutense, Sch Med, CIBERSAM,Dept Child & Adolescent Psychiat, Hosp Gen Univ Gregorio Maranon,IiSGM,Inst Psychia, Madrid, Spain; [Armando, Marco; Eliez, Stephan] Univ Geneva, Dept Psychiat, Dev Imaging & Psychopathol, Geneva, Switzerland; [Campbell, Linda E.] Univ Newcastle, Sch Psychol, Newcastle, NSW, Australia; [Cubells, Joseph F.] Emory Univ, Sch Med, Dept Human Genet, Atlanta, GA USA; [Cubells, Joseph F.] Emory Univ, Emory Autism Ctr, Dept Psychiat & Behav Sci, Sch Med, Atlanta, GA USA; [Garcia-Minaur, Sixto] La Paz Univ Hosp, Inst Med & Mol Genet INGEMM, Madrid, Spain; [Gothelf, Doron] Edmond & Lily Safra Childrens Hosp, Sheba Med Ctr, Child Psychiat Div, Tel Hashomer, Israel; [Gothelf, Doron] Tel Aviv Univ, Sackler Fac Med, Tel Aviv, Israel; [Gothelf, Doron] Tel Aviv Univ, Sagol Sch Neurosci, Tel Aviv, Israel; [Kates, Wendy R.] SUNY Upstate Med Univ, Dept Psychiat & Behav Sci, Syracuse, NY USA; [Murphy, Kieran C.] Beaumont Hosp, Royal Coll Surg Ireland, Dept Psychiat, Dublin, Ireland; [Murphy, Clodagh M.; Murphy, Declan G.] Kings Coll London, Inst Psychiat Psychol & Neurosci IoPPN, Dept Forens & Neurodev Sci, London, England; [Philip, Nicole] CHU Timone Enfants, APHM, Dept Genet Med, Marseille, France; [Philip, Nicole] Aix Marseille Univ, MMG, INSERM, Marseille, France; [Repetto, Gabriela M.] Clin Alemana Univ Desarrollo, Fac Med, Ctr Genet & Genom, Santiago, Chile; [Shashi, Vandana] Duke Univ, Dept Pediat, Div Med Genet, Sch Med, Durham, NC USA; [Simon, Tony J.] Univ Calif Davis, MIND Inst, Sacramento, CA USA; [Simon, Tony J.] Univ Calif Davis, Dept Psychiat & Behav Sci, Sacramento, CA USA; [Suner, Damian Heine] Hosp Univ Son Espases, Genom Hlth Grp, Hlth Res Inst Balearic Isl IdISBa, Palma De Mallorca, Spain; [Suner, Damian Heine] Hosp Univ Son Espases, Mol Diagnost & Clin Genet Unit UDMGC, Hlth Res Inst Balearic Isl IdISBa, Palma De Mallorca, Spain; [Vicari, Stefano] Catholic Univ, Dept Life Sci & Publ Hlth, Rome, Italy; [Vicari, Stefano] IRCSS, Bambino Gesu Childrens Hosp, Child & Adolescent Psychiat Unit, Rome, Italy; [Scherer, Stephen W.; Vorstman, Jacob A. S.] SickKids Res Inst, Program Genet & Genome Biol, Toronto, ON, Canada; [Bearden, Carrie E.] Univ Calif Los Angeles, Dept Psychiat & Biobehav Sci, Semel Inst Neurosci & Human Behav, Los Angeles, CA USA; [Bearden, Carrie E.] Univ Calif Los Angeles, Dept Psychol, Semel Inst Neurosci & Human Behav, Los Angeles, CA USA; [Vorstman, Jacob A. S.] Univ Toronto, Hosp Sick Children, Dept Psychiat, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Oxford; Utrecht University; Utrecht University Medical Center; University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Cardiff University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Pennsylvania; University of Pennsylvania; Yeshiva University; Albert Einstein College of Medicine; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; KU Leuven; University Hospital Leuven; KU Leuven; Maastricht University; CIBER - Centro de Investigacion Biomedica en Red; CIBERSAM; Complutense University of Madrid; General University Gregorio Maranon Hospital; University of Geneva; University of Newcastle; Emory University; Emory University; Hospital Universitario La Paz; Chaim Sheba Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; Royal College of Surgeons - Ireland; University of London; King's College London; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Universidad del Desarrollo; Duke University; University of California System; University of California Davis; University of California System; University of California Davis; Hospital Universitari Son Espases; Institut Investigacio Sanitaria Illes Balears (IdISBa); Hospital Universitari Son Espases; Institut Investigacio Sanitaria Illes Balears (IdISBa); Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; IRCCS Bambino Gesu; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Vorstman, JAS (corresponding author), Univ Med Ctr Utrecht, Brain Ctr, Dept Psychiat, Utrecht, Netherlands.; Vorstman, JAS (corresponding author), SickKids Res Inst, Program Genet & Genome Biol, Toronto, ON, Canada.; Vorstman, JAS (corresponding author), Univ Toronto, Hosp Sick Children, Dept Psychiat, Toronto, ON, Canada.	jacob.vorstman@sickkids.ca	Heine-Suñer, Damian/J-8045-2012; Suñer, Damian Heine/AAW-9664-2020; Montero, Rosemarie Fritsch/C-3519-2009; Arango, Celso/AAZ-8314-2021; Scherer, Stephen W./B-3785-2013	Heine-Suñer, Damian/0000-0001-9374-1219; Suñer, Damian Heine/0000-0001-9374-1219; Montero, Rosemarie Fritsch/0000-0001-7694-1470; Arango, Celso/0000-0003-3382-4754; Scherer, Stephen W./0000-0002-8326-1999; Owen, Michael/0000-0003-4798-0862; Vermeesch, Joris/0000-0002-3071-1191; Davies, Robert/0000-0002-2252-0862; Vicari, Stefano/0000-0002-5395-2262; BUSA, Tiffany/0000-0003-4454-1979; McDonald-McGinn, Donna/0000-0003-4077-250X; Chawner, Samuel/0000-0002-2590-2874; Armando, Marco/0000-0001-7074-7212; Schneider, Maude/0000-0001-7147-8915; Bassett, Anne/0000-0002-0681-7279; Swillen, Ann/0000-0003-4258-4537; Costain, Gregory/0000-0003-0099-9945; Murphy, Declan/0000-0002-6664-7451	National Institute of Mental Health (NIMH) International Consortium on Brain and Behavior [U01MH101719, U01MH0101720, U01MH0101723, U01MH101722, EU01MH101724]; Lap-Chee Tsui Fellowship for Research Excellence; CIHR STAGE Fellowship; Brain and Behavior Research Foundation; NIMH [R01MH085953, 1U01MH119736-01]; NIH [RO1 MH064824]; Wellcome Trust [102428/Z/13/Z]; Canadian Institutes of Health Research [MOP-79518, MOP-89066, MOP-97800, MOP-111238]; McLaughlin Centre Accelerator grant; Canada Research Chairs program; Dalglish Chair; Academic Scholars Award from the Department of Psychiatry, University of Toronto; O'Brien Scholars Fund; Fondecyt [1171014]; ACT [192064]; Spanish Ministry of Science and Innovation, Instituto de Salud Carlos III [SAM16PE07CP1, PI16/02012, PI19/024]; CIBERSAM; Madrid Regional Government [B2017/BMD-3740 AGES-CM-2]; European Union [FP7-HEALTH-2013-2.2.1-2-603196]; European Union H2020 Program under the Innovative Medicines Initiative 2 Joint Undertaking [115916, 777394]; Fundacion Familia Alonso; Fundacion Alicia Koplowitz; Innovative Medicines Initiative 2 Joint Undertaking [777394]; NIHR Maudsley BRC; Binational Science Foundation [2017369]; MRC [MR/N026063/1] Funding Source: UKRI	National Institute of Mental Health (NIMH) International Consortium on Brain and Behavior; Lap-Chee Tsui Fellowship for Research Excellence; CIHR STAGE Fellowship(Canadian Institutes of Health Research (CIHR)); Brain and Behavior Research Foundation; NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome Trust(Wellcome TrustEuropean Commission); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); McLaughlin Centre Accelerator grant; Canada Research Chairs program(Canada Research Chairs); Dalglish Chair; Academic Scholars Award from the Department of Psychiatry, University of Toronto; O'Brien Scholars Fund; Fondecyt(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); ACT; Spanish Ministry of Science and Innovation, Instituto de Salud Carlos III(Instituto de Salud Carlos IIIMinistry of Science and Innovation, Spain (MICINN)Spanish Government); CIBERSAM; Madrid Regional Government; European Union(European Commission); European Union H2020 Program under the Innovative Medicines Initiative 2 Joint Undertaking; Fundacion Familia Alonso; Fundacion Alicia Koplowitz; Innovative Medicines Initiative 2 Joint Undertaking; NIHR Maudsley BRC; Binational Science Foundation(US-Israel Binational Science Foundation); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was supported by the National Institute of Mental Health (NIMH) International Consortium on Brain and Behavior in 22q11.2 Deletion Syndrome (U01MH101719, U01MH0101720, U01MH0101723, U01MH101722 and EU01MH101724); the Lap-Chee Tsui Fellowship for Research Excellence and the CIHR STAGE Fellowship (to R.W.D.); the Brain and Behavior Research Foundation (to J.A.S.V.; Young Investigator Award); NIMH R01MH085953 and 1U01MH119736-01 (to C.E.B.); NIH RO1 MH064824 (to W.K.); Wellcome Trust grant 102428/Z/13/Z (to N.W. and T.M.); Canadian Institutes of Health Research grants MOP-79518, MOP-89066, MOP-97800 and MOP-111238, a McLaughlin Centre Accelerator grant, the Canada Research Chairs program and Dalglish Chair (to A.S.B); the Academic Scholars Award from the Department of Psychiatry, University of Toronto and the O'Brien Scholars Fund (to E.B.); Fondecyt 1171014 and ACT 192064 (ANID-Chile) (to G.R.); Spanish Ministry of Science and Innovation, Instituto de Salud Carlos III (SAM16PE07CP1, PI16/02012, PI19/024), CIBERSAM, Madrid Regional Government (B2017/BMD-3740 AGES-CM-2), European Union Structural Funds, European Union Seventh Framework Program (FP7-HEALTH-2013-2.2.1-2-603196 Project PSYSCAN) and European Union H2020 Program under the Innovative Medicines Initiative 2 Joint Undertaking (grant agreement 115916, Project PRISM, and grant agreement 777394, Project AIMS-2-TRIALS), Fundacion Familia Alonso and Fundacion Alicia Koplowitz (to C.A); Innovative Medicines Initiative 2 Joint Undertaking (#777394 for the project AIMS-2-TRIALS), the NIHR Maudsley BRC (to D.M.); and Binational Science Foundation grant 2017369 (to R.E.G. and D.G.).	Bassett AS, 1999, BIOL PSYCHIAT, V46, P882, DOI 10.1016/S0006-3223(99)00114-6; Bearden CE, 2000, SCHIZOPHRENIA BULL, V26, P395, DOI 10.1093/oxfordjournals.schbul.a033461; Bergen SE, 2019, AM J PSYCHIAT, V176, P29, DOI 10.1176/appi.ajp.2018.17040467; Bycroft C, 2018, NATURE, V562, P203, DOI 10.1038/s41586-018-0579-z; Chawner SJRA, 2017, BRIT J PSYCHIAT, V211, P223, DOI 10.1192/bjp.bp.116.195651; Chelune G.J., 1993, NEUROPSYCHOLOGY, V7, P41, DOI [10.1037/0894-4105.7.1.41, DOI 10.1037/0894-4105.7.1.41, https://doi.org/10.1037/0894-4105.7.1.41]; Cleynen I, 2021, MOL PSYCHIATR, V26, P4496, DOI 10.1038/s41380-020-0654-3; Damask A, 2020, CIRCULATION, V141, P624, DOI 10.1161/CIRCULATIONAHA.119.044434; Davies G, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04362-x; Deary IJ, 2009, HUM GENET, V126, P215, DOI 10.1007/s00439-009-0655-4; Dickson H, 2012, PSYCHOL MED, V42, P743, DOI 10.1017/S0033291711001693; Duijff SN, 2012, BRIT J PSYCHIAT, V200, P462, DOI 10.1192/bjp.bp.111.097139; Euesden J, 2015, BIOINFORMATICS, V31, P1466, DOI 10.1093/bioinformatics/btu848; Fiksinski AM, 2018, AM J MED GENET A, V176, P2182, DOI 10.1002/ajmg.a.40387; Fuller R, 2002, AM J PSYCHIAT, V159, P1183, DOI 10.1176/appi.ajp.159.7.1183; Fullerton J. M., 2019, F1000RES; Gazal S, 2017, NAT GENET, V49, P1421, DOI 10.1038/ng.3954; Gibson G, 2019, PLOS GENET, V15, DOI 10.1371/journal.pgen.1008060; Gur RE, 2017, MOL PSYCHIATR, V22, P1664, DOI 10.1038/mp.2017.161; Insel TR, 2010, NATURE, V468, P187, DOI 10.1038/nature09552; Jones HJ, 2018, TRANSL PSYCHIAT, V8, DOI 10.1038/s41398-018-0204-9; Jones HJ, 2016, JAMA PSYCHIAT, V73, P221, DOI 10.1001/jamapsychiatry.2015.3058; Kahn RS, 2013, JAMA PSYCHIAT, V70, P1107, DOI 10.1001/jamapsychiatry.2013.155; Kates WR, 2019, PSYCHOL MED, V49, P1914, DOI 10.1017/S0033291718002696; Kaufman J, 1997, J AM ACAD CHILD PSY, V36, P980, DOI 10.1097/00004583-199707000-00021; Kaymaz N, 2012, PSYCHOL MED, V42, P2239, DOI 10.1017/S0033291711002911; Khandaker GM, 2011, SCHIZOPHR RES, V132, P220, DOI 10.1016/j.schres.2011.06.017; Klaassen P, 2016, AM J MED GENET B, V171, P790, DOI 10.1002/ajmg.b.32441; Kuchenbaecker KB, 2017, JNCI-J NATL CANCER I, V109, DOI 10.1093/jnci/djw302; Lecarpentier J, 2017, J CLIN ONCOL, V35, P2240, DOI 10.1200/JCO.2016.69.4935; Lin A, 2011, SCHIZOPHR RES, V132, P1, DOI 10.1016/j.schres.2011.06.014; MacCabe JH, 2013, JAMA PSYCHIAT, V70, P261, DOI 10.1001/2013.jamapsychiatry.43; Marder SR, 2019, NEW ENGL J MED, V381, P1753, DOI 10.1056/NEJMra1808803; Martin AR, 2017, AM J HUM GENET, V100, P635, DOI 10.1016/j.ajhg.2017.03.004; Meier MH, 2014, AM J PSYCHIAT, V171, P91, DOI 10.1176/appi.ajp.2013.12111438; Miller TJ, 2003, SCHIZOPHRENIA BULL, V29, P703, DOI 10.1093/oxfordjournals.schbul.a007040; Mollon J, 2018, JAMA PSYCHIAT, V75, P270, DOI 10.1001/jamapsychiatry.2017.4327; Murphy KC, 1999, ARCH GEN PSYCHIAT, V56, P940, DOI 10.1001/archpsyc.56.10.940; Pardinas AF, 2018, NAT GENET, V50, P381, DOI 10.1038/s41588-018-0059-2; Perkins DO, 2020, AM J PSYCHIAT, V177, P155, DOI 10.1176/appi.ajp.2019.18060721; Poulton R, 2000, ARCH GEN PSYCHIAT, V57, P1053, DOI 10.1001/archpsyc.57.11.1053; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Reichenberg A, 2010, AM J PSYCHIAT, V167, P160, DOI 10.1176/appi.ajp.2009.09040574; Rietveld CA, 2013, SCIENCE, V340, P1467, DOI 10.1126/science.1235488; Ripke S, 2014, NATURE, V511, P421, DOI 10.1038/nature13595; Rosso IM, 2000, SCHIZOPHRENIA BULL, V26, P367, DOI 10.1093/oxfordjournals.schbul.a033459; Sieradzka D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094398; Sommer IE, 2016, NPJ SCHIZOPHR, V2, DOI 10.1038/npjschz.2016.3; Spearman C, 1904, AM J PSYCHOL, V15, P201, DOI 10.2307/1412107; Sugrue LP, 2019, JAMA-J AM MED ASSOC, V321, P1820, DOI 10.1001/jama.2019.3893; Tansey KE, 2016, MOL PSYCHIATR, V21, P1085, DOI 10.1038/mp.2015.143; Torkamani A, 2018, NAT REV GENET, V19, P581, DOI 10.1038/s41576-018-0018-x; Trevethan R, 2017, FRONT PUBLIC HEALTH, V5, DOI 10.3389/fpubh.2017.00307; van Oel CJ, 2002, SCHIZOPHRENIA BULL, V28, P401, DOI 10.1093/oxfordjournals.schbul.a006949; Vorstman JAS, 2006, HUM MUTAT, V27, P814, DOI 10.1002/humu.20330; Vorstman JAS, 2015, JAMA PSYCHIAT, V72, P377, DOI 10.1001/jamapsychiatry.2014.2671; WALKER EF, 1993, AM J PSYCHIAT, V150, P1654; Woodberry KA, 2008, AM J PSYCHIAT, V165, P579, DOI 10.1176/appi.ajp.2008.07081242; Wray NR, 2014, J CHILD PSYCHOL PSYC, V55, P1068, DOI 10.1111/jcpp.12295; Yung AR, 2005, AUST NZ J PSYCHIAT, V39, P964, DOI 10.1080/j.1440-1614.2005.01714.x; Zammit S, 2004, ARCH GEN PSYCHIAT, V61, P354, DOI 10.1001/archpsyc.61.4.354	61	44	44	1	10	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	2020	26	12								10.1038/s41591-020-1103-1	http://dx.doi.org/10.1038/s41591-020-1103-1		NOV 2020	13	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	PB8QO	33169016	Green Accepted			2022-12-27	WOS:000588007500002
J	Stower, H				Stower, Hannah			Opening the door to gene therapy for ALS	NATURE MEDICINE			English	Editorial Material												h.stower@us.nature.com							0	0	0	0	8	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	AUG	2020	26	8					1170	1170		10.1038/s41591-020-1029-7	http://dx.doi.org/10.1038/s41591-020-1029-7		AUG 2020	1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	MX8ZF	32770163	Bronze			2022-12-27	WOS:000557134700010
J	Pai, MD				Pai, Madhukar			Covidization of research: what are the risks?	NATURE MEDICINE			English	Editorial Material								Every crisis is a strong call to mobilize the entire research community to respond. The COVID-19 pandemic is no exception. Researchers, universities, funders, philanthropies, journals, and journalists have all pivoted,en masse, to COVID-19. Everyone is 'Covidized', and it should worry us.	[Pai, Madhukar] McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada; [Pai, Madhukar] McGill Univ, Ctr Hlth, McGill Int TB Ctr, Res Inst, Montreal, PQ, Canada	McGill University; McGill University	Pai, MD (corresponding author), McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada.; Pai, MD (corresponding author), McGill Univ, Ctr Hlth, McGill Int TB Ctr, Res Inst, Montreal, PQ, Canada.	madhukar.pai@mcgill.ca	Pai, Madhukar/AAX-9901-2021; PAL, MRINAL/ABG-9676-2020	Pai, Madhukar/0000-0003-3667-4536; PAL, MRINAL/0000-0002-1032-272X					0	26	27	0	0	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	AUG	2020	26	8					1159	1159		10.1038/s41591-020-1015-0	http://dx.doi.org/10.1038/s41591-020-1015-0		JUL 2020	1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	MX8ZF	32719486	Bronze			2022-12-27	WOS:000552954000003
J	Stower, H				Stower, Hannah			Senolytic CAR T cells	NATURE MEDICINE			English	Editorial Material												h.stower@us.nature.com							0	1	1	0	1	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	JUL	2020	26	7					1009	1009		10.1038/s41591-020-0988-z	http://dx.doi.org/10.1038/s41591-020-0988-z		JUL 2020	1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	MK3XO	32651572	Bronze			2022-12-27	WOS:000547236500004
J	Gilbert, M; Dewatripont, M; Muraille, E; Platteau, JP; Goldman, M				Gilbert, Marius; Dewatripont, Mathias; Muraille, Eric; Platteau, Jean-Philippe; Goldman, Michel			Preparing for a responsible lockdown exit strategy	NATURE MEDICINE			English	Editorial Material									[Gilbert, Marius; Dewatripont, Mathias; Muraille, Eric; Goldman, Michel] Univ Libre Bruxelles, Brussels, Belgium; [Muraille, Eric; Platteau, Jean-Philippe] Univ Namur, Namur, Belgium	Universite Libre de Bruxelles; University of Namur	Goldman, M (corresponding author), Univ Libre Bruxelles, Brussels, Belgium.	mgoldman@i3health.eu	Mrl, Eric/ABC-5458-2021					Deaton A., 2020, DEATHS DESPAIR FUTUR; Dewatripont M., 2020, VOX CEPR POLICY PORT	2	51	52	0	4	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	MAY	2020	26	5					643	644		10.1038/s41591-020-0871-y	http://dx.doi.org/10.1038/s41591-020-0871-y		APR 2020	2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	ML1JP	32405055	Green Published, Green Submitted, Bronze			2022-12-27	WOS:000526350100003
J	Zeng, J; Wu, YX; Ren, CY; Bonanno, J; Shen, AH; Shea, D; Gehrke, JM; Clement, K; Luk, K; Yao, QM; Kim, R; Wolfe, SA; Manis, JP; Pinello, L; Joung, JK; Bauer, DE				Zeng, Jing; Wu, Yuxuan; Ren, Chunyan; Bonanno, Jasmine; Shen, Anne H.; Shea, Devlin; Gehrke, Jason M.; Clement, Kendell; Luk, Kevin; Yao, Qiuming; Kim, Rachel; Wolfe, Scot A.; Manis, John P.; Pinello, Luca; Joung, J. Keith; Bauer, Daniel E.			Therapeutic base editing of human hematopoietic stem cells	NATURE MEDICINE			English	Article							OFF-TARGET; GENOMIC DNA; MUTATION; ENHANCER; CCR5	A single therapeutic base edit of the BCL11A enhancer in human HSPCs can ameliorate cellular defects associated with sickle cell disease and beta-thalassemia in vitro and efficiently induce fetal hemoglobin expression upon engraftment in mice in vivo. Base editing by nucleotide deaminases linked to programmable DNA-binding proteins represents a promising approach to permanently remedy blood disorders, although its application in engrafting hematopoietic stem cells (HSCs) remains unexplored. In this study, we purified A3A (N57Q)-BE3 base editor for ribonucleoprotein (RNP) electroporation of human-peripheral-blood-mobilized CD34(+) hematopoietic stem and progenitor cells (HSPCs). We observed frequent on-target cytosine base edits at the BCL11A erythroid enhancer at +58 with few indels. Fetal hemoglobin (HbF) induction in erythroid progeny after base editing or nuclease editing was similar. A single therapeutic base edit of the BCL11A enhancer prevented sickling and ameliorated globin chain imbalance in erythroid progeny from sickle cell disease and beta-thalassemia patient-derived HSPCs, respectively. Moreover, efficient multiplex editing could be achieved with combined disruption of the BCL11A erythroid enhancer and correction of the HBB -28A>G promoter mutation. Finally, base edits could be produced in multilineage-repopulating self-renewing human HSCs with high frequency as assayed in primary and secondary recipient animals resulting in potent HbF induction in vivo. Together, these results demonstrate the potential of RNP base editing of human HSPCs as a feasible alternative to nuclease editing for HSC-targeted therapeutic genome modification.	[Zeng, Jing; Wu, Yuxuan; Ren, Chunyan; Bonanno, Jasmine; Shen, Anne H.; Shea, Devlin; Yao, Qiuming; Kim, Rachel; Bauer, Daniel E.] Harvard Med Sch, Div Hematol Oncol, Boston Childrens Hosp,Broad Inst,Dept Pediat, Dept Pediat Oncol,Dana Farber Canc Inst,Harvard S, Boston, MA 02115 USA; [Wu, Yuxuan] East China Normal Univ, Shanghai Key Lab Regulatory Biol, Inst Biomed Sci, Shanghai, Peoples R China; [Wu, Yuxuan] East China Normal Univ, Sch Life Sci, Shanghai, Peoples R China; [Gehrke, Jason M.; Clement, Kendell; Yao, Qiuming; Pinello, Luca; Joung, J. Keith] Massachusetts Gen Hosp, Mol Pathol Unit, Ctr Canc Res, Boston, MA 02114 USA; [Gehrke, Jason M.; Clement, Kendell; Yao, Qiuming; Pinello, Luca; Joung, J. Keith] Massachusetts Gen Hosp, Ctr Computat & Integrat Biol, Boston, MA 02114 USA; [Luk, Kevin; Wolfe, Scot A.] Univ Massachusetts, Sch Med, Dept Mol Cell & Canc Biol, Li Weibo Inst Rare Dis Res, Worcester, MA USA; [Kim, Rachel] Wellesley Coll, Dept Chem, Wellesley, MA 02181 USA; [Manis, John P.] Harvard Med Sch, Dept Lab Med, Boston Childrens Hosp, Dept Pathol, Boston, MA 02115 USA; [Pinello, Luca; Joung, J. Keith] Harvard Med Sch, Dept Pathol, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Dana-Farber Cancer Institute; Harvard Medical School; Massachusetts Institute of Technology (MIT); Broad Institute; East China Normal University; East China Normal University; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; University of Massachusetts System; University of Massachusetts Worcester; Wellesley College; Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Harvard Medical School	Bauer, DE (corresponding author), Harvard Med Sch, Div Hematol Oncol, Boston Childrens Hosp,Broad Inst,Dept Pediat, Dept Pediat Oncol,Dana Farber Canc Inst,Harvard S, Boston, MA 02115 USA.	daniel.bauer@childrens.harvard.edu	Clement, Kendell/AAZ-6854-2021; REN, CHUNYAN/F-1880-2017	REN, CHUNYAN/0000-0002-3913-2479; Shea, Devlin/0000-0002-5058-6770; Clement, Kendell/0000-0003-3808-0811	National Human Genome Research Institute [R00HG008399, RM1 HG009490]; National Institute of Allergy and Infectious Diseases [R01AI117839]; National Institute of General Medical Sciences [R01GM115911, R35 GM118158]; St. Jude Children's Research Hospital Collaborative Research Consortium; Desmond and Ann Heathwood MGH Research Scholar Award; National Heart, Lung, and Blood Institute [P01HL053749]; Burroughs Wellcome Fund	National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); St. Jude Children's Research Hospital Collaborative Research Consortium; Desmond and Ann Heathwood MGH Research Scholar Award; National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Burroughs Wellcome Fund(Burroughs Wellcome Fund)	We appreciate useful discussions with D. Liu, M. Weiss, S. Tsai, C. Brendel and M. Peters. We thank R. Mathieu and the Boston Children's Hospital flow cytometry staff for technical assistance, Z. Herbert and the Dana-Farber Cancer Institute molecular biology core for deep sequencing assistance and C. Brugnara, E. Esrick, D. Williams and the Boston Children's Hospital clinical staff for assistance with ss-thalassemia and SCD patient samples. We are grateful to the patients for their participation. L.P. was supported by the National Human Genome Research Institute (grant R00HG008399); S.A.W. was supported by the National Institute of Allergy and Infectious Diseases (grant R01AI117839) and the National Institute of General Medical Sciences (grant R01GM115911); and J.K.J. was supported by the National Institute of General Medical Sciences (grant R35 GM118158), the National Human Genome Research Institute (grant RM1 HG009490), the St. Jude Children's Research Hospital Collaborative Research Consortium and the Desmond and Ann Heathwood MGH Research Scholar Award. D.E.B. was supported by the National Heart, Lung, and Blood Institute (grant P01HL053749), the St. Jude Children's Research Hospital Collaborative Research Consortium and the Burroughs Wellcome Fund.	Bae S, 2014, BIOINFORMATICS, V30, P1473, DOI 10.1093/bioinformatics/btu048; Bauer DE, 2013, SCIENCE, V342, P253, DOI 10.1126/science.1242088; Canver MC, 2015, NATURE, V527, P192, DOI 10.1038/nature15521; Clement K, 2019, NAT BIOTECHNOL, V37, P224, DOI 10.1038/s41587-019-0032-3; Corces MR, 2016, NAT GENET, V48, P1193, DOI 10.1038/ng.3646; De Ravin SS, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aah3480; Dever DP, 2016, NATURE, V539, P384, DOI 10.1038/nature20134; DeWitt MA, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf9336; Eng B, 2007, HEMOGLOBIN, V31, P129, DOI 10.1080/03630260701284624; Fiorini C, 2017, AM J HEMATOL, V92, pE513, DOI 10.1002/ajh.24805; Gaudelli NM, 2017, NATURE, V551, P464, DOI 10.1038/nature24644; Gehrke JM, 2018, NAT BIOTECHNOL, V36, P977, DOI 10.1038/nbt.4199; Genovese P, 2014, NATURE, V510, P235, DOI 10.1038/nature13420; Grunewald J, 2019, NAT BIOTECHNOL, V37, P1041, DOI 10.1038/s41587-019-0236-6; Grunewald J, 2019, NATURE, V569, P433, DOI 10.1038/s41586-019-1161-z; Gundry MC, 2016, CELL REP, V17, P1453, DOI 10.1016/j.celrep.2016.09.092; Hoban MD, 2015, BLOOD, V125, P2597, DOI 10.1182/blood-2014-12-615948; Holt N, 2010, NAT BIOTECHNOL, V28, P839, DOI 10.1038/nbt.1663; Kluesner MG, 2018, CRISPR J, V1, P239, DOI 10.1089/crispr.2018.0014; Komor AC, 2016, NATURE, V533, P420, DOI 10.1038/nature17946; Li ZY, 2015, HEMOGLOBIN, V39, P115, DOI 10.3109/03630269.2014.1002844; McIntosh BE, 2015, STEM CELL REP, V4, P171, DOI 10.1016/j.stemcr.2014.12.005; Mohrin M, 2010, CELL STEM CELL, V7, P174, DOI 10.1016/j.stem.2010.06.014; Nishida K, 2016, SCIENCE, V353, DOI 10.1126/science.aaf8729; PONCZ M, 1982, J BIOL CHEM, V257, P5994; Qasim W, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aaj2013; Rees HA, 2018, NAT REV GENET, V19, P770, DOI 10.1038/s41576-018-0059-1; Seo H, 2018, NAT MED, V24, P1493, DOI 10.1038/s41591-018-0215-3; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Tebas P, 2014, NEW ENGL J MED, V370, P901, DOI 10.1056/NEJMoa1300662; Vierstra J, 2015, NAT METHODS, V12, P927, DOI [10.1038/NMETH.3554, 10.1038/nmeth.3554]; Wu YX, 2019, NAT MED, V25, P776, DOI 10.1038/s41591-019-0401-y; Zuo EW, 2019, SCIENCE, V364, P289, DOI 10.1126/science.aav9973	33	89	93	7	36	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	APR	2020	26	4					535	+		10.1038/s41591-020-0790-y	http://dx.doi.org/10.1038/s41591-020-0790-y		MAR 2020	15	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	QH1UE	32284612	Green Accepted			2022-12-27	WOS:000519842900003
J	Kohn, DB; Booth, C; Kang, EM; Pai, SY; Shaw, KL; Santilli, G; Armant, M; Buckland, KF; Choi, U; De Ravin, SS; Dorsey, MJ; Kuo, CY; Leon-Rico, D; Rivat, C; Izotova, N; Gilmour, K; Snell, K; Dip, JXB; Darwish, J; Morris, EC; Terrazas, D; Wang, LD; Bauser, CA; Paprotka, T; Kuhns, DB; Gregg, J; Raymond, HE; Everett, JK; Honnet, G; Biasco, L; Newburger, PE; Bushman, FD; Grez, M; Gaspar, HB; Williams, DA; Malech, HL; Galy, A; Thrasher, AJ; Buckland, KF; Bauser, CA; Honnet, G; Grez, M; Gaspar, HB; Galy, A; Thrasher, AJ				Kohn, Donald B.; Booth, Claire; Kang, Elizabeth M.; Pai, Sung-Yun; Shaw, Kit L.; Santilli, Giorgia; Armant, Myriam; Buckland, Karen F.; Choi, Uimook; De Ravin, Suk See; Dorsey, Morna J.; Kuo, Caroline Y.; Leon-Rico, Diego; Rivat, Christine; Izotova, Natalia; Gilmour, Kimberly; Snell, Katie; Dip, Jinhua Xu-Bayford; Darwish, Jinan; Morris, Emma C.; Terrazas, Dayna; Wang, Leo D.; Bauser, Christopher A.; Paprotka, Tobias; Kuhns, Douglas B.; Gregg, John; Raymond, Hayley E.; Everett, John K.; Honnet, Geraldine; Biasco, Luca; Newburger, Peter E.; Bushman, Frederic D.; Grez, Manuel; Gaspar, H. Bobby; Williams, David A.; Malech, Harry L.; Galy, Anne; Thrasher, Adrian J.; Buckland, Karen F.; Bauser, Christopher A.; Honnet, Geraldine; Grez, Manuel; Gaspar, H. Bobby; Galy, Anne; Thrasher, Adrian J.		Net4CGD Consortium; NetCGD Consortium	Lentiviral gene therapy for X-linked chronic granulomatous disease	NATURE MEDICINE			English	Article							STEM-CELL TRANSPLANTATION; TRANSGENE EXPRESSION; DNA INTEGRATION; SITES; ACTIVATION; FRAMEWORK; OXIDASE	Chronic granulomatous disease (CGD) is a rare inherited disorder of phagocytic cells(1,2). We report the initial results of nine severely affected X-linked CGD (X-CGD) patients who received ex vivo autologous CD34(+) hematopoietic stem and progenitor cell-based lentiviral gene therapy following myeloablative conditioning in first-in-human studies (trial registry nos. NCT02234934 and NCT01855685). The primary objectives were to assess the safety and evaluate the efficacy and stability of biochemical and functional reconstitution in the progeny of engrafted cells at 12 months. The secondary objectives included the evaluation of augmented immunity against bacterial and fungal infection, as well as assessment of hematopoietic stem cell transduction and engraftment. Two enrolled patients died within 3 months of treatment from pre-existing comorbidities. At 12 months, six of the seven surviving patients demonstrated stable vector copy numbers (0.4-1.8 copies per neutrophil) and the persistence of 16-46% oxidase-positive neutrophils. There was no molecular evidence of either clonal dysregulation or transgene silencing. Surviving patients have had no new CGD-related infections, and six have been able to discontinue CGD-related antibiotic prophylaxis. The primary objective was met in six of the nine patients at 12 months follow-up, suggesting that autologous gene therapy is a promising approach for CGD patients. Initial results from phase I/II lentiviral gene therapy trials provide early evidence supporting its safety and efficacy in treating patients with X-linked chronic granulomatous disease.	[Kohn, Donald B.; Shaw, Kit L.; Kuo, Caroline Y.; Terrazas, Dayna] Univ Calif Los Angeles, Los Angeles, CA 90095 USA; [Booth, Claire; Santilli, Giorgia; Buckland, Karen F.; Leon-Rico, Diego; Rivat, Christine; Izotova, Natalia; Gilmour, Kimberly; Snell, Katie; Dip, Jinhua Xu-Bayford; Darwish, Jinan; Biasco, Luca; Gaspar, H. Bobby; Thrasher, Adrian J.] Great Ormond St Inst Child Hlth, London, England; [Booth, Claire; Santilli, Giorgia; Buckland, Karen F.; Leon-Rico, Diego; Rivat, Christine; Izotova, Natalia; Gilmour, Kimberly; Snell, Katie; Dip, Jinhua Xu-Bayford; Darwish, Jinan; Biasco, Luca; Gaspar, H. Bobby; Thrasher, Adrian J.] Great Ormond St Hosp NHS Fdn Trust, London, England; [Kang, Elizabeth M.; Choi, Uimook; De Ravin, Suk See; Malech, Harry L.] NIAID, Lab Clin Immunol & Microbiol, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Pai, Sung-Yun; Armant, Myriam; Wang, Leo D.; Williams, David A.] Harvard Med Sch, Boston Childrens Hosp, Boston, MA 02115 USA; [Dorsey, Morna J.] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Morris, Emma C.] Univ Coll London Hosp NHS Fdn Trust, London, England; [Bauser, Christopher A.; Paprotka, Tobias] Eurofins Genom Sequencing Europe, Constance, Germany; [Kuhns, Douglas B.] Leidos Biomed Res Inc, Frederick Natl Lab Canc Res, Frederick, MD USA; [Gregg, John; Raymond, Hayley E.; Everett, John K.; Bushman, Frederic D.] Univ Penn, Philadelphia, PA 19104 USA; [Honnet, Geraldine; Galy, Anne] Genethon, Evry, France; [Newburger, Peter E.] Univ Massachusetts, Sch Med, Worcester, MA USA; [Grez, Manuel] Georg Speyer Haus, Frankfurt, Germany; [Gaspar, H. Bobby] Orchard Therapeut, London, England; [Galy, Anne] Univ Paris Saclay Genethon, Univ Evry, INSERM, Evry, France; [Wang, Leo D.] City Hope Natl Med Ctr, Beckman Res Inst, Duarte, CA USA; Univ Modena, Modena, Italy; Audentes Therapeut, San Francisco, CA USA; Univ Hosp Frankfurt, Frankfurt, Germany; Univ Zurich, Zurich, Switzerland; APHP Necker, Paris, France; Genosafe, Evry, France; Europa Inst Forsch & Entwicklung Transplantat Str, Berlin, Germany; Deutsch Krebforschungszentrum, Heidelberg, Germany	University of California System; University of California Los Angeles; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Harvard University; Boston Children's Hospital; Harvard Medical School; University of California System; University of California San Francisco; University College London Hospitals NHS Foundation Trust; University of London; University College London; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Pennsylvania; University of Massachusetts System; University of Massachusetts Worcester; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; City of Hope; Beckman Research Institute of City of Hope; Universita di Modena e Reggio Emilia; Goethe University Frankfurt; Goethe University Frankfurt Hospital; University of Zurich; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite	Kohn, DB (corresponding author), Univ Calif Los Angeles, Los Angeles, CA 90095 USA.; Thrasher, AJ (corresponding author), Great Ormond St Inst Child Hlth, London, England.; Thrasher, AJ (corresponding author), Great Ormond St Hosp NHS Fdn Trust, London, England.	dkohn@mednet.ucla.edu; a.thrasher@ucl.ac.uk	Dorsey, Morna/V-7270-2018; Galy, Anne/GQI-4255-2022; Booth, Claire/I-3667-2016; Kohn, Donald/N-5085-2016	Dorsey, Morna/0000-0002-9432-3542; Galy, Anne/0000-0002-0153-4392; Buckland, Karen/0000-0001-6989-2228; Booth, Claire/0000-0002-2626-5037; Kohn, Donald/0000-0003-1840-6087; Morris, Emma/0000-0003-4834-1130; Shaw, Kit/0000-0002-1293-8050; De Ravin, Suk See/0000-0002-9800-774X; Bauser, Christopher A./0000-0003-0466-4894; Kuo, Caroline/0000-0002-9302-0187	California Institute of Regenerative Medicine [CLIN2-08231, FA1-00613-1]; Gene Therapy Resource Program from NHLBI, NIH [CRB-SSS-S-15-004351 1840]; NIAID Intramural Program; NET4CGD (FP7 EU grant) [305011]; Wellcome Trust [104807/Z/14/Z]; Department of Pediatrics; Boston Children's Hospital; National Institute for Health Research Biomedical Research Centre at Great Ormond Street Hospital for Children NHS Foundation Trust/University College London Hospitals NHS Foundation Trust; University College London; French Muscular Dystrophy Association (AFM/Telethon); National Cancer Institute, NIH [HHSN261200800001E]; Division of Intramural Research, NIAID, NIH	California Institute of Regenerative Medicine(California Institute for Regenerative Medicine); Gene Therapy Resource Program from NHLBI, NIH; NIAID Intramural Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NET4CGD (FP7 EU grant); Wellcome Trust(Wellcome TrustEuropean Commission); Department of Pediatrics; Boston Children's Hospital; National Institute for Health Research Biomedical Research Centre at Great Ormond Street Hospital for Children NHS Foundation Trust/University College London Hospitals NHS Foundation Trust; University College London(General Electric); French Muscular Dystrophy Association (AFM/Telethon); National Cancer Institute, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Division of Intramural Research, NIAID, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors thank the patients and families of those included in the study, and members of the Net4GCD consortium (https://www.net4CGD.eu) including: Eurofins Genomics Sequencing Europe, Germany (formerly GATC Biotech AG); F. Mavilio, Genethon, France (currently at the University of Modena, Italy, and at Audentes Therapeutics); J. Schwaeble, University Hospital Frankfurt, Germany; J. Reichenbach, University of Zurich, Switzerland; M. Cavazzana, APHP Necker, Paris, France; S. Blanche, APHP Necker, Paris, France; S. Pouillot, Genosafe, Evry, France (currently at Genethon); K. Kuhlcke, Europaisches Institut fur Forschung und Entwicklung von Transplantationstrategien GmbH (Eufets), Germany; and M. Schmidt, Deutsches Krebforschungszentrum, Heidelberg, Germany. Editorial support was paid for by Orchard Therapeutics, Boston, MA, USA. This work was supported by research grants from the California Institute of Regenerative Medicine (nos. CLIN2-08231 and FA1-00613-1), the Gene Therapy Resource Program from NHLBI, NIH (no. CRB-SSS-S-15-004351 1840), the NIAID Intramural Program, NET4CGD (FP7 EU grant agreement no. 305011) and the Wellcome Trust (no. 104807/Z/14/Z); by funding from the Department of Medicine (now Department of Pediatrics), Boston Children's Hospital and the National Institute for Health Research Biomedical Research Centre at Great Ormond Street Hospital for Children NHS Foundation Trust/University College London Hospitals NHS Foundation Trust and University College London, and the French Muscular Dystrophy Association (AFM/Telethon). Clinical-grade vector was manufactured by Genethon BioProd/Yposeksi, Evry, France. Some oxidase activity analyses were funded in whole or in part by federal funds from the National Cancer Institute, NIH, under contract no. HHSN261200800001E. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products or organizations imply endorsement by the United States Government. Support was also provided by the Division of Intramural Research, NIAID, NIH.	Berry C, 2006, PLOS COMPUT BIOL, V2, P1450, DOI 10.1371/journal.pcbi.0020157; Berry CC, 2017, MOL THER-METH CLIN D, V4, P17, DOI 10.1016/j.omtm.2016.11.003; Berry CC, 2012, BIOINFORMATICS, V28, P755, DOI 10.1093/bioinformatics/bts004; Biasco L, 2016, CELL STEM CELL, V19, P107, DOI 10.1016/j.stem.2016.04.016; Biasco L, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.3010314; Brendel C, 2018, HUM GENE THER CL DEV, V29, P69, DOI 10.1089/humc.2017.245; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Dinauer MC, 2001, BLOOD, V97, P3738, DOI 10.1182/blood.V97.12.3738; Dulamea AO, 2018, NEURAL REGEN RES, V13, P945, DOI 10.4103/1673-5374.233431; Grez M, 2011, MOL THER, V19, P28, DOI 10.1038/mt.2010.232; Gungor T, 2014, LANCET, V383, P436, DOI [10.1016/s0140-6736(13)62069-3, 10.1016/S0140-6736(13)62069-3]; Holland SM, 2013, HEMATOL ONCOL CLIN N, V27, P89, DOI 10.1016/j.hoc.2012.11.002; Kang EM, 2010, BLOOD, V115, P783, DOI 10.1182/blood-2009-05-222760; Krueger F, 2011, BIOINFORMATICS, V27, P1571, DOI 10.1093/bioinformatics/btr167; Kuhns DB, 2010, NEW ENGL J MED, V363, P2600, DOI 10.1056/NEJMoa1007097; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Liu YP, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-7-r61; Marciano BE, 2018, J ALLERGY CLIN IMMUN, V141, P365, DOI 10.1016/j.jaci.2017.04.035; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Merten OW, 2011, HUM GENE THER, V22, P343, DOI 10.1089/hum.2010.060; Ott MG, 2006, NAT MED, V12, P401, DOI 10.1038/nm1393; Parta M, 2017, J CLIN IMMUNOL, V37, P548, DOI 10.1007/s10875-017-0422-6; Ribeil JA, 2017, NEW ENGL J MED, V376, P848, DOI 10.1056/NEJMoa1609677; Santilli G, 2011, MOL THER, V19, P122, DOI 10.1038/mt.2010.226; Scala S, 2018, NAT MED, V24, P1683, DOI 10.1038/s41591-018-0195-3; Schroder ARW, 2002, CELL, V110, P521, DOI 10.1016/S0092-8674(02)00864-4; Sherman E, 2017, MOL THER-METH CLIN D, V4, P39, DOI 10.1016/j.omtm.2016.11.002; Simonis A, 2018, ANN HEMATOL, V97, P1961, DOI 10.1007/s00277-018-3388-4; Stein S, 2010, NAT MED, V16, P198, DOI 10.1038/nm.2088; Thompson AA, 2018, NEW ENGL J MED, V378, P1479, DOI 10.1056/NEJMoa1705342; Weisser M, 2016, J ALLERGY CLIN IMMUN, V138, P219, DOI 10.1016/j.jaci.2015.11.028; Winkelstein JA, 2000, MEDICINE, V79, P155, DOI 10.1097/00005792-200005000-00003; Zanta-Boussif MA, 2009, GENE THER, V16, P605, DOI 10.1038/gt.2009.3	33	96	99	1	30	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	FEB	2020	26	2					200	+		10.1038/s41591-019-0735-5	http://dx.doi.org/10.1038/s41591-019-0735-5		JAN 2020	18	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	KK7DU	31988463	Green Submitted, Green Accepted			2022-12-27	WOS:000510552300001
J	Kilbride, MK				Kilbride, Madison K.			When variants are reclassified-the importance of personalized communication	NATURE MEDICINE			English	News Item								Thinking the e-mail was a system error, she almost didn't learn that her genetic test result had been revised. With the advent of commercial genomic screening, who is ethically responsible for communicating variant reclassification?	[Kilbride, Madison K.] Univ Penn, Perelman Sch Med, Dept Med Eth & Hlth Policy, Philadelphia, PA 19104 USA	University of Pennsylvania	Kilbride, MK (corresponding author), Univ Penn, Perelman Sch Med, Dept Med Eth & Hlth Policy, Philadelphia, PA 19104 USA.	madisonk@upenn.edu		Kilbride, Madison/0000-0002-8923-9944	NHGRI NIH HHS [T32 HG009496] Funding Source: Medline	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Aronson SJ, 2012, GENET MED, V14, P713, DOI 10.1038/gim.2012.19; Carrieri D, 2019, EUR J HUM GENET, V27, P169, DOI 10.1038/s41431-018-0285-1; Mersch J, 2018, JAMA-J AM MED ASSOC, V320, P1266, DOI 10.1001/jama.2018.13152	3	1	1	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JAN	2020	26	1					15	15		10.1038/s41591-019-0707-9	http://dx.doi.org/10.1038/s41591-019-0707-9			1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	KG3GZ	31932785	Bronze, Green Accepted			2022-12-27	WOS:000509831900009
J	Stower, H				Stower, Hannah			NONCOMMUNICABLE DISEASES A disease transition in sub-Saharan Africa	NATURE MEDICINE			English	Editorial Material																			0	5	5	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2019	25	11					1647	1647		10.1038/s41591-019-0659-0	http://dx.doi.org/10.1038/s41591-019-0659-0			1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	JT2KI	31700178	Bronze			2022-12-27	WOS:000500824300015
J	Shah, NN; Johnson, BD; Schneider, D; Zhu, FL; Szabo, A; Keever-Taylor, CA; Krueger, W; Worden, AA; Kadan, MJ; Yim, S; Cunningham, A; Hamadani, M; Fenske, TS; Dropulic, B; Orentas, R; Hari, P				Shah, Nirav N.; Johnson, Bryon D.; Schneider, Dina; Zhu, Fenlu; Szabo, Aniko; Keever-Taylor, Carolyn A.; Krueger, Winfried; Worden, Andrew A.; Kadan, Michael J.; Yim, Sharon; Cunningham, Ashley; Hamadani, Mehdi; Fenske, Timothy S.; Dropulic, Boro; Orentas, Rimas; Hari, Parameswaran			Bispecific anti-CD20, anti-CD19 CAR T cells for relapsed B cell malignancies: a phase 1 dose escalation and expansion trial	NATURE MEDICINE			English	Article							CYTOKINE RELEASE SYNDROME; CD19; BIOMARKERS; DIAGNOSIS; KINETICS	Chimeric antigen receptor (CAR) T cells targeting CD19 are a breakthrough treatment for relapsed, refractory B cell malignancies(1-5). Despite impressive outcomes, relapse with CD19(-)disease remains a challenge. We address this limitation through a first-in-human trial of bispecific anti-CD20, anti-CD19 (LV20.19) CAR T cells for relapsed, refractory B cell malignancies. Adult patients with B cell non-Hodgkin lymphoma or chronic lymphocytic leukemia were treated on a phase 1 dose escalation and expansion trial (NCT03019055) to evaluate the safety of 4-1BB-CD3 zeta LV20.19 CAR T cells and the feasibility of on-site manufacturing using the CliniMACS Prodigy system. CAR T cell doses ranged from 2.5 x 10(5)-2.5 x 10(6) cells per kg. Cell manufacturing was set at 14 d with the goal of infusing non-cryopreserved LV20.19 CAR T cells. The target dose of LV20.19 CAR T cells was met in all CAR-naive patients, and 22 patients received LV20.19 CAR T cells on protocol. In the absence of dose-limiting toxicity, a dose of 2.5 x 10(6) cells per kg was chosen for expansion. Grade 3-4 cytokine release syndrome occurred in one (5%) patient, and grade 3-4 neurotoxicity occurred in three (14%) patients. Eighteen (82%) patients achieved an overall response at day 28, 14 (64%) had a complete response, and 4 (18%) had a partial response. The overall response rate to the dose of 2.5 x 10(6) cells per kg with non-cryopreserved infusion (n = 12) was 100% (complete response, 92%; partial response, 8%). Notably, loss of the CD19 antigen was not seen in patients who relapsed or experienced treatment failure. In conclusion, on-site manufacturing and infusion of non-cryopreserved LV20.19 CAR T cells were feasible and therapeutically safe, showing low toxicity and high efficacy. Bispecific CARs may improve clinical responses by mitigating target antigen downregulation as a mechanism of relapse.	[Shah, Nirav N.; Johnson, Bryon D.; Zhu, Fenlu; Keever-Taylor, Carolyn A.; Yim, Sharon; Hamadani, Mehdi; Fenske, Timothy S.; Hari, Parameswaran] Med Coll Wisconsin, Div Hematol & Oncol, BMT & Cellular Therapy Program, Milwaukee, WI 53226 USA; [Schneider, Dina; Krueger, Winfried; Worden, Andrew A.; Kadan, Michael J.; Dropulic, Boro; Orentas, Rimas] Lentigen, Gaithersburg, MD 20878 USA; [Szabo, Aniko] Med Coll Wisconsin, Div Biostat, Milwaukee, WI 53226 USA; [Cunningham, Ashley] Med Coll Wisconsin, Dept Pathol, Milwaukee, WI 53226 USA; [Orentas, Rimas] Univ Washington, Sch Med, Dept Pediat, Ben Towne Ctr Childhood Canc Res, Seattle, WA 98195 USA	Medical College of Wisconsin; Medical College of Wisconsin; Medical College of Wisconsin; University of Washington; University of Washington Seattle	Shah, NN (corresponding author), Med Coll Wisconsin, Div Hematol & Oncol, BMT & Cellular Therapy Program, Milwaukee, WI 53226 USA.; Dropulic, B (corresponding author), Lentigen, Gaithersburg, MD 20878 USA.	nishah@mcw.edu; boro.dropulic@miltenyi.com	Szabo, Aniko/F-9656-2012	Szabo, Aniko/0000-0002-8129-0614; Keever-Taylor, Carolyn/0000-0002-3085-6876; Schneider, Dina/0000-0001-7130-7374; Yim, Sharon/0000-0001-6442-1320	MACC Fund; Children's Wisconsin Foundation; Lentigen Technology, a Miltenyi Biotec company; Drive for the Cure Foundation; Froedtert & Medical College of Wisconsin Cancer Center	MACC Fund; Children's Wisconsin Foundation; Lentigen Technology, a Miltenyi Biotec company; Drive for the Cure Foundation; Froedtert & Medical College of Wisconsin Cancer Center	We thank all study participants and the BMT & Cellular Therapy team from the Medical College of Wisconsin for their care of these patients and acknowledge the contributions of laboratory staff from BMT & Cellular Therapy, in particular H. Xu, K. Chaney and L. Luib, who were involved in LV20.19 CAR T cell manufacturing, coordinators K. Worzalla and J. Esselmann for administrative and logistical support and S. Heidtke for laboratory quality management oversight. Additionally, we would like to thank the MACC Fund and the Children's Wisconsin Foundation for their support of the Cell Therapy Lab. Lentigen Technology, a Miltenyi Biotec company, provided the lentiviral (LV20.19) vector used in this study and partial funding support for data collection. The Drive for the Cure Foundation and the Froedtert & Medical College of Wisconsin Cancer Center provided additional partial funding. The primary data analysis was conducted by N.N.S., B.D.J. and A.S.	Abramson JS, 2019, BLOOD, V134, DOI 10.1182/blood-2019-127508; Cancer Institute N, 2017, COMMON TERMINOLOGY C; Cheson BD, 2014, J CLIN ONCOL, V32, P3059, DOI 10.1200/JCO.2013.54.8800; Chou CK, 2019, BONE MARROW TRANSPL, V54, P780, DOI 10.1038/s41409-019-0602-5; Hallek M, 2008, BLOOD, V111, P5446, DOI 10.1182/blood-2007-06-093906; Hamieh M, 2019, NATURE, V568, P112, DOI 10.1038/s41586-019-1054-1; Hay KA, 2017, BLOOD, V130, P2295, DOI 10.1182/blood-2017-06-793141; HOSSAIN N, 2018, BLOOD S, V132, DOI DOI 10.1182/BLOOD-2018-99-110142; Jeurink PV, 2008, CRYOBIOLOGY, V57, P91, DOI 10.1016/j.cryobiol.2008.06.002; Lee DW, 2019, BIOL BLOOD MARROW TR, V25, P625, DOI 10.1016/j.bbmt.2018.12.758; Lee DW, 2014, BLOOD, V124, P188, DOI 10.1182/blood-2014-05-552729; Locke FL, 2019, LANCET ONCOL, V20, P31, DOI 10.1016/S1470-2045(18)30864-7; Majzner RG, 2018, CANCER DISCOV, V8, P1219, DOI 10.1158/2159-8290.CD-18-0442; Maude SL, 2018, NEW ENGL J MED, V378, P439, DOI 10.1056/NEJMoa1709866; Neelapu SS, 2017, NEW ENGL J MED, V377, P2531, DOI 10.1056/NEJMoa1707447; Neelapu SS, 2019, BLOOD, V134, DOI 10.1182/blood-2019-126218; Orlando EJ, 2018, NAT MED, V24, P1504, DOI 10.1038/s41591-018-0146-z; Pan J, 2020, BLOOD, V135, P387, DOI 10.1182/blood.2019003293; Panch SR, 2019, MOL THER, V27, P1275, DOI 10.1016/j.ymthe.2019.05.015; Schneider D, 2017, J IMMUNOTHER CANCER, V5, DOI 10.1186/s40425-017-0246-1; Schuster SJ, 2019, NEW ENGL J MED, V380, P45, DOI 10.1056/NEJMoa1804980; Schuster SJ, 2017, NEW ENGL J MED, V377, P2545, DOI 10.1056/NEJMoa1708566; Shah NN, 2019, NAT REV CLIN ONCOL, V16, P372, DOI 10.1038/s41571-019-0184-6; Shah NN, 2019, FRONT ONCOL, V9, DOI 10.3389/fonc.2019.00146; Shimabukuro-Vornhagen A, 2018, J IMMUNOTHER CANCER, V6, DOI 10.1186/s40425-018-0343-9; Sotillo E, 2015, CANCER DISCOV, V5, P1282, DOI 10.1158/2159-8290.CD-15-1020; Spiegel JY, 2019, J CLIN ONCOL, V37; Teachey DT, 2016, CANCER DISCOV, V6, P664, DOI 10.1158/2159-8290.CD-16-0040; Tong C, 2020, BLOOD, V136, P1632, DOI 10.1182/blood.2020005278; Tran E, 2017, NEW ENGL J MED, V377, P2593, DOI 10.1056/NEJMe1714680; Zah E, 2016, CANCER IMMUNOL RES, V4, P498, DOI 10.1158/2326-6066.CIR-15-0231; Zhu FL, 2018, CYTOTHERAPY, V20, P394, DOI 10.1016/j.jcyt.2017.09.005	32	141	147	5	22	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	OCT	2020	26	10					1569	+		10.1038/s41591-020-1081-3	http://dx.doi.org/10.1038/s41591-020-1081-3		OCT 2020	23	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	NX8MD	33020647				2022-12-27	WOS:000575801100004
J	Bernard, E; Nannya, Y; Hasserjian, RP; Devlin, SM; Tuechler, H; Medina-Martinez, JS; Yoshizato, T; Shiozawa, Y; Saiki, R; Malcovati, L; Levine, MF; Arango, JE; Zhou, YY; Sole, F; Cargo, CA; Haase, D; Creignou, M; Germing, U; Zhang, YM; Gundem, G; Sarian, A; van de Loosdrecht, AA; Jadersten, M; Tobiasson, M; Kosmider, O; Follo, MY; Thol, F; Pinheiro, RF; Santini, V; Kotsianidis, I; Boultwood, J; Santos, FPS; Schanz, J; Kasahara, S; Ishikawa, T; Tsurumi, H; Takaori-Kondo, A; Kiguchi, T; Polprasert, C; Bennett, JM; Klimek, VM; Savona, MR; Belickova, M; Ganster, C; Palomo, L; Sanz, G; Ades, L; Della Porta, MG; Smith, AG; Werner, Y; Patel, M; Viale, A; Vanness, K; Neuberg, DS; Stevenson, KE; Menghrajani, K; Bolton, KL; Fenaux, P; Pellagatti, A; Platzbecker, U; Heuser, M; Valent, P; Chiba, S; Miyazaki, Y; Finelli, C; Voso, MT; Shih, LY; Fontenay, M; Jansen, JH; Cervera, J; Atsuta, Y; Gattermann, N; Ebert, BL; Bejar, R; Greenberg, PL; Cazzola, M; Hellstrom-Lindberg, E; Ogawa, S; Papaemmanuil, E				Bernard, Elsa; Nannya, Yasuhito; Hasserjian, Robert P.; Devlin, Sean M.; Tuechler, Heinz; Medina-Martinez, Juan S.; Yoshizato, Tetsuichi; Shiozawa, Yusuke; Saiki, Ryunosuke; Malcovati, Luca; Levine, Max F.; Arango, Juan E.; Zhou, Yangyu; Sole, Francesc; Cargo, Catherine A.; Haase, Detlef; Creignou, Maria; Germing, Ulrich; Zhang, Yanming; Gundem, Gunes; Sarian, Araxe; van de Loosdrecht, Arjan A.; Jadersten, Martin; Tobiasson, Magnus; Kosmider, Olivier; Follo, Matilde Y.; Thol, Felicitas; Pinheiro, Ronald F.; Santini, Valeria; Kotsianidis, Ioannis; Boultwood, Jacqueline; Santos, Fabio P. S.; Schanz, Julie; Kasahara, Senji; Ishikawa, Takayuki; Tsurumi, Hisashi; Takaori-Kondo, Akifumi; Kiguchi, Toru; Polprasert, Chantana; Bennett, John M.; Klimek, Virginia M.; Savona, Michael R.; Belickova, Monika; Ganster, Christina; Palomo, Laura; Sanz, Guillermo; Ades, Lionel; Della Porta, Matteo Giovanni; Smith, Alexandra G.; Werner, Yesenia; Patel, Minal; Viale, Agnes; Vanness, Katelynd; Neuberg, Donna S.; Stevenson, Kristen E.; Menghrajani, Kamal; Bolton, Kelly L.; Fenaux, Pierre; Pellagatti, Andrea; Platzbecker, Uwe; Heuser, Michael; Valent, Peter; Chiba, Shigeru; Miyazaki, Yasushi; Finelli, Carlo; Voso, Maria Teresa; Shih, Lee-Yung; Fontenay, Michaela; Jansen, Joop H.; Cervera, Jose; Atsuta, Yoshiko; Gattermann, Norbert; Ebert, Benjamin L.; Bejar, Rafael; Greenberg, Peter L.; Cazzola, Mario; Hellstrom-Lindberg, Eva; Ogawa, Seishi; Papaemmanuil, Elli			Implications ofTP53allelic state for genome stability, clinical presentation and outcomes in myelodysplastic syndromes	NATURE MEDICINE			English	Article							ACUTE MYELOID-LEUKEMIA; MUTATIONAL LANDSCAPE; MONOSOMAL KARYOTYPE; ALLELE FREQUENCY; POINT MUTATIONS; TP53 MUTATIONS; SCORING SYSTEM; P53; PROGNOSIS; CLASSIFICATION	Clinical sequencing across a large prospective cohort of patients with myelodysplasic syndrome uncovers distinct associations between the mono- and biallelic states ofTP53and clinical presentation Tumor protein p53 (TP53) is the most frequently mutated gene in cancer(1,2). In patients with myelodysplastic syndromes (MDS),TP53mutations are associated with high-risk disease(3,4), rapid transformation to acute myeloid leukemia (AML)(5), resistance to conventional therapies(6-8)and dismal outcomes(9). Consistent with the tumor-suppressive role ofTP53, patients harbor both mono- and biallelic mutations(10). However, the biological and clinical implications ofTP53allelic state have not been fully investigated in MDS or any other cancer type. We analyzed 3,324 patients with MDS forTP53mutations and allelic imbalances and delineated two subsets of patients with distinct phenotypes and outcomes. One-third ofTP53-mutated patients had monoallelic mutations whereas two-thirds had multiple hits (multi-hit) consistent with biallelic targeting. Established associations with complex karyotype, few co-occurring mutations, high-risk presentation and poor outcomes were specific to multi-hit patients only.TP53multi-hit state predicted risk of death and leukemic transformation independently of the Revised International Prognostic Scoring System (IPSS-R)(11). Surprisingly, monoallelic patients did not differ fromTP53wild-type patients in outcomes and response to therapy. This study shows that consideration ofTP53allelic state is critical for diagnostic and prognostic precision in MDS as well as in future correlative studies of treatment response.	[Bernard, Elsa; Medina-Martinez, Juan S.; Levine, Max F.; Arango, Juan E.; Zhou, Yangyu; Gundem, Gunes; Werner, Yesenia; Papaemmanuil, Elli] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, Computat Oncol Serv, New York, NY 10021 USA; [Bernard, Elsa; Medina-Martinez, Juan S.; Levine, Max F.; Arango, Juan E.; Zhou, Yangyu; Sarian, Araxe; Patel, Minal; Papaemmanuil, Elli] Mem Sloan Kettering Canc Ctr, Ctr Hematol Malignancies, 1275 York Ave, New York, NY 10021 USA; [Nannya, Yasuhito; Yoshizato, Tetsuichi; Shiozawa, Yusuke; Saiki, Ryunosuke; Ogawa, Seishi] Kyoto Univ, Dept Pathol & Tumor Biol, Kyoto, Japan; [Hasserjian, Robert P.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Devlin, Sean M.] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10021 USA; [Malcovati, Luca; Cazzola, Mario] Univ Pavia, Dept Mol Med, Pavia, Italy; [Malcovati, Luca; Cazzola, Mario] IRCCS Fdn Policlin S Matteo, Dept Hematol, Pavia, Italy; [Sole, Francesc; Palomo, Laura] Inst Recerca Leucemia Josep Carreras, MDS Grp, Barcelona, Spain; [Cargo, Catherine A.] St James Univ Hosp, Haematol Malignancy Diagnost Serv, Leeds, W Yorkshire, England; [Haase, Detlef; Schanz, Julie; Ganster, Christina] Univ Med Ctr, Clin Hematol, Gottingen, Germany; [Haase, Detlef; Schanz, Julie; Ganster, Christina] Univ Med Ctr, Clin Med Oncol, Gottingen, Germany; [Creignou, Maria; Jadersten, Martin; Tobiasson, Magnus; Hellstrom-Lindberg, Eva] Karolinska Univ Hosp, Karolinska Inst, Ctr Hematol & Regenerat Med, Dept Med Huddinge, Stockholm, Sweden; [Germing, Ulrich; Gattermann, Norbert] Heinrich Heine Univ, Dept Hematol Oncol & Clin Immunol, Dusseldorf, Germany; [Zhang, Yanming] Mem Sloan Kettering Canc Ctr, Dept Pathol, 1275 York Ave, New York, NY 10021 USA; [van de Loosdrecht, Arjan A.] Vrije Univ Amsterdam, Med Ctr Amsterdam, Dept Hematol, Amsterdam, Netherlands; [Kosmider, Olivier; Fontenay, Michaela] Hop Cochin, AP HP, Dept Hematol, Paris, France; [Kosmider, Olivier; Fontenay, Michaela] Univ Paris 05, Univ Paris, Paris, France; [Follo, Matilde Y.] Univ Bologna, Dept Biomed & Neuromotor Sci, Bologna, Italy; [Thol, Felicitas; Heuser, Michael] Hannover Med Sch, Dept Hematol Hemostasis Oncol & Stem Cell Transpl, Hannover, Germany; [Pinheiro, Ronald F.] Univ Fed Ceara, Drug Res & Dev Ctr, Fortaleza, Ceara, Brazil; [Santini, Valeria] Univ Florence, AOU Careggi, Hematol, MDS Unit, Florence, Italy; [Kotsianidis, Ioannis] Democritus Univ Thrace, Sch Med, Dept Hematol, Alexandroupolis, Greece; [Boultwood, Jacqueline; Pellagatti, Andrea] Univ Oxford, Radcliffe Dept Med, Oxford, England; [Boultwood, Jacqueline; Pellagatti, Andrea] Oxford BRC Haematol Theme, Oxford, England; [Santos, Fabio P. S.] Hosp Israelita Albert Einstein, Oncol Hematol Ctr, Sao Paulo, Brazil; [Kasahara, Senji] Gifu Municipal Hosp, Dept Hematol, Gifu, Japan; [Ishikawa, Takayuki] Kobe City Med Ctr Gen Hosp, Dept Hematol, Kobe, Hyogo, Japan; [Tsurumi, Hisashi] Gifu Univ, Dept Hematol, Grad Sch Med, Gifu, Japan; [Takaori-Kondo, Akifumi] Kyoto Univ, Dept Hematol & Oncol, Grad Sch Med, Kyoto, Japan; [Kiguchi, Toru] Chugoku Cent Hosp, Dept Hematol, Fukuyama, Hiroshima, Japan; [Polprasert, Chantana] Chulalongkorn Univ, King Chulalongkorn Mem Hosp, Dept Med, Bangkok, Thailand; [Bennett, John M.] Univ Rochester, Med Ctr, Lab Med & Pathol, Hematol Oncol, Rochester, NY 14642 USA; [Klimek, Virginia M.; Menghrajani, Kamal; Bolton, Kelly L.] Mem Sloan Kettering Canc Ctr, Dept Med, 1275 York Ave, New York, NY 10021 USA; [Savona, Michael R.] Vanderbilt Univ, Sch Med, Vanderbilt Ingram Canc Ctr, Dept Med, Nashville, TN 37212 USA; [Belickova, Monika] Inst Hematol & Blood Transfus, Dept Genom, Prague, Czech Republic; [Sanz, Guillermo] Hosp Univ & Politecn La Fe, Dept Hematol, Valencia, Spain; [Sanz, Guillermo] Inst Salud Carlos III, CIBERONC, Madrid, Spain; [Ades, Lionel; Fenaux, Pierre] Hop St Louis, Dept Hematol, Paris, France; [Ades, Lionel; Fenaux, Pierre] Paris Univ, Paris, France; [Della Porta, Matteo Giovanni] Humanitas Res Hosp, Canc Ctr, Milan, Italy; [Della Porta, Matteo Giovanni] Humanitas Univ, Milan, Italy; [Smith, Alexandra G.] Univ York, Dept Hlth Sci, York, N Yorkshire, England; [Viale, Agnes; Vanness, Katelynd] Mem Sloan Kettering Canc Ctr, Integrated Genom Operat, 1275 York Ave, New York, NY 10021 USA; [Neuberg, Donna S.; Stevenson, Kristen E.] Dana Farber Canc Inst, Dept Data Sci, Boston, MA 02115 USA; [Platzbecker, Uwe] Univ Leipzig, Hematol & Cellular Therapy, Med Clin & Policlin 1, Leipzig, Germany; [Valent, Peter] Med Univ Vienna, Dept Internal Med 1, Div Hematol & Hemostaseol, Vienna, Austria; [Valent, Peter] Med Univ Vienna, Ludwig Boltzmann Inst Hematol & Oncol, Vienna, Austria; [Chiba, Shigeru] Univ Tsukuba, Fac Med, Dept Hematol, Tsukuba, Ibaraki, Japan; [Miyazaki, Yasushi] Nagasaki Univ, Atom Bomb Dis Inst, Dept Hematol, Nagasaki, Japan; [Finelli, Carlo] S Orsola Malpighi Univ Hosp, Inst Hematol, Bologna, Italy; [Voso, Maria Teresa] Tor Vergata Univ, Dept Biomedicine & Prevent, MDS Cooperat Grp GROM L, Rome, Italy; [Shih, Lee-Yung] Chang Gung Univ, Chang Gung Mem Hosp Linkou, Taoyuan, Taiwan; [Jansen, Joop H.] Radboud Univ Nijmegen, Med Ctr, Dept LABGK, Lab Hematol, Nijmegen, Netherlands; [Cervera, Jose] Univ Hosp La Fe, Dept Hematol, Valencia, Spain; [Cervera, Jose] Univ Hosp La Fe, Genet Unit, Valencia, Spain; [Atsuta, Yoshiko] Japanese Data Ctr Hematopoiet Cell Transplantat, Nagoya, Aichi, Japan; [Ebert, Benjamin L.] Dana Farber Canc Ctr, Dept Med Oncol, Boston, MA USA; [Ebert, Benjamin L.] Dana Farber Canc Ctr, Howard Hughes Med Inst, Boston, MA USA; [Bejar, Rafael] UC San Diego Moores Canc Ctr, La Jolla, CA USA; [Greenberg, Peter L.] Stanford Univ, Inst Canc, Stanford, CA 94305 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Kyoto University; Harvard University; Massachusetts General Hospital; Memorial Sloan Kettering Cancer Center; University of Pavia; IRCCS Fondazione San Matteo; Institut de Recerca Contra la Leucemia Josep Carreras (IJC); Saint James's University Hospital; University of Gottingen; University of Gottingen; Karolinska Institutet; Karolinska University Hospital; Heinrich Heine University Dusseldorf; Memorial Sloan Kettering Cancer Center; Vrije Universiteit Amsterdam; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; University of Bologna; Hannover Medical School; Universidade Federal do Ceara; University of Florence; Azienda Ospedaliero Universitaria Careggi; Democritus University of Thrace; University of Oxford; Hospital Israelita Albert Einstein; Gifu Municipal Hospital; Kobe City Medical Center General Hospital; Gifu University; Kyoto University; Chulalongkorn University; University of Rochester; Memorial Sloan Kettering Cancer Center; Vanderbilt University; Institute of Hematology Prague; Hospital Universitari i Politecnic La Fe; CIBER - Centro de Investigacion Biomedica en Red; CIBERONC; Instituto de Salud Carlos III; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Humanitas University; University of York - UK; Memorial Sloan Kettering Cancer Center; Harvard University; Dana-Farber Cancer Institute; Leipzig University; Medical University of Vienna; Ludwig Boltzmann Institute; Medical University of Vienna; University of Tsukuba; Nagasaki University; IRCCS Azienda Ospedaliero-Universitaria di Bologna; University of Rome Tor Vergata; Chang Gung Memorial Hospital; Chang Gung University; Radboud University Nijmegen; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Howard Hughes Medical Institute; Stanford University	Papaemmanuil, E (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, Computat Oncol Serv, New York, NY 10021 USA.; Papaemmanuil, E (corresponding author), Mem Sloan Kettering Canc Ctr, Ctr Hematol Malignancies, 1275 York Ave, New York, NY 10021 USA.	papaemme@mskcc.org	Malcovati, Luca/CAJ-1695-2022; Kotsianidis, Ioannis/AGH-1791-2022; Bernard, Elsa/AAD-8682-2020; Belickova, Monika/F-1710-2017; SANTINI, VALERIA/AAL-3135-2020; Yoshizato, Tetsuichi/AAD-7308-2019; Germing, Ulrich/AAX-1036-2021; Cervera, Jose/ABF-2143-2020; Sanchis, Laura Palomo/L-2140-2014; Cazzola, Mario/AAQ-8854-2021; Jansen, J.H./H-8054-2014; Patologia, Programa/AAI-4877-2021; KOTSIANIDIS, IOANNIS/ABH-1436-2021; Valent, Peter/B-8533-2016; Voso, Maria Teresa/F-1172-2014	Malcovati, Luca/0000-0002-1460-1611; Bernard, Elsa/0000-0002-2057-7187; Belickova, Monika/0000-0002-9158-881X; SANTINI, VALERIA/0000-0002-5439-2172; Yoshizato, Tetsuichi/0000-0003-4283-2983; Cervera, Jose/0000-0001-8252-1106; Sanchis, Laura Palomo/0000-0003-3176-6271; Cazzola, Mario/0000-0001-6984-8817; Jansen, J.H./0000-0001-9459-568X; KOTSIANIDIS, IOANNIS/0000-0001-7668-0186; Valent, Peter/0000-0003-0456-5095; Voso, Maria Teresa/0000-0002-6164-4761; Levine, Max/0000-0001-5156-9086; Werner, Yesenia/0000-0003-2691-8824; Bolton, Kelly/0000-0001-6584-3357; Della Porta, Matteo Giovanni/0000-0002-6915-5970; SANZ, GUILLERMO/0000-0002-2767-8191; Pellagatti, Andrea/0000-0002-6122-0221	Celgene Corporation through the MDS Foundation; Japan Agency for Medical Research and Development (AMED) [JP19cm0106501, JP19ck0106250, 15H05909, JP18ck0106353]; Japan Society for the Promotion of Science (JSPS) [KAKEN JP26221308, JP19H05656]; Ministry of Education, Culture, Sports, Science and Technology [hp160219]; Blood Cancer UK [13042]; Austrian Science Fund [F4704-B20]; MIUR-PRIN; Associazione Italiana per la Ricerca sul Cancro (AIRC, Milan, Italy) 5 per Mille project [21267, IG 20125]; AIRC 5 per Mille project [21267]; Francois Wallace Monahan Fellowship; EvansMDS Young Investigator award; European Hematology Association; American Society of Hematology; Gabrielle's Angels Foundation; V Foundation; Geoffrey Beene Foundation	Celgene Corporation through the MDS Foundation(Bristol-Myers SquibbCelgene Corporation); Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Blood Cancer UK; Austrian Science Fund(Austrian Science Fund (FWF)); MIUR-PRIN(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); Associazione Italiana per la Ricerca sul Cancro (AIRC, Milan, Italy) 5 per Mille project(Fondazione AIRC per la ricerca sul cancro); AIRC 5 per Mille project(Fondazione AIRC per la ricerca sul cancro); Francois Wallace Monahan Fellowship; EvansMDS Young Investigator award; European Hematology Association; American Society of Hematology; Gabrielle's Angels Foundation; V Foundation; Geoffrey Beene Foundation	This work was supported in part by grants from the Celgene Corporation through the MDS Foundation. It was also supported by grants-in-aid from the Japan Agency for Medical Research and Development (AMED) (JP19cm0106501, JP19ck0106250 and 15H05909 (S.O.) and JP18ck0106353 (Y.N.)), from the Japan Society for the Promotion of Science (JSPS) (KAKEN JP26221308, JP19H05656 (S.O.)) and from the Ministry of Education, Culture, Sports, Science and Technology (hp160219 (S.O.)). J.B. and A.P. acknowledge funding from Blood Cancer UK (grant 13042). P.V. was supported by the Austrian Science Fund (grant F4704-B20). M.Y.F. was supported by Italian MIUR-PRIN grants. L.M. was supported by the Associazione Italiana per la Ricerca sul Cancro (AIRC, Milan, Italy) 5 per Mille project (21267 and IG 20125). M.T.V. was supported by AIRC 5 per Mille project (21267). M.T.V. recruited patients through the GROM-L clinical network. E.B. was supported by the Francois Wallace Monahan Fellowship and an EvansMDS Young Investigator award. E.P. is a Josie Robertson Investigator and is supported by the European Hematology Association, the American Society of Hematology, Gabrielle's Angels Foundation, V Foundation and The Geoffrey Beene Foundation. We thank T. Iraca for logistical support.	Bejar R, 2011, NEW ENGL J MED, V364, P2496, DOI 10.1056/NEJMoa1013343; Boettcher S, 2019, SCIENCE, V365, P599, DOI 10.1126/science.aax3649; Bouaoun L, 2016, HUM MUTAT, V37, P865, DOI 10.1002/humu.23035; Breems DA, 2008, J CLIN ONCOL, V26, P4791, DOI 10.1200/JCO.2008.16.0259; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chakravarty D, 2017, JCO PRECIS ONCOL, V1; Chang MT, 2018, CANCER DISCOV, V8, P174, DOI 10.1158/2159-8290.CD-17-0321; Chang MT, 2016, NAT BIOTECHNOL, V34, P155, DOI 10.1038/nbt.3391; Cibulskis K, 2013, NAT BIOTECHNOL, V31, P213, DOI 10.1038/nbt.2514; Donehower LA, 2019, CELL REP, V28, P1370, DOI 10.1016/j.celrep.2019.07.001; Giacomelli AO, 2018, NAT GENET, V50, P1381, DOI 10.1038/s41588-018-0204-y; Goel S, 2016, LEUKEMIA, V30, P1793, DOI 10.1038/leu.2016.74; Greenberg PL, 2012, BLOOD, V120, P2454, DOI 10.1182/blood-2012-03-420489; Grinfeld J, 2018, NEW ENGL J MED, V379, P1416, DOI 10.1056/NEJMoa1716614; Haase D, 2019, LEUKEMIA, V33, P1747, DOI 10.1038/s41375-018-0351-2; Haferlach T, 2014, LEUKEMIA, V28, P241, DOI 10.1038/leu.2013.336; International Standing Committee on Human Cytogenetic Nomenclature, 2013, ISCN 2013 INT SYSTEM; Jadersten M, 2011, J CLIN ONCOL, V29, P1971, DOI 10.1200/JCO.2010.31.8576; Kandoth C, 2013, NATURE, V502, P333, DOI 10.1038/nature12634; Karczewski KJ, 2020, NATURE, V581, P434, DOI 10.1038/s41586-020-2308-7; Kastenhuber ER, 2017, CELL, V170, P1062, DOI 10.1016/j.cell.2017.08.028; KITAGAWA M, 1994, AM J PATHOL, V145, P338; Landrum MJ, 2014, NUCLEIC ACIDS RES, V42, pD980, DOI 10.1093/nar/gkt1113; Lang GA, 2004, CELL, V119, P861, DOI 10.1016/j.cell.2004.11.006; LAUSEN B, 1992, BIOMETRICS, V48, P73, DOI 10.2307/2532740; Levine AJ, 2019, J MOL CELL BIOL, V11, P524, DOI 10.1093/jmcb/mjz026; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Lindsley RC, 2017, NEW ENGL J MED, V376, P536, DOI 10.1056/NEJMoa1611604; Loizou E, 2019, CANCER DISCOV, V9, P962, DOI 10.1158/2159-8290.CD-18-1391; Malcovati L, 2011, BLOOD, V118, P6239, DOI 10.1182/blood-2011-09-377275; Montalban-Bravo G, 2020, BLOOD ADV, V4, P482, DOI 10.1182/bloodadvances.2019001101; Olive KP, 2004, CELL, V119, P847, DOI 10.1016/j.cell.2004.11.004; Papaemmanuil E, 2016, NEW ENGL J MED, V374, P2209, DOI 10.1056/NEJMoa1516192; Papaemmanuil E, 2013, BLOOD, V122, P3616, DOI 10.1182/blood-2013-08-518886; Platzbecker U, 2019, BLOOD, V133, P1096, DOI 10.1182/blood-2018-10-844696; Roman E, 2016, CANCER EPIDEMIOL, V42, P186, DOI 10.1016/j.canep.2016.03.011; Ruckner FG, 2012, BLOOD, V119, P2114, DOI 10.1182/blood-2011-08-375758; Sallman DA, 2016, LEUKEMIA, V30, P666, DOI 10.1038/leu.2015.304; Saunders CT, 2012, BIOINFORMATICS, V28, P1811, DOI 10.1093/bioinformatics/bts271; Schanz J, 2012, J CLIN ONCOL, V30, P820, DOI 10.1200/JCO.2011.35.6394; Smith A, 2018, INT J EPIDEMIOL, V47, P700, DOI 10.1093/ije/dyy044; Talevich E, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004873; Tate JG, 2019, NUCLEIC ACIDS RES, V47, pD941, DOI 10.1093/nar/gky1015; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Welch JS, 2016, NEW ENGL J MED, V375, P2023, DOI 10.1056/NEJMoa1605949; Wong TN, 2015, NATURE, V518, P552, DOI 10.1038/nature13968; Ye K, 2009, BIOINFORMATICS, V25, P2865, DOI 10.1093/bioinformatics/btp394; Yoshizato T, 2017, BLOOD, V129, P2347, DOI 10.1182/blood-2016-12-754796; Zehir A, 2017, NAT MED, V23, P703, DOI 10.1038/nm.4333	49	177	180	10	25	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	OCT	2020	26	10					1549	+		10.1038/s41591-020-1008-z	http://dx.doi.org/10.1038/s41591-020-1008-z		AUG 2020	27	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	NX8MD	32747829	Green Accepted, Green Submitted			2022-12-27	WOS:000555386300002
J	Miller, IF; Becker, AD; Grenfell, BT; Metcalf, CJE				Miller, Ian F.; Becker, Alexander D.; Grenfell, Bryan T.; Metcalf, C. Jessica E.			Disease and healthcare burden of COVID-19 in the United States	NATURE MEDICINE			English	Article							CORONAVIRUS	Projection of the number of COVID-19 cases and the associated burden on healthcare resources using a modified SEIR model reveals that rural regions in the United States are at risk of higher per capita case burdens, which could lead to health systems being overwhelmed in these areas. As of 24 April 2020, the SARS-CoV-2 epidemic has resulted in over 830,000 confirmed infections in the United States(1). The incidence of COVID-19, the disease associated with this new coronavirus, continues to rise. The epidemic threatens to overwhelm healthcare systems, and identifying those regions where the disease burden is likely to be high relative to the rest of the country is critical for enabling prudent and effective distribution of emergency medical care and public health resources. Globally, the risk of severe outcomes associated with COVID-19 has consistently been observed to increase with age(2,3). We used age-specific mortality patterns in tandem with demographic data to map projections of the cumulative case burden of COVID-19 and the subsequent burden on healthcare resources. The analysis was performed at the county level across the United States, assuming a scenario in which 20% of the population of each county acquires infection. We identified counties that will probably be consistently, heavily affected relative to the rest of the country across a range of assumptions about transmission patterns, such as the basic reproductive rate, contact patterns and the efficacy of quarantine. We observed a general pattern that per capita disease burden and relative healthcare system demand may be highest away from major population centers. These findings highlight the importance of ensuring equitable and adequate allocation of medical care and public health resources to communities outside of major urban areas.	[Miller, Ian F.; Becker, Alexander D.; Grenfell, Bryan T.; Metcalf, C. Jessica E.] Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA; [Grenfell, Bryan T.; Metcalf, C. Jessica E.] Princeton Univ, Woodrow Wilson Sch Publ Affairs, Princeton, NJ 08544 USA	Princeton University; Princeton University	Miller, IF (corresponding author), Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA.	ifmiller@princeton.edu			National Science Foundation Graduate Research Fellowships	National Science Foundation Graduate Research Fellowships(National Science Foundation (NSF))	We thank N. Davies and R. Eggo for providing data. I.F.M. and A.D.B. acknowledge funding from National Science Foundation Graduate Research Fellowships.	Adolph C, 2021, J HEALTH POLIT POLIC, V46, P211, DOI 10.1215/03616878-8802162; [Anonymous], 2010, 2010 US CENS TABL P2; [Anonymous], 2020, NY TIMES; [Anonymous], 2018, 2018 AHA ANN SURV DA; [Anonymous], 2020, COVIDVIEW WEEK 13; Davies NG, 2020, NAT MED, V26, P1205, DOI 10.1038/s41591-020-0962-9; Deng Xiaowei, 2020, medRxiv, DOI 10.1101/2020.03.04.20031005; Emanuel EJ, 2020, NEW ENGL J MED, V382, P2049, DOI 10.1056/NEJMsb2005114; Ferguson N. M., 2020, REPORT 9 IMPACT NONP, V10, DOI [10.25561/77482, DOI 10.1007/S11538-020-00726-X]; Funk S., 2020, SOCIALMIXR SOCIAL MI; Gamio L., 2020, NEW YORK TIMES; Grad S., 2020, SOCIAL DISTANCING ST, V2020, DOI [10.11392/jsao.49.40, DOI 10.1101/2020.03.22.20041079]; Hay J. A., 2020, PREPRINT; Hijmans R. J, 2019, GOESPHERE SPHERICAL; Holshue ML, 2020, NEW ENGL J MED, V382, P929, DOI 10.1056/NEJMoa2001191; Kucharski AJ, 2020, LANCET INFECT DIS, V20, P553, DOI 10.1016/S1473-3099(20)30144-4; Liu Y, 2020, J TRAVEL MED, V27, DOI 10.1093/jtm/taaa021; Lurie N, 2020, NEW ENGL J MED, V382, P1969, DOI 10.1056/NEJMp2005630; Mossong J, 2008, PLOS MED, V5, P381, DOI 10.1371/journal.pmed.0050074; Soetaert K, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i09; U.S. Census Bureau, 2018, AM COMMUNITY SURVEY; Wang C, 2020, LANCET, V395, P470, DOI 10.1016/S0140-6736(20)30185-9; White DB, 2020, JAMA-J AM MED ASSOC, V323, P1773, DOI 10.1001/jama.2020.5046; WHO, 2020, COR DIS COVID 19 PAN; Wu JM, 2022, CRIT REV FOOD SCI, V62, P783, DOI [10.1080/10408398.2020.1828813, 10.1038/s41591-020-0822-7]; Yang J, 2022, INT J ENVIRON AN CH, V102, P3638, DOI 10.1080/03067319.2020.1772775	26	206	209	8	38	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	AUG	2020	26	8					1212	+		10.1038/s41591-020-0952-y	http://dx.doi.org/10.1038/s41591-020-0952-y		JUN 2020	18	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	MX8ZF	32546823	Bronze			2022-12-27	WOS:000543580200001
J	Zhou, J; Li, C; Liu, XJ; Chiu, MC; Zhao, XY; Wang, D; Wei, YX; Lee, AR; Zhang, AJ; Chu, H; Cai, JP; Yip, CCY; Chan, IHY; Wong, KKY; Tsang, OTY; Chan, KH; Chan, JFW; To, KKW; Chen, HL; Yuen, KY				Zhou Jie; Li Cun; Liu Xiaojuan; Chiu Man Chun; Zhao Xiaoyu; Wang Dong; Wei Yuxuan; Lee, Andrew; Zhang, Anna Jinxia; Chu Hin; Cai Jian-Piao; Yip, Cyril Chik-Yan; Chan, Ivy Hau-Yee; Wong, Kenneth Kak-Yuen; Tsang, Owen Tak-Yin; Chan Kwok-Hung; Chan, Jasper Fuk-Woo; To, Kelvin Kai-Wang; Chen Honglin; Yuen, Kwok Yung			Infection of bat and human intestinal organoids by SARS-CoV-2	NATURE MEDICINE			English	Article							RESPIRATORY SYNDROME CORONAVIRUS; REPLICATION; PNEUMONIA; VIRUS; ACE2	A novel coronavirus-severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-emerged in humans in Wuhan, China, in December 2019 and has since disseminated globally(1,2). As of April 16, 2020, the confirmed case count of coronavirus disease 2019 (COVID-19) had surpassed 2 million. Based on full-genome sequence analysis, SARS-CoV-2 shows high homology to SARS-related coronaviruses identified in horseshoe bats(1,2). Here we show the establishment and characterization of expandable intestinal organoids derived from horseshoe bats of the Rhinolophus sinicus species that can recapitulate bat intestinal epithelium. These bat enteroids are fully susceptible to SARS-CoV-2 infection and sustain robust viral replication. Development of gastrointestinal symptoms in some patients with COVID-19 and detection of viral RNA in fecal specimens suggest that SARS-CoV-2 might cause enteric, in addition to respiratory, infection(3,4). Here we demonstrate active replication of SARS-CoV-2 in human intestinal organoids and isolation of infectious virus from the stool specimen of a patient with diarrheal COVID-19. Collectively, we established the first expandable organoid culture system of bat intestinal epithelium and present evidence that SARS-CoV-2 can infect bat intestinal cells. The robust SARS-CoV-2 replication in human intestinal organoids suggests that the human intestinal tract might be a transmission route of SARS-CoV-2. Bat and human intestinal organoids can support replication of SARS-CoV-2, enabling further characterization of the virus lifecycle and investigation of potential mechanisms of enteric infection in COVID-19.	[Zhou Jie; Zhang, Anna Jinxia; Chu Hin; Chan, Jasper Fuk-Woo; To, Kelvin Kai-Wang; Chen Honglin; Yuen, Kwok Yung] Univ Hong Kong, State Key Lab Emerging Infect Dis, Hong Kong, Peoples R China; [Zhou Jie; Li Cun; Liu Xiaojuan; Chiu Man Chun; Zhao Xiaoyu; Wang Dong; Wei Yuxuan; Lee, Andrew; Zhang, Anna Jinxia; Chu Hin; Cai Jian-Piao; Yip, Cyril Chik-Yan; Chan Kwok-Hung; Chan, Jasper Fuk-Woo; To, Kelvin Kai-Wang; Chen Honglin; Yuen, Kwok Yung] Univ Hong Kong, Li Ka Shing Fac Med, Dept Microbiol, Pokfulam, Hong Kong, Peoples R China; [Chan, Ivy Hau-Yee; Wong, Kenneth Kak-Yuen] Univ Hong Kong, Li Ka Shing Fac Med, Dept Surg, Hong Kong, Peoples R China; [Tsang, Owen Tak-Yin] Princess Margaret Hosp, Dept Med & Geriatr, Hong Kong, Peoples R China; [Chan, Jasper Fuk-Woo; To, Kelvin Kai-Wang; Yuen, Kwok Yung] Univ Hong Kong, Carol Yu Ctr Infect, Pokfulam, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong; University of Hong Kong; University of Hong Kong	Zhou, J; Yuen, KY (corresponding author), Univ Hong Kong, State Key Lab Emerging Infect Dis, Hong Kong, Peoples R China.; Zhou, J; Yuen, KY (corresponding author), Univ Hong Kong, Li Ka Shing Fac Med, Dept Microbiol, Pokfulam, Hong Kong, Peoples R China.; Yuen, KY (corresponding author), Univ Hong Kong, Carol Yu Ctr Infect, Pokfulam, Hong Kong, Peoples R China.	jiezhou@hku.hk; kyyuen@hku.hk	CHU, HIN/ABU-1193-2022; Chan, Kwok Hung/ABD-5399-2021; To, Kelvin/AAV-7007-2020; Li, Cun/ABD-9346-2020; CAI, Jian-piao/GYD-5763-2022; Yip, Chik Yan/B-7078-2013; CAI, Jian-Piao/HCI-0096-2022; Chan, Jasper F. W./D-8007-2013	CHU, HIN/0000-0003-2855-9837; To, Kelvin/0000-0002-1921-5824; CAI, Jian-piao/0000-0003-4077-3852; Chan, Jasper F. W./0000-0001-6336-6657; zhao, xiaoyu/0000-0002-0347-9104; Chiu, Man Chun/0000-0001-9503-6396; ZHOU, Jie/0000-0002-2948-3873	Health and Medical Research Fund of the Food and Health Bureau of the Hong Kong Special Administrative Region (HKSAR) [19180392]; Theme-based Research Scheme of the Research Grants Council, HKSAR [T11-707/15-R]; High Level Hospital-Summit Program in Guangdong, The University of Hong Kong-Shenzhen Hospital	Health and Medical Research Fund of the Food and Health Bureau of the Hong Kong Special Administrative Region (HKSAR); Theme-based Research Scheme of the Research Grants Council, HKSAR; High Level Hospital-Summit Program in Guangdong, The University of Hong Kong-Shenzhen Hospital	We thank the Center of PanorOmic Sciences and Electron Microscope Unit, Li Ka Shing Faculty of Medicine, University of Hong Kong, for assistance in confocal imaging and electron microscopy. We also thank Z. Shi for constructive discussion and critical revision of the manuscript; C.T. Shek and C.P. Tong for providing the horseshoe bats; and S. Sridhar for English language editing. This work was partly supported by funding from the Health and Medical Research Fund (project no. 19180392) of the Food and Health Bureau of the Hong Kong Special Administrative Region (HKSAR) to J.Z.; the Theme-based Research Scheme (T11-707/15-R) of the Research Grants Council, HKSAR, to K.Y.Y.; the High Level Hospital-Summit Program in Guangdong, The University of Hong Kong-Shenzhen Hospital, to K.Y.Y.; and donations from the Shaw Foundation Hong Kong, May Tam Mak Mei Yin, Richard Yu and Carol Yu, Michael Seak-Kan Tong, the Respiratory Viral Research Foundation Limited, Hui Ming, Hui Hoy and the Chow Sin Lan Charity Fund Limited and the Chan Yin Chuen Memorial Charitable Foundation to K.Y.Y.	Banerjee A, 2018, VIRUS RES, V248, P5, DOI 10.1016/j.virusres.2018.02.013; Bertram S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035876; Chan JFW, 2020, EMERG MICROBES INFEC, V9, P221, DOI 10.1080/22221751.2020.1719902; Clevers H, 2016, CELL, V165, P1586, DOI 10.1016/j.cell.2016.05.082; Dong D, 2017, MOL BIOL EVOL, V34, P20, DOI 10.1093/molbev/msw231; Ettayebi K, 2016, SCIENCE, V353, P1387, DOI 10.1126/science.aaf5211; Ge XY, 2013, NATURE, V503, P535, DOI 10.1038/nature12711; Good C, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aau4255; Heo I, 2018, NAT MICROBIOL, V3, P814, DOI 10.1038/s41564-018-0177-8; Hoffmann M, 2020, CELL, V181, P271, DOI 10.1016/j.cell.2020.02.052; Hu B, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006698; Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5; Huang IC, 2006, J BIOL CHEM, V281, P3198, DOI 10.1074/jbc.M508381200; Lau SKP, 2005, P NATL ACAD SCI USA, V102, P14040, DOI 10.1073/pnas.0506735102; Lau SKP, 2010, J VIROL, V84, P2808, DOI 10.1128/JVI.02219-09; Leung WK, 2003, GASTROENTEROLOGY, V125, P1011, DOI 10.1053/S0016-5085(03)01215-0; Lu RJ, 2020, LANCET, V395, P565, DOI 10.1016/S0140-6736(20)30251-8; Menachery VD, 2015, NAT MED, V21, P1508, DOI 10.1038/nm.3985; Munster VJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep21878; Openshaw PJ, 2009, MUCOSAL IMMUNOL, V2, P100, DOI 10.1038/mi.2008.79; Park JE, 2016, P NATL ACAD SCI USA, V113, P12262, DOI 10.1073/pnas.1608147113; Rothe C, 2020, NEW ENGL J MED, V382, P970, DOI 10.1056/NEJMc2001468; Saif LJ, 2010, VET CLIN N AM-FOOD A, V26, P349, DOI 10.1016/j.cvfa.2010.04.005; Sato T, 2011, GASTROENTEROLOGY, V141, P1762, DOI 10.1053/j.gastro.2011.07.050; Wang DW, 2020, JAMA-J AM MED ASSOC, V323, P1061, DOI 10.1001/jama.2020.1585; Wells AI, 2018, TRENDS IMMUNOL, V39, P848, DOI 10.1016/j.it.2018.08.008; Woo PCY, 2005, J VIROL, V79, P884, DOI 10.1128/JVI.79.2.884-895.2005; World Health Organization, 2020, WHO COVID 19 SIT REP; Xiao F, 2020, GASTROENTEROLOGY, V158, P1831, DOI 10.1053/j.gastro.2020.02.055; Xu Y, 2020, NAT MED, V26, P502, DOI 10.1038/s41591-020-0817-4; Yang XL, 2016, J VIROL, V90, P3253, DOI 10.1128/JVI.02582-15; Zhou J, 2017, SCI ADV, V3, DOI 10.1126/sciadv.aao4966; Zhou J, 2014, J INFECT DIS, V209, P1331, DOI 10.1093/infdis/jit504; Zhou P, 2020, NATURE, V579, P270, DOI 10.1038/s41586-020-2012-7; Zhou P, 2018, NATURE, V556, P255, DOI 10.1038/s41586-018-0010-9; Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017	37	290	297	11	72	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	JUL	2020	26	7					1077	+		10.1038/s41591-020-0912-6	http://dx.doi.org/10.1038/s41591-020-0912-6		MAY 2020	13	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	MK3XO	32405028	Bronze			2022-12-27	WOS:000532652200001
J	Stower, H				Stower, Hannah			Precision-medicine success in pancreatic cancer	NATURE MEDICINE			English	Editorial Material																			0	1	1	2	6	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	MAY	2020	26	5					649	649		10.1038/s41591-020-0903-7	http://dx.doi.org/10.1038/s41591-020-0903-7			1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	ML1JP	32405066	Bronze			2022-12-27	WOS:000549231500014
J							COVID 19 Investigation	Clinical and virologic characteristics of the first 12 patients with coronavirus disease 2019 (COVID-19) in the United States	NATURE MEDICINE			English	Article								Detailed clinical and virologic characteristics of the first 12 individuals with COVID-19 in the United States from the US Centers for Disease Control and Prevention. Data on the detailed clinical progression of COVID-19 in conjunction with epidemiological and virological characteristics are limited. In this case series, we describe the first 12 US patients confirmed to have COVID-19 from 20 January to 5 February 2020, including 4 patients described previously(1-3). Respiratory, stool, serum and urine specimens were submitted for SARS-CoV-2 real-time reverse-transcription polymerase chain reaction (rRT-PCR) testing, viral culture and whole genome sequencing. Median age was 53 years (range: 21-68); 8 patients were male. Common symptoms at illness onset were cough (n = 8) and fever (n = 7). Patients had mild to moderately severe illness; seven were hospitalized and demonstrated clinical or laboratory signs of worsening during the second week of illness. No patients required mechanical ventilation and all recovered. All had SARS-CoV-2 RNA detected in respiratory specimens, typically for 2-3 weeks after illness onset. Lowest real-time PCR with reverse transcription cycle threshold values in the upper respiratory tract were often detected in the first week and SARS-CoV-2 was cultured from early respiratory specimens. These data provide insight into the natural history of SARS-CoV-2. Although infectiousness is unclear, highest viral RNA levels were identified in the first week of illness. Clinicians should anticipate that some patients may worsen in the second week of illness.					Ahmed, Naseer/C-8119-2019	Ahmed, Naseer/0000-0002-0960-1123; Reese, Heather/0000-0002-5571-1614; /0000-0003-1039-8780; Ghinai, Isaac/0000-0003-1322-1331; Epstein, Lauren/0000-0002-1175-1112; Thornburg, Natalie/0000-0003-3523-3616; Rolfes, Melissa/0000-0002-0483-9941; Chiou, Howard/0000-0001-9223-3554; Wallace, Megan/0000-0003-4331-5785; Wong, Karen/0000-0002-5287-6456				[Anonymous], 2020, PEDIATR MED RODZ, V16, P9, DOI 10.15557/PiMR.2020.0003; Arentz M, 2020, JAMA-J AM MED ASSOC, V323, P1612, DOI 10.1001/jama.2020.4326; Bajema KL, 2020, MMWR-MORBID MORTAL W, V69, P166, DOI 10.15585/mmwr.mm6906e1; CDC Health Alert Network, 2020, UPD INT GUID OUTBR 2; Centers for Disease Control and Prevention, 2020, INT GUID COLL HANDL; Centers for Disease Control and Prevention, 2020, EV REP PERS INV PUI; Centers for Disease Control and Prevention, 2020, DISP NONH PAT COVID; Centers for Disease Control and Prevention, INT GUID COLL HANDL; Centers For Disease Control and Prevention, 2020, COVID 19 GUIDANCE MA; Chen WL, 2020, EMERG MICROBES INFEC, V9, P469, DOI 10.1080/22221751.2020.1732837; ClinicalTrials.gov, 2020, MILD MOD 2019 NCOV R; ClinicalTrials.gov, 2020, SEV 2019 NCOV REMD R; ClinicalTrials.gov, 2020, AD COVID 19 TREATM T; Ghinai I, 2020, LANCET, V395, P1137, DOI 10.1016/S0140-6736(20)30607-3; Guan W, 2020, NEW ENGL J MED, V382, P1708, DOI 10.1056/NEJMoa2002032; Holshue ML, 2020, NEW ENGL J MED, V382, P929, DOI 10.1056/NEJMoa2001191; Hunter JD, 2007, COMPUT SCI ENG, V9, P90, DOI 10.1109/MCSE.2007.55; Katoh Kazutaka, 2013, Mol Biol Evol, V30, P772, DOI 10.1093/molbev/mst010; Kim JY, 2020, J KOREAN MED SCI, V35, DOI 10.3346/jkms.2020.35.e86; Kumar S, 2018, MOL BIOL EVOL, V35, P1547, DOI 10.1093/molbev/msy096; Li H, 2018, BIOINFORMATICS, V34, P3094, DOI 10.1093/bioinformatics/bty191; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; McMichael T. M, 2020, PREPRINT MORB MORTAL; Mulangu S, 2019, NEW ENGL J MED, V381, P2293, DOI 10.1056/NEJMoa1910993; Pan Y, 2020, LANCET INFECT DIS, V20, P411, DOI 10.1016/S1473-3099(20)30113-4; Patrinos G., 2009, MOL DIAGNOSTICS, Vsecond, DOI [10.1016/C2009-0-01736-X, DOI 10.1016/C2009-0-01736-X]; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; R Core Team, 2021, R LANGUAGE ENV STAT; Scott SE, 2020, CLIN INFECT DIS, V71, P807, DOI 10.1093/cid/ciaa374; Van Rossum G., 1995, PYTHON TUTORIAL; Wang DW, 2020, J COASTAL RES, P1, DOI [10.2112/JCR-SI109-001.1, 10.1001/jama.2020.1585]; Wang ML, 2020, CELL RES, V30, P269, DOI 10.1038/s41422-020-0282-0; Warren TK, 2016, NATURE, V531, P381, DOI 10.1038/nature17180; Wolfel R, 2020, NATURE, V588, pE35, DOI 10.1038/s41586-020-2984-3; Zou LR, 2020, NEW ENGL J MED, V382, P1177, DOI 10.1056/NEJMc2001737	35	207	215	1	24	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	JUN	2020	26	6					861	+		10.1038/s41591-020-0877-5	http://dx.doi.org/10.1038/s41591-020-0877-5		APR 2020	20	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	LZ3ZG	32327757	Bronze			2022-12-27	WOS:000528517900002
J	Patani, R				Patani, Rickie			Human stem cell models of disease and the prognosis of academic medicine	NATURE MEDICINE			English	Editorial Material									[Patani, Rickie] UCL, Human Stem Cells & Neurodegenerat Lab, Francis Crick Inst, London, England	Francis Crick Institute; University of London; University College London	Patani, R (corresponding author), UCL, Human Stem Cells & Neurodegenerat Lab, Francis Crick Inst, London, England.	rickie.patani@crick.ac.uk	Patani, Rickie/J-3107-2018	Patani, Rickie/0000-0002-3825-7675	MRC [MR/S006591/1] Funding Source: UKRI; Medical Research Council [MR/S006591/1] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))			0	2	2	0	0	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	APR	2020	26	4					449	449		10.1038/s41591-020-0814-7	http://dx.doi.org/10.1038/s41591-020-0814-7			1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	QH1UE	32273599	Green Submitted, Bronze			2022-12-27	WOS:000618061900002
J	Stower, H				Stower, Hannah			Spread of SARS-CoV-2	NATURE MEDICINE			English	Editorial Material																			0	24	24	0	1	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	APR	2020	26	4					465	465		10.1038/s41591-020-0850-3	http://dx.doi.org/10.1038/s41591-020-0850-3			1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	QH1UE	32273606	Bronze			2022-12-27	WOS:000618061900013
J	Ienca, M; Vayena, E				Ienca, Marcello; Vayena, Effy			On the responsible use of digital data to tackle the COVID-19 pandemic	NATURE MEDICINE			English	Editorial Material								Large-scale collection of data could help curb the COVID-19 pandemic, but it should not neglect privacy and public trust. Best practices should be identified to maintain responsible data-collection and data-processing standards at a global scale.	[Ienca, Marcello; Vayena, Effy] Swiss Fed Inst Technol Zurich, Dept Hlth Sci & Technol, Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Ienca, M (corresponding author), Swiss Fed Inst Technol Zurich, Dept Hlth Sci & Technol, Zurich, Switzerland.	marcello.ienca@hest.ethz.ch	Vayena, Effy/ABD-8272-2021	Vayena, Effy/0000-0003-1303-5467; Ienca, Marcello/0000-0001-8835-5444				[Anonymous], 2020, JAMA-J AM MED ASSOC, DOI DOI 10.1001/JAMA.2020.3151; [Anonymous], 2020, THE ECONOMIST; Bates M, 2017, IEEE PULSE, V8, P18, DOI 10.1109/MPUL.2016.2627238; Bengtsson L, 2015, SCI REP-UK, V5, DOI 10.1038/srep08923; Mozur Paul., 2020, CORONAVIRUS FIGHT CH; Scarpino SV, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08616-0; Ward PR, 2017, FRONT PUBLIC HEALTH, V5, DOI 10.3389/fpubh.2017.00022; Wheeler NE, 2019, NAT REV MICROBIOL, V17, P269, DOI 10.1038/s41579-019-0153-1; Wu JT, 2020, LANCET, V395, P689, DOI 10.1016/S0140-6736(20)30260-9	9	212	213	4	61	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	APR	2020	26	4					463	464		10.1038/s41591-020-0832-5	http://dx.doi.org/10.1038/s41591-020-0832-5		MAR 2020	2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	QH1UE	32284619	Green Published, Bronze			2022-12-27	WOS:000521834100002
J	Pang, T				Pang, Tikki			For innovation-driven public health, facts outweigh opinions	NATURE MEDICINE			English	Editorial Material							DENGUE	In an increasingly hyper-polarized world, the weight of public perception can dissuade policymakers from implementing scientifically sound health policies. The scientific community has a responsibility to make facts outweigh opinion.	[Pang, Tikki] Natl Univ Singapore, Lee Kuan Yew Sch Publ Policy, Singapore, Singapore	National University of Singapore	Pang, T (corresponding author), Natl Univ Singapore, Lee Kuan Yew Sch Publ Policy, Singapore, Singapore.	spptep@nus.edu.sg						Beaglehole R, 2019, LANCET, V394, P718, DOI 10.1016/S0140-6736(19)31884-7; Fairchild A, 2019, SCIENCE, V366, P1318, DOI 10.1126/science.aba0032; Hamid M, 2005, LANCET, V366, P1758, DOI 10.1016/S0140-6736(05)67709-4; Hamid M, 2019, NY TIMES; House of Commons Science and Technology Committee, 2018, E CIG 7 SESS 2017 19; Japan Tobacco Inc, 2019, PRELIMINARY REPORT; Larson HJ, 2018, LANCET, V392, P2244, DOI 10.1016/S0140-6736(18)32608-4; Lee Peter N, 2018, F1000Res, V7, P1915, DOI 10.12688/f1000research.16928.1; McNeill A., 2018, EVIDENCE REV CIGARET; Pang T, 2018, LANCET, V391, P654, DOI 10.1016/S0140-6736(18)30245-9; Sagonowsky E, 2019, FIERCEPHARMA; Skidelsky R., 1992, JM KEYNES BIOGRAPHY; Smith MJ, 2019, LANCET, V394, P4; UNICEF & WHO, 2019, SIT REP 11 MEASL OUT; Wilder-Smith A, 2019, LANCET, V394, P2151, DOI 10.1016/S0140-6736(19)32525-5; World Health Organization, 2018, **DROPPED REF**, V93; Yasmin S, 2019, SCI AM, V320, P38	17	4	4	1	7	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	FEB	2020	26	2					160	162		10.1038/s41591-019-0748-0	http://dx.doi.org/10.1038/s41591-019-0748-0		FEB 2020	3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	KK7DU	32020085				2022-12-27	WOS:000511081800001
J	Breuss, MW; Antaki, D; George, RD; Kleiber, M; James, KN; Ball, LL; Hong, O; Mitra, I; Yang, XX; Wirth, SA; Gu, J; Garcia, CAB; Gujral, M; Brandler, WM; Musaev, D; Nguyen, A; McEvoy-Venneri, J; Knox, R; Sticca, E; Botello, MCC; Fenner, JU; Perez, MC; Arranz, M; Moffitt, AB; Wang, ZH; Hervas, A; Devinsky, O; Gymrek, M; Sebat, J; Gleeson, JG				Breuss, Martin W.; Antaki, Danny; George, Renee D.; Kleiber, Morgan; James, Kiely N.; Ball, Laurel L.; Hong, Oanh; Mitra, Ileena; Yang, Xiaoxu; Wirth, Sara A.; Gu, Jing; Garcia, Camila A. B.; Gujral, Madhusudan; Brandler, William M.; Musaev, Damir; Nguyen, An; McEvoy-Venneri, Jennifer; Knox, Renatta; Sticca, Evan; Botello, Martha Cristina Cancino; Uribe Fenner, Javiera; Perez, Maria Carcel; Arranz, Maria; Moffitt, Andrea B.; Wang, Zihua; Hervas, Amaia; Devinsky, Orrin; Gymrek, Melissa; Sebat, Jonathan; Gleeson, Joseph G.			Autism risk in offspring can be assessed through quantification of male sperm mosaicism	NATURE MEDICINE			English	Article							DE-NOVO MUTATIONS; INTELLECTUAL DISABILITY; STRUCTURAL VARIANTS; RECURRENCE RISK; AGE; RATES; DUPLICATIONS; PATTERNS; EPILEPSY; DESIGN	De novo mutations arising on the paternal chromosome make the largest known contribution to autism risk, and correlate with paternal age at the time of conception. The recurrence risk for autism spectrum disorders is substantial, leading many families to decline future pregnancies, but the potential impact of assessing parental gonadal mosaicism has not been considered. We measured sperm mosaicism using deep-whole-genome sequencing, for variants both present in an offspring and evident only in father's sperm, and identified single-nucleotide, structural and short tandem-repeat variants. We found that mosaicism quantification can stratify autism spectrum disorders recurrence risk due to de novo mutations into a vast majority with near 0% recurrence and a small fraction with a substantially higher and quantifiable risk, and we identify novel mosaic variants at risk for transmission to a future offspring. This suggests, therefore, that genetic counseling would benefit from the addition of sperm mosaicism assessment. Genetic analysis of paternal sperm from families with a child affected by autism reveals that the recurrent risk for transmitting disease-associated de novo mutations to future offspring is near 0% for most couples but is substantially higher for a small fraction of couples.	[Breuss, Martin W.; George, Renee D.; James, Kiely N.; Ball, Laurel L.; Yang, Xiaoxu; Wirth, Sara A.; Gu, Jing; Garcia, Camila A. B.; Musaev, Damir; Nguyen, An; McEvoy-Venneri, Jennifer; Knox, Renatta; Sticca, Evan; Gleeson, Joseph G.] Univ Calif San Diego, Howard Hughes Med Inst, Dept Neurosci, La Jolla, CA 92093 USA; [Breuss, Martin W.; George, Renee D.; James, Kiely N.; Ball, Laurel L.; Yang, Xiaoxu; Wirth, Sara A.; Gu, Jing; Garcia, Camila A. B.; Musaev, Damir; Nguyen, An; McEvoy-Venneri, Jennifer; Knox, Renatta; Sticca, Evan; Gleeson, Joseph G.] Rady Childrens Inst Genom Med, San Diego, CA 92123 USA; [Antaki, Danny; Kleiber, Morgan; Hong, Oanh; Gujral, Madhusudan; Brandler, William M.; Sebat, Jonathan] Univ Calif San Diego, Beyster Ctr Genom Psychiat Dis, La Jolla, CA 92093 USA; [Antaki, Danny; Kleiber, Morgan; Hong, Oanh; Gujral, Madhusudan; Brandler, William M.; Sebat, Jonathan] Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA; [Antaki, Danny; Kleiber, Morgan; Hong, Oanh; Gujral, Madhusudan; Brandler, William M.; Sebat, Jonathan] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Antaki, Danny; Hong, Oanh; Gujral, Madhusudan; Brandler, William M.; Sebat, Jonathan] Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA; [Mitra, Ileena; Gymrek, Melissa] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Mitra, Ileena; Gymrek, Melissa] Univ Calif San Diego, Dept Comp Sci & Engn, La Jolla, CA 92093 USA; [Knox, Renatta] Weill Cornell Med Coll, Dept Child Neurol, New York, NY USA; [Botello, Martha Cristina Cancino; Uribe Fenner, Javiera] Hosp Univ Mutua Terrassa, Child & Adolescent Mental Hlth Unit, Barcelona, Spain; [Perez, Maria Carcel; Arranz, Maria] Fundacio Docencia & Recerca Mutua Terrassa, Barcelona, Spain; [Moffitt, Andrea B.; Wang, Zihua] Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA; [Hervas, Amaia] Fundacio Docencia & Recerca Mutua Terrassa, Res Lab Unit, Barcelona, Spain; [Devinsky, Orrin] NYU, Dept Neurol, Epilepsy Div, Sch Med, New York, NY 10016 USA	Howard Hughes Medical Institute; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Cornell University; Hospital Universitario Mutua Terrassa; Cold Spring Harbor Laboratory; New York University	Gleeson, JG (corresponding author), Univ Calif San Diego, Howard Hughes Med Inst, Dept Neurosci, La Jolla, CA 92093 USA.; Gleeson, JG (corresponding author), Rady Childrens Inst Genom Med, San Diego, CA 92123 USA.; Sebat, J (corresponding author), Univ Calif San Diego, Beyster Ctr Genom Psychiat Dis, La Jolla, CA 92093 USA.; Sebat, J (corresponding author), Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA.; Sebat, J (corresponding author), Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA.; Sebat, J (corresponding author), Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA.	jsebat@ucsd.edu; jogleeson@ucsd.edu	Yang, Xiaoxu/HDM-3286-2022; Breuss, Martin/AAL-9509-2021; Wang, Zhiquan/HHS-6768-2022; Yang, Xiaoxu/L-2950-2019	Yang, Xiaoxu/0000-0003-0219-0023; Yang, Xiaoxu/0000-0003-0219-0023; Moffitt, Andrea/0000-0001-5964-7851; Devinsky, Orrin/0000-0003-0044-4632; Kleiber, Morgan/0000-0002-9241-642X	EMBO Long-Term Fellowship [ALTF 174-2015]; Marie Curie Actions of the European Commission [LTFCOFUND2013, GA-2013-609409]; Erwin Schrodinger Fellowship by the Austrian Science Fund [J 4197-B30]; NIH [U01MH108898, R01NS083823, MH076431, MH113715]; Simons Foundation Autism Research Initiative [571583]; Howard Hughes Medical Institute; Silverman Family Foundation; Finding a Cure for Epilepsy (FACES); Seizures	EMBO Long-Term Fellowship(European Molecular Biology Organization (EMBO)); Marie Curie Actions of the European Commission(European Commission); Erwin Schrodinger Fellowship by the Austrian Science Fund(Austrian Science Fund (FWF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Simons Foundation Autism Research Initiative; Howard Hughes Medical Institute(Howard Hughes Medical Institute); Silverman Family Foundation; Finding a Cure for Epilepsy (FACES); Seizures	We thank the participants in this study for their contribution. M.W.B. was supported by an EMBO Long-Term Fellowship (no. ALTF 174-2015), which is co-funded by the Marie Curie Actions of the European Commission (nos. LTFCOFUND2013 and GA-2013-609409), and an Erwin Schrodinger Fellowship by the Austrian Science Fund (no. J 4197-B30). This study was supported by grants to J.G.G. from the NIH (nos. U01MH108898 and R01NS083823); the Simons Foundation Autism Research Initiative to J.G.G. (no. 571583), J.S. and M. Wigler (laboratory leader for A.B.M. and Z.W.); the NIH (nos. MH076431 and MH113715) to J.S.; and the Howard Hughes Medical Institute to J.G.G. Sequencing support was provided by the Rady Children's Institute for Genomic Medicine and ONP. O.D. acknowledges support from the Silverman Family Foundation and Finding a Cure for Epilepsy (FACES) and Seizures. We thank B. Hamilton, N. Chi, V. Stanley, A. Marsh, M. Wigler and L. Alexandrov for suggestions. We thank R. Sinkovits, A. Majumdar, S. Strande and the San Diego Supercomputer Center for hosting the computing infrastructure necessary for completing this project.	Acuna-Hidalgo R, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1110-1; Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Bailey JA, 2002, SCIENCE, V297, P1003, DOI 10.1126/science.1072047; Bernkopf M, 2017, HUM MUTAT, V38, P1360, DOI 10.1002/humu.23281; Brandler WM, 2018, SCIENCE, V360, P327, DOI 10.1126/science.aan2261; Brandler WM, 2016, AM J HUM GENET, V98, P667, DOI 10.1016/j.ajhg.2016.02.018; Browning SR, 2011, NAT REV GENET, V12, P703, DOI 10.1038/nrg3054; Campbell IM, 2014, AM J HUM GENET, V95, P345, DOI 10.1016/j.ajhg.2014.08.010; Carvill GL, 2013, NAT GENET, V45, P1073, DOI 10.1038/ng.2727; Cibulskis K, 2013, NAT BIOTECHNOL, V31, P213, DOI 10.1038/nbt.2514; Collins R.L., 2016, CNVIEW VISUALIZATION, P049536, DOI [10.1101/049536, DOI 10.1101/049536]; Cooper DN, 2013, HUM GENET, V132, P1077, DOI 10.1007/s00439-013-1331-2; Escaramis G, 2015, BRIEF FUNCT GENOMICS, V14, P305, DOI 10.1093/bfgp/elv014; Freed D, 2014, GENES-BASEL, V5, P1064, DOI 10.3390/genes5041064; Gao ZY, 2019, P NATL ACAD SCI USA, V116, P9491, DOI 10.1073/pnas.1901259116; Gervais AL, 2010, NUCLEIC ACIDS RES, V38, pW308, DOI 10.1093/nar/gkq485; Goriely A, 2012, AM J HUM GENET, V90, P175, DOI 10.1016/j.ajhg.2011.12.017; Goss PJE, 1996, GENETICS, V143, P589; Hamdan FF, 2012, EUR J HUM GENET, V20, P796, DOI 10.1038/ejhg.2011.271; Hancarova M, 2019, AM J MED GENET A, V179, P2119, DOI 10.1002/ajmg.a.61302; Hehir-Kwa JY, 2011, J MED GENET, V48, P776, DOI 10.1136/jmedgenet-2011-100147; Huang AY, 2018, PLOS GENET, V14, DOI 10.1371/journal.pgen.1007395; Huang AY, 2017, NUCLEIC ACIDS RES, V45, DOI 10.1093/nar/gkx024; Iossifov I, 2014, NATURE, V515, P216, DOI 10.1038/nature13908; Jaiswal S, 2014, NEW ENGL J MED, V371, P2488, DOI 10.1056/NEJMoa1408617; Jonsson H, 2018, NAT GENET, V50, P1674, DOI 10.1038/s41588-018-0259-9; Jonsson H, 2017, NATURE, V549, P519, DOI 10.1038/nature24018; Karczewski K.J., 2019, GENOMICS, DOI [10.1101/531210, DOI 10.1101/531210]; Karolchik D, 2004, NUCLEIC ACIDS RES, V32, pD493, DOI 10.1093/nar/gkh103; Kim S, 2018, NAT METHODS, V15, P591, DOI 10.1038/s41592-018-0051-x; Kong A, 2012, NATURE, V488, P471, DOI 10.1038/nature11396; Koressaar T, 2007, BIOINFORMATICS, V23, P1289, DOI 10.1093/bioinformatics/btm091; Krupp DR, 2017, AM J HUM GENET, V101, P369, DOI 10.1016/j.ajhg.2017.07.016; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Lemke JR, 2013, NAT GENET, V45, P1067, DOI 10.1038/ng.2728; Michaelson JJ, 2012, CELL, V151, P1431, DOI 10.1016/j.cell.2012.11.019; Neale BM, 2012, NATURE, V485, P242, DOI 10.1038/nature11011; O'Roak BJ, 2012, NATURE, V485, P246, DOI 10.1038/nature10989; Pejaver V, 2017, BIORXIV, DOI [10.1101/134981, DOI 10.1101/134981]; Rahbari R, 2016, NAT GENET, V48, P126, DOI 10.1038/ng.3469; Regan JF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118270; Schwarz JM, 2010, NAT METHODS, V7, P575, DOI 10.1038/nmeth0810-575; Snyder MW, 2015, NAT REV GENET, V16, P344, DOI 10.1038/nrg3903; Turner DJ, 2008, NAT GENET, V40, P90, DOI 10.1038/ng.2007.40; Turner TN, 2017, CELL, V171, P710, DOI 10.1016/j.cell.2017.08.047; Untergasser A, 2007, NUCLEIC ACIDS RES, V35, pW71, DOI 10.1093/nar/gkm306; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Wilbe M, 2017, PRENATAL DIAG, V37, P1146, DOI 10.1002/pd.5156; Willems T, 2017, NAT METHODS, V14, P590, DOI [10.1038/NMETH.4267, 10.1038/nmeth.4267]; Wu HT, 2015, BIOTECHNIQUES, V58, P293, DOI 10.2144/000114280; Xia YC, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1464-8; Xu XJ, 2015, HUM MUTAT, V36, P861, DOI 10.1002/humu.22819; Yang X, 2017, TRANSL PSYCHIAT, V7, pe1176	53	48	50	1	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JAN	2020	26	1					143	+		10.1038/s41591-019-0711-0	http://dx.doi.org/10.1038/s41591-019-0711-0			25	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	KG3GZ	31873310	Green Submitted, Green Accepted			2022-12-27	WOS:000509831900037
J	Chen, IY; Joshi, S; Ghassemi, M				Chen, Irene Y.; Joshi, Shalmali; Ghassemi, Marzyeh			Treating health disparities with artificial intelligence	NATURE MEDICINE			English	Editorial Material								Healthcare is an imperfect practice, with disparities in care reflecting those in society. While algorithms may be misued to amplify biases, they may also be used to identify and correct disparities.	[Chen, Irene Y.] MIT, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Joshi, Shalmali; Ghassemi, Marzyeh] Vector Inst, Toronto, ON, Canada; [Ghassemi, Marzyeh] Univ Toronto, Dept Comp Sci, Toronto, ON, Canada; [Ghassemi, Marzyeh] Univ Toronto, Dept Med, Toronto, ON, Canada	Massachusetts Institute of Technology (MIT); University of Toronto; University of Toronto	Chen, IY (corresponding author), MIT, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	iychen@mit.edu			CIFAR AI Chair at the Vector Institute; NSERC	CIFAR AI Chair at the Vector Institute; NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	No funds were specifically solicited for this Comment. The principal investigators were partially supported by a CIFAR AI Chair at the Vector Institute and an NSERC Discovery Grant. M.G. is Canada Research Chair at the University of Toronto Departments of Computer Science and Medicine, and Canadian CIFAR AI Chair at the Vector Institute.	Abebe R, 2019, P INT AAAI C WEB SOC; Adamson AS, 2018, JAMA DERMATOL, V154, P1247, DOI 10.1001/jamadermatol.2018.2348; Alsan M., 2018, DOES DIVERSITY MATTE; [Anonymous], 2018, BIRTHS FINAL DATA 20; Buolamwini J., 2018, C FAIRNESS ACCOUNTAB, P77; Center for Disease Control & Prevention, 2019, MAT INF HLTH; Chen Irene Y, 2019, AMA J Ethics, V21, pE167, DOI 10.1001/amajethics.2019.167; [Committee on Understanding and Eliminating Racial and Ethnic Disparities in Health Care Institute of Medicine US], 2003, UNEQUAL TREATMENT CO; Gianfrancesco MA, 2018, JAMA INTERN MED, V178, P1544, DOI 10.1001/jamainternmed.2018.3763; Greenwood BN, 2018, P NATL ACAD SCI USA, V115, P8569, DOI 10.1073/pnas.1800097115; Haas JS, 2016, CANCER-AM CANCER SOC, V122, P611, DOI 10.1002/cncr.29805; Herrera-perez D, 2019, ELIFE, V8, DOI 10.7554/eLife.45183; Matthews TJ, 2015, INFANT MORTALITY STA; New York City Department of Health and Mental Hygiene, 2016, SEV MAT MORB NEW YOR; Oh SS, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001918; Pfohl S, 2019, P 2019 AAAI ACM C AI, P271; Popejoy AB, 2016, NATURE, V538, P161, DOI 10.1038/538161a; Singh Gopal K, 2019, Int J MCH AIDS, V8, P19, DOI 10.21106/ijma.271; Wesson DE, 2019, JAMA-J AM MED ASSOC, V322, P111, DOI 10.1001/jama.2019.1924; Zou J, 2018, NATURE, V559, P324, DOI 10.1038/d41586-018-05707-8	20	33	33	3	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JAN	2020	26	1					16	17		10.1038/s41591-019-0649-2	http://dx.doi.org/10.1038/s41591-019-0649-2			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	KG3GZ	31932779				2022-12-27	WOS:000509831900010
J	Hollon, TC; Pandian, B; Adapa, AR; Urias, E; Save, AV; Khalsa, SSS; Eichberg, DG; D'Amico, RS; Farooq, ZU; Lewis, S; Petridis, PD; Marie, T; Shah, AH; Garton, HJL; Maher, CO; Heth, JA; McKean, EL; Sullivan, SE; Hervey-Jumper, SL; Patil, PG; Thompson, BG; Sagher, O; McKhann, GM; Komotar, RJ; Ivan, ME; Snuderl, M; Otten, ML; Johnson, TD; Sisti, MB; Bruce, JN; Muraszko, KM; Trautman, J; Freudiger, CW; Canoll, P; Lee, H; Camelo-Piragua, S; Orringer, DA				Hollon, Todd C.; Pandian, Balaji; Adapa, Arjun R.; Urias, Esteban; Save, Akshay V.; Khalsa, Siri Sahib S.; Eichberg, Daniel G.; D'Amico, Randy S.; Farooq, Zia U.; Lewis, Spencer; Petridis, Petros D.; Marie, Tamara; Shah, Ashish H.; Garton, Hugh J. L.; Maher, Cormac O.; Heth, Jason A.; McKean, Erin L.; Sullivan, Stephen E.; Hervey-Jumper, Shawn L.; Patil, Parag G.; Thompson, B. Gregory; Sagher, Oren; McKhann, Guy M.; Komotar, Ricardo J.; Ivan, Michael E.; Snuderl, Matija; Otten, Marc L.; Johnson, Timothy D.; Sisti, Michael B.; Bruce, Jeffrey N.; Muraszko, Karin M.; Trautman, Jay; Freudiger, Christian W.; Canoll, Peter; Lee, Honglak; Camelo-Piragua, Sandra; Orringer, Daniel A.			Near real-time intraoperative brain tumor diagnosis using stimulated Raman histology and deep neural networks	NATURE MEDICINE			English	Article							CENTRAL-NERVOUS-SYSTEM; SCATTERING MICROSCOPY; UNITED-STATES; CANCER; SURGERY; WORLD	Intraoperative diagnosis is essential for providing safe and effective care during cancer surgery(1). The existing workflow for intraoperative diagnosis based on hematoxylin and eosin staining of processed tissue is time, resource and labor intensive(2,3). Moreover, interpretation of intraoperative histologic images is dependent on a contracting, unevenly distributed, pathology workforce(4). In the present study, we report a parallel workflow that combines stimulated Raman histology (SRH)(5-7), a label-free optical imaging method and deep convolutional neural networks (CNNs) to predict diagnosis at the bedside in near real-time in an automated fashion. Specifically, our CNNs, trained on over 2.5 million SRH images, predict brain tumor diagnosis in the operating room in under 150 s, an order of magnitude faster than conventional techniques (for example, 20-30 min)(2). In a multicenter, prospective clinical trial (n = 278), we demonstrated that CNN-based diagnosis of SRH images was noninferior to pathologist-based interpretation of conventional histologic images (overall accuracy, 94.6% versus 93.9%). Our CNNs learned a hierarchy of recognizable histologic feature representations to classify the major histopathologic classes of brain tumors. In addition, we implemented a semantic segmentation method to identify tumor-infiltrated diagnostic regions within SRH images. These results demonstrate how intraoperative cancer diagnosis can be streamlined, creating a complementary pathway for tissue diagnosis that is independent of a traditional pathology laboratory. A prospective, multicenter, case-control clinical trial evaluates the potential of artificial intelligence for providing accurate bedside diagnosis of patients with brain tumors.	[Hollon, Todd C.; Khalsa, Siri Sahib S.; Garton, Hugh J. L.; Maher, Cormac O.; Heth, Jason A.; McKean, Erin L.; Sullivan, Stephen E.; Hervey-Jumper, Shawn L.; Patil, Parag G.; Thompson, B. Gregory; Sagher, Oren; Muraszko, Karin M.; Orringer, Daniel A.] Univ Michigan, Dept Neurosurg, Ann Arbor, MI 48109 USA; [Pandian, Balaji; Adapa, Arjun R.; Urias, Esteban; Lewis, Spencer] Univ Michigan, Sch Med, Ann Arbor, MI USA; [Save, Akshay V.; Petridis, Petros D.] Columbia Univ, Coll Phys & Surg, New York, NY USA; [Eichberg, Daniel G.; Shah, Ashish H.; Komotar, Ricardo J.; Ivan, Michael E.] Univ Miami, Dept Neurol Surg, Miami, FL USA; [D'Amico, Randy S.; McKhann, Guy M.; Otten, Marc L.; Sisti, Michael B.; Bruce, Jeffrey N.] Columbia Univ, Dept Neurol Surg, New York, NY USA; [Farooq, Zia U.; Trautman, Jay; Freudiger, Christian W.] Invenio Imaging Inc, Santa Clara, CA USA; [Marie, Tamara] Columbia Univ, Dept Pediat Oncol, New York, NY USA; [McKean, Erin L.] Univ Michigan, Dept Otolaryngol, Ann Arbor, MI 48109 USA; [Snuderl, Matija] NYU, Dept Pathol, 550 1St Ave, New York, NY 10016 USA; [Johnson, Timothy D.] Univ Michigan, Sch Publ Hlth, Dept Biostat, Ann Arbor, MI 48109 USA; [Canoll, Peter] Columbia Univ, Dept Pathol & Cell Biol, New York, NY USA; [Lee, Honglak] Univ Michigan, Dept Elect Engn & Comp Sci, Ann Arbor, MI 48109 USA; [Camelo-Piragua, Sandra] Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA; [Orringer, Daniel A.] NYU, Dept Neurosurg, 550 1St Ave, New York, NY 10016 USA; [Hervey-Jumper, Shawn L.] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Columbia University; University of Miami; Columbia University; Columbia University; University of Michigan System; University of Michigan; New York University; University of Michigan System; University of Michigan; Columbia University; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; New York University; University of California System; University of California San Francisco	Orringer, DA (corresponding author), Univ Michigan, Dept Neurosurg, Ann Arbor, MI 48109 USA.; Orringer, DA (corresponding author), NYU, Dept Neurosurg, 550 1St Ave, New York, NY 10016 USA.	Daniel.Orringer@nyulangone.org	Bruce, Jeffrey N/AAC-5307-2022; Petridis, Petros/Q-5686-2018	Camelopiragua, Sandra/0000-0002-9606-9402; Hollon, Todd/0000-0001-5987-6531; McKean, Erin/0000-0002-7026-0903; Khalsa, Siri Sahib/0000-0003-0800-3866; Orringer, Daniel/0000-0001-6427-8376; Snuderl, Matija/0000-0003-0752-0917; Petridis, Petros/0000-0001-7608-5723	National Institutes of Health National Cancer Institute [R01CA226527-02]; Neurosurgery Research Education Fund; Cook Family Foundation; University of Michigan MTRAC	National Institutes of Health National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Neurosurgery Research Education Fund; Cook Family Foundation; University of Michigan MTRAC(University of Michigan System)	We thank T. Cichonski for manuscript editing. This work was supported by the National Institutes of Health National Cancer Institute (grant no. R01CA226527-02), Neurosurgery Research Education Fund, University of Michigan MTRAC and The Cook Family Foundation.	Abadi M., 2016, TENSORFLOW LARGE SCA; CARTER CL, 1989, CANCER-AM CANCER SOC, V63, P181, DOI 10.1002/1097-0142(19890101)63:1<181::AID-CNCR2820630129>3.0.CO;2-H; Chen PHC, 2019, NAT MED, V25, P1453, DOI 10.1038/s41591-019-0539-7; Coudray N, 2018, NAT MED, V24, P1559, DOI 10.1038/s41591-018-0177-5; Dammers R, 2010, ACTA NEUROCHIR, V152, P1915, DOI 10.1007/s00701-010-0752-0; Erhan D, 2009, U MONTR, V1341, P1, DOI DOI 10.2464/JILM.23.425; Esteva A, 2017, NATURE, V542, P115, DOI 10.1038/nature21056; Freudiger CW, 2014, NAT PHOTONICS, V8, P153, DOI [10.1038/nphoton.2013.360, 10.1038/NPHOTON.2013.360]; Freudiger CW, 2008, SCIENCE, V322, P1857, DOI 10.1126/science.1165758; Gal AA, 2005, JAMA-J AM MED ASSOC, V294, P3135, DOI 10.1001/jama.294.24.3135; Gulshan V, 2016, JAMA-J AM MED ASSOC, V316, P2402, DOI 10.1001/jama.2016.17216; He KM, 2015, IEEE I CONF COMP VIS, P1026, DOI 10.1109/ICCV.2015.123; Hoesli RC, 2017, OTOLARYNG HEAD NECK, V157, P448, DOI 10.1177/0194599817700388; Hollon TC, 2018, CANCER RES, V78, P278, DOI 10.1158/0008-5472.CAN-17-1974; Hou L, 2016, PROC CVPR IEEE, P2424, DOI 10.1109/CVPR.2016.266; Ji MB, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aab0195; Ji MB, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005954; Kohe S., 2017, J HISTOL HISTOPATHOL, V4, P4, DOI [10.7243/2055-091X-4-4, DOI 10.7243/2055-091X-4-4]; Krizhevsky A., 2012, ADV NEURAL INF PROCE; Litjens G, 2016, SCI REP-UK, V6, DOI 10.1038/srep26286; Liu Y, 2017, COMMUN MATH BIOL NEU, DOI 10.1080/10408398.2017.1329704; Louis DN, 2016, ACTA NEUROPATHOL, V131, P803, DOI 10.1007/s00401-016-1545-1; Lu FK, 2016, CANCER RES, V76, P3451, DOI 10.1158/0008-5472.CAN-16-0270; Metter DM, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2019.4337; Novis DA, 1997, ARCH PATHOL LAB MED, V121, P559; Orringer DA, 2017, NAT BIOMED ENG, V1, DOI 10.1038/s41551-016-0027; Ostrom QT, 2017, NEURO-ONCOLOGY, V19, pV1, DOI 10.1093/neuonc/nox158; Qin ZW, 2018, MATH FDN COMPUT, V1, P149, DOI 10.3934/mfc.2018008; Ratnavelu NDG, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010360.pub2; Robboy SJ, 2013, ARCH PATHOL LAB MED, V137, P1723, DOI 10.5858/arpa.2013-0200-OA; Sottoriva A, 2013, P NATL ACAD SCI USA, V110, P4009, DOI 10.1073/pnas.1219747110; Sullivan R, 2015, LANCET ONCOL, V16, P1193, DOI 10.1016/S1470-2045(15)00223-5; Syafrudin M, 2018, BDIOT 2018: PROCEEDINGS OF THE 2018 2ND INTERNATIONAL CONFERENCE ON BIG DATA AND INTERNET OF THINGS, P167, DOI 10.1145/3289430.3289470; Szegedy C., 2017, AAAI, DOI DOI 10.1016/J.PATREC.2014.01.008; Titano JJ, 2018, NAT MED, V24, P1337, DOI 10.1038/s41591-018-0147-y; Top 100 Lab Procedures Ranked by Service (2017), 2017, TOP 100 LAB PROCEDUR; Topol EJ, 2019, NAT MED, V25, P44, DOI 10.1038/s41591-018-0300-7; Viola KV, 2012, ARCH DERMATOL, V148, P473, DOI 10.1001/archdermatol.2011.2456; Yosinski Jason, 2014, NIPS, DOI DOI 10.1109/IJCNN.2016.7727519; Zeiler MD, 2014, LECT NOTES COMPUT SC, V8689, P818, DOI 10.1007/978-3-319-10590-1_53	40	219	223	28	191	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	JAN	2020	26	1					52	+		10.1038/s41591-019-0715-9	http://dx.doi.org/10.1038/s41591-019-0715-9			21	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	KG3GZ	31907460	Green Accepted, Green Submitted			2022-12-27	WOS:000509831900026
J	Unlu, G; Qi, XZ; Gamazon, ER; Melville, DB; Patel, N; Rushing, AR; Hashem, M; Al-Faifi, A; Chen, R; Li, BS; Cox, NJ; Alkuraya, FS; Knapik, EW				Unlu, Gokhan; Qi, Xinzi; Gamazon, Eric R.; Melville, David B.; Patel, Nisha; Rushing, Amy R.; Hashem, Mais; Al-Faifi, Abdullah; Chen, Rui; Li, Bingshan; Cox, Nancy J.; Alkuraya, Fowzan S.; Knapik, Ela W.			Phenome-based approach identifies RIC1-linked Mendelian syndrome through zebrafish models, biobank associations and clinical studies	NATURE MEDICINE			English	Article							EXTRACELLULAR-MATRIX; NUCLEOTIDE EXCHANGE; WIDE ASSOCIATION; GOLGI; COMPLEX; GENE; EXPRESSION; MUTATIONS; PROTEIN; TRAFFICKING	Integrated use of an animal model, a biobank for common diseases and a rare Mendelian disease leads to the discovery of a new syndrome and its pathological mechanism. Discovery of genotype-phenotype relationships remains a major challenge in clinical medicine. Here, we combined three sources of phenotypic data to uncover a new mechanism for rare and common diseases resulting from collagen secretion deficits. Using a zebrafish genetic screen, we identified the ric1 gene as being essential for skeletal biology. Using a gene-based phenome-wide association study (PheWAS) in the EHR-linked BioVU biobank, we show that reduced genetically determined expression of RIC1 is associated with musculoskeletal and dental conditions. Whole-exome sequencing identified individuals homozygous-by-descent for a rare variant in RIC1 and, through a guided clinical re-evaluation, it was discovered that they share signs with the BioVU-associated phenome. We named this new Mendelian syndrome CATIFA (cleft lip, cataract, tooth abnormality, intellectual disability, facial dysmorphism, attention-deficit hyperactivity disorder) and revealed further disease mechanisms. This gene-based, PheWAS-guided approach can accelerate the discovery of clinically relevant disease phenome and associated biological mechanisms.	[Unlu, Gokhan; Qi, Xinzi; Gamazon, Eric R.; Melville, David B.; Rushing, Amy R.; Cox, Nancy J.; Knapik, Ela W.] Vanderbilt Univ, Med Ctr, Dept Med, Div Med Genet, Nashville, TN 37235 USA; [Unlu, Gokhan; Qi, Xinzi; Gamazon, Eric R.; Rushing, Amy R.; Chen, Rui; Li, Bingshan; Cox, Nancy J.; Knapik, Ela W.] Vanderbilt Univ, Med Ctr, Vanderbilt Genet Inst, Nashville, TN 37235 USA; [Unlu, Gokhan; Knapik, Ela W.] Vanderbilt Univ, Dept Cell & Dev Biol, Nashville, TN 37235 USA; [Gamazon, Eric R.] Univ Cambridge, Clare Hall, Cambridge, England; [Patel, Nisha; Hashem, Mais; Alkuraya, Fowzan S.] King Faisal Specialist Hosp & Res Ctr, Dept Genet, Riyadh, Saudi Arabia; [Al-Faifi, Abdullah] Secur Forces Hosp, Dept Pediat, Riyadh, Saudi Arabia; [Chen, Rui; Li, Bingshan] Vanderbilt Univ, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA; [Unlu, Gokhan] Rockefeller Univ, Lab Metab Regulat & Genet, 1230 York Ave, New York, NY 10021 USA; [Melville, David B.] Univ Calif Berkeley, Howard Hughes Med Inst, Dept Mol & Cellular Biol, Berkeley, CA 94720 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; University of Cambridge; King Faisal Specialist Hospital & Research Center; Security Forces Hospital - Saudi Arabia; Vanderbilt University; Rockefeller University; Howard Hughes Medical Institute; University of California System; University of California Berkeley	Knapik, EW (corresponding author), Vanderbilt Univ, Med Ctr, Dept Med, Div Med Genet, Nashville, TN 37235 USA.; Knapik, EW (corresponding author), Vanderbilt Univ, Med Ctr, Vanderbilt Genet Inst, Nashville, TN 37235 USA.; Knapik, EW (corresponding author), Vanderbilt Univ, Dept Cell & Dev Biol, Nashville, TN 37235 USA.	ela.knapik@vumc.org	Gamazon, Eric/I-6873-2018; Knapik, Ela W./J-6172-2014; Li, Bingshan/ABE-6104-2020	Gamazon, Eric/0000-0003-4204-8734; Knapik, Ela W./0000-0002-2977-3619; Unlu, Gokhan/0000-0002-2704-2724	NIH [R01 MH113362, U01 HG009086, R35HG010718, T32 GM008554]; Saudi Human Genome Program; KSCDR; Vanderbilt International Scholar Program; AHA predoctoral fellowship [15PRE22940041]; Clare Hall, University of Cambridge, UK;  [U01HG004798];  [R01NS032830];  [RC2GM092618];  [P50GM115305];  [U01HG006378];  [U19HL065962];  [R01HD074711];  [S10RR025141];  [UL1TR002243];  [UL1TR000445];  [UL1RR024975]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024975] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Saudi Human Genome Program; KSCDR; Vanderbilt International Scholar Program; AHA predoctoral fellowship(American Heart Association); Clare Hall, University of Cambridge, UK; ; ; ; ; ; ; ; ; ; ; ; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	We are grateful to the families and participating individuals for their contribution. We thank the Sequencing and Genotyping Core Facilities at KFSHRC for their technical help. We thank C. Guthrie and A. Goodrich of ZCORE at VUMC for excellent zebrafish care. We thank the Vanderbilt University Nikon Center of Excellence and Vanderbilt University Cell Imaging Shared Resource (CISR) for technical support with confocal imaging and data analysis, and M. Vinogradova (CISR) for expertise and technical assistance with TEM. This manuscript is dedicated to the memory of K. Anderson Faulds. We acknowledge the NIH (no. R01 MH113362 to N.J.C. and E.W.K., no. U01 HG009086 to N.J.C. and B.L., no. R35HG010718 to E.R.G. and no. T32 GM008554 to D.B.M.) for financial support. We acknowledge the support of the Saudi Human Genome Program and KSCDR (to F.S.A.). G.U. was supported by the Vanderbilt International Scholar Program, and AHA predoctoral fellowship (no. 15PRE22940041). E.R.G. is grateful to the President and Fellows of Clare Hall, University of Cambridge, UK for a stimulating academic home during his fellowship in the college. We acknowledge VANTAGE and VICTR for construction and maintenance of the BioVU biorepository and the funding sources that support them-nos. S10RR025141, UL1TR002243, UL1TR000445 and UL1RR024975. BioVU genomic data are also supported by investigator-led projects that include nos. U01HG004798, R01NS032830, RC2GM092618, P50GM115305, U01HG006378, U19HL065962 and R01HD074711.	Aguet F, 2017, NATURE, V550, P204, DOI 10.1038/nature24277; Aizenberg M, 2011, J NEUROSCI, V31, P8708, DOI 10.1523/JNEUROSCI.6565-10.2011; [Anonymous], 2018, NAT MED, V24, P1483, DOI 10.1038/s41591-018-0231-3; Ardlie KG, 2015, SCIENCE, V348, P648, DOI 10.1126/science.1262110; Arnold WV, 2013, INT J BIOCHEM CELL B, V45, P1556, DOI 10.1016/j.biocel.2013.05.017; Bastarache L, 2018, SCIENCE, V359, P1233, DOI 10.1126/science.aal4043; Boyadjiev SA, 2006, NAT GENET, V38, P1192, DOI 10.1038/ng1876; Budick SA, 2000, J EXP BIOL, V203, P2565; Bycroft C, 2018, NATURE, V562, P203, DOI 10.1038/s41586-018-0579-z; Canty EG, 2005, J CELL SCI, V118, P1341, DOI 10.1242/jcs.01731; Chen LS, 2012, AM J HUM GENET, V91, P977, DOI 10.1016/j.ajhg.2012.09.017; Cox NJ, 2018, BIOCHEMISTRY-US, V57, P91, DOI 10.1021/acs.biochem.7b00870; Dale RM, 2011, DEV BIOL, V357, P518, DOI 10.1016/j.ydbio.2011.06.020; Del Nery E, 2006, TRAFFIC, V7, P394, DOI 10.1111/j.1600-0854.2006.00395.x; Denny JC, 2013, NAT BIOTECHNOL, V31, P1102, DOI 10.1038/nbt.2749; Denny JC, 2010, BIOINFORMATICS, V26, P1205, DOI 10.1093/bioinformatics/btq126; Detaint D, 2010, EUR HEART J, V31, P2223, DOI 10.1093/eurheartj/ehq258; Driever W, 1996, DEVELOPMENT, V123, P37; Eames BF, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002246; Eames BF, 2010, DEV BIOL, V341, P400, DOI 10.1016/j.ydbio.2010.02.035; Faivre L, 2007, AM J HUM GENET, V81, P454, DOI 10.1086/520125; FUIMAN LA, 1988, ANIM BEHAV, V36, P250, DOI 10.1016/S0003-3472(88)80268-9; Gamazon ER, 2015, NAT GENET, V47, P1091, DOI 10.1038/ng.3367; Gorur A, 2017, J CELL BIOL, V216, P1745, DOI 10.1083/jcb.201702135; Granato M, 1996, DEVELOPMENT, V123, P399; Habashi JP, 2006, SCIENCE, V312, P117, DOI 10.1126/science.1124287; Hatzopoulos AK, 2019, DIS MODEL MECH, V12, DOI 10.1242/dmm.041699; Heinemeier KM, 2007, J PHYSIOL-LONDON, V582, P1303, DOI 10.1113/jphysiol.2007.127639; Hoffmann K, 2005, BIOINFORMATICS, V21, P3565, DOI 10.1093/bioinformatics/bti571; Huber W, 2015, NAT METHODS, V12, P115, DOI [10.1038/NMETH.3252, 10.1038/nmeth.3252]; Ishikawa Y, 2013, BBA-MOL CELL RES, V1833, P2479, DOI 10.1016/j.bbamcr.2013.04.008; Judge DP, 2004, J CLIN INVEST, V114, P172, DOI 10.1172/JCI200420641; Kawakami K, 1999, GENE, V240, P239, DOI 10.1016/S0378-1119(99)00444-8; Khera AV, 2018, NAT GENET, V50, P1219, DOI 10.1038/s41588-018-0183-z; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kim JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018556; Klein C, 2018, EMBO MOL MED, V10, P1, DOI 10.15252/emmm.201708365; Knapik EW, 1998, NAT GENET, V18, P338, DOI 10.1038/ng0498-338; Knapik EW, 2000, MAMM GENOME, V11, P511, DOI 10.1007/s003350010098; Kwan KM, 2007, DEV DYNAM, V236, P3088, DOI 10.1002/dvdy.21343; Lang MR, 2006, NAT GENET, V38, P1198, DOI 10.1038/ng1880; Latimer A, 2010, MATRIX BIOL, V29, P89, DOI 10.1016/j.matbio.2009.10.002; Levic D, 2015, J MOL MED, V93, P165, DOI 10.1007/s00109-014-1247-x; Li Y, 2010, GENET EPIDEMIOL, V34, P816, DOI 10.1002/gepi.20533; Lonsdale J, 2013, NAT GENET, V45, P580, DOI 10.1038/ng.2653; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Luderman LN, 2017, CURR TOP DEV BIOL, V124, P81, DOI 10.1016/bs.ctdb.2016.11.004; Maddirevula S, 2018, GENET MED, V20, P1609, DOI 10.1038/gim.2018.50; Malhotra V, 2015, BIOCHEM SOC T, V43, P104, DOI 10.1042/BST20140286; MARTINEZ O, 1994, J CELL BIOL, V127, P1575, DOI 10.1083/jcb.127.6.1575; Melville DB, 2011, DIS MODEL MECH, V4, P763, DOI 10.1242/dmm.007625; Mienaltowski MJ, 2014, ADV EXP MED BIOL, V802, P5, DOI 10.1007/978-94-007-7893-1_2; Miserey-Lenkei S, 2010, NAT CELL BIOL, V12, P645, DOI 10.1038/ncb2067; Muller II, 2006, DEV DYNAM, V235, P2881, DOI 10.1002/dvdy.20925; Neuhauss SCF, 1996, DEVELOPMENT, V123, P357; Niu XB, 2014, J BIOL CHEM, V289, P11971, DOI 10.1074/jbc.M114.547190; Patel N, 2017, HUM GENET, V136, P205, DOI 10.1007/s00439-016-1747-6; Pingel J, 2014, J ANAT, V224, P548, DOI 10.1111/joa.12164; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Pusapati GV, 2012, J BIOL CHEM, V287, P42129, DOI 10.1074/jbc.M112.414565; Ritchie MD, 2010, AM J HUM GENET, V86, P560, DOI 10.1016/j.ajhg.2010.03.003; Roden DM, 2008, CLIN PHARMACOL THER, V84, P362, DOI 10.1038/clpt.2008.89; Roden DM, 2017, J PHYSIOL-LONDON, V595, P4109, DOI 10.1113/JP273122; Sarmah S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010367; Schejter ED, 2010, CURR OPIN CELL BIOL, V22, P566, DOI 10.1016/j.ceb.2010.08.009; Senkov O, 2014, PROG BRAIN RES, V214, P53, DOI 10.1016/B978-0-444-63486-3.00003-7; Siniossoglou S, 2000, EMBO J, V19, P4885, DOI 10.1093/emboj/19.18.4885; Soleman S, 2013, NEUROSCIENCE, V253, P194, DOI 10.1016/j.neuroscience.2013.08.050; Stednitz SJ, 2018, CURR BIOL, V28, P2445, DOI 10.1016/j.cub.2018.06.016; Subramanian A, 2014, ELIFE, V3, DOI 10.7554/eLife.02372; Unlu G, 2019, AM J HUM GENET, V104, P503, DOI 10.1016/j.ajhg.2019.01.017; Unlu G, 2014, INT J BIOCHEM CELL B, V47, P57, DOI 10.1016/j.biocel.2013.11.005; Valente C, 2010, NAT CELL BIOL, V12, P635, DOI 10.1038/ncb0710-635; Varshney GK, 2015, GENOME RES, V25, P1030, DOI 10.1101/gr.186379.114; Wakana Y, 2012, EMBO J, V31, P3976, DOI 10.1038/emboj.2012.235; Walker MB, 2007, BIOTECH HISTOCHEM, V82, P23, DOI 10.1080/10520290701333558; White J, 1999, J CELL BIOL, V147, P743, DOI 10.1083/jcb.147.4.743; White RJ, 2017, ELIFE, V6, DOI [10.7554/eLife.30860.001, 10.7554/eLife.30860]; Zou P, 2015, EXP EYE RES, V138, P104, DOI 10.1016/j.exer.2015.07.001	79	17	19	1	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JAN	2020	26	1					98	+		10.1038/s41591-019-0705-y	http://dx.doi.org/10.1038/s41591-019-0705-y			27	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	KG3GZ	31932796	Green Accepted			2022-12-27	WOS:000509831900033
J	Razavi, P; Li, BT; Brown, DN; Jung, B; Hubbell, E; Shen, RL; Abida, W; Juluru, K; De Bruijn, I; Hou, CL; Venn, O; Lim, R; Anand, A; Maddala, T; Gnerre, S; Satya, RV; Liu, QW; Shen, L; Eattock, N; Yue, J; Blocker, AW; Lee, M; Sehnert, A; Xu, H; Hall, MP; Santiago-Zayas, A; Novotny, WF; Isbell, JM; Rusch, VW; Plitas, G; Heerdt, AS; Ladanyi, M; Hyman, DM; Jones, DR; Morrow, M; Riely, GJ; Scher, HI; Rudin, CM; Robson, ME; Diaz, LA; Solit, DB; Aravanis, AM; Reis, JS				Razavi, Pedram; Li, Bob T.; Brown, David N.; Jung, Byoungsok; Hubbell, Earl; Shen, Ronglai; Abida, Wassim; Juluru, Krishna; De Bruijn, Ino; Hou, Chenlu; Venn, Oliver; Lim, Raymond; Anand, Aseem; Maddala, Tara; Gnerre, Sante; Satya, Ravi Vijaya; Liu, Qinwen; Shen, Ling; Eattock, Nicholas; Yue, Jeanne; Blocker, Alexander W.; Lee, Mark; Sehnert, Amy; Xu, Hui; Hall, Megan P.; Santiago-Zayas, Angie; Novotny, William F.; Isbell, James M.; Rusch, Valerie W.; Plitas, George; Heerdt, Alexandra S.; Ladanyi, Marc; Hyman, David M.; Jones, David R.; Morrow, Monica; Riely, Gregory J.; Scher, Howard I.; Rudin, Charles M.; Robson, Mark E.; Diaz, Luis A., Jr.; Solit, David B.; Aravanis, Alexander M.; Reis-Filho, Jorge S.			High-intensity sequencing reveals the sources of plasma circulating cell-free DNA variants	NATURE MEDICINE			English	Article							CLONAL HEMATOPOIESIS; TUMOR DNA; MUTATIONAL LANDSCAPE; ACQUIRED-RESISTANCE; SOMATIC MUTATIONS; LIQUID BIOPSIES; CANCER-PATIENTS; EVOLUTION; THERAPY; REPAIR	Accurate identification of tumor-derived somatic variants in plasma circulating cell-free DNA (cfDNA) requires understanding of the various biological compartments contributing to the cfDNA pool. We sought to define the technical feasibility of a high-intensity sequencing assay of cfDNA and matched white blood cell DNA covering a large genomic region (508 genes; 2 megabases; >60,000x raw depth) in a prospective study of 124 patients with metastatic cancer, with contemporaneous matched tumor tissue biopsies, and 47 controls without cancer. The assay displayed high sensitivity and specificity, allowing for de novo detection of tumor-derived mutations and inference of tumor mutational burden, microsatellite instability, mutational signatures and sources of somatic mutations identified in cfDNA. The vast majority of cfDNA mutations (81.6% in controls and 53.2% in patients with cancer) had features consistent with clonal hematopoiesis. This cfDNA sequencing approach revealed that clonal hematopoiesis constitutes a pervasive biological phenomenon, emphasizing the importance of matched cfDNA-white blood cell sequencing for accurate variant interpretation.	[Razavi, Pedram; Li, Bob T.; Abida, Wassim; Anand, Aseem; Santiago-Zayas, Angie; Hyman, David M.; Riely, Gregory J.; Scher, Howard I.; Rudin, Charles M.; Robson, Mark E.; Diaz, Luis A., Jr.; Solit, David B.] Mem Sloan Kettering Canc Ctr, Dept Med, 1275 York Ave, New York, NY 10021 USA; [Razavi, Pedram; Li, Bob T.; Abida, Wassim; Anand, Aseem; Santiago-Zayas, Angie; Isbell, James M.; Rusch, Valerie W.; Plitas, George; Heerdt, Alexandra S.; Hyman, David M.; Jones, David R.; Morrow, Monica; Riely, Gregory J.; Scher, Howard I.; Rudin, Charles M.; Robson, Mark E.; Diaz, Luis A., Jr.; Solit, David B.] Weill Cornell Med Coll, New York, NY 10065 USA; [Razavi, Pedram; Solit, David B.; Reis-Filho, Jorge S.] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, 1275 York Ave, New York, NY 10021 USA; [Brown, David N.; Lim, Raymond; Ladanyi, Marc; Reis-Filho, Jorge S.] Mem Sloan Kettering Canc Ctr, Dept Pathol, 1275 York Ave, New York, NY 10021 USA; [Jung, Byoungsok; Hubbell, Earl; Hou, Chenlu; Venn, Oliver; Maddala, Tara; Gnerre, Sante; Satya, Ravi Vijaya; Liu, Qinwen; Shen, Ling; Eattock, Nicholas; Yue, Jeanne; Blocker, Alexander W.; Lee, Mark; Sehnert, Amy; Xu, Hui; Hall, Megan P.; Novotny, William F.; Aravanis, Alexander M.] GRAIL Inc, Menlo Pk, CA USA; [Shen, Ronglai] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10021 USA; [Juluru, Krishna] Mem Sloan Kettering Canc Ctr, Dept Radiol, 1275 York Ave, New York, NY 10021 USA; [De Bruijn, Ino; Solit, David B.] Mem Sloan Kettering Canc Ctr, Marie Josee & Henry R Kravis Ctr Mol Oncol, 1275 York Ave, New York, NY 10021 USA; [Isbell, James M.; Rusch, Valerie W.; Plitas, George; Heerdt, Alexandra S.; Jones, David R.; Morrow, Monica] Mem Sloan Kettering Canc Ctr, Dept Surg, 1275 York Ave, New York, NY 10021 USA; [Blocker, Alexander W.] Foresite Capital Management, San Francisco, CA USA; [Lee, Mark] Genentech Inc, 460 Point San Bruno Blvd, San Francisco, CA 94080 USA; [Sehnert, Amy] MyoKardia, San Francisco, CA USA; [Novotny, William F.] BeiGene, San Mateo, CA USA	Memorial Sloan Kettering Cancer Center; Cornell University; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Roche Holding; Genentech	Razavi, P (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Med, 1275 York Ave, New York, NY 10021 USA.; Razavi, P (corresponding author), Weill Cornell Med Coll, New York, NY 10065 USA.; Razavi, P; Reis, JS (corresponding author), Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, 1275 York Ave, New York, NY 10021 USA.; Reis, JS (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Pathol, 1275 York Ave, New York, NY 10021 USA.	razavip@mskcc.org; reisfilj@mskcc.org	Riely, Gregory/AAF-4300-2019	Isbell, James/0000-0002-7305-876X; Razavi, Pedram/0000-0003-4236-0576; Juluru, Krishna/0000-0001-8203-8894; de Bruijn, Ino/0000-0001-5427-4750; /0000-0002-7300-5027; Li, Bob/0000-0001-6661-8733; Hubbell, Earl/0000-0001-7301-3759; Solit, David/0000-0002-6614-802X; Brown, David/0000-0002-8249-3632	GRAIL; National Institutes of Health [P30 CA008748, R01 CA234361]; Breast Cancer Alliance; Breast Cancer Research Foundation; Congressionally Directed Medical Research Programs [W81XWH-15-1-0547];  [GC229671]; NATIONAL CANCER INSTITUTE [P30CA008748, R01CA234361] Funding Source: NIH RePORTER	GRAIL; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Breast Cancer Alliance; Breast Cancer Research Foundation; Congressionally Directed Medical Research Programs(United States Department of Defense); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank the following GRAIL and Memorial Sloan Kettering Cancer Center associates for helpful discussions and contributions to this body of work: M. Berger, N. Schultz, C. Bain, M. Chung, M. Eriksen, T. Liu, R. Mauntz, A. Mich, J. Nguyen, Y. Park, S. Ramani, E. Scott, K. Shashidhar, C. Tom, S. Wen, D. Reales, J. Galle, R. Cambria and members of the Memorial Sloan Kettering Office of Clinical Research. This work was supported by GRAIL and National Institutes of Health awards P30 CA008748 (Memorial Sloan Kettering Cancer Center) and R01 CA234361 (D.B.S.), the Breast Cancer Alliance Young Investigator Award (P.R.), the Breast Cancer Research Foundation (J.S.R.-F.), and Congressionally Directed Medical Research Programs W81XWH-15-1-0547 (J.S.R.-F.) and GC229671 (J.S.R.-F.).	Acuna-Hidalgo R, 2017, AM J HUM GENET, V101, P50, DOI 10.1016/j.ajhg.2017.05.013; Adalsteinsson VA, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00965-y; Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Aravanis AM, 2017, CELL, V168, P571, DOI 10.1016/j.cell.2017.01.030; Armstrong AJ, 2018, JAMA ONCOL, V4, P944, DOI 10.1001/jamaoncol.2018.1093; Bettegowda C, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007094; Bowman RL, 2018, CELL STEM CELL, V22, P157, DOI 10.1016/j.stem.2018.01.011; Busque L, 2018, STEM CELLS, V36, P1287, DOI 10.1002/stem.2845; Carter SL, 2012, NAT BIOTECHNOL, V30, P413, DOI 10.1038/nbt.2203; Chabon JJ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11815; Chang MT, 2018, CANCER DISCOV, V8, P174, DOI 10.1158/2159-8290.CD-17-0321; Cheng DT, 2015, J MOL DIAGN, V17, P251, DOI 10.1016/j.jmoldx.2014.12.006; Choi M, 2009, P NATL ACAD SCI USA, V106, P19096, DOI 10.1073/pnas.0910672106; Cohen JD, 2018, SCIENCE, V359, P926, DOI 10.1126/science.aar3247; Coombs CC, 2017, CELL STEM CELL, V21, P374, DOI 10.1016/j.stem.2017.07.010; Dawson SJ, 2013, NEW ENGL J MED, V368, P1199, DOI 10.1056/NEJMoa1213261; de Bruin EC, 2014, SCIENCE, V346, P251, DOI 10.1126/science.1253462; Diaz LA, 2014, J CLIN ONCOL, V32, P579, DOI 10.1200/JCO.2012.45.2011; Genovese G, 2014, NEW ENGL J MED, V371, P2477, DOI 10.1056/NEJMoa1409405; Gerhauser C, 2018, CANCER CELL, V34, P996, DOI 10.1016/j.ccell.2018.10.016; Gillis NK, 2017, LANCET ONCOL, V18, P112, DOI 10.1016/S1470-2045(16)30627-1; Guibert N, 2018, ANN ONCOL, V29, P1049, DOI 10.1093/annonc/mdy005; Hsu JI, 2018, CELL STEM CELL, V23, P700, DOI 10.1016/j.stem.2018.10.004; Hu YB, 2018, CLIN CANCER RES, V24, P4437, DOI 10.1158/1078-0432.CCR-18-0143; Jaiswal S, 2017, NEW ENGL J MED, V377, P111, DOI 10.1056/NEJMoa1701719; Jaiswal S, 2014, NEW ENGL J MED, V371, P2488, DOI 10.1056/NEJMoa1408617; Jamal-Hanjani M, 2017, NEW ENGL J MED, V376, P2109, DOI 10.1056/NEJMoa1616288; Janku F, 2017, CLIN CANCER RES, V23, P5648, DOI 10.1158/1078-0432.CCR-17-0291; Kandoth C, 2013, NATURE, V502, P333, DOI 10.1038/nature12634; Kinde I, 2011, P NATL ACAD SCI USA, V108, P9530, DOI 10.1073/pnas.1105422108; Lanman RB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140712; Le DT, 2015, NEW ENGL J MED, V372, P2509, DOI 10.1056/NEJMoa1500596; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; LEON SA, 1977, CANCER RES, V37, P646; Liu J, 2019, ANN ONCOL, V30, P464, DOI 10.1093/annonc/mdy513; Mansukhani S, 2018, CLIN CHEM, V64, P1626, DOI 10.1373/clinchem.2018.289629; Merker JD, 2018, ARCH PATHOL LAB MED, V142, P1242, DOI 10.5858/arpa.2018-0901-SA; Murtaza M, 2013, NATURE, V497, P108, DOI 10.1038/nature12065; Newman AM, 2016, NAT BIOTECHNOL, V34, P547, DOI 10.1038/nbt.3520; Nik-Zainal S, 2016, NATURE, V534, P47, DOI 10.1038/nature17676; Niu BF, 2014, BIOINFORMATICS, V30, P1015, DOI 10.1093/bioinformatics/btt755; Parikh AR, 2019, NAT MED, V25, P1415, DOI 10.1038/s41591-019-0561-9; Phallen J, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aan2415; Polak P, 2017, NAT GENET, V49, P1476, DOI 10.1038/ng.3934; Przybyl J, 2018, CLIN CANCER RES, V24, P2688, DOI 10.1158/1078-0432.CCR-17-3704; Razavi P, 2018, CANCER CELL, V34, P427, DOI 10.1016/j.ccell.2018.08.008; Risques RA, 2018, PLOS GENET, V14, DOI 10.1371/journal.pgen.1007108; Rosenthal R, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0893-4; Rothwell DG, 2019, NAT MED, V25, P738, DOI 10.1038/s41591-019-0380-z; Sacher AG, 2016, JAMA ONCOL, V2, P1014, DOI 10.1001/jamaoncol.2016.0173; Schultheis AM, 2016, JNCI-J NATL CANCER I, V108, DOI 10.1093/jnci/djv427; Shen RL, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkw520; Steensma DP, 2015, BLOOD, V126, P9, DOI 10.1182/blood-2015-03-631747; STROUN M, 1987, EUR J CANCER CLIN ON, V23, P707, DOI 10.1016/0277-5379(87)90266-5; Swanton C, 2018, J CLIN ONCOL, V36, DOI 10.1200/JCO.2018.36.15_suppl.12003; Tamborero D, 2013, BIOINFORMATICS, V29, P2238, DOI 10.1093/bioinformatics/btt395; Thompson JC, 2016, CLIN CANCER RES, V22, P5772, DOI 10.1158/1078-0432.CCR-16-1231; Ulmert D, 2012, EUR UROL, V62, P78, DOI 10.1016/j.eururo.2012.01.037; Wan JCM, 2017, NAT REV CANCER, V17, P223, DOI 10.1038/nrc.2017.7; Xie MC, 2014, NAT MED, V20, P1472, DOI 10.1038/nm.3733; Young AL, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12484; Zehir A, 2017, NAT MED, V23, P703, DOI 10.1038/nm.4333; Zink F, 2017, BLOOD, V130, P742, DOI 10.1182/blood-2017-02-769869	63	301	313	9	42	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	2019	25	12					1928	+		10.1038/s41591-019-0652-7	http://dx.doi.org/10.1038/s41591-019-0652-7			27	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	JT2KO	31768066	Green Accepted			2022-12-27	WOS:000500824900036
J	Gu, W; Deng, XD; Lee, M; Sucu, YD; Arevalo, S; Stryke, D; Federman, S; Gopez, A; Reyes, K; Zorn, K; Sample, H; Yu, GX; Ishpuniani, G; Briggs, B; Chow, ED; Berger, A; Wilson, MR; Wang, C; Hsu, E; Miller, S; DeRisi, JL; Chiu, CY				Gu, Wei; Deng, Xianding; Lee, Marco; Sucu, Yasemin D.; Arevalo, Shaun; Stryke, Doug; Federman, Scot; Gopez, Allan; Reyes, Kevin; Zorn, Kelsey; Sample, Hannah; Yu, Guixia; Ishpuniani, Gurpreet; Briggs, Benjamin; Chow, Eric D.; Berger, Amy; Wilson, Michael R.; Wang, Candace; Hsu, Elaine; Miller, Steve; DeRisi, Joseph L.; Chiu, Charles Y.			Rapid pathogen detection by metagenomic next-generation sequencing of infected body fluids	NATURE MEDICINE			English	Article							IN-HOSPITAL MORTALITY; CELL-FREE DNA; ANTIMICROBIAL THERAPY; BACTERIAL-MENINGITIS; HUMAN VIROME; REAL-TIME; IDENTIFICATION; DIAGNOSIS; DURATION	We developed a metagenomic next-generation sequencing (mNGS) test using cell-free DNA from body fluids to identify pathogens. The performance of mNGS testing of 182 body fluids from 160 patients with acute illness was evaluated using two sequencing platforms in comparison to microbiological testing using culture, 16S bacterial PCR and/or 28S-internal transcribed ribosomal gene spacer (28S-ITS) fungal PCR. Test sensitivity and specificity of detection were 79 and 91% for bacteria and 91 and 89% for fungi, respectively, by Illumina sequencing; and 75 and 81% for bacteria and 91 and 100% for fungi, respectively, by nanopore sequencing. In a case series of 12 patients with culture/PCR-negative body fluids but for whom an infectious diagnosis was ultimately established, seven (58%) were mNGS positive. Real-time computational analysis enabled pathogen identification by nanopore sequencing in a median 50-min sequencing and 6-h sample-to-answer time. Rapid mNGS testing is a promising tool for diagnosis of unknown infections from body fluids. A universal method enables high-specificity, unbiased pathogen detection from diverse body fluids using metagenomic sequencing and may accelerate clinical decisions.	[Gu, Wei; Deng, Xianding; Sucu, Yasemin D.; Arevalo, Shaun; Stryke, Doug; Federman, Scot; Gopez, Allan; Reyes, Kevin; Yu, Guixia; Ishpuniani, Gurpreet; Briggs, Benjamin; Wang, Candace; Hsu, Elaine; Miller, Steve; Chiu, Charles Y.] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA; [Gu, Wei; Deng, Xianding; Sucu, Yasemin D.; Arevalo, Shaun; Stryke, Doug; Federman, Scot; Gopez, Allan; Reyes, Kevin; Yu, Guixia; Ishpuniani, Gurpreet; Briggs, Benjamin; Wang, Candace; Miller, Steve; Chiu, Charles Y.] UCSF Abbott Viral Diagnost & Discovery Ctr, San Francisco, CA 94143 USA; [Lee, Marco] Leeds Teaching Hosp NHS Trust, Leeds, W Yorkshire, England; [Zorn, Kelsey; Sample, Hannah; Chow, Eric D.; DeRisi, Joseph L.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA USA; [Berger, Amy] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Wilson, Michael R.] Univ Calif San Francisco, Weill Inst Neurosci, San Francisco, CA 94143 USA; [Wilson, Michael R.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA USA; [DeRisi, Joseph L.] Chan Zuckerberg Biohub, San Francisco, CA USA; [Chiu, Charles Y.] Univ Calif San Francisco, Dept Med, Div Infect Dis, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of Leeds; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Chiu, CY (corresponding author), Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA.; Chiu, CY (corresponding author), UCSF Abbott Viral Diagnost & Discovery Ctr, San Francisco, CA 94143 USA.; Chiu, CY (corresponding author), Univ Calif San Francisco, Dept Med, Div Infect Dis, San Francisco, CA 94143 USA.	charles.chiu@ucsf.edu		Gu, Wei/0000-0002-2480-6645; Wang, Candace/0000-0002-4678-7860; Zorn, Kelsey/0000-0003-1227-2137; Reyes, Kevin/0000-0003-3708-444X; Wilson, Michael/0000-0002-8705-5084	NIH [K08-CA230156]; Burroughs-Wellcome Award; Abbott Laboratories; NIH/NHLBI grant [R01-HL105704]; NIH/NIAID [R33-AI120977]; California Initiative to Advance Precision Medicine; UC Center for Accelerated Innovation - NIH [U54HL119893]; NIH/NCATS UCSF-CTSI [UL1TR000004]; Charles and Helen Schwab Foundation	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs-Wellcome Award(Burroughs Wellcome Fund); Abbott Laboratories(Abbott Laboratories); NIH/NHLBI grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); California Initiative to Advance Precision Medicine; UC Center for Accelerated Innovation - NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/NCATS UCSF-CTSI; Charles and Helen Schwab Foundation	We thank H. Reyes, A. Chan, D. Ingebrigtsen, L. Dang, W. Lorizio, J. Streithorst, B. Fung and the UCSF clinical laboratory staff for assistance with orthogonal testing. We thank R. Da for assistance with sequencing runs. We thank S. Shiboski for biostatistics feedback. We thank members of the Chiu, Miller and DeRisi laboratories for feedback and support. This work was funded in part by an NIH grant (no. K08-CA230156) and a Burroughs-Wellcome Award to W.G., by Abbott Laboratories (C.Y.C.), a NIH/NHLBI grant (no. R01-HL105704, to C.Y.C.), a NIH/NIAID grant (no. R33-AI120977, to C.Y.C.), the California Initiative to Advance Precision Medicine (C.Y.C.), a UC Center for Accelerated Innovation grant funded by NIH grant U54HL119893 and NIH/NCATS UCSF-CTSI grant UL1TR000004 (C.Y.C.), and the Charles and Helen Schwab Foundation (C.Y.C.).	Abril MK, 2016, OPEN FORUM INFECT DI, V3, DOI 10.1093/ofid/ofw144; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; [Anonymous], 2013, JAMA-J AM MED ASSOC, V310, P2191, DOI [DOI 10.1001/JAMA.2013.281053, 10.1001/jama.2013.281053]; Blauwkamp TA, 2019, NAT MICROBIOL, V4, P663, DOI 10.1038/s41564-018-0349-6; Burnham P, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04745-0; Chan KCA, 2003, CANCER RES, V63, P2028; Charalampous T, 2019, NAT BIOTECHNOL, V37, P783, DOI 10.1038/s41587-019-0156-5; Chiu CY, 2019, NAT REV GENET, V20, P341, DOI 10.1038/s41576-019-0113-7; Corless CE, 2000, J CLIN MICROBIOL, V38, P1747, DOI 10.1128/JCM.38.5.1747-1752.2000; Costales C, 2018, J CLIN MICROBIOL, V56, DOI 10.1128/JCM.01358-17; De Mattos-Arruda L, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9839; De Vlaminck I, 2013, CELL, V155, P1178, DOI 10.1016/j.cell.2013.10.034; Deng XD, 2020, NAT MICROBIOL, V5, P443, DOI 10.1038/s41564-019-0637-9; Dudley JC, 2019, CANCER DISCOV, V9, P500, DOI 10.1158/2159-8290.CD-18-0825; Fan HC, 2010, CLIN CHEM, V56, P1279, DOI 10.1373/clinchem.2010.144188; Faria NR, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0356-2; Focosi D, 2016, CLIN MICROBIOL INFEC, V22, P589, DOI 10.1016/j.cmi.2016.04.007; Glimaker M, 2015, CLIN INFECT DIS, V60, P1162, DOI 10.1093/cid/civ011; Greninger AL, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0235-2; Greninger AL, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0220-9; Grumaz S, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0326-8; Gu W, 2019, ANNU REV PATHOL-MECH, V14, P319, DOI 10.1146/annurev-pathmechdis-012418-012751; Hoggard M, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.02208; Ivy MI, 2018, J CLIN MICROBIOL, V56, DOI [10.1128/JCM.00402-18, 10.1128/jcm.00402-18]; Janda JM, 2007, J CLIN MICROBIOL, V45, P2761, DOI 10.1128/JCM.01228-07; Kafetzopoulou LE, 2019, SCIENCE, V363, P74, DOI 10.1126/science.aau9343; Klindworth A, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks808; Kumar A, 2006, CRIT CARE MED, V34, P1589, DOI 10.1097/01.CCM.0000217961.75225.E9; Langelier C, 2018, P NATL ACAD SCI USA, V115, pE12353, DOI 10.1073/pnas.1809700115; Leo S, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18092011; Llor C, 2014, THER ADV DRUG SAF, V5, P229, DOI 10.1177/2042098614554919; Long Y, 2016, ARCH MED RES, V47, P365, DOI 10.1016/j.arcmed.2016.08.004; Lucas MJ, 2016, J INFECTION, V73, P18, DOI 10.1016/j.jinf.2016.04.009; McGill F, 2016, LANCET, V388, P3036, DOI 10.1016/S0140-6736(16)30654-7; McIntyre ABR, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1299-7; Messacar K, 2017, J CLIN MICROBIOL, V55, P715, DOI 10.1128/JCM.02264-16; Miller S, 2019, GENOME RES, V29, P831, DOI 10.1101/gr.238170.118; Mongkolrattanothai K, 2017, J PEDIATR INFECT DIS, V6, P393, DOI 10.1093/jpids/piw066; Naccache SN, 2014, GENOME RES, V24, P1180, DOI 10.1101/gr.171934.113; Pan WY, 2015, CLIN CHEM, V61, P514, DOI 10.1373/clinchem.2014.235457; Petti CA, 2005, J CLIN MICROBIOL, V43, P6123, DOI 10.1128/JCM.43.12.6123-6125.2005; Quick J, 2016, NATURE, V530, P228, DOI 10.1038/nature16996; Raith EP, 2017, JAMA-J AM MED ASSOC, V317, P290, DOI 10.1001/jama.2016.20328; Rea B, 2019, AM J CLIN PATHOL, V151, P63, DOI 10.1093/ajcp/aqy086; Reuwer AQ, 2019, J APPL MICROBIOL, V126, P661, DOI 10.1111/jam.14156; Salipante SJ, 2014, APPL ENVIRON MICROB, V80, P7583, DOI 10.1128/AEM.02206-14; Sardi SI, 2016, J CLIN MICROBIOL, V54, P2348, DOI 10.1128/JCM.00877-16; Schlaberg R, 2017, J INFECT DIS, V215, P1407, DOI 10.1093/infdis/jix148; Schlaberg R, 2017, ARCH PATHOL LAB MED, V141, P776, DOI 10.5858/arpa.2016-0539-RA; Schmidt K, 2017, J ANTIMICROB CHEMOTH, V72, P104, DOI 10.1093/jac/dkw397; Simner PJ, 2018, CLIN INFECT DIS, V66, P778, DOI 10.1093/cid/cix881; Singal AK, 2014, ALIMENT PHARM THER, V40, P105, DOI 10.1111/apt.12797; Springer SU, 2018, ELIFE, V7, DOI 10.7554/eLife.32143; Strain MC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055943; Taylor SC, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02217-x; Thoendel MJ, 2018, CLIN INFECT DIS, V67, P1333, DOI 10.1093/cid/ciy303; Wang YX, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aap8793; Weiss SL, 2014, CRIT CARE MED, V42, P2409, DOI 10.1097/CCM.0000000000000509; Wilson MR, 2019, NEW ENGL J MED, V380, P2327, DOI 10.1056/NEJMoa1803396; Wilson MR, 2018, JAMA NEUROL, V75, P947, DOI 10.1001/jamaneurol.2018.0463; Wilson MR, 2015, ANN NEUROL, V78, P722, DOI 10.1002/ana.24499; Wilson MR, 2014, NEW ENGL J MED, V370, P2408, DOI 10.1056/NEJMoa1401268; Zaharia M, 2011, ARXIV, p1111.5572; Zhang HJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006108; Zinter MS, 2019, MICROBIOME, V7, DOI 10.1186/s40168-019-0678-6	65	135	143	12	71	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	JAN	2021	27	1					115	+		10.1038/s41591-020-1105-z	http://dx.doi.org/10.1038/s41591-020-1105-z		NOV 2020	26	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	PS4ZO	33169017	Green Accepted			2022-12-27	WOS:000588007500001
J	Motzer, RJ; Robbins, PB; Powles, T; Albiges, L; Haanen, JB; Larkin, J; Mu, XJ; Ching, KA; Uemura, M; Pal, SK; Alekseev, B; Gravis, G; Campbell, MT; Penkov, K; Lee, JL; Hariharan, S; Wang, X; Zhang, WD; Wang, J; Chudnovsky, A; di Pietro, A; Donahue, AC; Choueiri, TK				Motzer, Robert J.; Robbins, Paul B.; Powles, Thomas; Albiges, Laurence; Haanen, John B.; Larkin, James; Mu, Xinmeng Jasmine; Ching, Keith A.; Uemura, Motohide; Pal, Sumanta K.; Alekseev, Boris; Gravis, Gwenaelle; Campbell, Matthew T.; Penkov, Konstantin; Lee, Jae Lyun; Hariharan, Subramanian; Wang, Xiao; Zhang, Weidong; Wang, Jing; Chudnovsky, Aleksander; di Pietro, Alessandra; Donahue, Amber C.; Choueiri, Toni K.			Avelumab plus axitinib versus sunitinib in advanced renal cell carcinoma: biomarker analysis of the phase 3 JAVELIN Renal 101 trial	NATURE MEDICINE			English	Article							TUMOR; CANCER; EXPRESSION; LANDSCAPE	We report on molecular analyses of baseline tumor samples from the phase 3 JAVELIN Renal 101 trial (n = 886; NCT02684006), which demonstrated significantly prolonged progression-free survival (PFS) with first-line avelumab + axitinib versus sunitinib in advanced renal cell carcinoma (aRCC). We found that neither expression of the commonly assessed biomarker programmed cell death ligand 1 (PD-L1) nor tumor mutational burden differentiated PFS in either study arm. Similarly, the presence of Fc gamma R single nucleotide polymorphisms was unimpactful. We identified important biological features associated with differential PFS between the treatment arms, including new immunomodulatory and angiogenesis gene expression signatures (GESs), previously undescribed mutational profiles and their corresponding GESs, and several HLA types. These findings provide insight into the determinants of response to combined PD-1/PD-L1 and angiogenic pathway inhibition and may aid in the development of strategies for improved patient care in aRCC.	[Motzer, Robert J.] Mem Sloan Kettering Canc Ctr, Dept Med Oncol, 1275 York Ave, New York, NY 10021 USA; [Robbins, Paul B.] Pfizer, Translat Oncol, San Diego, CA USA; [Powles, Thomas] Queen Mary Univ London, St Bartholomews Hosp, Dept Genitourinary Oncol, Barts Canc Inst,Expt Canc Med Ctr, London, England; [Albiges, Laurence] Inst Gustave Roussy, Dept Med Oncol, Villejuif, France; [Haanen, John B.] Netherlands Canc Inst, Div Med Oncol, Amsterdam, Netherlands; [Larkin, James] Royal Marsden NHS Fdn Trust, London, England; [Mu, Xinmeng Jasmine; Ching, Keith A.; Wang, Xiao] Pfizer, Computat Biol, San Diego, CA USA; [Uemura, Motohide] Osaka Univ Hosp, Grad Sch Med, Osaka, Japan; [Pal, Sumanta K.] City Hope Comprehens Canc Ctr, Dept Med Oncol, Duarte, CA USA; [Alekseev, Boris] Moscow Sci Res Oncol Inst, Sci, Moscow, Russia; [Gravis, Gwenaelle] Inst Paoli Calmettes, Dept Med Oncol, Marseille, France; [Campbell, Matthew T.] Univ Texas MD Anderson Canc Ctr, Dept Genitourinary Med Oncol, Houston, TX 77030 USA; [Penkov, Konstantin] Euromedserv, Private Med Inst, St Petersburg, Russia; [Lee, Jae Lyun] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Oncol, Seoul, South Korea; [Hariharan, Subramanian] Pfizer, Oncol, New York, NY USA; [Zhang, Weidong; Wang, Jing] Pfizer, Biostat, Cambridge, MA USA; [Chudnovsky, Aleksander] Pfizer, Oncol, Cambridge, MA USA; [di Pietro, Alessandra] Pfizer, Immunooncol, Milan, Italy; [Donahue, Amber C.] Pfizer, Translat Oncol, La Jolla, CA USA; [Choueiri, Toni K.] Dana Farber Canc Inst, Dept Med Oncol, Lank Ctr Genitourinary Oncol, Boston, MA 02115 USA; [Choueiri, Toni K.] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA; [Wang, Xiao] Lyell Immunopharma, San Francisco, CA USA; [Zhang, Weidong] Jounce Therapeut, Cambridge, MA USA; [Chudnovsky, Aleksander] Ipsen, Cambridge, MA USA	Memorial Sloan Kettering Cancer Center; Pfizer; University of London; Queen Mary University London; UNICANCER; Gustave Roussy; Netherlands Cancer Institute; Royal Marsden NHS Foundation Trust; Pfizer; Osaka University; City of Hope; UNICANCER; Institut Paoli-Calmette (IPC); University of Texas System; UTMD Anderson Cancer Center; University of Ulsan; Asan Medical Center; Pfizer; Pfizer; Pfizer; Pfizer; Pfizer; Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital	Motzer, RJ (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Med Oncol, 1275 York Ave, New York, NY 10021 USA.; Choueiri, TK (corresponding author), Dana Farber Canc Inst, Dept Med Oncol, Lank Ctr Genitourinary Oncol, Boston, MA 02115 USA.; Choueiri, TK (corresponding author), Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA.	motzerr@mskcc.org; toni_choueiri@dfci.harvard.edu	uemura, motohide/G-6101-2011; Choueiri, Toni/K-5238-2019; Haanen, John/AAD-8578-2022; Gravis, Gwenaelle/CAG-3019-2022; Haanen, John/AAD-8534-2022; Alekseev, Boris/O-1008-2017	Choueiri, Toni/0000-0002-9201-3217; Gravis, Gwenaelle/0000-0002-3127-1554; Haanen, John/0000-0001-5884-7704; Alekseev, Boris/0000-0002-3398-4128; Larkin, James/0000-0001-5569-9523	Pfizer; MSKCC Support Grant/Core Grant [P30 CA008748]; Merck (Darmstadt, Germany)	Pfizer(Pfizer); MSKCC Support Grant/Core Grant; Merck (Darmstadt, Germany)(Merck & Company)	The trial was sponsored by Pfizer and is part of an alliance between Pfizer and Merck (Darmstadt, Germany), who provided the study drugs. The investigators worked with Pfizer on the trial design, collection and analysis of data and interpretation of results. Datasets were reviewed by the authors, and all authors participated fully in developing and reviewing the report for publication. Funding for a professional medical writer with access to the data was provided by the sponsors. All authors had full access to all data, and the first author had final responsibility for the decision to submit for publication. The authors vouch for the completeness and accuracy of the data and its analysis, and the fidelity of the trial to the protocol and statistical analysis plan. The authors thank the patients and their families and the investigators, coinvestigators and study teams at each of the participating centers. The authors also thank R.-Y. Tzeng, D. Eleuteri, E. Conley and J. Imus for their assistance with programming and Y. Waumans, K. Marien and D. Peeters from Histogenex. Patients treated at MSKCC were supported in part by a MSKCC Support Grant/Core Grant (P30 CA008748). Medical writing support was provided by S. Rosebeck of ClinicalThinking and funded by Pfizer and Merck (Darmstadt, Germany).	ANDERSEN PK, 1982, ANN STAT, V10, P1100, DOI 10.1214/aos/1176345976; Ayers M, 2017, J CLIN INVEST, V127, P2930, DOI 10.1172/JCI91190; Barnes TA, 2017, BRIT J CANCER, V117, P451, DOI 10.1038/bjc.2017.220; Brauer MJ, 2013, CLIN CANCER RES, V19, P3681, DOI 10.1158/1078-0432.CCR-12-3635; Chew GL, 2019, DEV CELL, V50, P658, DOI 10.1016/j.devcel.2019.06.011; CHOUEIRI TK, 2019, J CLIN ONCOL S, V37; Choueiri TK, 2018, LANCET ONCOL, V19, P451, DOI 10.1016/S1470-2045(18)30107-4; Choueiri TK, 2016, CLIN CANCER RES, V22, P5461, DOI 10.1158/1078-0432.CCR-15-2839; Choueiri TK, 2015, CLIN CANCER RES, V21, P1071, DOI 10.1158/1078-0432.CCR-14-1993; Coates CJ, 2017, CELL MOL LIFE SCI, V74, P293, DOI 10.1007/s00018-016-2326-7; Creighton CJ, 2013, NATURE, V499, P43, DOI 10.1038/nature12222; Crompton BD, 2014, CANCER DISCOV, V4, P1326, DOI 10.1158/2159-8290.CD-13-1037; Fehrenbacher L, 2016, LANCET, V387, P1837, DOI 10.1016/S0140-6736(16)00587-0; Geng LN, 2012, DEV CELL, V22, P38, DOI 10.1016/j.devcel.2011.11.013; Grobner SN, 2018, NATURE, V555, P321, DOI 10.1038/nature25480; Ha H, 2017, THERANOSTICS, V7, P1543, DOI 10.7150/thno.15625; Heery CR, 2017, LANCET ONCOL, V18, P587, DOI 10.1016/S1470-2045(17)30239-5; Hubler MJ, 2016, J NUTR BIOCHEM, V34, P1, DOI 10.1016/j.jnutbio.2015.11.002; Hugo W, 2016, CELL, V165, P35, DOI 10.1016/j.cell.2016.02.065; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Liberzon A, 2015, CELL SYST, V1, P417, DOI 10.1016/j.cels.2015.12.004; Liberzon A, 2011, BIOINFORMATICS, V27, P1739, DOI 10.1093/bioinformatics/btr260; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Masiero M, 2013, CANCER CELL, V24, P229, DOI 10.1016/j.ccr.2013.06.004; McDermott DF, 2018, NAT MED, V24, P749, DOI 10.1038/s41591-018-0053-3; Motzer RJ, 2018, NEW ENGL J MED, V378, P1277, DOI 10.1056/NEJMoa1712126; Motzer RJ, 2019, NEW ENGL J MED, V380, P1103, DOI 10.1056/NEJMoa1816047; Nakano O, 2001, CANCER RES, V61, P5132; Newman AM, 2015, NAT METHODS, V12, P453, DOI [10.1038/nmeth.3337, 10.1038/NMETH.3337]; Oberg JA, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0389-6; Powles T, 2015, J IMMUNOTHER CANC S2, V3, pP83; Riaz N, 2017, CELL, V171, P934, DOI 10.1016/j.cell.2017.09.028; Ribas A, 2015, CANCER DISCOV, V5, P915, DOI 10.1158/2159-8290.CD-15-0563; Rini BI, 2019, NEW ENGL J MED, V380, P1116, DOI 10.1056/NEJMoa1816714; Robinson G, 2012, NATURE, V488, P43, DOI 10.1038/nature11213; Roland CL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007669; Russo L, 2018, J CLIN ONCOL, V36, DOI 10.1200/JCO.2018.36.15_suppl.e13603; Scheller J, 2011, BBA-MOL CELL RES, V1813, P878, DOI 10.1016/j.bbamcr.2011.01.034; Sharma V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064691; Smith KGC, 2010, NAT REV IMMUNOL, V10, P674, DOI 10.1038/nri2762; Szolek A, 2014, BIOINFORMATICS, V30, P3310, DOI 10.1093/bioinformatics/btu548; Therneau T.M., 2000, MODELING SURVIVAL DA; Zelenay S, 2015, CELL, V162, P1257, DOI 10.1016/j.cell.2015.08.015; Zou H, 2005, J R STAT SOC B, V67, P301, DOI 10.1111/j.1467-9868.2005.00503.x	44	148	150	1	11	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2020	26	11					1733	+		10.1038/s41591-020-1044-8	http://dx.doi.org/10.1038/s41591-020-1044-8		SEP 2020	22	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	OT0SR	32895571	Green Accepted			2022-12-27	WOS:000566880900002
J	Juno, JA; Tan, HX; Lee, WS; Reynaldi, A; Kelly, HG; Wragg, K; Esterbauer, R; Kent, HE; Batten, CJ; Mordant, FL; Gherardin, NA; Pymm, P; Dietrich, MH; Scott, NE; Tham, WH; Godfrey, DI; Subbarao, K; Davenport, MP; Kent, SJ; Wheatley, AK				Juno, Jennifer A.; Tan, Hyon-Xhi; Lee, Wen Shi; Reynaldi, Arnold; Kelly, Hannah G.; Wragg, Kathleen; Esterbauer, Robyn; Kent, Helen E.; Batten, C. Jane; Mordant, Francesca L.; Gherardin, Nicholas A.; Pymm, Phillip; Dietrich, Melanie H.; Scott, Nichollas E.; Tham, Wai-Hong; Godfrey, Dale, I; Subbarao, Kanta; Davenport, Miles P.; Kent, Stephen J.; Wheatley, Adam K.			Humoral and circulating follicular helper T cell responses in recovered patients with COVID-19	NATURE MEDICINE			English	Article							RESPIRATORY SYNDROME CORONAVIRUS; NEUTRALIZING ANTIBODIES; SARS-COV-2	The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic has dramatically expedited global vaccine development efforts(1-3), most targeting the viral 'spike' glycoprotein (S). S localizes on the virion surface and mediates recognition of cellular receptor angiotensin-converting enzyme 2 (ACE2)(4-6). Eliciting neutralizing antibodies that block S-ACE2 interaction(7-9), or indirectly prevent membrane fusion(10), constitute an attractive modality for vaccine-elicited protection(11). However, although prototypic S-based vaccines show promise in animal models(12-14), the immunogenic properties of S in humans are poorly resolved. In this study, we characterized humoral and circulating follicular helper T cell (cTFH) immunity against spike in recovered patients with coronavirus disease 2019 (COVID-19). We found that S-specific antibodies, memory B cells and cTFH are consistently elicited after SARS-CoV-2 infection, demarking robust humoral immunity and positively associated with plasma neutralizing activity. Comparatively low frequencies of B cells or cTFH specific for the receptor binding domain of S were elicited. Notably, the phenotype of S-specific cTFH differentiated subjects with potent neutralizing responses, providing a potential biomarker of potency for S-based vaccines entering the clinic. Overall, although patients who recovered from COVID-19 displayed multiple hallmarks of effective immune recognition of S, the wide spectrum of neutralizing activity observed suggests that vaccines might require strategies to selectively target the most potent neutralizing epitopes. In a cohort of recovered patients with COVID-19, virus spike-specific antibodies were consistently elicited, but neutralizing activity was highly variable and inversely correlated with the proportion of CCR6(+)CXCR3(-)spike-specific circulating follicular helper T cells.	[Juno, Jennifer A.; Tan, Hyon-Xhi; Lee, Wen Shi; Kelly, Hannah G.; Wragg, Kathleen; Esterbauer, Robyn; Kent, Helen E.; Batten, C. Jane; Mordant, Francesca L.; Gherardin, Nicholas A.; Scott, Nichollas E.; Godfrey, Dale, I; Subbarao, Kanta; Kent, Stephen J.; Wheatley, Adam K.] Univ Melbourne, Peter Doherty Inst Infect & Immun, Dept Microbiol & Immunol, Melbourne, Vic, Australia; [Reynaldi, Arnold; Davenport, Miles P.] Univ New South Wales, Kirby Inst, Kensington, NSW, Australia; [Kelly, Hannah G.; Esterbauer, Robyn; Kent, Stephen J.; Wheatley, Adam K.] Univ Melbourne, Australian Res Council Ctr Excellence Convergent, Melbourne, Vic, Australia; [Kent, Helen E.; Kent, Stephen J.] Monash Univ, Alfred Hosp, Melbourne Sexual Hlth Ctr, Melbourne, Vic, Australia; [Kent, Helen E.; Kent, Stephen J.] Monash Univ, Alfred Hosp, Dept Infect Dis, Melbourne, Vic, Australia; [Kent, Helen E.; Kent, Stephen J.] Monash Univ, Cent Clin Sch, Melbourne, Vic, Australia; [Gherardin, Nicholas A.; Godfrey, Dale, I] Univ Melbourne, Australian Res Council Ctr Excellence Adv Mol Ima, Melbourne, Vic, Australia; [Pymm, Phillip; Dietrich, Melanie H.; Tham, Wai-Hong] Walter & Eliza Hall Inst Med Res, Parkville, Vic, Australia; [Pymm, Phillip; Dietrich, Melanie H.] Univ Melbourne, Dept Med Biol, Melbourne, Vic, Australia; [Subbarao, Kanta] Peter Doherty Inst Infect & Immun, WHO Collaborating Ctr Reference & Res Influenza, Melbourne, Vic, Australia	University of Melbourne; University of New South Wales Sydney; Kirby Institute; University of Melbourne; Florey Institute of Neuroscience & Mental Health; Monash University; Florey Institute of Neuroscience & Mental Health; Monash University; Monash University; University of Melbourne; Walter & Eliza Hall Institute; University of Melbourne; World Health Organization	Kent, SJ; Wheatley, AK (corresponding author), Univ Melbourne, Peter Doherty Inst Infect & Immun, Dept Microbiol & Immunol, Melbourne, Vic, Australia.; Kent, SJ; Wheatley, AK (corresponding author), Univ Melbourne, Australian Res Council Ctr Excellence Convergent, Melbourne, Vic, Australia.	skent@unimelb.edu.au; awheatley@unimelb.edu.au	Lee, Wen Shi/AAQ-9937-2021; Juno, Jennifer/AAK-9930-2021; Tham, Wai-Hong/L-3173-2018	Lee, Wen Shi/0000-0001-7285-4054; Juno, Jennifer/0000-0002-9072-1017; Mordant, Francesca/0000-0002-3754-2642; Batten, Caroline/0000-0003-2691-9915; Esterbauer, Robyn/0000-0002-7091-0048; Kelly, Hannah/0000-0002-4652-5609; Tan, Hyon Xhi/0000-0003-1064-3934; Davenport, Miles/0000-0002-4751-1831; Tham, Wai-Hong/0000-0001-7950-8699; Kent, Stephen/0000-0002-8539-4891; Pymm, Phillip/0000-0003-2722-4621	Victorian Government; Medical Research Future Fund (MRFF) [GNT2002073]; ARC Centre of Excellence in Convergent Bio-Nano Science and Technology; National Health and Medical Research Council (NHMRC) [APP1149990]; NHMRC [GNT1162760]; Jack Ma Foundation; A2 Milk Company; Howard Hughes Medical Institute-Wellcome Trust International Research Scholar [208693/Z/17/Z]; Australian Government Department of Health	Victorian Government; Medical Research Future Fund (MRFF)(Medical Research Future Fund (MRFF)); ARC Centre of Excellence in Convergent Bio-Nano Science and Technology(Australian Research Council); National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Jack Ma Foundation; A2 Milk Company; Howard Hughes Medical Institute-Wellcome Trust International Research Scholar; Australian Government Department of Health(Australian GovernmentDepartment of Health & Ageing)	We thank the generous participation of the trial individuals for providing samples. The SARS-CoV-2 RBD expression plasmids were kindly provided by F. Krammer (Icahn School of Medicine at Mt. Sinai). The human and mouse ACE2 expression plasmids were kindly provided by M. Thomas (Monash University). We acknowledge V. Jameson and staff at the Melbourne Cytometry Platform (Melbourne Brain Centre node) for provision of flow cytometry services. We thank the Melbourne Mass Spectrometry and Proteomics Facility of the Bio21 Molecular Science and Biotechnology Institute at the University of Melbourne for the support of mass spectrometry analysis. This study was supported by the Victorian Government and Medical Research Future Fund (MRFF) GNT2002073 (to W.-H.T., D.I.G., M.P.D., S.J.K. and A.K.W.), the ARC Centre of Excellence in Convergent Bio-Nano Science and Technology (to S.J.K.), National Health and Medical Research Council (NHMRC) program grant APP1149990 (to S.J.K. and M.P.D.), NHMRC project grant GNT1162760 (to A.K.W), the Jack Ma Foundation (to D.I.G., N.A.G. and K.S.) and the A2 Milk Company (to K.S.). W-H.T. is a Howard Hughes Medical Institute-Wellcome Trust International Research Scholar (208693/Z/17/Z). J.A.J., D.I.G., M.P.D., W.-H.T., S.J.K. and A.K.W. are supported by NHMRC fellowships. The Melbourne WHO Collaborating Centre for Reference and Research on Influenza is supported by the Australian Government Department of Health.	Amanat F, 2020, NAT MED, V26, P1033, DOI [10.1101/2020.03.17.20037713, 10.1038/s41591-020-0913-5]; Amanat F, 2020, IMMUNITY, V52, P583, DOI 10.1016/j.immuni.2020.03.007; Bentebibel SE, 2016, SCI REP-UK, V6, DOI 10.1038/srep26494; Bentebibel SE, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005191; Bern Marshall, 2012, Curr Protoc Bioinformatics, VChapter 13, DOI 10.1002/0471250953.bi1320s40; Braun J., 2020, PRESENCE SARS COV 2, DOI [DOI 10.1101/2020.04.17.20061440, 10.1101/2020.04.17.20061440]; Brenna E, 2020, CELL REP, V30, P137, DOI 10.1016/j.celrep.2019.12.016; Brochet X, 2008, NUCLEIC ACIDS RES, V36, pW503, DOI 10.1093/nar/gkn316; Brouwer PJM, 2020, SCIENCE, V369, P643, DOI 10.1126/science.abc5902; Caly L, 2020, MED J AUSTRALIA, V212, P459, DOI 10.5694/mja2.50569; Cao YL, 2020, CELL, V182, P73, DOI 10.1016/j.cell.2020.05.025; Crotty S, 2019, IMMUNITY, V50, P1132, DOI 10.1016/j.immuni.2019.04.011; Dan JM, 2016, J IMMUNOL, V197, P983, DOI 10.4049/jimmunol.1600318; Farooq F, 2016, SCI REP-UK, V6, DOI 10.1038/srep27944; Gao Q, 2020, SCIENCE, V369, P77, DOI 10.1126/science.abc1932; Godoy-Lozano EE, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0276-1; Grifoni A, 2020, CELL, V181, P1489, DOI 10.1016/j.cell.2020.05.015; Hoffmann M, 2020, CELL, V181, P271, DOI 10.1016/j.cell.2020.02.052; Houser KV, 2016, J INFECT DIS, V213, P1557, DOI 10.1093/infdis/jiw080; Hughes CS, 2019, NAT PROTOC, V14, P68, DOI 10.1038/s41596-018-0082-x; Jiang SB, 2020, TRENDS IMMUNOL, V41, P355, DOI 10.1016/j.it.2020.03.007; Koutsakos M, 2019, J IMMUNOL, V202, P360, DOI 10.4049/jimmunol.1800986; Koutsakos M, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aan8405; Lan J, 2020, NATURE, V581, P215, DOI 10.1038/s41586-020-2180-5; Lau D, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aai8153; Lee LY, 2016, J PROTEOME RES, V15, P3904, DOI 10.1021/acs.jproteome.6b00438; Liu Y, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-08165-y; Lurie N, 2020, NEW ENGL J MED, V382, P1969, DOI 10.1056/NEJMp2005630; Lv Huibin, 2020, bioRxiv, DOI 10.1101/2020.03.15.993097; Morita R, 2011, IMMUNITY, V34, P108, DOI 10.1016/j.immuni.2010.12.012; Niessl J, 2020, EBIOMEDICINE, V54, DOI 10.1016/j.ebiom.2020.102727; Okba NMA, 2020, EMERG INFECT DIS, V26, P1478, DOI 10.3201/eid2607.200841; Ou XY, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15562-9; Robbiani Davide F, 2020, Nature, V584, P437, DOI [10.1101/2020.05.13.092619, 10.1038/s41586-020-2456-9]; Rogers TF, 2020, SCIENCE, V369, P956, DOI 10.1126/science.abc7520; Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505; Subbarao K, 2004, J VIROL, V78, P3572, DOI 10.1128/JVI.78.7.3572-3577.2004; Le TT, 2020, NAT REV DRUG DISCOV, V19, P305, DOI 10.1038/d41573-020-00073-5; Tiller T, 2008, J IMMUNOL METHODS, V329, P112, DOI 10.1016/j.jim.2007.09.017; van Doremalen N, 2020, NATURE, V586, P578, DOI [10.1101/2020.05.13.093195, 10.1038/s41586-020-2608-y]; Weiskopf D, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.abd2071; Wrapp D, 2020, SCIENCE, V367, P1260, DOI [10.1101/2020.02.11.944462, 10.1126/science.abb2507]; Wu F., 2020, MEDRXIV, DOI [10.1101/2020.03.30.20047365, 10.1101/2020.03.30.20047365v2, 10.1101/2020.03.30.20047365., DOI 10.1101/2020.03.30.20, 10.2139/ssrn.3566211]; Wu XL, 2011, SCIENCE, V333, P1593, DOI 10.1126/science.1207532; Wu Y, 2020, SCIENCE, V368, P1274, DOI 10.1126/science.abc2241; Yan RH, 2020, SCIENCE, V367, P1444, DOI 10.1126/science.abb2762; Yu JY, 2020, SCIENCE, V369, P806, DOI 10.1126/science.abc6284; Zhang J, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-46533-w; Zhou WM, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-433	49	228	232	3	17	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	SEP	2020	26	9								10.1038/s41591-020-0995-0	http://dx.doi.org/10.1038/s41591-020-0995-0		JUL 2020	22	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	PF3EM	32661393	Bronze			2022-12-27	WOS:000548125100003
J	Silveira, MF; Barros, AJD; Horta, BL; Pellanda, LC; Victora, GD; Dellagostin, OA; Struchiner, CJ; Burattini, MN; Valim, ARM; Berlezi, EM; Mesa, JM; Ikeda, MLR; Mesenburg, MA; Mantesso, M; Dall'Agnol, MM; Bittencourt, RA; Hartwig, FP; Menezes, AMB; Barros, FC; Hallal, PC; Victora, CG				Silveira, Mariangela F.; Barros, Aluisio J. D.; Horta, Bernardo L.; Pellanda, Lucia C.; Victora, Gabriel D.; Dellagostin, Odir A.; Struchiner, Claudio J.; Burattini, Marcelo N.; Valim, Andreia R. M.; Berlezi, Evelise M.; Mesa, Jeovany M.; Ikeda, Maria Leticia R.; Mesenburg, Marilia A.; Mantesso, Marina; Dall'Agnol, Marinel M.; Bittencourt, Raqueli A.; Hartwig, Fernando P.; Menezes, Ana M. B.; Barros, Fernando C.; Hallal, Pedro C.; Victora, Cesar G.			Population-based surveys of antibodies against SARS-CoV-2 in Southern Brazil	NATURE MEDICINE			English	Article								Population-based data on COVID-19 are urgently needed. We report on three rounds of probability sample household surveys in the state of Rio Grande do Sul (Brazil), carried out in nine large municipalities using the Wondfo lateral flow point-of-care test for immunoglobulin M and G antibodies against SARS-CoV-2 (https://en.wondfo.com.cn/product/ wondfo-sars-cov-2-antibody-test-lateral-flow-method-2/). Before survey use, the assay underwent four validation studies with pooled estimates of sensitivity (84.8%; 95% confidence interval (CI) = 81.4-87.8%) and specificity (99.0%; 95% CI = 97.8-99.7%). We calculated that the seroprevalence was 0.048% (2/4,151; 95% CI = 0.006-0.174) on 11-13 April (round 1), 0.135% (6/4,460; 95% CI = 0.049-0.293%) on 25-27 April (round 2) and 0.222% (10/4,500; 95% CI = 0.107-0.408) on 9-11 May (round 3), with a significant upward trend over the course of the surveys. Of 37 family members of positive individuals, 17 (35%) were also positive. The epidemic is at an early stage in the state, and there is high compliance with social distancing, unlike in other parts of Brazil. Periodic survey rounds will continue to monitor trends until at least the end of September, and our population-based data will inform decisions on preventive policies and health system preparedness at the state level.	[Silveira, Mariangela F.; Barros, Aluisio J. D.; Horta, Bernardo L.; Dellagostin, Odir A.; Hartwig, Fernando P.; Menezes, Ana M. B.; Barros, Fernando C.; Hallal, Pedro C.; Victora, Cesar G.] Univ Fed Pelotas, Pelotas, RS, Brazil; [Pellanda, Lucia C.; Mesenburg, Marilia A.] Fundacao Univ Fed Ciencias Saude Porto Alegre, Porto Alegre, RS, Brazil; [Victora, Gabriel D.] Rockefeller Univ, Lab Lymphocyte Dynam, 1230 York Ave, New York, NY 10021 USA; [Struchiner, Claudio J.] Fundacao Getulio Vargas, Rio De Janeiro, Brazil; [Burattini, Marcelo N.] Univ Sao Paulo, Sao Paulo, Brazil; [Valim, Andreia R. M.] Univ Santa Cruz, Santa Cruz Do Sul, RS, Brazil; [Berlezi, Evelise M.] Univ Ijui, Ijui, Brazil; [Mesa, Jeovany M.] IMED Passo Fundo, Passo Fundo, RS, Brazil; [Ikeda, Maria Leticia R.] Univ Vale Rio dos Sinos, Sao Leopoldo, Brazil; [Mantesso, Marina] Univ Caxias Sul, Caxias Do Sul, RS, Brazil; [Dall'Agnol, Marinel M.] Univ Fed Santa Maria, Santa Maria, RS, Brazil; [Bittencourt, Raqueli A.] Secretaria Municipal Saude Uruguaiana, Uruguaiana, Brazil	Universidade Federal de Pelotas; Universidade Federal de Ciencias da Saude de Porto Alegre; Rockefeller University; Escola de Pos-Graduacao em Economia (EPGE); Getulio Vargas Foundation; Universidade de Sao Paulo; Universidade do Vale do Rio dos Sinos (Unisinos); Universidade de Caxias do Sul; Universidade Federal de Santa Maria (UFSM)	Hallal, PC (corresponding author), Univ Fed Pelotas, Pelotas, RS, Brazil.	prchallal@gmail.com	Dellagostin, Odir/C-2331-2009; MESA, JEOVANY MARTINEZ/AAE-9703-2020; Struchiner, Claudio J/M-9360-2013; Mesenburg, Marilia Arndt/GRJ-6044-2022; Pellanda, Lucia/ABC-1687-2020; Horta, Bernardo/A-7604-2008; Menezes, Ana MB/G-7266-2012; Barros, Aluisio JD/A-7417-2008; Pellanda, Lucia C/B-4701-2010; Struchiner, Claudio Jose/HGB-9492-2022; Valim, Andreia R M/L-1009-2018	Dellagostin, Odir/0000-0003-2803-4088; Struchiner, Claudio J/0000-0003-2114-847X; Horta, Bernardo/0000-0001-9843-412X; Menezes, Ana MB/0000-0002-2996-9427; Barros, Aluisio JD/0000-0002-2022-8729; Pellanda, Lucia C/0000-0002-8776-2248; Valim, Andreia R M/0000-0001-9611-3103; Reis, AlessanRSS/0000-0001-8486-7469; Barros, Fernando/0000-0001-5973-1746	UNIMED Porto Alegre; Instituto Cultural Floresta; Instituto Serrapilheira	UNIMED Porto Alegre; Instituto Cultural Floresta; Instituto Serrapilheira	This work was started through the Data Committee created by the State of Rio Grande do Sul government to fight the COVID-19 pandemics. The tests used in the study have been provided by the Brazilian Ministry of Health. Funding for data collection was provided by UNIMED Porto Alegre, Instituto Cultural Floresta and Instituto Serrapilheira.	[Anonymous], 2020, INF PREL 13 MAY 2020; [Anonymous], 2019, PROJ POP; [Anonymous], 2020, COM TECN INQ EP SARS; [Anonymous], 2020, USC LA COUNT STUD EA; [Anonymous], 2020, COR DIS 19 REP S KOR; Barreto Mauricio Lima, 2020, Rev. bras. epidemiol., V23, pe200032, DOI 10.1590/1980-549720200032; Bendavid E, 2020, COVID 19 ANTIBODY SE, DOI [10.1101/2020.04.14.20062463, DOI 10.1101/2020.04.14.20062463]; Dellagostin OA, 2020, SENSITIVITY SPECIFIC, P1, DOI 10.1101/2020.05.06.20093476; Diggle P.J., 2011, DIGGLE EPIDEMIOLOGY, V2011, P1, DOI DOI 10.1155/2011/608719; Gudbjartsson DF, 2020, NEW ENGL J MED, V382, P2302, DOI 10.1056/NEJMoa2006100; Hallal PC, 2020, CIENC SAUDE COLETIVA, V25, P2395, DOI 10.1590/1413-81232020256.1.09632020; Horta BL, 2015, INT J EPIDEMIOL, V44, P441, DOI 10.1093/ije/dyv017; INSTITUTO BRASILEIRO DE GEOGRAFIA E ESTATiSTICA, 2016, PESQ NAC AM DOM SINT; Lumley T., 2004, J STAT SOFTW, V9, P1, DOI [10.18637/jss.v009.i08, DOI 10.18637/JSS.V009.I08]; Ogris G, 2020, COVID 19 PREVALENCE; Pearce N, 2020, AM J PUBLIC HEALTH, V110, P949, DOI 10.2105/AJPH.2020.305708; Public Health Agency of Sweden, 2020, HUFVUDSTADSBLAD 0606; RCore Team, 2020, R LANG ENV STAT COMP; Regalado A, 2020, MIT TECHNOLOGY REV; Viechtbauer W, 2010, J STAT SOFTW, V36, P1, DOI 10.18637/jss.v036.i03; Whitman JD, 2020, NAT BIOTECHNOL, V38, P1174, DOI [10.1038/s41587-020-0659-0, 10.1101/2020.04.25.20074856]; WHO, 2020, ADV US POINT OF CAR; WHO, 2020, CRIT REL COVID 19 PA	24	88	92	0	3	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	AUG	2020	26	8					1196	+		10.1038/s41591-020-0992-3	http://dx.doi.org/10.1038/s41591-020-0992-3		JUL 2020	6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	MX8ZF	32641783	Bronze			2022-12-27	WOS:000546536800001
J	Loembe, MM; Tshangela, A; Salyer, SJ; Varma, JK; Ouma, AEO; Nkengasong, JN				Massinga Loembe, Marguerite; Tshangela, Akhona; Salyer, Stephanie J.; Varma, Jay K.; Ouma, Ahmed E. Ogwell; Nkengasong, John N.			COVID-19 in Africa: the spread and response	NATURE MEDICINE			English	Editorial Material								Given the current trends in incidence and underlying healthcare systems vulnerabilities, Africa could become the next epicenter of the COVID-19 pandemic. As the pandemic transitions to more widespread community transmission, how can the lessons learned thus far be consolidated to effectively curb the spread of COVID-19 while minimizing social disruption and negative humanitarian and economic consequences?	[Massinga Loembe, Marguerite; Tshangela, Akhona; Salyer, Stephanie J.; Varma, Jay K.; Ouma, Ahmed E. Ogwell; Nkengasong, John N.] Africa Ctr Dis Control & Prevent, Addis Ababa, Ethiopia		Nkengasong, JN (corresponding author), Africa Ctr Dis Control & Prevent, Addis Ababa, Ethiopia.	nkengasongj@africa-union.org		Massinga Loembe, Marguerite/0000-0002-7822-566X				[Anonymous], 2020, MONDE; [Anonymous], 2020, FRANCE 24; Cornish Lisa, 2020, DEVEX; Financial Times, 2020, FINANCIAL TIMES; Gilbert M, 2020, LANCET, V395, P871, DOI 10.1016/S0140-6736(20)30411-6; Guan W, 2020, NEW ENGL J MED, V382, P1708, DOI 10.1056/NEJMoa2002032; Nkengasong J, 2020, NATURE, V580, P565, DOI 10.1038/d41586-020-01265-0; Nkengasong JN, 2020, LANCET, V395, P841, DOI 10.1016/S0140-6736(20)30464-5; Parpia AS, 2016, EMERG INFECT DIS, V22, P433, DOI 10.3201/eid2203.150977; Setipa J, 2020, TELEGRAPH; Verity R, 2020, LANCET INFECT DIS, V20, P669, DOI 10.1016/S1473-3099(20)30243-7	11	107	107	3	6	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	JUL	2020	26	7					999	1003		10.1038/s41591-020-0961-x	http://dx.doi.org/10.1038/s41591-020-0961-x		JUN 2020	5	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	MK3XO	32528154	Bronze			2022-12-27	WOS:000539886500001
J	Liao, MF; Liu, Y; Yuan, J; Wen, YL; Xu, G; Zhao, JJ; Cheng, L; Li, JX; Wang, X; Wang, FX; Liu, L; Amit, I; Zhang, SY; Zhang, Z				Liao, Mingfeng; Liu, Yang; Yuan, Jing; Wen, Yanling; Xu, Gang; Zhao, Juanjuan; Cheng, Lin; Li, Jinxiu; Wang, Xin; Wang, Fuxiang; Liu, Lei; Amit, Ido; Zhang, Shuye; Zhang, Zheng			Single-cell landscape of bronchoalveolar immune cells in patients with COVID-19	NATURE MEDICINE			English	Article							T-CELLS; PROTECTION; SIGNATURES; RESPONSES	Respiratory immune characteristics associated with Coronavirus Disease 2019 (COVID-19) severity are currently unclear. We characterized bronchoalveolar lavage fluid immune cells from patients with varying severity of COVID-19 and from healthy people by using single-cell RNA sequencing. Proinflammatory monocyte-derived macrophages were abundant in the bronchoalveolar lavage fluid from patients with severe COVID-9. Moderate cases were characterized by the presence of highly clonally expanded CD8(+) T cells. This atlas of the bronchoalveolar immune microenvironment suggests potential mechanisms underlying pathogenesis and recovery in COVID-19. Single-cell transcriptome and T cell receptor analysis of bronchoalveolar lavage fluid suggests enrichment of proinflammatory macrophages in patients with severe COVID-19 and the presence of clonally expanded CD8(+) T cells in patients with moderate COVID-19.	[Liao, Mingfeng; Liu, Yang; Wen, Yanling; Xu, Gang; Zhao, Juanjuan; Cheng, Lin; Wang, Xin; Liu, Lei; Zhang, Zheng] Shenzhen Third Peoples Hosp, Inst Hepatol, Natl Clin Res Ctr Infect Dis, Shenzhen, Peoples R China; [Yuan, Jing; Li, Jinxiu; Wang, Fuxiang] Shenzhen Third Peoples Hosp, Dept Infect Dis, Shenzhen, Peoples R China; [Liu, Lei; Zhang, Zheng] Southern Univ Sci & Technol, Sch Med, Affiliated Hosp 2, Shenzhen, Peoples R China; [Amit, Ido] Weizmann Inst Sci, Dept Immunol, Rehovot, Israel; [Zhang, Shuye] Fudan Univ, Shanghai Publ Hlth Clin Ctr, Shanghai, Peoples R China	Southern University of Science & Technology; Weizmann Institute of Science; Fudan University	Liu, L; Zhang, Z (corresponding author), Shenzhen Third Peoples Hosp, Inst Hepatol, Natl Clin Res Ctr Infect Dis, Shenzhen, Peoples R China.; Liu, L; Zhang, Z (corresponding author), Southern Univ Sci & Technol, Sch Med, Affiliated Hosp 2, Shenzhen, Peoples R China.; Amit, I (corresponding author), Weizmann Inst Sci, Dept Immunol, Rehovot, Israel.; Zhang, SY (corresponding author), Fudan Univ, Shanghai Publ Hlth Clin Ctr, Shanghai, Peoples R China.	liulei3322@aliyun.com; ido.amit@weizmann.ac.il; zhangshuye@shphc.org.cn; zhangzheng1975@aliyun.com	Zhang, Shuye/ABG-7815-2021	Zhang, Shuye/0000-0002-4749-6790; Liu, Yang/0000-0002-5221-7725	Science and Technology Innovation Committee of Shenzhen Municipality [202002073000002]; National Natural Science Foundation of China [91442127, 81700540]	Science and Technology Innovation Committee of Shenzhen Municipality; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	We acknowledge the work and contribution of all the health providers from Shenzhen Third People's Hospital. This study was supported by the Science and Technology Innovation Committee of Shenzhen Municipality (202002073000002) and the National Natural Science Foundation of China (91442127 to Z.Z.; 81700540 to Y.L.).	Aibar S, 2017, NAT METHODS, V14, P1083, DOI [10.1038/NMETH.4463, 10.1038/nmeth.4463]; Bonnardel J, 2018, CURR OPIN IMMUNOL, V50, P64, DOI 10.1016/j.coi.2017.12.001; Cao XT, 2020, NAT REV IMMUNOL, V20, P269, DOI 10.1038/s41577-020-0308-3; Channappanavar R, 2016, CELL HOST MICROBE, V19, P181, DOI 10.1016/j.chom.2016.01.007; Channappanavar R, 2014, J VIROL, V88, P11034, DOI 10.1128/JVI.01505-14; Chen DY, 2020, J CLIN INVEST, V130, P768, DOI [10.1172/JCI126277, 10.1172/JCI126277.]; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Evren E, 2020, IMMUNOLOGY, V160, P126, DOI 10.1111/imm.13154; Finak G, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0844-5; Guan W, 2020, NEW ENGL J MED, V382, P1708, DOI 10.1056/NEJMoa2002032; Kumar BV, 2017, CELL REP, V20, P2921, DOI 10.1016/j.celrep.2017.08.078; Liberzon A, 2015, CELL SYST, V1, P417, DOI 10.1016/j.cels.2015.12.004; Liu L, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.123158; Liu WJ, 2017, ANTIVIR RES, V137, P82, DOI 10.1016/j.antiviral.2016.11.006; Morse C, 2019, EUR RESPIR J, V54, DOI 10.1183/13993003.02441-2018; Pont F, 2019, NUCLEIC ACIDS RES, V47, DOI 10.1093/nar/gkz601; Reyfman PA, 2019, AM J RESP CRIT CARE, V199, P1517, DOI 10.1164/rccm.201712-2410OC; Stuart T, 2019, CELL, V177, P1888, DOI 10.1016/j.cell.2019.05.031; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Yu GC, 2012, OMICS, V16, P284, DOI 10.1089/omi.2011.0118; Zhao JC, 2010, J VIROL, V84, P9318, DOI 10.1128/JVI.01049-10; Zhou F, 2020, LANCET, V20, P384, DOI [10.1016/S1473-3099(20)30134-1, DOI 10.1016/S1473-3099(20)30134-1]	22	1205	1213	21	118	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	JUN	2020	26	6					842	+		10.1038/s41591-020-0901-9	http://dx.doi.org/10.1038/s41591-020-0901-9		MAY 2020	12	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	LZ3ZG	32398875	Green Submitted, Bronze			2022-12-27	WOS:000532113900004
J	Krystal, JH; McNeil, RL				Krystal, John H.; McNeil, Robert L., Jr.			Responding to the hidden pandemic for healthcare workers: stress	NATURE MEDICINE			English	Editorial Material									[Krystal, John H.; McNeil, Robert L., Jr.] Yale Univ, New Haven, CT 06520 USA	Yale University	Krystal, JH (corresponding author), Yale Univ, New Haven, CT 06520 USA.	john.krystal@yale.edu			National Institute of Health Grant, Yale Clinical & Translational Science Award [5UL1TR0018663]	National Institute of Health Grant, Yale Clinical & Translational Science Award	Supported by a National Institute of Health Grant, Yale Clinical & Translational Science Award (5UL1TR0018663; J.H.K. and R.L.M., co-directors).	Mohammed A, 2015, LANCET PSYCHIAT, V2, P955, DOI 10.1016/S2215-0366(15)00451-4; Petzold MB, 2020, NERVENARZT, V91, P417, DOI 10.1007/s00115-020-00905-0	2	50	51	0	4	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	MAY	2020	26	5					639	639		10.1038/s41591-020-0878-4	http://dx.doi.org/10.1038/s41591-020-0878-4		APR 2020	1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	ML1JP	32350461	Bronze			2022-12-27	WOS:000529597900001
J	Kerschbaumer, A; Smolen, JS; Herkner, H; Stefanova, T; Chwala, E; Aletaha, D				Kerschbaumer, Andreas; Smolen, Josef S.; Herkner, Harald; Stefanova, Tijen; Chwala, Eva; Aletaha, Daniel			Efficacy outcomes in phase 2 and phase 3 randomized controlled trials in rheumatology	NATURE MEDICINE			English	Article							ANTI-INTERLEUKIN-17A MONOCLONAL-ANTIBODY; SELECTIVE JAK-3 INHIBITOR; ANTITUMOR NECROSIS FACTOR; PLACEBO-CONTROLLED TRIAL; PROOF-OF-CONCEPT; INADEQUATE RESPONSE; DOUBLE-BLIND; PSORIATIC-ARTHRITIS; AMERICAN-COLLEGE; CLASSIFICATION CRITERIA	A meta-analysis comparing primary efficacy outcomes of phase 2 and phase 3 randomized controlled trials in rheumatoid arthritis and psoriatic arthritis shows that phase 2 studies consistently overestimate the effect sizes anticipated in subsequent phase 3 trials. Phase 3 trials are the mainstay of drug development across medicine but have often not met expectations set by preceding phase 2 studies. A systematic meta-analysis evaluated all randomized controlled, double-blind trials investigating targeted disease-modifying anti-rheumatic drugs in rheumatoid and psoriatic arthritis. Primary outcomes of American College of Rheumatology (ACR) 20 responses were compared by mixed-model logistic regression, including exploration of potential determinants of efficacy overestimation. In rheumatoid arthritis, phase 2 trial outcomes systematically overestimated subsequent phase 3 results (odds ratio comparing ACR20 in phase 2 versus phase 3: 1.39, 95% confidence interval: 1.25-1.57, P < 0.001). Data for psoriatic arthritis trials were similar, but not statistically significant (odds ratio comparing ACR20 in phase 2 versus phase 3: 1.35, 95% confidence interval: 0.94-1.94, P = 0.09). Differences in inclusion criteria largely explained the observed differences in efficacy findings. Our findings have implications for all stakeholders in new therapeutic development and testing, as well as potential ethical implications.	[Kerschbaumer, Andreas; Smolen, Josef S.; Stefanova, Tijen; Aletaha, Daniel] Med Univ Vienna, Div Rheumatol, Dept Internal Med 3, Vienna, Austria; [Herkner, Harald] Med Univ Vienna, Dept Emergency Med, Vienna, Austria; [Chwala, Eva] Med Univ Vienna, Univ Lib, Vienna, Austria	Medical University of Vienna; Medical University of Vienna; Medical University of Vienna	Aletaha, D (corresponding author), Med Univ Vienna, Div Rheumatol, Dept Internal Med 3, Vienna, Austria.	daniel.aletaha@meduniwien.ac.at		Herkner, Harald/0000-0003-1329-6149; Chwala, Eva/0000-0001-7686-5535				Aletaha D, 2008, ANN RHEUM DIS, V67, P1360, DOI 10.1136/ard.2008.091454; Aletaha D, 2010, ANN RHEUM DIS, V69, P1580, DOI [10.1136/ard.2010.138461, 10.1002/art.27584]; [Anonymous], 2002, ARTHRITIS RHEUM, V46, pS33; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; AstraZeneca, 2018, UPD TULIP 1 PHAS 3 T; Baeten D, 2013, LANCET, V382, P1705, DOI 10.1016/S0140-6736(13)61134-4; Breneman D, 2002, ARCH DERMATOL, V138, P325, DOI 10.1001/archderm.138.3.325; Burmester GR, 2017, ANN RHEUM DIS, V76, P1020, DOI 10.1136/annrheumdis-2016-210624; Burmester GR, 2013, ANN RHEUM DIS, V72, P1445, DOI 10.1136/annrheumdis-2012-202450; Comi G, 2008, LANCET, V371, P2085, DOI 10.1016/S0140-6736(08)60918-6; Dechartres A, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2304; Emery P, 2010, ANN RHEUM DIS, V69, P1629, DOI 10.1136/ard.2009.119933; Felson DT, 2011, ANN RHEUM DIS, V70, P404, DOI 10.1002/art.30129; FELSON DT, 1995, ARTHRITIS RHEUM, V38, P727, DOI 10.1002/art.1780380602; Fleischmann R, 2009, ANN RHEUM DIS, V68, P805, DOI 10.1136/ard.2008.099291; Fleischmann RM, 2015, ARTHRITIS RHEUMATOL, V67, P334, DOI 10.1002/art.38949; Fransen J, 2006, ANN RHEUM DIS, V65, P1373, DOI 10.1136/ard.2006.051706; Furie R, 2017, ARTHRITIS RHEUMATOL, V69, P376, DOI 10.1002/art.39962; Gan HK, 2012, J NATL CANCER I, V104, P590, DOI 10.1093/jnci/djs141; Genovese MC, 2016, ANN RHEUM DIS, V75, P1979, DOI 10.1136/annrheumdis-2015-208901; Genovese MC, 2016, ARTHRITIS RHEUMATOL, V68, P46, DOI 10.1002/art.39473; Genovese MC, 2014, J RHEUMATOL, V41, P2120, DOI 10.3899/jrheum.140238; Genovese MC, 2014, ANN RHEUM DIS, V73, P1607, DOI 10.1136/annrheumdis-2013-204760; Genovese MC, 2014, ARTHRITIS RHEUMATOL, V66, P1693, DOI 10.1002/art.38617; Genovese MC, 2013, ANN RHEUM DIS, V72, P1453, DOI 10.1136/annrheumdis-2012-202864; Genovese MC, 2011, ARTHRITIS RHEUM-US, V63, P337, DOI 10.1002/art.30114; Grayling MJ, 2019, JNCI-J NATL CANCER I, V111, P1255, DOI 10.1093/jnci/djz126; Heald P, 2003, J AM ACAD DERMATOL, V49, P801, DOI 10.1016/S0190-9622(03)01475-0; Higgins JPT, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5928; Kim Y, 2013, AM STAT, V67, P171, DOI 10.1080/00031305.2013.817357; Kirby S, 2012, PHARM STAT, V11, P373, DOI 10.1002/pst.1521; LABBE KA, 1987, ANN INTERN MED, V107, P224, DOI 10.7326/0003-4819-107-2-224; Liang F, 2019, EUR J CANCER, V121, P19, DOI 10.1016/j.ejca.2019.08.006; Maini RN, 1998, ARTHRITIS RHEUM, V41, P1552, DOI 10.1002/1529-0131(199809)41:9<1552::AID-ART5>3.0.CO;2-W; McInnes IB, 2014, ANN RHEUM DIS, V73, P349, DOI 10.1136/annrheumdis-2012-202646; Mease P, 2012, ANN RHEUM DIS, V71, P1183, DOI 10.1136/annrheumdis-2011-200704; Mease PJ, 2018, ARTHRITIS RHEUMATOL, V70, P1778, DOI 10.1002/art.40579; Mease PJ, 2016, ARTHRITIS RHEUMATOL, V68, P2163, DOI 10.1002/art.39700; Mease PJ, 2014, NEW ENGL J MED, V370, P2295, DOI 10.1056/NEJMoa1315231; Sandborn WJ, 2011, CLIN GASTROENTEROL H, V9, P670, DOI 10.1016/j.cgh.2011.04.031; Schreiber S, 2005, GASTROENTEROLOGY, V129, P807, DOI 10.1053/j.gastro.2005.06.064; Smolen JS, 2015, ANN RHEUM DIS, V74, P1567, DOI 10.1136/annrheumdis-2014-207090; Smolen JS, 2014, ANN RHEUM DIS, V73, P1616, DOI 10.1136/annrheumdis-2013-205137; Sterne JAC, 2000, J CLIN EPIDEMIOL, V53, P1119, DOI 10.1016/S0895-4356(00)00242-0; Sterne JAC, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4002; Takeuchi T, 2016, MOD RHEUMATOL, V26, P15, DOI 10.3109/14397595.2015.1074648; Takeuchi T, 2015, MOD RHEUMATOL, V25, P21, DOI 10.3109/14397595.2014.896448; Tang M, 2017, J CLIN ONCOL, V35, DOI 10.1200/JCO.2017.35.4_suppl.227; Taylor W, 2006, ARTHRITIS RHEUM, V54, P2665, DOI 10.1002/art.21972; Umscheid CA, 2011, POSTGRAD MED, V123, P194, DOI 10.3810/pgm.2011.09.2475; Vollmer TL, 2014, J NEUROL, V261, P773, DOI 10.1007/s00415-014-7264-4; Wang SJ, 2006, PHARM STAT, V5, P85, DOI 10.1002/pst.217; Weinblatt ME, 2003, ARTHRITIS RHEUM-US, V48, P35, DOI 10.1002/art.10697; Weinblatt ME, 2008, ARTHRITIS RHEUM-US, V58, P3309, DOI 10.1002/art.23992; Weinblatt ME, 2015, ARTHRITIS RHEUMATOL, V67, P2591, DOI 10.1002/art.39249; Weinblatt ME, 2014, ARTHRITIS RHEUMATOL, V66, P3255, DOI 10.1002/art.38851; Weinblatt ME, 2010, NEW ENGL J MED, V363, P1303, DOI 10.1056/NEJMoa1000500; Zia MI, 2005, J CLIN ONCOL, V23, P6982, DOI 10.1200/JCO.2005.06.679	59	3	3	0	4	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	JUN	2020	26	6					974	+		10.1038/s41591-020-0833-4	http://dx.doi.org/10.1038/s41591-020-0833-4		APR 2020	14	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	LZ3ZG	32313250				2022-12-27	WOS:000527507000002
J	He, X; Lau, EHY; Wu, P; Deng, XL; Wang, J; Hao, XX; Lau, YC; Wong, JSY; Guan, YJ; Tan, XH; Mo, XN; Chen, YQ; Liao, BL; Chen, WL; Hu, FY; Zhang, Q; Zhong, MQ; Wu, YR; Zhao, LZ; Zhang, FC; Cowling, BJ; Li, F; Leung, GM				He, Xi; Lau, Eric H. Y.; Wu, Peng; Deng, Xilong; Wang, Jian; Hao, Xinxin; Lau, Yiu Chung; Wong, Jessica Y.; Guan, Yujuan; Tan, Xinghua; Mo, Xiaoneng; Chen, Yanqing; Liao, Baolin; Chen, Weilie; Hu, Fengyu; Zhang, Qing; Zhong, Mingqiu; Wu, Yanrong; Zhao, Lingzhai; Zhang, Fuchun; Cowling, Benjamin J.; Li, Fang; Leung, Gabriel M.			Temporal dynamics in viral shedding and transmissibility of COVID-19	NATURE MEDICINE			English	Article							HONG-KONG; LOAD; SARS	We report temporal patterns of viral shedding in 94 patients with laboratory-confirmed COVID-19 and modeled COVID-19 infectiousness profiles from a separate sample of 77 infector-infectee transmission pairs. We observed the highest viral load in throat swabs at the time of symptom onset, and inferred that infectiousness peaked on or before symptom onset. We estimated that 44% (95% confidence interval, 25-69%) of secondary cases were infected during the index cases' presymptomatic stage, in settings with substantial household clustering, active case finding and quarantine outside the home. Disease control measures should be adjusted to account for probable substantial presymptomatic transmission. Presymptomatic transmission of SARS-CoV-2 is estimated to account for a substantial proportion of COVID-19 cases.	[He, Xi; Deng, Xilong; Wang, Jian; Guan, Yujuan; Tan, Xinghua; Mo, Xiaoneng; Chen, Yanqing; Liao, Baolin; Chen, Weilie; Hu, Fengyu; Zhang, Qing; Zhong, Mingqiu; Wu, Yanrong; Zhao, Lingzhai; Zhang, Fuchun; Li, Fang] Guangzhou Med Univ, Guangzhou Peoples Hosp 8, Guangzhou, Peoples R China; [Lau, Eric H. Y.; Wu, Peng; Hao, Xinxin; Lau, Yiu Chung; Wong, Jessica Y.; Cowling, Benjamin J.; Leung, Gabriel M.] Univ Hong Kong, World Hlth Org Collaborating Ctr Infect Dis Epide, Sch Publ Hlth, Hong Kong, Peoples R China	Guangzhou Medical University; University of Hong Kong; World Health Organization	Lau, EHY (corresponding author), Univ Hong Kong, World Hlth Org Collaborating Ctr Infect Dis Epide, Sch Publ Hlth, Hong Kong, Peoples R China.	ehylau@hku.hk	Lau, Eric/AAJ-6588-2021	Lau, Eric/0000-0002-6688-9637; Li, Fang/0000-0002-8960-8404; Leung, Gabriel/0000-0002-2503-6283	Department of Science and Technology of Guangdong Province [2020B111108001]; Health and Medical Research Fund from the Government of the Hong Kong Special Administrative Region	Department of Science and Technology of Guangdong Province; Health and Medical Research Fund from the Government of the Hong Kong Special Administrative Region	This work was supported by Department of Science and Technology of Guangdong Province (project no. 2020B111108001, to F.L.) and a commissioned grant from the Health and Medical Research Fund from the Government of the Hong Kong Special Administrative Region (to B.J.C.).	Bai Y, 2020, JAMA-J AM MED ASSOC, V323, P1406, DOI [10.1056/NEJMoa2001316, 10.1001/jama.2020.2565]; Chen WL, 2020, EMERG MICROBES INFEC, V9, P469, DOI 10.1080/22221751.2020.1732837; Ganyani T, 2020, ESTIMATING GENERATIO, DOI DOI 10.1101/2020.03.05.20031815; Hellewell J, 2020, LANCET GLOB HEALTH, V8, pE488, DOI 10.1016/S2214-109X(20)30074-7; Ip DKM, 2017, CLIN INFECT DIS, V64, P736, DOI 10.1093/cid/ciw841; Li Q, 2020, NEW ENGL J MED, V382, P1199, DOI 10.1056/NEJMoa2001316; Nishiura H, 2020, INT J INFECT DIS, V93, P284, DOI 10.1016/j.ijid.2020.02.060; Peiris JSM, 2003, LANCET, V361, P1767, DOI 10.1016/S0140-6736(03)13412-5; Pitzer VE, 2007, AM J EPIDEMIOL, V166, P355, DOI 10.1093/aje/kwm082; Riley S, 2003, SCIENCE, V300, P1961, DOI 10.1126/science.1086478; To KKW, 2020, LANCET INFECT DIS, V20, P565, DOI 10.1016/S1473-3099(20)30196-1; Tong ZD, 2020, EMERG INFECT DIS, V26, P1052, DOI 10.3201/eid2605.200198; Tsang TK, 2015, J INFECT DIS, V212, P1420, DOI 10.1093/infdis/jiv225; Wolfel R, 2020, NATURE, V588, pE35; Wu JT, 2020, LANCET, V395, P689, DOI 10.1016/S0140-6736(20)30260-9; Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3; Zou LR, 2020, NEW ENGL J MED, V382, P1177, DOI 10.1056/NEJMc2001737	17	1714	1733	14	166	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAY	2020	26	5								10.1038/s41591-020-0869-5	http://dx.doi.org/10.1038/s41591-020-0869-5		APR 2020	10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	MW4CE	32296168	Green Submitted, Bronze			2022-12-27	WOS:000526227300001
J	Fairfax, BP; Taylor, CA; Watson, RA; Nassiri, I; Danielli, S; Fang, H; Mahe, EA; Cooper, R; Woodcock, V; Traill, Z; Al-Mossawi, MH; Knight, JC; Klenerman, P; Payne, M; Middleton, MR				Fairfax, Benjamin P.; Taylor, Chelsea A.; Watson, Robert A.; Nassiri, Isar; Danielli, Sara; Fang, Hai; Mahe, Elise A.; Cooper, Rosalin; Woodcock, Victoria; Traill, Zoe; Al-Mossawi, M. Hussein; Knight, Julian C.; Klenerman, Paul; Payne, Miranda; Middleton, Mark R.			Peripheral CD8(+) T cell characteristics associated with durable responses to immune checkpoint blockade in patients with metastatic melanoma	NATURE MEDICINE			English	Article							THERAPY	Immune checkpoint blockade (ICB) of PD-1 and CTLA-4 to treat metastatic melanoma (MM) has variable therapeutic benefit. To explore this in peripheral samples, we characterized CD8(+) T cell gene expression across a cohort of patients with MM receiving anti-PD-1 alone (sICB) or in combination with anti-CTLA-4 (cICB). Whereas CD8(+) transcriptional responses to sICB and cICB involve a shared gene set, the magnitude of cICB response is over fourfold greater, with preferential induction of mitosis- and interferon-related genes. Early samples from patients with durable clinical benefit demonstrated overexpression of T cell receptor-encoding genes. By mapping T cell receptor clonality, we find that responding patients have more large clones (those occupying >0.5% of repertoire) post-treatment than non-responding patients or controls, and this correlates with effector memory T cell percentage. Single-cell RNA-sequencing of eight post-treatment samples demonstrates that large clones overexpress genes implicated in cytotoxicity and characteristic of effector memory T cells, including CCL4, GNLY and NKG7. The 6-month clinical response to ICB in patients with MM is associated with the large CD8(+) T cell clone count 21 d after treatment and agnostic to clonal specificity, suggesting that post-ICB peripheral CD8(+) clonality can provide information regarding long-term treatment response and, potentially, facilitate treatment stratification. Transcriptomic analysis of peripheral CD8(+) T cells in a cohort of patients with metastatic melanoma receiving checkpoint inhibitors shows that the number of large clones early post-treatment is strongly associated with six-month clinical outcome.	[Fairfax, Benjamin P.; Taylor, Chelsea A.; Watson, Robert A.; Nassiri, Isar; Mahe, Elise A.; Cooper, Rosalin] Univ Oxford, MRC Weatherall Inst Mol Med, Oxford, England; [Fairfax, Benjamin P.; Taylor, Chelsea A.; Watson, Robert A.; Nassiri, Isar; Danielli, Sara; Mahe, Elise A.; Cooper, Rosalin; Woodcock, Victoria; Payne, Miranda; Middleton, Mark R.] Univ Oxford, Dept Oncol, Oxford, England; [Fairfax, Benjamin P.; Taylor, Chelsea A.; Watson, Robert A.; Nassiri, Isar; Danielli, Sara; Mahe, Elise A.; Cooper, Rosalin; Woodcock, Victoria; Payne, Miranda; Middleton, Mark R.] Oxford Univ Hosp NHS Fdn Trust, Oxford Canc Ctr, Oxford, England; [Fairfax, Benjamin P.; Danielli, Sara; Knight, Julian C.; Klenerman, Paul; Middleton, Mark R.] Oxford Univ Hosp NHS Fdn Trust, NIHR Oxford Biomed Res Ctr, Oxford, England; [Fang, Hai; Knight, Julian C.] Univ Oxford, Wellcome Ctr Human Genet, Nuffield Dept Med, Oxford, England; [Traill, Zoe] Oxford Univ Hosp NHS Fdn Trust, Churchill Hosp, Dept Radiol, Oxford, England; [Al-Mossawi, M. Hussein] Univ Oxford, Botnar Res Ctr, NDORMS, Oxford, England; [Klenerman, Paul] John Radcliffe Hosp, Translat Gastroenterol Unit, Oxford, England	University of Oxford; University of Oxford; Oxford University Hospitals NHS Foundation Trust; Oxford University Hospitals NHS Foundation Trust; University of Oxford; University of Oxford; Wellcome Centre for Human Genetics; Oxford University Hospitals NHS Foundation Trust; University of Oxford; University of Oxford; University of Oxford	Fairfax, BP (corresponding author), Univ Oxford, MRC Weatherall Inst Mol Med, Oxford, England.; Fairfax, BP (corresponding author), Univ Oxford, Dept Oncol, Oxford, England.; Fairfax, BP (corresponding author), Oxford Univ Hosp NHS Fdn Trust, Oxford Canc Ctr, Oxford, England.; Fairfax, BP (corresponding author), Oxford Univ Hosp NHS Fdn Trust, NIHR Oxford Biomed Res Ctr, Oxford, England.	benjamin.fairfax@oncology.ox.ac.uk	Knight, Julian Charles/W-2399-2019	Knight, Julian Charles/0000-0002-0377-5536; klenerman, paul/0000-0003-4307-9161; Cooper, Rosalin/0000-0002-8548-1178; Woodcock, Victoria/0000-0001-7656-728X; Danielli, Sara/0000-0003-4608-5751; Taylor, Chelsea/0000-0002-1635-4167; Fairfax, Benjamin/0000-0001-7413-5002; Watson, Robert/0000-0002-8838-9406	Wellcome Intermediate Clinical Fellowship [201488/Z/16/Z]; CRUK predoctoral Fellowship [ANR00740]; CRUK Clinical Research Training Fellowship; Engineering & Physical Sciences Research Council; Balliol Jowett Society [D4T00070]; Wellcome Trust Investigator Award [204969/Z/16/Z]; NIHR Senior Fellowship; Wellcome Trust [WT109965MA]; CRUK CTAAC Clinical Trials Fellowship [C2195/A19716]; NIHR Oxford Biomedical Research Centre; EPSRC [1963686] Funding Source: UKRI	Wellcome Intermediate Clinical Fellowship(Wellcome Trust); CRUK predoctoral Fellowship; CRUK Clinical Research Training Fellowship; Engineering & Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Balliol Jowett Society; Wellcome Trust Investigator Award(Wellcome Trust); NIHR Senior Fellowship; Wellcome Trust(Wellcome Trust); CRUK CTAAC Clinical Trials Fellowship; NIHR Oxford Biomedical Research Centre(National Institute for Health Research (NIHR)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	We are very grateful to all patients who generously contributed samples and participated in the study. We thank all the staff of the Day Treatment Unit, Oxford Cancer Centre, and N. Coupe and R. Matin for assistance in collecting patient samples. We thank R. Morgan for discussion and advice. This study was funded by a Wellcome Intermediate Clinical Fellowship to B.P.F. (no. 201488/Z/16/Z), additionally supporting E.A.M. and I.N. R.A.W. was a National Institute for Health Research (NIHR) Academic Clinical Fellow and was supported by a CRUK predoctoral Fellowship (no. ANR00740). R.C. is supported by a CRUK Clinical Research Training Fellowship. C.A.T. is funded by the Engineering & Physical Sciences Research Council and the Balliol Jowett Society (no. D4T00070). J.C.K. is funded by a Wellcome Trust Investigator Award (no. 204969/Z/16/Z). P.K. is supported by a NIHR Senior Fellowship and Wellcome Trust Award (no. WT109965MA). V.W. was supported by a CRUK CTAAC Clinical Trials Fellowship (no. C2195/A19716), and also by the NIHR Oxford Biomedical Research Centre. The views expressed are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health.	Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Blank CU, 2016, SCIENCE, V352, P658, DOI 10.1126/science.aaf2834; Bolotin DA, 2015, NAT METHODS, V12, P380, DOI 10.1038/nmeth.3364; Brochez L, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05047-1; Dahlin JS, 2018, BLOOD, V131, pE1, DOI 10.1182/blood-2017-12-821413; Das R, 2015, J IMMUNOL, V194, P950, DOI 10.4049/jimmunol.1401686; Daud AI, 2016, J CLIN ONCOL, V34, P4102, DOI 10.1200/JCO.2016.67.2477; Davoli T, 2017, SCIENCE, V355, DOI 10.1126/science.aaf8399; Dixon P, 2003, J VEG SCI, V14, P927, DOI 10.1111/j.1654-1103.2003.tb02228.x; Durovic B, 2013, J VIROL, V87, P6526, DOI 10.1128/JVI.00169-13; Fang H, 2019, NAT GENET, V51, P1082, DOI 10.1038/s41588-019-0456-1; Fang H, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0384-y; Gillespie GMA, 2000, J VIROL, V74, P8140, DOI 10.1128/JVI.74.17.8140-8150.2000; Huang AC, 2017, NATURE, V545, P60, DOI 10.1038/nature22079; Huber W, 2015, NAT METHODS, V12, P115, DOI [10.1038/NMETH.3252, 10.1038/nmeth.3252]; Jacquelot N, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00608-2; Jun G, 2012, AM J HUM GENET, V91, P839, DOI 10.1016/j.ajhg.2012.09.004; Kim D, 2015, NAT METHODS, V12, P357, DOI [10.1038/NMETH.3317, 10.1038/nmeth.3317]; Krieg C, 2018, NAT MED, V24, P1773, DOI 10.1038/s41591-018-0094-7; Kugel CH, 2018, CLIN CANCER RES, V24, P5347, DOI 10.1158/1078-0432.CCR-18-1116; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; LOVE MI, 2014, GENOME BIOL, V15, DOI DOI 10.1186/S13059-014-0550-8; Lun Aaron T L, 2016, F1000Res, V5, P2122; Lun ATL, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0947-7; McCarthy DJ, 2017, BIOINFORMATICS, V33, P1179, DOI 10.1093/bioinformatics/btw777; McQuade JL, 2018, LANCET ONCOL, V19, P310, DOI 10.1016/S1470-2045(18)30078-0; Miao D, 2018, NAT GENET, V50, P1271, DOI 10.1038/s41588-018-0200-2; Nicolet B. P, 2019, CD29 MARKS SUPERIOR, DOI [10.1101/562512, DOI 10.1101/562512]; Pan D, 2018, SCIENCE, V359, P770, DOI 10.1126/science.aao1710; Patin E, 2018, NAT IMMUNOL, V19, P302, DOI 10.1038/s41590-018-0049-7; Roh W, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aah3560; Russo PST, 2018, BMC BIOINFORMATICS, V19, DOI 10.1186/s12859-018-2053-1; Simoni Y, 2018, NATURE, V557, P575, DOI 10.1038/s41586-018-0130-2; Stuart T, 2019, CELL, V177, P1888, DOI 10.1016/j.cell.2019.05.031; Suessmuth Y, 2015, BLOOD, V125, P3835, DOI 10.1182/blood-2015-03-631853; Tumeh PC, 2014, NATURE, V515, P568, DOI 10.1038/nature13954; Wang GC, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003647; Wang WS, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-146; Weekes MP, 1999, J VIROL, V73, P2099, DOI 10.1128/JVI.73.3.2099-2108.1999; Zheng CH, 2017, CELL, V169, P1342, DOI 10.1016/j.cell.2017.05.035	42	118	120	3	34	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	FEB	2020	26	2					193	+		10.1038/s41591-019-0734-6	http://dx.doi.org/10.1038/s41591-019-0734-6		FEB 2020	22	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	KK7DU	32042196	Green Accepted			2022-12-27	WOS:000512529400002
J	Picton, HM; Balen, AH				Picton, H. M.; Balen, A. H.			Transgenerational PCOS transmission	NATURE MEDICINE			English	Editorial Material							POLYCYSTIC-OVARY-SYNDROME; WOMEN	There is a transgenerational increase in the susceptibility of female offspring to developing PCOS that occurs via the female germline and is linked to fetal exposure to excess androgen.	[Picton, H. M.] Univ Leeds, Reprod & Early Dev Res Grp, Discovery & Translat Sci Dept, Leeds Inst Cardiovasc & Metab Med,Sch Med, Leeds, W Yorkshire, England; [Balen, A. H.] Leeds Teaching Hosp NHS Trust, Leeds Fertil, Leeds, W Yorkshire, England	University of Leeds; University of Leeds	Picton, HM (corresponding author), Univ Leeds, Reprod & Early Dev Res Grp, Discovery & Translat Sci Dept, Leeds Inst Cardiovasc & Metab Med,Sch Med, Leeds, W Yorkshire, England.	H.M.Picton@leeds.ac.uk						Balen AH, 2016, HUM REPROD UPDATE, V22, P687, DOI 10.1093/humupd/dmw025; Conti M, 2018, HUM REPROD UPDATE, V24, P245, DOI 10.1093/humupd/dmx040; Fauser BCJM, 2004, HUM REPROD, V19, P41, DOI 10.1093/humrep/deh098; O'Reilly MW, 2017, J CLIN ENDOCR METAB, V102, P3327, DOI 10.1210/jc.2017-00947; Risal S, 2019, NAT MED, V25, P1894, DOI 10.1038/s41591-019-0666-1; Scott R, 2018, CURR OPIN OBSTET GYN, V30, P163, DOI 10.1097/GCO.0000000000000455; Stener-Victorin E, 2010, J CLIN ENDOCR METAB, V95, P810, DOI 10.1210/jc.2009-1908; Tata B, 2018, NAT MED, V24, P834, DOI 10.1038/s41591-018-0035-5; Teede HJ, 2018, FERTIL STERIL, V110, P364, DOI 10.1016/j.fertnstert.2018.05.004; Wijeyaratne CN, 2013, EXPERT REV ENDOCRINO, V8, P71, DOI [10.1586/EEM.12.73, 10.1586/eem.12.73]	10	6	6	2	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	2019	25	12					1818	1820		10.1038/s41591-019-0678-x	http://dx.doi.org/10.1038/s41591-019-0678-x			4	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	JT2KO	31792458				2022-12-27	WOS:000500824900021
J	Schulien, I; Kemming, J; Oberhardt, V; Wild, K; Seidel, LM; Killmer, S; Sagar; Daul, F; Lago, MS; Decker, A; Luxenburger, H; Binder, B; Bettinger, D; Sogukpinar, O; Rieg, S; Panning, M; Huzly, D; Schwemmle, M; Kochs, G; Waller, CF; Nieters, A; Duerschmied, D; Emmerich, F; Mei, HRE; Schulz, AR; Llewellyn-Lacey, S; Price, DA; Boettler, T; Bengsch, B; Thimme, R; Hofmann, M; Neumann-Haefelin, C				Schulien, Isabel; Kemming, Janine; Oberhardt, Valerie; Wild, Katharina; Seidel, Lea M.; Killmer, Saskia; Sagar; Daul, Franziska; Salvat Lago, Marilyn; Decker, Annegrit; Luxenburger, Hendrik; Binder, Benedikt; Bettinger, Dominik; Sogukpinar, Oezlem; Rieg, Siegbert; Panning, Marcus; Huzly, Daniela; Schwemmle, Martin; Kochs, Georg; Waller, Cornelius F.; Nieters, Alexandra; Duerschmied, Daniel; Emmerich, Florian; Mei, Henrik E.; Schulz, Axel Ronald; Llewellyn-Lacey, Sian; Price, David A.; Boettler, Tobias; Bengsch, Bertram; Thimme, Robert; Hofmann, Maike; Neumann-Haefelin, Christoph			Characterization of pre-existing and induced SARS-CoV-2-specific CD8(+) T cells	NATURE MEDICINE			English	Article							CORONAVIRUS; RESPONSES	Emerging data indicate that SARS-CoV-2-specific CD8(+) T cells targeting different viral proteins are detectable in up to 70% of convalescent individuals(1-5). However, very little information is currently available about the abundance, phenotype, functional capacity and fate of pre-existing and induced SARS-CoV-2-specific CD8(+) T cell responses during the natural course of SARS-CoV-2 infection. Here, we define a set of optimal and dominant SARS-CoV-2-specific CD8(+) T cell epitopes. We also perform a high-resolution ex vivo analysis of pre-existing and induced SARS-CoV-2-specific CD8(+) T cells, applying peptide-loaded major histocompatibility complex class I (pMHCI) tetramer technology. We observe rapid induction, prolonged contraction and emergence of heterogeneous and functionally competent cross-reactive and induced memory CD8(+) T cell responses in cross-sectionally analyzed individuals with mild disease following SARS-CoV-2 infection and three individuals longitudinally assessed for their T cells pre- and post-SARS-CoV-2 infection. SARS-CoV-2-specific memory CD8(+) T cells exhibited functional characteristics comparable to influenza-specific CD8(+) T cells and were detectable in SARS-CoV-2 convalescent individuals who were seronegative for anti-SARS-CoV-2 antibodies targeting spike (S) and nucleoprotein (N). These results define cross-reactive and induced SARS-CoV-2-specific CD8(+) T cell responses as potentially important determinants of immune protection in mild SARS-CoV-2 infection. Functionally competent memory CD8(+) T cells specific for different viral epitopes are induced by SARS-CoV-2 infection and can be detected in the absence of virus-specific antibodies.	[Schulien, Isabel; Kemming, Janine; Oberhardt, Valerie; Wild, Katharina; Seidel, Lea M.; Killmer, Saskia; Daul, Franziska; Salvat Lago, Marilyn; Decker, Annegrit; Luxenburger, Hendrik; Binder, Benedikt; Bettinger, Dominik; Sogukpinar, Oezlem; Rieg, Siegbert; Boettler, Tobias; Bengsch, Bertram; Thimme, Robert; Hofmann, Maike; Neumann-Haefelin, Christoph] Univ Freiburg, Freiburg Univ Med Ctr, Dept Med Gastroenterol Hepatol Endocrin & Infect, Fac Med, Freiburg, Germany; [Kemming, Janine; Oberhardt, Valerie; Seidel, Lea M.; Daul, Franziska] Univ Freiburg, Fac Biol, Freiburg, Germany; [Wild, Katharina] Univ Freiburg, Fac Chem & Pharm, Freiburg, Germany; [Seidel, Lea M.] Univ Freiburg, SGBM Spemann Grad Sch Biol & Med, Freiburg, Germany; [Seidel, Lea M.; Bengsch, Bertram] Univ Freiburg, Signalling Res Ctr BIOSS, Freiburg, Germany; [Seidel, Lea M.; Bengsch, Bertram] Univ Freiburg, Signalling Res Ctr CIBSS, Freiburg, Germany; [Sagar] Max Planck Inst Immunobiol & Epigenet, Freiburg, Germany; [Luxenburger, Hendrik; Binder, Benedikt] Univ Freiburg, IMM PACT, Fac Med, Freiburg, Germany; [Bettinger, Dominik; Boettler, Tobias] Univ Freiburg, Berta Ottenstein Programme, Fac Med, Freiburg, Germany; [Panning, Marcus; Huzly, Daniela; Schwemmle, Martin; Kochs, Georg] Univ Freiburg, Freiburg Univ Med Ctr, Inst Virol, Fac Med, Freiburg, Germany; [Waller, Cornelius F.] Univ Freiburg, Freiburg Univ Med Ctr, Fac Med, Dept Haematol Oncol & Stem Cell Transplantat, Freiburg, Germany; [Nieters, Alexandra] Univ Freiburg, Freiburg Univ Med Ctr, Fac Med, Ctr Biobanking FREEZE Biobanking, Freiburg, Germany; [Duerschmied, Daniel] Univ Freiburg, Fac Med, Freiburg Univ Med Ctr, Dept Med Interdisciplinary Med Intens Care 3, Freiburg, Germany; [Emmerich, Florian] Univ Freiburg, Freiburg Univ Med Ctr, Inst Transfus Med & Gene Therapy, Fac Med, Freiburg, Germany; [Mei, Henrik E.; Schulz, Axel Ronald] German Rheumatism Res Ctr Berlin DRFZ, Berlin, Germany; [Llewellyn-Lacey, Sian; Price, David A.] Cardiff Univ, Sch Med, Div Infect & Immun, Cardiff, Wales; [Price, David A.] Cardiff Univ, Syst Immun Res Inst, Sch Med, Cardiff, Wales	University of Freiburg; University of Freiburg; University of Freiburg; University of Freiburg; University of Freiburg; University of Freiburg; Max Planck Society; University of Freiburg; University of Freiburg; University of Freiburg; University of Freiburg; University of Freiburg; University of Freiburg; University of Freiburg; Deutsches Rheuma-Forschungszentrum (DRFZ); Cardiff University; Cardiff University	Thimme, R; Hofmann, M; Neumann-Haefelin, C (corresponding author), Univ Freiburg, Freiburg Univ Med Ctr, Dept Med Gastroenterol Hepatol Endocrin & Infect, Fac Med, Freiburg, Germany.	robert.thimme@uniklinik-freiburg.de; maike.hofmann@uniklinik-freiburg.de; christoph.neumann-haefelin@uniklinik-freiburg.de	Hofmann, Maike/ABH-7388-2020; Price, David A/C-7876-2013; Boettler, Tobias/E-3331-2012; Duerschmied, D./K-8182-2015; Bengsch, Bertram/ABF-2142-2020; Neumann-Haefelin, Christoph/E-5550-2011	Price, David A/0000-0001-9416-2737; Boettler, Tobias/0000-0002-1195-055X; Duerschmied, D./0000-0001-5249-4012; Bengsch, Bertram/0000-0003-2552-740X; Neumann-Haefelin, Christoph/0000-0001-7351-1387; Huzly, Daniela/0000-0002-1641-5943; Waller, Cornelius/0000-0002-5777-0212; , Dr. Sagar/0000-0002-8657-4704; Luxenburger, Hendrik/0000-0001-7182-8620; Kemming, Janine/0000-0002-7967-9313	Medical Faculty - Federal Ministry of Education and Research [01KI1722]; COVID-19 research grant of the Ministry of Science, Research and Art, State of Baden-Wuerttemberg [CRC 1160-Project A02, CRC/TRR 179-Project 02, CRC 1160-Project A06, CRC/TRR 179-Project 04, BE-5496/5-1]; German Research Foundation (DFG) [272983813, CRC 1160, 256073931]; Margarete von Wrangell fellowship (State of Baden-Wuerttemberg); Berta-Ottenstein Programme, Faculty of Medicine, University of Freiburg; DFG [ME3644/5-1, 324736178]; Wellcome Trust Senior Investigator Award [100326/Z/12/Z]	Medical Faculty - Federal Ministry of Education and Research; COVID-19 research grant of the Ministry of Science, Research and Art, State of Baden-Wuerttemberg; German Research Foundation (DFG)(German Research Foundation (DFG)); Margarete von Wrangell fellowship (State of Baden-Wuerttemberg); Berta-Ottenstein Programme, Faculty of Medicine, University of Freiburg; DFG(German Research Foundation (DFG)); Wellcome Trust Senior Investigator Award(Wellcome Trust)	We thank all donors for participating in the current study and the FREEZE-Biobank Center for biobanking (Freiburg University Medical Center) and the Medical Faculty for support. The study was funded by the Federal Ministry of Education and Research (grant no. 01KI1722, to G.K., M.H., M.P., M.S. and R.T.) and by a COVID-19 research grant of the Ministry of Science, Research and Art, State of Baden-Wuerttemberg (to C.N.H. and B.B.). The presented work was also supported by CRC/TRR 179-Project 01 and CRC 1160-Project A02 (to R.T.), CRC/TRR 179-Project 02 and CRC 1160-Project A06 (to C.N.H.), CRC/TRR 179-Project 04 (to T.B.), CRC/TRR 179-Project 20 and CRC 1160-Project A02 (to M.H.), CRC/TRR 179-Project 21, CRC 1160-Project A03 and BE-5496/5-1 (to B.B.) of the German Research Foundation (DFG; TRR 179 project no. 272983813; CRC 1160 project no. 256073931). M.H. was supported by a Margarete von Wrangell fellowship (State of Baden-Wuerttemberg). D.B. and T.B. are supported by the Berta-Ottenstein Programme, Faculty of Medicine, University of Freiburg. H.E.M. was supported by DFG ME3644/5-1(project no. 324736178) and D.A.P. by a Wellcome Trust Senior Investigator Award (100326/Z/12/Z). The funding body had no role in the decision to write or submit the manuscript.	Alanio C, 2010, BLOOD, V115, P3718, DOI 10.1182/blood-2009-10-251124; Belkina AC, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-13055-y; Bendall SC, 2014, CELL, V157, P714, DOI 10.1016/j.cell.2014.04.005; Bengsch B, 2018, IMMUNITY, V48, P1029, DOI 10.1016/j.immuni.2018.04.026; Cao WCC, 2007, NEW ENGL J MED, V357, P1162, DOI 10.1056/NEJMc070348; Grifoni A, 2020, CELL, V181, P1489, DOI 10.1016/j.cell.2020.05.015; Grifoni A, 2020, CELL HOST MICROBE, V27, P671, DOI 10.1016/j.chom.2020.03.002; Hachim A, 2020, NAT IMMUNOL, V21, P1293, DOI 10.1038/s41590-020-0773-7; Juno JA, 2020, NAT MED, V26, DOI 10.1038/s41591-020-0995-0; Klenerman P, 2018, IMMUNOL REV, V283, P99, DOI 10.1111/imr.12653; Le Bert N, 2020, NATURE, V584, P457, DOI 10.1038/s41586-020-2550-z; Liu L, 2022, IEEE T KNOWL DATA EN, V34, P2293, DOI [10.1109/TKDE.2020.3004939, 10.1101/2020.06.17.153486]; Ng OW, 2016, VACCINE, V34, P2008, DOI 10.1016/j.vaccine.2016.02.063; Ni L, 2020, IMMUNITY, V52, P971, DOI 10.1016/j.immuni.2020.04.023; Nielsen M, 2003, PROTEIN SCI, V12, P1007, DOI 10.1110/ps.0239403; Peng YC, 2020, NAT IMMUNOL, V21, P1336, DOI [10.1038/s41590-020-0782-6, 10.1101/2020.06.05.134551]; Price DA, 2005, J EXP MED, V202, P1349, DOI 10.1084/jem.20051357; Sekine T, 2020, CELL, V183, P158, DOI 10.1016/j.cell.2020.08.017; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Stassen SV, 2020, BIOINFORMATICS, V36, P2778, DOI 10.1093/bioinformatics/btaa042; Urbani S, 2005, J EXP MED, V201, P675, DOI 10.1084/jem.20041058; van de Sandt CE, 2015, J INFECT DIS, V212, P81, DOI 10.1093/infdis/jiv018; Weiskopf D, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.abd2071; Wieland D, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15050; Zanotelli V., 2020, BODENMILLER GROUP IM	25	162	164	11	37	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	JAN	2021	27	1					78	+		10.1038/s41591-020-01143-2	http://dx.doi.org/10.1038/s41591-020-01143-2		NOV 2020	24	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	PS4ZO	33184509	Bronze			2022-12-27	WOS:000588901000001
J	Wilding, J				Wilding, John			Weight loss is the major player in bariatric surgery benefits	NATURE MEDICINE			English	Editorial Material							GASTRIC BYPASS; TYPE-2; ASSOCIATION	A metabolic study comparing people who lost weight through dieting or through bariatric surgery shows that the effects on diabetes are due to weight loss.	[Wilding, John] Univ Liverpool, Dept Cardiovasc & Metab Med, Inst Life Course & Med Sci, Liverpool, Merseyside, England; [Wilding, John] Aintree Univ Hosp NHS Fdn Trust, Ctr Clin Sci, Liverpool, Merseyside, England	University of Liverpool; Aintree University Hospitals NHS Foundation Trust; University of Liverpool	Wilding, J (corresponding author), Univ Liverpool, Dept Cardiovasc & Metab Med, Inst Life Course & Med Sci, Liverpool, Merseyside, England.; Wilding, J (corresponding author), Aintree Univ Hosp NHS Fdn Trust, Ctr Clin Sci, Liverpool, Merseyside, England.	j.p.h.wilding@liverpool.ac.uk	Wilding, John/ABB-6443-2020	Wilding, John/0000-0003-2839-8404				Chondronikola M, 2016, J INTERN MED, V280, P476, DOI 10.1111/joim.12527; Korner J, 2007, SURG OBES RELAT DIS, V3, P597, DOI 10.1016/j.soard.2007.08.004; Lean MEJ, 2018, LANCET, V391, P541, DOI 10.1016/S0140-6736(17)33102-1; Lim EL, 2011, DIABETOLOGIA, V54, P2506, DOI 10.1007/s00125-011-2204-7; Mingrone G, 2015, LANCET, V386, P964, DOI 10.1016/S0140-6736(15)00075-6; O'Kane M, 2020, OBES REV, V21, DOI 10.1111/obr.13087; PORIES WJ, 1995, ANN SURG, V222, P339, DOI 10.1097/00000658-199509000-00011; Salehi M, 2018, J CLIN ENDOCR METAB, V103, P2815, DOI 10.1210/jc.2018-00528; Sjostrom L, 2014, JAMA-J AM MED ASSOC, V311, P2297, DOI 10.1001/jama.2014.5988; Sumithran P, 2011, NEW ENGL J MED, V365, P1597, DOI 10.1056/NEJMoa1105816; Yoshino M, 2020, NEW ENGL J MED, V383, P721, DOI 10.1056/NEJMoa2003697	11	1	2	0	4	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2020	26	11					1678	1679		10.1038/s41591-020-1117-8	http://dx.doi.org/10.1038/s41591-020-1117-8		OCT 2020	2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	OT0SR	33060852				2022-12-27	WOS:000577964800001
J	Bockorny, B; Semenisty, V; Macarulla, T; Borazanci, E; Wolpin, BM; Stemmer, SM; Golan, T; Geva, R; Borad, MJ; Pedersen, KS; Park, JO; Ramirez, RA; Abad, DG; Feliu, J; Munoz, A; Ponz-Sarvise, M; Peled, A; Lustig, TM; Bohana-Kashtan, O; Shaw, SM; Sorani, E; Chaney, M; Kadosh, S; Haras, AV; Von Hoff, DD; Hidalgo, M				Bockorny, Bruno; Semenisty, Valerya; Macarulla, Teresa; Borazanci, Erkut; Wolpin, Brian M.; Stemmer, Salomon M.; Golan, Talia; Geva, Ravit; Borad, Mitesh J.; Pedersen, Katrina S.; Park, Joon Oh; Ramirez, Robert A.; Abad, David G.; Feliu, Jaime; Munoz, Andres; Ponz-Sarvise, Mariano; Peled, Amnon; Lustig, Tzipora M.; Bohana-Kashtan, Osnat; Shaw, Stephen M.; Sorani, Ella; Chaney, Marya; Kadosh, Shaul; Haras, Abi Vainstein; Von Hoff, Daniel D.; Hidalgo, Manuel			BL-8040, a CXCR4 antagonist, in combination with pembrolizumab and chemotherapy for pancreatic cancer: the COMBAT trial	NATURE MEDICINE			English	Article							HUMAN CD34(+) CELLS; MOBILIZATION; IMMUNOTHERAPY; INHIBITORS; EFFICACY; ANTIBODY; GROWTH; BKT140	Results from the phase IIa COMBAT trial combining CXCR4 and PD-1 inhibition in patients with metastatic cancer show encouraging clinical responses in association with enhanced antitumor immune activation. Programmed cell death 1 (PD-1) inhibitors have limited effect in pancreatic ductal adenocarcinoma (PDAC), underscoring the need to co-target alternative pathways. CXC chemokine receptor 4 (CXCR4) blockade promotes T cell tumor infiltration and is synergistic with anti-PD-1 therapy in PDAC mouse models. We conducted a phase IIa, open-label, two-cohort study to assess the safety, efficacy and immunobiological effects of the CXCR4 antagonist BL-8040 (motixafortide) with pembrolizumab and chemotherapy in metastatic PDAC (). The primary outcome was objective response rate (ORR). Secondary outcomes were overall survival (OS), disease control rate (DCR) and safety. In cohort 1, 37 patients with chemotherapy-resistant disease received BL-8040 and pembrolizumab. The DCR was 34.5% in the evaluable population (modified intention to treat, mITT; N = 29), including nine patients (31%) with stable disease and one patient (3.4%) with partial response. Median OS (mOS) was 3.3 months in the ITT population. Notably, in patients receiving study drugs as second-line therapy, the mOS was 7.5 months. BL-8040 increased CD8(+) effector T cell tumor infiltration, decreased myeloid-derived suppressor cells (MDSCs) and further decreased circulating regulatory T cells. In cohort 2, 22 patients received BL-8040 and pembrolizumab with chemotherapy, with an ORR, DCR and median duration of response of 32%, 77% and 7.8 months, respectively. These data suggest that combined CXCR4 and PD-1 blockade may expand the benefit of chemotherapy in PDAC and warrants confirmation in subsequent randomized trials.	[Bockorny, Bruno] Beth Israel Deaconess Med Ctr, Div Med Oncol, Boston, MA 02215 USA; [Bockorny, Bruno; Wolpin, Brian M.] Harvard Med Sch, Boston, MA 02115 USA; [Semenisty, Valerya] Rambam Hlth Care Campus, Oncol, Haifa, Israel; [Macarulla, Teresa] Vall dHebron Univ Hosp, Vall dHebron Inst Oncol, IOB Quiron, Barcelona, Spain; [Borazanci, Erkut; Von Hoff, Daniel D.] HonorHlth Res Inst, Scottsdale, AZ USA; [Borazanci, Erkut; Von Hoff, Daniel D.] Translat Genom Res Inst, Phoenix, AZ USA; [Wolpin, Brian M.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Stemmer, Salomon M.] Rabin Med Ctr, Davidoff Ctr, Inst Oncol, Petah Tiqwa, Israel; [Stemmer, Salomon M.; Golan, Talia] Tel Aviv Univ, Sackler Fac Med, Tel Aviv, Israel; [Golan, Talia] Chaim Sheba Med Ctr, Oncol, Tel Hashomer, Israel; [Geva, Ravit] Tel Aviv Sourasky Med Ctr, Oncol, Tel Aviv, Israel; [Geva, Ravit] Tel Aviv Univ, Tel Aviv, Israel; [Borad, Mitesh J.] Mayo Clin Canc Ctr, Oncol, Scottsdale, AZ USA; [Pedersen, Katrina S.] Washington Univ, Sch Med, Oncol, St Louis, MO USA; [Park, Joon Oh] Sungkyunkwan Univ, Samsung Med Ctr, Hematol Oncol, Sch Med, Seoul, South Korea; [Ramirez, Robert A.] Ochsner Med Ctr, Oncol, New Orleans, LA USA; [Abad, David G.] Grp Oncol Fuenlabrada, Madrid, Spain; [Feliu, Jaime] Inst Invest Hosp Univ La Paz IdIPAZ, CIBERONC, Catedra UAM AMGEN, Madrid, Spain; [Munoz, Andres] Univ Complutense, Inst Invest Sanitaria Hosp Gregorio Maranon, Med Oncol Serv, Madrid, Spain; [Ponz-Sarvise, Mariano] Univ Navarra, Clin Univ Navarra, IDISNA, Pamplona, Spain; [Ponz-Sarvise, Mariano] Univ Navarra, Program Solid Tumors CIMA, IDISNA, Pamplona, Spain; [Peled, Amnon] Hebrew Univ Jerusalem, Goldyne Savad Inst Gene Therapy, Jerusalem, Israel; [Lustig, Tzipora M.; Bohana-Kashtan, Osnat; Shaw, Stephen M.; Sorani, Ella; Haras, Abi Vainstein] BioLineRx Ltd, Modiin, Israel; [Chaney, Marya] Merck & Co Inc, Early Oncol Dev, Kenilworth, NJ USA; [Kadosh, Shaul] StatExcellence Ltd, Nesher, Israel; [Hidalgo, Manuel] Weill Cornell Med, Joan & Sanford I Weill Dept Med, New York, NY 10065 USA; [Hidalgo, Manuel] New York Presbyterian Hosp, New York, NY 10038 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Rambam Health Care Campus; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut d'Oncologia (VHIO); Translational Genomics Research Institute; Harvard University; Dana-Farber Cancer Institute; Rabin Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Chaim Sheba Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; Tel Aviv University; Mayo Clinic; Mayo Clinic Phoenix; Washington University (WUSTL); Sungkyunkwan University (SKKU); Samsung Medical Center; Ochsner Health System; CIBER - Centro de Investigacion Biomedica en Red; CIBERONC; Hospital Universitario La Paz; Complutense University of Madrid; University of Navarra; University of Navarra; Hebrew University of Jerusalem; Merck & Company; Cornell University; NewYork-Presbyterian Hospital	Hidalgo, M (corresponding author), Weill Cornell Med, Joan & Sanford I Weill Dept Med, New York, NY 10065 USA.; Hidalgo, M (corresponding author), New York Presbyterian Hosp, New York, NY 10038 USA.	mah4006@med.cornell.edu	Ramirez, Robert A/G-4443-2015; Ponz-Sarvise, Mariano/H-4104-2017	Ponz-Sarvise, Mariano/0000-0002-3240-729X; Pedersen, Katrina/0000-0003-2793-6901; Borazanci, Erkut/0000-0001-5136-5462; Ramirez, Robert/0000-0001-8762-5852; Macarulla, Teresa/0000-0002-5856-4082	BioLineRx; Merck Sharp Dohme Corp.	BioLineRx; Merck Sharp Dohme Corp.(Merck & Company)	We thank the patients and their families for their participation in this study. This work was supported by BioLineRx and Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc. (Kenilworth, NJ, USA). Flow cytometry acquisition was performed at Sheba Medical Center (Tel HaShomer, Ramat Gan, Israel). MultiOmyx tests and analysis were performed at Neogenomics Laboratories (Aliso Viejo, CA, USA). The sponsor BioLineRx participated in the conception of this study. Data were analyzed and interpreted by BioLineRx in collaboration with the academic authors. The sponsor staff, M.H. and B.B., had access to all of the data. All authors vouch for the accuracy and completeness of the data and analyses reported and for the fidelity of the study to the protocol.	Abraham M, 2009, LEUKEMIA, V23, P1378, DOI 10.1038/leu.2009.56; Abraham M, 2007, STEM CELLS, V25, P2158, DOI 10.1634/stemcells.2007-0161; Abraham M, 2017, CLIN CANCER RES, V23, P6790, DOI 10.1158/1078-0432.CCR-16-2919; Benedicto A, 2018, ONCOL REP, V39, P2022, DOI 10.3892/or.2018.6254; Blando J, 2019, P NATL ACAD SCI USA, V116, P1692, DOI 10.1073/pnas.1811067116; Brahmer JR, 2012, NEW ENGL J MED, V366, P2455, DOI 10.1056/NEJMoa1200694; Brown JS, 2018, BRIT J CANCER, V118, P312, DOI 10.1038/bjc.2017.376; Cubas R, 2018, J IMMUNOL, V201, P2273, DOI 10.4049/jimmunol.1800275; Deng Y, 2017, ONCOGENE, V36, P1090, DOI 10.1038/onc.2016.273; Fahham D, 2012, J THORAC CARDIOV SUR, V144, P1167, DOI 10.1016/j.jtcvs.2012.07.031; Feig C, 2013, P NATL ACAD SCI USA, V110, P20212, DOI 10.1073/pnas.1320318110; Gaur P, 2018, J CLIN ONCOL, V36, DOI 10.1200/JCO.2018.36.5_suppl.73; Gerdes MJ, 2013, P NATL ACAD SCI USA, V110, P11982, DOI 10.1073/pnas.1300136110; Hu ZSI, 2018, CLIN CANCER RES, V24, P1326, DOI 10.1158/1078-0432.CCR-17-3099; Klein S, 2018, CANCER RES, V78, P1471, DOI 10.1158/0008-5472.CAN-17-0454; Marabelle A, 2020, J CLIN ONCOL, V38, P1, DOI 10.1200/JCO.19.02105; McKenzie JA, 2018, JNCI-J NATL CANCER I, V110, P777, DOI 10.1093/jnci/djx257; O'Reilly EM, 2019, JAMA ONCOL, V5, P1431, DOI 10.1001/jamaoncol.2019.1588; Peled A, 2019, J IMMUNOTHER CANCER, V7; Peled A, 2014, CLIN CANCER RES, V20, P469, DOI 10.1158/1078-0432.CCR-13-1302; Royal RE, 2010, J IMMUNOTHER, V33, P828, DOI 10.1097/CJI.0b013e3181eec14c; Schwickart M, 2016, CYTOM PART B-CLIN CY, V90, P209, DOI 10.1002/cyto.b.21327; Seo YD, 2019, CLIN CANCER RES, V25, P3934, DOI 10.1158/1078-0432.CCR-19-0081; Tamamura H, 2003, ORG BIOMOL CHEM, V1, P3656, DOI 10.1039/b306473p; Tamamura H, 2003, FEBS LETT, V550, P79, DOI 10.1016/S0014-5793(03)00824-X; Wang-Gillam A, 2019, EUR J CANCER, V108, P78, DOI 10.1016/j.ejca.2018.12.007; Wang-Gillam A, 2016, LANCET, V387, P545, DOI 10.1016/S0140-6736(15)00986-1; Zitvogel L, 2008, NAT REV IMMUNOL, V8, P59, DOI 10.1038/nri2216	28	177	183	11	74	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	JUN	2020	26	6					878	+		10.1038/s41591-020-0880-x	http://dx.doi.org/10.1038/s41591-020-0880-x		MAY 2020	18	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	LZ3ZG	32451495				2022-12-27	WOS:000535406400001
J	Zhou, YY; Song, WM; Andhey, PS; Swain, A; Levy, T; Miller, KR; Poliani, PL; Cominelli, M; Grover, S; Gilfillan, S; Cella, M; Ulland, TK; Zaitsev, K; Miyashita, A; Ikeuchi, T; Sainouchi, M; Kakita, A; Bennett, DA; Schneider, JA; Nichols, MR; Beausoleil, SA; Ulrich, JD; Holtzman, DM; Artyomov, MN; Colonna, M				Zhou, Yingyue; Song, Wilbur M.; Andhey, Prabhakar S.; Swain, Amanda; Levy, Tyler; Miller, Kelly R.; Poliani, Pietro L.; Cominelli, Manuela; Grover, Shikha; Gilfillan, Susan; Cella, Marina; Ulland, Tyler K.; Zaitsev, Konstantin; Miyashita, Akinori; Ikeuchi, Takeshi; Sainouchi, Makoto; Kakita, Akiyoshi; Bennett, David A.; Schneider, Julie A.; Nichols, Michael R.; Beausoleil, Sean A.; Ulrich, Jason D.; Holtzman, David M.; Artyomov, Maxim N.; Colonna, Marco			Human and mouse single-nucleus transcriptomics reveal TREM2-dependent and TREM2-independent cellular responses in Alzheimer's disease (vol 26, pg 131, 2020)	NATURE MEDICINE			English	Correction												martyomov@wustl.edu; mcolonna@wustl.edu	Cominelli, Manuela/J-9988-2016	Cominelli, Manuela/0000-0002-4520-6104; Sainouchi, Makoto/0000-0002-3451-3600; Zaitsev, Konstantin/0000-0003-3749-0886; Zhou, Yingyue/0000-0002-0923-1046				Zhou YY, 2020, NAT MED, V26, P131, DOI 10.1038/s41591-019-0695-9	1	1	1	3	12	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	JUN	2020	26	6					981	981		10.1038/s41591-020-0922-4	http://dx.doi.org/10.1038/s41591-020-0922-4		MAY 2020	1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	LZ3ZG	32409732	Bronze			2022-12-27	WOS:000532886000001
J	Longley, RJ; White, MT; Takashima, E; Brewster, J; Morita, M; Harbers, M; Obadia, T; Robinson, LJ; Matsuura, F; Liu, ZSJ; Li-Wai-Suen, CSN; Tham, WH; Healer, J; Huon, C; Chitnis, CE; Nguitragool, W; Monteiro, W; Proietti, C; Doolan, DL; Siqueira, AM; Ding, XC; Gonzalez, IJ; Kazura, J; Lacerda, M; Sattabongkot, J; Tsuboi, T; Mueller, I				Longley, Rhea J.; White, Michael T.; Takashima, Eizo; Brewster, Jessica; Morita, Masayuki; Harbers, Matthias; Obadia, Thomas; Robinson, Leanne J.; Matsuura, Fumie; Liu, Zoe S. J.; Li-Wai-Suen, Connie S. N.; Tham, Wai-Hong; Healer, Julie; Huon, Christele; Chitnis, Chetan E.; Nguitragool, Wang; Monteiro, Wuelton; Proietti, Carla; Doolan, Denise L.; Siqueira, Andre M.; Ding, Xavier C.; Gonzalez, Iveth J.; Kazura, James; Lacerda, Marcus; Sattabongkot, Jetsumon; Tsuboi, Takafumi; Mueller, Ivo			Development and validation of serological markers for detecting recent Plasmodium vivax infection	NATURE MEDICINE			English	Article							NATURALLY ACQUIRED ANTIBODIES; FALCIPARUM; MALARIA; IDENTIFICATION; PROTECTION; EXPOSURE; ANTIGENS	A major gap in the Plasmodium vivax elimination toolkit is the identification of individuals carrying clinically silent and undetectable liver-stage parasites, called hypnozoites. This study developed a panel of serological exposure markers capable of classifying individuals with recent P. vivax infections who have a high likelihood of harboring hypnozoites. We measured IgG antibody responses to 342 P. vivax proteins in longitudinal clinical cohorts conducted in Thailand and Brazil and identified candidate serological markers of exposure. Candidate markers were validated using samples from year-long observational cohorts conducted in Thailand, Brazil and the Solomon Islands and antibody responses to eight P. vivax proteins classified P. vivax infections in the previous 9 months with 80% sensitivity and specificity. Mathematical models demonstrate that a serological testing and treatment strategy could reduce P. vivax prevalence by 59-69%. These eight antibody responses can serve as a biomarker, identifying individuals who should be targeted with anti-hypnozoite therapy.	[Longley, Rhea J.; Brewster, Jessica; Robinson, Leanne J.; Liu, Zoe S. J.; Li-Wai-Suen, Connie S. N.; Mueller, Ivo] Walter & Eliza Hall Inst Med Res, Populat Hlth & Immun Div, Melbourne, Vic, Australia; [Longley, Rhea J.; Robinson, Leanne J.; Liu, Zoe S. J.; Li-Wai-Suen, Connie S. N.; Tham, Wai-Hong; Healer, Julie; Mueller, Ivo] Univ Melbourne, Dept Med Biol, Melbourne, Vic, Australia; [Longley, Rhea J.; Sattabongkot, Jetsumon] Mahidol Univ, Fac Trop Med, Mahidol Vivax Res Unit, Bangkok, Thailand; [White, Michael T.; Obadia, Thomas; Mueller, Ivo] Inst Pasteur, Dept Parasites & Insectes Vecteurs, Unite Malaria Parasites & Hotes, Paris, France; [Takashima, Eizo; Morita, Masayuki; Tsuboi, Takafumi] Ehime Univ, Proteo Sci Ctr, Div Malaria Res, Matsuyama, Ehime, Japan; [Harbers, Matthias; Matsuura, Fumie] CellFree Sci Co Ltd, Yokohama, Kanagawa, Japan; [Harbers, Matthias] RIKEN, Ctr Integrated Med Sci IMS, Yokohama, Kanagawa, Japan; [Obadia, Thomas] CNRS, USR 3756, Inst Pasteur, Hub Bioinformat & Biostat,Dept Biol Computat, Paris, France; [Robinson, Leanne J.] Burnet Inst, Melbourne, Vic, Australia; [Tham, Wai-Hong; Healer, Julie] Walter & Eliza Hall Inst Med Res, Infect & Immun Div, Melbourne, Vic, Australia; [Huon, Christele; Chitnis, Chetan E.] Inst Pasteur, Dept Parasites & Insect Vectors, Malaria Parasite Biol & Vaccines, Paris, France; [Nguitragool, Wang] Mahidol Univ, Fac Trop Med, Dept Mol Trop Med & Genet, Bangkok, Thailand; [Monteiro, Wuelton; Lacerda, Marcus] Fundacao Med Trop Dr Heitor Vieira Dourado, Manaus, Amazonas, Brazil; [Monteiro, Wuelton] Univ Estado Amazonas, Manaus, Amazonas, Brazil; [Proietti, Carla; Doolan, Denise L.] James Cook Univ, Australian Inst Trop Hlth & Med, Ctr Mol Therapeut, Cairns, Qld, Australia; [Proietti, Carla; Doolan, Denise L.] QIMR Berghofer Med Res Inst, Brisbane, Qld, Australia; [Siqueira, Andre M.] Fiocruz MS, Inst Nacl Infectol Evandro Chagas, Rio De Janeiro, Brazil; [Ding, Xavier C.; Gonzalez, Iveth J.] Fdn Innovat New Diagnost, Geneva, Switzerland; [Kazura, James] Case Western Reserve Univ, Ctr Global Hlth & Dis, Cleveland, OH 44106 USA; [Lacerda, Marcus] Fiocruz MS, Inst Leonidas & Maria Deane, Manaus, Amazonas, Brazil	University of Melbourne; Mahidol University; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Ehime University; RIKEN; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Burnet Institute; Walter & Eliza Hall Institute; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Mahidol University; Universidade do Estado do Amazonas; James Cook University; QIMR Berghofer Medical Research Institute; Fundacao Oswaldo Cruz; Foundation For Innovative New Diagnostics; Case Western Reserve University; Fundacao Oswaldo Cruz	Mueller, I (corresponding author), Walter & Eliza Hall Inst Med Res, Populat Hlth & Immun Div, Melbourne, Vic, Australia.; Mueller, I (corresponding author), Univ Melbourne, Dept Med Biol, Melbourne, Vic, Australia.; Mueller, I (corresponding author), Inst Pasteur, Dept Parasites & Insectes Vecteurs, Unite Malaria Parasites & Hotes, Paris, France.	mueller@wehi.edu.au	Tsuboi, Takafumi/AAK-6145-2021; Prachumsri, Jetsumon/AAZ-7732-2021; Siqueira, Andre M/G-1340-2010; Tham, Wai-Hong/L-3173-2018	Siqueira, Andre M/0000-0003-2208-0294; Doolan, Denise/0000-0001-7354-8817; Li Wai Suen, Connie/0000-0003-0529-0804; Tham, Wai-Hong/0000-0001-7950-8699; Liu, Zoe Shih-Jung/0000-0002-0269-0119; Harbers, Matthias/0000-0002-5613-7220; Proietti, Carla/0000-0002-6290-0261; Sattabongkot, Jetsumon/0000-0002-3938-4588; Nguitragool, Wang/0000-0002-5484-7130; Takashima, Eizo/0000-0001-9070-8499	Global Health Innovative Technology Fund [T2015-142]; National Institute of Allergy and Infectious Diseases (National Institutes of Health) [5R01 AI 104822, 5U19AI089686-06]; National Health and Medical Research Council Australia [1092789, 1134989, 1143187]; TransEPI consortium - Bill and Melinda Gates Foundation; FIND; Australian government; British government; National Research Council of Thailand; NHMRC Senior Research Fellowship [1043345]; NHMRC Principal Research Fellowship [1023636]; Japan Society for the Promotion of Science [JP15H05276, JP16K15266]; Howard Hughes Medical Institute-Wellcome Trust [208693/Z/17/Z]; WEHI	Global Health Innovative Technology Fund; National Institute of Allergy and Infectious Diseases (National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Health and Medical Research Council Australia(National Health and Medical Research Council (NHMRC) of Australia); TransEPI consortium - Bill and Melinda Gates Foundation; FIND; Australian government(Australian GovernmentCGIAR); British government; National Research Council of Thailand(National Research Council of Thailand (NRCT)); NHMRC Senior Research Fellowship(National Health and Medical Research Council (NHMRC) of Australia); NHMRC Principal Research Fellowship(National Health and Medical Research Council (NHMRC) of Australia); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Howard Hughes Medical Institute-Wellcome Trust; WEHI	We acknowledge the extensive field teams that contributed to sample collection and qPCR assays, including A. Kuehn, Y. W. Quah, P. Sripoorote and A. Waltmann. We thank all the individuals who participated in each of the studies and thank the Australian and Thai Red Cross and the RBB for donation of plasma samples. We thank the Volunteer Blood Donor Registry at WEHI for donation of plasma samples and L. Laskos and J. Harris for their collection and advice. We thank C. King (Case Western Reserve University) for provision of the Papua New Guinea control plasma pool. M. Bahlo (Walter and Eliza Hall Institute) is thanked for her advice on algorithm development. We acknowledge funding from the Global Health Innovative Technology Fund (T2015-142 to I.M.), the National Institute of Allergy and Infectious Diseases (National Institutes of Health grant 5R01 AI 104822 to J.S. and 5U19AI089686-06 to J.K.) and the National Health and Medical Research Council Australia (1092789 and 1134989 to I.M. and 1143187 to W.-H.T.). Cohort samples were derived from field studies originally funded by the TransEPI consortium (supported by the Bill and Melinda Gates Foundation). This work has been supported by FIND with funding from the Australian and British governments. We also acknowledge support from the National Research Council of Thailand. This work was made possible through Victorian State Government Operational Infrastructure Support and Australian Government National Health and Medical Research Council (NHMRC) Independent Research Institute Infrastructure Support Scheme. I.M. is supported by an NHMRC Senior Research Fellowship (1043345). D.L.D. is supported by an NHMRC Principal Research Fellowship (1023636). T.T. was supported in part by Japan Society for the Promotion of Science Grant-in-Aid for Scientific Research (KAKENHI, JP15H05276, JP16K15266). W.H.T. is a Howard Hughes Medical Institute-Wellcome Trust International Research Scholar (208693/Z/17/Z). R.J.L. received the Page Betheras Award from WEHI to provide funding for technical support for this project during parental leave. M. V.G.L. and W.M.M. are fellows of the Brazilian National Council for Scientific and Technological Development.	Alonso PL, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000406; Arama C, 2015, OPEN FORUM INFECT DI, V2, DOI 10.1093/ofid/ofv118; Battle KE, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-144; Borremans B, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004882; Boyle MJ, 2017, INT J PARASITOL, V47, P99, DOI 10.1016/j.ijpara.2016.06.002; Cheng Y, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-1837-5; Cole-Tobian JL, 2009, INFECT IMMUN, V77, P4009, DOI 10.1128/IAI.00158-09; Cook J, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-86; Cook J, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-169; Ding XC, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005516; Douglas NM, 2011, CLIN INFECT DIS, V52, P612, DOI 10.1093/cid/ciq249; Fornace KM, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006432; Franca CT, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005014; Franca CT, 2016, PLOS NEGLECT TROP D, V10, DOI [10.1371/journal.pntd.0004639, 10.1371/journal.pntd.0005091]; Franca CT, 2017, ELIFE, V6, DOI 10.7554/eLife.28673; Greenhouse B, 2018, AM J TROP MED HYG, V99, P1120, DOI 10.4269/ajtmh.18-0303; Gruszczyk J, 2018, SCIENCE, V359, P48, DOI 10.1126/science.aan1078; Gwyn S, 2016, J IMMUNOL METHODS, V435, P27, DOI 10.1016/j.jim.2016.05.008; Harris I, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-254; Healer J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072504; Helb DA, 2015, P NATL ACAD SCI USA, V112, pE4438, DOI 10.1073/pnas.1501705112; Herman LS, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006457; Hester J, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002569; Hietanen J, 2016, INFECT IMMUN, V84, P677, DOI 10.1128/IAI.01117-15; Jiang JQ, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0055729, 10.1371/journal.pone.0068482]; KIRKPATRICK S, 1983, SCIENCE, V220, P671, DOI 10.1126/science.220.4598.671; Ladeia-Andrade S, 2007, MEM I OSWALDO CRUZ, V102, P943, DOI 10.1590/S0074-02762007000800009; Landry ML, 2011, CURR OPIN PEDIATR, V23, P91, DOI 10.1097/MOP.0b013e328341ebd9; Longley RJ, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005888; Longley RJ, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-1826-8; Longley RJ, 2016, CLIN VACCINE IMMUNOL, V23, P117, DOI 10.1128/CVI.00501-15; LOOAREESUWAN S, 1987, LANCET, V2, P1052, DOI 10.1016/S0140-6736(87)91479-6; Lu F, 2014, J PROTEOMICS, V102, P66, DOI 10.1016/j.jprot.2014.02.029; Mogeni P, 2017, J INFECT DIS, V216, P1091, DOI 10.1093/infdis/jix321; Moreira CM, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0884-z; Mueller I, 2009, LANCET INFECT DIS, V9, P555, DOI 10.1016/S1473-3099(09)70177-X; Nguitragool W, 2019, INT J PARASITOL, V49, P455, DOI 10.1016/j.ijpara.2019.01.004; Ntege EH, 2017, EXPERT REV VACCINES, V16, P769, DOI 10.1080/14760584.2017.1341317; Ong KIC, 2017, BMJ GLOB HEALTH, V2, DOI 10.1136/bmjgh-2017-000415; Parker DM, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0712-5; Quah YW, 2019, MALARIA J, V18, DOI 10.1186/s12936-019-2727-9; Rabinovich RN, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002456; Richards JS, 2010, CLIN INFECT DIS, V51, pE50, DOI 10.1086/656413; Robinson LJ, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001891; Rosanas-Urgell A, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-361; Soares IS, 1999, MOL MED, V5, P459; Sutanto I, 2018, CLIN INFECT DIS, V67, P1364, DOI 10.1093/cid/ciy231; Tibshirani R., 2009, SPRINGER SERIES STAT, DOI [10.1007/978-0-387-84858-7, DOI 10.1007/978-0-387-84858-7]; Tsuboi T, 2008, INFECT IMMUN, V76, P1702, DOI 10.1128/IAI.01539-07; Waltmann A, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003758; Wampfler R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076316; Wang B, 2015, INFECT IMMUN, V83, P3083, DOI 10.1128/IAI.03067-14; Welch RJ, 2008, CLIN VACCINE IMMUNOL, V15, P1483, DOI 10.1128/CVI.00174-08; White MT, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05860-8; White MT, 2018, MALARIA J, V17, DOI 10.1186/s12936-018-2318-1; White MT, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2016.0048; White MT, 2014, J INFECT DIS, V210, P1115, DOI 10.1093/infdis/jiu219; White NJ, 2012, ADV PARASIT, V80, P113, DOI 10.1016/B978-0-12-397900-1.00002-5; White NJ, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-297; Woodberry T, 2008, J INFECT DIS, V198, P134, DOI 10.1086/588711; World Health Organization, 2018, MAL SURV MON EV REF	61	44	46	2	7	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	MAY	2020	26	5					741	+		10.1038/s41591-020-0841-4	http://dx.doi.org/10.1038/s41591-020-0841-4			16	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	ML1MY	32405064	Green Submitted			2022-12-27	WOS:000549240200001
J	Schalper, KA; Carleton, M; Zhou, M; Chen, T; Feng, Y; Huang, SP; Walsh, AM; Baxi, V; Pandya, D; Baradet, T; Locke, D; Wu, QY; Reilly, TP; Phillips, P; Nagineni, V; Gianino, N; Gu, JL; Zhao, HY; Perez-Gracia, JL; Sanmamed, MF; Melero, I				Schalper, Kurt A.; Carleton, Michael; Zhou, Ming; Chen, Tian; Feng, Ye; Huang, Shu-Pang; Walsh, Alice M.; Baxi, Vipul; Pandya, Dimple; Baradet, Timothy; Locke, Darren; Wu, Qiuyan; Reilly, Timothy P.; Phillips, Penny; Nagineni, Venkata; Gianino, Nicole; Gu, Jianlei; Zhao, Hongyu; Luis Perez-Gracia, Jose; Sanmamed, Miguel F.; Melero, Ignacio			Elevated serum interleukin-8 is associated with enhanced intratumor neutrophils and reduced clinical benefit of immune-checkpoint inhibitors	NATURE MEDICINE			English	Article							SUPPRESSOR-CELLS; NIVOLUMAB; PD-1; IPILIMUMAB; DOCETAXEL	Serum interleukin-8 (IL-8) levels and tumor neutrophil infiltration are associated with worse prognosis in advanced cancers. Here, using a large-scale retrospective analysis, we show that elevated baseline serum IL-8 levels are associated with poor outcome in patients (n = 1,344) with advanced cancers treated with nivolumab and/or ipilimumab, everolimus or docetaxel in phase 3 clinical trials, revealing the importance of assessing serum IL-8 levels in identifying unfavorable tumor immunobiology and as an independent biomarker in patients receiving immune-checkpoint inhibitors.	[Schalper, Kurt A.; Nagineni, Venkata; Gianino, Nicole] Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06510 USA; [Carleton, Michael; Baradet, Timothy; Locke, Darren; Phillips, Penny] Bristol Myers Squibb, Dept Translat Med, Princeton, NJ USA; [Zhou, Ming; Chen, Tian; Feng, Ye; Huang, Shu-Pang] Bristol Myers Squibb, Dept Global Biometr Sci, Princeton, NJ USA; [Walsh, Alice M.; Baxi, Vipul] Bristol Myers Squibb, Dept Translat Bioinformat, Princeton, NJ USA; [Pandya, Dimple; Wu, Qiuyan; Reilly, Timothy P.] Bristol Myers Squibb, Dept Res & Early Dev, Princeton, NJ USA; [Gu, Jianlei; Zhao, Hongyu] Yale Univ, Sch Publ Hlth, Dept Biostat, New Haven, CT USA; [Luis Perez-Gracia, Jose; Sanmamed, Miguel F.; Melero, Ignacio] Clin Univ Navarra, Oncol Dept, Pamplona, Spain; [Luis Perez-Gracia, Jose; Sanmamed, Miguel F.; Melero, Ignacio] Ctr Invest Biomed Red Canc CIBERONC, Madrid, Spain; [Sanmamed, Miguel F.] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT USA; [Sanmamed, Miguel F.; Melero, Ignacio] Univ Navarra, Ctr Invest Med Aplicada CIMA, Dept Immunol & Immunotherapy, Pamplona, Spain	Yale University; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Yale University; University of Navarra; CIBER - Centro de Investigacion Biomedica en Red; CIBERONC; Yale University; University of Navarra	Schalper, KA (corresponding author), Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06510 USA.; Melero, I (corresponding author), Clin Univ Navarra, Oncol Dept, Pamplona, Spain.; Melero, I (corresponding author), Ctr Invest Biomed Red Canc CIBERONC, Madrid, Spain.; Melero, I (corresponding author), Univ Navarra, Ctr Invest Med Aplicada CIMA, Dept Immunol & Immunotherapy, Pamplona, Spain.	kurt.schalper@yale.edu; imelero@unav.es	Gu, Jianlei/ABD-5512-2020; Melero, Ignacio/T-7600-2019; Perez-Gracia, Jose Luis/I-8372-2017; Zhou, Ming/L-7408-2013; F Sanmamed, Miguel/I-5572-2017	Melero, Ignacio/0000-0002-1360-348X; Perez-Gracia, Jose Luis/0000-0003-4941-9075; Zhou, Ming/0000-0003-4101-3185; F Sanmamed, Miguel/0000-0002-7295-6074; Gu, Jian-lei/0000-0002-9337-5017	Bristol-Myers Squibb; Yale SPORE in Lung Cancer [P50CA196530]; Department of Defense-Lung Cancer Research Program [W81XWH-16-1-0160]; Yale Cancer Center Support Grant [P30CA016359]; Stand Up To Cancer-American Cancer Society Lung Cancer Dream Team Translational Research Grant [SU2C-AACR-DT1715, SU2C-AACR-DT22-17]; Mark Foundation [19-029-MIA]; MINECO [SAF2017-83267-C2-1-R]; European Union's Horizon 2020 research and innovation program [635122]; Fundacion de la Asociacion Espanola Contra el Cancer (AECC); Instituto de Salud Carlos III, Fondo de Investigacion Sanitaria (Spain)	Bristol-Myers Squibb(Bristol-Myers Squibb); Yale SPORE in Lung Cancer; Department of Defense-Lung Cancer Research Program; Yale Cancer Center Support Grant; Stand Up To Cancer-American Cancer Society Lung Cancer Dream Team Translational Research Grant; Mark Foundation; MINECO(Spanish Government); European Union's Horizon 2020 research and innovation program; Fundacion de la Asociacion Espanola Contra el Cancer (AECC); Instituto de Salud Carlos III, Fondo de Investigacion Sanitaria (Spain)(Instituto de Salud Carlos III)	We thank the patients and their families who made this study possible and the clinical study teams who participated in this study; DAKO for collaborative development of the PD-L1 IHC 28-8 pharmDx assay; Bristol-Myers Squibb and ONO Pharmaceutical Company Ltd. This study was supported by Bristol-Myers Squibb, Yale SPORE in Lung Cancer (P50CA196530), Department of Defense-Lung Cancer Research Program (W81XWH-16-1-0160), Yale Cancer Center Support Grant (P30CA016359), Stand Up To Cancer-American Cancer Society Lung Cancer Dream Team Translational Research Grant (SU2C-AACR-DT1715 and SU2C-AACR-DT22-17) and a grant from the Mark Foundation (19-029-MIA). I.M. is funded by MINECO SAF2017-83267-C2-1-R (AEI/FEDER, UE; I.M), European Union's Horizon 2020 research and innovation program (635122, PROCROP) and Fundacion de la Asociacion Espanola Contra el Cancer (AECC). M.F.S. is supported by a Miguel Servet contract from Instituto de Salud Carlos III, Fondo de Investigacion Sanitaria (Spain). The results shown here are in part based on data generated by the TCGA Research Network (https://www.cancer.gov/tcga).Writing and editorial assistance was provided by B. L. Phillips of Chrysalis Medical Communications, funded by Bristol-Myers Squibb.	Alfaro C, 2016, CLIN CANCER RES, V22, P3924, DOI 10.1158/1078-0432.CCR-15-2463; Ayers M, 2017, J CLIN INVEST, V127, P2930, DOI 10.1172/JCI91190; BAGGIOLINI M, 1989, J CLIN INVEST, V84, P1045, DOI 10.1172/JCI114265; Baggiolini M, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00285; Bilusic M, 2019, J IMMUNOTHER CANCER, V7, DOI 10.1186/s40425-019-0706-x; Borghaei H, 2015, NEW ENGL J MED, V373, P1627, DOI 10.1056/NEJMoa1507643; Brahmer J, 2015, NEW ENGL J MED, V373, P123, DOI 10.1056/NEJMoa1504627; CARLETON M, 2018, J CLIN ONCOL S, V36; Chalmers ZR, 2017, GENOME MED, V9, DOI 10.1186/s13073-017-0424-2; Coffelt SB, 2016, NAT REV CANCER, V16, P431, DOI 10.1038/nrc.2016.52; Conroy Siobhan, 2018, Oncotarget, V9, P15721, DOI 10.18632/oncotarget.24595; Datar I, 2019, CLIN CANCER RES, V25, P4663, DOI 10.1158/1078-0432.CCR-18-4142; David JM, 2016, VACCINES-BASEL, V4, DOI 10.3390/vaccines4030022; Gabrilovich DI, 2012, NAT REV IMMUNOL, V12, P253, DOI 10.1038/nri3175; Havel JJ, 2019, NAT REV CANCER, V19, P133, DOI 10.1038/s41568-019-0116-x; Heagerty PJ, 2000, BIOMETRICS, V56, P337, DOI 10.1111/j.0006-341X.2000.00337.x; Kapanadze T, 2013, J HEPATOL, V59, P1007, DOI 10.1016/j.jhep.2013.06.010; Moore BB, 1999, AM J PATHOL, V154, P1503, DOI 10.1016/S0002-9440(10)65404-1; Motzer RJ, 2015, NEW ENGL J MED, V373, P1803, DOI 10.1056/NEJMoa1510665; O'Donnell JS, 2019, NAT REV CLIN ONCOL, V16, P151, DOI 10.1038/s41571-018-0142-8; Riaz N, 2017, CELL, V171, P934, DOI 10.1016/j.cell.2017.09.028; Ribas A, 2017, CANCER RES, V77, DOI 10.1158/1538-7445.AM2017-CT073; Ribas A, 2018, SCIENCE, V359, P1350, DOI 10.1126/science.aar4060; Sanmamed MF, 2017, ANN ONCOL, V28, P1988, DOI 10.1093/annonc/mdx190; Schalper KA, 2016, CLIN CANCER RES, V22, P2102, DOI 10.1158/1078-0432.CCR-16-0169; Schalper KA, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/dju435; Siemers NO, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179726; Templeton AJ, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju124; Valsecchi ME, 2015, NEW ENGL J MED, V373, P1270, DOI [10.1056/NEJMoa1504030, 10.1056/NEJMc1509660]; Villarroel-Espindola F, 2018, CLIN CANCER RES, V24, P1562, DOI 10.1158/1078-0432.CCR-17-2542; Wargo JA, 2015, SEMIN ONCOL, V42, P601, DOI 10.1053/j.seminoncol.2015.05.007; Weber JS, 2016, LANCET ONCOL, V17, P943, DOI 10.1016/S1470-2045(16)30126-7; Weinstein JN, 2013, NAT GENET, V45, P1113, DOI 10.1038/ng.2764	33	175	176	8	29	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAY	2020	26	5					688	+		10.1038/s41591-020-0856-x	http://dx.doi.org/10.1038/s41591-020-0856-x			16	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	ML1LF	32405062	Green Accepted			2022-12-27	WOS:000549235700002
J	Williams, LM; Hack, LM				Williams, Leanne M.; Hack, Laura M.			A precision medicine-based, 'fast-fail' approach for psychiatry	NATURE MEDICINE			English	Editorial Material							DISORDERS; ANHEDONIA		[Williams, Leanne M.; Hack, Laura M.] Stanford Univ, Psychiat & Behav Sci, Stanford, CA 94305 USA; [Williams, Leanne M.; Hack, Laura M.] VA Palo Alto Hlth Care Syst, Mental Illness Res Educ & Clin Ctr, Palo Alto, CA 94304 USA	Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System	Williams, LM (corresponding author), Stanford Univ, Psychiat & Behav Sci, Stanford, CA 94305 USA.; Williams, LM (corresponding author), VA Palo Alto Hlth Care Syst, Mental Illness Res Educ & Clin Ctr, Palo Alto, CA 94304 USA.	leawilliams@stanford.edu	Williams, Leanne/GLU-4975-2022	Williams, Leanne/0000-0001-9987-7360				Carlezon WA, 2016, DEPRESS ANXIETY, V33, P895, DOI 10.1002/da.22500; Epstein J, 2006, AM J PSYCHIAT, V163, P1784, DOI 10.1176/appi.ajp.163.10.1784; Friedrich M J, 2017, JAMA, V317, P1517, DOI 10.1001/jama.2017.3826; Insel T, 2010, AM J PSYCHIAT, V167, P748, DOI 10.1176/appi.ajp.2010.09091379; Keedwell PA, 2005, BIOL PSYCHIAT, V58, P843, DOI 10.1016/j.biopsych.2005.05.019; Krystal AD, 2020, NAT MED, V26, P760, DOI 10.1038/s41591-020-0806-7; Rizvi SJ, 2016, NEUROSCI BIOBEHAV R, V65, P21, DOI 10.1016/j.neubiorev.2016.03.004; Roehrig C, 2016, HEALTH AFFAIR, V35, P1130, DOI 10.1377/hlthaff.2015.1659; Rush AJ, 2006, AM J PSYCHIAT, V163, P1905, DOI 10.1176/appi.ajp.163.11.1905; Uher R, 2012, PSYCHOL MED, V42, P967, DOI 10.1017/S0033291711001905; World Health Organization, 2020, MENT HLTH SUIC DAT	11	2	2	0	2	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	MAY	2020	26	5					653	654		10.1038/s41591-020-0854-z	http://dx.doi.org/10.1038/s41591-020-0854-z			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	ML1JP	32405056				2022-12-27	WOS:000549231500017
J	Rubino, F; Puhl, RM; Cummings, DE; Eckel, RH; Ryan, DH; Mechanick, JI; Nadglowski, J; Salas, XR; Schauer, PR; Twenefour, D; Apovian, CM; Aronne, LJ; Batterham, RL; Berthoud, HR; Boza, C; Busetto, L; Dicker, D; De Groot, M; Eisenberg, D; Flint, SW; Huang, TT; Kaplan, LM; Kirwan, JP; Korner, J; Kyle, TK; Laferrere, B; le Roux, CW; McIver, L; Mingrone, G; Nece, P; Reid, TJ; Rogers, AM; Rosenbaum, M; Seeley, RJ; Torres, AJ; Dixon, JB				Rubino, Francesco; Puhl, Rebecca M.; Cummings, David E.; Eckel, Robert H.; Ryan, Donna H.; Mechanick, Jeffrey, I; Nadglowski, Joe; Salas, Ximena Ramos; Schauer, Phillip R.; Twenefour, Douglas; Apovian, Caroline M.; Aronne, Louis J.; Batterham, Rachel L.; Berthoud, Hans-Rudolph; Boza, Camilo; Busetto, Luca; Dicker, Dror; De Groot, Mary; Eisenberg, Daniel; Flint, Stuart W.; Huang, Terry T.; Kaplan, Lee M.; Kirwan, John P.; Korner, Judith; Kyle, Ted K.; Laferrere, Blandine; le Roux, Carel W.; McIver, LaShawn; Mingrone, Geltrude; Nece, Patricia; Reid, Tirissa J.; Rogers, Ann M.; Rosenbaum, Michael; Seeley, Randy J.; Torres, Antonio J.; Dixon, John B.			Joint international consensus statement for ending stigma of obesity	NATURE MEDICINE			English	Article							PERCEIVED WEIGHT DISCRIMINATION; PUTATIVE CONTRIBUTORS; METABOLIC SURGERY; BODY-WEIGHT; FOOD-INTAKE; IMPACT; BIAS; OVERWEIGHT; OUTCOMES; ADULTS	People with obesity commonly face a pervasive, resilient form of social stigma. They are often subject to discrimination in the workplace as well as in educational and healthcare settings. Research indicates that weight stigma can cause physical and psychological harm, and that affected individuals are less likely to receive adequate care. For these reasons, weight stigma damages health, undermines human and social rights, and is unacceptable in modern societies. To inform healthcare professionals, policymakers, and the public about this issue, a multidisciplinary group of international experts, including representatives of scientific organizations, reviewed available evidence on the causes and harms of weight stigma and, using a modified Delphi process, developed a joint consensus statement with recommendations to eliminate weight bias. Academic institutions, professional organizations, media, public-health authorities, and governments should encourage education about weight stigma to facilitate a new public narrative about obesity, coherent with modern scientific knowledge.	[Rubino, Francesco; Mingrone, Geltrude] Kings Coll London, Sch Life Course Sci, Dept Diabet, London, England; [Rubino, Francesco] Kings Coll Hosp London, Bariatr & Metab Surg, London, England; [Puhl, Rebecca M.] Univ Connecticut, Rudd Ctr Food Policy & Obes, Hartford, CT 06112 USA; [Cummings, David E.] Univ Washington, UW Med Diabet Inst, Seattle, WA 98195 USA; [Cummings, David E.] Univ Washington, Weight Management Program, Virginia Puget Sound Hlth Care Syst, Seattle, WA 98195 USA; [Eckel, Robert H.] Univ Colorado, Div Endocrinol Metab & Diabet, Anschutz Med Campus, Aurora, CO USA; [Eckel, Robert H.] Univ Colorado, Div Cardiol, Anschutz Med Campus, Aurora, CO USA; [Ryan, Donna H.; Schauer, Phillip R.] Louisiana State Univ, Pennington Biomed Res Ctr, Baton Rouge, LA 70808 USA; [Mechanick, Jeffrey, I] Mt Sinai Heart, Marie Josee & Henry R Kravis Ctr Clin Cardiovasc, New York, NY USA; [Mechanick, Jeffrey, I] Icahn Sch Med Mt Sinai, Div Cardiol, New York, NY 10029 USA; [Mechanick, Jeffrey, I] Icahn Sch Med Mt Sinai, Div Endocrinol Diabet & Bone Dis, New York, NY 10029 USA; [Nadglowski, Joe; Nece, Patricia] Obes Act Coalit, Tampa, FL USA; [Salas, Ximena Ramos] Obes Canada, Edmonton, AB, Canada; [Salas, Ximena Ramos] European Assoc Study Obes, Teddington, Middx, England; [Twenefour, Douglas] Diabet UK, London, England; [Apovian, Caroline M.] Boston Univ, Sch Med, Boston, MA 02118 USA; [Apovian, Caroline M.] Boston Med Ctr, Ctr Nutr & Weight Management, Boston, MA USA; [Aronne, Louis J.] Weill Cornell Med, Div Endocrinol Diabet & Metab, Comprehens Weight Control Ctr, New York, NY USA; [Batterham, Rachel L.] Univ Coll London Hosp Biomed Res Ctr, Natl Inst Hlth Res, London, England; [Batterham, Rachel L.] Univ Coll London Hosp Fdn Trust, London, England; [Batterham, Rachel L.] UCL, Ctr Obes Res, Dept Med, London, England; [Berthoud, Hans-Rudolph] Louisiana State Univ Syst, Pennington Biomed Res Ctr, Neurobiol Nutr & Metab Dept, Baton Rouge, LA USA; [Boza, Camilo] Univ Adolfo Ibanez, Ctr Innovac Clin Las Condes, Santiago, Chile; [Busetto, Luca] Univ Padua, Dept Internal Med, Padua, Italy; [Dicker, Dror] Tel Aviv Univ, Hasharon Hosp, Sackler Sch Med, Rabin Med Ctr, Tel Aviv, Israel; [Dicker, Dror] European Assoc Study Obes, Obes Management Task Force, Teddington, Middx, England; [De Groot, Mary] Indiana Univ Sch Med, Dept Med, Indianapolis, IN 46202 USA; [Eisenberg, Daniel] Stanford Sch Med, Dept Surg, Stanford, CA USA; [Eisenberg, Daniel] Palo Alto Virginia Hlth Care Syst, Stanford, CA USA; [Flint, Stuart W.] Univ Leeds, Sch Psychol, Leeds, W Yorkshire, England; [Flint, Stuart W.] Univ Leeds, Nexus, Scaled Insights, Leeds, W Yorkshire, England; [Huang, Terry T.] Ctr Syst & Community Design, Dept Hlth Policy & Management, New York, NY USA; [Huang, Terry T.] CUNY, Grad Sch Publ Hlth & Hlth Policy, NYU CUNY Prevent Res Ctr, New York, NY 10021 USA; [Kaplan, Lee M.] Massachusetts Gen Hosp, Obes Metab & Nutr Inst, Boston, MA 02114 USA; [Kirwan, John P.] Pennington Biomed Res Ctr, Integrated Physiol & Mol Med, 6400 Perkins Rd, Baton Rouge, LA 70808 USA; [Korner, Judith] Columbia Univ, Dept Med, Irving Med Ctr, New York, NY USA; [Kyle, Ted K.] ConscienHealth, Pittsburgh, PA USA; [Laferrere, Blandine] Columbia Univ, Div Endocrinol, New York, NY USA; [le Roux, Carel W.] Univ Coll Dublin, Diabet Complicat Res Ctr, Dublin, Ireland; [McIver, LaShawn] Amer Diabet Assoc, Govt Affairs & Advocacy, Arlington, VA USA; [Mingrone, Geltrude] IRCCS, Fdn Policlin Univ A Gemelli, Rome, Italy; [Mingrone, Geltrude] Catholic Univ, Rome, Italy; [Reid, Tirissa J.] Columbia Univ Coll Phys & Surg, Div Endocrinol Diabet & Metab, 630 W 168th St, New York, NY 10032 USA; [Rogers, Ann M.] Penn State Hershey Med Ctr, Hershey, PA USA; [Rosenbaum, Michael] Columbia Univ, Irving Med Ctr, New York, NY USA; [Seeley, Randy J.] Univ Michigan, Dept Surg, Ann Arbor, MI 48109 USA; [Torres, Antonio J.] Univ Complutense Madrid, Hosp Clin San Carlos, Madrid, Spain; [Dixon, John B.] Baker IDI Heart & Diabet Inst, Melbourne, Vic, Australia	University of London; King's College London; King's College Hospital NHS Foundation Trust; King's College Hospital; University of Connecticut; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Boston University; Boston Medical Center; Cornell University; University College London Hospitals NHS Foundation Trust; University of London; University College London; University of London; University College London; Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center; Universidad Adolfo Ibanez; University of Padua; Rabin Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Indiana University System; Indiana University Bloomington; Stanford University; University of Leeds; University of Leeds; City University of New York (CUNY) System; Harvard University; Massachusetts General Hospital; Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center; Columbia University; NewYork-Presbyterian Hospital; Columbia University; University College Dublin; American Diabetes Association; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Columbia University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Columbia University; NewYork-Presbyterian Hospital; University of Michigan System; University of Michigan; Complutense University of Madrid; Hospital Clinico San Carlos; Baker Heart and Diabetes Institute	Rubino, F (corresponding author), Kings Coll London, Sch Life Course Sci, Dept Diabet, London, England.; Rubino, F (corresponding author), Kings Coll Hosp London, Bariatr & Metab Surg, London, England.	francesco.rubino@kcl.ac.uk	Aronne, Louis/ABC-8865-2020; Puhl, Rebecca/ABE-9260-2021; Twenefour, Douglas/AAQ-9300-2021	Schauer, Philip/0000-0002-4029-7537; Le Roux, Carel/0000-0001-5521-5445; Mingrone, Geltrude/0000-0003-2021-528X; Huang, Terry/0000-0001-5544-5187; Batterham, Rachel/0000-0002-5477-8585; Ryan, Donna/0000-0001-8374-2277; Seeley, Randy/0000-0002-3721-5625	Medtronic; Ethicon; Novo Nordisk; Fractyl Laboratories; GI Dynamics; Cairn Diagnostics; Keyron; Aventic Group	Medtronic(Medtronic); Ethicon; Novo Nordisk(Novo Nordisk); Fractyl Laboratories(Randox Laboratories); GI Dynamics; Cairn Diagnostics; Keyron; Aventic Group	We thank O. Barata Cavalcanti from the World Obesity Federation (WOF) for her critical role in this consensus conference as moderator of the Delphi process, and E. Papada, D. Qanaq, G. Chamseddine, S. Cremona, and M.F. Russo from King's College London for their assistance with formatting of tables. We acknowledge contributions of W. Cefalu, who participated as a member of the expert panel in his role of Chief Scientific, Medical and Mission Officer of the American Diabetes Association. The face-to-face meeting of the expert panel was hosted by the WCITD2019, which supported travel expenses. WCITD2019 was managed by Kenes Group and was supported by Medtronic (major sponsor), Ethicon (major sponsor), Novo Nordisk, Fractyl Laboratories, GI Dynamics, Cairn Diagnostics, Keyron, and Aventic Group. These sponsors played no role in the selection of voting delegates, the Delphi process, the WCITD2019 program, or the writing of this paper.	Agerstrom J, 2011, J APPL PSYCHOL, V96, P790, DOI 10.1037/a0021594; Alberga AS, 2019, PRIM HEALTH CARE RES, V20, DOI 10.1017/S1463423619000227; Aldrich T, 2010, J MIDWIFERY WOM HEAL, V55, P344, DOI 10.1016/j.jmwh.2009.10.001; Andreyeva T, 2008, OBESITY, V16, P1129, DOI 10.1038/oby.2008.35; Arble DM, 2009, OBESITY, V17, P2100, DOI 10.1038/oby.2009.264; Ata RN, 2010, OBESITY FACTS, V3, P41, DOI 10.1159/000276547; Barry CL, 2011, PEDIATRICS, V128, P132, DOI 10.1542/peds.2010-3924; Batterham RL, 2016, DIABETES CARE, V39, P893, DOI 10.2337/dc16-0145; Bauer C, 2004, GESUNDHEITSWESEN, V66, P246, DOI 10.1055/s-2004-812979; Blaine B, 2002, SEX ROLES, V46, P351, DOI 10.1023/A:1020284731543; BORJESON M, 1976, ACTA PAEDIATR SCAND, V65, P279, DOI 10.1111/j.1651-2227.1976.tb04887.x; Bray GA, 2017, OBES REV, V18, P715, DOI 10.1111/obr.12551; Brewis A, 2018, GLOBALIZATION HEALTH, V14, DOI 10.1186/s12992-018-0337-x; Callahan D, 2013, HASTINGS CENT REP, V43, P34, DOI 10.1002/hast.114; Chassaing B, 2015, NATURE, V519, P92, DOI 10.1038/nature14232; Colley Rachel C, 2011, Health Rep, V22, P15; Colley Rachel C, 2011, Health Rep, V22, P7; Corrigan PW, 2006, J SOC CLIN PSYCHOL, V25, P875, DOI 10.1521/jscp.2006.25.8.875; Cummings DE, 2018, DIABETOLOGIA, V61, P257, DOI 10.1007/s00125-017-4513-y; Dixon JB, 2016, SURG OBES RELAT DIS, V12, P1171, DOI 10.1016/j.soard.2015.11.027; Dolan P, 2019, JAMA SURG, V154, P264, DOI 10.1001/jamasurg.2018.4650; Equality and Human Rights Commission, 2010, EQUALITY ACT 2010; Flint SW, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.00647; Flint SW, 2014, INT J DISCRIM LAW, V14, P183, DOI 10.1177/1358229114534550; Flint Stuart W, 2015, BMC Obes, V2, P31, DOI 10.1186/s40608-015-0064-2; Franz MJ, 2007, J AM DIET ASSOC, V107, P1755, DOI 10.1016/j.jada.2007.07.017; Gordon, 1994, FUTURES RES METHODOL, V4, P2; Gruskin Sofia, 1998, Health Hum Rights, V2, P1; Gudzune KA, 2014, PATIENT EDUC COUNS, V97, P128, DOI 10.1016/j.pec.2014.06.019; Hall KD, 2016, OBESITY, V24, P2026, DOI 10.1002/oby.21635; Hall KD, 2012, AM J CLIN NUTR, V95, P989, DOI 10.3945/ajcn.112.036350; Han SeungYong, 2018, BMC Obes, V5, P18, DOI 10.1186/s40608-018-0195-3; Hansen B, 2018, DEVIANT BEHAV, V39, P137, DOI 10.1080/01639625.2016.1263081; Hayden-Wade HA, 2005, OBES RES, V13, P1381, DOI 10.1038/oby.2005.167; Heindel JJ, 2015, NAT REV ENDOCRINOL, V11, P653, DOI 10.1038/nrendo.2015.163; Heuer CA, 2011, J HEALTH COMMUN, V16, P976, DOI 10.1080/10810730.2011.561915; Hilbert A, 2017, OBESITY FACTS, V10, P101, DOI 10.1159/000456012; Hilbert A, 2009, PSYCHOL HEALTH, V24, P749, DOI 10.1080/08870440801947787; Hunger JM, 2014, JAMA PEDIATR, V168, P579, DOI 10.1001/jamapediatrics.2014.122; Jackson SE, 2015, INT J OBESITY, V39, P858, DOI 10.1038/ijo.2014.186; Jackson SE, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-014592; Jackson SE, 2016, OBESITY, V24, P2515, DOI 10.1002/oby.21657; Kaplan LM, 2018, OBESITY, V26, P61, DOI 10.1002/oby.22054; Keith CJ, 2018, SURG OBES RELAT DIS, V14, P631, DOI 10.1016/j.soard.2018.01.017; Keith SW, 2006, INT J OBESITY, V30, P1585, DOI 10.1038/sj.ijo.0803326; Kim JJ, 2017, CURR OBES REP, V6, P238, DOI 10.1007/s13679-017-0269-4; Kim SH, 2007, J HEALTH COMMUN, V12, P359, DOI 10.1080/10810730701326051; LEIBEL RL, 1995, NEW ENGL J MED, V332, P621, DOI 10.1056/NEJM199503093321001; Lydecker JA, 2018, J BEHAV MED, V41, P784, DOI 10.1007/s10865-018-9929-4; Maes HHM, 1997, BEHAV GENET, V27, P325, DOI 10.1023/A:1025635913927; Major B, 2014, J EXP SOC PSYCHOL, V51, P74, DOI 10.1016/j.jesp.2013.11.009; Mannan M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157240; McAllister EJ, 2009, CRIT REV FOOD SCI, V49, P868, DOI 10.1080/10408390903372599; Morton GJ, 2006, NATURE, V443, P289, DOI 10.1038/nature05026; Papadopoulos S, 2015, OBESITY, V23, P1743, DOI 10.1002/oby.21187; Parker R, 2003, SOC SCI MED, V57, P13, DOI 10.1016/S0277-9536(02)00304-0; Pearl RL, 2018, SOC ISS POLICY REV, V12, P146, DOI 10.1111/sipr.12043; Persky S, 2011, ANN BEHAV MED, V41, P363, DOI 10.1007/s12160-010-9242-0; Phelan SM, 2015, OBES REV, V16, P319, DOI 10.1111/obr.12266; Pomeranz JL, 2013, OBESITY, V21, P469, DOI 10.1002/oby.20094; Pont SJ, 2017, PEDIATRICS, V140, DOI 10.1542/peds.2017-3034; Pontzer H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040503; Puhl R, 2013, INT J OBESITY, V37, P612, DOI 10.1038/ijo.2012.110; Puhl RM, 2008, INT J OBESITY, V32, P992, DOI 10.1038/ijo.2008.22; Puhl RM, 2015, INT J OBESITY, V39, P1166, DOI 10.1038/ijo.2015.32; Puhl R, 2015, CURR OBES REP, V4, P182, DOI 10.1007/s13679-015-0153-z; Puhl RM, 2018, OBESITY, V26, P167, DOI 10.1002/oby.22029; Puhl RM, 2017, PREV MED, V100, P173, DOI 10.1016/j.ypmed.2017.04.023; Puhl RM, 2015, MILBANK Q, V93, P691, DOI 10.1111/1468-0009.12162; Puhl RM, 2013, J HEALTH COMMUN, V18, P805, DOI 10.1080/10810730.2012.757393; Puhl RM, 2013, BEST PRACT RES CL EN, V27, P117, DOI 10.1016/j.beem.2012.12.002; Puhl RM, 2009, OBESITY, V17, P941, DOI 10.1038/oby.2008.636; Quick V, 2013, INT J BEHAV NUTR PHY, V10, DOI 10.1186/1479-5868-10-37; Rubino F, 2016, DIABETES CARE, V39, P861, DOI 10.2337/dc16-0236; Rudolph CW, 2009, J VOCAT BEHAV, V74, P1, DOI 10.1016/j.jvb.2008.09.008; Rushing B, 2017, COMMONWEALTH MASSACH; Sabin JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048448; Sattler KM, 2018, HEALTH PSYCHOL OPEN, V5, DOI 10.1177/2055102918759691; Schulte PA, 2007, AM J PUBLIC HEALTH, V97, P428, DOI 10.2105/AJPH.2006.086900; Schvey NA, 2011, OBESITY, V19, P1957, DOI 10.1038/oby.2011.204; Sharma AM, 2010, OBES REV, V11, P362, DOI 10.1111/j.1467-789X.2009.00689.x; Shinall J. B, 2015, VANDERBILT LAW EC RE; Sjostrom L, 2013, J INTERN MED, V273, P219, DOI 10.1111/joim.12012; Spahlholz J, 2016, OBES REV, V17, P43, DOI 10.1111/obr.12343; STUNKARD AJ, 1986, NEW ENGL J MED, V314, P193, DOI 10.1056/NEJM198601233140401; Sumithran P, 2011, NEW ENGL J MED, V365, P1597, DOI 10.1056/NEJMoa1105816; Sutin AR, 2015, PSYCHOL SCI, V26, P1803, DOI 10.1177/0956797615601103; Sutin AR, 2014, OBESITY, V22, P1959, DOI 10.1002/oby.20789; Sutin AR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070048; Takizawa R, 2015, PSYCHOL MED, V45, P2705, DOI 10.1017/S0033291715000653; Teachman BA, 2003, HEALTH PSYCHOL, V22, P68, DOI 10.1037/0278-6133.22.1.68; Tremblay A, 2008, APPL PHYSIOL NUTR ME, V33, P791, DOI 10.1139/H08-038; Tyrrell J, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i582; Vadiveloo M, 2017, ANN BEHAV MED, V51, P94, DOI 10.1007/s12160-016-9831-7; Vartanian LR, 2016, APPETITE, V102, P3, DOI 10.1016/j.appet.2016.01.034; Vartanian LR, 2013, OBES SURG, V23, P1545, DOI 10.1007/s11695-013-0918-y; Waasdorp TE, 2018, AM J ORTHOPSYCHIAT, V88, P483, DOI 10.1037/ort0000294; Wadden TA, 2011, NEW ENGL J MED, V365, P1969, DOI 10.1056/NEJMoa1109220; Wu YK, 2018, J ADV NURS, V74, P1030, DOI 10.1111/jan.13511	100	235	242	8	20	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	APR	2020	26	4					485	497		10.1038/s41591-020-0803-x	http://dx.doi.org/10.1038/s41591-020-0803-x			13	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	QH1UE	32127716	Green Published, hybrid			2022-12-27	WOS:000618061900022
J	Ruth, KS; Day, FR; Tyrrell, J; Thompson, DJ; Wood, AR; Mahajan, A; Beaumont, RN; Wittemans, L; Martin, S; Busch, AS; Erzurumluoglu, AM; Hollis, B; O'Mara, TA; McCarthy, MI; Langenberg, C; Easton, DF; Wareham, NJ; Burgess, S; Murray, A; Ong, KK; Frayling, TM; Perry, JRB				Ruth, Katherine S.; Day, Felix R.; Tyrrell, Jessica; Thompson, Deborah J.; Wood, Andrew R.; Mahajan, Anubha; Beaumont, Robin N.; Wittemans, Laura; Martin, Susan; Busch, Alexander S.; Erzurumluoglu, A. Mesut; Hollis, Benjamin; O'Mara, Tracy A.; McCarthy, Mark, I; Langenberg, Claudia; Easton, Douglas F.; Wareham, Nicholas J.; Burgess, Stephen; Murray, Anna; Ong, Ken K.; Frayling, Timothy M.; Perry, John R. B.		Endometrial Canc Assoc Consortium	Using human genetics to understand the disease impacts of testosterone in men and women	NATURE MEDICINE			English	Article							HORMONE-BINDING GLOBULIN; ENDOGENOUS SEX-HORMONES; MENDELIAN RANDOMIZATION; METABOLIC SYNDROME; PROSTATE-CANCER; RISK; ASSOCIATION; DENSITY; BIAS	Genetic analysis of data from over 400,000 participants in the UK Biobank Study shows that circulating testosterone levels have sex-specific implications for cardiometabolic diseases and cancer outcomes. Testosterone supplementation is commonly used for its effects on sexual function, bone health and body composition, yet its effects on disease outcomes are unknown. To better understand this, we identified genetic determinants of testosterone levels and related sex hormone traits in 425,097 UK Biobank study participants. Using 2,571 genome-wide significant associations, we demonstrate that the genetic determinants of testosterone levels are substantially different between sexes and that genetically higher testosterone is harmful for metabolic diseases in women but beneficial in men. For example, a genetically determined 1 s.d. higher testosterone increases the risks of type 2 diabetes (odds ratio (OR) = 1.37 (95% confidence interval (95% CI): 1.22-1.53)) and polycystic ovary syndrome (OR = 1.51 (95% CI: 1.33-1.72)) in women, but reduces type 2 diabetes risk in men (OR = 0.86 (95% CI: 0.76-0.98)). We also show adverse effects of higher testosterone on breast and endometrial cancers in women and prostate cancer in men. Our findings provide insights into the disease impacts of testosterone and highlight the importance of sex-specific genetic analyses.	[Ruth, Katherine S.; Tyrrell, Jessica; Wood, Andrew R.; Beaumont, Robin N.; Martin, Susan; Murray, Anna; Frayling, Timothy M.] Univ Exeter, Med Sch, Exeter, Devon, England; [Day, Felix R.; Wittemans, Laura; Busch, Alexander S.; Erzurumluoglu, A. Mesut; Hollis, Benjamin; Langenberg, Claudia; Wareham, Nicholas J.; Ong, Ken K.; Perry, John R. B.] Univ Cambridge, MRC, Epidemiol Unit, Cambridge, England; [Thompson, Deborah J.; Easton, Douglas F.] Univ Cambridge, Ctr Canc Genet Epidemiol, Cambridge, England; [Mahajan, Anubha; Wittemans, Laura; McCarthy, Mark, I] Univ Oxford, Wellcome Ctr Human Genet, Oxford, England; [Busch, Alexander S.] Univ Copenhagen, Int Ctr Res & Res Training Endocrine Disrupt Male, Copenhagen, Denmark; [Busch, Alexander S.] Univ Copenhagen, Dept Growth & Reprod, Copenhagen, Denmark; [O'Mara, Tracy A.] QIMR Berghofer Med Res Inst, Dept Genet, Brisbane, Qld, Australia; [McCarthy, Mark, I] Univ Oxford, Oxford Ctr Diabet, Oxford, England; [McCarthy, Mark, I] Oxford Univ Hosp NHS Fdn Trust, John Radcliffe Hosp, Oxford NIHR Biomed Res Ctr, Oxford, England; [Burgess, Stephen] Univ Cambridge, MRC Biostat Unit, Cambridge, England; [Burgess, Stephen] Univ Cambridge, BHF Cardiovasc Epidemiol Unit, Cambridge, England; [Ong, Ken K.] Univ Cambridge, Dept Paediat, Cambridge, England; [McCarthy, Mark, I] Genentech Inc, San Francisco, CA USA	University of Exeter; University of Cambridge; University of Cambridge; University of Oxford; Wellcome Centre for Human Genetics; University of Copenhagen; University of Copenhagen; QIMR Berghofer Medical Research Institute; University of Oxford; Oxford University Hospitals NHS Foundation Trust; University of Oxford; MRC Biostatistics Unit; University of Cambridge; University of Cambridge; University of Cambridge; Roche Holding; Genentech	Frayling, TM (corresponding author), Univ Exeter, Med Sch, Exeter, Devon, England.; Perry, JRB (corresponding author), Univ Cambridge, MRC, Epidemiol Unit, Cambridge, England.	T.M.Frayling@exeter.ac.uk; john.perry@mrc-epid.cam.ac.uk	Wood, Andrew R/AAB-3807-2019; Erzurumluoglu, A Mesut/E-4445-2018	Wood, Andrew R/0000-0003-1726-948X; Erzurumluoglu, A Mesut/0000-0003-1322-8138; O'Mara, Tracy/0000-0002-5436-3232; Murray, Anna/0000-0002-2351-2522; Day, Felix/0000-0003-3789-7651; Frayling, Timothy/0000-0001-8362-2603; Tyrrell, Jess/0000-0002-9256-6065; Busch, Alexander Siegfried/0000-0003-4417-569X; Burgess, Stephen/0000-0001-5365-8760; Martin, Susan/0000-0001-8746-0947	European Research Council [SZ-245 50371-GLUCOSEGENES-FP7-IDEAS-ERC]; Wellcome Trust; Royal Society [104150/Z/14/Z]; Academy of Medical Sciences Springboard award - Wellcome Trust; GCRF [SBF004\1079]; Medical Research Council [MC_UU_12015/1, MC_UU_12015/2]; MRC [MC_UU_00002/7, MC_PC_12028, MC_UU_12015/1, MR/T002239/1, MC_UU_12015/2, MC_UU_00006/2] Funding Source: UKRI	European Research Council(European Research Council (ERC)European Commission); Wellcome Trust(Wellcome Trust); Royal Society(Royal Society of London); Academy of Medical Sciences Springboard award - Wellcome Trust; GCRF; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This research has been conducted using the UK Biobank resource under application numbers 9072, 9055, 9797 and 44448. The authors acknowledge the use of the University of Exeter High-Performance Computing facility in carrying out this work. We thank K. Patel, R. Andrews and T. McDonald for their advice on the derivation of testosterone measures and their roles in PCOS and diabetes. We thank the MAGIC consortium and I. Barroso for sharing prepublication sex-specific glycemic trait GWAS data. A.R.W. and T.M.F. are supported by the European Research Council grant no. SZ-245 50371-GLUCOSEGENES-FP7-IDEAS-ERC. R.N.B. is funded by the Wellcome Trust and Royal Society grant no. 104150/Z/14/Z. J.T. is supported by the Academy of Medical Sciences Springboard award which is supported by the Wellcome Trust and GCRF (grant no. SBF004\1079). This work was supported by the Medical Research Council (Unit Programme numbers MC_UU_12015/1 and MC_UU_12015/2).	Baillargeon J, 2018, JAMA-J AM MED ASSOC, V320, P200, DOI 10.1001/jama.2018.7999; Bann D, 2015, OBESITY, V23, P1486, DOI 10.1002/oby.21092; Bhasin S, 2018, J CLIN ENDOCR METAB, V103, P1715, DOI 10.1210/jc.2018-00229; Bowden J, 2016, GENET EPIDEMIOL, V40, P304, DOI 10.1002/gepi.21965; Bowden J, 2015, INT J EPIDEMIOL, V44, P512, DOI 10.1093/ije/dyv080; Brand JS, 2011, INT J EPIDEMIOL, V40, P189, DOI 10.1093/ije/dyq158; Bycroft C, 2018, NATURE, V562, P203, DOI 10.1038/s41586-018-0579-z; Chan KJ, 2018, ENDOCR PRACT, V24, P565, DOI 10.4158/EP-2017-0247; Chen HY, 2010, J BIOL CHEM, V285, P27776, DOI 10.1074/jbc.M110.156091; Chung Michael C, 2017, J Pathol Inform, V8, P28, DOI 10.4103/jpi.jpi_28_17; Conway G, 2014, EUR J ENDOCRINOL, V171, pP1, DOI 10.1530/EJE-14-0253; Coviello AD, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002805; Day FR, 2016, AM J HUM GENET, V98, P392, DOI 10.1016/j.ajhg.2015.12.019; Day N, 1999, BRIT J CANCER, V80, P95; Ding EL, 2006, JAMA-J AM MED ASSOC, V295, P1288, DOI 10.1001/jama.295.11.1288; Ding EL, 2009, NEW ENGL J MED, V361, P1152, DOI 10.1056/NEJMoa0804381; Eriksson AL, 2018, J CLIN ENDOCR METAB, V103, P991, DOI 10.1210/jc.2017-02060; Finucane HK, 2018, NAT GENET, V50, P621, DOI 10.1038/s41588-018-0081-4; Ganna A, 2019, SCIENCE, V365, P882, DOI 10.1126/science.aat7693; Grossmann M, 2015, CLIN ENDOCRINOL, V83, P344, DOI 10.1111/cen.12664; Haas ME, 2018, AM J HUM GENET, V103, P461, DOI 10.1016/j.ajhg.2018.08.004; Handelsman DJ, 2013, MED J AUSTRALIA, V199, P548, DOI 10.5694/mja13.10111; Huang G, 2018, J CLIN ENDOCR METAB, V103, P1678, DOI 10.1210/jc.2017-02545; Huang G, 2014, J CLIN ENDOCR METAB, V99, pE1287, DOI 10.1210/jc.2013-4160; Jayasena CN, 2019, CLIN ENDOCRINOL, V90, P391, DOI 10.1111/cen.13906; Jones SE, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-08259-7; Kemp JP, 2017, NAT GENET, V49, P1468, DOI 10.1038/ng.3949; Klap J, 2015, J UROLOGY, V193, P403, DOI 10.1016/j.juro.2014.07.123; Loh PR, 2015, NAT GENET, V47, P284, DOI 10.1038/ng.3190; Mahajan A, 2018, NAT GENET, V50, P1505, DOI 10.1038/s41588-018-0241-6; Metsalu T, 2015, NUCLEIC ACIDS RES, V43, pW566, DOI 10.1093/nar/gkv468; Odet F, 2006, ENDOCRINOLOGY, V147, P4374, DOI 10.1210/en.2006-0484; Ohlsson C, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002313; Perry JRB, 2010, HUM MOL GENET, V19, P535, DOI 10.1093/hmg/ddp522; Rees DA, 2011, INT J EPIDEMIOL, V40, P207, DOI 10.1093/ije/dyq254; Roddam AW, 2008, J NATL CANCER I, V100, P170, DOI 10.1093/jnci/djm323; Ruth KS, 2016, EUR J HUM GENET, V24, P284, DOI 10.1038/ejhg.2015.102; Snyder PJ, 2018, ENDOCR REV, V39, P369, DOI 10.1210/er.2017-00234; Vermeulen A, 1999, J CLIN ENDOCR METAB, V84, P3666, DOI 10.1210/jc.84.10.3666; Watts EL, 2018, EUR UROL, V74, P585, DOI 10.1016/j.eururo.2018.07.024; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011; Yao QM, 2018, ENDOCR CONNECT, V7, P220, DOI 10.1530/EC-17-0253; Zhu ZH, 2016, NAT GENET, V48, P481, DOI 10.1038/ng.3538	43	165	171	11	52	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	FEB	2020	26	2					252	+		10.1038/s41591-020-0751-5	http://dx.doi.org/10.1038/s41591-020-0751-5		FEB 2020	20	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	KK7DU	32042192	Green Accepted, Green Submitted			2022-12-27	WOS:000512529400005
J	Shilo, S; Rossman, H; Segal, E				Shilo, Smadar; Rossman, Hagai; Segal, Eran			Axes of a revolution: challenges and promises of big data in healthcare	NATURE MEDICINE			English	Review							MULTI-OMIC DATA; COHORT PROFILE; UK BIOBANK; CARDIOVASCULAR-DISEASE; PREDICTION; MEDICINE; FUTURE; EPIDEMIOLOGY; ASSOCIATIONS; FRAMINGHAM	Health data are increasingly being generated at a massive scale, at various levels of phenotyping and from different types of resources. Concurrent with recent technological advances in both data-generation infrastructure and data-analysis methodologies, there have been many claims that these events will revolutionize healthcare, but such claims are still a matter of debate. Addressing the potential and challenges of big data in healthcare requires an understanding of the characteristics of the data. Here we characterize various properties of medical data, which we refer to as 'axes' of data, describe the considerations and tradeoffs taken when such data are generated, and the types of analyses that may achieve the tasks at hand. We then broadly describe the potential and challenges of using big data in healthcare resources, aiming to contribute to the ongoing discussion of the potential of big data resources to advance the understanding of health and disease. Health data are being generated and collected at an unprecedented scale, but whether big data will truly revolutionize healthcare is still a matter of much debate.	[Shilo, Smadar; Rossman, Hagai; Segal, Eran] Weizmann Inst Sci, Dept Comp Sci & Appl Math, Rehovot, Israel; [Shilo, Smadar; Rossman, Hagai; Segal, Eran] Weizmann Inst Sci, Dept Mol Cell Biol, Rehovot, Israel; [Shilo, Smadar] Rambam Healthcare Campus, Pediat Diabet Unit, Ruth Rappaport Childrens Hosp, Haifa, Israel	Weizmann Institute of Science; Weizmann Institute of Science; Rambam Health Care Campus	Segal, E (corresponding author), Weizmann Inst Sci, Dept Comp Sci & Appl Math, Rehovot, Israel.; Segal, E (corresponding author), Weizmann Inst Sci, Dept Mol Cell Biol, Rehovot, Israel.	eran.segal@weizmann.ac.il		Rossman, Hagai/0000-0002-5613-8004; Segal, Eran/0000-0002-6859-1164; Shilo, Smadar/0000-0003-2399-1866				Agniel D, 2018, BMJ-BRIT MED J, V361, DOI 10.1136/bmj.k1479; Ahlqvist E, 2018, LANCET DIABETES ENDO, V6, P361, DOI 10.1016/S2213-8587(18)30051-2; Al Kuwari H, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2522-7; All Us Res Program Investigators, 2019, NEW ENGL J MED, V381, P668, DOI 10.1056/NEJMsr1809937; Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS67, DOI [10.2337/dc13-S067, 10.2337/dc10-S062, 10.2337/dc12-s064, 10.2337/dc11-S062]; Avati A, 2018, BMC MED INFORM DECIS, V18, DOI 10.1186/s12911-018-0677-8; Awadalla P, 2013, INT J EPIDEMIOL, V42, P1285, DOI 10.1093/ije/dys160; Barker DJP, 1998, CLIN SCI, V95, P115, DOI 10.1042/CS19980019; Baro E, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/639021; Beesley LJ, 2020, STAT MED, V39, P773, DOI 10.1002/sim.8445; Bengio Y, 2013, IEEE T PATTERN ANAL, V35, P1798, DOI 10.1109/TPAMI.2013.50; Benke K, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15122796; Berg D, 2014, MOVEMENT DISORD, V29, P454, DOI 10.1002/mds.25844; Booker CL, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-249; Breyer MD, 2014, EXPERT OPIN DRUG DIS, V9, P115, DOI 10.1517/17460441.2014.870150; Brieger K, 2019, AM J HUM GENET, V105, P65, DOI 10.1016/j.ajhg.2019.05.006; Brodniewicz T, 2010, ACTA POL PHARM, V67, P578; Burton-Jeangros C, 2015, LIFE COURSE RES SOC, V4, P197, DOI 10.1007/978-3-319-20484-0_10; Bycroft C, 2018, NATURE, V562, P203, DOI 10.1038/s41586-018-0579-z; Calvert JS, 2016, COMPUT BIOL MED, V74, P69, DOI 10.1016/j.compbiomed.2016.05.003; Chen MS, 2014, CANCER-AM CANCER SOC, V120, P1091, DOI 10.1002/cncr.28575; Chen ZM, 2011, INT J EPIDEMIOL, V40, P1652, DOI 10.1093/ije/dyr120; Ching T, 2018, J R SOC INTERFACE, V15, DOI 10.1098/rsif.2017.0387; Cho I, 2012, NAT REV GENET, V13, P260, DOI 10.1038/nrg3182; Christensen Henry, 2012, Clin Epidemiol, V4, P37, DOI 10.2147/CLEP.S33042; Cios KJ, 2002, ARTIF INTELL MED, V26, P1, DOI 10.1016/S0933-3657(02)00049-0; Cohen IG, 2019, JAMA-J AM MED ASSOC, V322, P1141, DOI 10.1001/jama.2019.11365; Colditz GA, 1997, J WOMENS HEALTH, V6, P49, DOI 10.1089/jwh.1997.6.49; Collins FS, 2015, NEW ENGL J MED, V372, P793, DOI 10.1056/NEJMp1500523; Dickerman BA, 2019, NAT MED, V25, P1601, DOI 10.1038/s41591-019-0597-x; Dudley JT, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002648; Einav L, 2018, SCIENCE, V360, P1462, DOI 10.1126/science.aar5045; Evans R S, 2016, Yearb Med Inform, VSuppl 1, pS48, DOI 10.15265/IYS-2016-s006; Finan C, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aag1166; FitzGerald G, 2018, SCIENCE, V361, P552, DOI 10.1126/science.aau7779; Garrett-Bakelman FE, 2019, SCIENCE, V364, P144, DOI 10.1126/science.aau8650; Gaziano JM, 2016, J CLIN EPIDEMIOL, V70, P214, DOI 10.1016/j.jclinepi.2015.09.016; Gebru T, 2021, COMMUN ACM, V64, P86, DOI 10.1145/3458723; Geserick M, 2018, NEW ENGL J MED, V379, P1303, DOI 10.1056/NEJMoa1803527; Ghassemi Marzyeh, 2018, ARXIV PREPRINT ARXIV; Gligorijevic V, 2016, PROTEOMICS, V16, P741, DOI 10.1002/pmic.201500396; Goldberger AL, 2000, CIRCULATION, V101, pE215, DOI 10.1161/01.CIR.101.23.e215; Golding J, 2001, PAEDIATR PERINAT EP, V15, P74; GOULD AL, 1995, STAT MED, V14, P1039, DOI 10.1002/sim.4780140922; Grad FP, 2002, B WORLD HEALTH ORGAN, V80, P981; Hayden E., 2014, NATURE NEWS; Hernan M. A., 2019, CHANCE, V32, P42; Hernan MA, 2016, AM J EPIDEMIOL, V183, P758, DOI 10.1093/aje/kwv254; Hewitt R, 2013, BIOPRESERV BIOBANK, V11, P309, DOI 10.1089/bio.2013.0042; Howe CJ, 2016, EPIDEMIOLOGY, V27, P91, DOI 10.1097/EDE.0000000000000409; Hripcsak G, 2015, STUD HEALTH TECHNOL, V216, P574, DOI 10.3233/978-1-61499-564-7-574; Hu PF, 2018, FRONT GENET, V9, DOI 10.3389/fgene.2018.00238; Jiang CQ, 2010, J HUM HYPERTENS, V24, P139, DOI 10.1038/jhh.2009.52; Johansson F., 2016, ARXIV160503661; Johnson AEW, 2016, SCI DATA, V3, DOI 10.1038/sdata.2016.35; Kaprio J, 2013, TWIN RES HUM GENET, V16, P157, DOI 10.1017/thg.2012.142; Kaufman DJ, 2009, AM J HUM GENET, V85, P643, DOI 10.1016/j.ajhg.2009.10.002; Kinkorova J, 2016, EPMA J, V7, DOI 10.1186/s13167-016-0053-7; Kohane IS, 2011, NAT REV GENET, V12, P417, DOI 10.1038/nrg2999; Koopmans R, 2015, SOC SCI RES, V53, P162, DOI 10.1016/j.ssresearch.2015.05.010; Krizhevsky A, 2017, COMMUN ACM, V60, P84, DOI 10.1145/3065386; Krokstad S, 2013, INT J EPIDEMIOL, V42, P968, DOI 10.1093/ije/dys095; Kwon Eun Jin, 2017, Obstet Gynecol Sci, V60, P506, DOI 10.5468/ogs.2017.60.6.506; Lakhani CM, 2019, NAT GENET, V51, P327, DOI 10.1038/s41588-018-0313-7; Lau B, 2007, AIDS RES HUM RETROV, V23, P769, DOI 10.1089/aid.2006.0171; Lawton M, 2018, J NEUROL NEUROSUR PS, V89, P1279, DOI 10.1136/jnnp-2018-318337; LeCun Y, 2015, NATURE, V521, P436, DOI 10.1038/nature14539; Lee Jae-Eun, 2012, Osong Public Health Res Perspect, V3, P185, DOI 10.1016/j.phrp.2012.07.007; Leitsalu L, 2015, INT J EPIDEMIOL, V44, P1137, DOI 10.1093/ije/dyt268; Liao YL, 1999, AM HEART J, V137, P837, DOI 10.1016/S0002-8703(99)70407-2; Lin JC, 2017, GIGASCIENCE, V7, DOI 10.1093/gigascience/gix110; Lipton ZC, 2018, COMMUN ACM, V61, P36, DOI 10.1145/3233231; Magnus P, 2016, INT J EPIDEMIOL, V45, P382, DOI 10.1093/ije/dyw029; Mahmood SS, 2014, LANCET, V383, P999, DOI 10.1016/S0140-6736(13)61752-3; Mason CE, 2014, ADV EXP MED BIOL, V799, P15, DOI 10.1007/978-1-4614-8778-4_2; Matthews H, 2016, PROTEOMES, V4, DOI 10.3390/proteomes4030028; Montgomery J, 2017, NEW BIOETH, V23, P81, DOI 10.1080/20502877.2017.1314893; Nagai A, 2017, J EPIDEMIOL, V27, pS2, DOI 10.1016/j.je.2016.12.005; Nelson MR, 2015, NAT GENET, V47, P856, DOI 10.1038/ng.3314; Obermeyer Z, 2019, SCIENCE, V366, P447, DOI 10.1126/science.aax2342; Obermeyer Z, 2017, BMJ-BRIT MED J, V359, DOI 10.1136/bmj.j5468; Obermeyer Z, 2016, NEW ENGL J MED, V375, P1216, DOI 10.1056/NEJMp1606181; Organization for Economic Cooperation and Development, 2006, GLOSS STAT TERMS BIO; Paik H, 2015, SCI REP, V5; Palsson B, 2010, NAT CHEM BIOL, V6, P787, DOI 10.1038/nchembio.462; Pearl J.., 2009, CAUSALITY; Phelan Matthew, 2017, EGEMS (Wash DC), V5, P22, DOI 10.5334/egems.243; Popejoy AB, 2016, NATURE, V538, P161, DOI 10.1038/538161a; Price WN, 2019, NAT MED, V25, P37, DOI 10.1038/s41591-018-0272-7; Pushpakom S, 2019, NAT REV DRUG DISCOV, V18, P41, DOI 10.1038/nrd.2018.168; Qiu X, 2017, EUR J EPIDEMIOL, V32, P337, DOI 10.1007/s10654-017-0239-x; Rajkomar A, 2019, NEW ENGL J MED, V380, P1347, DOI 10.1056/NEJMra1814259; Rajkomar A, 2018, NPJ DIGIT MED, V1, DOI 10.1038/s41746-018-0029-1; Reshef DN, 2011, SCIENCE, V334, P1518, DOI 10.1126/science.1205438; Rivers E, 2001, NEW ENGL J MED, V345, P1368, DOI 10.1056/NEJMoa010307; Rodwin MA, 2009, JAMA-J AM MED ASSOC, V302, P86, DOI 10.1001/jama.2009.965; Rothschild D, 2018, NATURE, V555, P210, DOI 10.1038/nature25973; Rumsfeld JS, 2016, NAT REV CARDIOL, V13, P350, DOI 10.1038/nrcardio.2016.42; Scholtens S, 2015, INT J EPIDEMIOL, V44, P1172, DOI 10.1093/ije/dyu229; Senn S, 2018, NATURE, V563, P619, DOI 10.1038/d41586-018-07535-2; Shah T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071345; Shimabukuro DW, 2017, BMJ OPEN RESPIR RES, V4, DOI 10.1136/bmjresp-2017-000234; Shmueli G, 2010, STAT SCI, V25, P289, DOI 10.1214/10-STS330; Smith GD, 2003, INT J EPIDEMIOL, V32, P1, DOI 10.1093/ije/dyg070; Sudlow C, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001779; Swanson JM, 2012, LANCET, V380, P110, DOI 10.1016/S0140-6736(12)61179-9; Tapia-Conyer R, 2006, INT J EPIDEMIOL, V35, P243, DOI 10.1093/ije/dyl042; Thenganatt MA, 2014, JAMA NEUROL, V71, P499, DOI 10.1001/jamaneurol.2013.6233; Tigchelaar EF, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-006772; Tiik M, 2010, STUD HEALTH TECHNOL, V156, P171, DOI 10.3233/978-1-60750-565-5-171; Tomasev N, 2019, NATURE, V572, P116, DOI 10.1038/s41586-019-1390-1; Topol Eric J, 2014, Cell, V157, P241, DOI 10.1016/j.cell.2014.02.012; Topol EJ, 2019, NAT MED, V25, P44, DOI 10.1038/s41591-018-0300-7; Tutton R, 2004, TRENDS BIOTECHNOL, V22, P284, DOI 10.1016/j.tibtech.2004.04.007; Udler MS, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002654; Vashisht R, 2018, JAMA NETW OPEN, V1, DOI 10.1001/jamanetworkopen.2018.1755; Vogt H, 2019, BMJ-BRIT MED J, V366, DOI 10.1136/bmj.l5270; Wang S, 2019, ARXIV190708322; Weber GM, 2014, JAMA-J AM MED ASSOC, V311, P2479, DOI 10.1001/jama.2014.4228; Weng W.H., 2019, ARXIV190909248; Wilkinson Mark D, 2016, Sci Data, V3, P160018, DOI 10.1038/sdata.2016.18; Wolford BN, 2018, HUM MOL GENET, V27, pR14, DOI 10.1093/hmg/ddy081; Xu S, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2019.10967; Young AI, 2019, SCIENCE, V365, P1396, DOI 10.1126/science.aax3710; Yusuf S, 2019, LANCET, V395, P795, DOI [10.1016/S0140-6736(19)32008-2, DOI 10.1016/S0140-6736(19)32008-2, 10.1016/s0140-6736(19)32008-2]; Zeevi D, 2019, NATURE, V568, P43, DOI 10.1038/s41586-019-1065-y; Zeevi D, 2015, CELL, V163, P1079, DOI 10.1016/j.cell.2015.11.001	127	101	106	11	43	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	JAN	2020	26	1					29	38		10.1038/s41591-019-0727-5	http://dx.doi.org/10.1038/s41591-019-0727-5			10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	KG3GZ	31932803				2022-12-27	WOS:000509831900023
J	Fischer, A; Dewatripont, M; Goldman, M				Fischer, Alain; Dewatripont, Mathias; Goldman, Michel			Benefit Corporation: a path to affordable gene therapies?	NATURE MEDICINE			English	Editorial Material								With the growing number of efficient gene therapies on the market, now is the time to take actions to ensure reasonable pricing of gene therapy products. Among these, we propose to incentivize gene therapy companies to adopt a status that translates their corporate social responsibility into concrete commitments.	[Fischer, Alain] INSERM UMR 1163, Hop Necker Enfants Malades, AP HP, Coll France Assistance Publ, Paris, France; [Dewatripont, Mathias] Univ Libre Bruxelles, Ecares Solvay Brussels Sch Econ & Management, Brussels, Belgium; [Dewatripont, Mathias; Goldman, Michel] Univ Bruxelles, I3h Inst, Brussels, Belgium	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Universite Libre de Bruxelles; Universite Libre de Bruxelles	Fischer, A (corresponding author), INSERM UMR 1163, Hop Necker Enfants Malades, AP HP, Coll France Assistance Publ, Paris, France.; Goldman, M (corresponding author), Univ Bruxelles, I3h Inst, Brussels, Belgium.	alain.fischer@aphp.fr; mgoldman@i3health.eu						Bach P. B., 2019, STAT; Brody B, 1996, HASTINGS CENT REP, V26, P5, DOI 10.2307/3528570; Cummings B, 2012, COLUMBIA LAW REV, V112, P578; High KA, 2019, NEW ENGL J MED, V381, P455, DOI 10.1056/NEJMra1706910; Marsden G, 2017, GENE THERAPY UNDERST; WHO, 2019, IMPR TRANSP MARK MED	6	12	12	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	2019	25	12					1813	1814		10.1038/s41591-019-0676-z	http://dx.doi.org/10.1038/s41591-019-0676-z			3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	JT2KO	31768067				2022-12-27	WOS:000500824900018
J	Risal, S; Pei, Y; Lu, HJ; Manti, M; Fornes, R; Pui, HP; Zhao, ZY; Massart, J; Ohlsson, C; Lindgren, E; Crisosto, N; Maliqueo, M; Echiburu, B; de Guevara, AL; Sir-Petermann, T; Larsson, H; Rosenqvist, MA; Cesta, CE; Benrick, A; Deng, QL; Stener-Victorin, E				Risal, Sanjiv; Pei, Yu; Lu, Haojiang; Manti, Maria; Fornes, Romina; Pui, Han-Pin; Zhao, Zhiyi; Massart, Julie; Ohlsson, Claes; Lindgren, Eva; Crisosto, Nicolas; Maliqueo, Manuel; Echiburu, Barbara; de Guevara, Amanda Ladron; Sir-Petermann, Teresa; Larsson, Henrik; Rosenqvist, Mina A.; Cesta, Carolyn E.; Benrick, Anna; Deng, Qiaolin; Stener-Victorin, Elisabet			Prenatal androgen exposure and transgenerational susceptibility to polycystic ovary syndrome	NATURE MEDICINE			English	Article							INSULIN-RESISTANCE; WOMEN; HEALTH; ONSET; TESTOSTERONE; DYSFUNCTION; INHERITANCE; PREGNANCY; DAUGHTERS; GENETICS	How obesity and elevated androgen levels in women with polycystic ovary syndrome (PCOS) affect their offspring is unclear. In a Swedish nationwide register-based cohort and a clinical case-control study from Chile, we found that daughters of mothers with PCOS were more likely to be diagnosed with PCOS. Furthermore, female mice (F-0) with PCOS-like traits induced by late-gestation injection of dihydrotestosterone, with and without obesity, produced female F-1-F-3 offspring with PCOS-like reproductive and metabolic phenotypes. Sequencing of single metaphase II oocytes from F-1-F-3 offspring revealed common and unique altered gene expression across all generations. Notably, four genes were also differentially expressed in serum samples from daughters in the case-control study and unrelated women with PCOS. Our findings provide evidence of transgenerational effects in female offspring of mothers with PCOS and identify possible candidate genes for the prediction of a PCOS phenotype in future generations.	[Risal, Sanjiv; Pei, Yu; Lu, Haojiang; Manti, Maria; Fornes, Romina; Pui, Han-Pin; Zhao, Zhiyi; Lindgren, Eva; Deng, Qiaolin; Stener-Victorin, Elisabet] Karolinska Inst, Dept Physiol & Pharmacol, Stockholm, Sweden; [Pei, Yu; Deng, Qiaolin] Karolinska Univ Hosp, Ctr Mol Med, Stockholm, Sweden; [Zhao, Zhiyi] Shandong Prov Qianfoshan Hosp, Dept Gynecol, Jinan, Shandong, Peoples R China; [Massart, Julie] Karolinska Inst, Dept Mol Med & Surg, Stockholm, Sweden; [Ohlsson, Claes] Univ Gothenburg, Sahlgrenska Acad, Inst Med, Ctr Bone & Arthrit Res,Dept Internal Med & Clin N, Gothenburg, Sweden; [Crisosto, Nicolas; Maliqueo, Manuel; Echiburu, Barbara; de Guevara, Amanda Ladron; Sir-Petermann, Teresa] Univ Chile, Sch Med, West Div, Endocrinol & Metab Lab, Carlos Schachtebeck 299, Santiago, Chile; [Crisosto, Nicolas] Clin Las Condes, Endocrinol Unit, Santiago, Chile; [Larsson, Henrik; Rosenqvist, Mina A.] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Larsson, Henrik] Orebro Univ, Sch Med Sci, Orebro, Sweden; [Cesta, Carolyn E.] Karolinska Inst, Ctr Pharmacoepidemiol, Dept Med Solna, Stockholm, Sweden; [Benrick, Anna] Univ Gothenburg, Sahlgrenska Acad, Dept Physiol, Gothenburg, Sweden; [Benrick, Anna] Univ Skovde, Sch Hlth & Educ, Skovde, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Shandong First Medical University & Shandong Academy of Medical Sciences; Karolinska Institutet; University of Gothenburg; Universidad de Chile; Clinica Las Condes; Karolinska Institutet; Orebro University; Karolinska Institutet; University of Gothenburg; University of Skovde	Deng, QL; Stener-Victorin, E (corresponding author), Karolinska Inst, Dept Physiol & Pharmacol, Stockholm, Sweden.; Deng, QL (corresponding author), Karolinska Univ Hosp, Ctr Mol Med, Stockholm, Sweden.	qiaolin.deng@ki.se; elisabet.stener-victorin@ki.se	Deng, Qiaolin/AAD-6905-2020; Massart, Julie/AAA-3077-2019; Ohlsson, Claes/AGP-3544-2022; Cesta, Carolyn E/AAM-2039-2021; Echiburú, Bárbara/M-1659-2017; Stener-Victorin, Elisabet/W-6322-2018; Risal, Semuel/AAD-9739-2021; Risal, Sanjiv/K-9883-2017; Rosenqvist, Mina/P-6531-2018	Massart, Julie/0000-0001-8213-5459; Ohlsson, Claes/0000-0002-9633-2805; Cesta, Carolyn E/0000-0001-5759-9366; Echiburú, Bárbara/0000-0001-6535-3104; Stener-Victorin, Elisabet/0000-0002-3424-1502; Risal, Semuel/0000-0003-2155-4902; Pui, Han-Pin/0000-0003-4099-0478; Manti, Maria/0000-0003-4370-4780; Risal, Sanjiv/0000-0003-1723-5431; Fornes, Romina/0000-0002-4862-3819; Rosenqvist, Mina/0000-0002-2788-2061	Swedish Medical Research Council [2014-2775, 2018-02435, 2014-2870, 2018-02119]; Novo Nordisk Foundation [NNF17OC0026724, NNF18OC0033992, NNF19OC0056647]; Strategic Research Program in Diabetes at the Karolinska Institutet; Adlerbertska Research Foundation; Karolinska Institutet KID funding; Swedish Association of Medical Research; Ake Wiberg Foundation; Stockholm County Council; Karolinska Institutet; Royal Swedish Academy of Sciences (KVA) [BS2015-0012]; National Fund for Scientific and Technological Development (FONDECYT) [1071007, 1151531]; FONDECYT [1181798]	Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Strategic Research Program in Diabetes at the Karolinska Institutet; Adlerbertska Research Foundation; Karolinska Institutet KID funding(Karolinska Institutet); Swedish Association of Medical Research; Ake Wiberg Foundation; Stockholm County Council(Stockholm County Council); Karolinska Institutet(Karolinska Institutet); Royal Swedish Academy of Sciences (KVA); National Fund for Scientific and Technological Development (FONDECYT)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT)	We thank S. Pilstrom, J. Victorin and S. Edstrom for technical assistance during animal work; TSE Systems and the Metabolic Phenotyping Centre at the Strategic Research Program in Diabetes at the Karolinska Institutet; and the electron microscopy unit EMil at Huddinge University Hospital at the Karolinska Institutet. This work was funded by the Swedish Medical Research Council (project no. 2014-2775, 2018-02435 ESV; 2014-2870 QD; 2018-02119 MR), the Novo Nordisk Foundation (NNF17OC0026724, NNF18OC0033992 and NNF19OC0056647 ESV) and the Strategic Research Program in Diabetes at the Karolinska Institutet to E.S.-V.; the Adlerbertska Research Foundation to E.S.-V.; Karolinska Institutet KID funding to E.S.-V. and Q.D.; the Swedish Association of Medical Research and the Ake Wiberg Foundation to Q.D.; the Regional Agreement on Medical Training and Clinical Research between the Stockholm County Council and the Karolinska Institutet to E.S.-V.; the Royal Swedish Academy of Sciences (KVA, BS2015-0012) to S.R.; the National Fund for Scientific and Technological Development (FONDECYT) project no. 1071007 and 1151531 to T.S.-P.; and FONDECYT project no. 1181798 to M.M. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Aiken CE, 2014, HUM REPROD UPDATE, V20, P63, DOI 10.1093/humupd/dmt043; Azziz R, 2016, NAT REV ENDOCRINOL, V12, P184, DOI 10.1038/nrendo.2016.9; Barrett ES, 2018, J DEV ORIG HLTH DIS, V9, P307, DOI 10.1017/S2040174417001118; Beck ARP, 1998, P NATL ACAD SCI USA, V95, P2331, DOI 10.1073/pnas.95.5.2331; Benrick A, 2017, P NATL ACAD SCI USA, V114, pE7187, DOI 10.1073/pnas.1708854114; Butler A, 2018, NAT BIOTECHNOL, V36, P411, DOI 10.1038/nbt.4096; Cavalli G, 2019, NATURE, V571, P489, DOI 10.1038/s41586-019-1411-0; Cesta C. E., 2019, PSYCHOL MED, DOI [10.1017/S0029171900424, DOI 10.1017/S0029171900424]; Chen D, 2018, CELL REP, V25, P3591, DOI 10.1016/j.celrep.2018.12.011; Crisosto N, 2007, J CLIN ENDOCR METAB, V92, P2739, DOI 10.1210/jc.2007-0267; Crisosto N, 2019, FERTIL STERIL, V111, P381, DOI 10.1016/j.fertnstert.2018.10.011; Crisosto N, 2012, FERTIL STERIL, V97, P218, DOI 10.1016/j.fertnstert.2011.10.002; Dapas M, 2019, J CLIN ENDOCR METAB, V104, P3835, DOI 10.1210/jc.2018-02496; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Doherty DA, 2015, OBSTET GYNECOL, V125, P1397, DOI 10.1097/AOG.0000000000000852; Dumesic DA, 2019, J CLIN ENDOCR METAB, V104, P2171, DOI 10.1210/jc.2018-02086; Dumesic DA, 2015, ENDOCR REV, V36, P487, DOI 10.1210/er.2015-1018; Fornes R, 2019, INT J OBESITY, V43, P2176, DOI 10.1038/s41366-018-0314-8; Fornes R, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08559-w; Furuhashi M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00177-w; Gu MC, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07066-2; Gudmundsdottir B, 2018, CELL REP, V23, P3236, DOI 10.1016/j.celrep.2018.05.043; Guerrero-Bosagna C, 2012, REPROD TOXICOL, V34, P694, DOI 10.1016/j.reprotox.2012.09.005; Guerrero-Bosagna C, 2012, MOL CELL ENDOCRINOL, V354, P3, DOI 10.1016/j.mce.2011.10.004; Hanson MA, 2014, PHYSIOL REV, V94, P1027, DOI 10.1152/physrev.00029.2013; Hentze MW, 2018, NAT REV MOL CELL BIO, V19, P327, DOI 10.1038/nrm.2017.130; Homburg R, 2017, REPROD BIOL ENDOCRIN, V15, DOI 10.1186/s12958-017-0282-1; Hu M, 2015, P NATL ACAD SCI USA, V112, P14348, DOI 10.1073/pnas.1507514112; Jagannath A, 2013, CELL, V154, P1100, DOI 10.1016/j.cell.2013.08.004; Kaiser S, 2015, BIOL REPROD, V93, DOI 10.1095/biolreprod.114.126474; Kim DA, 2014, MOL CELL BIOL, V34, P1460, DOI 10.1128/MCB.01223-13; Kokosar M, 2016, SCI REP-UK, V6, DOI 10.1038/srep22883; Li C, 2013, J BIOL CHEM, V288, P17908, DOI 10.1074/jbc.M113.458836; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Luotola K, 2018, GYNECOL ENDOCRINOL, V34, P40, DOI 10.1080/09513590.2017.1342793; Maliqueo M, 2015, HUM REPROD, V30, P692, DOI 10.1093/humrep/deu351; Manikkam M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046249; Manneras-Holm L, 2011, J CLIN ENDOCR METAB, V96, pE304, DOI 10.1210/jc.2010-1290; Manti M, 2020, CARDIOVASC RES, V116, P619, DOI 10.1093/cvr/cvz180; Manti M, 2018, FASEB J, V32, P4158, DOI 10.1096/fj.201701263RR; March WA, 2010, HUM REPROD, V25, P544, DOI 10.1093/humrep/dep399; McAllister JM, 2014, P NATL ACAD SCI USA, V111, pE1519, DOI 10.1073/pnas.1400574111; Mehlem A, 2013, NAT PROTOC, V8, P1149, DOI 10.1038/nprot.2013.055; Meyer C, 2018, MOL CELL, V69, P622, DOI 10.1016/j.molcel.2018.01.011; Miyamoto K, 2017, PROTEIN SCI, V26, P1681, DOI 10.1002/pro.3201; Nilsson ME, 2015, ENDOCRINOLOGY, V156, P2492, DOI 10.1210/en.2014-1890; O'Reilly MW, 2017, J CLIN ENDOCR METAB, V102, P3327, DOI 10.1210/jc.2017-00947; Palomba S, 2013, HUM REPROD, V28, P2838, DOI 10.1093/humrep/det250; Palomba S, 2012, CLIN ENDOCRINOL, V77, P898, DOI 10.1111/j.1365-2265.2012.04443.x; Petta S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186136; Picelli S, 2013, NAT METHODS, V10, P1096, DOI [10.1038/nmeth.2639, 10.1038/NMETH.2639]; Ribeiro JR, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00045; Roland AV, 2010, J ENDOCRINOL, V207, P213, DOI 10.1677/JOE-10-0217; Roos N, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d6309; Saben JL, 2016, CELL REP, V16, P1, DOI 10.1016/j.celrep.2016.05.065; Sasaki D, 2015, MAMM GENOME, V26, P619, DOI 10.1007/s00335-015-9597-4; Sharma N, 2016, DEVELOPMENT, V143, P787, DOI 10.1242/dev.128553; Sir-Petermann T, 2009, J CLIN ENDOCR METAB, V94, P1923, DOI 10.1210/jc.2008-2836; Skinner MK, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-228; Stener-Victorin E, 2010, J CLIN ENDOCR METAB, V95, P810, DOI 10.1210/jc.2009-1908; SWANSON M, 1981, J CLIN ULTRASOUND, V9, P219, DOI 10.1002/jcu.1870090504; Tao WW, 2015, J BIOL CHEM, V290, P20086, DOI 10.1074/jbc.M115.657742; Tee MK, 2016, MOL CELL ENDOCRINOL, V434, P25, DOI 10.1016/j.mce.2016.06.011; Torchen LC, 2019, J CLIN ENDOCR METAB, V104, P3355, DOI 10.1210/jc.2018-02313; Wang FF, 2015, P NATL ACAD SCI USA, V112, P4743, DOI 10.1073/pnas.1418216112; Weissenrieder JS, 2019, PROSTATE, V79, P21, DOI 10.1002/pros.23707; Witham EA, 2012, ENDOCRINOLOGY, V153, P4522, DOI 10.1210/en.2012-1283; Xavier MJ, 2019, HUM REPROD UPDATE, V25, P519, DOI 10.1093/humupd/dmz017; Yu GC, 2012, OMICS, V16, P284, DOI 10.1089/omi.2011.0118; Zhang YY, 2018, MOL CELL, V72, P1021, DOI 10.1016/j.molcel.2018.10.029	70	102	107	5	38	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	2019	25	12					1894	+		10.1038/s41591-019-0666-1	http://dx.doi.org/10.1038/s41591-019-0666-1			27	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	JT2KO	31792459	Green Submitted			2022-12-27	WOS:000500824900033
J	Stower, H				Stower, Hannah			CARDIOVASCULAR DISEASE Immunotherapy for heart injury	NATURE MEDICINE			English	Editorial Material																			0	2	2	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	2019	25	12					1799	1799		10.1038/s41591-019-0688-8	http://dx.doi.org/10.1038/s41591-019-0688-8			1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	JT2KO	31806902	Bronze			2022-12-27	WOS:000500824900008
J	Gerdts, E; Regitz-Zagrosek, V				Gerdts, Eva; Regitz-Zagrosek, Vera			Sex differences in cardiometabolic disorders	NATURE MEDICINE			English	Review							CORONARY-HEART-DISEASE; LEFT-VENTRICULAR HYPERTROPHY; END-POINT REDUCTION; CARDIAC-RESYNCHRONIZATION THERAPY; ISCHEMIA-REPERFUSION INJURY; SUBCUTANEOUS ADIPOSE-TISSUE; ESTROGEN-RECEPTOR-ALPHA; LEFT ATRIAL SIZE; BODY-MASS INDEX; RISK-FACTORS	The prevalence of cardiometabolic disorders in both women and men has increased worldwide and is linked to a rise in obesity and obesity-associated associated clustering of other cardiometabolic risk factors such as hypertension, impaired glucose regulation and dyslipidemia. However, the predominance of common types of cardiometabolic disorders such as heart failure, atrial fibrillation and ischemic heart disease is sex specific, and our identification of these and the underlying mechanisms is only just emerging. New evidence suggests that sex hormones, sex-specific molecular mechanisms and gender influence glucose and lipid metabolisms, as well as cardiac energy metabolism, and function. Here we review sex differences in cardiometabolic risk factors, associated preclinical and clinical cardiac disorders and potential therapeutic avenues.	[Gerdts, Eva] Univ Bergen, Dept Clin Sci, Bergen, Norway; [Regitz-Zagrosek, Vera] Charite, Berlin Inst Gender Med, Berlin, Germany; [Regitz-Zagrosek, Vera] DZHK, Partner Site Berlin, Berlin, Germany	University of Bergen; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; German Centre for Cardiovascular Research	Gerdts, E (corresponding author), Univ Bergen, Dept Clin Sci, Bergen, Norway.	eva.gerdts@med.uib.no		Regitz-Zagrosek, Vera/0000-0002-3566-3467				Al-Salameh A, 2019, MAYO CLIN PROC, V94, P287, DOI 10.1016/j.mayocp.2018.08.007; Albrektsen G, 2017, ATHEROSCLEROSIS, V261, P52, DOI 10.1016/j.atherosclerosis.2017.04.009; Alpert MA, 2014, TRANSL RES, V164, P345, DOI 10.1016/j.trsl.2014.04.010; Ball J, 2018, J AM HEART ASSOC, V7, DOI 10.1161/JAHA.117.008414; Bella JN, 2001, AM J CARDIOL, V87, P1260, DOI 10.1016/S0002-9149(01)01516-8; Bella JN, 2006, AM J CARDIOL, V98, P834, DOI 10.1016/j.amjcard.2006.03.069; Berger JS, 2009, JAMA-J AM MED ASSOC, V302, P874, DOI 10.1001/jama.2009.1227; Blum S, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.116.005401; Bohm C, 2013, AM J PHYSIOL-HEART C, V305, pH211, DOI 10.1152/ajpheart.00593.2012; Bots SH, 2019, JACC-HEART FAIL, V7, P258, DOI 10.1016/j.jchf.2019.01.009; Chen JQ, 2004, J CELL BIOCHEM, V93, P358, DOI 10.1002/jcb.20178; Cho NH, 2018, DIABETES RES CLIN PR, V138, P271, DOI 10.1016/j.diabres.2018.02.023; Conen D, 2013, INT J CARDIOL, V168, P1894, DOI 10.1016/j.ijcard.2012.12.060; Costantino S, 2019, EUR HEART J, V40, P997, DOI 10.1093/eurheartj/ehy903; Czubryt MP, 2003, P NATL ACAD SCI USA, V100, P1711, DOI 10.1073/pnas.0337639100; de Simone G, 2017, CARDIOVASC DIABETOL, V16, DOI 10.1186/s12933-017-0542-6; de Simone G, 2016, DIABETOL METAB SYNDR, V8, DOI 10.1186/s13098-016-0193-x; de Simone G, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000144; De Simone G, 2011, J HYPERTENS, V29, P1431, DOI 10.1097/HJH.0b013e328347a093; de Simone G, 2010, HYPERTENSION, V56, P99, DOI 10.1161/HYPERTENSIONAHA.110.150128; Despres JP, 2000, ARTERIOSCL THROM VAS, V20, P1932, DOI 10.1161/01.ATV.20.8.1932; DEVEREUX RB, 1993, CIRCULATION, V88, P1444, DOI 10.1161/01.CIR.88.4.1444; Diedrich M, 2007, INT J MOL MED, V20, P865; Dworatzek E, 2019, CARDIOVASC RES, V115, P315, DOI 10.1093/cvr/cvy185; Eskerud I, 2019, INT J CARDIOL, V286, P1, DOI 10.1016/j.ijcard.2019.03.059; Essop MF, 2007, FEBS J, V274, P5278, DOI 10.1111/j.1742-4658.2007.06051.x; Eugene Andy R, 2016, Med Sci (Basel), V4, DOI 10.3390/medsci4040018; Ferrara LA, 2014, NUTR METAB CARDIOVAS, V24, P271, DOI 10.1016/j.numecd.2013.08.009; Flegal KM, 2016, JAMA-J AM MED ASSOC, V315, P2284, DOI 10.1001/jama.2016.6458; Fliegner D, 2010, AM J PHYSIOL-REG I, V298, pR1597, DOI 10.1152/ajpregu.00825.2009; Fox CS, 2007, CIRCULATION, V116, P39, DOI 10.1161/CIRCULATIONAHA.106.675355; Fryar Cheryl D, 2017, NCHS Data Brief, P1; Garcia M, 2016, CIRC RES, V118, P1273, DOI 10.1161/CIRCRESAHA.116.307547; Gerdts E, 2002, HYPERTENSION, V39, P739, DOI 10.1161/hy0302.105683; Gerdts E, 2008, HYPERTENSION, V51, P1109, DOI 10.1161/HYPERTENSIONAHA.107.107474; Gerdts E, 2007, HYPERTENSION, V49, P311, DOI 10.1161/01.HYP.0000254322.96189.85; Gerdts E, 2018, INT J CARDIOL, V258, P257, DOI 10.1016/j.ijcard.2017.12.086; Gillis AM, 2017, CIRCULATION, V135, P593, DOI 10.1161/CIRCULATIONAHA.116.025312; Halland H, 2019, NUTR METAB CARDIOVAS, V29, P710, DOI 10.1016/j.numecd.2019.03.012; Halland H, 2018, NUTR METAB CARDIOVAS, V28, P1054, DOI 10.1016/j.numecd.2018.06.014; Ho JE, 2013, CIRC-HEART FAIL, V6, P279, DOI 10.1161/CIRCHEARTFAILURE.112.972828; Huxley R, 2006, BMJ-BRIT MED J, V332, P73, DOI 10.1136/bmj.38678.389583.7C; Huxley RR, 2011, CIRCULATION, V123, P1501, DOI [10.1161/circulationaha.110.009035, 10.1161/CIRCULATIONAHA.110.009035]; Irwin RW, 2012, J NEUROENDOCRINOL, V24, P236, DOI 10.1111/j.1365-2826.2011.02251.x; Izzo R, 2017, HYPERTENSION, V69, P136, DOI 10.1161/HYPERTENSIONAHA.116.08158; Jackson CA, 2015, PREV MED, V81, P92, DOI 10.1016/j.ypmed.2015.08.013; Jankowska EA, 2009, JAMA-J AM MED ASSOC, V301, P1892, DOI 10.1001/jama.2009.639; January CT, 2014, J AM COLL CARDIOL, V64, pE1, DOI [10.1161/CIR.0000000000000041, 10.1016/j.jacc.2014.03.022, 10.1161/CIR.0000000000000142, 10.1016/j.jacc.2014.03.021]; Juutilainen A, 2004, DIABETES CARE, V27, P2898, DOI 10.2337/diacare.27.12.2898; Kararigas G, 2014, EUR J HEART FAIL, V16, P1160, DOI 10.1002/ejhf.171; Kararigas G, 2012, J AM COLL CARDIOL, V59, P410, DOI 10.1016/j.jacc.2011.09.054; Kellman P, 2009, MAGN RESON MED, V61, P215, DOI 10.1002/mrm.21657; Kim JS, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.117.006077; Kirchhof P, 2016, EUROPACE, V18, DOI [10.1016/j.rec.2016.11.033, 10.1093/europace/euw295, 10.5603/KP.2016.0172]; Labounty TM, 2013, EUR HEART J-CARD IMG, V14, P456, DOI 10.1093/ehjci/jes179; Lagranha CJ, 2010, CIRC RES, V106, P1681, DOI 10.1161/CIRCRESAHA.109.213645; Lang RM, 2015, EUR HEART J-CARD IMG, V16, P233, DOI 10.1093/ehjci/jev014; Lavie CJ, 2017, J AM COLL CARDIOL, V70, P2022, DOI 10.1016/j.jacc.2017.09.002; Lee DS, 2009, CIRCULATION, V119, P3070, DOI 10.1161/CIRCULATIONAHA.108.815944; Lehti M, 2013, CIRCULATION, V128, P2364, DOI 10.1161/CIRCULATIONAHA.113.001551; Lew J, 2017, CIRCULATION, V135, P544, DOI 10.1161/CIRCULATIONAHA.116.023005; Liu H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085272; Liu JK, 2010, J CLIN ENDOCR METAB, V95, P5419, DOI 10.1210/jc.2010-1378; Lonnebakken MT, 2019, OPEN HEART, V6, DOI 10.1136/openhrt-2018-000981; Lyon A, 2015, CURR DIABETES REP, V15, DOI 10.1007/s11892-015-0662-x; Marques A, 2018, EUR J PUBLIC HEALTH, V28, P295, DOI 10.1093/eurpub/ckx143; Mauvais-Jarvis F, 2015, BIOL SEX DIFFER, V6, DOI 10.1186/s13293-015-0033-y; Mieres JH, 2011, J WOMENS HEALTH, V20, P1261, DOI 10.1089/jwh.2010.2595; Miller VM, 2008, PHARMACOL REV, V60, P210, DOI 10.1124/pr.107.08002; Mongraw-Chaffin ML, 2015, LANCET DIABETES ENDO, V3, P437, DOI 10.1016/S2213-8587(15)00086-8; Moore JX, 2017, PREV CHRONIC DIS, V14, DOI 10.5888/pcd14.160287; Moss AJ, 2009, NEW ENGL J MED, V361, P1329, DOI 10.1056/NEJMoa0906431; Muller DN, 2007, BIOCHEM J, V403, P109, DOI 10.1042/BJ20061328; Murphy E, 2017, CARDIOVASC RES, V113, P370, DOI 10.1093/cvr/cvx008; Nelson JK, 2016, CIRC RES, V118, P410, DOI 10.1161/CIRCRESAHA.115.307298; Ng ACT, 2018, CIRC-CARDIOVASC IMAG, V11, DOI 10.1161/CIRCIMAGING.117.007372; Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8; O'Neill S, 2015, OBES REV, V16, P1, DOI 10.1111/obr.12229; Oertelt-Prigione S, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0304-9; Pelletier R, 2016, J AM COLL CARDIOL, V67, P127, DOI 10.1016/j.jacc.2015.10.067; Pelletier R, 2015, PSYCHOSOM MED, V77, P517, DOI 10.1097/PSY.0000000000000186; Peters SAE, 2016, ATHEROSCLEROSIS, V248, P123, DOI 10.1016/j.atherosclerosis.2016.03.016; Peters SAE, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010007; Peters SAE, 2014, DIABETOLOGIA, V57, P1542, DOI 10.1007/s00125-014-3260-6; Petrov G, 2014, JACC-CARDIOVASC IMAG, V7, P1073, DOI 10.1016/j.jcmg.2014.06.017; Petrov G, 2010, CIRCULATION, V122, pS23, DOI 10.1161/CIRCULATIONAHA.109.927764; Ponikowski P, 2016, EUR HEART J, V37, P2129, DOI 10.1093/eurheartj/ehw128; Rattanasopa C, 2015, J STEROID BIOCHEM, V147, P1, DOI 10.1016/j.jsbmb.2014.11.009; Razavi AC, 2019, BIOL SEX DIFFER, V10, DOI 10.1186/s13293-019-0240-z; Regitz-Zagrosek V, 2004, ARCH MAL COEUR VAISS, V97, P899; Regitz-Zagrosek V, 2007, GENDER MED, V4, pS162, DOI 10.1016/S1550-8579(07)80056-8; Regitz-Zagrosek V, 2016, EUR HEART J, V37, P24, DOI 10.1093/eurheartj/ehv598; Resnick HE, 2002, DIABETES CARE, V25, P1246, DOI 10.2337/diacare.25.7.1246; Rettberg JR, 2014, FRONT NEUROENDOCRIN, V35, P8, DOI 10.1016/j.yfrne.2013.08.001; Sanchez-Ruderisch H, 2019, BIOL SEX DIFFER, V10, DOI 10.1186/s13293-019-0222-1; Santema BT, 2019, LANCET, V394, P1254, DOI 10.1016/S0140-6736(19)31792-1; Savji N, 2018, JACC-HEART FAIL, V6, P701, DOI 10.1016/j.jchf.2018.05.018; Schulman-Marcus J, 2016, JACC-CARDIOVASC IMAG, V9, P364, DOI 10.1016/j.jcmg.2016.02.010; Schulze PC, 2016, CIRC RES, V118, P1736, DOI 10.1161/CIRCRESAHA.116.306842; Scuteri A, 2014, HYPERTENSION, V64, P1219, DOI 10.1161/HYPERTENSIONAHA.114.04127; Shah ASV, 2015, BMJ-BRIT MED J, V350, DOI [10.1136/bmj.h626, 10.1136/bmj.g7873]; Sharashova E., 2019, EUR HEART J; Shaw LJ, 2009, J AM COLL CARDIOL, V54, P1561, DOI 10.1016/j.jacc.2009.04.098; Shungin D, 2015, NATURE, V518, P187, DOI 10.1038/nature14132; Srivastava S, 1999, J CLIN INVEST, V104, P503, DOI 10.1172/JCI7094; Stirone C, 2005, MOL PHARMACOL, V68, P959, DOI 10.1124/mol.105.014662; Stocco C, 2012, STEROIDS, V77, P27, DOI 10.1016/j.steroids.2011.10.013; Sulo G, 2018, EUR J PREV CARDIOL, V25, P1031, DOI 10.1177/2047487318780033; Sun LY, 2014, J MOL CELL CARDIOL, V75, P1, DOI 10.1016/j.yjmcc.2014.06.012; Tadic M, 2019, J HYPERTENS, V37, P50, DOI 10.1097/HJH.0000000000001838; Tang ASL, 2010, NEW ENGL J MED, V363, P2385, DOI 10.1056/NEJMoa1009540; Taqueti VR, 2017, CIRCULATION, V135, P566, DOI 10.1161/CIRCULATIONAHA.116.023266; Tiyerili V, 2012, J MOL CELL CARDIOL, V53, P268, DOI 10.1016/j.yjmcc.2012.05.008; Tsang TSM, 2008, EUR HEART J, V29, P2227, DOI 10.1093/eurheartj/ehn324; Ventura-Clapier R, 2017, CARDIOVASC RES, V113, P711, DOI 10.1093/cvr/cvx066; Wei J, 2016, AM J PHYSIOL-HEART C, V310, pH14, DOI 10.1152/ajpheart.00612.2015; Westphal C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073490; Williams B, 2018, EUR HEART J, V39, P3021, DOI 10.1093/eurheartj/ehy339; Witt H, 2008, J MOL MED, V86, P1013, DOI 10.1007/s00109-008-0385-4; Yancy CW, 2017, J CARD FAIL, V23, P628, DOI [10.1161/CIR.0000000000000509, 10.1016/j.jacc.2017.04.025]; Zhai PY, 2000, AM J PHYSIOL-HEART C, V278, pH1640, DOI 10.1152/ajpheart.2000.278.5.H1640; Zhai PY, 2000, AM J PHYSIOL-HEART C, V279, pH2766, DOI 10.1152/ajpheart.2000.279.6.H2766; Zhang L, 2007, J HYPERTENS, V25, P407, DOI 10.1097/HJH.0b013e328010beee; Zylla MM, 2016, HEART RHYTHM, V13, P1837, DOI 10.1016/j.hrthm.2016.06.005	124	140	143	1	14	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2019	25	11					1657	1666		10.1038/s41591-019-0643-8	http://dx.doi.org/10.1038/s41591-019-0643-8			10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	JT2KI	31700185				2022-12-27	WOS:000500824300022
J	Nakamura, Y; Taniguchi, H; Ikeda, M; Bando, H; Kato, K; Morizane, C; Esaki, T; Komatsu, Y; Kawamoto, Y; Takahashi, N; Ueno, M; Kagawa, Y; Nishina, T; Kato, T; Yamamoto, Y; Furuse, J; Denda, T; Kawakami, H; Oki, E; Nakajima, T; Nishida, N; Yamaguchi, K; Yasui, H; Goto, M; Matsuhashi, N; Ohtsubo, K; Yamazaki, K; Tsuji, A; Okamoto, W; Tsuchihara, K; Yamanaka, T; Miki, I; Sakamoto, Y; Ichiki, H; Hata, M; Yamashita, R; Ohtsu, A; Odegaard, JI; Yoshino, T				Nakamura, Yoshiaki; Taniguchi, Hiroya; Ikeda, Masafumi; Bando, Hideaki; Kato, Ken; Morizane, Chigusa; Esaki, Taito; Komatsu, Yoshito; Kawamoto, Yasuyuki; Takahashi, Naoki; Ueno, Makoto; Kagawa, Yoshinori; Nishina, Tomohiro; Kato, Takeshi; Yamamoto, Yoshiyuki; Furuse, Junji; Denda, Tadamichi; Kawakami, Hisato; Oki, Eiji; Nakajima, Takako; Nishida, Naohiro; Yamaguchi, Kensei; Yasui, Hisateru; Goto, Masahiro; Matsuhashi, Nobuhisa; Ohtsubo, Koushiro; Yamazaki, Kentaro; Tsuji, Akihito; Okamoto, Wataru; Tsuchihara, Katsuya; Yamanaka, Takeharu; Miki, Izumi; Sakamoto, Yasutoshi; Ichiki, Hiroko; Hata, Masayuki; Yamashita, Riu; Ohtsu, Atsushi; Odegaard, Justin, I; Yoshino, Takayuki			Clinical utility of circulating tumor DNA sequencing in advanced gastrointestinal cancer: SCRUM-Japan GI-SCREEN and GOZILA studies	NATURE MEDICINE			English	Article							CELL LUNG-CANCER; CHOLANGIOCARCINOMA; MULTICENTER; VALIDATION; RESISTANCE; MUTATIONS; BIOPSIES; TRIALS	Comprehensive genomic profiling enables genomic biomarker detection in advanced solid tumors. Here, to evaluate the utility of circulating tumor DNA (ctDNA) genotyping, we compare trial enrollment using ctDNA sequencing in 1,687 patients with advanced gastrointestinal (GI) cancer in SCRUM-Japan GOZILA (no. UMIN000016343), an observational ctDNA-based screening study, to enrollment using tumor tissue sequencing in the same centers and network (GI-SCREEN, 5,621 patients). ctDNA genotyping significantly shortened the screening duration (11 versus 33 days, P < 0.0001) and improved the trial enrollment rate (9.5 versus 4.1%, P < 0.0001) without compromising treatment efficacy compared to tissue genotyping. We also describe the clonal architecture of ctDNA profiles in similar to 2,000 patients with advanced GI cancer, which reinforces the relevance of many targetable oncogenic drivers and highlights multiple new drivers as candidates for clinical development. ctDNA genotyping has the potential to accelerate innovation in precision medicine and its delivery to individual patients.	[Nakamura, Yoshiaki; Taniguchi, Hiroya; Ohtsu, Atsushi; Yoshino, Takayuki] Natl Canc Ctr Hosp East, Dept Gastroenterol & Gastrointestinal Oncol, Kashiwa, Chiba, Japan; [Nakamura, Yoshiaki; Taniguchi, Hiroya; Okamoto, Wataru; Tsuchihara, Katsuya; Miki, Izumi; Sakamoto, Yasutoshi; Ichiki, Hiroko; Hata, Masayuki] Natl Canc Ctr Hosp East, Translat Res Support Sect, Kashiwa, Chiba, Japan; [Ikeda, Masafumi] Natl Canc Ctr Hosp East, Dept Hepatobiliary & Pancreat Oncol, Kashiwa, Chiba, Japan; [Bando, Hideaki] Aichi Canc Ctr Hosp, Dept Clin Oncol, Nagoya, Aichi, Japan; [Kato, Ken] Natl Canc Ctr, Dept Gastrointestinal Oncol, Tokyo, Japan; [Kato, Ken] Natl Canc Ctr, Biobank Translat Res Support Sect, Tokyo, Japan; [Morizane, Chigusa] Natl Canc Ctr, Dept Hepatobiliary & Pancreat Oncol, Tokyo, Japan; [Esaki, Taito] Natl Hosp Org Kyushu Canc Ctr, Dept Gastrointestinal & Med Oncol, Fukuoka, Japan; [Komatsu, Yoshito; Kawamoto, Yasuyuki] Hokkaido Univ Hosp, Dept Canc Ctr, Sapporo, Hokkaido, Japan; [Takahashi, Naoki] Saitama Canc Ctr, Dept Gastroenterol, Saitama, Japan; [Ueno, Makoto] Kanagawa Canc Ctr, Dept Gastroenterol, Hepatobiliary & Pancreat Med Oncol Div, Yokohama, Kanagawa, Japan; [Kagawa, Yoshinori] Kansai Rosai Hosp, Dept Colorectal Surg, Amagasaki, Hyogo, Japan; [Nishina, Tomohiro] Natl Hosp Org Shikoku Canc Ctr, Dept Gastrointestinal Med Oncol, Matsuyama, Ehime, Japan; [Kato, Takeshi] Natl Hosp Org Osaka Natl Hosp, Dept Surg, Osaka, Japan; [Yamamoto, Yoshiyuki] Univ Tsukuba Hosp, Dept Gastroenterol & Hepatol, Tsukuba, Ibaraki, Japan; [Furuse, Junji] Kyorin Univ Hosp, Dept Med Oncol, Mitaka, Tokyo, Japan; [Denda, Tadamichi] Chiba Canc Ctr, Div Gastroenterol, Chiba, Japan; [Kawakami, Hisato] Kindai Univ Hosp, Dept Med Oncol, Osakasayama, Japan; [Oki, Eiji] Kyushu Univ, Grad Sch Med Sci, Dept Surg & Sci, Fukuoka, Japan; [Nakajima, Takako] St Marianna Univ, Sch Med, Dept Med Oncol, Kawasaki, Kanagawa, Japan; [Nishida, Naohiro] Osaka Univ, Grad Sch Med, Dept Frontier Sci Canc & Chemotherapy, Suita, Osaka, Japan; [Yamaguchi, Kensei] Japanese Fdn Canc Res, Dept Gastroenterol Chemotherapy, Canc Inst Hosp, Tokyo, Japan; [Yasui, Hisateru] Kobe City Med Ctr, Dept Med Oncol, Gen Hosp, Kobe, Hyogo, Japan; [Goto, Masahiro] Osaka Med Coll Hosp, Canc Chemotherapy Ctr, Takatsuki, Osaka, Japan; [Matsuhashi, Nobuhisa] Gifu Univ, Grad Sch Med, Dept Surg Oncol, Gifu, Japan; [Ohtsubo, Koushiro] Kanazawa Univ, Canc Res Inst, Div Med Oncol, Kanazawa, Ishikawa, Japan; [Yamazaki, Kentaro] Shizuoka Canc Ctr, Div Gastrointestinal Oncol, Shizuoka, Japan; [Tsuji, Akihito] Kagawa Univ Hosp, Dept Clin Oncol, Miki, Kagawa, Japan; [Okamoto, Wataru] Hiroshima Univ Hosp, Canc Treatment Ctr, Hiroshima, Japan; [Tsuchihara, Katsuya; Yamashita, Riu] Natl Canc Ctr, Div Translat Informat, Exploratory Oncol Res & Clin Trial Ctr, Kashiwa, Chiba, Japan; [Yamanaka, Takeharu] Natl Canc Ctr Hosp East, Div Biostat, Kashiwa, Chiba, Japan; [Odegaard, Justin, I] Guardant Hlth, Redwood City, CA USA	National Cancer Center - Japan; National Cancer Center - Japan; National Cancer Center - Japan; Aichi Cancer Center; National Cancer Center - Japan; National Cancer Center - Japan; National Cancer Center - Japan; Kyushu Cancer Center; Hokkaido University; Kanagawa Prefectural Cancer Center; Kansai Rosai Hospital; Osaka National Hospital; University of Tsukuba; Kyorin University; Chiba Cancer Center; Kyushu University; Saint Marianna University; Osaka University; Japanese Foundation for Cancer Research; Kobe City Medical Center General Hospital; Osaka Medical College; Gifu University; Kanazawa University; Shizuoka Cancer Center; Kagawa University; Hiroshima University; National Cancer Center - Japan; National Cancer Center - Japan	Yoshino, T (corresponding author), Natl Canc Ctr Hosp East, Dept Gastroenterol & Gastrointestinal Oncol, Kashiwa, Chiba, Japan.	tyoshino@east.ncc.go.jp	Okamoto, Wataru/AIE-0808-2022; Kawamoto, Yasuyuki/GWQ-7700-2022; Morizane, Chigusa/AFV-4780-2022; Kawakami, Hisato/L-6845-2019	Morizane, Chigusa/0000-0002-6560-7503; Kawakami, Hisato/0000-0002-3280-4850; Kato, Ken/0000-0002-1733-5072; Yamamoto, Yoshiyuki/0000-0002-2932-5904; Ikeda, Masafumi/0000-0002-4050-2086; Bando, Hideaki/0000-0001-5041-2765	Japan Agency for Medical Research and Development [19ck0106445h0002]; National Cancer Center Research and Development Fund [31-A-5]; SCRUM-Japan Funds	Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED)); National Cancer Center Research and Development Fund(National Cancer Center - Japan); SCRUM-Japan Funds	The authors thank all of the patients and their families who participated in this study; all SCRUM-Japan GI-SCREEN and GOZILA investigators and site personnel; M. Yuasa, Y. Ogata, S. Horasawa, M. Fujita, T. Nakamura, K. Kitajima, N. Kuramoto, H. Sokuoka and H. Uchigata (Translational Research Support Section, National Cancer Center Hospital East, Kashiwa, Japan) for study management and data center support; and Genomedia Inc. for data analysis. This work was supported by grants from the Japan Agency for Medical Research and Development (no. 19ck0106445h0002 to Y.N.), National Cancer Center Research and Development Fund (no. 31-A-5 to A.O.) and SCRUM-Japan Funds (http://www.scrum-japan.ncc.go.jp/index.html).	Abou-Alfa GK, 2020, LANCET ONCOL, V21, P796, DOI 10.1016/S1470-2045(20)30157-1; Aggarwal C, 2019, JAMA ONCOL, V5, P173, DOI 10.1001/jamaoncol.2018.4305; Aguirre AJ, 2017, CANCER CELL, V32, P185, DOI 10.1016/j.ccell.2017.07.007; Banales JM, 2016, NAT REV GASTRO HEPAT, V13, P261, DOI 10.1038/nrgastro.2016.51; Bando H, 2017, CURR PROB CANCER, V41, P166, DOI 10.1016/j.currproblcancer.2017.02.003; Brown University, 2017, NATURE, V541, P169, DOI [DOI 10.1038/NATURE20805, 10.1038/nature20805]; Chakravarty Debyani, 2017, JCO Precis Oncol, V2017, DOI 10.1200/PO.17.00011; Chalmers ZR, 2017, GENOME MED, V9, DOI 10.1186/s13073-017-0424-2; Deng JY, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01730-x; Golan T, 2019, NEW ENGL J MED, V381, P317, DOI 10.1056/NEJMoa1903387; Golan T, 2017, ONCOLOGIST, V22, P804, DOI 10.1634/theoncologist.2016-0415; Hu YB, 2017, CLIN CANCER RES, V23, P7351, DOI 10.1158/1078-0432.CCR-17-1745; Kopetz S, 2019, NEW ENGL J MED, V381, P1632, DOI 10.1056/NEJMoa1908075; Leighl NB, 2019, CLIN CANCER RES, V25, P4691, DOI 10.1158/1078-0432.CCR-19-0624; Li H., 2013, ARXIV, DOI DOI 10.48550/ARXIV.1303.3997; Li SQ, 2018, NAT REV CANCER, V18, P767, DOI 10.1038/s41568-018-0076-6; Lih CJ, 2017, J MOL DIAGN, V19, P313, DOI 10.1016/j.jmoldx.2016.10.007; Lim C, 2016, J THORAC ONCOL, V11, P79, DOI 10.1016/j.jtho.2015.09.006; Maron SB, 2019, CLIN CANCER RES, V25, P7098, DOI 10.1158/1078-0432.CCR-19-1704; Meric-Bernstam F, 2016, ANN ONCOL, V27, P795, DOI 10.1093/annonc/mdw018; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Nakamura Y, 2020, ESMO OPEN, V5, DOI 10.1136/esmoopen-2019-000600; Nakamura Y, 2018, ONCOLOGIST, V23, P1310, DOI 10.1634/theoncologist.2017-0621; Nance T, 2018, CANCER RES, V78, DOI 10.1158/1538-7445.AM2018-4272; Odegaard JI, 2018, CLIN CANCER RES, V24, P3539, DOI 10.1158/1078-0432.CCR-17-3831; Parikh AR, 2019, NAT MED, V25, P1415, DOI 10.1038/s41591-019-0561-9; Rothwell DG, 2019, NAT MED, V25, P738, DOI 10.1038/s41591-019-0380-z; Salem ME, 2018, MOL CANCER RES, V16, P805, DOI 10.1158/1541-7786.MCR-17-0735; Spiegel ML, 2017, CANCER-AM CANCER SOC, V123, P4800, DOI 10.1002/cncr.31056; Strickler JH, 2018, CANCER DISCOV, V8, P164, DOI 10.1158/2159-8290.CD-17-1009; Thompson JC, 2016, CLIN CANCER RES, V22, P5772, DOI 10.1158/1078-0432.CCR-16-1231; Villaflor V, 2016, ONCOTARGET, V7, P66880, DOI 10.18632/oncotarget.11801; Willis J, 2019, CLIN CANCER RES, V25, P7035, DOI 10.1158/1078-0432.CCR-19-1324; Zhang L, 2017, JNCI-J NATL CANCER I, V109, DOI 10.1093/jnci/djw332	34	107	110	0	6	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	2020	26	12								10.1038/s41591-020-1063-5	http://dx.doi.org/10.1038/s41591-020-1063-5		OCT 2020	16	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	PB8QO	33020649				2022-12-27	WOS:000575801100008
J	Meran, L; Massie, I; Campinoti, S; Weston, AE; Gaifulina, R; Tullie, L; Faull, P; Orford, M; Kucharska, A; Baulies, A; Novellasdemunt, L; Angelis, N; Hirst, E; Konig, J; Tedeschi, AM; Pellegata, AF; Eli, S; Snijders, AP; Collinson, L; Thapar, N; Thomas, GMH; Eaton, S; Bonfanti, P; De Coppi, P; Li, VSW				Meran, Laween; Massie, Isobel; Campinoti, Sara; Weston, Anne E.; Gaifulina, Riana; Tullie, Lucinda; Faull, Peter; Orford, Michael; Kucharska, Anna; Baulies, Anna; Novellasdemunt, Laura; Angelis, Nikolaos; Hirst, Elizabeth; Konig, Julia; Tedeschi, Alfonso Maria; Pellegata, Alessandro Filippo; Eli, Susanna; Snijders, Ambrosius P.; Collinson, Lucy; Thapar, Nikhil; Thomas, Geraint M. H.; Eaton, Simon; Bonfanti, Paola; De Coppi, Paolo; Li, Vivian S. W.			Engineering transplantable jejunal mucosal grafts using patient-derived organoids from children with intestinal failure	NATURE MEDICINE			English	Article							SHORT-BOWEL SYNDROME; HUMAN COLON; REGENERATION; TEDUGLUTIDE; ABSORPTION; CITRULLINE; DELIVERY; SCAFFOLD; MODEL	In a first step toward developing autologous tissue grafts for the treatment of children with intestinal failure, patient-derived jejunal organoids seeded on scaffolds of decellularized human intestinal matrix formed grafts that had jejunal properties and formed luminal structures when transplanted into mice. Intestinal failure, following extensive anatomical or functional loss of small intestine, has debilitating long-term consequences for children(1). The priority of patient care is to increase the length of functional intestine, particularly the jejunum, to promote nutritional independence(2). Here we construct autologous jejunal mucosal grafts using biomaterials from pediatric patients and show that patient-derived organoids can be expanded efficiently in vitro. In parallel, we generate decellularized human intestinal matrix with intact nanotopography, which forms biological scaffolds. Proteomic and Raman spectroscopy analyses reveal highly analogous biochemical profiles of human small intestine and colon scaffolds, indicating that they can be used interchangeably as platforms for intestinal engineering. Indeed, seeding of jejunal organoids onto either type of scaffold reliably reconstructs grafts that exhibit several aspects of physiological jejunal function and that survive to form luminal structures after transplantation into the kidney capsule or subcutaneous pockets of mice for up to 2 weeks. Our findings provide proof-of-concept data for engineering patient-specific jejunal grafts for children with intestinal failure, ultimately aiding in the restoration of nutritional autonomy.	[Meran, Laween; Massie, Isobel; Campinoti, Sara; Weston, Anne E.; Tullie, Lucinda; Faull, Peter; Kucharska, Anna; Baulies, Anna; Novellasdemunt, Laura; Angelis, Nikolaos; Hirst, Elizabeth; Konig, Julia; Snijders, Ambrosius P.; Collinson, Lucy; Bonfanti, Paola; Li, Vivian S. W.] Francis Crick Inst, Stem Cell & Canc Biol Lab, London, England; [Meran, Laween; Campinoti, Sara; Tullie, Lucinda; Orford, Michael; Tedeschi, Alfonso Maria; Pellegata, Alessandro Filippo; Eli, Susanna; Thapar, Nikhil; Eaton, Simon; Bonfanti, Paola; De Coppi, Paolo] UCL, Stem Cell & Regenerat Med Sect, DBC, Great Ormond St Inst Child Hlth, London, England; [Gaifulina, Riana; Thomas, Geraint M. H.] UCL, Dept Cell & Dev Biol, London, England; [De Coppi, Paolo] Great Ormond St Hosp Sick Children, Specialist Neonatal & Paediat Serv, London, England; [Thapar, Nikhil] Queensland Childrens Hosp, Gastroenterol Hepatol & Liver Transplant, Brisbane, Qld, Australia	Francis Crick Institute; University of London; University College London; University of London; University College London; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust	Li, VSW (corresponding author), Francis Crick Inst, Stem Cell & Canc Biol Lab, London, England.; De Coppi, P (corresponding author), UCL, Stem Cell & Regenerat Med Sect, DBC, Great Ormond St Inst Child Hlth, London, England.; De Coppi, P (corresponding author), Great Ormond St Hosp Sick Children, Specialist Neonatal & Paediat Serv, London, England.	p.decoppi@ucl.ac.uk; vivian.li@crick.ac.uk	König, Julia/GVS-7641-2022; de Andrés San Cristóbal, Marta/ABF-5806-2021	Angelis, Nikolaos/0000-0002-5149-7665; Faull, Peter/0000-0001-8491-8086; Weston, Anne/0000-0001-6701-224X; Campinoti, Sara/0000-0003-0056-5792; Eaton, Simon/0000-0003-0892-9204; De Coppi, Paolo/0000-0002-1659-0207; Novellasdemunt Vilaseca, Laura/0000-0003-1590-9842; Bonfanti, Paola/0000-0001-9655-3766; Meran, Laween/0000-0002-1802-1905	Horizon 2020 grant [INTENS 668294]; Francis Crick Institute from Cancer Research UK [FC001105]; UK Medical Research Council [FC001105]; Wellcome Trust [FC001105]; NIHR Professorship; NIHR UCL BRC-GOSH; Great Ormond Street Hospital Children's Charity; Oak Foundation; European Research Council [639429]; Rosetrees Trust [M553, M362-F1]; UCL Therapeutic Acceleration Support Fund (MRC CiC); National Institute for Health Research Biomedical Research Centre at Great Ormond Street Hospital for Children NHS Foundation Trust (GOSH BRC); GOSHCC Studentship [V6116]; NIHR UCL BRC-GOSH Crick Clinical Research Training Fellowships; Rosetrees Trust [M362] Funding Source: researchfish; BBSRC [BB/R013667/1] Funding Source: UKRI; MRC [MC_PC_14118, MR/N028414/1] Funding Source: UKRI	Horizon 2020 grant; Francis Crick Institute from Cancer Research UK; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); NIHR Professorship; NIHR UCL BRC-GOSH; Great Ormond Street Hospital Children's Charity; Oak Foundation; European Research Council(European Research Council (ERC)European Commission); Rosetrees Trust(Rosetrees Trust); UCL Therapeutic Acceleration Support Fund (MRC CiC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research Biomedical Research Centre at Great Ormond Street Hospital for Children NHS Foundation Trust (GOSH BRC); GOSHCC Studentship; NIHR UCL BRC-GOSH Crick Clinical Research Training Fellowships; Rosetrees Trust(Rosetrees Trust); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank STEMCELL Technologies for providing organoid culture reagent, A. Darbyshire for assistance with mechanical testing data, F. Scottoni for his surgical assistance in collecting pig intestine and B. Jones, P.S. Chia, SNAPS and the Gastroenterology Unit at GOSH for coordinating patient material and information. We also thank the Francis Crick Institute's Science Technology Platforms, Experimental Histopathology (E. Nye), Electron Microscopy, Mass Spectrometry Proteomics, Mechanical Engineering, Biological Resources Facility and In Vivo Imaging, for their technical support and advice and J. Brock from the Research Illustration & Graphics team for the contributions to figure illustration. This work was funded by Horizon 2020 grant INTENS 668294 on the project 'Intestinal Tissue Engineering Solution for Children with Short Bowel Syndrome'. The laboratory of V.S.W.L. is funded by the Francis Crick Institute, which receives its core funding from Cancer Research UK (FC001105), the UK Medical Research Council (FC001105) and the Wellcome Trust (FC001105). P.D.C. is supported by an NIHR Professorship, NIHR UCL BRC-GOSH, the Great Ormond Street Hospital Children's Charity and the Oak Foundation. L.M. and L.T. are funded by NIHR UCL BRC-GOSH Crick Clinical Research Training Fellowships. P.B. is supported by the European Research Council (no. 639429), the Rosetrees Trust (M553; M362-F1), the UCL Therapeutic Acceleration Support Fund (MRC CiC) and the National Institute for Health Research Biomedical Research Centre at Great Ormond Street Hospital for Children NHS Foundation Trust (GOSH BRC). S.C. was supported by GOSHCC Studentship V6116.	Atala A, 2006, LANCET, V367, P1241, DOI 10.1016/S0140-6736(06)68438-9; Bankhead P, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17204-5; BORGSTROM B, 1957, J CLIN INVEST, V36, P1521, DOI 10.1172/JCI103549; BOYDE TRC, 1980, ANAL BIOCHEM, V107, P424, DOI 10.1016/0003-2697(80)90404-2; Cardona A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038011; Chen HJ, 2016, NAT BIOTECHNOL, V34, P845, DOI 10.1038/nbt.3586; Chen Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep13708; Costello CM, 2014, BIOTECHNOL BIOENG, V111, P1222, DOI 10.1002/bit.25180; Elliott MJ, 2012, LANCET, V380, P994, DOI 10.1016/S0140-6736(12)60737-5; Fragkos KC, 2018, UNITED EUR GASTROENT, V6, P181, DOI 10.1177/2050640617737632; Giobbe GG, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-13605-4; Giuffrida P, 2019, INFLAMM BOWEL DIS, V25, P1740, DOI 10.1093/ibd/izz115; Goulet O, 2006, GASTROENTEROLOGY, V130, pS16, DOI 10.1053/j.gastro.2005.12.002; Grant CN, 2015, AM J PHYSIOL-GASTR L, V308, pG664, DOI 10.1152/ajpgi.00111.2014; Hirsch T, 2017, NATURE, V551, P327, DOI 10.1038/nature24487; Hussey GS, 2018, CELL MOL GASTROENTER, V5, P1, DOI 10.1016/j.jcmgh.2017.09.004; Jeppesen PB, 2018, GASTROENTEROLOGY, V154, P874, DOI 10.1053/j.gastro.2017.11.023; Kitano K, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00779-y; Kochar B, 2018, EXPERT OPIN DRUG SAF, V17, P733, DOI 10.1080/14740338.2018.1483332; Ladd MR, 2019, TISSUE ENG PT A, V25, P1225, DOI [10.1089/ten.TEA.2018.0239, 10.1089/ten.tea.2018.0239]; Lieber CA, 2003, APPL SPECTROSC, V57, P1363, DOI 10.1366/000370203322554518; Martin LY, 2018, PEDIATR RES, V83, P249, DOI 10.1038/pr.2017.234; Maru Y, 2016, METHODS MOL BIOL, V1422, P13, DOI 10.1007/978-1-4939-3603-8_2; Mazza G, 2015, SCI REP-UK, V5, DOI 10.1038/srep13079; Meran L, 2017, STEM CELLS INT, V2017, DOI 10.1155/2017/7970385; Naba A, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.014647; Nichols JE, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aao3926; O'Keefe SJD, 2006, CLIN GASTROENTEROL H, V4, P6, DOI 10.1016/j.cgh.2005.10.002; Ott HC, 2010, NAT MED, V16, P927, DOI 10.1038/nm.2193; Quarta M, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15613; Rama P, 2010, NEW ENGL J MED, V363, P147, DOI 10.1056/NEJMoa0905955; Rivera AM, 2016, PEDIATR SURG INT, V32, P529, DOI 10.1007/s00383-016-3885-2; Sato T, 2011, GASTROENTEROLOGY, V141, P1762, DOI 10.1053/j.gastro.2011.07.050; Schwartz DM, 2017, TISSUE ENG PART C-ME, V23, P565, DOI [10.1089/ten.tec.2017.0269, 10.1089/ten.TEC.2017.0269]; Schweinlin M, 2016, TISSUE ENG PART C-ME, V22, P873, DOI [10.1089/ten.tec.2016.0101, 10.1089/ten.TEC.2016.0101]; Shaffiey SA, 2016, REGEN MED, V11, P45, DOI 10.2217/rme.15.70; Spencer AU, 2005, ANN SURG, V242, P403, DOI 10.1097/01.sla.0000179647.24046.03; Totonelli G, 2012, BIOMATERIALS, V33, P3401, DOI 10.1016/j.biomaterials.2012.01.012; Urbani L, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06385-w; Uygun BE, 2010, NAT MED, V16, P814, DOI 10.1038/nm.2170; Yamamoto S, 2013, AM J PHYSIOL-GASTR L, V305, pG241, DOI 10.1152/ajpgi.00480.2012	41	42	43	7	26	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	OCT	2020	26	10					1593	+		10.1038/s41591-020-1024-z	http://dx.doi.org/10.1038/s41591-020-1024-z		SEP 2020	24	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	NX8MD	32895569	Green Submitted, Green Accepted			2022-12-27	WOS:000566880900005
J	Dujardin, S; Commins, C; Lathuiliere, A; Beerepoot, P; Fernandes, AR; Kamath, TV; De Los Santos, MB; Klickstein, N; Corjuc, DL; Corjuc, BT; Dooley, PM; Viode, A; Oakley, DH; Moore, BD; Mullin, K; Jean-Gilles, D; Clark, R; Atchison, K; Moore, R; Chibnik, LB; Tanzi, RE; Frosch, MP; Serrano-Pozo, A; Elwood, F; Steen, JA; Kennedy, ME; Hyman, BT				Dujardin, Simon; Commins, Caitlin; Lathuiliere, Aurelien; Beerepoot, Pieter; Fernandes, Analiese R.; Kamath, Tarun, V; De Los Santos, Mark B.; Klickstein, Naomi; Corjuc, Diana L.; Corjuc, Bianca T.; Dooley, Patrick M.; Viode, Arthur; Oakley, Derek H.; Moore, Benjamin D.; Mullin, Kristina; Jean-Gilles, Dinorah; Clark, Ryan; Atchison, Kevin; Moore, Renee; Chibnik, Lori B.; Tanzi, Rudolph E.; Frosch, Matthew P.; Serrano-Pozo, Alberto; Elwood, Fiona; Steen, Judith A.; Kennedy, Matthew E.; Hyman, Bradley T.			Tau molecular diversity contributes to clinical heterogeneity in Alzheimer's disease	NATURE MEDICINE			English	Article							NEUROPATHOLOGIC ASSESSMENT; NEUROFIBRILLARY TANGLES; ASSOCIATION GUIDELINES; NATIONAL INSTITUTE; MOUSE MODEL; PROTEIN; AGGREGATION; PATHOLOGY; PROPAGATION; PLAQUES	Alzheimer's disease (AD) causes unrelenting, progressive cognitive impairments, but its course is heterogeneous, with a broad range of rates of cognitive decline(1). The spread of tau aggregates (neurofibrillary tangles) across the cerebral cortex parallels symptom severity(2,3). We hypothesized that the kinetics of tau spread may vary if the properties of the propagating tau proteins vary across individuals. We carried out biochemical, biophysical, MS and both cell- and animal-based-bioactivity assays to characterize tau in 32 patients with AD. We found striking patient-to-patient heterogeneity in the hyperphosphorylated species of soluble, oligomeric, seed-competent tau. Tau seeding activity correlates with the aggressiveness of the clinical disease, and some post-translational modification (PTM) sites appear to be associated with both enhanced seeding activity and worse clinical outcomes, whereas others are not. These data suggest that different individuals with 'typical' AD may have distinct biochemical features of tau. These data are consistent with the possibility that individuals with AD, much like people with cancer, may have multiple molecular drivers of an otherwise common phenotype, and emphasize the potential for personalized therapeutic approaches for slowing clinical progression of AD. A molecular analysis of tau from patients with sporadic Alzheimer's disease reveals striking diversity in biochemical properties between patients, which influences seeding activity and correlates with the aggressiveness of the disease.	[Dujardin, Simon; Commins, Caitlin; Lathuiliere, Aurelien; Fernandes, Analiese R.; Kamath, Tarun, V; De Los Santos, Mark B.; Klickstein, Naomi; Corjuc, Diana L.; Corjuc, Bianca T.; Dooley, Patrick M.; Oakley, Derek H.; Moore, Benjamin D.; Chibnik, Lori B.; Serrano-Pozo, Alberto; Hyman, Bradley T.] Massachusetts Gen Hosp, Dept Neurol, Alzheimer Res Unit, Charlestown, MA 02129 USA; [Dujardin, Simon; Lathuiliere, Aurelien; Beerepoot, Pieter; Viode, Arthur; Oakley, Derek H.; Moore, Benjamin D.; Chibnik, Lori B.; Tanzi, Rudolph E.; Frosch, Matthew P.; Serrano-Pozo, Alberto; Steen, Judith A.; Hyman, Bradley T.] Harvard Med Sch, Boston, MA 02115 USA; [Beerepoot, Pieter; Viode, Arthur; Steen, Judith A.] Boston Childrens Hosp, FM Kirby Neurobiol Ctr, Boston, MA USA; [Dooley, Patrick M.; Oakley, Derek H.; Frosch, Matthew P.] Massachusetts Gen Hosp, CS Kubik Lab Neuropathol, Boston, MA 02114 USA; [Mullin, Kristina; Tanzi, Rudolph E.] Massachusetts Gen Hosp, Dept Neurol, Genet & Aging Res Unit, Charlestown, MA USA; [Jean-Gilles, Dinorah; Clark, Ryan; Atchison, Kevin; Moore, Renee; Elwood, Fiona; Kennedy, Matthew E.] Merck & Co Inc, Dept Neurosci, Boston, MA USA; [Chibnik, Lori B.] Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA USA; [Moore, Benjamin D.] Aquinnah Pharmaceut, Cambridge, MA USA; [Elwood, Fiona] Novartis Inst BioMed Res, Cambridge, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Merck & Company; Harvard University; Harvard T.H. Chan School of Public Health; Novartis	Hyman, BT (corresponding author), Massachusetts Gen Hosp, Dept Neurol, Alzheimer Res Unit, Charlestown, MA 02129 USA.; Hyman, BT (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.	bhyman@mgh.harvard.edu	Lathuiliere, Aurelien/N-8586-2019; Serrano-Pozo, Alberto/L-1519-2019; Oakley, Derek/ABA-4689-2020; Frosch, Matthew P/ABD-7456-2021; Dujardin, Simon/ABA-1796-2020	Lathuiliere, Aurelien/0000-0002-5191-5214; Serrano-Pozo, Alberto/0000-0003-0899-7530; Oakley, Derek/0000-0002-6998-9510; Frosch, Matthew P/0000-0002-3940-9861; Corjuc, Bianca/0000-0002-6697-9691; Dujardin, Simon/0000-0002-5614-341X; Beerepoot, Pieter/0000-0003-3721-3213; Fernandes, Analiese R./0000-0002-3906-7806; Chibnik, Lori/0000-0001-6293-806X; Kamath, Tarun/0000-0002-6148-6433; De Los Santos, Mark/0000-0002-7195-5141	Merck; Alzheimer's Association [2018-AARF-591935, AACSF-19-617308]; Martin L. and Sylvia Seevak Hoffman Fellowship for Alzheimer's Research; Tau Consortium; Cure Alzheimer's Fund; JPB Foundation; Swiss National Science Foundation [P2ELP3_184403];  [NIH/NIA-5P50AG005134-35];  [1RF1AG059789];  [1RF1AG058674];  [1P30AG062421];  [1K08AG064039]	Merck(Merck & Company); Alzheimer's Association(Alzheimer's Association); Martin L. and Sylvia Seevak Hoffman Fellowship for Alzheimer's Research; Tau Consortium; Cure Alzheimer's Fund; JPB Foundation; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); ; ; ; ; 	This work was supported in part by a research agreement to Massachusetts General Hospital from Merck and by the NIH/NIA-5P50AG005134-35 (B.T.H.), 1RF1AG059789 (B.T.H.), 1RF1AG058674 (B.T.H.), 1P30AG062421 (B.T.H.), 1K08AG064039 (A.S.-P.). The authors also want to thank additional funding sources: Alzheimer's Association (2018-AARF-591935 (S.D.), AACSF-19-617308 (A.L.)), the Martin L. and Sylvia Seevak Hoffman Fellowship for Alzheimer's Research (S.D.), the Tau Consortium (B.T.H.), the Cure Alzheimer's Fund (R.E.T.), the JPB Foundation (B.T.H. and R.E.T.), and the Swiss National Science Foundation (P2ELP3_184403 (A.L.)). We thank J. A. Gonzalez for helping with brain sampling, M. C. Potter for input in early phases of the work, P. Davies (Albert Einstein College of Medicine, New York City) for generously providing with PHF1 antibody and M. Diamond (UT Southwertern, Dallas, Texas) for the generous gift of the TauRD-P301S-CFP/YFP cells.	Andorfer C, 2003, J NEUROCHEM, V86, P582, DOI 10.1046/j.1471-4159.2003.01879.x; Aoyagi A, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aat8462; Arakhamia T, 2020, CELL, V180, P633, DOI 10.1016/j.cell.2020.01.027; Arganda-Carreras I, 2017, BIOINFORMATICS, V33, P2424, DOI 10.1093/bioinformatics/btx180; ARRIAGADA PV, 1992, NEUROLOGY, V42, P631, DOI 10.1212/WNL.42.3.631; Bennett RE, 2017, AM J PATHOL, V187, P1601, DOI 10.1016/j.ajpath.2017.03.011; Bielefeld-Sevigny M, 2009, ASSAY DRUG DEV TECHN, V7, P90, DOI 10.1089/adt.2009.9996; Boluda S, 2015, ACTA NEUROPATHOL, V129, P221, DOI 10.1007/s00401-014-1373-0; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Calafate S, 2016, CELL REP, V17, P931, DOI 10.1016/j.celrep.2016.09.063; Clavaguera F, 2013, P NATL ACAD SCI USA, V110, P9535, DOI 10.1073/pnas.1301175110; Colin M, 2020, ACTA NEUROPATHOL, V139, P3, DOI 10.1007/s00401-019-02087-9; Courade JP, 2018, ACTA NEUROPATHOL, V136, P729, DOI 10.1007/s00401-018-1911-2; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; DeVos SL, 2018, BRAIN, V141, P2194, DOI 10.1093/brain/awy117; DeVos SL, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00267; Dujardin S, 2019, ADV EXP MED BIOL, V1184, P305, DOI 10.1007/978-981-32-9358-8_23; Dujardin S, 2018, ACTA NEUROPATHOL COM, V6, DOI 10.1186/s40478-018-0637-7; Duyckaerts C, 1998, ACTA NEUROL BELG, V98, P180; Falcon B, 2019, NATURE, V568, P420, DOI 10.1038/s41586-019-1026-5; Falcon B, 2018, NATURE, V561, P137, DOI 10.1038/s41586-018-0454-y; Falcon B, 2015, J BIOL CHEM, V290, P1049, DOI 10.1074/jbc.M114.589309; Fitzpatrick AWP, 2017, NATURE, V547, P185, DOI 10.1038/nature23002; Giannakopoulos P, 2003, NEUROLOGY, V60, P1495, DOI 10.1212/01.WNL.0000063311.58879.01; Gomathinayagam S, 2015, J BIOTECHNOL, V208, P13, DOI 10.1016/j.jbiotec.2015.05.005; Harper JD, 1997, ANNU REV BIOCHEM, V66, P385, DOI 10.1146/annurev.biochem.66.1.385; He ZH, 2018, NAT MED, V24, P29, DOI 10.1038/nm.4443; Holmes BB, 2014, P NATL ACAD SCI USA, V111, pE4376, DOI 10.1073/pnas.1411649111; Hyman BT, 2012, ALZHEIMERS DEMENT, V8, P1, DOI 10.1016/j.jalz.2011.10.007; Iba M, 2013, J NEUROSCI, V33, P1024, DOI 10.1523/JNEUROSCI.2642-12.2013; Ingelsson M, 2004, NEUROLOGY, V62, P925, DOI 10.1212/01.WNL.0000115115.98960.37; Iqbal K, 2005, ANN NEUROL, V58, P748, DOI 10.1002/ana.20639; Kiris E, 2011, J BIOL CHEM, V286, P14257, DOI 10.1074/jbc.M111.219311; Komarova NL, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002251; Kovacs GG, 2015, NEUROPATH APPL NEURO, V41, P3, DOI 10.1111/nan.12208; Lasagna-Reeves CA, 2012, SCI REP-UK, V2, DOI 10.1038/srep00700; Montine TJ, 2012, ACTA NEUROPATHOL, V123, P1, DOI 10.1007/s00401-011-0910-3; Muller T, 2017, MOL CELL PROTEOMICS, V16, P1173, DOI 10.1074/mcp.M116.064048; Nobuhara CK, 2017, AM J PATHOL, V187, P1399, DOI 10.1016/j.ajpath.2017.01.022; Perez-Riverol Y, 2019, NUCLEIC ACIDS RES, V47, pD442, DOI 10.1093/nar/gky1106; Planel E, 2008, J NEUROSCI, V28, P12798, DOI 10.1523/JNEUROSCI.4101-08.2008; Sanders DW, 2014, NEURON, V82, P1271, DOI 10.1016/j.neuron.2014.04.047; Schilling B, 2012, MOL CELL PROTEOMICS, V11, P202, DOI 10.1074/mcp.M112.017707; Schneider A, 1999, BIOCHEMISTRY-US, V38, P3549, DOI 10.1021/bi981874p; Serrano-Pozo A, 2013, J NEUROPATH EXP NEUR, V72, P1182, DOI 10.1097/NEN.0000000000000016; Serrano-Pozo A, 2011, AM J PATHOL, V179, P1373, DOI 10.1016/j.ajpath.2011.05.047; Shahani N, 2006, J NEUROSCI, V26, P6103, DOI 10.1523/JNEUROSCI.4245-05.2006; Shi Y, 2017, NATURE, V549, P523, DOI 10.1038/nature24016; Singh TJ, 1996, FEBS LETT, V387, P145, DOI 10.1016/0014-5793(96)00485-1; Takeda S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9490; Usenovic M, 2015, J NEUROSCI, V35, P14234, DOI 10.1523/JNEUROSCI.1523-15.2015; Wang JZ, 2007, EUR J NEUROSCI, V25, P59, DOI 10.1111/j.1460-9568.2006.05226.x; Wang YF, 2015, SCI REP-UK, V5, DOI 10.1038/srep15709; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/NMETH.1322, 10.1038/nmeth.1322]; Yanamandra K, 2013, NEURON, V80, P402, DOI 10.1016/j.neuron.2013.07.046; Zhang WJ, 2020, NATURE, V580, P283, DOI 10.1038/s41586-020-2043-0	56	146	146	10	38	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	AUG	2020	26	8					1256	+		10.1038/s41591-020-0938-9	http://dx.doi.org/10.1038/s41591-020-0938-9		JUN 2020	30	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	MX8ZF	32572268	Green Accepted			2022-12-27	WOS:000542094400004
J	Stower, H				Stower, Hannah			y Vaccination combats antimicrobial resistance	NATURE MEDICINE			English	Editorial Material												h.stower@us.nature.com							0	0	0	0	0	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	JUN	2020	26	6					822	822		10.1038/s41591-020-0957-6	http://dx.doi.org/10.1038/s41591-020-0957-6		JUN 2020	1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	LZ3ZG	32528146	Bronze			2022-12-27	WOS:000539886500006
J	Avasthi, P; Neill, US; Porter, KPM; Weeraratna, AT				Avasthi, Prachee; Neill, Ushma S.; Pollack Porter, Keshia M.; Weeraratna, Ashani T.			Preserve junior faculty in biomedical sciences during and after the pandemic	NATURE MEDICINE			English	Editorial Material									[Avasthi, Prachee] Univ Kansas, Med Ctr, Dept Anat & Cell Biol, Kansas City, KS 66103 USA; [Avasthi, Prachee] Univ Kansas, Med Ctr, Dept Opthamol, Kansas City, KS 66103 USA; [Neill, Ushma S.] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA; [Pollack Porter, Keshia M.; Weeraratna, Ashani T.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Policy & Management, Baltimore, MD 21205 USA; [Pollack Porter, Keshia M.; Weeraratna, Ashani T.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Biochem & Mol Biol, Baltimore, MD 21205 USA; [Weeraratna, Ashani T.] Johns Hopkins Kimmel Canc Ctr, Baltimore, MD 21287 USA	University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center; Memorial Sloan Kettering Cancer Center; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Medicine	Weeraratna, AT (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Policy & Management, Baltimore, MD 21205 USA.; Weeraratna, AT (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Biochem & Mol Biol, Baltimore, MD 21205 USA.; Weeraratna, AT (corresponding author), Johns Hopkins Kimmel Canc Ctr, Baltimore, MD 21287 USA.	aweeraratna@jhu.edu		Avasthi, Prachee/0000-0002-1688-722X					0	4	4	0	0	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	JUL	2020	26	7					1003	1004		10.1038/s41591-020-0943-z	http://dx.doi.org/10.1038/s41591-020-0943-z		JUN 2020	2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	MK3XO	32514172	Bronze			2022-12-27	WOS:000538976400002
J	Long, QX; Liu, BZ; Deng, HJ; Wu, GC; Deng, K; Chen, YK; Liao, P; Qiu, JF; Lin, Y; Cai, XF; Wang, DQ; Hu, Y; Ren, JH; Tang, N; Xu, YY; Yu, LH; Mo, Z; Gong, F; Zhang, XL; Tian, WG; Hu, L; Zhang, XX; Xiang, JL; Du, HX; Liu, HW; Lang, CH; Luo, XH; Wu, SB; Cui, XP; Zhou, Z; Zhu, MM; Wang, J; Xue, CJ; Li, XF; Wang, L; Li, ZJ; Wang, K; Niu, CC; Yang, QJ; Tang, XJ; Zhang, Y; Liu, XM; Li, JJ; Zhang, DC; Zhang, F; Liu, P; Yuan, J; Li, Q; Hu, JL; Chen, J; Huang, AL				Long, Quan-Xin; Liu, Bai-Zhong; Deng, Hai-Jun; Wu, Gui-Cheng; Deng, Kun; Chen, Yao-Kai; Liao, Pu; Qiu, Jing-Fu; Lin, Yong; Cai, Xue-Fei; Wang, De-Qiang; Hu, Yuan; Ren, Ji-Hua; Tang, Ni; Xu, Yin-Yin; Yu, Li-Hua; Mo, Zhan; Gong, Fang; Zhang, Xiao-Li; Tian, Wen-Guang; Hu, Li; Zhang, Xian-Xiang; Xiang, Jiang-Lin; Du, Hong-Xin; Liu, Hua-Wen; Lang, Chun-Hui; Luo, Xiao-He; Wu, Shao-Bo; Cui, Xiao-Ping; Zhou, Zheng; Zhu, Man-Man; Wang, Jing; Xue, Cheng-Jun; Li, Xiao-Feng; Wang, Li; Li, Zhi-Jie; Wang, Kun; Niu, Chang-Chun; Yang, Qing-Jun; Tang, Xiao-Jun; Zhang, Yong; Liu, Xia-Mao; Li, Jin-Jing; Zhang, De-Chun; Zhang, Fan; Liu, Ping; Yuan, Jun; Li, Qin; Hu, Jie-Li; Chen, Juan; Huang, Ai-Long			Antibody responses to SARS-CoV-2 in patients with COVID-19	NATURE MEDICINE			English	Article							CORONAVIRUS	We report acute antibody responses to SARS-CoV-2 in 285 patients with COVID-19. Within 19 days after symptom onset, 100% of patients tested positive for antiviral immunoglobulin-G (IgG). Seroconversion for IgG and IgM occurred simultaneously or sequentially. Both IgG and IgM titers plateaued within 6 days after seroconversion. Serological testing may be helpful for the diagnosis of suspected patients with negative RT-PCR results and for the identification of asymptomatic infections. A cross-sectional study of hospitalized patients with COVID-19 and a longitudinal follow-up study of patients with COVID-19 suggest that SARS-CoV2-specific IgG or IgM seroconversion occurs within 20 days post symptom onset.	[Long, Quan-Xin; Deng, Hai-Jun; Lin, Yong; Cai, Xue-Fei; Wang, De-Qiang; Hu, Yuan; Ren, Ji-Hua; Tang, Ni; Yuan, Jun; Hu, Jie-Li; Chen, Juan; Huang, Ai-Long] Chongqing Med Univ, Minist Educ, Key Lab Mol Biol Infect Dis, Chongqing, Peoples R China; [Liu, Bai-Zhong; Xu, Yin-Yin; Yu, Li-Hua; Mo, Zhan; Gong, Fang; Zhang, Xiao-Li; Tian, Wen-Guang; Hu, Li] Chongqing Med Univ, Yongchuan Hosp Affiliated, Chongqing, Peoples R China; [Wu, Gui-Cheng; Zhang, Xian-Xiang; Xiang, Jiang-Lin; Du, Hong-Xin; Liu, Hua-Wen; Lang, Chun-Hui; Luo, Xiao-He; Wu, Shao-Bo; Cui, Xiao-Ping; Zhou, Zheng] Chongqing Univ, Three Gorges Hosp, Chongqing, Peoples R China; [Wu, Gui-Cheng; Zhang, Xian-Xiang; Xiang, Jiang-Lin; Du, Hong-Xin; Liu, Hua-Wen; Lang, Chun-Hui; Luo, Xiao-He; Cui, Xiao-Ping; Zhou, Zheng] Chongqing Three Gorges Cent Hosp, Chongqing, Peoples R China; [Deng, Kun; Zhu, Man-Man] Chongqing Med Univ, Hosp Affiliated 3, Chongqing, Peoples R China; [Chen, Yao-Kai; Wang, Jing; Xue, Cheng-Jun; Li, Xiao-Feng; Wang, Li] Chongqing Publ Hlth Med Ctr, Div Infect Dis, Chongqing, Peoples R China; [Liao, Pu; Li, Zhi-Jie; Wang, Kun; Niu, Chang-Chun; Yang, Qing-Jun] Chongqing Peoples Hosp, Lab Dept, Chongqing, Peoples R China; [Qiu, Jing-Fu; Tang, Xiao-Jun; Zhang, Yong] Chongqing Med Univ, Sch Publ Hlth & Management, Chongqing, Peoples R China; [Liu, Xia-Mao; Li, Jin-Jing] Chongqing Med Univ, Affiliated Hosp 2, Chongqing, Peoples R China; [Zhang, De-Chun; Zhang, Fan] Wanzhou Peoples Hosp, Chongqing, Peoples R China; [Liu, Ping] BioScience Co Ltd, Chongqing, Peoples R China; [Li, Qin] Chongqing Ctr Dis Control & Prevent, Chongqing, Peoples R China	Chongqing Medical University; Chongqing Medical University; Chongqing University; Chongqing Three Gorges University; Chongqing Medical University; Chongqing Medical University; Chongqing Medical University	Hu, JL; Chen, J; Huang, AL (corresponding author), Chongqing Med Univ, Minist Educ, Key Lab Mol Biol Infect Dis, Chongqing, Peoples R China.	102564@cqmu.edu.cn; chenjuan2014@cqmu.edu.cn; ahuang@cqmu.edu.cn	li, xiaofeng/GXF-9442-2022; Long, Quanxin/AAK-6199-2021; , jieli/AAX-1660-2020; li, xiao/GSN-6181-2022	, jieli/0000-0002-9869-659X; Huang, Ailong/0000-0003-0148-7423	Emergency Project from the Science & Technology Commission of Chongqing; Major National S&T Program grant from the Science & Technology Commission of China [2017ZX10202203, 2017ZX10302201]	Emergency Project from the Science & Technology Commission of Chongqing; Major National S&T Program grant from the Science & Technology Commission of China	We thank C.-Y. Yang and L.Y. Kwan for critical reviewing of the manuscript. This work was supported by the Emergency Project from the Science & Technology Commission of Chongqing and a Major National S&T Program grant (2017ZX10202203 and 2017ZX10302201) from the Science & Technology Commission of China.	Corman VM, 2016, CLIN INFECT DIS, V62, P477, DOI 10.1093/cid/civ951; Drosten C, 2014, NEW ENGL J MED, V371, P828, DOI 10.1056/NEJMoa1405858; Hsueh PR, 2004, CLIN MICROBIOL INFEC, V10, P1062, DOI 10.1111/j.1469-0691.2004.01009.x; Li G, 2003, NEW ENGL J MED, V349, P508, DOI 10.1056/NEJM200307313490520; Meyer B, 2014, VIRUS RES, V194, P175, DOI 10.1016/j.virusres.2014.03.018; Park WB, 2015, EMERG INFECT DIS, V21, P2186, DOI 10.3201/eid2112.151421; Tang YW, 2020, J CLIN MICROBIOL, V58, DOI 10.1128/JCM.00512-20; Zou LR, 2020, NEW ENGL J MED, V382, P1177, DOI 10.1056/NEJMc2001737	8	5794	8149	1401	2214	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	JUN	2020	26	6					845	+		10.1038/s41591-020-0897-1	http://dx.doi.org/10.1038/s41591-020-0897-1		APR 2020	13	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	LZ3ZG	32350462	Bronze			2022-12-27	WOS:000529597900002
J	Kazer, SW; Aicher, TP; Muema, DM; Carroll, SL; Ordovas-Montanes, J; Miao, VCN; Tu, AA; Ziegler, CGK; Nyquist, SK; Wong, EB; Ismail, N; Dong, M; Moodley, A; Berger, B; Love, JC; Dong, KTL; Leslie, A; Ndhlovu, ZM; Ndung'u, T; Walker, BD; Shalek, AK				Kazer, Samuel W.; Aicher, Toby P.; Muema, Daniel M.; Carroll, Shaina L.; Ordovas-Montanes, Jose; Miao, Vincent N.; Tu, Ang A.; Ziegler, Carly G. K.; Nyquist, Sarah K.; Wong, Emily B.; Ismail, Nasreen; Dong, Mary; Moodley, Amber; Berger, Bonnie; Love, J. Christopher; Dong, Krista L.; Leslie, Alasdair; Ndhlovu, Zaza M.; Ndung'u, Thumbi; Walker, Bruce D.; Shalek, Alex K.			Integrated single-cell analysis of multicellular immune dynamics during hyperacute HIV-1 infection	NATURE MEDICINE			English	Article							T-CELLS; INTERLEUKIN-6; MARKER; MEMORY	Single-cell RNA-sequencing of blood from HIV-1-infected individuals obtained before initiation of antiretroviral therapy provides insights into the initial immune responses during early infection that might shape future outcomes. Cellular immunity is critical for controlling intracellular pathogens, but individual cellular dynamics and cell-cell cooperativity in evolving human immune responses remain poorly understood. Single-cell RNA-sequencing (scRNA-seq) represents a powerful tool for dissecting complex multicellular behaviors in health and disease(1,2) and nominating testable therapeutic targets(3). Its application to longitudinal samples could afford an opportunity to uncover cellular factors associated with the evolution of disease progression without potentially confounding inter-individual variability(4). Here, we present an experimental and computational methodology that uses scRNA-seq to characterize dynamic cellular programs and their molecular drivers, and apply it to HIV infection. By performing scRNA-seq on peripheral blood mononuclear cells from four untreated individuals before and longitudinally during acute infection(5), we were powered within each to discover gene response modules that vary by time and cell subset. Beyond previously unappreciated individual- and cell-type-specific interferon-stimulated gene upregulation, we describe temporally aligned gene expression responses obscured in bulk analyses, including those involved in proinflammatory T cell differentiation, prolonged monocyte major histocompatibility complex II upregulation and persistent natural killer (NK) cell cytolytic killing. We further identify response features arising in the first weeks of infection, for example proliferating natural killer cells, which potentially may associate with future viral control. Overall, our approach provides a unified framework for characterizing multiple dynamic cellular responses and their coordination.	[Kazer, Samuel W.; Aicher, Toby P.; Ordovas-Montanes, Jose; Miao, Vincent N.; Ziegler, Carly G. K.; Nyquist, Sarah K.; Dong, Mary; Love, J. Christopher; Dong, Krista L.; Ndhlovu, Zaza M.; Ndung'u, Thumbi; Walker, Bruce D.; Shalek, Alex K.] Ragon Inst MGH MIT & Harvard, Cambridge, MA 02139 USA; [Kazer, Samuel W.; Aicher, Toby P.; Ordovas-Montanes, Jose; Miao, Vincent N.; Ziegler, Carly G. K.; Nyquist, Sarah K.; Shalek, Alex K.] MIT, IMES, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Kazer, Samuel W.; Ordovas-Montanes, Jose; Shalek, Alex K.] MIT, Dept Chem, Cambridge, MA 02139 USA; [Kazer, Samuel W.; Aicher, Toby P.; Ordovas-Montanes, Jose; Miao, Vincent N.; Ziegler, Carly G. K.; Nyquist, Sarah K.; Shalek, Alex K.] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Muema, Daniel M.; Wong, Emily B.; Leslie, Alasdair; Ndhlovu, Zaza M.; Ndung'u, Thumbi] African Hlth Res Inst, Durban, South Africa; [Muema, Daniel M.; Ismail, Nasreen; Moodley, Amber; Ndung'u, Thumbi; Walker, Bruce D.] Univ KwaZulu Natal, Doris Duke Med Res Inst, Nelson R Mandela Sch Med, HIV Pathogenesis Programme, Durban, South Africa; [Carroll, Shaina L.] Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA; [Ordovas-Montanes, Jose] Boston Childrens Hosp, Div Gastroenterol, Boston, MA USA; [Ordovas-Montanes, Jose] Harvard Stem Cell Inst, Cambridge, MA USA; [Miao, Vincent N.; Ziegler, Carly G. K.; Shalek, Alex K.] Harvard Med Sch, Program Hlth Sci & Technol, Boston, MA 02115 USA; [Miao, Vincent N.; Ziegler, Carly G. K.; Shalek, Alex K.] MIT, Boston, MA USA; [Tu, Ang A.; Love, J. Christopher; Shalek, Alex K.] MIT, Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Tu, Ang A.; Love, J. Christopher] MIT, Dept Chem Engn, Cambridge, MA 02139 USA; [Nyquist, Sarah K.; Shalek, Alex K.] MIT, Program Computat & Syst Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Nyquist, Sarah K.; Berger, Bonnie] MIT, Comp Sci & Artificial Intelligence Lab, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Wong, Emily B.] Massachusetts Gen Hosp, Div Infect Dis, Boston, MA 02114 USA; [Wong, Emily B.; Ndung'u, Thumbi] UCL, Div Infect & Immun, London, England; [Wong, Emily B.] Harvard Med Sch, Boston, MA 02115 USA; [Berger, Bonnie] MIT, Dept Math, Cambridge, MA 02139 USA; [Ndhlovu, Zaza M.; Walker, Bruce D.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA; Max Planck Inst Infect Biol, Berlin, Germany	Harvard University; Harvard Medical School; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of Kwazulu Natal; University of California System; University of California Berkeley; Harvard University; Boston Children's Hospital; Harvard University; Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts General Hospital; University of London; University College London; Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute; Max Planck Society	Walker, BD; Shalek, AK (corresponding author), Ragon Inst MGH MIT & Harvard, Cambridge, MA 02139 USA.; Shalek, AK (corresponding author), MIT, IMES, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Shalek, AK (corresponding author), MIT, Dept Chem, Cambridge, MA 02139 USA.; Shalek, AK (corresponding author), Broad Inst MIT & Harvard, Cambridge, MA 02142 USA.; Walker, BD (corresponding author), Univ KwaZulu Natal, Doris Duke Med Res Inst, Nelson R Mandela Sch Med, HIV Pathogenesis Programme, Durban, South Africa.; Shalek, AK (corresponding author), Harvard Med Sch, Program Hlth Sci & Technol, Boston, MA 02115 USA.; Shalek, AK (corresponding author), MIT, Boston, MA USA.; Shalek, AK (corresponding author), MIT, Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Shalek, AK (corresponding author), MIT, Program Computat & Syst Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Walker, BD (corresponding author), Howard Hughes Med Inst, Chevy Chase, MD 20815 USA.	BWALKER@mgh.harvard.edu; shalek@mit.edu		Ordovas-Montanes, Jose/0000-0001-5444-5601; Ziegler, Carly/0000-0002-8279-7150; Kazer, Samuel/0000-0002-7380-9594; Muema, Daniel/0000-0001-7995-1682; Miao, Vincent/0000-0002-4040-5171; Wong, Emily Beth/0000-0003-4755-5380	Searle Scholars Program; Beckman Young Investigator Program; Pew-Stewart Scholars Program for Cancer Research; National Institutes for Health [2U19AI089992, 2R01HL095791, 1U54CA217377, 2P01AI039671, 5U24AI118672, 2RM1HG006193, 1R01AI138546, 1R37AI067073, 1R01HL134539, 1R01DA046277, 1K08AI118538, UM1AI100663, UM1AI144462, 1R01AI145305]; Bill and Melinda Gates Foundation [OPP1066973, INV-002703]; NSF Graduate Student Fellowship Award; Hugh Hampton Young Memorial Fund Fellowship; Damon Runyon Cancer Research Foundation [DRG-2274-16]; Gilead Sciences [00406]; International AIDS Vaccine Initiative [UKZNRSA1001]; South African National Research Foundation [64809]; Witten Family Foundation; Dan and Marjorie Sullivan Foundation; Mark and Lisa Schwartz Foundation; AIDS Healthcare Foundation; Harvard University Center for AIDS Research (CFAR - United States National Institutes of Health: NIAID) [P30 AI060354]; Harvard University Center for AIDS Research (CFAR - United States National Institutes of Health: NCI) [P30 AI060354]; Harvard University Center for AIDS Research (CFAR - United States National Institutes of Health: NICHD) [P30 AI060354]; Harvard University Center for AIDS Research (CFAR - United States National Institutes of Health: NHLBI) [P30 AI060354]; Harvard University Center for AIDS Research (CFAR - United States National Institutes of Health: NIDA) [P30 AI060354]; Harvard University Center for AIDS Research (CFAR - United States National Institutes of Health: NIMH) [P30 AI060354]; Harvard University Center for AIDS Research (CFAR - United States National Institutes of Health: NIA) [P30 AI060354]; Harvard University Center for AIDS Research (CFAR - United States National Institutes of Health: FIC) [P30 AI060354]; Harvard University Center for AIDS Research (CFAR - United States National Institutes of Health: OAR) [P30 AI060354]; Sub-Saharan African Network for TB/HIV Research Excellence; DELTAS Africa Initiative [DEL-15-006]; New Partnership for Africa's Development Planning and Coordinating Agency (NEPAD Agency); Wellcome Trust [107752/Z/15/Z, 210662/Z/18/Z]; United Kingdom Government; Sloan Fellowship in Chemistry	Searle Scholars Program; Beckman Young Investigator Program; Pew-Stewart Scholars Program for Cancer Research; National Institutes for Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); NSF Graduate Student Fellowship Award; Hugh Hampton Young Memorial Fund Fellowship; Damon Runyon Cancer Research Foundation; Gilead Sciences(Gilead Sciences); International AIDS Vaccine Initiative; South African National Research Foundation(National Research Foundation - South Africa); Witten Family Foundation; Dan and Marjorie Sullivan Foundation; Mark and Lisa Schwartz Foundation; AIDS Healthcare Foundation; Harvard University Center for AIDS Research (CFAR - United States National Institutes of Health: NIAID); Harvard University Center for AIDS Research (CFAR - United States National Institutes of Health: NCI); Harvard University Center for AIDS Research (CFAR - United States National Institutes of Health: NICHD); Harvard University Center for AIDS Research (CFAR - United States National Institutes of Health: NHLBI); Harvard University Center for AIDS Research (CFAR - United States National Institutes of Health: NIDA); Harvard University Center for AIDS Research (CFAR - United States National Institutes of Health: NIMH); Harvard University Center for AIDS Research (CFAR - United States National Institutes of Health: NIA); Harvard University Center for AIDS Research (CFAR - United States National Institutes of Health: FIC); Harvard University Center for AIDS Research (CFAR - United States National Institutes of Health: OAR); Sub-Saharan African Network for TB/HIV Research Excellence; DELTAS Africa Initiative; New Partnership for Africa's Development Planning and Coordinating Agency (NEPAD Agency); Wellcome Trust(Wellcome TrustEuropean Commission); United Kingdom Government; Sloan Fellowship in Chemistry	We thank the individuals who participated in the FRESH study, as well as FRESH and HIV Pathogenesis Programme staff; M. Waring, N. Bonheur and E. Koscher for flow cytometry and sorting services through the Ragon Institute Imaging Core-Flow Cytometry Facility; A. Piechocka-Trocha for sample handling and reagent preparation; M. Cole and N. Yosef for advice on computational methodology; D. Kwon, S. Bloom and M. Hayward for participant intake and sexually transmitted infection data; M. Carrington and A. Bashirova for HLA genotyping; O. Ndumnego, S. Rasehlo and N. A. Akilimali for support with Luminex and ELISA; H. KlOverpris, D. Lingwood and S. Pillai for insightful discussions; and R. Leeson for copy editing. This work was supported, in part, by the Searle Scholars Program, the Beckman Young Investigator Program, the Pew-Stewart Scholars Program for Cancer Research, a Sloan Fellowship in Chemistry, the National Institutes for Health (2U19AI089992, 2R01HL095791, 1U54CA217377, 2P01AI039671, 5U24AI118672, 2RM1HG006193, 1R01AI138546, 1R37AI067073, 1R01HL134539, 1R01DA046277, 1K08AI118538, UM1AI100663, UM1AI144462 and 1R01AI145305), the Bill and Melinda Gates Foundation (OPP1066973 and INV-002703), an NSF Graduate Student Fellowship Award, the Hugh Hampton Young Memorial Fund Fellowship, the Damon Runyon Cancer Research Foundation (HHMI Fellow DRG-2274-16), Gilead Sciences (grant ID 00406), the International AIDS Vaccine Initiative (UKZNRSA1001), the South African National Research Foundation (grant no. 64809), the Witten Family Foundation, Dan and Marjorie Sullivan Foundation, the Mark and Lisa Schwartz Foundation, Ursula Brunner, the AIDS Healthcare Foundation and the Harvard University Center for AIDS Research (CFAR, P30 AI060354, which is supported by the following institutes and centers co-funded by and participating with the United States National Institutes of Health: NIAID, NCI, NICHD, NHLBI, NIDA, NIMH, NIA, FIC and OAR), the Sub-Saharan African Network for TB/HIV Research Excellence and DELTAS Africa Initiative (grant no. DEL-15-006). The DELTAS Africa Initiative is an independent funding scheme of the African Academy of Sciences (AAS)'s Alliance for Accelerating Excellence in Science in Africa and supported by the New Partnership for Africa's Development Planning and Coordinating Agency (NEPAD Agency) with funding from the Wellcome Trust (grant nos. 107752/Z/15/Z and 210662/Z/18/Z) and the United Kingdom Government. The views expressed in this publication are those of the authors and not necessarily those of AAS, NEPAD Agency, Wellcome Trust or the United Kingdom Government.	Athanasiadis EI, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-02305-6; Bosinger SE, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003597; Bosinger SE, 2009, J CLIN INVEST, V119, P3556, DOI 10.1172/JCI40115; Butler A, 2018, NAT BIOTECHNOL, V36, P411, DOI 10.1038/nbt.4096; Cerwenka A, 2016, NAT REV IMMUNOL, V16, P112, DOI 10.1038/nri.2015.9; Corleis B, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173161; Dong KL, 2018, LANCET HIV, V5, pE35, DOI 10.1016/S2352-3018(17)30146-7; Fiebig EW, 2003, AIDS, V17, P1871, DOI 10.1097/00002030-200309050-00005; Gierahn TM, 2017, NAT METHODS, V14, P395, DOI 10.1038/nmeth.4179; Gomes T, 2019, TRENDS IMMUNOL, V40, P1011, DOI 10.1016/j.it.2019.09.004; Gulzar N, 2004, CURR HIV RES, V2, P23, DOI 10.2174/1570162043485077; Gutierrez-Arcelus M, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08604-4; Hoffmann M, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005661; Hou WQ, 2014, J VIROL, V88, P8479, DOI 10.1128/JVI.00724-14; Jakubzick CV, 2017, NAT REV IMMUNOL, V17, P349, DOI 10.1038/nri.2017.28; Jiao YM, 2012, VIRAL IMMUNOL, V25, P333, DOI 10.1089/vim.2012.0011; Joint United Nations Programme on HIV and AIDS, 2019, UNAIDS DAT 2019; Kang HM, 2018, NAT BIOTECHNOL, V36, P89, DOI 10.1038/nbt.4042; Kaspersen KA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164220; Kramer A, 2014, BIOINFORMATICS, V30, P523, DOI 10.1093/bioinformatics/btt703; Kumar L, 2007, BIOINFORMATION, V2, P5, DOI 10.6026/97320630002005; Kurtulus S, 2015, J CLIN INVEST, V125, P4053, DOI 10.1172/JCI81187; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Linderman GC, 2019, NAT METHODS, V16, P243, DOI 10.1038/s41592-018-0308-4; Luban J, 2012, CELL HOST MICROBE, V12, P408, DOI 10.1016/j.chom.2012.10.002; Lugli E, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00390; Martin-Gayo E, 2018, GENOME BIOL, V19, DOI 10.1186/s13059-017-1385-x; MATSUSAKA T, 1993, P NATL ACAD SCI USA, V90, P10193, DOI 10.1073/pnas.90.21.10193; Ndhlovu ZM, 2015, IMMUNITY, V43, P591, DOI 10.1016/j.immuni.2015.08.012; Ndung'u T, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aau2798; Ng D, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00094; O'Brien M, 2013, ADV EXP MED BIOL, V762, P71, DOI 10.1007/978-1-4614-4433-6_3; Ordovas-Montanes J, 2018, NATURE, V560, P649, DOI 10.1038/s41586-018-0449-8; Pijuan-Sala B, 2018, NAT REV MOL CELL BIO, V19, P399, DOI 10.1038/s41580-018-0002-5; Ranasinghe S, 2016, IMMUNITY, V45, P917, DOI 10.1016/j.immuni.2016.09.015; Reeves RK, 2015, NAT IMMUNOL, V16, P927, DOI 10.1038/ni.3227; Regev A, 2017, ELIFE, V6, DOI 10.7554/eLife.27041; Robb ML, 2016, CURR OPIN HIV AIDS, V11, P555, DOI 10.1097/COH.0000000000000316; Saelens W, 2019, NAT BIOTECHNOL, V37, P547, DOI 10.1038/s41587-019-0071-9; Samten B, 2013, CELL MOL IMMUNOL, V10, P456, DOI 10.1038/cmi.2013.38; Schoggins JW, 2011, CURR OPIN VIROL, V1, P519, DOI 10.1016/j.coviro.2011.10.008; Scully E, 2016, CURR HIV-AIDS REP, V13, P85, DOI 10.1007/s11904-016-0310-3; Shalek AK, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aan4730; Shive CL, 2015, AIDS, V29, P1263, DOI 10.1097/QAD.0000000000000735; Sloan RD, 2013, J VIROL, V87, P8110, DOI 10.1128/JVI.00815-13; Tirosh I, 2019, ANNU REV CANC BIOL, V3, P151, DOI 10.1146/annurev-cancerbio-030518-055609; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; TROMBETTA JJ, 2014, CURR PROTOC MOL BIOL, V107, P1, DOI DOI 10.1002/0471142727.MB0422S107; Tu AA, 2019, NAT IMMUNOL, V20, P1692, DOI 10.1038/s41590-019-0544-5; Vargas-Inchaustegui DA, 2010, INFECT IMMUN, V78, P301, DOI 10.1128/IAI.00959-09; Villani AC, 2017, SCIENCE, V356, DOI 10.1126/science.aah4573; Walker BD, 2013, NAT REV IMMUNOL, V13, P487, DOI 10.1038/nri3478; Wang TY, 2019, BMC BIOINFORMATICS, V20, DOI 10.1186/s12859-019-2599-6; Yue FY, 2008, J VIROL, V82, P6767, DOI 10.1128/JVI.02550-07; Zhang B, 2005, STAT APPL GENET MOL, V4, DOI 10.2202/1544-6115.1128	56	45	45	1	19	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	APR	2020	26	4					511	+		10.1038/s41591-020-0799-2	http://dx.doi.org/10.1038/s41591-020-0799-2		MAR 2020	27	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	QH1UE	32251406	Green Published, Green Submitted, hybrid			2022-12-27	WOS:000521529700002
J	Goncalves-Sa, J				Goncalves-Sa, Joana			In the fight against the new coronavirus outbreak, we must also struggle with human bias	NATURE MEDICINE			English	Editorial Material								A compounding factor of the outbreak is the potential for the general public to misunderstand the facts and design conspiracy theories.	[Goncalves-Sa, Joana] Nova Sch Business & Econ, Carcavelos, Portugal	Universidade Nova de Lisboa	Goncalves-Sa, J (corresponding author), Nova Sch Business & Econ, Carcavelos, Portugal.	joana.g.sa@novasbe.pt							0	14	15	0	22	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	MAR	2020	26	3					305	305		10.1038/s41591-020-0802-y	http://dx.doi.org/10.1038/s41591-020-0802-y		MAR 2020	1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	KU0MC	32152585	Green Published, Bronze			2022-12-27	WOS:000518737200003
J	Cehajic-Kapetanovic, J; Xue, KM; de la Camara, CMF; Nanda, A; Davies, A; Wood, LJ; Salvetti, AP; Fischer, MD; Aylward, JW; Barnard, AR; Jolly, JK; Luo, E; Lujan, BJ; Ong, T; Girach, A; Black, GCM; Gregori, NZ; Davis, JL; Rosa, PR; Lotery, AJ; Lam, BL; Stanga, PE; MacLaren, RE				Cehajic-Kapetanovic, Jasmina; Xue, Kanmin; Martinez-Fernandez de la Camara, Cristina; Nanda, Anika; Davies, Alexandra; Wood, Laura J.; Salvetti, Anna Paola; Fischer, M. Dominik; Aylward, James W.; Barnard, Alun R.; Jolly, Jasleen K.; Luo, Edmond; Lujan, Brandon J.; Ong, Tuyen; Girach, Aniz; Black, Graeme C. M.; Gregori, Ninel Z.; Davis, Janet L.; Rosa, Potyra R.; Lotery, Andrew J.; Lam, Byron L.; Stanga, Paulo E.; MacLaren, Robert E.			Initial results from a first-in-human gene therapy trial on X-linked retinitis pigmentosa caused by mutations in RPGR	NATURE MEDICINE			English	Article							OPTICAL COHERENCE TOMOGRAPHY; RETINAL DYSTROPHY; EFFICACY; SAFETY; STABILITY; VECTOR; ZONE	Retinal gene therapy has shown great promise in treating retinitis pigmentosa (RP), a primary photoreceptor degeneration that leads to severe sight loss in young people. In the present study, we report the first-in-human phase 1/2, dose-escalation clinical trial for X-linked RP caused by mutations in the RP GTPase regulator (RPGR) gene in 18 patients over up to 6 months of follow-up (: NCT03116113). The primary outcome of the study was safety, and secondary outcomes included visual acuity, microperimetry and central retinal thickness. Apart from steroid-responsive subretinal inflammation in patients at the higher doses, there were no notable safety concerns after subretinal delivery of an adeno-associated viral vector encoding codon-optimized human RPGR (AAV8-coRPGR), meeting the pre-specified primary endpoint. Visual field improvements beginning at 1 month and maintained to the last point of follow-up were observed in six patients.	[Cehajic-Kapetanovic, Jasmina; Xue, Kanmin; Martinez-Fernandez de la Camara, Cristina; Nanda, Anika; Davies, Alexandra; Wood, Laura J.; Salvetti, Anna Paola; Fischer, M. Dominik; Aylward, James W.; Barnard, Alun R.; Jolly, Jasleen K.; MacLaren, Robert E.] Univ Oxford, Dept Clin Neurosci, Nuffield Lab Ophthalmol, Oxford, England; [Cehajic-Kapetanovic, Jasmina; Xue, Kanmin; Martinez-Fernandez de la Camara, Cristina; Nanda, Anika; Davies, Alexandra; Wood, Laura J.; Salvetti, Anna Paola; Aylward, James W.; Barnard, Alun R.; Jolly, Jasleen K.; MacLaren, Robert E.] Oxford Univ Hosp NHS Fdn Trust, Oxford Eye Hosp, Oxford, England; [Luo, Edmond; Ong, Tuyen; Girach, Aniz] Nightstar Therapeut Ltd, London, England; [Lujan, Brandon J.] Oregon Hlth & Sci Univ, Casey Eye Inst, Portland, OR 97201 USA; [Black, Graeme C. M.; Stanga, Paulo E.] Manchester Univ Hosp NHS Fdn Trust, St Marys Hosp, Manchester Ctr Genom Med, Manchester, Lancs, England; [Black, Graeme C. M.; Stanga, Paulo E.] Manchester Univ Hosp NHS Fdn Trust, Manchester Acad Hlth Sci Ctr, Manchester Royal Eye Hosp, Manchester Vis Regenerat Lab, Manchester, Lancs, England; [Black, Graeme C. M.; Stanga, Paulo E.] Univ Manchester, Fac Biol Med & Hlth, Sch Biol Sci, Manchester, Lancs, England; [Gregori, Ninel Z.; Davis, Janet L.; Rosa, Potyra R.; Lam, Byron L.] Bascom Palmer Eye Inst, Miami, FL 33136 USA; [Lotery, Andrew J.] Univ Southampton, Fac Med, Clin Neurosci Res Grp, Clin & Expt Sci, Southampton, Hants, England; [Lotery, Andrew J.] Univ Hosp Southampton NHS Fdn Trust, Southampton, Hants, England	University of Oxford; Oxford University Hospitals NHS Foundation Trust; Oregon Health & Science University; University of Manchester; Wythenshawe Hospital NHS Foundation Trust; Manchester Royal Eye Hospital; University of Manchester; Wythenshawe Hospital NHS Foundation Trust; University of Manchester; Bascom Palmer Eye Institute; University of Southampton; University of Southampton; University Hospital Southampton NHS Foundation Trust	MacLaren, RE (corresponding author), Univ Oxford, Dept Clin Neurosci, Nuffield Lab Ophthalmol, Oxford, England.; MacLaren, RE (corresponding author), Oxford Univ Hosp NHS Fdn Trust, Oxford Eye Hosp, Oxford, England.	enquiries@eye.ox.ac.uk	wei, wei/HHR-8613-2022; Xue, Kanmin/AIC-7111-2022; Jolly, Jasleen Kaur/AAC-1873-2019; Martinez, Cristina/ABH-7295-2020; Davis, Janet L/GPC-8037-2022; Black, Graeme/K-7374-2015	Jolly, Jasleen Kaur/0000-0001-9878-4621; Martinez, Cristina/0000-0002-6612-6162; Davis, Janet L/0000-0001-6395-5881; Xue, Kanmin/0000-0003-0065-9131; Cehajic-Kapetanovic, Jasmina/0000-0002-9956-6412; Salvetti, Anna Paola/0000-0002-5513-2241; Lotery, Andrew/0000-0001-5541-4305; Black, Graeme/0000-0001-8727-6592; (Wood) Taylor, Laura/0000-0001-7072-0853	Biogen Inc.	Biogen Inc.(Biogen)	We thank all trial participants for their commitment to the trial and for attending their follow-up visits, and staff members of the Eye Research Group Oxford for their support throughout the study. The trial was sponsored by Nightstar Therapeutics, now Biogen Inc. (https://clinicaltrials.gov/: NCT03116113), with additional research infrastructure support provided by the National Institute for Health Research (NIHR), Oxford Biomedical Research Centre. The views expressed are those of the authors and not necessarily those of the NIHR or the UK Department of Health. We thank B. Lujan, Medical Director of the Casey Eye Institute Reading Center, Portland, OR, USA and the Doheny Image Reading Center, Doheny Eye Institute, Los Angeles, CA, USA, both of which independently reviewed and verified the findings from the SD-OCT data.	Baker CK, 2018, FRONT CELL NEUROSCI, V12, DOI 10.3389/fncel.2018.00316; Bennett J, 2017, MOL THER, V25, P1076, DOI 10.1016/j.ymthe.2017.03.008; Bennett J, 2016, LANCET, V388, P661, DOI 10.1016/S0140-6736(16)30371-3; Birch DG, 2015, OPHTHALMOLOGY, V122, P833, DOI 10.1016/j.ophtha.2014.11.005; Boye SE, 2013, MOL THER, V21, P509, DOI 10.1038/mt.2012.280; Cideciyan AV, 2018, INVEST OPHTH VIS SCI, V59, P4558, DOI 10.1167/iovs.18-24931; Cukras C, 2018, MOL THER, V26, P2282, DOI 10.1016/j.ymthe.2018.05.025; Deng WT, 2015, HUM GENE THER, V26, P593, DOI 10.1089/hum.2015.035; DiCarlo JE, 2018, J CLIN INVEST, V128, P2177, DOI 10.1172/JCI120429; Duncan JL, 2007, INVEST OPHTH VIS SCI, V48, P3283, DOI 10.1167/iovs.06-1422; Duncan JL, 2018, TRANSL VIS SCI TECHN, V7, DOI 10.1167/tvst.7.4.6; Fischer MD, 2017, MOL THER, V25, P1854, DOI 10.1016/j.ymthe.2017.05.005; Hood DC, 2011, INVEST OPHTH VIS SCI, V52, P101, DOI 10.1167/iovs.10-5799; KLEIN R, 1983, OPHTHALMOLOGY, V90, P1357; MacLaren RE, 2014, LANCET, V383, P1129, DOI 10.1016/S0140-6736(13)62117-0; Maguire AM, 2008, NEW ENGL J MED, V358, P2240, DOI 10.1056/NEJMoa0802315; Megaw RD, 2015, EXP EYE RES, V138, P32, DOI 10.1016/j.exer.2015.06.007; Pawlyk BS, 2016, GENE THER, V23, P196, DOI 10.1038/gt.2015.93; Russell S, 2017, LANCET, V390, P849, DOI 10.1016/S0140-6736(17)31868-8; Sahel JA, 2015, CSH PERSPECT MED, V5, DOI 10.1101/cshperspect.a017111; STORER BE, 1989, BIOMETRICS, V45, P925, DOI 10.2307/2531693; Sun X, 2016, P NATL ACAD SCI USA, V113, pE2925, DOI 10.1073/pnas.1523201113; Talib M, 2019, RETINA-J RET VIT DIS, V39, P1186, DOI 10.1097/IAE.0000000000002125; Tang PH, 2019, OSLI RETINA, V50, pE44, DOI 10.3928/23258160-20190129-18; Tee JJL, 2017, AM J OPHTHALMOL, V178, P18, DOI 10.1016/j.ajo.2017.03.012; Vandenberghe LH, 2015, CSH PERSPECT MED, V5, DOI 10.1101/cshperspect.a017442; Wu ZJ, 2015, HUM MOL GENET, V24, P3956, DOI 10.1093/hmg/ddv134; Xue K, 2017, EYE, V31, P1308, DOI 10.1038/eye.2017.158	28	110	114	3	31	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	MAR	2020	26	3					354	+		10.1038/s41591-020-0763-1	http://dx.doi.org/10.1038/s41591-020-0763-1		FEB 2020	15	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	KU0MC	32094925	Green Accepted, Green Submitted			2022-12-27	WOS:000515477500004
J	Ameratunga, S; Woodward, A				Ameratunga, Shanthi; Woodward, Alistair			Rising injuries in a hotter climate	NATURE MEDICINE			English	Editorial Material							WEATHER	A statistical model based on an analysis of routinely collected data from 1980 to 2017 predicts 1,601 excess injury deaths per year in the contiguous USA if average temperatures rise by 1.5 degrees C.	[Ameratunga, Shanthi; Woodward, Alistair] Univ Auckland, Epidemiol & Biostat Sect, Sch Populat Hlth, Fac Med & Hlth Sci, Auckland, New Zealand	University of Auckland	Ameratunga, S (corresponding author), Univ Auckland, Epidemiol & Biostat Sect, Sch Populat Hlth, Fac Med & Hlth Sci, Auckland, New Zealand.	s.ameratunga@auckland.ac.nz						Balbus JM, 2009, J OCCUP ENVIRON MED, V51, P33, DOI 10.1097/JOM.0b013e318193e12e; Greenough G, 2001, ENVIRON HEALTH PERSP, V109, P191, DOI 10.2307/3435009; Hosking J, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-695; Kim Y, 2019, ENVIRON HEALTH PERSP, V127, DOI 10.1289/EHP4898; Klinenberg E., 2015, HEAT WAVE SOCIAL AUT; Orru H, 2017, INT J BIOMETEOROL, V61, P963, DOI 10.1007/s00484-016-1270-4; Parks RM, 2020, NAT MED, V26, P65, DOI 10.1038/s41591-019-0721-y; Roberts I, 2005, INJURY PREV, V11, P326, DOI 10.1136/ip.2005.009910; Robertson L, 2018, INJURY PREV, V24, P232, DOI 10.1136/injuryprev-2017-042419; Smith KR, 2014, CLIMATE CHANGE 2014: IMPACTS, ADAPTATION, AND VULNERABILITY, PT A: GLOBAL AND SECTORAL ASPECTS, P709; Tin ST, 2012, ENVIRON HEALTH-GLOB, V11, DOI 10.1186/1476-069X-11-12; WHO, 2014, INJ VOIL FACTS 2014	12	2	2	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JAN	2020	26	1					22	23		10.1038/s41591-019-0728-4	http://dx.doi.org/10.1038/s41591-019-0728-4			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	KG3GZ	31932799				2022-12-27	WOS:000509831900019
J	Parks, RM; Bennett, JE; Tamura-Wicks, H; Kontis, V; Toumi, R; Danaei, G; Ezzati, M				Parks, Robbie M.; Bennett, James E.; Tamura-Wicks, Helen; Kontis, Vasilis; Toumi, Ralf; Danaei, Goodarz; Ezzati, Majid			Anomalously warm temperatures are associated with increased injury deaths	NATURE MEDICINE			English	Article							CLIMATE-CHANGE; UNITED-STATES; OLDER-ADULTS; MORTALITY; HEAT; AGGRESSION; WEATHER; SUICIDE; IMPACT; CRIME	Temperatures that deviate from the long-term local norm affect human health, and are projected to become more frequent as the global climate changes(1). There are limited data on how such anomalies affect deaths from injuries. In the present study, we used data on mortality and temperature over 38 years (1980-2017) in the contiguous USA and formulated a Bayesian spatio-temporal model to quantify how anomalous temperatures, defined as deviations of monthly temperature from the local average monthly temperature over the entire analysis period, affect deaths from unintentional (transport, falls and drownings) and intentional (assault and suicide) injuries, by age group and sex. We found that a 1.5 degrees C anomalously warm year, as envisioned under the Paris Climate Agreement(2), would be associated with an estimated 1,601 (95% credible interval 1,430-1,776) additional injury deaths. Of these additional deaths, 84% would occur in males, mostly in adolescence to middle age. These would comprise increases in deaths from drownings, transport, assault and suicide, offset partly by a decline in deaths from falls in older ages. The findings demonstrate the need for targeted interventions against injuries during periods of anomalously warm temperatures, especially as these episodes are likely to increase with global climate change. Bayesian spatio-temporal modeling of mortality from injuries in the contiguous USA shows increases in the number of deaths attributable to abnormal temperature fluctuations due to global heating.	[Parks, Robbie M.; Bennett, James E.; Tamura-Wicks, Helen; Kontis, Vasilis; Ezzati, Majid] Imperial Coll London, MRC Ctr Environm & Hlth, London, England; [Parks, Robbie M.; Bennett, James E.; Tamura-Wicks, Helen; Kontis, Vasilis; Ezzati, Majid] Imperial Coll London, Sch Publ Hlth, Dept Epidemiol & Biostat, London, England; [Parks, Robbie M.] Columbia Univ, Earth Inst, New York, NY USA; [Parks, Robbie M.] Columbia Univ, Int Res Inst Climate & Soc, New York, NY USA; [Bennett, James E.; Ezzati, Majid] Imperial Coll London, Abdul Latif Jameel Inst Dis & Emergency Analyt, London, England; [Toumi, Ralf] Imperial Coll London, Space & Atmospher Phys, London, England; [Danaei, Goodarz] Harvard TH Chan Sch Publ Hlth, Boston, MA USA; [Ezzati, Majid] Imperial Coll London, WHO Collaborating Ctr NCD Surveillance & Epidemio, London, England	Imperial College London; Imperial College London; Columbia University; Columbia University; Imperial College London; Imperial College London; Harvard University; Harvard T.H. Chan School of Public Health; Imperial College London	Ezzati, M (corresponding author), Imperial Coll London, MRC Ctr Environm & Hlth, London, England.; Ezzati, M (corresponding author), Imperial Coll London, Sch Publ Hlth, Dept Epidemiol & Biostat, London, England.; Ezzati, M (corresponding author), Imperial Coll London, Abdul Latif Jameel Inst Dis & Emergency Analyt, London, England.; Ezzati, M (corresponding author), Imperial Coll London, WHO Collaborating Ctr NCD Surveillance & Epidemio, London, England.	majid.ezzati@imperial.ac.uk	Parks, Robbie M/AAC-2426-2019	Parks, Robbie M/0000-0002-7916-1717; Kontis, Vasilis/0000-0002-0485-1561	Wellcome Trust ISSF Studentship; Wellcome Trust [209376/Z/17/Z]; US Environmental Protection Agency (EPA), as part of the Center for Clean Air Climate Solution [R835873]; MRC [MR/S019669/1] Funding Source: UKRI	Wellcome Trust ISSF Studentship(Wellcome Trust); Wellcome Trust(Wellcome TrustEuropean Commission); US Environmental Protection Agency (EPA), as part of the Center for Clean Air Climate Solution; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	R.M.P. was supported by a Wellcome Trust ISSF Studentship. The development of statistical methods was supported by grants from the Wellcome Trust (grant no. 209376/Z/17/Z). Work on the US mortality data was supported by a grant from the US Environmental Protection Agency (EPA), as part of the Center for Clean Air Climate Solution (assistance agreement no. R835873). This article has not been formally reviewed by the EPA. The views expressed in this document are solely those of the authors and do not necessarily reflect those of the EPA. The EPA does not endorse any products or commercial services mentioned in this publication. We thank M. Blangiardo, S. Flaxman and C. Paciorek for discussions on the statistical model, and K. Bhalla, H. Frumkin, A. Haines and T. Kjellstrom for suggestions of relevant studies.	Ambrose AF, 2013, MATURITAS, V75, P51, DOI 10.1016/j.maturitas.2013.02.009; ANDERSON CA, 1989, PSYCHOL BULL, V106, P74, DOI 10.1037/0033-2909.106.1.74; [Anonymous], 2013, J TRANSPORTATION TEC, DOI [DOI 10.4236/JTTS.2013.31003, 10.4236/jtts.2013.31003]; BARON RA, 1976, J PERS SOC PSYCHOL, V33, P245, DOI 10.1037/0022-3514.33.3.245; Basu R, 2009, ENVIRON HEALTH-GLOB, V8, DOI 10.1186/1476-069X-8-40; Bennett JE, 2019, PLOS MED, V16, DOI 10.1371/journal.pmed.1002856; Bennett JE, 2014, NAT CLIM CHANGE, V4, P269, DOI [10.1038/NCLIMATE2123, 10.1038/nclimate2123]; BESAG J, 1991, ANN I STAT MATH, V43, P1, DOI 10.1007/BF00116466; Bobb JF, 2017, AM J EPIDEMIOL, V185, P283, DOI 10.1093/aje/kww219; Burke M, 2018, NAT CLIM CHANGE, V8, P723, DOI 10.1038/s41558-018-0222-x; Daanen HAM, 2003, APPL ERGON, V34, P597, DOI 10.1016/S0003-6870(03)00055-3; Datla S, 2013, PROCD SOC BEHV, V104, P497, DOI 10.1016/j.sbspro.2013.11.143; European Centre for Medium-Range Weather Forecasts (ECMWF), 2019, ERA5 REAN DAT; Gasparrini A, 2015, LANCET, V386, P369, DOI 10.1016/S0140-6736(14)62114-0; Gasparrini A, 2017, LANCET PLANET HEALTH, V1, pE360, DOI 10.1016/S2542-5196(17)30156-0; Gelman A, 2006, BAYESIAN ANAL, V1, P515, DOI 10.1214/06-BA117A; Glaeser EL, 1996, Q J ECON, V111, P507, DOI 10.2307/2946686; Haines A, 2019, NEW ENGL J MED, V380, P263, DOI 10.1056/NEJMra1807873; Huang CR, 2011, ENVIRON HEALTH PERSP, V119, P1681, DOI 10.1289/ehp.1103456; Intergovernmental Panel on Climate Change (IPCC), 2013, CLIM CHANG 2013 PHYS; Kelsey JL, 2010, J AM GERIATR SOC, V58, P2135, DOI 10.1111/j.1532-5415.2010.03062.x; Knorr-Held L, 2000, STAT MED, V19, P2555, DOI 10.1002/1097-0258(20000915/30)19:17/18<2555::AID-SIM587>3.0.CO;2-#; Kontis V, 2017, LANCET, V389, P1323, DOI 10.1016/S0140-6736(16)32381-9; Mach KJ, 2019, NATURE, V571, P193, DOI 10.1038/s41586-019-1300-6; Mackie R. R., 1977, VIGILANCE NATP C SER, V3, P537; Majeed H, 2017, LANCET PLANET HEALTH, V1, pE94, DOI 10.1016/S2542-5196(17)30045-1; Masson-Delmorte V, 2018, GLOBAL WARMING 1 5 C; McMichael AJ, 2006, LANCET, V367, P859, DOI 10.1016/S0140-6736(06)68079-3; Opinium, 2018, BRITS DRINK MOR ALC; Orru H, 2017, INT J BIOMETEOROL, V61, P963, DOI 10.1007/s00484-016-1270-4; Parks RM, 2018, ELIFE, V7, DOI 10.7554/eLife.35500; Rau R, 2007, DEMOGR RES MONOGR, P1, DOI 10.1007/978-3-540-44902-7; Rey G, 2007, INT ARCH OCC ENV HEA, V80, P615, DOI 10.1007/s00420-007-0173-4; Robertson L, 2018, INJURY PREV, V24, P232, DOI 10.1136/injuryprev-2017-042419; Robertson LS, 2018, J TRANSP HEALTH, V9, P161, DOI 10.1016/j.jth.2018.04.005; Roh H-J, 2016, J COLD REG ENG, V22, P1394; Roh HJ, 2016, KSCE J CIV ENG, V20, P1514, DOI 10.1007/s12205-015-0236-0; Rotton J, 2003, ENVIRON BEHAV, V35, P802, DOI 10.1177/0013916503255565; Rue H., 2005, GAUSSIAN MARKOV RAND, DOI [10.1007/s00184-007-0162-3, DOI 10.1007/S00184-007-0162-3]; Rue H, 2009, J R STAT SOC B, V71, P319, DOI 10.1111/j.1467-9868.2008.00700.x; Shi LH, 2015, NAT CLIM CHANGE, V5, P988, DOI 10.1038/NCLIMATE2704; Simpson D, 2017, STAT SCI, V32, P1, DOI 10.1214/16-STS576; Smith KR, 2014, CLIMATE CHANGE 2014: IMPACTS, ADAPTATION, AND VULNERABILITY, PT A: GLOBAL AND SECTORAL ASPECTS, P709; Talaei A, 2014, J FORENSIC SCI, V59, P1397, DOI 10.1111/1556-4029.12471; United Nations, 2015, REP C PART UN FRAM C; Voas RB, 2012, J STUD ALCOHOL DRUGS, V73, P341, DOI 10.15288/jsad.2012.73.341; Watts N, 2018, LANCET, V392, P2479, DOI 10.1016/S0140-6736(18)32594-7; Wyon DP, 1996, ERGONOMICS, V39, P61, DOI 10.1080/00140139608964434; Xu Jiaquan, 2014, NCHS Data Brief, P1; Ye XF, 2012, ENVIRON HEALTH PERSP, V120, P19, DOI [10.1289/ehp.1003198, 10.1289/ehp.120-a19]; Zivin JG, 2014, J LABOR ECON, V32, P1, DOI 10.1086/671766; ZLATOPER TJ, 1991, ACCIDENT ANAL PREV, V23, P431, DOI 10.1016/0001-4575(91)90062-A	52	42	42	3	17	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	JAN	2020	26	1					65	+		10.1038/s41591-019-0721-y	http://dx.doi.org/10.1038/s41591-019-0721-y			13	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	KG3GZ	31932800	Green Published, hybrid, Green Submitted			2022-12-27	WOS:000509831900028
J	Esteki, MZ; Viltrop, T; Tsuiko, O; Tiirats, A; Koel, M; Noukas, M; Zilina, O; Teearu, K; Marjonen, H; Kahila, H; Meekels, J; Soderstrom-Anttila, V; Suikkari, AM; Tiitinen, A; Magi, R; Koks, S; Kaminen-Ahola, N; Kurg, A; Voet, T; Vermeesch, JR; Salumets, A				Esteki, Masoud Zamani; Viltrop, Triin; Tsuiko, Olga; Tiirats, Airi; Koel, Mariann; Noukas, Margit; Zilina, Olga; Teearu, Katre; Marjonen, Heidi; Kahila, Hanna; Meekels, Jeroen; Soderstrom-Anttila, Viveca; Suikkari, Anne-Maria; Tiitinen, Aila; Magi, Reedik; Koks, Sulev; Kaminen-Ahola, Nina; Kurg, Ants; Voet, Thierry; Vermeesch, Joris Robert; Salumets, Andres			In vitro fertilization does not increase the incidence of de novo copy number alterations in fetal and placental lineages	NATURE MEDICINE			English	Article							HIDDEN-MARKOV MODEL; HUMAN-EMBRYOS; CHROMOSOME INSTABILITY; MOSAICISM; GENOME; ANEUPLOIDY; COMMON; ABNORMALITIES; CONSTITUTION; BLASTOCYSTS	Although chromosomal instability (CIN) is a common phenomenon in cleavage-stage embryogenesis following in vitro fertilization (IVF)(1-3), its rate in naturally conceived human embryos is unknown. CIN leads to mosaic embryos that contain a combination of genetically normal and abnormal cells, and is significantly higher in in vitro-produced preimplantation embryos as compared to in vivo-conceived preimplantation embryos(4). Even though embryos with CIN-derived complex aneuploidies may arrest between the cleavage and blastocyst stages of embryogenesis(5,6), a high number of embryos containing abnormal cells can pass this strong selection barrier(7,8). However, neither the prevalence nor extent of CIN during prenatal development and at birth, following IVF treatment, is well understood. Here we profiled the genomic landscape of fetal and placental tissues postpartum from both IVF and naturally conceived children, to investigate the prevalence and persistence of large genetic aberrations that probably arose from IVF-related CIN. We demonstrate that CIN is not preserved at later stages of prenatal development, and that de novo numerical aberrations or large structural DNA imbalances occur at similar rates in IVF and naturally conceived live-born neonates. Our findings affirm that human IVF treatment has no detrimental effect on the chromosomal constitution of fetal and placental lineages.	[Esteki, Masoud Zamani; Meekels, Jeroen] Maastricht Univ, Dept Clin Genet, Med Ctr, Maastricht, Netherlands; [Esteki, Masoud Zamani] Maastricht Univ, GROW Sch Oncol & Dev, Dept Genet & Cell Biol, Maastricht, Netherlands; [Esteki, Masoud Zamani; Tsuiko, Olga; Voet, Thierry; Vermeesch, Joris Robert] Katholieke Univ Leuven, Dept Human Genet, Univ Hosp Leuven, Ctr Human Genet, Leuven, Belgium; [Viltrop, Triin; Tsuiko, Olga] Univ Tartu, Inst Biomed & Translat Med, Dept Biomed, Tartu, Estonia; [Tiirats, Airi; Salumets, Andres] Univ Tartu, Inst Clin Med, Dept Obstet & Gynecol, Tartu, Estonia; [Koel, Mariann] Univ Tartu, Inst Mol & Cell Biol, Dept Cell Biol, Tartu, Estonia; [Noukas, Margit; Zilina, Olga; Teearu, Katre; Kurg, Ants] Univ Tartu, Inst Mol & Cell Biol, Dept Biotechnol, Tartu, Estonia; [Noukas, Margit; Magi, Reedik] Univ Tartu, Inst Genom, Estonian Genome Ctr, Tartu, Estonia; [Marjonen, Heidi; Kaminen-Ahola, Nina] Univ Helsinki, Dept Med & Clin Genet, Medicum, Helsinki, Finland; [Kahila, Hanna; Tiitinen, Aila; Salumets, Andres] Univ Helsinki, Dept Obstet & Gynecol, Helsinki, Finland; [Kahila, Hanna; Tiitinen, Aila; Salumets, Andres] Helsinki Univ Hosp, Helsinki, Finland; [Soderstrom-Anttila, Viveca; Suikkari, Anne-Maria] Vaestoliitto Fertil Clin, Helsinki, Finland; [Koks, Sulev] Murdoch Univ, Ctr Mol Med & Innovat Therapeut, Murdoch, WA, Australia; [Koks, Sulev] Perron Inst Neurol & Translat Sci, Nedlands, WA, Australia; [Voet, Thierry] Wellcome Trust Sanger Inst, Sanger EBI Single Cell Genom Ctr, Cambridge, England; [Salumets, Andres] Competence Ctr Hlth Technol, Tartu, Estonia	Maastricht University; Maastricht University; KU Leuven; University Hospital Leuven; University of Tartu; University of Tartu; University of Tartu; University of Tartu; University of Tartu; University of Helsinki; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; Family Federation of Finland; Murdoch University; Wellcome Trust Sanger Institute	Esteki, MZ (corresponding author), Maastricht Univ, Dept Clin Genet, Med Ctr, Maastricht, Netherlands.; Esteki, MZ (corresponding author), Maastricht Univ, GROW Sch Oncol & Dev, Dept Genet & Cell Biol, Maastricht, Netherlands.; Esteki, MZ; Voet, T; Vermeesch, JR (corresponding author), Katholieke Univ Leuven, Dept Human Genet, Univ Hosp Leuven, Ctr Human Genet, Leuven, Belgium.; Salumets, A (corresponding author), Univ Tartu, Inst Clin Med, Dept Obstet & Gynecol, Tartu, Estonia.; Salumets, A (corresponding author), Univ Helsinki, Dept Obstet & Gynecol, Helsinki, Finland.; Salumets, A (corresponding author), Helsinki Univ Hosp, Helsinki, Finland.; Voet, T (corresponding author), Wellcome Trust Sanger Inst, Sanger EBI Single Cell Genom Ctr, Cambridge, England.; Salumets, A (corresponding author), Competence Ctr Hlth Technol, Tartu, Estonia.	masoud.zamaniesteki@mumc.nl; thierry.voet@kuleuven.be; joris.vermeesch@kuleuven.be; andres.salumets@ccht.ee	Voet, Thierry/E-8877-2017; Mägi, Reedik/AAJ-9679-2021; Kurg, Ants/AAM-1292-2020; Koks, Sulev/H-3655-2015	Voet, Thierry/0000-0003-1204-9963; Kurg, Ants/0000-0002-0829-1987; Kaminen-Ahola, Nina/0000-0003-1255-4716; Zamani Esteki, Masoud/0000-0003-3909-0050; Koel, Mariann/0000-0001-8567-7296; Tsuiko, Olga/0000-0003-4189-2992; Koks, Sulev/0000-0001-6087-6643; Vermeesch, Joris/0000-0002-3071-1191	Estonian Ministry of Education and Research [IUT34-16]; Enterprise Estonia [EU48695]; Horizon 2020 innovation (WIDENLIFE) [EU692065]; European Union [EU324509]; Helsinki University Hospital fund; Faculty of Medicine, University of Helsinki fund; EVA (Erfelijkheid Voortplanting & Aanleg) specialty program fund of Maastricht University Medical Centre (MUMC+); Estonian Research Council [IUT20-60, IUT24-6]; European Union through the European Regional Development Fund Project [2014-2020.4.01.15-0012, 2014-2020.4.01.16-0125]; KU Leuven [C1/018]; FWO [G.0392.14N]	Estonian Ministry of Education and Research(Ministry of Education and Research, Estonia); Enterprise Estonia; Horizon 2020 innovation (WIDENLIFE); European Union(European Commission); Helsinki University Hospital fund; Faculty of Medicine, University of Helsinki fund; EVA (Erfelijkheid Voortplanting & Aanleg) specialty program fund of Maastricht University Medical Centre (MUMC+); Estonian Research Council(Estonian Research Council); European Union through the European Regional Development Fund Project; KU Leuven(KU Leuven); FWO(FWO)	We gratefully thank all families that participated in this study in Estonia and Finland. This research was funded by an institutional research grant from the Estonian Ministry of Education and Research (no. IUT34-16 to A.S.); Enterprise Estonia (grant no. EU48695 to A.S.); the Horizon 2020 innovation (WIDENLIFE) (grant no. EU692065 to A.K.); the European Union's FP7 Marie Curie Industry-Academia Partnerships and Pathways (grant no. EU324509 to A.S.); the Helsinki University Hospital fund (to A.Tiitinen); the Faculty of Medicine, University of Helsinki fund (to N.K.-A.); the EVA (Erfelijkheid Voortplanting & Aanleg) specialty program fund of Maastricht University Medical Centre (MUMC+) (to M.Z.E.); the Estonian Research Council (grant nos. IUT20-60 and IUT24-6); the European Union through the European Regional Development Fund Project (nos. 2014-2020.4.01.15-0012 GENTRANSMED and 2014-2020.4.01.16-0125 to R.M.); and KU Leuven funding (no. C1/018) and FWO grant (no. G.0392.14N to J.R.V. and T.Voet). We thank B. de Greef, A. van Montfoort and N. Davarzani for statistical consultations.	ANGELL RR, 1983, NATURE, V303, P336, DOI 10.1038/303336a0; Baart EB, 2006, HUM REPROD, V21, P223, DOI 10.1093/humrep/dei291; Biesecker LG, 2013, NAT REV GENET, V14, P307, DOI 10.1038/nrg3424; Bolton H, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11165; Chavez SL, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2249; Chow S. C., 2003, SAMPLE SIZE CALCULAT; Cohen J.E., 1988, STAT POWER ANAL BEHA; Colella S, 2007, NUCLEIC ACIDS RES, V35, P2013, DOI 10.1093/nar/gkm076; Conlin LK, 2010, HUM MOL GENET, V19, P1263, DOI 10.1093/hmg/ddq003; DELHANTY JDA, 1993, HUM MOL GENET, V2, P1183, DOI 10.1093/hmg/2.8.1183; Destouni A, 2018, HUM REPROD, V33, P2302, DOI 10.1093/humrep/dey325; Destouni A, 2016, GENOME RES, V26, P567, DOI 10.1101/gr.200527.115; Dimitriadou E, 2017, HUM REPROD, V32, P687, DOI 10.1093/humrep/dex011; Dimitriadou E, 2015, METHODS MOL BIOL, V1347, P197, DOI 10.1007/978-1-4939-2990-0_14; Esteki MZ, 2015, AM J HUM GENET, V96, P894, DOI 10.1016/j.ajhg.2015.04.011; Fragouli E, 2011, HUM REPROD, V26, P480, DOI 10.1093/humrep/deq344; Greco E, 2015, NEW ENGL J MED, V373, P2089, DOI 10.1056/NEJMc1500421; HARPER JC, 1995, PRENATAL DIAG, V15, P41, DOI 10.1002/pd.1970150109; Kalousek DK, 1996, J MED GENET, V33, P529, DOI 10.1136/jmg.33.7.529; Kasak L, 2015, SCI REP-UK, V5, DOI 10.1038/srep08342; Ledbetter DH, 2009, NAT MED, V15, P490, DOI 10.1038/nm0509-490; Liu PF, 2017, CELL, V168, P830, DOI 10.1016/j.cell.2017.01.037; McCoy RC, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005601; Mccoy RC, 2015, SCIENCE, V348, P235, DOI 10.1126/science.aaa3337; Merla G, 2010, HUM GENET, V128, P3, DOI 10.1007/s00439-010-0827-2; Metsalu T, 2014, EPIGENETICS-US, V9, P1397, DOI 10.4161/15592294.2014.970052; Munne S, 2017, HUM REPROD, V32, P743, DOI 10.1093/humrep/dex031; MUNNE S, 1995, AM J OBSTET GYNECOL, V172, P1191, DOI 10.1016/0002-9378(95)91479-X; Munne S, 2017, FERTIL STERIL, V108, P62, DOI 10.1016/j.fertnstert.2017.05.002; Newman TB., 2015, DESIGNING CLIN RES; Nilsen G, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-591; Popovic M, 2018, HUM REPROD, V33, P1342, DOI 10.1093/humrep/dey106; Reimand J, 2016, NUCLEIC ACIDS RES, V44, pW83, DOI 10.1093/nar/gkw199; Sankilampi U, 2013, ANN MED, V45, P446, DOI 10.3109/07853890.2013.803739; Santos MA, 2010, HUM REPROD, V25, P1916, DOI 10.1093/humrep/deq139; Sildver K., 2015, EESTI ARST, V94, P465; SPAEPEN M, 1992, FEMS MICROBIOL LETT, V99, P89, DOI 10.1016/0378-1097(92)90293-W; STEPTOE PC, 1978, LANCET, V2, P366; Szafranski P, 2010, HUM MUTAT, V31, P840, DOI 10.1002/humu.21284; Tsuiko O, 2017, HUM REPROD, V32, P2348, DOI 10.1093/humrep/dex286; van Bon BWM, 2009, J MED GENET, V46, P511, DOI 10.1136/jmg.2008.063412; van Echten-Arends J, 2011, HUM REPROD UPDATE, V17, P620, DOI 10.1093/humupd/dmr014; Vanneste E, 2009, HUM REPROD, V24, P2679, DOI 10.1093/humrep/dep266; Vanneste E, 2009, NAT MED, V15, P577, DOI 10.1038/nm.1924; Voet T, 2017, CELL, V168, P751, DOI 10.1016/j.cell.2017.02.008; Voet T, 2013, NUCLEIC ACIDS RES, V41, P6119, DOI 10.1093/nar/gkt345; Wang K, 2007, GENOME RES, V17, P1665, DOI 10.1101/gr.6861907; Ziebe S, 2003, HUM REPROD, V18, P2575, DOI 10.1093/humrep/deg489	48	19	19	1	5	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2019	25	11					1699	+		10.1038/s41591-019-0620-2	http://dx.doi.org/10.1038/s41591-019-0620-2			15	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	JT2KI	31686035	Green Submitted			2022-12-27	WOS:000500824300027
J	Lees, JS; Welsh, CE; Celis-Morales, CA; Mackay, D; Lewsey, J; Gray, SR; Lyall, DM; Cleland, JG; Gill, JMR; Jhund, PS; Pell, J; Sattar, N; Welsh, P; Mark, PB				Lees, Jennifer S.; Welsh, Claire E.; Celis-Morales, Carlos A.; Mackay, Daniel; Lewsey, James; Gray, Stuart R.; Lyall, Donald M.; Cleland, John G.; Gill, Jason M. R.; Jhund, Pardeep S.; Pell, Jill; Sattar, Naveed; Welsh, Paul; Mark, Patrick B.			Glomerular filtration rate by differing measures, albuminuria and prediction of cardiovascular disease, mortality and end-stage kidney disease	NATURE MEDICINE			English	Article							CYSTATIN C; COLLABORATIVE METAANALYSIS; SERUM CREATININE; LDL CHOLESTEROL; TASK-FORCE; ALL-CAUSE; RISK; ASSOCIATION; HEART; UK	Chronic kidney disease is common in the general population and associated with excess cardiovascular disease (CVD), but kidney function does not feature in current CVD risk-prediction models. We tested three formulae for estimated glomerular filtration rate (eGFR) to determine which was the most clinically informative for predicting CVD and mortality. Using data from 440,526 participants from UK Biobank, eGFR was calculated using serum creatinine, cystatin C (eGFRcys) and creatinine-cystatin C. Associations of each eGFR with CVD outcome and mortality were compared using Cox models and adjusting for atherosclerotic risk factors (per relevant risk scores), and the predictive utility was determined by the C-statistic and categorical net reclassification index. We show that eGFRcys is most strongly associated with CVD and mortality, and, along with albuminuria, adds predictive discrimination to current CVD risk scores, whilst traditional creatinine-based measures are weakly associated with risk. Clinicians should consider measuring eGFRcys as part of cardiovascular risk assessment.	[Lees, Jennifer S.; Welsh, Claire E.; Celis-Morales, Carlos A.; Mackay, Daniel; Gray, Stuart R.; Cleland, John G.; Gill, Jason M. R.; Jhund, Pardeep S.; Sattar, Naveed; Welsh, Paul; Mark, Patrick B.] Univ Glasgow, Inst Cardiovasc & Med Sci, Glasgow, Lanark, Scotland; [Lewsey, James; Lyall, Donald M.; Pell, Jill] Univ Glasgow, Glasgow Inst Hlth & Wellbeing, Glasgow, Lanark, Scotland	University of Glasgow; University of Glasgow	Lees, JS (corresponding author), Univ Glasgow, Inst Cardiovasc & Med Sci, Glasgow, Lanark, Scotland.	jennifer.lees@glasgow.ac.uk	Welsh, Paul/H-5249-2019; Jhund, Pardeep/GLS-9508-2022; Cleland, John G./AAZ-4185-2020; Welsh, Claire E/AAB-3743-2019; Celis-Morales, Carlos/AAJ-5103-2020; Lees, Jennifer S/AAE-6299-2022; Mark, Patrick/N-5536-2014; Gray, Stuart/L-2489-2017	Welsh, Paul/0000-0002-7970-3643; Jhund, Pardeep/0000-0003-4306-5317; Cleland, John G./0000-0002-1471-7016; Welsh, Claire E/0000-0001-9477-0775; Lees, Jennifer S/0000-0001-6331-0178; Mark, Patrick/0000-0003-3387-2123; Gray, Stuart/0000-0001-8969-9636; , Donald/0000-0002-4565-9656	Chest, Heart and Stroke Association Scotland [Res16/A165]; Kidney Research UK [TF_013_20161125]; British Heart Foundation Centre of Excellence Award [RE/13/5/30177]	Chest, Heart and Stroke Association Scotland; Kidney Research UK(Kidney Research UK (KRUK)); British Heart Foundation Centre of Excellence Award	We thank the participants of the UK Biobank. The work in this study was supported by a grant from Chest, Heart and Stroke Association Scotland (grant no. Res16/A165). J.S.L. has personal funding from a Kidney Research UK Training Fellowship Award (no. TF_013_20161125) and is supported by a British Heart Foundation Centre of Excellence Award (no. RE/13/5/30177).	Allen N, 2012, HEALTH POLICY TECHN, V1, P123, DOI 10.1016/j.hlpt.2012.07.003; [Anonymous], 2016, UK BIOB SHOWC DET AS; [Anonymous], 2019, UK BIOB SHOWC BIOM A; [Anonymous], 2014, COST STAT CHRON KIDN; [Anonymous], 2011, UK BIOB SHOWC BLOOD; [Anonymous], 2007, UK BIOB PROT LARG SC; Baigent C, 2011, LANCET, V377, P2181, DOI 10.1016/S0140-6736(11)60739-3; Bush K, 2017, DEFINITIONS END STAG; Chartier-Harlin MC, 2004, LANCET, V364, P1167, DOI 10.1016/S0140-6736(04)17103-1; Elliott P, 2008, INT J EPIDEMIOL, V37, P234, DOI 10.1093/ije/dym276; Evans M, 2018, KIDNEY INT REP, V3, P625, DOI 10.1016/j.ekir.2018.01.002; Fry A, 2017, AM J EPIDEMIOL, V186, P1026, DOI 10.1093/aje/kwx246; Gansevoort RT, 2013, LANCET, V382, P339, DOI 10.1016/S0140-6736(13)60595-4; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Goff DC, 2014, CIRCULATION, V129, pS49, DOI 10.1161/01.cir.0000437741.48606.98; Grams ME, 2018, KIDNEY INT, V93, P1442, DOI 10.1016/j.kint.2018.01.009; Herrington WG, 2016, LANCET DIABETES ENDO, V4, P829, DOI 10.1016/S2213-8587(16)30156-5; Hill NR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158765; Hippisley-Cox J, 2017, BMJ-BRIT MED J, V357, P2099, DOI DOI 10.1136/BMJ.J2099; Inker LA, 2012, NEW ENGL J MED, V367, P20, DOI 10.1056/NEJMoa1114248; Israni AK, 2010, AM J TRANSPLANT, V10, P338, DOI 10.1111/j.1600-6143.2009.02949.x; Kasiske BL, 1996, J AM SOC NEPHROL, V7, P158; Kdigo, 2013, KIDNEY INT, V3, P182, DOI [10.7326/M13-2453, DOI 10.7326/M13-2453]; Lamb EJ, 2014, BMC NEPHROL, V15, DOI 10.1186/1471-2369-15-13; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Levin A, 2007, KIDNEY INT, V71, P31, DOI 10.1038/sj.ki.5002009; Levin A, 2013, KIDNEY INT SUPPL, V3, P5, DOI 10.1038/kisup.2012.77; Matsushita K, 2015, LANCET DIABETES ENDO, V3, P514, DOI 10.1016/S2213-8587(15)00040-6; Matsushita K, 2010, LANCET, V375, P2073, DOI 10.1016/S0140-6736(10)60674-5; Mehrotra R, 2017, J AM SOC NEPHROL, V28, P395, DOI 10.1681/ASN.2016070769; Myers GL, 2006, CLIN CHEM, V52, P5, DOI 10.1373/clinchem.2005.0525144; National Institute for Health and Clinical Excellence (NICE), 2014, CHRON KIDN DIS AD AS; Neri L, 2019, NEPHROL DIAL TRANSPL, V34, P682, DOI 10.1093/ndt/gfy273; Nitsch D, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f324; Piepoli MF, 2016, ATHEROSCLEROSIS, V252, P207, DOI [10.1177/2047487316653709, 10.1016/j.atherosclerosis.2016.05.037]; Public Health England, 2014, CHRON KIDN DIS PREV; Salgado JV, 2013, J CARDIOL, V62, P331, DOI 10.1016/j.jjcc.2013.05.015; Sarnak MJ, 2003, HYPERTENSION, V42, P1050, DOI 10.1161/01.HYP.0000102971.85504.7c; Sharples E, 2017, NEPHRON, V137, P73, DOI 10.1159/000481365; Shlipak MG, 2013, NEW ENGL J MED, V369, P932, DOI 10.1056/NEJMoa1214234; Shlipak MG, 2013, AM J KIDNEY DIS, V62, P595, DOI 10.1053/j.ajkd.2013.03.027; SPRINT Research Group, 2015, N Engl J Med, V373, P2103, DOI 10.1056/NEJMoa1511939; Tangri N, 2011, JAMA-J AM MED ASSOC, V305, P1553, DOI 10.1001/jama.2011.451; van der Velde M, 2011, KIDNEY INT, V79, P1341, DOI 10.1038/ki.2010.536; van Diepen M, 2017, NEPHROL DIAL TRANSPL, V32, P1, DOI 10.1093/ndt/gfw459; Welsh C, 2019, CIRCULATION, V140, P542, DOI 10.1161/CIRCULATIONAHA.119.041149; Witte EC, 2009, J AM SOC NEPHROL, V20, P436, DOI 10.1681/ASN.2008030292; Zi MT, 2018, IMMUNOL LETT, V196, P80, DOI 10.1016/j.imlet.2018.01.006	48	93	96	0	20	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2019	25	11					1753	+		10.1038/s41591-019-0627-8	http://dx.doi.org/10.1038/s41591-019-0627-8			15	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	JT2KI	31700174	Green Accepted			2022-12-27	WOS:000500824300035
J	Chemi, F; Rothwell, DG; McGranahan, N; Gulati, S; Abbosh, C; Pearce, SP; Zhou, C; Wilson, GA; Jamal-Hanjani, M; Birkbak, N; Pierce, J; Kim, CS; Ferdous, S; Burt, DJ; Slane-Tan, D; Gomes, F; Moore, D; Shah, R; Al Bakir, M; Hiley, C; Veeriah, S; Summers, Y; Crosbie, P; Ward, S; Mesquita, B; Dynowski, M; Biswas, D; Tugwood, J; Blackhall, F; Miller, C; Hackshaw, A; Brady, G; Swanton, C; Dive, C				Chemi, Francesca; Rothwell, Dominic G.; McGranahan, Nicholas; Gulati, Sakshi; Abbosh, Chris; Pearce, Simon P.; Zhou, Cong; Wilson, Gareth A.; Jamal-Hanjani, Mariam; Birkbak, Nicolai; Pierce, Jackie; Kim, Chang Sik; Ferdous, Saba; Burt, Deborah J.; Slane-Tan, Daniel; Gomes, Fabio; Moore, David; Shah, Rajesh; Al Bakir, Maise; Hiley, Crispin; Veeriah, Selvaraju; Summers, Yvonne; Crosbie, Philip; Ward, Sophia; Mesquita, Barbara; Dynowski, Marek; Biswas, Dhruva; Tugwood, Jonathan; Blackhall, Fiona; Miller, Crispin; Hackshaw, Allan; Brady, Ged; Swanton, Charles; Dive, Caroline		TRACERx Consortium	Pulmonary venous circulating tumor cell dissemination before tumor resection and disease relapse	NATURE MEDICINE			English	Article							CANCER PATIENTS; RECURRENCE; METASTASIS	Approximately 50% of patients with early-stage non-small-cell lung cancer (NSCLC) who undergo surgery with curative intent will relapse within 5 years(1,2). Detection of circulating tumor cells (CTCs) at the time of surgery may represent a tool to identify patients at higher risk of recurrence for whom more frequent monitoring is advised. Here we asked whether CellSearch-detected pulmonary venous CTCs (PV-CTCs) at surgical resection of early-stage NSCLC represent subclones responsible for subsequent disease relapse. PV-CTCs were detected in 48% of 100 patients enrolled into the TRACERx study(3), were associated with lung-cancer-specific relapse and remained an independent predictor of relapse in multivariate analysis adjusted for tumor stage. In a case study, genomic profiling of single PV-CTCs collected at surgery revealed higher mutation overlap with metastasis detected 10 months later (91%) than with the primary tumor (79%), suggesting that early-disseminating PV-CTCs were responsible for disease relapse. Together, PV-CTC enumeration and genomic profiling highlight the potential of PV-CTCs as early predictors of NSCLC recurrence after surgery. However, the limited sensitivity of PV-CTCs in predicting relapse suggests that further studies using a larger, independent cohort are warranted to confirm and better define the potential clinical utility of PV-CTCs in early-stage NSCLC.	[Chemi, Francesca; Rothwell, Dominic G.; Gulati, Sakshi; Pearce, Simon P.; Zhou, Cong; Pierce, Jackie; Kim, Chang Sik; Ferdous, Saba; Burt, Deborah J.; Slane-Tan, Daniel; Mesquita, Barbara; Tugwood, Jonathan; Brady, Ged; Dive, Caroline] Univ Manchester, Canc Res UK Manchester Inst, Clin & Expt Pharmacol Grp, Alderley Pk, Manchester, Lancs, England; [Chemi, Francesca; Gomes, Fabio; Crosbie, Philip; Blackhall, Fiona; Brady, Ged; Dive, Caroline] Univ Manchester, Canc Res UK Lung Canc Ctr Excellence, Manchester, Lancs, England; [McGranahan, Nicholas; Jamal-Hanjani, Mariam; Hiley, Crispin; Swanton, Charles] UCL, Inst Canc, Canc Res UK Lung Canc Ctr Excellence, London, England; [McGranahan, Nicholas; Abbosh, Chris; Wilson, Gareth A.; Jamal-Hanjani, Mariam; Birkbak, Nicolai; Moore, David; Hiley, Crispin; Veeriah, Selvaraju; Hackshaw, Allan; Swanton, Charles] UCL, Inst Canc, London, England; [McGranahan, Nicholas; Wilson, Gareth A.; Birkbak, Nicolai; Al Bakir, Maise; Ward, Sophia; Biswas, Dhruva; Swanton, Charles] Francis Crick Inst, Canc Evolut & Genome Instabil Lab, London, England; [Birkbak, Nicolai] Aarhus Univ, Dept Mol Med, Aarhus, Denmark; [Shah, Rajesh] Manchester Univ NHS Fdn Trust, Wythenshawe Hosp, Dept Thorac Surg, Manchester, Lancs, England; [Summers, Yvonne; Crosbie, Philip; Blackhall, Fiona] Univ Manchester, Fac Biol Med & Hlth, Div Canc Sci, Manchester, Lancs, England; [Crosbie, Philip] Manchester Univ NHS Fdn Trust, Wythenshawe Hosp, North West Lung Ctr, Manchester, Lancs, England; [Dynowski, Marek] Univ Manchester, Canc Res UK Manchester Inst, Sci Comp Core Facil, Alderley Pk, Manchester, Lancs, England; [Miller, Crispin] Univ Manchester, Canc Res UK Manchester Inst, RNA Biol, Alderley Pk, Manchester, Lancs, England	Cancer Research UK; University of Manchester; Cancer Research UK; University of Manchester; Cancer Research UK; University of London; University College London; University of London; University College London; Francis Crick Institute; Aarhus University; Wythenshawe Hospital NHS Foundation Trust; Wythenshawe Hospital; University of Manchester; Wythenshawe Hospital NHS Foundation Trust; Wythenshawe Hospital; Cancer Research UK; University of Manchester; Cancer Research UK; University of Manchester	Brady, G; Dive, C (corresponding author), Univ Manchester, Canc Res UK Manchester Inst, Clin & Expt Pharmacol Grp, Alderley Pk, Manchester, Lancs, England.; Brady, G; Dive, C (corresponding author), Univ Manchester, Canc Res UK Lung Canc Ctr Excellence, Manchester, Lancs, England.; Swanton, C (corresponding author), UCL, Inst Canc, Canc Res UK Lung Canc Ctr Excellence, London, England.; Swanton, C (corresponding author), UCL, Inst Canc, London, England.; Swanton, C (corresponding author), Francis Crick Inst, Canc Evolut & Genome Instabil Lab, London, England.	ged.brady@cruk.manchester.ac.uk; charles.swanton@crick.ac.uk; caroline.dive@cruk.manchester.ac.uk	McGranahan, Nicholas/ABD-6561-2021; Aerts, Hugo/ABF-2821-2020; Blackhall, Fiona/N-2186-2015; Ottensmeier, Christian/E-8131-2012	McGranahan, Nicholas/0000-0001-9537-4045; Aerts, Hugo/0000-0002-2122-2003; Blackhall, Fiona/0000-0001-8716-3395; Quezada, Sergio/0000-0002-9763-1700; Johnson, Diana/0000-0003-0479-1228; Shackcloth, Michael/0000-0002-6494-9907; Birkbak, Nicolai/0000-0003-1613-9587; De Sousa, Paulo/0000-0003-3011-4116; Rothwell, Dominic/0000-0002-8757-3893; Priest, Lynsey/0000-0003-3780-8508; Rathinam, Sridhar/0000-0002-1065-0045; Chemi, Francesca/0000-0002-6652-5243; Escudero, Mickael/0000-0002-1336-815X; Pearce, Simon/0000-0002-1680-5538; Dive, Caroline/0000-0002-1726-8850; Ottensmeier, Christian/0000-0003-3619-1657; Le Quesne, John/0000-0003-3552-7446; Crosbie, Phil/0000-0001-8941-4813; Gomes, Fabio/0000-0003-0922-2665; Navani, Neal/0000-0002-6412-7516; Swanton, Charles/0000-0002-4299-3018	Cancer Research UK [C11496/A17786, C5759/A27412, C5759/A25254, FC001169, FC001202]; CRUK Lung Cancer Centre of Excellence; CANCER-ID Consortium [115749-Cancer-ID]; Menarini Biomarkers Singapore PTE Ltd.; Manchester Experimental Cancer Medicine Centre; Manchester NIHR Biomedical Research Centre; Manchester MRC Single Cell Research Centre [MR/M008908/1]; Francis Crick Institute; UK Medical Research Council [FC001169, FC001202]; Wellcome Trust [FC001169, FC001202]; Cancer Research UK; CRUK Lung Cancer Centre of Excellence, Stand Up 2 Cancer (SU2C); Rosetrees Trust; Butterfield and Stoneygate Trusts; NovoNordisk Foundation [ID16584]; Prostate Cancer Foundation; Breast Cancer Research Foundation (BCRF); European Research Council (ERC) [FP7-THESEUS-617844]; European Commission ITN [607722]; European Research Council [835297]; National Institute for Health Research; University College London Hospitals Biomedical Research Centre; Cancer Research UK University College London Experimental Cancer Medicine Centre; The Francis Crick Institute [10233] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); CRUK Lung Cancer Centre of Excellence; CANCER-ID Consortium; Menarini Biomarkers Singapore PTE Ltd.(Menarini Group); Manchester Experimental Cancer Medicine Centre; Manchester NIHR Biomedical Research Centre(National Institute for Health Research (NIHR)); Manchester MRC Single Cell Research Centre(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Francis Crick Institute; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); Cancer Research UK(Cancer Research UK); CRUK Lung Cancer Centre of Excellence, Stand Up 2 Cancer (SU2C); Rosetrees Trust(Rosetrees Trust); Butterfield and Stoneygate Trusts; NovoNordisk Foundation(Novo Nordisk FoundationNovocure Limited); Prostate Cancer Foundation; Breast Cancer Research Foundation (BCRF); European Research Council (ERC)(European Research Council (ERC)European Commission); European Commission ITN; European Research Council(European Research Council (ERC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); University College London Hospitals Biomedical Research Centre(General Electric); Cancer Research UK University College London Experimental Cancer Medicine Centre; The Francis Crick Institute	We sincerely thank the patients and their families for donating blood samples for research. We thank E. Aidaros-Talbot for administrative assistance with the manuscript. We also thank J. Shaw for kindly providing plasma (relapse time point) of patient CRUK0242. TRACERx is funded by Cancer Research UK (grant C11496/A17786). This research was supported by Cancer Research UK-Core funding to the CRUK Manchester Institute (C5759/A27412) Centre, funding to the CRUK Manchester Centre (C5759/A25254) and funding of the CRUK Lung Cancer Centre of Excellence. Support was also received from the Manchester Experimental Cancer Medicine Centre and Manchester NIHR Biomedical Research Centre. F.C. is funded by the CANCER-ID Consortium (115749-Cancer-ID). B.M. is funded by Menarini Biomarkers Singapore PTE Ltd. C.S.K. is funded by The Manchester MRC Single Cell Research Centre (MR/M008908/1). C.S. is Royal Society Napier Research Professor. This work was supported by the Francis Crick Institute, which receives its core funding from Cancer Research UK (FC001169, FC001202), the UK Medical Research Council (FC001169, FC001202) and the Wellcome Trust (FC001169, FC001202). C.S. is funded by Cancer Research UK (TRACERx and CRUK Cancer Immunotherapy Catalyst Network), the CRUK Lung Cancer Centre of Excellence, Stand Up 2 Cancer (SU2C), the Rosetrees Trust, the Butterfield and Stoneygate Trusts, NovoNordisk Foundation (ID16584), the Prostate Cancer Foundation and the Breast Cancer Research Foundation (BCRF). The research leading to these results has received funding from the European Research Council (ERC) under the European Union's Seventh Framework Programme (FP7/2007-2013) Consolidator Grant (FP7-THESEUS-617844), European Commission ITN (FP7PloidyNet 607722), an ERC Advanced Grant (PROTEUS) from the European Research Council under the European Union's Horizon 2020 research and innovation programme (grant agreement 835297). Support was also provided to C. S. by the National Institute for Health Research, the University College London Hospitals Biomedical Research Centre and the Cancer Research UK University College London Experimental Cancer Medicine Centre.	Abbosh C, 2017, NATURE, V545, P446, DOI 10.1038/nature22364; Aceto N, 2015, TRENDS CANCER, V1, P44, DOI 10.1016/j.trecan.2015.07.006; Altman DG, 2012, BMC MED, V10, DOI [10.1186/1741-7015-10-51, 10.1371/journal.pmed.1001216]; Andrews S., 2010, FASTQC QUALITY CONTR; Baccelli I, 2013, NAT BIOTECHNOL, V31, P539, DOI 10.1038/nbt.2576; Cibulskis K, 2013, NAT BIOTECHNOL, V31, P213, DOI 10.1038/nbt.2514; Crosbie PAJ, 2016, J THORAC ONCOL, V11, P1793, DOI 10.1016/j.jtho.2016.06.017; Deleye L, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19509-5; GILL R, 1987, BIOMETRIKA, V74, P289, DOI 10.2307/2336143; Girotti MR, 2016, CANCER DISCOV, V6, P286, DOI 10.1158/2159-8290.CD-15-1336; Ha G, 2012, GENOME RES, V22, P1995, DOI 10.1101/gr.137570.112; Heagerty PJ, 2005, BIOMETRICS, V61, P92, DOI 10.1111/j.0006-341X.2005.030814.x; Heitzer E, 2013, CANCER RES, V73, P2965, DOI 10.1158/0008-5472.CAN-12-4140; Hodgkinson C, 2015, LUNG CANCER, V87, pS1, DOI 10.1016/S0169-5002(15)50001-9; Jamal-Hanjani M, 2017, NEW ENGL J MED, V376, P2109, DOI 10.1056/NEJMoa1616288; Jamal-Hanjani M, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001906; Kassambara A., 2017, R PACKAGE VERSION 0; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Lin CW, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2876; Lohr JG, 2014, NAT BIOTECHNOL, V32, P479, DOI 10.1038/nbt.2892; Mesquita B, 2017, MOL ONCOL, V11, P1687, DOI 10.1002/1878-0261.12113; Mohan S, 2017, TRANSL LUNG CANCER R, V6, P454, DOI 10.21037/tlcr.2017.06.04; Morrow CJ, 2016, ANN ONCOL, V27, P1155, DOI 10.1093/annonc/mdw122; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; R Code Team, 2013, R LANG ENV STAT COMP; Romero-Palacios PJ, 2019, CRIT REV ONCOL HEMAT, V136, P31, DOI 10.1016/j.critrevonc.2019.02.003; Rothwell DG, 2016, MOL ONCOL, V10, P566, DOI 10.1016/j.molonc.2015.11.006; Siegel RL, 2017, CA-CANCER J CLIN, V67, P7, DOI 10.3322/caac.21387; Tamborero D, 2018, GENOME MED, V10, DOI 10.1186/s13073-018-0531-8; Taylor MD, 2012, ANN THORAC SURG, V93, P1813, DOI 10.1016/j.athoracsur.2012.03.031; Therneau T., 2015, PACKAGE SURVIVAL ANA; THERNEAU TM, 1990, BIOMETRIKA, V77, P147, DOI 10.1093/biomet/77.1.147; Uramoto H, 2014, TRANSL LUNG CANCER R, V3, P242, DOI 10.3978/j.issn.2218-6751.2013.12.05; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603	34	94	101	4	59	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	OCT	2019	25	10					1534	+		10.1038/s41591-019-0593-1	http://dx.doi.org/10.1038/s41591-019-0593-1			12	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	JC3GJ	31591595	Green Submitted, Green Accepted			2022-12-27	WOS:000489166700022
J	Joshi, K; de Massy, MR; Ismail, M; Reading, JL; Uddin, I; Woolston, A; Hatipoglu, E; Oakes, T; Rosenthal, R; Peacock, T; Ronel, T; Noursadeghi, M; Turati, V; Furness, AJS; Georgiou, A; Wong, YNS; Ben Aissa, A; Sunderland, MW; Jamal-Hanjani, M; Veeriah, S; Birkbak, NJ; Wilson, GA; Hiley, CT; Ghorani, E; Guerra-Assuncao, JA; Herrero, J; Enver, T; Hadrup, SR; Hackshaw, A; Peggs, KS; McGranahan, N; Swanton, C; Quezada, SA; Chain, B				Joshi, Kroopa; de Massy, Marc Robert; Ismail, Mazlina; Reading, James L.; Uddin, Imran; Woolston, Annemarie; Hatipoglu, Emine; Oakes, Theres; Rosenthal, Rachel; Peacock, Thomas; Ronel, Tahel; Noursadeghi, Mahdad; Turati, Virginia; Furness, Andrew J. S.; Georgiou, Andrew; Wong, Yien Ning Sophia; Ben Aissa, Assma; Sunderland, Mariana Werner; Jamal-Hanjani, Mariam; Veeriah, Selvaraju; Birkbak, Nicolai J.; Wilson, Gareth A.; Hiley, Crispin T.; Ghorani, Ehsan; Guerra-Assuncao, Jose Afonso; Herrero, Javier; Enver, Tariq; Hadrup, Sine R.; Hackshaw, Allan; Peggs, Karl S.; McGranahan, Nicholas; Swanton, Charles; Quezada, Sergio A.; Chain, Benny		TRACERx Consortium	Spatial heterogeneity of the T cell receptor repertoire reflects the mutational landscape in lung cancer	NATURE MEDICINE			English	Article							TUMOR-INFILTRATING LYMPHOCYTES; INTRATUMOR HETEROGENEITY; BLOCKADE; FEATURES; REVEALS; EVOLUTION; SEQUENCES; RESPONSES	Somatic mutations together with immunoediting drive extensive heterogeneity within non-small-cell lung cancer (NSCLC). Herein we examine heterogeneity of the T cell antigen receptor (TCR) repertoire. The number of TCR sequences selectively expanded in tumors varies within and between tumors and correlates with the number of nonsynonymous mutations. Expanded TCRs can be subdivided into TCRs found in all tumor regions (ubiquitous) and those present in a subset of regions (regional). The number of ubiquitous and regional TCRs correlates with the number of ubiquitous and regional nonsynonymous mutations, respectively. Expanded TCRs form part of clusters of TCRs of similar sequence, suggestive of a spatially constrained antigen-driven process. CD8(+) tumor-infiltrating lymphocytes harboring ubiquitous TCRs display a dysfunctional tissue-resident phenotype. Ubiquitous TCRs are preferentially detected in the blood at the time of tumor resection as compared to routine follow-up. These findings highlight a noninvasive method to identify and track relevant tumor-reactive TCRs for use in adoptive T cell immunotherapy.	[Joshi, Kroopa; de Massy, Marc Robert; Reading, James L.; Hatipoglu, Emine; Furness, Andrew J. S.; Georgiou, Andrew; Wong, Yien Ning Sophia; Ben Aissa, Assma; Sunderland, Mariana Werner; Ghorani, Ehsan; Peggs, Karl S.; Quezada, Sergio A.] UCL, Dept Res Haematol, Canc Immunol Unit, Inst Canc, London, England; [Joshi, Kroopa; Hatipoglu, Emine; Furness, Andrew J. S.] Royal Marsden NHS Fdn Trust, Dept Med Oncol, London, England; [Ismail, Mazlina; Uddin, Imran; Woolston, Annemarie; Oakes, Theres; Peacock, Thomas; Ronel, Tahel; Noursadeghi, Mahdad; Chain, Benny] UCL, Div Infect & Immun, London, England; [Rosenthal, Rachel; Ben Aissa, Assma; Jamal-Hanjani, Mariam; Veeriah, Selvaraju; Wilson, Gareth A.; Hiley, Crispin T.; Hackshaw, Allan; McGranahan, Nicholas; Swanton, Charles; Quezada, Sergio A.] UCL, Canc Res UK Lung Canc Ctr Excellence, Inst Canc, London, England; [Rosenthal, Rachel; Guerra-Assuncao, Jose Afonso; Herrero, Javier] UCL, Bill Lyons Informat Ctr, Inst Canc, London, England; [Peacock, Thomas] UCL, Dept Comp Sci, Computat Math & Phys Life Sci & Expt Biol, London, England; [Turati, Virginia] UCL, Dept Canc Biol, Inst Canc, London, England; [Birkbak, Nicolai J.; Wilson, Gareth A.; Swanton, Charles] Francis Crick Inst, Canc Evolut & Genome Instabil Lab, London, England; [Enver, Tariq] UCL, Inst Canc, London, England; [Hadrup, Sine R.] Tech Univ Denmark, Dept Hlth Technol, Lyngby, Denmark; [Chain, Benny] UCL, Dept Comp Sci, London, England	University of London; University College London; Royal Marsden NHS Foundation Trust; University of London; University College London; Cancer Research UK; University of London; University College London; University of London; University College London; University of London; University College London; University of London; University College London; Francis Crick Institute; University of London; University College London; Technical University of Denmark; University of London; University College London	Quezada, SA (corresponding author), UCL, Dept Res Haematol, Canc Immunol Unit, Inst Canc, London, England.; Chain, B (corresponding author), UCL, Div Infect & Immun, London, England.; Swanton, C; Quezada, SA (corresponding author), UCL, Canc Res UK Lung Canc Ctr Excellence, Inst Canc, London, England.; Swanton, C (corresponding author), Francis Crick Inst, Canc Evolut & Genome Instabil Lab, London, England.; Chain, B (corresponding author), UCL, Dept Comp Sci, London, England.	c.swanton@crick.ac.uk; s.quezada@ucl.ac.uk; b.chain@ucl.ac.uk	Quezada, Sergio/ABF-6466-2020; McGranahan, Nicholas/ABD-6561-2021; Aerts, Hugo/ABF-2821-2020; Herrero, Javier/H-6971-2019; Ottensmeier, Christian/E-8131-2012; Hadrup, Sine Reker/P-3388-2014	Quezada, Sergio/0000-0002-9763-1700; McGranahan, Nicholas/0000-0001-9537-4045; Aerts, Hugo/0000-0002-2122-2003; Herrero, Javier/0000-0001-7313-717X; Ottensmeier, Christian/0000-0003-3619-1657; Navani, Neal/0000-0002-6412-7516; Shackcloth, Michael/0000-0002-6494-9907; Le Quesne, John/0000-0003-3552-7446; Robert de Massy, Marc/0000-0002-3048-1680; Swanton, Charles/0000-0002-4299-3018; De Sousa, Paulo/0000-0003-3011-4116; Uddin, Imran/0000-0003-0736-3149; Birkbak, Nicolai/0000-0003-1613-9587; Crosbie, Phil/0000-0001-8941-4813; Johnson, Diana/0000-0003-0479-1228; Rathinam, Sridhar/0000-0002-1065-0045; Noursadeghi, Mahdad/0000-0002-4774-0853; Peacock, Thomas/0000-0001-9385-116X; Hadrup, Sine Reker/0000-0002-5937-4344; Turati, Virginia/0000-0002-1013-9490; Ben Aissa, Assma/0000-0002-8190-9683; Ronel, Tahel/0000-0002-9513-9181; Priest, Lynsey/0000-0003-3780-8508	Cancer Immunotherapy Accelerator Award [C33499/A20265]; CRUK's Lung Cancer Centre of Excellence [C5759/A20465]; National Institute for Health Research UCL Hospitals Biomedical Research Centre; Cancer Research UK (CRUK); CRUK Senior Cancer Research Fellowship [C36463/A22246]; Sam Keen Foundation; Institute of Cancer Research Biomedical Research Centre; Royal Marsden Cancer Charity; UCL Biomedical Research Centre; Cancer Research UK studentship; MRC Clinical Infrastructure award [MR/M009033/1]; Rosetrees and Stoneygate Trust [A1388]; CRUK Biotherapeutics Programme grant [C36463/A20764]; Khoo Teck Puat UK Foundation via the UCL Cancer Institute Research Trust [539288]; ERC [StG 677268 NextDART]; Royal Society Napier Research Professor; Francis Crick Institute; Cancer Research UK; UK Medical Research Council [FC001169]; Wellcome Trust [FC001169]; CRUK Cancer Immunotherapy Catalyst Network; CRUK Lung Cancer Centre of Excellence, Stand Up 2 Cancer (SU2C); Rosetrees Trust; Stoneygate Trusts; NovoNordisk Foundation [ID16584]; Prostate Cancer Foundation; Breast Cancer Research Foundation (BCRF); European Research Council (ERC) [FP7-THESEUS-617844]; European Commission ITN [607722]; ERC Advanced Grant (PROTEUS) from the European Research Council under the European Union [835297]; National Institute for Health Research; University College London Hospitals Biomedical Research Centre; Cancer Research UK University College London Experimental Cancer Medicine Centre; MRC [MR/M009033/1, MR/N000838/1] Funding Source: UKRI; The Francis Crick Institute [10233] Funding Source: researchfish	Cancer Immunotherapy Accelerator Award; CRUK's Lung Cancer Centre of Excellence; National Institute for Health Research UCL Hospitals Biomedical Research Centre; Cancer Research UK (CRUK)(Cancer Research UK); CRUK Senior Cancer Research Fellowship; Sam Keen Foundation; Institute of Cancer Research Biomedical Research Centre; Royal Marsden Cancer Charity(Royal Society of New ZealandMarsden Fund (NZ)); UCL Biomedical Research Centre; Cancer Research UK studentship(Cancer Research UK); MRC Clinical Infrastructure award(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Rosetrees and Stoneygate Trust(Rosetrees Trust); CRUK Biotherapeutics Programme grant; Khoo Teck Puat UK Foundation via the UCL Cancer Institute Research Trust; ERC(European Research Council (ERC)European Commission); Royal Society Napier Research Professor; Francis Crick Institute; Cancer Research UK(Cancer Research UK); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); CRUK Cancer Immunotherapy Catalyst Network; CRUK Lung Cancer Centre of Excellence, Stand Up 2 Cancer (SU2C); Rosetrees Trust(Rosetrees Trust); Stoneygate Trusts; NovoNordisk Foundation(Novo Nordisk FoundationNovocure Limited); Prostate Cancer Foundation; Breast Cancer Research Foundation (BCRF); European Research Council (ERC)(European Research Council (ERC)European Commission); European Commission ITN; ERC Advanced Grant (PROTEUS) from the European Research Council under the European Union; National Institute for Health Research(National Institute for Health Research (NIHR)); University College London Hospitals Biomedical Research Centre(General Electric); Cancer Research UK University College London Experimental Cancer Medicine Centre; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); The Francis Crick Institute	This work was undertaken with support from the Cancer Immunotherapy Accelerator Award (CITA-CRUK; C33499/A20265), CRUK's Lung Cancer Centre of Excellence (C5759/A20465), the National Institute for Health Research UCL Hospitals Biomedical Research Centre (B.C., C.S., S.A.Q., M.N.), a Cancer Research UK (CRUK) Project Grant (B.C.), a CRUK Senior Cancer Research Fellowship (S.A.Q.; C36463/A22246), the Sam Keen Foundation, the Royal Marsden Hospital NHS Foundation Trust and Institute of Cancer Research Biomedical Research Centre, the Royal Marsden Cancer Charity, the UCL Biomedical Research Centre (K.J.), a Cancer Research UK studentship (M.R.D.M.) and an MRC Clinical Infrastructure award (MR/M009033/1). S.A.Q. receives funding from the Rosetrees and Stoneygate Trust (A1388), a CRUK Biotherapeutics Programme grant (C36463/A20764) and a donation from the Khoo Teck Puat UK Foundation via the UCL Cancer Institute Research Trust (539288). S.R.H. was supported by the ERC grant StG 677268 NextDART. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the article. C.S. is Royal Society Napier Research Professor. This work was supported by the Francis Crick Institute, which receives its core funding from Cancer Research UK (FC001169, FC001202), the UK Medical Research Council (FC001169, FC001202) and the Wellcome Trust (FC001169, FC001202). C.S. is funded by Cancer Research UK (TRACERx and CRUK Cancer Immunotherapy Catalyst Network), the CRUK Lung Cancer Centre of Excellence, Stand Up 2 Cancer (SU2C), the Rosetrees Trust, the Butterfield and Stoneygate Trusts, NovoNordisk Foundation (ID16584), the Prostate Cancer Foundation and the Breast Cancer Research Foundation (BCRF). The research leading to these results has received funding from the European Research Council (ERC) under the European Union's Seventh Framework Programme (FP7/2007-2013) Consolidator Grant (FP7-THESEUS-617844), European Commission ITN (FP7-PloidyNet 607722), an ERC Advanced Grant (PROTEUS) from the European Research Council under the European Union's Horizon 2020 research and innovation programme (grant agreement 835297). Support was also provided to C.S. by the National Institute for Health Research, the University College London Hospitals Biomedical Research Centre and the Cancer Research UK University College London Experimental Cancer Medicine Centre. We thank all the patients who participated in this study and all members of the TRACERx Consortium.	Ahmadzadeh M, 2019, SCI IMMUNOL, V4, DOI 10.1126/sciimmunol.aao4310; Anagnostou V, 2017, CANCER DISCOV, V7, P264, DOI 10.1158/2159-8290.CD-16-0828; Bai XL, 2015, SCI REP-UK, V5, DOI 10.1038/srep13664; Balachandran VP, 2017, NATURE, V551, P512, DOI 10.1038/nature24462; Bengsch B, 2018, IMMUNITY, V48, P1029, DOI 10.1016/j.immuni.2018.04.026; Bengsch B, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000947; Best K, 2015, SCI REP-UK, V5, DOI 10.1038/srep14629; Cha E, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008211; Cui C, 2019, CANCER SCI, V110, P61, DOI 10.1111/cas.13877; Cui JH, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02729; Dash P, 2017, NATURE, V547, P89, DOI 10.1038/nature22383; Emerson RO, 2013, J PATHOL, V231, P433, DOI 10.1002/path.4260; Feng L, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05538-z; Ganesan AP, 2017, NAT IMMUNOL, V18, P940, DOI 10.1038/ni.3775; Gerlinger M, 2013, J PATHOL, V231, P424, DOI 10.1002/path.4284; Glanville J, 2017, NATURE, V547, P94, DOI 10.1038/nature22976; Gros A, 2014, J CLIN INVEST, V124, P2246, DOI [10.1172/JC173639, 10.1172/JCI73639]; Hogan SA, 2019, CANCER IMMUNOL RES, V7, P77, DOI 10.1158/2326-6066.CIR-18-0136; Hopkins AC, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.122092; Huang AC, 2017, NATURE, V545, P60, DOI 10.1038/nature22079; Jamal-Hanjani M, 2017, NEW ENGL J MED, V376, P2109, DOI 10.1056/NEJMoa1616288; Jamal-Hanjani M, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001906; Jimenez-Sanchez A, 2017, CELL, V170, P927, DOI 10.1016/j.cell.2017.07.025; Jin YB, 2018, CANCER IMMUNOL IMMUN, V67, P1719, DOI 10.1007/s00262-018-2237-6; Kuang MC, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08289-z; Kvistborg P, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008918; Lavin Y, 2017, CELL, V169, P750, DOI 10.1016/j.cell.2017.04.014; Lin KR, 2018, CANCER MED-US, V7, P3755, DOI 10.1002/cam4.1610; McGranahan N, 2016, SCIENCE, V351, P1463, DOI 10.1126/science.aaf1490; Miao D, 2018, NAT GENET, V50, P1271, DOI 10.1038/s41588-018-0200-2; Oakes T, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01267; Pasetto A, 2016, CANCER IMMUNOL RES, V4, P734, DOI 10.1158/2326-6066.CIR-16-0001; Reuben A, 2017, CANCER DISCOV, V7, P1088, DOI 10.1158/2159-8290.CD-17-0256; Reuben A, 2017, NPJ GENOM MED, V2, DOI 10.1038/s41525-017-0013-8; Robert L, 2014, CLIN CANCER RES, V20, P2424, DOI 10.1158/1078-0432.CCR-13-2648; Rosenthal R, 2019, NATURE, V567, P479, DOI 10.1038/s41586-019-1032-7; Scheper W, 2019, NAT MED, V25, P89, DOI 10.1038/s41591-018-0266-5; Sherwood AM, 2013, CANCER IMMUNOL IMMUN, V62, P1453, DOI 10.1007/s00262-013-1446-2; Simoni Y, 2018, NATURE, V557, P575, DOI 10.1038/s41586-018-0130-2; Snyder A, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002309; Sun YX, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00430; Thomas N, 2013, BIOINFORMATICS, V29, P542, DOI 10.1093/bioinformatics/btt004; Thommen DS, 2018, NAT MED, V24, P994, DOI 10.1038/s41591-018-0057-z; Tumeh PC, 2014, NATURE, V515, P568, DOI 10.1038/nature13954; Uddin I, 2019, METHODS MOL BIOL, V1884, P15, DOI 10.1007/978-1-4939-8885-3_2; Wang T, 2017, CANCER IMMUNOL RES, V5, P148, DOI 10.1158/2326-6066.CIR-16-0107; Yusko E, 2019, CANCER IMMUNOL RES, V7, P458, DOI 10.1158/2326-6066.CIR-18-0226; Zhang CT, 2019, INT J CANCER, V144, P818, DOI 10.1002/ijc.31760	48	84	87	1	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	OCT	2019	25	10					1549	+		10.1038/s41591-019-0592-2	http://dx.doi.org/10.1038/s41591-019-0592-2			27	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	JC3GJ	31591606	Green Accepted, Green Submitted			2022-12-27	WOS:000489166700024
J	Wong, M; Mayoh, C; Lau, LMS; Khuong-Quang, DA; Pinese, M; Kumar, A; Barahona, P; Wilkie, EE; Sullivan, P; Bowen-James, R; Syed, M; Martincorena, I; Abascal, F; Sherstyuk, A; Bolanos, NA; Baber, J; Priestley, P; Dolman, MEM; Fleuren, EDG; Gauthier, ME; Mould, EVA; Gayevskiy, V; Gifford, AJ; Grebert-Wade, D; Strong, PA; Manouvrier, E; Warby, M; Thomas, DM; Kirk, J; Tucker, K; O'Brien, T; Alvaro, F; McCowage, GB; Dalla-Pozza, L; Gottardo, NG; Tapp, H; Wood, P; Khaw, SL; Hansford, JR; Moore, AS; Norris, MD; Trahair, TN; Lock, RB; Tyrrell, V; Haber, M; Marshall, GM; Ziegler, DS; Ekert, PG; Cowley, MJ				Wong, Marie; Mayoh, Chelsea; Lau, Loretta M. S.; Khuong-Quang, Dong-Anh; Pinese, Mark; Kumar, Amit; Barahona, Paulette; Wilkie, Emilie E.; Sullivan, Patricia; Bowen-James, Rachel; Syed, Mustafa; Martincorena, Inigo; Abascal, Federico; Sherstyuk, Alexandra; Bolanos, Noemi A.; Baber, Jonathan; Priestley, Peter; Dolman, M. Emmy M.; Fleuren, Emmy D. G.; Gauthier, Marie-Emilie; Mould, Emily V. A.; Gayevskiy, Velimir; Gifford, Andrew J.; Grebert-Wade, Dylan; Strong, Patrick A.; Manouvrier, Elodie; Warby, Meera; Thomas, David M.; Kirk, Judy; Tucker, Katherine; O'Brien, Tracey; Alvaro, Frank; McCowage, Geoffry B.; Dalla-Pozza, Luciano; Gottardo, Nicholas G.; Tapp, Heather; Wood, Paul; Khaw, Seong-Lin; Hansford, Jordan R.; Moore, Andrew S.; Norris, Murray D.; Trahair, Toby N.; Lock, Richard B.; Tyrrell, Vanessa; Haber, Michelle; Marshall, Glenn M.; Ziegler, David S.; Ekert, Paul G.; Cowley, Mark J.			Whole genome, transcriptome and methylome profiling enhances actionable target discovery in high-risk pediatric cancer	NATURE MEDICINE			English	Article							AMINO-ACID SUBSTITUTIONS; CLINICAL INTERPRETATION; SOLID TUMORS; MUTATIONS; LANDSCAPE; MEDICINE; ONCOLOGY; THERAPY; ADULTS; SERVER	The Zero Childhood Cancer Program is a precision medicine program to benefit children with poor-outcome, rare, relapsed or refractory cancer. Using tumor and germline whole genome sequencing (WGS) and RNA sequencing (RNAseq) across 252 tumors from high-risk pediatric patients with cancer, we identified 968 reportable molecular aberrations (39.9% in WGS and RNAseq, 35.1% in WGS only and 25.0% in RNAseq only). Of these patients, 93.7% had at least one germline or somatic aberration, 71.4% had therapeutic targets and 5.2% had a change in diagnosis. WGS identified pathogenic cancer-predisposing variants in 16.2% of patients. In 76 central nervous system tumors, methylome analysis confirmed diagnosis in 71.1% of patients and contributed to a change of diagnosis in two patients (2.6%). To date, 43 patients have received a recommended therapy, 38 of whom could be evaluated, with 31% showing objective evidence of clinical benefit. Comprehensive molecular profiling resolved the molecular basis of virtually all high-risk cancers, leading to clinical benefit in some patients. The Zero Childhood Cancer pediatric precision medicine program informs treatment recommendations for children with high-risk cancers through comprehensive molecular profiling	[Wong, Marie; Mayoh, Chelsea; Lau, Loretta M. S.; Pinese, Mark; Kumar, Amit; Barahona, Paulette; Wilkie, Emilie E.; Sullivan, Patricia; Bowen-James, Rachel; Syed, Mustafa; Sherstyuk, Alexandra; Bolanos, Noemi A.; Dolman, M. Emmy M.; Fleuren, Emmy D. G.; Gauthier, Marie-Emilie; Mould, Emily V. A.; Gifford, Andrew J.; Grebert-Wade, Dylan; Strong, Patrick A.; Manouvrier, Elodie; Norris, Murray D.; Trahair, Toby N.; Lock, Richard B.; Tyrrell, Vanessa; Haber, Michelle; Marshall, Glenn M.; Ziegler, David S.; Ekert, Paul G.; Cowley, Mark J.] UNSW Sydney, Childrens Canc Inst, Lowy Canc Ctr, Kensington, NSW, Australia; [Wong, Marie; Mayoh, Chelsea; Lau, Loretta M. S.; Pinese, Mark; Wilkie, Emilie E.; Bolanos, Noemi A.; Fleuren, Emmy D. G.; Gifford, Andrew J.; O'Brien, Tracey; Norris, Murray D.; Trahair, Toby N.; Lock, Richard B.; Haber, Michelle; Marshall, Glenn M.; Ziegler, David S.; Ekert, Paul G.; Cowley, Mark J.] UNSW Sydney, Sch Womens & Childrens Hlth, Kensington, NSW, Australia; [Wong, Marie; Pinese, Mark; Gayevskiy, Velimir; Thomas, David M.; Cowley, Mark J.] Garvan Inst Med Res, Kinghorn Ctr Clin Genom, Darlinghurst, NSW, Australia; [Lau, Loretta M. S.; Bolanos, Noemi A.; O'Brien, Tracey; Trahair, Toby N.; Marshall, Glenn M.; Ziegler, David S.] Sydney Childrens Hosp, Kids Canc Ctr, Randwick, NSW, Australia; [Khuong-Quang, Dong-Anh; Khaw, Seong-Lin; Hansford, Jordan R.] Royal Childrens Hosp, Childrens Canc Ctr, Parkville, Vic, Australia; [Khuong-Quang, Dong-Anh; Khaw, Seong-Lin; Ekert, Paul G.] Royal Childrens Hosp, Murdoch Childrens Res Inst, Parkville, Vic, Australia; [Kumar, Amit; Ekert, Paul G.] Peter MacCallum Canc Ctr, Melbourne, Vic, Australia; [Martincorena, Inigo; Abascal, Federico] Wellcome Trust Sanger Inst, Hinxton, England; [Baber, Jonathan; Priestley, Peter] Hartwig Med Fdn, Amsterdam, Netherlands; [Baber, Jonathan; Priestley, Peter] Hartwig Med Fdn Australia, Sydney, NSW, Australia; [Gifford, Andrew J.] Prince Wales Hosp, Dept Anat Pathol, Randwick, NSW, Australia; [Warby, Meera; McCowage, Geoffry B.; Dalla-Pozza, Luciano] Childrens Hosp Westmead, Canc Ctr Children, Westmead, NSW, Australia; [Kirk, Judy] Westmead Hosp, Crown Princess Mary Canc Ctr, Familial Canc Serv, Westmead, NSW, Australia; [Kirk, Judy] Univ Sydney, Sydney Med Sch, Ctr Canc Res, Westmead Inst Med Res, Westmead, NSW, Australia; [Tucker, Katherine] Prince Wales Hosp, Hereditary Canc Ctr, Randwick, NSW, Australia; [Tucker, Katherine] Univ New South Wales, Prince Wales Hosp, Clin Sch, Randwick, NSW, Australia; [Alvaro, Frank] John Hunter Childrens Hosp, New Lambton Hts, NSW, Australia; [Gottardo, Nicholas G.] Perth Childrens Hosp, Dept Paediat & Adolescent Oncol Haematol, Nedlands, WA, Australia; [Gottardo, Nicholas G.] Telethon Kids Inst, Brain Tumour Res Program, Nedlands, WA, Australia; [Tapp, Heather] Womens & Childrens Hosp, Adelaide, SA, Australia; [Wood, Paul] Monash Childrens Hosp, Melbourne, Vic, Australia; [Moore, Andrew S.] Queensland Childrens Hosp, Oncol Serv, Brisbane, Qld, Australia; [Moore, Andrew S.] Univ Queensland, Child Hlth Res Ctr, Brisbane, Qld, Australia; [Norris, Murray D.] Univ New South Wales, Ctr Childhood Canc Res, UNSW Sydney, Kensington, NSW, Australia	Children's Cancer Institute; University of New South Wales Sydney; University of New South Wales Sydney; Garvan Institute of Medical Research; Royal Children's Hospital Melbourne; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; Peter Maccallum Cancer Center; Wellcome Trust Sanger Institute; University of Sydney; University of Sydney; University of Sydney; Westmead Institute for Medical Research; University of New South Wales Sydney; Telethon Kids Institute; Womens & Childrens Hospital Australia; University of Queensland; University of New South Wales Sydney	Ziegler, DS; Ekert, PG; Cowley, MJ (corresponding author), UNSW Sydney, Childrens Canc Inst, Lowy Canc Ctr, Kensington, NSW, Australia.; Ziegler, DS; Ekert, PG; Cowley, MJ (corresponding author), UNSW Sydney, Sch Womens & Childrens Hlth, Kensington, NSW, Australia.; Cowley, MJ (corresponding author), Garvan Inst Med Res, Kinghorn Ctr Clin Genom, Darlinghurst, NSW, Australia.; Ziegler, DS (corresponding author), Sydney Childrens Hosp, Kids Canc Ctr, Randwick, NSW, Australia.; Ekert, PG (corresponding author), Royal Childrens Hosp, Murdoch Childrens Res Inst, Parkville, Vic, Australia.; Ekert, PG (corresponding author), Peter MacCallum Canc Ctr, Melbourne, Vic, Australia.	d.ziegler@unsw.edu.au; pekert@ccia.org.au; mcowley@ccia.org.au	McCowage, Geoffrey/ABB-5072-2020; Fleuren, Emmy/AAE-3463-2021; Ekert, Paul/Q-1842-2015; Mayoh, Chelsea/AAE-7349-2021; Thomas, David/AAD-2877-2019; Moore, Andrew S/I-6275-2012; Fleuren, Emmy/C-5799-2018	McCowage, Geoffrey/0000-0003-3471-8443; Ekert, Paul/0000-0002-2976-8617; Mayoh, Chelsea/0000-0002-6398-3046; Thomas, David/0000-0002-2527-5428; Moore, Andrew S/0000-0001-8062-1779; Gottardo, Nicholas/0000-0002-1082-6776; Ziegler, David/0000-0001-7451-7916; Fleuren, Emmy/0000-0001-6202-6861; Sullivan, Patricia/0000-0002-4886-8883; Lock, Richard/0000-0002-3436-9071; Bowen-James, Rachel/0000-0002-9062-3644; Hansford, Jordan/0000-0001-7733-383X; Alvaro, Frank/0000-0003-2828-8758; Wilkie, Emilie/0000-0002-6008-8193; Martincorena, Inigo/0000-0003-1122-4416; Khuong Quang, Dong Anh/0000-0001-6305-7790; Lau, Loretta/0000-0002-3172-0970; Pinese, Mark/0000-0001-5078-6687; Dolman, Emmy/0000-0002-0567-5918; Haber, Michelle/0000-0003-2036-8817; Baber, Jonathan/0000-0002-5238-7994; Wong-Erasmus, Marie/0000-0003-0066-6606; Trahair, Toby/0000-0002-3295-228X; Cowley, Mark/0000-0002-9519-5714	Australian Government; Australian Federal Government Department of Health; New South Wales State Government; Australian Cancer Research Foundation; Kids Cancer Alliance, Cancer Therapeutics Cooperative Research Centre; Steven Walter Children's Cancer Foundation; Hyundai Help 4 Kids Foundation; Lions International; ALCCRF; University of New South Wales; Australian Genomics Health Alliance; New South Wales Ministry of Health; Medical Research Future Fund; Australian Brain Cancer Mission; Minderoo Foundation's Collaborate Against Cancer Initiative; Zero Childhood Cancer Capacity Campaign; Children's Cancer Institute; Sydney Children's Hospital Foundation; National Health and Medical Research Council of Australia [APP1059804, APP1157871]; Cancer Institute of New South Wales; New South Wales Health; Cancer Australia; My Room [1165556]	Australian Government(Australian GovernmentCGIAR); Australian Federal Government Department of Health; New South Wales State Government; Australian Cancer Research Foundation; Kids Cancer Alliance, Cancer Therapeutics Cooperative Research Centre; Steven Walter Children's Cancer Foundation; Hyundai Help 4 Kids Foundation; Lions International; ALCCRF; University of New South Wales; Australian Genomics Health Alliance; New South Wales Ministry of Health; Medical Research Future Fund(Medical Research Future Fund (MRFF)); Australian Brain Cancer Mission; Minderoo Foundation's Collaborate Against Cancer Initiative; Zero Childhood Cancer Capacity Campaign; Children's Cancer Institute; Sydney Children's Hospital Foundation; National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Cancer Institute of New South Wales; New South Wales Health; Cancer Australia; My Room	We sincerely thank patients and parents for participating in this study. We thank the many clinicians and health professionals for their time acquiring consenting patients and for collection and coordination of samples and associated clinical data at Sydney Children's Hospital, Randwick; The Children's Hospital at Westmead; the John Hunter Hospital; the Queensland Children's Hospital; the Royal Children's Hospital Melbourne; the Monash Children's Hospital; the Adelaide Women's & Children's Hospital; and the Perth Children's Hospital. We thank M. Weber (Prince of Wales Hospital) for assistance with anatomical pathology expert input. The authors thank the Sydney Children's Tumour Bank Network for providing samples and related clinical information for this study. We thank the staff of the Personalised Medicine Theme of the Children's Cancer Institute for their dedicated work on Zero Childhood Cancer. We thank M. Dinger, B. Lundie, J. Stockmeyer, A. Statham, J. Copty and the staff at the Kinghorn Centre for Clinical Genomics for helpful discussions related to, and rapid processing of, WGS; J. Mattick and M. Dziadek from the Garvan Institute for helpful discussions related to WGS and for supporting fundraising initiatives; S. Eggers and the staff at the Murdoch Children's Research Institute/Victorian Comprehensive Genetics Service for rapid processing of RNAseq; and the staff at the Australian Genome Research Facility for rapid processing of methylation data. We thank the team from the National Computational Infrastructure, which is supported by the Australian Government. We thank G. Asimenos, D. Pollard and the team from DNAnexus for support with genomic data processing and helpful discussions regarding pipeline development. We thank the Australian Federal Government Department of Health, the New South Wales State Government and the Australian Cancer Research Foundation for funding to establish infrastructure to support the Zero Childhood Cancer personalized medicine program. We thank the Kids Cancer Alliance, Cancer Therapeutics Cooperative Research Centre, for supporting the development of a personalized medicine program; Tour de Cure for supporting tumor biobank personnel; The Steven Walter Children's Cancer Foundation and The Hyundai Help 4 Kids Foundation for supporting G.M.M. and P.G.E.; and the Lions Kids Cancer Genome Project, a joint initiative of Lions International Foundation, the Australian Lions Children's Cancer Research Foundation (ALCCRF), the Garvan Institute of Medical Research, the Children's Cancer Institute and the Kids Cancer Centre, Sydney Children's Hospital. Lions International and ALCCRF provided funding to perform WGS and for key personnel, with thanks to J. Collins for project governance and advocacy. We thank the Cure Brain Cancer Foundation for supporting RNA sequencing of patients with brain tumors; the Kids Cancer Project for supporting molecular profiling and molecular and clinical trial personnel; and the University of New South Wales, W. Peters and the Australian Genomics Health Alliance for providing personnel funding support. The New South Wales Ministry of Health-funded Luminesce Alliance provided funding support for computational personnel and infrastructure.; r The Medical Research Future Fund, the Australian Brain Cancer Mission, the Minderoo Foundation's Collaborate Against Cancer Initiative and funds raised through the Zero Childhood Cancer Capacity Campaign, a joint initiative of the Children's Cancer Institute and the Sydney Children's Hospital Foundation, supported the national clinical trial and associated clinical and research personnel. We thank the Kinghorn Foundation for personnel support. We thank the National Health and Medical Research Council of Australia (fellowships APP1059804 and APP1157871 to R.B.L), the Cancer Institute of New South Wales and New South Wales Health (fellowship funding for M.J.C.). We thank the 2018 Priority-Driven Collaborative Cancer Research Scheme, co-funded by Cancer Australia and My Room, for personnel and computational support (grant no. 1165556 awarded to M.J.C.). Zero Childhood Cancer is a joint initiative led by the Children's Cancer Institute and Sydney Children's Hospital, Randwick.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Allen CE, 2017, JNCI-J NATL CANCER I, V109, DOI 10.1093/jnci/djw274; [Anonymous], 2019, GRIDSS PURPLE LINX U, DOI [10.1101/781013, DOI 10.1101/781013]; Bailey ML, 2014, MOL CANCER THER, V13, P724, DOI 10.1158/1535-7163.MCT-13-0749; Bell RJA, 2016, MOL CANCER RES, V14, P315, DOI 10.1158/1541-7786.MCR-16-0003; Berger MF, 2018, NAT REV CLIN ONCOL, V15, P353, DOI 10.1038/s41571-018-0002-6; Blombery P, 2019, BRIT J HAEMATOL, V186, pE188, DOI 10.1111/bjh.16069; Cameron DL, 2017, GENOME RES, V27, P2050, DOI 10.1101/gr.222109.117; Campbell BB, 2017, CELL, V171, P1042, DOI 10.1016/j.cell.2017.09.048; Campbell PJ, 2020, NATURE, V578, P82, DOI 10.1038/s41586-020-1969-6; Capper D, 2018, NATURE, V555, P469, DOI 10.1038/nature26000; Chang W, 2016, CLIN CANCER RES, V22, P3810, DOI 10.1158/1078-0432.CCR-15-2717; Cheng J, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1653-z; Choi Y, 2015, BIOINFORMATICS, V31, P2745, DOI 10.1093/bioinformatics/btv195; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Craig DW, 2016, SCI REP-UK, V6, DOI 10.1038/srep24607; Croft D, 2014, NUCLEIC ACIDS RES, V42, pD472, DOI 10.1093/nar/gkt1102; Davidson NM, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0167-x; Davies H, 2017, NAT MED, V23, P517, DOI 10.1038/nm.4292; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dong CL, 2015, HUM MOL GENET, V24, P2125, DOI 10.1093/hmg/ddu733; Donson AM, 2007, J NEUROPATH EXP NEUR, V66, P740, DOI 10.1097/nen.0b013e3181257190; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Fairley S, 2020, NUCLEIC ACIDS RES, V48, pD941, DOI 10.1093/nar/gkz836; Fu WQ, 2013, NATURE, V493, P216, DOI 10.1038/nature11690; Garrido-Martin D, 2018, PLOS COMPUT BIOL, V14, DOI 10.1371/journal.pcbi.1006360; Gayevskiy V, 2019, BIOINFORMATICS, V35, P122, DOI 10.1093/bioinformatics/bty540; Gervais R, 2005, ANN ONCOL, V16, P90, DOI 10.1093/annonc/mdi018; Gough SM, 2011, BLOOD, V118, P6247, DOI 10.1182/blood-2011-07-328880; Griffith M, 2017, NAT GENET, V49, P170, DOI 10.1038/ng.3774; Grobner SN, 2018, NATURE, V555, P321, DOI 10.1038/nature25480; Gu ZH, 2019, NAT GENET, V51, P296, DOI 10.1038/s41588-018-0315-5; Guieze R, 2019, CANCER CELL, V36, P369, DOI 10.1016/j.ccell.2019.08.005; Haas BJ, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1842-9; Haradhvala NJ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04002-4; Harris MH, 2016, JAMA ONCOL, V2, P608, DOI 10.1001/jamaoncol.2015.5689; Harttrampf AC, 2017, CLIN CANCER RES, V23, P6101, DOI 10.1158/1078-0432.CCR-17-0381; Hoskinson DC, 2017, CURR OPIN GENET DEV, V42, P33, DOI 10.1016/j.gde.2017.01.001; Hyun OJ, 2016, RADIOLOGY, V280, P576, DOI 10.1148/radiol.2016142043; Jaganathan K, 2019, CELL, V176, P535, DOI 10.1016/j.cell.2018.12.015; Jian XQ, 2014, NUCLEIC ACIDS RES, V42, P13534, DOI 10.1093/nar/gku1206; Jones DTW, 2008, CANCER RES, V68, P8673, DOI 10.1158/0008-5472.CAN-08-2097; Jones DTW, 2019, NAT REV CANCER, V19, P420, DOI 10.1038/s41568-019-0169-x; Jouhilahti EM, 2016, DEVELOPMENT, V143, P3459, DOI 10.1242/dev.134510; Kanehisa M, 2017, NUCLEIC ACIDS RES, V45, pD353, DOI 10.1093/nar/gkw1092; Karczewski KJ, 2020, NATURE, V581, P434, DOI 10.1038/s41586-020-2308-7; Khater F, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2019.2906; Khaw SL, 2016, BLOOD, V128, P1382, DOI 10.1182/blood-2016-03-707414; KIM S, 2017, BIODATA MIN, V10; Kohashi K, 2016, MODERN PATHOL, V29, P1232, DOI 10.1038/modpathol.2016.106; Kurzrock R, 2015, CELL CYCLE, V14, P2219, DOI 10.1080/15384101.2015.1041695; Lee DP, 2005, J CLIN ONCOL, V23, P8431, DOI 10.1200/JCO.2005.02.1568; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Leung JWC, 2017, GENE DEV, V31, P260, DOI 10.1101/gad.292516.116; Li H., 2013, ARXIV, DOI DOI 10.48550/ARXIV.1303.3997; Ma XT, 2018, NATURE, V555, P371, DOI 10.1038/nature25795; Marks LJ, 2017, FRONT PEDIATR, V5, DOI 10.3389/fped.2017.00265; McFarland JM, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06916-5; McLaren W, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0974-4; Mody RJ, 2015, JAMA-J AM MED ASSOC, V314, P913, DOI 10.1001/jama.2015.10080; Nielsen M, 2010, J NATL CANCER I, V102, P1724, DOI 10.1093/jnci/djq370; Northcott PA, 2017, NATURE, V547, P311, DOI 10.1038/nature22973; Paila U, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003153; Parsons DW, 2016, JAMA ONCOL, V2, P616, DOI 10.1001/jamaoncol.2015.5699; Parsons DW, 2019, J CLIN ONCOL, V37, DOI 10.1200/JCO.2019.37.15_suppl.10011; Pincez T, 2017, PEDIATR BLOOD CANCER, V64, DOI 10.1002/pbc.26365; Pinese M, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-14079-0; Priestley P, 2019, NATURE, V575, P210, DOI 10.1038/s41586-019-1689-y; Pugh TJ, 2013, NAT GENET, V45, P279, DOI 10.1038/ng.2529; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Rentzsch P, 2019, NUCLEIC ACIDS RES, V47, pD886, DOI 10.1093/nar/gky1016; Rheinbay E, 2020, NATURE, V578, P102, DOI 10.1038/s41586-020-1965-x; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Rodon J, 2019, NAT MED, V25, P751, DOI 10.1038/s41591-019-0424-4; Rosenthal R, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0893-4; Saunders CT, 2012, BIOINFORMATICS, V28, P1811, DOI 10.1093/bioinformatics/bts271; Shihab HA, 2013, HUM MUTAT, V34, P57, DOI 10.1002/humu.22225; Shlien A, 2015, NAT GENET, V47, P257, DOI 10.1038/ng.3202; Signal B, 2018, BIOINFORMATICS, V34, P920, DOI 10.1093/bioinformatics/btx688; Sondka Z, 2018, NAT REV CANCER, V18, P696, DOI 10.1038/s41568-018-0060-1; Stathis A, 2018, CANCER DISCOV, V8, P24, DOI 10.1158/2159-8290.CD-17-0605; Steliarova-Foucher E, 2018, LANCET ONCOL, V19, P1159, DOI 10.1016/S1470-2045(18)30423-6; Stewart E, 2018, CANCER CELL, V34, P411, DOI 10.1016/j.ccell.2018.07.012; Van der Auwera Geraldine A, 2013, Curr Protoc Bioinformatics, V43, DOI [10.1002/0471250953.bi1201s43, 10.1002/0471250953.bi1110s43]; Tate JG, 2019, NUCLEIC ACIDS RES, V47, pD941, DOI 10.1093/nar/gky1015; Van Allen EM, 2013, J CLIN ONCOL, V31, P1825, DOI 10.1200/JCO.2013.48.7215; Vaser R, 2016, NAT PROTOC, V11, P1, DOI 10.1038/nprot.2015.123; Vaske OM, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2019.13968; Villalobos-Ortiz M, 2020, CELL DEATH DIFFER, V27, P999, DOI 10.1038/s41418-019-0391-9; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Wen PY, 2017, J CLIN ONCOL, V35, P2439, DOI 10.1200/JCO.2017.72.7511; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wimmer K, 2008, HUM GENET, V124, P105, DOI 10.1007/s00439-008-0542-4; Worst BC, 2016, EUR J CANCER, V65, P91, DOI 10.1016/j.ejca.2016.06.009; Xiong HY, 2015, SCIENCE, V347, DOI 10.1126/science.1254806; Zhang JH, 2016, NEW ENGL J MED, V374, P1391, DOI 10.1056/NEJMc1600338; Ziegler DS, 2018, BRIT J CANCER, V119, P693, DOI 10.1038/s41416-018-0251-2; Zimmerman MW, 2018, CANCER DISCOV, V8, P320, DOI 10.1158/2159-8290.CD-17-0993	99	89	90	4	15	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2020	26	11					1742	+		10.1038/s41591-020-1072-4	http://dx.doi.org/10.1038/s41591-020-1072-4		OCT 2020	29	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	OT0SR	33020650				2022-12-27	WOS:000575801100003
J	Adam, DC; Wu, P; Wong, JY; Lau, EHY; Tsang, TK; Cauchemez, S; Leung, GM; Cowling, BJ				Adam, Dillon C.; Wu, Peng; Wong, Jessica Y.; Lau, Eric H. Y.; Tsang, Tim K.; Cauchemez, Simon; Leung, Gabriel M.; Cowling, Benjamin J.			Clustering and superspreading potential of SARS-CoV-2 infections in Hong Kong	NATURE MEDICINE			English	Article							ACUTE-RESPIRATORY-SYNDROME; MERS-COV OUTBREAK; SOUTH-KOREA; TRANSMISSION; COVID-19; CHINA; EPIDEMIOLOGY; CONTACTS; EVENTS; SIZE	Superspreading events (SSEs) have characterized previous epidemics of severe acute respiratory syndrome coronavirus (SARS-CoV) and Middle East respiratory syndrome coronavirus (MERS-CoV) infections(1-6). For SARS-CoV-2, the degree to which SSEs are involved in transmission remains unclear, but there is growing evidence that SSEs might be a typical feature of COVID-19(7,8). Using contact tracing data from 1,038 SARS-CoV-2 cases confirmed between 23 January and 28 April 2020 in Hong Kong, we identified and characterized all local clusters of infection. We identified 4-7 SSEs across 51 clusters (n = 309 cases) and estimated that 19% (95% confidence interval, 15-24%) of cases seeded 80% of all local transmission. Transmission in social settings was associated with more secondary cases than households when controlling for age (P = 0.002). Decreasing the delay between symptom onset and case confirmation did not result in fewer secondary cases (P = 0.98), although the odds that an individual being quarantined as a contact interrupted transmission was 14.4 (95% CI, 1.9-107.2). Public health authorities should focus on rapidly tracing and quarantining contacts, along with implementing restrictions targeting social settings to reduce the risk of SSEs and suppress SARS-CoV-2 transmission. Cases linked to superspreading events are estimated to account for 80% of all local transmission of SARS-CoV-2 in Hong Kong in a study with implications for public health policies.	[Adam, Dillon C.; Wu, Peng; Wong, Jessica Y.; Lau, Eric H. Y.; Tsang, Tim K.; Leung, Gabriel M.; Cowling, Benjamin J.] Univ Hong Kong, Li Ka Shing Fac Med, Sch Publ Hlth, WHO Collaborating Ctr Infect Dis Epidemiol & Cont, Hong Kong, Peoples R China; [Adam, Dillon C.] Univ New South Wales, Kirby Inst, Biosecur Program, Sydney, NSW, Australia; [Cauchemez, Simon] Inst Pasteur, Math Modelling Infect Dis Unit, Paris, France	University of Hong Kong; World Health Organization; University of New South Wales Sydney; Kirby Institute; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Wu, P (corresponding author), Univ Hong Kong, Li Ka Shing Fac Med, Sch Publ Hlth, WHO Collaborating Ctr Infect Dis Epidemiol & Cont, Hong Kong, Peoples R China.	pengwu@hku.hk	Lau, Eric/AAJ-6588-2021	Lau, Eric/0000-0002-6688-9637; Adam, Dillon/0000-0002-7485-9905; Wu, Peng/0000-0003-1157-9401; Wong, Jessica Y/0000-0001-5309-1661	Health and Medical Research Fund, Food and Health Bureau, Government of the Hong Kong Special Administrative Region (SAR) [COVID190118]; Research Grants Council of the Hong Kong SAR Government [T11-712/19-N]	Health and Medical Research Fund, Food and Health Bureau, Government of the Hong Kong Special Administrative Region (SAR); Research Grants Council of the Hong Kong SAR Government(Hong Kong Research Grants Council)	We thank the Department of Health of the Food and Health Bureau of the Government of Hong Kong for conducting the outbreak investigation and providing the data for the analysis. This project was supported by the Health and Medical Research Fund, Food and Health Bureau, Government of the Hong Kong Special Administrative Region (SAR; grant no. COVID190118) and the Theme-based Research Scheme (project no. T11-712/19-N) of the Research Grants Council of the Hong Kong SAR Government.	Arons MM, 2020, NEW ENGL J MED, V382, P2081, DOI 10.1056/NEJMoa2008457; Bi QF, 2020, LANCET INFECT DIS, V20, P911, DOI 10.1016/S1473-3099(20)30287-5; Blumberg S, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002993; Cho SY, 2016, LANCET, V388, P994, DOI 10.1016/S0140-6736(16)30623-7; Cowling BJ, 2015, EUROSURVEILLANCE, V20, P7, DOI 10.2807/1560-7917.ES2015.20.25.21163; Cowling BJ, 2020, LANCET PUBLIC HEALTH, V5, pE279, DOI 10.1016/S2468-2667(20)30090-6; Endo Akira, 2020, Wellcome Open Res, V5, P67, DOI [10.12688/wellcomeopenres.15842.1, 10.12688/wellcomeopenres.15842.3]; Ferretti L, 2020, SCIENCE, V368, P619, DOI 10.1126/science.abb6936; Furuse Y, 2020, EMERG INFECT DIS, V26, P2176, DOI 10.3201/eid2609.202272; HE X, 2020, NAT MED, V26, P672, DOI DOI 10.1038/S41591-020-0869-5; Hellewell J, 2020, LANCET GLOB HEALTH, V8, pE488, DOI 10.1016/S2214-109X(20)30074-7; Houlihan C., 2020, SARS COV 2 VIRUS ANT, DOI [10.1101/2020.06.08.20120584, DOI 10.1101/2020.06.08.20120584V1]; Kim KH, 2017, J HOSP INFECT, V95, P207, DOI 10.1016/j.jhin.2016.10.008; Kucharski AJ, 2015, EUROSURVEILLANCE, V20, P14, DOI 10.2807/1560-7917.ES2015.20.25.21167; Leung GM, 2020, NEW ENGL J MED, V382, DOI 10.1056/NEJMc2009790; Leung KS-S, 2020, TERRITORY WIDE STUDY; Li YG, 2004, AM J EPIDEMIOL, V160, P719, DOI 10.1093/aje/kwh273; Lloyd-Smith JO, 2005, NATURE, V438, P355, DOI 10.1038/nature04153; Lu JY, 2020, EMERG INFECT DIS, V26, P1628, DOI 10.3201/eid2607.200764; Nishiura H, 2012, J THEOR BIOL, V294, P48, DOI 10.1016/j.jtbi.2011.10.039; Peiris JSM, 2003, LANCET, V361, P1767, DOI 10.1016/S0140-6736(03)13412-5; Pitzer VE, 2007, AM J EPIDEMIOL, V166, P355, DOI 10.1093/aje/kwm082; Ryu S, 2020, EMERG INFECT DIS, V26, P2406, DOI 10.3201/eid2610.201886; Shen Z, 2004, EMERG INFECT DIS, V10, P256, DOI 10.3201/eid1002.030732; Tariq A, 2020, BMC MED, V18, DOI [10.1186/s12916-020-01615-9, 10.1101/2020.02.21.20026435]; Wallinga J, 2004, AM J EPIDEMIOL, V160, P509, DOI 10.1093/aje/kwh255; Wang SX, 2006, EPIDEMIOL INFECT, V134, P786, DOI 10.1017/S095026880500556X; Woolhouse MEJ, 1997, P NATL ACAD SCI USA, V94, P338, DOI 10.1073/pnas.94.1.338; Wu P, 2020, RES SQUARE, DOI 10.21203/rs.3.rs- 34047/v1; Xu XK, 2020, CLIN INFECT DIS, V71, P3163, DOI 10.1093/cid/ciaa790; Zhang S, 2020, INT J INFECT DIS, V93, P201, DOI 10.1016/j.ijid.2020.02.033; Zhao S, 2020, INT J INFECT DIS, V92, P214, DOI 10.1016/j.ijid.2020.01.050	32	290	292	9	31	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2020	26	11					1714	+		10.1038/s41591-020-1092-0	http://dx.doi.org/10.1038/s41591-020-1092-0		SEP 2020	13	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	OT0SR	32943787	Bronze, Green Submitted			2022-12-27	WOS:000570449200001
J	Stower, H				Stower, Hannah			Anti-mosquito immunity	NATURE MEDICINE			English	Editorial Material												h.stower@us.nature.com							0	0	0	0	1	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	JUL	2020	26	7					1009	1009		10.1038/s41591-020-0990-5	http://dx.doi.org/10.1038/s41591-020-0990-5		JUL 2020	1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	MK3XO	32651575	Bronze			2022-12-27	WOS:000547236500008
J	Long, QX; Tang, XJ; Shi, QL; Li, Q; Deng, HJ; Yuan, J; Hu, JL; Xu, W; Zhang, Y; Lv, FJ; Su, K; Zhang, F; Gong, J; Wu, B; Liu, XM; Li, JJ; Qiu, JF; Chen, J; Huang, AL				Long, Quan-Xin; Tang, Xiao-Jun; Shi, Qiu-Lin; Li, Qin; Deng, Hai-Jun; Yuan, Jun; Hu, Jie-Li; Xu, Wei; Zhang, Yong; Lv, Fa-Jin; Su, Kun; Zhang, Fan; Gong, Jiang; Wu, Bo; Liu, Xia-Mao; Li, Jin-Jing; Qiu, Jing-Fu; Chen, Juan; Huang, Ai-Long			Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections	NATURE MEDICINE			English	Article							ANTIBODY-RESPONSES; CORONAVIRUS; COV	A cohort of asymptomatic patients infected with SARS-CoV-2 had significantly lower levels of virus-specific IgG antibodies compared to a cohort of age- and sex-matched symptomatic infected patients. The clinical features and immune responses of asymptomatic individuals infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have not been well described. We studied 37 asymptomatic individuals in the Wanzhou District who were diagnosed with RT-PCR-confirmed SARS-CoV-2 infections but without any relevant clinical symptoms in the preceding 14 d and during hospitalization. Asymptomatic individuals were admitted to the government-designated Wanzhou People's Hospital for centralized isolation in accordance with policy(1). The median duration of viral shedding in the asymptomatic group was 19 d (interquartile range (IQR), 15-26 d). The asymptomatic group had a significantly longer duration of viral shedding than the symptomatic group (log-rankP = 0.028). The virus-specific IgG levels in the asymptomatic group (median S/CO, 3.4; IQR, 1.6-10.7) were significantly lower (P = 0.005) relative to the symptomatic group (median S/CO, 20.5; IQR, 5.8-38.2) in the acute phase. Of asymptomatic individuals, 93.3% (28/30) and 81.1% (30/37) had reduction in IgG and neutralizing antibody levels, respectively, during the early convalescent phase, as compared to 96.8% (30/31) and 62.2% (23/37) of symptomatic patients. Forty percent of asymptomatic individuals became seronegative and 12.9% of the symptomatic group became negative for IgG in the early convalescent phase. In addition, asymptomatic individuals exhibited lower levels of 18 pro- and anti-inflammatory cytokines. These data suggest that asymptomatic individuals had a weaker immune response to SARS-CoV-2 infection. The reduction in IgG and neutralizing antibody levels in the early convalescent phase might have implications for immunity strategy and serological surveys.	[Long, Quan-Xin; Deng, Hai-Jun; Yuan, Jun; Hu, Jie-Li; Chen, Juan; Huang, Ai-Long] Chongqing Med Univ, Key Lab Mol Biol Infect Dis, Minist Educ, Chongqing, Peoples R China; [Tang, Xiao-Jun; Shi, Qiu-Lin; Xu, Wei; Zhang, Yong; Qiu, Jing-Fu] Chongqing Med Univ, Sch Publ Hlth & Management, Chongqing, Peoples R China; [Li, Qin; Su, Kun] Chongqing Ctr Dis Control & Prevent, Chongqing, Peoples R China; [Lv, Fa-Jin] Chongqing Med Univ, Affiliated Hosp 1, Dept Radiol, Chongqing, Peoples R China; [Zhang, Fan; Gong, Jiang] Wanzhou Peoples Hosp, Chongqing, Peoples R China; [Wu, Bo] Wanzhou Dist Ctr Dis Control & Prevent, Chongqing, Peoples R China; [Liu, Xia-Mao; Li, Jin-Jing] Chongqing Med Univ, Affiliated Hosp 2, Chongqing, Peoples R China	Chongqing Medical University; Chongqing Medical University; Chongqing Medical University; Chongqing Medical University	Chen, J; Huang, AL (corresponding author), Chongqing Med Univ, Key Lab Mol Biol Infect Dis, Minist Educ, Chongqing, Peoples R China.; Qiu, JF (corresponding author), Chongqing Med Univ, Sch Publ Hlth & Management, Chongqing, Peoples R China.	jfqiu@126.com; chenjuan2014@cqmu.edu.cn; ahuang@cqmu.edu.cn	Long, Quanxin/AAK-6199-2021; Zhang, Yong/B-7089-2016; , jieli/AAX-1660-2020	Zhang, Yong/0000-0003-1436-5951; , jieli/0000-0002-9869-659X; Long, Quanxin/0000-0003-1857-2798; deng, hai jun/0000-0002-4890-192X; Huang, Ailong/0000-0003-0148-7423	National Science and Technology Major Project [2017ZX10202203]; Science & Technology Commission of Chongqing; National Natural Science Foundation of China [81871656, 8181101099]	National Science and Technology Major Project; Science & Technology Commission of Chongqing; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	We thank C.-Y. Yang and B. Anderson for critical review of the manuscript. This study received the following funding: the National Science and Technology Major Project (2017ZX10202203); the Emergency Project from the Science & Technology Commission of Chongqing; and the National Natural Science Foundation of China (grant nos. 81871656 and 8181101099). We acknowledge all patients involved in the study.	Atkinson B, 2020, LANCET, V395, P1339, DOI 10.1016/S0140-6736(20)30868-0; Bai Y, 2020, JAMA-J AM MED ASSOC, V323, P1406, DOI [10.1056/NEJMoa2001316, 10.1001/jama.2020.2565]; Cao WCC, 2007, NEW ENGL J MED, V357, P1162, DOI 10.1056/NEJMc070348; Chan JFW, 2020, LANCET, V395, P514, DOI 10.1016/S0140-6736(20)30154-9; Chen NS, 2020, LANCET, V395, P507, DOI 10.1016/S0140-6736(20)30211-7; Choe PG, 2017, EMERG INFECT DIS, V23, P1079, DOI 10.3201/eid2307.170310; Gudbjartsson DF, 2020, NEW ENGL J MED, V382, P2302, DOI 10.1056/NEJMoa2006100; Guo X., 2020, MEDRXIV, DOI 10.1101/2020.02.12.20021386v1; Hu ZL, 2020, SCI CHINA LIFE SCI, V63, P706, DOI 10.1007/s11427-020-1661-4; Kissler SM, 2020, SCIENCE, V368, P860, DOI 10.1126/science.abb5793; LONG QX, 2020, NAT MED 0429; Mizumoto K, 2020, EUROSURVEILLANCE, V25, P2, DOI 10.2807/1560-7917.ES.2020.25.10.2000180; *NAT HLTH COMM PEO, 2020, COVID 19 PREV CONTR; National Health Commission of the People's Republic of China, 2020, COVID 19 TREATM GUID, V5th; Ni L, 2020, IMMUNITY, V52, P971, DOI 10.1016/j.immuni.2020.04.023; Nishiura H, 2020, INT J INFECT DIS, V94, P154, DOI 10.1016/j.ijid.2020.03.020; NORHEIM OF, 2020, NAT MED; Oh MD, 2016, NEW ENGL J MED, V375, P1303, DOI 10.1056/NEJMc1511695; Payne DC, 2016, EMERG INFECT DIS, V22, P1824, DOI 10.3201/eid2210.160706; Phelan AL, 2020, LANCET, V395, P1595, DOI 10.1016/S0140-6736(20)31034-5; Suthar MS, 2020, CELL REP MED, V1, DOI [10.1016/j.xcrm.2020.100040, 10.1101/2020.05.03.20084442]; Thevarajan I, 2020, NAT MED, V26, P453, DOI 10.1038/s41591-020-0819-2; Wang D, 2020, J AEROSPACE ENG, V33, DOI 10.1061/(ASCE)AS.1943-5525.0001149; Wang XL, 2020, CLIN INFECT DIS, V71, P2688, DOI 10.1093/cid/ciaa721; Weitz JS, 2020, NAT MED, V26, P849, DOI 10.1038/s41591-020-0895-3; Wu F., 2020, MEDRXIV, DOI [10.1101/2020.03.30.20047365, 10.1101/2020.03.30.20047365v2, 10.1101/2020.03.30.20047365., DOI 10.1101/2020.03.30.20, 10.2139/ssrn.3566211]; Wu LP, 2007, EMERG INFECT DIS, V13, P1562, DOI 10.3201/eid1310.070576; Xiong Y, 2020, INVEST RADIOL, V55, P332, DOI 10.1097/RLI.0000000000000674; Xu D, 2005, EUR J CLIN MICROBIOL, V24, P165, DOI 10.1007/s10096-005-1299-5; Young BE, 2020, JAMA-J AM MED ASSOC, V323, P1488, DOI 10.1001/jama.2020.3204; Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3	31	1518	1559	19	26	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	AUG	2020	26	8					1200	+		10.1038/s41591-020-0965-6	http://dx.doi.org/10.1038/s41591-020-0965-6		JUN 2020	9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	MX8ZF	32555424	Bronze			2022-12-27	WOS:000541202800001
J	Iwasaki, A				Iwasaki, Akiko			Antidote to toxic principal investigators	NATURE MEDICINE			English	Editorial Material									[Iwasaki, Akiko] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06519 USA; [Iwasaki, Akiko] Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06511 USA; [Iwasaki, Akiko] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA	Yale University; Yale University; Howard Hughes Medical Institute	Iwasaki, A (corresponding author), Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06519 USA.; Iwasaki, A (corresponding author), Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06511 USA.; Iwasaki, A (corresponding author), Howard Hughes Med Inst, Chevy Chase, MD 20815 USA.	akiko.iwasaki@yale.edu			Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)			0	2	2	0	1	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	APR	2020	26	4					457	457		10.1038/s41591-020-0831-6	http://dx.doi.org/10.1038/s41591-020-0831-6			1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	QH1UE	32273601	Bronze			2022-12-27	WOS:000618061900006
J	Stower, H				Stower, Hannah			Smoking cessation and type 2 diabetes	NATURE MEDICINE			English	Editorial Material																			0	1	1	0	2	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	FEB	2020	26	2					163	163		10.1038/s41591-020-0779-6	http://dx.doi.org/10.1038/s41591-020-0779-6			1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	KK7DU	32047321	Bronze			2022-12-27	WOS:000512899200033
J	Durham, BH; Rodrigo, EL; Picarsic, J; Abramson, D; Rotemberg, V; De Munck, S; Pannecoucke, E; Lu, SX; Pastore, A; Yoshimi, A; Mandelker, D; Ceyhan-Birsoy, O; Ulaner, GA; Walsh, M; Yabe, M; Petrova-Drus, K; Arcila, ME; Ladanyi, M; Solit, DB; Berger, MF; Hyman, DM; Lacouture, ME; Erickson, C; Saganty, R; Ki, M; Dunkel, IJ; Lopez, VSM; Mora, J; Haroche, J; Emile, JF; Decaux, O; Geissmann, F; Savvides, SN; Drilon, A; Diamond, EL; Abdel-Wahab, O				Durham, Benjamin H.; Rodrigo, Estibaliz Lopez; Picarsic, Jennifer; Abramson, David; Rotemberg, Veronica; De Munck, Steven; Pannecoucke, Erwin; Lu, Sydney X.; Pastore, Alessandro; Yoshimi, Akihide; Mandelker, Diana; Ceyhan-Birsoy, Ozge; Ulaner, Gary A.; Walsh, Michael; Yabe, Mariko; Petrova-Drus, Kseniya; Arcila, Maria E.; Ladanyi, Marc; Solit, David B.; Berger, Michael F.; Hyman, David M.; Lacouture, Mario E.; Erickson, Caroline; Saganty, Ruth; Ki, Michelle; Dunkel, Ira J.; Lopez, Vicente Santa-Maria; Mora, Jaume; Haroche, Julien; Emile, Jean-Francois; Decaux, Olivier; Geissmann, Frederic; Savvides, Savvas N.; Drilon, Alexander; Diamond, Eli L.; Abdel-Wahab, Omar			Activating mutations in CSF1R and additional receptor tyrosine kinases in histiocytic neoplasms	NATURE MEDICINE			English	Article							JUVENILE XANTHOGRANULOMA; CELL	Histiocytoses are clonal hematopoietic disorders frequently driven by mutations mapping to the BRAF and MEK1 and MEK2 kinases. Currently, however, the developmental origins of histiocytoses in patients are not well understood, and clinically meaningful therapeutic targets outside of BRAF and MEK are undefined. In this study, we uncovered activating mutations in CSF1R and rearrangements in RET and ALK that conferred dramatic responses to selective inhibition of RET (selpercatinib) and crizotinib, respectively, in patients with histiocytosis.	[Durham, Benjamin H.; Lu, Sydney X.; Pastore, Alessandro; Yoshimi, Akihide; Ladanyi, Marc; Solit, David B.; Berger, Michael F.; Erickson, Caroline; Saganty, Ruth; Ki, Michelle; Abdel-Wahab, Omar] Mem Sloan Kettering Canc Ctr, Dept Med, Human Oncol & Pathogenesis Program, 1275 York Ave, New York, NY 10021 USA; [Durham, Benjamin H.; Mandelker, Diana; Ceyhan-Birsoy, Ozge; Yabe, Mariko; Petrova-Drus, Kseniya; Arcila, Maria E.; Ladanyi, Marc; Berger, Michael F.] Mem Sloan Kettering Canc Ctr, Dept Pathol, 1275 York Ave, New York, NY 10021 USA; [Rodrigo, Estibaliz Lopez; Walsh, Michael; Dunkel, Ira J.] Mem Sloan Kettering Canc Ctr, Dept Pediat, 1275 York Ave, New York, NY 10021 USA; [Rodrigo, Estibaliz Lopez; Geissmann, Frederic] Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Immunol Program, 1275 York Ave, New York, NY 10021 USA; [Picarsic, Jennifer] Univ Pittsburgh, Sch Med, UPMC Dept Pathol, Pittsburgh, PA USA; [Picarsic, Jennifer] UPMC Childrens Hosp Pittsburgh, Pittsburgh, PA USA; [Abramson, David] Mem Sloan Kettering Canc Ctr, Dept Surg, Ophthalm Oncol Serv, 1275 York Ave, New York, NY 10021 USA; [Rotemberg, Veronica; Lacouture, Mario E.] Mem Sloan Kettering Canc Ctr, Dept Dermatol, 1275 York Ave, New York, NY 10021 USA; [De Munck, Steven; Pannecoucke, Erwin; Savvides, Savvas N.] Univ Ghent, Dept Biochem & Microbiol, Ghent, Belgium; [De Munck, Steven; Pannecoucke, Erwin; Savvides, Savvas N.] VIB UGent Ctr Inflammat Res, Ghent, Belgium; [Ulaner, Gary A.] Mem Sloan Kettering Canc Ctr, Dept Radiol, 1275 York Ave, New York, NY 10021 USA; [Hyman, David M.; Drilon, Alexander] Mem Sloan Kettering Canc Ctr, Dept Med, 1275 York Ave, New York, NY 10021 USA; [Lopez, Vicente Santa-Maria; Mora, Jaume] Hosp St Joan de Deu, Div Pediat Oncol, Barcelona, Spain; [Haroche, Julien] Univ Hosp La Pitie Salpetriere, AP HP, Ctr Reference Histiocytoses, Dept Internal Med, Paris, France; [Emile, Jean-Francois] Univ Hosp Ambroise Pare, AP HP, Dept Pathol, Boulogne, France; [Decaux, Olivier] Hop Pontchaillou CHU Rennes, Serv Hematol Clin, Rennes, France; [Diamond, Eli L.] Mem Sloan Kettering Canc Ctr, Dept Neurol, 1275 York Ave, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Ghent University; Flanders Institute for Biotechnology (VIB); Ghent University; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; University of Barcelona; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Memorial Sloan Kettering Cancer Center	Abdel-Wahab, O (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Med, Human Oncol & Pathogenesis Program, 1275 York Ave, New York, NY 10021 USA.; Diamond, EL (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Neurol, 1275 York Ave, New York, NY 10021 USA.	diamone1@mskcc.org; abdelwao@mskcc.org	/AAR-7818-2021; /AGZ-3814-2022; Arcila, Maria/ABE-2235-2021; Yoshimi, Akihide/I-3792-2019; Picarsic, Jennifer/R-1272-2016	/0000-0002-3621-4807; /0000-0002-3621-4807; Yoshimi, Akihide/0000-0002-0664-7281; Solit, David/0000-0002-6614-802X; De Munck, Steven/0000-0001-5094-223X; Lu, Sydney/0000-0002-2217-1674; Picarsic, Jennifer/0000-0002-3718-6422	Genentech; Histiocytosis Association; Erdheim-Chester Disease Global Alliance; American Society of Hematology; Leukemia AMP; Lymphoma Society; Pershing Square Sohn Foundation; Functional Genomics Initiative of Memorial Sloan Kettering Cancer Center; Society of Memorial Sloan Kettering; Translational and Integrative Medicine Award of Memorial Sloan Kettering; Geoffrey Beene Center of Memorial Sloan Kettering; Nonna's Garden Foundation; Flanders Institute for Biotechnology-Belgium; National Institutes of Health [K08CA218901, UL1TR001857, P30CA008748, 1R01CA201247]; NATIONAL CANCER INSTITUTE [K08CA218901, R01CA201247] Funding Source: NIH RePORTER	Genentech(Roche HoldingGenentech); Histiocytosis Association; Erdheim-Chester Disease Global Alliance; American Society of Hematology; Leukemia AMP; Lymphoma Society(Leukemia and Lymphoma Society); Pershing Square Sohn Foundation(Pershing Square Sohn Cancer Research Alliance); Functional Genomics Initiative of Memorial Sloan Kettering Cancer Center; Society of Memorial Sloan Kettering; Translational and Integrative Medicine Award of Memorial Sloan Kettering; Geoffrey Beene Center of Memorial Sloan Kettering; Nonna's Garden Foundation; Flanders Institute for Biotechnology-Belgium; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank the patients and their families for participating in this study, as well as L. Schmitt of UPMC Children's Hospital of Pittsburgh for histologic technical support. This work was supported by Genentech and grants from the Histiocytosis Association, the Erdheim-Chester Disease Global Alliance, the American Society of Hematology, the Leukemia & Lymphoma Society, the Pershing Square Sohn Foundation, the Functional Genomics Initiative of Memorial Sloan Kettering Cancer Center, the Society of Memorial Sloan Kettering, the Translational and Integrative Medicine Award of Memorial Sloan Kettering, the Geoffrey Beene Center of Memorial Sloan Kettering, the Frame Fund, Nonna's Garden Foundation, the Flanders Institute for Biotechnology-Belgium and the National Institutes of Health (K08CA218901, UL1TR001857, P30CA008748 and 1R01CA201247).	Alexandrov LB, 2019, BIORXIV, DOI [10.1101/322859, DOI 10.1101/322859]; Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Badalian-Very G, 2010, BLOOD, V116, P1919, DOI 10.1182/blood-2010-04-279083; Benayed R, 2019, CLIN CANCER RES, V25, P4712, DOI 10.1158/1078-0432.CCR-19-0225; Cambiaghi S, 2004, PEDIATR DERMATOL, V21, P97, DOI 10.1111/j.0736-8046.2004.21201.x; Cammenga J, 2005, BLOOD, V106, P3958, DOI 10.1182/blood-2005-02-0583; Chakraborty R, 2014, BLOOD, V124, P3007, DOI 10.1182/blood-2014-05-577825; Chantorn R, 2008, PEDIATR DERMATOL, V25, P470, DOI 10.1111/j.1525-1470.2008.00752.x; Cheng DT, 2015, J MOL DIAGN, V17, P251, DOI 10.1016/j.jmoldx.2014.12.006; Cortes-Ciriano I, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15180; Dai XM, 2002, BLOOD, V99, P111, DOI 10.1182/blood.V99.1.111; Diamond EL, 2019, NATURE, V567, P521, DOI 10.1038/s41586-019-1012-y; Diamond EL, 2016, CANCER DISCOV, V6, P154, DOI [10.1158/2159-8290.CD-15-0913, 10.1158/2159-8290.CD-NB2016-001]; Durham BH, 2017, BLOOD, V130, P1644, DOI [10.1182/blood-2017-01765107, 10.1182/blood-2017-01-765107]; Elegheert J, 2012, NAT STRUCT MOL BIOL, V19, P938, DOI 10.1038/nsmb.2367; Elegheert J, 2011, STRUCTURE, V19, P1762, DOI 10.1016/j.str.2011.10.012; Felix J, 2015, STRUCTURE, V23, P1621, DOI 10.1016/j.str.2015.06.019; Felix J, 2013, STRUCTURE, V21, P528, DOI 10.1016/j.str.2013.01.018; Gruber TA, 2012, CANCER CELL, V22, P683, DOI 10.1016/j.ccr.2012.10.007; Huang MN, 2015, SCI REP-UK, V5, DOI 10.1038/srep13321; Hyman DM, 2015, NEW ENGL J MED, V373, P726, DOI 10.1056/NEJMoa1502309; KATZ AM, 1991, J AM ACAD DERMATOL, V24, P32, DOI 10.1016/0190-9622(91)70005-M; Mass E, 2017, NATURE, V549, P389, DOI 10.1038/nature23672; Maxson JE, 2016, CLIN CANCER RES, V22, P757, DOI 10.1158/1078-0432.CCR-14-3100; Rosenthal R, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0893-4; Walter M, 2007, J MOL BIOL, V367, P839, DOI 10.1016/j.jmb.2007.01.036; Walters DK, 2006, CANCER CELL, V10, P65, DOI 10.1016/j.ccr.2006.06.002; Zhang JH, 2012, NATURE, V481, P157, DOI 10.1038/nature10725	28	73	72	1	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	2019	25	12					1839	1842		10.1038/s41591-019-0653-6	http://dx.doi.org/10.1038/s41591-019-0653-6			4	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	JT2KO	31768065	Green Accepted			2022-12-27	WOS:000500824900026
J	Furman, D; Campisi, J; Verdin, E; Carrera-Bastos, P; Targ, S; Franceschi, C; Ferrucci, L; Gilroy, DW; Fasano, A; Miller, GW; Miller, AH; Mantovani, A; Weyand, CM; Barzilai, N; Goronzy, JJ; Rando, TA; Effros, RB; Lucia, A; Kleinstreuer, N; Slavich, GM				Furman, David; Campisi, Judith; Verdin, Eric; Carrera-Bastos, Pedro; Targ, Sasha; Franceschi, Claudio; Ferrucci, Luigi; Gilroy, Derek W.; Fasano, Alessio; Miller, Gary W.; Miller, Andrew H.; Mantovani, Alberto; Weyand, Cornelia M.; Barzilai, Nir; Goronzy, Jorg J.; Rando, Thomas A.; Effros, Rita B.; Lucia, Alejandro; Kleinstreuer, Nicole; Slavich, George M.			Chronic inflammation in the etiology of disease across the life span	NATURE MEDICINE			English	Article							C-REACTIVE PROTEIN; CORONARY-HEART-DISEASE; SUPPLEMENTATION LOWERS INFLAMMATION; ADIPOSE-TISSUE; IMMUNE-SYSTEM; SECRETORY PHENOTYPE; DIABETES-MELLITUS; PHYSICAL-ACTIVITY; HEALTH CONSEQUENCES; CELLULAR SENESCENCE	Although intermittent increases in inflammation are critical for survival during physical injury and infection, recent research has revealed that certain social, environmental and lifestyle factors can promote systemic chronic inflammation (SCI) that can, in turn, lead to several diseases that collectively represent the leading causes of disability and mortality worldwide, such as cardiovascular disease, cancer, diabetes mellitus, chronic kidney disease, non-alcoholic fatty liver disease and autoimmune and neurodegenerative disorders. In the present Perspective we describe the multi-level mechanisms underlying SCI and several risk factors that promote this health-damaging phenotype, including infections, physical inactivity, poor diet, environmental and industrial toxicants and psychological stress. Furthermore, we suggest potential strategies for advancing the early diagnosis, prevention and treatment of SCI.	[Furman, David; Campisi, Judith; Verdin, Eric] Buck Inst Res Aging, Novato, CA 94945 USA; [Furman, David] Stanford Univ, Sch Med, Inst Immun Transplantat & Infect, Stanford 1000 Immunomes Project, Stanford, CA 94305 USA; [Furman, David] Univ Austral, CONICET, Inst Res Translat Med, Buenos Aires, DF, Argentina; [Furman, David; Targ, Sasha] Iuve Inc, San Mateo, CA 94401 USA; [Campisi, Judith] Lawrence Berkeley Natl Lab, Berkeley, CA USA; [Carrera-Bastos, Pedro] Lund Univ, Skane Univ Hosp, Reg Skane, Ctr Primary Hlth Care Res, Malmo, Sweden; [Targ, Sasha] Univ Calif San Francisco, Med Scientist Training Program, San Francisco, CA 94143 USA; [Franceschi, Claudio] IRCCS Inst Neurol Sci Bologna, Bologna, Italy; [Franceschi, Claudio] Lobachevsky Univ, Dept Appl Math, Nizhnii Novgorod, Russia; [Franceschi, Claudio] Lobachevsky Univ, Lab Syst Biol Aging, Nizhnii Novgorod, Russia; [Ferrucci, Luigi] NIA, Translat Gerontol Branch, NIH, Baltimore, MD 21224 USA; [Gilroy, Derek W.] UCL, Div Med, Ctr Clin Pharmacol & Therapeut, London, England; [Fasano, Alessio] Harvard Med Sch, MassGen Hosp Children, Boston, MA 02115 USA; [Miller, Gary W.] Columbia Univ, Sch Publ Hlth, Dept Environm Hlth Sci, Med Ctr, New York, NY USA; [Miller, Andrew H.] Emory Univ, Sch Med, Dept Psychiat & Behav Sci, Atlanta, GA USA; [Mantovani, Alberto] Humanitas Clin & Res Ctr, Milan, Italy; [Mantovani, Alberto] Humanitas Univ, Dept Biomed Sci, Milan, Italy; [Mantovani, Alberto] Queen Mary Univ, Barts & London Sch Med, William Harvey Res Inst, London, England; [Weyand, Cornelia M.] Stanford Univ, Dept Med, Div Immunol & Rheumatol, Stanford, CA 94305 USA; [Barzilai, Nir] Albert Einstein Coll Med, Dept Med, New York, NY USA; [Barzilai, Nir] Albert Einstein Coll Med, Dept Genet, New York, NY USA; [Goronzy, Jorg J.; Rando, Thomas A.] Stanford Univ, Sch Med, Paul F Glenn Ctr Biol Aging, Stanford, CA 94305 USA; [Rando, Thomas A.] Vet Affairs Palo Alto Hlth Care Syst, Ctr Tissue Regenerat Repair & Restorat, Palo Alto, CA USA; [Rando, Thomas A.] Stanford Univ, Sch Med, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA; [Effros, Rita B.] Univ Calif Los Angeles, Dept Pathol, Los Angeles, CA 90024 USA; [Lucia, Alejandro] Univ Europea Madrid, Fac Sport Sci, Madrid, Spain; [Lucia, Alejandro] Hosp 12 Octubre I 12, Res Inst, Madrid, Spain; [Kleinstreuer, Nicole] NIEHS, Biostat & Computat Biol Branch, Div Intramural Res, NIH,Dept Hlth & Human Serv, POB 12233, Res Triangle Pk, NC 27709 USA; [Kleinstreuer, Nicole] NIEHS, NTP Interagency Ctr Evaluat Alternat Toxicol Meth, NIH, Dept Hlth & Human Serv, POB 12233, Res Triangle Pk, NC 27709 USA; [Slavich, George M.] Univ Calif Los Angeles, Cousins Ctr Psychoneuroimmunol, Los Angeles, CA USA; [Slavich, George M.] Univ Calif Los Angeles, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90024 USA	Buck Institute for Research on Aging; Stanford University; Austral University; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; Lund University; Skane University Hospital; University of California System; University of California San Francisco; IRCCS Istituto delle Scienze Neurologiche di Bologna (ISNB); Lobachevsky State University of Nizhni Novgorod; Lobachevsky State University of Nizhni Novgorod; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of London; University College London; Harvard University; Harvard Medical School; Massachusetts General Hospital; Columbia University; Emory University; Humanitas University; University of London; Queen Mary University London; Stanford University; Yeshiva University; Yeshiva University; Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Stanford University; University of California System; University of California Los Angeles; European University of Madrid; Hospital Universitario 12 de Octubre; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Furman, D (corresponding author), Buck Inst Res Aging, Novato, CA 94945 USA.; Furman, D (corresponding author), Stanford Univ, Sch Med, Inst Immun Transplantat & Infect, Stanford 1000 Immunomes Project, Stanford, CA 94305 USA.; Furman, D (corresponding author), Univ Austral, CONICET, Inst Res Translat Med, Buenos Aires, DF, Argentina.; Furman, D (corresponding author), Iuve Inc, San Mateo, CA 94401 USA.	furmand@stanford.edu	Gilroy, Derek W/C-2588-2009; Carrera-Bastos, Pedro/ABG-3591-2021; Slavich, George M/C-6208-2008; Fasano, Alessio/K-5486-2016; Gilroy, Derek/AAP-7227-2020; Mantovani, Alberto/HCI-7449-2022; Weyand, Cornelia/AAH-3343-2021; Slavich, George/ABD-5450-2021; Kleinstreuer, Nicole/F-7203-2019	Slavich, George M/0000-0001-5710-3818; Fasano, Alessio/0000-0002-2134-0261; Gilroy, Derek/0000-0003-3476-0844; Mantovani, Alberto/0000-0001-5578-236X; Goronzy, Jorg/0000-0001-7670-1856; Kleinstreuer, Nicole/0000-0002-7914-3682; Verdin, Eric/0000-0003-3703-3183; Carrera-Bastos, Pedro/0000-0002-4218-1300; Lucia, Alejandro/0000-0002-5565-0997; Rando, Thomas/0000-0001-5843-8564	National Institutes of Health (NIH); Buck Institute for Research on Aging; National Institute on Aging; Glenn Foundation; SENS Foundation; Ministry of Education and Science of the Russian Federation [074-02-2018-330]; Horizon 2020 Framework Programme [634821]; JPco-fuND (ADAGE); National Institute of Aging, NIH; MRC (UK); Wellcome Trust; NIH [R01 DK104344, P01 AG036695, K08 MH103443]; European Research Commission [PHII-669415]; Associazione Italiana Ricerca sul Cancro [IG 19014, 5x1000 9962, 21147]; Fondazione Cariplo; Italian Ministry of Health; UCLA AIDS Institute; Spanish Ministry of Economy and Competitiveness; Fondos FEDER [PI15/00558, PI18/00139]; Society in Science-Branco Weiss Fellowship; Brain & Behavior Research Foundation [23958]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK040561] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K08MH103443] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Buck Institute for Research on Aging; National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Glenn Foundation; SENS Foundation; Ministry of Education and Science of the Russian Federation(Ministry of Education and Science, Russian Federation); Horizon 2020 Framework Programme; JPco-fuND (ADAGE); National Institute of Aging, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); MRC (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Research Commission(European CommissionEuropean Commission Joint Research Centre); Associazione Italiana Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); Fondazione Cariplo(Fondazione Cariplo); Italian Ministry of Health(Ministry of Health, Italy); UCLA AIDS Institute; Spanish Ministry of Economy and Competitiveness(Spanish Government); Fondos FEDER(European Commission); Society in Science-Branco Weiss Fellowship; Brain & Behavior Research Foundation(NARSAD); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was made possible by support from the National Institutes of Health (NIH) and the Buck Institute for Research on Aging to D.F., the National Institute on Aging, Glenn and SENS Foundations, and the Buck Institute for Research on Aging to J.C.; the Ministry of Education and Science of the Russian Federation Agreement (074-02-2018-330) and Horizon 2020 Framework Programme (634821, PROPAG-AGING) and JPco-fuND (ADAGE) to C.F.; the Intramural Research Program of the National Institute of Aging, NIH to L.F.; the MRC (UK) and Wellcome Trust to D.W.G.; NIH grant (R01 DK104344) to A.F.; the European Research Commission (PHII-669415), Associazione Italiana Ricerca sul Cancro (Projects IG 19014, 5x1000 9962 and 21147), Fondazione Cariplo, and Italian Ministry of Health to A.M.; NIH grant (P01 AG036695) to T.A.R.; the National Institute on Aging and UCLA AIDS Institute to R.B.E.; the Spanish Ministry of Economy and Competitiveness and Fondos FEDER (PI15/00558 and PI18/00139) to A.L.; and a Society in Science-Branco Weiss Fellowship, NARSAD Young Investigator Grant 23958 from the Brain & Behavior Research Foundation and NIH grant (K08 MH103443) to G.M.S. This work represents the opinion of the authors and does not reflect official NIH policy.	Abu Mweis S, 2018, J HUM NUTR DIET, V31, P67, DOI 10.1111/jhn.12493; Afshin A, 2019, LANCET, V393, P1958, DOI 10.1016/S0140-6736(19)30041-8; Aghaeepour N, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aan2946; Agmon-Levin N, 2009, ANN NY ACAD SCI, V1173, P675, DOI 10.1111/j.1749-6632.2009.04671.x; Ahluwalia N, 2001, MECH AGEING DEV, V122, P1269, DOI 10.1016/S0047-6374(01)00266-4; Alpert A, 2019, NAT MED, V25, P487, DOI 10.1038/s41591-019-0381-y; Alvarez HAO, 2018, NEUROSCI BIOBEHAV R, V92, P226, DOI 10.1016/j.neubiorev.2018.06.002; Arai Y, 2015, EBIOMEDICINE, V2, P1549, DOI 10.1016/j.ebiom.2015.07.029; Armstrong AW, 2013, JAMA DERMATOL, V149, P84, DOI 10.1001/2013.jamadermatol.406; Aron-Wisnewsky J, 2019, GUT, V68, P70, DOI 10.1136/gutjnl-2018-316103; Beharka AA, 2001, J GERONTOL A-BIOL, V56, pB81, DOI 10.1093/gerona/56.2.B81; Bennett JM, 2018, FRONT MED-LAUSANNE, V5, DOI 10.3389/fmed.2018.00316; Bentley J, 2017, US TRENDS FOOD AVAIL; Bishehsari F, 2017, ALCOHOL RES-CURR REV, V38, P163; Bjarnason I, 2018, GASTROENTEROLOGY, V154, P500, DOI 10.1053/j.gastro.2017.10.049; Blasbalg TL, 2011, AM J CLIN NUTR, V93, P950, DOI 10.3945/ajcn.110.006643; Blazkova J, 2017, J IMMUNOL, V198, P2479, DOI 10.4049/jimmunol.1601855; Bonaventura P, 2015, AUTOIMMUN REV, V14, P277, DOI 10.1016/j.autrev.2014.11.008; Booth FW, 2012, COMPR PHYSIOL, V2, P1143, DOI 10.1002/cphy.c110025; Breen L, 2013, J CLIN ENDOCR METAB, V98, P2604, DOI 10.1210/jc.2013-1502; Brodin P, 2015, CELL, V160, P37, DOI 10.1016/j.cell.2014.12.020; Burska AN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128889; Calder PC, 2018, P NUTR SOC, V77, P52, DOI [10.1017/S0029665117003950, 10.1017/s0029665117003950]; Calder PC, 2013, BRIT J NUTR, V109, pS1, DOI 10.1017/S0007114512005119; Calder PC, 2017, BIOCHEM SOC T, V45, P1105, DOI 10.1042/BST20160474; Campisi J, 2013, ANNU REV PHYSIOL, V75, P685, DOI 10.1146/annurev-physiol-030212-183653; Cani PD, 2018, NAT REV GASTRO HEPAT, V15, P671, DOI 10.1038/s41575-018-0025-6; Carrera-Bastos P, 2011, RES REP CLIN CARDIOL, V2, P15, DOI 10.2147/RRCC.S16919; Carroll JE, 2016, BRAIN BEHAV IMMUN, V51, P223, DOI 10.1016/j.bbi.2015.08.024; Chakravarthy MV, 2004, J APPL PHYSIOL, V96, P3, DOI 10.1152/japplphysiol.00757.2003; Chandola T, 2006, BMJ-BRIT MED J, V332, P521, DOI 10.1136/bmj.38693.435301.80; Chassaing B, 2017, GUT, V66, P1414, DOI 10.1136/gutjnl-2016-313099; Chou J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054676; Chou RC, 2016, CNS DRUGS, V30, P1111, DOI 10.1007/s40263-016-0374-z; Cohen S, 2012, P NATL ACAD SCI USA, V109, P5995, DOI 10.1073/pnas.1118355109; Collins FS, 2008, SCIENCE, V319, P906, DOI 10.1126/science.1154619; Coppe JP, 2010, ANNU REV PATHOL-MECH, V5, P99, DOI 10.1146/annurev-pathol-121808-102144; Cordain L, 2000, AM J CLIN NUTR, V71, P682, DOI 10.1093/ajcn/71.3.682; Danaei G, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000058; Davis MM, 2017, NAT IMMUNOL, V18, P725, DOI 10.1038/ni.3768; de la Iglesia HO, 2016, CURR BIOL, V26, pR271, DOI 10.1016/j.cub.2016.01.071; Dickinson S, 2008, AM J CLIN NUTR, V87, P1188; Dregan A, 2014, CIRCULATION, V130, P837, DOI 10.1161/CIRCULATIONAHA.114.009990; Effros RB, 2016, MECH AGEING DEV, V158, P46, DOI 10.1016/j.mad.2015.09.003; Elisia I, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188881; Eriksson UK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070076; Ezzati M, 2017, LANCET, V390, P2627, DOI 10.1016/S0140-6736(17)32129-3; Fagundes CP, 2013, BRAIN BEHAV IMMUN, V27, P8, DOI 10.1016/j.bbi.2012.06.014; Fedewa MV, 2017, BRIT J SPORT MED, V51, P670, DOI 10.1136/bjsports-2016-095999; Ferrucci L, 2018, NAT REV CARDIOL, V15, P505, DOI 10.1038/s41569-018-0064-2; Fiuza-Luces C, 2018, NAT REV CARDIOL, V15, P731, DOI 10.1038/s41569-018-0065-1; Fleming TP, 2018, LANCET, V391, P1842, DOI [10.1016/S0140-6736(18)30312-X, 10.1016/s0140-6736(18)30312-x]; Floreani A, 2016, CLIN REV ALLERG IMMU, V50, P287, DOI 10.1007/s12016-015-8493-8; Fourati S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10369; Franceschi C, 2018, NAT REV ENDOCRINOL, V14, P576, DOI 10.1038/s41574-018-0059-4; Franceschi C, 2017, TRENDS ENDOCRIN MET, V28, P199, DOI 10.1016/j.tem.2016.09.005; Frank D, 2019, CELL DEATH DIFFER, V26, P99, DOI 10.1038/s41418-018-0212-6; Frasca D, 2017, FRONT IMMUNOL, V8, DOI [10.3389/fimmu.2017.01745, 10.3389/fimmu.2017.01003]; Fullerton JN, 2016, NAT REV DRUG DISCOV, V15, P551, DOI 10.1038/nrd.2016.39; Furman D, 2017, NAT MED, V23, P174, DOI 10.1038/nm.4267; Furman D, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa2293; Gistera A, 2017, NAT REV NEPHROL, V13, DOI 10.1038/nrneph.2017.51; Grant BF, 2017, JAMA PSYCHIAT, V74, P911, DOI 10.1001/jamapsychiatry.2017.2161; Grant RW, 2015, OBESITY, V23, P512, DOI 10.1002/oby.21003; Gurven M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055679; Hall KD, 2018, OBESITY, V26, P11, DOI 10.1002/oby.22073; Hallal PC, 2012, LANCET, V380, P247, DOI 10.1016/S0140-6736(12)60646-1; Hatori M, 2017, NPJ AGING MECH DIS, V3, DOI 10.1038/s41514-017-0010-2; Hayashino Y, 2014, METABOLISM, V63, P431, DOI 10.1016/j.metabol.2013.08.018; Heneka MT, 2014, NAT REV IMMUNOL, V14, P463, DOI 10.1038/nri3705; Himbert C, 2017, CANCER PREV RES, V10, P494, DOI 10.1158/1940-6207.CAPR-16-0322; Hotamisligil GS, 2017, NATURE, V542, P177, DOI 10.1038/nature21363; Jayashree B, 2014, MOL CELL BIOCHEM, V388, P203, DOI 10.1007/s11010-013-1911-4; Jiang C, 2018, CELL, V175, P277, DOI 10.1016/j.cell.2018.08.060; Jin CC, 2013, CELL METAB, V17, P873, DOI 10.1016/j.cmet.2013.05.011; Kaplan H, 2017, LANCET, V389, P1730, DOI 10.1016/S0140-6736(17)30752-3; Kaptoge S, 2010, LANCET, V375, P132, DOI 10.1016/S0140-6736(09)61717-7; Katzmarzyk PT, 2017, PROG CARDIOVASC DIS, V60, P3, DOI 10.1016/j.pcad.2017.01.004; Kazankov K, 2019, NAT REV GASTRO HEPAT, V16, P145, DOI 10.1038/s41575-018-0082-x; Kennedy BK, 2014, CELL, V159, P708, DOI 10.1016/j.cell.2014.10.039; Kiecolt-Glaser JK, 2012, BRAIN BEHAV IMMUN, V26, P988, DOI 10.1016/j.bbi.2012.05.011; Kiecolt-Glaser JK, 2011, BRAIN BEHAV IMMUN, V25, P1725, DOI 10.1016/j.bbi.2011.07.229; Kivimaki M, 2018, NAT REV CARDIOL, V15, P215, DOI 10.1038/nrcardio.2017.189; Kleinstreuer NC, 2014, NAT BIOTECHNOL, V32, P583, DOI 10.1038/nbt.2914; Kotas ME, 2015, CELL, V160, P816, DOI 10.1016/j.cell.2015.02.010; Kuipers RS, 2012, NUTR RES REV, V25, P96, DOI 10.1017/S0954422412000017; Kume T, 2017, J CLIN RES PEDIATR E, V9, P31, DOI 10.4274/jcrpe.3682; Le Bastard Q, 2018, ALIMENT PHARM THER, V47, P332, DOI 10.1111/apt.14451; Le Belle JE, 2014, STEM CELL REP, V3, P725, DOI 10.1016/j.stemcr.2014.09.004; Le Chatelier E, 2013, NATURE, V500, P541, DOI 10.1038/nature12506; Leproult R, 2014, DIABETES, V63, P1860, DOI 10.2337/db13-1546; Lerner A, 2015, AUTOIMMUN REV, V14, P479, DOI 10.1016/j.autrev.2015.01.009; Liebert MA, 2013, ANN HUM BIOL, V40, P228, DOI 10.3109/03014460.2012.759621; Lindeberg S, 1997, AM J CLIN NUTR, V66, P845, DOI 10.1093/ajcn/66.4.845; LINDEBERG S, 1993, J INTERN MED, V233, P269, DOI 10.1111/j.1365-2796.1993.tb00986.x; Lindeberg SA, 1999, METABOLISM, V48, P1216, DOI 10.1016/S0026-0495(99)90258-5; Liston A, 2017, NAT REV IMMUNOL, V17, P208, DOI 10.1038/nri.2016.151; Lunn RM, 2017, SCI TOTAL ENVIRON, V607, P1073, DOI 10.1016/j.scitotenv.2017.07.056; Macpherson AJ, 2017, NAT REV IMMUNOL, V17, P508, DOI 10.1038/nri.2017.58; McCarter K, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-012296; McDade TW, 2012, P NATL ACAD SCI USA, V109, P17281, DOI 10.1073/pnas.1202244109; McDade TW, 2012, AM J HUM BIOL, V24, P675, DOI 10.1002/ajhb.22296; McDade TW, 2011, AM J HUM BIOL, V23, P313, DOI 10.1002/ajhb.21128; McDade TW, 2010, P ROY SOC B-BIOL SCI, V277, P1129, DOI 10.1098/rspb.2009.1795; Meneses-Echavez JF, 2016, CANCER EPIDEM BIOMAR, V25, P1009, DOI 10.1158/1055-9965.EPI-15-1061; Miller AH, 2016, NAT REV IMMUNOL, V16, P22, DOI 10.1038/nri.2015.5; Miller GE, 2011, PSYCHOL BULL, V137, P959, DOI 10.1037/a0024768; Moore SC, 2016, JAMA INTERN MED, V176, P816, DOI 10.1001/jamainternmed.2016.1548; Morrisette-Thomas V, 2014, MECH AGEING DEV, V139, P49, DOI 10.1016/j.mad.2014.06.005; Mozaffarian D, 2009, EUR J CLIN NUTR, V63, pS5, DOI 10.1038/sj.ejcn.1602973; Muller DN, 2019, NAT REV IMMUNOL, V19, P243, DOI 10.1038/s41577-018-0113-4; Netea MG, 2017, NAT IMMUNOL, V18, P826, DOI 10.1038/ni.3790; Niedzwiecki MM, 2019, ANNU REV PHARMACOL, V59, P107, DOI 10.1146/annurev-pharmtox-010818-021315; Nielsen FH, 2014, CURR OPIN CLIN NUTR, V17, P525, DOI 10.1097/MCO.0000000000000093; Pawelec G, 2005, IMMUNOL REV, V205, P257, DOI 10.1111/j.0105-2896.2005.00271.x; Pellegrinelli V, 2016, DIABETOLOGIA, V59, P1075, DOI 10.1007/s00125-016-3933-4; Perez LM, 2016, J PHYSIOL-LONDON, V594, P3187, DOI 10.1113/JP271691; Petta S, 2016, GASTROENTEROLOGY, V150, P145, DOI 10.1053/j.gastro.2015.09.007; Proctor MJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116206; Qi YF, 2017, J AM MED DIR ASSOC, V18, DOI 10.1016/j.jamda.2017.05.018; Raichlen DA, 2017, AM J HUM BIOL, V29, DOI 10.1002/ajhb.22919; Razzoli M, 2018, AGING CELL, V17, DOI 10.1111/acel.12778; Redlich K, 2012, NAT REV DRUG DISCOV, V11, P234, DOI 10.1038/nrd3669; Reitsma MB, 2017, LANCET, V389, P1885, DOI 10.1016/S0140-6736(17)30819-X; Renz H, 2017, J ALLERGY CLIN IMMUN, V140, P24, DOI 10.1016/j.jaci.2017.05.015; Reutrakul S, 2018, METABOLISM, V84, P56, DOI 10.1016/j.metabol.2018.02.010; Richards JL, 2016, CLIN TRANSL IMMUNOL, V5, DOI 10.1038/cti.2016.29; Ridker PM, 2017, NEW ENGL J MED, V377, P1119, DOI 10.1056/NEJMoa1707914; Ridker PM, 2016, J AM COLL CARDIOL, V67, P712, DOI 10.1016/j.jacc.2015.11.037; Rook G, 2017, LANCET, V390, P521, DOI 10.1016/S0140-6736(17)30566-4; Root-Bernstein R, 2014, CURR ALLERGY ASTHM R, V14, DOI 10.1007/s11882-013-0407-3; Rose SMSF, 2019, NAT MED, V25, P792, DOI 10.1038/s41591-019-0414-6; Roth GA, 2018, LANCET, V392, P1736, DOI [10.1016/S0140-6736(18)32203-7, 10.1016/s0140-6736(18)32203-7]; Roubenoff R, 1998, J GERONTOL A-BIOL, V53, pM20, DOI 10.1093/gerona/53A.1.M20; Santos-Lozano A, 2016, MAYO CLIN PROC, V91, P999, DOI 10.1016/j.mayocp.2016.04.024; Schipper HS, 2012, TRENDS ENDOCRIN MET, V23, P407, DOI 10.1016/j.tem.2012.05.011; Schnabel L, 2019, JAMA INTERN MED, V179, P490, DOI 10.1001/jamainternmed.2018.7289; Serhan CN, 2018, J CLIN INVEST, V128, P2657, DOI 10.1172/JCI97943; Serhan CN, 2014, NATURE, V510, P92, DOI 10.1038/nature13479; Shen-Orr SS, 2016, CELL SYST, V3, P374, DOI 10.1016/j.cels.2016.09.009; Shen-Orr SS, 2013, CURR OPIN IMMUNOL, V25, P542, DOI 10.1016/j.coi.2013.07.009; Simmen FA, 2011, EUR J CANCER PREV, V20, P539, DOI 10.1097/CEJ.0b013e328348fc21; Singer K, 2017, J CLIN INVEST, V127, P65, DOI [10.1172/JCI88882, 10.1172/jci88882]; Slavich G. M., OXFORD HDB STRESS ME; Slavich GM, 2019, PSYCHOPHARMACOLOGY, V236, P3063, DOI 10.1007/s00213-019-05326-9; Slavich GM, 2015, BRAIN BEHAV IMMUN, V45, P13, DOI 10.1016/j.bbi.2014.10.012; Slavich GM, 2014, PSYCHOL BULL, V140, P774, DOI 10.1037/a0035302; Slavich GM, 2013, CLIN PSYCHOL SCI, V1, P331, DOI 10.1177/2167702613478594; Slavich GM, 2010, P NATL ACAD SCI USA, V107, P14817, DOI 10.1073/pnas.1009164107; Sly PD, 2016, ANN GLOB HEALTH, V82, P3, DOI 10.1016/j.aogh.2016.01.004; Sochocka M, 2017, CURR NEUROPHARMACOL, V15, P996, DOI 10.2174/1570159X15666170313122937; Sonnenburg ED, 2019, NAT REV MICROBIOL, V17, P383, DOI 10.1038/s41579-019-0191-8; Steptoe A, 2013, P NATL ACAD SCI USA, V110, P5797, DOI 10.1073/pnas.1219686110; Stout MB, 2017, PHYSIOLOGY, V32, P9, DOI 10.1152/physiol.00012.2016; Straub RH, 2010, J INTERN MED, V267, P543, DOI 10.1111/j.1365-2796.2010.02218.x; Straub RH, 2017, NAT REV RHEUMATOL, V13, P743, DOI 10.1038/nrrheum.2017.172; Straub RH, 2016, EVOL MED PUBLIC HLTH, P37, DOI 10.1093/emph/eow001; Straub RH, 2015, SEMIN ARTHRITIS RHEU, V45, P220, DOI 10.1016/j.semarthrit.2015.04.014; Sturgeon C, 2016, TISSUE BARRIERS, V4, DOI 10.1080/21688370.2016.1251384; Su LF, 2013, COLD SH Q B, V78, P203, DOI 10.1101/sqb.2013.78.022905; Taniguchi K, 2018, NAT REV IMMUNOL, V18, P309, DOI 10.1038/nri.2017.142; Tchernof A, 2013, PHYSIOL REV, V93, P359, DOI 10.1152/physrev.00033.2011; Thompson PA, 2015, CARCINOGENESIS, V36, pS232, DOI 10.1093/carcin/bgv038; Tobaldini E, 2019, NAT REV CARDIOL, V16, P213, DOI 10.1038/s41569-018-0109-6; Touitou Y, 2017, LIFE SCI, V173, P94, DOI 10.1016/j.lfs.2017.02.008; Valtorta NK, 2016, HEART, V102, P1009, DOI 10.1136/heartjnl-2015-308790; van Dijk G, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00173; van Niekerk G, 2018, METABOLISM, V82, P14, DOI 10.1016/j.metabol.2017.12.007; Verschoor CP, 2017, J INFECT DIS, V216, P191, DOI 10.1093/infdis/jix257; Versini M, 2014, AUTOIMMUN REV, V13, P981, DOI 10.1016/j.autrev.2014.07.001; Virgin HW, 2009, CELL, V138, P30, DOI 10.1016/j.cell.2009.06.036; Vlassara H, 2011, NAT REV ENDOCRINOL, V7, P526, DOI 10.1038/nrendo.2011.74; Wahid A, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.115.002495; Wang C, 2014, J IMMUNOL, V192, P603, DOI 10.4049/jimmunol.1301384; Yuan JH, 2018, J GERONTOL A-BIOL, V73, P1027, DOI 10.1093/gerona/gly002; Zhang JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078151; Zhu Y, 2014, CURR OPIN CLIN NUTR, V17, P324, DOI 10.1097/MCO.0000000000000065; Zitvogel L, 2017, NAT IMMUNOL, V18, P843, DOI 10.1038/ni.3754; Zmora N, 2017, CELL METAB, V25, P506, DOI 10.1016/j.cmet.2017.02.006	179	1011	1023	45	239	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	2019	25	12					1822	1832		10.1038/s41591-019-0675-0	http://dx.doi.org/10.1038/s41591-019-0675-0			11	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	JT2KO	31806905	Bronze, Green Submitted, Green Accepted			2022-12-27	WOS:000500824900023
J	Roep, BO				Roep, Bart O.			A viral link for type 1 diabetes	NATURE MEDICINE			English	Editorial Material							INFECTION; VIRUS; ONSET	Enteroviral infection persistence as determined by host genetic susceptibility, rather than independent, short-lived infections, may contribute to islet autoimmunity and be a precursor to the development of type 1 diabetes.	[Roep, Bart O.] Natl Med Ctr, Beckman Res Inst, Dept Diabet Immunol, Duarte, CA USA; [Roep, Bart O.] Natl Med Ctr, Beckman Res Inst, Diabet & Metab Res Inst, Duarte, CA USA	City of Hope; Beckman Research Institute of City of Hope; City of Hope; Beckman Research Institute of City of Hope	Roep, BO (corresponding author), Natl Med Ctr, Beckman Res Inst, Dept Diabet Immunol, Duarte, CA USA.; Roep, BO (corresponding author), Natl Med Ctr, Beckman Res Inst, Diabet & Metab Res Inst, Duarte, CA USA.	broep@coh.org	Roep, Bart/AAD-7609-2021					Dotta F, 2007, P NATL ACAD SCI USA, V104, P5115, DOI 10.1073/pnas.0700442104; Flodstrom M, 2002, NAT IMMUNOL, V3, P373, DOI 10.1038/ni771; Kracht MJL, 2017, NAT MED, V23, P501, DOI 10.1038/nm.4289; Krogvold L, 2015, DIABETES, V64, P1682, DOI 10.2337/db14-1370; Leete P, 2016, DIABETES, V65, P1362, DOI 10.2337/db15-1615; Skog O, 2019, DIABETOLOGIA, V62, P1097, DOI 10.1007/s00125-019-4841-1; Thomas NJ, 2018, LANCET DIABETES ENDO, V6, P122, DOI 10.1016/S2213-8587(17)30362-5; Vehik K, 2019, NAT MED, V25, P1865, DOI 10.1038/s41591-019-0667-0; Woittiez NJC, 2015, IMMUNOTHERAPY-UK, V7, P163, DOI 10.2217/imt.14.104; YOON JW, 1979, NEW ENGL J MED, V300, P1173, DOI 10.1056/NEJM197905243002102	10	6	6	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	2019	25	12					1816	1818		10.1038/s41591-019-0689-7	http://dx.doi.org/10.1038/s41591-019-0689-7			4	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	JT2KO	31792457				2022-12-27	WOS:000500824900020
J	Stower, H				Stower, Hannah			MICROBIOTA Gut-brain communication	NATURE MEDICINE			English	Editorial Material																			0	1	1	2	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	2019	25	12					1799	1799		10.1038/s41591-019-0685-y	http://dx.doi.org/10.1038/s41591-019-0685-y			1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	JT2KO	31806899	Bronze			2022-12-27	WOS:000500824900007
J	Davies, KE; Chamberlain, JS				Davies, Kay E.; Chamberlain, Jeffrey S.			Surrogate gene therapy for muscular dystrophy	NATURE MEDICINE			English	Editorial Material							MUSCLE FUNCTION		[Davies, Kay E.] Univ Oxford, Dept Physiol Anat & Genet, MDUK Oxford Neuromuscular Ctr, Oxford, England; [Chamberlain, Jeffrey S.] Univ Washington, Sch Med, Wellstone Muscular Dystrophy Specialized Res Ctr, Dept Neurol, Seattle, WA USA; [Chamberlain, Jeffrey S.] Univ Washington, Sch Med, Dept Med, Wellstone Muscular Dystrophy Specialized Res Ctr, Seattle, WA 98195 USA; [Chamberlain, Jeffrey S.] Univ Washington, Sch Med, Dept Biochem, Wellstone Muscular Dystrophy Specialized Res Ctr, Seattle, WA 98195 USA	University of Oxford; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Davies, KE (corresponding author), Univ Oxford, Dept Physiol Anat & Genet, MDUK Oxford Neuromuscular Ctr, Oxford, England.	kay.davies@dpag.ox.ac.uk		Davies, Kay/0000-0001-8807-8520; Chamberlain, Jeffrey/0000-0001-5299-0059	MRC [MR/N010698/1] Funding Source: UKRI; Medical Research Council [MR/N010698/1] Funding Source: Medline; NIAMS NIH HHS [R01 AR044533, R01 AR040864, P50 AR065139] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Chamberlain JR, 2017, MOL THER, V25, P1125, DOI 10.1016/j.ymthe.2017.02.019; Crudele JM, 2019, HUM MOL GENET, V28, pR102, DOI 10.1093/hmg/ddz128; Duan DS, 2018, MOL THER, V26, P2337, DOI 10.1016/j.ymthe.2018.07.011; Guiraud S, 2019, HUM MOL GENET, V28, P2189, DOI 10.1093/hmg/ddz049; Guiraud S, 2017, CURR OPIN PHARMACOL, V34, P36, DOI 10.1016/j.coph.2017.04.002; Guiraud S, 2015, ANNU REV GENOM HUM G, V16, P281, DOI 10.1146/annurev-genom-090314-025003; Harper SQ, 2002, NAT MED, V8, P253, DOI 10.1038/nm0302-253; Kennedy TL, 2018, MOL THER-METH CLIN D, V11, P92, DOI 10.1016/j.omtm.2018.10.005; Mendell JR, 2010, NEW ENGL J MED, V363, P1429, DOI 10.1056/NEJMoa1000228; Odom GL, 2008, MOL THER, V16, P1539, DOI 10.1038/mt.2008.149; Ramos JN, 2019, MOL THER, V27, P623, DOI 10.1016/j.ymthe.2019.01.002; Song YF, 2019, NAT MED, V25, P1505, DOI 10.1038/s41591-019-0594-0	12	7	7	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	OCT	2019	25	10					1473	1474		10.1038/s41591-019-0604-2	http://dx.doi.org/10.1038/s41591-019-0604-2			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	JC3GJ	31591598	Green Submitted			2022-12-27	WOS:000489166700013
J	Ramakrishna, S; Shah, NIN				Ramakrishna, Sneha; Shah, Nirali N.			Using single-cell analysis to predict CAR T cell outcomes	NATURE MEDICINE			English	Editorial Material							CD19	Single-cell analysis provides novel insights into elements of CAR T cell toxicities and response.	[Ramakrishna, Sneha] Stanford Univ, Dept Pediat, Div Pediat Hematol Oncol, Palo Alto, CA 94304 USA; [Shah, Nirali N.] NCI, Pediat Oncol Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA	Stanford University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Shah, NIN (corresponding author), NCI, Pediat Oncol Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA.	nirali.shah@nih.gov		Ramakrishna, Sneha/0000-0001-7445-3190				Das RK, 2019, CANCER DISCOV, V9, P492, DOI 10.1158/2159-8290.CD-18-1314; Deng Q, 2020, NAT MED, V26, DOI 10.1038/s41591-020-1061-7; Eshhar Z., 2008, V181, P329; Finney OC, 2019, J CLIN INVEST, V129, P2123, DOI 10.1172/JCI125423; Fraietta JA, 2018, NAT MED, V24, P563, DOI 10.1038/s41591-018-0010-1; Gust J, 2017, CANCER DISCOV, V7, P1404, DOI 10.1158/2159-8290.CD-17-0698; Locke FL, 2020, BLOOD ADV, V4, P4898, DOI 10.1182/bloodadvances.2020002394; Locke FL, 2019, LANCET ONCOL, V20, P31, DOI 10.1016/S1470-2045(18)30864-7; Neelapu SS, 2017, NEW ENGL J MED, V377, P2531, DOI 10.1056/NEJMoa1707447; Norelli M, 2018, NAT MED, V24, P739, DOI 10.1038/s41591-018-0036-4; Parker KR, 2020, CELL, V183, P126, DOI 10.1016/j.cell.2020.08.022; Schuster SJ, 2017, NEW ENGL J MED, V377, P2545, DOI 10.1056/NEJMoa1708566; Sommermeyer D, 2016, LEUKEMIA, V30, P492, DOI 10.1038/leu.2015.247	13	2	2	3	12	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	2020	26	12					1813	1814		10.1038/s41591-020-01157-w	http://dx.doi.org/10.1038/s41591-020-01157-w		NOV 2020	2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	PB8QO	33230341				2022-12-27	WOS:000591980700005
J	Maldini, CR; Claiborne, DT; Okawa, K; Chen, T; Dopkin, DL; Shan, XC; Power, KA; Trifonova, RT; Krupp, K; Phelps, M; Vrbanac, VD; Tanno, S; Bateson, T; Leslie, GJ; Hoxie, JA; Boutwell, CL; Riley, JL; Allen, TM				Maldini, Colby R.; Claiborne, Daniel T.; Okawa, Ken; Chen, Tao; Dopkin, Derrick L.; Shan, Xiaochuan; Power, Karen A.; Trifonova, Radiana T.; Krupp, Katharine; Phelps, Meredith; Vrbanac, Vladimir D.; Tanno, Serah; Bateson, Timothy; Leslie, George J.; Hoxie, James A.; Boutwell, Christian L.; Riley, James L.; Allen, Todd M.			Dual CD4-based CAR T cells with distinct costimulatory domains mitigate HIV pathogenesis in vivo	NATURE MEDICINE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; ANTIGEN RECEPTOR; HUMANIZED MICE; PERSISTENCE; ACTIVATION; TRANSMISSION; RESISTANCE; EXPRESSION; THERAPY; CCR5	Chimeric antigen receptor T cells targeting HIV-infected cells prevent T cell loss and reduce virus in blood and tissues of HIV-infected humanized mice, highlighting a path toward a cell-based therapy for HIV infection. An effective strategy to cure HIV will likely require a potent and sustained antiviral T cell response. Here we explored the utility of chimeric antigen receptor (CAR) T cells, expressing the CD4 ectodomain to confer specificity for the HIV envelope, to mitigate HIV-induced pathogenesis in bone marrow, liver, thymus (BLT) humanized mice. CAR T cells expressing the 4-1BB/CD3-zeta endodomain were insufficient to prevent viral rebound and CD4(+)T cell loss after the discontinuation of antiretroviral therapy. Through iterative improvements to the CAR T cell product, we developed Dual-CAR T cells that simultaneously expressed both 4-1BB/CD3-zeta and CD28/CD3-zeta endodomains. Dual-CAR T cells exhibited expansion kinetics that exceeded 4-1BB-, CD28- and third-generation costimulated CAR T cells, elicited effector functions equivalent to CD28-costimulated CAR T cells and prevented HIV-induced CD4(+)T cell loss despite persistent viremia. Moreover, when Dual-CAR T cells were protected from HIV infection through expression of the C34-CXCR4 fusion inhibitor, these cells significantly reduced acute-phase viremia, as well as accelerated HIV suppression in the presence of antiretroviral therapy and reduced tissue viral burden. Collectively, these studies demonstrate the enhanced therapeutic potency of a novel Dual-CAR T cell product with the potential to effectively treat HIV infection.	[Maldini, Colby R.; Riley, James L.] Univ Penn, Ctr Cellular Immunotherapies, Perelman Sch Med, Dept Microbiol, Philadelphia, PA 19104 USA; [Claiborne, Daniel T.; Okawa, Ken; Chen, Tao; Power, Karen A.; Trifonova, Radiana T.; Krupp, Katharine; Phelps, Meredith; Vrbanac, Vladimir D.; Tanno, Serah; Bateson, Timothy; Boutwell, Christian L.; Allen, Todd M.] Ragon Inst MGH MIT & Harvard, Cambridge, MA 02139 USA; [Dopkin, Derrick L.; Shan, Xiaochuan] Univ Penn, Perelman Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Vrbanac, Vladimir D.; Tanno, Serah] Massachusetts Gen Hosp, Human Immune Syst Mouse Program, Boston, MA 02114 USA; [Leslie, George J.; Hoxie, James A.] Univ Penn, Dept Med, Perelman Sch Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Harvard University; Harvard Medical School; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute; University of Pennsylvania; Pennsylvania Medicine; Harvard University; Massachusetts General Hospital; University of Pennsylvania; Pennsylvania Medicine	Riley, JL (corresponding author), Univ Penn, Ctr Cellular Immunotherapies, Perelman Sch Med, Dept Microbiol, Philadelphia, PA 19104 USA.; Allen, TM (corresponding author), Ragon Inst MGH MIT & Harvard, Cambridge, MA 02139 USA.	rileyj@upenn.edu; tallen2@mgh.harvard.edu	Allen, Todd/F-5473-2011	Allen, Todd/0000-0002-6609-1318; Riley, James/0000-0002-1057-576X; Phelps, Meredith/0000-0003-3522-4226; Trifonova, Radiana/0000-0002-6191-1970	NIH - NIAID [P01HL129903, U19AI117950, UM1AI126620]; NIH - NIDA [P01HL129903, U19AI117950, UM1AI126620]; NIH - NIMH [P01HL129903, U19AI117950, UM1AI126620]; NIH - NINDS [P01HL129903, U19AI117950, UM1AI126620]; T32 grant [AI007632]; NIAID F32 grant [AI136750]; Ragon Institute of MGH, MIT and Harvard; MGH Scholars program	NIH - NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH - NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIH - NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIH - NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); T32 grant; NIAID F32 grant; Ragon Institute of MGH, MIT and Harvard; MGH Scholars program	We thank C. Ellebrecht and A. Payne (University of Pennsylvania) for the HIV<INF>YU2</INF> Envelope-transduced K562 cell line. We thank W. Garcia-Beltran for artistic contributions. This study was supported by NIH grants P01HL129903 (T.M.A.), U19AI117950 (J.L.R.) and UM1AI126620 (J.L.R.) funded by NIAID, NIDA, NIMH and NINDS; T32 grant AI007632 (C.R.M.); and an NIAID F32 grant AI136750 (D.T.C.). We also acknowledge support from the Ragon Institute of MGH, MIT and Harvard and the MGH Scholars program (T.M.A.). We thank the Human Immune System Mouse Core at the Ragon Institute of MGH, MIT and Harvard and the Stem Cell and Xenograft Core at the University of Pennsylvania for the generation of BLT humanized mice, the Penn Center for AIDS Research (P30-AI045008) for purified human T cells, and the Allen and Riley laboratories for helpful comments.	Abate-Daga D, 2016, MOL THER-ONCOLYTICS, V3, DOI 10.1038/mto.2016.14; Alfei F, 2019, NATURE, V571, P265, DOI 10.1038/s41586-019-1326-9; Ali A, 2016, J VIROL, V90, P6999, DOI 10.1128/JVI.00805-16; Anthony-Gonda K, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aav5685; Appay V, 2002, NAT MED, V8, P379, DOI 10.1038/nm0402-379; Boritz EA, 2016, CELL, V166, P1004, DOI 10.1016/j.cell.2016.06.039; Boutwell CL, 2009, J VIROL, V83, P2460, DOI 10.1128/JVI.01970-08; Brainard DM, 2009, J VIROL, V83, P7305, DOI 10.1128/JVI.02207-08; Brelot A, 2000, J BIOL CHEM, V275, P23736, DOI 10.1074/jbc.M000776200; Brentjens RJ, 2007, CLIN CANCER RES, V13, P5426, DOI 10.1158/1078-0432.CCR-07-0674; Buggert M, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004251; Carpenito C, 2009, P NATL ACAD SCI USA, V106, P3360, DOI 10.1073/pnas.0813101106; Cheng Z, 2018, MOL THER, V26, P976, DOI 10.1016/j.ymthe.2018.01.022; Claiborne DT, 2019, J VIROL, V93, DOI 10.1128/JVI.00814-19; Claiborne DT, 2015, P NATL ACAD SCI USA, V112, pE1480, DOI 10.1073/pnas.1421607112; Clayton KL, 2018, NAT IMMUNOL, V19, P475, DOI 10.1038/s41590-018-0085-3; Colovos C, 2012, IMMUNOTHERAPY-UK, V4, P899, DOI 10.2217/imt.12.91; Deeks SG, 2002, MOL THER, V5, P788, DOI 10.1006/mthe.2002.0611; Denton PW, 2008, PLOS MED, V5, P79, DOI 10.1371/journal.pmed.0050016; Deymier MJ, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005154; Dudek TE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003984; Estes JD, 2017, NAT MED, V23, P1271, DOI 10.1038/nm.4411; GROSS G, 1989, P NATL ACAD SCI USA, V86, P10024, DOI 10.1073/pnas.86.24.10024; Guedan S, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.96976; Hale M, 2017, MOL THER, V25, P570, DOI 10.1016/j.ymthe.2016.12.023; Herzig E, 2019, CELL, V179, P880, DOI 10.1016/j.cell.2019.10.002; Hindson BJ, 2011, ANAL CHEM, V83, P8604, DOI 10.1021/ac202028g; Holt N, 2010, NAT BIOTECHNOL, V28, P839, DOI 10.1038/nbt.1663; Hombach AA, 2012, ONCOIMMUNOLOGY, V1, DOI 10.4161/onci.19855; JOHNSON D, 1986, CELL, V47, P545, DOI 10.1016/0092-8674(86)90619-7; June CH, 2018, NEW ENGL J MED, V379, P64, DOI 10.1056/NEJMra1706169; Karpel ME, 2015, CURR OPIN VIROL, V13, P75, DOI 10.1016/j.coviro.2015.05.002; Kawalekar OU, 2016, IMMUNITY, V44, P380, DOI 10.1016/j.immuni.2016.01.021; Khan O, 2019, NATURE, V571, P211, DOI 10.1038/s41586-019-1325-x; Kim GB, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02310; Leibman RS, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006613; Leslie GJ, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005983; Martinez-Torres F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108663; Maude SL, 2014, NEW ENGL J MED, V371, P1507, DOI 10.1056/NEJMoa1407222; Milone MC, 2009, MOL THER, V17, P1453, DOI 10.1038/mt.2009.83; Moir S, 2011, ANNU REV PATHOL-MECH, V6, P223, DOI 10.1146/annurev-pathol-011110-130254; Neelapu SS, 2017, NEW ENGL J MED, V377, P2531, DOI 10.1056/NEJMoa1707447; Pardi N, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14630; Park JH, 2018, NEW ENGL J MED, V378, P449, DOI 10.1056/NEJMoa1709919; Perez EE, 2008, NAT BIOTECHNOL, V26, P808, DOI 10.1038/nbt1410; Peterson CW, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006956; Porter DL, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac5415; Prince JL, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003041; Pule MA, 2005, MOL THER, V12, P933, DOI 10.1016/j.ymthe.2005.04.016; Quintarelli C, 2018, ONCOIMMUNOLOGY, V7, DOI 10.1080/2162402X.2018.1433518; Richardson MW, 2008, J VIROL, V82, P11117, DOI 10.1128/JVI.01046-08; Salter AI, 2018, SCI SIGNAL, V11, DOI 10.1126/scisignal.aat6753; Scholler J, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003761; Schuster SJ, 2019, NEW ENGL J MED, V380, P45, DOI 10.1056/NEJMoa1804980; Scott AC, 2019, NATURE, V571, P270, DOI 10.1038/s41586-019-1324-y; Seo H, 2019, P NATL ACAD SCI USA, V116, P12410, DOI 10.1073/pnas.1905675116; Seung E, 2013, J INFECT DIS, V208, pS155, DOI 10.1093/infdis/jit448; Song DG, 2011, CANCER RES, V71, P4617, DOI 10.1158/0008-5472.CAN-11-0422; Sun ZF, 2007, J EXP MED, V204, P705, DOI 10.1084/jem.20062411; Tebas P, 2014, NEW ENGL J MED, V370, P901, DOI 10.1056/NEJMoa1300662; van der Stegen SJC, 2015, NAT REV DRUG DISCOV, V14, P499, DOI 10.1038/nrd4597; Ventura JD, 2019, PLOS PATHOG, V15, DOI 10.1371/journal.ppat.1008161; Walker B, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a007054; Wang XL, 2011, BLOOD, V118, P1255, DOI 10.1182/blood-2011-02-337360; Wang ZX, 2017, INT J DISTRIB SENS N, V13, DOI 10.1177/1550147717726309; Weinkove R, 2019, CLIN TRANSL IMMUNOL, V8, DOI 10.1002/cti2.1049; Wright JK, 2011, J VIROL, V85, P3996, DOI 10.1128/JVI.02520-10; Yao C, 2019, NAT IMMUNOL, V20, P890, DOI 10.1038/s41590-019-0403-4; Zhao ZG, 2015, CANCER CELL, V28, P415, DOI 10.1016/j.ccell.2015.09.004; Zhen A, 2017, J CLIN INVEST, V127, P260, DOI 10.1172/JCI89488	70	27	28	1	29	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2020	26	11					1776	+		10.1038/s41591-020-1039-5	http://dx.doi.org/10.1038/s41591-020-1039-5		AUG 2020	25	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	OT0SR	32868878	Green Accepted			2022-12-27	WOS:000564531600001
J	Cader, FZ; Hu, XH; Goh, WL; Wienand, K; Ouyang, J; Mandato, E; Redd, R; Lawton, LN; Chen, PH; Weirather, JL; Schackmann, RCJ; Li, B; Ma, WJ; Armand, P; Rodig, SJ; Neuberg, D; Liu, XS; Shipp, MA				Cader, Fathima Zumla; Hu, Xihao; Goh, Walter L.; Wienand, Kirsty; Ouyang, Jing; Mandato, Elisa; Redd, Robert; Lawton, Lee N.; Chen, Pei-Hsuan; Weirather, Jason L.; Schackmann, Ron C. J.; Li, Bo; Ma, Wenjiang; Armand, Philippe; Rodig, Scott J.; Neuberg, Donna; Liu, X. Shirley; Shipp, Margaret A.			A peripheral immune signature of responsiveness to PD-1 blockade in patients with classical Hodgkin lymphoma	NATURE MEDICINE			English	Article							REED-STERNBERG CELLS; CD8(+) T-CELLS; ANALYSIS REVEALS; PHASE-II; EXPRESSION; CD4(+); PEMBROLIZUMAB; NIVOLUMAB; RESPONSES; EVASION	PD-1 blockade is highly effective in classical Hodgkin lymphomas (cHLs), which exhibit frequent copy-number gains ofCD274(PD-L1) andPDC1LG2(PD-L2) on chromosome 9p24.1. However, in this largely MHC-class-I-negative tumor, the mechanism of action of anti-PD-1 therapy remains undefined. We utilized the complementary approaches of T cell receptor (TCR) sequencing and cytometry by time-of-flight analysis to obtain a peripheral immune signature of responsiveness to PD-1 blockade in 56 patients treated in the CheckMate 205 phase II clinical trial (NCT02181738). Anti-PD-1 therapy was most effective in patients with a diverse baseline TCR repertoire and an associated expansion of singleton clones during treatment. CD4(+), but not CD8(+), TCR diversity significantly increased during therapy, most strikingly in patients who had achieved complete responses. Additionally, patients who responded to therapy had an increased abundance of activated natural killer cells and a newly identified CD3(-)CD68(+)CD4(+)GrB(+)subset. These studies highlight the roles of recently expanded, clonally diverse CD4(+)T cells and innate effectors in the efficacy of PD-1 blockade in cHL.	[Cader, Fathima Zumla; Wienand, Kirsty; Ouyang, Jing; Mandato, Elisa; Lawton, Lee N.; Ma, Wenjiang; Armand, Philippe; Shipp, Margaret A.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Hu, Xihao; Redd, Robert; Neuberg, Donna; Liu, X. Shirley] Dana Farber Canc Inst, Dept Data Sci, Boston, MA 02115 USA; [Hu, Xihao; Li, Bo; Liu, X. Shirley] Harvard TH Chan Sch Publ Hlth, Boston, MA 02115 USA; [Goh, Walter L.; Schackmann, Ron C. J.] Harvard Med Sch, Dept Cell Biol, Boston, MA 02115 USA; [Chen, Pei-Hsuan; Weirather, Jason L.] Dana Farber Canc Inst, Ctr Immunooncol, Boston, MA 02115 USA; [Rodig, Scott J.] Brigham & Womens Hosp, Dept Pathol, 75 Francis St, Boston, MA 02115 USA; [Cader, Fathima Zumla] AstraZeneca, City House, Cambridge, England; [Hu, Xihao] GV20 Therapeut LLC, Cambridge, MA USA; [Wienand, Kirsty] Gottingen Comprehens Canc Ctr, Dept Hematol & Oncol, Gottingen, Germany; [Schackmann, Ron C. J.] Merus, Utrecht, Netherlands; [Li, Bo] UT Southwestern Med Ctr, Lyda Hill Dept Bioinformat, Dallas, TX USA; [Ma, Wenjiang] Clar Healthcare, Boston, MA USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; AstraZeneca; University of Texas System; University of Texas Southwestern Medical Center Dallas	Shipp, MA (corresponding author), Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA.; Liu, XS (corresponding author), Dana Farber Canc Inst, Dept Data Sci, Boston, MA 02115 USA.; Liu, XS (corresponding author), Harvard TH Chan Sch Publ Hlth, Boston, MA 02115 USA.	xsliu@ds.dfci.harvard.edu; Margaret_Shipp@dfci.harvard.edu	mandato, elisa/AGI-6364-2022	mandato, elisa/0000-0002-7443-2821; Hu, Xihao/0000-0002-3517-6351; Weirather, Jason/0000-0003-0556-0616; Redd, Robert/0000-0002-1329-5288; Cader, Fathima/0000-0001-5107-0146	Bloodwise Fellowship [14042]; Helen Gurley Brown Fellowship [R01 CA161026]; Miller Family Fund; BMS International Immuno-Oncology Network [R01 CA234018]	Bloodwise Fellowship; Helen Gurley Brown Fellowship; Miller Family Fund; BMS International Immuno-Oncology Network	This work was supported in part by Bloodwise Fellowship 14042 and a Helen Gurley Brown Fellowship (F.Z.C.), a R01 CA161026 (M.A.S.), the Miller Family Fund (M.A.S.), the BMS International Immuno-Oncology Network (M.A.S. and S.J.R.) and a R01 CA234018 (X.S.L.). The authors thank L. Boyne (Dana-Farber Cancer Institute) for providing editorial assistance.	Acharya N, 2019, IMMUNITY, V51, P606, DOI 10.1016/j.immuni.2019.09.018; Alspach E, 2019, NATURE, V574, P696, DOI 10.1038/s41586-019-1671-8; Ansell SM, 2015, NEW ENGL J MED, V372, P311, DOI 10.1056/NEJMoa1411087; Armand P, 2018, J CLIN ONCOL, V36, P1428, DOI 10.1200/JCO.2017.76.0793; Armand P, 2016, J CLIN ONCOL, V34, P3733, DOI 10.1200/JCO.2016.67.3467; Bakhru P, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.93265; Barry KC, 2018, NAT MED, V24, P1178, DOI 10.1038/s41591-018-0085-8; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Cader FZ, 2018, BLOOD, V132, P825, DOI 10.1182/blood-2018-04-843714; Carey CD, 2017, BLOOD, V130, P2420, DOI 10.1182/blood-2017-03-770719; Carlson CS, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3680; Chen R, 2017, J CLIN ONCOL, V35, P2125, DOI 10.1200/JCO.2016.72.1316; Choi IK, 2018, P NATL ACAD SCI USA, V115, pE686, DOI 10.1073/pnas.1713607115; CUZICK J, 1985, STAT MED, V4, P87, DOI 10.1002/sim.4780040112; Elavazhagan S, 2015, J IMMUNOL, V194, P2786, DOI 10.4049/jimmunol.1402316; Freud AG, 2017, IMMUNITY, V47, P820, DOI 10.1016/j.immuni.2017.10.008; Glowala-Kosinska M, 2016, BIOL BLOOD MARROW TR, V22, P834, DOI 10.1016/j.bbmt.2016.01.014; Godfrey DI, 2019, NAT IMMUNOL, V20, P1110, DOI 10.1038/s41590-019-0444-8; Green MR, 2010, BLOOD, V116, P3268, DOI 10.1182/blood-2010-05-282780; Hogan SA, 2019, CANCER IMMUNOL RES, V7, P77, DOI 10.1158/2326-6066.CIR-18-0136; Hu XH, 2019, NAT GENET, V51, P560, DOI 10.1038/s41588-018-0339-x; Im SJ, 2016, NATURE, V537, P417, DOI 10.1038/nature19330; Jacquelot N, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00608-2; Johnson DB, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10582; Juneja VR, 2017, J EXP MED, V214, P895, DOI 10.1084/jem.20160801; Kamphorst AO, 2017, SCIENCE, V355, P1423, DOI 10.1126/science.aaf0683; Kanzler H, 1996, J EXP MED, V184, P1495, DOI 10.1084/jem.184.4.1495; Keskin DB, 2019, NATURE, V565, P234, DOI 10.1038/s41586-018-0792-9; Kreiter S, 2015, NATURE, V520, P692, DOI 10.1038/nature14426; Krieg C, 2018, NAT MED, V24, P144, DOI 10.1038/nm.4466; Kurtulus S, 2019, IMMUNITY, V50, P181, DOI 10.1016/j.immuni.2018.11.014; Linnemann C, 2015, NAT MED, V21, P81, DOI 10.1038/nm.3773; Ljungman P, 2009, BONE MARROW TRANSPL, V44, P521, DOI 10.1038/bmt.2009.263; Mackall CL, 2000, STEM CELLS, V18, P10, DOI 10.1634/stemcells.18-1-10; Manjarrez-Orduno N, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01613; Mathas S, 2016, SEMIN HEMATOL, V53, P139, DOI 10.1053/j.seminhematol.2016.05.007; Merryman RW, 2017, BLOOD ADV, V1, P2643, DOI 10.1182/bloodadvances.2017012534; Miller BC, 2019, NAT IMMUNOL, V20, P326, DOI 10.1038/s41590-019-0312-6; Ott PA, 2017, NATURE, V547, P217, DOI 10.1038/nature22991; Pauken KE, 2016, SCIENCE, V354, P1160, DOI 10.1126/science.aaf2807; Perez-Diez A, 2007, BLOOD, V109, P5346, DOI 10.1182/blood-2006-10-051318; Pillay J, 2013, CELL MOL LIFE SCI, V70, P3813, DOI 10.1007/s00018-013-1286-4; Porichis F, 2018, J IMMUNOL, V201, P971, DOI 10.4049/jimmunol.1701551; Ramchandren R, 2019, J CLIN ONCOL, V37, P1997, DOI 10.1200/JCO.19.00315; Reichel J, 2015, BLOOD, V125, P1061, DOI 10.1182/blood-2014-11-610436; Rempala GA, 2013, J MATH BIOL, V67, P1339, DOI 10.1007/s00285-012-0589-7; Roemer MGM, 2018, J CLIN ONCOL, V36, P942, DOI 10.1200/JCO.2017.77.3994; Roemer MGM, 2016, CANCER IMMUNOL RES, V4, P910, DOI 10.1158/2326-6066.CIR-16-0201; Roemer MGM, 2016, J CLIN ONCOL, V34, P2690, DOI 10.1200/JCO.2016.66.4482; Sade-Feldman M, 2018, CELL, V175, P998, DOI 10.1016/j.cell.2018.10.038; Samusik N, 2016, NAT METHODS, V13, P493, DOI [10.1038/nmeth.3863, 10.1038/NMETH.3863]; Sen DR, 2016, SCIENCE, V354, P1165, DOI 10.1126/science.aae0491; Shi YK, 2019, LANCET HAEMATOL, V6, pE12, DOI 10.1016/S2352-3026(18)30192-3; Siddiqui I, 2019, IMMUNITY, V50, P195, DOI 10.1016/j.immuni.2018.12.021; Song YQ, 2020, LEUKEMIA, V34, P533, DOI 10.1038/s41375-019-0545-2; Song YQ, 2019, CLIN CANCER RES, V25, P7363, DOI 10.1158/1078-0432.CCR-19-1680; Spitzer MH, 2017, CELL, V168, P487, DOI 10.1016/j.cell.2016.12.022; Tumeh PC, 2014, NATURE, V515, P568, DOI 10.1038/nature13954; Vari F, 2018, BLOOD, V131, P1809, DOI 10.1182/blood-2017-07-796342; Weniger MA, 2018, J CLIN INVEST, V128, P2996, DOI 10.1172/JCI95993; Wherry EJ, 2015, NAT REV IMMUNOL, V15, P486, DOI 10.1038/nri3862; Wienand K, 2019, BLOOD ADV, V3, P4065, DOI 10.1182/bloodadvances.2019001012; Yost KE, 2019, NAT MED, V25, P1251, DOI 10.1038/s41591-019-0522-3; Zuazo M, 2019, EMBO MOL MED, V11, DOI 10.15252/emmm.201910293	64	49	52	2	8	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	SEP	2020	26	9								10.1038/s41591-020-1006-1	http://dx.doi.org/10.1038/s41591-020-1006-1		AUG 2020	29	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	PF3EM	32778827	Green Accepted			2022-12-27	WOS:000558228200003
J	Sherrard-Smith, E; Hogan, AB; Hamlet, A; Watson, OJ; Whittaker, C; Winskill, P; Ali, F; Mohammad, AB; Uhomoibhi, P; Maikore, I; Ogbulafor, N; Nikau, J; Kont, MD; Challenger, JD; Verity, R; Lambert, B; Cairns, M; Rao, B; Baguelin, M; Whittles, LK; Lees, JA; Bhatia, S; Knock, ES; Okell, L; Slater, HC; Ghani, AC; Walker, PGT; Okoko, OO; Churcher, TS				Sherrard-Smith, Ellie; Hogan, Alexandra B.; Hamlet, Arran; Watson, Oliver J.; Whittaker, Charlie; Winskill, Peter; Ali, Fatima; Mohammad, Audu B.; Uhomoibhi, Perpetua; Maikore, Ibrahim; Ogbulafor, Nnenna; Nikau, Jamilu; Kont, Mara D.; Challenger, Joseph D.; Verity, Robert; Lambert, Ben; Cairns, Matthew; Rao, Bhargavi; Baguelin, Marc; Whittles, Lilith K.; Lees, John A.; Bhatia, Sangeeta; Knock, Edward S.; Okell, Lucy; Slater, Hannah C.; Ghani, Azra C.; Walker, Patrick G. T.; Okoko, Okefu Oyale; Churcher, Thomas S.			The potential public health consequences of COVID-19 on malaria in Africa	NATURE MEDICINE			English	Article							CLINICAL CHARACTERISTICS; PLASMODIUM-FALCIPARUM; CHILDREN; TRANSMISSION; BURDEN	Transmission dynamics models of COVID-19 and malaria reveal how different scenarios of COVID-19 spread and varying levels of interruption to antimalarial programs could result in increased deaths in sub-Saharan Africa. The burden of malaria is heavily concentrated in sub-Saharan Africa (SSA) where cases and deaths associated with COVID-19 are rising(1). In response, countries are implementing societal measures aimed at curtailing transmission of SARS-CoV-2(2,3). Despite these measures, the COVID-19 epidemic could still result in millions of deaths as local health facilities become overwhelmed(4). Advances in malaria control this century have been largely due to distribution of long-lasting insecticidal nets (LLINs)(5), with many SSA countries having planned campaigns for 2020. In the present study, we use COVID-19 and malaria transmission models to estimate the impact of disruption of malaria prevention activities and other core health services under four different COVID-19 epidemic scenarios. If activities are halted, the malaria burden in 2020 could be more than double that of 2019. In Nigeria alone, reducing case management for 6 months and delaying LLIN campaigns could result in 81,000 (44,000-119,000) additional deaths. Mitigating these negative impacts is achievable, and LLIN distributions in particular should be prioritized alongside access to antimalarial treatments to prevent substantial malaria epidemics.	[Sherrard-Smith, Ellie; Hogan, Alexandra B.; Hamlet, Arran; Watson, Oliver J.; Whittaker, Charlie; Winskill, Peter; Kont, Mara D.; Challenger, Joseph D.; Verity, Robert; Lambert, Ben; Baguelin, Marc; Whittles, Lilith K.; Lees, John A.; Bhatia, Sangeeta; Knock, Edward S.; Okell, Lucy; Slater, Hannah C.; Ghani, Azra C.; Walker, Patrick G. T.; Churcher, Thomas S.] Imperial Coll London, MRC, Ctr Global Infect Dis Anal, London, England; [Ali, Fatima; Mohammad, Audu B.; Uhomoibhi, Perpetua; Maikore, Ibrahim; Ogbulafor, Nnenna; Nikau, Jamilu; Okoko, Okefu Oyale] Natl Malaria Eliminat Programme, Abuja, Nigeria; [Cairns, Matthew] London Sch Hyg & Trop Med, Trop Epidemiol Grp, London, England; [Rao, Bhargavi] Med Sans Frontieres Operat Ctr Amsterdam, Manson Unit, London, England; [Baguelin, Marc] London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London, England; [Slater, Hannah C.] PATH, Seattle, WA USA	Imperial College London; University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine	Churcher, TS (corresponding author), Imperial Coll London, MRC, Ctr Global Infect Dis Anal, London, England.	thomas.churcher@imperial.ac.uk	Rao, Bhargavi/AAH-6172-2021	/0000-0002-8913-0391; Challenger, Joseph/0000-0001-6029-1733; Hamlet, Arran/0000-0003-0871-0640; Whittaker, Charles/0000-0002-5003-2575; Watson, Oliver/0000-0003-2374-0741; Maikore, Ibrahim/0000-0003-2778-7723; Nikau, Jamilu/0000-0001-7971-2630; Sherrard-Smith, Ellie/0000-0001-8317-7992; Hogan, Alexandra/0000-0002-6271-9921; Verity, Robert/0000-0002-3902-8567; Rao, V. Bhargavi/0000-0002-4406-1636; Okell, Lucy/0000-0001-7202-6873; Lees, John/0000-0001-5360-1254	UK Medical Research Council under UK Department for International Development [MR/R015600/1]; Wellcome Trust [200222/Z/15/Z]; Bill and Melinda Gates Foundation; MRC [MC_PC_19012, MR/R015600/1, MR/R010161/1] Funding Source: UKRI	UK Medical Research Council under UK Department for International Development; Wellcome Trust(Wellcome Trust); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by funding from the UK Medical Research Council under a concordat with the UK Department for International Development (no. MR/R015600/1 to M.B, L.O, P.W., A.G. and T.C), the Wellcome Trust (no. 200222/Z/15/Z to T.C.) and the Bill and Melinda Gates Foundation (to A.G.). We thank all those who facilitated collation of the data provided by the NMEP in Nigeria. The maps in the figures were prepared using GADM v.3.6.	Aghdam MK, 2020, INFECT DIS-NOR, V52, P427, DOI 10.1080/23744235.2020.1747634; [Anonymous], 2019, DEM HLTH SURV; [Anonymous], 2014, GUID TEMP MAL CONTR; [Anonymous], 2020, CHIN J PEDIAT, DOI [10.3760/cma.j.issn.0578-1310.2020.0002, DOI 10.3760/CMA.J.ISSN.0578-1310.2020.0002]; Bhatt S, 2015, NATURE, V526, P207, DOI 10.1038/nature15535; Bialek S, 2020, MMWR-MORBID MORTAL W, V69, P422, DOI 10.15585/mmwr.mm6914e4; Brand SPC, 2020, FORECASTING SCALE CO, DOI [10.1101/2020.04.09.20059865, DOI 10.1101/2020.04.09.20059865]; Cai JH, 2020, CLIN INFECT DIS, V71, P1547, DOI 10.1093/cid/ciaa198; Cai Q, 2020, EUR J ALLERGY CLIN I, DOI [10.1111/all.14309, DOI 10.1111/ALL.14309]; Cairns M, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1879; Chan JFW, 2020, LANCET, V395, P514, DOI 10.1016/S0140-6736(20)30154-9; Chang D, 2020, JAMA-J AM MED ASSOC, V323, P1092, DOI 10.1001/jama.2020.1623; Chen D, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.11122; [陈锋 Chen Feng], 2020, [中华儿科杂志, Chinese Journal of Pediatrics], V58, P179; Chen G, 2020, J CLIN INVEST, V130, P2620, DOI 10.1172/JCI137244; Chen NS, 2020, LANCET, V395, P507, DOI 10.1016/S0140-6736(20)30211-7; Churcher TS, 2016, ELIFE, V5, DOI 10.7554/eLife.16090; Dalrymple U, 2019, MALARIA J, V18, DOI 10.1186/s12936-019-2830-y; de Waroux OL, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-3073-1; Diop BZ, 2020, BMJ GLOB HEALTH, V5, DOI 10.1136/bmjgh-2020-002699; Du WJ, 2020, INFECTION, V48, P445, DOI 10.1007/s15010-020-01427-2; Feng K, 2020, ZHONGHUA ER KE ZA ZH, V58, pE7, DOI [10.3760/cma.j.cn112140-20200210-00071, DOI 10.3760/CMA.J.CN112140-20200210-00071]; Ferguson N. M., 2020, REPORT 9 IMPACT NONP, V10, DOI [10.25561/77482, DOI 10.1007/S11538-020-00726-X]; Flaxman S, 2020, NATURE, V584, P257, DOI 10.1038/s41586-020-2405-7; Garske T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056487; Global Malaria Programme, 2017, GLOB MAL PROGR ACH M, V4; Griffi JT, 2016, LANCET INFECT DIS, V16, P465, DOI 10.1016/S1473-3099(15)00423-5; Guan W, 2020, NEW ENGL J MED, V382, P1708, DOI 10.1056/NEJMoa2002032; Hemingway J, 2016, LANCET, V387, P1785, DOI 10.1016/S0140-6736(15)00417-1; Hogan AB, 2020, LANCET GLOB HEALTH, V8, pE1132, DOI 10.1016/S2214-109X(20)30288-6; Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5; Jiang J., 2020, CHIN PEDIAT EMERG ME, V27, pE003, DOI DOI 10.3760/CMA.J.ISSN.1673-4912.2020.0003; Kam KQ, 2020, CLIN INFECT DIS, V71, P847, DOI 10.1093/cid/ciaa201; Li B, 2020, INDIAN PEDIATR, V57, P423, DOI 10.1007/s13312-020-1816-8; Li W, 2020, PEDIATR RADIOL, V50, P796, DOI 10.1007/s00247-020-04656-7; Liu J, 2020, EBIOMEDICINE, V55, DOI 10.1016/j.ebiom.2020.102763; Liu WY, 2020, NEW ENGL J MED, V382, P1370, DOI 10.1056/NEJMc2003717; Liu YJ, 2020, ARTECH HSE MOB COMM, P1; Lu XX, 2020, NEW ENGL J MED, V382, P1663, DOI 10.1056/NEJMc2005073; Ma Yao-Ling, 2020, Zhongguo Dang Dai Er Ke Za Zhi, V22, P290; Loembe MM, 2020, NAT MED, V26, P999, DOI 10.1038/s41591-020-0961-x; Murthy S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116949; Phan LT, 2020, NEW ENGL J MED, V382, P872, DOI 10.1056/NEJMc2001272; Qiu HY, 2020, LANCET INFECT DIS, V20, P689, DOI 10.1016/S1473-3099(20)30198-5; Schwartz DA, 2020, VIRUSES-BASEL, V12, DOI 10.3390/v12020194; Shen QX, 2020, PEDIATR PULM, V55, P1424, DOI 10.1002/ppul.24762; Sherrard-Smith E, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07357-w; Sinha IP, 2020, LANCET RESP MED, V8, P446, DOI 10.1016/S2213-2600(20)30152-1; Song FX, 2020, RADIOLOGY, V295, P210, DOI [10.1148/radiol.2020200274, 10.1148/radiol.2020209021]; Su L, 2020, EMERG MICROBES INFEC, V9, P707, DOI 10.1080/22221751.2020.1744483; Sun D, 2020, WORLD J PEDIATR, V16, P251, DOI 10.1007/s12519-020-00354-4; [谭鑫 Tan Xin], 2020, [中国当代儿科杂志, Chinese Journal of Contemporary Pediatrics], V22, P294; Tan YP, 2020, J CLIN VIROL, V127, DOI 10.1016/j.jcv.2020.104353; Tangena JAA, 2020, MALARIA J, V19, DOI 10.1186/s12936-020-03216-6; The Government Public Relations Department, 2020, PRACTICAL CONSIDERAT, P1; Thompson H. A, 2020, PREPRINT, DOI [10.1101/2020.07.03.20144949, DOI 10.1101/2020.07.03.20144949]; Tong ZD, 2020, EMERG INFECT DIS, V26, P1052, DOI 10.3201/eid2605.200198; Verity R, 2020, LANCET INFECT DIS, V20, P669, DOI 10.1016/S1473-3099(20)30243-7; Walker PGT, 2020, SCIENCE, V369, P413, DOI 10.1126/science.abc0035; Walker PGT, 2016, LANCET GLOB HEALTH, V4, pE474, DOI 10.1016/S2214-109X(16)30073-0; Wang DW, 2020, JAMA-J AM MED ASSOC, V323, P1061, DOI 10.1001/jama.2020.1585; [王端 Wang Duan], 2020, [中华儿科杂志, Chinese Journal of Pediatrics], V58, P269; Wang HZ, 2020, PEDIATR INFECT DIS J, V39, pE69, DOI 10.1097/INF.0000000000002690; Wei M, 2020, JAMA-J AM MED ASSOC, V323, P1313, DOI 10.1001/jama.2020.2131; WHO, 2019, WORLD MALARIA REPORT; WHO, 2020, GLOB MAL PROGR TAIL; World Health Organization, 2017, DEPRESSION; Xia W, 2020, PEDIATR PULM, V55, P1169, DOI 10.1002/ppul.24718; Xing YH, 2020, J MICROBIOL IMMUNOL, V53, P473, DOI 10.1016/j.jmii.2020.03.021; Xu Y, 2020, NAT MED, V26, P502, DOI 10.1038/s41591-020-0817-4; Yang P, 2020, J INFECTION, V80, P684, DOI 10.1016/j.jinf.2020.02.024; Yang XB, 2020, LANCET RESP MED, V8, P475, DOI 10.1016/S2213-2600(20)30079-5; Yuehua Z, 2020, CHINESE J PEDIAT, V58, P182; Zeng L K, 2020, Zhonghua Er Ke Za Zhi, V58, pE009, DOI 10.3760/cma.j.issn.0578-1310.2020.0009; Zhang JJ, 2020, ALLERGY, V75, P1730, DOI 10.1111/all.14238; Zhang MQ, 2020, ZHONGHUA JIE HE HE H, V43, P215, DOI 10.3760/cma.j.issn.1001-0939.2020.03.015; Zheng F, 2020, CURR MED SCI, V40, P275, DOI 10.1007/s11596-020-2172-6; Zhou Yun, 2020, Zhongguo Dang Dai Er Ke Za Zhi, V22, P215	78	71	71	4	14	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	SEP	2020	26	9								10.1038/s41591-020-1025-y	http://dx.doi.org/10.1038/s41591-020-1025-y		AUG 2020	19	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	PF3EM	32770167	Green Accepted, Green Submitted, Bronze			2022-12-27	WOS:000557134700007
J	Riether, C; Pabst, T; Hopner, S; Bacher, U; Hinterbrandner, M; Banz, Y; Muller, R; Manz, MG; Gharib, WH; Francisco, D; Bruggmann, R; van Rompaey, L; Moshir, M; Delahaye, T; Gandini, D; Erzeel, E; Hultberg, A; Fung, S; de Haard, H; Leupin, N; Ochsenbein, AF				Riether, Carsten; Pabst, Thomas; Hoepner, Sabine; Bacher, Ulrike; Hinterbrandner, Magdalena; Banz, Yara; Mueller, Rouven; Manz, Markus G.; Gharib, Walid H.; Francisco, David; Bruggmann, Remy; van Rompaey, Luc; Moshir, Mahan; Delahaye, Tim; Gandini, Domenica; Erzeel, Ellen; Hultberg, Anna; Fung, Samson; de Haard, Hans; Leupin, Nicolas; Ochsenbein, Adrian F.			Targeting CD70 with cusatuzumab eliminates acute myeloid leukemia stem cells in patients treated with hypomethylating agents	NATURE MEDICINE			English	Article							OLDER PATIENTS; AZACITIDINE; AML; DNA; RECOMMENDATIONS; MULTICENTER; POPULATIONS; DECITABINE; EXPRESSION; DIAGNOSIS	Acute myeloid leukemia (AML) is driven by leukemia stem cells (LSCs) that resist conventional chemotherapy and are the major cause of relapse(1,2). Hypomethylating agents (HMAs) are the standard of care in the treatment of older or unfit patients with AML, but responses are modest and not durable(3-5). Here we demonstrate that LSCs upregulate the tumor necrosis factor family ligand CD70 in response to HMA treatment resulting in increased CD70/CD27 signaling. Blocking CD70/CD27 signaling and targeting CD70-expressing LSCs with cusatuzumab, a human alpha CD70 monoclonal antibody with enhanced antibody-dependent cellular cytotoxicity activity, eliminated LSCs in vitro and in xenotransplantation experiments. Based on these preclinical results, we performed a phase 1/2 trial in previously untreated older patients with AML with a single dose of cusatuzumab monotherapy followed by a combination therapy with the HMA azacitidine (NCT03030612). We report results from the phase 1 dose escalation part of the clinical trial. Hematological responses in the 12 patients enrolled included 8 complete remission, 2 complete remission with incomplete blood count recovery and 2 partial remission with 4 patients achieving minimal residual disease negativity by flow cytometry at <10(-3). Median time to response was 3.3 months. Median progression-free survival was not reached yet at the time of the data cutoff. No dose-limiting toxicities were reported and the maximum tolerated dose of cusatuzumab was not reached. Importantly, cusatuzumab treatment substantially reduced LSCs and triggered gene signatures related to myeloid differentiation and apoptosis.	[Riether, Carsten; Pabst, Thomas; Hoepner, Sabine; Hinterbrandner, Magdalena; Ochsenbein, Adrian F.] Univ Bern, Bern Univ Hosp, Dept Med Oncol, Inselspital, Bern, Switzerland; [Riether, Carsten; Hoepner, Sabine; Hinterbrandner, Magdalena; Ochsenbein, Adrian F.] Univ Bern, Dept BioMed Res DBMR, Bern, Switzerland; [Bacher, Ulrike] Univ Bern, Bern Univ Hosp, Dept Hematol, Inselspital, Bern, Switzerland; [Bacher, Ulrike] Univ Bern, Bern Univ Hosp, Cent Hematol Lab, Inselspital, Bern, Switzerland; [Hinterbrandner, Magdalena] Univ Bern, Grad Sch Cellular & Biomed Sci, Bern, Switzerland; [Banz, Yara] Univ Bern, Inst Pathol, Bern, Switzerland; [Mueller, Rouven; Manz, Markus G.] Univ Hosp Zurich, Dept Med Oncol & Hematol, Zurich, Switzerland; [Mueller, Rouven; Manz, Markus G.] Univ Zurich, Zurich, Switzerland; [Gharib, Walid H.; Francisco, David; Bruggmann, Remy] Univ Bern, Interfac Bioinformat Unit, Bern, Switzerland; [Gharib, Walid H.; Francisco, David; Bruggmann, Remy] Univ Bern, SIB Swiss Inst Bioinformat, Bern, Switzerland; [van Rompaey, Luc; Moshir, Mahan; Delahaye, Tim; Gandini, Domenica; Erzeel, Ellen; Hultberg, Anna; Fung, Samson; de Haard, Hans; Leupin, Nicolas] argenx BVBA, Zwijnaarde, Belgium; [Fung, Samson] Fung Consulting Healthcare & Life Sci, Eching, Germany	University of Bern; University Hospital of Bern; University of Bern; University of Bern; University Hospital of Bern; University of Bern; University Hospital of Bern; University of Bern; University of Bern; University of Zurich; University Zurich Hospital; University of Zurich; University of Bern; Swiss Institute of Bioinformatics; University of Bern	Riether, C; Ochsenbein, AF (corresponding author), Univ Bern, Bern Univ Hosp, Dept Med Oncol, Inselspital, Bern, Switzerland.; Riether, C; Ochsenbein, AF (corresponding author), Univ Bern, Dept BioMed Res DBMR, Bern, Switzerland.	carsten.riether@insel.ch; adrian.ochsenbein@insel.ch	Riether, Carsten/ABC-7699-2021; Riether, Carsten/K-8603-2013	Riether, Carsten/0000-0001-7512-513X; Riether, Carsten/0000-0001-7512-513X; Gharib, Walid/0000-0003-4831-8408; Manz, Markus/0000-0002-4676-7931; Ochsenbein, Adrian/0000-0003-1773-5436; Bruggmann, Remy/0000-0001-5629-6363	Swiss National Science Foundation [31003A_149768, 310030B_13313, 310030_179394]; Swiss Cancer League [KLS-3346-02-2014]; Sassella Foundation; Fondazione Dr. Carlo Gianella; Wolfermann-Nageli Foundation; Olga Mayenfisch Foundation; Alfred und Anneliese Sutter-Stottner Foundation; Fondazione per la Ricerca sulla Trasfusione e sui Trapianti; argenx; SAKK/Gateway/Rising Tide Foundation	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swiss Cancer League; Sassella Foundation; Fondazione Dr. Carlo Gianella; Wolfermann-Nageli Foundation; Olga Mayenfisch Foundation; Alfred und Anneliese Sutter-Stottner Foundation; Fondazione per la Ricerca sulla Trasfusione e sui Trapianti; argenx; SAKK/Gateway/Rising Tide Foundation	We thank U. Luthi and T. Chiorazzo for providing excellent technical assistance; the FACSlab of the Department for BioMedical Research for assistance with cell sorting; the Next Generation Sequencing Platform of the University of Bern for performing the high-throughput sequencing experiments; and the Interfaculty Bioinformatics Unit of the University of Bern for providing the high-performance computing infrastructure. We especially thank the teams of the Clinical Research Unit of the Department of Medical Oncology, Bern University Hospital and University Hospital Zurich, the University of Zurich and the histopathology laboratory at the Institute of Pathology, Bern. In addition, we thank B. Lambrecht from Ghent University for helpful discussions during the preparation of the manuscript. The preclinical work was supported by grants from the Swiss National Science Foundation (nos. 31003A_149768 and 310030B_13313 to A.F.O., and 310030_179394 to C.R.), the Swiss Cancer League (no. KLS-3346-02-2014), the Sassella Foundation, the Fondazione Dr. Carlo Gianella, the Wolfermann-Nageli Foundation, the Olga Mayenfisch Foundation, Alfred und Anneliese Sutter-Stottner Foundation and the Fondazione per la Ricerca sulla Trasfusione e sui Trapianti (to C.R.). The clinical study was financed by argenx. The translational work was supported by the SAKK/Gateway/Rising Tide Foundation (to A.F.O).	Armour KL, 1999, EUR J IMMUNOL, V29, P2613, DOI 10.1002/(SICI)1521-4141(199908)29:08<2613::AID-IMMU2613>3.0.CO;2-J; Bertrand P, 2013, GENE CHROMOSOME CANC, V52, P764, DOI 10.1002/gcc.22072; BOWMAN MR, 1994, J IMMUNOL, V152, P1756; Butler A, 2018, NAT BIOTECHNOL, V36, P411, DOI 10.1038/nbt.4096; Carr IM, 2009, BIOINFORMATICS, V25, P3244, DOI 10.1093/bioinformatics/btp583; Cashen AF, 2010, J CLIN ONCOL, V28, P556, DOI 10.1200/JCO.2009.23.9178; Cheson BD, 2003, J CLIN ONCOL, V21, P4642, DOI 10.1200/JCO.2003.04.036; Chou TC, 2010, CANCER RES, V70, P440, DOI 10.1158/0008-5472.CAN-09-1947; Craddock C, 2013, LEUKEMIA, V27, P1028, DOI 10.1038/leu.2012.312; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dohner H, 2017, BLOOD, V129, P424, DOI 10.1182/blood-2016-08-733196; Dombret H, 2015, BLOOD, V126, P291, DOI 10.1182/blood-2015-01-621664; Garzon R, 2009, BLOOD, V113, P6411, DOI 10.1182/blood-2008-07-170589; Ge HT, 2017, INT J CANCER, V141, P1434, DOI 10.1002/ijc.30830; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Hu YF, 2009, J IMMUNOL METHODS, V347, P70, DOI 10.1016/j.jim.2009.06.008; Ilicic T, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0888-1; Kantarjian HM, 2012, J CLIN ONCOL, V30, P2670, DOI 10.1200/JCO.2011.38.9429; Kersten B, 2016, BRIT J HAEMATOL, V173, P219, DOI 10.1111/bjh.13941; LAPIDOT T, 1994, NATURE, V367, P645, DOI 10.1038/367645a0; Liu NF, 2013, ONCOTARGETS THER, V6, P615, DOI 10.2147/OTT.S44445; Liu SJ, 2010, CANCER CELL, V17, P333, DOI 10.1016/j.ccr.2010.03.008; Lu QJ, 2005, J IMMUNOL, V174, P6212, DOI 10.4049/jimmunol.174.10.6212; Majeti R, 2009, CELL, V138, P286, DOI 10.1016/j.cell.2009.05.045; Marcucci G, 2005, J CLIN PHARMACOL, V45, P597, DOI 10.1177/0091270004271947; Murone M, 2017, MOL CANCER THER, V16, P1497, DOI 10.1158/1535-7163.MCT-16-0889; Nolte MA, 2009, IMMUNOL REV, V229, P216, DOI 10.1111/j.1600-065X.2009.00774.x; Paczulla AM, 2017, HAEMATOLOGICA, V102, P854, DOI 10.3324/haematol.2016.153528; Perl AE, 2017, HEMATOL-AM SOC HEMAT, P54, DOI 10.1182/asheducation-2017.1.54; Perna F, 2017, CANCER CELL, V32, P506, DOI 10.1016/j.ccell.2017.09.004; Pollyea DA, 2018, NAT MED, V24, P1859, DOI 10.1038/s41591-018-0233-1; Riether C, 2017, J EXP MED, V214, P359, DOI 10.1084/jem.20152008; Schuurhuis GJ, 2018, BLOOD, V131, P1275, DOI 10.1182/blood-2017-09-801498; Shinkawa T, 2003, J BIOL CHEM, V278, P3466, DOI 10.1074/jbc.M210665200; Silence K, 2014, MABS-AUSTIN, V6, P523, DOI 10.4161/mabs.27398; Thomas D, 2017, BLOOD, V129, P1577, DOI 10.1182/blood-2016-10-696054; VESELY J, 1977, CANCER RES, V37, P3684; Wang JCY, 2005, TRENDS CELL BIOL, V15, P494, DOI 10.1016/j.tcb.2005.07.004	38	60	64	5	16	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	SEP	2020	26	9								10.1038/s41591-020-0910-8	http://dx.doi.org/10.1038/s41591-020-0910-8		JUN 2020	17	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	PF3EM	32601337				2022-12-27	WOS:000544159600001
J	Brand-Miller, J; Buyken, A				Brand-Miller, Jennie; Buyken, Anette			y Mapping postprandial responses sets the scene for targeted dietary advice	NATURE MEDICINE			English	Editorial Material								A machine-learning model can predict differences between people in how they respond to meals.	[Brand-Miller, Jennie] Univ Sydney, Sydney, NSW, Australia; [Buyken, Anette] Paderborn Univ, Paderborn, Germany	University of Sydney; University of Paderborn	Brand-Miller, J (corresponding author), Univ Sydney, Sydney, NSW, Australia.; Buyken, A (corresponding author), Paderborn Univ, Paderborn, Germany.	jennie.brandmiller@sydney.edu.au; anette.buyken@uni-paderborn.de	Brand-Miller, Jennie/A-6835-2013	Brand-Miller, Jennie/0000-0002-6797-8754; Buyken, Anette/0000-0002-4301-1127				Bao JS, 2011, AM J CLIN NUTR, V93, P984, DOI 10.3945/ajcn.110.005033; Berry SE, 2020, NAT MED, V26, P964, DOI 10.1038/s41591-020-0934-0; Buyken AE, 2010, DIABETOLOGIA, V53, P406, DOI 10.1007/s00125-009-1629-8; Celis-Morales C, 2017, INT J EPIDEMIOL, V46, P578, DOI 10.1093/ije/dyw186; Livesey G, 2019, NUTRIENTS, V11, DOI 10.3390/nu11061436; Livesey Geoffrey, 2019, Mayo Clin Proc Innov Qual Outcomes, V3, P52, DOI 10.1016/j.mayocpiqo.2018.12.007; Nordestgaard BG, 2014, LANCET, V384, P626, DOI 10.1016/S0140-6736(14)61177-6; Ordovas JM, 2018, BMJ-BRIT MED J, V361, DOI 10.1136/bmj.k2173; Temelkova-Kurktschiev TS, 2000, DIABETES CARE, V23, P1830, DOI 10.2337/diacare.23.12.1830; Wycherley TP, 2012, AM J CLIN NUTR, V96, P1281, DOI 10.3945/ajcn.112.044321; Zafar MI, 2019, AM J CLIN NUTR, V110, P891, DOI 10.1093/ajcn/nqz149; Zeevi D, 2015, CELL, V163, P1079, DOI 10.1016/j.cell.2015.11.001	12	4	4	0	5	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	JUN	2020	26	6					828	830		10.1038/s41591-020-0909-1	http://dx.doi.org/10.1038/s41591-020-0909-1		JUN 2020	3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	LZ3ZG	32528152				2022-12-27	WOS:000539886500010
J	Gaye, B; Khoury, S; Cene, CW; Kingue, S; N'Guetta, R; Lassale, C; Balde, D; Diop, IB; Dowd, JB; Mills, MC; Jouven, X				Gaye, Bamba; Khoury, Stephanie; Cene, Crystal W.; Kingue, Samuel; N'Guetta, Roland; Lassale, Camille; Balde, Dadhi; Diop, Ibrahima Bara; Dowd, Jennifer Beam; Mills, Melinda C.; Jouven, Xavier			Socio-demographic and epidemiological consideration of Africa's COVID-19 response: what is the possible pandemic course?	NATURE MEDICINE			English	Editorial Material							GLOBAL BURDEN	Africa is said to be the next possible hotspot for COVID-19. However, we believe this is still preventable.	[Gaye, Bamba; Khoury, Stephanie; Cene, Crystal W.; Kingue, Samuel; N'Guetta, Roland; Balde, Dadhi; Diop, Ibrahima Bara; Jouven, Xavier] African Res Network, Kumasi, Ghana; [Gaye, Bamba; Khoury, Stephanie; Jouven, Xavier] Univ Paris, Integrat Epidemiol Cardiovasc Dis, Paris Cardiovasc Res Ctr, INSERM U970, Paris, France; [Cene, Crystal W.] Univ N Carolina, Dept Med, Div Gen Internal Med, Chapel Hill Sch Med, Chapel Hill, NC 27515 USA; [Cene, Crystal W.] Univ N Carolina, Cecil G Sheps Ctr Hlth Serv Res, Sch Med, Chapel Hill, NC 27515 USA; [Kingue, Samuel] Univ Yaounde, Minist Publ Hlth, Yaounde, Cameroon; [N'Guetta, Roland] Inst Cardiol Abidjan, Abidjan, Cote Ivoire; [Lassale, Camille] Inst Salud Carlos III, CIBER Pathophysiol Obes & Nutr, Madrid, Spain; [Balde, Dadhi] Univ Hosp Conakry, Dept Cardiol, Conakry, Guinea; [Diop, Ibrahima Bara] Univ Hosp Fann, Dept Cardiol, Dakar, Senegal; [Dowd, Jennifer Beam; Mills, Melinda C.] Univ Oxford, Nuffield Coll, Leverhulme Ctr Demog Sci, Oxford, England; [Jouven, Xavier] Georges Pompidou European Hosp, Dept Cardiol, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of Yaounde I; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Instituto de Salud Carlos III; University of Oxford; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite	Gaye, B (corresponding author), African Res Network, Kumasi, Ghana.; Gaye, B (corresponding author), Univ Paris, Integrat Epidemiol Cardiovasc Dis, Paris Cardiovasc Res Ctr, INSERM U970, Paris, France.	bamba.gaye@inserm.fr	Lassale, Camille/ABE-7813-2020	Lassale, Camille/0000-0002-9340-2708; Khoury, Stephanie/0000-0002-8888-276X				[Anonymous], 2020, TIME; Chan K, 2011, ADV OPTOELECTRON, V2011, DOI [10.1155/2011/734690, 10.1155/2011/196707]; Dowd JB, 2020, P NATL ACAD SCI USA, V117, P9696, DOI 10.1073/pnas.2004911117; Fanidi A., 2020, EUR HEART J, DOI [10.1093/eurheartj/ehaa278, DOI 10.1093/EURHEARTJ/EHAA278]; Fasina FO, 2014, EUROSURVEILLANCE, V19, P11, DOI 10.2807/1560-7917.ES2014.19.40.20920; Foreman KJ, 2018, LANCET, V392, P2052, DOI [10.1016/S0140-6736(18)31694-5, 10.1016/s0140-6736(18)31694-5]; Gaye B, 2019, BMJ GLOB HEALTH, V4, DOI 10.1136/bmjgh-2019-001396; Gouda HN, 2019, LANCET GLOB HEALTH, V7, pE1375, DOI 10.1016/S2214-109X(19)30374-2; Kearney PM, 2005, LANCET, V365, P217, DOI 10.1016/S0140-6736(05)70151-3; Nkengasong JN, 2020, LANCET, V395, P841, DOI 10.1016/S0140-6736(20)30464-5; Richardson S, 2020, JAMA, DOI [DOI 10.1001/JAMA.2020.6775, 10.1001/jama.2020.6775]; Sajadi MM, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.11834; Tan JG, 2005, J EPIDEMIOL COMMUN H, V59, P186, DOI 10.1136/jech.2004.020180; Wang DW, 2020, J COASTAL RES, P1, DOI [10.2112/JCR-SI109-001.1, 10.1001/jama.2020.1585]	14	19	19	0	1	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	JUL	2020	26	7					996	999		10.1038/s41591-020-0960-y	http://dx.doi.org/10.1038/s41591-020-0960-y		JUN 2020	4	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	MK3XO	32528153	Green Submitted, Bronze			2022-12-27	WOS:000539886500011
J	[Anonymous]				[Anonymous]			Clinical and epidemiological characteristics of children with COVID-19	NATURE MEDICINE			English	Editorial Material																			0	6	6	0	6	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	APR	2020	26	4					465	465		10.1038/s41591-020-0846-z	http://dx.doi.org/10.1038/s41591-020-0846-z			1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	QH1UE	32273605	Bronze			2022-12-27	WOS:000618061900011
J	Hyland, SL; Faltys, M; Huser, M; Lyu, XR; Gumbsch, T; Esteban, C; Bock, C; Horn, M; Moor, M; Rieck, B; Zimmermann, M; Bodenham, D; Borgwardt, K; Ratsch, G; Merz, TM				Hyland, Stephanie L.; Faltys, Martin; Huser, Matthias; Lyu, Xinrui; Gumbsch, Thomas; Esteban, Cristobal; Bock, Christian; Horn, Max; Moor, Michael; Rieck, Bastian; Zimmermann, Marc; Bodenham, Dean; Borgwardt, Karsten; Ratsch, Gunnar; Merz, Tobias M.			Early prediction of circulatory failure in the intensive care unit using machine learning	NATURE MEDICINE			English	Article							MORTALITY; INTERVENTION; THERAPY; LACTATE; PATIENT; IMPACT	Intensive-care clinicians are presented with large quantities of measurements from multiple monitoring systems. The limited ability of humans to process complex information hinders early recognition of patient deterioration, and high numbers of monitoring alarms lead to alarm fatigue. We used machine learning to develop an early-warning system that integrates measurements from multiple organ systems using a high-resolution database with 240 patient-years of data. It predicts 90% of circulatory-failure events in the test set, with 82% identified more than 2 h in advance, resulting in an area under the receiver operating characteristic curve of 0.94 and an area under the precision-recall curve of 0.63. On average, the system raises 0.05 alarms per patient and hour. The model was externally validated in an independent patient cohort. Our model provides early identification of patients at risk for circulatory failure with a much lower false-alarm rate than conventional threshold-based systems. A machine-learning algorithm based on an array of demographic, physiological and clinical information is able to predict, hours in advance, circulatory failure of patients in the intensive-care unit.	[Hyland, Stephanie L.; Huser, Matthias; Lyu, Xinrui; Esteban, Cristobal; Zimmermann, Marc; Ratsch, Gunnar] Swiss Fed Inst Technol, Dept Comp Sci, Zurich, Switzerland; [Hyland, Stephanie L.; Ratsch, Gunnar] Mem Sloan Kettering Canc Ctr, Computat Biol Program, 1275 York Ave, New York, NY 10021 USA; [Hyland, Stephanie L.; Ratsch, Gunnar] Weill Cornell Med, Triinst PhD Program Computat Biol & Med, New York, NY 10065 USA; [Hyland, Stephanie L.; Huser, Matthias; Lyu, Xinrui; Esteban, Cristobal; Ratsch, Gunnar] Zurich Univ Hosp, Med Informat Unit, Zurich, Switzerland; [Faltys, Martin; Merz, Tobias M.] Univ Bern, Univ Hosp, Dept Intens Care Med, Bern, Switzerland; [Gumbsch, Thomas; Bock, Christian; Horn, Max; Moor, Michael; Rieck, Bastian; Bodenham, Dean; Borgwardt, Karsten] Swiss Fed Inst Technol, Dept Biosyst Sci & Engn, Basel, Switzerland; [Gumbsch, Thomas; Bock, Christian; Horn, Max; Moor, Michael; Rieck, Bastian; Bodenham, Dean; Borgwardt, Karsten; Ratsch, Gunnar] Swiss Inst Bioinformat, Lausanne, Switzerland; [Ratsch, Gunnar] Swiss Fed Inst Technol, Dept Biol, Zurich, Switzerland; [Merz, Tobias M.] Auckland City Hosp, Cardiovasc Intens Care Unit, Auckland, New Zealand	Swiss Federal Institutes of Technology Domain; ETH Zurich; Memorial Sloan Kettering Cancer Center; Cornell University; University of Zurich; University Zurich Hospital; University of Bern; University Hospital of Bern; Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Institute of Bioinformatics; Swiss Federal Institutes of Technology Domain; ETH Zurich; Auckland City Hospital	Ratsch, G (corresponding author), Swiss Fed Inst Technol, Dept Comp Sci, Zurich, Switzerland.; Ratsch, G (corresponding author), Mem Sloan Kettering Canc Ctr, Computat Biol Program, 1275 York Ave, New York, NY 10021 USA.; Ratsch, G (corresponding author), Weill Cornell Med, Triinst PhD Program Computat Biol & Med, New York, NY 10065 USA.; Ratsch, G (corresponding author), Zurich Univ Hosp, Med Informat Unit, Zurich, Switzerland.; Merz, TM (corresponding author), Univ Bern, Univ Hosp, Dept Intens Care Med, Bern, Switzerland.; Borgwardt, K (corresponding author), Swiss Fed Inst Technol, Dept Biosyst Sci & Engn, Basel, Switzerland.; Borgwardt, K; Ratsch, G (corresponding author), Swiss Inst Bioinformat, Lausanne, Switzerland.; Ratsch, G (corresponding author), Swiss Fed Inst Technol, Dept Biol, Zurich, Switzerland.; Merz, TM (corresponding author), Auckland City Hosp, Cardiovasc Intens Care Unit, Auckland, New Zealand.	karsten.borgwardt@bsse.ethz.ch; gunnar.raetsch@inf.ethz.ch; tobiasm@adhb.govt.nz	Rieck, Bastian/J-7507-2019; Horn, Max/AAB-5655-2020; Bock, Christian/K-9175-2019	Rieck, Bastian/0000-0003-4335-0302; Horn, Max/0000-0002-8269-9948; Bock, Christian/0000-0002-0701-5868; Borgwardt, Karsten/0000-0001-7221-2393	Swiss National Science Foundation [176005]; Swiss National Science Foundation (SNSF) [155913]; ETH Zurich	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swiss National Science Foundation (SNSF)(Swiss National Science Foundation (SNSF)); ETH Zurich(ETH Zurich)	Funding for this work was provided by the Swiss National Science Foundation (grant no. 176005 to G.R. and T.M.M. and SNSF Starting Grant no. 155913 to K.B.). G.R., S.L.H. and K.B. received core funding from ETH Zurich. We gratefully acknowledge the helpful discussions with H. Strathmann and V. Gal. We thank V. Andreas, X. Bonilla, D. Sidebotham, N. Toussaint and I. Jarchum for proofreading the manuscript.	[Anonymous], 2016, P ICML; Bock C, 2018, BIOINFORMATICS, V34, P438, DOI 10.1093/bioinformatics/bty246; Borowski M, 2011, BIOMED TECH, V56, P73, DOI 10.1515/BMT.2011.005; Brallier JW, 2017, J NEUROSURG ANESTH, V29, P388, DOI 10.1097/ANA.0000000000000332; Brier G. W., 1950, MONTHLY WEATHER REVI, V78, P1, DOI DOI 10.1175/1520-0493(1950)078<0001:VOFEIT>2.0.CO;2; Cho OM, 2016, HEALTHC INFORM RES, V22, P46, DOI 10.4258/hir.2016.22.1.46; Choi E, 2016, ADV NEUR IN, V29; Christensen M, 2014, INTENS CRIT CARE NUR, V30, P204, DOI 10.1016/j.iccn.2014.02.003; Davis J, 2006, P 23 INT C MACH LEAR, P233, DOI [DOI 10.1145/1143844.1143874, 10.1145/1143844.1143874]; De Luca G, 2004, CIRCULATION, V109, P1223, DOI 10.1161/01.CIR.0000121424.76486.20; Deng L, 2018, BMC BIOINFORMATICS, V19, DOI 10.1186/s12859-018-2527-1; Dietterich T. G, 2002, JOINT IAPR INT WORKS, V2396, P15; Duke G, 2004, Crit Care Resusc, V6, P261; E. Institute, 2019, 2019 TOP 10 HLTH TEC; Ehrenfeld J. M., 2013, MONITORING TECHNOLOG; Engstrom PG, 2013, NAT METHODS, V10, P1185, DOI [10.1038/NMETH.2722, 10.1038/nmeth.2722]; Evans J, 2018, CAN J ANESTH, V65, P627, DOI 10.1007/s12630-018-1087-1; Fackler JC, 2009, CRIT CARE, V13, DOI 10.1186/cc7740; Falk AC, 2016, INTENS CRIT CARE NUR, V35, P74, DOI 10.1016/j.iccn.2016.01.002; Fihn SD, 2014, HEALTH AFFAIR, V33, P1203, DOI 10.1377/hlthaff.2014.0054; Ghassemi M, 2014, PROCEEDINGS OF THE 20TH ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING (KDD'14), P75, DOI 10.1145/2623330.2623742; Ghosh Shameek, 2016, IEEE J Biomed Health Inform, V20, P1416, DOI 10.1109/JBHI.2015.2453478; Gouezel C, 2017, BRIT J ANAESTH, V119, P1110, DOI 10.1093/bja/aex338; Graham KC, 2010, AM J CRIT CARE, V19, P28, DOI 10.4037/ajcc2010651; Graves A, 2012, STUD COMPUT INTELL, V385, P1, DOI [10.1007/978-3-642-24797-2, 10.1162/neco.1997.9.1.1]; Harutyunyan H., 2017, MULTITASK LEARNING B; Johnson AEW, 2016, SCI DATA, V3, DOI 10.1038/sdata.2016.35; Ke Guolin, 2017, ADV NEURAL INFORM PR, P3146; Komorowski M, 2018, NAT MED, V24, P1716, DOI 10.1038/s41591-018-0213-5; Krumholz HM, 2014, HEALTH AFFAIR, V33, P1163, DOI 10.1377/hlthaff.2014.0053; Lakhani P, 2017, RADIOLOGY, V284, P574, DOI 10.1148/radiol.2017162326; Lamontagne F, 2018, INTENS CARE MED, V44, P12, DOI 10.1007/s00134-017-5016-5; Lundberg SM, 2017, ADV NEUR IN, V30; Madabhushi A, 2016, MED IMAGE ANAL, V33, P170, DOI 10.1016/j.media.2016.06.037; Martin C, 2015, SHOCK, V44, P305, DOI 10.1097/SHK.0000000000000426; McIntyre WF, 2018, JAMA-J AM MED ASSOC, V319, P1889, DOI 10.1001/jama.2018.4528; Meyer A, 2018, LANCET RESP MED, V6, P905, DOI 10.1016/S2213-2600(18)30300-X; Numata Y, 2006, J ADV NURS, V55, P435, DOI 10.1111/j.1365-2648.2006.03941.x; Nuti SV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109583; Ortolani P, 2006, EUR HEART J, V27, P1550, DOI 10.1093/eurheartj/ehl006; Pollard TJ, 2018, SCI DATA, V5, DOI 10.1038/sdata.2018.178; Rajkomar A, 2018, NPJ DIGIT MED, V1, DOI 10.1038/s41746-018-0029-1; Ren O., 2018, 2018 IEEE INT C HEAL, P144; Rivers E, 2001, NEW ENGL J MED, V345, P1368, DOI 10.1056/NEJMoa010307; Ruppel H, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0205901; Sarica A, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00329; Scholz KH, 2018, EUR HEART J, V39, P1065, DOI 10.1093/eurheartj/ehy004; Seymour CW, 2017, NEW ENGL J MED, V376, P2235, DOI 10.1056/NEJMoa1703058; Simpson KR, 2019, J NURS CARE QUAL, V34, P66, DOI 10.1097/NCQ.0000000000000335; Tomasev N, 2019, NATURE, V572, P116, DOI 10.1038/s41586-019-1390-1; Tsay R., 2005, ANAL FINANCIAL TIME, DOI DOI 10.1002/0471746193; Vairavan S, 2012, COMPUT CARDIOL CONF, V39, P393; van Donkelaar CE, 2016, CRIT CARE MED, V44, P966, DOI 10.1097/CCM.0000000000001569; Verburg IWM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109684; Vincent JL, 2018, ANN INTENSIVE CARE, V8, DOI 10.1186/s13613-018-0448-9; Vincent JL, 2013, NEW ENGL J MED, V369, P1726, DOI 10.1056/NEJMra1208943; Wallace DJ, 2012, NEW ENGL J MED, V366, P2093, DOI 10.1056/NEJMsa1201918; Wolf A, 2018, BIOSENSORS-BASEL, V8, DOI 10.3390/bios8040122; Wright MC, 2016, APPL CLIN INFORM, V7, P912, DOI 10.4338/ACI-2016-03-RA-0033; Wu M, 2017, J AM MED INFORM ASSN, V24, P488, DOI 10.1093/jamia/ocw138; Ye LX, 2009, KDD-09: 15TH ACM SIGKDD CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P947	62	97	98	6	35	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	MAR	2020	26	3					364	+		10.1038/s41591-020-0789-4	http://dx.doi.org/10.1038/s41591-020-0789-4		MAR 2020	26	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	KU0MC	32152583	Bronze			2022-12-27	WOS:000518737200002
J	Spector-Bagdady, K				Spector-Bagdady, Kayte			Hospitals should act now to notify patients about research use of their data and biospecimens	NATURE MEDICINE			English	Editorial Material							PRIVACY; ETHICS	Private industry is increasingly soliciting hospitals to sell or share health data and biospecimens, but current laws offer more disclosure and consent protections for research participants than for patients receiving clinical care. Hospitals can offer more protections than required by law, however, and should move toward greater transparency with their patients about the research use of clinical health data and biospecimens to respect patients and avoid distrust.	[Spector-Bagdady, Kayte] Univ Michigan, Sch Med, Ctr Bioeth & Social Sci Med, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Spector-Bagdady, K (corresponding author), Univ Michigan, Sch Med, Ctr Bioeth & Social Sci Med, Ann Arbor, MI 48109 USA.	kaytesb@med.umich.edu			National Human Genome Research Institute [K01HG010496]; National Center for Advancing Translational Science [UL1TR002240]	National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Center for Advancing Translational Science	I thank V. Blanc, P. Lombardo, and H. Fernandez Lynch for thoughtful comments on a previous draft of this Comment. This work was funded by the National Human Genome Research Institute (K01HG010496) and the National Center for Advancing Translational Science (UL1TR002240).	[Anonymous], 2019, GUARDIAN; Cohen IG, 2019, JAMA-J AM MED ASSOC, V322, P1141, DOI 10.1001/jama.2019.11365; Copeland R., 2019, WALL STR J; Department of Homeland Security, 2015, FED REGISTER, V173, P53933; Department of Homeland Security, 2017, FED REGISTER, V12, P7149; Faden RR, 2013, HASTINGS CENT REP, V43, pS16, DOI 10.1002/hast.134; Farr C, 2019, CNBC; Grady C, 2017, NEW ENGL J MED, V376, P856, DOI 10.1056/NEJMra1603773; Jagsi R, 2017, J CLIN ONCOL, V35, P2315, DOI 10.1200/JCO.2016.72.0284; Jones JH., 1981, BAD BLOOD TUSKEGEE S; Peppercorn J, 2019, ONCOLOGIST, V24, P1, DOI [10.1634/theoncologist.2017-0519, DOI 10.1634/THEONCOLOGIST.2017-0519]; Price WN, 2019, NAT MED, V25, P37, DOI 10.1038/s41591-018-0272-7; Price WN, 2019, SCIENCE, V363, P448, DOI 10.1126/science.aav5133; Skloot R, 2011, IMMORTAL LIFE HENRIE; Smith JD, 2017, J CLIN ONCOL, V35, P1879, DOI 10.1200/JCO.2016.68.4522; Spector-Bagdady K, 2019, J CLIN TRANSL SCI, DOI [10.1017/cts.2019.308, DOI 10.1017/CTS.2019.308]; Spector-Bagdady K, 2018, HEALTH AFFAIR, V37, P1313, DOI 10.1377/hlthaff.2018.0159	17	2	3	0	2	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	MAR	2020	26	3					306	308		10.1038/s41591-020-0795-6	http://dx.doi.org/10.1038/s41591-020-0795-6			3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	KU0MC	32161402	Green Accepted			2022-12-27	WOS:000519405000005
J	Stower, H				Stower, Hannah			Irrepressible memories for PTSD	NATURE MEDICINE			English	Editorial Material												h.stower@us.nature.com							0	3	3	0	1	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	MAR	2020	26	3					312	312		10.1038/s41591-020-0811-x	http://dx.doi.org/10.1038/s41591-020-0811-x			1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	KU0MC	32161407	Bronze			2022-12-27	WOS:000519405000008
J	Dagan, N; Elnekave, E; Barda, N; Bregman-Amitai, O; Bar, A; Orlovsky, M; Bachmat, E; Balicer, RD				Dagan, Noa; Elnekave, Eldad; Barda, Noam; Bregman-Amitai, Orna; Bar, Amir; Orlovsky, Mila; Bachmat, Eitan; Balicer, Ran D.			Automated opportunistic osteoporotic fracture risk assessment using computed tomography scans to aid in FRAX underutilization	NATURE MEDICINE			English	Article							ROUTINE ABDOMINAL CT; HEALTH-CARE; VERTEBRAL FRACTURES; HIP-FRACTURES; DXA; COLONOGRAPHY; ATTENUATION; CHALLENGES; CONTRAST; TRENDS	A retrospective analysis of existing computed tomography scans shows the feasibility of an automated process for evaluating osteoporotic fracture risk that could be used as an initial screening tool when FRAX inputs are unavailable. Methods for identifying patients at high risk for osteoporotic fractures, including dual-energy X-ray absorptiometry (DXA)(1,2) and risk predictors like the Fracture Risk Assessment Tool (FRAX)(3-6), are underutilized. We assessed the feasibility of automatic, opportunistic fracture risk evaluation based on routine abdomen or chest computed tomography (CT) scans. A CT-based predictor was created using three automatically generated bone imaging biomarkers (vertebral compression fractures (VCFs), simulated DXA T-scores and lumbar trabecular density) and CT metadata of age and sex. A cohort of 48,227 individuals (51.8% women) aged 50-90 with available CTs before 2012 (index date) were assessed for 5-year fracture risk using FRAX with no bone mineral density (BMD) input (FRAXnb) and the CT-based predictor. Predictions were compared to outcomes of major osteoporotic fractures and hip fractures during 2012-2017 (follow-up period). Compared with FRAXnb, the major osteoporotic fracture CT-based predictor presented better receiver operating characteristic area under curve (AUC), sensitivity and positive predictive value (PPV) (+1.9%, +2.4% and +0.7%, respectively). The AUC, sensitivity and PPV measures of the hip fracture CT-based predictor were noninferior to FRAXnb at a noninferiority margin of 1%. When FRAXnb inputs are not available, the initial evaluation of fracture risk can be done completely automatically based on a single abdomen or chest CT, which is often available for screening candidates(7,8).	[Dagan, Noa; Barda, Noam; Balicer, Ran D.] Clalit Hlth Serv, Clalit Res Inst, Tel Aviv, Israel; [Dagan, Noa; Barda, Noam; Bachmat, Eitan] Ben Gurion Univ Negev, Dept Comp Sci, Beer Sheva, Israel; [Dagan, Noa; Barda, Noam; Balicer, Ran D.] Ben Gurion Univ Negev, Sch Publ Hlth, Beer Sheva, Israel; [Elnekave, Eldad] Rabin Med Ctr, Beilinson Hosp, Dept Diagnost Radiol, Petah Tiqwa, Israel; [Elnekave, Eldad; Bregman-Amitai, Orna; Bar, Amir; Orlovsky, Mila] Zebra Med Vis Ltd, Shefayim, Israel	Clalit Health Services; Ben Gurion University; Ben Gurion University; Rabin Medical Center; Tel Aviv University	Dagan, N (corresponding author), Clalit Hlth Serv, Clalit Res Inst, Tel Aviv, Israel.; Dagan, N (corresponding author), Ben Gurion Univ Negev, Dept Comp Sci, Beer Sheva, Israel.; Dagan, N (corresponding author), Ben Gurion Univ Negev, Sch Publ Hlth, Beer Sheva, Israel.	noada@clalit.org.il	Dagan, Noa/ABC-3018-2021; Bar, Amir/AGB-8963-2022; Barda, Noam/AAC-9434-2020	Dagan, Noa/0000-0001-8811-7825; Barda, Noam/0000-0002-3400-235X; Elnekave, Eldad/0000-0002-3197-7338; Bregman-Amitai, Orna/0000-0001-5534-5311	Israel Innovation Authority (Ministry of Social Equality) [64727]	Israel Innovation Authority (Ministry of Social Equality)	We thank S. Krispin for her assistance in editing and reviewing the manuscript. This study was supported by a grant given to Clalit Health Services and Zebra Medical Vision by the Israel Innovation Authority (Ministry of Social Equality), to promote digitalized transformation in health care (grant number 64727). The Israel Innovation Authority did not have any active involvement in the study process.	Adams AL, 2018, J BONE MINER RES, V33, P1291, DOI 10.1002/jbmr.3423; Bar A., 2017, P SOC PHOTO-OPT INS, V10134; Beaudoin C, 2019, OSTEOPOROSIS INT, V30, P721, DOI 10.1007/s00198-019-04919-6; Brauer CA, 2009, JAMA-J AM MED ASSOC, V302, P1573, DOI 10.1001/jama.2009.1462; Bregman-Armitai O., 2019, Patent, Patent No. [WO2016013005A2, 2016013005]; Burge R, 2007, J BONE MINER RES, V22, P465, DOI [10.1359/jbmr.061113, 10.1359/JBMR.061113]; Cebul RD, 2008, J ECON PERSPECT, V22, P93, DOI 10.1257/jep.22.4.93; Compston J, 2017, ARCH OSTEOPOROS, V12, DOI 10.1007/s11657-017-0324-5; Cosman F, 2014, OSTEOPOROSIS INT, V25, P2359, DOI 10.1007/s00198-014-2794-2; Curtis JR, 2008, J BONE MINER RES, V23, P1061, DOI [10.1359/jbmr.080232, 10.1359/JBMR.080232]; Dagan N, 2017, BMJ-BRIT MED J, V356, pi6755; Dyer SM, 2016, BMC GERIATR, V16, DOI 10.1186/s12877-016-0332-0; Fraser LA, 2011, OSTEOPOROSIS INT, V22, P829, DOI 10.1007/s00198-010-1465-1; GENANT HK, 1993, J BONE MINER RES, V8, P1137, DOI 10.1002/jbmr.5650080915; Gross R, 1998, HEALTH POLICY, V45, P99, DOI 10.1016/S0168-8510(98)00030-X; Harrell FE, 2015, SPRINGER SER STAT, DOI 10.1007/978-3-319-19425-7; HERNLUND E, 2013, ARCH OSTEOPOROS, V8, DOI DOI 10.1007/S11657-013-0136-1; Herring B, 2010, HEALTH ECON, V19, P438, DOI 10.1002/hec.1484; Hess EP, 2014, J PATIENT SAF, V10, P52, DOI 10.1097/PTS.0b013e3182948b1a; Huntjens Kirsten M B, 2014, J Bone Joint Surg Am, V96, pe29, DOI 10.2106/JBJS.L.00223; Jang S, 2019, RADIOLOGY, V291, P359, DOI 10.1148/radiol.2019181648; Kanis JA, 2008, OSTEOPOROSIS INT, V19, P385, DOI 10.1007/s00198-007-0543-5; Karr AF, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0221459; Korthoewer Daniela, 2012, Arch Osteoporos, V7, P193, DOI 10.1007/s11657-012-0097-9; Krishnaraj A, 2019, J AM COLL RADIOL, V16, P1473, DOI 10.1016/j.jacr.2019.02.033; Lee SJ, 2016, OSTEOPOROSIS INT, V27, P1131, DOI 10.1007/s00198-015-3318-4; Lee SJ, 2017, AM J ROENTGENOL, V209, P395, DOI 10.2214/AJR.17.17820; Lee S, 2013, J KOREAN NEUROSURG S, V54, P384, DOI 10.3340/jkns.2013.54.5.384; Levin DC, 2014, AM J ROENTGENOL, V202, P1069, DOI 10.2214/AJR.13.11504; Lewiecki EM, 2009, CLEV CLIN J MED, V76, P457, DOI 10.3949/ccjm.76a.09019; Marques A, 2015, ANN RHEUM DIS, V74, P1958, DOI 10.1136/annrheumdis-2015-207907; Marshall A, 2009, BMC MED RES METHODOL, V9, DOI 10.1186/1471-2288-9-57; Medical Advisory Secretariat, 2006, Ont Health Technol Assess Ser, V6, P1; Melton LJ, 1999, OSTEOPOROSIS INT, V10, P214, DOI 10.1007/s001980050218; Nagels J, 2017, J DIGIT IMAGING, V30, P609, DOI 10.1007/s10278-017-9963-8; National Institute for Health and Care Excellence, 2008, AL ET RIS RAL STRONT; Pickhardt PJ, 2016, OSTEOPOROSIS INT, V27, P147, DOI 10.1007/s00198-015-3224-9; Pickhardt PJ, 2019, BRIT J RADIOL, V92, DOI 10.1259/bjr.20180726; Pickhardt PJ, 2015, J CLIN DENSITOM, V18, P5, DOI 10.1016/j.jocd.2014.03.002; Pickhardt PJ, 2013, ANN INTERN MED, V158, P588, DOI 10.7326/0003-4819-158-8-201304160-00003; Pickhardt PJ, 2011, J BONE MINER RES, V26, P2194, DOI 10.1002/jbmr.428; Pressman AR, 2011, J CLIN DENSITOM, V14, P407, DOI 10.1016/j.jocd.2011.06.006; Ronneberger O, 2015, LECT NOTES COMPUT SC, V9351, P234, DOI 10.1007/978-3-319-24574-4_28; Silverman Stuart L, 2010, Curr Osteoporos Rep, V8, P192, DOI 10.1007/s11914-010-0032-1; Sing T, 2015, ROCR VISUALIZING PER; Sirota-Cohen C, 2019, J DIGIT IMAGING, V32, P211, DOI 10.1007/s10278-018-0142-3; Steyerberg E., 2009, CLIN PREDICTION MODE; Summers RM, 2011, J COMPUT ASSIST TOMO, V35, P212, DOI 10.1097/RCT.0b013e3182032537; Van Buuren S., 2014, R PACKAGE VERSION, V2, P22; Viswanathan M, 2018, JAMA-J AM MED ASSOC, V319, P2532, DOI 10.1001/jama.2018.6537; Walker E, 2011, J GEN INTERN MED, V26, P192, DOI 10.1007/s11606-010-1513-8; Ziemlewicz TJ, 2016, J BONE MINER RES, V31, P1835, DOI 10.1002/jbmr.2856	52	31	31	1	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JAN	2020	26	1					77	+		10.1038/s41591-019-0720-z	http://dx.doi.org/10.1038/s41591-019-0720-z			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	KG3GZ	31932801				2022-12-27	WOS:000509831900030
J	Williams, SA; Kivimaki, M; Langenberg, C; Hingorani, AD; Casas, JP; Bouchard, C; Jonasson, C; Sarzynski, MA; Shipley, MJ; Alexander, L; Ash, J; Bauer, T; Chadwick, J; Datta, G; DeLisle, RK; Hagar, Y; Hinterberg, M; Ostroff, R; Weiss, S; Ganz, P; Wareham, NJ				Williams, Stephen A.; Kivimaki, Mika; Langenberg, Claudia; Hingorani, Aroon D.; Casas, J. P.; Bouchard, Claude; Jonasson, Christian; Sarzynski, Mark A.; Shipley, Martin J.; Alexander, Leigh; Ash, Jessica; Bauer, Tim; Chadwick, Jessica; Datta, Gargi; DeLisle, Robert Kirk; Hagar, Yolanda; Hinterberg, Michael; Ostroff, Rachel; Weiss, Sophie; Ganz, Peter; Wareham, Nicholas J.			Plasma protein patterns as comprehensive indicators of health	NATURE MEDICINE			English	Article							PREVENTION; SELECTION; CARE	Proteins are effector molecules that mediate the functions of genes(1,2) and modulate comorbidities(3-10), behaviors and drug treatments(11.) They represent an enormous potential resource for personalized, systemic and data-driven diagnosis, prevention, monitoring and treatment. However, the concept of using plasma proteins for individualized health assessment across many health conditions simultaneously has not been tested. Here, we show that plasma protein expression patterns strongly encode for multiple different health states, future disease risks and lifestyle behaviors. We developed and validated protein-phenotype models for 11 different health indicators: liver fat, kidney filtration, percentage body fat, visceral fat mass, lean body mass, cardiopulmonary fitness, physical activity, alcohol consumption, cigarette smoking, diabetes risk and primary cardiovascular event risk. The analyses were prospectively planned, documented and executed at scale on archived samples and clinical data, with a total of similar to 85 million protein measurements in 16,894 participants. Our proof-of-concept study demonstrates that protein expression patterns reliably encode for many different health issues, and that large-scale protein scanning(12-16) coupled with machine learning is viable for the development and future simultaneous delivery of multiple measures of health. We anticipate that, with further validation and the addition of more protein-phenotype models, this approach could enable a single-source, individualized so-called liquid health check.	[Williams, Stephen A.; Alexander, Leigh; Ash, Jessica; Bauer, Tim; Chadwick, Jessica; Datta, Gargi; DeLisle, Robert Kirk; Hagar, Yolanda; Hinterberg, Michael; Ostroff, Rachel; Weiss, Sophie] SomaLogic Inc, Boulder, CO 80301 USA; [Kivimaki, Mika; Shipley, Martin J.] UCL, Dept Epidemiol & Publ Hlth, London, England; [Langenberg, Claudia; Wareham, Nicholas J.] Univ Cambridge, MRC Epidemiol Unit, Cambridge, England; [Hingorani, Aroon D.] UCL, Inst Cardiovasc Sci, London, England; [Hingorani, Aroon D.] UCL, British Heart Fdn Res Accelerator, London, England; [Hingorani, Aroon D.] Hlth Data Res UK, London, England; [Casas, J. P.] Vet Affairs Boston Healthcare Syst, Massachusetts Vet Epidemiol & Res Informat Ctr, Boston, MA USA; [Bouchard, Claude] Louisiana State Univ, Pennington Biomed Res Ctr, Baton Rouge, LA 70808 USA; [Jonasson, Christian] NTNU Norwegian Univ Sci & Technol, Fac Med & Hlth Sci, HUNT Res Ctr, Trondheim, Norway; [Jonasson, Christian] NTNU Norwegian Univ Sci & Technol, Fac Med & Hlth Sci, KG Jebsen Ctr Genet Epidemiol, Trondheim, Norway; [Sarzynski, Mark A.] Univ South Carolina, Dept Exercise Sci, Arnold Sch Publ Hlth, Columbia, SC 29208 USA; [Ganz, Peter] Univ Calif San Francisco, Zuckerberg San Francisco Gen Hosp, Ctr Excellence Vasc Res, Div Cardiol, San Francisco, CA 94143 USA	University of London; University College London; University of Cambridge; University of London; University College London; University of London; University College London; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System; Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center; Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); University of South Carolina System; University of South Carolina Columbia; University of California System; University of California San Francisco	Williams, SA (corresponding author), SomaLogic Inc, Boulder, CO 80301 USA.	swilliams@somalogic.com	Kivimaki, Mika/B-3607-2012; Sarzynski, Mark/A-9798-2014; Langenberg, Claudia/ABG-9067-2021; Bouchard, Claude/AAE-2035-2019; Datta, Gargi/I-4104-2019; Bouchard, Claude/A-7637-2009	Kivimaki, Mika/0000-0002-4699-5627; Langenberg, Claudia/0000-0002-5017-7344; Datta, Gargi/0000-0002-1314-7824; Bouchard, Claude/0000-0002-0048-491X; Jonasson, Christian/0000-0002-7694-6025; Williams, Stephen/0000-0002-8661-4315; Ganz, Peter/0000-0002-0437-8882; Hingorani, Aroon/0000-0001-8365-0081	UK Medical Research Council UK [MR/R024227/1]; US National Institutes on Aging (NIH) [US R01AG056477, R01AG062553]; British Heart Foundation [RG/16/11/32334]; National Institute for Health Research University College London Hospitals Biomedical Research Centre; UCL BHF Research Accelerator [AA/18/6/34223]; UK Medical Research Council [MC_UU_12015/1]; Norwegian Ministry of Health; Norwegian University of Science and Technology; Norwegian Research Council; Central Norway Regional Health Authority; Nord-Trondelag County Council; Norwegian Institute of Public Health; US National Heart, Lung and Blood Institute grants (NIH/NHLBI) [R01HL146462, HL45670]; SomaLogic, Inc.; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL146462] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG056477] Funding Source: NIH RePORTER; MRC [MC_UU_12015/1, MR/S011676/1, MR/R024227/1] Funding Source: UKRI	UK Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); US National Institutes on Aging (NIH); British Heart Foundation(British Heart Foundation); National Institute for Health Research University College London Hospitals Biomedical Research Centre(General Electric); UCL BHF Research Accelerator; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Norwegian Ministry of Health; Norwegian University of Science and Technology; Norwegian Research Council(Research Council of NorwayEuropean Commission); Central Norway Regional Health Authority; Nord-Trondelag County Council; Norwegian Institute of Public Health; US National Heart, Lung and Blood Institute grants (NIH/NHLBI); SomaLogic, Inc.; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The Whitehall II study is supported by the UK Medical Research Council UK (no. MR/R024227/1, to M.K.), the US National Institutes on Aging (NIH, nos. US R01AG056477, R01AG062553) to M.K. and the British Heart Foundation (no. RG/16/11/32334) to M.J.S. A.D.H. is a NIHR Senior Investigator and was also supported, in part, by the National Institute for Health Research University College London Hospitals Biomedical Research Centre and the UCL BHF Research Accelerator (AA/18/6/34223). FENLAND (the Fenland study, no. 10.22025/2017.10.101.00001) is funded by UK Medical Research Council (no. MC_UU_12015/1), and N.W. is a NIHR senior investigator. We also thank the Fenland Study Investigators, Fenland Study Co-ordination team and the Epidemiology Field, Data and Laboratory teams. HUNT3 is funded by the Norwegian Ministry of Health, Norwegian University of Science and Technology and Norwegian Research Council, Central Norway Regional Health Authority, the Nord-Trondelag County Council and the Norwegian Institute of Public Health. The HERITAGE Family study was funded by the US National Heart, Lung and Blood Institute grants (NIH/NHLBI, no. R01HL146462 to M.A.S.) and no. HL45670 (HERITAGE, to C.B.). All authors are grateful to all volunteers/participants in all of the cohorts, and to the general practitioners, other physicans and practice staff for assistance with recruitment. SomaScan assays and the Covance study were funded by SomaLogic, Inc. The authors also thank A. Lowell (leader of the SomaLogic assay team), D. Perry for the bioinformatics of quality control, J. Williams for the agreements with the study institutions and J. Zach for clinical data organization and management.	Barry E, 2017, BMJ-BRIT MED J, V356, DOI 10.1136/bmj.i6538; Brody E, 2012, J MOL BIOL, V422, P595, DOI 10.1016/j.jmb.2012.06.021; Candia J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14755-5; Christensson A, 2018, PROTEOM CLIN APPL, V12, DOI 10.1002/prca.201700067; de Silva CGD, 2019, INT J OBESITY, V43, P2225, DOI 10.1038/s41366-018-0257-0; Dimitrov DV, 2016, HEALTHC INFORM RES, V22, P156, DOI 10.4258/hir.2016.22.3.156; Emilsson V, 2018, SCIENCE, V361, P769, DOI 10.1126/science.aaq1327; Ezkurdia I, 2014, HUM MOL GENET, V23, P5866, DOI 10.1093/hmg/ddu309; Fielding Cory M, 2014, Curr Hepatol Rep, V13, P151; Flores M, 2013, PERS MED, V10, P565, DOI 10.2217/pme.13.57; Forouzanfar MH, 2015, LANCET, V386, P2287, DOI 10.1016/S0140-6736(15)00128-2; Ganna A, 2012, AM J EPIDEMIOL, V175, P715, DOI 10.1093/aje/kwr374; Ganz P, 2016, JAMA-J AM MED ASSOC, V315, P2532, DOI 10.1001/jama.2016.5951; Gold L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015004; Han ZJ, 2018, DIAGNOSTICS, V8, DOI 10.3390/diagnostics8040071; Harrell FE, 2015, SPRINGER SER STAT, DOI 10.1007/978-3-319-19425-7; Hobbs FDR, 2010, QJM-INT J MED, V103, P727, DOI 10.1093/qjmed/hcq122; Kim CH, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-26640-w; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Lin HS, 2008, SCIENCE, V320, P807, DOI 10.1126/science.1154370; Maruthappu M, 2016, LANCET DIABETES ENDO, V4, P299, DOI 10.1016/S2213-8587(16)00073-5; Menni C, 2015, J GERONTOL A-BIOL, V70, P809, DOI 10.1093/gerona/glu121; Middleton KR, 2013, AM J LIFESTYLE MED, V7, P395, DOI 10.1177/1559827613488867; Musich S, 2016, POPUL HEALTH MANAG, V19, P389, DOI 10.1089/pop.2015.0171; O'Dwyer DN, 2017, SCI REP-UK, V7, DOI 10.1038/srep46560; Ostroff RM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046091; Ostroff Rachel M, 2010, PLoS One, V5, pe15003, DOI 10.1371/journal.pone.0015003; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Robson J, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-008840; Rohloff JC, 2014, MOL THER-NUCL ACIDS, V3, DOI 10.1038/mtna.2014.49; Ross R, 2016, CIRCULATION, V134, pE653, DOI 10.1161/CIR.0000000000000461; Shuster A, 2012, BRIT J RADIOL, V85, P1, DOI 10.1259/bjr/38447238; Sun BB, 2018, NATURE, V558, P73, DOI 10.1038/s41586-018-0175-2; Tasaki S, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05044-4; Thrush AB, 2018, INT J OBESITY, V42, P353, DOI 10.1038/ijo.2017.286; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Usher-Smith JA, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i3139; Williams SA, 2018, CIRCULATION, V137, P999, DOI 10.1161/CIRCULATIONAHA.117.028213; Wood GC, 2017, SCI REP-UK, V7, DOI 10.1038/srep43238; Yki-Jarvinen H, 2014, LANCET DIABETES ENDO, V2, P901, DOI 10.1016/S2213-8587(14)70032-4; Zou H, 2005, J R STAT SOC B, V67, P301, DOI 10.1111/j.1467-9868.2005.00503.x	41	113	113	7	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	2019	25	12					1851	+		10.1038/s41591-019-0665-2	http://dx.doi.org/10.1038/s41591-019-0665-2			17	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	JT2KO	31792462	Green Submitted, Green Accepted			2022-12-27	WOS:000500824900028
J	Gomez-Banoy, N; Guseh, JS; Li, G; Rubio-Navarro, A; Chen, T; Poirier, B; Putzel, G; Rosselot, C; Pabon, MA; Camporez, JP; Bhambhani, V; Hwang, SJ; Yao, C; Perry, RJ; Mukherjee, S; Larson, MG; Levy, D; Dow, LE; Shulman, GI; Dephoure, N; Garcia-Ocana, A; Hao, MM; Spiegelman, BM; Ho, JE; Lo, JC				Gomez-Banoy, Nicolas; Guseh, J. Sawalla; Li, Ge; Rubio-Navarro, Alfonso; Chen, Tong; Poirier, BreAnne; Putzel, Gregory; Rosselot, Carolina; Pabon, Maria A.; Camporez, Joao Paulo; Bhambhani, Vijeta; Hwang, Shih-Jen; Yao, Chen; Perry, Rachel J.; Mukherjee, Sushmita; Larson, Martin G.; Levy, Daniel; Dow, Lukas E.; Shulman, Gerald I.; Dephoure, Noah; Garcia-Ocana, Adolfo; Hao, Mingming; Spiegelman, Bruce M.; Ho, Jennifer E.; Lo, James C.			Adipsin preserves beta cells in diabetic mice and associates with protection from type 2 diabetes in humans	NATURE MEDICINE			English	Article							INSULIN-RESISTANCE; EUROPEAN SUBJECTS; MASS; DEDIFFERENTIATION; ROSIGLITAZONE; MECHANISM; CYTOKINES; METFORMIN; REPORTER; GLUCOSE	Type 2 diabetes is characterized by insulin resistance and a gradual loss of pancreatic beta cell mass and function(1,2). Currently, there are no therapies proven to prevent beta cell loss and some, namely insulin secretagogues, have been linked to accelerated beta cell failure, thereby limiting their use in type 2 diabetes(3,4). The adipokine adipsin/complement factor D controls the alternative complement pathway and generation of complement component C3a, which acts to augment beta cell insulin secretion(5). In contrast to other insulin secretagogues, we show that chronic replenishment of adipsin in diabetic db/db mice ameliorates hyperglycemia and increases insulin levels while preserving beta cells by blocking dedifferentiation and death. Mechanistically, we find that adipsin/C3a decreases the phosphatase Dusp26; forced expression of Dusp26 in beta cells decreases expression of core beta cell identity genes and sensitizes to cell death. In contrast, pharmacological inhibition of DUSP26 improves hyperglycemia in diabetic mice and protects human islet cells from cell death. Pertaining to human health, we show that higher concentrations of circulating adipsin are associated with a significantly lower risk of developing future diabetes among middle-aged adults after adjusting for body mass index (BMI). Collectively, these data suggest that adipsin/C3a and DUSP26-directed therapies may represent a novel approach to achieve beta cell health to treat and prevent type 2 diabetes.	[Gomez-Banoy, Nicolas; Rubio-Navarro, Alfonso; Chen, Tong; Poirier, BreAnne; Pabon, Maria A.; Lo, James C.] Weill Cornell Med, Weill Ctr Metab Hlth, New York, NY 10065 USA; [Gomez-Banoy, Nicolas; Rubio-Navarro, Alfonso; Chen, Tong; Poirier, BreAnne; Pabon, Maria A.; Lo, James C.] Weill Cornell Med, Dept Med, Div Cardiol, New York, NY 10065 USA; [Guseh, J. Sawalla; Bhambhani, Vijeta; Ho, Jennifer E.] Harvard Med Sch, Cardiovasc Res Ctr, Corrigan Minehan Heart Ctr, Boston, MA 02115 USA; [Guseh, J. Sawalla; Bhambhani, Vijeta; Ho, Jennifer E.] Harvard Med Sch, Massachusetts Gen Hosp, Dept Med, Div Cardiol, Boston, MA 02115 USA; [Li, Ge; Mukherjee, Sushmita; Hao, Mingming] Weill Cornell Med, Dept Biochem, New York, NY USA; [Putzel, Gregory] Weill Cornell Med, Dept Med, Jill Roberts Inst Res Inflammatory Bowel Dis, New York, NY USA; [Rosselot, Carolina; Garcia-Ocana, Adolfo] Icahn Sch Med Mt Sinai, Diabet Obes & Metab Inst, New York, NY 10029 USA; [Camporez, Joao Paulo; Perry, Rachel J.; Shulman, Gerald I.] Yale Sch Med, Dept Internal Med, New Haven, CT USA; [Camporez, Joao Paulo; Perry, Rachel J.; Shulman, Gerald I.] Yale Sch Med, Dept Cellular & Mol Physiol, New Haven, CT USA; [Hwang, Shih-Jen; Yao, Chen; Levy, Daniel] NHLBI, Populat Sci Branch, Div Intramural Res, NIH, Bldg 10, Bethesda, MD 20892 USA; [Hwang, Shih-Jen; Yao, Chen; Larson, Martin G.; Levy, Daniel] Framingham Heart Dis Epidemiol Study, Framingham, MA USA; [Larson, Martin G.] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA USA; [Dow, Lukas E.; Dephoure, Noah] Weill Cornell Med, Dept Med, Sandra & Edward Meyer Canc Ctr, New York, NY USA; [Spiegelman, Bruce M.] Dana Farber Canc Inst, Boston, MA 02115 USA; [Spiegelman, Bruce M.] Harvard Med Sch, Boston, MA 02115 USA	Cornell University; Cornell University; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Massachusetts General Hospital; Cornell University; Cornell University; Icahn School of Medicine at Mount Sinai; Yale University; Yale University; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Framingham Heart Study; Boston University; Cornell University; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School	Lo, JC (corresponding author), Weill Cornell Med, Weill Ctr Metab Hlth, New York, NY 10065 USA.; Lo, JC (corresponding author), Weill Cornell Med, Dept Med, Div Cardiol, New York, NY 10065 USA.; Ho, JE (corresponding author), Harvard Med Sch, Cardiovasc Res Ctr, Corrigan Minehan Heart Ctr, Boston, MA 02115 USA.; Ho, JE (corresponding author), Harvard Med Sch, Massachusetts Gen Hosp, Dept Med, Div Cardiol, Boston, MA 02115 USA.	jho1@mgh.harvard.edu; jlo@med.cornell.edu	Levy, Daniel/ABB-2752-2021; Rubio, Alfonso/ABH-5028-2020; Guseh, James/AAB-2712-2022; Levy, Daniel/ABF-6873-2021; Hwang, Shih-Jen/HGU-5826-2022; Lo, James/GYR-1149-2022; Pabon Porras, Maria/CAG-5118-2022; Dephoure, Noah/N-7818-2014	Rubio, Alfonso/0000-0001-5677-3123; Guseh, James/0000-0003-0992-5635; Levy, Daniel/0000-0003-1843-8724; Lo, James/0000-0003-0244-1670; Dephoure, Noah/0000-0001-5802-2657; Camporez, Joao Paulo/0000-0003-3486-4301; Gomez-Banoy, Nicolas/0000-0002-3552-1768; Perry, Rachel/0000-0003-0748-8064; Dow, Lukas/0000-0001-7048-1418	American Diabetes Association [1-18-PMF-032]; MGH NIH [HL007208]; John S. LaDue Memorial Fellowship; MGH Physician Scientist Development Program; Weill Cornell Department of Medicine; JPB Foundation; Jill Roberts IBD Institute; NIH [DK097303, R03 DK111762, R01 DK121844, R01 HL140224, R01 HL134893, P30 DK020541-38]; National Heart, Lung and Blood Institute [N01-HC-25195, HHSN268201500001I]; Division of Intramural Research of the National Heart, Lung and Blood Institute; Yale Mouse Metabolic Phenotyping Center via NIH [U24 DK-059635, R01 DK116774, R01 DK114793, P30 DK045735]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK121140, P30DK045735, R01DK121844, K08DK097303] Funding Source: NIH RePORTER	American Diabetes Association(American Diabetes Association); MGH NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); John S. LaDue Memorial Fellowship; MGH Physician Scientist Development Program; Weill Cornell Department of Medicine; JPB Foundation; Jill Roberts IBD Institute; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Division of Intramural Research of the National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Yale Mouse Metabolic Phenotyping Center via NIH; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	N.G.-B. is supported by an American Diabetes Association postdoctoral fellowship (1-18-PMF-032). J.S.G. was supported by an MGH NIH T32 Training Grant (HL007208), the John S. LaDue Memorial Fellowship and the MGH Physician Scientist Development Program. This work was supported by a Weill Cornell Department of Medicine Seed Grant for Innovative Research to J.C.L., the JPB Foundation (to B.M.S.), Jill Roberts IBD Institute (to G.P.) and NIH grants DK097303 (to J.C.L.), R03 DK111762 (to J.C.L.), R01 DK121844 (to J.C.L.), R01 HL140224 (to J.E.H.) and R01 HL134893 (to J.E.H.). This work was partially supported by the National Heart, Lung and Blood Institute's Framingham Heart Study (contracts N01-HC-25195 and HHSN268201500001I) and by the Division of Intramural Research (to P.C., G. S., C.L., S.-J.H. and D.L.) of the National Heart, Lung and Blood Institute. We acknowledge support from the Yale Mouse Metabolic Phenotyping Center via NIH grants nos. U24 DK-059635, R01 DK116774, R01 DK114793 and P30 DK045735 (all to G.I.S.). We acknowledge the Microscopy and Image Analysis Core Facility at Weill Cornell Medicine for analysis of the images presented in this study, J. Cao for his help with confocal microscopy and the Human Islet and Adenovirus Core of the Einstein-Sinai Diabetes Research Center (NIH grant no. P30 DK020541-38) for the human islet studies. The views expressed in this Letter are those of the authors and do not necessarily represent the views of the National Institute of Diabetes and Digestive and Kidney Diseases, National Heart, Lung and Blood Institute, the National Institutes of Health or the US Department of Health and Human Services.	Alejandro EU, 2015, MOL ASPECTS MED, V42, P19, DOI 10.1016/j.mam.2014.12.002; Ardlie KG, 2015, SCIENCE, V348, P648, DOI 10.1126/science.1262110; BARON AD, 1987, DIABETES, V36, P274, DOI 10.2337/diabetes.36.3.274; Belgardt BF, 2015, NAT MED, V21, P619, DOI 10.1038/nm.3862; Bray NL, 2016, NAT BIOTECHNOL, V34, P888, DOI 10.1038/nbt0816-888d; Burns SM, 2015, CELL METAB, V21, P126, DOI 10.1016/j.cmet.2014.12.010; Camporez JPG, 2013, ENDOCRINOLOGY, V154, P1021, DOI 10.1210/en.2012-1989; Carson RT, 1999, J IMMUNOL METHODS, V227, P41, DOI 10.1016/S0022-1759(99)00069-1; Chen EY, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-128; Dahan T, 2017, DIABETES, V66, P426, DOI 10.2337/db16-0641; Dalboge LS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082813; DeFronzo RA, 2015, NAT REV DIS PRIMERS, V1, DOI 10.1038/nrdp.2015.19; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; duPont NC, 2005, J REPROD IMMUNOL, V66, P175, DOI 10.1016/j.jri.2005.03.005; Elias JE, 2007, NAT METHODS, V4, P207, DOI 10.1038/nmeth1019; Ferrannini E, 2010, CELL METAB, V11, P349, DOI 10.1016/j.cmet.2010.04.009; Gomez-Banoy N, 2017, METHODS MOL BIOL, V1566, P108, DOI 10.1007/978-1-4939-6820-6_11; Guo SL, 2013, J CLIN INVEST, V123, P3305, DOI 10.1172/JCI65390; Henquin JC, 2011, DIABETOLOGIA, V54, P1720, DOI 10.1007/s00125-011-2118-4; Huttlin EL, 2010, CELL, V143, P1174, DOI 10.1016/j.cell.2010.12.001; Ilegems E, 2013, P NATL ACAD SCI USA, V110, P20581, DOI 10.1073/pnas.1313696110; Ishida E, 2017, DIABETES, V66, P2092, DOI 10.2337/db16-1213; Kahn SE, 2006, NEW ENGL J MED, V355, P2427, DOI 10.1056/NEJMoa066224; Kahn SE, 2014, LANCET, V383, P1068, DOI 10.1016/S0140-6736(13)62154-6; KANNEL WB, 1979, AM J EPIDEMIOL, V110, P281, DOI 10.1093/oxfordjournals.aje.a112813; Kasuga M, 2006, J CLIN INVEST, V116, P1756, DOI 10.1172/JCI29189; Kettunen J, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11122; Kim-Muller JY, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12631; Kuleshov MV, 2016, NUCLEIC ACIDS RES, V44, pW90, DOI 10.1093/nar/gkw377; Lee JJ, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.115.002545; Li G, 2016, J CELL SCI, V129, P2865, DOI 10.1242/jcs.190843; Liao Y, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt214; Lo JC, 2014, CELL, V158, P41, DOI 10.1016/j.cell.2014.06.005; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Mellado-Gil J, 2011, DIABETES, V60, P525, DOI 10.2337/db09-1305; Mezza T, 2014, DIABETES, V63, P994, DOI 10.2337/db13-1013; Ouchi N, 2011, NAT REV IMMUNOL, V11, P85, DOI 10.1038/nri2921; Pelossof R, 2017, NAT BIOTECHNOL, V35, P350, DOI 10.1038/nbt.3807; Prentki M, 2006, J CLIN INVEST, V116, P1802, DOI 10.1172/JCI29103; Rahier J, 2008, DIABETES OBES METAB, V10, P32, DOI 10.1111/j.1463-1326.2008.00969.x; Rappsilber J, 2003, ANAL CHEM, V75, P663, DOI 10.1021/ac026117i; ROSEN BS, 1989, SCIENCE, V244, P1483, DOI 10.1126/science.2734615; Rosen ED, 2014, CELL, V156, P20, DOI 10.1016/j.cell.2013.12.012; Sharma RB, 2014, CURR DIABETES REP, V14, DOI 10.1007/s11892-014-0492-2; Shi Y, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.207; Soneson C, 2015, F1000 RES, V4, P1521, DOI [10.12688/f1000research.7563.1, DOI 10.12688/F1000RESEARCH.7563.2]; Song M, 2009, BIOCHEM BIOPH RES CO, V381, P491, DOI 10.1016/j.bbrc.2009.02.069; Sotoodehnia N, 2010, NAT GENET, V42, P1068, DOI 10.1038/ng.716; Splansky GL, 2007, AM J EPIDEMIOL, V165, P1328, DOI 10.1093/aje/kwm021; Staley JR, 2016, BIOINFORMATICS, V32, P3207, DOI 10.1093/bioinformatics/btw373; Talchai C, 2012, CELL, V150, P1223, DOI 10.1016/j.cell.2012.07.029; Turner RC, 1999, JAMA-J AM MED ASSOC, V281, P2005, DOI 10.1001/jama.281.21.2005; Wang JY, 2006, J NEUROCHEM, V98, P89, DOI 10.1111/j.1471-4159.2006.03852.x; Wang TJ, 2011, NAT MED, V17, P448, DOI 10.1038/nm.2307; Zhou Q, 2018, J DIABETES INVEST, V9, P1128, DOI 10.1111/jdi.12819	56	60	61	2	35	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2019	25	11					1739	+		10.1038/s41591-019-0610-4	http://dx.doi.org/10.1038/s41591-019-0610-4			23	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	JT2KI	31700183	Green Accepted			2022-12-27	WOS:000500824300033
J	Powles, T; Kockx, M; Rodriguez-Vida, A; Duran, I; Crabb, SJ; Van der Heijden, MS; Szabados, B; Pous, AF; Gravis, G; Herranz, UA; Protheroe, A; Ravaud, A; Maillet, D; Mendez, MJ; Suarez, C; Linch, M; Prendergast, A; van Dam, PJ; Stanoeva, D; Daelemans, S; Mariathasan, S; Tea, JS; Mousa, K; Banchereau, R; Castellano, D				Powles, Thomas; Kockx, Mark; Rodriguez-Vida, Alejo; Duran, Ignacio; Crabb, Simon J.; Van der Heijden, Michiel S.; Szabados, Bernadett; Pous, Albert Font; Gravis, Gwenaelle; Anido Herranz, Urbano; Protheroe, Andrew; Ravaud, Alain; Maillet, Denis; Jose Mendez, Maria; Suarez, Cristina; Linch, Mark; Prendergast, Aaron; van Dam, Pieter-Jan; Stanoeva, Diana; Daelemans, Sofie; Mariathasan, Sanjeev; Tea, Joy S.; Mousa, Kelly; Banchereau, Romain; Castellano, Daniel			Clinical efficacy and biomarker analysis of neoadjuvant atezolizumab in operable urothelial carcinoma in the ABACUS trial	NATURE MEDICINE			English	Article							INVASIVE BLADDER-CANCER; CHEMOTHERAPY; CISPLATIN; BLOCKADE	Antibodies targeting PD-1 or its ligand 1 PD-L1 such as atezolizumab, have great efficacy in a proportion of metastatic urothelial cancers1,2. Biomarkers may facilitate identification of these responding tumors3. Neoadjuvant use of these agents is associated with pathological complete response in a spectrum of tumors, including urothelial cancer4-7. Sequential tissue sampling from these studies allowed for detailed on-treatment biomarker analysis. Here, we present a single-arm phase 2 study, investigating two cycles of atezolizumab before cystectomy in 95 patients with muscle-invasive urothelial cancer (ClinicalTrials. gov identifier: NCT02662309). Pathological complete response was the primary endpoint. Secondary endpoints focused on safety, relapse-free survival and biomarker analysis. The pathological complete response rate was 31% (95% confidence interval: 21-41%), achieving the primary efficacy endpoint. Baseline biomarkers showed that the presence of preexisting activated T cells was more prominent than expected and correlated with outcome. Other established biomarkers, such as tumor mutational burden, did not predict outcome, differentiating this from the metastatic setting. Dynamic changes to gene expression signatures and protein biomarkers occurred with therapy, whereas changes in DNA alterations with treatment were uncommon. Responding tumors showed predominant expression of genes related to tissue repair after treatment, making tumor biomarker interpretation challenging in this group. Stromal factors such as transforming growth factor-beta and fibroblast activation protein were linked to resistance, as was high expression of cell cycle gene signatures after treatment.	[Powles, Thomas; Szabados, Bernadett; Prendergast, Aaron; Mousa, Kelly] Queen Mary Univ London, Barts Canc Inst, Barts Expt Canc Med Ctr, London, England; [Kockx, Mark; van Dam, Pieter-Jan; Stanoeva, Diana; Daelemans, Sofie] HistogeneX NV, Antwerp, Belgium; [Rodriguez-Vida, Alejo] Hosp del Mar, Dept Med Oncol, Barcelona, Spain; [Duran, Ignacio] CSIC, Hosp Univ Virgen Rocio, IBiS, Inst Biomed Sevilla, Seville, Spain; [Duran, Ignacio] Univ Seville, Seville, Spain; [Crabb, Simon J.] Univ Southampton, Southampton Expt Canc Med Ctr, Southampton, Hants, England; [Van der Heijden, Michiel S.] Netherlands Canc Inst, Dept Med Oncol, Amsterdam, Netherlands; [Pous, Albert Font] Hosp Badalona Germans Trias & Pujol, Badalona Appl Res Grp Oncol B ARGO IGTP, Catalan Inst Oncol, Badalona, Spain; [Gravis, Gwenaelle] Inst Paoli Calmettes, Marseille, France; [Anido Herranz, Urbano] Hosp Clin Univ Santiago, Dept Med Oncol, Santiago De Compostela, Spain; [Protheroe, Andrew] Churchill Hosp, Dept Med Oncol, Oxford, England; [Ravaud, Alain] Univ Bordeaux, CHU Bordeaux, Hop St Andre, Dept Med Oncol, Bordeaux, France; [Maillet, Denis] Hosp Lyon Sud, Dept Med Oncol, Lyon, France; [Jose Mendez, Maria] Reina Sofia Univ Hosp, Dept Med Oncol, Cordoba, Spain; [Suarez, Cristina] Univ Autonoma Barcelona, Vall dHebron Univ Hosp, Vall dHebron Inst Oncol, Barcelona, Spain; [Linch, Mark] Univ Coll London Hosp, Dept Med Oncol, London, England; [Daelemans, Sofie] Univ Antwerp, Fac Pharmaceut Biomed & Vet Sci, Med Biochem, Antwerp, Belgium; [Mariathasan, Sanjeev; Tea, Joy S.; Banchereau, Romain] Genentech Inc, San Francisco, CA USA; [Castellano, Daniel] Hosp 12 Octubre, Dept Med Oncol, Madrid, Spain	University of London; Queen Mary University London; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS); Virgen del Rocio University Hospital; University of Sevilla; University of Southampton; Netherlands Cancer Institute; Catalan Institute of Oncology; Hospital Germans Trias i Pujol; UNICANCER; Institut Paoli-Calmette (IPC); Complexo Hospitalario Universitario de Santiago de Compostela; University of Oxford; CHU Bordeaux; UDICE-French Research Universities; Universite de Bordeaux; CHU Lyon; Hospital Universitario Reina Sofia - Cordoba; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut d'Oncologia (VHIO); University College London Hospitals NHS Foundation Trust; University of London; University College London; University of Antwerp; Roche Holding; Genentech; Hospital Universitario 12 de Octubre	Powles, T (corresponding author), Queen Mary Univ London, Barts Canc Inst, Barts Expt Canc Med Ctr, London, England.	t.powles@qmul.ac.uk	Gravis, Gwenaelle/CAG-3019-2022; Herranz, Urbano Anido/AAF-8572-2021	Gravis, Gwenaelle/0000-0002-3127-1554; Herranz, Urbano Anido/0000-0003-0376-5642; Suarez, Cristina/0000-0002-0502-5528; van Dam, Pieter-Jan/0000-0001-9074-8271; Crabb, Simon/0000-0003-3521-9064; DURAN, IGNACIO/0000-0001-8571-7163; Szabados, Bernadett/0000-0002-8786-0032	Queen Mary University of London; Roche; Cancer Research UK; UK Experimental Cancer Medicine Network; La Roche-Hoffmann	Queen Mary University of London; Roche(Roche Holding); Cancer Research UK(Cancer Research UK); UK Experimental Cancer Medicine Network; La Roche-Hoffmann	We thank the patients and their families as well as all of the investigators and their staff involved in ABACUS. The Experiment Cancer Medicine Centre at Barts Cancer Institute organized and had oversight of all aspects of the study. T.P. was the chief investigator, imCORE (Roche) and Histogenex performed aspects of the biomarker analysis. Queen Mary University of London was the Sponsor of the study. Roche granted QMUL funding for the study and supplied the study drug. J. Bull and M. Jacobson also provided financial support for aspects of the biomarker analysis. We are grateful to the members of the Data Monitoring Committee: M. Bower, Chelsea and Westminster Hospital NHS Foundation Trust; J. Peters, Barts Health NHS Trust; J. Catto and Sheffield Teaching Hospitals NHS Trust. We are grateful to the following people who helped with the study: C. Lawrence, C. Tyson and J. Bansal of the Experiment Cancer Medicine Centre at Barts Cancer Institute; S. Tabuteau and C. Gazille of Le Centre Hospitalier Universitaire de Bordeaux; the investigators and project managers of the Spanish Oncology Genitourinary Group; A. Moreno and M. De Figueora of Apices; and H. Schrijver and E. van Schaffelaar of the Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital. We acknowledge Cancer Research UK, the UK Experimental Cancer Medicine Network and La Roche-Hoffmann for funding.	A'Hern RP, 2001, STAT MED, V20, P859, DOI 10.1002/sim.721; Amaria RN, 2018, NAT MED, V24, P1649, DOI 10.1038/s41591-018-0197-1; [Anonymous], 2018, J CLIN ONCOL S; Bahleda R, 2019, CLIN CANCER RES, V25, P4888, DOI 10.1158/1078-0432.CCR-18-3334; Bellmunt J, 2017, CANCER TREAT REV, V54, P58, DOI 10.1016/j.ctrv.2017.01.007; Blank CU, 2018, NAT MED, V24, P1655, DOI 10.1038/s41591-018-0198-0; Cloughesy TF, 2019, NAT MED, V25, P477, DOI 10.1038/s41591-018-0337-7; Forde PM, 2018, NEW ENGL J MED, V378, P1976, DOI 10.1056/NEJMoa1716078; Griffiths G, 2011, J CLIN ONCOL, V29, P2171, DOI 10.1200/JCO.2010.32.3139; Huang AC, 2019, NAT MED, V25, P454, DOI 10.1038/s41591-019-0357-y; Kim HS, 2016, CLIN CANCER RES, V22, P1086, DOI 10.1158/1078-0432.CCR-15-1208; Loriot Y, 2019, NEW ENGL J MED, V381, P338, DOI 10.1056/NEJMoa1817323; Mariathasan S, 2018, NATURE, V554, P544, DOI 10.1038/nature25501; Nassar AH, 2019, CLIN CANCER RES, V25, P2458, DOI 10.1158/1078-0432.CCR-18-3147; Necchi A, 2018, J CLIN ONCOL, V36, P3353, DOI 10.1200/JCO.18.01148; Nowacki TM, 2007, CELL IMMUNOL, V247, P36, DOI 10.1016/j.cellimm.2007.07.004; Powles T, 2018, LANCET, V391, P748, DOI 10.1016/S0140-6736(17)33297-X; Reardon ZD, 2015, EUR UROL, V67, P165, DOI 10.1016/j.eururo.2014.01.009; Richards KE, 2017, ONCOGENE, V36, P1770, DOI 10.1038/onc.2016.353; Rosenberg JE, 2016, LANCET, V387, P1909, DOI 10.1016/S0140-6736(16)00561-4; Sjodahl G, 2012, CLIN CANCER RES, V18, P3377, DOI 10.1158/1078-0432.CCR-12-0077-T; Sun L, 2018, ONCOIMMUNOLOGY, V7, DOI 10.1080/2162402X.2018.1488359; Teo MY, 2018, J CLIN ONCOL, V36, P1685, DOI 10.1200/JCO.2017.75.7740; Warrick JI, 2019, EUR UROL, V75, P18, DOI 10.1016/j.eururo.2018.09.003; Wynn TA, 2012, NAT MED, V18, P1028, DOI 10.1038/nm.2807	25	231	232	4	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2019	25	11					1706	+		10.1038/s41591-019-0628-7	http://dx.doi.org/10.1038/s41591-019-0628-7			18	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	JT2KI	31686036	Green Accepted, Green Submitted			2022-12-27	WOS:000500824300028
J	Quer, G; Radin, JM; Gadaleta, M; Baca-Motes, K; Ariniello, L; Ramos, E; Kheterpal, V; Topol, EJ; Steinhubl, SR				Quer, Giorgio; Radin, Jennifer M.; Gadaleta, Matteo; Baca-Motes, Katie; Ariniello, Lauren; Ramos, Edward; Kheterpal, Vik; Topol, Eric J.; Steinhubl, Steven R.			Wearable sensor data and self-reported symptoms for COVID-19 detection	NATURE MEDICINE			English	Article							DEVICE DATA	A smartphone app that combines smartwatch and activity tracker data together with self-reported symptoms allows continuous monitoring of SARS-CoV-2 infection. Traditional screening for COVID-19 typically includes survey questions about symptoms and travel history, as well as temperature measurements. Here, we explore whether personal sensor data collected over time may help identify subtle changes indicating an infection, such as in patients with COVID-19. We have developed a smartphone app that collects smartwatch and activity tracker data, as well as self-reported symptoms and diagnostic testing results, from individuals in the United States, and have assessed whether symptom and sensor data can differentiate COVID-19 positive versus negative cases in symptomatic individuals. We enrolled 30,529 participants between 25 March and 7 June 2020, of whom 3,811 reported symptoms. Of these symptomatic individuals, 54 reported testing positive and 279 negative for COVID-19. We found that a combination of symptom and sensor data resulted in an area under the curve (AUC) of 0.80 (interquartile range (IQR): 0.73-0.86) for discriminating between symptomatic individuals who were positive or negative for COVID-19, a performance that is significantly better (P < 0.01) than a model(1) that considers symptoms alone (AUC = 0.71; IQR: 0.63-0.79). Such continuous, passively captured data may be complementary to virus testing, which is generally a one-off or infrequent sampling assay.	[Quer, Giorgio; Radin, Jennifer M.; Gadaleta, Matteo; Baca-Motes, Katie; Ariniello, Lauren; Ramos, Edward; Topol, Eric J.; Steinhubl, Steven R.] Scripps Res Translat Inst, La Jolla, CA 92037 USA; [Ramos, Edward; Kheterpal, Vik] CareEvolution, Ann Arbor, MI USA		Quer, G (corresponding author), Scripps Res Translat Inst, La Jolla, CA 92037 USA.	gquer@scripps.edu	Gadaleta, Matteo/AAD-5045-2020	Gadaleta, Matteo/0000-0001-6470-6537; Topol, Eric/0000-0002-1478-4729; Steinhubl, Steve/0000-0002-9256-7914; Kheterpal, Vik/0000-0002-4752-4229; Radin, Jennifer/0000-0003-3843-0842	National Center for Advancing Translational Sciences (NCATS) at the National Institutes of Health (NIH) [UL1TR002550]	National Center for Advancing Translational Sciences (NCATS) at the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was funded by grant no. UL1TR002550 from the National Center for Advancing Translational Sciences (NCATS) at the National Institutes of Health (NIH; E.J.T. and S.R.S.). We thank N. Dalton for his support of DETECT. We also thank D. Oran, T. Peters, R. Kamyar and C. Nowak for their contributions to DETECT.	[Anonymous], 2020, EV HLTH BARDA PARTN; [Anonymous], 2020, COR DAT; [Anonymous], 2020, NEW COVID 19 TEST DA; [Anonymous], 2019, MEDRXIV, DOI [DOI 10.1101/19008771, 10.1101/19008771]; [Anonymous], 2020, COV; [Anonymous], 2020, TEMPR STUD; Basch EM, 2017, J CLIN ONCOL, V35, DOI 10.1200/JCO.2017.35.18_suppl.LBA2; Bell SK, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.5867; Bradford L, 2020, J LAW BIOSCI, V7, DOI 10.1093/jlb/lsaa034; Centers for Disease Control and Prevention (CDC), 2020, SLEEP SLEEP DIS 2020; Chau NVV., 2020, CLIN INFECT DIS, V71, P2679, DOI 10.1093/cid/ciaa711; Coravos A, 2020, NPJ DIGIT MED, V3, DOI 10.1038/s41746-020-0237-3; Ferretti L, 2020, SCIENCE, V368, P619, DOI 10.1126/science.abb6936; Inui Shohei, 2020, Radiol Cardiothorac Imaging, V2, pe200110, DOI [10.1148/ryct.2020204002, 10.1148/ryct.2020200110]; Jaiswal SJ, 2020, JAMA INTERN MED, V180, P1694, DOI 10.1001/jamainternmed.2020.2834; Jing QL, 2020, LANCET INFECT DIS, V20, P1141, DOI 10.1016/S1473-3099(20)30471-0; Long QX, 2020, NAT MED, V26, P1200, DOI 10.1038/s41591-020-0965-6; Meng H, 2020, J INFECTION, V81, pE33, DOI 10.1016/j.jinf.2020.04.004; Menni C, 2020, NAT MED, V26, P1037, DOI 10.1038/s41591-020-0916-2; Milechin L., 2017, 218818 BIORXIV, DOI [10.1101/218818, DOI 10.1101/218818]; Mishra T., 2020, EARLY DETECTION COVI, DOI [10.1101/2020.07.06.20147512, DOI 10.1101/2020.07.06.20147512]; Natarajan Aravind, 2020, npj Digital Medicine, V3, DOI 10.1038/s41746-020-00363-7; Oran DP, 2020, ANN INTERN MED, V173, P362, DOI 10.7326/M20-3012; Pratap A, 2020, NPJ DIGIT MED, V3, DOI 10.1038/s41746-020-0224-8; Quer G, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0227709; Radin JM, 2020, LANCET DIGIT HEALTH, V2, pE85, DOI 10.1016/S2589-7500(19)30222-5; Richardson S, 2020, JAMA-J AM MED ASSOC, V323, P2052, DOI 10.1001/jama.2020.6775; Rivera SC, 2019, HEALTH QUAL LIFE OUT, V17, DOI 10.1186/s12955-019-1220-z; Sharma R., 2020, CORONAVIRUS DIS 2019, P55, DOI [10.1007/978-981-15-4814-7_6, DOI 10.1007/978-981-15-4814-7_6]; Shen B, 2020, CELL, V182, P59, DOI 10.1016/j.cell.2020.05.032; Steinhubl SR, 2019, NPJ DIGIT MED, V2, DOI 10.1038/s41746-019-0203-0; Steinhubl SR, 2017, LANCET, V390, P2135, DOI 10.1016/S0140-6736(17)32741-1; Tabata S, 2020, LANCET INFECT DIS, V20, P1043, DOI 10.1016/S1473-3099(20)30482-5; Vogels E.A, 2020, ON IN 5 AM US SMART; Zhu GK, 2020, DISCRETE DYN NAT SOC, V2020, DOI 10.1155/2020/6152041	35	165	165	13	40	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	JAN	2021	27	1					73	+		10.1038/s41591-020-1123-x	http://dx.doi.org/10.1038/s41591-020-1123-x		OCT 2020	9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	PS4ZO	33122860	Green Submitted, Bronze			2022-12-27	WOS:000582832800001
J	Laing, AG; Lorenc, A; del Barrio, ID; Das, A; Fish, M; Monin, L; Munoz-Ruiz, M; McKenzie, DR; Hayday, TS; Francos-Quijorna, I; Kamdar, S; Joseph, M; Davies, D; Davis, R; Jennings, A; Zlatareva, I; Vantourout, P; Wu, Y; Sofra, V; Cano, F; Greco, M; Theodoridis, E; Freedman, J; Gee, S; Chan, JNE; Ryan, S; Bugallo-Blanco, E; Peterson, P; Kisand, K; Haljasmagi, L; Chadli, L; Moingeon, P; Martinez, L; Merrick, B; Bisnauthsing, K; Brooks, K; Ibrahim, MAA; Mason, J; Gomez, FL; Babalola, K; Abdul-Jawad, S; Cason, J; Mant, C; Seow, J; Graham, C; Doores, KJ; Di Rosa, F; Edgeworth, J; Shankar-Hari, M; Hayday, AC				Laing, Adam G.; Lorenc, Anna; del Barrio, Irene del Molino; Das, Abhishek; Fish, Matthew; Monin, Leticia; Munoz-Ruiz, Miguel; McKenzie, Duncan R.; Hayday, Thomas S.; Francos-Quijorna, Isaac; Kamdar, Shraddha; Joseph, Magdalene; Davies, Daniel; Davis, Richard; Jennings, Aislinn; Zlatareva, Iva; Vantourout, Pierre; Wu, Yin; Sofra, Vasiliki; Cano, Florencia; Greco, Maria; Theodoridis, Efstathios; Freedman, Joshua; Gee, Sarah; Chan, Julie Nuo En; Ryan, Sarah; Bugallo-Blanco, Eva; Peterson, Part; Kisand, Kai; Haljasmagi, Liis; Chadli, Loubna; Moingeon, Philippe; Martinez, Lauren; Merrick, Blair; Bisnauthsing, Karen; Brooks, Kate; Ibrahim, Mohammad A. A.; Mason, Jeremy; Gomez, Federico Lopez; Babalola, Kola; Abdul-Jawad, Sultan; Cason, John; Mant, Christine; Seow, Jeffrey; Graham, Carl; Doores, Katie J.; Di Rosa, Francesca; Edgeworth, Jonathan; Shankar-Hari, Manu; Hayday, Adrian C.			A dynamic COVID-19 immune signature includes associations with poor prognosis	NATURE MEDICINE			English	Article							CYTOKINE STORM; T-LYMPHOCYTES; CELLS; INFECTION	A common immune signature in the blood of patients with COVID-19, who are otherwise clinically heterogeneous, sheds light into the pathogenesis and clinical progression of the disease. Improved understanding and management of COVID-19, a potentially life-threatening disease, could greatly reduce the threat posed by its etiologic agent, SARS-CoV-2. Toward this end, we have identified a core peripheral blood immune signature across 63 hospital-treated patients with COVID-19 who were otherwise highly heterogeneous. The signature includes discrete changes in B and myelomonocytic cell composition, profoundly altered T cell phenotypes, selective cytokine/chemokine upregulation and SARS-CoV-2-specific antibodies. Some signature traits identify links with other settings of immunoprotection and immunopathology; others, including basophil and plasmacytoid dendritic cell depletion, correlate strongly with disease severity; while a third set of traits, including a triad of IP-10, interleukin-10 and interleukin-6, anticipate subsequent clinical progression. Hence, contingent upon independent validation in other COVID-19 cohorts, individual traits within this signature may collectively and individually guide treatment options; offer insights into COVID-19 pathogenesis; and aid early, risk-based patient stratification that is particularly beneficial in phasic diseases such as COVID-19.	[Laing, Adam G.; Lorenc, Anna; del Barrio, Irene del Molino; Das, Abhishek; Fish, Matthew; Hayday, Thomas S.; Kamdar, Shraddha; Joseph, Magdalene; Davies, Daniel; Davis, Richard; Jennings, Aislinn; Zlatareva, Iva; Vantourout, Pierre; Wu, Yin; Sofra, Vasiliki; Theodoridis, Efstathios; Freedman, Joshua; Gee, Sarah; Shankar-Hari, Manu; Hayday, Adrian C.] Kings Coll London, Sch Immunol & Microbial Sci, Peter Gorer Dept Immunobiol, London, England; [del Barrio, Irene del Molino; Wu, Yin] UCL, UCL Canc Inst, London, England; [Das, Abhishek] London Sch Hyg & Trop Med, London, England; [Fish, Matthew; Jennings, Aislinn; Shankar-Hari, Manu] Guys & St Thomas NHS Fdn Trust, Dept Intens Care Med, London, England; [Monin, Leticia; Munoz-Ruiz, Miguel; McKenzie, Duncan R.; Wu, Yin; Cano, Florencia; Greco, Maria; Hayday, Adrian C.] Francis Crick Inst, London, England; [Francos-Quijorna, Isaac] Kings Coll London, Wolfson Ctr Age Related Dis, IoPPN, Regenerat Grp, London, England; [Davies, Daniel] Royal Free NHS Fdn Trust, Dept Plast & Reconstruct Surg, London, England; [Chan, Julie Nuo En; Bugallo-Blanco, Eva; Abdul-Jawad, Sultan] Kings Coll London, Comprehens Canc Ctr, Sch Canc & Pharmaceut Sci, London, England; [Ryan, Sarah] Kings Coll London, Dept Inflammat Biol, London, England; [Peterson, Part; Kisand, Kai; Haljasmagi, Liis] Univ Tartu, Inst Biomed & Translat Med, Mol Pathol Res Grp, Tartu, Estonia; [Chadli, Loubna; Moingeon, Philippe] Ctr Therapeut Innovat Immunoinflammat, Servier, France; [Martinez, Lauren; Brooks, Kate] Guys & St Thomas NHS Fdn Trust, Infect Dis Dept, London, England; [Merrick, Blair; Bisnauthsing, Karen; Edgeworth, Jonathan] Guys & St Thomas NHS Fdn Trust, Ctr Clin Infect & Diagnost Res, Dept Infect Dis, London, England; [Ibrahim, Mohammad A. A.] Kings Coll Hosp NHS Fdn Trust, Immunol Med, London, England; [Mason, Jeremy; Gomez, Federico Lopez; Babalola, Kola] European Bioinformat Inst EMBL EBI, Wellcome Genome Campus, Hinxton, England; [Cason, John; Mant, Christine; Seow, Jeffrey; Graham, Carl; Doores, Katie J.] Kings Coll London, Sch Immunol & Microbial Sci, Dept Infect Dis, London, England; [Cason, John; Mant, Christine] Kings Coll London, Sch Immunol & Microbial Sci, Dept Infect Dis, Infect Dis Biobank, London, England; [Di Rosa, Francesca] Natl Res Council Italy CNR, Inst Mol Biol & Pathol, Rome, Italy	University of London; King's College London; University of London; University College London; University of London; London School of Hygiene & Tropical Medicine; Guy's & St Thomas' NHS Foundation Trust; Francis Crick Institute; University of London; King's College London; University of London; King's College London; University of London; King's College London; University of Tartu; Guy's & St Thomas' NHS Foundation Trust; Guy's & St Thomas' NHS Foundation Trust; King's College Hospital NHS Foundation Trust; European Molecular Biology Laboratory (EMBL); University of London; King's College London; University of London; King's College London; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biologia e Patologia Molecolari (IBPM-CNR)	Shankar-Hari, M; Hayday, AC (corresponding author), Kings Coll London, Sch Immunol & Microbial Sci, Peter Gorer Dept Immunobiol, London, England.; Shankar-Hari, M (corresponding author), Guys & St Thomas NHS Fdn Trust, Dept Intens Care Med, London, England.; Hayday, AC (corresponding author), Francis Crick Inst, London, England.	manu.shankar-hari@kcl.ac.uk; adrian.hayday@kcl.ac.uk	Merrick, Blair/GVS-6214-2022; Di Rosa, Francesca/AAW-8612-2020; Shankar-Hari, Manu/I-6948-2012; Lorenc, Anna/AAA-3138-2022; Muñoz-Ruiz, Miguel/AAC-3549-2021; Francos-Quijorna, Isaac/AAA-8811-2021; Ibrahim, Mohammad A. A./G-1387-2011; Peterson, Part/A-5788-2009	Merrick, Blair/0000-0002-6061-6064; Di Rosa, Francesca/0000-0003-0252-9138; Shankar-Hari, Manu/0000-0002-5338-2538; Lorenc, Anna/0000-0002-1406-7607; Muñoz-Ruiz, Miguel/0000-0001-7986-3527; Francos-Quijorna, Isaac/0000-0003-2514-4206; Ibrahim, Mohammad A. A./0000-0002-0116-597X; Zlatareva, Iva/0000-0001-8027-8042; Hayday, Thomas/0000-0003-2268-5250; Ryan, Sarah/0000-0002-0650-3069; McKenzie, Duncan/0000-0003-0961-8846; Monin Aldama, Leticia/0000-0002-4951-8105; Gee, Sarah/0000-0002-2997-6563; Fish, Matthew/0000-0001-6462-3889; HAYDAY, ADRIAN/0000-0002-9495-5793; Peterson, Part/0000-0001-6755-791X; Doores, Katie/0000-0002-5507-1725; Babalola, Kola/0000-0003-1384-8433; Wu, Yin/0000-0003-4080-3935; Chan, Julie Nuo En/0000-0002-8043-2190; Jennings, Aislinn/0000-0002-6954-5717; Das, Abhishek/0000-0002-8798-035X; del Molino del Barrio, Irene/0000-0001-8906-805X; Lopez Gomez, Federico/0000-0002-7138-3542	Cancer ImmunoTherapy Accelerator award from CRUK; CRUK City of London Major Cancer Centre studentship; Wellcome Trust [106292/Z/14/Z, FC001093]; Rosetrees Trust; King's Together Seed Fund; Gamma Delta Therapeutics; John Black Charitable Foundation; Francis Crick Institute; Cancer Research UK [FC001093]; MRC [FC001093]; NIHR Clinician Scientist Award [CS-2016-16-011]; NIHR Biomedical Research Centre for the Infectious Diseases Biobank [RJ112/N027]; NIHR Biomedical Research Centre for support of Infection and Immunity [RJ112/N027]; EMBO ALTF [198-2018]; Irvington Fellowship-Cancer Research Institute; National Institute of Academic Anaesthesia BJA-RCOA PhD Fellowship [WKR0-2018-0047]; NIHR Fellowship; Clinical Immunology Research Fund for the King's College Hospital Charitable Trust; UK MRC [MR/N013700/2]; EMBL core funding; European Union's Horizon 2020 Research and Innovation Programme [730879]; Estonian Research Council [PRG377]; Versus Arthritis [20265] Funding Source: researchfish; The Francis Crick Institute [10794, 10729, 10093, 10787] Funding Source: researchfish	Cancer ImmunoTherapy Accelerator award from CRUK; CRUK City of London Major Cancer Centre studentship; Wellcome Trust(Wellcome Trust); Rosetrees Trust(Rosetrees Trust); King's Together Seed Fund; Gamma Delta Therapeutics; John Black Charitable Foundation; Francis Crick Institute; Cancer Research UK(Cancer Research UK); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIHR Clinician Scientist Award; NIHR Biomedical Research Centre for the Infectious Diseases Biobank; NIHR Biomedical Research Centre for support of Infection and Immunity; EMBO ALTF; Irvington Fellowship-Cancer Research Institute; National Institute of Academic Anaesthesia BJA-RCOA PhD Fellowship; NIHR Fellowship; Clinical Immunology Research Fund for the King's College Hospital Charitable Trust; UK MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); EMBL core funding; European Union's Horizon 2020 Research and Innovation Programme; Estonian Research Council(Estonian Research Council); Versus Arthritis(Versus Arthritis); The Francis Crick Institute	We thank patients and blood donors who consented in this study and the medical and research teams at Guy's and St. Thomas Trust hospitals. We thank F. Shah, Z. Collins, S. Papaioannou, C. Trouillet, S. Cipolat and A. Day for logistics; M. Brown, S. Irshad, M. Malim and S. Neil for support and guidance; the Flow Cytometry core at the NIHR Biomedical Research Centre of Guy's and St Thomas' Hospital and King's College London; R. Ellis, M.T. Barberio, R. Yorke, F. Kyle, S. Acors, K. Steel, O. Hemmings, V. Munoz and J. Warren for technical support and advice. We thank Google for research credits, Basecamp for free unlimited usage of their platform and volunteers at Crowdfight COVID-19. The work was supported by: a Cancer ImmunoTherapy Accelerator award from CRUK (A.C.H.; IDMDB); a CRUK City of London Major Cancer Centre studentship (M.J.); the Wellcome Trust (A.C.H., P.V., I.Z. and V.S.; 106292/Z/14/Z); the Rosetrees Trust (A.C.H.); King's Together Seed Fund (A.C.H.); Gamma Delta Therapeutics (R.D., D.D. and S.K.); The John Black Charitable Foundation (A.C.H.); and the Francis Crick Institute (A.C.H., L.M. and F.C.), which receives core funding from Cancer Research UK (FC001093), the MRC (FC001093) and the Wellcome Trust (FC001093); NIHR Clinician Scientist Award CS-2016-16-011 (M.S.H.); the NIHR Biomedical Research Centre for the Infectious Diseases Biobank (J.C. and C.M.) and for support of Infection and Immunity (J.E.; RJ112/N027); EMBO ALTF 198-2018 (M.M.R.); an Irvington Fellowship-Cancer Research Institute (D.M.); National Institute of Academic Anaesthesia BJA-RCOA PhD Fellowship WKR0-2018-0047 (M.F.), NIHR Fellowship (A.D. and Y.W.); Clinical Immunology Research Fund for the King's College Hospital Charitable Trust (M.A.A.I.); UK MRC (MR/N013700/2) (C.G.); EMBL core funding and the European Union's Horizon 2020 Research and Innovation Programme under grant agreement no. 730879 (F.G., J.B. and J.M.) and Estonian Research Council grant PRG377 (P.P., K.K. and L.H.). The authors also acknowledge King's College London, the Francis Crick Institute and the EBI for institutional support. The views expressed are those of the authors and not necessarily those of the UK NHS, the NIHR or the Department of Health and Social Care.	Abeler-Dorner L, 2020, NAT IMMUNOL, V21, P86, DOI 10.1038/s41590-019-0549-0; Agrati C, 2001, MOL MED, V7, P11, DOI 10.1007/BF03401834; [Anonymous], 2019, SCI REP UK, DOI DOI 10.1038/S41598-019-51294-7; BIRON CA, 1989, NEW ENGL J MED, V320, P1731, DOI 10.1056/NEJM198906293202605; Blanco-Melo D, 2020, CELL, V181, P1036, DOI 10.1016/j.cell.2020.04.026; Carsana L, 2020, LANCET INFECT DIS, V20, P1135, DOI 10.1016/S1473-3099(20)30434-5; Casrouge A, 2012, CLIN EXP IMMUNOL, V167, P137, DOI 10.1111/j.1365-2249.2011.04488.x; Chen RC, 2020, J ALLERGY CLIN IMMUN, V146, P89, DOI 10.1016/j.jaci.2020.05.003; Crivellato E, 2010, INT ARCH ALLERGY IMM, V151, P89, DOI 10.1159/000235998; Cunha BA, 2009, CLIN INFECT DIS, V49, P1454, DOI 10.1086/644496; Docherty AB, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1985; Duan K, 2020, P NATL ACAD SCI USA, V117, P9490, DOI 10.1073/pnas.2004168117; Dunning J, 2018, NAT IMMUNOL, V19, P625, DOI 10.1038/s41590-018-0111-5; Ellinghaus D., 2020, N ENGL J MED, DOI [10.1056/NEJMoa2020283, DOI 10.1056/NEJMOA2020283]; da Mota NVF, 2018, SHOCK, V50, P293, DOI 10.1097/SHK.0000000000001078; Ghnewa YG, 2020, MED KLIN-INTENSIVMED, V115, P10, DOI 10.1007/s00063-020-00683-2; Giamarellos-Bourboulis EJ, 2020, CELL HOST MICROBE, V27, P992, DOI 10.1016/j.chom.2020.04.009; Gordon David E, 2020, bioRxiv, DOI 10.1101/2020.03.22.002386; Grifoni A, 2020, CELL, V181, P1489, DOI 10.1016/j.cell.2020.05.015; Guan W, 2020, NEW ENGL J MED, V382, P1708, DOI 10.1056/NEJMoa2002032; Guo C, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17834-w; Horby P, 2020, N ENGL J MED, DOI DOI 10.1056/NEJMOA2021436; Huang KJ, 2005, J MED VIROL, V75, P185, DOI 10.1002/jmv.20255; Ju B, 2020, NATURE, V584, P115, DOI 10.1038/s41586-020-2380-z; Kuri-Cervantes L, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.abd7114; Kwissa M, 2014, CELL HOST MICROBE, V16, P115, DOI 10.1016/j.chom.2014.06.001; Lafarge X, 2001, J INFECT DIS, V184, P533, DOI 10.1086/322843; Liu J, 2020, EBIOMEDICINE, V55, DOI 10.1016/j.ebiom.2020.102763; Luchsinger L. L., 2020, SEROLOGICAL ANAL NEW, DOI [10.1101/2020.06.08.20124792, DOI 10.1101/2020.06.08.20124792]; Mathew D, 2020, SCIENCE, V369, P1209, DOI 10.1126/science.abc8511; Mehta P, 2020, LANCET, V395, P1033, DOI 10.1016/S0140-6736(20)30628-0; Mendes-Aguiar CD, 2009, CLIN EXP IMMUNOL, V157, P377, DOI 10.1111/j.1365-2249.2009.03970.x; Merle NS, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00257; Meyer S, 2016, CELL, V166, P582, DOI 10.1016/j.cell.2016.06.024; Moore JB, 2020, SCIENCE, V368, P473, DOI 10.1126/science.abb8925; Munoz-Ruiz M, 2020, J AUTOIMMUN, V112, DOI 10.1016/j.jaut.2020.102466; Nizzoli G, 2013, BLOOD, V122, P932, DOI 10.1182/blood-2013-04-495424; Ong EZY, 2020, CELL HOST MICROBE, V27, P879, DOI 10.1016/j.chom.2020.03.021; Pan D, 2020, ECLINICALMEDICINE, V23, DOI 10.1016/j.eclinm.2020.100404; Pickering S, 2020, COMP ASSESSMENT MULT, DOI [10.1101/2020.06.02.20120345, DOI 10.1101/2020.06.02.20120345]; Saif LJ, 2004, REV SCI TECH OIE, V23, P643, DOI 10.20506/rst.23.2.1513; Schaller T, 2020, JAMA-J AM MED ASSOC, V323, P2518, DOI 10.1001/jama.2020.8907; Sekine T., 2020, ROBUST T CELL IMMUNI, DOI [10.1101/2020.06.29.174888, DOI 10.1101/2020.06.29.174888]; Shang J, 2020, P NATL ACAD SCI USA, V117, P11727, DOI 10.1073/pnas.2003138117; Shankar-Hari M, 2017, CRIT CARE MED, V45, P875, DOI [10.1097/ccm.0000000000002380, 10.1097/CCM.0000000000002380]; Shin HS, 2019, CLIN INFECT DIS, V68, P984, DOI 10.1093/cid/ciy595; Simonetti S, 2019, SCAND J IMMUNOL, V89, DOI 10.1111/sji.12735; Sobolev O, 2016, NAT IMMUNOL, V17, P204, DOI 10.1038/ni.3328; Steinberg Eric, 2020, Emerg Med Pract, V22, pCD1; Swystun LL, 2016, BLOOD, V128, P753, DOI 10.1182/blood-2016-05-718114; Vabret N, 2020, IMMUNITY, V52, P910, DOI 10.1016/j.immuni.2020.05.002; Weiskopf D, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.abd2071; Wilk AJ, 2020, NAT MED, V26, P1070, DOI [10.1101/2020.04.17.20069930, 10.1038/s41591-020-0944-y]; Wilson J. G, 2020, JCI INSIGHT; Wolfel R, 2020, NATURE, V581, P465, DOI 10.1038/s41586-020-2196-x; Yang RR, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.10182; Zavascki AP, 2020, NEW ENGL J MED, V382, P1859, DOI 10.1056/NEJMc2005203; Zheng MJ, 2020, CELL MOL IMMUNOL, V17, P533, DOI 10.1038/s41423-020-0402-2; Zhou P, 2020, NATURE, V579, P270, DOI 10.1038/s41586-020-2012-7; Zou LR, 2020, NEW ENGL J MED, V382, P1177, DOI 10.1056/NEJMc2001737	60	469	471	5	45	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	OCT	2020	26	10					1623	+		10.1038/s41591-020-1038-6	http://dx.doi.org/10.1038/s41591-020-1038-6		AUG 2020	33	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	NX8MD	32807934	Bronze			2022-12-27	WOS:000560288000008
J	Ramlall, V; Thangaraj, PM; Meydan, C; Foox, J; Butler, D; Kim, J; May, B; De Freitas, JK; Glicksberg, BS; Mason, CE; Tatonetti, NP; Shapira, SD				Ramlall, Vijendra; Thangaraj, Phyllis M.; Meydan, Cem; Foox, Jonathan; Butler, Daniel; Kim, Jacob; May, Ben; De Freitas, Jessica K.; Glicksberg, Benjamin S.; Mason, Christopher E.; Tatonetti, Nicholas P.; Shapira, Sagi D.			Immune complement and coagulation dysfunction in adverse outcomes of SARS-CoV-2 infection	NATURE MEDICINE			English	Article							THROMBOSIS; INSIGHTS; GENETICS	A combination of clinical and molecular analyses supports an association between disorders of immune complement or coagulation with poor outcome in patients with SARS-CoV-2 infection. Understanding the pathophysiology of SARS-CoV-2 infection is critical for therapeutic and public health strategies. Viral-host interactions can guide discovery of disease regulators, and protein structure function analysis points to several immune pathways, including complement and coagulation, as targets of coronaviruses. To determine whether conditions associated with dysregulated complement or coagulation systems impact disease, we performed a retrospective observational study and found that history of macular degeneration (a proxy for complement-activation disorders) and history of coagulation disorders (thrombocytopenia, thrombosis and hemorrhage) are risk factors for SARS-CoV-2-associated morbidity and mortality-effects that are independent of age, sex or history of smoking. Transcriptional profiling of nasopharyngeal swabs demonstrated that in addition to type-I interferon and interleukin-6-dependent inflammatory responses, infection results in robust engagement of the complement and coagulation pathways. Finally, in a candidate-driven genetic association study of severe SARS-CoV-2 disease, we identified putative complement and coagulation-associated loci including missense, eQTL and sQTL variants of critical complement and coagulation regulators. In addition to providing evidence that complement function modulates SARS-CoV-2 infection outcome, the data point to putative transcriptional genetic markers of susceptibility. The results highlight the value of using a multimodal analytical approach to reveal determinants and predictors of immunity, susceptibility and clinical outcome associated with infection.	[Ramlall, Vijendra; Thangaraj, Phyllis M.; Tatonetti, Nicholas P.] Columbia Univ, Dept Biomed Informat, New York, NY 10027 USA; [Ramlall, Vijendra] Columbia Univ, Dept Physiol & Cellular Biophys, New York, NY USA; [Thangaraj, Phyllis M.] Columbia Univ, Vagelos Coll Phys & Surg, New York, NY USA; [Meydan, Cem; Foox, Jonathan; Butler, Daniel; Mason, Christopher E.] Weill Cornell Med, HRH Prince Alwaleed Bin Talal Bin Abdulaziz Alsau, New York, NY USA; [Meydan, Cem; May, Ben] Columbia Univ, Herbert Irving Comprehens Canc Ctr, New York, NY USA; [Foox, Jonathan; Butler, Daniel; Mason, Christopher E.] Weill Cornell Med, Dept Physiol & Biophys, New York, NY USA; [Kim, Jacob; Tatonetti, Nicholas P.; Shapira, Sagi D.] Columbia Univ, Dept Syst Biol, New York, NY 10027 USA; [De Freitas, Jessica K.; Glicksberg, Benjamin S.] Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY 10029 USA; [De Freitas, Jessica K.; Glicksberg, Benjamin S.] Icahn Sch Med Mt Sinai, Hasso Plattner Inst Digital Hlth Mt Sinai, New York, NY 10029 USA; [Mason, Christopher E.] Weill Cornell Med, WorldQuant Initiat Quantitat Predict, New York, NY USA; [Mason, Christopher E.] Weill Cornell Med, Feil Family Brain & Mind Res Inst, New York, NY USA	Columbia University; Columbia University; Columbia University; Cornell University; Columbia University; Cornell University; Columbia University; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Cornell University; Cornell University	Tatonetti, NP (corresponding author), Columbia Univ, Dept Biomed Informat, New York, NY 10027 USA.; Tatonetti, NP; Shapira, SD (corresponding author), Columbia Univ, Dept Syst Biol, New York, NY 10027 USA.	nick.tatonetti@columbia.edu; ss4197@columbia.edu	Mason, Christopher/HCH-3977-2022	Glicksberg, Benjamin/0000-0003-4515-8090; Meydan, Cem/0000-0002-0663-6216; Shapira, Sagi/0000-0002-5425-3682; Butler, Daniel J./0000-0002-3687-8419	US National Institutes of Health [5R01GM109018, R21AI147201, 5U54CA209997, R35GM131905, F30HL140946, S10OD012351, S10OD021764]; Starr Cancer Consortium [I13-0052]; WorldQuant Foundation; Pershing Square Sohn Cancer Research Alliance; NASA [NNX14AH50G, NNX17AB26G]; National Institutes of Health [R21AI129851, R01MH117406, R01AI151059]	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Starr Cancer Consortium; WorldQuant Foundation; Pershing Square Sohn Cancer Research Alliance(Pershing Square Sohn Cancer Research Alliance); NASA(National Aeronautics & Space Administration (NASA)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was funded by US National Institutes of Health grants 5R01GM109018, R21AI147201 and 5U54CA209997 to S.S., R35GM131905 to N.P.T., F30HL140946 to P.T. and equipment grants S10OD012351 and S10OD021764 to the Columbia University Department of Systems Biology. C.E.M. thanks the Scientific Computing Unit, XSEDE Supercomputing Resources, the Starr Cancer Consortium (I13-0052) and funding from the WorldQuant Foundation, the Pershing Square Sohn Cancer Research Alliance, NASA (NNX14AH50G, NNX17AB26G) and the National Institutes of Health (R21AI129851, R01MH117406, R01AI151059).	Aguet F, 2017, NATURE, V550, P204, DOI 10.1038/nature24277; Ambati J, 2013, NAT REV IMMUNOL, V13, P438, DOI 10.1038/nri3459; Brodie A, 2016, NUCLEIC ACIDS RES, V44, P6046, DOI 10.1093/nar/gkw500; Butler Daniel J, 2020, bioRxiv, DOI 10.1101/2020.04.20.048066; Bycroft C, 2018, NATURE, V562, P203, DOI 10.1038/s41586-018-0579-z; Chang CC, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0047-8; Chen G, 2020, J CLIN INVEST, V130, P2620, DOI 10.1172/JCI137244; Ellinghaus D, 2020, NEW ENGL J MED, V383, P1522, DOI 10.1056/NEJMoa2020283; Ermert D, 2016, IMMUNOL LETT, V169, P82, DOI 10.1016/j.imlet.2015.11.014; Gary-Bobo M, 2007, CURR MED CHEM, V14, P2945, DOI 10.2174/092986707782794005; Goeijenbier M, 2012, J MED VIROL, V84, P1680, DOI 10.1002/jmv.23354; Han XK, 2020, J HUM GENET, V65, P657, DOI 10.1038/s10038-020-0750-x; Holers VM, 2014, ANNU REV IMMUNOL, V32, P433, DOI 10.1146/annurev-immunol-032713-120154; Hosmer DW, 2008, APPL SURVIVAL ANAL R, V2nd; Lasso G, 2020, PREPRINT, DOI [10.1101/2020.06.18.159467, DOI 10.1101/2020.06.18.159467]; Lasso G, 2019, CELL, V178, P1526, DOI 10.1016/j.cell.2019.08.005; Liszewski MK, 2017, ANNU REV PATHOL-MECH, V12, P25, DOI 10.1146/annurev-pathol-012615-044145; Mastaglio S, 2020, CLIN IMMUNOL, V215, DOI 10.1016/j.clim.2020.108450; Merle NS, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00262; Moore JB, 2020, SCIENCE, V368, P473, DOI 10.1126/science.abb8925; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Morange PE, 2015, THROMB HAEMOSTASIS, V114, P910, DOI 10.1160/TH15-05-0410; Nascimento EJM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006782; Pastor AF, 2013, HUM IMMUNOL, V74, P1225, DOI 10.1016/j.humimm.2013.05.005; Polubriaginof FCG, 2019, J AM MED INFORM ASSN, V26, P730, DOI 10.1093/jamia/ocz113; Rehman AA, 2013, J CELL PHYSIOL, V228, P1665, DOI 10.1002/jcp.24266; Risitano AM, 2020, NAT REV IMMUNOL, V20, P343, DOI 10.1038/s41577-020-0320-7; Smith NL, 2011, CIRCULATION, V123, P1864, DOI 10.1161/CIRCULATIONAHA.110.009480; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sudlow C, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001779; Weisel JW, 2019, J THROMB HAEMOST, V17, P271, DOI 10.1111/jth.14360; Wu JL, 2019, DRUG DES DEV THER, V13, P2413, DOI 10.2147/DDDT.S206355; Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3; Zoller B, 2019, BLOOD, V134, P1568, DOI 10.1182/blood.2019002597	34	120	124	3	18	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	OCT	2020	26	10					1609	+		10.1038/s41591-020-1021-2	http://dx.doi.org/10.1038/s41591-020-1021-2		AUG 2020	22	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	NX8MD	32747830	Bronze, Green Accepted, Green Published			2022-12-27	WOS:000555386300004
J	Menni, C; Valdes, AM; Freidin, MB; Sudre, CH; Nguyen, LH; Drew, DA; Ganesh, S; Varsavsky, T; Cardoso, MJ; Moustafa, JSES; Visconti, A; Hysi, P; Bowyer, RCE; Mangino, M; Falchi, M; Wolf, J; Ourselin, S; Chan, AT; Steves, CJ; Spector, TD				Menni, Cristina; Valdes, Ana M.; Freidin, Maxim B.; Sudre, Carole H.; Nguyen, Long H.; Drew, David A.; Ganesh, Sajaysurya; Varsavsky, Thomas; Cardoso, M. Jorge; Moustafa, Julia S. El-Sayed; Visconti, Alessia; Hysi, Pirro; Bowyer, Ruth C. E.; Mangino, Massimo; Falchi, Mario; Wolf, Jonathan; Ourselin, Sebastien; Chan, Andrew T.; Steves, Claire J.; Spector, Tim D.			Real-time tracking of self-reported symptoms to predict potential COVID-19	NATURE MEDICINE			English	Article								A total of 2,618,862 participants reported their potential symptoms of COVID-19 on a smartphone-based app. Among the 18,401 who had undergone a SARS-CoV-2 test, the proportion of participants who reported loss of smell and taste was higher in those with a positive test result (4,668 of 7,178 individuals; 65.03%) than in those with a negative test result (2,436 of 11,223 participants; 21.71%) (odds ratio = 6.74; 95% confidence interval = 6.31-7.21). A model combining symptoms to predict probable infection was applied to the data from all app users who reported symptoms (805,753) and predicted that 140,312 (17.42%) participants are likely to have COVID-19. Analysis of data from a smartphone-based app designed for large-scale tracking of potential COVID-19 symptoms, used by over 2.5 million participants in the United Kingdom and United States, shows that loss of taste and smell sensations is predictive of potential SARS-CoV-2 infection.	[Menni, Cristina; Valdes, Ana M.; Freidin, Maxim B.; Moustafa, Julia S. El-Sayed; Visconti, Alessia; Hysi, Pirro; Bowyer, Ruth C. E.; Mangino, Massimo; Falchi, Mario; Steves, Claire J.; Spector, Tim D.] Kings Coll London, Dept Twin Res & Genet Epidemiol, London, England; [Valdes, Ana M.] Nottingham City Hosp, Acad Rheumatol, Clin Sci, Nottingham, England; [Sudre, Carole H.; Varsavsky, Thomas; Cardoso, M. Jorge; Ourselin, Sebastien] Kings Coll London, Sch Biomed Engn & Imaging Sci, London, England; [Nguyen, Long H.; Drew, David A.; Chan, Andrew T.] Massachusetts Gen Hosp, Clin & Translat Epidemiol Unit, Boston, MA 02114 USA; [Nguyen, Long H.; Drew, David A.; Chan, Andrew T.] Harvard Med Sch, Boston, MA 02115 USA; [Ganesh, Sajaysurya; Wolf, Jonathan] Zoe Global, London, England; [Mangino, Massimo] Guys & St Thomas Fdn Trust, NIHR Biomed Res Ctr, London, England	University of London; King's College London; Nottingham University Hospital NHS Trust; Nottingham City Hospital; University of London; King's College London; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Guy's & St Thomas' NHS Foundation Trust	Menni, C; Steves, CJ; Spector, TD (corresponding author), Kings Coll London, Dept Twin Res & Genet Epidemiol, London, England.	cristina.menni@kcl.ac.uk; tim.spector@kcl.ac.uk	Visconti, Alessia/B-9974-2015; Sudre, Carole H./AAX-6672-2020; Mangino, Massimo/F-5134-2011; Freydin, Maxim/A-5603-2011; Varsavsky, Thomas/AAU-7605-2021; Cardoso, M. Jorge/N-5511-2018; Ourselin, Sebastien/K-6960-2015	Visconti, Alessia/0000-0003-4144-2019; Sudre, Carole H./0000-0001-5753-428X; Mangino, Massimo/0000-0002-2167-7470; Freydin, Maxim/0000-0002-1439-6259; Varsavsky, Thomas/0000-0002-8624-8116; Falchi, Mario/0000-0002-5646-1004; Hysi, Pirro/0000-0001-5752-2510; Valdes, Ana M./0000-0003-1141-4471; El-Sayed Moustafa, Julia Sarah/0000-0001-6963-6654; Steves, Claire/0000-0002-4910-0489; Nguyen, Long/0000-0002-5436-4219; Cardoso, M. Jorge/0000-0003-1284-2558; Bowyer, Ruth/0000-0002-6941-8160; Ourselin, Sebastien/0000-0002-5694-5340; Ganesh, Sajaysurya/0000-0002-3720-4176	Zoe Global; Wellcome Trust [212904/Z/18/Z]; Medical Research Council/British Heart Foundation Ancestry and Biological Informative Markers for Stratification of Hypertension (AIMHY) [MR/M016560/1]; European Union; Chronic Disease Research Foundation; NIHR Clinical Research Facility; Biomedical Research Centre (based at Guy's and St Thomas' NHS Foundation Trust); King's College London; Medical Research Council AIM HY project grant; National Institute for Health Research Nottingham Biomedical Research Centre; Alzheimer's Society Junior Fellowship [AS-JF-17-011]; Wellcome/EPSRC Centre for Medical Engineering [WT203148/Z/16/Z]; Wellcome Flagship Programme [WT213038/Z/18/Z]; Evergrande COVID-19 Response Fund Award through the Massachusetts Consortium on Pathogen Readiness (MassCPR); UK Research and Innovation London Medical Imaging & Artificial Intelligence Centre for Value-Based Healthcare; MRC [MR/M004422/1] Funding Source: UKRI	Zoe Global; Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council/British Heart Foundation Ancestry and Biological Informative Markers for Stratification of Hypertension (AIMHY); European Union(European Commission); Chronic Disease Research Foundation; NIHR Clinical Research Facility; Biomedical Research Centre (based at Guy's and St Thomas' NHS Foundation Trust); King's College London(General Electric); Medical Research Council AIM HY project grant; National Institute for Health Research Nottingham Biomedical Research Centre; Alzheimer's Society Junior Fellowship; Wellcome/EPSRC Centre for Medical Engineering(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Wellcome Flagship Programme; Evergrande COVID-19 Response Fund Award through the Massachusetts Consortium on Pathogen Readiness (MassCPR); UK Research and Innovation London Medical Imaging & Artificial Intelligence Centre for Value-Based Healthcare; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We express our sincere thanks to all of the participants who entered data into the app, including study volunteers enrolled in cohorts within the Coronavirus Pandemic Epidemiology (COPE) consortium. We thank the staff of Zoe Global, the Department of Twin Research at King's College London and the Clinical and Translational Epidemiology Unit at Massachusetts General Hospital for tireless work in contributing to the running of the study and data collection. We thank E. Segal and his laboratory for helpful input. This work was supported by Zoe Global. The Department of Twin Research receives grants from the Wellcome Trust (212904/Z/18/Z) and Medical Research Council/British Heart Foundation Ancestry and Biological Informative Markers for Stratification of Hypertension (AIMHY; MR/M016560/1), and support from the European Union, the Chronic Disease Research Foundation, Zoe Global, the NIHR Clinical Research Facility and the Biomedical Research Centre (based at Guy's and St Thomas' NHS Foundation Trust in partnership with King's College London). C.M. is funded by the Chronic Disease Research Foundation and by the Medical Research Council AIM HY project grant. A.M.V. is supported by the National Institute for Health Research Nottingham Biomedical Research Centre. C.H.S. received an Alzheimer's Society Junior Fellowship (AS-JF-17-011). S.O. and M.J.C. are funded by the Wellcome/EPSRC Centre for Medical Engineering (WT203148/Z/16/Z) and Wellcome Flagship Programme (WT213038/Z/18/Z). A.T.C. is the Stuart and Suzanne Steele MGH Research Scholar and is a team leader for the Stand Up to Cancer Foundation. A.T.C., L.H.N. and D.A.D. are supported by an Evergrande COVID-19 Response Fund Award through the Massachusetts Consortium on Pathogen Readiness (MassCPR). This work was also supported by the UK Research and Innovation London Medical Imaging & Artificial Intelligence Centre for Value-Based Healthcare.	Brann D, 2020, NONNEURONAL EXPRESSI, DOI DOI 10.1101/2020.03.25.009084V3; Drew D.A., 2020, SCIENCE; Eliezer M, 2020, JAMA OTOLARYNGOL, V146, P674, DOI 10.1001/jamaoto.2020.0832; Gane SB, 2020, RHINOLOGY, V58, P299, DOI 10.4193/Rhin20.114; Hopkiins C., 2020, LOSS SENSE SMELL MAR; IACOBUCCI G, 2020, BMJ-BRIT MED J, V368, DOI DOI 10.1136/bmj.m1202; LeDell E, 2015, ELECTRON J STAT, V9, P1583, DOI 10.1214/15-EJS1035; Oleszkiewicz A, 2020, PHILOS T R SOC B, V375, DOI 10.1098/rstb.2019.0265; Roberts M, 2020, BBC NEWS; Rossman H, 2020, NAT MED, V26, P634, DOI 10.1038/s41591-020-0857-9; Spinato G, 2020, JAMA-J AM MED ASSOC, V323, P2089, DOI 10.1001/jama.2020.6771; Sungnak W, 2020, NAT MED, V26, P681, DOI 10.1038/s41591-020-0868-6; Whittington A. M, 2020, BMJ-BRIT MED J	13	685	699	3	38	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	JUL	2020	26	7					1037	+		10.1038/s41591-020-0916-2	http://dx.doi.org/10.1038/s41591-020-0916-2		MAY 2020	8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	MK3XO	32393804	Green Accepted, Green Submitted, Bronze			2022-12-27	WOS:000531781900004
J	Weitz, JS; Beckett, SJ; Coenen, AR; Demory, D; Dominguez-Mirazo, M; Dushoff, J; Leung, CY; Li, GL; Magalie, A; Park, SW; Rodriguez-Gonzalez, R; Shivam, S; Zhao, CNY				Weitz, Joshua S.; Beckett, Stephen J.; Coenen, Ashley R.; Demory, David; Dominguez-Mirazo, Marian; Dushoff, Jonathan; Leung, Chung-Yin; Li, Guanlin; Magalie, Andreea; Park, Sang Woo; Rodriguez-Gonzalez, Rogelio; Shivam, Shashwat; Zhao, Conan Y.			Modeling shield immunity to reduce COVID-19 epidemic spread	NATURE MEDICINE			English	Article							TRANSMISSION DYNAMICS; CORONAVIRUS; MULTISCALE; INFECTION; NETWORK; WUHAN	A new study models the potential effects of preferentially deploying recovered individuals, who are seropositive for anti-SARS-CoV-2 antibodies, into the community to reduce the number of interactions between susceptible and infected people, thereby limiting transmission of the virus. The COVID-19 pandemic has precipitated a global crisis, with more than 1,430,000 confirmed cases and more than 85,000 confirmed deaths globally as of 9 April 2020(1-4). Mitigation and suppression of new infections have emerged as the two predominant public health control strategies(5). Both strategies focus on reducing new infections by limiting human-to-human interactions, which could be both socially and economically unsustainable in the long term. We have developed and analyzed an epidemiological intervention model that leverages serological tests(6,7) to identify and deploy recovered individuals(8) as focal points for sustaining safer interactions via interaction substitution, developing what we term 'shield immunity' at the population scale. The objective of a shield immunity strategy is to help to sustain the interactions necessary for the functioning of essential goods and services(9) while reducing the probability of transmission. Our shield immunity approach could substantively reduce the length and reduce the overall burden of the current outbreak, and can work synergistically with social distancing. The present model highlights the value of serological testing as part of intervention strategies, in addition to its well-recognized roles in estimating prevalence(10,11) and in the potential development of plasma-based therapies(12-15).	[Weitz, Joshua S.; Beckett, Stephen J.; Demory, David; Dominguez-Mirazo, Marian; Leung, Chung-Yin; Magalie, Andreea; Rodriguez-Gonzalez, Rogelio; Zhao, Conan Y.] Georgia Inst Technol, Sch Biol Sci, Atlanta, GA 30332 USA; [Weitz, Joshua S.; Coenen, Ashley R.; Leung, Chung-Yin; Li, Guanlin] Georgia Inst Technol, Sch Phys, Atlanta, GA 30332 USA; [Weitz, Joshua S.] Georgia Inst Technol, Ctr Microbial Dynam & Infect, Atlanta, GA 30332 USA; [Dominguez-Mirazo, Marian; Li, Guanlin; Magalie, Andreea; Rodriguez-Gonzalez, Rogelio; Zhao, Conan Y.] Georgia Inst Technol, Interdisciplinary Grad Program Quantitat Biosci, Atlanta, GA 30332 USA; [Dushoff, Jonathan] McMaster Univ, Dept Biol, Hamilton, ON, Canada; [Dushoff, Jonathan] McMaster Univ, DeGroote Inst Infect Dis Res, Hamilton, ON, Canada; [Park, Sang Woo] Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA; [Shivam, Shashwat] Georgia Inst Technol, Sch Elect & Comp Engn, Atlanta, GA 30332 USA	University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology; McMaster University; McMaster University; Princeton University; University System of Georgia; Georgia Institute of Technology	Weitz, JS (corresponding author), Georgia Inst Technol, Sch Biol Sci, Atlanta, GA 30332 USA.; Weitz, JS (corresponding author), Georgia Inst Technol, Sch Phys, Atlanta, GA 30332 USA.; Weitz, JS (corresponding author), Georgia Inst Technol, Ctr Microbial Dynam & Infect, Atlanta, GA 30332 USA.	jsweitz@gatech.edu		Rodriguez Gonzalez, Rogelio/0000-0002-5460-4999; Zhao, Conan/0000-0001-5714-2286; Beckett, Stephen/0000-0002-4410-2960; Dushoff, Jonathan/0000-0003-0506-4794; Dominguez-Mirazo, Marian/0000-0001-8653-3091	Simons Foundation [329108]; Army Research Office [W911NF1910384]; National Institutes of Health [1R01AI46592-01]; National Science Foundation [1806606, 1829636]; Canadian Institutes of Health Research; Natural Sciences and Engineering Research Council of Canada	Simons Foundation; Army Research Office; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	We thank P.S. Dodds, M. Lipsitch, K. Levy, D. Muratore, A. Sanz and J. Shaman for comments and feedback in the initial stages of development, and A. Kraay, B. Lopman and K. Nelson for discussions on serological testing characteristics as part of ongoing collaborative work. Tweet threads by T. Bedford and N. Christakis were influential in refining initial ideas into the current form. Research effort by J.S.W. and co-authors at the Georgia Institute of Technology was enabled by support from grants from the Simons Foundation (SCOPE Award ID 329108), the Army Research Office (W911NF1910384), the National Institutes of Health (1R01AI46592-01) and the National Science Foundation (1806606 and 1829636). J.D. was supported in part by grants from the Canadian Institutes of Health Research and the Natural Sciences and Engineering Research Council of Canada.	Amanat F, 2020, NAT MED, V26, P1033, DOI [10.1101/2020.03.17.20037713, 10.1038/s41591-020-0913-5]; [Anonymous], 2020, GLOB OPT TOOLB; [Anonymous], NAT COVID 19 CONV PL; [Anonymous], 2018, ANN ESTIMATES RESIDE; Bai Y, 2020, JAMA-J AM MED ASSOC, V323, P1406, DOI [10.1056/NEJMoa2001316, 10.1001/jama.2020.2565]; Balcan D, 2009, P NATL ACAD SCI USA, V106, P21484, DOI 10.1073/pnas.0906910106; Bansal S, 2007, J R SOC INTERFACE, V4, P879, DOI 10.1098/rsif.2007.1100; Bellan SE, 2014, LANCET, V384, P1499, DOI 10.1016/S0140-6736(14)61839-0; Bezanson J, 2017, SIAM REV, V59, P65, DOI 10.1137/141000671; Bolker B.M., 2020, RECONCILING EARLY OU, DOI [10.1101/2020.01.30.20019877, DOI 10.1101/2020.01.30.20019877]; CALLOW KA, 1990, EPIDEMIOL INFECT, V105, P435, DOI 10.1017/S0950268800048019; Chan Kwok-Hung, 2013, J Infect, V67, P130, DOI 10.1016/j.jinf.2013.03.015; Chen L, 2020, LANCET INFECT DIS, V20, P398, DOI 10.1016/S1473-3099(20)30141-9; Chinazzi M, 2020, SCIENCE, V368, P395, DOI 10.1126/science.aba9757; Colizza V, 2006, P NATL ACAD SCI USA, V103, P2015, DOI 10.1073/pnas.0510525103; Dhama K, 2020, CLIN MICROBIOL REV, V33, DOI 10.1128/CMR.00028-20; Dormand J.R., 1980, J COMPUT APPL MATH, V6, P19, DOI [10.1016/0771-050X(80)90013-3, DOI 10.1016/0771-050X(80)90013-3]; Duan K, 2020, P NATL ACAD SCI USA, V117, P9490, DOI 10.1073/pnas.2004168117; Emanuel EJ, 2020, NY TIMES; Eubank S, 2020, B MATH BIOL, V82, DOI 10.1007/s11538-020-00726-x; Fauci AS, 2020, NEW ENGL J MED, V382, P1268, DOI 10.1056/NEJMe2002387; Flaxman S., 2020, 13 IMP COLL; Gottlieb Scott., 2020, NATL CORONAVIRUS RES; Hadfield J, 2018, BIOINFORMATICS, V34, P4121, DOI 10.1093/bioinformatics/bty407; Hennekens CH, 2020, AM J MED, V133, P648, DOI 10.1016/j.amjmed.2020.03.001; Kissler SM, 2020, SCIENCE, V368, P860, DOI 10.1126/science.abb5793; Klompas M, 2020, ANN INTERN MED, V172, P619, DOI 10.7326/M20-0751; Kraemer MUG, 2020, SCIENCE, V368, P493, DOI 10.1126/science.abb4218; Li RY, 2020, SCIENCE, V368, P489, DOI [10.1126/science.abb3221, 10.1101/2020.02.14.20023127]; Lipsitch M, 2020, NEW ENGL J MED, V382, P1194, DOI 10.1056/NEJMp2002125; Lou B, SEROLOGY CHARACTERIS, DOI 10.1101/2020.03.23.20041707; Lourenco J., 2020, MEDRXIV, DOI [10.1101/2020.03.24.20042291, 10.1101/2020.03.24.20042291v1, DOI 10.1101/2020.03.24.20042291]; Mckee M, 2020, NAT MED, V26, P640, DOI 10.1038/s41591-020-0863-y; McMichael TM, 2020, NEW ENGL J MED, V382, P2005, DOI 10.1056/NEJMoa2005412; Nakvasina M.A., 2016, Vestn. Voronezh. Gos. Univ., Ser.: Khim., Biol., Farm., P67, DOI [DOI 10.1093/cid/ciaa344, DOI 10.1093/CID/CIAA344]; Okba NMA, 2020, EMERG INFECT DIS, V26, P1478, DOI 10.3201/eid2607.200841; Onder G, 2020, JAMA-J AM MED ASSOC, V323, P1775, DOI 10.1001/jama.2020.4683; Park Sang Woo, 2020, medRxiv, DOI 10.1101/2020.03.09.20033514; Rackauckas C., 2017, J OPEN RES STW, V5, P15, DOI 10.5334/jors.151; Roback JD, 2020, JAMA-J AM MED ASSOC, V323, P1561, DOI 10.1001/jama.2020.4940; Shampine LF, 1997, SIAM J SCI COMPUT, V18, P1, DOI 10.1137/S1064827594276424; Soetaert K, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i09; Tsitouras C, 2011, COMPUT MATH APPL, V62, P770, DOI 10.1016/j.camwa.2011.06.002; Verity R, 2020, LANCET INFECT DIS, V20, P669, DOI 10.1016/S1473-3099(20)30243-7; Watts DJ, 2005, P NATL ACAD SCI USA, V102, P11157, DOI 10.1073/pnas.0501226102; WHITLEY D, 1994, STAT COMPUT, V4, P65, DOI 10.1007/BF00175354; Wu JM, 2022, CRIT REV FOOD SCI, V62, P783, DOI [10.1080/10408398.2020.1828813, 10.1038/s41591-020-0822-7]; Wu JT, 2020, LANCET, V395, P689, DOI 10.1016/S0140-6736(20)30260-9; Zhou P, 2020, NATURE, V579, P270, DOI 10.1038/s41586-020-2012-7	49	114	114	0	22	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	JUN	2020	26	6					849	+		10.1038/s41591-020-0895-3	http://dx.doi.org/10.1038/s41591-020-0895-3		MAY 2020	19	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	LZ3ZG	32382154	Green Accepted, Bronze			2022-12-27	WOS:000530983800004
J	Xu, Y; Li, XF; Zhu, B; Liang, HY; Fang, CX; Gong, Y; Guo, QZ; Sun, X; Zhao, DY; Shen, J; Zhang, HY; Liu, HS; Xia, HM; Tang, JL; Zhang, K; Gong, ST				Xu, Yi; Li, Xufang; Zhu, Bing; Liang, Huiying; Fang, Chunxiao; Gong, Yu; Guo, Qiaozhi; Sun, Xin; Zhao, Danyang; Shen, Jun; Zhang, Huayan; Liu, Hongsheng; Xia, Huimin; Tang, Jinling; Zhang, Kang; Gong, Sitang			Characteristics of pediatric SARS-CoV-2 infection and potential evidence for persistent fecal viral shedding	NATURE MEDICINE			English	Article							CORONAVIRUS	We report epidemiological and clinical investigations on ten pediatric SARS-CoV-2 infection cases confirmed by real-time reverse transcription PCR assay of SARS-CoV-2 RNA. Symptoms in these cases were nonspecific and no children required respiratory support or intensive care. Chest X-rays lacked definite signs of pneumonia, a defining feature of the infection in adult cases. Notably, eight children persistently tested positive on rectal swabs even after nasopharyngeal testing was negative, raising the possibility of fecal-oral transmission. Children infected with the COVID-19 outbreak coronavirus, SARS-CoV-2, show mild symptoms but prolonged shedding of viral RNA in feces, suggesting that the fecal-oral route might play a role in virus transmission.	[Xu, Yi; Li, Xufang; Fang, Chunxiao; Gong, Yu; Shen, Jun; Zhang, Huayan; Gong, Sitang] Guangzhou Med Univ, Dept Pediat, Guangzhou Women & Childrens Med Ctr, Guangzhou, Peoples R China; [Li, Xufang] Guangzhou Med Univ, Dept Ctr Lab, Guangzhou Women & Childrens Med Ctr, Guangzhou, Peoples R China; [Zhu, Bing; Xia, Huimin; Tang, Jinling] Guangzhou Med Univ, Guangzhou Women & Childrens Med Ctr, Clin Data Ctr, Guangzhou, Peoples R China; [Liang, Huiying; Zhang, Huayan; Xia, Huimin; Tang, Jinling; Gong, Sitang] Guangzhou Med Univ, Guangdong Prov Childrens Med Res Ctr, Guangzhou Women & Childrens Med Ctr, Guangzhou, Peoples R China; [Guo, Qiaozhi; Sun, Xin; Zhao, Danyang] Guangzhou Med Univ, Dept Med Adm, Guangzhou Women & Childrens Med Ctr, Guangzhou, Peoples R China; [Zhang, Huayan] Childrens Hosp Philadelphia, Div Neonatol, Philadelphia, PA 19104 USA; [Zhang, Huayan] Childrens Hosp Philadelphia, Dept Pediat, Philadelphia, PA 19104 USA; [Zhang, Huayan] Univ Penn, Philadelphia, PA 19104 USA; [Liu, Hongsheng] Guangzhou Med Univ, Dept Radiol, Guangzhou Women & Childrens Med Ctr, Guangzhou, Peoples R China; [Xia, Huimin; Zhang, Kang] Guangzhou Med Univ, Guangzhou Women & Childrens Med Ctr, Guangdong Prov Key Lab Res Struct Birth Defect Di, Guangzhou, Peoples R China; [Zhang, Kang] Guangzhou Regenerat Med & Hlth Guangdong Lab, Guangzhou, Peoples R China; [Zhang, Kang] Macau Univ Sci & Technol, Fac Med, Ctr Biomed & Innovat, Macau, Peoples R China	Guangzhou Medical University; Guangzhou Medical University; Guangzhou Medical University; Guangzhou Medical University; Guangzhou Medical University; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Guangzhou Medical University; Guangzhou Medical University; Guangzhou Regenerative Medicine & Health Guangdong Laboratory (Bioisland Laboratory); Macau University of Science & Technology	Gong, ST (corresponding author), Guangzhou Med Univ, Dept Pediat, Guangzhou Women & Childrens Med Ctr, Guangzhou, Peoples R China.; Xia, HM; Tang, JL (corresponding author), Guangzhou Med Univ, Guangzhou Women & Childrens Med Ctr, Clin Data Ctr, Guangzhou, Peoples R China.; Xia, HM; Tang, JL; Gong, ST (corresponding author), Guangzhou Med Univ, Guangdong Prov Childrens Med Res Ctr, Guangzhou Women & Childrens Med Ctr, Guangzhou, Peoples R China.; Xia, HM; Zhang, K (corresponding author), Guangzhou Med Univ, Guangzhou Women & Childrens Med Ctr, Guangdong Prov Key Lab Res Struct Birth Defect Di, Guangzhou, Peoples R China.; Zhang, K (corresponding author), Guangzhou Regenerat Med & Hlth Guangdong Lab, Guangzhou, Peoples R China.; Zhang, K (corresponding author), Macau Univ Sci & Technol, Fac Med, Ctr Biomed & Innovat, Macau, Peoples R China.	huiminxia@hotmail.com; jltang@cuhk.edu.hk; kang.zhang@gmail.com; sitangg@126.com	Zhang, Kang/Y-2740-2019; Guo, qiaozhi/GPF-8271-2022; Tang, Jin-Ling/AAJ-4090-2021	Zhang, Kang/0000-0002-4549-1697; Xia, Huimin/0000-0002-0103-1672	National Key Research and Development Program of China [2019YFB1404803]; Guangzhou Regenerative Medicine Guangdong Laboratory [2020GZR110306001]; CDCs of Guangzhou City	National Key Research and Development Program of China; Guangzhou Regenerative Medicine Guangdong Laboratory; CDCs of Guangzhou City(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This work was funded by the National Key Research and Development Program of China (2019YFB1404803) and Guangzhou Regenerative Medicine Guangdong Laboratory (2020GZR110306001). We thank the CDCs of Guangzhou City and Guangdong Province for helping with confirmation of the diagnosis of the viral infection.	Chen NS, 2020, LANCET, V395, P507, DOI 10.1016/S0140-6736(20)30211-7; Guan W, 2020, NEW ENGL J MED, V382, P1708, DOI 10.1056/NEJMoa2002032; Holshue ML, 2020, NEW ENGL J MED, V382, P929, DOI 10.1056/NEJMoa2001191; Munster VJ, 2020, NEW ENGL J MED, V382, P692, DOI 10.1056/NEJMp2000929; Wang C, 2020, LANCET, V395, P470, DOI 10.1016/S0140-6736(20)30185-9; Wang DW, 2020, J COASTAL RES, P1, DOI [10.2112/JCR-SI109-001.1, 10.1001/jama.2020.1585]; World Health Organization, 2020, 36 WHO; Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017; Zhu ZQ, 2015, J CLIN VIROL, V69, P30, DOI 10.1016/j.jcv.2015.05.013	9	861	926	7	303	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	APR	2020	26	4					502	+		10.1038/s41591-020-0817-4	http://dx.doi.org/10.1038/s41591-020-0817-4		MAR 2020	6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	QH1UE	32284613	Green Published, Bronze			2022-12-27	WOS:000519422600001
J	Moyer, TJ; Kato, Y; Abraham, W; Chang, JYH; Kulp, DW; Watson, N; Turner, HL; Menis, S; Abbott, RK; Bhiman, JN; Melo, MB; Simon, HA; Herrera-De la Mata, S; Liang, S; Seumois, G; Agarwal, Y; Li, N; Burton, DR; Ward, AB; Schief, WR; Crotty, S; Irvine, DJ				Moyer, Tyson J.; Kato, Yu; Abraham, Wuhbet; Chang, Jason Y. H.; Kulp, Daniel W.; Watson, Nicki; Turner, Hannah L.; Menis, Sergey; Abbott, Robert K.; Bhiman, Jinal N.; Melo, Mariane B.; Simon, Hayley A.; Herrera-De la Mata, Sara; Liang, Shu; Seumois, Gregory; Agarwal, Yash; Li, Na; Burton, Dennis R.; Ward, Andrew B.; Schief, William R.; Crotty, Shane; Irvine, Darrell J.			Engineered immunogen binding to alum adjuvant enhances humoral immunity	NATURE MEDICINE			English	Article							ANTIBODY-RESPONSES; ANTIGEN ADSORPTION; NALP3 INFLAMMASOME; HIV; VACCINE; CELLS; ACTIVATION; RNA; STIMULATION; PRECURSORS	Adjuvants are central to the efficacy of subunit vaccines. Aluminum hydroxide (alum) is the most commonly used vaccine adjuvant, yet its adjuvanticity is often weak and mechanisms of triggering antibody responses remain poorly understood. We demonstrate that site-specific modification of immunogens with short peptides composed of repeating phosphoserine (pSer) residues enhances binding to alum and prolongs immunogen bioavailability. The pSer-modified immunogens formulated in alum elicited greatly increased germinal center, antibody, neutralizing antibody, memory and long-lived plasma cell responses compared to conventional alum-adsorbed immunogens. Mechanistically, pSer-immunogen:alum complexes form nanoparticles that traffic to lymph nodes and trigger B cell activation through multivalent and oriented antigen display. Direct uptake of antigen-decorated alum particles by B cells upregulated antigen processing and presentation pathways, further enhancing B cell activation. These data provide insights into mechanisms of action of alum and introduce a readily translatable approach to significantly improve humoral immunity to subunit vaccines using a clinical adjuvant. Alum coupled to protein immunogens via site-specific phosphoserine-containing linkers enhances long-lived B cell responses and can selectively direct antibodies toward protective neutralizing epitopes.	[Moyer, Tyson J.; Abraham, Wuhbet; Chang, Jason Y. H.; Melo, Mariane B.; Agarwal, Yash; Li, Na; Irvine, Darrell J.] MIT, Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA; [Moyer, Tyson J.; Kato, Yu; Kulp, Daniel W.; Turner, Hannah L.; Menis, Sergey; Abbott, Robert K.; Bhiman, Jinal N.; Melo, Mariane B.; Burton, Dennis R.; Ward, Andrew B.; Schief, William R.; Crotty, Shane; Irvine, Darrell J.] Scripps Res Inst, Consortium HIV AIDS Vaccine Dev, La Jolla, CA 92037 USA; [Kato, Yu; Abbott, Robert K.; Simon, Hayley A.; Herrera-De la Mata, Sara; Liang, Shu; Seumois, Gregory; Crotty, Shane] La Jolla Inst Immunol, Div Vaccine Discovery, La Jolla, CA USA; [Kulp, Daniel W.] Wistar Inst Anat & Biol, Vaccine & Immunotherapy Ctr, 3601 Spruce St, Philadelphia, PA 19104 USA; [Kulp, Daniel W.; Turner, Hannah L.; Menis, Sergey; Bhiman, Jinal N.; Burton, Dennis R.; Ward, Andrew B.; Schief, William R.] Scripps Res Inst, Int AIDS Vaccine Initiat Neutralizing Antibody Ct, La Jolla, CA 92037 USA; [Watson, Nicki] Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA; [Turner, Hannah L.; Ward, Andrew B.] Scripps Res Inst, Dept Integrat Struct & Computat Biol, La Jolla, CA 92037 USA; [Bhiman, Jinal N.; Burton, Dennis R.; Schief, William R.] Scripps Res Inst, Dept Immunol & Microbiol, La Jolla, CA 92037 USA; [Bhiman, Jinal N.; Melo, Mariane B.; Burton, Dennis R.; Schief, William R.; Irvine, Darrell J.] Ragon Inst MGH MIT & Harvard Univ, Cambridge, MA 02139 USA; [Agarwal, Yash; Irvine, Darrell J.] MIT, Dept Biol Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Crotty, Shane] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Irvine, Darrell J.] MIT, Dept Mat Sci & Engn, Cambridge, MA 02139 USA; [Irvine, Darrell J.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA	Massachusetts Institute of Technology (MIT); Scripps Research Institute; La Jolla Institute for Immunology; The Wistar Institute; International AIDS Vaccine Initiative; Scripps Research Institute; Massachusetts Institute of Technology (MIT); Whitehead Institute; Scripps Research Institute; Scripps Research Institute; Harvard University; Harvard Medical School; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute; Massachusetts Institute of Technology (MIT); University of California System; University of California San Diego; Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute	Irvine, DJ (corresponding author), MIT, Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA.; Irvine, DJ (corresponding author), Scripps Res Inst, Consortium HIV AIDS Vaccine Dev, La Jolla, CA 92037 USA.; Irvine, DJ (corresponding author), Ragon Inst MGH MIT & Harvard Univ, Cambridge, MA 02139 USA.; Irvine, DJ (corresponding author), MIT, Dept Biol Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Irvine, DJ (corresponding author), MIT, Dept Mat Sci & Engn, Cambridge, MA 02139 USA.; Irvine, DJ (corresponding author), Howard Hughes Med Inst, Chevy Chase, MD 20815 USA.	djirvine@mit.edu	Ward, Andrew/ABD-7728-2021; Bhiman, Jinal/ABA-6029-2021; Schief, William/ABF-3645-2020	Ward, Andrew/0000-0001-7153-3769; Bhiman, Jinal/0000-0001-6354-4003; Schief, William/0000-0002-1120-0150; Herrera-De La Mata, Sara/0000-0002-9519-9520; Kato, Yu/0000-0003-4743-1775; Agarwal, Yash/0000-0001-7785-7828; Chang, Jason Y.H./0000-0002-2238-8232; Abbott, Robert/0000-0003-0335-1175; Seumois, Gregory/0000-0002-8164-6852	NIAID [UM1AI100663, UM1AI144462, AI125068, AI048240, K99AI145762, AI113867]; Koch Institute Support (core) grant from National Cancer Institute [P30-CA14051]; Ragon Institute of MGH, MIT and Harvard; International AIDS Vaccine Initiative (IAVI) Neutralizing Antibody Consortium (NAC) and Center; Collaboration for AIDS Vaccine Discovery	NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Koch Institute Support (core) grant from National Cancer Institute; Ragon Institute of MGH, MIT and Harvard; International AIDS Vaccine Initiative (IAVI) Neutralizing Antibody Consortium (NAC) and Center; Collaboration for AIDS Vaccine Discovery	This work was supported in part by the NIAID under awards UM1AI100663 and UM1AI144462 (to D.J.I., W.R.S., S.C. and D.R.B.), AI125068 (to S.C. and D.J.I.), AI048240 (to D.J.I.), K99AI145762 (to R.K.A.) and AI113867 (to W.R.S.), the Koch Institute Support (core) grant P30-CA14051 from the National Cancer Institute, the Ragon Institute of MGH, MIT and Harvard and by the International AIDS Vaccine Initiative (IAVI) Neutralizing Antibody Consortium (NAC) and Center (to D.R.B., A.B.W. and W.R.S.); and through the Collaboration for AIDS Vaccine Discovery funding for the IAVI NAC Center (to D.R.B., A.B.W. and W.R.S.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. D.J.I. is an investigator of the Howard Hughes Medical Institute.	Abbott RK, 2018, IMMUNITY, V48, P133, DOI 10.1016/j.immuni.2017.11.023; Attard TJ, 2009, INT J PEPT RES THER, V15, P69, DOI 10.1007/s10989-008-9165-9; Bianchi M, 2018, IMMUNITY, V49, P288, DOI 10.1016/j.immuni.2018.07.009; Busse CE, 2014, EUR J IMMUNOL, V44, P597, DOI 10.1002/eji.201343917; Butler A, 2018, NAT BIOTECHNOL, V36, P411, DOI 10.1038/nbt.4096; Drane D, 2007, EXPERT REV VACCINES, V6, P761, DOI 10.1586/14760584.6.5.761; Egan PM, 2009, VACCINE, V27, P3175, DOI 10.1016/j.vaccine.2009.03.054; Eisenbarth SC, 2008, NATURE, V453, P1122, DOI 10.1038/nature06939; Finak G, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0844-5; Flach TL, 2011, NAT MED, V17, P479, DOI 10.1038/nm.2306; Flarend RE, 1997, VACCINE, V15, P1314, DOI 10.1016/S0264-410X(97)00041-8; Francica JR, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7565; Ghimire TR, 2012, IMMUNOL LETT, V147, P55, DOI 10.1016/j.imlet.2012.06.002; Gupta RK, 1996, VACCINE, V14, P1412, DOI 10.1016/S0264-410X(96)00073-4; Guven E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074445; Hansen B, 2007, VACCINE, V25, P6618, DOI 10.1016/j.vaccine.2007.06.049; Harris JR, 2012, MICRON, V43, P192, DOI 10.1016/j.micron.2011.07.012; Havenar-Daughton C, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aat0381; Havenar-Daughton C, 2017, IMMUNOL REV, V275, P49, DOI 10.1111/imr.12512; HogenEsch H, 2002, VACCINE, V20, pS34, DOI 10.1016/S0264-410X(02)00169-X; HogenEsch H, 2018, NPJ VACCINES, V3, DOI 10.1038/s41541-018-0089-x; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; Hu JK, 2015, J VIROL, V89, P10383, DOI 10.1128/JVI.01653-15; Iyer S, 2003, VACCINE, V21, P1219, DOI 10.1016/S0264-410X(02)00556-X; Jardine J, 2013, SCIENCE, V340, P711, DOI 10.1126/science.1234150; Jardine JG, 2016, SCIENCE, V351, P1458, DOI 10.1126/science.aad9195; Jardine JG, 2015, SCIENCE, V349, P156, DOI 10.1126/science.aac5894; Khurana S, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000624; Kool M, 2008, J IMMUNOL, V181, P3755, DOI 10.4049/jimmunol.181.6.3755; Kool M, 2012, J MED MICROBIOL, V61, P927, DOI 10.1099/jmm.0.038943-0; Kulp DW, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01549-6; Lee JA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-237; Leroux-Roels G, 2016, CLIN IMMUNOL, V169, P16, DOI 10.1016/j.clim.2016.05.007; Li HF, 2008, J IMMUNOL, V181, P17, DOI 10.4049/jimmunol.181.1.17; Liberzon A, 2015, CELL SYST, V1, P417, DOI 10.1016/j.cels.2015.12.004; Lovgren-Bengtsson K, 2000, METH MOLEC MED, V42, P239; Lu FJ, 2013, VACCINE, V31, P4362, DOI 10.1016/j.vaccine.2013.07.019; McKee AS, 2017, CURR OPIN IMMUNOL, V47, P44, DOI 10.1016/j.coi.2017.06.005; Morefield GL, 2005, VACCINE, V23, P1502, DOI 10.1016/j.vaccine.2004.08.048; Moyer TJ, 2016, J CLIN INVEST, V126, P799, DOI 10.1172/JCI81083; Noe SM, 2010, VACCINE, V28, P3588, DOI 10.1016/j.vaccine.2010.02.085; Pauthner M, 2017, IMMUNITY, V46, P1073, DOI 10.1016/j.immuni.2017.05.007; Picelli S, 2014, NAT PROTOC, V9, P171, DOI 10.1038/nprot.2014.006; Platt EJ, 1998, J VIROL, V72, P2855, DOI 10.1128/JVI.72.4.2855-2864.1998; Plotkin SA, 2010, CLIN VACCINE IMMUNOL, V17, P1055, DOI 10.1128/CVI.00131-10; RAMANATHAN VD, 1979, IMMUNOLOGY, V37, P881; Rappuoli R, 2011, NATURE, V473, P463, DOI 10.1038/nature10124; Reed SG, 2013, NAT MED, V19, P1597, DOI 10.1038/nm.3409; Rosales SL, 2018, METHODS MOL BIOL, V1799, P275, DOI 10.1007/978-1-4939-7896-0_21; Sarzotti-Kelsoe M, 2014, J IMMUNOL METHODS, V409, P131, DOI 10.1016/j.jim.2013.11.022; Sok D, 2016, SCIENCE, V353, P1557, DOI 10.1126/science.aah3945; Steichen JM, 2016, IMMUNITY, V45, P483, DOI 10.1016/j.immuni.2016.08.016; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Tze LE, 2011, J EXP MED, V208, P149, DOI 10.1084/jem.20092203; Weaver GC, 2016, NAT PROTOC, V11, P193, DOI 10.1038/nprot.2016.009; Wei XP, 2003, NATURE, V422, P307, DOI 10.1038/nature01470; Wei XP, 2002, ANTIMICROB AGENTS CH, V46, P1896, DOI 10.1128/AAC.46.6.1896-1905.2002; WEISSBURG RP, 1995, PHARMACEUT RES, V12, P1439, DOI 10.1023/A:1016266916893; Yu DN, 2005, ANN NY ACAD SCI, V1059, P145, DOI 10.1196/annals.1339.047; Zhu XC, 2004, J IMMUNOL, V173, P7141, DOI 10.4049/jimmunol.173.12.7141	61	91	96	8	82	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	MAR	2020	26	3					430	+		10.1038/s41591-020-0753-3	http://dx.doi.org/10.1038/s41591-020-0753-3		FEB 2020	28	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	KU0MC	32066977	Green Published, Bronze, Green Accepted			2022-12-27	WOS:000514065500002
J	Mian, A; Khan, S				Mian, Areeb; Khan, Shujhat			Medical education-training toward a greener future	NATURE MEDICINE			English	Editorial Material								As medical students, we have a responsibility to our future patients, but our training is not preparing us for healthcare provision in the era of climate change, say Areeb Mian and Shujhat Khan.	[Mian, Areeb; Khan, Shujhat] Imperial Coll London, Dept Med, London, England	Imperial College London	Mian, A (corresponding author), Imperial Coll London, Dept Med, London, England.	areeb.mian@nhs.net; shujhat.khan@nhs.net		Mian, Areeb/0000-0002-4035-4052; Khan, Shujhat/0000-0001-7125-4815					0	3	3	0	2	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	FEB	2020	26	2					156	156		10.1038/s41591-019-0702-1	http://dx.doi.org/10.1038/s41591-019-0702-1		JAN 2020	1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	KK7DU	31907458	Bronze			2022-12-27	WOS:000510551400001
J	Lafaille, FG; Harschnitz, O; Lee, YS; Zhang, P; Hasek, ML; Kerner, G; Itan, Y; Ewaleifoh, O; Rapaport, F; Carlile, TM; Carter-Timofte, ME; Paquet, D; Dobbs, K; Zimmer, B; Gao, DX; Rojas-Duran, MF; Kwart, D; Rattina, V; Ciancanelli, MJ; McAlpine, JL; Lorenzo, L; Boucherit, S; Rozenberg, F; Halwani, R; Henry, B; Amenzoui, N; Alsum, Z; Marques, L; Church, JA; Al-Muhsen, S; Tardieu, M; Bousfiha, AA; Paludan, SR; Mogensen, TH; Quintana-Murci, L; Tessier-Lavigne, M; Smith, GA; Notarangelo, LD; Studer, L; Gilbert, W; Abel, L; Casanova, JL; Zhang, SY				Lafaille, Fabien G.; Harschnitz, Oliver; Lee, Yoon Seung; Zhang, Peng; Hasek, Mary L.; Kerner, Gaspard; Itan, Yuval; Ewaleifoh, Osefame; Rapaport, Franck; Carlile, Thomas M.; Carter-Timofte, Madalina E.; Paquet, Dominik; Dobbs, Kerry; Zimmer, Bastian; Gao, Daxing; Rojas-Duran, Maria F.; Kwart, Dylan; Rattina, Vimel; Ciancanelli, Michael J.; McAlpine, Jessica L.; Lorenzo, Lazaro; Boucherit, Soraya; Rozenberg, Flore; Halwani, Rabih; Henry, Benoit; Amenzoui, Naima; Alsum, Zobaida; Marques, Laura; Church, Joseph A.; Al-Muhsen, Saleh; Tardieu, Marc; Bousfiha, Ahmed Aziz; Paludan, Soren R.; Mogensen, Trine Hyrup; Quintana-Murci, Lluis; Tessier-Lavigne, Marc; Smith, Gregory A.; Notarangelo, Luigi D.; Studer, Lorenz; Gilbert, Wendy; Abel, Laurent; Casanova, Jean-Laurent; Zhang, Shen-Ying			Human SNORA31 variations impair cortical neuron-intrinsic immunity to HSV-1 and underlie herpes simplex encephalitis	NATURE MEDICINE			English	Article							NF-KAPPA-B; TLR3 DEFICIENCY; VIRUS ENCEPHALITIS; INBORN-ERRORS; RNA; PSEUDOURIDINE; PROTEIN; RECOGNITION; INHIBITION; MUTATIONS	Herpes simplex virus-1 (HSV-1) encephalitis (HSE) is typically sporadic. Inborn errors of TLR3- and DBR1-mediated central nervous system cell-intrinsic immunity can account for forebrain and brainstem HSE, respectively. We report five unrelated patients with forebrain HSE, each heterozygous for one of four rare variants of SNORA31, encoding a small nucleolar RNA of the H/ACA class that are predicted to direct the isomerization of uridine residues to pseudouridine in small nuclear RNA and ribosomal RNA. We show that CRISPR/Cas9-introduced bi- and monoallelic SNORA31 deletions render human pluripotent stem cell (hPSC)-derived cortical neurons susceptible to HSV-1. Accordingly, SNORA31-mutated patient hPSC-derived cortical neurons are susceptible to HSV-1, like those from TLR3- or STAT1-deficient patients. Exogenous interferon (IFN)-beta renders SNORA31- and TLR3- but not STAT1-mutated neurons resistant to HSV-1. Finally, transcriptome analysis of SNORA31-mutated neurons revealed normal responses to TLR3 and IFN-alpha/beta stimulation but abnormal responses to HSV-1. Human SNORA31 thus controls central nervous system neuron-intrinsic immunity to HSV-1 by a distinctive mechanism.	[Lafaille, Fabien G.; Lee, Yoon Seung; Zhang, Peng; Hasek, Mary L.; Itan, Yuval; Rapaport, Franck; Gao, Daxing; Ciancanelli, Michael J.; Abel, Laurent; Casanova, Jean-Laurent; Zhang, Shen-Ying] Rockefeller Univ, St Giles Lab Human Genet Infect Dis, Rockefeller Branch, 1230 York Ave, New York, NY 10021 USA; [Harschnitz, Oliver; Zimmer, Bastian; McAlpine, Jessica L.; Studer, Lorenz] Sloan Kettering Inst Canc Res, Ctr Stem Cell Biol, New York, NY USA; [Harschnitz, Oliver; Zimmer, Bastian; McAlpine, Jessica L.; Studer, Lorenz] Sloan Kettering Inst Canc Res, Dev Biol Program, New York, NY USA; [Lee, Yoon Seung; Kerner, Gaspard; Rattina, Vimel; Lorenzo, Lazaro; Boucherit, Soraya; Abel, Laurent; Casanova, Jean-Laurent; Zhang, Shen-Ying] Necker Hosp Sick Children, Necker Branch, Lab Human Genet Infect Dis, Paris, France; [Lee, Yoon Seung; Kerner, Gaspard; Rattina, Vimel; Lorenzo, Lazaro; Boucherit, Soraya; Abel, Laurent; Casanova, Jean-Laurent; Zhang, Shen-Ying] Paris Descartes Univ, Imagine Inst, Paris, France; [Itan, Yuval] Icahn Sch Med Mt Sinai, Charles Bronfman Inst Personalized Med, New York, NY 10029 USA; [Itan, Yuval] Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY 10029 USA; [Ewaleifoh, Osefame; Smith, Gregory A.] Northwestern Univ, Feinberg Sch Med, Dept Microbiol Immunol, Chicago, IL 60611 USA; [Carlile, Thomas M.; Tessier-Lavigne, Marc] Biogen, Cambridge, MA USA; [Carter-Timofte, Madalina E.; Mogensen, Trine Hyrup] Aarhus Univ Hosp, Dept Infect Dis, Aarhus, Denmark; [Carter-Timofte, Madalina E.; Paludan, Soren R.; Mogensen, Trine Hyrup] Aarhus Univ, Dept Biomed, Aarhus, Denmark; [Paquet, Dominik; Kwart, Dylan] Rockefeller Univ, Lab Brain Dev & Repair, 1230 York Ave, New York, NY 10021 USA; [Paquet, Dominik] Ludwig Maximilians Univ Munchen, Univ Hosp, Inst Stroke & Dementia Res, Munich, Germany; [Paquet, Dominik] Munich Cluster Syst Neurol SyNergy, Munich, Germany; [Dobbs, Kerry; Notarangelo, Luigi D.] NIAID, Lab Clin Immunol & Microbiol, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Rojas-Duran, Maria F.; Gilbert, Wendy] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT USA; [Rozenberg, Flore] Paris Descartes Univ, Sorbonne Paris Cite Univ, Hosp Grp Paris Ctr Univ, Virol Dept,Welf Serv Paris Hosp, Paris, France; [Halwani, Rabih] Univ Sharjah, SIMR, Dept Clin Sci, Coll Med, Sharjah, U Arab Emirates; [Henry, Benoit] Hop La Pitie Salpetriere, Dept Infect Dis, Paris, France; [Amenzoui, Naima; Bousfiha, Ahmed Aziz] Hassan Ii Univ, Childrens Ibn Rushd Hosp, Clin Immunol Unit, Casablanca, Morocco; [Amenzoui, Naima; Bousfiha, Ahmed Aziz] Hassan Ii Univ, Fac Med & Pharm, Inflammat & Allergy LICIA, Clin Immunol Lab, Casablanca, Morocco; [Alsum, Zobaida] King Saud Univ, Dept Pediat, Coll Med, Immunol Res Lab, Riyadh, Saudi Arabia; [Marques, Laura] Porto Hosp Ctr, Dept Pediat, Infect Dis & Immunodeficiencies Unit, Porto, Portugal; [Church, Joseph A.] Univ Southern Calif, Childrens Hosp Los Angeles, Dept Pediat, Los Angeles, CA USA; [Church, Joseph A.] Univ Southern Calif, Keck Sch Med, Los Angeles, CA USA; [Al-Muhsen, Saleh] King Saud Univ, Prince Naif Ctr Immunol Res, Riyadh, Saudi Arabia; [Tardieu, Marc] South Paris Univ Hosp, Paris Hosp Welf Serv, Dept Pediat Neurol, Paris, France; [Mogensen, Trine Hyrup] Aarhus Univ, Dept Clin Med, Aarhus, Denmark; [Quintana-Murci, Lluis] Inst Pasteur, CNRS, Unit Human Evolutionary Genet, UMR2000, Paris, France; [Tessier-Lavigne, Marc] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Casanova, Jean-Laurent] Necker Hosp Sick Children, Pediat Immunohematol Unit, Paris, France; [Casanova, Jean-Laurent] Howard Hughes Med Inst, New York, NY 10065 USA	Rockefeller University; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Northwestern University; Feinberg School of Medicine; Biogen; Aarhus University; Aarhus University; Rockefeller University; University of Munich; University of Munich; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Yale University; UDICE-French Research Universities; Universite Paris Cite; University of Sharjah; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Hassan II University of Casablanca; Hassan II University of Casablanca; Mohammed First University of Oujda; King Saud University; Children's Hospital Los Angeles; University of Southern California; University of Southern California; King Saud University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Antoine-Beclere - APHP; Aarhus University; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Stanford University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Howard Hughes Medical Institute	Casanova, JL; Zhang, SY (corresponding author), Rockefeller Univ, St Giles Lab Human Genet Infect Dis, Rockefeller Branch, 1230 York Ave, New York, NY 10021 USA.; Casanova, JL; Zhang, SY (corresponding author), Necker Hosp Sick Children, Necker Branch, Lab Human Genet Infect Dis, Paris, France.; Casanova, JL; Zhang, SY (corresponding author), Paris Descartes Univ, Imagine Inst, Paris, France.; Casanova, JL (corresponding author), Necker Hosp Sick Children, Pediat Immunohematol Unit, Paris, France.; Casanova, JL (corresponding author), Howard Hughes Med Inst, New York, NY 10065 USA.	casanova@rockefeller.edu; shzh289@rockefeller.edu	Quintana-Murci, Lluis/AAB-7468-2022; Zhang, Peng/I-4665-2019; Al-muhsen, saleh/E-9315-2014; Studer, Lorenz/ABH-1491-2021	Zhang, Peng/0000-0002-6129-567X; Al-muhsen, saleh/0000-0003-3698-9968; Studer, Lorenz/0000-0003-0741-7987; Dobbs, Kerry/0000-0002-3432-3137; Smith, Gregory/0000-0001-9644-8472; Paquet, Dominik/0000-0003-2065-1639; Harschnitz, Oliver/0000-0001-6496-881X; Mogensen, Trine Hyrup/0000-0002-1853-9704; McAlpine, Jessica/0000-0003-0592-8601	National Center for Advancing Translational Sciences, National Institutes of Health (NIH) [UL1TR000043, UL1TR001866]; NIH [R01AI088364, R01NS072381, R01GM101316]; Integrative Biology of Emerging Infectious Diseases Laboratory of Excellence [ANR-10-LABX-62-IBEID]; French National Research Agency (ANR) [ANR-10-IAHU-01]; ANR [ANR-14-CE14-0008-01]; Lundbeck Foundation [R268-2016-3927]; Rockefeller University; INSERM; Paris Descartes University; St Giles Foundation; New York Stem Cell Foundation; Merck; Division of Intramural Research, National Institute of Allergy and Infectious Diseases, NIH; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI088364] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS072381] Funding Source: NIH RePORTER	National Center for Advancing Translational Sciences, National Institutes of Health (NIH); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Integrative Biology of Emerging Infectious Diseases Laboratory of Excellence; French National Research Agency (ANR)(French National Research Agency (ANR)); ANR(French National Research Agency (ANR)); Lundbeck Foundation(Lundbeckfonden); Rockefeller University; INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Paris Descartes University; St Giles Foundation; New York Stem Cell Foundation; Merck(Merck & Company); Division of Intramural Research, National Institute of Allergy and Infectious Diseases, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We warmly thank the patients and their families for participating in this study. We thank F. Sami Alkuraya from the Saudi Human Genome Project for providing us with the minor allele frequency of the reported variant. We thank J. Tchieu and G. Ciceri for providing advice concerning the protocol for iPSC differentiation into CNS neurons. We thank K. Bohannon from the Feinberg School of Medicine at Northwestern University for providing HSV-1 strain Patton encoding the mCherry-UL25 fusion. We thank members of both branches of the Laboratory of Human Genetics of Infectious Diseases for helpful discussions: T. Kochetkov for technical assistance; B. Bigio, V. Ratinna, Y. Seeleuthner, B. Boisson and A. Cobat for bioinformatic assistance; and D. Papandrea, C. Patissier and Y. Nemirovskaya for administrative assistance. This work was conducted in the two branches of the Laboratory of Human Genetics of Infectious Diseases, and was funded in part by the National Center for Advancing Translational Sciences, National Institutes of Health (NIH), Clinical and Translational Science Award program (grant nos. UL1TR000043 and UL1TR001866), NIH grants (nos. R01AI088364 to J.L.C. and S.Y.Z., R01NS072381 to J.-L.C. and S.-Y.Z. and R01GM101316 to W.G.); a grant from the Integrative Biology of Emerging Infectious Diseases Laboratory of Excellence (no. ANR-10-LABX-62-IBEID to L.A.) and the French National Research Agency (ANR) under the 'Investments for the future' program (no. ANR-10-IAHU-01 to L.A.), the ANR grant IEIHSEER (no. ANR-14-CE14-0008-01 to S.-Y.Z.), the Lundbeck Foundation (grant no. R268-2016-3927 to S.R.P.), the Rockefeller University, INSERM, Paris Descartes University and the St Giles Foundation. The New York Stem Cell Foundation supported F.G.L. and D.P. F.G.L. also was supported by a Merck Postdoctoral Fellowship at The Rockefeller University. Funding for this work was also provided in part by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, NIH.	Abel L, 2010, J PEDIATR-US, V157, P623, DOI 10.1016/j.jpeds.2010.04.020; Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Andersen LL, 2015, J EXP MED, V212, P1371, DOI 10.1084/jem.20142274; [Anonymous], 2016, SCI TRANSL MED, V8; Audry M, 2011, J ALLERGY CLIN IMMUN, V128, P610, DOI 10.1016/j.jaci.2011.04.059; Belkaya S, 2017, J AM COLL CARDIOL, V69, P1653, DOI 10.1016/j.jacc.2017.01.043; Carlile TM, 2014, NATURE, V515, P143, DOI 10.1038/nature13802; Casrouge A, 2006, SCIENCE, V314, P308, DOI 10.1126/science.1128346; Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529; Consortium T.G.P., 2015, NATURE, V526, P7; Davydov EV, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001025; de Diego RP, 2010, IMMUNITY, V33, P400, DOI 10.1016/j.immuni.2010.08.014; Desai P, 1998, J VIROL, V72, P7563, DOI 10.1128/JVI.72.9.7563-7568.1998; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Duker AL, 2010, EUR J HUM GENET, V18, P1196, DOI 10.1038/ejhg.2010.102; Dupuis S, 2003, NAT GENET, V33, P388, DOI 10.1038/ng1097; Frankish A, 2019, NUCLEIC ACIDS RES, V47, pD766, DOI 10.1093/nar/gky955; Ganot P, 1997, CELL, V89, P799, DOI 10.1016/S0092-8674(00)80263-9; Gu ZG, 2016, BIOINFORMATICS, V32, P2847, DOI 10.1093/bioinformatics/btw313; Guo YQ, 2011, J EXP MED, V208, P2083, DOI 10.1084/jem.20101568; Herman M, 2012, J EXP MED, V209, P1567, DOI 10.1084/jem.20111316; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Huffmaster NJ, 2015, P NATL ACAD SCI USA, V112, P12818, DOI 10.1073/pnas.1512559112; Itan Y, 2016, NAT METHODS, V13, P109, DOI 10.1038/nmeth.3739; Itan Y, 2015, P NATL ACAD SCI USA, V112, P13615, DOI 10.1073/pnas.1518646112; Jacobs BL, 1996, VIROLOGY, V219, P339, DOI 10.1006/viro.1996.0259; Jady BE, 2001, EMBO J, V20, P541, DOI 10.1093/emboj/20.3.541; Jenkinson EM, 2016, NAT GENET, V48, P1185, DOI 10.1038/ng.3661; Jorjani H, 2016, NUCLEIC ACIDS RES, V44, P5068, DOI 10.1093/nar/gkw386; Jubelt B, 2011, CURR NEUROL NEUROSCI, V11, P543, DOI 10.1007/s11910-011-0228-5; Kato H, 2008, J EXP MED, V205, P1601, DOI 10.1084/jem.20080091; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kiss AM, 2004, MOL CELL BIOL, V24, P5797, DOI 10.1128/MCB.24.13.5797-5807.2004; Lafaille FG, 2012, NATURE, V491, P769, DOI 10.1038/nature11583; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Lim HK, 2014, NEUROLOGY, V83, P1888, DOI 10.1212/WNL.0000000000000999; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Marie-Line B, 1999, EMBO J, V18, P13; Martin K., 2014, NAT GENET, V46, P8; Martin M., 2011, EMBNET J, V17, P10, DOI 10.14806/ej.17.1.200; McMahon M, 2015, WIRES RNA, V6, P173, DOI 10.1002/wrna.1266; Ni JW, 1997, CELL, V89, P565, DOI 10.1016/S0092-8674(00)80238-X; Oughtred R, 2019, NUCLEIC ACIDS RES, V47, pD529, DOI 10.1093/nar/gky1079; Paquet D, 2016, NATURE, V533, P125, DOI 10.1038/nature17664; Penzo M, 2018, BIOMOLECULES, V8, DOI 10.3390/biom8020038; Polex-Wolf J, 2018, J CLIN INVEST, V128, P960, DOI 10.1172/JCI97007; Qi YC, 2017, NAT BIOTECHNOL, V35, P154, DOI 10.1038/nbt.3777; Quach H, 2009, AM J HUM GENET, V84, P316, DOI 10.1016/j.ajhg.2009.01.022; REED L. J., 1938, AMER JOUR HYG, V27, P493; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Sancho-Shimizu V, 2011, J CLIN INVEST, V121, P4889, DOI 10.1172/JCI59259; Sato R, 2018, NAT IMMUNOL, V19, P1071, DOI 10.1038/s41590-018-0203-2; Serkan B, 2017, J AM COLL CARDIOL, V69, P13; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Wang LG, 2012, BIOINFORMATICS, V28, P2184, DOI 10.1093/bioinformatics/bts356; Wang Z, 2012, MOL BIOL REP, V39, P10013, DOI 10.1007/s11033-012-1870-y; Whitley RJ, 2006, ANTIVIR RES, V71, P141, DOI 10.1016/j.antiviral.2006.04.002; Whitley Richard J, 2015, Continuum (Minneap Minn), V21, P1704, DOI 10.1212/CON.0000000000000243; Zhang P, 2017, J MOL BIOL, V429, P416, DOI 10.1016/j.jmb.2016.10.013; Zhang P, 2018, BIOINFORMATICS, V34, P4307, DOI 10.1093/bioinformatics/bty536; Zhang P, 2017, BRIEF BIOINFORM, V18, P1057, DOI 10.1093/bib/bbw071; Zhang SY, 2007, SCIENCE, V317, P1522, DOI 10.1126/science.1139522; Zhang SY, 2019, CURR OPIN IMMUNOL, V59, P88, DOI 10.1016/j.coi.2019.03.008; Zhang SY, 2018, CELL, V172, P952, DOI 10.1016/j.cell.2018.02.019; Zhang SY, 2013, CURR OPIN IMMUNOL, V25, P19, DOI 10.1016/j.coi.2012.11.001	66	54	56	2	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	2019	25	12					1873	+		10.1038/s41591-019-0672-3	http://dx.doi.org/10.1038/s41591-019-0672-3			25	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	JT2KO	31806906	Green Submitted, Green Accepted			2022-12-27	WOS:000500824900031
J	Stower, H				Stower, Hannah			DIABETES Delaying diabetes onset	NATURE MEDICINE			English	Editorial Material																			0	0	0	1	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	2019	25	12					1798	1798		10.1038/s41591-019-0681-2	http://dx.doi.org/10.1038/s41591-019-0681-2			1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	JT2KO	31806893	Bronze			2022-12-27	WOS:000500824900004
J	Stower, H				Stower, Hannah			HIV Editing hope for a future cure	NATURE MEDICINE			English	Editorial Material																			0	0	0	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	2019	25	12					1799	1799		10.1038/s41591-019-0683-0	http://dx.doi.org/10.1038/s41591-019-0683-0			1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	JT2KO	31806895	Bronze			2022-12-27	WOS:000500824900011
J	Seoane, JA; Kirkland, JG; Caswell-Jin, JL; Crabtree, GR; Curtis, C				Seoane, Jose A.; Kirkland, Jacob G.; Caswell-Jin, Jennifer L.; Crabtree, Gerald R.; Curtis, Christina			Chromatin regulators mediate anthracycline sensitivity in breast cancer	NATURE MEDICINE			English	Article							GENE-EXPRESSION; CHEMOTHERAPY; LANDSCAPE; COMPLEXES; POLYCOMB; TRIALS; TRANSCRIPTION; SIGNATURE; INFERENCE; NETWORKS	Anthracyclines are a highly effective component of curative breast cancer chemotherapy but are associated with substantial morbidity(1,2). Because anthracyclines work in part by inhibiting topoisomerase-II (TOP2) on accessible DNA(3,4), we hypothesized that chromatin regulatory genes (CRGs) that mediate DNA accessibility might predict anthracycline response. We studied the role of CRGs in anthracycline sensitivity in breast cancer through integrative analysis of patient and cell line data. We identified a consensus set of 38 CRGs associated with anthracycline response across ten cell line datasets. By evaluating the interaction between expression and treatment in predicting survival in a metacohort of 1006 patients with early-stage breast cancer, we identified 54 CRGs whose expression levels dictate anthracycline benefit across the clinical subgroups; of these CRGs, 12 overlapped with those identified in vitro. CRGs that promote DNA accessibility, including Trithorax complex members, were associated with anthracycline sensitivity when highly expressed, whereas CRGs that reduce accessibility, such as Polycomb complex proteins, were associated with decreased anthracycline sensitivity. We show that KDM4B modulates TOP2 accessibility to chromatin, elucidating a mechanism of TOP2 inhibitor sensitivity. These findings indicate that CRGs mediate anthracycline benefit by altering DNA accessibility, with implications for the stratification of patients with breast cancer and treatment decision making.	[Seoane, Jose A.; Caswell-Jin, Jennifer L.; Curtis, Christina] Stanford Univ, Sch Med, Dept Med Oncol, Stanford, CA 94305 USA; [Seoane, Jose A.; Kirkland, Jacob G.; Curtis, Christina] Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA; [Seoane, Jose A.; Curtis, Christina] Stanford Univ, Sch Med, Stanford Canc Inst, Stanford, CA 94305 USA; [Kirkland, Jacob G.; Crabtree, Gerald R.] Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA; [Crabtree, Gerald R.] Stanford Univ, Sch Med, Dept Dev Biol, Stanford, CA 94305 USA; [Crabtree, Gerald R.] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford Cancer Institute; Stanford University; Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University	Curtis, C (corresponding author), Stanford Univ, Sch Med, Dept Med Oncol, Stanford, CA 94305 USA.; Curtis, C (corresponding author), Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA.; Curtis, C (corresponding author), Stanford Univ, Sch Med, Stanford Canc Inst, Stanford, CA 94305 USA.; Crabtree, GR (corresponding author), Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA.; Crabtree, GR (corresponding author), Stanford Univ, Sch Med, Dept Dev Biol, Stanford, CA 94305 USA.; Crabtree, GR (corresponding author), Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA.	crabtree@stanford.edu; cncurtis@stanford.edu	Kirkland, Jacob/AAY-5948-2020; Seoane, Jose A./A-5926-2011	Seoane, Jose A./0000-0002-3856-9177; Caswell-Jin, Jennifer/0000-0002-5711-8355; Kirkland, Jacob/0000-0001-5617-7065; Crabtree, Robert/0000-0002-6639-8707; Curtis, Christina/0000-0003-0166-3802	Stanford Cancer Institute-Translational Research Award; Department of Defense [W81XWH-16-1-0084]; V Foundation for Cancer Research; National Cancer Institute [R01CA 182514, U01CA217851, R01CA163915]; Breast Cancer Research Foundation; Howard Hughes Medical Institute; Susan G. Komen Postdoctoral Fellowship [PDF16377256]; PHS - National Cancer Institute, Department of Health and Human Services [T32 CA09151]; American Society of Clinical Oncology from the Conquer Cancer Foundation; Damon Runyon Physician-Scientist Training Award; NATIONAL CANCER INSTITUTE [R01CA182514, U01CA217851, R01CA163915] Funding Source: NIH RePORTER	Stanford Cancer Institute-Translational Research Award; Department of Defense(United States Department of Defense); V Foundation for Cancer Research; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Breast Cancer Research Foundation; Howard Hughes Medical Institute(Howard Hughes Medical Institute); Susan G. Komen Postdoctoral Fellowship(Susan G. Komen Breast Cancer Foundation); PHS - National Cancer Institute, Department of Health and Human Services; American Society of Clinical Oncology from the Conquer Cancer Foundation; Damon Runyon Physician-Scientist Training Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank breast cancer research advocates S. Brain, D. Heditsian and V. Lee for helpful discussions. We thank E. Chory for illustrating Fig. 3b. The results shown here are in part based on data generated by the TCGA Research Network: http://cancergenome.nih.gov/. This work was supported in part by a Stanford Cancer Institute-Translational Research Award, a Department of Defense grant (W81XWH-16-1-0084) and a V Foundation for Cancer Research grant to C.C. and G.R.C. C.C. is also supported by the National Cancer Institute (R01CA 182514, U01CA217851) and the Breast Cancer Research Foundation. G.R.C. is also supported by the National Cancer Institute (R01CA163915) and the Howard Hughes Medical Institute. J.A.S. is supported by a Susan G. Komen Postdoctoral Fellowship (PDF16377256). J.G.K. is supported by PHS grant number T32 CA09151, awarded by the National Cancer Institute, Department of Health and Human Services. J.L.C. is supported by an American Society of Clinical Oncology Young Investigator Award from the Conquer Cancer Foundation and a Damon Runyon Physician-Scientist Training Award.	Aittokallio T, 2006, BRIEF BIOINFORM, V7, P243, DOI 10.1093/bib/bbl022; Albain K, 2012, LANCET, V379, P432, DOI 10.1016/S0140-6736(11)61625-5; Alvarez MJ, 2016, NAT GENET, V48, P838, DOI 10.1038/ng.3593; Aydin OZ, 2014, CELL CYCLE, V13, P3016, DOI 10.4161/15384101.2014.956551; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Blum JL, 2017, J CLIN ONCOL, V35, P2647, DOI 10.1200/JCO.2016.71.4147; Cardoso F, 2016, NEW ENGL J MED, V375, P717, DOI 10.1056/NEJMoa1602253; Ciriello G, 2013, NAT GENET, V45, P1127, DOI 10.1038/ng.2762; Cirillo LA, 2002, MOL CELL, V9, P279, DOI 10.1016/S1097-2765(02)00459-8; Costello JC, 2014, NAT BIOTECHNOL, V32, P1202, DOI 10.1038/nbt.2877; Curtis C, 2012, NATURE, V486, P346, DOI 10.1038/nature10983; Desmedt C, 2008, CLIN CANCER RES, V14, P5158, DOI 10.1158/1078-0432.CCR-07-4756; Dykhuizen EC, 2013, NATURE, V497, P624, DOI 10.1038/nature12146; Fillmore CM, 2015, NATURE, V520, P239, DOI 10.1038/nature14122; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Hafner M, 2017, SCI DATA, V4, DOI 10.1038/sdata.2017.166; Haibe-Kains B, 2008, BIOINFORMATICS, V24, P2200, DOI 10.1093/bioinformatics/btn374; Haibe-Kains B, 2012, JNCI-J NATL CANCER I, V104, P311, DOI 10.1093/jnci/djr545; Hauri S, 2016, CELL REP, V17, P583, DOI 10.1016/j.celrep.2016.08.096; Haverty PM, 2016, NATURE, V533, P333, DOI 10.1038/nature17987; Heiser LM, 2012, P NATL ACAD SCI USA, V109, P2724, DOI 10.1073/pnas.1018854108; Hirano T, 2012, GENE DEV, V26, P1659, DOI 10.1101/gad.194746.112; Hodges HC, 2018, NAT STRUCT MOL BIOL, V25, P61, DOI 10.1038/s41594-017-0007-3; Hothorn T, 2008, BIOMETRICS, V64, P1263, DOI 10.1111/j.1541-0420.2008.00995.x; Iorio F, 2016, CELL, V166, P740, DOI 10.1016/j.cell.2016.06.017; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Kao KJ, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-143; King HW, 2018, GENOME RES, V28, P1494, DOI 10.1101/gr.237180.118; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Korotkevich G., 2016, BIORXIV, DOI [10.1101/060012, DOI 10.1101/060012, 10.1101/060012v3]; Lachmann A, 2016, BIOINFORMATICS, V32, P2233, DOI 10.1093/bioinformatics/btw216; Lai AY, 2011, NAT REV CANCER, V11, P588, DOI 10.1038/nrc3091; Li Y, 2010, NAT MED, V16, P214, DOI 10.1038/nm.2090; Losada A, 2014, NAT REV CANCER, V14, P389, DOI 10.1038/nrc3743; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Maire V, 2013, CANCER RES, V73, P813, DOI 10.1158/0008-5472.CAN-12-2633; Margolin AA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S1-S7; Miller EL, 2017, NAT STRUCT MOL BIOL, V24, P344, DOI 10.1038/nsmb.3384; Miller LD, 2005, P NATL ACAD SCI USA, V102, P13550, DOI 10.1073/pnas.0506230102; Morone F, 2015, NATURE, V524, P65, DOI 10.1038/nature14604; Morrison AJ, 2009, NAT REV MOL CELL BIO, V10, P373, DOI 10.1038/nrm2693; Mpindi JP, 2016, NATURE, V540, pE5, DOI 10.1038/nature20171; Nagalla S, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r34; Oppikofer M, 2017, EMBO REP, V18, P1697, DOI 10.15252/embr.201744011; Paik S, 2006, J CLIN ONCOL, V24, P3726, DOI 10.1200/JCO.2005.04.7985; Pawitan Y, 2005, BREAST CANCER RES, V7, pR953, DOI 10.1186/bcr1325; Praga C, 2005, J CLIN ONCOL, V23, P4179, DOI 10.1200/JCO.2005.05.029; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Rothwell PM, 2005, LANCET, V365, P176, DOI 10.1016/S0140-6736(05)17709-5; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schuettengruber B, 2017, CELL, V171, P34, DOI 10.1016/j.cell.2017.08.002; Seashore-Ludlow B, 2015, CANCER DISCOV, V5, P1210, DOI 10.1158/2159-8290.CD-15-0235; Smirnov P, 2016, BIOINFORMATICS, V32, P1244, DOI 10.1093/bioinformatics/btv723; Sparano JA, 2018, NEW ENGL J MED, V379, P111, DOI 10.1056/NEJMoa1804710; Sparano JA, 2015, NEW ENGL J MED, V373, P2005, DOI 10.1056/NEJMoa1510764; Talbert PB, 2012, EPIGENET CHROMATIN, V5, DOI 10.1186/1756-8935-5-7; Tiscornia G, 2006, NAT PROTOC, V1, P234, DOI 10.1038/nprot.2006.36; Wilson BG, 2010, CANCER CELL, V18, P316, DOI 10.1016/j.ccr.2010.09.006	58	17	17	1	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2019	25	11					1721	+		10.1038/s41591-019-0638-5	http://dx.doi.org/10.1038/s41591-019-0638-5			21	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	JT2KI	31700186	Green Accepted			2022-12-27	WOS:000500824300030
J	Courtiol, P; Maussion, C; Moarii, M; Pronier, E; Pilcer, S; Sefta, M; Manceron, P; Toldo, S; Zaslavskiy, M; Le Stang, N; Girard, N; Elemento, O; Nicholson, AG; Blay, JY; Galateau-Salle, F; Wainrib, G; Clozel, T				Courtiol, Pierre; Maussion, Charles; Moarii, Matahi; Pronier, Elodie; Pilcer, Samuel; Sefta, Meriem; Manceron, Pierre; Toldo, Sylvain; Zaslavskiy, Mikhail; Le Stang, Nolwenn; Girard, Nicolas; Elemento, Olivier; Nicholson, Andrew G.; Blay, Jean-Yves; Galateau-Salle, Francoise; Wainrib, Gilles; Clozel, Thomas			Deep learning-based classification of mesothelioma improves prediction of patient outcome	NATURE MEDICINE			English	Article							PROGNOSTIC-SIGNIFICANCE; PLEURAL MESOTHELIOMA	Malignant mesothelioma (MM) is an aggressive cancer primarily diagnosed on the basis of histological criteria(1). The 2015 World Health Organization classification subdivides mesothelioma tumors into three histological types: epithelioid, biphasic and sarcomatoid MM. MM is a highly complex and heterogeneous disease, rendering its diagnosis and histological typing difficult and leading to suboptimal patient care and decisions regarding treatment modalities(2). Here we have developed a new approach-based on deep convolutional neural networks-called MesoNet to accurately predict the overall survival of mesothelioma patients from whole-slide digitized images, without any pathologist-provided locally annotated regions. We validated MesoNet on both an internal validation cohort from the French MESOBANK and an independent cohort from The Cancer Genome Atlas (TCGA). We also demonstrated that the model was more accurate in predicting patient survival than using current pathology practices. Furthermore, unlike classical black-box deep learning methods, MesoNet identified regions contributing to patient outcome prediction. Strikingly, we found that these regions are mainly located in the stroma and are histological features associated with inflammation, cellular diversity and vacuolization. These findings suggest that deep learning models can identify new features predictive of patient survival and potentially lead to new biomarker discoveries.	[Courtiol, Pierre; Maussion, Charles; Moarii, Matahi; Pronier, Elodie; Pilcer, Samuel; Sefta, Meriem; Manceron, Pierre; Toldo, Sylvain; Zaslavskiy, Mikhail; Wainrib, Gilles; Clozel, Thomas] Owkin Inc, Owkin Lab, New York, NY 10003 USA; [Le Stang, Nolwenn; Galateau-Salle, Francoise] MESOPATH MESOBANK Canc Ctr Leon Berard, Dept Biopathol, Lyon, France; [Girard, Nicolas] Univ Claud Bernard Lyon 1, Univ Lyon, Lyon, France; [Girard, Nicolas] Inst Curie, Inst Thorax Curie Montsouris, Paris, France; [Elemento, Olivier] Weill Cornell Med, Inst Computat Biomed, Dept Physiol & Biophys, New York, NY USA; [Elemento, Olivier] Weill Cornell Med, Caryl & Israel Englander Inst Precis Med, WorldQuant Initiat Quantitat Predict, New York, NY USA; [Nicholson, Andrew G.] Royal Brompton & Harefield Hosp NHS Fdn Trust, Dept Histopathol, London, England; [Nicholson, Andrew G.] Imperial Coll, Natl Heart & Lung Inst, London, England; [Blay, Jean-Yves] Ctr Leon Berard, Dept Med Oncol, Lyon, France	UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Cornell University; Cornell University; Royal Brompton & Harefield NHS Foundation Trust; Harefield Hospital; Imperial College London; UNICANCER; Centre Leon Berard	Clozel, T (corresponding author), Owkin Inc, Owkin Lab, New York, NY 10003 USA.	thomas.clozel@owkin.com	Blay, Jean-Yves/N-3966-2016; Girard, Nicolas/ABE-3618-2021	Blay, Jean-Yves/0000-0001-7190-120X; Girard, Nicolas/0000-0001-9909-2299; LE STANG, Nolwenn/0000-0001-9522-6552; Maussion, Charles/0000-0003-2266-5276; galateau salle, francoise/0000-0002-2814-1644				Baas P., 2015, ANN ONCOL, V21, P126; Beck AH, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002564; Brcic L, 2018, ARCH PATHOL LAB MED, V142, P747, DOI 10.5858/arpa.2017-0295-OA; Campanella G, 2019, NAT MED, V25, P1301, DOI 10.1038/s41591-019-0508-1; Chen T., 2016, KDD16 P 22 ACM, DOI DOI 10.1145/2939672.2939785; Coudray N, 2018, NAT MED, V24, P1559, DOI 10.1038/s41591-018-0177-5; Courtiol P., 2018, CLASSIFICATION DIS L, DOI DOI 10.1109/CVPR.2017.243; Dacic S, 2008, VIRCHOWS ARCH, V453, P627, DOI 10.1007/s00428-008-0689-3; Esteva A, 2017, NATURE, V542, P115, DOI 10.1038/nature21056; Galateau-Salle F, 2016, J THORAC ONCOL, V11, P142, DOI 10.1016/j.jtho.2015.11.005; Galateau-Salle F, 2014, ANN PATHOL, V34, P51, DOI 10.1016/j.annpat.2014.01.009; HE KM, 2016, PROC CVPR IEEE, P770, DOI DOI 10.1109/CVPR.2016.90; Hmeljaki J, 2018, CANCER DISCOV, V8, P1548, DOI 10.1158/2159-8290.CD-18-0804; Hou L, 2016, PROC CVPR IEEE, P2424, DOI 10.1109/CVPR.2016.266; Junttila MR, 2013, NATURE, V501, P346, DOI 10.1038/nature12626; Kadota K, 2011, J THORAC ONCOL, V6, P896, DOI 10.1097/JTO.0b013e318211127a; Kindler HL, 2018, J CLIN ONCOL, V36, P1343, DOI 10.1200/JCO.2017.76.6394; Krizhevsky A., 2012, ADV NEURAL INF PROCE; Lacourt A, 2017, OCCUP ENVIRON MED, V74, P691, DOI 10.1136/oemed-2016-104133; LeCun Y, 2015, NATURE, V521, P436, DOI 10.1038/nature14539; Mobadersany P, 2018, P NATL ACAD SCI USA, V115, pE2970, DOI 10.1073/pnas.1717139115; Mukhopadhyay S, 2018, AM J SURG PATHOL, V42, P39, DOI 10.1097/PAS.0000000000000948; Nagpal K, 2019, NPJ DIGIT MED, V2, DOI 10.1038/s41746-019-0112-2; Noonan CW, 2017, ANN TRANSL MED, V5, DOI 10.21037/atm.2017.03.74; Opitz I, 2015, J THORAC ONCOL, V10, P1634, DOI 10.1097/JTO.0000000000000661; Pillai K, 2015, AM J CLIN ONCOL-CANC, V38, P388, DOI 10.1097/COC.0b013e3182a0e867; Robinson BWS, 2005, NEW ENGL J MED, V353, P1591, DOI 10.1056/NEJMra050152; Ronneberger O, 2015, LECT NOTES COMPUT SC, V9351, P234, DOI 10.1007/978-3-319-24574-4_28; Rosen LE, 2018, MODERN PATHOL, V31, P598, DOI 10.1038/modpathol.2017.170; Salle FG, 2018, J THORAC ONCOL, V13, P1189, DOI 10.1016/j.jtho.2018.04.023; Schaumberg A. J., 2018, LARGE SCALE ANNOTATI, DOI [10.1101/396663, DOI 10.1101/396663]; Shrestha R, 2019, GENOME MED, V11, DOI 10.1186/s13073-019-0620-3; Ujiie H., 2015, ONCOIMMUNOLOGY, V4, P1; Uno H, 2011, STAT MED, V30, P1105, DOI 10.1002/sim.4154; Wang D., 2016, ARXIV PREPRINT ARXIV; Yap TA, 2017, NAT REV CANCER, V17, P475, DOI 10.1038/nrc.2017.42; Yu KH, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12474; Zarella MD, 2019, ARCH PATHOL LAB MED, V143, P222, DOI 10.5858/arpa.2018-0343-RA	38	147	151	8	44	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	OCT	2019	25	10					1519	+		10.1038/s41591-019-0583-3	http://dx.doi.org/10.1038/s41591-019-0583-3			16	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	JC3GJ	31591589				2022-12-27	WOS:000489166700020
J	Fernandez, DM; Rahman, AH; Fernandez, NF; Chudnovskiy, A; Amir, ED; Amadori, L; Khan, NS; Wong, CK; Shamailova, R; Hill, CA; Wang, ZC; Remark, R; Li, JR; Pina, C; Faries, C; Awad, AJ; Moss, N; Bjorkegren, JLM; Kim-Schulze, S; Gnjatic, S; Ma'ayan, A; Mocco, J; Faries, P; Merad, M; Giannarelli, C				Fernandez, Dawn M.; Rahman, Adeeb H.; Fernandez, Nicolas F.; Chudnovskiy, Aleksey; Amir, El-ad David; Amadori, Letizia; Khan, Nayaab S.; Wong, Christine K.; Shamailova, Roza; Hill, Christopher A.; Wang, Zichen; Remark, Romain; Li, Jennifer R.; Pina, Christian; Faries, Christopher; Awad, Ahmed J.; Moss, Noah; Bjorkegren, Johan L. M.; Kim-Schulze, Seunghee; Gnjatic, Sacha; Ma'ayan, Avi; Mocco, J.; Faries, Peter; Merad, Miriam; Giannarelli, Chiara			Single-cell immune landscape of human atherosclerotic plaques	NATURE MEDICINE			English	Article							ACUTE CORONARY SYNDROMES; T-CELLS; MACROPHAGES; EXPRESSION; ACTIVATION; DISEASE; PHAGOCYTOSIS; PATHOGENESIS; THERAPY; DENSITY	Atherosclerosis is driven by multifaceted contributions of the immune system within the circulation and at vascular focal sites. However, specific characteristics of dysregulated immune cells within atherosclerotic lesions that lead to clinical events such as ischemic stroke or myocardial infarction are poorly understood. Here, using single-cell proteomic and transcriptomic analyses, we uncovered distinct features of both T cells and macrophages in carotid artery plaques of patients with clinically symptomatic disease (recent stroke or transient ischemic attack) compared to asymptomatic disease (no recent stroke). Plaques from symptomatic patients were characterized by a distinct subset of CD4(+) T cells and by T cells that were activated and differentiated. Moreover, some T cell subsets in these plaques presented markers of T cell exhaustion. Additionally, macrophages from these plaques contained alternatively activated phenotypes, including subsets associated with plaque vulnerability. In plaques from asymptomatic patients, T cells and macrophages were activated and displayed evidence of interleukin-1 beta signaling. The identification of specific features of innate and adaptive immune cells in plaques that are associated with cerebrovascular events may enable the design of more precisely tailored cardiovascular immunotherapies.	[Fernandez, Dawn M.; Khan, Nayaab S.; Wong, Christine K.; Shamailova, Roza; Hill, Christopher A.; Moss, Noah; Giannarelli, Chiara] Icahn Sch Med Mt Sinai, Cardiovasc Res Ctr, Dept Med, New York, NY 10029 USA; [Rahman, Adeeb H.; Chudnovskiy, Aleksey; Remark, Romain; Kim-Schulze, Seunghee; Gnjatic, Sacha; Merad, Miriam; Giannarelli, Chiara] Icahn Sch Med Mt Sinai, Precis Immunol Inst, New York, NY 10029 USA; [Rahman, Adeeb H.; Fernandez, Nicolas F.; Amir, El-ad David; Kim-Schulze, Seunghee; Gnjatic, Sacha; Merad, Miriam] Icahn Sch Med Mt Sinai, Human Immune Monitoring Ctr, New York, NY 10029 USA; [Rahman, Adeeb H.; Amadori, Letizia; Bjorkegren, Johan L. M.; Giannarelli, Chiara] Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY 10029 USA; [Wang, Zichen; Ma'ayan, Avi] Icahn Sch Med Mt Sinai, Mt Sinai Ctr Bioinformat, Dept Pharmacol Sci, New York, NY 10029 USA; [Li, Jennifer R.; Pina, Christian; Faries, Christopher; Faries, Peter] Icahn Sch Med Mt Sinai, Dept Surg, Vasc Div, New York, NY 10029 USA; [Awad, Ahmed J.; Mocco, J.] Icahn Sch Med Mt Sinai, Cerebrovasc Ctr, Dept Neurosurg, New York, NY 10029 USA; [Bjorkegren, Johan L. M.] Karolinska Inst, Karolinska Univ Sjukhuset, Dept Med, Integrated Cardio MetabolicCtr, Huddinge, Sweden; [Kim-Schulze, Seunghee] Icahn Sch Med Mt Sinai, Hematol & Med Oncol Div, Tish Canc Inst, New York, NY 10029 USA; [Gnjatic, Sacha; Merad, Miriam] Icahn Sch Med Mt Sinai, Dept Oncol Sci, Tish Canc Inst, New York, NY 10029 USA; [Remark, Romain] Innate Pharma, Marseille, France; [Awad, Ahmed J.] Med Coll Wisconsin, Dept Neurosurg, Milwaukee, WI 53226 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Karolinska Institutet; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Medical College of Wisconsin	Giannarelli, C (corresponding author), Icahn Sch Med Mt Sinai, Cardiovasc Res Ctr, Dept Med, New York, NY 10029 USA.; Giannarelli, C (corresponding author), Icahn Sch Med Mt Sinai, Precis Immunol Inst, New York, NY 10029 USA.; Giannarelli, C (corresponding author), Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY 10029 USA.	chiara.giannarelli@mssm.edu	Moss, Noah/GON-3831-2022; Ma'ayan, Avi/AAG-3131-2019; Khan, Nayaab/AAD-3230-2022; Amadori, Letizia/AAB-4525-2019; Wang, Zichen/M-8554-2017	Moss, Noah/0000-0001-6247-3477; Ma'ayan, Avi/0000-0002-6904-1017; Amadori, Letizia/0000-0003-1125-4631; Shamailova, Roza/0000-0002-3749-4556; Gnjatic, Sacha/0000-0001-5643-9520; Fernandez, Dawn/0000-0003-1738-1754; Walker, Laura/0000-0003-4944-1993; Wang, Zichen/0000-0002-1415-1286	NIH [U24 AI118644, U19 AI128949, S10OD023547-01, K23HL111339, R03HL135289, R21TR001739, UH2TR002067, T32HL007824, R01HL125863, U54HL127624, U24CA224260]; American Heart Association [14SFRN20490315]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007824] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank the Human Immune Monitoring Center (HIMC), in particular O. Mayovska, V. Guo, X.I. Qin, H.E. Xie, M. Patel, M. Davila, B. Lee, S. Bradford, L. Walker and K. Tuballes. We thank S. Sajja and P.S. Chong for their coordination efforts. We are grateful to A. Kamphorst for her critical review of this manuscript. We thank the Biorepository and Pathology Core of the Icahn School of Medicine at Mount Sinai. This work utilized mass cytometry instrumentation supported by NIH grant no. S10OD023547-01. This work was funded by NIH grants nos. K23HL111339 and R03HL135289. C.G. was also funded by NIH grants nos. R21TR001739 and UH2TR002067, and partially supported by the American Heart Association (14SFRN20490315). D.F. is supported by NIH grant no. T32HL007824. J.L.M.B. is supported by NIH grants nos. R01HL125863 and R21TR001739. A.M. and Z.W. are supported by NIH grants nos. U54HL127624 (LINCSDCIC) and U24CA224260 (IDG-KMC). M.M. is supported by NIH grants nos. U24 AI118644 and U19 AI128949.	Amir ED, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01315; Amir ED, 2013, NAT BIOTECHNOL, V31, P545, DOI 10.1038/nbt.2594; Ayroldi E, 1998, BLOOD, V92, P4212, DOI 10.1182/blood.V92.11.4212.423k42_4212_4219; Azizi E, 2018, CELL, V174, P1293, DOI 10.1016/j.cell.2018.05.060; Baker CM, 2012, P NATL ACAD SCI USA, V109, P10474, DOI 10.1073/pnas.1114214109; Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; Bu DX, 2011, ARTERIOSCL THROM VAS, V31, P1100, DOI 10.1161/ATVBAHA.111.224709; Carlson CS, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3680; Chen EY, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-128; Cochain C, 2018, CIRC RES, V122, P1661, DOI 10.1161/CIRCRESAHA.117.312509; Cochain C, 2016, BASIC RES CARDIOL, V111, DOI 10.1007/s00395-016-0589-7; Cole JE, 2018, CARDIOVASC RES, V114, P1360, DOI 10.1093/cvr/cvy109; Cremer S, 2019, CIRCULATION, V139, P1320, DOI 10.1161/CIRCULATIONAHA.117.029015; Darvin P, 2018, EXP MOL MED, V50, DOI 10.1038/s12276-018-0191-1; DAYNES RA, 1991, J EXP MED, V174, P1323, DOI 10.1084/jem.174.6.1323; Dumitriu IE, 2012, CIRC RES, V110, P857, DOI 10.1161/CIRCRESAHA.111.261933; Eagar TN, 2004, IMMUNITY, V20, P407, DOI 10.1016/S1074-7613(04)00081-0; Edwards JD, 2017, CAN MED ASSOC J, V189, pE954, DOI 10.1503/cmaj.161142; Fernandez NF, 2017, SCI DATA, V4, DOI 10.1038/sdata.2017.151; Fienberg HG, 2012, CYTOM PART A, V81A, P467, DOI 10.1002/cyto.a.22067; Finn AV, 2010, ARTERIOSCL THROM VAS, V30, P1282, DOI 10.1161/ATVBAHA.108.179739; Ghattas A, 2013, J AM COLL CARDIOL, V62, P1541, DOI 10.1016/j.jacc.2013.07.043; Guo L, 2018, J CLIN INVEST, V128, P1106, DOI 10.1172/JCI93025; Haghverdi L, 2018, NAT BIOTECHNOL, V36, P421, DOI 10.1038/nbt.4091; Herder C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025734; Herrmann J, 2009, EUR HEART J, V30, P2930, DOI 10.1093/eurheartj/ehp309; Hogan PG, 2017, CELL CALCIUM, V63, P66, DOI 10.1016/j.ceca.2017.01.014; Huang CY, 2018, MOL MED REP, V18, P509, DOI 10.3892/mmr.2018.8982; Huangfu Ning, 2018, Biochem Biophys Res Commun, V495, P2111, DOI 10.1016/j.bbrc.2017.12.086; Jain A, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05489-7; Jawien J, 2012, CURR PHARM BIOTECHNO, V13, P2435, DOI 10.2174/1389201011208062435; Jia DL, 2019, CIRC RES, V124, P1323, DOI 10.1161/CIRCRESAHA.118.314569; Kamphorst AO, 2017, SCIENCE, V355, P1423, DOI 10.1126/science.aaf0683; Kirsch I, 2015, MOL ONCOL, V9, P2063, DOI 10.1016/j.molonc.2015.09.003; Krammer PH, 2007, NAT REV IMMUNOL, V7, P532, DOI 10.1038/nri2115; Kuleshov MV, 2016, NUCLEIC ACIDS RES, V44, pW90, DOI 10.1093/nar/gkw377; Kumar BV, 2017, CELL REP, V20, P2921, DOI 10.1016/j.celrep.2017.08.078; Kumar MP, 2018, CELL REP, V25, P1458, DOI 10.1016/j.celrep.2018.10.047; Lai LY, 2015, CYTOM PART A, V87A, P369, DOI 10.1002/cyto.a.22640; Lambrechts D, 2018, NAT MED, V24, P1277, DOI 10.1038/s41591-018-0096-5; Lavin Y, 2017, CELL, V169, P750, DOI 10.1016/j.cell.2017.04.014; Lee DJ, 2000, J BIOL CHEM, V275, P141, DOI 10.1074/jbc.275.1.141; Levine JH, 2015, CELL, V162, P184, DOI 10.1016/j.cell.2015.05.047; Li WW, 2019, FASEB J, V33, P3317, DOI 10.1096/fj.201801375RR; Libby P, 2017, EUR HEART J, V38, P801, DOI 10.1093/eurheartj/ehw599; Lin JD, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.124574; Ma J, 2012, J NEUROIMMUNE PHARM, V7, P750, DOI 10.1007/s11481-012-9367-y; Mackey RH, 2018, RHEUM DIS CLIN N AM, V44, P475, DOI 10.1016/j.rdc.2018.03.006; Marra P, 2014, CANCER RES, V74, P4908, DOI 10.1158/0008-5472.CAN-14-0637; Mathieu M, 2013, IMMUNOL CELL BIOL, V91, P82, DOI 10.1038/icb.2012.53; McInnes IB, 2007, NAT REV IMMUNOL, V7, P429, DOI 10.1038/nri2094; Methe H, 2005, J AM COLL CARDIOL, V45, P1939, DOI 10.1016/j.jacc.2005.03.040; Mihaylova B, 2012, LANCET, V380, P581, DOI 10.1016/S0140-6736(12)60367-5; Moore KJ, 2013, NAT REV IMMUNOL, V13, P709, DOI 10.1038/nri3520; Moore KJ, 2011, CELL, V145, P341, DOI 10.1016/j.cell.2011.04.005; MORENO PR, 1994, CIRCULATION, V90, P775, DOI 10.1161/01.CIR.90.2.775; Pazianas M, 2006, ANN NY ACAD SCI, V1068, P543, DOI 10.1196/annals.1346.055; Ramilowski JA, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8866; Read KA, 2016, EXP HEMATOL, V44, P799, DOI 10.1016/j.exphem.2016.06.003; Ridker PM, 2017, NEW ENGL J MED, V377, P1119, DOI 10.1056/NEJMoa1707914; Ridker PM, 2019, NEW ENGL J MED, V380, P752, DOI 10.1056/NEJMoa1809798; Rigamonti E, 2008, ARTERIOSCL THROM VAS, V28, P1050, DOI 10.1161/ATVBAHA.107.158998; Rollings CM, 2018, SCI SIGNAL, V11, DOI 10.1126/scisignal.aap8112; Singh S, 2015, NAT REV GASTRO HEPAT, V12, P26, DOI 10.1038/nrgastro.2014.202; STARY HC, 1995, CIRCULATION, V92, P1355, DOI 10.1161/01.CIR.92.5.1355; Stoeckius M, 2017, NAT METHODS, V14, P865, DOI [10.1038/nmeth.4380, 10.1038/NMETH.4380]; Strioga M, 2011, IMMUNOLOGY, V134, P17, DOI 10.1111/j.1365-2567.2011.03470.x; Sutterwala FS, 2014, ANN NY ACAD SCI, V1319, P82, DOI 10.1111/nyas.12458; Tabas I, 2017, IMMUNITY, V47, P621, DOI 10.1016/j.immuni.2017.09.008; Tanay A, 2017, NATURE, V541, P331, DOI 10.1038/nature21350; Tziakas DN, 2008, EUR HEART J, V29, P2713, DOI 10.1093/eurheartj/ehn382; Vallieres F, 2013, J IMMUNOL, V190, P2904, DOI 10.4049/jimmunol.1201941; Van der Heiden K, 2016, THROMB HAEMOSTASIS, V115, P501, DOI 10.1160/TH15-07-0614; Versari D, 2006, ARTERIOSCL THROM VAS, V26, P2132, DOI 10.1161/01.ATV.0000232501.08576.73; Waickman AT, 2017, CYTOKINE, V99, P266, DOI 10.1016/j.cyto.2017.08.004; Wherry EJ, 2015, NAT REV IMMUNOL, V15, P486, DOI 10.1038/nri3862; Winkels H, 2018, CIRC RES, V122, P1675, DOI 10.1161/CIRCRESAHA.117.312513; Xiao H, 2018, INT J RHEUM DIS, V21, P477, DOI 10.1111/1756-185X.13247; Yi JS, 2010, IMMUNOLOGY, V129, P474, DOI 10.1111/j.1365-2567.2010.03255.x	79	283	287	18	80	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	OCT	2019	25	10					1576	+		10.1038/s41591-019-0590-4	http://dx.doi.org/10.1038/s41591-019-0590-4			26	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	JC3GJ	31591603	Green Accepted			2022-12-27	WOS:000489166700027
J	Rader, B; Scarpino, SV; Nande, A; Hill, AL; Adlam, B; Reiner, RC; Pigott, DM; Gutierrez, B; Zarebski, AE; Shrestha, M; Brownstein, JS; Castro, MC; Dye, C; Tian, HY; Pybus, OG; Kraemer, MUG				Rader, Benjamin; Scarpino, Samuel, V; Nande, Anjalika; Hill, Alison L.; Adlam, Ben; Reiner, Robert C.; Pigott, David M.; Gutierrez, Bernardo; Zarebski, Alexander E.; Shrestha, Munik; Brownstein, John S.; Castro, Marcia C.; Dye, Christopher; Tian, Huaiyu; Pybus, Oliver G.; Kraemer, Moritz U. G.			Crowding and the shape of COVID-19 epidemics	NATURE MEDICINE			English	Article							TRANSMISSION; WUHAN; CHINA	Analysis of spatial heterogeneity of crowding in China and Italy, together with COVID-19 case data, show that cities with higher crowding have longer epidemics and higher attack rates after the first epidemic wave. The coronavirus disease 2019 (COVID-19) pandemic is straining public health systems worldwide, and major non-pharmaceutical interventions have been implemented to slow its spread(1-4). During the initial phase of the outbreak, dissemination of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was primarily determined by human mobility from Wuhan, China(5,6). Yet empirical evidence on the effect of key geographic factors on local epidemic transmission is lacking(7). In this study, we analyzed highly resolved spatial variables in cities, together with case count data, to investigate the role of climate, urbanization and variation in interventions. We show that the degree to which cases of COVID-19 are compressed into a short period of time (peakedness of the epidemic) is strongly shaped by population aggregation and heterogeneity, such that epidemics in crowded cities are more spread over time, and crowded cities have larger total attack rates than less populated cities. Observed differences in the peakedness of epidemics are consistent with a meta-population model of COVID-19 that explicitly accounts for spatial hierarchies. We paired our estimates with globally comprehensive data on human mobility and predict that crowded cities worldwide could experience more prolonged epidemics.	[Rader, Benjamin; Brownstein, John S.] Boston Childrens Hosp, Computat Epidemiol Lab, Boston, MA USA; [Rader, Benjamin] Boston Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA USA; [Scarpino, Samuel, V; Shrestha, Munik] Northeastern Univ, Network Sci Inst, Boston, MA 02115 USA; [Scarpino, Samuel, V] ISI Fdn, Turin, Italy; [Scarpino, Samuel, V] Santa Fe Inst, Santa Fe, NM 87501 USA; [Nande, Anjalika; Hill, Alison L.; Adlam, Ben] Harvard Univ, Program Evolutionary Dynam, Cambridge, MA 02138 USA; [Hill, Alison L.] Johns Hopkins Univ, Inst Computat Med, Baltimore, MD USA; [Reiner, Robert C.; Pigott, David M.] Univ Washington, Dept Hlth Metr, Seattle, WA 98195 USA; [Reiner, Robert C.; Pigott, David M.] Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA 98195 USA; [Gutierrez, Bernardo; Zarebski, Alexander E.; Dye, Christopher; Pybus, Oliver G.; Kraemer, Moritz U. G.] Univ Oxford, Dept Zool, Oxford, England; [Gutierrez, Bernardo] Univ San Francisco Quito USFQ, Sch Biol & Environm Sci, Quito, Ecuador; [Brownstein, John S.] Harvard Med Sch, Boston, MA 02115 USA; [Castro, Marcia C.] Harvard TH Chan Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA USA; [Tian, Huaiyu] Beijing Normal Univ, Coll Global Change & Earth Syst Sci, State Key Lab Remote Sensing Sci, Beijing, Peoples R China; [Pybus, Oliver G.] Royal Vet Coll, Dept Pathobiol & Populat Sci, London, England	Harvard University; Boston Children's Hospital; Boston University; Northeastern University; The Santa Fe Institute; Harvard University; Johns Hopkins University; University of Washington; University of Washington Seattle; Institute for Health Metrics & Evaluation; University of Washington; University of Washington Seattle; University of Oxford; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Beijing Normal University; University of London; University of London Royal Veterinary College	Scarpino, SV (corresponding author), Northeastern Univ, Network Sci Inst, Boston, MA 02115 USA.; Scarpino, SV (corresponding author), ISI Fdn, Turin, Italy.; Scarpino, SV (corresponding author), Santa Fe Inst, Santa Fe, NM 87501 USA.; Pybus, OG; Kraemer, MUG (corresponding author), Univ Oxford, Dept Zool, Oxford, England.; Pybus, OG (corresponding author), Royal Vet Coll, Dept Pathobiol & Populat Sci, London, England.	s.scarpino@northeastern.edu; oliver.pybus@zoo.ox.ac.uk; moritz.kraemer@zoo.ox.ac.uk	Gutierrez, Bernardo/AAQ-6684-2021; Dye, Christopher/AIC-4659-2022; Pybus, Oliver G/B-2640-2012; Tian, Huaiyu/G-1934-2016; Nande, Anjalika/GON-3363-2022; Castro, Marcia/S-2681-2019	Gutierrez, Bernardo/0000-0002-9220-2739; Pybus, Oliver G/0000-0002-8797-2667; Tian, Huaiyu/0000-0002-4466-0858; Nande, Anjalika/0000-0003-1726-6633; Castro, Marcia/0000-0003-4606-2795; Rader, Benjamin/0000-0002-6095-0193; Hill, Alison Lynn/0000-0002-6583-3623; Pigott, David/0000-0002-6731-4034	Google.org; European Commission; Branco Weiss Fellowship; Oxford Martin School; Beijing Science and Technology Planning Project [Z201100005420010]; National Institutes of Health [DP5OD019851]	Google.org; European Commission(European CommissionEuropean Commission Joint Research Centre); Branco Weiss Fellowship; Oxford Martin School; Beijing Science and Technology Planning Project; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The authors thank K. Cordiano for statistical assistance. We thank the members of the Open COVID-19 Data Working Group. The members of the group are listed in the Supplementary Note. B.R. acknowledges funding from Google.org. M.U.G.K. acknowledges funding from the European Commission H2020 program (MOOD project) and a Branco Weiss Fellowship. O.G.P., M.U.G.K., A.E.Z. and H.T. acknowledge funding from the Oxford Martin School. H.T. acknowledges funding from the Beijing Science and Technology Planning Project (Z201100005420010). A.L.H. and A.N. acknowledge funding from the National Institutes of Health (DP5OD019851). The funding bodies had no role in study design, data collection and analysis, preparation of the manuscript or the decision to publish. All authors saw and approved the manuscript.	ANDERSON R M, 1991; Aurora Big Data, 2017, 2017 MOBILE MAP APP; Baker RE, 2020, SCIENCE, V369, P315, DOI 10.1126/science.abc2535; Bassolas A, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12809-y; Chetty R, 2016, JAMA-J AM MED ASSOC, V315, P1750, DOI 10.1001/jama.2016.4226; Crawford JM, 2010, EMERG INFECT DIS, V16, P8, DOI 10.3201/eid1601.091167; Dalziel BD, 2018, SCIENCE, V362, P75, DOI 10.1126/science.aat6030; DOXSEYWHITFIELD E, 2015, PAP APPL GEOGR, V0001; Flaxman S, 2020, NATURE, V584, P257, DOI 10.1038/s41586-020-2405-7; Florczyk A., 2019, GHS UCDB R2019A GHS; Fraher EP, 2020, NEW ENGL J MED, V382, P2181, DOI 10.1056/NEJMp2006376; Gog JR, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003635; Grasselli G, 2020, JAMA-J AM MED ASSOC, V323, P1545, DOI 10.1001/jama.2020.4031; Ji YP, 2020, LANCET GLOB HEALTH, V8, pE480, DOI 10.1016/S2214-109X(20)30068-1; KISSLER SM, 2020, SCIENCE, V5793, P1; Kissler SM, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-18271-5; Kraemer MUG, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2015.0468; Kraemer MUG, 2020, SCIENCE, V368, P493, DOI 10.1126/science.abb4218; Kucharski AJ, 2020, LANCET INFECT DIS, V20, P1, DOI [10.1056/NEJMoa2001316, DOI 10.1056/NEJMoa2001316, 10.1016/S1473-3099(19)30711-X]; Lai SJ, 2020, NATURE, V585, P410, DOI [10.1101/2020.03.03.20029843, 10.1038/s41586-020-2293-x]; Leung K, 2020, LANCET, V395, P1382, DOI 10.1016/S0140-6736(20)30746-7; Li Q, 2020, NEW ENGL J MED, V382, P1199, DOI 10.1056/NEJMoa2001316; Lipsitch M, 2020, NEW ENGL J MED, V382, P1194, DOI 10.1056/NEJMp2002125; LLOYD M, 1967, J ANIM ECOL, V36, P1, DOI 10.2307/3012; Lloyd-Smith JO, 2005, NATURE, V438, P355, DOI 10.1038/nature04153; Mat NFC, 2020, J TRAVEL MED, V27, DOI 10.1093/jtm/taaa059; MAY RM, 1984, MATH BIOSCI, V72, P83, DOI 10.1016/0025-5564(84)90063-4; Meyers LA, 2007, B AM MATH SOC, V44, P63; Ramshaw RE, 2019, SCI DATA, V6, DOI 10.1038/s41597-019-0330-0; Reiczigel J, 2005, J PARASITOL, V91, P245, DOI 10.1645/GE-281R1; Riou J, 2020, EUROSURVEILLANCE, V25, P7, DOI 10.2807/1560-7917.ES.2020.25.4.2000058; Rocklov J, 2020, J TRAVEL MED, V27, DOI 10.1093/jtm/taaa038; Rosenbaum L, 2020, NEW ENGL J MED, V382, P1873, DOI 10.1056/NEJMp2005492; Sattenspiel L, 2003, B MATH BIOL, V65, P1, DOI 10.1006/bulm.2002.0317; Shaman J, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000316; Shaman J, 2009, P NATL ACAD SCI USA, V106, P3243, DOI 10.1073/pnas.0806852106; Southwood, 1978, ECOLOGICAL METHODS, P7; Tian HY, 2020, SCIENCE, V368, P638, DOI 10.1126/science.abb6105; Wade MJ, 2018, J ANIM ECOL, V87, P1221, DOI 10.1111/1365-2656.12854; Watts DJ, 2005, P NATL ACAD SCI USA, V102, P11157, DOI 10.1073/pnas.0501226102; Wilson R. J., 2019, PREPRINT; World Health Organization, 171 WHO; Xu B., 2020, FIGSHARE, DOI [10.6084/m9.figshare.11949279, DOI 10.6084/M9.FIGSHARE.11949279]; Xu B, 2020, LANCET INFECT DIS, V3099, P30119, DOI DOI 10.1016/S1473-3099(20)30119-5; Xu B, 2020, SCI DATA, V7, DOI 10.1038/s41597-020-0448-0; Zhang JJ, 2020, SCIENCE, V368, P1481, DOI 10.1126/science.abb8001; Zhao S, 2020, J TRAVEL MED, V27, DOI 10.1093/jtm/taaa022	47	109	113	2	28	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	2020	26	12								10.1038/s41591-020-1104-0	http://dx.doi.org/10.1038/s41591-020-1104-0		OCT 2020	17	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	PB8QO	33020651	Green Accepted, Green Submitted, Bronze			2022-12-27	WOS:000575801100001
J	Edridge, AWD; Kaczorowska, J; Hoste, ACR; Bakker, M; Klein, M; Loens, K; Jebbink, MF; Matser, A; Kinsella, CM; Rueda, P; Ieven, M; Goossens, H; Prins, M; Sastre, P; Deijs, M; van der Hoek, L				Edridge, Arthur W. D.; Kaczorowska, Joanna; Hoste, Alexis C. R.; Bakker, Margreet; Klein, Michelle; Loens, Katherine; Jebbink, Maarten F.; Matser, Amy; Kinsella, Cormac M.; Rueda, Paloma; Ieven, Margareta; Goossens, Herman; Prins, Maria; Sastre, Patricia; Deijs, Martin; van der Hoek, Lia			Seasonal coronavirus protective immunity is short-lasting	NATURE MEDICINE			English	Article							IMMUNOASSAY; NL63; ANTIBODIES	A key unsolved question in the current coronavirus disease 2019 (COVID-19) pandemic is the duration of acquired immunity. Insights from infections with the four seasonal human coronaviruses might reveal common characteristics applicable to all human coronaviruses. We monitored healthy individuals for more than 35 years and determined that reinfection with the same seasonal coronavirus occurred frequently at 12 months after infection. The durability of immunity to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is unknown. Lessons from seasonal coronavirus infections in humans show that reinfections can occur within 12 months of initial infection, coupled with changes in levels of virus-specific antibodies.	[Edridge, Arthur W. D.; Kaczorowska, Joanna; Bakker, Margreet; Klein, Michelle; Jebbink, Maarten F.; Kinsella, Cormac M.; Deijs, Martin; van der Hoek, Lia] Univ Amsterdam, Lab Expt Virol, Dept Med Microbiol & Infect Prevent, Amsterdam Infect & Immun Inst,Amsterdam UMC, Amsterdam, Netherlands; [Hoste, Alexis C. R.; Rueda, Paloma; Sastre, Patricia] Inmunol & Genet Aplicada SA, INGENASA, Madrid, Spain; [Loens, Katherine; Ieven, Margareta; Goossens, Herman] Univ Antwerp, Dept Med Microbiol, Vaccine & Infect Dis Inst VAXINFECTIO, Antwerp, Belgium; [Loens, Katherine; Goossens, Herman] Univ Hosp Antwerp, Dept Microbiol, Edegem, Belgium; [Matser, Amy; Prins, Maria] Publ Hlth Serv Amsterdam, Dept Infect Dis, Amsterdam, Netherlands; [Prins, Maria] Univ Amsterdam, Amsterdam UMC, Dept Infect Dis, Amsterdam Infect & Immun Inst, Amsterdam, Netherlands	University of Amsterdam; University of Antwerp; University of Antwerp; Public Health Service Amsterdam; University of Amsterdam	van der Hoek, L (corresponding author), Univ Amsterdam, Lab Expt Virol, Dept Med Microbiol & Infect Prevent, Amsterdam Infect & Immun Inst,Amsterdam UMC, Amsterdam, Netherlands.	c.m.vanderhoek@amsterdamumc.nl		Kinsella, Cormac/0000-0001-9865-4608; Matser, Amy/0000-0003-4291-1905; Hoste, Alexis/0000-0001-6724-6062; Edridge, Arthur/0000-0001-9264-5874	Center for Infectious Disease Control of the Netherlands National Institute for Public Health and the Environment; GRACE network [LSHM-CT-2005-518226]; PREPARE project (European Union FP7 Programme) [602525]; European Union's Horizon 2020 Research and Innovation Programme, under Marie Skodowska-Curie Actions [721367]; Amsterdam University Medical Center	Center for Infectious Disease Control of the Netherlands National Institute for Public Health and the Environment; GRACE network; PREPARE project (European Union FP7 Programme); European Union's Horizon 2020 Research and Innovation Programme, under Marie Skodowska-Curie Actions; Amsterdam University Medical Center	The authors gratefully acknowledge the Amsterdam Cohort Studies (ACS) on HIV infection and AIDS, a collaboration among the Public Health Service of Amsterdam, the Amsterdam University Medical Center of the University of Amsterdam, the Sanquin Blood Supply Foundation, the Medical Center Jan van Goyen and the HIV Focus Center of the DC-Clinics. It is part of the Netherlands HIV Monitoring Foundation and financially supported by the Center for Infectious Disease Control of the Netherlands National Institute for Public Health and the Environment. The authors thank all ACS participants for their contribution, as well as the ACS study nurses, data managers and lab technicians. We thank K. Jacobs for his help with lifting of GRACE consortium samples and D. Eggink for PREPARE consortium samples. We acknowledge the GRACE network (LSHM-CT-2005-518226), the European Science Foundation Research Networking Programmes network TRACE and the PREPARE project (funded through the European Union FP7 Programme no. 602525). This work was supported by a grant from the European Union's Horizon 2020 Research and Innovation Programme, under Marie Skodowska-Curie Actions grant agreement no. 721367 (HONOURs), Amsterdam University Medical Center funding connected to HONOURs and the Amsterdam University Medical Center PhD scholarship of A. W. D. Edridge.	Blanchard EG, 2011, J VIROL METHODS, V177, P100, DOI 10.1016/j.jviromet.2011.07.005; CALLOW KA, 1990, EPIDEMIOL INFECT, V105, P435, DOI 10.1017/S0950268800048019; Dijkman R, 2008, J CLIN MICROBIOL, V46, P2368, DOI 10.1128/JCM.00533-08; Dijkman R, 2012, J CLIN VIROL, V53, P135, DOI 10.1016/j.jcv.2011.11.011; Gobat N, 2018, LANCET, V392, P38; Gorse GJ, 2020, J MED VIROL, V92, P512, DOI 10.1002/jmv.25715; Hoek L. van der, 2004, Nature Medicine, V10, P368, DOI 10.1038/nm1024; Ibarrondo FJ, 2020, NEW ENGL J MED, V383, P1085, DOI 10.1056/NEJMc2025179; Ieven M, 2018, CLIN MICROBIOL INFEC, V24, P1158, DOI 10.1016/j.cmi.2018.02.004; Lehmann C, 2008, DIAGN MICR INFEC DIS, V61, P40, DOI 10.1016/j.diagmicrobio.2007.12.002; Li Y, 2020, J INFECT DIS, V222, P1090, DOI 10.1093/infdis/jiaa436; Loens K, 2012, J CLIN MICROBIOL, V50, P977, DOI 10.1128/JCM.00200-11; Long QX, 2020, NAT MED, V26, P1200, DOI 10.1038/s41591-020-0965-6; Pyrc K, 2006, J MOL BIOL, V364, P964, DOI 10.1016/j.jmb.2006.09.074; Reed L.J., 1938, SIMPLE METHOD ESTIMA, V27, P493, DOI [10.1093/oxfordjournals.aje.a118408, DOI 10.1093/OXFORDJOURNALS.AJE.A118408]; REED SE, 1984, J MED VIROL, V13, P179, DOI 10.1002/jmv.1890130208; Sastre P, 2011, CLIN VACCINE IMMUNOL, V18, P113, DOI 10.1128/CVI.00355-10; Severance EG, 2008, CLIN VACCINE IMMUNOL, V15, P1805, DOI 10.1128/CVI.00124-08; van Bilsen WPH, 2020, AIDS, V34, P301, DOI 10.1097/QAD.0000000000002417	19	354	357	2	17	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2020	26	11					1691	+		10.1038/s41591-020-1083-1	http://dx.doi.org/10.1038/s41591-020-1083-1		SEP 2020	12	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	OT0SR	32929268	Bronze, Green Submitted			2022-12-27	WOS:000569298900002
J	Edwards, KM				Edwards, Kathryn M.			Vaccines targeting SARS-CoV-2 tested in humans	NATURE MEDICINE			English	Editorial Material								Vaccines directed against SARS-CoV-2 have been administered to healthy volunteers and have been shown to stimulate a brisk humoral and cellular immune response. All vaccines were generally well tolerated with mostly mild to moderate local and systemic reactions.	[Edwards, Kathryn M.] Vanderbilt Univ, Med Ctr, Vanderbilt Vaccine Res Program, Nashville, TN 37235 USA	Vanderbilt University	Edwards, KM (corresponding author), Vanderbilt Univ, Med Ctr, Vanderbilt Vaccine Res Program, Nashville, TN 37235 USA.	kathryn.edwards@vumc.org						Corbett KS, 2020, NEW ENGL J MED, V383, P1544, DOI 10.1056/NEJMoa2024671; Ewer K, 2017, HUM VACC IMMUNOTHER, V13, P3020, DOI 10.1080/21645515.2017.1383575; Folegatti PM, 2020, LANCET, V396, P467, DOI 10.1016/S0140-6736(20)31604-4; Graham BS, 2018, NAT IMMUNOL, V19, P20, DOI 10.1038/s41590-017-0007-9; Jackson LA, 2020, NEW ENGL J MED, V383, P1920, DOI 10.1056/NEJMoa2022483; Lambert PH, 2020, VACCINE, V38, P4783, DOI 10.1016/j.vaccine.2020.05.064; Lee GM, 2020, JAMA-J AM MED ASSOC, V324, P546, DOI 10.1001/jama.2020.13167; Martin JE, 2008, VACCINE, V26, P6338, DOI 10.1016/j.vaccine.2008.09.026; Modjarrad K, 2019, LANCET INFECT DIS, V19, P1013, DOI 10.1016/S1473-3099(19)30266-X; Mulligan MJ, 2020, NATURE, V586, P589, DOI 10.1038/s41586-020-2639-4; Pardi N, 2018, NAT REV DRUG DISCOV, V17, P261, DOI 10.1038/nrd.2017.243; Tseng CT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035421	12	4	4	0	1	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	SEP	2020	26	9					1336	1338		10.1038/s41591-020-1048-4	http://dx.doi.org/10.1038/s41591-020-1048-4		AUG 2020	3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	PF3EM	32839620	Bronze			2022-12-27	WOS:000562338700003
J	Merad, M				Merad, Miriam			Reflections from a mother scientist	NATURE MEDICINE			English	Editorial Material								Being a parent scientist can feel like a catch-22, feeling guilty for both the time spent away from the children and the time spent away from the bench. Embracing healthy boundaries can be liberating but will only go so far if childcare remains unaffordable.	[Merad, Miriam] Icahn Sch Med Mt Sinai, Precis Immunol Inst, New York, NY 10029 USA; [Merad, Miriam] Icahn Sch Med Mt Sinai, Tisch Canc Inst, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Merad, M (corresponding author), Icahn Sch Med Mt Sinai, Precis Immunol Inst, New York, NY 10029 USA.; Merad, M (corresponding author), Icahn Sch Med Mt Sinai, Tisch Canc Inst, New York, NY 10029 USA.	miriam.merad@mssm.edu							0	0	0	1	1	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	SEP	2020	26	9					1316	1316		10.1038/s41591-020-1052-8	http://dx.doi.org/10.1038/s41591-020-1052-8		AUG 2020	1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	PF3EM	32839622	Bronze			2022-12-27	WOS:000562338700001
J	Stower, H				Stower, Hannah			y A personal approach for Parkinson's disease	NATURE MEDICINE			English	Editorial Material												h.stower@us.nature.com							0	0	0	0	1	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	JUN	2020	26	6					822	822		10.1038/s41591-020-0958-5	http://dx.doi.org/10.1038/s41591-020-0958-5		JUN 2020	1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	LZ3ZG	32528148	Bronze			2022-12-27	WOS:000539886500008
J	Hata, AN; Shaw, AT				Hata, Aaron N.; Shaw, Alice T.			Resistance looms for KRAS(G12C) inhibitors	NATURE MEDICINE			English	Editorial Material							CANCER	Cells develop a heterogeneous response to KRAS inhibitors, bypassing their anti-growth effects by producing more of the protein that does not bind the inhibitor.	[Hata, Aaron N.] Massachusetts Gen Hosp, Ctr Canc, Boston, MA 02114 USA; [Hata, Aaron N.] Harvard Med Sch, Boston, MA 02115 USA; [Shaw, Alice T.] Novartis Inst Biomed Res, Cambridge, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Novartis	Hata, AN (corresponding author), Massachusetts Gen Hosp, Ctr Canc, Boston, MA 02114 USA.; Hata, AN (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.	ahata@mgh.harvard.edu; ashaw1@mgh.harvard.edu						Canon J, 2019, NATURE, V575, P217, DOI 10.1038/s41586-019-1694-1; Hallin J, 2020, CANCER DISCOV, V10, P54, DOI 10.1158/2159-8290.CD-19-1167; Hata AN, 2016, NAT MED, V22, P262, DOI 10.1038/nm.4040; Lito P, 2016, SCIENCE, V351, P604, DOI 10.1126/science.aad6204; Mainardi S, 2018, NAT MED, V24, P961, DOI 10.1038/s41591-018-0023-9; Misale S, 2019, CLIN CANCER RES, V25, P796, DOI 10.1158/1078-0432.CCR-18-0368; Ostrem JM, 2013, NATURE, V503, P548, DOI 10.1038/nature12796; Patricelli MP, 2016, CANCER DISCOV, V6, P316, DOI 10.1158/2159-8290.CD-15-1105; Prahallad A, 2012, NATURE, V483, P100, DOI 10.1038/nature10868; Ruess DA, 2018, NAT MED, V24, P954, DOI 10.1038/s41591-018-0024-8; Shaffer SM, 2017, NATURE, V546, P431, DOI 10.1038/nature22794; Xue JY, 2020, NATURE, V577, P421, DOI 10.1038/s41586-019-1884-x	12	29	30	2	21	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	FEB	2020	26	2					169	170		10.1038/s41591-020-0765-z	http://dx.doi.org/10.1038/s41591-020-0765-z		FEB 2020	2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	KK7DU	32020086				2022-12-27	WOS:000511081800002
J	Stower, H				Stower, Hannah			Antibiotic tolerance leads to antibiotic resistance	NATURE MEDICINE			English	Editorial Material																			0	1	1	1	21	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	FEB	2020	26	2					163	163		10.1038/s41591-020-0778-7	http://dx.doi.org/10.1038/s41591-020-0778-7			1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	KK7DU	32047319	Bronze			2022-12-27	WOS:000512899200032
J	Nkengasong, J				Nkengasong, John			China's response to a novel coronavirus stands in stark contrast to the 2002 SARS outbreak response	NATURE MEDICINE			English	Article								The strengthening of the Chinese Center for Disease Control and Prevention has been a turning point in outbreak responses in the area. This represents very welcome progress and development for global health security and diplomacy.	[Nkengasong, John] Africa Ctr Dis Control & Prevent, Addis Ababa, Ethiopia		Nkengasong, J (corresponding author), Africa Ctr Dis Control & Prevent, Addis Ababa, Ethiopia.	nkengasongj@africa-union.org						[Anonymous], 2020, REUTERS; [Anonymous], 2003, CNN; Cheung E., 2020, S CHINA MORNING POST; Cohen J, 2020, SCIENCE, V367, P234, DOI 10.1126/science.367.6475.234; Juan D., 2020, WUHAN WET MARKET CLO; Lai L., 2020, STRAITS TIMES 0414; Lee J.-W., 2004, LEARNING SARS PREPAR; Levine J., 2020, NEW YORK POST; Li CY, 2016, AM J PUBLIC HEALTH, V106, P2093, DOI 10.2105/AJPH.2016.303508; Mukherjee S, 2017, INDIAN J DERMATOL, V62, P459, DOI 10.4103/ijd.IJD_379_17; Smith RD, 2006, SOC SCI MED, V63, P3113, DOI 10.1016/j.socscimed.2006.08.004; WebMD, 2004, SARS TIM OUTBR; Wee, 2020, NEW YORK TIMES; World Health Organization, 2020, MENT HLTH PSYCH CONS; World Population Review, 2020, WUH POP 2020; Zhou Y, 2019, QUARTZ AFRICA   0728	16	75	80	4	73	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	MAR	2020	26	3					310	311		10.1038/s41591-020-0771-1	http://dx.doi.org/10.1038/s41591-020-0771-1		JAN 2020	2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	KU0MC	31988464	Green Published, Bronze			2022-12-27	WOS:000510552300004
J	Fitzgerald, RC				Fitzgerald, Rebecca C.			Big data is crucial to the early detection of cancer	NATURE MEDICINE			English	Editorial Material								Among the many promises of big data, one of the most exciting could be the potential to unlock the detection of cancer before advanced malignancy ensures, which means opening up a whole new understanding of the disease.	[Fitzgerald, Rebecca C.] Univ Cambridge, MRC Canc Unit, Canc Prevent, Cambridge, England; [Fitzgerald, Rebecca C.] Univ Cambridge, MRC Canc Unit, Canc Res UK Int Alliance Canc Early Detect ACED, Cambridge, England	University of Cambridge; University of Cambridge	Fitzgerald, RC (corresponding author), Univ Cambridge, MRC Canc Unit, Canc Prevent, Cambridge, England.; Fitzgerald, RC (corresponding author), Univ Cambridge, MRC Canc Unit, Canc Res UK Int Alliance Canc Early Detect ACED, Cambridge, England.	rcf29@mrc-cu.cam.ac.uk		Fitzgerald, Rebecca/0000-0002-3434-3568				Atkin WS, 2010, LANCET, V375, P1624, DOI 10.1016/S0140-6736(10)60551-X; Jacobs IJ, 2016, LANCET, V387, P945, DOI 10.1016/S0140-6736(15)01224-6; Walter JE, 2016, LANCET ONCOL, V17, P907, DOI 10.1016/S1470-2045(16)30069-9; Welch HG, 2019, NEW ENGL J MED, V381, P1378, DOI 10.1056/NEJMsr1905447	4	14	14	1	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JAN	2020	26	1					19	20		10.1038/s41591-019-0725-7	http://dx.doi.org/10.1038/s41591-019-0725-7			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	KG3GZ	31932790				2022-12-27	WOS:000509831900013
J	Stower, H				Stower, Hannah			Initial promise for NASH therapy	NATURE MEDICINE			English	Editorial Material												h.stower@us.nature.com							0	0	0	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JAN	2020	26	1					21	21		10.1038/s41591-019-0742-6	http://dx.doi.org/10.1038/s41591-019-0742-6			1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	KG3GZ	31932793	Bronze			2022-12-27	WOS:000509831900017
J	Zhou, YY; Song, WM; Andhey, PS; Swain, A; Levy, T; Miller, KR; Poliani, PL; Cominelli, M; Grover, S; Gilfillan, S; Cella, M; Ulland, TK; Zaitsev, K; Miyashita, A; Ikeuchi, T; Sainouchi, M; Kakita, A; Bennett, DA; Schneider, JA; Nichols, MR; Beausoleil, SA; Ulrich, JD; Holtzman, DM; Artyomov, MN; Colonna, M				Zhou, Yingyue; Song, Wilbur M.; Andhey, Prabhakar S.; Swain, Amanda; Levy, Tyler; Miller, Kelly R.; Poliani, Pietro L.; Cominelli, Manuela; Grover, Shikha; Gilfillan, Susan; Cella, Marina; Ulland, Tyler K.; Zaitsev, Konstantin; Miyashita, Akinori; Ikeuchi, Takeshi; Sainouchi, Makoto; Kakita, Akiyoshi; Bennett, David A.; Schneider, Julie A.; Nichols, Michael R.; Beausoleil, Sean A.; Ulrich, Jason D.; Holtzman, David M.; Artyomov, Maxim N.; Colonna, Marco			Human and mouse single-nucleus transcriptomics reveal TREM2-dependent and TREM2-independent cellular responses in Alzheimer's disease	NATURE MEDICINE			English	Article							PROTEIN-PHOSPHORYLATION; MICROGLIAL RESPONSE; BETA; EXPRESSION; MICE; RISK; ALPHA(1)-ANTICHYMOTRYPSIN; NEURODEGENERATION; MUTATIONS; PATHOLOGY	Glia have been implicated in Alzheimer's disease (AD) pathogenesis. Variants of the microglia receptor triggering receptor expressed on myeloid cells 2 (TREM2) increase AD risk, and activation of disease-associated microglia (DAM) is dependent on TREM2 in mouse models of AD. We surveyed gene-expression changes associated with AD pathology and TREM2 in 5XFAD mice and in human AD by single-nucleus RNA sequencing. We confirmed the presence of Trem2-dependent DAM and identified a previously undiscovered Serpina3n(+)C4b(+) reactive oligodendrocyte population in mice. Interestingly, remarkably different glial phenotypes were evident in human AD. Microglia signature was reminiscent of IRF8-driven reactive microglia in peripheral-nerve injury. Oligodendrocyte signatures suggested impaired axonal myelination and metabolic adaptation to neuronal degeneration. Astrocyte profiles indicated weakened metabolic coordination with neurons. Notably, the reactive phenotype of microglia was less evident in TREM2-R47H and TREM2-R62H carriers than in non-carriers, demonstrating a TREM2 requirement in both mouse and human AD, despite the marked species-specific differences. Single-nucleus RNA sequencing in a mouse model of A beta accumulation and postmortem brain tissue from people with Alzheimer's disease reveals substantial species-specific differences in transcriptional signatures, but both point to the contribution of glia and the importance of TREM2.	[Zhou, Yingyue; Song, Wilbur M.; Andhey, Prabhakar S.; Swain, Amanda; Gilfillan, Susan; Cella, Marina; Zaitsev, Konstantin; Artyomov, Maxim N.; Colonna, Marco] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63130 USA; [Levy, Tyler; Beausoleil, Sean A.] Bluefin Biomed, Beverly, MA USA; [Miller, Kelly R.] NanoString, Seattle, WA USA; [Poliani, Pietro L.; Cominelli, Manuela] Univ Brescia, Pathol Unit, Mol & Translat Med Dept, Brescia, Italy; [Grover, Shikha; Nichols, Michael R.] Univ Missouri, Dept Chem & Biochem, St Louis, MO 63121 USA; [Ulland, Tyler K.] Univ Wisconsin, Dept Pathol & Lab Med, Madison, WI USA; [Miyashita, Akinori; Ikeuchi, Takeshi] Niigata Univ, Brain Res Inst, Dept Mol Genet, Niigata, Japan; [Sainouchi, Makoto; Kakita, Akiyoshi] Niigata Univ, Brain Res Inst, Dept Pathol, Niigata, Japan; [Bennett, David A.; Schneider, Julie A.] Rush Univ, Med Ctr, Rush Alzheimers Dis Ctr, Chicago, IL 60612 USA; [Bennett, David A.; Schneider, Julie A.] Rush Univ, Med Ctr, Dept Neurol Sci, Chicago, IL 60612 USA; [Ulrich, Jason D.; Holtzman, David M.] Washington Univ, Sch Med, Dept Neurol, Hope Ctr Neurol Disorders,Knight ADRC, St Louis, MO 63110 USA; [Zaitsev, Konstantin] ITMO Univ, Comp Technol Dept, St Petersburg, Russia	Washington University (WUSTL); University of Brescia; University of Missouri System; University of Missouri Saint Louis; University of Wisconsin System; University of Wisconsin Madison; Niigata University; Niigata University; Rush University; Rush University; Washington University (WUSTL); ITMO University	Artyomov, MN; Colonna, M (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63130 USA.	martyomov@wustl.edu; mcolonna@wustl.edu	Zhou, Yingyue/AGF-3542-2022; Cella, Marina/ABA-8564-2020; Cominelli, Manuela/J-9988-2016; Zaitsev, Konstantin/AAU-5733-2021	Cominelli, Manuela/0000-0002-4520-6104; Zaitsev, Konstantin/0000-0003-3749-0886; Ulland, Tyler/0000-0002-6507-4989; Sainouchi, Makoto/0000-0002-3451-3600; Zhou, Yingyue/0000-0002-0923-1046	Strategic Research Program for Brain Sciences from Japan Agency for Medical Research and Development, AMED; NIH [RF1 AG051485, R21 AG059176, RF1 AG059082, RF1 AG047644, R01 NS090934, R15 GM119070]; Cure Alzheimer's Fund; JPB Foundation	Strategic Research Program for Brain Sciences from Japan Agency for Medical Research and Development, AMED(Japan Agency for Medical Research and Development (AMED)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cure Alzheimer's Fund; JPB Foundation	We would like to thank K. Murphy and T. Murphy for generously providing us Irf8-overexpression constructs and Irf8<SUP>-/-</SUP> mice. We thank S. Kumar for the help with IF on human PPFE samples, and B. Zinselmeyer and B. Saunders for their help with confocal images. We thank B. Schmidt for helpful discussions. We thank I. Kawaki and the Collaborative Research Project of the BRI, Niigata University. A. Kakita is supported by the Strategic Research Program for Brain Sciences from Japan Agency for Medical Research and Development, AMED. This work was supported by the NIH (RF1 AG051485, R21 AG059176, and RF1 AG059082 to M. Colonna, RF1 AG047644 and R01 NS090934 to D.M.H., R15 GM119070 to M.R.N.), the Cure Alzheimer's Fund (to M. Colonna and D.M.H.) and the JPB Foundation (to D.M.H).	Angelova DM, 2019, J NEUROCHEM, V151, P676, DOI 10.1111/jnc.14860; Beausoleil SA, 2006, NAT BIOTECHNOL, V24, P1285, DOI 10.1038/nbt1240; Bohlen CJ, 2019, ANNU REV GENET, V53, P263, DOI 10.1146/annurev-genet-112618-043515; Butler A, 2018, NAT BIOTECHNOL, V36, P411, DOI 10.1038/nbt.4096; De Strooper B, 2016, CELL, V164, P603, DOI 10.1016/j.cell.2015.12.056; Dickey CA, 2003, J NEUROSCI, V23, P5219; Elias JE, 2010, METHODS MOL BIOL, V604, P55, DOI 10.1007/978-1-60761-444-9_5; Finak G, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0844-5; Geiss GK, 2008, NAT BIOTECHNOL, V26, P317, DOI 10.1038/nbt1385; Gjoneska E, 2015, NATURE, V518, P365, DOI 10.1038/nature14252; Gosselin D, 2017, SCIENCE, V356, DOI 10.1126/science.aal3222; Gouwens LK, 2018, ACS CHEM NEUROSCI, V9, P1416, DOI 10.1021/acschemneuro.8b00029; Griciuc A, 2013, NEURON, V78, P631, DOI 10.1016/j.neuron.2013.04.014; Han PC, 2015, JAMA NEUROL, V72, P333, DOI 10.1001/jamaneurol.2014.3625; Harboe M, 2018, GLIA, V66, P934, DOI 10.1002/glia.23293; Heneka MT, 2015, NAT IMMUNOL, V16, P229, DOI 10.1038/ni.3102; Hong S, 2016, SCIENCE, V352, P712, DOI 10.1126/science.aad8373; Huttlin EL, 2010, CELL, V143, P1174, DOI 10.1016/j.cell.2010.12.001; Ioannou MS, 2019, CELL, V177, P1522, DOI 10.1016/j.cell.2019.04.001; Jakel S, 2019, NATURE, V566, P543, DOI 10.1038/s41586-019-0903-2; Jay TR, 2015, J EXP MED, V212, P287, DOI 10.1084/jem.20142322; KAMBOH MI, 1995, NAT GENET, V10, P486, DOI 10.1038/ng0895-486; Keren-Shaul H, 2017, CELL, V169, P1276, DOI 10.1016/j.cell.2017.05.018; Krasemann S, 2017, IMMUNITY, V47, P566, DOI 10.1016/j.immuni.2017.08.008; Liddelow SA, 2017, NATURE, V541, P481, DOI 10.1038/nature21029; Long JM, 2019, CELL, V179, P312, DOI 10.1016/j.cell.2019.09.001; MA JY, 1994, NATURE, V372, P92, DOI 10.1038/372092a0; Masuda T, 2019, NATURE, V566, P388, DOI 10.1038/s41586-019-0924-x; Masuda T, 2012, CELL REP, V1, P334, DOI 10.1016/j.celrep.2012.02.014; Mathys H, 2019, NATURE, V570, P332, DOI 10.1038/s41586-019-1195-2; Mathys H, 2017, CELL REP, V21, P366, DOI 10.1016/j.celrep.2017.09.039; McAlister GC, 2014, ANAL CHEM, V86, P7150, DOI 10.1021/ac502040v; McAlister GC, 2012, ANAL CHEM, V84, P7469, DOI 10.1021/ac301572t; McKeon RJ, 1999, J NEUROSCI, V19, P10778, DOI 10.1523/JNEUROSCI.19-24-10778.1999; Mecollari V, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00328; Molinuevo JL, 2018, ACTA NEUROPATHOL, V136, P821, DOI 10.1007/s00401-018-1932-x; Mucke L, 2000, AM J PATHOL, V157, P2003, DOI 10.1016/S0002-9440(10)64839-0; Nilsson LNG, 2001, J NEUROSCI, V21, P1444, DOI 10.1523/JNEUROSCI.21-05-01444.2001; Oakley H, 2006, J NEUROSCI, V26, P10129, DOI 10.1523/JNEUROSCI.1202-06.2006; Olah M, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-02926-5; Richter-Landsberg C, 2008, J MOL NEUROSCI, V35, P55, DOI 10.1007/s12031-007-9017-7; Rothhammer V, 2018, NATURE, V557, P724, DOI 10.1038/s41586-018-0119-x; Schultz CC, 2014, PSYCHOL MED, V44, P811, DOI 10.1017/S0033291713001414; Seyfried NT, 2017, CELL SYST, V4, P60, DOI 10.1016/j.cels.2016.11.006; Song WM, 2018, J EXP MED, V215, P745, DOI 10.1084/jem.20171529; Stine WB, 2011, METHODS MOL BIOL, V670, P13, DOI 10.1007/978-1-60761-744-0_2; Tozaki-Saitoh H, 2019, GLIA, V67, P729, DOI 10.1002/glia.23570; Ulland TK, 2018, NAT REV NEUROL, V14, P667, DOI 10.1038/s41582-018-0072-1; Vardarajan BN, 2015, ANN NEUROL, V77, P215, DOI 10.1002/ana.24305; Wang HB, 2017, DEV CELL, V40, P566, DOI 10.1016/j.devcel.2017.03.001; Wang L, 2012, P NATL ACAD SCI USA, V109, P16743, DOI 10.1073/pnas.1208011109; Wang YM, 2016, J EXP MED, V213, P667, DOI 10.1084/jem.20151948; Wang YM, 2015, CELL, V160, P1061, DOI 10.1016/j.cell.2015.01.049; Winkler C, 2014, BRIT J PHARMACOL, V171, P905, DOI 10.1111/bph.12462; Yuan P, 2016, NEURON, V90, P724, DOI 10.1016/j.neuron.2016.05.003; Zhang PS, 2019, NAT NEUROSCI, V22, P719, DOI 10.1038/s41593-019-0372-9; Zhou YY, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09234-6	57	285	292	23	114	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JAN	2020	26	1					131	+		10.1038/s41591-019-0695-9	http://dx.doi.org/10.1038/s41591-019-0695-9			30	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	KG3GZ	31932797	Green Accepted			2022-12-27	WOS:000509831900036
J	Segovia-Miranda, F; Morales-Navarrete, H; Kucken, M; Moser, V; Seifert, S; Repnik, U; Rost, F; Brosch, M; Hendricks, A; Hinz, S; Rocken, C; Lutjohann, D; Kalaidzidis, Y; Schafmayer, C; Brusch, L; Hampe, J; Zerial, M				Segovia-Miranda, Fabian; Morales-Navarrete, Hernan; Kuecken, Michael; Moser, Vincent; Seifert, Sarah; Repnik, Urska; Rost, Fabian; Brosch, Mario; Hendricks, Alexander; Hinz, Sebastian; Roecken, Christoph; Luetjohann, Dieter; Kalaidzidis, Yannis; Schafmayer, Clemens; Brusch, Lutz; Hampe, Jochen; Zerial, Marino			Three-dimensional spatially resolved geometrical and functional models of human liver tissue reveal new aspects of NAFLD progression	NATURE MEDICINE			English	Article							NONALCOHOLIC STEATOHEPATITIS; URSODEOXYCHOLIC ACID; IMAGE-ANALYSIS; BILE-ACIDS; DISEASE; BILIARY; CHROMATIN; BIOPSY; FLOW; PATHOGENESIS	Early disease diagnosis is key to the effective treatment of diseases. Histopathological analysis of human biopsies is the gold standard to diagnose tissue alterations. However, this approach has low resolution and overlooks 3D (three-dimensional) structural changes resulting from functional alterations. Here, we applied multiphoton imaging, 3D digital reconstructions and computational simulations to generate spatially resolved geometrical and functional models of human liver tissue at different stages of non-alcoholic fatty liver disease (NAFLD). We identified a set of morphometric cellular and tissue parameters correlated with disease progression, and discover profound topological defects in the 3D bile canalicular (BC) network. Personalized biliary fluid dynamic simulations predicted an increased pericentral biliary pressure and micro-cholestasis, consistent with elevated cholestatic biomarkers in patients' sera. Our spatially resolved models of human liver tissue can contribute to high-definition medicine by identifying quantitative multiparametric cellular and tissue signatures to define disease progression and provide new insights into NAFLD pathophysiology.	[Segovia-Miranda, Fabian; Morales-Navarrete, Hernan; Seifert, Sarah; Repnik, Urska; Kalaidzidis, Yannis; Zerial, Marino] Max Planck Inst Mol Cell Biol & Genet, Dresden, Germany; [Kuecken, Michael; Rost, Fabian; Brusch, Lutz] Tech Univ Dresden, Ctr Informat Serv & High Performance Comp, Dresden, Germany; [Moser, Vincent; Brosch, Mario; Hampe, Jochen] Tech Univ Dresden TU Dresden, Univ Hosp Carl Gustav Carus, Dept Med Gastroenterol & Hepatol 1, Dresden, Germany; [Rost, Fabian] Max Planck Inst Phys Komplexer Syst, Dresden, Germany; [Brosch, Mario; Hampe, Jochen] Tech Univ Dresden TU Dresden, CRTD, Dresden, Germany; [Hendricks, Alexander; Hinz, Sebastian; Schafmayer, Clemens] Univ Hosp Rostock, Dept Gen Surg, Rostock, Germany; [Roecken, Christoph] Univ Hosp Schleswig Holstein, Kiel, Germany; [Luetjohann, Dieter] Univ Hosp Bonn, Inst Clin Chem & Clin Pharmacol, Bonn, Germany; [Kalaidzidis, Yannis] Moscow MV Lomonosov State Univ, Fac Bioengn & Bioinformat, Moscow, Russia	Max Planck Society; Technische Universitat Dresden; Technische Universitat Dresden; Carl Gustav Carus University Hospital; Max Planck Society; Technische Universitat Dresden; University of Rostock; University of Kiel; Schleswig Holstein University Hospital; University of Bonn; Lomonosov Moscow State University	Zerial, M (corresponding author), Max Planck Inst Mol Cell Biol & Genet, Dresden, Germany.; Hampe, J (corresponding author), Tech Univ Dresden TU Dresden, Univ Hosp Carl Gustav Carus, Dept Med Gastroenterol & Hepatol 1, Dresden, Germany.; Hampe, J (corresponding author), Tech Univ Dresden TU Dresden, CRTD, Dresden, Germany.	jochen.hampe@uniklinikum-dresden.de; zerial@mpi-cbg.de	Hampe, Jochen/A-2555-2010; Kalaidzidis, Yannis/H-3094-2016; Morales-Navarrete, Hernan/AAE-2316-2019; Röcken, Christoph/A-9239-2010	Hampe, Jochen/0000-0002-2421-6127; Kalaidzidis, Yannis/0000-0002-6137-1193; Morales-Navarrete, Hernan/0000-0002-9578-2556; Röcken, Christoph/0000-0002-6989-8002; Rost, Fabian/0000-0001-6466-2589; PD Dr. Hinz, Sebastian/0000-0001-9350-9196	German Federal Ministry of Education and Research (BMBF) [031L0038, 031L0033, 031L0031, 031L0082B, 031L008A, 031L0044]; European Research Council (ERC) [695646]; Max Planck Society (MPG)	German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); European Research Council (ERC)(European Research Council (ERC)); Max Planck Society (MPG)(Max Planck Society)	We are grateful to O. Ostrenko, J. Francisco Miquel Poblete and S. Nehring for fruitful discussions, and S. Bundschuh for helping setting up the multiphoton microscope. We thank the Center for Information Services and High Performance Computing (ZIH) of the TU Dresden for the generous provision of computing power. We would also like to thank the following Services and Facilities of the Max Planck Institute of Molecular Cell Biology and Genetics for their support: Light Microscopy Facility (LMF) and the Electron Microscopy Facility. This work was financially supported by the German Federal Ministry of Education and Research (BMBF) (LiSyM, grant no. 031L0038 to M.Z.; grant no. 031L0033 to L.B.; grant no. 031L0031 to J.H.; DYNAFLOW, grant no. 031L0082B to M.Z.; grant no. 031L008A to L.B.; and SYSBIO II, grant no. 031L0044 to M.Z.), European Research Council (ERC) (grant no. 695646 to M.Z.) and the Max Planck Society (MPG).	Ahishali E, 2010, J GASTROEN HEPATOL, V25, P619, DOI 10.1111/j.1440-1746.2009.06142.x; Allwein E. L., 2000, J MACHINE LEARNING R, V1, P113, DOI DOI 10.1162/15324430152733133; Amalou H, 2012, NAT REV GASTRO HEPAT, V9, P683, DOI 10.1038/nrgastro.2012.100-c1; Arab JP, 2017, HEPATOLOGY, V65, P350, DOI 10.1002/hep.28709; Aranha MM, 2008, EUR J GASTROEN HEPAT, V20, P519, DOI 10.1097/MEG.0b013e3282f4710a; Aravinthan A, 2012, J CLIN PATHOL, V65, P557, DOI 10.1136/jclinpath-2011-200641; Ricci MA, 2017, CURR OPIN GENET DEV, V46, P186, DOI 10.1016/j.gde.2017.07.010; Bartels PH, 1998, ANAL QUANT CYTOL, V20, P407; Bedossa P, 2017, LIVER INT, V37, P85, DOI 10.1111/liv.13301; Brosch M, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06611-5; CARLSON E, 1977, AM J PATHOL, V86, P301; Carman PC, 1997, CHEM ENG RES DES, V75, pS32, DOI 10.1016/S0263-8762(97)80003-2; Chalasani N, 2008, J HEPATOL, V48, P829, DOI 10.1016/j.jhep.2008.01.016; Chan Ting-Ting, 2016, Clin Liver Dis (Hoboken), V8, P19, DOI 10.1002/cld.563; Chow MD, 2017, MOL ASPECTS MED, V56, P34, DOI 10.1016/j.mam.2017.04.004; COLEMAN R, 1979, BIOCHEM J, V178, P201, DOI 10.1042/bj1780201; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; CSENDES A, 1979, GASTROENTEROLOGY, V77, P1203; Day CP, 1998, HEPATOLOGY, V27, P1463, DOI 10.1002/hep.510270601; Debbaut C, 2014, COMPUT METHOD BIOMEC, V17, P1295, DOI 10.1080/10255842.2012.744399; Debbaut C, 2012, J BIOMECH ENG-T ASME, V134, DOI 10.1115/1.4005545; Donner MG, 2001, HEPATOLOGY, V34, P351, DOI 10.1053/jhep.2001.26213; Doube M, 2010, BONE, V47, P1076, DOI 10.1016/j.bone.2010.08.023; Dzierlenga AL, 2018, J BIOCHEM MOL TOXIC, V32, DOI 10.1002/jbt.22035; ELIAS H, 1949, AM J ANAT, V85, P379, DOI 10.1002/aja.1000850303; Felmlee DJ, 2018, HEPATOLOGY, V67, P784, DOI 10.1002/hep.29554; Ferslew BC, 2015, DIGEST DIS SCI, V60, P3318, DOI 10.1007/s10620-015-3776-8; Fischer S, 2004, EUR J GASTROEN HEPAT, V16, P305; Friedman SL, 2018, NAT MED, V24, P908, DOI 10.1038/s41591-018-0104-9; Hagerling R, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.93424; Hall A, 2017, SCI REP-UK, V7, DOI 10.1038/srep40977; Hamilton PW, 2014, METHODS, V70, P59, DOI 10.1016/j.ymeth.2014.06.015; HARALICK RM, 1973, IEEE T SYST MAN CYB, VSMC3, P610, DOI 10.1109/TSMC.1973.4309314; Hardwick RN, 2011, DRUG METAB DISPOS, V39, P2395, DOI 10.1124/dmd.111.041012; Hardy T, 2016, ANNU REV PATHOL-MECH, V11, P451, DOI 10.1146/annurev-pathol-012615-044224; Ho KJ, 1996, DIGEST DIS SCI, V41, P2409, DOI 10.1007/BF02100136; Hu JR, 2017, ACTA MECH SINICA-PRC, V33, P823, DOI 10.1007/s10409-017-0674-7; Jahn D, 2018, HEPATOLOGY, V67, P464, DOI 10.1002/hep.29543; Jansen PLM, 2018, HEPATOLOGY, V67, P1624, DOI 10.1002/hep.29618; Jansen PLM, 2017, HEPATOLOGY, V65, P722, DOI 10.1002/hep.28965; Jorgensen T, 1996, CYTOMETRY, V24, P277, DOI 10.1002/(SICI)1097-0320(19960701)24:3<277::AID-CYTO11>3.0.CO;2-N; Kipp H, 2001, J BIOL CHEM, V276, P7218, DOI 10.1074/jbc.M007794200; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Kochan K, 2015, J BIOPHOTONICS, V8, P597, DOI 10.1002/jbio.201400077; Levene AP, 2010, HISTOPATHOLOGY, V56, P426, DOI 10.1111/j.1365-2559.2010.03501.x; Luo XY, 2007, WORLD J GASTROENTERO, V13, P1384, DOI 10.3748/wjg.v13.i9.1384; Lutjohann D, 2004, INT J CLIN PHARM TH, V42, P307; Marinelli RA, 2003, J BIOL CHEM, V278, P43157, DOI 10.1074/jbc.M305899200; Menshykau D, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-08212-8; Meyer K, 2017, CELL SYST, V4, P277, DOI 10.1016/j.cels.2017.02.008; Mills S.E., 2012, HISTOLOGY PATHOLOGIS, P309; Morales-Navarrete H., 2019, ELIFE, V8, P1035; Morales-Navarrete H., 2015, ELIFE, V4, P841; Morales-Navarrete H, 2016, I S BIOMED IMAGING, P536, DOI 10.1109/ISBI.2016.7493325; Nalbantoglu I, 2014, WORLD J GASTROENTERO, V20, P9026, DOI 10.3748/wjg.v20.i27.9026; Orr JA, 2007, ANAL QUANT CYTOL, V29, P17; Ostrenko O, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-40853-7; Piergiovanni M, 2017, J BIOMECH, V63, P125, DOI 10.1016/j.jbiomech.2017.08.011; Pollock G, 2017, J GASTROEN HEPATOL, V32, P1303, DOI 10.1111/jgh.13738; Preibisch S, 2009, BIOINFORMATICS, V25, P1463, DOI 10.1093/bioinformatics/btp184; Puri P, 2018, HEPATOLOGY, V67, P534, DOI 10.1002/hep.29359; Rademaker H, 2017, PHYS REV E, V95, DOI 10.1103/PhysRevE.95.042402; Retico A, 2015, J NEUROIMAGING, V25, P552, DOI 10.1111/jon.12163; Richardson DS, 2015, CELL, V162, P246, DOI 10.1016/j.cell.2015.06.067; Sabersky RH., 1971, FLUID FLOW 1 COURSE; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Starruy J, 2014, BIOINFORMATICS, V30, P1331, DOI 10.1093/bioinformatics/btt772; Steinacher D, 2017, DIGEST DIS, V35, P282, DOI 10.1159/000454853; Tainaka K, 2016, ANNU REV CELL DEV BI, V32, P713, DOI 10.1146/annurev-cellbio-111315-125001; Takahashi Y, 2014, WORLD J GASTROENTERO, V20, P15539, DOI 10.3748/wjg.v20.i42.15539; Tanaka N, 2017, NAT BIOMED ENG, V1, P796, DOI 10.1038/s41551-017-0139-0; Torkamani A, 2017, CELL, V170, P828, DOI 10.1016/j.cell.2017.08.007; Trauner M, 1998, NEW ENGL J MED, V339, P1217, DOI 10.1056/NEJM199810223391707; Treyer A, 2013, COMPR PHYSIOL, V3, P243, DOI 10.1002/cphy.c120009; Wakabayashi Y, 2005, P NATL ACAD SCI USA, V102, P15087, DOI 10.1073/pnas.0503702102; Walther TC, 2017, ANNU REV CELL DEV BI, V33, P491, DOI 10.1146/annurev-cellbio-100616-060608; Wang L, 2004, HEPATOLOGY, V39, P892, DOI 10.1002/hep.20039; Wang MJ, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.167; Wattacheril J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057165; Wieckowska A, 2006, HEPATOLOGY, V44, P27, DOI 10.1002/hep.21223	80	30	30	1	29	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	2019	25	12					1885	+		10.1038/s41591-019-0660-7	http://dx.doi.org/10.1038/s41591-019-0660-7			21	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	JT2KO	31792455	Green Submitted, Green Accepted			2022-12-27	WOS:000500824900032
J	Schubert, RD; Hawes, IA; Ramachandran, PS; Ramesh, A; Crawford, ED; Pak, JE; Wu, W; Cheung, CK; O'Donovan, BD; Tato, CM; Lyden, A; Tan, M; Sit, R; Sowa, GA; Sample, HA; Zorn, KC; Banerji, D; Khan, LM; Bove, R; Hauser, SL; Gelfand, AA; Johnson-Kerner, BL; Nash, K; Krishnamoorthy, KS; Chitnis, T; Ding, JZ; McMillan, HJ; Chiu, CY; Briggs, B; Glaser, CA; Yen, C; Chu, V; Wadford, DA; Dominguez, SR; Ng, TFF; Marine, RL; Lopez, AS; Nix, WA; Soldatos, A; Gorman, MP; Benson, L; Messacar, K; Konopka-Anstadt, JL; Oberste, MS; DeRisi, JL; Wilson, MR				Schubert, Ryan D.; Hawes, Isobel A.; Ramachandran, Prashanth S.; Ramesh, Akshaya; Crawford, Emily D.; Pak, John E.; Wu, Wesley; Cheung, Carly K.; O'Donovan, Brian D.; Tato, Cristina M.; Lyden, Amy; Tan, Michelle; Sit, Rene; Sowa, Gavin A.; Sample, Hannah A.; Zorn, Kelsey C.; Banerji, Debarko; Khan, Lillian M.; Bove, Riley; Hauser, Stephen L.; Gelfand, Amy A.; Johnson-Kerner, Bethany L.; Nash, Kendall; Krishnamoorthy, Kalpathy S.; Chitnis, Tanuja; Ding, Joy Z.; McMillan, Hugh J.; Chiu, Charles Y.; Briggs, Benjamin; Glaser, Carol A.; Yen, Cynthia; Chu, Victoria; Wadford, Debra A.; Dominguez, Samuel R.; Ng, Terry Fei Fan; Marine, Rachel L.; Lopez, Adriana S.; Nix, W. Allan; Soldatos, Ariane; Gorman, Mark P.; Benson, Leslie; Messacar, Kevin; Konopka-Anstadt, Jennifer L.; Oberste, M. Steven; DeRisi, Joseph L.; Wilson, Michael R.			Pan-viral serology implicates enteroviruses in acute flaccid myelitis	NATURE MEDICINE			English	Article							UNITED-STATES; D68; CHILDREN; ANTIBODIES; CALIFORNIA; COLORADO; USA	Since 2012, the United States of America has experienced a biennial spike in pediatric acute flaccid myelitis (AFM)(1-6). Epidemiologic evidence suggests non-polio enteroviruses (EVs) are a potential etiology, yet EV RNA is rarely detected in cerebrospinal fluid (CSF)(2). CSF from children with AFM (n = 42) and other pediatric neurologic disease controls (n = 58) were investigated for intrathecal antiviral antibodies, using a phage display library expressing 481,966 overlapping peptides derived from all known vertebrate and arboviruses (VirScan). Metagenomic next-generation sequencing (mNGS) of AFM CSF RNA (n = 20 cases) was also performed, both unbiased sequencing and with targeted enrichment for EVs. Using VirScan, the viral family significantly enriched by the CSF of AFM cases relative to controls was Picornaviridae, with the most enriched Picornaviridae peptides belonging to the genus Enterovirus (n = 29/42 cases versus 4/58 controls). EV VP1 ELISA confirmed this finding (n = 22/26 cases versus 7/50 controls). mNGS did not detect additional EV RNA. Despite rare detection of EV RNA, pan-viral serology frequently identified high levels of CSF EV-specific antibodies in AFM compared with controls, providing further evidence for a causal role of non-polio EVs in AFM.	[Schubert, Ryan D.; Hawes, Isobel A.; Ramachandran, Prashanth S.; Ramesh, Akshaya; Bove, Riley; Hauser, Stephen L.; Gelfand, Amy A.; Johnson-Kerner, Bethany L.; Nash, Kendall; Wilson, Michael R.] Univ Calif San Francisco, Weill Inst Neurosci, San Francisco, CA 94143 USA; [Schubert, Ryan D.; Hawes, Isobel A.; Ramachandran, Prashanth S.; Ramesh, Akshaya; Banerji, Debarko; Bove, Riley; Hauser, Stephen L.; Gelfand, Amy A.; Johnson-Kerner, Bethany L.; Nash, Kendall; Wilson, Michael R.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; [Crawford, Emily D.; Pak, John E.; Wu, Wesley; Cheung, Carly K.; Tato, Cristina M.; Lyden, Amy; Tan, Michelle; Sit, Rene; DeRisi, Joseph L.] Chan Zuckerberg Biohub, San Francisco, CA USA; [Crawford, Emily D.] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA; [O'Donovan, Brian D.; Sample, Hannah A.; Zorn, Kelsey C.; Khan, Lillian M.; DeRisi, Joseph L.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA USA; [Sowa, Gavin A.] Univ Calif San Francisc, Sch Med, San Francisco, CA USA; [Krishnamoorthy, Kalpathy S.; Chitnis, Tanuja] Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA; [Chitnis, Tanuja] Brigham & Womens Hosp, Dept Neurol, 75 Francis St, Boston, MA 02115 USA; [Ding, Joy Z.; McMillan, Hugh J.] Univ Ottawa, Childrens Hosp Eastern Ontario, Div Neurol, Ottawa, ON, Canada; [Chiu, Charles Y.] Univ Calif San Francisco, Div Infect Dis, Dept Lab Med & Med, San Francisco, CA 94143 USA; [Briggs, Benjamin] Univ Calif San Francisco, Dept Pediat, Div Infect Dis, San Francisco, CA USA; [Glaser, Carol A.] Kaiser Permanente Oakland Med Ctr, Dept Pediat Infect Dis, Oakland, CA USA; [Yen, Cynthia; Chu, Victoria; Wadford, Debra A.] Calif Dept Publ Hlth, Div Communicable Dis Control, Richmond, CA USA; [Dominguez, Samuel R.; Messacar, Kevin] Univ Colorado, Sch Med, Childrens Hosp Colorado, Aurora, CO USA; [Dominguez, Samuel R.; Messacar, Kevin] Univ Colorado, Sch Med, Dept Pediat, Aurora, CO USA; [Ng, Terry Fei Fan; Marine, Rachel L.; Lopez, Adriana S.; Nix, W. Allan; Konopka-Anstadt, Jennifer L.; Oberste, M. Steven] Ctr Dis Control & Prevent, Div Viral Dis, Atlanta, GA USA; [Soldatos, Ariane] NINDS, NIH, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA; [Gorman, Mark P.; Benson, Leslie] Boston Childrens Hosp, Dept Neurol, Boston, MA USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Harvard University; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital; University of Ottawa; Children's Hospital of Eastern Ontario; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Kaiser Permanente; California Department of Public Health; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; Centers for Disease Control & Prevention - USA; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); Harvard University; Boston Children's Hospital	Wilson, MR (corresponding author), Univ Calif San Francisco, Weill Inst Neurosci, San Francisco, CA 94143 USA.; Wilson, MR (corresponding author), Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA.	michael.wilson@ucsf.edu	McMillan, Hugh/AAA-1989-2021; Ramesh, Akshaya/GWR-3496-2022; Ng, Terry Fei Fan/H-5305-2019	McMillan, Hugh/0000-0001-8927-2018; Ng, Terry Fei Fan/0000-0002-4815-8697; Tato, Cristina M./0000-0002-0614-756X; Hawes, Isobel/0000-0003-1719-0114; Crawford, Emily/0000-0003-4182-2337; Wilson, Michael/0000-0002-8705-5084; Schubert, Ryan/0000-0002-3132-5831; Gelfand, Amy/0000-0002-0911-7905; Wadford, Debra/0000-0002-8630-427X; Marine, Rachel/0000-0002-3875-2959; Konopka-Anstadt, Jennifer/0000-0002-4062-5350; Sample, Hannah/0000-0002-5398-3907; Messacar, Kevin/0000-0001-5830-3491; Sowa, Gavin/0000-0002-2089-8116; soldatos, ariane/0000-0003-3570-5230	National Multiple Sclerosis Society-American Brain Foundation [FAN-1608-25607]; UCSF Biomedical Sciences Graduate Program; American Academy of Neurology [P0534134]; University of California, San Francisco (UCSF) Dean's Office Medical Student Research Program; UCSF Bioinformatics Graduate Program; NIH [K08NS096117, K23AI28069]; Chan Zuckerberg Biohub; Rachleff family; Sandler Foundation; William K. Bowes, Jr. Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K23AI128069] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R35NS111644, K08NS096117] Funding Source: NIH RePORTER	National Multiple Sclerosis Society-American Brain Foundation; UCSF Biomedical Sciences Graduate Program; American Academy of Neurology; University of California, San Francisco (UCSF) Dean's Office Medical Student Research Program; UCSF Bioinformatics Graduate Program; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Chan Zuckerberg Biohub; Rachleff family; Sandler Foundation; William K. Bowes, Jr. Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work is supported by a National Multiple Sclerosis Society-American Brain Foundation Clinician Scientist Development Award (no. FAN-1608-25607 to R.D.S.), the UCSF Biomedical Sciences Graduate Program (to I.A.H.), an American Academy of Neurology Clinical Research Training Scholarship (no. P0534134 to P.S.R.), the University of California, San Francisco (UCSF) Dean's Office Medical Student Research Program (G.A.S.), UCSF Bioinformatics Graduate Program (B.O.), NIH grant nos. K08NS096117 (to M.R.W.) and K23AI28069 (to K.M.), the Chan Zuckerberg Biohub (J.L.D., C.M.T., J.E.P., E.D.C., W.W., C.K.C., A.L., M.T. and R.S.), an endowment from the Rachleff family (to M.R.W.), and the Sandler and William K. Bowes, Jr. Foundations (M.R.W., K.C.Z., H.A.S., C.Y.C., L.M.K., B.O. and J.L.D.). We thank H. Sandler, W. Bowes, Jr., and D. and A. Rachleff for their encouragement. We thank the patients and their families for their participation in this study.	Aliabadi N, 2016, EMERG INFECT DIS, V22, P1387, DOI 10.3201/eid2208.151949; [Anonymous], 2018, REV STAND SURV CAS D; Ayscue P, 2014, MMWR-MORBID MORTAL W, V63, P903; Baker SC, 2005, NAT METHODS, V2, P731, DOI 10.1038/nmeth1005-731; Centers for Disease Control and Prevention, AFM CONF US CAS; Chabierski S, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-246; Dyda A, 2018, EUROSURVEILLANCE, V23, P16, DOI 10.2807/1560-7917.ES.2018.23.3.17-00310; Gao F, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-26; Gilden D, 2009, LANCET NEUROL, V8, P731, DOI 10.1016/S1474-4422(09)70134-6; Greninger AL, 2015, LANCET INFECT DIS, V15, P671, DOI 10.1016/S1473-3099(15)70093-9; Gu W, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0904-5; Hixon AM, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006199; Iverson SA, 2017, MMWR-MORBID MORTAL W, V66, P758, DOI 10.15585/mmwr.mm6628a4; Jubelt B, 2014, HAND CLINIC, V123, P379, DOI 10.1016/B978-0-444-53488-0.00018-3; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Mandel-Brehm C, 2019, NEW ENGL J MED, V381, P47, DOI 10.1056/NEJMoa1816721; Mayday MY, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0206194; Mckay SL, 2018, MMWR-MORBID MORTAL W, V67, P1273, DOI 10.15585/mmwr.mm6745e1; Messacar K, 2019, J CLIN VIROL, V113, P24, DOI 10.1016/j.jcv.2019.01.008; Messacar K, 2019, JAMA-J AM MED ASSOC, V321, P831, DOI 10.1001/jama.2019.1016; Messacar K, 2018, MMWR-MORBID MORTAL W, V67, P1017, DOI 10.15585/mmwr.mm6736a5; Messacar K, 2018, LANCET INFECT DIS, V18, pE239, DOI 10.1016/S1473-3099(18)30094-X; Messacar K, 2016, ANN NEUROL, V80, P326, DOI 10.1002/ana.24730; Mishra N, 2019, MBIO, V10, DOI 10.1128/mBio.01903-19; Moline H, 2019, MMWR-MORBID MORTAL W, V68, P356, DOI 10.15585/mmwr.mm6815a4; O'Donovan B, 2018, BIORXIV, DOI [10.1101/502187, DOI 10.1101/502187]; Pou C, 2019, NAT MED, V25, P591, DOI 10.1038/s41591-019-0392-8; Pruss H, 2012, ANN NEUROL, V72, P902, DOI 10.1002/ana.23689; Quan J, 2019, NUCLEIC ACIDS RES, V47, DOI 10.1093/nar/gkz418; Ramachandran PS, 2018, NEUROL CLIN, V36, P687, DOI 10.1016/j.ncl.2018.07.004; Ramesh A, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0218318; SAMUELSON A, 1994, CLIN DIAGN LAB IMMUN, V1, P336, DOI 10.1128/CDLI.1.3.336-341.1994; Sejvar JJ, 2016, CLIN INFECT DIS, V63, P737, DOI 10.1093/cid/ciw372; Van Haren K, 2015, JAMA-J AM MED ASSOC, V314, P2663, DOI 10.1001/jama.2015.17275; Xu GJ, 2015, SCIENCE, V348, DOI 10.1126/science.aaa0698; Zhang JJ, 2014, BIOINFORMATICS, V30, P614, DOI 10.1093/bioinformatics/btt593	36	53	53	0	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2019	25	11					1748	+		10.1038/s41591-019-0613-1	http://dx.doi.org/10.1038/s41591-019-0613-1			15	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	JT2KI	31636453	Green Submitted, Green Accepted			2022-12-27	WOS:000500824300034
J	Stower, H				Stower, Hannah			The Huntington's mutation implicated in early development	NATURE MEDICINE			English	Editorial Material												h.stower@us.nature.com							0	0	0	0	0	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	SEP	2020	26	9					1331	1331		10.1038/s41591-020-1068-0	http://dx.doi.org/10.1038/s41591-020-1068-0			1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	PF3EM	32908281				2022-12-27	WOS:000598942000013
J	Stower, H				Stower, Hannah			A future boost for anti-PD1 responses	NATURE MEDICINE			English	Editorial Material												h.stower@us.nature.com							0	0	0	0	2	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	SEP	2020	26	9					1331	1331		10.1038/s41591-020-1065-3	http://dx.doi.org/10.1038/s41591-020-1065-3			1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	PF3EM	32908280				2022-12-27	WOS:000598942000015
J	Budd, J; Miller, BS; Manning, EM; Lampos, V; Zhuang, MD; Edelstein, M; Rees, G; Emery, VC; Stevens, MM; Keegan, N; Short, MJ; Pillay, D; Manley, E; Cox, IJ; Heymann, D; Johnson, AM; McKendry, RA				Budd, Jobie; Miller, Benjamin S.; Manning, Erin M.; Lampos, Vasileios; Zhuang, Mengdie; Edelstein, Michael; Rees, Geraint; Emery, Vincent C.; Stevens, Molly M.; Keegan, Neil; Short, Michael J.; Pillay, Deenan; Manley, Ed; Cox, Ingemar J.; Heymann, David; Johnson, Anne M.; McKendry, Rachel A.			Digital technologies in the public-health response to COVID-19	NATURE MEDICINE			English	Review							SURVEILLANCE; DISEASES	Digital technologies are being harnessed to support the public-health response to COVID-19 worldwide, including population surveillance, case identification, contact tracing and evaluation of interventions on the basis of mobility data and communication with the public. These rapid responses leverage billions of mobile phones, large online datasets, connected devices, relatively low-cost computing resources and advances in machine learning and natural language processing. This Review aims to capture the breadth of digital innovations for the public-health response to COVID-19 worldwide and their limitations, and barriers to their implementation, including legal, ethical and privacy barriers, as well as organizational and workforce barriers. The future of public health is likely to become increasingly digital, and we review the need for the alignment of international strategies for the regulation, evaluation and use of digital technologies to strengthen pandemic management, and future preparedness for COVID-19 and other infectious diseases. The COVID-19 pandemic has resulted in an accelerated development of applications for digital health, including symptom monitoring and contact tracing. Their potential is wide ranging and must be integrated into conventional approaches to public health for best effect.	[Budd, Jobie; Miller, Benjamin S.; Manning, Erin M.; McKendry, Rachel A.] UCL, London Ctr Nanotechnol, London, England; [Budd, Jobie; McKendry, Rachel A.] UCL, Div Med, London, England; [Lampos, Vasileios; Cox, Ingemar J.] UCL, Dept Comp Sci, London, England; [Zhuang, Mengdie] UCL, Ctr Adv Spatial Anal, London, England; [Edelstein, Michael] Ctr Global Secur, Chatham House, London, England; [Rees, Geraint] UCL, Fac Life Sci, London, England; [Emery, Vincent C.] Univ Surrey, Dept Microbial Sci, Guildford, Surrey, England; [Stevens, Molly M.] Imperial Coll London, Dept Mat, London, England; [Stevens, Molly M.] Imperial Coll London, Dept Bioengn, London, England; [Keegan, Neil] Newcastle Univ, Translat & Clin Res Inst, Newcastle, England; [Short, Michael J.] UCL, Dept Int Trade, London, England; [Pillay, Deenan] UCL, Div Infect & Immun, London, England; [Manley, Ed] Univ Leeds, Sch Geog, Leeds, W Yorkshire, England; [Cox, Ingemar J.] Univ Copenhagen, Dept Comp Sci, Copenhagen, Denmark; [Heymann, David] London Sch Hyg & Trop Med, London, England; [Johnson, Anne M.] UCL, Inst Global Hlth, London, England	University of London; University College London; University of London; University College London; University of London; University College London; University of London; University College London; University of London; University College London; University of Surrey; Imperial College London; Imperial College London; Newcastle University - UK; University of London; University College London; University of London; University College London; University of Leeds; University of Copenhagen; University of London; London School of Hygiene & Tropical Medicine; University of London; University College London	McKendry, RA (corresponding author), UCL, London Ctr Nanotechnol, London, England.; McKendry, RA (corresponding author), UCL, Div Med, London, England.	r.a.mckendry@ucl.ac.uk	Edelstein, Michael/GQY-7219-2022; Rees, Geraint/C-1493-2008; Emery, Vincent/G-8928-2013	Edelstein, Michael/0000-0002-7323-0806; Rees, Geraint/0000-0002-9623-7007; Lampos, Vasileios/0000-0001-8555-2063; Stevens, Molly/0000-0002-7335-266X; Miller, Benjamin/0000-0003-3032-018X; Johnson, Anne/0000-0003-1330-7100; Emery, Vincent/0000-0001-5893-9756; Zhuang, Mengdie/0000-0002-4546-1033; Manley, Ed/0000-0002-8904-0513	EPSRC [EP/R00529X/1]; Google; Microsoft; Telefonica; IRC Next Steps Plus: Ultra-Sensitive Enhanced NanoSensing of Anti-Microbial Resistance (u-sense) [EP/R018391/1]; NIHR; Wellcome Trust; CRUK; EPSRC/MRC/UKRI; H2020; ERC; EPSRC [EP/R018391/1, EP/K031953/1] Funding Source: UKRI; MRC [MC_PC_19070] Funding Source: UKRI	EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Google(Google Incorporated); Microsoft(Microsoft); Telefonica; IRC Next Steps Plus: Ultra-Sensitive Enhanced NanoSensing of Anti-Microbial Resistance (u-sense); NIHR(National Institute for Health Research (NIHR)); Wellcome Trust(Wellcome Trust); CRUK(Cancer Research UK); EPSRC/MRC/UKRI(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); H2020; ERC(European Research Council (ERC)European Commission); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	A.M.J., I.J.C., V.C.E., B.S.M., E.M.M., D.P., M.M.S., N.K. and R.A.M. received funding from the EPSRC for i-sense IRC in Agile Early Warning Sensing Systems for Infectious Diseases and AMR (EP/R00529X/1), and collaborate with Google, Microsoft and Telefonica, as well as diagnostic companies. N.K., R.A.M. and M.M.S. received funding from IRC Next Steps Plus: Ultra-Sensitive Enhanced NanoSensing of Anti-Microbial Resistance (u-sense, EP/R018391/1). A.M.J. received funding from NIHR. G.R. undertakes paid consultancy work for Google Health, and undertakes research on predictive analytics in brain imaging funded by the Wellcome Trust. M.M.S. is a consultant for 30T/Edixomed, Simmons and Simmons and Origin Sciences, and receives research grant funding from CRUK, The Wellcome Trust, EPSRC/MRC/UKRI, H2020 and ERC, as well as other grants.	Adams Emily R, 2020, Wellcome Open Res, V5, P139, DOI 10.12688/wellcomeopenres.15927.1; Amnesty International, HALT COVID 19 CONT T; Anderson M., 2020, AM TURN TECHN COVID; [Anonymous], 2020, NATURE, V580, P563, DOI 10.1038/d41586-020-01264-1; [Anonymous], KOREA TIMES; [Anonymous], 2020, SINGAPORE COVID 19 S; [Anonymous], 2020, APPLE NEWSROOM 0410; [Anonymous], 2020, MED TECH INNOVATION; Apple, COVID 19 MOB TRENDS; Armitage H, 2020, STANFORD MED NEWS CT; Australia Government Department of Health, 2020, COVIDSAFE APP; Ball P, 2020, NATURE, V581, P371, DOI 10.1038/d41586-020-01452-z; Beaunoyer E, 2020, COMPUT HUM BEHAV, V111, DOI 10.1016/j.chb.2020.106424; Bogoch II, 2020, J TRAVEL MED, V27, DOI 10.1093/jtm/taaa008; Bonsall D., 2020, SUSTAINABLE CONTAINM; Buckee CO, 2020, SCIENCE, V368, P145, DOI 10.1126/science.abb8021; Burlacu A, 2020, CURBING AI INDUCED E, DOI [10.1101/2020.04.28.20082776, DOI 10.1101/2020.04.28.20082776]; Calvo RA, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1373; Centre for Health Protection Department of Health, LAT SIT NOV COR INF; China Data Lab, 2020, HARV DAT, DOI DOI 10.7910/DVN/FAEZIO; Chinazzi M, 2020, SCIENCE, V368, P395, DOI 10.1126/science.aba9757; Connor P., 2020, MORE 9 10 PEOPLE WOR; Deasy J, 2020, FORECASTING ULTRAEAR; Department of Immunization, 2019, VACC BIOL IVB SAG ST; Depoux A, 2020, J TRAVEL MED, V27, DOI 10.1093/jtm/taaa031; Edelstein M, 2018, EMERG INFECT DIS, V24, P1324, DOI 10.3201/eid2407.151830; Estcourt CS, 2017, LANCET PUBLIC HEALTH, V2, pE182, DOI 10.1016/S2468-2667(17)30034-8; European Commission, 2020, COR COMM AD REC SUPP; Ferretti L, 2020, SCIENCE, V368, P619, DOI 10.1126/science.abb6936; FIND, SARS COV 2 DIAGN PIP; Fraser C, 2004, P NATL ACAD SCI USA, V101, P6146, DOI 10.1073/pnas.0307506101; Gomide J., 2011, P 3 INT WEB SCI C, V3, DOI DOI 10.1145/2527031.2527049; Gong MC, 2020, J MED INTERNET RES, V22, DOI 10.2196/18948; GoodSAM, 2020, INST LOC VID CONS 99; Google, COVID 19 COMM MOB RE; Google, SOS AL HELP; Gostic K, 2020, ELIFE, V9, DOI 10.7554/eLife.55570; Government of India, 2020, AAR SET MOB APP; Green A, 2020, LANCET, V395, P682, DOI 10.1016/S0140-6736(20)30382-2; Green K, 2020, MOL ANTIBODY POINT O; Greenhalgh T, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.m1182; GSMA, 2020, MOB EC 2020; Gupta M., 2020, ARXIV200409246; HealthMap, COVID 19; Heneghan C., 2020, COVID 19 WHAT PROPOR; Heymann DL, 2017, AM J PUBLIC HEALTH, V107, P845, DOI 10.2105/AJPH.2017.303795; Hopman J, 2020, JAMA-J AM MED ASSOC, V323, P1549, DOI 10.1001/jama.2020.4169; Human Rights Watch, 2020, MYANM END WORLDS LON; Ienca M, 2020, NAT MED, V26, P463, DOI 10.1038/s41591-020-0832-5; ITU (International Telecommunication Union), 2019, MEAS DIG DEV FACTS F; Jia JSS, 2020, NATURE, V582, P389, DOI [10.1038/s41586-020-2284-y, 10.1109/LGRS.2020.3028443]; Jia P, 2020, NAT MED, V26, P990, DOI 10.1038/s41591-020-0921-5; Kemp S., 2020, DIGITAL 2020 GLOBAL; Klepac P, 2020, CONTACTS CONTEXT LAR, DOI [10.1101/2020.02.16.20023754, DOI 10.1101/2020.02.16.20023754]; Koppeschaar Carl E, 2017, JMIR Public Health Surveill, V3, pe66, DOI 10.2196/publichealth.7429; Kraemer MUG, 2020, SCIENCE, V368, P493, DOI 10.1126/science.abb4218; Kupferschmidt K, 2020, SCIENCE, V367, P1061, DOI 10.1126/science.367.6482.1061; Kupferschmidt K, 2020, SCIENCE, V367, P963, DOI 10.1126/science.367.6481.963; Laghi A, 2020, LANCET DIGIT HEALTH, V2, pE225, DOI 10.1016/S2589-7500(20)30079-0; Lampos V., 2020, ARXIV200308086; Lampos V, 2015, DATA MIN KNOWL DISC, V29, P1434, DOI 10.1007/s10618-015-0427-9; Lampos V, 2015, SCI REP-UK, V5, DOI 10.1038/srep12760; Land KJ, 2019, NAT MICROBIOL, V4, P46, DOI 10.1038/s41564-018-0295-3; Leung GM, 2004, ANN INTERN MED, V141, P662, DOI 10.7326/0003-4819-141-9-200411020-00006; Limaye RJ, 2020, LANCET DIGIT HEALTH, V2019, P2019; Linklaters, 40 COUNTR PLOUGH AH; Liu S, 2020, LANCET PSYCHIAT, V7, pE17, DOI 10.1016/S2215-0366(20)30077-8; Lloyd-Sherlock P, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.m1052; Lu Y, 2020, J INFECTION, V81, pE82, DOI 10.1016/j.jinf.2020.03.050; Mallapaty S, 2020, NATURE, V580, P571, DOI 10.1038/d41586-020-01115-z; Marmot M, 2020, HLTH EQUITY ENGLAND; Mashamba-Thompson Tivani P., 2020, DIAGNOSTICS, V10, DOI [DOI 10.3390/DIAGNOSTICS10040198, 10.3390/diagnosilcs10040198, 10.3390/diagnostics10040198]; McCall B, 2020, LANCET DIGIT HEALTH, V2, pE166, DOI 10.1016/S2589-7500(20)30054-6; McKendry RA, 2020, NATURE, V580, P29, DOI 10.1038/d41586-020-00908-6; Medicines and Healthcare products Regulatory Agency, 2020, TARG PROD PROF ANT T; Mei XY, 2020, NAT MED, V26, P1224, DOI 10.1038/s41591-020-0931-3; Menni C, 2020, NAT MED, V26, P1037, DOI 10.1038/s41591-020-0916-2; Merchant RM, 2020, JAMA-J AM MED ASSOC, V323, P2011, DOI 10.1001/jama.2020.4469; Microsoft, 2020, BING COVID 19 DAT; Ministry of Health, 2020, UPD COVID 19 COR DIS; Ministry of Health, 2020, HAMAGEN MIN HLTH APP; Mudanyali O, 2012, LAB CHIP, V12, P2678, DOI [10.1039/c2lc40235a, 10.1039/c21c40235a]; Nay O, 2020, LANCET PUBLIC HEALTH, V5, pE238, DOI 10.1016/S2468-2667(20)30092-X; Nextstrain team, GEN EP NOV COR GLOB; Office for National Statistics, EXPL UKS DIG DIV; Oliver N, 2020, SCI ADV, V6, DOI 10.1126/sciadv.abc0764; Parker MJ, 2020, J MED ETHICS, V46, P427, DOI 10.1136/medethics-2020-106314; Pepe E., 2020, COVID 19 OUTBREAK RE, DOI DOI 10.1101/2020.03.22.20039933; Perez S., 2020, APP STORES SAW RECOR; Pham M., 2020, MOBILE WORLD LIVE; Phelan AL, 2020, LANCET, V395, P1595, DOI 10.1016/S0140-6736(20)31034-5; Public Health England, 2020, J CLIN MICROBIOL, DOI DOI 10.1128/JCM.00941-20; QASIM M, 2020, J MED INTERNET RES, V22, DOI DOI 10.3390/E22020200; Qin L, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17072365; Quick J, 2016, NATURE, V530, P228, DOI 10.1038/nature16996; Quilty BJ, 2020, EUROSURVEILLANCE, V25, P4, DOI 10.2807/1560-7917.ES.2020.25.5.2000080; Raamkumar AS, 2020, J MED INTERNET RES, V22, DOI 10.2196/19334; RIMMER A, 2020, BMJ-BRIT MED J, V369, DOI DOI 10.1136/BMJ.M1562; Russel T. W., USING DELAY ADJUSTED; Santow E, 2020, SCIENCE, V368, P9, DOI 10.1126/science.abb9369; Schumacher S, 2020, 8 CHARTS INTERNET US; Secretary of State for Health and Social Care, 2019, TOPOL REV PREPARING; Segal E, 2020, NAT MED, V26, P1161, DOI 10.1038/s41591-020-0929-x; Smith GE, 2017, J PUBLIC HEALTH-UK, V39, pE111, DOI 10.1093/pubmed/fdw054; Stoyanov SR, 2015, JMIR MHEALTH UHEALTH, V3, DOI 10.2196/mhealth.3422; Sun KY, 2020, LANCET DIGIT HEALTH, V2, pE201, DOI 10.1016/S2589-7500(20)30026-1; The Academy of Medical Sciences, 2019, INT RES EP PREP RESP; The Government of the Hong Kong Special Administrative Region, 2020, TOG WE FIGHT VIR STA; The World Bank, MOB CELL SUBS 100 PE; The World Bank, WORLD BANK ED COVID; Thorlund K, 2020, LANCET DIGIT HEALTH, V2, pE286, DOI 10.1016/S2589-7500(20)30086-8; Ting DSW, 2020, NAT MED, V26, P459, DOI 10.1038/s41591-020-0824-5; Tognotti E, 2013, EMERG INFECT DIS, V19, P254, DOI 10.3201/eid1902.120312; Udugama B, 2020, ACS NANO, V14, P3822, DOI 10.1021/acsnano.0c02624; United Nations Department of Economic and Social Affairs, 2020, COVID 19 EMBR DIG GO; Wang S, 2021, EUR RADIOL, V31, P6096, DOI [10.1007/s00330-021-07715-1, 10.1079/9781789246070.0001]; Wesolowski Amy, 2014, PLoS Curr, V6, DOI 10.1371/currents.outbreaks.0177e7fcf52217b8b634376e2f3efc5e; WhatsApp, 2020, WHATSAPP CAN HELP YO; WHO, 2020, 160 WHO; WHO, 2020, COORD GLOB RES ROADM; WHO, 2020, DRAFT GLOB STRAT DIG; Wood CS, 2019, NATURE, V566, P467, DOI 10.1038/s41586-019-0956-2; World Health Organization, 2020, EPI BRAIN; World Health Organization, 2021, NOV COR 2019 NCOV SI; World Health Organization, 2018, REV AN APPR SEAS INF; World Health Organization, WHO COR DIS COV 19 D; World Health Organization, 2020, EP INT OP SOURC EIOS; World Health Organization, 2020, DIR GEN OP REM MED B; World Health Organization (WHO), 2016, INT HLTH REG 2005; World Heatlh Organisation, 2019, REC DIG INT HLTH SYS; Wu F, 2020, NATURE, V579, P265, DOI 10.1038/s41586-020-2008-3; Wynants L, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1328; Zastrow Mark, 2020, Nature, DOI 10.1038/d41586-020-00740-y; Zhang JJ, 2020, LANCET INFECT DIS, V20, P793, DOI 10.1016/S1473-3099(20)30230-9; Zheng, 2020, HARVARD BUS REV; Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017	137	316	321	52	187	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	AUG	2020	26	8					1183	1192		10.1038/s41591-020-1011-4	http://dx.doi.org/10.1038/s41591-020-1011-4		AUG 2020	10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	MX8ZF	32770165	Bronze, Green Submitted			2022-12-27	WOS:000557134700003
J	Stower, H				Stower, Hannah			Trying out personalized therapy in NSCLC	NATURE MEDICINE			English	Editorial Material												h.stower@us.nature.com							0	0	0	0	1	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	AUG	2020	26	8					1170	1170		10.1038/s41591-020-1028-8	http://dx.doi.org/10.1038/s41591-020-1028-8		AUG 2020	1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	MX8ZF	32770160	Bronze			2022-12-27	WOS:000557134700013
J	Robilotti, EV; Babady, NE; Mead, PA; Rolling, T; Perez-Johnston, R; Bernardes, M; Bogler, Y; Caldararo, M; Figueroa, CJ; Glickman, MS; Joanow, A; Kaltsas, A; Lee, YJ; Lucca, A; Mariano, A; Morjaria, S; Nawar, T; Papanicolaou, GA; Predmore, J; Redelman-Sidi, G; Schmidt, E; Seo, SK; Sepkowitz, K; Shah, MK; Wolchok, JD; Hohl, TM; Taur, Y; Kamboj, M				Robilotti, Elizabeth V.; Babady, N. Esther; Mead, Peter A.; Rolling, Thierry; Perez-Johnston, Rocio; Bernardes, Marilia; Bogler, Yael; Caldararo, Mario; Figueroa, Cesar J.; Glickman, Michael S.; Joanow, Alexa; Kaltsas, Anna; Lee, Yeon Joo; Lucca, Anabella; Mariano, Amanda; Morjaria, Sejal; Nawar, Tamara; Papanicolaou, Genovefa A.; Predmore, Jacqueline; Redelman-Sidi, Gil; Schmidt, Elizabeth; Seo, Susan K.; Sepkowitz, Kent; Shah, Monika K.; Wolchok, Jedd D.; Hohl, Tobias M.; Taur, Ying; Kamboj, Mini			Determinants of COVID-19 disease severity in patients with cancer	NATURE MEDICINE			English	Article								As of 10 April 2020, New York State had 180,458 cases of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and 9,385 reported deaths. Patients with cancer comprised 8.4% of deceased individuals(1). Population-based studies from China and Italy suggested a higher coronavirus disease 2019 (COVID-19) death rate in patients with cancer(2,3), although there is a knowledge gap as to which aspects of cancer and its treatment confer risk of severe COVID-19(4). This information is critical to balance the competing safety considerations of reducing SARS-CoV-2 exposure and cancer treatment continuation. From 10 March to 7 April 2020, 423 cases of symptomatic COVID-19 were diagnosed at Memorial Sloan Kettering Cancer Center (from a total of 2,035 patients with cancer tested). Of these, 40% were hospitalized for COVID-19, 20% developed severe respiratory illness (including 9% who required mechanical ventilation) and 12% died within 30 d. Age older than 65 years and treatment with immune checkpoint inhibitors (ICIs) were predictors for hospitalization and severe disease, whereas receipt of chemotherapy and major surgery were not. Overall, COVID-19 in patients with cancer is marked by substantial rates of hospitalization and severe outcomes. The association observed between ICI and COVID-19 outcomes in our study will need further interrogation in tumor-specific cohorts. Analysis of a large, single-center cohort of patients with cancer who were infected with COVID-19 uncovers factors associated with disease severity and interactions with anti-cancer therapies	[Robilotti, Elizabeth V.; Babady, N. Esther; Mead, Peter A.; Rolling, Thierry; Bernardes, Marilia; Bogler, Yael; Caldararo, Mario; Figueroa, Cesar J.; Glickman, Michael S.; Joanow, Alexa; Kaltsas, Anna; Lee, Yeon Joo; Lucca, Anabella; Mariano, Amanda; Morjaria, Sejal; Nawar, Tamara; Papanicolaou, Genovefa A.; Predmore, Jacqueline; Redelman-Sidi, Gil; Schmidt, Elizabeth; Seo, Susan K.; Sepkowitz, Kent; Shah, Monika K.; Hohl, Tobias M.; Taur, Ying; Kamboj, Mini] Mem Sloan Kettering Canc Ctr, Dept Med, Infect Dis, 1275 York Ave, New York, NY 10021 USA; [Robilotti, Elizabeth V.; Kamboj, Mini] Mem Sloan Kettering Canc Ctr, Infect Control, 1275 York Ave, New York, NY 10021 USA; [Robilotti, Elizabeth V.; Mead, Peter A.; Figueroa, Cesar J.; Glickman, Michael S.; Kaltsas, Anna; Lee, Yeon Joo; Morjaria, Sejal; Papanicolaou, Genovefa A.; Redelman-Sidi, Gil; Seo, Susan K.; Sepkowitz, Kent; Shah, Monika K.; Wolchok, Jedd D.; Hohl, Tobias M.; Taur, Ying; Kamboj, Mini] Cornell Univ, Dept Med, Joan & Sanford Weill Med Coll, New York, NY 10065 USA; [Babady, N. Esther] Mem Sloan Kettering Canc Ctr, Dept Lab Med, Clin Microbiol Serv, 1275 York Ave, New York, NY 10021 USA; [Perez-Johnston, Rocio] Mem Sloan Kettering Canc Ctr, Dept Radiol, 1275 York Ave, New York, NY 10021 USA; [Lucca, Anabella] Mem Sloan Kettering Canc Ctr, Employee Hlth & Wellness Serv, 1275 York Ave, New York, NY 10021 USA; [Wolchok, Jedd D.] Mem Sloan Kettering Canc Ctr, Dept Med, Ludwig Ctr, Human Oncol & Pathogenesis Program, 1275 York Ave, New York, NY 10021 USA; [Wolchok, Jedd D.] Mem Sloan Kettering Canc Ctr, Dept Med, Parker Inst Canc Immunotherapy, 1275 York Ave, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Cornell University; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Kamboj, M (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Med, Infect Dis, 1275 York Ave, New York, NY 10021 USA.; Kamboj, M (corresponding author), Mem Sloan Kettering Canc Ctr, Infect Control, 1275 York Ave, New York, NY 10021 USA.; Kamboj, M (corresponding author), Cornell Univ, Dept Med, Joan & Sanford Weill Med Coll, New York, NY 10065 USA.	kambojm@mskcc.org		Rolling, Thierry/0000-0002-0277-5067; Lee, Yeon Joo/0000-0002-2997-0217; Lucca Bianchi, Anabella/0000-0002-0064-1081	Memorial Sloan Kettering Cancer Center [P30 CA008748]; Burroughs Wellcome Fund Investigator in the Pathogenesis of Infectious Diseases Award; Ludwig Collaborative and Swim Across America Laboratory; Parker Institute for Cancer Immunotherapy; Memorial Sloan Kettering Cancer Center Department of Medicine and Weill Cornell Medicine	Memorial Sloan Kettering Cancer Center; Burroughs Wellcome Fund Investigator in the Pathogenesis of Infectious Diseases Award; Ludwig Collaborative and Swim Across America Laboratory; Parker Institute for Cancer Immunotherapy; Memorial Sloan Kettering Cancer Center Department of Medicine and Weill Cornell Medicine	This study was supported by the Memorial Sloan Kettering Cancer Center core grant (P30 CA008748), the Burroughs Wellcome Fund Investigator in the Pathogenesis of Infectious Diseases Award (to T.M.H.), the Ludwig Collaborative and Swim Across America Laboratory (to J.D.W.), the Parker Institute for Cancer Immunotherapy (to J.D.W.), the Memorial Sloan Kettering Cancer Center Department of Medicine and Weill Cornell Medicine.	CDC COVID-19 Response Team, 2020, MMWR-MORBID MORTAL W, V69, P343, DOI [10.15585/mmwr.mm6912e2, 10.15585/mmwr.mm6915e4]; Centers for Disease Control and Prevention, 2020, REAL TIM RT PCR PAN; Chow N, 2020, MMWR-MORBID MORTAL W, V69, P382, DOI 10.15585/mmwr.mm6913e2; Dai MY, 2020, CANCER DISCOV, V10, P783, DOI 10.1158/2159-8290.CD-20-0422; Del Castillo M, 2016, CLIN INFECT DIS, V63, P1490, DOI 10.1093/cid/ciw539; Garassino M. C., 2020, 2020 VIRT M AM ASS C; Garg S, 2020, MMWR-MORBID MORTAL W, V69, P458, DOI 10.15585/mmwr.mm6915e3; Guan W, 2020, NEW ENGL J MED, V382, P1708, DOI 10.1056/NEJMoa2002032; Hijano DR, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.03097; Hosmer D. W., 1999, APPL SURVIVAL ANAL; Hosmer DavidW., 2000, APPL LOGISTIC REGRES; Hwang SW, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-93; Kuderer NM, 2020, LANCET, V395, P1907, DOI 10.1016/S0140-6736(20)31187-9; Lee LYW, 2020, LANCET, V395, P1919, DOI 10.1016/S0140-6736(20)31173-9; Liang WH, 2020, LANCET ONCOL, V21, P335, DOI 10.1016/S1470-2045(20)30096-6; Luo J, 2020, CANCER DISCOV, V10, P1121, DOI 10.1158/2159-8290.CD-20-0596; Mehta V, 2020, CANCER DISCOV, V10, P935, DOI 10.1158/2159-8290.CD-20-0516; Miyashita H, 2020, ANN ONCOL, V31, P1088, DOI 10.1016/j.annonc.2020.04.006; New York State Department of Health, 2020, COVID 19 TRACK; Onder G, 2020, JAMA-J AM MED ASSOC, V323, P1775, DOI 10.1001/jama.2020.4683; Vardhana SA, 2020, J EXP MED, V217, DOI 10.1084/jem.20200678; Whisenant JG, 2020, CANCER CELL, V37, P742, DOI 10.1016/j.ccell.2020.05.008; WHO, 2019, REP WHO CHIN JOINT M; World Health Organization (WHO), 2020, 2019 NOVEL CORONAVIR; Wu ZY, 2020, JAMA-J AM MED ASSOC, V323, P1239, DOI 10.1001/jama.2020.2648; Xu Z, 2020, LANCET RESP MED, V8, P420, DOI 10.1016/S2213-2600(20)30076-X; Yu J, 2020, JAMA ONCOL, V6, P1108, DOI 10.1001/jamaoncol.2020.0980	27	344	352	4	23	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	AUG	2020	26	8					1218	+		10.1038/s41591-020-0979-0	http://dx.doi.org/10.1038/s41591-020-0979-0		JUN 2020	7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	MX8ZF	32581323	Bronze, Green Accepted			2022-12-27	WOS:000543164300001
J	Nuzzo, PV; Berchuck, JE; Korthauer, K; Spisak, S; Nassar, AH; Abou Alaiwi, S; Chakravarthy, A; Shen, SY; Bakouny, Z; Boccardo, F; Steinharter, J; Bouchard, G; Curran, CR; Pan, WT; Baca, SC; Seo, JH; Lee, GSM; Michaelson, MD; Chang, SL; Waikar, SS; Sonpavde, G; Irizarry, RA; Pomerantz, M; De Carvalho, DD; Choueiri, TK; Freedman, ML				Nuzzo, Pier Vitale; Berchuck, Jacob E.; Korthauer, Keegan; Spisak, Sandor; Nassar, Amin H.; Abou Alaiwi, Sarah; Chakravarthy, Ankur; Shen, Shu Yi; Bakouny, Ziad; Boccardo, Francesco; Steinharter, John; Bouchard, Gabrielle; Curran, Catherine R.; Pan, Wenting; Baca, Sylvan C.; Seo, Ji-Heui; Lee, Gwo-Shu Mary; Michaelson, M. Dror; Chang, Steven L.; Waikar, Sushrut S.; Sonpavde, Guru; Irizarry, Rafael A.; Pomerantz, Mark; De Carvalho, Daniel D.; Choueiri, Toni K.; Freedman, Matthew L.			Detection of renal cell carcinoma using plasma and urine cell-free DNA methylomes	NATURE MEDICINE			English	Article								A cell-free DNA-methylation sequencing assay accurately identifies renal cell carcinoma using plasma and urine samples. Improving early cancer detection has the potential to substantially reduce cancer-related mortality. Cell-free methylated DNA immunoprecipitation and high-throughput sequencing (cfMeDIP-seq) is a highly sensitive assay capable of detecting early-stage tumors. We report accurate classification of patients across all stages of renal cell carcinoma (RCC) in plasma (area under the receiver operating characteristic (AUROC) curve of 0.99) and demonstrate the validity of this assay to identify patients with RCC using urine cell-free DNA (cfDNA; AUROC of 0.86).	[Nuzzo, Pier Vitale; Berchuck, Jacob E.; Nassar, Amin H.; Abou Alaiwi, Sarah; Bakouny, Ziad; Steinharter, John; Bouchard, Gabrielle; Curran, Catherine R.; Pan, Wenting; Baca, Sylvan C.; Seo, Ji-Heui; Lee, Gwo-Shu Mary; Sonpavde, Guru; Pomerantz, Mark; Choueiri, Toni K.; Freedman, Matthew L.] Harvard Med Sch, Dana Farber Canc Inst, Lank Ctr Genitourinary Oncol, Dept Med Oncol, Boston, MA 02115 USA; [Nuzzo, Pier Vitale; Berchuck, Jacob E.; Spisak, Sandor; Nassar, Amin H.; Abou Alaiwi, Sarah; Baca, Sylvan C.; Seo, Ji-Heui; Lee, Gwo-Shu Mary; Pomerantz, Mark; Freedman, Matthew L.] Harvard Med Sch, Dana Farber Canc Inst, Ctr Funct Canc Epigenet, Boston, MA 02115 USA; [Nuzzo, Pier Vitale; Boccardo, Francesco] Univ Genoa, Sch Med, Dept Internal Med & Med Specialties, Genoa, Italy; [Korthauer, Keegan] Univ British Columbia, Dept Stat, Vancouver, BC, Canada; [Korthauer, Keegan] BC Childrens Hosp, Res Inst, Vancouver, BC, Canada; [Chakravarthy, Ankur; Shen, Shu Yi; De Carvalho, Daniel D.] Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON, Canada; [Boccardo, Francesco] IRCCS San Martino Polyclin Hosp, Acad Unit Med Oncol, Genoa, Italy; [Baca, Sylvan C.; Choueiri, Toni K.; Freedman, Matthew L.] Eli & Edythe L Broad Inst, Cambridge, MA 02142 USA; [Michaelson, M. Dror] Massachusetts Gen Hosp, Canc Ctr, Hematol Oncol, Boston, MA 02114 USA; [Chang, Steven L.] Brigham & Womens Hosp, Div Urol, 75 Francis St, Boston, MA 02115 USA; [Waikar, Sushrut S.] Brigham & Womens Hosp, Div Renal Med, 75 Francis St, Boston, MA 02115 USA; [Waikar, Sushrut S.] Boston Univ, Med Ctr, Sect Nephrol, Boston, MA USA; [Irizarry, Rafael A.] Harvard Univ, Dept Biostat, Cambridge, MA 02138 USA; [Irizarry, Rafael A.] Harvard Med Sch, Dana Farber Canc Inst, Dept Data Sci, Boston, MA 02115 USA; [De Carvalho, Daniel D.] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; University of Genoa; University of British Columbia; BC Childrens Hospital; University of British Columbia; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Boston University; Harvard University; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; University of Toronto	Choueiri, TK; Freedman, ML (corresponding author), Harvard Med Sch, Dana Farber Canc Inst, Lank Ctr Genitourinary Oncol, Dept Med Oncol, Boston, MA 02115 USA.; Freedman, ML (corresponding author), Harvard Med Sch, Dana Farber Canc Inst, Ctr Funct Canc Epigenet, Boston, MA 02115 USA.; Choueiri, TK; Freedman, ML (corresponding author), Eli & Edythe L Broad Inst, Cambridge, MA 02142 USA.	toni_choueiri@dfci.harvard.edu; mfreedman@partners.org	Choueiri, Toni/K-5238-2019; Abou Alaiwi, Sarah/GRO-6827-2022; Bakouny, Ziad/A-1149-2018; Korthauer, Keegan/I-5740-2019; Nuzzo, Pier Vitale/GRX-4635-2022	Choueiri, Toni/0000-0002-9201-3217; Abou Alaiwi, Sarah/0000-0002-7073-3432; Bakouny, Ziad/0000-0003-1906-5704; Korthauer, Keegan/0000-0002-4565-1654; Nuzzo, Pier Vitale/0000-0002-5618-8079; Shen, Shu Yi/0000-0001-7036-2291; De Carvalho, Daniel/0000-0002-8572-5259; /0000-0003-4914-1157; Nassar, Amin/0000-0002-8084-9105; Michaelson, Dror/0000-0001-9249-6338	Claudia Adams Barr Program for Innovative Cancer Research; DFCI Medical Oncology grant award; H.L. Snyder Medical Research Foundation; British Colombia Children's Hospital Research Institute (BCCHRI) Investigator Grant Award Program; BCCHRI Establishment Award; Provincial Health Services Authority; Children's & Women's Health Centre of BC; BC Children's Hospital Foundation; Canadian Institutes of Health Research (CIHR) Banting Fellowship	Claudia Adams Barr Program for Innovative Cancer Research; DFCI Medical Oncology grant award; H.L. Snyder Medical Research Foundation; British Colombia Children's Hospital Research Institute (BCCHRI) Investigator Grant Award Program; BCCHRI Establishment Award; Provincial Health Services Authority; Children's & Women's Health Centre of BC; BC Children's Hospital Foundation; Canadian Institutes of Health Research (CIHR) Banting Fellowship(Canadian Institutes of Health Research (CIHR))	This study was conducted with support from Rebecca and Nathan Milikowsky (M.P.), the Claudia Adams Barr Program for Innovative Cancer Research (M.L.F.), a DFCI Medical Oncology grant award (M.L.F. and M.P.) and the H.L. Snyder Medical Research Foundation (M.L.F.). K.K. is funded by the British Colombia Children's Hospital Research Institute (BCCHRI) Investigator Grant Award Program and the BCCHRI Establishment Award and acknowledges support from Provincial Health Services Authority, the Children's & Women's Health Centre of BC and the BC Children's Hospital Foundation. A.C. is supported by a Canadian Institutes of Health Research (CIHR) Banting Fellowship.	Aryee MJ, 2014, BIOINFORMATICS, V30, P1363, DOI 10.1093/bioinformatics/btu049; Cohen JD, 2018, SCIENCE, V359, P926, DOI 10.1126/science.aar3247; Colaprico A, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkv1507; Creighton CJ, 2013, NATURE, V499, P43, DOI 10.1038/nature12222; Dudley JC, 2019, CANCER DISCOV, V9, P500, DOI 10.1158/2159-8290.CD-18-0825; Ewels P, 2016, BIOINFORMATICS, V32, P3047, DOI 10.1093/bioinformatics/btw354; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; Gill IS, 2010, NEW ENGL J MED, V362, P624, DOI 10.1056/NEJMcp0910041; Hauser S, 2013, ANTICANCER RES, V33, P4651; Ibn Sina A, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07214-w; Inoshita M, 2015, BIOL SEX DIFFER, V6, DOI 10.1186/s13293-015-0029-7; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lasseter K, 2020, GENET MED, V22, P1366, DOI 10.1038/s41436-020-0801-x; Law CW, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r29; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lienhard M, 2014, BIOINFORMATICS, V30, P284, DOI 10.1093/bioinformatics/btt650; Moss J, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07466-6; Pal SK, 2017, EUR UROL, V72, P557, DOI 10.1016/j.eururo.2017.03.046; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; Schoots IG, 2017, J UROLOGY, V198, P12, DOI 10.1016/j.juro.2016.09.160; Shen SY, 2019, NAT PROTOC, V14, P2749, DOI 10.1038/s41596-019-0202-2; Shen SY, 2018, NATURE, V563, P579, DOI 10.1038/s41586-018-0703-0; Sing T, 2005, BIOINFORMATICS, V21, P3940, DOI 10.1093/bioinformatics/bti623; Skrypkina I, 2016, DIS MARKERS, V2016, DOI 10.1155/2016/3693096; Triche TJ, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt090; Zill OA, 2018, CLIN CANCER RES, V24, P3528, DOI 10.1158/1078-0432.CCR-17-3837	26	92	94	5	32	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	JUL	2020	26	7					1041	+		10.1038/s41591-020-0933-1	http://dx.doi.org/10.1038/s41591-020-0933-1		JUN 2020	11	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	MK3XO	32572266	Green Accepted, Green Published			2022-12-27	WOS:000542094400002
J	Davies, NG; Klepac, P; Liu, Y; Prem, K; Jit, M; Eggo, RM				Davies, Nicholas G.; Klepac, Petra; Liu, Yang; Prem, Kiesha; Jit, Mark; Eggo, Rosalind M.		CMMID COVID-19 Working Grp	Age-dependent effects in the transmission and control of COVID-19 epidemics	NATURE MEDICINE			English	Article							SCHOOL CLOSURE; INFLUENZA; DYNAMICS; DISEASE; IMPACT; SARS	A new epidemiological study shows reduced susceptibility to SARS-CoV-2 and decreased risk of developing severe symptoms in people aged younger than 20 years, suggesting that children have limited contribution to spread of COVID-19. The COVID-19 pandemic has shown a markedly low proportion of cases among children(1-4). Age disparities in observed cases could be explained by children having lower susceptibility to infection, lower propensity to show clinical symptoms or both. We evaluate these possibilities by fitting an age-structured mathematical model to epidemic data from China, Italy, Japan, Singapore, Canada and South Korea. We estimate that susceptibility to infection in individuals under 20 years of age is approximately half that of adults aged over 20 years, and that clinical symptoms manifest in 21% (95% credible interval: 12-31%) of infections in 10- to 19-year-olds, rising to 69% (57-82%) of infections in people aged over 70 years. Accordingly, we find that interventions aimed at children might have a relatively small impact on reducing SARS-CoV-2 transmission, particularly if the transmissibility of subclinical infections is low. Our age-specific clinical fraction and susceptibility estimates have implications for the expected global burden of COVID-19, as a result of demographic differences across settings. In countries with younger population structures-such as many low-income countries-the expected per capita incidence of clinical cases would be lower than in countries with older population structures, although it is likely that comorbidities in low-income countries will also influence disease severity. Without effective control measures, regions with relatively older populations could see disproportionally more cases of COVID-19, particularly in the later stages of an unmitigated epidemic.	[Davies, Nicholas G.; Klepac, Petra; Liu, Yang; Prem, Kiesha; Jit, Mark; Eggo, Rosalind M.] London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London, England	University of London; London School of Hygiene & Tropical Medicine	Davies, NG; Eggo, RM (corresponding author), London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London, England.	nicholas.davies@lshtm.ac.uk; r.eggo@lshtm.ac.uk	Jit, Mark/HDM-7797-2022	Jit, Mark/0000-0001-6658-8255; Abbott, Sam/0000-0001-8057-8037; Davies, Nicholas/0000-0002-1740-1412; Liu, Yang/0000-0002-9368-0425; Eggo, Rosalind M/0000-0002-0362-6717; Gilbert, Nigel/0000-0002-5937-2410; Quilty, Billy/0000-0002-9094-3728; Bosse, Nikos I./0000-0002-7750-5280; Flasche, Stefan/0000-0002-5808-2606	National Institutes of Health Research [HPRU-2012-10096]; Bill & Melinda Gates Foundation [INV-003174]; Royal Society [RP\EA\180004]; National Institute for Health Research (NIHR) [16/137/109]; UK Government; HDR UK [MR/S003975/1]; MRC [MC_PC 19065]; NIHR [16/137/109, PR-OD-1017-20002]; Wellcome Trust [206250/Z/17/Z, 208812/Z/17/Z, 210758/Z/18/Z]; Department of Health and Social Care; ESRC [ES/P010873/1]; Elrha's Research for Health in Humanitarian Crises (R2HC) Programme; UK Government (DFID); UK National Institute for Health Research (NIHR); Challenges Research Fund (GCRF) project 'RECAP' [ES/P010873/1]; European Research Commission Starting Grant [757699]; Economic and Social Research Council [ES/P010873/1] Funding Source: researchfish; MRC [MC_PC_19065, MR/S003975/1] Funding Source: UKRI	National Institutes of Health Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); Royal Society(Royal Society of London); National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); UK Government; HDR UK; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIHR(National Institute for Health Research (NIHR)); Wellcome Trust(Wellcome Trust); Department of Health and Social Care; ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Elrha's Research for Health in Humanitarian Crises (R2HC) Programme; UK Government (DFID); UK National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); Challenges Research Fund (GCRF) project 'RECAP'; European Research Commission Starting Grant; Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	N.G.D. acknowledges funding from the National Institutes of Health Research (HPRU-2012-10096). P.K., Y.L., K.P. and M.J. acknowledge partial funding by the Bill & Melinda Gates Foundation (INV-003174). This work was funded in part by the Royal Society under award no. RP\EA\180004 (P.K.). Y.L. and M.J. acknowledge partial funding by the National Institute for Health Research (NIHR) (16/137/109) using UK aid from the UK Government to support global health research. The views expressed in this publication are those of the author(s) and not necessarily those of the NIHR or the UK Department of Health and Social Care. R.M.E. acknowledges funding from HDR UK (grant no. MR/S003975/1) and MRC (grant no. MC_PC 19065). The members of the CMMID COVID-19 working group acknowledge funding as follows: C.A.B.P. and BJ.Q. (NIHR 16/137/109), A.J.K. (Wellcome Trust grant no. 206250/Z/17/Z), H.G. (funded by the Department of Health and Social Care using UK Aid funding and managed by the NIHR; the views expressed in this publication are those of the author(s) and not necessarily those of the Department of Health and Social Care (ITCRZ 03010)), S.C. (Wellcome Trust grant no. 208812/Z/17/Z), A.G. (Global Challenges Research Fund (GCRF) for the project 'RECAP' managed through RCUK and ESRC (ES/P010873/1)), K.v.Z. (supported by Elrha's Research for Health in Humanitarian Crises (R2HC) Programme, which aims to improve health outcomes by strengthening the evidence base for public health interventions in humanitarian crises; the R2HC programme is funded by the UK Government (DFID), the Wellcome Trust and the UK National Institute for Health Research (NIHR)), J.D.M. (Wellcome Trust grant no. 210758/Z/18/Z), C.D. (NIHR 16/137/109), W.J.E. and J.H. (Wellcome Trust grant no. 210758/Z/18/Z), T.W.R. (Wellcome Trust grant no. 206250/Z/17/Z), S.A. (Wellcome Trust grant no. 210758/Z/18/Z), S.F. (Wellcome Trust grant no. 210758/Z/18/Z), N.I.B. and Y.F.S. (NIHR EPIC grant no. 16/137/109), S.F. (Wellcome Trust grant no. 208812/Z/17/Z), A.R. (NIHR grant no. PR-OD-1017-20002), C.I.J. (Global Challenges Research Fund (GCRF) project 'RECAP' managed through RCUK and ESRC (ES/P010873/1)) and R.M.G.J.H. (European Research Commission Starting Grant no. 757699).	Anderson RM, 2004, PHILOS T R SOC B, V359, P1091, DOI 10.1098/rstb.2004.1490; [Anonymous], 2020, MILANO METROPOLITAN; [Anonymous], 2020, COVID 19 CANADA; [Anonymous], 2020, AG BREAK POP BIRM; [Anonymous], 2017, COMM COLD; [Anonymous], 2020, DATA SCI COVID 19 DS; [Anonymous], 2020, COVID 19 2020 OPEN L; [Anonymous], 2020, BULAWAYO CITY ZIMBAB; [Anonymous], 2020, CHIN STAT YB 2005 20; [Anonymous], 2020, GLOBAL BURDEN DIS; [Anonymous], 2020, SHANGHAI OBSERVER; [Anonymous], 2020, B SORVEGLIANZA INTEG; Bai Y, 2020, JAMA-J AM MED ASSOC, V323, P1406, DOI [10.1056/NEJMoa2001316, 10.1001/jama.2020.2565]; Bi QF, 2020, LANCET INFECT DIS, V20, P911, DOI 10.1016/S1473-3099(20)30287-5; Cauchemez S, 2008, NATURE, V452, P750, DOI 10.1038/nature06732; Cauchemez S, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-207; Cauchemez S, 2009, LANCET INFECT DIS, V9, P473, DOI 10.1016/S1473-3099(09)70176-8; Cereda D., 2020, EARLY PHASE COVID 19, VarXiv, p2003.09320; Chan Kwai Peng, 2005, Environmental Health and Preventive Medicine, V10, P255, DOI 10.1007/BF02897699; Chau NVV., 2020, CLIN INFECT DIS, V71, P2679, DOI 10.1093/cid/ciaa711; Clark A, 2020, LANCET GLOB HLTH; Cohen AL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128580; Cohen C, 2013, EMERG INFECT DIS, V19, P1766, DOI 10.3201/eid1911.130546; Cowling BJ, 2012, CLIN INFECT DIS, V54, P1778, DOI 10.1093/cid/cis307; Docherty A. B, 2020, FEATURES 16749 HOSPI, DOI 10.1101/2020.04.23.20076042; Dong YY, 2020, PEDIATRICS, V145, DOI 10.1542/peds.2020-0702; Eames KTD, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002425; Epidemiology Working Group for NCIP Epidemic Response Chinese Center for Disease Control and Prevention, 2020, Zhonghua Liu Xing Bing Xue Za Zhi, V41, P145, DOI 10.3760/cma.j.issn.0254-6450.2020.02.003; Galanti M, 2019, EPIDEMIOL INFECT, V147, DOI 10.1017/S0950268819000505; Greer AL, 2010, EPIDEMIOL INFECT, V138, P1542, DOI 10.1017/S0950268810000579; Guan W, 2020, NEW ENGL J MED, V382, P1708, DOI 10.1056/NEJMoa2002032; Gudbjartsson DF, 2020, NEW ENGL J MED, V382, P2302, DOI 10.1056/NEJMoa2006100; Huang Angkana T, 2020, Nat Commun, V11, P4704, DOI [10.1101/2020.04.14.20065771, 10.1038/s41467-020-18450-4]; Kissler SM, 2020, SCIENCE, V368, P860, DOI 10.1126/science.abb5793; Koh A, 2020, SINGAPORE COVID 19 C; Kucharski AJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128070; Lau JTF, 2003, J EPIDEMIOL COMMUN H, V57, P864, DOI 10.1136/jech.57.11.864; Lavezzo E., 2020, SUPPRESSION COVID 1, DOI [10.1101/2020.04.17.20053157v1, DOI 10.1101/2020.04.17.20053157V1, 10.1038/s41586-020-2488-1]; Lipsitch M, 2020, NEW ENGL J MED, V382, P1194, DOI 10.1056/NEJMp2002125; Liu Y, 2020, ACTIVE LATENT TUBERC, DOI 10.1101/2020.03.10.20033795; Ludvigsson JF, 2020, ACTA PAEDIATR, V109, P1088, DOI 10.1111/apa.15270; Melegaro A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170459; Mossong J, 2008, PLOS MED, V5, P381, DOI 10.1371/journal.pmed.0050074; Murray J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132078; Nickbakhsh S, 2020, J INFECT DIS, V222, P17, DOI 10.1093/infdis/jiaa185; Onder G, 2020, JAMA-J AM MED ASSOC, V323, P1775, DOI 10.1001/jama.2020.4683; Prem K, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005697; Riccardo F, 2020, MEDRXIV, DOI [10.1101/2020.04.08.20056861, DOI 10.1101/2020.04.08.20056861V1]; Shim E, 2020, INT J INFECT DIS, V93, P339, DOI 10.1016/j.ijid.2020.03.031; Spiegelhalter DJ, 2002, J R STAT SOC B, V64, P583, DOI 10.1111/1467-9868.00353; Sun KY, 2020, LANCET DIGIT HEALTH, V2, pE201, DOI 10.1016/S2589-7500(20)30026-1; Ter Braak CJF, 2006, STAT COMPUT, V16, P239, DOI 10.1007/s11222-006-8769-1; Tsagarakis NJ, 2018, MEDICINE, V97, DOI [10.1097/md.0000000000010903, 10.1097/MD.0000000000010903]; Van Kerckhove K, 2013, AM J EPIDEMIOL, V178, P1655, DOI 10.1093/aje/kwt196; Varin C, 2011, STAT SINICA, V21, P5; Viner RM, 2020, LANCET CHILD ADOLESC, V4, P397, DOI 10.1016/S2352-4642(20)30095-X; Williams CM, 2020, LANCET INFECT DIS, V20, P607, DOI [10.1016/S1473-3099(19)30707-8, 10.1016/S1473-3099(19)30307-8]; Xu B, 2020, LANCET INFECT DIS, V20, P534, DOI 10.1016/S1473-3099(20)30119-5; Yang Y, 2020, EPIDEMIOLOGICAL CLIN, DOI [10.1101/2020.02.10.20021675, DOI 10.1101/2020]; Zhang JJ, 2020, SCIENCE, V368, P1481, DOI 10.1126/science.abb8001; Zhang JJ, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-51609-8; Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3	63	796	807	2	34	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	AUG	2020	26	8					1205	+		10.1038/s41591-020-0962-9	http://dx.doi.org/10.1038/s41591-020-0962-9		JUN 2020	20	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	MX8ZF	32546824	Bronze, Green Submitted			2022-12-27	WOS:000540688800001
J	Black, A; MacCannell, DR; Sibley, TR; Bedford, T				Black, Allison; MacCannell, Duncan R.; Sibley, Thomas R.; Bedford, Trevor			Ten recommendations for supporting open pathogen genomic analysis in public health	NATURE MEDICINE			English	Article								Increasingly, public-health agencies are using pathogen genomic sequence data to support surveillance and epidemiological investigations. As access to whole-genome sequencing has grown, greater amounts of molecular data have helped improve the ability to detect and track outbreaks of diseases such as COVID-19, investigate transmission chains and explore large-scale population dynamics, such as the spread of antibiotic resistance. However, the wide adoption of whole-genome sequencing also poses new challenges for public-health agencies that must adapt to support a new set of expertise, which means that the capacity to perform genomic data assembly and analysis has not expanded as widely as the adoption of sequencing itself. In this Perspective, we make recommendations for developing an accessible, unified informatic ecosystem to support pathogen genomic analysis in public-health agencies across income settings. We hope that the creation of this ecosystem will allow agencies to effectively and efficiently share data, workflows and analyses and thereby increase the reproducibility, accessibility and auditability of pathogen genomic analysis while also supporting agency autonomy. To support progress in genomic epidemiology, a transparent, user-friendly approach is required.	[Black, Allison; Bedford, Trevor] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Black, Allison; Sibley, Thomas R.; Bedford, Trevor] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, 1124 Columbia St, Seattle, WA 98104 USA; [MacCannell, Duncan R.] Ctr Dis Control & Prevent, Off Adv Mol Detect, Atlanta, GA 30333 USA	University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; Centers for Disease Control & Prevention - USA	MacCannell, DR (corresponding author), Ctr Dis Control & Prevent, Off Adv Mol Detect, Atlanta, GA 30333 USA.	fms2@cdc.gov		Black, Allison/0000-0002-6618-4127	Bill and Melinda Gates Foundation; National Science Foundation Graduate Research Fellowship Program [DGE-1256082]; NIH [R35 GM119774-01]	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); National Science Foundation Graduate Research Fellowship Program(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We are grateful to all of the public health professionals who took the time to participate in these interviews and discuss their experiences with us in depth; without them, this work would not have been possible. We thank all the participants in the Open Public Health Bioinformatics Meeting for contributing to this discussion, and in particular D. Aanensen, J. Carrico, R. Neher and D. Park for their edits and suggestions to this paper. This work was supported by a grant from the Bill and Melinda Gates Foundation to the CDC Foundation. A.B. is supported by the National Science Foundation Graduate Research Fellowship Program under grant no. DGE-1256082. T.B. is a Pew Biomedical Scholar and is supported by NIH R35 GM119774-01. The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the Centers for Diseases Control and Prevention.	Andersen KG, 2020, NAT MED, V26, P450, DOI 10.1038/s41591-020-0820-9; Armstrong GL, 2019, NEW ENGL J MED, V381, P2569, DOI 10.1056/NEJMsr1813907; Bedford T, 2020, CRYPTIC TRANSMISSION, DOI [10.1101/2020.04.02.20051417, DOI 10.1101/2020.04.02.20051417]; Centers for Disease Control and Prevention (CDC), 2003, MMWR Morb Mortal Wkly Rep, V52, P913; Dooley DM, 2018, NPJ SCI FOOD, V2, DOI 10.1038/s41538-018-0032-6; Doyle RM, 2018, J CLIN MICROBIOL, V56, DOI [10.1128/JCM.00666-18, 10.1128/jcm.00666-18]; Eden JS, 2020, VIRUS EVOL, V6, DOI 10.1093/ve/veaa027; Fauver JR, 2020, CELL, V181, P990, DOI 10.1016/j.cell.2020.04.021; Fielding Roy Thomas, 2000, THESIS U CALIFORNIA; Folarin OA, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0515-y; Gwinn M, 2019, JAMA-J AM MED ASSOC, V321, P893, DOI 10.1001/jama.2018.21669; Lu J, 2020, CELL, V181, P997, DOI 10.1016/j.cell.2020.04.023; Lu RJ, 2020, LANCET, V395, P565, DOI 10.1016/S0140-6736(20)30251-8; Quick J, 2016, NATURE, V530, P228, DOI 10.1038/nature16996; Siddle KJ, 2018, NEW ENGL J MED, V379, P1745, DOI 10.1056/NEJMoa1804498; Timme RE, 2017, PEERJ, V5, DOI 10.7717/peerj.3893; Wilkinson Mark D, 2016, Sci Data, V3, P160018, DOI 10.1038/sdata.2016.18; Zehender G, 2020, J MED VIROL, V92, P1637, DOI 10.1002/jmv.25794	18	31	31	2	3	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	JUN	2020	26	6					832	841		10.1038/s41591-020-0935-z	http://dx.doi.org/10.1038/s41591-020-0935-z		JUN 2020	10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	LZ3ZG	32528156	Bronze, Green Accepted			2022-12-27	WOS:000539886500007
J	Trost, M				Trost, Matthias			Supporting the UK National Health Service during the COVID-19 crisis from an academic perspective	NATURE MEDICINE			English	Editorial Material									[Trost, Matthias] Newcastle Univ, Newcastle Upon Tyne, Tyne & Wear, England	Newcastle University - UK	Trost, M (corresponding author), Newcastle Univ, Newcastle Upon Tyne, Tyne & Wear, England.	matthias.trost@newcastle.ac.uk							0	0	0	0	0	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	JUL	2020	26	7					989	989		10.1038/s41591-020-0885-5	http://dx.doi.org/10.1038/s41591-020-0885-5		MAY 2020	1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	MK3XO	32393801	Bronze			2022-12-27	WOS:000531781900001
J	Norheim, OF				Norheim, Ole F.			Protecting the population with immune individuals	NATURE MEDICINE			English	Editorial Material								Modeling an approach in which people who have recovered from COVID-19 are returned to society to reduce interactions between infected people and vulnerable people indicates the effectiveness of such an approach in reducing deaths.	[Norheim, Ole F.] Univ Bergen, Bergen Ctr Eth & Prior Setting, Dept Global Publ Hlth & Primary Care, Bergen, Norway	University of Bergen	Norheim, OF (corresponding author), Univ Bergen, Bergen Ctr Eth & Prior Setting, Dept Global Publ Hlth & Primary Care, Bergen, Norway.	Ole.Norheim@uib.no	Norheim, Ole Frithjof/AAC-8771-2020	Norheim, Ole Frithjof/0000-0002-5748-5956				Adler M.D., 2019, MEASURING SOCIAL WEL; Daniels Norman, 2008, JUST HLTH M HLTH NEE; Emanuel EJ, 2020, NEW ENGL J MED, V382, P2049, DOI 10.1056/NEJMsb2005114; Parfit Derek, 2011, WHAT MATTERS 2 VOLUM; Weitz JS, 2020, NAT MED, V26, P849, DOI 10.1038/s41591-020-0895-3; World Health Organization (WHO), 2014, MAK FAIR CHOIC PATH	6	10	10	0	3	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	JUN	2020	26	6					823	824		10.1038/s41591-020-0896-2	http://dx.doi.org/10.1038/s41591-020-0896-2		MAY 2020	2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	LZ3ZG	32382153	Bronze			2022-12-27	WOS:000530983800001
J	Dore, GJ; Martinello, M; Alavi, M; Grebely, J				Dore, Gregory J.; Martinello, Marianne; Alavi, Maryam; Grebely, Jason			Global elimination of hepatitis C virus by 2030: why not?	NATURE MEDICINE			English	Editorial Material							INTERVENTIONS	The World Health Organization's targets for eliminating hepatitis C virus by 2030 have been deemed ambitious by many. However, we believe they are achievable, provided they are supported by global commitment.	[Dore, Gregory J.; Martinello, Marianne; Alavi, Maryam; Grebely, Jason] Univ New South Wales, Kirby Inst, Sydney, NSW, Australia	University of New South Wales Sydney; Kirby Institute	Dore, GJ (corresponding author), Univ New South Wales, Kirby Inst, Sydney, NSW, Australia.	gdore@kirby.unsw.edu.au	Dore, Gregory John/ABD-5665-2021	Dore, Gregory John/0000-0002-4741-2622	Australian Government Department of Health and Ageing	Australian Government Department of Health and Ageing(Australian GovernmentDepartment of Health & Ageing)	The Kirby Institute is funded by the Australian Government Department of Health and Ageing. The views expressed in this publication do not necessarily represent the position of the Australian Government. G.J.D. is an advisory board member and has received honoraria from Merck, Gilead, and Abbvie, and has received research grant funding from Merck, Gilead, and Abbvie, as well as travel sponsorship from Merck, Gilead, and AbbVie. J.G. has received research support and is a consultant for AbbVie, Cepheid, Gilead Sciences, and Merck.	Alavi M, 2019, J HEPATOL, V71, P281, DOI 10.1016/j.jhep.2019.04.014; CHOO QL, 1989, SCIENCE, V244, P359, DOI 10.1126/science.2523562; Dore GJ, 2015, CLIN INFECT DIS, V60, P1829, DOI 10.1093/cid/civ197; Elsharkawy A, 2018, J HEPATOL, V68, P691, DOI 10.1016/j.jhep.2017.11.034; Fraser H, 2018, ADDICTION, V113, P173, DOI 10.1111/add.13948; Hajarizadeh B, 2018, J VIRAL HEPATITIS, V25, P640, DOI 10.1111/jvh.12852; Hajarizadeh B, 2013, NAT REV GASTRO HEPAT, V10, P553, DOI 10.1038/nrgastro.2013.107; Larney S, 2017, LANCET GLOB HEALTH, V5, pE1208, DOI [10.1016/S2214-109X(17)30373-X, 10.1016/s2214-109x(17)30373-x]; Moon S, 2019, NEW ENGL J MED, V380, P607, DOI 10.1056/NEJMp1813728; Naghavi M, 2017, LANCET, V390, P1151, DOI 10.1016/S0140-6736(17)32152-9; Scott N, 2018, J HEPATOL, V68, P932, DOI 10.1016/j.jhep.2017.12.013; World Health Organization, 2016, GLOB HLTH SECT STRAT	12	22	23	0	2	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	FEB	2020	26	2					157	160		10.1038/s41591-019-0706-x	http://dx.doi.org/10.1038/s41591-019-0706-x			4	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	KK7DU	32047317				2022-12-27	WOS:000512899200005
J	Kim, D; Kobayashi, T; Voisin, B; Jo, JH; Sakamoto, K; Jin, SP; Kelly, M; Pasieka, HB; Naff, JL; Meyerle, JH; Ikpeama, ID; Fahle, GA; Davis, FP; Rosenzweig, SD; Alejo, JC; Pittaluga, S; Kong, HH; Freeman, AF; Nagao, K				Kim, Doyoung; Kobayashi, Tetsuro; Voisin, Benjamin; Jo, Jay-Hyun; Sakamoto, Keiko; Jin, Seon-Pil; Kelly, Michael; Pasieka, Helena B.; Naff, Jessica L.; Meyerle, Jon H.; Ikpeama, Ijeoma D.; Fahle, Gary A.; Davis, Fred P.; Rosenzweig, Sergio D.; Alejo, Julie C.; Pittaluga, Stefania; Kong, Heidi H.; Freeman, Alexandra F.; Nagao, Keisuke			Targeted therapy guided by single-cell transcriptomic analysis in drug-induced hypersensitivity syndrome: a case report	NATURE MEDICINE			English	Article							LYMPHOCYTE-TRANSFORMATION TEST; T-CELLS; EOSINOPHILIA; SENSITIVITY; DIAGNOSIS; DYNAMICS; ADULTS; JAK3	Drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms (DiHS/DRESS) is a potentially fatal multiorgan inflammatory disease associated with herpesvirus reactivation and subsequent onset of autoimmune diseases(1-4). Pathophysiology remains elusive and therapeutic options are limited. Cases refractory to corticosteroid therapy pose a clinical challenge(1,5) and approximately 30% of patients with DiHS/DRESS develop complications, including infections and inflammatory and autoimmune diseases(1,2,5). Progress in single-cell RNA sequencing (scRNA-seq) provides an opportunity to dissect human disease pathophysiology at unprecedented resolutions(6), particularly in diseases lacking animal models, such as DiHS/DRESS. We performed scRNA-seq on skin and blood from a patient with refractory DiHS/DRESS, identifying the JAK-STAT signaling pathway as a potential target. We further showed that central memory CD4(+) T cells were enriched with DNA from human herpesvirus 6b. Intervention via tofacitinib enabled disease control and tapering of other immunosuppressive agents. Tofacitinib, as well as antiviral agents, suppressed culprit-induced T cell proliferation in vitro, further supporting the roles of the JAK-STAT pathway and herpesviruses in mediating the adverse drug reaction. Thus, scRNA-seq analyses guided successful therapeutic intervention in the patient with refractory DiHS/DRESS. scRNA-seq may improve our understanding of complicated human disease pathophysiology and provide an alternative approach in personalized medicine. Single-cell RNA sequencing facilitates successful therapeutic treatment of a patient with a rare and severe drug-induced inflammatory skin reaction.	[Kim, Doyoung; Kobayashi, Tetsuro; Voisin, Benjamin; Sakamoto, Keiko; Jin, Seon-Pil; Nagao, Keisuke] Natl Inst Arthrit & Musculoskeletal & Skin Dis NI, Cutaneous Leukocyte Biol Sect, Dermatol Branch, NIH, Bethesda, MD 20892 USA; [Jo, Jay-Hyun; Kong, Heidi H.] NIAMS, Cutaneous Microbiome & Inflammat Sect, Dermatol Branch, NIH, Bethesda, MD USA; [Kelly, Michael] Frederick Natl Lab Canc Res, Canc Res Technol Program, Single Cell Anal Facil, Frederick, MD USA; [Pasieka, Helena B.] MedStar Washington Hosp Ctr, Dept Dermatol, Washington, DC USA; [Pasieka, Helena B.] Georgetown Univ Hosp, Washington, DC 20007 USA; [Naff, Jessica L.; Meyerle, Jon H.] Walter Reed Natl Mil Med Ctr, Dept Dermatol, Bethesda, MD USA; [Ikpeama, Ijeoma D.; Fahle, Gary A.] NIH, Dept Lab Med, Ctr Clin, Bldg 10, Bethesda, MD 20892 USA; [Davis, Fred P.] NIAMS, Mol Immunol & Inflammat Branch, NIH, Bethesda, MD USA; [Rosenzweig, Sergio D.] NIH, Serv Immunol, Dept Lab Med, Ctr Clin, Bldg 10, Bethesda, MD 20892 USA; [Alejo, Julie C.; Pittaluga, Stefania] NCI, Pathol Lab, Ctr Canc Res, NIH, Bldg 10, Bethesda, MD 20892 USA; [Freeman, Alexandra F.] NIAID, Lab Clin Immunol & Microbiol, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Kim, Doyoung] Yonsei Univ, Coll Med, Dept Dermatol, Seoul, South Korea; [Kim, Doyoung] Yonsei Univ, Coll Med, Cutaneous Biol Res Inst, Seoul, South Korea	National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); MedStar Washington Hospital Center; Georgetown University; Walter Reed National Military Medical Center; National Institutes of Health (NIH) - USA; NIH Clinical Center (CC); National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); National Institutes of Health (NIH) - USA; NIH Clinical Center (CC); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Nagao, K (corresponding author), Natl Inst Arthrit & Musculoskeletal & Skin Dis NI, Cutaneous Leukocyte Biol Sect, Dermatol Branch, NIH, Bethesda, MD 20892 USA.	keisuke.nagao@nih.gov		Kobayashi, Tetsuro/0000-0003-2316-4748; Voisin, Benjamin/0000-0003-1314-2908; Kim, Do Young/0000-0002-0194-9854	Intramural Research Program of NIAMS; National Cancer Institute [HHSN261200800001E]; NIAID, NIH	Intramural Research Program of NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank the NIAMS flow cytometry and sequencing cores for technical support, the patient and volunteers, V. Pillai, M. Taylor and B. Higgins, for their contributions. This research was supported by the Intramural Research Program of NIAMS, National Cancer Institute (contract HHSN261200800001E) and NIAID, NIH.	Battiwalla M, 2007, BIOL BLOOD MARROW TR, V13, P765, DOI 10.1016/j.bbmt.2007.03.009; Beck LA, 2014, NEW ENGL J MED, V371, P130, DOI 10.1056/NEJMoa1314768; Butler A, 2018, NAT BIOTECHNOL, V36, P411, DOI 10.1038/nbt.4096; Campbell JJ, 2001, J IMMUNOL, V166, P877, DOI 10.4049/jimmunol.166.2.877; Corren J, 2011, NEW ENGL J MED, V365, P1088, DOI 10.1056/NEJMoa1106469; Curtis JR, 2016, ANN RHEUM DIS, V75, P1843, DOI 10.1136/annrheumdis-2016-209131; de Masson A, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aar5894; Homey B, 2002, NAT MED, V8, P157, DOI 10.1038/nm0202-157; Honda T, 2015, ACTA DERM-VENEREOL, V95, P606, DOI 10.2340/00015555-2027; Husain Z, 2013, J AM ACAD DERMATOL, V68, DOI 10.1016/j.jaad.2013.01.032; Illing PT, 2012, NATURE, V486, P554, DOI 10.1038/nature11147; Ishida T, 2014, ALLERGY, V69, P798, DOI 10.1111/all.12410; Kano Y, 2015, J DERMATOL, V42, P276, DOI 10.1111/1346-8138.12770; Leonard WJ, 2019, IMMUNITY, V50, P832, DOI 10.1016/j.immuni.2019.03.028; Ljungman P, 2006, J CLIN VIROL, V37, pS87, DOI 10.1016/S1386-6532(06)70018-X; Milbradt J, 2009, J CLIN VIROL, V46, P24, DOI 10.1016/j.jcv.2009.05.017; MIYAZAKI T, 1994, SCIENCE, V266, P1045, DOI 10.1126/science.7973659; Musette P, 2017, FRONT MED-LAUSANNE, V4, DOI 10.3389/fmed.2017.00179; Nyfeler B, 1997, CLIN EXP ALLERGY, V27, P175, DOI 10.1111/j.1365-2222.1997.tb00690.x; Picard D, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001116; Pichler WJ, 2015, INT ARCH ALLERGY IMM, V168, P13, DOI 10.1159/000441280; Pichler WJ, 2004, ALLERGY, V59, P809, DOI 10.1111/j.1398-9995.2004.00547.x; Pohlmann C, 2007, CLIN INFECT DIS, V44, pE118, DOI 10.1086/518282; Qiu XJ, 2017, NAT METHODS, V14, P979, DOI [10.1038/NMETH.4402, 10.1038/nmeth.4402]; Reiss Y, 2001, J EXP MED, V194, P1541, DOI 10.1084/jem.194.10.1541; RUSSELL SM, 1994, SCIENCE, V266, P1042, DOI 10.1126/science.7973658; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Shalek AK, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aan4730; Teraki Y, 2017, DERMATOLOGY, V233, P242, DOI 10.1159/000475546; Trapnell C, 2014, NAT BIOTECHNOL, V32, P381, DOI 10.1038/nbt.2859; Duong TA, 2017, LANCET, V390, P1996, DOI 10.1016/S0140-6736(16)30378-6; Ushigome Y, 2013, J AM ACAD DERMATOL, V68, P721, DOI 10.1016/j.jaad.2012.10.017; Vela M, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00012; Villarino AV, 2017, NAT IMMUNOL, V18, P374, DOI 10.1038/ni.3691; Weng WK, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3007420; WITTHUHN BA, 1994, NATURE, V370, P153, DOI 10.1038/370153a0; Zhou YY, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09234-6	37	55	59	3	26	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	FEB	2020	26	2					236	+		10.1038/s41591-019-0733-7	http://dx.doi.org/10.1038/s41591-019-0733-7		JAN 2020	20	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	KK7DU	31959990	Green Accepted			2022-12-27	WOS:000510551600002
J	Bravo-Hernandez, M; Tadokoro, T; Navarro, MR; Platoshyn, O; Kobayashi, Y; Marsala, S; Miyanohara, A; Juhas, S; Juhasova, J; Skalnikova, H; Tomori, Z; Vanicky, I; Studenovska, H; Proks, V; Chen, PX; Govea-Perez, N; Ditsworth, D; Ciacci, JD; Gao, S; Zhu, WL; Ahrens, ET; Driscoll, SP; Glenn, TD; McAlonis-Downes, M; Da Cruz, S; Pfaff, SL; Kaspar, BK; Cleveland, DW; Marsala, M				Bravo-Hernandez, Mariana; Tadokoro, Takahiro; Navarro, Michael R.; Platoshyn, Oleksandr; Kobayashi, Yoshiomi; Marsala, Silvia; Miyanohara, Atsushi; Juhas, Stefan; Juhasova, Jana; Skalnikova, Helena; Tomori, Zoltan; Vanicky, Ivo; Studenovska, Hana; Proks, Vladimir; Chen, PeiXi; Govea-Perez, Noe; Ditsworth, Dara; Ciacci, Joseph D.; Gao, Shang; Zhu, Wenlian; Ahrens, Eric T.; Driscoll, Shawn P.; Glenn, Thomas D.; McAlonis-Downes, Melissa; Da Cruz, Sandrine; Pfaff, Samuel L.; Kaspar, Brian K.; Cleveland, Don W.; Marsala, Martin			Spinal subpial delivery of AAV9 enables widespread gene silencing and blocks motoneuron degeneration in ALS	NATURE MEDICINE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; DISEASE PROGRESSION; MUTANT SOD1; EXTENDS SURVIVAL; MOTOR-NEURONS; MOUSE MODEL; THERAPY; OLIGODENDROCYTES; ONSET	Injection of AAV-shRNA below the pial surface of the spinal cord prevents onset or ameliorates progression in a mouse model of ALS, and achieves widespread delivery to the spinal cord and brain motor centers in adult pigs and non-human primates. Gene silencing with virally delivered shRNA represents a promising approach for treatment of inherited neurodegenerative disorders. In the present study we develop a subpial technique, which we show in adult animals successfully delivers adeno-associated virus (AAV) throughout the cervical, thoracic and lumbar spinal cord, as well as brain motor centers. One-time injection at cervical and lumbar levels just before disease onset in mice expressing a familial amyotrophic lateral sclerosis (ALS)-causing mutant SOD1 produces long-term suppression of motoneuron disease, including near-complete preservation of spinal alpha-motoneurons and muscle innervation. Treatment after disease onset potently blocks progression of disease and further alpha-motoneuron degeneration. A single subpial AAV9 injection in adult pigs or non-human primates using a newly designed device produces homogeneous delivery throughout the cervical spinal cord white and gray matter and brain motor centers. Thus, spinal subpial delivery in adult animals is highly effective for AAV-mediated gene delivery throughout the spinal cord and supraspinal motor centers.	[Bravo-Hernandez, Mariana; Tadokoro, Takahiro; Navarro, Michael R.; Platoshyn, Oleksandr; Kobayashi, Yoshiomi; Marsala, Silvia; Miyanohara, Atsushi; Chen, PeiXi; Govea-Perez, Noe; Marsala, Martin] Univ Calif San Diego, Dept Anesthesiol, Neuroregenerat Lab, La Jolla, CA 92093 USA; [Tadokoro, Takahiro] Univ Ryukyus, Dept Anesthesiol, Nishihara, Okinawa, Japan; [Miyanohara, Atsushi] Univ Calif San Diego, Vector Core Lab, La Jolla, CA 92093 USA; [Juhas, Stefan; Juhasova, Jana; Skalnikova, Helena] AS CR Vvi, Inst Anim Physiol & Genet, Libechov, Czech Republic; [Tomori, Zoltan] Slovak Acad Sci, Inst Expt Phys, Dept Biophys, Kosice, Slovakia; [Vanicky, Ivo; Marsala, Martin] Slovak Acad Sci, Inst Neurobiol, Kosice, Slovakia; [Studenovska, Hana; Proks, Vladimir] Czech Acad Sci, Inst Macromol Chem, Dept Biomat & Bioanalogous Syst, Prague, Czech Republic; [Govea-Perez, Noe; Ditsworth, Dara; McAlonis-Downes, Melissa; Da Cruz, Sandrine; Cleveland, Don W.] Univ Calif San Diego, Ludwig Inst Canc Res, La Jolla, CA 92093 USA; [Govea-Perez, Noe; Ditsworth, Dara; McAlonis-Downes, Melissa; Da Cruz, Sandrine; Cleveland, Don W.] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Ciacci, Joseph D.] Univ Calif San Diego, Dept Neurosurg, La Jolla, CA 92093 USA; [Gao, Shang; Zhu, Wenlian; Ahrens, Eric T.] Univ Calif San Diego, Dept Radiol, La Jolla, CA 92093 USA; [Driscoll, Shawn P.; Glenn, Thomas D.; Pfaff, Samuel L.] Salk Inst Biol Studies, Gene Express Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA; [Driscoll, Shawn P.; Glenn, Thomas D.; Pfaff, Samuel L.] Salk Inst Biol Studies, Howard Hughes Med Inst, La Jolla, CA 92037 USA; [Kaspar, Brian K.] Avexis Inc, Chicago, IL USA	University of California System; University of California San Diego; University of the Ryukyus; University of California System; University of California San Diego; Czech Academy of Sciences; Institute of Animal Physiology & Genetics of the Czech Academy of Sciences; Slovak Academy of Sciences; Slovak Academy of Sciences; Czech Academy of Sciences; Institute of Macromolecular Chemistry of the Czech Academy of Sciences; Ludwig Institute for Cancer Research; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Salk Institute; Howard Hughes Medical Institute; Salk Institute	Marsala, M (corresponding author), Univ Calif San Diego, Dept Anesthesiol, Neuroregenerat Lab, La Jolla, CA 92093 USA.; Marsala, M (corresponding author), Slovak Acad Sci, Inst Neurobiol, Kosice, Slovakia.	mmarsala@ucsd.edu	Tomori, Zoltan/B-6706-2011; Kobayashi, Yoshiomi/W-5573-2019; Studenovska, Hana/H-4251-2014; Proks, Vladimir/C-1642-2013; Vanicky, Ivo/ABB-2298-2021; Cleveland, Don/AAN-9783-2021	Studenovska, Hana/0000-0001-7917-1790; Chen, Peixi/0000-0002-7584-4609; Kupcova Skalnikova, Helena/0000-0003-0591-5018; Bravo-Hernandez, Mariana/0000-0001-8762-0357; Marsala, Martin/0000-0001-5048-6422; Tomori, Zoltan/0000-0002-0685-0247	National Sustainability Program I, of the Czech Ministry of Education, Youth and Sports [LO1609]; RVO [67985904]; Slovak Research and Development Agency [APVV-15-0665, APVV 14-0847]; Scientific Grant Agency of the Ministry of Education, Science, Research and Sport of the Slovak Republic; Slovak Academy of Sciences [VEGA 2/0086/16]; Czech Science Foundation [18-04393S]; NIH [R01-EB024015]; California Institute for Regenerative Medicine [LA1-C12-06919]; ALS Association; Sanford Porcine Center	National Sustainability Program I, of the Czech Ministry of Education, Youth and Sports; RVO; Slovak Research and Development Agency(Slovak Research and Development Agency); Scientific Grant Agency of the Ministry of Education, Science, Research and Sport of the Slovak Republic; Slovak Academy of Sciences(Slovak Academy of Sciences); Czech Science Foundation(Grant Agency of the Czech Republic); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); ALS Association; Sanford Porcine Center	H. Skalnikova, S.J. and J.J. are supported by the National Sustainability Program I, of the Czech Ministry of Education, Youth and Sports (no. LO1609) and RVO (no. 67985904). Z.T. is supported by the Slovak Research and Development Agency (APVV-15-0665) and by the Scientific Grant Agency of the Ministry of Education, Science, Research and Sport of the Slovak Republic and the Slovak Academy of Sciences (VEGA 2/0086/16). I.V. is supported by the Slovak Research and Development Agency (APVV 14-0847). H. Studenovska and V.P. are supported by the Czech Science Foundation (project no. 18-04393S). E.T.A is supported by the NIH (grant no. R01-EB024015) and the California Institute for Regenerative Medicine (grant no. LA1-C12-06919). B.K.K, D.W.C. and M.M. are supported by the ALS Association and Sanford Porcine Center.	Biferi MG, 2017, MOL THER, V25, P2038, DOI 10.1016/j.ymthe.2017.05.017; Boillee S, 2006, SCIENCE, V312, P1389, DOI 10.1126/science.1123511; Borel F, 2016, HUM GENE THER, V27, P1015, DOI 10.1089/hum.2015.122.correx2; Caravaca AS, 2017, J NEURAL ENG, V14, DOI 10.1088/1741-2552/aa7a42; Chapleau MW, 2011, HEART FAIL REV, V16, P109, DOI 10.1007/s10741-010-9174-6; Federici T, 2009, CTS-CLIN TRANSL SCI, V2, P165, DOI 10.1111/j.1752-8062.2008.00084.x; Filali M, 2011, BEHAV BRAIN RES, V225, P215, DOI 10.1016/j.bbr.2011.07.034; Foust KD, 2013, MOL THER, V21, P2148, DOI 10.1038/mt.2013.211; Gros-Louis F, 2010, J NEUROCHEM, V113, P1188, DOI 10.1111/j.1471-4159.2010.06683.x; Hefferan MP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042614; Herzog A, 1997, J NEUROSCI METH, V72, P57, DOI 10.1016/S0165-0270(96)00156-2; Howland DS, 2002, P NATL ACAD SCI USA, V99, P1604, DOI 10.1073/pnas.032539299; Iannitti T, 2018, MOL THER-NUCL ACIDS, V12, P75, DOI 10.1016/j.omtn.2018.04.015; Ilieva H, 2009, J CELL BIOL, V187, P761, DOI 10.1083/jcb.200908164; Kang SH, 2013, NAT NEUROSCI, V16, P571, DOI 10.1038/nn.3357; Kaur SJ, 2016, GENE, V577, P109, DOI 10.1016/j.gene.2015.11.049; Lai NC, 2012, HUM GENE THER, V23, P255, DOI 10.1089/hum.2011.094; Linden D, 1998, ELECTROMYOGR MOTOR C, V109, P387, DOI 10.1016/S0924-980X(98)00035-6; Matsumoto A, 2006, J NEUROSCI RES, V83, P119, DOI 10.1002/jnr.20708; McCampbell A, 2018, J CLIN INVEST, V128, P3558, DOI 10.1172/JCI99081; McGoldrick P, 2013, BBA-MOL BASIS DIS, V1832, P1421, DOI 10.1016/j.bbadis.2013.03.012; Miyanohara A, 2016, MOL THER-METH CLIN D, V3, DOI 10.1038/mtm.2016.46; Parone PA, 2013, J NEUROSCI, V33, P4657, DOI 10.1523/JNEUROSCI.1119-12.2013; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; Shemisa Kamal, 2014, J Med Case Rep, V8, P224, DOI 10.1186/1752-1947-8-224; Shimizu T, 1996, CLIN AUTON RES, V6, P241, DOI 10.1007/BF02291141; Smith RA, 2006, J CLIN INVEST, V116, P2290, DOI 10.1172/JCI25424; Stoica L, 2016, ANN NEUROL, V79, P687, DOI 10.1002/ana.24618; Tadokoro T, 2017, JOVE-J VIS EXP, V125, P55770; Tanaka Y, 2013, J NEUROL, V260, P2380, DOI 10.1007/s00415-013-7005-0; Usvald D, 2010, CELL TRANSPLANT, V19, P1103, DOI 10.3727/096368910X503406; van Zundert B, 2017, NEUROSCI LETT, V636, P32, DOI 10.1016/j.neulet.2016.07.059; Vecchia LD, 2015, PHYSIOL MEAS, V36, P659, DOI 10.1088/0967-3334/36/4/659; WONG PC, 1995, NEURON, V14, P1105, DOI 10.1016/0896-6273(95)90259-7; Xiao X, 1998, J VIROL, V72, P2224, DOI 10.1128/JVI.72.3.2224-2232.1998; Xu QH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032581; Yamanaka K, 2008, P NATL ACAD SCI USA, V105, P7594, DOI 10.1073/pnas.0802556105; Yamanaka K, 2008, NAT NEUROSCI, V11, P251, DOI 10.1038/nn2047	38	48	49	5	36	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JAN	2020	26	1					118	+		10.1038/s41591-019-0674-1	http://dx.doi.org/10.1038/s41591-019-0674-1			35	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	KG3GZ	31873312	Green Accepted			2022-12-27	WOS:000509831900035
J	Khan, S; Zhang, X; Lv, DW; Zhang, Q; He, YH; Zhang, PY; Liu, XG; Thummuri, D; Yuan, YX; Wiegand, JS; Pei, J; Zhang, WZ; Sharma, A; McCurdy, CR; Kuruvilla, VM; Baran, N; Ferrando, AA; Kim, YM; Rogojina, A; Houghton, PJ; Huang, GC; Hromas, R; Konopleva, M; Zheng, GR; Zhou, DH				Khan, Sajid; Zhang, Xuan; Lv, Dongwen; Zhang, Qi; He, Yonghan; Zhang, Peiyi; Liu, Xingui; Thummuri, Dinesh; Yuan, Yaxia; Wiegand, Janet S.; Pei, Jing; Zhang, Weizhou; Sharma, Abhisheak; McCurdy, Christopher R.; Kuruvilla, Vinitha M.; Baran, Natalia; Ferrando, Adolfo A.; Kim, Yong-mi; Rogojina, Anna; Houghton, Peter J.; Huang, Guangcun; Hromas, Robert; Konopleva, Marina; Zheng, Guangrong; Zhou, Daohong			A selective BCL-X-L PROTAC degrader achieves safe and potent antitumor activity	NATURE MEDICINE			English	Article							INDUCED PROTEIN-DEGRADATION; UBIQUITIN LIGASE; CANCER; FAMILY; INHIBITOR; VENETOCLAX; DISCOVERY; DEATH; NAVITOCLAX; KNOCKDOWN	B-cell lymphoma extra large (BCL-X-L) is a well-validated cancer target. However, the on-target and dose-limiting thrombocytopenia limits the use of BCL-X-L inhibitors, such as ABT263, as safe and effective anticancer agents. To reduce the toxicity of ABT263, we converted it into DT2216, a BCL-X-L proteolysis-targeting chimera (PROTAC), that targets BCL-X-L to the Von Hippel-Lindau (VHL) E3 ligase for degradation. We found that DT2216 was more potent against various BCL-X-L-dependent leukemia and cancer cells but considerably less toxic to platelets than ABT263 in vitro because VHL is poorly expressed in platelets. In vivo, DT2216 effectively inhibits the growth of several xenograft tumors as a single agent or in combination with other chemotherapeutic agents, without causing appreciable thrombocytopenia. These findings demonstrate the potential to use PROTAC technology to reduce on-target drug toxicities and rescue the therapeutic potential of previously undruggable targets. Furthermore, DT2216 may be developed as a safe first-in-class anticancer agent targeting BCL-X-L.	[Khan, Sajid; Lv, Dongwen; He, Yonghan; Liu, Xingui; Thummuri, Dinesh; Yuan, Yaxia; Wiegand, Janet S.; Pei, Jing; Zhou, Daohong] Univ Florida, Dept Pharmacodynam, Gainesville, FL 32610 USA; [Zhang, Xuan; Zhang, Peiyi; McCurdy, Christopher R.; Zheng, Guangrong] Univ Florida, Coll Pharm, Dept Med Chem, Gainesville, FL 32610 USA; [Zhang, Qi; Kuruvilla, Vinitha M.; Baran, Natalia; Konopleva, Marina] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA; [Zhang, Weizhou] Univ Florida, Coll Med, Dept Pathol Immunol & Lab Med, Gainesville, FL USA; [Sharma, Abhisheak] Univ Florida, Coll Pharm, Dept Pharmaceut, Gainesville, FL 32610 USA; [Ferrando, Adolfo A.] Columbia Univ, Dept Pediat Pathol Cell Biol & Syst Biol, New York, NY USA; [Ferrando, Adolfo A.] Columbia Univ, Inst Canc Genet, New York, NY USA; [Kim, Yong-mi] Childrens Hosp Los Angeles, Dept Pediat, Los Angeles, CA 90027 USA; [Rogojina, Anna; Houghton, Peter J.] Univ Texas Hlth Sci Ctr San Antonio, Greehey Childrens Canc Res Inst, San Antonio, TX 78229 USA; [Huang, Guangcun; Hromas, Robert] Univ Texas Hlth Sci Ctr San Antonio, Dept Med, Long Sch Med, San Antonio, TX 78229 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; University of Texas System; UTMD Anderson Cancer Center; State University System of Florida; University of Florida; State University System of Florida; University of Florida; Columbia University; Columbia University; Children's Hospital Los Angeles; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio	Zhou, DH (corresponding author), Univ Florida, Dept Pharmacodynam, Gainesville, FL 32610 USA.; Zheng, GR (corresponding author), Univ Florida, Coll Pharm, Dept Med Chem, Gainesville, FL 32610 USA.	zhengg@cop.ufl.edu; zhoudaohong@cop.ufl.edu	Lv, DongWen/H-2693-2016; Baran, Natalia/AFQ-7237-2022; Khan, Sajid/AAR-8954-2020; Sharma, Abhisheak/V-8401-2017; kim, y/AAR-6095-2020; khan, sajid/HGE-2406-2022; He, Yonghan/P-7271-2014; Huang, Guangcun/B-8399-2008; ZHANG, XUAN/L-4393-2017	Lv, DongWen/0000-0003-4677-8996; Baran, Natalia/0000-0003-0618-4798; Khan, Sajid/0000-0003-1331-8846; Sharma, Abhisheak/0000-0003-0553-4039; He, Yonghan/0000-0003-4409-4590; Huang, Guangcun/0000-0003-1695-1153; Liu, Xingui/0000-0003-2659-8007; ZHANG, XUAN/0000-0001-6062-6708; Kim, Yong-Mi/0000-0003-3793-6438	US National Institutes of Health (NIH) [R01 CA211963, R01 CA219836, R01 GM109645, R01 CA205224, R01 CA200673, R01 CA203834, R21 CA223371, R35 CA210065, R01 CA172809]; Department of Defense [BC180227]; Schwab Charitable fund; CPRIT [RP160716]; NATIONAL CANCER INSTITUTE [R01CA200673, R01CA203834, R01CA219836, R01CA211963, R01CA242003] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); Schwab Charitable fund; CPRIT; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by US National Institutes of Health (NIH) grants R01 CA211963 (D.Z.), R01 CA219836 (D.Z.), R01 GM109645 (R.H.), R01 CA205224 (R.H.), R01 CA200673 (W.Z.), R01 CA203834 (W.Z.), R21 CA223371 (G.Z.), R35 CA210065 (A.F.), R01 CA172809 (Y.-M.K.), Department of Defense grant BC180227 (W.Z.), the Schwab Charitable fund (M.K.) and CPRIT grant RP160716 (P.J.H.). Mass spectrometric support was provided by Alan J. Tackett and Samuel G. Mackintosh in the UAMS Proteomics Core Facility.	Ackler S, 2010, CANCER CHEMOTH PHARM, V66, P869, DOI 10.1007/s00280-009-1232-1; Adams JM, 2007, ONCOGENE, V26, P1324, DOI 10.1038/sj.onc.1210220; Amundson SA, 2000, CANCER RES, V60, P6101; Ashkenazi A, 2017, NAT REV DRUG DISCOV, V16, P273, DOI 10.1038/nrd.2016.253; Berger S, 2016, ELIFE, V5, DOI [10.7554/elife.20352, 10.7554/eLife.20352]; Bondeson DP, 2018, CELL CHEM BIOL, V25, P78, DOI 10.1016/j.chembiol.2017.09.010; Bondeson DP, 2015, NAT CHEM BIOL, V11, P611, DOI [10.1038/NCHEMBIO.1858, 10.1038/nchembio.1858]; Bray PF, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-1; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chen J, 2011, MOL CANCER THER, V10, P2340, DOI 10.1158/1535-7163.MCT-11-0415; Churcher I, 2018, J MED CHEM, V61, P444, DOI 10.1021/acs.jmedchem.7b01272; Deeks ED, 2016, DRUGS, V76, P979, DOI 10.1007/s40265-016-0596-x; Delbridge ARD, 2015, CELL DEATH DIFFER, V22, P1071, DOI 10.1038/cdd.2015.50; Delbridge ARD, 2016, NAT REV CANCER, V16, P99, DOI 10.1038/nrc.2015.17; Deshaies RJ, 2015, NAT CHEM BIOL, V11, P634, DOI 10.1038/nchembio.1887; Farmer T, 2019, MOL BIOL CELL, V30, P1138, DOI 10.1091/mbc.E19-01-0044; FDA, 2018, BIOAN METH VAL GUID; Gadd MS, 2017, NAT CHEM BIOL, V13, P514, DOI [10.1038/NCHEMBIO.2329, 10.1038/nchembio.2329]; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Garner TP, 2017, CURR OPIN CHEM BIOL, V39, P133, DOI 10.1016/j.cbpa.2017.06.014; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hikita H, 2009, HEPATOLOGY, V50, P1217, DOI 10.1002/hep.23126; Huang HT, 2018, CELL CHEM BIOL, V25, P88, DOI 10.1016/j.chembiol.2017.10.005; Igney FH, 2002, NAT REV CANCER, V2, P277, DOI 10.1038/nrc776; Itchaki G, 2016, THER ADV HEMATOL, V7, P270, DOI 10.1177/2040620716655350; Kaefer A, 2014, CANCER CHEMOTH PHARM, V74, P593, DOI 10.1007/s00280-014-2530-9; Kissopoulou A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081809; Koch R, 2019, BLOOD, V133, P566, DOI 10.1182/blood-2018-07-865527; Kotschy A, 2016, NATURE, V538, P477, DOI 10.1038/nature19830; Lai AC, 2017, NAT REV DRUG DISCOV, V16, P101, DOI 10.1038/nrd.2016.211; Lai AC, 2016, ANGEW CHEM INT EDIT, V55, P807, DOI 10.1002/anie.201507634; Leverson JD, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa4642; Lu J, 2015, CHEM BIOL, V22, P755, DOI 10.1016/j.chembiol.2015.05.009; Lv DW, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006868; Mason KD, 2007, CELL, V128, P1173, DOI 10.1016/j.cell.2007.01.037; Morowski M, 2013, BLOOD, V121, P4938, DOI 10.1182/blood-2012-10-461459; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Nowak RP, 2018, NAT CHEM BIOL, V14, P706, DOI 10.1038/s41589-018-0055-y; Ohoka N, 2016, CURR CANCER DRUG TAR, V16, P136, DOI 10.2174/1568009616666151112122502; Oltersdorf T, 2005, NATURE, V435, P677, DOI 10.1038/nature03579; Opferman JT, 2016, FEBS J, V283, P2661, DOI 10.1111/febs.13472; Perini GF, 2018, J HEMATOL ONCOL, V11, DOI 10.1186/s13045-018-0608-2; Pompili L, 2016, J EXP CLIN CANC RES, V35, DOI 10.1186/s13046-016-0462-4; Raina K, 2016, P NATL ACAD SCI USA, V113, P7124, DOI 10.1073/pnas.1521738113; Reed JC, 2008, BLOOD, V111, P3322, DOI 10.1182/blood-2007-09-078162; Riching KM, 2018, ACS CHEM BIOL, V13, P2758, DOI 10.1021/acschembio.8b00692; Rinder HM, 1998, BLOOD, V91, P1288, DOI 10.1182/blood.V91.4.1288; Roberts AW, 2016, NEW ENGL J MED, V374, P311, DOI 10.1056/NEJMoa1513257; Runcie AC, 2016, CURR OPIN CHEM BIOL, V33, P186, DOI 10.1016/j.cbpa.2016.06.031; Saenz DT, 2017, LEUKEMIA, V31, P1951, DOI 10.1038/leu.2016.393; Schoenwaelder SM, 2011, BLOOD, V118, P1663, DOI 10.1182/blood-2011-04-347849; Singh R, 2019, NAT REV MOL CELL BIO, V20, P175, DOI 10.1038/s41580-018-0089-8; Smith BE, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-08027-7; Souers AJ, 2013, NAT MED, V19, P202, DOI 10.1038/nm.3048; Tao ZF, 2014, ACS MED CHEM LETT, V5, P1088, DOI 10.1021/ml5001867; Thomas S, 2013, EXPERT OPIN THER TAR, V17, P61, DOI 10.1517/14728222.2013.733001; Tse C, 2008, CANCER RES, V68, P3421, DOI 10.1158/0008-5472.CAN-07-5836; Tyanova S, 2016, NAT METHODS, V13, P731, DOI [10.1038/nmeth.3901, 10.1038/NMETH.3901]; Vizcaino JA, 2013, NUCLEIC ACIDS RES, V41, pD1063, DOI 10.1093/nar/gks1262; Vogler M., 2014, J ADV MED, V2014; Vogler M, 2011, BLOOD, V117, P7145, DOI 10.1182/blood-2011-03-344812; Winter GE, 2015, SCIENCE, V348, P1376, DOI 10.1126/science.aab1433; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/NMETH.1322, 10.1038/nmeth.1322]; Zengerle M, 2015, ACS CHEM BIOL, V10, P1770, DOI 10.1021/acschembio.5b00216	64	194	195	25	130	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	2019	25	12					1938	+		10.1038/s41591-019-0668-z	http://dx.doi.org/10.1038/s41591-019-0668-z			26	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	JT2KO	31792461	Green Accepted			2022-12-27	WOS:000500824900037
J	Ralston, J; Nugent, R				Ralston, Johanna; Nugent, Rachel			Toward a broader response to cardiometabolic disease	NATURE MEDICINE			English	Editorial Material								Cardiometabolic disease is the leading cause of death and disability in the world, driven in part by the rise in unhealthy diets, poor air quality and other byproducts of economic development. A new economic model is needed, one that places people rather than profits at its center.	[Ralston, Johanna] World Obes Federat, London, England; [Nugent, Rachel] RTI Int, Seattle, WA USA	Research Triangle Institute	Ralston, J (corresponding author), World Obes Federat, London, England.	jralston@worldobesity.org; rnugent@rti.org		Nugent, Rachel/0000-0001-6421-9077				Alleyne G, 2013, LANCET, V381, P566, DOI 10.1016/S0140-6736(12)61806-6; Collins T, 2018, GLOB PUBLIC HEALTH, V13, P1152, DOI 10.1080/17441692.2017.1394481; Dieleman JL, 2016, LANCET, V387, P2536, DOI 10.1016/S0140-6736(16)30168-4; Gies E, 2017, NATURE, V551, pS145, DOI 10.1038/d41586-017-07510-3; Jamison DT, 2013, LANCET, V382, P1898, DOI 10.1016/S0140-6736(13)62105-4; Kemm J., 2004, HLTH IMPACT ASSESSME; Kraay A., 2018, METHODOLOGY WORLD BA; Mendenhall E, 2017, LANCET, V389, P951, DOI 10.1016/S0140-6736(17)30402-6; Niessen LW, 2018, LANCET, V391, P2036, DOI [10.1016/S0140-6736(18)30482-3, 10.1016/s0140-6736(18)30482-3]; Nugent R, 2019, LANCET, V394, P622, DOI 10.1016/S0140-6736(19)31762-3; Nugent R, 2018, LANCET, V391, P2029, DOI 10.1016/S0140-6736(18)30667-6; Stiglitz J., 2009, MEASUREMENT EC PERFO; Whitmee S, 2015, LANCET, V386, P1973, DOI 10.1016/S0140-6736(15)60901-1; WHO Commission on Macroeconomics and Health, 2001, MACR HLTH INV HLTH E	14	17	23	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2019	25	11					1644	1646		10.1038/s41591-019-0642-9	http://dx.doi.org/10.1038/s41591-019-0642-9			3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	JT2KI	31700172				2022-12-27	WOS:000500824300010
J	Zalocusky, KA; Nelson, MR; Huang, YD				Zalocusky, Kelly A.; Nelson, Maxine R.; Huang, Yadong			NEURODEGENERATION An Alzheimer's-disease-protective APOE mutation	NATURE MEDICINE			English	Editorial Material							APOLIPOPROTEIN-E; RISK	Homozygous APOE3-Christchurch (R136S) mutation protects a presenilin 1 (PSEN1) mutation carrier from developing Alzheimer's disease until her seventies.	[Zalocusky, Kelly A.; Nelson, Maxine R.; Huang, Yadong] Gladstone Inst Neurol Dis, San Francisco, CA 94158 USA; [Zalocusky, Kelly A.; Huang, Yadong] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94115 USA; [Nelson, Maxine R.; Huang, Yadong] Univ Calif San Francisco, Biomed Sci Program, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Huang, YD (corresponding author), Gladstone Inst Neurol Dis, San Francisco, CA 94158 USA.; Huang, YD (corresponding author), Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94115 USA.; Huang, YD (corresponding author), Univ Calif San Francisco, Biomed Sci Program, San Francisco, CA 94143 USA.	yadong.huang@gladstone.ucsf.edu		Huang, Yadong/0000-0002-5871-4589; Nelson, Maxine/0000-0003-1990-5099				Acosta-Baena N, 2011, LANCET NEUROL, V10, P213, DOI 10.1016/S1474-4422(10)70323-9; Arboleda-Velasquez JF, 2019, NAT MED, V25, P1680, DOI 10.1038/s41591-019-0611-3; Chen J, 2012, PROCEEDINGS OF THE 2ND INTERNATIONAL CONFERENCE ON COMPUTER AND INFORMATION APPLICATIONS (ICCIA 2012), P1204; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Liu CC, 2013, NAT REV NEUROL, V9, P106, DOI 10.1038/nrneurol.2012.263; Mahley RW, 1999, J LIPID RES, V40, P1933; Najm R, 2019, MOL NEURODEGENER, V14, DOI 10.1186/s13024-019-0324-6; Quiroz YT, 2018, JAMA NEUROL, V75, P548, DOI 10.1001/jamaneurol.2017.4907; Rauch JN, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-24904-z; Wang CZ, 2018, NAT MED, V24, P647, DOI 10.1038/s41591-018-0004-z	10	9	9	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2019	25	11					1648	1649		10.1038/s41591-019-0634-9	http://dx.doi.org/10.1038/s41591-019-0634-9			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	JT2KI	31686033				2022-12-27	WOS:000500824300016
J	Jin, SC; Dong, WL; Kundishora, AJ; Panchagnula, S; Moreno-De-Luca, A; Furey, CG; Allocco, AA; Walker, RL; Nelson-Williams, C; Smith, H; Dunbar, A; Conine, S; Lu, QS; Zeng, X; Sierant, MC; Knight, JR; Sullivan, W; Duy, PQ; DeSpenza, T; Reeves, BC; Karimy, JK; Marlier, A; Castaldi, C; Tikhonova, IR; Li, BY; Pena, HP; Broach, JR; Kabachelor, EM; Ssenyonga, P; Hehnly, C; Ge, L; Keren, B; Timberlake, AT; Goto, J; Mangano, FT; Johnston, JM; Butler, WE; Warf, BC; Smith, ER; Schiff, SJ; Limbrick, DD; Heuer, G; Jackson, EM; Iskandar, BJ; Mane, S; Haider, S; Guclu, B; Bayri, Y; Sahin, Y; Duncan, CC; Apuzzo, MLJ; DiLuna, ML; Hoffman, EJ; Sestan, N; Ment, LR; Alper, SL; Bilguvar, K; Geschwind, DH; Gunel, M; Lifton, RP; Kahle, KT				Jin, Sheng Chih; Dong, Weilai; Kundishora, Adam J.; Panchagnula, Shreyas; Moreno-De-Luca, Andres; Furey, Charuta G.; Allocco, August A.; Walker, Rebecca L.; Nelson-Williams, Carol; Smith, Hannah; Dunbar, Ashley; Conine, Sierra; Lu, Qiongshi; Zeng, Xue; Sierant, Michael C.; Knight, James R.; Sullivan, William; Duy, Phan Q.; DeSpenza, Tyrone; Reeves, Benjamin C.; Karimy, Jason K.; Marlier, Arnaud; Castaldi, Christopher; Tikhonova, Irina R.; Li, Boyang; Pena, Helena Perez; Broach, James R.; Kabachelor, Edith M.; Ssenyonga, Peter; Hehnly, Christine; Ge, Li; Keren, Boris; Timberlake, Andrew T.; Goto, June; Mangano, Francesco T.; Johnston, James M.; Butler, William E.; Warf, Benjamin C.; Smith, Edward R.; Schiff, Steven J.; Limbrick, David D., Jr.; Heuer, Gregory; Jackson, Eric M.; Iskandar, Bermans J.; Mane, Shrikant; Haider, Shozeb; Guclu, Bulent; Bayri, Yasar; Sahin, Yener; Duncan, Charles C.; Apuzzo, Michael L. J.; DiLuna, Michael L.; Hoffman, Ellen J.; Sestan, Nenad; Ment, Laura R.; Alper, Seth L.; Bilguvar, Kaya; Geschwind, Daniel H.; Gunel, Murat; Lifton, Richard P.; Kahle, Kristopher T.			Exome sequencing implicates genetic disruption of prenatal neuro-gliogenesis in sporadic congenital hydrocephalus	NATURE MEDICINE			English	Article							DE-NOVO MUTATION; VENTRICULAR ZONE DISRUPTION; COWDEN-SYNDROME; PTEN; SPECTRUM; CHILDREN; AUTISM; RARE; EXPRESSION; FRAMEWORK	Congenital hydrocephalus (CH), characterized by enlarged brain ventricles, is considered a disease of excessive cerebrospinal fluid (CSF) accumulation and thereby treated with neurosurgical CSF diversion with high morbidity and failure rates. The poor neurodevelopmental outcomes and persistence of ventriculomegaly in some post-surgical patients highlight our limited knowledge of disease mechanisms. Through whole-exome sequencing of 381 patients (232 trios) with sporadic, neurosurgically treated CH, we found that damaging de novo mutations account for >17% of cases, with five different genes exhibiting a significant de novo mutation burden. In all, rare, damaging mutations with large effect contributed to similar to 22% of sporadic CH cases. Multiple CH genes are key regulators of neural stem cell biology and converge in human transcriptional networks and cell types pertinent for fetal neuro-gliogenesis. These data implicate genetic disruption of early brain development, not impaired CSF dynamics, as the primary pathomechanism of a significant number of patients with sporadic CH.	[Jin, Sheng Chih; Dong, Weilai; Zeng, Xue; Sierant, Michael C.; Lifton, Richard P.] Rockefeller Univ, Lab Human Genet & Gen, 1230 York Ave, New York, NY 10021 USA; [Jin, Sheng Chih; Dong, Weilai; Nelson-Williams, Carol; Zeng, Xue; Sierant, Michael C.; Knight, James R.; Mane, Shrikant; Bilguvar, Kaya; Gunel, Murat; Lifton, Richard P.; Kahle, Kristopher T.] Yale Univ, Sch Med, Dept Genet, New Haven, CT 06510 USA; [Jin, Sheng Chih] Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA; [Kundishora, Adam J.; Panchagnula, Shreyas; Furey, Charuta G.; Allocco, August A.; Smith, Hannah; Dunbar, Ashley; Conine, Sierra; Sullivan, William; Duy, Phan Q.; DeSpenza, Tyrone; Reeves, Benjamin C.; Karimy, Jason K.; Marlier, Arnaud; Duncan, Charles C.; Apuzzo, Michael L. J.; DiLuna, Michael L.; Gunel, Murat; Kahle, Kristopher T.] Yale Univ, Sch Med, Dept Neurosurg, New Haven, CT 06520 USA; [Moreno-De-Luca, Andres] Geisinger, Genom Med Inst, Autism & Dev Med Inst, Dept Radiol, Danville, PA USA; [Furey, Charuta G.] Barrow Neurol Inst, Dept Neurosurg, Phoenix, AZ 85013 USA; [Walker, Rebecca L.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Ctr Autism Res & Treatment,Semel Inst, Los Angeles, CA 90095 USA; [Lu, Qiongshi; Ge, Li] Univ Wisconsin, Dept Biostat & Med Informat, Madison, WI USA; [Knight, James R.; Castaldi, Christopher; Tikhonova, Irina R.; Mane, Shrikant; Bilguvar, Kaya] Yale Univ, Yale Ctr Genome Anal, New Haven, CT USA; [Li, Boyang] Yale Sch Publ Hlth, Dept Biostat, New Haven, CT USA; [Pena, Helena Perez; Haider, Shozeb] UCL, Dept Pharmaceut & Biol Chem, Sch Pharm, London, England; [Broach, James R.] Penn State Coll Med, Inst Personalized Med, Hershey, PA USA; [Kabachelor, Edith M.; Ssenyonga, Peter] CURE Childrens Hosp Uganda, Mbale, Uganda; [Hehnly, Christine; Schiff, Steven J.] Penn State Univ, Dept Neurosurg, University Pk, PA 16802 USA; [Hehnly, Christine; Schiff, Steven J.] Penn State Univ, Dept Engn Sci & Mech, 227 Hammond Bldg, University Pk, PA 16802 USA; [Hehnly, Christine; Schiff, Steven J.] Penn State Univ, Dept Phys, 104 Davey Lab, University Pk, PA 16802 USA; [Hehnly, Christine; Schiff, Steven J.] Penn State Univ, Ctr Neural Engn & Infect Dis Dynam, University Pk, PA 16802 USA; [Keren, Boris] Sorbonne Univ, GRC Deficience Intellectuelle & Autisme, Ctr Reference Deficiences Intellectuelles Causes, Grp Hosp Pitie Salpetriere,Dept Genet, Paris, France; [Keren, Boris] Sorbonne Univ, GRC Deficience Intellectuelle & Autisme, GHUEP Hop Trousseau, Paris, France; [Timberlake, Andrew T.] NYU, Langone Med Ctr, Hansjorg Wyss Dept Plast Surg, New York, NY USA; [Goto, June; Mangano, Francesco T.] Cincinnati Childrens Hosp Med Ctr, Div Pediat Neurosurg, Cincinnati, OH 45229 USA; [Johnston, James M.] Univ Alabama Birmingham, Sch Med, Dept Neurosurg, Birmingham, AL USA; [Butler, William E.] Harvard Med Sch, Massachusetts Gen Hosp, Dept Neurosurg, Boston, MA 02115 USA; [Warf, Benjamin C.; Smith, Edward R.] Harvard Med Sch, Dept Neurosurg, Boston Childrens Hosp, Boston, MA 02115 USA; [Limbrick, David D., Jr.] Washington Univ, Sch Med, Dept Neurol Surg & Pediat, St Louis, MO USA; [Heuer, Gregory] Hosp Univ Penn, Dept Neurosurg, 3400 Spruce St, Philadelphia, PA 19104 USA; [Heuer, Gregory] Childrens Hosp Philadelphia, Div Neurosurg, Philadelphia, PA 19104 USA; [Jackson, Eric M.] Johns Hopkins Sch Med, Dept Neurosurg, Baltimore, MD USA; [Iskandar, Bermans J.] Univ Wisconsin, Sch Med, Dept Neurol Surg, Madison, WI USA; [Guclu, Bulent] Kartal Dr Lutfi Kirdar Res & Training Hosp, Istanbul, Turkey; [Bayri, Yasar; Sahin, Yener] Marmara Univ, Dept Neurosurg, Sch Med, Istanbul, Turkey; [Hoffman, Ellen J.] Yale Univ, Sch Med, Yale Child Study Ctr, New Haven, CT USA; [Sestan, Nenad] Yale Sch Med, Dept Neurosci, New Haven, CT USA; [Sestan, Nenad] Yale Sch Med, Kavli Inst Neurosci, New Haven, CT USA; [Ment, Laura R.] Yale Univ, Sch Med, Dept Pediat, New Haven, CT 06510 USA; [Ment, Laura R.] Yale Univ, Sch Med, Dept Neurol, New Haven, CT 06510 USA; [Alper, Seth L.] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Div Nephrol, Dept Med, Boston, MA 02115 USA; [Geschwind, Daniel H.] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Vasc Biol Res Ctr, Dept Med, Boston, MA 02115 USA; [Geschwind, Daniel H.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA; [Kahle, Kristopher T.] Yale Univ, Sch Med, Dept Cellular & Mol Physiol, New Haven, CT 06510 USA	Rockefeller University; Yale University; Washington University (WUSTL); Yale University; Barrow Neurological Institute; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Wisconsin System; University of Wisconsin Madison; Yale University; Yale University; University of London; University College London; University of London School of Pharmacy; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; New York University; NYU Langone Medical Center; Cincinnati Children's Hospital Medical Center; University of Alabama System; University of Alabama Birmingham; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Boston Children's Hospital; Harvard Medical School; Washington University (WUSTL); University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Johns Hopkins University; Johns Hopkins Medicine; University of Wisconsin System; University of Wisconsin Madison; Istanbul Kartal Dr Lutfi Kirdar Training & Research Hospital; Marmara University; Yale University; Yale University; Yale University; Yale University; Yale University; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Yale University	Kahle, KT (corresponding author), Yale Univ, Sch Med, Dept Genet, New Haven, CT 06510 USA.; Kahle, KT (corresponding author), Yale Univ, Sch Med, Dept Neurosurg, New Haven, CT 06520 USA.	kristopher.kahle@yale.edu	Ge, Li/AAF-6253-2021; şahin, yener/AAA-1891-2021; De Luca, Andres Moreno/AAB-3570-2021; Lu, Qiongshi/AAF-5002-2021	şahin, yener/0000-0001-9539-357X; De Luca, Andres Moreno/0000-0002-2732-4043; Lu, Qiongshi/0000-0002-4514-0969; Hehnly, Christine/0000-0003-3739-0690; Smith, Edward/0000-0002-6317-8450; Jin, Sheng Chih/0000-0002-5777-7262; Goto, June/0000-0002-4000-9750; Furey, Charuta/0000-0003-3313-2563; Johnston, James/0000-0001-8564-1808; Dong, Weilai/0000-0002-8376-1758; DeSpenza Jr., Tyrone/0000-0002-3789-6440; Reeves, Benjamin/0000-0002-5924-6991	Hydrocephalus Association (HA); Yale-National Institutes of Health (NIH) Center for Mendelian Genomics [5U54HG006504]; NIH Director's Pioneer Award [DP1HD086071]; NIH Director's Transformative Award [1R01AI145057]; NIH Medical Scientist Training Program (NIH/National Institute of General Medical Sciences) [T32GM007205]; NIH Clinical and Translational Science Award from the National Center for Advancing Translational Science [TL1 TR001864]; James Hudson Brown - Alexander B. Coxe Fellowship at Yale School of Medicine; American Heart Association Postdoctoral Fellowship [18POST34060008]; K99/R00 Pathway to Independence Award [K99HL143036, R00HL143036-02]; American Heart Association Predoctoral Fellowship [19PRE34380842]; Pediatric Hydrocephalus Foundation; Rudi Schulte Research Institute;  [R01 NS111029-01A1];  [R01 NS109358];  [K12 228168]	Hydrocephalus Association (HA); Yale-National Institutes of Health (NIH) Center for Mendelian Genomics; NIH Director's Pioneer Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Director's Transformative Award; NIH Medical Scientist Training Program (NIH/National Institute of General Medical Sciences); NIH Clinical and Translational Science Award from the National Center for Advancing Translational Science; James Hudson Brown - Alexander B. Coxe Fellowship at Yale School of Medicine; American Heart Association Postdoctoral Fellowship(American Heart Association); K99/R00 Pathway to Independence Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association Predoctoral Fellowship(American Heart Association); Pediatric Hydrocephalus Foundation; Rudi Schulte Research Institute; ; ; 	We are grateful to the patients and their families who participated in this research. We thank the Hydrocephalus Association (HA) for their support. We also thank J. Koschnitzky (HA), J. Rockefeller (Yale), J. Freeman (Yale) and J. Nicolleli (Yale) for their help and support. This work is supported by the Yale-National Institutes of Health (NIH) Center for Mendelian Genomics (5U54HG006504); NIH Director's Pioneer Award DP1HD086071 and NIH Director's Transformative Award 1R01AI145057 (S.J.S.); R01 NS111029-01A1, R01 NS109358, K12 228168 and the Rudi Schulte Research Institute (K.K.); NIH Medical Scientist Training Program (NIH/National Institute of General Medical Sciences Grant T32GM007205); NIH Clinical and Translational Science Award from the National Center for Advancing Translational Science (TL1 TR001864); James Hudson Brown - Alexander B. Coxe Fellowship at Yale School of Medicine, the American Heart Association Postdoctoral Fellowship (18POST34060008), the K99/R00 Pathway to Independence Award (K99HL143036 and R00HL143036-02) (S.C.J.); the American Heart Association Predoctoral Fellowship (19PRE34380842, W.D.); the Pediatric Hydrocephalus Foundation (P.H.F.). We thank M. C. Kruer at Phoenix Children's Hospital and H. Zhao at Yale School of Public Health for critical discussion.	Albright AL., 2008, PRINCIPLES PRACTICE; Baynam G, 2015, AM J MED GENET A, V167, P1659, DOI 10.1002/ajmg.a.37070; Bondurant CP, 1995, PEDIATR NEUROSURG, V23, P254, DOI 10.1159/000120968; Bult CJ, 2019, NUCLEIC ACIDS RES, V47, pD801, DOI 10.1093/nar/gky1056; Chalhoub N, 2009, ANNU REV PATHOL-MECH, V4, P127, DOI 10.1146/annurev.pathol.4.110807.092311; Chen HH, 2017, J ALLERGY CLIN IMMUN, V139, P607, DOI 10.1016/j.jaci.2016.03.059; CHERVENAK FA, 1984, LANCET, V2, P179; Da GP, 2006, P NATL ACAD SCI USA, V103, P2057, DOI 10.1073/pnas.0510949103; Divina P, 2009, EUR J HUM GENET, V17, P759, DOI 10.1038/ejhg.2008.257; Dogruluk T, 2015, CANCER RES, V75, P5341, DOI 10.1158/0008-5472.CAN-15-1654; Dong CL, 2015, HUM MOL GENET, V24, P2125, DOI 10.1093/hmg/ddu733; Duran D, 2019, NEURON, V101, P429, DOI 10.1016/j.neuron.2018.11.041; Etchegaray A, 2020, CHILD NERV SYST, V36, P1645, DOI 10.1007/s00381-020-04526-5; Foerster P, 2017, DEVELOPMENT, V144, P201, DOI 10.1242/dev.138271; Furey CG, 2018, NEURON, V99, P302, DOI 10.1016/j.neuron.2018.06.019; Garrison E., 2012, ARXIV PREP ARXIV, V1207, P3907, DOI [10.48550/arXiv.1207.3907, DOI 10.48550/ARXIV.1207.3907]; Gavino C, 2011, MOL CELL NEUROSCI, V47, P100, DOI 10.1016/j.mcn.2011.03.004; Gilmore JH, 2001, SCHIZOPHR RES, V48, P219, DOI 10.1016/S0920-9964(00)00140-7; Groszer M, 2001, SCIENCE, V294, P2186, DOI 10.1126/science.1065518; Harmacek L, 2014, DEV NEUROBIOL, V74, P483, DOI 10.1002/dneu.22142; Haverkamp F, 1999, EUR J PEDIATR, V158, P474, DOI 10.1007/s004310051123; Hehr U, 2007, NEUROGENETICS, V8, P279, DOI 10.1007/s10048-007-0096-y; Henzi R, 2020, CELL TISSUE RES, V381, P141, DOI 10.1007/s00441-020-03182-0; Iossifov I, 2014, NATURE, V515, P216, DOI 10.1038/nature13908; Jacquet BV, 2009, DEVELOPMENT, V136, P4021, DOI 10.1242/dev.041129; Jin SC, 2017, NAT GENET, V49, P1593, DOI 10.1038/ng.3970; Kahle KT, 2016, LANCET, V387, P788, DOI 10.1016/S0140-6736(15)60694-8; Karczewski KJ, 2020, NATURE, V581, P434, DOI 10.1038/s41586-020-2308-7; Keppler-Noreuil KM, 2016, AM J MED GENET C, V172, P402, DOI 10.1002/ajmg.c.31531; Kousi M, 2016, ANNU REV NEUROSCI, V39, P409, DOI 10.1146/annurev-neuro-070815-014023; Krumm N, 2015, NAT GENET, V47, P582, DOI 10.1038/ng.3303; Kurata H, 2018, BRAIN DEV-JPN, V40, P36, DOI 10.1016/j.braindev.2017.07.005; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Li J., 2018, SCI REP-UK, V8, P1, DOI DOI 10.1038/S41598-017-18546-W; Li L, 2003, J CELL BIOCHEM, V88, P24, DOI 10.1002/jcb.10312; Li MF, 2018, SCIENCE, V362, P1264, DOI 10.1126/science.aat7615; Lian GW, 2019, CEREB CORTEX, V29, P1938, DOI 10.1093/cercor/bhy073; Lian GW, 2016, DEVELOPMENT, V143, P4509, DOI 10.1242/dev.139295; Lindquist B, 2006, EUR CHILD ADOLES PSY, V15, P214, DOI 10.1007/s00787-006-0525-8; Liu PX, 2009, NAT REV DRUG DISCOV, V8, P627, DOI 10.1038/nrd2926; Manzini MC, 2012, AM J HUM GENET, V91, P541, DOI 10.1016/j.ajhg.2012.07.009; Martinez-Glez V, 2010, AM J MED GENET A, V152A, P3101, DOI 10.1002/ajmg.a.33514; McAllister JP, 2017, J NEUROPATH EXP NEUR, V76, P358, DOI 10.1093/jnen/nlx017; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Mcrae JF, 2017, NATURE, V542, P433, DOI 10.1038/nature21062; Mirzaa GM, 2016, JAMA NEUROL, V73, P836, DOI 10.1001/jamaneurol.2016.0363; Guerra MM, 2015, J NEUROPATH EXP NEUR, V74, P653, DOI 10.1097/NEN.0000000000000203; Movsas TZ, 2013, J PEDIATR-US, V163, P73, DOI 10.1016/j.jpeds.2012.12.084; Narayanan R, 2015, CELL REP, V13, P1842, DOI 10.1016/j.celrep.2015.10.046; O'Rourke DJ, 2012, CLIN DYSMORPHOL, V21, P91, DOI 10.1097/MCD.0b013e328351639d; Oda K, 2008, CANCER RES, V68, P8127, DOI 10.1158/0008-5472.CAN-08-0755; Palma V, 2005, DEVELOPMENT, V132, P335, DOI 10.1242/dev.01567; Palma V, 2004, DEVELOPMENT, V131, P337, DOI 10.1242/dev.00930; Palmen SJMC, 2005, PSYCHOL MED, V35, P561, DOI 10.1017/S0033291704003496; Duy PQ, 2019, TRENDS MOL MED, V25, P467, DOI 10.1016/j.molmed.2019.03.004; Pilarski R, 2004, J MED GENET, V41, P323, DOI 10.1136/jmg.2004.018036; Polioudakis D, 2019, NEURON, V103, P785, DOI 10.1016/j.neuron.2019.06.011; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Raudvere U, 2019, NUCLEIC ACIDS RES, V47, pW191, DOI 10.1093/nar/gkz369; Riviere JB, 2012, NAT GENET, V44, P934, DOI 10.1038/ng.2331; Ruzzo EK, 2019, CELL, V178, P850, DOI 10.1016/j.cell.2019.07.015; Samocha K. E., 2017, REGIONAL MISSENSE CO, DOI [10.1101/148353, DOI 10.1101/148353]; Samocha KE, 2014, NAT GENET, V46, P944, DOI 10.1038/ng.3050; Sarquis MS, 2006, AM J HUM GENET, V79, P23, DOI 10.1086/504392; Satterstrom FK, 2020, CELL, V180, P568, DOI 10.1016/j.cell.2019.12.036; Schonichen A, 2010, BBA-MOL CELL RES, V1803, P152, DOI 10.1016/j.bbamcr.2010.01.014; Shaheen R, 2017, ANN NEUROL, V81, P890, DOI 10.1002/ana.24964; Van der Auwera Geraldine A, 2013, Curr Protoc Bioinformatics, V43, DOI [10.1002/0471250953.bi1201s43, 10.1002/0471250953.bi1110s43]; Taliun Daniel, 2021, Nature, V590, P290, DOI 10.1038/s41586-021-03205-y; Tissir F, 2013, NAT REV NEUROSCI, V14, P525, DOI 10.1038/nrn3525; Tully HM, 2014, EUR J MED GENET, V57, P359, DOI 10.1016/j.ejmg.2014.06.002; Wagner C, 2003, J NEUROPATH EXP NEUR, V62, P1019, DOI 10.1093/jnen/62.10.1019; Walker RL, 2019, CELL, V179, P750, DOI 10.1016/j.cell.2019.09.021; Wallmeier J, 2019, AM J HUM GENET, V105, P1030, DOI 10.1016/j.ajhg.2019.09.022; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Wang MQ, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8101198; Ware J. S., 2015, CURRENT PROT HUMAN G, V87, P21; Wei Q, 2015, BIOINFORMATICS, V31, P1375, DOI 10.1093/bioinformatics/btu839; Welte T, 2019, GENE DEV, V33, P1221, DOI 10.1101/gad.328492.119; Zega K, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00372	80	33	34	3	14	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2020	26	11					1754	+		10.1038/s41591-020-1090-2	http://dx.doi.org/10.1038/s41591-020-1090-2		OCT 2020	25	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	OT0SR	33077954	Green Submitted, Green Accepted			2022-12-27	WOS:000579706700002
J	Heczey, A; Courtney, AN; Montalbano, A; Robinson, S; Liu, K; Li, MM; Ghatwai, N; Dakhova, O; Liu, B; Raveh-Sadka, T; Chauvin-Fleurence, CN; Xu, X; Ngai, H; Di Pierro, EJ; Savoldo, B; Dotti, G; Metelitsa, LS				Heczey, Andras; Courtney, Amy N.; Montalbano, Antonino; Robinson, Simon; Liu, Ka; Li, Mingmei; Ghatwai, Nisha; Dakhova, Olga; Liu, Bin; Raveh-Sadka, Tali; Chauvin-Fleurence, Cynthia N.; Xu, Xin; Ngai, Ho; Di Pierro, Erica J.; Savoldo, Barbara; Dotti, Gianpietro; Metelitsa, Leonid S.			Anti-GD2 CAR-NKT cells in patients with relapsed or refractory neuroblastoma: an interim analysis	NATURE MEDICINE			English	Article							TUMOR-ASSOCIATED MACROPHAGES; KILLER-T-CELLS; ANTITUMOR-ACTIVITY; LYMPHODEPLETION; INHIBITION	V alpha 24-invariant natural killer T (NKT) cells have shown potent anti-tumor properties in murine tumor models and have been linked to favorable outcomes in patients with cancer. However, low numbers of these cells in humans have hindered their clinical applications. Here we report interim results from all three patients enrolled on dose level 1 in a phase 1 dose-escalation trial of autologous NKT cells engineered to co-express a GD2-specific chimeric antigen receptor (CAR) with interleukin-15 in children with relapsed or resistant neuroblastoma (NCT03294954). Primary and secondary objectives were to assess safety and anti-tumor responses, respectively, with immune response evaluation as an additional objective. We ex vivo expanded highly pure NKT cells (mean +/- s.d., 94.7 +/- 3.8%) and treated patients with 3 x 10(6)CAR-NKT cells per square meter of body surface area after lymphodepleting conditioning with cyclophosphamide/fludarabine (Cy/Flu). Cy/Flu conditioning was the probable cause for grade 3-4 hematologic adverse events, as they occurred before CAR-NKT cell infusion, and no dose-limiting toxicities were observed. CAR-NKT cells expanded in vivo, localized to tumors and, in one patient, induced an objective response with regression of bone metastatic lesions. These initial results suggest that CAR-NKT cells can be expanded to clinical scale and safely applied to treat patients with cancer. In an interim analysis of a first-in-human phase 1 trial of patients with neuroblastoma, highly pure GD2-specific CAR-NKT cells were well tolerated with no observed dose-limiting toxicities.	[Heczey, Andras; Courtney, Amy N.; Robinson, Simon; Liu, Ka; Li, Mingmei; Ghatwai, Nisha; Liu, Bin; Chauvin-Fleurence, Cynthia N.; Xu, Xin; Ngai, Ho; Di Pierro, Erica J.; Metelitsa, Leonid S.] Baylor Coll Med, Texas Childrens Canc Ctr, Dept Pediat, Houston, TX 77030 USA; [Heczey, Andras; Metelitsa, Leonid S.] Baylor Coll Med, Dept Pathol & Immunol, Houston, TX 77030 USA; [Heczey, Andras; Dakhova, Olga; Metelitsa, Leonid S.] Baylor Coll Med, Ctr Cell & Gene Therapy, Houston, TX 77030 USA; [Montalbano, Antonino; Raveh-Sadka, Tali] Immunai Inc, New York, NY USA; [Savoldo, Barbara; Dotti, Gianpietro] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27515 USA	Baylor College of Medicine; Texas Children's Cancer Center; Baylor College of Medicine; Baylor College of Medicine; University of North Carolina; University of North Carolina Chapel Hill	Heczey, A; Metelitsa, LS (corresponding author), Baylor Coll Med, Texas Childrens Canc Ctr, Dept Pediat, Houston, TX 77030 USA.; Heczey, A; Metelitsa, LS (corresponding author), Baylor Coll Med, Dept Pathol & Immunol, Houston, TX 77030 USA.; Heczey, A; Metelitsa, LS (corresponding author), Baylor Coll Med, Ctr Cell & Gene Therapy, Houston, TX 77030 USA.	axheczey@txch.org; lsmeteli@txch.org	liu, kaiwen/GVS-5259-2022	Heczey, Andras/0000-0002-4263-9115; Xu, Xin/0000-0002-9485-8782; Chauvin-Fleurence, Cynthia/0000-0001-6425-8543	Alex's Lemonade Stand Foundation for Childhood Cancer, Kuur Therapeutics; American Cancer Society; Cookies for Kids' Cancer Foundation; Cancer Prevention and Research Institute of Texas (Baylor College of Medicine Comprehensive Cancer Center Training Program) [RP160283]	Alex's Lemonade Stand Foundation for Childhood Cancer, Kuur Therapeutics; American Cancer Society(American Cancer Society); Cookies for Kids' Cancer Foundation; Cancer Prevention and Research Institute of Texas (Baylor College of Medicine Comprehensive Cancer Center Training Program)	The authors are grateful to M. Brenner, H. Heslop and personnel from the cGMP facility at the Center for Cell and Gene Therapy for manufacturing CAR-NKT cells; A. Sher, K. Kukreja and P. Srivaths; staff of the Flow Cytometry Core Laboratory of the Texas Children's Cancer and Hematology Center; P. Saha for excellent technical assistance; and E. Chomsky, E. Kiner and H. Sharim for help with scRNA-seq. This work was supported by grants and contracts from Alex's Lemonade Stand Foundation for Childhood Cancer, Kuur Therapeutics (to L.S.M. and A.H.), the American Cancer Society (to A.H.), Cookies for Kids' Cancer Foundation (to L.S.M.) and the Cancer Prevention and Research Institute of Texas (Baylor College of Medicine Comprehensive Cancer Center Training Program, RP160283, to H.N.).	Butler A, 2018, NAT BIOTECHNOL, V36, P411, DOI 10.1038/nbt.4096; Chang DH, 2005, J EXP MED, V201, P1503, DOI 10.1084/jem.20042592; Cohn SL, 2009, J CLIN ONCOL, V27, P289, DOI 10.1200/JCO.2008.16.6785; Cortesi F, 2018, CELL REP, V22, P3006, DOI 10.1016/j.celrep.2018.02.058; Decarolis B, 2013, J CLIN ONCOL, V31, P944, DOI 10.1200/JCO.2012.45.8794; Exley MA, 2001, J IMMUNOL, V167, P5531, DOI 10.4049/jimmunol.167.10.5531; Exley MA, 2017, CLIN CANCER RES, V23, P3510, DOI 10.1158/1078-0432.CCR-16-0600; Gattinoni L, 2005, J EXP MED, V202, P907, DOI 10.1084/jem.20050732; Ghassemi S, 2018, CANCER IMMUNOL RES, V6, P1100, DOI 10.1158/2326-6066.CIR-17-0405; Godfrey DI, 2004, NAT REV IMMUNOL, V4, P231, DOI 10.1038/nri1309; Guo XY, 2018, NAT MED, V24, P978, DOI 10.1038/s41591-018-0045-3; Hafemeister C, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1874-1; Heczey A, 2017, MOL THER, V25, P2214, DOI 10.1016/j.ymthe.2017.05.012; Heczey A, 2014, BLOOD, V124, P2824, DOI 10.1182/blood-2013-11-541235; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Liu DF, 2012, J CLIN INVEST, V122, P2221, DOI 10.1172/JCI59535; Metelitsa LS, 2011, CLIN IMMUNOL, V140, P119, DOI 10.1016/j.clim.2010.10.005; Metelitsa LS, 2004, J EXP MED, V199, P1213, DOI 10.1084/jem.20031462; Motohashi S, 2011, CLIN IMMUNOL, V140, P167, DOI 10.1016/j.clim.2011.01.009; Ngai H, 2018, J IMMUNOL, V201, P2141, DOI 10.4049/jimmunol.1800429; Noy R, 2014, IMMUNITY, V41, P49, DOI 10.1016/j.immuni.2014.06.010; Park JR, 2017, J CLIN ONCOL, V35, P2580, DOI 10.1200/JCO.2016.72.0177; Rotolo A, 2018, CANCER CELL, V34, P596, DOI 10.1016/j.ccell.2018.08.017; Savage AK, 2008, IMMUNITY, V29, P391, DOI 10.1016/j.immuni.2008.07.011; SCHULZ G, 1984, CANCER RES, V44, P5914; Song LP, 2009, J CLIN INVEST, V119, P1524, DOI 10.1172/JCI37869; Stoeckius M, 2018, GENOME BIOL, V19, DOI 10.1186/s13059-018-1603-1; Stuart T, 2019, CELL, V177, P1888, DOI 10.1016/j.cell.2019.05.031; Tachibana T, 2005, CLIN CANCER RES, V11, P7322, DOI 10.1158/1078-0432.CCR-05-0877; Tian GW, 2016, J CLIN INVEST, V126, P2341, DOI 10.1172/JCI83476; Xu X, 2019, CLIN CANCER RES, V25, P7126, DOI 10.1158/1078-0432.CCR-19-0421; Yost KE, 2019, NAT MED, V25, P1251, DOI 10.1038/s41591-019-0522-3; Zhang L, 2018, NATURE, V564, P268, DOI 10.1038/s41586-018-0694-x	33	83	85	2	20	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2020	26	11					1686	+		10.1038/s41591-020-1074-2	http://dx.doi.org/10.1038/s41591-020-1074-2		OCT 2020	17	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	OT0SR	33046868	Green Submitted			2022-12-27	WOS:000577080500001
J	Deng, Q; Han, GC; Puebla-Osorio, N; Ma, NCJ; Chasen, PSB; Dai, EY; Dang, MH; Jain, N; Yang, HP; Wang, YX; Zhang, SJ; Wang, RP; Chen, RZ; Showell, J; Ghosh, S; Patchva, S; Zhang, Q; Sun, R; Hagemeister, F; Fayad, L; Samaniego, F; Lee, HC; Nastoupil, LJ; Fowler, N; Davis, RE; Westin, J; Neelapu, SS; Wang, LH; Green, MR				Deng, Qing; Han, Guangchun; Puebla-Osorio, Nahum; Ma, N. Chun John; Chasen, Paolo Strati Beth; Dai, Enyu; Dang, Minghao; Jain, Neeraj; Yang, Haopeng; Wang, Yuanxin; Zhang, Shaojun; Wang, Ruiping; Chen, Runzhe; Showell, Jordan; Ghosh, Sreejoyee; Patchva, Sridevi; Zhang, Qi; Sun, Ryan; Hagemeister, Frederick; Fayad, Luis; Samaniego, Felipe; Lee, Hans C.; Nastoupil, Loretta J.; Fowler, Nathan; Davis, R. Eric; Westin, Jason; Neelapu, Sattva S.; Wang, Linghua; Green, Michael R.			Characteristics of anti-CD19 CAR T cell infusion products associated with efficacy and toxicity in patients with large B cell lymphomas	NATURE MEDICINE			English	Article							CYTOKINE RELEASE SYNDROME; CD8(+); THERAPY; IMMUNOTHERAPY; EXHAUSTION; SUBSETS; NEUROTOXICITY; ACTIVATION; BIOMARKERS; PATHWAYS	Single-cell transcriptomics reveals that the heterogeneity of anti-CD19 CAR T cell infusion products contributes to variability in clinical response, early molecular response and development of immune effector cell-associated neurotoxicity syndrome in patients with large B cell lymphomas. Autologous chimeric antigen receptor (CAR) T cell therapies targeting CD19 have high efficacy in large B cell lymphomas (LBCLs), but long-term remissions are observed in less than half of patients, and treatment-associated adverse events, such as immune effector cell-associated neurotoxicity syndrome (ICANS), are a clinical challenge. We performed single-cell RNA sequencing with capture-based cell identification on autologous axicabtagene ciloleucel (axi-cel) anti-CD19 CAR T cell infusion products to identify transcriptomic features associated with efficacy and toxicity in 24 patients with LBCL. Patients who achieved a complete response by positron emission tomography/computed tomography at their 3-month follow-up had three-fold higher frequencies of CD8 T cells expressing memory signatures than patients with partial response or progressive disease. Molecular response measured by cell-free DNA sequencing at day 7 after infusion was significantly associated with clinical response (P= 0.008), and a signature of CD8 T cell exhaustion was associated (q= 2.8 x 10(-149)) with a poor molecular response. Furthermore, a rare cell population with monocyte-like transcriptional features was associated (P= 0.0002) with high-grade ICANS. Our results suggest that heterogeneity in the cellular and molecular features of CAR T cell infusion products contributes to variation in efficacy and toxicity after axi-cel therapy in LBCL, and that day 7 molecular response might serve as an early predictor of CAR T cell efficacy.	[Deng, Qing; Puebla-Osorio, Nahum; Ma, N. Chun John; Jain, Neeraj; Yang, Haopeng; Showell, Jordan; Ghosh, Sreejoyee; Patchva, Sridevi; Zhang, Qi; Hagemeister, Frederick; Fayad, Luis; Samaniego, Felipe; Lee, Hans C.; Nastoupil, Loretta J.; Fowler, Nathan; Davis, R. Eric; Westin, Jason; Neelapu, Sattva S.; Green, Michael R.] Univ Texas MD Anderson Canc Ctr, Dept Lymphoma & Myeloma, Houston, TX 77030 USA; [Han, Guangchun; Dai, Enyu; Dang, Minghao; Wang, Yuanxin; Zhang, Shaojun; Wang, Ruiping; Chen, Runzhe; Wang, Linghua; Green, Michael R.] Univ Texas MD Anderson Canc Ctr, Dept Genom Med, Houston, TX 77030 USA; [Chasen, Paolo Strati Beth] Univ Texas MD Anderson Canc Ctr, Dept Nucl Med, Houston, TX 77030 USA; [Sun, Ryan] Univ Texas MD Anderson Canc Ctr, Dept Biostat, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Neelapu, SS; Green, MR (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Lymphoma & Myeloma, Houston, TX 77030 USA.; Wang, LH; Green, MR (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Genom Med, Houston, TX 77030 USA.	sneelapu@mdanderson.org; lwang22@mdanderson.org; mgreen5@mdanderson.org	Han, Guangchun/AAU-8230-2021; Ghosh, Sreejoyee/AAQ-8421-2020; ZHANG, QI/AAD-2659-2021	ZHANG, QI/0000-0003-3813-8032; Ma, John/0000-0002-2000-8144; Puebla, Nahum/0000-0001-6498-5230; Deng, Qing/0000-0001-5116-461X; , guangchun/0000-0001-9277-2507; Wang, Linghua/0000-0001-9380-0266; JAIN, NEERAJ/0000-0002-3736-8621; Yang, Haopeng/0000-0002-3870-2679; Westin, Jason/0000-0002-1824-2337	Schweitzer Family Fund; University of Texas MD Anderson Cancer Center B-Cell Lymphoma Moonshot; National Cancer Institute Cancer Center [P30 CA016672]; University of Texas MD Anderson Cancer Center; Leukemia and Lymphoma Society	Schweitzer Family Fund; University of Texas MD Anderson Cancer Center B-Cell Lymphoma Moonshot; National Cancer Institute Cancer Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); University of Texas MD Anderson Cancer Center; Leukemia and Lymphoma Society(Leukemia and Lymphoma Society)	This work was supported by the Schweitzer Family Fund (J.R.W., R.E.D. and M.R.G.), The University of Texas MD Anderson Cancer Center B-Cell Lymphoma Moonshot (S.S.N. and M.R.G.), a National Cancer Institute Cancer Center Support Grant to The University of Texas MD Anderson Cancer Center (P30 CA016672) and Institutional Research Grant start-up research funds provided to L.W. and M.R.G. by The University of Texas MD Anderson Cancer Center. H.Y. is supported by a Fellow Award from the Leukemia and Lymphoma Society. M.R.G. is supported by a Scholar Award from the Leukemia and Lymphoma Society.	Baumeister SH, 2016, ANNU REV IMMUNOL, V34, P539, DOI 10.1146/annurev-immunol-032414-112049; Blackburn SD, 2009, NAT IMMUNOL, V10, P29, DOI 10.1038/ni.1679; Burugu S, 2018, SEMIN CANCER BIOL, V52, P39, DOI 10.1016/j.semcancer.2017.10.001; Butler A, 2018, NAT BIOTECHNOL, V36, P411, DOI 10.1038/nbt.4096; Cherkassky L, 2016, J CLIN INVEST, V126, P3130, DOI 10.1172/JCI83092; Chong EA, 2017, BLOOD, V129, P1039, DOI 10.1182/blood-2016-09-738245; Das RK, 2019, CANCER DISCOV, V9, P492, DOI 10.1158/2159-8290.CD-18-1314; Doering TA, 2012, IMMUNITY, V37, P1130, DOI 10.1016/j.immuni.2012.08.021; Finney OC, 2019, J CLIN INVEST, V129, P2123, DOI 10.1172/JCI125423; Fraietta JA, 2018, NATURE, V558, P307, DOI 10.1038/s41586-018-0178-z; Fraietta JA, 2018, NAT MED, V24, P563, DOI 10.1038/s41591-018-0010-1; Gargett T, 2019, CYTOTHERAPY, V21, P593, DOI 10.1016/j.jcyt.2019.03.003; Gargett T, 2016, MOL THER, V24, P1135, DOI 10.1038/mt.2016.63; Goldrath AW, 2004, P NATL ACAD SCI USA, V101, P16885, DOI 10.1073/pnas.0407417101; Green MR, 2020, CANCER DISCOV, V10, P492, DOI 10.1158/2159-8290.CD-20-0037; Gust J, 2017, CANCER DISCOV, V7, P1404, DOI 10.1158/2159-8290.CD-17-0698; Hanzelmann S, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-7; Hay KA, 2017, BLOOD, V130, P2295, DOI 10.1182/blood-2017-06-793141; Jerby-Arnon L, 2018, CELL, V175, P984, DOI 10.1016/j.cell.2018.09.006; Josefsson SE, 2019, CANCER IMMUNOL RES, V7, P355, DOI 10.1158/2326-6066.CIR-18-0351; KAZAZI F, 1989, J GEN VIROL, V70, P2661, DOI 10.1099/0022-1317-70-10-2661; Koboldt DC, 2012, GENOME RES, V22, P568, DOI 10.1101/gr.129684.111; Kochenderfer JN, 2009, J IMMUNOTHER, V32, P689, DOI 10.1097/CJI.0b013e3181ac6138; Kurtz DM, 2018, J CLIN ONCOL, V36, P2845, DOI 10.1200/JCO.2018.78.5246; Kurtz DM, 2015, BLOOD, V125, P3679, DOI 10.1182/blood-2015-03-635169; Le RQ, 2018, ONCOLOGIST, V23, P943, DOI 10.1634/theoncologist.2018-0028; Lee B, 1999, P NATL ACAD SCI USA, V96, P5215, DOI 10.1073/pnas.96.9.5215; Lee DW, 2019, BIOL BLOOD MARROW TR, V25, P625, DOI 10.1016/j.bbmt.2018.12.758; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Li HJ, 2019, CELL, V176, P775, DOI 10.1016/j.cell.2018.11.043; Locke FL, 2019, LANCET ONCOL, V20, P31, DOI 10.1016/S1470-2045(18)30864-7; Man K, 2017, IMMUNITY, V47, P1129, DOI 10.1016/j.immuni.2017.11.021; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Miller BC, 2019, NAT IMMUNOL, V20, P326, DOI 10.1038/s41590-019-0312-6; Mueller KT, 2018, CLIN CANCER RES, V24, P6175, DOI 10.1158/1078-0432.CCR-18-0758; Nazarov VI, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0613-1; Neelapu SS, 2017, NEW ENGL J MED, V377, P2531, DOI 10.1056/NEJMoa1707447; Neelapu SS, 2018, NAT REV CLIN ONCOL, V15, P47, DOI 10.1038/nrclinonc.2017.148; Norelli M, 2018, NAT MED, V24, P739, DOI 10.1038/s41591-018-0036-4; Quigley M, 2010, NAT MED, V16, P1147, DOI 10.1038/nm.2232; Reuben A, 2017, CANCER DISCOV, V7, P1088, DOI 10.1158/2159-8290.CD-17-0256; Roschewski M, 2015, LANCET ONCOL, V16, P541, DOI 10.1016/S1470-2045(15)70106-3; Rossi J, 2018, BLOOD, V132, P804, DOI 10.1182/blood-2018-01-828343; Sade-Feldman M, 2018, CELL, V175, P998, DOI 10.1016/j.cell.2018.10.038; Santomasso BD, 2018, CANCER DISCOV, V8, P958, DOI 10.1158/2159-8290.CD-17-1319; Savas P, 2018, NAT MED, V24, P986, DOI 10.1038/s41591-018-0078-7; Scherer F, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aai8545; Schuster SJ, 2019, NEW ENGL J MED, V380, P45, DOI 10.1056/NEJMoa1804980; Shah NN, 2019, NAT REV CLIN ONCOL, V16, P372, DOI 10.1038/s41571-019-0184-6; Sommermeyer D, 2016, LEUKEMIA, V30, P492, DOI 10.1038/leu.2015.247; Strati P, 2020, BLOOD ADV, V4, P3123, DOI 10.1182/bloodadvances.2020002328; Taraseviciute A, 2018, CANCER DISCOV, V8, P750, DOI 10.1158/2159-8290.CD-17-1368; Teachey DT, 2016, CANCER DISCOV, V6, P664, DOI 10.1158/2159-8290.CD-16-0040; Uhlen M, 2019, SCIENCE, V366, P1471, DOI 10.1126/science.aax9198; van der Leun AM, 2020, NAT REV CANCER, V20, P218, DOI 10.1038/s41568-019-0235-4; Wang JM, 2020, CANCER IMMUNOL RES, V8, P794, DOI 10.1158/2326-6066.CIR-19-0619	56	123	125	1	22	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	2020	26	12								10.1038/s41591-020-1061-7	http://dx.doi.org/10.1038/s41591-020-1061-7		OCT 2020	26	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	PB8QO	33020644	Green Accepted			2022-12-27	WOS:000575801100002
J	Dziubanska-Kusibab, PJ; Berger, H; Battistini, F; Bouwman, BAM; Iftekhar, A; Katainen, R; Cajuso, T; Crosetto, N; Orozco, M; Aaltonen, LA; Meyer, TF				Dziubanska-Kusibab, Paulina J.; Berger, Hilmar; Battistini, Federica; Bouwman, Britta A. M.; Iftekhar, Amina; Katainen, Riku; Cajuso, Tatiana; Crosetto, Nicola; Orozco, Modesto; Aaltonen, Lauri A.; Meyer, Thomas F.			Colibactin DNA-damage signature indicates mutational impact in colorectal cancer	NATURE MEDICINE			English	Article							MOLECULAR-DYNAMICS; DISCOVERY; TRACTS; BREAKS	The mucosal epithelium is a common target of damage by chronic bacterial infections and the accompanying toxins, and most cancers originate from this tissue. We investigated whether colibactin, a potent genotoxin(1) associated with certain strains of Escherichia coli(2), creates a specific DNA-damage signature in infected human colorectal cells. Notably, the genomic contexts of colibactin-induced DNA double-strand breaks were enriched for an AT-rich hexameric sequence motif, associated with distinct DNA-shape characteristics. A survey of somatic mutations at colibactin target sites of several thousand cancer genomes revealed notable enrichment of this motif in colorectal cancers. Moreover, the exact double-strand-break loci corresponded with mutational hot spots in cancer genomes, reminiscent of a trinucleotide signature previously identified in healthy colorectal epithelial cells(3). The present study provides evidence for the etiological role of colibactin in human cancer. Identification of a DNA-damage signature induced by colibactin, a toxin expressed by some strains of Escherichia coli, is enriched in human colorectal cancers.	[Dziubanska-Kusibab, Paulina J.; Berger, Hilmar; Iftekhar, Amina; Meyer, Thomas F.] Max Planck Inst Infect Biol, Dept Mol Biol, Berlin, Germany; [Battistini, Federica; Orozco, Modesto] Barcelona Inst Sci & Technol, IRB Barcelona, Inst Res Biomed, Barcelona, Spain; [Bouwman, Britta A. M.; Crosetto, Nicola] Karolinska Inst, Dept Med Biochem & Biophys, Sci Life Lab, Stockholm, Sweden; [Katainen, Riku; Cajuso, Tatiana; Aaltonen, Lauri A.] Univ Helsinki, Appl Tumor Genom Res Program, Biomedicum, Helsinki, Finland; [Katainen, Riku; Cajuso, Tatiana; Aaltonen, Lauri A.] Univ Helsinki, Dept Med & Clin Genet, Biomedicum, Helsinki, Finland; [Orozco, Modesto] Univ Barcelona, Dept Biochem & Biomed, Barcelona, Spain	Max Planck Society; Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; Karolinska Institutet; University of Helsinki; University of Helsinki; University of Barcelona	Meyer, TF (corresponding author), Max Planck Inst Infect Biol, Dept Mol Biol, Berlin, Germany.	meyer@mpiib-berlin.mpg.de	Katainen, Riku/GYR-0921-2022; Aaltonen, Lauri/A-5375-2010; Meyer, Thomas F./J-2485-2013	Aaltonen, Lauri/0000-0001-6839-4286; Berger, Hilmar/0000-0002-6304-4946; Meyer, Thomas F./0000-0002-6120-8679; Bouwman, Britta/0000-0002-9827-9497; Iftekhar, Amina/0000-0002-0001-5590; Dziubanska-Kusibab, Paulina/0000-0002-0932-3522; Katainen, Riku/0000-0003-4575-4239	IMPRS-IDI graduate school; Rubicon fellowship from the Netherlands Organisation for Scientific Research; German Research Foundation [ME705/18-1]; Spanish Ministry of Science [BIO2015-64802-R, BFU2014-61670-EXP, BFU201452864-R]; Catalan Government [2014-SGR]; Instituto de Salud Carlos III: Instituto Nacional de Bioinformatica [PT 13/000/0030]; Biomolecular and Bioinformatics Resources Platform [Elixir-Excelerate 676559, BioExcel2:823830]; EU Horizon 2020 research and innovation program [Elixir-Excelerate 676559, BioExcel2:823830]; MINECO Severo Ochoa Award of Excellence; Ragnar Soderberg Foundation; Swedish Foundation for Strategic Research [BD15-0095]; Strategic Research Programme in Cancer (StratCan) at Karolinska Institutet; Academy of Finland (Finnish Center of Excellence) [312041]; Jane and Aatos Erkko Foundation; Sigrid Juselius Foundation; Helsinki Institute of Life Science; Cancer Society of Finland; Academy of Finland [319083, 320149]; Academy of Finland (iCAN Flagship) [320185]	IMPRS-IDI graduate school; Rubicon fellowship from the Netherlands Organisation for Scientific Research; German Research Foundation(German Research Foundation (DFG)); Spanish Ministry of Science(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Catalan Government; Instituto de Salud Carlos III: Instituto Nacional de Bioinformatica; Biomolecular and Bioinformatics Resources Platform; EU Horizon 2020 research and innovation program; MINECO Severo Ochoa Award of Excellence; Ragnar Soderberg Foundation; Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Strategic Research Programme in Cancer (StratCan) at Karolinska Institutet; Academy of Finland (Finnish Center of Excellence)(Academy of Finland); Jane and Aatos Erkko Foundation; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Helsinki Institute of Life Science; Cancer Society of Finland; Academy of Finland(Academy of Finland); Academy of Finland (iCAN Flagship)	The results shown here are in whole or part based on data generated by the TCGA Research Network: https://www.cancer.gov/tcga. We thank S. Garnerone from N.C.'s laboratory for processing raw sBLISS data, P. D. Dans from the Biophysical Chemistry Lab, Department of Biological Science (CENUR Litoral Norte), UdelaR, Universidad de la Republica, for constructive discussions about the theoretical model of colibactin, U. Dobrindt from University of Munster for providing E. coli strains, and K. Lapid and R. Zietlow for editing the manuscript. We also acknowledge the computational resources provided by the CSC-IT Center for Science, Finland. P.J.D.-K. was supported by the IMPRS-IDI graduate school. B.A.M.B. was supported by a Rubicon fellowship from the Netherlands Organisation for Scientific Research. M.O. is an academic researcher of Institucio Catalana de Recerca i Estudis Avancats. The present study was supported by the German Research Foundation (grant no. ME705/18-1) to T.F.M., by the Spanish Ministry of Science (grant nos. BIO2015-64802-R, BFU2014-61670-EXP and BFU201452864-R), the Catalan Government (grant no. 2014-SGR), Instituto de Salud Carlos III: Instituto Nacional de Bioinformatica (PT 13/000/0030), the Biomolecular and Bioinformatics Resources Platform and the EU Horizon 2020 research and innovation program (grant nos. Elixir-Excelerate 676559 and BioExcel2:823830), and the MINECO Severo Ochoa Award of Excellence to the IRB Barcelona, and by the Ragnar Soderberg Foundation, the Swedish Foundation for Strategic Research (BD15-0095) and the Strategic Research Programme in Cancer (StratCan) at Karolinska Institutet to N.C. L.A.A. was supported by grants from the Academy of Finland (Finnish Center of Excellence no. 312041, Academy Professor grant nos. 319083 and 320149, iCAN Flagship 320185), Jane and Aatos Erkko Foundation, Sigrid Juselius Foundation, Helsinki Institute of Life Science and the Cancer Society of Finland.	Alexandrov LB, 2020, NATURE, V578, P94, DOI 10.1038/s41586-020-1943-3; [Anonymous], 2018, LANG ENV STAT COMP; ARCAMONE F, 1964, NATURE, V203, P1064, DOI 10.1038/2031064a0; Arthur JC, 2012, SCIENCE, V338, P120, DOI 10.1126/science.1224820; Bailey MH, 2018, CELL, V173, P371, DOI [10.1016/j.cell.2018.02.060, 10.1016/j.cell.2018.07.034]; Bailey TL, 2011, BIOINFORMATICS, V27, P1653, DOI 10.1093/bioinformatics/btr261; Bembom O, 2017, SEQLOGO SEQUENCE LOG; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Bleich RM, 2019, SCIENCE, V363, P689, DOI 10.1126/science.aaw5475; BOGER DL, 1995, P NATL ACAD SCI USA, V92, P3642, DOI 10.1073/pnas.92.9.3642; Buc E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056964; Canela A, 2017, CELL, V170, P507, DOI 10.1016/j.cell.2017.06.034; Case D. A., 2018, AMBER 2018; Castellarin M, 2012, GENOME RES, V22, P299, DOI 10.1101/gr.126516.111; Chiu TP, 2016, BIOINFORMATICS, V32, P1211, DOI 10.1093/bioinformatics/btv735; Choi JY, 2010, J MOL BIOL, V404, P34, DOI 10.1016/j.jmb.2010.09.015; Cibulskis K, 2013, NAT BIOTECHNOL, V31, P213, DOI 10.1038/nbt.2514; Cougnoux A, 2014, GUT, V63, P1932, DOI 10.1136/gutjnl-2013-305257; Dans PD, 2016, NUCLEIC ACIDS RES, V44, P4052, DOI 10.1093/nar/gkw264; Drsata T, 2014, NUCLEIC ACIDS RES, V42, P7383, DOI 10.1093/nar/gku338; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Dziubaska-Kusibab P. J., 2019, COLIBACTIN DNA DAMAG, DOI [10.1101/819854v1, DOI 10.1101/819854V1]; Ellrott K, 2018, CELL SYST, V6, P271, DOI 10.1016/j.cels.2018.03.002; FINLAY AC, 1951, J AM CHEM SOC, V73, P341, DOI 10.1021/ja01145a113; Gaffney DJ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003036; Gelpi JL, 2001, PROTEINS, V45, P428, DOI 10.1002/prot.1159; Giannakis M, 2016, CELL REP, V15, P857, DOI 10.1016/j.celrep.2016.03.075; Gothe HJ, 2019, MOL CELL, V75, P267, DOI 10.1016/j.molcel.2019.05.015; Healy AR, 2016, J AM CHEM SOC, V138, P5426, DOI 10.1021/jacs.6b02276; Hibbing ME, 2010, NAT REV MICROBIOL, V8, P15, DOI 10.1038/nrmicro2259; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Iannelli F, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15656; Igarashi Y, 2003, J ANTIBIOT, V56, P107, DOI 10.7164/antibiotics.56.107; Ivani I, 2016, NAT METHODS, V13, P55, DOI [10.1038/NMETH.3658, 10.1038/nmeth.3658]; Iyama T, 2013, DNA REPAIR, V12, P620, DOI 10.1016/j.dnarep.2013.04.015; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Katainen R, 2018, NAT PROTOC, V13, P2580, DOI 10.1038/s41596-018-0052-3; Katainen R, 2015, NAT GENET, V47, P818, DOI 10.1038/ng.3335; Lee-Six H, 2019, NATURE, V574, P532, DOI 10.1038/s41586-019-1672-7; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Mantello Camila C, 2012, BMC Res Notes, V5, P329, DOI 10.1186/1756-0500-5-329; Martin LP, 2008, CLIN CANCER RES, V14, P1291, DOI 10.1158/1078-0432.CCR-07-2238; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; NELSON HCM, 1987, NATURE, V330, P221, DOI 10.1038/330221a0; Nougayrede JP, 2006, SCIENCE, V313, P848, DOI 10.1126/science.1127059; Perez A, 2007, J AM CHEM SOC, V129, P14739, DOI 10.1021/ja0753546; Pleguezuelos-Manzano C, 2020, NATURE, V580, P269, DOI 10.1038/s41586-020-2080-8; Putze J, 2009, INFECT IMMUN, V77, P4696, DOI 10.1128/IAI.00522-09; Roe DR, 2013, J CHEM THEORY COMPUT, V9, P3084, DOI 10.1021/ct400341p; Rosenthal R, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0893-4; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; Sheffield NC, 2016, BIOINFORMATICS, V32, P587, DOI 10.1093/bioinformatics/btv612; Speir ML, 2016, NUCLEIC ACIDS RES, V44, pD717, DOI 10.1093/nar/gkv1275; TAKAHASHI I, 1988, J ANTIBIOT, V41, P1915, DOI 10.7164/antibiotics.41.1915; Tamborero D, 2018, GENOME MED, V10, DOI 10.1186/s13073-018-0531-8; Tate JG, 2019, NUCLEIC ACIDS RES, V47, pD941, DOI 10.1093/nar/gky1015; Tse WC, 2004, CHEM BIOL, V11, P1607, DOI 10.1016/j.chembiol.2003.08.012; Tubbs A, 2018, CELL, V174, P1127, DOI 10.1016/j.cell.2018.07.011; van Zundert GCP, 2016, J MOL BIOL, V428, P720, DOI 10.1016/j.jmb.2015.09.014; Vizcaino MI, 2015, NAT CHEM, V7, P411, DOI [10.1038/NCHEM.2221, 10.1038/nchem.2221]; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Watanabe T, 1998, GASTROENTEROLOGY, V115, P642, DOI 10.1016/S0016-5085(98)70143-X; Wilson MR, 2019, SCIENCE, V363, P709, DOI 10.1126/science.aar7785; Xue MZ, 2020, BIOCHEMISTRY-US, V59, P892, DOI 10.1021/acs.biochem.9b01070; Xue MZ, 2019, SCIENCE, V365, P1000, DOI 10.1126/science.aax2685; Yan W. X., 2017, PROTOC EXCH, P1, DOI [10.1038/protex.2017.018, DOI 10.1038/PROTEX.2017.018]; Yan WX, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15058; Yang F, 2015, MUTAT RES-FUND MOL M, V773, P9, DOI 10.1016/j.mrfmmm.2015.01.007; Yuan GC, 2005, SCIENCE, V309, P626, DOI 10.1126/science.1112178; Zha L, 2017, NAT CHEM BIOL, V13, P1063, DOI [10.1038/NCHEMBIO.2448, 10.1038/nchembio.2448]; Zha L, 2016, ACS CHEM BIOL, V11, P1287, DOI 10.1021/acschembio.6b00014	73	78	79	3	22	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	JUL	2020	26	7					1063	+		10.1038/s41591-020-0908-2	http://dx.doi.org/10.1038/s41591-020-0908-2		JUN 2020	25	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	MK3XO	32483361	Green Accepted			2022-12-27	WOS:000537041000004
J	Leborgne, C; Barbon, E; Alexander, JM; Hanby, H; Delignat, S; Cohen, DM; Collaud, F; Muraleetharan, S; Lupo, D; Silverberg, J; Huang, KR; van Wittengerghe, L; Marolleau, B; Miranda, A; Fabiano, A; Daventure, V; Beck, H; Anguela, XM; Ronzitti, G; Armour, SM; Lacroix-Desmazes, S; Mingozzi, F				Leborgne, Christian; Barbon, Elena; Alexander, Jeffrey M.; Hanby, Hayley; Delignat, Sandrine; Cohen, Daniel M.; Collaud, Fanny; Muraleetharan, Saghana; Lupo, Dan; Silverberg, Joseph; Huang, Karen; van Wittengerghe, Laetitia; Marolleau, Beatrice; Miranda, Adeline; Fabiano, Anna; Daventure, Victoria; Beck, Heena; Anguela, Xavier M.; Ronzitti, Giuseppe; Armour, Sean M.; Lacroix-Desmazes, Sebastien; Mingozzi, Federico			IgG-cleaving endopeptidase enables in vivo gene therapy in the presence of anti-AAV neutralizing antibodies	NATURE MEDICINE			English	Article							NONHUMAN PRIMATE MODEL; FACTOR-IX; HEMOPHILIA; VECTORS; LIVER; TRANSDUCTION; MODULATION; TOLERANCE	Neutralizing antibodies to adeno-associated virus (AAV) vectors are highly prevalent in humans(1,2), and block liver transduction(3-5) and vector readministration(6); thus, they represent a major limitation to in vivo gene therapy. Strategies aimed at overcoming anti-AAV antibodies are being studied(7), which often involve immunosuppression and are not efficient in removing pre-existing antibodies. Imlifidase (IdeS) is an endopeptidase able to degrade circulating IgG that is currently being tested in transplant patients(8). Here, we studied if IdeS could eliminate anti-AAV antibodies in the context of gene therapy. We showed efficient cleavage of pooled human IgG (intravenous Ig) in vitro upon endopeptidase treatment. In mice passively immunized with intravenous Ig, IdeS administration decreased anti-AAV antibodies and enabled efficient liver gene transfer. The approach was scaled up to nonhuman primates, a natural host for wild-type AAV. IdeS treatment before AAV vector infusion was safe and resulted in enhanced liver transduction, even in the setting of vector readministration. Finally, IdeS reduced anti-AAV antibody levels from human plasma samples in vitro, including plasma from prospective gene therapy trial participants. These results provide a potential solution to overcome pre-existing antibodies to AAV-based gene therapy. An IgG-cleaving endopeptidase can degrade circulating anti-adeno-associated virus antibodies in mice and nonhuman primates in vivo, as well as in human plasma in vitro, offering a potential solution for a major hurdle in gene therapy.	[Leborgne, Christian; Barbon, Elena; Collaud, Fanny; van Wittengerghe, Laetitia; Marolleau, Beatrice; Miranda, Adeline; Fabiano, Anna; Ronzitti, Giuseppe; Mingozzi, Federico] Univ Paris Saclay, Univ Evry, INSERM, Genethon INTEGRARE,UMR S951, Evry, France; [Alexander, Jeffrey M.; Hanby, Hayley; Cohen, Daniel M.; Muraleetharan, Saghana; Lupo, Dan; Silverberg, Joseph; Huang, Karen; Beck, Heena; Anguela, Xavier M.; Armour, Sean M.; Mingozzi, Federico] Spark Therapeut, Philadelphia, PA USA; [Delignat, Sandrine; Daventure, Victoria; Lacroix-Desmazes, Sebastien] Univ Paris, Sorbonne Univ, Ctr Rech Cordeliers, Paris, France; [Daventure, Victoria; Lacroix-Desmazes, Sebastien] INSERM, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm)	Mingozzi, F (corresponding author), Univ Paris Saclay, Univ Evry, INSERM, Genethon INTEGRARE,UMR S951, Evry, France.; Mingozzi, F (corresponding author), Spark Therapeut, Philadelphia, PA USA.; Lacroix-Desmazes, S (corresponding author), Univ Paris, Sorbonne Univ, Ctr Rech Cordeliers, Paris, France.; Lacroix-Desmazes, S (corresponding author), INSERM, Paris, France.	sebastien.lacroix-desmazes@crc.jussieu.fr; federico.mingozzi@sparktx.com	Ronzitti, Giuseppe/C-2566-2018	Ronzitti, Giuseppe/0000-0002-9184-0210; Fabiano, Anna/0000-0002-7604-6967	Institut National de la Sante et de la Recherche Medicale, Centre National de la Recherche Scientifique, Sorbonne Universite	Institut National de la Sante et de la Recherche Medicale, Centre National de la Recherche Scientifique, Sorbonne Universite	We thank the staff of the Nantes-Atlantic National College of Veterinary Medicine, Food Science and Engineering and Virscio staff for their help in designing and performing the NHP studies. We also thank the Spark Therapeutics vector production, bioanalytical, immunology, liver, sample management and laboratory information management teams for their contribution to the NHP studies. The work was supported by the Institut National de la Sante et de la Recherche Medicale, Centre National de la Recherche Scientifique, Sorbonne Universite.	Agniswamy J, 2004, J BIOL CHEM, V279, P52789, DOI 10.1074/jbc.M410698200; Aronson SJ, 2019, HUM GENE THER, V30, P1297, DOI 10.1089/hum.2019.143; Boutin S, 2010, HUM GENE THER, V21, P704, DOI 10.1089/hum.2009.182; Gao GP, 2002, P NATL ACAD SCI USA, V99, P11854, DOI 10.1073/pnas.182412299; George LA, 2017, NEW ENGL J MED, V377, P2215, DOI 10.1056/NEJMoa1708538; Jiang HY, 2006, BLOOD, V108, P3321, DOI 10.1182/blood-2006-04-017913; Jordan SC, 2017, NEW ENGL J MED, V377, P442, DOI 10.1056/NEJMoa1612567; Kizlik-Masson C, 2019, BLOOD, V133, P2427, DOI 10.1182/blood.2019000437; Li C, 2012, GENE THER, V19, P288, DOI 10.1038/gt.2011.90; Lisowski L, 2014, NATURE, V506, P382, DOI 10.1038/nature12875; Lorant T, 2018, AM J TRANSPLANT, V18, P2752, DOI 10.1111/ajt.14733; Manno CS, 2006, NAT MED, V12, P342, DOI 10.1038/nm1358; McIntosh J, 2013, BLOOD, V121, P3335, DOI 10.1182/blood-2012-10-462200; Meliani A, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06621-3; Meliani A, 2015, HUM GENE THER METHOD, V26, P45, DOI 10.1089/hgtb.2015.037; Mendell JR, 2017, NEW ENGL J MED, V377, P1713, DOI 10.1056/NEJMoa1706198; Miesbach W, 2018, BLOOD, V131, P1022, DOI 10.1182/blood-2017-09-804419; Mingozzi F, 2007, BLOOD, V110, P2334, DOI 10.1182/blood-2007-03-080093; Mingozzi F, 2017, ANNU REV VIROL, V4, P511, DOI 10.1146/annurev-virology-101416-041936; Mingozzi F, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005795; Mingozzi F, 2012, MOL THER, V20, P1410, DOI 10.1038/mt.2012.84; Nathwani AC, 2011, MOL THER, V19, P876, DOI 10.1038/mt.2010.274; Pasi KJ, 2017, NEW ENGL J MED, V377, P819, DOI [10.1056/NEJMoa1616569, 10.1056/NEJMoa1708483]; Puzzo F, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aam6375; Scallan CD, 2006, BLOOD, V107, P1810, DOI 10.1182/blood-2005-08-3229; von Pawel-Rammingen U, 2002, EMBO J, V21, P1607, DOI 10.1093/emboj/21.7.1607; Winstedt L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132011	27	99	103	3	18	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	JUL	2020	26	7					1096	+		10.1038/s41591-020-0911-7	http://dx.doi.org/10.1038/s41591-020-0911-7		JUN 2020	20	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	MK3XO	32483358	Green Submitted			2022-12-27	WOS:000537041000005
J	Sarma, GP; Levey, A; Faundez, V				Sarma, Gopal P.; Levey, Allan; Faundez, Victor			The physician-scientist, 75 years after Vannevar Bush-rethinking the 'bench' and 'bedside' dichotomy	NATURE MEDICINE			English	Editorial Material									[Sarma, Gopal P.] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Sarma, Gopal P.] Massachusetts Gen Hosp, Analyt & Translat Genet Unit, Boston, MA 02114 USA; [Levey, Allan] Emory Univ, Sch Med, Dept Neurol, Atlanta, GA 30322 USA; [Faundez, Victor] Emory Univ, Dept Cell Biol, Atlanta, GA 30322 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts General Hospital; Emory University; Emory University	Sarma, GP (corresponding author), Broad Inst MIT & Harvard, Cambridge, MA 02142 USA.; Sarma, GP (corresponding author), Massachusetts Gen Hosp, Analyt & Translat Genet Unit, Boston, MA 02114 USA.	gsarma@broadinstitute.org	Levey, Allan/F-2104-2011	Levey, Allan/0000-0002-3153-502X; Faundez, Victor/0000-0002-2114-5271; Sarma, Gopal/0000-0002-9413-6202				Brass LF, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.133009; Bush, 1945, SCI THE ENDLESS FRON, DOI DOI 10.1016/j.techsoc.2019.03.007; Ching T, 2018, J R SOC INTERFACE, V15, DOI 10.1098/rsif.2017.0387; Daye D, 2015, J CLIN INVEST, V125, P883, DOI 10.1172/JCI80933; Moawad H., 2013, CAREERS CLIN MED; Narayanamurti V., 2016, CYCLES INVENTION DIS; Roberts SF, 2012, ACAD MED, V87, P266, DOI 10.1097/ACM.0b013e3182446fa3; Rosenberg LE, 2008, JAMA-J AM MED ASSOC, V300, P1208, DOI 10.1001/jama.300.10.1208; Sarma G. P., 2020, F1000 RES, V8, P2123; Sutton J, 1996, ACAD MED, V71, P454, DOI 10.1097/00001888-199605000-00013; Topol E., 2019, DEEP MED ARTIFICIAL	11	3	3	0	0	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	APR	2020	26	4					461	462		10.1038/s41591-020-0828-1	http://dx.doi.org/10.1038/s41591-020-0828-1			3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	QH1UE	32273602				2022-12-27	WOS:000618061900009
J	Versluis, JM; Long, GV; Blank, CU				Versluis, Judith M.; Long, Georgina V.; Blank, Christian U.			Learning from clinical trials of neoadjuvant checkpoint blockade	NATURE MEDICINE			English	Article							T-CELL INVIGORATION; STAGE-III MELANOMA; TUMOR MICROENVIRONMENT; COMBINED NIVOLUMAB; IMMUNE ACTIVATION; IPILIMUMAB; SURVIVAL; THERAPY; IMMUNOTHERAPY; PEMBROLIZUMAB	Neoadjuvant checkpoint inhibition, in which the therapy is administered before surgery, is a promising new approach to managing bulky but resectable melanoma, and is also being explored in other cancers. This strategy has a high pathologic response rate, which correlates with survival outcomes. The fact that biopsies are routinely available provides a unique opportunity for understanding the responses to therapy and carrying out reverse translation in which these data are used to select therapies in the clinic or in trials that are more likely to improve patient outcomes. In this Perspective, we discuss the rationale for neoadjuvant immunotherapy in resectable solid tumors based on preclinical and human translational data, summarize the results of recent clinical trials and ongoing research, and focus on future directions for enhancing reverse translation.	[Versluis, Judith M.; Blank, Christian U.] Netherlands Canc Inst, Dept Med Oncol, Amsterdam, Netherlands; [Versluis, Judith M.; Blank, Christian U.] Netherlands Canc Inst, Div Mol Oncol & Immunol, Amsterdam, Netherlands; [Long, Georgina V.] Univ Sydney, Melanoma Inst Australia, Sydney, NSW, Australia; [Long, Georgina V.] Royal North Shore Hosp, Sydney, NSW, Australia; [Long, Georgina V.] Mater Hosp, Sydney, NSW, Australia	Netherlands Cancer Institute; Netherlands Cancer Institute; Melanoma Institute Australia; University of Sydney; Royal North Shore Hospital	Blank, CU (corresponding author), Netherlands Canc Inst, Dept Med Oncol, Amsterdam, Netherlands.; Blank, CU (corresponding author), Netherlands Canc Inst, Div Mol Oncol & Immunol, Amsterdam, Netherlands.	c.blank@nki.nl	Long, Georgina/C-1771-2013	Long, Georgina/0000-0001-8894-3545; Versluis, Judith M./0000-0002-3423-9912	NHMRC Practitioner Fellowship; University of Sydney Medical Foundation	NHMRC Practitioner Fellowship(National Health and Medical Research Council (NHMRC) of Australia); University of Sydney Medical Foundation(University of Sydney)	G.V.L. is supported by an NHMRC Practitioner Fellowship and the University of Sydney Medical Foundation.	Ajani JA, 2005, J CLIN ONCOL, V23, P1237, DOI 10.1200/JCO.2005.01.305; Akondy RS, 2015, P NATL ACAD SCI USA, V112, P3050, DOI 10.1073/pnas.1500475112; Akondy RS, 2009, J IMMUNOL, V183, P7919, DOI 10.4049/jimmunol.0803903; Al-Shibli KI, 2008, CLIN CANCER RES, V14, P5220, DOI 10.1158/1078-0432.CCR-08-0133; Amaria RN, 2019, LANCET ONCOL, V20, pE378, DOI 10.1016/S1470-2045(19)30332-8; Amaria RN, 2018, NAT MED, V24, P1649, DOI 10.1038/s41591-018-0197-1; [Anonymous], 2017, J IMMUNOTHER CANCER, V5, DOI 10.1186/s40425-017-0297-3; [Anonymous], 2018, ANN ONCOL S10, DOI DOI 10.1093/ANNONC/MDY424.047; [Anonymous], 2019, J IMMUNOTHER CANCER, V7, P282; Ayers M, 2017, J CLIN INVEST, V127, P2930, DOI 10.1172/JCI91190; Bellmunt J, 2017, NEW ENGL J MED, V376, P1015, DOI 10.1056/NEJMoa1613683; Blackburn SD, 2009, NAT IMMUNOL, V10, P29, DOI 10.1038/ni.1679; Blank CU, 2019, ANN ONCOL, V30, P535; Blank CU, 2018, NAT MED, V24, P1655, DOI 10.1038/s41591-018-0198-0; Blank CU, 2016, SCIENCE, V352, P658, DOI 10.1126/science.aaf2834; Bloemendal M, 2019, ANN SURG ONCOL, V26, P3945, DOI 10.1245/s10434-019-07274-2; Bottcher JP, 2018, CELL, V172, P1022, DOI 10.1016/j.cell.2018.01.004; Borghaei H, 2015, NEW ENGL J MED, V373, P1627, DOI 10.1056/NEJMoa1507643; Brand A, 2016, CELL METAB, V24, P657, DOI 10.1016/j.cmet.2016.08.011; Cascone T, 2019, J CLIN ONCOL, V37; Chen G, 2018, NATURE, V560, P382, DOI 10.1038/s41586-018-0392-8; Chen H, 2009, P NATL ACAD SCI USA, V106, P2729, DOI 10.1073/pnas.0813175106; Cortazar P, 2014, LANCET, V384, P164, DOI 10.1016/S0140-6736(13)62422-8; Cottrell TR, 2018, ANN ONCOL, V29, P1853, DOI 10.1093/annonc/mdy218; Deken MA, 2016, ONCOIMMUNOLOGY, V5, DOI 10.1080/2162402X.2016.1238557; Diab A, 2018, J CLIN ONCOL, V36, DOI 10.1200/JCO.2018.36.15_suppl.3006; Dieu-Nosjean MC, 2016, IMMUNOL REV, V271, P260, DOI 10.1111/imr.12405; Eggermont AMM, 2016, NEW ENGL J MED, V375, P1845, DOI 10.1056/NEJMoa1611299; Eggermont AMM, 2018, NEW ENGL J MED, V378, P1789, DOI 10.1056/NEJMoa1802357; Fan XZ, 2014, J EXP MED, V211, P715, DOI 10.1084/jem.20130590; Foppen MHG, 2016, ANN ONCOL, V27, P1138, DOI 10.1093/annonc/mdw134; Forde PM, 2018, NEW ENGL J MED, V378, P1976, DOI 10.1056/NEJMoa1716078; Frederick DT, 2013, CLIN CANCER RES, V19, P1225, DOI 10.1158/1078-0432.CCR-12-1630; Gonzalez M., 2017, ANN ONCOL, V28, pV428; Gonzalez M, 2018, J CLIN ONCOL, V36, DOI 10.1200/JCO.2018.36.15_suppl.TPS9604; Hackshaw A, 2005, BRIT J CANCER, V93, P1215, DOI 10.1038/sj.bjc.6602858; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Huang AC, 2019, NAT MED, V25, P454, DOI 10.1038/s41591-019-0357-y; Huang AC, 2017, NATURE, V545, P60, DOI 10.1038/nature22079; Hugo W, 2016, CELL, V165, P35, DOI 10.1016/j.cell.2016.02.065; Jansen Y, 2016, ANN ONCOL, V27, DOI 10.1093/annonc/mdw379.22; Joseph RW, 2018, CLIN CANCER RES, V24, P4960, DOI 10.1158/1078-0432.CCR-17-2386; Kelderman S, 2014, CANCER IMMUNOL IMMUN, V63, P449, DOI 10.1007/s00262-014-1528-9; Khunger A, 2019, THER ADV MED ONCOL, V11, DOI 10.1177/1758835919866959; Le Bourgeois T, 2018, FRONT ONCOL, V8, DOI 10.3389/fonc.2018.00237; Le DT, 2017, SCIENCE, V357, P409, DOI 10.1126/science.aan6733; Lee JHJ, 2018, PIGM CELL MELANOMA R, V31, P404, DOI 10.1111/pcmr.12675; Lemery S, 2017, NEW ENGL J MED, V377, P1409, DOI 10.1056/NEJMp1709968; Lio J, 2019, ONCOIMMUNOLOGY, V8, DOI 10.1080/2162402X.2019.1581530; Liu J, 2016, CANCER DISCOV, V6, P1382, DOI 10.1158/2159-8290.CD-16-0577; Long GV, 2019, LANCET ONCOL, V20, P961, DOI 10.1016/S1470-2045(19)30331-6; Lorenzen S, 2013, ANN ONCOL, V24, P2068, DOI 10.1093/annonc/mdt141; LUI VK, 1975, BRIT J CANCER, V32, P323, DOI 10.1038/bjc.1975.230; Menzies AM, 2019, J CLIN ONCOL, V37, DOI 10.1200/JCO.2019.37.15_suppl.9503; Motzer RJ, 2018, NEW ENGL J MED, V378, P1277, DOI 10.1056/NEJMoa1712126; Naing A, 2018, CANCER CELL, V34, P775, DOI 10.1016/j.ccell.2018.10.007; O'Donnell JS, 2019, CLIN CANCER RES, V25, P5743, DOI 10.1158/1078-0432.CCR-18-2641; Overman MJ, 2018, J CLIN ONCOL, V36, P773, DOI 10.1200/JCO.2017.76.9901; Park IJ, 2012, J CLIN ONCOL, V30, P1770, DOI 10.1200/JCO.2011.39.7901; Petrelli F, 2014, EUR UROL, V65, P350, DOI 10.1016/j.eururo.2013.06.049; Poggio M, 2019, CELL, V177, P414, DOI 10.1016/j.cell.2019.02.016; Pradelli E, 2009, INT J CANCER, V125, P2586, DOI 10.1002/ijc.24665; Reijers I, 2019, J CLIN ONCOL, V37, DOI 10.1200/JCO.2019.37.15_suppl.TPS9605; Renner K, 2015, EUR J IMMUNOL, V45, P2504, DOI 10.1002/eji.201545473; Ribas A, 2018, SCIENCE, V359, P1350, DOI 10.1126/science.aar4060; Ribas A, 2017, CELL, V170, P1109, DOI 10.1016/j.cell.2017.08.027; Rizvi NA, 2015, LANCET ONCOL, V16, P257, DOI 10.1016/S1470-2045(15)70054-9; Robert C, 2015, NEW ENGL J MED, V372, P320, DOI 10.1056/NEJMoa1412082; Rozeman EA, 2019, ANN ONCOL, V30, pv910; Rozeman EA, 2017, ANN ONCOL, V28, pv428; Rozeman EA, 2019, LANCET ONCOL, V20, P948, DOI 10.1016/S1470-2045(19)30151-2; Schachter J, 2017, LANCET, V390, P1853, DOI 10.1016/S0140-6736(17)31601-X; Schermers B, 2019, BRIT J SURG, V106, P519, DOI 10.1002/bjs.11168; Schumacher TN, 2019, ANNU REV IMMUNOL, V37, P173, DOI 10.1146/annurev-immunol-042617-053402; Schumacher TN, 2015, SCIENCE, V348, P69, DOI 10.1126/science.aaa4971; Sharma P, 2007, P NATL ACAD SCI USA, V104, P3967, DOI 10.1073/pnas.0611618104; Shrotriya S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143080; Snyder A, 2014, NEW ENGL J MED, V371, P2189, DOI 10.1056/NEJMoa1406498; Spranger S, 2017, CANCER CELL, V31, P711, DOI 10.1016/j.ccell.2017.04.003; Spranger S, 2015, NATURE, V523, P231, DOI 10.1038/nature14404; Stein JE, 2020, CLIN CANCER RES, V26, P545, DOI 10.1158/1078-0432.CCR-19-2379; Tarhini A, 2018, J IMMUNOTHER CANCER, V6, DOI 10.1186/s40425-018-0428-5; Tatsumi T, 2002, J EXP MED, V196, P619, DOI 10.1084/jem.20012142; Tetzlaff MT, 2018, ANN ONCOL, V29, P1861, DOI 10.1093/annonc/mdy226; Tokunaga R, 2018, CANCER TREAT REV, V63, P40, DOI 10.1016/j.ctrv.2017.11.007; Tumeh PC, 2014, NATURE, V515, P568, DOI 10.1038/nature13954; Valsecchi ME, 2015, NEW ENGL J MED, V373, P1270, DOI [10.1056/NEJMoa1504030, 10.1056/NEJMc1509660]; Van der Heijden MS, 2019, ANN ONCOL, V30, P358; von Minckwitz G, 2012, J CLIN ONCOL, V30, P1796, DOI 10.1200/JCO.2011.38.8595; Voorwerk L, 2019, NAT MED, V25, P920, DOI 10.1038/s41591-019-0432-4; Warburg O, 1927, J GEN PHYSIOL, V8, P519, DOI 10.1085/jgp.8.6.519; Weber J, 2017, NEW ENGL J MED, V377, P1824, DOI 10.1056/NEJMoa1709030; Weber JS, 2019, J CLIN ONCOL, V37, DOI 10.1200/JCO.2019.37.15_suppl.100; Wilmott JS, 2012, CLIN CANCER RES, V18, P1386, DOI 10.1158/1078-0432.CCR-11-2479; Wolchok JD, 2017, NEW ENGL J MED, V377, P1345, DOI 10.1056/NEJMoa1709684; Yarchoan M, 2017, NEW ENGL J MED, V377, P2500, DOI 10.1056/NEJMc1713444; Zelenay S, 2015, CELL, V162, P1257, DOI 10.1016/j.cell.2015.08.015	98	53	57	1	4	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	APR	2020	26	4					475	484		10.1038/s41591-020-0829-0	http://dx.doi.org/10.1038/s41591-020-0829-0			10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	QH1UE	32273608				2022-12-27	WOS:000618061900021
J	Nkengasong, J				Nkengasong, John			China's response to a novel coronavirus stands in stark contrast to the 2002 SARS outbreak response (vol 26, pg 310, 2020)	NATURE MEDICINE			English	Correction								An amendment to this paper has been published and can be accessed via a link at the top of the paper.				nkengasongj@africa-union.org						Nkengasong J, 2020, NAT MED, V26, P310, DOI 10.1038/s41591-020-0771-1	1	1	1	1	5	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	MAR	2020	26	3					441	441		10.1038/s41591-020-0816-5	http://dx.doi.org/10.1038/s41591-020-0816-5			1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	KU0MC	32139890	Green Published, Bronze			2022-12-27	WOS:000519405000032
J	Bhattacharyya, RP; Bandyopadhyay, N; Ma, PJ; Son, SS; Liu, JM; He, LL; Wu, LD; Khafizov, R; Boykin, R; Cerqueira, GC; Pironti, A; Rudy, RF; Patel, MM; Yang, R; Skerry, J; Nazarian, E; Musser, KA; Taylor, J; Pierce, VM; Earl, AM; Cosimi, LA; Shoresh, N; Beechem, J; Livny, J; Hung, DT				Bhattacharyya, Roby P.; Bandyopadhyay, Nirmalya; Ma, Peijun; Son, Sophie S.; Liu, Jamin; He, Lorrie L.; Wu, Lidan; Khafizov, Rustem; Boykin, Rich; Cerqueira, Gustavo C.; Pironti, Alejandro; Rudy, Robert F.; Patel, Milesh M.; Yang, Rui; Skerry, Jennifer; Nazarian, Elizabeth; Musser, Kimberly A.; Taylor, Jill; Pierce, Virginia M.; Earl, Ashlee M.; Cosimi, Lisa A.; Shoresh, Noam; Beechem, Joseph; Livny, Jonathan; Hung, Deborah T.			Simultaneous detection of genotype and phenotype enables rapid and accurate antibiotic susceptibility determination	NATURE MEDICINE			English	Article							CARBAPENEM RESISTANCE; MECHANISMS; THERAPY	Multidrug resistant organisms are a serious threat to human health(1,2). Fast, accurate antibiotic susceptibility testing (AST) is a critical need in addressing escalating antibiotic resistance, since delays in identifying multidrug resistant organisms increase mortality(3,4) and use of broad-spectrum antibiotics, further selecting for resistant organisms. Yet current growth-based AST assays, such as broth microdilution(5), require several days before informing key clinical decisions. Rapid AST would transform the care of patients with infection while ensuring that our antibiotic arsenal is deployed as efficiently as possible. Growth-based assays are fundamentally constrained in speed by doubling time of the pathogen, and genotypic assays are limited by the ever-growing diversity and complexity of bacterial antibiotic resistance mechanisms. Here we describe a rapid assay for combined genotypic and phenotypic AST through RNA detection, GoPhAST-R, that classifies strains with 94-99% accuracy by coupling machine learning analysis of early antibiotic-induced transcriptional changes with simultaneous detection of key genetic resistance determinants to increase accuracy of resistance detection, facilitate molecular epidemiology and enable early detection of emerging resistance mechanisms. This two-pronged approach provides phenotypic AST 24-36 h faster than standard workflows, with <4 h assay time on a pilot instrument for hybridization-based multiplexed RNA detection implemented directly from positive blood cultures.	[Bhattacharyya, Roby P.; Bandyopadhyay, Nirmalya; Ma, Peijun; Son, Sophie S.; Liu, Jamin; He, Lorrie L.; Cerqueira, Gustavo C.; Pironti, Alejandro; Rudy, Robert F.; Patel, Milesh M.; Yang, Rui; Earl, Ashlee M.; Shoresh, Noam; Livny, Jonathan; Hung, Deborah T.] Broad Inst MIT & Harvard, Infect Dis & Microbiome Program, Cambridge, MA 02142 USA; [Bhattacharyya, Roby P.] Massachusetts Gen Hosp, Dept Med, Infect Dis Div, Boston, MA 02114 USA; [Wu, Lidan; Khafizov, Rustem; Boykin, Rich; Beechem, Joseph] NanoString Technol Inc, Seattle, WA USA; [Cerqueira, Gustavo C.] Personal Genome Diagnost, Ellicott City, MD USA; [Skerry, Jennifer; Pierce, Virginia M.] Massachusetts Gen Hosp, Dept Pathol, Microbiol Lab, Boston, MA 02114 USA; [Nazarian, Elizabeth; Musser, Kimberly A.; Taylor, Jill] New York State Dept Hlth, Wadsworth Ctr, Albany, NY USA; [Cosimi, Lisa A.] Brigham & Womens Hosp, Dept Med, Infect Dis Div, 75 Francis St, Boston, MA 02115 USA; [Hung, Deborah T.] Harvard Med Sch, Dept Genet, Boston, MA 02115 USA; [Hung, Deborah T.] Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; [Hung, Deborah T.] Massachusetts Gen Hosp, Ctr Computat & Integrat Biol, Boston, MA 02114 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; State University of New York (SUNY) System; Wadsworth Center; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital	Hung, DT (corresponding author), Broad Inst MIT & Harvard, Infect Dis & Microbiome Program, Cambridge, MA 02142 USA.; Hung, DT (corresponding author), Harvard Med Sch, Dept Genet, Boston, MA 02115 USA.; Hung, DT (corresponding author), Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA.; Hung, DT (corresponding author), Massachusetts Gen Hosp, Ctr Computat & Integrat Biol, Boston, MA 02114 USA.	hung@molbio.mgh.harvard.edu	Bhattacharyya, Roby/AAF-7670-2019; Cerqueira, Gustavo/AAV-7398-2020; Son, Sophie/AAF-4317-2019	Bhattacharyya, Roby/0000-0001-6955-5088; Cerqueira, Gustavo/0000-0002-7692-3886; Son, Sophie/0000-0002-5859-4679; Liu, Chieh Ming Jamin/0000-0001-6386-3709; Musser, Kimberlee/0000-0003-1922-5405; /0000-0003-3150-6170; Pierce, Virginia/0000-0002-3723-1326; He, Lorrie/0000-0002-8438-6603	National Institute of Allergy and Infectious Diseases of the National Institutes of Health [1R01AI117043-05, 1K08AI119157-04, HHSN272200900018C]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI117043, K08AI119157] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank T. Abeel for valuable early discussions about the approach to machine learning for feature selection and strain classification; E. Lander, B. Birren, C. Nusbaum and C. Russ for input on RNA-seq experiments and overall strategy; and G. Giannoukos and D. Ciulla for valuable contributions to RNA-seq methods development. This publication was supported in part by the National Institute of Allergy and Infectious Diseases of the National Institutes of Health (award nos. 1R01AI117043-05 to D.T.H. and 1K08AI119157-04 to R.P.B., and contract no. HHSN272200900018C). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adler A, 2015, ANTIMICROB AGENTS CH, V59, P5014, DOI 10.1128/AAC.00533-15; Allix-Beguec C, 2018, NEW ENGL J MED, V379, P1403, DOI 10.1056/NEJMoa1800474; [Anonymous], 2018, M100 CLIN LAB STAND, V30; [Anonymous], 2018, M07 METHODS DILUTION, V11th ed.; Arzanlou M, 2017, ESSAYS BIOCHEM, V61, P49, DOI 10.1042/EBC20160063; Barczak AK, 2012, P NATL ACAD SCI USA, V109, P6217, DOI 10.1073/pnas.1119540109; Bhattacharyya R. P., 2018, HARRISONS PRINCIPLES; Bonomo RA, 2018, CLIN INFECT DIS, V66, P1290, DOI 10.1093/cid/cix893; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Brown LD, 2001, STAT SCI, V16, P101, DOI 10.1214/ss/1009213286; Burnham CAD, 2017, NAT REV MICROBIOL, V15, P697, DOI 10.1038/nrmicro.2017.103; Caniaux I, 2017, EUR J CLIN MICROBIOL, V36, P415, DOI 10.1007/s10096-016-2846-y; Cermak N, 2016, NAT BIOTECHNOL, V34, P1052, DOI 10.1038/nbt.3666; Cerqueira GC, 2017, P NATL ACAD SCI USA, V114, P1135, DOI 10.1073/pnas.1616248114; Charnot-Katsikas A, 2018, J CLIN MICROBIOL, V56, DOI 10.1128/JCM.01166-17; Cubero M, 2015, BMC MICROBIOL, V15, DOI 10.1186/s12866-015-0510-9; EFRON B, 1983, AM STAT, V37, P36, DOI 10.2307/2685844; Ellington MJ, 2017, CLIN MICROBIOL INFEC, V23, P2, DOI 10.1016/j.cmi.2016.11.012; Evans SR, 2016, CLIN INFECT DIS, V62, P181, DOI 10.1093/cid/civ837; Florio W, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.01097; Geiss GK, 2008, NAT BIOTECHNOL, V26, P317, DOI 10.1038/nbt1385; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Hou HW, 2015, LAB CHIP, V15, P2297, DOI 10.1039/c5lc00311c; Jia BF, 2017, NUCLEIC ACIDS RES, V45, pD566, DOI 10.1093/nar/gkw1004; Kadri SS, 2018, CLIN INFECT DIS, V67, P1803, DOI 10.1093/cid/ciy378; Kumar A, 2006, CRIT CARE MED, V34, P1589, DOI 10.1097/01.CCM.0000217961.75225.E9; Letunic I, 2019, NUCLEIC ACIDS RES, V47, pW256, DOI 10.1093/nar/gkz239; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lomovskaya O, 2017, ANTIMICROB AGENTS CH, V61, DOI [10.1128/aac.01443-17, 10.1128/AAC.01443-17]; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lutgring JD, 2016, J CLIN MICROBIOL, V54, P529, DOI 10.1128/JCM.02771-15; Ma PJ, 2018, ANTIMICROB AGENTS CH, V62, DOI [10.1128/AAC.01281-18, 10.1128/aac.01281-18]; Marshall S, 2017, ANTIMICROB AGENTS CH, V61, DOI 10.1128/AAC.02243-16; McMullen AR, 2017, CLIN CHEM, V63, P723, DOI 10.1373/clinchem.2016.264804; Milheirico C, 2017, ANTIMICROB AGENTS CH, V61, DOI 10.1128/AAC.02500-16; Nordmann P, 2012, TRENDS MOL MED, V18, P263, DOI 10.1016/j.molmed.2012.03.003; Parks T, 2012, NEW ENGL J MED, V367, P90, DOI [10.1056/NEJMra1108296, 10.1056/NEJMc1202013, 10.1056/NEJMc1204960]; Quach DT, 2016, EBIOMEDICINE, V4, P95, DOI 10.1016/j.ebiom.2016.01.020; Robnik-Sikonja M, 2003, MACH LEARN, V53, P23, DOI 10.1023/A:1025667309714; Shishkin AA, 2015, NAT METHODS, V12, P323, DOI [10.1038/NMETH.3313, 10.1038/nmeth.3313]; Smith Kenneth P, 2018, Antimicrob Agents Chemother, V62, DOI [10.1128/AAC.00433-18, 10.1128/aac.00433-18]; Spafford K, 2019, J CLIN MICROBIOL, V57, DOI 10.1128/JCM.00674-19; van Belkum A, 2017, ANN LAB MED, V37, P475, DOI 10.3343/alm.2017.37.6.475; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Weisenberg SA, 2009, DIAGN MICR INFEC DIS, V64, P233, DOI 10.1016/j.diagmicrobio.2009.02.004; Wiegand I, 2008, NAT PROTOC, V3, P163, DOI 10.1038/nprot.2007.521; Woodworth KR, 2018, MMWR-MORBID MORTAL W, V67, P396, DOI 10.15585/mmwr.mm6713e1; World Health Organization, 2014, ANT RES GLOB REP SUR	48	50	52	4	54	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	2019	25	12					1858	+		10.1038/s41591-019-0650-9	http://dx.doi.org/10.1038/s41591-019-0650-9			21	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	JT2KO	31768064	Green Accepted			2022-12-27	WOS:000500824900029
J	Arboleda-Velasquez, JF; Lopera, F; O'Hare, M; Delgado-Tirado, S; Marino, C; Chmielewska, N; Saez-Torres, KL; Amarnani, D; Schultz, AP; Sperling, RA; Leyton-Cifuentes, D; Chen, KW; Baena, A; Aguillon, D; Rios-Romenets, S; Giraldo, M; Guzman-Velez, E; Norton, DJ; Pardilla-Delgado, E; Artola, A; Sanchez, JS; Acosta-Uribe, J; Lalli, M; Kosik, KS; Huentelman, MJ; Zetterberg, H; Blennow, K; Reiman, RA; Luo, J; Chen, YH; Thiyyagura, P; Su, Y; Jun, GR; Naymik, M; Gai, XW; Bootwalla, M; Ji, JL; Shen, LS; Miller, JB; Kim, LA; Tariot, PN; Johnson, KA; Reiman, EM; Quiroz, YT				Arboleda-Velasquez, Joseph F.; Lopera, Francisco; O'Hare, Michael; Delgado-Tirado, Santiago; Marino, Claudia; Chmielewska, Natalia; Saez-Torres, Kahira L.; Amarnani, Dhanesh; Schultz, Aaron P.; Sperling, Reisa A.; Leyton-Cifuentes, David; Chen, Kewei; Baena, Ana; Aguillon, David; Rios-Romenets, Silvia; Giraldo, Margarita; Guzman-Velez, Edmarie; Norton, Daniel J.; Pardilla-Delgado, Enmanuelle; Artola, Arabiye; Sanchez, Justin S.; Acosta-Uribe, Juliana; Lalli, Matthew; Kosik, Kenneth S.; Huentelman, Matthew J.; Zetterberg, Henrik; Blennow, Kaj; Reiman, Rebecca A.; Luo, Ji; Chen, Yinghua; Thiyyagura, Pradeep; Su, Yi; Jun, Gyungah R.; Naymik, Marcus; Gai, Xiaowu; Bootwalla, Moiz; Ji, Jianling; Shen, Lishuang; Miller, John B.; Kim, Leo A.; Tariot, Pierre N.; Johnson, Keith A.; Reiman, Eric M.; Quiroz, Yakeel T.			Resistance to autosomal dominant Alzheimer's disease in an APOE3 Christchurch homozygote: a case report	NATURE MEDICINE			English	Article							HUMAN APOLIPOPROTEIN-E; AGE-OF-ONSET; BINDING; VARIANTS; MUTATION; ALLELE	We identified a PSEN1 (presenilin 1) mutation carrier from the world's largest autosomal dominant Alzheimer's disease kindred, who did not develop mild cognitive impairment until her seventies, three decades after the expected age of clinical onset. The individual had two copies of the APOE3 Christchurch (R136S) mutation, unusually high brain amyloid levels and limited tau and neurodegenerative measurements. Our findings have implications for the role of APOE in the pathogenesis, treatment and prevention of Alzheimer's disease.	[Arboleda-Velasquez, Joseph F.; O'Hare, Michael; Delgado-Tirado, Santiago; Marino, Claudia; Chmielewska, Natalia; Saez-Torres, Kahira L.; Amarnani, Dhanesh; Leyton-Cifuentes, David; Kim, Leo A.] Harvard Med Sch, Schepens Eye Res Inst, Mass Eye & Ear, Boston, MA 02115 USA; [Arboleda-Velasquez, Joseph F.; O'Hare, Michael; Delgado-Tirado, Santiago; Marino, Claudia; Chmielewska, Natalia; Saez-Torres, Kahira L.; Amarnani, Dhanesh; Leyton-Cifuentes, David; Miller, John B.; Kim, Leo A.] Harvard Med Sch, Dept Ophthalmol, Boston, MA 02115 USA; [Arboleda-Velasquez, Joseph F.; Lopera, Francisco; Baena, Ana; Aguillon, David; Rios-Romenets, Silvia; Giraldo, Margarita; Quiroz, Yakeel T.] Univ Antioquia, Grp Neurociencias Antioquia, Medellin, Colombia; [Arboleda-Velasquez, Joseph F.; Chmielewska, Natalia] Boston Coll, Boston, MA USA; [Schultz, Aaron P.; Sperling, Reisa A.; Guzman-Velez, Edmarie; Norton, Daniel J.; Pardilla-Delgado, Enmanuelle; Artola, Arabiye; Sanchez, Justin S.; Johnson, Keith A.] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Schultz, Aaron P.; Sperling, Reisa A.; Johnson, Keith A.; Quiroz, Yakeel T.] Harvard Med Sch, Dept Neurol, Boston, MA 02115 USA; [Sperling, Reisa A.; Johnson, Keith A.] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA; [Leyton-Cifuentes, David] Univ Escuela Ingn Antioquia EIA, Medellin, Colombia; [Chen, Kewei; Luo, Ji; Chen, Yinghua; Thiyyagura, Pradeep; Su, Yi; Tariot, Pierre N.; Reiman, Eric M.] Banner Alzheimers Inst, Phoenix, AZ USA; [Chen, Kewei; Tariot, Pierre N.; Reiman, Eric M.] Univ Arizona, Tucson, AZ USA; [Chen, Kewei; Reiman, Eric M.] Arizona State Univ, Tempe, AZ USA; [Guzman-Velez, Edmarie; Norton, Daniel J.; Pardilla-Delgado, Enmanuelle; Artola, Arabiye; Quiroz, Yakeel T.] Harvard Med Sch, Dept Psychiat, Boston, MA 02115 USA; [Norton, Daniel J.] Gordon Coll, Dept Psychol, Wenham, MA USA; [Acosta-Uribe, Juliana; Lalli, Matthew; Kosik, Kenneth S.] Univ Calif Santa Barbara, Dept Mol Cellular Dev Biol, Neurosci Res Inst, Santa Barbara, CA 93106 USA; [Huentelman, Matthew J.; Reiman, Rebecca A.; Naymik, Marcus; Reiman, Eric M.] Translat Genom Res Inst, Neurogen Div, Phoenix, AZ USA; [Zetterberg, Henrik; Blennow, Kaj] Sahlgrens Univ Hosp, Clin Neurochemistry Lab, Molndal, Sweden; [Zetterberg, Henrik; Blennow, Kaj] Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Dept Psychiat & Neurochem, Molndal, Sweden; [Zetterberg, Henrik] UCL, Queen Sq Inst Neurol, Dept Neurodegenerat Dis, London, England; [Zetterberg, Henrik] UCL, UK Dementia Res Inst, London, England; [Jun, Gyungah R.] Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA; [Gai, Xiaowu; Bootwalla, Moiz; Ji, Jianling; Shen, Lishuang] Childrens Hosp Los Angeles, Dept Pathol & Lab Med, Ctr Personalized Med, Los Angeles, CA 90027 USA; [Gai, Xiaowu; Ji, Jianling] Univ Southern Calif, Keck Sch Med, Dept Pathol, Los Angeles, CA 90007 USA; [Miller, John B.] Harvard Med Sch, Mass Eye & Ear, Boston, MA 02115 USA; [Johnson, Keith A.] Harvard Med Sch, Dept Radiol, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Schepens Eye Research Institute; Harvard University; Harvard Medical School; Universidad de Antioquia; Boston College; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Banner Research; Banner Health; Banner Alzheimer's Institute; University of Arizona; Arizona State University; Arizona State University-Tempe; Harvard University; Harvard Medical School; University of California System; University of California Santa Barbara; Translational Genomics Research Institute; Sahlgrenska University Hospital; University of Gothenburg; University of London; University College London; University of London; University College London; Boston University; Children's Hospital Los Angeles; University of Southern California; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Arboleda-Velasquez, JF (corresponding author), Harvard Med Sch, Schepens Eye Res Inst, Mass Eye & Ear, Boston, MA 02115 USA.; Arboleda-Velasquez, JF (corresponding author), Harvard Med Sch, Dept Ophthalmol, Boston, MA 02115 USA.; Arboleda-Velasquez, JF; Quiroz, YT (corresponding author), Univ Antioquia, Grp Neurociencias Antioquia, Medellin, Colombia.; Arboleda-Velasquez, JF (corresponding author), Boston Coll, Boston, MA USA.; Quiroz, YT (corresponding author), Harvard Med Sch, Dept Neurol, Boston, MA 02115 USA.; Reiman, EM (corresponding author), Banner Alzheimers Inst, Phoenix, AZ USA.; Reiman, EM (corresponding author), Univ Arizona, Tucson, AZ USA.; Reiman, EM (corresponding author), Arizona State Univ, Tempe, AZ USA.; Quiroz, YT (corresponding author), Harvard Med Sch, Dept Psychiat, Boston, MA 02115 USA.; Reiman, EM (corresponding author), Translat Genom Res Inst, Neurogen Div, Phoenix, AZ USA.	joseph_arboleda@meei.harvard.edu; eric.reiman@bannerhealth.com; yquiroz@mgh.harvard.edu	Shen, Lishuang/B-3040-2013; Ji, Jianling/AAS-7117-2021; Kim, Leo/Y-3323-2018; chen, ying/HHS-8254-2022; Miller, John J/GZG-5663-2022	Ji, Jianling/0000-0003-4941-3538; Kim, Leo/0000-0001-9106-6416; Leyton Cifuentes, David/0000-0002-7450-4207; Bootwalla, Moiz/0000-0001-6158-7114; Shen, Lishuang/0000-0002-0436-0199; gai, Xiaowu/0000-0001-8679-9703; Pardilla-Delgado, Enmanuelle/0000-0003-1149-3157; O'Hare, Michael/0000-0002-2833-3697; /0000-0001-9978-093X	US National Institutes of Health (NIH) Office of the Director [DP5 OD019833]; US National Institute on Aging [R01 AG054671, R01 AG031581, P30 AG19610, RF01 AG057519]; Massachusetts General Hospital Executive Committee on Research; Massachusetts General Hospital; Alzheimer's Association; US National Institute of Neurological Disorders and Stroke [UH3 NS100121, RF1 NS110048]; National Institute on Aging [UH3 NS100121, RF1 NS110048]; Grimshaw-Gudewicz Charitable Foundation; Banner Alzheimer's Foundation; Nomis Foundation; Anonymous Foundation; State of Arizona; MRC [UKDRI-1003] Funding Source: UKRI; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [UH3NS100121, RF1NS110048] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG031581, P30AG019610, R01AG054671, P30AG062421] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP5OD019833] Funding Source: NIH RePORTER	US National Institutes of Health (NIH) Office of the Director(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Massachusetts General Hospital Executive Committee on Research; Massachusetts General Hospital(General Electric); Alzheimer's Association(Alzheimer's Association); US National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Grimshaw-Gudewicz Charitable Foundation; Banner Alzheimer's Foundation; Nomis Foundation; Anonymous Foundation; State of Arizona; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The authors thank the Colombian families with ADAD for making this work possible. This study was supported by US National Institutes of Health (NIH) Office of the Director grant DP5 OD019833 and US National Institute on Aging grant R01 AG054671, Claflin Distinguished Scholar Award from the Massachusetts General Hospital Executive Committee on Research, Physician/Scientist Development Award from the Massachusetts General Hospital, and Alzheimer's Association Research Grant to Y.T.Q.; US National Institute of Neurological Disorders and Stroke and National Institute on Aging co-funded grants UH3 NS100121 and RF1 NS110048 to J.F.A.-V.; Grimshaw-Gudewicz Charitable Foundation grant to J.F.A.-V., J.B.M., and L.A.K.; Banner Alzheimer's Foundation and Nomis Foundation grants to E.M.R. and P.N.T.; Anonymous Foundation grant to E.M.R.; US National Institute on Aging grants R01 AG031581 and P30 AG19610 to E.M.R.; US National Institute on Aging grant RF01 AG057519 to G.R.J.; and a State of Arizona grant to E.M.R. We also thank A. Koutoulas for technical support with DNA sequencing, B. Hyman from Massachusetts General Hospital for providing expression plasmids for the split-luciferase complementation assay, and Y. Alekseyev, A. LeClerc, M.J. Mistretta, J. Horvath, and J. Campbell from the Boston University Department of Medicine Single Cell Sequencing Core and Boston University Microarray and Sequencing Resource Core Facilities for reagents and technical support for single-cell RNA sequencing.	Acosta-Baena N, 2011, LANCET NEUROL, V10, P213, DOI 10.1016/S1474-4422(10)70323-9; Aguirre-Acevedo DC, 2007, REV NEUROLOGIA, V45, P655, DOI 10.33588/rn.4511.2007086; Becker JA, 2011, ANN NEUROL, V69, P1032, DOI 10.1002/ana.22333; Braak H, 1997, NEUROBIOL AGING, V18, pS85, DOI 10.1016/S0197-4580(97)00062-6; Braak H, 2006, J ALZHEIMERS DIS, V9, P35; Butler A, 2018, NAT BIOTECHNOL, V36, P411, DOI 10.1038/nbt.4096; Chien DT, 2013, J ALZHEIMERS DIS, V34, P457, DOI 10.3233/JAD-122059; CORDER EH, 1994, NAT GENET, V7, P180, DOI 10.1038/ng0694-180; Fisher S, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-1-r1; Fleisher AS, 2015, JAMA NEUROL, V72, P316, DOI 10.1001/jamaneurol.2014.3314; Futamura M, 2005, J BIOL CHEM, V280, P5414, DOI 10.1074/jbc.M411719200; Gisslen M, 2016, EBIOMEDICINE, V3, P135, DOI 10.1016/j.ebiom.2015.11.036; Hashimoto T, 2012, J NEUROSCI, V32, P15181, DOI 10.1523/JNEUROSCI.1542-12.2012; Hedden T, 2009, J NEUROSCI, V29, P12686, DOI 10.1523/JNEUROSCI.3189-09.2009; Hudry E, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3007000; Johnson KA, 2016, ANN NEUROL, V79, P110, DOI 10.1002/ana.24546; Knight WD, 2009, ALZ DIS ASSOC DIS, V23, P410, DOI 10.1097/WAD.0b013e31819cb7f3; LALAZAR A, 1988, J BIOL CHEM, V263, P3542; Lalli MA, 2015, MOL PSYCHIATR, V20, P1294, DOI 10.1038/mp.2015.131; Llado A, 2010, EUR J NEUROL, V17, P994, DOI 10.1111/j.1468-1331.2010.02949.x; Logan J, 2000, NUCL MED BIOL, V27, P661, DOI 10.1016/S0969-8051(00)00137-2; Mahley RW, 1999, J LIPID RES, V40, P1933; Mormino EC, 2014, JAMA NEUROL, V71, P1379, DOI 10.1001/jamaneurol.2014.2031; Preische O, 2019, NAT MED, V25, P277, DOI 10.1038/s41591-018-0304-3; Quiroz YT, 2018, JAMA NEUROL, V75, P548, DOI 10.1001/jamaneurol.2017.4907; Rauch JN, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-24904-z; Shoup TM, 2013, J LABELLED COMPD RAD, V56, P736, DOI 10.1002/jlcr.3098; Smedley D, 2016, AM J HUM GENET, V99, P595, DOI 10.1016/j.ajhg.2016.07.005; Thordardottir S, 2018, ALZHEIMERS RES THER, V10, DOI 10.1186/s13195-018-0374-y; Velez JI, 2016, MOL PSYCHIATR, V21, P916, DOI 10.1038/mp.2015.177; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Wang L, 2016, JAMA NEUROL, V73, P1070, DOI 10.1001/jamaneurol.2016.2078; WARDELL MR, 1987, J CLIN INVEST, V80, P483, DOI 10.1172/JCI113096; Yamauchi Y, 2008, BIOCHEMISTRY-US, V47, P6702, DOI 10.1021/bi8003999; Zhong L, 2016, MOL NEURODEGENER, V11, DOI 10.1186/s13024-016-0069-4	35	178	180	2	51	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2019	25	11					1680	+		10.1038/s41591-019-0611-3	http://dx.doi.org/10.1038/s41591-019-0611-3			10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	JT2KI	31686034	Green Submitted, Green Accepted			2022-12-27	WOS:000500824300024
J	Singer, JR; Blosser, EG; Zindl, CL; Silberger, DJ; Conlan, S; Laufer, VA; DiToro, D; Deming, C; Kumar, R; Morrow, CD; Segre, JA; Gray, MJ; Randolph, DA; Weaver, CT				Singer, Jeffrey R.; Blosser, Emily G.; Zindl, Carlene L.; Silberger, Daniel J.; Conlan, Sean; Laufer, Vincent A.; DiToro, Daniel; Deming, Clay; Kumar, Ranjit; Morrow, Casey D.; Segre, Julia A.; Gray, Michael J.; Randolph, David A.; Weaver, Casey T.			Preventing dysbiosis of the neonatal mouse intestinal microbiome protects against late-onset sepsis	NATURE MEDICINE			English	Article							LACTIC-ACID BACTERIA; GASTROINTESTINAL-TRACT; ANTIBIOTIC-TREATMENT; COLONIZATION; INFANTS; TRANSMISSION; PROBIOTICS; ADHESIN	Late-onset sepsis (LOS) is thought to result from systemic spread of commensal microbes from the intestines of premature infants. Clinical use of probiotics for LOS prophylaxis has varied owing to limited efficacy, reflecting an incomplete understanding of relationships between development of the intestinal microbiome, neonatal dysbiosis and LOS. Using a model of LOS, we found that components of the developing microbiome were both necessary and sufficient to prevent LOS. Maternal antibiotic exposure that eradicated or enriched transmission of Lactobacillus murinus exacerbated and prevented disease, respectively. Prophylactic administration of some, but not all Lactobacillus spp. was protective, as was administration of Escherichia coli. Intestinal oxygen level was a major driver of colonization dynamics, albeit via mechanisms distinct from those in adults. These results establish a link between neonatal dysbiosis and LOS, and provide a basis for rational selection of probiotics that modulate primary succession of the microbiome to prevent disease.	[Singer, Jeffrey R.; Zindl, Carlene L.; Silberger, Daniel J.; Laufer, Vincent A.; DiToro, Daniel; Weaver, Casey T.] Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA; [Blosser, Emily G.; Randolph, David A.] Univ Alabama Birmingham, Dept Pediat, Birmingham, AL USA; [Conlan, Sean; Deming, Clay; Segre, Julia A.] NHGRI, NIH, Bethesda, MD 20892 USA; [Kumar, Ranjit] Univ Alabama Birmingham, Inst Informat, Ctr Clin & Translat Sci, Birmingham, AL USA; [Morrow, Casey D.] Univ Alabama Birmingham, Dept Cell Dev & Integrat Biol, Birmingham, AL USA; [Gray, Michael J.] Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA; [Blosser, Emily G.] Ochsner Hlth Syst, Dept Obstet & Gynecol, New Orleans, LA USA; [Randolph, David A.] Rocky Mt Hosp Children, Div Neonatal Perinatal Med, Denver, CO USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Ochsner Health System	Singer, JR; Weaver, CT (corresponding author), Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA.	jrsinger@uab.edu; cweaver@uab.edu	Singer, Jeffrey/AAO-7314-2020; Conlan, Sean/B-4401-2008	Singer, Jeffrey/0000-0001-7033-3001; Conlan, Sean/0000-0001-6848-3465; Blosser, Emily G/0000-0002-2457-1516; Zindl, Carlene/0000-0003-4841-3552	Comprehensive Cancer Center [P30AR050948]; Center for Clinical Translational Science [UL1TR001417]; University-Wide Institutional Core and Heflin Center for Genomic Sciences; NIH [F30DK105680]; UAB - NIH [T32GM008361]; NHGRI; UAB; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007051] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008361] Funding Source: NIH RePORTER	Comprehensive Cancer Center; Center for Clinical Translational Science; University-Wide Institutional Core and Heflin Center for Genomic Sciences; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UAB - NIH; NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); UAB; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank members of the Weaver laboratory for their helpful comments, G. Gaskins and C. Rutledge for their administrative support and S.E. Winter (UT Southwestern), N. Ambalavanan, C.O. Elson III, R.G. Lorenz, R.D. Hatton and L.A. Harrington (UAB) for their advice. We thank M. Wu (University of North Dakota), G. O'Toole (Dartmouth University) and C. Orihuela (UAB) for providing critical reagents to this study (Supplementary Tables 3 and 4). We also thank D. O'Quinn, J. Wright and H. Turner for their technical assistance. Additionally, we are grateful to T. Schaub and S. Sinclair at the UAB Gnotobiotic Animal Core, S. Samuel and K. Zinn at the UAB Small Animal Imaging Core, and J. Day and the La Jolla Institute of Allergy and Immunology Sequencing Facility. Finally, we thank W. Duck and P. Basu Thakur for their advice and technical assistance and P. Thomas and M. Park for bioinformatics analysis. We acknowledge the following for their support of the Microbiome Resource at the University of Alabama at Birmingham: the Comprehensive Cancer Center (P30AR050948), the Center for Clinical Translational Science (UL1TR001417) and the University-Wide Institutional Core and Heflin Center for Genomic Sciences. This study used the Nephele platform from the National Institute of Allergy and Infectious Diseases Office of Cyber Infrastructure and Computational Biology in Bethesda and utilized the high-performance computational capabilities of the National Institutes of Health (NIH) Biowulf Linux cluster. Whole-genome sequencing was performed at the NIH Intramural Sequencing Center. This work was supported by NIH F30DK105680 (J.R.S.), the UAB Medical Scientist Training Program, supported by NIH T32GM008361 (E.G.B., D.D., V.A.L. and J.R.S.), NHGRI Intramural Research funds (J.A.S.) and UAB institutional funds (C.T.W. and D.A.R.).	Bates D, 2013, J STAT SOFTW, V52, P1, DOI 10.18637/jss.v052.i05; Birchenough GMH, 2013, INFECT IMMUN, V81, P3264, DOI 10.1128/IAI.00268-13; Bokulich NA, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad7121; Byndloss MX, 2018, NAT REV MICROBIOL, V16, P103, DOI 10.1038/nrmicro.2017.158; Byndloss MX, 2017, SCIENCE, V357, P570, DOI 10.1126/science.aam9949; Corsini I, 2017, PEDIATR RES, V81, P364, DOI 10.1038/pr.2016.214; Cramton SE, 2001, INFECT IMMUN, V69, P4079, DOI 10.1128/IAI.69.6.4079-4085.2001; de Goffau MC, 2019, NATURE, V572, P329, DOI 10.1038/s41586-019-1451-5; Dermyshi E, 2017, NEONATOLOGY, V112, P9, DOI 10.1159/000454668; Deshmukh HS, 2014, NAT MED, V20, P528, DOI 10.1038/nm.3542; Dong Y, 2015, ARCH DIS CHILD-FETAL, V100, pF257, DOI 10.1136/archdischild-2014-306213; Elkins CA, 2004, APPL ENVIRON MICROB, V70, P7200, DOI 10.1128/AEM.70.12.7200-7209.2004; Eren AM, 2013, METHODS ECOL EVOL, V4, P1111, DOI 10.1111/2041-210X.12114; FAJARDO C, 2018, J MATERN-FETAL NEO M, V64, P1; Ferretti P, 2018, CELL HOST MICROBE, V24, P133, DOI 10.1016/j.chom.2018.06.005; Friedman ES, 2018, P NATL ACAD SCI USA, V115, P4170, DOI 10.1073/pnas.1718635115; Gibson MK, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.24, 10.1038/nmicrobiol.2016.24]; Graham PL, 2007, PEDIATR INFECT DIS J, V26, P1153, DOI 10.1097/INF.0b013e31814619d4; Grozdanov L, 2004, J BACTERIOL, V186, P5432, DOI 10.1128/JB.186.16.5432-5441.2004; Hinsa SM, 2003, MOL MICROBIOL, V49, P905, DOI 10.1046/j.1365-2958.2003.03615.x; Hosny M., 2017, HUM MICROBIOME J, V4, P14, DOI DOI 10.1016/j.humic.2016.09.002; Howe K, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-197; Johnson RC, 2018, NEW ENGL J MED, V379, P2529, DOI [10.1056/NEJMoa1803238, 10.1056/nejmoa1803238]; Kelly CJ, 2015, CELL HOST MICROBE, V17, P662, DOI 10.1016/j.chom.2015.03.005; Kim YG, 2017, SCIENCE, V356, P312, DOI 10.1126/science.aag2029; Knoop KA, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aao1314; Ko KS, 2017, VIRULENCE, V8, P485, DOI 10.1080/21505594.2016.1240862; Koren S, 2017, GENOME RES, V27, P722, DOI 10.1101/gr.215087.116; Korpela K, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20827-x; Kumar Ranjit, 2014, Curr Protoc Hum Genet, V82, DOI 10.1002/0471142905.hg1808s82; Kuppala VS, 2011, J PEDIATR-US, V159, P720, DOI 10.1016/j.jpeds.2011.05.033; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Langstraat J, 2001, INFECT IMMUN, V69, P5805, DOI 10.1128/IAI.69.9.5805-5812.2001; LEE A, 1972, INFECT IMMUN, V5, P1; Lee YS, 2018, CELL HOST MICROBE, V24, P833, DOI 10.1016/j.chom.2018.11.002; Litvak Y, 2019, CELL HOST MICROBE, V25, P128, DOI 10.1016/j.chom.2018.12.003; Litvak Y, 2018, SCIENCE, V362, P1017, DOI 10.1126/science.aat9076; Liu L, 2015, LANCET, V385, P430, DOI 10.1016/S0140-6736(14)61698-6; LodinovaZadnikova R, 1997, BIOL NEONATE, V71, P224, DOI 10.1159/000244421; Madan JC, 2012, ARCH DIS CHILD-FETAL, V97, pF456, DOI 10.1136/fetalneonatal-2011-301373; Mai V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052876; McKenzie GJ, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-39; MEADOW J, 2014, Q2OLIGO CONVERT QIIM; Milani C, 2018, APPL ENVIRON MICROB, V84, DOI [10.1128/AEM00706-18, 10.1128/AEM.00706-18, 10.1128/aem.00706-18]; MIRANDA JC, 1984, DEV PHARMACOL THERAP, V7, P303, DOI 10.1159/000457179; Nurk S, 2013, J COMPUT BIOL, V20, P714, DOI 10.1089/cmb.2013.0084; Ormerod KL, 2016, MICROBIOME, V4, DOI 10.1186/s40168-016-0181-2; Pamer EG, 2016, SCIENCE, V352, P535, DOI 10.1126/science.aad9382; Panigrahi P, 2017, NATURE, V548, P407, DOI 10.1038/nature23480; Parm U, 2015, NUTR RES, V35, P496, DOI 10.1016/j.nutres.2015.04.006; Pedersen MB, 2012, ANNU REV FOOD SCI T, V3, P37, DOI 10.1146/annurev-food-022811-101255; Rao SC, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2015-3684; Reed BD, 2018, J PEDIATR-US, V197, P97, DOI 10.1016/j.jpeds.2018.01.056; Rivera-Chavez F, 2016, CELL HOST MICROBE, V19, P443, DOI 10.1016/j.chom.2016.03.004; Ammor MS, 2007, FOOD MICROBIOL, V24, P559, DOI 10.1016/j.fm.2006.11.001; Schulman J, 2015, PEDIATRICS, V135, P826, DOI 10.1542/peds.2014-3409; Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60; Segers ME, 2014, MICROB CELL FACT, V13, DOI 10.1186/1475-2859-13-S1-S7; Singh AK, 2018, REDOX BIOL, V16, P11, DOI 10.1016/j.redox.2018.02.003; Stoll BJ, 2015, JAMA-J AM MED ASSOC, V314, P1039, DOI 10.1001/jama.2015.10244; Suez J, 2019, NAT MED, V25, P716, DOI 10.1038/s41591-019-0439-x; Taft DH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130604; Tarr PI, 2016, SEMIN FETAL NEONAT M, V21, P388, DOI 10.1016/j.siny.2016.06.002; Tegtmeier D, 2016, SYST APPL MICROBIOL, V39, P319, DOI 10.1016/j.syapm.2016.05.003; Tourneur E, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/270301; Treangen TJ, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0524-x; Ulas T, 2017, NAT IMMUNOL, V18, P622, DOI 10.1038/ni.3745; van den Akker CHP, 2018, J PEDIATR GASTR NUTR, V67, P103, DOI 10.1097/MPG.0000000000001897; Viswanathan S, 2016, J PERINATOL, V36, P1106, DOI 10.1038/jp.2016.144; Weingarten RA, 2018, MBIO, V9, DOI 10.1128/mBio.02011-17; Wilck N, 2017, NATURE, V551, P585, DOI 10.1038/nature24628; Wood DE, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-3-r46; Wyres KL, 2016, MICROB GENOMICS, V2, DOI 10.1099/mgen.0.000102; Yassour M, 2018, CELL HOST MICROBE, V24, P146, DOI 10.1016/j.chom.2018.06.007; Yassour M, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad0917	75	54	58	3	18	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2019	25	11					1772	+		10.1038/s41591-019-0640-y	http://dx.doi.org/10.1038/s41591-019-0640-y			24	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	JT2KI	31700190	Green Accepted			2022-12-27	WOS:000500824300037
J	Khan, TA; Revah, O; Gordon, A; Yoon, SJ; Krawisz, AK; Goold, C; Sun, YS; Kim, CH; Tian, Y; Li, MY; Schaepe, JM; Ikeda, K; Amin, ND; Sakai, N; Yazawa, M; Kushan, L; Nishino, S; Porteus, MH; Rapoport, JL; Bernstein, JA; O'Hara, R; Bearden, CE; Hallmayer, JF; Huguenard, JR; Geschwind, DH; Dolmetsch, RE; Pasca, SP				Khan, Themasap A.; Revah, Omer; Gordon, Aaron; Yoon, Se-Jin; Krawisz, Anna K.; Goold, Carleton; Sun, Yishan; Kim, Chul Hoon; Tian, Yuan; Li, Min-Yin; Schaepe, Julia M.; Ikeda, Kazuya; Amin, Neal D.; Sakai, Noriaki; Yazawa, Masayuki; Kushan, Leila; Nishino, Seiji; Porteus, Matthew H.; Rapoport, Judith L.; Bernstein, Jonathan A.; O'Hara, Ruth; Bearden, Carrie E.; Hallmayer, Joachim F.; Huguenard, John R.; Geschwind, Daniel H.; Dolmetsch, Ricardo E.; Pasca, Sergiu P.			Neuronal defects in a human cellular model of 22q11.2 deletion syndrome	NATURE MEDICINE			English	Article							PSYCHIATRIC-DISORDERS; ANTIPSYCHOTIC-DRUGS; RECEPTOR MODULATION; MOUSE MODEL; HIGH-RATES; EXPRESSION; SCHIZOPHRENIA; EXCITABILITY; BRAIN; STEM	A human stem cell-derived model helps to uncover neuronal phenotypes associated with genetic forms of neuropsychiatric disease. 22q11.2 deletion syndrome (22q11DS) is a highly penetrant and common genetic cause of neuropsychiatric disease. Here we generated induced pluripotent stem cells from 15 individuals with 22q11DS and 15 control individuals and differentiated them into three-dimensional (3D) cerebral cortical organoids. Transcriptional profiling across 100 days showed high reliability of differentiation and revealed changes in neuronal excitability-related genes. Using electrophysiology and live imaging, we identified defects in spontaneous neuronal activity and calcium signaling in both organoid- and 2D-derived cortical neurons. The calcium deficit was related to resting membrane potential changes that led to abnormal inactivation of voltage-gated calcium channels. Heterozygous loss ofDGCR8recapitulated the excitability and calcium phenotypes and its overexpression rescued these defects. Moreover, the 22q11DS calcium abnormality could also be restored by application of antipsychotics. Taken together, our study illustrates how stem cell derived models can be used to uncover and rescue cellular phenotypes associated with genetic forms of neuropsychiatric disease.	[Khan, Themasap A.; Revah, Omer; Yoon, Se-Jin; Li, Min-Yin; Schaepe, Julia M.; Amin, Neal D.; Sakai, Noriaki; Nishino, Seiji; O'Hara, Ruth; Hallmayer, Joachim F.; Pasca, Sergiu P.] Stanford Univ, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA; [Khan, Themasap A.] Stanford Univ, Program Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA; [Gordon, Aaron; Tian, Yuan; Geschwind, Daniel H.] Univ Calif Los Angeles, Dept Neurol, Program Neurogenet, Los Angeles, CA USA; [Krawisz, Anna K.; Goold, Carleton; Sun, Yishan; Kim, Chul Hoon; Yazawa, Masayuki] Stanford Univ, Dept Neurobiol, Stanford, CA 94305 USA; [Kim, Chul Hoon] Yonsei Univ, Dept Pharmacol, Coll Med, Seoul, South Korea; [Tian, Yuan] Univ Calif Los Angeles, Interdept PhD Program Bioinformat, Los Angeles, CA USA; [Ikeda, Kazuya; Porteus, Matthew H.; Bernstein, Jonathan A.] Stanford Univ, Dept Pediat, Stanford, CA 94305 USA; [Kushan, Leila; Bearden, Carrie E.] Univ Calif Los Angeles, Dept Psychiat & Biobehav Sci, Los Angeles, CA USA; [Rapoport, Judith L.] Natl Inst Mental Hlth, Child Psychiat Branch, Bethesda, MD USA; [Bearden, Carrie E.] Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA USA; [Bearden, Carrie E.] Univ Calif Los Angeles, Semel Inst Neurosci, Ctr Neurobehav Genet, Human Behav, Los Angeles, CA USA; [Huguenard, John R.] Stanford Univ, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA; [Geschwind, Daniel H.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA USA; [Geschwind, Daniel H.] Univ Calif Los Angeles, Semel Inst, Ctr Autism Res & Treatment, Los Angeles, CA USA; [Geschwind, Daniel H.] Univ Calif Los Angeles, Inst Precis Hlth, Los Angeles, CA USA; [Dolmetsch, Ricardo E.] Novartis Inst BioMed Res, Cambridge, MA USA; [Pasca, Sergiu P.] Stanford Univ, Wu Tsai Neurosci Inst, Stanford Brain Organogenesis Program, Stanford, CA 94305 USA; [Krawisz, Anna K.] Beth Israel Deaconess Med Ctr, Dept Med, Div Cardiol, Boston, MA USA; [Yazawa, Masayuki] Columbia Univ, Vagelos Coll Phys & Surg, Dept Mol Pharmacol & Therapeut, Columbia Stem Cell Initiat,Dept Rehabil & Regener, New York, NY USA	Stanford University; Stanford University; University of California System; University of California Los Angeles; Stanford University; Yonsei University; Yonsei University Health System; University of California System; University of California Los Angeles; Stanford University; University of California System; University of California Los Angeles; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Stanford University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Novartis; Stanford University; Harvard University; Beth Israel Deaconess Medical Center; Columbia University	Pasca, SP (corresponding author), Stanford Univ, Wu Tsai Neurosci Inst, Stanford Brain Organogenesis Program, Stanford, CA 94305 USA.	spasca@stanford.edu	Revah, Omer/AAW-4048-2021; Huguenard, John/I-5016-2012; Pasca, Sergiu/AAY-3949-2021	Huguenard, John/0000-0002-6950-1191; Pasca, Sergiu/0000-0002-3216-3248; Revah, Omer/0000-0002-4002-5689; Krawisz, Anna/0000-0002-1462-3773; Li, Min-Yin/0000-0002-8102-632X; Amin, Neal/0000-0003-2027-1329; Kim, Chul Hoon/0000-0002-7360-429X; Yoon, Se-Jin/0000-0001-8412-5991; Ikeda, Kazuya/0000-0003-3671-5940; Schaepe, Julia/0000-0003-0416-0469	US National Institutes of Health (NIH) BRAINS Award [MH107800]; NARSAD Young Investigator Award (Behavioral and Brain Foundation); MQ Fellow Award; NYSCF Robertson Stem Cell Investigator Award; CZI Ben Barres Investigator Award; Stanford Human Brain Organogenesis Program; Brain Rejuvenation Project; Uytengsu Research Funds; Kwan Research Fund; California Institute of Regenerative Medicine (CIRM); NIH [R01MH100900, R01MH100900-S1]; NIMH [R01 MH085953, R01 MH085953-08:S1, 5R37 MH060233, 5R01 MH094714]; National Research Foundation of Korea grant [NRF-2019R1A2C3002354]; Lucile Packard Foundation for Children's Health; National Institute of Mental Health; Stanford Graduate Fellowship (SGF); National Science Foundation (NSF) Fellowship; Stanford Dean's Fellowship; Feldman Gift Fund; Maternal and Child Health Research Institute (MCHRI) Fellowship; Autism Science Foundation (ASF); Brain and Behavior Research Foundation (BBRF) Young Investigator award; HHMI Fellowship; Stanford Bio-X Undergraduate Fellowship; DGIST RAMP;D Program of the Korean Ministry of Science and ICT AMP; Future Planning [14-BD-16]	US National Institutes of Health (NIH) BRAINS Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NARSAD Young Investigator Award (Behavioral and Brain Foundation)(NARSAD); MQ Fellow Award; NYSCF Robertson Stem Cell Investigator Award; CZI Ben Barres Investigator Award; Stanford Human Brain Organogenesis Program; Brain Rejuvenation Project; Uytengsu Research Funds; Kwan Research Fund; California Institute of Regenerative Medicine (CIRM)(California Institute for Regenerative Medicine); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Research Foundation of Korea grant(National Research Foundation of Korea); Lucile Packard Foundation for Children's Health; National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Stanford Graduate Fellowship (SGF)(Stanford University); National Science Foundation (NSF) Fellowship(National Science Foundation (NSF)); Stanford Dean's Fellowship; Feldman Gift Fund; Maternal and Child Health Research Institute (MCHRI) Fellowship; Autism Science Foundation (ASF); Brain and Behavior Research Foundation (BBRF) Young Investigator award; HHMI Fellowship(Howard Hughes Medical Institute); Stanford Bio-X Undergraduate Fellowship; DGIST RAMP;D Program of the Korean Ministry of Science and ICT AMP; Future Planning	We thank the families who participated in this study. We acknowledge J. Andersen, J. Y. Park and all members of the Pasca Laboratory for support, as well as A. Trevino, A. E. Urban and H. Gai at Stanford University for scientific discussions and technical support. This work was supported by the US National Institutes of Health (NIH) BRAINS Award (MH107800), the NARSAD Young Investigator Award (Behavioral and Brain Foundation), the MQ Fellow Award, the NYSCF Robertson Stem Cell Investigator Award, the CZI Ben Barres Investigator Award, the Stanford Human Brain Organogenesis Program and the Brain Rejuvenation Project, Uytengsu Research Funds, the Kwan Research Fund and the California Institute of Regenerative Medicine (CIRM) (to S.P.P.); NIH R01MH100900 (J.F.H., C.E.B., R.O., J.A.B., D.H.G. and S.P.P.) and R01MH100900-S1 (J.F.H. and S.P.P.); NIMH R01 MH085953 and R01 MH085953-08:S1 (CEB); NIMH 5R37 MH060233 and 5R01 MH094714 (D.H.G.); National Research Foundation of Korea grant no. NRF-2019R1A2C3002354 (to C.H.K); the Lucile Packard Foundation for Children's Health (anonymous gift for 22q11DS research; M.H.P.); the National Institute of Mental Health (J.L.R.); Stanford Graduate Fellowship (SGF) and National Science Foundation (NSF) Fellowship (T.A.K.); the Stanford Dean's Fellowship, the Feldman Gift Fund and the Maternal and Child Health Research Institute (MCHRI) Fellowship (O.R.); the Autism Science Foundation (ASF) and the Brain and Behavior Research Foundation (BBRF) Young Investigator award (A.G.); the HHMI Fellowship (A.K.K.); the Stanford Bio-X Undergraduate Fellowship (J.M.S.); the DGIST R&D Program of the Korean Ministry of Science and ICT & Future Planning, 14-BD-16 (C.-H.K.).	Akam E, 2004, BIOCHEM PHARMACOL, V67, P2039, DOI 10.1016/j.bcp.2004.02.017; Anwar IJ, 2016, J NEUROPHYSIOL, V115, P1389, DOI 10.1152/jn.00387.2015; Barreto-Chang Odmara L, 2009, J Vis Exp, DOI 10.3791/1067; Bassett Anne S, 2008, Curr Psychiatry Rep, V10, P148; Birey F, 2017, NATURE, V545, P54, DOI 10.1038/nature22330; Butler A, 2018, NAT BIOTECHNOL, V36, P411, DOI 10.1038/nbt.4096; Chun S, 2014, SCIENCE, V344, P1178, DOI 10.1126/science.1253895; Chun SK, 2013, J NEUROSCI, V33, P7345, DOI 10.1523/JNEUROSCI.4500-12.2013; Demaerel W, 2019, GENOME RES, V29, P1389, DOI 10.1101/gr.248682.119; Demontis D, 2019, NAT GENET, V51, P63, DOI 10.1038/s41588-018-0269-7; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Drew LJ, 2011, MOL CELL NEUROSCI, V47, P293, DOI 10.1016/j.mcn.2011.05.008; Drew LJ, 2011, INT J DEV NEUROSCI, V29, P259, DOI 10.1016/j.ijdevneu.2010.09.007; Eaton CB, 2019, EPILEPSIA, V60, P818, DOI 10.1111/epi.14722; Fernandez A, 2019, NEURON, V102, P1127, DOI 10.1016/j.neuron.2019.04.013; Finucane HK, 2015, NAT GENET, V47, P1228, DOI 10.1038/ng.3404; Fromer M, 2016, NAT NEUROSCI, V19, P1442, DOI 10.1038/nn.4399; Gardner DM, 2005, CAN MED ASSOC J, V172, P1703, DOI 10.1503/cmaj.1041064; Gee S, 2012, J NEUROSCI, V32, P4959, DOI 10.1523/JNEUROSCI.5835-11.2012; Gokhale A, 2019, J NEUROSCI, V39, P3561, DOI 10.1523/JNEUROSCI.1983-18.2019; Gritz SM, 2013, HUM GENOMICS, V7, DOI 10.1186/1479-7364-7-8; Grove J, 2019, NAT GENET, V51, P431, DOI 10.1038/s41588-019-0344-8; Han JJ, 2004, GENE DEV, V18, P3016, DOI 10.1101/gad.1262504; Hansen KD, 2012, BIOSTATISTICS, V13, P204, DOI 10.1093/biostatistics/kxr054; Hernandez-Lopez S, 2000, J NEUROSCI, V20, P8987; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Kapur S, 2000, AM J PSYCHIAT, V157, P514, DOI 10.1176/appi.ajp.157.4.514; Karayiorgou M, 2010, NAT REV NEUROSCI, V11, P402, DOI 10.1038/nrn2841; Kobrynski LJ, 2007, LANCET, V370, P1443, DOI 10.1016/S0140-6736(07)61601-8; Korotkevich G., 2019, 060012 BIORXIV, DOI 10.1101/060012v2; Krey JF, 2013, NAT NEUROSCI, V16, P201, DOI 10.1038/nn.3307; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li P, 2016, CURR TOP MED CHEM, V16, P3385, DOI 10.2174/1568026616666160608084834; Lin MY, 2016, BMC SYST BIOL, V10, DOI 10.1186/s12918-016-0366-0; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; McQuate A, 2017, CELL REP, V21, P60, DOI 10.1016/j.celrep.2017.09.023; Monks S, 2014, SCHIZOPHR RES, V153, P231, DOI 10.1016/j.schres.2014.01.020; Moore AR, 2009, CEREB CORTEX, V19, P1795, DOI 10.1093/cercor/bhn206; Morrow BE, 2018, AM J MED GENET A, V176, P2070, DOI 10.1002/ajmg.a.40504; Moskvina V, 2009, MOL PSYCHIATR, V14, P252, DOI 10.1038/mp.2008.133; Murphy KC, 1999, ARCH GEN PSYCHIAT, V56, P940, DOI 10.1001/archpsyc.56.10.940; Oldham MC, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-63; Olsen L, 2018, LANCET PSYCHIAT, V5, P573, DOI 10.1016/S2215-0366(18)30168-8; Pardinas AF, 2018, NAT GENET, V50, P381, DOI 10.1038/s41588-018-0059-2; Parikshak NN, 2016, NATURE, V540, P423, DOI 10.1038/nature20612; Pasca AM, 2015, NAT METHODS, V12, P671, DOI [10.1038/nmeth.3415, 10.1038/NMETH.3415]; Pasca SP, 2018, NATURE, V553, P437, DOI 10.1038/nature25032; Pasca SP, 2011, NAT MED, V17, P1657, DOI 10.1038/nm.2576; Perez MF, 2006, J NEUROPHYSIOL, V96, P2217, DOI 10.1152/jn.00254.2006; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Ripke S, 2014, NATURE, V511, P421, DOI 10.1038/nature13595; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Sanders SJ, 2019, NAT MED, V25, P1477, DOI 10.1038/s41591-019-0581-5; Santana N, 2009, CEREB CORTEX, V19, P849, DOI 10.1093/cercor/bhn134; Schneider M, 2014, AM J PSYCHIAT, V171, P627, DOI 10.1176/appi.ajp.2013.13070864; Schofield CM, 2011, NEURAL DEV, V6, DOI 10.1186/1749-8104-6-11; SEEMAN P, 1976, NATURE, V261, P717, DOI 10.1038/261717a0; Sigurdsson T, 2010, NATURE, V464, P763, DOI 10.1038/nature08855; Sloan SA, 2018, NAT PROTOC, V13, P2062, DOI 10.1038/s41596-018-0032-7; Sloan SA, 2017, NEURON, V95, P779, DOI 10.1016/j.neuron.2017.07.035; Smoller JW, 2013, LANCET, V381, P1371, DOI 10.1016/S0140-6736(12)62129-1; Sullivan PF, 2012, NAT REV GENET, V13, P537, DOI 10.1038/nrg3240; Sun Y, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.25; Sun ZY, 2018, TRANSL PSYCHIAT, V8, DOI 10.1038/s41398-018-0132-8; Toyoshima M, 2016, TRANSL PSYCHIAT, V6, DOI 10.1038/tp.2016.206; Vorstman JAS, 2006, J AM ACAD CHILD PSY, V45, P1104, DOI 10.1097/01.chi.0000228131.56956.c1; Wheeler DG, 2012, CELL, V149, P1112, DOI 10.1016/j.cell.2012.03.041; Wu H, 2015, BIOINFORMATICS, V31, P233, DOI 10.1093/bioinformatics/btu640; Yasumoto F, 2004, CELL MOL NEUROBIOL, V24, P877, DOI 10.1007/s10571-004-6927-6; Yazawa M, 2011, NATURE, V471, P230, DOI 10.1038/nature09855; Yoon SJ, 2019, NAT METHODS, V16, P75, DOI 10.1038/s41592-018-0255-0; Yu N, 2014, PROG MOL BIOL TRANSL, V123, P53, DOI 10.1016/B978-0-12-397897-4.00011-5; Zamponi GW, 2015, PHARMACOL REV, V67, P821, DOI 10.1124/pr.114.009654; Zhao DJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132387; Zinkstok JR, 2019, LANCET PSYCHIAT, V6, P951, DOI 10.1016/S2215-0366(19)30076-8	75	45	47	1	14	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	2020	26	12								10.1038/s41591-020-1043-9	http://dx.doi.org/10.1038/s41591-020-1043-9		SEP 2020	33	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	PB8QO	32989314	Green Accepted			2022-12-27	WOS:000573494400002
J	Abdel-Mohsen, M; Richman, D; Siliciano, RF; Nussenzweig, MC; Howell, BJ; Martinez-Picado, J; Chomont, N; Bar, KJ; Yu, XG; Lichterfeld, M; Alcami, J; Hazuda, D; Bushman, F; Siliciano, JD; Betts, MR; Spivak, AM; Planelles, V; Hahn, BH; Smith, DM; Ho, YC; Buzon, MJ; Gaebler, C; Paiardini, M; Li, QS; Estes, JD; Hope, TJ; Kostman, J; Mounzer, K; Caskey, M; Fox, L; Frank, I; Riley, JL; Tebas, P; Montaner, LJ				Abdel-Mohsen, Mohamed; Richman, Douglas; Siliciano, Robert F.; Nussenzweig, Michel C.; Howell, Bonnie J.; Martinez-Picado, Javier; Chomont, Nicolas; Bar, Katharine J.; Yu, Xu G.; Lichterfeld, Mathias; Alcami, Jose; Hazuda, Daria; Bushman, Frederic; Siliciano, Janet D.; Betts, Michael R.; Spivak, Adam M.; Planelles, Vicente; Hahn, Beatrice H.; Smith, Davey M.; Ho, Ya-Chi; Buzon, Maria J.; Gaebler, Christian; Paiardini, Mirko; Li, Qingsheng; Estes, Jacob D.; Hope, Thomas J.; Kostman, Jay; Mounzer, Karam; Caskey, Marina; Fox, Lawrence; Frank, Ian; Riley, James L.; Tebas, Pablo; Montaner, Luis J.		BEAT HIV Delaney Collaborator	Recommendations for measuring HIV reservoir size in cure-directed clinical trials	NATURE MEDICINE			English	Article							CD4(+) T-CELLS; PLASMACYTOID DENDRITIC CELL; VIRUS TYPE-1 RNA; LATENT RESERVOIR; ANTIRETROVIRAL THERAPY; QUANTITATIVE ASSAY; IMMUNE ACTIVATION; VIRAL RESERVOIRS; DNA INTEGRATION; LYMPHOID-TISSUE	A strategy for assessing the effectiveness of different strategies for HIV cure is presented. Therapeutic strategies are being clinically tested either to eradicate latent HIV reservoirs or to achieve virologic control in the absence of antiretroviral therapy. Attaining this goal will require a consensus on how best to measure the numbers of persistently infected cells with the potential to cause viral rebound after antiretroviral-therapy cessation in assessing the results of cure-directed strategies in vivo. Current measurements assess various aspects of the HIV provirus and its functionality and produce divergent results. Here, we provide recommendations from the BEAT-HIV Martin Delaney Collaboratory on which viral measurements should be prioritized in HIV-cure-directed clinical trials.	[Abdel-Mohsen, Mohamed; Montaner, Luis J.] Wistar Inst Anat & Biol, 3601 Spruce St, Philadelphia, PA 19104 USA; [Richman, Douglas; Smith, Davey M.] VA San Diego Healthcare Syst, San Diego, CA USA; [Richman, Douglas; Smith, Davey M.] Univ Calif San Diego, San Diego, CA 92103 USA; [Siliciano, Robert F.; Siliciano, Janet D.] Johns Hopkins Univ, Baltimore, MD USA; [Nussenzweig, Michel C.; Gaebler, Christian; Caskey, Marina] Rockefeller Univ, 1230 York Ave, New York, NY 10021 USA; [Howell, Bonnie J.; Hazuda, Daria] Merck & Co Inc, Kenilworth, NJ USA; [Martinez-Picado, Javier] IrsiCaixa AIDS Res Inst, Badalona, Spain; [Martinez-Picado, Javier] Univ Vic Cent Univ Catalonia UVic UCC, Vic, Spain; [Martinez-Picado, Javier] Catalan Inst Res & Adv Studies ICREA, Barcelona, Spain; [Chomont, Nicolas] Univ Montreal, Montreal, PQ, Canada; [Bar, Katharine J.; Bushman, Frederic; Betts, Michael R.; Hahn, Beatrice H.; Frank, Ian; Riley, James L.; Tebas, Pablo] Univ Penn, Philadelphia, PA 19104 USA; [Yu, Xu G.; Lichterfeld, Mathias] Ragon Inst MGH MIT & Harvard, Cambridge, MA USA; [Yu, Xu G.; Lichterfeld, Mathias] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA; [Alcami, Jose; Buzon, Maria J.] Inst Salud Carlos III, AIDS Immunopathogenesis Unit, Madrid, Spain; [Alcami, Jose; Buzon, Maria J.] Univ Barcelona, Infect Dis Unit, IBIDAPS, Hosp Clin, Barcelona, Spain; [Spivak, Adam M.; Planelles, Vicente] Univ Utah, Salt Lake City, UT USA; [Ho, Ya-Chi] Yale Sch Med, New Haven, CT USA; [Paiardini, Mirko] Yerkes Natl Primate Res Ctr, Div Microbiol & Immunol, Atlanta, GA USA; [Paiardini, Mirko] Emory Univ, Atlanta, GA 30322 USA; [Paiardini, Mirko] Emory Univ, Sch Med, Dept Pathol & Lab Med, Atlanta, GA 30322 USA; [Li, Qingsheng] Univ Nebraska, Sch Biol Sci, Lincoln, NE USA; [Li, Qingsheng] Univ Nebraska, Nebraska Ctr Virol, Lincoln, NE USA; [Estes, Jacob D.] Oregon Hlth & Sci Univ, Vaccine & Gene Therapy Inst, Beaverton, OR USA; [Estes, Jacob D.] Oregon Hlth & Sci Univ, Oregon Natl Primate Res Ctr, Beaverton, OR USA; [Hope, Thomas J.] Northwestern Univ, Chicago, IL 60611 USA; [Kostman, Jay; Mounzer, Karam] Philadelphia FIGHT, Jonathan Lax Ctr, Philadelphia, PA USA; [Fox, Lawrence] NIAID, Div AIDS, NIH, North Bethesda, MD USA	The Wistar Institute; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System; University of California System; University of California San Diego; Johns Hopkins University; Rockefeller University; Merck & Company; Institut de Recerca de la Sida - IrsiCaixa; Universitat de Vic - Universitat Central de Catalunya (UVic-UCC); ICREA; Universite de Montreal; University of Pennsylvania; Harvard University; Harvard Medical School; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute; Harvard University; Brigham & Women's Hospital; Instituto de Salud Carlos III; University of Barcelona; Hospital Clinic de Barcelona; Utah System of Higher Education; University of Utah; Yale University; Emory University; Emory University; University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln; Oregon Health & Science University; Oregon Health & Science University; Oregon National Primate Research Center; Northwestern University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Montaner, LJ (corresponding author), Wistar Inst Anat & Biol, 3601 Spruce St, Philadelphia, PA 19104 USA.	montaner@wistar.org	Martinez-Picado, Javier/G-5507-2012; Chomont, Nicolas/ABG-2545-2020; Gaebler, Christian/GWZ-2628-2022; Alcami, Pepe/T-2242-2018	Martinez-Picado, Javier/0000-0002-4916-2129; Chomont, Nicolas/0000-0001-9747-5018; Gaebler, Christian/0000-0001-7295-8128; Alcami, Pepe/0000-0003-0023-7377; richman, douglas/0000-0003-0962-9254; Abdel-Mohsen, Mohamed/0000-0002-9945-4314; Howell, Bonnie/0000-0002-5915-9943; Riley, James/0000-0002-1057-576X	NIH [1UM1Al126620, R01 AI065279, U01 AI065279, R01 DA048728, R01 DA049666, R01 DK123733, R01 AG062383, R01NS117458, R21 AI143385]; Kean Family Professorship [UM1 AI126603, UM1 AI126620, UM1 AI12661, P30 AI094189, R01 AI143567, AI 124843, AI141009, DA047037, AI118402, P50 AI150464, R37 AI14868, U19AI117950, U19AI149680, UM1AI126620]; Philadelphia Foundation [R21 AI129636, R21 NS106970, AI117841, AI120008, AI124776, AI130005, AI122377, AI135940, AI116228, AI078799, HL134539, AI125109, DA047034]; Foundation for AIDS Research (amfAR) impact grant [109840-65-RGRL]; W.W. Smith Charitable Trust grant [A1901]; Campbell Foundation; Mizutani Foundation for Glycoscience; Wistar Cancer Center Support grant [P30 CA010815-49S2]; Penn Center for AIDS Research [P30 AI 045008]; Miguel Servet program - Spanish Health Institute Carlos III [CP17/00179]; Howard Hughes Medical Institute; Bill and Melinda Gates Foundation [OPP1115715, 75N93019C00070, AI133706, AI110164, AI141258, AI143411-01A1, AI149672, CA206466, DK119945, INV-002704, OD011092-60, OPPO1108533]; W.W. Smith AIDS Research Grant; Gilead AIDS Research Grant; Gilead Research Scholar Grant; NIH CARE Martin Delaney Collaboratory [1UM1AI126619 0]; UCSD NIH CFAR [AI306214]; Department of Veterans Affairs; James B. Pendleton Charitable Trust	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Kean Family Professorship; Philadelphia Foundation; Foundation for AIDS Research (amfAR) impact grant; W.W. Smith Charitable Trust grant; Campbell Foundation; Mizutani Foundation for Glycoscience; Wistar Cancer Center Support grant; Penn Center for AIDS Research; Miguel Servet program - Spanish Health Institute Carlos III; Howard Hughes Medical Institute(Howard Hughes Medical Institute); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); W.W. Smith AIDS Research Grant; Gilead AIDS Research Grant; Gilead Research Scholar Grant(Gilead Sciences); NIH CARE Martin Delaney Collaboratory; UCSD NIH CFAR; Department of Veterans Affairs(US Department of Veterans Affairs); James B. Pendleton Charitable Trust	This work was supported by the NIH-funded BEAT-HIV Martin Delaney Collaboratory to cure HIV-1 infection (1UM1Al126620). L.J.M. is also supported by NIH R01 AI065279, U01 AI065279, R01 DA048728, R01 DA049666, the Kean Family Professorship and the Philadelphia Foundation (Roberts I. Jacobs Fund). M.A.-M. is supported by NIH grants (R01 DK123733, R01 AG062383, R01NS117458, R21 AI143385, R21 AI129636 and R21 NS106970), The Foundation for AIDS Research (amfAR) impact grant 109840-65-RGRL, W.W. Smith Charitable Trust grant A1901, The Campbell Foundation, Mizutani Foundation for Glycoscience, Wistar Cancer Center Support grant P30 CA010815-49S2 and the Penn Center for AIDS Research (P30 AI 045008). M.J.B. is supported by The Miguel Servet program funded by the Spanish Health Institute Carlos III (CP17/00179). M.L. is supported by NIH grants AI117841, AI120008, AI124776, AI130005, AI122377 and AI135940. X.G.Y. is supported by NIH grants AI116228, AI078799, HL134539, AI125109 and DA047034. R.F.S. is supported by NIH grants UM1 AI126603, UM1 AI126620, UM1 AI12661 and P30 AI094189, the Howard Hughes Medical Institute and the Bill and Melinda Gates Foundation (OPP1115715). V.P. is supported by NIH grants R01 AI143567 and AI 124843. Y.-C.H. is supported by a Yale Top Scholar Award, a Rudolf J. Anderson Fellowship, NIH grants AI141009, DA047037, AI118402, P50 AI150464, P30 AI094189 and R37 AI14868, a W.W. Smith AIDS Research Grant, a Gilead AIDS Research Grant and a Gilead Research Scholar Grant. J.D.E. is supported by the NIH and Bill and Melinda Gates Foundation grants 75N93019C00070, AI133706, AI110164, AI141258, AI143411-01A1, AI149672, CA206466, DK119945, INV-002704, OD011092-60 and OPPO1108533. D.R. is supported by the NIH CARE Martin Delaney Collaboratory (1UM1AI126619 0), the UCSD NIH CFAR (AI306214), the Department of Veterans Affairs and the James B. Pendleton Charitable Trust. J.L.R. is supported by NIH grants U19AI117950, U19AI149680 and UM1AI126620.	Abdel-Mohsen M, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aar6759; Abdel-Mohsen M, 2015, AIDS, V29, P411, DOI 10.1097/QAD.0000000000000572; Abreu CM, 2019, MBIO, V10, DOI 10.1128/mBio.01659-19; Andrade VM, 2020, P NATL ACAD SCI USA, V117, P9981, DOI 10.1073/pnas.1917034117; Banga R, 2016, NAT MED, V22, P754, DOI 10.1038/nm.4113; Baxter AE, 2017, NAT PROTOC, V12, P2029, DOI 10.1038/nprot.2017.079; Berry CC, 2017, MOL THER-METH CLIN D, V4, P17, DOI 10.1016/j.omtm.2016.11.003; Bertagnolli LN, 2018, NATURE, V561, pE17, DOI 10.1038/s41586-018-0494-3; Biggar RJ, 2007, J NATL CANCER I, V99, P962, DOI 10.1093/jnci/djm010; Bruner KM, 2019, NATURE, V566, P120, DOI 10.1038/s41586-019-0898-8; Bruner KM, 2016, NAT MED, V22, P1043, DOI 10.1038/nm.4156; Bullen CK, 2014, NAT MED, V20, P425, DOI 10.1038/nm.3489; Burbelo PD, 2014, J INFECT DIS, V209, P1613, DOI 10.1093/infdis/jit667; Butler SL, 2001, NAT MED, V7, P631, DOI 10.1038/87979; Cabrera C, 2015, CLIN CHEM, V61, P1372, DOI 10.1373/clinchem.2015.243287; Cai YH, 2019, J VIROL, V93, DOI 10.1128/JVI.01073-18; Carbone A, 2017, CURR OPIN HIV AIDS, V12, P39, DOI 10.1097/COH.0000000000000333; Cesana D, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00609-1; Chaillon A, 2020, J CLIN INVEST, V130, P1699, DOI 10.1172/JCI134815; Chargin A, 2015, J CLIN MICROBIOL, V53, P60, DOI 10.1128/JCM.02539-14; Chen HC, 2017, NAT STRUCT MOL BIOL, V24, P47, DOI 10.1038/nsmb.3328; Chew GM, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005349; Chomont N, 2009, NAT MED, V15, P893, DOI 10.1038/nm.1972; Chun TW, 2008, J INFECT DIS, V197, P714, DOI 10.1086/527324; Chun TW, 1997, NATURE, V387, P183, DOI 10.1038/387183a0; Chun TW, 1997, P NATL ACAD SCI USA, V94, P13193, DOI 10.1073/pnas.94.24.13193; Chun TW, 1998, P NATL ACAD SCI USA, V95, P8869, DOI 10.1073/pnas.95.15.8869; Cillo AR, 2014, P NATL ACAD SCI USA, V111, P7078, DOI 10.1073/pnas.1402873111; Cohen YZ, 2018, J EXP MED, V215, P2311, DOI 10.1084/jem.20180936; Cohn LB, 2015, CELL, V160, P420, DOI 10.1016/j.cell.2015.01.020; Crooks AM, 2015, J INFECT DIS, V212, P1361, DOI 10.1093/infdis/jiv218; De Scheerder MA, 2019, CELL HOST MICROBE, V26, P347, DOI 10.1016/j.chom.2019.08.003; Deleage C, 2018, RETROVIROLOGY, V15, DOI 10.1186/s12977-017-0387-9; Deleage Claire, 2016, Pathog Immun, V1, P68; Descours B, 2017, NATURE, V543, P564, DOI 10.1038/nature21710; Dinoso JB, 2009, P NATL ACAD SCI USA, V106, P9403, DOI 10.1073/pnas.0903107106; Einkauf KB, 2019, J CLIN INVEST, V129, P988, DOI 10.1172/JCI124291; Eisele E, 2012, IMMUNITY, V37, P377, DOI 10.1016/j.immuni.2012.08.010; Emmanouil Papasavvas L.A, 2020, CLIN INFECT DIS, DOI [10.1093/cid/ciaa809, DOI 10.1093/CID/CIAA809]; Eriksson S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003174; Estes JD, 2017, NAT MED, V23, P1271, DOI 10.1038/nm.4411; Fidler S, 2020, LANCET, V395, P888, DOI 10.1016/S0140-6736(19)32990-3; Finzi D, 1999, NAT MED, V5, P512, DOI 10.1038/8394; Finzi D, 1997, SCIENCE, V278, P1295, DOI 10.1126/science.278.5341.1295; Fromentin R, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005761; Gaebler C, 2019, J EXP MED, V216, P2253, DOI 10.1084/jem.20190896; Ganor Y, 2019, NAT MICROBIOL, V4, P633, DOI 10.1038/s41564-018-0335-z; Giron LB, 2020, AIDS, V34, P681, DOI 10.1097/QAD.0000000000002476; Gondim M, 2019, J VIRUS ERAD, V5, pabstr PP 314; Grau-Exposito J, 2017, MBIO, V8, DOI [10.1128/mBio.00876-17, 10.1128/mbio.00876-17]; Hatano H, 2013, J INFECT DIS, V208, P50, DOI 10.1093/infdis/jis630; Henrich TJ, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002417; Hill AL, 2014, P NATL ACAD SCI USA, V111, P13475, DOI 10.1073/pnas.1406663111; Ho YC, 2013, CELL, V155, P540, DOI 10.1016/j.cell.2013.09.020; Hong FY, 2018, VIROLOGY, V521, P51, DOI 10.1016/j.virol.2018.05.018; Hosmane NN, 2017, J EXP MED, V214, P959, DOI 10.1084/jem.20170193; Imamichi H, 2020, P NATL ACAD SCI USA, V117, P3704, DOI 10.1073/pnas.1917876117; Julg B, 2019, LANCET HIV, V6, pE259, DOI 10.1016/S2352-3018(19)30052-9; Keating SM, 2017, J INFECT DIS, V216, P72, DOI 10.1093/infdis/jix225; Kumar AM, 2007, J NEUROVIROL, V13, P210, DOI 10.1080/13550280701327038; Kwon KJ, 2020, SCI TRANSL MED, V12, DOI 10.1126/scitranslmed.aax6795; Lada SM, 2018, J CLIN MICROBIOL, V56, DOI 10.1128/JCM.01158-18; Laird GM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003398; Lee E, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.02214; Lee GQ, 2017, J CLIN INVEST, V127, P2689, DOI 10.1172/JCI93289; Lee SK, 2017, JAIDS-J ACQ IMM DEF, V74, P221, DOI [10.1097/QAI.0000000000001187, 10.1097/qai.0000000000001187]; Lewinski MK, 2005, J VIROL, V79, P6610, DOI 10.1128/JVI.79.11.6610-6619.2005; Li JZ, 2016, AIDS, V30, P343, DOI 10.1097/QAD.0000000000000953; Liszewski MK, 2009, METHODS, V47, P254, DOI 10.1016/j.ymeth.2009.01.002; Lorenzi JCC, 2016, P NATL ACAD SCI USA, V113, pE7908, DOI 10.1073/pnas.1617789113; Luzuriaga K, 2015, NEW ENGL J MED, V372, P786, DOI 10.1056/NEJMc1413931; Massanella M, 2018, EBIOMEDICINE, V36, P113, DOI 10.1016/j.ebiom.2018.09.036; Moron-Lopez S, 2019, CLIN INFECT DIS, V69, P1320, DOI 10.1093/cid/ciy1095; Moron-Lopez S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175899; O'Doherty U, 2002, J VIROL, V76, P10942, DOI 10.1128/JVI.76.21.10942-10950.2002; Pacanowski M, 2004, J INFECT DIS, V190, P1889, DOI 10.1086/425020; Palmer S, 2003, J CLIN MICROBIOL, V41, P4531, DOI 10.1128/JCM.41.10.4531-4536.2003; PANTALEO G, 1993, NATURE, V362, P355, DOI 10.1038/362355a0; Papasavvas E, 2018, AIDS, V32, P1763, DOI 10.1097/QAD.0000000000001909; Papasavvas E, 2015, IMMUNOLOGY, V145, P380, DOI 10.1111/imm.12452; Pardons M, 2019, PLOS PATHOG, V15, DOI 10.1371/journal.ppat.1007619; Passaes CPB, 2017, J VIROL, V91, DOI [10.1128/JVI.02296-16, 10.1128/jvi.02296-16]; Pasternak AO, 2008, J CLIN MICROBIOL, V46, P2206, DOI 10.1128/JCM.00055-08; Pasternak AO, 2020, JCI INSIGHT, V5, DOI 10.1172/jci.insight.134196; Pasternak AO, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-41; Pate KAM, 2015, J INFECT DIS, V212, P1387, DOI 10.1093/infdis/jiv230; Patro SC, 2019, P NATL ACAD SCI USA, V116, P25891, DOI 10.1073/pnas.1910334116; Peluso MJ, 2020, JCI INSIGHT, V5, DOI 10.1172/jci.insight.132997; Pinzone MR, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08431-7; Pitman MC, 2018, LANCET HIV, V5, pE317, DOI 10.1016/S2352-3018(18)30039-0; Plantin J, 2018, RETROVIROLOGY, V15, DOI 10.1186/s12977-017-0385-y; Pollack RA, 2017, CELL HOST MICROBE, V21, P494, DOI 10.1016/j.chom.2017.03.008; Procopio FA, 2015, EBIOMEDICINE, V2, P874, DOI 10.1016/j.ebiom.2015.06.019; Richman DD, 2009, SCIENCE, V323, P1304, DOI 10.1126/science.1165706; Rodger AJ, 2013, AIDS, V27, P973, DOI 10.1097/QAD.0b013e32835cae9c; Ruiz A, 2019, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.03162; Salantes DB, 2018, J CLIN INVEST, V128, P3102, DOI 10.1172/JCI120194; Schroder ARW, 2002, CELL, V110, P521, DOI 10.1016/S0092-8674(02)00864-4; Sherman E, 2017, MOL THER-METH CLIN D, V4, P39, DOI 10.1016/j.omtm.2016.11.002; Sherrill-Mix S, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-90; Siliciano JD, 2003, NAT MED, V9, P727, DOI 10.1038/nm880; Strain MC, 2013, CURR OPIN HIV AIDS, V8, P106, DOI 10.1097/COH.0b013e32835d811b; Tebas P, 2014, NEW ENGL J MED, V370, P901, DOI 10.1056/NEJMoa1300662; Tomescu C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103209; van Lunzen J, 2007, CURR OPIN HIV AIDS, V2, P1, DOI 10.1097/COH.0b013e328011aab1; Vandergeeten C, 2014, J VIROL, V88, P12385, DOI 10.1128/JVI.00609-14; Vibholm LK, 2019, J VIROL, V93, DOI [10.1128/JVI.01920-18, 10.1128/jvi.01920-18]; Wandeler G, 2016, CURR OPIN HIV AIDS, V11, P492, DOI 10.1097/COH.0000000000000298; Wang GP, 2007, GENOME RES, V17, P1186, DOI 10.1101/gr.6286907; Williams JP, 2014, ELIFE, V3, DOI 10.7554/eLife.03821; Wong JK, 1997, SCIENCE, V278, P1291, DOI 10.1126/science.278.5341.1291; Wu GX, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.92901; Yu JJQ, 2008, VIROLOGY, V379, P78, DOI 10.1016/j.virol.2008.05.030; Yukl SA, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aap9927; Yukl SA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003347; Yukl SA, 2010, J INFECT DIS, V202, P1553, DOI 10.1086/656722; Zerbato JM, 2019, CLIN INFECT DIS, V69, P1919, DOI 10.1093/cid/ciz108; Zucchetto A, 2016, JAIDS-J ACQ IMM DEF, V73, P190, DOI 10.1097/QAI.0000000000001033	118	55	56	0	11	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	SEP	2020	26	9					1339	1350		10.1038/s41591-020-1022-1	http://dx.doi.org/10.1038/s41591-020-1022-1		SEP 2020	12	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	PF3EM	32895573	Green Accepted			2022-12-27	WOS:000566880900001
J	Devkota, S				Devkota, Suzanne			The gut microbiome during acute lifestyle transition	NATURE MEDICINE			English	Editorial Material							URBANIZATION		[Devkota, Suzanne] Cedars Sinai Med Ctr, F Widjaja Fdn, Inflammatory Bowel & Immunobiol Res Inst, Los Angeles, CA 90048 USA	Cedars Sinai Medical Center	Devkota, S (corresponding author), Cedars Sinai Med Ctr, F Widjaja Fdn, Inflammatory Bowel & Immunobiol Res Inst, Los Angeles, CA 90048 USA.	suzanne.devkota@cshs.org	Devkota, Suzanne/AAG-1958-2021	Devkota, Suzanne/0000-0001-5575-9362				David LA, 2014, NATURE, V505, P559, DOI 10.1038/nature12820; Girard C, 2017, MSPHERE, V2, DOI 10.1128/mSphere.00297-16; Keohane DM, 2020, NAT MED, V26, P1089, DOI 10.1038/s41591-020-0963-8; MACDONALD JS, 1962, SOC RES, V29, P433; Martinez I, 2015, CELL REP, V11, P527, DOI 10.1016/j.celrep.2015.03.049; Qin JJ, 2012, NATURE, V490, P55, DOI 10.1038/nature11450; Sabeti PC, 2007, NATURE, V449, P913, DOI 10.1038/nature06250; Satterthwaite D, 2010, PHILOS T R SOC B, V365, P2809, DOI 10.1098/rstb.2010.0136; Smits SA, 2017, SCIENCE, V357, P802, DOI 10.1126/science.aan4834; Stein MM, 2016, NEW ENGL J MED, V375, P411, DOI 10.1056/NEJMoa1508749; Tang WHW, 2013, NEW ENGL J MED, V368, P1575, DOI 10.1056/NEJMoa1109400; Thaiss CA, 2014, CELL, V159, P514, DOI 10.1016/j.cell.2014.09.048	12	3	3	0	8	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	JUL	2020	26	7					1013	1015		10.1038/s41591-020-0980-7	http://dx.doi.org/10.1038/s41591-020-0980-7		JUL 2020	3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	MK3XO	32632191				2022-12-27	WOS:000545954500003
J	Irungu, EM; Baeten, JM				Irungu, Elizabeth M.; Baeten, Jared M.			PrEP rollout in Africa: status and opportunity	NATURE MEDICINE			English	Article							HIV PREEXPOSURE PROPHYLAXIS; SUB-SAHARAN AFRICA; ANTIRETROVIRAL PROPHYLAXIS; SERODISCORDANT COUPLES; PREVENTION; ADHERENCE; TENOFOVIR; PREGNANCY; HEALTH; WOMEN	Following recommendations by the World Health Organization in 2015, and key clinical trials, countries in sub-Saharan Africa, the region with the highest burden of human immunodeficiency virus (HIV), developed policies that incorporate pre-exposure prophylaxis (PrEP) into national HIV-prevention strategies. By the end of 2019, more than one third of people receiving PrEP globally were in Africa. Crucial understandings gained from early rollout among at-risk populations, such as HIV-serodiscordant couples, adolescent girls and young women, female sex workers, and men who have sex with men, include the importance of strategies for maintaining persistent adherence to PrEP and novel approaches to making PrEP services accessible, simplified and efficient. This Perspective will discuss the current status of these programs and how to further widen their implementation.	[Irungu, Elizabeth M.] Jomo Kenyatta Univ Agr & Technol, Coll Hlth Sci, Nairobi, Kenya; [Irungu, Elizabeth M.; Baeten, Jared M.] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA; [Baeten, Jared M.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Baeten, Jared M.] Univ Washington, Dept Med, Seattle, WA 98195 USA	Jomo Kenyatta University of Agriculture & Technology; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Baeten, JM (corresponding author), Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA.; Baeten, JM (corresponding author), Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA.; Baeten, JM (corresponding author), Univ Washington, Dept Med, Seattle, WA 98195 USA.	jbaeten@uw.edu		Irungu, Elizabeth/0000-0002-7401-3758	US National Institutes of Health [R01 MH095507, P30 AI027757]; Bill & Melinda Gates Foundation [OPP1056051]	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR)	Supported by US National Institutes of Health under grants R01 MH095507 and P30 AI027757, and the Bill & Melinda Gates Foundation under grant OPP1056051.	Acom CP, 2019, 20 ICASA INT C AIDS; Amankwaa I, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0204091; AVAC, PREPWATCH; Barnighausen K, 2020, AIDS CARE, V32, P267, DOI 10.1080/09540121.2019.1653437; Baeten JM, 2012, NEW ENGL J MED, V367, P399, DOI 10.1056/NEJMoa1108524; Baeten JM, 2019, LANCET, V394, P303, DOI 10.1016/S0140-6736(19)31288-7; Baeten JM, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002099; Baeten JM, 2014, LANCET INFECT DIS, V14, P1055, DOI 10.1016/S1473-3099(14)70937-5; Bassett IV, 2019, J COMMUN HEALTH, V44, P1150, DOI 10.1007/s10900-019-00698-7; Bekker LG, 2018, LANCET HIV, V5, pE68, DOI 10.1016/S2352-3018(17)30156-X; Beyrer C, 2012, LANCET, V380, P424, DOI 10.1016/S0140-6736(12)61022-8; Celum CL, 2019, PREP ADHERENCE EFFEC; Celum CL, 2015, J INT AIDS SOC, V18, P61, DOI 10.7448/IAS.18.4.20227; Claassen C.W., 2019, 1 YEAR IMPLEMENTATIO; Coelho LE, 2019, LANCET HIV, V6, pE788, DOI 10.1016/S2352-3018(19)30238-3; Cowan FM, 2018, LANCET HIV, V5, pE417, DOI 10.1016/S2352-3018(18)30111-5; Downing J, 2008, INT J PALLIAT NURS, V14, P560, DOI 10.12968/ijpn.2008.14.11.31761; Dunkle KL, 2008, LANCET, V371, P2183, DOI 10.1016/S0140-6736(08)60953-8; Eakle R., 2018, J INT AIDS SOC, V21; Fonner VA, 2016, AIDS, V30, P1973, DOI 10.1097/QAD.0000000000001145; Food and Drugh Administration, 2012, AIDSINFO; Geibel S, 2017, J ADOLESCENT HEALTH, V60, pS35, DOI 10.1016/j.jadohealth.2016.09.026; Gill K., 2017, INT AIDS C JUL 23 26; Govender E, 2017, CULT HEALTH SEX, V19, P1268, DOI 10.1080/13691058.2017.1309682; Grabbe KL, 2010, JAMA-J AM MED ASSOC, V304, P346, DOI 10.1001/jama.2010.1011; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Haberer JE, 2015, AIDS, V29, P1277, DOI 10.1097/QAD.0000000000000647; Hagopian A, 2017, GLOBAL HEALTH ACTION, V10, DOI 10.1080/16549716.2017.1306391; Hartmann M, 2018, AIDS BEHAV, V22, P3468, DOI 10.1007/s10461-018-2044-2; Heffron R, 2018, AIDS, V32, P1707, DOI 10.1097/QAD.0000000000001867; Heffron R, 2018, AIDS BEHAV, V22, P1758, DOI 10.1007/s10461-017-1902-7; Heffron Renee, 2017, Gates Open Res, V1, P3, DOI 10.12688/gatesopenres.12752.2; Henderson F., 2015, INT AIDS C 18 22 JUL; Hladik W, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4428-z; IDF (International Diabetes Federation), 2021, CONSOLIDATED GUIDELI, V10th ed.; Irungu E., 2019, C RETR OPP INF CROI; Irungu E., 2019, IAS; Irungu EM, 2019, GLOB PUBLIC HEALTH, V14, P1524, DOI 10.1080/17441692.2019.1588908; Irungu EM, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1899-y; Joint United Nations Programme on HIV and AIDS, 2019, UNAIDS DAT 2019; Joint United Nations Programme on HIV and AIDS, 2018, MIL GO CLOS GAPS BRE; Kambutse I, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0207650; Karuga RN, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151716; Kempf M.C., 2020, WEEXPAND PREP DEMONS; Kimani M, 2019, J INT AIDS SOC, V22, DOI 10.1002/jia2.25323; Kinuthia J, 2020, LANCET HIV, V7, pE38, DOI 10.1016/S2352-3018(19)30335-2; Koss C., 2019, INT AIDS C 21 24 JUL; Koss CA, 2020, LANCET HIV, V7, pE249, DOI 10.1016/S2352-3018(19)30433-3; Krakower DS, 2016, CURR OPIN HIV AIDS, V11, P41, DOI 10.1097/COH.0000000000000206; Kyongo J., 2018, 22 INT AIDS C; Lahuerta M, 2017, JAIDS-J ACQ IMM DEF, V76, P343, DOI 10.1097/QAI.0000000000001518; Lamontagne E, 2018, EUR J PUBLIC HEALTH, V28, P967, DOI 10.1093/eurpub/cky023; Mack Natasha, 2014, J Int AIDS Soc, V17, P19157, DOI 10.7448/IAS.17.3.19157; Marrazzo JM, 2015, NEW ENGL J MED, V372, P509, DOI 10.1056/NEJMoa1402269; Masyuko S, 2018, SEX HEALTH, V15, P578, DOI 10.1071/SH18090; Matthews LT, 2014, JAIDS-J ACQ IMM DEF, V67, P91, DOI 10.1097/QAI.0000000000000246; Matthias A., 2017, GATES OPEN RES; Mayer CM, 2019, J INT AIDS SOC, V22, DOI 10.1002/jia2.25276; Mboup A, 2018, J INT AIDS SOC, V21, DOI 10.1002/jia2.25208; Medley A, 2009, AIDS EDUC PREV, V21, P181, DOI 10.1521/aeap.2009.21.3.181; Mugwanya KK, 2019, PLOS MED, V16, DOI 10.1371/journal.pmed.1002885; Mugwanya KK, 2018, IMPLEMENT SCI, V13, DOI 10.1186/s13012-018-0809-7; Mugwanya KK, 2018, JAIDS-J ACQ IMM DEF, V77, P206, DOI 10.1097/QAI.0000000000001575; Murnane PM, 2014, AIDS, V28, P1825, DOI 10.1097/QAD.0000000000000290; Mutagoma M, 2017, INT J STD AIDS, V28, P1082, DOI 10.1177/0956462416688137; Mutegi J., 2019, CHARACTERISTICS ORAL; Mutua G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033103; Nakku-Joloba E, 2019, J INT AIDS SOC, V22, DOI 10.1002/jia2.25225; National AIDS and STI Control Program (NASCOP), 2017, FRAM IMPL PREEXP PRO; National AIDS and STI Control Programme, 2018, STAT IMPL OR PREEXP; Ngure K, 2016, AIDS PATIENT CARE ST, V30, P78, DOI 10.1089/apc.2015.0259; O'Malley G, 2019, CURR HIV-AIDS REP, V16, P141, DOI 10.1007/s11904-019-00437-6; Ongwen P., 2019, ADOLESCENT GIRLS PRE; OPTIONS, 2019, PREP LEARN NETW REG; Ortblad KF, 2019, TRIALS, V20, DOI 10.1186/s13063-019-3521-2; Pilgrim N, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196280; Pillay Y., 2018, 22 INT AIDS C; Pillay Y, 2017, 9 IAS C HIV SCI; Pintye J, 2018, AIDS PATIENT CARE ST, V32, P538, DOI 10.1089/apc.2018.0058; Pyra M, 2018, AIDS BEHAV, V22, P3718, DOI 10.1007/s10461-018-2221-3; Pyra M, 2018, JAIDS-J ACQ IMM DEF, V77, P41, DOI 10.1097/QAI.0000000000001561; Pyra MN, 2019, J INT AIDS SOC, V22, DOI 10.1002/jia2.25370; Risher K, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.3.18715; Rousseau-Jemwa E., 2018, INT AIDS C JUL 23 27; Smith D. K., 2011, Morbidity and Mortality Weekly Report, V60, P65; Stankevitz K, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0218556; Teclessou J N, 2017, Bull Soc Pathol Exot, V110, P270, DOI 10.1007/s13149-017-0565-y; Todd CS, 2017, CURR OPIN HIV AIDS, V12, P475, DOI 10.1097/COH.0000000000000402; Tung EL, 2018, SEX HEALTH, V15, P556, DOI 10.1071/SH18084; UNAIDS, 2019, AIDSINFO; UNAIDS, 2014, GAP REP SEX WORK; Van Damme L, 2012, NEW ENGL J MED, V367, P411, DOI 10.1056/NEJMoa1202614; Van der Elst EM, 2013, AIDS BEHAV, V17, P2162, DOI 10.1007/s10461-012-0317-8; van der Elst EM, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.4.18748; van der Elst EM, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.4.18741; van der Straten A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089118; Wagner L., HIV RES PREV C HIVR4; Ware NC, 2015, AIDS BEHAV, V19, P811, DOI 10.1007/s10461-014-0899-4; Ware NC, 2012, JAIDS-J ACQ IMM DEF, V59, P463, DOI 10.1097/QAI.0b013e31824a060b; Wekesah, 2019, COMPREHENSIVE SEXUAL; Were D., 2019, MANIFESTATIONS STIGM; WHO, 2017, TECHN BRIEF PREV HIV; Wood BR, 2018, SEX HEALTH, V15, P601, DOI 10.1071/SH18062; World Health Organization, 2015, GUID START ANT THER	104	26	26	1	3	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	MAY	2020	26	5					655	664		10.1038/s41591-020-0872-x	http://dx.doi.org/10.1038/s41591-020-0872-x			10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	ML1JP	32405065				2022-12-27	WOS:000549231500018
J	Theruvath, J; Sotillo, E; Mount, CW; Graef, CM; Delaidelli, A; Heitzeneder, S; Labanieh, L; Dhingra, S; Leruste, A; Majzner, RG; Xu, P; Mueller, S; Yecies, DW; Finetti, MA; Williamson, D; Johann, PD; Kool, M; Pfister, S; Hasselblatt, M; Fruhwald, MC; Delattre, O; Surdez, D; Bourdeaut, F; Puget, S; Zaidi, S; Mitra, SS; Cheshier, S; Sorensen, PH; Monje, M; Mackall, CL				Theruvath, Johanna; Sotillo, Elena; Mount, Christopher W.; Graef, Claus Moritz; Delaidelli, Alberto; Heitzeneder, Sabine; Labanieh, Louai; Dhingra, Shaurya; Leruste, Amaury; Majzner, Robbie G.; Xu, Peng; Mueller, Sabine; Yecies, Derek W.; Finetti, Martina A.; Williamson, Daniel; Johann, Pascal D.; Kool, Marcel; Pfister, Stefan; Hasselblatt, Martin; Fruehwald, Michael C.; Delattre, Olivier; Surdez, Didier; Bourdeaut, Franck; Puget, Stephanie; Zaidi, Sakina; Mitra, Siddhartha S.; Cheshier, Samuel; Sorensen, Poul H.; Monje, Michelle; Mackall, Crystal L.			Locoregionally administered B7-H3-targeted CAR T cells for treatment of atypical teratoid/rhabdoid tumors	NATURE MEDICINE			English	Article							ANTIGEN; CANCER; B7-H3; EXPRESSION; EFFICACY; SURVIVAL; THERAPY; ABSENCE; TARGETS; HER2	Atypical teratoid/rhabdoid tumors (ATRTs) typically arise in the central nervous system (CNS) of children under 3 years of age. Despite intensive multimodal therapy (surgery, chemotherapy and, if age permits, radiotherapy), median survival is 17 months(1,2). We show that ATRTs robustly express B7-H3/CD276 that does not result from the inactivating mutations in SMARCB1 (refs. (3,4)), which drive oncogenesis in ATRT, but requires residual SWItch/Sucrose Non-Fermentable (SWI/SNF) activity mediated by BRG1/SMARCA4. Consistent with the embryonic origin of ATRT(5,6), B7-H3 is highly expressed on the prenatal, but not postnatal, brain. B7-H3.BB.z-chimeric antigen receptor (CAR) T cells administered intracerebroventricularly or intratumorally mediate potent antitumor effects against cerebral ATRT xenografts in mice, with faster kinetics, greater potency and reduced systemic levels of inflammatory cytokines compared to CAR T cells administered intravenously. CAR T cells administered ICV also traffic from the CNS into the periphery; following clearance of ATRT xenografts, B7-H3.BB.z-CAR T cells administered intracerebroventricularly or intravenously mediate antigen-specific protection from tumor rechallenge, both in the brain and periphery. These results identify B7-H3 as a compelling therapeutic target for this largely incurable pediatric tumor and demonstrate important advantages of locoregional compared to systemic delivery of CAR T cells for the treatment of CNS malignancies. CAR T cells administered intracerebroventricularly or intratumorally exhibit more rapid kinetics, reduced systemic toxicity and greater therapeutic potency as compared to intravenously delivered CAR T cells in atypical teratoid/rhabdoid tumor xenograft mouse models.	[Theruvath, Johanna; Sotillo, Elena; Graef, Claus Moritz; Heitzeneder, Sabine; Labanieh, Louai; Dhingra, Shaurya; Leruste, Amaury; Majzner, Robbie G.; Xu, Peng; Johann, Pascal D.; Bourdeaut, Franck; Monje, Michelle; Mackall, Crystal L.] Stanford Univ, Dept Pediat, Sch Med, Stanford, CA 94305 USA; [Mount, Christopher W.; Monje, Michelle] Stanford Univ, Dept Neurol, Sch Med, Stanford, CA 94305 USA; [Delaidelli, Alberto; Sorensen, Poul H.] British Columbia Canc Res Ctr, Dept Mol Oncol, Vancouver, BC, Canada; [Labanieh, Louai] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Majzner, Robbie G.; Monje, Michelle; Mackall, Crystal L.] Stanford Univ, Stanford Canc Inst, Sch Med, Stanford, CA 94305 USA; [Mueller, Sabine] Univ Calif San Francisco, Dept Neurol, San Francisco, CA USA; [Mueller, Sabine] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA USA; [Mueller, Sabine] Univ Calif San Francisco, Dept Pediat, San Francisco, CA USA; [Yecies, Derek W.; Monje, Michelle] Stanford Univ, Dept Neurosurg, Sch Med, Stanford, CA 94305 USA; [Finetti, Martina A.; Williamson, Daniel] Newcastle Univ, Northern Inst Canc Res, Wolfson Childhood Canc Res Ctr, Newcastle Upon Tyne, Tyne & Wear, England; [Johann, Pascal D.; Kool, Marcel; Pfister, Stefan] Hopp Childrens Canc Ctr Heidelberg, Heidelberg, Germany; [Johann, Pascal D.; Kool, Marcel; Pfister, Stefan] German Canc Res Ctr, Div Pediat Neurooncol, Heidelberg, Germany; [Johann, Pascal D.; Kool, Marcel; Pfister, Stefan] German Canc Consortium, Heidelberg, Germany; [Pfister, Stefan] Heidelberg Univ Hosp, Dept Pediat Hematol & Oncol, Heidelberg, Germany; [Hasselblatt, Martin] Munster Univ Hosp, Inst Neuropathol, Munster, Germany; [Fruehwald, Michael C.] Univ Childrens Hosp Augsburg, Swabian Childrens Canc Ctr, Augsburg, Germany; [Fruehwald, Michael C.] EU RHAB Registry Ctr, Augsburg, Germany; [Delattre, Olivier; Surdez, Didier; Bourdeaut, Franck; Zaidi, Sakina] Paris Sci Lettres Res Univ, INSERM, U830, Paris, France; [Mueller, Sabine; Delattre, Olivier; Surdez, Didier; Bourdeaut, Franck; Zaidi, Sakina] Paris Sci Lettres Res Univ, SIREDO Care Innovat & Res Children Adolescents &, Inst Curie, Paris, France; [Puget, Stephanie] Paris Univ, Necker Enfants Malad Hosp, AP HP, Dept Neurosurg, Paris, France; [Mitra, Siddhartha S.] Univ Colorado Anschutz Med Campus, Pediat, Aurora, CO USA; [Cheshier, Samuel] Univ Utah, Primary Childrens Hosp, Dept Neurosurg, Div Pediat Neurosurg, Salt Lake City, UT USA; [Cheshier, Samuel] Univ Utah, Huntsman Canc Inst, Salt Lake City, UT USA; [Monje, Michelle] Stanford Univ, Dept Pathol, Sch Med, Stanford, CA 94305 USA; [Monje, Michelle] Stanford Univ, Stanford Inst Stem Cell & Regenerat Med, Sch Med, Stanford, CA 94305 USA; [Mackall, Crystal L.] Stanford Univ, Dept Med, Sch Med, Stanford, CA 94305 USA	Stanford University; Stanford University; British Columbia Cancer Agency; Stanford University; Stanford Cancer Institute; Stanford University; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Stanford University; Newcastle University - UK; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; University of Munster; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris Cite; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; University of Colorado System; University of Colorado Anschutz Medical Campus; Utah System of Higher Education; University of Utah; Huntsman Cancer Institute; Utah System of Higher Education; University of Utah; Stanford University; Stanford University; Stanford University	Mackall, CL (corresponding author), Stanford Univ, Dept Pediat, Sch Med, Stanford, CA 94305 USA.; Mackall, CL (corresponding author), Stanford Univ, Stanford Canc Inst, Sch Med, Stanford, CA 94305 USA.; Mackall, CL (corresponding author), Stanford Univ, Dept Med, Sch Med, Stanford, CA 94305 USA.	cmackall@stanford.edu	Johann, Pascal David/AAT-9368-2021; Pfister, Stefan M/F-6860-2013; Surdez, Didier/ABG-4565-2020	Pfister, Stefan M/0000-0002-5447-5322; Sotillo, Elena/0000-0002-3993-1932; Finetti, Martina Anna/0000-0001-8173-1646; Heitzeneder, Sabine/0000-0001-8770-2192	German Cancer Aid (Deutsche Krebshilfe) [P-91650709]; St Baldrick's/Stand Up To Cancer Pediatric Dream Team Translational Cancer Research Grant; Parker Institute for Cancer Immunotherapy; Virginia and D.K. Ludwig Fund for Cancer Research; National Cancer Institute [5P30CA12443]; Be Brooks Brave Fund St. Baldrick's Scholar Award; Nuovo-Soldati Foundation; ITMO Cancer AVIESAN (Alliance Nationale pour les Sciences de la Vie et de la Sante/National Alliance for the Life Sciences and Health) within the framework of the French Cancer Plan; INSTINCT network program grant; The Brain Tumour Charity; Great Ormond Street Hospital Children's Charity; Children with Cancer UK [16/193]; Ligue Nationale Contre le Cancer; ERA-NET TRANSCAN (JTC 2014) [TRAN201501238]; TRANSCAN JTC 2017 [TRANS201801292]; ITCC-P4 project [H2020-lMI2-JTl-201 5-07, 116064]; St Baldrick's Foundation; Interdisziplinare Zentrum fur Klinische Forschung Munster [Ha3/017/20]; Deutsche Forschungsgemeinschaft (DFG) [HA 3060/8-1]; DFG [1516/4-1]; Tashia and John Morgridge Endowed Postdoctoral Fellowship from the Child Health Research Institute at Lucile Packard Children's Hospital; National Institute of Neurological Disorders and Stroke of the National Institutes of Health [R25NS065741]; Ludwig Cancer Center, Department of Neurosurgery at Stanford University; Huntsman Cancer Institute, Department of Neurosurgery, University of Utah; Ty Louis Campbell St. Baldrick's Foundation Scholar; Kathryn S.R. Lowry Endowed Chari in Neurosurgery; Siebel Scholars Award; The Andrew McDonough B+ (Be Positive) Foundation; The Morgan Adams Brain Tumor Foundation; American Cancer Society Institutional Research Grant; Plachy-Rubin foundation	German Cancer Aid (Deutsche Krebshilfe)(Deutsche Krebshilfe); St Baldrick's/Stand Up To Cancer Pediatric Dream Team Translational Cancer Research Grant; Parker Institute for Cancer Immunotherapy; Virginia and D.K. Ludwig Fund for Cancer Research; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Be Brooks Brave Fund St. Baldrick's Scholar Award; Nuovo-Soldati Foundation; ITMO Cancer AVIESAN (Alliance Nationale pour les Sciences de la Vie et de la Sante/National Alliance for the Life Sciences and Health) within the framework of the French Cancer Plan; INSTINCT network program grant; The Brain Tumour Charity; Great Ormond Street Hospital Children's Charity; Children with Cancer UK; Ligue Nationale Contre le Cancer(Ligue nationale contre le cancer); ERA-NET TRANSCAN (JTC 2014); TRANSCAN JTC 2017; ITCC-P4 project; St Baldrick's Foundation; Interdisziplinare Zentrum fur Klinische Forschung Munster; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); DFG(German Research Foundation (DFG)); Tashia and John Morgridge Endowed Postdoctoral Fellowship from the Child Health Research Institute at Lucile Packard Children's Hospital; National Institute of Neurological Disorders and Stroke of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Ludwig Cancer Center, Department of Neurosurgery at Stanford University; Huntsman Cancer Institute, Department of Neurosurgery, University of Utah; Ty Louis Campbell St. Baldrick's Foundation Scholar; Kathryn S.R. Lowry Endowed Chari in Neurosurgery; Siebel Scholars Award; The Andrew McDonough B+ (Be Positive) Foundation; The Morgan Adams Brain Tumor Foundation; American Cancer Society Institutional Research Grant(American Cancer Society); Plachy-Rubin foundation	J.Theruvath is supported by German Cancer Aid (Deutsche Krebshilfe) grant no. P-91650709. This work was supported by a St Baldrick's/Stand Up To Cancer Pediatric Dream Team Translational Cancer Research Grant (C.L.M., A.D., P.H.S., M.M., R. G.M.). Stand Up To Cancer is a program of the Entertainment Industry Foundation administered by the American Association for Cancer Research. C.L.M. is a member of the Parker Institute for Cancer Immunotherapy, which supports the Stanford University Cancer Immunotherapy Program. The work was also supported by the Virginia and D.K. Ludwig Fund for Cancer Research (C.L.M. and M.M.) and by National Cancer Institute grant no. 5P30CA12443 (C.L.M.). R.G.M. is supported by the Be Brooks Brave Fund St. Baldrick's Scholar Award. A.L. is supported by the Nuovo-Soldati Foundation and by ITMO Cancer AVIESAN (Alliance Nationale pour les Sciences de la Vie et de la Sante/National Alliance for the Life Sciences and Health) within the framework of the French Cancer Plan. M.A.F. and D.W. receive funding as part of the INSTINCT network program grant, cofunded by The Brain Tumour Charity, Great Ormond Street Hospital Children's Charity and Children with Cancer UK (16/193). O.D., D.S. and S.Z. are supported by the Ligue Nationale Contre le Cancer (equipe labellisee) and by the following grants: ERA-NET TRANSCAN (JTC 2014, no. TRAN201501238), TRANSCAN JTC 2017 (no.TRANS201801292) and H2020-lMI2-JTl-201 5-07 (116064, ITCC-P4 project). F.B. is supported by the St Baldrick's Foundation. M.H. is funded by Interdisziplinare Zentrum fur Klinische Forschung Munster (no. Ha3/017/20) and Deutsche Forschungsgemeinschaft (DFG, no. HA 3060/8-1). M.C.F. is funded by DFG no. 1516/4-1. D.W.Y. is supported by the Tashia and John Morgridge Endowed Postdoctoral Fellowship from the Child Health Research Institute at Lucile Packard Children's Hospital as well as the National Institute of Neurological Disorders and Stroke of the National Institutes of Health under award no. R25NS065741. S.C. was supported by the Ludwig Cancer Center, Department of Neurosurgery at Stanford University, and the Huntsman Cancer Institute, Department of Neurosurgery, University of Utah. He was also supported as the Ty Louis Campbell St. Baldrick's Foundation Scholar and Kathryn S.R. Lowry Endowed Chari in Neurosurgery. S.C. was also supported by kind gifts from the Victoria and Rider McDowell Family Foundation, Cancer-A-Gogo, J. and C. Fisher, and C. Comey and J. Huang. S.S.M. is supported by the Siebel Scholars Award, The Andrew McDonough B+ (Be Positive) Foundation, The Morgan Adams Brain Tumor Foundation, the American Cancer Society Institutional Research Grant and the Plachy-Rubin foundation. We thank Y.-J. Cho (Oregon Health & Science University) for providing the ATRT-CHB-1 cell line and E. Huellman (Amsterdam University) for providing the VU-397 cell line. We thank J. Huang for assistance with mouse colony maintenance. We thank the Stanford Human Immune Monitoring Center for their support with the Luminex assays. We thank the Stanford Neuropathology Department for their help acquiring tissues. The illustrations for Fig. 2b and Extended Data Fig. 3b were used and modified from Servier Medical ART, licensed under a Creative Commons Attribution 3.0 Generic License (http://smart.servier.com/).	Biegel JA, 1999, CANCER RES, V59, P74; Brown CE, 2016, NEW ENGL J MED, V375, P2561, DOI 10.1056/NEJMoa1610497; Cardoso-Moreira M, 2019, NATURE, V571, P505, DOI 10.1038/s41586-019-1338-5; Chauvin C, 2017, CELL REP, V21, P1737, DOI 10.1016/j.celrep.2017.10.076; D'Aloia MM, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0278-6; D'cunja J, 2007, EUR J CANCER, V43, P1581, DOI 10.1016/j.ejca.2007.03.003; Du HW, 2019, CANCER CELL, V35, P221, DOI 10.1016/j.ccell.2019.01.002; Erkek S, 2019, CANCER CELL, V35, P95, DOI 10.1016/j.ccell.2018.11.014; Fischer-Valuck BW, 2017, CANCER-AM CANCER SOC, V123, P682, DOI 10.1002/cncr.30405; Fruhwald MC, 2016, NEURO-ONCOLOGY, V18, P764, DOI 10.1093/neuonc/nov264; Fry TJ, 2018, NAT MED, V24, P20, DOI 10.1038/nm.4441; Gholamin S, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aaf2968; Ginn KF, 2012, FRONT ONCOL, V2, DOI 10.3389/fonc.2012.00114; Gust J, 2017, CANCER DISCOV, V7, P1404, DOI 10.1158/2159-8290.CD-17-0698; Hall MP, 2012, ACS CHEM BIOL, V7, P1848, DOI 10.1021/cb3002478; Han ZY, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10421; Hashizume R, 2010, NEURO-ONCOLOGY, V12, P366, DOI 10.1093/neuonc/nop033; Hasselblatt M, 2013, GENE CHROMOSOME CANC, V52, P185, DOI 10.1002/gcc.22018; Hay KA, 2017, BLOOD, V130, P2295, DOI 10.1182/blood-2017-06-793141; Hegde M, 2016, J CLIN INVEST, V126, P3036, DOI 10.1172/JCI83416; Hofmeyer KA, 2008, P NATL ACAD SCI USA, V105, P10277, DOI 10.1073/pnas.0805458105; Johann PD, 2016, CANCER CELL, V29, P379, DOI 10.1016/j.ccell.2016.02.001; Kim JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018556; Kochenderfer JN, 2009, J IMMUNOTHER, V32, P689, DOI 10.1097/CJI.0b013e3181ac6138; Kramer K, 2010, J NEURO-ONCOL, V97, P409, DOI 10.1007/s11060-009-0038-7; Kremers GJ, 2006, BIOCHEMISTRY-US, V45, P6570, DOI 10.1021/bi0516273; Krenciute G, 2017, CANCER IMMUNOL RES, V5, P571, DOI 10.1158/2326-6066.CIR-16-0376; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Lee DW, 2015, LANCET, V385, P517, DOI 10.1016/S0140-6736(14)61403-3; Lee RS, 2012, J CLIN INVEST, V122, P2983, DOI 10.1172/JCI64400; Liu L, 2004, NEUROBIOL DIS, V17, P516, DOI 10.1016/j.nbd.2004.08.005; Loo D, 2012, CLIN CANCER RES, V18, P3834, DOI 10.1158/1078-0432.CCR-12-0715; Majzner RG, 2019, NAT MED, V25, P1341, DOI 10.1038/s41591-019-0564-6; Majzner RG, 2019, CLIN CANCER RES, V25, P2560, DOI 10.1158/1078-0432.CCR-18-0432; Majzner RG, 2018, CANCER DISCOV, V8, P1219, DOI 10.1158/2159-8290.CD-18-0442; Miller JA, 2014, NATURE, V508, P199, DOI 10.1038/nature13185; Mount CW, 2018, NAT MED, V24, P572, DOI 10.1038/s41591-018-0006-x; O'Rourke DM, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aaa0984; Pfister SM, 2010, ACTA NEUROPATHOL, V120, P553, DOI 10.1007/s00401-010-0751-5; Priceman SJ, 2018, CLIN CANCER RES, V24, P95, DOI 10.1158/1078-0432.CCR-17-2041; Seaman S, 2017, CANCER CELL, V31, P501, DOI 10.1016/j.ccell.2017.03.005; Seeringer A, 2014, CANCER GENET-NY, V207, P429, DOI 10.1016/j.cancergen.2014.06.028; Sun MY, 2002, J IMMUNOL, V168, P6294, DOI 10.4049/jimmunol.168.12.6294; Taraseviciute A, 2018, CANCER DISCOV, V8, P750, DOI 10.1158/2159-8290.CD-17-1368; Torchia J, 2016, CANCER CELL, V30, P891, DOI 10.1016/j.ccell.2016.11.003; Vladoiu MC, 2019, NATURE, V572, P67, DOI 10.1038/s41586-019-1158-7; von Hoff K, 2011, PEDIATR BLOOD CANCER, V57, P978, DOI 10.1002/pbc.23236; Walker AJ, 2017, MOL THER, V25, P2189, DOI 10.1016/j.ymthe.2017.06.008; Xu H, 2009, CANCER RES, V69, P6275, DOI 10.1158/0008-5472.CAN-08-4517	49	105	108	3	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAY	2020	26	5					712	+		10.1038/s41591-020-0821-8	http://dx.doi.org/10.1038/s41591-020-0821-8		APR 2020	22	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	ML1MK	32341579	Green Accepted			2022-12-27	WOS:000528996000002
J	Wang, ZC; Tang, K				Wang, Zhicheng; Tang, Kun			Combating COVID-19: health equity matters	NATURE MEDICINE			English	Editorial Material								COVID-19 has affected vulnerable populations disproportionately across China and the world. Solid social and scientific evidence to tackle health inequity in the current COVID-19 pandemic is in urgent need.	[Wang, Zhicheng; Tang, Kun] Tsinghua Univ, Sch Med, Res Ctr Publ Hlth, Beijing, Peoples R China	Tsinghua University	Tang, K (corresponding author), Tsinghua Univ, Sch Med, Res Ctr Publ Hlth, Beijing, Peoples R China.	tangk@mail.tsinghua.edu.cn	Tang, Kun/GSD-3218-2022					Ambrus A, 2020, AM ECON REV, V110, P475, DOI 10.1257/aer.20190759; [Anonymous], 2020, XINHUA NEWS; Klinenberg E., 2015, HEAT WAVE SOCIAL AUT; Lowcock Elizabeth C, 2012, Am J Public Health, V102, pe51, DOI 10.2105/AJPH.2012.300814; Marmot M, 2002, HEALTH AFFAIR, V21, P31, DOI 10.1377/hlthaff.21.2.31; Marmot M, 2018, EPIDEMIOLOGY, V29, P5, DOI 10.1097/EDE.0000000000000773; Semenza JC, 1996, NEW ENGL J MED, V335, P84, DOI 10.1056/NEJM199607113350203; State Council, 2016, LEXISNEXIS; Wang C, 2020, LANCET, V395, P470, DOI 10.1016/S0140-6736(20)30185-9	9	170	176	1	44	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	APR	2020	26	4					458	458		10.1038/s41591-020-0823-6	http://dx.doi.org/10.1038/s41591-020-0823-6		MAR 2020	1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	QH1UE	32284617	Bronze			2022-12-27	WOS:000521691700001
J	Chung, HU; Rwei, AY; Hourlier-Fargette, A; Xu, S; Lee, KY; Dunne, EC; Xie, ZQ; Liu, CR; Carlini, A; Kim, DH; Ryu, D; Kulikova, E; Cao, JY; Odland, IC; Fields, KB; Hopkins, B; Banks, A; Ogle, C; Grande, D; Park, JB; Kim, J; Irie, M; Jang, H; Lee, JH; Park, Y; Kim, J; Jo, HH; Hahm, H; Avila, R; Xu, YH; Namkoong, M; Kwak, JW; Suen, E; Paulus, MA; Kim, RJ; Parsons, BV; Human, KA; Kim, SS; Patel, M; Reuther, W; Kim, HS; Lee, SH; Leedle, JD; Yun, YJ; Rigali, S; Son, T; Jung, IW; Arafa, H; Soundararajan, VR; Ollech, A; Shukla, A; Bradley, A; Schau, M; Rand, CM; Marsillio, LE; Harris, ZL; Huang, YG; Hamvas, A; Paller, AS; Weese-Mayer, DE; Lee, JY; Rogers, JA				Chung, Ha Uk; Rwei, Alina Y.; Hourlier-Fargette, Aurelie; Xu, Shuai; Lee, KunHyuck; Dunne, Emma C.; Xie, Zhaoqian; Liu, Claire; Carlini, Andrea; Kim, Dong Hyun; Ryu, Dennis; Kulikova, Elena; Cao, Jingyue; Odland, Ian C.; Fields, Kelsey B.; Hopkins, Brad; Banks, Anthony; Ogle, Christopher; Grande, Dominic; Park, Jun Bin; Kim, Jongwon; Irie, Masahiro; Jang, Hokyung; Lee, JooHee; Park, Yerim; Kim, Jungwoo; Jo, Han Heul; Hahm, Hyoungjo; Avila, Raudel; Xu, Yeshou; Namkoong, Myeong; Kwak, Jean Won; Suen, Emily; Paulus, Max A.; Kim, Robin J.; Parsons, Blake V.; Human, Kelia A.; Kim, Seung Sik; Patel, Manish; Reuther, William; Kim, Hyun Soo; Lee, Sung Hoon; Leedle, John D.; Yun, Yeojeong; Rigali, Sarah; Son, Taeyoung; Jung, Inhwa; Arafa, Hany; Soundararajan, Vinaya R.; Ollech, Ayelet; Shukla, Avani; Bradley, Allison; Schau, Molly; Rand, Casey M.; Marsillio, Lauren E.; Harris, Zena L.; Huang, Yonggang; Hamvas, Aaron; Paller, Amy S.; Weese-Mayer, Debra E.; Lee, Jong Yoon; Rogers, John A.			Skin-interfaced biosensors for advanced wireless physiological monitoring in neonatal and pediatric intensive-care units	NATURE MEDICINE			English	Article							BLOOD-PRESSURE CHANGES; PULSE TRANSIT-TIME; RANDOMIZED CONTROLLED-TRIAL; KANGAROO MOTHER CARE; INFANTS; SEISMOCARDIOGRAPHY; MARKER	Standard clinical care in neonatal and pediatric intensive-care units (NICUs and PICUs, respectively) involves continuous monitoring of vital signs with hard-wired devices that adhere to the skin and, in certain instances, can involve catheter-based pressure sensors inserted into the arteries. These systems entail risks of causing iatrogenic skin injuries, complicating clinical care and impeding skin-to-skin contact between parent and child. Here we present a wireless, non-invasive technology that not only offers measurement equivalency to existing clinical standards for heart rate, respiration rate, temperature and blood oxygenation, but also provides a range of important additional features, as supported by data from pilot clinical studies in both the NICU and PICU. These new modalities include tracking movements and body orientation, quantifying the physiological benefits of skin-to-skin care, capturing acoustic signatures of cardiac activity, recording vocal biomarkers associated with tonality and temporal characteristics of crying and monitoring a reliable surrogate for systolic blood pressure. These platforms have the potential to substantially enhance the quality of neonatal and pediatric critical care. Soft electronic patches worn on the skin of infants or children in intensive-care units have a wide range of capabilities in aiding critical care, including monitoring of hemodynamic parameters, cardiac activity, movement and crying.	[Chung, Ha Uk; Rwei, Alina Y.; Hourlier-Fargette, Aurelie; Xu, Shuai; Lee, KunHyuck; Liu, Claire; Carlini, Andrea; Banks, Anthony; Irie, Masahiro; Namkoong, Myeong; Kwak, Jean Won; Patel, Manish; Arafa, Hany; Lee, Jong Yoon; Rogers, John A.] Northwestern Univ, Simpson Querrey Inst, Chicago, IL 60611 USA; [Chung, Ha Uk; Irie, Masahiro] Northwestern Univ, Dept Elect & Comp Engn, Evanston, IL USA; [Chung, Ha Uk; Rwei, Alina Y.; Hourlier-Fargette, Aurelie; Xu, Shuai; Lee, KunHyuck; Liu, Claire; Carlini, Andrea; Kim, Dong Hyun; Ryu, Dennis; Odland, Ian C.; Fields, Kelsey B.; Banks, Anthony; Ogle, Christopher; Grande, Dominic; Park, Jun Bin; Irie, Masahiro; Jang, Hokyung; Avila, Raudel; Xu, Yeshou; Kwak, Jean Won; Kim, Robin J.; Parsons, Blake V.; Patel, Manish; Arafa, Hany; Huang, Yonggang; Paller, Amy S.; Lee, Jong Yoon; Rogers, John A.] Northwestern Univ, Ctr Biointegrated Elect, Evanston, IL 60208 USA; [Xu, Shuai; Soundararajan, Vinaya R.; Ollech, Ayelet] Northwestern Univ, Dept Dermatol, Feinberg Sch Med, Chicago, IL 60611 USA; [Lee, KunHyuck; Carlini, Andrea; Fields, Kelsey B.; Avila, Raudel; Xu, Yeshou; Patel, Manish; Huang, Yonggang; Paller, Amy S.; Rogers, John A.] Northwestern Univ, Dept Mat Sci & Engn, Evanston, IL 60208 USA; [Dunne, Emma C.; Hopkins, Brad; Bradley, Allison; Rand, Casey M.; Weese-Mayer, Debra E.] Ann & Robert H Lurie Childrens Hosp Chicago, Dept Pediat, Div Pediat Auton Med, Chicago, IL 60611 USA; [Xie, Zhaoqian] Dalian Univ Technol, Dept Engn Mech, State Key Lab Struct Anal Ind Equipment, Dalian, Peoples R China; [Liu, Claire; Namkoong, Myeong; Human, Kelia A.; Arafa, Hany; Rogers, John A.] Northwestern Univ, Dept Biomed Engn, Evanston, IL 60208 USA; [Kim, Dong Hyun; Hahm, Hyoungjo; Kim, Seung Sik; Kim, Hyun Soo; Lee, Sung Hoon; Lee, Jong Yoon] Univ Illinois, Dept Elect & Comp Engn, Urbana, IL 61801 USA; [Ryu, Dennis; Kulikova, Elena; Cao, Jingyue; Lee, JooHee; Patel, Manish; Leedle, John D.; Rigali, Sarah; Lee, Jong Yoon] Sibel Inc, Evanston, IL 60201 USA; [Kim, Jongwon] Korea Inst Sci & Technol, Photoelect Hybrids Res Ctr, Seoul, South Korea; [Kim, Jongwon; Jung, Inhwa] Kyung Hee Univ, Dept Mech Engn, Yongin, South Korea; [Jang, Hokyung; Kim, Hyun Soo; Yun, Yeojeong; Son, Taeyoung; Rogers, John A.] Univ Illinois, Frederick Seitz Materials Res Lab, Urbana, IL 61801 USA; [Park, Yerim; Kim, Jungwoo; Jo, Han Heul] Univ Illinois, Dept Comp Sci, Urbana, IL USA; [Avila, Raudel; Xu, Yeshou; Kwak, Jean Won; Huang, Yonggang; Rogers, John A.] Northwestern Univ, Dept Mech Engn, Evanston, IL 60208 USA; [Avila, Raudel; Xu, Yeshou; Huang, Yonggang] Northwestern Univ, Dept Civil & Environm Engn, Evanston, IL USA; [Xu, Yeshou] Southeast Univ, Key Lab C&PC Struct, Minist Educ, Nanjing, Peoples R China; [Suen, Emily] Northwestern Univ, Dept Neurobiol, Evanston, IL USA; [Paulus, Max A.] Northwestern Univ, Dept Biol, Evanston, IL USA; [Patel, Manish] Univ Illinois, Coll Med Chicago, Chicago, IL USA; [Reuther, William] North Carolina State Univ, Dept Graph Design & Ind Design, Raleigh, NC USA; [Shukla, Avani; Marsillio, Lauren E.; Harris, Zena L.; Hamvas, Aaron; Paller, Amy S.; Weese-Mayer, Debra E.] Ann & Robert H Lurie Childrens Hosp Chicago, Dept Pediat, Chicago, IL 60611 USA; [Schau, Molly; Hamvas, Aaron] Ann & Robert H Lurie Childrens Hosp Chicago, Dept Pediat, Div Neonatol, Chicago, IL 60611 USA; [Rand, Casey M.; Hamvas, Aaron; Weese-Mayer, Debra E.] Ann & Robert H Lurie Childrens Hosp Chicago, Stanley Manne Children's Res Inst, Chicago, IL 60611 USA; [Marsillio, Lauren E.; Harris, Zena L.] Ann & Robert H Lurie Childrens Hosp Chicago, Div Pediat Crit Care Med, Dept Pediat, Chicago, IL 60611 USA; [Rogers, John A.] Northwestern Univ, Dept Chem, Evanston, IL 60208 USA; [Rogers, John A.] Northwestern Univ, Dept Neurol Surg, Feinberg Sch Med, Chicago, IL 60611 USA	Northwestern University; Northwestern University; Northwestern University; Northwestern University; Feinberg School of Medicine; Northwestern University; Ann & Robert H. Lurie Children's Hospital of Chicago; Dalian University of Technology; Northwestern University; University of Illinois System; University of Illinois Urbana-Champaign; Korea Institute of Science & Technology (KIST); Kyung Hee University; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; Northwestern University; Northwestern University; Southeast University - China; Northwestern University; Northwestern University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of North Carolina; North Carolina State University; Ann & Robert H. Lurie Children's Hospital of Chicago; Ann & Robert H. Lurie Children's Hospital of Chicago; Ann & Robert H. Lurie Children's Hospital of Chicago; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Northwestern University; Feinberg School of Medicine	Lee, JY; Rogers, JA (corresponding author), Northwestern Univ, Simpson Querrey Inst, Chicago, IL 60611 USA.; Lee, JY; Rogers, JA (corresponding author), Northwestern Univ, Ctr Biointegrated Elect, Evanston, IL 60208 USA.; Rogers, JA (corresponding author), Northwestern Univ, Dept Mat Sci & Engn, Evanston, IL 60208 USA.; Weese-Mayer, DE (corresponding author), Ann & Robert H Lurie Childrens Hosp Chicago, Dept Pediat, Div Pediat Auton Med, Chicago, IL 60611 USA.; Rogers, JA (corresponding author), Northwestern Univ, Dept Biomed Engn, Evanston, IL 60208 USA.; Lee, JY (corresponding author), Univ Illinois, Dept Elect & Comp Engn, Urbana, IL 61801 USA.; Lee, JY (corresponding author), Sibel Inc, Evanston, IL 60201 USA.; Rogers, JA (corresponding author), Univ Illinois, Frederick Seitz Materials Res Lab, Urbana, IL 61801 USA.; Rogers, JA (corresponding author), Northwestern Univ, Dept Mech Engn, Evanston, IL 60208 USA.; Weese-Mayer, DE (corresponding author), Ann & Robert H Lurie Childrens Hosp Chicago, Dept Pediat, Chicago, IL 60611 USA.; Weese-Mayer, DE (corresponding author), Ann & Robert H Lurie Childrens Hosp Chicago, Stanley Manne Children's Res Inst, Chicago, IL 60611 USA.; Rogers, JA (corresponding author), Northwestern Univ, Dept Chem, Evanston, IL 60208 USA.; Rogers, JA (corresponding author), Northwestern Univ, Dept Neurol Surg, Feinberg Sch Med, Chicago, IL 60611 USA.	DWeese-Mayer@luriechildrens.org; jongyoon.lee@sibelhealth.com; jrogers@northwestern.edu	Ollech, Ayelet/ABC-5497-2020; Huang, Yonggang/B-6998-2009; Liu, Claire/AAY-4713-2021; Liu, Claire/AAT-3732-2020; Rogers, John/L-2798-2016; Liu, Claire/GXF-5777-2022; Xu, Yeshou/ABG-9767-2021; Kulikova, Elena/GPF-9038-2022; Xie, Zhaoqian/AAD-5087-2019	Liu, Claire/0000-0003-4308-389X; Xu, Yeshou/0000-0002-4417-1878; Xie, Zhaoqian/0000-0003-1320-817X; Odland, Ian Christopher/0000-0002-2418-4479; Lee, Sung Hoon/0000-0003-4082-0786; Arafa, Hany/0000-0003-3191-8212; Hamvas, Aaron/0000-0002-5749-7797; Hourlier-Fargette, Aurelie/0000-0002-0148-4145; Carlini, Andrea/0000-0003-1688-6208; Chung, Ha Uk/0000-0003-3592-8944; Patel, Manish/0000-0003-3835-9601; Human, Kelia/0000-0002-3709-5037; Reuther, William/0000-0002-5573-1367; Harris, Zena Leah/0000-0003-0110-8438	Bill & Melinda Gates Foundation [OPP1182909, OPP1193311]; Gerber Foundation; Friends of Prentice Foundation; Save the Children [999002170]; National Institutes of Health's National Center for Advancing Translational Sciences [TL1TR001423]; WCAS Undergraduate Research Grant Program; National Natural Science Foundation of China [11402134, 11320101001]; National Basic Research program of China [2015CB351900]; National Science Foundation [1400159, 1534120, 1635443]; Center for Bio-Integrated Electronics of the Simpson Querrey Institute at Northwestern University; Soft and Hybrid Nanotechnology Experimental (SHyNE) Resource (NSF) [ECCS-1542205]; Materials Research Science and Engineering Center [DMR-1720139]; State of Illinois and Northwestern University	Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); Gerber Foundation; Friends of Prentice Foundation; Save the Children; National Institutes of Health's National Center for Advancing Translational Sciences; WCAS Undergraduate Research Grant Program; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research program of China(National Basic Research Program of China); National Science Foundation(National Science Foundation (NSF)); Center for Bio-Integrated Electronics of the Simpson Querrey Institute at Northwestern University; Soft and Hybrid Nanotechnology Experimental (SHyNE) Resource (NSF); Materials Research Science and Engineering Center(National Science Foundation (NSF)); State of Illinois and Northwestern University	D.E.W.-M., A.H., C.M.R., R.G. and J.A.R. acknowledge funding from the Bill & Melinda Gates Foundation (OPP1182909). S.X. and J.A.R. acknowledge additional funding from the Bill & Melinda Gates Foundation (OPP1193311). D.E.W.-M., A.H., C.M.R., R.G. and J.A.R. acknowledge support from the Gerber Foundation. A.S.P., D.E.W.-M., A.H. and J.A.R. recognize the Friends of Prentice Foundation for their support. J.A.R. and S.X. also recognize support from Save the Children (award 999002170). A.Y.R. gratefully acknowledges funding support by the National Institutes of Health's National Center for Advancing Translational Sciences, grant TL1TR001423. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. E.S. recognizes funding support from the WCAS Undergraduate Research Grant Program, which is administered by Northwestern University's Weinberg College of Arts and Sciences. The conclusions, opinions and other statements in this publication are the author's and not necessarily those of the sponsoring institution. This work is also supported by the National Natural Science Foundation of China (11402134 and 11320101001), the National Basic Research program of China (2015CB351900) and the National Science Foundation (1400159, 1534120 and 1635443). The materials and engineering efforts were supported by the Center for Bio-Integrated Electronics of the Simpson Querrey Institute at Northwestern University. This work utilized Northwestern University Micro/Nano Fabrication Facility (NUFAB), which is partially supported by Soft and Hybrid Nanotechnology Experimental (SHyNE) Resource (NSF ECCS-1542205), the Materials Research Science and Engineering Center (DMR-1720139), the State of Illinois and Northwestern University.	Alaie HF, 2016, SPEECH COMMUN, V77, P28, DOI 10.1016/j.specom.2015.12.001; [Anonymous], 2002, ANESTHESIOL CLIN N A; August DL., 2018, J NEONATAL NURS, V24, P173, DOI DOI 10.1016/j.jnn.2017.08.003; Barbeau DY, 2017, CHILDREN-BASEL, V4, DOI 10.3390/children4100090; Baserga Mariana C, 2002, J Perinatol, V22, P416, DOI 10.1038/sj.jp.7210713; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Bonner Oliver, 2017, BMJ Innov, V3, P12, DOI 10.1136/bmjinnov-2016-000145; Boundy EO, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2015-2238; Brzezinski M, 2009, ANESTH ANALG, V109, P1763, DOI 10.1213/ANE.0b013e3181bbd416; Cattaneo A, 1998, ACTA PAEDIATR, V87, P976, DOI 10.1080/080352598750031653; Chung HU, 2019, SCIENCE, V363, P947, DOI 10.1126/science.aau0780; Cilley R E, 1992, Semin Pediatr Surg, V1, P174; CORWIN MJ, 1995, PEDIATRICS, V96, P73; Daw, 2016, J ADV BIOMED ENG TEC, DOI [10.15379/2409-3394.2016.03.01.04, DOI 10.15379/2409-3394.2016.03.01.04]; Dehghani K, 2015, J CLIN NEONATOL, V4, P26, DOI 10.4103/2249-4847.151163; Di Rienzo M, 2013, AUTON NEUROSCI-BASIC, V178, P50, DOI 10.1016/j.autneu.2013.04.005; Fahn S., 2011, PRINCIPLES PRACTICE; Fanaroff JM, 2006, SEMIN FETAL NEONAT M, V11, P174, DOI 10.1016/j.siny.2006.01.002; Foo JYA, 2006, PHYSIOL MEAS, V27, P685, DOI 10.1088/0967-3334/27/8/003; Fu TH, 2008, J MED BIOL ENG, V28, P229; Galland BC, 2007, SLEEP, V30, P891, DOI 10.1093/sleep/30.7.891; Hadush MY, 2017, BMC PEDIATR, V17, DOI 10.1186/s12887-017-0866-0; Huntsman RJ, 2008, PAED CHILD HEALT-CAN, V13, P680, DOI 10.1093/pch/13.8.680; Inan Omer T, 2018, CIRC-HEART FAIL, V11, pe004313; JAMES DK, 1979, ARCH DIS CHILD, V54, P226, DOI 10.1136/adc.54.3.226; Joseph R, 1985, Ann Acad Med Singap, V14, P576; Joshi R, 2018, IEEE J TRANSL ENG HE, V6, DOI 10.1109/JTEHM.2018.2875703; Leeudomwong T, 2017, ENG J-THAIL, V21, DOI 10.4186/ej.2017.21.7.181; Levy J, 2017, PEDIATR PULM, V52, P84, DOI 10.1002/ppul.23513; Liu GZ, 2011, TELEMED E-HEALTH, V17, P705, DOI 10.1089/tmj.2011.0022; Liu YH, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1601185; Lund CH, 2004, JOGNN-J OBST GYN NEO, V33, P320, DOI 10.1177/0884217504265174; Ma YJ, 2018, P NATL ACAD SCI USA, V115, P11144, DOI 10.1073/pnas.1814392115; Mahoney Marla C, 2005, Pediatr Phys Ther, V17, P194, DOI 10.1097/01.pep.0000176574.70254.60; MEANS LW, 1982, NEUROPSYCHOLOGIA, V20, P715, DOI 10.1016/0028-3932(82)90073-2; Mutashar S, 2014, SENSORS-BASEL, V14, P11522, DOI 10.3390/s140711522; Newman JD, 2007, BEHAV BRAIN RES, V182, P155, DOI 10.1016/j.bbr.2007.02.011; Oranges T, 2015, ADV WOUND CARE, V4, P587, DOI 10.1089/wound.2015.0642; Pandia K., 2013, 2013 35 ANN INT C IE, P6881; Payne RA, 2006, J APPL PHYSIOL, V100, P136, DOI 10.1152/japplphysiol.00657.2005; Peter L, 2014, IRBM, V35, P271, DOI 10.1016/j.irbm.2014.07.002; Pickering TG, 2005, CIRCULATION, V111, P697, DOI 10.1161/01.CIR.0000154900.76284.F6; Reggiannini B, 2013, J SPEECH LANG HEAR R, V56, P1416, DOI 10.1044/1092-4388(2013/11-0298); Sahoo PK, 2017, SENSORS-BASEL, V17, DOI 10.3390/s17040711; Scheer BV, 2002, CRIT CARE, V6, P198, DOI 10.1186/cc1489; Sharma M, 2017, TECHNOLOGIES, V5, DOI 10.3390/technologies5020021; Shinya Y, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.02195; Shinya Y, 2014, BIOL LETTERS, V10, DOI 10.1098/rsbl.2014.0350; Shwayder Tor, 2005, Dermatol Ther, V18, P87, DOI 10.1111/j.1529-8019.2005.05011.x; Wheeler Derek S., 2007, PEDIAT CRITICAL CARE; WILSON RA, 1993, AM J CARDIOL, V71, P536, DOI 10.1016/0002-9149(93)90508-A; WIPPERMANN CF, 1995, J CLIN MONITOR, V11, P324, DOI 10.1007/BF01616991; World Health Organization (WHO), 2003, KANGAROO MOTHER CARE; Xu Jiaquan, 2018, Natl Vital Stat Rep, V67, P1	54	146	149	46	253	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	MAR	2020	26	3					418	+		10.1038/s41591-020-0792-9	http://dx.doi.org/10.1038/s41591-020-0792-9			25	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	KU0MC	32161411	Green Accepted, Green Submitted			2022-12-27	WOS:000519405000030
J	Langenberg, MCC; Hoogerwerf, MA; Koopman, JPR; Janse, JJ; Kos-van Oosterhoud, J; Feijt, C; Jochems, SP; de Dood, CJ; van Schuijlenburg, R; Ozir-Fazalalikhan, A; Manurung, MD; Sartono, E; van der Beek, MT; Winkel, BMF; Verbeek-Menken, PH; Stam, KA; van Leeuwen, FWB; Meij, P; van Diepen, A; van Lieshout, L; van Dam, GJ; Corstjens, PLAM; Hokke, CH; Yazdanbakhsh, M; Visser, LG; Roestenberg, M				Langenberg, Marijke C. C.; Hoogerwerf, Marie-Astrid; Koopman, Jan Pieter R.; Janse, Jacqueline J.; Kos-van Oosterhoud, Janneke; Feijt, Carola; Jochems, Simon P.; de Dood, Claudia J.; van Schuijlenburg, Roos; Ozir-Fazalalikhan, Arifa; Manurung, Mikhael D.; Sartono, Erliyani; van der Beek, Martha T.; Winkel, Beatrice M. F.; Verbeek-Menken, Petra H.; Stam, Koen A.; van Leeuwen, Fijs W. B.; Meij, Pauline; van Diepen, Angela; van Lieshout, Lisette; van Dam, Govert J.; Corstjens, Paul L. A. M.; Hokke, Cornelis H.; Yazdanbakhsh, Maria; Visser, Leo G.; Roestenberg, Meta			A controlled human Schistosoma mansoni infection model to advance novel drugs, vaccines and diagnostics	NATURE MEDICINE			English	Article							ANTIBODY-RESPONSE; IMMUNE-RESPONSES; WORM BURDEN; IMMUNOGENICITY; REINFECTION; HAEMATOBIUM; PREVALENCE; ANTIGENS; EFFICACY; TRIAL	Schistosomiasis treatment relies on the use of a single drug, praziquantel, which is insufficient to control transmission in highly endemic areas(1). Novel medicines and vaccines are urgently needed(2,3). An experimental human model for schistosomiasis could accelerate the development of these products. We performed a dose-escalating clinical safety trial in 17 volunteers with male Schistosoma mansoni cercariae, which do not produce eggs (clinicaltrials.gov ), at the Leiden University Medical Center, the Netherlands. The primary endpoints were adverse events and infectivity. We found a dose-related increase in adverse events related to acute schistosomiasis syndrome, which occurred in 9 of 17 volunteers. Overall, 5 volunteers (all 3 of the high dose group and 2 of 11 of the medium dose group) reported severe adverse events. Worm-derived circulating anodic antigen, the biomarker of the primary infection endpoint, peaked in 82% of volunteers at 3-10 weeks following exposure. All volunteers showed IgM and IgG1 seroconversion and worm-specific cytokine production by CD4(+) T cells. All volunteers were cured with praziquantel provided at 12 weeks after exposure. Infection with 20 Schistosoma mansoni cercariae led to severe adverse events in 18% of volunteers and high infection rates. This infection model paves the way for fast-track product development for treatment and prevention of schistosomiasis.	[Langenberg, Marijke C. C.; Hoogerwerf, Marie-Astrid; Koopman, Jan Pieter R.; Janse, Jacqueline J.; Kos-van Oosterhoud, Janneke; Feijt, Carola; Jochems, Simon P.; van Schuijlenburg, Roos; Ozir-Fazalalikhan, Arifa; Manurung, Mikhael D.; Sartono, Erliyani; Winkel, Beatrice M. F.; Stam, Koen A.; van Diepen, Angela; van Lieshout, Lisette; van Dam, Govert J.; Hokke, Cornelis H.; Yazdanbakhsh, Maria; Roestenberg, Meta] Leiden Univ, Dept Parasitol, Med Ctr, Leiden, Netherlands; [de Dood, Claudia J.; Corstjens, Paul L. A. M.] Leiden Univ, Med Ctr, Dept Cell & Chem Biol, Leiden, Netherlands; [van der Beek, Martha T.] Leiden Univ, Dept Med MicroBiol, Med Ctr, Leiden, Netherlands; [Verbeek-Menken, Petra H.; Visser, Leo G.; Roestenberg, Meta] Leiden Univ, Dept Infect Dis, Med Ctr, Leiden, Netherlands; [van Leeuwen, Fijs W. B.] Leiden Univ, Dept Radiol, Intervent Mol Imaging Lab, Med Ctr, Leiden, Netherlands; [Meij, Pauline] Leiden Univ, Med Ctr, Dept Clin Pharm & Toxicol, Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Roestenberg, M (corresponding author), Leiden Univ, Dept Parasitol, Med Ctr, Leiden, Netherlands.; Roestenberg, M (corresponding author), Leiden Univ, Dept Infect Dis, Med Ctr, Leiden, Netherlands.	m.roestenberg@lumc.nl	van leeuwen, Fijs/AAX-2098-2021; Visser, Leo/AAH-5755-2021; Hokke, Cornelis Hendrik/AAQ-4712-2021; Yazdanbakhsh, Maria/AAI-3996-2020; Corstjens, Paul/Y-6310-2018; Jochems, Simon/FFT-0345-2022; Roestenberg, Meta/AAP-9413-2021; Ozir-Fazalalikhan, A/V-5436-2018; van Schuijlenburg, Roos/AFR-8022-2022; Jochems, Simon/AAT-9156-2021	van leeuwen, Fijs/0000-0002-6844-4025; Hokke, Cornelis Hendrik/0000-0003-3545-7804; Yazdanbakhsh, Maria/0000-0002-7666-1441; Corstjens, Paul/0000-0002-0004-0526; Roestenberg, Meta/0000-0002-5052-2830; Ozir-Fazalalikhan, A/0000-0002-0613-8372; van Schuijlenburg, Roos/0000-0003-4413-5604; Jochems, Simon/0000-0002-4835-1032; Langenberg, Marijke/0000-0002-3720-1522; Koopman, Jan Pieter/0000-0003-1335-9402; Manurung, Mikhael/0000-0003-2728-1829	Netherlands Organization for Health Research and Development [016.156.076]; Gisela Thier Fellowship from LUMC [14-0645]; Dioraphte Foundation [16020405]; European Union [707404]	Netherlands Organization for Health Research and Development(Netherlands Organization for Health Research and Development); Gisela Thier Fellowship from LUMC; Dioraphte Foundation; European Union(European Commission)	We thank P. van Genderen for reviewing the safety data and providing his advice as safety monitor of our study. We thank M. Casacuberta Partal, M.A.A. Erkens, J.L. FehrmannNaumann, M.S. Ganesh, H. Gerritsma, G.C. Hardeman, P.T. Hoekstra-Mevius, Y.C.M. Kruize, Y.D. Mouwenda, H.H. Smits, K. Suijk-Benschop, J.J.C. de Vries and C.J.G. van Zeijl-van der Ham for their laboratory, clinical and data-analyzing support during the study. Most of all we thank all volunteers participating in the study, without whom the study could not have been performed. Dr. Roestenberg was supported by a Veni grant (no. 016.156.076) from the Netherlands Organization for Health Research and Development and a Gisela Thier Fellowship (no. 14-0645) from LUMC. Dr. Langenberg and Dr. Hoogerwerf were supported by a grant from Dioraphte Foundation (no. 16020405). The funding sources had no role in collecting, analyzing, interpreting or reporting the data. Dr. Jochems has received funding from the European Union's Horizon 2020 Research and Innovation Programme under Marie Sklodowska-Curie grant agreement no. 707404. The opinions expressed in this document reflect only the author's view. The European Commission is not responsible for any use that may be made of the information that it contains.	AGNEW A, 1995, PARASITOLOGY, V111, P67, DOI 10.1017/S0031182000064611; [Anonymous], 2000, OFFICIAL J EUROPEAN, V327; [Anonymous], STAT VACC RES DEV VA; [Anonymous], 2013, JAMA-J AM MED ASSOC, V310, P2191, DOI [DOI 10.1001/JAMA.2013.281053, 10.1001/jama.2013.281053]; Balasingam S, 2016, INT J INFECT DIS, V49, P18, DOI 10.1016/j.ijid.2016.05.013; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Bergquist R, 2017, INFECT DIS POVERTY, V6, DOI 10.1186/s40249-017-0286-2; Caldas IR, 2008, ACTA TROP, V108, P109, DOI 10.1016/j.actatropica.2008.05.027; Chen WH, 2016, CLIN INFECT DIS, V62, P1329, DOI 10.1093/cid/ciw145; Colley DG, 2014, LANCET, V383, P2253, DOI 10.1016/S0140-6736(13)61949-2; Colley DG, 2013, AM J TROP MED HYG, V88, P426, DOI 10.4269/ajtmh.12-0639; Corstjens PLAM, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0857-7; Corstjens PLAM, 2014, PARASITOLOGY, V141, P1841, DOI 10.1017/S0031182014000626; Dalton JP, 1997, PARASITOLOGY, V115, P29, DOI 10.1017/S0031182097001091; Deelder A M, 1973, Acta Leiden, V39, P5; DEELDER AM, 1980, AM J TROP MED HYG, V29, P401, DOI 10.4269/ajtmh.1980.29.401; DEELDER AM, 1989, T ROY SOC TROP MED H, V83, P364, DOI 10.1016/0035-9203(89)90506-3; Faulkner H, 2001, PARASITE IMMUNOL, V23, P509, DOI 10.1046/j.1365-3024.2001.00408.x; Janse JJ, 2018, J INFECT DIS, V218, P1142, DOI 10.1093/infdis/jiy275; Jin C, 2017, LANCET, V390, P2472, DOI 10.1016/S0140-6736(17)32149-9; Kariuki TM, 2005, PARASITE IMMUNOL, V27, P281, DOI 10.1111/j.1365-3024.2005.00783.x; Kariuki TM, 2004, INFECT IMMUN, V72, P5526, DOI 10.1128/IAI.72.9.5526-5529.2004; King CH, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001321; Kuznetsova A, 2017, J STAT SOFTW, V82, P1, DOI 10.18637/jss.v082.i13; Langenberg MCC, 2019, ANN INTERN MED, V170, P732, DOI 10.7326/L18-0438; Meltzer E, 2013, CURR INFECT DIS REP, V15, P211, DOI 10.1007/s11908-013-0329-1; Merrifield M, 2016, VACCINE, V34, P2988, DOI 10.1016/j.vaccine.2016.03.079; Mo AX, 2016, VACCINE, V34, P995, DOI 10.1016/j.vaccine.2015.12.032; NASH TE, 1978, AM J TROP MED HYG, V27, P944, DOI 10.4269/ajtmh.1978.27.944; Obeng BB, 2008, ANN TROP MED PARASIT, V102, P625, DOI 10.1179/136485908X337490; PARRINO TA, 1977, NEW ENGL J MED, V297, P86, DOI 10.1056/NEJM197707142970204; RICHTER D, 1995, PARASITOL TODAY, V11, P288, DOI 10.1016/0169-4758(95)80041-7; Rocha MOC, 1996, TROP MED INT HEALTH, V1, P213; Roestenberg M, 2018, LANCET INFECT DIS, V18, pE312, DOI 10.1016/S1473-3099(18)30177-4; Rohart F, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005752; Santini-Oliveira M, 2016, VACCINE, V34, P586, DOI 10.1016/j.vaccine.2015.10.027; Siddiqui AJ, 2018, ANN NY ACAD SCI, V1425, P19, DOI 10.1111/nyas.13866; Singh A, 2019, BIOINFORMATICS, V35, P3055, DOI 10.1093/bioinformatics/bty1054; Sombetzki M, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00861; Soonawala D, 2011, AM J TROP MED HYG, V84, P43, DOI 10.4269/ajtmh.2011.10-0260; Sousa MS, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00682; Staal SL, 2018, INT ARCH ALLERGY IMM, V177, P192, DOI 10.1159/000490952; Thompson LJ, 2016, NAT IMMUNOL, V17, P297, DOI 10.1038/ni.3329; Tukahebwa EM, 2013, T ROY SOC TROP MED H, V107, P397, DOI 10.1093/trstmh/trt024; van den Biggelaar AHJ, 2002, J INFECT DIS, V186, P1474, DOI 10.1086/344352; van Grootveld R, 2018, EUR J CLIN MICROBIOL, V37, P1709, DOI 10.1007/s10096-018-3303-x; vanDam GJ, 1996, J INFECT DIS, V173, P1232, DOI 10.1093/infdis/173.5.1232; VISSER LG, 1995, CLIN INFECT DIS, V20, P280, DOI 10.1093/clinids/20.2.280; Vos T, 2015, LANCET, V386, P743, DOI 10.1016/S0140-6736(15)60692-4; Walk J, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1434-z; Wickham H., 2016, GGPLOT2 ELEGANT GRAP, DOI 10.1007/978-3-319-24277-4; Winkel BMF, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02510; Zhang WD, 2018, ANN NY ACAD SCI, V1425, P38, DOI 10.1111/nyas.13942	53	45	45	0	9	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	MAR	2020	26	3					326	+		10.1038/s41591-020-0759-x	http://dx.doi.org/10.1038/s41591-020-0759-x		FEB 2020	16	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	KU0MC	32066978	Green Published, Bronze			2022-12-27	WOS:000514065500004
J	Ordonez, AA; Wang, HC; Magombedze, G; Ruiz-Bedoya, CA; Srivastava, S; Chen, AL; Tucker, EW; Urbanowski, ME; Pieterse, L; Cardozo, EF; Lodge, MA; Shah, MNR; Holt, DP; Mathews, WB; Dannals, RF; Gobburu, JVS; Peloquin, CA; Rowe, SP; Gumbo, T; Ivaturi, VD; Jain, SK				Ordonez, Alvaro A.; Wang, Hechuan; Magombedze, Gesham; Ruiz-Bedoya, Camilo A.; Srivastava, Shashikant; Chen, Allen; Tucker, Elizabeth W.; Urbanowski, Michael E.; Pieterse, Lisa; Fabian Cardozo, E.; Lodge, Martin A.; Shah, Maunank R.; Holt, Daniel P.; Mathews, William B.; Dannals, Robert F.; Gobburu, Jogarao V. S.; Peloquin, Charles A.; Rowe, Steven P.; Gumbo, Tawanda; Ivaturi, Vijay D.; Jain, Sanjay K.			Dynamic imaging in patients with tuberculosis reveals heterogeneous drug exposures in pulmonary lesions	NATURE MEDICINE			English	Article							RIFAMPICIN; PHARMACOKINETICS; PENETRATION; MODEL; CHEMOTHERAPEUTICS; AUTOINDUCTION; PYRAZINAMIDE; RIFAPENTINE; RESISTANCE; STABILITY	Tuberculosis (TB) is the leading cause of death from a single infectious agent, requiring at least 6 months of multidrug treatment to achieve cure(1). However, the lack of reliable data on antimicrobial pharmacokinetics (PK) at infection sites hinders efforts to optimize antimicrobial dosing and shorten TB treatments(2). In this study, we applied a new tool to perform unbiased, noninvasive and multicompartment measurements of antimicrobial concentration-time profiles in humans(3). Newly identified patients with rifampin-susceptible pulmonary TB were enrolled in a first-in-human study(4) using dynamic [C-11]rifampin (administered as a microdose) positron emission tomography (PET) and computed tomography (CT). [C-11]rifampin PET-CT was safe and demonstrated spatially compartmentalized rifampin exposures in pathologically distinct TB lesions within the same patients, with low cavity wall rifampin exposures. Repeat PET-CT measurements demonstrated independent temporal evolution of rifampin exposure trajectories in different lesions within the same patients. Similar findings were recapitulated by PET-CT in experimentally infected rabbits with cavitary TB and confirmed using postmortem mass spectrometry. Integrated modeling of the PET-captured concentration-time profiles in hollow-fiber bacterial kill curve experiments provided estimates on the rifampin dosing required to achieve cure in 4 months. These data, capturing the spatial and temporal heterogeneity of intralesional drug PK, have major implications for antimicrobial drug development. Distinct patterns of exposure to a first-line tuberculosis drug in separate lung lesions within patients are revealed by PET-CT imaging. Use of the technique might help optimize the duration and dosing of antimicrobial drugs.	[Ordonez, Alvaro A.; Ruiz-Bedoya, Camilo A.; Chen, Allen; Tucker, Elizabeth W.; Pieterse, Lisa; Jain, Sanjay K.] Johns Hopkins Univ, Sch Med, Ctr Infect & Inflammat Imaging Res, Baltimore, MD 21218 USA; [Ordonez, Alvaro A.; Ruiz-Bedoya, Camilo A.; Tucker, Elizabeth W.; Urbanowski, Michael E.; Pieterse, Lisa; Shah, Maunank R.; Jain, Sanjay K.] Johns Hopkins Univ, Sch Med, Ctr TB Res, Baltimore, MD 21218 USA; [Ordonez, Alvaro A.; Ruiz-Bedoya, Camilo A.; Jain, Sanjay K.] Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21205 USA; [Wang, Hechuan; Gobburu, Jogarao V. S.; Ivaturi, Vijay D.] Univ Maryland, Sch Pharm, Ctr Translat Med, Baltimore, MD 21201 USA; [Magombedze, Gesham; Srivastava, Shashikant; Gumbo, Tawanda] Baylor Univ, Med Ctr, Ctr Infect Dis Res & Expt Therapeut, Dallas, TX USA; [Magombedze, Gesham; Srivastava, Shashikant; Gumbo, Tawanda] Texas Tech Univ, Hlth Sci Ctr, Dallas, TX USA; [Chen, Allen; Lodge, Martin A.; Holt, Daniel P.; Mathews, William B.; Dannals, Robert F.; Rowe, Steven P.; Jain, Sanjay K.] Johns Hopkins Univ, Sch Med, Russell H Morgan Dept Radiol & Radiol Sci, Baltimore, MD 21218 USA; [Tucker, Elizabeth W.; Pieterse, Lisa] Johns Hopkins Univ, Sch Med, Dept Anesthesiol & Crit Care Med, Baltimore, MD 21205 USA; [Urbanowski, Michael E.; Shah, Maunank R.] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Fabian Cardozo, E.] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, 1124 Columbia St, Seattle, WA 98104 USA; [Peloquin, Charles A.] Univ Florida, Coll Pharm, Infect Dis Pharmacokinet Lab, Pharmacotherapy & Translat Res, Gainesville, FL USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; University System of Maryland; University of Maryland Baltimore; Baylor University; Baylor University Medical Center; Texas Tech University System; Texas Tech University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Fred Hutchinson Cancer Center; State University System of Florida; University of Florida	Jain, SK (corresponding author), Johns Hopkins Univ, Sch Med, Ctr Infect & Inflammat Imaging Res, Baltimore, MD 21218 USA.; Jain, SK (corresponding author), Johns Hopkins Univ, Sch Med, Ctr TB Res, Baltimore, MD 21218 USA.; Jain, SK (corresponding author), Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21205 USA.; Jain, SK (corresponding author), Johns Hopkins Univ, Sch Med, Russell H Morgan Dept Radiol & Radiol Sci, Baltimore, MD 21218 USA.	sjain5@jhmi.edu	Srivastava, Shashikant/I-4704-2019; Srivastava, Shashikant/D-5311-2013; Ordonez, Alvaro/AAC-9996-2022	Srivastava, Shashikant/0000-0002-8786-8851; Ordonez, Alvaro/0000-0002-8571-0655; Tucker, Elizabeth W/0000-0002-0971-3635; Jain, Sanjay/0000-0001-9620-7070; Cardozo Ojeda, Erwing/0000-0001-8690-9896	US National Institutes of Health [R01-HL131829]; Director's Transformative Research Award [R01-EB020539];  [R56-AI145435]	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Director's Transformative Research Award; 	We thank all the patients who participated in the study. Additionally, we thank the Maryland Department of Health and Mental Hygiene for recruiting patients with TB; R. Abdallah, C. Voicu, J. Sanchez-Bautista, S. Frey and L. Shinehouse (Johns Hopkins Hospitals) for coordinating the human imaging studies; and M. Klunk for helping with the animal experiments. This work was funded by the US National Institutes of Health (grant R01-HL131829), Director's Transformative Research Award (grant R01-EB020539) and R56-AI145435 to S.K.J.	Aarnoutse RE, 2017, ANTIMICROB AGENTS CH, V61, DOI [10.1128/AAC.01054-17, 10.1128/aac.01054-17]; ACOCELLA G, 1977, ARZNEIMITTEL-FORSCH, V27, P1221; Benator D, 2002, LANCET, V360, P528, DOI 10.1016/S0140-6736(02)09742-8; Boeree MJ, 2017, LANCET INFECT DIS, V17, P39, DOI 10.1016/S1473-3099(16)30274-2; Boeree MJ, 2015, AM J RESP CRIT CARE, V191, P1058, DOI 10.1164/rccm.201407-1264OC; CANETTI G, 1965, AM REV RESPIR DIS, V92, P687; Center for Drug Evaluation and Research, 2005, GUID IND EST MAX SAF; Chigutsa E, 2015, ANTIMICROB AGENTS CH, V59, P38, DOI 10.1128/AAC.03931-14; DeMarco VP, 2015, ANTIMICROB AGENTS CH, V59, P5768, DOI 10.1128/AAC.01146-15; Dheda K, 2018, AM J RESP CRIT CARE, V198, P1208, DOI [10.1164/rccm.201711-2333OC, 10.1164/rccm.201711-2333oc]; Diacon AH, 2007, ANTIMICROB AGENTS CH, V51, P2994, DOI 10.1128/AAC.01474-06; Dorman SE, 2012, J INFECT DIS, V206, P1030, DOI 10.1093/infdis/jis461; Ehrlich P, 1913, LANCET, V2, P445; Grobbelaar M, 2019, INFECT GENET EVOL, V74, DOI 10.1016/j.meegid.2019.103937; Gumbo T, 2015, CLIN INFECT DIS, V61, pS25, DOI 10.1093/cid/civ427; HEDLUND LW, 1983, SEMIN RESPIR MED, V5, P76, DOI 10.1055/s-2007-1011435; Hunter RL, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02108; Jain SK, 2018, NAT IMMUNOL, V19, P521, DOI 10.1038/s41590-018-0119-x; Kjellsson MC, 2012, ANTIMICROB AGENTS CH, V56, P446, DOI 10.1128/AAC.05208-11; Lappin G, 2013, EXPERT OPIN DRUG MET, V9, P817, DOI 10.1517/17425255.2013.786042; LeGuellec C, 1997, THER DRUG MONIT, V19, P669, DOI 10.1097/00007691-199712000-00011; Liu L, 2010, J MED CHEM, V53, P2882, DOI 10.1021/jm901858n; LOOS U, 1985, KLIN WOCHENSCHR, V63, P1205, DOI 10.1007/BF01733779; Magombedze G, 2018, CLIN INFECT DIS, V67, pS349, DOI 10.1093/cid/ciy623; NAU R, 1992, J ANTIMICROB CHEMOTH, V29, P719, DOI 10.1093/jac/29.6.719; NITTI V, 1977, CHEMOTHERAPY, V23, P1, DOI 10.1159/000221963; NIX DE, 1991, ANTIMICROB AGENTS CH, V35, P1953, DOI 10.1128/AAC.35.10.1953; Ordonez AA, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aax8251; Ordonez AA, 2019, ACS INFECT DIS, V5, P1996, DOI 10.1021/acsinfecdis.9b00207; Pan H, 2005, NATURE, V434, P767, DOI 10.1038/nature03419; Pasipanodya JG, 2018, CLIN INFECT DIS, V67, pS284, DOI 10.1093/cid/ciy610; Pasipanodya JG, 2013, J INFECT DIS, V208, P1464, DOI 10.1093/infdis/jit352; Peloquin CA, 2017, ANTIMICROB AGENTS CH, V61, DOI 10.1128/AAC.00038-17; Prideaux B, 2015, NAT MED, V21, P1223, DOI 10.1038/nm.3937; Reynolds J, 2014, EXPERT OPIN DRUG MET, V10, P813, DOI 10.1517/17425255.2014.895813; Rifat D, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aai7786; Rubinstein LV, 2010, STAT MED, V29, P1072, DOI 10.1002/sim.3840; Samara E, 2017, BONE JOINT RES, V6, P296, DOI 10.1302/2046-3758.65.BJR-2017-0276.R1; Smythe W, 2012, ANTIMICROB AGENTS CH, V56, P2091, DOI 10.1128/AAC.05792-11; Svensson RJ, 2018, J INFECT DIS, V218, P991, DOI 10.1093/infdis/jiy242; Svensson RJ, 2018, CLIN PHARMACOL THER, V103, P674, DOI 10.1002/cpt.778; Swaminathan S, 2016, CLIN INFECT DIS, V63, pS63, DOI 10.1093/cid/ciw471; te Brake LHM, 2019, AM J RESP CRIT CARE, V199, P1166, DOI 10.1164/rccm.201811-2101LE; Tucker EW, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aau0965; U.S. Food and Drug Administration, 2006, GUID IND INV REV EXP; Urbanowski ME, 2018, J INFECT DIS, V218, P53, DOI 10.1093/infdis/jiy127; US Food and Drug Administration, 2010, GUID IND RES RAD DRU; Velasquez GE, 2018, AM J RESP CRIT CARE, V198, P657, DOI 10.1164/rccm.201712-2524OC; Wagner CC, 2011, ADV DRUG DELIVER REV, V63, P539, DOI 10.1016/j.addr.2010.09.011; WHO, 2019, GLOB TUB REP	50	47	48	1	17	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	APR	2020	26	4					529	+		10.1038/s41591-020-0770-2	http://dx.doi.org/10.1038/s41591-020-0770-2		FEB 2020	18	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	QH1UE	32066976	Green Accepted			2022-12-27	WOS:000514065500005
J	Yofe, I; Dahan, R; Amit, I				Yofe, Ido; Dahan, Rony; Amit, Ido			Single-cell genomic approaches for developing the next generation of immunotherapies	NATURE MEDICINE			English	Article							T-CELLS; ANTITUMOR-ACTIVITY; ANTIBODIES; LANDSCAPE; INNATE	Recent progress in single-cell genomics urges its application in drug development, particularly of cancer immunotherapies. Current immunotherapy pipelines are focused on functional outcome and simple cellular and molecular readouts. A thorough mechanistic understanding of the cells and pathways targeted by immunotherapy agents is lacking, which limits the success rate of clinical trials. A large leap forward can be made if the immunotherapy target cells and pathways are characterized at high resolution before and after treatment, in clinical cohorts and model systems. This will enable rapid development of effective immunotherapies and data-driven design of synergistic drug combinations. In this Perspective, we discuss how emerging single-cell genomic technologies can serve as an engine for target identification and drug development. Amit and colleagues discuss where single-cell genomic technologies can be applied both in trial design and in the clinical trial stage to improve the development of immunotherapies.	[Yofe, Ido; Dahan, Rony; Amit, Ido] Weizmann Inst Sci, Dept Immunol, Rehovot, Israel	Weizmann Institute of Science	Amit, I (corresponding author), Weizmann Inst Sci, Dept Immunol, Rehovot, Israel.	ido.amit@weizmann.ac.il		Dahan, Rony/0000-0002-8420-7601	Cancer Research Institute; Chan Zuckerberg Initiative; HHMI International Scholar award; Merck KGaA, Darmstadt, Germany; European Research Council Consolidator Grant (ERC-COG) [724471-HemTree2.0]; Thompson Family Foundation; MRA Established Investigator Award [509044]; Eden and Steven Romick Professorial Chair and Eden and Steven Romick Post-Doctoral Fellowship Fund; Israel Science Foundation [703/15]; Ernest and Bonnie Beutler Research Program for Excellence in Genomic Medicine; Helen and Martin Kimmel award for innovative investigation; NeuroMac DFG/Transregional Collaborative Research Center Grant; International Progressive MS Alliance/NMSS [PA-1604-08459]; Adelis Foundation grant; Teva Pharmaceutical Industries research grant; Rising Tide Translation Cancer Research Fund; Melanoma Research Alliance (MRA) Young Investigator Award; Israel Cancer Research Fund (ICRF) Research Career Development Award; Israel Cancer Association Research Grant; Mizutani Foundation for Glycoscience; Emerson Collective Cancer Research Fund; Israel Science Foundation (ISF) Individual Research Grant; Moross Integrated Cancer Center, a Harry J. Lloyd Trust Career Development Award; Flight Attendant Medical Research Institute (FAMRI) Research Grants; Ira and Diana Riklis Fund for CAR-T Therapy; Enoch Foundation; Pearl Welinsky Merlo Foundation; Benoziyo Fund for the Advancement of Science; Gerty Schwarz Schaier	Cancer Research Institute; Chan Zuckerberg Initiative; HHMI International Scholar award(Howard Hughes Medical Institute); Merck KGaA, Darmstadt, Germany; European Research Council Consolidator Grant (ERC-COG); Thompson Family Foundation; MRA Established Investigator Award; Eden and Steven Romick Professorial Chair and Eden and Steven Romick Post-Doctoral Fellowship Fund; Israel Science Foundation(Israel Science Foundation); Ernest and Bonnie Beutler Research Program for Excellence in Genomic Medicine; Helen and Martin Kimmel award for innovative investigation; NeuroMac DFG/Transregional Collaborative Research Center Grant; International Progressive MS Alliance/NMSS; Adelis Foundation grant; Teva Pharmaceutical Industries research grant(Teva Pharmaceutical Industries); Rising Tide Translation Cancer Research Fund; Melanoma Research Alliance (MRA) Young Investigator Award; Israel Cancer Research Fund (ICRF) Research Career Development Award; Israel Cancer Association Research Grant; Mizutani Foundation for Glycoscience; Emerson Collective Cancer Research Fund; Israel Science Foundation (ISF) Individual Research Grant; Moross Integrated Cancer Center, a Harry J. Lloyd Trust Career Development Award; Flight Attendant Medical Research Institute (FAMRI) Research Grants; Ira and Diana Riklis Fund for CAR-T Therapy; Enoch Foundation; Pearl Welinsky Merlo Foundation; Benoziyo Fund for the Advancement of Science; Gerty Schwarz Schaier	We thank J.-P. Halle (Merck KGaA, Darmstadt) for critical discussions, input and feedback on this manuscript, and G. Brodsky from the Scientific Illustration unit of the Weizmann Institute for artwork. I.Y. is a Cancer Research Institute Irvington Fellow supported by the Cancer Research Institute. I.A. is supported by the Chan Zuckerberg Initiative; an HHMI International Scholar award; a Merck KGaA, Darmstadt, Germany, research grant; European Research Council Consolidator Grant (ERC-COG) 724471-HemTree2.0; the Thompson Family Foundation; an MRA Established Investigator Award (509044); an Eden and Steven Romick Professorial Chair and Eden and Steven Romick Post-Doctoral Fellowship Fund; the Israel Science Foundation (703/15); the Ernest and Bonnie Beutler Research Program for Excellence in Genomic Medicine; the Helen and Martin Kimmel award for innovative investigation; the NeuroMac DFG/Transregional Collaborative Research Center Grant; an International Progressive MS Alliance/NMSS PA-1604-08459; and an Adelis Foundation grant. I.A. is the incumbent of the Alan and Laraine Fischer Career Development Chair. R.D. is supported by a Teva Pharmaceutical Industries research grant, the Rising Tide Translation Cancer Research Fund, a Melanoma Research Alliance (MRA) Young Investigator Award, an Israel Cancer Research Fund (ICRF) Research Career Development Award, an Israel Cancer Association Research Grant, the Mizutani Foundation for Glycoscience, the Emerson Collective Cancer Research Fund, an Israel Science Foundation (ISF) Individual Research Grant, the Moross Integrated Cancer Center, a Harry J. Lloyd Trust Career Development Award, Flight Attendant Medical Research Institute (FAMRI) Research Grants, the Ira and Diana Riklis Fund for CAR-T Therapy, the Enoch Foundation, the Pearl Welinsky Merlo Foundation and the Benoziyo Fund for the Advancement of Science, and by a grant from Gerty Schwarz Schaier. R. D. is the incumbent of the Rina Gudinski Career Development Chair.	Azizi E, 2018, CELL, V174, P1293, DOI 10.1016/j.cell.2018.05.060; Bibeau F, 2009, J CLIN ONCOL, V27, P1122, DOI 10.1200/JCO.2008.18.0463; Christmas BJ, 2018, CANCER IMMUNOL RES, V6, P1561, DOI 10.1158/2326-6066.CIR-18-0070; Dahan R, 2015, CANCER CELL, V28, P285, DOI 10.1016/j.ccell.2015.08.004; Giladi A, 2018, CELL, V172, P14, DOI 10.1016/j.cell.2017.11.011; Gubin MM, 2018, CELL, V175, P1014, DOI 10.1016/j.cell.2018.09.030; Keener AB, 2019, NAT MED, V25, P1322, DOI 10.1038/d41591-019-00017-6; Keren L, 2018, CELL, V174, P1373, DOI 10.1016/j.cell.2018.08.039; Lareau CA, 2019, NAT BIOTECHNOL, V37, P916, DOI 10.1038/s41587-019-0147-6; Lavin Y, 2017, CELL, V169, P750, DOI 10.1016/j.cell.2017.04.014; Li HJ, 2019, CELL, V176, P775, DOI 10.1016/j.cell.2018.11.043; Lux A, 2013, J CLIN IMMUNOL, V33, pS4, DOI 10.1007/s10875-012-9782-0; Mariathasan S, 2018, NATURE, V554, P544, DOI 10.1038/nature25501; Pauken KE, 2016, SCIENCE, V354, P1160, DOI 10.1126/science.aaf2807; Peterson VM, 2017, NAT BIOTECHNOL, V35, P936, DOI 10.1038/nbt.3973; Pincetic A, 2014, NAT IMMUNOL, V15, P707, DOI 10.1038/ni.2939; Regev A, 2017, ELIFE, V6, DOI 10.7554/eLife.27041; Satpathy AT, 2019, NAT BIOTECHNOL, V37, P925, DOI 10.1038/s41587-019-0206-z; Savage P, 2017, CELL REP, V21, P1140, DOI 10.1016/j.celrep.2017.10.015; Scott AC, 2019, NATURE, V571, P270, DOI 10.1038/s41586-019-1324-y; Selby MJ, 2013, CANCER IMMUNOL RES, V1, P32, DOI 10.1158/2326-6066.CIR-13-0013; Sharma A, 2019, CLIN CANCER RES, V25, P1233, DOI 10.1158/1078-0432.CCR-18-0762; Siddiqui I, 2019, IMMUNITY, V50, P195, DOI 10.1016/j.immuni.2018.12.021; Simpson TR, 2013, J EXP MED, V210, P1695, DOI 10.1084/jem.20130579; Smith P, 2012, P NATL ACAD SCI USA, V109, P6181, DOI 10.1073/pnas.1203954109; Soerensen MM, 2018, J CLIN ONCOL, V36, DOI 10.1200/JCO.2018.36.15_suppl.e15155; Stahl PL, 2016, SCIENCE, V353, P78, DOI 10.1126/science.aaf2403; Stoeckius M, 2017, NAT METHODS, V14, P865, DOI [10.1038/nmeth.4380, 10.1038/NMETH.4380]; Vargas FA, 2018, CANCER CELL, V33, P649, DOI 10.1016/j.ccell.2018.02.010; Wolchok JD, 2017, NEW ENGL J MED, V377, P1345, DOI 10.1056/NEJMoa1709684; Yost KE, 2019, NAT MED, V25, P1251, DOI 10.1038/s41591-019-0522-3; Zheng CH, 2017, CELL, V169, P1342, DOI 10.1016/j.cell.2017.05.035; Ziegenhain C, 2017, MOL CELL, V65, P631, DOI 10.1016/j.molcel.2017.01.023; Zilionis R, 2019, IMMUNITY, V50, P1317, DOI 10.1016/j.immuni.2019.03.009; Zitvogel L, 2016, NAT REV CANCER, V16, P759, DOI 10.1038/nrc.2016.91	35	42	43	3	22	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	FEB	2020	26	2					171	177		10.1038/s41591-019-0736-4	http://dx.doi.org/10.1038/s41591-019-0736-4		FEB 2020	7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	KK7DU	32015555				2022-12-27	WOS:000510822600003
J	Stower, H				Stower, Hannah			A successful phase 3 trial for lupus	NATURE MEDICINE			English	Editorial Material																			0	0	0	0	0	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	FEB	2020	26	2					163	163		10.1038/s41591-020-0777-8	http://dx.doi.org/10.1038/s41591-020-0777-8			1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	KK7DU	32047320	Bronze			2022-12-27	WOS:000512899200034
J	Stower, H				Stower, Hannah			NEUROSCIENCE Single-cell insights into neurology	NATURE MEDICINE			English	Editorial Material																			0	0	0	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	2019	25	12					1799	1799		10.1038/s41591-019-0686-x	http://dx.doi.org/10.1038/s41591-019-0686-x			1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	JT2KO	31806900	Bronze			2022-12-27	WOS:000500824900010
J	Biswas, D; Birkbak, NJ; Rosenthal, R; Hiley, CT; Lim, EL; Papp, K; Boeing, S; Krzystanek, M; Djureinovic, D; La Fleur, L; Greco, M; Dome, B; Fillinger, J; Brunnstrom, H; Wu, Y; Moore, DA; Skrzypski, M; Abbosh, C; Litchfield, K; Al Bakir, M; Watkins, TBK; Veeriah, S; Wilson, GA; Jamal-Hanjani, M; Moldvay, J; Botling, J; Chinnaiyan, AM; Micke, P; Hackshaw, A; Bartek, J; Csabai, I; Szallasi, Z; Herrero, J; McGranahan, N; Swanton, C				Biswas, Dhruva; Birkbak, Nicolai J.; Rosenthal, Rachel; Hiley, Crispin T.; Lim, Emilia L.; Papp, Krisztian; Boeing, Stefan; Krzystanek, Marcin; Djureinovic, Dijana; La Fleur, Linnea; Greco, Maria; Doeme, Balazs; Fillinger, Janos; Brunnstrom, Hans; Wu, Yin; Moore, David A.; Skrzypski, Marcin; Abbosh, Christopher; Litchfield, Kevin; Al Bakir, Maise; Watkins, Thomas B. K.; Veeriah, Selvaraju; Wilson, Gareth A.; Jamal-Hanjani, Mariam; Moldvay, Judit; Botling, Johan; Chinnaiyan, Arul M.; Micke, Patrick; Hackshaw, Allan; Bartek, Jiri; Csabai, Istvan; Szallasi, Zoltan; Herrero, Javier; McGranahan, Nicholas; Swanton, Charles		TRACERx Consortium	A clonal expression biomarker associates with lung cancer mortality	NATURE MEDICINE			English	Article							GENE-EXPRESSION; EARLY-STAGE; INTRATUMOR HETEROGENEITY; R/BIOCONDUCTOR PACKAGE; PROGNOSTIC SIGNATURES; SURVIVAL PREDICTION; VALIDATION; EVOLUTION; PROFILES; ADENOCARCINOMAS	An aim of molecular biomarkers is to stratify patients with cancer into disease subtypes predictive of outcome, improving diagnostic precision beyond clinical descriptors such as tumor stage(1). Transcriptomic intratumor heterogeneity (RNA-ITH) has been shown to confound existing expression-based biomarkers across multiple cancer types(2-6). Here, we analyze multi-region whole-exome and RNA sequencing data for 156 tumor regions from 48 patients enrolled in the TRACERx study to explore and control for RNA-ITH in non-small cell lung cancer. We find that chromosomal instability is a major driver of RNA-ITH, and existing prognostic gene expression signatures are vulnerable to tumor sampling bias. To address this, we identify genes expressed homogeneously within individual tumors that encode expression modules of cancer cell proliferation and are often driven by DNA copy-number gains selected early in tumor evolution. Clonal transcriptomic biomarkers overcome tumor sampling bias, associate with survival independent of clinicopathological risk factors, and may provide a general strategy to refine biomarker design across cancer types.	[Biswas, Dhruva; Birkbak, Nicolai J.; Rosenthal, Rachel; Hiley, Crispin T.; Lim, Emilia L.; Wu, Yin; Skrzypski, Marcin; Abbosh, Christopher; Veeriah, Selvaraju; Wilson, Gareth A.; Jamal-Hanjani, Mariam; McGranahan, Nicholas; Swanton, Charles] UCL, Inst Canc, Canc Res UK Lung Canc Ctr Excellence, Paul OGorman Bldg, London, England; [Biswas, Dhruva; Rosenthal, Rachel; Herrero, Javier] UCL, Inst Canc, Bill Lyons Informat Ctr, Paul OGorman Bldg, London, England; [Biswas, Dhruva; Birkbak, Nicolai J.; Rosenthal, Rachel; Hiley, Crispin T.; Lim, Emilia L.; Litchfield, Kevin; Al Bakir, Maise; Watkins, Thomas B. K.; Wilson, Gareth A.; Swanton, Charles] Francis Crick Inst, Canc Evolut & Genome Instabil Lab, London, England; [Birkbak, Nicolai J.] Aarhus Univ, Dept Mol Med, Aarhus, Denmark; [Birkbak, Nicolai J.] Aarhus Univ, Bioinformat Res Ctr, Aarhus, Denmark; [Papp, Krisztian; Csabai, Istvan] Eotvos Lorand Univ, Dept Phys Complex Syst, Budapest, Hungary; [Boeing, Stefan] Francis Crick Inst, Bioinformat & Biostat, London, England; [Krzystanek, Marcin; Bartek, Jiri; Szallasi, Zoltan] Danish Canc Soc, Res Ctr, Copenhagen, Denmark; [Djureinovic, Dijana; La Fleur, Linnea; Botling, Johan; Micke, Patrick] Uppsala Univ, Dept Immunol Genet & Pathol, Uppsala, Sweden; [Greco, Maria] Francis Crick Inst, Genom Equipment Pk, London, England; [Doeme, Balazs; Moldvay, Judit] Semmelweis Univ, Natl Koranyi Inst Pulmonol, Dept Tumor Biol, Budapest, Hungary; [Doeme, Balazs] Med Univ Vienna, Ctr Comprehens Canc, Div Thorac Surg, Vienna, Austria; [Doeme, Balazs] Semmelweis Univ, Natl Inst Oncol, Dept Thorac Surg, Budapest, Hungary; [Fillinger, Janos] Semmelweis Univ, Natl Koranyi Inst Pulmonol, Dept Pathol, Budapest, Hungary; [Fillinger, Janos] Natl Inst Oncol, Dept Pathol, Budapest, Hungary; [Brunnstrom, Hans] Lund Univ, Lab Med Reg Skane, Dept Clin Sci Lund, Pathol, Lund, Sweden; [Moore, David A.] UCL Canc Inst, Dept Pathol, London, England; [Skrzypski, Marcin] Med Univ Gdansk, Dept Oncol & Radiotherapy, Gdansk, Poland; [Moldvay, Judit; Szallasi, Zoltan] Semmelweis Univ, Dept Pathol 2, SE NAP Brain Metastasis Res Grp, Budapest, Hungary; [Chinnaiyan, Arul M.] Univ Michigan, Michigan Ctr Translat Pathol, Ann Arbor, MI 48109 USA; [Chinnaiyan, Arul M.] Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA; [Chinnaiyan, Arul M.] Univ Michigan, Rogel Canc Ctr, Ann Arbor, MI 48109 USA; [Chinnaiyan, Arul M.] Univ Michigan, Dept Urol, Ann Arbor, MI 48109 USA; [Chinnaiyan, Arul M.] Univ Michigan, Howard Hughes Med Inst, Ann Arbor, MI 48109 USA; [Hackshaw, Allan] UCL, Canc Res UK, London, England; [Hackshaw, Allan] UCL, Univ Coll London Canc Trials Ctr, London, England; [Bartek, Jiri] Karolinska Inst, Dept Med Biochem & Biophys, Stockholm, Sweden; [Szallasi, Zoltan] Harvard Med Sch, Boston Childrens Hosp, Computat Hlth Informat Program, Boston, MA 02115 USA; [McGranahan, Nicholas] UCL, Univ Coll London Canc Inst, Canc Genome Evolut Res Grp, London, England	Cancer Research UK; University of London; University College London; University of London; University College London; Francis Crick Institute; Aarhus University; Aarhus University; Eotvos Lorand University; Francis Crick Institute; Danish Cancer Society; Uppsala University; Francis Crick Institute; Semmelweis University; Medical University of Vienna; National Institute of Oncology Hungary; Semmelweis University; Semmelweis University; National Institute of Oncology Hungary; Lund University; University of London; University College London; Fahrenheit Universities; Medical University Gdansk; Semmelweis University; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Howard Hughes Medical Institute; University of Michigan System; University of Michigan; Cancer Research UK; University of London; University College London; University of London; University College London; Karolinska Institutet; Harvard University; Boston Children's Hospital; Harvard Medical School; University of London; University College London	Birkbak, NJ; McGranahan, N; Swanton, C (corresponding author), UCL, Inst Canc, Canc Res UK Lung Canc Ctr Excellence, Paul OGorman Bldg, London, England.; Birkbak, NJ; Swanton, C (corresponding author), Francis Crick Inst, Canc Evolut & Genome Instabil Lab, London, England.; Birkbak, NJ (corresponding author), Aarhus Univ, Dept Mol Med, Aarhus, Denmark.; Birkbak, NJ (corresponding author), Aarhus Univ, Bioinformat Res Ctr, Aarhus, Denmark.; McGranahan, N (corresponding author), UCL, Univ Coll London Canc Inst, Canc Genome Evolut Res Grp, London, England.	nbirkbak@clin.au.dk; nicholas.mcgranahan.10@ucl.ac.uk; charles.swanton@crick.ac.uk	Brunnström, Hans/AAZ-6803-2020; McGranahan, Nicholas/ABD-6561-2021; Csabai, Istvan/F-6045-2011; Aerts, Hugo/ABF-2821-2020; Botling, Johan/ABA-2586-2020; Herrero, Javier/H-6971-2019; Ottensmeier, Christian/E-8131-2012	Brunnström, Hans/0000-0001-7402-138X; McGranahan, Nicholas/0000-0001-9537-4045; Csabai, Istvan/0000-0001-9232-9898; Aerts, Hugo/0000-0002-2122-2003; Botling, Johan/0000-0003-2226-3517; Herrero, Javier/0000-0001-7313-717X; Escudero, Mickael/0000-0002-1336-815X; Ottensmeier, Christian/0000-0003-3619-1657; Litchfield, Kevin/0000-0002-3725-0914; Skrzypski, Marcin/0000-0002-4391-4318; Navani, Neal/0000-0002-6412-7516; Dome, Balazs/0000-0001-8799-8624; De Sousa, Paulo/0000-0003-3011-4116; Rathinam, Sridhar/0000-0002-1065-0045; Le Quesne, John/0000-0003-3552-7446; Priest, Lynsey/0000-0003-3780-8508; Birkbak, Nicolai/0000-0003-1613-9587; Johnson, Diana/0000-0003-0479-1228; Quezada, Sergio/0000-0002-9763-1700; Szallasi, Zoltan/0000-0001-5395-7509; Swanton, Charles/0000-0002-4299-3018; Crosbie, Phil/0000-0001-8941-4813; Papp, Krisztian/0000-0003-0619-8233; Shackcloth, Michael/0000-0002-6494-9907; Wu, Yin/0000-0003-4080-3935	MBPhD program at University College London; NIHR BRC at University College London Hospitals; Aarhus University Research Foundation; Danish Cancer Society; Hungarian Science Foundation [OTKA-K129065]; Breast Cancer Research Foundation [BCRF-18-159]; Wellcome Trust [FC001169]; Royal Society [211179/Z/18/Z]; Cancer Research UK (CRUK); Rosetrees; Royal Society Napier Research Professor; Francis Crick Institute; Cancer Research UK; UK Medical Research Council [FC001169, MR/P014712/1]; CRUK Cancer Immunotherapy Catalyst Network; CRUK Lung Cancer Centre of Excellence, Stand Up 2 Cancer (SU2C); Rosetrees Trust; Stoneygate Trusts; NovoNordisk Foundation [ID16584]; Prostate Cancer Foundation; Breast Cancer Research Foundation (BCRF); European Research Council (ERC) [FP7-THESEUS-617844]; European Commission ITN [607722]; ERC Advanced Grant (PROTEUS) from the European Research Council under the European Union [835297]; National Institute for Health Research; University College London Hospitals Biomedical Research Centre; Cancer Research UK University College London Experimental Cancer Medicine Centre;  [NVKP_16-1-2016-0004];  [NAP2-2017-1.2.1-NKP-0002]; MRC [MR/M009033/1, MR/P014712/1] Funding Source: UKRI; The Francis Crick Institute [10233] Funding Source: researchfish	MBPhD program at University College London; NIHR BRC at University College London Hospitals; Aarhus University Research Foundation; Danish Cancer Society(Danish Cancer Society); Hungarian Science Foundation(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Breast Cancer Research Foundation; Wellcome Trust(Wellcome Trust); Royal Society(Royal Society of London); Cancer Research UK (CRUK)(Cancer Research UK); Rosetrees(Rosetrees Trust); Royal Society Napier Research Professor; Francis Crick Institute; Cancer Research UK(Cancer Research UK); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); CRUK Cancer Immunotherapy Catalyst Network; CRUK Lung Cancer Centre of Excellence, Stand Up 2 Cancer (SU2C); Rosetrees Trust(Rosetrees Trust); Stoneygate Trusts; NovoNordisk Foundation(Novo Nordisk FoundationNovocure Limited); Prostate Cancer Foundation; Breast Cancer Research Foundation (BCRF); European Research Council (ERC)(European Research Council (ERC)European Commission); European Commission ITN; ERC Advanced Grant (PROTEUS) from the European Research Council under the European Union; National Institute for Health Research(National Institute for Health Research (NIHR)); University College London Hospitals Biomedical Research Centre(General Electric); Cancer Research UK University College London Experimental Cancer Medicine Centre; ; ; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); The Francis Crick Institute	D.B. was the recipient of a Jean Shanks Foundation MBPhD studentship and also receives funding from the MBPhD program at University College London, as well as the NIHR BRC at University College London Hospitals. N.J.B. is a fellow of the Lundbeck Foundation and acknowledges funding from the Aarhus University Research Foundation and the Danish Cancer Society. K.L. is funded by the UK Medical Research Council (MR/P014712/1). J.M., B.D. and J.F. are supported by the Hungarian Science Foundation (OTKA-K129065). I.C. is supported by NVKP_16-1-2016-0004. Z.S. is supported by NAP2-2017-1.2.1-NKP-0002 and the Breast Cancer Research Foundation (BCRF-18-159). N.M. is a Sir Henry Dale Fellow, jointly funded by the Wellcome Trust and the Royal Society (grant number 211179/Z/18/Z), and also receives funding from Cancer Research UK (CRUK), Rosetrees and the NIHR BRC at University College London Hospitals. C.S. is Royal Society Napier Research Professor. This work was supported by the Francis Crick Institute, which receives its core funding from Cancer Research UK (FC001169, FC001202), the UK Medical Research Council (FC001169, FC001202) and the Wellcome Trust (FC001169, FC001202). C. S. is funded by Cancer Research UK (TRACERx and CRUK Cancer Immunotherapy Catalyst Network), the CRUK Lung Cancer Centre of Excellence, Stand Up 2 Cancer (SU2C), the Rosetrees Trust, the Butterfield and Stoneygate Trusts, NovoNordisk Foundation (ID16584), the Prostate Cancer Foundation and the Breast Cancer Research Foundation (BCRF). The research leading to these results has received funding from the European Research Council (ERC) under the European Union's Seventh Framework Programme (FP7/2007-2013) Consolidator Grant (FP7-THESEUS-617844), European Commission ITN (FP7-PloidyNet 607722), an ERC Advanced Grant (PROTEUS) from the European Research Council under the European Union's Horizon 2020 research and innovation programme (grant agreement 835297). Support was also provided to C.S. by the National Institute for Health Research, the University College London Hospitals Biomedical Research Centre and the Cancer Research UK University College London Experimental Cancer Medicine Centre.	Bachtiary B, 2006, CLIN CANCER RES, V12, P5632, DOI 10.1158/1078-0432.CCR-06-0357; BARRANCO SC, 1994, CANCER RES, V54, P5351; Beer DG, 2002, NAT MED, V8, P816, DOI 10.1038/nm733; Bianchi F, 2007, J CLIN INVEST, V117, P3436, DOI 10.1172/JCI32007; Blackhall FH, 2004, NEOPLASIA, V6, P761, DOI 10.1593/neo.04301; Boutros PC, 2015, GENOME RES, V25, P1508, DOI 10.1101/gr.191114.115; Burrell RA, 2013, NATURE, V501, P338, DOI 10.1038/nature12625; Campbell JD, 2016, NAT GENET, V48, P607, DOI 10.1038/ng.3564; Chen HY, 2007, NEW ENGL J MED, V356, P11, DOI 10.1056/NEJMoa060096; Chen JJW, 2001, CANCER RES, V61, P5223; Cleary B, 2017, CELL, V171, P1424, DOI 10.1016/j.cell.2017.10.023; Collisson EA, 2014, NATURE, V511, P543, DOI 10.1038/nature13385; Danaher P, 2017, J IMMUNOTHER CANCER, V5, DOI 10.1186/s40425-017-0215-8; Der SD, 2014, J THORAC ONCOL, V9, P59, DOI 10.1097/JTO.0000000000000042; Djureinovic D, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.86837; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Durinck S, 2009, NAT PROTOC, V4, P1184, DOI 10.1038/nprot.2009.97; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; Garber ME, 2001, P NATL ACAD SCI USA, V98, P13784, DOI 10.1073/pnas.241500798; Gentles AJ, 2015, NAT MED, V21, P938, DOI 10.1038/nm.3909; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Goldstraw P, 2007, J THORAC ONCOL, V2, P706, DOI 10.1097/JTO.0b013e31812f3c1a; Goldstraw P, 2016, J THORAC ONCOL, V11, P39, DOI 10.1016/j.jtho.2015.09.009; Gulati S, 2015, LANCET ONCOL, V16, pE376, DOI 10.1016/S1470-2045(15)00090-X; Gulati S, 2014, EUR UROL, V66, P936, DOI 10.1016/j.eururo.2014.06.053; Gyanchandani R, 2016, CLIN CANCER RES, V22, P5362, DOI 10.1158/1078-0432.CCR-15-2889; Hammerman PS, 2012, NATURE, V489, P519, DOI 10.1038/nature11404; Hugo W, 2016, CELL, V165, P35, DOI 10.1016/j.cell.2016.02.065; Ishwaran H, 2008, ANN APPL STAT, V2, P841, DOI 10.1214/08-AOAS169; Jamal-Hanjani M, 2017, NEW ENGL J MED, V376, P2109, DOI 10.1056/NEJMoa1616288; Jiang P, 2018, NAT MED, V24, P1550, DOI 10.1038/s41591-018-0136-1; Kim TM, 2015, CLIN CANCER RES, V21, P4461, DOI 10.1158/1078-0432.CCR-14-2413; Kratz JR, 2012, LANCET, V379, P823, DOI 10.1016/S0140-6736(11)61941-7; Krzystanek M, 2016, BIOMARK RES, V4, DOI 10.1186/s40364-016-0058-3; Lambrechts D, 2018, NAT MED, V24, P1277, DOI 10.1038/s41591-018-0096-5; Lee WC, 2018, MODERN PATHOL, V31, P947, DOI 10.1038/s41379-018-0029-3; Li BL, 2017, JAMA ONCOL, V3, P1529, DOI 10.1001/jamaoncol.2017.1609; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li QY, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-474; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Mlecnik B, 2018, JNCI-J NATL CANCER I, V110, DOI 10.1093/jnci/djx123; Okayama H, 2012, CANCER RES, V72, P100, DOI 10.1158/0008-5472.CAN-11-1403; Pignon JP, 2008, J CLIN ONCOL, V26, P3552, DOI 10.1200/JCO.2007.13.9030; Raz DJ, 2008, CLIN CANCER RES, V14, P5565, DOI 10.1158/1078-0432.CCR-08-0544; Reka AK, 2014, CARCINOGENESIS, V35, P1292, DOI 10.1093/carcin/bgu041; Robinson DR, 2017, NATURE, V548, P297, DOI 10.1038/nature23306; Rosenthal R, 2019, NATURE, V567, P479, DOI 10.1038/s41586-019-1032-7; Rousseaux S, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005723; Shedden K, 2008, NAT MED, V14, P822, DOI 10.1038/nm.1790; Shukla S, 2017, JNCI-J NATL CANCER I, V109, DOI 10.1093/jnci/djw200; Strauss GM, 2008, J CLIN ONCOL, V26, P5043, DOI 10.1200/JCO.2008.16.4855; Subramanian J, 2010, JNCI-J NATL CANCER I, V102, P464, DOI 10.1093/jnci/djq025; Svensson V, 2018, NAT METHODS, V15, P343, DOI 10.1038/nmeth.4636; Tang H, 2017, ANN ONCOL, V28, P733, DOI 10.1093/annonc/mdw683; Tang H, 2013, CLIN CANCER RES, V19, P1577, DOI 10.1158/1078-0432.CCR-12-2321; Uhlen M, 2017, SCIENCE, V357, P660, DOI 10.1126/science.aan2507; Van Loo P, 2010, P NATL ACAD SCI USA, V107, P16910, DOI 10.1073/pnas.1009843107; Vargas AJ, 2016, NAT REV CANCER, V16, P525, DOI 10.1038/nrc.2016.56; Venet D, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002240; Wan YW, 2016, BIOINFORMATICS, V32, P952, DOI 10.1093/bioinformatics/btv677; Wistuba II, 2013, CLIN CANCER RES, V19, P6261, DOI 10.1158/1078-0432.CCR-13-0596; Yachida S, 2010, NATURE, V467, P1114, DOI 10.1038/nature09515; Yates LR, 2015, NAT MED, V21, P751, DOI 10.1038/nm.3886; Yu GC, 2016, MOL BIOSYST, V12, P477, DOI 10.1039/c5mb00663e	64	45	45	1	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	OCT	2019	25	10					1540	+		10.1038/s41591-019-0595-z	http://dx.doi.org/10.1038/s41591-019-0595-z			23	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	JC3GJ	31591602	Green Accepted, Green Submitted			2022-12-27	WOS:000489166700023
J	Ehrhardt, SA; Zehner, M; Krahling, V; Cohen-Dvashi, H; Kreer, C; Elad, N; Gruell, H; Ercanoglu, MS; Schommers, P; Gieselmann, L; Eggeling, R; Dahlke, C; Wolf, T; Pfeifer, N; Addo, MM; Diskin, R; Becker, S; Klein, F				Ehrhardt, Stefanie A.; Zehner, Matthias; Kraehling, Verena; Cohen-Dvashi, Hadas; Kreer, Christoph; Elad, Nadav; Gruell, Henning; Ercanoglu, Meryem S.; Schommers, Philipp; Gieselmann, Lutz; Eggeling, Ralf; Dahlke, Christine; Wolf, Timo; Pfeifer, Nico; Addo, Marylyn M.; Diskin, Ron; Becker, Stephan; Klein, Florian			Polyclonal and convergent antibody response to Ebola virus vaccine rVSV-ZEBOV	NATURE MEDICINE			English	Article							HUMAN MONOCLONAL-ANTIBODIES; NEUTRALIZING ANTIBODIES; MEDIATED PROTECTION; GLYCOPROTEIN; INFECTION; COCKTAIL; FEATURES; DISEASE; SYSTEM; TRIAL	Recombinant vesicular stomatitis virus-Zaire Ebola virus (rVSV-ZEBOV) is the most advanced Ebola virus vaccine candidate and is currently being used to combat the outbreak of Ebola virus disease (EVD) in the Democratic Republic of the Congo (DRC). Here we examine the humoral immune response in a subset of human volunteers enrolled in a phase 1 rVSV-ZEBOV vaccination trial by performing comprehensive single B cell and electron microscopy structure analyses. Four studied vaccinees show polyclonal, yet reproducible and convergent B cell responses with shared sequence characteristics. EBOV-targeting antibodies cross-react with other Ebolavirus species, and detailed epitope mapping revealed overlapping target epitopes with antibodies isolated from EVD survivors. Moreover, in all vaccinees, we detected highly potent EBOV-neutralizing antibodies with activities comparable or superior to the monoclonal antibodies currently used in clinical trials. These include antibodies combining the IGHV3-15/IGLV1-40 immunoglobulin gene segments that were identified in all investigated individuals. Our findings will help to evaluate and direct current and future vaccination strategies and offer opportunities for novel EVD therapies.	[Ehrhardt, Stefanie A.; Zehner, Matthias; Kreer, Christoph; Gruell, Henning; Ercanoglu, Meryem S.; Schommers, Philipp; Gieselmann, Lutz; Klein, Florian] Univ Cologne, Inst Virol, Fac Med, Expt Immunol Lab, Cologne, Germany; [Ehrhardt, Stefanie A.; Zehner, Matthias; Kreer, Christoph; Gruell, Henning; Ercanoglu, Meryem S.; Schommers, Philipp; Gieselmann, Lutz; Klein, Florian] Univ Hosp Cologne, Cologne, Germany; [Kraehling, Verena; Becker, Stephan] Philipps Univ Marburg, Inst Virol, Fac Med, Marburg, Germany; [Kraehling, Verena; Becker, Stephan] German Ctr Infect Res, Partner Site Giessen Marburg Langen, Marburg, Germany; [Cohen-Dvashi, Hadas; Diskin, Ron] Weizmann Inst Sci, Dept Biol Struct, Rehovot, Israel; [Elad, Nadav] Weizmann Inst Sci, Dept Chem Res Support, Rehovot, Israel; [Gruell, Henning; Schommers, Philipp; Klein, Florian] German Ctr Infect Res, Partner Site Bonn Cologne, Cologne, Germany; [Schommers, Philipp] Univ Cologne, Fac Med, Dept Internal Med 1, Cologne, Germany; [Eggeling, Ralf; Pfeifer, Nico] Univ Tubingen, Dept Comp Sci, Methods Med Informat, Tubingen, Germany; [Dahlke, Christine; Addo, Marylyn M.] Univ Med Ctr Hamburg Eppendorf, Div Infect Dis, Dept Med 1, Hamburg, Germany; [Dahlke, Christine; Addo, Marylyn M.] Bernhard Nocht Inst Trop Med, Dept Clin Immunol Infect Dis, Hamburg, Germany; [Dahlke, Christine; Addo, Marylyn M.] German Ctr Infect Res, Partner Site Hamburg Lubeck Borstel Riems, Hamburg, Germany; [Wolf, Timo] Univ Hosp Frankfurt, Dept Infect Dis, Frankfurt, Germany; [Pfeifer, Nico] Univ Tubingen, Fac Med, Tubingen, Germany; [Pfeifer, Nico] German Ctr Infect Res, Partner Site Tubingen, Tubingen, Germany; [Klein, Florian] Univ Hosp Cologne, CMMC, Cologne, Germany; [Klein, Florian] Univ Cologne, Cologne, Germany	University of Cologne; University of Cologne; Philipps University Marburg; German Center for Infection Research; Weizmann Institute of Science; Weizmann Institute of Science; German Center for Infection Research; University of Cologne; University of Cologne; Eberhard Karls University of Tubingen; University of Hamburg; University Medical Center Hamburg-Eppendorf; Bernhard Nocht Institut fur Tropenmedizin; German Center for Infection Research; Goethe University Frankfurt; Goethe University Frankfurt Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; German Center for Infection Research; University of Cologne; University of Cologne	Klein, F (corresponding author), Univ Cologne, Inst Virol, Fac Med, Expt Immunol Lab, Cologne, Germany.; Klein, F (corresponding author), Univ Hosp Cologne, Cologne, Germany.; Klein, F (corresponding author), German Ctr Infect Res, Partner Site Bonn Cologne, Cologne, Germany.; Klein, F (corresponding author), Univ Hosp Cologne, CMMC, Cologne, Germany.; Klein, F (corresponding author), Univ Cologne, Cologne, Germany.	florian.klein@uk-koeln.de	Eggeling, Ralf/P-3403-2019; Schommers, Philipp/AAB-2978-2019; Zehner, Matthias/AAV-9709-2020; Pfeifer, Nico/G-1559-2016; Wolf, Timo/AAQ-3521-2021; Kreer, Christoph/ABG-7275-2021; Addo, Marylyn M./GNP-2548-2022	Eggeling, Ralf/0000-0002-3583-1029; Schommers, Philipp/0000-0003-3375-6800; Zehner, Matthias/0000-0001-5745-0836; Wolf, Timo/0000-0002-3819-9540; Kreer, Christoph/0000-0002-9140-9850; Addo, Marylyn/0000-0003-2836-9224; Pfeifer, Nico/0000-0002-4647-8566; Dahlke, Christine/0000-0002-2056-9195; Elad, Nadav/0000-0001-6222-2280; Grull, Henning/0000-0002-0725-7138	Irving and Cherna Moskowitz Center for Nano and Bio-Nano Imaging at the Weizmann Institute of Science [EBOV-GP/3T0331, EBOV-GP/4m0368, 6QD8]; Irving and Cherna Moskowitz Center; German Center for Infection Research (DZIF); German Research Foundation [CRC 1279, CRC 1310, KL2389/2-1]; European Research Council [ERC-StG639961]; DFG Cluster of Excellence 'Machine Learning-New Perspectives for Science' [EXC 2064/1, 390727645]	Irving and Cherna Moskowitz Center for Nano and Bio-Nano Imaging at the Weizmann Institute of Science; Irving and Cherna Moskowitz Center; German Center for Infection Research (DZIF); German Research Foundation(German Research Foundation (DFG)); European Research Council(European Research Council (ERC)European Commission); DFG Cluster of Excellence 'Machine Learning-New Perspectives for Science'	We thank all study participants who devoted time to our research. We thank all members of the Klein, Becker, Diskin and Pfeifer Laboratories for helpful discussion; D. Weiland and S. Borregaard for help with recruitment and study implementation; C. Scheid and U. Holtig for supervising leukapheresis procedures of enrolled study participants; H. Janicki, K. Jain and C. Ruping for help with sample processing, antibody cloning and antibody production; the Cologne Center for Genomics (CCG) for sequencing support; M. Carroll for providing sera of EVD survivors and S. Fehling and T. Strecker for analysis of the neutralizing activity of sera from EVD survivors. Diffraction experiments were performed at beamline ID23-2 at the European Synchrotron Radiation Facility (ESRF), Grenoble, France. We are grateful to S. Hutin at the ESRF for providing assistance in using beamline ID23-2. Electron microscopy studies were supported in part by the Irving and Cherna Moskowitz Center for Nano and Bio-Nano Imaging at the Weizmann Institute of Science. Coordinate files, structure factors and density maps of 3T0331Fab, EBOV-GP/3T0331 and EBOV-GP/4m0368 were deposited and are available at the Protein Data Bank under accession codes 6QCU, 6QD7 and 6QD8, respectively. This work was funded by grants from the German Center for Infection Research (DZIF, M.M.A., S.B. and F.K.), the German Research Foundation (CRC 1279, F.K.; CRC 1310, F.K.; Heisenberg-Program KL2389/2-1, F.K.), the European Research Council (ERC-StG639961, F.K.) and the DFG Cluster of Excellence 'Machine Learning-New Perspectives for Science' (EXC 2064/1, project no. 390727645, N.P.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Baize S, 1999, NAT MED, V5, P423, DOI 10.1038/7422; Bornholdt ZA, 2019, CELL HOST MICROBE, V25, P49, DOI 10.1016/j.chom.2018.12.005; Bornholdt ZA, 2016, SCIENCE, V351, P1078, DOI 10.1126/science.aad5788; Bramble MS, 2018, J INFECT DIS, V218, P1929, DOI 10.1093/infdis/jiy453; Cagigi A, 2018, J INFECT DIS, V218, pS537, DOI 10.1093/infdis/jiy450; Cagigi A, 2018, J INFECT DIS, V218, pS528, DOI 10.1093/infdis/jiy333; Caskey M, 2015, NATURE, V522, P487, DOI 10.1038/nature14411; Clarke DK, 2016, VACCINE, V34, P6597, DOI 10.1016/j.vaccine.2016.06.071; Cohen J, 2018, SCIENCE, V362, P1225, DOI 10.1126/science.362.6420.1225; Corti D, 2016, SCIENCE, V351, P1339, DOI 10.1126/science.aad5224; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Damon IK, 2018, NEW ENGL J MED, V379, P1981, DOI 10.1056/NEJMp1811751; Davey RT, 2018, J INFECT DIS, V218, pS690, DOI 10.1093/infdis/jiy334; Davey RT, 2016, NEW ENGL J MED, V375, P1448, DOI 10.1056/NEJMoa1604330; Davis CW, 2019, CELL, V177, P1566, DOI 10.1016/j.cell.2019.04.036; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Fields B. N., 2007, FIELDS VIROLOGY; Flyak AI, 2018, NAT MICROBIOL, V3, P670, DOI 10.1038/s41564-018-0157-z; Flyak AI, 2016, CELL, V164, P392, DOI 10.1016/j.cell.2015.12.022; Gaebler C, 2013, J IMMUNOL METHODS, V397, P47, DOI 10.1016/j.jim.2013.09.003; Gaudinski MR, 2019, LANCET, V393, P889, DOI 10.1016/S0140-6736(19)30036-4; Khurana S, 2016, NAT MED, V22, P1439, DOI 10.1038/nm.4201; Kieny MP, 2016, LANCET, V387, P1509, DOI [10.1016/S0140-6736(16)00686-3, 10.1016/S0140-6736(16)32621-6]; King LB, 2019, CURR OPIN VIROL, V34, P140, DOI 10.1016/j.coviro.2019.01.003; Klein F, 2012, NATURE, V492, P118, DOI 10.1038/nature11604; Kupferschmidt K., 2019, SCIENCE, DOI [10.1126/science.aaz1032, DOI 10.1126/SCIENCE.AAZ1032]; Ledgerwood JE, 2017, NEW ENGL J MED, V376, P928, DOI [10.1056/NEJMoa1410863, 10.1056/nejmoa1410863]; Lee JE, 2008, NATURE, V454, P177, DOI 10.1038/nature07082; Liu Q, 2017, SCI REP-UK, V7, DOI 10.1038/srep45552; Maruyama T, 1999, J VIROL, V73, P6024, DOI 10.1128/JVI.73.7.6024-6030.1999; Marzi A, 2015, SCIENCE, V348, P439, DOI 10.1126/science.aaa4919; Marzi A, 2013, P NATL ACAD SCI USA, V110, P1893, DOI 10.1073/pnas.1209591110; Maxmen A, 2018, NATURE, V564, P174, DOI 10.1038/d41586-018-07618-0; Maxmen A, 2018, NATURE, V561, P14, DOI 10.1038/d41586-018-06132-7; Mbala-Kingebeni P, 2019, CLIN INFECT DIS, V68, P330, DOI 10.1093/cid/ciy527; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Medaglini D, 2017, CURR OPIN VIROL, V23, P88, DOI 10.1016/j.coviro.2017.03.008; Misasi J, 2016, SCIENCE, V351, P1343, DOI 10.1126/science.aad6117; Mittler E, 2018, J INFECT DIS, V218, pS318, DOI 10.1093/infdis/jiy424; Murin CD, 2014, P NATL ACAD SCI USA, V111, P17182, DOI 10.1073/pnas.1414164111; Norn CH, 2017, PROTEINS, V85, P30, DOI 10.1002/prot.25185; Pallesen J, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.128, 10.1038/nmicrobiol.2016.128]; Pascal KE, 2018, J INFECT DIS, V218, pS612, DOI 10.1093/infdis/jiy285; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Punjani A, 2017, NAT METHODS, V14, P290, DOI [10.1038/nmeth.4169, 10.1038/NMETH.4169]; Qiu XG, 2014, NATURE, V514, P47, DOI 10.1038/nature13777; Qiu XG, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003876; Qiu XG, 2011, CLIN IMMUNOL, V141, P218, DOI 10.1016/j.clim.2011.08.008; Rijal P, 2019, CELL REP, V27, P172, DOI 10.1016/j.celrep.2019.03.020; Robbiani DF, 2017, CELL, V169, P597, DOI 10.1016/j.cell.2017.04.024; Rohou A, 2015, J STRUCT BIOL, V192, P216, DOI 10.1016/j.jsb.2015.08.008; Saphire EO, 2018, NAT IMMUNOL, V19, P1169, DOI 10.1038/s41590-018-0233-9; Saphire EO, 2018, CELL, V174, P938, DOI 10.1016/j.cell.2018.07.033; Setliff I, 2018, CELL HOST MICROBE, V23, P845, DOI 10.1016/j.chom.2018.05.001; Shears P, 2015, J HOSP INFECT, V90, P1, DOI 10.1016/j.jhin.2015.01.002; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Sivapalasingam S, 2018, LANCET INFECT DIS, V18, P884, DOI 10.1016/S1473-3099(18)30397-9; Suder E, 2018, HUM VACC IMMUNOTHER, V14, P2107, DOI 10.1080/21645515.2018.1473698; Throsby M, 2006, J VIROL, V80, P6982, DOI 10.1128/JVI.00551-06; Tiller T, 2008, J IMMUNOL METHODS, V329, P112, DOI 10.1016/j.jim.2007.09.017; Towner JS, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000212; Vander Heiden JA, 2014, BIOINFORMATICS, V30, P1930, DOI 10.1093/bioinformatics/btu138; von Boehmer L, 2016, NAT PROTOC, V11, P1908, DOI 10.1038/nprot.2016.102; Warfield KL, 2018, J INFECT DIS, V218, pS553, DOI 10.1093/infdis/jiy316; WHO, 2018, COMP US EB VACC CONT; WHO, 2018, EB VACC BACKGR PAP S; WHO, 2016, EB SIT REP 2016; WHO, 2019, WHO REAFF COMM DEM R; WHO, 2019, EB HAEM FEV; Winter G, 2010, J APPL CRYSTALLOGR, V43, P186, DOI 10.1107/S0021889809045701; Wong G, 2018, EXPERT OPIN BIOL TH, V18, P159, DOI 10.1080/14712598.2018.1404572; Wong G, 2014, VACCINE, V32, P5722, DOI 10.1016/j.vaccine.2014.08.028; World Health Organization, 2019, PREL RES EFF RVSV ZE; Ye J, 2013, NUCLEIC ACIDS RES, V41, pW34, DOI 10.1093/nar/gkt382; Zhao YG, 2016, NATURE, V535, P169, DOI 10.1038/nature18615	78	57	60	2	13	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	OCT	2019	25	10					1589	+		10.1038/s41591-019-0602-4	http://dx.doi.org/10.1038/s41591-019-0602-4			25	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	JC3GJ	31591605	Bronze			2022-12-27	WOS:000489166700028
J	Bejon, P				Bejon, Philip			Malaria parasites hide in plain sight in the dry season	NATURE MEDICINE			English	Editorial Material							PLASMODIUM-FALCIPARUM; PERSISTENCE	Plasmodium falciparum parasites survive the dry season by accepting increased clearance rates through the host spleen, which leads to a persistent lower-level infection.	[Bejon, Philip] KEMRI Wellcome Trust Res Programme, Kilifi, Kenya; [Bejon, Philip] Univ Oxford, Nuffield Dept Med, Oxford, England	University of Oxford	Bejon, P (corresponding author), KEMRI Wellcome Trust Res Programme, Kilifi, Kenya.; Bejon, P (corresponding author), Univ Oxford, Nuffield Dept Med, Oxford, England.	pbejon@kemri-wellcome.org			Wellcome Trust [203077] Funding Source: Medline	Wellcome Trust(Wellcome Trust)		Andrade CM, 2020, NAT MED, V26, DOI 10.1038/s41591-020-1084-0; Bediako Y, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0683-6; Huestis DL, 2014, INFECT GENET EVOL, V28, P648, DOI 10.1016/j.meegid.2014.05.027; Lee WC, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01444; Mackinnon MJ, 2004, PHILOS T R SOC B, V359, P965, DOI 10.1098/rstb.2003.1414; Molineaux L, 2020, GARKI PROJECT RES EP, V8; Rono MK, 2018, NAT ECOL EVOL, V2, P377, DOI 10.1038/s41559-017-0419-9; Nguyen TN, 2018, LANCET INFECT DIS, V18, P565, DOI 10.1016/S1473-3099(18)30046-X; White NJ, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-297	9	1	1	0	3	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	2020	26	12					1816	1818		10.1038/s41591-020-01171-y	http://dx.doi.org/10.1038/s41591-020-01171-y		NOV 2020	3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	PB8QO	33230342	Green Accepted			2022-12-27	WOS:000591980700003
J	Stower, H				Stower, Hannah			Targeting an epigenetic weakness	NATURE MEDICINE			English	Editorial Material																			0	0	0	0	0	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	OCT	2020	26	10					1512	1512		10.1038/s41591-020-1109-8	http://dx.doi.org/10.1038/s41591-020-1109-8			1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	QH1TN	33029024				2022-12-27	WOS:000618059800003
J	Ansumana, R; Sankoh, O; Zumla, A				Ansumana, Rashid; Sankoh, Osman; Zumla, Alimuddin			Effects of disruption from COVID-19 on antimalarial strategies	NATURE MEDICINE			English	Editorial Material							MALARIA	Modeling the impact of COVID-19-mitigation strategies on malarial case management and prevention by health services in sub-Saharan Africa predicts 81,000 additional deaths in Nigeria and 769,000 in sub-Saharan Africa in 2020.	[Ansumana, Rashid; Sankoh, Osman] Njala Univ, Sch Community Hlth Sci, Bo, Sierra Leone; [Sankoh, Osman] Stat Sierra Leone, Freetown, Sierra Leone; [Sankoh, Osman] Univ Witwatersrand, Fac Hlth Sci, Sch Publ Hlth, Johannesburg, South Africa; [Sankoh, Osman] Heidelberg Univ, Med Sch, Heidelberg Inst Global Hlth, Heidelberg, Germany; [Zumla, Alimuddin] UCL, Div Infect & Immun, Ctr Clin Microbiol, London, England; [Zumla, Alimuddin] UCL Hosp NIHR Biomed Res Ctr, London, England	Njala University; University of Witwatersrand; Ruprecht Karls University Heidelberg; University of London; University College London	Ansumana, R (corresponding author), Njala Univ, Sch Community Hlth Sci, Bo, Sierra Leone.	r.ansumana@njala.edu.sl	ZUMLA, Alimuddin/ABA-8208-2020; Ansumana, Rashid/AGQ-7401-2022; Sankoh, Osman/ABB-3755-2020	ZUMLA, Alimuddin/0000-0002-5111-5735; Sankoh, Osman/0000-0003-4405-9808; Ansumana, Rashid/0000-0002-1973-7200	European and Developing Countries Clinical Trials Partnership the EU Horizon 2020 Framework Programme for Research and Innovation	European and Developing Countries Clinical Trials Partnership the EU Horizon 2020 Framework Programme for Research and Innovation	R.A. and A.Z. are members of the Pan-African Network on Emerging and Re-emerging Infections (PANDORA-ID-NET) funded by the European and Developing Countries Clinical Trials Partnership the EU Horizon 2020 Framework Programme for Research and Innovation. A.Z. is a UK National Institute for Health Research senior investigator.	Dittrich S, 2020, LANCET GLOB HEALTH, V8, pE879, DOI 10.1016/S2214-109X(20)30210-2; Kapepula PM, 2020, AM J TROP MED HYG, V103, P960, DOI 10.4269/ajtmh.20-0820; Pallangyo E, 2020, MIDWIFERY, V89, DOI 10.1016/j.midw.2020.102775; Ranasinghe S, 2015, J ETHNOPHARMACOL, V166, P200, DOI 10.1016/j.jep.2015.03.028; Sherrard-Smith E, 2020, NAT MED, V26, DOI 10.1038/s41591-020-1025-y	5	9	9	0	0	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	SEP	2020	26	9					1334	1336		10.1038/s41591-020-1047-5	http://dx.doi.org/10.1038/s41591-020-1047-5		AUG 2020	3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	PF3EM	32807937	Bronze			2022-12-27	WOS:000560288000002
J	Avram, R; Olgin, JE; Kuhar, P; Hughes, JW; Marcus, GM; Pletcher, MJ; Aschbacher, K; Tison, GH				Avram, Robert; Olgin, Jeffrey E.; Kuhar, Peter; Hughes, J. Weston; Marcus, Gregory M.; Pletcher, Mark J.; Aschbacher, Kirstin; Tison, Geoffrey H.			A digital biomarker of diabetes from smartphone-based vascular signals	NATURE MEDICINE			English	Article							RESTING HEART-RATE; PERFORMANCE; RISK; A1C; PHOTOPLETHYSMOGRAM; ASSOCIATION	The global burden of diabetes is rapidly increasing, from 451 million people in 2019 to 693 million by 2045(1). The insidious onset of type 2 diabetes delays diagnosis and increases morbidity(2). Given the multifactorial vascular effects of diabetes, we hypothesized that smartphone-based photoplethysmography could provide a widely accessible digital biomarker for diabetes. Here we developed a deep neural network (DNN) to detect prevalent diabetes using smartphone-based photoplethysmography from an initial cohort of 53,870 individuals (the 'primary cohort'), which we then validated in a separate cohort of 7,806 individuals (the 'contemporary cohort') and a cohort of 181 prospectively enrolled individuals from three clinics (the 'clinic cohort'). The DNN achieved an area under the curve for prevalent diabetes of 0.766 in the primary cohort (95% confidence interval: 0.750-0.782; sensitivity 75%, specificity 65%) and 0.740 in the contemporary cohort (95% confidence interval: 0.723-0.758; sensitivity 81%, specificity 54%). When the output of the DNN, called the DNN score, was included in a regression analysis alongside age, gender, race/ethnicity and body mass index, the area under the curve was 0.830 and the DNN score remained independently predictive of diabetes. The performance of the DNN in the clinic cohort was similar to that in other validation datasets. There was a significant and positive association between the continuous DNN score and hemoglobin A1c (P <= 0.001) among those with hemoglobin A1c data. These findings demonstrate that smartphone-based photoplethysmography provides a readily attainable, non-invasive digital biomarker of prevalent diabetes. A deep neural network applied to smartphone-based vascular imaging can detect diabetes, opening new possibilities for non-invasive diagnosis.	[Avram, Robert; Olgin, Jeffrey E.; Marcus, Gregory M.; Aschbacher, Kirstin; Tison, Geoffrey H.] Univ Calif San Francisco, Dept Med, Div Cardiol, San Francisco, CA 94143 USA; [Avram, Robert; Olgin, Jeffrey E.; Marcus, Gregory M.; Aschbacher, Kirstin; Tison, Geoffrey H.] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94115 USA; [Kuhar, Peter] Azumio Inc, Redwood City, CA USA; [Hughes, J. Weston] Univ Calif Berkeley, Dept Comp Sci, Berkeley, CA 94720 USA; [Pletcher, Mark J.] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA USA; [Aschbacher, Kirstin; Tison, Geoffrey H.] Univ Calif San Francisco, Bakar Computat Hlth Sci Inst, San Francisco, CA 94143 USA; [Aschbacher, Kirstin] Univ Calif San Francisco, Dept Psychiat, Weill Inst Neurosci, San Francisco, CA USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California Berkeley; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Tison, GH (corresponding author), Univ Calif San Francisco, Dept Med, Div Cardiol, San Francisco, CA 94143 USA.; Tison, GH (corresponding author), Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94115 USA.; Tison, GH (corresponding author), Univ Calif San Francisco, Bakar Computat Hlth Sci Inst, San Francisco, CA 94143 USA.	geoff.tison@ucsf.edu	Avram, Robert/AAK-9539-2021; Marcus, Gregory/AAN-8584-2021	Avram, Robert/0000-0002-8490-0270; Marcus, Gregory/0000-0001-5197-7696; Tison, Geoffrey H/0000-0002-0310-3326; Aschbacher, Kirstin/0000-0001-6191-6432	CTSI grant [KL2 TR001870]; Fonds de la recherche en sante du Quebec [274831]; National Institutes of Health NHLBI [K23HL135274]; National Institutes of Health [U2CEB021881]; PCORI contract [PPRN-1306-04709]	CTSI grant; Fonds de la recherche en sante du Quebec(Fonds de la Recherche en Sante du Quebec); National Institutes of Health NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); PCORI contract(Patient-Centered Outcomes Research Institute - PCORI)	We acknowledge A. Markowitz for editorial support made possible by CTSI grant KL2 TR001870. R.A. received support from the "Fonds de la recherche en sante du Quebec" (grant 274831). G.H.T. received support from the National Institutes of Health NHLBI K23HL135274. J.E.O., M.J.P. and G.M.M. received support from the National Institutes of Health (U2CEB021881). M.J.P. is partially supported by a PCORI contract supporting the Health eHeart Alliance (PPRN-1306-04709). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Allen J, 2007, PHYSIOL MEAS, V28, pR1, DOI 10.1088/0967-3334/28/3/R01; Alty SR, 2007, IEEE T BIO-MED ENG, V54, P2268, DOI 10.1109/TBME.2007.897805; Amer Diabet Assoc, 2012, DIABETES CARE, V35, pS64, DOI [10.2337/dc12-S064, 10.2337/dc09-S062, 10.2337/dc11-S011]; Avram R, 2019, NPJ DIGIT MED, V2, DOI 10.1038/s41746-019-0134-9; Benichou T, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195166; Bertoni AG, 2002, DIABETES CARE, V25, P471, DOI 10.2337/diacare.25.3.471; Camacho JE, 2016, ENDOCR PRACT, V22, P1288, DOI 10.4158/EP161267.OR; Carnethon MR, 2003, CIRCULATION, V107, P2190, DOI 10.1161/01.CIR.0000066324.74807.95; Cho NH, 2018, DIABETES RES CLIN PR, V138, P271, DOI 10.1016/j.diabres.2018.02.023; Coravos A, 2019, NPJ DIGIT MED, V2, DOI 10.1038/s41746-019-0090-4; Dixit S, 2016, HEART RHYTHM, V13, P3, DOI 10.1016/j.hrthm.2015.08.004; Elgendi M, 2019, NPJ DIGIT MED, V2, DOI 10.1038/s41746-019-0136-7; Elgendi M, 2012, CURR CARDIOL REV, V8, P14, DOI 10.2174/157340312801215782; Emami S, 1999, IEEE T EDUC, V42, P311, DOI 10.1109/13.804537; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; Ferri C, 2009, PATTERN RECOGN LETT, V30, P27, DOI 10.1016/j.patrec.2008.08.010; Glas AS, 2003, J CLIN EPIDEMIOL, V56, P1129, DOI 10.1016/S0895-4356(03)00177-X; Goodfellow I, 2016, ADAPT COMPUT MACH LE, P1; Gulshan V, 2016, JAMA-J AM MED ASSOC, V316, P2402, DOI 10.1001/jama.2016.17216; Guo YJ, 2019, J AM COLL CARDIOL, V74, P2162, DOI 10.1016/j.jacc.2019.08.1055; Hannun AY, 2019, NAT MED, V25, P65, DOI 10.1038/s41591-018-0268-3; HARRIS MI, 1992, DIABETES CARE, V15, P815, DOI 10.2337/diacare.15.7.815; He KM, 2015, IEEE I CONF COMP VIS, P1026, DOI 10.1109/ICCV.2015.123; HE KM, 2016, PROC CVPR IEEE, P770, DOI DOI 10.1109/CVPR.2016.90; Karakaya J, 2014, J RES MED SCI, V19, P1051; Kim DI, 2016, HEART, V102, P1757, DOI 10.1136/heartjnl-2015-309119; LeCun Y, 2015, NATURE, V521, P436, DOI 10.1038/nature14539; Lilia C. M., 2015, J CARDIOVASC DIS DIA, V03, P219; Lindstrom J, 2003, DIABETES CARE, V26, P725, DOI 10.2337/diacare.26.3.725; Liu Liyuan, 2019, ARXIV190803265; Mathews WC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024946; Moreno EM, 2017, IEEE T BIO-MED ENG, V64, P341, DOI 10.1109/TBME.2016.2554661; Nair V., 2010, P 27 INT C INT C MAC, P807; Nirala N, 2019, BIOCYBERN BIOMED ENG, V39, P38, DOI 10.1016/j.bbe.2018.09.007; Noble Douglas, 2011, BMJ, V343, pd7163, DOI 10.1136/bmj.d7163; Otsuka T, 2006, CIRC J, V70, P304, DOI 10.1253/circj.70.304; Pew Research Center, 2019, SMARTPHONE OWNERSHIP; Pilt K, 2014, PHYSIOL MEAS, V35, P2027, DOI 10.1088/0967-3334/35/10/2027; Pisano ED, 2005, NEW ENGL J MED, V353, P1773, DOI 10.1056/NEJMoa052911; Schonauer M, 2008, DIABETES VASC DIS RE, V5, P336, DOI 10.3132/dvdr.2008.047; Selvin E, 2011, DIABETES CARE, V34, P84, DOI 10.2337/dc10-1235; Singh JP, 2000, AM J CARDIOL, V86, P309, DOI 10.1016/S0002-9149(00)00920-6; Srivastava N, 2014, J MACH LEARN RES, V15, P1929; WHO, 2011, WORLD REPORT ON DISABILITY, P1; Yosinski J., 2015, ICML DEEP LEARN WORK; Zhang HB, 2018, JAMA INTERN MED, V178, P239, DOI 10.1001/jamainternmed.2017.7821	46	29	29	7	28	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	OCT	2020	26	10					1576	+		10.1038/s41591-020-1010-5	http://dx.doi.org/10.1038/s41591-020-1010-5		AUG 2020	21	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	NX8MD	32807931	Green Accepted			2022-12-27	WOS:000560288000001
J	Amit, M; Kimhi, H; Bader, T; Chen, JC; Glassberg, E; Benov, A				Amit, Moran; Kimhi, Heli; Bader, Tarif; Chen, Jacob; Glassberg, Elon; Benov, Avi			Mass-surveillance technologies to fight coronavirus spread: the case of Israel	NATURE MEDICINE			English	Editorial Material								As the COVID-19 pandemic escalates, teams around the world are now advocating for a new approach to monitoring transmission: tapping into cellphone location data to track infection spread and warn people who may have been exposed. Here we present data collected in Israel through this approach so far and discuss the privacy concerns, alternatives and different 'flavors' of cellphone surveillance. We also propose safeguards needed to minimize the risk for civil rights.	[Amit, Moran; Kimhi, Heli] Univ Texas MD Anderson Canc Ctr, Dept Head & Neck Surg, Houston, TX 77030 USA; [Bader, Tarif; Glassberg, Elon; Benov, Avi] Israel Def Forces, Med Corps, Ramat Gan, Israel; [Bader, Tarif] Hebrew Univ Jerusalem, Dept Mil Med, Jerusalem, Israel; [Chen, Jacob] Minist Hlth, Med Directorate, Jerusalem, Israel; [Glassberg, Elon] Uniformed Serv Univ Hlth Sci, Bethesda, MD 20814 USA; [Glassberg, Elon; Benov, Avi] Bar Ilan Univ, Azrieli Fac Med, Safed, Israel	University of Texas System; UTMD Anderson Cancer Center; Hebrew University of Jerusalem; Uniformed Services University of the Health Sciences - USA; Bar Ilan University	Benov, A (corresponding author), Israel Def Forces, Med Corps, Ramat Gan, Israel.; Benov, A (corresponding author), Bar Ilan Univ, Azrieli Fac Med, Safed, Israel.	avi.benov@gmail.com	Benov, Avi/AAZ-7750-2020; Chen, Jacob/ABG-4448-2020; Benov, Avi/GYR-1158-2022	Chen, Jacob/0000-0002-1941-1550; Benov, Avi/0000-0003-1901-9038				Li Q, 2020, NEW ENGL J MED, V382, P1199, DOI 10.1056/NEJMoa2001316; Lis J., 2020, HAARETZ; Massaro E, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-53127-z; McMichael TM, 2020, NEW ENGL J MED, V382, P2005, DOI 10.1056/NEJMoa2005412	4	22	22	1	4	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	AUG	2020	26	8					1167	1169		10.1038/s41591-020-0927-z	http://dx.doi.org/10.1038/s41591-020-0927-z			3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	MX8ZF	32457444	Bronze			2022-12-27	WOS:000558006900009
J	Gupta, A; Madhavan, MV; Sehgal, K; Nair, N; Mahajan, S; Sehrawat, TS; Bikdeli, B; Ahluwalia, N; Ausiello, JC; Wan, EY; Freedberg, DE; Kirtane, AJ; Parikh, SA; Maurer, MS; Nordvig, AS; Accili, D; Bathon, JM; Mohan, S; Bauer, KA; Leon, MB; Krumholz, HM; Uriel, N; Mehra, MR; Elkind, MSV; Stone, GW; Schwartz, A; Ho, DD; Bilezikian, JP; Landry, DW				Gupta, Aakriti; Madhavan, Mahesh V.; Sehgal, Kartik; Nair, Nandini; Mahajan, Shiwani; Sehrawat, Tejasav S.; Bikdeli, Behnood; Ahluwalia, Neha; Ausiello, John C.; Wan, Elaine Y.; Freedberg, Daniel E.; Kirtane, Ajay J.; Parikh, Sahil A.; Maurer, Mathew S.; Nordvig, Anna S.; Accili, Domenico; Bathon, Joan M.; Mohan, Sumit; Bauer, Kenneth A.; Leon, Martin B.; Krumholz, Harlan M.; Uriel, Nir; Mehra, Mandeep R.; Elkind, Mitchell S. V.; Stone, Gregg W.; Schwartz, Allan; Ho, David D.; Bilezikian, John P.; Landry, Donald W.			Extrapulmonary manifestations of COVID-19	NATURE MEDICINE			English	Review							ANGIOTENSIN-CONVERTING ENZYME-2; CRITICALLY-ILL ADULTS; NEW-YORK-CITY; SARS CORONAVIRUS; CYTOKINE STORM; FUNCTIONAL RECEPTOR; KAWASAKI-DISEASE; ACE2; MANAGEMENT; LUNG	Recent clinical observations have prompted clinicians to think of COVID-19 as being more than a respiratory disease. Although COVID-19 is most well known for causing substantial respiratory pathology, it can also result in several extrapulmonary manifestations. These conditions include thrombotic complications, myocardial dysfunction and arrhythmia, acute coronary syndromes, acute kidney injury, gastrointestinal symptoms, hepatocellular injury, hyperglycemia and ketosis, neurologic illnesses, ocular symptoms, and dermatologic complications. Given that ACE2, the entry receptor for the causative coronavirus SARS-CoV-2, is expressed in multiple extrapulmonary tissues, direct viral tissue damage is a plausible mechanism of injury. In addition, endothelial damage and thromboinflammation, dysregulation of immune responses, and maladaptation of ACE2-related pathways might all contribute to these extrapulmonary manifestations of COVID-19. Here we review the extrapulmonary organ-specific pathophysiology, presentations and management considerations for patients with COVID-19 to aid clinicians and scientists in recognizing and monitoring the spectrum of manifestations, and in developing research priorities and therapeutic strategies for all organ systems involved.	[Gupta, Aakriti; Madhavan, Mahesh V.; Bikdeli, Behnood; Wan, Elaine Y.; Parikh, Sahil A.; Maurer, Mathew S.; Leon, Martin B.; Uriel, Nir; Schwartz, Allan] Columbia Univ, Irving Med Ctr, NewYork Presbyterian, Div Cardiol,Dept Med, New York, NY USA; [Gupta, Aakriti; Madhavan, Mahesh V.; Bikdeli, Behnood; Kirtane, Ajay J.; Parikh, Sahil A.; Leon, Martin B.; Stone, Gregg W.] Cardiovasc Res Fdn, Clin Trials Ctr, New York, NY USA; [Gupta, Aakriti; Mahajan, Shiwani; Bikdeli, Behnood; Accili, Domenico; Krumholz, Harlan M.] Yale New Haven Med Ctr, Ctr Outcomes Res & Evaluat, 20 York St, New Haven, CT 06504 USA; [Sehgal, Kartik; Bauer, Kenneth A.] Beth Israel Deaconess Med Ctr, Dept Med, Div Hematol & Oncol, Boston, MA 02215 USA; [Sehgal, Kartik] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Sehgal, Kartik; Bauer, Kenneth A.; Mehra, Mandeep R.] Harvard Med Sch, Boston, MA 02115 USA; [Nair, Nandini; Ausiello, John C.; Accili, Domenico; Bilezikian, John P.] Columbia Univ, Irving Med Ctr, NewYork Presbyterian, Div Endocrinol,Dept Med, New York, NY USA; [Mahajan, Shiwani; Krumholz, Harlan M.] Yale Univ, Sch Med, Dept Internal Med, Div Cardiol, New Haven, CT 06510 USA; [Sehrawat, Tejasav S.] Mayo Clin, Dept Med, Div Gastroenterol & Hepatol, Rochester, MN USA; [Ahluwalia, Neha] Icahn Sch Med Mt Sinai, Dept Pediat, Div Cardiol, New York, NY 10029 USA; [Freedberg, Daniel E.] Columbia Univ, Irving Med Ctr, NewYork Presbyterian, Div Digest & Liver,Dis Dept Med, New York, NY USA; [Nordvig, Anna S.; Elkind, Mitchell S. V.] Columbia Univ, Dept Neurol, Vagelos Coll Phys & Surg, New York, NY USA; [Nordvig, Anna S.; Elkind, Mitchell S. V.] NewYork Presbyterian Hosp, New York, NY USA; [Bathon, Joan M.] Columbia Univ, Irving Med Ctr, NewYork Presbyterian, Div Rheumatol,Dept Med, New York, NY USA; [Mohan, Sumit; Landry, Donald W.] Columbia Univ, Irving Med Ctr, NewYork Presbyterian, Div Nephrol,Dept Med, New York, NY 10027 USA; [Mohan, Sumit; Elkind, Mitchell S. V.] Columbia Univ, Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY USA; [Krumholz, Harlan M.] Yale Sch Publ Hlth, Dept Hlth Policy & Management, New Haven, CT USA; [Mehra, Mandeep R.] Brigham & Womens Hosp, Dept Med, Heart & Vasc Ctr, Div Cardiovasc Med, 75 Francis St, Boston, MA 02115 USA; [Stone, Gregg W.] Icahn Sch Med Mt Sinai, Zena & Michael A Wiener Cardiovasc Inst, Dept Med, Div Cardiol, New York, NY 10029 USA; [Ho, David D.] Columbia Univ, Irving Med Ctr, NewYork Presbyterian, Aaron Diamond AIDS Res Ctr,Dept Med, New York, NY USA	Columbia University; NewYork-Presbyterian Hospital; Cardiovascular Research Foundation (CRF); Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Columbia University; NewYork-Presbyterian Hospital; Yale University; Mayo Clinic; Icahn School of Medicine at Mount Sinai; Columbia University; NewYork-Presbyterian Hospital; Columbia University; NewYork-Presbyterian Hospital; Columbia University; NewYork-Presbyterian Hospital; Columbia University; NewYork-Presbyterian Hospital; Columbia University; Yale University; Harvard University; Brigham & Women's Hospital; Icahn School of Medicine at Mount Sinai; Columbia University; NewYork-Presbyterian Hospital	Landry, DW (corresponding author), Columbia Univ, Irving Med Ctr, NewYork Presbyterian, Div Nephrol,Dept Med, New York, NY 10027 USA.	dwl1@cumc.columbia.edu	Sehgal, Kartik/B-5837-2019; Mohan, Sumit/I-5625-2019	Sehgal, Kartik/0000-0003-4391-6943; Mohan, Sumit/0000-0002-5305-9685; Sehrawat, Tejasav/0000-0001-7346-5683; Nordvig, Anna Starikovsky/0000-0003-3360-9157; Mahajan, Shiwani/0000-0002-5617-489X; ahluwalia, neha/0000-0002-7383-3260; Gupta, Aakriti/0000-0001-9103-9872	National Heart, Lung, and Blood Institute of the US National Institutes of Health [T32 HL007854]; US National Institutes of Health [K23 DK111847, K08HL122526, R01HL152236, R03HL146881]; Department of Defense [PR181960]; National Institutes of Neurological Disorders and Stroke [5T32 NS007153]; National Institutes of Arthritis, Musculoskeletal and Skin Diseases [R01 AR050026, U01AR068043]; National Institute of Diabetes and Digestive and Kidney [R01-DK114893, R01-MD014161, U01-DK116066]	National Heart, Lung, and Blood Institute of the US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); National Institutes of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institutes of Arthritis, Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); National Institute of Diabetes and Digestive and Kidney(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We acknowledge BioRender for design support for Fig. 1 and Julie Der-Nigoghossian for design support for Fig. 2. M. V. M. is supported by an institutional grant by the National Heart, Lung, and Blood Institute of the US National Institutes of Health to Columbia University Irving Medical Center (T32 HL007854). E. Y. W. is supported by the US National Institutes of Health (K08HL122526, R01HL152236, and R03HL146881). D. E. F. is funded in part by US National Institutes of Health grant K23 DK111847 and by Department of Defense funding PR181960. A. S. N. is supported by National Institutes of Neurological Disorders and Stroke grant 5T32 NS007153. J. M. B. is supported by the National Institutes of Arthritis, Musculoskeletal and Skin Diseases (R01 AR050026 and U01AR068043). S. M. is supported by National Institute of Diabetes and Digestive and Kidney grants R01-DK114893, R01-MD014161, and U01-DK116066.	Abu-Ashour W, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-2975-2; Ackermann M, 2020, NEW ENGL J MED, V383, P120, DOI 10.1056/NEJMoa2015432; Ahmed I, 2020, BRIT J HAEMATOL, V190, pE37, DOI 10.1111/bjh.16849; Akalin E, 2020, NEW ENGL J MED, V382, P2475, DOI 10.1056/NEJMc2011117; Alhazzani W., 2020, INTENS CARE MED, V46, P854, DOI [DOI 10.1007/s00134-020-06022-5, 10.1007/s00134-020-06022-5]; American Academy of Dermatology, 2020, GUID US MED COVID 19; American College of Cardiology, 2020, MAN HOSP COVID 19 PA; American College of Cardiology, 2020, HFSA ACC AHA STAT AD; American Diabetes Association, 2020, INP INS PROT COVID 1; American Society of Nephrology, 2020, REC CAR HOSP PAT COV; [Anonymous], 2020, PEDIATR MED RODZ, V16, P9, DOI 10.15557/PiMR.2020.0003; [Anonymous], 2020, JAMA-J AM MED ASSOC, DOI [DOI 10.1016/j.jinf.2020.03.037, DOI 10.1001/jama.2020.3786]; Arentz M, 2020, JAMA-J AM MED ASSOC, V323, P1612, DOI 10.1001/jama.2020.4326; Argenziano Michael G, 2020, medRxiv, DOI 10.1101/2020.04.20.20072116; Baldi E, 2020, NEW ENGL J MED, V383, P496, DOI 10.1056/NEJMc2010418; Bangalore S, 2020, NEW ENGL J MED, V382, P2478, DOI 10.1056/NEJMc2009020; Bangash MN, 2020, LANCET GASTROENTEROL, V5, P529, DOI 10.1016/S2468-1253(20)30084-4; Baron M, 2016, CELL SYST, V3, P346, DOI 10.1016/j.cels.2016.08.011; Bashyam AM, 2020, J DERMATOL TREAT, V31, P317, DOI 10.1080/09546634.2020.1742438; Baud D, 2020, JAMA-J AM MED ASSOC, V323, P2198, DOI 10.1001/jama.2020.7233; Belhadjer Z, 2020, CIRCULATION, V142, P429, DOI 10.1161/CIRCULATIONAHA.120.048360; Bhatraju PK, 2020, NEW ENGL J MED, V382, P2012, DOI 10.1056/NEJMoa2004500; Bhimraj Adarsh, 2020, Clin Infect Dis, DOI 10.1093/cid/ciaa478; Bikdeli B, 2020, THROMB HAEMOSTASIS, V120, P1004, DOI 10.1055/s-0040-1713152; Bikdeli B, 2020, J AM COLL CARDIOL, V75, P2950, DOI 10.1016/j.jacc.2020.04.031; Breslin N, 2020, AM J OBSTET GYNECOL, DOI [10.1016/j.ajogmf.2020.100118, DOI 10.1016/J.AJOGMF.2020.100118]; Bunyavanich S, 2020, JAMA-J AM MED ASSOC, V323, P2427, DOI 10.1001/jama.2020.8707; Campbell KH, 2020, JAMA-J AM MED ASSOC, V323, P2520, DOI 10.1001/jama.2020.8904; Cao B, 2020, NEW ENGL J MED, V382, P1787, DOI 10.1056/NEJMoa2001282; Cao W, 2020, CELL RES, V30, P367, DOI 10.1038/s41422-020-0327-4; Carey IM, 2018, DIABETES CARE, V41, P513, DOI 10.2337/dc17-2131; CASTELL JV, 1989, FEBS LETT, V242, P237, DOI 10.1016/0014-5793(89)80476-4; Channappanavar R, 2017, SEMIN IMMUNOPATHOL, V39, P529, DOI 10.1007/s00281-017-0629-x; Cheema M, 2020, CAN J OPHTHALMOL, V55, pE125, DOI 10.1016/j.jcjo.2020.03.003; Chen HJ, 2020, LANCET, V395, P809, DOI 10.1016/S0140-6736(20)30360-3; Chen NS, 2020, LANCET, V395, P507, DOI 10.1016/S0140-6736(20)30211-7; Cheng YC, 2020, KIDNEY INT, V97, P829, DOI 10.1016/j.kint.2020.03.005; Chow N, 2020, MMWR-MORBID MORTAL W, V69, P382, DOI 10.15585/mmwr.mm6913e2; Chu H, 2016, J INFECT DIS, V213, P904, DOI 10.1093/infdis/jiv380; Chu KH, 2005, KIDNEY INT, V67, P698, DOI 10.1111/j.1523-1755.2005.67130.x; Clerkin KJ, 2020, CIRCULATION, V141, P1648, DOI 10.1161/CIRCULATIONAHA.120.046941; Connors JM, 2020, BLOOD, V135, P2033, DOI 10.1182/blood.2020006000; Copin MC, 2020, INTENS CARE MED, V46, P1124, DOI 10.1007/s00134-020-06057-8; Creel-Bulos C, 2020, NEW ENGL J MED, V382, DOI 10.1056/NEJMc2010459; Cui SP, 2020, J THROMB HAEMOST, V18, P1421, DOI 10.1111/jth.14830; Cummings Matthew J, 2020, medRxiv, DOI [10.1016/S0140-6736(20)31189-2, 10.1101/2020.04.15.20067157]; de Simone G, 2020, POS STAT ESC COUNC H; Desforges M, 2014, VIRUS RES, V194, P145, DOI 10.1016/j.virusres.2014.09.011; Deshpande C, 2020, ANN INTERN MED, V173, P394, DOI 10.7326/M20-3255; Di Giambenedetto S, 2020, J MED VIROL, V92, P1787, DOI 10.1002/jmv.25897; Diaz-Guimaraens B, 2020, JAMA DERMATOL, V156, P820, DOI 10.1001/jamadermatol.2020.1741; Dolhnikoff M, 2020, J THROMB HAEMOST, V18, P1517, DOI 10.1111/jth.14844; Dong ES, 2020, LANCET INFECT DIS, V20, P533, DOI 10.1016/S1473-3099(20)30120-1; Dong L, 2020, JAMA-J AM MED ASSOC, V323, P1846, DOI 10.1001/jama.2020.4621; Driggin E, 2020, J AM COLL CARDIOL, V75, P2352, DOI 10.1016/j.jacc.2020.03.031; Eizirik DL, 2001, DIABETES, V50, pS64, DOI 10.2337/diabetes.50.2007.S64; Elshafeey F, 2020, INT J GYNECOL OBSTET, V150, P47, DOI 10.1002/ijgo.13182; Engelmann B, 2013, NAT REV IMMUNOL, V13, P34, DOI 10.1038/nri3345; Epelman S, 2008, J AM COLL CARDIOL, V52, P750, DOI 10.1016/j.jacc.2008.02.088; Faigle R, 2020, NEUROHOSPITALIST, V10, P11, DOI 10.1177/1941874419845229; Fan BE, 2020, AM J HEMATOL, V95, pE131, DOI 10.1002/ajh.25774; Fang L, 2020, LANCET RESP MED, V8, pE21, DOI 10.1016/S2213-2600(20)30116-8; Feng Y, 2020, AM J RESP CRIT CARE, V201, P1380, DOI 10.1164/rccm.202002-0445OC; Fischer K, 2007, BLOOD, V109, P3812, DOI 10.1182/blood-2006-07-035972; Fix OK, 2020, HEPATOLOGY, V72, P287, DOI 10.1002/hep.31281; Fox SE, 2020, PULMONARY CARDIAC PA, DOI [10.1101/2020.04.06.20050575, DOI 10.1101/2020.04.06.20050575]; Franceschi AM, 2020, AM J NEURORADIOL, V41, P1173, DOI 10.3174/ajnr.A6595; Fried JA, 2020, CIRCULATION, V141, P1930, DOI 10.1161/CIRCULATIONAHA.120.047164; Friedman DJ, 2020, ANNU REV PHYSIOL, V82, P323, DOI 10.1146/annurev-physiol-021119-034345; Gallagher PE, 2008, AM J PHYSIOL-HEART C, V295, pH2373, DOI 10.1152/ajpheart.00426.2008; Casas CG, 2020, BRIT J DERMATOL, V183, P71, DOI 10.1111/bjd.19163; Giannis D, 2020, J CLIN VIROL, V127, DOI 10.1016/j.jcv.2020.104362; Gianotti R, 2020, ACTA DERM-VENEREOL, V100, DOI 10.2340/00015555-3490; Gordon JB, 2009, J AM COLL CARDIOL, V54, P1911, DOI 10.1016/j.jacc.2009.04.102; Goyal P, 2020, NEW ENGL J MED, V382, P2372, DOI 10.1056/NEJMc2010419; Gu J, 2005, J EXP MED, V202, P415, DOI 10.1084/jem.20050828; Guo T, 2020, JAMA CARDIOL, V5, P811, DOI 10.1001/jamacardio.2020.1017; Gupta N, 2019, THROMB RES, V181, P77, DOI 10.1016/j.thromres.2019.07.013; Gurwitz D, 2020, DRUG DEVELOP RES, V81, P537, DOI 10.1002/ddr.21656; Hamming I, 2004, J PATHOL, V203, P631, DOI 10.1002/path.1570; Hantoushzadeh S, 2020, AM J OBSTET GYNECOL, V223, DOI 10.1016/j.ajog.2020.04.030; Harmer D, 2002, FEBS LETT, V532, P107, DOI 10.1016/S0014-5793(02)03640-2; Hartung HP, 2020, NAT REV NEUROL, V16, P347, DOI 10.1038/s41582-020-0368-9; Helms J, 2020, NEW ENGL J MED, V382, DOI 10.1056/NEJMc2015132; Helms J, 2020, INTENS CARE MED, V46, P1089, DOI 10.1007/s00134-020-06062-x; Hibbert K, 2012, CHEST, V142, P785, DOI 10.1378/chest.12-0117; Hirsch JS, 2020, KIDNEY INT, V98, P209, DOI 10.1016/j.kint.2020.05.006; Hoffmann M, 2020, CELL, V181, P271, DOI 10.1016/j.cell.2020.02.052; Holmes KV, 2003, J CLIN INVEST, V111, P1605, DOI [10.1172/JCI18819, 10.1172/JCI200318819]; Hotchkiss RS, 2020, NEW ENGL J MED, V382, P1270, DOI 10.1056/NEJMcibr1917242; Hu Y, 2020, NEW ENGL J MED, V382, P1708; Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5; Huang KJ, 2005, J MED VIROL, V75, P185, DOI 10.1002/jmv.20255; Imai Y, 2005, NATURE, V436, P112, DOI 10.1038/nature03712; Iwasaki A, 2014, NAT REV IMMUNOL, V14, P315, DOI 10.1038/nri3665; Jackson SP, 2019, BLOOD, V133, P906, DOI 10.1182/blood-2018-11-882993; Jia JL, 2020, J AM ACAD DERMATOL, V83, P687, DOI 10.1016/j.jaad.2020.05.059; Joob B, 2020, J AM ACAD DERMATOL, V82, pE177, DOI 10.1016/j.jaad.2020.03.036; Joshi N, 1999, NEW ENGL J MED, V341, P1906, DOI 10.1056/NEJM199912163412507; Kim J, 2020, GASTROENTEROLOGY, V159, P1155, DOI 10.1053/j.gastro.2020.05.031; Kim KD, 2007, NAT MED, V13, P1248, DOI 10.1038/nm1633; Kirkpatrick JN, 2020, J AM COLL CARDIOL, V75, P3078, DOI [10.1016/j.echo.2020.04.001, 10.1016/j.jacc.2020.04.002]; Kissling S, 2020, KIDNEY INT, V98, P228, DOI 10.1016/j.kint.2020.04.006; Klok FA, 2020, THROMB RES, V191, P145, DOI [10.1016/j.thromres.2020.04.013, 10.1016/j.thromres.2020.04.041]; Kollias A, 2020, BRIT J HAEMATOL, V189, P846, DOI 10.1111/bjh.16727; Koupenova M, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09607-x; Kuba K, 2005, NAT MED, V11, P875, DOI 10.1038/nm1267; Kuba K, 2010, PHARMACOL THERAPEUT, V128, P119, DOI 10.1016/j.pharmthera.2010.06.003; Kwong JC, 2018, NEW ENGL J MED, V378, P345, DOI 10.1056/NEJMoa1702090; Laffel L, 1999, DIABETES-METAB RES, V15, P412, DOI 10.1002/(SICI)1520-7560(199911/12)15:6<412::AID-DMRR72>3.0.CO;2-8; Lakkireddy DR, 2020, CIRCULATION, V141, pE823, DOI 10.1161/CIRCULATIONAHA.120.047063; Lamers MM, 2020, SCIENCE, V369, P50, DOI 10.1126/science.abc1669; Lan J, 2020, NATURE, V581, P215, DOI 10.1038/s41586-020-2180-5; Lan TQ, 2020, IND CROP PROD, V145, DOI 10.1016/j.indcrop.2020.112128; Larsen CP, 2020, KIDNEY INT REP, V5, P935, DOI 10.1016/j.ekir.2020.04.002; Lax SF, 2020, ANN INTERN MED, V173, P350, DOI 10.7326/M20-2566; Lechien JR, 2020, EUR ARCH OTO-RHINO-L, V277, P2251, DOI 10.1007/s00405-020-05965-1; Lei CH, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16048-4; Levi M, 2017, THROMB RES, V149, P38, DOI 10.1016/j.thromres.2016.11.007; Li F, 2005, SCIENCE, V309, P1864, DOI 10.1126/science.1116480; Li H, 2020, LANCET, V395, P1517, DOI 10.1016/S0140-6736(20)30920-X; Li JY, 2020, JAMA CARDIOL, V5, P825, DOI 10.1001/jamacardio.2020.1624; Li JY, 2020, DIABETES OBES METAB, V22, P1935, DOI 10.1111/dom.14057; Li N., 2020, CLIN INFECT DIS, DOI [10.1093/cid/ciaa352, DOI 10.1093/CID/CIAA352]; Li WH, 2003, NATURE, V426, P450, DOI 10.1038/nature02145; Li YC, 2020, J MED VIROL, V92, P552, DOI 10.1002/jmv.25728; Liang L, 2020, ACTA OPHTHALMOL, V98, P223, DOI [10.1001/jamaophthalmol.2020.1291, 10.1111/aos.14413]; Liang WH, 2020, JAMA INTERN MED, V180, P1081, DOI 10.1001/jamainternmed.2020.2033; Lippi G, 2020, CLIN CHIM ACTA, V506, P145, DOI 10.1016/j.cca.2020.03.022; Llitjos JF, 2020, J THROMB HAEMOST, V18, P1743, DOI 10.1111/jth.14869; Lodigiani C, 2020, THROMB RES, V191, P9, DOI 10.1016/j.thromres.2020.04.024; Lu XX, 2020, NEW ENGL J MED, V382, P1663, DOI 10.1056/NEJMc2005073; Lui RN, 2020, J GASTROEN HEPATOL, V35, P749, DOI 10.1111/jgh.15053; Lyden P, 2020, STROKE, V51, P1910, DOI 10.1161/STROKEAHA.120.030023; Mak JWY, 2020, LANCET GASTROENTEROL, V5, P644, DOI 10.1016/S2468-1253(20)30122-9; Mancia G, 2020, NEW ENGL J MED, V382, P2431, DOI 10.1056/NEJMoa2006923; Mao L, 2020, JAMA NEUROL, V77, P683, DOI 10.1001/jamaneurol.2020.1127; Mao R, 2020, LANCET GASTROENTEROL, V5, P667, DOI 10.1016/S2468-1253(20)30126-6; Marinho PM, 2020, LANCET, V395, P1610, DOI 10.1016/S0140-6736(20)31014-X; McClean KM, 2008, THORAX, V63, P649, DOI 10.1136/thx.2007.086801; McCowen KC, 2001, CRIT CARE CLIN, V17, P107, DOI 10.1016/S0749-0704(05)70154-8; McCrindle BW, 2017, CIRCULATION, V135, pE927, DOI 10.1161/CIR.0000000000000484; Mehta P, 2020, LANCET, V395, P1033, DOI 10.1016/S0140-6736(20)30628-0; Merad M, 2020, NAT REV IMMUNOL, V20, P355, DOI 10.1038/s41577-020-0331-4; Moriguchi T, 2020, INT J INFECT DIS, V94, P55, DOI 10.1016/j.ijid.2020.03.062; Nahum J, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.10478; Naicker S, 2020, KIDNEY INT, V97, P824, DOI 10.1016/j.kint.2020.03.001; Nicholls JM, 2003, LANCET, V361, P1773, DOI 10.1016/S0140-6736(03)13413-7; Nobel YR, 2020, GASTROENTEROLOGY, V159, P373, DOI 10.1053/j.gastro.2020.04.017; Onder G, 2020, JAMA-J AM MED ASSOC, V323, P1775, DOI 10.1001/jama.2020.4683; Oxley TJ, 2020, NEW ENGL J MED, V382, DOI 10.1056/NEJMc2009787; Pan L, 2020, AM J GASTROENTEROL, V115, P766, DOI 10.14309/ajg.0000000000000620; Pan XW, 2020, INTENS CARE MED, V46, P1114, DOI 10.1007/s00134-020-06026-1; Paranjpe I, 2020, J AM COLL CARDIOL, V76, P122, DOI 10.1016/j.jacc.2020.05.001; Park Matthew D, 2020, Nat Rev Immunol, V20, P351, DOI 10.1038/s41577-020-0317-2; Patane L, 2020, AM J OBSTET GYNECOL, DOI [10.1016/j.ajogmf.2020.100145, DOI 10.1016/J.AJOGMF.2020.100145]; Patel AB, 2020, JAMA-J AM MED ASSOC, V323, P1769, DOI 10.1001/jama.2020.4812; Peerapornratana S, 2019, KIDNEY INT, V96, P1083, DOI 10.1016/j.kint.2019.05.026; Pei GC, 2020, J AM SOC NEPHROL, V31, P1157, DOI 10.1681/ASN.2020030276; Pereira MR, 2020, AM J TRANSPLANT, V20, P1800, DOI 10.1111/ajt.15941; Perini P, 2020, LANCET, V395, P1546, DOI 10.1016/S0140-6736(20)31051-5; Petrilli CM, 2020, BMJ-BRIT MED J, V369, DOI [10.1136/bmj.m1966, 10.12890/2020_001747]; Pilotto A, 2020, ANN NEUROL, V88, P423, DOI 10.1002/ana.25783; Poissy J, 2020, CIRCULATION, V142, P184, DOI 10.1161/CIRCULATIONAHA.120.047430; Poyiadji N, 2020, RADIOLOGY, V296, pE119, DOI 10.1148/radiol.2020201187; Puelles VG, 2020, NEW ENGL J MED, V383, P590, DOI [10.1056/NEJMc2013400, 10.1056/NEJMc2011400]; Qi FR, 2020, BIOCHEM BIOPH RES CO, V526, P135, DOI 10.1016/j.bbrc.2020.03.044; Qin C, 2020, CLIN INFECT DIS, V71, P762, DOI 10.1093/cid/ciaa248; Rajala MW, 2003, ENDOCRINOLOGY, V144, P3765, DOI 10.1210/en.2003-0580; Ramacciotti E, 2019, CLIN APPL THROMB-HEM, V25, DOI 10.1177/1076029618821184; Ranard Lauren S, 2020, Crit Pathw Cardiol, V19, P49, DOI 10.1097/HPC.0000000000000223; Ranucci M, 2020, J THROMB HAEMOST, V18, P1747, DOI 10.1111/jth.14854; Recalcati S, 2020, J EUR ACAD DERMATOL, V34, pE346, DOI 10.1111/jdv.16533; Recalcati S, 2020, J EUR ACAD DERMATOL, V34, pE212, DOI 10.1111/jdv.16387; Redd WD, 2020, GASTROENTEROLOGY, V159, P765, DOI 10.1053/j.gastro.2020.04.045; Ren B, 2020, CIRCULATION, V142, P181, DOI 10.1161/CIRCULATIONAHA.120.047407; Repesse X, 2017, ANN TRANSL MED, V5, DOI 10.21037/atm.2017.06.66; Reynolds HR, 2020, NEW ENGL J MED, V382, P2441, DOI 10.1056/NEJMoa2008975; Richardson S, 2020, JAMA-J AM MED ASSOC, V323, P2052, DOI 10.1001/jama.2020.6775; Riphagen S, 2020, LANCET, V395, P1607, DOI [10.1016/50140-6736(20)31094-1, 10.1016/S0140-6736(20)31094-1]; ROBSON SC, 1994, BRIT J HAEMATOL, V86, P322, DOI 10.1111/j.1365-2141.1994.tb04733.x; Ronco C, 2020, LANCET RESP MED, V8, P738, DOI 10.1016/S2213-2600(20)30229-0; Ruan QR, 2020, INTENS CARE MED, V46, P846, DOI 10.1007/s00134-020-05991-x; Sala S, 2020, EUR HEART J, V41, P1861, DOI 10.1093/eurheartj/ehaa286; Schwartz DA, 2020, ARCH PATHOL LAB MED, V144, P799, DOI 10.5858/arpa.2020-0901-SA; Semple JW, 2011, NAT REV IMMUNOL, V11, P264, DOI 10.1038/nri2956; Shang J, 2020, NATURE, V581, P221, DOI 10.1038/s41586-020-2179-y; Shekerdemian LS, 2020, JAMA PEDIATR, V174, P868, DOI 10.1001/jamapediatrics.2020.1948; Shi SB, 2020, JAMA CARDIOL, V5, P802, DOI 10.1001/jamacardio.2020.0950; Simonnet A, 2020, OBESITY, V28, P1195, DOI 10.1002/oby.22831; Smither SJ, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11070647; Spinato G, 2020, JAMA-J AM MED ASSOC, V323, P2089, DOI 10.1001/jama.2020.6771; Spyropoulos AC, 2020, J THROMB HAEMOST, V18, P1859, DOI 10.1111/jth.14929; Strawn WB, 1999, HYPERTENSION, V33, P207, DOI 10.1161/01.HYP.33.1.207; Su H, 2020, KIDNEY INT, V98, P219, DOI 10.1016/j.kint.2020.04.003; Sultan S, 2020, GASTROENTEROLOGY, V159, P739, DOI 10.1053/j.gastro.2020.03.072; Sungnak W, 2020, NAT MED, V26, P681, DOI 10.1038/s41591-020-0868-6; Sutton D, 2020, NEW ENGL J MED, V382, P2163, DOI 10.1056/NEJMc2009316; Szerlip M, 2020, CATHETER CARDIO INTE, V96, P586, DOI 10.1002/ccd.28887; Tang N, 2020, J THROMB HAEMOST, V18, P844, DOI 10.1111/jth.14768; Tavazzi G, 2020, INTENS CARE MED, V46, P1121, DOI 10.1007/s00134-020-06040-3; Tavazzi G, 2020, EUR J HEART FAIL, V22, P911, DOI 10.1002/ejhf.1828; Terpos E, 2020, AM J HEMATOL, V95, P834, DOI 10.1002/ajh.25829; Teuwen LA, 2020, NAT REV IMMUNOL, V20, P389, DOI 10.1038/s41577-020-0343-0; Thachil J, 2020, J THROMB HAEMOST, V18, P1795, DOI 10.1111/jth.14841; Tian SF, 2020, J THORAC ONCOL, V15, P700, DOI 10.1016/j.jtho.2020.02.010; Toscano G, 2020, NEW ENGL J MED, V382, P2574, DOI 10.1056/NEJMc2009191; Tursen U, 2020, DERMATOL THER, V33, DOI 10.1111/dth.13476; Ullah Waqas, 2020, JACC Case Rep, V2, P1379, DOI 10.1016/j.jaccas.2020.04.008; Vaduganathan M, 2020, NEW ENGL J MED, V382, P1653, DOI 10.1056/NEJMsr2005760; Vaira LA, 2020, HEAD NECK-J SCI SPEC, V42, P1252, DOI 10.1002/hed.26204; Valeri AM, 2020, J AM SOC NEPHROL, V31, P1409, DOI 10.1681/ASN.2020040470; Varga Z, 2020, LANCET, V395, P1417, DOI 10.1016/S0140-6736(20)30937-5; Walls AC, 2020, CELL, V181, P281, DOI [10.1016/j.cell.2020.02.058, 10.1016/j.cell.2020.11.032]; Walters TE, 2017, EUROPACE, V19, P1280, DOI 10.1093/europace/euw246; Wander P, 2020, AM J GASTROENTEROL, V115, P941, DOI 10.14309/ajg.0000000000000660; Wang DW, 2020, JAMA-J AM MED ASSOC, V323, P1061, DOI 10.1001/jama.2020.1585; Wang QH, 2020, CELL, V181, P894, DOI 10.1016/j.cell.2020.03.045; Wei C, 2020, J DRUGS DERMATOL, V19, P554, DOI 10.36849/JDD.2020.2005; Welt FGP, 2020, J AM COLL CARDIOL, V75, P2372, DOI 10.1016/j.jacc.2020.03.021; Wichmann D, 2020, ANN INTERN MED, V173, P268, DOI 10.7326/M20-2003; Wolfel R, 2020, NATURE, V581, P465, DOI 10.1038/s41586-020-2196-x; Wrapp D, 2020, SCIENCE, V367, P1260, DOI [10.1101/2020.02.11.944462, 10.1126/science.abb2507]; Wu CM, 2020, JAMA INTERN MED, V180, P934, DOI 10.1001/jamainternmed.2020.0994; Wu ZY, 2020, JAMA-J AM MED ASSOC, V323, P1239, DOI 10.1001/jama.2020.2648; Xiao F, 2020, GASTROENTEROLOGY, V158, P1831, DOI 10.1053/j.gastro.2020.02.055; Xu H, 2020, INT J ORAL SCI, V12, DOI [10.1038/s41368-020-0074-X, 10.1038/s41368-020-0074-x]; Xu Zhe, 2020, Lancet Respir Med, V8, P420, DOI 10.1016/S2213-2600(20)30076-X; Yaghi S, 2020, STROKE, V51, P2002, DOI 10.1161/STROKEAHA.120.030335; Yan J, 2020, AM J OBSTET GYNECOL, V223, DOI 10.1016/j.ajog.2020.04.014; Yang G, 2020, HYPERTENSION, V76, P51, DOI 10.1161/HYPERTENSIONAHA.120.15143; Yang JK, 2010, ACTA DIABETOL, V47, P193, DOI 10.1007/s00592-009-0109-4; Ye MH, 2006, J AM SOC NEPHROL, V17, P3067, DOI 10.1681/ASN.2006050423; Yeaman MR, 2010, CELL MOL LIFE SCI, V67, P525, DOI 10.1007/s00018-009-0210-4; Yuki K, 2020, CLIN IMMUNOL, V215, DOI 10.1016/j.clim.2020.108427; Zeng H, 2020, JAMA-J AM MED ASSOC, V323, P1848, DOI 10.1001/jama.2020.4861; Zhang C, 2020, LANCET GASTROENTEROL, V5, P428, DOI 10.1016/S2468-1253(20)30057-1; Zhang H, 2020, GUT, V69, P1010, DOI 10.1136/gutjnl-2020-320953; Zhang HL, 2020, ANN INTERN MED, V172, P629, DOI 10.7326/M20-0533; Zhang P, 2020, CIRC RES, V126, P1671, DOI 10.1161/CIRCRESAHA.120.317134; Zhang XN, 2020, NATURE, V583, P437, DOI [10.1038/s41586-020-2355-0, 10.1007/s00521-020-05117-w]; Zhao H, 2020, LANCET NEUROL, V19, P383, DOI 10.1016/S1474-4422(20)30109-5; Zheng YY, 2020, NAT REV CARDIOL, V17, P259, DOI 10.1038/s41569-020-0360-5; Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3; Zhou P, 2020, NATURE, V579, P270, DOI 10.1038/s41586-020-2012-7; Ziegler CGK, 2020, CELL, V181, P1016, DOI 10.1016/j.cell.2020.04.035; Zuo Y, 2020, JCI INSIGHT, V5, DOI 10.1172/jci.insight.138999	247	1286	1329	30	119	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	JUL	2020	26	7					1017	1032		10.1038/s41591-020-0968-3	http://dx.doi.org/10.1038/s41591-020-0968-3		JUL 2020	16	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	MK3XO	32651579	Bronze			2022-12-27	WOS:000547236500007
J	Rockett, RJ; Arnott, A; Lam, C; Sadsad, R; Timms, V; Gray, KA; Eden, JS; Chang, S; Gall, M; Draper, J; Sim, EM; Bachmann, NL; Carter, I; Basile, K; Byun, R; O'Sullivan, MV; Chen, SCA; Maddocks, S; Sorrell, TC; Dwyer, DE; Holmes, EC; Kok, J; Prokopenko, M; Sintchenko, V				Rockett, Rebecca J.; Arnott, Alicia; Lam, Connie; Sadsad, Rosemarie; Timms, Verlaine; Gray, Karen-Ann; Eden, John-Sebastian; Chang, Sheryl; Gall, Mailie; Draper, Jenny; Sim, Eby M.; Bachmann, Nathan L.; Carter, Ian; Basile, Kerri; Byun, Roy; O'Sullivan, Matthew V.; Chen, Sharon C-A; Maddocks, Susan; Sorrell, Tania C.; Dwyer, Dominic E.; Holmes, Edward C.; Kok, Jen; Prokopenko, Mikhail; Sintchenko, Vitali			Revealing COVID-19 transmission in Australia by SARS-CoV-2 genome sequencing and agent-based modeling	NATURE MEDICINE			English	Article							GENERATION; TOOL	In January 2020, a novel betacoronavirus (familyCoronaviridae), named severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), was identified as the etiological agent of a cluster of pneumonia cases occurring in Wuhan City, Hubei Province, China(1,2). The disease arising from SARS-CoV-2 infection, coronavirus disease 2019 (COVID-19), subsequently spread rapidly causing a worldwide pandemic. Here we examine the added value of near real-time genome sequencing of SARS-CoV-2 in a subpopulation of infected patients during the first 10 weeks of COVID-19 containment in Australia and compare findings from genomic surveillance with predictions of a computational agent-based model (ABM). Using the Australian census data, the ABM generates over 24 million software agents representing the population of Australia, each with demographic attributes of an anonymous individual. It then simulates transmission of the disease over time, spreading from specific infection sources, using contact rates of individuals within different social contexts. We report that the prospective sequencing of SARS-CoV-2 clarified the probable source of infection in cases where epidemiological links could not be determined, significantly decreased the proportion of COVID-19 cases with contentious links, documented genomically similar cases associated with concurrent transmission in several institutions and identified previously unsuspected links. Only a quarter of sequenced cases appeared to be locally acquired and were concordant with predictions from the ABM. These high-resolution genomic data are crucial to track cases with locally acquired COVID-19 and for timely recognition of independent importations once border restrictions are lifted and trade and travel resume. The combination of nearly real-time genome sequencing of SARS-CoV-2 in infected patients during the first 10 weeks of COVID-19 containment in Australia and epidemiological modeling is helping in understanding the dynamics of the COVID-19 pandemic and potentially guiding public health decisions.	[Rockett, Rebecca J.; Arnott, Alicia; Lam, Connie; Sadsad, Rosemarie; Timms, Verlaine; Gray, Karen-Ann; Eden, John-Sebastian; O'Sullivan, Matthew V.; Chen, Sharon C-A; Sorrell, Tania C.; Dwyer, Dominic E.; Holmes, Edward C.; Kok, Jen; Prokopenko, Mikhail; Sintchenko, Vitali] Univ Sydney, Marie Bashir Inst Infect Dis & Biosecur, Sydney, NSW, Australia; [Rockett, Rebecca J.; Arnott, Alicia; Lam, Connie; Sadsad, Rosemarie; Timms, Verlaine; Gray, Karen-Ann; Sim, Eby M.; Bachmann, Nathan L.; O'Sullivan, Matthew V.; Chen, Sharon C-A; Sorrell, Tania C.; Dwyer, Dominic E.; Kok, Jen; Sintchenko, Vitali] Westmead Hosp, Ctr Infect Dis & Microbiol Publ Hlth, Westmead, NSW, Australia; [Arnott, Alicia; Gall, Mailie; Draper, Jenny; Sim, Eby M.; Bachmann, Nathan L.; Carter, Ian; Basile, Kerri; O'Sullivan, Matthew V.; Chen, Sharon C-A; Maddocks, Susan; Dwyer, Dominic E.; Kok, Jen; Sintchenko, Vitali] NSW Hlth Pathol Inst Clin Pathol & Med Res, Ctr Infect Dis & Microbiol Lab Serv, Westmead, NSW, Australia; [Sadsad, Rosemarie] Univ Sydney, Sydney Informat Hub, Core Res Facil, Sydney, NSW, Australia; [Eden, John-Sebastian] Westmead Inst Med Res, Ctr Virus Res, Westmead, NSW, Australia; [Chang, Sheryl; Prokopenko, Mikhail] Univ Sydney, Ctr Complex Syst, Fac Engn, Sydney, NSW, Australia; [Byun, Roy] NSW Minist Hlth, Hlth Protect NSW, Sydney, NSW, Australia; [Sorrell, Tania C.; Sintchenko, Vitali] Westmead Inst Med Res, Ctr Infect Dis & Microbiol, Westmead, NSW, Australia; [Holmes, Edward C.] Univ Sydney, Sch Life & Environm Sci, Sydney, NSW, Australia; [Rockett, Rebecca J.; Arnott, Alicia] Univ Sydney, Sch Med Sci, Sydney, NSW, Australia	University of Sydney; University of Sydney; University of Sydney; University of Sydney; Westmead Institute for Medical Research; University of Sydney; University of Sydney; Westmead Institute for Medical Research; University of Sydney; University of Sydney	Sintchenko, V (corresponding author), Univ Sydney, Marie Bashir Inst Infect Dis & Biosecur, Sydney, NSW, Australia.; Sintchenko, V (corresponding author), Westmead Hosp, Ctr Infect Dis & Microbiol Publ Hlth, Westmead, NSW, Australia.; Sintchenko, V (corresponding author), NSW Hlth Pathol Inst Clin Pathol & Med Res, Ctr Infect Dis & Microbiol Lab Serv, Westmead, NSW, Australia.; Sintchenko, V (corresponding author), Westmead Inst Med Res, Ctr Infect Dis & Microbiol, Westmead, NSW, Australia.	vitali.sintchenko@sydney.edu.au	Timms, Verlaine/E-8326-2011; Sorrell, Tania/AAZ-5286-2020; Prokopenko, Mikhail/A-3995-2008; Holmes, Edward/GVR-9499-2022	Timms, Verlaine/0000-0002-3883-4428; Prokopenko, Mikhail/0000-0002-4215-0344; Sadsad, Rosemarie/0000-0003-2488-953X; Gall, Mailie/0000-0001-7018-2426; Rockett, Rebecca/0000-0003-4329-5198; Eden, John-Sebastian/0000-0003-1374-3551; Lam, Connie/0000-0003-0998-5400; Chang, Sheryl/0000-0002-6119-828X; Basile, Kerri/0000-0003-0647-4314; Sim, Eby/0000-0002-3716-7344; Draper, Jenny/0000-0002-6916-6442; Holmes, Edward/0000-0001-9596-3552; CARTER, IAN/0000-0002-1911-3561	NSW Ministry of Health; National Health and Medical Research Council Centre for Research Excellence in Emerging Infectious Diseases [GNT1102962]; Australian Research Council [DP200103005]	NSW Ministry of Health; National Health and Medical Research Council Centre for Research Excellence in Emerging Infectious Diseases; Australian Research Council(Australian Research Council)	Members of the ICPMR SARS-CoV-2 Study Group include L. Donovan, S. Kumar, T. Tran, H. Rahman, D. Ko, T. Sivaruban, E. Martinez, A. Ginn, Q. Wang and K. Pey. Members of the ABM team include N. Harding, C. Zachreson and O. Cliff. We acknowledge the Sydney Informatics Hub and use of the University of Sydney's high-performance computing cluster, Artemis. We thank the NSW Pathology partner laboratories, ACT Pathology, Douglass Hanly Moir, Australian Clinical Laboratories and Laverty Pathology for referring samples for genomic surveillance. Expert advice and epidemiological information provided by the NSW public health surveillance units at the NSW Health Protection are also gratefully acknowledged. The authors are indebted to all researchers and their organizations who have shared SARS-CoV-2 genome data on GISAID. This study was supported by the Prevention Research Support Program funded by the NSW Ministry of Health and the National Health and Medical Research Council Centre for Research Excellence in Emerging Infectious Diseases (no. GNT1102962). V.S. and M.P. are supported by an Australian Research Council grant (no. DP200103005). The funders of this study had no role in study design, data collection, data analysis and interpretation, or writing of the article.	Anderson RM, 2020, LANCET, V395, P931, DOI 10.1016/S0140-6736(20)30567-5; [Anonymous], 2020, COR DIS 2019 COVID 1; [Anonymous], 2020, NSW COVID 19 CAS STA; [Anonymous], 2020, LIM PUBL GATH COR CO; Australian Government Department of Health, 2019, COVID 19; Bedford J, 2020, LANCET, V395, P1015, DOI 10.1016/S0140-6736(20)30673-5; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Chan JFW, 2020, LANCET, V395, P514, DOI 10.1016/S0140-6736(20)30154-9; Chang SL, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-19393-6; Cliff OM, 2018, SIMUL MODEL PRACT TH, V87, P412, DOI 10.1016/j.simpat.2018.07.005; Deng XD, 2020, SCIENCE, V369, P582, DOI 10.1126/science.abb9263; Di Giallonardo F, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10090476; Eden JS, 2020, VIRUS EVOL, V6, DOI 10.1093/ve/veaa027; Fournet J, 2016, SCI REP-UK, V6, DOI 10.1038/srep24593; Gardy JL, 2018, NAT REV GENET, V19, P9, DOI 10.1038/nrg.2017.88; Ghinai I, 2020, LANCET, V395, P1137, DOI 10.1016/S0140-6736(20)30607-3; Grubaugh ND, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-018-1618-7; Grubaugh ND, 2019, NAT MICROBIOL, V4, P10, DOI 10.1038/s41564-018-0296-2; Gudbjartsson DF, 2020, NEW ENGL J MED, V382, P2302, DOI 10.1056/NEJMoa2006100; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Gurevich A, 2013, BIOINFORMATICS, V29, P1072, DOI 10.1093/bioinformatics/btt086; Hadfield J, 2018, BIOINFORMATICS, V34, P4121, DOI 10.1093/bioinformatics/bty407; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kim D, 2016, GENOME RES, V26, P1721, DOI 10.1101/gr.210641.116; Li RY, 2020, SCIENCE, V368, P489, DOI [10.1126/science.abb3221, 10.1101/2020.02.14.20023127]; Lourenco J, 2020, FUNDAMENTAL PRINCIPL, DOI [10.1101/2020.03.24.20042291, DOI 10.1101/2020.03.24.20042291(2020)]; Lu J, 2020, CELL, V181, P997, DOI 10.1016/j.cell.2020.04.023; Lu RJ, 2020, LANCET, V395, P565, DOI 10.1016/S0140-6736(20)30251-8; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; Ribeiro CD, 2018, SCIENCE, V362, P404, DOI 10.1126/science.aau5229; Sagulenko P, 2018, VIRUS EVOL, V4, DOI 10.1093/ve/vex042; Shen ZJ, 2020, CLIN INFECT DIS, V71, P713, DOI 10.1093/cid/ciaa203; Shu YL, 2017, EUROSURVEILLANCE, V22, P2, DOI 10.2807/1560-7917.ES.2017.22.13.30494; Sintchenko V, 2007, NAT REV MICROBIOL, V5, P464, DOI 10.1038/nrmicro1656; Sintchenko V, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h1314; Sintchenko V, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S2-S10; Spitzer M, 2014, NAT METHODS, V11, P121, DOI 10.1038/nmeth.2811; Verity R, 2020, LANCET INFECT DIS, V20, P669, DOI 10.1016/S1473-3099(20)30243-7; Villabona-Arenas CJ, 2020, NAT MICROBIOL, V5, P876, DOI 10.1038/s41564-020-0738-5; WHO, 2020, 67 WHO; WHO, 2019, REP WHO CHIN JOINT M; World Health Organization, 2021, NOV COR 2019 NCOV SI; World Health Organization, 2020, LAB TESTING 2019 NOV; Wu F, 2020, NATURE, V579, P265, DOI 10.1038/s41586-020-2008-3; Yu GC, 2017, METHODS ECOL EVOL, V8, P28, DOI 10.1111/2041-210X.12628; Zachreson C, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aau5294	46	151	153	12	47	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	SEP	2020	26	9								10.1038/s41591-020-1000-7	http://dx.doi.org/10.1038/s41591-020-1000-7		JUL 2020	12	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	PF3EM	32647358	Bronze			2022-12-27	WOS:000546919600001
J	Banner, NF				Banner, Natalie F.			The human side of health data	NATURE MEDICINE			English	Editorial Material									[Banner, Natalie F.] Wellcome Trust Res Labs, London, England		Banner, NF (corresponding author), Wellcome Trust Res Labs, London, England.	n.banner@wellcome.ac.uk		Banner, Natalie/0000-0002-7329-2601					0	1	1	0	0	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	JUL	2020	26	7					995	995		10.1038/s41591-020-0838-z	http://dx.doi.org/10.1038/s41591-020-0838-z			1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	MK3XO	32661398	Bronze			2022-12-27	WOS:000548716500006
J	Berry, SE; Valdes, AM; Drew, DA; Asnicar, F; Mazidi, M; Wolf, J; Capdevila, J; Hadjigeorgiou, G; Davies, R; Al Khatib, H; Bonnett, C; Ganesh, S; Bakker, E; Hart, D; Mangino, M; Merino, J; Linenberg, I; Wyatt, P; Ordovas, JM; Gardner, CD; Delahanty, LM; Chan, AT; Segata, N; Franks, PW; Spector, TD				Berry, Sarah E.; Valdes, Ana M.; Drew, David A.; Asnicar, Francesco; Mazidi, Mohsen; Wolf, Jonathan; Capdevila, Joan; Hadjigeorgiou, George; Davies, Richard; Al Khatib, Haya; Bonnett, Christopher; Ganesh, Sajaysurya; Bakker, Elco; Hart, Deborah; Mangino, Massimo; Merino, Jordi; Linenberg, Inbar; Wyatt, Patrick; Ordovas, Jose M.; Gardner, Christopher D.; Delahanty, Linda M.; Chan, Andrew T.; Segata, Nicola; Franks, Paul W.; Spector, Tim D.			Human postprandial responses to food and potential for precision nutrition	NATURE MEDICINE			English	Article							DIABETES PREVENTION PROGRAM; GENOME-WIDE ASSOCIATION; LIFE-STYLE INTERVENTION; WEIGHT-LOSS; NONFASTING TRIGLYCERIDES; INSULIN-SECRETION; GLUCOSE; RISK; FAT; DIETARY	Metabolic responses to food influence risk of cardiometabolic disease, but large-scale high-resolution studies are lacking. We recruitedn = 1,002 twins and unrelated healthy adults in the United Kingdom to the PREDICT 1 study and assessed postprandial metabolic responses in a clinical setting and at home. We observed large inter-individual variability (as measured by the population coefficient of variation (s.d./mean, %)) in postprandial responses of blood triglyceride (103%), glucose (68%) and insulin (59%) following identical meals. Person-specific factors, such as gut microbiome, had a greater influence (7.1% of variance) than did meal macronutrients (3.6%) for postprandial lipemia, but not for postprandial glycemia (6.0% and 15.4%, respectively); genetic variants had a modest impact on predictions (9.5% for glucose, 0.8% for triglyceride, 0.2% for C-peptide). Findings were independently validated in a US cohort (n = 100 people). We developed a machine-learning model that predicted both triglyceride (r = 0.47) and glycemic (r = 0.77) responses to food intake. These findings may be informative for developing personalized diet strategies. The ClinicalTrials.gov registration identifier is NCT03479866.	[Berry, Sarah E.; Al Khatib, Haya] Kings Coll London, Dept Nutr, London, England; [Valdes, Ana M.] Univ Nottingham, Sch Med, Nottingham, England; [Valdes, Ana M.] Nottingham NIHR Biomed Res Ctr, Nottingham, England; [Drew, David A.; Merino, Jordi; Delahanty, Linda M.; Chan, Andrew T.] Massachusetts Gen Hosp, Diabet Unit, Boston, MA 02114 USA; [Drew, David A.; Merino, Jordi; Delahanty, Linda M.; Chan, Andrew T.] Massachusetts Gen Hosp, Ctr Genom Med, Boston, MA 02114 USA; [Asnicar, Francesco; Segata, Nicola] Univ Trento, Dept CIBIO, Trento, Italy; [Mazidi, Mohsen; Hart, Deborah; Mangino, Massimo; Franks, Paul W.; Spector, Tim D.] Kings Coll London, Dept Twins Res & Genet Epidemiol, London, England; [Wolf, Jonathan; Capdevila, Joan; Hadjigeorgiou, George; Davies, Richard; Al Khatib, Haya; Bonnett, Christopher; Ganesh, Sajaysurya; Bakker, Elco; Linenberg, Inbar; Wyatt, Patrick] Zoe Global Ltd, London, England; [Merino, Jordi] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Merino, Jordi] Univ Rovira & Virgili, Inst Invest Sanitaria Pere Virgili, Reus, Spain; [Ordovas, Jose M.] Tufts Univ, JM USDA HNRCA, Boston, MA 02111 USA; [Ordovas, Jose M.] CEI UAM CSIC, IMDEA Food Inst, Madrid, Spain; [Gardner, Christopher D.] Univ Stanford, Stanford, CA USA; [Franks, Paul W.] Lund Univ, Dept Clin Sci, Malmo, Sweden; [Franks, Paul W.] Harvard Chan Sch Publ Hlth, Dept Nutr, Boston, MA USA	University of London; King's College London; University of Nottingham; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; University of Trento; University of London; King's College London; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Universitat Rovira i Virgili; Institut d'Investigacio Sanitaria Pere Virgili (IISPV); Tufts University; United States Department of Agriculture (USDA); Consejo Superior de Investigaciones Cientificas (CSIC); Lund University; Harvard University; Harvard T.H. Chan School of Public Health	Valdes, AM (corresponding author), Univ Nottingham, Sch Med, Nottingham, England.; Valdes, AM (corresponding author), Nottingham NIHR Biomed Res Ctr, Nottingham, England.; Spector, TD (corresponding author), Kings Coll London, Dept Twins Res & Genet Epidemiol, London, England.	ana.valdes@nottingham.ac.uk; tim.spector@kcl.ac.uk	Merino, Jordi/AAH-6853-2019; Asnicar, Francesco/AAB-9255-2020; Mangino, Massimo/F-5134-2011	Merino, Jordi/0000-0001-8312-1438; Asnicar, Francesco/0000-0003-3732-1468; Mangino, Massimo/0000-0002-2167-7470; Davies, Richard/0000-0003-2050-3994; Valdes, Ana M./0000-0003-1141-4471; Wolf, Jonathan/0000-0002-0530-2257; Hadjigeorgiou, George/0000-0001-7647-8471; Berry, Sarah/0000-0002-5819-5109	Abbott; Zoe Global; Wellcome Trust [212904/Z/18/Z]; Medical Research Council (MRC)/British Heart Foundation Ancestry and Biological Informative Markers for Stratification of Hypertension (AIMHY) [MR/M016560/1]; BBSRC [BB/NO12739/1]; European Research Council [CoG-2015_681742]; Swedish Research Council; Novo Nordisk Foundation; Swedish Foundation for Strategic Research (IRC award); National Institute for Health Research Nottingham Biomedical Research Centre; Wellcome Trust; Medical Research Council; European Union; Chronic Disease Research Foundation (CDRF); National Institute for Health Research (NIHR); Biomedical Research Centre based at Guy's and St Thomas' NHS Foundation Trust; King's College London; European Commission Horizon 2020 program (H2020-MSCA-IF-2015) [703787]; National Institutes of Health [P30 DK40561]; European Research Council (ERC-STG project MetaPG); European H2020 program (ONCOBIOME project) [825410]; European H2020 program (MASTER project) [818368]; National Cancer Institute of the National Institutes of Health [1U01CA230551]; MRC [MR/M016560/1, MR/N01183X/1] Funding Source: UKRI	Abbott(Abbott Laboratories); Zoe Global; Wellcome Trust(Wellcome Trust); Medical Research Council (MRC)/British Heart Foundation Ancestry and Biological Informative Markers for Stratification of Hypertension (AIMHY)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); European Research Council(European Research Council (ERC)European Commission); Swedish Research Council(Swedish Research CouncilEuropean Commission); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Swedish Foundation for Strategic Research (IRC award); National Institute for Health Research Nottingham Biomedical Research Centre; Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Union(European Commission); Chronic Disease Research Foundation (CDRF); National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); Biomedical Research Centre based at Guy's and St Thomas' NHS Foundation Trust; King's College London(General Electric); European Commission Horizon 2020 program (H2020-MSCA-IF-2015); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Research Council (ERC-STG project MetaPG); European H2020 program (ONCOBIOME project); European H2020 program (MASTER project); National Cancer Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We express our sincere thanks to the participants of the PREDICT 1 study. We thank M. McCarthy (University of Oxford) and L. Hodson (University of Oxford) for valuable feedback on the manuscript. We thank the staff of Z. Global, the Department of Twin Research and Massachusetts General Hospital, for their tireless work in contributing to the running of the study and data collection. We thank Abbott for their support with their CGMs. This work was supported by Zoe Global and also received support from grants from the Wellcome Trust (212904/Z/18/Z) and the Medical Research Council (MRC)/British Heart Foundation Ancestry and Biological Informative Markers for Stratification of Hypertension (AIMHY; MR/M016560/1). S.E.B. was supported in part by a grant funded by the BBSRC (BB/NO12739/1). P.W.F. was supported in part by grants from the European Research Council (CoG-2015_681742_NASCENT), Swedish Research Council, Novo Nordisk Foundation and the Swedish Foundation for Strategic Research (IRC award). A.M.V. was supported by the National Institute for Health Research Nottingham Biomedical Research Centre. TwinsUK is funded by the Wellcome Trust, Medical Research Council, European Union, Chronic Disease Research Foundation (CDRF), Zoe Global and the National Institute for Health Research (NIHR)-funded BioResource, Clinical Research Facility and Biomedical Research Centre based at Guy's and St Thomas' NHS Foundation Trust in partnership with King's College London. J.M. was supported by a fellowship funded by the European Commission Horizon 2020 program (H2020-MSCA-IF-2015-703787) and by National Institutes of Health grant P30 DK40561. N.S. received support from the European Research Council (ERC-STG project MetaPG), the European H2020 program (ONCOBIOME-825410 project and MASTER-818368 project), and the National Cancer Institute of the National Institutes of Health (1U01CA230551).	Afshin A, 2019, LANCET, V393, P1958, DOI 10.1016/S0140-6736(19)30041-8; Almgren P, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.93306; [Anonymous], 2015, DIABETES CARE, V38, pS8, DOI 10.2337/dc15-S005; Astley CM, 2018, CLIN CHEM, V64, P192, DOI 10.1373/clinchem.2017.280727; Atkinson FS, 2018, AM J CLIN NUTR, V108, P737, DOI 10.1093/ajcn/nqy164; Bansal S, 2007, JAMA-J AM MED ASSOC, V298, P309, DOI 10.1001/jama.298.3.309; Bell KJ, 2015, DIABETES CARE, V38, P1008, DOI 10.2337/dc15-0100; Berry S., 2020, PROTOCOL EXCHANGE, DOI [10.21203/rs.2.20798/v1, DOI 10.21203/RS.2.20798/V1]; Blaak EE, 2012, OBES REV, V13, P923, DOI 10.1111/j.1467-789X.2012.01011.x; Borch-Johnsen K, 2001, ARCH INTERN MED, V161, P397, DOI 10.1001/archinte.161.3.397; Bray GA, 2009, LANCET, V374, P1677, DOI 10.1016/S0140-6736(09)61457-4; Callahan BJ, 2016, NAT METHODS, V13, P581, DOI [10.1038/NMETH.3869, 10.1038/nmeth.3869]; Delahanty LM, 2014, DIABETES CARE, V37, P2738, DOI 10.2337/dc14-0018; Dubois C, 1998, AM J CLIN NUTR, V67, P31, DOI 10.1093/ajcn/67.1.31; Eitel I, 2017, INT J CARDIOL, V236, P335, DOI 10.1016/j.ijcard.2017.01.093; European Food Safety Authority, 2017, SUMM REP, V14, DOI [10.2903/sp.efsa.2017.e15121., DOI 10.2903/SP.EFSA.2017.E15121, 10.2903/sp.efsa.2017.e15121]; Flint A, 2000, INT J OBESITY, V24, P38, DOI 10.1038/sj.ijo.0801083; Garcia-Perez I, 2017, LANCET DIABETES ENDO, V5, P184, DOI 10.1016/S2213-8587(16)30419-3; Gardner CD, 2018, JAMA-J AM MED ASSOC, V319, P667, DOI 10.1001/jama.2018.0245; Gelman A., 2007, DATA ANAL USING REGR; Gloor GB, 2016, ANN EPIDEMIOL, V26, P322, DOI 10.1016/j.annepidem.2016.03.003; Goff DC, 2014, J AM COLL CARDIOL, V63, P2935, DOI [10.1016/j.jacc.2013.11.005, 10.1161/01.cir.0000437741.48606.98]; Hansson P, 2019, J NUTR, V149, P422, DOI 10.1093/jn/nxy291; Hastie T, 2013, ELEMENTS STAT LEARNI; Hughes RL, 2019, ADV NUTR, V10, P979, DOI 10.1093/advances/nmz049; Jackson KG, 2012, ATHEROSCLEROSIS, V220, P22, DOI 10.1016/j.atherosclerosis.2011.08.012; Jeong Yeseung, 2020, Prev Nutr Food Sci, V25, P9, DOI 10.3746/pnf.2020.25.1.9; Johansson J, 2010, SCAND J CLIN LAB INV, V70, P404, DOI 10.3109/00365513.2010.501113; Karpyn A, 2018, FOOD PUBLIC HLTH PRA; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Kolovou GD, 2011, CURR VASC PHARMACOL, V9, P258; Lee JG, 2017, KOREAN J RADIOL, V18, P570, DOI 10.3348/kjr.2017.18.4.570; Lindman AS, 2010, EUR J EPIDEMIOL, V25, P789, DOI 10.1007/s10654-010-9501-1; Madhu S, 2017, J CLIN LIPIDOL, V11, P1415, DOI 10.1016/j.jacl.2017.08.001; Moayyeri A, 2013, TWIN RES HUM GENET, V16, P144, DOI 10.1017/thg.2012.89; Mulligan AA, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004503; Nakamura A, 2015, J CARDIOL, V66, P435, DOI 10.1016/j.jjcc.2015.02.005; Ning F, 2010, DIABETES CARE, V33, P2211, DOI 10.2337/dc09-2328; Papandonatos GD, 2015, DIABETES, V64, P4312, DOI 10.2337/db15-0441; Prokopenko I, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004235; Purcell S, 2002, TWIN RES, V5, P554, DOI 10.1375/136905202762342026; Russell WR, 2016, CRIT REV FOOD SCI, V56, P541, DOI 10.1080/10408398.2013.792772; Salvatier J, 2016, PEERJ COMPUT SCI, DOI 10.7717/peerj-cs.55; Samson CE, 2012, INT J ENDOCRINOL MET, V10, DOI 10.5812/ijem.4783; Sanna S, 2019, NAT GENET, V51, P600, DOI 10.1038/s41588-019-0350-x; Saxena R, 2010, NAT GENET, V42, P142, DOI 10.1038/ng.521; SLINKER BK, 1985, AM J PHYSIOL, V249, pR1, DOI 10.1152/ajpregu.1985.249.1.R1; Soininen P, 2015, CIRC-CARDIOVASC GENE, V8, P192, DOI 10.1161/CIRCGENETICS.114.000216; Stumvoll M, 2005, LANCET, V365, P1333, DOI 10.1016/S0140-6736(05)61032-X; Taylor R, 2013, DIABETIC MED, V30, P267, DOI 10.1111/dme.12039; Tebani A, 2019, FRONT NUTR, V6, DOI 10.3389/fnut.2019.00041; Thomas AM, 2019, NAT MED, V25, P667, DOI 10.1038/s41591-019-0405-7; US Department of Health and Human Services; US Department of Agriculture, 2015, 2015 2020 DIET GUID; van Hees VT, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-31266-z; Verdi S, 2019, TWIN RES HUM GENET, V22, P523, DOI 10.1017/thg.2019.65; Viitasalo A, 2019, INT J OBESITY, V43, P2007, DOI 10.1038/s41366-019-0414-0; Wojcikowski M, 2017, SCI REP-UK, V7, DOI 10.1038/srep46710; Wojczynski MK, 2015, METABOLISM, V64, P1359, DOI 10.1016/j.metabol.2015.07.001; Zeevi D, 2015, CELL, V163, P1079, DOI 10.1016/j.cell.2015.11.001; Zierer J, 2018, NAT GENET, V50, P790, DOI 10.1038/s41588-018-0135-7	60	205	209	28	114	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	JUN	2020	26	6					964	+		10.1038/s41591-020-0934-0	http://dx.doi.org/10.1038/s41591-020-0934-0		JUN 2020	19	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	LZ3ZG	32528151	Green Accepted, Green Submitted			2022-12-27	WOS:000539886500005
J	Allen, BM; Hiam, KJ; Burnett, CE; Venida, A; DeBarge, R; Tenvooren, I; Marquez, DM; Cho, NW; Carmi, Y; Spitzer, MH				Allen, Breanna M.; Hiam, Kamir J.; Burnett, Cassandra E.; Venida, Anthony; DeBarge, Rachel; Tenvooren, Iliana; Marquez, Diana M.; Cho, Nam Woo; Carmi, Yaron; Spitzer, Matthew H.			Systemic dysfunction and plasticity of the immune macroenvironment in cancer models	NATURE MEDICINE			English	Article							T-CELL DYSFUNCTION; DENDRITIC CELLS; PD-L1 BLOCKADE; TGF-BETA; EXPRESSION; DIFFERENTIATION; PROGRESSION; REGULATOR; EXPANSION; SURVIVAL	Primary tumor presence and progression shape the systemic immune landscape and immune responses to pathogens in multiple murine tumor models. Understanding of the factors governing immune responses in cancer remains incomplete, limiting patient benefit. In this study, we used mass cytometry to define the systemic immune landscape in response to tumor development across five tissues in eight mouse tumor models. Systemic immunity was dramatically altered across models and time, with consistent findings in the peripheral blood of patients with breast cancer. Changes in peripheral tissues differed from those in the tumor microenvironment. Mice with tumor-experienced immune systems mounted dampened responses to orthogonal challenges, including reduced T cell activation during viral or bacterial infection. Antigen-presenting cells (APCs) mounted weaker responses in this context, whereas promoting APC activation rescued T cell activity. Systemic immune changes were reversed with surgical tumor resection, and many were prevented by interleukin-1 or granulocyte colony-stimulating factor blockade, revealing remarkable plasticity in the systemic immune state. These results demonstrate that tumor development dynamically reshapes the composition and function of the immune macroenvironment.	[Allen, Breanna M.; Hiam, Kamir J.; Burnett, Cassandra E.; Venida, Anthony; DeBarge, Rachel; Spitzer, Matthew H.] Univ Calif San Francisco, Grad Program Biomed Sci, San Francisco, CA 94143 USA; [Allen, Breanna M.; Hiam, Kamir J.; Burnett, Cassandra E.; DeBarge, Rachel; Tenvooren, Iliana; Marquez, Diana M.; Cho, Nam Woo; Spitzer, Matthew H.] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, Parker Inst Canc Immunotherapy, Dept Otolaryngol, San Francisco, CA 94143 USA; [Allen, Breanna M.; Hiam, Kamir J.; Burnett, Cassandra E.; DeBarge, Rachel; Tenvooren, Iliana; Marquez, Diana M.; Cho, Nam Woo; Spitzer, Matthew H.] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, Parker Inst Canc Immunotherapy, Dept Microbiol & Immunol, San Francisco, CA 94143 USA; [Venida, Anthony] Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA; [Cho, Nam Woo] Univ Calif San Francisco, Dept Radiat Oncol, San Francisco, CA USA; [Carmi, Yaron] Tel Aviv Univ, Sackler Sch Med, Dept Pathol, Tel Aviv, Israel	University of California System; University of California San Francisco; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Tel Aviv University; Sackler Faculty of Medicine	Spitzer, MH (corresponding author), Univ Calif San Francisco, Grad Program Biomed Sci, San Francisco, CA 94143 USA.; Spitzer, MH (corresponding author), Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, Parker Inst Canc Immunotherapy, Dept Otolaryngol, San Francisco, CA 94143 USA.; Spitzer, MH (corresponding author), Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, Parker Inst Canc Immunotherapy, Dept Microbiol & Immunol, San Francisco, CA 94143 USA.	matthew.spitzer@ucsf.edu		Venida, Anthony/0000-0001-6119-2999; Allen, Breanna/0000-0002-4830-6792; Spitzer, Matthew/0000-0002-5291-3819; Marquez, Diana/0000-0001-5343-8696; Hiam, Kamir/0000-0002-1956-0257	National Institutes of Health (NIH) [DP5OD023056, P50CA097257]; UCSF Program for Breakthrough Biomedical Research; Parker Institute for Cancer Immunotherapy; NIH [S10OD018040]; European Research Council [ERC-2008-AdG 232997]	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UCSF Program for Breakthrough Biomedical Research; Parker Institute for Cancer Immunotherapy; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Research Council(European Research Council (ERC)European Commission)	We thank the UCSF Flow Cytometry Core and S. Tamaki for CyTOF maintenance and M.H. Barcellos-Hoff, R. Levine, H. Okada, E. Engleman and J. Bluestone for cell lines, transgenic mice and reagents. We thank L. Lanier, Z. Werb, M.H. Barcellos-Hoff and L. Fong for insightful feedback. This work was supported by National Institutes of Health (NIH) grants DP5OD023056 and P50CA097257 (UCSF Brain Tumor SPORE Developmental Research Program), funds from the UCSF Program for Breakthrough Biomedical Research and investigator funding from the Parker Institute for Cancer Immunotherapy to M.H.S. and by NIH grant S10OD018040, which enabled procurement of the mass cytometer used in this study. This study makes use of data generated by the Norwegian Women and Cancer Study. A full list of investigators who contributed to the generation of the data is available at http://site.uit.no/nowac/.Funding for the project was provided by European Research Council grant ERC-2008-AdG 232997. The Norwegian Women and Cancer Study group is not responsible for the analysis or interpretation of the data presented.	Anz D, 2011, INT J CANCER, V129, P2417, DOI 10.1002/ijc.25902; Apte RN, 2006, EUR J CANCER, V42, P751, DOI 10.1016/j.ejca.2006.01.010; Aran D, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1349-1; Bair E, 2004, PLOS BIOL, V2, P511, DOI 10.1371/journal.pbio.0020108; Baluch A, 2013, CURR INFECT DIS REP, V15, P486, DOI 10.1007/s11908-013-0368-7; Barnstorf I, 2019, J EXP MED, V216, P571, DOI 10.1084/jem.20181589; Bianchini M, 2019, SCI IMMUNOL, V4, DOI 10.1126/sciimmunol.aar3054; Busch DH, 1998, IMMUNITY, V8, P353, DOI 10.1016/S1074-7613(00)80540-3; Casbon AJ, 2015, P NATL ACAD SCI USA, V112, pE566, DOI 10.1073/pnas.1424927112; Chamoto K, 2017, P NATL ACAD SCI USA, V114, pE761, DOI 10.1073/pnas.1620433114; Coffelt SB, 2015, NATURE, V522, P345, DOI 10.1038/nature14282; Curiel TJ, 2003, NAT MED, V9, P562, DOI 10.1038/nm863; Danna EA, 2004, CANCER RES, V64, P2205, DOI 10.1158/0008-5472.CAN-03-2646; Dumeaux V, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005680; Finck R, 2013, CYTOM PART A, V83A, P483, DOI 10.1002/cyto.a.22271; Foulds KE, 2002, J IMMUNOL, V168, P1528, DOI 10.4049/jimmunol.168.4.1528; Fourcade J, 2010, J EXP MED, V207, P2175, DOI 10.1084/jem.20100637; Fransen MF, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.124507; Gabrilovich DI, 1997, CLIN CANCER RES, V3, P483; Ghochikyan A, 2014, CLIN EXP METASTAS, V31, P185, DOI 10.1007/s10585-013-9619-0; Hanninen A, 2011, EUR J IMMUNOL, V41, P634, DOI 10.1002/eji.201040760; HEINZEL FP, 1989, J EXP MED, V169, P59, DOI 10.1084/jem.169.1.59; Herndler-Brandstetter D, 2018, IMMUNITY, V48, P716, DOI 10.1016/j.immuni.2018.03.015; Jung S, 2002, IMMUNITY, V17, P211, DOI 10.1016/S1074-7613(02)00365-5; Kaech SM, 2001, NAT IMMUNOL, V2, P415, DOI 10.1038/87720; Kather JN, 2018, ELIFE, V7, DOI 10.7554/eLife.36967; Klastersky J, 2004, ANN ONCOL, V15, P329, DOI 10.1093/annonc/mdh947; Kosaka A, 2014, CANCER IMMUNOL IMMUN, V63, P847, DOI 10.1007/s00262-014-1561-8; Lin H, 2018, J CLIN INVEST, V128, P805, DOI 10.1172/JCI96113; Mariathasan S, 2018, NATURE, V554, P544, DOI 10.1038/nature25501; Mathios D, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aag2942; McAllister SS, 2014, NAT CELL BIOL, V16, P717, DOI 10.1038/ncb3015; Meyer MA, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03600-6; Mita Y, 2018, INT IMMUNOL, V30, P559, DOI 10.1093/intimm/dxy050; Mittal R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093523; Mosely SIS, 2017, CANCER IMMUNOL RES, V5, P29, DOI 10.1158/2326-6066.CIR-16-0114; O'Hara MH, 2019, CANCER RES, V79, DOI 10.1158/1538-7445.AM2019-CT004; Osborne LC, 2014, SCIENCE, V345, P578, DOI 10.1126/science.1256942; Philip M, 2017, NATURE, V545, P452, DOI 10.1038/nature22367; Pickup M, 2013, NAT REV CANCER, V13, P788, DOI 10.1038/nrc3603; Ross EA, 2011, J IMMUNOL, V187, P1553, DOI 10.4049/jimmunol.1000502; Russ AJ, 2011, CELL IMMUNOL, V271, P104, DOI 10.1016/j.cellimm.2011.06.011; Singer C F, 2006, Int J Gynecol Cancer, V16 Suppl 2, P556, DOI 10.1111/j.1525-1438.2006.00695.x; Snell LM, 2018, IMMUNITY, V49, P378, DOI 10.1016/j.immuni.2018.08.002; Spitzer MH, 2017, CELL, V168, P487, DOI 10.1016/j.cell.2016.12.022; Spitzer MH, 2015, SCIENCE, V349, DOI 10.1126/science.1259425; Sun C, 2018, IMMUNITY, V48, P434, DOI 10.1016/j.immuni.2018.03.014; SUZUKI A, 1992, BRIT J CANCER, V65, P515, DOI 10.1038/bjc.1992.106; Tang HD, 2018, J CLIN INVEST, V128, P580, DOI 10.1172/JCI96061; Tseng WW, 2010, CLIN CANCER RES, V16, P3684, DOI 10.1158/1078-0432.CCR-09-2384; Wang L, 2019, NAT IMMUNOL, V20, P1220, DOI 10.1038/s41590-019-0429-7; Westcott PMK, 2015, NATURE, V517, P489, DOI 10.1038/nature13898; Wu TC, 2018, CANCER RES, V78, P5243, DOI 10.1158/0008-5472.CAN-18-0413; Wu WC, 2014, P NATL ACAD SCI USA, V111, P4221, DOI 10.1073/pnas.1320753111; Xie JF, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191065; Yost KE, 2019, NAT MED, V25, P1251, DOI 10.1038/s41591-019-0522-3; Zeitouni B, 2017, CANCER RES, V77, DOI 10.1158/1538-7445.AM2017-1840; Zhang S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164514; Zuckerman NS, 2013, INT J CANCER, V132, P2537, DOI 10.1002/ijc.27933; Zunder ER, 2015, NAT PROTOC, V10, P316, DOI 10.1038/nprot.2015.020	60	90	91	11	45	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	JUL	2020	26	7					1125	+		10.1038/s41591-020-0892-6	http://dx.doi.org/10.1038/s41591-020-0892-6		MAY 2020	30	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	MK3XO	32451499	Green Accepted			2022-12-27	WOS:000535417400001
J	Chrousos, GP; Mentis, AFA; Dardiotis, E				Chrousos, George P.; Mentis, Alexios-Fotios A.; Dardiotis, Efthimios			Biomedical research: lessons from the last decade's crisis and austerity-stricken small countries for the current COVID-19-related crisis	NATURE MEDICINE			English	Editorial Material							SCIENCE; HISTORY		[Chrousos, George P.] Natl & Kapodistrian Univ Athens, Aghia Sophia Childrens Hosp, Univ Res Inst Maternal & Child Hlth & Precis Med, Athens, Greece; [Chrousos, George P.] Natl & Kapodistrian Univ Athens, Aghia Sophia Childrens Hosp, UNESCO Chair Adolescent Hlth Care, Athens, Greece; [Mentis, Alexios-Fotios A.] Hellenic Pasteur Inst, Publ Hlth Labs, Athens, Greece; [Mentis, Alexios-Fotios A.] Univ Thessaly, Univ Hosp Larissa, Dept Microbiol, Larisa, Greece; [Dardiotis, Efthimios] Univ Thessaly, Univ Hosp Larissa, Dept Neurol, Larisa, Greece	National & Kapodistrian University of Athens; The Aghia Sophia Children's Hospital; National & Kapodistrian University of Athens; The Aghia Sophia Children's Hospital; General University Hospital of Larissa; University of Thessaly; General University Hospital of Larissa; University of Thessaly	Chrousos, GP (corresponding author), Natl & Kapodistrian Univ Athens, Aghia Sophia Childrens Hosp, Univ Res Inst Maternal & Child Hlth & Precis Med, Athens, Greece.; Chrousos, GP (corresponding author), Natl & Kapodistrian Univ Athens, Aghia Sophia Childrens Hosp, UNESCO Chair Adolescent Hlth Care, Athens, Greece.	chrousos@gmail.com	Mentis, Alexios-Fotios/AAT-5274-2021	Mentis, Alexios-Fotios/0000-0002-1480-390X				Ahmed A, 2020, AM J TROP MED HYG, V102, P494, DOI 10.4269/ajtmh.19-0674; Allen-Ramdial SAA, 2014, BIOSCIENCE, V64, P612, DOI 10.1093/biosci/biu076; Amann RI, 2019, SCIENCE, V363, P350, DOI 10.1126/science.aaw1280; [Anonymous], 2001, Nature, V409, P545; Brewster R, 2019, TRENDS MICROBIOL, V27, P824, DOI 10.1016/j.tim.2019.05.006; Ebenesersdottir SS, 2018, SCIENCE, V360, P1028, DOI 10.1126/science.aar2625; Featherstone K, 2015, NATURE, V518, P167, DOI 10.1038/518167a; Gurdasani D, 2019, CELL, V179, P984, DOI 10.1016/j.cell.2019.10.004; Herrmann B, 2013, IZA J EUR LABOR STUD, V2, DOI 10.1186/2193-9012-2-14; Higgs DR, 2012, LANCET, V379, P373, DOI 10.1016/S0140-6736(11)60283-3; Ioannidis JPA, 2004, FASEB J, V18, P936, DOI 10.1096/fj.03-1394lfe; Kollias G, 2015, NAT IMMUNOL, V16, P1206, DOI 10.1038/ni.3322; Makri A, 2018, NATURE, V559, P15, DOI 10.1038/d41586-018-05528-9; Mastellos DC, 2019, NAT IMMUNOL, V20, P1409, DOI 10.1038/s41590-019-0503-1; Mathieson I, 2018, NATURE, V555, P197, DOI 10.1038/nature25778; Mentis AFA, 2019, EUR J CLIN INVEST, V49, DOI 10.1111/eci.13167; Oulas A, 2016, ENVIRON MICROBIOL, V18, P1122, DOI 10.1111/1462-2920.13095; Pietri P, 2017, NATURE, V544, P416, DOI 10.1038/544416e; Press WH, 2013, SCIENCE, V342, P817, DOI 10.1126/science.342.6160.817; Silver JK, 2019, BMJ-BRIT MED J, V367, DOI 10.1136/bmj.l5888; Smith DR, 2015, EMBO REP, V16, P14, DOI 10.15252/embr.201439672; Synolakis C, 2009, NATURE, V461, P167, DOI 10.1038/461167a; Xu HC, 2017, DIABETES, V66, P2054, DOI 10.2337/db17-0173; Zhang ZW, 2015, J CLIN INVEST, V125, P1708, DOI 10.1172/JCI80335; 2019, NATURE, V572, P153	25	2	2	2	2	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	MAY	2020	26	5					644	646		10.1038/s41591-020-0859-7	http://dx.doi.org/10.1038/s41591-020-0859-7			4	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	ML1JP	32405057	Bronze			2022-12-27	WOS:000549231500008
J	Slyper, M; Porter, CBM; Ashenberg, O; Waldman, J; Drokhlyansky, E; Wakiro, I; Smillie, C; Smith-Rosario, G; Wu, JY; Dionne, D; Vigneau, S; Jane-Valbuena, J; Tickle, TL; Napolitano, S; Su, MJ; Patel, AG; Karlstrom, A; Gritsch, S; Nomura, M; Waghray, A; Gohil, SH; Tsankov, AM; Jerby-Arnon, L; Cohen, O; Klughammer, J; Rosen, Y; Gould, J; Nguyen, L; Hofree, M; Tramontozzi, PJ; Li, B; Wu, CJ; Izar, B; Haq, R; Hodi, FS; Yoon, CH; Hata, AN; Baker, SJ; Suva, ML; Bueno, R; Stover, EH; Clay, MR; Dyer, MA; Collins, NB; Matulonis, UA; Wagle, N; Johnson, BE; Rotem, A; Rozenblatt-Rosen, O; Regev, A				Slyper, Michal; Porter, Caroline B. M.; Ashenberg, Orr; Waldman, Julia; Drokhlyansky, Eugene; Wakiro, Isaac; Smillie, Christopher; Smith-Rosario, Gabriela; Wu, Jingyi; Dionne, Danielle; Vigneau, Sebastien; Jane-Valbuena, Judit; Tickle, Timothy L.; Napolitano, Sara; Su, Mei-Ju; Patel, Anand G.; Karlstrom, Asa; Gritsch, Simon; Nomura, Masashi; Waghray, Avinash; Gohil, Satyen H.; Tsankov, Alexander M.; Jerby-Arnon, Livnat; Cohen, Ofir; Klughammer, Johanna; Rosen, Yanay; Gould, Joshua; Lan Nguyen; Hofree, Matan; Tramontozzi, Peter J.; Li, Bo; Wu, Catherine J.; Izar, Benjamin; Haq, Rizwan; Hodi, F. Stephen; Yoon, Charles H.; Hata, Aaron N.; Baker, Suzanne J.; Suva, Mario L.; Bueno, Raphael; Stover, Elizabeth H.; Clay, Michael R.; Dyer, Michael A.; Collins, Natalie B.; Matulonis, Ursula A.; Wagle, Nikhil; Johnson, Bruce E.; Rotem, Asaf; Rozenblatt-Rosen, Orit; Regev, Aviv			A single-cell and single-nucleus RNA-Seq toolbox for fresh and frozen human tumors	NATURE MEDICINE			English	Article							CANCER; DISSOCIATION; EXPRESSION	Single-cell genomics is essential to chart tumor ecosystems. Although single-cell RNA-Seq (scRNA-Seq) profiles RNA from cells dissociated from fresh tumors, single-nucleus RNA-Seq (snRNA-Seq) is needed to profile frozen or hard-to-dissociate tumors. Each requires customization to different tissue and tumor types, posing a barrier to adoption. Here, we have developed a systematic toolbox for profiling fresh and frozen clinical tumor samples using scRNA-Seq and snRNA-Seq, respectively. We analyzed 216,490 cells and nuclei from 40 samples across 23 specimens spanning eight tumor types of varying tissue and sample characteristics. We evaluated protocols by cell and nucleus quality, recovery rate and cellular composition. scRNA-Seq and snRNA-Seq from matched samples recovered the same cell types, but at different proportions. Our work provides guidance for studies in a broad range of tumors, including criteria for testing and selecting methods from the toolbox for other tumors, thus paving the way for charting tumor atlases.	[Slyper, Michal; Porter, Caroline B. M.; Ashenberg, Orr; Waldman, Julia; Drokhlyansky, Eugene; Smillie, Christopher; Smith-Rosario, Gabriela; Dionne, Danielle; Jane-Valbuena, Judit; Tickle, Timothy L.; Tsankov, Alexander M.; Jerby-Arnon, Livnat; Klughammer, Johanna; Rosen, Yanay; Gould, Joshua; Lan Nguyen; Hofree, Matan; Rozenblatt-Rosen, Orit; Regev, Aviv] Broad Inst MIT & Harvard, Klarman Cell Observ, Cambridge, MA 02142 USA; [Wakiro, Isaac; Wu, Jingyi; Vigneau, Sebastien; Napolitano, Sara; Su, Mei-Ju; Gohil, Satyen H.; Cohen, Ofir; Li, Bo; Wu, Catherine J.; Izar, Benjamin; Haq, Rizwan; Suva, Mario L.; Stover, Elizabeth H.; Collins, Natalie B.; Wagle, Nikhil; Rotem, Asaf] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Wakiro, Isaac; Wu, Jingyi; Vigneau, Sebastien; Napolitano, Sara; Su, Mei-Ju; Gohil, Satyen H.; Cohen, Ofir; Wu, Catherine J.; Izar, Benjamin; Haq, Rizwan; Hodi, F. Stephen; Yoon, Charles H.; Stover, Elizabeth H.; Matulonis, Ursula A.; Wagle, Nikhil; Johnson, Bruce E.; Rotem, Asaf] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Wakiro, Isaac; Wu, Jingyi; Vigneau, Sebastien; Napolitano, Sara; Su, Mei-Ju; Cohen, Ofir; Izar, Benjamin; Wagle, Nikhil; Johnson, Bruce E.; Rotem, Asaf] Dana Farber Canc Inst, Ctr Canc Precis Med, Boston, MA 02115 USA; [Patel, Anand G.; Karlstrom, Asa; Baker, Suzanne J.; Dyer, Michael A.] St Jude Childrens Res Hosp, Dept Dev Neurobiol, 332 N Lauderdale St, Memphis, TN 38105 USA; [Patel, Anand G.] St Jude Childrens Res Hosp, Dept Oncol, 332 N Lauderdale St, Memphis, TN 38105 USA; [Gritsch, Simon; Nomura, Masashi; Suva, Mario L.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Gritsch, Simon; Nomura, Masashi; Li, Bo; Wu, Catherine J.; Izar, Benjamin; Hata, Aaron N.; Suva, Mario L.; Wagle, Nikhil] Harvard Med Sch, Boston, MA 02115 USA; [Gritsch, Simon; Nomura, Masashi; Suva, Mario L.] Massachusetts Gen Hosp, Canc Res Ctr, Boston, MA 02114 USA; [Waghray, Avinash] Massachusetts Gen Hosp, Ctr Regenerat Med, Boston, MA 02114 USA; [Tramontozzi, Peter J.; Bueno, Raphael] Brigham & Womens Hosp, Div Thorac Surg, 75 Francis St, Boston, MA 02115 USA; [Li, Bo] Massachusetts Gen Hosp, Div Rheumatol Allergy & Immunol, Ctr Immunol & Inflammatory Dis, Boston, MA 02114 USA; [Wu, Catherine J.; Hata, Aaron N.; Wagle, Nikhil] Brigham & Womens Hosp, Dept Internal Med, 75 Francis St, Boston, MA 02115 USA; [Izar, Benjamin] Harvard Med Sch, Lab Syst Pharmacol, Boston, MA 02115 USA; [Izar, Benjamin] Dana Farber Canc Inst, Ctr Immunol & Virol, Boston, MA 02115 USA; [Izar, Benjamin] Ludwig Ctr Canc Res Harvard, Boston, MA USA; [Izar, Benjamin; Hodi, F. Stephen] Dana Farber Canc Inst, Melanoma Dis Ctr, Boston, MA 02115 USA; [Yoon, Charles H.; Hata, Aaron N.] Brigham & Womens Hosp, Dept Surg Oncol, 75 Francis St, Boston, MA 02115 USA; [Hata, Aaron N.] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Clay, Michael R.] St Jude Childrens Res Hosp, Dept Pathol, 332 N Lauderdale St, Memphis, TN 38105 USA; [Dyer, Michael A.; Regev, Aviv] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA; [Collins, Natalie B.] Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; [Collins, Natalie B.] Boston Childrens Hosp, Div Pediat Hematol & Oncol, Boston, MA USA; [Regev, Aviv] MIT, Dept Biol, Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA; [Tsankov, Alexander M.] Icahn Sch Med Mt Sinai, New York, NY 10029 USA; [Izar, Benjamin] Columbia Univ, Med Ctr, Columbia Ctr Translat Immunol, New York, NY USA; [Izar, Benjamin] Columbia Univ, Med Ctr, Div Hematol & Oncol, New York, NY USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; St Jude Children's Research Hospital; St Jude Children's Research Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Harvard University; Massachusetts General Hospital; St Jude Children's Research Hospital; Howard Hughes Medical Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Boston Children's Hospital; Massachusetts Institute of Technology (MIT); Icahn School of Medicine at Mount Sinai; Columbia University; Columbia University	Rozenblatt-Rosen, O; Regev, A (corresponding author), Broad Inst MIT & Harvard, Klarman Cell Observ, Cambridge, MA 02142 USA.; Regev, A (corresponding author), Howard Hughes Med Inst, Chevy Chase, MD 20815 USA.; Regev, A (corresponding author), MIT, Dept Biol, Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA.	orit@broadinstitute.org; aregev@broadinstitute.org	Patel, Anand/G-9877-2018; Waghray, Avinash/AAD-5292-2021; Rozenblatt-Rosen, Orit/HDN-4182-2022; Li, Bo/AAS-8773-2021; Karlström, Åsa/A-8448-2015; Stover, Elizabeth/GYD-3476-2022	Patel, Anand/0000-0002-1438-8275; Waghray, Avinash/0000-0003-3242-2227; Li, Bo/0000-0003-0668-1620; Karlström, Åsa/0000-0003-3847-7309; Tickle, Timothy/0000-0002-6592-6272; Nomura, Masashi/0000-0001-6095-7849; Hofree, Matan/0000-0001-8368-0299; Waldman, Julia/0000-0002-0584-5833; Smillie, Chris/0000-0002-7606-3433	NCI, National Institutes of Health [HHSN261100039, HHSN261201500003I]; 'START: Standardization of Single-Cell and Single-Nucleus RNA-Seq Protocols for Tumors' project from the Chan Zuckerberg Initiative; Klarman Cell Observatory; EMBO Long-Term Fellowship [ALTF 738-2017]; Kay Kendall Leukaemia Fund; NIH/NCI [K08CA222663, CA225088]; Burroughs Wellcome Fund Career Award for Medical Scientists	NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); 'START: Standardization of Single-Cell and Single-Nucleus RNA-Seq Protocols for Tumors' project from the Chan Zuckerberg Initiative; Klarman Cell Observatory; EMBO Long-Term Fellowship(European Molecular Biology Organization (EMBO)); Kay Kendall Leukaemia Fund; NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Burroughs Wellcome Fund Career Award for Medical Scientists(Burroughs Wellcome Fund)	We thank all patients and their families. We thank J. Rood for help with editing, A. Hupalowska for help with figure preparation, the clinical research teams who supplied the samples, E. Todres Gelfand, N. Straub, L. DelloStritto, K. Helvie and S. Periyasamy for project management, R. Levy for NSCLC patient identification, patient consent and protocol optimization, M. Patel, A. Lako and S. Rodig for pathology review, the scientific team at Leidos Biomedical Research, Frederick National Laboratory for Cancer Research, especially R. Agarwal and Y. Mori, the team at National Cancer Institute (NCI), especially S. Hughes, P. Oberdoerffer and D. Singer, and the Human Tumor Atlas Network for helpful discussions. This project has been funded in part with federal funds from the NCI, National Institutes of Health, task order no. HHSN261100039 under contract no. HHSN261201500003I. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products or organizations imply endorsement by the US Government. This project was also funded in part by the 'START: Standardization of Single-Cell and Single-Nucleus RNA-Seq Protocols for Tumors' project from the Chan Zuckerberg Initiative and the Klarman Cell Observatory. R. Agarwal and Y. Mori from Leidos Biomedical Research and S. Hughes and P. Oberdoerffer from NCI were periodically updated about the progress of the project and the manuscript preparation; our funders did not play a role in the study design or manuscript preparation. A. Regev is an Investigator of the Howard Hughes Medical Institute. C.J.W. is a Scholar of the Leukemia and Lymphoma Society. J.K. was supported by an EMBO Long-Term Fellowship (ALTF 738-2017). S.G. was supported by the Kay Kendall Leukaemia Fund. B.I. was supported by NIH/NCI K08CA222663, NIH/NCI CA225088 and a Burroughs Wellcome Fund Career Award for Medical Scientists.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Aran D, 2019, NAT IMMUNOL, V20, P163, DOI 10.1038/s41590-018-0276-y; Bakken TE, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0209648; Baslan T, 2017, NAT REV CANCER, V17, P557, DOI 10.1038/nrc.2017.58; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Butler A, 2018, NAT BIOTECHNOL, V36, P411, DOI 10.1038/nbt.4096; Chevrier S, 2017, CELL, V169, P736, DOI 10.1016/j.cell.2017.04.016; Cieslik M, 2018, NAT REV GENET, V19, P93, DOI 10.1038/nrg.2017.96; Drokhlyansky E., 2019, ENTERIC NERVOUS SYST, DOI [10.1101/746743V4, DOI 10.1101/746743V4]; Filbin MG, 2018, SCIENCE, V360, P331, DOI 10.1126/science.aao4750; Gao RL, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00244-w; Gaublomme JT, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10756-2; Guillaumet-Adkins A, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1171-9; Habib N, 2017, NAT METHODS, V14, P955, DOI [10.1038/NMETH.4407, 10.1038/nmeth.4407]; Habib N, 2016, SCIENCE, V353, P925, DOI 10.1126/science.aad7038; Hermansen JU, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-36121-9; Jerby-Arnon L, 2018, CELL, V175, P984, DOI 10.1016/j.cell.2018.09.006; Kang HM, 2018, NAT BIOTECHNOL, V36, P89, DOI 10.1038/nbt.4042; Karaayvaz M, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06052-0; Lambrechts D, 2018, NAT MED, V24, P1277, DOI 10.1038/s41591-018-0096-5; Li B., 2019, CUMULUS CLOUD BASED, DOI [10.1101/823682V1, DOI 10.1101/823682V1]; Lun ATL, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1662-y; Macosko EZ, 2015, CELL, V161, P1202, DOI 10.1016/j.cell.2015.05.002; MCDIVITT RW, 1984, CANCER RES, V44, P2628; McInnes L., 2018, UMAP UNIFORM MANIFOL; Moonshot Cancer Initiative, GEN HUM TUM ATL; Neftel C, 2019, CELL, V178, P835, DOI 10.1016/j.cell.2019.06.024; Puram SV, 2017, CELL, V171, P1611, DOI 10.1016/j.cell.2017.10.044; Qi ZT, 2019, ORAL ONCOL, V99, DOI 10.1016/j.oraloncology.2019.104441; Rambow F, 2018, CELL, V174, P843, DOI 10.1016/j.cell.2018.06.025; Savas P, 2018, NAT MED, V24, P986, DOI 10.1038/s41591-018-0078-7; Shekhar K, 2016, CELL, V166, P1308, DOI 10.1016/j.cell.2016.07.054; Stewart E, 2017, NATURE, V549, P96, DOI 10.1038/nature23647; Stewart E, 2015, DEV BIOL, V407, P344, DOI 10.1016/j.ydbio.2015.02.002; Stoeckius M, 2018, GENOME BIOL, V19, DOI 10.1186/s13059-018-1603-1; Stoeckius M, 2017, NAT METHODS, V14, P865, DOI [10.1038/nmeth.4380, 10.1038/NMETH.4380]; Suva ML, 2019, MOL CELL, V75, P7, DOI 10.1016/j.molcel.2019.05.003; Tickle T., 2019, KLARMAN CELL OBSERVA; Tirosh I, 2016, NATURE, V539, P309, DOI 10.1038/nature20123; van den Brink SC, 2017, NAT METHODS, V14, P935, DOI 10.1038/nmeth.4437; van Galen P, 2019, CELL, V176, P1265, DOI 10.1016/j.cell.2019.01.031; Venteicher AS, 2017, SCIENCE, V355, DOI 10.1126/science.aai8478; Wolf FA, 2018, GENOME BIOL, V19, DOI 10.1186/s13059-017-1382-0; Wolock SL, 2019, CELL SYST, V8, P281, DOI 10.1016/j.cels.2018.11.005; Young M. D., 2018, SOUPX REMOVES AMBIEN, DOI [10.1101/303727V1, DOI 10.1101/303727V1]	45	142	145	11	29	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	MAY	2020	26	5					792	+		10.1038/s41591-020-0844-1	http://dx.doi.org/10.1038/s41591-020-0844-1			28	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	ML1MY	32405060	Green Published, hybrid, Green Submitted			2022-12-27	WOS:000549240200006
J	Brudno, JN; Lam, N; Vanasse, D; Shen, YW; Rose, JJ; Rossi, J; Xue, AL; Bot, A; Scholler, N; Mikkilineni, L; Roschewski, M; Dean, R; Cachau, R; Youkharibache, P; Patel, R; Hansen, B; Stroncek, DF; Rosenberg, SA; Gress, RE; Kochenderfer, JN				Brudno, Jennifer N.; Lam, Norris; Vanasse, Danielle; Shen, Yueh-wei; Rose, Jeremy J.; Rossi, John; Xue, Allen; Bot, Adrian; Scholler, Nathalie; Mikkilineni, Lekha; Roschewski, Mark; Dean, Robert; Cachau, Raul; Youkharibache, Philippe; Patel, Rashmika; Hansen, Brenna; Stroncek, David F.; Rosenberg, Steven A.; Gress, Ronald E.; Kochenderfer, James N.			Safety and feasibility of anti-CD19 CAR T cells with fully human binding domains in patients with B-cell lymphoma (vol 26, pg 270, 2020)	NATURE MEDICINE			English	Correction												kochendj@mail.nih.gov		Kochenderfer, James/0000-0002-4362-9875; Scholler, nathalie/0000-0003-3743-7102	Intramural NIH HHS [Z01 BC010984] Funding Source: Medline	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Brudno JN, 2020, NAT MED, V26, P270, DOI 10.1038/s41591-019-0737-3	1	0	0	2	9	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	MAY	2020	26	5					803	803		10.1038/s41591-020-0864-x	http://dx.doi.org/10.1038/s41591-020-0864-x		APR 2020	1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	ML1MY	32291416	Green Accepted, Bronze			2022-12-27	WOS:000526350100001
J	Han, XT; Hu, YX; Foschini, L; Chinitz, L; Jankelson, L; Ranganath, R				Han, Xintian; Hu, Yuxuan; Foschini, Luca; Chinitz, Larry; Jankelson, Lior; Ranganath, Rajesh			Deep learning models for electrocardiograms are susceptible to adversarial attack	NATURE MEDICINE			English	Article								Electrocardiogram (ECG) acquisition is increasingly widespread in medical and commercial devices, necessitating the development of automated interpretation strategies. Recently, deep neural networks have been used to automatically analyze ECG tracings and outperform physicians in detecting certain rhythm irregularities(1). However, deep learning classifiers are susceptible to adversarial examples, which are created from raw data to fool the classifier such that it assigns the example to the wrong class, but which are undetectable to the human eye(2,3). Adversarial examples have also been created for medical-related tasks(4,5). However, traditional attack methods to create adversarial examples do not extend directly to ECG signals, as such methods introduce square-wave artefacts that are not physiologically plausible. Here we develop a method to construct smoothed adversarial examples for ECG tracings that are invisible to human expert evaluation and show that a deep learning model for arrhythmia detection from single-lead ECG(6) is vulnerable to this type of attack. Moreover, we provide a general technique for collating and perturbing known adversarial examples to create multiple new ones. The susceptibility of deep learning ECG algorithms to adversarial misclassification implies that care should be taken when evaluating these models on ECGs that may have been altered, particularly when incentives for causing misclassification exist. The development of an algorithm that can imperceptibly manipulate electrocardiographic data to fool a deep learning model for diagnosing cardiac arrhythmia highlights the potential vulnerability of artificial intelligence-enabled diagnosis to adversarial attacks.	[Han, Xintian; Ranganath, Rajesh] NYU, Ctr Data Sci, New York, NY 10003 USA; [Hu, Yuxuan; Chinitz, Larry; Jankelson, Lior] NYU Langone Hlth, Leon H Charney Div Cardiol, New York, NY USA; [Foschini, Luca] Evidat Hlth Inc, San Mateo, CA USA; [Ranganath, Rajesh] NYU Langone Hlth, Dept Populat Hlth, New York, NY 10016 USA; [Ranganath, Rajesh] NYU, Courant Inst Math, New York, NY 10003 USA	New York University; NYU Langone Medical Center; NYU Langone Medical Center; New York University	Han, XT; Ranganath, R (corresponding author), NYU, Ctr Data Sci, New York, NY 10003 USA.; Ranganath, R (corresponding author), NYU Langone Hlth, Dept Populat Hlth, New York, NY 10016 USA.; Ranganath, R (corresponding author), NYU, Courant Inst Math, New York, NY 10003 USA.	xintian.han@nyu.edu; rajeshr@cims.nyu.edu			NIH [R01HL148248]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	X.H. and R.R. were supported in part by the NIH under award no. R01HL148248. We thank W. Lee, S. Mohan, M. Goldstein, A. Li, A.M. Puli, H. Singh, M. Sudarshan, and W. Whitney.	[Anonymous], 2010, I MED US COMM PREV G; Anwar MI, 2017, 2017 4TH INTERNATIONAL CONFERENCE ON SIGNAL PROCESSING AND INTEGRATED NETWORKS (SPIN), P280, DOI 10.1109/SPIN.2017.8049960; Clifford J, 2017, NAT-HIST-SOC, P1; Cohen J, 2019, PR MACH LEARN RES, V97; Feng Y, 2019, J ADVERTISING, V48, P292, DOI 10.1080/00913367.2019.1602858; Finlayson SG, 2019, SCIENCE, V363, P1287, DOI 10.1126/science.aaw4399; Galloway CD, 2019, JAMA CARDIOL, V4, P428, DOI 10.1001/jamacardio.2019.0640; Goodfellow I. J., 2015, P ICLR; Goodfellow S.D., 2018, MACHINE LEARNING HEA, P83; Hannun AY, 2019, NAT MED, V25, P65, DOI 10.1038/s41591-018-0268-3; Hong S, 2017, IEEE WIREL POWER TRA; Julian KD, 2019, J GUID CONTROL DYNAM, V42, P598, DOI 10.2514/1.G003724; Kennedy HL, 2013, PROG CARDIOVASC DIS, V56, P127, DOI 10.1016/j.pcad.2013.08.005; Krizhevsky A., 2009, LEARNING MULTIPLE LA; Kurakin Alexey, 2017, INT C LEARNING REPRE; Kwon JM, 2019, KOREAN CIRC J, V49, P629, DOI 10.4070/kcj.2018.0446; Lecun Y, 1998, P IEEE, V86, P2278, DOI 10.1109/5.726791; Lyle J, 2010, TRUSTED COMPUTING PR; Madry A., 2018, ICLR; McSharry PE, 2003, IEEE T BIO-MED ENG, V50, P289, DOI 10.1109/TBME.2003.808805; Nguyen MT, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-33424-9; Paschali M, 2018, LECT NOTES COMPUT SC, V11070, P493, DOI 10.1007/978-3-030-00928-1_56; Saria S, 2019, TUTORIAL SAFE RELIAB; Schmidt Ludwig, 2018, ADV NEURAL INFORM PR, V31, P5014; Szegedy C., 2014, 2014 INT C LEARNING, DOI DOI 10.48550/ARXIV.1312.6199; Uesato J, 2018, PR MACH LEARN RES, V80	27	43	46	10	31	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	MAR	2020	26	3					360	+		10.1038/s41591-020-0791-x	http://dx.doi.org/10.1038/s41591-020-0791-x		MAR 2020	8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	KU0MC	32152582	Green Accepted			2022-12-27	WOS:000518737200004
J	Rubino, F; Puhl, RM; Cummings, DE; Eckel, RH; Ryan, DH; Mechanick, JI; Nadglowski, J; Salas, XR; Schauer, PR; Twenefour, D; Apovian, CM; Aronne, LJ; Batterham, RL; Berthoud, HR; Boza, C; Busetto, L; Dicker, D; De Groot, M; Eisenberg, D; Flint, SW; Huang, TT; Kaplan, LM; Kirwan, JP; Korner, J; Kyle, TK; Laferrere, B; le Roux, CW; McIver, L; Mingrone, G; Nece, P; Reid, TJ; Rogers, AM; Rosenbaum, M; Seeley, RJ; Torres, AJ; Dixon, JB				Rubino, Francesco; Puhl, Rebecca M.; Cummings, David E.; Eckel, Robert H.; Ryan, Donna H.; Mechanick, Jeffrey I.; Nadglowski, Joe; Ramos Salas, Ximena; Schauer, Phillip R.; Twenefour, Douglas; Apovian, Caroline M.; Aronne, Louis J.; Batterham, Rachel L.; Berthoud, Hans-Rudolph; Boza, Camilo; Busetto, Luca; Dicker, Dror; De Groot, Mary; Eisenberg, Daniel; Flint, Stuart W.; Huang, Terry T.; Kaplan, Lee M.; Kirwan, John P.; Korner, Judith; Kyle, Ted K.; Laferrere, Blandine; le Roux, Carel W.; McIver, LaShawn; Mingrone, Geltrude; Nece, Patricia; Reid, Tirissa J.; Rogers, Ann M.; Rosenbaum, Michael; Seeley, Randy J.; Torres, Antonio J.; Dixon, John B.			Joint international consensus statement for ending stigma of obesity	LANCET DIABETES & ENDOCRINOLOGY			English	Article							PERCEIVED WEIGHT DISCRIMINATION; PUTATIVE CONTRIBUTORS; METABOLIC SURGERY; BODY-WEIGHT; FOOD-INTAKE; IMPACT; BIAS; OVERWEIGHT; OUTCOMES; CARE	People with obesity commonly face a pervasive, resilient form of social stigma. They are often subject to discrimination in the workplace as well as in educational and healthcare settings. Research indicates that weight stigma can cause physical and psychological harm, and that affected individuals are less likely to receive adequate care. For these reasons, weight stigma damages health, undermines human and social rights, and is unacceptable in modern societies. To inform healthcare professionals, policymakers, and the public about this issue, a multidisciplinary group of international experts, including representatives of scientific organizations, reviewed available evidence on the causes and harms of weight stigma and, using a modified Delphi process, developed a joint consensus statement with recommendations to eliminate weight bias. Academic institutions, professional organizations, media, public-health authorities, and governments should encourage education about weight stigma to facilitate a new public narrative about obesity, coherent with modern scientific knowledge.	[Rubino, Francesco; Mingrone, Geltrude] Kings Coll London, Dept Diabet, Sch Life Course Sci, London, England; [Rubino, Francesco] Kings Coll Hosp London, Bariatr & Metab Surg, London, England; [Puhl, Rebecca M.] Univ Connecticut, Rudd Ctr Food Policy & Obes, Hartford, CT 06112 USA; [Cummings, David E.] Univ Washington, UW Med Diabet Inst, Seattle, WA 98195 USA; [Cummings, David E.] Univ Washington, Weight Management Program, Virginia Puget Sound Hlth Care Syst, Seattle, WA 98195 USA; [Eckel, Robert H.] Univ Colorado Anschutz Med Campus, Div Endocrinol Diabet & Metab, Aurora, CO USA; [Eckel, Robert H.] Univ Colorado Anschutz Med Campus, Div Cardiol, Aurora, CO USA; [Ryan, Donna H.; Schauer, Phillip R.] Louisiana State Univ, Pennington Biomed Res Ctr, Baton Rouge, LA 70808 USA; [Mechanick, Jeffrey I.] Mt Sinai Heart, Marie Josee & Henry R Kravis Ctr Clin Cardiovasc, New York, NY USA; [Mechanick, Jeffrey I.] Icahn Sch Med Mt Sinai, Div Cardiol, New York, NY 10029 USA; [Mechanick, Jeffrey I.] Icahn Sch Med Mt Sinai, Div Endocrinol Diabet & Bone Dis, New York, NY 10029 USA; [Nadglowski, Joe; Nece, Patricia] Obes Act Coalit, Tampa, FL USA; [Ramos Salas, Ximena] Obes Canada, Edmonton, AB, Canada; [Ramos Salas, Ximena] European Assoc Study Obes, Teddington, Middx, England; [Twenefour, Douglas] Diabet UK, London, England; [Apovian, Caroline M.] Boston Univ, Sch Med, Boston, MA 02118 USA; [Apovian, Caroline M.] Boston Med Ctr, Ctr Nutr & Weight Management, Boston, MA USA; [Aronne, Louis J.] Weill Cornell Med, Div Endocrinol Diabet & Metab, Comprehens Weight Control Ctr, New York, NY USA; [Batterham, Rachel L.] Univ Coll London Hosp, Biomed Res Ctr, Natl Inst Hlth Res, London, England; [Batterham, Rachel L.] Univ Coll London Hosp Fdn Trust, London, England; [Batterham, Rachel L.] UCL, Dept Med, Ctr Obes Res, London, England; [Berthoud, Hans-Rudolph] Louisiana State Univ Syst, Pennington Biomed Res Ctr, Neurobiol Nutr & Metab Dept, Baton Rouge, LA USA; [Boza, Camilo] Univ Adolfo Ibanez, Clin Las Condes, Ctr Innovac, Santiago, Chile; [Busetto, Luca] Univ Padua, Dept Internal Med, Padua, Italy; [Dicker, Dror] Tel Aviv Univ, Sackler Sch Med, Rabin Med Ctr, Hasharon Hosp, Tel Aviv, Israel; [Dicker, Dror] European Assoc Study Obes, Obes Management Task Force, Teddington, Middx, England; [De Groot, Mary] Indiana Univ Sch Med, Dept Med, Indianapolis, IN 46202 USA; [Eisenberg, Daniel] Stanford Sch Med, Dept Surg, Stanford, CA 94305 USA; [Eisenberg, Daniel] Palo Alto Virginia Hlth Care Syst, Stanford, CA USA; [Flint, Stuart W.] Univ Leeds, Sch Psychol, Leeds, W Yorkshire, England; [Flint, Stuart W.] Univ Leeds, Nexus, Scaled Insights, Leeds, W Yorkshire, England; [Huang, Terry T.] Ctr Syst & Community Design, Dept Hlth Policy & Management, New York, NY USA; [Huang, Terry T.] CUNY, Grad Sch Publ Hlth & Hlth Policy, NYU CUNY Prevent Res Ctr, New York, NY USA; [Kaplan, Lee M.] Massachusetts Gen Hosp, Obes Metab & Nutr Inst, Boston, MA 02114 USA; [Kirwan, John P.] Pennington Biomed Res Ctr, Integrated Physiol & Mol Med, 6400 Perkins Rd, Baton Rouge, LA 70808 USA; [Korner, Judith] Columbia Univ, Dept Med, Irving Med Ctr, New York, NY USA; [Kyle, Ted K.] ConscienHealth, Pittsburgh, PA USA; [Laferrere, Blandine] Columbia Univ, Div Endocrinol, New York, NY USA; [le Roux, Carel W.] Univ Coll Dublin, Diabet Complicat Res Ctr, Dublin, Ireland; [McIver, LaShawn] Amer Diabet Assoc, Govt Affairs & Advocacy, Arlington, VA USA; [Mingrone, Geltrude] IRCCS, Fdn Policlin Univ A Gemelli, Rome, Italy; [Mingrone, Geltrude] Catholic Univ, Rome, Italy; [Reid, Tirissa J.] Columbia Univ, Coll Phys & Surg, Div Endocrinol Diabet & Metab, New York, NY USA; [Rogers, Ann M.] Penn State Hershey Med Ctr, Hershey, PA USA; [Rosenbaum, Michael] Columbia Univ, Irving Med Ctr, New York, NY USA; [Seeley, Randy J.] Univ Michigan, Dept Surg, Ann Arbor, MI 48109 USA; [Torres, Antonio J.] Univ Complutense Madrid, Hosp Clin San Carlos, Madrid, Spain; [Dixon, John B.] Baker IDI Heart & Diabet Inst, Melbourne, Vic, Australia	University of London; King's College London; King's College Hospital NHS Foundation Trust; King's College Hospital; University of Connecticut; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Boston University; Boston Medical Center; Cornell University; University College London Hospitals NHS Foundation Trust; University of London; University College London; University of London; University College London; University of London; University College London; Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center; Clinica Las Condes; Universidad Adolfo Ibanez; University of Padua; Rabin Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Indiana University System; Indiana University Bloomington; Stanford University; University of Leeds; University of Leeds; City University of New York (CUNY) System; Harvard University; Massachusetts General Hospital; Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center; Columbia University; NewYork-Presbyterian Hospital; Columbia University; University College Dublin; American Diabetes Association; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Columbia University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Columbia University; NewYork-Presbyterian Hospital; University of Michigan System; University of Michigan; Complutense University of Madrid; Hospital Clinico San Carlos; Baker Heart and Diabetes Institute	Rubino, F (corresponding author), Kings Coll London, Dept Diabet, Sch Life Course Sci, London, England.; Rubino, F (corresponding author), Kings Coll Hosp London, Bariatr & Metab Surg, London, England.	francesco.rubino@kcl.ac.uk	Aronne, Louis/ABC-8865-2020; Puhl, Rebecca/ABE-9260-2021; Twenefour, Douglas/AAQ-9300-2021	Schauer, Philip/0000-0002-4029-7537; Le Roux, Carel/0000-0001-5521-5445; Mingrone, Geltrude/0000-0003-2021-528X; Huang, Terry/0000-0001-5544-5187; Batterham, Rachel/0000-0002-5477-8585; Ryan, Donna/0000-0001-8374-2277; Seeley, Randy/0000-0002-3721-5625	Medtronic; Ethicon; Novo Nordisk; Fractyl Laboratories; GI Dynamics; Cairn Diagnostics; Keyron; Aventic Group	Medtronic(Medtronic); Ethicon; Novo Nordisk(Novo Nordisk); Fractyl Laboratories(Randox Laboratories); GI Dynamics; Cairn Diagnostics; Keyron; Aventic Group	We thank O. Barata Cavalcanti from the World Obesity Federation (WOF) for her critical role in this consensus conference as moderator of the Delphi process, and E. Papada, D. Qanaq, G. Chamseddine, S. Cremona, and M.F. Russo from King's College London for their assistance with formatting of tables. We acknowledge contributions of W. Cefalu, who participated as a member of the expert panel in his role of Chief Scientific, Medical and Mission Officer of the American Diabetes Association. The face-to-face meeting of the expert panel was hosted by the WCITD2019, which supported travel expenses. WCITD2019 was managed by Kenes Group and was supported by Medtronic (major sponsor), Ethicon (major sponsor), Novo Nordisk, Fractyl Laboratories, GI Dynamics, Cairn Diagnostics, Keyron, and Aventic Group. These sponsors played no role in the selection of voting delegates, the Delphi process, the WCITD2019 program, or the writing of this paper.	Agerstrom J, 2011, J APPL PSYCHOL, V96, P790, DOI 10.1037/a0021594; Alberga AS, 2019, PRIM HEALTH CARE RES, V20, DOI 10.1017/S1463423619000227; Aldrich T, 2010, J MIDWIFERY WOM HEAL, V55, P344, DOI 10.1016/j.jmwh.2009.10.001; Andreyeva T, 2008, OBESITY, V16, P1129, DOI 10.1038/oby.2008.35; Arble DM, 2009, OBESITY, V17, P2100, DOI 10.1038/oby.2009.264; Ata RN, 2010, OBESITY FACTS, V3, P41, DOI 10.1159/000276547; Barry CL, 2011, PEDIATRICS, V128, P132, DOI 10.1542/peds.2010-3924; Batterham RL, 2016, DIABETES CARE, V39, P893, DOI 10.2337/dc16-0145; Bauer C, 2004, GESUNDHEITSWESEN, V66, P246, DOI 10.1055/s-2004-812979; Blaine B, 2002, SEX ROLES, V46, P351, DOI 10.1023/A:1020284731543; BORJESON M, 1976, ACTA PAEDIATR SCAND, V65, P279, DOI 10.1111/j.1651-2227.1976.tb04887.x; Bray GA, 2017, OBES REV, V18, P715, DOI 10.1111/obr.12551; Brewis A, 2018, GLOBALIZATION HEALTH, V14, DOI 10.1186/s12992-018-0337-x; Callahan D, 2013, HASTINGS CENT REP, V43, P34, DOI 10.1002/hast.114; Chassaing B, 2015, NATURE, V519, P92, DOI 10.1038/nature14232; Colley R. C., 2011, HLTH REPORTS, V22, P15; Colley Rachel C, 2011, Health Rep, V22, P7; Corrigan PW, 2006, J SOC CLIN PSYCHOL, V25, P875, DOI 10.1521/jscp.2006.25.8.875; Cummings DE, 2018, DIABETOLOGIA, V61, P257, DOI 10.1007/s00125-017-4513-y; Dixon JB, 2016, SURG OBES RELAT DIS, V12, P1171, DOI 10.1016/j.soard.2015.11.027; Dolan P, 2019, JAMA SURG, V154, P264, DOI 10.1001/jamasurg.2018.4650; Flint SW, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.00647; Flint SW, 2014, INT J DISCRIM LAW, V14, P183, DOI 10.1177/1358229114534550; Flint Stuart W, 2015, BMC Obes, V2, P31, DOI 10.1186/s40608-015-0064-2; Franz MJ, 2007, J AM DIET ASSOC, V107, P1755, DOI 10.1016/j.jada.2007.07.017; Gordon T.J., 1994, FUTURES RES METHODOL, V2, P1; Gruskin Sofia, 1998, Health Hum Rights, V2, P1; Gudzune KA, 2014, PATIENT EDUC COUNS, V97, P128, DOI 10.1016/j.pec.2014.06.019; Hall KD, 2016, OBESITY, V24, P2026, DOI 10.1002/oby.21635; Hall KD, 2012, AM J CLIN NUTR, V95, P989, DOI 10.3945/ajcn.112.036350; Hansen B, 2018, DEVIANT BEHAV, V39, P137, DOI 10.1080/01639625.2016.1263081; Hayden-Wade HA, 2005, OBES RES, V13, P1381, DOI 10.1038/oby.2005.167; Heindel JJ, 2015, NAT REV ENDOCRINOL, V11, P653, DOI 10.1038/nrendo.2015.163; Heuer CA, 2011, J HEALTH COMMUN, V16, P976, DOI 10.1080/10810730.2011.561915; Hilbert A, 2017, OBESITY FACTS, V10, P101, DOI 10.1159/000456012; Hilbert A, 2009, PSYCHOL HEALTH, V24, P749, DOI 10.1080/08870440801947787; Hunger JM, 2014, JAMA PEDIATR, V168, P579, DOI 10.1001/jamapediatrics.2014.122; Jackson SE, 2015, INT J OBESITY, V39, P858, DOI 10.1038/ijo.2014.186; Jackson SE, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-014592; Jackson SE, 2016, OBESITY, V24, P2515, DOI 10.1002/oby.21657; Kaplan LM, 2018, OBESITY, V26, P61, DOI 10.1002/oby.22054; Keith CJ, 2018, SURG OBES RELAT DIS, V14, P631, DOI 10.1016/j.soard.2018.01.017; Keith SW, 2006, INT J OBESITY, V30, P1585, DOI 10.1038/sj.ijo.0803326; Kim JJ, 2017, CURR OBES REP, V6, P238, DOI 10.1007/s13679-017-0269-4; Kim SH, 2007, J HEALTH COMMUN, V12, P359, DOI 10.1080/10810730701326051; LEIBEL RL, 1995, NEW ENGL J MED, V332, P621, DOI 10.1056/NEJM199503093321001; Lydecker JA, 2018, J BEHAV MED, V41, P784, DOI 10.1007/s10865-018-9929-4; Maes HHM, 1997, BEHAV GENET, V27, P325, DOI 10.1023/A:1025635913927; Major B, 2014, J EXP SOC PSYCHOL, V51, P74, DOI 10.1016/j.jesp.2013.11.009; Mannan M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157240; McAllister EJ, 2009, CRIT REV FOOD SCI, V49, P868, DOI 10.1080/10408390903372599; Morton GJ, 2006, NATURE, V443, P289, DOI 10.1038/nature05026; Papadopoulos S, 2015, OBESITY, V23, P1743, DOI 10.1002/oby.21187; Parker R, 2003, SOC SCI MED, V57, P13, DOI 10.1016/S0277-9536(02)00304-0; Pearl RL, 2018, SOC ISS POLICY REV, V12, P146, DOI 10.1111/sipr.12043; Persky S, 2011, ANN BEHAV MED, V41, P363, DOI 10.1007/s12160-010-9242-0; Phelan SM, 2015, OBES REV, V16, P319, DOI 10.1111/obr.12266; Pomeranz JL, 2013, OBESITY, V21, P469, DOI 10.1002/oby.20094; Pont SJ, 2017, PEDIATRICS, V140, DOI 10.1542/peds.2017-3034; Pontzer H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040503; Puhl R, 2013, INT J OBESITY, V37, P612, DOI 10.1038/ijo.2012.110; Puhl RM, 2008, INT J OBESITY, V32, P992, DOI 10.1038/ijo.2008.22; Puhl RM, 2015, INT J OBESITY, V39, P1166, DOI 10.1038/ijo.2015.32; Puhl R, 2015, CURR OBES REP, V4, P182, DOI 10.1007/s13679-015-0153-z; Puhl RM, 2018, OBESITY, V26, P167, DOI 10.1002/oby.22029; Puhl RM, 2017, PREV MED, V100, P173, DOI 10.1016/j.ypmed.2017.04.023; Puhl RM, 2015, MILBANK Q, V93, P691, DOI 10.1111/1468-0009.12162; Puhl RM, 2013, BEST PRACT RES CL EN, V27, P117, DOI 10.1016/j.beem.2012.12.002; Puhl RM, 2013, J HEALTH COMMUN, V18, P686, DOI 10.1080/10810730.2012.743631; Puhl RM, 2009, OBESITY, V17, P941, DOI 10.1038/oby.2008.636; Quick V, 2013, INT J BEHAV NUTR PHY, V10, DOI 10.1186/1479-5868-10-37; Rubino F, 2016, DIABETES CARE, V39, P861, DOI 10.2337/dc16-0236; Rudolph CW, 2009, J VOCAT BEHAV, V74, P1, DOI 10.1016/j.jvb.2008.09.008; Sabin JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048448; Sattler KM, 2018, HEALTH PSYCHOL OPEN, V5, DOI 10.1177/2055102918759691; Schuck N, 2018, INVEST OPHTH VIS SCI, V59; Schulte PA, 2007, AM J PUBLIC HEALTH, V97, P428, DOI 10.2105/AJPH.2006.086900; Schvey NA, 2011, OBESITY, V19, P1957, DOI 10.1038/oby.2011.204; Sharma AM, 2010, OBES REV, V11, P362, DOI 10.1111/j.1467-789X.2009.00689.x; Shinall Jennifer P., 2015, OCCUPATIONAL CHARACT; Sjostrom L, 2013, J INTERN MED, V273, P219, DOI 10.1111/joim.12012; Spahlholz J, 2016, OBES REV, V17, P43, DOI 10.1111/obr.12343; STUNKARD AJ, 1986, NEW ENGL J MED, V314, P193, DOI 10.1056/NEJM198601233140401; Sumithran P, 2011, NEW ENGL J MED, V365, P1597, DOI 10.1056/NEJMoa1105816; Sutin AR, 2015, PSYCHOL SCI, V26, P1803, DOI 10.1177/0956797615601103; Sutin AR, 2014, OBESITY, V22, P1959, DOI 10.1002/oby.20789; Sutin AR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070048; Takizawa R, 2015, PSYCHOL MED, V45, P2705, DOI 10.1017/S0033291715000653; Teachman BA, 2003, HEALTH PSYCHOL, V22, P68, DOI 10.1037/0278-6133.22.1.68; Tremblay A, 2008, APPL PHYSIOL NUTR ME, V33, P791, DOI 10.1139/H08-038; Tyrrell J, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i582; Vadiveloo M, 2017, ANN BEHAV MED, V51, P94, DOI 10.1007/s12160-016-9831-7; Vartanian LR, 2016, APPETITE, V102, P3, DOI 10.1016/j.appet.2016.01.034; Vartanian LR, 2013, OBES SURG, V23, P1545, DOI 10.1007/s11695-013-0918-y; Waasdorp TE, 2018, AM J ORTHOPSYCHIAT, V88, P483, DOI 10.1037/ort0000294; Wadden TA, 2011, NEW ENGL J MED, V365, P1969, DOI 10.1056/NEJMoa1109220; Wu YK, 2018, J ADV NURS, V74, P1030, DOI 10.1111/jan.13511	98	235	242	8	20	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	2213-8587	2213-8595		LANCET DIABETES ENDO	Lancet Diabetes Endocrinol.	MAY	2020	8	5					374	374		10.1038/s41591-020-0803-x	http://dx.doi.org/10.1038/s41591-020-0803-x		MAR 2020	1	Endocrinology & Metabolism	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Endocrinology & Metabolism	LL8UQ	32127716	Green Published, hybrid			2022-12-27	WOS:000517862700001
J	Barthelemy, NR; Li, Y; Joseph-Mathurin, N; Gordon, BA; Hassenstab, J; Benzinger, TLS; Buckles, V; Fagan, AM; Perrin, RJ; Goate, AM; Morris, JC; Karch, CM; Xiong, CJ; Allegri, R; Mendez, PC; Berman, SB; Ikeuchi, T; Mori, H; Shimada, H; Shoji, M; Suzuki, K; Noble, J; Farlow, M; Chhatwal, J; Graff-Radford, NR; Salloway, S; Schofield, PR; Masters, CL; Martins, RN; O'Connor, A; Fox, NC; Levin, J; Jucker, M; Gabelle, A; Lehmann, S; Sato, C; Bateman, RJ; McDade, E; Allegri, R; Allegri, R; Bateman, R; Bechara, J; Benzinger, T; Berman, S; Bodge, C; Brandon, S; Brooks, W; Buck, J; Buckles, V; Chea, S; Chhatwal, J; Mendez, PC; Chui, HL; Cinco, J; Clifford, J; Cruchaga, C; Donahue, T; Douglas, J; Edigo, N; Erekin-Taner, N; Fagan, A; Farlow, M; Fitzpatrick, C; Flynn, G; Fox, N; Franklin, E; Fujii, H; Gant, C; Gardener, S; Ghetti, B; Goate, A; Goldman, J; Gordon, B; Graff-Radford, N; Gray, J; Groves, A; Hassenstab, J; Hoechst-Swisher, L; Holtzman, D; Hornbeck, R; DiBari, SH; Ikeuchi, T; Ikonomovic, S; Jerome, G; Jucker, M; Karch, C; Kasuga, K; Kawarabayashi, T; Klunk, W; Koeppe, R; Kuder-Buletta, E; Laske, C; Lee, JH; Levin, J; Martins, R; Mason, NS; Masters, C; Maue-Dreyfus, D; McDade, E; Mori, H; Morris, J; Nagamatsu, A; Neimeyer, K; Noble, J; Norton, J; Perrin, R; Raichle, M; Renton, A; Ringman, J; Roh, JH; Salloway, S; Schofield, P; Shimada, H; Sigurdson, W; Sohrabi, H; Sparks, P; Suzuki, K; Taddei, K; Wang, PT; Xiong, CJ; Xu, X				Barthelemy, Nicolas R.; Li, Yan; Joseph-Mathurin, Nelly; Gordon, Brian A.; Hassenstab, Jason; Benzinger, Tammie. L. S.; Buckles, Virginia; Fagan, Anne M.; Perrin, Richard J.; Goate, Alison M.; Morris, John C.; Karch, Celeste M.; Xiong, Chengjie; Allegri, Ricardo; Mendez, Patricio Chrem; Berman, Sarah B.; Ikeuchi, Takeshi; Mori, Hiroshi; Shimada, Hiroyuki; Shoji, Mikio; Suzuki, Kazushi; Noble, James; Farlow, Martin; Chhatwal, Jasmeer; Graff-Radford, Neill R.; Salloway, Stephen; Schofield, Peter R.; Masters, Colin L.; Martins, Ralph N.; O'Connor, Antoinette; Fox, Nick C.; Levin, Johannes; Jucker, Mathias; Gabelle, Audrey; Lehmann, Sylvain; Sato, Chihiro; Bateman, Randall J.; McDade, Eric; Allegri, Ricardo; Allegri, Ricardo; Bateman, Randy; Bechara, Jacob; Benzinger, Tammie; Berman, Sarah; Bodge, Courtney; Brandon, Susan; Brooks, William (Bill); Buck, Jill; Buckles, Virginia; Chea, Sochenda; Chhatwal, Jasmeer; Mendez, Patricio; Chui, Helena; Cinco, Jake; Clifford, Jack; Cruchaga, Carlos; Donahue, Tamara; Douglas, Jane; Edigo, Noelia; Erekin-Taner, Nilufer; Fagan, Anne; Farlow, Martin; Fitzpatrick, Colleen; Flynn, Gigi; Fox, Nick; Franklin, Erin; Fujii, Hisako; Gant, Cortaiga; Gardener, Samantha; Ghetti, Bernardino; Goate, Alison; Goldman, Jill; Gordon, Brian; Graff-Radford, Neill; Gray, Julia; Groves, Alexander; Hassenstab, Jason; Hoechst-Swisher, Laura; Holtzman, David; Hornbeck, Russ; DiBari, Siri Houeland; Ikeuchi, Takeshi; Ikonomovic, Snezana; Jerome, Gina; Jucker, Mathias; Karch, Celeste; Kasuga, Kensaku; Kawarabayashi, Takeshi; Klunk, William (Bill); Koeppe, Robert; Kuder-Buletta, Elke; Laske, Christoph; Lee, Jae-Hong; Levin, Johannes; Martins, Ralph; Mason, Neal Scott; Masters, Colin; Maue-Dreyfus, Denise; McDade, Eric; Mori, Hiroshi; Morris, John; Nagamatsu, Akem; Neimeyer, Katie; Noble, James; Norton, Joanne; Perrin, Richard; Raichle, Marc; Renton, Alan; Ringman, John; Roh, Jee Hoon; Salloway, Stephen; Schofield, Peter; Shimada, Hiroyuki; Sigurdson, Wendy; Sohrabi, Hamid; Sparks, Paige; Suzuki, Kazushi; Taddei, Kevin; Wang, Peter; Xiong, Chengjie; Xu, Xiong		Dominantly Inherited Alzheimer Net	A soluble phosphorylated tau signature links tau, amyloid and the evolution of stages of dominantly inherited Alzheimer's disease	NATURE MEDICINE			English	Article							CEREBROSPINAL-FLUID; NEUROFIBRILLARY TANGLES; BETA TOXICITY; PROTEIN-TAU; BIOMARKERS; PLAQUES; PROGRESSION; AGE; ASSOCIATIONS; PREVENTION	Site-specific hyperphosphorylations of tau in the cerebrospinal fluid change with disease course, and correlate with pathology and cognitive decline in dominantly inherited Alzheimer's disease. Development of tau-based therapies for Alzheimer's disease requires an understanding of the timing of disease-related changes in tau. We quantified the phosphorylation state at multiple sites of the tau protein in cerebrospinal fluid markers across four decades of disease progression in dominantly inherited Alzheimer's disease. We identified a pattern of tau staging where site-specific phosphorylation changes occur at different periods of disease progression and follow distinct trajectories over time. These tau phosphorylation state changes are uniquely associated with structural, metabolic, neurodegenerative and clinical markers of disease, and some (p-tau217 and p-tau181) begin with the initial increases in aggregate amyloid-beta as early as two decades before the development of aggregated tau pathology. Others (p-tau205 and t-tau) increase with atrophy and hypometabolism closer to symptom onset. These findings provide insights into the pathways linking tau, amyloid-beta and neurodegeneration, and may facilitate clinical trials of tau-based treatments.	[Barthelemy, Nicolas R.; Li, Yan; Hassenstab, Jason; Buckles, Virginia; Fagan, Anne M.; Morris, John C.; Sato, Chihiro; Bateman, Randall J.; McDade, Eric] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA; [Li, Yan; Xiong, Chengjie] Washington Univ, Sch Med, Div Biostat, St Louis, MO 63110 USA; [Joseph-Mathurin, Nelly; Gordon, Brian A.; Benzinger, Tammie. L. S.] Washington Univ, Sch Med, Dept Radiol, St Louis, MO 63110 USA; [Perrin, Richard J.] Washington Univ, Sch Med, Dept Pathol, St Louis, MO 63110 USA; [Goate, Alison M.] Icahn Sch Med Mt Sinai, Dept Neurosci, New York, NY 10029 USA; [Karch, Celeste M.] Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA; [Allegri, Ricardo; Mendez, Patricio Chrem; Allegri, Ricardo; Allegri, Ricardo; Mendez, Patricio; Edigo, Noelia] Inst Invest Neurol Raul Correa, Fdn Lucha Enfermedades Neurol Infancia, Buenos Aires, Argentina; [Berman, Sarah B.] Univ Pittsburgh, Sch Med, Pittsburgh, PA USA; [Ikeuchi, Takeshi; Allegri, Ricardo; Ikeuchi, Takeshi; Kasuga, Kensaku] Niigata Univ, Niigata, Japan; [Mori, Hiroshi; Shimada, Hiroyuki; Allegri, Ricardo; Fujii, Hisako; Mori, Hiroshi; Shimada, Hiroyuki] Osaka City Univ, Osaka, Japan; [Shoji, Mikio; Allegri, Ricardo; Kawarabayashi, Takeshi; Nagamatsu, Akem; Suzuki, Kazushi] Hirosaki Univ, Hirosaki, Aomori, Japan; [Suzuki, Kazushi] Univ Tokyo, Tokyo, Japan; [Noble, James] Columbia Univ, Coll Phys & Surg, New York, NY USA; [Farlow, Martin] Indiana Univ, Dept Neurol, Indianapolis, IN 46204 USA; [Chhatwal, Jasmeer] Harvard Med Sch, Massachusetts Gen Hosp, Boston, MA 02115 USA; [Graff-Radford, Neill R.] Mayo Clin Jacksonville, Dept Neurol, Jacksonville, FL USA; [Salloway, Stephen] Butler Hosp, Providence, RI 02906 USA; [Salloway, Stephen] Brown Univ, Providence, RI 02912 USA; [Schofield, Peter R.; Allegri, Ricardo; Bechara, Jacob; Brooks, William (Bill); Schofield, Peter] Neurosci Res Australia, Sydney, NSW, Australia; [Schofield, Peter R.] Univ New South Wales, Sch Med Sci, Sydney, NSW, Australia; [Masters, Colin L.] Florey Inst Neurosci & Mental Hlth, Melbourne, Vic, Australia; [Masters, Colin L.; Allegri, Ricardo; Masters, Colin] Univ Melbourne, Melbourne, Vic, Australia; [Martins, Ralph N.; Allegri, Ricardo; Gardener, Samantha; Martins, Ralph; Sohrabi, Hamid; Taddei, Kevin] Edith Cowan Univ, Perth, WA, Australia; [O'Connor, Antoinette; Fox, Nick C.] UCL, Inst Neurol, Dementia Res Ctr, London, England; [Levin, Johannes; Allegri, Ricardo; DiBari, Siri Houeland; Levin, Johannes] German Ctr Neurodegenerat Dis DZNE, Munich, Germany; [Levin, Johannes] Ludwig Maximilians Univ Munchen, Dept Neurol, Munich, Germany; [Levin, Johannes] Munich Cluster Syst Neurol SyNergy, Munich, Germany; [Jucker, Mathias; Allegri, Ricardo; Jucker, Mathias; Kuder-Buletta, Elke; Laske, Christoph] German Ctr Neurodegenerat Dis DZNE, Tubingen, Germany; [Jucker, Mathias] Univ Tubingen, Hertie Inst Clin Brain Res, Tubingen, Germany; [Gabelle, Audrey; Lehmann, Sylvain] CHU Montpellier, Lab Biochim & Prote Clin, INSERM UM, Montpellier, France; [Gabelle, Audrey; Lehmann, Sylvain] CHU Montpellier, CRB, INSERM UM, Montpellier, France; [Allegri, Ricardo; Bateman, Randy; Benzinger, Tammie; Brandon, Susan; Buckles, Virginia; Cruchaga, Carlos; Donahue, Tamara; Fagan, Anne; Flynn, Gigi; Franklin, Erin; Gant, Cortaiga; Gordon, Brian; Gray, Julia; Groves, Alexander; Hassenstab, Jason; Hoechst-Swisher, Laura; Holtzman, David; Hornbeck, Russ; Jerome, Gina; Karch, Celeste; Maue-Dreyfus, Denise; McDade, Eric; Morris, John; Norton, Joanne; Perrin, Richard; Raichle, Marc; Sigurdson, Wendy; Wang, Peter; Xiong, Chengjie; Xu, Xiong] Washington Univ, St Louis Sch Med, St Louis, MO USA; [Allegri, Ricardo; Berman, Sarah; Ikonomovic, Snezana; Klunk, William (Bill)] Univ Pittsburgh, Pittsburgh, PA USA; [Allegri, Ricardo; Bodge, Courtney; Salloway, Stephen] Brown Univ, Butler Hosp, Providence, RI 02912 USA; [Allegri, Ricardo; Buck, Jill; Farlow, Martin; Ghetti, Bernardino] Indiana Univ, Bloomington, IN USA; [Chea, Sochenda; Clifford, Jack; Erekin-Taner, Nilufer; Graff-Radford, Neill] Mayo Clin Jacksonville, Jacksonville, FL USA; [Chhatwal, Jasmeer; Fitzpatrick, Colleen; Sparks, Paige] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA; [Chhatwal, Jasmeer] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Chui, Helena; Ringman, John] Univ Southern Calif, Los Angeles, CA 90007 USA; [Cinco, Jake; Douglas, Jane; Fox, Nick] UCL, London, England; [Goate, Alison; Renton, Alan] Icahn Sch Med Mt Sinai, New York, NY 10029 USA; [Goldman, Jill; Neimeyer, Katie; Noble, James] Columbia Univ, New York, NY USA; [Koeppe, Robert] Univ Michigan, Ann Arbor, MI 48109 USA; [Lee, Jae-Hong; Roh, Jee Hoon] Asan Med Ctr, Seoul, South Korea; [Mason, Neal Scott] Univ Pittsburgh, Med Ctr, Pittsburgh, PA USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Icahn School of Medicine at Mount Sinai; Washington University (WUSTL); Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Niigata University; Osaka Metropolitan University; Hirosaki University; University of Tokyo; Columbia University; Indiana University System; Indiana University-Purdue University Indianapolis; Harvard University; Harvard Medical School; Massachusetts General Hospital; Mayo Clinic; Butler Hospital Rhode Island; Brown University; Neuroscience Research Australia; University of New South Wales Sydney; Florey Institute of Neuroscience & Mental Health; University of Melbourne; Edith Cowan University; University of London; University College London; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); University of Munich; University of Munich; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; CHU de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; CHU de Montpellier; Saint Louis University; Washington University (WUSTL); Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Brown University; Butler Hospital Rhode Island; Indiana University System; Indiana University Bloomington; Mayo Clinic; Harvard University; Brigham & Women's Hospital; Harvard University; Massachusetts General Hospital; University of Southern California; University of London; University College London; Icahn School of Medicine at Mount Sinai; Columbia University; University of Michigan System; University of Michigan; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Bateman, RJ; McDade, E (corresponding author), Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA.	batemanr@wustl.edu; ericmcdade@wustl.edu	Fox, Nick C/AAE-1849-2021; Cruchaga, Carlos/ABF-4065-2020; JH, Roh/F-4078-2014; Gordon, Brian/U-7794-2019; Levin, Johannes/W-8686-2019; Kasuga, Kensaku/AAQ-6627-2020; Sohrabi, Hamid Reza/ABY-5173-2022; Fox, Nick C/B-1319-2009; Benzinger, Tammie/L-6104-2013; ALLEGRI, RICARDO FRANCISCO/AAY-4898-2021; Lehmann, Sylvain/P-1301-2017; Berman, Sarah/I-2792-2014; Gardener, Samantha/D-1718-2016; Sohrabi, Hamid Reza/L-2461-2016	Fox, Nick C/0000-0002-6660-657X; Cruchaga, Carlos/0000-0002-0276-2899; JH, Roh/0000-0002-3243-0529; Gordon, Brian/0000-0003-2109-2955; Levin, Johannes/0000-0001-5092-4306; Kasuga, Kensaku/0000-0002-2178-0769; Fox, Nick C/0000-0002-6660-657X; Benzinger, Tammie/0000-0002-8114-0552; Brooks, William Seymour/0000-0001-8603-4233; Joseph-Mathurin, Nelly/0000-0002-9735-5152; Sato, Chihiro/0000-0002-7639-8727; Klunk, William/0000-0001-5512-0251; Lehmann, Sylvain/0000-0001-6117-562X; Goate, Alison/0000-0002-0576-2472; Masters, Colin/0000-0003-3072-7940; Berman, Sarah/0000-0002-5096-4962; Morris, John/0000-0001-9820-5618; Bateman, Randall/0000-0002-7729-1702; Shoji, Mikio/0000-0003-1027-1712; Gardener, Samantha/0000-0002-1933-5260; Sohrabi, Hamid Reza/0000-0001-8017-8682	National Institute on Aging, German Center for Neurodegenerative Diseases and Raul Carrea Institute for Neurological Research (FLENI) [UF1AG032438]; Japan Agency for Medical Research and Development; Korea Health Technology R&D Project, through the Korea Health Industry Development Institute; MRC Dementias Platform UK [MR/L023784/1, MR/009076/1]; AOI Lady Biobank CHU; Alzheimer's Association Research Fellowship [AARF-16-443265]; Fondation Plan Alzheimer; BrightFocus [A20143845]; National Institute of Neurological Disorders and Stroke; National Institute on Aging [R01NS095773];  [K23 AG046363]; MRC [MR/L023784/1, UKDRI-1001] Funding Source: UKRI	National Institute on Aging, German Center for Neurodegenerative Diseases and Raul Carrea Institute for Neurological Research (FLENI); Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED)); Korea Health Technology R&D Project, through the Korea Health Industry Development Institute; MRC Dementias Platform UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); AOI Lady Biobank CHU; Alzheimer's Association Research Fellowship; Fondation Plan Alzheimer; BrightFocus(BrightFocus Foundation); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); ; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Data collection and sharing for this project was supported by the DIAN (UF1AG032438), funded by the National Institute on Aging, German Center for Neurodegenerative Diseases and Raul Carrea Institute for Neurological Research (FLENI), with partial support via research and development grants for dementia from the Japan Agency for Medical Research and Development and the Korea Health Technology R&D Project, through the Korea Health Industry Development Institute, MRC Dementias Platform UK (MR/L023784/1 and MR/009076/1) and AOI Lady Biobank CHU. The development and performance of the mass spectrometry analyses was supported by the Alzheimer's Association Research Fellowship (AARF-16-443265 to N.R.B.), Fondation Plan Alzheimer (to A.G. and S.L.), BrightFocus (A20143845 to R.J.B.), the National Institute of Neurological Disorders and Stroke (R01NS095773 to R.J.B.) and the National Institute on Aging (K23 AG046363 to E.M.). This manuscript has been reviewed by DIAN Study investigators for scientific content and consistency of data interpretation with previous DIAN Study publications. We acknowledge the altruism of the participants and their families and contributions of the DIAN research and support staff at each of the participating sites for their contributions to this study. We thank J. Ringman and B. Ghetti for reviewing the manuscript and making suggestions.	[Anonymous], 2012, CLIN INVESTIG, DOI DOI 10.4155/CLI.12.93; ARRIAGADA PV, 1992, NEUROLOGY, V42, P631, DOI 10.1212/WNL.42.3.631; Barthelemy NR, 2016, J PROTEOME RES, V15, P667, DOI 10.1021/acs.jproteome.5b01001; Bateman RJ, 2017, ALZHEIMERS DEMENT, V13, P8, DOI 10.1016/j.jalz.2016.07.005; Bateman RJ, 2012, NEW ENGL J MED, V367, P795, DOI 10.1056/NEJMoa1202753; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Benzinger TLS, 2013, P NATL ACAD SCI USA, V110, pE4502, DOI 10.1073/pnas.1317918110; Buerger K, 2006, BRAIN, V129, P3035, DOI 10.1093/brain/awl269; Cohen AD, 2018, ALZHEIMERS DEMENT, V14, P743, DOI 10.1016/j.jalz.2018.01.002; CROWTHER RA, 1991, P NATL ACAD SCI USA, V88, P2288, DOI 10.1073/pnas.88.6.2288; del Campo M, 2012, BIOMARK MED, V6, P419, DOI [10.2217/bmm.12.46, 10.2217/BMM.12.46]; Fagan AM, 2007, ARCH NEUROL-CHICAGO, V64, P343, DOI 10.1001/archneur.64.3.noc60123; Fagan AM, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007901; Fitzpatrick AWP, 2017, NATURE, V547, P185, DOI 10.1038/nature23002; Fleisher AS, 2015, JAMA NEUROL, V72, P316, DOI 10.1001/jamaneurol.2014.3314; GOEDERT M, 1989, NEURON, V3, P519, DOI 10.1016/0896-6273(89)90210-9; Gordon BA, 2019, BRAIN, V142, P1063, DOI 10.1093/brain/awz019; Gordon BA, 2018, LANCET NEUROL, V17, P241, DOI 10.1016/S1474-4422(18)30028-0; GRUNDKEIQBAL I, 1986, P NATL ACAD SCI USA, V83, P4913, DOI 10.1073/pnas.83.13.4913; Hampel H, 2004, ARCH GEN PSYCHIAT, V61, P95, DOI 10.1001/archpsyc.61.1.95; He ZH, 2018, NAT MED, V24, P29, DOI 10.1038/nm.4443; Hu WT, 2013, NEUROLOGY, V81, P1945, DOI 10.1212/01.wnl.0000436625.63650.27; Ittner A, 2016, SCIENCE, V354, P904, DOI 10.1126/science.aah6205; Ittner LM, 2010, CELL, V142, P387, DOI 10.1016/j.cell.2010.06.036; Jack CR, 2019, BRAIN, V142, P3230, DOI 10.1093/brain/awz268; Jack CR, 2016, NEUROLOGY, V87, P539, DOI 10.1212/WNL.0000000000002923; Jack CR, 2018, ALZHEIMERS DEMENT, V14, P535, DOI 10.1016/j.jalz.2018.02.018; Jin M, 2011, P NATL ACAD SCI USA, V108, P5819, DOI 10.1073/pnas.1017033108; Johnson KA, 2016, ANN NEUROL, V79, P110, DOI 10.1002/ana.24546; Kimura T, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00044; La Joie R, 2018, NEUROLOGY, V90, pE282, DOI 10.1212/WNL.0000000000004860; Lim YY, 2016, BRAIN, V139, P2766, DOI 10.1093/brain/aww200; Luo JQ, 2015, BIOMETRICAL J, V57, P1084, DOI 10.1002/bimj.201400131; Maia LF, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006446; Mattsson N, 2019, ALZHEIMERS DEMENT, V15, P570, DOI 10.1016/j.jalz.2018.12.001; Mattsson N, 2017, EMBO MOL MED, V9, P1212, DOI 10.15252/emmm.201707809; McDade E, 2018, NEUROLOGY, V91, pE1295, DOI 10.1212/WNL.0000000000006277; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Medina M, 2015, EXPERT REV NEUROTHER, V15, P115, DOI 10.1586/14737175.2015.1000864; MORI H, 1995, NEUROSCI LETT, V186, P181, DOI 10.1016/0304-3940(95)11291-4; MORRIS JC, 1993, NEUROLOGY, V43, P2412, DOI 10.1212/WNL.43.11.2412-a; Okonkwo OC, 2011, ARCH NEUROL-CHICAGO, V68, P113, DOI 10.1001/archneurol.2010.334; Patterson BW, 2015, ANN NEUROL, V78, P439, DOI 10.1002/ana.24454; Potter R, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005615; Price JL, 1999, ANN NEUROL, V45, P358, DOI 10.1002/1531-8249(199903)45:3<358::AID-ANA12>3.0.CO;2-X; PRICE JL, 1991, NEUROBIOL AGING, V12, P295, DOI 10.1016/0197-4580(91)90006-6; Qian J, 2017, JAMA NEUROL, V74, P540, DOI 10.1001/jamaneurol.2016.5953; Quiroz YT, 2018, JAMA NEUROL, V75, P548, DOI 10.1001/jamaneurol.2017.4907; Quiroz YT, 2013, J NEUROL NEUROSUR PS, V84, P556, DOI 10.1136/jnnp-2012-303299; Ridha BH, 2006, LANCET NEUROL, V5, P828, DOI 10.1016/S1474-4422(06)70550-6; Ryman DC, 2014, NEUROLOGY, V83, P253, DOI 10.1212/WNL.0000000000000596; Saman S, 2012, J BIOL CHEM, V287, P3842, DOI 10.1074/jbc.M111.277061; Sato C, 2018, NEURON, V97, P1284, DOI 10.1016/j.neuron.2018.02.015; Schelle J, 2017, ALZHEIMERS DEMENT, V13, P701, DOI 10.1016/j.jalz.2016.09.005; Schindler SE, 2019, ALZHEIMERS DEMENT, V15, P655, DOI 10.1016/j.jalz.2018.12.019; Storandt M, 2014, NEUROPSYCHOLOGY, V28, P19, DOI 10.1037/neu0000030; Su Y, 2015, NEUROIMAGE, V107, P55, DOI 10.1016/j.neuroimage.2014.11.058; Toledo JB, 2013, ACTA NEUROPATHOL, V126, P659, DOI 10.1007/s00401-013-1151-4; van der Kant R, 2019, CELL STEM CELL, V24, P363, DOI 10.1016/j.stem.2018.12.013; VANDERMEEREN M, 1993, J NEUROCHEM, V61, P1828, DOI 10.1111/j.1471-4159.1993.tb09823.x; Xiong CJ, 2016, NEUROLOGY, V86, P1499, DOI 10.1212/WNL.0000000000002593; Yamada K, 2011, J NEUROSCI, V31, P13110, DOI 10.1523/JNEUROSCI.2569-11.2011; Yanamandra K, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aal2029; Zempel H, 2010, J NEUROSCI, V30, P11938, DOI 10.1523/JNEUROSCI.2357-10.2010	64	197	201	15	88	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	MAR	2020	26	3					398	+		10.1038/s41591-020-0781-z	http://dx.doi.org/10.1038/s41591-020-0781-z			20	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	KU0MC	32161412	Green Submitted, Green Published, Green Accepted			2022-12-27	WOS:000519405000028
J	Stower, H				Stower, Hannah			NK cells join the anti-cancer armory	NATURE MEDICINE			English	Editorial Material												h.stower@us.nature.com							0	0	0	0	1	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	MAR	2020	26	3					312	312		10.1038/s41591-020-0808-5	http://dx.doi.org/10.1038/s41591-020-0808-5			1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	KU0MC	32161409	Bronze			2022-12-27	WOS:000519405000009
J	Poon, LLM; Peiris, M				Poon, Leo L. M.; Peiris, Malik			Emergence of a novel human coronavirus threatening human health	NATURE MEDICINE			English	Editorial Material									[Poon, Leo L. M.; Peiris, Malik] Univ Hong Kong, LKS Fac Med, Sch Publ Hlth, Hong Kong, Peoples R China	University of Hong Kong	Peiris, M (corresponding author), Univ Hong Kong, LKS Fac Med, Sch Publ Hlth, Hong Kong, Peoples R China.	malik@hku.hk	Poon, Leo/AAP-6887-2020					Bai Y, 2020, JAMA-J AM MED ASSOC, V323, P1406, DOI [10.1056/NEJMoa2001316, 10.1001/jama.2020.2565]; Chan JFW, 2020, LANCET, V395, P514, DOI 10.1016/S0140-6736(20)30154-9; Chen NS, 2020, LANCET, V395, P507, DOI 10.1016/S0140-6736(20)30211-7; Choe PG, 2017, EMERG INFECT DIS, V23, P1079, DOI 10.3201/eid2307.170310; Corman VM, 2016, P NATL ACAD SCI USA, V113, P9864, DOI 10.1073/pnas.1604472113; Guan W, 2020, NEW ENGL J MED, V382, P1708, DOI 10.1056/NEJMoa2002032; Lu RJ, 2020, LANCET, V395, P565, DOI 10.1016/S0140-6736(20)30251-8; Rothe C, 2020, NEW ENGL J MED, V382, P970, DOI 10.1056/NEJMc2001468; Tian XL, 2020, EMERG MICROBES INFEC, V9, P382, DOI 10.1080/22221751.2020.1729069; Uyeki TM, 2020, NEW ENGL J MED, V382; Wan YS, 2020, J VIROL, V94, DOI 10.1128/JVI.02015-19; Wong JY, 2013, EPIDEMIOLOGY, V24, P830, DOI 10.1097/EDE.0b013e3182a67448; Wu JT, 2020, LANCET, V395, P689, DOI 10.1016/S0140-6736(20)30260-9; Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017	14	87	91	3	35	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	MAR	2020	26	3					317	319		10.1038/s41591-020-0796-5	http://dx.doi.org/10.1038/s41591-020-0796-5		FEB 2020	3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	KU0MC	32108160	Green Published, Bronze			2022-12-27	WOS:000516891000001
J	Milanez-Almeida, P; Martins, AJ; Germain, RN; Tsang, JS				Milanez-Almeida, Pedro; Martins, Andrew J.; Germain, Ronald N.; Tsang, John S.			Cancer prognosis with shallow tumor RNA sequencing	NATURE MEDICINE			English	Article							IMPROVING DEVELOPMENT; REGULARIZATION PATHS; MOLECULAR SIGNATURE; SIGNALING PATHWAYS; BREAST-CANCER; HETEROGENEITY; GENES; DIAGNOSIS; SURVIVAL; MODELS	Application of machine-learning models on very shallow RNA sequencing data maintains predictive performance across different tumor types. Disrupted molecular pathways are often robustly associated with disease outcome in cancer(1-3). Although biologically informative transcriptional pathways can be revealed by RNA sequencing (RNA-seq) at up to hundreds of folds reduction in conventionally used coverage(4-6), it remains unknown how low-depth sequencing datasets perform in the challenging context of developing transcriptional signatures to predict clinical outcomes. Here we assessed the possibility of cancer prognosis with shallow tumor RNA-seq, which would potentially enable cost-effective assessment of much larger numbers of samples for deeper biological and predictive insights. By statistically modeling the relative risk of an adverse outcome for thousands of subjects in The Cancer Genome Atlas(7-13), we present evidence that subsampled tumor RNA-seq data with a few hundred thousand reads per sample provide sufficient information for outcome prediction in several types of cancer. Analysis of predictive models revealed robust contributions from pathways known to be associated with outcomes. Our findings indicate that predictive models of outcomes in cancer may be developed with dramatically increases in sample numbers at low cost, thus potentially enabling the development of more realistic predictive models that incorporate diverse variables and their interactions. This strategy could also be used, for example, in longitudinal analysis of multiple regions of a tumor alongside treatment for quantitative modeling and prediction of outcome in personalized oncology.	[Milanez-Almeida, Pedro; Germain, Ronald N.] NIAID, Lymphocyte Biol Sect, Lab Immune Syst Biol, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Milanez-Almeida, Pedro; Tsang, John S.] NIH, TransNIH Ctr Human Immunol CHI, Bldg 10, Bethesda, MD 20892 USA; [Martins, Andrew J.; Tsang, John S.] NIAID, Multiscale Syst Biol Sect, Lab Immune Syst Biol, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Milanez-Almeida, P (corresponding author), NIAID, Lymphocyte Biol Sect, Lab Immune Syst Biol, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.; Milanez-Almeida, P (corresponding author), NIH, TransNIH Ctr Human Immunol CHI, Bldg 10, Bethesda, MD 20892 USA.	pedromilanez@gmail.com	Germain, Ronald/ABE-7090-2020; Milanez-Almeida, Pedro/AAN-1124-2020; Martins, Andrew/AAU-7039-2021	Martins, Andrew/0000-0002-1832-1924; Milanez-Almeida, Pedro/0000-0001-8285-957X	Intramural Research Program of the National Institute of Allergy and Infectious Disease (NIAID), National Institutes of Health (NIH)	Intramural Research Program of the National Institute of Allergy and Infectious Disease (NIAID), National Institutes of Health (NIH)	We would like to thank S. J. Chanock for early critical comments and for reviewing the manuscript, as well as E. Condiff, A. Gola, H. Wong and S. Uderhardt for fruitful suggestions and discussions. This work was supported by the Intramural Research Program of the National Institute of Allergy and Infectious Disease (NIAID), National Institutes of Health (NIH) and the Institutes supporting the Trans-NIH Center for Human Immunology. This study used the Office of Cyber Infrastructure and Computational Biology (OCICB) High Performance Computing (HPC) cluster at NIAID.	[Anonymous], 2019, R LANG ENV STAT COMP; [Anonymous], 2017, FOR FOR LOOP CONSTR; Auguie B., 2017, GRIDEXTRA MISCELLANE; Budhu A, 2006, CANCER CELL, V10, P99, DOI 10.1016/j.ccr.2006.06.016; Cieslik M, 2018, NAT REV GENET, V19, P93, DOI 10.1038/nrg.2017.96; Colaprico A, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkv1507; Cuzick J, 2011, LANCET ONCOL, V12, P245, DOI 10.1016/S1470-2045(10)70295-3; Dai HY, 2005, CANCER RES, V65, P4059, DOI 10.1158/0008-5472.CAN-04-3953; Dang CV, 2012, GENE DEV, V26, P877, DOI 10.1101/gad.189365.112; Ding L, 2018, CELL, V173, P305, DOI 10.1016/j.cell.2018.03.033; Dupuy A, 2007, JNCI-J NATL CANCER I, V99, P147, DOI 10.1093/jnci/djk018; E F, 2019, RMS REGRESSION MODEL; Ein-Dor L, 2005, BIOINFORMATICS, V21, P171, DOI 10.1093/bioinformatics/bth469; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; Gentles AJ, 2015, NAT MED, V21, P938, DOI 10.1038/nm.3909; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Hahn WC, 2002, NAT REV CANCER, V2, P331, DOI 10.1038/nrc795; Heimberg G, 2016, CELL SYST, V2, P239, DOI 10.1016/j.cels.2016.04.001; Huber W, 2015, NAT METHODS, V12, P115, DOI [10.1038/NMETH.3252, 10.1038/nmeth.3252]; Hutter C, 2018, CELL, V173, P283, DOI 10.1016/j.cell.2018.03.042; Kliebenstein DJ, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00213; Kuhn M, 2008, J STAT SOFTW, V28, P1, DOI 10.18637/jss.v028.i05; Kumar-Sinha C, 2018, NAT BIOTECHNOL, V36, P46, DOI 10.1038/nbt.4017; Kurtz DM, 2019, CELL, V178, P699, DOI 10.1016/j.cell.2019.06.011; Law CW, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r29; Liberzon A, 2015, CELL SYST, V1, P417, DOI 10.1016/j.cels.2015.12.004; Liu JF, 2018, CELL, V173, P400, DOI 10.1016/j.cell.2018.02.052; Liu Y, 2018, CANCER CELL, V33, P721, DOI 10.1016/j.ccell.2018.03.010; McGranahan N, 2017, CELL, V168, P613, DOI 10.1016/j.cell.2017.01.018; Merlos-Suarez A, 2011, CELL STEM CELL, V8, P511, DOI 10.1016/j.stem.2011.02.020; Pollen AA, 2014, NAT BIOTECHNOL, V32, P1053, DOI 10.1038/nbt.2967; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Robinson DG, 2014, BIOINFORMATICS, V30, P3424, DOI 10.1093/bioinformatics/btu552; Rosenwald A, 2003, CANCER CELL, V3, P185, DOI 10.1016/S1535-6108(03)00028-X; *RSTUDIO INC, 2016, RSTUDIO INT DEV ENV; Sanchez-Vega F, 2018, CELL, V173, P321, DOI 10.1016/j.cell.2018.03.035; Senft D, 2017, TRENDS MOL MED, V23, P874, DOI 10.1016/j.molmed.2017.08.003; Simon N, 2011, J STAT SOFTW, V39, P1; Statnikov A, 2010, CELL HOST MICROBE, V7, P100, DOI 10.1016/j.chom.2010.01.003; Tang Y, 2016, R J, V8, P474, DOI 10.32614/rj-2016-060; Therneau T.M., 2000, MODELING SURVIVAL DA; Thorsson V, 2018, IMMUNITY, V48, P812, DOI [10.1016/j.immuni.2018.03.023, 10.1016/j.immuni.2019.08.004]; Tothill RW, 2008, CLIN CANCER RES, V14, P5198, DOI 10.1158/1078-0432.CCR-08-0196; Venet D, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002240; Vogelstein B, 2004, NAT MED, V10, P789, DOI 10.1038/nm1087; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Weiner J, 2018, TMOD FEATURE SET ENR; Weinstein JN, 2013, NAT GENET, V45, P1113, DOI 10.1038/ng.2764; Wickham H., 2020, DPLYR GRAMMAR DATA M; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Zaas AK, 2010, CELL HOST MICROBE, V7, P102, DOI 10.1016/j.chom.2010.02.002; Zou H, 2005, J R STAT SOC B, V67, P301, DOI 10.1111/j.1467-9868.2005.00503.x	52	21	21	0	12	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	FEB	2020	26	2					188	+		10.1038/s41591-019-0729-3	http://dx.doi.org/10.1038/s41591-019-0729-3		FEB 2020	19	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	KK7DU	32042193				2022-12-27	WOS:000512529400004
J	Drilon, A; Clark, JW; Weiss, J; Ou, SHI; Camidge, DR; Solomon, BJ; Otterson, GA; Villaruz, LC; Riely, GJ; Heist, RS; Awad, MM; Shapiro, GI; Satouchi, M; Hida, T; Hayashi, H; Murphy, DA; Wang, SC; Li, S; Usari, T; Wilner, KD; Paik, PK				Drilon, Alexander; Clark, Jeffrey W.; Weiss, Jared; Ou, Sai-Hong Ignatius; Camidge, D. Ross; Solomon, Benjamin J.; Otterson, Gregory A.; Villaruz, Liza C.; Riely, Gregory J.; Heist, Rebecca S.; Awad, Mark M.; Shapiro, Geoffrey I.; Satouchi, Miyako; Hida, Toyoaki; Hayashi, Hidetoshi; Murphy, Danielle A.; Wang, Sherry C.; Li, Sherry; Usari, Tiziana; Wilner, Keith D.; Paik, Paul K.			Antitumor activity of crizotinib in lung cancers harboring a MET exon 14 alteration	NATURE MEDICINE			English	Article							C-MET; MUTATIONS; AMPLIFICATION; SITE; ADENOCARCINOMA; CHEMOTHERAPY; INHIBITION; ACTIVATION; CARCINOMA; DELETION	MET exon 14 alterations are oncogenic drivers of non-small-cell lung cancers (NSCLCs)(1). These alterations are associated with increased MET activity and preclinical sensitivity to MET inhibition(2). Crizotinib is a multikinase inhibitor with potent activity against MET3. The antitumor activity and safety of crizotinib were assessed in 69 patients with advanced NSCLCs harboring MET exon 14 alterations. Objective response rate was 32% (95% confidence interval (CI), 21-45) among 65 response-evaluable patients. Objective responses were observed independent of the molecular heterogeneity that characterizes these cancers and did not vary by splice-site region and mutation type of the MET exon 14 alteration, concurrent increased MET copy number or the detection of a MET exon 14 alteration in circulating tumor DNA. The median duration of response was 9.1 months (95% CI, 6.4-12.7). The median progression-free survival was 7.3 months (95% CI, 5.4-9.1). MET exon 14 alteration defines a molecular subgroup of NSCLCs for which MET inhibition with crizotinib is active. These results address an unmet need for targeted therapy in people with lung cancers with MET exon 14 alterations and adds to an expanding list of genomically driven therapies for oncogenic subsets of NSCLC. Results from an expansion cohort of the PROFILE 1001 trial describe the anti-tumor activity of crizotinib in people with non-small-cell lung cancer harboring a MET exon 14 alteration.	[Drilon, Alexander; Riely, Gregory J.; Paik, Paul K.] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA; [Drilon, Alexander] Weill Cornell Med Coll, New York, NY 10065 USA; [Clark, Jeffrey W.; Heist, Rebecca S.] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Weiss, Jared] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27515 USA; [Ou, Sai-Hong Ignatius] Univ Calif Irvine, Sch Med, Orange, CA 92668 USA; [Camidge, D. Ross] Univ Colorado, Ctr Canc, Denver, CO 80262 USA; [Solomon, Benjamin J.] Peter MacCallum Canc Ctr, Melbourne, Vic, Australia; [Otterson, Gregory A.] Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA; [Villaruz, Liza C.] Univ Pittsburgh, Med Ctr, Hillman Canc Ctr, Pittsburgh, PA USA; [Awad, Mark M.; Shapiro, Geoffrey I.] Dana Farber Canc Inst, Boston, MA 02115 USA; [Satouchi, Miyako] Hyogo Canc Ctr, Akashi, Hyogo, Japan; [Hida, Toyoaki] Aichi Canc Ctr, Nagoya, Aichi, Japan; [Hayashi, Hidetoshi] Kindai Univ, Dept Med, Osaka, Japan; [Murphy, Danielle A.; Li, Sherry; Wilner, Keith D.] Pfizer Oncol, La Jolla, CA USA; [Wang, Sherry C.] Pfizer Oncol, San Francisco, CA USA; [Usari, Tiziana] Pfizer Oncol, Milan, Italy	Memorial Sloan Kettering Cancer Center; Cornell University; Harvard University; Massachusetts General Hospital; University of North Carolina; University of North Carolina Chapel Hill; University of California System; University of California Irvine; University of Colorado System; University of Colorado Denver; Peter Maccallum Cancer Center; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Harvard University; Dana-Farber Cancer Institute; Hyogo Cancer Center; Aichi Cancer Center; Kindai University (Kinki University); Pfizer; Pfizer; Pfizer	Drilon, A (corresponding author), Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA.; Drilon, A (corresponding author), Weill Cornell Med Coll, New York, NY 10065 USA.	drilona@mskcc.org	Ou, Sai-Hong/AAA-3389-2020; Riely, Gregory/AAF-4300-2019	Solomon, Benjamin/0000-0003-3059-5730; Drilon, Alexander/0000-0001-6806-9061	Pfizer Inc.; Pfizer; National Institutes of Health [P30 CA008748]	Pfizer Inc.(Pfizer); Pfizer(Pfizer); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank the patients, their families and caregivers, and participating clinical sites and teams. For biomarker analyses, we acknowledge A.C. Donahue and C. Deshpande for their support. J.N. Raksin and J.G. Martins at inScience Communications, Springer Healthcare, provided medical writing support, funded by Pfizer Inc. This study was supported by Pfizer. A.D., G.J.R. and P.K.P. are supported by the National Institutes of Health award P30 CA008748.	Awad MM, 2019, LUNG CANCER, V133, P96, DOI 10.1016/j.lungcan.2019.05.011; Awad MM, 2016, J CLIN ONCOL, V34, P879, DOI 10.1200/JCO.2015.64.2777; Awad MM, 2016, J CLIN ONCOL, V34, P721, DOI 10.1200/JCO.2015.63.4600; Benayed R, 2019, CLIN CANCER RES, V25, P4712, DOI 10.1158/1078-0432.CCR-19-0225; Camidge DR, 2018, NEW ENGL J MED, V379, P2027, DOI 10.1056/NEJMoa1810171; Camidge DR, 2012, LANCET ONCOL, V13, P1011, DOI 10.1016/S1470-2045(12)70344-3; Cui JJ, 2011, J MED CHEM, V54, P6342, DOI 10.1021/jm2007613; Drilon A, 2017, J THORAC ONCOL, V12, P15, DOI 10.1016/j.jtho.2016.10.014; Drilon A, 2016, CLIN CANCER RES, V22, P2832, DOI 10.1158/1078-0432.CCR-16-0229; Drilon AE, 2016, J CLIN ONCOL, V34, DOI 10.1200/JCO.2016.34.15_suppl.108; Frampton GM, 2015, CANCER DISCOV, V5, P850, DOI 10.1158/2159-8290.CD-15-0285; Garon EB, 2014, LANCET, V384, P665, DOI 10.1016/S0140-6736(14)60845-X; Genovese G, 2014, NEW ENGL J MED, V371, P2477, DOI 10.1056/NEJMoa1409405; Guo R, 2019, J CLIN ONCOL, V37, DOI [10.1200/JCO.2019.37.15_suppl.9006, DOI 10.1200/JCO.2019.37.15_SUPPL.9006]; Heist RS, 2016, ONCOLOGIST, V21, P481, DOI 10.1634/theoncologist.2015-0510; Jenkins RW, 2015, CLIN LUNG CANCER, V16, pE101, DOI 10.1016/j.cllc.2015.01.009; Kong-Beltran M, 2006, CANCER RES, V66, P283, DOI 10.1158/0008-5472.CAN-05-2749; Kwak E. L, 2009, J CLIN ONCOL, V27, DOI [10.1200/jco.2009.27.15s.3509, DOI 10.1200/JCO.2009.27.15S.3509]; Kwak EL, 2010, NEW ENGL J MED, V363, P1693, DOI 10.1056/NEJMoa1006448; Landi L, 2019, CLIN CANCER RES, V25, P7312, DOI 10.1158/1078-0432.CCR-19-0994; Lee C, 2015, J THORAC ONCOL, V10, pE113, DOI 10.1097/JTO.0000000000000645; Lee GD, 2017, J THORAC ONCOL, V12, P1233, DOI 10.1016/j.jtho.2017.04.031; Liu XW, 2016, J CLIN ONCOL, V34, P794, DOI 10.1200/JCO.2015.62.0674; Lu S, 2019, CANCER RES, V79, DOI 10.1158/1538-7445.AM2019-CT031; Ma PC, 2005, CANCER RES, V65, P1479, DOI 10.1158/0008-5472.CAN-04-2650; Mendenhall MA, 2015, J THORAC ONCOL, V10, pE33, DOI 10.1097/JTO.0000000000000491; National Comprehensive Cancer Network, 2019, NCCN CLIN PRACT GUID; Noonan SA, 2016, J THORAC ONCOL, V11, P1293, DOI 10.1016/j.jtho.2016.04.033; OKEN MM, 1982, AM J CLIN ONCOL-CANC, V5, P649, DOI 10.1097/00000421-198212000-00014; Onozato R, 2009, J THORAC ONCOL, V4, P5, DOI 10.1097/JTO.0b013e3181913e0e; Paik PK, 2015, CANCER DISCOV, V5, P842, DOI 10.1158/2159-8290.CD-14-1467; PAIK PK, 2019, J CLIN ONCOL S, V37, DOI DOI 10.1200/JCO.2019.37.15_SUPPL.9005; Palma NA., 2013, J CLIN ONCOL, V31, P11068, DOI [10.1200/jco.2013.31.15_suppl.11068, DOI 10.1200/JCO.2013.31.15_SUPPL.11068]; Peschard P, 2001, MOL CELL, V8, P995, DOI 10.1016/S1097-2765(01)00378-1; Sandler A, 2006, NEW ENGL J MED, V355, P2542, DOI 10.1056/NEJMoa061884; Scagliotti GV, 2008, J CLIN ONCOL, V26, P3543, DOI 10.1200/JCO.2007.15.0375; Schrock AB, 2016, J THORAC ONCOL, V11, P1493, DOI 10.1016/j.jtho.2016.06.004; Shaw AT, 2014, NEW ENGL J MED, V371, P1963, DOI 10.1056/NEJMoa1406766; Shaw AT, 2013, NEW ENGL J MED, V368, P2385, DOI 10.1056/NEJMoa1214886; Shepherd FA, 2000, J CLIN ONCOL, V18, P2095, DOI 10.1200/JCO.2000.18.10.2095; Socinski MA, 2018, NEW ENGL J MED, V378, P2288, DOI 10.1056/NEJMoa1716948; Soria JC, 2018, NEW ENGL J MED, V378, P113, DOI 10.1056/NEJMoa1713137; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205; Tong JH, 2016, CLIN CANCER RES, V22, P3048, DOI 10.1158/1078-0432.CCR-15-2061; Wolf J, 2019, J CLIN ONCOL, V37	45	158	164	5	27	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JAN	2020	26	1					47	+		10.1038/s41591-019-0716-8	http://dx.doi.org/10.1038/s41591-019-0716-8			12	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	KG3GZ	31932802	Green Accepted			2022-12-27	WOS:000509831900025
J	Stower, H				Stower, Hannah			CANCER THERAPY A new strategy for prostate cancer	NATURE MEDICINE			English	Editorial Material																			0	0	0	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	2019	25	12					1798	1798		10.1038/s41591-019-0680-3	http://dx.doi.org/10.1038/s41591-019-0680-3			1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	JT2KO	31806896	Bronze			2022-12-27	WOS:000500824900003
J	Prausnitz, MR; Gomaa, Y; Li, W				Prausnitz, Mark R.; Gomaa, Yasmine; Li, Wei			Microneedle patch drug delivery in the gut	NATURE MEDICINE			English	Editorial Material									[Prausnitz, Mark R.; Gomaa, Yasmine; Li, Wei] Georgia Inst Technol, Sch Chem & Biomol Engn, Atlanta, GA 30332 USA; [Gomaa, Yasmine] Alexandria Univ, Fac Pharm, Dept Pharmaceut, El Khartoum Sq, Alexandria, Egypt	University System of Georgia; Georgia Institute of Technology; Egyptian Knowledge Bank (EKB); Alexandria University	Prausnitz, MR (corresponding author), Georgia Inst Technol, Sch Chem & Biomol Engn, Atlanta, GA 30332 USA.	prausnitz@gatech.edu		Prausnitz, Mark/0000-0002-9076-8448; LI, WEI/0000-0002-9339-7267				Abramson A, 2019, NAT MED, V25, P1512, DOI 10.1038/s41591-019-0598-9; Bhatnagar S, 2017, J CONTROL RELEASE, V260, P164, DOI 10.1016/j.jconrel.2017.05.029; Grover N., 2019, ENDPOINTS NEWS; Homayun B, 2019, PHARMACEUTICS, V11, DOI 10.3390/pharmaceutics11030129; Hou A, 2017, DERMATOL SURG, V43, P321, DOI 10.1097/DSS.0000000000000924; Lipinski CA, 1997, ADV DRUG DELIVER REV, V23, P3, DOI 10.1016/S0169-409X(96)00423-1; Liu C, 2018, EXPERT OPIN DRUG DEL, V15, P223, DOI 10.1080/17425247.2017.1395853; Marcum ZA, 2013, JAMA-J AM MED ASSOC, V309, P2105, DOI 10.1001/jama.2013.4638; Prausnitz M. R., 1997, ANNU REV CHEM BIOMOL, V8, P177; Rubin RR, 2009, DIABETES EDUCATOR, V35, P1014, DOI 10.1177/0145721709345773	10	24	25	6	85	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	OCT	2019	25	10					1471	1472		10.1038/s41591-019-0606-0	http://dx.doi.org/10.1038/s41591-019-0606-0			3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	JC3GJ	31591600				2022-12-27	WOS:000489166700012
J	Yamamoto, TN; Kishton, RJ; Restifo, NP				Yamamoto, Tori N.; Kishton, Rigel J.; Restifo, Nicholas P.			Developing neoantigen-targeted T cell-based treatments for solid tumors	NATURE MEDICINE			English	Review							HUMAN COLON-CANCER; METASTATIC MELANOMA; CLASS-I; INFILTRATING LYMPHOCYTES; ACQUIRED-RESISTANCE; CHECKPOINT BLOCKADE; ANTITUMOR IMMUNITY; NORMAL-TISSUES; PD-1 BLOCKADE; GENE-THERAPY	Stimulating an immune response against cancer through adoptive transfer of tumor-targeting lymphocytes has shown great promise in hematological malignancies, but clinical efficacy against many common solid epithelial cancers remains low. Targeting 'neoantigens'-the somatic mutations expressed only by tumor cells-might enable tumor destruction without causing undue damage to vital healthy tissues. Major challenges to targeting neoantigens with T cells include heterogeneity and variability in antigen processing and presentation of targets by tumors, and an incomplete understanding of which T cell qualities are essential for clinically effective therapies. Finally, the prospect of targeting somatic tumor mutations to promote T cell destruction of cancer must contend with the biology that not all tumor-expressed 'neoepitopes' actually generate neoantigens that can be functionally recognized and provoke an effective immune response. In this Review, we discuss the promise, progress and challenges for improving neoantigen-targeted T cell-based immunotherapies for cancer.	[Yamamoto, Tori N.; Kishton, Rigel J.; Restifo, Nicholas P.] NCI, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Yamamoto, Tori N.; Kishton, Rigel J.; Restifo, Nicholas P.] NCI, Ctr Cell Based Therapy, NIH, Bethesda, MD 20892 USA; [Yamamoto, Tori N.] Univ Penn, Immunol Grad Grp, Philadelphia, PA 19104 USA; [Restifo, Nicholas P.] Lyell Immunopharma, San Francisco, CA 94080 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Pennsylvania	Restifo, NP (corresponding author), NCI, Ctr Canc Res, NIH, Bethesda, MD 20892 USA.; Restifo, NP (corresponding author), NCI, Ctr Cell Based Therapy, NIH, Bethesda, MD 20892 USA.; Restifo, NP (corresponding author), Lyell Immunopharma, San Francisco, CA 94080 USA.	restifon@mail.nih.gov		Yamamoto, Tori/0000-0003-1965-7822; Restifo, Nicholas P./0000-0003-4229-4580	Intramural Research Program of the NCI; Cancer Moonshot Program for the Center for Cell-Based Therapy at the NCI, NIH	Intramural Research Program of the NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Cancer Moonshot Program for the Center for Cell-Based Therapy at the NCI, NIH	We thank P.-H. Lee for helpful discussions and E. He for illustration design. This work was supported by the Intramural Research Program of the NCI and the Cancer Moonshot Program for the Center for Cell-Based Therapy at the NCI, NIH.	Ahmadzadeh M, 2009, BLOOD, V114, P1537, DOI 10.1182/blood-2008-12-195792; Ahmed N, 2015, J CLIN ONCOL, V33, P1688, DOI 10.1200/JCO.2014.58.0225; Ali M, 2019, NAT PROTOC, V14, P1926, DOI 10.1038/s41596-019-0170-6; Anagnostou V, 2017, CANCER DISCOV, V7, P264, DOI 10.1158/2159-8290.CD-16-0828; Antonia SJ, 2017, NEW ENGL J MED, V377, P1919, DOI 10.1056/NEJMoa1709937; Azizi E, 2018, CELL, V174, P1293, DOI 10.1016/j.cell.2018.05.060; Bausch-Fluck D, 2018, P NATL ACAD SCI USA, V115, pE10988, DOI 10.1073/pnas.1808790115; Beatty GL, 2018, GASTROENTEROLOGY, V155, P29, DOI 10.1053/j.gastro.2018.03.029; Brown CE, 2016, NEW ENGL J MED, V375, P2561, DOI 10.1056/NEJMoa1610497; Brudno JN, 2018, J CLIN ONCOL, V36, P2267, DOI 10.1200/JCO.2018.77.8084; Buonaguro L, 2011, CLIN VACCINE IMMUNOL, V18, P23, DOI 10.1128/CVI.00286-10; Burrell RA, 2013, NATURE, V501, P338, DOI 10.1038/nature12625; Cafri G, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08304-z; Carreno BM, 2015, SCIENCE, V348, P803, DOI 10.1126/science.aaa3828; Chapuis AG, 2019, NAT MED, V25, P1064, DOI 10.1038/s41591-019-0472-9; Chen HL, 1996, NAT GENET, V13, P210, DOI 10.1038/ng0696-210; Ciriello G, 2013, NAT GENET, V45, P1127, DOI 10.1038/ng.2762; Cohen AD, 2019, J CLIN INVEST, V129, P2210, DOI 10.1172/JCI126397; Crompton JG, 2014, IMMUNOL REV, V257, P264, DOI 10.1111/imr.12135; Drost J, 2018, NAT REV CANCER, V18, P407, DOI 10.1038/s41568-018-0007-6; Dudley ME, 2008, J CLIN ONCOL, V26, P5233, DOI 10.1200/JCO.2008.16.5449; Duhen T, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05072-0; Francis JM, 2014, CANCER DISCOV, V4, P956, DOI 10.1158/2159-8290.CD-13-0879; Fry TJ, 2018, NAT MED, V24, P20, DOI 10.1038/nm.4441; Gajewski TF, 2015, SEMIN ONCOL, V42, P663, DOI 10.1053/j.seminoncol.2015.05.011; Gargett T, 2016, MOL THER, V24, P1135, DOI 10.1038/mt.2016.63; Gattinoni L, 2011, NAT MED, V17, P1290, DOI 10.1038/nm.2446; Goff SL, 2019, J IMMUNOTHER, V42, P126, DOI 10.1097/CJI.0000000000000260; Goff SL, 2016, J CLIN ONCOL, V34, P2389, DOI 10.1200/JCO.2016.66.7220; Goff SL, 2010, J IMMUNOTHER, V33, P840, DOI 10.1097/CJI.0b013e3181f05b91; Goodyear O, 2010, BLOOD, V116, P1908, DOI 10.1182/blood-2009-11-249474; Gros A, 2016, NAT MED, V22, P433, DOI 10.1038/nm.4051; Gros A, 2014, J CLIN INVEST, V124, P2246, DOI [10.1172/JC173639, 10.1172/JCI73639]; Gubin MM, 2014, NATURE, V515, P577, DOI 10.1038/nature13988; Guedan S, 2019, MOL THER-METH CLIN D, V12, P145, DOI 10.1016/j.omtm.2018.12.009; Hinrichs CS, 2011, BLOOD, V117, P808, DOI 10.1182/blood-2010-05-286286; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Holderfield M, 2014, NAT REV CANCER, V14, P455, DOI 10.1038/nrc3760; Jaigirdar A, 2016, J IMMUNOTHER, V39, P105, DOI 10.1097/CJI.0000000000000116; Jiang Y, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.162; Johnson LA, 2009, BLOOD, V114, P535, DOI 10.1182/blood-2009-03-211714; Katt ME, 2016, FRONT BIOENG BIOTECH, V4, DOI 10.3389/fbioe.2016.00012; Kerkar SP, 2016, J IMMUNOTHER, V39, P181, DOI 10.1097/CJI.0000000000000119; Keskin DB, 2019, NATURE, V565, P234, DOI 10.1038/s41586-018-0792-9; Klebanoff CA, 2005, P NATL ACAD SCI USA, V102, P9571, DOI 10.1073/pnas.0503726102; Klebanoff CA, 2016, J CLIN INVEST, V126, P318, DOI 10.1172/JCI81217; Klebanoff CA, 2016, NAT MED, V22, P26, DOI 10.1038/nm.4015; Kochenderfer JN, 2017, MOL THER, V25, P2245, DOI 10.1016/j.ymthe.2017.07.004; Kochenderfer JN, 2010, BLOOD, V116, P4099, DOI 10.1182/blood-2010-04-281931; Kreiter S, 2015, NATURE, V520, P692, DOI 10.1038/nature14426; Lanitis E, 2014, HUM GENE THER, V25, P730, DOI 10.1089/hum.2014.006; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Le DT, 2017, SCIENCE, V357, P409, DOI 10.1126/science.aan6733; Liu S, 2019, J IMMUNOTHER CANCER, V7, DOI 10.1186/s40425-019-0629-6; Lohr JG, 2014, NAT BIOTECHNOL, V32, P479, DOI 10.1038/nbt.2892; Lu YC, 2018, MOL THER, V26, P379, DOI 10.1016/j.ymthe.2017.10.018; Maeda T, 2016, CANCER RES, V76, P6839, DOI 10.1158/0008-5472.CAN-16-1149; Malekzadeh P, 2019, J CLIN INVEST, V129, P1109, DOI 10.1172/JCI123791; Maude SL, 2018, NEW ENGL J MED, V378, P439, DOI 10.1056/NEJMoa1709866; Maus MV, 2016, MOL THER-ONCOLYTICS, V3, DOI 10.1038/mto.2016.23; Melero I, 2014, NAT REV CLIN ONCOL, V11, P509, DOI 10.1038/nrclinonc.2014.111; Miller BC, 2019, NAT IMMUNOL, V20, P326, DOI 10.1038/s41590-019-0312-6; Mitra A, 2013, TRENDS BIOTECHNOL, V31, P347, DOI 10.1016/j.tibtech.2013.03.006; Miyagi T, 2003, J GASTROEN HEPATOL, V18, P32, DOI 10.1046/j.1440-1746.2003.02921.x; Morgan RA, 2013, J IMMUNOTHER, V36, P133, DOI 10.1097/CJI.0b013e3182829903; Motz GT, 2014, NAT MED, V20, P607, DOI 10.1038/nm.3541; Motzer RJ, 2018, NEW ENGL J MED, V378, P1277, DOI 10.1056/NEJMoa1712126; Murtaza M, 2013, NATURE, V497, P108, DOI 10.1038/nature12065; MUUL LM, 1987, J IMMUNOL, V138, P989; Neelapu SS, 2017, NEW ENGL J MED, V377, P2531, DOI 10.1056/NEJMoa1707447; Nielsen M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000796; O'Rourke DM, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aaa0984; Ott PA, 2017, NATURE, V547, P217, DOI 10.1038/nature22991; Park TS, 2016, J IMMUNOTHER, V39, P1, DOI 10.1097/CJI.0000000000000101; Parkhurst M, 2017, CLIN CANCER RES, V23, P2491, DOI 10.1158/1078-0432.CCR-16-2680; Parkhurst MR, 2019, CANCER DISCOV, V9, P1022, DOI 10.1158/2159-8290.CD-18-1494; Parkhurst MR, 2011, MOL THER, V19, P620, DOI 10.1038/mt.2010.272; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Pasetto A, 2016, CANCER IMMUNOL RES, V4, P734, DOI 10.1158/2326-6066.CIR-16-0001; Patel S, 2016, BIOL BLOOD MARROW TR, V22, P536, DOI 10.1016/j.bbmt.2015.12.007; Patel SJ, 2017, NATURE, V548, P537, DOI 10.1038/nature23477; Paulos CM, 2007, J CLIN INVEST, V117, P2197, DOI 10.1172/JCI32205; Porgador A, 1997, IMMUNITY, V6, P715, DOI 10.1016/S1074-7613(00)80447-1; Powles T, 2014, NATURE, V515, P558, DOI 10.1038/nature13904; Prickett TD, 2016, CANCER IMMUNOL RES, V4, P669, DOI 10.1158/2326-6066.CIR-15-0215; Rammensee HG, 1999, IMMUNOGENETICS, V50, P213, DOI 10.1007/s002510050595; Reay PA, 2000, J IMMUNOL, V164, P5626, DOI 10.4049/jimmunol.164.11.5626; Restifo NP, 2012, NAT REV IMMUNOL, V12, P269, DOI 10.1038/nri3191; Restifo NP, 1996, J NATL CANCER I, V88, P100, DOI 10.1093/jnci/88.2.100; RIDDELL SR, 1990, J IMMUNOL METHODS, V128, P189, DOI 10.1016/0022-1759(90)90210-M; Rizvi NA, 2015, SCIENCE, V348, P124, DOI 10.1126/science.aaa1348; Robbins PF, 2015, CLIN CANCER RES, V21, P1019, DOI 10.1158/1078-0432.CCR-14-2708; Robbins PF, 2013, NAT MED, V19, P747, DOI 10.1038/nm.3161; Rosenberg SA, 2004, NAT MED, V10, P909, DOI 10.1038/nm1100; ROSENBERG SA, 1985, NEW ENGL J MED, V313, P1485, DOI 10.1056/NEJM198512053132327; Rosenberg SA, 2015, SCIENCE, V348, P62, DOI 10.1126/science.aaa4967; Sahin U, 2017, NATURE, V547, P222, DOI 10.1038/nature23003; Scanlan MJ, 2002, CANCER RES, V62, P4041; Scheper W, 2019, NAT MED, V25, P89, DOI 10.1038/s41591-018-0266-5; Schmitt TM, 2013, BLOOD, V122, P348, DOI 10.1182/blood-2013-01-478164; Shimizu Y, 2019, FRONT ONCOL, V9, DOI 10.3389/fonc.2019.00248; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Soiffer R, 1998, P NATL ACAD SCI USA, V95, P13141, DOI 10.1073/pnas.95.22.13141; Srivastava S, 2019, CANCER CELL, V35, P489, DOI 10.1016/j.ccell.2019.02.003; Srivastava S, 2018, J IMMUNOL, V200, P459, DOI 10.4049/jimmunol.1701155; Stevanovic S, 2017, SCIENCE, V356, P200, DOI 10.1126/science.aak9510; Stevanovic S, 2015, J CLIN ONCOL, V33, P1543, DOI 10.1200/JCO.2014.58.9093; Sykulev Y, 1996, IMMUNITY, V4, P565, DOI 10.1016/S1074-7613(00)80483-5; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; Tran E, 2017, NAT IMMUNOL, V18, P255, DOI 10.1038/ni.3682; Tran E, 2016, NEW ENGL J MED, V375, P2255, DOI 10.1056/NEJMoa1609279; Tran E, 2015, SCIENCE, V350, P1387, DOI 10.1126/science.aad1253; Tran E, 2014, SCIENCE, V344, P641, DOI 10.1126/science.1251102; Van Allen EM, 2015, SCIENCE, V350, P207, DOI 10.1126/science.aad0095; Verdegaal EME, 2016, NATURE, V536, P91, DOI 10.1038/nature18945; Vigneron Nathalie, 2013, Cancer Immun, V13, P15; Vizcardo R, 2018, CELL REP, V22, P3175, DOI 10.1016/j.celrep.2018.02.087; Vodnala SK, 2019, SCIENCE, V363, P1417, DOI 10.1126/science.aau0135; Wang DY, 2018, JAMA ONCOL, V4, P1721, DOI 10.1001/jamaoncol.2018.3923; Wolchok JD, 2013, NEW ENGL J MED, V369, P122, DOI 10.1056/NEJMoa1302369; Wooldridge L, 2012, J BIOL CHEM, V287, P1168, DOI 10.1074/jbc.M111.289488; Xu YY, 2018, CELL DISCOV, V4, DOI 10.1038/s41421-018-0066-6; Yamamoto TN, 2019, J CLIN INVEST, V129, P1551, DOI 10.1172/JCI121491; Yossef R, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.122467; Zacharakis N, 2018, NAT MED, V24, P724, DOI 10.1038/s41591-018-0040-8; Zaretsky JM, 2016, NEW ENGL J MED, V375, P819, DOI 10.1056/NEJMoa1604958; Zhu J, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00784-1	127	95	101	3	79	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	OCT	2019	25	10					1488	1499		10.1038/s41591-019-0596-y	http://dx.doi.org/10.1038/s41591-019-0596-y			12	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	JC3GJ	31591590				2022-12-27	WOS:000489166700016
J	Choueiri, TK; Kaelin, WG				Choueiri, Toni K.; Kaelin, William G., Jr.			Targeting the HIF2-VEGF axis in renal cell carcinoma	NATURE MEDICINE			English	Article							ENDOTHELIAL GROWTH-FACTOR; HYPOXIA-INDUCIBLE FACTOR; HIPPEL-LINDAU-DISEASE; RANDOMIZED PHASE-II; PAS-B DOMAIN; DOUBLE-BLIND; INTERFERON-ALPHA; HIF-ALPHA; TUMOR SUPPRESSION; MAMMALIAN TARGET	Anticancer therapies that target the HIF oxygen-sensing pathways are moving into the clinic, in particular in kidney cancer. Insights into the role of the tumor suppressor pVHL in oxygen sensing motivated the testing of drugs that target the transcription factor HIF or HIF-responsive growth factors, such as VEGF, for the treatment of cancers caused byVHLinactivation, such as clear-cell renal cell carcinoma (ccRCC). Multiple VEGF inhibitors are now approved for the treatment of ccRCC, and a HIF2 alpha inhibitor has advanced to phase 3 development for this disease. These inhibitors are now also increasingly combined with immune-checkpoint blockers. In this Perspective, we describe the understanding of the mechanisms of oxygen sensing and hypoxia signaling that resulted in the development of HIF2 alpha-targeted therapies for patients with VHL-associated tumors. We also present future directions for extending the use of these therapies to other cancers.	[Choueiri, Toni K.; Kaelin, William G., Jr.] Brigham & Womens Hosp, Dana Farber Canc Inst, 75 Francis St, Boston, MA 02115 USA; [Choueiri, Toni K.; Kaelin, William G., Jr.] Harvard Med Sch, Boston, MA 02115 USA; [Kaelin, William G., Jr.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA	Harvard University; Brigham & Women's Hospital; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Howard Hughes Medical Institute	Choueiri, TK; Kaelin, WG (corresponding author), Brigham & Womens Hosp, Dana Farber Canc Inst, 75 Francis St, Boston, MA 02115 USA.; Choueiri, TK; Kaelin, WG (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.; Kaelin, WG (corresponding author), Howard Hughes Med Inst, Chevy Chase, MD 20815 USA.	toni_choueiri@dfci.harvard.edu; william_kaelin@dfci.harvard.edu	Choueiri, Toni/K-5238-2019	Choueiri, Toni/0000-0002-9201-3217				Amin A, 2018, J IMMUNOTHER CANCER, V6, DOI 10.1186/s40425-018-0420-0; Awada A, 2005, BRIT J CANCER, V92, P1855, DOI 10.1038/sj.bjc.6602584; Bakouny Z, 2020, CANCER DISCOV, V10, P348, DOI 10.1158/2159-8290.CD-19-1525; Beroukhim R, 2009, CANCER RES, V69, P4674, DOI 10.1158/0008-5472.CAN-09-0146; Bhargava P, 2011, CURR ONCOL REP, V13, P103, DOI 10.1007/s11912-011-0154-3; Bindra RS, 2002, CANCER RES, V62, P3014; Bommi-Reddy A, 2008, P NATL ACAD SCI USA, V105, P16484, DOI 10.1073/pnas.0806574105; Braun DA, 2020, NAT MED, V26, P909, DOI 10.1038/s41591-020-0839-y; Bristol Myers Squibb company, BRIST MYERS SQUIBB A; Bruick RK, 2001, SCIENCE, V294, P1337, DOI 10.1126/science.1066373; Carlo MI, 2016, ONCOLOGIST, V21, P787, DOI 10.1634/theoncologist.2016-0145; Chakraborty AA, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aal5272; Chan DA, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002394; Chan J, 2002, CANCER CELL, V1, P257, DOI 10.1016/S1535-6108(02)00042-9; Chen WF, 2016, NATURE, V539, P112, DOI 10.1038/nature19796; Cheng XT, 2020, J CLIN INVEST, V130, P2237, DOI 10.1172/JCI133194; Cherkasova E, 2011, ONCOGENE, V30, P4697, DOI 10.1038/onc.2011.179; Cho DC, 2010, CLIN CANCER RES, V16, P3628, DOI 10.1158/1078-0432.CCR-09-3022; Cho H, 2016, COLD SH Q B, V81, P113, DOI 10.1101/sqb.2016.81.030833; Cho H, 2016, NATURE, V539, P107, DOI 10.1038/nature19795; Choueiri T, 2019, 14 EUR INT KIDN CANC; Choueiri TK, 2019, ANN ONCOL, V30, P362; Choueiri TK, 2015, NEW ENGL J MED, V373, P1814, DOI 10.1056/NEJMoa1510016; Choueiri TK, 2020, J CLIN ONCOL, V38; Choueiri TK, 2018, EUR J CANCER, V94, P115, DOI 10.1016/j.ejca.2018.02.012; Choueiri TK, 2017, J CLIN ONCOL, V35, P591, DOI 10.1200/JCO.2016.70.7398; Choueiri TK, 2017, NEW ENGL J MED, V376, P354, DOI 10.1056/NEJMra1601333; Choueiri TK, 2016, LANCET ONCOL, V17, P917, DOI 10.1016/S1470-2045(16)30107-3; Chowdhury S, 2017, J CLIN ONCOL, V35, DOI 10.1200/JCO.2017.35.15_suppl.4506; Ciamporcero E, 2015, MOL CANCER THER, V14, P101, DOI 10.1158/1535-7163.MCT-14-0094; Cockman ME, 2000, J BIOL CHEM, V275, P25733, DOI 10.1074/jbc.M002740200; Courtney KD, 2019, CLIN CANCER RES, V15, P793; Courtney KD, 2018, J CLIN ONCOL, V36, P867, DOI 10.1200/JCO.2017.74.2627; Creighton CJ, 2013, NATURE, V499, P43, DOI 10.1038/nature12222; Dahia PLM, 2017, CANCER CELL, V31, P159, DOI 10.1016/j.ccell.2017.01.009; Dahia PLM, 2014, NAT REV CANCER, V14, P108, DOI 10.1038/nrc3648; Dengler VL, 2014, CRIT REV BIOCHEM MOL, V49, P1, DOI 10.3109/10409238.2013.838205; Dibble CC, 2009, MOL CELL BIOL, V29, P5657, DOI 10.1128/MCB.00735-09; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Escudier B, 2007, LANCET, V370, P2103, DOI 10.1016/S0140-6736(07)61904-7; Escudier B, 2007, NEW ENGL J MED, V356, P125, DOI 10.1056/NEJMoa060655; Escudier B, 2010, J CLIN ONCOL, V28, P2144, DOI 10.1200/JCO.2009.26.7849; Escudier B, 2009, J CLIN ONCOL, V27, P3312, DOI 10.1200/JCO.2008.19.5511; Feldman DR, 2009, J CLIN ONCOL, V27, P1432, DOI 10.1200/JCO.2008.19.0108; Fishbein L, 2017, CANCER CELL, V31, P181, DOI 10.1016/j.ccell.2017.01.001; Flaherty KT, 2015, J CLIN ONCOL, V33, P2384, DOI 10.1200/JCO.2015.60.9727; Gerlinger M, 2014, NAT GENET, V46, P225, DOI 10.1038/ng.2891; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Gnarra JR, 1996, P NATL ACAD SCI USA, V93, P10589, DOI 10.1073/pnas.93.20.10589; GOLDE DW, 1981, ANN INTERN MED, V95, P71, DOI 10.7326/0003-4819-95-1-71; Gordan JD, 2008, CANCER CELL, V14, P435, DOI 10.1016/j.ccr.2008.10.016; Gossage L, 2015, NAT REV CANCER, V15, P55, DOI 10.1038/nrc3844; Graham J, 2018, J CLIN ONCOL, V36, P3567, DOI 10.1200/JCO.2018.79.0147; Guo ZQ, 2017, ONCOTARGET, V8, P89761, DOI 10.18632/oncotarget.21125; Hu LX, 2020, CANCER DISCOV, V10, P460, DOI 10.1158/2159-8290.CD-19-0837; Hua H, 2019, J HEMATOL ONCOL, V12, DOI 10.1186/s13045-019-0754-1; Huang HH, 2010, NAT REV CANCER, V10, P575, DOI 10.1038/nrc2894; Hudes G, 2007, NEW ENGL J MED, V356, P2271, DOI 10.1056/NEJMoa066838; Iliopoulos O, 1996, P NATL ACAD SCI USA, V93, P10595, DOI 10.1073/pnas.93.20.10595; ILIOPOULOS O, 1995, NAT MED, V1, P822, DOI 10.1038/nm0895-822; Ivan M, 2002, P NATL ACAD SCI USA, V99, P13459, DOI 10.1073/pnas.192342099; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Janiszewska AD, 2013, WSPOLCZESNA ONKOL, V17, P123, DOI 10.5114/wo.2013.34613; Jonasch E, 2020, J CLIN ONCOL, V38; Jonker L, 2014, MICROCIRCULATION, V21, P93, DOI 10.1111/micc.12099; Jubb AM, 2004, J CLIN PATHOL, V57, P504, DOI 10.1136/jcp.2003.012963; Kaelin WG, 2008, NAT REV CANCER, V8, P865, DOI 10.1038/nrc2502; Kaelin WG, 2008, MOL CELL, V30, P393, DOI 10.1016/j.molcel.2008.04.009; Kaelin WG, 2007, ANNU REV PATHOL-MECH, V2, P145, DOI 10.1146/annurev.pathol.2.010506.092049; Kamura T, 2000, P NATL ACAD SCI USA, V97, P10430, DOI 10.1073/pnas.190332597; Katoh M, 2019, NAT REV CLIN ONCOL, V16, P105, DOI 10.1038/s41571-018-0115-y; Kim WY, 2004, J CLIN ONCOL, V22, P4991, DOI 10.1200/JCO.2004.05.061; Klapper JA, 2008, CANCER-AM CANCER SOC, V113, P293, DOI 10.1002/cncr.23552; Koehler AN, 2010, CURR OPIN CHEM BIOL, V14, P331, DOI 10.1016/j.cbpa.2010.03.022; Kondo K, 2003, PLOS BIOL, V1, P439, DOI 10.1371/journal.pbio.0000083; Kondo K, 2002, CANCER CELL, V1, P237, DOI 10.1016/S1535-6108(02)00043-0; Koochekpour S, 1999, MOL CELL BIOL, V19, P5902; Krieg M, 2000, ONCOGENE, V19, P5435, DOI 10.1038/sj.onc.1203938; LaFleur MW, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09656-2; Lalani AKA, 2017, ONCOTARGET, V8, P103428, DOI 10.18632/oncotarget.21952; LATIF F, 1993, SCIENCE, V260, P1317, DOI 10.1126/science.8493574; Ledford H, 2019, NATURE, V574, P161, DOI 10.1038/d41586-019-02963-0; Lee YS, 2005, CLIN CANCER RES, V11, P1059; Li LJ, 2007, MOL CELL BIOL, V27, P5381, DOI 10.1128/MCB.00282-07; Maher ER, 1997, MEDICINE, V76, P381, DOI 10.1097/00005792-199711000-00001; Mandriota SJ, 2002, CANCER CELL, V1, P459, DOI 10.1016/S1535-6108(02)00071-5; Maranchie JK, 2002, CANCER CELL, V1, P247, DOI 10.1016/S1535-6108(02)00044-2; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; McKay RR, 2018, J CLIN ONCOL, V36, P3615, DOI 10.1200/JCO.2018.79.0253; Minamishima YA, 2009, MOL CELL BIOL, V29, P5729, DOI 10.1128/MCB.00331-09; Mohlin S, 2017, P NATL ACAD SCI USA, V114, pE10856, DOI 10.1073/pnas.1716644115; Molina AM, 2014, CANCER CHEMOTH PHARM, V73, P181, DOI 10.1007/s00280-013-2339-y; Montani M, 2010, AM J SURG PATHOL, V34, P806, DOI 10.1097/PAS.0b013e3181ddf54d; Motzer RJ, 2018, NEW ENGL J MED, V378, P1277, DOI 10.1056/NEJMoa1712126; Motzer RJ, 2015, NEW ENGL J MED, V373, P1803, DOI 10.1056/NEJMoa1510665; Motzer RJ, 2008, LANCET, V372, P449, DOI 10.1016/S0140-6736(08)61039-9; Motzer RJ, 2007, NEW ENGL J MED, V356, P115, DOI 10.1056/NEJMoa065044; Motzer RJ, 2020, J CLIN ONCOL, V38; Motzer RJ, 2019, NEW ENGL J MED, V380, P1103, DOI 10.1056/NEJMoa1816047; Motzer RJ, 2016, LANCET ONCOL, V17, pE4, DOI 10.1016/S1470-2045(15)00543-4; Motzer RJ, 2015, LANCET ONCOL, V16, P1473, DOI 10.1016/S1470-2045(15)00290-9; Motzer RJ, 2015, J CLIN ONCOL, V33, P1430, DOI 10.1200/JCO.2014.59.0703; Motzer RJ, 2013, NEW ENGL J MED, V369, P722, DOI 10.1056/NEJMoa1303989; Motzer RJ, 2013, LANCET ONCOL, V14, P552, DOI 10.1016/S1470-2045(13)70093-7; Motzer RJ, 2009, J CLIN ONCOL, V27, P3584, DOI 10.1200/JCO.2008.20.1293; Nakaigawa N, 2006, CANCER RES, V66, P3699, DOI 10.1158/0008-5472.CAN-05-0617; Nicholson HE, 2019, SCI SIGNAL, V12, DOI 10.1126/scisignal.aay0482; O'Reilly KE, 2006, CANCER RES, V66, P1500, DOI 10.1158/0008-5472.CAN-05-2925; Ohh M, 2000, NAT CELL BIOL, V2, P423, DOI 10.1038/35017054; Palmer AC, 2017, CELL, V171, P1678, DOI 10.1016/j.cell.2017.11.009; Panda A, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.121522; Papadopoulos KP, 2018, J CLIN ONCOL, V36, DOI 10.1200/JCO.2018.36.15_suppl.2508; Pennacchietti S, 2003, CANCER CELL, V3, P347, DOI 10.1016/S1535-6108(03)00085-0; Powles T, 2016, J CLIN ONCOL, V34, P1660, DOI 10.1200/JCO.2015.64.8808; Powles T, 2016, EUR UROL, V69, P450, DOI 10.1016/j.eururo.2015.08.035; Purdue MP, 2011, NAT GENET, V43, P60, DOI 10.1038/ng.723; Rankin EB, 2014, P NATL ACAD SCI USA, V111, P13373, DOI 10.1073/pnas.1404848111; Raval RR, 2005, MOL CELL BIOL, V25, P5675, DOI 10.1128/MCB.25.13.5675-5686.2005; Renfrow JJ, 2018, FUTURE MED CHEM, V10, P2227, DOI 10.4155/fmc-2018-0163; Rini B, 2012, CANCER-AM CANCER SOC, V118, P6152, DOI 10.1002/cncr.27632; Rini BI, 2019, J CLIN ONCOL, V37, DOI 10.1200/JCO.2019.37.7_suppl.558; Rini BI, 2019, LANCET, V393, P2404, DOI 10.1016/S0140-6736(19)30723-8; Rini BI, 2019, NEW ENGL J MED, V380, P1116, DOI 10.1056/NEJMoa1816714; Rini BI, 2011, LANCET, V378, P1931, DOI 10.1016/S0140-6736(11)61613-9; Rogers JL, 2013, J MED CHEM, V56, P1739, DOI 10.1021/jm301847z; Santoni M, 2014, BBA-REV CANCER, V1845, P221, DOI 10.1016/j.bbcan.2014.01.007; Saxton RA, 2017, CELL, V168, P960, DOI [10.1016/j.cell.2017.03.035, 10.1016/j.cell.2017.02.004]; Scheuermann TH, 2013, NAT CHEM BIOL, V9, P271, DOI [10.1038/nchembio.1185, 10.1038/NCHEMBIO.1185]; Scheuermann TH, 2009, P NATL ACAD SCI USA, V106, P450, DOI 10.1073/pnas.0808092106; Schietke RE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031034; Schodel J, 2012, NAT GENET, V44, P420, DOI 10.1038/ng.2204; Sennino B, 2012, CANCER DISCOV, V2, P270, DOI 10.1158/2159-8290.CD-11-0240; Sgambati MT, 2000, AM J HUM GENET, V66, P84, DOI 10.1086/302726; Shen C, 2011, CANCER DISCOV, V1, P222, DOI 10.1158/2159-8290.CD-11-0098; Shojaei F, 2010, CANCER RES, V70, P10090, DOI 10.1158/0008-5472.CAN-10-0489; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Siemeister G, 1996, CANCER RES, V56, P2299; Smith CC, 2018, J CLIN INVEST, V128, P4804, DOI 10.1172/JCI121476; Smith TG, 2006, PLOS MED, V3, P1178, DOI 10.1371/journal.pmed.0030290; Sternberg CN, 2013, EUR J CANCER, V49, P1287, DOI 10.1016/j.ejca.2012.12.010; Sternberg CN, 2010, J CLIN ONCOL, V28, P1061, DOI 10.1200/JCO.2009.23.9764; Strowd RE, 2019, J CLIN ONCOL, V37, DOI 10.1200/JCO.2019.37.15_suppl.2027; Strumberg D, 2005, J CLIN ONCOL, V23, P965, DOI 10.1200/JCO.2005.06.124; Takahashi Y, 2008, J CLIN INVEST, V118, P1584, DOI 10.1172/JCI34409C1; Tanimoto K, 2000, EMBO J, V19, P4298, DOI 10.1093/emboj/19.16.4298; Tannir NM, 2020, J CLIN ONCOL, V38; Thompson JM, 2017, ONCOGENE, V36, P1080, DOI 10.1038/onc.2016.272; Toschi A, 2008, J BIOL CHEM, V283, P34495, DOI 10.1074/jbc.C800170200; Tykodi SS, 2019, J CLIN ONCOL, V37, DOI 10.1200/JCO.2019.37.15_suppl.4570; Uniacke J, 2012, NATURE, V486, P126, DOI 10.1038/nature11055; Von-Hippel E, 1904, ARCH OPHTHALMOL-CHIC, V59, P23, DOI [10.1007/BF01994821, DOI 10.1007/BF01994821]; Voss MH, 2017, CLIN CANCER RES, V23, P3557, DOI 10.1158/1078-0432.CCR-16-2395; Wallace EM, 2016, CANCER RES, V76, P5491, DOI 10.1158/0008-5472.CAN-16-0473; Wang Y, 2009, NAT MED, V15, P319, DOI 10.1038/nm.1922; Wehn PM, 2018, J MED CHEM, V61, P9691, DOI 10.1021/acs.jmedchem.8b01196; Wei SC, 2018, CANCER DISCOV, V8, P1069, DOI 10.1158/2159-8290.CD-18-0367; Wilhelm SM, 2004, CANCER RES, V64, P7099, DOI 10.1158/0008-5472.CAN-04-1443; Wu DL, 2015, NATURE, V524, P303, DOI 10.1038/nature14883; Xu R, 2019, J MED CHEM, V62, P6876, DOI 10.1021/acs.jmedchem.9b00719; Yakes FM, 2011, MOL CANCER THER, V10, P2298, DOI 10.1158/1535-7163.MCT-11-0264; Yamamoto Y, 2014, VASC CELL, V6, DOI 10.1186/2045-824X-6-18; Yang GY, 2017, DRUG METAB REV, V49, P105, DOI 10.1080/03602532.2017.1293682; Yang JC, 2003, NEW ENGL J MED, V349, P427, DOI 10.1056/NEJMoa021491; Yarchoan M, 2017, NEW ENGL J MED, V377, P2500, DOI 10.1056/NEJMc1713444; Yi M, 2019, MOL CANCER, V18, DOI 10.1186/s12943-019-0974-6; Yu F, 2001, P NATL ACAD SCI USA, V98, P9630, DOI 10.1073/pnas.181341498; Zheng B, 2015, CANCER LETT, V357, P468, DOI 10.1016/j.canlet.2014.11.012; Zhou L, 2016, ONCOGENE, V35, P2687, DOI 10.1038/onc.2015.343; ZHUANG ZP, 1995, AM J PATHOL, V146, P620; ZHUANG ZP, 1994, ACTA CYTOL, V38, P671; Zhuang ZP, 1996, MODERN PATHOL, V9, P838; Zimmer M, 2004, MOL CANCER RES, V2, P89	173	135	140	7	28	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	OCT	2020	26	10					1519	1530		10.1038/s41591-020-1093-z	http://dx.doi.org/10.1038/s41591-020-1093-z		OCT 2020	12	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	NX8MD	33020645				2022-12-27	WOS:000575801100007
J	Nimri, R; Battelino, T; Laffel, LM; Slover, RH; Schatz, D; Weinzimer, SA; Dovc, K; Danne, T; Phillip, M				Nimri, Revital; Battelino, Tadej; Laffel, Lori M.; Slover, Robert H.; Schatz, Desmond; Weinzimer, Stuart A.; Dovc, Klemen; Danne, Thomas; Phillip, Moshe		NextDREAM Consortium	Insulin dose optimization using an automated artificial intelligence-based decision support system in youths with type 1 diabetes	NATURE MEDICINE			English	Article							INTENSIVE TREATMENT	Despite the increasing adoption of insulin pumps and continuous glucose monitoring devices, most people with type 1 diabetes do not achieve their glycemic goals(1). This could be related to a lack of expertise or inadequate time for clinicians to analyze complex sensor-augmented pump data. We tested whether frequent insulin dose adjustments guided by an automated artificial intelligence-based decision support system (AI-DSS) is as effective and safe as those guided by physicians in controlling glucose levels. ADVICE4U was a six-month, multicenter, multinational, parallel, randomized controlled, non-inferiority trial in 108 participants with type 1 diabetes, aged 10-21 years and using insulin pump therapy (ClinicalTrials.gov no. NCT03003806). Participants were randomized 1:1 to receive remote insulin dose adjustment every three weeks guided by either an AI-DSS, (AI-DSS arm, n=54) or by physicians (physician arm, n=54). The results for the primary efficacy measure-the percentage of time spent within the target glucose range (70-180mgdl(-1) (3.9-10.0mmoll(-1)))-in the AI-DSS arm were statistically non-inferior to those in the physician arm (50.211.1% versus 51.6 +/- 11.3%, respectively, P<1x10(-7)). The percentage of readings below 54mgdl(-1) (<3.0mmoll(-1)) within the AI-DSS arm was statistically non-inferior to that in the physician arm (1.3 +/- 1.4% versus 1.0 +/- 0.9%, respectively, P<0.0001). Three severe adverse events related to diabetes (two severe hypoglycemia, one diabetic ketoacidosis) were reported in the physician arm and none in the AI-DSS arm. In conclusion, use of an automated decision support tool for optimizing insulin pump settings was non-inferior to intensive insulin titration provided by physicians from specialized academic diabetes centers.The randomized-controlled trial ADVICE4U demonstrates non-inferiority of an automated AI-based decision support system compared with advice from expert physicians for optimal insulin dosing in youths with type 1 diabetes.	[Nimri, Revital; Phillip, Moshe] Schneider Childrens Med Ctr Israel, Jesse Z & Sara Lea Shafer Inst Endocrinol & Diabe, Natl Ctr Childhood Diabet, Petah Tiqwa, Israel; [Battelino, Tadej; Dovc, Klemen] Univ Ljubljana, Dept Endocrinol Diabet & Metab Dis, UMC Univ Childrens Hosp Ljubljana, Ljubljana, Slovenia; [Battelino, Tadej; Dovc, Klemen] Univ Ljubljana, Fac Med, Ljubljana, Slovenia; [Laffel, Lori M.] Harvard Med Sch, Joslin Diabet Ctr, One Joslin Pl, Boston, MA 02115 USA; [Slover, Robert H.] Univ Colorado, Barbara Davis Ctr Childhood Diabet, Anschutz Med Campus, Aurora, CO USA; [Schatz, Desmond] Univ Florida, Coll Med, Dept Pediat, Gainesville, FL USA; [Weinzimer, Stuart A.] Yale Sch Med, Pediat Endocrinol & Diabet, New Haven, CT USA; [Danne, Thomas] Childrens Hosp BULT, Diabet Ctr Children & Adolescents, Hannover, Germany; [Phillip, Moshe] Tel Aviv Univ, Sackler Fac Med, Tel Aviv, Israel	University of Ljubljana; University of Ljubljana; Harvard University; Harvard Medical School; Joslin Diabetes Center, Inc.; University of Colorado System; University of Colorado Anschutz Medical Campus; State University System of Florida; University of Florida; Yale University; Tel Aviv University; Sackler Faculty of Medicine	Phillip, M (corresponding author), Schneider Childrens Med Ctr Israel, Jesse Z & Sara Lea Shafer Inst Endocrinol & Diabe, Natl Ctr Childhood Diabet, Petah Tiqwa, Israel.; Phillip, M (corresponding author), Tel Aviv Univ, Sackler Fac Med, Tel Aviv, Israel.	mosheph@tauex.tau.ac.il		Battelino, Tadej/0000-0002-0273-4732; Dovc, Klemen/0000-0001-9201-2145; Nimri, Revital/0000-0003-3571-4938; Isganaitis, Elvira/0000-0003-3477-0305; Messer, Laurel/0000-0001-7493-0989				Abramson Joseph H, 2011, Epidemiol Perspect Innov, V8, P1, DOI 10.1186/1742-5573-8-1; Aleppo G, 2017, DIABETES CARE, V40, P538, DOI 10.2337/dc16-2482; Beck RW, 2015, DIABETES TECHNOL THE, V17, P536, DOI 10.1089/dia.2015.0169; Bergenstal RM, 2019, LANCET, V393, P1138, DOI 10.1016/S0140-6736(19)30368-X; Cefalu WT, 2019, DIABETES CARE, V42, pS103, DOI 10.2337/dc19S010; Chiang JL, 2018, DIABETES CARE, V41, P2026, DOI 10.2337/dci18-0023; Davidson MB, 2009, DIABETES CARE, V32, P370, DOI 10.2337/dc08-2046; DCCT Res Grp, 1987, DIABETES CARE, V10, P1; Edelman SV, 2018, DIABETES CARE, V41, P2265, DOI 10.2337/dc18-1150; FOSTER NC, 2018, DIABETES S1, V67, P1689, DOI DOI 10.2337/DB18-1689-P; Hahn Seokyung, 2012, Korean J Pediatr, V55, P403, DOI 10.3345/kjp.2012.55.11.403; International Diabetes Federation, IDF DIABETES ATLAS, V10th; Comellas MJ, 2017, DIABETES TECHNOL THE, V19, P633, DOI 10.1089/dia.2017.0180; Lu H, 2015, BMC HEALTH SERV RES, V15, DOI 10.1186/s12913-015-1185-5; Markowitz JT, 2014, J PEDIATR-US, V164, P1384, DOI 10.1016/j.jpeds.2014.01.045; Miller KM, 2015, DIABETES CARE, V38, P971, DOI 10.2337/dc15-0078; Nathan DM, 2005, NEW ENGL J MED, V353, P2643, DOI 10.1056/nejmoa052187; Nimri R, 2018, DIABETES OBES METAB, V20, P2458, DOI 10.1111/dom.13408; Patterson CC, 2019, DIABETOLOGIA, V62, P408, DOI 10.1007/s00125-018-4763-3; Petitti DB, 2009, J PEDIATR-US, V155, P668, DOI 10.1016/j.jpeds.2009.05.025; Pihoker C, 2018, PEDIATR DIABETES, V19, P84, DOI 10.1111/pedi.12757; Shalitin S, 2014, ACTA DIABETOL, V51, P247, DOI 10.1007/s00592-013-0510-x; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Tamborlane WV, 2008, NEW ENGL J MED, V359, P1464, DOI 10.1056/NEJMoa0805017; Vigersky RA, 2014, J CLIN ENDOCR METAB, V99, P3112, DOI 10.1210/jc.2014-2257; Zisser H, 2010, DIABETES TECHNOL THE, V12, P955, DOI 10.1089/dia.2010.0064	26	42	45	7	16	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	SEP	2020	26	9								10.1038/s41591-020-1045-7	http://dx.doi.org/10.1038/s41591-020-1045-7			23	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	PF3EM	32908282				2022-12-27	WOS:000598942000023
J	Suriben, R; Chen, M; Higbee, J; Oeffinger, J; Ventura, R; Li, B; Mondal, K; Gao, ZY; Ayupova, D; Taskar, P; Li, DN; Starck, SR; Chen, HIH; McEntee, M; Katewa, SD; Phung, V; Wang, M; Kekatpure, A; Lakshminarasimhan, D; White, A; Olland, A; Haldankar, R; Solloway, MJ; Hsu, JY; Wang, Y; Tang, J; Lindhout, DA; Allan, BB				Suriben, Rowena; Chen, Michael; Higbee, Jared; Oeffinger, Julie; Ventura, Richard; Li, Betty; Mondal, Kalyani; Gao, Zhengyu; Ayupova, Dina; Taskar, Pranali; Li, Diana; Starck, Shelley R.; Chen, Hung-I Harry; McEntee, Michele; Katewa, Subhash D.; Phung, Van; Wang, Marilyn; Kekatpure, Avantika; Lakshminarasimhan, Damodharan; White, Andre; Olland, Andrea; Haldankar, Raj; Solloway, Mark J.; Hsu, Jer-Yuan; Wang, Yan; Tang, Jie; Lindhout, Darrin A.; Allan, Bernard B.			Antibody-mediated inhibition of GDF15-GFRAL activity reverses cancer cachexia in mice	NATURE MEDICINE			English	Article							DIFFERENTIAL EXPRESSION ANALYSIS; WEIGHT-LOSS; RECEPTOR; GDF15; LIPOLYSIS; PROTEIN; RET	Cancer cachexia is a highly prevalent condition associated with poor quality of life and reduced survival(1). Tumor-induced perturbations in the endocrine, immune and nervous systems drive anorexia and catabolic changes in adipose tissue and skeletal muscle, hallmarks of cancer cachexia(2-4). However, the molecular mechanisms driving cachexia remain poorly defined, and there are currently no approved drugs for the condition. Elevation in circulating growth differentiation factor 15 (GDF15) correlates with cachexia and reduced survival in patients with cancer(5-8), and a GDNF family receptor alpha like (GFRAL)-Ret proto-oncogene (RET) signaling complex in brainstem neurons that mediates GDF15-induced weight loss in mice has recently been described(9-12). Here we report a therapeutic antagonistic monoclonal antibody, 3P10, that targets GFRAL and inhibits RET signaling by preventing the GDF15-driven interaction of RET with GFRAL on the cell surface. Treatment with 3P10 reverses excessive lipid oxidation in tumor-bearing mice and prevents cancer cachexia, even under calorie-restricted conditions. Mechanistically, activation of the GFRAL-RET pathway induces expression of genes involved in lipid metabolism in adipose tissues, and both peripheral chemical sympathectomy and loss of adipose triglyceride lipase protect mice from GDF15-induced weight loss. These data uncover a peripheral sympathetic axis by which GDF15 elicits a lipolytic response in adipose tissue independently of anorexia, leading to reduced adipose and muscle mass and function in tumor-bearing mice. Pharmacological inhibition of GFRAL-RET signaling in preclinical tumor models supports the therapeutic potential for reversing GDF15-dependent cachexia in people with cancer.	[Suriben, Rowena; Chen, Michael; Higbee, Jared; Oeffinger, Julie; Ventura, Richard; Li, Betty; Mondal, Kalyani; Gao, Zhengyu; Ayupova, Dina; Taskar, Pranali; Li, Diana; Starck, Shelley R.; Chen, Hung-I Harry; McEntee, Michele; Katewa, Subhash D.; Phung, Van; Wang, Marilyn; Kekatpure, Avantika; Haldankar, Raj; Solloway, Mark J.; Hsu, Jer-Yuan; Wang, Yan; Tang, Jie; Lindhout, Darrin A.] NGM Biopharmaceut, San Francisco, CA USA; [Lakshminarasimhan, Damodharan; White, Andre; Olland, Andrea] XTAL Biostruct, Natick, MA USA; [Allan, Bernard B.] Takeda Pharmaceut, Cambridge, MA 02139 USA		Allan, BB (corresponding author), Takeda Pharmaceut, Cambridge, MA 02139 USA.	ber.allan71@gmail.com		Taskar, Pranali/0000-0001-9677-6273				Agustsson T, 2007, CANCER RES, V67, P5531, DOI 10.1158/0008-5472.CAN-06-4585; Argiles JM, 2014, NAT REV CANCER, V14, P754, DOI 10.1038/nrc3829; Baracos VE, 2018, NAT REV DIS PRIMERS, V4, DOI 10.1038/nrdp.2017.105; Burfeind KG, 2016, SEMIN CELL DEV BIOL, V54, P42, DOI 10.1016/j.semcdb.2015.10.038; Campos CA, 2018, NATURE, V555, P617, DOI 10.1038/nature25511; Coll AP, 2020, NATURE, V578, P444, DOI 10.1038/s41586-019-1911-y; Das SK, 2011, SCIENCE, V333, P233, DOI 10.1126/science.1198973; De Vita G, 2000, CANCER RES, V60, P3727; Emmerson PJ, 2017, NAT MED, V23, P1215, DOI 10.1038/nm.4393; Evans WJ, 2008, CLIN NUTR, V27, P793, DOI 10.1016/j.clnu.2008.06.013; Fukawa T, 2016, NAT MED, V22, P666, DOI 10.1038/nm.4093; Holm L, 2010, CURR OPIN CLIN NUTR, V13, P526, DOI 10.1097/MCO.0b013e32833c3c64; Hsu JY, 2017, NATURE, V550, P255, DOI 10.1038/nature24042; Johnen H, 2007, NAT MED, V13, P1333, DOI 10.1038/nm1677; Klein RD, 1997, NATURE, V387, P717, DOI 10.1038/42722; Lerner L, 2016, J CACHEXIA SARCOPENI, V7, P467, DOI 10.1002/jcsm.12077; Lerner L, 2015, J CACHEXIA SARCOPENI, V6, P317, DOI 10.1002/jcsm.12033; Li C, 2016, J CELL MOL MED, V20, P1420, DOI 10.1111/jcmm.12830; Li J, 2019, ELIFE, V8, DOI [10.7554/eLife.47650, 10.7554/eLife.47650.001]; Luan HH, 2019, CELL, V178, P1231, DOI 10.1016/j.cell.2019.07.033; McCarthy DJ, 2012, NUCLEIC ACIDS RES, V40, P4288, DOI 10.1093/nar/gks042; Mullican SE, 2017, NAT MED, V23, P1150, DOI 10.1038/nm.4392; Parkash V, 2008, J BIOL CHEM, V283, P35164, DOI 10.1074/jbc.M802543200; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Ryden M, 2008, CANCER-AM CANCER SOC, V113, P1695, DOI 10.1002/cncr.23802; Staff AC, 2010, GYNECOL ONCOL, V118, P237, DOI 10.1016/j.ygyno.2010.05.032; Strelau J, 2009, J NEUROSCI, V29, P13640, DOI 10.1523/JNEUROSCI.1133-09.2009; Tisdale MJ, 2005, PHYSIOLOGY, V20, P340, DOI 10.1152/physiol.00019.2005; Treanor JJS, 1996, NATURE, V382, P80, DOI 10.1038/382080a0; Tsai VWW, 2018, CELL METAB, V28, P353, DOI 10.1016/j.cmet.2018.07.018; Yang LD, 2017, NAT MED, V23, P1158, DOI 10.1038/nm.4394; Zeisel A, 2018, CELL, V174, P999, DOI 10.1016/j.cell.2018.06.021	32	82	84	9	31	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	AUG	2020	26	8					1264	+		10.1038/s41591-020-0945-x	http://dx.doi.org/10.1038/s41591-020-0945-x		JUL 2020	16	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	MX8ZF	32661391				2022-12-27	WOS:000548106700001
J	Haak, BW; Wiersinga, WJ				Haak, Bastiaan W.; Wiersinga, W. Joost			Uncovering hidden antimicrobial resistance patterns within the hospital microbiome	NATURE MEDICINE			English	Editorial Material									[Haak, Bastiaan W.; Wiersinga, W. Joost] Univ Amsterdam, Amsterdam Univ Med Ctr, AMC, Ctr Expt & Mol Med, Amsterdam, Netherlands; [Wiersinga, W. Joost] Univ Amsterdam, Amsterdam Univ Med Ctr, AMC, Dept Internal Med,Div Infect Dis, Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	Wiersinga, WJ (corresponding author), Univ Amsterdam, Amsterdam Univ Med Ctr, AMC, Ctr Expt & Mol Med, Amsterdam, Netherlands.; Wiersinga, WJ (corresponding author), Univ Amsterdam, Amsterdam Univ Med Ctr, AMC, Dept Internal Med,Div Infect Dis, Amsterdam, Netherlands.	w.j.wiersinga@amsterdamumc.nl		Wiersinga, Willem/0000-0003-2277-1343; Haak, Bastiaan W./0000-0002-3903-5441				Baker S, 2018, SCIENCE, V360, P733, DOI 10.1126/science.aar3777; Baker S, 2015, SCIENCE, V347, P1064, DOI 10.1126/science.aaa2868; Bertrand D, 2019, NAT BIOTECHNOL, V37, P937, DOI 10.1038/s41587-019-0191-2; Chng KR, 2020, NAT MED, V26, P941, DOI 10.1038/s41591-020-0894-4; Finley RL, 2013, CLIN INFECT DIS, V57, P704, DOI 10.1093/cid/cit355; Ho CM, 2012, ANTIMICROB AGENTS CH, V56, P5693, DOI 10.1128/AAC.00761-12; Holmes AH, 2016, LANCET, V387, P176, DOI 10.1016/S0140-6736(15)00473-0; Lax S, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aah6500; Magill SS, 2014, NEW ENGL J MED, V370, P1198, DOI 10.1056/NEJMoa1306801; San Millan A, 2018, TRENDS MICROBIOL, V26, P978, DOI 10.1016/j.tim.2018.06.007	10	3	3	3	10	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	JUN	2020	26	6					826	828		10.1038/s41591-020-0919-z	http://dx.doi.org/10.1038/s41591-020-0919-z		JUN 2020	3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	LZ3ZG	32514170				2022-12-27	WOS:000538976400004
J	Bryant, KL; Stalnecker, CA; Zeitouni, D; Klomp, JE; Peng, S; Tikunov, AP; Gunda, V; Pierobon, M; Waters, AM; George, SD; Tomar, G; Papke, B; Hobbs, GA; Yan, L; Hayes, TK; Diehl, JN; Goode, GD; Chaika, NV; Wang, YX; Zhang, GF; Witkiewicz, AK; Knudsen, ES; Petricoin, EF; Singh, PK; Macdonald, JM; Tran, NL; Lyssiotis, CA; Ying, HQ; Kimmelman, AC; Cox, AD; Der, CJ				Bryant, Kirsten L.; Stalnecker, Clint A.; Zeitouni, Daniel; Klomp, Jennifer E.; Peng, Sen; Tikunov, Andrey P.; Gunda, Venugopal; Pierobon, Mariaelena; Waters, Andrew M.; George, Samuel D.; Tomar, Garima; Papke, Bjorn; Hobbs, G. Aaron; Yan, Liang; Hayes, Tikvah K.; Diehl, J. Nathaniel; Goode, Gennifer D.; Chaika, Nina V.; Wang, Yingxue; Zhang, Guo-Fang; Witkiewicz, Agnieszka K.; Knudsen, Erik S.; Petricoin, Emanuel F., III; Singh, Pankaj K.; Macdonald, Jeffrey M.; Tran, Nhan L.; Lyssiotis, Costas A.; Ying, Haoqiang; Kimmelman, Alec C.; Cox, Adrienne D.; Der, Channing J.			Combination of ERK and autophagy inhibition as a treatment approach for pancreatic cancer (vol 25, pg 628, 2019)	NATURE MEDICINE			English	Correction								An amendment to this paper has been published and can be accessed via a link at the top of the paper.				cjder@med.unc.edu	Yan, Liang/AAF-6382-2022; Lyssiotis, Costas A/AAI-1923-2019; Pierobon, Mariaelena/GXA-0544-2022; Yan, Liang/AFE-8595-2022	Yan, Liang/0000-0002-3002-5431; Lyssiotis, Costas A/0000-0001-9309-6141; Yan, Liang/0000-0002-3002-5431; Papke, Bjoern/0000-0001-8156-7508; Bryant, Kirsten/0000-0003-4026-0942; Waters, Andrew/0000-0002-6058-5878; Singh, Pankaj/0000-0001-8903-0131				Bryant KL, 2019, NAT MED, V25, P628, DOI 10.1038/s41591-019-0368-8	1	6	6	3	15	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	JUN	2020	26	6					982	982		10.1038/s41591-020-0947-8	http://dx.doi.org/10.1038/s41591-020-0947-8		JUN 2020	1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	LZ3ZG	32483362	Bronze			2022-12-27	WOS:000537041000001
J	Wu, JT; Leung, K; Bushman, M; Kishore, N; Niehus, R; de Salazar, PM; Cowling, BJ; Lipsitch, M; Leung, GM				Wu, Joseph T.; Leung, Kathy; Bushman, Mary; Kishore, Nishant; Niehus, Rene; de Salazar, Pablo M.; Cowling, Benjamin J.; Lipsitch, Marc; Leung, Gabriel M.			Estimating clinical severity of COVID-19 from the transmission dynamics in Wuhan, China (vol 26, pg 506, 2020)	NATURE MEDICINE			English	Correction												joewu@hku.hk	Wu, Joseph/ABD-5880-2021; Leung, Kathy/D-5605-2017; Wu, Joseph Tsz Kei/C-4450-2009	Leung, Kathy/0000-0003-4777-388X; Wu, Joseph Tsz Kei/0000-0002-3155-5987				Wu JM, 2022, CRIT REV FOOD SCI, V62, P783, DOI [10.1080/10408398.2020.1828813, 10.1038/s41591-020-0822-7]	1	8	8	2	8	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	JUL	2020	26	7					1149	1150		10.1038/s41591-020-0920-6	http://dx.doi.org/10.1038/s41591-020-0920-6		MAY 2020	2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	MK3XO	32661399	Bronze, Green Published			2022-12-27	WOS:000534724000001
J	't Hoen, E				't Hoen, Ellen			Protect against market exclusivity in the fight against COVID-19	NATURE MEDICINE			English	Editorial Material								Patents and other intellectual properties could slow down the scale-up and accessibility of treatments and vaccines against COVID-19.	['t Hoen, Ellen] Med Law & Policy, Groningen, Netherlands		't Hoen, E (corresponding author), Med Law & Policy, Groningen, Netherlands.	ellenthoen@medicineslawandpolicy.net		't Hoen, Ellen/0000-0003-4477-6866					0	7	7	3	18	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	JUN	2020	26	6					813	813		10.1038/s41591-020-0876-6	http://dx.doi.org/10.1038/s41591-020-0876-6		MAY 2020	1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	LZ3ZG	32382151	Bronze			2022-12-27	WOS:000530983800002
J	Chalabi, M; Fanchi, LF; Dijkstra, KK; Van den Berg, JG; Aalbers, AG; Sikorska, K; Lopez-Yurda, M; Grootscholten, C; Beets, GL; Snaebjornsson, P; Maas, M; Mertz, M; Veninga, V; Bounova, G; Broeks, A; Beets-Tan, RG; de Wijkerslooth, TR; van Lent, AU; Marsman, HA; Nuijten, E; Kok, NF; Kuiper, M; Verbeek, WH; Kok, M; Van Leerdam, ME; Schumacher, TN; Voest, EE; Haanen, JB				Chalabi, Myriam; Fanchi, Lorenzo F.; Dijkstra, Krijn K.; Van den Berg, Jose G.; Aalbers, Arend G.; Sikorska, Karolina; Lopez-Yurda, Marta; Grootscholten, Cecile; Beets, Geerard L.; Snaebjornsson, Petur; Maas, Monique; Mertz, Marjolijn; Veninga, Vivien; Bounova, Gergana; Broeks, Annegien; Beets-Tan, Regina G.; de Wijkerslooth, Thomas R.; van Lent, Anja U.; Marsman, Hendrik A.; Nuijten, Elvira; Kok, Niels F.; Kuiper, Maria; Verbeek, Wieke H.; Kok, Marleen; Van Leerdam, Monique E.; Schumacher, Ton N.; Voest, Emile E.; Haanen, John B.			Neoadjuvant immunotherapy leads to pathological responses in MMR-proficient and MMR-deficient early-stage colon cancers	NATURE MEDICINE			English	Article							DNA MISMATCH REPAIR; NIVOLUMAB	PD-1 plus CTLA-4 blockade is highly effective in advanced-stage, mismatch repair (MMR)-deficient (dMMR) colorectal cancers, yet not in MMR-proficient (pMMR) tumors. We postulated a higher efficacy of neoadjuvant immunotherapy in early-stage colon cancers. In the exploratory NICHE study (ClinicalTrials.gov: NCT03026140), patients with dMMR or pMMR tumors received a single dose of ipilimumab and two doses of nivolumab before surgery, the pMMR group with or without celecoxib. The primary objective was safety and feasibility; 40 patients with 21 dMMR and 20 pMMR tumors were treated, and 3 patients received nivolumab monotherapy in the safety run-in. Treatment was well tolerated and all patients underwent radical resections without delays, meeting the primary endpoint. Of the patients who received ipilimumab + nivolumab (20 dMMR and 15 pMMR tumors), 35 were evaluable for efficacy and translational endpoints. Pathological response was observed in 20/20 (100%; 95% exact confidence interval (CI): 86-100%) dMMR tumors, with 19 major pathological responses (MPRs, <= 10% residual viable tumor) and 12 pathological complete responses. In pMMR tumors, 4/15 (27%; 95% exact CI: 8-55%) showed pathological responses, with 3 MPRs and 1 partial response. CD8(+)PD-1(+) T cell infiltration was predictive of response in pMMR tumors. These data indicate that neoadjuvant immunotherapy may have the potential to become the standard of care for a defined group of colon cancer patients when validated in larger studies with at least 3 years of disease-free survival data.	[Chalabi, Myriam; Grootscholten, Cecile; de Wijkerslooth, Thomas R.; Kuiper, Maria; Verbeek, Wieke H.; Van Leerdam, Monique E.; Voest, Emile E.] Netherlands Canc Inst, Gastrointestinal Oncol, Amsterdam, Netherlands; [Chalabi, Myriam; Fanchi, Lorenzo F.; Dijkstra, Krijn K.; Veninga, Vivien; Schumacher, Ton N.; Voest, Emile E.; Haanen, John B.] Netherlands Canc Inst, Mol Oncol & Immunol, Amsterdam, Netherlands; [Chalabi, Myriam; Kok, Marleen; Haanen, John B.] Netherlands Canc Inst, Med Oncol, Amsterdam, Netherlands; [Fanchi, Lorenzo F.; Dijkstra, Krijn K.; Veninga, Vivien; Bounova, Gergana; Schumacher, Ton N.; Voest, Emile E.] Oncode Inst, Utrecht, Netherlands; [Van den Berg, Jose G.; Snaebjornsson, Petur] Netherlands Canc Inst, Pathol, Amsterdam, Netherlands; [Aalbers, Arend G.; Beets, Geerard L.; Kok, Niels F.] Netherlands Canc Inst, Surg Oncol, Amsterdam, Netherlands; [Sikorska, Karolina; Lopez-Yurda, Marta; Nuijten, Elvira] Netherlands Canc Inst, Biometr, Amsterdam, Netherlands; [Lopez-Yurda, Marta] Princess Maxima Ctr Pediat Oncol, Utrecht, Netherlands; [Beets, Geerard L.; Beets-Tan, Regina G.] Maastricht Univ, GROW Sch Oncol & Dev Biol, Maastricht, Netherlands; [Maas, Monique; Beets-Tan, Regina G.] Netherlands Canc Inst, Radiol, Amsterdam, Netherlands; [Mertz, Marjolijn] Netherlands Canc Inst, Bioimaging Facil, Amsterdam, Netherlands; [Bounova, Gergana] Netherlands Canc Inst, Mol Carcinogenesis, Amsterdam, Netherlands; [Broeks, Annegien] Netherlands Canc Inst, Core Facil Mol Pathol & Biobanking, Amsterdam, Netherlands; [van Lent, Anja U.] Onze Lieve Vrouw Hosp, Gastroenterol & Hepatol, Amsterdam, Netherlands; [Marsman, Hendrik A.] Onze Lieve Vrouw Hosp, Surg, Amsterdam, Netherlands; [Kok, Marleen] Netherlands Canc Inst, Tumor Biol & Immunol, Amsterdam, Netherlands	Netherlands Cancer Institute; Netherlands Cancer Institute; Netherlands Cancer Institute; Netherlands Cancer Institute; Netherlands Cancer Institute; Netherlands Cancer Institute; Maastricht University; Netherlands Cancer Institute; Netherlands Cancer Institute; Netherlands Cancer Institute; Netherlands Cancer Institute; Onze Lieve Vrouwe Gasthuis Hospital; Onze Lieve Vrouwe Gasthuis Hospital; Netherlands Cancer Institute	Chalabi, M; Voest, EE (corresponding author), Netherlands Canc Inst, Gastrointestinal Oncol, Amsterdam, Netherlands.; Chalabi, M; Voest, EE (corresponding author), Netherlands Canc Inst, Mol Oncol & Immunol, Amsterdam, Netherlands.; Chalabi, M (corresponding author), Netherlands Canc Inst, Med Oncol, Amsterdam, Netherlands.; Voest, EE (corresponding author), Oncode Inst, Utrecht, Netherlands.	m.chalabi@nki.nl; e.voest@nki.nl	Haanen, John/AAD-8578-2022; Haanen, John/AAD-8534-2022; van Leerdam, Monique/AAV-9185-2020; Beets-Tan, Regina/AAZ-9119-2020; Beets, Geerard/G-2682-2013; Schumacher, Ton/Y-2432-2019	Haanen, John/0000-0001-5884-7704; van Leerdam, Monique/0000-0002-5719-3208; Beets, Geerard/0000-0002-1671-9912; Schumacher, Ton/0000-0003-0517-8804; Mertz, Marjolijn/0000-0002-9188-3579; Lopez-Yurda, Marta/0000-0003-3678-3222; Snaebjornsson, Petur/0000-0002-1086-8108	BMS International Immuno-Oncology Network; NKI	BMS International Immuno-Oncology Network; NKI	We thank all patients and their families for participating in the present study. We thank: the Core Facility of Molecular Pathology and Biobanking, L. Braaf, S. Cornelissen and D. Peters for their support in processing of samples; C. Van Rooijen for setting up CD8/PD-1 co-stains; R. Kerkhoven and the Genomics Core Facility for their support with sequencing; the Flow Cytometry Core Facility for their support in flow cytometry; J. Lips from Adaptive Biotechnologies for his support; L. Al-van Wijck from the scientific administration department for data management; L. Hoes, F. Weeber, J. Westra, S. Visser and S. Kaing for facilitating sample acquisition and processing; A. Van der Leun for support in TIL isolation; T. Korse, M. Lucas and E. Platte for PBMC acquisition and processing; A. Atsma, P. Bottenberg, S. Oosterloo, M. van Wijngaarden, P. Den Hartog and S. Dokter for patient care; M. Mok, I. Honing, M. Van Nes and N. De Jong for patient care in the OLVG; P. Drillenburg for sample acquisition; Merus for provision of anti-PD-1 for in vitro experiments; M. Toebes, X. Kong and M. Ligtenberg for the lentiviral HLA-A2 vector and MART-1 peptide; S. Vanhoutvin for legal support; A. Evans, D. Tauriello, G. Sonke and H. Van Tinteren for scientific input. The present study was funded by the BMS International Immuno-Oncology Network and sponsored by the NKI. The funding source had no role in design and execution of the study, data analysis or writing of the manuscript.	Amaria RN, 2018, NAT MED, V24, P1649, DOI 10.1038/s41591-018-0197-1; Andre T, 2015, J CLIN ONCOL, V33, P4176, DOI 10.1200/JCO.2015.63.4238; [Anonymous], 2016, ANN ONCOL; [Anonymous], 2019, ANN ONCOL S5, DOI DOI 10.1093/ANNONC/MDZ246.001; [Anonymous], REV COMM TERM CRIT A; Ayers M, 2017, J CLIN INVEST, V127, P2930, DOI 10.1172/JCI91190; Blank CU, 2018, NAT MED, V24, P1655, DOI 10.1038/s41591-018-0198-0; Blank CU, 2016, SCIENCE, V352, P658, DOI 10.1126/science.aaf2834; Brierley JD, 2017, TNM CLASSIFICATION M; Calon A, 2012, CANCER CELL, V22, P571, DOI 10.1016/j.ccr.2012.08.013; Cattaneo CM, 2020, NAT PROTOC, V15, P15, DOI 10.1038/s41596-019-0232-9; Cloughesy TF, 2019, NAT MED, V25, P477, DOI 10.1038/s41591-018-0337-7; Cottrell TR, 2018, ANN ONCOL, V29, P1853, DOI 10.1093/annonc/mdy218; Diaz LA, 2015, NEW ENGL J MED, V373, P1979, DOI 10.1056/NEJMc1510353; Dijkstra KK, 2018, CELL, V174, P1586, DOI 10.1016/j.cell.2018.07.009; Dudley ME, 2003, J IMMUNOTHER, V26, P332, DOI 10.1097/00002371-200307000-00005; Fabrizio DA, 2018, J GASTROINTEST ONCOL, V9, P610, DOI 10.21037/jgo.2018.05.06; Germano G, 2017, NATURE, V552, P116, DOI 10.1038/nature24673; Gomez-Eerland R, 2014, HUM GENE THER METHOD, V25, P277, DOI 10.1089/hgtb.2014.004; Guinney J, 2015, NAT MED, V21, P1350, DOI 10.1038/nm.3967; Huang AC, 2019, NAT MED, V25, P454, DOI 10.1038/s41591-019-0357-y; Jorritsma A, 2007, BLOOD, V110, P3564, DOI 10.1182/blood-2007-02-075010; Le DT, 2015, NEW ENGL J MED, V372, P2509, DOI 10.1056/NEJMoa1500596; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Maby P, 2015, CANCER RES, V75, P3446, DOI 10.1158/0008-5472.CAN-14-3051; Mandal R, 2019, SCIENCE, V364, P485, DOI 10.1126/science.aau0447; MANDARD AM, 1994, CANCER, V73, P2680, DOI 10.1002/1097-0142(19940601)73:11<2680::AID-CNCR2820731105>3.0.CO;2-C; Mariathasan S, 2018, NATURE, V554, P544, DOI 10.1038/nature25501; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Mlecnik B, 2016, IMMUNITY, V44, P698, DOI 10.1016/j.immuni.2016.02.025; Mooi JK, 2018, ANN ONCOL, V29, P2240, DOI 10.1093/annonc/mdy410; Overman MJ, 2018, J CLIN ONCOL, V36, P773, DOI 10.1200/JCO.2017.76.9901; Overman MJ, 2017, LANCET ONCOL, V18, P1182, DOI 10.1016/S1470-2045(17)30422-9; Powles T, 2019, NAT MED, V25, P1706, DOI 10.1038/s41591-019-0628-7; Romero P, 2002, IMMUNOL REV, V188, P81, DOI 10.1034/j.1600-065X.2002.18808.x; Sinicrope FA, 2013, J CLIN ONCOL, V31, P3664, DOI 10.1200/JCO.2013.48.9591; Taube JM, 2014, CLIN CANCER RES, V20, P5064, DOI 10.1158/1078-0432.CCR-13-3271; Tauriello DVF, 2018, NATURE, V554, P538, DOI 10.1038/nature25492; Tetzlaff MT, 2018, ANN ONCOL, V29, P1861, DOI 10.1093/annonc/mdy226; Thommen DS, 2018, NAT MED, V24, P994, DOI 10.1038/s41591-018-0057-z; Tumeh PC, 2014, NATURE, V515, P568, DOI 10.1038/nature13954; van de Wetering M, 2015, CELL, V161, P933, DOI 10.1016/j.cell.2015.03.053; Yang X, 2018, NEW ENGL J MED, V379, DOI 10.1056/NEJMc1808251; Young L, 2010, NAT PROTOC, V5, P929, DOI 10.1038/nprot.2010.43; Zelenay S, 2015, CELL, V162, P1257, DOI 10.1016/j.cell.2015.08.015	46	342	368	9	71	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	APR	2020	26	4					566	+		10.1038/s41591-020-0805-8	http://dx.doi.org/10.1038/s41591-020-0805-8		APR 2020	21	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	QH1UE	32251400	Green Published			2022-12-27	WOS:000524576000002
J	Miyazaki, T; Nakajima, W; Hatano, M; Shibata, Y; Kuroki, Y; Arisawa, T; Serizawa, A; Sano, A; Kogami, S; Yamanoue, T; Kimura, K; Hirata, Y; Takada, Y; Ishiwata, Y; Sonoda, M; Tokunaga, M; Seki, C; Nagai, Y; Minamimoto, T; Kawamura, K; Zhang, MR; Ikegaya, N; Iwasaki, M; Kunii, N; Kimura, Y; Yamashita, F; Taguri, M; Tani, H; Nagai, N; Koizumi, T; Nakajima, S; Mimura, M; Yuzaki, M; Kato, H; Higuchi, M; Uchida, H; Takahashi, T				Miyazaki, Tomoyuki; Nakajima, Waki; Hatano, Mai; Shibata, Yusuke; Kuroki, Yoko; Arisawa, Tetsu; Serizawa, Asami; Sano, Akane; Kogami, Sayaka; Yamanoue, Tomomi; Kimura, Kimito; Hirata, Yushi; Takada, Yuuki; Ishiwata, Yoshinobu; Sonoda, Masaki; Tokunaga, Masaki; Seki, Chie; Nagai, Yuji; Minamimoto, Takafumi; Kawamura, Kazunori; Zhang, Ming-Rong; Ikegaya, Naoki; Iwasaki, Masaki; Kunii, Naoto; Kimura, Yuichi; Yamashita, Fumio; Taguri, Masataka; Tani, Hideaki; Nagai, Nobuhiro; Koizumi, Teruki; Nakajima, Shinichiro; Mimura, Masaru; Yuzaki, Michisuke; Kato, Hiroki; Higuchi, Makoto; Uchida, Hiroyuki; Takahashi, Takuya			Visualization of AMPA receptors in living human brain with positron emission tomography	NATURE MEDICINE			English	Article							GRAPHICAL ANALYSIS; EXTRACELLULAR LEVELS; PET; BINDING	Although aberrations in the number and function of glutamate AMPA (alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid) receptors are thought to underlie neuropsychiatric disorders, no methods are currently available for visualizing AMPA receptors in the living human brain. Here we developed a positron emission tomography (PET) tracer for AMPA receptors. A derivative of 4-[2-(phenylsulfonylamino)ethylthio]-2,6-difluoro-phenoxyacetamide radiolabeled with C-11 ([C-11]K-2) showed specific binding to AMPA receptors. Our clinical trial with healthy human participants confirmed reversible binding of [C-11]K-2 in the brain according to Logan graphical analysis (; study design: non-randomized, single arm; primary outcome: dynamics and distribution volumes of [C-11]K-2 in the brain; secondary outcome: adverse events of [C-11]K-2 during the 4-10 d following dosing; this trial met prespecified endpoints). In an exploratory clinical study including patients with epilepsy, we detected increased [C-11]K-2 uptake in the epileptogenic focus of patients with mesial temporal lobe epilepsy, which was closely correlated with the local AMPA receptor protein distribution in surgical specimens from the same individuals (; study design: non-randomized, single arm; primary outcome: correlation between [C-11]K-2 uptake measured with PET before surgery and AMPA receptor protein density examined by biochemical study after surgery; secondary outcome: adverse events during the 7 d following PET scan; this trial met prespecified endpoints). Thus, [C-11]K-2 is a potent PET tracer for AMPA receptors, potentially providing a tool to examine the involvement of AMPA receptors in neuropsychiatric disorders.	[Miyazaki, Tomoyuki; Nakajima, Waki; Hatano, Mai; Shibata, Yusuke; Kuroki, Yoko; Arisawa, Tetsu; Serizawa, Asami; Sano, Akane; Kogami, Sayaka; Yamanoue, Tomomi; Kimura, Kimito; Hirata, Yushi; Takada, Yuuki; Takahashi, Takuya] Yokohama City Univ, Grad Sch Med, Dept Physiol, Yokohama, Kanagawa, Japan; [Ishiwata, Yoshinobu] Yokohama City Univ, Grad Sch Med, Dept Radiol, Yokohama, Kanagawa, Japan; [Sonoda, Masaki; Ikegaya, Naoki] Yokohama City Univ, Grad Sch Med, Dept Neurosurg, Yokohama, Kanagawa, Japan; [Tokunaga, Masaki; Seki, Chie; Nagai, Yuji; Minamimoto, Takafumi; Higuchi, Makoto] Natl Inst Quantum & Radiol Sci & Technol, Dept Funct Brain Imaging Res, Natl Inst Radiol Sci, Chiba, Japan; [Kawamura, Kazunori; Zhang, Ming-Rong] Natl Inst Quantum & Radiol Sci & Technol, Dept Radiopharmaceut Dev, Natl Inst Radiol Sci, Chiba, Japan; [Iwasaki, Masaki] Natl Ctr Hosp Neurol & Psychiat, Dept Neurosurg, Kodaira, Tokyo, Japan; [Kunii, Naoto] Univ Tokyo, Grad Sch Med, Dept Neurosurg, Tokyo, Japan; [Kimura, Yuichi] Kindai Univ, Fac Biol Oriented Sci & Technol, Kinokawa, Japan; [Yamashita, Fumio] Iwate Med Univ, Inst Biomed Sci, Div Ultrahigh Field Strength MRI, Yahaba, Iwate, Japan; [Taguri, Masataka] Yokohama City Univ, Sch Data Sci, Dept Data Sci, Yokohama, Kanagawa, Japan; [Tani, Hideaki; Nagai, Nobuhiro; Koizumi, Teruki; Nakajima, Shinichiro; Mimura, Masaru; Uchida, Hiroyuki] Keio Univ, Sch Med, Dept Neuropsychiat, Tokyo, Japan; [Yuzaki, Michisuke] Keio Univ, Sch Med, Dept Physiol, Tokyo, Japan; [Kato, Hiroki] Osaka Univ, Grad Sch Med, Dept Nucl Med & Tracer Kinet, Osaka, Japan	Yokohama City University; Yokohama City University; Yokohama City University; National Institutes for Quantum Science & Technology; National Institutes for Quantum Science & Technology; National Center for Neurology & Psychiatry - Japan; University of Tokyo; Iwate Medical University; Yokohama City University; Keio University; Keio University; Osaka University	Takahashi, T (corresponding author), Yokohama City Univ, Grad Sch Med, Dept Physiol, Yokohama, Kanagawa, Japan.	takahast@yokohama-cu.ac.jp	Uchida, Hiroyuki/I-4867-2015; Ikegaya, Naoki/AAP-8607-2020; Yuzaki, Michisuke/K-5328-2013; Kunii, Naoto/AGH-2837-2022; Iwasaki, Masaki/AAH-4985-2020	Uchida, Hiroyuki/0000-0002-0628-7036; Yuzaki, Michisuke/0000-0002-5750-3544; Kunii, Naoto/0000-0002-8992-380X; Iwasaki, Masaki/0000-0002-4204-7144; Sonoda, Masaki/0000-0002-4612-5728; Nagai, Yuji/0000-0001-7005-0749; Arisawa, Tetsu/0000-0001-7694-8728	Special Coordination Funds for Promoting Science and Technology; AMED [JP19dm0107124, JP18dm0207023, JP19lm0203007, 19dm0107125]	Special Coordination Funds for Promoting Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); AMED	We gratefully thank T. Inoue for comprehensive support. This project was supported by Special Coordination Funds for Promoting Science and Technology (T.T.) and AMED under grants JP19dm0107124 (T.T.), JP18dm0207023 (T.T.), JP19lm0203007 (T.T.) and 19dm0107125 (M.M.).	Abe H, 2018, SCIENCE, V360, P50, DOI 10.1126/science.aao2300; Arstad E, 2006, BIOORGAN MED CHEM, V14, P4712, DOI 10.1016/j.bmc.2006.03.034; Chang PKY, 2012, EUR J NEUROSCI, V35, P1908, DOI 10.1111/j.1460-9568.2012.08165.x; Chernet E, 2005, LIFE SCI, V78, P340, DOI 10.1016/j.lfs.2005.04.075; Citraro R, 2014, EXPERT OPIN THER TAR, V18, P319, DOI 10.1517/14728222.2014.874416; CURRAS MC, 1992, MOL PHARMACOL, V41, P520; Diering GH, 2018, NEURON, V100, P314, DOI 10.1016/j.neuron.2018.10.018; Finnema SJ, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf6667; Fleming JJ, 2010, BIOORGAN MED CHEM, V18, P1381, DOI 10.1016/j.bmc.2009.12.072; Gao M, 2006, BIOORG MED CHEM LETT, V16, P2229, DOI 10.1016/j.bmcl.2006.01.042; Hammers A, 2003, HUM BRAIN MAPP, V19, P224, DOI 10.1002/hbm.10123; Herguedas B, 2019, SCIENCE, V364, P352, DOI 10.1126/science.aav9011; Holmes SE, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09562-7; Innis RB, 2007, J CEREBR BLOOD F MET, V27, P1533, DOI 10.1038/sj.jcbfm.9600493; Jitsuki S, 2011, NEURON, V69, P780, DOI 10.1016/j.neuron.2011.01.016; Kessels HW, 2009, NEURON, V61, P340, DOI 10.1016/j.neuron.2009.01.015; Koga K, 2016, EJNMMI RES, V6, DOI 10.1186/s13550-016-0170-2; Kondej M, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19103105; Krauss GL, 2012, NEUROLOGY, V78, P1408, DOI 10.1212/WNL.0b013e318254473a; Lee HG, 2015, J AM CHEM SOC, V137, P648, DOI 10.1021/ja512115s; LOGAN J, 1990, J CEREBR BLOOD F MET, V10, P740, DOI 10.1038/jcbfm.1990.127; Logan J, 1996, J CEREBR BLOOD F MET, V16, P834, DOI 10.1097/00004647-199609000-00008; Logan J, 2000, NUCL MED BIOL, V27, P661, DOI 10.1016/S0969-8051(00)00137-2; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; Oi N, 2015, J MED CHEM, V58, P8444, DOI 10.1021/acs.jmedchem.5b00712; Sekiguchi M, 1997, J NEUROSCI, V17, P5760; STEIN E, 1992, MOL PHARMACOL, V42, P864; Takahata K, 2017, EJNMMI RES, V7, DOI 10.1186/s13550-017-0313-0; Takemoto K, 2017, NAT BIOTECHNOL, V35, P38, DOI 10.1038/nbt.3710; TOSSMAN U, 1986, ACTA PHYSIOL SCAND, V127, P547, DOI 10.1111/j.1748-1716.1986.tb07939.x; TOTH E, 1992, NEUROCHEM RES, V17, P265, DOI 10.1007/BF00966669; Tracy TE, 2011, EMBO J, V30, P1577, DOI 10.1038/emboj.2011.59; Ward SE, 2010, BRIT J PHARMACOL, V160, P181, DOI 10.1111/j.1476-5381.2010.00726.x; Yuan GY, 2016, BIOORG MED CHEM LETT, V26, P4857, DOI 10.1016/j.bmcl.2016.07.078; Zanos P, 2016, NATURE, V533, P481, DOI 10.1038/nature17998; Zhao JP, 2019, MOL BRAIN, V12, DOI 10.1186/s13041-019-0427-6; Zhao Y, 2019, SCIENCE, V364, P355, DOI 10.1126/science.aaw8250; Zilles K, 1999, NEUROSCIENCE, V94, P1051, DOI 10.1016/S0306-4522(99)00392-9	38	28	28	0	15	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	FEB	2020	26	2					281	+		10.1038/s41591-019-0723-9	http://dx.doi.org/10.1038/s41591-019-0723-9		JAN 2020	25	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	KK7DU	31959988				2022-12-27	WOS:000510551600001
J	Stower, H				Stower, Hannah			A conjugate vaccine for typhoid	NATURE MEDICINE			English	Editorial Material												h.stower@us.nature.com							0	0	0	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JAN	2020	26	1					21	21		10.1038/s41591-019-0743-5	http://dx.doi.org/10.1038/s41591-019-0743-5			1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	KG3GZ	31932795	Bronze			2022-12-27	WOS:000509831900016
J	Stower, H				Stower, Hannah			DIGITAL MEDICINE Machines match humans in image-based diagnoses	NATURE MEDICINE			English	Editorial Material																			0	1	1	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	2019	25	12					1798	1798		10.1038/s41591-019-0679-9	http://dx.doi.org/10.1038/s41591-019-0679-9			1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	JT2KO	31806897	Bronze			2022-12-27	WOS:000500824900005
J	Vehik, K; Lynch, KF; Wong, MC; Tian, XJ; Ross, MC; Gibbs, RA; Ajami, NJ; Petrosino, JF; Rewers, M; Toppari, J; Ziegler, AG; She, JX; Lernmark, A; Akolkar, B; Hagopian, WA; Schatz, DA; Krischer, JP; Hyoty, H; Lloyd, RE				Vehik, Kendra; Lynch, Kristian F.; Wong, Matthew C.; Tian, Xiangjun; Ross, Matthew C.; Gibbs, Richard A.; Ajami, Nadim J.; Petrosino, Joseph F.; Rewers, Marian; Toppari, Jorma; Ziegler, Anette G.; She, Jin-Xiong; Lernmark, Ake; Akolkar, Beena; Hagopian, William A.; Schatz, Desmond A.; Krischer, Jeffrey P.; Hyoty, Heikki; Lloyd, Richard E.		TEDDY Study Grp	Prospective virome analyses in young children at increased genetic risk for type 1 diabetes	NATURE MEDICINE			English	Article							BETA-CELL AUTOIMMUNITY; ISLET AUTOIMMUNITY; COXSACKIEVIRUS B1; ENTEROVIRUS RNA; ENVIRONMENTAL DETERMINANTS; GUT MICROBIOME; INDUCTION; INFECTION; RECEPTOR; SURVEILLANCE	Viruses are implicated in autoimmune destruction of pancreatic islet beta cells, which results in insulin deficiency and type 1 diabetes (T1D)(1-4). Certain enteroviruses can infect beta cells in vitro(5), have been detected in the pancreatic islets of patients with T1D(6) and have shown an association with T1D in meta-analyses(4). However, establishing consistency in findings across studies has proven difficult. Obstacles to convincingly linking RNA viruses to islet autoimmunity may be attributed to rapid viral mutation rates, the cyclical periodicity of viruses(7) and the selection of variants with altered pathogenicity and ability to spread in populations. beta cells strongly express cell-surface coxsackie and adenovirus receptor (CXADR) genes, which can facilitate enterovirus infection(8). Studies of human pancreata and cultured islets have shown significant variation in enteroviral virulence to beta cells between serotypes and within the same serotype(9,10). In this large-scale study of known eukaryotic DNA and RNA viruses in stools from children, we evaluated fecally shed viruses in relation to islet autoimmunity and T1D. This study showed that prolonged enterovirus B rather than independent, short-duration enterovirus B infections may be involved in the development of islet autoimmunity, but not T1D, in some young children. Furthermore, we found that fewer early-life human mastadenovirus C infections, as well as CXADR rs6517774, independently correlated with islet autoimmunity.	[Vehik, Kendra; Lynch, Kristian F.; Krischer, Jeffrey P.] Univ S Florida, Morsani Coll Med, Hlth Informat Inst, Tampa, FL 33620 USA; [Wong, Matthew C.; Tian, Xiangjun; Ross, Matthew C.; Ajami, Nadim J.; Petrosino, Joseph F.; Lloyd, Richard E.] Baylor Coll Med, Dept Mol Virol & Microbiol, Alkek Ctr Metagen & Microbiome Res, Houston, TX 77030 USA; [Gibbs, Richard A.] Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA; [Rewers, Marian] Univ Colorado, Barbara Davis Ctr Diabet, Aurora, CO USA; [Toppari, Jorma] Turku Univ Hosp, Dept Pediat, Turku, Finland; [Toppari, Jorma] Univ Turku, Inst Biomed, Res Ctr Integrat Physiol & Pharmacol, Turku, Finland; [Ziegler, Anette G.] Helmholtz Zentrum Munchen, Diabet Res Inst, Munich, Germany; [Ziegler, Anette G.] Tech Univ Munich, Forsch Grp Diabet, Klinikum Rechts Isar, Munich, Germany; [Ziegler, Anette G.] Forsch Grp Diabet eV, Munich, Germany; [She, Jin-Xiong] Augusta Univ, Med Coll Georgia, Ctr Biotechnol & Genom Med, Augusta, GA USA; [Lernmark, Ake] Lund Univ, Skane Univ Hosp, CRC, Dept Clin Sci, Malmo, Sweden; [Akolkar, Beena] NIDDK, Bethesda, MD 20892 USA; [Hagopian, William A.] Pacific Northwest Res Inst, 720 Broadway,(, Seattle, WA 98122 USA; [Schatz, Desmond A.] Univ Florida, Dept Pediat, Inst Diabet, Gainesville, FL USA; [Hyoty, Heikki] Tampere Univ, Fac Med & Hlth Technol, Dept Virol, Tampere, Finland; [Hyoty, Heikki] Pirkanmaa Hosp Dist, Fimlab Labs, Tampere, Finland	State University System of Florida; University of South Florida; Baylor College of Medicine; Baylor College of Medicine; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Turku; University of Turku; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; University System of Georgia; Augusta University; Lund University; Skane University Hospital; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); State University System of Florida; University of Florida; Tampere University; Pirkanmaa Hospital District	Vehik, K (corresponding author), Univ S Florida, Morsani Coll Med, Hlth Informat Inst, Tampa, FL 33620 USA.	kendra.vehik@epi.usf.edu	Lernmark, Åke/F-8140-2015	Lernmark, Åke/0000-0003-1735-0499; Mattila, Markus/0000-0002-7829-9474; Hyoty, Heikki/0000-0003-0370-4145; Kurppa, Kalle/0000-0003-4757-2164	NIDDK [U01 DK63829, U01 DK63861, U01 DK63821, U01 DK63865, U01 DK63863, U01 DK63836, U01 DK63790, UC4 DK63829, UC4 DK63861, UC4 DK63821, UC4 DK63865, UC4 DK63863, UC4 DK63836, UC4 DK95300, UC4 DK100238, UC4 DK106955, UC4 DK112243, UC4 DK117483, HHSN267200700014C]; National Institute of Allergy and Infectious Diseases; National Institute of Child Health and Human Development; National Institute of Environmental Health Sciences; Centers for Disease Control and Prevention; JDRF; NIH/NCATS [UL1 TR000064, UL1 TR001082]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001082] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK063861, UC4DK112243, U01DK063836, U01DK063863, U01DK063821, U01DK063865, UC4DK117483, U01DK063829] Funding Source: NIH RePORTER	NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); JDRF(Juvenile Diabetes Research Foundation); NIH/NCATS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The TEDDY Study is funded by U01 DK63829, U01 DK63861, U01 DK63821, U01 DK63865, U01 DK63863, U01 DK63836, U01 DK63790, UC4 DK63829, UC4 DK63861, UC4 DK63821, UC4 DK63865, UC4 DK63863, UC4 DK63836, UC4 DK95300, UC4 DK100238, UC4 DK106955, UC4 DK112243, UC4 DK117483 and contract number HHSN267200700014C from the NIDDK, National Institute of Allergy and Infectious Diseases, National Institute of Child Health and Human Development, National Institute of Environmental Health Sciences, Centers for Disease Control and Prevention and JDRF. This work was supported in part by the NIH/NCATS Clinical and Translational Science Awards to the University of Florida (UL1 TR000064) and the University of Colorado (UL1 TR001082).	Abedi GR, 2015, MMWR-MORBID MORTAL W, V64, P940, DOI 10.15585/mmwr.mm6434a3; Ajami NJ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05658-8; Alexander JP, 1997, J INFECT DIS, V175, pS176, DOI 10.1093/infdis/175.Supplement_1.S176; Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS67, DOI [10.2337/dc13-S067, 10.2337/dc10-S062, 10.2337/dc12-s064, 10.2337/dc11-S062]; Anagandula M, 2014, J MED VIROL, V86, P1402, DOI 10.1002/jmv.23835; [Anonymous], 2018, HDB MODERN STAT METH; Bessaud M, 2016, SCI REP-UK, V6, DOI 10.1038/srep38831; Bonifacio E, 2010, J CLIN ENDOCR METAB, V95, P3360, DOI 10.1210/jc.2010-0293; Bushnell B., 2016, BBMAP SHORT READ ALI; Busse N, 2017, ONCOTARGET, V8, P12620, DOI 10.18632/oncotarget.14896; Chung Pei-Wen, 2001, Journal of Microbiology Immunology and Infection, V34, P167; Cinek O, 2014, DIABETOLOGIA, V57, P2193, DOI 10.1007/s00125-014-3327-4; Clem AL, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-65; Garnett CT, 2009, J VIROL, V83, P2417, DOI 10.1128/JVI.02392-08; Greninger AL, 2015, LANCET INFECT DIS, V15, P671, DOI 10.1016/S1473-3099(15)70093-9; Hagopian WA, 2011, PEDIATR DIABETES, V12, P733, DOI 10.1111/j.1399-5448.2011.00774.x; Hamalainen S, 2014, J MED VIROL, V86, P1412, DOI 10.1002/jmv.23903; Hodik M, 2016, BMJ OPEN DIAB RES CA, V4, DOI 10.1136/bmjdrc-2015-000179; Honkanen H, 2017, DIABETOLOGIA, V60, P424, DOI 10.1007/s00125-016-4177-z; Ifie E, 2018, DIABETOLOGIA, V61, P2344, DOI 10.1007/s00125-018-4704-1; Ingle H, 2019, NAT MICROBIOL, V4, P1120, DOI 10.1038/s41564-019-0416-7; Ito M, 2000, CIRC RES, V86, P275, DOI 10.1161/01.RES.86.3.275; Krischer J, 2007, PEDIATR DIABETES, V8, P286; Krischer JP, 2017, DIABETES, V66, P3122, DOI 10.2337/db17-0261; Krischer JP, 2017, DIABETES CARE, V40, P1194, DOI 10.2337/dc17-0238; Krogvold L, 2015, DIABETES, V64, P1682, DOI 10.2337/db14-1370; Laassri M, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006943; Laitinen OH, 2014, DIABETES, V63, P446, DOI 10.2337/db13-0619; Lee HS, 2013, DIABETOLOGIA, V56, P1705, DOI 10.1007/s00125-013-2924-y; Lee HS, 2014, DIABETES-METAB RES, V30, P424, DOI 10.1002/dmrr.2510; Leveque N, 2017, J VIROL, V91, DOI 10.1128/JVI.00423-17; MELNICK JL, 1980, J MED VIROL, V5, P205, DOI 10.1002/jmv.1890050305; Messacar K, 2016, J MED VIROL, V88, P739, DOI 10.1002/jmv.24410; Oikarinen S, 2014, DIABETES, V63, P655, DOI 10.2337/db13-0620; Oikarinen S, 2011, DIABETES, V60, P276, DOI 10.2337/db10-0186; Parkes M, 2013, NAT REV GENET, V14, P661, DOI 10.1038/nrg3502; Richardson SJ, 2013, DIABETOLOGIA, V56, P185, DOI 10.1007/s00125-012-2745-4; Roivainen M, 2002, DIABETOLOGIA, V45, P693, DOI 10.1007/s00125-002-0805-x; Roivainen M, 2000, J CLIN ENDOCR METAB, V85, P432, DOI 10.1210/jc.85.1.432; Salminen K, 2003, J MED VIROL, V69, P91, DOI 10.1002/jmv.10260; Schneider VA, 2017, GENOME RES, V27, P849, DOI 10.1101/gr.213611.116; SHAFREN DR, 1995, J VIROL, V69, P3873, DOI 10.1128/JVI.69.6.3873-3877.1995; Simonen-Tikka ML, 2011, DIABETOLOGIA, V54, P2995, DOI 10.1007/s00125-011-2305-3; Sioofy-Khojine AB, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201959; Sioofy-Khojine AB, 2018, DIABETOLOGIA, V61, P1193, DOI 10.1007/s00125-018-4561-y; Stene LC, 2010, DIABETES, V59, P3174, DOI 10.2337/db10-0866; Stewart CJ, 2018, NATURE, V562, P583, DOI 10.1038/s41586-018-0617-x; Tapia G, 2011, DIABETES CARE, V34, P151, DOI 10.2337/dc10-1413; TEDDY Study Group, ANN NY ACAD SCI, V1150, P1; Uusitalo U, 2016, JAMA PEDIATR, V170, P20, DOI 10.1001/jamapediatrics.2015.2757; van der Werf N, 2007, DIABETES-METAB RES, V23, P169, DOI 10.1002/dmrr.695; Vatanen T, 2018, NATURE, V562, P589, DOI 10.1038/s41586-018-0620-2; Vehik K, 2013, DIABETES-METAB RES, V29, P557, DOI 10.1002/dmrr.2427; Wang Z, 2010, MICROB ECOL, V59, P623, DOI 10.1007/s00248-010-9636-3; Yeung WCG, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d35; Ylipaasto P, 2004, DIABETOLOGIA, V47, P225, DOI 10.1007/s00125-003-1297-z	56	95	96	1	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	2019	25	12					1865	+		10.1038/s41591-019-0667-0	http://dx.doi.org/10.1038/s41591-019-0667-0			15	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	JT2KO	31792456	Green Accepted, Green Submitted			2022-12-27	WOS:000500824900030
J	Luban, J				Luban, Jeremy			RETRACTION: The hidden cost of genetic resistance to HIV-1 (Retraction Article, vol 25, pg 878, 2019) (Retraction of Vol 25, Pg 878, 2019)	NATURE MEDICINE			English	Retraction																		Luban J, 2019, NAT MED, V25, P878, DOI 10.1038/s41591-019-0481-8	1	0	0	0	0	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2019	25	11					1796	1796		10.1038/s41591-019-0636-7	http://dx.doi.org/10.1038/s41591-019-0636-7			1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	JT2KI	31595085	Bronze			2022-12-27	WOS:000500824300039
J	Owens, K; Walker, A				Owens, Kellie; Walker, Alexis			Those designing healthcare algorithms must become actively anti-racist	NATURE MEDICINE			English	Editorial Material								Many widely used health algorithms have been shown to encode and reinforce racial health inequities, prioritizing the needs of white patients over those of patients of color. Because automated systems are becoming so crucial to access to health, researchers in the field of artificial intelligence must become actively anti-racist. Here we list some concrete steps to enable anti-racist practices in medical research and practice.	[Owens, Kellie] Data & Soc Res Inst, New York, NY USA; [Walker, Alexis] Johns Hopkins Univ, Berman Inst Bioeth, Baltimore, MD 21218 USA	Johns Hopkins University	Walker, A (corresponding author), Johns Hopkins Univ, Berman Inst Bioeth, Baltimore, MD 21218 USA.	awalker@jhu.edu		Walker, Alexis/0000-0001-8316-2571	NHGRI NIH HHS [T32 HG009496] Funding Source: Medline	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Benjamin R, 2019, SCIENCE, V366, P421, DOI 10.1126/science.aaz3873; Benjamin R, 2016, SCI TECHNOL HUM VAL, V41, P967, DOI 10.1177/0162243916656059; Benjamin Ruha, 2019, RACE TECHNOLOGY ABOL; Boyd D, 2012, INFORM COMMUN SOC, V15, P662, DOI 10.1080/1369118X.2012.678878; Cooper HLF, 2016, J URBAN HEALTH, V93, pS1, DOI 10.1007/s11524-016-0040-2; Forscher PS, 2019, J PERS SOC PSYCHOL, V117, P522, DOI 10.1037/pspa0000160; Hardeman RR, 2020, NEW ENGL J MED, V383, P197, DOI 10.1056/NEJMp2021072; Noble SU., 2018, ALGORITHMS OPPRESSIO; Noor P, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.m363; Obermeyer Z, 2019, SCIENCE, V366, P447, DOI 10.1126/science.aax2342; Vyas DA, 2020, NEW ENGL J MED, V383, P874, DOI 10.1056/NEJMms2004740	14	10	10	3	6	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	SEP	2020	26	9					1327	1328		10.1038/s41591-020-1020-3	http://dx.doi.org/10.1038/s41591-020-1020-3			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	PF3EM	32908272	Green Accepted			2022-12-27	WOS:000598942000009
J	Manna, E				Manna, Elaine			"My disability has become an ability"	NATURE MEDICINE			English	Editorial Material								A patient partner provides perspectives on the development of the SPIRIT-AI and CONSORT-AI guidelines.				rockprit@icloud.com							0	0	0	0	2	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	SEP	2020	26	9					1317	1317		10.1038/s41591-020-1053-7	http://dx.doi.org/10.1038/s41591-020-1053-7		AUG 2020	1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	PF3EM	32839623				2022-12-27	WOS:000562338700002
J	Corsi, DJ; Donelle, J; Sucha, E; Hawken, S; Hsu, H; El-Chaar, D; Bisnaire, L; Fell, D; Wen, SW; Walker, M				Corsi, Daniel J.; Donelle, Jessy; Sucha, Ewa; Hawken, Steven; Hsu, Helen; El-Chaar, Darine; Bisnaire, Lise; Fell, Deshayne; Wen, Shi Wu; Walker, Mark			Maternal cannabis use in pregnancy and child neurodevelopmental outcomes	NATURE MEDICINE			English	Article							MARIJUANA USE; EXPOSURE; TRENDS; MODEL; DIAGNOSIS	In a cohort of nearly half a million births in Ontario, Canada, maternal cannabis use in pregnancy was associated with an increased incidence of autism spectrum disorder diagnosis in the offspring. Cannabis use in pregnancy has increased(1,2), and many women continue to use it throughout pregnancy(3). With the legalization of recreational cannabis in many jurisdictions, there is concern about potentially adverse childhood outcomes related to prenatal exposure(4). Using the provincial birth registry containing information on cannabis use during pregnancy, we perform a retrospective analysis of all live births in Ontario, Canada, between 1 April 2007 and 31 March 2012. We link pregnancy and birth data to provincial health administrative databases to ascertain child neurodevelopmental outcomes. We use matching techniques to control for confounding and Cox proportional hazards regression models to examine associations between prenatal cannabis use and child neurodevelopment. We find an association between maternal cannabis use in pregnancy and the incidence of autism spectrum disorder in the offspring. The incidence of autism spectrum disorder diagnosis was 4.00 per 1,000 person-years among children with exposure compared to 2.42 among unexposed children, and the fully adjusted hazard ratio was 1.51 (95% confidence interval: 1.17-1.96) in the matched cohort. The incidence of intellectual disability and learning disorders was higher among offspring of mothers who use cannabis in pregnancy, although less statistically robust. We emphasize a cautious interpretation of these findings given the likelihood of residual confounding.	[Corsi, Daniel J.; Hawken, Steven; El-Chaar, Darine; Wen, Shi Wu; Walker, Mark] Ottawa Hosp Res Inst, Ottawa, ON, Canada; [Corsi, Daniel J.; Fell, Deshayne] CHEO Res Inst, Ottawa, ON, Canada; [Corsi, Daniel J.; Hawken, Steven; Fell, Deshayne; Wen, Shi Wu] Univ Ottawa, Sch Epidemiol & Publ Hlth, Ottawa, ON, Canada; [Donelle, Jessy; Sucha, Ewa] Ottawa Hosp Res Inst, ICES UOttawa, Ottawa, ON, Canada; [Hsu, Helen] Univ Ottawa, Dept Family Med, Ottawa, ON, Canada; [El-Chaar, Darine; Wen, Shi Wu; Walker, Mark] Univ Ottawa, Depatment Obstet & Gynecol, Ottawa, ON, Canada; [Bisnaire, Lise] CHEO, BORN Ontario, Ottawa, ON, Canada	University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; Children's Hospital of Eastern Ontario; University of Ottawa; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; University of Ottawa; University of Ottawa; Children's Hospital of Eastern Ontario	Corsi, DJ (corresponding author), Ottawa Hosp Res Inst, Ottawa, ON, Canada.; Corsi, DJ (corresponding author), CHEO Res Inst, Ottawa, ON, Canada.; Corsi, DJ (corresponding author), Univ Ottawa, Sch Epidemiol & Publ Hlth, Ottawa, ON, Canada.	dcorsi@ohri.ca		El-Chaar, Darine/0000-0002-8266-0242	ICES - Ontario Ministry of Health and Long-Term Care (MOHLTC); Canadian Institutes of Health Research	ICES - Ontario Ministry of Health and Long-Term Care (MOHLTC)(Ministry of Health and Long-Term Care, Ontario); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This study was supported by ICES, which is funded by an annual grant from the Ontario Ministry of Health and Long-Term Care (MOHLTC). The opinions, results and conclusions reported in this paper are those of the authors and are independent from the funding sources. No endorsement by ICES or the Ontario MOHLTC is intended or should be inferred. Parts of this material are based on data and/or information compiled and provided by CIHI. However, the analyses, conclusions, opinions and statements expressed in the material are those of the author(s) and not necessarily those of CIHI. This study is based in part on data provided by BORN, part of the Children's Hospital of Eastern Ontario. The interpretation and conclusions contained herein do not necessarily represent those of BORN Ontario. Funding was received from the Canadian Institutes of Health Research (D.J.C., D.E.-C., H.H., D.F. and M.W.). The funder was not involved in study design, analysis or interpretation of data. The funder was not involved in the writing of the manuscript or in the decision to publish.	al-Haddad BJS, 2019, JAMA PSYCHIAT, V76, P594, DOI 10.1001/jamapsychiatry.2019.0029; Austin PC, 2009, STAT MED, V28, P3083, DOI 10.1002/sim.3697; Brown HK, 2017, JAMA-J AM MED ASSOC, V317, P1544, DOI 10.1001/jama.2017.3415; Brown QL, 2017, JAMA-J AM MED ASSOC, V317, P207, DOI 10.1001/jama.2016.17383; Burke JP, 2014, AUTISM, V18, P321, DOI 10.1177/1362361312467709; Correa F, 2016, REPRODUCTION, V152, pR191, DOI 10.1530/REP-16-0167; Corsi DJ, 2020, BJOG-INT J OBSTET GY, V127, P17, DOI 10.1111/1471-0528.15985; Corsi DJ, 2019, JAMA-J AM MED ASSOC, V322, P145, DOI 10.1001/jama.2019.8734; Corsi DJ, 2019, CAN J PUBLIC HEALTH, V110, P76, DOI 10.17269/s41997-018-0148-0; Corsi DJ, 2013, INT J EPIDEMIOL, V42, P172, DOI 10.1093/ije/dyt022; Dow-Edwards DL, 2006, NEUROTOXICOL TERATOL, V28, P386, DOI 10.1016/j.ntt.2006.03.003; El Marroun H, 2009, J AM ACAD CHILD PSY, V48, P1173, DOI 10.1097/CHI.0b013e3181bfa8ee; Fergusson DM, 2002, BJOG-INT J OBSTET GY, V109, P21, DOI 10.1016/S1470-0328(02)01020-0; FLURY BK, 1986, AM STAT, V40, P249, DOI 10.2307/2684560; Frenette P, 2013, AUTISM, V17, P184, DOI 10.1177/1362361311413399; Greaves L, 2004, CAN WOMAN STUD, V24, P87; Hauck TS, 2017, CAN J PSYCHIAT, V62, P393, DOI 10.1177/0706743716689055; HAYES JS, 1991, W INDIAN MED J, V40, P120; Ho DE, 2007, POLIT ANAL, V15, P199, DOI 10.1093/pan/mpl013; Iacus SM, 2011, J AM STAT ASSOC, V106, P345, DOI 10.1198/jasa.2011.tm09599; Jansson LM, 2018, JAMA-J AM MED ASSOC, V320, P545, DOI 10.1001/jama.2018.8401; Keimpema E, 2011, TRENDS PHARMACOL SCI, V32, P551, DOI 10.1016/j.tips.2011.05.004; Kline J.S., 1989, CONCEPTION BIRTH EPI; Lin E, 2013, J INTELL DISABIL RES, V57, P462, DOI 10.1111/jir.12002; Lipscombe LL, 2007, LANCET, V369, P750, DOI 10.1016/S0140-6736(07)60361-4; Mayes LC, 2002, NEUROTOXICOL TERATOL, V24, P385, DOI 10.1016/S0892-0362(02)00200-3; McLemore GL, 2016, DATA BRIEF, V9, P753, DOI 10.1016/j.dib.2016.10.005; Minnes Sonia, 2011, Addict Sci Clin Pract, V6, P57; Pattanapongthorn J., 2014, STUDY THAI EARLY CHI, P1; Quan HD, 2009, HYPERTENSION, V54, P1423, DOI 10.1161/HYPERTENSIONAHA.109.139279; Richardson KA, 2016, NEUROTOXICOL TERATOL, V58, P5, DOI 10.1016/j.ntt.2016.08.003; Statistics Canada, 2016, POST COD CONV FIL PL; Steele LS, 2004, MED CARE, V42, P960, DOI 10.1097/00005650-200410000-00004; Stone R., 2015, HEAL JUSTICE, V3, P2, DOI [10.1186/s40352-015-0015-5, DOI 10.1186/S40352-015-0015-5]; Volkow ND, 2019, JAMA-J AM MED ASSOC, V322, P167, DOI 10.1001/jama.2019.7982; VORHEES CV, 1989, ANN NY ACAD SCI, V562, P31, DOI 10.1111/j.1749-6632.1989.tb21005.x; Wu CS, 2011, FUTUR NEUROL, V6, P459, DOI 10.2217/FNL.11.27; Yonkers KA, 2011, J SUBST USE, V16, P372, DOI 10.3109/14659891003721133; Young-Wolff KC, 2017, JAMA-J AM MED ASSOC, V318, P2490, DOI 10.1001/jama.2017.17225	39	48	48	3	15	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	OCT	2020	26	10					1536	+		10.1038/s41591-020-1002-5	http://dx.doi.org/10.1038/s41591-020-1002-5		AUG 2020	10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	NX8MD	32778828				2022-12-27	WOS:000558228200001
J	Stower, H				Stower, Hannah			Seeds of hope in COVID-19 vaccine preliminary data	NATURE MEDICINE			English	Editorial Material												h.stower@us.nature.com							0	0	0	0	1	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	AUG	2020	26	8					1170	1170		10.1038/s41591-020-1031-0	http://dx.doi.org/10.1038/s41591-020-1031-0		AUG 2020	1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	MX8ZF	32770162	Bronze			2022-12-27	WOS:000557134700006
J	Uwimana, A; Legrand, E; Stokes, BH; Ndikumana, JLM; Warsame, M; Umulisa, N; Ngamije, D; Munyaneza, T; Mazarati, JB; Munguti, K; Campagne, P; Criscuolo, A; Ariey, F; Murindahabi, M; Ringwald, P; Fidock, DA; Mbituyumuremyi, A; Menard, D				Uwimana, Aline; Legrand, Eric; Stokes, Barbara H.; Ndikumana, Jean-Louis Mangala; Warsame, Marian; Umulisa, Noella; Ngamije, Daniel; Munyaneza, Tharcisse; Mazarati, Jean-Baptiste; Munguti, Kaendi; Campagne, Pascal; Criscuolo, Alexis; Ariey, Frederic; Murindahabi, Monique; Ringwald, Pascal; Fidock, David A.; Mbituyumuremyi, Aimable; Menard, Didier			Emergence and clonal expansion of in vitro artemisinin-resistantPlasmodium falciparum kelch13R561H mutant parasites in Rwanda	NATURE MEDICINE			English	Article							PLASMODIUM-FALCIPARUM MALARIA; ARTEMISININ RESISTANCE; CAMBODIA; SPREAD	Artemisinin resistance (delayedP. falciparumclearance following artemisinin-based combination therapy), is widespread across Southeast Asia but to date has not been reported in Africa(1-4). Here we genotyped theP. falciparum K13(Pfkelch13) propeller domain, mutations in which can mediate artemisinin resistance(5,6), in pretreatment samples collected from recent dihydroarteminisin-piperaquine and artemether-lumefantrine efficacy trials in Rwanda(7). While cure rates were >95% in both treatment arms, thePfkelch13R561H mutation was identified in 19 of 257 (7.4%) patients at Masaka. Phylogenetic analysis revealed the expansion of an indigenous R561H lineage. Gene editing confirmed that this mutation can drive artemisinin resistance in vitro. This study provides evidence for the de novo emergence ofPfkelch13-mediated artemisinin resistance in Rwanda, potentially compromising the continued success of antimalarial chemotherapy in Africa. Identification in Rwanda of mutations inPlasmodium falciparumcapable of conferring in vitro resistance to artemisinin, an essential medicine for the treatment of malaria, underscore the crucial need for surveillance in Africa to safeguard efficacy of life-saving therapies.	[Uwimana, Aline; Ndikumana, Jean-Louis Mangala; Mbituyumuremyi, Aimable] Rwanda Biomed Ctr RBC, Malaria & Other Parasit Dis Div, Kigali, Rwanda; [Legrand, Eric; Menard, Didier] Inst Pasteur, Malaria Genet & Resistance Unit, Paris, France; [Stokes, Barbara H.; Fidock, David A.] Columbia Univ, Dept Microbiol & Immunol, Irving Med Ctr, New York, NY USA; [Warsame, Marian] Univ Gothenburg, Gothenburg, Sweden; [Umulisa, Noella] JHPIEGO, Maternal & Child Survival Program, Baltimore, MD USA; [Umulisa, Noella] Impact Malaria Rwanda, Kigali, Rwanda; [Ngamije, Daniel] Minist Hlth, Kigali, Rwanda; [Munyaneza, Tharcisse; Mazarati, Jean-Baptiste] Rwanda Biomed Ctr RBC, BIOS, Natl Reference Lab NRL, Kigali, Rwanda; [Munguti, Kaendi] US Presidents Malaria Initiat, Kigali, Rwanda; [Campagne, Pascal; Criscuolo, Alexis; Ringwald, Pascal; Fidock, David A.] Hub Bioinformat & Biostat, Dept Biol Computat, Paris, France; [Ariey, Frederic] Univ Paris, Hop Cochin, Inst Cochin, INSERM 1016,Serv Parasitol Mycol, Paris, France; [Murindahabi, Monique] Roll Back Malaria West & Cent Africa, Kigali, Rwanda; [Ringwald, Pascal] WHO, Global Malaria Programme, Geneva, Switzerland; [Fidock, David A.] Columbia Univ, Dept Med, Div Infect Dis, Irving Med Ctr, New York, NY USA	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Columbia University; NewYork-Presbyterian Hospital; University of Gothenburg; Jhpiego; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; World Health Organization; Columbia University; NewYork-Presbyterian Hospital	Uwimana, A (corresponding author), Rwanda Biomed Ctr RBC, Malaria & Other Parasit Dis Div, Kigali, Rwanda.; Menard, D (corresponding author), Inst Pasteur, Malaria Genet & Resistance Unit, Paris, France.	Aline.Uwimana@rbc.gov.rw; dmenard@pasteur.fr	Menard, Didier/O-3294-2013; ariey, frederic/P-1185-2017	Menard, Didier/0000-0003-1357-4495; ariey, frederic/0000-0002-0680-1090; Legrand, Eric/0000-0003-4725-0712; Stokes, Barbara/0000-0001-9519-487X; Criscuolo, Alexis/0000-0002-8212-5215	World Bank through the East African Public Health Laboratory Networking Project; Bill and Melinda Gates Foundation through the World Health Organization [OPP1140599]; US Department of Defense [W81XWH-19-1-0086]; National Institutes of Health [R01 AI109023]	World Bank through the East African Public Health Laboratory Networking Project; Bill and Melinda Gates Foundation through the World Health Organization; US Department of Defense(United States Department of Defense); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the World Bank through the East African Public Health Laboratory Networking Project (A.U., JL.M.N., A.M., T.M. and JB.M.), the Bill and Melinda Gates Foundation through the World Health Organization (grant OPP1140599, D.M. and P.R.), the US Department of Defense W81XWH-19-1-0086 (D.A.F.) and the National Institutes of Health R01 AI109023 (D.A.F.). This work used the computational and storage services (TARS cluster) provided by the IT department at Institut Pasteur, Paris. We thank all patients who contributed samples and their guardians in the communities of the Kicukiro (Masaka), Bugesera (Ruhuha), Rusizi (Bugarama), Gisagara (Kibirizi), Nyagatare (Nyarurema) and Kayonza (Rukara) and all team members in the health centers. We are also grateful to the members of the Malaria and Other Parasitic Diseases Division at the Rwanda Biomedical Center for their support. We acknowledge L. Duval (National Museum of Natural History, Paris) who furnished the probes for Plasmodium DNA capture and B. Izac who performed Illumina sequencing. We also thank B. Menu, C. Gicquel, N. Jolly, M. Ait Ahmed, V. Pirard and S. Ouchhi (Institut Pasteur, Paris) for their support.	Amaratunga C, 2019, BMC MED, V17, DOI 10.1186/s12916-018-1207-3; Amato R, 2018, LANCET INFECT DIS, V18, P337, DOI [10.1016/S1473-3099(18)30068-9, 10.1016/s1473-3099(18)30068-9]; Amato R, 2017, LANCET INFECT DIS, V17, P164, DOI [10.1016/S1473-3099(16)30409-1, 10.1016/s1473-3099(16)30409-1]; Amato R, 2016, ELIFE, V5, DOI 10.7554/eLife.08714; Ariey F, 2014, NATURE, V505, P50, DOI 10.1038/nature12876; Ashley EA, 2014, NEW ENGL J MED, V371, P411, DOI 10.1056/NEJMoa1314981; Barrett MP, 2019, NAT REV MICROBIOL, V17, P607, DOI 10.1038/s41579-019-0238-x; Birnbaum J, 2020, SCIENCE, V367, P51, DOI 10.1126/science.aax4735; Blasco B, 2017, NAT MED, V23, P917, DOI 10.1038/nm.4381; Bwire GM, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-60549-7; Conrad MD, 2019, LANCET INFECT DIS, V19, pE338, DOI 10.1016/S1473-3099(19)30261-0; Dhingra SK, 2019, LANCET INFECT DIS, V19, P1168, DOI 10.1016/S1473-3099(19)30543-2; Dondorp AM, 2009, NEW ENGL J MED, V361, P455, DOI 10.1056/NEJMoa0808859; Hamilton WL, 2019, LANCET INFECT DIS, V19, P943, DOI 10.1016/S1473-3099(19)30392-5; Huang ZJ, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-269; Imwong M, 2017, LANCET INFECT DIS, V17, P491, DOI [10.1016/S1473-3099(17)30048-8, 10.1016/s1473-3099(17)30048-8]; Mathieu LC, 2020, ELIFE, V9, DOI 10.7554/eLife.51015; Menard D, 2016, NEW ENGL J MED, V374, P2453, DOI 10.1056/NEJMoa1513137; Menard D, 2017, CSH PERSPECT MED, V7, DOI 10.1101/cshperspect.a025619; Miotto O, 2015, NAT GENET, V47, P226, DOI 10.1038/ng.3189; Mishra N, 2015, ANTIMICROB AGENTS CH, V59, P2548, DOI 10.1128/AAC.04632-14; Murray CJL, 2012, LANCET, V379, P413, DOI 10.1016/S0140-6736(12)60034-8; O'Flaherty K, 2019, J INFECT DIS, V220, P1178, DOI 10.1093/infdis/jiz247; Ocan M, 2019, MALARIA J, V18, DOI 10.1186/s12936-019-2701-6; Ross LS, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05652-0; Scott N, 2018, MALARIA J, V17, DOI 10.1186/s12936-018-2418-y; Sekihara M, 2019, EMERGENCE ARTEMISIN, DOI [10.1101/621813, DOI 10.1101/621813]; Sidhu ABS, 2006, J INFECT DIS, V194, P528, DOI 10.1086/507115; Slater HC, 2016, MALARIA J, V15, DOI 10.1186/s12936-015-1075-7; Straimer J, 2015, SCIENCE, V347, P428, DOI 10.1126/science.1260867; Uwimana A, 2019, T ROY SOC TROP MED H, V113, P312, DOI 10.1093/trstmh/trz009; van der Pluijm RW, 2019, LANCET INFECT DIS, V19, P952, DOI 10.1016/S1473-3099(19)30391-3; Wang XX, 2020, MALARIA J, V19, DOI 10.1186/s12936-020-3140-0; White NJ, 2014, LANCET, V383, P723, DOI 10.1016/S0140-6736(13)60024-0; WHO, 2018, WORLD MAL REP 2018; Witkowski B, 2017, LANCET INFECT DIS, V17, P174, DOI [10.1016/s1473-3099(16)30415-7, 10.1016/S1473-3099(16)30415-7]; Witkowski B, 2013, LANCET INFECT DIS, V13, P1043, DOI 10.1016/S1473-3099(13)70252-4; World Health Organization, 2008, METH TECHN CLIN TRIA; World Health Organization, 2018, STAT REP ART RES ACT; WWARN, 2015, BMC MED, V13, DOI [10.1186/s12916-015-0445-x, DOI 10.1186/S12916-015-0445-X]; Yang T, 2019, CELL REP, V29, P2917, DOI 10.1016/j.celrep.2019.10.095	41	219	224	9	23	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	OCT	2020	26	10					1602	+		10.1038/s41591-020-1005-2	http://dx.doi.org/10.1038/s41591-020-1005-2		AUG 2020	14	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	NX8MD	32747827	Green Published, hybrid, Green Accepted			2022-12-27	WOS:000555386300003
J	Murray, MF; Giovanni, MA				Murray, Michael F.; Giovanni, Monica A.			Bringing monogenic disease screening to the clinic	NATURE MEDICINE			English	Editorial Material								The Healthy Nevada Project shows that otherwise invisible disease risk can be revealed through DNA-based screening. Identifying these monogenic risks could be the first step toward a new population health-screening program.	[Murray, Michael F.] Yale Sch Med, Dept Genet, New Haven, CT 06510 USA; [Giovanni, Monica A.] Yale New Haven Hlth Syst, New Haven, CT 06519 USA	Yale University; Yale University	Murray, MF (corresponding author), Yale Sch Med, Dept Genet, New Haven, CT 06510 USA.; Giovanni, MA (corresponding author), Yale New Haven Hlth Syst, New Haven, CT 06519 USA.	michael.murray@yale.edu; monica.giovanni@yale.edu						Abul-Husn NS, 2019, GENOME MED, V12, DOI 10.1186/s13073-019-0691-1; Biesecker LG, 2009, GENOME RES, V19, P1665, DOI 10.1101/gr.092841.109; Calonge N, 2008, ANN INTERN MED, V149, P627, DOI 10.7326/0003-4819-149-9-200811040-00243; Grzymski JJ, 2020, NAT MED, V26, P1235, DOI 10.1038/s41591-020-0982-5; Johnston JJ, 2012, AM J HUM GENET, V91, P97, DOI 10.1016/j.ajhg.2012.05.021; Manickam K, 2018, JAMA NETW OPEN, V1, DOI 10.1001/jamanetworkopen.2018.2140; Manrai AK, 2016, NEW ENGL J MED, V375, P655, DOI 10.1056/NEJMsa1507092; Murray MF, 2020, JAMA-J AM MED ASSOC, V323, P307, DOI 10.1001/jama.2019.18640; Murray MF, 2016, GENET MED, V18, P765, DOI 10.1038/gim.2015.134; WILSON JMG, 1968, B OFIC SANIT PANAM, V65, P281; Winawer SJ, 2015, DIGEST DIS SCI, V60, P596, DOI 10.1007/s10620-014-3466-y	11	6	6	1	4	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	AUG	2020	26	8					1172	1174		10.1038/s41591-020-1017-y	http://dx.doi.org/10.1038/s41591-020-1017-y		JUL 2020	3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	MX8ZF	32733075				2022-12-27	WOS:000557201500001
J	Koopmans, M; Haagmans, B				Koopmans, Marion; Haagmans, Bart			Assessing the extent of SARS-CoV-2 circulation through serological studies	NATURE MEDICINE			English	Editorial Material								The COVID-19 pandemic has highlighted the crucial importance of antibody surveys in estimating the incidence of SARS-CoV-2 infection at a population level. Studies in Brazil and China address the use of serology to obtain a better estimate of the infection rate.	[Koopmans, Marion; Haagmans, Bart] Erasmus MC, Virosci Dept, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC	Koopmans, M (corresponding author), Erasmus MC, Virosci Dept, Rotterdam, Netherlands.	m.koopmans@erasmusmc.nl	Haagmans, Bart/E-9791-2015	Haagmans, Bart/0000-0001-6221-2015				Anesi George L., ANN INTERN MED, V174, P613, DOI [10.7326/M20-5327, DOI 10.7326/M20-5327]; Coish J.M, 2020, J MICROBES INFECT, DOI [10.1016/j.micinf.2020.06.006, DOI 10.1016/J.MICINF.2020.06.006]; GeurtsvanKessel CH, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17317-y; Gudbjartsson DF, 2020, NEW ENGL J MED, V382, P2302, DOI 10.1056/NEJMoa2006100; Kissler SM, 2020, SCIENCE, V368, P860, DOI 10.1126/science.abb5793; Lavezzo E, 2020, NATURE, V584, P425, DOI 10.1038/s41586-020-2488-1; Leung GM, 2006, EPIDEMIOL INFECT, V134, P211, DOI 10.1017/S0950268805004826; Ou XY, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15562-9; Silveira MF, 2020, NAT MED, V26, P1196, DOI 10.1038/s41591-020-0992-3; Xu X, 2020, NAT MED, V26, P1193, DOI 10.1038/s41591-020-0949-6	10	25	25	0	4	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	AUG	2020	26	8					1171	1172		10.1038/s41591-020-1018-x	http://dx.doi.org/10.1038/s41591-020-1018-x		JUL 2020	2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	MX8ZF	32719488	Bronze			2022-12-27	WOS:000552954000004
J	Stower, H				Stower, Hannah			CNS barrier-forming organoids	NATURE MEDICINE			English	Editorial Material												h.stower@us.nature.com							0	0	0	0	1	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	JUL	2020	26	7					1009	1009		10.1038/s41591-020-0991-4	http://dx.doi.org/10.1038/s41591-020-0991-4		JUL 2020	1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	MK3XO	32651576	Bronze			2022-12-27	WOS:000547236500009
J	Stower, H				Stower, Hannah			Patching up hearts	NATURE MEDICINE			English	Editorial Material																			0	1	1	2	3	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	MAY	2020	26	5					649	649		10.1038/s41591-020-0904-6	http://dx.doi.org/10.1038/s41591-020-0904-6			1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	ML1JP	32405067	Bronze			2022-12-27	WOS:000549231500011
J	Sungnak, W; Huang, N; Becavin, C; Berg, M; Queen, R; Litvinukova, M; Talavera-Lopez, C; Maatz, H; Reichart, D; Sampaziotis, F; Worlock, KB; Yoshida, M; Barnes, JL				Sungnak, Waradon; Huang, Ni; Becavin, Christophe; Berg, Marijn; Queen, Rachel; Litvinukova, Monika; Talavera-Lopez, Carlos; Maatz, Henrike; Reichart, Daniel; Sampaziotis, Fotios; Worlock, Kaylee B.; Yoshida, Masahiro; Barnes, Josephine L.		HCA Lung Biological	SARS-CoV-2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes	NATURE MEDICINE			English	Article							FUNCTIONAL RECEPTOR; CORONAVIRUS; TRANSMISSION; PROTEIN; WUHAN; ACE2	We investigated SARS-CoV-2 potential tropism by surveying expression of viral entry-associated genes in single-cell RNA-sequencing data from multiple tissues from healthy human donors. We co-detected these transcripts in specific respiratory, corneal and intestinal epithelial cells, potentially explaining the high efficiency of SARS-CoV-2 transmission. These genes are co-expressed in nasal epithelial cells with genes involved in innate immunity, highlighting the cells' potential role in initial viral infection, spread and clearance. The study offers a useful resource for further lines of inquiry with valuable clinical samples from COVID-19 patients and we provide our data in a comprehensive, open and user-friendly fashion at www.covid19cellatlas.org.	[Sungnak, Waradon; Huang, Ni; Litvinukova, Monika; Talavera-Lopez, Carlos] Wellcome Sanger Inst, Cambridge, England; [Becavin, Christophe] Univ Cote Azur, CNRS, IPMC, Sophia Antipolis, France; [Berg, Marijn] Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Med Biol, Groningen, Netherlands; [Berg, Marijn] Univ Groningen, Univ Med Ctr Groningen, Groningen Res Inst Asthma, Groningen, Netherlands; [Berg, Marijn] Univ Groningen, Univ Med Ctr Groningen, COPD, Groningen, Netherlands; [Queen, Rachel] Newcastle Univ, Fac Med Sci, Biosci Inst, Bioinformat Core Facil, Newcastle Upon Tyne, Tyne & Wear, England; [Litvinukova, Monika; Maatz, Henrike] Helmholtz Assoc MDC, Max Delbruck Ctr Mol Med, Cardiovasc & Metab Sci, Berlin, Germany; [Reichart, Daniel] Harvard Med Sch, Dept Genet, Boston, MA 02115 USA; [Sampaziotis, Fotios] Univ Cambridge, Wellcome & MRC Cambridge Stem Cell Inst, Cambridge, England; [Sampaziotis, Fotios] Addenbrookes Hosp, Dept Med, Cambridge, England; [Sampaziotis, Fotios] Cambridge Univ Hosp, Cambridge Liver Unit, Cambridge, England; [Worlock, Kaylee B.; Yoshida, Masahiro; Barnes, Josephine L.] UCL, Div Med, UCL Resp, London, England	Wellcome Trust Sanger Institute; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; University of Groningen; University of Groningen; University of Groningen; Newcastle University - UK; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Harvard University; Harvard Medical School; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Cambridge; University of London; University College London	Sungnak, W (corresponding author), Wellcome Sanger Inst, Cambridge, England.	ws4@sanger.ac.uk	Bécavin, Christophe/AAA-2046-2020; Zerti, Darin/AAF-7078-2021; Talavera-Lopez, Carlos/AFH-6676-2022; Zaragosi, Laure-Emmanuelle/P-9887-2016; Falk, Christine/Q-4143-2016; Gupta, Ravindra/G-5529-2015; Barbry, Pascal/O-5021-2016	Bécavin, Christophe/0000-0003-1555-3153; Zerti, Darin/0000-0003-0865-8088; Zaragosi, Laure-Emmanuelle/0000-0001-6747-7928; Kaminski, Naftali/0000-0001-5917-4601; Figueiredo, Francisco/0000-0002-5876-288X; Falk, Christine/0000-0003-1376-7318; Noseda, Michela/0000-0002-9553-5029; Powell, Joseph/0000-0002-5070-4124; , Yan/0000-0003-2025-027X; Gupta, Ravindra/0000-0001-9751-1808; Litvinukova, Monika/0000-0002-6713-3647; Nikolic, Marko/0000-0001-6304-6848; Nawijn, Martijn/0000-0003-3372-6521; Brazma, Alvis/0000-0001-5988-7409; Talavera-Lopez, Carlos/0000-0001-8590-2393; Saeb-Parsy, Kourosh/0000-0002-0633-3696; Berg, Marijn/0000-0002-9870-1571; Worlock, Kaylee/0000-0002-5656-7634; Barnes, Josephine/0000-0001-9938-3176; Barbry, Pascal/0000-0001-9632-6483; Yoshida, Masahiro/0000-0002-3521-5322; Tata, Purushothama Rao/0000-0003-4837-0337	Wellcome Sanger Institute [WT206194]; Wellcome Strategic Scientific Support award 'Pilot projects for the Human Cell Atlas' [WT211276/Z/18/Z]; Chan Zuckerberg Initiative; European Union's H2020 Research and Innovation Program [874656]; Newton Fund; MRC; Thailand Research Fund; Thailand's National Science and Technology Development Agency; GSK Ltd.; Netherlands Lung Foundation [5.1.14.020, 4.1.18.226]; HubMap consortium; Stanford Child Health Research Institute-Woods Family Faculty Scholarship; HubMap; LENDULET-BIOMAG grant [2018-342]; European Regional Development Fund [GINOP-2.3.2-15-2016-00006, GINOP-2.3.2-15-2016-00026, GINOP-2.3.2-15-2016-00037]; UK Regenerative Medicine Platform [MR/5005579/1]; Fondation pour la Recherche Medicale [DEQ20180339158]; Agence Nationale de la Recherche (UCAJEDI) [ANR-15-IDEX-01]; Agence Nationale de la Recherche (SAHARRA) [ANR-19-CE14-0027]; Agence Nationale de la Recherche (France Genomique) [ANR-10-INBS-09-03]; Conseil Departemental des Alpes Maritimes [2016-294DGADSH-CV, 2019-390DGADSH-CV]; National Institutes of Health (NIH) [R01HL145372]; DOD [W81XWH1910416, W81WH-16-2-0018]; NIH [5R24HD000836, K08HL130595, R01HL127349, U01HL145567, HL135124, AG049665, AI135964, 5U24AI118672, U01 HL148856, DK043351, R01 HL135156, R01 MD010443, R01 HL128439, P01 HL132821, P01 HL107202, R01 HL117004]; Eunice Kennedy Shriver National Institute of Child Health and Human; Leducq foundation; ERC Advanced grant; Doris Duke Charitable Foundation; Three Lakes Foundation; National Research Foundation of Korea; Wellcome Trust; Rutherford Fund Fellowship; Rosetrees Trust [M899]; BHF/DZHK grant; British Heart Foundation [PG/16/47/32156]; Richard and Susan Smith Family Foundation; Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center; National Health; NHLBI/NIH [R01HL146557]; MRC [MR/P009581/1, MR/SO35907/1]; German Research Foundation (DFG) [EXC2151/1, 390873048, 329123747, 347286815]; HGF grant sparse2big; Bill and Melinda Gates Foundation; University College London, Birkbeck MRC Doctoral Training Programme; National Key RD Program [2019YFA0801703]; National Natural Science Foundation of China [31871370]; NJH Regenerative Medicine and Genome Editing Program (REGEN); BBSRC [BB/V01126X/1, BB/T004460/1] Funding Source: UKRI; EPSRC [TS/H001220/1] Funding Source: UKRI; MRC [MR/R015635/1, G0900879, MR/S035826/1, MR/S005579/1, G0701448, MC_PC_17230, MR/R006237/1, MR/S036334/1, MR/S035907/1] Funding Source: UKRI; Medical Research Council [MR/P009581/1, MR/S035907/1, MR/S005579/1] Funding Source: researchfish; Rosetrees Trust [M944] Funding Source: researchfish	Wellcome Sanger Institute; Wellcome Strategic Scientific Support award 'Pilot projects for the Human Cell Atlas'; Chan Zuckerberg Initiative; European Union's H2020 Research and Innovation Program; Newton Fund; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Thailand Research Fund(Thailand Research Fund (TRF)); Thailand's National Science and Technology Development Agency; GSK Ltd.; Netherlands Lung Foundation; HubMap consortium; Stanford Child Health Research Institute-Woods Family Faculty Scholarship; HubMap; LENDULET-BIOMAG grant; European Regional Development Fund(European Commission); UK Regenerative Medicine Platform; Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Agence Nationale de la Recherche (UCAJEDI)(French National Research Agency (ANR)); Agence Nationale de la Recherche (SAHARRA)(French National Research Agency (ANR)); Agence Nationale de la Recherche (France Genomique)(French National Research Agency (ANR)); Conseil Departemental des Alpes Maritimes; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DOD(United States Department of Defense); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Eunice Kennedy Shriver National Institute of Child Health and Human; Leducq foundation(Leducq Foundation); ERC Advanced grant(European Research Council (ERC)); Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); Three Lakes Foundation; National Research Foundation of Korea(National Research Foundation of Korea); Wellcome Trust(Wellcome Trust); Rutherford Fund Fellowship; Rosetrees Trust(Rosetrees Trust); BHF/DZHK grant; British Heart Foundation(British Heart Foundation); Richard and Susan Smith Family Foundation; Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center; National Health; NHLBI/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); German Research Foundation (DFG)(German Research Foundation (DFG)); HGF grant sparse2big; Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); University College London, Birkbeck MRC Doctoral Training Programme(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Key RD Program; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NJH Regenerative Medicine and Genome Editing Program (REGEN); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Rosetrees Trust(Rosetrees Trust)	We are grateful to C. Bargmann, J. Farrar and S. Aldridge for stimulating discussions. We thank J. Eliasova (scientific illustrator) for support with the design of figures, S. Sansum for support in document processing and M. Prete, V. Kiselev and the Wellcome Sanger Cellular Genetics IT Team, as well as P. Bevan, for support with setting up the website portal. The human embryonic and fetal material was provided by the Joint Medical Research Council (MRC)/Wellcome (MR/R006237/1) Human Developmental Biology Resource (www.hdbr.org). This publication is part of the HCA (www.humancellatlas.org/publications). This work was supported by the Wellcome Sanger Institute core funding (WT206194) and the Wellcome Strategic Scientific Support award 'Pilot projects for the Human Cell Atlas' (WT211276/Z/18/Z), a Seed Network grant from the Chan Zuckerberg Initiative to P.B., T.D., T.E.D., O.E., P.H., N.H., N.K., M.K., K.B.M., A.M., M.C.N., M.N., D.P., J.R., P.R.T., S.Q., A.R., O.R., M.A.S., J.S., J.G.S., C.E.S., H.B.S., D.S., A.M.T., J.W. and K.Z. and by the European Union's H2020 Research and Innovation Program under grant agreement no. 874656 (discovAIR) to P.B., A.B., M.K., S.L., J.L., K.B.M., M.C.N., K.S.P., C.S., H.B.S., J.S., F.J.T. and M.vd.B. W.S. acknowledges funding from the Newton Fund, MRC, The Thailand Research Fund and Thailand's National Science and Technology Development Agency. M.C.N acknowledges funding from GSK Ltd., Netherlands Lung Foundation project no. 5.1.14.020 and 4.1.18.226. T.D. acknowledges funding from HubMap consortium and Stanford Child Health Research Institute-Woods Family Faculty Scholarship. T.E.D. acknowledges funding from HubMap. P.H. acknowledges funding from LENDULET-BIOMAG grant (2018-342) and the European Regional Development Fund (GINOP-2.3.2-15-2016-00006, GINOP-2.3.2-15-2016-00026, GINOP-2.3.2-15-2016-00037). J.L.B. acknowledges funding from the MRC and the UK Regenerative Medicine Platform (MR/5005579/1). P.B. acknowledges funding from Fondation pour la Recherche Medicale (DEQ20180339158), Agence Nationale de la Recherche (UCAJEDI, ANR-15-IDEX-01; SAHARRA, ANR-19-CE14-0027; France Genomique, ANR-10-INBS-09-03) and Conseil Departemental des Alpes Maritimes (2016-294DGADSH-CV; 2019-390DGADSH-CV). N.E.B. and J.K. acknowledge funding from National Institutes of Health (NIH) grant R01HL145372 and DOD grant W81XWH1910416. I.G. acknowledges funding from NIH (5R24HD000836) and the Eunice Kennedy Shriver National Institute of Child Health and Human. N.H., J.G.S. and C.E.S. acknowledge funding by the Leducq foundation. N.H. is recipient of an ERC Advanced grant. J.K. acknowledges funding from NIH grant K08HL130595 and the Doris Duke Charitable Foundation. N.K. acknowledges funding from NIH grants R01HL127349, U01HL145567 and an unrestricted grant from Three Lakes Foundation. M.K. acknowledges HHMI and Wall Center for Pulmonary Vascular Disease. H.L. acknowledges funding from National Research Foundation of Korea. K.M. acknowledges funding from Wellcome Trust. A.M. acknowledges funding from NIH grants HL135124, AG049665 and AI135964. M.Z.N. acknowledges funding from Rutherford Fund Fellowship allocated by the MRC and the UK Regenerative Medicine Platform (MR/5005579/1 to M.Z.N.). M.Z.N. and M.Y. have been funded by the Rosetrees Trust (M899). M.N. acknowledges funding from a BHF/DZHK grant and British Heart Foundation (PG/16/47/32156). J.O.-M. acknowledges funding from Richard and Susan Smith Family Foundation. D.P. acknowledges funding from Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center. J.P.; acknowledges funding from National Health and MRC. P.R.T. acknowledges funding from R01HL146557 from NHLBI/NIH. E.L.R. acknowledges funding from MRC MR/P009581/1 and MR/SO35907/1. A.R. and O. R. acknowledge HHMI, the Klarman Cell Observatory and the Manton Foundation. K.S.-P. acknowledges NIHR Cambridge Biomedical Research Centre. C.S. acknowledges the Swedish Research Council, Swedish Cancer Society and CPI. H.B.S. acknowledges the German Center for Lung Research and the Helmholtz Association. J.S. acknowledges Boehringer Ingelheim, by the German Research Foundation (DFG; EXC2151/1, ImmunoSensation2, the immune sensory system, project no. 390873048), project nos. 329123747, 347286815) and by the HGF grant sparse2big. A.K.S. acknowledges the Beckman Young Investigator Program, a Sloan Fellowship in Chemistry, the NIH (5U24AI118672) and the Bill and Melinda Gates Foundation. F.J.T. acknowledges the German Center for Lung Research. M.vd.B. acknowledges the Ministry of Economic Affairs and Climate Policy by means of the PPP. K.B.W. is funded by the University College London, Birkbeck MRC Doctoral Training Programme. J.W. and Y.Y. acknowledge NIH, U01 HL148856 LungMap phase II. R.X. acknowledges the NIH (DK043351). H.Z. is supported by the National Key R&D Program (no. 2019YFA0801703) and National Natural Science Foundation of China (no. 31871370). M.A.S. acknowledges funding from NIH grants R01 HL135156, R01 MD010443, R01 HL128439, P01 HL132821, P01 HL107202, R01 HL117004, and DOD Grant W81WH-16-2-0018 and NJH Regenerative Medicine and Genome Editing Program (REGEN).	[Anonymous], 2002, Bull World Health Organ, V80, P983; [Anonymous], SINGLE CELL ATLAS HU; [Anonymous], N ENGL J MED; Baron M, 2016, CELL SYST, V3, P346, DOI 10.1016/j.cels.2016.08.011; Bertram S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035876; Braga FAV, 2019, NAT MED, V25, P1153, DOI 10.1038/s41591-019-0468-5; Broszeit F, 2019, CELL REP, V27, P3284, DOI 10.1016/j.celrep.2019.05.048; Chen NS, 2020, LANCET, V395, P507, DOI 10.1016/S0140-6736(20)30211-7; Cheng JB, 2018, CELL REP, V25, P871, DOI 10.1016/j.celrep.2018.09.006; Coburn BJ, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-30; Guo JT, 2018, CELL RES, V28, P1141, DOI 10.1038/s41422-018-0099-2; Habib N, 2017, NAT METHODS, V14, P955, DOI [10.1038/NMETH.4407, 10.1038/nmeth.4407]; Hamming I, 2004, J PATHOL, V203, P631, DOI 10.1002/path.1570; Henry GH, 2018, CELL REP, V25, P3530, DOI 10.1016/j.celrep.2018.11.086; Hoffmann M, 2020, CELL, V181, P271, DOI 10.1016/j.cell.2020.02.052; Iwata-Yoshikawa N, 2019, J VIROL, V93, DOI 10.1128/JVI.01815-18; Killerby ME, 2020, EMERG INFECT DIS, V26, P191, DOI 10.3201/eid2602.190697; Kucharski AJ, 2015, EUROSURVEILLANCE, V20, P14, DOI 10.2807/1560-7917.ES2015.20.25.21167; Li Q., 2020, NEW ENGL J MED, V382, P1199; Li WH, 2003, NATURE, V426, P450, DOI 10.1038/nature02145; MacParland SA, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06318-7; Madissoon E, 2019, GENOME BIOL, V21, DOI 10.1186/s13059-019-1906-x; Martin JC, 2019, CELL, V178, P1493, DOI 10.1016/j.cell.2019.08.008; Matsuyama S, 2010, J VIROL, V84, P12658, DOI 10.1128/JVI.01542-10; Park JE, 2020, SCIENCE, V367, P868, DOI 10.1126/science.aay3224; Popescu DM, 2019, NATURE, V574, P365, DOI 10.1038/s41586-019-1652-y; Qi FR, 2020, BIOCHEM BIOPH RES CO, V526, P135, DOI 10.1016/j.bbrc.2020.03.044; Raj VS, 2013, NATURE, V495, P251, DOI 10.1038/nature12005; Riou J, 2020, EUROSURVEILLANCE, V25, P7, DOI 10.2807/1560-7917.ES.2020.25.4.2000058; Smillie CS, 2019, CELL, V178, P714, DOI 10.1016/j.cell.2019.06.029; Stewart BJ, 2019, SCIENCE, V365, P1461, DOI 10.1126/science.aat5031; Vento-Tormo R, 2018, NATURE, V563, P347, DOI 10.1038/s41586-018-0698-6; Voigt AP, 2019, EXP EYE RES, V184, P234, DOI 10.1016/j.exer.2019.05.001; Wallinga J, 2004, AM J EPIDEMIOL, V160, P509, DOI 10.1093/aje/kwh255; Xu Y, 2020, NAT MED, V26, P502, DOI 10.1038/s41591-020-0817-4; YEAGER CL, 1992, NATURE, V357, P420, DOI 10.1038/357420a0; Zhao Y., 2020, SINGLE CELL RNA EXPR, P1, DOI [10.1101/2020.01.26.919985, DOI 10.1101/2020.01.26.919985]; Zhou P, 2020, NATURE, V588, pE6, DOI [10.1038/s41586-020-2951-z, 10.1038/s41586-020-2012-7]; Zhou Y, 2015, ANTIVIR RES, V116, P76, DOI 10.1016/j.antiviral.2015.01.011; Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017; Zou X, 2020, FRONT MED-PRC, V14, P185, DOI 10.1007/s11684-020-0754-0	41	1356	1396	17	123	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	MAY	2020	26	5					681	+		10.1038/s41591-020-0868-6	http://dx.doi.org/10.1038/s41591-020-0868-6		APR 2020	12	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	ML1LF	32327758	Green Accepted, Green Published, Green Submitted, Bronze			2022-12-27	WOS:000528517900001
J	Tsai, ABG; Glass, DR; Juntilla, M; Hartmann, FJ; Oak, JS; Fernandez-Pol, S; Ohgami, RS; Bendall, SC				Tsai, Albert G.; Glass, David R.; Juntilla, Marisa; Hartmann, Felix J.; Oak, Jean S.; Fernandez-Pol, Sebastian; Ohgami, Robert S.; Bendall, Sean C.			Multiplexed single-cell morphometry for hematopathology diagnostics	NATURE MEDICINE			English	Article							MASS CYTOMETRY; CLONALITY; STANDARDIZATION; LEUKEMIA; LYMPHOPROLIFERATIONS; MONOCYTES; REVEALS	The diagnosis of lymphomas and leukemias requires hematopathologists to integrate microscopically visible cellular morphology with antibody-identified cell surface molecule expression. To merge these into one high-throughput, highly multiplexed, single-cell assay, we quantify cell morphological features by their underlying, antibody-measurable molecular components, which empowers mass cytometers to 'see' like pathologists. When applied to 71 diverse clinical samples, single-cell morphometric profiling reveals robust and distinct patterns of 'morphometric' markers for each major cell type. Individually, lamin B1 highlights acute leukemias, lamin A/C helps distinguish normal from neoplastic mature T cells, and VAMP-7 recapitulates light-cytometric side scatter. Combined with machine learning, morphometric markers form intuitive visualizations of normal and neoplastic cellular distribution and differentiation. When recalibrated for myelomonocytic blast enumeration, this approach is superior to flow cytometry and comparable to expert microscopy, bypassing years of specialized training. The contextualization of traditional surface markers on independent morphometric frameworks permits more sensitive and automated diagnosis of complex hematopoietic diseases. A scalable mass cytometry-based method for morphometrically classifying hematopoietic cells demonstrates diagnostic utility when applied to clinical samples.	[Tsai, Albert G.; Glass, David R.; Juntilla, Marisa; Hartmann, Felix J.; Oak, Jean S.; Fernandez-Pol, Sebastian; Bendall, Sean C.] Stanford Univ, Dept Pathol, Stanford, CA 94305 USA; [Glass, David R.; Bendall, Sean C.] Stanford Univ, Immunol Grad Program, Stanford, CA 94305 USA; [Ohgami, Robert S.] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94140 USA	Stanford University; Stanford University; University of California System; University of California San Francisco	Bendall, SC (corresponding author), Stanford Univ, Dept Pathol, Stanford, CA 94305 USA.; Bendall, SC (corresponding author), Stanford Univ, Immunol Grad Program, Stanford, CA 94305 USA.	bendall@stanford.edu	Bendall, Sean/AGG-0126-2022	Fernandez-Pol, Sebastian/0000-0002-0428-0199; Tsai, Albert/0000-0002-6607-3347; Angelo, Michael/0000-0003-1531-5067; Glass, David/0000-0001-9924-167X; Oak, Jean/0000-0001-5220-4628; Bendall, Sean/0000-0003-1341-2453	Damon Runyon Cancer Research Foundation (DRCRF) award [DRG-118-16]; Stanford Department of Pathology Seed Grant; Stanford Graduate Fellowship; Bio-X Stanford Interdisciplinary Graduate Fellowship; EMBO organization (EMBO Long-Term Fellowship); Novartis Foundation for Medical-Biological Research; Swiss National Science Foundation (SNF Early Postdoc Mobility); DRCRF Fellowship [DRG-2017-09]; NIH [1DP2OD022550-01, 1R01AG056287-01, 1R01AG057915-01, 1-R00-GM104148-01, 1U24CA224309-01, 5U19AI116484-02, U19 AI104209]; Bill and Melinda Gates Foundation; Stanford Cancer Institute	Damon Runyon Cancer Research Foundation (DRCRF) award; Stanford Department of Pathology Seed Grant; Stanford Graduate Fellowship(Stanford University); Bio-X Stanford Interdisciplinary Graduate Fellowship; EMBO organization (EMBO Long-Term Fellowship); Novartis Foundation for Medical-Biological Research; Swiss National Science Foundation (SNF Early Postdoc Mobility)(Swiss National Science Foundation (SNSF)); DRCRF Fellowship; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Stanford Cancer Institute	A.T. was supported by a Damon Runyon Cancer Research Foundation (DRCRF) award (DRG-118-16) and a Stanford Department of Pathology Seed Grant. D.G. was supported by a Stanford Graduate Fellowship, and a Bio-X Stanford Interdisciplinary Graduate Fellowship. F.H. was supported by the EMBO organization (EMBO Long-Term Fellowship), the Novartis Foundation for Medical-Biological Research and the Swiss National Science Foundation (SNF Early Postdoc Mobility). S.B. was supported by the DRCRF Fellowship (DRG-2017-09), NIH awards 1DP2OD022550-01, 1R01AG056287-01, 1R01AG057915-01, 1-R00-GM104148-01, 1U24CA224309-01, 5U19AI116484-02 and U19 AI104209, The Bill and Melinda Gates Foundation, and a Translational Research Award from the Stanford Cancer Institute. We also thank L. Keren for her helpful comments and suggestions about the manuscript during its preparation.	American Cancer Society, 2018, CANC FACTS FIG 2015; Amir ED, 2013, NAT BIOTECHNOL, V31, P545, DOI 10.1038/nbt.2594; Angelo M, 2014, NAT MED, V20, P436, DOI 10.1038/nm.3488; Becht E, 2019, NAT BIOTECHNOL, V37, P38, DOI 10.1038/nbt.4314; Behbehani GK, 2017, CLIN LAB MED, V37, P945, DOI 10.1016/j.cll.2017.07.010; Boone Elke, 2013, Methods Mol Biol, V971, P65, DOI 10.1007/978-1-62703-269-8_4; Carr J. H., 2004, CLIN HEMATOLOGY ATLA; Chung JW, 2012, ANN CLIN LAB SCI, V42, P271; de Swart L, 2017, ANN HEMATOL, V96, P1105, DOI 10.1007/s00277-017-3009-7; Font P, 2015, ANN HEMATOL, V94, P565, DOI 10.1007/s00277-014-2252-4; Friedman J., 2001, ELEMENTS STAT LEARNI, DOI 10.1007/978-0-387-21606-5; Giesen C, 2014, NAT METHODS, V11, P417, DOI [10.1038/NMETH.2869, 10.1038/nmeth.2869]; Goasguen JE, 2009, HAEMATOL-HEMATOL J, V94, P994, DOI 10.3324/haematol.2008.005421; Groenen Patricia J T A, 2008, J Hematop, V1, P97, DOI 10.1007/s12308-008-0013-9; Hartmann FJ, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-28791-2; Hodes A, 2019, SEMIN HEMATOL, V56, P58, DOI 10.1053/j.seminhematol.2018.07.001; Jamieson AR, 2010, MED PHYS, V37, P339, DOI 10.1118/1.3267037; Kalina T, 2012, LEUKEMIA, V26, P1986, DOI 10.1038/leu.2012.122; Keren L, 2018, CELL, V174, P1373, DOI 10.1016/j.cell.2018.08.039; Kleinsteuber K, 2016, CYTOM PART A, V89A, P903, DOI 10.1002/cyto.a.22935; Kotrova M, 2018, CYTOM PART A, V93A, P1118, DOI 10.1002/cyto.a.23604; Kussick SJ, 2005, AM J CLIN PATHOL, V124, P170, DOI 10.1309/6PBP78G4FBA1FDG6; Lacy Paige, 2006, Allergy Asthma Clin Immunol, V2, P98, DOI 10.1186/1710-1492-2-3-98; Langerak AW, 2007, LEUKEMIA, V21, P222, DOI 10.1038/sj.leu.2404482; Langerak AW, 2012, LEUKEMIA, V26, P2159, DOI 10.1038/leu.2012.246; Manley HR, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02867; Mei HE, 2016, CYTOM PART A, V89A, P292, DOI 10.1002/cyto.a.22778; Nguyen D, 2007, FLOW CYTOMETRY HEMAT; Popova EY, 2006, EXP HEMATOL, V34, P453, DOI 10.1016/j.exphem.2006.01.003; Rahman AH, 2016, CYTOM PART A, V89A, P601, DOI 10.1002/cyto.a.22826; Rowat AC, 2013, J BIOL CHEM, V288, P8610, DOI 10.1074/jbc.M112.441535; Stern AD, 2017, CYTOM PART A, V91A, P14, DOI 10.1002/cyto.a.23000; Stoeckius M, 2017, NAT METHODS, V14, P865, DOI [10.1038/nmeth.4380, 10.1038/NMETH.4380]; Swerdlow SH., 2017, WHO CLASSIFICATION T, V2, P453; Tembhare P, 2011, AM J CLIN PATHOL, V135, P890, DOI 10.1309/AJCPV2D1DDSGJDBW; van Dongen JJM, 2012, LEUKEMIA, V26, P1908, DOI 10.1038/leu.2012.120; van Dongen JJM, 2003, LEUKEMIA, V17, P2257, DOI 10.1038/sj.leu.2403202; Xu Y, 2005, AM J CLIN PATHOL, V124, P799, DOI 10.1309/HFJ1XKTD77J1UTFM; Zunder ER, 2015, NAT PROTOC, V10, P316, DOI 10.1038/nprot.2015.020	39	12	12	4	21	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	MAR	2020	26	3					408	+		10.1038/s41591-020-0783-x	http://dx.doi.org/10.1038/s41591-020-0783-x			26	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	KU0MC	32161403	Green Accepted			2022-12-27	WOS:000519405000029
J	Niessl, J; Baxter, AE; Mendoza, P; Jankovic, M; Cohen, YZ; Butler, AL; Lu, CL; Dube, M; Shimeliovich, I; Gruell, H; Klein, F; Caskey, M; Nussenzweig, MC; Kaufmann, DE				Niessl, Julia; Baxter, Amy E.; Mendoza, Pilar; Jankovic, Mila; Cohen, Yehuda Z.; Butler, Allison L.; Lu, Ching-Lan; Dube, Mathieu; Shimeliovich, Irina; Gruell, Henning; Klein, Florian; Caskey, Marina; Nussenzweig, Michel C.; Kaufmann, Daniel E.			Combination anti-HIV-1 antibody therapy is associated with increased virus-specific T cell immunity	NATURE MEDICINE			English	Article							HIV-1; INFECTION; RESERVOIR; RESPONSES; VIREMIA	T cell responses specific for HIV-1 Gag peptides increased in HIV-positive recipients of two broadly neutralizing antibodies with prolonged suppression of blood viremia during antiretroviral treatment interruption. Combination antiretroviral therapy (ART) is highly effective in controlling human immunodeficiency virus (HIV)-1 but requires lifelong medication due to the existence of a latent viral reservoir(1,2). Potent broadly neutralizing antibodies (bNAbs) represent a potential alternative or adjuvant to ART. In addition to suppressing viremia, bNAbs may have T cell immunomodulatory effects as seen for other forms of immunotherapy(3). However, this has not been established in individuals who are infected with HIV-1. Here, we document increased HIV-1 Gag-specific CD8(+) T cell responses in the peripheral blood of all nine study participants who were infected with HIV-1 with suppressed blood viremia, while receiving bNAb therapy during ART interruption(4). Increased CD4(+) T cell responses were detected in eight individuals. The increased T cell responses were due both to newly detectable reactivity to HIV-1 Gag epitopes and the expansion of pre-existing measurable responses. These data demonstrate that bNAb therapy during ART interruption is associated with enhanced HIV-1-specific T cell responses. Whether these augmented T cell responses can contribute to bNAb-mediated viral control remains to be determined.	[Niessl, Julia; Baxter, Amy E.; Dube, Mathieu; Kaufmann, Daniel E.] Ctr Hosp Univ Montreal CRCHUM, Res Ctr, Montreal, PQ, Canada; [Niessl, Julia; Baxter, Amy E.; Kaufmann, Daniel E.] Univ Montreal, Montreal, PQ, Canada; [Niessl, Julia; Baxter, Amy E.; Kaufmann, Daniel E.] CHAVD, La Jolla, CA 92037 USA; [Mendoza, Pilar; Jankovic, Mila; Cohen, Yehuda Z.; Butler, Allison L.; Lu, Ching-Lan; Shimeliovich, Irina; Caskey, Marina; Nussenzweig, Michel C.] Rockefeller Univ, Lab Mol Immunol, 1230 York Ave, New York, NY 10021 USA; [Gruell, Henning; Klein, Florian] Univ Cologne, Fac Med, Inst Virol, Lab Expt Immunol, Cologne, Germany; [Gruell, Henning; Klein, Florian] Univ Cologne, Univ Hosp Cologne, Cologne, Germany; [Gruell, Henning] Univ Cologne, Fac Med, Dept Internal Med 1, Cologne, Germany; [Gruell, Henning; Klein, Florian] German Ctr Infect Res DZIF, Partner Site Bonn Cologne, Cologne, Germany; [Klein, Florian] Univ Cologne, Ctr Mol Med Cologne, Cologne, Germany; [Baxter, Amy E.] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA; [Lu, Ching-Lan] Columbia Univ, Med Ctr, Dept Internal Med, New York, NY USA	Universite de Montreal; Universite de Montreal; Rockefeller University; University of Cologne; University of Cologne; University of Cologne; German Center for Infection Research; University of Cologne; University of Cologne; University of Pennsylvania; Pennsylvania Medicine; Columbia University	Kaufmann, DE (corresponding author), Ctr Hosp Univ Montreal CRCHUM, Res Ctr, Montreal, PQ, Canada.; Kaufmann, DE (corresponding author), Univ Montreal, Montreal, PQ, Canada.; Kaufmann, DE (corresponding author), CHAVD, La Jolla, CA 92037 USA.; Nussenzweig, MC (corresponding author), Rockefeller Univ, Lab Mol Immunol, 1230 York Ave, New York, NY 10021 USA.	nussen@mail.rockefeller.edu; daniel.kaufmann@umontreal.ca	Dubé, Mathieu/AAN-7908-2020	Niessl, Julia/0000-0001-8852-1924; Grull, Henning/0000-0002-0725-7138; Dube, Mathieu/0000-0002-5522-9019	Canadian Institutes for Health Research [152977, 154049]; Canada Foundation for Innovation Program Leader grant [31756]; FRQS AIDS and Infectious Diseases Network; National Institutes of Health [UM1 AI-100663, AI-144462, R01AI-129795]; Einstein-Rockefeller-CUNY Center for AIDS Research [1P30AI124414-01A1]; BEAT-HIV Delaney grant [UM1 AI-126620]; Robertson Fund; Bill and Melinda Gates Foundation Collaboration for AIDS Vaccine Discovery [OPP1092074, OPP1124068]; Quebec Health Research Fund (FRQS); Department of Microbiology, Immunology and Infectious Diseases, Universite de Montreal; CIHR Fellowship Award [152536]; Merit Award of the Quebec Health Research Fund (FRQS)	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Canada Foundation for Innovation Program Leader grant(Canada Foundation for Innovation); FRQS AIDS and Infectious Diseases Network; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Einstein-Rockefeller-CUNY Center for AIDS Research; BEAT-HIV Delaney grant; Robertson Fund; Bill and Melinda Gates Foundation Collaboration for AIDS Vaccine Discovery; Quebec Health Research Fund (FRQS); Department of Microbiology, Immunology and Infectious Diseases, Universite de Montreal; CIHR Fellowship Award(Canadian Institutes of Health Research (CIHR)); Merit Award of the Quebec Health Research Fund (FRQS)	We thank the clinical staff in the Laboratory of Molecular Immunology at the Rockefeller University and the Division of Infectious Diseases at the University Hospital Cologne, as well as all study participants for their invaluable role in this project; D. Gauchat, P. St-Onge and the CRCHUM Flow Cytometry Platform and O. Debbeche and the CRCHUM BSL3 platform for technical assistance. The following reagents were obtained through the NIH AIDS Reagent Program, Division of AIDS, NIAID, NIH: Consensus B peptide pools for Gag (cat. no.12425), Pol (cat. no. 12438), Nef (cat. no. 12545), gp120 and gp41 (pools made using HIV-1 Consensus B Env Peptide Set, cat. no. 9480), Consensus B Gag Peptide Set (cat. no. 8117) and HIV-1BaL (cat. no. 510) from S. Gartner, M. Popovic and R. Gallo32. This study was supported by the Canadian Institutes for Health Research (grant nos. 152977 and 154049 to D.E.K), a Canada Foundation for Innovation Program Leader grant (no. 31756 to D.E.K); the FRQS AIDS and Infectious Diseases Network; the National Institutes of Health UM1 AI-100663 (CHAVI-ID) and AI-144462 (CHAVD); R01AI-129795 (M.C.N.); the Einstein-Rockefeller-CUNY Center for AIDS Research (1P30AI124414-01A1); BEAT-HIV Delaney grant UM1 AI-126620 (M.C.); and the Robertson Fund. We acknowledge grants from the Bill and Melinda Gates Foundation Collaboration for AIDS Vaccine Discovery, nos. OPP1092074 and OPP1124068 (M.C.N.). J.N. is supported by scholarships from the Quebec Health Research Fund (FRQS) and the Department of Microbiology, Immunology and Infectious Diseases, Universite de Montreal. A.E.B. is the recipient of a CIHR Fellowship Award no. 152536. D.E.K is supported by a Merit Award of the Quebec Health Research Fund (FRQS). M.C.N. is an HHMI Investigator.	Achenbach CJ, 2015, LANCET HIV, V2, pE82, DOI 10.1016/S2352-3018(15)00026-0; Almeida JR, 2007, J EXP MED, V204, P2473, DOI 10.1084/jem.20070784; Betts MR, 2006, BLOOD, V107, P4781, DOI 10.1182/blood-2005-12-4818; Borducchi EN, 2018, NATURE, V563, P360, DOI 10.1038/s41586-018-0600-6; Caskey M, 2019, NAT MED, V25, P547, DOI 10.1038/s41591-019-0412-8; Chun TW, 1997, P NATL ACAD SCI USA, V94, P13193, DOI 10.1073/pnas.94.24.13193; Fagard C, 2003, ARCH INTERN MED, V163, P1220, DOI 10.1001/archinte.163.10.1220; Finzi D, 1997, SCIENCE, V278, P1295, DOI 10.1126/science.278.5341.1295; Freel SA, 2010, J VIROL, V84, P4998, DOI 10.1128/JVI.00138-10; GARTNER S, 1986, SCIENCE, V233, P215, DOI 10.1126/science.3014648; Goonetilleke N, 2009, J EXP MED, V206, P1253, DOI 10.1084/jem.20090365; Gray CM, 1999, J IMMUNOL, V162, P1780; KOUP RA, 1994, J VIROL, V68, P4650, DOI 10.1128/JVI.68.7.4650-4655.1994; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lu CL, 2018, P NATL ACAD SCI USA, V115, pE11341, DOI 10.1073/pnas.1813512115; Lu CL, 2016, SCIENCE, V352, P1001, DOI 10.1126/science.aaf1279; Mendoza P, 2018, NATURE, V561, P479, DOI 10.1038/s41586-018-0531-2; Morou A, 2019, NAT IMMUNOL, V20, P1059, DOI 10.1038/s41590-019-0418-x; Nishimura Y, 2017, NATURE, V543, P559, DOI 10.1038/nature21435; Oxenius A, 2002, P NATL ACAD SCI USA, V99, P13747, DOI 10.1073/pnas.202372199; PATARCA R, 1984, NATURE, V312, P496, DOI 10.1038/312496a0; Pelletier S, 2010, J HEPATOL, V53, P805, DOI 10.1016/j.jhep.2010.05.013; Pereyra F, 2008, J INFECT DIS, V197, P563, DOI 10.1086/526786; PIATAK M, 1993, SCIENCE, V259, P1749, DOI 10.1126/science.8096089; Prebensen C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176527; Reiss S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186998; Rosenberg ES, 1997, SCIENCE, V278, P1447, DOI 10.1126/science.278.5342.1447; Saez-Cirion A, 2010, NAT PROTOC, V5, P1033, DOI 10.1038/nprot.2010.73; Salazar-Gonzalez JF, 2008, J VIROL, V82, P3952, DOI 10.1128/JVI.02660-07; Scheid JF, 2016, NATURE, V535, P556, DOI 10.1038/nature18929; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033	32	64	64	0	12	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	FEB	2020	26	2					222	+		10.1038/s41591-019-0747-1	http://dx.doi.org/10.1038/s41591-019-0747-1		FEB 2020	22	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	KK7DU	32015556	Green Published, Green Accepted, Bronze			2022-12-27	WOS:000510822600004
J	Stower, H				Stower, Hannah			HEALTH POLICY A mixed year for e-cigarettes	NATURE MEDICINE			English	Editorial Material																			0	0	0	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	2019	25	12					1798	1798		10.1038/s41591-019-0682-1	http://dx.doi.org/10.1038/s41591-019-0682-1			1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	JT2KO	31806894	Bronze			2022-12-27	WOS:000500824900002
J	Sadanand, S				Sadanand, Saheli			NEURO-ONCOLOGY Synaptic input drives brain tumor progression	NATURE MEDICINE			English	Editorial Material														Sadanand, Saheli/0000-0001-6675-3492					0	0	0	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2019	25	11					1647	1647		10.1038/s41591-019-0657-2	http://dx.doi.org/10.1038/s41591-019-0657-2			1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	JT2KI	31700179	Bronze			2022-12-27	WOS:000500824300014
J	Ganesh, K; Wu, C; O'Rourke, KP; Szeglin, BC; Zheng, YY; Sauve, CEG; Adileh, M; Wasserman, I; Marco, MR; Kim, AS; Shady, M; Sanchez-Vega, F; Karthaus, WR; Won, HH; Choi, SH; Pelossof, R; Barlas, A; Ntiamoah, P; Pappou, E; Elghouayel, A; Strong, JS; Chen, CT; Harris, JW; Weiser, MR; Nash, GM; Guillem, JG; Wei, IH; Kolesnick, RN; Veeraraghavan, H; Ortiz, EJ; Petkovska, I; Cercek, A; Manova-Todorova, KO; Saltz, LB; Lavery, JA; DeMatteo, RP; Massague, J; Paty, PB; Yaeger, R; Chen, X; Patil, S; Clevers, H; Berger, MF; Lowe, SW; Shia, JR; Romesser, PB; Dow, LE; Garcia-Aguilar, J; Sawyers, CL; Smith, JJ				Ganesh, Karuna; Wu, Chao; O'Rourke, Kevin P.; Szeglin, Bryan C.; Zheng, Youyun; Sauve, Charles-Etienne Gabriel; Adileh, Mohammad; Wasserman, Isaac; Marco, Michael R.; Kim, Amanda S.; Shady, Maha; Sanchez-Vega, Francisco; Karthaus, Wouter R.; Won, Helen H.; Choi, Seo-Hyun; Pelossof, Raphael; Barlas, Afsar; Ntiamoah, Peter; Pappou, Emmanouil; Elghouayel, Arthur; Strong, James S.; Chen, Chin-Tung; Harris, Jennifer W.; Weiser, Martin R.; Nash, Garrett M.; Guillem, Jose G.; Wei, Iris H.; Kolesnick, Richard N.; Veeraraghavan, Harini; Ortiz, Eduardo J.; Petkovska, Iva; Cercek, Andrea; Manova-Todorova, Katia O.; Saltz, Leonard B.; Lavery, Jessica A.; DeMatteo, Ronald P.; Massague, Joan; Paty, Philip B.; Yaeger, Rona; Chen, Xi; Patil, Sujata; Clevers, Hans; Berger, Michael F.; Lowe, Scott W.; Shia, Jinru; Romesser, Paul B.; Dow, Lukas E.; Garcia-Aguilar, Julio; Sawyers, Charles L.; Smith, J. Joshua			A rectal cancer organoid platform to study individual responses to chemoradiation	NATURE MEDICINE			English	Article							COLORECTAL-CANCER; PREOPERATIVE CHEMORADIOTHERAPY; POSTOPERATIVE CHEMOTHERAPY; NEOADJUVANT CHEMOTHERAPY; GERMAN CAO/ARO/AIO-04; TRANSPLANTATION; FLUOROURACIL; MULTICENTER; OXALIPLATIN; THERAPY	Rectal cancer (RC) is a challenging disease to treat that requires chemotherapy, radiation and surgery to optimize outcomes for individual patients. No accurate model of RC exists to answer fundamental research questions relevant to patients. We established a biorepository of 65 patient-derived RC organoid cultures (tumoroids) from patients with primary, metastatic or recurrent disease. RC tumoroids retained molecular features of the tumors from which they were derived, and their ex vivo responses to clinically relevant chemotherapy and radiation treatment correlated with the clinical responses noted in individual patients' tumors. Upon engraftment into murine rectal mucosa, human RC tumoroids gave rise to invasive RC followed by metastasis to lung and liver. Importantly, engrafted tumors displayed the heterogenous sensitivity to chemotherapy observed clinically. Thus, the biology and drug sensitivity of RC clinical isolates can be efficiently interrogated using an organoid-based, ex vivo platform coupled with in vivo endoluminal propagation in animals.	[Ganesh, Karuna; Kolesnick, Richard N.] Mem Sloan Kettering Canc Ctr, Mol Pharmacol Program, Sloan Kettering Inst, 1275 York Ave, New York, NY 10021 USA; [Ganesh, Karuna; Cercek, Andrea; Saltz, Leonard B.; Yaeger, Rona] Mem Sloan Kettering Canc Ctr, Dept Med, Gastrointestinal Oncol Serv, 1275 York Ave, New York, NY 10021 USA; [Wu, Chao; Karthaus, Wouter R.; Sawyers, Charles L.; Smith, J. Joshua] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, 1275 York Ave, New York, NY 10021 USA; [Wu, Chao; Szeglin, Bryan C.; Sauve, Charles-Etienne Gabriel; Adileh, Mohammad; Wasserman, Isaac; Marco, Michael R.; Sanchez-Vega, Francisco; Choi, Seo-Hyun; Pelossof, Raphael; Pappou, Emmanouil; Elghouayel, Arthur; Strong, James S.; Chen, Chin-Tung; Harris, Jennifer W.; Weiser, Martin R.; Nash, Garrett M.; Guillem, Jose G.; Wei, Iris H.; Paty, Philip B.; Garcia-Aguilar, Julio; Smith, J. Joshua] Mem Sloan Kettering Canc Ctr, Dept Surg, Colorectal Serv, 1275 York Ave, New York, NY 10021 USA; [O'Rourke, Kevin P.; Massague, Joan; Lowe, Scott W.] Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Canc Biol & Genet Program, 1275 York Ave, New York, NY 10021 USA; [O'Rourke, Kevin P.] Rockefeller Univ, Weill Cornell Med, Sloan Kettering Triinst MD PhD Program, 1230 York Ave, New York, NY 10021 USA; [Szeglin, Bryan C.] Albert Einstein Coll Med, Bronx, NY 10467 USA; [Zheng, Youyun; Shady, Maha; Won, Helen H.; Ntiamoah, Peter; Berger, Michael F.; Shia, Jinru] Mem Sloan Kettering Canc Ctr, Dept Pathol, 1275 York Ave, New York, NY 10021 USA; [Zheng, Youyun; Shady, Maha; Won, Helen H.; Berger, Michael F.] Mem Sloan Kettering Canc Ctr, Marie Josee & Henry R Kravis Ctr Mol Oncol, 1275 York Ave, New York, NY 10021 USA; [Kim, Amanda S.; Romesser, Paul B.] Mem Sloan Kettering Canc Ctr, Dept Radiat Oncol, 1275 York Ave, New York, NY 10021 USA; [Sanchez-Vega, Francisco] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, Computat Oncol Serv, New York, NY 10021 USA; [Barlas, Afsar; Manova-Todorova, Katia O.] Mem Sloan Kettering Canc Ctr, Mol Cytol Core Facil, 1275 York Ave, New York, NY 10021 USA; [Veeraraghavan, Harini] Mem Sloan Kettering Canc Ctr, Dept Med Phys, New York, NY 10021 USA; [Ortiz, Eduardo J.; Petkovska, Iva] Mem Sloan Kettering Canc Ctr, Dept Radiol, 1275 York Ave, New York, NY 10021 USA; [Lavery, Jessica A.; Patil, Sujata] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10021 USA; [DeMatteo, Ronald P.] Hosp Univ Penn, Dept Surg, 3400 Spruce St, Philadelphia, PA 19104 USA; [Chen, Xi] Sylvestor Comprehens Canc Ctr, Dept Publ Hlth Sci, Miami, FL USA; [Clevers, Hans] Univ Med Ctr, Royal Netherlands Acad Arts & Sci, Hubrecht Inst, Utrecht, Netherlands; [Shia, Jinru] Mem Sloan Kettering Canc Ctr, Dept Pathol, Gastrointestinal Pathol, 1275 York Ave, New York, NY 10021 USA; [Dow, Lukas E.] Weill Cornell Med, Weill Cornell Grad Sch Med Sci, Dept Med & Biochem, Sandra & Edward Meyer Canc Ctr, New York, NY USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Cornell University; Rockefeller University; Yeshiva University; Albert Einstein College of Medicine; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; University of Pennsylvania; Pennsylvania Medicine; Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center; Memorial Sloan Kettering Cancer Center; Cornell University; Qatar Foundation (QF); Weill Cornell Medical College Qatar	Sawyers, CL; Smith, JJ (corresponding author), Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, 1275 York Ave, New York, NY 10021 USA.; Smith, JJ (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Surg, Colorectal Serv, 1275 York Ave, New York, NY 10021 USA.	sawyersc@mskcc.org; smithj5@mskcc.org	; Szeglin, Bryan/G-1494-2015; Wu, Chao/B-8060-2014	Petkovska, Iva/0000-0002-4373-6494; Kolesnick, Richard/0000-0002-1686-6162; Dow, Lukas/0000-0001-7048-1418; Szeglin, Bryan/0000-0002-7866-7548; Garcia-Aguilar, Julio/0000-0003-2451-0948; Wu, Chao/0000-0003-0260-2868; Karthaus, Wouter R./0000-0002-9234-9044	MSK Molecular Core Cytology Facility [P30CA008748]; NIH/NCI Cancer Center Support Grant [P30 CA008748]; National Cancer Institute of the National Institutes of Health [R25CA020449]; NIH/NCI [1CA200110-01A1]; MSK Colorectal Cancer Research Center; American Society of Colon and Rectal Surgeons Career Development Award; Joel J. Roslyn Faculty Research Award; American Society of Colon and Rectal Surgeons Limited Project Grant; MSK Department of Surgery Junior Faculty Award; John Wasserman Colon and Rectal Cancer Fund; Colorectal Cancer Alliance; Chris4Life Research Award; Stand Up to Cancer (SU2C) Colorectal Cancer Dream Team Translational Research Grant [SU2C: AACR-DR22-17]; Stand Up to Cancer is a program of the Entertainment Industry Foundation; scientific partner of SU2C; NIH via the National Cancer Institute; Howard Hughes Medical Institute; National Institutes of Health [CA94060, CA12924]; Starr Cancer Consortium [I8-A8-030]; American Cancer Society Postdoctoral Fellowship; AACR Basic Cancer Research Fellowship; Conquer Cancer Foundation of ASCO Young Investigator Award, Shulamit Katzman Endowed Postdoctoral Research Fellowship; SU2C Colorectal Cancer Dream Team Translational Research Grant [SU2C: AACR-DR22-17]; MSKCC Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center; NIH [U54 OD020355-01]; Medical Scientist Training Program grant from the National Institute of General Medical Sciences of the National Institutes of Health [T32GM07739]; Stand Up to Cancer Colorectal Cancer Dream Team Translational Research Grant [SU2C: AACR-DR22-17]; NCI/NIH [CA 181280-01]; Memorial Sloan Kettering Cancer Center Imaging and Radiation Sciences Program; K12 Paul Calebresi Career Development Award for Clinical Oncology [K12 CA184746]; NIH loan repayment program award (LRP); NATIONAL CANCER INSTITUTE [P30CA008748, K12CA184746, P01CA129243, K08CA230213] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [U54OD020355] Funding Source: NIH RePORTER	MSK Molecular Core Cytology Facility; NIH/NCI Cancer Center Support Grant; National Cancer Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); MSK Colorectal Cancer Research Center; American Society of Colon and Rectal Surgeons Career Development Award; Joel J. Roslyn Faculty Research Award; American Society of Colon and Rectal Surgeons Limited Project Grant; MSK Department of Surgery Junior Faculty Award; John Wasserman Colon and Rectal Cancer Fund; Colorectal Cancer Alliance; Chris4Life Research Award; Stand Up to Cancer (SU2C) Colorectal Cancer Dream Team Translational Research Grant; Stand Up to Cancer is a program of the Entertainment Industry Foundation; scientific partner of SU2C; NIH via the National Cancer Institute; Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Starr Cancer Consortium; American Cancer Society Postdoctoral Fellowship(American Cancer Society); AACR Basic Cancer Research Fellowship; Conquer Cancer Foundation of ASCO Young Investigator Award, Shulamit Katzman Endowed Postdoctoral Research Fellowship; SU2C Colorectal Cancer Dream Team Translational Research Grant; MSKCC Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Scientist Training Program grant from the National Institute of General Medical Sciences of the National Institutes of Health; Stand Up to Cancer Colorectal Cancer Dream Team Translational Research Grant; NCI/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Memorial Sloan Kettering Cancer Center Imaging and Radiation Sciences Program; K12 Paul Calebresi Career Development Award for Clinical Oncology; NIH loan repayment program award (LRP)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank our patients for giving consent and thereby allowing us access to their tissues for use in this study. We thank B. Carver for critical review of the manuscript as it developed. We thank A. Jungbluth for initial discussion on tissue fixation and immunostaining of the murine rectal tissues. We thank S. Chandarlapaty for discussions regarding the chemoresistance assays and cetuximab resistance assay. We thank L. Diaz for critical comments as this work developed. We thank N. Kemeny for advice, guidance and encouragement as this project developed. We thank N. Fan, S. Fujisawa, X. Liu, M. Turkekul, E. Chan and the Molecular Cytology Core for expert assistance and critical feedback in the design and execution of tissue embedding, immunostaining and processing of tissues, in addition to microscopy assistance. We thank the MSK Molecular Core Cytology Facility for critical technical assistance in performing tissue sections, immunohistochemical stains, scans and analysis (Institutional Core Grant Number P30CA008748). We thank R. Shah for initial discussions on set-up of the MSKIMPACT experiments. We thank H. Park and L. Lee for assistance with preparation and processing of tumor and tumoroid specimens for IHC and immunofluorescence. We thank P. Watson of Memorial Sloan Kettering for sharing the Ubc-eGFP-Luc vector. We thank M. Gonzalez and R. Andrade for their work curating patient tissue and slides for analyses. We also thank members of the Sawyers laboratory for critical review, lively discussion, and helpful comments on this work as it developed. In addition, we thank R. Beauchamp and J. Goldenring for constructive criticism and comments in the development and presentation of this work. The authors thank J. Novak of Memorial Sloan Kettering for editorial assistance. This work was supported in part by the NIH/NCI Cancer Center Support Grant P30 CA008748. Research reported in this publication was supported by the National Cancer Institute of the National Institutes of Health under Award Number R25CA020449. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. J.J.S. was supported by NIH/NCI grant 5R01-CA182551-04 and the MSK Colorectal Cancer Research Center. J.J.S. is also supported by the American Society of Colon and Rectal Surgeons Career Development Award, the Joel J. Roslyn Faculty Research Award, the American Society of Colon and Rectal Surgeons Limited Project Grant, the MSK Department of Surgery Junior Faculty Award and the John Wasserman Colon and Rectal Cancer Fund. J.J.S. is also supported by the Colorectal Cancer Alliance and the Chris4Life Research Award. The work was funded in part by a Stand Up to Cancer (SU2C) Colorectal Cancer Dream Team Translational Research Grant (Grant Number: SU2C: AACR-DR22-17) (J.J.S., A.C., L.E.D., K.G.). Stand Up to Cancer is a program of the Entertainment Industry Foundation. Research grants are administered by the American Association of Cancer Research, the scientific partner of SU2C. J.J.S. is partly supported by a loan repayment grant from the NIH via the National Cancer Institute for this work. J.J.S. is also supported in part by funding from the Howard Hughes Medical Institute via C.L.S.P.B.P and M.A. are funded in part by gifts from Corinne Berezuk, Michael Stieber, and Patrick A. Gerschel. C.L.S. is an investigator of the Howard Hughes Medical Institute.; This project was supported by National Institutes of Health grants CA155169, CA193837, CA224079, CA092629, CA160001, CA008748 and Starr Cancer Consortium grant I10-0062. K. G. was supported by National Institutes of Health grants K08-CA230213 and T32-CA009207, and by an American Cancer Society Postdoctoral Fellowship, AACR Basic Cancer Research Fellowship, Conquer Cancer Foundation of ASCO Young Investigator Award, Shulamit Katzman Endowed Postdoctoral Research Fellowship, and a SU2C Colorectal Cancer Dream Team Translational Research Grant (SU2C: AACR-DR22-17). J.M. is supported by National Institutes of Health grants CA94060 and CA12924, and by the MSKCC Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center. S.W.L., L.E.D. and K.P.O. are supported by grants from the NIH (U54 OD020355-01) and by the Starr Cancer Consortium (I8-A8-030). S.W.L. is an investigator of the Howard Hughes Medical Institute. K.P.O. was supported by an F30 Award from the NIH/NCI (1CA200110-01A1) and by a Medical Scientist Training Program grant from the National Institute of General Medical Sciences of the National Institutes of Health under award number T32GM07739 to the Weill CornellRockefeller-Sloan Kettering Tri-Institutional MD-PhD Program. L.E.D. is supported by a Stand Up to Cancer Colorectal Cancer Dream Team Translational Research Grant (Grant Number: SU2C: AACR-DR22-17) and was supported by a K22 Career Development Award from the NCI/NIH (CA 181280-01). P.B.R. is supported by the Memorial Sloan Kettering Cancer Center Imaging and Radiation Sciences Program. P.B.R. is also supported in part by a K12 Paul Calebresi Career Development Award for Clinical Oncology (K12 CA184746) and an NIH loan repayment program award (LRP).	Allegra CJ, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/djv248; Benson A. B., 2019, NCCN GUIDELINES VERS; Bonneville R, 2017, JCO PRECIS ONCOL, V1, DOI 10.1200/PO.17.00073; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Cercek A, 2014, J NATL COMPR CANC NE, V12, P513, DOI 10.6004/jnccn.2014.0056; Chakravarty Debyani, 2017, JCO Precis Oncol, V2017, DOI 10.1200/PO.17.00011; Ding PR, 2012, ANN SURG, V256, P111, DOI 10.1097/SLA.0b013e31825b3a2b; Dow LE, 2015, CELL, V161, P1539, DOI 10.1016/j.cell.2015.05.033; Emons G, 2017, MOL CANCER RES, V15, P1481, DOI 10.1158/1541-7786.MCR-17-0205; Fleming M, 2012, J GASTROINTEST ONCOL, V3, P153, DOI 10.3978/j.issn.2078-6891.2012.030; Fujii M, 2016, CELL STEM CELL, V18, P827, DOI 10.1016/j.stem.2016.04.003; Funakoshi K, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13402-3; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Gock M, 2018, WORLD J GASTROENTERO, V24, P4880, DOI 10.3748/wjg.v24.i43.4880; HEROLD KM, 1988, ONCOGENE, V3, P423; Kleiman LB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082982; Maas M, 2010, LANCET ONCOL, V11, P835, DOI 10.1016/S1470-2045(10)70172-8; Martens MH, 2016, JNCI-J NATL CANCER I, V108, DOI 10.1093/jnci/djw171; O'Rourke KP, 2017, NAT BIOTECHNOL, V35, P577, DOI 10.1038/nbt.3837; Park IJ, 2012, J CLIN ONCOL, V30, P1770, DOI 10.1200/JCO.2011.39.7901; Renehan AG, 2016, LANCET ONCOL, V17, P174, DOI 10.1016/S1470-2045(15)00467-2; Robinson SM, 2013, BRIT J CANCER, V109, P2396, DOI 10.1038/bjc.2013.604; Rodel C, 2015, LANCET ONCOL, V16, P979, DOI 10.1016/S1470-2045(15)00159-X; Rodel C, 2012, LANCET ONCOL, V13, P679, DOI 10.1016/S1470-2045(12)70187-0; Roerink SF, 2018, NATURE, V556, P457, DOI 10.1038/s41586-018-0024-3; Roper J, 2017, NAT BIOTECHNOL, V35, P569, DOI 10.1038/nbt.3836; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Sato T, 2011, GASTROENTEROLOGY, V141, P1762, DOI 10.1053/j.gastro.2011.07.050; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Schrag D, 2014, J CLIN ONCOL, V32, P513, DOI 10.1200/JCO.2013.51.7904; Shen RL, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkw520; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Smith J. J., 2015, 2015 GASTR CANC S, V6; Smith JJ, 2019, JAMA ONCOL, V5, DOI 10.1001/jamaoncol.2018.5896; Smith JJ, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1632-z; Smith JJ, 2015, J CLIN ONCOL, V33, P1797, DOI 10.1200/JCO.2014.60.1054; Van Cutsem E, 2009, NEW ENGL J MED, V360, P1408, DOI 10.1056/NEJMoa0805019; van de Wetering M, 2015, CELL, V161, P933, DOI 10.1016/j.cell.2015.03.053; van der Valk MJM, 2018, LANCET, V391, P2537, DOI 10.1016/S0140-6736(18)31078-X; Viera AJ, 2005, FAM MED, V37, P360; Vlachogiannis G, 2018, SCIENCE, V359, P920, DOI 10.1126/science.aao2774; Walker JA, 2004, GENOMICS, V83, P518, DOI 10.1016/j.ygeno.2003.09.003; Weeber F, 2015, P NATL ACAD SCI USA, V112, P13308, DOI 10.1073/pnas.1516689112; Yarilin D, 2015, SCI REP-UK, V5, DOI 10.1038/srep09534; Ye XY, 2016, MOLECULES, V21, DOI 10.3390/molecules21101347; Zehir A, 2017, NAT MED, V23, P703, DOI 10.1038/nm.4333	46	192	198	9	60	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	OCT	2019	25	10					1607	+		10.1038/s41591-019-0584-2	http://dx.doi.org/10.1038/s41591-019-0584-2			22	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	JC3GJ	31591597	Green Accepted			2022-12-27	WOS:000489166700030
J	Corcoran, RB				Corcoran, Ryan B.			Liquid biopsy versus tumor biopsy for clinical-trial recruitment	NATURE MEDICINE			English	Editorial Material							DNA ANALYSIS; THERAPY	Studies demonstrate the efficacy of screening by liquid biopsy for enrollment in clinical trials of precision cancer therapy.	[Corcoran, Ryan B.] Harvard Med Sch, Massachusetts Gen Hosp, Ctr Canc, Boston, MA 02115 USA; [Corcoran, Ryan B.] Harvard Med Sch, Dept Med, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School	Corcoran, RB (corresponding author), Harvard Med Sch, Massachusetts Gen Hosp, Ctr Canc, Boston, MA 02115 USA.; Corcoran, RB (corresponding author), Harvard Med Sch, Dept Med, Boston, MA 02115 USA.	rbcorcoran@partners.org						Corcoran RB, 2018, NEW ENGL J MED, V379, P1754, DOI 10.1056/NEJMra1706174; Kurtz DM, 2018, J CLIN ONCOL, V36, P2845, DOI 10.1200/JCO.2018.78.5246; Leighl NB, 2019, CLIN CANCER RES, V25, P4691, DOI 10.1158/1078-0432.CCR-19-0624; Lennon AM, 2020, SCIENCE, V369, P49, DOI 10.1126/science.abb9601; Liu MC, 2020, ANN ONCOL, V31, P745, DOI 10.1016/j.annonc.2020.02.011; Nakamura Y, 2020, NAT MED, V26, DOI 10.1038/s41591-020-1063-5; Parikh AR, 2020, CLIN CANCER RES, V26, P1877, DOI 10.1158/1078-0432.CCR-19-3467; Parikh AR, 2019, NAT MED, V25, P1415, DOI 10.1038/s41591-019-0561-9; Reinert T, 2019, JAMA ONCOL, V5, P1124, DOI 10.1001/jamaoncol.2019.0528; Siravegna G, 2019, ANN ONCOL, V30, P1580, DOI 10.1093/annonc/mdz227; Tie J, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf6219; Turner NC, 2020, LANCET ONCOL, V21, P1296, DOI [10.11016/S1470-2045(20)30444-7, 10.1016/S1470-2045(20)30444-7]	12	17	17	1	14	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	2020	26	12					1815	1816		10.1038/s41591-020-01169-6	http://dx.doi.org/10.1038/s41591-020-01169-6		NOV 2020	2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	PB8QO	33230339				2022-12-27	WOS:000591980700001
J	Reiner, RC; Barber, RM; Collins, JK; Zheng, P; Adolph, C; Albright, J; Antony, CM; Aravkin, AY; Bachmeier, SD; Bang-Jensen, B; Bannick, MS; Bloom, S; Carter, A; Castro, E; Causey, K; Chakrabarti, S; Charlson, FJ; Cogen, RM; Combs, E; Dai, XC; Dangel, WJ; Earl, L; Ewald, SB; Ezalarab, M; Ferrari, AJ; Flaxman, A; Frostad, JJ; Fullman, N; Gakidou, E; Gallagher, J; Glenn, SD; Goosmann, EA; He, JW; Henry, NJ; Hulland, EN; Hurst, B; Johanns, C; Kendrick, PJ; Khemani, A; Larson, SL; Lazzar-Atwood, A; LeGrand, KE; Lescinsky, H; Lindstrom, A; Linebarger, E; Lozano, R; Ma, R; Mansson, J; Magistro, B; Herrera, AMM; Marczak, LB; Miller-Petrie, MK; Mokdad, AH; Morgan, JD; Naik, P; Odell, CM; O'Halloran, JK; Osgood-Zimmerman, AE; Ostroff, SM; Pasovic, M; Penberthy, L; Phipps, G; Pigott, DM; Pollock, I; Ramshaw, RE; Redford, SB; Reinke, G; Rolfe, S; Santomauro, DF; Shackleton, JR; Shaw, DH; Sheena, BS; Sholokhov, A; Sorensen, RJD; Sparks, G; Spurlock, EE; Subart, ML; Syailendrawati, R; Torre, AE; Troeger, CE; Vos, T; Watson, A; Watson, S; Wiens, KE; Woyczynski, L; Xu, LM; Zhang, JZ; Hay, SI; Lim, SS; Murray, CJL				Reiner, Robert C., Jr.; Barber, Ryan M.; Collins, James K.; Zheng, Peng; Adolph, Christopher; Albright, James; Antony, Catherine M.; Aravkin, Aleksandr Y.; Bachmeier, Steven D.; Bang-Jensen, Bree; Bannick, Marlena S.; Bloom, Sabina; Carter, Austin; Castro, Emma; Causey, Kate; Chakrabarti, Suman; Charlson, Fiona J.; Cogen, Rebecca M.; Combs, Emily; Dai, Xiaochen; Dangel, William James; Earl, Lucas; Ewald, Samuel B.; Ezalarab, Maha; Ferrari, Alize J.; Flaxman, Abraham; Frostad, Joseph Jon; Fullman, Nancy; Gakidou, Emmanuela; Gallagher, John; Glenn, Scott D.; Goosmann, Erik A.; He, Jiawei; Henry, Nathaniel J.; Hulland, Erin N.; Hurst, Benjamin; Johanns, Casey; Kendrick, Parkes J.; Khemani, Apurva; Larson, Samantha Leigh; Lazzar-Atwood, Alice; LeGrand, Kate E.; Lescinsky, Haley; Lindstrom, Akiaja; Linebarger, Emily; Lozano, Rafael; Ma, Rui; Mansson, Johan; Magistro, Beatrice; Herrera, Ana M. Mantilla; Marczak, Laurie B.; Miller-Petrie, Molly K.; Mokdad, Ali H.; Morgan, Julia Deryn; Naik, Paulami; Odell, Christopher M.; O'Halloran, James K.; Osgood-Zimmerman, Aaron E.; Ostroff, Samuel M.; Pasovic, Maja; Penberthy, Louise; Phipps, Geoffrey; Pigott, David M.; Pollock, Ian; Ramshaw, Rebecca E.; Redford, Sofia Boston; Reinke, Grace; Rolfe, Sam; Santomauro, Damian Francesco; Shackleton, John R.; Shaw, David H.; Sheena, Brittney S.; Sholokhov, Aleksei; Sorensen, Reed J. D.; Sparks, Gianna; Spurlock, Emma Elizabeth; Subart, Michelle L.; Syailendrawati, Ruri; Torre, Anna E.; Troeger, Christopher E.; Vos, Theo; Watson, Alexandrea; Watson, Stefanie; Wiens, Kirsten E.; Woyczynski, Lauren; Xu, Liming; Zhang, Jize; Hay, Simon I.; Lim, Stephen S.; Murray, Christopher J. L.		IHME Covid 19 Forecasting Team	Modeling COVID-19 scenarios for the United States	NATURE MEDICINE			English	Article							MORTALITY; PNEUMONIA; ALTITUDE; OUTBREAK; IMPACT	We use COVID-19 case and mortality data from 1 February 2020 to 21 September 2020 and a deterministic SEIR (susceptible, exposed, infectious and recovered) compartmental framework to model possible trajectories of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections and the effects of non-pharmaceutical interventions in the United States at the state level from 22 September 2020 through 28 February 2021. Using this SEIR model, and projections of critical driving covariates (pneumonia seasonality, mobility, testing rates and mask use per capita), we assessed scenarios of social distancing mandates and levels of mask use. Projections of current non-pharmaceutical intervention strategies by state-with social distancing mandates reinstated when a threshold of 8 deaths per million population is exceeded (reference scenario)-suggest that, cumulatively, 511,373 (469,578-578,347) lives could be lost to COVID-19 across the United States by 28 February 2021. We find that achieving universal mask use (95% mask use in public) could be sufficient to ameliorate the worst effects of epidemic resurgences in many states. Universal mask use could save an additional 129,574 (85,284-170,867) lives from September 22, 2020 through the end of February 2021, or an additional 95,814 (60,731-133,077) lives assuming a lesser adoption of mask wearing (85%), when compared to the reference scenario. A modeling study using case and mortality data from the first 8 months of the COVID-19 pandemic in the United States explores five potential future scenarios of social distancing mandates and mask use at the state level, with projections of the course of the epidemic through winter 2021.	[Reiner, Robert C., Jr.; Barber, Ryan M.; Collins, James K.; Zheng, Peng; Albright, James; Antony, Catherine M.; Aravkin, Aleksandr Y.; Bachmeier, Steven D.; Bannick, Marlena S.; Bloom, Sabina; Carter, Austin; Castro, Emma; Causey, Kate; Chakrabarti, Suman; Charlson, Fiona J.; Cogen, Rebecca M.; Combs, Emily; Dai, Xiaochen; Dangel, William James; Earl, Lucas; Ewald, Samuel B.; Ezalarab, Maha; Ferrari, Alize J.; Flaxman, Abraham; Frostad, Joseph Jon; Fullman, Nancy; Gakidou, Emmanuela; Gallagher, John; Glenn, Scott D.; Goosmann, Erik A.; He, Jiawei; Henry, Nathaniel J.; Hulland, Erin N.; Hurst, Benjamin; Johanns, Casey; Kendrick, Parkes J.; Larson, Samantha Leigh; Lazzar-Atwood, Alice; LeGrand, Kate E.; Lescinsky, Haley; Linebarger, Emily; Lozano, Rafael; Ma, Rui; Mansson, Johan; Herrera, Ana M. Mantilla; Marczak, Laurie B.; Miller-Petrie, Molly K.; Mokdad, Ali H.; Morgan, Julia Deryn; Naik, Paulami; Odell, Christopher M.; O'Halloran, James K.; Osgood-Zimmerman, Aaron E.; Ostroff, Samuel M.; Pasovic, Maja; Penberthy, Louise; Phipps, Geoffrey; Pigott, David M.; Pollock, Ian; Ramshaw, Rebecca E.; Redford, Sofia Boston; Rolfe, Sam; Santomauro, Damian Francesco; Shackleton, John R.; Shaw, David H.; Sheena, Brittney S.; Sholokhov, Aleksei; Sorensen, Reed J. D.; Sparks, Gianna; Spurlock, Emma Elizabeth; Subart, Michelle L.; Syailendrawati, Ruri; Torre, Anna E.; Troeger, Christopher E.; Vos, Theo; Watson, Alexandrea; Watson, Stefanie; Wiens, Kirsten E.; Woyczynski, Lauren; Xu, Liming; Zhang, Jize; Hay, Simon I.; Lim, Stephen S.; Murray, Christopher J. L.] Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA 98195 USA; [Reiner, Robert C., Jr.; Aravkin, Aleksandr Y.; Flaxman, Abraham; Gakidou, Emmanuela; Lozano, Rafael; Mokdad, Ali H.; Pigott, David M.; Vos, Theo; Hay, Simon I.; Lim, Stephen S.; Murray, Christopher J. L.] Univ Washington, Sch Med, Dept Hlth Metr Sci, Seattle, WA 98195 USA; [Adolph, Christopher; Bang-Jensen, Bree; Magistro, Beatrice; Reinke, Grace] Univ Washington, Dept Polit Sci, Seattle, WA 98195 USA; [Adolph, Christopher] Univ Washington, Ctr Stat & Social Sci, Seattle, WA 98195 USA; [Aravkin, Aleksandr Y.] Univ Washington, Dept Appl Math, Seattle, WA 98195 USA; [Charlson, Fiona J.] Univ Queensland, Queensland Ctr Mental Hlth Res, Brisbane, Qld, Australia; [Ferrari, Alize J.; Lindstrom, Akiaja; Herrera, Ana M. Mantilla; Santomauro, Damian Francesco] Univ Queensland, Sch Publ Hlth, Brisbane, Qld, Australia; [Ferrari, Alize J.; Khemani, Apurva; Lindstrom, Akiaja; Herrera, Ana M. Mantilla] Queensland Ctr Mental Hlth Res, Brisbane, Qld, Australia; [Henry, Nathaniel J.] Univ Oxford, Big Data Inst, Oxford, England; [Hulland, Erin N.; Sorensen, Reed J. D.] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA; [Khemani, Apurva] QIMR Berghofer Med Res Inst, Brisbane, Qld, Australia; [Ostroff, Samuel M.] Univ Washington, Henry M Jackson Sch Int Studies, Seattle, WA 98195 USA; [Santomauro, Damian Francesco] Queensland Ctr Mental Hlth Res, Policy & Epidemiol Grp, Brisbane, Qld, Australia	Institute for Health Metrics & Evaluation; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Queensland Centre for Mental Health Research; University of Queensland; University of Queensland; Queensland Centre for Mental Health Research; University of Oxford; University of Washington; University of Washington Seattle; QIMR Berghofer Medical Research Institute; University of Washington; University of Washington Seattle; Queensland Centre for Mental Health Research	Hay, SI (corresponding author), Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA 98195 USA.; Hay, SI (corresponding author), Univ Washington, Sch Med, Dept Hlth Metr Sci, Seattle, WA 98195 USA.	sihay@uw.edu	Mokdad, Ali H./AAD-1232-2022; Hay, Simon Iain/F-8967-2015; Dai, Xiaochen/ABG-4201-2020; Ferrari, Alize J/G-1746-2011; Chakrabarti, Suman/AAY-1792-2021; ., ./AAK-8908-2021; Charlson, Fiona/R-8963-2019; Lozano, Rafael/T-5352-2018	Mokdad, Ali H./0000-0002-4994-3339; Hay, Simon Iain/0000-0002-0611-7272; Dai, Xiaochen/0000-0002-0289-7814; Ferrari, Alize J/0000-0002-7863-9117; Chakrabarti, Suman/0000-0002-5078-2173; ., ./0000-0002-6002-3031; Charlson, Fiona/0000-0003-2876-5040; Lozano, Rafael/0000-0002-7356-8823; Hulland, Erin/0000-0003-0525-1856; LINDSTROM, Akiaja/0000-0002-4029-0108; Adolph, Christopher/0000-0001-8550-6438; Marczak, Laurie/0000-0001-5979-4261; Wiens, Kirsten E./0000-0003-4093-4054	Bill AMP; Melinda Gates Foundation; state of Washington; National Science Foundation [FAIN: 2031096]	Bill AMP; Melinda Gates Foundation(CGIAR); state of Washington; National Science Foundation(National Science Foundation (NSF))	We thank the various Departments of Health and frontline health professionals who are not only responding to this epidemic daily, but also providing the necessary data to inform this work. IHME warmly acknowledges the support of these and others (http://www.healthdata.org/covid/acknowledgements/) who have made our COVID19 estimation efforts possible. The authors are also grateful to B. Bell for insightful discussions about methodology. This work was supported by the Bill & Melinda Gates Foundation, as well as funding from the state of Washington and the National Science Foundation (award no. FAIN: 2031096) with partial funds awarded to R.C.R., A.Y.A. and S.D.B. We also extend a note of particular thanks to J. Stanton and J. Nordstrom for their generous support.	Abbafati C, 2020, LANCET, V396, P1204, DOI 10.1016/S0140-6736(20)30925-9; Adolph C, 2021, J HEALTH POLIT POLIC, V46, P211, DOI 10.1215/03616878-8802162; Ainslie Kylie E C, 2020, Wellcome Open Res, V5, P81, DOI 10.12688/wellcomeopenres.15843.1; Andersen KG, 2020, NAT MED, V26, P450, DOI 10.1038/s41591-020-0820-9; Anderson RM, 2020, LANCET, V395, P931, DOI 10.1016/S0140-6736(20)30567-5; [Anonymous], 2020, NEW ENGL J MED, V383, P1479, DOI 10.1056/NEJMe2029812; Bar-Zeev N, 2020, LANCET, V396, P448, DOI 10.1016/S0140-6736(20)31611-1; Beigel JH, 2020, NEW ENGL J MED, V383, P1813, DOI 10.1056/NEJMoa2007764; Bjornstad ON, 2020, NAT METHODS, V17, P557, DOI 10.1038/s41592-020-0856-2; Bjornstad ON, 2020, NAT METHODS, V17, P455, DOI 10.1038/s41592-020-0822-z; Boulware DR, 2020, NEW ENGL J MED, V383, P517, DOI 10.1056/NEJMoa2016638; Callaway E, 2020, NATURE, V581, P363, DOI 10.1038/d41586-020-01092-3; Chu DK, 2020, LANCET, V395, P1973, DOI 10.1016/S0140-6736(20)31142-9; Cintron-Arias A, 2009, MATH BIOSCI ENG, V6, P261, DOI 10.3934/mbe.2009.6.261; Fine P, 2011, CLIN INFECT DIS, V52, P911, DOI 10.1093/cid/cir007; Flaxman S, 2020, NATURE, V584, P257, DOI 10.1038/s41586-020-2405-7; Folegatti PM, 2020, LANCET, V396, P467, DOI 10.1016/S0140-6736(20)31604-4; Friedman Joseph, 2020, medRxiv, DOI 10.1101/2020.07.13.20151233; GBD 2019 Diseases Injuries and Impairments Collaborators, LANCET; GBD 2019 Population and Fertility Collaborators, LANCET; Horton R., 2020, COVID 19 CATASTROPHE; IHME COVID-19 Forecasting Team, 2020, GLOB PROJ POT LIV SA, DOI [10.1101/2020.10.08.20209510, DOI 10.1101/2020.10.08.20209510]; Khan AJ, 2009, B WORLD HEALTH ORGAN, V87, P193, DOI 10.2471/BLT.07.048264; Killerby ME, 2018, J CLIN VIROL, V101, P52, DOI 10.1016/j.jcv.2018.01.019; Kissler SM, 2020, SCIENCE, V368, P860, DOI 10.1126/science.abb5793; Lasry A, 2020, MMWR-MORBID MORTAL W, V69, P451, DOI 10.15585/mmwr.mm6915e2; Lauer SA, 2020, ANN INTERN MED, V172, P577, DOI 10.7326/M20-0504; Leung NHL, 2020, NAT MED, V26, P676, DOI 10.1038/s41591-020-0843-2; Liang MM, 2020, TRAVEL MED INFECT DI, V36, DOI 10.1016/j.tmaid.2020.101751; Lopez L, 2020, NAT HUM BEHAV, V4, P746, DOI 10.1038/s41562-020-0908-8; Lyu W, 2020, HEALTH AFFAIR, V39, P1419, DOI 10.1377/hlthaff.2020.00818; Mckee M, 2020, NAT MED, V26, P640, DOI 10.1038/s41591-020-0863-y; Miller IF, 2020, NAT MED, V26, P1212, DOI 10.1038/s41591-020-0952-y; Ngonghala CN, 2020, MATH BIOSCI, V325, DOI 10.1016/j.mbs.2020.108364; Peak CM, 2017, P NATL ACAD SCI USA, V114, P4023, DOI 10.1073/pnas.1616438114; Perez-Padilla R, 2004, INT J TUBERC LUNG D, V8, P1315; Perez-Padilla R, 2013, SALUD PUBLICA MEXICO, V55, P92, DOI 10.1590/S0036-36342013000100013; Pollan M, 2020, LANCET, V396, P535, DOI 10.1016/S0140-6736(20)31483-5; Shaman J, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000316; Troeger C, 2018, LANCET INFECT DIS, V18, P1191, DOI 10.1016/S1473-3099(18)30310-4; Troeger CE, 2020, LANCET INFECT DIS, V20, P60, DOI 10.1016/S1473-3099(19)30410-4; Wang J., HIGH TEMPERATURE HIG; Wang YM, 2020, LANCET, V395, P1569, DOI 10.1016/S0140-6736(20)31022-9; Wang Y, 2020, BMJ GLOB HEALTH, V5, DOI 10.1136/bmjgh-2020-002794; WHO, 2020, WHO COR COVID 19 DAS; World Health Organization, 2021, NOV COR 2019 NCOV SI; Xu B, 2020, SCI DATA, V7, DOI 10.1038/s41597-020-0448-0; Xu B, 2020, LANCET INFECT DIS, V20, P534, DOI 10.1016/S1473-3099(20)30119-5; Zheng P., 2019, TRIMMED CONSTRAINED; Zhu FC, 2020, LANCET, V396, P479, DOI 10.1016/S0140-6736(20)31605-6	50	195	196	12	47	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	JAN	2021	27	1					94	+		10.1038/s41591-020-1132-9	http://dx.doi.org/10.1038/s41591-020-1132-9		OCT 2020	27	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	PS4ZO	33097835	Green Accepted, hybrid, Green Published			2022-12-27	WOS:000583452800001
J	Hoertel, N; Blachier, M; Blanco, C; Olfson, M; Massetti, M; Rico, MS; Limosin, F; Leleu, H				Hoertel, Nicolas; Blachier, Martin; Blanco, Carlos; Olfson, Mark; Massetti, Marc; Sanchez Rico, Marina; Limosin, Frederic; Leleu, Henri			A stochastic agent-based model of the SARS-CoV-2 epidemic in France	NATURE MEDICINE			English	Article								Many European countries have responded to the COVID-19 pandemic by implementing nationwide protection measures and lockdowns(1). However, the epidemic could rebound when such measures are relaxed, possibly leading to a requirement for a second or more, repeated lockdowns(2). Here, we present results of a stochastic agent-based microsimulation model of the COVID-19 epidemic in France. We examined the potential impact of post-lockdown measures, including physical distancing, mask-wearing and shielding individuals who are the most vulnerable to severe COVID-19 infection, on cumulative disease incidence and mortality, and on intensive care unit (ICU)-bed occupancy. While lockdown is effective in containing the viral spread, once lifted, regardless of duration, it would be unlikely to prevent a rebound. Both physical distancing and mask-wearing, although effective in slowing the epidemic and in reducing mortality, would also be ineffective in ultimately preventing ICUs from becoming overwhelmed and a subsequent second lockdown. However, these measures coupled with the shielding of vulnerable people would be associated with better outcomes, including lower mortality and maintaining an adequate ICU capacity to prevent a second lockdown. Benefits would nonetheless be markedly reduced if most people do not adhere to these measures, or if they are not maintained for a sufficiently long period. A new study that models the COVID-19 epidemic in France suggests that although a second peak is likely unavoidable, maintaining social distancing and wearing masks when lockdown restrictions are lifted, as well as continuing to shelter vulnerable individuals, will reduce mortality and avoid overwhelming ICU facilities.	[Hoertel, Nicolas; Sanchez Rico, Marina; Limosin, Frederic] Corentin Celton Hosp, AP HP Ctr, DMU Psychiat & Addictol, Issy Les Moulineaux, France; [Hoertel, Nicolas; Limosin, Frederic] INSERM U1266, Paris, France; [Hoertel, Nicolas; Limosin, Frederic] Paris Univ, Paris, France; [Blachier, Martin; Massetti, Marc; Leleu, Henri] Publ Hlth Expertise, Paris, France; [Blanco, Carlos] NIDA, Bethesda, MD 20892 USA; [Olfson, Mark] Columbia Univ, New York State Psychiat Inst, New York, NY USA; [Sanchez Rico, Marina] Univ Complutense Madrid, Campus Somosaguas, Pozuelo De Alarcon, Spain	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Corentin-Celton - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; National Institutes of Health (NIH) - USA; NIH National Institute on Drug Abuse (NIDA); Columbia University; New York State Psychiatry Institute; Complutense University of Madrid	Hoertel, N (corresponding author), Corentin Celton Hosp, AP HP Ctr, DMU Psychiat & Addictol, Issy Les Moulineaux, France.; Hoertel, N (corresponding author), INSERM U1266, Paris, France.; Hoertel, N (corresponding author), Paris Univ, Paris, France.	nico.hoertel@yahoo.fr	Olfson, Mark/AAA-8547-2021; , Hoertel/H-9457-2015	, Hoertel/0000-0002-7890-1349; Sanchez-Rico, Marina/0000-0002-1121-8641				Adam D, 2020, NATURE, V580, P316, DOI 10.1038/d41586-020-01003-6; Ai T, 2020, RADIOLOGY, V296, pE32, DOI 10.1148/radiol.2020200642; Anderson RM, 2020, LANCET, V395, P931, DOI 10.1016/S0140-6736(20)30567-5; Baker RE, 2020, SCIENCE, V369, P315, DOI 10.1126/science.abc2535; Bootsma MCJ, 2007, P NATL ACAD SCI USA, V104, P7588, DOI 10.1073/pnas.0611071104; Brooks Samantha K, 2020, Lancet, V395, P912, DOI 10.1016/S0140-6736(20)30460-8; Cheng KK, 2022, LANCET, V399, pE39, DOI 10.1016/S0140-6736(20)30918-1; Chevance A, 2020, ENCEPHALE, V46, P193, DOI 10.1016/j.encep.2020.04.005; Epstein JM, 2009, NATURE, V460, P687, DOI 10.1038/460687a; Eubank S, 2004, NATURE, V429, P180, DOI 10.1038/nature02541; Gilbert E, 2010, AM BEHAV SCI, V53, P1367, DOI 10.1177/0002764210361690; Hoertel Nicolas, 2020, medRxiv, DOI 10.1101/2020.04.23.20076885; Iacopini I, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10431-6; Jewell NP, 2020, JAMA-J AM MED ASSOC, V323, P1893, DOI 10.1001/jama.2020.6585; John TJ, 2000, EUR J EPIDEMIOL, V16, P601, DOI 10.1023/A:1007626510002; Kissler SM, 2020, SCIENCE, V368, P860, DOI 10.1126/science.abb5793; Kucharski AJ, 2020, LANCET INFECT DIS, V20, P553, DOI 10.1016/S1473-3099(20)30144-4; Liang MM, 2020, TRAVEL MED INFECT DI, V36, DOI 10.1016/j.tmaid.2020.101751; Liu Y, 2020, J TRAVEL MED, V27, DOI 10.1093/jtm/taaa021; Nicola M, 2020, INT J SURG, V78, P185, DOI 10.1016/j.ijsu.2020.04.018; Perez L, 2009, INT J HEALTH GEOGR, V8, DOI 10.1186/1476-072X-8-50; Petri G, 2018, PHYS REV LETT, V121, DOI 10.1103/PhysRevLett.121.228301; Riley S, 2007, SCIENCE, V316, P1298, DOI 10.1126/science.1134695; Salje H, 2020, SCIENCE, V369, P208, DOI 10.1126/science.abc3517; Venkatramanan S, 2018, EPIDEMICS-NETH, V22, P43, DOI 10.1016/j.epidem.2017.02.010; Williamson E, 2020, MEDRXIV, V7, P1, DOI [10.1101/2020.05.06.20092999v1, 10.1101/2020.05.06.20092999]	26	123	125	6	32	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	SEP	2020	26	9								10.1038/s41591-020-1001-6	http://dx.doi.org/10.1038/s41591-020-1001-6		JUL 2020	16	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	PF3EM	32665655	Bronze			2022-12-27	WOS:000548473800001
J	Izar, B; Tirosh, I; Stover, EH; Wakiro, I; Cuoco, MS; Alter, I; Rodman, C; Leeson, R; Su, MJ; Shah, P; Iwanicki, M; Walker, SR; Kanodia, A; Melms, JC; Mei, SL; Lin, JR; Porter, CBM; Slyper, M; Waldman, J; Jerby-Arnon, L; Ashenberg, O; Brinker, TJ; Mills, C; Rogava, M; Vigneau, S; Sorger, PK; Garraway, LA; Konstantinopoulos, PA; Liu, JF; Matulonis, U; Johnson, BE; Rozenblatt-Rosen, O; Rotem, A; Regev, A				Izar, Benjamin; Tirosh, Itay; Stover, Elizabeth H.; Wakiro, Isaac; Cuoco, Michael S.; Alter, Idan; Rodman, Christopher; Leeson, Rachel; Su, Mei-Ju; Shah, Parin; Iwanicki, Marcin; Walker, Sarah R.; Kanodia, Abhay; Melms, Johannes C.; Mei, Shaolin; Lin, Jia-Ren; Porter, Caroline B. M.; Slyper, Michal; Waldman, Julia; Jerby-Arnon, Livnat; Ashenberg, Orr; Brinker, Titus J.; Mills, Caitlin; Rogava, Meri; Vigneau, Sebastien; Sorger, Peter K.; Garraway, Levi A.; Konstantinopoulos, Panagiotis A.; Liu, Joyce F.; Matulonis, Ursula; Johnson, Bruce E.; Rozenblatt-Rosen, Orit; Rotem, Asaf; Regev, Aviv			A single-cell landscape of high-grade serous ovarian cancer	NATURE MEDICINE			English	Article							HETEROGENEITY; DRUG; FIBROBLASTS	Malignant abdominal fluid (ascites) frequently develops in women with advanced high-grade serous ovarian cancer (HGSOC) and is associated with drug resistance and a poor prognosis(1). To comprehensively characterize the HGSOC ascites ecosystem, we used single-cell RNA sequencing to profile similar to 11,000 cells from 22 ascites specimens from 11 patients with HGSOC. We found significant inter-patient variability in the composition and functional programs of ascites cells, including immunomodulatory fibroblast sub-populations and dichotomous macrophage populations. We found that the previously described immunoreactive and mesenchymal subtypes of HGSOC, which have prognostic implications, reflect the abundance of immune infiltrates and fibroblasts rather than distinct subsets of malignant cells(2). Malignant cell variability was partly explained by heterogeneous copy number alteration patterns or expression of a stemness program. Malignant cells shared expression of inflammatory programs that were largely recapitulated in single-cell RNA sequencing of similar to 35,000 cells from additionally collected samples, including three ascites, two primary HGSOC tumors and three patient ascites-derived xenograft models. Inhibition of the JAK/STAT pathway, which was expressed in both malignant cells and cancer-associated fibroblasts, had potent anti-tumor activity in primary short-term cultures and patient-derived xenograft models. Our work contributes to resolving the HSGOC landscape(3-5)and provides a resource for the development of novel therapeutic approaches. Single-cell transcriptomics analysis of malignant ascites samples from patients with high-grade serous ovarian cancer reveals inter- and intra-patient heterogeneity in malignant cells, cancer-associated fibroblasts and macrophages.	[Izar, Benjamin; Stover, Elizabeth H.; Wakiro, Isaac; Leeson, Rachel; Su, Mei-Ju; Shah, Parin; Kanodia, Abhay; Melms, Johannes C.; Vigneau, Sebastien; Konstantinopoulos, Panagiotis A.; Liu, Joyce F.; Matulonis, Ursula; Johnson, Bruce E.; Rotem, Asaf] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Izar, Benjamin; Vigneau, Sebastien; Johnson, Bruce E.; Rotem, Asaf] Dana Farber Canc Inst, Ctr Canc Genom, Boston, MA 02115 USA; [Izar, Benjamin; Cuoco, Michael S.; Rodman, Christopher; Porter, Caroline B. M.; Slyper, Michal; Waldman, Julia; Jerby-Arnon, Livnat; Ashenberg, Orr; Rozenblatt-Rosen, Orit; Rotem, Asaf; Regev, Aviv] Broad Inst MIT & Harvard, Klarman Cell Observ, Cambridge, MA 02142 USA; [Izar, Benjamin] Ludwig Ctr Canc Res Harvard, Boston, MA USA; [Izar, Benjamin; Su, Mei-Ju; Mei, Shaolin; Lin, Jia-Ren; Mills, Caitlin; Rogava, Meri; Sorger, Peter K.] Harvard Med Sch, Lab Syst Pharmacol, Boston, MA 02115 USA; [Tirosh, Itay; Alter, Idan] Weizmann Inst Sci, Dept Mol Cell Biol, Rehovot, Israel; [Iwanicki, Marcin] Stevens Inst Technol, Chem & Chem Biol, Hoboken, NJ 07030 USA; [Walker, Sarah R.] Univ New Hampshire, Coll Life Sci & Agr, Mol Cellular & Biomed Sci, Durham, NH 03824 USA; [Brinker, Titus J.] German Canc Res Ctr, Heidelberg, Germany; [Garraway, Levi A.] Genentech Inc, San Francisco, CA USA; [Regev, Aviv] MIT, Dept Biol, Cambridge, MA 02139 USA; [Regev, Aviv] MIT, Ludwig Ctr Canc Res, Boston, MA 02115 USA; [Regev, Aviv] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA; [Izar, Benjamin] Columbia Univ, Med Ctr, Columbia Ctr Translat Immunol, New York, NY USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard Medical School; Weizmann Institute of Science; Stevens Institute of Technology; University System Of New Hampshire; University of New Hampshire; Helmholtz Association; German Cancer Research Center (DKFZ); Roche Holding; Genentech; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute; Columbia University	Regev, A (corresponding author), Broad Inst MIT & Harvard, Klarman Cell Observ, Cambridge, MA 02142 USA.; Regev, A (corresponding author), MIT, Dept Biol, Cambridge, MA 02139 USA.; Regev, A (corresponding author), MIT, Ludwig Ctr Canc Res, Boston, MA 02115 USA.; Regev, A (corresponding author), Howard Hughes Med Inst, Chevy Chase, MD 20815 USA.	itay.tirosh@weizmann.ac.il; aregev@broadinstitute.org	Shah, Parin/J-6018-2019; Rozenblatt-Rosen, Orit/HDN-4182-2022; Stover, Elizabeth/GYD-3476-2022	Shah, Parin/0000-0003-4648-7830; Kanodia, Abhay Rajkumar/0000-0002-7645-002X; Waldman, Julia/0000-0002-0584-5833; Cuoco, Michael/0000-0003-2163-5120; Mei, Shaolin/0000-0002-2193-764X; Melms, Johannes/0000-0002-5410-6586	Marsha Rivkin Scientific Scholar Award; Susan F. Smith Center for Women's Cancers Cancer Research Award; Wong Family Award for Translational Cancer Research; Ludwig Center for Cancer Research at Harvard; Ludwig Center for Cancer Research at MIT; Burroughs Wellcome Fund Career Award for Medical Scientists; Dana-Farber Cancer Institute Claudia Adams Barr Program for Innovative Cancer Research; National Cancer Institute [K08CA222663, U54CA225088]; Israel Cancer Research Fund; STARR Cancer Consortium; Human Frontier Science Program; Mexican Friends New Generation; Benoziyo Endowment Fund for the Advancement of Science; Koch Institute Support (core) grant from the National Cancer Institute [P30CA14051]; Klarman Cell Observatory;  [R33-CA202820]	Marsha Rivkin Scientific Scholar Award; Susan F. Smith Center for Women's Cancers Cancer Research Award; Wong Family Award for Translational Cancer Research; Ludwig Center for Cancer Research at Harvard; Ludwig Center for Cancer Research at MIT; Burroughs Wellcome Fund Career Award for Medical Scientists(Burroughs Wellcome Fund); Dana-Farber Cancer Institute Claudia Adams Barr Program for Innovative Cancer Research; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Israel Cancer Research Fund; STARR Cancer Consortium; Human Frontier Science Program(Human Frontier Science Program); Mexican Friends New Generation; Benoziyo Endowment Fund for the Advancement of Science; Koch Institute Support (core) grant from the National Cancer Institute; Klarman Cell Observatory; 	We thank the patients and their families. We also thank: L. MacDonald, A. McKelvey, J. Gelissen, J. Jacob, L. Frackiewicz, L. Dellostritto, K. Helvie and N. Straub from the Division of Gynecologic Oncology and the Center for Cancer Genomics at the Dana-Farber Cancer Institute for coordinating the clinical samples; members of the Belfer Center for Applied Cancer Science at the Dana-Farber Cancer Institute (particularly S. Palakurthi and P. Kirschmeier) for assistance with the PDX experiments; Jennifer Guerriero for helpful discussions; and L. Gaffney for help with the artwork. This work was supported by a Marsha Rivkin Scientific Scholar Award (to B.I. and E.H.S.), a Susan F. Smith Center for Women's Cancers Cancer Research Award (to B.I. and E.H.S.), the Wong Family Award for Translational Cancer Research (to B.I.), the Ludwig Center for Cancer Research at Harvard (to B.I.) and at MIT (to A.Regev), the Burroughs Wellcome Fund Career Award for Medical Scientists (to B.I.), the Dana-Farber Cancer Institute Claudia Adams Barr Program for Innovative Cancer Research (to B.I.), K08CA222663 from the National Cancer Institute (to B.I.), the Israel Cancer Research Fund (to I.T.), the STARR Cancer Consortium (to I.T. and A.Regev), the Human Frontier Science Program (to I.T.), the Mexican Friends New Generation (to I.T.), the Benoziyo Endowment Fund for the Advancement of Science (to I.T.), grant U54CA225088 from the National Cancer Institute (to P.K.S. and B.I.), the Koch Institute Support (core) grant P30CA14051 from the National Cancer Institute (to A.Regev), grant R33-CA202820 (to A.Regev and A.Rotem) and the Klarman Cell Observatory (A.Regev). A.Regev is an investigator of the Howard Hughes Medical Institute.	Ahmed N, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00256; Aran D, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9971; Axelrod ML, 2019, CLIN CANCER RES, V25, P2392, DOI 10.1158/1078-0432.CCR-18-3200; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Biton M, 2018, CELL, V175, P1307, DOI 10.1016/j.cell.2018.10.008; Blaskovich MA, 2003, CANCER RES, V63, P1270; Calon A, 2015, NAT GENET, V47, P320, DOI 10.1038/ng.3225; Cancer Genome Atlas Research Network, 2011, Nature, V474, P609, DOI 10.1038/nature10166; Carter SL, 2012, NAT BIOTECHNOL, V30, P413, DOI 10.1038/nbt.2203; Cirri P, 2011, AM J CANCER RES, V1, P482; Davidowitz RA, 2014, J CLIN INVEST, V124, P2611, DOI 10.1172/JCI69815; Dijkgraaf EM, 2013, CANCER RES, V73, P2480, DOI 10.1158/0008-5472.CAN-12-3542; Duan ZF, 2006, CLIN CANCER RES, V12, P5055, DOI 10.1158/1078-0432.CCR-06-0861; GAZDAR AF, 1986, CANCER RES, V46, P6011; Hu ZY, 2020, CANCER CELL, V37, P226, DOI 10.1016/j.ccell.2020.01.003; Huang W, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-1; Iliopoulos D, 2009, CELL, V139, P693, DOI 10.1016/j.cell.2009.10.014; Iwanicki MP, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.86829; Izar B, 2016, CURR PROTOC MOL BIOL, V116, P2881; Jimenez-Sanchez A, 2017, CELL, V170, P927, DOI 10.1016/j.cell.2017.07.025; Kommoss S, 2017, CLIN CANCER RES, V23, P3794, DOI 10.1158/1078-0432.CCR-16-2196; Lin JR, 2018, ELIFE, V7, DOI 10.7554/eLife.31657; Liu JF, 2017, CLIN CANCER RES, V23, P1263, DOI 10.1158/1078-0432.CCR-16-1237; Matulonis UA, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.61; Miao YX, 2019, CELL, V177, P1172, DOI 10.1016/j.cell.2019.03.025; Nelson EA, 2008, BLOOD, V112, P5095, DOI 10.1182/blood-2007-12-129718; Ohlund D, 2017, J EXP MED, V214, P579, DOI 10.1084/jem.20162024; Patch AM, 2015, NATURE, V521, P489, DOI 10.1038/nature14410; Patel AP, 2014, SCIENCE, V344, P1396, DOI 10.1126/science.1254257; Peterson VM, 2013, P NATL ACAD SCI USA, V110, pE4978, DOI 10.1073/pnas.1315370110; Picelli S, 2013, NAT METHODS, V10, P1096, DOI [10.1038/nmeth.2639, 10.1038/NMETH.2639]; Pitt JM, 2016, ANN ONCOL, V27, P1482, DOI 10.1093/annonc/mdw168; Puram SV, 2017, CELL, V171, P1611, DOI 10.1016/j.cell.2017.10.044; Rodig SJ, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aar3342; Rotem A, 2015, P NATL ACAD SCI USA, V112, P5708, DOI 10.1073/pnas.1505979112; Shih AJ, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0206785; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Silva IA, 2011, CANCER RES, V71, P3991, DOI 10.1158/0008-5472.CAN-10-3175; Slyper M, 2020, NAT MED, V26, P792, DOI 10.1038/s41591-020-0844-1; Smillie CS, 2019, CELL, V178, P714, DOI 10.1016/j.cell.2019.06.029; Tirosh I, 2016, NATURE, V539, P309, DOI 10.1038/nature20123; Tirosh I, 2016, SCIENCE, V352, P189, DOI 10.1126/science.aad0501; Trombetta John J, 2014, Curr Protoc Mol Biol, V107, DOI 10.1002/0471142727.mb0422s107; Venteicher AS, 2017, SCIENCE, V355, DOI 10.1126/science.aai8478; Winterhoff BJ, 2017, GYNECOL ONCOL, V144, P598, DOI 10.1016/j.ygyno.2017.01.015; Wu XL, 2014, ONCOTARGET, V5, P9546, DOI 10.18632/oncotarget.2542; Zhang AW, 2018, CELL, V173, P1755, DOI 10.1016/j.cell.2018.03.073	47	128	131	5	39	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	AUG	2020	26	8					1271	+		10.1038/s41591-020-0926-0	http://dx.doi.org/10.1038/s41591-020-0926-0		JUN 2020	23	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	MX8ZF	32572264	Green Submitted, Green Accepted			2022-12-27	WOS:000542094400003
J	Stower, H				Stower, Hannah			y Understanding the ketogenic diet	NATURE MEDICINE			English	Editorial Material												h.stower@us.nature.com							0	2	2	0	1	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	JUN	2020	26	6					822	822		10.1038/s41591-020-0956-7	http://dx.doi.org/10.1038/s41591-020-0956-7		JUN 2020	1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	LZ3ZG	32528150	Bronze			2022-12-27	WOS:000539886500004
J	Powles, T; Kockx, M; Rodriguez-Vida, A; Duran, I; Crabb, SJ; Van Der Heijden, MS; Szabados, B; Pous, AF; Gravis, G; Herranz, UA; Protheroe, A; Ravaud, A; Maillet, D; Mendez, MJ; Suarez, C; Linch, M; Prendergast, A; van Dam, PJ; Stanoeva, D; Daelemans, S; Mariathasan, S; Tea, JS; Mousa, K; Banchereau, R; Castellano, D				Powles, Thomas; Kockx, Mark; Rodriguez-Vida, Alejo; Duran, Ignacio; Crabb, Simon J.; Van Der Heijden, Michiel S.; Szabados, Bernadett; Pous, Albert Font; Gravis, Gwenaelle; Herranz, Urbano Anido; Protheroe, Andrew; Ravaud, Alain; Maillet, Denis; Mendez, Maria Jose; Suarez, Cristina; Linch, Mark; Prendergast, Aaron; van Dam, Pieter-Jan; Stanoeva, Diana; Daelemans, Sofie; Mariathasan, Sanjeev; Tea, Joy S.; Mousa, Kelly; Banchereau, Romain; Castellano, Daniel			Clinical efficacy and biomarker analysis of neoadjuvant atezolizumab in operable urothelial carcinoma in the ABACUS trial (vol 25, pg 1706, 2019)	NATURE MEDICINE			English	Correction												t.powles@qmul.ac.uk	Herranz, Urbano Anido/AAF-8572-2021; Gravis, Gwenaelle/CAG-3019-2022	Herranz, Urbano Anido/0000-0003-0376-5642; Gravis, Gwenaelle/0000-0002-3127-1554; Crabb, Simon/0000-0003-3521-9064; Suarez, Cristina/0000-0002-0502-5528; Szabados, Bernadett/0000-0002-8786-0032; van Dam, Pieter-Jan/0000-0001-9074-8271; DURAN, IGNACIO/0000-0001-8571-7163				Powles T, 2019, NAT MED, V25, P1706, DOI 10.1038/s41591-019-0628-7	1	1	1	1	4	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	JUN	2020	26	6					983	983		10.1038/s41591-020-0923-3	http://dx.doi.org/10.1038/s41591-020-0923-3		MAY 2020	1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	LZ3ZG	32555515	Bronze			2022-12-27	WOS:000533048300001
J	Arunachalam, PS; Charles, TP; Joag, V; Bollimpelli, VS; Scott, MKD; Wimmers, F; Burton, SL; Labranche, CC; Petitdemange, C; Gangadhara, S; Styles, TM; Quarnstrom, CF; Walter, KA; Ketas, TJ; Legere, T; Reddy, PBJ; Kasturi, SP; Tsai, A; Yeung, BZ; Gupta, S; Tomai, M; Vasilakos, J; Shaw, GM; Kang, CY; Moore, JP; Subramaniam, S; Khatri, P; Montefiori, D; Kozlowski, PA; Derdeyn, CA; Hunter, E; Masopust, D; Amara, RR; Pulendran, B				Arunachalam, Prabhu S.; Charles, Tysheena P.; Joag, Vineet; Bollimpelli, Venkata S.; Scott, Madeleine K. D.; Wimmers, Florian; Burton, Samantha L.; Labranche, Celia C.; Petitdemange, Caroline; Gangadhara, Sailaja; Styles, Tiffany M.; Quarnstrom, Clare F.; Walter, Korey A.; Ketas, Thomas J.; Legere, Traci; Reddy, Pradeep Babu Jagadeesh; Kasturi, Sudhir Pai; Tsai, Anthony; Yeung, Bertrand Z.; Gupta, Shakti; Tomai, Mark; Vasilakos, John; Shaw, George M.; Kang, Chil-Yong; Moore, John P.; Subramaniam, Shankar; Khatri, Purvesh; Montefiori, David; Kozlowski, Pamela A.; Derdeyn, Cynthia A.; Hunter, Eric; Masopust, David; Amara, Rama R.; Pulendran, Bali			T cell-inducing vaccine durably prevents mucosal SHIV infection even with lower neutralizing antibody titers	NATURE MEDICINE			English	Article							HIV-1 INFECTION; ENVELOPE; RESPONSES; RESISTANCE; AIDS; SIV; IMMUNIZATION; REPLICATION; ACQUISITION; EXPRESSION	Recent efforts toward an HIV vaccine focus on inducing broadly neutralizing antibodies, but eliciting both neutralizing antibodies (nAbs) and cellular responses may be superior. Here, we immunized macaques with an HIV envelope trimer, either alone to induce nAbs, or together with a heterologous viral vector regimen to elicit nAbs and cellular immunity, including CD8(+) tissue-resident memory T cells. After ten vaginal challenges with autologous virus, protection was observed in both vaccine groups at 53.3% and 66.7%, respectively. A nAb titer >300 was generally associated with protection but in the heterologous viral vector + nAb group, titers <300 were sufficient. In this group, protection was durable as the animals resisted six more challenges 5 months later. Antigen stimulation of T cells in ex vivo vaginal tissue cultures triggered antiviral responses in myeloid and CD4(+) T cells. We propose that cellular immune responses reduce the threshold of nAbs required to confer superior and durable protection. An HIV vaccine that elicits both antibodies and cellular immune responses confers long-lasting protection against viral challenge in nonhuman primates.	[Arunachalam, Prabhu S.; Scott, Madeleine K. D.; Wimmers, Florian; Khatri, Purvesh; Pulendran, Bali] Stanford Univ, Inst Immun Transplantat & Infect, Sch Med, Stanford, CA 94305 USA; [Charles, Tysheena P.; Burton, Samantha L.; Kasturi, Sudhir Pai; Derdeyn, Cynthia A.; Hunter, Eric] Yerkes Natl Primate Res Ctr, Emory Vaccine Ctr, Dept Pathol & Lab Med, Atlanta, GA 30329 USA; [Joag, Vineet; Quarnstrom, Clare F.; Masopust, David] Univ Minnesota, Dept Microbiol & Immunol, Ctr Immunol, Minneapolis, MN 55455 USA; [Bollimpelli, Venkata S.; Petitdemange, Caroline; Gangadhara, Sailaja; Styles, Tiffany M.; Legere, Traci; Reddy, Pradeep Babu Jagadeesh; Kasturi, Sudhir Pai; Amara, Rama R.] Emory Univ, Yerkes Natl Primate Res Ctr, Dept Microbiol & Immunol, Emory Vaccine Ctr, Atlanta, GA 30322 USA; [Scott, Madeleine K. D.; Khatri, Purvesh] Stanford Univ, Ctr Biomed Informat, Dept Med, Stanford, CA 94305 USA; [Labranche, Celia C.; Montefiori, David] Duke Univ, Dept Surg, Sch Med, Durham, NC USA; [Walter, Korey A.; Kozlowski, Pamela A.] Louisiana State Univ, Hlth Sci Ctr, Dept Microbiol Immunol & Parasitol, New Orleans, LA USA; [Ketas, Thomas J.; Moore, John P.] Cornell Univ, Weill Med Coll, Dept Microbiol & Immunol, New York, NY 10021 USA; [Tsai, Anthony; Yeung, Bertrand Z.] BioLegend, San Diego, CA USA; [Gupta, Shakti; Subramaniam, Shankar] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA; [Tomai, Mark] 3M Corp Res & Mat Lab, St Paul, MN USA; [Vasilakos, John] 3M Drug Delivery Syst, St Paul, MN USA; [Shaw, George M.] Univ Penn, Dept Med, Philadelphia, PA 19104 USA; [Kang, Chil-Yong] Univ Western Ontario, Schulich Sch Med & Dent, Dept Microbiol & Immunol, London, ON, Canada; [Pulendran, Bali] Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA; [Pulendran, Bali] Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA 94305 USA; [Petitdemange, Caroline] Inst Pasteur, HIV Inflammat & Persistence Unit, Paris, France; [Reddy, Pradeep Babu Jagadeesh] Pfizer, Andover, MA USA	Stanford University; Emory University; University of Minnesota System; University of Minnesota Twin Cities; Emory University; Stanford University; Duke University; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Cornell University; University of California System; University of California San Diego; 3M; 3M; University of Pennsylvania; Western University (University of Western Ontario); Stanford University; Stanford University; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Pfizer	Pulendran, B (corresponding author), Stanford Univ, Inst Immun Transplantat & Infect, Sch Med, Stanford, CA 94305 USA.; Derdeyn, CA; Hunter, E (corresponding author), Yerkes Natl Primate Res Ctr, Emory Vaccine Ctr, Dept Pathol & Lab Med, Atlanta, GA 30329 USA.; Masopust, D (corresponding author), Univ Minnesota, Dept Microbiol & Immunol, Ctr Immunol, Minneapolis, MN 55455 USA.; Amara, RR (corresponding author), Emory Univ, Yerkes Natl Primate Res Ctr, Dept Microbiol & Immunol, Emory Vaccine Ctr, Atlanta, GA 30322 USA.; Pulendran, B (corresponding author), Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA.; Pulendran, B (corresponding author), Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA 94305 USA.	cderdey@emory.edu; ehunte4@emory.edu; masopust@umn.edu; ramara@emory.edu; bpulend@stanford.edu	Amara, Rama/AAO-8136-2021; Bollimpelli, Venkata Satish/AAH-7097-2021; Pulendran, Bali/AAW-9550-2021	S ARUNACHALAM, PRABHU/0000-0003-0090-5689; Walter, Korey/0000-0001-6353-5422; Pulendran, Bali/0000-0001-6517-4333; Khatri, Purvesh/0000-0002-4143-4708	NIH (Emory Consortium for Innovative AIDS Research in Nonhuman Primates) [UM1 AI124436]; NIAID (Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery) [UM1AI100663]; Bill and Melinda Gates Foundation Center for AIDS Vaccine Discovery; HIVRAD [P01 AI 110657]; Yerkes National Primate Research Center Grant [ORIP/OD P51OD011132]; NIH, Office of Research Infrastructure Programs	NIH (Emory Consortium for Innovative AIDS Research in Nonhuman Primates)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAID (Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery); Bill and Melinda Gates Foundation Center for AIDS Vaccine Discovery; HIVRAD; Yerkes National Primate Research Center Grant; NIH, Office of Research Infrastructure Programs(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank all animal staff at the Yerkes National Primate Research Center at Emory University for help with the macaque study and B. Wehrle and Z. S. Momin for technical assistance in processing samples. We thank J. Yewdell and D. Barouch for providing VV-Gag and Ad5-Gag viral vectors, respectively. We thank A. Dey of the International AIDS Vaccine Initiative for providing us with BG505 SOSIP.664 for vaccinations. We thank CFAR Immunology/Emory Vaccine Center Flow Cytometry Core, especially K. Gill and Stanford Shared FACS Facility, especially M. Rieck, for the support with flow cytometry. We thank S. Liang and S. Wang at the CFAR Immunology Core for viral load assays. We thank the Genome Sequencing Service Center by the Stanford Center for Genomics and Personalized Medicine, especially K. Garam, for gene expression library preparation and sequencing. We thank Y. Rosenberg at the Human Immune Monitoring Center for the Luminex assay. We thank S. de Jong, Pulendran laboratory, for critical reading of the first draft of the manuscript. TZM-bl cells were obtained through the NIH AIDS Reagent Program, Division of AIDS, NIAID, NIH: TZM-bl cells (cat. no. 8129) from J. C. Kappes and X. Wu. We acknowledge the NIH AIDS Reagent Program for Gag and Env peptide pool reagents. This work was supported by NIH grants UM1 AI124436 (Emory Consortium for Innovative AIDS Research in Nonhuman Primates, Principal Investigators E.H. and R.R.A.), NIAID UM1AI100663 (Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery to B.P. (Principal Investigator of the program, D. Burton) and the Bill and Melinda Gates Foundation Center for AIDS Vaccine Discovery (to B.P.) and HIVRAD P01 AI 110657 (to J.P.M.). This project was funded in part by the Yerkes National Primate Research Center Grant No. ORIP/OD P51OD011132, supported by the NIH, Office of Research Infrastructure Programs. We thank W. Ding for preparation of the SHIV.BG505 challenge stock.	Abdelwahab SF, 2003, P NATL ACAD SCI USA, V100, P15006, DOI 10.1073/pnas.2035075100; Akondy RS, 2009, J IMMUNOL, V183, P7919, DOI 10.4049/jimmunol.0803903; Baldauf HM, 2012, NAT MED, V18, P1682, DOI 10.1038/nm.2964; Bar KJ, 2016, NEW ENGL J MED, V375, P2037, DOI 10.1056/NEJMoa1608243; Barouch DH, 2000, SCIENCE, V290, P486, DOI 10.1126/science.290.5491.486; Benlahrech A, 2009, P NATL ACAD SCI USA, V106, P19940, DOI 10.1073/pnas.0907898106; Boehm U, 1997, ANNU REV IMMUNOL, V15, P749, DOI 10.1146/annurev.immunol.15.1.749; Boliar S, 2012, J VIROL, V86, P8031, DOI 10.1128/JVI.00771-12; Buchbinder SP, 2008, LANCET, V372, P1881, DOI 10.1016/S0140-6736(08)61591-3; BULLER RML, 1985, NATURE, V317, P813, DOI 10.1038/317813a0; Carnathan DG, 2015, P NATL ACAD SCI USA, V112, P518, DOI 10.1073/pnas.1407466112; Chamcha V, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aav1800; Chanzu N, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00202; Derdeyn CA, 2004, SCIENCE, V303, P2019, DOI 10.1126/science.1093137; Dey AK, 2018, BIOTECHNOL BIOENG, V115, P885, DOI 10.1002/bit.26498; Finak G, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0844-5; Fraser KA, 2013, IMMUNITY, V39, P171, DOI 10.1016/j.immuni.2013.07.003; Gary EN, 2018, J IMMUNOL RES, V2018, DOI 10.1155/2018/3734207; Gautam R, 2016, NATURE, V533, P105, DOI 10.1038/nature17677; Goulder PJR, 2008, NAT REV IMMUNOL, V8, P619, DOI 10.1038/nri2357; Hansen SG, 2016, SCIENCE, V351, P714, DOI 10.1126/science.aac9475; Hansen SG, 2011, NATURE, V473, P523, DOI 10.1038/nature10003; Hu HT, 2014, P NATL ACAD SCI USA, V111, P13439, DOI 10.1073/pnas.1400446111; Iyer SS, 2016, J VIROL, V90, P8842, DOI 10.1128/JVI.01163-16; Jones AT, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08739-4; Jones AT, 2018, J VIROL, V92, DOI 10.1128/JVI.01796-17; Kilgore KM, 2015, J VIROL, V89, P8130, DOI 10.1128/JVI.01221-14; Kozlowski PA, 2000, J ACQ IMMUN DEF SYND, V24, P297; Li B, 2006, J VIROL, V80, P5211, DOI 10.1128/JVI.00201-06; Li B, 2010, J VIROL, V84, P6248, DOI 10.1128/JVI.00295-10; Li H, 2016, P NATL ACAD SCI USA, V113, pE3413, DOI 10.1073/pnas.1606636113; Li S, 2014, NAT IMMUNOL, V15, P195, DOI 10.1038/ni.2789; Lynch RM, 2011, J VIROL, V85, P905, DOI 10.1128/JVI.02006-10; Lynch RM, 2010, VIROLOGY, V404, P59, DOI 10.1016/j.virol.2010.04.010; McDermott AB, 2012, AIDS, V26, P1281, DOI 10.1097/QAD.0b013e328353bcaf; McLaren PJ, 2015, RETROVIROLOGY, V12, DOI 10.1186/s12977-015-0165-5; McLinden R, 2012, AIDS, V26, P1452, DOI 10.1097/QAD.0b013e3283550b8e; McMichael AJ, 2014, NAT IMMUNOL, V15, P319, DOI 10.1038/ni.2844; Mendoza P, 2018, NATURE, V561, P479, DOI 10.1038/s41586-018-0531-2; Miller JD, 2008, IMMUNITY, V28, P710, DOI 10.1016/j.immuni.2008.02.020; Montefiori David C., 2009, V485, P395, DOI 10.1007/978-1-59745-170-3_26; Mudd PA, 2012, NATURE, V491, P129, DOI 10.1038/nature11443; Murphy MK, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003173; Ndhlovu ZM, 2015, IMMUNITY, V43, P591, DOI 10.1016/j.immuni.2015.08.012; Oh JE, 2019, NATURE, V571, P122, DOI 10.1038/s41586-019-1285-1; Pauthner M, 2017, IMMUNITY, V46, P1073, DOI 10.1016/j.immuni.2017.05.007; Pauthner MG, 2019, IMMUNITY, V50, P241, DOI 10.1016/j.immuni.2018.11.011; Paxton WA, 1996, NAT MED, V2, P412, DOI 10.1038/nm0496-412; Pegu A, 2019, CELL HOST MICROBE, V26, P336, DOI 10.1016/j.chom.2019.08.014; Petitdemange C, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.126047; Phillips B, 2017, CLIN VACCINE IMMUNOL, V24, DOI 10.1128/CVI.00231-17; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Rong R, 2007, J VIROL, V81, P5658, DOI 10.1128/JVI.00257-07; Rong R, 2007, J VIROL, V81, P1350, DOI 10.1128/JVI.01839-06; Rong R, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000594; Rosato PC, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08534-1; Rose NF, 2001, CELL, V106, P539, DOI 10.1016/S0092-8674(01)00482-2; Sanders RW, 2015, SCIENCE, V349, DOI 10.1126/science.aac4223; Sanders RW, 2017, IMMUNOL REV, V275, P161, DOI 10.1111/imr.12481; Sanders RW, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003618; Schenkel JM, 2014, SCIENCE, V346, P98, DOI 10.1126/science.1254536; Schenkel JM, 2013, NAT IMMUNOL, V14, P509, DOI 10.1038/ni.2568; Shingai M, 2014, J EXP MED, V211, P2061, DOI 10.1084/jem.20132494; Shiver JW, 2002, NATURE, V415, P331, DOI 10.1038/415331a; Smith SA, 2019, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.03163; Smith SA, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005989; Steinert EM, 2015, CELL, V161, P737, DOI 10.1016/j.cell.2015.03.031; Stoeckius M, 2017, NAT METHODS, V14, P865, DOI [10.1038/nmeth.4380, 10.1038/NMETH.4380]; Vezys V, 2009, NATURE, V457, P196, DOI 10.1038/nature07486; Villani AC, 2017, SCIENCE, V356, DOI 10.1126/science.aah4573; Walker B, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a007054; Walker BD, 2011, NAT MED, V17, P1194, DOI 10.1038/nm.2529; Wu KY, 2009, J GEN VIROL, V90, P1135, DOI 10.1099/vir.0.009019-0	74	66	69	2	14	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	JUN	2020	26	6					932	+		10.1038/s41591-020-0858-8	http://dx.doi.org/10.1038/s41591-020-0858-8		MAY 2020	23	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	LZ3ZG	32393800	hybrid, Green Published			2022-12-27	WOS:000531781900003
J	Harris, M; Bhatti, Y; Buckley, J; Sharma, D				Harris, Matthew; Bhatti, Yasser; Buckley, Jim; Sharma, Dhananjaya			Fast and frugal innovations in response to the COVID-19 pandemic	NATURE MEDICINE			English	Editorial Material							HEALTH-CARE		[Harris, Matthew] Imperial Coll London, London, England; [Bhatti, Yasser] Queen Mary Univ London, London, England; [Buckley, Jim] Royal Free Hosp, London, England; [Sharma, Dhananjaya] Govt NSCB Med Coll & Allied Hosp, Dept Surg, Jabalpur, India	Imperial College London; University of London; Queen Mary University London; University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School	Harris, M (corresponding author), Imperial Coll London, London, England.	m.harris@imperial.ac.uk		Buckley, Jim/0000-0001-8110-5135; Bhatti, Yasser/0000-0001-5284-0261; Harris, Matthew/0000-0002-0005-9710	NW London National Institute for Health Research (NIHR) Applied Research Collaboration; NW London NIHR Applied Research Collaboration; Imperial NIHR Biomedical Research Centre	NW London National Institute for Health Research (NIHR) Applied Research Collaboration; NW London NIHR Applied Research Collaboration; Imperial NIHR Biomedical Research Centre(National Institute for Health Research (NIHR))	No funding was received in direct relation to this article. M.H. is supported in part by the NW London National Institute for Health Research (NIHR) Applied Research Collaboration. Imperial College London is grateful for support from the NW London NIHR Applied Research Collaboration and the Imperial NIHR Biomedical Research Centre. The views expressed in this publication are those of the authors and not necessarily those of the NIHR or the Department of Health and Social Care.	Ankel S, 2020, BUS INSIDER; [Anonymous], 2020, OXFORD NEWS EVENTS; [Anonymous], 2020, ECONOMIST 0326; [Anonymous], EXAMINER 0422; Basu RR., 2013, J MANAG GLOB SUSTAIN, V2, P63, DOI [DOI 10.13185/JM2013.01204, 10.13185/JM2013.01204]; Bhattacharyya O, 2017, GLOBALIZATION HEALTH, V13, DOI 10.1186/s12992-016-0225-1; Bhatti Y, 2018, FRUGAL INNOVATION: MODELS, MEANS, METHODS, P1, DOI 10.1017/9781316986783; Bhatti Y, 2017, HEALTH AFFAIR, V36, P1912, DOI 10.1377/hlthaff.2017.0480; Cash-Gibson L, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191901; Department of Health and Social Care. UK Government, 2020, GUID RAP MAN VENT SY; Etherington D., 2020, TECHCRUNCH; Gautret P, 2020, INT J ANTIMICROB AG, V56, DOI 10.1016/j.ijantimicag.2020.105949; Govindarajan V., 2012, REVERSE INNOVATION C; Govindarajan V, 2013, HARVARD BUS REV, V91, P117; Guerin C, 2013, NEW ENGL J MED, V368, P2159, DOI 10.1056/NEJMoa1214103; Hadengue M, 2017, INT J EMERG MARK, V12, P142, DOI 10.1108/IJoEM-12-2015-0272; Haelle T., 2020, FORBES; Haines A, 2020, LANCET, V395, P1173, DOI 10.1016/S0140-6736(20)30735-2; Harris M, 2017, HEALTH AFFAIR, V36, P1997, DOI 10.1377/hlthaff.2017.0773; Harris M, 2017, GLOBALIZATION HEALTH, V13, DOI 10.1186/s12992-017-0304-y; Harris M, 2015, GLOBALIZATION HEALTH, V11, DOI 10.1186/s12992-015-0130-z; Henderson WR, 2014, CAN RESPIR J, V21, P213, DOI 10.1155/2014/472136; Hutt D, 2020, EURONEWS; India Today Web Desk, 2020, INDIA TODAY; Istratii Romina., 2020, CONVIVIAL THINKING; Lokugamage AU, 2020, J MED ETHICS, V46, P265, DOI 10.1136/medethics-2019-105866; Macinko James, 2015, N Engl J Med, V372, P2177, DOI 10.1056/NEJMp1501140; McGillivray B, 2018, RES INTEGR PEER REV, V3, DOI 10.1186/s41073-018-0049-z; Nandi T, 2020, LIVEMINT; Ohnsman A., 2020, FORBES; Prabhu J, 2017, PHILOS T R SOC A, V375, DOI 10.1098/rsta.2016.0372; Prahalad CK, 2009, FORTUNE BOTTOM PYRAM; Sackur S, 2020, BBC WORLD NEWS HARDT; Simpson P, 2020, SOCIOLOGY, V54, P856, DOI 10.1177/0038038519897907; Skopec M, 2019, BMJ-BRIT MED J, V367, DOI 10.1136/bmj.l6205; Wadge H., BRAZILS FAMILY HLTH; Wiah S., 2020, BMJ OPINION BLOG; 2020, UCL NEWS	38	58	58	4	15	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	JUN	2020	26	6					814	817		10.1038/s41591-020-0889-1	http://dx.doi.org/10.1038/s41591-020-0889-1		MAY 2020	4	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	LZ3ZG	32393803	Bronze, Green Submitted			2022-12-27	WOS:000531781900002
J	Sakaue, S; Kanai, M; Karjalainen, J; Akiyama, M; Kurki, M; Matoba, N; Takahashi, A; Hirata, M; Kubo, M; Matsuda, K; Murakami, Y; Daly, MJ; Kamatani, Y; Okada, Y				Sakaue, Saori; Kanai, Masahiro; Karjalainen, Juha; Akiyama, Masato; Kurki, Mitja; Matoba, Nana; Takahashi, Atsushi; Hirata, Makoto; Kubo, Michiaki; Matsuda, Koichi; Murakami, Yoshinori; Daly, Mark J.; Kamatani, Yoichiro; Okada, Yukinori			Trans-biobank analysis with 676,000 individuals elucidates the association of polygenic risk scores of complex traits with human lifespan	NATURE MEDICINE			English	Article							ALL-CAUSE MORTALITY; CARDIOVASCULAR OUTCOMES; BLOOD-PRESSURE; JAPAN; EVENTS	Cross-biobank analysis reveals that polygenic risk scores (PRS) for hypertension and obesity are associated with shorter lifespan, serving as a proof-of-principle that PRS could pinpoint causal risk factors that affect long-term health outcomes. While polygenic risk scores (PRSs) are poised to be translated into clinical practice through prediction of inborn health risks(1), a strategy to utilize genetics to prioritize modifiable risk factors driving heath outcome is warranted(2). To this end, we investigated the association of the genetic susceptibility to complex traits with human lifespan in collaboration with three worldwide biobanks (n(total) = 675,898; BioBank Japan (n = 179,066), UK Biobank (n = 361,194) and FinnGen (n = 135,638)). In contrast to observational studies, in which discerning the cause-and-effect can be difficult, PRSs could help to identify the driver biomarkers affecting human lifespan. A high systolic blood pressure PRS was trans-ethnically associated with a shorter lifespan (hazard ratio = 1.03[1.02-1.04], P-meta = 3.9 x 10(-13)) and parental lifespan (hazard ratio = 1.06[1.06-1.07], P = 2.0 x 10(-86)). The obesity PRS showed distinct effects on lifespan in Japanese and European individuals (P-heterogeneity = 9.5 x 10(-8) for BMI). The causal effect of blood pressure and obesity on lifespan was further supported by Mendelian randomization studies. Beyond genotype-phenotype associations, our trans-biobank study offers a new value of PRSs in prioritization of risk factors that could be potential targets of medical treatment to improve population health.	[Sakaue, Saori; Kanai, Masahiro; Akiyama, Masato; Matoba, Nana; Takahashi, Atsushi; Kamatani, Yoichiro] RIKEN Ctr Integrat Med Sci, Lab Stat Anal, Yokohama, Kanagawa, Japan; [Sakaue, Saori; Kanai, Masahiro; Okada, Yukinori] Osaka Univ, Dept Stat Genet, Grad Sch Med, Suita, Osaka, Japan; [Sakaue, Saori] Univ Tokyo, Grad Sch Med, Dept Allergy & Rheumatol, Tokyo, Japan; [Kanai, Masahiro; Karjalainen, Juha; Kurki, Mitja; Daly, Mark J.] Massachusetts Gen Hosp, Analyt & Translat Genet Unit, Boston, MA 02114 USA; [Kanai, Masahiro; Karjalainen, Juha; Kurki, Mitja; Daly, Mark J.] Broad Inst Harvard & MIT, Program Med & Populat Genet, Cambridge, MA USA; [Kanai, Masahiro; Karjalainen, Juha; Kurki, Mitja; Daly, Mark J.] Broad Inst Harvard & MIT, Stanley Ctr Psychiat Res, Cambridge, MA USA; [Kanai, Masahiro] Harvard Med Sch, Dept Biomed Informat, Boston, MA 02115 USA; [Kanai, Masahiro; Karjalainen, Juha; Kurki, Mitja; Daly, Mark J.] Univ Helsinki, FIMM, Helsinki, Finland; [Akiyama, Masato] Kyushu Univ, Grad Sch Med Sci, Dept Ophthalmol, Fukuoka, Fukuoka, Japan; [Takahashi, Atsushi] Natl Cerebral & Cardiovasc Ctr, Res Inst, Dept Genom Med, Suita, Osaka, Japan; [Hirata, Makoto] Univ Tokyo, Inst Med Sci, Lab Genome Technol, Tokyo, Japan; [Kubo, Michiaki] RIKEN Ctr Integrat Med Sci, Yokohama, Kanagawa, Japan; [Matsuda, Koichi] Univ Tokyo, Grad Sch Frontier Sci, Dept Computat Biol & Med Sci, Tokyo, Japan; [Murakami, Yoshinori] Univ Tokyo, Inst Med Sci, Div Mol Pathol, Tokyo, Japan; [Kamatani, Yoichiro] Univ Tokyo, Grad Sch Frontier Sci, Dept Computat Biol & Med Sci, Lab Complex Trait Genom, Tokyo, Japan; [Okada, Yukinori] Osaka Univ, Immunol Frontier Res Ctr WPI IFReC, Lab Stat Immunol, Suita, Osaka, Japan; [Okada, Yukinori] Osaka Univ, Inst Open & Transdisciplinary Res Initiat, Integrated Frontier Res Med Sci Div, Suita, Osaka, Japan	RIKEN; Osaka University; University of Tokyo; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard Medical School; University of Helsinki; Kyushu University; National Cerebral & Cardiovascular Center - Japan; University of Tokyo; RIKEN; University of Tokyo; University of Tokyo; University of Tokyo; Osaka University; Osaka University	Okada, Y (corresponding author), Osaka Univ, Dept Stat Genet, Grad Sch Med, Suita, Osaka, Japan.; Okada, Y (corresponding author), Osaka Univ, Immunol Frontier Res Ctr WPI IFReC, Lab Stat Immunol, Suita, Osaka, Japan.; Okada, Y (corresponding author), Osaka Univ, Inst Open & Transdisciplinary Res Initiat, Integrated Frontier Res Med Sci Div, Suita, Osaka, Japan.	yokada@sg.med.osaka-u.ac.jp	Akiyama, Masato/AHC-2589-2022; Kurki, Mitja/GWM-5671-2022; Kanai, Masahiro/AAD-6726-2021	Kanai, Masahiro/0000-0001-5165-4408; Sakaue, Saori/0000-0003-3618-9717; Juonala, Markus/0000-0001-9498-364X; Takahashi, Atsushi/0000-0001-7099-8767; Matoba, Nana/0000-0001-5329-0134	Tailor-Made Medical Treatment Program (the BBJ Project) of the Ministry of Education, Culture, Sports, Science, and Technology (MEXT); Japan Agency for Medical Research and Development (AMED); Business Finland [HUS 4685/31/2016, UH 4386/31/2016]; AbbVie; AstraZeneca; Biogen; Celgene; Genentech; GSK; MSD; Pfizer; Sanofi; Japan Society for the Promotion of Science (JSPS) KAKENHI [15H05911, 19H01021]; AMED [JP19gm6010001, JP19ek0410041, JP19ek0109413, JP19km0405211]; Takeda Science Foundation; Bioinformatics Initiative of Osaka University Graduate School of Medicine, Osaka University; Nakajima Foundation Fellowship; Masason Foundation	Tailor-Made Medical Treatment Program (the BBJ Project) of the Ministry of Education, Culture, Sports, Science, and Technology (MEXT); Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); Business Finland; AbbVie(AbbVie); AstraZeneca(AstraZeneca); Biogen(Biogen); Celgene(Bristol-Myers SquibbCelgene Corporation); Genentech(Roche HoldingGenentech); GSK(GlaxoSmithKline); MSD; Pfizer(Pfizer); Sanofi; Japan Society for the Promotion of Science (JSPS) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); AMED; Takeda Science Foundation(Takeda Science Foundation (TSF)); Bioinformatics Initiative of Osaka University Graduate School of Medicine, Osaka University; Nakajima Foundation Fellowship; Masason Foundation	We thank all the participants of BBJ, UKB and FinnGen. We thank A. Palotie for his support for the data analysis of FinnGen, B. M. Neale and N. Baya for sharing and discussing their idea on LOGO, and A. R. Martin for the PRS analysis on UKB. We thank K. Yamamoto for supporting our analyses. This research was supported by the Tailor-Made Medical Treatment Program (the BBJ Project) of the Ministry of Education, Culture, Sports, Science, and Technology (MEXT), the Japan Agency for Medical Research and Development (AMED). The FinnGen project is funded by two grants from Business Finland (HUS 4685/31/2016 and UH 4386/31/2016) and nine industry partners (AbbVie, AstraZeneca, Biogen, Celgene, Genentech, GSK, MSD, Pfizer and Sanofi). The following biobanks are acknowledged for collecting the FinnGen project samples: Auria Biobank (https://www.auria.fi/biopankki/), THL Biobank (https://thl.fi/en/web/thl-biobank), Helsinki Biobank (https://www.terveyskyla.fi/helsinginbiopankki/), Northern Finland Biobank Borealis (https://www.ppshp.fi/Tutkimus-ja-opetus/Biopankki), Finnish Clinical Biobank Tampere (https://www.tays.fi/biopankki), Biobank of Eastern Finland (https://ita-suomenbiopankki.fi), Central Finland Biobank (https://www.ksshp.fi/fi-FI/Potilaalle/Biopankki), Finnish Red Cross Blood Service Biobank (https://www.bloodservice.fi/Research%20Projects/biobanking), Terveystalo Biobank Finland (https://www.terveystalo.com/fi/Yritystietoa/Terveystalo-Biopankki/Biopankki/). Y.O. was supported by the Japan Society for the Promotion of Science (JSPS) KAKENHI (15H05911, 19H01021), AMED (JP19gm6010001, JP19ek0410041, JP19ek0109413, and JP19km0405211), the Takeda Science Foundation, and the Bioinformatics Initiative of Osaka University Graduate School of Medicine, Osaka University. M.Kanai was supported by a Nakajima Foundation Fellowship and the Masason Foundation.	Akiyama M, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12276-5; All Us Res Program Investigators, 2019, NEW ENGL J MED, V381, P668, DOI 10.1056/NEJMsr1809937; Bonaccio M, 2016, BLOOD, V127, P1614, DOI 10.1182/blood-2016-01-692814; Browning BL, 2016, AM J HUM GENET, V98, P116, DOI 10.1016/j.ajhg.2015.11.020; Bulik-Sullivan B, 2015, NAT GENET, V47, P1236, DOI 10.1038/ng.3406; Bulik-Sullivan BK, 2015, NAT GENET, V47, P291, DOI 10.1038/ng.3211; Burgess S, 2013, GENET EPIDEMIOL, V37, P658, DOI 10.1002/gepi.21758; Burgess S, 2013, INT J EPIDEMIOL, V42, P1134, DOI 10.1093/ije/dyt093; Bycroft C, 2018, NATURE, V562, P203, DOI 10.1038/s41586-018-0579-z; Chen GM, 2011, HYPERTENSION, V57, P891, DOI 10.1161/HYPERTENSIONAHA.110.162446; Davey Smith G, 2014, HUM MOL GENET, V23, pR89, DOI 10.1093/hmg/ddu328; Dorresteijn JAN, 2012, HYPERTENSION, V59, P14, DOI 10.1161/HYPERTENSIONAHA.111.179143; Duncan L, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11112-0; Emerging Risk Factors Collaboration, 2012, Int J Epidemiol, V41, P1419, DOI 10.1093/ije/dys086; Fischer K, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001606; Frieser MJ, 2018, HEALTH PSYCHOL, V37, P1134, DOI 10.1037/hea0000683; Gerdts E, 2018, INT J CARDIOL, V258, P257, DOI 10.1016/j.ijcard.2017.12.086; GRAMBSCH PM, 1994, BIOMETRIKA, V81, P515; He J, 2009, LANCET, V374, P1765, DOI 10.1016/S0140-6736(09)61199-5; Hirata M, 2017, J EPIDEMIOL, V27, pS9, DOI 10.1016/j.je.2016.12.003; Hirata M, 2017, J EPIDEMIOL, V27, pS22, DOI 10.1016/j.je.2016.12.006; Ihira H, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197164; Joshi PK, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00934-5; Kanai M, 2018, NAT GENET, V50, P390, DOI 10.1038/s41588-018-0047-6; Khera AV, 2018, NAT GENET, V50, P1219, DOI 10.1038/s41588-018-0183-z; Kunutsor SK, 2014, INT J EPIDEMIOL, V43, P187, DOI 10.1093/ije/dyt192; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; Ligthart S, 2018, AM J HUM GENET, V103, P691, DOI 10.1016/j.ajhg.2018.09.009; Mahajan A, 2018, NAT GENET, V50, P1505, DOI 10.1038/s41588-018-0241-6; Martin AR, 2019, NAT GENET, V51, P584, DOI 10.1038/s41588-019-0379-x; McLaren W, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0974-4; Mega JL, 2015, LANCET, V385, P2264, DOI 10.1016/S0140-6736(14)61730-X; Nagai A, 2017, J EPIDEMIOL, V27, pS2, DOI 10.1016/j.je.2016.12.005; Natarajan P, 2017, CIRCULATION, V135, P2091, DOI 10.1161/CIRCULATIONAHA.116.024436; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Ravnskov U, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010401; Rawshani A, 2018, NEW ENGL J MED, V379, P633, DOI 10.1056/NEJMoa1800256; Richardson TG, 2019, ELIFE, V8, DOI 10.7554/eLife.43657; Robinson MR, 2017, NAT HUM BEHAV, V1, DOI 10.1038/s41562-016-0016; Schumacher FR, 2018, NAT GENET, V50, P928, DOI 10.1038/s41588-018-0142-8; Sohail M, 2019, ELIFE, V8, DOI 10.7554/eLife.39702; Sotos-Prieto M, 2017, NEW ENGL J MED, V377, P143, DOI [10.1056/NEJMoa1613502, 10.1056/nejmoa1613502]; Stolberg HO, 2004, AM J ROENTGENOL, V183, P1539, DOI 10.2214/ajr.183.6.01831539; Thun MJ, 2013, NEW ENGL J MED, V368, P351, DOI 10.1056/NEJMsa1211127; Timmers PRHJ, 2019, ELIFE, V8, DOI 10.7554/eLife.39856; Torkamani A, 2018, NAT REV GENET, V19, P581, DOI 10.1038/s41576-018-0018-x; Ueshima H, 2003, J HUM HYPERTENS, V17, P631, DOI 10.1038/sj.jhh.1001606; Zheng W, 2011, NEW ENGL J MED, V364, P719, DOI 10.1056/NEJMoa1010679	48	34	35	1	7	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	APR	2020	26	4					542	+		10.1038/s41591-020-0785-8	http://dx.doi.org/10.1038/s41591-020-0785-8		MAR 2020	17	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	QH1UE	32251405	Green Submitted			2022-12-27	WOS:000521529700005
J	Harper, J; Gordon, S; Chan, CN; Wang, H; Lindemuth, E; Galardi, C; Falcinelli, SD; Raines, SLM; Read, JL; Nguyen, K; McGary, CS; Nekorchuk, M; Busman-Sahay, K; Schawalder, J; King, C; Pino, M; Micci, L; Cervasi, B; Jean, S; Sanderson, A; Johns, B; Koblansky, AA; Amrine-Madsen, H; Lifson, J; Margolis, DM; Silvestri, G; Bar, KJ; Favre, D; Estes, JD; Paiardini, M				Harper, Justin; Gordon, Shari; Chan, Chi Ngai; Wang, Hong; Lindemuth, Emily; Galardi, Cristin; Falcinelli, Shane D.; Raines, Samuel L. M.; Read, Jenna L.; Nguyen, Kevin; McGary, Colleen S.; Nekorchuk, Michael; Busman-Sahay, Kathleen; Schawalder, James; King, Colin; Pino, Maria; Micci, Luca; Cervasi, Barbara; Jean, Sherrie; Sanderson, Andrew; Johns, Brian; Koblansky, A. Alicia; Amrine-Madsen, Heather; Lifson, Jeffrey; Margolis, David M.; Silvestri, Guido; Bar, Katharine J.; Favre, David; Estes, Jacob D.; Paiardini, Mirko			CTLA-4 and PD-1 dual blockade induces SIV reactivation without control of rebound after antiretroviral therapy interruption	NATURE MEDICINE			English	Article							T-CELL TOLERANCE; IN-VIVO; LYMPHOID-TISSUES; HIV RESERVOIR; INFECTION; REPLICATION; EXPRESSION; NIVOLUMAB; CD4(+); TRANSCRIPTION	Immune checkpoint blockade has been proposed as a potentially curative strategy to reduce the HIV reservoir. Studies in monkeys now show that this approach alone is ineffective at enabling viral control after antiretroviral treatment interruption. The primary human immunodeficiency virus (HIV) reservoir is composed of resting memory CD4(+) T cells, which often express the immune checkpoint receptors programmed cell death protein 1 (PD-1) and cytotoxic T lymphocyte-associated protein 4 (CTLA-4), which limit T cell activation via synergistic mechanisms. Using simian immunodeficiency virus (SIV)-infected, long-term antiretroviral therapy (ART)-treated rhesus macaques, we demonstrate that PD-1, CTLA-4 and dual CTLA-4/PD-1 immune checkpoint blockade using monoclonal antibodies is well tolerated, with evidence of bioactivity in blood and lymph nodes. Dual blockade was remarkably more effective than PD-1 blockade alone in enhancing T cell cycling and differentiation, expanding effector-memory T cells and inducing robust viral reactivation in plasma and peripheral blood mononuclear cells. In lymph nodes, dual CTLA-4/PD-1 blockade, but not PD-1 alone, decreased the total and intact SIV-DNA in CD4(+) T cells, and SIV-DNA and SIV-RNA in B cell follicles, a major site of viral persistence during ART. None of the tested interventions enhanced SIV-specific CD8(+) T cell responses during ART or viral control after ART interruption. Thus, despite CTLA-4/PD-1 blockade inducing robust latency reversal and reducing total levels of integrated virus, the degree of reservoir clearance was still insufficient to achieve viral control. These results suggest that immune checkpoint blockade regimens targeting PD-1 and/or CTLA-4, if performed in people living with HIV with sustained aviremia, are unlikely to induce HIV remission in the absence of additional interventions.	[Harper, Justin; Wang, Hong; Nguyen, Kevin; McGary, Colleen S.; King, Colin; Pino, Maria; Micci, Luca; Cervasi, Barbara; Silvestri, Guido; Paiardini, Mirko] Emory Univ, Div Microbiol & Immunol, Yerkes Natl Primate Res Ctr, Atlanta, GA 30322 USA; [Gordon, Shari; Johns, Brian; Favre, David] GlaxoSmithKline, HIV Discovery Performance Unit, Res Triangle Pk, NC USA; [Gordon, Shari; Galardi, Cristin; Falcinelli, Shane D.; Raines, Samuel L. M.; Read, Jenna L.; Schawalder, James; Johns, Brian; Koblansky, A. Alicia; Amrine-Madsen, Heather; Margolis, David M.; Favre, David] Univ N Carolina, UNC HIV Cure Ctr, Chapel Hill, NC 27515 USA; [Gordon, Shari; Galardi, Cristin; Falcinelli, Shane D.; Raines, Samuel L. M.; Read, Jenna L.; Schawalder, James; Johns, Brian; Koblansky, A. Alicia; Amrine-Madsen, Heather; Margolis, David M.; Favre, David; Estes, Jacob D.] Univ N Carolina, Dept Med, Chapel Hill, NC 27515 USA; [Chan, Chi Ngai; Nekorchuk, Michael; Busman-Sahay, Kathleen; Estes, Jacob D.] Oregon Hlth & Sci Univ, Vaccine & Gene Therapy Inst, Beaverton, OR USA; [Lindemuth, Emily; Bar, Katharine J.] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA; [Galardi, Cristin; Schawalder, James; Koblansky, A. Alicia; Amrine-Madsen, Heather] ViiV Healthcare, HIV Discovery, Res Triangle Pk, NC USA; [Jean, Sherrie] Emory Univ, Div Anim Resources, Yerkes Natl Primate Res Ctr, Atlanta, GA 30322 USA; [Sanderson, Andrew] GlaxoSmithKline, Biopharm Innovat, Stevenage, Herts, England; [Lifson, Jeffrey] Frederick Natl Lab Canc Res, AIDS & Canc Virus Program, Frederick, MD USA; [Silvestri, Guido; Paiardini, Mirko] Emory Univ, Sch Med, Dept Pathol & Lab Med, Atlanta, GA 30322 USA; [Estes, Jacob D.] Oregon Hlth & Sci Univ, Oregon Natl Primate Res Ctr, Beaverton, OR USA	Emory University; GlaxoSmithKline; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Oregon Health & Science University; University of Pennsylvania; Pennsylvania Medicine; GlaxoSmithKline; Emory University; GlaxoSmithKline; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Emory University; Oregon Health & Science University; Oregon National Primate Research Center	Paiardini, M (corresponding author), Emory Univ, Div Microbiol & Immunol, Yerkes Natl Primate Res Ctr, Atlanta, GA 30322 USA.; Paiardini, M (corresponding author), Emory Univ, Sch Med, Dept Pathol & Lab Med, Atlanta, GA 30322 USA.	mirko.paiardini@emory.edu	Favre, David/AAP-2861-2021	Favre, David/0000-0002-0231-114X; Falcinelli, Shane/0000-0002-3554-226X; Harper, Justin/0000-0002-6948-3501; Pino Claveria, Maria/0000-0003-4954-5215	NIAID, NIH [R01AI116379, R21/R33AI116171, UM1AI124436]; GlaxoSmithKline from the Collaboratory of AIDS Researchers for Eradication (CARE) [5105399, 1UM1AI126619-01]; Qura Therapeutics from the Collaboratory of AIDS Researchers for Eradication (CARE) [5105399, 1UM1AI126619-01]; Virology & Drug Discovery Core of Emory CFAR [P30AI050409]; ORIP/OD awards [P51OD011132, P51OD011092]; National Cancer Institute, National Institutes of Health [HHSN261200800001E]	NIAID, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); GlaxoSmithKline from the Collaboratory of AIDS Researchers for Eradication (CARE); Qura Therapeutics from the Collaboratory of AIDS Researchers for Eradication (CARE); Virology & Drug Discovery Core of Emory CFAR; ORIP/OD awards; National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank S. Ehnert, C. Souder and E. Strobert (Research Resources and Veterinary Medicine) at YNPRC for providing animal and veterinary care, as well as the Emory Flow Cytometry Core. We thank C. Ashman, G. Jones, L. Anderson and A. Barnard from GSK for assisting with the preparation and quality control of the therapeutic antibodies, as well as K. Fraley, A. Mayer and G. Page from GSK for measuring antibody and antidrug antibody levels. We also thank R. Shoemaker, K. Oswald and W. Bosche at Leidos Biomedical Research for technical assistance. The SIVmac239 strain used to infect the RMs was provided by K. Van Rompay of UC-Davis, anti-Gag tetramers were provided by D. Long at the NIH Tetramer Core Facility at Emory, and ART was supplied through ViiV Healthcare and GSK. This work was supported by the NIAID, NIH, under awards R01AI116379 and R21/R33AI116171 to M.P. and award UM1AI124436 (Emory CIAR). Support for this work was also provided by GlaxoSmithKline and Qura Therapeutics under subcontract 5105399 from the Collaboratory of AIDS Researchers for Eradication (CARE, 1UM1AI126619-01) to D.M., the Virology & Drug Discovery Core of Emory CFAR (P30AI050409), ORIP/OD awards P51OD011132 (YNPRC) and P51OD011092 (ONPRC), and in part with federal funds from the National Cancer Institute, National Institutes of Health, under contract no. HHSN261200800001E. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products or organizations imply endorsement by the US Government.	Amancha PK, 2013, J IMMUNOL, V191, P6060, DOI 10.4049/jimmunol.1302044; Amara RR, 2001, SCIENCE, V292, P69, DOI 10.1126/science.1058915; Banga R, 2016, NAT MED, V22, P754, DOI 10.1038/nm.4113; Bar KJ, 2016, NEW ENGL J MED, V375, P2037, DOI 10.1056/NEJMoa1608243; Bekerman E, 2019, ANTIMICROB AGENTS CH, V63, DOI 10.1128/AAC.01163-19; Bender AM, 2019, CELL HOST MICROBE, V26, P73, DOI 10.1016/j.chom.2019.06.005; Borducchi EN, 2018, NATURE, V564, pE8, DOI 10.1038/s41586-018-0721-y; Bruner KM, 2019, NATURE, V566, P120, DOI 10.1038/s41586-019-0898-8; Cecchinato V, 2008, J IMMUNOL, V180, P5439, DOI 10.4049/jimmunol.180.8.5439; Cook MR, 2019, JAMA ONCOL, V5, P1049, DOI 10.1001/jamaoncol.2018.6737; Day CL, 2006, NATURE, V443, P350, DOI 10.1038/nature05115; Del Prete GQ, 2016, AIDS RES HUM RETROV, V32, P163, DOI [10.1089/AID.2015.0130, 10.1089/aid.2015.0130]; Deleage Claire, 2016, Pathog Immun, V1, P68; Estes JD, 2017, NAT MED, V23, P1271, DOI 10.1038/nm.4411; Evans VA, 2018, AIDS, V32, P1491, DOI [10.1097/QAD.0000000000001849, 10.1097/qad.0000000000001849]; Fife BT, 2008, IMMUNOL REV, V224, P166, DOI 10.1111/j.1600-065X.2008.00662.x; Finnefrock AC, 2009, J IMMUNOL, V182, P980, DOI 10.4049/jimmunol.182.2.980; Fromentin R, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08798-7; Fromentin R, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005761; Guihot A, 2018, ANN ONCOL, V29, P517, DOI 10.1093/annonc/mdx696; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hansen SG, 2017, NATURE, V547, P123, DOI 10.1038/nature22984; Hansen SG, 2011, NATURE, V473, P523, DOI 10.1038/nature10003; Hao CY, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000007325; Hardtke S, 2005, BLOOD, V106, P1924, DOI 10.1182/blood-2004-11-4494; Hryniewicz A, 2006, BLOOD, V108, P3834, DOI 10.1182/blood-2006-04-010637; Koelzer VH, 2016, J IMMUNOTHER CANCER, V4, DOI 10.1186/s40425-016-0117-1; Le Garff G, 2017, AIDS, V31, P1048, DOI 10.1097/QAD.0000000000001429; Li HS, 2015, EUR J IMMUNOL, V45, P298, DOI 10.1002/eji.201444911; Li H, 2016, P NATL ACAD SCI USA, V113, pE3413, DOI 10.1073/pnas.1606636113; McGary CS, 2017, IMMUNITY, V47, P776, DOI 10.1016/j.immuni.2017.09.018; Micci L, 2015, J CLIN INVEST, V125, P4497, DOI 10.1172/JCI81400; Mylvaganam GH, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.122940; Nilsson J, 2006, BLOOD, V108, P3808, DOI 10.1182/blood-2006-05-021576; Okoye AA, 2018, NAT MED, V24, P1430, DOI 10.1038/s41591-018-0130-7; Pallikkuth S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003471; Pearce EL, 2003, SCIENCE, V302, P1041, DOI 10.1126/science.1090148; Perez VL, 1997, IMMUNITY, V6, P411, DOI 10.1016/S1074-7613(00)80284-8; Perreau M, 2013, J EXP MED, V210, P143, DOI 10.1084/jem.20121932; Policicchio BB, 2018, J VIROL, V92, DOI 10.1128/JVI.02100-17; Roederer M, 2011, CYTOM PART A, V79A, P167, DOI 10.1002/cyto.a.21015; Salantes DB, 2018, J CLIN INVEST, V128, P3102, DOI 10.1172/JCI120194; Scott MJ, 2017, MABS-AUSTIN, V9, P85, DOI 10.1080/19420862.2016.1249078; Scully EP, 2018, ANN ONCOL, V29, P2141, DOI 10.1093/annonc/mdy259; Shetty RD, 2012, J CLIN INVEST, V122, P1712, DOI 10.1172/JCI60612; Trautmann L, 2006, NAT MED, V12, P1198, DOI 10.1038/nm1482; Valsecchi ME, 2015, NEW ENGL J MED, V373, P1270, DOI [10.1056/NEJMoa1504030, 10.1056/NEJMc1509660]; Velu V, 2016, J IMMUNOL, V197, P1832, DOI 10.4049/jimmunol.1600143; Velu V, 2009, NATURE, V458, P206, DOI 10.1038/nature07662; Wang CY, 2014, CANCER IMMUNOL RES, V2, P846, DOI 10.1158/2326-6066.CIR-14-0040; Weiss L, 2004, BLOOD, V104, P3249, DOI 10.1182/blood-2004-01-0365; Wightman F, 2015, AIDS, V29, P504, DOI 10.1097/QAD.0000000000000562; [No title captured]	53	36	38	1	6	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	APR	2020	26	4					519	+		10.1038/s41591-020-0782-y	http://dx.doi.org/10.1038/s41591-020-0782-y		MAR 2020	24	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	QH1UE	32284611	Green Submitted, Green Accepted			2022-12-27	WOS:000519842900002
J	Laughney, AM; Hu, J; Campbell, NR; Bakhoum, SF; Setty, M; Lavallee, VP; Xie, YB; Masilionis, I; Carr, AJ; Kottapalli, S; Allaj, V; Mattar, M; Rekhtman, N; Xavier, JB; Mazutisz, L; Poirier, JT; Rudin, CM; Pe'er, D; Massague, J				Laughney, Ashley M.; Hu, Jing; Campbell, Nathaniel R.; Bakhoum, Samuel F.; Setty, Manu; Lavallee, Vincent-Philippe; Xie, Yubin; Masilionis, Ignas; Carr, Ambrose J.; Kottapalli, Sanjay; Allaj, Viola; Mattar, Marissa; Rekhtman, Natasha; Xavier, Joao B.; Mazutisz, Linas; Poirier, John T.; Rudin, Charles M.; Pe'er, Dana; Massague, Joan			Regenerative lineages and immune-mediated pruning in lung cancer metastasis	NATURE MEDICINE			English	Article							EMBRYONIC STEM-CELLS; OPEN-ACCESS DATABASE; GENE-EXPRESSION; DIFFERENTIATION; EPITHELIUM; ADENOCARCINOMA; PROGENITORS; PROGRESSION; POPULATIONS; MECHANISMS	Developmental processes underlying normal tissue regeneration have been implicated in cancer, but the degree of their enactment during tumor progression and under the selective pressures of immune surveillance, remain unknown. Here we show that human primary lung adenocarcinomas are characterized by the emergence of regenerative cell types, typically seen in response to lung injury, and by striking infidelity among transcription factors specifying most alveolar and bronchial epithelial lineages. In contrast, metastases are enriched for key endoderm and lung-specifying transcription factors, SOX2 and SOX9, and recapitulate more primitive transcriptional programs spanning stem-like to regenerative pulmonary epithelial progenitor states. This developmental continuum mirrors the progressive stages of spontaneous outbreak from metastatic dormancy in a mouse model and exhibits SOX9-dependent resistance to natural killer cells. Loss of developmental stage-specific constraint in macrometastases triggered by natural killer cell depletion suggests a dynamic interplay between developmental plasticity and immune-mediated pruning during metastasis. Single-cell analysis of lung cancer progression uncovers developmental and regenerative programs co-opted by cancer cells and immune-mediated pruning during metastatic outbreak	[Laughney, Ashley M.; Hu, Jing; Campbell, Nathaniel R.; Massague, Joan] Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Canc Biol & Genet Program, 1275 York Ave, New York, NY 10021 USA; [Laughney, Ashley M.; Campbell, Nathaniel R.; Setty, Manu; Lavallee, Vincent-Philippe; Xie, Yubin; Masilionis, Ignas; Carr, Ambrose J.; Kottapalli, Sanjay; Xavier, Joao B.; Mazutisz, Linas; Pe'er, Dana] Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Computat & Syst Biol Program, 1275 York Ave, New York, NY 10021 USA; [Laughney, Ashley M.] Weill Cornell Med, Inst Computat Biomed, New York, NY USA; [Laughney, Ashley M.] Weill Cornell Med, Dept Physiol & Biophys, New York, NY USA; [Laughney, Ashley M.] Weill Cornell Med, Sandra & Edward Meyer Canc Ctr, New York, NY USA; [Campbell, Nathaniel R.] Rockefeller Univ, Sloan Kettering Inst, Weill Cornell, Triinst MD PhD Program, 1230 York Ave, New York, NY 10021 USA; [Bakhoum, Samuel F.] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, 1275 York Ave, New York, NY 10021 USA; [Bakhoum, Samuel F.] Mem Sloan Kettering Canc Ctr, Dept Radiat Oncol, 1275 York Ave, New York, NY 10021 USA; [Xie, Yubin] Rockefeller Univ, Triinst Training Program Computat Biol & Med, Weill Cornell, Sloan Kettering Inst, 1230 York Ave, New York, NY 10021 USA; [Masilionis, Ignas; Kottapalli, Sanjay; Mazutisz, Linas] Mem Sloan Kettering Canc Ctr, Alan & Sandra Gerry Metastasis & Tumor Ecosyst Ct, 1275 York Ave, New York, NY 10021 USA; [Allaj, Viola; Mattar, Marissa; Rudin, Charles M.] Mem Sloan Kettering Canc Ctr, Mol Pharmacol Program, 1275 York Ave, New York, NY 10021 USA; [Allaj, Viola; Mattar, Marissa; Rudin, Charles M.] Mem Sloan Kettering Canc Ctr, Dept Med, 1275 York Ave, New York, NY 10021 USA; [Rekhtman, Natasha] Mem Sloan Kettering Canc Ctr, Dept Pathol, 1275 York Ave, New York, NY 10021 USA; [Poirier, John T.] NYU, Langone Hlth, Perlmutter Canc Ctr, New York, NY USA; [Pe'er, Dana] Mem Sloan Kettering Canc Ctr, Parker Inst Canc Immunotherapy, 1275 York Ave, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Cornell University; Cornell University; Cornell University; Memorial Sloan Kettering Cancer Center; Rockefeller University; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Rockefeller University; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; New York University; Memorial Sloan Kettering Cancer Center	Massague, J (corresponding author), Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Canc Biol & Genet Program, 1275 York Ave, New York, NY 10021 USA.; Pe'er, D (corresponding author), Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Computat & Syst Biol Program, 1275 York Ave, New York, NY 10021 USA.; Pe'er, D (corresponding author), Mem Sloan Kettering Canc Ctr, Parker Inst Canc Immunotherapy, 1275 York Ave, New York, NY 10021 USA.	peerd@mskcc.org; j-massague@ski.mskcc.org	Xavier, Joao/H-5471-2011	Xavier, Joao/0000-0003-3592-1689; Xie, Yubin/0000-0003-2542-2544; Poirier, John/0000-0001-9795-5644; Laughney, Ashley/0000-0001-9435-953X; Mattar, Marissa/0000-0002-2846-9914; Campbell, Nathaniel/0000-0002-0355-0708; Setty, Manu/0000-0002-0344-2627; Masilionis, Ignas/0000-0001-7937-9014	National Institutes of Health [U54-CA209975, P01-CA129243, DP1-HD084071, R01CA164729, P30-CA008748]; DoD Innovator Award [W81XWH-12-0074]; Burroughs Wellcome Fund Career Award at the Scientific Interface; Lung Cancer Research Foundation; Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center at MSKCC; Kirschstein-NRSA [F30-CA220954];  [T32-GM007729]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DoD Innovator Award; Burroughs Wellcome Fund Career Award at the Scientific Interface(Burroughs Wellcome Fund); Lung Cancer Research Foundation; Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center at MSKCC; Kirschstein-NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); 	We thank the Thoracic Oncology Service, the Flow Cytometry Core, the Molecular Cytology Core, the Genomic Editing and Screening Core and the Integrated Genomics Operation at MSKCC for their assistance. We especially thank the tissue donors at MSKCC for participating in this study. We thank J. Nainys and V. Kiseliovas for providing hands-on training of single-cell library preparations. We thank E. Azizi and T. Nawy for their critical feedback on this manuscript and F. Bakhoum and V. Bakhoum for their support. This work was supported by National Institutes of Health grants U54-CA209975 (J.M. and D.P.), P01-CA129243 (J.M.), DP1-HD084071 (D.P.), R01CA164729 (D.P.), P30-CA008748 (J.M.); DoD Innovator Award W81XWH-12-0074 (J.M.); and awards from the Burroughs Wellcome Fund Career Award at the Scientific Interface (A.M.L.), the Lung Cancer Research Foundation (A.M.L.), the Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center at MSKCC (A.M.L. and J.H.), the Kirschstein-NRSA F30-CA220954 Predoctoral Fellowship (N.R.C.) and by a T32-GM007729 Medical Scientist Training Program Grant (N.R.C.).	Abbas AR, 2005, GENES IMMUN, V6, P319, DOI 10.1038/sj.gene.6364173; Azizi E, 2018, CELL, V174, P1293, DOI 10.1016/j.cell.2018.05.060; Beumer J, 2016, DEVELOPMENT, V143, P3639, DOI 10.1242/dev.133132; Bremnes RM, 2016, J THORAC ONCOL, V11, P789, DOI 10.1016/j.jtho.2016.01.015; Cancer Genome Atlas Research Network, 2014, Nature, V511, P543, DOI [10.1038/s41586-018-0228-6, 10.1038/nature13385]; Cheng DT, 2015, J MOL DIAGN, V17, P251, DOI 10.1016/j.jmoldx.2014.12.006; Coifman RR, 2005, P NATL ACAD SCI USA, V102, P7426, DOI 10.1073/pnas.0500334102; Davoli T, 2017, SCIENCE, V355, DOI 10.1126/science.aaf8399; Degryse AL, 2010, AM J PHYSIOL-LUNG C, V299, pL442, DOI 10.1152/ajplung.00026.2010; Du YN, 2017, THORAX, V72, P481, DOI 10.1136/thoraxjnl-2016-209598; Du YN, 2015, THORAX, V70, P1092, DOI 10.1136/thoraxjnl-2015-207035; Er EE, 2018, NAT CELL BIOL, V20, P966, DOI 10.1038/s41556-018-0138-8; Finak G, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0844-5; Guha A, 2012, P NATL ACAD SCI USA, V109, P12592, DOI 10.1073/pnas.1204710109; Gyorffy B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082241; Haghverdi L, 2016, NAT METHODS, V13, P845, DOI 10.1038/nmeth.3971; Halko N, 2011, SIAM REV, V53, P217, DOI 10.1137/090771806; He KM, 2017, IEEE I CONF COMP VIS, P2980, DOI [10.1109/ICCV.2017.322, 10.1109/TPAMI.2018.2844175]; Jacomy M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098679; Jeffrey KL, 2006, NAT IMMUNOL, V7, P274, DOI 10.1038/ni1310; Jobe AH, 2016, FETAL NEONATAL LUNG; Jung H, 2012, J EXP MED, V209, P2409, DOI 10.1084/jem.20120565; Klein AM, 2015, CELL, V161, P1187, DOI 10.1016/j.cell.2015.04.044; Kotton DN, 2014, NAT MED, V20, P822, DOI 10.1038/nm.3642; Kumar PA, 2011, CELL, V147, P525, DOI 10.1016/j.cell.2011.10.001; Lambrechts D, 2018, NAT MED, V24, P1277, DOI 10.1038/s41591-018-0096-5; Lavin Y, 2017, CELL, V169, P750, DOI 10.1016/j.cell.2017.04.014; Lawson WE, 2005, AM J RESP CRIT CARE, V171, P899, DOI 10.1164/rccm.200311-1535OC; Lee JH, 2017, CELL, V170, P1149, DOI 10.1016/j.cell.2017.07.028; Levine JH, 2015, CELL, V162, P184, DOI 10.1016/j.cell.2015.05.047; Li S, 2014, NAT IMMUNOL, V15, P195, DOI 10.1038/ni.2789; Li ZH, 2010, MOL BIOL CELL, V21, P2598, DOI 10.1091/mbc.E09-07-0609; Liberzon A, 2011, BIOINFORMATICS, V27, P1739, DOI 10.1093/bioinformatics/btr260; LOKEN MR, 1977, J HISTOCHEM CYTOCHEM, V25, P899, DOI 10.1177/25.7.330738; Long EO, 2008, IMMUNOL REV, V224, P70, DOI 10.1111/j.1600-065X.2008.00660.x; Malladi S, 2016, CELL, V165, P45, DOI 10.1016/j.cell.2016.02.025; Massague J, 2016, NATURE, V529, P298, DOI 10.1038/nature17038; Mathelier A, 2016, NUCLEIC ACIDS RES, V44, pD110, DOI 10.1093/nar/gkv1176; Mathelier A, 2014, NUCLEIC ACIDS RES, V42, pD142, DOI 10.1093/nar/gkt997; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; Mor-Vaknin N, 2003, NAT CELL BIOL, V5, P59, DOI 10.1038/ncb898; Morrisey EE, 2010, DEV CELL, V18, P8, DOI 10.1016/j.devcel.2009.12.010; Murry CE, 2008, CELL, V132, P661, DOI 10.1016/j.cell.2008.02.008; Nakamura N, 2006, ONCOGENE, V25, P4245, DOI 10.1038/sj.onc.1209442; Niakan KK, 2010, GENE DEV, V24, P312, DOI 10.1101/gad.1833510; Novershtern N, 2011, CELL, V144, P296, DOI 10.1016/j.cell.2011.01.004; Nowotschin S, 2019, NATURE, V569, P361, DOI 10.1038/s41586-019-1127-1; Okubo T, 2005, DEVELOPMENT, V132, P1363, DOI 10.1242/dev.01678; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Priceman SJ, 2010, BLOOD, V115, P1461, DOI 10.1182/blood-2009-08-237412; Rawlins EL, 2009, DEVELOPMENT, V136, P3741, DOI 10.1242/dev.037317; Rock JR, 2009, P NATL ACAD SCI USA, V106, P12771, DOI 10.1073/pnas.0906850106; Seguin CA, 2008, CELL STEM CELL, V3, P182, DOI 10.1016/j.stem.2008.06.018; Setty M, 2019, NAT BIOTECHNOL, V37, P451, DOI 10.1038/s41587-019-0068-4; Setty M, 2016, NAT BIOTECHNOL, V34, P637, DOI 10.1038/nbt.3569; Shen RL, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkw520; Smith BA, 2018, CELL REP, V24, P3353, DOI 10.1016/j.celrep.2018.08.062; Tanjore H, 2009, AM J RESP CRIT CARE, V180, P657, DOI 10.1164/rccm.200903-0322OC; Tata PR, 2018, DEV CELL, V44, P679, DOI 10.1016/j.devcel.2018.02.024; Tirosh I, 2016, NATURE, V539, P309, DOI 10.1038/nature20123; Treutlein B, 2014, NATURE, V509, P371, DOI 10.1038/nature13173; Valle S, 1999, IND ENG CHEM RES, V38, P4389, DOI 10.1021/ie990110i; van der Maaten L, 2008, J MACH LEARN RES, V9, P2579; van Dijk D, 2018, CELL, V174, P716, DOI 10.1016/j.cell.2018.05.061; Vaughan AE, 2015, NATURE, V517, P621, DOI 10.1038/nature14112; Weber K, 2011, NAT MED, V17, P504, DOI 10.1038/nm.2338; Winslow MM, 2011, NATURE, V473, P101, DOI 10.1038/nature09881; Xia H, 2017, J CLIN INVEST, V127, P2586, DOI 10.1172/JCI90832; Yarilin D, 2015, SCI REP-UK, V5, DOI 10.1038/srep09534; Zacharias WJ, 2018, NATURE, V555, P251, DOI 10.1038/nature25786; Zaret KS, 2008, SCIENCE, V322, P1490, DOI 10.1126/science.1161431; Zepp JA, 2017, CELL, V170, P1134, DOI 10.1016/j.cell.2017.07.034; Zilionis R, 2019, IMMUNITY, V50, P1317, DOI 10.1016/j.immuni.2019.03.009; Zilionis R, 2017, NAT PROTOC, V12, DOI 10.1038/nprot.2016.154; Zuo W, 2015, NATURE, V517, P616, DOI 10.1038/nature13903	75	142	143	5	44	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	FEB	2020	26	2					259	+		10.1038/s41591-019-0750-6	http://dx.doi.org/10.1038/s41591-019-0750-6		FEB 2020	37	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	KK7DU	32042191	Green Accepted			2022-12-27	WOS:000512529400006
J	Carmona, J				Carmona, Javier			CLINICAL ONCOLOGY PARP inhibitors for all ovarian cancers	NATURE MEDICINE			English	Editorial Material																			0	1	1	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2019	25	11					1647	1647		10.1038/s41591-019-0655-4	http://dx.doi.org/10.1038/s41591-019-0655-4			1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	JT2KI	31700176	Bronze			2022-12-27	WOS:000500824300012
J	Stower, H				Stower, Hannah			Mystery carcinogens	NATURE MEDICINE			English	Editorial Material												h.stower@us.nature.com							0	0	0	0	0	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2020	26	11					1677	1677		10.1038/s41591-020-1136-5	http://dx.doi.org/10.1038/s41591-020-1136-5		NOV 2020	1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	OT0SR	33154588				2022-12-27	WOS:000587145800002
J	Andrade, CM; Fleckenstein, H; Thomson-Luque, R; Doumbo, S; Lima, NF; Anderson, C; Hibbert, J; Hopp, CS; Tran, TM; Li, SP; Niangaly, M; Cisse, H; Doumtabe, D; Skinner, J; Sturdevant, D; Ricklefs, S; Virtaneva, K; Asghar, M; Homann, MV; Turner, L; Martins, J; Allman, EL; N'Dri, ME; Winkler, V; Llinas, M; Lavazec, C; Martens, C; Farnert, A; Kayentao, K; Ongoiba, A; Lavstsen, T; Osorio, NS; Otto, TD; Recker, M; Traore, B; Crompton, PD; Portugal, S				Andrade, Carolina M.; Fleckenstein, Hannah; Thomson-Luque, Richard; Doumbo, Safiatou; Lima, Nathalia F.; Anderson, Carrie; Hibbert, Julia; Hopp, Christine S.; Tran, Tuan M.; Li, Shanping; Niangaly, Moussa; Cisse, Hamidou; Doumtabe, Didier; Skinner, Jeff; Sturdevant, Dan; Ricklefs, Stacy; Virtaneva, Kimmo; Asghar, Muhammad; Homann, Manijeh Vafa; Turner, Louise; Martins, Joana; Allman, Erik L.; N'Dri, Marie-Esther; Winkler, Volker; Llinas, Manuel; Lavazec, Catherine; Martens, Craig; Farnert, Anna; Kayentao, Kassoum; Ongoiba, Aissata; Lavstsen, Thomas; Osorio, Nuno S.; Otto, Thomas D.; Recker, Mario; Traore, Boubacar; Crompton, Peter D.; Portugal, Silvia			Increased circulation time of Plasmodium falciparum underlies persistent asymptomatic infection in the dry season	NATURE MEDICINE			English	Article							ERYTHROCYTE-MEMBRANE PROTEIN-1; MALIAN CHILDREN; MALARIA; TRANSMISSION; REVEALS; TRANSCRIPTOME; VIRULENCE; CYTOKINES; SELECTION; PARASITES	Malaria cases are predominant during the rainy seasons in many endemic regions owing to the life cycle of the mosquito vector. How Plasmodium falciparum adapts in humans during the intervening dry season, without causing malaria symptoms or killing the host, offers new insights into its persistence in humans. The dry season is a major challenge for Plasmodium falciparum parasites in many malaria endemic regions, where water availability limits mosquito vectors to only part of the year. How P. falciparum bridges two transmission seasons months apart, without being cleared by the human host or compromising host survival, is poorly understood. Here we show that low levels of P. falciparum parasites persist in the blood of asymptomatic Malian individuals during the 5- to 6-month dry season, rarely causing symptoms and minimally affecting the host immune response. Parasites isolated during the dry season are transcriptionally distinct from those of individuals with febrile malaria in the transmission season, coinciding with longer circulation within each replicative cycle of parasitized erythrocytes without adhering to the vascular endothelium. Low parasite levels during the dry season are not due to impaired replication but rather to increased splenic clearance of longer-circulating infected erythrocytes, which likely maintain parasitemias below clinical and immunological radar. We propose that P. falciparum virulence in areas of seasonal malaria transmission is regulated so that the parasite decreases its endothelial binding capacity, allowing increased splenic clearance and enabling several months of subclinical parasite persistence.	[Andrade, Carolina M.; Fleckenstein, Hannah; Thomson-Luque, Richard; Lima, Nathalia F.; Anderson, Carrie; Hibbert, Julia; Portugal, Silvia] Heidelberg Univ Hosp, Ctr Infect Dis, Parasitol, Heidelberg, Germany; [Doumbo, Safiatou; Niangaly, Moussa; Cisse, Hamidou; Doumtabe, Didier; Kayentao, Kassoum; Ongoiba, Aissata; Traore, Boubacar] Univ Sci Tech & Technol Bamako, Mali Int Ctr Excellence Res, Bamako, Mali; [Hopp, Christine S.; Li, Shanping; Skinner, Jeff; Crompton, Peter D.] NIAID, Immunogenet Lab, NIH, Rockville, MD 20852 USA; [Tran, Tuan M.] Indiana Univ Sch Med, Div Infect Dis, Indianapolis, IN 46202 USA; [Sturdevant, Dan; Ricklefs, Stacy; Virtaneva, Kimmo; Martens, Craig] NIAID, Rocky Mt Lab, Res Technol Sect, Genom Unit,NIH, Hamilton, MT 59840 USA; [Asghar, Muhammad; Homann, Manijeh Vafa; Farnert, Anna] Karolinska Inst, Div Infect Dis, Dept Med Solna, Stockholm, Sweden; [Asghar, Muhammad; Homann, Manijeh Vafa; Farnert, Anna] Karolinska Univ Hosp, Dept Infect Dis, Stockholm, Sweden; [Turner, Louise; Lavstsen, Thomas] Univ Copenhagen, Fac Hlth & Med Sci, Dept Immunol & Microbiol, Ctr Med Parasitol, Copenhagen N, Denmark; [Turner, Louise; Lavstsen, Thomas] Copenhagen Univ Hosp, Dept Infect Dis, Rigshosp, Copenhagen, Denmark; [Martins, Joana; Osorio, Nuno S.] Univ Minho, Life & Hlth Sci Res Inst ICVS, Sch Med, Braga, Portugal; [Martins, Joana; Osorio, Nuno S.] ICVS 3Bs PT Govt Associate Lab, Braga, Portugal; [Allman, Erik L.; Llinas, Manuel] Penn State Univ, Huck Ctr Malaria Res, Dept Biochem & Mol Biol, State Coll, PA USA; [N'Dri, Marie-Esther; Lavazec, Catherine] Univ Paris, Inst Cochin, Paris, France; [Winkler, Volker] Heidelberg Univ Hosp, Inst Global Hlth, Heidelberg, Germany; [Llinas, Manuel] Penn State Univ, Dept Chem, State Coll, PA USA; [Otto, Thomas D.] Univ Glasgow, MVLS, Inst Infect Immun & Inflammat, Glasgow, Lanark, Scotland; [Recker, Mario] Univ Exeter, Ctr Math & Environm, Penryn Campus, Penryn, England; [Portugal, Silvia] German Ctr Infect Res DZIF, Heidelberg, Germany; [Portugal, Silvia] Max Planck Inst Infect Biol, Berlin, Germany	Ruprecht Karls University Heidelberg; University of Science & Technology of Bamako; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Indiana University System; Indiana University Bloomington; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; University of Copenhagen; Rigshospitalet; University of Copenhagen; Universidade do Minho; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Ruprecht Karls University Heidelberg; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; University of Glasgow; University of Exeter; German Center for Infection Research; Max Planck Society	Portugal, S (corresponding author), Heidelberg Univ Hosp, Ctr Infect Dis, Parasitol, Heidelberg, Germany.; Portugal, S (corresponding author), German Ctr Infect Res DZIF, Heidelberg, Germany.; Portugal, S (corresponding author), Max Planck Inst Infect Biol, Berlin, Germany.	portugal@mpiib-berlin.mpg.de	Asghar, Muhammad/C-6730-2013; DOUMBO, Safiatou/ABH-6825-2020; Osório, Nuno S./AAF-4307-2020; Lavazec, Catherine/A-4285-2016; Winkler, Volker Franz/GYV-4278-2022; Otto, Thomas/ABE-7632-2020; Tran, Tuan M./H-9439-2019	Asghar, Muhammad/0000-0002-9017-2206; Osório, Nuno S./0000-0003-0949-5399; Lavazec, Catherine/0000-0003-1533-7282; Winkler, Volker Franz/0000-0002-9974-1145; Tran, Tuan M./0000-0002-1928-861X; Skinner, Jeff/0000-0001-5697-0442; Andrade, Carolina/0000-0002-9763-8857; Portugal, Silvia/0000-0003-4567-9101; Farnert, Anna/0000-0001-7583-282X; Otto, Thomas/0000-0002-1246-7404; Allman, Erik/0000-0002-6560-0889; Hopp, Christine/0000-0002-0528-9531	Flow Cytometry Core Facility of DKFZ in Heidelberg, Germany; Immunology Core Lab of the UCRC in Bamako, Mali; German Center for Infection Research (DZIF); European Research Council under the European Union's Horizon 2020 Research and Innovation Programme [759534]; Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) [240245660 SFB 1129]; Division of Intramural Research, National Institute of Allergy and Infectious Diseases, of the National Institutes of Health; European Union's Horizon 2020 Research and Innovation Programme under Marie Skodowska-Curie grant [DLV-839998]	Flow Cytometry Core Facility of DKFZ in Heidelberg, Germany; Immunology Core Lab of the UCRC in Bamako, Mali; German Center for Infection Research (DZIF); European Research Council under the European Union's Horizon 2020 Research and Innovation Programme(European Research Council (ERC)); Deutsche Forschungsgemeinschaft (DFG, German Research Foundation)(German Research Foundation (DFG)); Division of Intramural Research, National Institute of Allergy and Infectious Diseases, of the National Institutes of Health; European Union's Horizon 2020 Research and Innovation Programme under Marie Skodowska-Curie grant	We thank the residents of Kalifabougou, Mali, for participating in this study. We acknowledge the support of the Flow Cytometry Core Facility of DKFZ in Heidelberg, Germany, and the Immunology Core Lab of the UCRC in Bamako, Mali. We thank the Metabolomics Core Facility at Penn State University and A. Patterson and P. Smith from the Penn State Metabolomics Core. We thank Z. Bozdech and the lab at Nanyang Technological University, Singapore, for help and expertise with RNA extraction. This work was supported by the German Center for Infection Research (DZIF), the European Research Council under the European Union's Horizon 2020 Research and Innovation Programme (grant agreement 759534), the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) projektnummer240245660 SFB 1129 of the German Research Foundation and the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, of the National Institutes of Health. R.T.L. was funded by the European Union's Horizon 2020 Research and Innovation Programme under Marie Skodowska-Curie grant agreement DLV-839998.	Abdi AI, 2016, SCI REP-UK, V6, DOI 10.1038/srep19882; Allman Erik L, 2016, Antimicrob Agents Chemother, V60, P6635, DOI 10.1128/AAC.01224-16; Almelli T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114401; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; [Anonymous], 2013, PREPRINTS; Auburn S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022213; Babiker HA, 1998, AM J TROP MED HYG, V59, P582, DOI 10.4269/ajtmh.1998.59.582; Bachmann A, 2019, PLOS PATHOG, V15, DOI 10.1371/journal.ppat.1007906; Billker O, 1998, NATURE, V392, P289, DOI 10.1038/32667; Bousema T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042821; Boyle MJ, 2010, P NATL ACAD SCI USA, V107, P14378, DOI 10.1073/pnas.1009198107; Bozdech Z, 2003, PLOS BIOL, V1, P85, DOI 10.1371/journal.pbio.0000005; Brancucci NMB, 2017, CELL, V171, P1532, DOI 10.1016/j.cell.2017.10.020; Broadbent KM, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1603-4; Brugat T, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2016.276; Burte F, 2013, BLOOD, V121, P3016, DOI 10.1182/blood-2012-10-461418; Cajka T, 2016, METABOLOMICS, V12, DOI 10.1007/s11306-015-0929-x; Cham GKK, 2010, INFECT IMMUN, V78, P4653, DOI 10.1128/IAI.00593-10; Chotivanich K, 2000, J INFECT DIS, V181, P1206, DOI 10.1086/315353; Cornet S, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004308; Cowman AF, 2012, J CELL BIOL, V198, P961, DOI 10.1083/jcb.201206112; Crabb BS, 1997, CELL, V89, P287, DOI 10.1016/S0092-8674(00)80207-X; Crompton PD, 2008, J INFECT DIS, V198, P1265, DOI 10.1086/592224; Crompton PD, 2010, P NATL ACAD SCI USA, V107, P6958, DOI 10.1073/pnas.1001323107; Dahlback M, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-78; Daily JP, 2007, NATURE, V450, P1091, DOI 10.1038/nature06311; Deans AM, 2006, AM J TROP MED HYG, V74, P554, DOI 10.4269/ajtmh.2006.74.554; Deplaine G, 2011, BLOOD, V117, pE88, DOI 10.1182/blood-2010-10-312801; Dicko A, 2005, TROP MED INT HEALTH, V10, P550, DOI 10.1111/j.1365-3156.2005.01418.x; Drakeley C, 2006, TRENDS PARASITOL, V22, P424, DOI 10.1016/j.pt.2006.07.001; Goncalves BP, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01270-4; HOMMEL M, 1983, J EXP MED, V157, P1137, DOI 10.1084/jem.157.4.1137; Hopp C. S, 2020, PLASMODIUM FALCIPARU, DOI DOI 10.1101/2020.04.12.030049V2; Howick VM, 2019, SCIENCE, V365, P774, DOI 10.1126/science.aaw2619; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Kim D, 2015, NAT METHODS, V12, P357, DOI [10.1038/NMETH.3317, 10.1038/nmeth.3317]; Kimenyi KM, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02398; Lavstsen T, 2003, MALARIA J, V2, DOI 10.1186/1475-2875-2-27; Lavstsen T, 2012, P NATL ACAD SCI USA, V109, pE1791, DOI 10.1073/pnas.1120455109; Lee HJ, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aar3619; Lehmann T, 2010, AM J TROP MED HYG, V83, P601, DOI 10.4269/ajtmh.2010.09-0779; Lemieux JE, 2009, P NATL ACAD SCI USA, V106, P7559, DOI 10.1073/pnas.0811829106; Liljander A, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-78; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lyke KE, 2004, INFECT IMMUN, V72, P5630, DOI 10.1128/IAI.72.10.5630-5637.2004; Males S, 2008, CLIN INFECT DIS, V46, P516, DOI 10.1086/526529; Mancio-Silva L, 2017, NATURE, V547, P213, DOI 10.1038/nature23009; Marcais G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130821; Marti M, 2004, SCIENCE, V306, P1930, DOI 10.1126/science.1102452; Martin M, 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, 10.10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; O'Donnell A, 2009, T ROY SOC TROP MED H, V103, P679, DOI 10.1016/j.trstmh.2009.03.023; Obeng-Adjei N, 2020, JCI INSIGHT, V5, DOI 10.1172/jci.insight.137262; Oh SS, 2000, MOL BIOCHEM PARASIT, V108, P237, DOI 10.1016/S0166-6851(00)00227-9; Otto Thomas D, 2019, Wellcome Open Res, V4, P193, DOI 10.12688/wellcomeopenres.15590.1; Otto Thomas D, 2018, Wellcome Open Res, V3, P52, DOI 10.12688/wellcomeopenres.14571.1; Otto TD, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5754; Ouedraogo AL, 2016, J INFECT DIS, V213, P90, DOI 10.1093/infdis/jiv370; Oyegue-Liabagui SL, 2017, AM J CLIN EXP IMMUNO, V6, P9; Park GS, 2012, J PEDIATR INFECT DIS, V1, P16, DOI [10.1093/JPIDS/PIS010, 10.1093/jpids/pis010]; Portugal S, 2017, CLIN INFECT DIS, V64, P645, DOI 10.1093/cid/ciw849; Pradeu T, 2016, SCI IMMUNOL, V1, DOI 10.1126/sciimmunol.aag0479; Radfar A, 2009, NAT PROTOC, V4, P1899, DOI 10.1038/nprot.2009.198; Rask TS, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000933; Ratsimbasoa A, 2008, AM J TROP MED HYG, V79, P670, DOI 10.4269/ajtmh.2008.79.670; ROBERTS DJ, 1992, NATURE, V357, P689, DOI 10.1038/357689a0; Rono MK, 2018, NAT ECOL EVOL, V2, P377, DOI 10.1038/s41559-017-0419-9; Schalkwijk J, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aas9917; SMITH T, 1994, STAT MED, V13, P2345, DOI 10.1002/sim.4780132206; Snounou G, 1999, T ROY SOC TROP MED H, V93, P369, DOI 10.1016/S0035-9203(99)90120-7; Sonden K, 2015, J INFECT DIS, V212, P608, DOI 10.1093/infdis/jiv088; Spence PJ, 2013, NATURE, V498, P228, DOI 10.1038/nature12231; Stanisic DI, 2018, INFECT IMMUN, V86, DOI 10.1128/IAI.00479-17; Tonkin CJ, 2004, MOL BIOCHEM PARASIT, V137, P13, DOI 10.1016/j.molbiopara.2004.05.009; Tonkin-Hill GQ, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2004328; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; Tran TM, 2013, CLIN INFECT DIS, V57, P40, DOI 10.1093/cid/cit174; Tsugawa H, 2015, NAT METHODS, V12, P523, DOI 10.1038/nmeth.3393; Virtaneva K, 2005, P NATL ACAD SCI USA, V102, P9014, DOI 10.1073/pnas.0503671102; Weinberg JB, 2016, SCI REP-UK, V6, DOI 10.1038/srep29151; Weinberger LS, 2015, CURR OPIN CELL BIOL, V37, P111, DOI 10.1016/j.ceb.2015.10.005; World Health Organization, 2019, WORLD MALARIA REPORT; Zerbino D. R, 2010, CURRENT PROTOCOLS BI	82	38	37	0	9	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	2020	26	12								10.1038/s41591-020-1084-0	http://dx.doi.org/10.1038/s41591-020-1084-0		OCT 2020	29	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	PB8QO	33106664	Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000584042900003
J	Bloor, AJC; Patel, A; Griffin, JE; Gilleece, MH; Radia, R; Yeung, DT; Drier, D; Larson, LS; Uenishi, GI; Hei, D; Kelly, K; Slukvin, I; Rasko, JEJ				Bloor, Adrian J. C.; Patel, Amit; Griffin, James E.; Gilleece, Maria H.; Radia, Rohini; Yeung, David T.; Drier, Diana; Larson, Laurie S.; Uenishi, Gene I.; Hei, Derek; Kelly, Kilian; Slukvin, Igor; Rasko, John E. J.			Production, safety and efficacy of iPSC-derived mesenchymal stromal cells in acute steroid-resistant graft versus host disease: a phase I, multicenter, open-label, dose-escalation study	NATURE MEDICINE			English	Article							PLURIPOTENT STEM-CELLS; INDUCTION; THERAPY; TRIAL	A GMP-compliant process for generating human iPSC-derived mesenchymal stromal cells tested in a phase 1 trial is safe and well tolerated in subjects with acute steroid-resistant graft versus host disease. The therapeutic potential of donor-derived mesenchymal stromal cells (MSCs) has been investigated in diverse diseases(1), including steroid-resistant acute graft versus host disease (SR-aGvHD)(2). However, conventional manufacturing approaches are hampered by challenges with scalability and interdonor variability, and clinical trials have shown inconsistent outcomes(3,4). Induced pluripotent stem cells (iPSCs) have the potential to overcome these challenges, due to their capacity for multilineage differentiation and indefinite proliferation(5,6). Nonetheless, human clinical trials of iPSC-derived cells have not previously been completed. CYP-001 (iPSC-derived MSCs) is produced using an optimized, good manufacturing practice (GMP)-compliant manufacturing process. We conducted a phase 1, open-label clinical trial (no. NCT02923375) in subjects with SR-aGvHD. Sixteen subjects were screened and sequentially assigned to cohort A or cohort B (n = 8 per group). One subject in cohort B withdrew before receiving CYP-001 and was excluded from analysis. All other subjects received intravenous infusions of CYP-001 on days 0 and 7, at a dose level of either 1 x 10(6)cells per kg body weight, to a maximum of 1 x 10(8)cells per infusion (cohort A), or 2 x 10(6)cells per kg body weight, to a maximum dose of 2 x 10(8)cells per infusion (cohort B). The primary objective was to assess the safety and tolerability of CYP-001, while the secondary objectives were to evaluate efficacy based on the proportion of participants who showed a complete response (CR), overall response (OR) and overall survival (OS) by days 28/100. CYP-001 was safe and well tolerated. No serious adverse events were assessed as related to CYP-001. OR, CR and OS rates by day 100 were 86.7, 53.3 and 86.7%, respectively. The therapeutic application of iPSC-derived MSCs may now be explored in diverse inflammatory and immune-mediated diseases.	[Bloor, Adrian J. C.; Patel, Amit] Christie NHS Fdn Trust, Haematol & Transplant Unit, Manchester, Lancs, England; [Bloor, Adrian J. C.] Univ Manchester, Sch Med Sci, Manchester, Lancs, England; [Griffin, James E.] Univ Hosp Bristol NHS Fdn Trust, Dept Bone Marrow Transplantat, Bristol, Avon, England; [Gilleece, Maria H.] Leeds Teaching Hosp NHS Trust, Dept Haematol, Leeds, W Yorkshire, England; [Radia, Rohini] Nottingham Univ Hosp NHS Trust, Dept Haematol, Nottingham, England; [Yeung, David T.] Univ Adelaide, Sch Med, Adelaide, SA, Australia; [Yeung, David T.] Royal Adelaide Hosp, Adelaide, SA, Australia; [Drier, Diana; Larson, Laurie S.] Univ Wisconsin, Waisman Biomfg, Madison, WI USA; [Uenishi, Gene I.; Slukvin, Igor] Univ Wisconsin, Dept Cell & Regenerat Biol, Madison, WI USA; [Hei, Derek] BlueRock Therapeut, Cambridge, MA USA; [Kelly, Kilian] Cynata Therapeut Ltd, Carlton, Vic, Australia; [Rasko, John E. J.] Royal Prince Alfred Hosp, Dept Cell & Mol Therapies, Camperdown, NSW, Australia; [Rasko, John E. J.] Univ Sydney, Centenary Inst, Gene & Stem Cell Therapy Program, Sydney, NSW, Australia; [Rasko, John E. J.] Univ Sydney, Fac Med & Hlth, Cent Clin Sch, Sydney, NSW, Australia	Christie NHS Foundation Trust; University of Manchester; University of Bristol; University of Leeds; Nottingham University Hospital NHS Trust; University of Adelaide; Royal Adelaide Hospital; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Sydney; University of Sydney; Centenary Institute; University of Sydney	Bloor, AJC (corresponding author), Christie NHS Fdn Trust, Haematol & Transplant Unit, Manchester, Lancs, England.; Bloor, AJC (corresponding author), Univ Manchester, Sch Med Sci, Manchester, Lancs, England.; Rasko, JEJ (corresponding author), Royal Prince Alfred Hosp, Dept Cell & Mol Therapies, Camperdown, NSW, Australia.; Rasko, JEJ (corresponding author), Univ Sydney, Centenary Inst, Gene & Stem Cell Therapy Program, Sydney, NSW, Australia.; Rasko, JEJ (corresponding author), Univ Sydney, Fac Med & Hlth, Cent Clin Sch, Sydney, NSW, Australia.	adrian.bloor@christie.nhs.uk; j.rasko@centenary.org.au		rasko, John/0000-0003-2975-807X; Bloor, Adrian/0000-0003-4550-220X; Patel, Amit/0000-0003-0029-4611	National Health and Medical Research Council [1177305]; Cure the Future; Therapeutic Innovation Australia	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Cure the Future; Therapeutic Innovation Australia	We thank the University of Wisconsin Bioinformatics Resource Center for providing mRNA-seq analysis services, and all site investigators, coinvestigators, study coordinators, other study staff and study participants. Medical writer C. Markey, of Markey Medical Consulting Pty Ltd, assisted in the preparation of an earlier version of a draft manuscript describing this work. J.E.J.R. is supported by a National Health and Medical Research Council Investigator Grant (1177305) for 'driving clinical cell and gene therapy in Australia', as well as funding from Cure the Future, Therapeutic Innovation Australia and an anonymous foundation.	Bader P, 2018, BONE MARROW TRANSPL, V53, P852, DOI 10.1038/s41409-018-0102-z; Borowicz S, 2014, JOVE-J VIS EXP, DOI 10.3791/51998; Chen GK, 2011, NAT METHODS, V8, P424, DOI [10.1038/nmeth.1593, 10.1038/NMETH.1593]; De Jong CN, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187184; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Elgaz S, 2019, TRANSFUS MED HEMOTH, V46, P27, DOI 10.1159/000496809; Francois M, 2012, MOL THER, V20, P187, DOI 10.1038/mt.2011.189; Galipeau J, 2018, CELL STEM CELL, V22, P824, DOI 10.1016/j.stem.2018.05.004; Galipeau J, 2013, CYTOTHERAPY, V15, P2, DOI 10.1016/j.jcyt.2012.10.002; Galleu A, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aam7828; Garnett C, 2013, THER ADV HEMATOL, V4, P366, DOI 10.1177/2040620713489842; Greinix HT, 2000, BLOOD, V96, P2426; Harrell CR, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8121605; Jagasia M, 2020, BLOOD, V135, P1739, DOI 10.1182/blood.2020004823; Kabat M, 2020, STEM CELL TRANSL MED, V9, P17, DOI 10.1002/sctm.19-0202; Kebriaei P, 2020, BIOL BLOOD MARROW TR, V26, P835, DOI 10.1016/j.bbmt.2019.08.029; Ketterl N, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0233-8; Khan MA, 2019, STEM CELL RES THER, V10, DOI 10.1186/s13287-019-1397-4; Koch JM, 2016, CYTOTHERAPY, V18, P219, DOI 10.1016/j.jcyt.2015.10.013; Le Blanc K, 2004, LANCET, V363, P1439, DOI 10.1016/S0140-6736(04)16104-7; Mack AA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027956; Mandai Michiko, 2017, N Engl J Med, V377, P792, DOI 10.1056/NEJMc1706274; Martin I, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aat2189; Millar JE, 2020, AM J RESP CRIT CARE, V202, P383, DOI 10.1164/rccm.201911-2143OC; Ozay EI, 2019, STEM CELL RES, V35, DOI 10.1016/j.scr.2019.101401; Park JH, 2014, KOREAN J INTERN MED, V29, P630, DOI 10.3904/kjim.2014.29.5.630; PRZEPIORKA D, 1995, BONE MARROW TRANSPL, V15, P825; Royce SG, 2019, FASEB J, V33, P6402, DOI 10.1096/fj.201802307R; Royce SG, 2017, FASEB J, V31, P4168, DOI 10.1096/fj.201700178R; Sharma RR, 2014, TRANSFUSION, V54, P1418, DOI 10.1111/trf.12421; Siegel G, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-146; Slukvin I., 2017, Patent, Patent No. [WO2017156580A1, 2017156580]; Slukvin II, 2018, CELL MOL LIFE SCI, V75, P3507, DOI 10.1007/s00018-018-2871-3; Stoddard-Bennett T, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8010026; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Uenishi G, 2014, STEM CELL REP, V3, P1073, DOI 10.1016/j.stemcr.2014.09.014; Vodyanik MA, 2010, CELL STEM CELL, V7, P718, DOI 10.1016/j.stem.2010.11.011; von Bahr L, 2012, BIOL BLOOD MARROW TR, V18, P557, DOI 10.1016/j.bbmt.2011.07.023; Wagner W, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002213; Wegmeyer H, 2013, STEM CELLS DEV, V22, P2606, DOI 10.1089/scd.2013.0016; Yla-Herttuala S, 2018, MOL THER, V26, P2077, DOI 10.1016/j.ymthe.2018.08.006; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zeiser R, 2020, NEW ENGL J MED, V382, P1800, DOI 10.1056/NEJMoa1917635	43	101	102	1	7	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2020	26	11					1720	+		10.1038/s41591-020-1050-x	http://dx.doi.org/10.1038/s41591-020-1050-x		SEP 2020	12	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	OT0SR	32929265	Bronze			2022-12-27	WOS:000569298900001
J	Giudice, LC				Giudice, Linda C.			Multidimensional transcriptomic mapping of human endometrium at single-cell resolution	NATURE MEDICINE			English	Editorial Material								Single-cell RNA sequencing across the menstrual cycle reveals human endometrial cell-specific preparation for embryo implantation, menstruation and tissue renewal.	[Giudice, Linda C.] Univ Calif San Francisco, Ctr Reprod Sci, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Giudice, LC (corresponding author), Univ Calif San Francisco, Ctr Reprod Sci, San Francisco, CA 94143 USA.	linda.giudice@ucsf.edu						Altmae S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10098-3; Coutifaris C, 2004, FERTIL STERIL, V82, P1264, DOI 10.1016/j.fertnstert.2004.03.069; FERENCZY A, 1972, FERTIL STERIL, V23, P515; Fitzgerald HC, 2019, P NATL ACAD SCI USA, V116, P23132, DOI 10.1073/pnas.1915389116; Fung JN, 2017, HUM REPROD, V32, P893, DOI 10.1093/humrep/dex006; Moore L, 2020, NATURE, V580, P640, DOI 10.1038/s41586-020-2214-z; NOYES RW, 1950, FERTIL STERIL, V1, P3, DOI 10.1016/s0015-0282(16)30062-0; Suryawanshi H, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aau4788; Van Der Wijst MGP, 2020, ELIFE, V9, DOI 10.7554/eLife.52155; Vento-Tormo R, 2018, NATURE, V563, P347, DOI 10.1038/s41586-018-0698-6; Vickovic S, 2019, NAT METHODS, V16, P987, DOI 10.1038/s41592-019-0548-y; Wang W, 2020, NAT MED, DOI [10.1038/10.1038/s41591-020-1040-z, DOI 10.1038/10.1038/S41591-020-1040-Z]	12	3	3	0	13	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	OCT	2020	26	10					1513	1514		10.1038/s41591-020-1075-1	http://dx.doi.org/10.1038/s41591-020-1075-1		SEP 2020	2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	NX8MD	32929267				2022-12-27	WOS:000569298900004
J	Wang, WX; Vilella, F; Alama, P; Moreno, I; Mignardi, M; Isakova, A; Pan, WY; Simon, C; Quake, SR				Wang, Wanxin; Vilella, Felipe; Alama, Pilar; Moreno, Inmaculada; Mignardi, Marco; Isakova, Alina; Pan, Wenying; Simon, Carlos; Quake, Stephen R.			Single-cell transcriptomic atlas of the human endometrium during the menstrual cycle	NATURE MEDICINE			English	Article							GENE-EXPRESSION; IMMUNOHISTOCHEMICAL ANALYSIS; PROGESTERONE-RECEPTORS; EVOLUTION; DECIDUALIZATION; IDENTIFICATION; IMPLANTATION; RECEPTIVITY; ESTROGEN; TOOL	Single-cell transcriptomics analysis of endometrium samples from healthy women collected across the menstrual cycle provides insights into the cellular and molecular changes surrounding and during the implantation window in the absence of pregnancy. In a human menstrual cycle the endometrium undergoes remodeling, shedding and regeneration, all of which are driven by substantial gene expression changes in the underlying cellular hierarchy. Despite its importance in human fertility and regenerative biology, our understanding of this unique type of tissue homeostasis remains rudimentary. We characterized the transcriptomic transformation of human endometrium at single-cell resolution across the menstrual cycle, resolving cellular heterogeneity in multiple dimensions. We profiled the behavior of seven endometrial cell types, including a previously uncharacterized ciliated cell type, during four major phases of endometrial transformation, and found characteristic signatures for each cell type and phase. We discovered that the human window of implantation opens with an abrupt and discontinuous transcriptomic activation in the epithelia, accompanied with a widespread decidualization feature in the stromal fibroblasts. Our study provides a high-resolution molecular and cellular characterization of human endometrial transformation across the menstrual cycle, providing insights into this essential physiological process.	[Wang, Wanxin; Isakova, Alina; Pan, Wenying; Quake, Stephen R.] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Vilella, Felipe; Moreno, Inmaculada; Simon, Carlos] Stanford Univ, Dept Obstet & Gynecol, Stanford, CA 94305 USA; [Vilella, Felipe; Moreno, Inmaculada; Simon, Carlos] INCLIVA Hlth Res Inst, Igenomix Fdn, Valencia, Spain; [Alama, Pilar] IVI Valencia, Valencia, Spain; [Mignardi, Marco; Quake, Stephen R.] Chan Zuckerberg Biohub, San Francisco, CA 94158 USA; [Simon, Carlos] Univ Valencia, Dept Obstet & Gynecol, Valencia, Spain; [Quake, Stephen R.] Stanford Univ, Dept Appl Phys, Stanford, CA 94305 USA	Stanford University; Stanford University; University of Valencia; University of Valencia; Stanford University	Quake, SR (corresponding author), Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA.; Simon, C (corresponding author), Stanford Univ, Dept Obstet & Gynecol, Stanford, CA 94305 USA.; Simon, C (corresponding author), INCLIVA Hlth Res Inst, Igenomix Fdn, Valencia, Spain.; Quake, SR (corresponding author), Chan Zuckerberg Biohub, San Francisco, CA 94158 USA.; Simon, C (corresponding author), Univ Valencia, Dept Obstet & Gynecol, Valencia, Spain.; Quake, SR (corresponding author), Stanford Univ, Dept Appl Phys, Stanford, CA 94305 USA.	carlos.simon@uv.es; steve@quake-lab.org	Vilella, Felipe/C-2970-2018; Moreno, Inmaculada/D-3955-2018; Simon, Carlos/G-2186-2014	Moreno, Inmaculada/0000-0001-6910-7509; Simon, Carlos/0000-0003-0902-9531; Vilella, Felipe/0000-0002-0039-9846	March of Dimes; Chan Zuckerberg Biohub; MINECO/FEDER [SAF-2015-67164-R]; Stanford Bio-X Graduate Bowes Fellowship; Miguel Servet Program TypeII of ISCIII [CPII18/00020]; FIS project [PI18/00957]; IVI-RMA Valencia; Igenomix Foundation	March of Dimes(March of Dimes); Chan Zuckerberg Biohub; MINECO/FEDER(Spanish Government); Stanford Bio-X Graduate Bowes Fellowship; Miguel Servet Program TypeII of ISCIII; FIS project; IVI-RMA Valencia; Igenomix Foundation	We thank H. Ding for valuable discussions and advice; N. Neff and J. Okamoto for sequencing expertise; F. B. Yu, S. Darmanis and F. Zanini for technical expertise and discussions; S. Crasta and S. Kolluru for technical assistance; and the Stanford Cell Science Imaging Facility for assistance with imaging. This study was jointly supported by the March of Dimes, Chan Zuckerberg Biohub and MINECO/FEDER (no. SAF-2015-67164-R, to C.S.) (Spanish Government). W.W. was supported by the Stanford Bio-X Graduate Bowes Fellowship and Chan Zuckerberg Biohub. F.V. was supported by the Miguel Servet Program TypeII of ISCIII (no. CPII18/00020) and the FIS project (no. PI18/00957). P.A. was supported by IVI-RMA Valencia. I.M. was supported by the Igenomix Foundation. M.M. and A.I. were supported by Chan Zuckerberg Biohub. W.P. was supported by the March of Dimes.	Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bellofiore N, 2017, AM J OBSTET GYNECOL, V216, DOI 10.1016/j.ajog.2016.07.041; Benda C, 1894, KLENUSCHES HDB HAN S; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Crichton E. G., 2000, REPROD BIOL BATS; CROXATTO HB, 1978, AM J OBSTET GYNECOL, V132, P629, DOI 10.1016/0002-9378(78)90854-2; Diaz-Gimeno P, 2011, FERTIL STERIL, V95, P50, DOI 10.1016/j.fertnstert.2010.04.063; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Emera D, 2012, BIOESSAYS, V34, P26, DOI 10.1002/bies.201100099; Fan XJ, 2012, ENDOCRINOLOGY, V153, P1063, DOI 10.1210/en.2011-1826; FILANT J, 2013, BIOL REPROD, V88; Guo Y, 2006, BIOSTATISTICS, V7, P100, DOI 10.1093/biostatistics/kxi043; Hanna J, 2006, NAT MED, V12, P1065, DOI 10.1038/nm1452; HASTIE T, 1989, J AM STAT ASSOC, V84, P502, DOI 10.2307/2289936; Hood BL, 2015, BIOL REPROD, V92, DOI 10.1095/biolreprod.114.127217; Jeong JW, 2010, BIOL REPROD, V83, P396, DOI 10.1095/biolreprod.109.083154; Ji ZC, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkw430; Kelleher AM, 2019, FASEB J, V33, P8543, DOI 10.1096/fj.201900013R; Kim TH, 2016, CELL REP, V16, P2053, DOI 10.1016/j.celrep.2016.07.056; Kowalczyk MS, 2015, GENOME RES, V25, P1860, DOI 10.1101/gr.192237.115; Krjutskov K, 2016, HUM REPROD, V31, P844, DOI 10.1093/humrep/dew008; Lachmann A, 2016, BIOINFORMATICS, V32, P2233, DOI 10.1093/bioinformatics/btw216; Lessey BA, 1996, AM J REPROD IMMUNOL, V35, P195; LESSEY BA, 1988, J CLIN ENDOCR METAB, V67, P334, DOI 10.1210/jcem-67-2-334; LESSEY BA, 1989, FERTIL STERIL, V51, P409; Lucas ES, 2020, COMMUN BIOL, V3, DOI 10.1038/s42003-020-0763-1; Macosko EZ, 2015, CELL, V161, P1202, DOI 10.1016/j.cell.2015.05.002; MANN HB, 1947, ANN MATH STAT, V18, P50, DOI 10.1214/aoms/1177730491; Marco E, 2014, P NATL ACAD SCI USA, V111, pE5643, DOI 10.1073/pnas.1408993111; Martin RD, 2007, YEARB PHYS ANTHROPOL, V50, P59, DOI 10.1002/ajpa.20734; Masuda H, 2012, CELL TRANSPLANT, V21, P2201, DOI 10.3727/096368911X637362; McGinnis CS, 2019, CELL SYST, V8, P329, DOI 10.1016/j.cels.2019.03.003; NOYES RW, 1950, FERTIL STERIL, V1, P3, DOI 10.1016/s0015-0282(16)30062-0; Okada H, 2014, J OBSTET GYNAECOL RE, V40, P1180, DOI 10.1111/jog.12392; Park Y, 2016, MOL BIOL EVOL, V33, P3161, DOI 10.1093/molbev/msw193; Petropoulos S, 2016, CELL, V167, P285, DOI [10.1016/j.cell.2016.03.023, 10.1016/j.cell.2016.08.009]; Ramathal CY, 2010, SEMIN REPROD MED, V28, P17, DOI 10.1055/s-0029-1242989; Riesewijk A, 2003, MOL HUM REPROD, V9, P253, DOI 10.1093/molehr/gag037; Ruiz-Alonso M, 2012, BBA-MOL BASIS DIS, V1822, P1931, DOI 10.1016/j.bbadis.2012.05.004; Schwab KE, 2007, HUM REPROD, V22, P2903, DOI 10.1093/humrep/dem265; Stuart T, 2019, CELL, V177, P1888, DOI 10.1016/j.cell.2019.05.031; Suryawanshi H, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aau4788; Talbi S, 2006, ENDOCRINOLOGY, V147, P1097, DOI 10.1210/en.2005-1076; Tempest N, 2018, HUM REPROD, V33, P1052, DOI 10.1093/humrep/dey083; TheGeneOntologyConsortium, 2017, Nucleic Acids Res, V45, pD331, DOI 10.1093/nar/gkw1108; Tirosh I, 2016, NATURE, V539, P309, DOI 10.1038/nature20123; Tkacik G, 2011, J PHYS-CONDENS MAT, V23, DOI 10.1088/0953-8984/23/15/153102; Tulac S, 2003, J CLIN ENDOCR METAB, V88, P3860, DOI 10.1210/jc.2003-030494; Turco MY, 2017, NAT CELL BIOL, V19, P568, DOI 10.1038/ncb3516; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; van der Maaten L, 2008, J MACH LEARN RES, V9, P2579; Vento-Tormo R, 2018, NATURE, V563, P347, DOI 10.1038/s41586-018-0698-6; Whitfield ML, 2002, MOL BIOL CELL, V13, P1977, DOI 10.1091/mbc.02-02-0030; Wilcox AJ, 1999, NEW ENGL J MED, V340, P1796, DOI 10.1056/NEJM199906103402304; Wu B, 2018, CELL ATLAS HUMAN UTE, DOI 10.1101/267849; Yin Y, 2005, J BIOCHEM, V137, P677, DOI 10.1093/jb/mvi087; Zhou F, 2015, CELL, V162, DOI 10.1016/j.cell.2015.06.048; ZHOU J, 1994, J CLIN ENDOCR METAB, V79, P1723, DOI 10.1210/jc.79.6.1723	59	115	115	9	40	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	OCT	2020	26	10					1644	+		10.1038/s41591-020-1040-z	http://dx.doi.org/10.1038/s41591-020-1040-z		SEP 2020	27	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	NX8MD	32929266				2022-12-27	WOS:000569298900003
J	Norgeot, B; Quer, G; Beaulieu-Jones, BK; Torkamani, A; Dias, R; Gianfrancesco, M; Arnaout, R; Kohane, IS; Saria, S; Topol, E; Obermeyer, Z; Yu, B; Butte, AJ				Norgeot, Beau; Quer, Giorgio; Beaulieu-Jones, Brett K.; Torkamani, Ali; Dias, Raquel; Gianfrancesco, Milena; Arnaout, Rima; Kohane, Isaac S.; Saria, Suchi; Topol, Eric; Obermeyer, Ziad; Yu, Bin; Butte, Atul J.			Minimum information about clinical artificial intelligence modeling: the MI-CLAIM checklist	NATURE MEDICINE			English	Editorial Material							ALGORITHM; COMPUTER; HEALTH	Here we present the MI-CLAIM checklist, a tool intended to improve transparent reporting of AI algorithms in medicine.	[Norgeot, Beau; Arnaout, Rima; Butte, Atul J.] Univ Calif San Francisco, Bakar Computat Hlth Sci Inst, San Francisco, CA 94143 USA; [Quer, Giorgio; Torkamani, Ali; Dias, Raquel; Topol, Eric] Scripps Res Translat Inst, San Diego, CA USA; [Beaulieu-Jones, Brett K.; Kohane, Isaac S.] Dept Biomed Informat, Boston, MA USA; [Gianfrancesco, Milena] Univ Calif San Francisco, Dept Med, Div Rheumatol, San Francisco, CA 94143 USA; [Saria, Suchi] Johns Hopkins Univ, Dept Comp Sci, Baltimore, MD 21218 USA; [Saria, Suchi] Bayesian Hlth, New York, NY USA; [Obermeyer, Ziad] Univ Calif Berkeley, Sch Publ Hlth, Div Hlth Policy & Management, Berkeley, CA 94720 USA; [Yu, Bin] Univ Calif Berkeley, Dept Stat, Berkeley, CA 94720 USA; [Yu, Bin] Univ Calif Berkeley, Dept Elect Engn & Comp Sci, Berkeley, CA 94720 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Johns Hopkins University; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Butte, AJ (corresponding author), Univ Calif San Francisco, Bakar Computat Hlth Sci Inst, San Francisco, CA 94143 USA.	atul.butte@ucsf.edu		Topol, Eric/0000-0002-1478-4729; Torkamani, Ali/0000-0003-0232-8053				Ching T, 2018, J R SOC INTERFACE, V15, DOI 10.1098/rsif.2017.0387; Esteva A, 2019, NAT MED, V25, P24, DOI 10.1038/s41591-018-0316-z; Gulshan V, 2016, JAMA-J AM MED ASSOC, V316, P2402, DOI 10.1001/jama.2016.17216; Henry KE, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aab3719; Lipton Z. C., 2018, QUEUE, V16, P31, DOI [10.1145/32363863241340., DOI 10.1145/3236386.3241340]; Liu XX, 2020, NAT MED, V26, P1364, DOI 10.1038/s41591-020-1034-x; Lundberg S., 2017, ARXIV; Moher David, 2012, Int J Surg, V10, P28, DOI 10.1016/j.ijsu.2011.10.001; Norgeot B, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2019.0606; Obermeyer Z, 2019, SCIENCE, V366, P447, DOI 10.1126/science.aax2342; Pan J., 2016, ARXIV; Poplin R, 2018, NAT BIOMED ENG, V2, P158, DOI 10.1038/s41551-018-0195-0; Rajkomar A, 2018, NPJ DIGIT MED, V1, DOI 10.1038/s41746-018-0029-1; Rivera SC, 2020, LANCET DIGIT HEALTH, V2, pE549, DOI [10.1038/s41591-020-1037-7, 10.1016/S2589-7500(20)30219-3, 10.1136/bmj.m3210]; SCHWARTZ WB, 1970, NEW ENGL J MED, V283, P1257, DOI 10.1056/NEJM197012032832305; Schwarz CG, 2019, NEW ENGL J MED, V381, P1684, DOI 10.1056/NEJMc1908881; SHORTLIFFE EH, 1973, COMPUT BIOMED RES, V6, P544, DOI 10.1016/0010-4809(73)90029-3; SHORTLIFFE EH, 1975, COMPUT BIOMED RES, V8, P303, DOI 10.1016/0010-4809(75)90009-9; Subbaswamy A, 2020, BIOSTATISTICS, V21, P345, DOI 10.1093/biostatistics/kxz041; Topol E.J., 2019, DEEP MED ARTIFICIAL; von Elm E, 2007, ANN INTERN MED, V147, P573, DOI 10.7326/0003-4819-147-8-200710160-00010; Zou J, 2019, NAT GENET, V51, P12, DOI 10.1038/s41588-018-0295-5	22	102	102	3	7	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	SEP	2020	26	9					1320	1324		10.1038/s41591-020-1041-y	http://dx.doi.org/10.1038/s41591-020-1041-y			5	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	PF3EM	32908275	Green Accepted			2022-12-27	WOS:000598942000007
J	Adhikari, AN; Gallagher, RC; Wang, YQ; Currier, RJ; Amatuni, G; Bassaganyas, L; Chen, F; Kundu, K; Kvale, M; Mooney, SD; Nussbaum, RL; Randi, SS; Sanford, J; Shieh, JT; Srinivasan, R; Sunderam, U; Tang, H; Vaka, D; Zou, YY; Koenig, BA; Kwok, PY; Risch, N; Puck, JM; Brenner, SE				Adhikari, Aashish N.; Gallagher, Renata C.; Wang, Yaqiong; Currier, Robert J.; Amatuni, George; Bassaganyas, Laia; Chen, Flavia; Kundu, Kunal; Kvale, Mark; Mooney, Sean D.; Nussbaum, Robert L.; Randi, Savanna S.; Sanford, Jeremy; Shieh, Joseph T.; Srinivasan, Rajgopal; Sunderam, Uma; Tang, Hao; Vaka, Dedeepya; Zou, Yangyun; Koenig, Barbara A.; Kwok, Pui-Yan; Risch, Neil; Puck, Jennifer M.; Brenner, Steven E.			The role of exome sequencing in newborn screening for inborn errors of metabolism	NATURE MEDICINE			English	Article							DEHYDROGENASE-DEFICIENCY; WHOLE-EXOME; GENE; POPULATION; DISORDERS; VARIANTS; DNA; ASSOCIATION; ANNOTATION; MUTATIONS	Whole-exome sequencing is not sensitive or specific enough to replace the gold standard of tandem mass spectrometry screening of rare inborn errors of metabolism, but can help to reduce false positives and facilitate the timely resolution of ambiguous cases. Public health newborn screening (NBS) programs provide population-scale ascertainment of rare, treatable conditions that require urgent intervention. Tandem mass spectrometry (MS/MS) is currently used to screen newborns for a panel of rare inborn errors of metabolism (IEMs)(1-4). The NBSeq project evaluated whole-exome sequencing (WES) as an innovative methodology for NBS. We obtained archived residual dried blood spots and data for nearly all IEM cases from the 4.5 million infants born in California between mid-2005 and 2013 and from some infants who screened positive by MS/MS, but were unaffected upon follow-up testing. WES had an overall sensitivity of 88% and specificity of 98.4%, compared to 99.0% and 99.8%, respectively for MS/MS, although effectiveness varied among individual IEMs. Thus, WES alone was insufficiently sensitive or specific to be a primary screen for most NBS IEMs. However, as a secondary test for infants with abnormal MS/MS screens, WES could reduce false-positive results, facilitate timely case resolution and in some instances even suggest more appropriate or specific diagnosis than that initially obtained. This study represents the largest, to date, sequencing effort of an entire population of IEM-affected cases, allowing unbiased assessment of current capabilities of WES as a tool for population screening.	[Adhikari, Aashish N.; Wang, Yaqiong; Kundu, Kunal; Zou, Yangyun; Brenner, Steven E.] Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA; [Adhikari, Aashish N.; Gallagher, Renata C.; Bassaganyas, Laia; Chen, Flavia; Kvale, Mark; Nussbaum, Robert L.; Shieh, Joseph T.; Vaka, Dedeepya; Koenig, Barbara A.; Kwok, Pui-Yan; Risch, Neil; Puck, Jennifer M.; Brenner, Steven E.] Univ Calif San Francisco, Inst Human Genet, San Francisco, CA 94143 USA; [Gallagher, Renata C.; Currier, Robert J.; Amatuni, George; Shieh, Joseph T.; Puck, Jennifer M.] Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94143 USA; [Chen, Flavia; Koenig, Barbara A.] Univ Calif San Francisco, Program Bioeth, San Francisco, CA 94143 USA; [Kundu, Kunal; Srinivasan, Rajgopal; Sunderam, Uma] Tata Consultancy Serv, Innovat Labs, Hyderabad, India; [Mooney, Sean D.] Univ Washington, Dept Biomed Informat & Med Educ, Seattle, WA 98195 USA; [Nussbaum, Robert L.] Invitae, San Francisco, CA USA; [Randi, Savanna S.; Sanford, Jeremy] Univ Calif Santa Cruz, Dept Mol Cellular & Dev Biol, Ctr Mol Biol RNA, UC Santa Cruz Genom Inst, Santa Cruz, CA 95064 USA; [Tang, Hao] Calif Dept Publ Hlth, Genet Dis Screening Program, Richmond, CA USA; [Kwok, Pui-Yan; Puck, Jennifer M.] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA; [Kwok, Pui-Yan] Univ Calif San Francisco, Dept Dermatol, San Francisco, CA USA; [Risch, Neil] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA USA; [Puck, Jennifer M.] UCSF Benioff Childrens Hosp, Div Allergy Immunol & Blood & Marrow Transplantat, San Francisco, CA 94158 USA; [Brenner, Steven E.] Univ Calif Berkeley, Ctr Computat Biol, Berkeley, CA 94720 USA; [Brenner, Steven E.] Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94143 USA	University of California System; University of California Berkeley; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Tata Sons; Tata Consultancy Services Limited (TCS); University of Washington; University of Washington Seattle; University of California System; University of California Santa Cruz; California Department of Public Health; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California Berkeley; University of California System; University of California San Francisco	Adhikari, AN; Brenner, SE (corresponding author), Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA.; Adhikari, AN; Puck, JM; Brenner, SE (corresponding author), Univ Calif San Francisco, Inst Human Genet, San Francisco, CA 94143 USA.; Puck, JM (corresponding author), Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94143 USA.; Puck, JM (corresponding author), Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA.; Puck, JM (corresponding author), UCSF Benioff Childrens Hosp, Div Allergy Immunol & Blood & Marrow Transplantat, San Francisco, CA 94158 USA.; Brenner, SE (corresponding author), Univ Calif Berkeley, Ctr Computat Biol, Berkeley, CA 94720 USA.; Brenner, SE (corresponding author), Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94143 USA.	anadhikari@berkeley.edu; jennifer.puck@ucsf.edu; brenner@compbio.berkeley.edu	Brenner, Steven E/A-8729-2008; Kwok, Pui-Yan/F-7725-2014	Brenner, Steven E/0000-0001-7559-6185; Kwok, Pui-Yan/0000-0002-5087-3059; MOONEY, SEAN D/0000-0003-2654-0833; Wang, Yaqiong/0000-0002-1447-7868; Currier, Robert/0000-0001-9168-5604; Chen, Flavia/0000-0003-3908-2720; Gallagher, Renata/0000-0003-1611-0354; Adhikari, Aashish/0000-0003-4305-9494	National Institutes of Health [U19HD077627]; Tata Consultancy Services; California Biobank Program [496]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Tata Consultancy Services; California Biobank Program	The authors are grateful for expert technical and computational assistance from many diligent contributors, including W. Chan, J.-M. Chandonia, A. Chellappan, N. Dabbiru, B. Dispensa, A. Neumann, A. Nguyen, A. Rao, S. Rana and Z.-Y. Wu. The work was funded by the National Institutes of Health grant U19HD077627 as part of the NSIGHT project, a joint program between the National Human Genome Research Institute and the Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health. This work was also supported by a research agreement with Tata Consultancy Services. The biospecimens and/or data used in this study were obtained from the California Biobank Program (SIS request no. 496). The CPDH is not responsible for the results or conclusions drawn by the authors of this publication.	Adams DR, 2018, NEW ENGL J MED, V379, P1353, DOI 10.1056/NEJMra1711801; Ahmed H, 2019, J COMPUT BIOL, V26, P225, DOI 10.1089/cmb.2018.0199; Bassaganyas L, 2018, HUM MUTAT, V39, P167, DOI 10.1002/humu.23356; BATSHAW ML, 1986, J PEDIATR-US, V108, P236, DOI 10.1016/S0022-3476(86)80989-1; Bell CJ, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001756; Berg JS, 2017, PEDIATRICS, V139, DOI 10.1542/peds.2016-2252; Bergeron A, 2001, J BIOL CHEM, V276, P15225, DOI 10.1074/jbc.M009341200; Biesecker LG, 2019, GENET MED, V21, P41, DOI 10.1038/s41436-018-0019-3; Biesecker LG, 2014, NEW ENGL J MED, V370, P2418, DOI 10.1056/NEJMra1312543; Bodian DL, 2016, GENET MED, V18, P221, DOI 10.1038/gim.2015.111; Calonge N, 2010, GENET MED, V12, P153, DOI 10.1097/GIM.0b013e3181d2af04; Chamberlin ME, 1997, AM J HUM GENET, V60, P540; Clark MM, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aat6177; Corvelo A, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001016; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Farnaes L, 2018, NPJ GENOM MED, V3, DOI 10.1038/s41525-018-0049-4; Feuchtbaum L, 2018, GENET MED, V20, P831, DOI 10.1038/gim.2017.199; Feuchtbaum L, 2012, GENET MED, V14, P937, DOI 10.1038/gim.2012.76; French CE, 2019, INTENS CARE MED, V45, P627, DOI 10.1007/s00134-019-05552-x; Friedman JM, 2019, GENET MED, V21, P498, DOI 10.1038/s41436-018-0055-z; Fromer M, 2012, AM J HUM GENET, V91, P597, DOI 10.1016/j.ajhg.2012.08.005; Gallant NM, 2012, MOL GENET METAB, V106, P55, DOI 10.1016/j.ymgme.2012.02.007; Goldfeder RL, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0269-0; Hall PL, 2014, GENET MED, V16, P889, DOI 10.1038/gim.2014.62; Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111; Henriques BJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107157; Hoffmann S, 2017, IDOLIZING AUTHORSHIP: LITERARY CELEBRITY AND THE CONSTRUCTION OF IDENTITY, 1800 TO THE PRESENT, P31; Hu JX, 2014, PEDIATR INFECT DIS J, V33, P1077, DOI 10.1097/INF.0000000000000368; Jethva R, 2008, MOL GENET METAB, V95, P195, DOI 10.1016/j.ymgme.2008.09.007; Jian XQ, 2017, METHODS MOL BIOL, V1498, P191, DOI 10.1007/978-1-4939-6472-7_13; Jian XQ, 2014, NUCLEIC ACIDS RES, V42, P13534, DOI 10.1093/nar/gku1206; Jun G, 2012, AM J HUM GENET, V91, P839, DOI 10.1016/j.ajhg.2012.09.004; Kingsmore SF, 2019, AM J HUM GENET, V105, P719, DOI 10.1016/j.ajhg.2019.08.009; Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892; Landrum MJ, 2018, NUCLEIC ACIDS RES, V46, pD1062, DOI 10.1093/nar/gkx1153; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Mak CM, 2013, CRIT REV CL LAB SCI, V50, P142, DOI 10.3109/10408363.2013.847896; Rodriguez JM, 2013, NUCLEIC ACIDS RES, V41, pD110, DOI 10.1093/nar/gks1058; Matern D, 2003, PEDIATRICS, V112, P74, DOI 10.1542/peds.112.1.74; McHugh DMS, 2011, GENET MED, V13, P230, DOI 10.1097/GIM.0b013e31820d5e67; Peng G, 2019, GENET MED, V21, P896, DOI 10.1038/s41436-018-0272-5; Punwani D, 2016, NEW ENGL J MED, V375, P2165, DOI 10.1056/NEJMoa1509164; Regaldo A., 2017, TECHNOLOGY REV; Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Stenson PD, 2003, HUM MUTAT, V21, P577, DOI 10.1002/humu.10212; Sterne-Weiler T, 2011, GENOME RES, V21, P1563, DOI 10.1101/gr.118638.110; Van der Auwera Geraldine A, 2013, Curr Protoc Bioinformatics, V43, DOI [10.1002/0471250953.bi1201s43, 10.1002/0471250953.bi1110s43]; Sulonen AM, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-9-r94; Sunderam U., 2020, DNA DRIED BLOOD SPOT, DOI 10.1101/2020.05.19.105304; Tabor HK, 2014, AM J HUM GENET, V95, P183, DOI 10.1016/j.ajhg.2014.07.006; Tang H, 2016, GENET MED, V18, P259, DOI 10.1038/gim.2015.154; Tiranti V, 2004, AM J HUM GENET, V74, P239, DOI 10.1086/381653; Vockley J, 2000, MOL GENET METAB, V71, P10, DOI 10.1006/mgme.2000.3066; Wang Y., 2020, PERTURBATION ROBUSTN, DOI 10.1101/2020.06.29.173815; Wang ZQ, 2011, J MOL MED, V89, P569, DOI 10.1007/s00109-011-0725-7; Wilcken B, 2003, NEW ENGL J MED, V348, P2304, DOI 10.1056/NEJMoa025225; Wolfe L., 2018, GENEREVIEWS; Yorifuji T, 1998, CLIN GENET, V54, P349, DOI 10.1034/j.1399-0004.1998.5440415.x	60	61	68	5	26	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	SEP	2020	26	9								10.1038/s41591-020-0966-5	http://dx.doi.org/10.1038/s41591-020-0966-5		AUG 2020	25	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	PF3EM	32778825	Green Accepted			2022-12-27	WOS:000558228200004
J	Ayoub, R; Ruddy, RM; Cox, E; Oyefiade, A; Derkach, D; Laughlin, S; Ades-aron, B; Shirzadi, Z; Fieremans, E; MacIntosh, BJ; de Medeiros, CB; Skocic, J; Bouffet, E; Miller, FD; Morshead, CM; Mabbott, DJ				Ayoub, Ramy; Ruddy, Rebecca M.; Cox, Elizabeth; Oyefiade, Adeoye; Derkach, Daniel; Laughlin, Suzanne; Ades-aron, Benjamin; Shirzadi, Zahra; Fieremans, Els; MacIntosh, Bradley J.; de Medeiros, Cynthia B.; Skocic, Jovanka; Bouffet, Eric; Miller, Freda D.; Morshead, Cindi M.; Mabbott, Donald J.			Assessment of cognitive and neural recovery in survivors of pediatric brain tumors in a pilot clinical trial using metformin	NATURE MEDICINE			English	Article							HIPPOCAMPAL NEUROGENESIS; WHITE-MATTER; STEM-CELLS; ADULT NEUROGENESIS; DENTATE GYRUS; MOUSE MODEL; MEMORY; CHILDREN; IRRADIATION; IMPAIRMENT	We asked whether pharmacological stimulation of endogenous neural precursor cells (NPCs) may promote cognitive recovery and brain repair, focusing on the drug metformin, in parallel rodent and human studies of radiation injury. In the rodent cranial radiation model, we found that metformin enhanced the recovery of NPCs in the dentate gyrus, with sex-dependent effects on neurogenesis and cognition. A pilot double-blind, placebo-controlled crossover trial was conducted (ClinicalTrials.gov,) in survivors of pediatric brain tumors who had been treated with cranial radiation. Safety, feasibility, cognitive tests and MRI measures of white matter and the hippocampus were evaluated as endpoints. Twenty-four participants consented and were randomly assigned to complete 12-week cycles of metformin (A) and placebo (B) in either an AB or BA sequence with a 10-week washout period at crossover. Blood draws were conducted to monitor safety. Feasibility was assessed as recruitment rate, medication adherence and procedural adherence. Linear mixed modeling was used to examine cognitive and MRI outcomes as a function of cycle, sequence and treatment. We found no clinically relevant safety concerns and no serious adverse events associated with metformin. Sequence effects were observed for all cognitive outcomes in our linear mixed models. For the subset of participants with complete data in cycle 1, metformin was associated with better performance than placebo on tests of declarative and working memory. We present evidence that a clinical trial examining the effects of metformin on cognition and brain structure is feasible in long-term survivors of pediatric brain tumors and that metformin is safe to use and tolerable in this population. This pilot trial was not intended to test the efficacy of metformin for cognitive recovery and brain growth, but the preliminary results are encouraging and warrant further investigation in a large multicenter phase 3 trial.	[Ayoub, Ramy; Cox, Elizabeth; Oyefiade, Adeoye; de Medeiros, Cynthia B.; Skocic, Jovanka; Miller, Freda D.; Mabbott, Donald J.] Hosp Sick Children, Res Inst, Neurosci & Mental Hlth Program, Toronto, ON, Canada; [Ayoub, Ramy; Cox, Elizabeth; Oyefiade, Adeoye; Mabbott, Donald J.] Univ Toronto, Dept Psychol, Toronto, ON, Canada; [Ruddy, Rebecca M.; Derkach, Daniel; Miller, Freda D.; Morshead, Cindi M.] Univ Toronto, Inst Med Sci, Toronto, ON, Canada; [Laughlin, Suzanne] Hosp Sick Children, Diagnost Imaging, Toronto, ON, Canada; [Laughlin, Suzanne] Univ Toronto, Dept Med Imaging, Toronto, ON, Canada; [Ades-aron, Benjamin; Fieremans, Els] NYU, Dept Radiol, Grossman Sch Med, Ctr Biomed Imaging, 560 1St Ave, New York, NY 10016 USA; [Shirzadi, Zahra; MacIntosh, Bradley J.] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada; [Shirzadi, Zahra; MacIntosh, Bradley J.] Univ Toronto, Sunnybrook Res Inst, Hurvitz Brain Sci, Toronto, ON, Canada; [Bouffet, Eric] Hosp Sick Children, Div Haematol Oncol, Toronto, ON, Canada; [Bouffet, Eric] Univ Toronto, Dept Paediat, Toronto, ON, Canada; [Miller, Freda D.] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada; [Miller, Freda D.] Univ Toronto, Dept Physiol, Toronto, ON, Canada; [Morshead, Cindi M.] Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON, Canada; [Morshead, Cindi M.] Univ Toronto, Dept Surg, Div Anat, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; New York University; University of Toronto; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; University of Toronto; University of Toronto; University of Toronto	Mabbott, DJ (corresponding author), Hosp Sick Children, Res Inst, Neurosci & Mental Hlth Program, Toronto, ON, Canada.; Mabbott, DJ (corresponding author), Univ Toronto, Dept Psychol, Toronto, ON, Canada.; Morshead, CM (corresponding author), Univ Toronto, Inst Med Sci, Toronto, ON, Canada.; Morshead, CM (corresponding author), Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON, Canada.; Morshead, CM (corresponding author), Univ Toronto, Dept Surg, Div Anat, Toronto, ON, Canada.	cindi.morshead@utoronto.ca; donald.mabbott@sickkids.ca		Ayoub, Ramy/0000-0001-7099-9284; Ades-Aron, Benjamin/0000-0001-5077-3341; MacIntosh, Bradley/0000-0001-7300-2355; Fieremans, Els/0000-0002-1384-8591; Derkach, Daniel/0000-0002-8515-9795	Brain Canada; Stem Cell Network; Ontario Institute for Regenerative Medicine; Medicine By Design (CFREF); Garron Family Cancer Centre; CIHR graduate student fellowship	Brain Canada; Stem Cell Network; Ontario Institute for Regenerative Medicine; Medicine By Design (CFREF); Garron Family Cancer Centre; CIHR graduate student fellowship(Canadian Institutes of Health Research (CIHR))	We wish to thank A. Willan, Clinical Trials Methodologist, Ontario Child Health Support Unit, Research Institute, The Hospital for Sick Children, for consulting on and developing our analytic approach while blind to the trial data. We also wish to thank the research personnel and clinical staff who made this trial possible, particularly V. Ramaswamy, U. Bartels, U. Tabori and A. Huang, as well as N. Sarvaria, D. Thomas, E. Barlev, J. Dutton, J. Gammon, L. Lauer, A. Decker, A. Ferkul, D. McRae, T. Rayner, R. Weiss and M. Lalancette. We would also like to thank J. Wang, D. Kaplan and P. Frankland for frequent discussions and advice during the course of this work. Finally, we wish to thank J. Tseng for her technical support in improving the presentation of our figures. This work was supported by grants from Brain Canada (F.D.M., D.J.M., C.M.M.), the Stem Cell Network (F.D.M., D.J.M., C.M.M.), the Ontario Institute for Regenerative Medicine (F.D.M., D.J.M., C.M.M.), Medicine By Design (CFREF), and the Garron Family Cancer Centre (D.J.M., E.B.). R.M.R. was supported by a CIHR graduate student fellowship.	Ades-Aron B, 2018, NEUROIMAGE, V183, P532, DOI 10.1016/j.neuroimage.2018.07.066; Anagnostou E, 2016, JAMA PSYCHIAT, V73, P928, DOI 10.1001/jamapsychiatry.2016.1232; Andersson JLR, 2016, NEUROIMAGE, V125, P1063, DOI 10.1016/j.neuroimage.2015.10.019; Avants BB, 2014, FRONT NEUROINFORM, V8, DOI 10.3389/fninf.2014.00044; Babona-Pilipos R, 2012, JOVE-J VIS EXP, V2012, P4193; Benavides S, 2005, PHARMACOTHERAPY, V25, P803, DOI 10.1592/phco.2005.25.6.803; Bjornstad P, 2018, CIRCULATION, V138, P2895, DOI 10.1161/CIRCULATIONAHA.118.035525; Bridger T, 2006, ARCH PEDIAT ADOL MED, V160, P241, DOI 10.1001/archpedi.160.3.241; Chang A, 2000, J NEUROSCI, V20, P6404, DOI 10.1523/JNEUROSCI.20-17-06404.2000; Chow A, 2016, STEM CELL RES, V16, P79, DOI 10.1016/j.scr.2015.12.007; Coles-Takabe BLK, 2008, STEM CELLS, V26, P2938, DOI 10.1634/stemcells.2008-0558; Collier Q, 2015, MAGN RESON MED, V73, P2174, DOI 10.1002/mrm.25351; Curtis E, 2018, CELL STEM CELL, V22, P941, DOI 10.1016/j.stem.2018.05.014; Dadwal P, 2015, STEM CELL REP, V5, P166, DOI 10.1016/j.stemcr.2015.06.011; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Decker AL, 2017, HIPPOCAMPUS, V27, P1140, DOI 10.1002/hipo.22758; Dy ABC, 2018, CLIN GENET, V93, P216, DOI 10.1111/cge.13039; Engvig A, 2012, HUM BRAIN MAPP, V33, P2390, DOI 10.1002/hbm.21370; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Fieremans E, 2011, NEUROIMAGE, V58, P177, DOI 10.1016/j.neuroimage.2011.06.006; Fischl B, 2001, IEEE T MED IMAGING, V20, P70, DOI 10.1109/42.906426; Fukuda A, 2005, J NEUROCHEM, V92, P569, DOI 10.1111/j.1471-4159.2004.02894.x; Gantois I, 2017, NAT MED, V23, P674, DOI 10.1038/nm.4335; Gershon RC, 2013, NEUROLOGY, V80, pS2, DOI 10.1212/WNL.0b013e3182872e5f; Gibson EM, 2014, SCIENCE, V344, P487, DOI 10.1126/science.1252304; Gupta N, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004373; Hellstraom NAK, 2009, STEM CELLS, V27, P634, DOI 10.1634/stemcells.2008-0732; Hendrikse J, 2004, RADIOLOGY, V233, P899, DOI 10.1148/radiol.2333031276; Hsia YF, 2012, BRIT J CLIN PHARMACO, V73, P135, DOI 10.1111/j.1365-2125.2011.04063.x; Jelescu IO, 2016, NEUROIMAGE, V132, P104, DOI 10.1016/j.neuroimage.2016.02.004; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Kahalley LS, 2020, J CLIN ONCOL, V38, DOI 10.1200/JCO.19.01706; Kellner E, 2016, MAGN RESON MED, V76, P1574, DOI 10.1002/mrm.26054; Krull KR, 2018, J CLIN ONCOL, V36, DOI 10.1200/JCO.2017.76.4696; Lazarini F, 2011, TRENDS NEUROSCI, V34, P20, DOI 10.1016/j.tins.2010.09.006; Lebel C, 2011, J NEUROSCI, V31, P10937, DOI 10.1523/JNEUROSCI.5302-10.2011; Leszczynski M, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00168; Lin YF, 2018, FRONT AGING NEUROSCI, V10, DOI 10.3389/fnagi.2018.00227; Luchsinger JA, 2016, J ALZHEIMERS DIS, V51, P501, DOI 10.3233/JAD-150493; Miller FD, 2012, CELL STEM CELL, V10, P650, DOI 10.1016/j.stem.2012.05.004; Ming GL, 2011, NEURON, V70, P687, DOI 10.1016/j.neuron.2011.05.001; Monje ML, 2003, SCIENCE, V302, P1760, DOI 10.1126/science.1088417; Monje ML, 2002, NAT MED, V8, P955, DOI 10.1038/nm749; Moreno-Jimenez EP, 2019, NAT MED, V25, P554, DOI 10.1038/s41591-019-0375-9; Moxon-Emre I, 2014, J CLIN ONCOL, V32, P1760, DOI 10.1200/JCO.2013.52.3290; Nusrat L, 2018, FRONT AGING NEUROSCI, V10, DOI 10.3389/fnagi.2018.00093; Ou ZR, 2018, BRAIN BEHAV IMMUN, V69, P351, DOI 10.1016/j.bbi.2017.12.009; Ould-Brahim F, 2018, STEM CELLS DEV, V27, P1085, DOI 10.1089/scd.2018.0055; Pereira AC, 2007, P NATL ACAD SCI USA, V104, P5638, DOI 10.1073/pnas.0611721104; Redmond KJ, 2013, NEURO-ONCOLOGY, V15, P1455, DOI 10.1093/neuonc/not213; Riggs L, 2017, NEURO-ONCOLOGY, V19, P440, DOI 10.1093/neuonc/now177; Riggs L, 2014, J INT NEUROPSYCH SOC, V20, P168, DOI 10.1017/S135561771300129X; Rola R, 2004, EXP NEUROL, V188, P316, DOI 10.1016/j.expneurol.2004.05.005; Roughton K, 2012, EUR J NEUROSCI, V36, P2763, DOI 10.1111/j.1460-9568.2012.08197.x; Ruddy RM, 2020, BRAIN RES, V1727, DOI 10.1016/j.brainres.2019.146548; Ruddy RM, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aax1912; Sato Y, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00715; Scafidi J, 2014, NATURE, V506, P230, DOI 10.1038/nature12880; Scantlebury N, 2016, NEUROPSYCHOLOGY, V30, P425, DOI 10.1037/neu0000258; Schmidt M., 1996, W PSYCHOL SERVICES; Shirzadi Z, 2015, J MAGN RESON IMAGING, V42, P1377, DOI 10.1002/jmri.24918; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Sorrells SF, 2018, NATURE, V555, P377, DOI 10.1038/nature25975; Spiller HA, 2004, ANN PHARMACOTHER, V38, P776, DOI 10.1345/aph.1D468; Sun J, 2019, MEDICINE, V98, DOI [10.1097/md.0000000000014249, 10.1097/MD.0000000000014249]; Talley JL, 1993, CAVLT 2 CHILDRENS AU; Tanokashira D, 2018, FEBS OPEN BIO, V8, P1104, DOI 10.1002/2211-5463.12436; Vakil E, 2010, CLIN NEUROPSYCHOL, V24, P662, DOI 10.1080/13854040903493522; van Osch MJP, 2002, NEUROIMAGE, V17, P469, DOI 10.1006/nimg.2002.1214; Veraart J, 2016, NEUROIMAGE, V142, P384, DOI 10.1016/j.neuroimage.2016.08.016; Veraart J, 2016, MAGN RESON MED, V76, P1582, DOI 10.1002/mrm.26059; Wang J, 2012, CELL STEM CELL, V11, P23, DOI 10.1016/j.stem.2012.03.016; Wang J, 2010, DEV CELL, V18, P114, DOI 10.1016/j.devcel.2009.10.023; Wellek S, 2012, DTSCH ARZTEBL INT, V109, P276, DOI 10.3238/arztebl.2012.0276; Zammit AR, 2017, BEHAV BRAIN RES, V317, P157, DOI 10.1016/j.bbr.2016.09.038; Zheng FL, 2018, FRONT AGING NEUROSCI, V10, DOI 10.3389/fnagi.2018.00320	78	37	37	2	20	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	AUG	2020	26	8					1285	+		10.1038/s41591-020-0985-2	http://dx.doi.org/10.1038/s41591-020-0985-2		JUL 2020	22	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	MX8ZF	32719487	Green Accepted			2022-12-27	WOS:000552954000006
J	Corr, EM; Brown, EJ; Albers, KB; Yamaguchi, N; Narke, D; Schlegel, M; Sharma, M; Shanley, LC; Barrett, TJ; Rahman, K; Mezzano, V; Fisher, EA; Park, DS; Newman, JD; Quail, DF; Nelson, ER; Caan, BJ; Jones, LW; Moore, KJ				Corr, Emma M.; Brown, Emily J.; Albers, Kathleen B.; Yamaguchi, Naoko; Narke, Deven; Schlegel, Martin; Sharma, Monika; Shanley, Lianne C.; Barrett, Tessa J.; Rahman, Karishma; Mezzano, Valeria; Fisher, Edward A.; Park, David S.; Newman, Jonathan D.; Quail, Daniela F.; Nelson, Erik R.; Caan, Bette J.; Jones, Lee W.; Moore, Kathryn J.			Myocardial infarction accelerates breast cancer via innate immune reprogramming	NATURE MEDICINE			English	Article							HEART-FAILURE; CARDIOVASCULAR-DISEASE; SUPPRESSOR-CELLS; INCREASED RISK; SURVIVORS; TISSUE	Disruption of systemic homeostasis by either chronic or acute stressors, such as obesity(1)or surgery(2), alters cancer pathogenesis. Patients with cancer, particularly those with breast cancer, can be at increased risk of cardiovascular disease due to treatment toxicity and changes in lifestyle behaviors(3-5). While elevated risk and incidence of cardiovascular events in breast cancer is well established, whether such events impact cancer pathogenesis is not known. Here we show that myocardial infarction (MI) accelerates breast cancer outgrowth and cancer-specific mortality in mice and humans. In mouse models of breast cancer, MI epigenetically reprogrammed Ly6C(hi)monocytes in the bone marrow reservoir to an immunosuppressive phenotype that was maintained at the transcriptional level in monocytes in both the circulation and tumor. In parallel, MI increased circulating Ly6C(hi)monocyte levels and recruitment to tumors and depletion of these cells abrogated MI-induced tumor growth. Furthermore, patients with early-stage breast cancer who experienced cardiovascular events after cancer diagnosis had increased risk of recurrence and cancer-specific death. These preclinical and clinical results demonstrate that MI induces alterations in systemic homeostasis, triggering cross-disease communication that accelerates breast cancer. By reprogramming innate immune cells to an immunosuppressive phenotype, myocardial infarction accelerates breast cancer progression in mice, and the clinical relevance of these findings was demonstrated in individuals with early-stage breast cancer who experienced cardiovascular events after cancer diagnosis.	[Corr, Emma M.; Brown, Emily J.; Albers, Kathleen B.; Yamaguchi, Naoko; Narke, Deven; Schlegel, Martin; Sharma, Monika; Shanley, Lianne C.; Barrett, Tessa J.; Mezzano, Valeria; Fisher, Edward A.; Park, David S.; Newman, Jonathan D.; Moore, Kathryn J.] NYU, Sch Med, Dept Med, Cardiovasc Res Ctr,Leon H Charney Div Cardiol, New York, NY 10016 USA; [Caan, Bette J.] Kaiser Permanente Northern Calif, Div Res, Oakland, CA USA; [Rahman, Karishma] NYU, Div Adv Res Technol, Expt Pathol, Sch Med, New York, NY USA; [Newman, Jonathan D.] NYU, Ctr Prevent Cardiovasc Dis, Sch Med, New York, NY USA; [Quail, Daniela F.] McGill Univ, Rosalind & Morris Goodman Canc Res Ctr, Montreal, PQ, Canada; [Quail, Daniela F.] McGill Univ, Dept Med, Div Expt Med, Montreal, PQ, Canada; [Quail, Daniela F.] McGill Univ, Fac Med, Dept Physiol, Montreal, PQ, Canada; [Nelson, Erik R.] Univ Illinois, Dept Mol & Integrat Physiol, Urbana, IL USA; [Nelson, Erik R.] Univ Illinois, Canc Ctr Illinois, Urbana, IL USA; [Nelson, Erik R.] Univ Illinois, Canc Ctr, Chicago, IL USA; [Nelson, Erik R.] Univ Illinois, Div Nutr Sci, Urbana, IL USA; [Nelson, Erik R.] Univ Illinois, Carl R Woese Inst Genom Biol, Anticanc Discovery Pets People Theme, Urbana, IL USA; [Jones, Lee W.] Mem Sloan Kettering Canc Ctr, Dept Med, 1275 York Ave, New York, NY 10021 USA; [Jones, Lee W.] Weill Cornell Med Coll, New York, NY USA; [Moore, Kathryn J.] NYU, Sch Med, Dept Cell Biol, New York, NY 10016 USA	New York University; Kaiser Permanente; New York University; New York University; McGill University; McGill University; McGill University; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; Memorial Sloan Kettering Cancer Center; Cornell University; New York University	Moore, KJ (corresponding author), NYU, Sch Med, Dept Med, Cardiovasc Res Ctr,Leon H Charney Div Cardiol, New York, NY 10016 USA.; Moore, KJ (corresponding author), NYU, Sch Med, Dept Cell Biol, New York, NY 10016 USA.	Kathryn.moore@nyumc.org	Fisher, Edward/ABE-7469-2020; Afonso, Milessa/J-2078-2014; Moore, Kathryn/ABE-6416-2020; Mezzano, Valeria/A-7758-2015; Nelson, Erik/B-5158-2013	Afonso, Milessa/0000-0003-3435-0722; Moore, Kathryn/0000-0003-2505-2547; van Solingen, Coen/0000-0002-5817-2003; Shanley, Lianne C/0000-0001-9810-5545; Yamaguchi, Naoko/0000-0002-6042-3529; Mezzano, Valeria/0000-0003-4675-9146; Fisher, Edward/0000-0001-9802-143X; Barrett, Tessa/0000-0003-0751-1578; Koelwyn, Graeme/0000-0002-3476-0919; Newman, Alexandra/0000-0001-8938-2428; Nelson, Erik/0000-0002-8887-1905; Newman, Jonathan/0000-0001-6855-7305	National Institutes of Health/National Cancer Institute [P30CA016087]; National Institutes of Health [R35HL135799, P01HL131478, P01HL131481, T32HL098129, K23HL125991, R01CA234025, R01CA129059, R01HL132073]; NYU Cancer Institute Center Support Grant [NCIP30CA16087]; NYU Shared Instrumentation Grant [S10 OD021747]; Memorial Sloan Kettering Cancer Center Support Grant/Core Grant [P30 CA008748]; American Heart Association [19CDA34630066, 19POST34380010, 18CDA34110203, 20POST35080180]; Canadian Institutes of Health Research [PJT159742]; AKTIV Against Cancer; Susan G. Komen Foundation [CCR18548032]; Brain Tumor Funders' Collaborative; Canada Foundation for Innovation; Tier II Canada Research Chair in tumor microenvironment research	National Institutes of Health/National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NYU Cancer Institute Center Support Grant; NYU Shared Instrumentation Grant; Memorial Sloan Kettering Cancer Center Support Grant/Core Grant; American Heart Association(American Heart Association); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); AKTIV Against Cancer; Susan G. Komen Foundation(Susan G. Komen Breast Cancer Foundation); Brain Tumor Funders' Collaborative; Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Tier II Canada Research Chair in tumor microenvironment research	Tissue sectioning and histological analyses were provided by the New York University (NYU) Langone's Experimental Pathology Research Laboratory. Cell sorting/flow cytometry technologies were provided by NYU Langone's Cytometry and Cell Sorting Laboratory, which is supported in part by grant P30CA016087 from the National Institutes of Health/National Cancer Institute. This work was supported by funding from the National Institutes of Health (R35HL135799 to K.J.M., P01HL131478 and P01HL131481 to K.J.M. and E.A.F., T32HL098129 to C.v.S., K23HL125991 to J.D.N., R01CA234025 to E.R.N., R01CA129059 to B.J.C. and R01HL132073 to D.S.P.); NYU Cancer Institute Center Support Grant NCIP30CA16087; NYU Shared Instrumentation Grant S10 OD021747; the Memorial Sloan Kettering Cancer Center Support Grant/Core Grant (P30 CA008748)), the American Heart Association (19CDA34630066 to C.v.S., 19POST34380010 to M.S., 18CDA34110203 to T.J.B. and 20POST35080180 to N.Y.), the Canadian Institutes of Health Research (Doctoral Foreign Study Award to G.J.K. and PJT159742 to D.F.Q.), AKTIV Against Cancer (L.W.J.) and the Susan G. Komen Foundation (CCR18548032 to D.F.Q.). D.F.Q. is also supported by the Brain Tumor Funders' Collaborative, Canada Foundation for Innovation and a Tier II Canada Research Chair in tumor microenvironment research.	Amend SR, 2016, J VIS EXP, V14, P53936; Biswas S, 2014, BREAST CANCER RES TR, V143, P265, DOI 10.1007/s10549-013-2811-8; Bronte V, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12150; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Caan B, 2005, CANCER CAUSE CONTROL, V16, P545, DOI 10.1007/s10552-004-8340-3; Cesano A, 2015, J IMMUNOTHER CANCER, V3, DOI 10.1186/s40425-015-0088-7; Cheng SC, 2016, NAT IMMUNOL, V17, P406, DOI 10.1038/ni.3398; Christ A, 2018, CELL, V172, P162, DOI 10.1016/j.cell.2017.12.013; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Engblom C, 2016, NAT REV CANCER, V16, P447, DOI 10.1038/nrc.2016.54; Franklin RA, 2014, SCIENCE, V344, P921, DOI 10.1126/science.1252510; Ginestier C, 2010, J CLIN INVEST, V120, P485, DOI 10.1172/JCI39397; Hasin T, 2016, J AM COLL CARDIOL, V68, P265, DOI 10.1016/j.jacc.2016.04.053; Hasin T, 2013, J AM COLL CARDIOL, V62, P881, DOI 10.1016/j.jacc.2013.04.088; Hershman DL, 2018, J CLIN ONCOL, V36, P2710, DOI 10.1200/JCO.2017.77.4414; Hohl TM, 2009, CELL HOST MICROBE, V6, P470, DOI 10.1016/j.chom.2009.10.007; Hooning MJ, 2007, JNCI-J NATL CANCER I, V99, P365, DOI 10.1093/jnci/djk064; Jones LW, 2007, J AM COLL CARDIOL, V50, P1435, DOI 10.1016/j.jacc.2007.06.037; Krall JA, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aan3464; Kurotaki D, 2018, CELL REP, V22, P2628, DOI 10.1016/j.celrep.2018.02.048; Kwan M, 2008, CANCER CAUSE CONTROL, V19, P1065, DOI 10.1007/s10552-008-9170-5; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Libby P, 2016, J AM COLL CARDIOL, V67, P1091, DOI 10.1016/j.jacc.2015.12.048; Liberzon A, 2011, BIOINFORMATICS, V27, P1739, DOI 10.1093/bioinformatics/btr260; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; McAllister SS, 2014, NAT CELL BIOL, V16, P717, DOI 10.1038/ncb3015; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Meijers WC, 2018, CIRCULATION, V138, P678, DOI 10.1161/CIRCULATIONAHA.117.030816; Mitroulis I, 2018, CELL, V172, P147, DOI 10.1016/j.cell.2017.11.034; Moorlag SJCFM, 2018, IMMUNOL REV, V281, P28, DOI 10.1111/imr.12617; Nahrendorf M, 2007, J EXP MED, V204, P3037, DOI 10.1084/jem.20070885; Nam S, 2016, J LEUKOCYTE BIOL, V100, P1273, DOI 10.1189/jlb.1A0215-068RR; Nelson ER, 2013, SCIENCE, V342, P1094, DOI 10.1126/science.1241908; Netea MG, 2016, SCIENCE, V352, DOI 10.1126/science.aaf1098; Panse J, 2008, BRIT J CANCER, V99, P930, DOI 10.1038/sj.bjc.6604621; Peinado H, 2017, NAT REV CANCER, V17, P302, DOI 10.1038/nrc.2017.6; Quail DF, 2019, NAT REV ENDOCRINOL, V15, P139, DOI 10.1038/s41574-018-0126-x; Ramkhelawon B, 2014, NAT MED, V20, P377, DOI 10.1038/nm.3467; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Shipp C, 2016, CELL MOL LIFE SCI, V73, P4043, DOI 10.1007/s00018-016-2278-y; Ugel S, 2015, J CLIN INVEST, V125, P3365, DOI 10.1172/JCI80006; Waight JD, 2013, J CLIN INVEST, V123, P4464, DOI 10.1172/JCI68189; Wendeln AC, 2018, NATURE, V556, P332, DOI 10.1038/s41586-018-0023-4	43	69	68	5	16	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	SEP	2020	26	9								10.1038/s41591-020-0964-7	http://dx.doi.org/10.1038/s41591-020-0964-7		JUL 2020	26	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	PF3EM	32661390	Green Accepted			2022-12-27	WOS:000548125100002
J	Alivernini, S; MacDonald, L; Elmesmari, A; Finlay, S; Tolusso, B; Gigante, MR; Petricca, L; Di Mario, C; Bui, L; Perniola, S; Attar, M; Gessi, M; Fedele, AL; Chilaka, S; Somma, D; Sansom, SN; Filer, A; McSharry, C; Millar, NL; Kirschner, K; Nerviani, A; Lewis, MJ; Pitzalis, C; Clark, AR; Ferraccioli, G; Udalova, I; Buckley, CD; Gremese, E; McInnes, IB; Otto, TD; Kurowska-Stolarska, M				Alivernini, Stefano; MacDonald, Lucy; Elmesmari, Aziza; Finlay, Samuel; Tolusso, Barbara; Gigante, Maria Rita; Petricca, Luca; Di Mario, Clara; Bui, Laura; Perniola, Simone; Attar, Moustafa; Gessi, Marco; Fedele, Anna Laura; Chilaka, Sabarinadh; Somma, Domenico; Sansom, Stephen N.; Filer, Andrew; McSharry, Charles; Millar, Neal L.; Kirschner, Kristina; Nerviani, Alessandra; Lewis, Myles J.; Pitzalis, Costantino; Clark, Andrew R.; Ferraccioli, Gianfranco; Udalova, Irina; Buckley, Christopher D.; Gremese, Elisa; McInnes, Iain B.; Otto, Thomas D.; Kurowska-Stolarska, Mariola			Distinct synovial tissue macrophage subsets regulate inflammation and remission in rheumatoid arthritis	NATURE MEDICINE			English	Article							RESIDENT MACROPHAGES; HETEROGENEITY	Immune-regulatory mechanisms of drug-free remission in rheumatoid arthritis (RA) are unknown. We hypothesized that synovial tissue macrophages (STM), which persist in remission, contribute to joint homeostasis. We used single-cell transcriptomics to profile 32,000 STMs and identified phenotypic changes in patients with early/active RA, treatment-refractory/active RA and RA in sustained remission. Each clinical state was characterized by different frequencies of nine discrete phenotypic clusters within four distinct STM subpopulations with diverse homeostatic, regulatory and inflammatory functions. This cellular atlas, combined with deep-phenotypic, spatial and functional analyses of synovial biopsy fluorescent activated cell sorted STMs, revealed two STM subpopulations (MerTK(pos)TREM2(high)and MerTK(pos)LYVE1(pos)) with unique remission transcriptomic signatures enriched in negative regulators of inflammation. These STMs were potent producers of inflammation-resolving lipid mediators and induced the repair response of synovial fibroblasts in vitro. A low proportion of MerTK(pos)STMs in remission was associated with increased risk of disease flare after treatment cessation. Therapeutic modulation of MerTK(pos)STM subpopulations could therefore be a potential treatment strategy for RA. Multiple subpopulations of synovial tissue macrophages with varied transcriptional, phenotypic and functional features may contribute to disease flare and tissue repair in patients with active rheumatoid arthritis and patients in clinical remission.	[Alivernini, Stefano; MacDonald, Lucy; Elmesmari, Aziza; Finlay, Samuel; Sansom, Stephen N.; Filer, Andrew; Clark, Andrew R.; Udalova, Irina; Buckley, Christopher D.; Gremese, Elisa; McInnes, Iain B.; Otto, Thomas D.; Kurowska-Stolarska, Mariola] Res Inflammatory Arthrit Ctr Versus Arthrit RACE, Rome, Italy; [Alivernini, Stefano; Tolusso, Barbara; Gigante, Maria Rita; Petricca, Luca; Fedele, Anna Laura; Gremese, Elisa] Fdn Policlin Univ A Gemelli IRCCS, Div Rheumatol, Rome, Italy; [Alivernini, Stefano; Di Mario, Clara; Perniola, Simone; Ferraccioli, Gianfranco; Gremese, Elisa] Univ Cattolica Sacro Cuore, Inst Rheumatol, Rome, Italy; [Alivernini, Stefano; MacDonald, Lucy; Elmesmari, Aziza; Finlay, Samuel; Chilaka, Sabarinadh; Somma, Domenico; McSharry, Charles; Millar, Neal L.; McInnes, Iain B.; Otto, Thomas D.; Kurowska-Stolarska, Mariola] Univ Glasgow, Inst Infect Immun & Inflammat, Glasgow, Lanark, Scotland; [Bui, Laura; Gessi, Marco] Fdn Policlin Univ A Gemelli IRCCS, Div Pathol, Rome, Italy; [Attar, Moustafa; Sansom, Stephen N.; Udalova, Irina; Buckley, Christopher D.] Univ Oxford, Kennedy Inst Rheumatol, Oxford, England; [Filer, Andrew; Clark, Andrew R.; Buckley, Christopher D.] Univ Birmingham, Inst Inflammat & Ageing, Birmingham, W Midlands, England; [Filer, Andrew; Buckley, Christopher D.] Univ Birmingham, Univ Hosp Birmingham NHS Fdn Trust, NIHR Birmingham Biomed Res Ctr, Birmingham, W Midlands, England; [Kirschner, Kristina] Univ Glasgow, Inst Canc Sci, Glasgow, Lanark, Scotland; [Nerviani, Alessandra; Lewis, Myles J.; Pitzalis, Costantino] Queen Mary Univ London, William Harvey Res Inst, Ctr Expt Med & Rheumatol, London, England	Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; University of Glasgow; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; University of Oxford; University of Birmingham; University of Birmingham; University of Glasgow; University of London; Queen Mary University London	Alivernini, S; Otto, TD; Kurowska-Stolarska, M (corresponding author), Res Inflammatory Arthrit Ctr Versus Arthrit RACE, Rome, Italy.; Alivernini, S (corresponding author), Fdn Policlin Univ A Gemelli IRCCS, Div Rheumatol, Rome, Italy.; Alivernini, S (corresponding author), Univ Cattolica Sacro Cuore, Inst Rheumatol, Rome, Italy.; Alivernini, S; Otto, TD; Kurowska-Stolarska, M (corresponding author), Univ Glasgow, Inst Infect Immun & Inflammat, Glasgow, Lanark, Scotland.	stefano.alivernini@unicatt.it; thomasdan.otto@glasgow.ac.uk; mariola.kurowska-stolarska@glasgow.ac.uk	MacDonald, Lucy/AAS-3057-2020; Petricca, Luca/B-1461-2019; di mario, clara/AET-0736-2022; Tolusso, Barbara/K-8995-2018; Perniola, Simone/AAU-7158-2020; Lewis, Myles J/AAW-2453-2021; Clark, Andrew/AAN-4043-2021; Gessi, Marco/K-2572-2018; Buckley, Christopher/AAN-6378-2021; Filer, Andrew/AAP-9179-2021; Otto, Thomas/ABE-7632-2020; Somma, Domenico/X-9553-2019	MacDonald, Lucy/0000-0001-7727-3873; Tolusso, Barbara/0000-0002-9108-6609; Perniola, Simone/0000-0001-6918-4731; Lewis, Myles J/0000-0001-9365-5345; Buckley, Christopher/0000-0001-6924-6402; Filer, Andrew/0000-0001-8164-6249; Somma, Domenico/0000-0003-2486-7250; Di Mario, Clara/0000-0001-9459-3326; Kirschner, Kristina/0000-0001-7607-8670; Petricca, Luca/0000-0003-3544-3162; ALIVERNINI, STEFANO/0000-0002-7383-4212; Pitzalis, Costantino/0000-0003-1326-5051; Gigante, Maria Rita/0000-0001-9509-1977; Nerviani, Alessandra/0000-0003-4064-4014; Otto, Thomas/0000-0002-1246-7404; Gremese, Elisa/0000-0002-2248-1058	Research into Inflammatory Arthritis Centre Versus Arthritis UK [20298, 22072]; Ricerca Finalizzata Ministero della Salute [GR-2018-12366992]; Versus Arthritis UK Program [21802]; Versus Arthritis UK [22272]; Wellcome Trust [204820/Z/16/Z]; BPF_Medical Research Trust; Universita Cattolica del Sacro Cuore [R4124500654]; MRC [G0800648, MR/S025308/1] Funding Source: UKRI	Research into Inflammatory Arthritis Centre Versus Arthritis UK; Ricerca Finalizzata Ministero della Salute(Ministry of Health, ItalyMinistry of Health Italy - Ricerca Finalizzata (MOH-RF)); Versus Arthritis UK Program; Versus Arthritis UK(Versus Arthritis); Wellcome Trust(Wellcome Trust); BPF_Medical Research Trust; Universita Cattolica del Sacro Cuore; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank the patients and healthy volunteers who participated in this study. We thank D. Vaughan for her outstanding support in cell sorting and phenotyping; D. Riggans (University of Glasgow Mail Room), who facilitated smooth deliveries of clinical samples from Rome to Glasgow and Oxford; A. Corbyn, T. Khoyratty and J. Webber (The Kennedy Institute of Rheumatology, Oxford, UK) for assistance in preparing cells for single-cell sequencing; C. Giampa and O. Parolini (Istituto di Anatomia Umana e Biologia Cellulare, Universita Cattolica del Sacro Cuore, Rome, Italy) for support with fluorescent microscopy; J. Galbraith and P. Herzyk (Glasgow Polyomics) for rapid scRNA-seq of samples for the revised version of this manuscript; and L. Lemgruber Soares for help with confocal microscopy. This work was supported by the Research into Inflammatory Arthritis Centre Versus Arthritis UK, based in the Universities of Glasgow, Birmingham, Newcastle and Oxford (nos. 20298 and 22072) to L.M., S.F., S.N.S., A.F., A.R.C., I.U., C.D.B., T.D.O., I.B.M. and M.K.-S.; linea D1 (no. R4124500654) (Universita Cattolica del Sacro Cuore, no. R4124500654, to S.A.); Ricerca Finalizzata Ministero della Salute (no. GR-2018-12366992, to S.A.); Versus Arthritis UK Program (grant no. 21802, to A.R.C., M.K.-S. and A.E.); Versus Arthritis UK (grant no. 22272, to M.K.-S.); Wellcome Trust (no. 204820/Z/16/Z, to T.D.O. and M.K.-S.); and BPF_Medical Research Trust (to C.M.).	A-Gonzalez N, 2017, J EXP MED, V214, P1281, DOI 10.1084/jem.20161375; Alivernini S, 2018, FRONT MED-LAUSANNE, V5, DOI 10.3389/fmed.2018.00186; Alivernini S, 2017, ANN RHEUM DIS, V76, P1228, DOI 10.1136/annrheumdis-2016-210424; Alivernini S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12970; Alivernini S, 2016, ARTHRITIS RES THER, V18, DOI 10.1186/s13075-016-0927-z; Alten R, 2011, J RHEUMATOL, V38, P1745, DOI 10.3899/jrheum.110400; Baker KF, 2019, J AUTOIMMUN, V105, DOI 10.1016/j.jaut.2019.06.009; Boeters DM, 2019, ANN RHEUM DIS, V78, P1497, DOI 10.1136/annrheumdis-2018-214868; Boulet S, 2019, P NATL ACAD SCI USA, V116, P15150, DOI 10.1073/pnas.1821296116; Bykerk VP, 2012, RHEUMATOLOGY, V51, P16, DOI 10.1093/rheumatology/kes281; Croft AP, 2019, NATURE, V570, P246, DOI 10.1038/s41586-019-1263-7; Culemann S, 2019, NATURE, V572, P670, DOI 10.1038/s41586-019-1471-1; Davies LC, 2013, NAT IMMUNOL, V14, P986, DOI 10.1038/ni.2705; Finak G, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0844-5; Firestein G.S., 2016, KELLEY FIRESTEINS TX, VVolume 1; Firestein GS, 2017, IMMUNITY, V46, P183, DOI 10.1016/j.immuni.2017.02.006; Freeman CL, 2015, BLOOD, V126, P2646, DOI 10.1182/blood-2015-09-670802; Gremese E, 2018, ANN RHEUM DIS, V77, P1391, DOI 10.1136/annrheumdis-2018-212941; Hanna RN, 2012, CIRC RES, V110, P416, DOI 10.1161/CIRCRESAHA.111.253377; Herenius MMJ, 2011, ANN RHEUM DIS, V70, P1160, DOI 10.1136/ard.2010.141549; HOGG N, 1985, IMMUNOLOGY, V56, P673; Humby F, 2019, ANN RHEUM DIS, V78, P761, DOI 10.1136/annrheumdis-2018-214539; Jaitin DA, 2019, CELL, V178, P686, DOI 10.1016/j.cell.2019.05.054; Kahles F, 2014, MOL METAB, V3, P384, DOI 10.1016/j.molmet.2014.03.004; KAPLAN JE, 1990, J ACQ IMMUN DEF SYND, V3, P1096; Koenis DS, 2018, CELL REP, V24, P2127, DOI 10.1016/j.celrep.2018.07.065; Krenn V, 2006, HISTOPATHOLOGY, V49, P358, DOI 10.1111/j.1365-2559.2006.02508.x; Kuo D, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aau8587; Kurowska-Stolarska M, 2017, RMD OPEN, V3, DOI 10.1136/rmdopen-2017-000527; Kurowska-Stolarska M, 2011, P NATL ACAD SCI USA, V108, P11193, DOI 10.1073/pnas.1019536108; Lewis MJ, 2019, CELL REP, V28, P2455, DOI 10.1016/j.celrep.2019.07.091; Lim HY, 2018, IMMUNITY, V49, P326, DOI [10.1016/j.immuni.2018.06.008, 10.1016/j.immuni.2018.12.009]; Liu J, 2013, EUR J MED CHEM, V65, P83, DOI 10.1016/j.ejmech.2013.03.035; Machado P, 2011, ANN RHEUM DIS, V70, P15, DOI 10.1136/ard.2010.130625; Mahajan S, 2015, J BIOL CHEM, V290, P18304, DOI 10.1074/jbc.M115.638064; Mandelin AM, 2018, ARTHRITIS RHEUMATOL, V70, P841, DOI 10.1002/art.40453; Misharin AV, 2014, CELL REP, V9, P591, DOI 10.1016/j.celrep.2014.09.032; Mizoguchi F, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-02892-y; Nagy G, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0707-1; Najm A, 2018, ARTHRITIS RES THER, V20, DOI 10.1186/s13075-018-1762-1; Nolting J, 2009, J EXP MED, V206, P2131, DOI 10.1084/jem.20090639; Perdiguero EG, 2015, NATURE, V518, P547, DOI 10.1038/nature13989; Rauber S, 2017, NAT MED, V23, P938, DOI 10.1038/nm.4373; Roberts AW, 2017, IMMUNITY, V47, P913, DOI 10.1016/j.immuni.2017.10.006; Rothlin CV, 2007, CELL, V131, P1124, DOI 10.1016/j.cell.2007.10.034; Singh JA, 2004, ANN RHEUM DIS, V63, P785, DOI 10.1136/ard.2003.013383; Smolen JS, 2018, NAT REV DIS PRIMERS, V4, DOI 10.1038/nrdp.2018.1; Stephenson W, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02659-x; Stuart T, 2019, CELL, V177, P1888, DOI 10.1016/j.cell.2019.05.031; Udalova IA, 2016, NAT REV RHEUMATOL, V12, P472, DOI 10.1038/nrrheum.2016.91; van der Touw W, 2017, CANCER IMMUNOL IMMUN, V66, P1079, DOI 10.1007/s00262-017-2023-x; Vattakuzhi Y, 2012, ARTHRITIS RHEUM-US, V64, P2201, DOI 10.1002/art.34403; Villani AC, 2017, SCIENCE, V356, DOI 10.1126/science.aah4573; Vogt L, 2006, J CLIN INVEST, V116, P2817, DOI 10.1172/JCI25673; Wang SW, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01298; Waterborg CEJ, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00742; Weiss M, 2015, P NATL ACAD SCI USA, V112, P11001, DOI 10.1073/pnas.1506254112; Wood MJ, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.125325; Yeo L, 2016, ANN RHEUM DIS, V75, P763, DOI 10.1136/annrheumdis-2014-206921; Zhang F, 2019, NAT IMMUNOL, V20, P928, DOI 10.1038/s41590-019-0378-1	60	154	154	20	72	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	AUG	2020	26	8					1295	+		10.1038/s41591-020-0939-8	http://dx.doi.org/10.1038/s41591-020-0939-8		JUN 2020	30	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	MX8ZF	32601335	Green Submitted, Green Published			2022-12-27	WOS:000544159600003
J	Liu, Y; Jain, A; Eng, C; Way, DH; Lee, K; Bui, P; Kanada, K; Marinho, GD; Gallegos, J; Gabriele, S; Gupta, V; Singh, N; Natarajan, V; Hofmann-Wellenhof, R; Corrado, GS; Peng, LH; Webster, DR; Ai, D; Huang, SJ; Liu, Y; Dunn, RC; Coz, D				Liu, Yuan; Jain, Ayush; Eng, Clara; Way, David H.; Lee, Kang; Bui, Peggy; Kanada, Kimberly; de Oliveira Marinho, Guilherme; Gallegos, Jessica; Gabriele, Sara; Gupta, Vishakha; Singh, Nalini; Natarajan, Vivek; Hofmann-Wellenhof, Rainer; Corrado, Greg S.; Peng, Lily H.; Webster, Dale R.; Ai, Dennis; Huang, Susan J.; Liu, Yun; Dunn, R. Carter; Coz, David			A deep learning system for differential diagnosis of skin diseases	NATURE MEDICINE			English	Article							PRIMARY-CARE; GLOBAL BURDEN; IMAGE CLASSIFICATION; DERMATOLOGY; PRACTITIONERS; PREVALENCE; CANCER; UPDATE	A deep learning system able to identify the most common skin conditions may help clinicians in making more accurate diagnoses in routine clinical practice Skin conditions affect 1.9 billion people. Because of a shortage of dermatologists, most cases are seen instead by general practitioners with lower diagnostic accuracy. We present a deep learning system (DLS) to provide a differential diagnosis of skin conditions using 16,114 de-identified cases (photographs and clinical data) from a teledermatology practice serving 17 sites. The DLS distinguishes between 26 common skin conditions, representing 80% of cases seen in primary care, while also providing a secondary prediction covering 419 skin conditions. On 963 validation cases, where a rotating panel of three board-certified dermatologists defined the reference standard, the DLS was non-inferior to six other dermatologists and superior to six primary care physicians (PCPs) and six nurse practitioners (NPs) (top-1 accuracy: 0.66 DLS, 0.63 dermatologists, 0.44 PCPs and 0.40 NPs). These results highlight the potential of the DLS to assist general practitioners in diagnosing skin conditions.	[Liu, Yuan; Jain, Ayush; Eng, Clara; Way, David H.; Lee, Kang; Bui, Peggy; Gallegos, Jessica; Gabriele, Sara; Gupta, Vishakha; Singh, Nalini; Natarajan, Vivek; Corrado, Greg S.; Peng, Lily H.; Webster, Dale R.; Ai, Dennis; Liu, Yun; Dunn, R. Carter; Coz, David] Google Hlth, Palo Alto, CA USA; [Bui, Peggy] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Kanada, Kimberly; Huang, Susan J.] Adv Clin, Deerfield, IL USA; [de Oliveira Marinho, Guilherme] Adecco Staffing, Santa Clara, CA USA; [Singh, Nalini] MIT, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Hofmann-Wellenhof, Rainer] Med Univ Graz, Graz, Austria	University of California System; University of California San Francisco; Massachusetts Institute of Technology (MIT); Medical University of Graz	Liu, Y (corresponding author), Google Hlth, Palo Alto, CA USA.	liuyun@google.com	Natarajan, Vivek/AAG-4944-2021	Liu, Yun/0000-0003-4079-8275				Cruz-Roa AA, 2013, LECT NOTES COMPUT SC, V8150, P403, DOI 10.1007/978-3-642-40763-5_50; [Anonymous], SNOMED HOM PAG; [Anonymous], 2012, DISTR US PRIM CAR WO; Awadalla F, 2008, FAM MED, V40, P507; Barnett ML, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2019.0096; Boer A, 2007, INDIAN J DERMATOL VE, V73, P138, DOI 10.4103/0378-6323.31909; Brinker TJ, 2019, EUR J CANCER, V113, P47, DOI 10.1016/j.ejca.2019.04.001; Chihara L, 2018, MATH STAT RESAMPLING; Codella NCF, 2018, 2018 IEEE 15 INT S B, DOI [10.1109/ISBI.2018.8363547, DOI 10.1109/ISBI.2018.8363547, 10.1109/isbi.2018.8363547]; Collins GS, 2015, BRIT J SURG, V102, P148, DOI 10.1002/bjs.9736; Cutrone M, 2007, J EUR ACAD DERMATOL, V21, P175, DOI 10.1111/j.1468-3083.2006.01885.x; Dean  J., 2012, ADV NEURAL INFORM PR, P1223; Eng C, 2020, BRIT J DERMATOL, V182, P1277, DOI 10.1111/bjd.18609; Esteva A, 2017, NATURE, V542, P115, DOI 10.1038/nature21056; Federman DG, 1997, AM J MANAG CARE, V3, P1487; Federman DG, 1999, ARCH FAM MED, V8, P170, DOI 10.1001/archfami.8.2.170; Feng H, 2018, JAMA DERMATOL, V154, P1265, DOI 10.1001/jamadermatol.2018.3022; Guyatt G., 2015, CUREUS J MED SCIENCE, V3rd ed., DOI DOI 10.7759/CUR; Haenssle HA, 2018, ANN ONCOL, V29, P1836, DOI 10.1093/annonc/mdy166; Hahn Seokyung, 2012, Korean J Pediatr, V55, P403, DOI 10.3345/kjp.2012.55.11.403; Han SS, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191493; Hay RJ, 2014, J INVEST DERMATOL, V134, P1527, DOI 10.1038/jid.2013.446; He SY, 2014, J AM ACAD DERMATOL, V71, P731, DOI 10.1016/j.jaad.2014.05.023; Ioffe S, 2015, ARXIV 1502 03167, V32, P448; JOHNSON MLT, 1994, ARCH DERMATOL, V130, P850, DOI 10.1001/archderm.130.7.850; Karimkhani C, 2017, JAMA DERMATOL, V153, P406, DOI 10.1001/jamadermatol.2016.5538; Krauss JC, 2016, J AM MED INFORM ASSN, V23, P859, DOI 10.1093/jamia/ocv211; Lowell BA, 2001, J AM ACAD DERMATOL, V45, P250, DOI 10.1067/mjd.2001.114598; Maron RC, 2019, EUR J CANCER, V119, P57, DOI 10.1016/j.ejca.2019.06.013; Mishra S., 2019, P IEEE C COMP VIS PA; Moreno G, 2007, AUSTRALAS J DERMATOL, V48, P77, DOI 10.1111/j.1440-0960.2007.00340.x; Mounessa JS, 2018, J TELEMED TELECARE, V24, P263, DOI 10.1177/1357633X17696587; Okuboyejo DA, 2013, LECT NOTES ENG COMP, VAo,, P850; Opitz D., 1999, J ARTIF INTELL RES, V11, P169, DOI [10.1613/jair.614, DOI 10.1613/JAIR.614]; Prabhu V, 2019, P 4 C MACH LEARN HLT; Ramsay DL, 1996, J AM ACAD DERMATOL, V35, P1005, DOI 10.1016/S0190-9622(96)90137-1; Resneck J, 2004, J AM ACAD DERMATOL, V50, P50, DOI 10.1016/j.jaad.2003.07.001; Romano C, 2006, MYCOSES, V49, P383, DOI 10.1111/j.1439-0507.2006.01251.x; Russakovsky O, 2015, INT J COMPUT VISION, V115, P211, DOI 10.1007/s11263-015-0816-y; Seth D, 2017, CURR DERMATOL REP, V6, P204, DOI 10.1007/s13671-017-0192-7; Simpson CR, 2007, CLIN EXP ALLERGY, V37, P1586, DOI 10.1111/j.1365-2222.2007.02830.x; Snoek C. G. M., 2005, 13th Annual ACM International Conference on Multimedia, P399, DOI 10.1145/1101149.1101236; STERN RS, 1993, J AM ACAD DERMATOL, V29, P773, DOI 10.1016/0190-9622(93)70243-M; Sun XX, 2016, LECT NOTES COMPUT SC, V9910, P206, DOI 10.1007/978-3-319-46466-4_13; Sundararajan M, 2017, PR MACH LEARN RES, V70; Szegedy C, 2017, AAAI CONF ARTIF INTE, P4278; Tran Hue, 2005, Australas J Dermatol, V46, P230, DOI 10.1111/j.1440-0960.2005.00189.x; Tschandl P, 2019, LANCET ONCOL, V20, P938, DOI 10.1016/S1470-2045(19)30333-X; Webber W, 2010, ACM T INFORM SYST, V28, DOI 10.1145/1852102.1852106; Whited JD, 2013, J TELEMED TELECARE, V19, P197, DOI 10.1177/1357633X13487116; Wilmer EN, 2014, CUTIS, V94, P285; Yang JF, 2018, PROC CVPR IEEE, P1258, DOI 10.1109/CVPR.2018.00137; Yim KM, 2018, TELEMED E-HEALTH, V24, P691, DOI 10.1089/tmj.2017.0253; Yuan YD, 2017, IEEE T MED IMAGING, V36, P1876, DOI 10.1109/TMI.2017.2695227	54	144	144	12	75	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	JUN	2020	26	6					900	+		10.1038/s41591-020-0842-3	http://dx.doi.org/10.1038/s41591-020-0842-3		MAY 2020	14	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	LZ3ZG	32424212	Green Submitted			2022-12-27	WOS:000534540300002
J	Yim, J; Chopra, R; Spitz, T; Winkens, J; Obika, A; Kelly, C; Askham, H; Lukic, M; Huemer, J; Fasler, K; Moraes, G; Meyer, C; Wilson, M; Dixon, J; Hughes, C; Rees, G; Khaw, PT; Karthikesalingam, A; King, D; Hassabis, D; Suleyman, M; Back, T; Ledsam, JR; Keane, PA; De Fauw, J				Yim, Jason; Chopra, Reena; Spitz, Terry; Winkens, Jim; Obika, Annette; Kelly, Christopher; Askham, Harry; Lukic, Marko; Huemer, Josef; Fasler, Katrin; Moraes, Gabriella; Meyer, Clemens; Wilson, Marc; Dixon, Jonathan; Hughes, Cian; Rees, Geraint; Khaw, Peng T.; Karthikesalingam, Alan; King, Dominic; Hassabis, Demis; Suleyman, Mustafa; Back, Trevor; Ledsam, Joseph R.; Keane, Pearse A.; De Fauw, Jeffrey			Predicting conversion to wet age-related macular degeneration using deep learning	NATURE MEDICINE			English	Article							RETINAL-PIGMENT EPITHELIUM; DRUSEN VOLUME; CHOROIDAL NEOVASCULARIZATION; RETICULAR PSEUDODRUSEN; VISUAL OUTCOMES; PROGRESSION; PREVALENCE; DELAY; MANAGEMENT; DELIVERY	In individuals diagnosed with age-related macular degeneration in one eye, a deep learning model can predict progression to the 'wet', sight-threatening form of the disease in the second eye within a 6-month time frame. Progression to exudative 'wet' age-related macular degeneration (exAMD) is a major cause of visual deterioration. In patients diagnosed with exAMD in one eye, we introduce an artificial intelligence (AI) system to predict progression to exAMD in the second eye. By combining models based on three-dimensional (3D) optical coherence tomography images and corresponding automatic tissue maps, our system predicts conversion to exAMD within a clinically actionable 6-month time window, achieving a per-volumetric-scan sensitivity of 80% at 55% specificity, and 34% sensitivity at 90% specificity. This level of performance corresponds to true positives in 78% and 41% of individual eyes, and false positives in 56% and 17% of individual eyes at the high sensitivity and high specificity points, respectively. Moreover, we show that automatic tissue segmentation can identify anatomical changes before conversion and high-risk subgroups. This AI system overcomes substantial interobserver variability in expert predictions, performing better than five out of six experts, and demonstrates the potential of using AI to predict disease progression.	[Yim, Jason; Chopra, Reena; Obika, Annette; Meyer, Clemens; Hassabis, Demis; Suleyman, Mustafa; Back, Trevor; Ledsam, Joseph R.; De Fauw, Jeffrey] DeepMind, London, England; [Chopra, Reena; Lukic, Marko; Huemer, Josef; Fasler, Katrin; Moraes, Gabriella; Khaw, Peng T.; Keane, Pearse A.] Moorfields Eye Hosp, NIHR Biomed Res Ctr, London, England; [Chopra, Reena; Lukic, Marko; Huemer, Josef; Fasler, Katrin; Moraes, Gabriella; Khaw, Peng T.; Keane, Pearse A.] UCL Inst Ophthalmol, London, England; [Spitz, Terry; Winkens, Jim; Kelly, Christopher; Askham, Harry; Wilson, Marc; Dixon, Jonathan; Hughes, Cian; Karthikesalingam, Alan; King, Dominic] Google Hlth, London, England; [Rees, Geraint] UCL, London, England	University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust; University of London; University College London; University of London; University College London	Ledsam, JR; De Fauw, J (corresponding author), DeepMind, London, England.; Keane, PA (corresponding author), Moorfields Eye Hosp, NIHR Biomed Res Ctr, London, England.; Keane, PA (corresponding author), UCL Inst Ophthalmol, London, England.	jledsam@google.com; pearse.keane1@nhs.net; defauw@google.com	Rees, Geraint/C-1493-2008	Rees, Geraint/0000-0002-9623-7007; Keane, Pearse/0000-0002-9239-745X; Lukic, Marko/0000-0002-7636-8368; Khaw, Sir Peng Tee/0000-0002-8087-2268; Kelly, Christopher/0000-0002-1246-844X; Spitz, Terry/0000-0002-9791-3767	NIHR [NIHR-CS-2014-14-023]; College of Optometrists, United Kingdom; MRC [MC_PC_19005] Funding Source: UKRI; UKRI [MR/T019050/1] Funding Source: UKRI	NIHR(National Institute for Health Research (NIHR)); College of Optometrists, United Kingdom; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UKRI	We thank the patients under the care of Moorfields Eye Hospital. We would also like to thank B. Romera-Paredes, O. Ronneberger, N. Tomasev, S. Blackwell, J. Schrouff, M. Chesus, C. Cooper, V. Cornelius, A. Khawaja, R. Ahamed, T. Corkett, R. Ogbe, Y. Ibitoye, M. Bawn, J. Besley, C. Meaden, C. Chorley, S. Rowley, A. Ahmad, K. Clancy, C. Semturs, A. Varadarajan, B. Babenko, I. Traynis, Y. Liu, L. Peng, N. Hammel, K. Blumer, K. Kavukcuoglu, S. Bouton, G. Corrado, E. Manna, A. C. Bird, W. Tucker, Y. Obadeyi, Z. Jessa, D. Sim, M. Natkunarajah and A. Jindal. P.A.K. is supported by an NIHR Clinician Scientist Award (no. NIHR-CS-2014-14-023). The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health. R.C. receives studentship support from the College of Optometrists, United Kingdom.	Abdelfattah NS, 2016, INVEST OPHTH VIS SCI, V57, P1839, DOI 10.1167/iovs.15-18572; Age-Related Eye Dis Study Res Grp, 2001, AM J OPHTHALMOL, V132, P668; Amoaku W, 2012, EYE, V26, pS2, DOI 10.1038/eye.2011.343; Anand R, 2000, OPHTHALMOLOGY, V107, P2224; [Anonymous], 2005, ARCH OPHTHALMOL-CHIC, V123, P1570, DOI DOI 10.1001/ARCHOPHT.123.11.1570; Ardila D, 2019, NAT MED, V25, P954, DOI 10.1038/s41591-019-0447-x; Babenko B, 2019, PREDICTING PROGRESSI; Balaratnasingam C, 2016, AM J OPHTHALMOL, V172, P28, DOI 10.1016/j.ajo.2016.09.008; Balaratnasingam C, 2016, INVEST OPHTH VIS SCI, V57, P5479, DOI 10.1167/iovs.16-19816; Banerjee I, 2019, ARXIV PREPRINT ARXIV; Bek T, 2018, GRAEF ARCH CLIN EXP, V256, P2061, DOI 10.1007/s00417-018-4100-z; Bogunovic H, 2017, INVEST OPHTH VIS SCI, V58, pBIO141, DOI 10.1167/iovs.17-21789; BRESSLER SB, 1990, ARCH OPHTHALMOL-CHIC, V108, P1442, DOI 10.1001/archopht.1990.01070120090035; Buchlovsky P., 2019, TF REPLICATOR DISTRI; Campochiaro PA, 2019, OPHTHALMOLOGY, V126, P1141, DOI 10.1016/j.ophtha.2019.03.036; Carnevali A, 2018, OPHTHALMOL RETINA, V2, P922, DOI 10.1016/j.oret.2018.02.002; Chew EY, 2009, ARCH OPHTHALMOL-CHIC, V127, P1678, DOI 10.1001/archophthalmol.2009.312; Christenbury JG, 2013, OPHTHALMOLOGY, V120, P1038, DOI 10.1016/j.ophtha.2012.10.018; Cicek Ozgun, 2016, Medical Image Computing and Computer-Assisted Intervention - MICCAI 2016. 19th International Conference. Proceedings: LNCS 9901, P424, DOI 10.1007/978-3-319-46723-8_49; Cohen SY, 2007, BRIT J OPHTHALMOL, V91, P354, DOI 10.1136/bjo.2006.101022; Curcio CA, 2017, INVEST OPHTH VIS SCI, V58, P211, DOI 10.1167/iovs.17-21872; De Fauw J, 2018, NAT MED, V24, P1342, DOI 10.1038/s41591-018-0107-6; De Fauw Jeffrey, 2016, F1000Res, V5, P1573; Dias JRD, 2018, OPHTHALMOLOGY, V125, P255, DOI 10.1016/j.ophtha.2017.08.030; Dugel PU, 2020, OPHTHALMOLOGY, V127, P72, DOI 10.1016/j.ophtha.2019.04.017; Esteva A, 2017, NATURE, V542, P115, DOI 10.1038/nature21056; Fasler K, 2019, 2 BIORXIV, DOI DOI 10.1101/615252; Folgar FA, 2016, OPHTHALMOLOGY, V123, P39, DOI 10.1016/j.ophtha.2015.09.016; Folgar FA, 2012, INVEST OPHTH VIS SCI, V53, P4626, DOI 10.1167/iovs.12-9813; Fragiotta S, 2018, RETINA-J RET VIT DIS, V38, P245, DOI 10.1097/IAE.0000000000001540; Goodfellow I., 2015, TENSORFLOW LARGE SCA; Hinton Geoffrey, NIPS DEEP LEARN REP; Jager RD, 2008, NEW ENGL J MED, V358, P2606, DOI 10.1056/NEJMra0801537; Kingma DP., 2014, ADAM METHOD STOCHAST; Klein R, 1997, OPHTHALMOLOGY, V104, P7, DOI 10.1016/S0161-6420(97)30368-6; Krause J, 2018, OPHTHALMOLOGY, V125, P1264, DOI 10.1016/j.ophtha.2018.01.034; Lee J, 2019, AM J OPHTHALMOL, V208, P103, DOI 10.1016/j.ajo.2019.07.013; Lek JJ, 2018, OPHTHALMOL RETINA, V2, P792, DOI 10.1016/j.oret.2018.01.005; Lim JH, 2012, AM J OPHTHALMOL, V153, P678, DOI 10.1016/j.ajo.2011.09.013; Maguire MG, 2013, OPHTHALMOLOGY, V120, P2035, DOI 10.1016/j.ophtha.2013.03.017; Muether PS, 2011, GRAEF ARCH CLIN EXP, V249, P633, DOI 10.1007/s00417-010-1520-9; NIHR Oxford Biomedical Research Centre, 2019, WORLDS 1 GEN THER OP; Owen CG, 2012, BRIT J OPHTHALMOL, V96, P752, DOI 10.1136/bjophthalmol-2011-301109; Poplin R, 2018, NAT BIOMED ENG, V2, P158, DOI 10.1038/s41551-018-0195-0; Rein DB, 2009, ARCH OPHTHALMOL-CHIC, V127, P533, DOI 10.1001/archophthalmol.2009.58; Reynolds M, OPEN SOURCING SONNET; Roisman L, 2016, OPHTHALMOLOGY, V123, P1309, DOI 10.1016/j.ophtha.2016.01.044; Rudnicka AR, 2015, AM J OPHTHALMOL, V160, P85, DOI 10.1016/j.ajo.2015.04.003; Russakoff DB, 2019, INVEST OPHTH VIS SCI, V60, P712, DOI 10.1167/iovs.18-25325; Sadda SR, 2018, OPHTHALMOLOGY, V125, P537, DOI 10.1016/j.ophtha.2017.09.028; Sahni J, 2019, OPHTHALMOLOGY, V126, P1155, DOI 10.1016/j.ophtha.2019.03.023; Schmidt-Erfurth U, 2018, INVEST OPHTH VIS SCI, V59, P3199, DOI 10.1167/iovs.18-24106; Tomasev N, 2019, NATURE, V572, P116, DOI 10.1038/s41586-019-1390-1; Tonekaboni Sana, 2019, MACHINE LEARNING HEA, P359; UK Information Commissioner's Office, 2015, AN MAN DAT PROT RISK; Vander JF, 2006, YEARB OPHTHALMOL, V2006, P119; VanderBeek BL, 2011, AM J OPHTHALMOL, V152, P273, DOI 10.1016/j.ajo.2011.02.004; Veerappan M, 2016, OPHTHALMOLOGY, V123, P2554, DOI 10.1016/j.ophtha.2016.08.047; Wang K, 2015, IEEE ICC, P7007, DOI 10.1109/ICC.2015.7249443; Wong WL, 2014, LANCET GLOB HEALTH, V2, pE106, DOI 10.1016/S2214-109X(13)70145-1; Xie Saining, 2018, EUR C COMP VIS; Zarranz-Ventura J, 2014, OPHTHALMOLOGY, V121, P1966, DOI 10.1016/j.ophtha.2014.04.026; Zhou Q, 2016, OPHTHALMOLOGY, V123, P1530, DOI 10.1016/j.ophtha.2016.02.043; Zweifel SA, 2010, OPHTHALMOLOGY, V117, P1775, DOI 10.1016/j.ophtha.2010.01.027	64	84	86	1	32	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	JUN	2020	26	6					892	+		10.1038/s41591-020-0867-7	http://dx.doi.org/10.1038/s41591-020-0867-7		MAY 2020	25	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	LZ3ZG	32424211	Green Submitted			2022-12-27	WOS:000534540300001
J	Bakouny, Z; Choueiri, TK				Bakouny, Ziad; Choueiri, Toni K.			IL-8 and cancer prognosis on immunotherapy	NATURE MEDICINE			English	Editorial Material									[Bakouny, Ziad; Choueiri, Toni K.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute	Choueiri, TK (corresponding author), Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA.	toni_choueiri@dfci.harvard.edu	Bakouny, Ziad/A-1149-2018; Choueiri, Toni/K-5238-2019	Bakouny, Ziad/0000-0003-1906-5704; Choueiri, Toni/0000-0002-9201-3217				Alfaro C, 2017, CANCER TREAT REV, V60, P24, DOI 10.1016/j.ctrv.2017.08.004; Bilusic M., 2019, J IMMUNOTHER CANCER, V7, P1; DeNardo DG, 2019, NAT REV IMMUNOL, V19, P369, DOI 10.1038/s41577-019-0127-6; Freidlin B, 2014, NAT REV CLIN ONCOL, V11, P81, DOI 10.1038/nrclinonc.2013.218; Ha H, 2017, THERANOSTICS, V7, P1543, DOI 10.7150/thno.15625; Hayes DF, 2015, MOL ONCOL, V9, P960, DOI 10.1016/j.molonc.2014.10.004; Mariathasan S, 2018, NATURE, V554, P544, DOI 10.1038/nature25501; McDermott DF, 2018, NAT MED, V24, P749, DOI 10.1038/s41591-018-0053-3; Sanmamed MF, 2017, ANN ONCOL, V28, P1988, DOI 10.1093/annonc/mdx190; Schalper KA, 2020, NAT MED, V26, P688, DOI 10.1038/s41591-020-0856-x; Yuen KC, 2020, NAT MED, V26, P693, DOI 10.1038/s41591-020-0860-1	11	44	46	0	6	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	MAY	2020	26	5					650	651		10.1038/s41591-020-0873-9	http://dx.doi.org/10.1038/s41591-020-0873-9			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	ML1JP	32405061				2022-12-27	WOS:000549231500015
J	Yuen, KC; Liu, LF; Gupta, V; Madireddi, S; Keerthivasan, S; Li, CF; Rishipathak, D; Williams, P; Kadel, EE; Koeppen, H; Chen, YJ; Modrusan, Z; Grogan, JL; Banchereau, R; Leng, N; Thastrom, A; Shen, XD; Hashimoto, K; Tayama, D; van der Heijden, MS; Rosenberg, JE; McDermott, DF; Powles, T; Hegde, PS; Huseni, MA; Mariathasan, S				Yuen, Kobe C.; Liu, Li-Fen; Gupta, Vinita; Madireddi, Shravan; Keerthivasan, Shilpa; Li, Congfen; Rishipathak, Deepali; Williams, Patrick; Kadel, Edward E., III; Koeppen, Hartmut; Chen, Ying-Jiun; Modrusan, Zora; Grogan, Jane L.; Banchereau, Romain; Leng, Ning; Thastrom, AnnChristine; Shen, Xiadong; Hashimoto, Kenji; Tayama, Darren; van der Heijden, Michiel S.; Rosenberg, Jonathan E.; McDermott, David F.; Powles, Thomas; Hegde, Priti S.; Huseni, Mahrukh A.; Mariathasan, Sanjeev			High systemic and tumor-associated IL-8 correlates with reduced clinical benefit of PD-L1 blockade	NATURE MEDICINE			English	Article							METASTATIC UROTHELIAL CARCINOMA; SUPPRESSOR-CELLS; OPEN-LABEL; INTERLEUKIN-8; MULTICENTER; ATEZOLIZUMAB; CHEMOTHERAPY; RESISTANCE; CXCR2	Although elevated plasma interleukin-8 (pIL-8) has been associated with poor outcome to immune checkpoint blockade(1), this has not been comprehensively evaluated in large randomized studies. Here we analyzed circulating pIL-8 and IL8 gene expression in peripheral blood mononuclear cells and tumors of patients treated with atezolizumab (anti-PD-L1 monoclonal antibody) from multiple randomized trials representing 1,445 patients with metastatic urothelial carcinoma (mUC) and metastatic renal cell carcinoma. High levels of IL-8 in plasma, peripheral blood mononuclear cells and tumors were associated with decreased efficacy of atezolizumab in patients with mUC and metastatic renal cell carcinoma, even in tumors that were classically CD8(+) T cell inflamed. Low baseline pIL-8 in patients with mUC was associated with increased response to atezolizumab and chemotherapy. Patients with mUC who experienced on-treatment decreases in pIL-8 exhibited improved overall survival when treated with atezolizumab but not with chemotherapy. Single-cell RNA sequencing of the immune compartment showed that IL8 is primarily expressed in circulating and intratumoral myeloid cells and that high IL8 expression is associated with downregulation of the antigen-presentation machinery. Therapies that can reverse the impacts of IL-8-mediated myeloid inflammation will be essential for improving outcomes of patients treated with immune checkpoint inhibitors.	[Yuen, Kobe C.; Liu, Li-Fen; Gupta, Vinita; Madireddi, Shravan; Keerthivasan, Shilpa; Li, Congfen; Rishipathak, Deepali; Williams, Patrick; Kadel, Edward E., III; Koeppen, Hartmut; Chen, Ying-Jiun; Modrusan, Zora; Grogan, Jane L.; Banchereau, Romain; Leng, Ning; Thastrom, AnnChristine; Shen, Xiadong; Tayama, Darren; Hegde, Priti S.; Huseni, Mahrukh A.; Mariathasan, Sanjeev] Genentech Inc, 460 Point San Bruno Blvd, San Francisco, CA 94080 USA; [Hashimoto, Kenji] Roche Prod Ltd, Welwyn Garden City, Herts, England; [van der Heijden, Michiel S.] Netherlands Canc Inst, Amsterdam, Netherlands; [Rosenberg, Jonathan E.] Mem Sloan Kettering Canc Ctr, Dept Med, Genitourinary Oncol Serv, 1275 York Ave, New York, NY 10021 USA; [McDermott, David F.] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; [Powles, Thomas] Queen Mary Univ London, Barts Canc Inst, Barts Expt Canc Med Ctr, London, England	Roche Holding; Genentech; Roche Holding; Netherlands Cancer Institute; Memorial Sloan Kettering Cancer Center; Harvard University; Beth Israel Deaconess Medical Center; University of London; Queen Mary University London	Huseni, MA; Mariathasan, S (corresponding author), Genentech Inc, 460 Point San Bruno Blvd, San Francisco, CA 94080 USA.	huseni.mahrukh@gene.com; mariathasan.sanjeev@gene.com		MADIREDDI, SHRAVAN/0000-0002-7069-1252; Hashimoto, Kenji/0000-0001-8826-2037	DFHCC KCP SPORE grant [5P50CA101942]	DFHCC KCP SPORE grant	We thank L. Goldstein and T. Wu for technical assistance for scRNA-seq analysis. We thank L. Rangell for assistance in IL8 in situ hybridization experiments. Editorial assistance was provided by Anshin Biosolutions (Santa Clara). D.F.M. was supported by a DFHCC KCP SPORE grant (5P50CA101942).	Alfaro C, 2016, CLIN CANCER RES, V22, P3924, DOI 10.1158/1078-0432.CCR-15-2463; Aran D, 2019, NAT IMMUNOL, V20, P163, DOI 10.1038/s41590-018-0276-y; BAGGIOLINI M, 1989, J CLIN INVEST, V84, P1045, DOI 10.1172/JCI114265; Balar AV, 2017, LANCET, V389, P67, DOI 10.1016/S0140-6736(16)32455-2; Blank CU, 2016, SCIENCE, V352, P658, DOI 10.1126/science.aaf2834; Bruchard M, 2013, NAT MED, V19, P57, DOI 10.1038/nm.2999; Cristescu R, 2018, SCIENCE, V362, P197, DOI 10.1126/science.aar3593; David JM, 2016, VACCINES-BASEL, V4, DOI 10.3390/vaccines4030022; Fernando RI, 2011, CANCER RES, V71, P5296, DOI 10.1158/0008-5472.CAN-11-0156; Gabrilovich DI, 2012, NAT REV IMMUNOL, V12, P253, DOI 10.1038/nri3175; Gupta V, 2016, BIOANALYSIS, V8, P2415, DOI 10.4155/bio-2016-0196; Jakubzick CV, 2017, NAT REV IMMUNOL, V17, P349, DOI 10.1038/nri.2017.28; Jiang P, 2018, NAT MED, V24, P1550, DOI 10.1038/s41591-018-0136-1; Lawrence M, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003118; Lee YS, 2012, BRIT J CANCER, V106, P1833, DOI 10.1038/bjc.2012.177; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; Mariathasan S, 2018, NATURE, V554, P544, DOI 10.1038/nature25501; McDermott DF, 2018, NAT MED, V24, P749, DOI 10.1038/s41591-018-0053-3; Najjar YG, 2017, CLIN CANCER RES, V23, P2346, DOI 10.1158/1078-0432.CCR-15-1823; Powles T, 2018, LANCET, V391, P748, DOI 10.1016/S0140-6736(17)33297-X; Powles T, 2014, NATURE, V515, P558, DOI 10.1038/nature13904; Ridker PM, 2017, LANCET, V390, P1833, DOI 10.1016/S0140-6736(17)32247-X; Rini BI, 2016, LANCET ONCOL, V17, P1599, DOI 10.1016/S1470-2045(16)30408-9; Rosenberg JE, 2016, LANCET, V387, P1909, DOI 10.1016/S0140-6736(16)00561-4; Ruffell B, 2015, CANCER CELL, V27, P462, DOI 10.1016/j.ccell.2015.02.015; Ruffell B, 2012, TRENDS IMMUNOL, V33, P119, DOI 10.1016/j.it.2011.12.001; Sanmamed MF, 2017, ANN ONCOL, V28, P1988, DOI 10.1093/annonc/mdx190; Sanmamed MF, 2014, CLIN CANCER RES, V20, P5697, DOI 10.1158/1078-0432.CCR-13-3203; Sharma P, 2017, CELL, V168, P707, DOI 10.1016/j.cell.2017.01.017; Steele CW, 2016, CANCER CELL, V29, P832, DOI 10.1016/j.ccell.2016.04.014; Stuart T, 2019, CELL, V177, P1888, DOI 10.1016/j.cell.2019.05.031; Ugel S, 2015, J CLIN INVEST, V125, P3365, DOI 10.1172/JCI80006; Wu TD, 2016, METHODS MOL BIOL, V1418, P283, DOI 10.1007/978-1-4939-3578-9_15; Wu TD, 2010, BIOINFORMATICS, V26, P873, DOI 10.1093/bioinformatics/btq057; Yost KE, 2019, NAT MED, V25, P1251, DOI 10.1038/s41591-019-0522-3	35	135	137	4	19	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	MAY	2020	26	5					693	+		10.1038/s41591-020-0860-1	http://dx.doi.org/10.1038/s41591-020-0860-1			25	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	ML1LF	32405063	Green Accepted			2022-12-27	WOS:000549235700003
J	Stower, H				Stower, Hannah			Understanding cancer genetics through a global collaboration	NATURE MEDICINE			English	Editorial Material												h.stower@us.nature.com							0	0	0	0	0	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	MAR	2020	26	3					312	312		10.1038/s41591-020-0809-4	http://dx.doi.org/10.1038/s41591-020-0809-4			1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	KU0MC	32161406	Bronze			2022-12-27	WOS:000519405000011
J	Ennishi, D; Healy, S; Bashashati, A; Saberi, S; Hother, C; Mottok, A; Chan, FC; Chong, L; Abraham, L; Kridel, R; Boyle, M; Meissner, B; Aoki, T; Takata, K; Woolcock, BW; Vigano, E; Gold, M; Molday, LL; Molday, RS; Telenius, A; Li, MY; Wretham, N; Dos Santos, N; Wong, M; Viller, NN; Uger, RA; Duns, G; Baticados, A; Madero, A; Bristow, BN; Farinha, P; Slack, GW; Ben-Neriah, S; Lai, D; Zhang, AW; Salehi, S; Shulha, HP; Chiu, DS; Mostafavi, S; Gerrie, AS; Huang, DW; Rushton, C; Villa, D; Sehn, LH; Savage, KJ; Mungall, AJ; Weng, AP; Bally, MB; Morin, RD; Freue, GVC; Staudt, LM; Connors, JM; Marra, MA; Shah, SP; Gascoyne, RD; Scott, DW; Steidl, C				Ennishi, Daisuke; Healy, Shannon; Bashashati, Ali; Saberi, Saeed; Hother, Christoffer; Mottok, Anja; Chan, Fong Chun; Chong, Lauren; Abraham, Libin; Kridel, Robert; Boyle, Merrill; Meissner, Barbara; Aoki, Tomohiro; Takata, Katsuyoshi; Woolcock, Bruce W.; Vigano, Elena; Gold, Michael; Molday, Laurie L.; Molday, Robert S.; Telenius, Adele; Li, Michael Y.; Wretham, Nicole; Dos Santos, Nancy; Wong, Mark; Viller, Natasja N.; Uger, Robert A.; Duns, Gerben; Baticados, Abigail; Madero, Angel; Bristow, Brianna N.; Farinha, Pedro; Slack, Graham W.; Ben-Neriah, Susana; Lai, Daniel; Zhang, Allen W.; Salehi, Sohrab; Shulha, Hennady P.; Chiu, Derek S.; Mostafavi, Sara; Gerrie, Alina S.; Huang, Da Wei; Rushton, Christopher; Villa, Diego; Sehn, Laurie H.; Savage, Kerry J.; Mungall, Andrew J.; Weng, Andrew P.; Bally, Marcel B.; Morin, Ryan D.; Cohen Freue, Gabriela V.; Staudt, Louis M.; Connors, Joseph M.; Marra, Marco A.; Shah, Sohrab P.; Gascoyne, Randy D.; Scott, David W.; Steidl, Christian			TMEM30A loss-of-function mutations drive lymphomagenesis and confer therapeutically exploitable vulnerability in B-cell lymphoma	NATURE MEDICINE			English	Article							PHOSPHATIDYLSERINE EXPOSURE; PHOSPHOLIPID FLIPPASES; SIRP-ALPHA; EXPRESSION; RITUXIMAB; RECEPTOR; SIGNAL; CHEMOTHERAPY; P4-ATPASES; MECHANISM	Integrative analysis in patients with diffuse large B-cell lymphoma uncovers that biallelic mutations on TMEM30A are associated with a favorable outcome and enhanced sensitivity to CD47 blockade. Transmembrane protein 30A (TMEM30A) maintains the asymmetric distribution of phosphatidylserine, an integral component of the cell membrane and 'eat-me' signal recognized by macrophages. Integrative genomic and transcriptomic analysis of diffuse large B-cell lymphoma (DLBCL) from the British Columbia population-based registry uncovered recurrent biallelic TMEM30A loss-of-function mutations, which were associated with a favorable outcome and uniquely observed in DLBCL. Using TMEM30A-knockout systems, increased accumulation of chemotherapy drugs was observed in TMEM30A-knockout cell lines and TMEM30A-mutated primary cells, explaining the improved treatment outcome. Furthermore, we found increased tumor-associated macrophages and an enhanced effect of anti-CD47 blockade limiting tumor growth in TMEM30A-knockout models. By contrast, we show that TMEM30A loss-of-function increases B-cell signaling following antigen stimulation-a mechanism conferring selective advantage during B-cell lymphoma development. Our data highlight a multifaceted role for TMEM30A in B-cell lymphomagenesis, and characterize intrinsic and extrinsic vulnerabilities of cancer cells that can be therapeutically exploited.	[Ennishi, Daisuke; Healy, Shannon; Hother, Christoffer; Mottok, Anja; Chan, Fong Chun; Chong, Lauren; Kridel, Robert; Boyle, Merrill; Meissner, Barbara; Aoki, Tomohiro; Takata, Katsuyoshi; Woolcock, Bruce W.; Vigano, Elena; Telenius, Adele; Li, Michael Y.; Duns, Gerben; Baticados, Abigail; Madero, Angel; Bristow, Brianna N.; Farinha, Pedro; Slack, Graham W.; Ben-Neriah, Susana; Shulha, Hennady P.; Gerrie, Alina S.; Villa, Diego; Sehn, Laurie H.; Savage, Kerry J.; Connors, Joseph M.; Gascoyne, Randy D.; Scott, David W.; Steidl, Christian] British Columbia Canc, Ctr Lymphoid Canc, Vancouver, BC, Canada; [Ennishi, Daisuke] Okayama Univ Hosp, Dept Hematol & Oncol, Okayama, Japan; [Bashashati, Ali; Saberi, Saeed; Lai, Daniel; Zhang, Allen W.; Salehi, Sohrab; Shah, Sohrab P.] British Columbia Canc, Mol Oncol, Vancouver, BC, Canada; [Mottok, Anja] Ulm Univ, Inst Human Genet, Ulm, Germany; [Mottok, Anja] Ulm Univ, Med Ctr, Ulm, Germany; [Chan, Fong Chun] Univ British Columbia, Bioinformat Grad Program, Vancouver, BC, Canada; [Abraham, Libin; Gold, Michael] Univ British Columbia, Dept Microbiol & Immunol, Vancouver, BC, Canada; [Molday, Laurie L.; Molday, Robert S.] Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC, Canada; [Wretham, Nicole; Dos Santos, Nancy; Bally, Marcel B.] British Columbia Canc, Dept Expt Therapeut, Vancouver, BC, Canada; [Wong, Mark; Viller, Natasja N.; Uger, Robert A.] Trillium Therapeut Inc, Mississauga, ON, Canada; [Chiu, Derek S.; Mostafavi, Sara; Cohen Freue, Gabriela V.] Univ British Columbia, Dept Stat, Vancouver, BC, Canada; [Mostafavi, Sara; Marra, Marco A.] Univ British Columbia, Dept Med Genet, Vancouver, BC, Canada; [Huang, Da Wei; Staudt, Louis M.] NCI, Lymphoid Malignancies Branch, NIH, Bethesda, MD 20892 USA; [Rushton, Christopher; Morin, Ryan D.] Simon Fraser Univ, Dept Mol Biol & Biochem, Burnaby, BC, Canada; [Mungall, Andrew J.; Morin, Ryan D.; Marra, Marco A.; Shah, Sohrab P.] British Columbia Canc, Canadas Michael Smith Genome Sci Ctr, Vancouver, BC, Canada; [Weng, Andrew P.] British Columbia Canc, Terry Fox Lab, Vancouver, BC, Canada; [Shah, Sohrab P.; Gascoyne, Randy D.; Steidl, Christian] Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC, Canada	Okayama University; Ulm University; Ulm University; University of British Columbia; University of British Columbia; University of British Columbia; University of British Columbia; University of British Columbia; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Simon Fraser University; University of British Columbia	Scott, DW; Steidl, C (corresponding author), British Columbia Canc, Ctr Lymphoid Canc, Vancouver, BC, Canada.; Steidl, C (corresponding author), Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC, Canada.	dscott8@bccancer.bc.ca; CSteidl@bccancer.bc.ca	Morin, Ryan/AAE-7824-2019; Gascoyne, Randy D/A-6009-2013; Marra, Marco A/B-5987-2008; Savage, Kerry/HCH-5539-2022; Mungall, Andrew J./U-7067-2018; Mottok, Anja/AAO-1801-2021; Villa, Diego/CAF-2455-2022	Morin, Ryan/0000-0003-2932-7800; Gascoyne, Randy D/0000-0002-2610-5690; Marra, Marco A/0000-0001-7146-7175; Mungall, Andrew J./0000-0002-0905-2742; Villa, Diego/0000-0002-4625-3009; Madero Rincon, Angel/0000-0002-6238-4658; Dos Santos, Nancy/0000-0003-3619-8306; Gerrie, Alina/0000-0003-4727-1425; Kridel, Robert/0000-0003-0287-7124; Hother, Christoffer Egeberg/0000-0001-8778-9662; Rushton, Christopher/0000-0001-6306-9361; Mottok, Anja/0000-0003-3125-0494; Farinha, Pedro/0000-0001-9364-9391; Bristow, Brianna/0000-0002-0411-916X	Terry Fox Research Institute; Large Scale Applied Research Project (LSARP) from Genome Canada [13124]; Genome British Columbia [271LYM]; Canadian Institutes of Health Research (CIHR); British Columbia Cancer Foundation (BCCF); Michael Smith Foundation for Health Research (MSFHR); Japanese Society for The Promotion of Science; British Columbia Cancer Agency Centre for Lymphoid Cancer; Genome Canada; Genome British Columbia, CIHR; Alfred Benzon foundation; Mildred-Scheel-Cancer-Foundation (German Cancer Aid); MSFHR and Lymphoma Canada; Michael Smith Foundation for Health Research; NSERC Discovery grant - CIHR New Investigator Award; CIHR [PJT-148649]; Canada Research Chair in Computational Cancer Genomics; CIHR Foundation; BCCF; Uehara Memorial Foundation; Kanae Foundation for the Promotion of Medical Science; CIHR grant [PJT-152946]; Canada Research Chair in Vision and Macular Degeneration	Terry Fox Research Institute; Large Scale Applied Research Project (LSARP) from Genome Canada; Genome British Columbia; Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); British Columbia Cancer Foundation (BCCF); Michael Smith Foundation for Health Research (MSFHR)(Michael Smith Foundation for Health Research); Japanese Society for The Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); British Columbia Cancer Agency Centre for Lymphoid Cancer; Genome Canada(Genome Canada); Genome British Columbia, CIHR; Alfred Benzon foundation; Mildred-Scheel-Cancer-Foundation (German Cancer Aid); MSFHR and Lymphoma Canada; Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research); NSERC Discovery grant - CIHR New Investigator Award; CIHR(Canadian Institutes of Health Research (CIHR)); Canada Research Chair in Computational Cancer Genomics; CIHR Foundation(Canadian Institutes of Health Research (CIHR)); BCCF; Uehara Memorial Foundation(Uehara Memorial Foundation); Kanae Foundation for the Promotion of Medical Science; CIHR grant(Canadian Institutes of Health Research (CIHR)); Canada Research Chair in Vision and Macular Degeneration	This study was supported by a Program Project Grant from the Terry Fox Research Institute (R.D.G, grant no. 1023; C.S., grant no. 1061), a Large Scale Applied Research Project (LSARP) from Genome Canada (C.S., grant no. 13124), Genome British Columbia (C.S., 271LYM), Canadian Institutes of Health Research (CIHR) (C.S., GP1-155873) and the British Columbia Cancer Foundation (BCCF). D.E. was supported by fellowships from the Michael Smith Foundation for Health Research (MSFHR), Canadian Institutes of Health Research (CIHR) and Japanese Society for The Promotion of Science. D.W.S. is supported by the British Columbia Cancer Foundation (BCCF) and the Michael Smith Foundation for Health Research (MSFHR). J.M.C. was the Clinical Director of the British Columbia Cancer Agency Centre for Lymphoid Cancer and received research funding support from the Terry Fox Research Institute, Genome Canada, Genome British Columbia, CIHR and the BCCF. C.H. was supported by the Alfred Benzon foundation. A.M. is supported by fellowships from the Mildred-Scheel-Cancer-Foundation (German Cancer Aid), the MSFHR and Lymphoma Canada. E.V. is supported by a fellowship from the Michael Smith Foundation for Health Research. G.V.C.F is supported by an NSERC Discovery grant. R.D.M. is funded by a CIHR New Investigator Award. M.A.M. is UBC Canada Research Chair in Genome Science and is pleased to acknowledge support from CIHR (FDN-143288) and the Terry Fox Research Institute. S.P.S. holds the Canada Research Chair in Computational Cancer Genomics, is a MSFHR scholar, holds a CIHR Foundation grant and acknowledges support from the BCCF. T.A. was supported by the Japanese Society for the Promotion of Science and the Uehara Memorial Foundation. T.A. received research funding support from The Kanae Foundation for the Promotion of Medical Science. L.A., as well as the experiments carried out by L.A., were supported by CIHR grant PJT-152946 (to M.R.G.). R.S.M holds a Canada Research Chair in Vision and Macular Degeneration and acknowledges support from CIHR (PJT-148649). K.T. was supported by fellowships from the Uehara Memorial Foundation. We thank E. Toombs for assistance in performing research, analyzing and interpreting data.	Advani R, 2018, NEW ENGL J MED, V379, P1711, DOI 10.1056/NEJMoa1807315; Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Andersen JP, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00275; Barclay AN, 2014, ANNU REV IMMUNOL, V32, P25, DOI 10.1146/annurev-immunol-032713-120142; Birge RB, 2016, CELL DEATH DIFFER, V23, P962, DOI 10.1038/cdd.2016.11; Chapuy B, 2018, NAT MED, V24, P679, DOI 10.1038/s41591-018-0016-8; Coiffier B, 2002, NEW ENGL J MED, V346, P235, DOI 10.1056/NEJMoa011795; Coleman JA, 2011, J BIOL CHEM, V286, P17205, DOI 10.1074/jbc.M111.229419; Das R, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000556; Ding JR, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9554; Elliott JI, 2006, BLOOD, V108, P1611, DOI 10.1182/blood-2005-11-012328; Elliott JI, 2005, NAT CELL BIOL, V7, P808, DOI 10.1038/ncb1279; Ennishi D, 2019, J CLIN ONCOL, V37, P190, DOI 10.1200/JCO.18.01583; Ennishi D, 2017, BLOOD, V129, P2760, DOI 10.1182/blood-2016-11-747022; Freeman SA, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7168; Gagnon E, 2012, J EXP MED, V209, P2423, DOI 10.1084/jem.20120790; Hankins HM, 2015, TRAFFIC, V16, P35, DOI 10.1111/tra.12233; Kridel R, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002197; Lohr JG, 2012, P NATL ACAD SCI USA, V109, P3879, DOI 10.1073/pnas.1121343109; Lopez-Marques RL, 2014, PFLUG ARCH EUR J PHY, V466, P1227, DOI 10.1007/s00424-013-1363-4; Mattila PK, 2016, J CELL BIOL, V212, P267, DOI 10.1083/jcb.201504137; Mattila PK, 2013, IMMUNITY, V38, P461, DOI 10.1016/j.immuni.2012.11.019; Moreno-Smith M, 2013, J CLIN INVEST, V123, P2119, DOI 10.1172/JCI65425; Morin RD, 2011, NATURE, V476, P298, DOI 10.1038/nature10351; Nagata S, 2016, CELL DEATH DIFFER, V23, P952, DOI 10.1038/cdd.2016.7; Pasqualucci L, 2011, NAT GENET, V43, P830, DOI 10.1038/ng.892; Petrova PS, 2017, CLIN CANCER RES, V23, P1068, DOI 10.1158/1078-0432.CCR-16-1700; Phelan JD, 2018, NATURE, V560, P387, DOI 10.1038/s41586-018-0290-0; Puts CF, 2009, BBA-MOL CELL BIOL L, V1791, P603, DOI 10.1016/j.bbalip.2009.02.005; Raghupathy R, 2015, CELL, V161, P581, DOI 10.1016/j.cell.2015.03.048; Reddy A, 2017, CELL, V171, P481, DOI 10.1016/j.cell.2017.09.027; Rosenwald A, 2002, NEW ENGL J MED, V346, P1937, DOI 10.1056/NEJMoa012914; Schmitz R, 2018, NEW ENGL J MED, V378, P1396, DOI 10.1056/NEJMoa1801445; Segawa K, 2018, J BIOL CHEM, V293, P2172, DOI 10.1074/jbc.RA117.000289; Segawa K, 2015, TRENDS CELL BIOL, V25, P639, DOI 10.1016/j.tcb.2015.08.003; Segawa K, 2014, SCIENCE, V344, P1164, DOI 10.1126/science.1252809; Sehn LH, 2005, J CLIN ONCOL, V23, P5027, DOI 10.1200/JCO.2005.09.137; Shipp MA, 2002, NAT MED, V8, P68, DOI 10.1038/nm0102-68; Suzuki J, 2016, P NATL ACAD SCI USA, V113, P9509, DOI 10.1073/pnas.1610403113; Suzuki J, 2014, J BIOL CHEM, V289, P30257, DOI 10.1074/jbc.M114.583419; Suzuki J, 2013, SCIENCE, V341, P403, DOI 10.1126/science.1236758; Suzuki J, 2010, NATURE, V468, P834, DOI 10.1038/nature09583; Swerdlow S. H, 2008, WHO CLASSIFICATION T, V2; Swerdlow SH, 2016, BLOOD, V127, P2375, DOI 10.1182/blood-2016-01-643569; Treanor B, 2012, IMMUNOLOGY, V136, P21, DOI 10.1111/j.1365-2567.2012.03564.x; Treanor B, 2010, IMMUNITY, V32, P187, DOI 10.1016/j.immuni.2009.12.005; van Blitterswijk WJ, 2013, BBA-MOL CELL BIOL L, V1831, P663, DOI 10.1016/j.bbalip.2012.10.008; van der Mark VA, 2013, INT J MOL SCI, V14, P7897, DOI 10.3390/ijms14047897; Zhang J, 2013, P NATL ACAD SCI USA, V110, P1398, DOI 10.1073/pnas.1205299110	49	26	27	3	9	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	APR	2020	26	4					577	+		10.1038/s41591-020-0757-z	http://dx.doi.org/10.1038/s41591-020-0757-z		FEB 2020	29	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	QH1UE	32094924	Green Accepted			2022-12-27	WOS:000515477500001
J	Dussupt, V; Sankhala, RS; Gromowski, GD; Donofrio, G; De La Barreras, RA; Larocca, RA; Zaky, W; Mendez-Rivera, L; Choe, M; Davidsons, E; McCracken, MK; Brien, JD; Abbink, P; Bai, HJ; Bryans, AL; Bias, CH; Berry, IM; Boteros, N; Cooks, T; Doria-Rose, NA; Escuers, AGI; Frimpong, JA; Geretzt, A; Hernanders, M; Hollidge, BS; Jian, NB; Kabra, K; Leggat, DJ; Liu, JY; Pinto, AK; Rutvisuttinunt, W; Setliff, I; Tran, U; Townsley, S; Doranzs, BJ; Rolland, M; McDermott, AB; Georgiev, IS; Thomas, R; Robb, ML; Eckels, KH; Barranco, E; Koren, M; Smith, DR; Jarman, RG; George, SL; Stephenson, KE; Barouch, DH; Modjarradl, K; Michaels, NL; Joyce, MG; Krebs, SJ				Dussupt, Vincent; Sankhala, Rajeshwer S.; Gromowski, Gregory D.; Donofrio, Gina; De La Barreras, Rafael A.; Larocca, Rafael A.; Zaky, Weam; Mendez-Rivera, Letzibeth; Choe, Misook; Davidsons, Edgar; McCracken, Michael K.; Brien, James D.; Abbink, Peter; Bai, Hongjun; Bryans, Aubrey L.; Bias, Candace Hope; Berry, Irina Maljkovic; Boteros, Nubia; Cooks, Tanya; Doria-Rose, Nicole A.; Grinyo i Escuers, Ariadna; Frimpong, Justice Akuoku; Geretzt, Aviva; Hernanders, Mayda; Hollidge, Bradley S.; Jian, Ningbo; Kabra, Kareem; Leggat, David J.; Liu, Jinyan; Pinto, Amelia K.; Rutvisuttinunt, Wiriya; Setliff, Ian; Tran, Ursula; Townsley, Samantha; Doranzs, Benjamin J.; Rolland, Morgane; McDermott, Adrian B.; Georgiev, Ivelin S.; Thomas, Rasmi; Robb, Merlin L.; Eckels, Kenneth H.; Barranco, Elizabeth; Koren, Michael; Smith, Darci R.; Jarman, Richard G.; George, Sarah L.; Stephenson, Kathryn E.; Barouch, Dan H.; Modjarradl, Kayvon; Michaels, Nelson L.; Joyce, M. Gordon; Krebs, Shelly J.			Potent Zika and dengue cross-neutralizing antibodies induced by Zika vaccination in a dengue-experienced donor	NATURE MEDICINE			English	Article							MONOCLONAL-ANTIBODIES; STRUCTURAL BASIS; VIRUS-VACCINE; RT-PCR; IDENTIFICATION; IMMUNOGENICITY; DETERMINANTS; EFFICIENT; DESIGN; SAFETY	Zika virus (ZIKV) has caused significant disease, with widespread cases of neurological pathology and congenital neurologic defects. Rapid vaccine development has led to a number of candidates capable of eliciting potent ZIKV-neutralizing antibodies (reviewed in refs. (1-3)). Despite advances in vaccine development, it remains unclear how ZIKV vaccination affects immune responses in humans with prior flavivirus immunity. Here we show that a single-dose immunization of ZIKV purified inactivated vaccine (ZPIV)(4-7) in a dengue virus (DENV)-experienced human elicited potent cross-neutralizing antibodies to both ZIKV and DENV. Using a unique ZIKV virion-based sorting strategy, we isolated and characterized multiple antibodies, including one termed MZ4, which targets a novel site of vulnerability centered on the Envelope (E) domain I/III linker region and protects mice from viremia and viral dissemination following ZIKV or DENV-2 challenge. These data demonstrate that Zika vaccination in a DENV-experienced individual can boost pre-existing flavivirus immunity and elicit protective responses against both ZIKV and DENV. ZPIV vaccination in Puerto Rican individuals with prior flavivirus experience yielded similar cross-neutralizing potency after a single vaccination, highlighting the potential benefit of ZIKV vaccination in flavivirus-endemic areas. Zika virus vaccination elicits Zika and dengue virus cross-neutralizing antibodies in flavivirus-exposed individuals, potentially enhancing the protective efficacy of the vaccine in flavivirus-endemic regions.	[Dussupt, Vincent; Sankhala, Rajeshwer S.; Donofrio, Gina; Zaky, Weam; Mendez-Rivera, Letzibeth; Choe, Misook; Bai, Hongjun; Geretzt, Aviva; Jian, Ningbo; Tran, Ursula; Townsley, Samantha; Rolland, Morgane; Thomas, Rasmi; Modjarradl, Kayvon; Joyce, M. Gordon; Krebs, Shelly J.] Walter Reed Army Inst Res, Emerging Infect Dis Branch, Ctr Infect Dis Res, Silver Spring, MD 20910 USA; [Dussupt, Vincent; Sankhala, Rajeshwer S.; Donofrio, Gina; Zaky, Weam; Mendez-Rivera, Letzibeth; Choe, Misook; Bai, Hongjun; Geretzt, Aviva; Jian, Ningbo; Tran, Ursula; Townsley, Samantha; Rolland, Morgane; Thomas, Rasmi; Robb, Merlin L.; Joyce, M. Gordon; Krebs, Shelly J.] Walter Reed Army Inst Res, US Mil HIV Res Program, Ctr Infect Dis Res, Silver Spring, MD 20910 USA; [Dussupt, Vincent; Sankhala, Rajeshwer S.; Donofrio, Gina; Zaky, Weam; Mendez-Rivera, Letzibeth; Choe, Misook; Bai, Hongjun; Geretzt, Aviva; Jian, Ningbo; Tran, Ursula; Townsley, Samantha; Rolland, Morgane; Thomas, Rasmi; Robb, Merlin L.; Joyce, M. Gordon; Krebs, Shelly J.] Henry M Jackson Fdn Adv Mil Med, Bethesda, MD 20817 USA; [Gromowski, Gregory D.; McCracken, Michael K.; Berry, Irina Maljkovic; Rutvisuttinunt, Wiriya; Koren, Michael; Jarman, Richard G.] Walter Reed Army Inst Res, Viral Dis Branch, Ctr Infect Dis Res, Silver Spring, MD USA; [De La Barreras, Rafael A.; Bias, Candace Hope; Boteros, Nubia; Cooks, Tanya; Kabra, Kareem; Eckels, Kenneth H.] Walter Reed Army Inst Res, Pilot Bioprod Facil, Ctr Enabling Capabil, Silver Spring, MD USA; [Larocca, Rafael A.; Abbink, Peter; Liu, Jinyan; Stephenson, Kathryn E.; Barouch, Dan H.] Harvard Med Sch, Ctr Virol & Vaccine Res, Beth Israel Deaconess Med Ctr, Boston, MA 02115 USA; [Larocca, Rafael A.; Abbink, Peter; Liu, Jinyan; Stephenson, Kathryn E.; Barouch, Dan H.] Ragon Inst MGH, Cambridge, MA USA; [Davidsons, Edgar; Bryans, Aubrey L.; Grinyo i Escuers, Ariadna; Hernanders, Mayda; Doranzs, Benjamin J.] Integral Mol, Philadelphia, PA USA; [Brien, James D.; Pinto, Amelia K.] St Louis Univ, Sch Med, Dept Mol Microbiol & Immunol, St Louis, MO USA; [Doria-Rose, Nicole A.; Leggat, David J.; McDermott, Adrian B.] NIAID, Vaccine Res Ctr, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Frimpong, Justice Akuoku; Hollidge, Bradley S.; Smith, Darci R.] US Army, Med Res Inst Infect Dis, Ft Detrick, MD 21702 USA; [Setliff, Ian; Georgiev, Ivelin S.] Vanderbilt Univ, Med Ctr, Vanderbilt Vaccine Ctr, Nashville, TN USA; [Barranco, Elizabeth] Ponce Hlth Sci Univ, CAIMED Ctr, Ponce, PR USA; [George, Sarah L.] St Louis Univ, Sch Med, Dept Internal Med, Div Infect Dis Allergy & Immunol, St Louis, MO USA; [George, Sarah L.] St Louis VA Med Ctr, St Louis, MO USA; [Michaels, Nelson L.] Walter Reed Army Inst Res, Ctr Infect Dis Res, Silver Spring, MD USA; [Smith, Darci R.] Naval Med Res Ctr, Immunodiagnost Dept, Biol Def Res Directorate, Ft Detrick, MD USA	United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc; United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Ragon Institute; Saint Louis University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Vanderbilt University; Ponce Health Sciences University; Saint Louis University; United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); Naval Medical Research Center (NMRC)	Joyce, MG; Krebs, SJ (corresponding author), Walter Reed Army Inst Res, Emerging Infect Dis Branch, Ctr Infect Dis Res, Silver Spring, MD 20910 USA.; Joyce, MG; Krebs, SJ (corresponding author), Walter Reed Army Inst Res, US Mil HIV Res Program, Ctr Infect Dis Res, Silver Spring, MD 20910 USA.; Joyce, MG; Krebs, SJ (corresponding author), Henry M Jackson Fdn Adv Mil Med, Bethesda, MD 20817 USA.	gjoyce@eidresearch.org; skrebs@hivresearch.org	Thomas, Rasmi/AAI-4921-2020; Setliff, Ian/AAE-3603-2020; Pinto, Amelia K/O-6658-2018; McDermott, Adrian B/E-7306-2011; McCracken, Michael/AEV-0033-2022; Assumpcao Larocca, Rafael/H-1655-2015; Setliff, Marion/L-8029-2016; Krebs, Shelly/D-8015-2016	Pinto, Amelia K/0000-0002-7147-3978; McDermott, Adrian/0000-0003-0616-9117; Maljkovic Berry, Irina/0000-0001-8555-5352; McCracken, Michael/0000-0002-4035-5485; George, Sarah/0000-0002-9699-1042; Assumpcao Larocca, Rafael/0000-0002-9995-1804; Dussupt, Vincent/0000-0002-8579-6356; Grinyo i Escuer, Ariadna/0000-0003-0185-2734; Tran, Ursula/0000-0003-2891-2821; Setliff, Marion/0000-0003-4726-6132; Leggat, David/0000-0003-4019-7170; Krebs, Shelly/0000-0003-1136-1760	US Department of the Army; Defense Health Agency [0130602D16]; US Department of Defense, Defense Health Agency [0130602D16]; Henry M. Jackson Foundation; Harvard Catalyst, Harvard Clinical and Translational Science Center (National Center for Research Resources and the National Center for Advancing Translational Sciences, National Institutes of Health) [UL1 TR001102]; Harvard University; Vaccine Treatment Evaluation Unit (VTEU) at Saint Louis University [HHSN2722013000021I]; National Institute of Allergy and Infectious Diseases, National Institutes of Health; Henry M. Jackson Foundation [W81XWH-07-2-0067]; National Institute of General Medical Sciences from the National Institutes of Health at the Advanced Photon Source, Argonne National Laboratory [P41 GM103403]; UChicago Argonne for the US Department of Energy, Office of Biological and Environmental Research [DE-AC02-06CH11357]; DOE Office of Science by Brookhaven National Laboratory [DE-SC0012704]; NIH [HHSN272201400058C]	US Department of the Army; Defense Health Agency; US Department of Defense, Defense Health Agency(United States Department of Defense); Henry M. Jackson Foundation; Harvard Catalyst, Harvard Clinical and Translational Science Center (National Center for Research Resources and the National Center for Advancing Translational Sciences, National Institutes of Health); Harvard University; Vaccine Treatment Evaluation Unit (VTEU) at Saint Louis University; National Institute of Allergy and Infectious Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Henry M. Jackson Foundation; National Institute of General Medical Sciences from the National Institutes of Health at the Advanced Photon Source, Argonne National Laboratory; UChicago Argonne for the US Department of Energy, Office of Biological and Environmental Research; DOE Office of Science by Brookhaven National Laboratory(United States Department of Energy (DOE)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We sincerely thank the clinical trial participants and staff. In addition, we thank M. Creegan, M. Eller and the MHRP FlowCore facility for help with FACS sorting and C. Kuklis, Q. Chen, D. Barvir, A. Srikanth, T. Li, C. Fung, B. Yadav, B. Sumlin, G. Ballarini, N. Burrell, R. Olson and A. Dean for technical support. X-ray diffraction data were collected at beamlines at the Advanced Photon Source, Argonne National Laboratory, and the National Synchrotron Light Source II. This work was primarily funded by the US Department of the Army and the Defense Health Agency (0130602D16) to K.M. Work at BIDMC under D.B. was performed with support from the US Department of Defense, Defense Health Agency (0130602D16), the Henry M. Jackson Foundation and the Harvard Catalyst, Harvard Clinical and Translational Science Center (National Center for Research Resources and the National Center for Advancing Translational Sciences, National Institutes of Health Award UL1 TR001102) and with financial contributions from Harvard University and its affiliated academic healthcare centers. The ZPIV vaccine trial in Puerto Rico was funded by the Vaccine Treatment Evaluation Unit (VTEU) at Saint Louis University (contract no. HHSN2722013000021I) under S.L.G. The network of VTEUs is supported by the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health. The funders of the clinical trials were involved in the clinical study design, clinical study operations and approval of the clinical protocols. The ZPIV program leads (K.M. and N.L.M.) and the study sponsors had final responsibility for the decision to submit for publication. This work was supported by a cooperative agreement (W81XWH-07-2-0067) between the Henry M. Jackson Foundation for the Advancement of Military Medicine and the US Department of Defense (DoD) under the leadership of N.L.M. and M.R. The Structural Biology Center (SBC) and Northeastern Collaborative Access Team (NE-CAT) beamlines are funded by the National Institute of General Medical Sciences from the National Institutes of Health (P41 GM103403) at the Advanced Photon Source, Argonne National Laboratory. SBC-CAT is operated by UChicago Argonne for the US Department of Energy, Office of Biological and Environmental Research under contract no. DE-AC02-06CH11357. This research used ID-17-1 (AMX) beamline of the National Synchrotron Light Source II, a US Department of Energy (DOE) Office of Science User Facility operated for the DOE Office of Science by Brookhaven National Laboratory under contract no. DE-SC0012704. In addition, this work was supported by NIH contract no. HHSN272201400058C to B.J.D. Material has been reviewed by the Walter Reed Army Institute of Research. The content is solely the responsibility of the authors and does not necessarily represent the official views of Harvard Catalyst, Harvard University and its affiliated academic healthcare centers or the National Institutes of Health. The opinions or assertions contained herein are the private views of the authors, and are not to be construed as official, or as reflecting true views of the Department of the Army or the Department of Defense. The investigators have adhered to the policies for protection of human subjects as prescribed in AR 70-25.	Abbink P, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aao4163; Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157; Barba-Spaeth G, 2016, NATURE, V536, P48, DOI 10.1038/nature18938; Barouch DH, 2017, IMMUNITY, V46, P176, DOI 10.1016/j.immuni.2017.02.005; CHAPPEL MS, 1991, P NATL ACAD SCI USA, V88, P9036, DOI 10.1073/pnas.88.20.9036; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cockburn JJB, 2012, EMBO J, V31, P767, DOI 10.1038/emboj.2011.439; Cox KS, 2016, MABS-AUSTIN, V8, P129, DOI 10.1080/19420862.2015.1109757; Dai LP, 2016, CELL HOST MICROBE, V19, P696, DOI 10.1016/j.chom.2016.04.013; Davidson E, 2014, IMMUNOLOGY, V143, P13, DOI 10.1111/imm.12323; Dejnirattisai W, 2015, NAT IMMUNOL, V16, P170, DOI 10.1038/ni.3058; Doria-Rose NA, 2014, NATURE, V509, P55, DOI 10.1038/nature13036; Gallichotte EN, 2015, MBIO, V6, DOI 10.1128/mBio.01461-15; GENTRY MK, 1982, AM J TROP MED HYG, V31, P548, DOI 10.4269/ajtmh.1982.31.548; HENCHAL EA, 1982, AM J TROP MED HYG, V31, P830, DOI 10.4269/ajtmh.1982.31.830; Hezareh M, 2001, J VIROL, V75, P12161, DOI 10.1128/JVI.75.24.12161-12168.2001; Klungthong C, 2015, J CLIN VIROL, V63, P25, DOI 10.1016/j.jcv.2014.12.009; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952; Liao HX, 2009, J VIROL METHODS, V158, P171, DOI 10.1016/j.jviromet.2009.02.014; Lu XS, 2019, CELL REP, V26, P438, DOI 10.1016/j.celrep.2018.12.065; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McCracken MK, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006487; Men R, 2004, J VIROL, V78, P4665, DOI 10.1128/JVI.78.9.4665-4674.2004; Modjarrad K, 2018, LANCET, V391, P563, DOI 10.1016/S0140-6736(17)33106-9; Morabito KM, 2017, J INFECT DIS, V216, pS957, DOI 10.1093/infdis/jix464; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pierson TC, 2018, NATURE, V560, P573, DOI 10.1038/s41586-018-0446-y; Renner M, 2018, NAT IMMUNOL, V19, P1248, DOI 10.1038/s41590-018-0227-7; Robbiani DF, 2017, CELL, V169, P597, DOI 10.1016/j.cell.2017.04.024; Robinson LN, 2015, CELL, V162, P493, DOI 10.1016/j.cell.2015.06.057; Rodriguez-Barraquer I, 2019, SCIENCE, V363, P607, DOI 10.1126/science.aav6618; Sapparapu G, 2016, NATURE, V540, P443, DOI 10.1038/nature20564; Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316; Strong M, 2006, P NATL ACAD SCI USA, V103, P8060, DOI 10.1073/pnas.0602606103; Thomas SJ, 2013, AM J TROP MED HYG, V88, P73, DOI 10.4269/ajtmh.2012.12-0361; Tiller T, 2008, J IMMUNOL METHODS, V329, P112, DOI 10.1016/j.jim.2007.09.017; Wang JQ, 2017, CELL, V171, P229, DOI 10.1016/j.cell.2017.09.002; Wang QH, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aai8336; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659; Ye J, 2013, NUCLEIC ACIDS RES, V41, pW34, DOI 10.1093/nar/gkt382; Zhao HY, 2016, CELL, V166, P1016, DOI 10.1016/j.cell.2016.07.020	42	35	36	1	13	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	FEB	2020	26	2					228	+		10.1038/s41591-019-0746-2	http://dx.doi.org/10.1038/s41591-019-0746-2		FEB 2020	27	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	KK7DU	32015557	Bronze, Green Accepted, Green Published			2022-12-27	WOS:000510822600002
J	Wiens, J; Price, WN; Sjoding, MW				Wiens, Jenna; Price, W. Nicholson; Sjoding, Michael W.			Diagnosing bias in data-driven algorithms for healthcare	NATURE MEDICINE			English	Editorial Material								A recent analysis highlighting the potential for algorithms to perpetuate existing racial biases in healthcare underscores the importance of thinking carefully about the labels used during algorithm development.	[Wiens, Jenna] Univ Michigan, Div Comp Sci & Engn, Ann Arbor, MI 48109 USA; [Price, W. Nicholson] Univ Michigan, Sch Law, Ann Arbor, MI 48109 USA; [Sjoding, Michael W.] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Wiens, J (corresponding author), Univ Michigan, Div Comp Sci & Engn, Ann Arbor, MI 48109 USA.	wiensj@umich.edu		Price, Nicholson/0000-0003-0729-290X	NLM NIH HHS [R01 LM013325] Funding Source: Medline	NLM NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))		Bayati M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109264; Benjamin R., 2013, PEOPLES SCI BODIES R; Caruana R, 2015, KDD'15: PROCEEDINGS OF THE 21ST ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P1721, DOI 10.1145/2783258.2788613; Komorowski M, 2018, NAT MED, V24, P1716, DOI 10.1038/s41591-018-0213-5; Liu VX, 2017, AM J RESP CRIT CARE, V196, P856, DOI 10.1164/rccm.201609-1848OC; National Academy of Medicine, 2017, EFFECTIVE CARE HIGH; Nemati S, 2018, CRIT CARE MED, V46, P547, DOI [10.1097/CCM.0000000000002936, 10.1097/ccm.0000000000002936]; Obermeyer Z, 2019, SCIENCE, V366, P447, DOI 10.1126/science.aax2342; Oh J, 2018, INFECT CONT HOSP EP, V39, P425, DOI 10.1017/ice.2018.16; Schoenman JA, 2011, UNDERSTANDING US HLT; Schulam P, 2017, ADV NEUR IN, V30; Silver D, 2017, NATURE, V550, P354, DOI 10.1038/nature24270	12	15	15	2	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JAN	2020	26	1					25	26		10.1038/s41591-019-0726-6	http://dx.doi.org/10.1038/s41591-019-0726-6			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	KG3GZ	31932798				2022-12-27	WOS:000509831900021
J	Mori, M; Furuhashi, K; Danielsson, JA; Hirata, Y; Kakiuchi, M; Lin, CS; Ohta, M; Riccio, P; Takahashi, Y; Xu, XJ; Emala, CW; Lu, C; Nakauchi, H; Cardoso, WV				Mori, Munemasa; Furuhashi, Kazuhiro; Danielsson, Jennifer A.; Hirata, Yuichi; Kakiuchi, Miwako; Lin, Chyuan-Sheng; Ohta, Mayu; Riccio, Paul; Takahashi, Yusuke; Xu, Xinjing; Emala, Charles W.; Lu, Chao; Nakauchi, Hiromitsu; Cardoso, Wellington V.			Generation of functional lungs via conditional blastocyst complementation using pluripotent stem cells	NATURE MEDICINE			English	Article							IN-VIVO; GROUND-STATE; MOUSE; INACTIVATION; REGENERATION; PROGENITORS; DERIVATION; PANCREAS; FGF10; GENE	Millions of people worldwide with incurable end-stage lung disease die because of inadequate treatment options and limited availability of donor organs for lung transplantation(1). Current bioengineering strategies to regenerate the lung have not been able to replicate its extraordinary cellular diversity and complex three-dimensional arrangement, which are indispensable for life-sustaining gas exchange(2,3). Here we report the successful generation of functional lungs in mice through a conditional blastocyst complementation (CBC) approach that vacates a specific niche in chimeric hosts and allows for initiation of organogenesis by donor mouse pluripotent stem cells (PSCs). We show that wild-type donor PSCs rescued lung formation in genetically defective recipient mouse embryos unable to specify (due to Ctnnb1(cnull) mutation) or expand (due to Fgfr2(cnull) mutation) early respiratory endodermal progenitors. Rescued neonates survived into adulthood and had lungs functionally indistinguishable from those of wild-type littermates. Efficient chimera formation and lung complementation required newly developed culture conditions that maintained the developmental potential of the donor PSCs and were associated with global DNA hypomethylation and increased H4 histone acetylation. These results pave the way for the development of new strategies for generating lungs in large animals to enable modeling of human lung disease as well as cell-based therapeutic interventions(4-6).	[Mori, Munemasa; Ohta, Mayu; Riccio, Paul; Cardoso, Wellington V.] Columbia Univ, Irving Med Ctr, Columbia Ctr Human Dev, New York, NY 10032 USA; [Mori, Munemasa; Ohta, Mayu; Riccio, Paul; Cardoso, Wellington V.] Columbia Univ, Irving Med Ctr, Dept Med, Div Pulm Allergy Crit Care, New York, NY 10032 USA; [Furuhashi, Kazuhiro; Hirata, Yuichi; Kakiuchi, Miwako] Columbia Univ, Irving Med Ctr, Columbia Ctr Translat Immunol, Dept Med, New York, NY USA; [Danielsson, Jennifer A.; Emala, Charles W.] Columbia Univ, Irving Med Ctr, Dept Anesthesiol, New York, NY USA; [Lin, Chyuan-Sheng] Columbia Univ, Irving Med Ctr, Coll Phys & Surg, Dept Pathol & Cell Biol,Bernard & Shirlee Brown G, New York, NY USA; [Takahashi, Yusuke; Nakauchi, Hiromitsu] Stanford Univ, Sch Med, Inst Stem Cell Biol & Regenerat Med, Dept Genet, Stanford, CA 94305 USA; [Takahashi, Yusuke; Nakauchi, Hiromitsu] Univ Tokyo, Inst Med Sci, Div Stem Cell Therapy, Distinguished Prof Unit,Minato Ku, Tokyo, Japan; [Xu, Xinjing; Lu, Chao; Cardoso, Wellington V.] Columbia Univ, Irving Med Ctr, Dept Genet & Dev, New York, NY 10032 USA; [Xu, Xinjing; Lu, Chao; Cardoso, Wellington V.] Columbia Univ, Irving Med Ctr, Herbert Irving Comprehens Canc Ctr, New York, NY 10032 USA	Columbia University; NewYork-Presbyterian Hospital; Columbia University; NewYork-Presbyterian Hospital; Columbia University; NewYork-Presbyterian Hospital; Columbia University; NewYork-Presbyterian Hospital; Columbia University; NewYork-Presbyterian Hospital; Stanford University; University of Tokyo; Columbia University; NewYork-Presbyterian Hospital; Columbia University; NewYork-Presbyterian Hospital	Mori, M; Cardoso, WV (corresponding author), Columbia Univ, Irving Med Ctr, Columbia Ctr Human Dev, New York, NY 10032 USA.; Mori, M; Cardoso, WV (corresponding author), Columbia Univ, Irving Med Ctr, Dept Med, Div Pulm Allergy Crit Care, New York, NY 10032 USA.; Nakauchi, H (corresponding author), Stanford Univ, Sch Med, Inst Stem Cell Biol & Regenerat Med, Dept Genet, Stanford, CA 94305 USA.; Nakauchi, H (corresponding author), Univ Tokyo, Inst Med Sci, Div Stem Cell Therapy, Distinguished Prof Unit,Minato Ku, Tokyo, Japan.; Cardoso, WV (corresponding author), Columbia Univ, Irving Med Ctr, Dept Genet & Dev, New York, NY 10032 USA.; Cardoso, WV (corresponding author), Columbia Univ, Irving Med Ctr, Herbert Irving Comprehens Canc Ctr, New York, NY 10032 USA.	mm4452@cumc.columbia.edu; nakauchi@stanford.edu; wvc2104@cumc.columbia.edu		Kakiuchi, Miwako/0000-0002-6300-6771; Lu, Chao/0000-0003-0982-8122; Mori, Munemasa/0000-0002-7283-7198	CCTI flow cytometry core [LSRII: NIH S10RR027050]; Columbia Stem Cell Initiative (CSCI) Flow Cytometry core (FACS Area); Department of Defense [PR161857]; NIH-NHLBI [1 R01 HL148223-01, R35-HL135834-01]; CIRM [LA1_C12-06917]; Damon Runyon Foundation [DFS-28-18]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R35HL135834, R01HL148223] Funding Source: NIH RePORTER	CCTI flow cytometry core; Columbia Stem Cell Initiative (CSCI) Flow Cytometry core (FACS Area); Department of Defense(United States Department of Defense); NIH-NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); CIRM(California Institute for Regenerative Medicine); Damon Runyon Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank J. Qian, J. Huang, A. Kuforiji and M. Jiang for technical assistance, and D. Kotton and L. Oikonomou (CReM, Boston University) for invaluable reagents. We also thank the helpful scientific input from members of the Cardoso's lab and the Columbia Center for Human Development (J. Lu, H. Snoeck, S. Huang, J. Que, F. Constantini, J. Bhattacharya and M. Bacchetta) as well as from M. Morimoto (RIKEN, Japan), T. Matozaki (Kobe University), H. Masaki, S. Hamanaka (University of Tokyo) and T. Nishimura (Stanford University). We also thank K. Kennedy for help in editing the manuscript. We would like to acknowledge the support from the CCTI flow cytometry core (LSRII: NIH S10RR027050) and Columbia Stem Cell Initiative (CSCI) Flow Cytometry core (FACS Area). This work was funded by the Department of Defense, PR161857 and NIH-NHLBI 1 R01 HL148223-01 to M.M., CIRM Research Leadership Award, LA1_C12-06917 to H.N., NIH-NHLBI R35-HL135834-01 to W.V.C., Giannandrea Family Dale F. Frey Breakthrough Scientist of the Damon Runyon Foundation (DFS-28-18) and a Pew-Stewart Scholar for Cancer Research to C.L.	Brault V, 2001, DEVELOPMENT, V128, P1253; CHEN JZ, 1993, P NATL ACAD SCI USA, V90, P4528, DOI 10.1073/pnas.90.10.4528; Chen YW, 2017, NAT CELL BIOL, V19, P542, DOI 10.1038/ncb3510; Choi S, 2017, NATURE, V543, P221, DOI 10.1038/nature21426; De Moerlooze L, 2000, DEVELOPMENT, V127, P483; Dye BR, 2016, ELIFE, V5, DOI 10.7554/eLife.19732; Freedman BS, 2018, NEPHRON, V138, P42, DOI 10.1159/000480370; Furusawa T, 2004, BIOL REPROD, V70, P1452, DOI 10.1095/biolreprod.103.024190; Golde WT, 2005, LAB ANIMAL, V34, P39, DOI 10.1038/laban1005-39; Goss AM, 2009, DEV CELL, V17, P290, DOI 10.1016/j.devcel.2009.06.005; Harris KS, 2006, P NATL ACAD SCI USA, V103, P2208, DOI 10.1073/pnas.0510839103; Harris-Johnson KS, 2009, P NATL ACAD SCI USA, V106, P16287, DOI 10.1073/pnas.0902274106; Huang SXL, 2015, NAT PROTOC, V10, DOI 10.1038/nprot.2015.023; Ke MT, 2016, CELL REP, V14, P2718, DOI 10.1016/j.celrep.2016.02.057; Kobayashi T, 2010, CELL, V142, P787, DOI 10.1016/j.cell.2010.07.039; Kotton DN, 2014, NAT MED, V20, P822, DOI 10.1038/nm.3642; Kretsovali A, 2012, STEM CELLS INT, V2012, DOI 10.1155/2012/184154; Leitch HG, 2013, NAT STRUCT MOL BIOL, V20, P311, DOI 10.1038/nsmb.2510; Longmire TA, 2012, CELL STEM CELL, V10, P398, DOI 10.1016/j.stem.2012.01.019; Lu C, 2016, SCIENCE, V352, P844, DOI 10.1126/science.aac7272; Lyko F, 2018, NAT REV GENET, V19, P81, DOI 10.1038/nrg.2017.80; Matsunari H, 2013, P NATL ACAD SCI USA, V110, P4557, DOI 10.1073/pnas.1222902110; Mikami M, 2017, AM J RESP CELL MOL, V56, P628, DOI 10.1165/rcmb.2016-0292OC; Mori M, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15857; Mori M, 2015, DEVELOPMENT, V142, P258, DOI 10.1242/dev.116855; Ott HC, 2010, NAT MED, V16, P927, DOI 10.1038/nm.2193; Petersen TH, 2010, SCIENCE, V329, P538, DOI 10.1126/science.1189345; Rosen C, 2015, NAT MED, V21, P869, DOI 10.1038/nm.3889; Sekine K, 1999, NAT GENET, V21, P138, DOI 10.1038/5096; Singer BD, 2016, AM J PHYSIOL-LUNG C, V310, pL796, DOI 10.1152/ajplung.00334.2015; Stadtfeld M, 2010, NATURE, V465, P175, DOI 10.1038/nature09017; STONE KC, 1992, AM J RESP CELL MOL, V6, P235, DOI 10.1165/ajrcmb/6.2.235; Suchy F, 2018, CELL STEM CELL, V22, P21, DOI 10.1016/j.stem.2017.12.003; Usui JI, 2012, AM J PATHOL, V180, P2417, DOI 10.1016/j.ajpath.2012.03.007; Valapour M, 2019, Am J Transplant, V19 Suppl 2, P404, DOI 10.1111/ajt.15279; Vaughan AE, 2015, NATURE, V517, P621, DOI 10.1038/nature14112; Wu J, 2017, CELL, V168, P473, DOI 10.1016/j.cell.2016.12.036; Xu XL, 1998, DEVELOPMENT, V125, P753; Yagi M, 2017, NATURE, V548, P224, DOI 10.1038/nature23286; Yamaguchi T, 2017, NATURE, V542, P191, DOI 10.1038/nature21070; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Yu K, 2003, DEVELOPMENT, V130, P3063, DOI 10.1242/dev.00491	43	37	38	0	24	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2019	25	11					1691	+		10.1038/s41591-019-0635-8	http://dx.doi.org/10.1038/s41591-019-0635-8			26	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	JT2KI	31700187	Green Accepted			2022-12-27	WOS:000500824300026
J	Stower, H				Stower, Hannah			Treating tinnitus	NATURE MEDICINE			English	Editorial Material												h.stower@us.nature.com							0	0	0	0	11	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2020	26	11					1677	1677	eabb2830	10.1038/s41591-020-1138-3	http://dx.doi.org/10.1038/s41591-020-1138-3		NOV 2020	1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	OT0SR	33154587				2022-12-27	WOS:000587145800005
J	Kolodziejczyk, AA; Federici, S; Zmora, N; Mohapatra, G; Dori-Bachash, M; Hornstein, S; Leshem, A; Reuveni, D; Zigmond, E; Tobar, A; Salame, TM; Harmelin, A; Shlomai, A; Shapiro, H; Amit, I; Elinav, E				Kolodziejczyk, Aleksandra A.; Federici, Sara; Zmora, Niv; Mohapatra, Gayatree; Dori-Bachash, Mally; Hornstein, Shanni; Leshem, Avner; Reuveni, Debby; Zigmond, Ehud; Tobar, Ana; Salame, Tomer Meir; Harmelin, Alon; Shlomai, Amir; Shapiro, Hagit; Amit, Ido; Elinav, Eran			Acute liver failure is regulated by MYC- and microbiome-dependent programs	NATURE MEDICINE			English	Article							HEPATIC STELLATE CELLS; INTESTINAL MICROBIOTA; HOMEOSTASIS; SENESCENCE; PATHWAY; INJURY; P38	A single-cell map of transcriptomic changes during acute liver failure unveils new insights into pathogenesis and potential therapeutic targets. Acute liver failure (ALF) is a fulminant complication of multiple etiologies, characterized by rapid hepatic destruction, multi-organ failure and mortality. ALF treatment is mainly limited to supportive care and liver transplantation. Here we utilize the acetaminophen (APAP) and thioacetamide (TAA) ALF models in characterizing 56,527 single-cell transcriptomes to define the mouse ALF cellular atlas. We demonstrate that unique, previously uncharacterized stellate cell, endothelial cell, Kupffer cell, monocyte and neutrophil subsets, and their intricate intercellular crosstalk, drive ALF. We unravel a common MYC-dependent transcriptional program orchestrating stellate, endothelial and Kupffer cell activation during ALF, which is regulated by the gut microbiome through Toll-like receptor (TLR) signaling. Pharmacological inhibition of MYC, upstream TLR signaling checkpoints or microbiome depletion suppress this cell-specific, MYC-dependent program, thereby attenuating ALF. In humans, we demonstrate upregulated hepatic MYC expression in ALF transplant recipients compared to healthy donors. Collectively we demonstrate that detailed cellular/genetic decoding may enable pathway-specific ALF therapeutic intervention.	[Kolodziejczyk, Aleksandra A.; Federici, Sara; Zmora, Niv; Mohapatra, Gayatree; Dori-Bachash, Mally; Hornstein, Shanni; Leshem, Avner; Shapiro, Hagit; Amit, Ido; Elinav, Eran] Weizmann Inst Sci, Immunol Dept, Rehovot, Israel; [Zmora, Niv; Reuveni, Debby; Zigmond, Ehud; Tobar, Ana; Shlomai, Amir] Tel Aviv Univ, Sackler Fac Med, Tel Aviv, Israel; [Zmora, Niv; Reuveni, Debby; Zigmond, Ehud] Tel Aviv Sourasky Med Ctr, Res Ctr Digest Tract & Liver Dis, Tel Aviv, Israel; [Leshem, Avner] Tel Aviv Sourasky Med Ctr, Dept Surg, Tel Aviv, Israel; [Tobar, Ana] Beilinson Med Ctr, Dept Pathol, Rabin Med Ctr, Petah Tiqwa, Israel; [Salame, Tomer Meir] Weizmann Inst Sci, Dept Biol Serv, Rehovot, Israel; [Harmelin, Alon] Weizmann Inst Sci, Dept Vet Resources, Rehovot, Israel; [Shlomai, Amir] Beilinson Med Ctr, Rabin Med Ctr, Dept Med D, Petah Tiqwa, Israel; [Shlomai, Amir] Beilinson Med Ctr, Rabin Med Ctr, Liver Inst, Petah Tiqwa, Israel; [Elinav, Eran] DKFZ, Div Canc Microbiome Res, Heidelberg, Germany	Weizmann Institute of Science; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; Rabin Medical Center; Weizmann Institute of Science; Weizmann Institute of Science; Rabin Medical Center; Rabin Medical Center; Helmholtz Association; German Cancer Research Center (DKFZ)	Amit, I; Elinav, E (corresponding author), Weizmann Inst Sci, Immunol Dept, Rehovot, Israel.; Elinav, E (corresponding author), DKFZ, Div Canc Microbiome Res, Heidelberg, Germany.	ido.amit@weizmann.ac.il; eran.elinav@weizmann.ac.il	Federici, Sara/ABD-4056-2021; Kołodziejczyk, Aleksandra/K-1985-2014; Shapiro, Hagit/F-8648-2015; Elinav, Eran/ABE-8881-2020	Kołodziejczyk, Aleksandra/0000-0002-2903-8884; Elinav, Eran/0000-0002-5775-2110; Federici, Sara/0000-0002-3663-5142; Leshem, Avner/0000-0003-4082-2036	EMBO Long Term Fellowship [2016-1088]; European Union's Horizon 2020 research and innovation program under Marie Sklodowska-Curie grant [747114]; Chan Zuckerberg Initiative; HHMI international scholar award; European Research Council consolidator grant (ERC-COG) [724471-Hem-Tree2.0]; Thompson Family Foundation; MRA established investigator award [509044]; Israel Science Foundation [703/15]; Ernest and Bonnie Beutler Research Program for Excellence in Genomic Medicine; Helen and Martin Kimmel award for innovative investigation; NeuroMac DFG/Transregional Collaborative Research Center grant; International Progressive MS Alliance/NMSS [PA-1604-08459]; Adelis Foundation; SCA award of the Wolfson Foundation; Leona M. and Harry B. Helmsley Charitable Trust; Pearl Welinsky Merlo Scientific Progress Research Fund; Lawrence and Sandra Post Family Foundation; Daniel Morris Trust; Park Avenue Charitable Fund; Hanna and Dr Ludwik Wallach Cancer Research Fund; Howard and Nancy Marks Charitable Fund; estate of Malka Moskowitz; estate of Myron H. Ackerman; estate of Bernard Bishin; V. R. Schwartz Research Fellow Chair; European Research Council; Israel Science Foundation; Israel Ministry of Science and Technology; Israel Ministry of Health; Helmholtz Foundation; Else Kroener Fresenius Foundation; Garvan Institute; European Crohn's and Colitis Organization; Deutsch-Israelische Projektkooperation; Welcome Trust	EMBO Long Term Fellowship(European Molecular Biology Organization (EMBO)); European Union's Horizon 2020 research and innovation program under Marie Sklodowska-Curie grant; Chan Zuckerberg Initiative; HHMI international scholar award(Howard Hughes Medical Institute); European Research Council consolidator grant (ERC-COG); Thompson Family Foundation; MRA established investigator award; Israel Science Foundation(Israel Science Foundation); Ernest and Bonnie Beutler Research Program for Excellence in Genomic Medicine; Helen and Martin Kimmel award for innovative investigation; NeuroMac DFG/Transregional Collaborative Research Center grant; International Progressive MS Alliance/NMSS; Adelis Foundation; SCA award of the Wolfson Foundation; Leona M. and Harry B. Helmsley Charitable Trust; Pearl Welinsky Merlo Scientific Progress Research Fund; Lawrence and Sandra Post Family Foundation; Daniel Morris Trust; Park Avenue Charitable Fund; Hanna and Dr Ludwik Wallach Cancer Research Fund; Howard and Nancy Marks Charitable Fund; estate of Malka Moskowitz; estate of Myron H. Ackerman; estate of Bernard Bishin; V. R. Schwartz Research Fellow Chair; European Research Council(European Research Council (ERC)European Commission); Israel Science Foundation(Israel Science Foundation); Israel Ministry of Science and Technology(Ministry of Science, Technology and Space (MOST), Israel); Israel Ministry of Health; Helmholtz Foundation(Helmholtz Association); Else Kroener Fresenius Foundation; Garvan Institute; European Crohn's and Colitis Organization; Deutsch-Israelische Projektkooperation; Welcome Trust(Wellcome Trust)	We thank members of the Elinav laboratory and the DKFZ cancer-microbiome division for discussions. We thank C. Bar-Nathan for dedicated assistance with animal work. A.A.K. is a recipient of EMBO Long Term Fellowship no. 2016-1088 and the European Union's Horizon 2020 research and innovation program under Marie Sklodowska-Curie grant agreement no. 747114. I.A. is supported by the Chan Zuckerberg Initiative, an HHMI international scholar award, a European Research Council consolidator grant (ERC-COG, no. 724471-Hem-Tree2.0), the Thompson Family Foundation, an MRA established investigator award (no. 509044), the Israel Science Foundation (no. 703/15), the Ernest and Bonnie Beutler Research Program for Excellence in Genomic Medicine, a Helen and Martin Kimmel award for innovative investigation, a NeuroMac DFG/Transregional Collaborative Research Center grant, International Progressive MS Alliance/NMSS (no. PA-1604-08459), an Adelis Foundation grant and the SCA award of the Wolfson Foundation. E.E. is supported by Yael and Rami Ungar; the Leona M. and Harry B. Helmsley Charitable Trust; the Adelis Foundation; the Pearl Welinsky Merlo Scientific Progress Research Fund; the Lawrence and Sandra Post Family Foundation; the Daniel Morris Trust; the Park Avenue Charitable Fund; the Hanna and Dr Ludwik Wallach Cancer Research Fund; the Howard and Nancy Marks Charitable Fund; Aliza Moussaieff; the estates of Malka Moskowitz, Myron H. Ackerman and Bernard Bishin (for the WIS-Clalit Program); Donald and Susan Schwarz; the V. R. Schwartz Research Fellow Chair; grants funded by the European Research Council; Israel Science Foundation; Israel Ministry of Science and Technology; Israel Ministry of Health; the Helmholtz Foundation; the Else Kroener Fresenius Foundation; the Garvan Institute; the European Crohn's and Colitis Organization; Deutsch-Israelische Projektkooperation; and Welcome Trust. E.E. is the incumbent of the Sir Marc and Lady Tania Feldmann Professorial Chair; a senior fellow, Canadian Institute of Advanced Research and an international scholar; and The Bill & Melinda Gates Foundation and Howard Hughes Medical Institute.	Angerer P, 2016, BIOINFORMATICS, V32, P1241, DOI 10.1093/bioinformatics/btv715; Berger SB, 2015, CELL DEATH DISCOV, V1, DOI 10.1038/cddiscovery.2015.9; Bernal W, 2013, NEW ENGL J MED, V369, P2525, DOI 10.1056/NEJMra1208937; Bolyen E, 2019, NAT BIOTECHNOL, V37, P852, DOI 10.1038/s41587-019-0209-9; Brempelis KJ, 2016, CLIN TRANSL IMMUNOL, V5, DOI 10.1038/cti.2016.62; Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233; Cavalli M, 2020, OMICS, V24, P180, DOI 10.1089/omi.2019.0215; Clayton TA, 2006, NATURE, V440, P1073, DOI 10.1038/nature04648; Coppe JP, 2010, ANNU REV PATHOL-MECH, V5, P99, DOI 10.1146/annurev-pathol-121808-102144; Dambach DM, 2002, HEPATOLOGY, V35, P1093, DOI 10.1053/jhep.2002.33162; Dapito DH, 2012, CANCER CELL, V21, P504, DOI 10.1016/j.ccr.2012.02.007; Elinav E, 2011, CELL, V145, P745, DOI 10.1016/j.cell.2011.04.022; Fabregat I, 2016, FEBS J, V283, P2219, DOI 10.1111/febs.13665; Hajovsky H, 2012, CHEM RES TOXICOL, V25, P1955, DOI 10.1021/tx3002719; Hari P, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aaw0254; Hart JR, 2014, P NATL ACAD SCI USA, V111, P12556, DOI 10.1073/pnas.1319488111; Henao-Mejia J, 2012, NATURE, V482, P179, DOI 10.1038/nature10809; Heng TSP, 2008, NAT IMMUNOL, V9, P1091, DOI 10.1038/ni1008-1091; Hinson Jack A, 2010, Handb Exp Pharmacol, P369, DOI 10.1007/978-3-642-00663-0_12; Huebener P, 2015, J CLIN INVEST, V125, P539, DOI 10.1172/JCI76887; Jaeschke H, 2011, J GASTROEN HEPATOL, V26, P173, DOI 10.1111/j.1440-1746.2010.06592.x; Kalucka J, 2020, CELL, V180, P764, DOI 10.1016/j.cell.2020.01.015; Karlmark Karlin Raja, 2008, Expert Rev Gastroenterol Hepatol, V2, P233, DOI 10.1586/17474124.2.2.233; Krenkel O, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8050503; Krenkel O, 2017, NAT REV IMMUNOL, V17, P306, DOI 10.1038/nri.2017.11; Llopis M, 2016, GUT, V65, P830, DOI 10.1136/gutjnl-2015-310585; LOVE MI, 2014, GENOME BIOL, V15, DOI DOI 10.1186/S13059-014-0550-8; MacParland SA, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06318-7; Maerki C, 2009, J IMMUNOL, V182, P507, DOI 10.4049/jimmunol.182.1.507; Maeshima K, 2004, SHOCK, V21, P134, DOI 10.1097/01.shk.0000103386.98235.f6; Mannangatti P, 2015, J BIOL CHEM, V290, P10814, DOI 10.1074/jbc.M114.612192; Mayadas TN, 2014, ANNU REV PATHOL-MECH, V9, P181, DOI 10.1146/annurev-pathol-020712-164023; McDonald B, 2010, SCIENCE, V330, P362, DOI 10.1126/science.1195491; Mederacke I, 2015, NAT PROTOC, V10, P305, DOI 10.1038/nprot.2015.017; Nguyen T, 2009, J BIOL CHEM, V284, P13291, DOI 10.1074/jbc.R900010200; Poisson J, 2017, J HEPATOL, V66, P212, DOI 10.1016/j.jhep.2016.07.009; Ramachandran P, 2019, NATURE, V575, P512, DOI 10.1038/s41586-019-1631-3; Ramilowski JA, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8866; Reimand J, 2007, NUCLEIC ACIDS RES, V35, pW193, DOI 10.1093/nar/gkm226; Reynaert H, 2002, GUT, V50, P571, DOI 10.1136/gut.50.4.571; Ruhlemann MC, 2017, GUT, V66, P753, DOI 10.1136/gutjnl-2016-312180; Scaffidi P, 2002, NATURE, V418, P191, DOI 10.1038/nature00858; Schmidt-Arras D, 2016, J HEPATOL, V64, P1403, DOI 10.1016/j.jhep.2016.02.004; Seki E, 2007, NAT MED, V13, P1324, DOI 10.1038/nm1663; Shaulian E, 2002, NAT CELL BIOL, V4, pE131, DOI 10.1038/ncb0502-e131; Silvestre-Roig C, 2016, BLOOD, V127, P2173, DOI 10.1182/blood-2016-01-688887; Strauss O, 2017, SCI REP-UK, V7, DOI 10.1038/srep44356; Stuart T, 2019, CELL, V177, P1888, DOI 10.1016/j.cell.2019.05.031; Thaiss CA, 2016, CELL, V167, P1495, DOI 10.1016/j.cell.2016.11.003; Thomas MP, 2015, CELL REP, V11, P1079, DOI 10.1016/j.celrep.2015.04.026; Vyrla D, 2016, J IMMUNOL, V196, P4298, DOI 10.4049/jimmunol.1501609; Woolbright Benjamin L, 2017, J Clin Transl Res, V3, P170, DOI 10.18053/jctres.03.2017S1.003; Wu C, 2017, BLOOD, V130; Wu X, 2011, J CLIN INVEST, V121, P1009, DOI 10.1172/JCI44929; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; Yang CY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065070; Yang L, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00138; Zhou J, 2018, J CELL MOL MED, V22, P2908, DOI 10.1111/jcmm.13585	58	42	44	4	19	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	2020	26	12								10.1038/s41591-020-1102-2	http://dx.doi.org/10.1038/s41591-020-1102-2		OCT 2020	35	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	PB8QO	33106666	Green Published			2022-12-27	WOS:000584042900001
J	Killcoyne, S; Gregson, E; Wedge, DC; Woodcock, DJ; Eldridge, MD; de la Rue, R; Miremadi, A; Abbas, S; Blasko, A; Kosmidou, C; Januszewicz, W; Jenkins, AV; Gerstung, M; Fitzgerald, RC				Killcoyne, Sarah; Gregson, Eleanor; Wedge, David C.; Woodcock, Dan J.; Eldridge, Matthew D.; de la Rue, Rachel; Miremadi, Ahmad; Abbas, Sujath; Blasko, Adrienn; Kosmidou, Cassandra; Januszewicz, Wladyslaw; Jenkins, Aikaterini Varanou; Gerstung, Moritz; Fitzgerald, Rebecca C.			Genomic copy number predicts esophageal cancer years before transformation	NATURE MEDICINE			English	Article							BARRETTS-ESOPHAGUS; RADIOFREQUENCY ABLATION; PROGRESSION; P53; DYSPLASIA; ADENOCARCINOMA; METHYLATION; MANAGEMENT; DIAGNOSIS; RISK	Longitudinal molecular profiling of copy number alterations in patients with Barrett's esophagus can identify patients at higher risk of developing esophageal cancer. Recent studies show that aneuploidy and driver gene mutations precede cancer diagnosis by many years(1-4). We assess whether these genomic signals can be used for early detection and pre-emptive cancer treatment using the neoplastic precursor lesion Barrett's esophagus as an exemplar(5). Shallow whole-genome sequencing of 777 biopsies, sampled from 88 patients in Barrett's esophagus surveillance over a period of up to 15 years, shows that genomic signals can distinguish progressive from stable disease even 10 years before histopathological transformation. These findings are validated on two independent cohorts of 76 and 248 patients. These methods are low-cost and applicable to standard clinical biopsy samples. Compared with current management guidelines based on histopathology and clinical presentation, genomic classification enables earlier treatment for high-risk patients as well as reduction of unnecessary treatment and monitoring for patients who are unlikely to develop cancer.	[Killcoyne, Sarah; Gregson, Eleanor; Abbas, Sujath; Blasko, Adrienn; Kosmidou, Cassandra; Januszewicz, Wladyslaw; Jenkins, Aikaterini Varanou; Fitzgerald, Rebecca C.] Univ Cambridge, Med Res Council Canc Unit, Hutchison Med Res Council Res Ctr, Cambridge, England; [Killcoyne, Sarah; Gerstung, Moritz] European Bioinformat Inst EMBL EBI, European Mol Biol Lab, Hinxton, England; [Wedge, David C.; Woodcock, Dan J.] Univ Oxford, Big Data Inst, Oxford, England; [Wedge, David C.] Oxford Natl Inst Hlth Res Biomed Res Ctr, Oxford, England; [Wedge, David C.] Univ Manchester, Manchester Canc Res Ctr, Manchester, Lancs, England; [Eldridge, Matthew D.] Canc Res UK Cambridge Inst, Bioinformat Core, Cambridge, England; [de la Rue, Rachel; Miremadi, Ahmad] Cambridge Univ Hosp NHS Trust, Cambridge, England; [Gerstung, Moritz] European Mol Biol Lab EMBL, Genome Biol Unit, Heidelberg, Germany	University of Cambridge; European Molecular Biology Laboratory (EMBL); University of Oxford; University of Manchester; Cancer Research UK; CRUK Cambridge Institute; European Molecular Biology Laboratory (EMBL)	Fitzgerald, RC (corresponding author), Univ Cambridge, Med Res Council Canc Unit, Hutchison Med Res Council Res Ctr, Cambridge, England.; Gerstung, M (corresponding author), European Bioinformat Inst EMBL EBI, European Mol Biol Lab, Hinxton, England.; Gerstung, M (corresponding author), European Mol Biol Lab EMBL, Genome Biol Unit, Heidelberg, Germany.	moritz.gerstung@ebi.ac.uk; RCF29@MRC-CU.cam.ac.uk	Wedge, David/AAC-4977-2021	Abbas, Sujath/0000-0002-2541-4969; Gerstung, Moritz/0000-0001-6709-963X; Eldridge, Matthew/0000-0002-5799-8911; Wedge, David/0000-0002-7572-3196; Januszewicz, Wladyslaw/0000-0002-8200-2661; Kosmidou, Cassandra/0000-0003-2236-246X; Killcoyne, Sarah/0000-0003-3686-6167; Fitzgerald, Rebecca/0000-0002-3434-3568	Medical Research Council [RG84369]; United European Gastroenterology Research Prize [RG76026]; UK National Institute for Health Research Cambridge Biomedical Research Centre, from Addenbrooke's Hospital; Cancer Research UK; MRC [MC_UU_12022/2] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); United European Gastroenterology Research Prize; UK National Institute for Health Research Cambridge Biomedical Research Centre, from Addenbrooke's Hospital; Cancer Research UK(Cancer Research UK); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank the patients who donated tissue samples to this project. The laboratory of R.C.F. is funded by a Core Programme Grant from the Medical Research Council (grant RG84369). This work was also funded by a United European Gastroenterology Research Prize (RG76026). We thank the Human Research Tissue Bank, which is supported by the UK National Institute for Health Research Cambridge Biomedical Research Centre, from Addenbrooke's Hospital. Additional infrastructure support was provided from the Cancer Research UK-funded Experimental Cancer Medicine Centre. We also thank B. J. Reid, P. C. Galipeau and C. A. Sanchez from the Fred Hutchinson Cancer Research Center in Seattle, for their time and help in understanding their data, as well as A. Wolfgang Jung from the EMBL-EBI for advice on survival analysis.	Abelson S, 2018, NATURE, V559, P400, DOI 10.1038/s41586-018-0317-6; Alvi MA, 2013, CLIN CANCER RES, V19, P878, DOI 10.1158/1078-0432.CCR-12-2880; Blum AE, 2016, CANCER RES, V76, P5628, DOI 10.1158/0008-5472.CAN-16-0979; Esserman LJ, 2014, LANCET ONCOL, V15, pE234, DOI 10.1016/S1470-2045(13)70598-9; Fitzgerald RC, 2014, GUT, V63, P7, DOI 10.1136/gutjnl-2013-305372; Frankell AM, 2019, NAT GENET, V51, P506, DOI 10.1038/s41588-018-0331-5; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; Gerstung M, 2020, NATURE, V578, P122, DOI 10.1038/s41586-019-1907-7; Gregson EM, 2016, BRIT J CANCER, V115, P403, DOI 10.1038/bjc.2016.219; Jin Z, 2009, CANCER RES, V69, P4112, DOI 10.1158/0008-5472.CAN-09-0028; Kaye PV, 2010, HISTOPATHOLOGY, V57, P933, DOI 10.1111/j.1365-2559.2010.03715.x; Kaye PV, 2009, HISTOPATHOLOGY, V54, P699, DOI 10.1111/j.1365-2559.2009.03288.x; Keswani RN, 2006, CANCER EPIDEM BIOMAR, V15, P1243, DOI 10.1158/1055-9965.EPI-06-0010; Kim J, 2017, NATURE, V541, P169, DOI 10.1038/nature20805; Lee JJK, 2019, CELL, V177, P1842, DOI 10.1016/j.cell.2019.05.013; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Li X, 2015, CANCER PREV RES, V8, P845, DOI 10.1158/1940-6207.CAPR-15-0130; Li XH, 2014, CANCER PREV RES, V7, P114, DOI 10.1158/1940-6207.CAPR-13-0289; Maley CC, 2006, NAT GENET, V38, P468, DOI 10.1038/ng1768; Martinez P, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02621-x; Martinez P, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12158; Masclee GMC, 2014, ALIMENT PHARM THER, V39, P1321, DOI 10.1111/apt.12759; Mitchell TJ, 2018, CELL, V173, P611, DOI 10.1016/j.cell.2018.02.020; Nilsen G, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-591; Nones K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6224; Parasa S, 2018, GASTROENTEROLOGY, V154, P1282, DOI 10.1053/j.gastro.2017.12.009; Park WG, 2015, AM J GASTROENTEROL, V110, P60, DOI 10.1038/ajg.2014.384; Pettit K, 2015, AM J CLIN PATHOL, V144, pA382, DOI 10.1093/ajcp/144.suppl2.382; Phoa KN, 2014, JAMA-J AM MED ASSOC, V311, P1209, DOI 10.1001/jama.2014.2511; Reid BJ, 2001, AM J GASTROENTEROL, V96, P2839; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; Ross-Innes CS, 2015, NAT GENET, V47, P1038, DOI 10.1038/ng.3357; Scheinin I, 2014, GENOME RES, V24, P2022, DOI 10.1101/gr.175141.114; Secrier M, 2016, NAT GENET, V48, P1131, DOI 10.1038/ng.3659; Shaheen NJ, 2009, NEW ENGL J MED, V360, P2277, DOI 10.1056/NEJMoa0808145; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Sikkema M, 2009, AM J GASTROENTEROL, V104, P2673, DOI 10.1038/ajg.2009.437; Stachler MD, 2015, NAT GENET, V47, P1047, DOI 10.1038/ng.3343; Weaver JMJ, 2014, NAT GENET, V46, P837, DOI 10.1038/ng.3013; Younes M, 2017, HISTOPATHOLOGY, V71, P27, DOI 10.1111/his.13193	40	40	41	0	12	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2020	26	11					1726	+		10.1038/s41591-020-1033-y	http://dx.doi.org/10.1038/s41591-020-1033-y		SEP 2020	24	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	OT0SR	32895572	Green Accepted, Green Submitted			2022-12-27	WOS:000566880900006
J	Xu, X; Sun, J; Nie, S; Li, HY; Kong, YZ; Liang, M; Hou, JL; Huang, XZ; Li, DF; Ma, T; Peng, JQ; Gao, SK; Shao, Y; Zhu, H; Lau, JYN; Wang, GY; Xie, CB; Jiang, L; Huang, AL; Yang, ZL; Zhang, K; Hou, FF				Xu, Xin; Sun, Jian; Nie, Sheng; Li, Huiyuan; Kong, Yaozhong; Liang, Min; Hou, Jinlin; Huang, Xianzhong; Li, Dongfeng; Ma, Tean; Peng, Jiaqing; Gao, Shikui; Shao, Yong; Zhu, Hong; Lau, Johnson Yiu-Nam; Wang, Guangyu; Xie, Chunbao; Jiang, Li; Huang, Ailong; Yang, Zhenglin; Zhang, Kang; Hou, Fan Fan			Seroprevalence of immunoglobulin M and G antibodies against SARS-CoV-2 in China (vol 76, pg 151, 2020)	NATURE MEDICINE			English	Correction								An amendment to this paper has been published and can be accessed via a link at the top of the paper.	[Xu, Xin; Sun, Jian; Nie, Sheng; Liang, Min; Hou, Jinlin; Hou, Fan Fan] Natl Clin Res Ctr Kidney Dis, State Key Lab Organ Failure Res, Guangzhou, Peoples R China; [Xu, Xin; Sun, Jian; Nie, Sheng; Liang, Min; Hou, Jinlin; Zhu, Hong; Hou, Fan Fan] Southern Med Univ, Nanfang Hosp, Guangzhou, Peoples R China; [Li, Huiyuan; Huang, Xianzhong] Kingmed Ctr Clin Lab, Guangzhou, Peoples R China; [Kong, Yaozhong] First Peoples Hosp Foshan, Foshan, Peoples R China; [Li, Dongfeng] Peoples Hosp Honghu, Honghu, Peoples R China; [Ma, Tean] First Peoples Hosp Jingzhou, Jingzhou, Peoples R China; [Peng, Jiaqing] Jingzhou Cent Hosp, Jingzhou, Peoples R China; [Gao, Shikui] Honghu Tradit Chinese Med Hosp, Honghu, Peoples R China; [Shao, Yong] Second Peoples Hosp Honghu, Honghu, Peoples R China; [Lau, Johnson Yiu-Nam] Hong Kong Polytech Univ, Dept Appl Biol & Chem Technol, Hong Kong, Hong Kong, Peoples R China; [Wang, Guangyu] Tsinghua Univ, Dept Comp Sci & Technol, Beijing, Peoples R China; [Xie, Chunbao; Jiang, Li; Yang, Zhenglin] Univ Elect Sci & Technol China, Sichuan Prov Peoples Hosp, Inst Lab Med, Sichuan Prov Key Lab Human Dis Study, Chengdu, Peoples R China; [Huang, Ailong] Chongqing Med Univ, Key Lab Mol Biol Infect Dis, Minist Educ, Chongqing, Peoples R China; [Zhang, Kang] Macau Univ Sci & Technol, Fac Med, Ctr Biomed & Innovat, Macau, Peoples R China; [Zhang, Kang; Hou, Fan Fan] Guangzhou Regenerat Med & Hlth Guangdong Lab, Guangzhou, Peoples R China	Southern Medical University - China; Hong Kong Polytechnic University; Tsinghua University; Sichuan Provincial People's Hospital; University of Electronic Science & Technology of China; Chongqing Medical University; Macau University of Science & Technology; Guangzhou Regenerative Medicine & Health Guangdong Laboratory (Bioisland Laboratory)	Hou, FF (corresponding author), Natl Clin Res Ctr Kidney Dis, State Key Lab Organ Failure Res, Guangzhou, Peoples R China.; Hou, FF (corresponding author), Southern Med Univ, Nanfang Hosp, Guangzhou, Peoples R China.; Yang, ZL (corresponding author), Univ Elect Sci & Technol China, Sichuan Prov Peoples Hosp, Inst Lab Med, Sichuan Prov Key Lab Human Dis Study, Chengdu, Peoples R China.; Huang, AL (corresponding author), Chongqing Med Univ, Key Lab Mol Biol Infect Dis, Minist Educ, Chongqing, Peoples R China.; Zhang, K (corresponding author), Macau Univ Sci & Technol, Fac Med, Ctr Biomed & Innovat, Macau, Peoples R China.; Zhang, K; Hou, FF (corresponding author), Guangzhou Regenerat Med & Hlth Guangdong Lab, Guangzhou, Peoples R China.	ahuang1964@163.com; zliny@yahoo.com; kang.zhang@gmail.com; ffhouguangzhou@163.com	Xie, Chunbao/AFI-0902-2022					Xu X, 2020, NAT MED, V26, P1193, DOI 10.1038/s41591-020-0949-6	1	2	2	2	18	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	SEP	2020	26	9					1494	1494		10.1038/s41591-020-1058-2	http://dx.doi.org/10.1038/s41591-020-1058-2		AUG 2020	1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	PF3EM	32812013	Bronze, Green Published			2022-12-27	WOS:000560628700001
J	Stower, H				Stower, Hannah			T cells as regulators of senescence	NATURE MEDICINE			English	Editorial Material												h.stower@us.nature.com							0	0	0	0	1	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	JUN	2020	26	6					822	822		10.1038/s41591-020-0954-9	http://dx.doi.org/10.1038/s41591-020-0954-9		JUN 2020	1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	LZ3ZG	32528147	Bronze			2022-12-27	WOS:000539886500003
J	Stower, H				Stower, Hannah			Predicting the first episode of psychosis	NATURE MEDICINE			English	Editorial Material																			0	0	0	0	0	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	MAY	2020	26	5					649	649		10.1038/s41591-020-0907-3	http://dx.doi.org/10.1038/s41591-020-0907-3			1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	ML1JP	32405070	Bronze			2022-12-27	WOS:000549231500013
J	Bateman, RJ; Barthelemy, NR; Horie, K				Bateman, Randall J.; Barthelemy, Nicolas R.; Horie, Kanta			Another step forward in blood-based diagnostics for Alzheimer's disease	NATURE MEDICINE			English	Editorial Material							KINETICS	Measurement of phosphorylated tau protein in blood plasma allows Alzheimer's disease to be distinguished from other neurological diseases and may assist in disease detection during the prodromal stage.	[Bateman, Randall J.; Barthelemy, Nicolas R.; Horie, Kanta] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA	Washington University (WUSTL)	Bateman, RJ (corresponding author), Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA.	batemanr@wustl.edu		Bateman, Randall/0000-0002-7729-1702				Barthelemy NR, 2019, FRONT AGING NEUROSCI, V11, DOI 10.3389/fnagi.2019.00121; Barthelemy NR, 2019, J PREV ALZHEIMERS DI, V6, pS34; Bateman RJ, 2012, NEW ENGL J MED, V367, P795, DOI 10.1056/NEJMoa1202753; Janelidze S, 2020, NAT MED, V26, P379, DOI 10.1038/s41591-020-0755-1; Mielke MM, 2018, ALZHEIMERS DEMENT, V14, P989, DOI 10.1016/j.jalz.2018.02.013; Nakamura A, 2018, NATURE, V554, P249, DOI 10.1038/nature25456; Ovod V, 2017, ALZHEIMERS DEMENT, V13, P841, DOI 10.1016/j.jalz.2017.06.2266; Preische O, 2019, NAT MED, V25, P277, DOI 10.1038/s41591-018-0304-3; Sato C, 2018, NEURON, V97, P1284, DOI 10.1016/j.neuron.2018.02.015; Schindler SE, 2019, NEUROLOGY, V93, pE1647, DOI 10.1212/WNL.0000000000008081; Thijssen EH, 2020, NAT MED, V26, P387, DOI 10.1038/s41591-020-0762-2	11	19	19	4	24	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	MAR	2020	26	3					314	316		10.1038/s41591-020-0797-4	http://dx.doi.org/10.1038/s41591-020-0797-4		MAR 2020	3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	KU0MC	32132715				2022-12-27	WOS:000518096400003
J	Stower, H				Stower, Hannah			Delivering immunotherapy with bacteria	NATURE MEDICINE			English	Editorial Material												h.stower@us.nature.com							0	0	0	2	9	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	MAR	2020	26	3					312	312		10.1038/s41591-020-0812-9	http://dx.doi.org/10.1038/s41591-020-0812-9			1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	KU0MC	32161405	Bronze			2022-12-27	WOS:000519405000010
J	Reyes, M; Filbin, MR; Bhattacharyya, RP; Billman, K; Eisenhaure, T; Hung, DBT; Levy, BD; Baron, RM; Blainey, PC; Goldberg, MB; Hacohen, N				Reyes, Miguel; Filbin, Michael R.; Bhattacharyya, Roby P.; Billman, Kianna; Eisenhaure, Thomas; Hung, Deborah T.; Levy, Bruce D.; Baron, Rebecca M.; Blainey, Paul C.; Goldberg, Marcia B.; Hacohen, Nir			An immune-cell signature of bacterial sepsis	NATURE MEDICINE			English	Article							GENE-EXPRESSION; BIOMARKER; IMMUNOSUPPRESSION; OUTCOMES; SEQ	Dysregulation of the immune response to bacterial infection can lead to sepsis, a condition with high mortality. Multiple whole-blood gene-expression studies have defined sepsis-associated molecular signatures, but have not resolved changes in transcriptional states of specific cell types. Here, we used single-cell RNA-sequencing to profile the blood of people with sepsis (n = 29) across three clinical cohorts with corresponding controls (n = 36). We profiled total peripheral blood mononuclear cells (PBMCs, 106,545 cells) and dendritic cells (19,806 cells) across all subjects and, on the basis of clustering of their gene-expression profiles, defined 16 immune-cell states. We identified a unique CD14(+) monocyte state that is expanded in people with sepsis and validated its power in distinguishing these individuals from controls using public transcriptomic data from subjects with different disease etiologies and from multiple geographic locations (18 cohorts, n = 1,467 subjects). We identified a panel of surface markers for isolation and quantification of the monocyte state and characterized its epigenomic and functional phenotypes, and propose a model for its induction from human bone marrow. This study demonstrates the utility of single-cell genomics in discovering disease-associated cytologic signatures and provides insight into the cellular basis of immune dysregulation in bacterial sepsis. Single-cell transcriptomic analysis identifies a distinct gene signature associated with peripheral monocyte populations that distinguishes people with sepsis from those with sterile inflammation and uninfected controls.	[Reyes, Miguel; Filbin, Michael R.; Bhattacharyya, Roby P.; Billman, Kianna; Eisenhaure, Thomas; Hung, Deborah T.; Blainey, Paul C.; Goldberg, Marcia B.; Hacohen, Nir] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Reyes, Miguel; Blainey, Paul C.] MIT, Dept Biol Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Filbin, Michael R.] Massachusetts Gen Hosp, Dept Emergency Med, Boston, MA 02114 USA; [Filbin, Michael R.; Bhattacharyya, Roby P.; Hung, Deborah T.; Levy, Bruce D.; Baron, Rebecca M.; Goldberg, Marcia B.; Hacohen, Nir] Harvard Med Sch, Boston, MA 02115 USA; [Bhattacharyya, Roby P.; Goldberg, Marcia B.] Massachusetts Gen Hosp, Dept Med, Div Infect Dis, Ctr Bacterial Pathogenesis, Boston, MA 02114 USA; [Hung, Deborah T.; Levy, Bruce D.; Baron, Rebecca M.] Brigham & Womens Hosp, Dept Med, Div Pulm & Crit Care Med, 75 Francis St, Boston, MA 02115 USA; [Hacohen, Nir] Massachusetts Gen Hosp, Ctr Canc Res, Boston, MA 02114 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Massachusetts General Hospital	Blainey, PC; Goldberg, MB; Hacohen, N (corresponding author), Broad Inst MIT & Harvard, Cambridge, MA 02142 USA.; Blainey, PC (corresponding author), MIT, Dept Biol Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Goldberg, MB; Hacohen, N (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.; Goldberg, MB (corresponding author), Massachusetts Gen Hosp, Dept Med, Div Infect Dis, Ctr Bacterial Pathogenesis, Boston, MA 02114 USA.; Hacohen, N (corresponding author), Massachusetts Gen Hosp, Ctr Canc Res, Boston, MA 02114 USA.	pblainey@broadinstitute.org; marcia.goldberg@mgh.harvard.edu; nhacohen@broadinstitute.org		Blainey, Paul/0000-0002-4889-8783; Goldberg, Marcia/0000-0003-4266-9733	SPARC award from the Broad Institute; Ellison Foundation; Allergan Foundation; BARDA [1DSEP160030-01-00]; NIH NIAID [U24 AI118668]; David P. Ryan, MD Endowed Chair in Cancer Research; Mentored Clinical Scientist Research Career Development Award from the NIH [1K08AI119157-04]; Burroughs Wellcome Fund	SPARC award from the Broad Institute; Ellison Foundation(Lawrence Ellison Foundation); Allergan Foundation(AbbVieAllergan); BARDA; NIH NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); David P. Ryan, MD Endowed Chair in Cancer Research; Mentored Clinical Scientist Research Career Development Award from the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Fund(Burroughs Wellcome Fund)	We thank the subjects in our clinical cohorts for participating and donating blood for our study. We are also grateful to the clinical research coordinators and fellows who conducted patient enrollment and performed blood collections: B. Parry, K. Gohres, J. Lee, J. Hwang and K. Richards (MGH); K. Cummins, A. Higuera-Moreno, M. Pinilla-Vera and M. Benson (BWH). We thank A.-C. Villani, A. Arazi, J. Wenger and other members of the Blainey and Hacohen Labs (Broad Institute) for helpful discussions. We thank the Broad Flow Cytometry core for assistance in cell-sorting experiments, and the Broad Genomics Platform for assistance in sequencing. We also thank P. Khatri, S. Schaffert and M. Donato (Stanford University) for advice on bulk gene expression deconvolution and meta-analysis of published datasets. This work was supported by a SPARC award from the Broad Institute (M.B.G.), awards from the Ellison Foundation and the Allergan Foundation (M.B.G.), BARDA 1DSEP160030-01-00 (D.T.H.) and NIH NIAID U24 AI118668 (N.H. and P.C.B.). N.H. was supported by the David P. Ryan, MD Endowed Chair in Cancer Research, R.P.B. was supported by a Mentored Clinical Scientist Research Career Development Award from the NIH (1K08AI119157-04) and P.C.B. was supported by a Career Award at the Scientific Interface from the Burroughs Wellcome Fund.	Bauer M, 2016, EBIOMEDICINE, V6, P114, DOI 10.1016/j.ebiom.2016.03.006; Center for Medicare & Medicaid Services. Sepsis Bundle Project (SEP), SEPS BUNDL PROJ SEP; Chavakis T, 2019, NAT IMMUNOL, V20, P802, DOI 10.1038/s41590-019-0402-5; Cheng SC, 2016, NAT IMMUNOL, V17, P406, DOI 10.1038/ni.3398; Chowdhury RR, 2018, NATURE, V560, P644, DOI 10.1038/s41586-018-0439-x; Coopersmith CM, 2018, INTENS CARE MED, V44, P1400, DOI 10.1007/s00134-018-5175-z; Corces MR, 2017, NAT METHODS, V14, P959, DOI [10.1038/NMETH.4396, 10.1038/nmeth.4396]; Crinier A, 2018, IMMUNITY, V49, P971, DOI 10.1016/j.immuni.2018.09.009; Davenport EE, 2016, LANCET RESP MED, V4, P259, DOI 10.1016/S2213-2600(16)00046-1; Dolinay T, 2012, AM J RESP CRIT CARE, V185, P1225, DOI 10.1164/rccm.201201-0003OC; Filbin MR, 2018, CRIT CARE MED, V46, P1592, DOI 10.1097/CCM.0000000000003260; Gossez M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-35932-0; Haynes WA, 2017, BIOCOMPUTING, P144, DOI 10.1142/9789813207813_0015; Hotchkiss RS, 2013, LANCET INFECT DIS, V13, P260, DOI 10.1016/S1473-3099(13)70001-X; Jang JC, 2017, P NATL ACAD SCI USA, V114, pE10399, DOI 10.1073/pnas.1716015114; Kotliar D, 2019, ELIFE, V8, DOI 10.7554/eLife.43803; Landelle C, 2010, INTENS CARE MED, V36, P1859, DOI 10.1007/s00134-010-1962-x; Lang YJ, 2017, SHOCK, V47, P119, DOI 10.1097/SHK.0000000000000714; Levy Mitchell M, 2003, Intensive Care Med, V29, P530; Manz MG, 2014, NAT REV IMMUNOL, V14, P302, DOI 10.1038/nri3660; McHugh L, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001916; McPeak MB, 2017, J LEUKOCYTE BIOL, V102, P191, DOI 10.1189/jlb.4HI1216-537R; Nakahira K, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001577; Newman AM, 2015, NAT METHODS, V12, P453, DOI [10.1038/nmeth.3337, 10.1038/NMETH.3337]; Opal SM, 2014, CRIT CARE MED, V42, P1714, DOI 10.1097/CCM.0000000000000325; Orr SK, 2015, CRIT CARE MED, V43, P2642, DOI 10.1097/CCM.0000000000001312; Picelli S, 2014, NAT PROTOC, V9, P171, DOI 10.1038/nprot.2014.006; Prescott HC, 2016, AM J RESP CRIT CARE, V194, P147, DOI 10.1164/rccm.201512-2544CP; Ramilowski JA, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8866; Reyes M, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aau9223; Rodriguez S, 2009, BLOOD, V114, P4064, DOI 10.1182/blood-2009-04-214916; Rosenbauer F, 2007, NAT REV IMMUNOL, V7, P105, DOI 10.1038/nri2024; Rudd KE, 2018, CRIT CARE, V22, DOI 10.1186/s13054-018-2157-z; Schaack D, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0198555; Schrijver IT, 2019, FRONT IMMUNOL, V10, DOI [10.1155/2014/598654, 10.3389/fimmu.2019.00327]; Scicluna BP, 2019, AM J RESP CRIT CARE, V199, P936, DOI 10.1164/rccm.201811-2148ED; Scicluna BP, 2015, AM J RESP CRIT CARE, V192, P826, DOI 10.1164/rccm.201502-0355OC; Seymour CW, 2019, JAMA-J AM MED ASSOC, V321, P2003, DOI 10.1001/jama.2019.5791; Stoeckius M, 2018, GENOME BIOL, V19, DOI 10.1186/s13059-018-1603-1; Sunden-Cullberg J, 2007, CRIT CARE MED, V35, P1536, DOI 10.1097/01.CCM.0000266536.14736.03; Sweeney TE, 2018, CRIT CARE MED, V46, P915, DOI 10.1097/CCM.0000000000003084; Sweeney TE, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03078-2; Sweeney TE, 2017, CRIT CARE MED, V45, P1, DOI 10.1097/CCM.0000000000002021; Sweeney TE, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa5993; Ulas T, 2017, NAT IMMUNOL, V18, P622, DOI 10.1038/ni.3745; Vallania F, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07242-6; Veglia F, 2018, NAT IMMUNOL, V19, P108, DOI 10.1038/s41590-017-0022-x; Villani AC, 2017, SCIENCE, V356, DOI 10.1126/science.aah4573; Wolf FA, 2018, GENOME BIOL, V19, DOI 10.1186/s13059-017-1382-0; Zhang HJ, 2016, STEM CELL REP, V6, P940, DOI 10.1016/j.stemcr.2016.05.002; Zheng GXY, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14049	51	109	111	6	54	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	MAR	2020	26	3					333	+		10.1038/s41591-020-0752-4	http://dx.doi.org/10.1038/s41591-020-0752-4		FEB 2020	23	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	KU0MC	32066974	Green Accepted, Green Published			2022-12-27	WOS:000514065500006
J	Ahadi, S; Zhou, WY; Rose, SMSF; Sailani, MR; Contrepois, K; Avina, M; Ashland, M; Brunet, A; Snyder, M				Ahadi, Sara; Zhou, Wenyu; Schussler-Fiorenza Rose, Sophia Miryam; Sailani, M. Reza; Contrepois, Kevin; Avina, Monika; Ashland, Melanie; Brunet, Anne; Snyder, Michael			Personal aging markers and ageotypes revealed by deep longitudinal profiling	NATURE MEDICINE			English	Article							MECHANISMS; EXPRESSION; GROWTH	Longitudinal multiomics profiling of a cohort of healthy people reveals distinct aging patterns-termed ageotypes-in different individuals. The molecular changes that occur with aging are not well understood(1-4). Here, we performed longitudinal and deep multiomics profiling of 106 healthy individuals from 29 to 75 years of age and examined how different types of 'omic' measurements, including transcripts, proteins, metabolites, cytokines, microbes and clinical laboratory values, correlate with age. We identified both known and new markers that associated with age, as well as distinct molecular patterns of aging in insulin-resistant as compared to insulin-sensitive individuals. In a longitudinal setting, we identified personal aging markers whose levels changed over a short time frame of 2-3 years. Further, we defined different types of aging patterns in different individuals, termed 'ageotypes', on the basis of the types of molecular pathways that changed over time in a given individual. Ageotypes may provide a molecular assessment of personal aging, reflective of personal lifestyle and medical history, that may ultimately be useful in monitoring and intervening in the aging process.	[Ahadi, Sara; Zhou, Wenyu; Schussler-Fiorenza Rose, Sophia Miryam; Sailani, M. Reza; Contrepois, Kevin; Avina, Monika; Ashland, Melanie; Brunet, Anne; Snyder, Michael] Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA	Stanford University	Snyder, M (corresponding author), Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA.	mpsnyder@stanford.edu	; Schussler-Fiorenza Rose, Sophia Miryam/E-6411-2013	Ashland, Melanie/0000-0002-3340-3573; Zhou, Wenyu/0000-0002-8447-8815; Snyder, Michael/0000-0003-0784-7987; Schussler-Fiorenza Rose, Sophia Miryam/0000-0002-6311-6671	National Institutes of Health (NIH) Common Fund Human Microbiome Project [U54DK102556]; Stanford Clinical and Translational Science Award (NIH) [UL1TR001085]; Diabetes Genomics and Analysis Core of the Stanford Diabetes Research Center [P30DK116074]; NIH [K08 ES028825];  [S10OD020141]	National Institutes of Health (NIH) Common Fund Human Microbiome Project(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Stanford Clinical and Translational Science Award (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Diabetes Genomics and Analysis Core of the Stanford Diabetes Research Center; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); 	We thank numerous colleagues who contributed to this study, including all the authors of the Zhou et al. study<SUP>13</SUP>. We thank the Stanford Center for Genomics and Personalized Medicine (SCGPM) for providing the computing and data storage resources. We also thank the Jackson Laboratory for Genomic Medicine for contributing to this project. This work was supported by grants from the National Institutes of Health (NIH) Common Fund Human Microbiome Project (U54DK102556), by a grant award to the SCGPM Genome Sequencing Service Center (NIH, S10OD020141), by the Stanford Clinical and Translational Science Award to Spectrum (NIH, UL1TR001085) and by the Diabetes Genomics and Analysis Core of the Stanford Diabetes Research Center (P30DK116074). S.M.S.-F.R. was supported by NIH grant K08 ES028825.	Aunan JR, 2017, AGING DIS, V8, P628, DOI 10.14336/AD.2017.0103; Bae E, 2014, FEBS LETT, V588, P3074, DOI 10.1016/j.febslet.2014.06.034; Biagi E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010667; Bonafe M, 2003, J CLIN ENDOCR METAB, V88, P3299, DOI 10.1210/jc.2002-021810; Bonomini F, 2015, AGING DIS, V6, P109, DOI 10.14336/AD.2014.0305; Carter TA, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-6-r48; Cevenini E, 2008, EXPERT OPIN BIOL TH, V8, P1393, DOI 10.1517/14712598.8.9.1393 ; Edelberg Jay M, 2003, Cardiovasc Toxicol, V3, P27, DOI 10.1385/CT:3:1:27; Field AE, 2018, MOL CELL, V71, P882, DOI 10.1016/j.molcel.2018.08.008; Franceschi C, 2014, J GERONTOL A-BIOL, V69, pS4, DOI 10.1093/gerona/glu057; Galkin F, 2018, BIORXIV, DOI DOI 10.1101/507780; Gutch Manish, 2015, Indian J Endocrinol Metab, V19, P160, DOI 10.4103/2230-8210.146874; Hagstromer M, 2006, PUBLIC HEALTH NUTR, V9, P755, DOI 10.1079/PHN2005898; Horvath S, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-10-r115; Hung CW, 2010, AGEING RES REV, V9, pS36, DOI 10.1016/j.arr.2010.08.006; Kalyani RR, 2013, ENDOCRIN METAB CLIN, V42, P333, DOI 10.1016/j.ecl.2013.02.010; Knowles JW, 2013, METABOLISM, V62, P548, DOI 10.1016/j.metabol.2012.10.002; Kolovou G, 2014, CURR VASC PHARMACOL, V12, P682; Kreienkamp R, 2018, CELL REP, V22, P2006, DOI 10.1016/j.celrep.2018.01.090; Lean MEJ, 2003, EUR J CLIN NUTR, V57, P667, DOI 10.1038/sj.ejcn.1601596; Liu ZY, 2019, PLOS MED, V16, DOI 10.1371/journal.pmed.1002760; Liu Zuyun, 2018, PLoS Med, V15, pe1002718, DOI 10.1371/journal.pmed.1002718; Lopez-Otin C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039; Lu AT, 2019, AGING-US, V11, P303, DOI 10.18632/aging.101684; Ma XJ, 2018, AGING CELL, V17, DOI 10.1111/acel.12831; Mori K, 2010, CORONARY ARTERY DIS, V21, P281, DOI 10.1097/MCA.0b013e32832fe5d5; Pani LN, 2008, DIABETES CARE, V31, P1991, DOI 10.2337/dc08-0577; Peters MJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9570; Pola R, 2004, NEUROBIOL AGING, V25, P1361, DOI 10.1016/j.neurobiolaging.2004.02.028; Reiner AP, 2008, J THROMB HAEMOST, V6, P1625, DOI 10.1111/j.1538-7836.2008.03118.x; Rose SMSF, 2019, NAT MED, V25, P792, DOI 10.1038/s41591-019-0414-6; Ross GR, 2017, BIOL OPEN, V6, P326, DOI 10.1242/bio.022632; Steenman Marja, 2017, Biophys Rev, V9, P131, DOI 10.1007/s12551-017-0255-9; Wetzels JFM, 2007, KIDNEY INT, V72, P632, DOI 10.1038/sj.ki.5002374; Zhou WY, 2019, NATURE, V569, P663, DOI 10.1038/s41586-019-1236-x	35	100	103	3	29	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JAN	2020	26	1					83	+		10.1038/s41591-019-0719-5	http://dx.doi.org/10.1038/s41591-019-0719-5			15	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	KG3GZ	31932806	Green Accepted			2022-12-27	WOS:000509831900031
J	Artzi, NS; Shilo, S; Hadar, E; Rossman, H; Barbash-Hazan, S; Ben-Haroush, A; Balicer, RD; Feldman, B; Wiznitzer, A; Segal, E				Artzi, Nitzan Shalom; Shilo, Smadar; Hadar, Eran; Rossman, Hagai; Barbash-Hazan, Shiri; Ben-Haroush, Avi; Balicer, Ran D.; Feldman, Becca; Wiznitzer, Arnon; Segal, Eran			Prediction of gestational diabetes based on nationwide electronic health records	NATURE MEDICINE			English	Article							RISK-FACTORS; MELLITUS; ASSOCIATION; PREVALENCE; UNIVERSAL; PREGNANCY; GLUCOSE; PREVENTION; OBESITY; AGE	Leveraging the availability of nationwide electronic health records from over 500,000 pregnancies in Israel, a machine-learning approach offers an alternative means of predicting gestational diabetes at high accuracy in the early stages of pregnancy. Gestational diabetes mellitus (GDM) poses increased risk of short- and long-term complications for mother and offspring(1-4). GDM is typically diagnosed at 24-28 weeks of gestation, but earlier detection is desirable as this may prevent or considerably reduce the risk of adverse pregnancy outcomes(5,6). Here we used a machine-learning approach to predict GDM on retrospective data of 588,622 pregnancies in Israel for which comprehensive electronic health records were available. Our models predict GDM with high accuracy even at pregnancy initiation (area under the receiver operating curve (auROC) = 0.85), substantially outperforming a baseline risk score (auROC = 0.68). We validated our results on both a future validation set and a geographical validation set from the most populated city in Israel, Jerusalem, thereby emulating real-world performance. Interrogating our model, we uncovered previously unreported risk factors, including results of previous pregnancy glucose challenge tests. Finally, we devised a simpler model based on just nine questions that a patient could answer, with only a modest reduction in accuracy (auROC = 0.80). Overall, our models may allow early-stage intervention in high-risk women, as well as a cost-effective screening approach that could avoid the need for glucose tolerance tests by identifying low-risk women. Future prospective studies and studies on additional populations are needed to assess the real-world clinical utility of the model.	[Artzi, Nitzan Shalom; Shilo, Smadar; Rossman, Hagai; Wiznitzer, Arnon] Weizmann Inst Sci, Dept Comp Sci & Appl Math, Rehovot, Israel; [Artzi, Nitzan Shalom; Shilo, Smadar; Rossman, Hagai; Segal, Eran] Weizmann Inst Sci, Dept Mol Cell Biol, Rehovot, Israel; [Shilo, Smadar] Rambam Healthcare Campus, Ruth Rappaport Childrens Hosp, Pediat Diabet Unit, Haifa, Israel; [Hadar, Eran; Barbash-Hazan, Shiri; Ben-Haroush, Avi; Wiznitzer, Arnon] Rabin Med Ctr, Helen Schneider Hosp Women, Petah Tiqwa, Israel; [Hadar, Eran; Ben-Haroush, Avi; Wiznitzer, Arnon] Tel Aviv Univ, Sackler Fac Med, Tel Aviv, Israel; [Balicer, Ran D.; Feldman, Becca] Clalit Hlth Serv, Clalit Res Inst, Tel Aviv, Israel; [Balicer, Ran D.] Ben Gurion Univ Negev, Dept Publ Hlth, Fac Hlth Sci, Beer Sheva, Israel	Weizmann Institute of Science; Weizmann Institute of Science; Rambam Health Care Campus; Rabin Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Clalit Health Services; Ben Gurion University	Wiznitzer, A (corresponding author), Weizmann Inst Sci, Dept Comp Sci & Appl Math, Rehovot, Israel.; Segal, E (corresponding author), Weizmann Inst Sci, Dept Mol Cell Biol, Rehovot, Israel.; Wiznitzer, A (corresponding author), Rabin Med Ctr, Helen Schneider Hosp Women, Petah Tiqwa, Israel.; Wiznitzer, A (corresponding author), Tel Aviv Univ, Sackler Fac Med, Tel Aviv, Israel.	ArnonW@clalit.org.il; eran.segal@weizmann.ac.il	Hadar, Eran/AAU-2577-2020	Hadar, Eran/0000-0002-3101-2827; Rossman, Hagai/0000-0002-5613-8004; Segal, Eran/0000-0002-6859-1164; Artzi, Nitzan Shalom/0000-0002-2612-1607; Shilo, Smadar/0000-0003-2399-1866	Crown Human Genome Center - European Research Council; Israel Science Foundation	Crown Human Genome Center - European Research Council; Israel Science Foundation(Israel Science Foundation)	We thank G. Barabash, E. Barkan, I. Kalka and members of the Segal group for discussions. E.S. is supported by the Crown Human Genome Center, by D. L. Schwarz, J. N. Halpern and L. Steinberg, and by grants funded by the European Research Council and the Israel Science Foundation.	American Diabetes Association, 2018, Diabetes Care, V41, pS13, DOI 10.2337/dc18-S002; [Anonymous], MULTITASK PREDICTION; [Anonymous], DATA; Avati A, 2018, BMC MED INFORM DECIS, V18, DOI 10.1186/s12911-018-0677-8; Bain E, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010443.pub2; Biendata Competitions, KDD CUP FRESH AIR; CBS, REG STAT SECT; Chen T., 2016, KDD16 P 22 ACM, DOI DOI 10.1145/2939672.2939785; Chu SY, 2007, DIABETES CARE, V30, P2070, DOI 10.2337/dc06-2559a; Danilenko-Dixon DR, 1999, AM J OBSTET GYNECOL, V181, P798, DOI 10.1016/S0002-9378(99)70304-2; Davey RX, 2001, MED J AUSTRALIA, V174, P118, DOI 10.5694/j.1326-5377.2001.tb143181.x; Di Cianni G, 2003, DIABETES RES CLIN PR, V62, P131, DOI 10.1016/j.diabres.2003.07.004; Donovan L, 2013, ANN INTERN MED, V159, P115, DOI 10.7326/0003-4819-159-2-201307160-00657; Donovan PJ, 2010, AUST PRESCR, V33, P141; Dudley DJ, 2007, CLIN PERINATOL, V34, P611, DOI 10.1016/j.clp.2007.09.003; Fernandez-Delgado M, 2014, J MACH LEARN RES, V15, P3133; Hunt KJ, 2007, OBSTET GYN CLIN N AM, V34, P173, DOI 10.1016/j.ogc.2007.03.002; Josse J., 2019, CONSISTENCY SUPERVIS; Kalter-Leibovici O, 2012, DIABETES CARE, V35, P1894, DOI 10.2337/dc12-0041; Ke G., 2017, LIGHTGBM HIGHLY EFFI; Koivusalo SB, 2016, DIABETES CARE, V39, P24, DOI 10.2337/dc15-0511; Lamain-de Ruiter M, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i4338; Lao TT, 2006, DIABETES CARE, V29, P948, DOI 10.2337/diacare.29.04.06.dc05-2568; Lowe LP, 2012, DIABETES CARE, V35, P574, DOI 10.2337/dc11-1687; Lowe WL, 2018, JAMA-J AM MED ASSOC, V320, P1005, DOI 10.1001/jama.2018.11628; Lundberg SM, 2018, NAT BIOMED ENG, V2, P749, DOI 10.1038/s41551-018-0304-0; Lundberg SM, 2017, P 31 INT C NEUR INF, P4768; Miotto R, 2016, SCI REP-UK, V6, DOI 10.1038/srep26094; Oh J, 2018, INFECT CONT HOSP EP, V39, P425, DOI 10.1017/ice.2018.16; Omar K. B. A., 2018, XGBOOST LGBM PORTO S; Phelan Matthew, 2017, EGEMS (Wash DC), V5, P22, DOI 10.5334/egems.243; Qiu H, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16665-y; Scholtens DM, 2019, DIABETES CARE, V42, P381, DOI 10.2337/dc18-2021; Shepherd GM, 2017, FRONT NEUROANAT, V11, DOI 10.3389/fnana.2017.00100; Silva I, 2012, COMPUT CARDIOL CONF, V39, P245; State of Isreal Ministry of Health, MON PREGN MED EX PRE; Steyerberg EW, 2010, EPIDEMIOLOGY, V21, P128, DOI 10.1097/EDE.0b013e3181c30fb2; Syngelaki A, 2015, FETAL DIAGN THER, V38, P14, DOI 10.1159/000369970; Teh WT, 2011, AUST NZ J OBSTET GYN, V51, P26, DOI 10.1111/j.1479-828X.2011.01292.x; Tibshirani R., 2009, SPRINGER SERIES STAT, DOI [10.1007/978-0-387-84858-7, DOI 10.1007/978-0-387-84858-7]; US Department of Health and Human Services National Institutes of Health & Eunice Kennedy Shriver National Institute of Child Health and Human Development, 2012, AM I RISK GEST DIAB; van Leeuwen M, 2012, BJOG-INT J OBSTET GY, V119, P393, DOI 10.1111/j.1471-0528.2011.03254.x; Vandorsten James P, 2013, NIH Consens State Sci Statements, V29, P1; Vickers AJ, 2006, MED DECIS MAKING, V26, P565, DOI 10.1177/0272989X06295361; Wang C, 2017, AM J OBSTET GYNECOL, V216, P340, DOI 10.1016/j.ajog.2017.01.037; Williams MA, 2003, J REPROD MED, V48, P955; Zhang CL, 2011, AM J CLIN NUTR, V94, p1975S, DOI 10.3945/ajcn.110.001032; Zhao P, 2016, DIABETOLOGIA, V59, P2339, DOI 10.1007/s00125-016-4062-9	48	86	91	8	46	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	JAN	2020	26	1					71	+		10.1038/s41591-019-0724-8	http://dx.doi.org/10.1038/s41591-019-0724-8			16	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	KG3GZ	31932807				2022-12-27	WOS:000509831900029
J	Stower, H				Stower, Hannah			Common IBD pathogenic mechanisms	NATURE MEDICINE			English	Editorial Material												h.stower@us.nature.com							0	1	1	1	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JAN	2020	26	1					21	21		10.1038/s41591-019-0744-4	http://dx.doi.org/10.1038/s41591-019-0744-4			1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	KG3GZ	31932792	Bronze			2022-12-27	WOS:000509831900018
J	[Anonymous]				[Anonymous]			Big hopes for big data	NATURE MEDICINE			English	Editorial Material								Large-scale multi-modal information on patients' health is ever increasing, providing an opportunity to use big data for taking individualized medicine to a global scale.											0	19	19	3	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JAN	2020	26	1					1	1		10.1038/s41591-019-0740-8	http://dx.doi.org/10.1038/s41591-019-0740-8			1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	KG3GZ	31932805	Bronze			2022-12-27	WOS:000509831900001
J	Gao, JJ; Navai, N; Alhalabi, O; Siefker-Radtke, A; Campbell, MT; Tidwell, RS; Guo, CRC; Kamat, AM; Matin, SF; Araujo, JC; Shah, AY; Msaouel, P; Corn, P; Wang, JB; Papadopoulos, JN; Yadav, SS; Blando, JM; Duan, F; Basu, S; Liu, WN; Shen, Y; Zhang, YW; Macaluso, MD; Wang, Y; Chen, JF; Zhang, JH; Futreal, A; Dinney, C; Allison, JP; Goswami, S; Sharma, P				Gao, Jianjun; Navai, Neema; Alhalabi, Omar; Siefker-Radtke, Arlene; Campbell, Matthew T.; Tidwell, Rebecca Slack; Guo, Charles C.; Kamat, Ashish M.; Matin, Surena F.; Araujo, John C.; Shah, Amishi Y.; Msaouel, Pavlos; Corn, Paul; Wang, Jianbo; Papadopoulos, John N.; Yadav, Shalini S.; Blando, Jorge M.; Duan, Fei; Basu, Sreyashi; Liu, Wenbin; Shen, Yu; Zhang, Yuwei; Macaluso, Marc Daniel; Wang, Ying; Chen, Jianfeng; Zhang, Jianhua; Futreal, Andrew; Dinney, Colin; Allison, James P.; Goswami, Sangeeta; Sharma, Padmanee			Neoadjuvant PD-L1 plus CTLA-4 blockade in patients with cisplatin-ineligible operable high-risk urothelial carcinoma	NATURE MEDICINE			English	Article							BLADDER-CANCER; SINGLE-ARM; OPEN-LABEL; T-CELLS; B-CELLS; CHEMOTHERAPY; MULTICENTER; SURVIVAL; IMMUNOTHERAPY; CYSTECTOMY	Immune checkpoint therapy is being tested in the neoadjuvant setting for patients with localized urothelial carcinoma(1,2), with one study reporting data in cisplatin-ineligible patients who received anti-PD-L1 monotherapy(2) . The study reported that patients with bulky tumors, a known high-risk feature defined as greater than clinical T2 disease, had fewer responses, with pathological complete response rate of 17%2. Here we report on the first pilot combination neoadjuvant trial (NCT02812420) with anti-PD-L1 (durvalumab) plus anti-CTLA-4 (tremelimumab) in cisplatin-ineligible patients, with all tumors identified as having high-risk features (n = 28). High-risk features were defined by bulky tumors, variant histology, lymphovascular invasion, hydronephrosis and/or high-grade upper tract disease(3-5). The primary endpoint was safety and we observed 6 of 28 patients (21%) with grade >= 3 immune-related adverse events, consisting of asymptomatic laboratory abnormalities (n = 4), hepatitis and colitis (n = 2). We also observed pathological complete response of 37.5% and downstaging to pT1 or less in 58% of patients who completed surgery (n = 24). In summary, we provide initial safety, efficacy and biomarker data with neoadjuvant combination anti-PD-L1 plus anti-CTLA-4, which warrants further development for patients with localized urothelial carcinoma, especially cisplatin-ineligible patients with high-risk features who do not currently have an established standard-of-care neoadjuvant treatment.	[Gao, Jianjun; Siefker-Radtke, Arlene; Campbell, Matthew T.; Araujo, John C.; Shah, Amishi Y.; Msaouel, Pavlos; Corn, Paul; Wang, Jianbo; Chen, Jianfeng; Goswami, Sangeeta; Sharma, Padmanee] Univ Texas MD Anderson Canc Ctr, Dept Genitourinary Med Oncol, Houston, TX 77030 USA; [Navai, Neema; Kamat, Ashish M.; Matin, Surena F.; Papadopoulos, John N.; Dinney, Colin] Univ Texas MD Anderson Canc Ctr, Dept Urol, Houston, TX 77030 USA; [Alhalabi, Omar] Univ Texas MD Anderson Canc Ctr, Div Canc Med, Houston, TX 77030 USA; [Tidwell, Rebecca Slack; Shen, Yu] Univ Texas MD Anderson Canc Ctr, Dept Biostat, Houston, TX 77030 USA; [Guo, Charles C.] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA; [Yadav, Shalini S.; Blando, Jorge M.; Duan, Fei; Basu, Sreyashi; Liu, Wenbin; Zhang, Yuwei; Macaluso, Marc Daniel; Wang, Ying; Allison, James P.; Sharma, Padmanee] Univ Texas MD Anderson Canc Ctr, Immunotherapy Platform, Houston, TX 77030 USA; [Zhang, Jianhua; Futreal, Andrew] Univ Texas MD Anderson Canc Ctr, Dept Genom Med, Houston, TX 77030 USA; [Sharma, Padmanee] Univ Texas MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Gao, JJ; Sharma, P (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Genitourinary Med Oncol, Houston, TX 77030 USA.; Sharma, P (corresponding author), Univ Texas MD Anderson Canc Ctr, Immunotherapy Platform, Houston, TX 77030 USA.; Sharma, P (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77030 USA.	JGao1@mdanderson.org; PadSharma@mdanderson.org	Alhalabi, Omar/AAZ-4997-2021	Alhalabi, Omar/0000-0002-9658-2206; Tidwell, Rebecca/0000-0003-3041-8582; Campbell, Matthew/0000-0003-1915-4491; Duan, Fei/0000-0002-4659-0144; Dinney, Colin/0000-0002-8969-711X; Goswami, Sangeeta/0000-0001-9201-4503	AstraZeneca/MedImmune; MDACC Immunotherapy Platform, the MD Anderson Physician Scientist Award; Khalifa Physician Scientist Award; Andrew Sabin Family Foundation Fellows Award; Wendy and Leslie Irvin Barnhart Fund	AstraZeneca/MedImmune(AstraZeneca); MDACC Immunotherapy Platform, the MD Anderson Physician Scientist Award; Khalifa Physician Scientist Award; Andrew Sabin Family Foundation Fellows Award; Wendy and Leslie Irvin Barnhart Fund	This research is supported in part through an alliance between AstraZeneca/MedImmune and the MDACC Immunotherapy Platform, the MD Anderson Physician Scientist Award (J.G.), Khalifa Physician Scientist Award (J.G.), Andrew Sabin Family Foundation Fellows Award (J.G.) and Wendy and Leslie Irvin Barnhart Fund (J.G.). We thank the genomic medicine, CGL core team for WES. In addition, we thank Ashura Khan (Program Director) and the Immunotherapy Platform team for technical support. P.S. and J.P.A. are members of the Parker Institute for Cancer Immunotherapy, which supports their research work at MDACC.	Amaria RN, 2018, NAT MED, V24, P1649, DOI 10.1038/s41591-018-0197-1; Balar AV, 2017, LANCET ONCOL, V18, P1483, DOI 10.1016/S1470-2045(17)30616-2; Balar AV, 2017, LANCET, V389, P67, DOI 10.1016/S0140-6736(16)32455-2; Bamias A, 2018, ANN ONCOL, V29, P361, DOI 10.1093/annonc/mdx692; Bellmunt J, 2017, NEW ENGL J MED, V376, P1015, DOI 10.1056/NEJMoa1613683; Bellmunt J, 2014, ANN ONCOL, V25, P40, DOI 10.1093/annonc/mdu223; Cabrita R, 2020, NATURE, V577, P561, DOI 10.1038/s41586-019-1914-8; Carthon BC, 2010, CLIN CANCER RES, V16, P2861, DOI 10.1158/1078-0432.CCR-10-0569; Cibulskis K, 2013, NAT BIOTECHNOL, V31, P213, DOI 10.1038/nbt.2514; Culp SH, 2014, J UROLOGY, V191, P40, DOI 10.1016/j.juro.2013.07.061; European Association of Urology, 2019, EUROPEAN ASS UROLOGY; Forde PM, 2018, NEW ENGL J MED, V378, P1976, DOI 10.1056/NEJMoa1716078; Galsky MD, 2011, J CLIN ONCOL, V29, P2432, DOI 10.1200/JCO.2011.34.8433; Griffiths G, 2011, J CLIN ONCOL, V29, P2171, DOI 10.1200/JCO.2010.32.3139; Grossman HB, 2003, NEW ENGL J MED, V349, P859, DOI 10.1056/NEJMoa022148; Helmink BA, 2020, NATURE, V577, P549, DOI 10.1038/s41586-019-1922-8; Herbst RS, 2014, NATURE, V515, P563, DOI 10.1038/nature14011; Hundal J, 2019, NAT GENET, V51, P175, DOI 10.1038/s41588-018-0283-9; Hundal J, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0264-5; Iyer G, 2018, J CLIN ONCOL, V36, P1949, DOI 10.1200/JCO.2017.75.0158; Kim J, 2019, EUR UROL, V75, P961, DOI 10.1016/j.eururo.2019.02.017; Lee E, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000217; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Liakou CI, 2008, P NATL ACAD SCI USA, V105, P14987, DOI 10.1073/pnas.0806075105; Mayakonda A, 2018, GENOME RES, V28, P1747, DOI 10.1101/gr.239244.118; Miao D, 2018, NAT GENET, V50, P1271, DOI 10.1038/s41588-018-0200-2; Millikan R, 2001, J CLIN ONCOL, V19, P4005, DOI 10.1200/JCO.2001.19.20.4005; Moschini M, 2017, CLIN GENITOURIN CANC, V15, P67, DOI [10.1016/j.clgc.2016.06.002, 10.1016/j.clgc.2016.07.014]; Motzer RJ, 2018, NEW ENGL J MED, V378, P1277, DOI 10.1056/NEJMoa1712126; National Comprehensive Cancer Network, 2019, CLIN PRACT GUID ONC, V2019; Necchi A, 2018, J CLIN ONCOL, V36, P3353, DOI 10.1200/JCO.18.01148; Nombela P, 2019, CANCERS, V11, DOI 10.3390/cancers11030352; Nowicka Malgorzata, 2017, F1000Res, V6, P748, DOI 10.12688/f1000research.11622.3; Patel MR, 2018, LANCET ONCOL, V19, P51, DOI 10.1016/S1470-2045(17)30900-2; Petitprez F, 2020, NATURE, V577, P556, DOI 10.1038/s41586-019-1906-8; Plimack ER, 2014, J CLIN ONCOL, V32, P1895, DOI 10.1200/JCO.2013.53.2465; Powles T, 2019, NAT MED, V25, P1706, DOI 10.1038/s41591-019-0628-7; Powles T, 2017, J CLIN ONCOL, V35, DOI 10.1200/JCO.2017.35.6_suppl.286; Powles T, 2018, LANCET, V391, P748, DOI 10.1016/S0140-6736(17)33297-X; Rosenblatt R, 2012, EUR UROL, V61, P1229, DOI 10.1016/j.eururo.2011.12.010; Sharma P, 2016, LANCET ONCOL, V17, P1590, DOI 10.1016/S1470-2045(16)30496-X; Siefker-Radtke AO, 2013, CANCER-AM CANCER SOC, V119, P540, DOI 10.1002/cncr.27751; Sonpavde G, 2009, CANCER-AM CANCER SOC, V115, P4104, DOI 10.1002/cncr.24466; Stack EC, 2014, METHODS, V70, P46, DOI 10.1016/j.ymeth.2014.08.016; Tang DN, 2013, CANCER IMMUNOL RES, V1, P229, DOI 10.1158/2326-6066.CIR-13-0020; THALL PF, 1995, STAT MED, V14, P357, DOI 10.1002/sim.4780140404; Van der Heijden MS, 2019, ANN ONCOL, V30, P358; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Wang YY, 2019, HUM GENOME VAR, V6, DOI 10.1038/s41439-019-0061-y; Wei SC, 2019, P NATL ACAD SCI USA, V116, P22699, DOI 10.1073/pnas.1821218116; Wei SC, 2019, IMMUNITY, V50, P1084, DOI 10.1016/j.immuni.2019.03.004; Wei SC, 2017, CELL, V170, P1120, DOI 10.1016/j.cell.2017.07.024; Wolchok JD, 2013, NEW ENGL J MED, V369, P122, DOI 10.1056/NEJMoa1302369; Ye K, 2009, BIOINFORMATICS, V25, P2865, DOI 10.1093/bioinformatics/btp394	54	95	98	3	19	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	2020	26	12								10.1038/s41591-020-1086-y	http://dx.doi.org/10.1038/s41591-020-1086-y		OCT 2020	23	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	PB8QO	33046869				2022-12-27	WOS:000577080500002
J	Stower, H				Stower, Hannah			Personalized drug-metabolism assessment	NATURE MEDICINE			English	Editorial Material												h.stower@us.nature.com							0	1	1	1	2	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	JUL	2020	26	7					1009	1009		10.1038/s41591-020-0989-y	http://dx.doi.org/10.1038/s41591-020-0989-y		JUL 2020	1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	MK3XO	32651573	Bronze			2022-12-27	WOS:000547236500005
J	Keohane, DM; Ghosh, TS; Jeffery, IB; Molloy, MG; O'Toole, PW; Shanahan, F				Keohane, David M.; Ghosh, Tarini Shankar; Jeffery, Ian B.; Molloy, Michael G.; O'Toole, Paul W.; Shanahan, Fergus			Microbiome and health implications for ethnic minorities after enforced lifestyle changes	NATURE MEDICINE			English	Article							GUT MICROBIOME; DIET	The gut microbiomes of Irish Travellers, an ethnically distinct subpopulation of Ireland, have similarity to the microbiomes of non-industrialized populations, but externally imposed lifestyle changes may alter their microbiota, with potential health sequelae. Modern lifestyles increase the risk of chronic diseases, in part by modifying the microbiome, but the health effects of lifestyles enforced on ethnic minorities are understudied(1-3). Lifestyle affects the microbiome early in life, when the microbiome is assembled and the immune system is undergoing maturation(4-6). Moreover, the influence of lifestyle has been separated from genetic and geographic factors by studies of genetically similar populations and ethnically distinct groups living in the same geographic location(7-11). The lifestyle of Irish Travellers, an ethnically distinct subpopulation, changed with legislation in 2002 that effectively ended nomadism and altered their living conditions. Comparative metagenomics of gut microbiomes shows that Irish Travellers retain a microbiota similar to that of non-industrialized societies. Their microbiota is associated with non-dietary factors and is proportionately linked with risk of microbiome-related metabolic disease. Our findings suggest there are microbiome-related public health implications when ethnic minorities are pressured to change lifestyles.	[Keohane, David M.; Ghosh, Tarini Shankar; Jeffery, Ian B.; Molloy, Michael G.; O'Toole, Paul W.; Shanahan, Fergus] Univ Coll Cork, APC Microbiome Ireland, Cork, Ireland; [Keohane, David M.; Molloy, Michael G.; Shanahan, Fergus] Univ Coll Cork, Dept Med, Cork, Ireland; [Ghosh, Tarini Shankar; O'Toole, Paul W.] Univ Coll Cork, Sch Microbiol, Cork, Ireland	University College Cork; University College Cork; University College Cork	Shanahan, F (corresponding author), Univ Coll Cork, APC Microbiome Ireland, Cork, Ireland.; Shanahan, F (corresponding author), Univ Coll Cork, Dept Med, Cork, Ireland.	f.shanahan@ucc.ie	Shanahan, Fergus/ABF-2390-2020; O'Toole, Paul W/G-1593-2012; Ghosh, Tarini/AAW-5456-2020	Shanahan, Fergus/0000-0003-0467-0936; O'Toole, Paul W/0000-0001-5377-0824; Keohane, David/0000-0003-2231-0029; Ghosh, Tarini/0000-0001-9570-0365	Science Foundation Ireland (SFI) [12/RC/2273]; ICARE	Science Foundation Ireland (SFI)(Science Foundation Ireland); ICARE	We are deeply grateful to the Irish Traveller community. We are also grateful to B. O'Donoghue, C. Bernard and the members of the Traveller Visibility Group Health Unit in Cork city and K. McDonagh and members of the Travellers of North Cork (TNC) organization. We also thank A. Moloney of APC Microbiome Ireland for laboratory support and clinical nurses K. Power, C. Tobin and M. Daly, as well as L. Horgan and staff of the Irish Centre for Arthritis Research and Education (ICARE) Bone Densitometry Unit in Cork University Hospital. The guiding assistance of J. Sheehan is also acknowledged. The authors are supported in part by Science Foundation Ireland (SFI) in the form of a research center grant (no. 12/RC/2273) to APC Microbiome Ireland and by ICARE.	Abdalla S, 2010, 2 U COLL DUBL SCH PU; Abdalla S., 2010, ALL IRELAND TRAVELLE; Abdalla S, 2013, J PUBLIC HEALTH-UK, V35, P533, DOI 10.1093/pubmed/fds106; Barton W, 2018, GUT, V67, P625, DOI 10.1136/gutjnl-2016-313627; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Brito IL, 2016, NATURE, V535, P435, DOI 10.1038/nature18927; Claesson MJ, 2012, NATURE, V488, P178, DOI 10.1038/nature11319; Clemente JC, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500183; Cronin O, 2018, MSYSTEMS, V3, DOI 10.1128/mSystems.00044-18; De Filippo C, 2010, P NATL ACAD SCI USA, V107, P14691, DOI 10.1073/pnas.1005963107; Deschasaux M, 2018, NAT MED, V24, P1526, DOI 10.1038/s41591-018-0160-1; Downes M, 2009, PREV VET MED, V92, P140, DOI 10.1016/j.prevetmed.2009.07.005; Drescher LS, 2007, J NUTR, V137, P647, DOI 10.1093/jn/137.3.647; Franzosa EA, 2018, NAT METHODS, V15, P962, DOI 10.1038/s41592-018-0176-y; Gensollen T, 2016, SCIENCE, V352, P539, DOI 10.1126/science.aad9378; Ghosh TS, 2020, ELIFE, V9, DOI 10.7554/eLife.50240; Gilbert E, 2017, SCI REP-UK, V7, DOI 10.1038/srep42187; Goodrich JK, 2017, ANNU REV GENET, V51, P413, DOI 10.1146/annurev-genet-110711-155532; Goodrich JK, 2016, CELL HOST MICROBE, V19, P731, DOI 10.1016/j.chom.2016.04.017; He Y, 2018, NAT MED, V24, P1532, DOI 10.1038/s41591-018-0164-x; Irish Central Statistics Office, 2016, CENS POP 2016 RES PR; Janeiro MH, 2018, NUTRIENTS, V10, DOI 10.3390/nu10101398; Jha AR, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2005396; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Liu WJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep34826; McCann May, 1994, IRISH TRAVELLERS CUL; McCormick P, 2001, Ir Med J, V94, P203; Noronha A, 2019, NUCLEIC ACIDS RES, V47, pD614, DOI 10.1093/nar/gky992; Obregon-Tito AJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7505; Pasolli E, 2017, NAT METHODS, V14, P1023, DOI 10.1038/nmeth.4468; Ramezani A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-33018-5; Rampelli S, 2015, CURR BIOL, V25, P1682, DOI 10.1016/j.cub.2015.04.055; Rath S, 2017, MICROBIOME, V5, DOI 10.1186/s40168-017-0271-9; Romano KA, 2015, MBIO, V6, DOI 10.1128/mBio.02481-14; Round JL, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aao1603; Shanahan F, 2012, NAT REV GASTRO HEPAT, V9, P609, DOI 10.1038/nrgastro.2012.145; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Smits SA, 2017, SCIENCE, V357, P802, DOI 10.1126/science.aan4834; Sonnenburg ED, 2019, NAT REV MICROBIOL, V17, P383, DOI 10.1038/s41579-019-0191-8; Sung J, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15393; Topp CW, 2015, PSYCHOTHER PSYCHOSOM, V84, DOI 10.1159/000376585; Truong DT, 2015, NAT METHODS, V12, P902, DOI 10.1038/nmeth.3589; Vangay P, 2018, CELL, V175, P962, DOI 10.1016/j.cell.2018.10.029; Watson Dorothy, 2017, RES SERIES, V56; WILLETT WC, 1985, AM J EPIDEMIOL, V122, P51, DOI 10.1093/oxfordjournals.aje.a114086; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053	46	30	31	2	19	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	JUL	2020	26	7					1089	+		10.1038/s41591-020-0963-8	http://dx.doi.org/10.1038/s41591-020-0963-8		JUL 2020	17	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	MK3XO	32632193				2022-12-27	WOS:000545954500001
J	Tschandl, P; Rinner, C; Apalla, Z; Argenziano, G; Codella, N; Halpern, A; Janda, M; Lallas, A; Longo, C; Malvehy, J; Paoli, J; Puig, S; Rosendahl, C; Soyer, HP; Zalaudek, I; Kittler, H				Tschandl, Philipp; Rinner, Christoph; Apalla, Zoe; Argenziano, Giuseppe; Codella, Noel; Halpern, Allan; Janda, Monika; Lallas, Aimilios; Longo, Caterina; Malvehy, Josep; Paoli, John; Puig, Susana; Rosendahl, Cliff; Soyer, H. Peter; Zalaudek, Iris; Kittler, Harald			Human-computer collaboration for skin cancer recognition	NATURE MEDICINE			English	Article							CLASSIFICATION; ACCURACY	The rapid increase in telemedicine coupled with recent advances in diagnostic artificial intelligence (AI) create the imperative to consider the opportunities and risks of inserting AI-based support into new paradigms of care. Here we build on recent achievements in the accuracy of image-based AI for skin cancer diagnosis to address the effects of varied representations of AI-based support across different levels of clinical expertise and multiple clinical workflows. We find that good quality AI-based support of clinical decision-making improves diagnostic accuracy over that of either AI or physicians alone, and that the least experienced clinicians gain the most from AI-based support. We further find that AI-based multiclass probabilities outperformed content-based image retrieval (CBIR) representations of AI in the mobile technology environment, and AI-based support had utility in simulations of second opinions and of telemedicine triage. In addition to demonstrating the potential benefits associated with good quality AI in the hands of non-expert clinicians, we find that faulty AI can mislead the entire spectrum of clinicians, including experts. Lastly, we show that insights derived from AI class-activation maps can inform improvements in human diagnosis. Together, our approach and findings offer a framework for future studies across the spectrum of image-based diagnostics to improve human-computer collaboration in clinical practice. A systematic evaluation of the value of AI-based decision support in skin tumor diagnosis demonstrates the superiority of human-computer collaboration over each individual approach and supports the potential of automated approaches in diagnostic medicine.	[Tschandl, Philipp; Kittler, Harald] Med Univ Vienna, Dept Dermatol, ViDIR Grp, Vienna, Austria; [Rinner, Christoph] Med Univ Vienna, Ctr Med Stat Informat & Intelligent Syst CeMSIIS, Vienna, Austria; [Apalla, Zoe; Lallas, Aimilios] Aristotle Univ Thessaloniki, Dept Dermatol, Thessaloniki, Greece; [Argenziano, Giuseppe] Univ Campania, Dermatol Unit, Naples, Italy; [Codella, Noel] IBM TJ Watson Res Ctr, New York, NY USA; [Halpern, Allan] Mem Sloan Kettering Canc Ctr, Dermatol Serv, 1275 York Ave, New York, NY 10021 USA; [Janda, Monika] Univ Queensland, Fac Med, Ctr Hlth Serv Res, Brisbane, Qld, Australia; [Longo, Caterina] Univ Modena & Reggio Emilia, Dermatol Unit, Modena, Italy; [Longo, Caterina] Zienda Unita Sanitaria Locale IRCCS Reggio, Ctr Oncol Ad Alta Tecnol Diagnost Dermatol, Reggio Emilia, Italy; [Malvehy, Josep; Puig, Susana] Univ Barcelona, IDIBAPS, Hosp Clin Barcelona, Melanoma Unit,Dermatol Dept, Barcelona, Spain; [Malvehy, Josep; Puig, Susana] Inst Salud Carlos III, Ctr Invest Biomed Red Enfermedades Raras CIBER ER, Barcelona, Spain; [Paoli, John] Univ Gothenburg, Sahlgrenska Acad, Inst Clin Sci, Dept Dermatol & Venereol, Gothenburg, Sweden; [Paoli, John] Sahlgrens Univ Hosp, Reg Vastra Gotaland, Dept Dermatol & Venereol, Gothenburg, Sweden; [Rosendahl, Cliff] Univ Queensland, Fac Med, Brisbane, Qld, Australia; [Soyer, H. Peter] Univ Queensland, Diamantina Inst, Dermatol Res Ctr, Brisbane, Qld, Australia; [Zalaudek, Iris] Med Univ Trieste, Dept Dermatol, Trieste, Italy	Medical University of Vienna; Medical University of Vienna; Aristotle University of Thessaloniki; Universita della Campania Vanvitelli; International Business Machines (IBM); Memorial Sloan Kettering Cancer Center; University of Queensland; Universita di Modena e Reggio Emilia; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Instituto de Salud Carlos III; University of Gothenburg; Sahlgrenska University Hospital; University of Queensland; University of Queensland	Kittler, H (corresponding author), Med Univ Vienna, Dept Dermatol, ViDIR Grp, Vienna, Austria.	harald.kittler@meduniwien.ac.at	Rosendahl, Cliff/AAF-6077-2019; Puig, Susana/AAB-2091-2020; Kittler, Harald/K-7574-2013; Janda, Monika/C-3723-2009; Paoli, John/P-7629-2018; Lallas, Aimilios/O-4986-2019; Rosendahl, Cliff/D-1003-2011; Soyer, H. Peter/W-3791-2017; Rinner, Christoph/L-7854-2013	Rosendahl, Cliff/0000-0001-5182-2969; Puig, Susana/0000-0003-1337-9745; Janda, Monika/0000-0002-1728-8085; Paoli, John/0000-0003-1326-8535; Lallas, Aimilios/0000-0002-7193-0964; Rosendahl, Cliff/0000-0001-5182-2969; Soyer, H. Peter/0000-0002-4770-561X; Apalla, Zoe/0000-0002-9255-8196; KITTLER, HARALD/0000-0002-0051-8016; Tschandl, Philipp/0000-0003-0391-7810; halpern, allan/0000-0001-7320-1901; Rinner, Christoph/0000-0002-3847-5664				Barata C, 2015, IEEE J BIOMED HEALTH, V19, P1146, DOI 10.1109/JBHI.2014.2336473; Bien N, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002699; Bissoto A., 2019, CONSTRUCTING BIAS SK; Cai C. J., 2019, P ACM HUM COMP INT A; Cai CZ, 2019, 2019 THE 3RD INTERNATIONAL CONFERENCE ON HIGH PERFORMANCE COMPILATION, COMPUTING AND COMMUNICATIONS (HP3C 2019), P1, DOI 10.1145/3318265.3318296; Codella N., 2019, SKIN LESION ANAL MEL; Codella N.C., 2018, UNDERSTANDING INTERP, P97; Esteva A, 2017, NATURE, V542, P115, DOI 10.1038/nature21056; Finlayson SG, 2019, SCIENCE, V363, P1287, DOI 10.1126/science.aaw4399; Garg AX, 2005, JAMA-J AM MED ASSOC, V293, P1223, DOI 10.1001/jama.293.10.1223; Gessert N, 2020, METHODSX, V7, DOI 10.1016/j.mex.2020.100864; Gulshan V, 2016, JAMA-J AM MED ASSOC, V316, P2402, DOI 10.1001/jama.2016.17216; Haenssle H A, 2019, Ann Oncol, V30, p130e, DOI 10.1093/annonc/mdy520; Han SS, 2020, J INVEST DERMATOL, V140, P1753, DOI 10.1016/j.jid.2020.01.019; Han SS, 2018, J INVEST DERMATOL, V138, P1529, DOI 10.1016/j.jid.2018.01.028; He JX, 2019, NAT MED, V25, P30, DOI 10.1038/s41591-018-0307-0; Hekler A, 2019, EUR J CANCER, V120, P114, DOI 10.1016/j.ejca.2019.07.019; HOLM S, 1979, SCAND J STAT, V6, P65; Janda M, 2020, LANCET DIGIT HEALTH, V2, pE129, DOI 10.1016/S2589-7500(20)30001-7; Kaiming He, 2016, 2016 IEEE Conference on Computer Vision and Pattern Recognition (CVPR), P770, DOI 10.1109/CVPR.2016.90; Kingma D.P., 2015, PROC 3 INT C LEARN, P1; Lakhani P, 2017, RADIOLOGY, V284, P574, DOI 10.1148/radiol.2017162326; Lapuschkin S, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08987-4; Li XX, 2019, IEEE ENG MED BIO, P2797, DOI 10.1109/EMBC.2019.8857334; Marchetti MA, 2018, J AM ACAD DERMATOL, V78, P270, DOI 10.1016/j.jaad.2017.08.016; McKinney SM, 2020, NATURE, V577, P89, DOI 10.1038/s41586-019-1799-6; Mobiny A, 2019, J CLIN MED, V8, DOI 10.3390/jcm8081241; Navarrete-Dechent C, 2018, J INVEST DERMATOL, V138, P2277, DOI 10.1016/j.jid.2018.04.040; Paszke A., 2019, P ADV NEUR INF PROC, P8026; R Core Team, 2021, R LANGUAGE ENV STAT; Rinner C, 2020, J MED INTERNET RES, V22, DOI 10.2196/15597; Russakovsky O, 2015, INT J COMPUT VISION, V115, P211, DOI 10.1007/s11263-015-0816-y; Sadeghi M., 2018, UNDERSTANDING INTERP, P141, DOI [DOI 10.1007/978-3-030-02628-8_16, 10.1007/978-3-030-02628-8_16]; Samek W., 2019, EXPLAINABLE AI INTER; Selvaraju RR, 2020, INT J COMPUT VISION, V128, P336, DOI 10.1007/s11263-019-01228-7; Tschandl P, 2019, BRIT J DERMATOL, V181, P155, DOI 10.1111/bjd.17189; Tschandl P, 2019, LANCET ONCOL, V20, P938, DOI 10.1016/S1470-2045(19)30333-X; Tschandl P, 2018, SCI DATA, V5, DOI 10.1038/sdata.2018.161; Wang M, 2018, NEUROCOMPUTING, V312, P135, DOI 10.1016/j.neucom.2018.05.083; Webster P, 2020, LANCET, V395, P1180, DOI 10.1016/S0140-6736(20)30818-7; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Winkler JK, 2019, JAMA DERMATOL, V155, P1135, DOI 10.1001/jamadermatol.2019.1735	42	167	167	28	91	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	AUG	2020	26	8					1229	+		10.1038/s41591-020-0942-0	http://dx.doi.org/10.1038/s41591-020-0942-0		JUN 2020	10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	MX8ZF	32572267	Bronze, Green Submitted			2022-12-27	WOS:000542094400005
J	Stower, H				Stower, Hannah			Kawasaki disease in a COVID-19-struck region	NATURE MEDICINE			English	Editorial Material												h.stower@us.nature.com							0	1	1	0	4	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	JUN	2020	26	6					822	822		10.1038/s41591-020-0959-4	http://dx.doi.org/10.1038/s41591-020-0959-4		JUN 2020	1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	LZ3ZG	32528149	Bronze			2022-12-27	WOS:000539886500009
J	Challa, AP; Lavieri, RR; Lippmann, ES; Goldstein, JA; Bastarache, L; Pulley, JM; Aronoff, DM				Challa, Anup P.; Lavieri, Robert R.; Lippmann, Ethan S.; Goldstein, Jeffery A.; Bastarache, Lisa; Pulley, Jill M.; Aronoff, David M.			EHRs could clarify drug safety in pregnant people	NATURE MEDICINE			English	Editorial Material								Testing drug safety in people who are pregnant remains a wicked problem, but in the transition toward big data and machine learning, target trials could afford a viable alternative to randomized, controlled trials.	[Challa, Anup P.; Lavieri, Robert R.; Pulley, Jill M.] Vanderbilt Univ, Med Ctr, Vanderbilt Inst Clin & Translat Res, Nashville, TN 37235 USA; [Challa, Anup P.; Lippmann, Ethan S.] Vanderbilt Univ, Dept Chem & Biomol Engn, 221 Kirkland Hall, Nashville, TN 37235 USA; [Goldstein, Jeffery A.] Northwestern Univ, Dept Pathol, Feinberg Sch Med, Chicago, IL 60611 USA; [Bastarache, Lisa] Vanderbilt Univ, Med Ctr, Dept Biomed Informat, Nashville, TN USA; [Aronoff, David M.] Vanderbilt Univ, Med Ctr, Dept Med, Div Infect Dis, Nashville, TN USA; [Aronoff, David M.] Vanderbilt Univ, Med Ctr, Dept Obstet & Gynecol, Nashville, TN 37232 USA; [Aronoff, David M.] Vanderbilt Univ, Med Ctr, Dept Pathol Microbiol & Immunol, Nashville, TN USA	Vanderbilt University; Vanderbilt University; Northwestern University; Feinberg School of Medicine; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University	Challa, AP (corresponding author), Vanderbilt Univ, Med Ctr, Vanderbilt Inst Clin & Translat Res, Nashville, TN 37235 USA.; Challa, AP (corresponding author), Vanderbilt Univ, Dept Chem & Biomol Engn, 221 Kirkland Hall, Nashville, TN 37235 USA.	anup.p.challa.1@vumc.org		Challa, Anup/0000-0002-8886-7308; Goldstein, Jeffery/0000-0002-4086-057X	NCATS NIH HHS [UL1 TR002243] Funding Source: Medline	NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))		Challa AP, 2019, BIORXIV, DOI [10.1101/860627, DOI 10.1101/860627]; Goldstein JA, 2018, AM J REPROD IMMUNOL, V80, DOI 10.1111/aji.12971; Jerome RN, 2018, DRUG SAFETY, V41, P303, DOI 10.1007/s40264-017-0616-0; Labrecque JA, 2017, EUR J EPIDEMIOL, V32, P473, DOI 10.1007/s10654-017-0293-4; Schachter AD, 2011, REPROD TOXICOL, V31, P562, DOI 10.1016/j.reprotox.2010.11.008; van der Graaf R, 2018, TRIALS, V19, DOI 10.1186/s13063-017-2402-9; Vernetti L, 2017, SCI REP-UK, V7, DOI 10.1038/srep42296	7	1	1	0	2	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	JUN	2020	26	6					820	821		10.1038/s41591-020-0925-1	http://dx.doi.org/10.1038/s41591-020-0925-1			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	LZ3ZG	32457445				2022-12-27	WOS:000541166000012
J	Leung, NHL; Chu, DKW; Shiu, EYC; Chan, KH; McDevitt, JJ; Hau, BJP; Yen, HL; Li, YG; Ip, DKM; Peiris, JSM; Seto, WH; Leung, GM; Milton, DK; Cowling, BJ				Leung, Nancy H. L.; Chu, Daniel K. W.; Shiu, Eunice Y. C.; Chan, Kwok-Hung; McDevitt, James J.; Hau, Benien J. P.; Yen, Hui-Ling; Li, Yuguo; Ip, Dennis K. M.; Peiris, J. S. Malik; Seto, Wing-Hong; Leung, Gabriel M.; Milton, Donald K.; Cowling, Benjamin J.			Respiratory virus shedding in exhaled breath and efficacy of face masks (Apr, 10.1038/s41591-020-0843-2, 2020)	NATURE MEDICINE			English	Correction								An amendment to this paper has been published and can be accessed via a link at the top of the paper.				bcowling@hku.hk	Chan, Kwok Hung/ABD-5399-2021; Li, Yuguo/A-9469-2010; Leung, Nancy Hiu Lan/M-9080-2016; Milton, Donald K/G-3286-2010; Yen, Hui-Ling/GNH-5083-2022; Yen, Hui-Ling/C-4501-2009	Li, Yuguo/0000-0002-2281-4529; Leung, Nancy Hiu Lan/0000-0001-7314-840X; Milton, Donald K/0000-0002-0550-7834; Yen, Hui-Ling/0000-0003-2493-3609; Seto, Wing Hong/0000-0002-1139-9200	NIAID NIH HHS [RC1 AI086900] Funding Source: Medline; NCPDCID CDC HHS [U01 CI000446] Funding Source: Medline	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCPDCID CDC HHS		Leung NHL, 2020, NAT MED, V26, P676, DOI 10.1038/s41591-020-0843-2	1	14	14	5	39	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	JUN	2020	26	6					981	981		10.1038/s41591-020-0946-9	http://dx.doi.org/10.1038/s41591-020-0946-9		MAY 2020	1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	LZ3ZG	32461699	Green Published, Bronze			2022-12-27	WOS:000535873800001
J	Roberti, MP; Yonekura, S; Duong, CPM; Picard, M; Ferrere, G; Alou, MT; Rauber, C; Iebba, V; Lehmann, CHK; Amon, L; Dudziak, D; Derosa, L; Routy, B; Flament, C; Richard, C; Daillere, R; Fluckiger, A; Van Seuningen, I; Chamaillard, M; Vincent, A; Kourula, S; Opolon, P; Ly, P; Pizzato, E; Becharef, S; Paillet, J; Klein, C; Marliot, F; Pietrantonio, F; Benoist, S; Scoazec, JY; Dartigues, P; Hollebecque, A; Malka, D; Pages, F; Galon, J; Boneca, IG; Lepage, P; Ryffel, B; Raoult, D; Eggermont, A; Vanden Berghe, T; Ghiringhelli, F; Vandenabeele, P; Kroemer, G; Zitvogel, L				Roberti, Maria Paula; Yonekura, Satoru; Duong, Connie P. M.; Picard, Marion; Ferrere, Gladys; Alou, Maryam Tidjani; Rauber, Conrad; Iebba, Valerio; Lehmann, Christian H. K.; Amon, Lukas; Dudziak, Diana; Derosa, Lisa; Routy, Bertrand; Flament, Caroline; Richard, Corentin; Daillere, Romain; Fluckiger, Aurelie; Van Seuningen, Isabelle; Chamaillard, Mathias; Vincent, Audrey; Kourula, Stephanie; Opolon, Paule; Ly, Pierre; Pizzato, Eugenie; Becharef, Sonia; Paillet, Juliette; Klein, Christophe; Marliot, Florence; Pietrantonio, Filippo; Benoist, Stephane; Scoazec, Jean-Yves; Dartigues, Peggy; Hollebecque, Antoine; Malka, David; Pages, Franck; Galon, Jerome; Boneca, Ivo Gomperts; Lepage, Patricia; Ryffel, Bernard; Raoult, Didier; Eggermont, Alexander; Vanden Berghe, Tom; Ghiringhelli, Francois; Vandenabeele, Peter; Kroemer, Guido; Zitvogel, Laurence			Chemotherapy-induced ileal crypt apoptosis and the ileal microbiome shape immunosurveillance and prognosis of proximal colon cancer	NATURE MEDICINE			English	Article							T-CELL RESPONSES; MICROSATELLITE INSTABILITY; COLORECTAL-CANCER; HELPER-CELLS; STEM-CELLS; IDENTIFICATION; SURVIVAL	The prognosis of colon cancer (CC) is dictated by tumor-infiltrating lymphocytes, including follicular helper T (T-FH) cells and the efficacy of chemotherapy-induced immune responses. It remains unclear whether gut microbes contribute to the elicitation of T-FH cell-driven responses. Here, we show that the ileal microbiota dictates tolerogenic versus immunogenic cell death of ileal intestinal epithelial cells (IECs) and the accumulation of T-FH cells in patients with CC and mice. Suppression of IEC apoptosis led to compromised chemotherapy-induced immunosurveillance against CC in mice. Protective immune responses against CC were associated with residence of Bacteroides fragilis and Erysipelotrichaceae in the ileum. In the presence of these commensals, apoptotic ileal IECs elicited PD-1(+) T-FH cells in an interleukin-1R1- and interleukin-12-dependent manner. The ileal microbiome governed the efficacy of chemotherapy and PD-1 blockade in CC independently of microsatellite instability. These findings demonstrate that immunogenic ileal apoptosis contributes to the prognosis of chemotherapy-treated CC. Local microbiome composition influences treatment efficacy of chemotherapy in colon cancer via modulation of tolerogenic versus immunogenic ileal intestinal epithelial cell death, which in turn influences follicular helper T cell priming.	[Roberti, Maria Paula; Yonekura, Satoru; Duong, Connie P. M.; Picard, Marion; Ferrere, Gladys; Alou, Maryam Tidjani; Rauber, Conrad; Iebba, Valerio; Derosa, Lisa; Routy, Bertrand; Flament, Caroline; Daillere, Romain; Fluckiger, Aurelie; Opolon, Paule; Ly, Pierre; Pizzato, Eugenie; Becharef, Sonia; Eggermont, Alexander; Zitvogel, Laurence] Gustave Roussy Canc Campus GRCC, Villejuif, France; [Roberti, Maria Paula; Yonekura, Satoru; Duong, Connie P. M.; Picard, Marion; Ferrere, Gladys; Alou, Maryam Tidjani; Rauber, Conrad; Iebba, Valerio; Derosa, Lisa; Routy, Bertrand; Flament, Caroline; Daillere, Romain; Fluckiger, Aurelie; Ly, Pierre; Pizzato, Eugenie; Becharef, Sonia; Eggermont, Alexander; Zitvogel, Laurence] INSERM, Equipe Labellisee Ligue Natl Canc, U1015, Villejuif, France; [Roberti, Maria Paula; Derosa, Lisa; Flament, Caroline; Zitvogel, Laurence] Ctr Clin Invest Biotherapies Canc CICBT 1428, Villejuif, France; [Yonekura, Satoru; Rauber, Conrad; Routy, Bertrand; Paillet, Juliette; Zitvogel, Laurence] Univ Paris Saclay, Le Kremlin Bicetre, France; [Picard, Marion; Boneca, Ivo Gomperts] Inst Pasteur Paris, Unit Biol & Genet Bacterial Cell Wall, Paris, France; [Lehmann, Christian H. K.; Amon, Lukas; Dudziak, Diana] Friedrich Alexander Univ FAU Erlangen Nurnberg, Univ Hosp Erlangen, Dept Dermatol, Lab Dendrit Cell Biol, Med Immunol Campus Erlangen, Erlangen, Germany; [Richard, Corentin; Ghiringhelli, Francois] Ctr GF Leclerc, Dept Med Oncol, Dijon, France; [Richard, Corentin; Ghiringhelli, Francois] Plateform Transfer Biol Oncol, Dijon, France; [Van Seuningen, Isabelle; Vincent, Audrey] Univ Lille, Jean Pierre Aubert Res Ctr, CHU Lille, Inserm,UMR S 1172, Lille, France; [Chamaillard, Mathias] Univ Lille, Lab Cell Physiol, INSERM U1003, Lille, France; [Kourula, Stephanie; Vanden Berghe, Tom; Vandenabeele, Peter] VIB Inflammat Res Ctr, Mol Signaling & Cell Death Unit, Ghent, Belgium; [Kourula, Stephanie; Vanden Berghe, Tom; Vandenabeele, Peter] Univ Ghent, Dept Biomed Mol Biol, Ghent, Belgium; [Paillet, Juliette; Klein, Christophe; Kroemer, Guido] Univ Paris, Equipe Labellisee Ligue Canc, Sorbonne Univ, INSERM,U1138,Ctr Rech Cordeliers, Paris, France; [Paillet, Juliette; Kroemer, Guido] Gustave Roussy Canc Campus, Cell Biol & Metabol Platforms, Villejuif, France; [Marliot, Florence; Pages, Franck; Galon, Jerome] Ctr Rech Cordeliers, Lab Integrat Canc Immunol, INSERM, U1138, Paris, France; [Marliot, Florence; Pages, Franck; Galon, Jerome] Serv Immunol Biol, Hop Europeen Georges Pompidou, Paris, France; [Pietrantonio, Filippo] Fdn IRCCS Ist Nazl Tumori, Med Oncol Dept, Milan, Italy; [Pietrantonio, Filippo] Univ Milan, Dept Oncol & Hematooncol, Milan, Italy; [Benoist, Stephane] Hop Bicetre, Serv Chirurg Digest & Oncol, Le Kremlin Bicetre, France; [Scoazec, Jean-Yves; Dartigues, Peggy] Gustave Roussy Canc Campus, Dept Biol & Pathol Med, Villejuif, France; [Hollebecque, Antoine; Malka, David; Eggermont, Alexander] Gustave Roussy Canc Campus, Dept Med Oncol, Villejuif, France; [Boneca, Ivo Gomperts] INSERM, Equipe Avenir, Paris, France; [Lepage, Patricia] Univ Paris Saclay, Micalis Inst, AgroParisTech, INRA, Jouy En Josas, France; [Ryffel, Bernard] Univ Orleans, CNRS, Mol Immunol & Embryol, UMR 7355, Orleans, France; [Raoult, Didier] Univ Mediterranee, Fac Med, Unite Rickettsies, Marseille, France; [Vandenabeele, Peter] Univ Ghent, Methusalem Program, Ghent, Belgium; [Kroemer, Guido] Hop Europeen Georges Pompidou, AP HP, Pole Biol, Paris, France; [Kroemer, Guido; Zitvogel, Laurence] Chinese Acad Med Sci, Suzhou Inst Syst Med, Suzhou, Peoples R China; [Kroemer, Guido] Karolinska Univ Hosp, Dept Womens & Childrens Hlth, Stockholm, Sweden	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; University of Erlangen Nuremberg; UNICANCER; Centre Georges-Francois Leclerc; Universite de Lille - ISITE; CHU Lille; Universite de Lille; Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille; Flanders Institute for Biotechnology (VIB); Ghent University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; UNICANCER; Gustave Roussy; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Fondazione IRCCS Istituto Nazionale Tumori Milan; University of Milan; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy; UNICANCER; Gustave Roussy; Institut National de la Sante et de la Recherche Medicale (Inserm); AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Orleans; UDICE-French Research Universities; Aix-Marseille Universite; Ghent University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Chinese Academy of Medical Sciences - Peking Union Medical College; Karolinska Institutet; Karolinska University Hospital	Zitvogel, L (corresponding author), Gustave Roussy Canc Campus GRCC, Villejuif, France.; Zitvogel, L (corresponding author), INSERM, Equipe Labellisee Ligue Natl Canc, U1015, Villejuif, France.; Zitvogel, L (corresponding author), Ctr Clin Invest Biotherapies Canc CICBT 1428, Villejuif, France.; Zitvogel, L (corresponding author), Univ Paris Saclay, Le Kremlin Bicetre, France.; Zitvogel, L (corresponding author), Chinese Acad Med Sci, Suzhou Inst Syst Med, Suzhou, Peoples R China.	laurence.zitvogel@gustaveroussy.fr	Vandenabeele, Peter/AAD-5793-2022; Vanden Berghe, Tom/C-4916-2009; RAOULT, Didier/A-8434-2008; Rauber, Conrad/ABA-8389-2021; Yonekura, Satoru/R-2468-2016; Kroemer, Guido/AAY-9859-2020; Boneca, Ivo G/H-1677-2014; KROEMER, Guido/B-4263-2013; Lepage, Patricia/D-4362-2014; DEROSA, LISA/E-6814-2015; Berghe, Tom Vanden/N-2902-2019; Vincent, Audrey/I-2934-2016; Iebba, Valerio/P-1194-2016	Vandenabeele, Peter/0000-0002-6669-8822; Vanden Berghe, Tom/0000-0002-1633-0974; RAOULT, Didier/0000-0002-0633-5974; Yonekura, Satoru/0000-0003-4047-3016; Boneca, Ivo G/0000-0001-8122-509X; KROEMER, Guido/0000-0002-9334-4405; Lepage, Patricia/0000-0002-9501-6771; Berghe, Tom Vanden/0000-0002-1633-0974; ZITVOGEL, laurence/0000-0003-1596-0998; Derosa, Lisa/0000-0003-0527-2964; Lehmann, Christian/0000-0001-5927-9761; Amon, Lukas/0000-0003-3834-6114; Paillet, Juliette/0000-0001-7118-7165; Duong, Connie/0000-0002-9067-8557; ghiringhelli, francois/0000-0002-5465-8305; Tidjani Alou, Maryam/0000-0002-0167-6235; Vincent, Audrey/0000-0003-0058-2058; Iebba, Valerio/0000-0002-0716-306X; Kourula (nee Schulz), Stephanie/0000-0002-7667-7072; klein, christophe/0000-0001-8015-287X	Ligue Contre le Cancer (Equipe Labelisee); Agence Nationale de la Recherche (ANR) Francogermanique, ANR Projets blancs [ANR-19-CE15-0029]; ANR under the frame of E-Rare-2, the ERA-Net for Research on Rare Diseases; Association pour la Recherche sur le Cancer; BMS Foundation; Canceropole Ile-de-France; Chancelerie des Universites de Paris (Legs Poix), Fondation pour la Recherche Medicale; European Commission (ArtForce); European Research Council; Fondation Carrefour; Institut National du Cancer; Inserm; Institut Universitaire de France; LeDucq Foundation; LabEx Immuno-Oncology; RHU Torino Lumiere [ANR-16-RHUS-0008]; H2020 ONCOBIOME, the Seerave Foundation; SIRIC Stratified Oncology Cell DNA Repair and Tumor Immune Elimination; SIRIC Cancer Research and Personalized Medicine (CARPEM); FHU CARE, Dassault and Badinter Philantropia; Paris Alliance of Cancer Research Institutes; German Research Foundation [CRC1181-A7]; Centre National de la Recherche Scientifique; University of Orleans; Conseil General du Loiret and European Regional Development Fund (FEDER) [2016-00110366, EX005756]; ITMO Cancer AVIESAN (Alliance Nationale pour les Sciences de la Vie et de la Sante, National Alliance for Life Sciences & Health) of the Cancer Plan [HTE201601]	Ligue Contre le Cancer (Equipe Labelisee)(Ligue nationale contre le cancer); Agence Nationale de la Recherche (ANR) Francogermanique, ANR Projets blancs(French National Research Agency (ANR)); ANR under the frame of E-Rare-2, the ERA-Net for Research on Rare Diseases(French National Research Agency (ANR)); Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); BMS Foundation; Canceropole Ile-de-France(Region Ile-de-France); Chancelerie des Universites de Paris (Legs Poix), Fondation pour la Recherche Medicale; European Commission (ArtForce)(European CommissionEuropean Commission Joint Research Centre); European Research Council(European Research Council (ERC)European Commission); Fondation Carrefour; Institut National du Cancer(Institut National du Cancer (INCA) France); Inserm(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Institut Universitaire de France; LeDucq Foundation(Leducq Foundation); LabEx Immuno-Oncology; RHU Torino Lumiere; H2020 ONCOBIOME, the Seerave Foundation; SIRIC Stratified Oncology Cell DNA Repair and Tumor Immune Elimination; SIRIC Cancer Research and Personalized Medicine (CARPEM); FHU CARE, Dassault and Badinter Philantropia; Paris Alliance of Cancer Research Institutes; German Research Foundation(German Research Foundation (DFG)); Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); University of Orleans; Conseil General du Loiret and European Regional Development Fund (FEDER); ITMO Cancer AVIESAN (Alliance Nationale pour les Sciences de la Vie et de la Sante, National Alliance for Life Sciences & Health) of the Cancer Plan	We thank the animal facility team at Gustave Roussy. We thank technicians and pathologists from Centre GF Leclerc: L. Guyard, L. Arnould and S. Ladoire. We thank S. Brutin, A. Paci, M. Vetizou, T. Yamazaki, J.-E. Fahrner and A. G. Goubet for technical assistance. We thank D. Goere, R. Bonnet, P. Sauvanet, D. Pezet, J. Gagniere, F. Pagani and A. Martinetti for helping with human samples collection. We thank M. Merad, for scientific advice. We thank R. Forster (Institut fur Immunologie) and J. A. Harker (Imperial College) for providing knockout models. L.Z. and G.K. were supported by the Ligue Contre le Cancer (Equipe Labelisee); Agence Nationale de la Recherche (ANR) Francogermanique ANR-19-CE15-0029, ANR Projets blancs; ANR under the frame of E-Rare-2, the ERA-Net for Research on Rare Diseases; Association pour la Recherche sur le Cancer; BMS Foundation, Canceropole Ile-de-France; Chancelerie des Universites de Paris (Legs Poix), Fondation pour la Recherche Medicale; a donation by Elior; the European Commission (ArtForce); the European Research Council; Fondation Carrefour; Institut National du Cancer; Inserm; Institut Universitaire de France; LeDucq Foundation; the LabEx Immuno-Oncology; the RHU Torino Lumiere (ANR-16-RHUS-0008); H2020 ONCOBIOME, the Seerave Foundation; the SIRIC Stratified Oncology Cell DNA Repair and Tumor Immune Elimination; the SIRIC Cancer Research and Personalized Medicine (CARPEM); FHU CARE, Dassault and Badinter Philantropia and the Paris Alliance of Cancer Research Institutes. D.D. was supported by the German Research Foundation (CRC1181-A7). B. Ryffel was supported by Centre National de la Recherche Scientifique, the University of Orleans, the Conseil General du Loiret and European Regional Development Fund (FEDER No. 2016-00110366 and EX005756). M.C. was supported by ITMO Cancer AVIESAN (Alliance Nationale pour les Sciences de la Vie et de la Sante, National Alliance for Life Sciences & Health) within the framework of the Cancer Plan (HTE201601).	Alexander J, 2001, AM J PATHOL, V158, P527, DOI 10.1016/S0002-9440(10)63994-6; Bankhead P, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17204-5; Barbet G, 2018, IMMUNITY, V48, P584, DOI 10.1016/j.immuni.2018.02.015; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Belcheva A, 2015, MOL CELL ONCOL, V2, DOI 10.4161/23723548.2014.969630; Bindea G, 2013, IMMUNITY, V39, P782, DOI 10.1016/j.immuni.2013.10.003; Cardeno A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20740-3; Castle JC, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-190; Chen WG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039743; Coronell JAL, 2018, GENOM PROTEOM BIOINF, V16, P73, DOI 10.1016/j.gpb.2017.10.002; Enot DP, 2018, ONCOIMMUNOLOGY, V7, DOI 10.1080/2162402X.2018.1462431; Forster R, 1996, CELL, V87, P1037, DOI 10.1016/S0092-8674(00)81798-5; Geis AL, 2015, CANCER DISCOV, V5, P1098, DOI 10.1158/2159-8290.CD-15-0447; Geng JW, 2013, GUT PATHOG, V5, DOI 10.1186/1757-4749-5-2; Germano G, 2017, NATURE, V552, P116, DOI 10.1038/nature24673; Gu-Trantien C, 2013, J CLIN INVEST, V123, P2873, DOI 10.1172/JCI67428; Hildner K, 2008, IMMUNITY, V322, P5; Hollern DP, 2019, CANCER CELL, V179, pe21; Hollister K, 1950, J IMMUNOL, V191, P2013; Irrazabal T, 2014, MOL CELL, V54, P309, DOI 10.1016/j.molcel.2014.03.039; Junttila MR, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac7433; Keren Z, 2011, BLOOD, V117, P3104, DOI 10.1182/blood-2010-09-307983; Lagier JC, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.203, 10.1038/nmicrobiol.2016.203]; Lagier JC, 2015, CLIN MICROBIOL REV, V28, P237, DOI 10.1128/CMR.00014-14; Le DT, 2015, NEW ENGL J MED, V372, P2509, DOI 10.1056/NEJMoa1500596; Lehmann CHK, 2017, J EXP MED, V214, P1509, DOI 10.1084/jem.20160951; Lereclus E, 2017, BMC CANCER, V17, DOI 10.1186/s12885-017-3210-z; Liu ZJ, 2004, J IMMUNOL, V173, P4324, DOI 10.4049/jimmunol.173.7.4324; Madison BB, 2002, J BIOL CHEM, V277, P33275, DOI 10.1074/jbc.M204935200; Mlecnik B, 2011, J CLIN ONCOL, V29, P610, DOI 10.1200/JCO.2010.30.5425; Nakatsu G, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9727; Nigro G, 2014, CELL HOST MICROBE, V15, P792, DOI 10.1016/j.chom.2014.05.003; Nosho K, 2010, J PATHOL, V222, P350, DOI 10.1002/path.2774; Ogino S, 2009, CLIN CANCER RES, V15, P6412, DOI 10.1158/1078-0432.CCR-09-1438; Pages F, 2005, NEW ENGL J MED, V353, P2654, DOI 10.1056/NEJMoa051424; Pages F, 2018, LANCET, V391, P2128, DOI 10.1016/S0140-6736(18)30789-X; Pardi N, 2018, J EXP MED, V215, P1571, DOI 10.1084/jem.20171450; Purcell RV, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11237-6; Rizvi Sumera, 2018, Oncotarget, V9, P5892, DOI 10.18632/oncotarget.23638; Rodriguez CI, 2000, NAT GENET, V25, P139, DOI 10.1038/75973; Routy B, 2018, NAT REV CLIN ONCOL, V15, P382, DOI 10.1038/s41571-018-0006-2; Saffarian A, 2019, MBIO, V10, DOI 10.1128/mBio.01315-19; Salama P, 2009, J CLIN ONCOL, V27, P186, DOI 10.1200/JCO.2008.18.7229; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Sears CL, 2014, CELL HOST MICROBE, V15, P317, DOI 10.1016/j.chom.2014.02.007; Seng P, 2009, CLIN INFECT DIS, V49, P543, DOI 10.1086/600885; Shahda S., 2017, J CLIN ONCOL, V35, P3541, DOI 10.1200/JCO.2017.35.15_suppl.3541; Shia J, 2003, AM J SURG PATHOL, V27, P1407, DOI 10.1097/00000478-200311000-00002; Snook AE, 2009, CANCER RES, V69, P3537, DOI 10.1158/0008-5472.CAN-08-3386; Stoll G, 2018, ONCOIMMUNOLOGY, V7, DOI 10.1080/2162402X.2018.1484980; Tao YR, 2019, MOL ONCOL, V13, P1855, DOI 10.1002/1878-0261.12520; Thomas AM, 2019, NAT MED, V25, P667, DOI 10.1038/s41591-019-0405-7; Tosolini M, 2011, CANCER RES, V71, P1263, DOI 10.1158/0008-5472.CAN-10-2907; Tougeron D, 2009, MODERN PATHOL, V22, P1186, DOI 10.1038/modpathol.2009.80; Ueno H, 2015, NAT IMMUNOL, V16, P142, DOI 10.1038/ni.3054; Ugolini M, 2018, NAT IMMUNOL, V19, P386, DOI 10.1038/s41590-018-0068-4; van Vliet MJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000879; Wang H-F, 2016, SCI REP, V6; Yadav M, 2014, NATURE, V515, P572, DOI 10.1038/nature14001; Ziegler PK, 2018, CELL, V174, P88, DOI 10.1016/j.cell.2018.05.028	60	76	78	10	55	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	JUN	2020	26	6					919	+		10.1038/s41591-020-0882-8	http://dx.doi.org/10.1038/s41591-020-0882-8		MAY 2020	27	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	LZ3ZG	32451498	Green Submitted			2022-12-27	WOS:000535406400003
J	Raghunath, S; Cerna, AEU; Jing, LY; VanMaanen, DP; Stough, J; Hartzel, DN; Leader, JB; Kirchner, HL; Stumpe, MC; Hafez, A; Nemani, A; Carbonati, T; Johnson, KW; Young, K; Good, CW; Pfeifer, JM; Patel, AA; Delisle, BP; Alsaid, A; Beer, D; Haggerty, CM; Fornwalt, BK				Raghunath, Sushravya; Cerna, Alvaro E. Ulloa; Jing, Linyuan; VanMaanen, David P.; Stough, Joshua; Hartzel, Dustin N.; Leader, Joseph B.; Kirchner, H. Lester; Stumpe, Martin C.; Hafez, Ashraf; Nemani, Arun; Carbonati, Tanner; Johnson, Kipp W.; Young, Katelyn; Good, Christopher W.; Pfeifer, John M.; Patel, Aalpen A.; Delisle, Brian P.; Alsaid, Amro; Beer, Dominik; Haggerty, Christopher M.; Fornwalt, Brandon K.			Prediction of mortality from 12-lead electrocardiogram voltage data using a deep neural network	NATURE MEDICINE			English	Article							HEART-FAILURE; ARRHYTHMIA DETECTION; CLASSIFICATION; MODEL; RISK; DYSFUNCTION; ECG	By using data from electrocardiograms, a deep learning algorithm outperforms traditional risk scores in predicting death over the course of the next year and identifies at-risk individuals with seemingly normal electrocardiograms. The electrocardiogram (ECG) is a widely used medical test, consisting of voltage versus time traces collected from surface recordings over the heart(1). Here we hypothesized that a deep neural network (DNN) can predict an important future clinical event, 1-year all-cause mortality, from ECG voltage-time traces. By using ECGs collected over a 34-year period in a large regional health system, we trained a DNN with 1,169,662 12-lead resting ECGs obtained from 253,397 patients, in which 99,371 events occurred. The model achieved an area under the curve (AUC) of 0.88 on a held-out test set of 168,914 patients, in which 14,207 events occurred. Even within the large subset of patients (n = 45,285) with ECGs interpreted as 'normal' by a physician, the performance of the model in predicting 1-year mortality remained high (AUC = 0.85). A blinded survey of cardiologists demonstrated that many of the discriminating features of these normal ECGs were not apparent to expert reviewers. Finally, a Cox proportional-hazard model revealed a hazard ratio of 9.5 (P < 0.005) for the two predicted groups (dead versus alive 1 year after ECG) over a 25-year follow-up period. These results show that deep learning can add substantial prognostic information to the interpretation of 12-lead resting ECGs, even in cases that are interpreted as normal by physicians.	[Raghunath, Sushravya; Cerna, Alvaro E. Ulloa; Jing, Linyuan; VanMaanen, David P.; Stough, Joshua; Haggerty, Christopher M.; Fornwalt, Brandon K.] Geisinger, Dept Translat Data Sci & Informat, Danville, PA 17822 USA; [Stough, Joshua] Bucknell Univ, Dept Comp Sci, Lewisburg, PA 17837 USA; [Hartzel, Dustin N.; Leader, Joseph B.] Phen Analyt & Clin Data Core, Geisinger, Danville, PA USA; [Kirchner, H. Lester] Geisinger, Dept Populat Hlth Sci, Danville, PA USA; [Stumpe, Martin C.; Hafez, Ashraf; Nemani, Arun; Carbonati, Tanner; Johnson, Kipp W.] Tempus Labs Inc, Chicago, IL USA; [Young, Katelyn] Geisinger, Dept Internal Med, Danville, PA USA; [Good, Christopher W.; Alsaid, Amro; Beer, Dominik; Haggerty, Christopher M.; Fornwalt, Brandon K.] Geisinger, Heart Inst, Danville, PA 17822 USA; [Pfeifer, John M.] Evangel Hosp, Heart & Vasc Ctr, Lewisburg, PA USA; [Patel, Aalpen A.; Fornwalt, Brandon K.] Geisinger, Dept Radiol, Danville, PA USA; [Delisle, Brian P.] Univ Kentucky, Dept Physiol, Lexington, KY USA; [Delisle, Brian P.] Univ Kentucky, Cardiovasc Res Ctr, Lexington, KY USA	Bucknell University; University of Kentucky; University of Kentucky	Fornwalt, BK (corresponding author), Geisinger, Dept Translat Data Sci & Informat, Danville, PA 17822 USA.; Fornwalt, BK (corresponding author), Geisinger, Heart Inst, Danville, PA 17822 USA.	bkf@gatech.edu	Johnson, Kipp/I-1260-2019	Johnson, Kipp/0000-0002-5102-741X; Haggerty, Christopher/0000-0002-3227-4490; Raghunath, Sushravya/0000-0001-7623-3095; Carbonati, Tanner/0000-0003-1727-1723; Delisle, Brian/0000-0002-2146-327X				Acharya UR, 2017, COMPUT BIOL MED, V89, P389, DOI 10.1016/j.compbiomed.2017.08.022; Addison PS, 2005, PHYSIOL MEAS, V26, pR155, DOI 10.1088/0967-3334/26/5/R01; Al Rahhal MM, 2016, INFORM SCIENCES, V345, P340, DOI 10.1016/j.ins.2016.01.082; Asl BM, 2008, ARTIF INTELL MED, V44, P51, DOI 10.1016/j.artmed.2008.04.007; Attia ZI, 2019, J CARDIOVASC ELECTR, V30, P668, DOI 10.1111/jce.13889; Attia ZI, 2019, NAT MED, V25, P70, DOI 10.1038/s41591-018-0240-2; Attia ZI, 2019, LANCET, V6736, P1; BELFORTE G, 1979, IEEE T BIO-MED ENG, V26, P125, DOI 10.1109/TBME.1979.326470; Carreiras C., BIOSPPY BIOSIGNAL PR; Chen T., 2015, NIPS 2014 WORKSHOP H, P69, DOI DOI 10.5555/2996850.2996854; Chen TQ, 2016, KDD'16: PROCEEDINGS OF THE 22ND ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P785, DOI 10.1145/2939672.2939785; CHESEBRO JH, 1987, CIRCULATION, V76, P142, DOI 10.1161/01.CIR.76.1.142; COX DR, 1972, J R STAT SOC B, V34, P187; Curry SJ, 2018, JAMA-J AM MED ASSOC, V319, P2308, DOI 10.1001/jama.2018.6848; D'Agostino RB, 2008, CIRCULATION, V117, P743, DOI 10.1161/CIRCULATIONAHA.107.699579; Davie AP, 1996, BRIT MED J, V312, P222; Eagle KA, 2004, JAMA-J AM MED ASSOC, V291, P2727, DOI 10.1001/jama.291.22.2727; FYE WB, 1994, AM J CARDIOL, V73, P937, DOI 10.1016/0002-9149(94)90135-X; Goldman L, 1978, SURV ANESTHESIOL, V22, P482, DOI [10.1097/00132586-197810000-00051, DOI 10.1097/00132586-197810000-00051]; Goodfellow S.D., 2018, MACHINE LEARNING HEA, P83; Graves A, 2012, STUD COMPUT INTELL, V385, P1, DOI [10.1007/978-3-642-24797-2, 10.1162/neco.1997.9.1.1]; Hannun AY, 2019, NAT MED, V25, P65, DOI 10.1038/s41591-018-0268-3; Hedberg P, 2004, AM HEART J, V148, P524, DOI 10.1016/j.ahj.2004.03.034; Hwang WK, 2013, AM J MANAG CARE, V19, pE175; Kampouraki A, 2009, IEEE T INF TECHNOL B, V13, P512, DOI 10.1109/TITB.2008.2003323; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Karpagachelvi S., 2014, COMPUT INF SCI, DOI [10.5539/cis.v4n1p42, DOI 10.5539/CIS.V4N1P42]; Kenchaiah S, 2002, NEW ENGL J MED, V347, P305, DOI 10.1056/NEJMoa020245; Kingma DP., 2014, ADAM METHOD STOCHAST; Kohler BU, 2002, IEEE ENG MED BIOL, V21, P42, DOI 10.1109/51.993193; Lanza GA, 2007, PROG CARDIOVASC DIS, V50, P87, DOI 10.1016/j.pcad.2007.03.003; LEBLANC AR, 1986, CRIT REV BIOMED ENG, V14, P1; Levy WC, 2006, CIRCULATION, V113, P1424, DOI 10.1161/CIRCULATIONAHA.105.584102; Lin M, 2014, PUBLIC HEALTH NUTR, V17, P2029, DOI [10.1017/S1368980013002176, 10.1109/PLASMA.2013.6634954]; Liu WH, 2018, IEEE J BIOMED HEALTH, V22, P1434, DOI 10.1109/JBHI.2017.2771768; Lloyd-Jones DM, 2019, J AM COLL CARDIOL, V73, P3153, DOI 10.1016/j.jacc.2018.11.005; Luz EJD, 2016, COMPUT METH PROG BIO, V127, P144, DOI 10.1016/j.cmpb.2015.12.008; Madeiro JPV, 2012, MED ENG PHYS, V34, P1236, DOI 10.1016/j.medengphy.2011.12.011; Motwani M, 2017, EUR HEART J, V38, P500, DOI 10.1093/eurheartj/ehw188; Nair V., 2010, P 27 INT C INT C MAC, P807; PAN J, 1985, IEEE T BIO-MED ENG, V32, P230, DOI 10.1109/TBME.1985.325532; Prechelt L., 2012, NEURAL NETW TRICKS T, V7700, P55; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Selvaraju RR, 2020, INT J COMPUT VISION, V128, P336, DOI 10.1007/s11263-019-01228-7; Shah SJ, 2015, CIRCULATION, V131, P269, DOI 10.1161/CIRCULATIONAHA.114.010637; Smith SW, 2019, J ELECTROCARDIOL, V52, P88, DOI 10.1016/j.jelectrocard.2018.11.013; Springenberg JT, 2014, ARXIV; van Buuren S, 2011, J STAT SOFTW, V45, P1; Yu SN, 2007, PATTERN RECOGN LETT, V28, P1142, DOI 10.1016/j.patrec.2007.01.017	49	64	64	5	28	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	JUN	2020	26	6					886	+		10.1038/s41591-020-0870-z	http://dx.doi.org/10.1038/s41591-020-0870-z		MAY 2020	15	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	LZ3ZG	32393799	Green Submitted			2022-12-27	WOS:000531781900005
J	Donovan, LK; Delaidelli, A; Joseph, SK; Bielamowicz, K; Fousek, K; Holgado, BL; Manno, A; Srikanthan, D; Gad, AZ; Van Ommeren, R; Przelicki, D; Richman, C; Ramaswamy, V; Daniels, C; Pallota, JG; Douglas, T; Joynt, ACM; Haapasalo, J; Nor, C; Vladoiu, MC; Kuzan-Fischer, CM; Garzia, L; Mack, SC; Varadharajan, S; Baker, ML; Hendrikse, L; Ly, M; Kharas, K; Balin, P; Wu, XC; Qin, L; Huang, N; Stucklin, AG; Morrissy, AS; Cavalli, FMG; Luu, B; Suarez, R; De Antonellis, P; Michealraj, A; Rastan, A; Hegde, M; Komosa, M; Sirbu, O; Kumar, SA; Abdullaev, Z; Faria, CC; Yip, S; Hukin, J; Tabori, U; Hawkins, C; Aldape, K; Daugaard, M; Maris, JM; Sorensen, PH; Ahmed, N; Taylor, MD				Donovan, Laura K.; Delaidelli, Alberto; Joseph, Sujith K.; Bielamowicz, Kevin; Fousek, Kristen; Holgado, Borja L.; Manno, Alex; Srikanthan, Dilakshan; Gad, Ahmed Z.; Van Ommeren, Randy; Przelicki, David; Richman, Cory; Ramaswamy, Vijay; Daniels, Craig; Pallota, Jonelle G.; Douglas, Tajana; Joynt, Alyssa C. M.; Haapasalo, Joonas; Nor, Carolina; Vladoiu, Maria C.; Kuzan-Fischer, Claudia M.; Garzia, Livia; Mack, Stephen C.; Varadharajan, Srinidhi; Baker, Matthew L.; Hendrikse, Liam; Ly, Michelle; Kharas, Kaitlin; Balin, Polina; Wu, Xiaochong; Qin, Lei; Huang, Ning; Stucklin, Ana Guerreiro; Morrissy, A. Sorana; Cavalli, Florence M. G.; Luu, Betty; Suarez, Raul; De Antonellis, Pasqualino; Michealraj, Antony; Rastan, Avesta; Hegde, Meenakshi; Komosa, Martin; Sirbu, Olga; Kumar, Sachin A.; Abdullaev, Zied; Faria, Claudia C.; Yip, Stephen; Hukin, Juliette; Tabori, Uri; Hawkins, Cynthia; Aldape, Ken; Daugaard, Mads; Maris, John M.; Sorensen, Poul H.; Ahmed, Nabil; Taylor, Michael D.			Locoregional delivery of CAR T cells to the cerebrospinal fluid for treatment of metastatic medulloblastoma and ependymoma	NATURE MEDICINE			English	Article							ACUTE MYELOID-LEUKEMIA; DNA METHYLTRANSFERASE INHIBITORS; MYELODYSPLASTIC SYNDROMES; AZACITIDINE; REGRESSION; SUBGROUPS; THERAPY; IMMUNOTHERAPY; HETEROGENEITY; GLIOBLASTOMA	Intraventricularly delivered monovalent and trivalent CAR T cells exhibit greater therapeutic efficacy as compared with intravenously delivered CAR T cells in medulloblastoma xenograft mouse models and show potency in ependymoma xenograft mouse models. Recurrent medulloblastoma and ependymoma are universally lethal, with no approved targeted therapies and few candidates presently under clinical evaluation. Nearly all recurrent medulloblastomas and posterior fossa group A (PFA) ependymomas are located adjacent to and bathed by the cerebrospinal fluid, presenting an opportunity for locoregional therapy, bypassing the blood-brain barrier. We identify three cell-surface targets, EPHA2, HER2 and interleukin 13 receptor alpha 2, expressed on medulloblastomas and ependymomas, but not expressed in the normal developing brain. We validate intrathecal delivery of EPHA2, HER2 and interleukin 13 receptor alpha 2 chimeric antigen receptor T cells as an effective treatment for primary, metastatic and recurrent group 3 medulloblastoma and PFA ependymoma xenografts in mouse models. Finally, we demonstrate that administration of these chimeric antigen receptor T cells into the cerebrospinal fluid, alone or in combination with azacytidine, is a highly effective therapy for multiple metastatic mouse models of group 3 medulloblastoma and PFA ependymoma, thereby providing a rationale for clinical trials of these approaches in humans.	[Donovan, Laura K.; Holgado, Borja L.; Manno, Alex; Srikanthan, Dilakshan; Van Ommeren, Randy; Przelicki, David; Richman, Cory; Ramaswamy, Vijay; Daniels, Craig; Pallota, Jonelle G.; Douglas, Tajana; Joynt, Alyssa C. M.; Haapasalo, Joonas; Nor, Carolina; Vladoiu, Maria C.; Kuzan-Fischer, Claudia M.; Hendrikse, Liam; Ly, Michelle; Kharas, Kaitlin; Balin, Polina; Wu, Xiaochong; Qin, Lei; Huang, Ning; Stucklin, Ana Guerreiro; Cavalli, Florence M. G.; Luu, Betty; Suarez, Raul; De Antonellis, Pasqualino; Michealraj, Antony; Rastan, Avesta; Komosa, Martin; Sirbu, Olga; Kumar, Sachin A.; Tabori, Uri; Hawkins, Cynthia; Taylor, Michael D.] Hosp Sick Children, Arthur & Sonia Labatt Brain Tumour Res Ctr, Toronto, ON, Canada; [Donovan, Laura K.; Holgado, Borja L.; Manno, Alex; Srikanthan, Dilakshan; Van Ommeren, Randy; Przelicki, David; Richman, Cory; Daniels, Craig; Pallota, Jonelle G.; Douglas, Tajana; Joynt, Alyssa C. M.; Haapasalo, Joonas; Nor, Carolina; Vladoiu, Maria C.; Kuzan-Fischer, Claudia M.; Hendrikse, Liam; Ly, Michelle; Kharas, Kaitlin; Balin, Polina; Wu, Xiaochong; Qin, Lei; Huang, Ning; Stucklin, Ana Guerreiro; Cavalli, Florence M. G.; Luu, Betty; Suarez, Raul; De Antonellis, Pasqualino; Michealraj, Antony; Rastan, Avesta; Komosa, Martin; Sirbu, Olga; Kumar, Sachin A.; Tabori, Uri; Hawkins, Cynthia; Taylor, Michael D.] Hosp Sick Children, Dev & Stem Cell Biol Program, Toronto, ON, Canada; [Delaidelli, Alberto; Sorensen, Poul H.] British Columbia Canc Res Ctr, Dept Mol Oncol, Vancouver, BC, Canada; [Joseph, Sujith K.; Bielamowicz, Kevin; Fousek, Kristen; Gad, Ahmed Z.; Hegde, Meenakshi; Ahmed, Nabil] Texas Childrens Hosp, Baylor Coll Med, Houston, TX 77030 USA; [Joseph, Sujith K.; Bielamowicz, Kevin; Fousek, Kristen; Gad, Ahmed Z.; Baker, Matthew L.; Hegde, Meenakshi; Ahmed, Nabil] Texas Childrens Hosp, Baylor Coll Med, Houston Methodist Hosp, Ctr Cell & Gene Therapy, Houston, TX 77030 USA; [Srikanthan, Dilakshan; Van Ommeren, Randy; Przelicki, David; Vladoiu, Maria C.; Ly, Michelle; Kharas, Kaitlin; Balin, Polina] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada; [Richman, Cory; Hendrikse, Liam; Sirbu, Olga] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada; [Ramaswamy, Vijay] Hosp Sick Children, Dept Paediat, Div Haematol Oncol, Toronto, ON, Canada; [Garzia, Livia] McGill Univ, Hlth Ctr Res Inst, Canc Res Program, Montreal, PQ, Canada; [Mack, Stephen C.; Varadharajan, Srinidhi] Baylor Coll Med, Childrens Canc Ctr, Brain Tumour Program, Houston, TX 77030 USA; [Mack, Stephen C.; Varadharajan, Srinidhi] Baylor Coll Med, Dept Paediat, Houston, TX 77030 USA; [Morrissy, A. Sorana] Univ Calgary, Cumming Sch Med, Dept Biochem & Mol Biol, Calgary, AB, Canada; [Morrissy, A. Sorana] Univ Calgary, Charbonneau Canc Inst, Calgary, AB, Canada; [Abdullaev, Zied; Aldape, Ken] NCI, Pathol Lab, Ctr Canc Res, Bldg 10, Bethesda, MD 20892 USA; [Faria, Claudia C.] Hosp Santa Maria, Ctr Hosp Lisboa Norte, Div Neurosurg, Lisbon, Portugal; [Yip, Stephen] Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC, Canada; [Hukin, Juliette] British Columbia Childrens Hosp, Div Neurol, Vancouver, BC, Canada; [Daugaard, Mads] Univ British Columbia, Dept Urol Sci, Vancouver, BC, Canada; [Daugaard, Mads] Vancouver Coastal Hlth Res Inst, Vancouver Prostate Ctr, Vancouver, BC, Canada; [Maris, John M.] Childrens Hosp Philadelphia, Div Oncol, Philadelphia, PA 19104 USA; [Maris, John M.] Childrens Hosp Philadelphia, Ctr Childhood Canc Res, Philadelphia, PA 19104 USA; [Maris, John M.] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA; [Taylor, Michael D.] Hosp Sick Children, Div Neurosurg, Toronto, ON, Canada; [Taylor, Michael D.] Univ Toronto, Dept Lab Med & Pathobiol, Dept Surg, Toronto, ON, Canada; Univ Toronto, Dept Med Biophys, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); British Columbia Cancer Agency; Baylor College of Medicine; Baylor College of Medicine; The Methodist Hospital System; The Methodist Hospital - Houston; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); McGill University; Baylor College of Medicine; Texas Children's Cancer Center; Baylor College of Medicine; University of Calgary; University of Calgary; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Universidade de Lisboa; Hospital Santa Maria; University of British Columbia; BC Childrens Hospital; University of British Columbia; University of British Columbia; Vancouver Coastal Health Research Institute; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto	Taylor, MD (corresponding author), Hosp Sick Children, Arthur & Sonia Labatt Brain Tumour Res Ctr, Toronto, ON, Canada.; Taylor, MD (corresponding author), Hosp Sick Children, Dev & Stem Cell Biol Program, Toronto, ON, Canada.; Taylor, MD (corresponding author), Hosp Sick Children, Div Neurosurg, Toronto, ON, Canada.; Taylor, MD (corresponding author), Univ Toronto, Dept Lab Med & Pathobiol, Dept Surg, Toronto, ON, Canada.; Taylor, MD (corresponding author), Univ Toronto, Dept Med Biophys, Toronto, ON, Canada.	mdt.cns@gmail.com	Stucklin, Ana S. Guerreiro/Y-5794-2019; Hegde, Meenakshi/AAN-6400-2020; Yip, Stephen/E-9994-2012; de Antonellis, Pasqualino/AAT-1233-2020; Guerreiro Stücklin, Ana/GRR-4007-2022; Fousek, Kristen/AAO-9841-2020; Michealraj, Antony/AAJ-7925-2020; Joseph, Sujith/C-2835-2012; Daugaard, Mads/Y-6483-2018	Stucklin, Ana S. Guerreiro/0000-0003-3136-9241; Hegde, Meenakshi/0000-0002-7778-7871; Yip, Stephen/0000-0002-8514-9861; de Antonellis, Pasqualino/0000-0001-8551-9431; Guerreiro Stücklin, Ana/0000-0003-3136-9241; Fousek, Kristen/0000-0002-2307-5000; Michealraj, Antony/0000-0002-3967-0816; Hukin, Juliette/0000-0002-8727-8456; Kumar, Sachin/0000-0002-4853-3864; Faria, Claudia/0000-0003-1259-9922; Srikanthan, Dilakshan/0000-0002-7564-5458; Joseph, Sujith/0000-0003-4596-1270; Rastan, Azuravesta/0000-0002-8632-430X; Cavalli, Florence M. G./0000-0002-4409-9642; Gad, Ahmed/0000-0002-6149-3414; Kuzan-Fischer, Claudia Miranda/0000-0003-2226-0682; Daugaard, Mads/0000-0001-8383-055X; Hendrikse, Liam/0000-0002-0253-8512; Donovan, Laura/0000-0001-5557-5539	National Institutes of Health [R01CA148699, R01CA159859, U54 CA232568-01]; Pediatric Brain Tumour Foundation; Terry Fox Research Institute; Canadian Institutes of Health Research; Cure Search Foundation; b.r.a.i.n.child; Meagan's Walk; SWIFTY Foundation; Brain Tumour Charity; Genome Canada; Genome BC; Genome Quebec; Ontario Research Fund; Worldwide Cancer Research; V-Foundation for Cancer Research; Ontario Institute for Cancer Research - Government of Ontario; Canadian Cancer Society Research Institute Impact grant; Cancer Research UK Brain Tumour Award; Stand Up To Cancer (SU2C) St. Baldrick's Pediatric Dream Team Translational Research Grant by the Government of Canada through Genome Canada [SU2C-AACR-DT1113]; SU2C Canada Cancer Stem Cell Dream Team Research Funding by the Government of Canada through Genome Canada [SU2C-AACR-DT-19-15]; Government of Ontario; Garron Family Chair in Childhood Cancer Research at the Hospital for Sick Children; University of Toronto; SU2C St. Baldrick's Pediatric Dream Team Translational Research Grant [SU2C-AACR-DT1113]; Brain Canada NeuroDevNet	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pediatric Brain Tumour Foundation; Terry Fox Research Institute; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Cure Search Foundation; b.r.a.i.n.child; Meagan's Walk; SWIFTY Foundation; Brain Tumour Charity; Genome Canada(Genome Canada); Genome BC; Genome Quebec; Ontario Research Fund; Worldwide Cancer Research; V-Foundation for Cancer Research; Ontario Institute for Cancer Research - Government of Ontario; Canadian Cancer Society Research Institute Impact grant; Cancer Research UK Brain Tumour Award; Stand Up To Cancer (SU2C) St. Baldrick's Pediatric Dream Team Translational Research Grant by the Government of Canada through Genome Canada; SU2C Canada Cancer Stem Cell Dream Team Research Funding by the Government of Canada through Genome Canada; Government of Ontario; Garron Family Chair in Childhood Cancer Research at the Hospital for Sick Children; University of Toronto(University of Toronto); SU2C St. Baldrick's Pediatric Dream Team Translational Research Grant; Brain Canada NeuroDevNet	M.D.T. is supported by the National Institutes of Health (R01CA148699 and R01CA159859), the Pediatric Brain Tumour Foundation, the Terry Fox Research Institute, the Canadian Institutes of Health Research, the Cure Search Foundation, b.r.a.i.n.child, Meagan's Walk, SWIFTY Foundation, the Brain Tumour Charity, Genome Canada, Genome BC, Genome Quebec, the Ontario Research Fund, Worldwide Cancer Research, V-Foundation for Cancer Research and the Ontario Institute for Cancer Research through funding provided by the Government of Ontario. M.D.T. is also supported by a Canadian Cancer Society Research Institute Impact grant, a Cancer Research UK Brain Tumour Award and by a Stand Up To Cancer (SU2C) St. Baldrick's Pediatric Dream Team Translational Research Grant (SU2C-AACR-DT1113) and SU2C Canada Cancer Stem Cell Dream Team Research Funding (SU2C-AACR-DT-19-15) provided by the Government of Canada through Genome Canada and the Canadian Institutes of Health Research, with supplementary support from the Ontario Institute for Cancer Research through funding provided by the Government of Ontario. SU2C is a program of the Entertainment Industry Foundation administered by the American Association for Cancer Research. M.D.T. is also supported by the Garron Family Chair in Childhood Cancer Research at the Hospital for Sick Children and the University of Toronto. N.A. is supported by National Institutes of Health (U54 CA232568-01), SU2C St. Baldrick's Pediatric Dream Team Translational Research Grant (SU2C-AACR-DT1113). L.K.D. was supported by funding from Brain Canada NeuroDevNet. We thank P. Rose Matthew for her valuable help in making CAR T cells; S. Gottschalk for designing and constructing EPHA2 CAR; D. Trono for gifting psPAX2 and pMD2.G plasmids; S. Keir and D. Bigner for gifting Ep612 cells; and M. Essand for gifting pBMN(CMV-copGFP-Luc2-Puro) plasmid. The authors thank J. Loukides (Manager, Brain Tumour Biobank at SickKids) and recognize the Labatt Brain Tumour Research Centre and the Michael and Amira Dan Brain Tumour Bank Network. We gratefully thank the Pathology Research Program Laboratory, UHN, for their pathology assistance and the Centre for Phenogenomics for their animal husbandry support and BLI assistance. We thank S. Archer for technical writing assistance and editing and A. Carlow for manuscript support.	Ahmed N, 2007, CANCER RES, V67, P5957, DOI 10.1158/0008-5472.CAN-06-4309; Ahmed N, 2017, JAMA ONCOL, V3, P1094, DOI 10.1001/jamaoncol.2017.0184; Akhavan D, 2019, IMMUNOL REV, V290, P60, DOI 10.1111/imr.12773; Azemar M, 2003, BREAST CANCER RES TR, V82, P155, DOI 10.1023/B:BREA.0000004371.48757.19; Bergamaschi C, 2012, BLOOD, V120, pE1, DOI 10.1182/blood-2011-10-384362; Bette S, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22697-9; Bielamowicz K, 2018, NEURO-ONCOLOGY, V20, P506, DOI 10.1093/neuonc/nox182; Brown CE, 2018, MOL THER, V26, P31, DOI 10.1016/j.ymthe.2017.10.002; Brown CE, 2016, NEW ENGL J MED, V375, P2561, DOI 10.1056/NEJMoa1610497; Brown CE, 2015, CLIN CANCER RES, V21, P4062, DOI 10.1158/1078-0432.CCR-15-0428; Cavalli FMG, 2017, CANCER CELL, V31, P737, DOI 10.1016/j.ccell.2017.05.005; Chow KKH, 2013, MOL THER, V21, P629, DOI 10.1038/mt.2012.210; Fozza C, 2015, LEUKEMIA RES, V39, P957, DOI 10.1016/j.leukres.2015.06.007; Gang AO, 2014, BLOOD CANCER J, V4, DOI 10.1038/bcj.2014.14; Garzia L, 2018, CELL, V172, P1050, DOI 10.1016/j.cell.2018.01.038; Goff SL, 2019, J IMMUNOTHER, V42, P126, DOI 10.1097/CJI.0000000000000260; Goodyear OC, 2012, BLOOD, V119, P3361, DOI 10.1182/blood-2011-09-377044; Hegde M, 2016, J CLIN INVEST, V126, P3036, DOI 10.1172/JCI83416; Jin C, 2016, EMBO MOL MED, V8, P702, DOI 10.15252/emmm.201505869; Keu KV, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aag2196; Khatua S, 2017, EUR J CANCER, V70, P34, DOI 10.1016/j.ejca.2016.10.013; Kimura S, 2012, ANTICANCER RES, V32, P795; Kramer K, 2018, PEDIATR BLOOD CANCER, P65; Krebs S, 2014, CYTOTHERAPY, V16, P1121, DOI 10.1016/j.jcyt.2014.02.012; Mack SC, 2014, NATURE, V506, P445, DOI 10.1038/nature13108; Mack SC, 2018, NATURE, V553, P101, DOI 10.1038/nature25169; Majzner RG, 2019, CLIN CANCER RES, V25, P2560, DOI 10.1158/1078-0432.CCR-18-0432; McLendon RE, 1996, J NEUROPATH EXP NEUR, V55, P540, DOI 10.1097/00005072-199605000-00007; Mokhtari RB, 2017, ONCOTARGET, V8, P38022, DOI 10.18632/oncotarget.16723; Momparler RL, 2014, CLIN EPIGENETICS, V6, DOI 10.1186/1868-7083-6-19; Montalban-Bravo G, 2018, AM J HEMATOL, V93, P129, DOI 10.1002/ajh.24930; Morgan RA, 2010, MOL THER, V18, P843, DOI 10.1038/mt.2010.24; Morrissy AS, 2017, NAT GENET, V49, P780, DOI 10.1038/ng.3838; Morrissy AS, 2016, NATURE, V529, P351, DOI 10.1038/nature16478; Mount CW, 2018, NAT MED, V24, P572, DOI 10.1038/s41591-018-0006-x; Nellan A, 2018, J IMMUNOTHER CANCER, V6, DOI 10.1186/s40425-018-0340-z; Northcott PA, 2017, NATURE, V547, P311, DOI 10.1038/nature22973; Northcott PA, 2011, J CLIN ONCOL, V29, P1408, DOI 10.1200/JCO.2009.27.4324; O'Rourke DM, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aaa0984; Pajtler KW, 2015, CANCER CELL, V27, P728, DOI 10.1016/j.ccell.2015.04.002; Priceman SJ, 2018, CLIN CANCER RES, V24, P95, DOI 10.1158/1078-0432.CCR-17-2041; Pui CH, 2011, NAT REV CLIN ONCOL, V8, P540, DOI 10.1038/nrclinonc.2011.95; Qiu XN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012994; QUDDUS J, 1993, J CLIN INVEST, V92, P38, DOI 10.1172/JCI116576; Ramaswamy V, 2013, LANCET ONCOL, V14, P1200, DOI 10.1016/S1470-2045(13)70449-2; Rasouli J, 2015, J IMMUNOL, V194, P5085, DOI 10.4049/jimmunol.1403243; Rodriguez-Paredes M, 2011, NAT MED, V17, P330, DOI 10.1038/nm.2305; Schulz H, 2004, HAEMATOLOGICA, V89, P753; Stresemann C, 2008, INT J CANCER, V123, P8, DOI 10.1002/ijc.23607; Stritesky GL, 2008, J IMMUNOL, V181, P5948, DOI 10.4049/jimmunol.181.9.5948; Taylor MD, 2012, ACTA NEUROPATHOL, V123, P465, DOI 10.1007/s00401-011-0922-z; Terracina KP, 2016, CANCER IMMUNOL IMMUN, V65, P1061, DOI 10.1007/s00262-016-1868-8; Vladoiu MC, 2019, NATURE, V572, P67, DOI 10.1038/s41586-019-1158-7; Wang X, 2014, ACTA NEUROPATHOL, V154, P2262; Witt H, 2011, CANCER CELL, V20, P143, DOI 10.1016/j.ccr.2011.07.007; Wu X, 2012, NATURE, V482, P529, DOI 10.1038/nature10825	56	85	85	7	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAY	2020	26	5					720	+		10.1038/s41591-020-0827-2	http://dx.doi.org/10.1038/s41591-020-0827-2		APR 2020	30	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	ML1MK	32341580	Green Accepted			2022-12-27	WOS:000528996000001
J	Mars, N; Koskela, JT; Ripatti, P; Kiiskinen, TTJ; Havulinna, AS; Lindbohm, JV; Ahola-Olli, A; Kurki, M; Karjalainen, J; Palta, P; Neale, BM; Daly, M; Salomaa, V; Palotie, A; Widen, E; Ripatti, S				Mars, Nina; Koskela, Jukka T.; Ripatti, Pietari; Kiiskinen, Tuomo T. J.; Havulinna, Aki S.; Lindbohm, Joni V.; Ahola-Olli, Ari; Kurki, Mitja; Karjalainen, Juha; Palta, Priit; Neale, Benjamin M.; Daly, Mark; Salomaa, Veikko; Palotie, Aarno; Widen, Elisabeth; Ripatti, Samuli		FinnGen	Polygenic and clinical risk scores and their impact on age at onset and prediction of cardiometabolic diseases and common cancers	NATURE MEDICINE			English	Article							GENOMIC PREDICTION; PREVENTION	Polygenic risk scores (PRSs) have shown promise in predicting susceptibility to common diseases(1-3). We estimated their added value in clinical risk prediction of five common diseases, using large-scale biobank data (FinnGen; n = 135,300) and the FINRISK study with clinical risk factors to test genome-wide PRSs for coronary heart disease, type 2 diabetes, atrial fibrillation, breast cancer and prostate cancer. We evaluated the lifetime risk at different PRS levels, and the impact on disease onset and on prediction together with clinical risk scores. Compared to having an average PRS, having a high PRS contributed 21% to 38% higher lifetime risk, and 4 to 9 years earlier disease onset. PRSs improved model discrimination over age and sex in type 2 diabetes, atrial fibrillation, breast cancer and prostate cancer, and over clinical risk in type 2 diabetes, breast cancer and prostate cancer. In all diseases, PRSs improved reclassification over clinical thresholds, with the largest net reclassification improvements for early-onset coronary heart disease, atrial fibrillation and prostate cancer. This study provides evidence for the additional value of PRSs in clinical disease prediction. The practical applications of polygenic risk information for stratified screening or for guiding lifestyle and medical interventions in the clinical setting remain to be defined in further studies.	[Mars, Nina; Koskela, Jukka T.; Ripatti, Pietari; Kiiskinen, Tuomo T. J.; Havulinna, Aki S.; Ahola-Olli, Ari; Kurki, Mitja; Karjalainen, Juha; Palta, Priit; Daly, Mark; Palotie, Aarno; Widen, Elisabeth; Ripatti, Samuli] Univ Helsinki, Inst Mol Med Finland, FIMM, HiLIFE, Helsinki, Finland; [Havulinna, Aki S.; Salomaa, Veikko] Finnish Inst Hlth & Welf, Helsinki, Finland; [Lindbohm, Joni V.; Ripatti, Samuli] Univ Helsinki, Dept Publ Hlth, Clinicum, Helsinki, Finland; [Kurki, Mitja; Neale, Benjamin M.] Broad Inst MIT & Harvard, Stanley Ctr Psychiat Res, Program Med & Populat Genet & Genet Anal Platform, Cambridge, MA 02142 USA; [Kurki, Mitja; Palotie, Aarno] Massachusetts Gen Hosp, Dept Med, Psychiat & Neurodev Genet Unit, Dept Psychiat,Analyt & Translat Genet Unit, Boston, MA 02114 USA; [Kurki, Mitja; Palotie, Aarno] Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA; [Karjalainen, Juha; Daly, Mark; Palotie, Aarno; Ripatti, Samuli] Broad Inst MIT & Harvard Univ, Cambridge, MA 02142 USA; [Karjalainen, Juha; Neale, Benjamin M.] Massachusetts Gen Hosp, Analyt & Translat Genet Unit, Boston, MA 02114 USA; [Karjalainen, Juha; Neale, Benjamin M.] Harvard Med Sch, Boston, MA 02115 USA; [Palta, Priit] Univ Tartu, Inst Genom, Estonian Genome Ctr, Tartu, Estonia	University of Helsinki; University of Helsinki; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; University of Tartu	Ripatti, S (corresponding author), Univ Helsinki, Inst Mol Med Finland, FIMM, HiLIFE, Helsinki, Finland.; Ripatti, S (corresponding author), Univ Helsinki, Dept Publ Hlth, Clinicum, Helsinki, Finland.; Ripatti, S (corresponding author), Broad Inst MIT & Harvard Univ, Cambridge, MA 02142 USA.	samuli.ripatti@helsinki.fi	Kurki, Mitja/GWM-5671-2022; Havulinna, Aki/AAM-4769-2021; Palta, Priit/W-2477-2019	Palta, Priit/0000-0001-9320-7008; Paloneva, Juha/0000-0003-3340-9390; Kiiskinen, Tuomo/0000-0002-6306-8227; Mars, Nina/0000-0002-7259-5993; Schleutker, Johanna/0000-0002-1863-0305; Koskela, Jukka/0000-0002-0154-7222; Ripatti, Pietari/0000-0002-6530-3243; Palotie, Aarno/0000-0002-2527-5874; Juonala, Markus/0000-0001-9498-364X; Havulinna, Aki/0000-0002-4787-8959	THL biobank [BB2015_55.1]; THL [THL/2031/6.02.00/2017, THL/341/6.02.00/2018, THL/2222/6.02.00/2018, THL/283/6.02.00/2019]; Finnish Foundation for Cardiovascular Research; Sigrid Juselius Foundation; University of Helsinki; Academy of Finland Center of Excellence in Complex Disease Genetics [312062, 312074, 312075]; Academy of Finland [285380, 128650]; Finnish Innovation Fund Tekes [2273/31/2017]; Horizon 2020 Research and Innovation Programme [667301]; Ida Montin Foundation; Doctoral Programme in Population Health, University of Helsinki; Emil Aaltonen Foundation; Business Finland [HUS 4685/31/2016, UH 4386/31/2016]; AbbVie; AstraZeneca; Biogen; Celgene; Genentech; GSK; MSD; Pfizer; Sanofi	THL biobank; THL; Finnish Foundation for Cardiovascular Research; Sigrid Juselius Foundation(Sigrid Juselius Foundation); University of Helsinki; Academy of Finland Center of Excellence in Complex Disease Genetics(Academy of Finland); Academy of Finland(Academy of Finland); Finnish Innovation Fund Tekes; Horizon 2020 Research and Innovation Programme; Ida Montin Foundation; Doctoral Programme in Population Health, University of Helsinki; Emil Aaltonen Foundation; Business Finland; AbbVie(AbbVie); AstraZeneca(AstraZeneca); Biogen(Biogen); Celgene(Bristol-Myers SquibbCelgene Corporation); Genentech(Roche HoldingGenentech); GSK(GlaxoSmithKline); MSD; Pfizer(Pfizer); Sanofi	We thank S. Kivikko, H.-Y. Shen and U. Tuomainen for management assistance. The FINRISK analyses were conducted using the THL biobank permission for project BB2015_55.1. The FINRISK data used for the research were obtained from THL Biobank. For the Finnish Institute of Health and Welfare (THL)-driven FinnGen preparatory project (here called FinnGen), all patients and control subjects had provided informed consent for biobank research, based on the Finnish Biobank Act. Alternatively, older cohorts were based on study-specific consents and later transferred to the THL Biobank after approval by Valvira, the National Supervisory Authority for Welfare and Health. Recruitment protocols followed the biobank protocols approved by Valvira. The Ethics Review Board of the Hospital District of Helsinki and Uusimaa approved the FinnGen study protocol no. HUS/990/2017. The FinnGen preparatory project is approved by THL, approval number THL/2031/6.02.00/2017, amendments THL/341/6.02.00/2018, THL/2222/6.02.00/2018 and THL/283/6.02.00/2019. The following biobanks are acknowledged for collecting the FinnGen project samples: Auria Biobank (https://www.auria.fi/biopankki/en), THL Biobank (https://thl.fi/fi/web/thl-biopankki), Helsinki Biobank (https://www.terveyskyla.fi/helsinginbiopankki/en), Northern Finland Biobank Borealis (https://www.ppshp.fi/Tutkimus-ja-opetus/Biopankki), Finnish Clinical Biobank Tampere (https://www.tays.fi/en-US/Research_ and_development/Finnish_Clinical_Biobank_Tampere), Biobank of Eastern Finland (https://ita-suomenbiopankki.fi/), Central Finland Biobank (https://www.ksshp.fi/fi-FI/Potilaalle/Biopankki), Finnish Red Cross Blood Service Biobank (https://www.bloodservice.fi/Research%20Projects/biobanking).We thank all study participants for their generous participation in FINRISK and FinnGen. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. This work was supported by the Finnish Foundation for Cardiovascular Research (to S.R., V.S. and A.P.); Sigrid Juselius Foundation (to S.R. and A.P.); University of Helsinki HiLIFE Fellow grants 2017-2020 (to S.R.); Academy of Finland Center of Excellence in Complex Disease Genetics (grant number 312062 to S.R., 312074 to A.P., 312075 to M.D.); Academy of Finland (grant number 285380 to S.R., 128650 to A.P.); The Finnish Innovation Fund Tekes (grant number 2273/31/2017 to E.W.); Horizon 2020 Research and Innovation Programme (grant number 667301 (COSYN) to A.P.); Ida Montin Foundation (to P.R.); Doctoral Programme in Population Health, University of Helsinki (to P.R.); and Emil Aaltonen Foundation (to P.R.). The FinnGen project is funded by two grants from Business Finland (HUS 4685/31/2016 and UH 4386/31/2016) and nine industry partners (AbbVie, AstraZeneca, Biogen, Celgene, Genentech, GSK, MSD, Pfizer and Sanofi). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Abraham G, 2016, EUR HEART J, V37, P3267, DOI 10.1093/eurheartj/ehw450; Alonso A, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.112.000102; Amer Diabet Assoc, 2018, DIABETES CARE, V41, pS13, DOI 10.2337/dc18-S002; Bapat A, 2018, HEART, V104, P201, DOI 10.1136/heartjnl-2016-311027; Borodulin K, 2018, INT J EPIDEMIOL, V47, P696, DOI 10.1093/ije/dyx239; Brentnall AR, 2018, JAMA ONCOL, V4, DOI 10.1001/jamaoncol.2018.0174; Chatterjee N, 2016, NAT REV GENET, V17, P392, DOI 10.1038/nrg.2016.27; Choudhury PP, 2020, JNCI-J NATL CANCER I, V112, P278, DOI 10.1093/jnci/djz113; Goff DC, 2014, CIRCULATION, V129, pS49, DOI 10.1161/01.cir.0000437741.48606.98; Grundy SM, 2019, J AM COLL CARDIOL, V73, P3168, DOI 10.1016/j.jacc.2018.11.002; Inouye M, 2018, J AM COLL CARDIOL, V72, P1883, DOI 10.1016/j.jacc.2018.07.079; James SL, 2018, LANCET, V392, P1789, DOI [10.1016/S0140-6736(18)32279-7, 10.1016/s0140-6736(18)32279-7]; Khera AV, 2018, NAT GENET, V50, P1219, DOI 10.1038/s41588-018-0183-z; Khera AV, 2017, NEW ENGL J MED, V376, P1194, DOI 10.1056/NEJMc1700362; Kiiskinen T, 2020, TRANSL PSYCHIAT, V10, DOI 10.1038/s41398-019-0676-2; Lee A, 2019, GENET MED, V21, P1708, DOI 10.1038/s41436-018-0406-9; Lindbohm JV, 2019, LANCET PUBLIC HEALTH, V4, pE189, DOI 10.1016/S2468-2667(19)30023-4; Lindstrom J, 2003, DIABETES CARE, V26, P725, DOI 10.2337/diacare.26.3.725; Lubitz SA, 2017, CIRCULATION, V135, P1311, DOI 10.1161/CIRCULATIONAHA.116.024143; Maas P, 2016, JAMA ONCOL, V2, P1295, DOI 10.1001/jamaoncol.2016.1025; Mahajan A, 2018, NAT GENET, V50, P1505, DOI 10.1038/s41588-018-0241-6; Martin AR, 2019, NAT GENET, V51, P584, DOI 10.1038/s41588-019-0379-x; Mavaddat N, 2019, AM J HUM GENET, V104, P21, DOI 10.1016/j.ajhg.2018.11.002; May S, 1998, LIFETIME DATA ANAL, V4, P109, DOI 10.1023/A:1009612305785; McCarthy MI, 2017, DIABETOLOGIA, V60, P793, DOI 10.1007/s00125-017-4210-x; Mega JL, 2015, LANCET, V385, P2264, DOI 10.1016/S0140-6736(14)61730-X; Michailidou K, 2017, NATURE, V551, P92, DOI 10.1038/nature24284; Natarajan P, 2017, CIRCULATION, V135, P2091, DOI 10.1161/CIRCULATIONAHA.116.024436; Nielsen JB, 2018, NAT GENET, V50, P1234, DOI 10.1038/s41588-018-0171-3; Piepoli MF, 2016, EUR HEART J, V37, P2315, DOI 10.1093/eurheartj/ehw106; Royston P, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-152; Schumacher FR, 2018, NAT GENET, V50, P928, DOI 10.1038/s41588-018-0142-8; Seibert TM, 2018, BMJ-BRIT MED J, V360, DOI 10.1136/bmj.j5757; Terry MB, 2019, LANCET ONCOL, V20, P504, DOI 10.1016/S1470-2045(18)30902-1; Timpson NJ, 2018, NAT REV GENET, V19, P110, DOI 10.1038/nrg.2017.101; Torkamani A, 2018, NAT REV GENET, V19, P581, DOI 10.1038/s41576-018-0018-x; Vilhjalmsson BJ, 2015, AM J HUM GENET, V97, P576, DOI 10.1016/j.ajhg.2015.09.001; Visscher PM, 2017, AM J HUM GENET, V101, P5, DOI 10.1016/j.ajhg.2017.06.005; Wilson BJ, 2009, ANN INTERN MED, V151, P878, DOI [10.7326/0000605-200912150-00177, 10.7326/0003-4819-151-12-200912150-00177]; Zhou W, 2018, NAT GENET, V50, P1335, DOI 10.1038/s41588-018-0184-y	40	117	119	2	8	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	APR	2020	26	4					549	+		10.1038/s41591-020-0800-0	http://dx.doi.org/10.1038/s41591-020-0800-0			18	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	QH1UE	32273609	Green Accepted			2022-12-27	WOS:000618061900031
J	Kotliarov, Y; Sparks, R; Martins, AJ; Mule, MP; Lu, Y; Goswami, M; Kardava, L; Banchereau, R; Pascual, V; Biancotto, A; Chen, JG; Schwartzberg, PL; Bansal, N; Liu, CC; Cheung, F; Moir, S; Tsang, JS				Kotliarov, Yuri; Sparks, Rachel; Martins, Andrew J.; Mule, Matthew P.; Lu, Yong; Goswami, Meghali; Kardava, Lela; Banchereau, Romain; Pascual, Virginia; Biancotto, Angelique; Chen, Jinguo; Schwartzberg, Pamela L.; Bansal, Neha; Liu, Candace C.; Cheung, Foo; Moir, Susan; Tsang, John S.			Broad immune activation underlies shared set point signatures for vaccine responsiveness in healthy individuals and disease activity in patients with lupus	NATURE MEDICINE			English	Article							I INTERFERON; ENRICHMENT ANALYSIS; SYSTEMS BIOLOGY; CELLS; DIFFERENTIATION; ERYTHEMATOSUS; INFLAMMATION; POPULATIONS; AUTOIMMUNE; BIOMARKERS	Simultaneous single-cell protein and transcriptome analysis identifies a baseline immune circuit associated with antibody responses to vaccination in healthy individuals and the severity of disease flares in patients with a subtype of systemic lupus erythematosus. Responses to vaccination and to diseases vary widely across individuals, which may be partly due to baseline immune variations. Identifying such baseline predictors of immune responses and their biological basis is of broad interest, given their potential importance for cancer immunotherapy, disease outcomes, vaccination and infection responses. Here we uncover baseline blood transcriptional signatures predictive of antibody responses to both influenza and yellow fever vaccinations in healthy subjects. These same signatures evaluated at clinical quiescence are correlated with disease activity in patients with systemic lupus erythematosus with plasmablast-associated flares. CITE-seq profiling of 82 surface proteins and transcriptomes of 53,201 single cells from healthy high and low influenza vaccination responders revealed that our signatures reflect the extent of activation in a plasmacytoid dendritic cell-type I IFN-T/B lymphocyte network. Our findings raise the prospect that modulating such immune baseline states may improve vaccine responsiveness and mitigate undesirable autoimmune disease activity.	[Kotliarov, Yuri; Biancotto, Angelique; Chen, Jinguo; Schwartzberg, Pamela L.; Cheung, Foo; Tsang, John S.] NIAID, NIH, Ctr Human Immunol, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Sparks, Rachel; Martins, Andrew J.; Mule, Matthew P.; Lu, Yong; Goswami, Meghali; Bansal, Neha; Liu, Candace C.; Tsang, John S.] NIAID, Multiscale Syst Biol Sect, Lab Immune Syst Biol, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Mule, Matthew P.] Univ Cambridge, NIH Oxford Cambridge Scholars Program, Cambridge Inst Med Res, Cambridge, England; [Mule, Matthew P.] Univ Cambridge, Dept Med, Cambridge, England; [Kardava, Lela; Moir, Susan] NIAID, Cell Immunol Unit B, Immunoregulat Lab, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Banchereau, Romain; Pascual, Virginia] Baylor Inst Immunol Res, Dallas, TX USA; [Schwartzberg, Pamela L.] NIAID, Cell Signaling & Immun Sect, Lab Immune Syst Biol, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Kotliarov, Yuri] NCI, Biometr Res Program, Div Canc Treatment & Diag, NIH, Rockville, MD USA; [Goswami, Meghali] NHLBI, Lab Myeloid Malignancies, NIH, Bldg 10, Bethesda, MD 20892 USA; [Banchereau, Romain] Genentech Inc, Oncol Biomarker Dev, San Francisco, CA 94080 USA; [Pascual, Virginia] Weill Cornell Med, Drukier Inst Childrens Hlth, New York, NY USA; [Biancotto, Angelique] Sanofi Precis Immunol, Immunol & Inflammat Therapeut Area, Cambridge, MA USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Cambridge; University of Cambridge; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Baylor Scott & White Health; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Roche Holding; Genentech; Cornell University	Tsang, JS (corresponding author), NIAID, NIH, Ctr Human Immunol, 9000 Rockville Pike, Bethesda, MD 20892 USA.; Tsang, JS (corresponding author), NIAID, Multiscale Syst Biol Sect, Lab Immune Syst Biol, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	john.tsang@nih.gov	Martins, Andrew/AAU-7039-2021; biancotto, angelique/C-4632-2011; Pascual, Virginia/ABD-3099-2020	Martins, Andrew/0000-0002-1832-1924; biancotto, angelique/0000-0003-2271-009X; Mule, Matthew/0000-0001-8457-2716; Kotliarov, Yuri/0000-0002-6558-8883	Intramural Research Program of the National Institute of Allergy and Infectious Diseases (NIAID); NIH Institutes supporting the Center for Human Immunology	Intramural Research Program of the National Institute of Allergy and Infectious Diseases (NIAID); NIH Institutes supporting the Center for Human Immunology	We thank members of the Tsang Lab and the NIH Center for Human Immunology (CHI) for inputs and discussions; L. Failla for help with figures; D. Hirsch for testing the R code; and R. Germain and R. Apps for comments on the manuscript. This research was supported by the Intramural Research Program of the National Institute of Allergy and Infectious Diseases (NIAID) and Intramural Programs of the NIH Institutes supporting the Center for Human Immunology. Figure 6 was created with BioRender.com.	Andrews SF, 2015, J VIROL, V89, P3308, DOI 10.1128/JVI.02871-14; Arriens C, 2017, RHEUMATOLOGY, V56, P32, DOI 10.1093/rheumatology/kew407; Avey S, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aal4656; Banchereau J, 2006, IMMUNITY, V25, P383, DOI 10.1016/j.immuni.2006.08.010; Banchereau R, 2016, CELL, V165, P551, DOI 10.1016/j.cell.2016.03.008; Bates D, 2013, J STAT SOFTW, V52, P1, DOI 10.18637/jss.v052.i05; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bhattacharya S, 2014, IMMUNOL RES, V58, P234, DOI 10.1007/s12026-014-8516-1; Brodin P, 2017, NAT REV IMMUNOL, V17, P21, DOI 10.1038/nri.2016.125; Brodin P, 2015, CELL, V160, P37, DOI 10.1016/j.cell.2014.12.020; Butler A, 2018, NAT BIOTECHNOL, V36, P411, DOI 10.1038/nbt.4096; Carlson M., 2016, HGU95AV2 DB AFFYMETR; Chaussabel D, 2008, IMMUNITY, V29, P150, DOI 10.1016/j.immuni.2008.05.012; Chen DS, 2017, NATURE, V541, P321, DOI 10.1038/nature21349; Chen J, 2009, NUCLEIC ACIDS RES, V37, pW305, DOI 10.1093/nar/gkp427; Choi JK, 2003, BIOINFORMATICS, V19, pi84, DOI 10.1093/bioinformatics/btg1010; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Elgueta R, 2009, IMMUNOL REV, V229, P152, DOI 10.1111/j.1600-065X.2009.00782.x; Finak G, 2014, IMMUNESPACER THIN WR; Fourati S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10369; Gricks CS, 2004, BLOOD, V104, P4002, DOI 10.1182/blood-2004-02-0494; Hagan T, 2019, CELL, V178, P1313, DOI 10.1016/j.cell.2019.08.010; He XS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002574; Jego G, 2003, IMMUNITY, V19, P225, DOI 10.1016/S1074-7613(03)00208-5; Kang HM, 2018, NAT BIOTECHNOL, V36, P89, DOI 10.1038/nbt.4042; Klein SL, 2016, NAT REV IMMUNOL, V16, P626, DOI 10.1038/nri.2016.90; Korotkevich G., 2019, FAST GENE SET ENRICH, DOI 10.1101/060012v3; Kotas ME, 2015, CELL, V160, P816, DOI 10.1016/j.cell.2015.02.010; Krieg C, 2018, NAT MED, V24, P144, DOI 10.1038/nm.4466; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Lee JC, 2014, CLIN TRANSL IMMUNOL, V3, DOI 10.1038/cti.2014.8; Li S, 2014, NAT IMMUNOL, V15, P195, DOI 10.1038/ni.2789; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lu Y, 2016, IMMUNITY, V45, P1162, DOI 10.1016/j.immuni.2016.10.025; Lun A., 2019, SINGLECELLEXPERIMENT; Lun ATL, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0947-7; Marchant A, 2006, J INFECT DIS, V193, P1598, DOI 10.1086/503775; MULE MP, BIORXIV; Muskardin TLW, 2018, NAT REV RHEUMATOL, V14, P214, DOI 10.1038/nrrheum.2018.31; Nakaya HI, 2015, IMMUNITY, V43, P1186, DOI 10.1016/j.immuni.2015.11.012; Patin E, 2018, NAT IMMUNOL, V19, P302, DOI 10.1038/s41590-018-0049-7; Quach TD, 2016, J IMMUNOL, V196, P1060, DOI 10.4049/jimmunol.1501843; Querec TD, 2009, NAT IMMUNOL, V10, P116, DOI 10.1038/ni.1688; Rees F, 2017, RHEUMATOLOGY, V56, P1945, DOI 10.1093/rheumatology/kex260; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; Shimabukuro-Vornhagen A, 2014, J IMMUNOL, V193, P5294, DOI 10.4049/jimmunol.1203436; Stoeckius M, 2017, CITE SEQ PROTOCOLS; Stoeckius M, 2018, GENOME BIOL, V19, DOI 10.1186/s13059-018-1603-1; Stoeckius M, 2017, NAT METHODS, V14, P865, DOI [10.1038/nmeth.4380, 10.1038/NMETH.4380]; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Swiecki M, 2015, NAT REV IMMUNOL, V15, P471, DOI 10.1038/nri3865; Tsang JS, 2015, TRENDS IMMUNOL, V36, P479, DOI 10.1016/j.it.2015.06.005; Tsang JS, 2014, CELL, V157, P499, DOI 10.1016/j.cell.2014.03.031; Tsokos GC, 2016, NAT REV RHEUMATOL, V12, P716, DOI 10.1038/nrrheum.2016.186; van Lochem EG, 2004, CYTOM PART B-CLIN CY, V60B, P1, DOI 10.1002/cyto.b.20008; Verheul MK, 2015, CLIN IMMUNOL, V161, P2, DOI 10.1016/j.clim.2015.04.005; Waltman L, 2013, EUR PHYS J B, V86, DOI 10.1140/epjb/e2013-40829-0; Wang XB, 2012, BIOINFORMATICS, V28, P2534, DOI 10.1093/bioinformatics/bts485; Westra HJ, 2013, NAT GENET, V45, P1238, DOI 10.1038/ng.2756; Wickham H., 2016, GGPLOT2 ELEGANT GRAP; Willis JCD, 2015, NAT REV IMMUNOL, V15, P323, DOI 10.1038/nri3820; Zappia L, 2018, GIGASCIENCE, V7, DOI 10.1093/gigascience/giy083; Zyla J, 2019, BIOINFORMATICS, V35, P5146, DOI 10.1093/bioinformatics/btz447	64	67	68	1	9	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	APR	2020	26	4					618	+		10.1038/s41591-020-0769-8	http://dx.doi.org/10.1038/s41591-020-0769-8		FEB 2020	32	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	QH1UE	32094927	Green Accepted			2022-12-27	WOS:000515477500002
J	Stower, H				Stower, Hannah			OBESITY A refocus on the rural landscape	NATURE MEDICINE			English	Editorial Material																			0	0	0	1	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	2019	25	12					1799	1799		10.1038/s41591-019-0687-9	http://dx.doi.org/10.1038/s41591-019-0687-9			1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	JT2KO	31806901	Bronze			2022-12-27	WOS:000500824900009
J	Stower, H				Stower, Hannah			A new vaping-induced syndrome	NATURE MEDICINE			English	Editorial Material																			0	0	0	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	OCT	2019	25	10					1469	1469		10.1038/s41591-019-0617-x	http://dx.doi.org/10.1038/s41591-019-0617-x			1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	JC3GJ	31591587	Bronze			2022-12-27	WOS:000489166700006
J	Cerezo-Wallis, D; Contreras-Alcalde, M; Troule, K; Catena, X; Mucientes, C; Calvo, TG; Canon, E; Tejedo, C; Pennacchi, PC; Hogan, S; Kolblinger, P; Tejero, H; Chen, AX; Ibarz, N; Grana-Castro, O; Martinez, L; Munoz, J; Ortiz-Romero, P; Rodriguez-Peralto, JL; Gomez-Lopez, G; Al-Shahrour, F; Rabadan, R; Levesque, MP; Olmeda, D; Soengas, MS				Cerezo-Wallis, Daniela; Contreras-Alcalde, Marta; Troule, Kevin; Catena, Xavier; Mucientes, Cynthia; Calvo, Tonantzin G.; Canon, Estela; Tejedo, Cristina; Pennacchi, Paula C.; Hogan, Sabrina; Koelblinger, Peter; Tejero, Hector; Chen, Andrew X.; Ibarz, Nuria; Grana-Castro, Osvaldo; Martinez, Lola; Munoz, Javier; Ortiz-Romero, Pablo; Rodriguez-Peralto, Jose L.; Gomez-Lopez, Gonzalo; Al-Shahrour, Fatima; Rabadan, Raul; Levesque, Mitchell P.; Olmeda, David; Soengas, Maria S.			Midkine rewires the melanoma microenvironment toward a tolerogenic and immune-resistant state	NATURE MEDICINE			English	Article							CELL-DIFFERENTIATION; CLINICAL-RESPONSE; CTLA-4 BLOCKADE; CANCER; INFLAMMATION; POPULATIONS; MACROPHAGES; MECHANISMS; EXPRESSION; SIGNATURES	Tumor-secreted midkine modulates immune tolerance in the melanoma tumor microenvironment and determines resistance to immune checkpoint blockade. An open question in aggressive cancers such as melanoma is how malignant cells can shift the immune system to pro-tumorigenic functions. Here we identify midkine (MDK) as a melanoma-secreted driver of an inflamed, but immune evasive, microenvironment that defines poor patient prognosis and resistance to immune checkpoint blockade. Mechanistically, MDK was found to control the transcriptome of melanoma cells, allowing for coordinated activation of nuclear factor-kappa B and downregulation of interferon-associated pathways. The resulting MDK-modulated secretome educated macrophages towards tolerant phenotypes that promoted CD8(+)T cell dysfunction. In contrast, genetic targeting of MDK sensitized melanoma cells to anti-PD-1/anti-PD-L1 treatment. Emphasizing the translational relevance of these findings, the expression profile of MDK-depleted tumors was enriched in key indicators of a good response to immune checkpoint blockers in independent patient cohorts. Together, these data reveal that MDK acts as an internal modulator of autocrine and paracrine signals that maintain immune suppression in aggressive melanomas.	[Cerezo-Wallis, Daniela; Contreras-Alcalde, Marta; Catena, Xavier; Mucientes, Cynthia; Calvo, Tonantzin G.; Canon, Estela; Tejedo, Cristina; Pennacchi, Paula C.; Olmeda, David; Soengas, Maria S.] Spanish Natl Canc Res Ctr CNIO, Mol Oncol Programme, Melanoma Lab, Madrid, Spain; [Troule, Kevin; Tejero, Hector; Grana-Castro, Osvaldo; Gomez-Lopez, Gonzalo; Al-Shahrour, Fatima] Spanish Natl Canc Res Ctr CNIO, Bioinformat Unit, Madrid, Spain; [Hogan, Sabrina; Koelblinger, Peter; Levesque, Mitchell P.] Univ Zurich Hosp, Dept Dermatol, Zurich, Switzerland; [Chen, Andrew X.; Rabadan, Raul] Columbia Univ, Coll Phys & Surg, Dept Biomed Informat, Program Math Genom,Dept Syst Biol, New York, NY USA; [Ibarz, Nuria; Martinez, Lola] Spanish Natl Canc Res Ctr CNIO, Biotechnol Programme, Prote Unit, Madrid, Spain; [Ibarz, Nuria; Martinez, Lola] ProteoRed ISCIII, Madrid, Spain; [Munoz, Javier] Spanish Natl Canc Res Ctr CNIO, Biotechnol Programme, Flow Cytometry Unit, Madrid, Spain; [Ortiz-Romero, Pablo] Univ Complutense Madrid, Med Sch, Hosp 12 Octubre, Dermatol Serv, Madrid, Spain; [Rodriguez-Peralto, Jose L.] Univ Complutense Madrid, Med Sch, Hosp 12 Octubre, Inst Invest I 12, Madrid, Spain; [Rodriguez-Peralto, Jose L.] Univ Complutense Madrid, Med Sch, Hosp 12 Octubre, Pathol Serv, Madrid, Spain	Centro Nacional de Investigaciones Oncologicas (CNIO); Centro Nacional de Investigaciones Oncologicas (CNIO); University of Zurich; University Zurich Hospital; Columbia University; Centro Nacional de Investigaciones Oncologicas (CNIO); Centro Nacional de Investigaciones Oncologicas (CNIO); Complutense University of Madrid; Hospital Universitario 12 de Octubre; Complutense University of Madrid; Hospital Universitario 12 de Octubre; Complutense University of Madrid; Hospital Universitario 12 de Octubre	Olmeda, D; Soengas, MS (corresponding author), Spanish Natl Canc Res Ctr CNIO, Mol Oncol Programme, Melanoma Lab, Madrid, Spain.	dolmeda@cnio.es; msoengas@cnio.es	Martinez, Lola/ABG-2474-2020; Martinez, Lola/L-2308-2014; Gomez-Lopez, Gonzalo/D-9123-2016; Catena, Xavier/L-1577-2017; Munoz, Javier/I-4891-2012; Cerezo-Wallis, Daniela/L-1492-2017; CONTRERAS-ALCALDE, MARTA/L-1551-2017	Martinez, Lola/0000-0001-6273-6724; Gomez-Lopez, Gonzalo/0000-0002-4146-0551; Catena, Xavier/0000-0001-7885-2447; Olmeda, David/0000-0001-5513-5621; Munoz, Javier/0000-0003-3288-3496; Hogan (Schindler), Sabrina/0000-0003-3994-8109; Cerezo-Wallis, Daniela/0000-0002-4265-6898; Grana-Castro, Osvaldo/0000-0003-1615-4242; CONTRERAS-ALCALDE, MARTA/0000-0001-6473-9320	Spanish Ministry of Economy and Innovation [SAF2017-89533-R]; Melanoma Research Alliance; Worldwide Cancer Research; Asociacion Espanola Contra el Cancer (AECC); Spanish Ministry of Health [AES-PIS PI18/1057]; Fundacion BBVA-Becas Leonardo a Investigadores y Creadores Culturales 2018; Fundacion 'La Caixa'; AECC; MINECO [SAF2013-45504-R]; Ramon y Cajal Programme (MINECO) [RYC-2012-10651]; Immutrain Marie Skodowska-Curie ITN Grant; European Union's Horizon 2020 Research and Innovation Programme [641458]; Fundacion 'La Caixa' Health Research 2019;  [PT13/0001]	Spanish Ministry of Economy and Innovation(Spanish Government); Melanoma Research Alliance; Worldwide Cancer Research; Asociacion Espanola Contra el Cancer (AECC); Spanish Ministry of Health(Instituto de Salud Carlos IIISpanish Government); Fundacion BBVA-Becas Leonardo a Investigadores y Creadores Culturales 2018; Fundacion 'La Caixa'(La Caixa Foundation); AECC; MINECO(Spanish Government); Ramon y Cajal Programme (MINECO)(Spanish Government); Immutrain Marie Skodowska-Curie ITN Grant; European Union's Horizon 2020 Research and Innovation Programme; Fundacion 'La Caixa' Health Research 2019; 	We thank the colleagues at the CNIO Melanoma Group, as well as those at the laboratories of H. Peinado and Manuel V. (CNIO), for help and support, I. Blanco, S. Ruiz, V. Granda, S. Rueda (CNIO) and the Animal Facility, Histopathological Unit, Confocal Microscopy Unit and Crystallography and Protein Engineering Unit of CNIO for assistance with the mouse colonies and histopathological and protein analyses, and D. Sancho (CNIC) for the B16-OVA<SUP>GFP</SUP> cells and OT-I mouse strain, and for scientific guidance. P. Turko (University of Zurich) provided advice on the statistical analyses of tissue microarrays. We also thank the donors and the Biobank Hospital Universitario Puerta De Hierro Majadahonda (HUPHM)/Instituto De Investigacion Sanitaria Puerta De Hierro-Segovia De Arana (IDIPHISA) (PT17/0015/0020 in the Spanish National Biobanks Network) for the human specimens used in this study. M.S.S. is funded by grants from the Spanish Ministry of Economy and Innovation (SAF2017-89533-R), Team Science and Established Investigator awards by the Melanoma Research Alliance, and grants from Worldwide Cancer Research and Fundacion 'La Caixa' Health Research 2019. M.S.S., P.O.-R. and J.L.R.-P. are funded by a collaborative grant from the Asociacion Espanola Contra el Cancer (AECC). D.O. is funded by grants from the Spanish Ministry of Health (AES-PIS PI18/1057) and 'Fundacion BBVA-Becas Leonardo a Investigadores y Creadores Culturales 2018'. D.C.-W. was a recipient of a predoctoral fellowship from Fundacion 'La Caixa' and is currently funded by the AECC. The CNIO Proteomics Unit belongs to ProteoRed, PRB2-ISCIII, supported by grant PT13/0001. N.I. and J.M. are funded by SAF2013-45504-R (MINECO). J.M. is also supported by Ramon y Cajal Programme (MINECO) RYC-2012-10651. M.C.-A. and X.C. were funded by the Immutrain Marie Skodowska-Curie ITN Grant. S.H. received funding from the European Union's Horizon 2020 Research and Innovation Programme under grant agreement number 641458.	Akbani R, 2015, CELL, V161, P1681, DOI 10.1016/j.cell.2015.05.044; Ascierto ML, 2017, CLIN CANCER RES, V23, P3168, DOI 10.1158/1078-0432.CCR-17-0270; Ayers M, 2017, J CLIN INVEST, V127, P2930, DOI 10.1172/JCI91190; Berghaus LJ, 2010, COMP IMMUNOL MICROB, V33, P443, DOI 10.1016/j.cimid.2009.07.001; Chen PL, 2016, CANCER DISCOV, V6, P827, DOI 10.1158/2159-8290.CD-15-1545; Cristescu R, 2018, SCIENCE, V362, P197, DOI 10.1126/science.aar3593; Curtsinger JM, 2012, J IMMUNOL, V189, P659, DOI 10.4049/jimmunol.1102727; Dejonckheere E, 2011, CYTOKINE GROWTH F R, V22, P73, DOI 10.1016/j.cytogfr.2011.02.002; Enamorado M, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms16073; Gajewski TF, 2013, NAT IMMUNOL, V14, P1014, DOI 10.1038/ni.2703; Gide TN, 2019, CANCER CELL, V35, P238, DOI 10.1016/j.ccell.2019.01.003; Grana O, 2018, CURR BIOINFORM, V13, P583, DOI 10.2174/1574893612666170810153850; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Guo XF, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15770-3; Hanzelmann S, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-7; Havel JJ, 2019, NAT REV CANCER, V19, P133, DOI 10.1038/s41568-019-0116-x; Herradon G, 2019, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.00377; Herrscher H, 2020, CURR OPIN ONCOL, V32, P106, DOI 10.1097/CCO.0000000000000610; Hugo W, 2016, CELL, V165, P35, DOI 10.1016/j.cell.2016.02.065; Jerby-Arnon L, 2018, CELL, V175, P984, DOI 10.1016/j.cell.2018.09.006; Jewell R, 2015, PIGM CELL MELANOMA R, V28, DOI 10.1111/pcmr.12315; Jiang P, 2018, NAT MED, V24, P1550, DOI 10.1038/s41591-018-0136-1; Jones DR, 2014, BRIT J PHARMACOL, V171, P2925, DOI 10.1111/bph.12601; Jones SA, 2018, NAT REV IMMUNOL, V18, P773, DOI 10.1038/s41577-018-0066-7; Kadomatsu Kenji, 2005, Nagoya J Med Sci, V67, P71; Kessenbrock K, 2010, CELL, V141, P52, DOI 10.1016/j.cell.2010.03.015; Lachmann A, 2010, BIOINFORMATICS, V26, P2438, DOI 10.1093/bioinformatics/btq466; Li HJ, 2019, CELL, V176, P775, DOI 10.1016/j.cell.2018.11.043; Liberzon A, 2015, CELL SYST, V1, P417, DOI 10.1016/j.cels.2015.12.004; Liersch R, 2012, INT J ONCOL, V41, P2073, DOI 10.3892/ijo.2012.1665; Liou GY, 2017, CELL REP, V19, P1322, DOI 10.1016/j.celrep.2017.04.052; Liu D, 2019, NAT MED, V25, P1916, DOI 10.1038/s41591-019-0654-5; Mantovani A, 2017, NAT REV CLIN ONCOL, V14, P399, DOI 10.1038/nrclinonc.2016.217; Mariathasan S, 2018, NATURE, V554, P544, DOI 10.1038/nature25501; Masuda T, 2017, AM J PATHOL, V187, P740, DOI 10.1016/j.ajpath.2016.12.006; Meeth K, 2016, PIGM CELL MELANOMA R, V29, P590, DOI 10.1111/pcmr.12498; Neubert NJ, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aan3311; Newman AM, 2015, NAT METHODS, V12, P453, DOI [10.1038/nmeth.3337, 10.1038/NMETH.3337]; Ohuchida T, 2004, CANCER-AM CANCER SOC, V100, P2430, DOI 10.1002/cncr.20266; Olmeda D, 2019, ANTIMETASTATIC DSRNA, DOI [10.1101/2019.12.26.887943, DOI 10.1101/2019.12.26.887943]; Olmeda D, 2017, NATURE, V546, P676, DOI 10.1038/nature22977; Orecchioni M, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01084; Perrotta C, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01186; Poh AR, 2018, FRONT ONCOL, V8, DOI 10.3389/fonc.2018.00049; Riaz N, 2017, CELL, V171, P934, DOI 10.1016/j.cell.2017.09.028; Ribas A, 2018, SCIENCE, V359, P1350, DOI 10.1126/science.aar4060; Sakamoto K, 2012, PATHOL INT, V62, P445, DOI 10.1111/j.1440-1827.2012.02815.x; Sancho D, 2009, NATURE, V458, P899, DOI 10.1038/nature07750; Shabani F, 2018, INFLAMM RES, V67, P801, DOI 10.1007/s00011-018-1173-4; Shimoni Y, 2018, PLOS COMPUT BIOL, V14, DOI 10.1371/journal.pcbi.1006026; Snyder A, 2014, NEW ENGL J MED, V371, P2189, DOI 10.1056/NEJMoa1406498; Sorrelle N, 2017, J LEUKOCYTE BIOL, V102, P277, DOI 10.1189/jlb.3MR1116-475R; Spranger S, 2018, NAT REV CANCER, V18, P139, DOI 10.1038/nrc.2017.117; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; Thommen DS, 2018, CANCER CELL, V33, P547, DOI 10.1016/j.ccell.2018.03.012; Thorsson V, 2018, IMMUNITY, V48, P812, DOI [10.1016/j.immuni.2018.03.023, 10.1016/j.immuni.2019.08.004]; Tirosh I, 2016, SCIENCE, V352, P189, DOI 10.1126/science.aad0501; Van Allen EM, 2015, SCIENCE, V350, P207, DOI 10.1126/science.aad0095; Vasan N, 2019, NATURE, V575, P299, DOI 10.1038/s41586-019-1730-1; Weckbach LT, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19092559; Weckbach LT, 2014, BLOOD, V123, P1887, DOI 10.1182/blood-2013-06-510875; Weckbach LT, 2011, THESCIENTIFICWORLDJO, V11, P2491, DOI 10.1100/2011/517152; Wei SC, 2018, CANCER DISCOV, V8, P1069, DOI 10.1158/2159-8290.CD-18-0367; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/NMETH.1322, 10.1038/nmeth.1322]; Yoshihara K, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3612; Zhao SL, 2012, CANCER IMMUNOL IMMUN, V61, P1745, DOI 10.1007/s00262-012-1235-3	66	19	21	1	16	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	2020	26	12								10.1038/s41591-020-1073-3	http://dx.doi.org/10.1038/s41591-020-1073-3		OCT 2020	39	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	PB8QO	33077955				2022-12-27	WOS:000579706700003
J	Corbett, K				Corbett, Kizzmekia			The duty to mentor, be visible and represent	NATURE MEDICINE			English	Editorial Material								Kizzmekia 'Kizzy' Corbett, a viral immunologist and research fellow, is the team lead for coronavirus research within the Viral Pathogenesis Laboratory of the Vaccine Research Center at the National Institute of Allergy and Infectious Diseases, part of the US National Institutes of Health.	[Corbett, Kizzmekia] NIAID, Coronavirus Vaccines & Immunopathogenesis Team, Viral Pathogenesis Lab, Vaccine Res Ctr,NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Corbett, K (corresponding author), NIAID, Coronavirus Vaccines & Immunopathogenesis Team, Viral Pathogenesis Lab, Vaccine Res Ctr,NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	kizzmekia.corbett@nih.gov							0	2	2	0	1	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2020	26	11					1670	1670		10.1038/s41591-020-1122-y	http://dx.doi.org/10.1038/s41591-020-1122-y		OCT 2020	1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	OT0SR	33077956	Bronze			2022-12-27	WOS:000579706700001
J	Kontis, V; Bennett, JE; Rashid, T; Parks, RM; Pearson-Stuttard, J; Guillot, M; Asaria, P; Zhou, B; Battaglini, M; Corsetti, G; McKee, M; Di Cesare, M; Mathers, CD; Ezzati, M				Kontis, Vasilis; Bennett, James E.; Rashid, Theo; Parks, Robbie M.; Pearson-Stuttard, Jonathan; Guillot, Michel; Asaria, Perviz; Zhou, Bin; Battaglini, Marco; Corsetti, Gianni; McKee, Martin; Di Cesare, Mariachiara; Mathers, Colin D.; Ezzati, Majid			Magnitude, demographics and dynamics of the effect of the first wave of the COVID-19 pandemic on all-cause mortality in 21 industrialized countries	NATURE MEDICINE			English	Article							AMBIENT-TEMPERATURE; DEATHS; EUROPE; IMPACT; WINTER	The Coronavirus Disease 2019 (COVID-19) pandemic has changed many social, economic, environmental and healthcare determinants of health. We applied an ensemble of 16 Bayesian models to vital statistics data to estimate the all-cause mortality effect of the pandemic for 21 industrialized countries. From mid-February through May 2020, 206,000 (95% credible interval, 178,100-231,000) more people died in these countries than would have had the pandemic not occurred. The number of excess deaths, excess deaths per 100,000 people and relative increase in deaths were similar between men and women in most countries. England and Wales and Spain experienced the largest effect: similar to 100 excess deaths per 100,000 people, equivalent to a 37% (30-44%) relative increase in England and Wales and 38% (31-45%) in Spain. Bulgaria, New Zealand, Slovakia, Australia, Czechia, Hungary, Poland, Norway, Denmark and Finland experienced mortality changes that ranged from possible small declines to increases of 5% or less in either sex. The heterogeneous mortality effects of the COVID-19 pandemic reflect differences in how well countries have managed the pandemic and the resilience and preparedness of the health and social care system.	[Kontis, Vasilis; Bennett, James E.; Rashid, Theo; Pearson-Stuttard, Jonathan; Asaria, Perviz; Zhou, Bin; Di Cesare, Mariachiara; Ezzati, Majid] Imperial Coll London, Sch Publ Hlth, MRC Ctr Environm & Hlth, London, England; [Parks, Robbie M.] Columbia Univ, Earth Inst, New York, NY USA; [Parks, Robbie M.] Columbia Univ, Mailman Sch Publ Hlth, Dept Environm Hlth Sci, New York, NY USA; [Guillot, Michel] French Inst Demog Studies INED, Paris, France; [Guillot, Michel] Univ Penn, Dept Sociol, Populat Studies Ctr, Philadelphia, PA 19104 USA; [Battaglini, Marco; Corsetti, Gianni] Italian Natl Inst Stat Istat, Directorate Social Stat & Populat Census, Rome, Italy; [McKee, Martin] London Sch Hyg & Trop Med, Dept Hlth Serv Res & Policy, London, England; [Di Cesare, Mariachiara] Middlesex Univ London, Dept Nat Sci, London, England; [Ezzati, Majid] Imperial Coll London, Abdul Latif Jameel Inst Dis & Emergency Analyt, London, England; [Ezzati, Majid] Univ Ghana, Reg Inst Populat Studies, Legon, Ghana	Imperial College London; Columbia University; Columbia University; University of Pennsylvania; University of London; London School of Hygiene & Tropical Medicine; Middlesex University; Imperial College London; University of Ghana	Ezzati, M (corresponding author), Imperial Coll London, Sch Publ Hlth, MRC Ctr Environm & Hlth, London, England.; Ezzati, M (corresponding author), Imperial Coll London, Abdul Latif Jameel Inst Dis & Emergency Analyt, London, England.; Ezzati, M (corresponding author), Univ Ghana, Reg Inst Populat Studies, Legon, Ghana.	majid.ezzati@imperial.ac.uk	Parks, Robbie M/AAC-2426-2019	Parks, Robbie M/0000-0002-7916-1717; Mathers, Colin/0000-0002-0617-6731; Kontis, Vasilis/0000-0002-0485-1561; Zhou, Bin/0000-0002-1741-8628	Abdul Latif Jameel Institute for Disease and Emergency Analytics at Imperial College London; Pathways to Equitable Healthy Cities grant from the Wellcome Trust [209376/Z/17/Z]; MRC [MR/S019669/1] Funding Source: UKRI	Abdul Latif Jameel Institute for Disease and Emergency Analytics at Imperial College London; Pathways to Equitable Healthy Cities grant from the Wellcome Trust; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank L. Clearly and R. Jackson for information about data from New Zealand and G. Mangiameli for help with background materials and references. This study was partially supported by the Abdul Latif Jameel Institute for Disease and Emergency Analytics at Imperial College London. The development of methodology for estimating the effect of the pandemic as an extreme event was supported by the Pathways to Equitable Healthy Cities grant from the Wellcome Trust (209376/Z/17/Z).	[Anonymous], 2018, GLOB HLTH EST DEATHS; Baker MG, 2020, NEW ZEAL MED J, V133, P10; Basu R, 2002, EPIDEMIOL REV, V24, P190, DOI 10.1093/epirev/mxf007; Basu R, 2009, ENVIRON HEALTH-GLOB, V8, DOI 10.1186/1476-069X-8-40; Bennett JE, 2014, NAT CLIM CHANGE, V4, P269, DOI [10.1038/NCLIMATE2123, 10.1038/nclimate2123]; Berlin Isaiah, 1953, HEDGEHOG FOX ESSAY T; Bernstein L., 2020, WASHINGTON POST; Bhopal SS, 2020, LANCET, V396, P532, DOI 10.1016/S0140-6736(20)31748-7; Bouffanais R, 2020, NATURE, V583, P352, DOI 10.1038/d41586-020-02072-3; Briggs A., 2020, NHS TEST TRACE JOURN; Campbell, 2020, THE GUARDIAN; Comas-Herrera A., 2020, MORTALITY ASS COVID, DOI DOI 10.1038/nrclinonc.2015.201; Congdon P., 2014, APPL BAYESIAN MODELL; Cooper J., 2019, DOES UK HEALTHCARE S; Devlin H., 2020, GUARDIAN; Douglas M, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1557; European Centre for Medium-Range Weather Forecasts, 2019, ERA5 REAN DAT; Ezzati M, 2017, LANCET, V390, P2627, DOI 10.1016/S0140-6736(17)32129-3; Feinstein CA, 2002, DEMRES, V6, P469, DOI DOI 10.4054/DemRes.2002.6.17; Fowler T, 2015, EUR J PUBLIC HEALTH, V25, P339, DOI 10.1093/eurpub/cku073; Froud J., 2020, SYSTEMS FAIL UK ACUT; Fuller T., 2020, NEW YORK TIMES; Gasparrini A, 2015, LANCET, V386, P369, DOI 10.1016/S0140-6736(14)62114-0; Gaudino M, 2020, CIRCULATION, V142, P300, DOI 10.1161/CIRCULATIONAHA.120.047865; Gebhard C, 2020, BIOL SEX DIFFER, V11, DOI 10.1186/s13293-020-00304-9; Giles C, 2020, FINANCIAL TIMES; Graefe A, 2015, INT J FORECASTING, V31, P943, DOI 10.1016/j.ijforecast.2014.12.001; Guillot M., 2020, CONVERSATION; Hale T., 2020, OXFORD COVID 19 GOVT; Hiom S, 2020, SCI BLOG; Hirsch C, 2020, EUROPES CORONAVIRUS; Hyndman R. J., 2018, FORECASTING PRINCIPL; Jones Nicola, 2020, Nature, DOI 10.1038/d41586-020-01538-8; Kansagra AP, 2020, NEW ENGL J MED, V383, P400, DOI 10.1056/NEJMc2014816; Karanikolos M., 2020, COMP IS COVID 19 MOR; Klein A., 2020, NEWSCIENTIST; Kontis V, 2017, LANCET, V389, P1323, DOI 10.1016/S0140-6736(16)32381-9; MCKEE CM, 1989, EUR J EPIDEMIOL, V5, P178, DOI 10.1007/BF00156826; McKee M, 2020, GEROSCIENCE, V42, P1217, DOI 10.1007/s11357-020-00240-x; Merrick R., 2020, INDEPENDENT; Moon J., 2020, OPTIMISING TEST TRAC; Newton J, 2020, HEADLINES COUNTING C; Nguyen DH, 2021, GEROSCIENCE, V43, P159, DOI 10.1007/s11357-020-00263-4; Nunez JH, 2020, INJURY, V51, P1414, DOI 10.1016/j.injury.2020.05.016; O'Neill D, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m2096; Office for National Statistics, 2019, Q MORT REP ENGL OCT; Office for National Statistics, 2020, COMP ALL CAUS MORT E; Okell LC, 2020, LANCET, V395, pE110, DOI 10.1016/S0140-6736(20)31357-X; Organisation for Economic Co-operation and Development, 2020, OECD INC CISTR DAT I; Organisation for Economic Co-operation and Development, 2020, HOSP BEDS; Palladino R, 2016, AGE AGEING, V45, P431, DOI 10.1093/ageing/afw044; Palmer B, 2020, CHART WEEK COVID 19; Parks RM, 2020, NAT MED, V26, P65, DOI 10.1038/s41591-019-0721-y; Parks RM, 2018, ELIFE, V7, DOI 10.7554/eLife.35500; Pearce N, 2020, INT J EPIDEMIOL, V49, P1059, DOI 10.1093/ije/dyaa108; Pell M.B., 2020, REUTERS; Perraudin F, 2020, GUARDIAN; Peto J, 2020, ROY SOC OPEN SCI, V7, DOI 10.1098/rsos.200915; Royal Society DELVE Initiative, 2020, SCOP REP HOSP HLTH C; Rue H, 2009, J R STAT SOC B, V71, P319, DOI 10.1111/j.1467-9868.2008.00700.x; Sample I., 2020, GUARDIAN; Scally G, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1932; Schultz T, 2020, DW; Song XP, 2017, SCI TOTAL ENVIRON, V586, P241, DOI 10.1016/j.scitotenv.2017.01.212; Sorbye SH, 2017, J TIME SER ANAL, V38, P923, DOI 10.1111/jtsa.12242; Timmermann A, 2006, HBK ECON, V24, P135, DOI 10.1016/S1574-0706(05)01004-9; Wang HD, 2012, LANCET, V380, P2071, DOI 10.1016/S0140-6736(12)61719-X; Whitehead M, 1991, GEOL FORENINGAN STOC; Zhou B, 2019, LANCET, V394, P639, DOI 10.1016/S0140-6736(19)31145-6; Zhou B, 2016, LANCET, V387, P1513, DOI 10.1016/S0140-6736(16)00618-8	70	187	192	6	21	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	2020	26	12								10.1038/s41591-020-1112-0	http://dx.doi.org/10.1038/s41591-020-1112-0		OCT 2020	29	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	PB8QO	33057181	Bronze, Green Submitted			2022-12-27	WOS:000577237400001
J	Stower, H				Stower, Hannah			Maturing bioelectronics	NATURE MEDICINE			English	Editorial Material																			0	0	0	0	1	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	OCT	2020	26	10					1512	1512		10.1038/s41591-020-1108-9	http://dx.doi.org/10.1038/s41591-020-1108-9			1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	QH1TN	33029023				2022-12-27	WOS:000618059800005
J	Stower, H				Stower, Hannah			Intermittent fasting passes trial	NATURE MEDICINE			English	Editorial Material												h.stower@us.nature.com							0	0	0	1	7	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	AUG	2020	26	8					1170	1170		10.1038/s41591-020-1030-1	http://dx.doi.org/10.1038/s41591-020-1030-1		AUG 2020	1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	MX8ZF	32770161	Bronze			2022-12-27	WOS:000557134700004
J	Grzymski, JJ; Elhanan, G; Rosado, JAM; Smith, E; Schlauch, KA; Read, R; Rowan, C; Slotnick, N; Dabe, S; Metcalf, WJ; Lipp, B; Reed, H; Sharma, L; Levin, E; Kao, J; Rashkin, M; Bowes, J; Dunaway, K; Slonim, A; Washington, N; Ferber, M; Bolze, A; Lu, JT				Grzymski, J. J.; Elhanan, G.; Rosado, J. A. Morales; Smith, E.; Schlauch, K. A.; Read, R.; Rowan, C.; Slotnick, N.; Dabe, S.; Metcalf, W. J.; Lipp, B.; Reed, H.; Sharma, L.; Levin, E.; Kao, J.; Rashkin, M.; Bowes, J.; Dunaway, K.; Slonim, A.; Washington, N.; Ferber, M.; Bolze, A.; Lu, J. T.			Population genetic screening efficiently identifies carriers of autosomal dominant diseases	NATURE MEDICINE			English	Article							BREAST-CANCER; RECOMMENDATION; BRCA1; MODEL	Screening for a set of autosomal-dominant genetic conditions in a large, unselected cohort of individuals uncovers carriers who were missed by routine medical care, demonstrating the utility of broad genetic screening. Three inherited autosomal dominant conditions-BRCA-related hereditary breast and ovarian cancer (HBOC), Lynch syndrome (LS) and familial hypercholesterolemia (FH)-have been termed the Centers for Disease Control and Prevention Tier 1 (CDCT1) genetic conditions, for which early identification and intervention have a meaningful potential for clinical actionability and a positive impact on public health(1). In typical medical practice, genetic testing for these conditions is based on personal or family history, ethnic background or other demographic characteristics(2). In this study of a cohort of 26,906 participants in the Healthy Nevada Project (HNP), we first evaluated whether population screening could efficiently identify carriers of these genetic conditions and, second, we evaluated the impact of genetic risk on health outcomes for these participants. We found a 1.33% combined carrier rate for pathogenic and likely pathogenic (P/LP) genetic variants for HBOC, LS and FH. Of these carriers, 21.9% of participants had clinically relevant disease, among whom 70% had been diagnosed with relevant disease before age 65. Moreover, 90% of the risk carriers had not been previously identified, and less than 19.8% of these had documentation in their medical records of inherited genetic disease risk, including family history. In a direct follow-up survey with all carriers, only 25.2% of individuals reported a family history of relevant disease. Our experience with the HNP suggests that genetic screening in patients could identify at-risk carriers, who would not be otherwise identified in routine care.	[Grzymski, J. J.; Rowan, C.; Slonim, A.] Renown Hlth, Reno, NV 89502 USA; [Grzymski, J. J.; Elhanan, G.; Smith, E.; Schlauch, K. A.; Read, R.; Slotnick, N.; Dabe, S.; Metcalf, W. J.; Lipp, B.; Reed, H.] Desert Res Inst, Reno, NV 89512 USA; [Rosado, J. A. Morales; Ferber, M.] Mayo Clin, Ctr Individualized Med, Rochester, MN USA; [Rosado, J. A. Morales; Ferber, M.] Mayo Clin, Dept Hlth Sci Res, Rochester, MN USA; [Sharma, L.; Levin, E.; Kao, J.; Rashkin, M.; Bowes, J.; Dunaway, K.; Washington, N.; Bolze, A.; Lu, J. T.] Helix, San Mateo, CA 94401 USA	Nevada System of Higher Education (NSHE); Desert Research Institute NSHE; Mayo Clinic; Mayo Clinic	Grzymski, JJ (corresponding author), Renown Hlth, Reno, NV 89502 USA.; Grzymski, JJ (corresponding author), Desert Res Inst, Reno, NV 89512 USA.; Lu, JT (corresponding author), Helix, San Mateo, CA 94401 USA.	joe.grzymski@dri.edu; james.lu@helix.com		Morales-Rosado, Joel A./0000-0002-7710-2211; Read, Robert/0000-0002-6967-5634; Dabe, Shaun/0000-0002-2494-962X; Washington, Nicole/0000-0001-8936-9143; Grzymski, Joseph/0000-0003-2646-8958	Nevada Governor's Office of Economic Development Knowledge Fund [14685]; Renown Health [GR09183]	Nevada Governor's Office of Economic Development Knowledge Fund; Renown Health	J.J.G., G.E., E.S., K.A.S., R.R., W.J.M., B.L. and H.R. were supported by grants from the Nevada Governor's Office of Economic Development Knowledge Fund (no. 14685) and by Renown Health (no. GR09183). We thank all participants in the HNP. We also thank the operational teams of the HNP and Helix.	Abul-Husn NS, 2016, SCIENCE, V354, DOI 10.1126/science.aaf7000; Andermann A, 2008, B WORLD HEALTH ORGAN, V86, P317, DOI 10.2471/BLT.07.050112; [Anonymous], 2018, GENEREVIEWS; Baciu A, 2017, COMMUNITIES ACTION P; Bennette CS, 2015, GENET MED, V17, P587, DOI 10.1038/gim.2014.156; Bibbins-Domingo K, 2016, JAMA-J AM MED ASSOC, V315, P2564, DOI 10.1001/jama.2016.5989; Biesecker LG, 2018, GENET MED, V20, P1687, DOI 10.1038/gim.2018.42; Centers for Disease Control and Prevention Office of Public Health Genomics, 2019, TIER 1 GEN APPL TOOL; Chen SN, 2007, J CLIN ONCOL, V25, P1329, DOI 10.1200/JCO.2006.09.1066; Dewey FE, 2016, SCIENCE, V354, DOI 10.1126/science.aaf6814; Fahed AC, 2011, NUTR METAB, V8, DOI 10.1186/1743-7075-8-23; Grundy SM, 2019, J AM COLL CARDIOL, V73, pE285, DOI 10.1016/j.jacc.2018.11.003; Grzymski JJ, 2018, HLTH NEVADA PROJECT, DOI [10.1101/250274, DOI 10.1101/250274]; Haase A, 2012, CURR OPIN LIPIDOL, V23, P282, DOI 10.1097/MOL.0b013e3283556c33; Helix, 2017, PERS GEN PLATF WHIT; Iacocca MA, 2017, J LIPID RES, V58, P2202, DOI 10.1194/jlr.D079301; Khoury MJ, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002631; Kuchenbaecker KB, 2017, JAMA-J AM MED ASSOC, V317, P2402, DOI 10.1001/jama.2017.7112; Lindor NM, 2010, FAM CANCER, V9, P495, DOI 10.1007/s10689-010-9348-3; Manickam K, 2018, JAMA NETW OPEN, V1, DOI 10.1001/jamanetworkopen.2018.2140; National Comprehensive Cancer Network, 2017, NCCN CLIN PRACTICE G; National Comprehensive Cancer Network, 2019, GEN FAM HIGH RISK AS; Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30; Schmidt AY, 2017, J MOL DIAGN, V19, P809, DOI 10.1016/j.jmoldx.2017.07.003; Senter L, 2008, GASTROENTEROLOGY, V135, P419, DOI 10.1053/j.gastro.2008.04.026; Siu AL, 2016, ANN INTERN MED, V164, P279, DOI 10.7326/M15-2886; Sturm AC, 2018, J AM COLL CARDIOL, V72, P662, DOI 10.1016/j.jacc.2018.05.044; Tyrer J, 2004, STAT MED, V23, P1111, DOI 10.1002/sim.1668; Versmissen J, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a2423; Zhang L, 2019, GENET MED, V21, P1958, DOI 10.1038/s41436-019-0457-6	30	63	63	1	4	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	AUG	2020	26	8					1235	+		10.1038/s41591-020-0982-5	http://dx.doi.org/10.1038/s41591-020-0982-5		JUL 2020	11	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	MX8ZF	32719484				2022-12-27	WOS:000552954000005
J	Munnink, BOB; Nieuwenhuijse, DF; Stein, M; O'Toole, A; Haverkate, M; Mollers, M; Kamga, SK; Schapendonk, C; Pronk, M; Lexmond, P; van der Linden, A; Bestebroer, T; Chestakova, I; Overmars, RJ; van Nieuwkoop, S; Molenkamp, R; van der Eijk, AA; GeurtsvanKessel, C; Vennema, H; Meijer, A; Rambaut, A; van Dissel, J; Sikkema, RS; Timen, A; Koopmans, M				Oude Munnink, Bas B.; Nieuwenhuijse, David F.; Stein, Mart; O'Toole, Aine; Haverkate, Manon; Mollers, Madelief; Kamga, Sandra K.; Schapendonk, Claudia; Pronk, Mark; Lexmond, Pascal; van der Linden, Anne; Bestebroer, Theo; Chestakova, Irina; Overmars, Ronald J.; van Nieuwkoop, Stefan; Molenkamp, Richard; van der Eijk, Annemiek A.; GeurtsvanKessel, Corine; Vennema, Harry; Meijer, Adam; Rambaut, Andrew; van Dissel, Jaap; Sikkema, Reina S.; Timen, Aura; Koopmans, Marion		Dutch-Covid-19 Response Team	Rapid SARS-CoV-2 whole-genome sequencing and analysis for informed public health decision-making in the Netherlands	NATURE MEDICINE			English	Article							VIRUS; ZIKA	The combination of near to real-time whole-genome sequence analysis and epidemiology resulted in reliable assessments of the extent of SARS-CoV-2 transmission in the community, facilitating early decision-making to control local transmission of SARS-CoV-2 in the Netherlands. In late December 2019, a cluster of cases of pneumonia of unknown etiology were reported linked to a market in Wuhan, China(1). The causative agent was identified as the speciesSevere acute respiratory syndrome-related coronavirusand was named SARS-CoV-2 (ref. (2)). By 16 April the virus had spread to 185 different countries, infected over 2,000,000 people and resulted in over 130,000 deaths(3). In the Netherlands, the first case of SARS-CoV-2 was notified on 27 February. The outbreak started with several different introductory events from Italy, Austria, Germany and France followed by local amplification in, and later also outside, the south of the Netherlands. The combination of near to real-time whole-genome sequence analysis and epidemiology resulted in reliable assessments of the extent of SARS-CoV-2 transmission in the community, facilitating early decision-making to control local transmission of SARS-CoV-2 in the Netherlands. We demonstrate how these data were generated and analyzed, and how SARS-CoV-2 whole-genome sequencing, in combination with epidemiological data, was used to inform public health decision-making in the Netherlands.	[Oude Munnink, Bas B.; Nieuwenhuijse, David F.; Schapendonk, Claudia; Pronk, Mark; Lexmond, Pascal; van der Linden, Anne; Bestebroer, Theo; Chestakova, Irina; Overmars, Ronald J.; van Nieuwkoop, Stefan; Molenkamp, Richard; van der Eijk, Annemiek A.; GeurtsvanKessel, Corine; Sikkema, Reina S.; Koopmans, Marion] ErasmusMC, Dept Virosci, WHO Collaborating Ctr Arbovirus & Viral Hemorrhag, Fever Reference & Res, Rotterdam, Netherlands; [Stein, Mart; Haverkate, Manon; Mollers, Madelief; Kamga, Sandra K.; Vennema, Harry; Meijer, Adam; van Dissel, Jaap; Timen, Aura] Natl Inst Publ Hlth & Environm, Ctr Infect Dis Control, Bilthoven, Netherlands; [O'Toole, Aine; Rambaut, Andrew] Univ Edinburgh, Inst Evolutionary Biol, Edinburgh, Midlothian, Scotland	Erasmus University Rotterdam; Erasmus MC; Netherlands National Institute for Public Health & the Environment; University of Edinburgh	Koopmans, M (corresponding author), ErasmusMC, Dept Virosci, WHO Collaborating Ctr Arbovirus & Viral Hemorrhag, Fever Reference & Res, Rotterdam, Netherlands.	m.koopmans@erasmusmc.nl	Timen, Aura/GLV-4130-2022; Munnink, Bas B Oude/H-8435-2018; Reusken, Chantal/ABD-5168-2021; Wertheim, Heiman/F-3338-2016	Reusken, Chantal/0000-0003-4605-9174; Stein, Mart L./0000-0003-0502-7993; Molenkamp, Richard/0000-0002-9004-3850; Oude Munnink, Bas/0000-0002-9394-1189; Verweij, Jaco J./0000-0001-8553-931X; Wertheim, Heiman/0000-0002-5003-5565; Nieuwenhuijse, David/0000-0003-1310-5031	European Union [874735, 848096, 101003589]; European Joint Programme One Health EJP [773830]; NIAID/NIH [HHSN272201400008C]	European Union(European Commission); European Joint Programme One Health EJP; NIAID/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank the following additional members of the Dutch-Covid-19 response team: staff of the Department of Communicable Disease Control, Public Health Service Amsterdam, MHC Amsterdam, Amsterdam; staff of the Department of Communicable Disease Control, Public Health Service Gelderland-Zuid, MHC Gelderland-Zuid, Tiel; the Laboratorium Medische Microbiologie of JBZ, MHC Hart voor Brabant, Tilburg; staff of the Department of Communicable Disease Control, Public Health Service Utrecht, MHC Regio Utrecht, Utrecht; staff of the Department of Communicable Disease Control, Public Health Service Rotterdam-Rijnmond, MHC Rotterdam-Rijnmond, Rotterdam; staff of the Department of Communicable Disease Control, Public Health Service Zaanstreek-Waterland, MHC Zaanstreek Waterland, Zaandam; staff of the Department of Communicable Disease Control, Public Health Service Brabant Zuidoost, MHC Brabant Zuidoost, Eindhoven. We gratefully acknowledge the originating laboratories, where specimens were first obtained, and the submitting laboratories, where sequence data were generated and submitted to the EpiFlu Database of the GISAID, on which this research is based. All contributors of data may be contacted directly via the GISAID website (http://platform.gisaid.org).We also acknowledge M. de Graaf for her expertise in the interpretation of the early phylogenetic analysis. B.B.O.M., R.S.S., D.F.N., R.M. and M.K. received funding from the European Union's Horizon 2020 research and innovation programme under grant agreement numbers 874735 (VEO), 848096 (SHARP JA) and 101003589 (RECoVER) and C.S., B.B.O.M. and M.K. from the European Joint Programme One Health EJP under the grant agreement number 773830 (METASTAVA). Part of this work was funded by the NIAID/NIH contract HHSN272201400008C for T.B., P.L. and M.P.	Amid C, 2019, DATABASE-OXFORD, DOI 10.1093/database/baz136; [Anonymous], COV 19; Armstrong GL, 2019, NEW ENGL J MED, V381, P2569, DOI 10.1056/NEJMsr1813907; Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; Corman VM, 2020, EUROSURVEILLANCE, V25, P23, DOI 10.2807/1560-7917.ES.2020.25.3.2000045; Dong ES, 2020, LANCET INFECT DIS, V20, P533, DOI 10.1016/S1473-3099(20)30120-1; Elbe S, 2017, GLOB CHALL, V1, P33, DOI 10.1002/gch2.1018; Faria N. R., 2018, Science (Washington), V361, P894, DOI 10.1126/science.aat7115; Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036; Gire SK, 2014, SCIENCE, V345, P1369, DOI 10.1126/science.1259657; Gorbalenya AE, 2020, NAT MICROBIOL, V5, P536, DOI 10.1038/s41564-020-0695-z; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Khoury MJ, 2018, GENET MED, V20, P574, DOI 10.1038/gim.2017.211; Koster J, 2012, BIOINFORMATICS, V28, P2520, DOI 10.1093/bioinformatics/bts480; Kraaij-Dirkzwager M, 2014, EUROSURVEILLANCE, V19, P2, DOI 10.2807/1560-7917.ES2014.19.21.20817; Nguyen LT, 2015, MOL BIOL EVOL, V32, P268, DOI 10.1093/molbev/msu300; Li H, 2018, BIOINFORMATICS, V34, P3094, DOI 10.1093/bioinformatics/bty191; Martin M, 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, 10.10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; Minh BQ, 2020, MOL BIOL EVOL, V37, P1530, DOI 10.1093/molbev/msaa015; Modjarrad K, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1001935; Munnink BBO, 2019, INFECT GENET EVOL, V73, P49, DOI 10.1016/j.meegid.2019.04.015; Munnink BBO, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-59692-y; Munnink BBO, 2020, JOVE-J VIS EXP, DOI 10.3791/60906; Polonsky JA, 2019, PHILOS T R SOC B, V374, DOI 10.1098/rstb.2018.0276; Quick J, 2017, NAT PROTOC, V12, P1261, DOI 10.1038/nprot.2017.066; Quick J, 2016, NATURE, V530, P228, DOI 10.1038/nature16996; Rambaut A, 2018, SYST BIOL, V67, P901, DOI 10.1093/sysbio/syy032; Rambaut A, 2016, VIRUS EVOL, V2, DOI 10.1093/ve/vew007; Shu YL, 2017, EUROSURVEILLANCE, V22, P2, DOI 10.2807/1560-7917.ES.2017.22.13.30494; Suchard MA, 2018, VIRUS EVOL, V4, DOI 10.1093/ve/vey016; Timen A, 2009, EMERG INFECT DIS, V15, P1171, DOI [10.3201/eid1508.090015, 10.3201/eid1508.090051]; Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017	32	135	137	2	16	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	SEP	2020	26	9								10.1038/s41591-020-0997-y	http://dx.doi.org/10.1038/s41591-020-0997-y		JUL 2020	13	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	PF3EM	32678356	Green Published, Bronze			2022-12-27	WOS:000549319200001
J	Wong, SQ; Dawson, SJ				Wong, Stephen Q.; Dawson, Sarah-Jane			Combining liquid biopsies and PET-CT for early cancer detection	NATURE MEDICINE			English	Editorial Material								A simple blood test performed alongside PET-CT imaging facilitates early cancer detection in asymptomatic women.	[Wong, Stephen Q.; Dawson, Sarah-Jane] Peter MacCallum Canc Ctr, Melbourne, Vic, Australia; [Wong, Stephen Q.; Dawson, Sarah-Jane] Univ Melbourne, Sir Peter MacCallum Dept Oncol, Melbourne, Vic, Australia; [Dawson, Sarah-Jane] Univ Melbourne, Ctr Canc Res, Melbourne, Vic, Australia	Peter Maccallum Cancer Center; Peter Maccallum Cancer Center; University of Melbourne; University of Melbourne	Dawson, SJ (corresponding author), Peter MacCallum Canc Ctr, Melbourne, Vic, Australia.; Dawson, SJ (corresponding author), Univ Melbourne, Sir Peter MacCallum Dept Oncol, Melbourne, Vic, Australia.; Dawson, SJ (corresponding author), Univ Melbourne, Ctr Canc Res, Melbourne, Vic, Australia.	sarah-jane.dawson@petermac.org		Dawson, Sarah-Jane/0000-0002-8276-0374; Wong, Stephen Q./0000-0002-7335-2168				Chabon JJ, 2020, NATURE, V580, P245, DOI 10.1038/s41586-020-2140-0; Cohen JD, 2018, SCIENCE, V359, P926, DOI 10.1126/science.aar3247; Cristiano S, 2019, NATURE, V570, P385, DOI 10.1038/s41586-019-1272-6; Dawson SJ, 2013, NEW ENGL J MED, V368, P1199, DOI 10.1056/NEJMoa1213261; Hu Z, 2020, NAT GENET, V52, P701, DOI 10.1038/s41588-020-0628-z; Lennon AM, 2020, SCIENCE, V369, P49, DOI 10.1126/science.abb9601; Liu MC, 2020, ANN ONCOL, V31, P745, DOI 10.1016/j.annonc.2020.02.011; Shen SY, 2018, NATURE, V563, P579, DOI 10.1038/s41586-018-0703-0; Srivastava S, 2019, NAT REV CANCER, V19, P349, DOI 10.1038/s41568-019-0142-8; van der Pol Y, 2019, CANCER CELL, V36, P350, DOI 10.1016/j.ccell.2019.09.003; Wong SQ, 2017, J NUCL MED, V58, P869, DOI 10.2967/jnumed.117.190116	11	5	6	2	11	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	JUL	2020	26	7					1010	1011		10.1038/s41591-020-0970-9	http://dx.doi.org/10.1038/s41591-020-0970-9		JUN 2020	2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	MK3XO	32601339				2022-12-27	WOS:000544159600004
J	Donaldson, GP; Mucida, D				Donaldson, Gregory P.; Mucida, Daniel			Local cellular cues that influence the immunology of colorectal cancer treatment	NATURE MEDICINE			English	Editorial Material							B-CELLS; IMMUNOTHERAPY; SURVIVAL	Therapeutic interventions in colorectal cancer are dependent on immune responses to dying epithelial cells that are modulated by specific members of the gut microbiota.	[Donaldson, Gregory P.; Mucida, Daniel] Rockefeller Univ, Lab Mucosal Immunol, 1230 York Ave, New York, NY 10021 USA	Rockefeller University	Donaldson, GP; Mucida, D (corresponding author), Rockefeller Univ, Lab Mucosal Immunol, 1230 York Ave, New York, NY 10021 USA.	gdonaldson@rockefeller.edu; mucida@rockefeller.edu		Mucida, Daniel/0000-0002-0000-0452				Bindea G, 2013, IMMUNITY, V39, P782, DOI 10.1016/j.immuni.2013.10.003; Cabrita R, 2020, NATURE, V577, P561, DOI 10.1038/s41586-019-1914-8; Dejea CM, 2018, SCIENCE, V359, P592, DOI 10.1126/science.aah3648; Dekker E, 2019, LANCET, V394, P1467, DOI 10.1016/S0140-6736(19)32319-0; Esterhazy D, 2019, NATURE, V569, P126, DOI 10.1038/s41586-019-1125-3; Gopalakrishnan V, 2018, SCIENCE, V359, P97, DOI 10.1126/science.aan4236; Grivennikov SI, 2012, NATURE, V491, P254, DOI 10.1038/nature11465; Helmink BA, 2020, NATURE, V577, P549, DOI 10.1038/s41586-019-1922-8; Petitprez F, 2020, NATURE, V577, P556, DOI 10.1038/s41586-019-1906-8; Roberti MP, 2020, NAT MED, V26, P919, DOI 10.1038/s41591-020-0882-8; Routy B, 2018, SCIENCE, V359, P91, DOI 10.1126/science.aan3706; Zagato E, 2020, NAT MICROBIOL, V5, P511, DOI 10.1038/s41564-019-0649-5	12	1	1	1	8	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	JUN	2020	26	6					824	826		10.1038/s41591-020-0902-8	http://dx.doi.org/10.1038/s41591-020-0902-8		MAY 2020	3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	LZ3ZG	32451500				2022-12-27	WOS:000535417400002
J	Mei, XY; Lee, HC; Diao, KY; Huang, MQ; Lin, B; Liu, CY; Xie, ZY; Ma, YX; Robson, PM; Chung, M; Bernheim, A; Mani, V; Calcagno, C; Li, KW; Li, SL; Shan, H; Lv, J; Zhao, TT; Xia, JL; Long, QH; Steinberger, S; Jacobi, A; Deyer, T; Luksza, M; Liu, F; Little, BP; Fayad, ZA; Yang, Y				Mei, Xueyan; Lee, Hao-Chih; Diao, Kai-yue; Huang, Mingqian; Lin, Bin; Liu, Chenyu; Xie, Zongyu; Ma, Yixuan; Robson, Philip M.; Chung, Michael; Bernheim, Adam; Mani, Venkatesh; Calcagno, Claudia; Li, Kunwei; Li, Shaolin; Shan, Hong; Lv, Jian; Zhao, Tongtong; Xia, Junli; Long, Qihua; Steinberger, Sharon; Jacobi, Adam; Deyer, Timothy; Luksza, Marta; Liu, Fang; Little, Brent P.; Fayad, Zahi A.; Yang, Yang			Artificial intelligence-enabled rapid diagnosis of patients with COVID-19	NATURE MEDICINE			English	Article							WUHAN	For diagnosis of coronavirus disease 2019 (COVID-19), a SARS-CoV-2 virus-specific reverse transcriptase polymerase chain reaction (RT-PCR) test is routinely used. However, this test can take up to 2 d to complete, serial testing may be required to rule out the possibility of false negative results and there is currently a shortage of RT-PCR test kits, underscoring the urgent need for alternative methods for rapid and accurate diagnosis of patients with COVID-19. Chest computed tomography (CT) is a valuable component in the evaluation of patients with suspected SARS-CoV-2 infection. Nevertheless, CT alone may have limited negative predictive value for ruling out SARS-CoV-2 infection, as some patients may have normal radiological findings at early stages of the disease. In this study, we used artificial intelligence (AI) algorithms to integrate chest CT findings with clinical symptoms, exposure history and laboratory testing to rapidly diagnose patients who are positive for COVID-19. Among a total of 905 patients tested by real-time RT-PCR assay and next-generation sequencing RT-PCR, 419 (46.3%) tested positive for SARS-CoV-2. In a test set of 279 patients, the AI system achieved an area under the curve of 0.92 and had equal sensitivity as compared to a senior thoracic radiologist. The AI system also improved the detection of patients who were positive for COVID-19 via RT-PCR who presented with normal CT scans, correctly identifying 17 of 25 (68%) patients, whereas radiologists classified all of these patients as COVID-19 negative. When CT scans and associated clinical history are available, the proposed AI system can help to rapidly diagnose COVID-19 patients. Artificial intelligence algorithms integrating chest computed tomography scans and clinical information can diagnose COVID-19 with similar accuracy as compared to a senior radiologist.	[Mei, Xueyan; Liu, Chenyu; Ma, Yixuan; Robson, Philip M.; Calcagno, Claudia; Yang, Yang] Icahn Sch Med Mt Sinai, BioMed Engn & Imaging Inst, New York, NY 10029 USA; [Lee, Hao-Chih] Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY 10029 USA; [Diao, Kai-yue] Sichuan Univ, West China Hosp, Dept Radiol, Chengdu, Peoples R China; [Huang, Mingqian; Robson, Philip M.; Chung, Michael; Bernheim, Adam; Mani, Venkatesh; Calcagno, Claudia; Steinberger, Sharon; Jacobi, Adam; Fayad, Zahi A.; Yang, Yang] Icahn Sch Med Mt Sinai, Dept Diagnost Mol & Intervent Radiol, New York, NY 10029 USA; [Lin, Bin] Zhejiang Univ, Affiliated Hosp 2, Dept Radiol, Hangzhou, Peoples R China; [Xie, Zongyu] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Radiol, Zhuhai, Peoples R China; [Li, Kunwei; Li, Shaolin; Shan, Hong] Sun Yat Sen Univ, Affiliated Hosp 1, Guangdong Prov Key Lab Biomed Imaging, Zhuhai, Peoples R China; [Lv, Jian] Nanxishan Hosp, Dept Radiol, Guilin, Peoples R China; [Zhao, Tongtong] Second Peoples Hosp, Dept Radiol, Fuyang, Peoples R China; [Xia, Junli] Bozhou Bone Trauma Hosp Image Ctr, Dept Radiol, Bozhou, Peoples R China; [Long, Qihua] Wuhan Univ, Remin Hosp, Dept Radiol, Wuhan, Peoples R China; [Deyer, Timothy] East River Med Imaging, New York, NY USA; [Deyer, Timothy] Weill Cornell Med, Dept Radiol, New York, NY USA; [Luksza, Marta] Icahn Sch Med Mt Sinai, Dept Oncol Sci, New York, NY 10029 USA; [Liu, Fang; Little, Brent P.] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Sichuan University; Icahn School of Medicine at Mount Sinai; Zhejiang University; Sun Yat Sen University; Sun Yat Sen University; Wuhan University; Cornell University; Icahn School of Medicine at Mount Sinai; Harvard University; Massachusetts General Hospital	Yang, Y (corresponding author), Icahn Sch Med Mt Sinai, BioMed Engn & Imaging Inst, New York, NY 10029 USA.; Fayad, ZA; Yang, Y (corresponding author), Icahn Sch Med Mt Sinai, Dept Diagnost Mol & Intervent Radiol, New York, NY 10029 USA.; Little, BP (corresponding author), Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA.	blittle@partners.org; zahi.fayad@mssm.edu; yang.yang@mssm.edu	Ma, Yixuan/AHD-3710-2022; Mani, Venkatesh/B-8939-2011	Ma, Yixuan/0000-0001-8156-4091; Mei, Xueyan/0000-0001-7224-7318; Mani, Venkatesh/0000-0002-0432-2918; Liu, Chenyu/0000-0002-1935-7179; lin, bin/0000-0002-3647-2144; Chung, Michael/0000-0002-0976-4088; Yang, Yang/0000-0002-2841-4243; Li, Shaolin/0000-0001-6369-0908	US National Institutes of Health [NIH/NCRR-CTSA UL1TR001433, R01-HL071021, R01-HL128056, P01-HL121478, R01-HL135878, R01-HL144072, R01-HL143814]; Astra Zeneca; Daiichi Sankyo; Alexion; Horizon Pharma; Icahn School of Medicine at Mount Sinai	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Astra Zeneca(AstraZeneca); Daiichi Sankyo(Daiichi Sankyo Company Limited); Alexion; Horizon Pharma; Icahn School of Medicine at Mount Sinai	We thank the computational support by Biomedical Engineering and Imaging Institute at Icahn School of Medicine at Mount Sinai for this work. We also acknowledge input from the Mount Sinai Covid Informatics Center. Z.A.F. was funded by US National Institutes of Health (grant NIH/NCRR-CTSA UL1TR001433, R01-HL071021, R01-HL128056, P01-HL121478, R01-HL135878, R01-HL144072 and R01-HL143814). V.M. received funding support from Astra Zeneca, Daiichi Sankyo, Alexion and Horizon Pharma. P.R. was supported by US National Institutes of Health (grant R01-HL071021). Y.Y. was supported by start-up seed fund from Icahn School of Medicine at Mount Sinai. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funding agencies had no role in study design, data collection and analysis, preparation of the manuscript or the decision to publish.	Agresti A, 1998, AM STAT, V52, P119, DOI 10.2307/2685469; Ai T, 2020, RADIOLOGY, V296, pE32, DOI 10.1148/radiol.2020200642; [Anonymous], 2020, PEDIATR MED RODZ, V16, P9, DOI 10.15557/PiMR.2020.0003; Bai Y, 2020, JAMA-J AM MED ASSOC, V323, P1406, DOI [10.1056/NEJMoa2001316, 10.1001/jama.2020.2565]; Chan JFW, 2020, LANCET, V395, P514, DOI 10.1016/S0140-6736(20)30154-9; Chung MS, 2020, EUR RADIOL, V30, P2182, DOI [10.1148/radiol.2020200230, 10.1007/s00330-019-06574-1]; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Devries T., 2017, IMPROVED REGULARIZAT; Guan W, 2020, NEW ENGL J MED, V382, P1708, DOI 10.1056/NEJMoa2002032; HE KM, 2016, PROC CVPR IEEE, P770, DOI DOI 10.1109/CVPR.2016.90; Hosmer DW, 1997, STAT MED, V16, P965; Kanne JP, 2020, RADIOLOGY, V295, P16, DOI 10.1148/radiol.2020200241; Kingma DP., 2014, ADAM METHOD STOCHAST; Li L., 2020, RADIOLOGY, V296, pe65, DOI 10.1148/radiol.2020200905; Liu F, 2019, RADIOL-ARTIF INTELL, V1, DOI 10.1148/ryai.2019180091; Liu F, 2018, RADIOLOGY, V289, P160, DOI 10.1148/radiol.2018172986; McNemar Q., 1962, PSYCHOL STAT; Mercaldo ND, 2007, STAT MED, V26, P2170, DOI 10.1002/sim.2677; Nishiura H, 2020, J CLIN MED, V9, DOI 10.3390/jcm9020330; OQUAB M, 2015, PROC CVPR IEEE, P685, DOI DOI 10.1109/CVPR.2015.7298668; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Phan LT, 2020, NEW ENGL J MED, V382, P872, DOI 10.1056/NEJMc2001272; Phelan AL, 2020, JAMA-J AM MED ASSOC, V323, P709, DOI 10.1001/jama.2020.1097; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; Russakovsky O, 2015, INT J COMPUT VISION, V115, P211, DOI 10.1007/s11263-015-0816-y; Song FX, 2020, RADIOLOGY, V295, P210, DOI [10.1148/radiol.2020200274, 10.1148/radiol.2020209021]; Szegedy C., 2017, AAAI, DOI DOI 10.1016/J.PATREC.2014.01.008; Tan WJ, 2020, CHINA CDC WEEKLY, V2, P61; Wang DW, 2020, J COASTAL RES, P1, DOI [10.2112/JCR-SI109-001.1, 10.1001/jama.2020.1585]; Wang Y, 2019, LANCET, DOI [10.2139/ssrn.3441821, DOI 10.2139/SSRN.3441821]; Xie XZ, 2020, RADIOLOGY, V296, pE41, DOI 10.1148/radiol.2020200343; Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017	32	414	425	18	103	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	AUG	2020	26	8					1224	+		10.1038/s41591-020-0931-3	http://dx.doi.org/10.1038/s41591-020-0931-3		MAY 2020	11	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	MX8ZF	32427924	Bronze, Green Accepted			2022-12-27	WOS:000534188700001
J	Stower, H				Stower, Hannah			CARs for macrophages	NATURE MEDICINE			English	Editorial Material																			0	1	1	3	8	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	MAY	2020	26	5					649	649		10.1038/s41591-020-0905-5	http://dx.doi.org/10.1038/s41591-020-0905-5			1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	ML1JP	32405068	Bronze			2022-12-27	WOS:000549231500010
J	Levy, S				Levy, Sharon			The role of addiction-medicine specialists in the global fight against addiction	NATURE MEDICINE			English	Editorial Material									[Levy, Sharon] Harvard Med Sch, Boston Childrens Hosp, Adolescent Subst Use & Addict Program, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard Medical School	Levy, S (corresponding author), Harvard Med Sch, Boston Childrens Hosp, Adolescent Subst Use & Addict Program, Boston, MA 02115 USA.	sharon.levy@childrens.harvard.edu		Levy, Sharon/0000-0002-7353-3161					0	0	0	0	0	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	APR	2020	26	4					456	456		10.1038/s41591-020-0830-7	http://dx.doi.org/10.1038/s41591-020-0830-7			1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	QH1UE	32273600	Bronze			2022-12-27	WOS:000618061900005
J	Ting, DSW; Carin, L; Dzau, V; Wong, TY				Ting, Daniel Shu Wei; Carin, Lawrence; Dzau, Victor; Wong, Tien Y.			Digital technology and COVID-19	NATURE MEDICINE			English	Editorial Material							INTERNET; THINGS	The past decade has allowed the development of a multitude of digital tools. Now they can be used to remediate the COVID-19 outbreak.	[Ting, Daniel Shu Wei; Wong, Tien Y.] Duke NUS Med Sch, Singapore Hlth Serv SingHlth, Singapore, Singapore; [Carin, Lawrence; Dzau, Victor] Duke Univ, Durham, NC USA; [Dzau, Victor] US Natl Acad Med, Washington, DC USA	National University of Singapore; Duke University; National Academies of Sciences, Engineering & Medicine	Ting, DSW (corresponding author), Duke NUS Med Sch, Singapore Hlth Serv SingHlth, Singapore, Singapore.	daniel.ting.s.w@singhealth.com.sg	Wong, Tien Yin/AAC-9724-2020	Wong, Tien Yin/0000-0002-8448-1264; Carin, Lawrence/0000-0001-6277-7948; Ting, Daniel Shu Wei/0000-0003-2264-7174; Bidwai, Pooja Vishal/0000-0002-3077-4395				[Anonymous], 2020, LANCET; Heaven D, 2019, NATURE, V566, P141, DOI 10.1038/d41586-019-00447-9; Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5; LeCun Y., 2015, DEEP LEARNING NATURE, V521, P436, DOI [DOI 10.1038/NATURE14539, 10.1038/nature14539]; Perkel JM, 2017, NATURE, V542, P125, DOI 10.1038/542125a; Shilo S, 2020, NAT MED, V26, P29, DOI 10.1038/s41591-019-0727-5; Ting DSW, 2020, LANCET DIGIT HEALTH, V2, pE8, DOI 10.1016/S2589-7500(19)30217-1; Ting DSW, 2018, NAT MED, V24, P539, DOI 10.1038/s41591-018-0029-3; Wu JT, 2020, LANCET, V395, P689, DOI 10.1016/S0140-6736(20)30260-9	9	516	532	15	106	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	APR	2020	26	4					459	461		10.1038/s41591-020-0824-5	http://dx.doi.org/10.1038/s41591-020-0824-5		MAR 2020	3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	QH1UE	32284618	Green Published, Bronze			2022-12-27	WOS:000521834100001
J	Stower, H				Stower, Hannah			Snake venom-producing organoids	NATURE MEDICINE			English	Editorial Material																			0	0	0	0	2	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	FEB	2020	26	2					163	163		10.1038/s41591-020-0780-0	http://dx.doi.org/10.1038/s41591-020-0780-0			1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	KK7DU	32047322	Bronze			2022-12-27	WOS:000512899200030
J	Laperle, AH; Sances, S; Yucer, N; Dardov, VJ; Garcia, VJ; Ho, R; Fulton, AN; Jones, MR; Roxas, KM; Avalos, P; West, D; Banuelos, MG; Shu, Z; Murali, R; Maidment, NT; Van Eyk, JE; Tagliati, M; Svendsen, CN				Laperle, A. H.; Sances, S.; Yucer, N.; Dardov, V. J.; Garcia, V. J.; Ho, R.; Fulton, A. N.; Jones, M. R.; Roxas, K. M.; Avalos, P.; West, D.; Banuelos, M. G.; Shu, Z.; Murali, R.; Maidment, N. T.; Van Eyk, J. E.; Tagliati, M.; Svendsen, C. N.			iPSC modeling of young-onset Parkinson's disease reveals a molecular signature of disease and novel therapeutic candidates	NATURE MEDICINE			English	Article							PLURIPOTENT STEM-CELLS; ALPHA-SYNUCLEIN; DOPAMINE NEURONS; LYSOSOMAL DYSFUNCTION; EXPRESSION; AUTOPHAGY; DEGRADATION; GLUCOCEREBROSIDASE; MITOCHONDRIAL; METAANALYSIS	Young-onset Parkinson's disease (YOPD), defined by onset at <50 years, accounts for approximately 10% of all Parkinson's disease cases and, while some cases are associated with known genetic mutations, most are not. Here induced pluripotent stem cells were generated from control individuals and from patients with YOPD with no known mutations. Following differentiation into cultures containing dopamine neurons, induced pluripotent stem cells from patients with YOPD showed increased accumulation of soluble alpha-synuclein protein and phosphorylated protein kinase C alpha, as well as reduced abundance of lysosomal membrane proteins such as LAMP1. Testing activators of lysosomal function showed that specific phorbol esters, such as PEP005, reduced alpha-synuclein and phosphorylated protein kinase C alpha levels while increasing LAMP1 abundance. Interestingly, the reduction in alpha-synuclein occurred through proteasomal degradation. PEP005 delivery to mouse striatum also decreased alpha-synuclein production in vivo. Induced pluripotent stem cell-derived dopaminergic cultures reveal a signature in patients with YOPD who have no known Parkinson's disease-related mutations, suggesting that there might be other genetic contributions to this disorder. This signature was normalized by specific phorbol esters, making them promising therapeutic candidates. iPSC-derived midbrain dopaminergic neurons from patients with young-onset Parkinson's disease exhibit molecular abnormalities, including elevated alpha-synuclein and lysosomal dysfunction, which can be normalized with phorbol ester treatment.	[Laperle, A. H.; Sances, S.; Yucer, N.; Dardov, V. J.; Garcia, V. J.; Ho, R.; Fulton, A. N.; Roxas, K. M.; Avalos, P.; West, D.; Banuelos, M. G.; Svendsen, C. N.] Cedars Sinai Board Governors Regenerat Med Inst, Los Angeles, CA 90048 USA; [Jones, M. R.; Murali, R.; Van Eyk, J. E.] Cedars Sinai Med Ctr, Dept Biomed Sci, Los Angeles, CA 90048 USA; [Jones, M. R.] Cedars Sinai Med Ctr, Ctr Bioinformat & Funct Genom, Los Angeles, CA 90048 USA; [Shu, Z.; Maidment, N. T.] Univ Calif Los Angeles, Dept Psychiat & Biobehav Sci, Semel Inst Neurosci & Human Behav, Los Angeles, CA 90024 USA; [Murali, R.] Samuel Oschin Comprehens Canc Inst, Los Angeles, CA USA; [Murali, R.] Cedars Sinai Med Ctr, Div Immunol Res, Los Angeles, CA 90048 USA; [Van Eyk, J. E.] Cedars Sinai Med Ctr, Dept Med, Los Angeles, CA 90048 USA; [Van Eyk, J. E.] Cedars Sinai Med Ctr, Smidt Heart Inst, Los Angeles, CA 90048 USA; [Tagliati, M.] Cedars Sinai Med Ctr, Dept Neurol, Los Angeles, CA 90048 USA	Cedars Sinai Medical Center; Cedars Sinai Medical Center; University of California System; University of California Los Angeles; Cedars Sinai Medical Center; Cedars Sinai Medical Center; Cedars Sinai Medical Center; Cedars Sinai Medical Center; Cedars Sinai Medical Center	Svendsen, CN (corresponding author), Cedars Sinai Board Governors Regenerat Med Inst, Los Angeles, CA 90048 USA.	clive.svendsen@cshs.org	Shu, Zhan/AAL-3225-2021	Shu, Zhan/0000-0001-6195-3233; Ho, Ritchie/0000-0003-1496-4436; Tagliati, Michele/0000-0002-6722-8208; Laperle, Alexander/0000-0003-1983-5844; Murali, Ramachandran/0000-0002-8384-2793	Joseph Drown Foundation; Board of Governors Regenerative Medicine Institute; National Institutes of Health [5UG3NS105703-02]	Joseph Drown Foundation; Board of Governors Regenerative Medicine Institute; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank S. Svendsen for critical input and editing of the manuscript and T. Pierson for consultation on protein degradation and additional editing of the manuscript. We also thank A. Singleton and D. Hernandez for NeuroX analysis and WGS of patient samples, R. Holewinski for assistance with proteomic analysis and sample acquisition, V. Mattis and H. Park for assisting with striatal dissections, D. Torolina for sectioning and staining of mouse brains and G. Lawless for assistance with ELISA assays. We also thank the Cedars-Sinai Proteomics and Metabolomics Core. The majority of this work was supported by the Joseph Drown Foundation (C.N.S.) and the Board of Governors Regenerative Medicine Institute (C.N.S.) and a National Institutes of Health grant, 5UG3NS105703-02 (C.N.S.). Support for the clinical sample collection and patient information came from the Widjaja Family Foundation (M.T.). Support for the proteomics analysis was from the Advanced Clinical Biosystems Institute (J.E.V.E.).	Alcalay RN, 2010, ARCH NEUROL-CHICAGO, V67, P1116, DOI 10.1001/archneurol.2010.194; Asati V, 2016, EUR J MED CHEM, V109, P314, DOI 10.1016/j.ejmech.2016.01.012; Barrett R, 2014, STEM CELL TRANSL MED, V3, P1429, DOI 10.5966/sctm.2014-0121; Bennett MC, 1999, J BIOL CHEM, V274, P33855, DOI 10.1074/jbc.274.48.33855; Burbulla LF, 2017, SCIENCE, V357, P1255, DOI 10.1126/science.aam9080; Byers B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026159; Chang D, 2017, NAT GENET, V49, P1511, DOI 10.1038/ng.3955; Chesselet MF, 2012, NEUROTHERAPEUTICS, V9, P297, DOI 10.1007/s13311-012-0104-2; Deary Ian J, 2007, BMC Geriatr, V7, P28, DOI 10.1186/1471-2318-7-28; Decressac M, 2013, P NATL ACAD SCI USA, V110, pE1817, DOI 10.1073/pnas.1305623110; Dehay B, 2013, MOVEMENT DISORD, V28, P725, DOI 10.1002/mds.25462; Devine MJ, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1453; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Ebert AD, 2009, NATURE, V457, P277, DOI 10.1038/nature07677; Fujimori K, 2018, NAT MED, V24, P1579, DOI 10.1038/s41591-018-0140-5; Garg R, 2014, ONCOGENE, V33, P5225, DOI 10.1038/onc.2013.524; Halskau O, 2009, J BIOL CHEM, V284, P32758, DOI 10.1074/jbc.M109.027706; Hampson P, 2010, APOPTOSIS, V15, P946, DOI 10.1007/s10495-010-0507-7; Ho R, 2016, NAT NEUROSCI, V19, P1256, DOI 10.1038/nn.4345; Holm Liisa, 2006, Curr Protoc Bioinformatics, VChapter 5, DOI 10.1002/0471250953.bi0505s14; Imaizumi Y, 2012, MOL BRAIN, V5, DOI 10.1186/1756-6606-5-35; Ishikawa KI, 2018, METHODS MOL BIOL, V1759, P59, DOI 10.1007/7651_2017_10; Jiang GC, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005066; Kalia LV, 2015, LANCET, V386, P896, DOI 10.1016/S0140-6736(14)61393-3; Kikuchi T, 2017, NATURE, V548, P592, DOI 10.1038/nature23664; Kim DE, 2004, NUCLEIC ACIDS RES, V32, pW526, DOI 10.1093/nar/gkh468; Kim K, 2010, NATURE, V467, P285, DOI 10.1038/nature09342; Kriks S, 2011, NATURE, V480, P547, DOI 10.1038/nature10648; Lashuel HA, 2013, NAT REV NEUROSCI, V14, P38, DOI 10.1038/nrn3406; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li Y, 2016, NAT CELL BIOL, V18, P1065, DOI 10.1038/ncb3407; Li YH, 2011, ACTA NEUROL BELG, V111, P130; Mak SK, 2010, J BIOL CHEM, V285, P13621, DOI 10.1074/jbc.M109.074617; Marshall J, 2002, MOL THER, V6, P179, DOI 10.1006/mthe.2002.0650; Mazzulli JR, 2016, P NATL ACAD SCI USA, V113, P1931, DOI 10.1073/pnas.1520335113; Mazzulli JR, 2011, CELL, V146, P37, DOI 10.1016/j.cell.2011.06.001; Morin A, 2013, ELIFE, V2, DOI 10.7554/eLife.01456; Murphy KE, 2014, BRAIN, V137, P834, DOI 10.1093/brain/awt367; Nalls MA, 2019, LANCET NEUROL, V18, P1091, DOI 10.1016/S1474-4422(19)30320-5; Nalls MA, 2015, NEUROBIOL AGING, V36, DOI 10.1016/j.neurobiolaging.2014.07.028; Oliveira LMA, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.318; Ostrerova N, 1999, J NEUROSCI, V19, P5782, DOI 10.1523/JNEUROSCI.19-14-05782.1999; Pagano G, 2016, NEUROLOGY, V86, P1400, DOI 10.1212/WNL.0000000000002461; Parker SJ, 2016, PROTEOMICS, V16, P2221, DOI 10.1002/pmic.201600007; Puschmann A, 2013, PARKINSONISM RELAT D, V19, P407, DOI 10.1016/j.parkreldis.2013.01.020; Reyes S, 2012, J COMP NEUROL, V520, P2591, DOI 10.1002/cne.23051; Ridge PG, 2018, CURR GENET MED REP, V6, P1, DOI 10.1007/s40142-018-0132-2; Rizek P, 2016, CAN MED ASSOC J, V188, P1157, DOI 10.1503/cmaj.151179; Roczniak-Ferguson A, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002790; Sanchez-Danes A, 2012, EMBO MOL MED, V4, P380, DOI 10.1002/emmm.201200215; Sanders LH, 2014, NEUROBIOL DIS, V62, P381, DOI 10.1016/j.nbd.2013.10.013; Sarkar S, 2007, NAT CHEM BIOL, V3, P331, DOI 10.1038/nchembio883; Sarkar S, 2007, J BIOL CHEM, V282, P5641, DOI 10.1074/jbc.M609532200; Scheuer T, 2011, SEMIN CELL DEV BIOL, V22, P160, DOI 10.1016/j.semcdb.2010.10.002; Schneider BL, 2007, HUM MOL GENET, V16, P651, DOI 10.1093/hmg/ddm008; Schondorf DC, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5028; Schrag A, 2006, LANCET NEUROL, V5, P355, DOI 10.1016/S1474-4422(06)70411-2; Schubert OT, 2015, NAT PROTOC, V10, DOI 10.1038/nprot.2015.015; Schwab AJ, 2015, STEM CELL REP, V5, P1039, DOI 10.1016/j.stemcr.2015.11.004; Shi Y, 2017, NAT REV DRUG DISCOV, V16, P115, DOI 10.1038/nrd.2016.245; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Soldner F, 2009, CELL, V136, P964, DOI 10.1016/j.cell.2009.02.013; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Studer L, 2015, CELL STEM CELL, V16, P591, DOI 10.1016/j.stem.2015.05.004; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Suzuki S, 2017, BIOCHEM BIOPH RES CO, V483, P88, DOI 10.1016/j.bbrc.2016.12.188; Teo GS, 2015, J PROTEOMICS, V129, P108, DOI 10.1016/j.jprot.2015.09.013; Webb JL, 2003, J BIOL CHEM, V278, P25009, DOI 10.1074/jbc.M300227200; Wong YC, 2017, NAT MED, V23, P151, DOI 10.1038/nm.4269; Woodard CM, 2014, CELL REP, V9, P1173, DOI 10.1016/j.celrep.2014.10.023; Xilouri M, 2013, MOL NEUROBIOL, V47, P537, DOI 10.1007/s12035-012-8341-2; Xu Y, 2019, AUTOPHAGY, V15, P1017, DOI 10.1080/15548627.2019.1569928; Yu S, 2004, NEUROSCI LETT, V367, P34, DOI 10.1016/j.neulet.2004.05.118; ZHANG GG, 1995, CELL, V81, P917, DOI 10.1016/0092-8674(95)90011-X	74	56	57	0	23	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	FEB	2020	26	2					289	+		10.1038/s41591-019-0739-1	http://dx.doi.org/10.1038/s41591-019-0739-1		JAN 2020	28	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	KK7DU	31988461				2022-12-27	WOS:000510552300003
J	Baron, M; Maillet, J; Huyvaert, M; Dechaume, A; Boutry, R; Loiselle, H; Durand, E; Toussaint, B; Vaillant, E; Philippe, J; Thomas, J; Ghulam, A; Franc, S; Charpentier, G; Borys, JM; Levy-Marchal, C; Tauber, M; Scharfmann, R; Weill, J; Aubert, C; Kerr-Conte, J; Pattou, F; Roussel, R; Balkau, B; Marre, M; Boissel, M; Derhourhi, M; Gaget, S; Canouil, M; Froguel, P; Bonnefond, A				Baron, Morgane; Maillet, Julie; Huyvaert, Marlene; Dechaume, Aurelie; Boutry, Raphael; Loiselle, Helene; Durand, Emmanuelle; Toussaint, Benedicte; Vaillant, Emmanuel; Philippe, Julien; Thomas, Jeremy; Ghulam, Amjad; Franc, Sylvia; Charpentier, Guillaume; Borys, Jean-Michel; Levy-Marchal, Claire; Tauber, Maithe; Scharfmann, Raphael; Weill, Jacques; Aubert, Cecile; Kerr-Conte, Julie; Pattou, Francois; Roussel, Ronan; Balkau, Beverley; Marre, Michel; Boissel, Mathilde; Derhourhi, Mehdi; Gaget, Stefan; Canouil, Mickael; Froguel, Philippe; Bonnefond, Amelie			Loss-of-function mutations in MRAP2 are pathogenic in hyperphagic obesity with hyperglycemia and hypertension	NATURE MEDICINE			English	Article							RECEPTOR ACCESSORY PROTEIN-2; GENOME-WIDE ASSOCIATION; MELANOCORTIN RECEPTOR; INSULIN-RESISTANCE; RISK LOCI; GENETICS; DEFICIENCY; DATABASE; VARIANT; SIM1	The G-protein-coupled receptor accessory protein MRAP2 is implicated in energy control in rodents, notably via the melanocortin-4 receptor(1). Although some MRAP2 mutations have been described in people with obesity(1-3), their functional consequences on adiposity remain elusive. Using large-scale sequencing of MRAP2 in 9,418 people, we identified 23 rare heterozygous variants associated with increased obesity risk in both adults and children. Functional assessment of each variant shows that loss-of-function MRAP2 variants are pathogenic for monogenic hyperphagic obesity, hyperglycemia and hypertension. This contrasts with other monogenic forms of obesity characterized by excessive hunger, including melanocortin-4 receptor deficiency, that present with low blood pressure and normal glucose tolerance(4). The pleiotropic metabolic effect of loss-of-function mutations in MRAP2 might be due to the failure of different MRAP2-regulated G-protein-coupled receptors in various tissues including pancreatic islets.	[Baron, Morgane; Maillet, Julie; Huyvaert, Marlene; Dechaume, Aurelie; Boutry, Raphael; Loiselle, Helene; Durand, Emmanuelle; Toussaint, Benedicte; Vaillant, Emmanuel; Philippe, Julien; Boissel, Mathilde; Derhourhi, Mehdi; Gaget, Stefan; Canouil, Mickael; Froguel, Philippe; Bonnefond, Amelie] Univ Lille, European Genom Inst Diabet, Inst Pasteur Lille, CNRS,UMR 8199, Lille, France; [Thomas, Jeremy; Ghulam, Amjad] Ctr Hosp Reg Univ, Ctr Biol Pathol, Lab Biochim & Hormonol, Lille, France; [Franc, Sylvia; Charpentier, Guillaume] CERITD Ctr Etud & Rech Intensificat Traitement Di, Evry, France; [Franc, Sylvia; Charpentier, Guillaume] Univ Paris Sud, Sud Francilien Hosp, Dept Diabet, Orsay, Corbeil Essonne, France; [Borys, Jean-Michel] Fleurbaix Laventie Assoc, Laventie, France; [Levy-Marchal, Claire] Robert Debre Hosp, Dept Clin Epidemiol, Inserm, CIE 05, Paris, France; [Tauber, Maithe] Univ Toulouse III Paul Sabatier, Endocrinol Obes Bone Dis Genet & Med Gynecol, Hop Enfants, Inserm,UMR 1043, Toulouse, France; [Scharfmann, Raphael] Univ Paris 05, Inst Cochin, Inserm, U1016, Paris, France; [Weill, Jacques] Lille Hosp, Pediat Endocrine Dept, Lille, France; [Aubert, Cecile] Ildys Fdn, Roscoff, France; [Kerr-Conte, Julie; Pattou, Francois] Univ Lille, CHU Lille, EGID, Inserm,U1190, Lille, France; [Roussel, Ronan] Hop Bichat Claude Bernard, AP HP, DHU FIRE, Dept Diabetol Endocrinol & Nutr, Paris, France; [Roussel, Ronan; Marre, Michel] Inserm, U1138, Ctr Rech Cordeliers, Paris, France; [Roussel, Ronan] Univ Paris Diderot, UFR Med, Sorbonne Paris Cite, Paris, France; [Balkau, Beverley] Inserm, U1018, Ctr Res Epidemiol & Populat Hlth, Villejuif, France; [Balkau, Beverley] Univ Paris Sud, Univ Paris Saclay, Villejuif, France; [Marre, Michel] CMC Ambroise Pare, Neuilly Sur Seine, France; [Froguel, Philippe; Bonnefond, Amelie] Imperial Coll London, Sect Genom Common Dis, Dept Metab, London, England; [Philippe, Julien] Duke Univ, Med Ctr, Ctr Human Dis Modeling, Durham, NC USA	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; Universite de Lille - ISITE; CHU Lille; Centre Hospitalier Sud Francilien; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; CHU de Toulouse; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Universite de Lille - ISITE; CHU Lille; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; CHU Lille; Universite de Lille; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; Imperial College London; Duke University	Froguel, P; Bonnefond, A (corresponding author), Univ Lille, European Genom Inst Diabet, Inst Pasteur Lille, CNRS,UMR 8199, Lille, France.; Froguel, P; Bonnefond, A (corresponding author), Imperial Coll London, Sect Genom Common Dis, Dept Metab, London, England.	p.froguel@imperial.ac.uk; amelie.bonnefond@cnrs.fr	Bonnefond, Amélie/O-2784-2017; scharfmann, raphael/L-3296-2017; Philippe, Julien/R-5183-2019; Canouil, Mickaël/L-6657-2018; Pattou, Francois/O-6151-2017	Bonnefond, Amélie/0000-0001-9976-3005; Canouil, Mickaël/0000-0002-3396-4549; Pattou, Francois/0000-0001-8388-3766; Scharfmann, Raphael/0000-0001-7619-337X; Philippe, Julien/0000-0003-1906-7259; Boissel, Mathilde/0000-0001-5719-8749	French-speaking Society of Diabetes (Societe Francaise du Diabete); European Foundation for the Study of Diabetes/Lilly; French National Research Agency [ANR-10-LABX-46, ANR-10-EQPX-07-01]; European Research Council [ERC GEPIDIAB-294785, ERC Reg-Seq-715575]; FEDER; Region Nord Pas-de-Calais; Inserm	French-speaking Society of Diabetes (Societe Francaise du Diabete); European Foundation for the Study of Diabetes/Lilly(Eli Lilly); French National Research Agency(French National Research Agency (ANR)); European Research Council(European Research Council (ERC)European Commission); FEDER(European Commission); Region Nord Pas-de-Calais(Region Hauts-de-FranceEuropean Commission); Inserm(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission)	This work was supported by grants from the French-speaking Society of Diabetes (Societe Francaise du Diabete) to A.B., from the European Foundation for the Study of Diabetes/Lilly (to A.B.), from the French National Research Agency (ANR-10-LABX-46 (European Genomics Institute for Diabetes) and ANR-10-EQPX-07-01 (LIGAN-PM) to P.F.), from the European Research Council (ERC GEPIDIAB-294785 to P.F. and ERC Reg-Seq-715575 to A.B.), from FEDER (to P.F.) and from the 'Region Nord Pas-de-Calais' (to P.F.). A.B. was supported by Inserm.	Asai M, 2013, SCIENCE, V341, P275, DOI 10.1126/science.1233000; Balkau B, 1996, REV EPIDEMIOL SANTE, V44, P373; Bonnefond A, 2015, CELL METAB, V21, P357, DOI 10.1016/j.cmet.2014.12.020; Bradshaw PT, 2013, OBESITY, V21, P203, DOI 10.1002/oby.20248; Cefalu WT, 2019, DIABETES CARE, V42, pS13, DOI 10.2337/dc19-S002; Chaly AL, 2016, ELIFE, V5, DOI 10.7554/eLife.12397; Chan LF, 2009, P NATL ACAD SCI USA, V106, P6146, DOI 10.1073/pnas.0809918106; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Clement K, 2018, NAT MED, V24, P551, DOI 10.1038/s41591-018-0015-9; Geets E, 2016, MOL GENET METAB, V117, P383, DOI 10.1016/j.ymgme.2016.01.003; Greenfield JR, 2009, NEW ENGL J MED, V360, P44, DOI 10.1056/NEJMoa0803085; Agulleiro MJ, 2013, MOL ENDOCRINOL, V27, P1934, DOI 10.1210/me.2013-1099; Kuhnen P, 2016, NEW ENGL J MED, V375, P240, DOI 10.1056/NEJMoa1512693; Leger J, 1997, BRIT MED J, V315, P341; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liu XM, 2016, HUM MUTAT, V37, P235, DOI 10.1002/humu.22932; Mao YJ, 2016, CURR HYPERTENS REP, V18, DOI 10.1007/s11906-015-0622-5; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Meyre D, 2009, NAT GENET, V41, P157, DOI 10.1038/ng.301; Moustafa JSES, 2013, NAT REV ENDOCRINOL, V9, P402, DOI 10.1038/nrendo.2013.57; Ndiaye FK, 2017, MOL METAB, V6, P459, DOI 10.1016/j.molmet.2017.03.011; Novoselova TV, 2016, J ENDOCRINOL, V230, P13, DOI 10.1530/JOE-16-0057; Ravassard P, 2011, J CLIN INVEST, V121, P3589, DOI 10.1172/JCI58447; Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30; Romon M, 2004, INT J OBESITY, V28, P1227, DOI 10.1038/sj.ijo.0802725; Rouault AAJ, 2017, BBA-MOL BASIS DIS, V1863, P2462, DOI 10.1016/j.bbadis.2017.05.008; Schonnop L, 2016, OBESITY, V24, P1976, DOI 10.1002/oby.21576; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Soletto L, 2019, J ENDOCR SOC, V3, P314, DOI 10.1210/js.2018-00370; Srisai D, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00747-6; Stanley CA, 2016, J CLIN ENDOCR METAB, V101, P815, DOI 10.1210/jc.2015-3651; Sun JP, 2013, GENET EPIDEMIOL, V37, P334, DOI 10.1002/gepi.21717; Zhang JN, 2017, J ENDOCRINOL, V234, P155, DOI [10.1530/JOE-17-0131, 10.1530/joe-17-0131]	34	25	26	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2019	25	11					1733	+		10.1038/s41591-019-0622-0	http://dx.doi.org/10.1038/s41591-019-0622-0			15	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	JT2KI	31700171	Green Submitted, Green Accepted			2022-12-27	WOS:000500824300032
J	Dickerman, BA; Garcia-Albeniz, X; Logan, RW; Denaxas, S; Hernan, MA				Dickerman, Barbra A.; Garcia-Albeniz, Xabier; Logan, Roger W.; Denaxas, Spiros; Hernan, Miguel A.			Avoidable flaws in observational analyses: an application to statins and cancer	NATURE MEDICINE			English	Article							PROSTATE-CANCER; COLORECTAL-CANCER; RANDOMIZED EXPERIMENTS; TARGET TRIAL; REAL-WORLD; RISK; METAANALYSIS; VALIDATION; PROGESTIN; ESTROGEN	The increasing availability of large healthcare databases is fueling an intense debate on whether real-world data should play a role in the assessment of the benefit-risk of medical treatments. In many observational studies, for example, statin users were found to have a substantially lower risk of cancer than in meta-analyses of randomized trials. Although such discrepancies are often attributed to a lack of randomization in the observational studies, they might be explained by flaws that can be avoided by explicitly emulating a target trial (the randomized trial that would answer the question of interest). Using the electronic health records of 733,804 UK adults, we emulated a target trial of statins and cancer and compared our estimates with those obtained using previously applied analytic approaches. Over the 10-yr follow-up, 28,408 individuals developed cancer. Under the target trial approach, estimated observational analogs of intention-to-treat and per-protocol 10-yr cancer-free survival differences were -0.5% (95% confidence interval (CI) -1.0%, 0.0%) and -0.3% (95% CI -1.5%, 0.5%), respectively. By contrast, previous analytic approaches yielded estimates that appeared to be strongly protective. Our findings highlight the importance of explicitly emulating a target trial to reduce bias in the effect estimates derived from observational analyses.	[Dickerman, Barbra A.; Garcia-Albeniz, Xabier; Logan, Roger W.; Hernan, Miguel A.] Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Garcia-Albeniz, Xabier] RTI Hlth Solut, Barcelona, Spain; [Denaxas, Spiros] UCL, Inst Hlth Informat Res, London, England; [Denaxas, Spiros] UCL, Hlth Data Res UK HDR UK London, London, England; [Denaxas, Spiros] Alan Turing Inst, London, England; [Hernan, Miguel A.] Harvard TH Chan Sch Publ Hlth, Dept Biostat, Boston, MA USA; [Hernan, Miguel A.] Harvard Mit Div Hlth Sci & Technol, Boston, MA USA	Harvard University; Harvard T.H. Chan School of Public Health; Research Triangle Institute; University of London; University College London; University of London; University College London; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University	Dickerman, BA (corresponding author), Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA.	bad788@mail.harvard.edu		Garcia-Albeniz, Xabier/0000-0002-9814-2343; Dickerman, Barbra/0000-0003-2843-687X; Denaxas, Spiros/0000-0001-9612-7791	NIH [P01 CA134294]; ASISA Fellowship; NATIONAL CANCER INSTITUTE [P01CA134294] Funding Source: NIH RePORTER; ESRC [ES/L007517/1] Funding Source: UKRI; MRC [1940103] Funding Source: UKRI	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ASISA Fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This research was partly supported by NIH grant P01 CA134294. B.A.D. is supported by an ASISA Fellowship.	Bonovas S, 2008, INT J CANCER, V123, P899, DOI 10.1002/ijc.23550; Boudreau DM, 2004, CANCER-AM CANCER SOC, V100, P2308, DOI 10.1002/cncr.20271; Chen MJ, 2016, INT J CANCER, V138, P594, DOI 10.1002/ijc.29813; Clancy Z, 2013, CANCER CAUSE CONTROL, V24, P777, DOI 10.1007/s10552-013-0160-x; Collin SM, 2008, LANCET ONCOL, V9, P445, DOI 10.1016/S1470-2045(08)70104-9; Dale KM, 2006, JAMA-J AM MED ASSOC, V295, P74, DOI 10.1001/jama.295.1.74; Denaxas S, 2019, J AM MED INFORM ASSN, V26, P1545, DOI 10.1093/jamia/ocz105; Denaxas SC, 2012, INT J EPIDEMIOL, V41, P1625, DOI 10.1093/ije/dys188; Emberson JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029849; Flick ED, 2007, CANCER EPIDEM BIOMAR, V16, P2218, DOI 10.1158/1055-9965.EPI-07-0197; Flick ED, 2009, DRUGS, V69, P1445, DOI 10.2165/00003495-200969110-00004; Friis S, 2005, INT J CANCER, V114, P643, DOI 10.1002/ijc.20758; Garcia-Albeniz X, 2017, EUR J EPIDEMIOL, V32, P495, DOI 10.1007/s10654-017-0287-2; Gerstein HC, 2019, LANCET, V393, P210, DOI 10.1016/S0140-6736(18)32840-X; Graaf MR, 2004, J CLIN ONCOL, V22, P2388, DOI 10.1200/JCO.2004.02.027; Grodstein F, 1996, NEW ENGL J MED, V335, P453, DOI 10.1056/NEJM199608153350701; Hemingway H, 2018, EUR HEART J, V39, P1481, DOI 10.1093/eurheartj/ehx487; Hernan MA, 2006, BASIC CLIN PHARMACOL, V98, P237, DOI 10.1111/j.1742-7843.2006.pto_329.x; Hernan MA, 2008, EPIDEMIOLOGY, V19, P766, DOI 10.1097/EDE.0b013e3181875e61; Hernan MA, 2008, EPIDEMIOLOGY, V19, P789, DOI 10.1097/EDE.0b013e318188e85f; Hernan MA, 2016, J CLIN EPIDEMIOL, V79, P70, DOI 10.1016/j.jclinepi.2016.04.014; Hernan MA, 2016, AM J EPIDEMIOL, V183, P758, DOI 10.1093/aje/kwv254; Herrett E, 2015, INT J EPIDEMIOL, V44, P827, DOI 10.1093/ije/dyv098; Herrett E, 2010, BRIT J CLIN PHARMACO, V69, P4, DOI 10.1111/j.1365-2125.2009.03537.x; Hoffmeister M, 2007, INT J CANCER, V121, P1325, DOI 10.1002/ijc.22796; Khurana V, 2007, CHEST, V131, P1282, DOI 10.1378/chest.06-0931; Kuan V, 2019, LANCET DIGIT HEALTH, V1, pE63, DOI 10.1016/S2589-7500(19)30012-3; Mainous Arch G 3rd, 2010, Qual Prim Care, V18, P301; Maisonneuve P, 2005, NEW ENGL J MED, V353, P952; Manson JE, 2003, NEW ENGL J MED, V349, P523, DOI 10.1056/NEJMoa030808; Margulis AV, 2018, EPIDEMIOLOGY, V29, P308, DOI 10.1097/EDE.0000000000000786; Miettinen O S, 1983, Stat Med, V2, P267, DOI 10.1002/sim.4780020222; Morley KI, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110900; ONEIL M, 1995, METHOD INFORM MED, V34, P187; Poynter JN, 2005, NEW ENGL J MED, V352, P2184, DOI 10.1056/NEJMoa043792; Pradelli D, 2015, CANCER MED-US, V4, P770, DOI 10.1002/cam4.411; Robins JM, 2007, AM J EPIDEMIOL, V166, P994, DOI 10.1093/aje/kwm231; Sattar N, 2010, LANCET, V375, P735, DOI 10.1016/S0140-6736(09)61965-6; Setoguchi S, 2005, NEW ENGL J MED, V353, P952; Shannon J, 2005, AM J EPIDEMIOL, V162, P318, DOI 10.1093/aje/kwi203; Soni PD, 2019, J CLIN ONCOL, V37, P1209, DOI 10.1200/JCO.18.01074; THOMPSON WA, 1977, BIOMETRICS, V33, P463; US Food and Drug Administration, 2018, FRAM FDAS REAL WORLD; Visvanathan K, 2017, J CLIN ONCOL, V35, P1845, DOI 10.1200/JCO.2017.72.6414	44	94	94	2	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	OCT	2019	25	10					1601	+		10.1038/s41591-019-0597-x	http://dx.doi.org/10.1038/s41591-019-0597-x			17	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	JC3GJ	31591592	Green Accepted, Green Submitted			2022-12-27	WOS:000489166700029
J	Dummer, R; Lebbe, C; Atkinson, V; Mandala, M; Nathan, PD; Arance, A; Richtig, E; Yamazaki, N; Robert, C; Schadendorf, D; Tawbi, HA; Ascierto, PA; Ribas, A; Flaherty, KT; Pakhle, N; Campbell, CD; Gusenleitner, D; Masood, A; Brase, JC; Gasal, E; Long, GV				Dummer, Reinhard; Lebbe, Celeste; Atkinson, Victoria; Mandala, Mario; Nathan, Paul D.; Arance, Ana; Richtig, Erika; Yamazaki, Naoya; Robert, Caroline; Schadendorf, Dirk; Tawbi, Hussein A.; Ascierto, Paolo A.; Ribas, Antoni; Flaherty, Keith T.; Pakhle, Neha; Campbell, Catarina D.; Gusenleitner, Daniel; Masood, Aisha; Brase, Jan C.; Gasal, Eduard; Long, Georgina, V			Combined PD-1, BRAF and MEK inhibition in advanced BRAF-mutant melanoma: safety run-in and biomarker cohorts of COMBI-i	NATURE MEDICINE			English	Article							INVESTIGATOR-CHOICE CHEMOTHERAPY; ADVANCED METASTATIC MELANOMA; EXPRESSION; PEMBROLIZUMAB; DABRAFENIB; TRAMETINIB; SURVIVAL; UPDATE; IMMUNOTHERAPY; VEMURAFENIB	Immune and targeted therapies achieve long-term survival in metastatic melanoma; however, new treatment strategies are needed to improve patients' outcomes(1,2). We report on the efficacy, safety and biomarker analysis from the single-arm safety run-in (part 1;n = 9) and biomarker (part 2;n = 27) cohorts of the randomized, placebo-controlled, phase 3 COMBI-i trial (NCT02967692) of the anti-PD-1 antibody spartalizumab, in combination with the BRAF inhibitor dabrafenib and MEK inhibitor trametinib. Patients (n = 36) had previously untreated BRAF V600-mutant unresectable or metastatic melanoma. In part 1, the recommended phase 3 regimen was identified based on the incidence of dose-limiting toxicities (DLTs; primary endpoint): 400 mg of spartalizumab every 4 weeks plus 150 mg of dabrafenib twice daily plus 2 mg of trametinib once daily. Part 2 characterized changes in PD-L1 levels and CD8(+)cells following treatment (primary endpoint), and analyzed additional biomarkers. Assessments of efficacy and safety were key secondary endpoints (median follow-up, 24.3 months). Spartalizumab plus dabrafenib and trametinib led to an objective response rate (ORR) of 78%, including 44% complete responses (CRs). Grade >= 3 treatment-related adverse events (TRAEs) were experienced by 72% of patients. All patients had temporary dose modifications, and 17% permanently discontinued all three study drugs due to TRAEs. Early progression-free survival (PFS) events were associated with low tumor mutational burden/T cell-inflamed gene expression signature (GES) or high immunosuppressive tumor microenvironment (TME) GES levels at baseline; an immunosuppressive TME may also preclude CR. Overall, the efficacy, safety and on-treatment biomarker modulations associated with spartalizumab plus dabrafenib and trametinib are promising, and biomarkers that may predict long-term benefit were identified.	[Dummer, Reinhard] Univ Hosp Zurich, Skin Canc Ctr, Zurich, Switzerland; [Lebbe, Celeste] Univ Paris, Hop St Louis, AP HP, Dermatol & CIC, Paris, France; [Atkinson, Victoria] Univ Queensland, Greenslopes Private Hosp, Gallipoli Med Res Fdn, Greenslopes, Qld, Australia; [Mandala, Mario] Papa Giovanni XXIII Canc Ctr Hosp, Bergamo, Italy; [Nathan, Paul D.] Mt Vernon Canc Ctr, Northwood, Middx, England; [Arance, Ana] Hosp Clin Barcelona, Barcelona, Spain; [Richtig, Erika] Med Univ Graz, Graz, Austria; [Yamazaki, Naoya] Natl Canc Ctr, Tokyo, Japan; [Robert, Caroline] Gustave Roussy, Villejuif, France; [Robert, Caroline] Paris Sud Paris Saclay Univ, Villejuif, France; [Schadendorf, Dirk] Univ Hosp Essen, Essen, Germany; [Schadendorf, Dirk] German Canc Consortium, Heidelberg, Germany; [Tawbi, Hussein A.] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA; [Ascierto, Paolo A.] Ist Nazl Tumori IRCCS Fdn G Pascale, Naples, Italy; [Ribas, Antoni] Univ Calif Los Angeles, Los Angeles, CA USA; [Flaherty, Keith T.] Massachusetts Gen Hosp, Canc Ctr, Boston, MA 02114 USA; [Flaherty, Keith T.] Harvard Med Sch, Boston, MA 02115 USA; [Pakhle, Neha] Novartis Healthcare Private Ltd, Hyderabad, India; [Campbell, Catarina D.; Gusenleitner, Daniel] Novartis Inst BioMed Res Inc, Cambridge, MA USA; [Masood, Aisha; Gasal, Eduard] Novartis Pharmaceut, E Hanover, NJ USA; [Brase, Jan C.] Novartis Pharma AG, Basel, Switzerland; [Long, Georgina, V] Univ Sydney, Melanoma Inst Australia, Sydney, NSW, Australia; [Long, Georgina, V] Royal North Shore & Mater Hosp, Sydney, NSW, Australia	University of Zurich; University Zurich Hospital; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; University of Queensland; ASST Papa Giovanni XXIII; Mount Vernon Cancer Centre; University of Barcelona; Hospital Clinic de Barcelona; Medical University of Graz; National Cancer Center - Japan; UNICANCER; Gustave Roussy; UDICE-French Research Universities; Universite Paris Saclay; University of Duisburg Essen; Helmholtz Association; German Cancer Research Center (DKFZ); University of Texas System; UTMD Anderson Cancer Center; IRCCS Fondazione Pascale; University of California System; University of California Los Angeles; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Novartis; Novartis; Novartis; Novartis; Melanoma Institute Australia; University of Sydney; Royal North Shore Hospital	Dummer, R (corresponding author), Univ Hosp Zurich, Skin Canc Ctr, Zurich, Switzerland.	Reinhard.Dummer@usz.ch	Robert, Caroline/G-6157-2018; mandala, mario/AAB-8637-2022	Robert, Caroline/0000-0002-9493-0238; Schadendorf, Dirk/0000-0003-3524-7858; Nathan, Paul/0000-0002-2327-3250; Arance, Ana/0000-0003-2896-1957	Novartis Pharmaceuticals Corporation; Novartis Pharmaceuticals	Novartis Pharmaceuticals Corporation(Novartis); Novartis Pharmaceuticals(Novartis)	We thank the patients and their families for their participation. We also thank the study site staff, additional investigators, R. Leary, C. Unitt and S. Mahan (Next Generation Diagnostics) for their contributions. We thank K. Gibbs for biomarker sample management, as well as A. Savchenko, J. Choi, C. Wong, B. Fu, G. Gorgun and R. Ramesh for support with biomarker analyses. We thank Navigate Biopharma for DNA and RNA extraction, as well as HistoGeneX and Bioagilytix for biomarker testing. We also thank M. Voi (Novartis Pharmaceuticals) for guidance and critical review. We thank A. Lytle and A. Ghiretti (ArticulateScience LLC) for providing medical writing support, which was funded by Novartis Pharmaceuticals Corporation in accordance with Good Publication Practice guidelines (http://www.ismpp.org/gpp3). COMBI-i (NCT02967692) is sponsored by Novartis Pharmaceuticals.	Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Ascierto PA, 2020, EUR J CANCER, V126, P33, DOI 10.1016/j.ejca.2019.11.016; Ascierto PA, 2018, ONCOIMMUNOLOGY, V7, DOI 10.1080/2162402X.2018.1468955; Ascierto PA, 2019, NAT MED, V25, P941, DOI 10.1038/s41591-019-0448-9; Atkinson V, 2016, ASIA-PAC J CLIN ONCO, V12, P5, DOI 10.1111/ajco.12656; Cibulskis K, 2013, NAT BIOTECHNOL, V31, P213, DOI 10.1038/nbt.2514; Cristescu R, 2018, SCIENCE, V362, P197, DOI 10.1126/science.aar3593; Daud AI, 2016, J CLIN ONCOL, V34, P4102, DOI 10.1200/JCO.2016.67.2477; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dummer R, 2020, LANCET ONCOL, V21, P358, DOI 10.1016/S1470-2045(20)30062-0; Ferrucci PF, 2020, PIGM CELL MELANOMA R, V33, P148, DOI [10.1111/pcmr.12834, DOI 10.1111/PCMR.12834]; Gide TN, 2019, CANCER CELL, V35, P238, DOI 10.1016/j.ccell.2019.01.003; Hamid O, 2017, EUR J CANCER, V86, P37, DOI 10.1016/j.ejca.2017.07.022; Hodi FS, 2019, CANCER RES, V79, pCT037; Hu-Lieskovan S, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa4691; Kakavand H, 2015, CLIN CANCER RES, V21, P3140, DOI 10.1158/1078-0432.CCR-14-2023; Kelderman S, 2014, MOL ONCOL, V8, P1132, DOI 10.1016/j.molonc.2014.07.011; Larkin J, 2019, NEW ENGL J MED, V381, P1535, DOI 10.1056/NEJMoa1910836; Larkin J, 2018, J CLIN ONCOL, V36, P383, DOI 10.1200/JCO.2016.71.8023; Lee JH, 2017, ANN ONCOL, V28, P1130, DOI 10.1093/annonc/mdx026; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liberzon A, 2015, CELL SYST, V1, P417, DOI 10.1016/j.cels.2015.12.004; Liberzon A, 2011, BIOINFORMATICS, V27, P1739, DOI 10.1093/bioinformatics/btr260; LIN CC, 2018, ANN ONCOL, V29, P413, DOI DOI 10.1093/ANNONC/MDY288.032; Long GV, 2020, PIGM CELL MELANOMA R, V33, P148, DOI [10.1111/pcmr.12834, DOI 10.1111/PCMR.12834]; Mandala M, 2017, LAB INVEST, V97, P166, DOI 10.1038/labinvest.2016.132; Massi D, 2019, J IMMUNOTHER CANCER, V7, DOI 10.1186/s40425-019-0797-4; McArthur G, 2020, PIGM CELL MELANOMA R, V33, P148, DOI [10.1111/pcmr.12834, DOI 10.1111/PCMR.12834]; McArthur G. A, 2020, AM ASS CANC RES VIRT; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Menzies AM, 2015, ANN ONCOL, V26, P415, DOI 10.1093/annonc/mdu529; Oh S, 2020, JCO CLIN CANCER INFO, V4, P321, DOI 10.1200/CCI.19.00130; Osgood C, 2019, J CLIN ONCOL, V37, DOI 10.1200/JCO.2019.37.15_suppl.9508; Ribas A, 2019, CANCER RES, V79, DOI 10.1158/1538-7445.AM2019-4217; Ribas A, 2019, NAT MED, V25, P936, DOI 10.1038/s41591-019-0476-5; Ribas A, 2015, LANCET ONCOL, V16, P908, DOI 10.1016/S1470-2045(15)00083-2; Riester M, 2016, SOURCE CODE BIOL MED, V11, DOI 10.1186/s13029-016-0060-z; Robert C, 2019, NEW ENGL J MED, V381, P626, DOI 10.1056/NEJMoa1904059; Robert C, 2019, LANCET ONCOL, V20, P1239, DOI 10.1016/S1470-2045(19)30388-2; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Santiago-Walker A, 2016, CLIN CANCER RES, V22, P567, DOI 10.1158/1078-0432.CCR-15-0321; Schroder J, 2014, BIOINFORMATICS, V30, P1064, DOI 10.1093/bioinformatics/btt767; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sullivan RJ, 2019, NAT MED, V25, P929, DOI 10.1038/s41591-019-0474-7; Ugurel S, 2020, EUR J CANCER, V130, P126, DOI 10.1016/j.ejca.2020.02.021; Ugurel S, 2017, EUR J CANCER, V83, P247, DOI 10.1016/j.ejca.2017.06.028; Vilain RE, 2017, CLIN CANCER RES, V23, P5024, DOI 10.1158/1078-0432.CCR-16-0698; Wagle MC, 2018, NPJ PRECIS ONCOL, V2, DOI 10.1038/s41698-018-0051-4; Weber JS, 2019, ANN ONCOL, V30, P533; Wilmott JS, 2014, J IMMUNOL, V192, P2505, DOI 10.4049/jimmunol.1302616; Wilmott JS, 2012, CLIN CANCER RES, V18, P1386, DOI 10.1158/1078-0432.CCR-11-2479; Ye K, 2009, BIOINFORMATICS, V25, P2865, DOI 10.1093/bioinformatics/btp394; Yu CE, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00990	54	47	48	1	12	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	OCT	2020	26	10					1557	+		10.1038/s41591-020-1082-2	http://dx.doi.org/10.1038/s41591-020-1082-2		OCT 2020	21	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	NX8MD	33020648				2022-12-27	WOS:000575801100006
J	Stower, H				Stower, Hannah			An IBD metabolic signature	NATURE MEDICINE			English	Editorial Material																			0	0	0	0	0	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	OCT	2020	26	10					1512	1512		10.1038/s41591-020-1110-2	http://dx.doi.org/10.1038/s41591-020-1110-2			1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	QH1TN	33029025				2022-12-27	WOS:000618059800004
J	Weiss, DJ; Nelson, A; Vargas-Ruiz, CA; Gligoric, K; Bavadekar, S; Gabrilovich, E; Bertozzi-Villa, A; Rozier, J; Gibson, HS; Shekel, T; Kamath, C; Lieber, A; Schulman, K; Shao, Y; Qarkaxhija, V; Nandi, AK; Keddie, SH; Rumisha, S; Amratia, P; Arambepola, R; Chestnutt, EG; Millar, JJ; Symons, TL; Cameron, E; Battle, KE; Bhatt, S; Gething, PW				Weiss, D. J.; Nelson, A.; Vargas-Ruiz, C. A.; Gligoric, K.; Bavadekar, S.; Gabrilovich, E.; Bertozzi-Villa, A.; Rozier, J.; Gibson, H. S.; Shekel, T.; Kamath, C.; Lieber, A.; Schulman, K.; Shao, Y.; Qarkaxhija, V.; Nandi, A. K.; Keddie, S. H.; Rumisha, S.; Amratia, P.; Arambepola, R.; Chestnutt, E. G.; Millar, J. J.; Symons, T. L.; Cameron, E.; Battle, K. E.; Bhatt, S.; Gething, P. W.			Global maps of travel time to healthcare facilities	NATURE MEDICINE			English	Article							GEOGRAPHICAL INFORMATION; PHYSICAL ACCESS; OPENSTREETMAP; ACCESSIBILITY; INEQUALITIES; COMPLETENESS; MORTALITY; DISTANCE; QUALITY	Access to healthcare is a requirement for human well-being that is constrained, in part, by the allocation of healthcare resources relative to the geographically dispersed human population(1-3). Quantifying access to care globally is challenging due to the absence of a comprehensive database of healthcare facilities. We harness major data collection efforts underway by OpenStreetMap, Google Maps and academic researchers to compile the most complete collection of facility locations to date. Leveraging the geographically variable strengths of our facility datasets, we use an established methodology(4)to characterize travel time to healthcare facilities in unprecedented detail. We produce maps of travel time with and without access to motorized transport, thus characterizing travel time to healthcare for populations distributed across the wealth spectrum. We find that just 8.9% of the global population (646 million people) cannot reach healthcare within one hour if they have access to motorized transport, and that 43.3% (3.16 billion people) cannot reach a healthcare facility by foot within one hour. Our maps highlight an additional vulnerability faced by poorer individuals in remote areas and can help to estimate whether individuals will seek healthcare when it is needed, as well as providing an evidence base for efficiently distributing limited healthcare and transportation resources to underserved populations both now and in the future. A global analysis generating high-resolution maps of travel time shows that 91.1% of the world's population can reach a hospital or clinic within an hour if they have access to motorized transportation, but only 56.7% can do so by walking, highlighting additional inequities for underserved populations accessing healthcare.	[Weiss, D. J.; Vargas-Ruiz, C. A.; Bertozzi-Villa, A.; Gibson, H. S.; Nandi, A. K.; Rumisha, S.; Amratia, P.; Arambepola, R.; Chestnutt, E. G.; Millar, J. J.; Symons, T. L.] Univ Oxford, Nuffield Dept Med, Big Data Inst, Malaria Atlas Project, Oxford, England; [Weiss, D. J.; Rozier, J.; Keddie, S. H.; Cameron, E.; Gething, P. W.] Perth Childrens Hosp, Telethon Kids Inst, Nedlands, WA, Australia; [Weiss, D. J.; Cameron, E.; Gething, P. W.] Curtin Univ, Bentley, WA, Australia; [Nelson, A.] Univ Twente, ITC Fac Geoinformat Sci & Earth Observat, Dept Nat Resources, Enschede, Netherlands; [Gligoric, K.] Ecole Polytech Federale Lausanne, Swiss Fed Inst Technol Lausanne, Lausanne, Switzerland; [Bavadekar, S.; Gabrilovich, E.; Shekel, T.; Kamath, C.; Lieber, A.] Google, Mountain View, CA USA; [Bertozzi-Villa, A.; Battle, K. E.] Inst Dis Modeling, Bellevue, WA USA; [Schulman, K.] Stanford Univ, Palo Alto, CA 94304 USA; [Shao, Y.] Virginia Polytech Inst & State Univ, Dept Geog, Blacksburg, VA 24061 USA; [Qarkaxhija, V.] Vaccitech, Oxford Sci Pk, Oxford, England; [Bhatt, S.] Imperial Coll London, Dept Infect Dis Epidemiol, London, England	University of Oxford; Telethon Kids Institute; Curtin University; University of Twente; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Google Incorporated; Stanford University; Virginia Polytechnic Institute & State University; Imperial College London	Weiss, DJ (corresponding author), Univ Oxford, Nuffield Dept Med, Big Data Inst, Malaria Atlas Project, Oxford, England.; Weiss, DJ (corresponding author), Perth Childrens Hosp, Telethon Kids Inst, Nedlands, WA, Australia.; Weiss, DJ (corresponding author), Curtin Univ, Bentley, WA, Australia.	daniel.weiss@telethonkids.org.au	Gligorić, Kristina/AAL-5227-2021; Gething, Peter/ABD-2110-2020; Gething, Peter/GQR-1884-2022	Gligorić, Kristina/0000-0001-8726-740X; Gething, Peter/0000-0001-6759-5449; Keddie, Suzanne/0000-0003-1254-7794; Cameron, Ewan/0000-0002-8842-3811; Rozier, Jennifer/0000-0002-2610-7557; /0000-0002-7249-3778; Nandi, Amartya/0000-0001-6024-1699; Bhatt, Samir/0000-0002-0891-4611; Gibson, Harry/0000-0001-6779-3250; Amratia, Punam/0000-0002-5128-3288; Gabrilovich, Evgeniy/0000-0001-7933-1926; /0000-0002-6175-5648; /0000-0003-4533-9166	Google Earth Engine Research Award; Bill and Melinda Gates Foundation [OPP1197730]; MRC [MR/R015600/1] Funding Source: UKRI	Google Earth Engine Research Award(Google Incorporated); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank the OSM project organizers and its dedicated contributors for providing road and healthcare facility data that were essential for this research. The healthsites.io project greatly simplified the process of using the OSM healthcare facility locations. Funding for this work was provided by a Google Earth Engine Research Award entitled "Developing and validating an online accessibility mapping tool powered by Google Earth Engine" and from the Bill and Melinda Gates Foundation (OPP1197730).	Alegana VA, 2017, BMC MED RES METHODOL, V17, DOI 10.1186/s12874-017-0346-0; Alegana VA, 2012, INT J HEALTH GEOGR, V11, DOI 10.1186/1476-072X-11-6; Barbieri S, 2019, SCI DATA, V6, DOI 10.1038/s41597-019-0266-4; Barrington-Leigh C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180698; Battle KE, 2016, MALARIA J, V15, DOI 10.1186/s12936-015-1048-x; Brovelli MA, 2017, T GIS, V21, P191, DOI 10.1111/tgis.12182; Buzza C, 2011, J GEN INTERN MED, V26, pS648, DOI 10.1007/s11606-011-1762-1; Canavosio-Zuzelski R, 2013, ISPRS INT J GEO-INF, V2, P276, DOI 10.3390/ijgi2020276; Dijkstra E. W., 1959, NUMERISCHE MATH, V1, P269, DOI [DOI 10.1007/BF01386390, 10.1007/BF01386390]; Fullman N, 2018, LANCET, V391, P2236, DOI [10.1016/S0140-6736(18)30994-2, 10.1016/s0140-6736(18)30994-2]; Girres JF, 2010, T GIS, V14, P435, DOI 10.1111/j.1467-9671.2010.01203.x; Goodchild MF, 2007, GEOJOURNAL, V69, P211, DOI 10.1007/s10708-007-9111-y; Goodchild MF, 2012, SPAT STAT-NETH, V1, P110, DOI 10.1016/j.spasta.2012.03.002; Gorelick N, 2017, REMOTE SENS ENVIRON, V202, P18, DOI 10.1016/j.rse.2017.06.031; Gulliford Martin, 2002, J Health Serv Res Policy, V7, P186, DOI 10.1258/135581902760082517; Haklay M, 2010, ENVIRON PLANN B, V37, P682, DOI 10.1068/b35097; Haynes R, 2003, ENVIRON PLANN A, V35, P1733, DOI 10.1068/a35165; Hecht R, 2013, ISPRS INT J GEO-INF, V2, P1066, DOI 10.3390/ijgi2041066; Hulland EN, 2019, BMC MED, V17, DOI 10.1186/s12916-019-1459-6; ISO, 2013, 191572013 ISO; Jackson SP, 2013, ISPRS INT GEO-INF, V2, P507, DOI 10.3390/ijgi2020507; Johansson EW, 2020, BMC PUBLIC HEALTH, V20, DOI 10.1186/s12889-020-09043-3; Juran S, 2018, BMJ GLOB HEALTH, V3, DOI 10.1136/bmjgh-2018-000875; Kassile T, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-348; Maina J, 2019, SCI DATA, V6, DOI 10.1038/s41597-019-0142-2; Manongi R, 2014, TROP MED INT HEALTH, V19, P555, DOI 10.1111/tmi.12294; Najnin N, 2011, J HEALTH POPUL NUTR, V29, P523, DOI 10.3329/jhpn.v29i5.8907; Nelson A., 2008, TRAVEL TIME MAJOR CI; Nelson A, 2019, SCI DATA, V6, DOI 10.1038/s41597-019-0265-5; Nemet GF, 2000, SOC SCI MED, V50, P1197, DOI 10.1016/S0277-9536(99)00365-2; Noor AM, 2003, TROP MED INT HEALTH, V8, P917, DOI 10.1046/j.1365-3156.2003.01112.x; Perry B, 2000, SOC SCI MED, V50, P1177, DOI 10.1016/S0277-9536(99)00364-0; Saameli R., 2018, TECHNOLOGIES DEV INN, P53; STOCK R, 1983, SOC SCI MED, V17, P563, DOI 10.1016/0277-9536(83)90298-8; Syed ST, 2013, J COMMUN HEALTH, V38, P976, DOI 10.1007/s10900-013-9681-1; Tanser F, 2006, SOC SCI MED, V63, P691, DOI 10.1016/j.socscimed.2006.01.015; THADDEUS S, 1994, SOC SCI MED, V38, P1091, DOI 10.1016/0277-9536(94)90226-7; van Etten J, 2017, J STAT SOFTW, V76, P1, DOI 10.18637/jss.v076.i13; Wang FH, 2005, HEALTH PLACE, V11, P131, DOI 10.1016/j.healthplace.2004.02.003; Weiss DJ, 2018, NATURE, V553, P333, DOI 10.1038/nature25181; Weiss DJ, 2019, LANCET, V394, P322, DOI 10.1016/S0140-6736(19)31097-9; WHO, 2010, INCREASING ACCESS TO HEALTH WORKERS IN REMOTE AND RURAL AREAS THROUGH IMPROVED RETENTION: GLOBAL POLICY RECOMMENDATIONS, P1; Wong KLM, 2020, INT J EQUITY HEALTH, V19, DOI 10.1186/s12939-020-1123-y; Yaya S, 2016, BMJ GLOB HEALTH, V1, DOI 10.1136/bmjgh-2016-000085	44	45	45	14	24	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	2020	26	12								10.1038/s41591-020-1059-1	http://dx.doi.org/10.1038/s41591-020-1059-1		SEP 2020	11	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	PB8QO	32989313	Bronze			2022-12-27	WOS:000573494400001
J	Berard, A				Berard, Anick			The importance of generating more data on cannabis use in pregnancy	NATURE MEDICINE			English	Editorial Material								An increase in cannabis use is inevitable, and the spread of its legalization will probably result in increasing use during pregnancy. A study from Canada uses real-world data to quantify the cognitive effects on offspring ofin uterocannabis exposure.	[Berard, Anick] Univ Montreal, Fac Pharm, Montreal, PQ, Canada; [Berard, Anick] CHU Ste Justine, Montreal, PQ, Canada; [Berard, Anick] Univ Claude Bernard Lyon 1, Fac Med, Lyon, France	Universite de Montreal; Universite de Montreal; UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Berard, A (corresponding author), Univ Montreal, Fac Pharm, Montreal, PQ, Canada.; Berard, A (corresponding author), CHU Ste Justine, Montreal, PQ, Canada.; Berard, A (corresponding author), Univ Claude Bernard Lyon 1, Fac Med, Lyon, France.	anick.berard@umontreal.ca						Boukhris T, 2016, JAMA PEDIATR, V170, P117, DOI 10.1001/jamapediatrics.2015.3356; Corsi DJ, 2020, NAT MED, V26, P1536, DOI 10.1038/s41591-020-1002-5; Crume TL, 2018, J PEDIATR-US, V197, P90, DOI 10.1016/j.jpeds.2018.02.005; Fombonne E, 2001, PEDIATRICS, V107, P411, DOI 10.1542/peds.107.2.411; Friedrich J, 2016, BMC PHARMACOL TOXICO, V17, DOI 10.1186/s40360-016-0085-6; Murray RM, 2020, JAMA PSYCHIAT, V77, P777, DOI 10.1001/jamapsychiatry.2020.0339; Scheyer AF, 2019, TRENDS NEUROSCI, V42, P871, DOI 10.1016/j.tins.2019.08.010	7	3	3	0	3	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	OCT	2020	26	10					1515	1516		10.1038/s41591-020-1091-1	http://dx.doi.org/10.1038/s41591-020-1091-1		SEP 2020	2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	NX8MD	32968236				2022-12-27	WOS:000572324600001
J	Murphy, MP; Koepke, LS; Lopez, MT; Tong, XM; Ambrosi, TH; Gulati, GS; Marecic, O; Wang, YT; Ransom, RC; Hoover, MY; Steininger, H; Zhao, LM; Walkiewicz, MP; Quarto, N; Levi, B; Wan, DC; Weissman, IL; Goodman, SB; Yang, F; Longaker, MT; Chan, CKF				Murphy, Matthew P.; Koepke, Lauren S.; Lopez, Michael T.; Tong, Xinming; Ambrosi, Thomas H.; Gulati, Gunsagar S.; Marecic, Owen; Wang, Yuting; Ransom, Ryan C.; Hoover, Malachia Y.; Steininger, Holly; Zhao, Liming; Walkiewicz, Marcin P.; Quarto, Natalina; Levi, Benjamin; Wan, Derrick C.; Weissman, Irving L.; Goodman, Stuart B.; Yang, Fan; Longaker, Michael T.; Chan, Charles K. F.			Articular cartilage regeneration by activated skeletal stem cells	NATURE MEDICINE			English	Article							CHONDROCYTE IMPLANTATION; MICROFRACTURE TECHNIQUE; BONE-FORMATION; OSTEOARTHRITIS; KNEE; IDENTIFICATION; DEFECTS; REPAIR; PATHOGENESIS	Osteoarthritis (OA) is a degenerative disease resulting in irreversible, progressive destruction of articular cartilage(1). The etiology of OA is complex and involves a variety of factors, including genetic predisposition, acute injury and chronic inflammation(2-4). Here we investigate the ability of resident skeletal stem-cell (SSC) populations to regenerate cartilage in relation to age, a possible contributor to the development of osteoarthritis(5-7). We demonstrate that aging is associated with progressive loss of SSCs and diminished chondrogenesis in the joints of both mice and humans. However, a local expansion of SSCs could still be triggered in the chondral surface of adult limb joints in mice by stimulating a regenerative response using microfracture (MF) surgery. Although MF-activated SSCs tended to form fibrous tissues, localized co-delivery of BMP2 and soluble VEGFR1 (sVEGFR1), a VEGF receptor antagonist, in a hydrogel skewed differentiation of MF-activated SSCs toward articular cartilage. These data indicate that following MF, a resident stem-cell population can be induced to generate cartilage for treatment of localized chondral disease in OA. Endogenous skeletal stem cells are recruited to form cartilage in mice when stimulated by microfracture surgery together with localized delivery of growth factors, pointing to a new approach for treating cartilage defects.	[Murphy, Matthew P.; Gulati, Gunsagar S.; Marecic, Owen; Ransom, Ryan C.; Hoover, Malachia Y.; Weissman, Irving L.; Longaker, Michael T.; Chan, Charles K. F.] Stanford Univ, Sch Med, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA; [Murphy, Matthew P.; Koepke, Lauren S.; Lopez, Michael T.; Ambrosi, Thomas H.; Wang, Yuting; Ransom, Ryan C.; Steininger, Holly; Zhao, Liming; Quarto, Natalina; Wan, Derrick C.; Longaker, Michael T.; Chan, Charles K. F.] Stanford Univ, Dept Surg, Sch Med, Stanford, CA 94305 USA; [Murphy, Matthew P.] Univ Manchester, Manchester Acad Hlth Sci Ctr, Fac Biol Med & Hlth, Sch Biol Sci,Blond McIndoe Labs,Div Cell Matrix B, Manchester, Lancs, England; [Tong, Xinming; Goodman, Stuart B.; Yang, Fan] Stanford Univ, Dept Bioengn, Palo Alto, CA 94304 USA; [Wang, Yuting; Zhao, Liming] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Orthopaed Surg, Wuhan, Peoples R China; [Walkiewicz, Marcin P.] Stanford Univ, Dept Stanford Nano Shared Facil, Palo Alto, CA 94304 USA; [Levi, Benjamin] Univ Michigan, Dept Surg, Ann Arbor, MI 48109 USA; [Goodman, Stuart B.; Yang, Fan] Stanford Univ, Dept Orthopaed Surg, Palo Alto, CA 94304 USA	Stanford University; Stanford University; University of Manchester; Stanford University; Huazhong University of Science & Technology; Stanford University; University of Michigan System; University of Michigan; Stanford University	Longaker, MT; Chan, CKF (corresponding author), Stanford Univ, Sch Med, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA.; Longaker, MT; Chan, CKF (corresponding author), Stanford Univ, Dept Surg, Sch Med, Stanford, CA 94305 USA.	longaker@stanford.edu; chazchan@stanford.edu	Murphy, Matthew/ABD-5403-2021; Yang, Fan/GYU-4249-2022; Goodman, Stuart/AAZ-7499-2020; Tong, Xinming/F-4393-2016	Wan, Derrick/0000-0003-4666-1683; Goodman, Stuart/0000-0002-1919-3717; Ambrosi, Thomas/0000-0002-7149-041X; Tong, Xinming/0000-0001-7585-3866; Murphy, Matthew/0000-0003-0885-4089; Walkiewicz, Marcin/0000-0003-3710-0876; Steininger, Holly/0000-0001-8098-3753	NIH [R01 DE027323, R56 DE025597, R01 DE026730, R01 DE021683, R21 DE024230, U01HL099776, U24DE026914, R21 DE019274]; Oak Foundation; Hagey Laboratory; Pitch Johnson Fund; Gunn/Olivier Research Fund; Siebel Fellowship; PCF YI Award; Stinehart/Reed; American Federation of Aging Research and Arthritis National Research Foundation; HHMI Fellowship; German Research Foundation (DFG) Fellowship [399915929]; NIH, NIGMS [R01GM123069]; ACS Clowes Award; Department of Defense CDMRP [W81XWH-18-1-0653, OR170174]; PSRF National Endowment and Stanford TTE fellowship; National Center for Research Resources (NCRR) [1S10OD021514-01];  [CIRMTR1-01249];  [NIHNIAK99AG049958-01A1];  [NIH1R01AR071379];  [NIHS10 RR02933801]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Oak Foundation; Hagey Laboratory; Pitch Johnson Fund; Gunn/Olivier Research Fund; Siebel Fellowship; PCF YI Award; Stinehart/Reed; American Federation of Aging Research and Arthritis National Research Foundation; HHMI Fellowship(Howard Hughes Medical Institute); German Research Foundation (DFG) Fellowship(German Research Foundation (DFG)); NIH, NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); ACS Clowes Award; Department of Defense CDMRP(United States Department of Defense); PSRF National Endowment and Stanford TTE fellowship; National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); ; ; ; 	The authors thank N. Williams, C. Queen, C. Crumpton, E. Kang, M. Butcher, L. Quinn, P. Perira and R. Mann for advice and assistance, and A. McCarty, M. Alvarez, and VSC Staff for animal model support. The authors also thank M. Ekhart, and the PAN facility at Stanford for help in gene-expression analysis. In addition, the authors thank S. Goodman and the Orthopedic Department of Stanford for donation of human adult specimens. The study was supported by NIH (R01 DE027323, R56 DE025597, R01 DE026730, R01 DE021683, R21 DE024230, U01HL099776, U24DE026914 and R21 DE019274), CIRMTR1-01249, Oak Foundation, Hagey Laboratory, Pitch Johnson Fund and Gunn/Olivier Research Fund to M.T. Longaker; Siebel Fellowship, PCF YI Award, Stinehart/Reed, and NIHNIAK99AG049958-01A1, American Federation of Aging Research and Arthritis National Research Foundation to C.K.F.C.; HHMI Fellowship to G.S.G.; the German Research Foundation (DFG) Fellowship 399915929 to T.H.A.; NIH, NIGMS R01GM123069, NIH1R01AR071379, ACS Clowes Award, Department of Defense CDMRP W81XWH-18-1-0653, OR170174 to B.L; PSRF National Endowment and Stanford TTE fellowship to M.P.M.; NIHS10 RR02933801 to Stanford Stem Cell FACS core. The project was supported, in part, by Award Number 1S10OD021514-01 from the National Center for Research Resources (NCRR). Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the NCRR or the National Institutes of Health.	Adouni M, 2016, J BIOMECH, V49, P2891, DOI 10.1016/j.jbiomech.2016.06.031; Ambrosi TH, 2019, FRONT CELL DEV BIOL, V7, DOI 10.3389/fcell.2019.00189; Bijlsma JWJ, 2011, LANCET, V377, P2115, DOI 10.1016/S0140-6736(11)60243-2; Bragdon B, 2017, BONE, V101, P49, DOI 10.1016/j.bone.2017.04.002; Chan CKF, 2018, CELL, V175, P43, DOI 10.1016/j.cell.2018.07.029; Chan CKF, 2015, CELL, V160, P285, DOI 10.1016/j.cell.2014.12.002; Chandran PL, 2018, SOFT MATTER, V14, P2879, DOI 10.1039/c7sm02045g; Chung HJ, 2017, J NAT PROD, V80, P434, DOI 10.1021/acs.jnatprod.6b00964; Conrad B, 2018, TISSUE ENG PT A, V24, P1631, DOI [10.1089/ten.tea.2018.0011, 10.1089/ten.TEA.2018.0011]; Devitt BM, 2017, KNEE, V24, P508, DOI 10.1016/j.knee.2016.12.002; Eldracher M, 2014, AM J SPORT MED, V42, P2741, DOI 10.1177/0363546514547029; Fang H, 2014, NAT REV RHEUMATOL, V10, P413, DOI 10.1038/nrrheum.2014.46; Glyn-Jones S, 2015, LANCET, V386, P376, DOI 10.1016/S0140-6736(14)60802-3; Goldberg A, 2017, J ORTHOP SURG RES, V12, DOI 10.1186/s13018-017-0534-y; Gonzalez-Fernandez T, 2016, TISSUE ENG PT A, V22, P776, DOI [10.1089/ten.tea.2015.0576, 10.1089/ten.TEA.2015.0576]; Gronthos S, 2001, BONE, V28, P174, DOI 10.1016/S8756-3282(00)00424-5; Gulati GS, 2018, NAT PROTOC, V13, P1294, DOI 10.1038/nprot.2018.041; Hamilton JL, 2016, J BONE MINER RES, V31, P911, DOI 10.1002/jbmr.2828; Hoemann CD, 2015, AM J SPORT MED, V43, P2469, DOI 10.1177/0363546515593943; Hootman JM, 2016, ARTHRITIS RHEUMATOL, V68, P1582, DOI 10.1002/art.39692; Jiang YZ, 2015, NAT REV RHEUMATOL, V11, P206, DOI 10.1038/nrrheum.2014.200; Jo CH, 2014, STEM CELLS, V32, P1254, DOI 10.1002/stem.1634; Johnson VL, 2014, BEST PRACT RES CL RH, V28, P5, DOI 10.1016/j.berh.2014.01.004; Jones IA, 2019, NAT REV RHEUMATOL, V15, P77, DOI 10.1038/s41584-018-0123-4; Keeney M, 2016, J BIOMED MATER RES A, V104, P2099, DOI 10.1002/jbm.a.35735; Knutsen G, 2004, J BONE JOINT SURG AM, V86A, P455, DOI 10.2106/00004623-200403000-00001; Kratchmarova I, 2005, SCIENCE, V308, P1472, DOI 10.1126/science.1107627; Kretzschmar K, 2018, P NATL ACAD SCI USA, V115, pE12245, DOI 10.1073/pnas.1805829115; Liu-Bryan R, 2015, NAT REV RHEUMATOL, V11, P35, DOI 10.1038/nrrheum.2014.162; Loeser RF, 2017, J NAT PRODUCTS, V80, P434; Loeser RF, 2016, NAT REV RHEUMATOL, V12, P412, DOI 10.1038/nrrheum.2016.65; LURIA EA, 1987, CELL TISSUE RES, V248, P449; Makris EA, 2015, NAT REV RHEUMATOL, V11, P21, DOI 10.1038/nrrheum.2014.157; Marecic O, 2015, P NATL ACAD SCI USA, V112, P9920, DOI 10.1073/pnas.1513066112; Marques-Rocha JL, 2015, FASEB J, V29, P3595, DOI 10.1096/fj.14-260323; Marshall M, 2018, NAT REV RHEUMATOL, V14, P641, DOI 10.1038/s41584-018-0095-4; Mithoefer K, 2009, AM J SPORT MED, V37, P2053, DOI 10.1177/0363546508328414; Murray CJL, 2013, JAMA-J AM MED ASSOC, V310, P591, DOI 10.1001/jama.2013.13805; Nagai T, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/s13075-014-0427-y; Nagao M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13417-w; Pers YM, 2016, STEM CELL TRANSL MED, V5, P847, DOI 10.5966/sctm.2015-0245; Piuzzi NS, 2019, ORTHOPEDICS, V42, pE144, DOI 10.3928/01477447-20190118-04; Prockop DJ, 2010, CYTOTHERAPY, V12, P576, DOI 10.3109/14653249.2010.507330; Rahmati M, 2016, BONE, V85, P81, DOI 10.1016/j.bone.2016.01.019; Ransom RC, 2018, NAT COMMUN, V9; Ransom RC, 2018, NATURE, V563, P514, DOI 10.1038/s41586-018-0650-9; Ray A, 2015, DEVELOPMENT, V142, P1169, DOI 10.1242/dev.110940; Rinkevich Y, 2011, NATURE, V476, P409, DOI 10.1038/nature10346; Robinson WH, 2016, NAT REV RHEUMATOL, V12, P580, DOI 10.1038/nrrheum.2016.136; Sacchetti B, 2007, CELL, V131, P324, DOI 10.1016/j.cell.2007.08.025; Seita J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040321; Sipp D, 2018, NATURE, V561, P455, DOI 10.1038/d41586-018-06756-9; Steadman JR, 1999, ORTHOPADE, V28, P26, DOI 10.1007/PL00003545; Steinberg J, 2016, J ORTHOP RES, V34, P1105, DOI 10.1002/jor.23296; Taylor SEB, 2016, TISSUE ENG PT A, V22, P645, DOI [10.1089/ten.tea.2015.0366, 10.1089/ten.TEA.2015.0366]; Tevlin R, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aag2809; URIST MR, 1965, SCIENCE, V150, P893, DOI 10.1126/science.150.3698.893; Vanlauwe J, 2011, AM J SPORT MED, V39, P2566, DOI 10.1177/0363546511422220; Vega A, 2015, TRANSPLANTATION, V99, P1681, DOI 10.1097/TP.0000000000000678; Vos T, 2012, LANCET, V380, P2163, DOI 10.1016/S0140-6736(12)61729-2; Worthley DL, 2015, CELL, V160, P269, DOI 10.1016/j.cell.2014.11.042	61	80	87	16	114	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	OCT	2020	26	10					1583	+		10.1038/s41591-020-1013-2	http://dx.doi.org/10.1038/s41591-020-1013-2		AUG 2020	30	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	NX8MD	32807933	Green Accepted			2022-12-27	WOS:000560288000005
J	Centa, JL; Jodelka, FM; Hinrich, AJ; Johnson, TB; Ochaba, J; Jackson, M; Duelli, DM; Weimer, JM; Rigo, F; Hastings, ML				Centa, Jessica L.; Jodelka, Francine M.; Hinrich, Anthony J.; Johnson, Tyler B.; Ochaba, Joseph; Jackson, Michaela; Duelli, Dominik M.; Weimer, Jill M.; Rigo, Frank; Hastings, Michelle L.			Therapeutic efficacy of antisense oligonucleotides in mouse models of CLN3 Batten disease	NATURE MEDICINE			English	Article							NEURONAL CEROID-LIPOFUSCINOSIS; MEMBRANE-PROTEIN TOPOLOGY; TRANSMEMBRANE TOPOLOGY; I-TASSER; PREDICTION; AUTOPHAGY; MICE; NEURODEGENERATION; DEPOSITION; PHENOTYPE	CLN3 Batten disease is an autosomal recessive, neurodegenerative, lysosomal storage disease caused by mutations inCLN3, which encodes a lysosomal membrane protein(1-3). There are no disease-modifying treatments for this disease that affects up to 1 in 25,000 births, has an onset of symptoms in early childhood and typically is fatal by 20-30 years of life(4-7). Most patients with CLN3 Batten have a deletion encompassing exons 7 and 8 (CLN3 (increment ex7/8)), creating a reading frameshift(7,8). Here we demonstrate that mice with this deletion can be effectively treated using an antisense oligonucleotide (ASO) that induces exon skipping to restore the open reading frame. A single treatment of neonatal mice with an exon 5-targeted ASO-induced robust exon skipping for more than a year, improved motor coordination, reduced histopathology inCln3 (increment ex7/8)mice and increased survival in a new mouse model of the disease. ASOs also induced exon skipping in cell lines derived from patients with CLN3 Batten disease. Our findings demonstrate the utility of ASO-based reading-frame correction as an approach to treat CLN3 Batten disease and broaden the therapeutic landscape for ASOs in the treatment of other diseases using a similar strategy. An antisense oligonucleotide induces exon skipping in cell lines derived from patients with CLN3 Batten disease, and reduces lysosomal impairment and ameliorates neurological phenotypes in a mouse model of the disease.	[Centa, Jessica L.; Jodelka, Francine M.; Hinrich, Anthony J.; Hastings, Michelle L.] Rosalind Franklin Univ Med & Sci, Ctr Genet Dis, Chicago Med Sch, N Chicago, IL 60064 USA; [Centa, Jessica L.; Hastings, Michelle L.] Rosalind Franklin Univ Med & Sci, Sch Grad & Postdoctoral Studies, N Chicago, IL 60064 USA; [Johnson, Tyler B.; Weimer, Jill M.] Sanford Res, Pediat & Rare Dis Grp, Sioux Falls, SD USA; [Ochaba, Joseph; Jackson, Michaela; Rigo, Frank] Ionis Pharmaceut, Carlsbad, CA USA; [Duelli, Dominik M.] Rosalind Franklin Univ Med & Sci, Chicago Med Sch, Cellular & Mol Pharmacol, N Chicago, IL USA; [Weimer, Jill M.] Univ South Dakota, Sanford Sch Med, Dept Pediat, Sioux Falls, SD USA	Chicago Medical School; Rosalind Franklin University Medical & Science; Rosalind Franklin University Medical & Science; Sanford Health; Ionis Pharmaceuticals, Inc.; Chicago Medical School; Rosalind Franklin University Medical & Science; University of South Dakota	Hastings, ML (corresponding author), Rosalind Franklin Univ Med & Sci, Ctr Genet Dis, Chicago Med Sch, N Chicago, IL 60064 USA.; Hastings, ML (corresponding author), Rosalind Franklin Univ Med & Sci, Sch Grad & Postdoctoral Studies, N Chicago, IL 60064 USA.	michelle.hastings@rosalindfranklin.edu	Hastings, MICHELLE L./AAK-6627-2021	Hastings, Michelle L./0000-0002-4253-9261; Jodelka, Francine/0000-0001-9374-8437	NIH [NS113233, S10 OD010662]; Batten Disease Support and Research Alliance; ForeBatten Research Foundation	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Batten Disease Support and Research Alliance; ForeBatten Research Foundation	The authors thank Forbes Porter and An Dang Do (NIH/NICHD) and Beverly Davidson (Children's Hospital of Philadelphia) for human fibroblast cell lines and David Pearce (Sanford), David Mueller (RFUMS) and Susan Cotman (Harvard) for helpful discussions and other reagents. The authors also thank Maria Ruiz and Cecilia Reyes for technical support. This work was supported by NIH grant NS113233, the Batten Disease Support and Research Alliance and the ForeBatten Research Foundation. Quantitation of radioactive PCR products was performed on an instrument in the shared Proteomics facility at RFUMS obtained with NIH grant S10 OD010662.	Aldrich A, 2016, ANN NEUROL, V80, P909, DOI 10.1002/ana.24815; Baker BF, 1997, J BIOL CHEM, V272, P11994, DOI 10.1074/jbc.272.18.11994; Bernsel A, 2008, P NATL ACAD SCI USA, V105, P7177, DOI 10.1073/pnas.0711151105; Burkovetskaya M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095023; Cao Y, 2006, J BIOL CHEM, V281, P20483, DOI 10.1074/jbc.M602180200; Carcel-Trullols J, 2015, BBA-MOL BASIS DIS, V1852, P2242, DOI 10.1016/j.bbadis.2015.04.027; Chandrachud U, 2015, J BIOL CHEM, V290, P14361, DOI 10.1074/jbc.M114.621706; Chang JW, 2011, J NEUROCHEM, V116, P659, DOI 10.1111/j.1471-4159.2010.07158.x; Chishti MA, 2001, J BIOL CHEM, V276, P21562, DOI 10.1074/jbc.M100710200; Chresta CM, 2010, CANCER RES, V70, P288, DOI 10.1158/0008-5472.CAN-09-1751; Cialone J, 2012, J INHERIT METAB DIS, V35, P549, DOI 10.1007/s10545-011-9421-6; Cotman SL, 2002, HUM MOL GENET, V11, P2709, DOI 10.1093/hmg/11.22.2709; D'Andrea MR, 2002, NEUROSCI LETT, V323, P45, DOI 10.1016/S0304-3940(01)02444-2; Dangouloff T, 2019, THER CLIN RISK MANAG, V15, P1153, DOI 10.2147/TCRM.S172291; Darras BT, 2019, CNS DRUGS, V33, P919, DOI 10.1007/s40263-019-00656-w; De Vivo DC, 2019, NEUROMUSCULAR DISORD, V29, P842, DOI 10.1016/j.nmd.2019.09.007; Foust KD, 2010, NAT BIOTECHNOL, V28, P271, DOI 10.1038/nbt.1610; Gardiner RM, 2002, ADV NEUROL, V89, P211; Havens MA, 2016, NUCLEIC ACIDS RES, V44, P6549, DOI 10.1093/nar/gkw533; Hinrich AJ, 2016, EMBO MOL MED, V8, P328, DOI 10.15252/emmm.201505846; Hua YM, 2012, METHODS MOL BIOL, V867, P307, DOI 10.1007/978-1-61779-767-5_20; Johnson TB, 2019, NAT REV NEUROL, V15, P161, DOI 10.1038/s41582-019-0138-8; Kall L, 2005, BIOINFORMATICS, V21, pI251, DOI 10.1093/bioinformatics/bti1014; Kall L, 2004, J MOL BIOL, V338, P1027, DOI 10.1016/j.jmb.2004.03.016; Ke Q, 2019, WORLD J PEDIATR, V15, P219, DOI 10.1007/s12519-019-00242-6; Kimura S, 2007, AUTOPHAGY, V3, P452, DOI 10.4161/auto.4451; Klionsky DJ, 2016, AUTOPHAGY, V12, P1, DOI 10.1080/15548627.2015.1100356; Kousi M, 2012, HUM MUTAT, V33, P42, DOI 10.1002/humu.21624; Kovacs AD, 2015, DIS MODEL MECH, V8, P351, DOI 10.1242/dmm.018804; Kovacs AD, 2011, NEUROPHARMACOLOGY, V60, P405, DOI 10.1016/j.neuropharm.2010.10.010; Kyttala A, 2004, MOL BIOL CELL, V15, P1313, DOI 10.1091/mbc.E03-02-0120; LERNER TJ, 1995, CELL, V82, P949, DOI 10.1016/0092-8674(95)90274-0; Vidal-Donet JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055526; Maulik M, 2012, HUM MOL GENET, V21, P4857, DOI 10.1093/hmg/dds322; McClorey G, 2015, CURR OPIN PHARMACOL, V24, P52, DOI 10.1016/j.coph.2015.07.005; Mole SE, 2015, BBA-MOL BASIS DIS, V1852, P2237, DOI 10.1016/j.bbadis.2015.05.011; Nilsson P, 2013, CELL REP, V5, P61, DOI 10.1016/j.celrep.2013.08.042; Nugent T, 2008, FEBS LETT, V582, P1019, DOI 10.1016/j.febslet.2008.02.049; Omasits U, 2014, BIOINFORMATICS, V30, P884, DOI 10.1093/bioinformatics/btt607; Osorio NS, 2009, GENES BRAIN BEHAV, V8, P337, DOI 10.1111/j.1601-183X.2009.00478.x; Perland E, 2017, OPEN BIOL, V7, DOI 10.1098/rsob.170142; Pontikis CC, 2004, BRAIN RES, V1023, P231, DOI 10.1016/j.brainres.2004.07.030; Reynolds SM, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000213; Rigo F, 2014, J PHARMACOL EXP THER, V350, P46, DOI 10.1124/jpet.113.212407; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Sleat DE, 2016, GENE, V593, P284, DOI 10.1016/j.gene.2016.08.031; Sondhi D, 2014, HUM GENE THER, V25, P223, DOI 10.1089/hum.2012.253; Swayze EE, 2007, NUCLEIC ACIDS RES, V35, P687, DOI 10.1093/nar/gkl1071; Tsirigos KD, 2015, NUCLEIC ACIDS RES, V43, pW401, DOI 10.1093/nar/gkv485; Tyynela J, 2004, BRAIN PATHOL, V14, P349; Viklund H, 2008, BIOINFORMATICS, V24, P1662, DOI 10.1093/bioinformatics/btn221; Viklund H, 2008, BIOINFORMATICS, V24, P2928, DOI 10.1093/bioinformatics/btn550; Wang F, 2014, HUM GENET, V133, P331, DOI 10.1007/s00439-013-1381-5; Wang X, 2014, MOL NEURODEGENER, V9, DOI 10.1186/1750-1326-9-31; WISNIEWSKI KE, 1993, J INHERIT METAB DIS, V16, P312, DOI 10.1007/BF00710273; WISNIEWSKI KE, 1990, NEUROSCI LETT, V120, P94, DOI 10.1016/0304-3940(90)90176-A; Yang DS, 2014, BRAIN, V137, P3300, DOI 10.1093/brain/awu278; Yang JY, 2015, NUCLEIC ACIDS RES, V43, pW174, DOI 10.1093/nar/gkv342; Yasa S, 2020, J CELL SCI, V133, DOI 10.1242/jcs.234047	59	8	9	0	8	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	SEP	2020	26	9								10.1038/s41591-020-0986-1	http://dx.doi.org/10.1038/s41591-020-0986-1		JUL 2020	29	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	PF3EM	32719489	Green Accepted			2022-12-27	WOS:000552954000001
J	van der Graaf, R; Hoogerwerf, MA; de Vries, MC				van der Graaf, Rieke; Hoogerwerf, Marie-Astrid; de Vries, Martine C.			The ethics of deferred consent in times of pandemics	NATURE MEDICINE			English	Editorial Material								In the current COVID-19 pandemic, many researchers are applying to research ethics committees for deferred-consent procedures for protocols that aim either to test treatments or to obtain tissue or samples from research participants. However, the deferred-consent procedure has not been developed for pandemics. In this Comment, we interpret existing guidance documents and argue when and under which conditions deferred consent can be considered ethically acceptable in a pandemic.	[van der Graaf, Rieke] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Dept Med Humanities, Utrecht, Netherlands; [Hoogerwerf, Marie-Astrid] Leiden Univ, Med Ctr, Dept Parasitol, Leiden, Netherlands; [Hoogerwerf, Marie-Astrid] Leiden Univ, Med Ctr, Dept Infect Dis, Leiden, Netherlands; [de Vries, Martine C.] Leiden Univ, Med Ctr, Dept Med Eth & Hlth Law, Leiden, Netherlands	Utrecht University; Utrecht University Medical Center; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	van der Graaf, R (corresponding author), Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Dept Med Humanities, Utrecht, Netherlands.	r.vandergraaf@umcutrecht.nl	de Vries, Martine/AAE-3420-2022; Hoogerwerf, Marie-Astrid/V-5413-2018	de Vries, Martine/0000-0002-3178-7470; Hoogerwerf, Marie-Astrid/0000-0002-3088-3380				Cardone M, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.01131; CIOMS, 2016, INT ETH GUID HLTH RE; Dickert NW, 2020, AM J BIOETHICS, V20, P7, DOI 10.1080/15265161.2020.1745931; Henry BM, 2020, CLIN CHEM LAB MED, V58, P1021, DOI 10.1515/cclm-2020-0369; Johnson LR, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h4609; Mahevas M, 2020, BMJ-BRIT MED J, V369, DOI [10.1136/bmj.m2328, 10.1136/bmj.m1844]; Olsson A, 2020, TRIALS, V21, DOI 10.1186/s13063-020-4147-0; Torjesen I, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1409	8	12	12	0	2	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	SEP	2020	26	9					1328	1330		10.1038/s41591-020-0999-9	http://dx.doi.org/10.1038/s41591-020-0999-9		JUL 2020	3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	PF3EM	32651580	Bronze			2022-12-27	WOS:000547236500003
J	Lazarus, JV; Binagwaho, A; El-Mohandes, AAE; Fielding, JE; Larson, HJ; Plasencia, A; Andriukaitis, V; Ratzan, SC				Lazarus, Jeffrey V.; Binagwaho, Agnes; El-Mohandes, Ayman A. E.; Fielding, Jonathan E.; Larson, Heidi J.; Plasencia, Antoni; Andriukaitis, Vytenis; Ratzan, Scott C.			Keeping governments accountable: the COVID-19 Assessment Scorecard (COVID-SCORE)	NATURE MEDICINE			English	Editorial Material								Many actors in the response to COVID-19 are holding out for a vaccine to be developed. But in the meantime, tried and tested public-health measures for controlling outbreaks can be implemented. A scorecard can be used to assess governments' responses to the outbreak.	[Lazarus, Jeffrey V.; Plasencia, Antoni] Univ Barcelona, Barcelona Inst Global Hlth ISGlobal, Hosp Clin, Barcelona, Spain; [Binagwaho, Agnes] Univ Global Hlth Equ, Kigali, Rwanda; [El-Mohandes, Ayman A. E.; Ratzan, Scott C.] CUNY, Grad Sch Publ Hlth & Hlth Policy, New York, NY 10021 USA; [Fielding, Jonathan E.] Univ Calif Los Angeles, Fielding Sch Publ Hlth, Los Angeles, CA USA; [Fielding, Jonathan E.] Univ Calif Los Angeles, Geffen Sch Med, Los Angeles, CA USA; [Larson, Heidi J.] London Sch Hyg & Trop Med, London, England	ISGlobal; University of Barcelona; Hospital Clinic de Barcelona; City University of New York (CUNY) System; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of London; London School of Hygiene & Tropical Medicine	Lazarus, JV (corresponding author), Univ Barcelona, Barcelona Inst Global Hlth ISGlobal, Hosp Clin, Barcelona, Spain.	jeffrey.lazarus@isglobal.org	Lazarus, Jeffrey V./R-6248-2018; Larson, Heidi J./N-1018-2017	Lazarus, Jeffrey V./0000-0001-9618-2299; Larson, Heidi J./0000-0002-8477-7583				Binagwaho A, 2020, INT J HLTH POLICY MA; Calina D, 2020, INT J MOL MED, V46, P3, DOI 10.3892/ijmm.2020.4596; European Commission, 2020, EUR COUNC COUNC 2 AS; Harrison EA, 2020, EUR J EPIDEMIOL, V35, P325, DOI 10.1007/s10654-020-00634-3; Jamison DT, 2018, DIS CONTROL PRIORITI; Kwok KO, 2019, COMPUT STRUCT BIOTEC, V17, P186, DOI 10.1016/j.csbj.2019.01.003; Lazarus JV, 2020, BMJ OPEN, V10, DOI 10.1136/bmjopen-2019-035621; Magnusson R, 2016, ADV RIGHT HLTH VITAL; Nussbaumer-Streit B, 2020, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD013574.pub2, 10.1002/14651858.CD013574]; Polonsky JA, 2019, PHILOS T R SOC B, V374, DOI 10.1098/rstb.2018.0276; Ratzan Scott C, 2020, NAM Perspect, V2020, DOI [10.31478/202003a, 10.1080/10810730.2020.1894015]; Torero M, 2020, NATURE, V580, P588, DOI 10.1038/d41586-020-01181-3; Wada Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035069; WHO, 1946, INT HLTH C; WHO, 2007, EV BUS STRENGTH HLTH; World Health Organization, 2020, MEDCOMM; World Health Organization, 2011, BRIEF HIST DEV FRAME; Yamey G, 2020, LANCET, V395, P1405, DOI 10.1016/S0140-6736(20)30763-7	18	46	47	0	4	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	JUL	2020	26	7					1005	1008		10.1038/s41591-020-0950-0	http://dx.doi.org/10.1038/s41591-020-0950-0		JUN 2020	4	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	MK3XO	32528155	Bronze			2022-12-27	WOS:000539886500002
J	Blanchard, JW; Bula, M; Davila-Velderrain, J; Akay, LA; Zhu, LN; Frank, A; Victor, MB; Bonner, JM; Mathys, H; Lin, YT; Ko, T; Bennett, DA; Cam, HP; Kellis, M; Tsai, LH				Blanchard, Joel W.; Bula, Michael; Davila-Velderrain, Jose; Akay, Leyla Anne; Zhu, Lena; Frank, Alexander; Victor, Matheus B.; Bonner, Julia Maeve; Mathys, Hansruedi; Lin, Yuan-Ta; Ko, Tak; Bennett, David A.; Cam, Hugh P.; Kellis, Manolis; Tsai, Li-Huei			Reconstruction of the human blood-brain barrier in vitro reveals a pathogenic mechanism of APOE4 in pericytes	NATURE MEDICINE			English	Article							CEREBRAL AMYLOID ANGIOPATHY; PLURIPOTENT STEM-CELLS; SMOOTH-MUSCLE-CELLS; GENE; CALCINEURIN; MODEL; PREDICTORS; HEMORRHAGE; EXPRESSION; PATHOLOGY	In Alzheimer's disease, amyloid deposits along the brain vasculature lead to a condition known as cerebral amyloid angiopathy (CAA), which impairs blood-brain barrier (BBB) function and accelerates cognitive degeneration. Apolipoprotein (APOE4) is the strongest risk factor for CAA, yet the mechanisms underlying this genetic susceptibility are unknown. Here we developed an induced pluripotent stem cell-based three-dimensional model that recapitulates anatomical and physiological properties of the human BBB in vitro. Similarly to CAA, our in vitro BBB displayed significantly more amyloid accumulation in APOE4 compared to APOE3. Combinatorial experiments revealed that dysregulation of calcineurin-nuclear factor of activated T cells (NFAT) signaling and APOE in pericyte-like mural cells induces APOE4-associated CAA pathology. In the human brain, APOE and NFAT are selectively dysregulated in pericytes of APOE4 carriers, and inhibition of calcineurin-NFAT signaling reduces APOE4-associated CAA pathology in vitro and in vivo. Our study reveals the role of pericytes in APOE4-mediated CAA and highlights calcineurin-NFAT signaling as a therapeutic target in CAA and Alzheimer's disease. An iPSC-based three-dimensional model of the human blood-brain barrier reveals that NFAT and APOE dysregulation in pericyte-like mural cells contributes to cerebral amyloid angiopathy and can potentially be targeted to treat Alzheimer's disease.	[Blanchard, Joel W.; Bula, Michael; Akay, Leyla Anne; Zhu, Lena; Frank, Alexander; Victor, Matheus B.; Bonner, Julia Maeve; Mathys, Hansruedi; Lin, Yuan-Ta; Ko, Tak; Cam, Hugh P.; Tsai, Li-Huei] MIT, Picower Inst Learning & Memory, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Blanchard, Joel W.; Bula, Michael; Akay, Leyla Anne; Zhu, Lena; Frank, Alexander; Victor, Matheus B.; Bonner, Julia Maeve; Mathys, Hansruedi; Lin, Yuan-Ta; Cam, Hugh P.; Tsai, Li-Huei] MIT, Dept Brain & Cognit Sci, E25-618, Cambridge, MA 02139 USA; [Davila-Velderrain, Jose; Kellis, Manolis] MIT, Comp Sci & Artificial Intelligence Lab, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Davila-Velderrain, Jose; Mathys, Hansruedi; Kellis, Manolis; Tsai, Li-Huei] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Bennett, David A.] Rush Univ, Rush Alzheimers Dis Ctr, Med Ctr, Chicago, IL 60612 USA	Massachusetts Institute of Technology (MIT); Northwell Health; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Rush University	Tsai, LH (corresponding author), MIT, Picower Inst Learning & Memory, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Tsai, LH (corresponding author), MIT, Dept Brain & Cognit Sci, E25-618, Cambridge, MA 02139 USA.; Tsai, LH (corresponding author), Broad Inst MIT & Harvard, Cambridge, MA 02142 USA.	lhtsai@mit.edu	Kellis, Manolis/ABE-7385-2020; Davila-Velderrain, Jose/AGL-4662-2022	Kellis, Manolis/0000-0001-7113-9630; Bula, Michael/0000-0002-2164-0619; Davila-Velderrain, Jose/0000-0003-0271-6267; Frank, Alexander/0000-0003-0056-0174; Akay, Leyla Anne/0000-0002-5944-2466; Zhu, Lena/0000-0001-9871-3786	Neurodegeneration Consortium; Belfer Family Foundation; Oskar Fisher Project; Cure Alzheimer's Fund [RF1 AG062377, RF1 AG048056]; National Institutes of Health Common Fund's Library of Integrated Network-based Cellular Signatures program [U54HG008097, P30AG10161, R01AG15819, R01AG17917, U0161356, UG3NS115064]; HHMI Hannah Gray Postdoctoral Fellowship; Glenn Foundation for Medical Research; American Federation for Aging Research Postdoctoral Fellowship	Neurodegeneration Consortium; Belfer Family Foundation; Oskar Fisher Project; Cure Alzheimer's Fund; National Institutes of Health Common Fund's Library of Integrated Network-based Cellular Signatures program; HHMI Hannah Gray Postdoctoral Fellowship; Glenn Foundation for Medical Research; American Federation for Aging Research Postdoctoral Fellowship	We thank J. Penny, W.C. Huang, Y.M. Yang and P. Narayan for critically reading the manuscript, J.Z. Young, J. Ray, V. Buggia-Prevot, C. Fernandez, the Neurodegenerative Consortium and all Tsai laboratory members for helpful discussions, A. Marco for expertise and support with microscopy, J. Seo for expertise and guidance with western blotting and Y. Zhou, E. McNamara, P. Curtis and T. Garvey for administrative support. This work was supported by The Neurodegeneration Consortium, the Belfer Family Foundation and the Oskar Fisher Project to L.-H.T., Cure Alzheimer's Fund to L.-H.T. and MK, RF1 AG062377 to L-HT and MK, RF1 AG048056. The National Institutes of Health Common Fund's Library of Integrated Network-based Cellular Signatures program by U54HG008097 to L.-H.T. and J. Jaffe (Broad Institute), P30AG10161, R01AG15819, R01AG17917, U0161356 to D.A.B., UG3NS115064 to L.-H.T. and J.W.B. M.B.V. is supported by the HHMI Hannah Gray Postdoctoral Fellowship. J.W.B. was supported in part by The Glenn Foundation for Medical Research and American Federation for Aging Research Postdoctoral Fellowship during this work.	Andreone BJ, 2015, ANNU REV NEUROSCI, V38, P25, DOI 10.1146/annurev-neuro-071714-033835; Armulik A, 2011, DEV CELL, V21, P193, DOI 10.1016/j.devcel.2011.07.001; Armulik A, 2010, NATURE, V468, P557, DOI 10.1038/nature09522; Attwell D, 2016, J CEREBR BLOOD F MET, V36, P451, DOI 10.1177/0271678X15610340; Bennett DA, 2018, J ALZHEIMERS DIS, V64, pS161, DOI 10.3233/JAD-179939; Boroujerdi A, 2014, METHODS MOL BIOL, V1135, P383, DOI 10.1007/978-1-4939-0320-7_31; Mulero M, 2007, BBA-MOL CELL RES, V1773, P330, DOI 10.1016/j.bbamcr.2006.12.007; Chambers SM, 2012, NAT BIOTECHNOL, V30, P715, DOI 10.1038/nbt.2249; Chow BW, 2015, TRENDS NEUROSCI, V38, P598, DOI 10.1016/j.tins.2015.08.003; Daneman R, 2010, NATURE, V468, P562, DOI 10.1038/nature09513; Deli MA, 2005, CELL MOL NEUROBIOL, V25, P59, DOI 10.1007/s10571-004-1377-8; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Francesca B, 2010, CURR NEUROPHARMACOL, V8, P92, DOI 10.2174/157015910791233132; Fryer JD, 2003, J NEUROSCI, V23, P7889; Gautam J, 2016, SCI REP-UK, V6, DOI 10.1038/srep36450; GREENBERG SM, 1995, ANN NEUROL, V38, P254, DOI 10.1002/ana.410380219; Gwack Y, 2006, NATURE, V441, P646, DOI 10.1038/nature04631; He LQ, 2018, SCI DATA, V5, DOI 10.1038/sdata.2018.160; Iadecola C, 2017, NEURON, V96, P17, DOI 10.1016/j.neuron.2017.07.030; Iadecola C, 2013, NEURON, V80, P844, DOI 10.1016/j.neuron.2013.10.008; Israel MA, 2012, NATURE, V482, P216, DOI 10.1038/nature10821; JANZER RC, 1987, NATURE, V325, P253, DOI 10.1038/325253a0; Julia TCW, 2017, STEM CELL REP, V9, P600, DOI 10.1016/j.stemcr.2017.06.018; Kapturczak MH, 2004, TRANSPL P, V36, p25S, DOI 10.1016/j.transproceed.2004.01.018; Kim J, 2011, J NEUROSCI, V31, P18007, DOI 10.1523/JNEUROSCI.3773-11.2011; Kumar A, 2017, CELL REP, V19, P1902, DOI 10.1016/j.celrep.2017.05.019; Lee MY, 2011, ARTERIOSCL THROM VAS, V31, P2665, DOI 10.1161/ATVBAHA.111.235960; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Lin YT, 2018, NEURON, V98, P1141, DOI 10.1016/j.neuron.2018.05.008; Maloney B, 2007, J NEUROCHEM, V103, P1237, DOI 10.1111/j.1471-4159.2007.04831.x; Mathys H, 2019, NATURE, V1, P1; Nation DA, 2019, NAT MED, V25, P270, DOI 10.1038/s41591-018-0297-y; O'Brown NM, 2018, GENE DEV, V32, P466, DOI 10.1101/gad.309823.117; Orr AW, 2010, J VASC RES, V47, P168, DOI 10.1159/000250095; Patsch C, 2015, NAT CELL BIOL, V17, P994, DOI 10.1038/ncb3205; Premkumar DRD, 1996, AM J PATHOL, V148, P2083; Qian TC, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1701679; Ransohoff RM, 2016, SCIENCE, V353, P777, DOI 10.1126/science.aag2590; Reese LC, 2011, CURR NEUROPHARMACOL, V9, P685, DOI 10.2174/157015911798376316; Ringman JM, 2014, JAMA NEUROL, V71, P878, DOI 10.1001/jamaneurol.2014.681; Scheltens P, 2012, NAT REV NEUROL, V8, P68, DOI 10.1038/nrneurol.2011.222; Seetharaman S, 1998, J NEUROCHEM, V70, P1151, DOI 10.1046/j.1471-4159.1998.70031151.x; Shi YC, 2012, NAT PROTOC, V7, P1836, DOI 10.1038/nprot.2012.116; Shinohara M, 2016, ACTA NEUROPATHOL, V132, P225, DOI 10.1007/s00401-016-1580-y; Srinivasan B, 2015, JALA-J LAB AUTOM, V20, P107, DOI 10.1177/2211068214561025; Stebbins MJ, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aau7375; Strickland LA, 2005, J PATHOL, V206, P466, DOI 10.1002/path.1805; Taglialatela G, 2015, J ALZHEIMERS DIS, V47, P329, DOI 10.3233/JAD-150065; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Urich E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038149; Vanlandewijck M, 2018, NATURE, V554, P475, DOI 10.1038/nature25739; Vemuri P, 2015, BRAIN, V138, P761, DOI 10.1093/brain/awu393; Wang JS, 2018, P NATL ACAD SCI USA, V115, pE6437, DOI 10.1073/pnas.1721085115; Xu Q, 2006, J NEUROSCI, V26, P4985, DOI 10.1523/JNEUROSCI.5476-05.2006; Zhang Y, 2014, J NEUROSCI, V34, P11929, DOI [10.1523/JNEUROSCI.1860-14.2014, 10.11772/j.issn.1001-9081.2014.07.1929]; Zhao Z, 2015, CELL, V163, P1064, DOI 10.1016/j.cell.2015.10.067; Zlokovic BV, 2005, TRENDS NEUROSCI, V28, P202, DOI 10.1016/j.tins.2005.02.001	57	80	83	5	26	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	JUN	2020	26	6					952	+		10.1038/s41591-020-0886-4	http://dx.doi.org/10.1038/s41591-020-0886-4		JUN 2020	26	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	LZ3ZG	32514169	Green Submitted, Green Accepted			2022-12-27	WOS:000538976400006
J	Johnson, ECB; Dammer, EB; Duong, DM; Ping, LY; Zhou, MT; Yin, LM; Higginbotham, LA; Guajardo, A; White, B; Troncoso, JC; Thambisetty, M; Montine, TJ; Lee, EB; Trojanowski, JQ; Beach, TG; Reiman, EM; Haroutunian, V; Wang, MH; Schadt, E; Zhang, B; Dickson, DW; Ertekin-Taner, N; Golde, TE; Petyuk, VA; De Jager, PL; Bennett, DA; Wingo, TS; Rangaraju, S; Hajjar, I; Shulman, JM; Lah, JJ; Levey, AI; Seyfried, NT				Johnson, Erik C. B.; Dammer, Eric B.; Duong, Duc M.; Ping, Lingyan; Zhou, Maotian; Yin, Luming; Higginbotham, Lenora A.; Guajardo, Andrew; White, Bartholomew; Troncoso, Juan C.; Thambisetty, Madhav; Montine, Thomas J.; Lee, Edward B.; Trojanowski, John Q.; Beach, Thomas G.; Reiman, Eric M.; Haroutunian, Vahram; Wang, Minghui; Schadt, Eric; Zhang, Bin; Dickson, Dennis W.; Ertekin-Taner, Nilufer; Golde, Todd E.; Petyuk, Vladislav A.; De Jager, Philip L.; Bennett, David A.; Wingo, Thomas S.; Rangaraju, Srikant; Hajjar, Ihab; Shulman, Joshua M.; Lah, James J.; Levey, Allan I.; Seyfried, Nicholas T.			Large-scale proteomic analysis of Alzheimer's disease brain and cerebrospinal fluid reveals early changes in energy metabolism associated with microglia and astrocyte activation	NATURE MEDICINE			English	Article							RUSH MEMORY; PROTEIN ABUNDANCE; NETWORK APPROACH; COEXPRESSION; QUANTIFICATION; FRAMEWORK; CELL; PET	Large-scale, comprehensive proteomic profiling of Alzheimer's disease brain and cerebrospinal fluid reveals disease-associated protein coexpression modules and highlights the importance of glia and energy metabolism in disease pathogenesis. Our understanding of Alzheimer's disease (AD) pathophysiology remains incomplete. Here we used quantitative mass spectrometry and coexpression network analysis to conduct the largest proteomic study thus far on AD. A protein network module linked to sugar metabolism emerged as one of the modules most significantly associated with AD pathology and cognitive impairment. This module was enriched in AD genetic risk factors and in microglia and astrocyte protein markers associated with an anti-inflammatory state, suggesting that the biological functions it represents serve a protective role in AD. Proteins from this module were elevated in cerebrospinal fluid in early stages of the disease. In this study of >2,000 brains and nearly 400 cerebrospinal fluid samples by quantitative proteomics, we identify proteins and biological processes in AD brains that may serve as therapeutic targets and fluid biomarkers for the disease.	[Johnson, Erik C. B.; Dammer, Eric B.; Duong, Duc M.; Ping, Lingyan; Zhou, Maotian] Emory Univ, Sch Med, Goizueta Alzheimers Dis Res Ctr, Atlanta, GA 30322 USA; [Johnson, Erik C. B.; Ping, Lingyan; Zhou, Maotian; Higginbotham, Lenora A.; Wingo, Thomas S.; Rangaraju, Srikant; Hajjar, Ihab; Lah, James J.; Levey, Allan I.; Seyfried, Nicholas T.] Emory Univ, Sch Med, Dept Neurol, Atlanta, GA 30322 USA; [Johnson, Erik C. B.; Dammer, Eric B.; Duong, Duc M.; Ping, Lingyan; Zhou, Maotian; Yin, Luming; Levey, Allan I.; Seyfried, Nicholas T.] Emory Univ, Sch Med, Dept Biochem, Atlanta, GA 30322 USA; [Guajardo, Andrew; White, Bartholomew; Troncoso, Juan C.] Johns Hopkins Sch Med, Baltimore, MD USA; [Thambisetty, Madhav] NIA, Clin & Translat Neurosci Sect, Lab Behav Neurosci, NIH, Bethesda, MD 20892 USA; [Thambisetty, Madhav] Stanford Univ, Sch Med, Dept Pathol, Palo Alto, CA 94304 USA; [Montine, Thomas J.] Univ Penn, Dept Pathol & Lab Med, Ctr Neurodegenerat Dis Res, Perelman Sch Med, Philadelphia, PA USA; [Lee, Edward B.; Trojanowski, John Q.] Banner Sun Hlth Res Inst, Dept Pathol, Sun City, AZ USA; [Montine, Thomas J.; Reiman, Eric M.] Arizona State Univ, Banner Alzheimers Inst, Phoenix, AZ USA; [Beach, Thomas G.; Reiman, Eric M.] Univ Arizona, Phoenix, AZ USA; [Haroutunian, Vahram] Icahn Sch Med Mt Sinai, Dept Psychiat, New York, NY 10029 USA; [Haroutunian, Vahram] Icahn Sch Med Mt Sinai, Dept Neurosci, New York, NY 10029 USA; [Haroutunian, Vahram] MIRECC, JJ Peters VA Med Ctr, Bronx, NY USA; [Wang, Minghui; Schadt, Eric; Zhang, Bin] Icahn Sch Med Mt Sinai, Mt Sinai Ctr Transformat Dis Modeling, Dept Genet & Genom Sci, New York, NY 10029 USA; [Dickson, Dennis W.; Ertekin-Taner, Nilufer] Mayo Clin, Dept Neurosci, Jacksonville, FL 32224 USA; [Ertekin-Taner, Nilufer] Mayo Clin, Dept Neurol, Jacksonville, FL 32224 USA; [Golde, Todd E.] Univ Florida, Dept Neurosci, Ctr Translat Res Neurodegenerat Dis, McKnight Brain Inst, Gainesville, FL 32610 USA; [Petyuk, Vladislav A.] Pacific Northwest Natl Lab, Div Biol Sci, Richland, WA 99352 USA; [De Jager, Philip L.] Columbia Univ, Dept Neurol, Ctr Translat & Computat Neuroimmunol, Irving Med Ctr,Taub Inst,New York Presbyterian Ho, New York, NY USA; [Bennett, David A.] Rush Univ, Rush Alzheimers Dis Ctr, Med Ctr, Chicago, IL 60612 USA; [Wingo, Thomas S.] Emory Univ, Sch Med, Dept Human Genet, Atlanta, GA USA; [Shulman, Joshua M.] Baylor Coll Med, Dept Neurol, Houston, TX 77030 USA; [Shulman, Joshua M.] Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA; [Shulman, Joshua M.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Shulman, Joshua M.] Texas Childrens Hosp, Jan & Dan Duncan Neurol Res Inst, Houston, TX 77030 USA	Emory University; Emory University; Emory University; Johns Hopkins University; Johns Hopkins Medicine; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Stanford University; University of Pennsylvania; Pennsylvania Medicine; Banner Research; Banner Health; Banner Sun Health Research Institute; Arizona State University; Arizona State University-Downtown Phoenix; Banner Research; Banner Health; Banner Alzheimer's Institute; University of Arizona; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Mayo Clinic; Mayo Clinic; State University System of Florida; University of Florida; United States Department of Energy (DOE); Pacific Northwest National Laboratory; Columbia University; NewYork-Presbyterian Hospital; Rush University; Emory University; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Johnson, ECB (corresponding author), Emory Univ, Sch Med, Goizueta Alzheimers Dis Res Ctr, Atlanta, GA 30322 USA.; Johnson, ECB (corresponding author), Emory Univ, Sch Med, Dept Neurol, Atlanta, GA 30322 USA.; Johnson, ECB (corresponding author), Emory Univ, Sch Med, Dept Biochem, Atlanta, GA 30322 USA.	erik.c.b.johnson@emory.edu; alevey@emory.edu; nseyfri@emory.edu	Wingo, Thomas/AEM-2481-2022; Lee, Edward/AAU-8436-2021; Levey, Allan/F-2104-2011; Dammer, Eric B/V-8652-2019; Rangaraju, S/Q-1924-2018; Wang, Minghui/P-8300-2017	Wingo, Thomas/0000-0002-7679-6282; Levey, Allan/0000-0002-3153-502X; Dammer, Eric B/0000-0003-2947-7606; Rangaraju, S/0000-0003-2765-1500; Wang, Minghui/0000-0001-9171-4962; Johnson, Erik/0000-0002-0604-2944; Duong, Duc/0000-0001-5880-1888	National Institutes of Health [R01AG053960, R01AG057911, R01AG061800, RF1AG057471, RF1AG057470, R01AG057339, U01AG061357, P50AG025688, RF1AG051633, P30AG10161, R01AG15819, R01AG17917, U01AG61356, R01AG056533, K08NS099474]; National Institute on Aging (NIA);  [U01AG046170];  [RF1AG054014];  [RF1AG057440];  [R01AG057907];  [U01AG052411];  [P30AG10124];  [U01AG046161];  [R01AG050631];  [P50AG005146];  [U24NS072026];  [P30AG19610]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute on Aging (NIA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); ; ; ; ; ; ; ; ; ; ; 	We are grateful to those who agreed to donate their brains and CSF for research and who participated in the described observational studies. This study was supported by the following National Institutes of Health funding mechanisms: R01AG053960, R01AG057911, R01AG061800, RF1AG057471, RF1AG057470, R01AG061800, R01AG057911, R01AG057339, U01AG061357, P50AG025688, RF1AG057470, RF1AG051633, P30AG10161, R01AG15819, R01AG17917, U01AG61356, R01AG056533, K08NS099474, U01AG046170, RF1AG054014, RF1AG057440, R01AG057907, U01AG052411, P30AG10124, U01AG046161, R01AG050631, R01AG053960, R01AG057339, U01AG061357, P50AG005146, U24NS072026 and P30AG19610. The study was also supported in part by the intramural program of the National Institute on Aging (NIA).	Bai B, 2020, NEURON, V105, P975, DOI 10.1016/j.neuron.2019.12.015; Baker M, 2006, NATURE, V442, P916, DOI 10.1038/nature05016; Balsis S, 2015, CLIN NEUROPSYCHOL, V29, P1002, DOI 10.1080/13854046.2015.1119312; Barabasi AL, 2011, NAT REV GENET, V12, P56, DOI 10.1038/nrg2918; Beach TG, 2015, NEUROPATHOLOGY, V35, P354, DOI 10.1111/neup.12189; Bennett DA, 2005, NEUROEPIDEMIOLOGY, V25, P163, DOI 10.1159/000087446; Bennett DA, 2018, J ALZHEIMERS DIS, V64, pS161, DOI 10.3233/JAD-179939; Bennett DA, 2012, CURR ALZHEIMER RES, V9, P646; Bennett DA, 2012, CURR ALZHEIMER RES, V9, P628; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Butovsky O, 2014, NAT NEUROSCI, V17, P131, DOI 10.1038/nn.3599; Cerami E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008918; Clarke C, 2013, CARCINOGENESIS, V34, P2300, DOI 10.1093/carcin/bgt208; Clements CM, 2006, P NATL ACAD SCI USA, V103, P15091, DOI 10.1073/pnas.0607260103; Cox J, 2014, MOL CELL PROTEOMICS, V13, P2513, DOI 10.1074/mcp.M113.031591; Cruts M, 2006, NATURE, V442, P920, DOI 10.1038/nature05017; Dayon L, 2019, J PROTEOME RES, V18, P1162, DOI 10.1021/acs.jproteome.8b00809; Dayon L, 2018, ALZHEIMERS RES THER, V10, DOI 10.1186/s13195-018-0397-4; de Leeuw CA, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004219; Drummond E, 2017, ACTA NEUROPATHOL, V133, P933, DOI 10.1007/s00401-017-1691-0; Grubman A., MOUSE HUMAN MICROGLI, DOI [10.1101/639054, DOI 10.1101/639054]; Hamelin L, 2016, BRAIN, V139, P1252, DOI 10.1093/brain/aww017; Hammond TR, 2019, IMMUNITY, V50, P253, DOI 10.1016/j.immuni.2018.11.004; He ZS, 2017, ONCOTARGET, V8, P27904, DOI 10.18632/oncotarget.15842; Hickman S, 2018, NAT NEUROSCI, V21, P1359, DOI 10.1038/s41593-018-0242-x; Higginbotham L, INTEGRATED PROTEOMIC, DOI [10.1101/806752, DOI 10.1101/806752]; Holtman IR, 2015, ACTA NEUROPATHOL COM, V3, DOI 10.1186/s40478-015-0203-5; Huan TX, 2015, MOL SYST BIOL, V11, DOI 10.15252/msb.20145399; Huan TX, 2013, ARTERIOSCL THROM VAS, V33, P1427, DOI 10.1161/ATVBAHA.112.300112; Hulstaert F, 1999, NEUROLOGY, V52, P1555, DOI 10.1212/WNL.52.8.1555; Ince PG, 1998, NEUROPATH APPL NEURO, V24, P104, DOI 10.1046/j.1365-2990.1998.00108.x; Jack CR, 2016, NEUROLOGY, V87, P539, DOI 10.1212/WNL.0000000000002923; Jack CR, 2018, ALZHEIMERS DEMENT, V14, P535, DOI 10.1016/j.jalz.2018.02.018; Johnson ECB, 2018, MOL NEURODEGENER, V13, DOI 10.1186/s13024-018-0282-4; Jonsson T, 2013, NEW ENGL J MED, V368, P107, DOI 10.1056/NEJMoa1211103; Lambert JC, 2013, NAT GENET, V45, P1452, DOI 10.1038/ng.2802; Langfelder P, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001057; Luber CA, 2010, IMMUNITY, V32, P279, DOI 10.1016/j.immuni.2010.01.013; Luo YF, 2015, FREE RADICAL BIO MED, V79, P117, DOI 10.1016/j.freeradbiomed.2014.12.002; Mathur R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118463; McKenzie AT, 2017, MOL NEURODEGENER, V12, DOI 10.1186/s13024-017-0219-3; Mertins P, 2018, NAT PROTOC, V13, P1632, DOI 10.1038/s41596-018-0006-9; Miller JA, 2008, J NEUROSCI, V28, P1410, DOI 10.1523/JNEUROSCI.4098-07.2008; Miller JA, 2013, GENOME MED, V5, DOI 10.1186/gm452; MIRRA SS, 1991, NEUROLOGY, V41, P479, DOI 10.1212/WNL.41.4.479; O'Brien RJ, 2009, J ALZHEIMERS DIS, V18, P665, DOI 10.3233/JAD-2009-1179; Oldham MC, 2008, NAT NEUROSCI, V11, P1271, DOI 10.1038/nn.2207; Orre M, 2014, NEUROBIOL AGING, V35, P2746, DOI 10.1016/j.neurobiolaging.2014.06.004; Peterson AC, 2012, MOL CELL PROTEOMICS, V11, P1475, DOI 10.1074/mcp.O112.020131; Petyuk VA, 2010, METHODS, V50, P77, DOI 10.1016/j.ymeth.2009.07.009; Ping LY, 2018, SCI DATA, V5, DOI 10.1038/sdata.2018.36; Power JHT, 2008, ACTA NEUROPATHOL, V115, P611, DOI 10.1007/s00401-008-0373-3; Prince M, 2015, WORLD ALZHEIMERS REP; Ramanan VK, 2015, BRAIN, V138, P3076, DOI 10.1093/brain/awv231; Rangaraju S, 2018, MOL NEURODEGENER, V13, DOI 10.1186/s13024-018-0254-8; Ransohoff RM, 2009, ANNU REV IMMUNOL, V27, P119, DOI 10.1146/annurev.immunol.021908.132528; Rauniyar N, 2014, J PROTEOME RES, V13, P5293, DOI 10.1021/pr500880b; Sathe G, 2019, PROTEOM CLIN APPL, V13, DOI 10.1002/prca.201800105; Seyfried NT, 2017, CELL SYST, V4, P60, DOI 10.1016/j.cels.2016.11.006; Shaw LM, 2009, ANN NEUROL, V65, P403, DOI 10.1002/ana.21610; Sun M, 2017, ONCOTARGET, V8, P69594, DOI 10.18632/oncotarget.18646; Swarup V, IDENTIFICATION CONSE, DOI [10.1101/825802, DOI 10.1101/825802]; Ting L, 2011, NAT METHODS, V8, P937, DOI [10.1038/NMETH.1714, 10.1038/nmeth.1714]; Toledo JB, 2017, ALZHEIMERS DEMENT, V13, P965, DOI 10.1016/j.jalz.2017.01.020; Tran LM, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-121; Tukey JW, 1977, EXPLORATORY DATA ANA; Umoh ME, 2018, EMBO MOL MED, V10, P48, DOI 10.15252/emmm.201708202; Wang YM, 2015, CELL, V160, P1061, DOI 10.1016/j.cell.2015.01.049; Wingo AP, CEREBRAL ATHEROSCLER, DOI [10.1101/793349, DOI 10.1101/793349]; Wingo TS, 2017, J PROTEOME RES, V16, P3336, DOI 10.1021/acs.jproteome.7b00324; Yi L, 2019, ANAL CHEM, V91, P5794, DOI 10.1021/acs.analchem.9b00024; Yue ZL, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1889-0; Zamanian JL, 2012, J NEUROSCI, V32, P6391, DOI 10.1523/JNEUROSCI.6221-11.2012; Zhao M, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2015.414	74	268	274	22	190	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	MAY	2020	26	5					769	+		10.1038/s41591-020-0815-6	http://dx.doi.org/10.1038/s41591-020-0815-6		APR 2020	29	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	ML1MY	32284590	Green Accepted, Green Submitted			2022-12-27	WOS:000526266600001
J	Thijssen, EH; La Joie, R; Wolf, A; Strom, A; Wang, P; Iaccarino, L; Bourakova, V; Cobigo, Y; Heuer, H; Spina, S; VandeVrede, L; Chai, XY; Proctor, NK; Airey, DC; Shcherbinin, S; Evans, CD; Sims, JR; Zetterberg, H; Blennow, K; Karydas, AM; Teunissen, CE; Kramer, JH; Grinberg, LT; Seeley, WW; Rosen, H; Boeve, BF; Miller, BL; Rabinovici, GD; Dage, JL; Rojas, JC; Boxer, AL				Thijssen, Elisabeth H.; La Joie, Renaud; Wolf, Amy; Strom, Amelia; Wang, Ping; Iaccarino, Leonardo; Bourakova, Viktoriya; Cobigo, Yann; Heuer, Hilary; Spina, Salvatore; VandeVrede, Lawren; Chai, Xiyun; Proctor, Nicholas K.; Airey, David C.; Shcherbinin, Sergey; Duggan Evans, Cynthia; Sims, John R.; Zetterberg, Henrik; Blennow, Kaj; Karydas, Anna M.; Teunissen, Charlotte E.; Kramer, Joel H.; Grinberg, Lea T.; Seeley, William W.; Rosen, Howie; Boeve, Bradley F.; Miller, Bruce L.; Rabinovici, Gil D.; Dage, Jeffrey L.; Rojas, Julio C.; Boxer, Adam L.		Advancing Res Treatment Frontotemp	Diagnostic value of plasma phosphorylated tau181 in Alzheimer's disease and frontotemporal lobar degeneration	NATURE MEDICINE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; NEUROFILAMENT LIGHT-CHAIN; MILD COGNITIVE IMPAIRMENT; CSF BIOMARKERS; ASSOCIATION WORKGROUPS; NATIONAL INSTITUTE; FLUID BIOMARKERS; AMYLOID PET; DEMENTIA; NEUROPATHOLOGY	Plasma pTau181 concentrations are elevated specifically in patients diagnosed with Alzheimer's disease compared to those diagnosed with frontotemporal lobar degeneration or elderly controls, supporting its further development as a blood-based biomarker for AD. With the potential development of new disease-modifying Alzheimer's disease (AD) therapies, simple, widely available screening tests are needed to identify which individuals, who are experiencing symptoms of cognitive or behavioral decline, should be further evaluated for initiation of treatment. A blood-based test for AD would be a less invasive and less expensive screening tool than the currently approved cerebrospinal fluid or amyloid beta positron emission tomography (PET) diagnostic tests. We examined whether plasma tau phosphorylated at residue 181 (pTau181) could differentiate between clinically diagnosed or autopsy-confirmed AD and frontotemporal lobar degeneration. Plasma pTau181 concentrations were increased by 3.5-fold in AD compared to controls and differentiated AD from both clinically diagnosed (receiver operating characteristic area under the curve of 0.894) and autopsy-confirmed frontotemporal lobar degeneration (area under the curve of 0.878). Plasma pTau181 identified individuals who were amyloid beta-PET-positive regardless of clinical diagnosis and correlated with cortical tau protein deposition measured by F-18-flortaucipir PET. Plasma pTau181 may be useful to screen for tau pathology associated with AD.	[Thijssen, Elisabeth H.; La Joie, Renaud; Wolf, Amy; Strom, Amelia; Wang, Ping; Iaccarino, Leonardo; Bourakova, Viktoriya; Cobigo, Yann; Heuer, Hilary; Spina, Salvatore; VandeVrede, Lawren; Karydas, Anna M.; Kramer, Joel H.; Grinberg, Lea T.; Seeley, William W.; Rosen, Howie; Miller, Bruce L.; Rabinovici, Gil D.; Rojas, Julio C.; Boxer, Adam L.] Univ Calif San Francisco, Dept Neurol, Memory & Aging Ctr, San Francisco, CA 94115 USA; [Thijssen, Elisabeth H.; Teunissen, Charlotte E.] Vrije Univ, Amsterdam Univ, Med Ctr, Amsterdam Neurosci,Dept Clin Chem,Neurochem Lab, Amsterdam, Netherlands; [Chai, Xiyun; Proctor, Nicholas K.; Airey, David C.; Shcherbinin, Sergey; Duggan Evans, Cynthia; Sims, John R.; Dage, Jeffrey L.] Eli Lilly & Co, Indianapolis, IN 46285 USA; [Zetterberg, Henrik; Blennow, Kaj] Univ Gothenburg, Sahlgrenska Acad, Dept Psychiat & Neurochem, Inst Neurosci & Physiol, Molndal, Sweden; [Zetterberg, Henrik; Blennow, Kaj] Sahlgrens Univ Hosp, Clin Neurochem Lab, Molndal, Sweden; [Zetterberg, Henrik] UCL, Inst Neurol, Dept Neurodegenerat Dis, Queen Sq, London, England; [Zetterberg, Henrik] UCL, UK Dementia Res Inst, London, England; [Grinberg, Lea T.; Seeley, William W.] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94140 USA; [Boeve, Bradley F.] Mayo Clin, Dept Neurol, Rochester, MN USA; [Rabinovici, Gil D.] Univ Calif San Francisco, Dept Radiol & Biomed Imaging, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of Amsterdam; Vrije Universiteit Amsterdam; Eli Lilly; University of Gothenburg; Sahlgrenska University Hospital; University of London; University College London; University of London; University College London; University of California System; University of California San Francisco; Mayo Clinic; University of California System; University of California San Francisco	Boxer, AL (corresponding author), Univ Calif San Francisco, Dept Neurol, Memory & Aging Ctr, San Francisco, CA 94115 USA.	adam.boxer@ucsf.edu	Rojas, Julio/AAL-7973-2020; La Joie, Renaud/AAC-8569-2021; Hsiung, Robin/AAT-1661-2021	La Joie, Renaud/0000-0003-2581-8100; Hsiung, Robin/0000-0002-8017-0856; Teunissen, Charlotte/0000-0002-4061-0837; Miller, Bruce/0000-0002-2152-4220	LEFFTDS; ARTFL Consortium (LEFFTDS) - National Institute on Aging [U01 AG045390]; National Institute of Neurological Diseases and Stroke (ARTFL) part of the Rare Diseases Clinical Research Network (RDCRN), an initiative of the Office of Rare Diseases Research (ORDR), National Center for Advancing Translational Science (NCATS) [U54-NS092089]; NCATS; National Institute of Neurological Disorders and Stroke; Larry L. Hillblom Network; Tau Consortium; National Institute on Aging [U54-NS092089, R01-AG045611, P50-AG023501, P50-AG016574, P01-AG19724, R01-AG038791]; State of California Department of Health Services Alzheimer's Disease Research Center of California [04-33516]; Michael J. Fox Foundation; Alzheimer's Association [AARF-16-443577, K08AG052648];  [P01-AG019724-17];  [U24 AG21886];  [K24AG053435];  [K23AG059888]	LEFFTDS; ARTFL Consortium (LEFFTDS) - National Institute on Aging; National Institute of Neurological Diseases and Stroke (ARTFL) part of the Rare Diseases Clinical Research Network (RDCRN), an initiative of the Office of Rare Diseases Research (ORDR), National Center for Advancing Translational Science (NCATS); NCATS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Larry L. Hillblom Network; Tau Consortium; National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); State of California Department of Health Services Alzheimer's Disease Research Center of California; Michael J. Fox Foundation; Alzheimer's Association(Alzheimer's Association); ; ; ; 	S. Lowe designed and conducted Eli Lilly's study (NCT02624778) and provided a critical review of the manuscript. Data collection and dissemination of the data presented in this manuscript was supported by the LEFFTDS and ARTFL Consortium (LEFFTDS, U01 AG045390 (B.F.B. and H.R.)), funded by the National Institute on Aging and the National Institute of Neurological Diseases and Stroke (ARTFL, U54-NS092089 (A.L.B.)), part of the Rare Diseases Clinical Research Network (RDCRN), an initiative of the Office of Rare Diseases Research (ORDR), National Center for Advancing Translational Science (NCATS), and funded through a collaboration between NCATS and the National Institute of Neurological Disorders and Stroke, the Larry L. Hillblom Network and grant P01-AG019724-17 (B.L.M.). Samples from the National Centralized Repository for Alzheimer's Disease and Related Dementias (NCRAD), which receives government support under a cooperative agreement grant (U24 AG21886 (T. Foroud)), were used in this study. Imaging analyses were funded by the Tau Consortium, National Institute on Aging grants (R01-AG045611 (G.D.R.), P50-AG023501 (B.L.M.), P50-AG016574 (B.F.B.), P01-AG19724 (B.L.M.), R01-AG038791 (A.L.B.), U54-NS092089 (A.L.B.), State of California Department of Health Services Alzheimer's Disease Research Center of California grant (04-33516 (B.L.M.)); Michael J. Fox Foundation (G.D.R.); Alzheimer's Association (AARF-16-443577, R.L.J.) and K08AG052648 (S.S.). L.T.G. receives support from K24AG053435. J.C.R. receives support from K23AG059888. Avid Radiopharmaceuticals enabled use of the 18F-AV-1451 tracer by providing a precursor, but did not provide direct funding and was not involved in data analysis or interpretation. The funding agencies had no role in the design and conduct of the study, collection, management, analysis or interpretation of the data, preparation, review or approval of the manuscript or decision to submit the manuscript for publication.	Albert MS, 2011, ALZHEIMERS DEMENT, V7, P270, DOI 10.1016/j.jalz.2011.03.008; Alzheimer's Disease Neuroimaging Initiative (ADNI), 2010, ADNI2 PROC MAN; [Anonymous], 2019, NATURE, V574, P602; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Ashburner J, 2011, NEUROIMAGE, V55, P954, DOI 10.1016/j.neuroimage.2010.12.049; Bacioglu M, 2016, NEURON, V91, P56, DOI 10.1016/j.neuron.2016.05.018; Bahia Valéria Santoro, 2013, Dement. neuropsychol., V7, P19, DOI 10.1590/S1980-57642013DN70100004; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Braak H, 2011, J NEUROPATH EXP NEUR, V70, P960, DOI 10.1097/NEN.0b013e318232a379; Bridel C, 2019, JAMA NEUROL, V76, P1035, DOI 10.1001/jamaneurol.2019.1534; Buerger K, 2006, BRAIN, V129, P3035, DOI 10.1093/brain/awl269; Chen ZC, 2019, ALZHEIMERS DEMENT, V15, P487, DOI 10.1016/j.jalz.2018.09.010; Clark CM, 2012, LANCET NEUROL, V11, P669, DOI 10.1016/S1474-4422(12)70142-4; D'Elia LF, 1996, COLOR TRAILS TEST; del Campo M, 2018, ANN CLIN TRANSL NEUR, V5, P1163, DOI 10.1002/acn3.629; Devous MD, 2018, J NUCL MED, V59, P937, DOI 10.2967/jnumed.117.200691; Doraiswamy PM, 2014, MOL PSYCHIATR, V19, P1044, DOI 10.1038/mp.2014.9; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Ghetti B, 2015, NEUROPATH APPL NEURO, V41, P24, DOI 10.1111/nan.12213; Goodglass H., 1983, BOSTON NAMING TEST; Gorno-Tempini ML, 2011, NEUROLOGY, V76, P1006, DOI 10.1212/WNL.0b013e31821103e6; Halabi C, 2013, ALZ DIS ASSOC DIS, V27, P74, DOI 10.1097/WAD.0b013e31824a7df4; Hampel H, 2018, NAT REV NEUROL, V14, P639, DOI 10.1038/s41582-018-0079-7; Heaton R.K., 2004, REVISED COMPREHENSIV; Hoglinger GU, 2017, MOVEMENT DISORD, V32, P853, DOI 10.1002/mds.26987; Jack CR, 2018, BRAIN, V141, P1517, DOI 10.1093/brain/awy059; Janelidze S, 2016, SCI REP-UK, V6, DOI 10.1038/srep26801; Jones DT, 2018, NEUROLOGY, V90, pE947, DOI 10.1212/WNL.0000000000005117; Khalil M, 2018, NAT REV NEUROL, V14, P577, DOI 10.1038/s41582-018-0058-z; Knopman DS, 2019, BRAIN, V142, P1148, DOI 10.1093/brain/awz025; Kramer Joel H, 2003, Cogn Behav Neurol, V16, P211, DOI 10.1097/00146965-200312000-00002; La Joie R, 2019, ALZHEIMERS DEMENT, V15, P205, DOI 10.1016/j.jalz.2018.09.001; La Joie R, 2018, NEUROLOGY, V90, pE282, DOI 10.1212/WNL.0000000000004860; Landau SM, 2013, ANN NEUROL, V74, P826, DOI 10.1002/ana.23908; Lee SE, 2011, ANN NEUROL, V70, P327, DOI 10.1002/ana.22424; Ljubenkov PA, 2018, ANN CLIN TRANSL NEUR, V5, P1250, DOI 10.1002/acn3.643; Lynch CA, 2006, DEMENT GERIATR COGN, V21, P40, DOI 10.1159/000089218; Maass A, 2017, NEUROIMAGE, V157, P448, DOI 10.1016/j.neuroimage.2017.05.058; Malone IB, 2015, NEUROIMAGE, V104, P366, DOI 10.1016/j.neuroimage.2014.09.034; Marquie M, 2015, ANN NEUROL, V78, P787, DOI 10.1002/ana.24517; Mattsson N, 2019, JAMA NEUROL, V76, P791, DOI 10.1001/jamaneurol.2019.0765; Mattsson N, 2016, NEUROLOGY, V87, P1827, DOI 10.1212/WNL.0000000000003246; McKhann GM, 2011, ALZHEIMERS DEMENT, V7, P263, DOI 10.1016/j.jalz.2011.03.005; Meeter LH, 2017, NAT REV NEUROL, V13, P406, DOI 10.1038/nrneurol.2017.75; Meeter LHH, 2018, NEUROLOGY, V90, pE1231, DOI 10.1212/WNL.0000000000005261; Mielke MM, 2018, ALZHEIMERS DEMENT, V14, P989, DOI 10.1016/j.jalz.2018.02.013; Mielke MM, 2017, JAMA NEUROL, V74, P1073, DOI 10.1001/jamaneurol.2017.1359; Nakamura A, 2018, NATURE, V554, P249, DOI 10.1038/nature25456; Ossenkoppele R, 2018, JAMA-J AM MED ASSOC, V320, P1151, DOI 10.1001/jama.2018.12917; Ovod V, 2017, ALZHEIMERS DEMENT, V13, P841, DOI 10.1016/j.jalz.2017.06.2266; Palmqvist S, 2019, JAMA NEUROL, V76, P1060, DOI 10.1001/jamaneurol.2019.1632; Palmqvist S, 2015, NEUROLOGY, V85, P1240, DOI 10.1212/WNL.0000000000001991; PFEFFER RI, 1982, J GERONTOL, V37, P323, DOI 10.1093/geronj/37.3.323; Pontecorvo MJ, 2017, BRAIN, V140, P748, DOI 10.1093/brain/aww334; Preische O, 2019, NAT MED, V25, P277, DOI 10.1038/s41591-018-0304-3; Rabinovici G D, 2007, Am J Alzheimers Dis Other Demen, V22, P474, DOI 10.1177/1533317507308779; Rabinovici GD, 2011, NEUROLOGY, V77, P2034, DOI 10.1212/WNL.0b013e31823b9c5e; Rabinovici GD, 2019, JAMA-J AM MED ASSOC, V321, P1286, DOI 10.1001/jama.2019.2000; Rabinovici GD, 2010, CNS DRUGS, V24, P375, DOI 10.2165/11533100-000000000-00000; Rascovsky K, 2011, BRAIN, V134, P2456, DOI 10.1093/brain/awr179; Rivero-Santana A, 2017, J ALZHEIMERS DIS, V55, P625, DOI 10.3233/JAD-160366; Rohrer JD, 2016, NEUROLOGY, V87, P1329, DOI 10.1212/WNL.0000000000003154; Rojas JC, 2018, NEUROLOGY, V90, pE273, DOI 10.1212/WNL.0000000000004859; Scherling CS, 2014, ANN NEUROL, V75, P116, DOI 10.1002/ana.24052; Scholl M, 2019, MOL CELL NEUROSCI, V97, P18, DOI 10.1016/j.mcn.2018.12.001; Schwab AC., 1969, 3 S PARKINSONS DIS; Smith R, 2016, BRAIN, V139, P2372, DOI 10.1093/brain/aww163; Southekal S, 2018, J NUCL MED, V59, P944, DOI 10.2967/jnumed.117.200006; Steinacker P, 2018, NEUROLOGY, V91, pE1390, DOI 10.1212/WNL.0000000000006318; Tapiola T, 2009, ARCH NEUROL-CHICAGO, V66, P382, DOI 10.1001/archneurol.2008.596; van Harten AC, 2011, CLIN CHEM LAB MED, V49, P353, DOI 10.1515/CCLM.2011.086; Villeneuve S, 2015, BRAIN, V138, P2020, DOI 10.1093/brain/awv112; Xia MR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068910; YESAVAGE JA, 1983, J PSYCHIATR RES, V17, P37, DOI 10.1016/0022-3956(82)90033-4; YOUDEN W. J., 1950, CANCER, V3, P32, DOI 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3	76	268	271	4	93	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	MAR	2020	26	3					387	+		10.1038/s41591-020-0762-2	http://dx.doi.org/10.1038/s41591-020-0762-2		MAR 2020	21	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	KU0MC	32123386	Green Submitted, Green Accepted			2022-12-27	WOS:000517739000001
J	Mack, MR; Kim, BS				Mack, Madison R.; Kim, Brian S.			A precision medicine-based strategy for a severe adverse drug reaction	NATURE MEDICINE			English	Editorial Material							SYSTEMIC SYMPTOMS; EOSINOPHILIA; DRESS	Detailed single-cell RNA-sequencing analysis of skin and blood from a patient with DRESS, a severe adverse drug reaction, leads to a personalized, hypothesis-driven treatment.	[Mack, Madison R.; Kim, Brian S.] Washington Univ, Sch Med, Ctr Study Itch & Sensory Disorders, St Louis, MO 63110 USA; [Mack, Madison R.; Kim, Brian S.] Washington Univ, Sch Med, Dept Med, Div Dermatol, St Louis, MO 63110 USA; [Kim, Brian S.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Kim, BS (corresponding author), Washington Univ, Sch Med, Ctr Study Itch & Sensory Disorders, St Louis, MO 63110 USA.; Kim, BS (corresponding author), Washington Univ, Sch Med, Dept Med, Div Dermatol, St Louis, MO 63110 USA.; Kim, BS (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA.	briankim@wustl.edu	Kim, Brian/GZK-6649-2022	Kim, Brian/0000-0002-8100-7161; Mack, Madison/0000-0003-2812-0349				[Anonymous], 2015, PHARM PRACT; Chen CB, 2018, J IMMUNOL RES, V2018, DOI 10.1155/2018/6431694; Cho YT, 2017, J IMMUNOL RES, V2017, DOI 10.1155/2017/1503709; Cho YT, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18061243; Damsky William E, 2019, JAAD Case Rep, V5, P1018, DOI 10.1016/j.jdcr.2019.07.004; Kardaun SH, 2007, BRIT J DERMATOL, V156, P609, DOI 10.1111/j.1365-2133.2006.07704.x; Kim D, 2020, NAT MED, V26, P236, DOI 10.1038/s41591-019-0733-7; Miyagawa F, 2016, J DERMATOL SCI, V83, P151, DOI 10.1016/j.jdermsci.2016.05.001; Mockenhaupt M, 2017, Allergol Select, V1, P96, DOI 10.5414/ALX01508E; Sultana J, 2013, J PHARMACOL PHARMACO, V4, pS73, DOI 10.4103/0976-500X.120957	10	4	4	0	7	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	FEB	2020	26	2					167	168		10.1038/s41591-020-0756-0	http://dx.doi.org/10.1038/s41591-020-0756-0		FEB 2020	2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	KK7DU	32015558				2022-12-27	WOS:000510822600001
J	Moretti, A; Fonteyne, L; Giesert, F; Hoppmann, P; Meier, AB; Bozoglu, T; Baehr, A; Schneider, CM; Sinnecker, D; Klett, K; Frohlich, T; Rahman, FA; Haufe, T; Sun, S; Jurisch, V; Kessler, B; Hinkel, R; Dirschinger, R; Martens, E; Jilek, C; Graf, A; Krebs, S; Santamaria, G; Kurome, M; Zakhartchenko, V; Campbell, B; Voelse, K; Wolf, A; Ziegler, T; Reichert, S; Lee, S; Flenkenthaler, F; Dorn, T; Jeremias, I; Blum, H; Dendorfer, A; Schnieke, A; Krause, S; Walter, MC; Klymiuk, N; Laugwitz, KL; Wolf, E; Wurst, W; Kupatt, C				Moretti, A.; Fonteyne, L.; Giesert, F.; Hoppmann, P.; Meier, A. B.; Bozoglu, T.; Baehr, A.; Schneider, C. M.; Sinnecker, D.; Klett, K.; Froehlich, T.; Rahman, F. Abdel; Haufe, T.; Sun, S.; Jurisch, V.; Kessler, B.; Hinkel, R.; Dirschinger, R.; Martens, E.; Jilek, C.; Graf, A.; Krebs, S.; Santamaria, G.; Kurome, M.; Zakhartchenko, V.; Campbell, B.; Voelse, K.; Wolf, A.; Ziegler, T.; Reichert, S.; Lee, S.; Flenkenthaler, F.; Dorn, T.; Jeremias, I.; Blum, H.; Dendorfer, A.; Schnieke, A.; Krause, S.; Walter, M. C.; Klymiuk, N.; Laugwitz, K. L.; Wolf, E.; Wurst, W.; Kupatt, C.			Somatic gene editing ameliorates skeletal and cardiac muscle failure in pig and human models of Duchenne muscular dystrophy	NATURE MEDICINE			English	Article							MOUSE MODEL; EXPRESSION; RESTORATION; STRATEGY; MICE	Frameshift mutations in the DMD gene, encoding dystrophin, cause Duchenne muscular dystrophy (DMD), leading to terminal muscle and heart failure in patients. Somatic gene editing by sequence-specific nucleases offers new options for restoring the DMD reading frame, resulting in expression of a shortened but largely functional dystrophin protein. Here, we validated this approach in a pig model of DMD lacking exon 52 of DMD (DMD Delta 52), as well as in a corresponding patient-derived induced pluripotent stem cell model. In DMD Delta 52 pigs(1), intramuscular injection of adeno-associated viral vectors of serotype 9 carrying an intein-split Cas9 (ref. (2)) and a pair of guide RNAs targeting sequences flanking exon 51 (AAV9-Cas9-gE51) induced expression of a shortened dystrophin (DMD Delta 51-52) and improved skeletal muscle function. Moreover, systemic application of AAV9-Cas9-gE51 led to widespread dystrophin expression in muscle, including diaphragm and heart, prolonging survival and reducing arrhythmogenic vulnerability. Similarly, in induced pluripotent stem cell-derived myoblasts and cardiomyocytes of a patient lacking DMD Delta 52, AAV6-Cas9-g51-mediated excision of exon 51 restored dystrophin expression and amelioreate skeletal myotube formation as well as abnormal cardiomyocyte Ca2+ handling and arrhythmogenic susceptibility. The ability of Cas9-mediated exon excision to improve DMD pathology in these translational models paves the way for new treatment approaches in patients with this devastating disease. CRISPR-Cas9-mediated gene editing restores dystrophin expression in both pig and human induced pluripotent stem cell models of Duchenne muscular dystrophy, with beneficial effects on skeletal muscle and cardiac function.	[Moretti, A.; Hoppmann, P.; Meier, A. B.; Bozoglu, T.; Baehr, A.; Schneider, C. M.; Sinnecker, D.; Klett, K.; Rahman, F. Abdel; Haufe, T.; Sun, S.; Jurisch, V.; Hinkel, R.; Dirschinger, R.; Martens, E.; Jilek, C.; Santamaria, G.; Campbell, B.; Wolf, A.; Ziegler, T.; Lee, S.; Dorn, T.; Laugwitz, K. L.; Kupatt, C.] Tech Univ Munich, Klinikum Rechts Isar, Klin & Poliklin Innere Med 1, Munich, Germany; [Moretti, A.; Hoppmann, P.; Meier, A. B.; Bozoglu, T.; Baehr, A.; Schneider, C. M.; Sinnecker, D.; Klett, K.; Rahman, F. Abdel; Haufe, T.; Sun, S.; Jurisch, V.; Hinkel, R.; Dirschinger, R.; Martens, E.; Jilek, C.; Santamaria, G.; Campbell, B.; Wolf, A.; Ziegler, T.; Lee, S.; Dorn, T.; Laugwitz, K. L.; Kupatt, C.] German Ctr Cardiovasc Res DZHK, Munich Heart Alliance, Munich, Germany; [Fonteyne, L.; Froehlich, T.; Kessler, B.; Graf, A.; Krebs, S.; Kurome, M.; Zakhartchenko, V.; Flenkenthaler, F.; Blum, H.; Klymiuk, N.; Wolf, E.] Ludwig Maximilians Univ Munchen, Chair Mol Anim Breeding & Biotechnol, Gene Ctr, Munich, Germany; [Fonteyne, L.; Froehlich, T.; Kessler, B.; Graf, A.; Krebs, S.; Kurome, M.; Zakhartchenko, V.; Flenkenthaler, F.; Blum, H.; Klymiuk, N.; Wolf, E.] Ludwig Maximilians Univ Munchen, Dept Vet Sci, Munich, Germany; [Giesert, F.; Wurst, W.] Tech Univ Munich, Inst Dev Genet, Helmholtz Ctr, Munich, Germany; [Giesert, F.; Wurst, W.] Tech Univ Munich, Munich Sch Life Sci Weihenstephan, Munich, Germany; [Froehlich, T.; Kessler, B.; Graf, A.; Krebs, S.; Kurome, M.; Zakhartchenko, V.; Flenkenthaler, F.; Blum, H.; Klymiuk, N.; Wolf, E.] Ludwig Maximilians Univ Munchen, Lab Funct Genome Anal LAFUGA, Gene Ctr, Munich, Germany; [Voelse, K.; Jeremias, I.] German Ctr Environm Hlth HMGU, Res Unit Apoptosis Hemopoiet Stem Cells, Helmholtz Zentrum Munchen, Munich, Germany; [Reichert, S.; Krause, S.; Walter, M. C.] Ludwig Maximilians Univ Munchen, Friedrich Baur Inst, Dept Neurol, Munich, Germany; [Dendorfer, A.] Ludwig Maximilians Univ Munchen, Univ Hosp, Walter Brendel Ctr Expt Med, Munich, Germany; [Schnieke, A.] Tech Univ Munich, Chair Livestock Biotechnol, Sch Life Sci Weihenstephan, Munich, Germany; [Wurst, W.] Munich Cluster Syst Neurol SyNergy, German Ctr Neurodegenerat Dis, Munich, Germany	Technical University of Munich; German Centre for Cardiovascular Research; Munich Heart Alliance; University of Munich; University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; Technical University of Munich; University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; University of Munich; Technical University of Munich; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); University of Munich	Moretti, A; Kupatt, C (corresponding author), Tech Univ Munich, Klinikum Rechts Isar, Klin & Poliklin Innere Med 1, Munich, Germany.; Moretti, A; Kupatt, C (corresponding author), German Ctr Cardiovasc Res DZHK, Munich Heart Alliance, Munich, Germany.	amoretti@mytum.de; christian.kupatt@tum.de	Klymiuk, Nikolai/AAB-8345-2022; Haufe, Tobias/HGB-3483-2022; Giesert, Florian/AAF-6499-2020; Haufe, Tobias/AAN-5934-2021; Hinkel, Rabea/I-9165-2014; Moretti, Alessandra/O-9271-2015; Jeremias, Irmela/Q-5934-2019; Krause, Sabine/AAJ-1163-2020; Martens, Eimo/AAX-3975-2021; Fröhlich, Thomas/C-6735-2011	Klymiuk, Nikolai/0000-0003-3532-1659; Haufe, Tobias/0000-0003-2397-3764; Hinkel, Rabea/0000-0002-2936-0400; Moretti, Alessandra/0000-0001-5782-7832; Jeremias, Irmela/0000-0003-1773-7677; Krause, Sabine/0000-0002-3141-886X; Martens, Eimo/0000-0002-5801-0901; Fröhlich, Thomas/0000-0002-4709-3211; Wurst, Wolfgang/0000-0003-4422-7410; Kupatt, Christian/0000-0002-3611-1218; Sinnecker, Daniel/0000-0002-8116-9750; Ziegler, Tilman/0000-0003-2291-5861; Giesert, Florian/0000-0001-6825-8858; SANTAMARIA, Gianluca/0000-0001-9284-7492; Meier, Anna/0000-0001-6307-3248; Sun, Shicheng/0000-0002-9584-9909; Poch, Christine Maria/0000-0001-8492-2982	Else Kroner-Fresenius Foundation [2015/180, 2018/T20]; European Research Council (ERC) [788381, 681524]; German Research Foundation (DFG) Transregio Research Unit 152; German Research Foundation (DFG) Transregio Research Unit 127; German Research Foundation (DFG) Transregio Research Unit 267; German Center for Cardiovascular Research Munich Heart Alliance; Rhythmia system	Else Kroner-Fresenius Foundation; European Research Council (ERC)(European Research Council (ERC)European Commission); German Research Foundation (DFG) Transregio Research Unit 152(German Research Foundation (DFG)); German Research Foundation (DFG) Transregio Research Unit 127(German Research Foundation (DFG)); German Research Foundation (DFG) Transregio Research Unit 267(German Research Foundation (DFG)); German Center for Cardiovascular Research Munich Heart Alliance; Rhythmia system	We thank the patient with DMD and the healthy volunteer who provided blood for iPSC reprogramming. We acknowledge C. Scherb for technical assistance with the molecular cloning and G. Lederer (Cytogenetic Department, TUM) for karyotyping, as well as M. Ogris (MMCT Laboratory of Macromolecular Cancer Therapeutics, Department of Pharmaceutical Chemistry, University of Vienna, Austria) for advice on the G2 coating and A. Blutke (Research Unit Analytical Pathology, Helmholtz Centre Munich) for help with the pathological workup. A. Frank (Department of Apoptosis Research, Helmholtz Centre Munich) established the capillary western blot. M. Kosters (Gene Center, LMU) provided technical assistance with the mass spectrometry. The Muscular Dystrophy Association (USA) supports monoclonal antibody development in the laboratory of G. E. Morris, whom we thank for providing the MANDAG antibody against beta-dystroglycan. This work was supported by grants from the Else Kroner-Fresenius Foundation (2015/180 and 2018/T20 to C.K., E.W. and W.W.), the European Research Council (ERC 788381 to A.M. and ERC 681524 to I.J.), German Research Foundation (DFG) Transregio Research Units 152 (to A.M. and K.L.L.), 127 (to E.W., A.S., A.B., N.K. and C.K.) and 267 (to A.M., A.S., K.L.L. and C.K.), and the German Center for Cardiovascular Research Munich Heart Alliance (to A.M., K.L.L. and C.K.). Generous support from A. Klesius and coworkers (Boston Scientific) with the Rhythmia system is gratefully acknowledged.	Aartsma-Rus A, 2006, MUSCLE NERVE, V34, P135, DOI 10.1002/mus.20586; Aartsma-Rus A, 2009, HUM MUTAT, V30, P293, DOI 10.1002/humu.20918; Amoasii L, 2018, SCIENCE, V362, P86, DOI 10.1126/science.aau1549; BAR S, 1990, BIOCHEM J, V272, P557, DOI 10.1042/bj2720557; Bengtsson NE, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14454; Chew WL, 2016, NAT METHODS, V13, P868, DOI 10.1038/nmeth.3993; Childers MK, 2011, JOVE-J VIS EXP, V50, P2623; Choi IY, 2016, CELL REP, V15, P2301, DOI 10.1016/j.celrep.2016.05.016; Concordet JP, 2018, NUCLEIC ACIDS RES, V46, pW242, DOI 10.1093/nar/gky354; Dorn T, 2018, EMBO J, V37, DOI 10.15252/embj.201798133; El Refaey M, 2017, CIRC RES, V121, P923, DOI 10.1161/CIRCRESAHA.117.310996; Feingold B, 2017, CIRCULATION, V136, pE200, DOI 10.1161/CIR.0000000000000526; Fischer B, 2018, STEM CELL RES, V32, P65, DOI 10.1016/j.scr.2018.08.015; Fischer C, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-08003-1; Goemans NM, 2011, NEW ENGL J MED, V364, P1513, DOI 10.1056/NEJMoa1011367; Gramlich M, 2015, EMBO MOL MED, V7, P562, DOI 10.15252/emmm.201505047; Hinderer C, 2018, HUM GENE THER, V29, P285, DOI 10.1089/hum.2018.015; Hinkel R, 2017, J AM COLL CARDIOL, V69, P131, DOI 10.1016/j.jacc.2016.10.058; Jiwlawat N, 2018, STEM CELLS INT, V2018, DOI 10.1155/2018/6241681; Kawaguchi T, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19061546; Klymiuk N, 2013, HUM MOL GENET, V22, P4368, DOI 10.1093/hmg/ddt287; Kupatt C, 2007, J AM COLL CARDIOL, V49, P1575, DOI 10.1016/j.jacc.2006.11.047; Kupatt C, 2010, J AM COLL CARDIOL, V56, P414, DOI 10.1016/j.jacc.2010.03.050; Kurome M, 2015, METHODS MOL BIOL, V1222, P37, DOI 10.1007/978-1-4939-1594-1_4; Labun K, 2019, NUCLEIC ACIDS RES, V47, pW171, DOI 10.1093/nar/gkz365; Leyva-Leyva M, 2018, J MEMBRANE BIOL, V251, P535, DOI 10.1007/s00232-018-0036-9; Lian XJ, 2013, NAT PROTOC, V8, P162, DOI 10.1038/nprot.2012.150; Lindsay H, 2016, NAT BIOTECHNOL, V34, P701, DOI 10.1038/nbt.3628; Long CZ, 2016, SCIENCE, V351, P400, DOI 10.1126/science.aad5725; Martin P., 2007, MEASURING BEHAV INTR, DOI 10.1017/CBO9780511810893; Moretti A, 2010, NEW ENGL J MED, V363, P1397, DOI 10.1056/NEJMoa0908679; MOSER H, 1984, HUM GENET, V66, P17, DOI 10.1007/BF00275183; Nelson CE, 2019, NAT MED, V25, P427, DOI 10.1038/s41591-019-0344-3; Nelson CE, 2016, SCIENCE, V351, P403, DOI 10.1126/science.aad5143; Pathik Bhupesh, 2017, JACC Clin Electrophysiol, V3, P971, DOI 10.1016/j.jacep.2017.01.019; Perez-Riverol Y, 2019, NUCLEIC ACIDS RES, V47, pD442, DOI 10.1093/nar/gky1106; Pleger ST, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002097; Punnoose AR, 2016, PEDIATR CARDIOL, V37, P1290, DOI 10.1007/s00246-016-1432-5; Richter A, 2012, BMC BIOTECHNOL, V12, DOI 10.1186/1472-6750-12-84; RStudio Inc, 2015, RSTUDIO INT DEV R; Sharp PS, 2011, MOL THER, V19, P165, DOI 10.1038/mt.2010.213; Stauffer W, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-33592-8; Van der Auwera Geraldine A, 2013, Curr Protoc Bioinformatics, V43, DOI [10.1002/0471250953.bi1201s43, 10.1002/0471250953.bi1110s43]; Tabebordbar M, 2016, SCIENCE, V351, P407, DOI 10.1126/science.aad5177; Thajudeen A, 2015, PACE, V38, P663, DOI 10.1111/pace.12581; Truong DJJ, 2015, NUCLEIC ACIDS RES, V43, P6450, DOI 10.1093/nar/gkv601; Tyanova S, 2016, NAT PROTOC, V11, P2301, DOI 10.1038/nprot.2016.136; US National Institutes of Health, 1996, NIH PUBLICATION; van Deutekom JC, 2007, NEW ENGL J MED, V357, P2677, DOI 10.1056/NEJMoa073108; Verhaart IEC, 2014, MOL THER-NUCL ACIDS, V3, DOI 10.1038/mtna.2014.1; Vetter A, 2013, MOL PHARMACEUT, V10, P606, DOI 10.1021/mp300366f; Wagner DL, 2019, NAT MED, V25, P242, DOI 10.1038/s41591-018-0204-6; Walter MC, 2017, J CACHEXIA SARCOPENI, V8, P681, DOI 10.1002/jcsm.12245; White S, 2002, AM J HUM GENET, V71, P365, DOI 10.1086/341942; Young CS, 2016, CELL STEM CELL, V18, P533, DOI 10.1016/j.stem.2016.01.021; Zincarelli C, 2008, MOL THER, V16, P1073, DOI 10.1038/mt.2008.76	56	97	100	5	51	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	FEB	2020	26	2					207	+		10.1038/s41591-019-0738-2	http://dx.doi.org/10.1038/s41591-019-0738-2		JAN 2020	27	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	KK7DU	31988462	Green Accepted			2022-12-27	WOS:000510552300002
J	Brudno, JN; Lam, N; Vanasse, D; Shen, YW; Rose, JJ; Rossi, J; Xue, A; Bot, A; Scholler, N; Mikkilineni, L; Roschewski, M; Dean, R; Cachau, R; Youkharibache, P; Patel, R; Hansen, B; Stroncek, DF; Rosenberg, SA; Gress, RE; Kochenderfer, JN				Brudno, Jennifer N.; Lam, Norris; Vanasse, Danielle; Shen, Yueh-wei; Rose, Jeremy J.; Rossi, John; Xue, Allen; Bot, Adrian; Scholler, Nathalie; Mikkilineni, Lekha; Roschewski, Mark; Dean, Robert; Cachau, Raul; Youkharibache, Philippe; Patel, Rashmika; Hansen, Brenna; Stroncek, David F.; Rosenberg, Steven A.; Gress, Ronald E.; Kochenderfer, James N.			Safety and feasibility of anti-CD19 CAR T cells with fully human binding domains in patients with B-cell lymphoma	NATURE MEDICINE			English	Article							CHIMERIC-ANTIGEN-RECEPTOR; ADOPTIVE IMMUNOTHERAPY; THERAPY; REMISSIONS; CD19; LYMPHODEPLETION; TRANSPLANTATION; NEUROTOXICITY; MALIGNANCIES; LYMPHOCYTES	Anti-CD19 chimeric antigen receptor (CAR)-expressing T cells are an effective treatment for B-cell lymphoma, but often cause neurologic toxicity. We treated 20 patients with B-cell lymphoma on a phase I, first-in-human clinical trial of T cells expressing the new anti-CD19 CAR Hu19-CD828Z (). The primary objective was to assess safety and feasibility of Hu19-CD828Z T-cell therapy. Secondary objectives included assessments of blood levels of CAR T cells, anti-lymphoma activity, second infusions and immunogenicity. All objectives were met. Fifty-five percent of patients who received Hu19-CD828Z T cells obtained complete remission. Hu19-CD828Z T cells had clinical anti-lymphoma activity similar to that of T cells expressing FMC63-28Z, an anti-CD19 CAR tested previously by our group, which contains murine binding domains and is used in axicabtagene ciloleucel. However, severe neurologic toxicity occurred in only 5% of patients who received Hu19-CD828Z T cells, whereas 50% of patients who received FMC63-28Z T cells experienced this degree of toxicity (P = 0.0017). T cells expressing Hu19-CD828Z released lower levels of cytokines than T cells expressing FMC63-28Z. Lower levels of cytokines were detected in blood from patients who received Hu19-CD828Z T cells than in blood from those who received FMC63-28Z T cells, which could explain the lower level of neurologic toxicity associated with Hu19-CD828Z. Levels of cytokines released by CAR-expressing T cells particularly depended on the hinge and transmembrane domains included in the CAR design.	[Brudno, Jennifer N.; Lam, Norris; Vanasse, Danielle; Rose, Jeremy J.; Hansen, Brenna; Gress, Ronald E.; Kochenderfer, James N.] NCI, Expt Transplantat & Immunotherapy Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Shen, Yueh-wei; Rossi, John; Xue, Allen; Bot, Adrian; Scholler, Nathalie] Kite Pharma, Santa Monica, CA USA; [Mikkilineni, Lekha] NCI, Med Oncol Hematol Fellowship Program, Bethesda, MD 20892 USA; [Roschewski, Mark] NCI, Lymphoid Malignancy Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Dean, Robert] Cleveland Clin, Taussig Canc Ctr, Cleveland, OH 44106 USA; [Cachau, Raul] Frederick Natl Lab Canc Res, Adv Biomed Computat Sci, Frederick, MD USA; [Youkharibache, Philippe] NCI, Canc Data Sci Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Patel, Rashmika] NCI, Off Regulatory Affairs, NIH, Bethesda, MD 20892 USA; [Stroncek, David F.] NIH, Ctr Cellular Engn, Ctr Clin, Bldg 10, Bethesda, MD 20892 USA; [Rosenberg, Steven A.] NCI, Surg Branch, Ctr Canc Res, NIH, Bldg 10, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Cleveland Clinic Foundation; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH Clinical Center (CC); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Kochenderfer, JN (corresponding author), NCI, Expt Transplantat & Immunotherapy Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA.	kochendj@mail.nih.gov	Youkharibache, Philippe/AAH-6410-2020	Scholler, nathalie/0000-0003-3743-7102; Kochenderfer, James/0000-0002-4362-9875	NHLBI; National Cancer Institute Intramural funding; Kite, a Gilead Company	NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Cancer Institute Intramural funding; Kite, a Gilead Company	The clinical LSIN-Hu19-CD828Z vector was produced and gene-therapy monitoring was performed with assistance from the NHLBI-funded National Gene Vector Biorepository at Indiana University. We thank the following clinical units at the NIH clinical center for patient care: Experimental Transplantation and Immunotherapy Branch Clinical Service, the 3 Northeast Nursing Unit and the Department of Critical Care Medicine and the Intensive Care Unit staff. Funding for this work was from National Cancer Institute Intramural funding and Kite, a Gilead Company.	Alabanza L, 2017, MOL THER, V25, P2452, DOI 10.1016/j.ymthe.2017.07.013; Bello M, 2016, MOL BIOSYST, V12, P1350, DOI 10.1039/c6mb00058d; Brentjens RJ, 2007, CLIN CANCER RES, V13, P5426, DOI 10.1158/1078-0432.CCR-07-0674; Brudno JN, 2019, BLOOD REV, V34, P45, DOI 10.1016/j.blre.2018.11.002; Brudno JN, 2018, J CLIN ONCOL, V36, P2267, DOI 10.1200/JCO.2018.77.8084; Brudno JN, 2018, NAT REV CLIN ONCOL, V15, P31, DOI 10.1038/nrclinonc.2017.128; Brudno JN, 2016, BLOOD, V127, P3321, DOI 10.1182/blood-2016-04-703751; Brudno JN, 2016, J CLIN ONCOL, V34, P1112, DOI 10.1200/JCO.2015.64.5929; CACHAU RE, 1994, PROTEIN ENG, V7, P831, DOI 10.1093/protein/7.7.831; Cheson BD, 2007, J CLIN ONCOL, V25, P579, DOI 10.1200/JCO.2006.09.2403; De Angelo D, 2017, SITC 2017 ANN M; Feldman SA, 2011, HUM GENE THER, V22, P107, DOI 10.1089/hum.2010.064; Feucht J, 2019, NAT MED, V25, P82, DOI 10.1038/s41591-018-0290-5; Gattinoni L, 2005, J EXP MED, V202, P907, DOI 10.1084/jem.20050732; Ghorashian S, 2019, NAT MED, V25, P1408, DOI 10.1038/s41591-019-0549-5; Goff SL, 2016, J CLIN ONCOL, V34, P2389, DOI 10.1200/JCO.2016.66.7220; Gust J, 2019, ANN NEUROL, V86, P42, DOI 10.1002/ana.25502; Gust J, 2017, CANCER DISCOV, V7, P1404, DOI 10.1158/2159-8290.CD-17-0698; Hirayama AV, 2019, AM J HEMATOL, V94, pS42, DOI 10.1002/ajh.25445; Hughes MS, 2005, HUM GENE THER, V16, P457, DOI 10.1089/hum.2005.16.457; Johnson LA, 2017, CELL RES, V27, P38, DOI 10.1038/cr.2016.154; Karschnia P, 2019, BLOOD, V133, P2212, DOI 10.1182/blood-2018-12-893396; Kochenderfer JN, 2017, MOL THER, V25, P2245, DOI 10.1016/j.ymthe.2017.07.004; Kochenderfer JN, 2017, J CLIN ONCOL, V35, DOI 10.1200/JCO.2016.71.3024; Kochenderfer JN, 2015, J CLIN ONCOL, V33, P540, DOI 10.1200/JCO.2014.56.2025; Kochenderfer JN, 2012, BLOOD, V119, P2709, DOI 10.1182/blood-2011-10-384388; Kochenderfer JN, 2010, BLOOD, V116, P4099, DOI 10.1182/blood-2010-04-281931; Kochenderfer JN, 2010, BLOOD, V116, P3875, DOI 10.1182/blood-2010-01-265041; Kochenderfer JN, 2009, J IMMUNOTHER, V32, P689, DOI 10.1097/CJI.0b013e3181ac6138; Lee DW, 2019, BIOL BLOOD MARROW TR, V25, P625, DOI 10.1016/j.bbmt.2018.12.758; Locke FL, 2019, LANCET ONCOL, V20, P31, DOI 10.1016/S1470-2045(18)30864-7; Marrink SJ, 2019, CHEM REV, V119, P6184, DOI 10.1021/acs.chemrev.8b00460; Meierhoff G, 2002, DIABETES-METAB RES, V18, P367, DOI 10.1002/dmrr.320; Morgan RA, 2010, MOL THER, V18, P843, DOI 10.1038/mt.2010.24; National Cancer Institute Common Terminology Criteria for Adverse Events v3.0 (CTCAE), 2006, NATL CANC I COMMON T; Neelapu SS, 2017, NEW ENGL J MED, V377, P2531, DOI 10.1056/NEJMoa1707447; Neelapu SS, 2018, NAT REV CLIN ONCOL, V15, P47, DOI 10.1038/nrclinonc.2017.148; NORTH RJ, 1982, J EXP MED, V155, P1063, DOI 10.1084/jem.155.4.1063; Ramos CA, 2018, MOL THER, V26, P2727, DOI 10.1016/j.ymthe.2018.09.009; Ramos CA, 2016, ANNU REV MED, V67, P165, DOI 10.1146/annurev-med-051914-021702; Sadelain M, 2015, J CLIN INVEST, V125, P3392, DOI 10.1172/JCI80010; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Santomasso BD, 2018, CANCER DISCOV, V8, P958, DOI 10.1158/2159-8290.CD-17-1319; Savoldo B, 2011, J CLIN INVEST, V121, P1822, DOI 10.1172/JCI46110; Schuster SJ, 2019, NEW ENGL J MED, V380, P45, DOI 10.1056/NEJMoa1804980; Schuster SJ, 2017, NEW ENGL J MED, V377, P2545, DOI 10.1056/NEJMoa1708566; Sievers S. A., 2019, P AACR ANN M; Singh N, 2017, CYTOTHERAPY, V19, P867, DOI 10.1016/j.jcyt.2017.04.001; Taraseviciute A, 2018, CANCER DISCOV, V8, P750, DOI 10.1158/2159-8290.CD-17-1368; Teachey DT, 2016, CANCER DISCOV, V6, P664, DOI 10.1158/2159-8290.CD-16-0040; Turtle CJ, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf8621; Warren EH, 2010, BLOOD, V115, P3869, DOI 10.1182/blood-2009-10-248997; Ying ZT, 2019, NAT MED, V25, P947, DOI 10.1038/s41591-019-0421-7; Yokoyama S, 2018, ELIFE, V7, DOI 10.7554/eLife.37854; Zheng ZL, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-29	55	117	124	7	44	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	FEB	2020	26	2					270	+		10.1038/s41591-019-0737-3	http://dx.doi.org/10.1038/s41591-019-0737-3		JAN 2020	27	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	KK7DU	31959992	Green Accepted			2022-12-27	WOS:000510551600004
J	Morrow, EM				Morrow, Eric M.			Paternal sperm DNA mosaicism and recurrence risk of autism in families	NATURE MEDICINE			English	Editorial Material								Sequencing of paternal sperm DNA allows the identification of male germline mosaicism and may assist with recurrence risk prediction of de novo genetic variants associated with autism in some families.	[Morrow, Eric M.] Brown Univ, Dept Mol Biol Cell Biol & Biochem, Providence, RI 02912 USA; [Morrow, Eric M.] Emma Pendleton Bradley Hosp, Dev Disorders Genet Res Program, East Providence, RI 02915 USA; [Morrow, Eric M.] Brown Univ, Hassenfeld Child Hlth Innovat Inst, Providence, RI 02912 USA; [Morrow, Eric M.] Brown Univ, Ctr Translat Neurosci, Robert J & Nancy D Carney Inst Brain Sci, Providence, RI 02912 USA; [Morrow, Eric M.] Brown Univ, Brown Inst Translat Sci, Providence, RI 02912 USA	Brown University; Brown University; Brown University; Brown University	Morrow, EM (corresponding author), Brown Univ, Dept Mol Biol Cell Biol & Biochem, Providence, RI 02912 USA.; Morrow, EM (corresponding author), Emma Pendleton Bradley Hosp, Dev Disorders Genet Res Program, East Providence, RI 02915 USA.; Morrow, EM (corresponding author), Brown Univ, Hassenfeld Child Hlth Innovat Inst, Providence, RI 02912 USA.; Morrow, EM (corresponding author), Brown Univ, Ctr Translat Neurosci, Robert J & Nancy D Carney Inst Brain Sci, Providence, RI 02912 USA.; Morrow, EM (corresponding author), Brown Univ, Brown Inst Translat Sci, Providence, RI 02912 USA.	eric_morrow@brown.edu	Morrow, Eric/J-2767-2013	Morrow, Eric/0000-0003-3430-3520				Bernkopf M, 2017, HUM MUTAT, V38, P1360, DOI 10.1002/humu.23281; Breuss, 2019, NAT MED, DOI [10.1038/s41591-019-0711-0, DOI 10.1038/S41591-019-0711-0]; Hancarova M, 2019, AM J MED GENET A, V179, P2119, DOI 10.1002/ajmg.a.61302; Jonsson H, 2017, NATURE, V549, P519, DOI 10.1038/nature24018; Kong A, 2012, NATURE, V488, P471, DOI 10.1038/nature11396; Ramaswami Gokul, 2018, Handb Clin Neurol, V147, P321, DOI 10.1016/B978-0-444-63233-3.00021-X; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; Wilbe M, 2017, PRENATAL DIAG, V37, P1146, DOI 10.1002/pd.5156	8	3	3	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JAN	2020	26	1					26	28		10.1038/s41591-019-0732-8	http://dx.doi.org/10.1038/s41591-019-0732-8			3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	KG3GZ	31873313				2022-12-27	WOS:000509831900022
J	Emilsson, V; Gudnason, V; Jennings, LL				Emilsson, Valur; Gudnason, Vilmundur; Jennings, Lori L.			Predicting health and life span with the deep plasma proteome	NATURE MEDICINE			English	Editorial Material							NETWORKS	Recent large-scale proteomic studies reveal the association of levels of circulating proteins with life span and many health-related outcomes.	[Emilsson, Valur; Gudnason, Vilmundur] Iceland Heart Assoc, Kopavogur, Iceland; [Emilsson, Valur; Gudnason, Vilmundur] Univ Iceland, Fac Med, Reykjavik, Iceland; [Jennings, Lori L.] Novartis Inst BioMed Res, Cambridge, MA USA	Icelandic Heart Association; University of Iceland; Novartis	Emilsson, V (corresponding author), Iceland Heart Assoc, Kopavogur, Iceland.; Emilsson, V (corresponding author), Univ Iceland, Fac Med, Reykjavik, Iceland.	valur@hjarta.is	Gudnason, Vilmundur/K-6885-2015	Gudnason, Vilmundur/0000-0001-5696-0084; Emilsson, Valur/0000-0001-9982-0524				Cohen JD, 2018, SCIENCE, V359, P926, DOI 10.1126/science.aar3247; Conboy IM, 2005, NATURE, V433, P760, DOI 10.1038/nature03260; Dodgson SE, 2018, CELL, V173, P1, DOI 10.1016/j.cell.2018.03.012; Emilsson V, 2018, SCIENCE, V361, P769, DOI 10.1126/science.aaq1327; Lehallier B, 2019, NAT MED, V25, P1843, DOI 10.1038/s41591-019-0673-2; Middeldorp J, 2016, JAMA NEUROL, V73, P1325, DOI 10.1001/jamaneurol.2016.3185; Nakamura A, 2018, NATURE, V554, P249, DOI 10.1038/nature25456; Schadt EE, 2009, NATURE, V461, P218, DOI 10.1038/nature08454; Sherman RE, 2016, NEW ENGL J MED, V375, P2293, DOI 10.1056/NEJMsb1609216; Sun BB, 2018, NATURE, V558, P73, DOI 10.1038/s41586-018-0175-2; Villeda SA, 2011, NATURE, V477, P90, DOI 10.1038/nature10357; Williams SA, 2019, NAT MED, V25, P1851, DOI 10.1038/s41591-019-0665-2	12	9	9	1	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	2019	25	12					1815	1816		10.1038/s41591-019-0677-y	http://dx.doi.org/10.1038/s41591-019-0677-y			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	JT2KO	31806904				2022-12-27	WOS:000500824900019
J	Frodermann, V; Rohde, D; Courties, G; Severe, N; Schloss, MJ; Amatullah, H; McAlpine, CS; Cremer, S; Hoyer, FF; Ji, F; van Koeverden, ID; Herisson, F; Honold, L; Masson, GS; Zhang, S; Grune, J; Iwamoto, Y; Schmidt, SP; Wojtkiewicz, GR; Lee, IH; Gustafsson, K; Pasterkamp, G; de Jager, SCA; Sadreyev, RI; MacFadyen, J; Libby, P; Ridker, P; Scadden, DT; Naxerova, K; Jeffrey, KL; Swirski, FK; Nahrendorf, M				Frodermann, Vanessa; Rohde, David; Courties, Gabriel; Severe, Nicolas; Schloss, Maximilian J.; Amatullah, Hajera; McAlpine, Cameron S.; Cremer, Sebastian; Hoyer, Friedrich F.; Ji, Fei; van Koeverden, Ian D.; Herisson, Fanny; Honold, Lisa; Masson, Gustavo Santos; Zhang, Shuang; Grune, Jana; Iwamoto, Yoshiko; Schmidt, Stephen P.; Wojtkiewicz, Gregory R.; Lee, I-Hsiu; Gustafsson, Karin; Pasterkamp, Gerard; de Jager, Saskia C. A.; Sadreyev, Ruslan I.; MacFadyen, Jean; Libby, Peter; Ridker, Paul; Scadden, David T.; Naxerova, Kamila; Jeffrey, Kate L.; Swirski, Filip K.; Nahrendorf, Matthias			Exercise reduces inflammatory cell production and cardiovascular inflammation via instruction of hematopoietic progenitor cells	NATURE MEDICINE			English	Article							DIFFERENTIAL EXPRESSION ANALYSIS; MESENCHYMAL STROMAL CELLS; SERUM LEPTIN; STEM-CELLS; ATHEROSCLEROTIC PLAQUE; MYOCARDIAL-INFARCTION; PERIPHERAL-BLOOD; LEUKOCYTE COUNT; RECEPTOR; PREVENTION	A sedentary lifestyle, chronic inflammation and leukocytosis increase atherosclerosis; however, it remains unclear whether regular physical activity influences leukocyte production. Here we show that voluntary running decreases hematopoietic activity in mice. Exercise protects mice and humans with atherosclerosis from chronic leukocytosis but does not compromise emergency hematopoiesis in mice. Mechanistically, exercise diminishes leptin production in adipose tissue, augmenting quiescence-promoting hematopoietic niche factors in leptin-receptor-positive stromal bone marrow cells. Induced deletion of the leptin receptor in Prrx1-creER(T2); Lepr(fl/fl) mice reveals that leptin's effect on bone marrow niche cells regulates hematopoietic stem and progenitor cell (HSPC) proliferation and leukocyte production, as well as cardiovascular inflammation and outcomes. Whereas running wheel withdrawal quickly reverses leptin levels, the impact of exercise on leukocyte production and on the HSPC epigenome and transcriptome persists for several weeks. Together, these data show that physical activity alters HSPCs via modulation of their niche, reducing hematopoietic output of inflammatory leukocytes.	[Frodermann, Vanessa; Rohde, David; Courties, Gabriel; Schloss, Maximilian J.; McAlpine, Cameron S.; Cremer, Sebastian; Hoyer, Friedrich F.; Herisson, Fanny; Honold, Lisa; Masson, Gustavo Santos; Zhang, Shuang; Grune, Jana; Iwamoto, Yoshiko; Schmidt, Stephen P.; Wojtkiewicz, Gregory R.; Lee, I-Hsiu; Naxerova, Kamila; Swirski, Filip K.; Nahrendorf, Matthias] Harvard Med Sch, Massachusetts Gen Hosp, Dept Radiol, Ctr Syst Biol, Boston, MA 02115 USA; [Severe, Nicolas; Gustafsson, Karin; Scadden, David T.] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Severe, Nicolas; Gustafsson, Karin; Scadden, David T.] Massachusetts Gen Hosp, Ctr Regenerat Med, Boston, MA 02114 USA; [Severe, Nicolas; Gustafsson, Karin; Scadden, David T.] Massachusetts Gen Hosp, Ctr Canc, Boston, MA USA; [Amatullah, Hajera; Jeffrey, Kate L.] Harvard Med Sch, Gastrointestinal Unit, Boston, MA 02115 USA; [Amatullah, Hajera; Jeffrey, Kate L.] Harvard Med Sch, Massachusetts Gen Hosp, Ctr Study Inflammatory Bowel Dis, Boston, MA 02115 USA; [Ji, Fei] Harvard Med Sch, Dept Genet, Boston, MA 02115 USA; [Ji, Fei; Sadreyev, Ruslan I.] Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; [van Koeverden, Ian D.; de Jager, Saskia C. A.] Univ Med Ctr Utrecht, Dept Cardiol, Lab Expt Cardiol, Utrecht, Netherlands; [Pasterkamp, Gerard] Univ Med Ctr Utrecht, Lab Clin Chem & Haematol, Utrecht, Netherlands; [de Jager, Saskia C. A.] Univ Med Ctr Utrecht, Lab Translat Immunol, Utrecht, Netherlands; [Sadreyev, Ruslan I.] Harvard Med Sch, Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02115 USA; [MacFadyen, Jean; Libby, Peter; Ridker, Paul] Brigham & Womens Hosp, Dept Med, Div Cardiovasc Med, 75 Francis St, Boston, MA 02115 USA; [MacFadyen, Jean; Libby, Peter; Ridker, Paul] Harvard Med Sch, Boston, MA 02115 USA; [Nahrendorf, Matthias] Harvard Med Sch, Massachusetts Gen Hosp, Cardiovasc Res Ctr, Boston, MA 02115 USA; [Nahrendorf, Matthias] Univ Hosp Wuerzburg, Dept Internal Med 1, Wurzburg, Germany	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Massachusetts General Hospital; University of Wurzburg	Nahrendorf, M (corresponding author), Harvard Med Sch, Massachusetts Gen Hosp, Dept Radiol, Ctr Syst Biol, Boston, MA 02115 USA.; Nahrendorf, M (corresponding author), Harvard Med Sch, Massachusetts Gen Hosp, Cardiovasc Res Ctr, Boston, MA 02115 USA.; Nahrendorf, M (corresponding author), Univ Hosp Wuerzburg, Dept Internal Med 1, Wurzburg, Germany.	mnahrendorf@mgh.harvard.edu	Hoyer, Friedrich/AAC-8097-2022; Libby, Peter/AAY-6404-2021; Gustafsson, Karin/AAA-3796-2020; de+Jager, Saskia/ABC-4264-2020; Zhang, Shuang/AAR-5376-2021; de+Jager, Saskia/AAE-1132-2022; Wojtkiewicz, Gregory/L-3660-2018	Libby, Peter/0000-0002-1502-502X; Zhang, Shuang/0000-0001-5570-5954; Frodermann, Vanessa/0000-0001-5566-6692; McAlpine, Cameron/0000-0002-9832-6345; de Jager, Saskia/0000-0002-5233-0066; Naxerova, Kamila/0000-0001-7744-5110; Jeffrey, Kate/0000-0001-5746-0153; Wojtkiewicz, Gregory/0000-0002-3148-8411; Swirski, Filip/0000-0002-3163-9152	National Institutes of Health [P30 AR066261, HL142494, HL139598, HL131478, HL128264, AI07087, DK040561, T32HL076136]; European Union [667837]; Deutsche Forschungsgemeinschaft [CR 603/1-1, HO 5279/1-2, RO 5071/1-1]; Netherlands Organisation for Scientific Research [835.15.014]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL125428, T32HL076136, P01HL142494, P01HL131478, R35HL139598, R01HL128264] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR066261] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK040561] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Union(European Commission); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Netherlands Organisation for Scientific Research(Netherlands Organization for Scientific Research (NWO)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank M. Handley, E. Surette and A. Galvin of the HSCI-CRM Flow Cytometry Core Facility, Massachusetts General Hospital, for assistance with cell sorting, the Center for Skeletal Research Imaging and Biomechanical Testing Core (National Institutes of Health P30 AR066261), Massachusetts General Hospital, for bone histology and mu CT imaging, the Bioanalytics Core at the Diabetes and Obesity Center, Christina Lee Brown Envirome Institute, University of Louisville, for mass spectrometry analysis, the BPF Next-Gen Sequencing Core Facility at Harvard Medical School for their support for RNA-sequencing and K. Joyes for editing the manuscript. This work was funded in part by federal funds from the National Institutes of Health (HL142494, HL139598, HL131478, HL128264, AI07087, DK040561 and T32HL076136), the European Union's Horizon 2020 research and innovation program (grant agreement no. 667837), the Deutsche Forschungsgemeinschaft (CR 603/1-1, HO 5279/1-2 and RO 5071/1-1) and a fellowship from the Netherlands Organisation for Scientific Research (Rubicon Grant: 835.15.014). We acknowledge Servier Medical Art (https://smart.servier.com) for providing images of mice and components of the cartoon.	Abella V, 2017, NAT REV RHEUMATOL, V13, P100, DOI 10.1038/nrrheum.2016.209; Agha NH, 2018, BRAIN BEHAV IMMUN, V68, P66, DOI 10.1016/j.bbi.2017.10.001; Arnett DK, 2019, J AM COLL CARDIOL, V74, P1376, DOI 10.1016/j.jacc.2019.03.009; Asada N, 2017, INT J HEMATOL, V106, P45, DOI 10.1007/s12185-017-2262-9; Baker JM, 2011, FASEB J, V25, P4348, DOI 10.1096/fj.11-189043; Bennett BD, 1996, CURR BIOL, V6, P1170, DOI 10.1016/S0960-9822(02)70684-2; Bilic-Curcic I, 2005, GENESIS, V43, P87, DOI 10.1002/gene.20156; Bjorklund MM, 2014, CIRC RES, V114, P1684, DOI 10.1161/CIRCRESAHA.114.302937; Bouxsein ML, 2010, J BONE MINER RES, V25, P1468, DOI 10.1002/jbmr.141; Buenrostro Jason D, 2015, Curr Protoc Mol Biol, V109, DOI 10.1002/0471142727.mb2129s109; Cao JY, 2018, SCIENCE, V361, P1380, DOI 10.1126/science.aau0730; Corces MR, 2016, NAT GENET, V48, P1193, DOI 10.1038/ng.3646; De Lisio M, 2012, J APPL PHYSIOL, V113, P1576, DOI 10.1152/japplphysiol.00717.2012; de Visser L, 2005, BEHAV BRAIN RES, V160, P382, DOI 10.1016/j.bbr.2004.12.004; DeFalco J, 2001, SCIENCE, V291, P2608, DOI 10.1126/science.1056602; Ding L, 2012, NATURE, V481, P457, DOI 10.1038/nature10783; Duggal NA, 2019, NAT REV IMMUNOL, V19, P563, DOI 10.1038/s41577-019-0177-9; Engstrom G, 2009, CIRC-HEART FAIL, V2, P217, DOI 10.1161/CIRCHEARTFAILURE.108.827071; Fukao K, 2010, J ATHEROSCLER THROMB, V17, P1226, DOI 10.5551/jat.4788; Golan K, 2013, PHARMACEUTICALS, V6, P1145, DOI 10.3390/ph6091145; Groeneveld KM, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/509513; Halliday A, 2004, LANCET, V363, P1491; Heidt T, 2014, NAT MED, V20, P754, DOI 10.1038/nm.3589; Hirose H, 1998, CLIN SCI, V94, P633, DOI 10.1042/cs0940633; Ionita MG, 2010, ARTERIOSCL THROM VAS, V30, P1842, DOI 10.1161/ATVBAHA.110.209296; Ito K, 2014, NAT REV MOL CELL BIO, V15, P243, DOI 10.1038/nrm3772; Johannsen NM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031319; John S, 2011, NAT GENET, V43, P264, DOI 10.1038/ng.759; Kelesidis T, 2010, ANN INTERN MED, V152, P93, DOI 10.7326/0003-4819-152-2-201001190-00008; Konstantinides S, 2004, ARTERIOSCL THROM VAS, V24, P2196, DOI 10.1161/01.ATV.0000146531.79402.9a; Kunisaki Y, 2013, NATURE, V502, P637, DOI 10.1038/nature12612; Lam SW, 2011, CLIN CHEM LAB MED, V49, P493, DOI 10.1515/CCLM.2011.069; Lara-Astiaso D, 2014, SCIENCE, V345, P943, DOI 10.1126/science.1256271; Lavie CJ, 2019, CIRC RES, V124, P799, DOI 10.1161/CIRCRESAHA.118.312669; Lee DC, 2014, J AM COLL CARDIOL, V64, P472, DOI 10.1016/j.jacc.2014.04.058; Li H, 2012, BIOINFORMATICS, V28, P1838, DOI 10.1093/bioinformatics/bts280; Mabuchi T, 2005, DIABETES-METAB RES, V21, P441, DOI 10.1002/dmrr.540; Mackinnon L T, 1987, Adv Exp Med Biol, V216A, P869; Madjid M, 2004, J AM COLL CARDIOL, V44, P1945, DOI 10.1016/j.jacc.2004.07.056; McAlpine CS, 2019, NATURE, V566, P383, DOI 10.1038/s41586-019-0948-2; McCarthy DJ, 2012, NUCLEIC ACIDS RES, V40, P4288, DOI 10.1093/nar/gks042; Mehta S, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aag3160; Meissner M, 2011, ATHEROSCLEROSIS, V218, P323, DOI 10.1016/j.atherosclerosis.2011.06.040; Mendez-Ferrer S, 2010, NATURE, V466, P829, DOI 10.1038/nature09262; Mercier FE, 2016, STEM CELL REP, V6, P985, DOI 10.1016/j.stemcr.2016.04.010; Mignone JL, 2004, J COMP NEUROL, V469, P311, DOI 10.1002/cne.10964; Morrison SJ, 2014, NATURE, V505, P327, DOI 10.1038/nature12984; Nagareddy PR, 2014, CELL METAB, V19, P821, DOI 10.1016/j.cmet.2014.03.029; Nahrendorf M, 2015, CIRC RES, V116, P884, DOI 10.1161/CIRCRESAHA.116.303550; Orr JS, 2013, JOVE-J VIS EXP, DOI 10.3791/50707; Patro R, 2017, NAT METHODS, V14, P417, DOI 10.1038/nmeth.4197; Pellegrin M, 2009, MED SCI SPORT EXER, V41, P2128, DOI 10.1249/MSS.0b013e3181a8d530; Rajendran K, 2012, THROMB J, V10, DOI 10.1186/1477-9560-10-13; Ridker PM, 2017, NEW ENGL J MED, V377, P1119, DOI 10.1056/NEJMoa1707914; Ridker PM, 2016, EUR HEART J, V37, P1720, DOI 10.1093/eurheartj/ehw024; Rittirsch D, 2009, NAT PROTOC, V4, P31, DOI 10.1038/nprot.2008.214; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rostas I, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182801; Scheller EL, 2014, METHOD ENZYMOL, V537, P123, DOI 10.1016/B978-0-12-411619-1.00007-0; Shirato K, 2017, MEDIAT INFLAMM, V2017, DOI 10.1155/2017/9290416; Soneson C, 2015, F1000 RES, V4, P1521, DOI [10.12688/f1000research.7563.1, DOI 10.12688/F1000RESEARCH.7563.2]; SOPPI E, 1982, J CLIN LAB IMMUNOL, V8, P43; Surwit RS, 2000, DIABETES, V49, P1203, DOI 10.2337/diabetes.49.7.1203; Swirski FK, 2013, SCIENCE, V339, P161, DOI 10.1126/science.1230719; Tall AR, 2015, NAT REV IMMUNOL, V15, P104, DOI 10.1038/nri3793; Tanaka Y, 2010, NEUROIMMUNOMODULAT, V17, P279, DOI 10.1159/000290044; ten Berg MJ, 2007, CLIN CHEM LAB MED, V45, P13, DOI 10.1515/CCLM.2007.009; Tsujioka H, 2009, J AM COLL CARDIOL, V54, P130, DOI 10.1016/j.jacc.2009.04.021; Verhoeven BAN, 2004, EUR J EPIDEMIOL, V19, P1127, DOI 10.1007/s10564-004-2304-6; Wallerstedt SM, 2004, BLOOD PRESSURE, V13, P243, DOI 10.1080/08037050410021405; Yu GC, 2012, OMICS, V16, P284, DOI 10.1089/omi.2011.0118; Yu VWC, 2016, CELL, V167, P1310, DOI 10.1016/j.cell.2016.10.045; Yue R, 2016, CELL STEM CELL, V18, P782, DOI 10.1016/j.stem.2016.02.015; Zhou BO, 2014, CELL STEM CELL, V15, P154, DOI 10.1016/j.stem.2014.06.008	74	112	113	10	38	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2019	25	11					1761	+		10.1038/s41591-019-0633-x	http://dx.doi.org/10.1038/s41591-019-0633-x			31	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	JT2KI	31700184	Green Accepted			2022-12-27	WOS:000500824300036
J	Miranda, JJ; Barrientos-Gutierrez, T; Corvalan, C; Hyder, AA; Lazo-Porras, M; Oni, T; Wells, JCK				Miranda, J. Jaime; Barrientos-Gutierrez, Tonatiuh; Corvalan, Camila; Hyder, Adnan A.; Lazo-Porras, Maria; Oni, Tolu; Wells, Jonathan C. K.			Understanding the rise of cardiometabolic diseases in low- and middle-income countries	NATURE MEDICINE			English	Review							ULTRA-PROCESSED FOODS; SOCIETIES ENVIRONMENTAL COMMITTEE; TYPE-2 DIABETIC-PATIENTS; TOBACCO CONTROL POLICIES; AMBIENT AIR-POLLUTION; EARLY-LIFE ORIGINS; NONCOMMUNICABLE DISEASES; PUBLIC-HEALTH; GLOBAL BURDEN; CARDIOVASCULAR-DISEASE	Increases in the prevalence of noncommunicable diseases (NCDs), particularly cardiometabolic diseases such as cardiovascular disease, stroke and diabetes, and their major risk factors have not been uniform across settings: for example, cardiovascular disease mortality has declined over recent decades in high-income countries but increased in low- and middle-income countries (LMICs). The factors contributing to this rise are varied and are influenced by environmental, social, political and commercial determinants of health, among other factors. This Review focuses on understanding the rise of cardiometabolic diseases in LMICs, with particular emphasis on obesity and its drivers, together with broader environmental and macro determinants of health, as well as LMIC-based responses to counteract cardiometabolic diseases.	[Miranda, J. Jaime; Lazo-Porras, Maria] Univ Peruana Cayetano Heredia, CRONICAS Ctr Excellence Chron Dis, Lima, Peru; [Miranda, J. Jaime] Univ Peruana Cayetano Heredia, Sch Med, Lima, Peru; [Barrientos-Gutierrez, Tonatiuh] Natl Inst Publ Hlth, Ctr Populat Hlth Res, Cuernavaca, Morelos, Mexico; [Corvalan, Camila] Univ Chile, Inst Nutr & Food Technol, Unit Publ Hlth, Santiago, Chile; [Hyder, Adnan A.] George Washington Univ, Milken Inst Sch Publ Hlth, Washington, DC USA; [Lazo-Porras, Maria] Univ Geneva, Div Trop & Humanitarian Med, Geneva, Switzerland; [Oni, Tolu] Univ Cambridge, MRC Epidemiol Unit, Cambridge, England; [Oni, Tolu] Univ Cape Town, Sch Publ Hlth & Family Med, Div Publ Hlth Med, RICHE, Cape Town, South Africa; [Wells, Jonathan C. K.] UCL Great Ormond St Inst Child Hlth, Childhood Nutr Res Ctr, London, England	Universidad Peruana Cayetano Heredia; Universidad Peruana Cayetano Heredia; Instituto Nacional de Salud Publica; Universidad de Chile; George Washington University; University of Geneva; University of Cambridge; University of Cape Town; University of London; University College London	Miranda, JJ (corresponding author), Univ Peruana Cayetano Heredia, CRONICAS Ctr Excellence Chron Dis, Lima, Peru.; Miranda, JJ (corresponding author), Univ Peruana Cayetano Heredia, Sch Med, Lima, Peru.	Jaime.Miranda@upch.pe	Hyder, Adnan/AAT-9503-2021; Corvalan, Camila/B-2914-2011	Corvalan, Camila/0000-0003-3766-7709; Hyder, Adnan/0000-0002-7292-577X; Miranda, J. Jaime/0000-0002-4738-5468	Alliance for Health Policy and Systems Research [HQHSR1206660]; Bernard Lown Scholars in Cardiovascular Health Program at Harvard T.H. Chan School of Public Health [BLSCHP-1902]; Bloomberg Philanthropies; FONDECYT via CIENCIACTIVA/CONCYTEC; British Council; British Embassy; Newton-Paulet Fund [223-2018, 224-2018]; DFID/MRC/Wellcome Global Health Trials [MR/M007405/1]; Fogarty International Center [R21TW009982, D71TW010877]; Grand Challenges Canada [0335-04]; International Development Research Center Canada [IDRC 106887, 108167]; Inter-American Institute for Global Change Research [IAI CRN3036]; Medical Research Council [MR/P008984/1, MR/P024408/1, MR/P02386X/1]; US National Cancer Institute [1P20CA217231]; National Heart, Lung and Blood Institute [HHSN268200900033C, 5U01HL114180, 1UM1HL134590]; National Institute of Mental Health [1U19MH098780]; Swiss National Science Foundation [40P740-160366]; Wellcome [074833/Z/04/Z, 093541/Z/10/Z, 107435/Z/15/Z, 103994/Z/14/Z, 205177/Z/16/Z, 214185/Z/18/Z]; World Diabetes Foundation [WDF15-1224]; Bernard Lown Scholars in Cardiovascular Health Program at Harvard T.H. Chan School of Public Health; "Fondo Sectorial en Investigacion en Salud y Seguridad Social" from the National Council for Science and Technology of Mexico [CONACYT-FOSSIS-202671]; INTA, University of Chile; US National Institutes of Health's Fogarty International Center; Swiss Excellence Government Scholarship [2018.0698]; US National Institute for Health Research (NIHR) Global Health Research Group; US National Institute for Health Research (NIHR) Network on Diet and Activity; NIHR [16/137/34]; Stellenbosch Institute for Advanced Study; LIRA 2030 Africa Programme [LIRA2030-GR06/18]; Swedish International Development Cooperation Agency (Sida); University College London's Great Ormond Street Institute of Child Health; FOGARTY INTERNATIONAL CENTER [D71TW010877] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P20CA217231] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL114180, UM1HL134590] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [U19MH098780] Funding Source: NIH RePORTER; MRC [MR/M007405/1, MR/P024408/1] Funding Source: UKRI	Alliance for Health Policy and Systems Research; Bernard Lown Scholars in Cardiovascular Health Program at Harvard T.H. Chan School of Public Health; Bloomberg Philanthropies; FONDECYT via CIENCIACTIVA/CONCYTEC; British Council(The British Council in India); British Embassy; Newton-Paulet Fund; DFID/MRC/Wellcome Global Health Trials(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Grand Challenges Canada(CGIAR); International Development Research Center Canada(CGIAR); Inter-American Institute for Global Change Research; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); US National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Wellcome; World Diabetes Foundation; Bernard Lown Scholars in Cardiovascular Health Program at Harvard T.H. Chan School of Public Health; "Fondo Sectorial en Investigacion en Salud y Seguridad Social" from the National Council for Science and Technology of Mexico; INTA, University of Chile; US National Institutes of Health's Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Swiss Excellence Government Scholarship; US National Institute for Health Research (NIHR) Global Health Research Group; US National Institute for Health Research (NIHR) Network on Diet and Activity; NIHR(National Institute for Health Research (NIHR)); Stellenbosch Institute for Advanced Study; LIRA 2030 Africa Programme; Swedish International Development Cooperation Agency (Sida); University College London's Great Ormond Street Institute of Child Health; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	J.J.M. conceived the idea of linking child survival and adult population handicaps that will affect responses to NCDs and climate change while supported through an Erasmus Mundus Scholar at KIT Royal Tropical Institute, Amsterdam, in 2013. This idea was further elaborated through interactions with W. Pan, D. Beran, and F. Maldonado, among others. J.J.M. acknowledges having received support from the Alliance for Health Policy and Systems Research (HQHSR1206660), the Bernard Lown Scholars in Cardiovascular Health Program at Harvard T.H. Chan School of Public Health (BLSCHP-1902), Bloomberg Philanthropies, FONDECYT via CIENCIACTIVA/CONCYTEC, British Council, British Embassy and Newton-Paulet Fund (223-2018, 224-2018), DFID/MRC/Wellcome Global Health Trials (MR/M007405/1), Fogarty International Center (R21TW009982, D71TW010877), Grand Challenges Canada (0335-04), International Development Research Center Canada (IDRC 106887, 108167), Inter-American Institute for Global Change Research (IAI CRN3036), Medical Research Council (MR/P008984/1, MR/P024408/1, MR/P02386X/1), US National Cancer Institute (1P20CA217231), National Heart, Lung and Blood Institute (HHSN268200900033C, 5U01HL114180, 1UM1HL134590), National Institute of Mental Health (1U19MH098780), Swiss National Science Foundation (40P740-160366), Wellcome (074833/Z/04/Z, 093541/Z/10/Z, 107435/Z/15/Z, 103994/Z/14/Z, 205177/Z/16/Z, 214185/Z/18/Z) and the World Diabetes Foundation (WDF15-1224). T.B.-G. was supported by Bloomberg Philanthropies, the Bernard Lown Scholars in Cardiovascular Health Program at Harvard T.H. Chan School of Public Health, the "Fondo Sectorial en Investigacion en Salud y Seguridad Social" from the National Council for Science and Technology of Mexico (CONACYT-FOSSIS-202671) and Wellcome (205177/Z/16/Z). C.C. receives a salary as assistant professor at INTA, University of Chile. A.A.H. did not receive external funding for this work but has internal support as director of the Center on Commercial Determinants of Health, Milken Institute School of Public Health, George Washington University. He has received support from numerous agencies including current funding from the US National Institutes of Health's Fogarty International Center. M.L.-P. receives funding from the Swiss Excellence Government Scholarship (2018.0698). T.O. is supported by the US National Institute for Health Research (NIHR) Global Health Research Group and Network on Diet and Activity. The views expressed in this publication are those of the author and not necessarily those of the National Health Service, the NIHR or the Department of Health. Funding from NIHR (16/137/34) is gratefully acknowledged. T.O. is also supported by the Stellenbosch Institute for Advanced Study Iso Lomso Fellowship and LIRA 2030 Africa Programme (LIRA2030-GR06/18), implemented by the International Science Council (ISC) in partnership with the Network of African Science Academies (NASAC) with support from the Swedish International Development Cooperation Agency (Sida). J.C.K.W. receives a salary as a professor at University College London's Great Ormond Street Institute of Child Health. The authors acknowledge N. Paichadze and I. Bari from the Milken Institute School of Public Health, George Washington University, for their support with the case study on alcohol.	Academy of Medical Sciences, 2015, MULT MORB GLOB HLTH; Al-Kubaisy W, 2012, PROCD SOC BEHV, V38, P59, DOI 10.1016/j.sbspro.2012.03.324; Allemandi L, 2018, PUBLIC HEALTH NUTR, V21, P238, DOI 10.1017/S1368980017001446; [Anonymous], 2005, HLTH EFFECTS TRANSPO; [Anonymous], 2002, HLTH CIT IN AFR REG; Colchero MA, 2017, HEALTH AFFAIR, V36, P564, DOI 10.1377/hlthaff.2016.1231; Babor TF, 2013, AM J PUBLIC HEALTH, V103, P206, DOI 10.2105/AJPH.2012.300847; Bacardi-Gascon M, 2015, NUTR HOSP, V31, P1928, DOI 10.3305/nh.2015.31.5.8730; Baker P, 2016, GLOBALIZATION HEALTH, V12, DOI 10.1186/s12992-016-0223-3; Balakrishnan K, 2018, ENVIRON RES, V161, P524, DOI 10.1016/j.envres.2017.11.050; Barrientos-Gutierrez T, 2018, SALUD PUBLICA MEXICO, V60, P586, DOI 10.21149/9534; Basu S, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001540; Battersby J., 2014, URBAN FORUM, V25, P143, DOI [10.1007/s12132-014-9225-5, DOI 10.1007/S12132-014-9225-5]; Bennett JE, 2018, LANCET, V392, P1072, DOI 10.1016/S0140-6736(18)31992-5; Benziger CP, 2016, GLOB HEART, V11, P393, DOI 10.1016/j.gheart.2016.10.024; Beratarrechea A, 2019, J AM HEART ASSOC, V8, DOI 10.1161/JAHA.118.011799; Beratarrechea A, 2016, PROG CARDIOVASC DIS, V58, P661, DOI 10.1016/j.pcad.2016.03.003; Bixby H, 2019, NATURE, V569, P260, DOI 10.1038/s41586-019-1171-x; Black RE, 2008, LANCET, V371, P243, DOI 10.1016/S0140-6736(07)61690-0; Bloom DE, 2011, GLOBAL EC BURDEN NON, DOI DOI 10.1192/BJP.184.5.393; Bonjour S, 2013, ENVIRON HEALTH PERSP, V121, P784, DOI 10.1289/ehp.1205987; Bowry ADK, 2015, CAN J CARDIOL, V31, P1151, DOI 10.1016/j.cjca.2015.06.028; Brandkvist M, 2019, BMJ-BRIT MED J, V366, DOI 10.1136/bmj.l4067; BreatheLife, 2018, ACCR GHAN IS 1 AFR C; Buse K, 2017, GLOBALIZATION HEALTH, V13, DOI 10.1186/s12992-017-0255-3; Busse P, 2016, GLOB HEALTH PROMOT, V23, P50, DOI 10.1177/1757975914547923; Carey G, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-009002; Carrillo-Larco RM, 2018, JMIR MHEALTH UHEALTH, V6, DOI 10.2196/10226; Cediel G, 2018, PUBLIC HEALTH NUTR, V21, P125, DOI 10.1017/S1368980017001161; Chakraborty D, 2018, ECOTOX ENVIRON SAFE, V161, P706, DOI 10.1016/j.ecoenv.2018.06.024; Collins TE, 2019, BMJ-BRIT MED J, V366, DOI 10.1136/bmj.l4499; COOK GP, 1986, T I BRIT GEOGR, V11, P57, DOI 10.2307/622070; Correa T, 2019, PUBLIC HEALTH NUTR, V22, P1113, DOI 10.1017/S1368980018003130; Corvalan C, 2017, OBES REV, V18, P7, DOI 10.1111/obr.12571; Corvalan C, 2019, OBES REV, V20, P367, DOI 10.1111/obr.12802; CRAVIOTO J, 1966, PEDIATRICS, V38, P319; Crimmins EM, 2006, P NATL ACAD SCI USA, V103, P498, DOI 10.1073/pnas.0501470103; Curto A, 2019, EPIDEMIOLOGY, V30, P492, DOI 10.1097/EDE.0000000000001014; Louzada MLD, 2018, PUBLIC HEALTH NUTR, V21, P94, DOI 10.1017/S1368980017001434; de Onis M, 2016, MATERN CHILD NUTR, V12, P12, DOI 10.1111/mcn.12231; Demaio A., 2013, PLOS CURR; Diageo, OUR PLAN W PROGR CON; Diez-Canseco F, 2018, J MED INTERNET RES, V20, DOI 10.2196/jmir.9208; Diez-Canseco Francisco, 2014, Rev. perú. med. exp. salud publica, V31, P131; do Carmo AS, 2018, CAD SAUDE PUBLICA, V34, DOI [10.1590/0102-311X00014918, 10.1590/0102-311x00014918]; Druetz T, 2018, BMC MED ETHICS, V19, DOI 10.1186/s12910-018-0288-z; Dunford EK, 2019, OBES REV, V20, P107, DOI 10.1111/obr.12879; Dutta A, 2012, TOXICOL APPL PHARM, V261, P255, DOI 10.1016/j.taap.2012.04.004; Echouffo-Tcheugui JB, 2018, BMJ GLOB HEALTH, V3, DOI 10.1136/bmjgh-2018-000866; Egbujie BA, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0198424; Ekeland AG, 2010, INT J MED INFORM, V79, P736, DOI 10.1016/j.ijmedinf.2010.08.006; Epstein MB, 2013, INT J HYG ENVIR HEAL, V216, P523, DOI 10.1016/j.ijheh.2012.12.006; Esser MB, 2015, AM J PUBLIC HEALTH, V105, P2220, DOI 10.2105/AJPH.2015.302831; European Society of Cardiology, 2019, COMM BAS SALT SUBST; European Society of Cardiology, 2019, POP BAS SALT SUBST S; Ezzati M, 2018, NATURE, V559, P507, DOI 10.1038/s41586-018-0306-9; Ezzati M, 2017, LANCET, V390, P2627, DOI 10.1016/S0140-6736(17)32129-3; Ezzati M, 2015, NAT REV CARDIOL, V12, P508, DOI 10.1038/nrcardio.2015.82; Ford ES, 2011, ANNU REV PUBL HEALTH, V32, P5, DOI 10.1146/annurev-publhealth-031210-101211; Fottrell E, 2019, LANCET DIABETES ENDO, V7, P200, DOI 10.1016/S2213-8587(19)30001-4; Franz C., 2018, Eurohealth, V24, P21; Freudenberg N, 2008, J PUBLIC HEALTH POL, V29, P86, DOI 10.1057/palgrave.jphp.3200158; Frieden TR, 2010, AM J PUBLIC HEALTH, V100, P590, DOI 10.2105/AJPH.2009.185652; Friel S, 2011, ANNU REV PUBL HEALTH, V32, P133, DOI 10.1146/annurev-publhealth-071910-140612; Lopez-Barron RG, 2015, NUTR HOSP, V31, P2047, DOI 10.3305/nh.2015.31.5.8669; Geng EH, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002288; Ghebreyesus TA, 2018, LANCET, V391, P1973, DOI 10.1016/S0140-6736(18)30675-5; Gluckman PD, 2004, SCIENCE, V305, P1733, DOI 10.1126/science.1095292; Gregg EW, 2016, LANCET DIABETES ENDO, V4, P537, DOI 10.1016/S2213-8587(16)30010-9; Groenewald P, 2010, B WORLD HEALTH ORGAN, V88, P444, DOI 10.2471/BLT.09.069435; Grote M, 2016, TRANSPORT RES D-TR E, V43, P95, DOI 10.1016/j.trd.2015.12.010; Habitat III, NEW URB AG; Harris J., 2019, INCREASING DISPARITI; Hastings G, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5124; Hawkes C, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0383-7; Hawkins B, 2018, GLOB PUBLIC HEALTH, V13, P1, DOI 10.1080/17441692.2016.1161815; He J, 2017, JAMA-J AM MED ASSOC, V318, P1016, DOI 10.1001/jama.2017.11358; Headey DD, 2019, J NUTR, V149, P2020, DOI 10.1093/jn/nxz158; Heller O, 2019, HEALTH POLICY PLANN, V34, P370, DOI 10.1093/heapol/czz043; Hernandez-Cordero S, 2017, NUTR DIABETES, V7, DOI 10.1038/nutd.2016.52; Hoddinott J, 2013, AM J CLIN NUTR, V98, P1170, DOI 10.3945/ajcn.113.064584; Horton R, 2019, LANCET, V393, P1922, DOI 10.1016/S0140-6736(19)31038-4; Huffman MD, 2015, J AM COLL CARDIOL, V65, P1371, DOI 10.1016/j.jacc.2015.02.023; Hui RL, 2019, J MANAG CARE SPEC PH, V25, P927, DOI 10.18553/jmcp.2019.25.8.927; Hunter-Adams J, 2019, APPETITE, V137, P244, DOI 10.1016/j.appet.2019.03.012; Hurst JR, 2018, LANCET GLOB HEALTH, V6, pE1270, DOI 10.1016/S2214-109X(18)30391-7; INEBRIA, 2015, 12 C INEBRIA 24 25 S; Inglis SC, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007228.pub2; International Energy Agency, CO2 EM STAT; International Life Sciences Institute, MISS OP PRINC; Jaacks LM, 2019, LANCET DIABETES ENDO, V7, P231, DOI 10.1016/S2213-8587(19)30026-9; Jacob AM, 2019, J HEALTH POLLUT, V9, DOI 10.5696/2156-9614-9.22.190608; Miranda JJ, 2011, HEART, V97, P787, DOI 10.1136/hrt.2010.218537; Jaspers L, 2015, EUR J EPIDEMIOL, V30, P163, DOI 10.1007/s10654-014-9983-3; Jernigan DH, 2012, AM J PUBLIC HEALTH, V102, P80, DOI 10.2105/AJPH.2011.300269; Jiwani S. S., LANCET GLOB HLTH; Jobanputra K, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002180; Johnson RC, 2011, AM J PUBLIC HEALTH, V101, P2317, DOI 10.2105/AJPH.2011.300252; Kain J, 2005, OBES RES, V13, P2178, DOI 10.1038/oby.2005.270; Kelland K, 2011, REUTERS; Kelly B, 2019, OBES REV, V20, P116, DOI 10.1111/obr.12840; Kengne AP, 2017, INT J EPIDEMIOL, V46, P1421, DOI 10.1093/ije/dyx078; Khafaie MA, 2013, DIABETES CARE, V36, P625, DOI 10.2337/dc12-0388; Khafaie MA, 2018, J EXPO SCI ENV EPID, V28, P328, DOI 10.1038/s41370-017-0001-1; Kickbusch I, 2016, LANCET GLOB HEALTH, V4, pE895, DOI 10.1016/S2214-109X(16)30217-0; Kinney PL, 2011, ENVIRON SCI POLICY, V14, P369, DOI 10.1016/j.envsci.2011.02.005; Knai C, 2018, MILBANK Q, V96, P472, DOI 10.1111/1468-0009.12339; Kontis V, 2019, CIRCULATION, V140, P715, DOI 10.1161/CIRCULATIONAHA.118.038160; Krishna B, 2017, BMJ-BRIT MED J, V359, DOI 10.1136/bmj.j5209; Kuruvilla Shyama, 2014, Bull World Health Organ, V92, P533, DOI 10.2471/BLT.14.138131; Lackland DT, 2014, STROKE, V45, P315, DOI 10.1161/01.str.0000437068.30550.cf; LASKI L, 2015, BMJ-BRIT MED J, V351, DOI DOI 10.1136/BMJ.H4119; Lee EN, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165461; Lee K, 2009, GLOB INST, P1; Levy DT, 2008, TOB CONTROL, V17, P53, DOI 10.1136/tc.2007.022319; Levy David, 2012, PLoS Med, V9, pe1001336, DOI 10.1371/journal.pmed.1001336; Limbani F, 2019, BMJ GLOB HEALTH, V4, DOI 10.1136/bmjgh-2018-001084; Lombard C, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1001941; Mannucci Pier Mannuccio, 2017, Int J Environ Res Public Health, V14, DOI 10.3390/ijerph14091048; Manthey J, 2019, LANCET, V393, P2493, DOI 10.1016/S0140-6736(18)32744-2; Marron-Ponce JA, 2019, J ACAD NUTR DIET, V119, P1852, DOI 10.1016/j.jand.2019.04.020; Martorell R, 2017, AM J HUM BIOL, V29, DOI 10.1002/ajhb.22952; Massri C, 2019, AM J PUBLIC HEALTH, V109, P1249, DOI [10.2105/AJPH.2019.305159, 10.2105/ajph.2019.305159]; Mendoza W, 2017, CARDIOL CLIN, V35, P1, DOI 10.1016/j.ccl.2016.08.004; Menezess Paulo R, 2015, Rev Fac Cien Med Univ Nac Cordoba, V72, P321; Mensah GA, 2017, CIRC RES, V120, P366, DOI 10.1161/CIRCRESAHA.116.309115; Metcalf CJE, 2015, EPIDEMICS-NETH, V10, P93, DOI 10.1016/j.epidem.2014.08.008; Mikkelsen B, 2019, BMJ-BRIT MED J, V364, DOI 10.1136/bmj.l257; Mileski M, 2017, JMIR MED INF, V5, DOI 10.2196/medinform.6603; Ministerio de Salud, 2019, CON ADV PUBL OCT; Ministerio de Salud Publica, 2018, OCT ET AL; Miranda J. Jaime, 2012, Rev. perú. med. exp. salud publica, V29, P366, DOI 10.1590/s1726-46342012000300012; Monteiro CA, 2019, PUBLIC HEALTH NUTR, V22, P936, DOI 10.1017/S1368980018003762; Moodie R, 2013, LANCET, V381, P670, DOI 10.1016/S0140-6736(12)62089-3; Mounier-Jack S, 2017, HEALTH POLICY PLANN, V32, P6, DOI 10.1093/heapol/czx039; Reynales-Shigematsu LM, 2015, REV PANAM SALUD PUBL, V38, P316; Navickas Rokas, 2016, J Comorb, V6, P4, DOI 10.15256/joc.2016.6.72; NCD Risk Factor Collaboration (NCD-RisC), 2016, Lancet, V387, P1513, DOI 10.1016/S0140-6736(16)00618-8; Niessen LW, 2018, LANCET, V391, P2036, DOI [10.1016/S0140-6736(18)30482-3, 10.1016/s0140-6736(18)30482-3]; Nugent R, 2019, LANCET, V394, P622, DOI 10.1016/S0140-6736(19)31762-3; Nugent R, 2018, LANCET, V391, P2029, DOI 10.1016/S0140-6736(18)30667-6; Ogedegbe G, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002561; Ojo T, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0212296; OMRAN AR, 1971, MILBANK MEML FUND Q, V49, P509, DOI 10.2307/3349375; Pan American Health Organization, ULTR FOOD DRINK PROD; Pan American Health Organization & Organisation for Economic Co-operation and Development, 2015, APPL MOD IMPR HLTH E; Pan American Health Organization/World Health Organization, 2018, AMB HOUS AIR POLL HL; Pande J N, 2002, Indian J Chest Dis Allied Sci, V44, P13; Parra DC, 2019, SALUD PUBLICA MEXICO, V61, P147, DOI 10.21149/9038; Pehlke EL, 2016, HEALTH PROMOT INT, V31, P542, DOI 10.1093/heapro/dav011; Peiris D, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0213708; Perez-Escamilla R, 2018, BMJ-BRIT MED J, V361, DOI [10.1136/bmj.k2252, 10.1136/bmj.j2252]; Peters DH, 2019, BMJ-BRIT MED J, V365, DOI 10.1136/bmj.l1868; Pomeroy E, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-46960-9; Popkin BM, 2018, OBES REV, V19, P1028, DOI 10.1111/obr.12694; Popkin BM, 2019, NATURE, V569, P200, DOI 10.1038/d41586-019-01182-x; Prabhakaran D, 2018, LANCET GLOB HEALTH, V6, pE1339, DOI 10.1016/S2214-109X(18)30407-8; Pries AM, 2017, MATERN CHILD NUTR, V13, DOI 10.1111/mcn.12412; Pucher J, 2007, TRANSPORT REV, V27, P379, DOI 10.1080/01441640601089988; Quadrelli R, 2007, ENERG POLICY, V35, P5938, DOI 10.1016/j.enpol.2007.07.001; Quistberg DA, 2019, J URBAN HEALTH, V96, P311, DOI 10.1007/s11524-018-00326-0; Rao N, 2014, EARLY CHILDHOOD DEV; Reyes M, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-7118-1; ROSE G, 1985, INT J EPIDEMIOL, V14, P32, DOI 10.1093/ije/14.1.32; Roth GA, 2017, J AM COLL CARDIOL, V70, P1, DOI 10.1016/j.jacc.2017.04.052; Roux AVD, 2019, GLOB CHALL, V3, DOI 10.1002/gch2.201800013; Roux AVD, 2011, AM J PUBLIC HEALTH, V101, P1627, DOI 10.2105/AJPH.2011.300149; Rubinstein A, 2016, LANCET DIABETES ENDO, V4, P52, DOI 10.1016/S2213-8587(15)00381-2; Ruby A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138303; Sa T. H. de, 2017, Environment International, V108, P22; Schnabel L, 2019, JAMA INTERN MED, V179, P490, DOI 10.1001/jamainternmed.2018.7289; Schraufnagel DE, 2019, CHEST, V155, P409, DOI 10.1016/j.chest.2018.10.042; Schraufnagel DE, 2019, CHEST, V155, P417, DOI 10.1016/j.chest.2018.10.041; Shi YS, 2018, SCI TOTAL ENVIRON, V631-632, P1504, DOI 10.1016/j.scitotenv.2018.03.146; Simone Abdoumaliq., 2018, NEW URBAN WORLDS INH; Sinharay R, 2018, LANCET, V391, P339, DOI 10.1016/S0140-6736(17)32643-0; Smit W, 2016, HEALTH PLACE, V39, P196, DOI 10.1016/j.healthplace.2016.04.006; Smith LC, 2015, WORLD DEV, V68, P180, DOI 10.1016/j.worlddev.2014.11.014; Smith R, 2019, NUTRIENTS, V11, DOI 10.3390/nu11040875; Spears D, 2019, ENVIRON HEALTH-GLOB, V18, DOI 10.1186/s12940-019-0501-7; Srour B, 2019, BMJ-BRIT MED J, V365, DOI 10.1136/bmj.l1451; Stanaway JD, 2018, LANCET, V392, P1923, DOI 10.1016/s0140-6736(18)32225-6; Steele EM, 2019, PREV MED, V125, P40, DOI 10.1016/j.ypmed.2019.05.004; Steele S, 2019, GLOBALIZATION HEALTH, V15, DOI 10.1186/s12992-019-0478-6; Stein DJ, 2019, BMJ-BRIT MED J, V364, DOI 10.1136/bmj.l295; Stenius K, 2010, ADDICTION, V105, P191, DOI 10.1111/j.1360-0443.2009.02688.x; Stoltze FM, 2018, PUBLIC HEALTH NUTR, V21, P454, DOI [10.1017/S1368980017002671, 10.1017/s1368980017002671]; Stuckler D., 2011, SICK SOC RESPONDING, P26, DOI DOI 10.1093/ACPROFOSO/9780199574407.003.0027; Stuckler D., 2011, SICK SOC RESPONDING, P87; Stuckler D, 2012, PLOS MED, V9, DOI [10.1371/journal.pmed.1001235, 10.1371/journal.pmed.1001242]; Su TC, 2011, PROG CARDIOVASC DIS, V53, P369, DOI 10.1016/j.pcad.2010.12.007; Swinburn B, 2013, OBES REV, V14, P1, DOI 10.1111/obr.12087; Swinburn BA, 2019, LANCET, V393, P791, DOI 10.1016/S0140-6736(18)32822-8; Takeshita T, 2011, INT J ENV RES PUB HE, V8, P3032, DOI 10.3390/ijerph8073032; Thomson DR, 2019, J URBAN HEALTH, V96, P514, DOI 10.1007/s11524-019-00363-3; Tian MY, 2015, CIRCULATION, V132, P815, DOI 10.1161/CIRCULATIONAHA.115.015373; Triana CA, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0207791; UN-Department of Economic and Social Affairs Population Division, 2010, WORLD URB PROSP 2009; UN-Habitat, 2015, STAT AFR CIT 2014 RE; United Nations, 2014, WORLD URBANIZATION P; United Nations Department of Economic and Social Affairs Population Division, 2015, POP 2030 DEM CHALL O; Unnikrishnan R, 2018, CURR DIABETES REP, V18, DOI 10.1007/s11892-018-1002-8; Vandevijvere S, 2019, OBES REV, V20, P10, DOI 10.1111/obr.12860; Vearey J, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-6674-8; Vedanthan R, 2017, CARDIOL CLIN, V35, P99, DOI 10.1016/j.ccl.2016.08.010; Victora CG, 2008, LANCET, V371, P340, DOI 10.1016/S0140-6736(07)61692-4; Wallace C, 2019, OBES REV, V20, P20, DOI 10.1111/obr.12884; Wang GY, 2013, J ADOLESCENT HEALTH, V52, pS14, DOI 10.1016/j.jadohealth.2012.04.019; Wang J, 2019, PEERJ, V7, DOI 10.7717/peerj.6932; Warner Kenneth E, 2014, Ann Am Thorac Soc, V11, P227, DOI 10.1513/AnnalsATS.201307-244PS; Webb P, 2018, BMJ-BRIT MED J, V361, DOI 10.1136/bmj.k2238; Wells JCK, 2016, METABOLIC GHETTO: AN EVOLUTIONARY PERSPECTIVE ON NUTRITION, POWER RELATIONS AND CHRONIC DISEASE; Wells JCK, 2013, EUR J CLIN NUTR, V67, P507, DOI 10.1038/ejcn.2013.31; Wells JCK, 2018, EUR J CLIN NUTR, V72, P688, DOI 10.1038/s41430-018-0142-x; Wells JCK, 2011, AM J HUM BIOL, V23, P65, DOI 10.1002/ajhb.21100; Wells JCK, 2010, AM J HUM BIOL, V22, P1, DOI 10.1002/ajhb.20994; WHO, 2016, AMBIENT AIR POLLUTIO; Woltmann E, 2012, AM J PSYCHIAT, V169, P790, DOI 10.1176/appi.ajp.2012.11111616; World Health Organization, 2004, GLOB STRAT DIET PHYS; World Health Organization, 2015, AD RESP HLTH SYST; World Health Organization, 2017, MOR PHYS ACT TRANSF; World Health Organization, 2016, GLOB REP URB HLTH EQ; World Health Organization, 2017, DOUBL BURD MALN; World Health Organization, 2015, GLOB STAT REP ROAD S; World Health Organization, NONC DIS KEY FACTS; World Health Organization, 2010, PACK ESS NONC PEN DI; World Health Organization, ALC KEY FACTS; World Health Organization, 2016, HLTH ALL POL FRAM CO; World Health Organization, 2019, BETT HLTH GLOB ACT P; World Health Organization, 2020, GLOBAL STATUS REPORT, DOI DOI 10.1037/COU0000248; World Health Organization (WHO), 2010, GLOB STRAT RED HARMF; World Heart Federation, WHF GLOB CVD ROADM; Worldwide Brewing Alliance, 2007, GLOB SOC RESP IN; Yamamoto SS, 2014, INT J HYG ENVIR HEAL, V217, P133, DOI 10.1016/j.ijheh.2013.08.003; Yapa HM, 2018, IMPLEMENT SCI, V13, DOI 10.1186/s13012-018-0847-1; Yusuf S, 2014, NEW ENGL J MED, V371, P818, DOI 10.1056/NEJMoa1311890; Yusuf S, 2001, CIRCULATION, V104, P2855, DOI 10.1161/hc4701.099488; Yusuf S, 2019, LANCET, V395, P795, DOI [10.1016/S0140-6736(19)32008-2, DOI 10.1016/S0140-6736(19)32008-2, 10.1016/s0140-6736(19)32008-2]; Zanaboni P, 2012, BMC MED INFORM DECIS, V12, DOI 10.1186/1472-6947-12-1; Zapata-Diomedi B, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184799	240	104	106	3	37	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2019	25	11					1667	1679		10.1038/s41591-019-0644-7	http://dx.doi.org/10.1038/s41591-019-0644-7			13	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	JT2KI	31700182	Green Submitted			2022-12-27	WOS:000500824300023
J	Rivera, SC; Liu, XX; Chan, AW; Denniston, AK; Calvert, MJ				Rivera, Samantha Cruz; Liu, Xiaoxuan; Chan, An-Wen; Denniston, Alastair K.; Calvert, Melanie J.		SPIRIT-Al CONSORT-Al Working Grp	Guidelines for clinical trial protocols for interventions involving artificial intelligence: the SPIRIT-AI extension	LANCET DIGITAL HEALTH			English	Review							SYSTEM; PREDICTION; STATEMENT; CANCER	The SPIRIT 2013 statement aims to improve the completeness of clinical trial protocol reporting by providing evidence-based recommendations for the minimum set of items to be addressed. This guidance has been instrumental in promoting transparent evaluation of new interventions. More recently, there has been a growing recognition that interventions involving artificial intelligence (AI) need to undergo rigorous, prospective evaluation to demonstrate their impact on health outcomes. The SPIRIT-AI (Standard Protocol Items: Recommendations for Interventional Trials-Artificial Intelligence) extension is a new reporting guideline for clinical trial protocols evaluating interventions with an AI component. It was developed in parallel with its companion statement for trial reports: CONSORT-AI (Consolidated Standards of Reporting Trials-Artificial Intelligence). Both guidelines were developed through a staged consensus process involving literature review and expert consultation to generate 26 candidate items, which were consulted upon by an international multi-stakeholder group in a two-stage Delphi survey (103 stakeholders), agreed upon in a consensus meeting (31 stakeholders) and refined through a checklist pilot (34 participants). The SPIRIT-AI extension includes 15 new items that were considered sufficiently important for clinical trial protocols of AI interventions. These new items should be routinely reported in addition to the core SPIRIT 2013 items. SPIRIT-AI recommends that investigators provide clear descriptions of the AI intervention, including instructions and skills required for use, the setting in which the AI intervention will be integrated, considerations for the handling of input and output data, the human-AI interaction and analysis of error cases. SPIRIT-AI will help promote transparency and completeness for clinical trial protocols for AI interventions. Its use will assist editors and peer reviewers, as well as the general readership, to understand, interpret, and critically appraise the design and risk of bias for a planned clinical trial.	[Rivera, Samantha Cruz; Denniston, Alastair K.; Calvert, Melanie J.] Univ Birmingham, Ctr Patient Reported Outcome Res, Inst Appl Hlth Res, Birmingham, W Midlands, England; [Liu, Xiaoxuan; Denniston, Alastair K.] Univ Birmingham, Acad Unit Ophthalmol, Inst Inflammat & Ageing, Coll Med & Dent Sci, Birmingham, W Midlands, England; [Rivera, Samantha Cruz; Liu, Xiaoxuan; Denniston, Alastair K.; Calvert, Melanie J.] Univ Birmingham, Birmingham Hlth Partners Ctr Regulatory Sci & Inn, Birmingham, W Midlands, England; [Liu, Xiaoxuan; Denniston, Alastair K.] Univ Hosp Birmingham NHS Fdn Trust, Dept Ophthalmol, Birmingham, W Midlands, England; [Liu, Xiaoxuan] Moorfields Eye Hosp NHS Fdn Trust, London, England; [Denniston, Alastair K.] Moorfields Hosp London NHS Fdn Trust, Natl Inst Hlth Res, Biomed Res Ctr ForOphthalmol, London, England; [Denniston, Alastair K.] UCL, Inst Ophthalmol, London, England; [Liu, Xiaoxuan; Denniston, Alastair K.; Calvert, Melanie J.] Hlth Data Res UK, London, England; [Calvert, Melanie J.] Univ Birmingham, Natl Inst Hlth Res, Surg Reconstruct & Microbiol Ctr, Birmingham, W Midlands, England; [Calvert, Melanie J.] Univ Birmingham, Natl Inst Hlth Res, Birmingham Biomed Res Ctr, Birmingham, W Midlands, England; [Calvert, Melanie J.] Univ Hosp Birmingham NHS Fdn Trust Birmingham, Birmingham, W Midlands, England; [Calvert, Melanie J.] Natl Inst Hlth Res, Appl Res Collaborat West Midlands, Birmingham, W Midlands, England; [Chan, An-Wen] Univ Toronto, WomensColl Res Inst, Womens Coll Hosp, Dept Med, Toronto, ON, Canada	University of Birmingham; University of Birmingham; University of Birmingham; University of Birmingham; University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust; University of London; University College London; University of Birmingham; University of Birmingham; University of Toronto; University Toronto Affiliates; Womens College Hospital	Denniston, AK (corresponding author), Univ Birmingham, Coll Med & Dent Sci, Inst Inflammat & Ageing, Birmingham B15 2TT, W Midlands, England.	a.denniston@bham.ac.uk	Denniston, Alastair/ABD-1238-2020; Calvert, Melanie/F-7055-2011	Denniston, Alastair/0000-0001-7849-0087; Calvert, Melanie/0000-0002-1856-837X; Collins, Gary/0000-0002-2772-2316; Liu, Xiaoxuan/0000-0002-1286-0038; Lee, Aaron/0000-0002-7452-1648; Rowley, Samuel/0000-0002-2468-801X; Keane, Pearse/0000-0002-9239-745X	Wellcome Trust Institutional Strategic Support Fund: Digital Health Pilot Grant; Research England (part of UK Research and Innovation); Health Data Research UK; Alan Turing Institute; University of Birmingham, UK; NIHR Birmingham Biomedical Research Centre; NIHR Surgical Reconstruction and Microbiology Research Centre; NIHR ARC West Midlands at the University of Birmingham; University Hospitals Birmingham NHS Foundation Trust; Innovate UK (part of UK Research and Innovation); Health Foundation; Macmillan Cancer Support; UCB Pharma; University of Ottawa Research Chair; US Food and Drug Administration (FDA); Office of the Director at the National Library of Medicine (NLM), US National Institutes of Health (NIH); NIH [7K01HL141771-02]; UKRI Future Leaders Fellowship; Moorfields Eye Charity Career Development Award; Engineering and Physical Sciences Research Council; UK Research and Innovation (UKRI); Accenture; Warwick Impact Fund; European Regional Development Fund; MRC [MC_PC_19005] Funding Source: UKRI	Wellcome Trust Institutional Strategic Support Fund: Digital Health Pilot Grant(Wellcome Trust); Research England (part of UK Research and Innovation)(UK Research & Innovation (UKRI)); Health Data Research UK; Alan Turing Institute; University of Birmingham, UK; NIHR Birmingham Biomedical Research Centre; NIHR Surgical Reconstruction and Microbiology Research Centre; NIHR ARC West Midlands at the University of Birmingham; University Hospitals Birmingham NHS Foundation Trust; Innovate UK (part of UK Research and Innovation)(UK Research & Innovation (UKRI)Innovate UK); Health Foundation; Macmillan Cancer Support; UCB Pharma(UCB Pharma SA); University of Ottawa Research Chair; US Food and Drug Administration (FDA)(United States Department of Health & Human Services); Office of the Director at the National Library of Medicine (NLM), US National Institutes of Health (NIH); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UKRI Future Leaders Fellowship(UK Research & Innovation (UKRI)); Moorfields Eye Charity Career Development Award; Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); UK Research and Innovation (UKRI)(UK Research & Innovation (UKRI)); Accenture; Warwick Impact Fund; European Regional Development Fund(European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank the participants who were involved in the Delphi study and Pilot study (Supplementary Note), Eliot Marston for providing strategic support (University of Birmingham, Birmingham, UK), and Charlotte Radovanovic (University Hospitals Birmingham NHS Foundation Trust, UK) and Anita Walker (University of Birmingham, UK) for administrative support. The views expressed in this publication are those of the authors, Delphi participants and stakeholder participants and may not represent the views of the broader stakeholder group or host institution. This work was funded by a Wellcome Trust Institutional Strategic Support Fund: Digital Health Pilot Grant, Research England (part of UK Research and Innovation), Health Data Research UK, and the Alan Turing Institute. The study was sponsored by the University of Birmingham, UK. The study funders and sponsors had no role in the design and conduct of the study; collection, management, analysis and interpretation of the data; preparation, review or approval of the manuscript; or decision to submit the manuscript for publication. MJC is a National Institute for Health Research (NIHR) Senior Investigator and receives funding from the NIHR Birmingham Biomedical Research Centre; the NIHR Surgical Reconstruction and Microbiology Research Centre and NITHR ARC West Midlands at the University of Birmingham and University Hospitals Birmingham NHS Foundation Trust; Health Data Research UK; Innovate UK (part of UK Research and Innovation); the Health Foundation; Macmillan Cancer Support; and UCB Pharma. ADa and JJD are also NIHR Senior Investigators. The views expressed in this article are those of the author(s) and not necessarily those of the NIHR, or the Department of Health and Social Care. DM is supported by a University of Ottawa Research Chair. MKEZ is supported by the US Food and Drug Administration (FDA), and DP is supported in part by the Office of the Director at the National Library of Medicine (NLM), US National Institutes of Health (NIH). AB is supported by an NIH award 7K01HL141771-02. PAK received grants from UKRI Future Leaders Fellowship and from Moorfields Eye Charity Career Development Award. SJV received funding from the Engineering and Physical Sciences Research Council, UK Research and Innovation (UKRI), Accenture, Warwick Impact Fund, Health Data Research UK, and European Regional Development Fund. SR is an employee of the UKRI. This article may not be consistent with NIH and/or FDA's views or policies. It reflects only the views and opinions of the authors.	Abramoff MD, 2016, INVEST OPHTH VIS SCI, V57, P5200, DOI 10.1167/iovs.16-19964; Caballero-Ruiz E, 2017, INT J MED INFORM, V102, P35, DOI 10.1016/j.ijmedinf.2017.02.014; Calvert M, 2018, JAMA-J AM MED ASSOC, V319, P483, DOI 10.1001/jama.2017.21903; Chan AW, 2013, ANN INTERN MED, V158, P200, DOI 10.7326/0003-4819-158-3-201302050-00583; Chan AW, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.e7586; Choi KJ, 2018, RADIOLOGY, V289, P688, DOI 10.1148/radiol.2018180763; Collins GS, 2019, LANCET, V393, P1577, DOI 10.1016/S0140-6736(19)30037-6; Dai L, 2019, CHIN J INTEGR MED, V25, P71, DOI 10.1007/s11655-018-2999-x; De Fauw J, 2018, NAT MED, V24, P1342, DOI 10.1038/s41591-018-0107-6; Esteva A, 2017, NATURE, V542, P115, DOI 10.1038/nature21056; Finlayson SG, 2019, SCIENCE, V363, P1287, DOI 10.1126/science.aaw4399; Fleuren LM, 2020, INTENS CARE MED, V46, P383, DOI 10.1007/s00134-019-05872-y; Gong DX, 2020, LANCET GASTROENTEROL, V5, P352, DOI 10.1016/S2468-1253(19)30413-3; Gregory J, 2020, J MAGN RESON IMAGING, V52, P248, DOI 10.1002/jmri.27035; Habli I, 2020, B WORLD HEALTH ORGAN, V98, P251, DOI 10.2471/BLT.19.237487; He JX, 2019, NAT MED, V25, P30, DOI 10.1038/s41591-018-0307-0; Heaven D, 2019, NATURE, V574, P163, DOI 10.1038/d41586-019-03013-5; International Medical Device Regulators Forum, 2019, UN DEV ID SYST UDI S; Kelly CJ, 2019, BMC MED, V17, DOI 10.1186/s12916-019-1426-2; Kiani A, 2020, NPJ DIGIT MED, V3, DOI 10.1038/s41746-020-0232-8; Kim H, 2020, RADIOLOGY, V296, P216, DOI 10.1148/radiol.2020192764; Kim Tae Won Benjamin, 2016, JMIR Rehabil Assist Technol, V3, pe12, DOI 10.2196/rehab.5148; Labovitz DL, 2017, STROKE, V48, P1416, DOI 10.1161/STROKEAHA.116.016281; Lee CS, 2020, LANCET DIGIT HEALTH, V2, pE279, DOI 10.1016/S2589-7500(20)30102-3; Lin HT, 2019, ECLINICALMEDICINE, V9, P52, DOI 10.1016/j.eclinm.2019.03.001; Liu XX, 2019, LANCET DIGIT HEALTH, V1, pE271, DOI 10.1016/S2589-7500(19)30123-2; Liu XX, 2019, NAT MED, V25, P1467, DOI 10.1038/s41591-019-0603-3; Liu XX, 2019, LANCET, V394, P1225, DOI 10.1016/S0140-6736(19)31819-7; McKinney SM, 2020, NATURE, V577, P89, DOI 10.1038/s41586-019-1799-6; Mendes-Soares H, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2018.8102; Nagendran M, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.m689; Nicolae A, 2017, INT J RADIAT ONCOL, V97, P822, DOI 10.1016/j.ijrobp.2016.11.036; Oakden-Rayner L, 2019, 190912475 ARXIV; Pooch EHP, 2019, 190901940 ARXIV; Rajpurkar P, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002686; Sarkis-Onofre R, 2015, J DENT, V43, P397, DOI 10.1016/j.jdent.2015.01.006; Sounderajah V, 2020, NAT MED, V26, P807, DOI 10.1038/s41591-020-0941-1; Su JR, 2020, GASTROINTEST ENDOSC, V91, P415, DOI 10.1016/j.gie.2019.08.026; Sutton RT, 2020, NPJ DIGIT MED, V3, DOI 10.1038/s41746-020-0221-y; Talmon J, 2009, INT J MED INFORM, V78, P1, DOI 10.1016/j.ijmedinf.2008.09.002; Tyler NS, 2020, NAT METAB, V2, P612, DOI 10.1038/s42255-020-0212-y; Voss C, 2019, JAMA PEDIATR, V173, P446, DOI 10.1001/jamapediatrics.2019.0285; Wang P, 2020, LANCET GASTROENTEROL, V5, P343, DOI [10.1016/S2468-1253(19)30411-X, 10.1016/S2468-1253(19)30411-x]; Wang P, 2019, GUT, V68, P1813, DOI 10.1136/gutjnl-2018-317500; Wiens J, 2019, NAT MED, V25, P1337, DOI 10.1038/s41591-019-0548-6; Wijnberge M, 2020, JAMA-J AM MED ASSOC, V323, P1052, DOI 10.1001/jama.2020.0592; Wu LL, 2019, GUT, V68, P2161, DOI 10.1136/gutjnl-2018-317366; Yim J, 2020, NAT MED, V26, P892, DOI 10.1038/s41591-020-0867-7; Zech JR, 2018, 180700431 ARXIV	50	104	104	9	19	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		2589-7500		LANCET DIGIT HEALTH	Lancet Digit. Health	OCT	2020	2	10					E549	E560		10.1016/S2589-7500(20)30219-3	http://dx.doi.org/10.1016/S2589-7500(20)30219-3			12	Medical Informatics; Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	Medical Informatics; General & Internal Medicine	OF3XN	32908284	Green Published, gold, Green Accepted			2022-12-27	WOS:000581145100012
J	Del Valle, DM; Kim-Schulze, S; Huang, HH; Beckmann, ND; Nirenberg, S; Wang, B; Lavin, Y; Swartz, TH; Madduri, D; Stock, A; Marron, TU; Xie, H; Patel, M; Tuballes, K; Van Oekelen, O; Rahman, A; Kovatch, P; Aberg, JA; Schadt, E; Jagannath, S; Mazumdar, M; Charney, AW; Firpo-Betancourt, A; Mendu, DR; Jhang, J; Reich, D; Sigel, K; Cordon-Cardo, C; Feldmann, M; Parekh, S; Merad, M; Gnjatic, S				Del Valle, Diane Marie; Kim-Schulze, Seunghee; Huang, Hsin-Hui; Beckmann, Noam D.; Nirenberg, Sharon; Wang, Bo; Lavin, Yonit; Swartz, Talia H.; Madduri, Deepu; Stock, Aryeh; Marron, Thomas U.; Xie, Hui; Patel, Manishkumar; Tuballes, Kevin; Van Oekelen, Oliver; Rahman, Adeeb; Kovatch, Patricia; Aberg, Judith A.; Schadt, Eric; Jagannath, Sundar; Mazumdar, Madhu; Charney, Alexander W.; Firpo-Betancourt, Adolfo; Mendu, Damodara Rao; Jhang, Jeffrey; Reich, David; Sigel, Keith; Cordon-Cardo, Carlos; Feldmann, Marc; Parekh, Samir; Merad, Miriam; Gnjatic, Sacha			An inflammatory cytokine signature predicts COVID-19 severity and survival	NATURE MEDICINE			English	Article								Elevated levels of serum IL-6 and TNF-alpha at the time of hospitalization are independent and significant predictors of clinical outcome in two cohorts of patients with COVID-19. Several studies have revealed that the hyper-inflammatory response induced by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a major cause of disease severity and death. However, predictive biomarkers of pathogenic inflammation to help guide targetable immune pathways are critically lacking. We implemented a rapid multiplex cytokine assay to measure serum interleukin (IL)-6, IL-8, tumor necrosis factor (TNF)-alpha and IL-1 beta in hospitalized patients with coronavirus disease 2019 (COVID-19) upon admission to the Mount Sinai Health System in New York. Patients (n = 1,484) were followed up to 41 d after admission (median, 8 d), and clinical information, laboratory test results and patient outcomes were collected. We found that high serum IL-6, IL-8 and TNF-alpha levels at the time of hospitalization were strong and independent predictors of patient survival (P < 0.0001,P = 0.0205 andP = 0.0140, respectively). Notably, when adjusting for disease severity, common laboratory inflammation markers, hypoxia and other vitals, demographics, and a range of comorbidities, IL-6 and TNF-alpha serum levels remained independent and significant predictors of disease severity and death. These findings were validated in a second cohort of patients (n = 231). We propose that serum IL-6 and TNF-alpha levels should be considered in the management and treatment of patients with COVID-19 to stratify prospective clinical trials, guide resource allocation and inform therapeutic options.	[Del Valle, Diane Marie; Kim-Schulze, Seunghee; Xie, Hui; Patel, Manishkumar; Tuballes, Kevin; Rahman, Adeeb; Merad, Miriam; Gnjatic, Sacha] Icahn Sch Med Mt Sinai, Human Immune Monitoring Ctr, New York, NY 10029 USA; [Del Valle, Diane Marie; Kim-Schulze, Seunghee; Marron, Thomas U.; Rahman, Adeeb; Merad, Miriam; Gnjatic, Sacha] Icahn Sch Med Mt Sinai, Precis Immunol Inst, New York, NY 10029 USA; [Del Valle, Diane Marie; Kim-Schulze, Seunghee; Marron, Thomas U.; Rahman, Adeeb; Parekh, Samir; Merad, Miriam; Gnjatic, Sacha] Icahn Sch Med Mt Sinai, Tisch Canc Inst, New York, NY 10029 USA; [Kim-Schulze, Seunghee; Parekh, Samir; Merad, Miriam; Gnjatic, Sacha] Icahn Sch Med Mt Sinai, Oncol Sci, New York, NY 10029 USA; [Huang, Hsin-Hui; Mazumdar, Madhu] Icahn Sch Med Mt Sinai, Inst Hlth Care Delivery Sci, New York, NY 10029 USA; [Huang, Hsin-Hui; Mazumdar, Madhu] Icahn Sch Med Mt Sinai, TCI Biostat Shared Resource Facil, New York, NY 10029 USA; [Huang, Hsin-Hui; Mazumdar, Madhu] Icahn Sch Med Mt Sinai, Populat Hlth Sci & Policy, New York, NY 10029 USA; [Beckmann, Noam D.; Nirenberg, Sharon; Van Oekelen, Oliver; Rahman, Adeeb; Kovatch, Patricia; Schadt, Eric; Charney, Alexander W.] Icahn Sch Med Mt Sinai, Genet & Genom Sci, New York, NY 10029 USA; [Nirenberg, Sharon; Kovatch, Patricia] Icahn Sch Med Mt Sinai, Dept Sci Comp, New York, NY 10029 USA; [Wang, Bo; Lavin, Yonit; Swartz, Talia H.; Madduri, Deepu; Marron, Thomas U.; Aberg, Judith A.; Jagannath, Sundar; Sigel, Keith; Parekh, Samir; Merad, Miriam; Gnjatic, Sacha] Icahn Sch Med Mt Sinai, Dept Med, New York, NY 10029 USA; [Stock, Aryeh; Firpo-Betancourt, Adolfo; Mendu, Damodara Rao; Jhang, Jeffrey; Cordon-Cardo, Carlos; Gnjatic, Sacha] Icahn Sch Med Mt Sinai, Pathol Mol & Cell Based Med, New York, NY 10029 USA; [Reich, David] Icahn Sch Med Mt Sinai, Anesthesiol Perioperat & Pain Med, New York, NY 10029 USA; [Feldmann, Marc] Univ Oxford, Kennedy Inst Rheumatol, Oxford, England	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; University of Oxford	Gnjatic, S (corresponding author), Icahn Sch Med Mt Sinai, Human Immune Monitoring Ctr, New York, NY 10029 USA.; Gnjatic, S (corresponding author), Icahn Sch Med Mt Sinai, Precis Immunol Inst, New York, NY 10029 USA.; Gnjatic, S (corresponding author), Icahn Sch Med Mt Sinai, Tisch Canc Inst, New York, NY 10029 USA.; Gnjatic, S (corresponding author), Icahn Sch Med Mt Sinai, Dept Med, New York, NY 10029 USA.; Gnjatic, S (corresponding author), Icahn Sch Med Mt Sinai, Pathol Mol & Cell Based Med, New York, NY 10029 USA.	sacha.gnjatic@mssm.edu	Van Oekelen, Oliver/AHH-5449-2022; XIE, HUI/AAU-7178-2021; Wang, Bo/ABC-5571-2020; Patel, Manishkumar Baldevbhai/AAA-7287-2022; Sigel, Keith Magnus/AAZ-7898-2021; Swartz, Talia H./AAN-8591-2020	Van Oekelen, Oliver/0000-0002-5824-197X; Patel, Manishkumar Baldevbhai/0000-0002-7949-5610; Sigel, Keith Magnus/0000-0002-4051-4861; Swartz, Talia H./0000-0003-1572-045X; Lavin, Yonit/0000-0003-0593-3910; Stock, Aryeh/0000-0003-1500-5819; Del Valle, Diane/0000-0001-6983-5362; Nirenberg, Sharon/0000-0002-8556-4213; Gnjatic, Sacha/0000-0001-5643-9520	National Cancer Institute [CA224319]; National Institutes of Health [K08AI120806]; Fast Grant fund; Cancer Center P30 grant [CA196521];  [U19 AI118610];  [U24 AI1186441];  [R01 CA244899];  [U01 DK124165];  [P01 CA190174]	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fast Grant fund; Cancer Center P30 grant; ; ; ; ; 	V Authors thank N. Fernandez for help with the clustergrammer tool and members of the Human Immune Monitoring Center for help with specimen handling. The authors wish to acknowledge R. Pande and M. Putnam at Bio-Techne for helping to provide instruments and assay kits for ELLA testing in a Clinical Laboratory Improvement Amendments environment in the timeliest possible way during the health crisis; and R. Hyland from Gilead for giving permission to use the remdesivir-related data. S.G., D.M.D.V., S.K.-S., Ma.M., H.-H.H., P.K., A.R. and Mi.M, were supported by National Cancer Institute U24 grant CA224319. S.G. is additionally supported by grants U01 DK124165 and P01 CA190174. T.H.S. was supported by National Institutes of Health K08AI120806. A.R. was supported by U19 AI118610 and U24 AI1186441. Mi.M. was supported by the Fast Grant fund. The Human Immune Monitoring Center and the Institute for Healthcare Delivery Science received support from Cancer Center P30 grant CA196521. S.P. was supported by grant R01 CA244899.	BAGGIOLINI M, 1989, J CLIN INVEST, V84, P1045, DOI 10.1172/JCI114265; Berger M, 2020, BIOSTATISTICS, V21, P449, DOI 10.1093/biostatistics/kxy069; Cascella M, 2020, STATPEARLS; Cox D. R., 1984, ANAL SURVIVAL DATA; Davila ML, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008226; Dinarello CA, 2012, NAT REV DRUG DISCOV, V11, P633, DOI 10.1038/nrd3800; Fehr AR, 2017, ANNU REV MED, V68, P387, DOI 10.1146/annurev-med-051215-031152; Feldmann M, 2020, LANCET, V395, P1407, DOI 10.1016/S0140-6736(20)30858-8; Gritti G., 2020, MEDRXIV, DOI 10.1101/2020.04.01.20048561; Harrell FE, 2001, REGRESSION MODELING; Herold T., 2020, J ALLERGY CLIN IMMUN, DOI 10.1101/2020.04.01.20047381; Horby P, 2021, NEW ENGL J MED, V384, P693, DOI [10.1056/NEJMoa2021436, 10.1056/NEJMoa2022926]; Jatiani SS, 2020, CL LYMPH MYELOM LEUK, V20, P632, DOI 10.1016/j.clml.2020.04.020; Ledford H, 2020, NATURE, V582, P469, DOI 10.1038/d41586-020-01824-5; Liu J, 2020, EBIOMEDICINE, V55, DOI 10.1016/j.ebiom.2020.102763; Lu XX, 2020, NEW ENGL J MED, V382, P1663, DOI 10.1056/NEJMc2005073; Madduri D, 2019, CL LYMPH MYELOM LEUK, V19, P537, DOI 10.1016/j.clml.2019.08.002; Mehta P, 2020, LANCET, V395, P1033, DOI 10.1016/S0140-6736(20)30628-0; Merad M, 2020, NAT REV IMMUNOL, V20, P355, DOI 10.1038/s41577-020-0331-4; Moore JB, 2020, SCIENCE, V368, P473, DOI 10.1126/science.abb8925; Nishimoto N, 2008, BLOOD, V112, P3959, DOI 10.1182/blood-2008-05-155846; Paranjpe Ishan, 2020, medRxiv, DOI 10.1101/2020.04.19.20062117; Rich JT, 2010, OTOLARYNG HEAD NECK, V143, P331, DOI 10.1016/j.otohns.2010.05.007; Richardson S, 2020, JAMA-J AM MED ASSOC, V323, P2052, DOI 10.1001/jama.2020.6775; Rohloff JC, 2014, MOL THER-NUCL ACIDS, V3, DOI 10.1038/mtna.2014.49; Royston P, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-33; Ruan QR, 2020, INTENS CARE MED, V46, P846, DOI 10.1007/s00134-020-05991-x; Satagopan JM, 2004, BRIT J CANCER, V91, P1229, DOI 10.1038/sj.bjc.6602102; Smith T., 2001, SAS C P; Vabret N, 2020, NAT REV IMMUNOL, V20, P338, DOI 10.1038/s41577-020-0319-0; Wang B, 2020, J HEMATOL ONCOL, V13, DOI 10.1186/s13045-020-00934-x; Wu CM, 2020, JAMA INTERN MED, V180, P934, DOI 10.1001/jamainternmed.2020.0994; Xu XL, 2020, P NATL ACAD SCI USA, V117, P10970, DOI 10.1073/pnas.2005615117; Zhang XN, 2020, NATURE, V583, P437, DOI [10.1038/s41586-020-2355-0, 10.1007/s00521-020-05117-w]	34	848	860	5	8	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	OCT	2020	26	10					1636	+		10.1038/s41591-020-1051-9	http://dx.doi.org/10.1038/s41591-020-1051-9		AUG 2020	17	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	NX8MD	32511562	Green Accepted, Bronze			2022-12-27	WOS:000562338700004
J	Zost, SJ; Gilchuk, P; Chen, RE; Case, JB; Reidy, JX; Trivette, A; Nargi, RS; Sutton, RE; Suryadevara, N; Chen, EC; Binshtein, E; Shrihari, S; Ostrowski, M; Chu, HY; Didier, JE; MacRenaris, KW; Jones, T; Day, S; Myers, L; Lee, FEH; Nguyen, DC; Sanz, I; Martinez, DR; Rothlauf, PW; Bloyet, LM; Whelan, SPJ; Baric, RS; Thackray, LB; Diamond, MS; Carnahan, RH; Crowe, JE				Zost, Seth J.; Gilchuk, Pavlo; Chen, Rita E.; Case, James Brett; Reidy, Joseph X.; Trivette, Andrew; Nargi, Rachel S.; Sutton, Rachel E.; Suryadevara, Naveenchandra; Chen, Elaine C.; Binshtein, Elad; Shrihari, Swathi; Ostrowski, Mario; Chu, Helen Y.; Didier, Jonathan E.; MacRenaris, Keith W.; Jones, Taylor; Day, Samuel; Myers, Luke; Eun-Hyung Lee, F.; Nguyen, Doan C.; Sanz, Ignacio; Martinez, David R.; Rothlauf, Paul W.; Bloyet, Louis-Marie; Whelan, Sean P. J.; Baric, Ralph S.; Thackray, Larissa B.; Diamond, Michael S.; Carnahan, Robert H.; Crowe, James E., Jr.			Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein	NATURE MEDICINE			English	Article							RESPIRATORY SYNDROME CORONAVIRUS; LENGTH INFECTIOUS CDNA; SARS CORONAVIRUS; MERS-COV; NEUTRALIZING ANTIBODIES; POTENT NEUTRALIZATION; STRUCTURAL DEFINITION; REVERSE GENETICS; EPITOPE	Antibodies are a principal determinant of immunity for most RNA viruses and have promise to reduce infection or disease during major epidemics. The novel coronavirus SARS-CoV-2 has caused a global pandemic with millions of infections and hundreds of thousands of deaths to date(1,2). In response, we used a rapid antibody discovery platform to isolate hundreds of human monoclonal antibodies (mAbs) against the SARS-CoV-2 spike (S) protein. We stratify these mAbs into five major classes on the basis of their reactivity to subdomains of S protein as well as their cross-reactivity to SARS-CoV. Many of these mAbs inhibit infection of authentic SARS-CoV-2 virus, with most neutralizing mAbs recognizing the receptor-binding domain (RBD) of S. This work defines sites of vulnerability on SARS-CoV-2 S and demonstrates the speed and robustness of advanced antibody discovery platforms. A platform for rapid antibody discovery enabled the isolation of hundreds of human monoclonal antibodies against SARS-CoV-2 and the prioritization of potent antibody candidates for clinical trials in patients with COVID-19.	[Zost, Seth J.; Gilchuk, Pavlo; Reidy, Joseph X.; Trivette, Andrew; Nargi, Rachel S.; Sutton, Rachel E.; Suryadevara, Naveenchandra; Binshtein, Elad; Jones, Taylor; Day, Samuel; Myers, Luke; Carnahan, Robert H.; Crowe, James E., Jr.] Vanderbilt Univ, Med Ctr, Vanderbilt Vaccine Ctr, Nashville, TN 37232 USA; [Chen, Rita E.; Diamond, Michael S.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO USA; [Chen, Rita E.; Case, James Brett; Shrihari, Swathi; Thackray, Larissa B.; Diamond, Michael S.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; [Chen, Elaine C.; Crowe, James E., Jr.] Vanderbilt Univ, Med Ctr, Dept Pathol Microbiol & Immunol, Nashville, TN 37232 USA; [Ostrowski, Mario] Univ Toronto, Dept Med, Toronto, ON, Canada; [Chu, Helen Y.] Univ Washington, Div Allergy & Infect Dis, Seattle, WA 98195 USA; [Didier, Jonathan E.; MacRenaris, Keith W.] Berkeley Lights Inc, Emeryville, CA USA; [Eun-Hyung Lee, F.; Nguyen, Doan C.; Sanz, Ignacio] Emory Univ, Dept Med, Atlanta, GA 30322 USA; [Martinez, David R.; Baric, Ralph S.] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC 27515 USA; [Rothlauf, Paul W.; Whelan, Sean P. J.] Harvard Med Sch, Program Virol, Boston, MA 02115 USA; [Rothlauf, Paul W.; Bloyet, Louis-Marie; Whelan, Sean P. J.; Diamond, Michael S.] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA; [Diamond, Michael S.] Washington Univ, Sch Med, Andrew M & Jane M Bursky Ctr Human Immunol, St Louis, MO USA; [Diamond, Michael S.] Washington Univ, Sch Med, Immunotherapy Programs, St Louis, MO USA; [Carnahan, Robert H.; Crowe, James E., Jr.] Vanderbilt Univ, Med Ctr, Dept Pediat, Nashville, TN 37232 USA	Vanderbilt University; Washington University (WUSTL); Washington University (WUSTL); Vanderbilt University; University of Toronto; University of Washington; University of Washington Seattle; Emory University; University of North Carolina; University of North Carolina Chapel Hill; Harvard University; Harvard Medical School; Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Vanderbilt University	Carnahan, RH; Crowe, JE (corresponding author), Vanderbilt Univ, Med Ctr, Vanderbilt Vaccine Ctr, Nashville, TN 37232 USA.; Crowe, JE (corresponding author), Vanderbilt Univ, Med Ctr, Dept Pathol Microbiol & Immunol, Nashville, TN 37232 USA.; Carnahan, RH; Crowe, JE (corresponding author), Vanderbilt Univ, Med Ctr, Dept Pediat, Nashville, TN 37232 USA.	robert.carnahan@vumc.org; james.crowe@vumc.org	Bloyet, Louis-Marie/AAB-6244-2022; Crowe, James/B-5549-2009; Suryadevara, Naveenchandra/AAQ-7626-2021; Carnahan, Robert H/N-7429-2013; martinez, david/GQI-0849-2022	Bloyet, Louis-Marie/0000-0002-5648-3190; Crowe, James/0000-0002-0049-1079; Carnahan, Robert H/0000-0001-5230-1532; suryadevara, naveenchandra/0000-0003-2571-1290; Binshtein, Elad/0000-0003-2745-104X; Myers, Luke/0000-0003-1132-2550; Shrihari, Swathi/0000-0002-8188-6936; Zost, Seth/0000-0001-6712-5076; Chen, Elaine/0000-0001-7883-8039	Defense Advanced Research Projects Agency (DARPA) [HR0011-18-2-0001]; NIH [T32 AI007151, 75N93019C00074, 75N93019C00062, 1S10RR028106-01A1, T32 AI095202]; Dolly Parton COVID-19 Research Fund at Vanderbilt; National Center for Advancing Translational Sciences [2 UL1 TR000445-06]; Helen Hay Whitney Foundation postdoctoral fellowship; Burroughs Wellcome Fund Postdoctoral Enrichment Program Award; 2019 Future Insight Prize from Merck KGaA	Defense Advanced Research Projects Agency (DARPA)(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dolly Parton COVID-19 Research Fund at Vanderbilt; National Center for Advancing Translational Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Helen Hay Whitney Foundation postdoctoral fellowship; Burroughs Wellcome Fund Postdoctoral Enrichment Program Award(Burroughs Wellcome Fund); 2019 Future Insight Prize from Merck KGaA	We thank M. Mayo and N. S. Galeano for coordination of human studies, D. O'Connor, N. Safdar, G. Baird, J. Shendure and S. Mubareka for helpful advice on human patients, A. Jones and the staff of the Vanderbilt VANTAGE core laboratory for expedited sequencing, R. Trosseth for assistance with data management and analysis, R. Bombardi and C. Soto for technical consultation on genomics approaches, A. Kim for production of a recombinant form of the mAb CR3022, C. Swearingen and the staff of Fedex Express Specialty Services for expedited transport services, V. Pai and K. Breinlinger of Berkeley Lights, and K. Louder and scientists at Twist Bioscience, B. Fritz at 10x Genomics and representatives at ACEA Biosciences for providing resources, outstanding expedited services and expert applications support. We thank A. Ward, S. Bangaru, P. McTamney, K. Ren and A. Barnes for protein reagents. This study was supported by Defense Advanced Research Projects Agency (DARPA) grant HR0011-18-2-0001, NIH contracts 75N93019C00074 and 75N93019C00062 and the Dolly Parton COVID-19 Research Fund at Vanderbilt. This work was supported by NIH grant 1S10RR028106-01A1 for the Next Generation Nucleic Acid Sequencer, housed in Vanderbilt Technologies for Advanced Genomics (VANTAGE) and supported by the National Center for Research Resources, grant UL1 RR024975-01, and is now at the National Center for Advancing Translational Sciences, grant 2 UL1 TR000445-06. S.J.Z. was supported by NIH T32 AI095202. J.B.C. is supported by a Helen Hay Whitney Foundation postdoctoral fellowship. D.R.M. was supported by NIH T32 AI007151 and a Burroughs Wellcome Fund Postdoctoral Enrichment Program Award. J.E.C. is the recipient of the 2019 Future Insight Prize from Merck KGaA, which supported this research with a research grant. The content is solely the responsibility of the authors and does not necessarily represent the official views of the US government or the other sponsors.	Bepler T., 2019, TOPAZ DENOISE GEN DE, DOI [10.1101/838920, DOI 10.1101/838920]; Brouwer PJM, 2020, SCIENCE, V369, P643, DOI 10.1126/science.abc5902; Cao Y., 2020, CELL, DOI [10.1016/j.cell.2020.05.025, DOI 10.1016/J.CELL.2020.05.025(2020)]; Case James Brett, 2020, bioRxiv, DOI 10.1101/2020.05.18.102038; Chen Z, 2017, J INFECT DIS, V215, P1807, DOI 10.1093/infdis/jix209; Chng J, 2015, MABS-AUSTIN, V7, P403, DOI 10.1080/19420862.2015.1008351; Choi JH, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0232757; Corti D, 2015, P NATL ACAD SCI USA, V112, P10473, DOI 10.1073/pnas.1510199112; Davis CW, 2019, CELL, V177, P1566, DOI 10.1016/j.cell.2019.04.036; Gilchuk P, NAT BIOMED ENG; Gilchuk P, 2020, IMMUNITY, V52, P388, DOI 10.1016/j.immuni.2020.01.001; Guthmiller JJ, 2019, METHODS MOL BIOL, V1904, P109, DOI 10.1007/978-1-4939-8958-4_5; Holshue ML, 2020, NEW ENGL J MED, V382, P929, DOI 10.1056/NEJMoa2001191; Jiang LW, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008140; Jiang SB, 2020, TRENDS IMMUNOL, V41, P355, DOI 10.1016/j.it.2020.03.007; Ju B, 2020, NATURE, V584, P115, DOI 10.1038/s41586-020-2380-z; Lan J, 2020, NATURE, V581, P215, DOI 10.1038/s41586-020-2180-5; Mastronarde DN, 2005, J STRUCT BIOL, V152, P36, DOI 10.1016/j.jsb.2005.07.007; Mukherjee S, 2016, VIROLOGY, V497, P33, DOI 10.1016/j.virol.2016.06.022; Nguyen DC, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05853-7; Niu PH, 2018, J INFECT DIS, V218, P1249, DOI 10.1093/infdis/jiy311; Ohi Melanie, 2004, Biol Proced Online, V6, P23, DOI 10.1251/bpo70; Punjani A, 2017, NAT METHODS, V14, P290, DOI [10.1038/nmeth.4169, 10.1038/NMETH.4169]; Robbiani Davide F, 2020, Nature, V584, P437, DOI [10.1101/2020.05.13.092619, 10.1038/s41586-020-2456-9]; Rockx B, 2008, J VIROL, V82, P3220, DOI 10.1128/JVI.02377-07; Rogers TF, 2020, SCIENCE, V369, P956, DOI 10.1126/science.abc7520; Scobey T, 2013, P NATL ACAD SCI USA, V110, P16157, DOI 10.1073/pnas.1311542110; Shi R, 2020, NATURE, V584, P120, DOI 10.1038/s41586-020-2381-y; Soto C.F.J., BMC BIOINFORMATICS; Soto C, 2019, NATURE, V566, P398, DOI 10.1038/s41586-019-0934-8; Sui JH, 2004, P NATL ACAD SCI USA, V101, P2536, DOI 10.1073/pnas.0307140101; Tang XC, 2014, P NATL ACAD SCI USA, V111, pE2018, DOI 10.1073/pnas.1402074111; ter Meulen J, 2004, LANCET, V363, P2139, DOI 10.1016/S0140-6736(04)16506-9; ter Meulen J, 2006, PLOS MED, V3, P1071, DOI 10.1371/journal.pmed.0030237; Walls AC, 2020, CELL, V181, P281, DOI [10.1016/j.cell.2020.02.058, 10.1016/j.cell.2020.11.032]; Wang L, 2018, J VIROL, V92, DOI 10.1128/JVI.01060-18; Wang NS, 2019, CELL REP, V28, P3395, DOI 10.1016/j.celrep.2019.08.052; Wec AZ, 2020, SCIENCE, V369, P731, DOI 10.1126/science.abc7424; Williamson LE, 2019, J VIROL, V93, DOI 10.1128/JVI.01439-18; Wrammert J, 2011, J EXP MED, V208, P181, DOI 10.1084/jem.20101352; Wrapp D, 2020, SCIENCE, V367, P1260, DOI [10.1101/2020.02.11.944462, 10.1126/science.abb2507]; Wu Y, 2020, SCIENCE, V368, P1274, DOI 10.1126/science.abc2241; Ying TL, 2014, J VIROL, V88, P7796, DOI 10.1128/JVI.00912-14; Yount B, 2003, P NATL ACAD SCI USA, V100, P12995, DOI 10.1073/pnas.1735582100; Zhang SY, 2018, CELL REP, V24, P441, DOI 10.1016/j.celrep.2018.06.041; Zhou P, 2020, NATURE, V588, pE6, DOI [10.1038/s41586-020-2951-z, 10.1038/s41586-020-2012-7]; Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017; Zhu ZY, 2007, P NATL ACAD SCI USA, V104, P12123, DOI 10.1073/pnas.0701000104; Zost S. J., NATURE	49	224	234	11	23	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	SEP	2020	26	9								10.1038/s41591-020-0998-x	http://dx.doi.org/10.1038/s41591-020-0998-x		JUL 2020	20	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	PF3EM	32511414	Green Accepted, Green Published, Green Submitted, Bronze			2022-12-27	WOS:000547236500001
J	Amanat, F; Stadlbauer, D; Strohmeier, S; Nguyen, THO; Chromikova, V; McMahon, M; Jiang, KJ; Arunkumar, GA; Jurczyszak, D; Polanco, J; Bermudez-Gonzalez, M; Kleiner, G; Aydillo, T; Miorin, L; Fierer, DS; Lugo, LA; Kojic, EM; Stoever, J; Liu, STH; Cunningham-Rundles, C; Felgner, PL; Moran, T; Garcia-Sastre, A; Caplivski, D; Cheng, ALC; Kedzierska, K; Vapalahti, O; Hepojoki, JM; Simon, V; Krammer, F				Amanat, Fatima; Stadlbauer, Daniel; Strohmeier, Shirin; Nguyen, Thi H. O.; Chromikova, Veronika; McMahon, Meagan; Jiang, Kaijun; Arunkumar, Guha Asthagiri; Jurczyszak, Denise; Polanco, Jose; Bermudez-Gonzalez, Maria; Kleiner, Giulio; Aydillo, Teresa; Miorin, Lisa; Fierer, Daniel S.; Lugo, Luz Amarilis; Kojic, Erna Milunka; Stoever, Jonathan; Liu, Sean T. H.; Cunningham-Rundles, Charlotte; Felgner, Philip L.; Moran, Thomas; Garcia-Sastre, Adolfo; Caplivski, Daniel; Cheng, Allen C.; Kedzierska, Katherine; Vapalahti, Olli; Hepojoki, Jussi M.; Simon, Viviana; Krammer, Florian			A serological assay to detect SARS-CoV-2 seroconversion in humans	NATURE MEDICINE			English	Article							SARS CORONAVIRUS; BINDING; ANTIBODIES; PROTEIN	Development of an enzyme-linked immunosorbent assay to detect antibodies to the SARS-CoV-2 spike protein in human sera and plasma. Here, we describe a serological enzyme-linked immunosorbent assay for the screening and identification of human SARS-CoV-2 seroconverters. This assay does not require the handling of infectious virus, can be adjusted to detect different antibody types in serum and plasma and is amenable to scaling. Serological assays are of critical importance to help define previous exposure to SARS-CoV-2 in populations, identify highly reactive human donors for convalescent plasma therapy and investigate correlates of protection.	[Amanat, Fatima; Stadlbauer, Daniel; Strohmeier, Shirin; Chromikova, Veronika; McMahon, Meagan; Jiang, Kaijun; Arunkumar, Guha Asthagiri; Jurczyszak, Denise; Polanco, Jose; Bermudez-Gonzalez, Maria; Kleiner, Giulio; Aydillo, Teresa; Miorin, Lisa; Liu, Sean T. H.; Moran, Thomas; Garcia-Sastre, Adolfo; Simon, Viviana; Krammer, Florian] Icahn Sch Med Mt Sinai, Dept Microbiol, New York, NY 10029 USA; [Amanat, Fatima; Arunkumar, Guha Asthagiri; Jurczyszak, Denise] Icahn Sch Med Mt Sinai, Grad Sch Biomed Sci, New York, NY 10029 USA; [Strohmeier, Shirin] Univ Nat Resources & Life Sci, Dept Biotechnol, Vienna, Austria; [Nguyen, Thi H. O.; Kedzierska, Katherine] Univ Melbourne, Peter Doherty Inst Infect & Immun, Dept Microbiol & Immunol, Melbourne, Vic, Australia; [Polanco, Jose] Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY 10029 USA; [Aydillo, Teresa; Miorin, Lisa; Simon, Viviana] Icahn Sch Med Mt Sinai, Global Hlth & Emerging Pathogens Inst, New York, NY 10029 USA; [Fierer, Daniel S.; Lugo, Luz Amarilis; Kojic, Erna Milunka; Simon, Viviana] Icahn Sch Med Mt Sinai, Div Infect Dis, Dept Med, New York, NY 10029 USA; [Stoever, Jonathan] Icahn Sch Med Mt Sinai, Div Pulm Crit Care & Sleep Med, New York, NY 10029 USA; [Liu, Sean T. H.] Mt Sinai Queens, Dept Med, Astoria, NY USA; [Liu, Sean T. H.] Mt Sinai Hlth Syst, Hosp Med, New York, NY USA; [Cunningham-Rundles, Charlotte] Icahn Sch Med Mt Sinai, Div Clin Immunol, Dept Med, New York, NY 10029 USA; [Cunningham-Rundles, Charlotte] Icahn Sch Med Mt Sinai, Dept Pediat, New York, NY 10029 USA; [Felgner, Philip L.] Univ Calif Irvine, Dept Physiol & Biophys, Irvine, CA USA; [Garcia-Sastre, Adolfo] Icahn Sch Med Mt Sinai, Tisch Canc Inst, New York, NY 10029 USA; [Fierer, Daniel S.; Caplivski, Daniel] Icahn Sch Med Mt Sinai, Travel Med Program, Div Infect Dis, New York, NY 10029 USA; [Cheng, Allen C.] Monash Univ, Sch Publ Hlth & Prevent Med, Melbourne, Vic, Australia; [Cheng, Allen C.] Alfred Hlth, Infect Prevent & Healthcare Epidemiol Unit, Melbourne, Vic, Australia; [Vapalahti, Olli; Hepojoki, Jussi M.] Univ Helsinki, Dept Virol, Medicum, Helsinki, Finland; [Vapalahti, Olli] Univ Helsinki, Fac Vet, Vet Biosci, Helsinki, Finland; [Vapalahti, Olli] Helsinki Univ Hosp HUSLAB, Dept Virol & Immunol, Helsinki, Finland; [Hepojoki, Jussi M.] Univ Zurich, Vetsuisse Fac, Inst Vet Pathol, Zurich, Switzerland	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; University of Natural Resources & Life Sciences, Vienna; University of Melbourne; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; University of California System; University of California Irvine; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Monash University; University of Helsinki; University of Helsinki; University of Zurich	Krammer, F (corresponding author), Icahn Sch Med Mt Sinai, Dept Microbiol, New York, NY 10029 USA.	florian.krammer@mssm.edu	simon, viviana/A-9131-2008; Arunkumar, Guha Asthagiri/J-6238-2019; Aydillo Gomez, Teresa Allende/W-4439-2019; Hepojoki, Jussi/W-4667-2017; Stadlbauer, Daniel/AAV-7433-2020; Krammer, Florian/H-3237-2019	simon, viviana/0000-0002-6416-5096; Arunkumar, Guha Asthagiri/0000-0003-3665-2708; Aydillo Gomez, Teresa Allende/0000-0003-3086-1058; Hepojoki, Jussi/0000-0001-5699-214X; Stadlbauer, Daniel/0000-0001-6792-7650; Krammer, Florian/0000-0003-4121-776X; Vapalahti, Olli/0000-0003-2270-6824; Jiang, Kaijun/0000-0002-3607-2220; Jurczyszak, Denise/0000-0003-4634-5672; Fierer, Daniel/0000-0002-3427-8022; Kleiner, Giulio/0000-0002-1830-3961; Liu, Sean/0000-0002-3842-6838	Mount Sinai Health System Translational Science Hub 'ConduITS' (NIH) [U54TR001433]; NIAID Centers of Excellence for Influenza Research and Surveillance (CEIRS) [HHSN272201400008C]; Collaborative Influenza Vaccine Innovation Centers (CIVIC) [75N93019C00051]; Open Philanthropy; Australian National Health and Medical Research Council (NHMRC) [1071916, 1102792]; Academy of Finland; Jane and Aatos Erkko Foundation; Helsinki University Hospital Funds	Mount Sinai Health System Translational Science Hub 'ConduITS' (NIH); NIAID Centers of Excellence for Influenza Research and Surveillance (CEIRS); Collaborative Influenza Vaccine Innovation Centers (CIVIC); Open Philanthropy; Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Academy of Finland(Academy of Finland); Jane and Aatos Erkko Foundation; Helsinki University Hospital Funds	We thank Y.-Z. Zhang (Fudan University) and E. Holmes (University of Sydney) for sharing the sequence of the first SARS-CoV-2 isolate in a very timely manner. We thank J. Garlick and J. Roney (Alfred Hospital, Melbourne) for data and specimen collection, N. Aboelregal for making many different NHIG products (Mount Sinai) available and L. Martinez-Sobrido (Texas Biomedical Research Institute) for initially characterizing mAb 1C7. We are also thankful to Genewiz for speeding up gene synthesis for this project, and for being very accommodating to our needs. Furthermore, we thank D. Tidmore for help with ordering primers quickly, and finally S. Dong for commuting to New Jersey on several occasions to pick up reagents from Genewiz. We also thank the Mount Sinai Health System Translational Science Hub 'ConduITS' (NIH grant U54TR001433) for supporting sample collection. The work of the Personalized Virology Initiative is supported by institutional funds and philanthropic donations. This work was partially supported by the NIAID Centers of Excellence for Influenza Research and Surveillance (CEIRS; contract HHSN272201400008C to F.K. and A.G.-S.), the Collaborative Influenza Vaccine Innovation Centers (CIVIC; contract 75N93019C00051 to F.K. and A.G.-S.), Open Philanthropy, the Australian National Health and Medical Research Council (NHMRC Program Grant 1071916 and NHMRC Research Fellowship Level B (1102792) to K.K.), the Academy of Finland to O.V. and J.M.H., as well as Jane and Aatos Erkko Foundation and Helsinki University Hospital Funds to O.V. Furthermore, we thank our generous community for providing essential funds and support for our SARS-CoV-2 and COVID-19 research efforts. The following reagent was deposited by the Centers for Disease Control and Prevention and obtained through BEI Resources, NIAID, NIH: SARS-Related Coronavirus 2, Isolate USA-WA1/2020, NR-52281. Finally, we thank all of the study participants for their contribution to the research. We wish the patients with COVID-19 a speedy recovery.	Amanat F, 2019, EMERG MICROBES INFEC, V8, P155, DOI 10.1080/22221751.2018.1564369; Amanat F, 2018, MSPHERE, V3, DOI 10.1128/mSphere.00189-18; Berry JD, 2010, MABS-AUSTIN, V2, P53, DOI 10.4161/mabs.2.1.10788; Gonzalez-Reiche Ana S., 2020, SCIENCE, DOI [10.1101/2020.03.24.006544, 10.1101/2020.04.08.20056929., 10.1126/science.abc1917]; Haveri A, 2020, EUROSURVEILLANCE, V25, P16, DOI 10.2807/1560-7917.ES.2020.25.11.2000266; Huang Angkana T, 2020, Nat Commun, V11, P4704, DOI [10.1101/2020.04.14.20065771, 10.1038/s41467-020-18450-4]; Khan Saahir, 2020, bioRxiv, DOI 10.1101/2020.03.24.006544; Kirchdoerfer RN, 2016, NATURE, V531, P118, DOI 10.1038/nature17200; Krammer F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043603; Letko M, 2020, NAT MICROBIOL, V5, P562, DOI [10.1038/s41564-020-0688-y, 10.1101/2020.01.22.915660]; Li F, 2005, SCIENCE, V309, P1864, DOI 10.1126/science.1116480; Li Q., 2020, NEW ENGL J MED, V382, P1199; Margine I, 2013, JOVE-J VIS EXP, DOI 10.3791/51112; Okba NMA, 2020, EMERG INFECT DIS, V26, P1478, DOI 10.3201/eid2607.200841; Pallesen J, 2017, P NATL ACAD SCI USA, V114, pE7348, DOI 10.1073/pnas.1707304114; Rajendran M, 2017, MBIO, V8, DOI [10.1128/mBio.02281-16, 10.1128/mbio.02281-16]; Shen CG, 2020, JAMA-J AM MED ASSOC, V323, P1582, DOI 10.1001/jama.2020.4783; Stadlbauer Daniel, 2020, Curr Protoc Microbiol, V57, pe100, DOI 10.1002/cpmc.100; ter Meulen J, 2006, PLOS MED, V3, P1071, DOI 10.1371/journal.pmed.0030237; Tian XL, 2020, EMERG MICROBES INFEC, V9, P382, DOI 10.1080/22221751.2020.1729069; Walls AC, 2020, CELL, V181, P281, DOI [10.1016/j.cell.2020.02.058, 10.1016/j.cell.2020.11.032]; Wohlbold TJ, 2017, NAT MICROBIOL, V2, P1415, DOI 10.1038/s41564-017-0011-8; Wrapp D, 2020, SCIENCE, V367, P1260, DOI [10.1101/2020.02.11.944462, 10.1126/science.abb2507]; Wu F, 2020, NATURE, V579, P265, DOI 10.1038/s41586-020-2008-3; Yuan J, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.4467	25	975	988	18	57	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	JUL	2020	26	7					1033	+		10.1038/s41591-020-0913-5	http://dx.doi.org/10.1038/s41591-020-0913-5		MAY 2020	12	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	MK3XO	32511441	Green Submitted, Green Accepted, Green Published, Bronze			2022-12-27	WOS:000532113900001
J	Wilk, AJ; Rustagi, A; Zhao, NQ; Roque, J; Martinez-Colon, GJ; McKechnie, JL; Ivison, GT; Ranganath, T; Vergara, R; Hollis, T; Simpson, LJ; Grant, P; Subramanian, A; Rogers, AJ; Blish, CA				Wilk, Aaron J.; Rustagi, Arjun; Zhao, Nancy Q.; Roque, Jonasel; Martinez-Colon, Giovanny J.; McKechnie, Julia L.; Ivison, Geoffrey T.; Ranganath, Thanmayi; Vergara, Rosemary; Hollis, Taylor; Simpson, Laura J.; Grant, Philip; Subramanian, Aruna; Rogers, Angela J.; Blish, Catherine A.			A single-cell atlas of the peripheral immune response in patients with severe COVID-19	NATURE MEDICINE			English	Article							FC-GAMMA RECEPTORS; NK CELLS; NEUTROPHILS	There is an urgent need to better understand the pathophysiology of Coronavirus disease 2019 (COVID-19), the global pandemic caused by SARS-CoV-2, which has infected more than three million people worldwide(1). Approximately 20% of patients with COVID-19 develop severe disease and 5% of patients require intensive care(2). Severe disease has been associated with changes in peripheral immune activity, including increased levels of pro-inflammatory cytokines(3,4) that may be produced by a subset of inflammatory monocytes(5,6), lymphopenia(7,8) and T cell exhaustion(9,10). To elucidate pathways in peripheral immune cells that might lead to immunopathology or protective immunity in severe COVID-19, we applied single-cell RNA sequencing (scRNA-seq) to profile peripheral blood mononuclear cells (PBMCs) from seven patients hospitalized for COVID-19, four of whom had acute respiratory distress syndrome, and six healthy controls. We identify reconfiguration of peripheral immune cell phenotype in COVID-19, including a heterogeneous interferon-stimulated gene signature, HLA class II downregulation and a developing neutrophil population that appears closely related to plasmablasts appearing in patients with acute respiratory failure requiring mechanical ventilation. Importantly, we found that peripheral monocytes and lymphocytes do not express substantial amounts of pro-inflammatory cytokines. Collectively, we provide a cell atlas of the peripheral immune response to severe COVID-19. Single-cell transcriptomic analysis identifies changes in peripheral immune cells in seven hospitalized patients with COVID-19, including HLA class II downregulation, a heterogeneous interferon-stimulated gene signature and low pro-inflammatory cytokine gene expression in monocytes and lymphocytes.	[Wilk, Aaron J.; Blish, Catherine A.] Stanford Univ, Sch Med, Stanford Med Scientist Training Program, Stanford, CA 94305 USA; [Wilk, Aaron J.; Zhao, Nancy Q.; McKechnie, Julia L.; Ivison, Geoffrey T.] Stanford Univ, Sch Med, Stanford Immunol Program, Stanford, CA 94305 USA; [Rustagi, Arjun; Roque, Jonasel; Martinez-Colon, Giovanny J.; Ranganath, Thanmayi; Vergara, Rosemary; Hollis, Taylor; Simpson, Laura J.; Grant, Philip; Subramanian, Aruna; Rogers, Angela J.; Blish, Catherine A.] Stanford Univ, Dept Med, Sch Med, Stanford, CA 94305 USA; [Blish, Catherine A.] Chan Zuckerberg Biohub, San Francisco, CA USA	Stanford University; Stanford University; Stanford University	Blish, CA (corresponding author), Stanford Univ, Sch Med, Stanford Med Scientist Training Program, Stanford, CA 94305 USA.; Rogers, AJ; Blish, CA (corresponding author), Stanford Univ, Dept Med, Sch Med, Stanford, CA 94305 USA.; Blish, CA (corresponding author), Chan Zuckerberg Biohub, San Francisco, CA USA.	ajrogers@stanford.edu; cblish@stanford.edu	Ranganath, Thanmayi/N-8616-2019	Ranganath, Thanmayi/0000-0001-9865-2119; Wilk, Aaron/0000-0003-1430-5852; Rogers, Angela/0000-0001-6969-6200; Martinez-Colon, Giovanny/0000-0001-6792-8004; Zhao, Nancy/0000-0001-6217-854X; Ivison, Geoffrey/0000-0002-3612-0069; Blish, Catherine/0000-0001-6946-7627; Rustagi, Arjun/0000-0002-6921-1012; Subramanian, Aruna/0000-0002-1373-6768	NIH/NHLBI [K23 HL125663]; Stanford Medical Scientist Training Program [T32 GM007365-44]; Stanford Bio-X Interdisciplinary Graduate Fellowship; Applied Genomics in Infectious Diseases [T32 AI007502-23]; National Science Scholarship from A*STAR Singapore; National Science Foundation Graduate Research Fellowship [DGE-1656518]; NIH [T32 AI007290-35]; NIH/NIDA [DP1 DA04608902]; Bill & Melinda Gates Foundation; Burroughs Wellcome Fund Investigators in the Pathogenesis of Infectious Diseases [1016687]	NIH/NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Stanford Medical Scientist Training Program; Stanford Bio-X Interdisciplinary Graduate Fellowship; Applied Genomics in Infectious Diseases; National Science Scholarship from A*STAR Singapore; National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); Burroughs Wellcome Fund Investigators in the Pathogenesis of Infectious Diseases(Burroughs Wellcome Fund)	We are grateful to all participants in this study. We thank S. Sim and the Stanford Functional Genomics Facility for the use of the Fragment Analyzer, as well as A. Detweiler and M. Tan at the Chan Zuckerberg Biohub for assistance with sequencing. We also thank the Stanford Research Computing Center for providing invaluable computational resources for data analysis. We are also grateful to K. Fetters for critical reading of the manuscript. The Stanford ICU Biobank and A.J.R. are funded by NIH/NHLBI K23 HL125663. A.J.W. is supported by the Stanford Medical Scientist Training Program (T32 GM007365-44) and the Stanford Bio-X Interdisciplinary Graduate Fellowship. A.R. is supported by Applied Genomics in Infectious Diseases training grant no. T32 AI007502-23. N.Q.Z. is supported by a National Science Scholarship from A*STAR Singapore. J.L.M. is supported by National Science Foundation Graduate Research Fellowship DGE-1656518. J.L.M. and G.I. are supported by NIH training grant no. T32 AI007290-35. C.A.B. is supported by NIH/NIDA DP1 DA04608902, a 2019 Sentinel Pilot Project from the Bill & Melinda Gates Foundation, and Burroughs Wellcome Fund Investigators in the Pathogenesis of Infectious Diseases #1016687. C.A.B. is the Tashia and John Morgridge Faculty Scholar in Pediatric Translational Medicine from the Stanford Maternal Child Health Research Institute and an Investigator of the Chan Zuckerberg Biohub. This study was approved by the Stanford Institutional Review Board (IRB-28205 and IRB-26571).	Aran D, 2019, NAT IMMUNOL, V20, P163, DOI 10.1038/s41590-018-0276-y; Balamurugan K, 2013, INT J BIOL SCI, V9, P917, DOI 10.7150/ijbs.7224; Bergen V, 2019, GEN RNA VELOCITY TRA, P820936; Blanco-Melo D, 2020, CELL, V181, P1036, DOI 10.1016/j.cell.2020.04.026; Butler A, 2018, NAT BIOTECHNOL, V36, P411, DOI 10.1038/nbt.4096; Caligiuri MA, 2008, BLOOD, V112, P461, DOI 10.1182/blood-2007-09-077438; Carter RA, 2018, CURR BIOL, V28, P2910, DOI 10.1016/j.cub.2018.07.062; Cassatella MA, 2019, TRENDS IMMUNOL, V40, P648, DOI 10.1016/j.it.2019.05.003; Cirovic B, 2017, STEM CELL REP, V8, P346, DOI 10.1016/j.stemcr.2016.12.015; Diao B, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.00827; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dong ES, 2020, LANCET INFECT DIS, V20, P533, DOI 10.1016/S1473-3099(20)30120-1; Ericson JA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108553; Evrard M, 2018, IMMUNITY, V48, P364, DOI 10.1016/j.immuni.2018.02.002; Fan XX, 2021, J INVEST SURG, V34, P826, DOI 10.1080/08941939.2019.1698679; Freytag Saskia, 2018, F1000Res, V7, P1297, DOI 10.12688/f1000research.15809.2; Giamarellos-Bourboulis EJ, 2020, CELL HOST MICROBE, V27, P992, DOI 10.1016/j.chom.2020.04.009; Gierahn TM, 2017, NAT METHODS, V14, P395, DOI 10.1038/nmeth.4179; Gordon CJ, 2020, J BIOL CHEM, V295, P6785, DOI 10.1074/jbc.RA120.013679; Guan W, 2020, NEW ENGL J MED, V382, P1708, DOI 10.1056/NEJMoa2002032; Guo C., 2020, TOCILIZUMAB TREATMEN, DOI [10.1101/2020.04.08.029769, DOI 10.1101/2020.04.08.029769]; Gutierrez-Arcelus M, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08604-4; Hadjadj J., 2020, IMPAIRED TYPE 1 INTE, DOI [10.1101/2020.04.19.20068015v1, DOI 10.1101/2020.04.19.20068015V1]; Hughes T.K., 2019, HIGHLY EFFICIENT MAS, DOI [10.1101/689273, DOI 10.1101/689273]; Hydes T, 2018, IMMUN INFLAMM DIS, V6, P34, DOI 10.1002/iid3.190; Kang HM, 2018, NAT BIOTECHNOL, V36, P89, DOI 10.1038/nbt.4042; Kazer SW, 2020, NAT MED, V26, P511, DOI 10.1038/s41591-020-0799-2; La Manno G, 2018, NATURE, V560, P494, DOI 10.1038/s41586-018-0414-6; Le Gars M, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02469; Lekstrom-Himes JA, 2001, STEM CELLS, V19, P125, DOI 10.1634/stemcells.19-2-125; Leonard S., 2020, FLEXDOTPLOT UNIVERSA, DOI [10.1101/2020.04.03.023655v1, DOI 10.1101/2020.04.03.023655V1]; Miller BC, 2019, NAT IMMUNOL, V20, P326, DOI 10.1038/s41590-019-0312-6; Nimmerjahn F, 2006, IMMUNITY, V24, P19, DOI 10.1016/j.immuni.2005.11.010; Ong E. Z, CELL HOST MICROBE; Palmer C, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-115; Petukhov V, 2018, GENOME BIOL, V19, DOI 10.1186/s13059-018-1449-6; Poli A, 2009, IMMUNOLOGY, V126, P458, DOI 10.1111/j.1365-2567.2008.03027.x; Qin C., CLIN INFECT DIS; Ranieri VM, 2012, JAMA-J AM MED ASSOC, V307, P2526, DOI 10.1001/jama.2012.5669; Schmidt T, 2012, J LEUKOCYTE BIOL, V91, P791, DOI 10.1189/jlb.0911483; Siegel D, 2017, J MED CHEM, V60, P1648, DOI 10.1021/acs.jmedchem.6b01594; Smith SL, 2020, BLOOD ADV, V4, P1388, DOI 10.1182/bloodadvances.2019000699; Villani AC, 2017, SCIENCE, V356, DOI 10.1126/science.aah4573; Waltman L, 2013, EUR PHYS J B, V86, DOI 10.1140/epjb/e2013-40829-0; Wilk AJ, 2018, J LEUKOCYTE BIOL, V103, P629, DOI 10.1002/JLB.6RI0917-390R; Wu ZY, 2020, JAMA-J AM MED ASSOC, V323, P1239, DOI 10.1001/jama.2020.2648; Xie HF, 2004, CELL, V117, P663, DOI 10.1016/S0092-8674(04)00419-2; Xie X, 2019, SINGLE CELL TRANSCRI, DOI [10.1101/792200v1, DOI 10.1101/792200]; Yvan-Charvet L, 2019, TRENDS IMMUNOL, V40, P598, DOI 10.1016/j.it.2019.05.004; Zhang B, INFECT DIS; Zhao JJ, 2019, SURG INFECT, V20, P480, DOI 10.1089/sur.2019.041; Zheng H.-Y, CELL MOL IMMUNOL; Zhou Y, NATL SCI REV; Zhu YFPP, 2018, CELL REP, V24, P2329, DOI 10.1016/j.celrep.2018.07.097; Zimmermann P, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00302	56	583	591	18	41	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	JUL	2020	26	7					1070	+		10.1038/s41591-020-0944-y	http://dx.doi.org/10.1038/s41591-020-0944-y		JUN 2020	21	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	MK3XO	32511639	Green Accepted, Green Published, Bronze			2022-12-27	WOS:000538976400003
